data_2mou_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mou _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.0 t70 . . . . . 0 CA--C 1.508 -0.635 0 N-CA-C 108.903 -0.777 . . . . 2.25 108.903 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.517 ' CD2' HD12 ' A' ' 87' ' ' ILE . 59.1 m-85 -63.86 -33.15 75.04 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.459 0.647 . . . . 0.45 109.341 177.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.58 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 5.7 mttp -70.1 -46.63 64.45 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 115.119 -0.946 . . . . 2.06 108.498 178.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -47.49 -48.58 27.04 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 112.324 0.49 . . . . 1.2 112.324 -176.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.577 ' O ' ' HB ' ' A' ' 10' ' ' THR . 0.2 OUTLIER -82.95 -34.06 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 121.291 0.567 . . . . 1.76 110.041 -173.032 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.564 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -78.83 -42.76 26.81 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.058 -0.973 . . . . 1.11 111.767 -176.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.823 HE21 ' HH ' ' A' ' 116' ' ' TYR . 34.6 mt-30 -59.35 -32.95 70.58 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.729 -1.123 . . . . 2.14 110.103 175.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.691 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 16.3 mm-40 -79.09 -41.7 28.07 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.104 -0.953 . . . . 3.04 108.778 173.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.61 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.3 OUTLIER -63.36 -35.53 80.71 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.039 -0.982 . . . . 1.1 111.625 -176.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.443 ' O ' HG11 ' A' ' 14' ' ' VAL . . . -46.26 -63.05 1.09 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.941 0.4 . . . . 1.04 111.4 170.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.407 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 10.4 pt20 -72.69 -9.86 59.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.289 -0.414 . . . . 2.31 112.051 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.691 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 51.0 mt-10 -77.95 -50.23 12.57 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.631 -0.507 . . . . 2.54 109.631 174.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.625 HG22 ' N ' ' A' ' 152' ' ' GLY . 5.8 p -68.65 -39.42 80.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 122.049 0.928 . . . . 1.21 109.393 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.407 ' HB3' ' HA ' ' A' ' 12' ' ' GLN . 0.8 OUTLIER -66.9 -27.57 67.61 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 114.548 -1.206 . . . . 1.26 108.93 173.184 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.93 -17.86 63.69 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 113.97 -1.468 . . . . 0.57 110.662 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.5 ' CD2' ' HA ' ' A' ' 14' ' ' VAL . 17.9 m-85 -90.63 -22.65 21.11 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.089 -0.556 . . . . 3.59 109.508 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.486 ' CB ' ' HZ ' ' A' ' 170' ' ' PHE . 0.1 OUTLIER -69.67 -24.38 63.6 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 120.184 -0.607 . . . . 2.1 109.385 176.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.23 9.7 27.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.324 -0.853 . . . . 3.26 110.118 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -123.08 74.9 1.25 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.444 -0.798 . . . . 2.16 109.108 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.437 HG23 ' CH2' ' A' ' 24' ' ' TRP . 53.2 p -102.83 88.84 3.29 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.453 0.644 . . . . 2.24 111.183 -172.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.1 p -173.4 168.64 4.55 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.659 -1.155 . . . . 2.46 110.127 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.57 9.69 62.24 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 121.171 -0.538 . . . . 1.45 112.908 175.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.456 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -120.44 -158.95 0.77 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.88 0.371 . . . . 2.24 111.395 -177.521 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.51 122.37 0.35 Allowed 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.155 -0.683 . . . . 3.43 109.155 -168.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.523 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 3.1 m -65.12 124.12 19.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 122.084 0.945 . . . . 2.21 111.252 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.3 p -102.02 -24.4 4.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 113.918 -1.492 . . . . 1.83 108.84 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 17.7 tppt? -147.81 112.73 5.44 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.903 -0.59 . . . . 2.87 111.89 -174.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.465 HG21 ' HA ' ' A' ' 34' ' ' THR . 43.2 p -130.0 151.04 50.98 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.163 -0.472 . . . . 1.92 110.314 173.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.3 t -118.84 -98.85 0.45 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.27 -0.423 . . . . 2.37 110.027 174.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -144.86 17.52 1.61 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.624 0.726 . . . . 4.84 110.035 176.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.555 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 13.1 tptm -167.92 -0.6 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.677 -0.692 . . . . 2.05 110.738 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.521 ' HA ' ' O ' ' A' ' 51' ' ' GLU . 41.7 pt -136.44 154.02 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 120.951 0.405 . . . . 1.42 110.802 -176.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.465 ' HA ' HG21 ' A' ' 29' ' ' THR . 54.4 m -150.2 99.59 2.82 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.675 -0.693 . . . . 1.22 111.299 -168.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.479 HG12 ' HA ' ' A' ' 189' ' ' PRO . 9.9 t -92.48 118.77 38.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.928 -0.397 . . . . 1.52 109.928 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.523 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -118.64 124.4 47.31 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.435 0.636 . . . . 1.74 111.117 -176.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.515 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 22.4 m -95.28 122.48 38.02 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.721 -1.127 . . . . 1.72 111.037 -175.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.456 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 29.1 ttmt . . . . . 0 C--N 1.324 -0.524 0 CA-C-N 116.508 -0.315 . . . . 2.45 111.354 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.515 ' OD1' ' HB3' ' A' ' 37' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.706 0.289 . . . . 2.45 110.251 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.704 HD23 ' N ' ' A' ' 48' ' ' TYR . 6.4 tt -96.97 147.55 23.87 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.283 -0.636 . . . . 1.49 109.283 -177.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.704 ' N ' HD23 ' A' ' 47' ' ' LEU . 46.9 m-85 -117.88 124.36 48.1 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.643 -0.502 . . . . 1.52 109.643 -176.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.419 ' NH1' ' HB2' ' A' ' 51' ' ' GLU . 1.4 tmm_? -117.88 120.69 38.65 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.343 -0.39 . . . . 3.34 109.989 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.523 ' CG1' ' HB3' ' A' ' 192' ' ' LEU . 11.3 p -103.45 149.79 7.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 120.696 -0.402 . . . . 1.98 110.088 177.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.521 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 34.1 tt0 -143.63 111.36 6.01 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.914 -0.584 . . . . 1.07 110.036 -172.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.555 ' HA2' ' O ' ' A' ' 32' ' ' LYS . . . -140.73 138.86 9.23 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.323 -0.941 . . . . 0.35 112.498 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.6 mt -90.23 113.93 27.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 120.168 -0.613 . . . . 1.3 110.786 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.44 ' CD1' ' HB3' ' A' ' 199' ' ' ALA . 57.4 mt -95.89 116.53 66.29 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.627 -0.715 . . . . 1.07 109.454 175.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -61.91 64.26 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 124.381 3.388 . . . . 0.74 113.065 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.555 ' HG2' ' CG1' ' A' ' 203' ' ' ILE . 12.4 tp10 -156.84 173.43 17.0 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.656 -0.868 . . . . 1.68 108.656 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.473 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 10.2 m -81.63 142.07 49.12 Favored Pre-proline 0 N--CA 1.423 -1.796 0 N-CA-C 109.332 -0.618 . . . . 1.58 109.332 178.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 57' ' ' SER . 31.2 Cg_exo -59.08 -12.31 15.3 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 123.723 2.949 . . . . 0.74 111.038 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.9 -50.21 37.49 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.825 -1.079 . . . . 1.31 111.292 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -71.02 -27.59 63.79 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.089 -0.708 . . . . 3.78 109.089 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.692 ' O ' HD11 ' A' ' 65' ' ' LEU . 47.0 mt -62.3 -55.8 24.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.86 -1.063 . . . . 1.09 109.666 173.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.523 ' HA ' ' CD1' ' A' ' 65' ' ' LEU . 13.7 p -71.84 -1.64 14.92 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.135 0.493 . . . . 1.94 110.83 176.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -88.85 -30.25 19.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.923 -0.58 . . . . 1.32 111.141 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.693 ' CE1' ' HB3' ' A' ' 65' ' ' LEU . 6.1 p90 -90.02 -46.07 8.75 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 120.774 -0.37 . . . . 0.79 111.06 -174.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.693 ' HB3' ' CE1' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -87.56 6.97 31.76 Favored 'General case' 0 CA--C 1.517 -0.302 0 O-C-N 121.811 -0.556 . . . . 2.15 110.535 -173.545 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -48.44 -63.43 1.08 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.8 -1.091 . . . . 2.06 112.496 -167.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.448 ' O ' ' HD2' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -154.73 -85.32 0.06 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 119.433 -0.907 . . . . 4.31 112.942 -175.683 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.625 ' HB ' ' CD1' ' A' ' 81' ' ' TYR . 9.1 t -141.06 21.52 2.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.965 0.412 . . . . 1.89 111.583 -164.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -115.95 0.98 21.31 Favored Glycine 0 C--N 1.311 -0.833 0 C-N-CA 118.716 -1.707 . . . . 1.71 113.97 -164.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.554 ' O ' HG21 ' A' ' 73' ' ' THR . 6.6 p-10 179.17 -31.81 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.258 -0.645 . . . . 2.19 109.258 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.614 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 18.3 ttt180 -34.57 -59.45 0.46 Allowed 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 125.649 1.58 . . . . 3.95 111.189 176.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.462 HG21 HD11 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -88.8 -6.98 10.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.879 -1.055 . . . . 1.42 111.223 -172.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.554 HG21 ' O ' ' A' ' 70' ' ' ASP . 0.7 OUTLIER -88.21 -45.13 10.34 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 120.326 -0.549 . . . . 1.45 110.523 -171.614 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.512 ' CZ3' ' HB2' ' A' ' 198' ' ' ASN . 18.7 p-90 -102.24 1.38 35.81 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 120.54 -0.464 . . . . 0.78 110.95 -174.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.614 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 5.3 t70 -71.03 -171.07 0.51 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.878 0.846 . . . . 2.19 111.578 -175.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.598 ' HD3' ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -126.34 -29.07 3.01 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.678 -1.146 . . . . 3.68 109.217 -175.694 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.1 m -120.01 8.87 11.08 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.372 -0.831 . . . . 2.08 110.142 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 39.6 mt -108.9 155.39 20.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.99 0.424 . . . . 1.16 110.336 178.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.537 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 5.2 mm-40 -132.04 -69.37 0.6 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.54 -0.755 . . . . 2.23 111.509 -175.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.463 HG21 ' HB3' ' A' ' 79' ' ' GLN . 14.4 t -139.01 134.05 41.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.125 -0.489 . . . . 1.44 110.377 -171.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.625 ' CD1' ' HB ' ' A' ' 68' ' ' THR . 15.9 t80 -117.53 137.05 52.82 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.827 -0.434 . . . . 5.73 109.827 175.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 20.3 m120 -136.6 124.58 22.81 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.655 -0.869 . . . . 1.86 108.655 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.476 ' CG ' ' HD3' ' A' ' 86' ' ' ARG . 21.4 tpp -80.21 97.2 6.83 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.163 -0.926 . . . . 2.52 109.272 -176.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.584 HG21 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -75.65 -77.08 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.099 -0.501 . . . . 1.19 111.817 -170.557 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -136.01 103.54 5.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.984 0.421 . . . . 2.59 110.459 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.476 ' HD3' ' CG ' ' A' ' 83' ' ' MET . 85.1 mtm180 -83.95 133.7 34.69 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.204 -0.665 . . . . 2.83 109.204 175.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.615 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -86.57 -47.16 16.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.624 -0.716 . . . . 1.17 109.32 -174.449 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.402 ' CG ' ' HZ2' ' A' ' 4' ' ' LYS . 22.7 m-20 -142.15 -152.34 0.4 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.224 -0.898 . . . . 1.86 108.948 175.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.3 m -88.33 -7.86 56.04 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.039 0.385 . . . . 1.94 112.039 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -134.4 14.99 3.77 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 120.365 -0.534 . . . . 1.87 110.481 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.615 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.5 OUTLIER -136.49 103.96 5.42 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 108.09 -1.078 . . . . 1.12 108.09 -178.68 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.589 ' O ' HD12 ' A' ' 114' ' ' LEU . 10.2 m-85 -120.65 172.59 7.75 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.008 0.432 . . . . 0.52 110.224 -173.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.584 ' O ' HG21 ' A' ' 84' ' ' VAL . 42.4 mt -132.56 128.46 57.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 107.541 -1.281 . . . . 1.1 107.541 168.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.597 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 26.1 p -106.6 129.91 54.45 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.407 -0.361 . . . . 2.61 111.542 -173.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.503 ' HA ' HD13 ' A' ' 112' ' ' ILE . 4.1 t60 -94.35 90.93 6.46 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.148 -1.056 . . . . 2.17 108.148 163.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.492 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 85.3 m -108.53 109.33 20.55 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.536 -0.756 . . . . 1.19 111.787 -173.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.422 ' O ' ' HB2' ' A' ' 79' ' ' GLN . 44.7 mm -77.65 121.46 30.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.564 -0.902 . . . . 1.63 108.564 171.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.436 HG22 ' CZ ' ' A' ' 111' ' ' PHE . 14.7 t -112.55 156.51 22.53 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.689 0.757 . . . . 1.72 111.222 -176.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.537 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 20.9 mt-30 . . . . . 0 C--N 1.312 -1.033 0 CA-C-N 114.481 -1.236 . . . . 2.29 108.938 176.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 62.0 mt . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 110.337 -0.245 . . . . 1.53 110.337 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.0 m -99.06 151.38 37.36 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.66 -0.496 . . . . 1.71 109.66 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.16 147.95 10.61 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.162 2.575 . . . . 1.31 112.195 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.478 ' HG2' HG21 ' A' ' 144' ' ' ILE . 42.6 mtt180 -121.97 157.08 32.08 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.709 -0.796 . . . . 4.06 111.748 -170.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.821 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 7.1 t0 -104.48 116.74 32.63 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.276 -0.875 . . . . 1.37 109.17 174.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.492 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 13.3 m-30 -100.56 109.77 21.88 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.89 -0.506 . . . . 3.01 110.664 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.597 ' HA ' ' O ' ' A' ' 94' ' ' CYS . 24.5 mm -104.96 76.15 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 N-CA-C 109.12 -0.696 . . . . 1.2 109.12 173.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.56 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 25.7 m-20 -99.54 124.15 44.46 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.649 -0.705 . . . . 1.86 110.435 -178.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.589 HD12 ' O ' ' A' ' 92' ' ' PHE . 3.5 tp -75.74 127.19 32.51 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 108.378 -0.971 . . . . 1.08 108.378 169.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -128.62 124.51 61.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-N 115.485 -0.78 . . . . 1.08 112.133 -163.582 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.823 ' HH ' HE21 ' A' ' 8' ' ' GLN . 67.5 t80 -114.36 121.13 42.67 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.923 -1.035 . . . . 2.81 110.943 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.459 HG12 HG23 ' A' ' 127' ' ' ILE . 88.7 mt -95.72 122.31 47.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.801 -0.636 . . . . 1.53 110.438 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -131.41 134.57 46.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.964 -0.562 . . . . 1.81 111.255 -173.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.0 tpp180 -112.93 100.49 8.68 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.908 -0.587 . . . . 3.22 109.616 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -75.11 107.39 7.16 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.571 -1.27 . . . . 1.28 107.571 169.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -26.44 97.12 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 O-C-N 125.024 1.453 . . . . 2.28 113.535 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 56.7 31.89 61.1 Favored Glycine 0 CA--C 1.51 -0.22 0 CA-C-N 114.565 -1.198 . . . . 0.79 113.242 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.639 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 0.8 OUTLIER -125.95 -49.01 1.61 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.957 -0.386 . . . . 2.06 109.957 179.372 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -157.56 141.3 15.79 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 110.259 -0.275 . . . . 1.73 110.259 -178.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -120.33 85.93 2.48 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.404 -0.961 . . . . 2.07 108.404 167.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.452 ' CG1' HG11 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -97.65 144.47 10.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.29 -1.323 . . . . 1.06 112.282 -171.71 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.645 ' O ' HG13 ' A' ' 127' ' ' ILE . 2.1 pt -109.03 116.1 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 108.1 -1.074 . . . . 1.26 108.1 161.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.566 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 43.3 p -83.94 159.05 21.36 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.822 -0.807 . . . . 1.53 108.822 173.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.56 ' HB3' ' HB3' ' A' ' 113' ' ' ASP . 20.4 m -153.15 128.64 9.97 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 120.675 0.274 . . . . 1.81 111.05 -175.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.527 ' HZ1' ' HB3' ' A' ' 130' ' ' LYS . 2.9 mtpm? -128.28 121.01 28.26 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 107.929 -1.137 . . . . 2.75 107.929 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 48.0 t -63.58 100.16 0.26 Allowed 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.318 -1.364 . . . . 1.94 107.318 174.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -108.58 140.08 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.057 0 CA-C-N 114.348 -1.296 . . . . 1.64 108.691 -165.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -96.2 73.15 2.9 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.182 -0.917 . . . . 2.17 109.633 -171.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.769 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -105.38 150.87 39.44 Favored Pre-proline 0 N--CA 1.437 -1.103 0 CA-C-N 114.704 -1.134 . . . . 0.67 109.234 -174.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -76.29 -9.77 19.04 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.736 2.291 . . . . 1.66 115.224 -169.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.769 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 7.4 tp10 -73.13 -13.25 61.14 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.906 -0.405 . . . . 3.5 109.906 -172.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -152.68 120.43 3.14 Favored Pre-proline 0 N--CA 1.449 -0.487 0 N-CA-C 113.419 0.896 . . . . 6.41 113.419 174.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -99.92 134.83 0.22 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 124.046 3.164 . . . . 2.31 111.774 167.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.4 ' HG3' ' HB2' ' A' ' 145' ' ' ARG . 83.1 Cg_endo -79.23 -159.31 0.1 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.592 2.195 . . . . 1.27 112.136 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.0 p -145.48 -167.84 2.8 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.434 -0.58 . . . . 1.88 109.434 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.1 t -88.58 -19.94 25.66 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.558 -0.457 . . . . 2.43 109.813 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -77.15 -32.26 56.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.053 -0.521 . . . . 2.18 109.95 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -130.58 114.97 16.12 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 115.659 -0.701 . . . . 1.33 109.461 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.478 HG21 ' HG2' ' A' ' 109' ' ' ARG . 2.0 tp -94.36 113.92 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 109.136 -0.69 . . . . 1.4 109.136 -175.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.821 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 41.4 ttp180 -50.4 99.41 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.122 -0.945 . . . . 5.14 109.672 173.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.6 122.04 26.85 Favored Glycine 0 N--CA 1.434 -1.483 0 CA-C-N 115.068 -0.969 . . . . 1.05 111.784 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -82.16 79.42 8.66 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.876 0.846 . . . . 4.68 110.955 177.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.433 ' OD1' HG23 ' A' ' 173' ' ' THR . 17.4 m-20 -85.79 87.69 7.44 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.888 -1.505 . . . . 2.29 108.435 172.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.463 ' HB2' ' HG2' ' A' ' 172' ' ' GLN . 96.4 m-70 -58.68 150.87 55.44 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-O 118.711 -0.661 . . . . 2.95 109.367 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.61 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 50.9 Cg_exo -18.62 68.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.198 1 C-N-CA 127.055 5.17 . . . . 0.77 116.12 -173.053 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 170' ' ' PHE . 19.6 p -97.24 -173.81 2.77 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.618 -1.174 . . . . 1.97 110.413 174.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.625 ' N ' HG22 ' A' ' 14' ' ' VAL . . . -174.04 -160.65 22.69 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 120.573 -0.823 . . . . 0.55 112.044 177.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.432 ' CE1' ' HG ' ' A' ' 65' ' ' LEU . 35.4 t80 -161.57 96.08 1.03 Allowed 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.291 -1.003 . . . . 0.8 108.291 -167.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.579 ' CG2' HG12 ' A' ' 168' ' ' VAL . 2.3 m -104.15 136.24 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 121.838 0.828 . . . . 1.03 111.188 -173.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 77.6 m -115.49 112.43 22.24 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.101 -0.954 . . . . 2.3 109.048 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.459 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 6.5 m -111.21 118.5 47.6 Favored Pre-proline 0 C--N 1.32 -0.7 0 C-N-CA 120.638 -0.425 . . . . 1.45 111.762 -169.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.639 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 39.6 Cg_exo -49.88 119.65 5.07 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.265 1.977 . . . . 0.72 111.136 170.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.57 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 60.4 mmm -79.68 -163.54 0.54 Allowed 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 120.916 0.389 . . . . 1.72 111.376 -177.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.413 ' H ' ' HB3' ' A' ' 158' ' ' MET . 6.2 tp10 -68.97 -26.33 64.98 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.476 0.655 . . . . 2.63 109.978 176.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -98.88 15.51 25.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.454 -0.794 . . . . 2.05 109.251 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.508 ' HB2' ' CD ' ' A' ' 162' ' ' PRO . 41.0 m-80 23.02 -87.81 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 126.051 1.74 . . . . 2.19 115.484 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.508 ' CD ' ' HB2' ' A' ' 161' ' ' ASN . 73.5 Cg_endo -72.31 -16.7 27.89 Favored 'Trans proline' 0 C--N 1.364 1.374 0 CA-C-N 121.539 1.585 . . . . 0.86 113.147 -174.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -90.93 -35.28 14.81 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.25 -0.432 . . . . 1.34 111.181 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.57 ' O ' ' HB2' ' A' ' 158' ' ' MET . 93.8 m-85 -139.51 133.26 30.62 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.763 -0.458 . . . . 1.46 109.763 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 32.4 t -125.99 148.09 49.37 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.514 0.673 . . . . 2.05 111.092 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.566 ' HB2' ' SD ' ' A' ' 158' ' ' MET . 1.8 tppp? -96.21 102.36 14.14 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.117 -0.947 . . . . 1.4 111.235 -177.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.421 HD13 ' CZ ' ' A' ' 153' ' ' PHE . 0.5 OUTLIER -86.84 109.32 19.21 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.511 -1.222 . . . . 1.07 109.006 177.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.579 HG12 ' CG2' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -131.32 128.74 61.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.439 0.638 . . . . 1.11 111.804 177.422 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 23.1 ttt -129.79 145.16 51.57 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.808 -0.633 . . . . 1.79 110.692 -174.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.595 ' CD1' HG21 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -125.72 141.73 51.86 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.463 -0.79 . . . . 4.22 109.474 -178.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 4.3 p -150.25 137.59 13.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 120.439 -0.504 . . . . 2.01 110.512 173.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.621 ' N ' HE21 ' A' ' 172' ' ' GLN . 0.0 OUTLIER -127.4 52.67 1.8 Allowed 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 122.528 1.156 . . . . 2.66 108.358 178.214 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.433 HG23 ' OD1' ' A' ' 148' ' ' ASN . 1.8 m -56.14 148.16 18.71 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 113.492 -1.686 . . . . 2.2 112.112 -174.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 . . . . . 0 CA--C 1.533 0.302 0 CA-C-N 115.571 -0.741 . . . . 2.45 112.666 -178.245 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.43 ' HA ' ' CE ' ' A' ' 186' ' ' LYS . 27.3 mm . . . . . 0 CA--C 1.5 -0.953 0 CA-C-O 122.947 1.356 . . . . 1.69 107.979 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.65 ' HA ' ' CG2' ' A' ' 187' ' ' THR . 1.4 mp -74.05 -35.16 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.691 0 CA-C-N 112.199 -2.273 . . . . 1.77 110.149 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -57.77 -26.42 61.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.961 -1.018 . . . . 2.89 109.833 171.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.43 ' CE ' ' HA ' ' A' ' 183' ' ' ILE . 50.9 mtmt -92.76 -36.87 12.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.512 -0.767 . . . . 1.71 111.224 176.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.65 ' CG2' ' HA ' ' A' ' 184' ' ' ILE . 6.2 t -68.49 -45.71 71.63 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.259 0.466 . . . . 1.3 112.259 -172.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' MET . . . . . 0.568 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 32.3 mmt -80.05 -57.88 0.64 Allowed Pre-proline 0 N--CA 1.464 0.258 0 N-CA-C 112.712 0.634 . . . . 1.39 112.712 -173.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.663 ' O ' HG12 ' A' ' 193' ' ' VAL . 39.5 Cg_exo -58.21 -40.23 78.05 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.642 1.561 . . . . 1.15 112.163 -175.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 69.8 m -77.24 -24.54 51.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.24 -0.436 . . . . 1.95 111.111 -175.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.557 ' HB2' ' O ' ' A' ' 187' ' ' THR . 46.5 t30 -80.15 -34.9 37.29 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.66 -0.416 . . . . 1.92 110.529 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.523 ' HB3' ' CG1' ' A' ' 50' ' ' VAL . 53.9 mt -68.91 -42.95 76.17 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 120.633 0.254 . . . . 1.68 111.027 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.663 HG12 ' O ' ' A' ' 189' ' ' PRO . 2.4 m -62.38 -31.43 51.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 121.65 0.738 . . . . 1.32 109.179 176.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.26 -31.12 60.68 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.366 -1.288 . . . . 2.6 111.076 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -68.75 -28.13 66.53 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 121.348 0.594 . . . . 2.73 109.775 171.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.529 ' O ' ' HD3' ' A' ' 200' ' ' LYS . 28.7 mt -81.86 -26.09 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-O 121.255 0.55 . . . . 1.11 111.206 173.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.449 ' HA ' HD22 ' A' ' 197' ' ' LEU . 37.6 mt -72.04 -43.06 65.55 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-N 116.346 -0.388 . . . . 1.57 110.403 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.512 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 5.4 p30 -55.71 -30.68 61.54 Favored 'General case' 0 C--O 1.213 -0.856 0 N-CA-C 108.428 -0.952 . . . . 2.18 108.428 170.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.63 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -76.19 -45.42 33.32 Favored 'General case' 0 N--CA 1.428 -1.537 0 O-C-N 121.64 -0.663 . . . . 1.04 110.422 -178.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.529 ' HD3' ' O ' ' A' ' 196' ' ' ILE . 1.5 mptm? -56.29 -45.11 80.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.877 -0.601 . . . . 1.51 111.263 174.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -86.52 -37.02 18.62 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.43 -0.805 . . . . 1.94 111.421 -173.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . 0.452 ' HA3' ' CH2' ' A' ' 74' ' ' TRP . . . -68.71 -32.58 74.51 Favored Glycine 0 N--CA 1.462 0.395 0 C-N-CA 120.999 -0.619 . . . . 0.47 111.746 177.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.63 ' HB ' ' O ' ' A' ' 199' ' ' ALA . 2.4 tp -69.88 -34.96 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 110.068 -0.345 . . . . 1.16 110.068 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -89.34 -20.55 23.89 Favored 'General case' 0 C--O 1.215 -0.714 0 N-CA-C 109.305 -0.628 . . . . 3.8 109.305 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.732 0 N-CA-C 108.719 -0.845 . . . . 1.28 108.719 168.096 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.426 ' O ' HD12 ' A' ' 6' ' ' ILE . 22.6 m-20 . . . . . 0 CA--C 1.508 -0.655 0 CA-C-O 121.254 0.549 . . . . 2.25 109.745 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.757 ' HA ' HD12 ' A' ' 6' ' ' ILE . 96.4 m-85 -68.64 -30.03 68.65 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.477 -0.783 . . . . 0.45 109.056 -176.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.653 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 3.0 tppp? -70.72 -7.42 44.61 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 114.95 -1.023 . . . . 2.06 109.986 176.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.71 -42.15 10.88 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.151 0.501 . . . . 1.2 109.804 174.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.757 HD12 ' HA ' ' A' ' 3' ' ' PHE . 1.3 mp -81.82 -43.9 19.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.98 -0.748 . . . . 1.76 108.98 -172.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.734 ' HA ' ' HE3' ' A' ' 130' ' ' LYS . . . -67.68 -47.96 67.98 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.546 -1.206 . . . . 1.11 111.653 -178.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.653 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 4.3 mt-30 -63.9 -27.02 68.86 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.27 -1.332 . . . . 2.14 110.722 -176.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.463 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 27.7 mt-30 -82.45 -39.2 22.89 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.201 -0.909 . . . . 3.04 109.211 171.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 1.069 HG21 ' HZ1' ' A' ' 130' ' ' LYS . 0.5 OUTLIER -65.44 -37.67 87.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.844 -1.071 . . . . 1.1 112.401 -177.67 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.508 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -47.36 -53.05 14.77 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.132 0.419 . . . . 1.04 112.132 176.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.505 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 28.3 pt20 -79.87 -4.54 52.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.75 0.31 . . . . 2.31 111.115 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 10' ' ' THR . 70.8 mm-40 -75.98 -54.38 6.96 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.206 -0.664 . . . . 2.54 109.206 172.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.644 HG22 ' N ' ' A' ' 152' ' ' GLY . 12.6 p -70.18 -36.83 69.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 114.82 -1.082 . . . . 1.21 110.334 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.505 ' HB3' ' HA ' ' A' ' 12' ' ' GLN . 0.6 OUTLIER -69.16 -24.4 64.07 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-O 122.059 0.933 . . . . 1.26 108.869 174.785 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.45 -17.74 68.95 Favored Glycine 0 CA--C 1.501 -0.833 0 CA-C-N 113.755 -1.566 . . . . 0.57 109.967 177.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.571 ' HA ' ' CB ' ' A' ' 20' ' ' ASP . 30.8 m-85 -90.39 -23.85 20.95 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 114.755 -0.723 . . . . 3.59 109.381 176.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.525 ' HA ' ' HZ ' ' A' ' 170' ' ' PHE . 66.2 t30 -66.48 -19.74 65.86 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-O 121.452 0.644 . . . . 2.1 109.541 176.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -120.2 10.58 11.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.433 -0.803 . . . . 3.26 110.294 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.571 ' CB ' ' HA ' ' A' ' 17' ' ' TYR . 9.2 t70 -86.07 -31.58 21.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.258 -0.883 . . . . 2.16 110.773 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.422 ' HA ' ' CZ2' ' A' ' 24' ' ' TRP . 1.3 t -16.65 86.99 0.0 OUTLIER 'General case' 0 C--O 1.235 0.309 0 O-C-N 125.485 1.741 . . . . 2.24 113.733 -169.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.5 t -172.64 137.48 0.8 Allowed 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.352 -1.749 . . . . 2.46 109.068 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.37 -11.5 68.77 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.637 -0.792 . . . . 1.45 112.19 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.805 ' HA ' ' HB3' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -104.39 -160.24 0.75 Allowed 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 120.97 0.414 . . . . 2.24 110.775 -179.634 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.49 ' HE2' ' HB3' ' A' ' 25' ' ' LYS . 2.0 tmmm? -170.48 128.97 0.83 Allowed 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 115.442 -0.799 . . . . 3.43 109.18 -174.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.58 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 0.1 OUTLIER -70.35 109.3 2.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-O 121.947 0.879 . . . . 2.21 109.374 175.017 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 p -93.19 -25.07 5.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 114.172 -1.376 . . . . 1.83 109.46 -172.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.474 ' HA ' ' HD2' ' A' ' 28' ' ' LYS . 17.4 tptp -153.95 132.03 11.78 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 119.755 -0.778 . . . . 2.87 112.015 -175.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.695 ' HB ' ' HA ' ' A' ' 34' ' ' THR . 0.0 OUTLIER -152.01 152.76 32.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.236 0.541 . . . . 1.92 112.06 177.292 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 35.6 m -104.6 25.68 9.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.423 -0.808 . . . . 2.37 110.499 175.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 30' ' ' SER . 28.6 mmmt 75.53 19.0 2.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.81 -0.632 . . . . 4.84 111.911 175.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.565 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 9.3 mmtp -164.76 -30.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.795 -0.639 . . . . 2.05 110.073 175.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.887 HG21 ' HA3' ' A' ' 52' ' ' GLY . 29.7 pt -110.87 136.9 45.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 108.629 -0.878 . . . . 1.42 108.629 171.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.695 ' HA ' ' HB ' ' A' ' 29' ' ' THR . 0.2 OUTLIER -140.35 115.62 9.91 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.506 0.194 . . . . 1.22 111.206 -162.439 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.671 HG21 HG23 ' A' ' 50' ' ' VAL . 6.2 t -99.67 115.04 39.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.957 0.408 . . . . 1.52 110.563 -177.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.58 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -107.81 122.76 47.42 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.844 -0.617 . . . . 1.74 110.226 -177.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.5 t -114.73 131.46 56.76 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.908 -0.587 . . . . 1.72 112.301 -172.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.805 ' HB3' ' HA ' ' A' ' 24' ' ' TRP . 56.5 pttt . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 115.516 -0.765 . . . . 2.45 110.057 167.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.443 -0.787 0 CA-C-O 121.39 0.614 . . . . 2.45 111.311 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.521 HD21 ' HB3' ' A' ' 170' ' ' PHE . 3.1 tt -104.8 133.64 49.28 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.735 -1.209 . . . . 1.49 107.735 176.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.446 ' N ' HD22 ' A' ' 47' ' ' LEU . 22.7 m-85 -117.54 124.42 48.67 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.959 -0.386 . . . . 1.52 109.959 -175.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.596 ' HD3' ' CH2' ' A' ' 24' ' ' TRP . 11.6 ttp180 -105.43 116.99 32.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.01 -0.541 . . . . 3.34 109.769 175.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.671 HG23 HG21 ' A' ' 35' ' ' VAL . 8.8 p -100.69 136.33 32.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 C-N-CA 119.802 -0.759 . . . . 1.98 109.027 174.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.869 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 27.6 tt0 -137.8 108.8 6.73 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.359 -0.837 . . . . 1.07 109.963 -169.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.887 ' HA3' HG21 ' A' ' 33' ' ' ILE . . . -139.4 140.42 10.84 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.248 -0.977 . . . . 0.35 111.828 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 67.7 mt -84.69 116.82 28.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 C-N-CA 120.005 -0.678 . . . . 1.3 110.656 178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.563 HG12 ' HD3' ' A' ' 200' ' ' LYS . 63.6 mt -101.54 113.35 65.85 Favored Pre-proline 0 C--N 1.314 -0.974 0 N-CA-C 108.355 -0.98 . . . . 1.07 108.355 173.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 164' ' ' TYR . 28.3 Cg_exo -64.12 56.25 0.22 Allowed 'Trans proline' 0 N--CA 1.478 0.561 0 C-N-CA 124.574 3.516 . . . . 0.74 114.105 -174.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 1.034 ' HG3' HG12 ' A' ' 203' ' ' ILE . 63.4 mm-40 -132.34 -157.19 0.8 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.628 -0.715 . . . . 1.68 109.581 176.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.411 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 62.7 p -101.11 145.44 30.42 Favored Pre-proline 0 N--CA 1.415 -2.19 0 CA-C-N 114.798 -1.092 . . . . 1.58 108.286 168.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 57' ' ' SER . 39.9 Cg_exo -56.84 -11.1 6.51 Favored 'Trans proline' 0 C--N 1.324 -0.727 0 C-N-CA 123.967 3.112 . . . . 0.74 110.989 175.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.406 ' H ' ' C ' ' A' ' 57' ' ' SER . . . -84.42 -48.47 9.61 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.857 -1.065 . . . . 1.31 111.438 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.616 ' HG2' HG13 ' A' ' 203' ' ' ILE . 3.4 tppt? -62.76 -33.62 75.54 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.52 -0.919 . . . . 3.78 108.52 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 1.027 HD22 HD12 ' A' ' 203' ' ' ILE . 70.9 mt -57.19 -56.91 15.65 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.737 -1.12 . . . . 1.09 110.864 173.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.475 ' HA ' ' CD1' ' A' ' 65' ' ' LEU . 53.0 m -65.92 -8.34 21.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.292 0.568 . . . . 1.94 110.643 177.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 60' ' ' LYS . 25.1 t70 -88.34 -32.31 18.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.672 -0.694 . . . . 1.32 111.83 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.602 ' CE1' ' HB3' ' A' ' 65' ' ' LEU . 16.2 p90 -79.58 -43.53 22.79 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 120.225 -0.59 . . . . 0.79 110.019 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.644 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -91.16 3.84 53.75 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 120.548 -0.461 . . . . 2.15 111.962 -174.523 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.409 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 24.8 t80 -14.1 -70.66 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 125.378 1.674 . . . . 2.06 113.475 -169.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.425 ' NE2' HG23 ' A' ' 115' ' ' VAL . 7.0 tp-100 -176.19 -47.17 0.01 OUTLIER 'General case' 0 C--N 1.341 0.233 0 N-CA-C 113.147 0.795 . . . . 4.31 113.147 172.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.631 ' OG1' ' HB2' ' A' ' 81' ' ' TYR . 10.6 t -160.11 23.14 0.17 Allowed 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.136 -0.626 . . . . 1.89 111.766 -167.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -126.94 -14.01 2.86 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 118.655 -1.736 . . . . 1.71 114.479 -170.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.653 ' O ' HG22 ' A' ' 73' ' ' THR . 4.8 t70 -157.17 -33.65 0.08 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.384 0.611 . . . . 2.19 110.726 -172.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.663 ' O ' ' HB3' ' A' ' 75' ' ' ASP . 2.0 ptp180 -52.3 -39.55 60.68 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.075 -0.966 . . . . 3.95 111.693 -173.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.485 ' H ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -87.96 -5.26 10.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.841 -0.618 . . . . 1.42 111.442 -175.492 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.653 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.3 t -88.63 -27.43 21.32 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 119.104 -1.038 . . . . 1.45 109.418 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.99 ' HZ3' ' HB2' ' A' ' 198' ' ' ASN . 30.7 p-90 -112.32 -0.2 15.5 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.914 -0.585 . . . . 0.78 111.888 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.682 ' CG ' ' HB2' ' A' ' 78' ' ' LEU . 0.9 OUTLIER -68.07 176.96 2.4 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 114.107 1.151 . . . . 2.19 114.107 -167.335 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.565 ' HZ1' ' HB2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -143.45 -4.41 0.88 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 113.708 -1.587 . . . . 3.68 111.412 170.43 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.8 m -121.35 6.82 10.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.437 0.636 . . . . 2.08 109.75 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.682 ' HB2' ' CG ' ' A' ' 75' ' ' ASP . 98.7 mt -118.52 -158.36 0.72 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.295 -0.866 . . . . 1.16 110.323 -175.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.429 ' HB3' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -173.57 -58.99 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.871 0.367 . . . . 2.23 111.201 -173.428 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 96' ' ' THR . 39.9 t -145.42 139.41 21.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.307 -0.406 . . . . 1.44 110.747 -169.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.631 ' HB2' ' OG1' ' A' ' 68' ' ' THR . 44.4 p90 -104.89 152.79 22.2 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.899 -0.591 . . . . 5.73 111.537 177.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.89 ' HB3' ' HB3' ' A' ' 95' ' ' HIS . 50.7 t-20 -160.09 104.72 1.51 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.477 -0.564 . . . . 1.86 109.477 172.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.499 ' HE3' ' HG2' ' A' ' 86' ' ' ARG . 3.9 ttt -74.2 92.45 2.23 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.394 -0.965 . . . . 2.52 108.394 176.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.477 HG21 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -77.12 -63.25 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.86 -0.609 . . . . 1.19 111.571 -169.329 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.529 ' HB3' HD12 ' A' ' 93' ' ' ILE . 9.5 t60 -140.09 113.83 8.75 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.824 -0.436 . . . . 2.59 109.824 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.499 ' HG2' ' HE3' ' A' ' 83' ' ' MET . 0.2 OUTLIER -97.07 132.71 42.59 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.516 -0.92 . . . . 2.83 108.516 175.814 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.65 HG12 ' O ' ' A' ' 91' ' ' THR . 0.1 OUTLIER -90.44 -48.84 14.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.148 0.499 . . . . 1.17 111.181 -170.298 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.54 ' CG ' ' H ' ' A' ' 89' ' ' SER . 25.3 t70 -157.14 -148.37 0.21 Allowed 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.588 -0.893 . . . . 1.86 108.588 -173.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.54 ' H ' ' CG ' ' A' ' 88' ' ' ASP . 47.6 t -59.26 -49.93 75.94 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.644 0.609 . . . . 1.94 112.644 -170.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.703 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 17.7 m-20 -139.91 39.93 1.98 Allowed 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.837 0.827 . . . . 1.87 108.895 -171.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.65 ' O ' HG12 ' A' ' 87' ' ' ILE . 1.7 m -135.08 113.21 11.19 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.356 -1.35 . . . . 1.12 107.356 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.585 ' O ' HD12 ' A' ' 114' ' ' LEU . 25.8 m-85 -131.0 174.32 10.12 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.594 0.711 . . . . 0.52 111.07 -173.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.529 HD12 ' HB3' ' A' ' 85' ' ' HIS . 29.9 mt -131.76 132.98 61.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 106.305 -1.739 . . . . 1.1 106.305 165.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 34.2 t -122.35 135.6 54.74 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.064 -0.654 . . . . 2.61 110.616 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.89 ' HB3' ' HB3' ' A' ' 82' ' ' ASN . 6.8 t-160 -99.66 80.7 2.39 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 124.37 1.044 . . . . 2.17 109.157 172.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.883 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 93.0 m -89.9 150.35 22.23 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 115.129 -0.941 . . . . 1.19 109.909 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.429 ' HB ' ' HB3' ' A' ' 79' ' ' GLN . 49.4 mm -101.48 131.16 49.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 108.618 -0.882 . . . . 1.63 108.618 167.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.622 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 17.2 m -110.5 126.45 54.39 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.857 -0.61 . . . . 1.72 111.493 -171.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 . . . . . 0 C--N 1.323 -0.552 0 CA-C-O 121.247 0.546 . . . . 2.29 110.405 177.265 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.499 ' CD1' HG22 ' A' ' 183' ' ' ILE . 3.4 mp . . . . . 0 N--CA 1.45 -0.447 0 N-CA-C 108.757 -0.831 . . . . 1.53 108.757 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.3 m -76.96 160.03 77.27 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 109.927 -0.397 . . . . 1.71 109.927 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.59 145.31 17.27 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.446 2.097 . . . . 1.31 111.249 174.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.771 ' CZ ' ' HA2' ' A' ' 146' ' ' GLY . 0.2 OUTLIER -107.44 141.44 38.84 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 119.803 -0.759 . . . . 4.06 110.164 -170.102 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.611 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 12.0 t70 -94.69 115.16 27.2 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 107.81 -1.181 . . . . 1.37 107.81 177.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.883 ' HB3' ' HB ' ' A' ' 96' ' ' THR . 63.9 t80 -97.87 108.92 21.74 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.789 -0.448 . . . . 3.01 109.789 -168.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.631 ' CG2' ' HE1' ' A' ' 134' ' ' PHE . 13.5 mm -123.71 75.81 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 N-CA-C 108.811 -0.811 . . . . 1.2 108.811 173.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.774 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 0.7 OUTLIER -109.41 124.78 51.57 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.466 -0.788 . . . . 1.86 110.745 -177.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 1.095 HD23 ' HE2' ' A' ' 130' ' ' LYS . 8.9 tp -75.61 117.03 16.94 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 115.275 -0.875 . . . . 1.08 109.275 171.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.425 HG23 ' NE2' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -118.41 123.97 72.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-N 114.484 -1.235 . . . . 1.08 111.491 -164.402 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.841 ' HE2' ' HD3' ' A' ' 118' ' ' LYS . 35.9 t80 -109.93 121.69 45.82 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.585 -0.734 . . . . 2.81 111.2 175.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.875 HG13 HG23 ' A' ' 127' ' ' ILE . 3.6 mp -87.39 99.42 8.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.505 -0.924 . . . . 1.53 108.505 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.841 ' HD3' ' HE2' ' A' ' 116' ' ' TYR . 57.3 tptt -102.28 131.16 49.04 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.893 -1.049 . . . . 1.81 110.079 -174.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.447 ' C ' ' HD2' ' A' ' 119' ' ' ARG . 4.0 tpt180 -125.61 88.97 2.95 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 108.505 -0.924 . . . . 3.22 108.505 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.645 ' CB ' ' HB3' ' A' ' 123' ' ' ASN . 53.9 m-85 -69.42 119.17 13.26 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.759 -1.11 . . . . 1.28 108.359 172.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -33.53 95.89 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 125.024 1.453 . . . . 2.28 112.955 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 53.95 42.05 69.45 Favored Glycine 0 CA--C 1.508 -0.38 0 CA-C-N 114.684 -1.144 . . . . 0.79 112.041 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.645 ' HB3' ' CB ' ' A' ' 120' ' ' TYR . 3.3 t-20 -132.71 -49.76 0.9 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.922 -0.639 . . . . 2.06 110.273 -175.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.431 ' CG ' ' HB ' ' A' ' 154' ' ' VAL . 3.9 tpp -158.37 144.31 16.99 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.637 -0.425 . . . . 1.73 111.383 -178.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.09 81.22 1.71 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.378 -0.971 . . . . 2.07 108.378 172.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.725 HG23 ' HB3' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -109.01 146.26 14.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.212 -0.904 . . . . 1.06 113.424 -170.541 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.875 HG23 HG13 ' A' ' 117' ' ' ILE . 4.6 pt -107.58 110.72 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.549 0.69 . . . . 1.26 109.155 161.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.508 ' HB3' ' HA ' ' A' ' 11' ' ' ALA . 15.8 p -93.83 112.4 24.25 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.325 0.583 . . . . 1.53 111.06 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.774 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 54.6 p -102.86 158.85 15.98 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.724 -0.671 . . . . 1.81 111.68 -171.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 1.095 ' HE2' HD23 ' A' ' 114' ' ' LEU . 4.5 mtmm -147.39 124.44 11.4 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 115.939 -0.573 . . . . 2.75 109.457 175.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 31.9 p -67.04 91.63 0.22 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.336 -0.987 . . . . 1.94 108.336 174.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.93 133.84 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 CA-C-N 115.131 -0.94 . . . . 1.64 109.274 -163.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.452 ' HB2' HH22 ' A' ' 145' ' ' ARG . 9.2 t70 -94.51 73.4 3.77 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.479 -1.237 . . . . 2.17 108.761 -167.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.743 ' O ' ' HB3' ' A' ' 137' ' ' TYR . 1.6 p90 -107.02 173.75 2.93 Favored Pre-proline 0 CA--C 1.554 1.101 0 CA-C-N 114.85 -1.068 . . . . 0.67 110.709 -170.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.598 ' HB2' ' OE2' ' A' ' 136' ' ' GLU . 60.2 Cg_exo -53.13 -48.61 21.16 Favored 'Trans proline' 0 N--CA 1.486 1.079 0 C-N-CA 123.292 2.661 . . . . 1.66 116.438 -171.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.686 ' HG2' ' CE2' ' A' ' 134' ' ' PHE . 0.6 OUTLIER -79.43 -9.3 59.57 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 121.53 0.681 . . . . 3.5 111.595 -173.147 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.811 ' HE1' ' HG3' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -54.4 -38.98 71.64 Favored Pre-proline 0 CA--C 1.556 1.196 0 N-CA-C 116.888 2.181 . . . . 6.41 116.888 -172.239 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.489 ' HD2' ' C ' ' A' ' 136' ' ' GLU . 34.2 Cg_exo -30.52 110.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 123.875 3.05 . . . . 2.31 115.901 -170.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.471 ' HG3' ' HB2' ' A' ' 145' ' ' ARG . 29.6 Cg_endo -89.88 -155.89 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 124.345 3.363 . . . . 1.27 112.308 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 38.8 m -148.47 143.92 27.05 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 108.727 -0.842 . . . . 1.88 108.727 177.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.7 p -58.17 -17.57 19.64 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.568 1.322 . . . . 2.43 114.568 -167.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -83.11 -15.93 48.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.099 0.409 . . . . 2.18 111.103 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -126.11 108.75 11.64 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.255 -1.017 . . . . 1.33 108.255 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.66 HG13 ' HE ' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -82.91 111.73 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 C-N-CA 120.123 -0.631 . . . . 1.4 109.395 -171.253 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.811 ' HG3' ' HE1' ' A' ' 137' ' ' TYR . 0.2 OUTLIER -41.36 113.91 0.45 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.939 0.4 . . . . 5.14 110.632 171.003 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.771 ' HA2' ' CZ ' ' A' ' 109' ' ' ARG . . . -51.29 130.18 33.21 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.047 -0.978 . . . . 1.05 112.478 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.853 ' HB3' ' HG3' ' A' ' 174' ' ' GLU . 0.2 OUTLIER -104.99 63.85 0.71 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.743 0.782 . . . . 4.68 109.873 175.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.581 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 81.8 m-20 -86.88 108.28 18.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.156 -1.384 . . . . 2.29 109.558 178.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -80.31 132.18 60.01 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 109.468 -0.567 . . . . 2.95 109.468 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.516 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 51.9 Cg_exo -9.25 61.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.009 1 C-N-CA 126.828 5.019 . . . . 0.77 115.628 -161.671 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . 0.693 ' HB3' ' O ' ' A' ' 170' ' ' PHE . 3.0 m -76.97 -174.75 3.24 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.931 -1.031 . . . . 1.97 109.618 174.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.644 ' N ' HG22 ' A' ' 14' ' ' VAL . . . -171.29 -163.94 26.14 Favored Glycine 0 N--CA 1.429 -1.784 0 C-N-CA 119.666 -1.254 . . . . 0.55 111.828 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.463 ' HB3' ' CG1' ' A' ' 127' ' ' ILE . 52.9 t80 -161.92 79.18 0.54 Allowed 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.687 -1.227 . . . . 0.8 107.687 -168.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.682 HG12 ' HB ' ' A' ' 126' ' ' ILE . 5.2 m -90.33 128.66 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-O 121.733 0.777 . . . . 1.03 110.422 -174.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 60.8 m -99.82 111.18 23.52 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.305 -0.998 . . . . 2.3 108.305 171.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.8 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 18.9 m -97.6 119.79 61.92 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 115.817 -0.629 . . . . 1.45 111.378 -170.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.507 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 50.7 Cg_exo -55.28 111.87 0.88 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.454 2.103 . . . . 0.72 111.074 170.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.469 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 74.3 mmm -74.99 -166.33 0.47 Allowed 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.373 0.606 . . . . 1.72 111.634 -177.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -70.97 -34.52 71.5 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.624 -0.88 . . . . 2.63 108.624 174.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -102.06 30.34 4.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.371 -1.286 . . . . 2.05 108.918 175.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.614 ' OD1' ' HD3' ' A' ' 162' ' ' PRO . 3.7 p30 -31.43 -48.86 0.42 Allowed Pre-proline 0 N--CA 1.475 0.815 0 N-CA-C 117.107 2.262 . . . . 2.19 117.107 -168.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.614 ' HD3' ' OD1' ' A' ' 161' ' ' ASN . 71.6 Cg_endo -76.83 -9.93 18.27 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 CA-C-N 121.976 1.741 . . . . 0.86 113.177 -175.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -116.47 -22.66 8.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.042 -0.526 . . . . 1.34 110.801 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 55' ' ' PRO . 61.8 m-85 -136.25 121.39 19.0 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.357 -0.608 . . . . 1.46 109.357 174.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 38.6 t -116.97 139.47 50.62 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.555 -0.458 . . . . 2.05 110.439 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.869 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 2.3 tppp? -89.12 105.35 17.73 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.866 0.841 . . . . 1.4 110.984 -177.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.505 HD13 HG12 ' A' ' 196' ' ' ILE . 0.9 OUTLIER -86.82 102.05 13.92 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.338 -0.846 . . . . 1.07 108.905 178.409 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.747 HG13 ' HG3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -124.5 119.33 56.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.955 0.884 . . . . 1.11 111.587 178.246 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 21.5 ttt -120.04 148.74 43.19 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.824 -1.08 . . . . 1.79 109.532 -175.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.693 ' O ' ' HB3' ' A' ' 151' ' ' CYS . 38.7 m-85 -127.09 135.06 50.24 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.336 -0.986 . . . . 4.22 108.336 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 173' ' ' THR . 7.8 p -126.69 118.58 51.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.682 0.753 . . . . 2.01 110.965 177.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.01 63.7 0.7 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.443 -0.947 . . . . 2.66 108.443 177.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 147' ' ' TYR . 3.8 t -98.24 154.18 17.97 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.767 -1.106 . . . . 2.2 110.145 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.853 ' HG3' ' HB3' ' A' ' 147' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 112.45 0.537 . . . . 2.45 112.45 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.571 ' HA ' ' HE3' ' A' ' 186' ' ' LYS . 8.2 mm . . . . . 0 CA--C 1.511 -0.555 0 CA-C-O 122.224 1.012 . . . . 1.69 109.147 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.674 ' HA ' HG21 ' A' ' 187' ' ' THR . 1.0 OUTLIER -74.96 -31.87 26.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 113.389 -1.732 . . . . 1.77 110.741 -177.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.89 -19.94 58.45 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.218 -1.03 . . . . 2.89 108.218 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.571 ' HE3' ' HA ' ' A' ' 183' ' ' ILE . 0.2 OUTLIER -91.89 -24.52 19.29 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.085 -1.416 . . . . 1.71 110.31 173.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.674 HG21 ' HA ' ' A' ' 184' ' ' ILE . 3.5 t -89.5 -41.14 12.21 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 119.975 -0.69 . . . . 1.3 112.763 -177.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' MET . . . . . 0.887 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 21.7 mmt -80.67 -65.64 0.26 Allowed Pre-proline 0 N--CA 1.467 0.383 0 O-C-N 121.619 -0.676 . . . . 1.39 112.108 -174.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.887 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 17.3 Cg_exo -65.63 -20.8 59.78 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.184 1.923 . . . . 1.15 112.162 -173.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.43 ' HB3' ' O ' ' A' ' 186' ' ' LYS . 22.6 t -84.64 -36.28 22.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.989 -0.551 . . . . 1.95 110.187 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -79.98 -37.06 35.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.249 -0.432 . . . . 1.92 111.579 -174.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.599 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 20.3 mt -67.07 -45.8 76.24 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 121.007 -0.277 . . . . 1.68 111.516 -175.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.794 ' HB ' HD11 ' A' ' 33' ' ' ILE . 27.9 m -71.73 -24.12 22.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.1 -0.64 . . . . 1.32 110.406 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.408 ' HB3' ' HE3' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -73.35 -32.83 64.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.869 -0.605 . . . . 2.6 110.755 174.058 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.639 ' HA ' ' OD1' ' A' ' 198' ' ' ASN . 2.2 m-85 -65.1 -30.74 71.7 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.139 0.495 . . . . 2.73 110.319 174.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.505 HG12 HD13 ' A' ' 167' ' ' LEU . 60.4 mt -79.6 -24.58 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-O 121.365 0.603 . . . . 1.11 110.644 175.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.475 ' HA ' HD22 ' A' ' 197' ' ' LEU . 34.2 mt -73.11 -42.82 62.51 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.274 -0.421 . . . . 1.57 110.827 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.99 ' HB2' ' HZ3' ' A' ' 74' ' ' TRP . 1.8 p-10 -67.43 -15.07 63.47 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.386 -0.926 . . . . 2.18 109.469 171.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.664 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -80.81 -42.27 21.95 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 109.404 -0.591 . . . . 1.04 109.404 173.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.563 ' HD3' HG12 ' A' ' 54' ' ' ILE . 28.1 mmtp -59.56 -44.69 93.2 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 121.553 0.692 . . . . 1.51 110.013 173.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -80.48 -39.81 27.33 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.897 -1.047 . . . . 1.94 110.984 -174.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -69.51 -31.2 70.92 Favored Glycine 0 CA--C 1.507 -0.464 0 C-N-CA 120.717 -0.754 . . . . 0.47 111.395 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 1.034 HG12 ' HG3' ' A' ' 56' ' ' GLU . 1.5 tp -71.69 -34.57 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 120.574 0.226 . . . . 1.16 110.449 177.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 66.4 mttm -86.12 -15.82 39.94 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-O 121.686 0.755 . . . . 3.8 109.173 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.952 0 CA-C-N 115.283 -0.871 . . . . 1.28 108.681 165.658 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.675 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.7 OUTLIER . . . . . 0 CA--C 1.513 -0.459 0 N-CA-C 112.202 0.445 . . . . 2.25 112.202 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.541 ' HB2' HG23 ' A' ' 87' ' ' ILE . 91.3 m-85 -61.2 -26.42 67.71 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 116.033 -0.53 . . . . 0.45 110.372 -170.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.54 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 45.8 tttt -73.05 -45.04 59.78 Favored 'General case' 0 N--CA 1.417 -2.099 0 N-CA-C 107.639 -1.245 . . . . 2.06 107.639 -177.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.49 -40.24 59.14 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.831 -0.622 . . . . 1.2 111.307 176.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.675 HD12 ' O ' ' A' ' 2' ' ' ASP . 2.3 mp -81.18 -38.89 16.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.869 0.842 . . . . 1.76 109.58 -174.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.662 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -75.36 -39.79 58.88 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.533 -1.212 . . . . 1.11 111.805 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 44.7 mt-30 -63.01 -30.03 71.29 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.609 -1.178 . . . . 2.14 109.688 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.614 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 79.6 mt-30 -79.35 -46.62 17.29 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.895 -1.048 . . . . 3.04 108.671 171.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.965 HG23 ' HZ2' ' A' ' 130' ' ' LYS . 0.3 OUTLIER -60.17 -37.19 79.42 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.946 -1.024 . . . . 1.1 112.59 -176.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.496 ' HA ' ' CB ' ' A' ' 128' ' ' SER . . . -51.72 -51.7 54.1 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-O 120.929 0.395 . . . . 1.04 111.494 178.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -80.45 -10.58 59.74 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.191 -0.459 . . . . 2.31 110.952 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.614 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 49.3 mt-10 -75.11 -50.66 15.65 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.381 0.61 . . . . 2.54 109.701 174.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.693 HG22 ' N ' ' A' ' 152' ' ' GLY . 11.2 p -71.96 -37.79 62.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 122.235 1.017 . . . . 1.21 109.925 -177.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.485 HD11 ' SD ' ' A' ' 124' ' ' MET . 0.9 OUTLIER -72.05 -20.54 61.66 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 114.591 -1.186 . . . . 1.26 109.199 173.837 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.437 ' HA2' ' NH1' ' A' ' 19' ' ' ARG . . . -66.16 -18.46 67.08 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 114.184 -1.371 . . . . 0.57 110.21 172.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.614 ' CD2' ' HA ' ' A' ' 14' ' ' VAL . 33.5 m-85 -88.93 -26.49 21.53 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.249 -0.475 . . . . 3.59 109.919 177.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.551 ' HB2' ' HZ ' ' A' ' 170' ' ' PHE . 12.1 t-20 -71.44 -20.48 62.1 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 119.884 -0.726 . . . . 2.1 109.775 173.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.437 ' NH1' ' HA2' ' A' ' 16' ' ' GLY . 20.1 mtp180 -97.89 -20.72 17.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.444 -0.798 . . . . 3.26 110.383 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -115.51 103.0 10.31 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.401 -0.818 . . . . 2.16 110.709 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.804 ' HB ' ' CH2' ' A' ' 24' ' ' TRP . 23.3 p -121.94 99.18 6.3 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.618 0.723 . . . . 2.24 109.862 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.7 m -148.27 144.62 27.75 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.497 -0.774 . . . . 2.46 111.149 -165.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.33 -45.31 3.02 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.793 -0.639 . . . . 1.45 114.12 169.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.804 ' CH2' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -82.59 -157.22 0.2 Allowed 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 113.137 0.792 . . . . 2.24 113.137 -172.386 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.987 ' HE3' ' HA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER 179.36 149.55 0.28 Allowed 'General case' 0 CA--C 1.494 -1.184 0 CA-C-N 115.161 -0.927 . . . . 3.43 110.087 -165.099 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 3.3 m -60.16 124.97 15.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 114.397 -1.274 . . . . 2.21 112.068 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.656 HG11 ' HE2' ' A' ' 48' ' ' TYR . 14.4 p -98.36 -25.46 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 114.262 -1.336 . . . . 1.83 108.22 174.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.493 ' HA ' ' HD2' ' A' ' 28' ' ' LYS . 20.8 tptt -154.68 149.39 26.52 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 119.672 -0.811 . . . . 2.87 111.262 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.574 HG22 ' HA ' ' A' ' 34' ' ' THR . 34.4 p -145.36 151.63 38.59 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.715 -0.675 . . . . 1.92 109.755 175.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.653 ' O ' ' HG2' ' A' ' 31' ' ' LYS . 42.3 m -128.59 44.97 2.86 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.851 0.357 . . . . 2.37 110.489 175.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.653 ' HG2' ' O ' ' A' ' 30' ' ' SER . 0.1 OUTLIER 62.38 19.81 11.37 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.509 1.123 . . . . 4.84 112.001 169.251 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.428 ' HA ' ' HD2' ' A' ' 32' ' ' LYS . 35.6 tptt -174.63 -20.93 0.01 OUTLIER 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.569 0.7 . . . . 2.05 109.885 175.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.786 HG21 ' HA3' ' A' ' 52' ' ' GLY . 41.8 pt -117.64 156.32 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.805 -1.089 . . . . 1.42 109.517 171.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.574 ' HA ' HG22 ' A' ' 29' ' ' THR . 88.4 m -151.54 115.33 4.91 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.648 -0.706 . . . . 1.22 110.408 -164.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.667 HG13 HG12 ' A' ' 50' ' ' VAL . 6.3 m -113.12 118.13 57.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.106 0.479 . . . . 1.52 112.009 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 2.7 p -101.15 128.48 47.22 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.552 -0.749 . . . . 1.74 110.645 177.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.579 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 42.5 t -106.71 128.4 54.17 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.161 -0.927 . . . . 1.72 111.058 -171.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 21.9 ttpp . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 116.335 -0.393 . . . . 2.45 111.015 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.0 m120 . . . . . 0 C--O 1.227 -0.113 0 N-CA-C 109.957 -0.386 . . . . 2.45 109.957 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.53 ' HG ' ' HB2' ' A' ' 172' ' ' GLN . 3.2 tt -98.59 135.27 40.36 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.25 -1.019 . . . . 1.49 108.25 177.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.656 ' HE2' HG11 ' A' ' 27' ' ' VAL . 60.1 m-85 -122.58 123.61 41.59 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.925 0.393 . . . . 1.52 110.336 -173.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.573 ' HD3' ' CD2' ' A' ' 170' ' ' PHE . 0.0 OUTLIER -99.02 103.38 15.32 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.129 -0.693 . . . . 3.34 109.129 178.361 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.76 HG23 ' HB3' ' A' ' 169' ' ' MET . 0.9 OUTLIER -85.92 150.13 4.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 108.745 -0.835 . . . . 1.98 108.745 178.477 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.823 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 74.1 tt0 -158.76 108.1 1.96 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.103 0.477 . . . . 1.07 110.0 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.786 ' HA3' HG21 ' A' ' 33' ' ' ILE . . . -145.33 145.08 13.95 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.846 -0.902 . . . . 0.35 110.846 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 66.2 mt -89.07 126.41 42.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 117.623 0.711 . . . . 1.3 111.249 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.463 ' HA ' ' HD2' ' A' ' 55' ' ' PRO . 44.9 mt -106.65 110.27 63.64 Favored Pre-proline 0 N--CA 1.447 -0.607 0 CA-C-N 115.995 -0.548 . . . . 1.07 109.797 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 54' ' ' ILE . 9.8 Cg_endo -52.1 66.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.477 0.511 1 C-N-CA 125.729 4.286 . . . . 0.74 113.598 174.574 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.609 ' HG2' HG13 ' A' ' 203' ' ' ILE . 10.1 tp10 -165.02 171.57 13.78 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.17 -1.048 . . . . 1.68 108.17 174.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.473 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 83.6 p -80.5 141.32 52.53 Favored Pre-proline 0 N--CA 1.428 -1.56 0 CA-C-O 121.477 0.656 . . . . 1.58 109.849 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.714 ' HA ' HD11 ' A' ' 61' ' ' LEU . 8.7 Cg_endo -51.7 -15.22 2.69 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 124.528 3.485 . . . . 0.74 111.734 171.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.53 -44.75 41.95 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.464 -0.789 . . . . 1.31 111.037 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.565 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 2.2 tpmt? -69.53 -30.64 68.52 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.028 -1.101 . . . . 3.78 108.028 178.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 1.038 HD22 HD12 ' A' ' 203' ' ' ILE . 94.0 mt -61.88 -57.73 10.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.33 -1.305 . . . . 1.09 110.73 175.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.46 ' HB3' ' HB3' ' A' ' 125' ' ' ASN . 17.4 p -64.73 -9.75 22.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.196 0.522 . . . . 1.94 110.507 176.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -89.24 -30.91 18.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.86 -0.609 . . . . 1.32 111.957 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.703 ' HD2' ' CZ2' ' A' ' 74' ' ' TRP . 18.7 p90 -89.84 -43.4 10.65 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 120.152 -0.619 . . . . 0.79 111.828 -172.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.678 HD11 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -90.77 5.54 47.89 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 120.371 -0.532 . . . . 2.15 112.061 -173.597 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.416 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 9.7 t80 -27.72 -69.58 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 O-C-N 124.743 1.277 . . . . 2.06 113.095 -167.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.456 ' HA ' ' CZ ' ' A' ' 71' ' ' ARG . 7.3 tt0 -175.1 -40.81 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 114.13 1.159 . . . . 4.31 114.13 173.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.8 t -155.06 7.13 0.26 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.527 0.936 . . . . 1.89 113.527 -163.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -116.6 0.26 20.17 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 118.709 -1.71 . . . . 1.71 115.209 -169.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.634 ' O ' HG23 ' A' ' 73' ' ' THR . 38.2 t70 -178.15 -27.82 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.385 0.592 . . . . 2.19 110.562 -177.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.622 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -55.29 -34.97 64.59 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 115.478 -0.783 . . . . 3.95 111.302 -172.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.789 HG21 HD11 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -92.77 -7.78 10.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.744 -0.382 . . . . 1.42 111.077 -175.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 70' ' ' ASP . 1.3 t -88.19 -27.96 21.5 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 119.914 -0.714 . . . . 1.45 109.743 -176.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.703 ' CZ2' ' HD2' ' A' ' 64' ' ' PHE . 29.4 p-90 -101.45 -8.88 21.59 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.168 -0.613 . . . . 0.78 111.282 177.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.696 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 27.6 t0 -87.36 159.3 18.78 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 114.286 1.217 . . . . 2.19 114.286 -165.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.4 ' H ' ' CG ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -98.75 -26.17 14.43 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 112.637 -2.074 . . . . 3.68 111.268 -176.306 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.2 m -105.83 -3.43 21.94 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.004 -0.739 . . . . 2.08 109.004 -173.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.789 HD11 HG21 ' A' ' 72' ' ' ILE . 72.6 mt -110.47 159.17 17.74 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.902 -1.045 . . . . 1.16 111.354 -174.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.555 ' CG ' ' HG3' ' A' ' 99' ' ' GLN . 9.8 mm-40 -138.9 -62.52 0.55 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.949 -1.023 . . . . 2.23 111.403 -176.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.529 HG21 ' HB3' ' A' ' 79' ' ' GLN . 23.6 t -140.48 124.72 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.439 -0.346 . . . . 1.44 111.047 -167.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.46 ' CD1' HD11 ' A' ' 72' ' ' ILE . 49.1 p90 -95.5 148.61 22.31 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 122.984 0.514 . . . . 5.73 110.987 175.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.73 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 18.2 m120 -156.91 108.1 2.38 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.651 -0.5 . . . . 1.86 109.651 169.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.475 ' CG ' ' HD3' ' A' ' 86' ' ' ARG . 0.7 OUTLIER -66.82 103.58 1.15 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.953 -0.758 . . . . 2.52 108.953 177.089 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.745 HG12 ' HG2' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -80.8 -82.15 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 121.167 0.508 . . . . 1.19 110.513 -173.298 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.59 ' HB3' HD11 ' A' ' 93' ' ' ILE . 9.3 t60 -126.12 104.86 8.47 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.541 -0.754 . . . . 2.59 109.273 -172.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.475 ' HD3' ' CG ' ' A' ' 83' ' ' MET . 47.5 mtm180 -92.75 115.23 27.92 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.437 -0.579 . . . . 2.83 109.437 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -80.21 -40.56 20.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.476 -0.784 . . . . 1.17 110.925 -169.725 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.456 ' CG ' ' H ' ' A' ' 89' ' ' SER . 12.4 t70 -151.63 -162.73 1.59 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.012 -0.736 . . . . 1.86 109.012 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.456 ' H ' ' CG ' ' A' ' 88' ' ' ASP . 34.1 t -76.23 -17.64 59.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 117.944 0.338 . . . . 1.94 111.368 -174.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.2 p30 -136.08 17.2 3.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.825 0.345 . . . . 1.87 110.792 -175.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.601 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -129.77 107.07 9.13 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.365 -0.976 . . . . 1.12 108.365 -178.383 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.594 ' O ' HD13 ' A' ' 114' ' ' LEU . 27.2 m-85 -125.44 170.92 10.91 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.314 0.578 . . . . 0.52 111.135 -172.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.637 ' O ' HG22 ' A' ' 84' ' ' VAL . 16.9 mt -137.36 121.56 23.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 107.409 -1.33 . . . . 1.1 107.409 170.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 14.3 t -111.92 127.84 55.97 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.244 0.545 . . . . 2.61 111.26 -176.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.73 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 26.0 t60 -81.66 83.11 7.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.753 0.787 . . . . 2.17 109.01 169.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 20.0 m -94.03 113.1 25.01 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.579 -1.191 . . . . 1.19 111.342 -177.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.424 ' CG1' ' HB ' ' A' ' 80' ' ' VAL . 43.4 mm -77.02 120.9 28.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 108.63 -0.878 . . . . 1.63 108.63 171.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.1 m -110.98 128.99 56.02 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.023 -0.99 . . . . 1.72 111.217 -171.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.555 ' HG3' ' CG ' ' A' ' 79' ' ' GLN . 22.4 mt-30 . . . . . 0 C--N 1.316 -0.886 0 CA-C-N 115.985 -0.552 . . . . 2.29 110.644 177.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.436 HG21 ' NH2' ' A' ' 109' ' ' ARG . 77.3 mt . . . . . 0 C--O 1.233 0.212 0 CA-C-O 121.065 0.46 . . . . 1.53 112.013 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.4 m -100.34 166.44 12.64 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 108.526 -0.916 . . . . 1.71 108.526 170.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -46.32 125.31 8.78 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.035 1.823 . . . . 1.31 110.893 173.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.589 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 29.5 ttm180 -102.65 151.99 21.71 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 120.042 -0.663 . . . . 4.06 110.141 -167.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.689 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 20.8 t0 -113.01 127.23 56.17 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.736 -0.666 . . . . 1.37 109.344 -171.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.423 ' HB2' ' O ' ' A' ' 96' ' ' THR . 3.5 m-30 -113.43 134.13 54.82 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.537 0.684 . . . . 3.01 111.305 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 1.061 HG12 ' HD2' ' A' ' 145' ' ' ARG . 35.2 mm -124.36 76.39 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 107.105 -1.443 . . . . 1.2 107.105 167.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 7.1 p-10 -85.88 115.75 23.7 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.116 -0.947 . . . . 1.86 109.994 -176.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 1.007 HD23 ' HE2' ' A' ' 130' ' ' LYS . 11.2 tp -80.65 111.58 17.21 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-O 121.914 0.864 . . . . 1.08 109.08 169.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 129' ' ' SER . 0.1 OUTLIER -119.09 125.31 74.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-N 113.841 -1.527 . . . . 1.08 111.544 -163.303 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.662 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 11.5 t80 -104.83 112.71 25.92 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 115.114 -0.948 . . . . 2.81 110.054 172.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.803 HG12 HG21 ' A' ' 127' ' ' ILE . 73.7 mt -94.14 99.57 9.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.639 -0.71 . . . . 1.53 109.607 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.501 ' HD2' ' CZ ' ' A' ' 120' ' ' TYR . 35.9 ttmt -118.14 141.02 48.93 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.931 -0.577 . . . . 1.81 109.872 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.491 ' O ' ' HD2' ' A' ' 119' ' ' ARG . 7.9 tmm_? -118.75 98.08 6.04 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.966 -0.753 . . . . 3.22 108.966 177.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.584 ' CB ' ' HB3' ' A' ' 123' ' ' ASN . 96.5 m-85 -64.66 114.05 4.15 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.631 -1.248 . . . . 1.28 107.631 172.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -37.21 99.07 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 O-C-N 124.572 1.17 . . . . 2.28 112.688 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 56.59 34.12 63.71 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 114.159 -1.382 . . . . 0.79 112.708 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.584 ' HB3' ' CB ' ' A' ' 120' ' ' TYR . 4.6 t-20 -127.48 -49.1 1.41 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.174 -0.513 . . . . 2.06 110.266 -177.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.554 ' HG2' ' HB ' ' A' ' 154' ' ' VAL . 3.9 ttm -163.08 133.76 4.65 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 120.323 -0.551 . . . . 1.73 112.127 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.552 ' ND2' ' HB2' ' A' ' 58' ' ' PRO . 29.1 m-80 -104.63 78.97 1.5 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.23 -1.026 . . . . 2.07 108.23 174.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.64 ' CG1' HG12 ' A' ' 154' ' ' VAL . 0.5 OUTLIER -103.91 139.77 23.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 113.387 0.884 . . . . 1.06 113.387 -169.21 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.803 HG21 HG12 ' A' ' 117' ' ' ILE . 25.7 pt -108.84 111.42 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 108.907 -0.775 . . . . 1.26 108.907 163.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.533 ' HB2' HG21 ' A' ' 10' ' ' THR . 13.4 p -97.29 109.4 22.16 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.46 0.647 . . . . 1.53 110.957 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.578 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 5.5 p -113.55 155.8 24.75 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.817 -0.628 . . . . 1.81 111.86 -168.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 1.007 ' HE2' HD23 ' A' ' 114' ' ' LEU . 14.8 mtmm -140.74 134.18 29.91 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 108.132 -1.062 . . . . 2.75 108.132 173.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 41.1 p -69.79 96.33 0.98 Allowed 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.955 -1.128 . . . . 1.94 107.955 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.424 HG12 ' HE2' ' A' ' 3' ' ' PHE . 2.3 t -107.56 124.01 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 CA-C-N 114.534 -1.212 . . . . 1.64 110.788 -163.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -98.19 48.68 1.0 Allowed 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 113.264 -1.789 . . . . 2.17 109.735 -165.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.795 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 1.5 p90 -81.68 159.14 67.21 Favored Pre-proline 0 C--N 1.313 -0.983 0 CA-C-N 113.343 -1.753 . . . . 0.67 110.549 -171.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 1.9 Cg_endo -47.84 -42.1 31.28 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.672 2.915 . . . . 1.66 115.709 -172.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.795 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 18.0 tt0 -70.27 -11.82 61.17 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 111.824 0.305 . . . . 3.5 111.824 -162.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.489 ' HB2' HG13 ' A' ' 84' ' ' VAL . 0.7 OUTLIER -157.3 99.74 1.93 Allowed Pre-proline 0 C--N 1.321 -0.654 0 C-N-CA 119.407 -0.917 . . . . 6.41 113.406 177.317 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -90.23 160.93 4.69 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.003 3.135 . . . . 2.31 111.42 171.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.534 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 87.3 Cg_endo -94.58 -161.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.91 2.407 . . . . 1.27 113.361 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.5 t -148.52 -157.47 0.82 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.585 -0.895 . . . . 1.88 108.585 -178.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.1 p -89.98 -36.72 14.8 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.617 -0.433 . . . . 2.43 111.397 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.31 -35.59 58.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.9 0.381 . . . . 2.18 110.171 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.689 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 99.2 m-85 -107.71 111.39 23.56 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 109.497 -0.557 . . . . 1.33 109.497 -178.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.589 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 1.1 tp -98.38 112.88 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 N-CA-C 108.87 -0.789 . . . . 1.4 108.87 -176.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 1.061 ' HD2' HG12 ' A' ' 112' ' ' ILE . 2.6 tpp85 -60.16 97.44 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.323 -0.992 . . . . 5.14 108.323 173.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -64.38 133.8 38.98 Favored Glycine 0 CA--C 1.503 -0.683 0 CA-C-N 115.575 -0.739 . . . . 1.05 112.288 -171.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.426 ' HB2' ' HG2' ' A' ' 174' ' ' GLU . 2.6 m-85 -83.74 79.25 9.52 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 122.308 1.052 . . . . 4.68 112.115 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.492 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 5.8 t30 -80.74 83.34 6.52 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 113.45 -1.705 . . . . 2.29 108.407 167.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.531 ' HB3' ' HD2' ' A' ' 150' ' ' PRO . 96.6 m-70 -49.63 161.3 0.52 Allowed Pre-proline 0 C--O 1.219 -0.534 0 CA-C-O 118.628 -0.701 . . . . 2.95 109.755 175.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' A' ' 149' ' ' HIS . 5.7 Cg_endo -47.5 75.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 124.276 3.318 . . . . 0.77 114.135 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 170' ' ' PHE . 25.4 p -138.61 167.61 21.57 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.057 -1.46 . . . . 1.97 107.057 175.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.693 ' N ' HG22 ' A' ' 14' ' ' VAL . . . -153.69 -138.74 2.72 Favored Glycine 0 N--CA 1.433 -1.562 0 C-N-CA 118.733 -1.699 . . . . 0.55 113.51 -167.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.451 ' HB3' ' CG1' ' A' ' 127' ' ' ILE . 63.3 t80 -163.06 93.19 0.79 Allowed 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 107.949 -1.13 . . . . 0.8 107.949 -163.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.646 HG11 ' HE1' ' A' ' 170' ' ' PHE . 7.7 m -102.81 138.29 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-O 121.88 0.848 . . . . 1.03 110.653 -176.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . 0.415 ' HB2' ' HB2' ' A' ' 125' ' ' ASN . 71.4 m -112.13 110.56 20.9 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.252 -0.885 . . . . 2.3 109.296 175.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.766 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 16.4 m -101.38 122.21 48.9 Favored Pre-proline 0 C--N 1.318 -0.766 0 C-N-CA 120.602 -0.439 . . . . 1.45 111.256 -169.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.499 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 51.4 Cg_exo -55.49 115.06 2.18 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.12 1.88 . . . . 0.72 110.689 170.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.509 ' SD ' ' HB2' ' A' ' 166' ' ' LYS . 74.6 mmm -75.08 -172.11 1.57 Allowed 'General case' 0 CA--C 1.505 -0.763 0 C-N-CA 120.765 -0.374 . . . . 1.72 110.75 -177.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -69.85 -31.64 69.6 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 108.537 -0.912 . . . . 2.63 108.537 170.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.558 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 2.6 mm-40 -98.3 27.85 4.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.928 -1.033 . . . . 2.05 108.79 175.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.571 ' OD1' ' HD3' ' A' ' 162' ' ' PRO . 5.5 p30 -36.52 -47.37 1.6 Allowed Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 116.226 1.936 . . . . 2.19 116.226 -166.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.571 ' HD3' ' OD1' ' A' ' 161' ' ' ASN . 72.8 Cg_endo -75.54 -14.57 19.96 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 CA-C-N 121.621 1.615 . . . . 0.86 113.208 -175.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -111.62 -27.31 8.61 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.001 0.429 . . . . 1.34 110.657 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.558 ' HB2' ' HB2' ' A' ' 160' ' ' GLU . 66.4 m-85 -140.65 131.77 26.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.512 -0.767 . . . . 1.46 109.546 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.666 ' HB2' ' HD3' ' A' ' 58' ' ' PRO . 17.5 t -126.99 152.92 46.57 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.843 -0.743 . . . . 2.05 111.125 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.868 ' HG3' HG13 ' A' ' 168' ' ' VAL . 1.8 tppp? -91.69 104.35 16.83 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.51 -0.768 . . . . 1.4 111.509 -176.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.617 HD12 HG12 ' A' ' 196' ' ' ILE . 0.7 OUTLIER -84.8 100.91 11.85 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.066 -0.97 . . . . 1.07 108.883 174.514 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.868 HG13 ' HG3' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -124.5 128.92 73.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.667 0.746 . . . . 1.11 110.8 178.025 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.76 ' HB3' HG23 ' A' ' 50' ' ' VAL . 25.2 ttt -132.51 162.49 31.1 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.858 -0.793 . . . . 1.79 108.858 -171.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.646 ' HE1' HG11 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -139.51 108.24 5.94 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.323 -1.362 . . . . 4.22 107.323 -173.468 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.436 HG11 ' OG1' ' A' ' 173' ' ' THR . 30.6 t -106.45 98.3 6.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 124.044 0.84 . . . . 2.01 109.878 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.53 ' HB2' ' HG ' ' A' ' 47' ' ' LEU . 49.9 tt0 -100.1 11.98 38.04 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 106.909 -1.515 . . . . 2.66 106.909 173.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 1.1 m -61.09 127.29 30.79 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.207 -1.815 . . . . 2.2 110.534 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.426 ' HG2' ' HB2' ' A' ' 147' ' ' TYR . 13.0 pt-20 . . . . . 0 CA--C 1.514 -0.431 0 N-CA-C 108.375 -0.972 . . . . 2.45 108.375 175.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.428 HG22 HD12 ' A' ' 106' ' ' ILE . 31.2 mm . . . . . 0 CA--C 1.515 -0.401 0 CA-C-O 122.467 1.127 . . . . 1.69 108.9 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.647 ' HA ' HG23 ' A' ' 187' ' ' THR . 1.2 mp -68.05 -36.87 77.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 113.073 -1.876 . . . . 1.77 111.555 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -63.94 -17.98 63.8 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.112 -0.699 . . . . 2.89 109.112 177.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -93.04 -45.28 7.99 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.381 -0.827 . . . . 1.71 109.919 172.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.647 HG23 ' HA ' ' A' ' 184' ' ' ILE . 6.8 t -63.58 -30.23 71.38 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.329 0.492 . . . . 1.3 112.329 -169.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' MET . . . . . 0.704 ' O ' ' HG ' ' A' ' 192' ' ' LEU . 0.2 OUTLIER -75.13 -63.39 0.72 Allowed Pre-proline 0 C--N 1.33 -0.244 0 C-N-CA 120.956 -0.298 . . . . 1.39 110.877 179.524 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.507 ' HD3' ' CB ' ' A' ' 188' ' ' MET . 32.2 Cg_exo -59.03 -33.62 98.77 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.275 1.984 . . . . 1.15 112.367 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.701 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 9.3 t -71.21 -22.61 61.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.825 0.345 . . . . 1.95 110.407 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -91.83 -43.68 9.38 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.031 -0.532 . . . . 1.92 110.733 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.704 ' HG ' ' O ' ' A' ' 188' ' ' MET . 51.7 mt -53.11 -59.39 4.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.575 -0.739 . . . . 1.68 111.703 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.476 ' O ' ' HG ' ' A' ' 197' ' ' LEU . 1.1 m -73.91 -30.57 28.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.089 -0.96 . . . . 1.32 109.345 -171.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.701 ' HB2' ' O ' ' A' ' 190' ' ' SER . 1.0 OUTLIER -67.79 -44.15 78.06 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 114.04 -1.436 . . . . 2.6 110.315 179.128 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.585 ' O ' ' HB2' ' A' ' 198' ' ' ASN . 0.9 OUTLIER -59.91 -27.42 66.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.045 0.45 . . . . 2.73 110.728 176.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.617 HG12 HD12 ' A' ' 167' ' ' LEU . 33.7 mt -79.27 -31.03 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 120.983 0.42 . . . . 1.11 111.286 173.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 94.7 mt -75.68 -30.7 59.45 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.235 0.54 . . . . 1.57 110.026 176.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.585 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 7.6 m-20 -47.22 -47.43 24.45 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.712 -1.131 . . . . 2.18 107.967 162.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.675 ' HA ' ' CE2' ' A' ' 64' ' ' PHE . . . -77.54 -44.84 27.27 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 115.005 -0.998 . . . . 1.04 111.292 -173.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 31.5 mmtp -54.63 -41.84 70.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.527 0.679 . . . . 1.51 110.696 175.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . 0.522 ' HA ' ' HE3' ' A' ' 204' ' ' LYS . 2.2 t70 -84.37 -47.62 10.52 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.969 -1.014 . . . . 1.94 110.094 -175.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . 0.528 ' HA2' ' HB3' ' A' ' 205' ' ' ALA . . . -63.25 -29.33 74.14 Favored Glycine 0 N--CA 1.459 0.232 0 C-N-CA 120.726 -0.749 . . . . 0.47 112.489 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 1.038 HD12 HD22 ' A' ' 61' ' ' LEU . 3.0 tp -69.79 -38.58 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-O 120.848 0.356 . . . . 1.16 110.453 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.522 ' HE3' ' HA ' ' A' ' 201' ' ' ASP . 0.0 OUTLIER -90.59 -17.16 27.41 Favored 'General case' 0 C--O 1.207 -1.169 0 N-CA-C 109.284 -0.635 . . . . 3.8 109.284 177.291 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.528 ' HB3' ' HA2' ' A' ' 202' ' ' GLY . . . . . . . . 0 C--N 1.318 -0.79 0 N-CA-C 109.171 -0.677 . . . . 1.28 109.171 168.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.611 ' O ' HD13 ' A' ' 6' ' ' ILE . 15.2 t70 . . . . . 0 CA--C 1.509 -0.621 0 N-CA-C 109.313 -0.625 . . . . 2.25 109.313 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.508 ' O ' HD22 ' A' ' 114' ' ' LEU . 70.5 m-85 -59.55 -34.82 73.16 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.667 0.746 . . . . 0.45 109.598 -177.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.565 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 45.1 tttt -70.48 -42.47 71.37 Favored 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 114.644 -1.162 . . . . 2.06 108.085 -178.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.89 -41.9 62.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.844 -0.617 . . . . 1.2 111.616 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.664 ' O ' ' HB ' ' A' ' 10' ' ' THR . 1.3 mp -79.26 -48.15 21.57 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 N-CA-C 108.714 -0.847 . . . . 1.76 108.714 -175.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -57.54 -47.42 82.06 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.779 -1.1 . . . . 1.11 111.974 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.565 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 13.1 mt-30 -60.34 -36.22 77.48 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 113.889 -1.505 . . . . 2.14 111.631 -176.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.27 -18.16 26.13 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.396 -0.82 . . . . 3.04 109.506 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.664 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -83.18 -38.6 22.11 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.19 -0.914 . . . . 1.1 111.233 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.406 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -49.54 -59.89 3.35 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-O 121.218 0.532 . . . . 1.04 110.81 176.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -67.4 -11.54 58.0 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.284 -0.871 . . . . 2.31 111.787 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.589 ' HB3' ' HA ' ' A' ' 10' ' ' THR . 0.6 OUTLIER -87.3 -42.11 13.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 110.267 -0.272 . . . . 2.54 110.267 -179.164 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.634 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -75.48 -34.16 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 122.305 1.05 . . . . 1.21 108.539 177.617 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.516 HD12 ' SD ' ' A' ' 124' ' ' MET . 0.6 OUTLIER -68.39 -29.29 67.95 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 114.32 -1.309 . . . . 1.26 108.379 172.305 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 20' ' ' ASP . . . -64.99 -17.93 63.91 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 113.571 -1.65 . . . . 0.57 110.706 177.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.634 ' CD2' ' HA ' ' A' ' 14' ' ' VAL . 23.6 m-85 -84.6 -26.25 28.04 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 109.427 -0.583 . . . . 3.59 109.427 176.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 170' ' ' PHE . 2.6 t30 -72.09 -15.75 62.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.768 -0.651 . . . . 2.1 110.086 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -116.31 10.97 14.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.456 -0.793 . . . . 3.26 110.467 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 27.5 t70 -111.36 107.22 16.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.943 -0.571 . . . . 2.16 110.684 -176.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.556 HG22 ' CZ2' ' A' ' 24' ' ' TRP . 53.3 p -125.87 112.75 16.35 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.624 0.25 . . . . 2.24 110.642 -176.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.2 p -177.5 117.65 0.1 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.861 -0.609 . . . . 2.46 111.817 -168.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.3 33.89 82.46 Favored Glycine 0 C--O 1.23 -0.144 0 C-N-CA 121.337 -0.458 . . . . 1.45 113.404 173.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.556 ' CZ2' HG22 ' A' ' 21' ' ' THR . 0.1 OUTLIER -119.97 -168.28 1.58 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.289 -0.634 . . . . 2.24 109.289 177.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 36' ' ' SER . 8.0 mtmm -174.95 156.42 2.2 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 107.999 -1.111 . . . . 3.43 107.999 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.565 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 2.3 p -78.46 119.64 27.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-O 121.817 0.817 . . . . 2.21 109.25 175.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 35' ' ' VAL . 8.2 p -86.61 -24.76 6.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 114.845 -1.07 . . . . 1.83 109.382 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 tppt? -172.31 150.73 2.41 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.634 0.605 . . . . 2.87 112.634 -176.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.512 HG23 ' HA ' ' A' ' 34' ' ' THR . 69.3 p -134.43 148.42 50.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.553 -0.749 . . . . 1.92 109.682 173.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.508 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 50.3 m -152.78 84.1 1.23 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.557 0.577 . . . . 2.37 112.557 177.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 30' ' ' SER . 3.2 mptp? 79.66 71.31 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.942 0.497 . . . . 4.84 111.365 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.465 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 65.2 mttm 73.26 20.87 3.19 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.299 -0.864 . . . . 2.05 111.724 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.489 ' HB ' ' H ' ' A' ' 30' ' ' SER . 2.5 mt -108.44 166.78 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.942 0 CA-C-O 121.149 0.499 . . . . 1.42 110.771 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.512 ' HA ' HG23 ' A' ' 29' ' ' THR . 48.7 m -158.43 102.54 1.74 Allowed 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.589 -1.187 . . . . 1.22 109.304 176.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 27' ' ' VAL . 21.8 t -96.3 103.1 14.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.993 -0.549 . . . . 1.52 109.537 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 81.0 p -96.22 123.49 39.87 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.502 0.667 . . . . 1.74 110.911 -178.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.0 p -94.36 127.85 40.5 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.762 -1.108 . . . . 1.72 110.898 -176.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt . . . . . 0 C--N 1.32 -0.706 0 CA-C-N 115.624 -0.716 . . . . 2.45 110.028 175.664 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.9 m120 . . . . . 0 N--CA 1.445 -0.698 0 CA-C-O 121.024 0.44 . . . . 2.45 110.887 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 171' ' ' VAL . 8.4 tt -87.76 140.75 29.19 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.468 -0.938 . . . . 1.49 108.468 173.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -121.52 118.49 29.43 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.658 -0.417 . . . . 1.52 110.42 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.422 ' HG3' ' CD2' ' A' ' 170' ' ' PHE . 37.1 ttt-85 -97.5 112.08 24.08 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.121 -0.696 . . . . 3.34 109.121 176.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.491 HG13 ' HB3' ' A' ' 169' ' ' MET . 0.9 OUTLIER -107.24 119.56 57.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.907 -0.588 . . . . 1.98 109.97 -172.848 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.53 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 35.9 tt0 -134.5 117.15 15.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.028 -0.533 . . . . 1.07 111.296 -166.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 32' ' ' LYS . . . -145.66 144.75 13.37 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 121.05 -0.595 . . . . 0.35 111.643 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 78.9 mt -86.09 131.5 34.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 117.249 0.525 . . . . 1.3 111.175 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.424 ' CD1' ' HB1' ' A' ' 199' ' ' ALA . 55.5 mt -110.46 108.24 58.37 Favored Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-N 115.493 -0.776 . . . . 1.07 109.034 176.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -62.37 56.12 0.13 Allowed 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 124.422 3.415 . . . . 0.74 115.393 -173.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -164.35 -162.97 0.71 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.876 -0.416 . . . . 1.68 109.876 167.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 78.2 p -77.45 138.12 63.6 Favored Pre-proline 0 N--CA 1.431 -1.424 0 CA-C-O 121.918 0.866 . . . . 1.58 112.135 -168.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.512 ' HA ' HD13 ' A' ' 61' ' ' LEU . 18.1 Cg_exo -62.44 -13.6 34.03 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.504 2.802 . . . . 0.74 109.899 172.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.46 -53.38 19.51 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.194 -1.366 . . . . 1.31 110.964 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.477 ' HG2' HD12 ' A' ' 203' ' ' ILE . 15.1 ttpt -68.62 -27.55 66.12 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.244 -1.021 . . . . 3.78 108.244 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.697 ' O ' HD11 ' A' ' 65' ' ' LEU . 28.9 mt -56.99 -60.45 3.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.159 -0.928 . . . . 1.09 110.409 170.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.8 p -62.57 -15.9 53.5 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 121.81 -0.556 . . . . 1.94 110.839 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -92.36 -26.73 17.94 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.048 0.758 . . . . 1.32 113.048 -176.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.648 ' CE2' ' HA ' ' A' ' 199' ' ' ALA . 6.5 p90 -89.2 -41.48 12.21 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.731 -0.606 . . . . 0.79 110.866 -174.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.697 HD11 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -92.93 7.92 41.94 Favored 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 120.761 -0.376 . . . . 2.15 110.02 -179.286 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -44.55 -71.53 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.214 -0.903 . . . . 2.06 112.452 -168.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -139.7 -74.42 0.36 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.204 -0.598 . . . . 4.31 112.522 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.703 ' HB ' ' CD1' ' A' ' 81' ' ' TYR . 9.0 t -156.77 30.92 0.31 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.753 0.787 . . . . 1.89 110.695 -168.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.0 -46.96 4.02 Favored Glycine 0 CA--C 1.49 -1.487 0 C-N-CA 120.01 -1.091 . . . . 1.71 112.636 -173.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.47 ' O ' HG23 ' A' ' 73' ' ' THR . 19.3 p-10 -152.6 -18.18 0.16 Allowed 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.151 -1.025 . . . . 2.19 110.795 -171.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.698 ' HA ' ' CZ2' ' A' ' 74' ' ' TRP . 2.7 ptp180 -48.89 -39.36 25.62 Favored 'General case' 0 C--O 1.218 -0.589 0 C-N-CA 122.759 0.423 . . . . 3.95 110.572 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.529 ' N ' ' HG3' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -88.58 -7.91 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 C-N-CA 120.569 -0.453 . . . . 1.42 111.242 -175.643 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 70' ' ' ASP . 0.8 OUTLIER -97.0 -32.76 11.84 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 119.791 -0.763 . . . . 1.45 111.135 -173.811 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.698 ' CZ2' ' HA ' ' A' ' 71' ' ' ARG . 7.8 p-90 -101.63 -3.49 28.23 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.55 -0.46 . . . . 0.78 111.283 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.695 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 4.8 t70 -65.06 -178.64 0.47 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.869 0.842 . . . . 2.19 112.356 -172.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.677 ' HG2' ' OD1' ' A' ' 198' ' ' ASN . 66.8 mmtt -104.56 -33.26 8.6 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.793 -1.094 . . . . 3.68 108.852 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.478 ' HA ' ' HB2' ' A' ' 99' ' ' GLN . 16.8 m -134.61 19.52 3.59 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.344 -0.844 . . . . 2.08 112.203 -170.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.479 HD11 HG23 ' A' ' 72' ' ' ILE . 27.7 mt -108.17 153.42 23.2 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.026 0.441 . . . . 1.16 110.508 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.486 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 26.1 mm-40 -134.28 -67.0 0.59 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.671 -0.695 . . . . 2.23 110.606 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 96' ' ' THR . 2.4 t -136.73 112.01 11.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.674 -0.694 . . . . 1.44 110.847 -170.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.703 ' CD1' ' HB ' ' A' ' 68' ' ' THR . 18.0 t80 -98.92 137.79 36.98 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.013 -0.736 . . . . 5.73 109.013 175.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -143.16 107.44 4.76 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.442 -0.577 . . . . 1.86 109.442 -175.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.467 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 2.8 mtm -66.77 102.25 0.92 Allowed 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.996 -0.742 . . . . 2.52 108.996 174.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.3 OUTLIER -72.9 -71.01 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.919 -0.582 . . . . 1.19 110.843 -170.075 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -133.19 118.66 18.9 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.677 -0.861 . . . . 2.59 108.677 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.467 ' HD3' ' SD ' ' A' ' 83' ' ' MET . 44.0 mtm180 -93.89 105.27 17.29 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.126 0.489 . . . . 2.83 109.965 -175.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.632 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -69.08 -44.45 81.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.355 -0.839 . . . . 1.17 110.945 -175.323 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.444 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 15.0 t70 -147.9 168.0 23.37 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.928 -1.033 . . . . 1.86 108.253 -173.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.2 m -68.05 -3.67 10.96 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.594 0.235 . . . . 1.94 111.112 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -130.77 4.52 4.56 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 110.177 -0.305 . . . . 1.87 110.177 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.632 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -133.3 108.79 8.95 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 109.114 -0.698 . . . . 1.12 109.114 -172.433 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.63 ' O ' HD12 ' A' ' 114' ' ' LEU . 17.1 m-85 -125.38 174.74 7.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.876 -0.602 . . . . 0.52 110.127 -174.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.557 HG23 ' CE1' ' A' ' 134' ' ' PHE . 39.4 mt -131.55 132.79 62.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 107.927 -1.138 . . . . 1.1 107.927 171.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.45 ' HB3' ' OH ' ' A' ' 81' ' ' TYR . 23.6 p -110.93 106.26 15.32 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.585 -0.446 . . . . 2.61 111.961 -171.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.576 ' HA ' ' O ' ' A' ' 111' ' ' PHE . 2.1 t60 -81.23 90.06 6.07 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.441 -0.948 . . . . 2.17 108.441 167.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.62 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 35.0 m -115.47 114.58 25.22 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.555 -0.748 . . . . 1.19 111.938 -171.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 38.1 mm -76.52 121.98 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 109.01 -0.737 . . . . 1.63 109.01 174.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' A' ' 109' ' ' ARG . 25.7 m -109.4 143.73 38.58 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.544 -1.207 . . . . 1.72 109.861 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.486 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 22.2 mt-30 . . . . . 0 C--N 1.323 -0.578 0 CA-C-N 115.693 -0.685 . . . . 2.29 111.625 -176.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 73.6 mt . . . . . 0 N--CA 1.451 -0.397 0 CA-C-O 121.163 0.506 . . . . 1.53 111.159 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.467 ' OG ' ' HD2' ' A' ' 108' ' ' PRO . 32.4 t -92.19 159.83 36.6 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.354 -0.839 . . . . 1.71 109.25 178.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.467 ' HD2' ' OG ' ' A' ' 107' ' ' SER . 97.2 Cg_exo -44.63 142.37 4.85 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.44 2.093 . . . . 1.31 111.374 171.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.693 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 29.1 ttp-105 -126.21 130.8 51.67 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.545 -0.462 . . . . 4.06 109.879 -167.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 9.1 t0 -104.73 125.07 50.45 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.736 -0.468 . . . . 1.37 109.736 -176.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.62 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 12.0 m-30 -95.97 143.65 26.96 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.244 0.545 . . . . 3.01 110.621 -172.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.629 ' CG2' ' HE1' ' A' ' 134' ' ' PHE . 26.9 mm -138.36 61.2 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 107.085 -1.45 . . . . 1.2 107.085 170.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.464 ' OD1' ' HB2' ' A' ' 148' ' ' ASN . 45.7 m-20 -96.46 125.41 40.93 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.658 -1.156 . . . . 1.86 109.766 -175.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.63 HD12 ' O ' ' A' ' 92' ' ' PHE . 7.7 tp -75.22 126.89 31.94 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.988 -0.551 . . . . 1.08 109.524 173.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -127.01 128.18 70.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.596 -0.729 . . . . 1.08 111.929 -165.475 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.521 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 7.7 t80 -113.15 114.23 26.5 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.156 -0.929 . . . . 2.81 110.324 175.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.454 HG12 HG23 ' A' ' 127' ' ' ILE . 71.9 mt -90.41 99.29 9.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.84 -0.618 . . . . 1.53 109.401 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.475 ' HB3' HG21 ' A' ' 126' ' ' ILE . 15.4 tppt? -102.4 123.06 45.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.572 -0.74 . . . . 1.81 110.948 -173.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -103.07 93.28 4.93 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.869 -0.605 . . . . 3.22 109.443 177.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -70.97 106.12 3.54 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 107.181 -1.414 . . . . 1.28 107.181 168.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -26.1 92.98 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 O-C-N 125.123 1.514 . . . . 2.28 113.631 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 53.7 43.27 68.98 Favored Glycine 0 CA--C 1.508 -0.385 0 CA-C-N 115.316 -0.856 . . . . 0.79 112.176 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.644 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 3.6 t-20 -139.02 -47.77 0.49 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.054 -0.573 . . . . 2.06 110.585 -174.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.516 ' SD ' HD12 ' A' ' 15' ' ' LEU . 2.4 mtt -161.13 121.21 2.69 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 120.953 0.406 . . . . 1.73 110.919 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -106.34 75.16 1.07 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.452 -0.944 . . . . 2.07 108.452 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.651 ' HA ' ' O ' ' A' ' 153' ' ' PHE . 0.5 OUTLIER -97.08 141.5 15.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.004 -0.998 . . . . 1.06 112.866 -172.173 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.695 ' O ' HG13 ' A' ' 127' ' ' ILE . 6.4 pt -109.45 108.97 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-O 121.756 0.789 . . . . 1.26 108.99 163.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 56.4 p -95.25 117.93 31.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.191 0.519 . . . . 1.53 110.955 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.548 ' HB2' ' SG ' ' A' ' 151' ' ' CYS . 20.1 m -114.6 151.57 33.25 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.199 0.523 . . . . 1.81 111.458 -174.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.456 ' CE ' HD23 ' A' ' 114' ' ' LEU . 10.3 mtmm -140.92 130.12 23.53 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.787 -0.82 . . . . 2.75 108.787 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.407 ' HB3' ' H ' ' A' ' 148' ' ' ASN . 21.7 p -73.76 101.46 3.71 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.832 -0.803 . . . . 1.94 108.832 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.3 m -105.72 173.55 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 120.048 -0.661 . . . . 1.64 110.173 -176.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -135.65 65.42 1.54 Allowed 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 122.069 0.938 . . . . 2.17 109.354 -174.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.629 ' HE1' ' CG2' ' A' ' 112' ' ' ILE . 1.0 OUTLIER -97.08 153.62 38.44 Favored Pre-proline 0 C--N 1.317 -0.839 0 CA-C-N 114.088 -1.414 . . . . 0.67 108.852 -175.644 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -83.39 5.42 6.41 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.082 1.855 . . . . 1.66 116.483 -166.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.581 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 11.8 tp10 -76.06 -15.95 60.02 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 119.253 0.933 . . . . 3.5 108.505 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -156.75 114.73 2.03 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 113.315 0.857 . . . . 6.41 113.315 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -95.06 139.43 0.98 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.671 2.914 . . . . 2.31 111.85 169.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -80.6 -165.4 0.34 Allowed 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.608 2.205 . . . . 1.27 112.988 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.1 m -147.62 152.37 37.78 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.94 -1.133 . . . . 1.88 107.94 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.1 t -61.45 -16.9 51.47 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.953 0.723 . . . . 2.43 112.953 -167.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -82.72 -18.52 40.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.943 0.402 . . . . 2.18 110.94 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.489 ' HB3' ' CB ' ' A' ' 110' ' ' ASP . 94.1 m-85 -130.82 109.15 10.37 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.73 -0.668 . . . . 1.33 109.804 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.693 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 2.1 tp -89.19 115.02 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 CA-C-N 115.795 -0.638 . . . . 1.4 109.659 -169.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.548 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 30.3 ttp180 -36.02 115.75 0.35 Allowed 'General case' 0 C--N 1.327 -0.403 0 O-C-N 124.618 1.198 . . . . 5.14 111.076 175.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -42.63 108.0 0.13 Allowed Glycine 0 CA--C 1.496 -1.096 0 O-C-N 124.655 1.222 . . . . 1.05 112.358 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.61 ' HB2' ' HB3' ' A' ' 174' ' ' GLU . 1.3 p90 -86.01 55.33 3.48 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.201 -0.499 . . . . 4.68 111.835 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.686 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 84.5 m-20 -98.64 65.36 1.57 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.489 -0.778 . . . . 2.29 110.702 -177.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -54.44 146.2 34.36 Favored Pre-proline 0 N--CA 1.467 0.379 0 CA-C-N 115.843 -0.617 . . . . 2.95 110.421 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -10.01 62.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.312 1 C-N-CA 126.853 5.035 . . . . 0.77 115.838 -161.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . 0.686 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 27.6 p -84.19 171.13 13.07 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.347 -1.297 . . . . 1.97 109.069 173.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' A' ' 169' ' ' MET . . . -167.8 -168.04 29.35 Favored Glycine 0 N--CA 1.433 -1.552 0 C-N-CA 119.744 -1.217 . . . . 0.55 111.854 177.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.651 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 39.9 t80 -162.66 77.01 0.46 Allowed 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 109.064 -0.717 . . . . 0.8 109.064 -165.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.551 ' CG2' HG12 ' A' ' 168' ' ' VAL . 3.9 m -89.27 121.6 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 122.034 0.921 . . . . 1.03 110.607 -175.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 32.3 m -100.43 112.74 25.13 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.037 -0.983 . . . . 2.3 108.728 175.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.404 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 7.1 m -106.8 111.43 63.83 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 116.492 -0.322 . . . . 1.45 111.406 -171.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.644 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 57.7 Cg_exo -52.16 119.34 5.62 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.421 2.081 . . . . 0.72 111.002 168.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 72.2 mtp -81.37 -169.98 2.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.976 0.417 . . . . 1.72 111.348 -176.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -67.28 -30.53 70.42 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.854 -0.795 . . . . 2.63 108.854 169.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.419 ' C ' ' HD2' ' A' ' 162' ' ' PRO . 47.1 mm-40 -104.32 28.79 6.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.607 -1.179 . . . . 2.05 109.274 175.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.572 ' OD1' ' HD3' ' A' ' 162' ' ' PRO . 4.8 p30 -34.81 -47.82 0.94 Allowed Pre-proline 0 N--CA 1.472 0.643 0 N-CA-C 116.16 1.911 . . . . 2.19 116.16 -171.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.572 ' HD3' ' OD1' ' A' ' 161' ' ' ASN . 66.3 Cg_endo -72.51 -25.09 18.27 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 CA-C-N 121.534 1.584 . . . . 0.86 112.378 -174.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -100.78 -25.55 14.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.761 -0.654 . . . . 1.34 110.919 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -142.48 119.99 11.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.986 -0.552 . . . . 1.46 110.238 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.583 ' OG ' HD11 ' A' ' 61' ' ' LEU . 13.8 p -114.47 140.83 48.4 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.169 0.509 . . . . 2.05 110.972 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.53 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 2.0 tppp? -91.51 104.04 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.892 0.853 . . . . 1.4 111.577 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.548 HD21 ' CE2' ' A' ' 153' ' ' PHE . 0.8 OUTLIER -89.49 111.61 22.55 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.87 -1.059 . . . . 1.07 109.241 177.756 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.551 HG12 ' CG2' ' A' ' 154' ' ' VAL . 0.1 OUTLIER -132.16 116.41 29.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 122.099 0.952 . . . . 1.11 111.91 175.094 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.491 ' HB3' HG13 ' A' ' 50' ' ' VAL . 19.4 ttt -112.57 158.99 19.29 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.462 -1.244 . . . . 1.79 108.817 -175.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.525 ' CD1' HG21 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -140.06 151.15 45.17 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 110.47 -0.196 . . . . 4.22 110.47 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.504 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 6.6 m -136.87 128.23 42.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 O-C-N 123.385 0.428 . . . . 2.01 110.931 173.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -108.15 49.7 0.8 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.106 -1.442 . . . . 2.66 107.106 174.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -47.68 130.65 14.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.383 -1.735 . . . . 2.2 113.541 -166.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.61 ' HB3' ' HB2' ' A' ' 147' ' ' TYR . 21.9 tt0 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.274 -0.876 . . . . 2.45 111.04 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.461 ' HA ' ' CE ' ' A' ' 186' ' ' LYS . 33.0 mm . . . . . 0 CA--C 1.503 -0.864 0 CA-C-O 122.528 1.156 . . . . 1.69 108.724 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.64 ' HA ' ' CG2' ' A' ' 187' ' ' THR . 1.4 mp -66.69 -34.14 68.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 112.889 -1.959 . . . . 1.77 110.597 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -62.04 -21.33 64.82 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.793 -1.094 . . . . 2.89 109.39 174.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.461 ' CE ' ' HA ' ' A' ' 183' ' ' ILE . 50.8 mtmt -92.53 -49.34 6.17 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.382 -0.826 . . . . 1.71 110.222 172.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.64 ' CG2' ' HA ' ' A' ' 184' ' ' ILE . 6.5 t -61.55 -35.08 76.74 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.328 0.492 . . . . 1.3 112.328 -168.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' MET . . . . . 0.598 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 2.1 mmt -80.35 -61.24 0.44 Allowed Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 119.921 -0.712 . . . . 1.39 111.946 -177.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.598 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 8.0 Cg_exo -73.38 -12.53 25.16 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.03 1.82 . . . . 1.15 112.545 -172.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.564 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 11.6 t -91.82 -33.48 14.94 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.784 -0.366 . . . . 1.95 110.311 176.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.2 OUTLIER -81.27 -38.4 26.92 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.44 -0.346 . . . . 1.92 110.538 -173.556 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 188' ' ' MET . 54.7 mt -67.61 -44.68 77.47 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.888 0.375 . . . . 1.68 111.277 -176.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.449 ' HB ' HD13 ' A' ' 33' ' ' ILE . 2.1 m -66.95 -31.94 55.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.54 0.686 . . . . 1.32 109.354 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.564 ' HB2' ' O ' ' A' ' 190' ' ' SER . 0.6 OUTLIER -74.34 -27.23 60.59 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.668 -1.151 . . . . 2.6 110.628 179.534 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.419 ' O ' ' HB2' ' A' ' 198' ' ' ASN . 2.6 t80 -73.66 -30.27 62.82 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.623 -0.88 . . . . 2.73 108.623 175.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.69 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 17.6 mt -77.25 -34.3 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 116.079 -0.51 . . . . 1.11 110.703 173.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 74.2 mt -67.49 -37.04 82.26 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 121.229 0.538 . . . . 1.57 109.702 174.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.677 ' OD1' ' HG2' ' A' ' 76' ' ' LYS . 22.0 m-20 -50.65 -36.26 34.66 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.718 -1.128 . . . . 2.18 109.671 167.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.648 ' HA ' ' CE2' ' A' ' 64' ' ' PHE . . . -81.04 -42.35 21.23 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 115.926 -0.579 . . . . 1.04 110.944 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.69 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 10.3 mmmm -58.81 -38.89 79.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.548 0.689 . . . . 1.51 110.164 176.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -88.75 -43.54 11.2 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.902 -1.045 . . . . 1.94 111.092 -178.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -66.75 -31.52 78.62 Favored Glycine 0 CA--C 1.504 -0.626 0 C-N-CA 121.009 -0.615 . . . . 0.47 111.984 -176.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.618 ' CD1' HD21 ' A' ' 61' ' ' LEU . 4.7 tp -67.67 -34.47 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-O 121.274 0.559 . . . . 1.16 110.107 178.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -87.21 -30.63 20.82 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.813 -0.631 . . . . 3.8 109.555 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.875 0 CA-C-N 115.353 -0.84 . . . . 1.28 109.231 168.277 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.568 ' O ' HD11 ' A' ' 6' ' ' ILE . 7.5 m-20 . . . . . 0 CA--C 1.503 -0.827 0 CA-C-O 120.744 0.307 . . . . 2.25 110.518 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.57 ' HA ' HD11 ' A' ' 6' ' ' ILE . 81.2 m-85 -60.67 -29.08 69.08 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 115.465 -0.789 . . . . 0.45 110.586 -170.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.603 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 21.0 ttmt -74.05 -37.13 64.38 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 107.952 -1.129 . . . . 2.06 107.952 -174.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.71 -37.23 78.32 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.568 -0.742 . . . . 1.2 110.556 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.612 HG21 ' HE3' ' A' ' 130' ' ' LYS . 1.7 mp -82.75 -39.35 15.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.922 0.868 . . . . 1.76 109.131 -174.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.66 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -75.89 -37.41 58.87 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.275 -1.329 . . . . 1.11 111.595 -177.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.603 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 15.2 mt-30 -65.94 -28.24 68.77 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.346 -0.843 . . . . 2.14 109.803 176.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -81.06 -34.89 32.42 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.753 -1.112 . . . . 3.04 109.555 174.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.702 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.3 OUTLIER -74.1 -36.5 64.26 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.067 -0.969 . . . . 1.1 111.486 -179.25 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.507 ' O ' ' HB3' ' A' ' 15' ' ' LEU . . . -46.14 -53.77 9.83 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-O 120.911 0.386 . . . . 1.04 110.651 172.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -78.81 -1.68 36.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.924 -0.58 . . . . 2.31 111.989 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.649 ' HB3' ' HA ' ' A' ' 10' ' ' THR . 0.8 OUTLIER -87.87 -49.45 7.09 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.767 -0.827 . . . . 2.54 108.767 175.389 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.651 HG22 ' N ' ' A' ' 152' ' ' GLY . 13.0 p -69.39 -40.7 80.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 122.237 1.017 . . . . 1.21 109.039 178.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.507 ' HB3' ' O ' ' A' ' 11' ' ' ALA . 0.9 OUTLIER -73.74 -17.92 61.05 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 114.378 -1.283 . . . . 1.26 109.186 175.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.537 ' HA2' ' NE ' ' A' ' 19' ' ' ARG . . . -58.0 -32.85 67.35 Favored Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 109.728 -1.349 . . . . 0.57 109.728 171.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.488 ' HD1' ' O ' ' A' ' 13' ' ' GLU . 9.5 m-85 -88.05 -15.71 35.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.872 -0.664 . . . . 3.59 109.894 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.48 ' HA ' ' NH1' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -89.43 -19.84 24.66 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 120.414 -0.514 . . . . 2.1 110.429 176.363 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.537 ' NE ' ' HA2' ' A' ' 16' ' ' GLY . 17.2 ptt180 -96.02 -21.58 17.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.35 -0.387 . . . . 3.26 111.574 -171.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -130.83 157.23 43.44 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 119.615 -0.834 . . . . 2.16 111.174 170.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 71.5 p -136.29 158.09 45.24 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.91 -1.041 . . . . 2.24 109.389 -173.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.0 t -170.17 -148.57 0.06 Allowed 'General case' 0 C--O 1.234 0.272 0 C-N-CA 120.083 -0.647 . . . . 2.46 111.05 -172.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.73 75.16 0.73 Allowed Glycine 0 C--N 1.331 0.29 0 CA-C-N 116.227 -0.442 . . . . 1.45 113.494 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.855 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -109.27 -153.06 0.5 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.4 -0.592 . . . . 2.24 109.4 172.203 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' A' ' 25' ' ' LYS . 8.5 ttpt -178.43 126.27 0.11 Allowed 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 108.263 -1.014 . . . . 3.43 108.263 -176.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.575 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 3.2 m -64.89 123.22 17.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 122.057 0.932 . . . . 2.21 110.667 174.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.9 p -93.74 -24.03 5.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 114.353 -1.294 . . . . 1.83 108.271 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.413 ' HD2' ' HA ' ' A' ' 28' ' ' LYS . 5.4 tptm -155.44 133.85 11.73 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 119.744 -0.782 . . . . 2.87 112.146 -177.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.852 HG21 ' HA ' ' A' ' 34' ' ' THR . 45.9 p -137.07 101.5 4.57 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.274 -0.639 . . . . 1.92 109.274 169.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 13.8 m -140.92 108.69 5.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.278 -0.419 . . . . 2.37 110.961 -175.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 30' ' ' SER . 56.7 mttm 79.6 64.46 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.752 0.657 . . . . 4.84 111.627 176.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 44.3 tptt 75.33 15.65 2.8 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.101 -0.5 . . . . 2.05 112.233 168.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.908 HG21 ' HA3' ' A' ' 52' ' ' GLY . 31.7 pt -135.08 169.96 20.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.551 0.691 . . . . 1.42 112.833 -172.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.852 ' HA ' HG21 ' A' ' 29' ' ' THR . 87.7 m -152.15 106.01 3.12 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.572 -1.195 . . . . 1.22 110.696 -169.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.963 HG12 HD12 ' A' ' 192' ' ' LEU . 2.3 t -101.95 108.13 23.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.252 -0.431 . . . . 1.52 110.31 -177.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.575 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 1.6 p -102.96 127.17 50.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.506 0.669 . . . . 1.74 111.38 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.2 p -98.02 121.65 40.19 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.12 -0.945 . . . . 1.72 111.385 -174.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.855 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 5.3 ttpp . . . . . 0 C--N 1.325 -0.468 0 CA-C-N 115.992 -0.549 . . . . 2.45 112.08 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 CA--C 1.512 -0.519 0 CA-C-O 120.646 0.26 . . . . 2.45 110.688 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.996 HD11 ' HB2' ' A' ' 172' ' ' GLN . 10.6 tt -86.25 135.55 33.51 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.379 -1.341 . . . . 1.49 107.379 170.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.442 ' HB2' HD22 ' A' ' 192' ' ' LEU . 99.6 m-85 -109.92 117.33 33.51 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.219 0.533 . . . . 1.52 110.321 -172.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.634 ' HD3' ' CZ3' ' A' ' 24' ' ' TRP . 28.3 ttt180 -93.75 107.53 19.4 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.225 -0.898 . . . . 3.34 110.279 177.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.555 HG23 HD21 ' A' ' 192' ' ' LEU . 0.0 OUTLIER -82.87 140.84 15.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.406 -0.961 . . . . 1.98 108.406 174.555 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.755 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 54.7 tt0 -151.52 108.61 3.56 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.054 0.454 . . . . 1.07 109.983 -178.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.908 ' HA3' HG21 ' A' ' 33' ' ' ILE . . . -145.46 154.9 26.23 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 111.153 -0.779 . . . . 0.35 111.153 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.0 mt -97.86 114.36 34.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 119.918 -0.713 . . . . 1.3 111.205 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.453 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 68.7 mt -92.31 111.6 51.2 Favored Pre-proline 0 N--CA 1.443 -0.821 0 N-CA-C 108.373 -0.973 . . . . 1.07 108.373 170.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 22.0 Cg_exo -66.52 54.57 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 124.266 3.311 . . . . 0.74 113.167 -177.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.657 ' HG2' HG13 ' A' ' 203' ' ' ILE . 10.8 tp10 -151.65 167.63 27.53 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 107.417 -1.327 . . . . 1.68 107.417 175.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.509 ' HB3' ' HA ' ' A' ' 162' ' ' PRO . 23.8 p -70.12 137.09 86.94 Favored Pre-proline 0 N--CA 1.431 -1.397 0 CA-C-O 121.683 0.754 . . . . 1.58 111.404 -176.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.798 ' HA ' HD13 ' A' ' 61' ' ' LEU . 6.3 Cg_endo -49.55 -18.18 2.31 Favored 'Trans proline' 0 C--O 1.23 0.116 0 C-N-CA 124.698 3.598 . . . . 0.74 111.677 170.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.85 -47.82 50.37 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.082 -0.963 . . . . 1.31 110.692 176.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.55 ' HB3' HD12 ' A' ' 203' ' ' ILE . 4.5 tppt? -68.02 -29.83 68.93 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.71 -0.848 . . . . 3.78 108.71 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 1.009 HD22 HD13 ' A' ' 203' ' ' ILE . 88.5 mt -60.02 -53.97 51.54 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.906 -1.043 . . . . 1.09 110.25 174.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.506 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 19.3 p -68.05 -12.61 61.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.107 0.479 . . . . 1.94 110.44 175.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.484 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 37.8 t70 -82.28 -33.06 29.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.794 -0.639 . . . . 1.32 111.409 -177.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.506 ' CE2' ' HA ' ' A' ' 61' ' ' LEU . 15.4 p90 -83.7 -47.51 11.13 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.404 -0.518 . . . . 0.79 110.976 -177.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.506 ' CD2' ' HA ' ' A' ' 62' ' ' SER . 0.7 OUTLIER -83.5 -1.79 54.46 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.4 -0.52 . . . . 2.15 111.904 -172.154 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -38.34 -47.94 1.28 Allowed 'General case' 0 C--N 1.327 -0.373 0 O-C-N 124.806 1.316 . . . . 2.06 114.448 -162.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -162.21 -84.09 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 114.261 1.208 . . . . 4.31 114.261 -175.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.746 ' HB ' ' CD1' ' A' ' 81' ' ' TYR . 10.8 t -150.86 13.57 0.71 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.406 0.521 . . . . 1.89 112.406 -166.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -111.25 -6.67 25.54 Favored Glycine 0 C--N 1.306 -1.132 0 C-N-CA 118.987 -1.578 . . . . 1.71 113.203 -165.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.734 ' O ' HG21 ' A' ' 73' ' ' THR . 12.9 t70 -162.41 -41.45 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.369 0.604 . . . . 2.19 110.136 -167.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.694 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 1.5 ptp180 -49.92 -47.42 52.3 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.904 -1.044 . . . . 3.95 111.64 -176.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.853 HG21 HD13 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -90.05 -8.04 10.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.697 -0.401 . . . . 1.42 111.054 -174.333 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.734 HG21 ' O ' ' A' ' 70' ' ' ASP . 4.8 t -83.29 -35.67 25.09 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 119.171 -1.011 . . . . 1.45 110.089 -176.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.713 ' HZ3' ' HB2' ' A' ' 198' ' ' ASN . 20.4 p-90 -103.27 -6.09 22.41 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.413 -0.515 . . . . 0.78 111.982 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.798 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 5.5 t70 -67.24 172.93 4.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.864 0.84 . . . . 2.19 112.288 -170.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.451 ' H ' ' HG3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -118.08 -11.12 10.22 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.52 -1.218 . . . . 3.68 111.61 -174.327 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.1 m -140.88 17.36 2.31 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.496 0.665 . . . . 2.08 109.899 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.853 HD13 HG21 ' A' ' 72' ' ' ILE . 21.9 mt -108.03 157.33 18.34 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.593 -0.73 . . . . 1.16 110.624 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.759 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 16.4 mm-40 -131.89 -71.1 0.56 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.577 -0.738 . . . . 2.23 111.074 -178.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.854 ' HB ' HD11 ' A' ' 97' ' ' ILE . 15.1 t -137.41 142.8 35.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.599 -0.728 . . . . 1.44 109.892 -170.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.746 ' CD1' ' HB ' ' A' ' 68' ' ' THR . 25.3 t80 -124.2 137.51 54.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.989 0.423 . . . . 5.73 110.431 176.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.879 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 5.3 m-20 -128.97 111.78 13.37 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.664 -0.865 . . . . 1.86 108.664 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.702 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 20.1 ttm -75.85 96.37 3.69 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.838 -0.801 . . . . 2.52 108.838 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.63 HG22 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -78.54 -83.31 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 116.36 -0.382 . . . . 1.19 111.741 -168.52 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.462 ' HB2' HD11 ' A' ' 93' ' ' ILE . 32.1 m170 -122.56 122.75 39.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.27 0.557 . . . . 2.59 110.25 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.744 ' HG2' ' HD2' ' A' ' 92' ' ' PHE . 81.2 mtm180 -105.68 108.79 20.49 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.225 -0.898 . . . . 2.83 109.219 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -72.68 -39.95 61.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.428 -0.806 . . . . 1.17 110.067 -173.763 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -152.08 -171.0 3.8 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.409 -0.814 . . . . 1.86 109.188 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.6 t -78.88 -5.56 53.9 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.795 0.331 . . . . 1.94 110.389 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -122.81 -4.3 8.63 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.94 -0.393 . . . . 1.87 109.94 -176.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.648 HG22 ' HD1' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -135.93 112.06 9.69 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.301 -0.629 . . . . 1.12 109.301 -169.132 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.744 ' HD2' ' HG2' ' A' ' 86' ' ' ARG . 10.8 m-85 -125.39 178.73 5.45 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.651 -0.5 . . . . 0.52 109.651 -177.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.63 ' O ' HG22 ' A' ' 84' ' ' VAL . 42.6 mt -133.0 128.94 57.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 107.094 -1.447 . . . . 1.1 107.094 168.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.5 ' SG ' ' HB2' ' A' ' 113' ' ' ASP . 6.6 p -113.18 112.32 23.58 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.122 0.487 . . . . 2.61 112.13 -170.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.879 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 4.7 t-160 -82.64 93.96 7.46 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.64 -0.874 . . . . 2.17 108.64 170.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 21.8 m -113.11 111.57 22.35 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.25 -0.432 . . . . 1.19 111.965 -172.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.854 HD11 ' HB ' ' A' ' 80' ' ' VAL . 3.4 mp -77.27 120.42 27.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 108.642 -0.874 . . . . 1.63 108.642 174.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 49.6 m -111.72 138.37 48.39 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.368 -0.833 . . . . 1.72 111.909 -170.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.759 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 42.6 mt-30 . . . . . 0 C--N 1.32 -0.687 0 CA-C-N 116.089 -0.505 . . . . 2.29 109.784 174.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.461 HG21 ' O ' ' A' ' 107' ' ' SER . 65.7 mt . . . . . 0 N--CA 1.448 -0.555 0 CA-C-O 120.937 0.398 . . . . 1.53 111.034 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.461 ' O ' HG21 ' A' ' 106' ' ' ILE . 19.8 m -94.26 164.88 18.87 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.661 -0.699 . . . . 1.71 109.539 173.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.22 141.67 30.65 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.234 1.956 . . . . 1.31 111.458 173.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.625 ' HG2' HG23 ' A' ' 144' ' ' ILE . 54.6 mtt180 -116.33 173.95 6.32 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.049 0.452 . . . . 4.06 110.689 -174.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.818 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 9.8 t70 -132.72 123.07 25.56 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.56 -0.746 . . . . 1.37 109.04 -177.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.525 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 9.6 m-30 -103.63 140.42 37.59 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.146 0.498 . . . . 3.01 111.366 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.662 HG13 ' HA ' ' A' ' 137' ' ' TYR . 25.5 mm -132.38 75.14 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.124 -0.944 . . . . 1.2 108.691 173.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.884 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 17.2 m-20 -99.85 123.18 43.84 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.695 -0.684 . . . . 1.86 110.808 -173.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.607 HD13 ' O ' ' A' ' 92' ' ' PHE . 7.6 tp -76.38 123.53 26.12 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 108.71 -0.848 . . . . 1.08 108.71 167.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -127.15 124.62 64.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.562 -0.744 . . . . 1.08 112.384 -163.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.66 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 54.5 t80 -109.75 118.23 35.97 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.273 -0.876 . . . . 2.81 110.947 174.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.479 HG13 ' HB ' ' A' ' 127' ' ' ILE . 5.1 mp -97.5 120.85 47.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.787 -0.642 . . . . 1.53 109.923 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.417 ' HB3' ' CE2' ' A' ' 116' ' ' TYR . 14.0 ptpt -140.56 147.41 39.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.041 0.448 . . . . 1.81 110.714 177.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.481 ' HD2' ' C ' ' A' ' 119' ' ' ARG . 1.7 tmm_? -125.64 99.97 6.23 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 109.014 -0.735 . . . . 3.22 109.014 -176.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -63.45 116.32 5.45 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.406 -1.331 . . . . 1.28 107.406 169.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.405 ' HA ' ' NH1' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -33.09 90.13 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 O-C-N 125.12 1.513 . . . . 2.28 114.682 -175.451 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 58.05 29.32 62.22 Favored Glycine 0 C--O 1.229 -0.198 0 CA-C-N 114.716 -1.129 . . . . 0.79 112.62 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.417 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 33.7 t-20 -119.72 -49.18 2.34 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.538 -0.541 . . . . 2.06 109.538 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.433 ' HE2' ' HB2' ' A' ' 124' ' ' MET . 1.9 mtm -161.93 122.74 2.64 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.972 0.415 . . . . 1.73 111.226 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.484 HD22 ' HB3' ' A' ' 62' ' ' SER . 59.3 t30 -109.4 80.82 1.36 Allowed 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.716 -0.846 . . . . 2.07 108.716 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.711 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -100.57 139.48 21.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.232 -0.895 . . . . 1.06 112.81 -173.191 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.645 ' O ' HG13 ' A' ' 127' ' ' ILE . 1.9 pt -108.64 116.58 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 108.318 -0.993 . . . . 1.26 108.318 160.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 26.5 p -87.54 156.98 19.27 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.102 -0.703 . . . . 1.53 109.102 175.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.884 ' HB3' ' HB3' ' A' ' 113' ' ' ASP . 50.2 m -153.9 136.35 15.02 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.758 0.313 . . . . 1.81 111.576 -178.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.882 ' HE2' ' HG3' ' A' ' 150' ' ' PRO . 4.6 mtpm? -131.04 122.77 27.37 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 107.824 -1.176 . . . . 2.75 107.824 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.574 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 70.4 p -64.49 99.02 0.28 Allowed 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.098 -1.445 . . . . 1.94 107.098 174.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.419 HG13 ' HE1' ' A' ' 3' ' ' PHE . 0.4 OUTLIER -107.57 137.34 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 CA-C-N 115.265 -0.879 . . . . 1.64 108.709 -165.531 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.602 ' HA ' ' CG ' ' A' ' 137' ' ' TYR . 9.8 p-10 -92.05 69.57 5.35 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.678 -1.147 . . . . 2.17 110.543 -167.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.711 ' CZ ' ' HB3' ' A' ' 136' ' ' GLU . 1.7 p90 -105.15 173.36 3.33 Favored Pre-proline 0 CA--C 1.546 0.82 0 CA-C-N 113.927 -1.488 . . . . 0.67 108.313 -176.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.527 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 31.8 Cg_exo -28.05 -57.17 0.12 Allowed 'Trans proline' 0 CA--C 1.548 1.182 0 C-N-CA 124.875 3.716 . . . . 1.66 116.964 -177.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.711 ' HB3' ' CZ ' ' A' ' 134' ' ' PHE . 17.8 tp10 -80.77 -21.44 41.03 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.635 0.606 . . . . 3.5 112.635 -174.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.662 ' HA ' HG13 ' A' ' 112' ' ' ILE . 17.8 t80 -49.43 -43.12 69.95 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 114.403 1.26 . . . . 6.41 114.403 -177.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.451 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 32.0 Cg_exo -39.31 119.55 0.52 Allowed 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 122.386 2.057 . . . . 2.31 113.28 175.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.899 ' HB3' ' HD3' ' A' ' 145' ' ' ARG . 50.6 Cg_endo -89.14 -163.1 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.422 2.748 . . . . 1.27 113.773 -172.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.5 m -142.73 -169.32 2.97 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.79 -0.819 . . . . 1.88 108.79 -175.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.8 t -80.46 -45.31 17.78 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.18 -0.608 . . . . 2.43 110.028 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -69.58 -28.31 65.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.073 -0.512 . . . . 2.18 110.86 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.818 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 65.5 m-85 -118.87 109.12 15.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.975 -0.557 . . . . 1.33 110.542 -174.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.625 HG23 ' HG2' ' A' ' 109' ' ' ARG . 2.5 tp -98.66 111.95 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-O 121.314 0.578 . . . . 1.4 109.695 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.899 ' HD3' ' HB3' ' A' ' 139' ' ' PRO . 4.7 mpt_? -57.89 100.48 0.06 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.814 -1.085 . . . . 5.14 110.888 176.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -66.99 115.53 7.31 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 110.404 -1.079 . . . . 1.05 110.404 174.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -84.55 86.16 7.33 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.486 0.66 . . . . 4.68 110.612 -173.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.463 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 90.5 m-20 -70.42 105.62 3.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.987 -1.006 . . . . 2.29 110.411 175.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.632 ' HB3' ' HB3' ' A' ' 172' ' ' GLN . 25.3 t60 -57.82 126.59 76.93 Favored Pre-proline 0 CA--C 1.506 -0.745 0 N-CA-C 107.609 -1.256 . . . . 2.95 107.609 167.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.882 ' HG3' ' HE2' ' A' ' 130' ' ' LYS . 23.7 Cg_exo -12.13 69.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 1 C-N-CA 126.853 5.035 . . . . 0.77 115.37 -173.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 24.1 p -77.47 178.41 7.24 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.241 -1.345 . . . . 1.97 110.574 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.651 ' N ' HG22 ' A' ' 14' ' ' VAL . . . -170.56 -164.9 27.06 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 120.309 -0.948 . . . . 0.55 111.675 175.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -161.38 73.19 0.44 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.632 -0.877 . . . . 0.8 108.632 -164.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.711 HG12 ' HB ' ' A' ' 126' ' ' ILE . 8.4 m -83.24 115.26 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-O 122.113 0.959 . . . . 1.03 110.32 -175.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 64.3 m -98.27 107.58 20.08 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.417 -0.811 . . . . 2.3 109.027 177.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.714 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 10.1 m -97.63 112.64 61.92 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 116.28 -0.418 . . . . 1.45 111.023 -170.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.538 ' HB3' ' ND2' ' A' ' 161' ' ' ASN . 52.4 Cg_exo -51.76 120.48 7.13 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.376 2.05 . . . . 0.72 110.598 172.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.95 ' HE1' ' HA ' ' A' ' 158' ' ' MET . 2.7 mmt -79.87 -167.92 1.43 Allowed 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.234 0.54 . . . . 1.72 111.453 -175.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -70.97 -16.78 62.66 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.485 -0.779 . . . . 2.63 110.026 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.513 ' HB3' ' HB1' ' A' ' 163' ' ' ALA . 38.6 mt-10 -117.38 21.16 13.26 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 115.467 -0.788 . . . . 2.05 110.408 178.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.673 ' HB3' ' CD ' ' A' ' 162' ' ' PRO . 18.7 t-20 29.79 -87.06 0.0 OUTLIER Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 125.87 1.668 . . . . 2.19 115.044 175.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.673 ' CD ' ' HB3' ' A' ' 161' ' ' ASN . 85.1 Cg_endo -75.81 -12.62 19.95 Favored 'Trans proline' 0 C--N 1.368 1.557 0 CA-C-N 121.888 1.71 . . . . 0.86 112.928 -175.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.513 ' HB1' ' HB3' ' A' ' 160' ' ' GLU . . . -89.97 -36.92 14.69 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.898 -0.592 . . . . 1.34 110.563 -178.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.678 ' O ' ' HB2' ' A' ' 158' ' ' MET . 73.6 m-85 -136.97 133.14 35.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.279 -0.419 . . . . 1.46 110.424 176.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.788 ' HB2' ' HD3' ' A' ' 58' ' ' PRO . 25.3 t -125.11 144.59 50.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.342 0.592 . . . . 2.05 110.951 174.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.755 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.8 tppp? -97.37 99.81 11.25 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.993 0.901 . . . . 1.4 110.684 -178.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.8 106.97 15.91 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.323 -1.308 . . . . 1.07 109.201 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.621 HG13 HG22 ' A' ' 154' ' ' VAL . 0.1 OUTLIER -129.41 126.27 63.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.675 0.75 . . . . 1.11 111.804 176.667 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 14.6 ttt -129.74 153.08 48.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.182 -0.917 . . . . 1.79 110.021 -171.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.767 ' HB3' HD23 ' A' ' 47' ' ' LEU . 47.6 m-85 -134.24 140.52 46.51 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.684 -0.234 . . . . 4.22 111.146 -178.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.591 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 4.7 m -140.07 131.6 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 O-C-N 123.645 0.591 . . . . 2.01 111.549 171.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.996 ' HB2' HD11 ' A' ' 47' ' ' LEU . 13.3 tt0 -120.02 33.55 5.56 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 105.954 -1.869 . . . . 2.66 105.954 169.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 35.9 m -54.94 147.27 15.77 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 112.697 -2.047 . . . . 2.2 112.733 -171.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 . . . . . 0 N--CA 1.448 -0.536 0 CA-C-N 115.573 -0.74 . . . . 2.45 110.663 178.876 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.515 ' HA ' ' HE2' ' A' ' 186' ' ' LYS . 24.4 mm . . . . . 0 CA--C 1.503 -0.845 0 CA-C-O 122.274 1.035 . . . . 1.69 108.331 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.662 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.2 mp -62.99 -35.7 72.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 112.986 -1.915 . . . . 1.77 110.726 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -57.19 -29.65 63.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.133 -0.94 . . . . 2.89 109.564 174.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.515 ' HE2' ' HA ' ' A' ' 183' ' ' ILE . 46.0 mtmt -93.05 -40.46 10.51 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.161 -0.927 . . . . 1.71 111.088 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.662 HG22 ' HA ' ' A' ' 184' ' ' ILE . 6.5 t -64.75 -37.67 88.39 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.236 0.458 . . . . 1.3 112.236 -171.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' MET . . . . . 0.797 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 7.7 mmt -74.88 -60.43 1.23 Allowed Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 120.747 -0.381 . . . . 1.39 111.347 -174.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.797 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 61.3 Cg_exo -54.02 -32.06 66.99 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.174 1.916 . . . . 1.15 112.579 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.739 ' O ' ' HB3' ' A' ' 194' ' ' ASN . 49.0 m -72.87 -23.71 60.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.431 -0.35 . . . . 1.95 111.031 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -92.56 -37.82 12.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.348 0.594 . . . . 1.92 111.6 -175.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.963 HD12 HG12 ' A' ' 35' ' ' VAL . 3.7 mt -67.02 -51.32 56.35 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.659 0.743 . . . . 1.68 110.79 -176.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.693 ' O ' HD21 ' A' ' 197' ' ' LEU . 1.6 m -69.6 -41.29 80.24 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.129 0 CA-C-N 115.061 -0.972 . . . . 1.32 108.756 -176.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.739 ' HB3' ' O ' ' A' ' 190' ' ' SER . 0.0 OUTLIER -57.48 -37.75 73.42 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.668 0.618 . . . . 2.6 112.668 178.706 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -64.28 -31.82 73.17 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 119.884 -0.726 . . . . 2.73 110.009 174.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.626 HG22 HG22 ' A' ' 33' ' ' ILE . 8.6 mt -78.58 -33.89 17.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 122.003 0.906 . . . . 1.11 111.205 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.693 HD21 ' O ' ' A' ' 193' ' ' VAL . 3.3 mm? -78.26 -30.6 48.69 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.014 -0.994 . . . . 1.57 110.723 -173.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.713 ' HB2' ' HZ3' ' A' ' 74' ' ' TRP . 12.1 p30 -67.39 -29.82 69.43 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.528 -1.286 . . . . 2.18 107.528 167.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.669 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -73.19 -37.25 66.55 Favored 'General case' 0 N--CA 1.435 -1.187 0 O-C-N 121.97 -0.456 . . . . 1.04 110.254 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 33.0 mmtp -61.7 -43.36 99.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.76 0.79 . . . . 1.51 109.915 174.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . 0.557 ' O ' ' HG3' ' A' ' 204' ' ' LYS . 10.2 t70 -81.69 -40.72 22.37 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.703 -1.135 . . . . 1.94 110.841 -171.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -70.98 -33.87 65.34 Favored Glycine 0 C--O 1.226 -0.406 0 C-N-CA 121.105 -0.569 . . . . 0.47 111.729 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 1.009 HD13 HD22 ' A' ' 61' ' ' LEU . 1.6 tp -70.17 -35.76 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 110.058 -0.349 . . . . 1.16 110.058 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.557 ' HG3' ' O ' ' A' ' 201' ' ' ASP . 2.2 pptp? -81.59 -23.95 36.77 Favored 'General case' 0 C--O 1.213 -0.846 0 N-CA-C 108.678 -0.86 . . . . 3.8 108.678 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.096 0 N-CA-C 109.094 -0.706 . . . . 1.28 109.094 167.758 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.436 ' O ' HD11 ' A' ' 6' ' ' ILE . 1.0 OUTLIER . . . . . 0 CA--C 1.512 -0.488 0 N-CA-C 112.547 0.573 . . . . 2.25 112.547 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.878 ' HA ' HD11 ' A' ' 6' ' ' ILE . 97.2 m-85 -68.53 -27.97 66.58 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.079 0.466 . . . . 0.45 109.837 -172.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.552 ' HD2' ' CG ' ' A' ' 88' ' ' ASP . 17.5 tttm -76.31 -2.45 31.66 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.551 -0.75 . . . . 2.06 109.697 177.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.591 ' O ' ' HG2' ' A' ' 9' ' ' GLN . . . -92.96 -43.44 8.93 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.398 0.618 . . . . 1.2 109.972 170.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.878 HD11 ' HA ' ' A' ' 3' ' ' PHE . 1.3 mp -81.57 -43.01 19.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 122.01 0.91 . . . . 1.76 109.398 -171.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.618 ' HB2' ' HB2' ' A' ' 116' ' ' TYR . . . -76.06 -37.31 58.42 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.105 -1.407 . . . . 1.11 111.584 -176.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.504 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 7.3 mt-30 -65.91 -29.73 70.2 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.474 -0.785 . . . . 2.14 109.992 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.597 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 79.1 mm-40 -77.69 -38.8 46.68 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.038 -0.983 . . . . 3.04 108.499 174.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.547 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.4 OUTLIER -65.57 -36.53 84.05 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.534 -1.212 . . . . 1.1 111.962 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.607 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -46.57 -59.49 2.97 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.198 0.523 . . . . 1.04 111.159 172.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -66.56 -16.65 64.32 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.49 -0.777 . . . . 2.31 112.045 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.597 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 44.2 mt-10 -73.32 -52.37 14.15 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.001 0.429 . . . . 2.54 109.888 175.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.689 HG21 ' N ' ' A' ' 152' ' ' GLY . 11.8 p -73.2 -40.17 57.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.649 0.738 . . . . 1.21 110.453 -177.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.538 HD23 ' HE3' ' A' ' 124' ' ' MET . 0.5 OUTLIER -67.2 -23.81 65.78 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-O 121.916 0.865 . . . . 1.26 108.824 173.523 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.95 -18.05 66.13 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 113.986 -1.461 . . . . 0.57 110.38 177.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.63 ' CD2' ' HA ' ' A' ' 14' ' ' VAL . 23.7 m-85 -91.14 -21.34 21.23 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.076 -0.712 . . . . 3.59 109.076 176.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.511 ' HA ' ' HZ ' ' A' ' 170' ' ' PHE . 3.5 t-20 -72.29 -14.82 61.85 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.463 0.649 . . . . 2.1 109.989 178.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.493 ' HD2' HD21 ' A' ' 15' ' ' LEU . 22.2 mtp180 -115.72 -20.38 10.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.484 -0.78 . . . . 3.26 110.835 -175.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -97.01 132.76 42.5 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.066 0.46 . . . . 2.16 111.413 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 43.1 p -134.21 119.28 18.6 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.85 -0.614 . . . . 2.24 109.637 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.457 ' HB2' ' HE3' ' A' ' 38' ' ' LYS . 0.8 OUTLIER -135.57 -143.87 0.2 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.862 -0.608 . . . . 2.46 110.343 -169.135 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.4 63.33 1.8 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.349 -0.453 . . . . 1.45 112.73 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.531 ' CH2' ' HD3' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -119.86 -175.76 3.04 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.15 -1.056 . . . . 2.24 108.15 171.393 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.445 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 8.7 mtpp -171.4 133.11 0.8 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.712 -0.848 . . . . 3.43 108.712 -176.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.765 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 1.6 p -59.96 116.73 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-O 121.714 0.769 . . . . 2.21 109.681 170.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.4 p -92.05 -23.7 5.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 114.695 -1.139 . . . . 1.83 109.081 -177.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 2.7 tppt? -153.1 139.63 18.72 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.82 -0.627 . . . . 2.87 111.488 -173.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.555 HG21 ' HA ' ' A' ' 34' ' ' THR . 31.2 p -137.92 142.93 40.58 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.002 -0.545 . . . . 1.92 110.373 175.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.722 ' HB3' HG12 ' A' ' 33' ' ' ILE . 35.4 t -89.95 -143.98 0.16 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.618 -1.253 . . . . 2.37 107.618 168.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -103.05 18.89 20.61 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.532 -0.467 . . . . 4.84 110.06 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.439 ' HD2' ' HA ' ' A' ' 32' ' ' LYS . 33.8 tptt -168.97 3.77 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.189 0.44 . . . . 2.05 112.189 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.944 HG22 ' HA3' ' A' ' 52' ' ' GLY . 42.8 pt -138.72 168.46 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.913 0.387 . . . . 1.42 111.735 -174.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.555 ' HA ' HG21 ' A' ' 29' ' ' THR . 88.0 m -146.59 119.56 8.76 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.223 -0.899 . . . . 1.22 110.64 -166.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.749 HG21 HG21 ' A' ' 50' ' ' VAL . 7.1 t -111.41 102.0 13.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.608 -0.516 . . . . 1.52 109.608 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.765 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 18.1 m -99.14 126.79 44.99 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.651 0.739 . . . . 1.74 111.338 -177.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 t -97.75 124.04 41.94 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.439 -1.255 . . . . 1.72 109.76 -177.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.457 ' HE3' ' HB2' ' A' ' 22' ' ' SER . 85.3 tttt . . . . . 0 C--N 1.317 -0.822 0 CA-C-N 115.618 -0.719 . . . . 2.45 110.151 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.4 m120 . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 121.483 0.659 . . . . 2.45 112.07 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.54 HD21 ' N ' ' A' ' 48' ' ' TYR . 4.3 tt -136.75 137.19 39.62 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.444 -1.688 . . . . 1.49 106.444 175.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.565 ' HB2' HG13 ' A' ' 171' ' ' VAL . 42.2 m-85 -118.52 128.3 54.45 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 120.545 -0.462 . . . . 1.52 110.992 -172.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.531 ' HD3' ' CH2' ' A' ' 24' ' ' TRP . 15.1 ttp180 -99.29 117.24 33.3 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.913 -0.773 . . . . 3.34 108.913 173.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.749 HG21 HG21 ' A' ' 35' ' ' VAL . 7.8 p -106.7 120.49 57.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 108.403 -0.962 . . . . 1.98 108.403 175.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.625 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 35.2 tt0 -139.98 121.06 14.7 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.225 -0.898 . . . . 1.07 110.419 -167.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.944 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -148.23 162.47 28.8 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 111.016 -0.834 . . . . 0.35 111.016 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.6 mt -97.6 119.11 45.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 C-N-CA 120.197 -0.601 . . . . 1.3 111.004 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.647 HG12 ' HD3' ' A' ' 200' ' ' LYS . 72.6 mt -97.3 114.12 64.29 Favored Pre-proline 0 N--CA 1.443 -0.785 0 N-CA-C 108.884 -0.784 . . . . 1.07 108.884 172.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 23.6 Cg_exo -65.66 57.14 0.36 Allowed 'Trans proline' 0 N--CA 1.474 0.347 0 C-N-CA 124.422 3.415 . . . . 0.74 113.223 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.461 ' HG2' HG13 ' A' ' 203' ' ' ILE . 11.4 tp10 -157.42 167.88 28.94 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 108.207 -1.035 . . . . 1.68 108.207 176.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.494 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 20.0 p -69.49 141.37 90.67 Favored Pre-proline 0 N--CA 1.429 -1.511 0 CA-C-O 122.09 0.948 . . . . 1.58 111.637 -175.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.58 ' HA ' HD13 ' A' ' 61' ' ' LEU . 32.3 Cg_exo -59.68 -15.39 31.22 Favored 'Trans proline' 0 CA--C 1.518 -0.29 0 C-N-CA 124.505 3.47 . . . . 0.74 110.534 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.03 -53.33 21.03 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.195 -1.366 . . . . 1.31 111.011 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.58 ' HA ' ' HB3' ' A' ' 63' ' ' ASP . 13.6 ttpt -70.97 -23.47 62.22 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.812 -0.81 . . . . 3.78 108.812 -177.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 1.046 HD21 HD12 ' A' ' 203' ' ' ILE . 45.0 mt -60.72 -55.74 29.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.006 -0.997 . . . . 1.09 109.756 171.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.1 p -68.63 -9.24 48.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.007 0.432 . . . . 1.94 110.724 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.58 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 29.4 t70 -90.17 -28.36 18.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.021 -0.536 . . . . 1.32 111.828 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.665 ' CD2' ' HA ' ' A' ' 61' ' ' LEU . 8.8 p90 -86.32 -43.69 12.69 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 120.378 -0.529 . . . . 0.79 110.967 -174.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.7 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -89.62 7.61 35.63 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.975 -0.29 . . . . 2.15 110.973 -174.462 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -53.19 -71.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.467 -0.788 . . . . 2.06 111.875 -164.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 165.08 133.56 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 108.363 -0.977 . . . . 4.31 108.363 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.89 ' HA ' ' NH2' ' A' ' 71' ' ' ARG . 5.8 t 46.73 31.63 1.48 Allowed 'General case' 0 C--N 1.313 -1.007 0 O-C-N 124.534 1.146 . . . . 1.89 112.66 177.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.546 ' O ' ' HB3' ' A' ' 70' ' ' ASP . . . -88.69 -44.7 5.11 Favored Glycine 0 N--CA 1.427 -1.947 0 CA-C-N 115.173 -0.921 . . . . 1.71 110.859 -176.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.546 ' HB3' ' O ' ' A' ' 69' ' ' GLY . 29.4 p-10 152.35 -5.12 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 113.139 -1.53 . . . . 2.19 108.23 -166.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.89 ' NH2' ' HA ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -46.96 -27.79 1.4 Allowed 'General case' 0 C--O 1.211 -0.957 0 N-CA-C 113.536 0.939 . . . . 3.95 113.536 178.757 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.711 HD13 ' NH1' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -92.18 -14.37 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 119.124 -1.031 . . . . 1.42 111.047 178.719 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.503 HG21 ' O ' ' A' ' 70' ' ' ASP . 0.7 OUTLIER -86.01 -28.05 24.42 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 120.27 -0.572 . . . . 1.45 110.239 -173.68 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.679 ' CE2' ' HA ' ' A' ' 71' ' ' ARG . 14.8 p-90 -107.22 -4.86 18.32 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.467 -0.493 . . . . 0.78 111.924 178.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.8 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 5.6 t70 -71.99 174.87 6.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.506 0.67 . . . . 2.19 111.453 -172.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.809 ' HG2' ' HB3' ' A' ' 198' ' ' ASN . 8.1 mmmt -108.91 -25.41 10.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.199 -0.909 . . . . 3.68 109.76 -177.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.6 m -127.6 11.51 6.78 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.34 -0.846 . . . . 2.08 111.266 -173.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.669 HD11 HG22 ' A' ' 72' ' ' ILE . 15.9 mt -107.36 152.23 24.44 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.142 0.496 . . . . 1.16 111.471 -178.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.528 ' HB3' HG23 ' A' ' 80' ' ' VAL . 43.2 mt-30 -118.92 -70.49 0.79 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.447 -0.797 . . . . 2.23 111.225 178.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.528 HG23 ' HB3' ' A' ' 79' ' ' GLN . 22.0 t -148.66 124.31 2.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.468 -0.787 . . . . 1.44 110.556 -166.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.909 ' HH ' ' HG3' ' A' ' 83' ' ' MET . 48.7 t80 -109.71 142.54 40.76 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.416 -0.514 . . . . 5.73 111.213 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.499 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 0.9 OUTLIER -136.74 118.71 15.3 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.928 -1.138 . . . . 1.86 107.928 -179.455 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.909 ' HG3' ' HH ' ' A' ' 81' ' ' TYR . 2.0 ttt -68.5 107.48 2.93 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.696 -0.684 . . . . 2.52 109.358 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.7 HG22 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -84.31 -71.57 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 120.22 -0.592 . . . . 1.19 111.411 -170.608 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -137.9 108.95 6.75 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.017 -0.538 . . . . 2.59 109.884 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.961 ' HG2' ' HD2' ' A' ' 92' ' ' PHE . 68.1 mtp180 -85.32 129.47 34.8 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.31 -0.626 . . . . 2.83 109.31 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.728 HG22 ' HB2' ' A' ' 3' ' ' PHE . 0.7 OUTLIER -86.99 -54.52 7.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.428 -0.805 . . . . 1.17 109.969 -172.217 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.552 ' CG ' ' HD2' ' A' ' 4' ' ' LYS . 6.8 m-20 -136.15 -142.98 0.18 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.636 -1.165 . . . . 1.86 108.808 -177.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.2 t -95.02 -12.22 27.01 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.609 -0.515 . . . . 1.94 109.609 175.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -128.27 3.54 5.75 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.039 -0.528 . . . . 1.87 110.428 -171.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.553 ' HB ' ' HB ' ' A' ' 87' ' ' ILE . 0.3 OUTLIER -132.38 121.35 23.33 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.599 -0.889 . . . . 1.12 108.599 -172.201 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.961 ' HD2' ' HG2' ' A' ' 86' ' ' ARG . 14.1 m-85 -133.21 176.14 8.77 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 120.954 0.407 . . . . 0.52 110.267 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.7 ' O ' HG22 ' A' ' 84' ' ' VAL . 21.8 mt -133.09 125.93 52.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 107.354 -1.35 . . . . 1.1 107.354 168.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.584 ' HA ' ' HE1' ' A' ' 81' ' ' TYR . 94.6 m -106.58 108.41 19.9 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.101 -0.499 . . . . 2.61 112.153 -169.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.574 ' HA ' ' O ' ' A' ' 111' ' ' PHE . 8.4 t60 -84.75 103.62 14.0 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.024 -0.732 . . . . 2.17 109.024 171.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.725 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 27.9 m -127.34 119.91 27.33 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.244 -0.435 . . . . 1.19 111.84 -173.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 32.9 mm -77.67 138.94 19.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.076 -0.713 . . . . 1.63 109.076 174.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 1.3 m -113.58 152.34 30.44 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.58 -0.737 . . . . 1.72 110.244 -171.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 . . . . . 0 C--N 1.316 -0.855 0 CA-C-N 116.397 -0.365 . . . . 2.29 110.147 177.106 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.526 HD11 HG22 ' A' ' 183' ' ' ILE . 5.2 mp . . . . . 0 N--CA 1.45 -0.459 0 N-CA-C 109.361 -0.607 . . . . 1.53 109.361 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.543 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 17.7 m -71.1 164.83 53.47 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.695 -0.684 . . . . 1.71 111.035 -178.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' A' ' 107' ' ' SER . 2.0 Cg_endo -45.15 114.6 0.7 Allowed 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 123.38 2.72 . . . . 1.31 111.397 176.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.59 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 23.0 ttp180 -102.99 158.54 16.22 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.99 -0.55 . . . . 4.06 110.836 -168.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.918 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 8.2 t0 -113.37 122.94 48.87 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.059 -0.719 . . . . 1.37 109.059 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.725 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 6.0 m-85 -99.38 132.07 44.96 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 120.855 0.36 . . . . 3.01 110.471 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.525 HD11 ' HA ' ' A' ' 95' ' ' HIS . 30.1 mm -133.46 68.09 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.069 -1.085 . . . . 1.2 108.069 171.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.9 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 4.5 m-20 -90.76 115.86 28.17 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.718 -1.128 . . . . 1.86 109.799 -177.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.634 ' O ' ' HA ' ' A' ' 129' ' ' SER . 6.3 tp -74.6 120.85 20.71 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 108.564 -0.902 . . . . 1.08 108.564 169.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.534 HG12 ' SG ' ' A' ' 94' ' ' CYS . 0.1 OUTLIER -125.46 126.15 70.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 115.115 -0.948 . . . . 1.08 111.824 -164.319 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.618 ' HB2' ' HB2' ' A' ' 7' ' ' ALA . 50.9 t80 -110.63 120.11 41.35 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 114.456 -1.247 . . . . 2.81 110.211 174.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.679 HG12 HG21 ' A' ' 127' ' ' ILE . 74.2 mt -100.25 103.26 14.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.824 -0.625 . . . . 1.53 110.359 -177.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.923 ' HZ3' ' HH ' ' A' ' 120' ' ' TYR . 26.7 ttmt -124.73 133.84 53.04 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.114 0.483 . . . . 1.81 110.211 177.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.533 ' O ' ' HD2' ' A' ' 119' ' ' ARG . 0.4 OUTLIER -110.91 119.57 39.53 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 108.573 -0.899 . . . . 3.22 108.573 173.057 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.923 ' HH ' ' HZ3' ' A' ' 118' ' ' LYS . 99.1 m-85 -75.98 104.8 6.68 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.455 -1.683 . . . . 1.28 106.455 164.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -52.04 98.3 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 122.302 1.049 . . . . 2.28 112.598 -171.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.402 ' C ' HD21 ' A' ' 123' ' ' ASN . . . 84.89 24.41 45.36 Favored Glycine 0 CA--C 1.504 -0.595 0 CA-C-N 113.451 -1.704 . . . . 0.79 112.14 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.62 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 1.0 OUTLIER -126.02 -57.71 1.41 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.723 -0.739 . . . . 2.06 109.617 175.224 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.538 ' HE3' HD23 ' A' ' 15' ' ' LEU . 2.8 mpp? -160.48 135.27 7.62 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.894 -0.594 . . . . 1.73 110.544 -170.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.427 ' HB2' ' HB2' ' A' ' 155' ' ' CYS . 21.9 m-80 -115.02 87.18 2.6 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.312 -0.996 . . . . 2.07 108.312 176.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.588 ' HB ' HG11 ' A' ' 154' ' ' VAL . 0.4 OUTLIER -110.0 143.76 19.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 112.976 0.732 . . . . 1.06 112.976 -170.527 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.679 HG21 HG12 ' A' ' 117' ' ' ILE . 5.2 pt -110.51 113.98 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.478 -0.934 . . . . 1.26 108.478 161.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.607 ' HB3' ' HA ' ' A' ' 11' ' ' ALA . 22.6 p -94.13 124.08 37.91 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.239 -0.437 . . . . 1.53 110.693 178.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.9 ' HB3' ' HB3' ' A' ' 113' ' ' ASP . 19.8 m -125.32 141.91 51.8 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.089 0.471 . . . . 1.81 111.801 -170.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.578 ' HE3' HG22 ' A' ' 6' ' ' ILE . 5.5 mtpm? -131.32 126.11 34.48 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 107.97 -1.122 . . . . 2.75 107.97 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.6 p -64.89 97.45 0.23 Allowed 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.337 -1.357 . . . . 1.94 107.337 172.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.68 140.27 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 N-CA-C 108.766 -0.827 . . . . 1.64 108.766 -165.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -97.23 81.37 3.02 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.162 -0.927 . . . . 2.17 108.676 -172.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.471 ' HE1' ' CG2' ' A' ' 112' ' ' ILE . 0.5 OUTLIER -111.74 152.54 44.2 Favored Pre-proline 0 C--N 1.311 -1.066 0 CA-C-N 114.374 -1.285 . . . . 0.67 109.902 -173.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.75 -18.94 66.19 Favored 'Trans proline' 0 N--CA 1.48 0.701 0 C-N-CA 123.732 2.954 . . . . 1.66 116.156 -167.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.422 ' CB ' ' CE2' ' A' ' 134' ' ' PHE . 2.6 tp10 -68.86 -29.33 67.61 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 121.608 0.718 . . . . 3.5 109.771 -172.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.486 ' CD2' HD13 ' A' ' 112' ' ' ILE . 32.4 t80 -158.25 106.94 1.7 Allowed Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 114.807 -1.088 . . . . 6.41 113.828 -175.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.461 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 3.7 Cg_endo -87.44 155.0 7.88 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.172 2.581 . . . . 2.31 109.881 161.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -67.27 -165.13 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 121.982 1.788 . . . . 1.27 112.438 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 13.9 t -136.47 -159.37 0.95 Allowed 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 109.071 -0.714 . . . . 1.88 109.071 -170.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 41.9 m -82.49 -42.05 18.96 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.39 -0.524 . . . . 2.43 111.693 -176.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -95.93 -29.9 13.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.095 0.474 . . . . 2.18 110.0 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.918 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 25.5 m-85 -85.14 109.5 18.32 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.739 -0.664 . . . . 1.33 110.113 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.59 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 0.9 OUTLIER -96.95 115.37 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 108.404 -0.962 . . . . 1.4 108.404 177.517 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.687 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 20.7 ttm180 -55.38 107.9 0.37 Allowed 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.084 -0.71 . . . . 5.14 109.084 174.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -59.4 111.13 3.18 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 110.959 -0.856 . . . . 1.05 110.959 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -84.01 75.5 10.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 122.183 0.992 . . . . 4.68 111.465 -175.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.538 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 16.5 m-20 -79.12 99.52 6.99 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 113.741 -1.572 . . . . 2.29 108.565 171.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.499 ' O ' ' N ' ' A' ' 151' ' ' CYS . 77.0 m-70 -60.25 152.84 61.26 Favored Pre-proline 0 C--O 1.22 -0.463 0 N-CA-C 107.513 -1.292 . . . . 2.95 107.513 173.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.547 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 32.1 Cg_exo -24.67 70.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.181 1 C-N-CA 126.116 4.544 . . . . 0.77 115.544 -173.494 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 170' ' ' PHE . 25.8 p -97.41 -174.26 2.88 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.987 -1.006 . . . . 1.97 109.907 176.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.689 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -172.26 -161.7 23.19 Favored Glycine 0 N--CA 1.433 -1.544 0 C-N-CA 119.775 -1.202 . . . . 0.55 112.001 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.467 ' CE2' ' HG ' ' A' ' 65' ' ' LEU . 72.4 t80 -161.83 91.17 0.8 Allowed 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.53 -0.915 . . . . 0.8 108.53 -168.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.591 ' CG2' HG11 ' A' ' 168' ' ' VAL . 2.4 m -100.96 131.15 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-O 121.856 0.836 . . . . 1.03 110.83 -173.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . 0.427 ' HB2' ' HB2' ' A' ' 125' ' ' ASN . 74.9 m -110.16 109.36 19.84 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.069 -0.969 . . . . 2.3 109.62 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.452 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 19.9 m -105.73 121.22 46.65 Favored Pre-proline 0 C--N 1.318 -0.801 0 N-CA-C 112.15 0.426 . . . . 1.45 112.15 -167.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.62 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 59.8 Cg_exo -51.69 126.02 18.55 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.953 2.435 . . . . 0.72 111.875 170.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.604 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 0.2 OUTLIER -88.01 -170.67 3.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.189 0.519 . . . . 1.72 111.561 -178.445 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -77.97 -24.45 48.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.426 0.631 . . . . 2.63 109.547 168.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 37.8 mt-10 -100.65 27.29 5.97 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.052 -1.092 . . . . 2.05 108.052 172.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.716 ' HB3' ' HD3' ' A' ' 162' ' ' PRO . 0.2 OUTLIER -14.99 -71.73 0.02 OUTLIER Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 126.478 1.911 . . . . 2.19 115.074 -174.188 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.716 ' HD3' ' HB3' ' A' ' 161' ' ' ASN . 73.0 Cg_endo -73.36 -15.86 24.93 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 121.268 1.312 . . . . 0.86 113.516 -170.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -104.45 -25.58 12.75 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.161 -0.472 . . . . 1.34 110.993 -176.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.604 ' O ' ' HB2' ' A' ' 158' ' ' MET . 49.6 m-85 -141.03 122.29 14.82 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.497 -0.557 . . . . 1.46 109.497 177.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 45.5 t -114.13 145.71 41.28 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.488 -0.485 . . . . 2.05 110.578 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.625 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.8 tppp? -92.13 101.83 14.35 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 122.049 0.928 . . . . 1.4 111.142 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 0.9 OUTLIER -87.49 105.01 17.01 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.385 -1.28 . . . . 1.07 109.31 178.748 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.591 HG11 ' CG2' ' A' ' 154' ' ' VAL . 0.1 OUTLIER -128.78 117.2 43.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 122.171 0.986 . . . . 1.11 112.004 178.112 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.416 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 23.0 ttt -116.97 147.25 42.45 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.814 -1.084 . . . . 1.79 109.496 -177.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.591 ' O ' ' HB2' ' A' ' 151' ' ' CYS . 92.9 m-85 -122.34 128.02 50.51 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.076 -0.713 . . . . 4.22 109.076 177.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.581 ' HB ' HD23 ' A' ' 192' ' ' LEU . 2.5 p -111.12 117.98 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-O 121.744 0.783 . . . . 2.01 110.003 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.623 HE22 ' HH ' ' A' ' 17' ' ' TYR . 13.7 tt0 -113.7 48.67 1.04 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.268 -1.012 . . . . 2.66 108.268 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.01 136.47 46.72 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.058 -1.428 . . . . 2.2 113.247 -170.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 . . . . . 0 N--CA 1.451 -0.392 0 CA-C-N 115.927 -0.579 . . . . 2.45 111.39 174.625 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.773 ' HA ' ' HE2' ' A' ' 186' ' ' LYS . 8.0 mm . . . . . 0 N--CA 1.47 0.574 0 CA-C-O 122.872 1.32 . . . . 1.69 109.398 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.675 ' HA ' ' CG2' ' A' ' 187' ' ' THR . 0.9 OUTLIER -86.46 -33.47 7.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 112.886 -1.961 . . . . 1.77 110.366 -169.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.462 ' OE2' ' HB3' ' A' ' 186' ' ' LYS . 0.0 OUTLIER -60.71 -25.53 66.49 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.558 -0.746 . . . . 2.89 110.612 173.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.773 ' HE2' ' HA ' ' A' ' 183' ' ' ILE . 0.0 OUTLIER -93.37 -36.53 12.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 1.71 110.477 174.774 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.675 ' CG2' ' HA ' ' A' ' 184' ' ' ILE . 5.7 t -66.47 -26.7 67.32 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 120.716 -0.394 . . . . 1.3 111.832 -171.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' MET . . . . . 0.604 ' HE1' HG21 ' A' ' 187' ' ' THR . 4.2 mmt -76.93 -60.09 0.85 Allowed Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.683 -0.407 . . . . 1.39 111.65 -177.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.504 ' O ' HG13 ' A' ' 193' ' ' VAL . 18.2 Cg_endo -60.54 -36.61 85.23 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 121.668 1.579 . . . . 1.15 111.76 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.591 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 7.8 t -70.07 -23.55 63.1 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.971 0.415 . . . . 1.95 110.763 -176.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.434 HD21 ' C ' ' A' ' 191' ' ' ASN . 0.2 OUTLIER -91.06 -45.59 8.61 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.332 -0.394 . . . . 1.92 110.494 -178.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.627 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 80.3 mt -72.14 -45.91 58.6 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.083 -0.508 . . . . 1.68 112.146 -170.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 189' ' ' PRO . 1.8 m -75.68 -33.25 25.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.736 0.779 . . . . 1.32 108.948 -173.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.591 ' HB2' ' O ' ' A' ' 190' ' ' SER . 1.1 t30 -62.94 -49.13 75.96 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.052 -1.431 . . . . 2.6 109.773 175.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.662 ' HA ' ' OD1' ' A' ' 198' ' ' ASN . 5.2 t80 -56.56 -30.49 63.19 Favored 'General case' 0 C--O 1.233 0.222 0 O-C-N 123.739 0.649 . . . . 2.73 109.999 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.612 ' O ' ' HB2' ' A' ' 199' ' ' ALA . 8.7 mt -78.7 -39.83 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-N 115.992 -0.549 . . . . 1.11 112.437 177.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.633 HD12 ' N ' ' A' ' 198' ' ' ASN . 2.8 pp -80.41 -21.72 41.96 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 119.304 -0.958 . . . . 1.57 111.076 -176.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.809 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 1.6 p-10 -74.64 -13.91 60.7 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 118.816 -1.153 . . . . 2.18 108.281 166.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' A' ' 196' ' ' ILE . . . -82.25 -27.31 32.52 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.266 -1.013 . . . . 1.04 108.266 170.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.647 ' HD3' HG12 ' A' ' 54' ' ' ILE . 26.3 mmtp -69.36 -38.85 78.29 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.543 -0.753 . . . . 1.51 109.333 173.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -86.53 -39.61 16.06 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 114.783 -1.099 . . . . 1.94 110.169 -176.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . 0.408 ' HA2' ' HB2' ' A' ' 205' ' ' ALA . . . -70.51 -29.55 69.74 Favored Glycine 0 CA--C 1.503 -0.715 0 C-N-CA 120.994 -0.622 . . . . 0.47 111.602 -178.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 1.046 HD12 HD21 ' A' ' 61' ' ' LEU . 2.8 tp -71.59 -31.47 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 109.606 -0.516 . . . . 1.16 109.606 177.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.553 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 53.3 mttp -86.5 -23.74 25.82 Favored 'General case' 0 C--O 1.204 -1.293 0 N-CA-C 108.836 -0.801 . . . . 3.8 108.836 176.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.408 ' HB2' ' HA2' ' A' ' 202' ' ' GLY . . . . . . . . 0 C--N 1.314 -0.973 0 N-CA-C 109.221 -0.659 . . . . 1.28 109.221 169.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.536 ' O ' HD13 ' A' ' 6' ' ' ILE . 10.1 m-20 . . . . . 0 CA--C 1.512 -0.503 0 CA-C-O 120.771 0.32 . . . . 2.25 110.929 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.483 ' CD2' HD12 ' A' ' 87' ' ' ILE . 95.4 m-85 -67.24 -32.14 72.98 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.604 0.716 . . . . 0.45 109.466 -176.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.542 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 18.1 tttt -75.48 -1.33 23.64 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 114.594 -1.185 . . . . 2.06 109.855 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -93.28 -42.47 9.31 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.951 -0.568 . . . . 1.2 110.06 171.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.637 ' O ' ' HB ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -84.2 -35.47 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-O 121.08 0.467 . . . . 1.76 110.511 -174.371 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.526 ' HB3' ' HB2' ' A' ' 116' ' ' TYR . . . -80.19 -40.7 26.69 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.096 -0.957 . . . . 1.11 111.338 -176.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.542 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 4.0 mt-30 -63.45 -32.8 74.34 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.079 -0.964 . . . . 2.14 109.658 176.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.627 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 13.2 mm100 -78.68 -42.75 27.69 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.613 -1.176 . . . . 3.04 109.1 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.637 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -60.24 -35.73 76.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.656 -0.702 . . . . 1.1 111.257 179.73 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.455 ' HA ' ' OG ' ' A' ' 128' ' ' SER . . . -48.79 -58.92 4.05 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 121.098 0.475 . . . . 1.04 110.94 171.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -71.99 -18.18 62.0 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.711 -0.677 . . . . 2.31 111.564 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.627 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 49.9 mt-10 -68.76 -56.73 7.12 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.03 -0.73 . . . . 2.54 109.03 172.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.705 HG22 ' CE2' ' A' ' 170' ' ' PHE . 11.9 p -68.97 -41.77 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.893 -0.594 . . . . 1.21 111.228 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.33 -31.55 65.81 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.543 -0.753 . . . . 1.26 109.219 174.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.62 -28.33 73.1 Favored Glycine 0 CA--C 1.503 -0.715 0 CA-C-N 114.21 -1.359 . . . . 0.57 110.324 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.491 ' HD1' ' O ' ' A' ' 13' ' ' GLU . 11.6 m-85 -93.05 -16.86 24.52 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.763 -0.718 . . . . 3.59 109.636 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.82 -6.16 40.1 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.54 0.686 . . . . 2.1 109.199 -175.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -110.16 -17.32 13.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.641 -1.163 . . . . 3.26 109.714 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -100.44 138.19 37.83 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.433 -0.803 . . . . 2.16 110.239 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 40.3 p -137.29 88.91 2.38 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.363 0.602 . . . . 2.24 111.336 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.1 p -173.78 146.25 1.24 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.173 -0.921 . . . . 2.46 111.451 -178.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.487 ' O ' ' HG3' ' A' ' 38' ' ' LYS . . . 92.81 2.27 67.11 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 121.294 -0.479 . . . . 1.45 112.807 174.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.481 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -120.04 -158.29 0.74 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.925 0.393 . . . . 2.24 110.878 -176.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.29 119.24 0.91 Allowed 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 108.811 -0.811 . . . . 3.43 108.811 -174.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.6 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 3.1 p -64.24 117.38 4.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 C-N-CA 119.37 -0.932 . . . . 2.21 109.726 175.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.4 p -94.09 -23.72 5.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 114.317 -1.311 . . . . 1.83 108.944 -176.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.516 ' C ' ' HD3' ' A' ' 28' ' ' LYS . 0.5 OUTLIER -157.57 123.71 4.79 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 120.252 -0.579 . . . . 2.87 110.199 -174.471 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -151.34 152.07 32.64 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.208 0.528 . . . . 1.92 111.485 -178.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.3 t -112.12 -147.95 0.42 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.579 -0.897 . . . . 2.37 108.579 175.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.405 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -99.32 25.87 6.53 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.444 0.64 . . . . 4.84 109.38 176.122 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.529 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 25.6 mmtm -156.73 -44.85 0.07 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 114.911 -1.04 . . . . 2.05 111.814 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.417 HG22 ' HA3' ' A' ' 52' ' ' GLY . 24.0 pt -104.87 160.42 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-O 120.766 0.317 . . . . 1.42 111.394 -175.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.58 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 2.6 m -149.72 109.9 4.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.548 -0.751 . . . . 1.22 110.487 -171.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.3 t -103.07 102.13 13.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.161 0.505 . . . . 1.52 109.943 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.6 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 2.9 p -97.48 124.66 41.78 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.5 -0.773 . . . . 1.74 111.693 -176.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.7 t -103.27 125.53 49.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.537 -1.211 . . . . 1.72 109.527 -175.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 23' ' ' GLY . 29.4 ttpt . . . . . 0 C--N 1.317 -0.818 0 CA-C-N 116.348 -0.387 . . . . 2.45 111.283 -176.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 . . . . . 0 N--CA 1.437 -1.101 0 CA-C-O 120.948 0.404 . . . . 2.45 110.992 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.712 HD23 ' CD1' ' A' ' 170' ' ' PHE . 4.9 tt -84.76 133.25 34.36 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.95 -1.13 . . . . 1.49 107.95 175.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.54 ' N ' HD21 ' A' ' 47' ' ' LEU . 97.9 m-85 -113.66 128.59 56.48 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.003 0.43 . . . . 1.52 110.092 -176.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.443 ' HD2' ' CH2' ' A' ' 24' ' ' TRP . 3.8 tmt_? -122.88 131.35 53.7 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.598 -0.728 . . . . 3.34 109.274 177.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 34' ' ' THR . 10.1 p -116.49 151.35 18.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.046 0.45 . . . . 1.98 110.543 -176.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.419 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 27.3 tt0 -148.36 108.81 4.14 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.444 -0.798 . . . . 1.07 109.408 -172.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.529 ' HA2' ' O ' ' A' ' 32' ' ' LYS . . . -140.91 138.5 8.93 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 119.978 -1.106 . . . . 0.35 112.306 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 67.6 mt -84.56 129.3 37.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.033 0.444 . . . . 1.3 110.139 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 63.8 mt -109.59 119.0 49.19 Favored Pre-proline 0 N--CA 1.442 -0.839 0 CA-C-N 115.767 -0.651 . . . . 1.07 109.612 177.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 34.0 Cg_exo -61.67 69.17 0.1 Allowed 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 124.262 3.308 . . . . 0.74 112.685 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.592 ' HG2' ' CG1' ' A' ' 203' ' ' ILE . 7.6 tp10 -163.79 176.68 9.3 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.061 -1.088 . . . . 1.68 108.061 176.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.5 ' H ' ' HG3' ' A' ' 56' ' ' GLU . 53.4 p -84.75 153.78 61.13 Favored Pre-proline 0 N--CA 1.427 -1.603 0 CA-C-O 121.332 0.587 . . . . 1.58 110.298 176.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.475 ' HA ' HD11 ' A' ' 61' ' ' LEU . 11.9 Cg_exo -68.28 -9.58 26.31 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.742 2.961 . . . . 0.74 110.26 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.53 -48.72 25.32 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.687 -1.142 . . . . 1.31 111.153 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.4 ' HG2' HG13 ' A' ' 203' ' ' ILE . 0.3 OUTLIER -72.93 -26.5 61.41 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.788 -0.819 . . . . 3.78 108.788 -178.392 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.566 HD22 ' CD1' ' A' ' 203' ' ' ILE . 83.3 mt -64.13 -53.49 48.81 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 114.729 -1.123 . . . . 1.09 109.796 173.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.413 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 18.1 m -64.29 -13.45 49.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.502 -0.772 . . . . 1.94 110.442 175.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -84.95 -42.82 14.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.833 -0.621 . . . . 1.32 111.564 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.555 ' CD2' ' HA ' ' A' ' 61' ' ' LEU . 11.9 p90 -73.3 -44.38 59.19 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 120.571 -0.452 . . . . 0.79 111.2 -174.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.413 ' CD2' ' HA ' ' A' ' 62' ' ' SER . 0.7 OUTLIER -80.79 -16.79 52.87 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 120.433 -0.507 . . . . 2.15 111.965 -173.264 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.642 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 34.8 t80 -26.3 -72.28 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 O-C-N 124.6 1.188 . . . . 2.06 113.811 -153.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.642 ' HG2' ' O ' ' A' ' 66' ' ' TYR . 5.4 mm-40 175.8 115.95 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.08 0 C-N-CA 124.32 1.048 . . . . 4.31 108.229 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.732 ' HB ' ' CD1' ' A' ' 81' ' ' TYR . 13.3 t 39.83 31.46 0.08 Allowed 'General case' 0 C--N 1.319 -0.753 0 O-C-N 124.348 1.03 . . . . 1.89 112.584 -177.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.3 -38.79 8.79 Favored Glycine 0 N--CA 1.436 -1.357 0 CA-C-N 115.5 -0.773 . . . . 1.71 113.001 -168.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.649 ' O ' HG23 ' A' ' 73' ' ' THR . 23.3 t70 169.59 -22.04 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.338 -0.986 . . . . 2.19 108.338 -163.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.766 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 3.9 ptp180 -43.8 -48.07 8.14 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 114.772 -1.103 . . . . 3.95 111.165 -178.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.544 ' N ' ' HG3' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -79.32 -16.08 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 C-N-CA 120.695 -0.402 . . . . 1.42 111.613 -172.325 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.649 HG23 ' O ' ' A' ' 70' ' ' ASP . 1.3 t -82.41 -35.86 27.25 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 119.8 -0.76 . . . . 1.45 109.995 -174.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.549 ' CZ2' ' HA ' ' A' ' 71' ' ' ARG . 16.8 p-90 -100.96 -3.7 29.01 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.343 -0.543 . . . . 0.78 111.387 -177.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.766 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 3.0 t70 -75.27 177.31 6.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.717 -0.674 . . . . 2.19 112.269 -170.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.579 ' HG3' ' OD1' ' A' ' 198' ' ' ASN . 0.0 OUTLIER -133.94 -12.43 2.56 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.539 -0.755 . . . . 3.68 111.4 179.246 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.4 m -111.33 -1.73 15.91 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.306 -0.998 . . . . 2.08 108.306 178.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 68.3 mt -110.79 176.81 4.88 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.566 -1.197 . . . . 1.16 110.037 -178.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -149.02 -67.95 0.22 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.495 -0.775 . . . . 2.23 110.002 -176.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.467 ' HB ' HD12 ' A' ' 97' ' ' ILE . 26.0 t -143.89 135.87 22.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.643 -0.708 . . . . 1.44 109.808 -173.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.732 ' CD1' ' HB ' ' A' ' 68' ' ' THR . 11.4 t80 -112.24 139.29 47.91 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.801 -0.444 . . . . 5.73 109.801 176.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.537 ' O ' ' HB3' ' A' ' 95' ' ' HIS . 17.1 m120 -137.71 114.76 10.8 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.902 -0.777 . . . . 1.86 108.902 175.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 48.6 tpp -75.53 113.02 12.47 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.736 -0.838 . . . . 2.52 108.736 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -85.88 -69.74 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.154 0.502 . . . . 1.19 110.201 -170.142 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -132.91 124.75 28.43 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.718 -0.673 . . . . 2.59 109.7 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.9 mtt180 -101.87 129.06 48.02 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.86 -0.793 . . . . 2.83 108.86 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -91.51 -39.08 11.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.468 0.651 . . . . 1.17 109.418 -176.336 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -150.7 -169.4 3.38 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.98 -1.009 . . . . 1.86 108.764 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.1 m -80.15 -4.41 52.86 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.858 0.361 . . . . 1.94 110.742 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -135.69 13.3 3.43 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 109.884 -0.414 . . . . 1.87 109.884 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.508 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -139.01 111.09 7.32 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 109.009 -0.737 . . . . 1.12 109.009 -176.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.574 ' O ' HD13 ' A' ' 114' ' ' LEU . 41.5 m-85 -128.76 178.96 5.98 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.845 -0.616 . . . . 0.52 110.274 -173.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.541 ' O ' HG23 ' A' ' 84' ' ' VAL . 39.1 mt -132.81 124.68 51.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 108.258 -1.016 . . . . 1.1 108.258 169.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.724 ' SG ' HG12 ' A' ' 115' ' ' VAL . 75.2 m -92.82 107.67 19.4 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.1 -0.5 . . . . 2.61 112.196 -171.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.537 ' HB3' ' O ' ' A' ' 82' ' ' ASN . 5.3 t60 -87.11 81.85 7.89 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.027 -1.101 . . . . 2.17 108.027 164.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.431 ' OG1' ' HB3' ' A' ' 94' ' ' CYS . 90.5 m -108.3 113.0 25.75 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.72 -1.127 . . . . 1.19 111.761 -170.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.467 HD12 ' HB ' ' A' ' 80' ' ' VAL . 3.2 mp -77.58 121.57 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 108.227 -1.027 . . . . 1.63 108.227 173.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.596 ' HB ' ' O ' ' A' ' 109' ' ' ARG . 71.8 m -111.27 149.37 31.14 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.94 -1.027 . . . . 1.72 110.771 -171.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 C--N 1.319 -0.749 0 CA-C-O 121.046 0.45 . . . . 2.29 110.559 -176.237 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 44.0 mt . . . . . 0 N--CA 1.447 -0.595 0 N-CA-C 109.95 -0.389 . . . . 1.53 109.95 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.8 m -77.17 155.1 82.41 Favored Pre-proline 0 C--N 1.319 -0.753 0 N-CA-C 109.366 -0.605 . . . . 1.71 109.366 174.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -44.71 122.92 4.4 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.681 2.254 . . . . 1.31 111.031 173.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.608 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 33.3 ttp180 -118.67 137.44 53.3 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.712 -0.395 . . . . 4.06 110.097 -167.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.585 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 22.0 t70 -107.47 147.52 30.36 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 120.754 0.311 . . . . 1.37 110.635 -171.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -118.81 155.64 30.82 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.366 0.603 . . . . 3.01 111.589 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.582 ' HA ' ' O ' ' A' ' 94' ' ' CYS . 35.5 mm -135.78 76.83 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 107.59 -1.263 . . . . 1.2 107.59 170.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 2.1 m-20 -98.91 120.61 39.63 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.579 -0.737 . . . . 1.86 110.577 -176.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.574 HD13 ' O ' ' A' ' 92' ' ' PHE . 9.4 tp -75.62 122.04 23.35 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 121.701 0.762 . . . . 1.08 109.361 172.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.724 HG12 ' SG ' ' A' ' 94' ' ' CYS . 0.1 OUTLIER -123.58 125.7 71.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-N 114.591 -1.186 . . . . 1.08 112.374 -165.123 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.526 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 91.0 t80 -112.87 123.92 51.42 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.332 -0.849 . . . . 2.81 110.637 172.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.503 HG13 HG21 ' A' ' 127' ' ' ILE . 4.5 mp -92.07 110.74 23.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.366 -0.834 . . . . 1.53 109.783 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.417 ' HB3' HG22 ' A' ' 126' ' ' ILE . 24.8 ttmm -113.41 142.82 45.44 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.032 -0.531 . . . . 1.81 110.596 -176.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -129.01 89.8 2.93 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 116.003 -0.544 . . . . 3.22 110.563 -174.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.433 ' HB3' ' HB2' ' A' ' 123' ' ' ASN . 36.9 m-85 -72.29 108.75 5.59 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 107.829 -1.174 . . . . 1.28 107.829 167.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -39.81 100.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 O-C-N 124.665 1.228 . . . . 2.28 112.813 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.41 ' C ' ' HG2' ' A' ' 157' ' ' PRO . . . 67.12 26.87 73.34 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 114.039 -1.437 . . . . 0.79 113.113 176.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.493 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 10.4 m120 -127.38 -46.13 1.49 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.688 -0.256 . . . . 2.06 110.64 176.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.537 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 5.8 mtm -162.19 131.17 4.3 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 120.516 -0.474 . . . . 1.73 111.96 -176.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -112.42 86.02 2.27 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.612 -1.255 . . . . 2.07 107.612 167.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.481 ' CG1' HG11 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -97.78 135.74 31.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.136 -0.938 . . . . 1.06 112.244 -172.576 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.665 ' O ' HG13 ' A' ' 127' ' ' ILE . 13.9 pt -101.05 108.89 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 108.576 -0.898 . . . . 1.26 108.576 164.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 1.7 m -75.86 161.05 29.31 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.624 -0.88 . . . . 1.53 108.624 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.542 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 11.3 p -157.33 121.11 4.18 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.334 0.588 . . . . 1.81 111.618 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.8 ttmt -127.94 110.71 12.81 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.436 -1.32 . . . . 2.75 107.436 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.402 ' OG ' ' HA ' ' A' ' 147' ' ' TYR . 22.9 t -58.71 98.84 0.04 OUTLIER 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 107.629 -1.248 . . . . 1.94 107.629 -178.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.427 HG11 ' HB3' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -107.59 133.84 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.107 0 CA-C-N 114.833 -1.076 . . . . 1.64 108.727 -165.321 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -94.09 71.15 3.94 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.898 -1.047 . . . . 2.17 109.076 -169.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.475 ' O ' ' HB3' ' A' ' 137' ' ' TYR . 1.8 p90 -99.26 175.06 2.62 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 114.4 -1.273 . . . . 0.67 109.488 -172.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -41.98 -50.4 5.2 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.739 2.959 . . . . 1.66 116.479 -174.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -88.12 -5.13 58.62 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.604 0.716 . . . . 3.5 111.604 -170.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.475 ' HB3' ' O ' ' A' ' 134' ' ' PHE . 22.8 t80 -56.72 -48.94 96.37 Favored Pre-proline 0 C--N 1.315 -0.927 0 N-CA-C 114.914 1.45 . . . . 6.41 114.914 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 137' ' ' TYR . 66.6 Cg_exo -32.29 110.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 123.821 3.014 . . . . 2.31 114.467 -174.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.618 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 82.3 Cg_endo -83.84 -160.72 0.12 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.687 2.925 . . . . 1.27 114.036 -175.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.9 p -136.64 -164.35 1.56 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.279 -0.873 . . . . 1.88 108.943 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.6 p -89.77 -29.83 18.42 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.126 -0.63 . . . . 2.43 110.972 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -83.45 -33.32 25.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 2.18 110.732 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -107.67 109.41 21.01 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 109.425 -0.583 . . . . 1.33 109.425 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.608 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 2.4 tp -100.63 106.66 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 C-N-CA 120.123 -0.631 . . . . 1.4 109.646 -176.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.618 ' NH2' ' HA ' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -59.43 99.98 0.07 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.109 -0.95 . . . . 5.14 110.715 178.825 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -65.82 122.24 21.54 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.597 -0.729 . . . . 1.05 111.297 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.493 ' HB3' ' HB2' ' A' ' 174' ' ' GLU . 3.5 t80 -85.05 78.55 9.87 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.623 0.725 . . . . 4.68 110.372 -177.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.669 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 89.0 m-20 -72.55 106.11 4.48 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.736 -1.12 . . . . 2.29 110.325 175.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.407 ' O ' ' N ' ' A' ' 151' ' ' CYS . 83.0 m-70 -75.91 144.77 76.65 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 109.545 -0.539 . . . . 2.95 109.545 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -13.49 61.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.181 1 C-N-CA 127.599 5.533 . . . . 0.77 116.374 -166.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . 0.669 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 19.7 p -89.99 -175.08 4.47 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.451 -0.795 . . . . 1.97 110.329 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.671 ' N ' HG21 ' A' ' 14' ' ' VAL . . . 178.99 -161.81 28.33 Favored Glycine 0 N--CA 1.435 -1.371 0 C-N-CA 120.456 -0.878 . . . . 0.55 111.479 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.438 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 32.5 t80 -161.38 91.42 0.85 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.075 -1.083 . . . . 0.8 108.075 -165.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.562 ' CG2' HG11 ' A' ' 168' ' ' VAL . 2.7 m -98.41 132.62 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-O 122.106 0.955 . . . . 1.03 111.123 -174.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 124' ' ' MET . 16.5 t -109.55 119.28 38.93 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.228 -0.897 . . . . 2.3 109.186 176.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.524 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 6.2 m -116.44 122.41 31.98 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.614 -0.266 . . . . 1.45 111.162 -171.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.493 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 46.0 Cg_exo -53.65 126.64 22.48 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.973 1.782 . . . . 0.72 110.655 169.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.619 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 70.8 mmm -85.24 -166.61 1.55 Allowed 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.119 0.485 . . . . 1.72 111.139 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -74.57 -35.51 63.03 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 121.562 0.696 . . . . 2.63 109.225 175.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -102.6 29.49 5.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.874 -1.057 . . . . 2.05 108.876 173.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.451 ' HB3' ' N ' ' A' ' 158' ' ' MET . 2.7 p-10 -28.5 -55.83 0.25 Allowed Pre-proline 0 N--CA 1.475 0.812 0 N-CA-C 116.407 2.002 . . . . 2.19 116.407 -171.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.408 ' HD3' ' CG ' ' A' ' 161' ' ' ASN . 55.3 Cg_endo -68.83 -13.59 37.19 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 121.738 1.656 . . . . 0.86 112.722 -173.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -109.92 -32.69 6.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.984 -0.553 . . . . 1.34 110.765 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.619 ' O ' ' HB2' ' A' ' 158' ' ' MET . 88.3 m-85 -138.76 126.91 22.66 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.417 -0.586 . . . . 1.46 109.417 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 73.6 m -125.65 154.22 42.67 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.181 0.515 . . . . 2.05 111.853 -176.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.524 ' HB3' ' HB2' ' A' ' 156' ' ' SER . 2.0 tppp? -96.77 105.25 17.34 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.887 0.851 . . . . 1.4 112.081 -174.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.438 HD13 ' CZ ' ' A' ' 153' ' ' PHE . 0.6 OUTLIER -92.82 108.82 20.29 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.579 -1.191 . . . . 1.07 109.242 175.572 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.562 HG11 ' CG2' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -129.92 134.2 63.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.448 0.642 . . . . 1.11 111.504 177.206 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.564 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 17.7 ttt -143.49 151.3 40.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.518 -0.765 . . . . 1.79 109.321 -174.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.712 ' CD1' HD23 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -136.03 151.96 50.4 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.366 -0.605 . . . . 4.22 109.366 170.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.532 ' N ' ' HD1' ' A' ' 170' ' ' PHE . 3.9 p -134.85 132.83 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 115.746 -0.661 . . . . 2.01 110.078 176.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.515 ' OE1' HD13 ' A' ' 47' ' ' LEU . 24.9 tt0 -121.09 65.73 0.86 Allowed 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 107.135 -1.432 . . . . 2.66 107.135 177.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.509 HG23 ' OD1' ' A' ' 148' ' ' ASN . 1.4 m -68.94 149.47 48.82 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 113.54 -1.664 . . . . 2.2 110.465 -175.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.493 ' HB2' ' HB3' ' A' ' 147' ' ' TYR . 4.0 tp10 . . . . . 0 N--CA 1.449 -0.524 0 CA-C-N 116.187 -0.46 . . . . 2.45 109.872 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 12.0 mm . . . . . 0 CA--C 1.509 -0.629 0 CA-C-O 122.551 1.167 . . . . 1.69 108.997 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.651 ' HA ' ' CG2' ' A' ' 187' ' ' THR . 0.9 OUTLIER -83.39 -37.12 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 113.113 -1.858 . . . . 1.77 110.516 -172.103 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.482 ' O ' ' HG2' ' A' ' 189' ' ' PRO . 9.2 pt-20 -64.41 -16.72 62.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.489 -0.778 . . . . 2.89 109.343 174.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -92.05 -43.7 9.26 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.775 -0.648 . . . . 1.71 110.376 170.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.651 ' CG2' ' HA ' ' A' ' 184' ' ' ILE . 13.5 t -64.83 -40.33 95.01 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.841 0.682 . . . . 1.3 112.841 -169.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' MET . . . . . 0.532 ' CE ' HG22 ' A' ' 187' ' ' THR . 0.1 OUTLIER -78.04 -61.2 0.61 Allowed Pre-proline 0 N--CA 1.467 0.424 0 CA-C-N 118.407 0.549 . . . . 1.39 111.951 -178.456 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.578 ' O ' HG13 ' A' ' 193' ' ' VAL . 51.6 Cg_exo -56.26 -38.74 94.54 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.04 1.827 . . . . 1.15 112.258 -176.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.401 ' O ' HG21 ' A' ' 193' ' ' VAL . 23.2 t -72.21 -37.31 69.26 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.414 -0.587 . . . . 1.95 109.414 -177.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.429 ' HA ' ' HB2' ' A' ' 194' ' ' ASN . 2.6 t-20 -67.4 -31.93 72.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.019 -0.537 . . . . 1.92 110.408 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.499 ' HB3' ' CG1' ' A' ' 50' ' ' VAL . 40.5 mt -69.34 -46.22 67.59 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 120.738 0.304 . . . . 1.68 111.007 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 189' ' ' PRO . 0.9 OUTLIER -65.06 -34.25 69.28 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 N-CA-C 108.716 -0.846 . . . . 1.32 108.716 176.543 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.429 ' HB2' ' HA ' ' A' ' 191' ' ' ASN . 35.0 m-20 -63.64 -45.32 90.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.179 -1.373 . . . . 2.6 111.483 178.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.416 ' HA ' ' ND2' ' A' ' 198' ' ' ASN . 6.3 m-85 -59.15 -31.38 68.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.967 0.413 . . . . 2.73 110.417 175.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.433 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 34.3 mt -81.75 -27.17 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-N 116.157 -0.474 . . . . 1.11 111.319 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.43 ' HA ' HD23 ' A' ' 197' ' ' LEU . 62.4 mt -74.57 -40.16 61.81 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-O 121.108 0.48 . . . . 1.57 109.811 175.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.579 ' OD1' ' HG3' ' A' ' 76' ' ' LYS . 76.5 m-20 -50.07 -37.86 35.6 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.706 -1.134 . . . . 2.18 108.53 166.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.629 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -78.17 -43.94 27.25 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 116.081 -0.509 . . . . 1.04 110.905 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.556 ' O ' ' HG3' ' A' ' 204' ' ' LYS . 35.6 mmtm -55.96 -44.5 78.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.256 0.551 . . . . 1.51 110.565 174.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -87.58 -38.41 15.99 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.495 -0.775 . . . . 1.94 110.856 -173.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -68.39 -29.42 73.08 Favored Glycine 0 C--O 1.228 -0.243 0 C-N-CA 121.102 -0.57 . . . . 0.47 111.999 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.629 ' HB ' ' O ' ' A' ' 199' ' ' ALA . 2.8 tp -70.55 -31.68 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-O 120.92 0.391 . . . . 1.16 109.949 177.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.556 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 89.3 mttt -84.33 -32.84 24.06 Favored 'General case' 0 C--O 1.21 -1.006 0 N-CA-C 108.514 -0.921 . . . . 3.8 108.514 176.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.95 0 CA-C-N 115.923 -0.581 . . . . 1.28 109.525 170.231 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.492 ' O ' HD12 ' A' ' 6' ' ' ILE . 9.0 m-20 . . . . . 0 CA--C 1.505 -0.78 0 N-CA-C 112.006 0.373 . . . . 2.25 112.006 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.596 ' HB2' HG21 ' A' ' 87' ' ' ILE . 76.0 m-85 -61.99 -26.54 68.28 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 121.236 0.541 . . . . 0.45 110.098 -172.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.641 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 39.4 tttt -80.93 -36.44 31.01 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 107.453 -1.314 . . . . 2.06 107.453 -176.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.18 -43.57 82.78 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.897 -0.592 . . . . 1.2 111.32 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.492 HD12 ' O ' ' A' ' 2' ' ' ASP . 0.9 OUTLIER -82.75 -32.88 10.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 122.169 0.985 . . . . 1.76 109.191 -172.648 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.645 ' HB2' ' HB2' ' A' ' 116' ' ' TYR . . . -81.21 -37.79 28.06 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.176 -1.375 . . . . 1.11 111.718 -177.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.862 HE21 ' HH ' ' A' ' 116' ' ' TYR . 19.5 mt-30 -61.77 -30.13 70.59 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.421 -0.809 . . . . 2.14 109.704 175.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.639 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 76.3 mt-30 -78.32 -39.67 38.99 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.482 -1.236 . . . . 3.04 109.365 173.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.656 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.4 OUTLIER -72.94 -33.47 65.94 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.424 -0.807 . . . . 1.1 112.198 -175.185 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -48.05 -57.92 5.15 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.986 0.422 . . . . 1.04 111.698 174.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.669 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 4.2 pt20 -76.57 1.33 17.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.259 -0.428 . . . . 2.31 111.605 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.639 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 10.6 mm-40 -82.8 -48.83 10.36 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.01 -0.737 . . . . 2.54 109.01 169.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.95 HG23 ' HD1' ' A' ' 170' ' ' PHE . 7.4 p -72.0 -34.06 49.45 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-O 121.47 0.653 . . . . 1.21 109.818 175.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.669 ' HB3' ' HA ' ' A' ' 12' ' ' GLN . 0.8 OUTLIER -68.15 -26.18 65.64 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 122.361 1.077 . . . . 1.26 108.325 172.609 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 20' ' ' ASP . . . -68.75 -20.05 73.84 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 113.797 -1.547 . . . . 0.57 109.627 177.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.633 ' HD2' ' HA ' ' A' ' 14' ' ' VAL . 32.1 m-85 -91.08 -22.27 20.81 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 114.315 -0.943 . . . . 3.59 109.376 176.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 15' ' ' LEU . 5.6 t-20 -60.06 -28.7 68.0 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.356 -0.838 . . . . 2.1 109.615 175.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.534 ' HD2' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -115.22 10.89 16.11 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.58 -0.448 . . . . 3.26 111.397 175.189 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.573 ' CB ' ' HA ' ' A' ' 17' ' ' TYR . 50.7 t0 -89.6 69.93 7.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.499 0.666 . . . . 2.16 109.69 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.561 HG23 ' CH2' ' A' ' 24' ' ' TRP . 34.5 p -104.96 105.86 16.09 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.674 -0.694 . . . . 2.24 110.812 -176.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.5 p -169.87 -88.18 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.558 -0.746 . . . . 2.46 111.454 -173.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.48 ' O ' ' HG3' ' A' ' 38' ' ' LYS . . . -84.76 52.18 4.66 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 116.086 -0.507 . . . . 1.45 113.418 -173.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.867 ' HZ3' ' HD3' ' A' ' 49' ' ' ARG . 0.2 OUTLIER -119.61 -160.05 0.8 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.572 -0.529 . . . . 2.24 109.572 176.21 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.1 ttpp -176.09 110.65 0.1 Allowed 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 108.634 -0.876 . . . . 3.43 108.634 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.704 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 0.9 OUTLIER -61.14 118.27 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 CA-C-O 121.818 0.818 . . . . 2.21 110.303 175.084 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.635 HG21 ' HH ' ' A' ' 48' ' ' TYR . 3.2 m -98.49 -25.16 4.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 114.317 -1.31 . . . . 1.83 110.011 -178.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.425 ' HB3' ' CG2' ' A' ' 35' ' ' VAL . 0.9 OUTLIER -154.67 135.39 13.58 Favored 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 119.472 -0.891 . . . . 2.87 110.09 -178.007 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.504 HG22 ' HA ' ' A' ' 34' ' ' THR . 73.2 p -138.98 153.26 48.15 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.282 0.563 . . . . 1.92 110.748 177.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.651 ' HB3' HG12 ' A' ' 33' ' ' ILE . 14.9 t -113.86 -164.4 0.93 Allowed 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.456 -1.313 . . . . 2.37 107.456 173.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -93.8 19.31 8.99 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.999 0.428 . . . . 4.84 109.912 -176.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.831 ' HA ' ' HE2' ' A' ' 32' ' ' LYS . 3.6 mmpt? -155.02 -17.98 0.11 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.119 -0.946 . . . . 2.05 111.573 175.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.802 HG22 ' HA3' ' A' ' 52' ' ' GLY . 35.8 pt -131.35 170.82 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.902 0.382 . . . . 1.42 111.907 -172.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.504 ' HA ' HG22 ' A' ' 29' ' ' THR . 23.1 m -160.81 123.12 3.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.325 -0.852 . . . . 1.22 110.423 -167.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.608 HG13 HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -112.48 113.85 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.18 0.514 . . . . 1.52 110.692 172.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.704 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.8 OUTLIER -102.6 125.61 49.39 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.627 -0.715 . . . . 1.74 109.871 176.619 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 78.1 p -93.16 125.04 37.55 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 108.65 -0.87 . . . . 1.72 108.65 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.653 ' HA ' ' HA ' ' A' ' 24' ' ' TRP . 57.8 tttm . . . . . 0 C--N 1.305 -1.364 0 CA-C-N 115.751 -0.659 . . . . 2.45 110.963 -168.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.445 -0.683 0 CA-C-O 120.972 0.415 . . . . 2.45 109.998 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.816 HD13 ' HE2' ' A' ' 170' ' ' PHE . 6.1 tt -78.04 147.85 34.59 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.76 -1.2 . . . . 1.49 107.76 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.815 ' HB3' HD13 ' A' ' 192' ' ' LEU . 4.9 m-85 -129.81 124.61 33.75 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 119.493 -0.883 . . . . 1.52 111.288 -172.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.867 ' HD3' ' HZ3' ' A' ' 24' ' ' TRP . 54.3 ttt-85 -120.54 109.56 15.41 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.356 -0.838 . . . . 3.34 109.147 177.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.608 HG21 HG13 ' A' ' 35' ' ' VAL . 10.4 p -100.31 150.22 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 109.515 -0.55 . . . . 1.98 109.515 -177.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.755 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 41.5 tt0 -156.03 109.6 2.73 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.856 -0.611 . . . . 1.07 110.078 -172.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.802 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -140.45 159.58 26.3 Favored Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 111.427 -0.669 . . . . 0.35 111.427 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.406 HD13 ' HZ1' ' A' ' 32' ' ' LYS . 59.6 mt -99.88 124.24 53.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 C-N-CA 120.57 -0.452 . . . . 1.3 110.753 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.629 HG12 ' HD2' ' A' ' 200' ' ' LYS . 85.7 mt -101.96 121.35 51.01 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 115.656 -0.702 . . . . 1.07 109.926 175.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -64.89 61.41 0.29 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.981 3.121 . . . . 0.74 112.878 177.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.801 ' HG2' HG13 ' A' ' 203' ' ' ILE . 6.9 tp10 -155.4 173.6 16.44 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.051 -1.092 . . . . 1.68 108.051 174.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.56 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 52.3 p -83.04 146.75 52.46 Favored Pre-proline 0 N--CA 1.425 -1.72 0 CA-C-O 121.838 0.828 . . . . 1.58 109.836 175.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.432 ' HA ' HD13 ' A' ' 61' ' ' LEU . 27.6 Cg_exo -60.72 -11.05 15.92 Favored 'Trans proline' 0 C--N 1.329 -0.461 0 C-N-CA 124.16 3.24 . . . . 0.74 111.478 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.36 -52.03 31.07 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.214 -0.903 . . . . 1.31 110.811 174.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.713 ' HE3' ' HB3' ' A' ' 64' ' ' PHE . 18.4 tptt -69.12 -24.03 64.06 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.516 -0.92 . . . . 3.78 108.516 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.742 ' HA ' ' CD1' ' A' ' 64' ' ' PHE . 46.5 mt -65.95 -58.71 4.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.642 -0.708 . . . . 1.09 110.323 172.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 125' ' ' ASN . 19.8 p -62.26 -11.23 13.84 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.83 -0.543 . . . . 1.94 110.56 176.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.469 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 25.2 t70 -90.9 -44.78 9.16 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.334 0.494 . . . . 1.32 112.334 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.823 ' HD2' ' CZ2' ' A' ' 74' ' ' TRP . 10.3 p90 -71.79 -43.26 65.98 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 121.032 -0.267 . . . . 0.79 110.721 -168.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.675 HD11 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -96.86 6.64 48.28 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.444 -0.503 . . . . 2.15 111.288 -174.59 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -42.18 -73.67 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.083 0.771 . . . . 2.06 113.083 -169.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.578 HE22 HG23 ' A' ' 115' ' ' VAL . 64.0 mm-40 -152.19 -63.24 0.17 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.17 0.509 . . . . 4.31 112.27 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.921 ' HB ' ' CD2' ' A' ' 81' ' ' TYR . 9.1 t -145.08 21.43 1.58 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.995 0.902 . . . . 1.89 109.359 -174.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -88.82 -29.82 17.06 Favored Glycine 0 CA--C 1.491 -1.44 0 CA-C-N 114.84 -1.073 . . . . 1.71 113.87 -168.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.648 ' O ' HG22 ' A' ' 73' ' ' THR . 10.4 t0 -167.28 -35.71 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.365 -0.976 . . . . 2.19 108.365 -166.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.757 ' HA ' ' CZ2' ' A' ' 74' ' ' TRP . 1.0 OUTLIER -47.83 -48.24 30.92 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 114.577 -1.192 . . . . 3.95 111.582 -172.245 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.892 HG23 HD12 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -87.35 -7.02 10.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 119.743 -0.783 . . . . 1.42 111.244 -172.675 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.648 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.4 t -90.65 -30.79 16.93 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 119.76 -0.776 . . . . 1.45 110.013 -177.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.993 ' HZ3' ' HB3' ' A' ' 198' ' ' ASN . 7.1 p-90 -102.54 -7.6 21.72 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 120.509 -0.476 . . . . 0.78 111.822 178.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.849 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 4.5 t70 -76.57 168.29 20.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.549 0.69 . . . . 2.19 111.702 -170.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.663 ' HD2' ' OD1' ' A' ' 194' ' ' ASN . 0.0 OUTLIER -118.51 -16.74 9.48 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.849 -1.069 . . . . 3.68 111.286 -177.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.4 m -113.83 7.94 17.2 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.911 -0.774 . . . . 2.08 108.911 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.892 HD12 HG23 ' A' ' 72' ' ' ILE . 29.8 mt -109.89 167.31 10.26 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.059 -0.973 . . . . 1.16 111.283 -178.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.592 ' HG2' ' HG2' ' A' ' 99' ' ' GLN . 6.6 mm100 -146.58 -71.25 0.24 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.393 -0.821 . . . . 2.23 110.686 -175.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.531 HG22 ' HB3' ' A' ' 79' ' ' GLN . 18.8 t -138.55 124.57 24.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.059 -0.973 . . . . 1.44 110.112 -170.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.921 ' CD2' ' HB ' ' A' ' 68' ' ' THR . 69.6 t80 -106.68 139.32 41.31 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.491 -0.483 . . . . 5.73 110.395 174.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.563 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 17.5 m120 -130.31 104.63 7.39 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.039 -0.726 . . . . 1.86 109.039 177.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.847 ' HE2' ' HG2' ' A' ' 86' ' ' ARG . 7.1 tpt -67.77 101.43 1.06 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.148 -0.933 . . . . 2.52 109.583 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.53 HG12 ' HG2' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -81.59 -83.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 120.481 -0.487 . . . . 1.19 111.551 -171.378 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.499 ' H ' HG22 ' A' ' 84' ' ' VAL . 49.3 m170 -118.35 127.16 53.43 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.001 0.429 . . . . 2.59 109.887 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.847 ' HG2' ' HE2' ' A' ' 83' ' ' MET . 25.5 mtm180 -108.58 120.9 43.8 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.763 -0.829 . . . . 2.83 108.763 176.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.596 HG21 ' HB2' ' A' ' 3' ' ' PHE . 0.8 OUTLIER -80.94 -55.3 8.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.424 -0.807 . . . . 1.17 112.022 -163.427 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -127.66 -83.28 0.6 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.933 -0.576 . . . . 1.86 111.085 -173.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.5 t -148.17 -31.35 0.28 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.243 0.544 . . . . 1.94 110.08 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -128.11 19.61 6.45 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.4 -0.818 . . . . 1.87 109.511 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.589 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -126.18 111.69 14.91 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.083 -1.08 . . . . 1.12 108.083 -176.802 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.724 ' HB3' ' HE3' ' A' ' 83' ' ' MET . 56.1 m-85 -122.88 171.5 9.16 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.799 -0.637 . . . . 0.52 110.566 -173.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.522 ' HB ' HG22 ' A' ' 84' ' ' VAL . 23.8 mt -131.12 130.59 63.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 107.678 -1.23 . . . . 1.1 107.678 165.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.696 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 26.5 p -101.74 128.72 47.94 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.582 -0.447 . . . . 2.61 111.353 -174.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.61 ' HA ' HD13 ' A' ' 112' ' ' ILE . 2.8 t60 -104.3 86.54 2.55 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.269 -1.011 . . . . 2.17 108.269 165.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.674 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 18.5 m -110.47 117.1 32.66 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.415 -0.811 . . . . 1.19 112.2 -168.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 42.0 mm -78.55 125.76 38.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 120.169 -0.612 . . . . 1.63 109.493 173.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.7 m -107.26 146.9 30.89 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.111 -0.949 . . . . 1.72 110.705 -173.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.592 ' HG2' ' HG2' ' A' ' 79' ' ' GLN . 1.8 mm100 . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 115.942 -0.572 . . . . 2.29 110.685 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 94.7 mt . . . . . 0 N--CA 1.451 -0.406 0 CA-C-O 121.263 0.554 . . . . 1.53 112.139 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.9 m -100.84 169.72 7.49 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.369 -0.832 . . . . 1.71 109.434 174.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -51.69 123.8 13.07 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.204 1.936 . . . . 1.31 110.74 171.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.661 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 39.6 ttm105 -114.82 149.22 37.38 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.382 -0.527 . . . . 4.06 110.267 -168.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.644 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 36.7 t0 -109.6 117.46 34.0 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.876 -0.416 . . . . 1.37 109.876 -174.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.674 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 9.2 m-30 -98.3 112.32 24.35 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.83 0.348 . . . . 3.01 110.877 -175.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.696 ' HA ' ' O ' ' A' ' 94' ' ' CYS . 15.2 mm -115.02 79.81 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 CA-C-N 115.509 -0.769 . . . . 1.2 109.317 172.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.567 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 45.6 m-20 -110.25 127.45 54.99 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.676 -0.693 . . . . 1.86 109.896 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.601 HD13 ' O ' ' A' ' 92' ' ' PHE . 4.0 tp -76.82 125.91 30.08 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 109.211 -0.663 . . . . 1.08 109.211 173.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.578 HG23 HE22 ' A' ' 67' ' ' GLN . 0.1 OUTLIER -123.92 125.64 71.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 115.233 -0.894 . . . . 1.08 112.321 -164.903 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.862 ' HH ' HE21 ' A' ' 8' ' ' GLN . 85.1 t80 -112.23 115.13 28.3 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.352 -0.84 . . . . 2.81 110.812 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.661 HG12 HG22 ' A' ' 127' ' ' ILE . 78.1 mt -91.27 99.29 9.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.974 -0.557 . . . . 1.53 109.668 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.554 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 2.6 tppp? -97.55 130.86 44.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.293 -0.867 . . . . 1.81 109.353 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.547 ' NH1' ' HA ' ' A' ' 121' ' ' GLU . 4.3 tmt_? -111.95 91.86 3.81 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 107.847 -1.168 . . . . 3.22 107.847 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -64.68 115.24 5.05 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 107.813 -1.181 . . . . 1.28 107.813 173.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.547 ' HA ' ' NH1' ' A' ' 119' ' ' ARG . 7.4 mm-40 -27.91 90.35 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 O-C-N 125.312 1.632 . . . . 2.28 113.398 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 52.62 41.67 57.21 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 115.271 -0.877 . . . . 0.79 112.81 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.518 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 4.1 t-20 -141.04 -39.0 0.41 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.395 0.146 . . . . 2.06 111.395 -175.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.472 ' CG ' ' HB ' ' A' ' 154' ' ' VAL . 3.4 tpp -157.13 118.32 3.67 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.312 -0.555 . . . . 1.73 111.22 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.5 ' HB3' ' HB3' ' A' ' 62' ' ' SER . 4.8 m-20 -101.08 73.67 1.54 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.509 -0.923 . . . . 2.07 108.509 175.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.688 ' HB ' HG13 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -92.34 138.48 19.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.189 -0.914 . . . . 1.06 112.667 -172.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.751 ' O ' HG13 ' A' ' 127' ' ' ILE . 1.1 pt -105.59 116.32 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 108.51 -0.922 . . . . 1.26 108.51 162.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 4.1 m -81.26 163.46 22.96 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.266 -0.642 . . . . 1.53 109.266 173.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.567 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 12.7 p -156.88 131.48 8.74 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.052 0.453 . . . . 1.81 110.968 176.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.582 ' HD3' HD22 ' A' ' 114' ' ' LEU . 20.0 mtpp -131.09 120.78 23.88 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 107.754 -1.202 . . . . 2.75 107.754 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.0 p -63.48 98.31 0.16 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.47 -0.937 . . . . 1.94 108.47 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.02 138.37 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-N 114.526 -1.215 . . . . 1.64 109.678 -165.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -100.81 74.79 1.66 Allowed 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 122.42 1.105 . . . . 2.17 110.306 -170.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.673 ' O ' ' HB3' ' A' ' 137' ' ' TYR . 3.8 p90 -106.37 175.93 1.88 Allowed Pre-proline 0 CA--C 1.554 1.127 0 CA-C-N 114.124 -1.398 . . . . 0.67 109.302 -174.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.608 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 25.0 Cg_exo -27.35 -67.27 0.05 OUTLIER 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 125.13 3.887 . . . . 1.66 117.308 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.644 ' HB3' ' CZ ' ' A' ' 134' ' ' PHE . 5.8 tp10 -68.63 -26.34 65.3 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.613 0.597 . . . . 3.5 112.613 -173.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.673 ' HB3' ' O ' ' A' ' 134' ' ' PHE . 0.5 OUTLIER -39.77 -55.23 3.72 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 115.331 1.604 . . . . 6.41 115.331 -171.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.435 ' HD2' ' O ' ' A' ' 135' ' ' PRO . 44.3 Cg_exo -35.72 106.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.366 1.495 0 C-N-CA 123.432 2.755 . . . . 2.31 114.408 -171.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.523 ' HB2' ' O ' ' A' ' 143' ' ' TYR . 72.9 Cg_endo -88.01 -147.54 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.274 2.65 . . . . 1.27 113.104 -174.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.438 ' H ' ' HB2' ' A' ' 139' ' ' PRO . 15.1 m -143.26 -171.98 3.6 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.785 -0.82 . . . . 1.88 108.785 -174.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.2 m -74.98 -38.45 61.66 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.0 -0.68 . . . . 2.43 111.247 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -77.39 -56.63 4.38 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.563 -0.532 . . . . 2.18 109.563 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.553 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 87.9 m-85 -79.41 109.49 13.82 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 115.715 -0.675 . . . . 1.33 110.16 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.661 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 1.9 tp -104.42 117.89 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 CA-C-N 115.199 -0.91 . . . . 1.4 109.495 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.644 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 0.1 OUTLIER -46.64 116.35 1.29 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.237 -0.892 . . . . 5.14 110.775 175.204 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -55.22 108.22 0.94 Allowed Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 114.971 -1.013 . . . . 1.05 111.793 176.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 1.106 ' HB3' ' HB3' ' A' ' 174' ' ' GLU . 0.2 OUTLIER -83.43 79.95 9.25 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.496 0.665 . . . . 4.68 109.878 177.174 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.666 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 84.8 m-20 -103.2 102.32 12.3 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.262 -1.336 . . . . 2.29 108.427 175.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -81.2 143.09 51.88 Favored Pre-proline 0 C--N 1.32 -0.685 0 C-N-CA 120.448 -0.501 . . . . 2.95 111.001 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.656 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 8.6 Cg_exo -10.07 59.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.411 1 C-N-CA 127.18 5.253 . . . . 0.77 116.355 -163.327 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . 0.756 ' HA ' ' CE1' ' A' ' 170' ' ' PHE . 7.8 p -85.58 -179.11 6.83 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.815 -1.084 . . . . 1.97 110.513 176.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.707 ' HA3' HG13 ' A' ' 14' ' ' VAL . . . -169.63 -168.09 31.09 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.393 -0.908 . . . . 0.55 111.677 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.561 ' CE1' HD11 ' A' ' 167' ' ' LEU . 60.8 t80 -160.18 80.8 0.69 Allowed 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.915 -1.143 . . . . 0.8 107.915 -165.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.688 HG13 ' HB ' ' A' ' 126' ' ' ILE . 7.1 m -89.53 124.52 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 121.829 0.823 . . . . 1.03 110.468 -173.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 56.6 m -106.08 113.31 26.78 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.523 -0.762 . . . . 2.3 109.165 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.739 ' HB3' ' HB3' ' A' ' 166' ' ' LYS . 15.5 t -106.07 121.72 44.69 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 116.203 -0.453 . . . . 1.45 111.535 -169.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.518 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 69.0 Cg_exo -51.7 114.99 1.83 Allowed 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.726 2.284 . . . . 0.72 111.26 169.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.655 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 0.2 OUTLIER -76.32 -167.97 0.88 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.266 0.555 . . . . 1.72 112.172 -177.03 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -67.51 -38.08 83.76 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.484 -0.932 . . . . 2.63 108.484 169.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.565 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 10.8 mm-40 -97.6 29.06 3.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.099 -1.409 . . . . 2.05 108.89 175.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.403 ' CG ' ' HD3' ' A' ' 162' ' ' PRO . 1.2 p-10 -23.84 -58.05 0.13 Allowed Pre-proline 0 N--CA 1.473 0.724 0 N-CA-C 116.515 2.043 . . . . 2.19 116.515 -169.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.403 ' HD3' ' CG ' ' A' ' 161' ' ' ASN . 63.1 Cg_endo -72.7 -19.51 24.09 Favored 'Trans proline' 0 C--N 1.35 0.621 0 CA-C-N 121.448 1.553 . . . . 0.86 113.451 -175.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -105.73 -25.27 12.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.743 0.306 . . . . 1.34 111.415 -177.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.655 ' O ' ' HB2' ' A' ' 158' ' ' MET . 52.9 m-85 -141.05 131.3 24.96 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.858 -0.793 . . . . 1.46 108.858 177.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.517 ' OG ' HD11 ' A' ' 61' ' ' LEU . 3.6 p -126.99 148.75 50.09 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.046 0.451 . . . . 2.05 111.468 -177.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.755 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.8 tppp? -91.67 104.43 16.9 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.824 0.821 . . . . 1.4 111.242 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.561 HD11 ' CE1' ' A' ' 153' ' ' PHE . 0.6 OUTLIER -89.4 106.41 18.43 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.481 -1.236 . . . . 1.07 109.762 176.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.631 HG11 HG22 ' A' ' 154' ' ' VAL . 0.1 OUTLIER -131.05 129.12 63.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.644 0.735 . . . . 1.11 111.911 176.394 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.593 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 18.2 ttt -137.8 131.7 31.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.228 -0.896 . . . . 1.79 110.17 -172.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.95 ' HD1' HG23 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -111.2 145.15 39.2 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.088 -0.645 . . . . 4.22 110.002 174.202 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.65 116.5 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-O 121.415 0.626 . . . . 2.01 110.895 176.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 170' ' ' PHE . 0.0 OUTLIER -94.98 77.28 3.56 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 106.673 -1.603 . . . . 2.66 106.673 168.109 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.57 HG22 ' HE2' ' A' ' 188' ' ' MET . 0.6 OUTLIER -74.65 128.31 35.25 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.317 -0.856 . . . . 2.2 110.89 -176.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 1.106 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 38.4 tp10 . . . . . 0 N--CA 1.447 -0.575 0 CA-C-O 121.261 0.553 . . . . 2.45 110.524 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.492 ' HA ' ' HE3' ' A' ' 186' ' ' LYS . 17.6 mm . . . . . 0 CA--C 1.511 -0.53 0 CA-C-O 122.356 1.074 . . . . 1.69 108.418 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.68 ' HA ' HG23 ' A' ' 187' ' ' THR . 1.0 OUTLIER -57.98 -37.7 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 CA-C-N 113.302 -1.772 . . . . 1.77 109.674 172.17 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -61.86 -22.39 65.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.633 -1.167 . . . . 2.89 110.056 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.492 ' HE3' ' HA ' ' A' ' 183' ' ' ILE . 48.1 mttt -91.51 -49.0 6.55 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.179 -0.674 . . . . 1.71 109.179 173.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.68 HG23 ' HA ' ' A' ' 184' ' ' ILE . 11.1 t -62.93 -33.54 75.56 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.378 0.881 . . . . 1.3 113.378 -165.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' MET . . . . . 0.616 ' CE ' HG22 ' A' ' 187' ' ' THR . 0.0 OUTLIER -71.72 -65.9 0.79 Allowed Pre-proline 0 N--CA 1.469 0.504 0 CA-C-N 118.888 0.767 . . . . 1.39 111.674 179.613 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.719 ' O ' HG12 ' A' ' 193' ' ' VAL . 27.5 Cg_endo -62.39 -41.79 31.52 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.486 1.457 . . . . 1.15 111.471 -176.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.707 ' O ' ' HB3' ' A' ' 194' ' ' ASN . 68.3 m -68.43 -22.82 64.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.364 -0.38 . . . . 1.95 111.377 -174.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 187' ' ' THR . 53.9 m-20 -90.21 -37.7 13.96 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.806 -0.358 . . . . 1.92 111.474 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.815 HD13 ' HB3' ' A' ' 48' ' ' TYR . 19.2 mt -60.8 -49.72 76.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.824 0.345 . . . . 1.68 111.039 176.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.719 HG12 ' O ' ' A' ' 189' ' ' PRO . 3.0 m -65.4 -31.6 54.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.63 0.729 . . . . 1.32 110.029 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.714 ' HA ' ' HG ' ' A' ' 197' ' ' LEU . 0.0 OUTLIER -73.19 -43.62 61.08 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.674 -1.148 . . . . 2.6 111.397 -177.747 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -62.36 -26.17 68.31 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.415 -0.957 . . . . 2.73 108.415 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.597 ' O ' ' HB1' ' A' ' 199' ' ' ALA . 20.7 mt -78.37 -44.58 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-N 115.177 -0.919 . . . . 1.11 113.25 175.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.795 HD12 ' N ' ' A' ' 198' ' ' ASN . 3.0 pp -74.1 -31.83 62.97 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 119.336 -0.946 . . . . 1.57 110.332 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.993 ' HB3' ' HZ3' ' A' ' 74' ' ' TRP . 9.9 m120 -61.82 -24.58 66.97 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.118 0.485 . . . . 2.18 110.017 165.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.825 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -80.77 -29.98 36.11 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 108.713 -0.847 . . . . 1.04 108.713 177.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.629 ' HD2' HG12 ' A' ' 54' ' ' ILE . 2.9 mptm? -67.02 -46.17 75.3 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.202 -0.908 . . . . 1.51 108.685 175.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.55 -24.8 25.34 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.832 -1.076 . . . . 1.94 110.797 -170.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . 0.423 ' O ' ' HB3' ' A' ' 205' ' ' ALA . . . -78.2 -28.17 56.53 Favored Glycine 0 N--CA 1.46 0.245 0 C-N-CA 120.492 -0.861 . . . . 0.47 111.477 174.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.825 ' HB ' ' O ' ' A' ' 199' ' ' ALA . 0.9 OUTLIER -76.95 -35.22 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 123.326 0.65 . . . . 1.16 110.214 173.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 40.2 mttm -78.17 -21.66 49.88 Favored 'General case' 0 C--O 1.216 -0.698 0 N-CA-C 108.91 -0.774 . . . . 3.8 108.91 175.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 202' ' ' GLY . . . . . . . . 0 C--N 1.321 -0.636 0 CA-C-N 115.549 -0.751 . . . . 1.28 109.1 170.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 . . . . . 0 CA--C 1.504 -0.807 0 CA-C-O 119.916 -0.088 . . . . 2.25 110.94 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.528 ' O ' ' HB1' ' A' ' 7' ' ' ALA . 65.2 m-85 -59.38 -35.0 73.1 Favored 'General case' 0 CA--C 1.502 -0.882 0 O-C-N 123.945 0.778 . . . . 0.45 110.497 -169.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.777 ' O ' ' HB3' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -74.82 -41.25 60.27 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-N 115.273 -0.876 . . . . 2.06 108.736 -177.4 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.98 -45.99 78.8 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.829 -0.623 . . . . 1.2 112.31 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.641 ' O ' ' HB ' ' A' ' 10' ' ' THR . 0.2 OUTLIER -79.44 -36.37 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 N-CA-C 108.906 -0.776 . . . . 1.76 108.906 -172.453 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.578 ' HB3' ' HB2' ' A' ' 116' ' ' TYR . . . -71.79 -47.74 51.33 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.517 -1.22 . . . . 1.11 111.474 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.777 ' HB3' ' O ' ' A' ' 4' ' ' LYS . 3.7 pt20 -53.3 -34.3 56.79 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.344 -1.298 . . . . 2.14 109.847 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.63 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 48.5 mt-30 -91.02 -31.63 16.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.879 -1.055 . . . . 3.04 109.985 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.641 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -66.42 -35.0 79.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.633 -0.712 . . . . 1.1 110.746 178.271 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.553 ' HA ' ' CB ' ' A' ' 128' ' ' SER . . . -47.44 -58.51 4.1 Favored 'General case' 0 C--O 1.226 -0.154 0 N-CA-C 112.02 0.378 . . . . 1.04 112.02 175.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.405 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 20.8 pt20 -74.96 -6.72 50.81 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.493 -0.322 . . . . 2.31 111.344 -178.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.63 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 16.6 mm-40 -81.43 -48.35 12.01 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 121.163 0.506 . . . . 2.54 109.707 175.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.71 HG22 ' N ' ' A' ' 152' ' ' GLY . 10.9 p -70.74 -37.77 70.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.798 0.809 . . . . 1.21 109.735 176.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.405 ' HB3' ' HA ' ' A' ' 12' ' ' GLN . 0.8 OUTLIER -67.24 -25.62 66.18 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 122.236 1.017 . . . . 1.26 108.338 173.068 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.491 ' HA2' ' CD ' ' A' ' 19' ' ' ARG . . . -67.86 -15.01 66.34 Favored Glycine 0 CA--C 1.5 -0.869 0 CA-C-N 113.679 -1.6 . . . . 0.57 110.539 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.8 m-30 -92.42 -19.48 22.01 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.019 -0.591 . . . . 3.59 109.489 177.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -89.88 -27.55 19.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.152 -0.476 . . . . 2.1 110.531 178.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.491 ' CD ' ' HA2' ' A' ' 16' ' ' GLY . 5.7 ptm180 -90.8 -20.25 22.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.254 0.55 . . . . 3.26 110.178 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -121.44 117.33 26.62 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.927 -0.768 . . . . 2.16 108.927 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.6 p -126.47 103.76 7.78 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.388 0.614 . . . . 2.24 111.407 -174.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.0 p -170.47 155.49 5.09 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.053 -0.976 . . . . 2.46 109.993 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.37 4.1 86.34 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.85 -0.69 . . . . 1.45 113.057 174.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.462 ' HA ' ' HB3' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -120.3 -158.07 0.73 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.815 0.341 . . . . 2.24 110.933 -178.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -172.3 125.36 0.52 Allowed 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 115.883 -0.599 . . . . 3.43 109.821 -173.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.64 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 2.5 p -69.28 112.06 3.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-O 122.29 1.043 . . . . 2.21 109.836 175.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.5 p -91.01 -23.5 5.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 113.812 -1.54 . . . . 1.83 109.138 -176.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.452 ' HB2' ' HZ1' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -156.64 124.15 5.41 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 120.223 -0.591 . . . . 2.87 111.768 -173.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.518 ' HB ' ' HA ' ' A' ' 34' ' ' THR . 0.4 OUTLIER -150.51 150.99 32.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.074 0.464 . . . . 1.92 111.062 -179.597 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.7 t -120.21 -141.09 0.34 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.503 -0.771 . . . . 2.37 109.322 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -101.55 17.7 22.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.984 0.421 . . . . 4.84 110.787 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.679 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 48.3 mmtt -154.46 -29.23 0.12 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.904 -0.589 . . . . 2.05 111.671 177.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.564 ' HA ' ' O ' ' A' ' 51' ' ' GLU . 17.8 pt -116.01 163.12 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 CA-C-O 120.767 0.317 . . . . 1.42 111.493 -172.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.518 ' HA ' ' HB ' ' A' ' 29' ' ' THR . 8.8 m -156.42 114.09 3.24 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.108 -0.951 . . . . 1.22 110.515 -172.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 49' ' ' ARG . 42.5 t -105.4 110.85 32.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.518 -0.31 . . . . 1.52 110.554 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.64 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 4.1 m -109.6 123.5 49.55 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.636 0.732 . . . . 1.74 111.092 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 28.2 p -108.2 131.11 55.0 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.32 -1.309 . . . . 1.72 112.781 -171.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.462 ' HB3' ' HA ' ' A' ' 24' ' ' TRP . 44.3 pttt . . . . . 0 C--N 1.323 -0.564 0 CA-C-N 115.128 -0.942 . . . . 2.45 110.176 171.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 . . . . . 0 N--CA 1.449 -0.523 0 CA-C-O 120.843 0.354 . . . . 2.45 110.611 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.611 HD13 ' NE2' ' A' ' 172' ' ' GLN . 4.0 tt -90.19 134.26 34.39 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.325 -0.991 . . . . 1.49 108.325 175.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.552 ' N ' HD21 ' A' ' 47' ' ' LEU . 69.1 m-85 -121.58 120.38 34.64 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.836 -0.431 . . . . 1.52 109.836 -177.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.3 OUTLIER -101.51 117.66 35.38 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.162 -0.681 . . . . 3.34 109.162 174.538 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.505 ' HB ' ' HB3' ' A' ' 192' ' ' LEU . 14.7 p -107.17 131.89 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 108.798 -0.816 . . . . 1.98 108.798 177.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 34.0 tt0 -136.06 117.92 15.18 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.644 -0.707 . . . . 1.07 110.783 -169.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.679 ' HA2' ' O ' ' A' ' 32' ' ' LYS . . . -142.24 144.38 14.07 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.872 -0.68 . . . . 0.35 111.675 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 92.4 mt -84.85 122.87 38.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 119.635 -0.826 . . . . 1.3 110.479 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.44 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 42.0 mt -105.11 110.69 64.79 Favored Pre-proline 0 N--CA 1.443 -0.816 0 N-CA-C 108.69 -0.856 . . . . 1.07 108.69 174.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 39.5 Cg_exo -63.11 54.89 0.15 Allowed 'Trans proline' 0 N--CA 1.476 0.491 0 C-N-CA 124.442 3.428 . . . . 0.74 113.915 -177.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.419 ' HG2' HG13 ' A' ' 203' ' ' ILE . 10.9 tp10 -151.16 168.38 24.85 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.657 -1.238 . . . . 1.68 107.657 174.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.423 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 73.3 p -69.74 144.48 93.68 Favored Pre-proline 0 N--CA 1.43 -1.433 0 CA-C-O 121.88 0.848 . . . . 1.58 111.117 -176.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.494 ' HA ' HD13 ' A' ' 61' ' ' LEU . 23.9 Cg_exo -61.31 -15.79 42.7 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.432 2.755 . . . . 0.74 110.125 175.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.4 -47.84 58.97 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.559 -1.201 . . . . 1.31 110.862 173.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.416 ' HG2' HG13 ' A' ' 203' ' ' ILE . 2.1 tpmt? -67.19 -30.08 69.93 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.049 -1.093 . . . . 3.78 108.049 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.646 HD23 ' CD1' ' A' ' 203' ' ' ILE . 55.8 mt -62.36 -54.92 33.4 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.867 -1.061 . . . . 1.09 110.205 174.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.6 p -62.96 -9.18 8.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.071 0.462 . . . . 1.94 110.717 176.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -91.35 -33.36 15.32 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.566 0.58 . . . . 1.32 112.566 174.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.685 ' CE2' ' HA ' ' A' ' 199' ' ' ALA . 2.9 p90 -78.31 -45.05 23.65 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 120.399 -0.52 . . . . 0.79 110.69 -169.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -83.51 -7.3 59.56 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 121.056 -0.258 . . . . 2.15 111.041 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -9.95 -72.69 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 O-C-N 125.571 1.794 . . . . 2.06 114.679 -159.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -158.52 -62.4 0.08 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.713 1.005 . . . . 4.31 113.713 -172.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.672 ' OG1' ' HB2' ' A' ' 81' ' ' TYR . 11.6 t -178.35 27.96 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.352 0.596 . . . . 1.89 109.543 -162.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -127.95 -16.91 2.12 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 119.249 -1.453 . . . . 1.71 113.138 -171.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.524 ' O ' HG21 ' A' ' 73' ' ' THR . 1.7 p30 -159.34 -21.6 0.07 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 111.896 0.332 . . . . 2.19 111.896 -177.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.7 ' HA ' ' NE1' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -67.47 -16.44 64.21 Favored 'General case' 0 C--O 1.217 -0.62 0 O-C-N 122.069 -0.394 . . . . 3.95 110.982 -174.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.445 HG23 HD13 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -90.48 -20.25 6.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.234 0.54 . . . . 1.42 109.937 173.521 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.524 HG21 ' O ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -82.2 -24.47 34.91 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.603 -0.726 . . . . 1.45 110.363 -170.667 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.7 ' NE1' ' HA ' ' A' ' 71' ' ' ARG . 24.9 p-90 -108.47 -4.35 17.37 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.276 -0.569 . . . . 0.78 111.205 177.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.651 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 2.9 t70 -74.92 177.68 6.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.815 0.817 . . . . 2.19 112.659 -168.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.07 -22.81 5.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.473 -1.24 . . . . 3.68 111.007 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.1 t -121.69 9.36 10.14 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.47 -0.567 . . . . 2.08 109.47 -176.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 36.4 mt -109.1 169.5 8.64 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.649 -0.705 . . . . 1.16 110.476 177.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.557 ' HG2' ' HG2' ' A' ' 99' ' ' GLN . 10.5 mm100 -147.41 -58.78 0.26 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.75 -0.659 . . . . 2.23 111.674 -173.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 96' ' ' THR . 25.6 t -138.15 117.9 15.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 1.44 111.254 -166.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.672 ' HB2' ' OG1' ' A' ' 68' ' ' THR . 45.3 p90 -89.99 151.32 21.74 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 116.194 -0.457 . . . . 5.73 110.852 174.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.422 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 4.2 m120 -158.95 108.94 1.98 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.603 -0.726 . . . . 1.86 109.52 173.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.785 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 13.5 ttm -71.1 103.99 2.9 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.604 -0.887 . . . . 2.52 108.604 177.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.665 HG22 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -84.78 -71.96 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 120.47 -0.492 . . . . 1.19 112.029 -170.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -136.37 107.61 6.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.205 -0.452 . . . . 2.59 109.833 -175.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.785 ' HD3' ' SD ' ' A' ' 83' ' ' MET . 28.3 mtm180 -93.72 112.41 24.28 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.588 -0.523 . . . . 2.83 109.588 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.623 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -75.69 -37.08 35.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.917 -0.583 . . . . 1.17 109.614 -178.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -157.69 -179.32 8.05 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.236 -0.893 . . . . 1.86 108.856 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.8 m -78.28 4.41 12.89 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.638 0.256 . . . . 1.94 110.907 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -138.35 6.17 2.54 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.355 -0.609 . . . . 1.87 109.355 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.623 ' O ' HG12 ' A' ' 87' ' ' ILE . 1.1 m -141.99 109.54 5.68 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.532 -0.914 . . . . 1.12 108.532 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.539 ' O ' HD13 ' A' ' 114' ' ' LEU . 33.9 m-85 -128.95 174.98 9.03 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.475 0.655 . . . . 0.52 110.764 -173.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.665 ' O ' HG22 ' A' ' 84' ' ' VAL . 36.2 mt -133.38 123.25 46.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 106.616 -1.624 . . . . 1.1 106.616 166.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 78.6 m -110.47 124.45 51.8 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.732 -0.387 . . . . 2.61 110.665 -173.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.524 ' HA ' ' O ' ' A' ' 111' ' ' PHE . 11.5 t-160 -89.39 118.75 29.28 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 108.507 -0.923 . . . . 2.17 108.507 168.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 89.8 m -136.98 123.45 20.83 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.727 -0.67 . . . . 1.19 111.228 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 46.5 mm -78.43 132.61 32.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 O-C-N 121.501 -0.749 . . . . 1.63 109.593 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.484 ' HB ' ' HB2' ' A' ' 109' ' ' ARG . 2.3 m -110.36 146.34 35.95 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.783 -0.644 . . . . 1.72 110.745 -174.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.557 ' HG2' ' HG2' ' A' ' 79' ' ' GLN . 7.5 mm-40 . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 115.908 -0.587 . . . . 2.29 110.443 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 65.4 mt . . . . . 0 N--CA 1.448 -0.566 0 CA-C-O 120.618 0.247 . . . . 1.53 110.72 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.3 m -84.04 153.24 63.2 Favored Pre-proline 0 N--CA 1.449 -0.496 0 CA-C-N 116.111 -0.495 . . . . 1.71 110.06 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -60.48 137.1 71.89 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.147 1.898 . . . . 1.31 110.01 174.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.484 ' HB2' ' HB ' ' A' ' 98' ' ' THR . 54.5 mtt180 -111.92 159.69 18.14 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.604 -0.839 . . . . 4.06 111.213 -172.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.681 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 12.9 t70 -107.35 143.14 36.07 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.72 -1.215 . . . . 1.37 107.72 176.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.566 ' HB3' ' HB ' ' A' ' 96' ' ' THR . 50.6 t80 -122.36 115.07 21.66 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.59 -0.522 . . . . 3.01 109.59 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.601 HG22 ' CE1' ' A' ' 134' ' ' PHE . 12.8 mm -132.7 85.85 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.016 -0.993 . . . . 1.2 108.517 175.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.545 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 1.0 OUTLIER -116.14 131.52 56.92 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.807 -0.633 . . . . 1.86 110.944 -177.453 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.595 ' O ' ' HA ' ' A' ' 129' ' ' SER . 6.6 tp -80.77 121.87 26.46 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.241 -0.89 . . . . 1.08 109.068 172.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.76 125.71 71.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-N 115.398 -0.819 . . . . 1.08 111.747 -165.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.578 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 11.6 t80 -107.5 118.73 37.49 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.059 -0.973 . . . . 2.81 110.634 177.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.402 HG13 HG23 ' A' ' 127' ' ' ILE . 4.7 mp -94.44 100.71 11.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.03 -0.532 . . . . 1.53 109.839 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -114.02 142.69 45.86 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.717 -0.475 . . . . 1.81 109.717 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.449 ' NH1' ' HA ' ' A' ' 121' ' ' GLU . 3.2 tmt_? -127.22 95.36 4.26 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 108.503 -0.925 . . . . 3.22 108.503 -177.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -64.67 118.49 8.97 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 107.901 -1.148 . . . . 1.28 107.901 174.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.449 ' HA ' ' NH1' ' A' ' 119' ' ' ARG . 8.0 mm-40 -38.24 90.47 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.923 1.389 . . . . 2.28 113.148 -175.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 62.97 36.06 92.93 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.178 -0.919 . . . . 0.79 112.419 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.522 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 2.2 t-20 -132.85 -45.41 0.87 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.526 -0.175 . . . . 2.06 110.526 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -157.81 131.03 7.62 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 120.733 0.302 . . . . 1.73 111.812 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -106.36 79.39 1.37 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.169 -1.048 . . . . 2.07 108.169 170.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.495 ' CG1' HG13 ' A' ' 154' ' ' VAL . 0.4 OUTLIER -99.82 140.9 17.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.586 -0.734 . . . . 1.06 112.801 -171.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.723 ' O ' HG13 ' A' ' 127' ' ' ILE . 4.3 pt -110.16 110.62 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-O 121.904 0.859 . . . . 1.26 108.766 162.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.553 ' CB ' ' HA ' ' A' ' 11' ' ' ALA . 53.2 p -93.92 113.5 25.52 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 121.853 -0.529 . . . . 1.53 110.208 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.595 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 7.0 m -110.91 150.58 29.01 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.411 -0.813 . . . . 1.81 111.203 -170.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.561 ' HB3' ' HZ3' ' A' ' 130' ' ' LYS . 3.5 mtpm? -136.62 117.58 14.24 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 107.606 -1.257 . . . . 2.75 107.606 175.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.408 ' HB2' ' H ' ' A' ' 148' ' ' ASN . 33.3 t -63.51 98.37 0.17 Allowed 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.075 -1.454 . . . . 1.94 107.075 175.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.436 HG12 ' HB3' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -108.16 141.58 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.035 0 CA-C-N 114.57 -1.196 . . . . 1.64 108.988 -163.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -100.47 71.02 1.51 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 122.291 1.043 . . . . 2.17 108.682 -170.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.76 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -98.2 159.52 30.5 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-N 113.668 -1.606 . . . . 0.67 110.629 -171.589 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.96 -12.96 16.02 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.941 2.427 . . . . 1.66 114.785 -171.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.76 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 5.6 tp10 -72.41 -16.93 61.84 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 109.388 -0.597 . . . . 3.5 109.388 -172.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -163.52 118.43 1.12 Allowed Pre-proline 0 N--CA 1.448 -0.558 0 N-CA-C 113.066 0.765 . . . . 6.41 113.066 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -92.73 145.63 2.55 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.306 2.671 . . . . 2.31 110.834 166.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -72.29 -155.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.538 2.159 . . . . 1.27 112.336 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.2 m -147.15 155.92 42.55 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.823 -0.806 . . . . 1.88 108.823 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.9 p -73.11 -0.25 13.55 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.197 0.443 . . . . 2.43 112.197 -173.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -105.16 -16.12 14.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.056 0.455 . . . . 2.18 110.006 175.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -132.36 108.91 9.49 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.515 -0.766 . . . . 1.33 109.904 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.7 tp -90.75 112.88 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 C-N-CA 120.366 -0.533 . . . . 1.4 110.523 -176.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.681 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 64.9 ttp85 -49.41 102.22 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.408 -0.815 . . . . 5.14 109.741 171.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -60.08 117.43 11.34 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 110.617 -0.993 . . . . 1.05 110.617 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.45 ' HB3' ' CB ' ' A' ' 174' ' ' GLU . 65.0 t80 -83.45 85.59 7.22 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.791 0.805 . . . . 4.68 111.17 -174.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.639 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 78.7 m-20 -77.83 98.81 5.7 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.426 -1.261 . . . . 2.29 109.539 171.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.434 ' O ' ' HB3' ' A' ' 172' ' ' GLN . 24.6 t-80 -71.71 129.83 87.9 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 108.062 -1.088 . . . . 2.95 108.062 176.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.493 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 46.1 Cg_exo -13.54 66.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.122 1 C-N-CA 126.973 5.115 . . . . 0.77 115.905 -163.396 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . 0.639 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 24.2 p -112.31 156.4 22.5 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.845 -1.07 . . . . 1.97 108.553 174.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.71 ' N ' HG22 ' A' ' 14' ' ' VAL . . . -145.23 -147.35 4.61 Favored Glycine 0 N--CA 1.433 -1.528 0 C-N-CA 119.256 -1.449 . . . . 0.55 113.624 -169.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.553 ' CZ ' HD23 ' A' ' 167' ' ' LEU . 55.1 t80 -162.06 92.06 0.82 Allowed 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.472 -0.936 . . . . 0.8 108.472 -164.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.555 ' CG2' HG12 ' A' ' 168' ' ' VAL . 2.4 m -102.06 132.3 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-O 121.696 0.76 . . . . 1.03 110.776 -175.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 37.0 m -112.52 107.68 16.51 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.371 -0.831 . . . . 2.3 109.272 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.452 ' O ' ' HB3' ' A' ' 166' ' ' LYS . 9.8 m -104.75 114.13 64.22 Favored Pre-proline 0 C--N 1.315 -0.916 0 C-N-CA 120.771 -0.371 . . . . 1.45 111.267 -169.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.522 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 53.1 Cg_exo -49.8 120.88 6.49 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.511 2.14 . . . . 0.72 111.397 174.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.57 ' SD ' ' HB2' ' A' ' 166' ' ' LYS . 87.3 mmm -76.17 -165.62 0.51 Allowed 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.03 0.443 . . . . 1.72 111.429 -176.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.433 ' H ' ' HB3' ' A' ' 158' ' ' MET . 13.1 mm-40 -66.09 -22.7 66.42 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.687 -0.688 . . . . 2.63 109.708 177.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -109.16 19.58 19.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.414 -0.812 . . . . 2.05 110.047 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.512 ' HB2' ' CD ' ' A' ' 162' ' ' PRO . 13.0 m120 27.2 -91.05 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.872 1.669 . . . . 2.19 115.483 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.512 ' CD ' ' HB2' ' A' ' 161' ' ' ASN . 93.2 Cg_endo -74.76 -13.41 21.99 Favored 'Trans proline' 0 C--N 1.366 1.496 0 CA-C-N 121.709 1.646 . . . . 0.86 112.866 -173.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -89.99 -34.68 15.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.042 -0.526 . . . . 1.34 110.672 -177.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.451 ' O ' ' HB2' ' A' ' 158' ' ' MET . 78.2 m-85 -139.88 132.0 28.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.393 -0.367 . . . . 1.46 110.24 176.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 34.9 t -123.59 145.01 49.23 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.595 0.712 . . . . 2.05 111.171 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.57 ' HB2' ' SD ' ' A' ' 158' ' ' MET . 15.3 tppt? -93.87 100.94 13.02 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.268 -0.878 . . . . 1.4 111.161 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.553 HD23 ' CZ ' ' A' ' 153' ' ' PHE . 0.9 OUTLIER -85.54 108.4 17.92 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.054 -0.975 . . . . 1.07 109.335 178.614 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.555 HG12 ' CG2' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -129.31 114.55 32.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-O 122.115 0.96 . . . . 1.11 111.319 177.349 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 18.7 ttt -115.63 141.51 47.97 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.539 -1.21 . . . . 1.79 110.693 -172.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.548 ' O ' ' HB2' ' A' ' 151' ' ' CYS . 73.7 m-85 -115.69 127.47 55.18 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.545 -0.752 . . . . 4.22 110.972 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.454 HG12 ' OG1' ' A' ' 173' ' ' THR . 1.0 OUTLIER -112.48 113.64 44.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.598 -0.728 . . . . 2.01 110.042 174.19 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.611 ' NE2' HD13 ' A' ' 47' ' ' LEU . 33.9 tt0 -116.18 41.3 2.64 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 106.001 -1.852 . . . . 2.66 106.001 171.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.454 ' OG1' HG12 ' A' ' 171' ' ' VAL . 18.9 m -69.65 149.82 47.69 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 112.53 -2.123 . . . . 2.2 110.46 -174.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.45 ' CB ' ' HB3' ' A' ' 147' ' ' TYR . 8.1 tt0 . . . . . 0 C--N 1.325 -0.475 0 CA-C-O 121.482 0.658 . . . . 2.45 111.435 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.43 ' HA ' ' CE ' ' A' ' 186' ' ' LYS . 27.9 mm . . . . . 0 CA--C 1.506 -0.715 0 CA-C-O 122.585 1.183 . . . . 1.69 108.985 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.59 ' HA ' ' CG2' ' A' ' 187' ' ' THR . 1.1 mp -64.88 -37.8 81.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 112.887 -1.96 . . . . 1.77 111.473 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -64.16 -17.92 63.95 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.314 -0.624 . . . . 2.89 109.314 175.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.43 ' CE ' ' HA ' ' A' ' 183' ' ' ILE . 49.5 mtmt -92.85 -43.59 8.91 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.75 -0.659 . . . . 1.71 110.299 173.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.59 ' CG2' ' HA ' ' A' ' 184' ' ' ILE . 15.1 t -61.1 -33.42 73.33 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.734 0.642 . . . . 1.3 112.734 -169.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' MET . . . . . 0.608 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 15.6 mmt -78.43 -59.39 0.71 Allowed Pre-proline 0 C--N 1.332 -0.173 0 C-N-CA 119.646 -0.821 . . . . 1.39 110.835 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.608 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 33.9 Cg_exo -62.93 -22.07 73.58 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 121.917 1.745 . . . . 1.15 112.216 -176.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.778 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 67.2 m -81.08 -22.96 38.81 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.796 -0.362 . . . . 1.95 110.489 175.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.2 OUTLIER -91.43 -37.59 13.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.814 0.34 . . . . 1.92 111.074 -176.635 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.505 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 2.2 mt -62.13 -56.92 13.98 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.558 0.694 . . . . 1.68 111.161 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 189' ' ' PRO . 1.6 m -66.93 -32.13 56.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.707 -1.133 . . . . 1.32 109.033 -175.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.778 ' HB2' ' O ' ' A' ' 190' ' ' SER . 26.4 t30 -63.1 -48.27 79.3 Favored 'General case' 0 C--O 1.208 -1.099 0 CA-C-N 113.911 -1.495 . . . . 2.6 109.727 177.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.517 ' O ' ' HB2' ' A' ' 198' ' ' ASN . 2.8 t80 -62.04 -25.33 67.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.956 0.407 . . . . 2.73 110.283 -178.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.43 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 14.6 mt -80.22 -29.57 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-O 120.993 0.425 . . . . 1.11 110.988 174.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 83.3 mt -74.93 -36.71 62.13 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.302 0.572 . . . . 1.57 109.481 174.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.517 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 4.9 m-20 -48.56 -39.17 22.69 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.756 -1.111 . . . . 2.18 108.995 163.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.685 ' HA ' ' CE2' ' A' ' 64' ' ' PHE . . . -80.5 -44.52 19.02 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 116.027 -0.533 . . . . 1.04 111.247 -176.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 28.7 mmtp -54.41 -46.23 73.1 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.734 0.778 . . . . 1.51 110.187 173.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -80.04 -45.44 18.33 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.614 -1.175 . . . . 1.94 110.416 -175.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -64.42 -31.55 81.23 Favored Glycine 0 C--O 1.228 -0.246 0 C-N-CA 121.004 -0.617 . . . . 0.47 112.555 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.67 ' HB ' ' O ' ' A' ' 199' ' ' ALA . 1.8 tp -69.89 -37.23 72.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.836 0.351 . . . . 1.16 110.202 178.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -85.13 -20.81 29.74 Favored 'General case' 0 C--O 1.21 -1.024 0 N-CA-C 109.071 -0.714 . . . . 3.8 109.071 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.974 0 CA-C-N 116.007 -0.542 . . . . 1.28 109.682 168.166 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.575 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.3 t70 . . . . . 0 CA--C 1.516 -0.357 0 CA-C-O 121.492 0.663 . . . . 2.25 109.639 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.724 ' HA ' HD12 ' A' ' 6' ' ' ILE . 98.8 m-85 -70.46 -29.87 66.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.289 -0.868 . . . . 0.45 109.367 -175.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.54 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 27.1 tttm -74.42 -3.88 33.25 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.822 -1.081 . . . . 2.06 109.766 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.95 -44.89 8.63 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.016 -0.538 . . . . 1.2 109.95 172.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.724 HD12 ' HA ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -82.98 -41.34 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-O 121.425 0.631 . . . . 1.76 110.727 -173.024 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.558 ' HB3' ' HB2' ' A' ' 116' ' ' TYR . . . -74.39 -39.59 62.59 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.988 -1.006 . . . . 1.11 111.34 -176.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 2.4 mt-30 -68.15 -27.01 66.06 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.82 -1.082 . . . . 2.14 110.232 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -81.79 -33.12 31.02 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.765 -1.107 . . . . 3.04 109.111 172.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.629 ' HA ' ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -71.49 -39.06 71.11 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.23 -0.895 . . . . 1.1 111.723 179.704 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.605 ' HA ' ' CB ' ' A' ' 128' ' ' SER . . . -48.15 -60.13 2.87 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-O 121.109 0.48 . . . . 1.04 111.87 176.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -76.55 0.11 21.22 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.174 -0.466 . . . . 2.31 111.579 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.629 ' HB3' ' HA ' ' A' ' 10' ' ' THR . 1.1 tt0 -90.73 -45.29 8.93 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.055 -0.72 . . . . 2.54 109.055 174.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.811 HG23 ' CE2' ' A' ' 170' ' ' PHE . 4.1 p -70.44 -47.39 65.97 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.041 0 N-CA-C 109.001 -0.74 . . . . 1.21 109.001 171.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.627 ' HG ' ' OD1' ' A' ' 18' ' ' ASN . 1.0 OUTLIER -61.77 -24.96 67.17 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.362 1.077 . . . . 1.26 108.338 175.038 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 20' ' ' ASP . . . -63.19 -21.22 63.79 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 113.774 -1.557 . . . . 0.57 110.406 178.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.931 ' CE1' ' HG3' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -87.25 -33.44 19.28 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.097 -0.705 . . . . 3.59 109.097 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.627 ' OD1' ' HG ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -80.38 -16.98 53.23 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.424 0.63 . . . . 2.1 110.073 -167.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.433 ' HD2' ' CD2' ' A' ' 15' ' ' LEU . 24.9 mtp180 -101.52 -20.35 15.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.142 -0.936 . . . . 3.26 110.133 175.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 16' ' ' GLY . 35.2 t70 -118.51 84.3 2.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.787 -0.642 . . . . 2.16 109.821 -178.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.9 p -108.0 127.02 53.4 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 120.916 0.389 . . . . 2.24 111.751 -172.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.4 t 173.23 162.23 0.14 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.366 -0.834 . . . . 2.46 109.522 -173.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.44 1.73 90.21 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 121.183 -0.532 . . . . 1.45 113.111 174.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -112.75 -157.39 0.62 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.837 0.351 . . . . 2.24 110.876 -177.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 tpmt? -173.24 118.1 0.3 Allowed 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 108.851 -0.796 . . . . 3.43 108.851 -172.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.657 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 2.8 m -63.19 116.87 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.989 0 CA-C-O 122.116 0.96 . . . . 2.21 110.789 176.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.426 HG11 ' HB2' ' A' ' 28' ' ' LYS . 10.9 p -98.38 -24.74 4.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 113.979 -1.464 . . . . 1.83 109.719 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.426 ' HB2' HG11 ' A' ' 27' ' ' VAL . 1.2 tmtt? -154.37 120.39 5.29 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 119.471 -0.892 . . . . 2.87 110.537 -170.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.543 ' HB ' ' HA ' ' A' ' 34' ' ' THR . 0.2 OUTLIER -149.71 135.05 18.25 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.477 0.656 . . . . 1.92 110.506 175.096 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.4 m -88.39 -68.35 0.77 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.841 -1.072 . . . . 2.37 111.299 -173.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -166.64 18.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 121.018 -0.273 . . . . 4.84 110.856 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.493 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 16.5 tttp 178.51 -28.95 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.351 0.595 . . . . 2.05 110.312 -174.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.699 HG23 ' HA3' ' A' ' 52' ' ' GLY . 30.0 pt -98.95 152.79 4.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.96 -1.018 . . . . 1.42 109.254 174.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 3.4 m -146.47 110.87 5.12 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 123.452 0.47 . . . . 1.22 111.04 -167.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.685 ' HA ' ' O ' ' A' ' 49' ' ' ARG . 13.0 t -103.45 112.73 38.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.995 -0.372 . . . . 1.52 109.995 -177.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.657 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 84.0 p -106.83 133.93 50.75 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.193 0.597 . . . . 1.74 110.685 -177.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 49.2 m -102.45 126.67 49.56 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.297 -0.41 . . . . 1.72 110.416 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp . . . . . 0 C--N 1.319 -0.723 0 CA-C-N 115.856 -0.611 . . . . 2.45 110.424 -177.569 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 . . . . . 0 CA--C 1.511 -0.541 0 N-CA-C 108.481 -0.933 . . . . 2.45 108.481 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.753 HD21 ' CD1' ' A' ' 170' ' ' PHE . 4.8 tt -82.52 130.0 35.03 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.829 -0.804 . . . . 1.49 108.829 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.505 ' N ' HD22 ' A' ' 47' ' ' LEU . 38.3 m-85 -115.45 119.12 35.17 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.466 -0.568 . . . . 1.52 109.466 -178.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.931 ' HG3' ' CE1' ' A' ' 17' ' ' TYR . 3.1 tmt_? -110.47 141.84 43.04 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.928 -0.578 . . . . 3.34 109.505 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 34' ' ' THR . 8.8 p -127.99 143.59 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-O 121.243 0.544 . . . . 1.98 109.862 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.483 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 33.4 tt0 -146.28 110.81 5.14 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.442 -0.799 . . . . 1.07 109.01 -173.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.699 ' HA3' HG23 ' A' ' 33' ' ' ILE . . . -137.81 134.72 7.11 Favored Glycine 0 N--CA 1.439 -1.13 0 C-N-CA 120.361 -0.923 . . . . 0.35 111.851 -176.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 64.4 mt -83.98 118.13 30.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 C-N-CA 119.798 -0.761 . . . . 1.3 110.327 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.462 HD11 ' HB3' ' A' ' 199' ' ' ALA . 72.3 mt -95.99 113.15 61.61 Favored Pre-proline 0 N--CA 1.435 -1.209 0 CA-C-N 115.132 -0.94 . . . . 1.07 108.599 175.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 24.9 Cg_exo -65.67 45.87 0.18 Allowed 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.825 3.017 . . . . 0.74 113.582 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.522 ' HG2' HG13 ' A' ' 203' ' ' ILE . 10.5 tp10 -135.72 178.09 7.32 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.539 -1.282 . . . . 1.68 107.539 177.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.448 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 47.9 t -81.1 139.66 49.31 Favored Pre-proline 0 N--CA 1.43 -1.473 0 CA-C-O 121.739 0.781 . . . . 1.58 110.234 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.527 ' HG3' ' HB3' ' A' ' 165' ' ' SER . 23.5 Cg_exo -61.35 -9.13 12.04 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 124.11 3.207 . . . . 0.74 110.658 177.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 63' ' ' ASP . . . -67.02 -52.3 44.14 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.981 -1.009 . . . . 1.31 110.82 174.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.584 ' HE3' ' HB3' ' A' ' 64' ' ' PHE . 7.4 tptt -72.12 -23.91 61.39 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.887 -0.783 . . . . 3.78 108.887 178.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.737 HD22 HD11 ' A' ' 203' ' ' ILE . 20.4 mt -64.42 -60.35 3.27 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.863 -0.608 . . . . 1.09 109.454 174.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.455 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 34.1 t -64.73 -14.13 57.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.563 -0.744 . . . . 1.94 110.306 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.429 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 22.6 t70 -80.83 -46.42 15.36 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.844 -0.616 . . . . 1.32 111.077 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.622 ' HB2' ' HZ2' ' A' ' 74' ' ' TRP . 7.0 p90 -76.21 -45.43 33.08 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 120.9 -0.32 . . . . 0.79 111.29 -171.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.455 ' CD2' ' HA ' ' A' ' 62' ' ' SER . 0.5 OUTLIER -80.66 -5.31 56.77 Favored 'General case' 0 CA--C 1.512 -0.487 0 O-C-N 121.833 -0.542 . . . . 2.15 111.184 -171.247 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.52 ' O ' ' HG3' ' A' ' 67' ' ' GLN . 13.0 t80 -50.73 -48.61 58.91 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 123.676 0.61 . . . . 2.06 112.181 -163.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.547 ' HG2' ' HH ' ' A' ' 81' ' ' TYR . 16.3 mt-30 155.84 115.22 0.0 OUTLIER 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 124.657 1.183 . . . . 4.31 109.32 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.818 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 6.3 t 42.53 31.49 0.29 Allowed 'General case' 0 C--N 1.315 -0.906 0 O-C-N 124.559 1.162 . . . . 1.89 113.397 175.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.93 -27.19 14.44 Favored Glycine 0 CA--C 1.496 -1.154 0 C-N-CA 120.039 -1.077 . . . . 1.71 112.166 -173.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.723 ' O ' HG23 ' A' ' 73' ' ' THR . 17.4 p-10 173.87 -28.77 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.677 -1.231 . . . . 2.19 107.677 -172.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.827 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 1.6 ptp180 -43.11 -54.43 4.4 Favored 'General case' 0 C--O 1.21 -0.983 0 CA-C-N 114.636 -1.165 . . . . 3.95 110.66 177.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.87 HG22 ' HB3' ' A' ' 78' ' ' LEU . 1.8 pp -78.34 -12.27 13.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.056 0.455 . . . . 1.42 111.503 -175.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.723 HG23 ' O ' ' A' ' 70' ' ' ASP . 1.2 t -90.22 -29.78 17.98 Favored 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 120.062 -0.655 . . . . 1.45 109.859 -168.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.622 ' HZ2' ' HB2' ' A' ' 64' ' ' PHE . 7.8 p-90 -111.53 -3.99 14.95 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.16 -0.473 . . . . 0.78 111.378 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.827 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 1.8 t70 -65.9 176.88 1.47 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 122.306 1.051 . . . . 2.19 113.399 -171.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.437 ' HG3' ' OD1' ' A' ' 194' ' ' ASN . 0.0 OUTLIER -123.0 -27.5 4.21 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.819 -1.537 . . . . 3.68 110.509 -178.037 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.42 ' HA ' ' HB2' ' A' ' 99' ' ' GLN . 50.0 m -113.12 0.58 15.0 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.073 -0.714 . . . . 2.08 109.073 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.87 ' HB3' HG22 ' A' ' 72' ' ' ILE . 53.2 mt -108.73 173.68 6.21 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.048 -0.978 . . . . 1.16 110.268 177.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.656 ' HG2' ' HG2' ' A' ' 99' ' ' GLN . 12.8 mm100 -156.87 -66.2 0.1 Allowed 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.734 0.778 . . . . 2.23 109.972 -174.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.458 HG21 ' HB3' ' A' ' 79' ' ' GLN . 17.3 t -136.96 119.17 19.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 114.586 -1.188 . . . . 1.44 109.835 -169.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.818 ' HB3' ' HB ' ' A' ' 68' ' ' THR . 0.4 OUTLIER -109.22 123.48 49.31 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.495 -0.558 . . . . 5.73 109.495 175.922 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.704 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 13.5 m120 -119.95 123.68 44.11 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.324 -0.991 . . . . 1.86 108.324 -176.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.769 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 18.3 ttm -87.73 99.01 11.77 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.69 -0.856 . . . . 2.52 108.69 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -77.49 -60.74 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.981 -0.554 . . . . 1.19 111.349 -163.742 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.63 130.29 19.07 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.862 -0.792 . . . . 2.59 108.862 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.769 ' HD3' ' SD ' ' A' ' 83' ' ' MET . 14.3 mtm180 -110.4 132.95 53.73 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.38 -0.6 . . . . 2.83 109.38 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.598 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -94.5 -44.45 13.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.769 -0.65 . . . . 1.17 111.097 -168.354 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -149.99 -161.99 1.46 Allowed 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.431 -0.951 . . . . 1.86 108.431 -174.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.1 m -65.22 -33.36 75.81 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 111.932 0.345 . . . . 1.94 111.932 -172.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -137.92 33.74 2.4 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.343 0.592 . . . . 1.87 109.647 -174.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.598 ' O ' HG12 ' A' ' 87' ' ' ILE . 1.7 m -132.54 107.09 8.23 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.971 -1.122 . . . . 1.12 107.971 -178.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.591 ' O ' HD11 ' A' ' 114' ' ' LEU . 16.9 m-85 -123.37 171.58 9.32 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.947 -0.57 . . . . 0.52 110.08 -173.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.526 ' O ' HG23 ' A' ' 84' ' ' VAL . 53.3 mt -121.81 129.87 75.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 109.11 -0.7 . . . . 1.1 109.11 170.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.82 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 0.0 OUTLIER -93.25 118.02 30.76 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.734 -1.121 . . . . 2.61 111.962 -170.432 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.704 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 22.2 t-160 -107.18 90.53 3.33 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.021 -0.733 . . . . 2.17 109.021 163.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.616 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 72.2 m -109.22 120.7 43.33 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.984 -0.553 . . . . 1.19 111.457 -176.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.8 mm -83.92 130.02 36.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.367 0.603 . . . . 1.63 110.028 174.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 3.0 m -106.11 152.58 23.23 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.793 -1.094 . . . . 1.72 110.124 -174.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.656 ' HG2' ' HG2' ' A' ' 79' ' ' GLN . 4.2 mm-40 . . . . . 0 C--N 1.319 -0.744 0 CA-C-O 121.25 0.547 . . . . 2.29 111.443 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 76.5 mt . . . . . 0 N--CA 1.451 -0.402 0 N-CA-C 109.624 -0.51 . . . . 1.53 109.624 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.1 m -99.19 157.79 33.42 Favored Pre-proline 0 C--N 1.32 -0.709 0 N-CA-C 109.319 -0.623 . . . . 1.71 109.319 175.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -47.97 116.54 1.99 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.814 2.342 . . . . 1.31 111.686 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.643 ' HG3' HG22 ' A' ' 144' ' ' ILE . 34.3 ttp180 -102.08 149.22 24.48 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.007 -0.738 . . . . 4.06 109.007 -173.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.4 ' OD1' ' HA ' ' A' ' 145' ' ' ARG . 2.5 p30 -114.25 147.85 38.36 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.813 -0.755 . . . . 1.37 110.135 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.616 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 15.1 m-85 -116.25 128.51 55.65 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.325 -0.852 . . . . 3.01 110.229 174.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.82 ' HA ' ' O ' ' A' ' 94' ' ' CYS . 22.6 mm -126.8 80.87 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.33 -0.85 . . . . 1.2 109.049 169.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.698 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 10.0 m-20 -113.64 129.09 56.63 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.872 -1.058 . . . . 1.86 109.215 -178.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.591 HD11 ' O ' ' A' ' 92' ' ' PHE . 3.8 tp -74.79 121.45 21.79 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.424 0.63 . . . . 1.08 109.401 176.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -115.71 123.74 71.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 114.96 -1.018 . . . . 1.08 111.497 -164.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.644 ' HE2' ' HE3' ' A' ' 118' ' ' LYS . 90.9 t80 -114.07 125.21 53.72 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.827 -1.078 . . . . 2.81 109.895 175.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 1.066 HG12 HG23 ' A' ' 127' ' ' ILE . 85.9 mt -98.79 104.33 15.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.312 0.577 . . . . 1.53 110.358 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.803 ' HZ2' ' HH ' ' A' ' 120' ' ' TYR . 5.0 tppp? -98.73 128.04 44.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.599 -0.728 . . . . 1.81 109.267 177.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.68 92.04 3.79 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.035 -0.728 . . . . 3.22 109.035 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.803 ' HH ' ' HZ2' ' A' ' 118' ' ' LYS . 59.5 m-85 -73.12 115.15 12.11 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 115.14 -0.936 . . . . 1.28 108.737 175.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -26.53 89.67 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 O-C-N 125.637 1.836 . . . . 2.28 113.252 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 53.83 42.44 69.16 Favored Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.789 -0.641 . . . . 0.79 112.672 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.49 ' C ' ' HD2' ' A' ' 157' ' ' PRO . 3.2 t-20 -135.75 -49.21 0.7 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.331 -0.434 . . . . 2.06 110.705 -176.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.575 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 5.4 mtm -161.98 120.24 2.26 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 120.726 -0.39 . . . . 1.73 111.787 -178.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -104.35 78.68 1.51 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.422 -0.955 . . . . 2.07 108.422 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.647 ' HB ' HG13 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -92.8 138.4 20.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 114.915 -1.039 . . . . 1.06 112.791 -172.594 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 1.066 HG23 HG12 ' A' ' 117' ' ' ILE . 38.0 pt -105.51 100.68 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.93 0.872 . . . . 1.26 109.34 165.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.605 ' CB ' ' HA ' ' A' ' 11' ' ' ALA . 11.8 p -85.73 110.58 19.43 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.842 -0.617 . . . . 1.53 110.707 178.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.698 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 1.9 p -106.4 135.87 47.14 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.408 -0.814 . . . . 1.81 110.691 -176.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.59 ' HE2' ' OG1' ' A' ' 10' ' ' THR . 10.6 ttmm -128.11 112.25 14.37 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.819 -1.178 . . . . 2.75 107.819 -177.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.8 p -57.88 98.39 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.914 0 CA-C-O 121.944 0.878 . . . . 1.94 109.067 -175.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.505 HG12 ' HB3' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -110.32 134.12 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.122 0 CA-C-N 114.587 -1.188 . . . . 1.64 109.034 -165.607 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -96.19 71.15 2.81 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.719 -1.128 . . . . 2.17 108.456 -172.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.646 ' CE1' HG21 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -99.5 159.54 29.78 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 114.447 -1.251 . . . . 0.67 110.471 -172.093 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.83 -27.64 75.27 Favored 'Trans proline' 0 N--CA 1.477 0.535 0 C-N-CA 123.861 3.041 . . . . 1.66 115.679 -168.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.417 ' HG2' ' CD2' ' A' ' 134' ' ' PHE . 12.1 mm-40 -71.72 -21.71 61.73 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 120.478 -0.489 . . . . 3.5 110.08 -166.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.571 ' CD2' HG13 ' A' ' 112' ' ' ILE . 57.0 t80 -134.26 108.23 11.33 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 112.916 0.71 . . . . 6.41 112.916 -177.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -97.6 119.12 0.15 Allowed 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 123.537 2.824 . . . . 2.31 110.76 162.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -63.24 -176.94 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.271 1.981 . . . . 1.27 112.24 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.0 m -146.63 -162.35 1.51 Allowed 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.598 -0.519 . . . . 1.88 109.598 -171.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.3 m -79.91 -40.69 27.67 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.297 -0.561 . . . . 2.43 111.337 -178.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -68.09 -42.63 80.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.037 0.446 . . . . 2.18 111.176 -176.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -105.19 134.79 47.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.711 -0.677 . . . . 1.33 110.172 -173.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.643 HG22 ' HG3' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -109.93 103.51 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 CA-C-N 116.034 -0.53 . . . . 1.4 109.702 -179.504 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.524 ' HE ' ' HB ' ' A' ' 112' ' ' ILE . 12.1 ttt180 -51.7 100.78 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.552 -1.204 . . . . 5.14 110.429 178.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.35 110.13 3.06 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.662 -0.699 . . . . 1.05 112.224 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.416 ' HB3' ' HB3' ' A' ' 174' ' ' GLU . 26.4 t80 -85.42 82.2 8.41 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.258 0.551 . . . . 4.68 109.649 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.524 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 47.1 m-80 -78.21 100.45 6.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.737 -0.665 . . . . 2.29 109.747 176.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -57.76 114.96 9.5 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.314 -0.625 . . . . 2.95 109.314 176.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.416 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 65.9 Cg_exo -7.0 67.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.681 1 C-N-CA 126.152 4.568 . . . . 0.77 115.187 -159.764 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . 0.717 ' HB3' ' O ' ' A' ' 170' ' ' PHE . 2.9 m -87.75 150.78 23.37 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 115.039 -0.982 . . . . 1.97 108.404 178.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.799 ' HA3' HG22 ' A' ' 14' ' ' VAL . . . -139.83 -162.86 9.28 Favored Glycine 0 CA--C 1.494 -1.265 0 C-N-CA 118.829 -1.653 . . . . 0.55 112.649 -176.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.591 ' HB3' HG12 ' A' ' 127' ' ' ILE . 0.4 OUTLIER -160.74 83.42 0.67 Allowed 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.364 -1.347 . . . . 0.8 107.364 -164.843 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.647 HG13 ' HB ' ' A' ' 126' ' ' ILE . 4.2 m -95.28 130.38 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 CA-C-O 121.933 0.873 . . . . 1.03 110.576 -175.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . 0.575 ' O ' ' HA ' ' A' ' 124' ' ' MET . 6.0 t -110.32 118.54 36.59 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.251 -0.886 . . . . 2.3 109.446 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.607 ' HB3' ' HB3' ' A' ' 166' ' ' LYS . 9.1 t -114.78 112.6 45.09 Favored Pre-proline 0 C--N 1.319 -0.749 0 C-N-CA 120.654 -0.418 . . . . 1.45 111.625 -170.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.49 ' HD2' ' C ' ' A' ' 123' ' ' ASN . 46.8 Cg_exo -55.18 118.56 5.3 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.11 1.873 . . . . 0.72 110.166 166.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.472 ' N ' ' HB3' ' A' ' 161' ' ' ASN . 72.3 mtp -79.5 -171.78 2.93 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.717 -0.393 . . . . 1.72 111.087 -175.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -67.24 -31.19 71.37 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.481 -0.933 . . . . 2.63 108.481 169.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.406 ' C ' ' HD2' ' A' ' 162' ' ' PRO . 24.2 mt-10 -102.45 27.87 6.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.362 -1.29 . . . . 2.05 109.213 176.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.501 ' OD1' ' HD3' ' A' ' 162' ' ' PRO . 7.0 p30 -38.84 -46.96 3.45 Favored Pre-proline 0 N--CA 1.473 0.694 0 N-CA-C 115.985 1.846 . . . . 2.19 115.985 -169.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.501 ' HD3' ' OD1' ' A' ' 161' ' ' ASN . 71.2 Cg_endo -72.45 -17.63 26.75 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 CA-C-N 121.336 1.513 . . . . 0.86 112.384 -174.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -109.62 -24.43 10.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.779 -0.646 . . . . 1.34 110.933 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 161' ' ' ASN . 79.1 m-85 -141.76 121.05 13.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.065 -0.516 . . . . 1.46 109.726 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.527 ' HB3' ' HG3' ' A' ' 58' ' ' PRO . 6.8 p -117.29 142.71 46.73 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.304 -0.558 . . . . 2.05 111.187 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.622 ' HG3' HG11 ' A' ' 168' ' ' VAL . 2.3 tppp? -94.31 104.41 16.4 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 122.1 0.952 . . . . 1.4 111.822 -174.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.487 HD23 ' HE1' ' A' ' 153' ' ' PHE . 0.7 OUTLIER -90.69 104.83 17.37 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.297 -1.32 . . . . 1.07 109.517 176.179 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.622 HG11 ' HG3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -127.86 126.06 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.803 0.811 . . . . 1.11 111.533 -179.642 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.611 ' HE3' ' HB3' ' A' ' 195' ' ' PHE . 12.2 ttm -141.4 148.58 39.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.248 -0.887 . . . . 1.79 109.486 -172.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.811 ' CE2' HG23 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -129.71 143.34 50.77 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.186 -0.606 . . . . 4.22 110.345 170.256 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.545 ' HB ' HD22 ' A' ' 192' ' ' LEU . 0.9 OUTLIER -119.9 118.81 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 O-C-N 124.86 1.35 . . . . 2.01 109.985 178.394 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.538 ' HB2' ' HG ' ' A' ' 47' ' ' LEU . 10.4 tt0 -121.81 48.73 1.65 Allowed 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 106.187 -1.783 . . . . 2.66 106.187 173.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.531 ' OG1' HG11 ' A' ' 171' ' ' VAL . 5.5 m -72.13 151.34 43.08 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.024 -1.898 . . . . 2.2 111.224 -174.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 18.5 tt0 . . . . . 0 N--CA 1.438 -1.061 0 CA-C-O 121.542 0.687 . . . . 2.45 109.821 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.424 ' HA ' ' HE3' ' A' ' 186' ' ' LYS . 16.2 mm . . . . . 0 CA--C 1.507 -0.708 0 CA-C-O 122.523 1.154 . . . . 1.69 108.909 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.668 ' HA ' HG23 ' A' ' 187' ' ' THR . 0.9 OUTLIER -70.01 -38.15 74.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 112.768 -2.014 . . . . 1.77 110.931 -178.728 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.69 -17.91 64.94 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.155 -0.683 . . . . 2.89 109.155 175.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.424 ' HE3' ' HA ' ' A' ' 183' ' ' ILE . 48.2 mtmt -93.01 -38.7 11.51 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.729 -0.668 . . . . 1.71 110.081 175.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.668 HG23 ' HA ' ' A' ' 184' ' ' ILE . 11.2 t -68.73 -24.61 64.49 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 112.348 0.499 . . . . 1.3 112.348 -171.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' MET . . . . . 0.528 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 0.2 OUTLIER -79.78 -63.65 0.36 Allowed Pre-proline 0 N--CA 1.467 0.402 0 CA-C-N 118.471 0.578 . . . . 1.39 111.699 179.418 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.528 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 25.4 Cg_exo -62.7 -25.53 75.07 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.296 1.997 . . . . 1.15 112.484 -176.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.742 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 68.4 m -82.95 -28.53 29.75 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.716 -0.394 . . . . 1.95 111.306 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.629 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.2 OUTLIER -90.55 -36.49 14.44 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.9 -0.32 . . . . 1.92 111.272 -173.474 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.545 HD22 ' HB ' ' A' ' 171' ' ' VAL . 48.4 mt -65.22 -47.04 78.21 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.183 0.516 . . . . 1.68 110.587 -177.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.487 ' HB ' HD12 ' A' ' 33' ' ' ILE . 2.0 m -67.9 -30.05 46.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.584 -0.735 . . . . 1.32 109.301 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.742 ' HB2' ' O ' ' A' ' 190' ' ' SER . 1.0 OUTLIER -71.6 -37.07 71.0 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.652 -1.158 . . . . 2.6 110.247 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.611 ' HB3' ' HE3' ' A' ' 169' ' ' MET . 12.2 m-85 -61.07 -34.03 74.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.027 0.441 . . . . 2.73 110.048 172.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.539 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 54.3 mt -79.63 -28.97 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 116.082 -0.508 . . . . 1.11 110.637 176.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 197' ' ' LEU . 53.2 mt -72.8 -36.47 67.56 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-N 116.317 -0.401 . . . . 1.57 110.233 176.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.58 ' ND2' ' HA ' ' A' ' 195' ' ' PHE . 67.2 m-20 -49.06 -47.61 44.78 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.303 -0.999 . . . . 2.18 108.303 164.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.845 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -67.24 -45.49 76.56 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 115.28 -0.873 . . . . 1.04 110.12 -175.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 61.2 mmtt -53.65 -48.18 69.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.403 0.621 . . . . 1.51 109.91 173.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -75.71 -39.99 56.46 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.04 -0.982 . . . . 1.94 111.305 -169.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -76.64 -28.23 59.71 Favored Glycine 0 N--CA 1.461 0.334 0 C-N-CA 120.056 -1.069 . . . . 0.47 111.739 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.845 ' HB ' ' O ' ' A' ' 199' ' ' ALA . 0.9 OUTLIER -71.51 -38.61 68.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 123.045 0.538 . . . . 1.16 110.832 172.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 96.4 mttt -83.76 -17.35 41.5 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.355 0.598 . . . . 3.8 109.406 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.03 0 N-CA-C 108.442 -0.947 . . . . 1.28 108.442 166.866 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.6 t70 . . . . . 0 N--CA 1.442 -0.844 0 N-CA-C 108.571 -0.899 . . . . 2.25 108.571 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.52 ' HA ' HD12 ' A' ' 6' ' ' ILE . 59.1 m-85 -66.66 -31.86 72.8 Favored 'General case' 0 CA--C 1.507 -0.707 0 O-C-N 123.58 0.55 . . . . 0.45 110.284 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 27.0 tttp -75.91 -44.34 40.76 Favored 'General case' 0 N--CA 1.418 -2.065 0 N-CA-C 107.598 -1.26 . . . . 2.06 107.598 -177.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.419 ' O ' ' HG3' ' A' ' 9' ' ' GLN . . . -50.16 -51.73 41.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.422 -0.808 . . . . 1.2 112.471 -177.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.52 HD12 ' HA ' ' A' ' 3' ' ' PHE . 0.4 OUTLIER -83.49 -30.6 8.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.312 -0.555 . . . . 1.76 110.758 -172.005 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.557 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -74.04 -41.54 61.65 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.85 0.833 . . . . 1.11 110.956 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.531 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 14.7 mt-30 -62.51 -31.23 71.96 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.259 -1.337 . . . . 2.14 110.216 177.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 5' ' ' ALA . 98.9 mt-30 -82.47 -30.85 29.7 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.999 -1.0 . . . . 3.04 109.204 174.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.605 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.6 OUTLIER -72.0 -37.72 69.77 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.682 -1.145 . . . . 1.1 111.202 -179.569 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.52 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -46.51 -62.62 1.29 Allowed 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.266 0.469 . . . . 1.04 112.266 174.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -70.01 -6.24 32.05 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.308 -0.406 . . . . 2.31 111.086 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.487 ' HB3' ' HA ' ' A' ' 10' ' ' THR . 0.2 OUTLIER -87.7 -43.0 12.24 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.215 -0.448 . . . . 2.54 110.136 179.666 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.684 HG21 ' N ' ' A' ' 152' ' ' GLY . 7.2 p -79.26 -29.83 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-O 121.841 0.829 . . . . 1.21 109.404 176.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 tt -76.15 -19.71 58.23 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 108.314 -0.995 . . . . 1.26 108.314 172.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.43 -23.42 66.65 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 113.931 -1.486 . . . . 0.57 109.62 170.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.558 ' CD2' ' HA ' ' A' ' 14' ' ' VAL . 26.3 m-85 -80.87 -32.82 34.77 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 114.935 -0.633 . . . . 3.59 109.925 176.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.462 ' ND2' ' HE2' ' A' ' 124' ' ' MET . 56.4 t30 -66.22 -13.19 59.92 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.699 0.761 . . . . 2.1 110.139 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.7 mtp180 -108.16 -2.16 19.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.285 -0.87 . . . . 3.26 109.323 178.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.461 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 28.9 t70 -105.65 119.66 39.71 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.349 -1.296 . . . . 2.16 110.473 -175.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.0 p -134.62 119.13 17.98 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.962 -0.384 . . . . 2.24 109.962 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.89 -162.58 1.3 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.252 -0.431 . . . . 2.46 111.127 -166.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -75.73 61.24 2.89 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 116.11 -0.496 . . . . 1.45 112.666 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.415 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -95.64 -156.5 0.52 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.369 -0.604 . . . . 2.24 109.369 175.067 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.48 132.65 0.29 Allowed 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 108.682 -0.859 . . . . 3.43 108.682 -178.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.578 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 2.1 p -67.57 117.45 9.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-O 121.689 0.757 . . . . 2.21 109.5 177.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.0 p -89.17 -24.37 5.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 114.748 -1.114 . . . . 1.83 108.919 -176.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.2 tptt -158.0 139.23 13.43 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.754 -0.657 . . . . 2.87 111.883 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.522 HG23 HG21 ' A' ' 26' ' ' VAL . 6.4 p -144.28 152.1 40.32 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 115.829 -0.623 . . . . 1.92 111.011 175.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.465 ' HB2' HG12 ' A' ' 33' ' ' ILE . 19.4 m -120.67 25.95 9.42 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.826 -0.625 . . . . 2.37 110.868 171.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp 68.93 39.44 1.84 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.479 0.657 . . . . 4.84 110.441 174.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.6 tptm 177.0 -30.59 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.505 -1.225 . . . . 2.05 108.313 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.517 HD11 ' HB ' ' A' ' 193' ' ' VAL . 23.0 pt -119.68 151.8 22.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 114.561 -1.199 . . . . 1.42 109.483 175.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.8 m -152.15 113.62 4.32 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 123.347 0.404 . . . . 1.22 111.158 -164.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.598 ' HA ' ' O ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -103.68 110.79 31.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.356 -0.537 . . . . 1.52 111.799 171.357 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.578 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 1.5 p -99.77 117.86 35.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.413 -0.812 . . . . 1.74 110.95 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 30.2 t -107.72 131.99 53.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.768 -1.106 . . . . 1.72 111.184 -173.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.415 ' HB3' ' HB3' ' A' ' 24' ' ' TRP . 27.8 pttt . . . . . 0 C--N 1.327 -0.39 0 N-CA-C 112.497 0.554 . . . . 2.45 112.497 172.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 . . . . . 0 N--CA 1.454 -0.255 0 CA-C-O 120.858 0.361 . . . . 2.45 111.555 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.559 HD23 ' N ' ' A' ' 48' ' ' TYR . 3.9 tt -120.25 143.59 48.22 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.755 -0.831 . . . . 1.49 108.755 -176.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.559 ' N ' HD23 ' A' ' 47' ' ' LEU . 46.2 m-85 -118.46 123.56 45.47 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.888 0.375 . . . . 1.52 110.884 -172.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.598 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 27.9 ttt180 -91.22 112.08 23.84 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.716 -0.846 . . . . 3.34 108.716 169.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 192' ' ' LEU . 0.2 OUTLIER -104.95 106.82 21.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.757 0.789 . . . . 1.98 109.523 -175.715 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 42.8 tt0 -128.68 146.52 50.86 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.819 -1.082 . . . . 1.07 110.763 -169.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.49 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -168.81 146.83 10.64 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 111.018 -0.833 . . . . 0.35 111.018 175.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.42 HG12 ' HE2' ' A' ' 166' ' ' LYS . 65.9 mt -92.84 116.68 34.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 117.813 0.807 . . . . 1.3 110.428 175.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.445 HG12 ' HD3' ' A' ' 200' ' ' LYS . 70.1 mt -99.29 109.56 55.06 Favored Pre-proline 0 N--CA 1.439 -0.984 0 CA-C-N 115.314 -0.857 . . . . 1.07 108.775 174.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 53' ' ' ILE . 32.1 Cg_exo -61.11 65.66 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 124.406 3.404 . . . . 0.74 112.551 178.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.635 ' HG2' ' CG1' ' A' ' 203' ' ' ILE . 9.9 tp10 -157.12 174.23 15.8 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.858 -1.065 . . . . 1.68 108.144 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.493 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 38.1 t -79.94 139.49 53.59 Favored Pre-proline 0 N--CA 1.423 -1.804 0 CA-C-O 121.506 0.67 . . . . 1.58 109.91 179.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.531 ' HB3' ' SG ' ' A' ' 155' ' ' CYS . 31.7 Cg_exo -58.05 -15.0 20.84 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 123.91 3.073 . . . . 0.74 110.694 177.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.85 -49.15 55.27 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.519 -1.219 . . . . 1.31 111.171 175.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.418 ' HG2' HD13 ' A' ' 203' ' ' ILE . 29.4 ttmt -71.79 -28.28 63.51 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.627 0.727 . . . . 3.78 109.162 -177.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.533 HD21 ' CD1' ' A' ' 203' ' ' ILE . 68.0 mt -63.87 -51.37 64.87 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.689 -1.142 . . . . 1.09 109.75 173.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.476 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 18.2 m -67.41 -10.94 56.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.751 -0.658 . . . . 1.94 110.413 175.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -88.8 -32.68 17.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.828 -0.624 . . . . 1.32 111.72 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.521 ' CD2' ' HA ' ' A' ' 61' ' ' LEU . 8.7 p90 -82.02 -44.86 16.09 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.277 -0.569 . . . . 0.79 111.186 -176.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.476 ' CD2' ' HA ' ' A' ' 62' ' ' SER . 0.8 OUTLIER -79.5 -7.66 58.6 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.372 -0.531 . . . . 2.15 111.402 -173.872 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -36.37 -57.74 0.73 Allowed 'General case' 0 N--CA 1.465 0.291 0 O-C-N 125.02 1.45 . . . . 2.06 113.399 -157.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -156.9 -81.71 0.07 Allowed 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 112.198 0.444 . . . . 4.31 112.198 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.582 ' HB ' ' CD1' ' A' ' 81' ' ' TYR . 8.9 t -149.33 31.2 0.75 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 122.168 0.985 . . . . 1.89 109.655 -165.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.0 -39.8 4.22 Favored Glycine 0 CA--C 1.489 -1.543 0 CA-C-N 115.099 -0.955 . . . . 1.71 113.173 -169.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.513 ' O ' HG21 ' A' ' 73' ' ' THR . 3.1 p30 -163.61 -22.34 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.786 -0.707 . . . . 2.19 111.034 -171.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.564 ' O ' ' HB3' ' A' ' 75' ' ' ASP . 13.1 ptm180 -50.68 -33.17 21.57 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 122.913 0.485 . . . . 3.95 110.553 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.488 HG22 ' HG3' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -99.37 -2.74 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 CA-C-N 115.779 -0.646 . . . . 1.42 111.261 -177.726 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.513 HG21 ' O ' ' A' ' 70' ' ' ASP . 1.2 t -96.42 -30.67 13.24 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 119.523 -0.871 . . . . 1.45 110.568 -178.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.528 ' CZ2' ' HA ' ' A' ' 71' ' ' ARG . 13.7 p-90 -107.74 0.59 22.42 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.969 0.414 . . . . 0.78 111.39 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.564 ' HB3' ' O ' ' A' ' 71' ' ' ARG . 1.7 p-10 -58.9 -179.74 0.07 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 114.435 1.272 . . . . 2.19 114.435 -172.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.499 ' HG3' ' OD1' ' A' ' 194' ' ' ASN . 0.0 OUTLIER -143.11 -2.58 1.0 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 113.438 -1.71 . . . . 3.68 111.108 172.853 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 m -132.48 4.97 4.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.943 0.878 . . . . 2.08 108.94 -176.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.52 ' HB2' ' CG ' ' A' ' 75' ' ' ASP . 91.5 mt -119.1 -170.99 2.02 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.579 -1.191 . . . . 1.16 110.868 -174.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 97' ' ' ILE . 8.4 mm100 -161.31 -65.39 0.06 Allowed 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.779 0.8 . . . . 2.23 109.685 -176.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.422 HG21 ' HB3' ' A' ' 79' ' ' GLN . 6.1 t -142.3 147.07 21.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.755 -1.111 . . . . 1.44 109.146 -172.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.582 ' CD1' ' HB ' ' A' ' 68' ' ' THR . 11.6 t80 -136.29 129.61 31.7 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.807 -0.442 . . . . 5.73 109.807 177.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -131.04 121.39 24.94 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.871 -0.788 . . . . 1.86 108.871 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.538 ' HE3' ' HA ' ' A' ' 83' ' ' MET . 1.3 tpt -81.19 92.96 6.38 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.371 -0.831 . . . . 2.52 108.777 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -71.93 -83.08 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.34 -0.846 . . . . 1.19 111.112 -167.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -113.32 114.54 26.81 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.319 0.581 . . . . 2.59 109.695 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.42 ' HG2' ' HD1' ' A' ' 92' ' ' PHE . 80.9 mtm180 -97.4 108.07 20.72 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.31 -0.859 . . . . 2.83 109.204 178.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.69 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -78.47 -47.15 24.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.865 -0.607 . . . . 1.17 110.845 -173.501 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -146.04 -179.87 7.01 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.607 -0.886 . . . . 1.86 108.607 -174.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.9 m -66.8 -17.01 64.66 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.155 0.428 . . . . 1.94 112.155 -174.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -139.28 27.9 2.3 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 120.098 -0.641 . . . . 1.87 110.37 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.69 ' O ' HG12 ' A' ' 87' ' ' ILE . 1.6 m -141.17 112.61 7.49 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 107.979 -1.119 . . . . 1.12 107.979 177.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.549 ' O ' HD13 ' A' ' 114' ' ' LEU . 3.6 m-85 -134.88 177.03 8.12 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.984 -0.553 . . . . 0.52 109.876 -175.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.67 ' O ' HG23 ' A' ' 84' ' ' VAL . 22.1 mt -125.8 131.03 72.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 107.336 -1.357 . . . . 1.1 107.336 169.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.718 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 14.5 p -104.68 132.59 50.75 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.831 -0.348 . . . . 2.61 111.731 -174.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.547 ' HA ' HD13 ' A' ' 112' ' ' ILE . 14.6 t60 -103.46 95.28 5.97 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.962 -0.755 . . . . 2.17 108.962 166.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.62 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 27.4 m -115.66 121.33 42.22 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.317 -0.856 . . . . 1.19 110.838 -174.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.442 ' O ' ' HB2' ' A' ' 79' ' ' GLN . 44.5 mm -77.95 114.99 19.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.08 -0.711 . . . . 1.63 109.08 175.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.0 m -93.85 136.45 34.12 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.072 -0.967 . . . . 1.72 110.532 -175.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 24.0 mt-30 . . . . . 0 C--N 1.324 -0.523 0 CA-C-O 121.374 0.606 . . . . 2.29 111.065 178.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 17.5 mt . . . . . 0 N--CA 1.451 -0.386 0 N-CA-C 110.405 -0.22 . . . . 1.53 110.405 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 25.2 m -100.31 151.84 37.66 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 108.988 -0.745 . . . . 1.71 108.988 172.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -50.19 126.42 17.27 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.715 2.276 . . . . 1.31 111.401 177.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.465 ' HG2' HG22 ' A' ' 144' ' ' ILE . 19.5 mtm180 -101.82 164.53 11.68 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.502 0.668 . . . . 4.06 112.004 -169.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.735 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 10.1 t0 -107.27 113.22 26.47 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.667 -1.151 . . . . 1.37 108.968 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.62 ' HB3' ' HB ' ' A' ' 96' ' ' THR . 57.4 t80 -100.41 107.45 19.21 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.653 -0.869 . . . . 3.01 108.653 -178.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.718 ' HA ' ' O ' ' A' ' 94' ' ' CYS . 8.5 mm -122.41 82.73 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 CA-C-N 115.404 -0.816 . . . . 1.2 108.911 177.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.522 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 1.9 m-20 -116.13 130.21 56.69 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.663 -0.698 . . . . 1.86 110.276 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.664 ' O ' ' HA ' ' A' ' 129' ' ' SER . 3.8 tp -75.34 122.54 23.89 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 115.008 -0.996 . . . . 1.08 109.519 176.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -121.8 125.45 73.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-N 114.915 -1.039 . . . . 1.08 111.875 -163.685 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.557 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 70.7 t80 -110.05 125.01 52.49 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.666 -1.152 . . . . 2.81 111.075 176.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.439 HG13 HG23 ' A' ' 127' ' ' ILE . 3.7 mp -95.42 104.66 16.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.711 -0.677 . . . . 1.53 109.371 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.494 ' HD3' ' CE1' ' A' ' 120' ' ' TYR . 36.2 tttm -109.34 149.59 29.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.119 0.485 . . . . 1.81 110.502 -175.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.1 tpp85 -126.59 97.78 5.15 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 121.65 0.738 . . . . 3.22 109.572 -176.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.494 ' CE1' ' HD3' ' A' ' 118' ' ' LYS . 24.7 m-85 -77.28 107.65 9.84 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 106.727 -1.583 . . . . 1.28 106.727 167.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -39.75 95.57 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 124.736 1.273 . . . . 2.28 112.758 -175.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 64.26 36.81 93.69 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 114.514 -1.221 . . . . 0.79 112.345 178.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.48 ' C ' ' HD2' ' A' ' 157' ' ' PRO . 2.1 t-20 -138.53 -43.2 0.49 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.535 -0.332 . . . . 2.06 110.591 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.462 ' HE2' ' ND2' ' A' ' 18' ' ' ASN . 1.1 mpt? -156.76 135.44 11.61 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.39 0.614 . . . . 1.73 111.97 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -112.78 84.89 2.06 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.821 -1.177 . . . . 2.07 107.821 170.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 153' ' ' PHE . 0.6 OUTLIER -105.77 136.91 38.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.624 -0.716 . . . . 1.06 112.351 -171.184 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.69 ' O ' HG13 ' A' ' 127' ' ' ILE . 5.5 pt -111.52 103.06 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 122.279 1.038 . . . . 1.26 109.077 167.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.52 ' HB3' ' HA ' ' A' ' 11' ' ' ALA . 28.6 p -90.45 122.39 33.26 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.657 -0.702 . . . . 1.53 110.656 -178.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.664 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 5.3 m -120.31 140.08 51.8 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.575 -0.739 . . . . 1.81 111.108 -169.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.539 ' HB3' ' HZ3' ' A' ' 130' ' ' LYS . 2.9 mtpm? -128.13 121.56 29.86 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 107.918 -1.141 . . . . 2.75 107.918 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.417 ' CB ' ' HA ' ' A' ' 147' ' ' TYR . 20.8 p -63.05 98.37 0.13 Allowed 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.32 -0.993 . . . . 1.94 108.32 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -109.6 131.7 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 CA-C-N 114.516 -1.22 . . . . 1.64 109.084 -166.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.52 65.84 3.22 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.526 -1.216 . . . . 2.17 108.821 -168.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.697 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 0.3 OUTLIER -95.16 156.06 38.23 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 113.86 -1.518 . . . . 0.67 110.054 -171.48 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -69.97 -20.17 34.19 Favored 'Trans proline' 0 N--CA 1.473 0.32 0 C-N-CA 123.328 2.685 . . . . 1.66 115.337 -167.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.697 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 7.2 tp10 -72.87 -15.92 61.59 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.169 0.509 . . . . 3.5 109.824 -171.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -158.43 111.01 1.68 Allowed Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 113.314 0.857 . . . . 6.41 113.314 175.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -97.67 144.21 0.68 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 124.033 3.156 . . . . 2.31 111.894 167.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.42 ' HG3' ' HB2' ' A' ' 145' ' ' ARG . 61.5 Cg_endo -75.64 -172.21 1.25 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.53 2.154 . . . . 1.27 112.265 178.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.5 m -141.66 -167.87 2.53 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.331 -0.989 . . . . 1.88 108.331 -175.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.4 m -73.23 -37.04 66.52 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.056 -0.658 . . . . 2.43 111.191 -178.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -73.92 -60.39 2.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.176 0.512 . . . . 2.18 109.89 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.545 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 36.7 m-85 -87.19 112.56 22.1 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 115.688 -0.687 . . . . 1.33 109.98 -178.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.465 HG22 ' HG2' ' A' ' 109' ' ' ARG . 1.7 tp -100.89 119.05 48.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 115.21 -0.904 . . . . 1.4 109.262 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.735 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 28.7 ttm-85 -51.44 100.61 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 O-C-N 124.06 0.85 . . . . 5.14 109.735 173.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -58.0 106.03 0.73 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.748 -0.941 . . . . 1.05 110.748 176.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.417 ' HA ' ' CB ' ' A' ' 131' ' ' SER . 22.6 t80 -83.99 87.39 7.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.573 0.701 . . . . 4.68 111.119 -172.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.736 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 24.3 m-80 -83.31 114.47 21.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.388 -0.823 . . . . 2.29 109.807 174.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -71.33 129.49 88.9 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.254 -1.017 . . . . 2.95 108.254 175.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.605 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 15.7 Cg_exo -16.55 69.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.973 1 C-N-CA 126.505 4.804 . . . . 0.77 116.205 -166.143 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . 0.736 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 21.9 p -97.77 -173.79 2.71 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.818 -1.083 . . . . 1.97 108.879 171.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.757 ' O ' ' HG3' ' A' ' 169' ' ' MET . . . -171.66 -150.26 7.05 Favored Glycine 0 CA--C 1.493 -1.323 0 C-N-CA 119.231 -1.462 . . . . 0.55 112.262 -177.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 57.7 t80 -161.23 96.49 1.08 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.684 -0.858 . . . . 0.8 108.684 -164.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.659 ' CG2' HG12 ' A' ' 168' ' ' VAL . 1.2 m -103.96 132.06 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-O 121.972 0.892 . . . . 1.03 110.824 -176.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . 0.531 ' SG ' ' HB3' ' A' ' 58' ' ' PRO . 10.6 t -112.4 111.69 22.72 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.068 -0.969 . . . . 2.3 109.511 177.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.49 ' HB3' ' HB3' ' A' ' 166' ' ' LYS . 27.4 t -108.9 112.34 60.24 Favored Pre-proline 0 C--N 1.316 -0.872 0 C-N-CA 120.867 -0.333 . . . . 1.45 111.346 -166.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.48 ' HD2' ' C ' ' A' ' 123' ' ' ASN . 53.5 Cg_exo -49.66 124.41 12.21 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.424 2.083 . . . . 0.72 111.161 172.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.607 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 0.2 OUTLIER -79.15 -167.78 1.27 Allowed 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.066 0.46 . . . . 1.72 111.699 -175.511 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.75 -25.67 64.86 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.798 0.809 . . . . 2.63 109.236 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -103.04 24.95 10.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.8 -1.091 . . . . 2.05 109.011 178.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.507 ' HB2' ' CD ' ' A' ' 162' ' ' PRO . 15.4 m120 13.73 -82.59 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 126.402 1.881 . . . . 2.19 115.67 178.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.507 ' CD ' ' HB2' ' A' ' 161' ' ' ASN . 94.3 Cg_endo -74.2 -12.02 23.19 Favored 'Trans proline' 0 C--N 1.362 1.289 0 CA-C-N 120.932 1.369 . . . . 0.86 113.639 -172.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -102.3 -30.98 10.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.335 -0.393 . . . . 1.34 111.452 -176.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.607 ' O ' ' HB2' ' A' ' 158' ' ' MET . 42.3 m-85 -133.78 135.51 43.92 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.607 0.242 . . . . 1.46 110.789 177.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 26.7 t -128.8 146.7 50.84 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.415 0.626 . . . . 2.05 111.124 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 156' ' ' SER . 14.3 tppt? -99.66 101.81 13.11 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.181 -0.918 . . . . 1.4 111.034 -178.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -84.67 104.28 14.51 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.631 -1.168 . . . . 1.07 108.992 178.615 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.659 HG12 ' CG2' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -131.86 114.15 24.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 122.509 1.147 . . . . 1.11 111.574 177.653 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.757 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 16.8 ttt -118.8 151.09 38.69 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 114.284 -1.325 . . . . 1.79 108.284 -176.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.7 ' O ' ' HB2' ' A' ' 151' ' ' CYS . 68.8 m-85 -120.08 139.4 52.62 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 120.272 -0.571 . . . . 4.22 110.358 173.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.403 HG21 HD21 ' A' ' 192' ' ' LEU . 1.1 t -119.13 121.47 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 O-C-N 123.854 0.722 . . . . 2.01 110.402 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -123.98 43.37 3.0 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.326 -1.361 . . . . 2.66 107.326 178.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 6.8 m -69.31 137.42 52.96 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 113.379 -1.737 . . . . 2.2 111.513 -172.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 . . . . . 0 N--CA 1.451 -0.409 0 CA-C-N 116.326 -0.397 . . . . 2.45 111.213 -179.141 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.405 ' HA ' ' CE ' ' A' ' 186' ' ' LYS . 40.2 mm . . . . . 0 CA--C 1.502 -0.882 0 CA-C-O 122.858 1.313 . . . . 1.69 107.809 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.587 ' HA ' HG21 ' A' ' 187' ' ' THR . 1.4 mp -63.51 -36.23 75.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 112.034 -2.348 . . . . 1.77 109.775 175.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -58.89 -26.26 64.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.699 -1.137 . . . . 2.89 109.993 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.405 ' CE ' ' HA ' ' A' ' 183' ' ' ILE . 43.9 mtmt -93.13 -44.37 8.4 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.644 -0.707 . . . . 1.71 110.036 177.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.587 HG21 ' HA ' ' A' ' 184' ' ' ILE . 4.7 t -69.28 -30.8 68.98 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 115.997 -0.547 . . . . 1.3 112.049 -170.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' MET . . . . . 0.518 ' O ' ' HG ' ' A' ' 192' ' ' LEU . 1.4 mmt -80.29 -65.1 0.28 Allowed Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 112.473 0.546 . . . . 1.39 112.473 -172.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.502 ' O ' HG11 ' A' ' 193' ' ' VAL . 33.6 Cg_endo -63.37 -25.72 71.13 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 121.73 1.62 . . . . 1.15 112.944 -174.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.61 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 46.2 m -83.97 -31.48 25.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.912 0.387 . . . . 1.95 111.114 -177.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -90.87 -27.73 18.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.28 -0.418 . . . . 1.92 111.623 -173.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 188' ' ' MET . 68.0 mt -75.94 -42.94 47.14 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 120.033 -0.667 . . . . 1.68 110.312 -175.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.517 ' HB ' HD11 ' A' ' 33' ' ' ILE . 2.1 m -66.36 -31.29 52.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 108.803 -0.814 . . . . 1.32 108.803 176.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.61 ' HB2' ' O ' ' A' ' 190' ' ' SER . 1.6 t-20 -73.4 -32.33 64.39 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.33 -1.305 . . . . 2.6 110.311 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.546 ' O ' ' HB2' ' A' ' 198' ' ' ASN . 33.7 t80 -65.68 -30.92 71.67 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.169 -0.678 . . . . 2.73 109.169 175.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.46 ' O ' ' HB2' ' A' ' 199' ' ' ALA . 57.0 mt -78.08 -28.82 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 115.654 -0.703 . . . . 1.11 110.554 174.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 87.8 mt -72.41 -32.74 66.61 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 121.175 0.512 . . . . 1.57 110.025 174.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.546 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 26.2 m-80 -51.19 -42.74 61.08 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.098 -1.075 . . . . 2.18 108.098 165.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.561 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -73.88 -43.28 59.0 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 116.34 -0.391 . . . . 1.04 110.68 -177.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.445 ' HD3' HG12 ' A' ' 54' ' ' ILE . 31.7 mmtp -54.37 -44.32 72.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.524 0.678 . . . . 1.51 110.663 175.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . 0.421 ' HA ' ' HG2' ' A' ' 204' ' ' LYS . 31.4 t70 -85.74 -38.88 17.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.328 -0.851 . . . . 1.94 110.878 -174.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -68.07 -31.16 74.55 Favored Glycine 0 CA--C 1.507 -0.437 0 C-N-CA 120.397 -0.906 . . . . 0.47 111.648 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.635 ' CG1' ' HG2' ' A' ' 56' ' ' GLU . 3.0 tp -71.11 -32.9 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 109.496 -0.557 . . . . 1.16 109.496 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.421 ' HG2' ' HA ' ' A' ' 201' ' ' ASP . 5.6 pttp -87.29 -20.64 26.53 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 109.384 -0.598 . . . . 3.8 109.384 177.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.975 0 N-CA-C 108.394 -0.965 . . . . 1.28 108.394 166.162 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.518 ' O ' HD12 ' A' ' 6' ' ' ILE . 27.6 t70 . . . . . 0 CA--C 1.512 -0.486 0 N-CA-C 109.297 -0.631 . . . . 2.25 109.297 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.861 ' HA ' HD12 ' A' ' 6' ' ' ILE . 71.9 m-85 -62.81 -30.73 71.7 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.621 0.724 . . . . 0.45 109.145 174.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.759 ' HE3' ' HE1' ' A' ' 116' ' ' TYR . 66.3 tttt -70.52 -33.96 71.76 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 107.492 -1.299 . . . . 2.06 107.492 -177.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.72 -36.57 79.16 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.215 0.531 . . . . 1.2 110.542 177.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.861 HD12 ' HA ' ' A' ' 3' ' ' PHE . 2.0 mp -81.46 -41.29 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 CA-C-O 121.982 0.896 . . . . 1.76 108.722 -174.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.665 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -80.09 -33.19 39.0 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.808 -1.542 . . . . 1.11 112.147 -174.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.769 HE21 ' HH ' ' A' ' 116' ' ' TYR . 41.5 mt-30 -69.54 -23.58 63.6 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.788 0.804 . . . . 2.14 109.495 175.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.558 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 14.4 mm100 -84.43 -47.85 10.24 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.426 -1.261 . . . . 3.04 108.876 170.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.568 ' HB ' ' HA ' ' A' ' 7' ' ' ALA . 0.6 OUTLIER -55.11 -39.35 69.28 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.124 -0.943 . . . . 1.1 112.038 178.251 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.41 ' HA ' ' OG ' ' A' ' 128' ' ' SER . . . -46.54 -57.73 4.46 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.837 0.68 . . . . 1.04 112.837 174.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -80.38 -6.48 58.09 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.416 -0.356 . . . . 2.31 111.251 -177.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.558 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 9.6 mm-40 -78.58 -51.32 10.09 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.934 -0.765 . . . . 2.54 108.934 170.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.74 HG22 ' CD2' ' A' ' 170' ' ' PHE . 7.1 p -68.22 -39.61 81.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.636 -0.711 . . . . 1.21 110.455 177.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.574 HD23 ' HH ' ' A' ' 120' ' ' TYR . 0.6 OUTLIER -68.02 -19.68 64.93 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-O 122.077 0.942 . . . . 1.26 108.619 174.744 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.52 ' HA2' ' NE ' ' A' ' 19' ' ' ARG . . . -65.1 -22.7 69.12 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 113.876 -1.511 . . . . 0.57 110.088 175.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -92.1 -12.03 34.13 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 114.973 -0.613 . . . . 3.59 110.088 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -80.47 -20.44 43.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.777 0.798 . . . . 2.1 109.131 177.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.52 ' NE ' ' HA2' ' A' ' 16' ' ' GLY . 18.8 ptt180 -105.49 -5.57 20.15 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.079 -0.964 . . . . 3.26 109.325 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -86.26 114.62 23.23 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 114.731 -1.122 . . . . 2.16 110.544 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 40.8 p -134.69 101.79 5.06 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.829 -0.804 . . . . 2.24 108.829 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.446 ' HB2' ' H ' ' A' ' 23' ' ' GLY . 3.0 p -141.76 -148.87 0.25 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.404 -0.817 . . . . 2.46 111.757 -164.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.446 ' H ' ' HB2' ' A' ' 22' ' ' SER . . . -71.81 63.66 1.21 Allowed Glycine 0 CA--C 1.52 0.396 0 O-C-N 123.379 0.424 . . . . 1.45 113.289 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 1.013 ' HA ' ' HB3' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -104.96 -157.92 0.64 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.046 -0.724 . . . . 2.24 109.046 173.05 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -173.75 120.06 0.3 Allowed 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.183 -1.043 . . . . 3.43 108.183 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.875 HG22 HG21 ' A' ' 29' ' ' THR . 2.7 p -64.02 116.57 3.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 C-N-CA 119.458 -0.897 . . . . 2.21 109.531 177.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.441 HG12 ' HE2' ' A' ' 48' ' ' TYR . 11.1 p -88.86 -22.96 6.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 114.669 -1.15 . . . . 1.83 108.739 -177.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.528 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 1.9 tppp? -157.04 122.49 4.66 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 119.867 -0.733 . . . . 2.87 112.972 -175.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.875 HG21 HG22 ' A' ' 26' ' ' VAL . 37.8 p -129.35 140.31 51.42 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.215 -0.661 . . . . 1.92 109.215 167.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.6 m -124.8 -60.69 1.36 Allowed 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.41 -0.516 . . . . 2.37 112.014 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -152.07 73.22 1.04 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.3 -0.409 . . . . 4.84 110.765 -172.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.732 ' HE3' ' HB ' ' A' ' 53' ' ' ILE . 43.2 tttp 79.21 18.32 0.82 Allowed 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 122.133 0.968 . . . . 2.05 109.431 177.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.79 HG21 ' HA3' ' A' ' 52' ' ' GLY . 5.9 pt -129.63 146.16 34.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 114.198 -1.365 . . . . 1.42 109.704 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.682 ' HA ' HG22 ' A' ' 29' ' ' THR . 52.8 m -143.55 107.56 4.71 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.975 -1.011 . . . . 1.22 110.814 -166.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.405 ' O ' HG11 ' A' ' 27' ' ' VAL . 24.4 t -100.32 103.13 14.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.888 -0.596 . . . . 1.52 109.756 176.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.738 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 87.5 p -93.42 137.4 32.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.996 -0.547 . . . . 1.74 110.553 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.8 t -129.09 135.35 48.79 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.173 0.511 . . . . 1.72 111.483 -177.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 1.013 ' HB3' ' HA ' ' A' ' 24' ' ' TRP . 41.8 pttt . . . . . 0 C--N 1.32 -0.677 0 CA-C-N 115.151 -0.931 . . . . 2.45 108.824 172.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 . . . . . 0 N--CA 1.45 -0.445 0 CA-C-O 121.266 0.555 . . . . 2.45 110.855 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.687 HD11 ' HE1' ' A' ' 170' ' ' PHE . 10.1 tt -105.8 153.2 22.23 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.187 -0.915 . . . . 1.49 109.565 -177.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.441 ' HE2' HG12 ' A' ' 27' ' ' VAL . 42.7 m-85 -128.29 129.99 47.16 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.81 0.338 . . . . 1.52 111.059 -175.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.748 ' HD3' ' CZ3' ' A' ' 24' ' ' TRP . 41.0 ttt180 -106.94 119.9 40.6 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.226 -1.027 . . . . 3.34 108.226 168.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.726 HG11 ' HB3' ' A' ' 169' ' ' MET . 0.2 OUTLIER -111.13 122.37 65.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.773 -0.649 . . . . 1.98 109.564 -171.671 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 35.3 tt0 -138.87 148.27 43.46 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.084 -0.507 . . . . 1.07 110.633 -169.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.79 ' HA3' HG21 ' A' ' 33' ' ' ILE . . . -170.77 150.73 14.53 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 110.9 -0.88 . . . . 0.35 110.9 173.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.732 ' HB ' ' HE3' ' A' ' 32' ' ' LYS . 85.1 mt -92.19 112.03 25.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 117.693 0.746 . . . . 1.3 110.01 175.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.403 HG12 ' CE ' ' A' ' 200' ' ' LYS . 68.4 mt -89.71 116.4 66.25 Favored Pre-proline 0 N--CA 1.437 -1.084 0 CA-C-N 115.329 -0.851 . . . . 1.07 109.079 176.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.41 55.44 0.31 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 124.181 3.254 . . . . 0.74 112.965 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.835 ' HG2' HG13 ' A' ' 203' ' ' ILE . 7.3 tp10 -155.98 162.85 40.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.597 -1.26 . . . . 1.68 107.597 175.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.466 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 31.3 p -71.77 140.61 83.99 Favored Pre-proline 0 N--CA 1.432 -1.328 0 CA-C-O 121.65 0.738 . . . . 1.58 110.795 -176.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.711 ' HD3' ' HB2' ' A' ' 165' ' ' SER . 10.0 Cg_endo -52.46 -11.42 1.19 Allowed 'Trans proline' 0 CA--C 1.527 0.162 0 C-N-CA 124.495 3.463 . . . . 0.74 111.761 172.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.31 -46.12 61.45 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.837 -0.62 . . . . 1.31 110.713 174.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.906 ' HE2' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -65.05 -37.36 87.32 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 107.934 -1.136 . . . . 3.78 107.934 174.307 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.77 HD21 ' CD1' ' A' ' 203' ' ' ILE . 83.5 mt -60.69 -55.2 36.09 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.719 -1.128 . . . . 1.09 110.187 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.545 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 28.3 t -67.93 -13.87 62.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.063 -0.517 . . . . 1.94 110.637 176.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.906 ' HB3' ' HE2' ' A' ' 60' ' ' LYS . 21.3 t70 -81.06 -49.12 11.28 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.573 -0.451 . . . . 1.32 110.78 -178.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.631 ' CE2' ' HA ' ' A' ' 61' ' ' LEU . 17.2 p90 -70.12 -47.81 60.18 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 120.48 -0.488 . . . . 0.79 110.876 -174.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.545 ' CD2' ' HA ' ' A' ' 62' ' ' SER . 0.8 OUTLIER -76.9 -14.27 59.89 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 120.699 -0.4 . . . . 2.15 111.463 -168.539 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.475 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 30.9 t80 -22.04 -61.17 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 O-C-N 125.233 1.583 . . . . 2.06 113.932 -163.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.546 ' H ' ' NH2' ' A' ' 71' ' ' ARG . 17.3 tm0? 175.4 -51.04 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 O-C-N 123.492 0.495 . . . . 4.31 111.09 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.497 ' HB ' ' OE1' ' A' ' 67' ' ' GLN . 6.3 t -148.23 24.15 1.03 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.668 0.618 . . . . 1.89 112.668 -169.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.725 ' N ' HH12 ' A' ' 71' ' ' ARG . . . -129.26 0.91 6.08 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 117.928 -2.082 . . . . 1.71 115.96 -167.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.72 ' O ' HG22 ' A' ' 73' ' ' THR . 19.2 t70 -171.18 -41.46 0.02 OUTLIER 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 117.816 0.808 . . . . 2.19 110.467 -172.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.771 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -74.89 -20.34 59.76 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-N 115.692 -0.685 . . . . 3.95 112.038 -162.154 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.885 HG22 HD11 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -100.83 -7.98 9.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 119.102 -1.039 . . . . 1.42 109.995 177.295 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.72 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.4 t -87.05 -35.51 18.7 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 120.24 -0.584 . . . . 1.45 109.867 -174.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.607 ' HZ2' ' CD1' ' A' ' 64' ' ' PHE . 21.1 p-90 -105.64 -2.68 23.13 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 116.258 -0.428 . . . . 0.78 111.321 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.771 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 3.0 t70 -66.61 170.45 6.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.84 0.829 . . . . 2.19 112.601 -169.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.429 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -118.0 -21.54 8.26 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.374 -1.284 . . . . 3.68 111.182 -177.062 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.7 m -122.66 7.4 9.44 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.194 0.521 . . . . 2.08 109.66 -176.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.885 HD11 HG22 ' A' ' 72' ' ' ILE . 27.0 mt -108.78 179.79 4.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.77 -0.65 . . . . 1.16 111.347 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.602 ' HB3' HG22 ' A' ' 80' ' ' VAL . 15.3 mm-40 -151.91 -67.1 0.17 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.408 -0.814 . . . . 2.23 111.349 -175.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.602 HG22 ' HB3' ' A' ' 79' ' ' GLN . 21.5 t -143.09 126.05 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.831 -0.622 . . . . 1.44 110.3 -166.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -89.81 152.93 21.04 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.374 -0.375 . . . . 5.73 110.09 173.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.842 ' HB3' ' HB3' ' A' ' 95' ' ' HIS . 28.1 t-20 -148.99 99.58 2.98 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.401 -0.592 . . . . 1.86 109.401 165.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.542 ' HE1' ' HD3' ' A' ' 86' ' ' ARG . 16.9 ttp -69.9 99.1 1.35 Allowed 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.516 -0.92 . . . . 2.52 108.516 177.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.562 HG11 ' HG2' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -78.29 -95.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.718 -0.673 . . . . 1.19 111.648 -170.576 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.456 ' H ' HG23 ' A' ' 84' ' ' VAL . 23.0 t-160 -105.2 110.46 22.84 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.642 -0.503 . . . . 2.59 109.642 -178.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.542 ' HD3' ' HE1' ' A' ' 83' ' ' MET . 21.1 mtm180 -92.65 108.79 20.25 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.384 -0.599 . . . . 2.83 109.384 178.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.581 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -67.39 -40.72 85.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.092 -0.958 . . . . 1.17 109.463 -177.202 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' A' ' 90' ' ' ASP . 38.2 t70 -156.27 159.77 39.17 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.585 -1.643 . . . . 1.86 107.068 -177.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.1 m -72.13 16.87 0.11 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.906 0.384 . . . . 1.94 111.183 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.519 ' H ' ' C ' ' A' ' 88' ' ' ASP . 16.2 t70 -137.79 1.83 2.35 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.389 -0.967 . . . . 1.87 108.389 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.581 ' O ' HG12 ' A' ' 87' ' ' ILE . 1.7 m -145.29 112.09 5.91 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 109.184 -0.672 . . . . 1.12 109.184 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.549 ' O ' HD12 ' A' ' 114' ' ' LEU . 18.6 m-85 -123.61 177.73 5.54 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.199 0.523 . . . . 0.52 110.883 -172.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.561 ' HB ' HG23 ' A' ' 84' ' ' VAL . 40.9 mt -132.97 127.37 55.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 107.588 -1.264 . . . . 1.1 107.588 169.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.608 ' SG ' HG11 ' A' ' 115' ' ' VAL . 74.5 m -100.98 107.57 19.08 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.426 -0.352 . . . . 2.61 111.921 -172.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.842 ' HB3' ' HB3' ' A' ' 82' ' ' ASN . 19.5 t-160 -82.06 74.88 9.01 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.379 -0.971 . . . . 2.17 108.379 165.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 79.5 m -95.75 111.51 23.45 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.812 -1.085 . . . . 1.19 111.982 -174.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.501 HD13 ' HB ' ' A' ' 80' ' ' VAL . 3.4 mp -78.25 123.56 35.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.992 -0.744 . . . . 1.63 108.992 172.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.534 ' HB ' ' O ' ' A' ' 109' ' ' ARG . 91.1 m -110.35 146.94 34.91 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.951 -1.022 . . . . 1.72 109.778 -173.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 121.477 0.656 . . . . 2.29 111.672 -173.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.641 HG22 ' NH2' ' A' ' 109' ' ' ARG . 96.9 mt . . . . . 0 N--CA 1.449 -0.501 0 CA-C-O 121.528 0.68 . . . . 1.53 111.007 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.54 ' OG ' ' HD2' ' A' ' 108' ' ' PRO . 22.8 t -79.35 159.4 72.56 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 114.758 -1.11 . . . . 1.71 108.651 173.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.54 ' HD2' ' OG ' ' A' ' 107' ' ' SER . 47.6 Cg_exo -35.91 136.64 0.2 Allowed 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.363 2.709 . . . . 1.31 112.966 173.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.662 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 17.2 ttm180 -123.07 126.42 47.05 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.232 0.539 . . . . 4.06 109.779 -172.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.764 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 9.1 t0 -100.1 119.55 38.48 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.761 -0.654 . . . . 1.37 109.256 -172.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 95' ' ' HIS . 13.0 m-85 -100.1 145.77 27.57 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.153 0.502 . . . . 3.01 112.253 -173.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.956 HG13 ' HA ' ' A' ' 137' ' ' TYR . 29.4 mm -137.87 77.2 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 114.689 -1.142 . . . . 1.2 108.264 170.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.405 ' OD2' ' HB3' ' A' ' 148' ' ' ASN . 1.0 OUTLIER -104.0 124.01 48.25 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.426 -0.806 . . . . 1.86 110.514 -177.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.549 HD12 ' O ' ' A' ' 92' ' ' PHE . 12.8 tp -74.87 123.57 25.29 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.728 0.775 . . . . 1.08 109.41 169.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.608 HG11 ' SG ' ' A' ' 94' ' ' CYS . 0.1 OUTLIER -125.81 126.76 70.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 114.564 -1.198 . . . . 1.08 111.812 -168.232 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.899 ' HE2' ' HE2' ' A' ' 118' ' ' LYS . 87.9 t80 -111.17 128.57 55.95 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.396 -0.82 . . . . 2.81 110.966 175.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.805 HG13 HG22 ' A' ' 127' ' ' ILE . 1.9 mp -88.82 99.93 9.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.911 -0.774 . . . . 1.53 108.911 178.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.899 ' HE2' ' HE2' ' A' ' 116' ' ' TYR . 16.8 tppt? -97.3 123.99 41.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.773 -0.649 . . . . 1.81 110.156 -175.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.429 ' HA ' ' HD3' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -115.46 92.09 3.81 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.495 -0.775 . . . . 3.22 110.852 -178.249 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.623 ' CB ' ' HB3' ' A' ' 123' ' ' ASN . 97.7 m-85 -70.64 101.65 2.1 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 106.147 -1.798 . . . . 1.28 106.147 163.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -47.64 96.31 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.4 1.062 . . . . 2.28 112.289 -173.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 72.03 43.26 49.37 Favored Glycine 0 CA--C 1.503 -0.665 0 CA-C-N 113.796 -1.547 . . . . 0.79 111.757 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.623 ' HB3' ' CB ' ' A' ' 120' ' ' TYR . 2.4 t-20 -146.85 -49.07 0.19 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.089 -0.556 . . . . 2.06 109.978 -178.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.549 ' HB2' ' HD2' ' A' ' 120' ' ' TYR . 1.0 OUTLIER -155.86 135.18 12.29 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.071 0.462 . . . . 1.73 110.978 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.67 80.87 1.5 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.12 -1.067 . . . . 2.07 108.12 175.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.744 HG21 ' HB3' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -103.56 140.66 21.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.538 -0.755 . . . . 1.06 112.201 -172.526 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.805 HG22 HG13 ' A' ' 117' ' ' ILE . 9.0 pt -104.74 116.62 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 108.402 -0.962 . . . . 1.26 108.402 160.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 5.0 m -75.27 163.49 27.44 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.193 -0.912 . . . . 1.53 108.69 173.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 37.1 p -155.55 138.61 15.5 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.402 0.62 . . . . 1.81 110.852 178.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.567 ' HE3' ' HB3' ' A' ' 150' ' ' PRO . 11.4 ttmt -151.96 119.63 6.1 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.669 -0.696 . . . . 2.75 109.231 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.3 p -64.81 106.73 1.27 Allowed 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 108.59 -0.892 . . . . 1.94 108.59 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.5 m -104.7 151.96 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 119.546 -0.862 . . . . 1.64 109.495 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.55 ' HA ' ' CG ' ' A' ' 137' ' ' TYR . 6.5 p-10 -109.05 64.86 0.61 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 122.809 1.29 . . . . 2.17 110.533 -170.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.731 ' CZ ' ' HB3' ' A' ' 136' ' ' GLU . 2.3 p90 -100.91 176.46 1.89 Allowed Pre-proline 0 CA--C 1.555 1.149 0 CA-C-N 113.797 -1.547 . . . . 0.67 108.946 -176.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.655 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 23.7 Cg_exo -27.67 -59.61 0.1 OUTLIER 'Trans proline' 0 CA--C 1.548 1.218 1 C-N-CA 125.347 4.031 . . . . 1.66 117.504 -178.178 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.731 ' HB3' ' CZ ' ' A' ' 134' ' ' PHE . 4.6 tp10 -74.88 -24.97 58.64 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.439 0.533 . . . . 3.5 112.439 -173.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.956 ' HA ' HG13 ' A' ' 112' ' ' ILE . 21.2 t80 -50.68 -45.05 85.82 Favored Pre-proline 0 CA--C 1.553 1.067 0 N-CA-C 115.78 1.77 . . . . 6.41 115.78 -173.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.461 ' HD2' ' O ' ' A' ' 135' ' ' PRO . 36.7 Cg_exo -38.03 116.42 0.22 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 122.975 2.45 . . . . 2.31 114.185 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.662 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 9.6 Cg_endo -89.29 -165.0 0.18 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.883 3.055 . . . . 1.27 114.335 -173.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.0 m -145.03 -171.87 3.73 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.231 -0.895 . . . . 1.88 108.617 -176.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.9 t -81.37 -30.13 33.82 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.573 -0.451 . . . . 2.43 110.593 177.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 -79.65 -29.11 40.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.364 0.602 . . . . 2.18 110.124 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.755 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 34.9 m-85 -122.13 114.14 20.48 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.68 -0.691 . . . . 1.33 110.162 -176.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.662 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 1.5 tp -95.66 112.95 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 108.063 -1.088 . . . . 1.4 108.063 178.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.92 ' HD2' HG12 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -57.75 123.96 17.48 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.645 -1.161 . . . . 5.14 111.779 -174.457 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -42.27 99.52 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 113.973 -1.467 . . . . 1.05 113.176 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 1.105 ' HB2' ' HB3' ' A' ' 174' ' ' GLU . 1.7 p90 -85.5 68.45 10.44 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.304 -0.948 . . . . 4.68 110.902 178.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.405 ' HB3' ' OD2' ' A' ' 113' ' ' ASP . 55.9 t30 -103.31 110.49 22.49 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.112 -0.949 . . . . 2.29 110.361 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.585 ' HB3' ' HD2' ' A' ' 150' ' ' PRO . 28.7 m170 -61.37 164.32 9.14 Favored Pre-proline 0 C--O 1.219 -0.536 0 CA-C-O 118.225 -0.893 . . . . 2.95 108.675 171.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.585 ' HD2' ' HB3' ' A' ' 149' ' ' HIS . 7.6 Cg_endo -49.33 74.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 123.871 3.047 . . . . 0.77 113.982 -177.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . 0.718 ' HB3' ' O ' ' A' ' 170' ' ' PHE . 18.2 m -112.65 -173.68 2.3 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.355 -0.839 . . . . 1.97 108.745 177.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.662 ' O ' ' HG3' ' A' ' 169' ' ' MET . . . -174.98 -154.72 11.42 Favored Glycine 0 CA--C 1.494 -1.235 0 C-N-CA 118.65 -1.738 . . . . 0.55 112.74 -178.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.511 ' CE2' HD21 ' A' ' 167' ' ' LEU . 39.4 t80 -160.07 85.16 0.74 Allowed 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.317 -0.994 . . . . 0.8 108.317 -163.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.666 ' CG2' HG13 ' A' ' 168' ' ' VAL . 3.1 m -94.73 126.17 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 CA-C-O 121.862 0.839 . . . . 1.03 110.625 -173.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 63.9 m -106.69 106.52 17.08 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.439 -0.8 . . . . 2.3 109.171 176.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.68 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 13.2 m -101.09 120.05 56.26 Favored Pre-proline 0 C--N 1.314 -0.939 0 C-N-CA 120.796 -0.362 . . . . 1.45 111.211 -170.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.404 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 77.6 Cg_exo -51.05 119.59 5.57 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.402 2.068 . . . . 0.72 110.965 172.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.593 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 59.2 mmm -83.49 -167.89 1.89 Allowed 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.196 0.522 . . . . 1.72 111.917 -174.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -65.06 -32.84 74.75 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.983 0.897 . . . . 2.63 109.165 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -113.48 31.13 6.7 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.154 -1.385 . . . . 2.05 109.056 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' A' ' 164' ' ' TYR . 2.1 p-10 -23.37 -55.27 0.12 Allowed Pre-proline 0 N--CA 1.475 0.788 0 N-CA-C 116.505 2.039 . . . . 2.19 116.505 -172.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -67.81 -19.31 47.07 Favored 'Trans proline' 0 C--N 1.35 0.624 0 CA-C-N 121.649 1.625 . . . . 0.86 113.146 -175.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -111.89 -22.84 10.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.355 -0.384 . . . . 1.34 111.354 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.593 ' O ' ' HB2' ' A' ' 158' ' ' MET . 94.7 m-85 -138.93 129.3 25.67 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.436 -0.579 . . . . 1.46 109.436 176.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.711 ' HB2' ' HD3' ' A' ' 58' ' ' PRO . 21.9 t -127.22 148.75 50.2 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.054 -0.659 . . . . 2.05 111.598 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.68 ' HB3' ' HB2' ' A' ' 156' ' ' SER . 11.8 tppt? -91.77 100.6 13.27 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.919 0.866 . . . . 1.4 111.261 -178.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.511 HD21 ' CE2' ' A' ' 153' ' ' PHE . 1.0 OUTLIER -88.37 105.78 17.81 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.91 -1.041 . . . . 1.07 109.089 176.417 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.67 HG11 ' HG3' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -132.5 120.21 41.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 122.497 1.141 . . . . 1.11 111.927 177.772 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.726 ' HB3' HG11 ' A' ' 50' ' ' VAL . 19.0 ttt -122.69 160.92 24.85 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 113.999 -1.455 . . . . 1.79 108.165 -178.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.74 ' CD2' HG22 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -145.77 149.03 33.62 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.228 -1.027 . . . . 4.22 108.228 170.553 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.475 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 8.5 p -137.43 132.31 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 O-C-N 124.147 0.904 . . . . 2.01 111.006 -174.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.584 ' HB3' ' HB2' ' A' ' 149' ' ' HIS . 30.9 tt0 -119.93 64.83 0.82 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.587 -1.264 . . . . 2.66 107.587 175.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.487 HG22 ' HE1' ' A' ' 147' ' ' TYR . 0.2 OUTLIER -58.07 130.54 47.08 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.885 -1.507 . . . . 2.2 111.908 -173.032 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 1.105 ' HB3' ' HB2' ' A' ' 147' ' ' TYR . 12.1 tt0 . . . . . 0 N--CA 1.455 -0.197 0 CA-C-O 121.583 0.706 . . . . 2.45 111.948 -176.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.445 ' HA ' ' CE ' ' A' ' 186' ' ' LYS . 20.6 mm . . . . . 0 CA--C 1.506 -0.714 0 CA-C-O 122.465 1.126 . . . . 1.69 108.942 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.649 ' HA ' HG23 ' A' ' 187' ' ' THR . 1.0 OUTLIER -70.21 -37.54 71.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 112.91 -1.95 . . . . 1.77 111.489 -176.788 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -67.12 -17.1 64.72 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.149 -0.686 . . . . 2.89 109.149 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.445 ' CE ' ' HA ' ' A' ' 183' ' ' ILE . 45.8 mtmt -90.37 -49.32 6.6 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.415 -0.811 . . . . 1.71 109.211 171.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.649 HG23 ' HA ' ' A' ' 184' ' ' ILE . 11.3 t -60.04 -31.22 69.76 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.617 0.599 . . . . 1.3 112.617 -167.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' MET . . . . . 0.87 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 7.0 mmt -80.11 -61.23 0.45 Allowed Pre-proline 0 C--N 1.327 -0.399 0 C-N-CA 120.488 -0.485 . . . . 1.39 111.296 -176.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.87 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 37.8 Cg_exo -62.21 -26.14 77.4 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.132 1.888 . . . . 1.15 112.812 -178.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.541 ' O ' ' HB3' ' A' ' 194' ' ' ASN . 98.0 p -80.7 -30.42 36.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.021 0.438 . . . . 1.95 110.713 -178.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -90.46 -34.54 15.56 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.825 -0.625 . . . . 1.92 111.518 -172.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.526 HD21 HG13 ' A' ' 50' ' ' VAL . 78.2 mt -73.24 -42.03 63.02 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.57 -0.452 . . . . 1.68 111.607 -174.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.469 HG11 ' O ' ' A' ' 189' ' ' PRO . 1.5 m -70.56 -30.08 41.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.831 -0.803 . . . . 1.32 108.831 178.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.543 ' HA ' ' HB2' ' A' ' 197' ' ' LEU . 0.1 OUTLIER -73.88 -40.63 63.08 Favored 'General case' 0 C--O 1.208 -1.117 0 CA-C-N 114.138 -1.392 . . . . 2.6 111.209 178.013 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.46 ' HD1' ' HA ' ' A' ' 195' ' ' PHE . 1.7 m-30 -56.9 -33.25 66.73 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 118.576 0.626 . . . . 2.73 109.88 172.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.608 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 46.4 mt -77.41 -31.07 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-N 115.973 -0.558 . . . . 1.11 111.316 174.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.543 ' HB2' ' HA ' ' A' ' 194' ' ' ASN . 24.0 mt -70.0 -40.92 75.01 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 110.182 -0.303 . . . . 1.57 110.182 176.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.415 ' HB3' ' CZ3' ' A' ' 74' ' ' TRP . 3.8 m-20 -49.18 -45.33 43.97 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.974 -0.75 . . . . 2.18 108.974 166.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.822 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -66.76 -44.75 80.59 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.965 -0.561 . . . . 1.04 110.22 -177.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.608 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 35.3 mmtp -57.81 -45.83 85.53 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 109.446 -0.575 . . . . 1.51 109.446 172.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -67.47 -43.97 79.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.359 -0.837 . . . . 1.94 110.756 -171.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -78.45 -20.45 71.82 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.18 -1.01 . . . . 0.47 111.666 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.835 HG13 ' HG2' ' A' ' 56' ' ' GLU . 1.0 OUTLIER -78.68 -34.33 17.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 123.439 0.695 . . . . 1.16 109.885 173.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.566 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 99.2 mttt -80.16 -30.26 38.88 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 108.697 -0.853 . . . . 3.8 108.697 177.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.757 0 CA-C-N 115.836 -0.62 . . . . 1.28 109.57 170.725 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.427 ' OD2' HD13 ' A' ' 6' ' ' ILE . 36.4 t70 . . . . . 0 CA--C 1.512 -0.503 0 CA-C-O 120.743 0.306 . . . . 2.25 110.369 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.824 ' HA ' HD12 ' A' ' 6' ' ' ILE . 94.0 m-85 -64.98 -33.8 76.91 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.076 -0.712 . . . . 0.45 109.076 -176.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.634 ' HD2' ' CB ' ' A' ' 88' ' ' ASP . 33.5 tttm -73.79 -3.58 29.42 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.021 -0.99 . . . . 2.06 110.288 177.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 9' ' ' GLN . . . -91.37 -40.98 11.15 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.559 -0.534 . . . . 1.2 109.559 172.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.824 HD12 ' HA ' ' A' ' 3' ' ' PHE . 1.1 mp -82.51 -44.01 19.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.956 0.884 . . . . 1.76 109.487 -172.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.658 ' HB2' ' HB2' ' A' ' 116' ' ' TYR . . . -70.85 -39.3 73.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.302 -1.317 . . . . 1.11 111.422 -178.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.606 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 8.1 mt-30 -66.85 -26.14 66.76 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.99 -1.004 . . . . 2.14 110.384 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 5' ' ' ALA . 98.7 mt-30 -80.52 -37.11 32.19 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.082 -0.963 . . . . 3.04 108.843 172.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.646 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.4 OUTLIER -67.87 -37.48 81.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.666 -1.152 . . . . 1.1 111.614 -178.849 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.612 ' HA ' ' OG ' ' A' ' 128' ' ' SER . . . -46.43 -58.44 3.75 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.592 0.59 . . . . 1.04 112.592 176.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.508 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 13.1 pt20 -83.14 5.39 22.8 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.056 0.455 . . . . 2.31 110.803 -177.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.531 ' HB3' ' HA ' ' A' ' 10' ' ' THR . 0.2 OUTLIER -89.49 -49.94 6.39 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.182 -1.044 . . . . 2.54 108.182 174.978 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.675 HG21 ' N ' ' A' ' 152' ' ' GLY . 13.2 p -69.93 -36.44 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 121.828 0.823 . . . . 1.21 109.555 177.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.53 ' HG ' ' OD1' ' A' ' 18' ' ' ASN . 2.1 tt -72.87 -18.72 61.4 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 114.87 -1.059 . . . . 1.26 109.229 173.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 20' ' ' ASP . . . -61.94 -23.5 63.68 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.11 -1.405 . . . . 0.57 109.856 172.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.42 ' HB3' ' CE2' ' A' ' 170' ' ' PHE . 6.8 m-85 -91.33 -28.79 17.51 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.099 -0.55 . . . . 3.59 110.775 177.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.558 ' HA ' ' HZ ' ' A' ' 170' ' ' PHE . 0.1 OUTLIER -69.59 -15.75 63.27 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.777 -0.369 . . . . 2.1 111.335 179.401 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -117.59 -5.48 11.18 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 119.921 -0.711 . . . . 3.26 111.896 179.056 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 2.6 m-20 -121.99 135.75 54.87 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 120.919 0.39 . . . . 2.16 111.205 178.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.512 HG23 ' CZ2' ' A' ' 24' ' ' TRP . 64.4 p -137.61 120.47 16.42 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.05 -0.523 . . . . 2.24 111.411 -176.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.3 t -167.34 132.09 1.95 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.152 -0.476 . . . . 2.46 110.204 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.87 -6.06 82.04 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.859 -0.686 . . . . 1.45 113.669 172.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.803 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -111.75 -170.2 1.61 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.842 0.321 . . . . 2.24 110.625 -178.231 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.439 ' HE2' ' HB3' ' A' ' 25' ' ' LYS . 7.3 mtpt -178.6 133.22 0.13 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.884 -0.784 . . . . 3.43 108.884 -169.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.771 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 1.6 p -61.58 120.03 6.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 119.819 -0.753 . . . . 2.21 109.305 171.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 p -95.18 -23.5 5.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 114.708 -1.133 . . . . 1.83 109.123 -177.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.417 ' HD2' ' HA ' ' A' ' 28' ' ' LYS . 11.0 tptm -156.53 129.92 8.12 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.885 -0.598 . . . . 2.87 111.847 -173.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.463 HG23 HG21 ' A' ' 26' ' ' VAL . 40.2 p -122.09 149.44 43.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.429 -0.805 . . . . 1.92 109.584 173.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 51.1 m -150.4 69.78 1.0 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 121.185 -0.206 . . . . 2.37 111.204 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER 74.76 71.76 0.1 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.209 -0.451 . . . . 4.84 110.829 177.241 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.539 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 89.5 mttt 80.04 4.54 1.92 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.337 -0.847 . . . . 2.05 112.842 172.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.829 HG22 ' HA3' ' A' ' 52' ' ' GLY . 7.5 pt -115.66 143.61 25.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.069 0.461 . . . . 1.42 110.151 175.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 5.0 m -136.47 104.7 5.67 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.125 -0.943 . . . . 1.22 110.433 -163.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.7 HG22 HG23 ' A' ' 50' ' ' VAL . 3.4 t -96.48 98.85 8.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.864 -0.421 . . . . 1.52 109.864 -178.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.771 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 25.9 t -91.96 121.68 33.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.725 0.774 . . . . 1.74 110.357 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.3 t -109.01 135.21 50.55 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.341 -1.299 . . . . 1.72 110.56 -175.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.803 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 31.6 ttpt . . . . . 0 C--N 1.319 -0.759 0 CA-C-N 115.482 -0.781 . . . . 2.45 110.352 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 110.121 -0.326 . . . . 2.45 110.121 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.506 HD22 ' N ' ' A' ' 48' ' ' TYR . 2.9 tt -104.89 137.34 42.81 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.169 -1.049 . . . . 1.49 108.169 178.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.506 ' N ' HD22 ' A' ' 47' ' ' LEU . 58.2 m-85 -124.47 126.42 45.87 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.392 -0.367 . . . . 1.52 110.137 -173.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.706 ' HG3' ' CE2' ' A' ' 170' ' ' PHE . 2.5 tmm_? -113.36 120.27 40.52 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.38 -0.6 . . . . 3.34 109.38 175.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.7 HG23 HG22 ' A' ' 35' ' ' VAL . 7.6 p -101.9 138.68 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 108.769 -0.826 . . . . 1.98 108.769 177.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.606 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 51.6 tt0 -138.63 108.07 6.16 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.467 -0.788 . . . . 1.07 109.351 -169.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.829 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -138.34 142.39 13.08 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.031 -1.08 . . . . 0.35 112.195 -177.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.0 mt -86.8 124.29 40.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 C-N-CA 120.29 -0.564 . . . . 1.3 109.886 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.548 HG12 ' HD3' ' A' ' 200' ' ' LYS . 71.7 mt -105.95 113.76 63.38 Favored Pre-proline 0 C--N 1.312 -1.05 0 N-CA-C 108.834 -0.802 . . . . 1.07 108.834 175.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -62.18 67.49 0.12 Allowed 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 124.175 3.25 . . . . 0.74 112.043 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.69 ' HG2' ' CG1' ' A' ' 203' ' ' ILE . 8.0 tp10 -161.13 172.32 16.98 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.775 -1.194 . . . . 1.68 107.775 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.445 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 6.2 p -82.09 144.7 51.38 Favored Pre-proline 0 N--CA 1.427 -1.575 0 CA-C-O 121.748 0.785 . . . . 1.58 110.356 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.764 ' HG3' ' HG ' ' A' ' 165' ' ' SER . 23.8 Cg_exo -61.71 -13.25 29.11 Favored 'Trans proline' 0 C--N 1.332 -0.297 0 C-N-CA 124.108 3.206 . . . . 0.74 110.539 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.61 -51.47 34.83 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.526 -1.215 . . . . 1.31 111.028 175.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.601 ' HB3' HD11 ' A' ' 203' ' ' ILE . 26.2 ttmt -71.06 -27.9 63.98 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.885 -0.784 . . . . 3.78 108.885 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 1.071 HD21 HD12 ' A' ' 203' ' ' ILE . 42.7 mt -63.95 -53.13 55.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.697 -1.138 . . . . 1.09 109.945 174.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.549 ' HA ' ' CD1' ' A' ' 65' ' ' LEU . 34.7 t -65.91 -11.92 50.76 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.438 -0.346 . . . . 1.94 110.317 175.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.472 ' HB2' ' HA ' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -83.1 -40.25 20.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.217 -0.447 . . . . 1.32 111.497 -179.717 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.515 ' CD2' ' HA ' ' A' ' 61' ' ' LEU . 15.6 p90 -81.37 -42.79 19.96 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 120.813 -0.355 . . . . 0.79 111.166 -174.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.749 HD11 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -85.87 10.17 14.64 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.709 0.29 . . . . 2.15 110.726 -173.02 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.541 ' N ' HH12 ' A' ' 71' ' ' ARG . 1.0 OUTLIER -42.99 -71.29 0.08 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.155 -0.93 . . . . 2.06 112.683 -169.207 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.41 -57.3 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.183 1.549 . . . . 4.31 115.183 177.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.694 ' OG1' ' HB2' ' A' ' 81' ' ' TYR . 8.8 t -159.07 23.85 0.2 Allowed 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.852 -0.53 . . . . 1.89 112.298 -161.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -127.67 1.29 6.91 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 118.501 -1.809 . . . . 1.71 115.535 -166.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.617 ' O ' HG22 ' A' ' 73' ' ' THR . 24.5 t70 -173.27 -40.63 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 117.566 0.683 . . . . 2.19 110.784 -169.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.689 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -54.87 -38.52 67.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.501 -0.772 . . . . 3.95 111.362 -173.743 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.759 HG21 HD11 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -86.11 -7.46 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-O 120.969 0.414 . . . . 1.42 110.953 -176.499 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -90.34 -26.54 19.91 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 120.077 -0.649 . . . . 1.45 109.631 -175.584 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.519 ' CZ3' ' HB3' ' A' ' 198' ' ' ASN . 24.2 p-90 -111.2 -4.68 14.91 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.595 0.591 . . . . 0.78 112.595 178.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.689 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 4.2 t70 -70.6 174.33 6.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.684 0.754 . . . . 2.19 112.348 -171.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.563 ' HG2' ' OD1' ' A' ' 198' ' ' ASN . 1.3 mmtt -106.76 -29.04 9.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.857 -1.065 . . . . 3.68 109.313 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.1 m -128.28 20.63 6.26 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.671 -1.15 . . . . 2.08 111.109 -172.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.759 HD11 HG21 ' A' ' 72' ' ' ILE . 27.1 mt -110.17 155.94 21.3 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.995 0.426 . . . . 1.16 110.45 175.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.896 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 2.7 mm-40 -128.16 -61.44 1.1 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.859 -0.609 . . . . 2.23 112.269 -170.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.702 ' CG1' ' HB ' ' A' ' 97' ' ' ILE . 2.9 p -157.15 127.02 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.644 0.735 . . . . 1.44 111.9 -170.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.694 ' HB2' ' OG1' ' A' ' 68' ' ' THR . 48.6 p90 -89.67 143.96 26.38 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.454 -1.248 . . . . 5.73 110.936 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.766 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 51.1 m-80 -150.03 109.41 3.98 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.193 -0.669 . . . . 1.86 109.193 172.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.495 ' SD ' ' HB3' ' A' ' 92' ' ' PHE . 31.0 tpp -79.88 109.43 14.31 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.89 -0.782 . . . . 2.52 108.89 177.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.644 HG12 ' HG3' ' A' ' 136' ' ' GLU . 0.0 OUTLIER -85.07 -72.39 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.857 -0.61 . . . . 1.19 110.342 -168.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.491 ' HB2' HD12 ' A' ' 93' ' ' ILE . 8.0 m-70 -126.41 121.57 32.84 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.764 -0.653 . . . . 2.59 109.741 177.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 -100.47 125.51 46.79 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.136 -1.061 . . . . 2.83 108.136 175.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.724 HG23 ' HB2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -91.34 -58.27 3.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 116.22 -0.446 . . . . 1.17 111.994 -167.072 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.634 ' CB ' ' HD2' ' A' ' 4' ' ' LYS . 15.6 m-20 -144.92 35.89 1.13 Allowed 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.604 -0.438 . . . . 1.86 112.151 -165.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.9 t 73.21 -33.2 0.26 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.154 0.582 . . . . 1.94 112.42 176.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' A' ' 88' ' ' ASP . 8.5 m-20 -117.02 10.53 13.99 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 108.485 -0.932 . . . . 1.87 108.485 -177.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.601 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -138.92 116.2 11.12 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 114.962 -1.017 . . . . 1.12 108.394 -174.381 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.589 ' O ' HD12 ' A' ' 114' ' ' LEU . 46.5 m-85 -124.41 177.36 5.93 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.196 0.522 . . . . 0.52 110.745 -175.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.626 ' O ' HG21 ' A' ' 84' ' ' VAL . 43.1 mt -135.83 118.03 21.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 107.515 -1.291 . . . . 1.1 107.515 168.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 72.5 m -100.46 109.32 21.45 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.883 0.373 . . . . 2.61 111.931 -171.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.766 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 19.6 t-160 -80.04 69.96 6.53 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.56 -0.904 . . . . 2.17 108.56 170.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 96.5 m -95.92 114.72 26.47 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.511 -1.222 . . . . 1.19 111.427 -175.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.702 ' HB ' ' CG1' ' A' ' 80' ' ' VAL . 2.7 mp -85.11 127.53 39.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.614 -0.884 . . . . 1.63 108.614 172.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 109' ' ' ARG . 12.6 t -110.86 165.37 11.9 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.937 -0.574 . . . . 1.72 110.233 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.896 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 50.5 mt-30 . . . . . 0 C--N 1.312 -1.041 0 CA-C-N 115.673 -0.694 . . . . 2.29 109.429 175.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.3 mt . . . . . 0 N--CA 1.441 -0.912 0 N-CA-C 110.001 -0.37 . . . . 1.53 110.001 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.416 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 14.2 m -71.58 164.12 60.54 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 115.976 -0.556 . . . . 1.71 109.612 175.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 107' ' ' SER . 7.9 Cg_endo -51.06 113.62 1.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.072 1.848 . . . . 1.31 110.48 172.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.653 ' HG2' HG23 ' A' ' 144' ' ' ILE . 18.7 mtm180 -90.62 137.52 32.29 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 120.321 -0.552 . . . . 4.06 109.716 -173.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.832 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 9.9 t0 -94.42 126.85 39.95 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.905 -0.776 . . . . 1.37 108.905 -177.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 95' ' ' HIS . 6.9 m-85 -107.17 146.34 31.46 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.61 0.719 . . . . 3.01 111.576 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.816 HG12 ' HD2' ' A' ' 145' ' ' ARG . 25.2 mm -137.67 68.78 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 114.301 -1.318 . . . . 1.2 107.608 172.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.837 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 1.4 m-20 -90.54 115.56 27.78 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.627 -1.17 . . . . 1.86 110.088 -176.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 129' ' ' SER . 6.1 tp -74.84 119.18 18.67 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 108.745 -0.835 . . . . 1.08 108.745 169.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.2 OUTLIER -122.99 124.13 69.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-N 115.033 -0.985 . . . . 1.08 111.675 -164.24 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.658 ' HB2' ' HB2' ' A' ' 7' ' ' ALA . 79.8 t80 -107.77 119.76 40.34 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.973 -1.012 . . . . 2.81 110.769 176.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.792 HG13 HG23 ' A' ' 127' ' ' ILE . 3.9 mp -89.85 98.87 8.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.768 -0.651 . . . . 1.53 109.608 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.451 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 39.7 ttmt -106.77 141.4 38.08 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.702 -0.681 . . . . 1.81 109.508 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.447 ' C ' ' HD2' ' A' ' 119' ' ' ARG . 0.4 OUTLIER -131.75 104.19 6.77 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 109.01 -0.737 . . . . 3.22 109.01 -177.566 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.622 ' CB ' ' HB3' ' A' ' 123' ' ' ASN . 42.7 m-85 -71.43 114.67 9.75 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 106.959 -1.497 . . . . 1.28 106.959 167.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -41.61 96.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 O-C-N 124.514 1.134 . . . . 2.28 112.293 -175.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.43 ' C ' ' HG2' ' A' ' 157' ' ' PRO . . . 61.56 36.52 92.73 Favored Glycine 0 CA--C 1.508 -0.352 0 CA-C-N 114.496 -1.229 . . . . 0.79 112.276 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.622 ' HB3' ' CB ' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -133.82 -45.81 0.8 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.524 -0.338 . . . . 2.06 110.377 -178.614 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.533 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 0.3 OUTLIER -157.72 122.64 4.4 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.848 0.356 . . . . 1.73 111.393 -177.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 155' ' ' CYS . 13.4 m120 -104.26 73.83 1.15 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.756 -0.831 . . . . 2.07 108.756 174.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.654 ' HB ' HG11 ' A' ' 154' ' ' VAL . 1.2 tt -96.57 136.11 28.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 113.245 0.831 . . . . 1.06 113.245 -172.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.792 HG23 HG13 ' A' ' 117' ' ' ILE . 21.0 pt -104.87 109.82 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-O 121.98 0.895 . . . . 1.26 109.009 163.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.612 ' OG ' ' HA ' ' A' ' 11' ' ' ALA . 1.1 m -89.84 114.42 26.16 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.441 -0.799 . . . . 1.53 110.709 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.837 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 79.3 p -114.21 145.05 42.22 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.57 0.7 . . . . 1.81 111.753 -172.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.849 ' HZ2' ' HB3' ' A' ' 130' ' ' LYS . 6.3 mtpm? -133.78 123.75 25.41 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 107.677 -1.231 . . . . 2.75 107.677 174.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.468 ' HB2' ' H ' ' A' ' 148' ' ' ASN . 32.6 t -64.28 98.85 0.25 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 105.926 -1.879 . . . . 1.94 105.926 170.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.457 HG12 ' HB3' ' A' ' 134' ' ' PHE . 0.3 OUTLIER -105.41 132.62 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 CA-C-O 121.985 0.897 . . . . 1.64 109.021 -164.012 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -88.61 68.86 8.77 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 114.02 -1.445 . . . . 2.17 109.26 -166.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.692 ' HB2' ' HD2' ' A' ' 135' ' ' PRO . 0.4 OUTLIER -107.07 175.08 2.17 Favored Pre-proline 0 CA--C 1.548 0.875 0 CA-C-N 114.997 -1.001 . . . . 0.67 109.496 -172.226 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.692 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 3.0 Cg_exo -35.91 -51.28 1.06 Allowed 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 124.802 3.668 . . . . 1.66 116.632 -175.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.644 ' HG3' HG12 ' A' ' 84' ' ' VAL . 14.0 mm-40 -82.74 -21.59 34.67 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.5 0.667 . . . . 3.5 111.474 -172.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.804 ' HD2' ' HB ' ' A' ' 112' ' ' ILE . 60.3 t80 -56.01 -38.59 69.82 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 115.233 1.568 . . . . 6.41 115.233 -174.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 67.8 Cg_exo -41.46 114.88 0.36 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 122.055 1.837 . . . . 2.31 112.431 173.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.591 ' HG3' ' HB2' ' A' ' 145' ' ' ARG . 1.6 Cg_endo -85.23 -153.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.792 2.995 . . . . 1.27 113.982 -173.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.2 p -136.54 -158.77 0.89 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 114.923 -1.035 . . . . 1.88 108.572 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.3 p -90.28 -36.84 14.47 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.215 -0.594 . . . . 2.43 111.488 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -75.74 -48.27 22.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.356 -0.383 . . . . 2.18 111.661 -178.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.73 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 94.9 m-85 -93.75 125.07 38.16 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.028 0.442 . . . . 1.33 110.102 -177.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.653 HG23 ' HG2' ' A' ' 109' ' ' ARG . 1.1 tp -106.94 105.91 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-N 115.723 -0.671 . . . . 1.4 109.276 -177.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.832 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 0.8 OUTLIER -58.86 100.92 0.08 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.01 -0.996 . . . . 5.14 109.818 177.816 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -63.09 117.5 11.44 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.952 -0.642 . . . . 1.05 111.746 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.486 ' HB3' ' CB ' ' A' ' 174' ' ' GLU . 34.8 t80 -85.81 82.7 8.07 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.508 0.671 . . . . 4.68 110.496 -176.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.64 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 88.2 m-20 -70.93 106.1 3.52 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.284 -0.871 . . . . 2.29 109.849 173.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.489 ' O ' ' HB3' ' A' ' 172' ' ' GLN . 36.0 m-70 -68.04 131.44 92.27 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 108.347 -0.982 . . . . 2.95 108.347 174.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.8 ' HG3' ' HE2' ' A' ' 130' ' ' LYS . 83.4 Cg_exo -17.51 68.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.927 1 C-N-CA 126.722 4.948 . . . . 0.77 115.854 -169.409 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . 0.64 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 10.0 p -99.46 -174.6 2.77 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.077 -0.965 . . . . 1.97 108.866 173.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.675 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -173.67 -150.98 7.86 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 119.14 -1.505 . . . . 0.55 112.685 -177.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 23.0 t80 -162.35 93.05 0.84 Allowed 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.929 -1.137 . . . . 0.8 107.929 -164.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.654 HG11 ' HB ' ' A' ' 126' ' ' ILE . 5.9 m -101.55 134.09 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-O 121.933 0.873 . . . . 1.03 110.621 -177.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 124' ' ' MET . 8.9 t -113.28 122.63 48.01 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.036 -0.984 . . . . 2.3 109.37 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.581 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 21.3 m -117.83 114.92 37.27 Favored Pre-proline 0 C--N 1.319 -0.755 0 C-N-CA 120.636 -0.426 . . . . 1.45 112.015 -171.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.441 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 84.8 Cg_exo -49.94 121.84 8.11 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.607 2.205 . . . . 0.72 111.544 171.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.678 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 0.5 OUTLIER -79.64 -167.73 1.33 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.156 0.503 . . . . 1.72 112.268 -173.599 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -63.81 -30.78 71.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.237 -0.892 . . . . 2.63 108.631 172.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.541 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 13.5 mm-40 -103.3 26.8 7.9 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 114.536 -1.211 . . . . 2.05 109.231 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.639 ' HB3' ' HD3' ' A' ' 162' ' ' PRO . 49.7 t-20 4.74 -77.81 0.0 OUTLIER Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 126.23 1.812 . . . . 2.19 115.357 -177.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.639 ' HD3' ' HB3' ' A' ' 161' ' ' ASN . 71.6 Cg_endo -73.69 -13.29 24.59 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 121.396 1.397 . . . . 0.86 113.912 -172.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -105.79 -27.0 11.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.526 -0.306 . . . . 1.34 111.308 -176.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.678 ' O ' ' HB2' ' A' ' 158' ' ' MET . 67.8 m-85 -137.62 133.18 34.05 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.515 -0.55 . . . . 1.46 109.515 176.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.764 ' HG ' ' HG3' ' A' ' 58' ' ' PRO . 32.3 t -129.23 147.55 51.08 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.228 0.537 . . . . 2.05 110.896 177.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.606 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.6 tppp? -93.99 103.48 15.56 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 122.043 0.925 . . . . 1.4 110.993 -178.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.445 HD22 ' CZ ' ' A' ' 153' ' ' PHE . 0.6 OUTLIER -87.26 103.45 15.46 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.345 -1.298 . . . . 1.07 109.475 177.475 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.611 HG11 HG23 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -125.4 116.38 46.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.833 0.825 . . . . 1.11 111.327 178.436 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.603 ' HE1' HD22 ' A' ' 192' ' ' LEU . 48.6 ttp -121.97 145.59 47.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.355 -0.839 . . . . 1.79 109.945 -175.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.706 ' CE2' ' HG3' ' A' ' 49' ' ' ARG . 31.3 m-85 -119.3 134.9 54.97 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 109.098 -0.704 . . . . 4.22 109.098 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 2.7 p -120.8 119.13 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-O 121.55 0.691 . . . . 2.01 109.648 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.489 ' HB3' ' O ' ' A' ' 149' ' ' HIS . 9.3 tt0 -127.05 51.25 1.9 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.734 1.254 . . . . 2.66 108.133 -176.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 11.0 m -72.63 150.89 42.63 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 113.565 -1.652 . . . . 2.2 110.77 -174.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.486 ' CB ' ' HB3' ' A' ' 147' ' ' TYR . 3.3 tt0 . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 121.229 0.538 . . . . 2.45 111.136 -177.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 21.9 mm . . . . . 0 CA--C 1.506 -0.738 0 CA-C-O 122.64 1.21 . . . . 1.69 108.384 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.675 ' HA ' HG22 ' A' ' 187' ' ' THR . 0.9 OUTLIER -68.69 -32.76 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-N 112.602 -2.09 . . . . 1.77 110.187 179.563 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.51 ' O ' ' HD2' ' A' ' 189' ' ' PRO . 12.3 mm-40 -53.47 -34.39 57.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.282 -0.872 . . . . 2.89 109.206 167.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.541 ' O ' ' HB2' ' A' ' 190' ' ' SER . 43.4 mtmt -93.22 -12.35 30.43 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.823 -1.08 . . . . 1.71 111.917 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.675 HG22 ' HA ' ' A' ' 184' ' ' ILE . 6.8 t -92.98 -45.56 7.88 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 119.1 -1.04 . . . . 1.3 112.112 175.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' MET . . . . . 0.939 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 11.2 mmt -81.42 -67.47 0.22 Allowed Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 121.184 -0.947 . . . . 1.39 111.362 -173.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.939 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 29.5 Cg_exo -60.92 -31.4 91.48 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 121.975 1.783 . . . . 1.15 112.118 -176.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.541 ' HB2' ' O ' ' A' ' 186' ' ' LYS . 48.7 m -77.96 -29.53 49.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.35 -0.386 . . . . 1.95 111.717 -176.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 187' ' ' THR . 7.9 m120 -90.37 -29.82 17.81 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.881 -0.328 . . . . 1.92 111.425 -177.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.603 HD22 ' HE1' ' A' ' 169' ' ' MET . 42.1 mt -64.02 -48.06 77.8 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 120.907 -0.317 . . . . 1.68 111.265 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.781 ' HB ' HD13 ' A' ' 33' ' ' ILE . 1.1 m -67.08 -35.65 74.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.445 0.64 . . . . 1.32 109.778 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -68.15 -30.89 70.12 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.737 -1.119 . . . . 2.6 110.94 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.481 ' O ' ' HB2' ' A' ' 198' ' ' ASN . 8.0 t80 -73.88 -27.35 61.02 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.46 -0.57 . . . . 2.73 109.46 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.431 ' O ' ' HB1' ' A' ' 199' ' ' ALA . 25.6 mt -78.56 -27.78 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-O 121.353 0.597 . . . . 1.11 110.281 173.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.474 ' HA ' HD22 ' A' ' 197' ' ' LEU . 61.1 mt -71.66 -39.63 70.18 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 109.585 -0.524 . . . . 1.57 109.585 172.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.563 ' OD1' ' HG2' ' A' ' 76' ' ' LYS . 87.0 m-20 -49.63 -38.89 33.85 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.972 -1.013 . . . . 2.18 109.58 165.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.613 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -76.13 -42.88 45.52 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 116.356 -0.384 . . . . 1.04 110.744 -178.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.548 ' HD3' HG12 ' A' ' 54' ' ' ILE . 35.9 mmtm -59.12 -42.42 90.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.507 0.67 . . . . 1.51 110.904 175.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -86.66 -37.23 18.21 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.209 -0.905 . . . . 1.94 110.641 -174.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -70.72 -29.52 69.41 Favored Glycine 0 CA--C 1.503 -0.657 0 N-CA-C 111.395 -0.682 . . . . 0.47 111.395 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 1.071 HD12 HD21 ' A' ' 61' ' ' LEU . 2.8 tp -70.74 -33.49 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 109.629 -0.508 . . . . 1.16 109.629 177.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 40.9 mttp -85.79 -25.03 26.57 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 109.302 -0.629 . . . . 3.8 109.302 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.906 0 N-CA-C 108.71 -0.848 . . . . 1.28 108.71 167.061 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.571 ' O ' HD13 ' A' ' 6' ' ' ILE . 32.4 t70 . . . . . 0 CA--C 1.521 -0.163 0 N-CA-C 110.128 -0.323 . . . . 2.25 110.128 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.777 ' HA ' HD12 ' A' ' 6' ' ' ILE . 70.4 m-85 -61.78 -31.01 71.19 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 108.313 -0.995 . . . . 0.45 108.313 172.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.743 ' HZ1' ' HE1' ' A' ' 116' ' ' TYR . 36.7 tttp -60.34 -49.0 79.32 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 113.803 -1.544 . . . . 2.06 107.674 177.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.401 ' HB1' ' O ' ' A' ' 2' ' ' ASP . . . -50.11 -46.31 53.55 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.972 -0.558 . . . . 1.2 112.227 -178.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.777 HD12 ' HA ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -81.52 -36.81 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 CA-C-O 121.634 0.731 . . . . 1.76 110.02 -172.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.653 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -80.63 -30.57 36.69 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.588 -1.187 . . . . 1.11 111.568 -175.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.613 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 33.9 mt-30 -65.78 -32.24 73.66 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.783 -1.098 . . . . 2.14 109.087 175.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.604 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 12.5 mm100 -81.02 -45.38 16.65 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.418 -1.265 . . . . 3.04 109.059 175.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.493 ' HB ' ' HA ' ' A' ' 7' ' ' ALA . 0.6 OUTLIER -56.26 -37.4 69.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.202 -0.908 . . . . 1.1 111.192 176.78 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.573 ' HA ' ' CB ' ' A' ' 128' ' ' SER . . . -46.86 -60.84 2.16 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 120.819 0.343 . . . . 1.04 111.796 173.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -79.04 -6.62 56.83 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.323 -0.399 . . . . 2.31 111.087 -177.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.604 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 34.3 mm-40 -78.98 -47.21 16.74 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.248 0.547 . . . . 2.54 109.545 172.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.654 ' O ' ' HD2' ' A' ' 17' ' ' TYR . 9.9 p -74.63 -41.39 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.77 0.795 . . . . 1.21 109.115 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.432 HD12 ' HE1' ' A' ' 124' ' ' MET . 2.5 tt -68.72 -21.2 64.41 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-O 121.719 0.771 . . . . 1.26 109.155 174.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.37 -17.54 61.99 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 114.017 -1.447 . . . . 0.57 110.59 172.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.766 ' HH ' HG21 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -86.49 -33.47 20.33 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.541 -0.911 . . . . 3.59 108.541 177.865 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.517 ' ND2' HG23 ' A' ' 168' ' ' VAL . 2.8 t-20 -75.97 -6.47 51.1 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.648 0.737 . . . . 2.1 110.269 -176.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -120.55 11.31 11.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.476 -0.784 . . . . 3.26 110.582 176.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -139.01 111.4 7.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.154 -0.476 . . . . 2.16 109.772 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 44.4 p -129.01 109.28 11.08 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.102 0.477 . . . . 2.24 111.933 -171.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.2 p -170.47 160.31 7.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.659 -0.7 . . . . 2.46 111.119 -175.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.63 5.72 57.01 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 116.131 -0.486 . . . . 1.45 113.981 172.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.66 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -120.42 -163.8 1.04 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.922 0.361 . . . . 2.24 110.368 -177.363 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.59 135.18 0.23 Allowed 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.451 -0.795 . . . . 3.43 109.357 -178.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.651 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 2.3 m -66.97 118.7 11.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-O 121.81 0.814 . . . . 2.21 111.001 176.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.604 ' O ' ' HD2' ' A' ' 28' ' ' LYS . 11.4 p -95.87 -28.83 3.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 114.465 -1.243 . . . . 1.83 109.446 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.604 ' HD2' ' O ' ' A' ' 27' ' ' VAL . 4.1 mptp? -151.05 133.87 15.77 Favored 'General case' 0 C--O 1.216 -0.7 0 C-N-CA 120.06 -0.656 . . . . 2.87 110.829 -170.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.528 ' HB ' ' HA ' ' A' ' 34' ' ' THR . 0.0 OUTLIER -153.0 152.1 31.02 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.902 0.382 . . . . 1.92 111.3 175.074 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.424 ' HB3' HG12 ' A' ' 33' ' ' ILE . 27.0 t -117.03 27.22 9.26 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.909 -0.587 . . . . 2.37 110.591 -176.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.655 ' HZ3' ' HB2' ' A' ' 31' ' ' LYS . 3.9 ttmp? 68.48 24.35 7.12 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.814 0.816 . . . . 4.84 109.695 175.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.485 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 6.4 tptm -167.24 -40.75 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.921 -1.036 . . . . 2.05 109.209 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.533 HG21 ' HA3' ' A' ' 52' ' ' GLY . 21.1 pt -109.66 152.51 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 CA-C-N 115.242 -0.89 . . . . 1.42 108.983 170.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.528 ' HA ' ' HB ' ' A' ' 29' ' ' THR . 56.6 m -146.29 119.41 8.84 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 123.456 0.472 . . . . 1.22 110.717 -168.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.872 HG22 HG13 ' A' ' 50' ' ' VAL . 3.7 t -109.9 110.87 33.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.86 -0.609 . . . . 1.52 110.609 -175.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.657 ' OG ' ' HB3' ' A' ' 49' ' ' ARG . 97.5 p -100.65 131.49 46.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.192 -0.458 . . . . 1.74 109.934 177.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.8 p -102.76 125.0 49.33 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.892 -0.595 . . . . 1.72 110.991 -177.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.66 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 35.7 ttpt . . . . . 0 C--N 1.318 -0.783 0 CA-C-N 115.6 -0.727 . . . . 2.45 109.607 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 . . . . . 0 N--CA 1.451 -0.396 0 CA-C-O 120.707 0.289 . . . . 2.45 110.369 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.831 HD21 ' H ' ' A' ' 48' ' ' TYR . 2.2 tt -93.27 151.67 19.66 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 106.903 -1.517 . . . . 1.49 106.903 174.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.831 ' H ' HD21 ' A' ' 47' ' ' LEU . 49.9 m-85 -135.73 137.77 42.03 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.305 -0.558 . . . . 1.52 110.87 -170.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.719 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.9 OUTLIER -114.61 131.76 56.59 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 116.014 -0.539 . . . . 3.34 110.841 177.759 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.872 HG13 HG22 ' A' ' 35' ' ' VAL . 0.8 OUTLIER -113.11 143.99 21.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.272 0.558 . . . . 1.98 110.543 168.695 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.713 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 33.1 tt0 -140.94 109.19 5.81 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.897 -1.047 . . . . 1.07 108.921 178.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.533 ' HA3' HG21 ' A' ' 33' ' ' ILE . . . -136.55 143.52 14.93 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.569 -0.824 . . . . 0.35 111.199 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 59.5 mt -88.23 112.48 23.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 C-N-CA 119.936 -0.706 . . . . 1.3 110.352 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.656 HG12 ' HB2' ' A' ' 167' ' ' LEU . 20.8 mm -85.64 114.38 56.33 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 108.373 -0.973 . . . . 1.07 108.373 174.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -66.27 57.86 0.45 Allowed 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 123.584 2.856 . . . . 0.74 112.921 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.423 ' HB3' HG12 ' A' ' 203' ' ' ILE . 12.5 tp10 -158.81 168.1 27.71 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.521 -0.918 . . . . 1.68 108.521 174.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.419 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 34.7 p -70.59 147.41 94.65 Favored Pre-proline 0 N--CA 1.432 -1.335 0 CA-C-O 121.811 0.815 . . . . 1.58 110.849 -177.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.433 ' HG3' ' OG ' ' A' ' 165' ' ' SER . 18.7 Cg_exo -63.71 -9.33 18.13 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.911 3.074 . . . . 0.74 110.585 178.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.83 -54.47 13.43 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.902 -1.045 . . . . 1.31 110.87 175.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.715 ' O ' ' HE3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -69.63 -24.17 63.6 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.443 -0.947 . . . . 3.78 108.443 178.235 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.788 HD22 HD13 ' A' ' 203' ' ' ILE . 29.6 mt -63.64 -58.46 6.85 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.508 -0.552 . . . . 1.09 109.508 173.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.7 t -64.88 -10.86 31.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.06 0.457 . . . . 1.94 110.435 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.462 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 32.1 t70 -88.06 -37.34 16.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.995 -0.548 . . . . 1.32 111.935 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.636 ' O ' ' HB3' ' A' ' 71' ' ' ARG . 10.1 p90 -85.45 -45.67 11.62 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.371 -0.531 . . . . 0.79 111.259 -174.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.768 HD11 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -84.34 7.33 19.78 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.461 -0.57 . . . . 2.15 109.461 -172.758 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -48.93 -70.06 0.1 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.341 -1.299 . . . . 2.06 111.613 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.68 ' HG3' ' SG ' ' A' ' 94' ' ' CYS . 46.3 tt0 -179.38 -43.04 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.611 0.72 . . . . 4.31 110.159 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.404 ' HB ' ' CD2' ' A' ' 81' ' ' TYR . 5.1 t -149.72 29.43 0.75 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.158 -0.928 . . . . 1.89 109.283 -174.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' A' ' 70' ' ' ASP . . . -74.42 -36.67 49.11 Favored Glycine 0 N--CA 1.434 -1.499 0 C-N-CA 120.579 -0.819 . . . . 1.71 111.652 -170.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.637 ' O ' HG22 ' A' ' 73' ' ' THR . 20.7 p-10 163.73 -21.04 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 113.894 -1.153 . . . . 2.19 108.274 -164.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.78 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 1.2 ptp180 -39.64 -53.45 2.15 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-N 114.669 -1.151 . . . . 3.95 111.142 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.606 HG23 HD11 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -82.01 -13.13 12.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.347 -0.541 . . . . 1.42 111.447 -171.298 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.637 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.3 t -84.97 -30.16 24.47 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.592 -0.843 . . . . 1.45 109.949 -175.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.448 ' HZ2' ' HB2' ' A' ' 64' ' ' PHE . 17.8 p-90 -111.86 -4.07 14.71 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.442 0.534 . . . . 0.78 112.442 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.78 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 3.6 t70 -62.42 168.14 3.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 122.26 1.028 . . . . 2.19 113.655 -168.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.519 ' HG3' ' OD1' ' A' ' 198' ' ' ASN . 13.0 mmmt -90.95 -35.78 14.5 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.482 -1.69 . . . . 3.68 109.322 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.563 ' HA ' ' HB2' ' A' ' 99' ' ' GLN . 50.8 m -137.98 26.01 2.74 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.384 -1.28 . . . . 2.08 112.019 -171.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.606 HD11 HG23 ' A' ' 72' ' ' ILE . 44.2 mt -110.34 166.22 11.15 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.509 -0.476 . . . . 1.16 110.753 175.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.484 ' HB3' HG22 ' A' ' 80' ' ' VAL . 21.0 mm-40 -144.1 -63.85 0.37 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.807 -0.633 . . . . 2.23 111.346 -175.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.484 HG22 ' HB3' ' A' ' 79' ' ' GLN . 19.8 t -140.49 117.61 8.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.883 -0.599 . . . . 1.44 111.0 -166.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.404 ' CD2' ' HB ' ' A' ' 68' ' ' THR . 14.3 p90 -90.78 152.17 20.9 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.806 -0.442 . . . . 5.73 109.806 171.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.767 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 19.9 m120 -145.85 117.19 7.94 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.336 -0.987 . . . . 1.86 108.336 168.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.443 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 6.5 ttt -79.31 89.59 4.95 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.563 -0.903 . . . . 2.52 108.563 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -69.33 -81.57 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 115.647 -0.706 . . . . 1.19 111.231 -167.128 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.42 ' HB3' HD13 ' A' ' 93' ' ' ILE . 11.2 t60 -121.06 118.2 29.18 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.381 -0.6 . . . . 2.59 109.381 -178.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.443 ' HD3' ' SD ' ' A' ' 83' ' ' MET . 1.5 mtm180 -99.5 100.71 11.78 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.981 -0.554 . . . . 2.83 109.636 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.613 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -70.84 -41.25 77.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.399 -0.819 . . . . 1.17 110.588 -173.587 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -155.44 166.71 32.71 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.73 -1.123 . . . . 1.86 108.456 -172.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.9 m -62.33 -11.69 16.81 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.211 0.448 . . . . 1.94 112.211 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -128.27 11.45 6.42 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 120.761 -0.376 . . . . 1.87 110.226 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.613 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.7 OUTLIER -135.35 110.34 8.82 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.327 -0.62 . . . . 1.12 109.327 -174.066 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.549 ' O ' HD12 ' A' ' 114' ' ' LEU . 21.3 m-85 -128.85 171.46 12.26 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.745 -0.662 . . . . 0.52 110.616 -174.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.645 ' O ' HG23 ' A' ' 84' ' ' VAL . 32.5 mt -127.2 126.65 68.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 107.542 -1.281 . . . . 1.1 107.542 168.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.68 ' SG ' ' HG3' ' A' ' 67' ' ' GLN . 42.0 t -108.84 106.0 15.8 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.75 -0.659 . . . . 2.61 111.198 -165.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.767 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 39.0 t-80 -82.45 116.38 21.88 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.64 -0.874 . . . . 2.17 108.64 170.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.716 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 62.3 m -134.61 116.03 14.52 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 112.446 0.536 . . . . 1.19 112.446 -177.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 49.5 mm -78.11 128.19 38.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.678 -0.49 . . . . 1.63 109.678 174.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.718 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 2.1 m -102.6 147.66 26.52 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.691 -0.686 . . . . 1.72 110.905 -175.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.563 ' HB2' ' HA ' ' A' ' 77' ' ' SER . 0.8 OUTLIER . . . . . 0 C--N 1.32 -0.694 0 CA-C-N 115.693 -0.685 . . . . 2.29 111.232 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.3 mt . . . . . 0 N--CA 1.442 -0.852 0 N-CA-C 108.634 -0.876 . . . . 1.53 108.634 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.616 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 13.2 m -65.51 174.13 1.63 Allowed Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.087 -0.96 . . . . 1.71 110.867 -175.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.616 ' HD2' ' HB3' ' A' ' 107' ' ' SER . 81.6 Cg_exo -42.39 111.14 0.18 Allowed 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 122.761 2.308 . . . . 1.31 112.521 -175.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.718 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 33.3 ttp180 -100.26 159.86 14.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.603 -0.726 . . . . 4.06 110.408 -174.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.928 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 12.7 t70 -115.02 131.18 57.01 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.507 -0.553 . . . . 1.37 109.507 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.716 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 6.2 m-85 -108.88 127.7 54.27 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.079 0.466 . . . . 3.01 111.076 173.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.675 HD12 ' HD2' ' A' ' 95' ' ' HIS . 14.7 mm -134.35 77.42 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.955 -1.02 . . . . 1.2 108.481 169.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.681 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 0.5 OUTLIER -107.32 129.94 54.84 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.273 -0.876 . . . . 1.86 110.592 -178.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.594 ' O ' ' HA ' ' A' ' 129' ' ' SER . 7.6 tp -78.71 118.35 20.71 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-N 115.558 -0.746 . . . . 1.08 109.285 172.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.437 HG22 ' HB ' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -118.65 126.24 75.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 CA-C-N 114.931 -1.032 . . . . 1.08 111.137 -166.078 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.743 ' HE1' ' HZ1' ' A' ' 4' ' ' LYS . 57.0 t80 -108.51 113.48 26.54 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.25 -0.886 . . . . 2.81 110.39 174.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.645 HG12 HG21 ' A' ' 127' ' ' ILE . 56.4 mt -98.19 98.54 7.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.638 -0.71 . . . . 1.53 109.767 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.592 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 34.0 ttpt -117.73 134.61 54.73 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.232 0.539 . . . . 1.81 110.256 176.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.676 ' O ' ' HD2' ' A' ' 119' ' ' ARG . 1.0 OUTLIER -103.01 118.38 36.69 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.542 -0.91 . . . . 3.22 108.542 175.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.542 ' HB3' ' HB3' ' A' ' 123' ' ' ASN . 12.2 m-85 -74.4 107.91 6.85 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.2 -1.778 . . . . 1.28 106.2 164.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.4 ' HA ' HH11 ' A' ' 119' ' ' ARG . 6.5 pt-20 -37.27 98.87 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 O-C-N 124.55 1.156 . . . . 2.28 113.389 -175.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 57.53 47.09 90.78 Favored Glycine 0 CA--C 1.503 -0.662 0 CA-C-N 113.53 -1.668 . . . . 0.79 111.658 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.542 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 50.0 t30 -144.96 -53.89 0.3 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.616 -0.792 . . . . 2.06 109.886 -173.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.432 ' HE1' HD12 ' A' ' 15' ' ' LEU . 1.9 mpp? -159.04 122.41 3.76 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.562 -0.29 . . . . 1.73 110.484 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -104.92 81.52 1.75 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.441 -0.948 . . . . 2.07 108.441 177.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.606 ' CG1' HG13 ' A' ' 154' ' ' VAL . 0.4 OUTLIER -103.16 141.96 18.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.241 -0.89 . . . . 1.06 112.739 -170.789 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.645 HG21 HG12 ' A' ' 117' ' ' ILE . 2.9 pt -110.28 115.5 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 108.398 -0.964 . . . . 1.26 108.398 161.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.573 ' CB ' ' HA ' ' A' ' 11' ' ' ALA . 15.4 p -99.4 114.98 28.21 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.968 -0.56 . . . . 1.53 110.424 177.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.681 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 9.4 p -109.71 144.9 37.45 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.394 0.616 . . . . 1.81 112.046 -173.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.731 ' HB3' ' HZ1' ' A' ' 130' ' ' LYS . 4.8 mtpm? -127.9 123.8 35.85 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 107.618 -1.253 . . . . 2.75 107.618 176.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.416 ' HB3' ' N ' ' A' ' 148' ' ' ASN . 7.0 p -65.13 94.3 0.14 Allowed 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.72 -0.844 . . . . 1.94 108.72 177.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.444 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.6 OUTLIER -107.56 129.2 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 CA-C-N 115.152 -0.931 . . . . 1.64 109.26 -166.312 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -99.3 70.78 1.76 Allowed 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 114.309 -1.314 . . . . 2.17 107.916 -167.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.843 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 0.5 OUTLIER -101.89 154.87 37.05 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 113.552 -1.658 . . . . 0.67 109.829 -169.548 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.04 -1.6 11.28 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.433 2.088 . . . . 1.66 116.041 -168.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.843 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 4.7 tp10 -76.74 -13.8 60.0 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.073 -1.084 . . . . 3.5 108.073 -178.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.404 ' HB2' HG13 ' A' ' 84' ' ' VAL . 26.1 t80 -162.8 114.95 1.1 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.119 -0.946 . . . . 6.41 112.436 175.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -95.32 140.33 1.02 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.661 2.907 . . . . 2.31 111.346 168.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.472 ' HG3' ' HB2' ' A' ' 145' ' ' ARG . 37.3 Cg_endo -70.85 -164.58 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.588 2.192 . . . . 1.27 112.965 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.3 t -139.26 -173.49 3.61 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.237 -1.023 . . . . 1.88 108.237 -176.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.0 t -82.46 -41.39 19.86 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.248 -0.581 . . . . 2.43 110.265 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -57.15 -52.46 65.21 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.144 0.497 . . . . 2.18 110.309 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.928 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 61.9 m-85 -95.82 109.99 22.23 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.316 -0.856 . . . . 1.33 109.424 -175.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.596 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -88.46 107.52 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-N 115.67 -0.696 . . . . 1.4 109.611 -176.256 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 31.5 ttp85 -56.69 105.53 0.22 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.796 -0.638 . . . . 5.14 110.129 178.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.75 118.0 12.96 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.707 -0.679 . . . . 1.05 112.006 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.843 ' HB3' ' HB3' ' A' ' 174' ' ' GLU . 17.9 t80 -85.62 70.29 10.72 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.511 0.672 . . . . 4.68 109.628 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.66 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 11.6 t30 -64.69 96.56 0.18 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.47 -0.786 . . . . 2.29 110.083 176.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.86 117.74 28.39 Favored Pre-proline 0 C--O 1.222 -0.382 0 CA-C-N 115.758 -0.655 . . . . 2.95 110.242 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -18.32 70.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.101 1 C-N-CA 126.438 4.758 . . . . 0.77 115.664 -165.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 170' ' ' PHE . 4.4 p -122.99 169.71 10.89 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.789 -1.189 . . . . 1.97 107.789 172.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.648 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -152.21 -146.15 4.29 Favored Glycine 0 N--CA 1.434 -1.49 0 C-N-CA 118.325 -1.893 . . . . 0.55 113.805 -165.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.434 ' CZ ' HD12 ' A' ' 167' ' ' LEU . 5.8 t80 -161.36 96.77 1.08 Allowed 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.995 -1.113 . . . . 0.8 107.995 -162.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.606 HG13 ' CG1' ' A' ' 126' ' ' ILE . 4.5 m -105.83 137.88 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-O 121.679 0.752 . . . . 1.03 110.746 -175.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 83.8 m -117.71 109.63 16.85 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.161 -0.927 . . . . 2.3 109.899 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.558 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 15.4 m -111.06 125.59 30.34 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 120.794 -0.362 . . . . 1.45 111.51 -168.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 156' ' ' SER . 10.7 Cg_endo -54.54 121.05 9.08 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 122.454 2.102 . . . . 0.72 111.368 174.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.611 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 61.1 mmm -80.12 -162.85 0.48 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.217 0.532 . . . . 1.72 111.79 -176.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -70.44 -35.07 73.15 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.52 -0.763 . . . . 2.63 109.408 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -103.22 30.97 4.53 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.045 -0.98 . . . . 2.05 109.143 173.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.707 ' OD1' ' HD3' ' A' ' 162' ' ' PRO . 0.3 OUTLIER -19.77 -57.16 0.06 OUTLIER Pre-proline 0 N--CA 1.479 0.989 0 N-CA-C 117.164 2.283 . . . . 2.19 117.164 -171.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.707 ' HD3' ' OD1' ' A' ' 161' ' ' ASN . 69.8 Cg_endo -72.91 -18.17 24.71 Favored 'Trans proline' 0 C--N 1.351 0.701 0 CA-C-N 121.798 1.678 . . . . 0.86 113.255 -175.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -108.07 -26.61 10.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.196 -0.456 . . . . 1.34 110.92 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.611 ' O ' ' HB2' ' A' ' 158' ' ' MET . 94.1 m-85 -138.33 128.36 25.56 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.181 -0.674 . . . . 1.46 109.181 177.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.467 ' HB3' HD13 ' A' ' 61' ' ' LEU . 26.6 t -125.93 151.59 46.76 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.38 0.61 . . . . 2.05 111.599 -177.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.745 ' HG3' HG11 ' A' ' 168' ' ' VAL . 2.0 tppp? -90.73 103.45 16.15 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 122.019 0.914 . . . . 1.4 111.472 -176.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.746 HD11 HG12 ' A' ' 196' ' ' ILE . 0.5 OUTLIER -88.06 103.61 15.88 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.406 -1.27 . . . . 1.07 109.429 176.111 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.766 HG21 ' HH ' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -127.82 132.43 68.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.087 -0.645 . . . . 1.11 111.876 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.556 ' HE2' HG21 ' A' ' 171' ' ' VAL . 20.8 ttt -144.41 137.98 27.41 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.37 -0.377 . . . . 1.79 111.819 -170.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.664 ' CE1' ' HB2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -110.84 135.17 51.8 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 109.182 -0.673 . . . . 4.22 109.182 173.439 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 1.038 ' HB ' HD22 ' A' ' 192' ' ' LEU . 1.3 t -134.43 120.82 34.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 O-C-N 123.661 0.601 . . . . 2.01 111.056 177.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.79 ' HB2' ' HG ' ' A' ' 47' ' ' LEU . 1.3 tm0? -105.04 -32.64 8.62 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.462 -1.31 . . . . 2.66 107.462 168.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.66 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 13.2 m 20.75 107.86 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 O-C-N 126.281 2.238 . . . . 2.2 113.165 176.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.843 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 15.2 tp10 . . . . . 0 C--N 1.32 -0.681 0 CA-C-N 116.043 -0.526 . . . . 2.45 111.769 -161.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.494 ' HA ' ' CE ' ' A' ' 186' ' ' LYS . 11.9 mm . . . . . 0 CA--C 1.511 -0.529 0 CA-C-O 122.505 1.145 . . . . 1.69 108.76 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.637 ' HA ' HG22 ' A' ' 187' ' ' THR . 0.7 OUTLIER -66.13 -38.26 81.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 113.063 -1.88 . . . . 1.77 111.375 -177.234 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.15 -18.45 65.31 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.585 -0.524 . . . . 2.89 109.585 176.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.494 ' CE ' ' HA ' ' A' ' 183' ' ' ILE . 45.2 mtmt -91.84 -41.59 10.55 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.814 -0.63 . . . . 1.71 109.991 173.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.703 HG21 ' HE1' ' A' ' 188' ' ' MET . 14.6 t -63.04 -28.14 69.89 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.941 0.719 . . . . 1.3 112.941 -169.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' MET . . . . . 0.703 ' HE1' HG21 ' A' ' 187' ' ' THR . 2.4 mmt -76.05 -62.89 0.67 Allowed Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 120.249 -0.581 . . . . 1.39 111.503 -177.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.592 ' O ' HG13 ' A' ' 193' ' ' VAL . 28.3 Cg_endo -61.93 -32.26 84.75 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 121.812 1.674 . . . . 1.15 111.844 -177.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.638 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 24.6 m -73.88 -23.76 59.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.357 -0.383 . . . . 1.95 110.777 -177.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.2 OUTLIER -90.39 -38.03 13.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.912 -0.403 . . . . 1.92 109.912 -176.134 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 1.038 HD22 ' HB ' ' A' ' 171' ' ' VAL . 26.7 mt -59.3 -57.31 13.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.996 -0.547 . . . . 1.68 112.022 178.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 189' ' ' PRO . 1.8 m -65.44 -32.62 59.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.595 0.712 . . . . 1.32 109.379 -175.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.638 ' HB2' ' O ' ' A' ' 190' ' ' SER . 0.4 OUTLIER -65.32 -47.04 77.93 Favored 'General case' 0 C--O 1.208 -1.112 0 CA-C-N 114.217 -1.356 . . . . 2.6 109.843 176.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.86 -28.94 66.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.786 0.327 . . . . 2.73 111.026 178.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.746 HG12 HD11 ' A' ' 167' ' ' LEU . 22.1 mt -77.32 -31.61 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-O 121.414 0.626 . . . . 1.11 110.862 175.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 68.1 mt -73.56 -38.14 65.3 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 109.562 -0.532 . . . . 1.57 109.562 176.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.519 ' OD1' ' HG3' ' A' ' 76' ' ' LYS . 3.2 m-20 -53.11 -41.69 65.23 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.11 -1.07 . . . . 2.18 108.11 168.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.717 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -67.33 -49.8 62.61 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.944 -0.571 . . . . 1.04 110.129 -178.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.446 ' HD3' HD13 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -61.09 -41.16 96.15 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 114.984 -1.007 . . . . 1.51 110.843 -179.242 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -76.99 -47.18 21.45 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-N 115.259 -0.882 . . . . 1.94 110.089 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . 0.437 ' HA3' ' CZ2' ' A' ' 74' ' ' TRP . . . -69.89 -38.45 75.45 Favored Glycine 0 CA--C 1.505 -0.543 0 C-N-CA 120.811 -0.709 . . . . 0.47 112.117 -175.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.788 HD13 HD22 ' A' ' 61' ' ' LEU . 0.9 OUTLIER -58.04 -46.25 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 110.521 -0.178 . . . . 1.16 110.521 176.327 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -84.48 -23.57 29.82 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 120.382 -0.527 . . . . 3.8 109.841 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.88 0 N-CA-C 109.081 -0.711 . . . . 1.28 109.081 166.827 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.64 ' O ' HD12 ' A' ' 6' ' ' ILE . 7.0 m-20 . . . . . 0 CA--C 1.507 -0.684 0 CA-C-O 121.183 0.516 . . . . 2.25 110.206 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.529 ' CD2' HD13 ' A' ' 87' ' ' ILE . 93.5 m-85 -66.73 -32.83 74.39 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.384 -0.825 . . . . 0.45 109.326 -175.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.655 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 2.1 tppp? -69.52 -8.25 45.42 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.82 -1.082 . . . . 2.06 110.124 177.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -92.27 -41.68 10.26 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.229 0.538 . . . . 1.2 110.337 173.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.64 HD12 ' O ' ' A' ' 2' ' ' ASP . 1.8 mp -82.45 -43.07 18.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.754 0.788 . . . . 1.76 109.456 -171.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.517 ' HB3' ' HB2' ' A' ' 116' ' ' TYR . . . -72.15 -47.22 52.56 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.312 -1.313 . . . . 1.11 111.582 -178.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.655 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 6.2 mt-30 -63.19 -26.43 68.8 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.664 -1.153 . . . . 2.14 110.762 -178.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.565 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 24.9 mt-30 -84.82 -30.81 24.24 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.324 -0.853 . . . . 3.04 109.395 172.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.547 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.4 OUTLIER -74.35 -34.72 63.47 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.513 -0.767 . . . . 1.1 111.684 -177.386 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.435 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -45.87 -54.99 7.25 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 120.345 -0.542 . . . . 1.04 111.23 172.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -75.5 -6.66 51.3 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.775 -0.648 . . . . 2.31 112.042 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.565 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 32.1 mt-10 -80.59 -52.09 7.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.712 -0.477 . . . . 2.54 109.712 173.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.692 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 14.6 p -69.57 -40.94 80.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.844 0.831 . . . . 1.21 110.193 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.78 -25.45 65.61 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 121.978 0.894 . . . . 1.26 108.608 173.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.32 -17.5 66.28 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 113.79 -1.55 . . . . 0.57 110.394 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.692 ' CD2' ' HA ' ' A' ' 14' ' ' VAL . 15.1 m-85 -89.07 -24.68 22.24 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.572 -0.899 . . . . 3.59 108.572 177.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.419 ' OD1' HG21 ' A' ' 168' ' ' VAL . 47.9 t30 -73.61 -12.0 60.61 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-O 121.337 0.589 . . . . 2.1 110.018 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -111.62 -18.7 12.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.498 -0.774 . . . . 3.26 111.216 -176.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -136.09 84.13 2.06 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.326 -0.397 . . . . 2.16 111.459 -174.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -151.0 139.5 20.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 2.24 111.64 178.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.9 m -167.53 -45.26 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.017 -0.538 . . . . 2.46 110.031 -173.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -81.68 47.79 3.72 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.834 -0.621 . . . . 1.45 113.188 -176.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.537 ' O ' ' HE2' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -120.65 -147.3 0.39 Allowed 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.605 -0.517 . . . . 2.24 109.605 178.188 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.537 ' HE2' ' O ' ' A' ' 24' ' ' TRP . 0.0 OUTLIER 178.57 123.84 0.05 OUTLIER 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.954 -0.758 . . . . 3.43 108.954 -175.036 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.517 ' CG1' HG22 ' A' ' 34' ' ' THR . 3.7 m -65.13 119.81 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.818 0 CA-C-O 122.358 1.075 . . . . 2.21 111.605 176.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.57 -23.96 4.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 113.692 -1.595 . . . . 1.83 109.07 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 28' ' ' LYS . 8.3 tppt? -152.9 109.9 3.48 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 119.82 -0.752 . . . . 2.87 111.756 -176.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.602 ' HB ' ' HA ' ' A' ' 34' ' ' THR . 1.3 t -151.89 152.64 32.82 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.196 0.522 . . . . 1.92 111.484 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.7 t -113.24 -94.93 0.45 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.354 -0.839 . . . . 2.37 110.165 176.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -148.32 19.15 1.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.297 0.57 . . . . 4.84 110.737 176.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.657 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 38.5 mmtm -150.05 -33.92 0.18 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.707 -0.679 . . . . 2.05 110.138 176.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.5 HD13 ' HB ' ' A' ' 193' ' ' VAL . 16.3 pt -113.55 149.95 15.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.603 -0.726 . . . . 1.42 109.746 -177.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.602 ' HA ' ' HB ' ' A' ' 29' ' ' THR . 0.2 OUTLIER -151.17 107.67 3.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 123.12 0.262 . . . . 1.22 111.604 -166.248 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.526 ' CG2' HG11 ' A' ' 193' ' ' VAL . 21.4 t -95.57 109.63 22.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.953 0.406 . . . . 1.52 110.315 176.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 2.3 p -105.11 123.36 47.68 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.526 -0.761 . . . . 1.74 110.773 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 77.9 p -103.47 129.19 50.56 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.914 -1.039 . . . . 1.72 110.284 -174.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 24.5 ttpp . . . . . 0 C--N 1.317 -0.829 0 CA-C-N 115.996 -0.547 . . . . 2.45 111.289 -173.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 . . . . . 0 N--CA 1.442 -0.864 0 CA-C-O 121.054 0.454 . . . . 2.45 111.301 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.498 HD22 ' N ' ' A' ' 48' ' ' TYR . 3.2 tt -98.48 138.68 35.35 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.865 -1.161 . . . . 1.49 107.865 174.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.498 ' N ' HD22 ' A' ' 47' ' ' LEU . 73.2 m-85 -120.03 130.69 54.83 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 110.168 -0.308 . . . . 1.52 110.168 -174.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.464 ' HD3' ' CZ3' ' A' ' 24' ' ' TRP . 37.4 ttt-85 -120.29 121.42 38.63 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.268 -0.424 . . . . 3.34 110.06 175.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 34' ' ' THR . 9.4 p -104.99 145.98 12.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 120.11 -0.636 . . . . 1.98 109.655 174.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.527 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 29.6 tt0 -144.33 113.09 6.69 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.534 -0.757 . . . . 1.07 110.155 -171.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.657 ' HA2' ' O ' ' A' ' 32' ' ' LYS . . . -143.85 143.26 12.03 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.682 -0.771 . . . . 0.35 111.934 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.8 mt -87.54 120.59 36.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 120.147 -0.621 . . . . 1.3 110.691 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.451 ' CD1' ' HB1' ' A' ' 199' ' ' ALA . 36.4 mt -102.69 120.2 53.52 Favored Pre-proline 0 N--CA 1.442 -0.865 0 CA-C-N 115.556 -0.747 . . . . 1.07 109.728 178.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -62.57 60.03 0.14 Allowed 'Trans proline' 0 N--CA 1.473 0.319 0 C-N-CA 124.299 3.333 . . . . 0.74 113.93 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.601 ' HG2' HG13 ' A' ' 203' ' ' ILE . 9.6 tp10 -150.91 175.54 11.95 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.879 -0.785 . . . . 1.68 108.879 174.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.544 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 12.8 m -80.94 143.32 53.25 Favored Pre-proline 0 N--CA 1.425 -1.702 0 CA-C-O 121.365 0.602 . . . . 1.58 109.488 172.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 57' ' ' SER . 35.5 Cg_exo -57.95 -14.32 18.09 Favored 'Trans proline' 0 C--N 1.333 -0.272 0 C-N-CA 124.092 3.195 . . . . 0.74 111.501 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.32 -50.9 42.25 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.207 -0.906 . . . . 1.31 111.31 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.476 ' O ' ' HE3' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -67.66 -27.35 66.78 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.387 -0.968 . . . . 3.78 108.387 179.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.742 ' O ' HD12 ' A' ' 65' ' ' LEU . 40.6 mt -62.9 -57.96 9.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.19 -0.914 . . . . 1.09 110.473 172.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.663 ' OG ' ' HB3' ' A' ' 125' ' ' ASN . 66.5 m -60.49 -16.1 33.54 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.92 -0.488 . . . . 1.94 110.861 176.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -90.1 -43.96 10.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.243 0.46 . . . . 1.32 112.243 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.636 ' CE2' ' HA ' ' A' ' 199' ' ' ALA . 5.0 p90 -73.4 -43.43 60.51 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.739 -0.385 . . . . 0.79 110.905 -171.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.742 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -86.57 -7.17 58.59 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 120.433 -0.507 . . . . 2.15 111.616 -173.288 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.515 ' N ' HD11 ' A' ' 65' ' ' LEU . 11.8 t80 -18.79 -70.44 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.95 1.406 . . . . 2.06 114.005 -163.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.472 ' OE1' ' HB2' ' A' ' 94' ' ' CYS . 8.5 tt0 -174.32 -32.26 0.01 OUTLIER 'General case' 0 C--N 1.342 0.268 0 N-CA-C 114.296 1.221 . . . . 4.31 114.296 176.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.7 t -161.97 7.87 0.06 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 119.223 -0.991 . . . . 1.89 113.462 -166.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -115.0 -22.78 4.83 Favored Glycine 0 C--N 1.314 -0.686 0 C-N-CA 118.917 -1.611 . . . . 1.71 113.901 -168.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.65 ' O ' HG23 ' A' ' 73' ' ' THR . 4.5 t70 -150.39 -29.5 0.21 Allowed 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.609 -0.436 . . . . 2.19 110.574 -176.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.85 ' HA ' ' CZ2' ' A' ' 74' ' ' TRP . 9.7 ptm180 -50.19 -43.68 52.6 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 123.33 0.652 . . . . 3.95 111.452 -173.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.506 ' N ' ' HG3' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -83.5 -13.54 11.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.896 -0.593 . . . . 1.42 110.318 -173.262 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.65 HG23 ' O ' ' A' ' 70' ' ' ASP . 0.8 OUTLIER -84.91 -31.44 23.67 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 116.02 -0.536 . . . . 1.45 109.927 -176.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.85 ' CZ2' ' HA ' ' A' ' 71' ' ' ARG . 7.4 p-90 -106.29 -10.34 16.43 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 120.27 -0.572 . . . . 0.78 111.872 -176.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.66 ' OD2' ' HG ' ' A' ' 78' ' ' LEU . 27.4 t0 -83.3 172.58 12.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.967 0.889 . . . . 2.19 111.427 -177.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.575 ' H ' ' CG ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -122.04 -13.98 8.08 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 113.979 -1.464 . . . . 3.68 111.297 -172.47 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 74.7 m -115.56 8.77 15.2 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.303 -0.629 . . . . 2.08 109.303 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.66 ' HG ' ' OD2' ' A' ' 75' ' ' ASP . 54.0 mt -109.65 171.05 7.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.363 -0.835 . . . . 1.16 110.681 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.559 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 6.4 mm-40 -150.62 -63.37 0.2 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.592 0.59 . . . . 2.23 112.592 -171.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.48 HG23 ' HB3' ' A' ' 79' ' ' GLN . 39.4 t -141.65 127.94 19.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.907 0.384 . . . . 1.44 111.076 -168.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -97.67 146.06 25.7 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.825 -0.625 . . . . 5.73 110.219 174.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 17.2 m120 -155.13 102.5 2.31 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.447 -0.575 . . . . 1.86 109.447 174.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.09 110.06 2.38 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.196 -0.668 . . . . 2.52 109.196 177.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -93.14 -49.09 13.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.521 -0.309 . . . . 1.19 111.55 -172.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -147.74 108.13 4.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.124 0.487 . . . . 2.59 111.144 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.411 ' HG2' ' HD2' ' A' ' 92' ' ' PHE . 20.7 mtt180 -89.66 107.04 18.86 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.564 -0.744 . . . . 2.83 109.828 176.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.626 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -75.85 -41.34 39.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.095 0.474 . . . . 1.17 110.033 -177.805 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -155.6 -168.12 2.72 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.3 -1.0 . . . . 1.86 108.3 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.6 m -80.63 -5.62 57.15 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 117.567 0.167 . . . . 1.94 111.345 -177.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -130.16 4.35 4.82 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.83 -0.433 . . . . 1.87 109.83 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.626 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.5 OUTLIER -137.87 116.33 12.01 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.609 -0.885 . . . . 1.12 108.609 -173.564 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.557 ' O ' HD12 ' A' ' 114' ' ' LEU . 11.0 m-85 -137.2 176.29 8.84 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.232 0.539 . . . . 0.52 110.57 -175.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.554 ' O ' HG23 ' A' ' 84' ' ' VAL . 21.6 mt -134.94 127.43 48.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 106.759 -1.571 . . . . 1.1 106.759 166.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.472 ' HB2' ' OE1' ' A' ' 67' ' ' GLN . 31.2 t -117.15 129.58 56.06 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.389 -0.525 . . . . 2.61 111.266 -176.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.503 ' HA ' HD12 ' A' ' 112' ' ' ILE . 24.3 t60 -87.35 85.38 7.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.268 -0.878 . . . . 2.17 109.173 173.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 60.2 m -100.42 113.37 26.07 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.644 -1.162 . . . . 1.19 112.177 -173.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.463 HD11 ' OD1' ' A' ' 110' ' ' ASP . 31.0 mm -76.52 126.21 36.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.309 -0.626 . . . . 1.63 109.309 174.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.2 m -113.35 142.74 45.5 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.328 -0.851 . . . . 1.72 111.272 -174.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.559 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 25.3 mt-30 . . . . . 0 C--N 1.318 -0.796 0 N-CA-C 109.495 -0.557 . . . . 2.29 109.495 173.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.3 mt . . . . . 0 N--CA 1.45 -0.461 0 N-CA-C 110.156 -0.313 . . . . 1.53 110.156 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.1 m -87.44 152.41 52.22 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 116.163 -0.472 . . . . 1.71 110.325 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -47.97 143.08 14.27 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.686 2.257 . . . . 1.31 111.632 173.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.568 ' HG2' HG23 ' A' ' 144' ' ' ILE . 20.2 mtm180 -123.64 174.76 7.25 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.639 -0.504 . . . . 4.06 109.639 -173.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.676 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 31.0 t70 -131.61 138.88 48.99 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.339 -0.391 . . . . 1.37 110.045 176.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -110.07 125.54 53.06 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.105 -0.498 . . . . 3.01 110.375 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.606 ' O ' ' HA ' ' A' ' 131' ' ' SER . 47.6 mm -109.39 70.54 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 108.362 -0.977 . . . . 1.2 108.362 170.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.494 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 43.7 m-20 -88.35 117.7 27.46 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.638 -0.71 . . . . 1.86 111.03 -174.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.561 ' O ' ' HA ' ' A' ' 129' ' ' SER . 9.4 tp -75.0 124.7 27.44 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.342 -0.984 . . . . 1.08 108.342 165.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -132.25 126.5 55.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 115.465 -0.789 . . . . 1.08 112.404 -163.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.517 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 58.9 t80 -110.72 116.36 31.17 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.092 -0.958 . . . . 2.81 110.425 172.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.413 HG12 ' CG2' ' A' ' 127' ' ' ILE . 86.6 mt -94.31 112.0 26.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.54 -0.755 . . . . 1.53 110.222 -177.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.429 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 17.1 ttmm -137.95 142.43 40.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.132 -0.485 . . . . 1.81 110.63 -176.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.439 ' HD2' ' C ' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -117.72 113.72 22.27 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 107.86 -1.163 . . . . 3.22 107.86 172.472 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.422 ' CB ' ' HB3' ' A' ' 123' ' ' ASN . 56.0 m-85 -67.48 117.25 9.19 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.667 -1.235 . . . . 1.28 107.667 170.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.429 ' HA ' ' NE ' ' A' ' 119' ' ' ARG . 22.1 mm-40 -35.66 94.58 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 O-C-N 124.789 1.306 . . . . 2.28 112.938 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 58.8 41.71 96.13 Favored Glycine 0 CA--C 1.505 -0.569 0 CA-C-N 114.618 -1.174 . . . . 0.79 112.406 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.422 ' HB3' ' CB ' ' A' ' 120' ' ' TYR . 3.2 t-20 -138.68 -49.93 0.54 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.446 -0.377 . . . . 2.06 110.705 -177.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.409 ' O ' ' HA ' ' A' ' 119' ' ' ARG . 2.0 tpp -159.97 118.84 2.76 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.046 0.45 . . . . 1.73 111.491 -175.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.663 ' HB3' ' OG ' ' A' ' 62' ' ' SER . 6.0 m120 -97.93 79.21 2.61 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.779 -0.823 . . . . 2.07 108.779 177.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.5 ' HB ' HG11 ' A' ' 154' ' ' VAL . 0.5 OUTLIER -105.37 141.06 21.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 113.193 0.812 . . . . 1.06 113.193 -169.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.689 ' O ' HG13 ' A' ' 127' ' ' ILE . 2.3 pt -107.9 115.05 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 107.979 -1.119 . . . . 1.26 107.979 159.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.597 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 36.5 p -82.96 154.2 24.63 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.946 -0.761 . . . . 1.53 108.946 175.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.561 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 9.0 p -154.63 131.45 10.78 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.947 0.403 . . . . 1.81 111.858 -175.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.57 ' HB3' ' HZ3' ' A' ' 130' ' ' LYS . 1.0 OUTLIER -131.32 120.97 23.9 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 107.632 -1.248 . . . . 2.75 107.632 175.312 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.606 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 52.5 m -66.17 101.04 0.66 Allowed 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.215 -1.402 . . . . 1.94 107.215 175.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.99 143.21 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.879 0 CA-C-N 114.568 -1.196 . . . . 1.64 109.193 -164.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -95.27 70.72 3.21 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 122.983 1.373 . . . . 2.17 110.176 -170.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.559 ' O ' ' HB3' ' A' ' 137' ' ' TYR . 1.7 p90 -97.75 177.22 1.7 Allowed Pre-proline 0 CA--C 1.554 1.129 0 CA-C-N 113.688 -1.596 . . . . 0.67 109.326 -174.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.401 ' HB2' ' OE2' ' A' ' 136' ' ' GLU . 59.9 Cg_exo -44.28 -47.71 10.47 Favored 'Trans proline' 0 CA--C 1.55 1.304 0 C-N-CA 123.752 2.968 . . . . 1.66 117.106 -175.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.404 ' HG2' ' CE2' ' A' ' 134' ' ' PHE . 2.0 mm-40 -88.71 -5.15 58.3 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 121.595 -0.691 . . . . 3.5 111.416 -172.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.559 ' HB3' ' O ' ' A' ' 134' ' ' PHE . 22.9 t80 -54.33 -45.63 99.21 Favored Pre-proline 0 C--N 1.314 -0.961 0 N-CA-C 115.384 1.624 . . . . 6.41 115.384 -177.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 137' ' ' TYR . 24.7 Cg_exo -32.54 111.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 123.874 3.049 . . . . 2.31 114.875 -175.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.586 ' HA ' ' CZ ' ' A' ' 145' ' ' ARG . 5.8 Cg_exo -79.8 -160.81 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.282 2.655 . . . . 1.27 114.056 -177.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 13.6 m -145.58 -160.85 1.2 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.284 -1.326 . . . . 1.88 108.502 -176.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 31.1 t -88.69 -41.91 12.3 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.534 -0.467 . . . . 2.43 111.048 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -70.9 -30.9 67.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.898 0.38 . . . . 2.18 111.147 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -120.32 115.02 22.73 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 121.234 0.54 . . . . 1.33 110.327 -176.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.568 HG23 ' HG2' ' A' ' 109' ' ' ARG . 3.4 tp -105.53 113.81 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 115.23 -0.896 . . . . 1.4 109.967 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.676 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 5.2 mpt_? -54.74 99.61 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.763 -1.108 . . . . 5.14 110.914 175.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -67.51 112.51 4.84 Favored Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 109.372 -1.491 . . . . 1.05 109.372 171.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.476 ' HB3' ' CB ' ' A' ' 174' ' ' GLU . 3.2 t80 -84.16 81.45 8.8 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.362 0.601 . . . . 4.68 110.515 -169.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.632 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 70.7 m-20 -70.66 99.26 1.64 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.999 -1.001 . . . . 2.29 110.191 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 172' ' ' GLN . 70.9 m-70 -69.99 146.33 95.01 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.198 -0.455 . . . . 2.95 109.911 176.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.544 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 75.5 Cg_exo -15.21 64.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.239 1 C-N-CA 127.414 5.409 . . . . 0.77 115.709 -164.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . 0.632 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 25.4 p -89.81 -174.84 4.43 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.682 -1.144 . . . . 1.97 110.36 178.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.601 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -177.8 -161.09 25.45 Favored Glycine 0 N--CA 1.435 -1.41 0 C-N-CA 120.385 -0.912 . . . . 0.55 111.77 177.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.593 ' CE1' ' HG ' ' A' ' 65' ' ' LEU . 48.1 t80 -161.72 88.92 0.72 Allowed 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.474 -0.936 . . . . 0.8 108.474 -167.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.516 ' CG2' HG11 ' A' ' 168' ' ' VAL . 2.6 m -98.63 132.53 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-O 121.65 0.738 . . . . 1.03 110.864 -173.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 125' ' ' ASN . 47.8 m -113.55 108.57 17.35 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.508 -0.769 . . . . 2.3 109.352 177.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.476 ' HB3' ' HB3' ' A' ' 166' ' ' LYS . 18.3 t -102.31 122.99 44.69 Favored Pre-proline 0 C--N 1.312 -1.058 0 CA-C-O 120.842 0.353 . . . . 1.45 111.657 -167.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -52.79 118.1 4.39 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.766 2.311 . . . . 0.72 111.666 170.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.492 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 78.1 mmm -82.96 -165.08 0.98 Allowed 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 120.977 0.417 . . . . 1.72 111.411 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -76.89 -24.79 52.53 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.741 0.782 . . . . 2.63 109.138 173.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.415 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 22.5 mm-40 -102.57 27.06 7.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.823 -1.08 . . . . 2.05 108.821 172.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -12.22 -71.32 0.01 OUTLIER Pre-proline 0 N--CA 1.479 0.987 0 N-CA-C 115.675 1.732 . . . . 2.19 115.675 -174.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -72.7 -16.27 26.72 Favored 'Trans proline' 0 C--N 1.351 0.665 0 CA-C-N 120.498 1.213 . . . . 0.86 113.596 -172.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -103.09 -29.27 11.45 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.899 0.38 . . . . 1.34 110.885 -177.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.492 ' O ' ' HB2' ' A' ' 158' ' ' MET . 82.2 m-85 -139.93 125.98 19.78 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.348 -0.612 . . . . 1.46 109.348 177.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.416 ' OG ' HD11 ' A' ' 61' ' ' LEU . 4.4 p -122.13 147.81 45.69 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.156 0.503 . . . . 2.05 110.978 -177.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.527 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.9 tppp? -91.94 104.61 17.01 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.757 0.789 . . . . 1.4 111.009 -176.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.413 HD21 ' CZ ' ' A' ' 153' ' ' PHE . 0.8 OUTLIER -89.52 109.86 20.76 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.916 -1.038 . . . . 1.07 109.039 -179.371 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.516 HG11 ' CG2' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -130.58 128.76 63.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 121.692 0.758 . . . . 1.11 111.783 177.114 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.485 ' HG2' ' N ' ' A' ' 170' ' ' PHE . 23.0 ttm -124.3 153.05 42.32 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.306 -0.861 . . . . 1.79 109.536 -176.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.549 ' O ' ' HB2' ' A' ' 151' ' ' CYS . 8.6 m-85 -133.5 139.8 46.87 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.568 -0.901 . . . . 4.22 108.568 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 11.1 p -138.02 116.77 14.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.618 0.723 . . . . 2.01 111.533 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.462 ' O ' ' HB2' ' A' ' 149' ' ' HIS . 28.8 tt0 -111.26 56.76 0.63 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.646 -0.872 . . . . 2.66 108.646 174.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 9.1 t -73.45 145.53 45.68 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.877 0.846 . . . . 2.2 111.269 -174.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.476 ' CB ' ' HB3' ' A' ' 147' ' ' TYR . 6.6 tp10 . . . . . 0 N--CA 1.445 -0.676 0 CA-C-N 114.681 -1.145 . . . . 2.45 109.947 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.529 ' HA ' ' HE2' ' A' ' 186' ' ' LYS . 13.3 mm . . . . . 0 CA--C 1.507 -0.679 0 CA-C-O 122.432 1.111 . . . . 1.69 108.991 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.666 ' HA ' ' CG2' ' A' ' 187' ' ' THR . 1.2 mp -74.49 -34.72 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 CA-C-N 113.089 -1.868 . . . . 1.77 111.334 -176.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.414 ' O ' ' HG2' ' A' ' 189' ' ' PRO . 11.1 pt-20 -67.4 -17.25 64.65 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.93 -0.767 . . . . 2.89 108.93 176.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.529 ' HE2' ' HA ' ' A' ' 183' ' ' ILE . 51.6 mtmt -91.96 -42.67 9.88 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.376 -0.829 . . . . 1.71 109.953 171.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.666 ' CG2' ' HA ' ' A' ' 184' ' ' ILE . 7.4 t -70.01 -41.04 74.87 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.192 -0.603 . . . . 1.3 112.366 -170.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' MET . . . . . 0.535 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 34.9 mmm -76.38 -55.48 1.68 Allowed Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 112.441 0.534 . . . . 1.39 112.441 -174.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.535 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 23.8 Cg_exo -65.48 -19.07 60.93 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 121.945 1.763 . . . . 1.15 112.234 -175.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 51.5 m -85.87 -42.06 14.44 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.734 -0.469 . . . . 1.95 109.734 177.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -64.16 -39.13 93.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 1.92 111.136 -175.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.504 ' HB3' ' CG1' ' A' ' 50' ' ' VAL . 30.7 mt -68.05 -44.71 75.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.627 0.251 . . . . 1.68 111.179 -176.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.526 HG11 ' CG2' ' A' ' 35' ' ' VAL . 17.9 m -74.18 -24.85 19.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 120.27 -0.572 . . . . 1.32 110.56 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -68.71 -39.18 80.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.187 -0.46 . . . . 2.6 110.445 172.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.656 ' HA ' ' ND2' ' A' ' 198' ' ' ASN . 4.9 m-85 -70.8 -20.03 62.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.132 0.491 . . . . 2.73 111.014 176.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.671 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 33.5 mt -82.62 -29.55 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 C-N-CA 119.494 -0.882 . . . . 1.11 110.496 170.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 47.2 mt -69.38 -43.74 72.91 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.518 -0.31 . . . . 1.57 110.773 178.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.656 ' ND2' ' HA ' ' A' ' 195' ' ' PHE . 13.1 p30 -60.97 -22.6 64.63 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.964 -0.562 . . . . 2.18 109.886 171.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.686 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -80.79 -43.11 20.6 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 116.51 -0.314 . . . . 1.04 110.317 177.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.671 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 12.8 mmmm -57.1 -47.05 82.01 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.659 -0.867 . . . . 1.51 108.659 172.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -71.19 -45.87 62.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.266 -1.333 . . . . 1.94 111.53 -175.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -72.02 -22.76 78.69 Favored Glycine 0 N--CA 1.463 0.442 0 C-N-CA 120.517 -0.849 . . . . 0.47 112.099 -178.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.686 ' HB ' ' O ' ' A' ' 199' ' ' ALA . 1.0 OUTLIER -82.24 -36.16 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 120.966 0.412 . . . . 1.16 110.603 175.157 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 26.5 mtpt -73.87 -28.47 61.58 Favored 'General case' 0 C--O 1.209 -1.041 0 N-CA-C 108.636 -0.876 . . . . 3.8 108.636 176.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.983 0 CA-C-N 115.505 -0.771 . . . . 1.28 109.682 169.118 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.704 ' O ' HD11 ' A' ' 6' ' ' ILE . 20.1 t70 . . . . . 0 CA--C 1.513 -0.445 0 N-CA-C 110.058 -0.349 . . . . 2.25 110.058 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.699 ' HA ' HD13 ' A' ' 6' ' ' ILE . 96.0 m-85 -67.76 -30.11 69.48 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 122.006 0.908 . . . . 0.45 108.569 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.528 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 9.2 tttm -75.68 -4.32 39.63 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.916 -1.493 . . . . 2.06 109.893 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.407 ' O ' ' HG2' ' A' ' 9' ' ' GLN . . . -92.74 -46.22 7.66 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.339 0.59 . . . . 1.2 109.686 174.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.704 HD11 ' O ' ' A' ' 2' ' ' ASP . 0.0 OUTLIER -82.34 -38.8 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-N 115.693 -0.685 . . . . 1.76 110.464 -171.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.618 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -78.04 -38.08 45.41 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.843 -1.071 . . . . 1.11 111.391 -176.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.948 HE21 ' HH ' ' A' ' 116' ' ' TYR . 21.6 mt-30 -65.68 -25.79 67.49 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.179 -0.919 . . . . 2.14 110.316 177.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.507 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 16.4 mm100 -89.71 -36.45 15.2 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.051 -0.977 . . . . 3.04 109.531 173.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.589 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -64.81 -34.47 78.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.626 -0.716 . . . . 1.1 111.259 179.031 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.528 ' HA ' ' OG ' ' A' ' 128' ' ' SER . . . -48.21 -61.07 2.17 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.703 0.763 . . . . 1.04 110.464 171.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -66.71 -17.0 64.63 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.471 -1.24 . . . . 2.31 112.025 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 35.2 mt-10 -68.73 -57.35 5.77 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 109.595 -0.521 . . . . 2.54 109.595 174.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.721 ' CG2' ' HA ' ' A' ' 151' ' ' CYS . 1.2 t -70.4 -43.38 78.26 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 CA-C-O 121.811 0.815 . . . . 1.21 110.979 -174.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.499 HD23 ' HD2' ' A' ' 19' ' ' ARG . 1.0 OUTLIER -64.48 -33.11 75.12 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.471 -1.241 . . . . 1.26 109.308 174.813 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.406 ' HA2' ' HD3' ' A' ' 19' ' ' ARG . . . -65.07 -16.41 62.03 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 114.56 -1.2 . . . . 0.57 111.281 175.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.702 ' HD2' ' HA ' ' A' ' 14' ' ' VAL . 54.8 m-85 -89.58 -25.82 21.14 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 108.234 -1.024 . . . . 3.59 108.234 174.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.438 ' OD1' ' HE3' ' A' ' 124' ' ' MET . 2.1 t-20 -68.85 -10.63 58.0 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.635 0.731 . . . . 2.1 109.093 175.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.499 ' HD2' HD23 ' A' ' 15' ' ' LEU . 11.3 mtp180 -112.19 -20.79 11.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.875 -1.057 . . . . 3.26 110.322 178.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -123.08 58.93 1.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.775 0.798 . . . . 2.16 110.702 -176.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.846 ' HB ' ' CZ2' ' A' ' 24' ' ' TRP . 0.7 OUTLIER -122.89 127.57 49.15 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.856 -0.611 . . . . 2.24 110.544 176.687 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.5 t -179.28 -33.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.508 -0.769 . . . . 2.46 110.068 -170.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.85 -17.35 76.79 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.618 -0.719 . . . . 1.45 112.916 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 1.013 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -89.81 -155.99 0.39 Allowed 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 112.563 0.579 . . . . 2.24 112.563 179.324 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.501 ' HE3' ' HA ' ' A' ' 25' ' ' LYS . 0.8 OUTLIER -171.68 134.79 0.84 Allowed 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 115.204 -0.907 . . . . 3.43 109.465 -164.671 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.679 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 5.2 m -66.0 122.05 16.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 122.062 0.934 . . . . 2.21 111.486 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.482 HG23 ' HE2' ' A' ' 48' ' ' TYR . 30.1 m -95.76 -23.19 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-N 113.906 -1.497 . . . . 1.83 108.517 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.479 ' HD2' ' HA ' ' A' ' 28' ' ' LYS . 15.1 tptm -161.98 131.25 4.47 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 120.251 -0.579 . . . . 2.87 111.185 -176.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.756 HG22 ' HA ' ' A' ' 34' ' ' THR . 77.4 p -131.81 152.18 51.16 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.224 -0.444 . . . . 1.92 109.827 172.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.516 ' HB3' HG12 ' A' ' 33' ' ' ILE . 22.9 t -111.67 -138.98 0.38 Allowed 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.268 -0.641 . . . . 2.37 109.268 177.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -103.62 18.13 22.56 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 122.451 -0.155 . . . . 4.84 110.835 -178.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.3 tptt -175.12 2.98 0.01 OUTLIER 'General case' 0 C--O 1.237 0.422 0 N-CA-C 112.098 0.407 . . . . 2.05 112.098 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.89 HG21 ' HA3' ' A' ' 52' ' ' GLY . 38.1 pt -139.3 166.34 21.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 120.783 0.325 . . . . 1.42 111.376 -175.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.756 ' HA ' HG22 ' A' ' 29' ' ' THR . 24.1 m -152.02 112.38 4.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.425 -0.807 . . . . 1.22 110.685 -165.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.891 HG21 HG12 ' A' ' 50' ' ' VAL . 2.3 t -107.16 103.89 16.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.842 0.353 . . . . 1.52 110.242 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.679 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 4.3 p -102.5 127.58 49.49 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 122.957 0.503 . . . . 1.74 110.273 179.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 6.9 t -120.53 135.71 55.0 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.402 0.62 . . . . 1.72 112.152 -172.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 1.013 ' HB3' ' HB3' ' A' ' 24' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 114.77 -1.105 . . . . 2.45 109.632 175.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 121.413 0.625 . . . . 2.45 111.445 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.675 HD21 ' N ' ' A' ' 48' ' ' TYR . 5.2 tt -83.7 150.8 25.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.726 -1.125 . . . . 1.49 108.565 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.675 ' N ' HD21 ' A' ' 47' ' ' LEU . 70.9 m-85 -120.31 131.88 55.07 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.931 0.395 . . . . 1.52 110.941 -174.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.508 ' HG2' ' CE2' ' A' ' 170' ' ' PHE . 0.6 OUTLIER -112.44 115.45 28.7 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.266 -1.012 . . . . 3.34 108.266 173.22 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.891 HG12 HG21 ' A' ' 35' ' ' VAL . 2.0 m -101.49 150.35 6.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 120.407 -0.517 . . . . 1.98 110.477 173.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.631 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 45.7 tt0 -151.15 109.38 3.75 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.986 -1.006 . . . . 1.07 109.49 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.89 ' HA3' HG21 ' A' ' 33' ' ' ILE . . . -139.99 143.16 13.34 Favored Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 110.909 -0.876 . . . . 0.35 110.909 178.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.0 mt -88.62 125.3 41.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 C-N-CA 119.574 -0.85 . . . . 1.3 111.051 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.48 HG12 ' HD3' ' A' ' 200' ' ' LYS . 45.4 mt -106.04 99.1 21.13 Favored Pre-proline 0 N--CA 1.442 -0.871 0 N-CA-C 108.046 -1.094 . . . . 1.07 108.046 173.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.759 ' HA ' ' HA ' ' A' ' 164' ' ' TYR . 38.3 Cg_endo -65.14 49.89 0.2 Allowed 'Trans proline' 0 N--CA 1.479 0.67 1 C-N-CA 125.506 4.137 . . . . 0.74 115.406 -170.358 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.451 ' OE2' HG22 ' A' ' 54' ' ' ILE . 2.2 pm0 -139.34 -153.67 0.48 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.065 -0.717 . . . . 1.68 109.065 165.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.454 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 44.0 t -92.28 140.78 24.43 Favored Pre-proline 0 N--CA 1.422 -1.826 0 CA-C-O 122.006 0.908 . . . . 1.58 111.141 -174.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.889 ' HG3' ' HG ' ' A' ' 165' ' ' SER . 31.1 Cg_exo -57.36 -14.84 17.11 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 124.201 3.267 . . . . 0.74 110.306 174.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 63' ' ' ASP . . . -69.55 -47.34 63.99 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.939 -1.028 . . . . 1.31 111.134 174.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.961 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -66.54 -35.48 80.33 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.082 -1.081 . . . . 3.78 108.082 178.263 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 1.019 HD23 HD12 ' A' ' 203' ' ' ILE . 37.1 mt -60.72 -55.44 33.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.87 -1.059 . . . . 1.09 110.833 177.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.451 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 42.5 t -67.36 -10.27 49.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.68 0.276 . . . . 1.94 110.734 177.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.535 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -85.83 -45.72 11.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.475 -0.33 . . . . 1.32 111.158 -178.631 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.475 ' O ' ' HB3' ' A' ' 71' ' ' ARG . 11.3 p90 -77.78 -43.36 30.91 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.662 -0.245 . . . . 0.79 111.574 -172.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.451 ' CD2' ' HA ' ' A' ' 62' ' ' SER . 1.0 OUTLIER -75.31 -8.94 58.01 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 122.187 -0.321 . . . . 2.15 111.484 -169.406 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.516 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 26.2 t80 -26.4 -56.7 0.08 Allowed 'General case' 0 N--CA 1.462 0.151 0 O-C-N 125.431 1.707 . . . . 2.06 114.11 -163.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.516 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 8.5 tt0 166.02 -38.62 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.595 0.712 . . . . 4.31 110.861 -175.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.9 t -165.55 19.84 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.253 -0.885 . . . . 1.89 110.155 -164.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 70' ' ' ASP . . . -78.01 -34.68 37.11 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.252 -0.975 . . . . 1.71 111.702 -173.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.622 ' O ' HG23 ' A' ' 73' ' ' THR . 16.4 p-10 166.63 -17.7 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.12 -1.04 . . . . 2.19 108.549 -167.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.847 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -45.57 -38.21 6.25 Favored 'General case' 0 C--O 1.209 -1.034 0 CA-C-N 115.324 -0.853 . . . . 3.95 111.755 176.021 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.596 HG21 HD12 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -89.87 -7.47 10.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 120.383 -0.527 . . . . 1.42 111.386 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.622 HG23 ' O ' ' A' ' 70' ' ' ASP . 0.8 OUTLIER -92.41 -27.77 17.28 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 120.395 -0.522 . . . . 1.45 110.618 -173.352 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.805 ' HZ3' ' HB2' ' A' ' 198' ' ' ASN . 11.9 p-90 -112.79 -3.06 14.26 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.795 -0.362 . . . . 0.78 111.699 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.847 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 4.1 t70 -70.18 175.66 4.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 122.335 1.064 . . . . 2.19 112.231 -172.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.839 ' HD2' ' HB3' ' A' ' 198' ' ' ASN . 0.0 OUTLIER -118.37 -12.8 9.84 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.8 -1.545 . . . . 3.68 110.195 -174.166 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.52 ' HA ' ' HB2' ' A' ' 99' ' ' GLN . 0.1 OUTLIER -130.31 2.81 4.67 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.198 -0.91 . . . . 2.08 109.921 178.094 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.758 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 62.1 mt -109.15 149.82 28.78 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.057 -0.52 . . . . 1.16 110.834 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.569 ' HG2' ' HG2' ' A' ' 99' ' ' GLN . 15.0 mm100 -132.56 -59.02 0.92 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.465 -0.789 . . . . 2.23 111.288 -175.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.722 ' HB ' HD11 ' A' ' 97' ' ' ILE . 18.1 t -140.7 125.44 18.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.521 -0.763 . . . . 1.44 110.633 -165.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.444 ' CD2' HD13 ' A' ' 72' ' ' ILE . 50.4 p90 -94.88 153.53 17.66 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.601 -0.727 . . . . 5.73 110.44 174.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.478 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 1.2 m120 -152.82 109.37 3.42 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.718 -0.475 . . . . 1.86 109.718 167.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.5 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 3.3 ttt -75.03 94.87 2.93 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.266 -1.013 . . . . 2.52 108.266 178.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -74.66 -73.03 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-O 121.215 0.531 . . . . 1.19 111.258 -166.683 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -136.34 120.6 17.91 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.783 -0.644 . . . . 2.59 109.592 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.853 ' HG2' ' HD2' ' A' ' 92' ' ' PHE . 38.6 mtm180 -97.15 123.19 40.84 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.453 -0.794 . . . . 2.83 109.684 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.644 HG21 ' HB2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -82.37 -40.73 17.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.833 -0.621 . . . . 1.17 109.819 -174.123 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' A' ' 89' ' ' SER . 9.3 t70 -147.88 -161.92 1.44 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.384 -0.969 . . . . 1.86 108.384 177.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.437 ' H ' ' CG ' ' A' ' 88' ' ' ASP . 20.2 m -83.08 -7.78 59.61 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.739 0.304 . . . . 1.94 110.81 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -137.65 15.99 2.91 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.26 0.553 . . . . 1.87 110.258 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.698 HG21 ' HD2' ' A' ' 116' ' ' TYR . 0.7 OUTLIER -134.37 109.92 9.11 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 107.916 -1.142 . . . . 1.12 107.916 -179.287 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.853 ' HD2' ' HG2' ' A' ' 86' ' ' ARG . 5.1 m-85 -132.14 178.9 6.44 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.316 0.579 . . . . 0.52 110.797 -174.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.611 ' O ' HG23 ' A' ' 84' ' ' VAL . 19.3 mt -138.3 130.4 38.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 106.966 -1.494 . . . . 1.1 106.966 169.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 48.0 t -116.0 122.13 44.32 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.621 -0.432 . . . . 2.61 110.92 -172.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.535 ' HA ' HD13 ' A' ' 112' ' ' ILE . 10.5 t60 -85.95 83.98 7.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.862 0.839 . . . . 2.17 109.175 173.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.773 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 18.9 m -90.69 118.07 29.83 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.485 -1.234 . . . . 1.19 111.442 -176.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.722 HD11 ' HB ' ' A' ' 80' ' ' VAL . 3.5 mp -91.58 123.37 43.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.758 -0.831 . . . . 1.63 108.758 170.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 109' ' ' ARG . 15.2 t -110.29 171.41 7.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.061 -0.518 . . . . 1.72 110.978 -174.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.569 ' HG2' ' HG2' ' A' ' 79' ' ' GLN . 4.7 mm100 . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 115.107 -0.951 . . . . 2.29 111.897 -172.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.405 HD12 ' HB ' ' A' ' 187' ' ' THR . 64.2 mt . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 121.2 0.524 . . . . 1.53 110.964 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.478 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.3 p -100.66 176.33 1.96 Allowed Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.205 -0.907 . . . . 1.71 109.965 177.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 87.9 Cg_exo -47.55 109.9 0.26 Allowed 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 122.306 2.004 . . . . 1.31 111.135 174.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.63 ' HG3' HG21 ' A' ' 144' ' ' ILE . 18.4 ttm180 -111.06 151.69 27.77 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.168 -0.469 . . . . 4.06 111.134 -167.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.839 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 6.5 t70 -99.28 134.06 42.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.761 -0.654 . . . . 1.37 110.847 -176.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.773 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 17.8 m-85 -118.21 114.71 23.43 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.81 -0.632 . . . . 3.01 110.143 173.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.535 HD13 ' HA ' ' A' ' 95' ' ' HIS . 26.2 mm -108.95 76.24 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.722 -0.844 . . . . 1.2 108.722 170.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.754 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 1.6 m-20 -95.48 119.89 34.77 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.847 -0.615 . . . . 1.86 110.306 -178.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.653 ' O ' ' HA ' ' A' ' 129' ' ' SER . 3.9 tp -75.36 121.79 22.79 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 108.672 -0.862 . . . . 1.08 108.672 170.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -126.6 123.97 64.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-N 115.296 -0.865 . . . . 1.08 111.732 -164.14 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.948 ' HH ' HE21 ' A' ' 8' ' ' GLN . 24.1 t80 -105.95 111.91 24.75 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.786 -1.097 . . . . 2.81 110.023 175.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.921 HG12 HG21 ' A' ' 127' ' ' ILE . 73.2 mt -92.9 99.15 9.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.039 -0.528 . . . . 1.53 109.608 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.689 ' HB2' ' HE1' ' A' ' 116' ' ' TYR . 36.7 ttpt -124.35 138.17 54.4 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.989 -0.55 . . . . 1.81 110.546 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 119' ' ' ARG . 0.1 OUTLIER -116.09 111.95 21.03 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-O 122.117 0.961 . . . . 3.22 109.697 177.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.577 ' HB2' ' HB3' ' A' ' 123' ' ' ASN . 18.2 m-85 -68.05 104.0 1.65 Allowed 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 105.523 -2.028 . . . . 1.28 105.523 163.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -53.17 98.29 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 122.262 1.029 . . . . 2.28 113.023 -168.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 84.91 23.09 50.92 Favored Glycine 0 CA--C 1.504 -0.632 0 CA-C-N 113.483 -1.689 . . . . 0.79 111.785 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.577 ' HB3' ' HB2' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -127.33 -50.74 1.41 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.63 -0.785 . . . . 2.06 109.213 179.081 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.481 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 0.9 OUTLIER -161.47 143.06 11.54 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.138 -0.483 . . . . 1.73 111.282 -177.272 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -116.62 84.41 2.13 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.471 -0.937 . . . . 2.07 108.471 169.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.615 ' CG1' HG11 ' A' ' 154' ' ' VAL . 0.7 OUTLIER -102.26 135.0 41.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 112.951 0.722 . . . . 1.06 112.951 -172.141 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.921 HG21 HG12 ' A' ' 117' ' ' ILE . 31.7 pt -100.15 107.34 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.914 0.864 . . . . 1.26 109.023 164.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.528 ' OG ' ' HA ' ' A' ' 11' ' ' ALA . 1.2 m -88.38 109.38 19.95 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.453 -0.794 . . . . 1.53 110.638 -178.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.754 ' HB3' ' HB3' ' A' ' 113' ' ' ASP . 12.8 m -114.74 145.16 42.39 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.248 0.547 . . . . 1.81 111.733 -170.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.644 ' HB3' ' HZ1' ' A' ' 130' ' ' LYS . 3.2 mtpm? -137.66 121.78 17.94 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 107.387 -1.338 . . . . 2.75 107.387 174.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 78.9 p -64.04 98.4 0.21 Allowed 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.11 -1.441 . . . . 1.94 107.11 175.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.457 HG12 ' HB3' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -109.03 140.21 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.836 0 N-CA-C 108.731 -0.84 . . . . 1.64 108.731 -165.488 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -102.68 86.89 2.85 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 122.459 1.124 . . . . 2.17 109.245 -174.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.747 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 1.3 p90 -117.33 154.5 50.31 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 114.012 -1.449 . . . . 0.67 111.526 -166.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 3.2 Cg_exo -42.09 -47.0 7.01 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 124.77 3.646 . . . . 1.66 115.883 -174.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.747 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 7.3 tp10 -65.64 -25.55 67.41 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 120.731 0.301 . . . . 3.5 110.749 -163.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.542 ' HB2' HG12 ' A' ' 84' ' ' VAL . 10.1 t80 -150.26 101.77 3.15 Favored Pre-proline 0 N--CA 1.441 -0.908 0 N-CA-C 113.237 0.829 . . . . 6.41 113.237 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -88.94 134.4 2.63 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.261 2.641 . . . . 2.31 109.746 163.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.5 -171.92 0.41 Allowed 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.439 2.093 . . . . 1.27 112.424 -176.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 62.2 p -133.22 -179.7 5.66 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 109.356 -0.609 . . . . 1.88 109.356 -172.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.2 m -86.21 11.38 12.12 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.125 0.488 . . . . 2.43 110.658 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -120.14 -44.74 2.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.781 -0.645 . . . . 2.18 109.773 173.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.839 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 85.0 m-85 -94.28 109.71 21.51 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.193 -0.669 . . . . 1.33 109.193 175.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.63 HG21 ' HG3' ' A' ' 109' ' ' ARG . 1.0 OUTLIER -95.11 107.69 19.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.783 -0.644 . . . . 1.4 110.177 -175.391 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 2.7 ttp180 -56.84 99.88 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.407 -0.815 . . . . 5.14 109.803 175.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -66.23 128.87 31.25 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.097 -0.801 . . . . 1.05 111.097 179.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.65 ' HB3' ' HB3' ' A' ' 174' ' ' GLU . 65.0 t80 -84.84 86.84 7.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.524 0.678 . . . . 4.68 110.989 -175.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 53.1 t30 -82.06 116.18 21.53 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.153 -0.93 . . . . 2.29 109.361 171.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.733 ' HB3' ' HB3' ' A' ' 172' ' ' GLN . 57.6 t-80 -58.19 154.72 29.43 Favored Pre-proline 0 C--O 1.217 -0.614 0 CA-C-O 118.142 -0.932 . . . . 2.95 108.656 173.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.612 ' HD2' ' CD2' ' A' ' 149' ' ' HIS . 60.9 Cg_exo -37.74 78.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 123.916 3.077 . . . . 0.77 112.618 169.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . 0.721 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 72.7 m -135.1 149.49 50.06 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.973 -1.467 . . . . 1.97 107.904 -176.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.607 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -138.76 -147.0 5.07 Favored Glycine 0 N--CA 1.432 -1.623 0 C-N-CA 119.051 -1.547 . . . . 0.55 113.038 -170.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.655 ' HE1' HD22 ' A' ' 167' ' ' LEU . 7.5 t80 -160.74 82.72 0.66 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.915 -1.513 . . . . 0.8 106.915 -167.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.615 HG11 ' CG1' ' A' ' 126' ' ' ILE . 4.1 m -93.27 140.98 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 CA-C-O 122.044 0.926 . . . . 1.03 110.597 -172.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . 0.658 ' SG ' ' HB3' ' A' ' 58' ' ' PRO . 1.6 t -117.09 126.44 52.84 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 114.731 -1.122 . . . . 2.3 109.077 177.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.725 ' HB3' ' HB3' ' A' ' 166' ' ' LYS . 11.2 t -120.48 121.16 29.38 Favored Pre-proline 0 C--N 1.31 -1.138 0 C-N-CA 120.146 -0.622 . . . . 1.45 111.669 -172.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 67.8 Cg_exo -50.38 108.65 0.23 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.035 1.823 . . . . 0.72 110.373 166.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.718 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 54.0 mmm -72.06 -165.74 0.19 Allowed 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.67 0.747 . . . . 1.72 112.175 -174.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -67.25 -24.28 65.79 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.903 -1.044 . . . . 2.63 110.177 177.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.52 ' HB3' ' HB2' ' A' ' 163' ' ' ALA . 54.5 mm-40 -108.05 14.05 25.51 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.754 -0.657 . . . . 2.05 110.085 177.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.657 ' HB3' ' CD ' ' A' ' 162' ' ' PRO . 47.0 t-20 29.25 -89.84 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 125.684 1.594 . . . . 2.19 114.762 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.657 ' CD ' ' HB3' ' A' ' 161' ' ' ASN . 72.0 Cg_endo -74.42 -13.76 22.76 Favored 'Trans proline' 0 C--N 1.367 1.528 0 CA-C-N 121.854 1.698 . . . . 0.86 113.093 -175.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.52 ' HB2' ' HB3' ' A' ' 160' ' ' GLU . . . -91.76 -29.94 16.52 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.864 -0.607 . . . . 1.34 110.679 -177.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.759 ' HA ' ' HA ' ' A' ' 55' ' ' PRO . 85.3 m-85 -143.65 124.78 14.48 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.398 -0.593 . . . . 1.46 109.398 176.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.889 ' HG ' ' HG3' ' A' ' 58' ' ' PRO . 21.4 t -112.87 145.52 40.54 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 119.905 -0.718 . . . . 2.05 110.593 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.749 ' HG3' HG12 ' A' ' 168' ' ' VAL . 2.5 tppp? -94.01 112.59 24.44 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.519 0.676 . . . . 1.4 111.266 -176.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.655 HD22 ' HE1' ' A' ' 153' ' ' PHE . 0.6 OUTLIER -95.54 104.35 16.26 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.283 -0.871 . . . . 1.07 109.37 173.905 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.749 HG12 ' HG3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -125.4 134.54 66.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.223 0.535 . . . . 1.11 110.603 176.673 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.611 ' HB3' HG22 ' A' ' 50' ' ' VAL . 20.7 ttt -140.85 143.24 34.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.164 -0.471 . . . . 1.79 110.219 -169.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.702 ' O ' ' HB3' ' A' ' 151' ' ' CYS . 34.0 m-85 -120.42 139.13 53.28 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.057 -0.72 . . . . 4.22 109.057 177.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.494 ' HB ' HD23 ' A' ' 192' ' ' LEU . 0.9 OUTLIER -143.42 125.62 12.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 O-C-N 123.492 0.495 . . . . 2.01 111.286 178.551 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.733 ' HB3' ' HB3' ' A' ' 149' ' ' HIS . 20.3 tt0 -124.73 51.46 1.63 Allowed 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 107.158 -1.423 . . . . 2.66 107.158 171.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.516 ' HB ' ' SD ' ' A' ' 188' ' ' MET . 7.4 m -75.36 127.55 33.39 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.806 -1.543 . . . . 2.2 110.542 -175.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.65 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 28.6 tt0 . . . . . 0 C--N 1.323 -0.566 0 CA-C-N 115.491 -0.777 . . . . 2.45 111.554 -173.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.494 ' HA ' ' CE ' ' A' ' 186' ' ' LYS . 9.1 mm . . . . . 0 CA--C 1.502 -0.878 0 CA-C-O 122.802 1.287 . . . . 1.69 108.401 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.682 ' HA ' HG22 ' A' ' 187' ' ' THR . 0.9 OUTLIER -79.93 -34.33 15.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 112.541 -2.118 . . . . 1.77 109.924 -175.773 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -66.49 -18.6 65.45 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.935 -1.029 . . . . 2.89 109.584 172.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.494 ' CE ' ' HA ' ' A' ' 183' ' ' ILE . 53.0 mtmt -93.0 -44.61 8.33 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.413 -0.812 . . . . 1.71 110.79 174.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.682 HG22 ' HA ' ' A' ' 184' ' ' ILE . 14.3 t -66.09 -43.0 88.55 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.612 0.597 . . . . 1.3 112.612 -170.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' MET . . . . . 0.611 ' HE1' ' HA ' ' A' ' 188' ' ' MET . 29.1 mmt -73.68 -57.31 2.6 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 112.713 0.634 . . . . 1.39 112.713 -172.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.635 ' O ' HG11 ' A' ' 193' ' ' VAL . 27.3 Cg_endo -62.18 -30.48 82.01 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 121.616 1.544 . . . . 1.15 112.119 -177.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.2 t -75.99 -33.12 59.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.237 0.541 . . . . 1.95 109.824 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 187' ' ' THR . 63.9 t30 -73.0 -44.24 61.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.678 -0.692 . . . . 1.92 111.274 -174.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.573 ' HB3' HG21 ' A' ' 50' ' ' VAL . 18.5 mt -65.23 -42.62 93.24 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.754 0.311 . . . . 1.68 111.333 -175.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.635 HG11 ' O ' ' A' ' 189' ' ' PRO . 1.5 m -67.45 -31.89 54.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.908 0.861 . . . . 1.32 109.354 178.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.412 ' HB3' ' HE3' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -70.08 -34.68 73.47 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.284 -1.325 . . . . 2.6 110.997 177.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.622 ' HA ' ' ND2' ' A' ' 198' ' ' ASN . 3.3 m-85 -71.69 -24.53 61.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.24 0.543 . . . . 2.73 110.433 174.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.654 HG12 HD13 ' A' ' 167' ' ' LEU . 59.2 mt -82.08 -29.44 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-O 121.31 0.576 . . . . 1.11 110.511 172.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.477 HD22 ' HA ' ' A' ' 197' ' ' LEU . 44.6 mt -72.21 -42.6 65.57 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 116.16 -0.473 . . . . 1.57 110.736 177.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.839 ' HB3' ' HD2' ' A' ' 76' ' ' LYS . 5.9 p30 -59.55 -24.0 63.33 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 108.96 -0.755 . . . . 2.18 108.96 171.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.651 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -80.94 -44.83 17.63 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 120.415 -0.514 . . . . 1.04 110.222 176.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.48 ' HD3' HG12 ' A' ' 54' ' ' ILE . 22.5 mmtp -54.8 -42.89 72.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.02 -0.537 . . . . 1.51 110.856 175.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . 0.533 ' O ' ' HD3' ' A' ' 204' ' ' LYS . 9.9 t70 -87.88 -46.26 9.56 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.007 -0.542 . . . . 1.94 110.327 -178.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . 0.696 ' HA2' ' HB1' ' A' ' 205' ' ' ALA . . . -61.19 -25.9 65.22 Favored Glycine 0 C--O 1.224 -0.508 0 CA-C-N 115.849 -0.614 . . . . 0.47 112.277 -178.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 1.019 HD12 HD23 ' A' ' 61' ' ' LEU . 3.0 tp -67.89 -43.07 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-O 119.27 -0.395 . . . . 1.16 111.239 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.533 ' HD3' ' O ' ' A' ' 201' ' ' ASP . 0.0 OUTLIER -91.25 -13.54 32.56 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 118.732 0.696 . . . . 3.8 109.228 176.532 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.696 ' HB1' ' HA2' ' A' ' 202' ' ' GLY . . . . . . . . 0 C--N 1.314 -0.95 0 N-CA-C 108.532 -0.914 . . . . 1.28 108.532 164.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.1 t70 . . . . . 0 CA--C 1.504 -0.826 0 N-CA-C 109.288 -0.634 . . . . 2.25 109.288 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.666 ' HA ' HD12 ' A' ' 6' ' ' ILE . 96.6 m-85 -65.65 -37.03 85.4 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.191 -0.913 . . . . 0.45 109.186 -175.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.639 ' HG2' ' HG3' ' A' ' 8' ' ' GLN . 4.4 ttmt -81.75 2.94 27.62 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.121 -0.945 . . . . 2.06 110.476 -176.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -92.87 -49.42 6.06 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.359 0.599 . . . . 1.2 109.485 173.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.666 HD12 ' HA ' ' A' ' 3' ' ' PHE . 0.3 OUTLIER -83.8 -37.68 13.42 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.606 0 CA-C-N 115.354 -0.839 . . . . 1.76 110.181 -173.091 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.608 ' HB3' ' HB2' ' A' ' 116' ' ' TYR . . . -71.5 -44.1 65.32 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.587 0.708 . . . . 1.11 111.531 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.639 ' HG3' ' HG2' ' A' ' 4' ' ' LYS . 11.1 mt-30 -60.13 -32.83 71.38 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.917 -1.038 . . . . 2.14 110.516 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.557 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 25.6 mm-40 -85.75 -32.06 22.06 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.221 -0.899 . . . . 3.04 109.266 175.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.672 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.6 OUTLIER -62.26 -39.5 93.09 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.927 -1.033 . . . . 1.1 111.042 176.513 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.42 ' HA ' ' CB ' ' A' ' 128' ' ' SER . . . -47.43 -63.04 1.15 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 121.148 0.499 . . . . 1.04 111.529 173.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -71.57 -13.0 61.65 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.851 -0.613 . . . . 2.31 111.831 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.557 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 44.9 mm-40 -69.6 -58.12 4.34 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.764 0.792 . . . . 2.54 109.298 173.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.821 HG21 ' N ' ' A' ' 152' ' ' GLY . 5.3 p -68.01 -40.13 82.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 114.648 -1.16 . . . . 1.21 109.717 -177.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.556 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -68.14 -22.83 64.84 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 114.787 -1.097 . . . . 1.26 109.08 176.342 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.73 ' HA2' ' HD3' ' A' ' 19' ' ' ARG . . . -63.28 -25.34 68.29 Favored Glycine 0 CA--C 1.5 -0.847 0 CA-C-N 114.474 -1.239 . . . . 0.57 110.444 177.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -88.83 -12.25 42.48 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.699 -0.852 . . . . 3.59 108.699 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -83.96 -9.27 58.81 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.321 -0.854 . . . . 2.1 110.027 172.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.73 ' HD3' ' HA2' ' A' ' 16' ' ' GLY . 48.4 mtp180 -106.85 -23.89 12.23 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 116.183 -0.462 . . . . 3.26 110.884 -172.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -150.88 170.77 18.5 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.038 -0.528 . . . . 2.16 110.513 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.505 HG22 ' CZ2' ' A' ' 24' ' ' TRP . 75.1 p -133.51 134.02 42.91 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.57 -0.741 . . . . 2.24 109.792 -175.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.4 t -139.25 107.5 5.78 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.263 0.468 . . . . 2.46 112.263 -170.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.82 34.13 81.25 Favored Glycine 0 C--N 1.331 0.282 0 CA-C-N 115.528 -0.76 . . . . 1.45 114.405 168.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.906 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -121.29 -166.31 1.34 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 117.183 0.491 . . . . 2.24 110.273 175.141 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.61 140.38 0.6 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.392 -0.822 . . . . 3.43 109.225 -175.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.662 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 0.1 OUTLIER -60.33 117.08 2.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.457 -0.792 . . . . 2.21 110.378 174.01 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.9 p -92.05 -25.96 5.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 114.727 -1.124 . . . . 1.83 109.295 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.464 ' O ' HG22 ' A' ' 35' ' ' VAL . 3.0 tmmm? -161.24 146.63 14.01 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 119.264 -0.974 . . . . 2.87 112.274 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.863 HG22 ' HA ' ' A' ' 34' ' ' THR . 42.9 p -143.67 152.27 41.12 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.798 -0.637 . . . . 1.92 109.722 176.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.9 m -102.38 -90.01 0.36 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.523 -0.308 . . . . 2.37 110.631 176.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.481 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 82.0 tttt -155.28 31.65 0.38 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.122 0.487 . . . . 4.84 110.502 175.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.49 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 6.1 mmtm 178.9 -20.47 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.4 -0.818 . . . . 2.05 110.039 179.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.482 ' CD1' ' HB ' ' A' ' 193' ' ' VAL . 31.0 pt -115.45 160.85 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.353 -0.839 . . . . 1.42 110.701 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.863 ' HA ' HG22 ' A' ' 29' ' ' THR . 52.5 m -155.15 110.09 3.01 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.314 -0.857 . . . . 1.22 110.697 -163.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.733 ' HA ' ' O ' ' A' ' 49' ' ' ARG . 6.0 m -103.12 117.83 49.15 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 CA-C-O 121.023 0.44 . . . . 1.52 111.824 176.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.662 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 7.2 m -105.78 124.69 49.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.658 -0.701 . . . . 1.74 109.655 175.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.8 p -110.75 133.85 52.98 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.759 -0.655 . . . . 1.72 111.868 -172.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.906 ' HB3' ' HB3' ' A' ' 24' ' ' TRP . 23.0 pttt . . . . . 0 C--N 1.32 -0.696 0 CA-C-N 115.546 -0.752 . . . . 2.45 109.26 171.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.463 HD22 ' HH ' ' A' ' 48' ' ' TYR . 23.2 p-10 . . . . . 0 N--CA 1.451 -0.422 0 CA-C-O 121.531 0.681 . . . . 2.45 111.212 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.587 HD23 ' N ' ' A' ' 48' ' ' TYR . 3.5 tt -99.97 146.18 27.0 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.724 -1.125 . . . . 1.49 108.673 -176.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.62 ' HB2' HD12 ' A' ' 192' ' ' LEU . 56.9 m-85 -124.99 138.39 54.23 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 121.261 -0.176 . . . . 1.52 110.623 -177.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.733 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 4.3 ttm180 -104.65 120.0 40.29 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.093 -0.706 . . . . 3.34 109.093 167.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.658 ' HB ' ' HB3' ' A' ' 192' ' ' LEU . 9.0 p -102.93 134.73 43.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.004 -1.11 . . . . 1.98 108.004 172.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.618 ' HG3' ' HB ' ' A' ' 168' ' ' VAL . 2.7 tt0 -148.02 110.65 4.72 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.058 -0.519 . . . . 1.07 110.579 -165.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 32' ' ' LYS . . . -142.61 154.34 25.13 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 111.111 -0.796 . . . . 0.35 111.111 179.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.612 HD11 ' HZ2' ' A' ' 166' ' ' LYS . 2.7 mp -96.33 126.98 48.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 C-N-CA 119.256 -0.977 . . . . 1.3 110.393 176.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.493 ' CD1' ' HB1' ' A' ' 199' ' ' ALA . 66.2 mt -104.57 112.77 65.41 Favored Pre-proline 0 N--CA 1.44 -0.959 0 CA-C-N 114.937 -1.029 . . . . 1.07 109.33 177.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 28.8 Cg_exo -64.56 59.87 0.27 Allowed 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 124.259 3.306 . . . . 0.74 113.111 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.939 ' HG3' HG13 ' A' ' 203' ' ' ILE . 0.2 OUTLIER -134.37 -164.31 1.49 Allowed 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.041 -1.466 . . . . 1.68 107.041 174.075 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.561 ' H ' ' CD ' ' A' ' 56' ' ' GLU . 20.0 m -101.73 150.5 37.38 Favored Pre-proline 0 N--CA 1.421 -1.889 0 N-CA-C 108.816 -0.809 . . . . 1.58 108.816 169.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.55 ' HA ' HD13 ' A' ' 61' ' ' LEU . 14.9 Cg_exo -66.63 -7.72 18.92 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.605 2.87 . . . . 0.74 110.2 -178.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.68 -53.09 17.06 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.803 -1.09 . . . . 1.31 111.411 175.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.671 ' HE3' ' HB3' ' A' ' 64' ' ' PHE . 16.2 tptt -69.21 -28.29 66.24 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.254 -1.017 . . . . 3.78 108.254 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.681 ' O ' HD22 ' A' ' 65' ' ' LEU . 63.9 mt -62.45 -51.67 66.59 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.825 -1.08 . . . . 1.09 110.008 174.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.567 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 39.3 t -75.35 -4.96 42.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.735 0.302 . . . . 1.94 110.571 176.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.506 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 31.3 t70 -90.63 -43.06 10.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.313 -0.403 . . . . 1.32 110.829 178.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.794 ' O ' ' HB3' ' A' ' 71' ' ' ARG . 8.1 p90 -76.49 -44.97 33.02 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.903 -0.319 . . . . 0.79 111.146 -175.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.681 HD22 ' O ' ' A' ' 61' ' ' LEU . 1.2 pt? -77.64 6.2 7.73 Favored 'General case' 0 CA--C 1.509 -0.604 0 O-C-N 122.277 -0.264 . . . . 2.15 111.227 -164.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -46.77 -14.53 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.961 0 O-C-N 124.326 1.016 . . . . 2.06 113.074 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.627 ' HA ' ' HD2' ' A' ' 71' ' ' ARG . 0.4 OUTLIER 87.68 -38.18 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 124.73 1.212 . . . . 4.31 110.509 168.305 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.606 ' OG1' ' HB2' ' A' ' 81' ' ' TYR . 15.0 t -138.2 23.8 2.77 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.793 0.806 . . . . 1.89 110.811 -177.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -108.06 -61.29 0.55 Allowed Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 119.616 -1.278 . . . . 1.71 112.912 -177.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.679 ' O ' HG22 ' A' ' 73' ' ' THR . 18.9 t70 -134.05 -25.19 1.61 Allowed 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.881 0.848 . . . . 2.19 110.009 -169.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.794 ' HB3' ' O ' ' A' ' 64' ' ' PHE . 0.3 OUTLIER -69.0 -37.22 78.57 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 114.724 -1.125 . . . . 3.95 109.658 -163.385 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 1.101 HG22 HD13 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -76.11 -21.5 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 115.277 -0.874 . . . . 1.42 110.066 -176.223 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.679 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.2 t -81.02 -26.22 36.59 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 119.972 -0.691 . . . . 1.45 109.986 -172.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.705 ' CE2' ' HA ' ' A' ' 71' ' ' ARG . 24.8 p-90 -110.4 0.02 17.72 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.12 -0.491 . . . . 0.78 111.373 177.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.622 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 2.3 t70 -66.83 176.13 2.16 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.82 0.819 . . . . 2.19 112.527 -170.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.457 ' HD3' ' N ' ' A' ' 77' ' ' SER . 0.0 OUTLIER -129.19 -17.3 3.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.555 -1.202 . . . . 3.68 111.507 -174.636 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.457 ' N ' ' HD3' ' A' ' 76' ' ' LYS . 67.9 m -130.32 24.6 5.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.658 0.742 . . . . 2.08 109.372 178.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 1.101 HD13 HG22 ' A' ' 72' ' ' ILE . 18.9 mt -116.01 -167.21 1.23 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.301 -0.863 . . . . 1.16 112.293 177.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.462 ' HB3' HG22 ' A' ' 80' ' ' VAL . 1.9 mm100 -161.63 -74.79 0.05 Allowed 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.637 -0.71 . . . . 2.23 112.205 -167.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' A' ' 79' ' ' GLN . 23.0 t -139.4 122.09 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.917 0.389 . . . . 1.44 111.764 -167.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.606 ' HB2' ' OG1' ' A' ' 68' ' ' THR . 23.1 p90 -96.53 154.08 17.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.056 -0.52 . . . . 5.73 112.009 176.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.464 ' HB2' ' HD1' ' A' ' 95' ' ' HIS . 11.7 m-20 -162.08 111.29 1.48 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.46 -0.791 . . . . 1.86 109.541 168.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 30.9 ttm -72.26 109.87 6.3 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.15 -1.056 . . . . 2.52 108.15 174.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.511 HG23 ' HB ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -87.59 -88.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.893 0.377 . . . . 1.19 111.34 -170.73 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.536 ' HB3' HD13 ' A' ' 93' ' ' ILE . 54.3 t60 -113.34 124.81 53.33 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.174 0.511 . . . . 2.59 110.137 -177.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.0 mtt180 -104.68 133.96 48.64 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.942 -0.762 . . . . 2.83 108.942 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.519 HD12 ' CD2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -94.32 -39.38 10.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.685 0.755 . . . . 1.17 109.171 -175.789 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.423 ' HB2' ' HE2' ' A' ' 4' ' ' LYS . 4.0 t0 -150.9 -169.79 3.48 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.609 -1.178 . . . . 1.86 108.136 176.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.6 t -79.95 -3.57 48.78 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.74 0.305 . . . . 1.94 110.707 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -136.46 17.57 3.14 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.395 0.617 . . . . 1.87 109.758 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.694 HG22 ' HD2' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -138.42 108.37 6.34 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 108.662 -0.866 . . . . 1.12 108.662 179.513 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.592 ' O ' HD11 ' A' ' 114' ' ' LEU . 30.7 m-85 -126.58 177.23 6.64 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.418 0.628 . . . . 0.52 110.959 -173.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.536 HD13 ' HB3' ' A' ' 85' ' ' HIS . 28.4 mt -136.07 132.98 50.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 107.029 -1.471 . . . . 1.1 107.029 167.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.417 ' SG ' ' HB2' ' A' ' 113' ' ' ASP . 7.7 p -115.36 127.39 55.37 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.177 0.513 . . . . 2.61 111.927 -175.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.601 ' HD2' HD11 ' A' ' 112' ' ' ILE . 41.7 t-80 -89.51 91.32 8.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.721 -0.672 . . . . 2.17 109.192 169.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 86.7 m -110.34 109.17 19.49 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.399 -0.819 . . . . 1.19 111.592 -174.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.461 ' CG1' ' HB ' ' A' ' 80' ' ' VAL . 27.4 mm -77.85 120.07 27.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.699 -0.852 . . . . 1.63 108.699 171.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.4 t -110.77 153.96 24.6 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.14 0.495 . . . . 1.72 109.942 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 . . . . . 0 C--N 1.308 -1.234 0 CA-C-N 115.81 -0.632 . . . . 2.29 109.385 175.755 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.9 mt . . . . . 0 N--CA 1.445 -0.717 0 N-CA-C 110.152 -0.314 . . . . 1.53 110.152 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.433 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 13.7 m -86.05 163.46 42.95 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 109.108 -0.701 . . . . 1.71 109.108 176.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 107' ' ' SER . 9.3 Cg_endo -53.2 131.65 44.13 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.241 1.961 . . . . 1.31 111.254 174.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.634 ' HG2' HG22 ' A' ' 144' ' ' ILE . 45.9 mtt180 -106.44 157.06 17.91 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.101 -0.703 . . . . 4.06 109.101 -178.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.818 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 13.6 t0 -106.57 116.16 31.46 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.91 -0.774 . . . . 1.37 108.91 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.612 ' HE1' ' HA3' ' A' ' 146' ' ' GLY . 3.3 m-30 -99.57 128.39 45.68 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.012 0.435 . . . . 3.01 110.492 -177.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.801 HG13 ' HA ' ' A' ' 137' ' ' TYR . 27.3 mm -123.61 75.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 108.769 -0.826 . . . . 1.2 108.769 173.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.918 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 20.8 m-20 -89.83 118.03 29.11 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.163 -0.926 . . . . 1.86 109.786 -177.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.592 HD11 ' O ' ' A' ' 92' ' ' PHE . 3.8 tp -75.03 114.66 13.76 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 107.875 -1.157 . . . . 1.08 107.875 166.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -118.77 122.16 68.72 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 CA-C-N 114.474 -1.239 . . . . 1.08 111.121 -164.529 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.694 ' HD2' HG22 ' A' ' 91' ' ' THR . 29.1 t80 -106.32 111.11 23.56 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.656 -1.156 . . . . 2.81 109.252 176.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.975 HG12 HG21 ' A' ' 127' ' ' ILE . 82.5 mt -87.81 98.12 7.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.953 0.882 . . . . 1.53 109.27 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.651 ' HE2' ' HE1' ' A' ' 116' ' ' TYR . 16.2 tppt? -99.62 112.56 24.77 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.103 -1.408 . . . . 1.81 108.93 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.518 ' NH1' ' HG2' ' A' ' 121' ' ' GLU . 0.1 OUTLIER -106.13 108.86 20.58 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 122.108 0.956 . . . . 3.22 108.526 177.039 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.535 ' CB ' ' HB2' ' A' ' 123' ' ' ASN . 91.0 m-85 -76.61 108.36 9.56 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 105.933 -1.877 . . . . 1.28 105.933 167.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.518 ' HG2' ' NH1' ' A' ' 119' ' ' ARG . 44.7 mt-10 -40.21 93.35 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.879 1.362 . . . . 2.28 112.84 -174.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 71.0 35.27 64.72 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 114.634 -1.166 . . . . 0.79 112.497 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.535 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 13.3 m120 -133.32 -54.35 0.9 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.853 -0.673 . . . . 2.06 110.032 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.514 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 2.8 mpp? -160.07 121.8 3.21 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.154 -0.476 . . . . 1.73 110.655 -175.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -107.93 81.8 1.55 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.412 -0.958 . . . . 2.07 108.412 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.572 ' CG1' HG11 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -99.81 137.93 25.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.239 -0.891 . . . . 1.06 112.967 -170.709 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.975 HG21 HG12 ' A' ' 117' ' ' ILE . 41.2 pt -99.25 104.35 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 121.833 0.825 . . . . 1.26 109.281 166.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 0.7 OUTLIER -87.04 109.26 19.28 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.429 -0.805 . . . . 1.53 109.82 179.214 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.918 ' HB3' ' HB3' ' A' ' 113' ' ' ASP . 14.1 m -118.26 137.78 52.81 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.016 0.436 . . . . 1.81 112.132 -166.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.692 ' HZ3' ' HB3' ' A' ' 130' ' ' LYS . 3.4 mtpm? -132.47 124.6 28.87 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 107.732 -1.21 . . . . 2.75 107.732 178.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 15.6 p -64.37 99.82 0.32 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.924 -1.51 . . . . 1.94 106.924 173.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.43 135.69 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 CA-C-O 121.504 0.669 . . . . 1.64 109.369 -164.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -87.41 81.38 7.85 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.841 -1.072 . . . . 2.17 109.583 -171.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.74 ' CZ ' ' HB3' ' A' ' 136' ' ' GLU . 0.8 OUTLIER -121.96 176.26 2.1 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-N 115.092 -0.958 . . . . 0.67 108.469 -176.548 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.537 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 50.3 Cg_exo -24.43 -64.49 0.04 OUTLIER 'Trans proline' 0 CA--C 1.551 1.353 1 C-N-CA 125.474 4.116 . . . . 1.66 117.329 -179.386 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.74 ' HB3' ' CZ ' ' A' ' 134' ' ' PHE . 6.2 tp10 -72.8 -30.69 64.27 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.466 0.543 . . . . 3.5 112.466 -174.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.801 ' HA ' HG13 ' A' ' 112' ' ' ILE . 32.1 t80 -51.17 -41.87 77.48 Favored Pre-proline 0 CA--C 1.552 1.056 0 N-CA-C 115.651 1.722 . . . . 6.41 115.651 -170.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.457 ' HD2' ' O ' ' A' ' 135' ' ' PRO . 73.4 Cg_exo -45.86 108.43 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 122.515 2.143 . . . . 2.31 113.746 177.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.979 ' HB3' ' HD3' ' A' ' 145' ' ' ARG . 95.0 Cg_endo -99.97 -158.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.024 3.149 . . . . 1.27 114.053 -177.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.8 t -135.85 -155.09 0.61 Allowed 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.476 -1.305 . . . . 1.88 107.476 177.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.2 m -90.47 -41.19 11.57 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.405 -0.518 . . . . 2.43 111.451 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -64.45 -53.36 49.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.759 0.314 . . . . 2.18 110.538 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -95.48 108.94 21.2 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 108.923 -0.769 . . . . 1.33 108.923 175.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.634 HG22 ' HG2' ' A' ' 109' ' ' ARG . 1.2 tt -104.52 119.08 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 CA-C-N 115.056 -0.975 . . . . 1.4 110.721 -173.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.979 ' HD3' ' HB3' ' A' ' 139' ' ' PRO . 1.3 mpt_? -63.41 99.31 0.2 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.264 -1.334 . . . . 5.14 109.732 173.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.612 ' HA3' ' HE1' ' A' ' 111' ' ' PHE . . . -61.36 111.83 4.21 Favored Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 110.096 -1.202 . . . . 1.05 110.096 176.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.594 ' HB3' ' HB3' ' A' ' 174' ' ' GLU . 39.5 t80 -84.47 84.65 7.58 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.832 0.825 . . . . 4.68 110.441 -172.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.649 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 87.6 m-20 -72.82 99.57 2.68 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.485 -1.234 . . . . 2.29 109.838 174.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.507 ' HB2' ' HG2' ' A' ' 172' ' ' GLN . 51.0 m-70 -60.89 137.23 93.62 Favored Pre-proline 0 CA--C 1.51 -0.582 0 N-CA-C 107.992 -1.114 . . . . 2.95 107.992 172.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.672 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 32.3 Cg_exo -21.97 67.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.168 1 C-N-CA 126.79 4.994 . . . . 0.77 115.796 -170.176 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . 0.709 ' HB2' ' O ' ' A' ' 170' ' ' PHE . 22.3 p -96.0 -175.11 3.3 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.155 -0.93 . . . . 1.97 109.574 176.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.821 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -177.07 171.37 44.24 Favored Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 119.597 -1.287 . . . . 0.55 111.942 -177.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.607 ' HB3' ' CG1' ' A' ' 127' ' ' ILE . 2.6 t80 -140.26 84.39 1.96 Allowed 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.002 -1.481 . . . . 0.8 107.002 -159.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.572 HG11 ' CG1' ' A' ' 126' ' ' ILE . 2.9 m -93.16 143.36 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 121.988 0.899 . . . . 1.03 111.113 -170.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . 0.544 ' SG ' ' HB3' ' A' ' 58' ' ' PRO . 3.6 t -119.81 126.49 51.13 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.558 -1.201 . . . . 2.3 108.976 175.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.571 ' H ' ' HB3' ' A' ' 166' ' ' LYS . 5.5 m -119.02 112.18 36.55 Favored Pre-proline 0 C--N 1.318 -0.781 0 C-N-CA 119.234 -0.986 . . . . 1.45 111.43 -173.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 57.1 Cg_exo -51.27 105.52 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 121.77 1.647 . . . . 0.72 109.864 167.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.624 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 21.4 mtp -72.18 -171.23 0.72 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.548 0.69 . . . . 1.72 112.532 -170.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -62.59 -20.16 64.45 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.047 -0.979 . . . . 2.63 109.715 174.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 11.5 mm-40 -105.95 10.44 32.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.368 -0.833 . . . . 2.05 110.251 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.464 ' CB ' ' CD ' ' A' ' 162' ' ' PRO . 44.1 m-80 27.32 -93.48 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.928 0 N-CA-C 115.13 1.53 . . . . 2.19 115.13 -177.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.464 ' CD ' ' CB ' ' A' ' 161' ' ' ASN . 95.3 Cg_endo -76.04 -10.79 19.63 Favored 'Trans proline' 0 C--N 1.367 1.541 0 CA-C-N 121.864 1.701 . . . . 0.86 112.942 -173.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.46 ' HB2' ' HB3' ' A' ' 160' ' ' GLU . . . -89.76 -34.85 16.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.983 -0.553 . . . . 1.34 110.34 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.624 ' O ' ' HB2' ' A' ' 158' ' ' MET . 88.8 m-85 -140.35 118.94 12.3 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.375 -0.602 . . . . 1.46 109.375 178.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 69.4 m -116.93 136.86 52.62 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.311 0.576 . . . . 2.05 110.642 -178.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.685 ' HG3' HG13 ' A' ' 168' ' ' VAL . 41.1 tptt -80.34 128.53 33.66 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.645 -0.707 . . . . 1.4 111.784 -174.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.714 HD13 HG12 ' A' ' 196' ' ' ILE . 0.3 OUTLIER -112.45 100.77 9.02 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.303 -0.862 . . . . 1.07 110.575 165.885 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.685 HG13 ' HG3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -125.87 117.52 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 121.712 0.768 . . . . 1.11 110.981 175.445 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.424 ' SD ' ' O ' ' A' ' 152' ' ' GLY . 5.5 tpt -128.67 135.75 49.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.391 -0.822 . . . . 1.79 110.176 -173.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.709 ' O ' ' HB2' ' A' ' 151' ' ' CYS . 41.1 m-85 -111.29 128.07 55.83 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.685 -0.688 . . . . 4.22 109.311 -177.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.98 ' HB ' HD22 ' A' ' 192' ' ' LEU . 0.8 OUTLIER -110.41 121.04 62.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.361 0.601 . . . . 2.01 110.535 -176.016 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.507 ' HG2' ' HB2' ' A' ' 149' ' ' HIS . 49.9 tt0 -129.8 49.54 2.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 122.482 1.134 . . . . 2.66 108.417 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 22.0 m -77.31 140.24 39.97 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 113.772 -1.558 . . . . 2.2 111.448 -173.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.594 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 15.0 tt0 . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 115.598 -0.728 . . . . 2.45 111.699 -176.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 11.4 mm . . . . . 0 CA--C 1.509 -0.632 0 CA-C-O 122.386 1.088 . . . . 1.69 109.144 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.646 ' HA ' HG21 ' A' ' 187' ' ' THR . 0.7 OUTLIER -66.68 -38.35 81.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 113.001 -1.909 . . . . 1.77 111.106 -176.881 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -62.4 -21.47 65.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.872 -0.604 . . . . 2.89 109.382 176.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -92.46 -41.56 10.23 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.317 -0.856 . . . . 1.71 110.419 175.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.646 HG21 ' HA ' ' A' ' 184' ' ' ILE . 13.6 t -63.08 -35.28 79.73 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.071 0.767 . . . . 1.3 113.071 -168.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' MET . . . . . 0.773 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 30.9 mmt -77.72 -60.71 0.68 Allowed Pre-proline 0 C--N 1.33 -0.24 0 C-N-CA 120.266 -0.574 . . . . 1.39 111.52 -177.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.773 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 36.9 Cg_exo -58.17 -37.87 93.65 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.925 1.75 . . . . 1.15 112.399 -177.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 41.7 m -70.88 -32.45 69.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.789 0.328 . . . . 1.95 110.764 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -75.16 -43.02 54.74 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.911 -0.586 . . . . 1.92 110.053 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.98 HD22 ' HB ' ' A' ' 171' ' ' VAL . 95.2 mt -52.97 -55.17 25.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.453 -0.794 . . . . 1.68 112.264 176.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.673 HG12 ' O ' ' A' ' 189' ' ' PRO . 1.3 m -66.4 -31.57 54.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.668 0.747 . . . . 1.32 109.648 -177.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 190' ' ' SER . 0.6 OUTLIER -69.68 -38.06 76.88 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.49 -1.232 . . . . 2.6 111.202 179.028 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.51 ' HB3' ' HE2' ' A' ' 153' ' ' PHE . 3.1 m-30 -62.41 -32.89 73.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.021 0.439 . . . . 2.73 110.26 173.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.714 HG12 HD13 ' A' ' 167' ' ' LEU . 38.8 mt -79.44 -29.57 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-O 120.95 0.405 . . . . 1.11 111.065 177.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.481 HD22 ' HA ' ' A' ' 197' ' ' LEU . 51.9 mt -72.03 -37.52 69.71 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.037 0.446 . . . . 1.57 109.956 176.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.505 ' HB3' ' CH2' ' A' ' 74' ' ' TRP . 13.4 m120 -47.4 -50.55 22.29 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.841 -1.072 . . . . 2.18 108.676 163.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.813 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -66.29 -46.3 77.48 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 115.057 -0.974 . . . . 1.04 110.581 -174.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.704 ' O ' ' HG2' ' A' ' 204' ' ' LYS . 27.9 mmtp -53.69 -50.34 66.07 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 123.814 0.696 . . . . 1.51 109.615 174.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -76.44 -38.98 54.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.372 -0.831 . . . . 1.94 111.73 -169.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -68.78 -35.02 78.99 Favored Glycine 0 N--CA 1.463 0.447 0 C-N-CA 119.865 -1.16 . . . . 0.47 110.486 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.939 HG13 ' HG3' ' A' ' 56' ' ' GLU . 1.1 mp -65.07 -35.75 76.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 114.186 -1.007 . . . . 1.16 110.973 173.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.704 ' HG2' ' O ' ' A' ' 200' ' ' LYS . 52.7 mmtt -75.2 -39.34 60.23 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 108.81 -0.811 . . . . 3.8 108.81 177.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.933 0 CA-C-N 115.18 -0.918 . . . . 1.28 109.099 173.16 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.759 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.2 m-20 . . . . . 0 CA--C 1.507 -0.69 0 N-CA-C 109.087 -0.709 . . . . 2.25 109.087 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.64 ' HA ' ' CD1' ' A' ' 6' ' ' ILE . 89.8 m-85 -67.68 -34.02 76.08 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.203 -0.908 . . . . 0.45 109.096 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.592 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 21.9 tttp -78.92 -1.16 33.92 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 114.363 -1.289 . . . . 2.06 109.751 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -92.66 -43.85 8.88 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.295 0.569 . . . . 1.2 110.209 172.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.759 HD13 ' O ' ' A' ' 2' ' ' ASP . 0.0 OUTLIER -83.0 -37.24 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-N 115.519 -0.764 . . . . 1.76 110.269 -172.614 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.472 ' HB3' ' HB2' ' A' ' 116' ' ' TYR . . . -80.69 -40.85 24.72 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.483 -1.235 . . . . 1.11 111.535 -176.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.592 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 8.2 mt-30 -65.7 -29.6 70.17 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.2 -0.909 . . . . 2.14 110.153 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.656 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 14.8 mm100 -82.74 -33.59 27.42 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.211 -0.904 . . . . 3.04 109.208 175.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.653 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -70.92 -35.16 72.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.257 -0.883 . . . . 1.1 111.423 -179.469 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.44 ' HA ' ' OG ' ' A' ' 128' ' ' SER . . . -43.87 -61.54 1.4 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.928 0.394 . . . . 1.04 112.038 172.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -74.73 -11.08 60.08 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.477 -0.329 . . . . 2.31 111.728 -177.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.656 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 53.9 mt-10 -71.55 -56.01 6.72 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.069 -0.715 . . . . 2.54 109.069 172.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.743 HG23 ' N ' ' A' ' 152' ' ' GLY . 10.6 p -68.27 -38.21 79.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 122.838 1.304 . . . . 1.21 109.721 -175.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.439 ' HB3' ' O ' ' A' ' 11' ' ' ALA . 0.5 OUTLIER -76.11 -18.88 58.97 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 113.791 -1.55 . . . . 1.26 109.248 178.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.403 ' HA2' ' HD3' ' A' ' 19' ' ' ARG . . . -61.95 -27.93 69.5 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 114.144 -1.389 . . . . 0.57 110.04 172.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.446 ' HD1' ' O ' ' A' ' 13' ' ' GLU . 24.4 m-85 -86.03 -15.91 39.86 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.16 -0.52 . . . . 3.59 110.055 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -85.99 -3.51 58.95 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 119.526 -0.87 . . . . 2.1 110.051 172.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.403 ' HD3' ' HA2' ' A' ' 16' ' ' GLY . 35.2 mtp180 -105.62 -21.51 13.18 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.113 -0.367 . . . . 3.26 111.486 -178.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -146.26 154.1 41.34 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.242 -0.435 . . . . 2.16 111.018 174.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.491 ' HB ' ' CZ2' ' A' ' 24' ' ' TRP . 70.4 p -135.52 129.91 33.79 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.722 -0.672 . . . . 2.24 111.229 -172.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.5 p -174.85 157.0 2.36 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.192 0.307 . . . . 2.46 111.76 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.69 3.64 90.56 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.903 -0.59 . . . . 1.45 113.774 170.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.491 ' CZ2' ' HB ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -120.58 -158.39 0.75 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 117.191 0.496 . . . . 2.24 111.456 -176.511 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.37 119.88 0.32 Allowed 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 108.735 -0.839 . . . . 3.43 108.735 -174.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.58 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 0.3 OUTLIER -55.16 121.71 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-O 122.06 0.933 . . . . 2.21 111.389 174.64 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.13 -25.35 3.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 113.971 -1.468 . . . . 1.83 109.99 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.424 ' HD2' ' HA ' ' A' ' 28' ' ' LYS . 9.4 tptm -142.98 121.93 12.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 119.75 -0.78 . . . . 2.87 112.503 -173.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.463 HG23 ' HA ' ' A' ' 34' ' ' THR . 41.6 p -135.59 121.75 20.22 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.367 -0.605 . . . . 1.92 109.367 172.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.2 t -85.14 -79.01 0.24 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 121.064 -0.254 . . . . 2.37 110.415 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -164.08 19.37 0.06 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.479 0.657 . . . . 4.84 109.832 176.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -173.54 3.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.662 -0.699 . . . . 2.05 110.369 -175.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.48 ' CD1' ' HB ' ' A' ' 193' ' ' VAL . 28.9 pt -140.85 167.46 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-O 120.79 0.329 . . . . 1.42 110.875 -171.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.463 ' HA ' HG23 ' A' ' 29' ' ' THR . 26.2 m -152.95 104.72 2.86 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.208 -0.451 . . . . 1.22 111.19 -171.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.597 ' CG1' HD12 ' A' ' 192' ' ' LEU . 11.4 t -101.57 121.02 51.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 1.52 110.086 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.58 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 5.6 m -113.02 128.55 56.53 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.187 -0.46 . . . . 1.74 110.223 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.0 p -97.94 130.24 44.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.667 -0.697 . . . . 1.72 110.345 -176.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 57.9 tttm . . . . . 0 C--N 1.316 -0.87 0 CA-C-N 115.671 -0.695 . . . . 2.45 111.243 -173.832 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 . . . . . 0 N--CA 1.447 -0.579 0 CA-C-O 121.362 0.601 . . . . 2.45 111.355 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 171' ' ' VAL . 10.0 tt -93.5 152.38 19.1 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.023 -0.989 . . . . 1.49 109.56 -176.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.546 ' N ' HD23 ' A' ' 47' ' ' LEU . 71.7 m-85 -127.78 134.17 49.48 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.65 0.262 . . . . 1.52 110.745 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.539 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.8 OUTLIER -118.6 126.48 52.05 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 108.999 -0.741 . . . . 3.34 108.999 175.915 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 192' ' ' LEU . 14.8 p -114.75 150.03 16.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.725 -0.472 . . . . 1.98 109.725 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.447 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 37.9 tt0 -155.38 109.84 2.92 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.987 -0.552 . . . . 1.07 110.351 -170.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.408 ' HA3' HG21 ' A' ' 33' ' ' ILE . . . -138.83 160.43 25.7 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.615 -0.802 . . . . 0.35 111.791 178.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.402 ' O ' ' HD3' ' A' ' 55' ' ' PRO . 58.6 mt -100.89 114.92 41.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 C-N-CA 120.57 -0.452 . . . . 1.3 110.786 179.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 40.1 mt -94.42 112.83 59.15 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.666 -0.697 . . . . 1.07 109.431 175.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 53' ' ' ILE . 31.7 Cg_exo -61.34 70.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 124.566 3.511 . . . . 0.74 112.893 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.472 ' HG3' ' CG1' ' A' ' 203' ' ' ILE . 0.1 OUTLIER -155.06 -167.77 2.67 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.89 -1.05 . . . . 1.68 108.555 177.089 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.3 t -101.41 146.77 32.77 Favored Pre-proline 0 N--CA 1.421 -1.884 0 N-CA-C 108.485 -0.932 . . . . 1.58 108.485 174.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.599 ' HB3' ' SG ' ' A' ' 155' ' ' CYS . 24.6 Cg_exo -61.62 -12.7 26.0 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.486 2.791 . . . . 0.74 110.442 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.08 -44.65 53.28 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.74 -1.118 . . . . 1.31 111.325 176.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.48 ' CG ' HD12 ' A' ' 203' ' ' ILE . 6.5 tppt? -71.49 -31.94 67.68 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 108.293 -1.003 . . . . 3.78 108.293 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.572 HD21 ' CD1' ' A' ' 203' ' ' ILE . 63.6 mt -62.15 -51.91 65.96 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.388 -1.278 . . . . 1.09 110.429 175.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.8 m -64.7 -15.24 61.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.048 0.451 . . . . 1.94 110.613 173.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -84.73 -52.3 6.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.036 -0.529 . . . . 1.32 111.795 -177.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.696 ' CE2' ' HA ' ' A' ' 199' ' ' ALA . 10.2 p90 -70.03 -40.63 75.05 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.727 0.269 . . . . 0.79 111.727 -172.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.453 HD21 ' O ' ' A' ' 61' ' ' LEU . 0.6 OUTLIER -79.75 -21.35 44.58 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 120.357 -0.537 . . . . 2.15 112.054 -170.059 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.534 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 1.8 t80 -5.77 -71.77 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 O-C-N 125.214 1.571 . . . . 2.06 113.18 -156.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.534 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 4.8 tp60 175.93 -37.7 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.565 0.541 . . . . 4.31 111.815 167.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.414 ' OG1' ' HB2' ' A' ' 81' ' ' TYR . 12.7 t -146.57 12.02 1.14 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.364 0.505 . . . . 1.89 112.364 -168.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -118.99 -5.26 11.92 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 119.122 -1.513 . . . . 1.71 113.887 -171.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.647 ' O ' HG23 ' A' ' 73' ' ' THR . 0.5 OUTLIER -170.96 -31.74 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.631 0 CA-C-O 121.415 0.626 . . . . 2.19 109.844 -177.944 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.496 ' HG2' ' CD1' ' A' ' 78' ' ' LEU . 8.0 ttt180 -40.9 -50.09 3.23 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 125.461 1.504 . . . . 3.95 111.086 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.456 HG22 HD11 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -91.15 -7.52 10.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.813 -1.085 . . . . 1.42 111.241 -176.189 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER -84.79 -34.6 22.73 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 120.545 -0.462 . . . . 1.45 110.298 -173.758 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.662 ' CZ3' ' HB2' ' A' ' 198' ' ' ASN . 20.8 p-90 -91.78 -42.38 10.14 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 120.056 -0.658 . . . . 0.78 109.314 174.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.7 t70 56.83 141.96 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.203 1.927 . . . . 2.19 116.203 159.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.543 ' HD3' ' N ' ' A' ' 77' ' ' SER . 0.0 OUTLIER -139.29 -29.09 0.76 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.567 -0.742 . . . . 3.68 111.989 163.733 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.543 ' N ' ' HD3' ' A' ' 76' ' ' LYS . 63.0 m -136.51 22.18 3.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.081 0.943 . . . . 2.08 108.524 176.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.496 ' CD1' ' HG2' ' A' ' 71' ' ' ARG . 43.8 mt -110.01 -173.79 2.34 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.241 -1.345 . . . . 1.16 110.163 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.566 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 3.4 mm100 -160.36 -66.18 0.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.925 0.343 . . . . 2.23 111.925 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.48 ' HB ' ' CG1' ' A' ' 97' ' ' ILE . 40.4 t -143.71 133.53 20.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.984 0.421 . . . . 1.44 111.136 -167.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.414 ' HB2' ' OG1' ' A' ' 68' ' ' THR . 20.3 p90 -100.49 145.17 28.61 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.643 -0.708 . . . . 5.73 110.754 175.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.565 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 18.4 m120 -150.8 102.56 3.01 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.798 -0.816 . . . . 1.86 108.798 170.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.52 107.36 2.45 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.638 -0.505 . . . . 2.52 109.638 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.478 ' CG1' ' HG2' ' A' ' 136' ' ' GLU . 0.0 OUTLIER -84.36 -56.73 5.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.608 -0.723 . . . . 1.19 110.948 -170.433 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -147.51 113.05 5.65 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.001 -0.545 . . . . 2.59 110.244 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -95.91 120.78 36.79 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.562 -0.903 . . . . 2.83 108.562 176.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.603 HG12 ' O ' ' A' ' 91' ' ' THR . 1.2 mm -72.9 -53.35 18.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.976 -1.011 . . . . 1.17 110.277 -168.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.514 ' CG ' ' HZ3' ' A' ' 4' ' ' LYS . 1.3 p30 -140.23 -97.2 0.15 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.633 -0.712 . . . . 1.86 111.492 176.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.6 t -137.98 -12.44 1.46 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.846 -0.161 . . . . 1.94 111.041 -177.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -131.3 8.57 4.68 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.169 0.509 . . . . 1.87 109.713 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.603 ' O ' HG12 ' A' ' 87' ' ' ILE . 9.0 m -139.6 118.15 12.22 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 107.591 -1.263 . . . . 1.12 107.591 -172.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.595 ' O ' HD13 ' A' ' 114' ' ' LEU . 35.8 m-85 -132.92 174.99 9.75 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.243 0.544 . . . . 0.52 110.854 -171.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.523 HD13 ' CE1' ' A' ' 3' ' ' PHE . 25.5 mt -133.97 123.5 44.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 107.255 -1.387 . . . . 1.1 107.255 165.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.0 t -112.6 122.09 46.68 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.372 0.606 . . . . 2.61 111.532 -176.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.565 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 31.2 t-80 -78.84 88.74 4.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.864 0.84 . . . . 2.17 108.84 168.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 19.1 m -97.37 114.17 25.93 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.514 -1.221 . . . . 1.19 111.183 -176.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.48 ' CG1' ' HB ' ' A' ' 80' ' ' VAL . 36.8 mm -76.98 124.72 35.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.909 -0.774 . . . . 1.63 108.909 173.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.1 m -111.19 133.22 53.71 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.011 -0.995 . . . . 1.72 111.562 -170.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.566 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 30.6 mt-30 . . . . . 0 C--N 1.317 -0.823 0 N-CA-C 109.687 -0.486 . . . . 2.29 109.687 172.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 16.3 mt . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 109.879 -0.415 . . . . 1.53 109.879 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.414 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 15.5 m -99.43 169.21 8.43 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 109.867 -0.419 . . . . 1.71 109.867 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 107' ' ' SER . 80.1 Cg_exo -46.54 128.18 12.42 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.201 1.934 . . . . 1.31 111.108 172.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.59 ' HG2' ' O ' ' A' ' 144' ' ' ILE . 33.3 ttp180 -116.81 162.43 17.72 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 120.993 0.425 . . . . 4.06 110.068 -170.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.48 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 6.4 t70 -112.14 162.14 15.77 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.285 -1.006 . . . . 1.37 108.285 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.455 ' CE2' ' HB3' ' A' ' 113' ' ' ASP . 3.0 t80 -149.7 136.15 19.15 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.059 0.457 . . . . 3.01 111.266 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.631 ' O ' ' HA ' ' A' ' 131' ' ' SER . 46.3 mm -122.75 89.86 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 N-CA-C 108.423 -0.955 . . . . 1.2 108.423 172.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.455 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . 2.0 p30 -95.3 113.45 25.12 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.384 -0.825 . . . . 1.86 110.685 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.595 HD13 ' O ' ' A' ' 92' ' ' PHE . 8.4 tp -76.43 121.16 22.66 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 119.19 -1.004 . . . . 1.08 108.45 162.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -127.64 126.6 67.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-N 115.007 -0.997 . . . . 1.08 111.949 -165.872 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.93 ' HH ' ' HD3' ' A' ' 118' ' ' LYS . 10.2 t80 -109.42 113.1 25.62 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.201 -0.909 . . . . 2.81 110.42 174.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.447 HG12 HG23 ' A' ' 127' ' ' ILE . 80.4 mt -96.72 113.76 31.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.719 -0.673 . . . . 1.53 109.734 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.93 ' HD3' ' HH ' ' A' ' 116' ' ' TYR . 37.8 ttpt -137.74 141.14 40.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.004 0.43 . . . . 1.81 110.398 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.546 ' O ' ' HD3' ' A' ' 119' ' ' ARG . 0.1 OUTLIER -113.57 113.7 25.45 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 121.956 0.884 . . . . 3.22 109.012 177.31 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.536 ' CE1' ' HE3' ' A' ' 118' ' ' LYS . 3.5 m-85 -69.02 110.56 4.52 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.046 -1.465 . . . . 1.28 107.046 168.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -35.85 94.53 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 O-C-N 124.769 1.293 . . . . 2.28 113.141 -175.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 59.79 50.69 64.94 Favored Glycine 0 CA--C 1.504 -0.647 0 CA-C-N 114.63 -1.168 . . . . 0.79 111.842 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.523 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 60.8 t30 -149.36 -53.12 0.16 Allowed 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.99 -0.605 . . . . 2.06 110.061 -176.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.492 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 1.8 mpp? -158.73 119.67 3.34 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.864 0.364 . . . . 1.73 111.701 -177.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -101.71 84.5 2.57 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.209 -1.034 . . . . 2.07 108.209 176.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.512 ' HA ' ' HA ' ' A' ' 154' ' ' VAL . 0.5 OUTLIER -101.61 140.59 19.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 112.903 0.705 . . . . 1.06 112.903 -170.426 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.647 ' O ' HG13 ' A' ' 127' ' ' ILE . 8.0 pt -108.96 112.16 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 108.675 -0.861 . . . . 1.26 108.675 163.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.569 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 4.3 m -80.1 155.56 27.45 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.972 -0.751 . . . . 1.53 108.972 175.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 80.8 p -149.82 131.63 15.08 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.61 0.719 . . . . 1.81 111.821 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.8 mtpp -132.63 122.77 25.2 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.628 -1.249 . . . . 2.75 107.628 175.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.631 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 17.7 t -70.8 104.88 3.02 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 106.81 -1.552 . . . . 1.94 106.81 175.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.0 m -102.9 152.59 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 C-N-CA 119.417 -0.913 . . . . 1.64 110.01 -174.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.634 ' HA ' ' CG ' ' A' ' 137' ' ' TYR . 8.4 p-10 -108.47 55.65 0.64 Allowed 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 123.204 1.478 . . . . 2.17 109.872 -168.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 136' ' ' GLU . 0.7 OUTLIER -91.57 178.33 1.81 Allowed Pre-proline 0 CA--C 1.553 1.086 0 CA-C-N 112.719 -2.037 . . . . 0.67 109.083 -175.322 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.522 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 9.0 Cg_exo -32.19 -56.28 0.29 Allowed 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 124.654 3.57 . . . . 1.66 117.366 -176.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 134' ' ' PHE . 10.2 tp10 -74.18 -29.66 61.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.479 0.581 . . . . 3.5 112.389 -174.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.634 ' CG ' ' HA ' ' A' ' 133' ' ' ASP . 13.0 t80 -46.18 -42.24 26.76 Favored Pre-proline 0 CA--C 1.552 1.037 0 N-CA-C 116.1 1.889 . . . . 6.41 116.1 -173.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.456 ' HD2' ' O ' ' A' ' 135' ' ' PRO . 73.4 Cg_exo -42.58 107.07 0.08 OUTLIER 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.251 1.967 . . . . 2.31 113.165 176.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -96.68 -159.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.544 2.83 . . . . 1.27 113.487 -174.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.7 m -143.94 -161.8 1.34 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.419 -0.956 . . . . 1.88 108.419 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.2 m -82.86 -47.23 12.08 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.118 -0.633 . . . . 2.43 110.904 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -65.38 -23.31 66.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.311 -0.404 . . . . 2.18 111.263 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.48 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 95.0 m-85 -132.16 108.12 9.07 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.361 -0.607 . . . . 1.33 109.361 177.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.59 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -104.07 116.69 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 109.019 -0.734 . . . . 1.4 109.019 178.192 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.519 ' HD2' HG12 ' A' ' 112' ' ' ILE . 0.8 OUTLIER -59.58 98.72 0.05 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.382 -0.826 . . . . 5.14 109.686 172.377 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -59.61 114.3 6.13 Favored Glycine 0 CA--C 1.504 -0.609 0 N-CA-C 111.107 -0.797 . . . . 1.05 111.107 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -84.89 88.48 7.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.875 0.845 . . . . 4.68 111.17 -169.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 66.7 t30 -84.31 123.97 30.74 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.645 -1.161 . . . . 2.29 110.801 178.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.429 ' O ' ' N ' ' A' ' 151' ' ' CYS . 46.0 m80 -74.68 161.63 77.02 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 119.022 -0.513 . . . . 2.95 109.882 176.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 149' ' ' HIS . 5.4 Cg_endo -48.06 76.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 124.514 3.476 . . . . 0.77 114.651 -178.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . 0.692 ' SG ' ' HA ' ' A' ' 171' ' ' VAL . 14.3 p -129.53 -174.09 3.2 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.251 -1.018 . . . . 1.97 108.251 171.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.743 ' N ' HG23 ' A' ' 14' ' ' VAL . . . -167.79 -147.33 5.27 Favored Glycine 0 N--CA 1.436 -1.319 0 C-N-CA 118.542 -1.789 . . . . 0.55 113.426 -173.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.544 ' CZ ' HD11 ' A' ' 167' ' ' LEU . 39.2 t80 -160.94 94.42 1.02 Allowed 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.76 -1.2 . . . . 0.8 107.76 -162.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.655 ' CG2' HG13 ' A' ' 168' ' ' VAL . 3.4 m -105.76 148.98 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 CA-C-O 121.969 0.89 . . . . 1.03 111.307 -173.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . 0.599 ' SG ' ' HB3' ' A' ' 58' ' ' PRO . 12.1 t -117.44 137.72 52.32 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.911 -1.04 . . . . 2.3 108.597 173.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.484 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 12.6 m -129.61 116.57 18.37 Favored Pre-proline 0 C--N 1.31 -1.122 0 C-N-CA 120.394 -0.522 . . . . 1.45 111.038 -177.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 55.8 Cg_exo -49.85 122.43 9.0 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.496 2.131 . . . . 0.72 111.378 173.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.664 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 0.7 OUTLIER -80.43 -167.13 1.23 Allowed 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.055 0.455 . . . . 1.72 112.079 -175.9 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -67.8 -26.53 66.13 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.565 -0.743 . . . . 2.63 109.366 176.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.463 ' HB3' ' HB2' ' A' ' 163' ' ' ALA . 34.4 mm-40 -97.62 13.76 29.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.246 -0.888 . . . . 2.05 109.86 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.449 ' CB ' ' CD ' ' A' ' 162' ' ' PRO . 13.9 m120 25.78 -89.13 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 125.708 1.603 . . . . 2.19 115.21 -177.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' A' ' 161' ' ' ASN . 84.1 Cg_endo -74.32 -10.49 22.41 Favored 'Trans proline' 0 C--N 1.366 1.448 0 CA-C-N 121.596 1.606 . . . . 0.86 113.473 -174.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 160' ' ' GLU . . . -96.12 -34.51 11.67 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.536 -0.302 . . . . 1.34 111.573 -177.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.664 ' O ' ' HB2' ' A' ' 158' ' ' MET . 81.9 m-85 -136.64 135.34 38.2 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.981 -0.377 . . . . 1.46 109.981 178.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 57.4 m -126.09 143.77 50.99 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.35 0.595 . . . . 2.05 111.618 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 156' ' ' SER . 1.9 tppp? -91.64 107.96 19.57 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.38 -0.827 . . . . 1.4 110.751 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.544 HD11 ' CZ ' ' A' ' 153' ' ' PHE . 0.5 OUTLIER -93.08 107.67 19.41 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.209 -0.905 . . . . 1.07 109.309 175.224 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.655 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -131.77 129.4 61.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.865 0.841 . . . . 1.11 111.753 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.557 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 11.3 ttt -140.91 151.34 44.17 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.009 -0.996 . . . . 1.79 108.98 -172.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.703 ' CE2' HG21 ' A' ' 14' ' ' VAL . 1.0 OUTLIER -144.83 152.39 40.22 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.88 -0.785 . . . . 4.22 108.88 171.199 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.692 ' HA ' ' SG ' ' A' ' 151' ' ' CYS . 12.6 p -138.12 127.7 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 O-C-N 123.907 0.755 . . . . 2.01 111.728 -172.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.511 ' HB2' ' CD1' ' A' ' 47' ' ' LEU . 24.2 tt0 -116.65 48.83 1.22 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.044 0.926 . . . . 2.66 108.518 174.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 1.7 t -74.65 152.67 39.17 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.029 -0.987 . . . . 2.2 111.024 -173.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 . . . . . 0 N--CA 1.441 -0.898 0 CA-C-N 115.191 -0.913 . . . . 2.45 109.838 173.774 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.543 ' HA ' ' HE2' ' A' ' 186' ' ' LYS . 40.5 mm . . . . . 0 CA--C 1.51 -0.591 0 CA-C-O 122.508 1.147 . . . . 1.69 109.301 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.591 ' HA ' ' CG2' ' A' ' 187' ' ' THR . 1.5 mp -60.62 -35.57 64.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 112.678 -2.055 . . . . 1.77 111.14 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -70.14 -17.23 63.19 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.583 -0.735 . . . . 2.89 109.158 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.543 ' HE2' ' HA ' ' A' ' 183' ' ' ILE . 43.6 mtmt -92.11 -39.73 11.44 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.533 -0.758 . . . . 1.71 109.707 172.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.591 ' CG2' ' HA ' ' A' ' 184' ' ' ILE . 6.4 t -73.68 -36.63 65.33 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 119.645 -0.822 . . . . 1.3 112.538 -170.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' MET . . . . . 0.505 ' O ' HD13 ' A' ' 192' ' ' LEU . 37.6 mmm -70.32 -56.76 6.44 Favored Pre-proline 0 C--O 1.226 -0.176 0 C-N-CA 120.272 -0.571 . . . . 1.39 112.39 -175.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 188' ' ' MET . 18.9 Cg_endo -57.73 -18.76 35.17 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 122.232 1.955 . . . . 1.15 112.392 -176.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 33.9 t -86.24 -38.48 17.54 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.13 -0.693 . . . . 1.95 109.13 174.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -68.12 -42.71 79.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.324 -0.853 . . . . 1.92 111.638 -172.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.597 HD12 ' CG1' ' A' ' 35' ' ' VAL . 1.1 mt -62.02 -48.99 77.81 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.572 0.701 . . . . 1.68 110.959 -177.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.48 ' HB ' ' CD1' ' A' ' 33' ' ' ILE . 1.3 m -67.67 -32.65 57.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.057 -0.974 . . . . 1.32 109.672 -177.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 190' ' ' SER . 8.3 m-80 -76.68 -29.11 56.19 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.529 -1.214 . . . . 2.6 110.942 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.733 ' HA ' ' OD1' ' A' ' 198' ' ' ASN . 0.5 OUTLIER -66.38 -33.0 74.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.866 0.841 . . . . 2.73 109.475 171.071 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.672 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 22.6 mt -75.54 -27.86 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-N 115.707 -0.679 . . . . 1.11 110.799 173.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 53.1 mt -71.26 -42.42 68.81 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-N 116.651 -0.25 . . . . 1.57 111.365 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.733 ' OD1' ' HA ' ' A' ' 195' ' ' PHE . 1.4 p-10 -59.6 -23.75 63.23 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.155 -1.018 . . . . 2.18 108.952 171.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.696 ' HA ' ' CE2' ' A' ' 64' ' ' PHE . . . -81.32 -46.14 15.15 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 119.975 -0.69 . . . . 1.04 111.132 176.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.672 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 13.8 mmmm -55.22 -43.59 74.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 1.51 110.251 177.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -92.1 -33.82 14.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.738 -0.664 . . . . 1.94 112.013 -174.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -66.61 -29.1 74.21 Favored Glycine 0 N--CA 1.463 0.435 0 C-N-CA 120.784 -0.722 . . . . 0.47 111.377 176.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.572 ' CD1' HD21 ' A' ' 61' ' ' LEU . 3.2 tp -71.34 -28.67 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 109.44 -0.578 . . . . 1.16 109.44 176.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 79.1 mttt -79.07 -40.8 30.31 Favored 'General case' 0 C--O 1.209 -1.074 0 N-CA-C 107.861 -1.163 . . . . 3.8 107.861 174.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.042 0 CA-C-N 115.415 -0.811 . . . . 1.28 109.9 172.417 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.595 ' O ' HD11 ' A' ' 6' ' ' ILE . 15.3 t70 . . . . . 0 CA--C 1.51 -0.577 0 CA-C-O 121.758 0.789 . . . . 2.25 108.96 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.609 ' HA ' ' CD1' ' A' ' 6' ' ' ILE . 95.5 m-85 -71.82 -25.47 62.0 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.015 -0.993 . . . . 0.45 108.402 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.571 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 11.6 tptm -67.05 -9.44 39.21 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 114.716 -1.129 . . . . 2.06 109.669 175.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 2' ' ' ASP . . . -90.86 -49.98 6.14 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 115.823 -0.626 . . . . 1.2 109.658 175.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.609 ' CD1' ' HA ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -83.19 -34.54 11.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.453 0.644 . . . . 1.76 110.984 -170.834 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.555 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -79.13 -39.48 33.48 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.136 -0.938 . . . . 1.11 111.269 -176.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.571 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 5.6 mt-30 -67.6 -24.75 65.52 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.147 -1.388 . . . . 2.14 110.192 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.57 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 55.7 mt-30 -83.85 -50.56 7.97 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.099 -0.955 . . . . 3.04 108.827 170.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.553 ' HB ' ' HA ' ' A' ' 7' ' ' ALA . 0.8 OUTLIER -46.01 -44.92 15.54 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.029 0.932 . . . . 1.1 112.656 175.276 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.457 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -50.87 -55.99 14.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.063 0.459 . . . . 1.04 111.748 175.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -76.18 -5.99 49.3 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.088 -0.506 . . . . 2.31 111.586 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 39.3 mm-40 -81.13 -52.39 7.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.26 0.552 . . . . 2.54 109.553 172.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.857 HG23 ' CE2' ' A' ' 170' ' ' PHE . 6.4 p -68.37 -38.72 79.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.366 -0.834 . . . . 1.21 110.631 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.97 -22.36 65.92 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.178 -0.919 . . . . 1.26 108.805 173.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.541 ' HA2' ' NE ' ' A' ' 19' ' ' ARG . . . -64.05 -22.69 67.1 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 114.033 -1.44 . . . . 0.57 110.18 176.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.435 ' HA ' ' HB3' ' A' ' 20' ' ' ASP . 5.9 m-85 -90.34 -16.79 28.51 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.41 -0.589 . . . . 3.59 109.41 177.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.483 ' HB2' ' NH2' ' A' ' 49' ' ' ARG . 2.4 t-20 -76.51 -14.37 60.03 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.488 0.661 . . . . 2.1 109.937 176.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.541 ' NE ' ' HA2' ' A' ' 16' ' ' GLY . 10.9 ptt180 -113.49 8.95 17.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.467 -0.788 . . . . 3.26 109.668 174.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.435 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 25.5 t70 -112.83 92.82 4.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.198 -0.91 . . . . 2.16 109.502 175.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.466 HG22 ' CH2' ' A' ' 24' ' ' TRP . 24.0 p -131.36 88.82 2.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.236 0.541 . . . . 2.24 111.539 -176.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -177.45 -50.42 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.569 -0.741 . . . . 2.46 111.18 -178.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.87 -9.7 79.72 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 121.235 -0.507 . . . . 1.45 112.99 -174.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.514 ' CB ' ' HG2' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -76.93 -160.88 0.17 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.177 0.513 . . . . 2.24 111.426 177.209 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -171.7 114.62 0.36 Allowed 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 109.028 -0.731 . . . . 3.43 109.028 -175.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.558 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 1.7 m -64.82 128.02 26.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.963 0.887 . . . . 2.21 111.987 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.9 m -118.79 -24.32 3.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 113.845 -1.525 . . . . 1.83 110.46 -178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.458 ' HD2' ' HA ' ' A' ' 28' ' ' LYS . 15.5 tptp -145.96 129.55 17.0 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.037 -0.665 . . . . 2.87 111.518 -174.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.482 HG22 ' HA ' ' A' ' 34' ' ' THR . 24.1 p -146.06 152.78 39.88 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.21 -0.45 . . . . 1.92 110.527 178.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.2 t -106.6 -102.45 0.34 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.097 -0.705 . . . . 2.37 109.097 171.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -142.25 18.02 2.07 Favored 'General case' 0 N--CA 1.463 0.208 0 O-C-N 122.064 -0.398 . . . . 4.84 111.377 175.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -169.4 8.27 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.271 0.558 . . . . 2.05 110.07 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.488 HG22 ' HA3' ' A' ' 52' ' ' GLY . 12.7 pt -142.92 160.88 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 115.382 -0.827 . . . . 1.42 109.891 -176.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.482 ' HA ' HG22 ' A' ' 29' ' ' THR . 93.1 m -158.18 111.25 2.4 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 111.793 0.294 . . . . 1.22 111.793 -164.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.581 ' CG2' HG12 ' A' ' 193' ' ' VAL . 5.0 t -98.56 117.71 43.97 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 N-CA-C 109.379 -0.601 . . . . 1.52 109.379 177.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.558 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -118.81 125.25 49.14 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 116.11 -0.495 . . . . 1.74 110.218 -176.637 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 73.4 p -101.17 143.26 31.48 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.398 0.618 . . . . 1.72 112.169 -172.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.514 ' HG2' ' CB ' ' A' ' 24' ' ' TRP . 15.5 mtmt . . . . . 0 C--N 1.317 -0.825 0 CA-C-N 114.996 -1.002 . . . . 2.45 108.413 172.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 . . . . . 0 N--CA 1.451 -0.401 0 CA-C-O 121.564 0.697 . . . . 2.45 110.896 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' A' ' 37' ' ' SER . 10.0 tt -86.52 147.72 25.84 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.821 -1.082 . . . . 1.49 109.254 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.45 ' N ' HD21 ' A' ' 47' ' ' LEU . 92.9 m-85 -123.21 119.59 30.67 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.839 -0.344 . . . . 1.52 111.109 -175.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.764 ' CD ' ' HB3' ' A' ' 170' ' ' PHE . 21.8 tpt180 -110.73 117.65 34.04 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.309 -0.626 . . . . 3.34 109.309 173.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 34' ' ' THR . 12.5 p -103.94 150.61 7.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.75 0.31 . . . . 1.98 110.259 -179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.531 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 35.2 tt0 -153.41 122.06 6.35 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.785 -0.643 . . . . 1.07 110.764 -172.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.488 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -156.13 161.7 30.93 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.198 -0.761 . . . . 0.35 111.198 175.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 70.3 mt -98.11 130.39 46.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 117.345 0.572 . . . . 1.3 111.229 -178.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 61.9 mt -107.8 116.9 56.61 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.355 -0.839 . . . . 1.07 109.789 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -63.56 61.51 0.2 Allowed 'Trans proline' 0 N--CA 1.476 0.457 0 C-N-CA 124.172 3.248 . . . . 0.74 113.787 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.553 ' HG3' ' H ' ' A' ' 57' ' ' SER . 6.5 tp10 -152.29 -171.33 3.9 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.796 -0.816 . . . . 1.68 108.796 174.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.553 ' H ' ' HG3' ' A' ' 56' ' ' GLU . 73.9 p -89.76 146.42 35.41 Favored Pre-proline 0 N--CA 1.427 -1.62 0 CA-C-O 121.546 0.689 . . . . 1.58 110.517 176.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.578 ' HB3' ' SG ' ' A' ' 155' ' ' CYS . 37.2 Cg_exo -60.71 -11.19 16.45 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 124.102 3.201 . . . . 0.74 111.098 176.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.75 -51.52 10.4 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 114.752 -1.113 . . . . 1.31 110.919 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.454 ' CG ' HD12 ' A' ' 203' ' ' ILE . 3.6 tppt? -66.15 -30.3 70.75 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.283 -1.006 . . . . 3.78 108.283 -178.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.541 HD22 ' CD1' ' A' ' 203' ' ' ILE . 48.6 mt -60.67 -58.62 7.68 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.468 -1.242 . . . . 1.09 110.428 174.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.435 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 7.7 p -66.57 -6.55 15.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.866 0.365 . . . . 1.94 111.104 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -86.88 -41.38 14.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.402 -0.363 . . . . 1.32 111.896 176.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.557 ' O ' ' HB3' ' A' ' 71' ' ' ARG . 6.1 p90 -77.4 -41.28 40.59 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.47 -0.492 . . . . 0.79 110.844 -172.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.58 HD13 ' CD1' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -84.74 7.77 19.43 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 110.342 -0.244 . . . . 2.15 110.342 -171.546 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.472 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 41.1 t80 -55.99 0.6 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.878 0 O-C-N 124.216 0.948 . . . . 2.06 112.936 -173.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 15.8 mm100 82.13 -28.13 0.12 Allowed 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 124.315 1.046 . . . . 4.31 110.822 171.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.409 ' H ' ' C ' ' A' ' 66' ' ' TYR . 8.8 t -125.34 22.07 7.83 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.457 -1.312 . . . . 1.89 107.457 171.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.1 3.96 84.5 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 113.864 -1.516 . . . . 1.71 111.805 -176.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.702 ' O ' HG21 ' A' ' 73' ' ' THR . 12.0 t70 92.6 2.8 0.08 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 122.582 1.182 . . . . 2.19 108.333 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.811 ' HA ' ' CE2' ' A' ' 74' ' ' TRP . 5.6 ptm180 -54.34 -40.27 67.87 Favored 'General case' 0 C--O 1.209 -1.057 0 CA-C-N 113.535 -1.666 . . . . 3.95 110.088 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.721 ' N ' ' HG3' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -65.61 -26.02 38.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.646 -1.161 . . . . 1.42 110.792 -175.3 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.702 HG21 ' O ' ' A' ' 70' ' ' ASP . 0.9 OUTLIER -81.66 -31.25 32.39 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.491 -0.777 . . . . 1.45 109.986 -174.386 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.811 ' CE2' ' HA ' ' A' ' 71' ' ' ARG . 27.6 p-90 -111.57 0.82 16.55 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.283 -0.567 . . . . 0.78 111.396 -177.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.688 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 5.3 t70 -68.25 175.62 3.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.512 0.673 . . . . 2.19 111.723 -175.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.485 ' HG2' ' ND2' ' A' ' 198' ' ' ASN . 28.9 mmmt -95.96 -40.65 9.17 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.563 -0.744 . . . . 3.68 109.832 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.8 t -119.72 16.14 12.73 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.439 -0.8 . . . . 2.08 111.356 -171.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 56.1 mt -110.91 -179.32 3.71 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.537 -0.465 . . . . 1.16 111.924 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.569 ' HG2' ' HG2' ' A' ' 99' ' ' GLN . 12.0 mm-40 -154.94 -61.59 0.12 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.519 -0.764 . . . . 2.23 111.219 -175.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.672 ' O ' ' HA ' ' A' ' 96' ' ' THR . 30.6 t -142.46 127.74 16.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.377 -0.374 . . . . 1.44 110.648 -166.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.459 ' HB3' ' CD1' ' A' ' 72' ' ' ILE . 42.8 p90 -95.41 146.62 24.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.611 0.243 . . . . 5.73 110.639 176.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 58.4 m-80 -153.45 107.18 3.02 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.548 -0.538 . . . . 1.86 109.548 176.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.03 96.61 3.84 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.259 -0.645 . . . . 2.52 109.259 177.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -73.12 -62.78 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.352 0.596 . . . . 1.19 110.805 -169.358 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -133.97 113.96 12.73 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.275 -0.875 . . . . 2.59 108.824 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.2 mtt180 -98.28 103.74 15.71 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.971 -0.751 . . . . 2.83 108.971 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -72.23 -46.2 58.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.456 -0.793 . . . . 1.17 110.989 -171.551 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -141.92 -163.75 1.65 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.87 -0.789 . . . . 1.86 108.87 -173.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.4 m -81.18 -14.8 57.21 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.844 0.354 . . . . 1.94 110.3 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -131.82 14.81 4.83 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 110.078 -0.342 . . . . 1.87 110.078 -175.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.578 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.4 OUTLIER -134.11 110.95 9.95 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 108.682 -0.858 . . . . 1.12 108.682 -175.097 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.526 ' O ' HD13 ' A' ' 114' ' ' LEU . 21.7 m-85 -130.24 169.34 15.52 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.953 -0.567 . . . . 0.52 110.391 -173.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.593 ' O ' HG23 ' A' ' 84' ' ' VAL . 28.4 mt -135.06 123.89 41.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 107.43 -1.322 . . . . 1.1 107.43 169.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 65.2 m -110.27 125.44 53.12 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.636 -0.425 . . . . 2.61 111.315 -175.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 22.2 t60 -90.91 87.65 6.72 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 122.134 0.969 . . . . 2.17 108.702 168.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.672 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 89.6 m -102.56 130.77 49.51 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.275 -1.329 . . . . 1.19 109.926 -177.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.402 ' O ' ' HB2' ' A' ' 79' ' ' GLN . 47.1 mm -80.99 128.82 38.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 C-N-CA 119.671 -0.811 . . . . 1.63 108.891 172.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.575 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 1.5 m -102.28 143.95 31.41 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.969 -0.559 . . . . 1.72 110.255 -176.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.569 ' HG2' ' HG2' ' A' ' 79' ' ' GLN . 5.5 mm-40 . . . . . 0 C--N 1.323 -0.58 0 CA-C-N 115.948 -0.569 . . . . 2.29 110.804 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 60.4 mt . . . . . 0 N--CA 1.45 -0.447 0 N-CA-C 109.523 -0.547 . . . . 1.53 109.523 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 48.4 m -84.91 152.9 59.95 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 110.083 -0.34 . . . . 1.71 110.083 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.94 130.98 36.78 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.768 2.312 . . . . 1.31 111.048 177.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.641 ' HG2' ' O ' ' A' ' 144' ' ' ILE . 12.2 ttp180 -109.73 154.92 22.23 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.285 -0.566 . . . . 4.06 111.046 -167.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.427 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 5.1 t0 -95.33 140.82 29.67 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.658 -0.867 . . . . 1.37 108.658 174.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.655 ' CE1' ' HB2' ' A' ' 113' ' ' ASP . 13.4 t80 -123.76 108.74 12.85 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.664 -0.865 . . . . 3.01 108.664 -179.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.624 HG21 ' CE1' ' A' ' 134' ' ' PHE . 12.6 mm -124.1 74.78 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 107.933 -1.136 . . . . 1.2 107.933 173.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.655 ' HB2' ' CE1' ' A' ' 111' ' ' PHE . 1.0 OUTLIER -102.48 124.18 47.58 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.587 -0.733 . . . . 1.86 110.094 -176.39 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.526 HD13 ' O ' ' A' ' 92' ' ' PHE . 10.6 tp -76.98 121.97 24.23 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 115.265 -0.88 . . . . 1.08 109.364 174.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -122.82 123.95 69.36 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 CA-C-N 114.157 -1.383 . . . . 1.08 111.503 -166.561 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.555 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 53.8 t80 -117.22 125.4 51.09 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.647 -0.706 . . . . 2.81 110.571 175.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 126' ' ' ILE . 91.8 mt -96.96 99.24 8.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.484 -0.78 . . . . 1.53 110.54 -177.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -101.86 135.1 44.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.11 -0.95 . . . . 1.81 108.867 178.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.519 ' O ' ' HD3' ' A' ' 119' ' ' ARG . 0.1 OUTLIER -124.19 110.6 14.87 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 121.903 0.859 . . . . 3.22 108.907 176.368 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.564 ' CB ' ' HB3' ' A' ' 123' ' ' ASN . 59.3 m-85 -77.88 116.83 18.68 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.064 -1.088 . . . . 1.28 108.064 171.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.427 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 1.6 mp0 -28.7 93.72 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 O-C-N 125.086 1.491 . . . . 2.28 113.321 178.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 56.29 36.86 70.69 Favored Glycine 0 CA--C 1.507 -0.451 0 CA-C-N 115.117 -0.947 . . . . 0.79 112.312 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.564 ' HB3' ' CB ' ' A' ' 120' ' ' TYR . 59.2 t30 -128.83 -53.4 1.23 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.971 -0.614 . . . . 2.06 109.694 -176.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.554 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 0.4 OUTLIER -157.14 125.36 5.57 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.112 -0.495 . . . . 1.73 110.986 -179.069 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -107.75 82.59 1.67 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.248 -1.019 . . . . 2.07 108.248 175.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.492 ' CG1' HG12 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -100.93 139.37 22.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.892 -0.595 . . . . 1.06 112.421 -171.74 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.401 ' HB ' HG12 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -107.4 119.45 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 107.358 -1.349 . . . . 1.26 107.358 159.428 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.545 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 30.3 p -82.88 167.3 18.18 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.037 -0.727 . . . . 1.53 109.037 174.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.404 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 67.7 p -158.48 120.01 3.49 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.9 0.381 . . . . 1.81 110.231 -178.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.48 ' NZ ' HD21 ' A' ' 114' ' ' LEU . 3.1 ttpm? -131.95 115.01 15.32 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 108.128 -1.064 . . . . 2.75 108.128 -176.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 96.9 p -61.78 100.14 0.14 Allowed 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 107.698 -1.223 . . . . 1.94 107.698 -177.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.44 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -107.77 138.23 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.115 0 CA-C-N 115.163 -0.926 . . . . 1.64 108.847 -165.351 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -99.76 64.32 1.26 Allowed 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 122.432 1.11 . . . . 2.17 108.64 -168.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.797 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -90.74 162.02 34.52 Favored Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 113.387 -1.733 . . . . 0.67 110.64 -171.596 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -77.86 -12.91 16.21 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 123.072 2.514 . . . . 1.66 114.762 -173.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.797 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 5.7 tp10 -72.7 -17.78 61.6 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 109.48 -0.563 . . . . 3.5 109.48 -171.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -163.13 112.01 1.03 Allowed Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 113.351 0.871 . . . . 6.41 113.351 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -83.96 126.0 3.77 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 123.077 2.518 . . . . 2.31 110.035 163.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.445 ' HG3' ' HB2' ' A' ' 145' ' ' ARG . 11.2 Cg_endo -52.54 -92.47 0.0 OUTLIER 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 123.447 2.765 . . . . 1.27 114.956 -168.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.1 t -172.53 171.52 4.57 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.621 -0.511 . . . . 1.88 109.621 -174.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.8 p -90.22 -15.41 31.46 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.228 -0.656 . . . . 2.43 109.228 171.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -98.56 -50.44 4.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.582 -0.736 . . . . 2.18 110.133 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.427 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 40.2 m-85 -83.44 130.4 35.03 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 115.847 -0.615 . . . . 1.33 109.455 176.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.641 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -100.9 113.53 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 N-CA-C 107.991 -1.114 . . . . 1.4 107.991 -179.407 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.445 ' HB2' ' HG3' ' A' ' 139' ' ' PRO . 6.4 tmm_? -57.41 97.38 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.674 -1.232 . . . . 5.14 107.674 170.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.486 ' HA3' ' NH1' ' A' ' 109' ' ' ARG . . . -66.07 129.0 31.85 Favored Glycine 0 CA--C 1.49 -1.477 0 N-CA-C 110.63 -0.988 . . . . 1.05 110.63 -176.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -82.74 107.05 15.08 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.515 1.15 . . . . 4.68 110.733 -175.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -110.36 110.97 21.96 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.05 -1.886 . . . . 2.29 108.396 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.508 ' O ' ' N ' ' A' ' 151' ' ' CYS . 29.6 m-70 -57.63 163.29 3.91 Favored Pre-proline 0 C--O 1.217 -0.628 0 CA-C-O 118.174 -0.917 . . . . 2.95 109.012 175.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.509 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 1.2 Cg_endo -44.12 77.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 123.841 3.027 . . . . 0.77 113.719 178.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . 0.565 ' HB3' ' O ' ' A' ' 170' ' ' PHE . 45.4 m -108.96 -171.81 1.92 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.999 -1.0 . . . . 1.97 109.325 177.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.618 ' O ' ' HG3' ' A' ' 169' ' ' MET . . . 174.45 -153.29 16.04 Favored Glycine 0 N--CA 1.435 -1.421 0 C-N-CA 119.028 -1.558 . . . . 0.55 112.644 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.58 ' CD1' HD13 ' A' ' 65' ' ' LEU . 3.6 t80 -156.47 97.96 1.79 Allowed 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.517 -1.29 . . . . 0.8 107.517 -163.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.616 ' CG2' HG11 ' A' ' 168' ' ' VAL . 2.6 m -105.56 146.25 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 C-N-CA 119.705 -0.798 . . . . 1.03 110.856 -174.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . 0.578 ' SG ' ' HB3' ' A' ' 58' ' ' PRO . 18.5 t -118.57 138.19 52.72 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.042 -0.981 . . . . 2.3 108.439 173.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.507 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 12.4 m -123.24 111.22 30.41 Favored Pre-proline 0 C--N 1.307 -1.263 0 C-N-CA 120.697 -0.401 . . . . 1.45 110.878 -177.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.444 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 71.4 Cg_exo -50.22 117.74 3.4 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.43 2.087 . . . . 0.72 111.045 170.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.425 ' HB3' ' H ' ' A' ' 159' ' ' GLU . 88.6 mmm -79.13 -162.72 0.42 Allowed 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.066 0.46 . . . . 1.72 111.462 -175.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.425 ' H ' ' HB3' ' A' ' 158' ' ' MET . 19.7 mm-40 -75.38 -35.97 60.99 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.615 -0.883 . . . . 2.63 108.615 172.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.405 ' C ' ' HD2' ' A' ' 162' ' ' PRO . 16.5 mt-10 -96.92 29.18 3.16 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.161 -1.381 . . . . 2.05 108.636 174.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.52 ' ND2' ' HD3' ' A' ' 162' ' ' PRO . 5.2 p-10 -34.18 -47.28 0.77 Allowed Pre-proline 0 N--CA 1.471 0.611 0 N-CA-C 116.398 1.999 . . . . 2.19 116.398 -168.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.52 ' HD3' ' ND2' ' A' ' 161' ' ' ASN . 71.3 Cg_endo -73.94 -17.85 22.09 Favored 'Trans proline' 0 C--N 1.351 0.703 0 CA-C-N 121.755 1.662 . . . . 0.86 113.047 -176.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -109.16 -25.89 10.4 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.191 -0.459 . . . . 1.34 110.832 -178.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -138.3 124.7 20.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.825 -0.625 . . . . 1.46 109.467 176.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 3.7 p -125.62 142.25 51.61 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.155 0.502 . . . . 2.05 111.154 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.531 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.9 tppp? -88.27 119.6 28.83 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.629 0.728 . . . . 1.4 111.482 -175.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.559 HD11 ' CZ ' ' A' ' 153' ' ' PHE . 0.3 OUTLIER -101.96 117.17 34.27 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.244 -0.889 . . . . 1.07 110.099 176.64 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.616 HG11 ' CG2' ' A' ' 154' ' ' VAL . 0.1 OUTLIER -140.84 126.41 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-O 121.558 0.694 . . . . 1.11 112.413 177.699 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.618 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 12.1 ttt -145.44 145.72 31.23 Favored 'General case' 0 C--O 1.22 -0.485 0 C-N-CA 123.091 0.556 . . . . 1.79 110.919 -170.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.857 ' CE2' HG23 ' A' ' 14' ' ' VAL . 12.1 p90 -136.95 162.73 32.47 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.375 0.607 . . . . 4.22 112.223 171.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.524 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 1.4 m -136.54 143.53 35.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 113.592 -1.64 . . . . 2.01 110.481 173.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.479 ' HB3' ' HB2' ' A' ' 149' ' ' HIS . 7.7 tt0 -120.29 54.95 1.02 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.889 -1.522 . . . . 2.66 106.889 172.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.1 m -64.02 144.5 57.04 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 113.791 -1.55 . . . . 2.2 110.708 -173.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 C--O 1.233 0.217 0 C-N-CA 120.714 -0.394 . . . . 2.45 110.531 178.85 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.485 ' HA ' ' HE2' ' A' ' 186' ' ' LYS . 15.9 mm . . . . . 0 CA--C 1.508 -0.668 0 CA-C-O 122.498 1.142 . . . . 1.69 108.793 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.628 ' HA ' ' CG2' ' A' ' 187' ' ' THR . 1.1 mp -73.61 -33.05 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 113.103 -1.862 . . . . 1.77 111.168 -175.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 189' ' ' PRO . 10.4 pt-20 -65.57 -21.73 66.62 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.83 -0.804 . . . . 2.89 108.83 173.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.565 ' O ' ' HB2' ' A' ' 190' ' ' SER . 49.2 mtmt -92.36 -24.71 18.82 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.648 -0.705 . . . . 1.71 110.026 176.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.628 ' CG2' ' HA ' ' A' ' 184' ' ' ILE . 4.5 t -91.18 -47.98 7.2 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 119.499 -0.88 . . . . 1.3 112.772 -178.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' MET . . . . . 0.561 ' O ' ' HG ' ' A' ' 192' ' ' LEU . 0.0 OUTLIER -80.48 -71.04 0.15 Allowed Pre-proline 0 N--CA 1.471 0.593 0 CA-C-N 119.403 1.002 . . . . 1.39 112.447 -175.651 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.413 ' HG2' ' O ' ' A' ' 185' ' ' GLU . 44.7 Cg_endo -68.25 -22.93 39.53 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.307 1.338 . . . . 1.15 112.022 -171.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.565 ' HB2' ' O ' ' A' ' 186' ' ' LYS . 66.9 m -83.83 -23.99 31.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.733 -0.667 . . . . 1.95 110.707 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 187' ' ' THR . 55.0 t30 -89.85 -25.4 21.05 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.439 -0.505 . . . . 1.92 110.834 178.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 188' ' ' MET . 15.5 mt -68.84 -47.69 65.39 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.777 0.322 . . . . 1.68 111.029 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.581 HG12 ' CG2' ' A' ' 35' ' ' VAL . 3.8 m -67.89 -23.19 28.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 120.353 -0.539 . . . . 1.32 110.165 175.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -76.45 -31.06 57.6 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.831 -0.622 . . . . 2.6 110.835 176.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -67.14 -31.36 71.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.077 0.465 . . . . 2.73 109.78 171.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.551 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 63.2 mt -77.66 -30.07 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 116.121 -0.49 . . . . 1.11 110.62 174.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 57.1 mt -71.69 -38.76 70.56 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-O 121.468 0.651 . . . . 1.57 109.434 173.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.495 ' ND2' ' HA ' ' A' ' 75' ' ' ASP . 2.6 m120 -54.5 -35.26 62.94 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.393 -1.276 . . . . 2.18 109.112 167.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.659 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -75.59 -43.74 46.65 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 120.483 -0.487 . . . . 1.04 110.413 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.616 ' O ' ' HG3' ' A' ' 204' ' ' LYS . 32.0 mmtp -56.11 -44.21 78.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.135 0.493 . . . . 1.51 110.613 174.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -85.41 -41.14 15.69 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.585 -0.734 . . . . 1.94 111.419 -174.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . 0.496 ' HA3' ' CH2' ' A' ' 74' ' ' TRP . . . -68.26 -27.99 73.5 Favored Glycine 0 CA--C 1.507 -0.458 0 N-CA-C 111.502 -0.639 . . . . 0.47 111.502 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.659 ' HB ' ' O ' ' A' ' 199' ' ' ALA . 2.8 tp -71.7 -31.41 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 109.327 -0.62 . . . . 1.16 109.327 176.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.616 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 57.5 mttp -84.63 -25.07 28.8 Favored 'General case' 0 C--O 1.208 -1.093 0 N-CA-C 108.528 -0.916 . . . . 3.8 108.528 176.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.046 0 CA-C-N 115.675 -0.693 . . . . 1.28 109.701 170.433 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.736 ' O ' HD11 ' A' ' 6' ' ' ILE . 15.5 m-20 . . . . . 0 CA--C 1.5 -0.972 0 N-CA-C 108.392 -0.966 . . . . 2.25 108.392 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.797 ' HA ' HD13 ' A' ' 6' ' ' ILE . 82.7 m-85 -63.6 -35.63 81.14 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 114.676 -1.147 . . . . 0.45 109.168 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.739 ' O ' ' HB3' ' A' ' 8' ' ' GLN . 23.2 tptm -60.81 -47.97 83.92 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 115.302 -0.863 . . . . 2.06 109.074 178.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.17 -46.31 62.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.924 -0.58 . . . . 1.2 112.125 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.797 HD13 ' HA ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -80.63 -36.5 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 CA-C-O 121.674 0.75 . . . . 1.76 109.562 -172.148 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.633 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . . . -76.86 -43.24 36.92 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.239 -1.346 . . . . 1.11 111.472 -175.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.739 ' HB3' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -60.96 -33.53 73.34 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.202 -1.363 . . . . 2.14 109.086 -178.406 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.528 ' HG2' ' HG3' ' A' ' 8' ' ' GLN . 25.6 mm-40 -92.47 -32.85 14.74 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.86 -1.064 . . . . 3.04 110.674 -178.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.706 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.4 OUTLIER -75.75 -26.56 57.53 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.786 -0.365 . . . . 1.1 110.753 178.028 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -49.34 -44.39 44.54 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 120.208 -0.597 . . . . 1.04 111.811 170.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.66 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 4.0 pt20 -83.73 -1.5 54.27 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 122.075 -0.391 . . . . 2.31 110.986 176.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 29.4 mm-40 -88.45 -44.9 10.38 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.803 -0.443 . . . . 2.54 109.803 174.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.689 ' HA ' ' HE2' ' A' ' 170' ' ' PHE . 3.9 p -66.51 -39.96 85.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 122.116 0.96 . . . . 1.21 108.912 170.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.66 ' HB3' ' HA ' ' A' ' 12' ' ' GLN . 0.9 OUTLIER -66.9 -21.98 65.98 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 114.749 -1.114 . . . . 1.26 108.084 172.552 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.689 ' HA2' ' NE ' ' A' ' 19' ' ' ARG . . . -62.47 -24.44 65.86 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 113.909 -1.496 . . . . 0.57 110.268 176.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.447 ' HD1' ' O ' ' A' ' 13' ' ' GLU . 19.6 m-85 -92.55 -8.55 44.07 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.246 -0.477 . . . . 3.59 109.946 178.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.605 HD22 ' HE3' ' A' ' 124' ' ' MET . 0.3 OUTLIER -89.47 -10.97 44.36 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 119.295 -0.962 . . . . 2.1 108.608 176.999 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.689 ' NE ' ' HA2' ' A' ' 16' ' ' GLY . 19.5 ptt85 -122.64 3.25 9.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.618 -1.173 . . . . 3.26 110.561 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.636 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 23.0 t70 -90.28 112.8 24.47 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 116.223 -0.444 . . . . 2.16 110.821 -175.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.8 p -129.96 93.81 3.58 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.691 0.758 . . . . 2.24 109.334 176.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.1 t -127.26 -78.19 0.58 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.638 -1.165 . . . . 2.46 111.202 -169.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.09 60.38 0.55 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.52 -0.848 . . . . 1.45 112.374 -177.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -120.39 -163.73 1.03 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.107 0.479 . . . . 2.24 110.221 176.869 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.503 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 1.2 mtpp -176.77 135.65 0.22 Allowed 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.201 -1.037 . . . . 3.43 108.201 -172.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.607 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 3.2 m -66.55 123.88 20.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.895 0.855 . . . . 2.21 110.703 177.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.2 p -97.76 -23.25 4.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 114.199 -1.364 . . . . 1.83 108.795 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.507 ' HA ' ' HD2' ' A' ' 28' ' ' LYS . 10.0 tptm -155.47 112.93 3.32 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 119.995 -0.682 . . . . 2.87 111.824 -174.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.936 HG21 ' HA ' ' A' ' 34' ' ' THR . 75.2 p -130.97 126.93 37.32 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.54 -0.541 . . . . 1.92 109.54 172.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.3 m -85.18 -79.94 0.22 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.536 -0.302 . . . . 2.37 110.984 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.511 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 7.2 ptpp? -159.17 28.55 0.21 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.498 0.189 . . . . 4.84 110.894 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.609 ' HB2' ' HZ3' ' A' ' 32' ' ' LYS . 1.4 ttmp? 170.35 -20.7 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.979 -0.555 . . . . 2.05 110.31 -176.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.873 HG23 ' HA3' ' A' ' 52' ' ' GLY . 46.1 pt -109.26 157.3 9.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.771 -0.65 . . . . 1.42 110.486 178.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.936 ' HA ' HG21 ' A' ' 29' ' ' THR . 85.6 m -148.79 100.07 3.05 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.65 -0.705 . . . . 1.22 111.133 -164.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.93 HG12 HD12 ' A' ' 192' ' ' LEU . 2.3 t -96.06 106.98 19.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.871 0.367 . . . . 1.52 110.281 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.607 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 6.0 p -96.62 126.04 41.52 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.453 0.645 . . . . 1.74 110.735 177.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.2 t -103.29 127.75 50.53 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.782 -1.099 . . . . 1.72 109.199 -176.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.512 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 25.1 ttpp . . . . . 0 C--N 1.319 -0.744 0 CA-C-N 116.33 -0.395 . . . . 2.45 110.983 -177.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 N--CA 1.449 -0.509 0 N-CA-C 113.054 0.761 . . . . 2.45 113.054 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.74 HD23 ' CD1' ' A' ' 170' ' ' PHE . 9.7 tt -128.85 147.78 50.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.171 -1.377 . . . . 1.49 107.615 178.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.44 ' N ' HD21 ' A' ' 47' ' ' LEU . 94.0 m-85 -122.71 134.35 54.46 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.151 -0.62 . . . . 1.52 111.587 -170.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.486 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 2.6 tmt_? -130.67 118.56 21.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.813 -0.631 . . . . 3.34 111.044 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.891 HG12 HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -92.5 153.35 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-O 120.989 0.423 . . . . 1.98 110.642 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.479 ' CG ' ' HD2' ' A' ' 166' ' ' LYS . 16.3 tt0 -153.31 106.56 2.98 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.557 -0.905 . . . . 1.07 108.557 178.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.873 ' HA3' HG23 ' A' ' 33' ' ' ILE . . . -140.94 141.21 11.07 Favored Glycine 0 CA--C 1.498 -0.998 0 C-N-CA 120.239 -0.981 . . . . 0.35 111.542 -178.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' ' 165' ' ' SER . 61.6 mt -88.44 120.35 37.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 C-N-CA 120.206 -0.598 . . . . 1.3 110.89 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.645 HG12 ' HD3' ' A' ' 200' ' ' LYS . 63.7 mt -95.74 119.2 65.36 Favored Pre-proline 0 N--CA 1.443 -0.785 0 N-CA-C 109.096 -0.705 . . . . 1.07 109.096 173.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 28.1 Cg_exo -64.72 59.35 0.28 Allowed 'Trans proline' 0 N--CA 1.473 0.268 0 C-N-CA 124.08 3.187 . . . . 0.74 112.959 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.425 ' HG2' ' CG1' ' A' ' 203' ' ' ILE . 14.5 tp10 -156.21 175.85 13.45 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.287 -1.375 . . . . 1.68 107.287 177.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.422 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 43.3 p -88.81 141.66 30.01 Favored Pre-proline 0 N--CA 1.429 -1.522 0 CA-C-O 121.512 0.672 . . . . 1.58 110.211 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.794 ' HD3' ' HB3' ' A' ' 165' ' ' SER . 6.3 Cg_endo -49.34 -14.85 0.63 Allowed 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 124.963 3.775 . . . . 0.74 112.587 173.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.76 -47.74 29.45 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 116.11 -0.495 . . . . 1.31 111.204 176.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.624 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 1.4 tpmt? -67.64 -31.42 71.42 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.841 -1.17 . . . . 3.78 107.841 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 1.087 HD21 HD12 ' A' ' 203' ' ' ILE . 83.2 mt -63.23 -56.29 17.88 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.034 -1.439 . . . . 1.09 110.778 175.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.2 t -62.95 -12.17 23.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.67 0.271 . . . . 1.94 110.564 177.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -84.04 -41.91 16.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.369 -0.378 . . . . 1.32 112.0 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.765 ' HD2' ' CZ2' ' A' ' 74' ' ' TRP . 15.4 p90 -85.88 -42.02 14.46 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.399 0.518 . . . . 0.79 112.399 -170.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.728 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -89.95 4.49 49.89 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.06 0.391 . . . . 2.15 111.932 -170.08 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.601 ' O ' ' HG3' ' A' ' 67' ' ' GLN . 75.2 t80 -41.89 -73.1 0.05 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.973 0.731 . . . . 2.06 112.973 -166.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.601 ' HG3' ' O ' ' A' ' 66' ' ' TYR . 72.4 mt-30 -168.07 -61.57 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.7 0.762 . . . . 4.31 110.462 -178.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.846 ' HB ' ' CD2' ' A' ' 81' ' ' TYR . 10.2 t -126.23 26.19 6.5 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.111 -1.44 . . . . 1.89 107.111 178.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.686 ' O ' ' HB2' ' A' ' 70' ' ' ASP . . . -72.15 -14.12 76.48 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 113.531 -1.668 . . . . 1.71 112.735 -169.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.686 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 15.1 t70 132.91 -8.95 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 O-C-N 125.844 1.555 . . . . 2.19 107.051 -171.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.767 ' HA ' ' CE2' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -59.41 -36.24 75.48 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.525 -1.216 . . . . 3.95 111.239 -170.089 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 1.005 HG21 HD13 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -80.5 -14.14 12.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.581 -0.448 . . . . 1.42 110.973 -175.84 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.654 HG23 ' O ' ' A' ' 70' ' ' ASP . 1.1 t -88.11 -31.7 19.07 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 119.972 -0.691 . . . . 1.45 110.15 -176.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.887 ' HZ3' ' HB3' ' A' ' 198' ' ' ASN . 15.0 p-90 -100.64 -7.21 24.16 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.411 -0.516 . . . . 0.78 111.023 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.798 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 5.7 t70 -73.7 167.98 20.3 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.47 0.653 . . . . 2.19 110.267 -177.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.431 ' H ' ' HG3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -112.8 -16.17 12.8 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.923 -1.035 . . . . 3.68 111.512 -172.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.1 t -119.62 9.02 11.35 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.339 0.59 . . . . 2.08 109.456 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 1.005 HD13 HG21 ' A' ' 72' ' ' ILE . 19.9 mt -109.72 159.68 16.95 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.625 -0.716 . . . . 1.16 112.421 -175.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.573 ' HB3' HG22 ' A' ' 80' ' ' VAL . 7.7 mt-30 -131.94 -69.7 0.59 Allowed 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 114.807 -1.088 . . . . 2.23 110.432 178.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.573 HG22 ' HB3' ' A' ' 79' ' ' GLN . 21.3 t -142.84 136.32 26.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.875 -1.057 . . . . 1.44 110.254 -165.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.846 ' CD2' ' HB ' ' A' ' 68' ' ' THR . 80.6 t80 -116.91 146.56 42.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.053 0.454 . . . . 5.73 111.334 177.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.738 ' HB2' ' HD2' ' A' ' 95' ' ' HIS . 14.0 m120 -142.69 124.01 14.69 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.42 -0.809 . . . . 1.86 109.037 175.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.486 ' HG3' ' HH ' ' A' ' 81' ' ' TYR . 2.3 ttt -82.11 97.13 8.03 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.597 -0.89 . . . . 2.52 108.597 -178.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.692 HG11 ' HB2' ' A' ' 137' ' ' TYR . 0.1 OUTLIER -72.92 -80.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.914 -0.584 . . . . 1.19 111.908 -167.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.592 ' HB2' ' HG2' ' A' ' 136' ' ' GLU . 10.4 t60 -126.03 118.36 25.17 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.976 -0.75 . . . . 2.59 108.976 -177.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.429 ' HD3' ' SD ' ' A' ' 83' ' ' MET . 50.4 mtm180 -103.31 103.14 13.13 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.4 -0.593 . . . . 2.83 109.4 -175.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.608 HG23 ' HB2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -67.74 -41.32 85.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.081 -0.963 . . . . 1.17 110.402 -173.547 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -148.35 -161.38 1.33 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.878 -1.156 . . . . 1.86 107.878 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.7 m -93.4 3.87 54.9 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.07 0.462 . . . . 1.94 109.915 175.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -125.07 -3.43 7.58 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 109.07 -0.715 . . . . 1.87 109.07 -175.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.606 HG21 HD13 ' A' ' 114' ' ' LEU . 2.1 m -145.92 116.52 7.61 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 109.288 -0.634 . . . . 1.12 109.288 -171.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.575 ' HB2' HE22 ' A' ' 67' ' ' GLN . 10.8 m-85 -129.82 176.88 7.68 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.175 -0.676 . . . . 0.52 109.175 -177.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.665 HD12 ' HB2' ' A' ' 114' ' ' LEU . 1.3 mm -122.43 131.81 72.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 107.851 -1.166 . . . . 1.1 107.851 168.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.403 ' CB ' ' HE1' ' A' ' 81' ' ' TYR . 18.4 p -107.11 107.14 17.98 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.871 -0.331 . . . . 2.61 111.643 -173.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.738 ' HD2' ' HB2' ' A' ' 82' ' ' ASN . 49.4 t60 -81.72 103.57 11.5 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.385 -0.969 . . . . 2.17 108.385 167.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.819 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 33.1 m -125.4 111.18 14.83 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.891 -0.595 . . . . 1.19 111.75 -170.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' A' ' 79' ' ' GLN . 29.0 mm -77.11 136.56 24.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 120.142 -0.623 . . . . 1.63 109.739 177.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.501 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 1.8 m -112.75 147.05 37.67 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.988 -1.005 . . . . 1.72 109.942 -171.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.557 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 6.8 mt-30 . . . . . 0 C--N 1.317 -0.83 0 CA-C-N 115.962 -0.563 . . . . 2.29 110.403 -178.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 44.1 mt . . . . . 0 N--CA 1.445 -0.705 0 N-CA-C 109.722 -0.473 . . . . 1.53 109.722 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.8 p -68.15 157.34 87.58 Favored Pre-proline 0 C--O 1.237 0.44 0 CA-C-N 115.433 -0.803 . . . . 1.71 111.934 -172.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -45.44 124.44 6.51 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 123.252 2.635 . . . . 1.31 110.793 175.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.61 ' HG3' HG23 ' A' ' 144' ' ' ILE . 2.7 ttm180 -122.25 157.19 32.2 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.623 -0.831 . . . . 4.06 110.552 -168.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.625 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 12.3 t0 -126.52 131.03 51.69 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 109.608 -0.516 . . . . 1.37 109.608 176.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.819 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 20.0 m-85 -99.96 131.91 45.64 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 120.946 0.403 . . . . 3.01 110.436 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.47 HG22 ' HE1' ' A' ' 134' ' ' PHE . 20.5 mm -129.8 74.49 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 108.152 -1.055 . . . . 1.2 108.152 168.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.64 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 41.8 m-20 -106.44 140.28 39.59 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.981 -1.009 . . . . 1.86 109.304 -178.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.665 ' HB2' HD12 ' A' ' 93' ' ' ILE . 5.3 tp -81.93 122.6 27.96 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.162 -0.681 . . . . 1.08 109.162 174.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -117.35 124.05 72.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-O 122.236 1.017 . . . . 1.08 111.981 -166.84 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.89 ' CE2' ' HB3' ' A' ' 128' ' ' SER . 0.1 OUTLIER -113.51 118.42 34.4 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.552 -1.658 . . . . 2.81 110.02 -176.092 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 126' ' ' ILE . 3.9 mp -105.31 99.38 8.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.544 -0.539 . . . . 1.53 109.544 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -107.5 144.17 34.85 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.599 -0.728 . . . . 1.81 109.718 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.447 ' NH1' ' HA ' ' A' ' 121' ' ' GLU . 3.3 tmt_? -121.09 94.1 4.23 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 108.144 -1.058 . . . . 3.22 108.144 -176.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.561 ' CB ' ' HB2' ' A' ' 123' ' ' ASN . 89.5 m-85 -63.73 115.84 5.16 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 106.806 -1.553 . . . . 1.28 106.806 172.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.447 ' HA ' ' NH1' ' A' ' 119' ' ' ARG . 21.0 mt-10 -48.22 85.26 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 O-C-N 125.031 1.457 . . . . 2.28 113.014 -171.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 77.25 29.07 57.0 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 114.91 -1.041 . . . . 0.79 112.509 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.561 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 14.4 m120 -125.5 -51.04 1.62 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.668 -0.266 . . . . 2.06 110.337 178.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.605 ' HE3' HD22 ' A' ' 18' ' ' ASN . 1.9 mpt? -157.03 131.93 8.87 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.834 0.349 . . . . 1.73 111.267 -174.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.417 ' OD1' ' HG2' ' A' ' 119' ' ' ARG . 63.9 m-20 -105.91 79.5 1.43 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.611 -1.255 . . . . 2.07 107.611 171.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.612 ' HB ' HG11 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -89.52 124.83 42.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.699 -0.682 . . . . 1.06 112.213 -173.101 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.549 HG21 HD22 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -107.02 116.89 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 107.528 -1.286 . . . . 1.26 107.528 160.214 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.89 ' HB3' ' CE2' ' A' ' 116' ' ' TYR . 37.9 t -127.88 167.22 16.9 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.425 -0.954 . . . . 1.53 108.425 174.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.64 ' HB3' ' HB3' ' A' ' 113' ' ' ASP . 73.0 m -145.16 137.84 26.15 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.637 -0.505 . . . . 1.81 109.637 -168.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.473 ' HE2' ' HG3' ' A' ' 150' ' ' PRO . 47.0 tttm -123.86 116.21 22.57 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.302 -1.37 . . . . 2.75 107.302 -171.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.654 ' HB3' ' N ' ' A' ' 148' ' ' ASN . 11.8 p -58.65 101.29 0.08 Allowed 'General case' 0 N--CA 1.432 -1.354 0 O-C-N 124.26 0.975 . . . . 1.94 109.303 -173.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.435 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.8 OUTLIER -116.3 131.99 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.139 0 CA-C-N 114.933 -1.03 . . . . 1.64 109.918 -167.392 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -98.24 78.66 2.49 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.742 -1.117 . . . . 2.17 108.209 -175.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.798 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -109.96 156.88 39.22 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 115.395 -0.82 . . . . 0.67 110.264 -171.745 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -75.93 -16.61 18.11 Favored 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.818 2.345 . . . . 1.66 115.267 -169.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.798 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 8.6 tp10 -69.15 -16.47 63.65 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.311 0.577 . . . . 3.5 110.023 -171.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.692 ' HB2' HG11 ' A' ' 84' ' ' VAL . 1.7 t80 -165.5 104.61 0.75 Allowed Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.492 -0.777 . . . . 6.41 112.074 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -88.72 145.18 5.58 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.324 2.683 . . . . 2.31 110.813 170.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -70.27 -166.74 0.21 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.419 2.079 . . . . 1.27 111.762 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.4 m -140.21 -169.75 2.82 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.987 -0.746 . . . . 1.88 108.987 -174.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.9 t -79.45 -37.78 36.17 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 119.899 -0.72 . . . . 2.43 110.249 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -83.28 -17.64 41.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.086 0.469 . . . . 2.18 110.387 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.476 ' HB3' ' CB ' ' A' ' 110' ' ' ASP . 85.9 m-85 -114.65 108.3 16.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.844 -0.616 . . . . 1.33 110.28 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.61 HG23 ' HG3' ' A' ' 109' ' ' ARG . 1.0 OUTLIER -95.39 106.76 18.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.089 -0.505 . . . . 1.4 109.927 -178.267 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.625 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 35.1 ttm180 -50.16 105.37 0.09 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.977 -0.556 . . . . 5.14 111.156 178.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -64.32 112.72 5.23 Favored Glycine 0 N--CA 1.437 -1.281 0 CA-C-N 115.337 -0.847 . . . . 1.05 111.887 176.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.556 ' HB3' ' CB ' ' A' ' 174' ' ' GLU . 0.2 OUTLIER -85.58 93.05 8.71 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.058 0.456 . . . . 4.68 109.878 178.114 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.654 ' N ' ' HB3' ' A' ' 131' ' ' SER . 80.1 m-20 -88.86 81.64 6.9 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.579 -0.737 . . . . 2.29 109.741 175.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.526 ' CD2' ' HD2' ' A' ' 150' ' ' PRO . 0.1 OUTLIER -47.85 123.37 9.74 Favored Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 115.141 -0.936 . . . . 2.95 110.104 179.269 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.526 ' HD2' ' CD2' ' A' ' 149' ' ' HIS . 53.6 Cg_exo -14.31 67.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.223 1 C-N-CA 126.725 4.95 . . . . 0.77 115.712 -161.693 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . 0.706 ' HB2' ' O ' ' A' ' 170' ' ' PHE . 24.5 p -123.86 145.82 48.83 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.005 -0.998 . . . . 1.97 109.512 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.566 ' HA3' ' HG ' ' A' ' 128' ' ' SER . . . -151.26 -134.16 2.13 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 119.012 -1.566 . . . . 0.55 114.004 -175.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.599 ' CE1' HD22 ' A' ' 167' ' ' LEU . 33.0 t80 -161.59 80.71 0.58 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.644 -0.873 . . . . 0.8 108.644 -157.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.646 HG22 HG11 ' A' ' 168' ' ' VAL . 12.6 m -91.66 135.53 26.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.647 0.737 . . . . 1.03 110.561 -174.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . 0.54 ' HG ' HD13 ' A' ' 61' ' ' LEU . 15.2 t -112.19 124.21 51.94 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.271 -0.877 . . . . 2.3 109.122 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.932 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 5.2 m -115.8 110.24 44.45 Favored Pre-proline 0 C--N 1.311 -1.072 0 C-N-CA 120.133 -0.627 . . . . 1.45 111.656 -174.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.496 ' HA ' ' HG3' ' A' ' 58' ' ' PRO . 1.1 Cg_endo -49.2 116.93 2.5 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.668 2.245 . . . . 0.72 110.7 168.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.586 ' SD ' ' HB2' ' A' ' 166' ' ' LYS . 84.6 mmm -82.67 -167.23 1.54 Allowed 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.163 0.506 . . . . 1.72 111.737 -173.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -75.66 -22.35 56.82 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.703 -0.68 . . . . 2.63 109.677 172.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 43.8 mm-40 -104.42 27.56 7.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.829 -1.078 . . . . 2.05 108.805 173.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.732 ' HB3' ' HD3' ' A' ' 162' ' ' PRO . 48.1 t-20 -8.27 -73.24 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 126.547 1.939 . . . . 2.19 115.177 -176.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.732 ' HD3' ' HB3' ' A' ' 161' ' ' ASN . 73.0 Cg_endo -74.28 -13.49 23.15 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 121.312 1.342 . . . . 0.86 114.137 -171.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -108.64 -26.1 10.54 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.918 0.389 . . . . 1.34 111.081 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.57 ' HB2' ' HB2' ' A' ' 160' ' ' GLU . 89.4 m-85 -139.76 126.79 20.97 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.02 -0.537 . . . . 1.46 109.579 178.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.794 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 13.1 p -124.43 147.07 48.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.05 0.452 . . . . 2.05 111.228 -177.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.932 ' HB3' ' HB2' ' A' ' 156' ' ' SER . 1.6 tppp? -91.98 102.24 14.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.56 0.695 . . . . 1.4 111.47 -177.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.599 HD22 ' CE1' ' A' ' 153' ' ' PHE . 0.8 OUTLIER -90.61 107.29 19.08 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.288 -0.869 . . . . 1.07 109.396 175.827 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.646 HG11 HG22 ' A' ' 154' ' ' VAL . 0.1 OUTLIER -129.48 128.21 65.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.626 0.727 . . . . 1.11 111.87 178.084 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.531 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 11.7 ttt -137.97 135.92 36.47 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 115.253 -0.885 . . . . 1.79 109.897 -172.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.74 ' CD1' HD23 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -126.91 151.11 48.88 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.231 -0.588 . . . . 4.22 109.902 176.741 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.639 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 4.0 m -129.18 130.18 67.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-O 121.537 0.684 . . . . 2.01 112.017 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -119.8 37.31 4.24 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.396 -1.705 . . . . 2.66 106.396 170.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 6.7 m -52.21 131.75 32.88 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 113.27 -1.786 . . . . 2.2 111.259 -174.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.556 ' CB ' ' HB3' ' A' ' 147' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--N 1.333 -0.117 0 N-CA-C 112.029 0.381 . . . . 2.45 112.029 -169.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.609 ' HA ' ' HE3' ' A' ' 186' ' ' LYS . 35.3 mm . . . . . 0 CA--C 1.5 -0.955 0 CA-C-O 122.228 1.013 . . . . 1.69 108.77 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.67 ' HA ' ' CG2' ' A' ' 187' ' ' THR . 1.6 mp -66.66 -31.69 54.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 113.269 -1.787 . . . . 1.77 110.437 178.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.426 ' O ' ' HD2' ' A' ' 189' ' ' PRO . 7.5 mm-40 -65.46 -28.91 69.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.102 -0.954 . . . . 2.89 108.733 175.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.609 ' HE3' ' HA ' ' A' ' 183' ' ' ILE . 2.7 ptpt -93.08 -26.29 17.53 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.719 -1.128 . . . . 1.71 110.852 178.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.67 ' CG2' ' HA ' ' A' ' 184' ' ' ILE . 6.2 t -78.34 -44.33 25.41 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 119.996 -0.682 . . . . 1.3 112.01 -176.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' MET . . . . . 0.942 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 2.5 mmt -80.15 -68.63 0.21 Allowed Pre-proline 0 N--CA 1.455 -0.194 0 C-N-CA 120.058 -0.657 . . . . 1.39 110.756 -173.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.942 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 36.7 Cg_exo -60.6 -15.57 37.58 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 122.66 2.24 . . . . 1.15 113.184 -171.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 33.3 t -86.07 -45.27 11.56 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.734 -0.469 . . . . 1.95 109.734 175.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.643 ' HA ' ' HB2' ' A' ' 194' ' ' ASN . 6.5 t30 -85.17 -21.6 29.13 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.598 -0.441 . . . . 1.92 112.187 -167.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.93 HD12 HG12 ' A' ' 35' ' ' VAL . 2.4 mt -60.26 -51.97 67.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.872 0.844 . . . . 1.68 109.844 173.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.537 ' HB ' ' CD1' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -72.12 -32.32 42.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 114.594 -1.184 . . . . 1.32 109.781 -178.011 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.643 ' HB2' ' HA ' ' A' ' 191' ' ' ASN . 0.9 OUTLIER -72.24 -30.54 64.98 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.646 -1.161 . . . . 2.6 111.721 -179.327 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -70.58 -29.12 65.46 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.516 -0.474 . . . . 2.73 109.918 173.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.518 HG12 HD12 ' A' ' 167' ' ' LEU . 39.1 mt -76.18 -26.54 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-O 121.315 0.579 . . . . 1.11 110.375 173.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 197' ' ' LEU . 55.3 mt -70.0 -42.74 72.63 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 116.126 -0.488 . . . . 1.57 109.947 173.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.887 ' HB3' ' HZ3' ' A' ' 74' ' ' TRP . 91.2 m-20 -50.53 -33.21 20.74 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.983 -1.008 . . . . 2.18 109.846 168.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.66 ' HA ' ' CE2' ' A' ' 64' ' ' PHE . . . -80.52 -40.51 25.91 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 116.229 -0.441 . . . . 1.04 111.099 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.645 ' HD3' HG12 ' A' ' 54' ' ' ILE . 25.7 mmtm -60.05 -42.05 93.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.559 0.695 . . . . 1.51 110.094 176.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -84.51 -43.54 14.46 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.968 -1.015 . . . . 1.94 110.689 -176.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -65.01 -30.91 79.25 Favored Glycine 0 C--O 1.228 -0.235 0 C-N-CA 120.661 -0.78 . . . . 0.47 111.833 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 1.087 HD12 HD21 ' A' ' 61' ' ' LEU . 3.3 tp -70.53 -39.03 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 123.005 -0.115 . . . . 1.16 110.771 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 41.4 pttt -83.98 -28.42 27.77 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.524 -0.547 . . . . 3.8 109.524 -178.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.774 0 CA-C-N 115.374 -0.83 . . . . 1.28 109.356 170.26 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.5 mtm . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 120.754 0.312 . . . . 4.31 110.684 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -153.8 -64.31 0.14 Allowed 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.903 -0.777 . . . . 2.25 108.903 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.517 ' CD2' HD12 ' A' ' 87' ' ' ILE . 59.1 m-85 -63.86 -33.15 75.04 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.459 0.647 . . . . 0.45 109.341 177.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.58 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 5.7 mttp -70.1 -46.63 64.45 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 115.119 -0.946 . . . . 2.06 108.498 178.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -47.49 -48.58 27.04 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 112.324 0.49 . . . . 1.2 112.324 -176.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.577 ' O ' ' HB ' ' A' ' 10' ' ' THR . 0.2 OUTLIER -82.95 -34.06 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 121.291 0.567 . . . . 1.76 110.041 -173.032 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.564 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -78.83 -42.76 26.81 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.058 -0.973 . . . . 1.11 111.767 -176.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.823 HE21 ' HH ' ' A' ' 116' ' ' TYR . 34.6 mt-30 -59.35 -32.95 70.58 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.729 -1.123 . . . . 2.14 110.103 175.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.691 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 16.3 mm-40 -79.09 -41.7 28.07 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.104 -0.953 . . . . 3.04 108.778 173.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.61 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.3 OUTLIER -63.36 -35.53 80.71 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.039 -0.982 . . . . 1.1 111.625 -176.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.443 ' O ' HG11 ' A' ' 14' ' ' VAL . . . -46.26 -63.05 1.09 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.941 0.4 . . . . 1.04 111.4 170.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.407 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 10.4 pt20 -72.69 -9.86 59.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.289 -0.414 . . . . 2.31 112.051 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.691 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 51.0 mt-10 -77.95 -50.23 12.57 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.631 -0.507 . . . . 2.54 109.631 174.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.625 HG22 ' N ' ' A' ' 152' ' ' GLY . 5.8 p -68.65 -39.42 80.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 122.049 0.928 . . . . 1.21 109.393 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.407 ' HB3' ' HA ' ' A' ' 12' ' ' GLN . 0.8 OUTLIER -66.9 -27.57 67.61 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 114.548 -1.206 . . . . 1.26 108.93 173.184 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.93 -17.86 63.69 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 113.97 -1.468 . . . . 0.57 110.662 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.5 ' CD2' ' HA ' ' A' ' 14' ' ' VAL . 17.9 m-85 -90.63 -22.65 21.11 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.089 -0.556 . . . . 3.59 109.508 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.486 ' CB ' ' HZ ' ' A' ' 170' ' ' PHE . 0.1 OUTLIER -69.67 -24.38 63.6 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 120.184 -0.607 . . . . 2.1 109.385 176.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.23 9.7 27.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.324 -0.853 . . . . 3.26 110.118 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -123.08 74.9 1.25 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.444 -0.798 . . . . 2.16 109.108 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.437 HG23 ' CH2' ' A' ' 24' ' ' TRP . 53.2 p -102.83 88.84 3.29 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.453 0.644 . . . . 2.24 111.183 -172.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.1 p -173.4 168.64 4.55 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.659 -1.155 . . . . 2.46 110.127 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.57 9.69 62.24 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 121.171 -0.538 . . . . 1.45 112.908 175.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.456 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -120.44 -158.95 0.77 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.88 0.371 . . . . 2.24 111.395 -177.521 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.51 122.37 0.35 Allowed 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.155 -0.683 . . . . 3.43 109.155 -168.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.523 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 3.1 m -65.12 124.12 19.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 122.084 0.945 . . . . 2.21 111.252 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.3 p -102.02 -24.4 4.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 113.918 -1.492 . . . . 1.83 108.84 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 17.7 tppt? -147.81 112.73 5.44 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.903 -0.59 . . . . 2.87 111.89 -174.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.465 HG21 ' HA ' ' A' ' 34' ' ' THR . 43.2 p -130.0 151.04 50.98 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.163 -0.472 . . . . 1.92 110.314 173.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.3 t -118.84 -98.85 0.45 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.27 -0.423 . . . . 2.37 110.027 174.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -144.86 17.52 1.61 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.624 0.726 . . . . 4.84 110.035 176.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.555 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 13.1 tptm -167.92 -0.6 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.677 -0.692 . . . . 2.05 110.738 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.521 ' HA ' ' O ' ' A' ' 51' ' ' GLU . 41.7 pt -136.44 154.02 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 120.951 0.405 . . . . 1.42 110.802 -176.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.465 ' HA ' HG21 ' A' ' 29' ' ' THR . 54.4 m -150.2 99.59 2.82 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.675 -0.693 . . . . 1.22 111.299 -168.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.479 HG12 ' HA ' ' A' ' 189' ' ' PRO . 9.9 t -92.48 118.77 38.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.928 -0.397 . . . . 1.52 109.928 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.523 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -118.64 124.4 47.31 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.435 0.636 . . . . 1.74 111.117 -176.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.515 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 22.4 m -95.28 122.48 38.02 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.721 -1.127 . . . . 1.72 111.037 -175.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.456 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 29.1 ttmt -119.21 -90.85 0.57 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.508 -0.315 . . . . 2.45 111.354 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.84 130.72 5.79 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.246 -0.279 . . . . 2.17 110.246 -174.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.413 ' CB ' ' HB2' ' A' ' 172' ' ' GLN . 4.2 p -77.71 -40.61 40.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.577 -0.283 . . . . 2.51 110.947 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 67.25 -40.44 0.39 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.822 0.849 . . . . 7.41 112.679 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.94 18.92 7.18 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.749 -0.463 . . . . 6.84 109.749 174.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -167.27 149.45 5.98 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.418 -1.327 . . . . 6.42 107.418 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -79.77 59.34 3.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.098 0.475 . . . . 6.31 110.638 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.83 -129.61 1.91 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.968 -0.634 . . . . 1.74 112.482 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.515 ' OD1' ' HB3' ' A' ' 37' ' ' SER . 0.1 OUTLIER -151.51 152.48 33.03 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.706 0.289 . . . . 2.45 110.251 177.725 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.704 HD23 ' N ' ' A' ' 48' ' ' TYR . 6.4 tt -96.97 147.55 23.87 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.283 -0.636 . . . . 1.49 109.283 -177.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.704 ' N ' HD23 ' A' ' 47' ' ' LEU . 46.9 m-85 -117.88 124.36 48.1 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.643 -0.502 . . . . 1.52 109.643 -176.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.419 ' NH1' ' HB2' ' A' ' 51' ' ' GLU . 1.4 tmm_? -117.88 120.69 38.65 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.343 -0.39 . . . . 3.34 109.989 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.523 ' CG1' ' HB3' ' A' ' 192' ' ' LEU . 11.3 p -103.45 149.79 7.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 120.696 -0.402 . . . . 1.98 110.088 177.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.521 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 34.1 tt0 -143.63 111.36 6.01 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.914 -0.584 . . . . 1.07 110.036 -172.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.555 ' HA2' ' O ' ' A' ' 32' ' ' LYS . . . -140.73 138.86 9.23 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.323 -0.941 . . . . 0.35 112.498 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 63.6 mt -90.23 113.93 27.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 120.168 -0.613 . . . . 1.3 110.786 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.44 ' CD1' ' HB3' ' A' ' 199' ' ' ALA . 57.4 mt -95.89 116.53 66.29 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.627 -0.715 . . . . 1.07 109.454 175.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -61.91 64.26 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 124.381 3.388 . . . . 0.74 113.065 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.555 ' HG2' ' CG1' ' A' ' 203' ' ' ILE . 12.4 tp10 -156.84 173.43 17.0 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.656 -0.868 . . . . 1.68 108.656 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.473 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 10.2 m -81.63 142.07 49.12 Favored Pre-proline 0 N--CA 1.423 -1.796 0 N-CA-C 109.332 -0.618 . . . . 1.58 109.332 178.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 57' ' ' SER . 31.2 Cg_exo -59.08 -12.31 15.3 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 123.723 2.949 . . . . 0.74 111.038 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.9 -50.21 37.49 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.825 -1.079 . . . . 1.31 111.292 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -71.02 -27.59 63.79 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.089 -0.708 . . . . 3.78 109.089 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.692 ' O ' HD11 ' A' ' 65' ' ' LEU . 47.0 mt -62.3 -55.8 24.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.86 -1.063 . . . . 1.09 109.666 173.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.523 ' HA ' ' CD1' ' A' ' 65' ' ' LEU . 13.7 p -71.84 -1.64 14.92 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.135 0.493 . . . . 1.94 110.83 176.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -88.85 -30.25 19.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.923 -0.58 . . . . 1.32 111.141 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.693 ' CE1' ' HB3' ' A' ' 65' ' ' LEU . 6.1 p90 -90.02 -46.07 8.75 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 120.774 -0.37 . . . . 0.79 111.06 -174.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.693 ' HB3' ' CE1' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -87.56 6.97 31.76 Favored 'General case' 0 CA--C 1.517 -0.302 0 O-C-N 121.811 -0.556 . . . . 2.15 110.535 -173.545 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -48.44 -63.43 1.08 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.8 -1.091 . . . . 2.06 112.496 -167.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.448 ' O ' ' HD2' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -154.73 -85.32 0.06 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 119.433 -0.907 . . . . 4.31 112.942 -175.683 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.625 ' HB ' ' CD1' ' A' ' 81' ' ' TYR . 9.1 t -141.06 21.52 2.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.965 0.412 . . . . 1.89 111.583 -164.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -115.95 0.98 21.31 Favored Glycine 0 C--N 1.311 -0.833 0 C-N-CA 118.716 -1.707 . . . . 1.71 113.97 -164.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.554 ' O ' HG21 ' A' ' 73' ' ' THR . 6.6 p-10 179.17 -31.81 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.258 -0.645 . . . . 2.19 109.258 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.614 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 18.3 ttt180 -34.57 -59.45 0.46 Allowed 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 125.649 1.58 . . . . 3.95 111.189 176.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.462 HG21 HD11 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -88.8 -6.98 10.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.879 -1.055 . . . . 1.42 111.223 -172.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.554 HG21 ' O ' ' A' ' 70' ' ' ASP . 0.7 OUTLIER -88.21 -45.13 10.34 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 120.326 -0.549 . . . . 1.45 110.523 -171.614 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.512 ' CZ3' ' HB2' ' A' ' 198' ' ' ASN . 18.7 p-90 -102.24 1.38 35.81 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 120.54 -0.464 . . . . 0.78 110.95 -174.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.614 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 5.3 t70 -71.03 -171.07 0.51 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.878 0.846 . . . . 2.19 111.578 -175.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.598 ' HD3' ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -126.34 -29.07 3.01 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.678 -1.146 . . . . 3.68 109.217 -175.694 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.1 m -120.01 8.87 11.08 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.372 -0.831 . . . . 2.08 110.142 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 39.6 mt -108.9 155.39 20.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.99 0.424 . . . . 1.16 110.336 178.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.537 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 5.2 mm-40 -132.04 -69.37 0.6 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.54 -0.755 . . . . 2.23 111.509 -175.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.463 HG21 ' HB3' ' A' ' 79' ' ' GLN . 14.4 t -139.01 134.05 41.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.125 -0.489 . . . . 1.44 110.377 -171.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.625 ' CD1' ' HB ' ' A' ' 68' ' ' THR . 15.9 t80 -117.53 137.05 52.82 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.827 -0.434 . . . . 5.73 109.827 175.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 20.3 m120 -136.6 124.58 22.81 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.655 -0.869 . . . . 1.86 108.655 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.476 ' CG ' ' HD3' ' A' ' 86' ' ' ARG . 21.4 tpp -80.21 97.2 6.83 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.163 -0.926 . . . . 2.52 109.272 -176.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.584 HG21 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -75.65 -77.08 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.099 -0.501 . . . . 1.19 111.817 -170.557 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -136.01 103.54 5.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.984 0.421 . . . . 2.59 110.459 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.476 ' HD3' ' CG ' ' A' ' 83' ' ' MET . 85.1 mtm180 -83.95 133.7 34.69 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.204 -0.665 . . . . 2.83 109.204 175.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.615 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -86.57 -47.16 16.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.624 -0.716 . . . . 1.17 109.32 -174.449 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.402 ' CG ' ' HZ2' ' A' ' 4' ' ' LYS . 22.7 m-20 -142.15 -152.34 0.4 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.224 -0.898 . . . . 1.86 108.948 175.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.3 m -88.33 -7.86 56.04 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.039 0.385 . . . . 1.94 112.039 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -134.4 14.99 3.77 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 120.365 -0.534 . . . . 1.87 110.481 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.615 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.5 OUTLIER -136.49 103.96 5.42 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 108.09 -1.078 . . . . 1.12 108.09 -178.68 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.589 ' O ' HD12 ' A' ' 114' ' ' LEU . 10.2 m-85 -120.65 172.59 7.75 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.008 0.432 . . . . 0.52 110.224 -173.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.584 ' O ' HG21 ' A' ' 84' ' ' VAL . 42.4 mt -132.56 128.46 57.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 107.541 -1.281 . . . . 1.1 107.541 168.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.597 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 26.1 p -106.6 129.91 54.45 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.407 -0.361 . . . . 2.61 111.542 -173.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.503 ' HA ' HD13 ' A' ' 112' ' ' ILE . 4.1 t60 -94.35 90.93 6.46 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.148 -1.056 . . . . 2.17 108.148 163.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.492 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 85.3 m -108.53 109.33 20.55 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.536 -0.756 . . . . 1.19 111.787 -173.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.422 ' O ' ' HB2' ' A' ' 79' ' ' GLN . 44.7 mm -77.65 121.46 30.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.564 -0.902 . . . . 1.63 108.564 171.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.436 HG22 ' CZ ' ' A' ' 111' ' ' PHE . 14.7 t -112.55 156.51 22.53 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.689 0.757 . . . . 1.72 111.222 -176.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.537 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 20.9 mt-30 -107.48 37.7 2.34 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.481 -1.236 . . . . 2.29 108.938 176.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 66.7 m -79.76 65.18 4.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.909 -0.587 . . . . 4.07 110.045 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.456 ' HA ' ' HB ' ' A' ' 106' ' ' ILE . 46.2 p90 -117.82 128.21 54.63 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 115.552 -0.749 . . . . 6.11 110.263 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.545 ' H ' HD12 ' A' ' 106' ' ' ILE . . . -77.22 64.72 2.68 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.942 -1.026 . . . . 1.98 110.959 177.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 97.7 t 74.25 -42.09 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.077 -0.965 . . . . 3.6 112.939 172.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -167.4 -23.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 119.032 -1.556 . . . . 2.2 114.783 -176.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.0 m -83.55 2.82 35.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 117.874 0.837 . . . . 2.08 111.239 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.545 HD12 ' H ' ' A' ' 102' ' ' ALA . 62.0 mt -136.9 140.63 42.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.943 -0.571 . . . . 1.53 110.337 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.0 m -99.06 151.38 37.36 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.66 -0.496 . . . . 1.71 109.66 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.16 147.95 10.61 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.162 2.575 . . . . 1.31 112.195 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.478 ' HG2' HG21 ' A' ' 144' ' ' ILE . 42.6 mtt180 -121.97 157.08 32.08 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.709 -0.796 . . . . 4.06 111.748 -170.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.821 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 7.1 t0 -104.48 116.74 32.63 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.276 -0.875 . . . . 1.37 109.17 174.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.492 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 13.3 m-30 -100.56 109.77 21.88 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.89 -0.506 . . . . 3.01 110.664 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.597 ' HA ' ' O ' ' A' ' 94' ' ' CYS . 24.5 mm -104.96 76.15 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 N-CA-C 109.12 -0.696 . . . . 1.2 109.12 173.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.56 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 25.7 m-20 -99.54 124.15 44.46 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.649 -0.705 . . . . 1.86 110.435 -178.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.589 HD12 ' O ' ' A' ' 92' ' ' PHE . 3.5 tp -75.74 127.19 32.51 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 108.378 -0.971 . . . . 1.08 108.378 169.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -128.62 124.51 61.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-N 115.485 -0.78 . . . . 1.08 112.133 -163.582 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.823 ' HH ' HE21 ' A' ' 8' ' ' GLN . 67.5 t80 -114.36 121.13 42.67 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.923 -1.035 . . . . 2.81 110.943 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.459 HG12 HG23 ' A' ' 127' ' ' ILE . 88.7 mt -95.72 122.31 47.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.801 -0.636 . . . . 1.53 110.438 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -131.41 134.57 46.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.964 -0.562 . . . . 1.81 111.255 -173.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.0 tpp180 -112.93 100.49 8.68 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.908 -0.587 . . . . 3.22 109.616 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -75.11 107.39 7.16 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.571 -1.27 . . . . 1.28 107.571 169.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -26.44 97.12 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 O-C-N 125.024 1.453 . . . . 2.28 113.535 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 56.7 31.89 61.1 Favored Glycine 0 CA--C 1.51 -0.22 0 CA-C-N 114.565 -1.198 . . . . 0.79 113.242 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.639 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 0.8 OUTLIER -125.95 -49.01 1.61 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.957 -0.386 . . . . 2.06 109.957 179.372 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -157.56 141.3 15.79 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 110.259 -0.275 . . . . 1.73 110.259 -178.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -120.33 85.93 2.48 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.404 -0.961 . . . . 2.07 108.404 167.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.452 ' CG1' HG11 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -97.65 144.47 10.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.29 -1.323 . . . . 1.06 112.282 -171.71 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.645 ' O ' HG13 ' A' ' 127' ' ' ILE . 2.1 pt -109.03 116.1 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 108.1 -1.074 . . . . 1.26 108.1 161.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.566 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 43.3 p -83.94 159.05 21.36 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.822 -0.807 . . . . 1.53 108.822 173.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.56 ' HB3' ' HB3' ' A' ' 113' ' ' ASP . 20.4 m -153.15 128.64 9.97 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 120.675 0.274 . . . . 1.81 111.05 -175.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.527 ' HZ1' ' HB3' ' A' ' 130' ' ' LYS . 2.9 mtpm? -128.28 121.01 28.26 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 107.929 -1.137 . . . . 2.75 107.929 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 48.0 t -63.58 100.16 0.26 Allowed 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.318 -1.364 . . . . 1.94 107.318 174.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -108.58 140.08 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.057 0 CA-C-N 114.348 -1.296 . . . . 1.64 108.691 -165.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -96.2 73.15 2.9 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.182 -0.917 . . . . 2.17 109.633 -171.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.769 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -105.38 150.87 39.44 Favored Pre-proline 0 N--CA 1.437 -1.103 0 CA-C-N 114.704 -1.134 . . . . 0.67 109.234 -174.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -76.29 -9.77 19.04 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.736 2.291 . . . . 1.66 115.224 -169.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.769 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 7.4 tp10 -73.13 -13.25 61.14 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.906 -0.405 . . . . 3.5 109.906 -172.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -152.68 120.43 3.14 Favored Pre-proline 0 N--CA 1.449 -0.487 0 N-CA-C 113.419 0.896 . . . . 6.41 113.419 174.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -99.92 134.83 0.22 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 124.046 3.164 . . . . 2.31 111.774 167.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.4 ' HG3' ' HB2' ' A' ' 145' ' ' ARG . 83.1 Cg_endo -79.23 -159.31 0.1 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.592 2.195 . . . . 1.27 112.136 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.0 p -145.48 -167.84 2.8 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.434 -0.58 . . . . 1.88 109.434 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.1 t -88.58 -19.94 25.66 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.558 -0.457 . . . . 2.43 109.813 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -77.15 -32.26 56.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.053 -0.521 . . . . 2.18 109.95 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -130.58 114.97 16.12 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 115.659 -0.701 . . . . 1.33 109.461 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.478 HG21 ' HG2' ' A' ' 109' ' ' ARG . 2.0 tp -94.36 113.92 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 109.136 -0.69 . . . . 1.4 109.136 -175.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.821 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 41.4 ttp180 -50.4 99.41 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.122 -0.945 . . . . 5.14 109.672 173.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.6 122.04 26.85 Favored Glycine 0 N--CA 1.434 -1.483 0 CA-C-N 115.068 -0.969 . . . . 1.05 111.784 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.56 ' H ' ' NH1' ' A' ' 176' ' ' ARG . 2.8 m-85 -82.16 79.42 8.66 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.876 0.846 . . . . 4.68 110.955 177.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.433 ' OD1' HG23 ' A' ' 173' ' ' THR . 17.4 m-20 -85.79 87.69 7.44 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.888 -1.505 . . . . 2.29 108.435 172.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.463 ' HB2' ' HG2' ' A' ' 172' ' ' GLN . 96.4 m-70 -58.68 150.87 55.44 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-O 118.711 -0.661 . . . . 2.95 109.367 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.61 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 50.9 Cg_exo -18.62 68.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.198 1 C-N-CA 127.055 5.17 . . . . 0.77 116.12 -173.053 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 170' ' ' PHE . 19.6 p -97.24 -173.81 2.77 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.618 -1.174 . . . . 1.97 110.413 174.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.625 ' N ' HG22 ' A' ' 14' ' ' VAL . . . -174.04 -160.65 22.69 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 120.573 -0.823 . . . . 0.55 112.044 177.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.432 ' CE1' ' HG ' ' A' ' 65' ' ' LEU . 35.4 t80 -161.57 96.08 1.03 Allowed 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.291 -1.003 . . . . 0.8 108.291 -167.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.579 ' CG2' HG12 ' A' ' 168' ' ' VAL . 2.3 m -104.15 136.24 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 121.838 0.828 . . . . 1.03 111.188 -173.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 77.6 m -115.49 112.43 22.24 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.101 -0.954 . . . . 2.3 109.048 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.459 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 6.5 m -111.21 118.5 47.6 Favored Pre-proline 0 C--N 1.32 -0.7 0 C-N-CA 120.638 -0.425 . . . . 1.45 111.762 -169.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.639 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 39.6 Cg_exo -49.88 119.65 5.07 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.265 1.977 . . . . 0.72 111.136 170.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.57 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 60.4 mmm -79.68 -163.54 0.54 Allowed 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 120.916 0.389 . . . . 1.72 111.376 -177.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.413 ' H ' ' HB3' ' A' ' 158' ' ' MET . 6.2 tp10 -68.97 -26.33 64.98 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.476 0.655 . . . . 2.63 109.978 176.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -98.88 15.51 25.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.454 -0.794 . . . . 2.05 109.251 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.508 ' HB2' ' CD ' ' A' ' 162' ' ' PRO . 41.0 m-80 23.02 -87.81 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 126.051 1.74 . . . . 2.19 115.484 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.508 ' CD ' ' HB2' ' A' ' 161' ' ' ASN . 73.5 Cg_endo -72.31 -16.7 27.89 Favored 'Trans proline' 0 C--N 1.364 1.374 0 CA-C-N 121.539 1.585 . . . . 0.86 113.147 -174.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -90.93 -35.28 14.81 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.25 -0.432 . . . . 1.34 111.181 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.57 ' O ' ' HB2' ' A' ' 158' ' ' MET . 93.8 m-85 -139.51 133.26 30.62 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.763 -0.458 . . . . 1.46 109.763 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 32.4 t -125.99 148.09 49.37 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.514 0.673 . . . . 2.05 111.092 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.566 ' HB2' ' SD ' ' A' ' 158' ' ' MET . 1.8 tppp? -96.21 102.36 14.14 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.117 -0.947 . . . . 1.4 111.235 -177.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.421 HD13 ' CZ ' ' A' ' 153' ' ' PHE . 0.5 OUTLIER -86.84 109.32 19.21 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.511 -1.222 . . . . 1.07 109.006 177.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.579 HG12 ' CG2' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -131.32 128.74 61.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.439 0.638 . . . . 1.11 111.804 177.422 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 23.1 ttt -129.79 145.16 51.57 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.808 -0.633 . . . . 1.79 110.692 -174.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.595 ' CD1' HG21 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -125.72 141.73 51.86 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.463 -0.79 . . . . 4.22 109.474 -178.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 4.3 p -150.25 137.59 13.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 120.439 -0.504 . . . . 2.01 110.512 173.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.621 ' N ' HE21 ' A' ' 172' ' ' GLN . 0.0 OUTLIER -127.4 52.67 1.8 Allowed 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 122.528 1.156 . . . . 2.66 108.358 178.214 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.572 ' HB ' ' SD ' ' A' ' 175' ' ' MET . 1.8 m -56.14 148.16 18.71 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 113.492 -1.686 . . . . 2.2 112.112 -174.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.489 ' OE1' ' HB3' ' A' ' 176' ' ' ARG . 38.3 tt0 -83.24 -26.9 30.31 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.571 -0.741 . . . . 2.45 112.666 -178.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.572 ' SD ' ' HB ' ' A' ' 173' ' ' THR . 3.8 mpp? 44.45 56.07 5.27 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.167 0.508 . . . . 4.15 110.918 -173.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.56 ' NH1' ' H ' ' A' ' 147' ' ' TYR . 0.0 OUTLIER -71.8 -1.58 14.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.424 -0.807 . . . . 6.51 112.225 -175.413 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -81.97 -163.18 31.65 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.612 -0.804 . . . . 2.26 111.996 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -94.82 78.95 3.67 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.042 0.449 . . . . 6.69 110.296 -177.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.486 ' N ' HD13 ' A' ' 179' ' ' LEU . 2.2 mp -121.02 162.55 19.76 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 109.237 -0.653 . . . . 2.21 109.237 175.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 14.9 m -114.09 161.03 30.16 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 108.393 -0.966 . . . . 2.31 108.393 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.412 ' O ' ' HG2' ' A' ' 185' ' ' GLU . 75.1 Cg_exo -41.02 -50.1 4.29 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 122.751 2.3 . . . . 1.86 113.114 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.498 ' O ' ' HG3' ' A' ' 186' ' ' LYS . 12.6 m -70.18 -15.01 62.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.344 0.498 . . . . 2.45 112.344 -176.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.43 ' HA ' ' CE ' ' A' ' 186' ' ' LYS . 27.3 mm -84.59 -37.3 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-O 122.947 1.356 . . . . 1.69 107.979 -176.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.65 ' HA ' ' CG2' ' A' ' 187' ' ' THR . 1.4 mp -74.05 -35.16 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.691 0 CA-C-N 112.199 -2.273 . . . . 1.77 110.149 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 181' ' ' PRO . 36.3 mm-40 -57.77 -26.42 61.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.961 -1.018 . . . . 2.89 109.833 171.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 182' ' ' SER . 50.9 mtmt -92.76 -36.87 12.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.512 -0.767 . . . . 1.71 111.224 176.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.65 ' CG2' ' HA ' ' A' ' 184' ' ' ILE . 6.2 t -68.49 -45.71 71.63 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.259 0.466 . . . . 1.3 112.259 -172.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' MET . . . . . 0.568 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 32.3 mmt -80.05 -57.88 0.64 Allowed Pre-proline 0 N--CA 1.464 0.258 0 N-CA-C 112.712 0.634 . . . . 1.39 112.712 -173.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.663 ' O ' HG12 ' A' ' 193' ' ' VAL . 39.5 Cg_exo -58.21 -40.23 78.05 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.642 1.561 . . . . 1.15 112.163 -175.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 69.8 m -77.24 -24.54 51.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.24 -0.436 . . . . 1.95 111.111 -175.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.557 ' HB2' ' O ' ' A' ' 187' ' ' THR . 46.5 t30 -80.15 -34.9 37.29 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.66 -0.416 . . . . 1.92 110.529 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.523 ' HB3' ' CG1' ' A' ' 50' ' ' VAL . 53.9 mt -68.91 -42.95 76.17 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 120.633 0.254 . . . . 1.68 111.027 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.663 HG12 ' O ' ' A' ' 189' ' ' PRO . 2.4 m -62.38 -31.43 51.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 121.65 0.738 . . . . 1.32 109.179 176.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.26 -31.12 60.68 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.366 -1.288 . . . . 2.6 111.076 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -68.75 -28.13 66.53 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 121.348 0.594 . . . . 2.73 109.775 171.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.529 ' O ' ' HD3' ' A' ' 200' ' ' LYS . 28.7 mt -81.86 -26.09 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-O 121.255 0.55 . . . . 1.11 111.206 173.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.449 ' HA ' HD22 ' A' ' 197' ' ' LEU . 37.6 mt -72.04 -43.06 65.55 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-N 116.346 -0.388 . . . . 1.57 110.403 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.512 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 5.4 p30 -55.71 -30.68 61.54 Favored 'General case' 0 C--O 1.213 -0.856 0 N-CA-C 108.428 -0.952 . . . . 2.18 108.428 170.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.63 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -76.19 -45.42 33.32 Favored 'General case' 0 N--CA 1.428 -1.537 0 O-C-N 121.64 -0.663 . . . . 1.04 110.422 -178.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.529 ' HD3' ' O ' ' A' ' 196' ' ' ILE . 1.5 mptm? -56.29 -45.11 80.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.877 -0.601 . . . . 1.51 111.263 174.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -86.52 -37.02 18.62 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.43 -0.805 . . . . 1.94 111.421 -173.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . 0.452 ' HA3' ' CH2' ' A' ' 74' ' ' TRP . . . -68.71 -32.58 74.51 Favored Glycine 0 N--CA 1.462 0.395 0 C-N-CA 120.999 -0.619 . . . . 0.47 111.746 177.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.63 ' HB ' ' O ' ' A' ' 199' ' ' ALA . 2.4 tp -69.88 -34.96 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 110.068 -0.345 . . . . 1.16 110.068 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.472 ' O ' ' HB ' ' A' ' 208' ' ' THR . 65.3 mttm -89.34 -20.55 23.89 Favored 'General case' 0 C--O 1.215 -0.714 0 N-CA-C 109.305 -0.628 . . . . 3.8 109.305 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -63.92 -37.15 86.34 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.719 -0.845 . . . . 1.28 108.719 168.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.481 ' HE1' ' OD2' ' A' ' 70' ' ' ASP . 35.6 m80 -76.34 -41.38 48.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.249 -0.887 . . . . 4.34 111.831 174.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 203' ' ' ILE . 0.5 OUTLIER -87.14 -57.24 3.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.577 0.703 . . . . 3.0 110.977 -170.604 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.472 ' HB ' ' O ' ' A' ' 204' ' ' LYS . 97.3 m -81.23 146.17 57.66 Favored Pre-proline 0 C--N 1.315 -0.934 0 CA-C-N 114.874 -1.057 . . . . 2.01 110.2 -178.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -65.44 60.4 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.559 2.173 . . . . 2.59 111.914 171.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.7 t -107.09 22.8 15.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.755 0.788 . . . . 2.55 109.182 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 -90.08 2.5 55.17 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.385 -0.825 . . . . 6.11 109.749 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -68.78 -23.14 64.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.27 -0.877 . . . . 7.55 109.987 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -100.41 62.99 0.62 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.34 -1.104 . . . . 3.73 110.34 169.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -69.24 99.75 1.21 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.03 0.443 . . . . 6.11 110.868 -174.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . 0.41 ' HD2' ' O ' ' A' ' 73' ' ' THR . 37.0 t60 -93.03 111.38 22.99 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.944 -0.571 . . . . 7.27 110.093 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 47.6 t60 67.0 147.98 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 O-C-N 123.837 0.71 . . . . 6.82 111.21 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -72.52 112.69 8.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.283 0.563 . . . . 5.77 110.385 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 11.8 m -53.96 -46.14 71.52 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 114.74 -1.118 . . . . 6.85 112.461 -173.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -112.39 21.64 15.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.746 0.307 . . . . 9.48 110.231 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 18.7 m . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.104 -0.95 . . . . 8.48 110.755 -179.123 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.556 ' HG3' HG22 ' A' ' 87' ' ' ILE . 1.1 mpt? . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 120.862 0.363 . . . . 4.31 110.866 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.426 ' O ' HD12 ' A' ' 6' ' ' ILE . 22.6 m-20 -81.7 -26.06 34.95 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 121.254 0.549 . . . . 2.25 109.745 -176.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.757 ' HA ' HD12 ' A' ' 6' ' ' ILE . 96.4 m-85 -68.64 -30.03 68.65 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.477 -0.783 . . . . 0.45 109.056 -176.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.653 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 3.0 tppp? -70.72 -7.42 44.61 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 114.95 -1.023 . . . . 2.06 109.986 176.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.71 -42.15 10.88 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.151 0.501 . . . . 1.2 109.804 174.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.757 HD12 ' HA ' ' A' ' 3' ' ' PHE . 1.3 mp -81.82 -43.9 19.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.98 -0.748 . . . . 1.76 108.98 -172.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.734 ' HA ' ' HE3' ' A' ' 130' ' ' LYS . . . -67.68 -47.96 67.98 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.546 -1.206 . . . . 1.11 111.653 -178.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.653 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 4.3 mt-30 -63.9 -27.02 68.86 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.27 -1.332 . . . . 2.14 110.722 -176.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.463 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 27.7 mt-30 -82.45 -39.2 22.89 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.201 -0.909 . . . . 3.04 109.211 171.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 1.069 HG21 ' HZ1' ' A' ' 130' ' ' LYS . 0.5 OUTLIER -65.44 -37.67 87.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.844 -1.071 . . . . 1.1 112.401 -177.67 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.508 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -47.36 -53.05 14.77 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.132 0.419 . . . . 1.04 112.132 176.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.505 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 28.3 pt20 -79.87 -4.54 52.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.75 0.31 . . . . 2.31 111.115 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 10' ' ' THR . 70.8 mm-40 -75.98 -54.38 6.96 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.206 -0.664 . . . . 2.54 109.206 172.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.644 HG22 ' N ' ' A' ' 152' ' ' GLY . 12.6 p -70.18 -36.83 69.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 114.82 -1.082 . . . . 1.21 110.334 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.505 ' HB3' ' HA ' ' A' ' 12' ' ' GLN . 0.6 OUTLIER -69.16 -24.4 64.07 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-O 122.059 0.933 . . . . 1.26 108.869 174.785 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.45 -17.74 68.95 Favored Glycine 0 CA--C 1.501 -0.833 0 CA-C-N 113.755 -1.566 . . . . 0.57 109.967 177.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.571 ' HA ' ' CB ' ' A' ' 20' ' ' ASP . 30.8 m-85 -90.39 -23.85 20.95 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 114.755 -0.723 . . . . 3.59 109.381 176.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.525 ' HA ' ' HZ ' ' A' ' 170' ' ' PHE . 66.2 t30 -66.48 -19.74 65.86 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-O 121.452 0.644 . . . . 2.1 109.541 176.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -120.2 10.58 11.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.433 -0.803 . . . . 3.26 110.294 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.571 ' CB ' ' HA ' ' A' ' 17' ' ' TYR . 9.2 t70 -86.07 -31.58 21.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.258 -0.883 . . . . 2.16 110.773 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.422 ' HA ' ' CZ2' ' A' ' 24' ' ' TRP . 1.3 t -16.65 86.99 0.0 OUTLIER 'General case' 0 C--O 1.235 0.309 0 O-C-N 125.485 1.741 . . . . 2.24 113.733 -169.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.5 t -172.64 137.48 0.8 Allowed 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.352 -1.749 . . . . 2.46 109.068 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.37 -11.5 68.77 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.637 -0.792 . . . . 1.45 112.19 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.805 ' HA ' ' HB3' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -104.39 -160.24 0.75 Allowed 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 120.97 0.414 . . . . 2.24 110.775 -179.634 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.49 ' HE2' ' HB3' ' A' ' 25' ' ' LYS . 2.0 tmmm? -170.48 128.97 0.83 Allowed 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 115.442 -0.799 . . . . 3.43 109.18 -174.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.58 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 0.1 OUTLIER -70.35 109.3 2.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-O 121.947 0.879 . . . . 2.21 109.374 175.017 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 p -93.19 -25.07 5.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 114.172 -1.376 . . . . 1.83 109.46 -172.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.474 ' HA ' ' HD2' ' A' ' 28' ' ' LYS . 17.4 tptp -153.95 132.03 11.78 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 119.755 -0.778 . . . . 2.87 112.015 -175.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.695 ' HB ' ' HA ' ' A' ' 34' ' ' THR . 0.0 OUTLIER -152.01 152.76 32.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.236 0.541 . . . . 1.92 112.06 177.292 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 35.6 m -104.6 25.68 9.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.423 -0.808 . . . . 2.37 110.499 175.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 30' ' ' SER . 28.6 mmmt 75.53 19.0 2.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.81 -0.632 . . . . 4.84 111.911 175.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.565 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 9.3 mmtp -164.76 -30.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.795 -0.639 . . . . 2.05 110.073 175.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.887 HG21 ' HA3' ' A' ' 52' ' ' GLY . 29.7 pt -110.87 136.9 45.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 108.629 -0.878 . . . . 1.42 108.629 171.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.695 ' HA ' ' HB ' ' A' ' 29' ' ' THR . 0.2 OUTLIER -140.35 115.62 9.91 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.506 0.194 . . . . 1.22 111.206 -162.439 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.671 HG21 HG23 ' A' ' 50' ' ' VAL . 6.2 t -99.67 115.04 39.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.957 0.408 . . . . 1.52 110.563 -177.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.58 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -107.81 122.76 47.42 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.844 -0.617 . . . . 1.74 110.226 -177.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.5 t -114.73 131.46 56.76 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.908 -0.587 . . . . 1.72 112.301 -172.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.805 ' HB3' ' HA ' ' A' ' 24' ' ' TRP . 56.5 pttt -153.13 148.49 27.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.516 -0.765 . . . . 2.45 110.057 167.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.681 ' HA ' ' HA ' ' A' ' 46' ' ' ASN . . . -53.01 126.62 21.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.216 -0.447 . . . . 2.17 110.24 175.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.764 ' HG ' ' HB2' ' A' ' 47' ' ' LEU . 4.7 m -66.04 -22.4 66.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.618 -0.719 . . . . 2.51 111.771 -173.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 40' ' ' SER . 17.3 mmm180 76.08 -10.1 1.34 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 124.032 0.833 . . . . 7.41 112.412 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.39 -10.83 60.29 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.62 -0.511 . . . . 6.84 109.62 174.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.666 ' HD1' ' H ' ' A' ' 44' ' ' HIS . 0.5 OUTLIER 172.73 -169.95 0.03 OUTLIER 'General case' 0 C--O 1.236 0.378 0 N-CA-C 106.191 -1.781 . . . . 6.42 106.191 177.718 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.666 ' H ' ' HD1' ' A' ' 43' ' ' PHE . 19.9 t-80 -83.72 83.59 7.86 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.827 -0.749 . . . . 6.31 109.686 175.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.61 139.44 5.93 Favored Glycine 0 N--CA 1.432 -1.59 0 N-CA-C 108.61 -1.796 . . . . 1.74 108.61 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.681 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 4.5 m-20 -92.47 146.81 23.39 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.39 0.614 . . . . 2.45 111.311 -174.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.764 ' HB2' ' HG ' ' A' ' 40' ' ' SER . 3.1 tt -104.8 133.64 49.28 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.735 -1.209 . . . . 1.49 107.735 176.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.446 ' N ' HD22 ' A' ' 47' ' ' LEU . 22.7 m-85 -117.54 124.42 48.67 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.959 -0.386 . . . . 1.52 109.959 -175.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.596 ' HD3' ' CH2' ' A' ' 24' ' ' TRP . 11.6 ttp180 -105.43 116.99 32.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.01 -0.541 . . . . 3.34 109.769 175.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.671 HG23 HG21 ' A' ' 35' ' ' VAL . 8.8 p -100.69 136.33 32.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 C-N-CA 119.802 -0.759 . . . . 1.98 109.027 174.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.869 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 27.6 tt0 -137.8 108.8 6.73 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.359 -0.837 . . . . 1.07 109.963 -169.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.887 ' HA3' HG21 ' A' ' 33' ' ' ILE . . . -139.4 140.42 10.84 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.248 -0.977 . . . . 0.35 111.828 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 67.7 mt -84.69 116.82 28.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 C-N-CA 120.005 -0.678 . . . . 1.3 110.656 178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.563 HG12 ' HD3' ' A' ' 200' ' ' LYS . 63.6 mt -101.54 113.35 65.85 Favored Pre-proline 0 C--N 1.314 -0.974 0 N-CA-C 108.355 -0.98 . . . . 1.07 108.355 173.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 164' ' ' TYR . 28.3 Cg_exo -64.12 56.25 0.22 Allowed 'Trans proline' 0 N--CA 1.478 0.561 0 C-N-CA 124.574 3.516 . . . . 0.74 114.105 -174.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 1.034 ' HG3' HG12 ' A' ' 203' ' ' ILE . 63.4 mm-40 -132.34 -157.19 0.8 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.628 -0.715 . . . . 1.68 109.581 176.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.411 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 62.7 p -101.11 145.44 30.42 Favored Pre-proline 0 N--CA 1.415 -2.19 0 CA-C-N 114.798 -1.092 . . . . 1.58 108.286 168.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 57' ' ' SER . 39.9 Cg_exo -56.84 -11.1 6.51 Favored 'Trans proline' 0 C--N 1.324 -0.727 0 C-N-CA 123.967 3.112 . . . . 0.74 110.989 175.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.406 ' H ' ' C ' ' A' ' 57' ' ' SER . . . -84.42 -48.47 9.61 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.857 -1.065 . . . . 1.31 111.438 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.65 ' HD2' ' HB3' ' A' ' 206' ' ' HIS . 3.4 tppt? -62.76 -33.62 75.54 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.52 -0.919 . . . . 3.78 108.52 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 1.027 HD22 HD12 ' A' ' 203' ' ' ILE . 70.9 mt -57.19 -56.91 15.65 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.737 -1.12 . . . . 1.09 110.864 173.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.475 ' HA ' ' CD1' ' A' ' 65' ' ' LEU . 53.0 m -65.92 -8.34 21.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.292 0.568 . . . . 1.94 110.643 177.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 60' ' ' LYS . 25.1 t70 -88.34 -32.31 18.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.672 -0.694 . . . . 1.32 111.83 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.602 ' CE1' ' HB3' ' A' ' 65' ' ' LEU . 16.2 p90 -79.58 -43.53 22.79 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 120.225 -0.59 . . . . 0.79 110.019 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.644 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -91.16 3.84 53.75 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 120.548 -0.461 . . . . 2.15 111.962 -174.523 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.409 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 24.8 t80 -14.1 -70.66 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 125.378 1.674 . . . . 2.06 113.475 -169.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.425 ' NE2' HG23 ' A' ' 115' ' ' VAL . 7.0 tp-100 -176.19 -47.17 0.01 OUTLIER 'General case' 0 C--N 1.341 0.233 0 N-CA-C 113.147 0.795 . . . . 4.31 113.147 172.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.631 ' OG1' ' HB2' ' A' ' 81' ' ' TYR . 10.6 t -160.11 23.14 0.17 Allowed 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.136 -0.626 . . . . 1.89 111.766 -167.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -126.94 -14.01 2.86 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 118.655 -1.736 . . . . 1.71 114.479 -170.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.653 ' O ' HG22 ' A' ' 73' ' ' THR . 4.8 t70 -157.17 -33.65 0.08 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.384 0.611 . . . . 2.19 110.726 -172.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.663 ' O ' ' HB3' ' A' ' 75' ' ' ASP . 2.0 ptp180 -52.3 -39.55 60.68 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.075 -0.966 . . . . 3.95 111.693 -173.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.485 ' H ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -87.96 -5.26 10.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.841 -0.618 . . . . 1.42 111.442 -175.492 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.653 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.3 t -88.63 -27.43 21.32 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 119.104 -1.038 . . . . 1.45 109.418 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.99 ' HZ3' ' HB2' ' A' ' 198' ' ' ASN . 30.7 p-90 -112.32 -0.2 15.5 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.914 -0.585 . . . . 0.78 111.888 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.682 ' CG ' ' HB2' ' A' ' 78' ' ' LEU . 0.9 OUTLIER -68.07 176.96 2.4 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 114.107 1.151 . . . . 2.19 114.107 -167.335 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.565 ' HZ1' ' HB2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -143.45 -4.41 0.88 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 113.708 -1.587 . . . . 3.68 111.412 170.43 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.8 m -121.35 6.82 10.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.437 0.636 . . . . 2.08 109.75 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.682 ' HB2' ' CG ' ' A' ' 75' ' ' ASP . 98.7 mt -118.52 -158.36 0.72 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.295 -0.866 . . . . 1.16 110.323 -175.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.429 ' HB3' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -173.57 -58.99 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.871 0.367 . . . . 2.23 111.201 -173.428 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 96' ' ' THR . 39.9 t -145.42 139.41 21.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.307 -0.406 . . . . 1.44 110.747 -169.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.631 ' HB2' ' OG1' ' A' ' 68' ' ' THR . 44.4 p90 -104.89 152.79 22.2 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.899 -0.591 . . . . 5.73 111.537 177.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.89 ' HB3' ' HB3' ' A' ' 95' ' ' HIS . 50.7 t-20 -160.09 104.72 1.51 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.477 -0.564 . . . . 1.86 109.477 172.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.499 ' HE3' ' HG2' ' A' ' 86' ' ' ARG . 3.9 ttt -74.2 92.45 2.23 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.394 -0.965 . . . . 2.52 108.394 176.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.477 HG21 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -77.12 -63.25 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.86 -0.609 . . . . 1.19 111.571 -169.329 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.529 ' HB3' HD12 ' A' ' 93' ' ' ILE . 9.5 t60 -140.09 113.83 8.75 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.824 -0.436 . . . . 2.59 109.824 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.499 ' HG2' ' HE3' ' A' ' 83' ' ' MET . 0.2 OUTLIER -97.07 132.71 42.59 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.516 -0.92 . . . . 2.83 108.516 175.814 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.65 HG12 ' O ' ' A' ' 91' ' ' THR . 0.1 OUTLIER -90.44 -48.84 14.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.148 0.499 . . . . 1.17 111.181 -170.298 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.54 ' CG ' ' H ' ' A' ' 89' ' ' SER . 25.3 t70 -157.14 -148.37 0.21 Allowed 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.588 -0.893 . . . . 1.86 108.588 -173.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.54 ' H ' ' CG ' ' A' ' 88' ' ' ASP . 47.6 t -59.26 -49.93 75.94 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.644 0.609 . . . . 1.94 112.644 -170.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.703 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 17.7 m-20 -139.91 39.93 1.98 Allowed 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.837 0.827 . . . . 1.87 108.895 -171.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.65 ' O ' HG12 ' A' ' 87' ' ' ILE . 1.7 m -135.08 113.21 11.19 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.356 -1.35 . . . . 1.12 107.356 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.585 ' O ' HD12 ' A' ' 114' ' ' LEU . 25.8 m-85 -131.0 174.32 10.12 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.594 0.711 . . . . 0.52 111.07 -173.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.529 HD12 ' HB3' ' A' ' 85' ' ' HIS . 29.9 mt -131.76 132.98 61.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 106.305 -1.739 . . . . 1.1 106.305 165.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 34.2 t -122.35 135.6 54.74 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.064 -0.654 . . . . 2.61 110.616 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.89 ' HB3' ' HB3' ' A' ' 82' ' ' ASN . 6.8 t-160 -99.66 80.7 2.39 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 124.37 1.044 . . . . 2.17 109.157 172.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.883 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 93.0 m -89.9 150.35 22.23 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 115.129 -0.941 . . . . 1.19 109.909 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.429 ' HB ' ' HB3' ' A' ' 79' ' ' GLN . 49.4 mm -101.48 131.16 49.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 108.618 -0.882 . . . . 1.63 108.618 167.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.622 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 17.2 m -110.5 126.45 54.39 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.857 -0.61 . . . . 1.72 111.493 -171.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -91.96 43.04 1.12 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.247 0.546 . . . . 2.29 110.405 177.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.3 t -92.79 70.98 4.81 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.372 0.606 . . . . 4.07 109.703 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -112.24 114.41 27.18 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.412 -0.813 . . . . 6.11 110.731 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.6 ' HB2' ' HD2' ' A' ' 186' ' ' LYS . . . -70.52 71.64 0.48 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.897 -1.047 . . . . 1.98 110.099 173.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 92.6 t 77.53 -40.68 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 114.811 -1.086 . . . . 3.6 110.937 176.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 166.5 -16.11 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.833 -0.699 . . . . 2.2 112.473 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.8 m -65.63 -48.8 70.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.1 0.476 . . . . 2.08 109.82 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.721 HG22 HH11 ' A' ' 176' ' ' ARG . 3.4 mp -86.56 121.85 38.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 108.757 -0.831 . . . . 1.53 108.757 170.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.3 m -76.96 160.03 77.27 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 109.927 -0.397 . . . . 1.71 109.927 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.59 145.31 17.27 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.446 2.097 . . . . 1.31 111.249 174.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.771 ' CZ ' ' HA2' ' A' ' 146' ' ' GLY . 0.2 OUTLIER -107.44 141.44 38.84 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 119.803 -0.759 . . . . 4.06 110.164 -170.102 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.611 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 12.0 t70 -94.69 115.16 27.2 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 107.81 -1.181 . . . . 1.37 107.81 177.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.883 ' HB3' ' HB ' ' A' ' 96' ' ' THR . 63.9 t80 -97.87 108.92 21.74 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.789 -0.448 . . . . 3.01 109.789 -168.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.631 ' CG2' ' HE1' ' A' ' 134' ' ' PHE . 13.5 mm -123.71 75.81 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 N-CA-C 108.811 -0.811 . . . . 1.2 108.811 173.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.774 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 0.7 OUTLIER -109.41 124.78 51.57 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.466 -0.788 . . . . 1.86 110.745 -177.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 1.095 HD23 ' HE2' ' A' ' 130' ' ' LYS . 8.9 tp -75.61 117.03 16.94 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 115.275 -0.875 . . . . 1.08 109.275 171.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.425 HG23 ' NE2' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -118.41 123.97 72.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-N 114.484 -1.235 . . . . 1.08 111.491 -164.402 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.841 ' HE2' ' HD3' ' A' ' 118' ' ' LYS . 35.9 t80 -109.93 121.69 45.82 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.585 -0.734 . . . . 2.81 111.2 175.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.875 HG13 HG23 ' A' ' 127' ' ' ILE . 3.6 mp -87.39 99.42 8.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.505 -0.924 . . . . 1.53 108.505 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.841 ' HD3' ' HE2' ' A' ' 116' ' ' TYR . 57.3 tptt -102.28 131.16 49.04 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.893 -1.049 . . . . 1.81 110.079 -174.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.447 ' C ' ' HD2' ' A' ' 119' ' ' ARG . 4.0 tpt180 -125.61 88.97 2.95 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 108.505 -0.924 . . . . 3.22 108.505 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.645 ' CB ' ' HB3' ' A' ' 123' ' ' ASN . 53.9 m-85 -69.42 119.17 13.26 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.759 -1.11 . . . . 1.28 108.359 172.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -33.53 95.89 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 125.024 1.453 . . . . 2.28 112.955 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 53.95 42.05 69.45 Favored Glycine 0 CA--C 1.508 -0.38 0 CA-C-N 114.684 -1.144 . . . . 0.79 112.041 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.645 ' HB3' ' CB ' ' A' ' 120' ' ' TYR . 3.3 t-20 -132.71 -49.76 0.9 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.922 -0.639 . . . . 2.06 110.273 -175.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.431 ' CG ' ' HB ' ' A' ' 154' ' ' VAL . 3.9 tpp -158.37 144.31 16.99 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.637 -0.425 . . . . 1.73 111.383 -178.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.09 81.22 1.71 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.378 -0.971 . . . . 2.07 108.378 172.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.725 HG23 ' HB3' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -109.01 146.26 14.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.212 -0.904 . . . . 1.06 113.424 -170.541 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.875 HG23 HG13 ' A' ' 117' ' ' ILE . 4.6 pt -107.58 110.72 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.549 0.69 . . . . 1.26 109.155 161.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.508 ' HB3' ' HA ' ' A' ' 11' ' ' ALA . 15.8 p -93.83 112.4 24.25 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.325 0.583 . . . . 1.53 111.06 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.774 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 54.6 p -102.86 158.85 15.98 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.724 -0.671 . . . . 1.81 111.68 -171.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 1.095 ' HE2' HD23 ' A' ' 114' ' ' LEU . 4.5 mtmm -147.39 124.44 11.4 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 115.939 -0.573 . . . . 2.75 109.457 175.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 31.9 p -67.04 91.63 0.22 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.336 -0.987 . . . . 1.94 108.336 174.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.93 133.84 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 CA-C-N 115.131 -0.94 . . . . 1.64 109.274 -163.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.452 ' HB2' HH22 ' A' ' 145' ' ' ARG . 9.2 t70 -94.51 73.4 3.77 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.479 -1.237 . . . . 2.17 108.761 -167.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.743 ' O ' ' HB3' ' A' ' 137' ' ' TYR . 1.6 p90 -107.02 173.75 2.93 Favored Pre-proline 0 CA--C 1.554 1.101 0 CA-C-N 114.85 -1.068 . . . . 0.67 110.709 -170.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.598 ' HB2' ' OE2' ' A' ' 136' ' ' GLU . 60.2 Cg_exo -53.13 -48.61 21.16 Favored 'Trans proline' 0 N--CA 1.486 1.079 0 C-N-CA 123.292 2.661 . . . . 1.66 116.438 -171.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.686 ' HG2' ' CE2' ' A' ' 134' ' ' PHE . 0.6 OUTLIER -79.43 -9.3 59.57 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 121.53 0.681 . . . . 3.5 111.595 -173.147 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.811 ' HE1' ' HG3' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -54.4 -38.98 71.64 Favored Pre-proline 0 CA--C 1.556 1.196 0 N-CA-C 116.888 2.181 . . . . 6.41 116.888 -172.239 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.489 ' HD2' ' C ' ' A' ' 136' ' ' GLU . 34.2 Cg_exo -30.52 110.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 123.875 3.05 . . . . 2.31 115.901 -170.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.471 ' HG3' ' HB2' ' A' ' 145' ' ' ARG . 29.6 Cg_endo -89.88 -155.89 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 124.345 3.363 . . . . 1.27 112.308 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 38.8 m -148.47 143.92 27.05 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 108.727 -0.842 . . . . 1.88 108.727 177.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.7 p -58.17 -17.57 19.64 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.568 1.322 . . . . 2.43 114.568 -167.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -83.11 -15.93 48.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.099 0.409 . . . . 2.18 111.103 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -126.11 108.75 11.64 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.255 -1.017 . . . . 1.33 108.255 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.66 HG13 ' HE ' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -82.91 111.73 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 C-N-CA 120.123 -0.631 . . . . 1.4 109.395 -171.253 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.811 ' HG3' ' HE1' ' A' ' 137' ' ' TYR . 0.2 OUTLIER -41.36 113.91 0.45 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.939 0.4 . . . . 5.14 110.632 171.003 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.771 ' HA2' ' CZ ' ' A' ' 109' ' ' ARG . . . -51.29 130.18 33.21 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.047 -0.978 . . . . 1.05 112.478 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.853 ' HB3' ' HG3' ' A' ' 174' ' ' GLU . 0.2 OUTLIER -104.99 63.85 0.71 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.743 0.782 . . . . 4.68 109.873 175.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.581 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 81.8 m-20 -86.88 108.28 18.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.156 -1.384 . . . . 2.29 109.558 178.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -80.31 132.18 60.01 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 109.468 -0.567 . . . . 2.95 109.468 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.516 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 51.9 Cg_exo -9.25 61.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.009 1 C-N-CA 126.828 5.019 . . . . 0.77 115.628 -161.671 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . 0.693 ' HB3' ' O ' ' A' ' 170' ' ' PHE . 3.0 m -76.97 -174.75 3.24 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.931 -1.031 . . . . 1.97 109.618 174.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.644 ' N ' HG22 ' A' ' 14' ' ' VAL . . . -171.29 -163.94 26.14 Favored Glycine 0 N--CA 1.429 -1.784 0 C-N-CA 119.666 -1.254 . . . . 0.55 111.828 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.463 ' HB3' ' CG1' ' A' ' 127' ' ' ILE . 52.9 t80 -161.92 79.18 0.54 Allowed 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.687 -1.227 . . . . 0.8 107.687 -168.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.682 HG12 ' HB ' ' A' ' 126' ' ' ILE . 5.2 m -90.33 128.66 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-O 121.733 0.777 . . . . 1.03 110.422 -174.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 60.8 m -99.82 111.18 23.52 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.305 -0.998 . . . . 2.3 108.305 171.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.8 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 18.9 m -97.6 119.79 61.92 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 115.817 -0.629 . . . . 1.45 111.378 -170.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.507 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 50.7 Cg_exo -55.28 111.87 0.88 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.454 2.103 . . . . 0.72 111.074 170.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.469 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 74.3 mmm -74.99 -166.33 0.47 Allowed 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.373 0.606 . . . . 1.72 111.634 -177.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -70.97 -34.52 71.5 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.624 -0.88 . . . . 2.63 108.624 174.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -102.06 30.34 4.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.371 -1.286 . . . . 2.05 108.918 175.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.614 ' OD1' ' HD3' ' A' ' 162' ' ' PRO . 3.7 p30 -31.43 -48.86 0.42 Allowed Pre-proline 0 N--CA 1.475 0.815 0 N-CA-C 117.107 2.262 . . . . 2.19 117.107 -168.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.614 ' HD3' ' OD1' ' A' ' 161' ' ' ASN . 71.6 Cg_endo -76.83 -9.93 18.27 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 CA-C-N 121.976 1.741 . . . . 0.86 113.177 -175.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -116.47 -22.66 8.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.042 -0.526 . . . . 1.34 110.801 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 55' ' ' PRO . 61.8 m-85 -136.25 121.39 19.0 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.357 -0.608 . . . . 1.46 109.357 174.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 38.6 t -116.97 139.47 50.62 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.555 -0.458 . . . . 2.05 110.439 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.869 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 2.3 tppp? -89.12 105.35 17.73 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.866 0.841 . . . . 1.4 110.984 -177.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.505 HD13 HG12 ' A' ' 196' ' ' ILE . 0.9 OUTLIER -86.82 102.05 13.92 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.338 -0.846 . . . . 1.07 108.905 178.409 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.747 HG13 ' HG3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -124.5 119.33 56.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.955 0.884 . . . . 1.11 111.587 178.246 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 21.5 ttt -120.04 148.74 43.19 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.824 -1.08 . . . . 1.79 109.532 -175.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.693 ' O ' ' HB3' ' A' ' 151' ' ' CYS . 38.7 m-85 -127.09 135.06 50.24 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.336 -0.986 . . . . 4.22 108.336 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 173' ' ' THR . 7.8 p -126.69 118.58 51.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.682 0.753 . . . . 2.01 110.965 177.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.01 63.7 0.7 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.443 -0.947 . . . . 2.66 108.443 177.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 147' ' ' TYR . 3.8 t -98.24 154.18 17.97 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.767 -1.106 . . . . 2.2 110.145 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.853 ' HG3' ' HB3' ' A' ' 147' ' ' TYR . 0.0 OUTLIER -80.3 14.89 1.76 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.45 0.537 . . . . 2.45 112.45 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.667 ' HB2' ' O ' ' A' ' 174' ' ' GLU . 26.3 mmt 81.53 19.81 0.38 Allowed 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.598 0.713 . . . . 4.15 110.153 169.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.721 HH11 HG22 ' A' ' 106' ' ' ILE . 0.0 OUTLIER 39.39 74.4 0.09 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 113.77 -1.559 . . . . 6.51 113.257 172.352 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 108.82 -15.88 33.92 Favored Glycine 0 C--N 1.311 -0.809 0 CA-C-N 115.262 -0.881 . . . . 2.26 112.873 177.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 61.5 tttp 66.96 85.4 0.14 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.382 0.611 . . . . 6.69 110.416 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.566 HD23 HG13 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -88.81 -151.91 0.22 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.812 -0.631 . . . . 2.21 110.839 -176.097 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.424 ' OG ' ' HD2' ' A' ' 181' ' ' PRO . 26.6 t -111.28 152.79 44.07 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.017 -1.105 . . . . 2.31 108.017 174.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.424 ' HD2' ' OG ' ' A' ' 180' ' ' SER . 44.7 Cg_exo -36.25 -50.5 1.21 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.599 2.866 . . . . 1.86 114.205 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.1 m -65.12 -16.87 63.96 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.466 0.543 . . . . 2.45 112.466 -176.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.571 ' HA ' ' HE3' ' A' ' 186' ' ' LYS . 8.2 mm -92.01 -35.33 6.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 122.224 1.012 . . . . 1.69 109.147 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.674 ' HA ' HG21 ' A' ' 187' ' ' THR . 1.0 OUTLIER -74.96 -31.87 26.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 113.389 -1.732 . . . . 1.77 110.741 -177.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.89 -19.94 58.45 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.218 -1.03 . . . . 2.89 108.218 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.6 ' HD2' ' HB2' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -91.89 -24.52 19.29 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.085 -1.416 . . . . 1.71 110.31 173.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.674 HG21 ' HA ' ' A' ' 184' ' ' ILE . 3.5 t -89.5 -41.14 12.21 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 119.975 -0.69 . . . . 1.3 112.763 -177.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' MET . . . . . 0.887 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 21.7 mmt -80.67 -65.64 0.26 Allowed Pre-proline 0 N--CA 1.467 0.383 0 O-C-N 121.619 -0.676 . . . . 1.39 112.108 -174.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.887 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 17.3 Cg_exo -65.63 -20.8 59.78 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.184 1.923 . . . . 1.15 112.162 -173.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.43 ' HB3' ' O ' ' A' ' 186' ' ' LYS . 22.6 t -84.64 -36.28 22.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.989 -0.551 . . . . 1.95 110.187 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -79.98 -37.06 35.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.249 -0.432 . . . . 1.92 111.579 -174.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.599 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 20.3 mt -67.07 -45.8 76.24 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 121.007 -0.277 . . . . 1.68 111.516 -175.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.794 ' HB ' HD11 ' A' ' 33' ' ' ILE . 27.9 m -71.73 -24.12 22.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.1 -0.64 . . . . 1.32 110.406 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.408 ' HB3' ' HE3' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -73.35 -32.83 64.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.869 -0.605 . . . . 2.6 110.755 174.058 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.639 ' HA ' ' OD1' ' A' ' 198' ' ' ASN . 2.2 m-85 -65.1 -30.74 71.7 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.139 0.495 . . . . 2.73 110.319 174.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.505 HG12 HD13 ' A' ' 167' ' ' LEU . 60.4 mt -79.6 -24.58 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-O 121.365 0.603 . . . . 1.11 110.644 175.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.475 ' HA ' HD22 ' A' ' 197' ' ' LEU . 34.2 mt -73.11 -42.82 62.51 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.274 -0.421 . . . . 1.57 110.827 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.99 ' HB2' ' HZ3' ' A' ' 74' ' ' TRP . 1.8 p-10 -67.43 -15.07 63.47 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.386 -0.926 . . . . 2.18 109.469 171.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.664 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -80.81 -42.27 21.95 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 109.404 -0.591 . . . . 1.04 109.404 173.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.563 ' HD3' HG12 ' A' ' 54' ' ' ILE . 28.1 mmtp -59.56 -44.69 93.2 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 121.553 0.692 . . . . 1.51 110.013 173.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -80.48 -39.81 27.33 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.897 -1.047 . . . . 1.94 110.984 -174.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -69.51 -31.2 70.92 Favored Glycine 0 CA--C 1.507 -0.464 0 C-N-CA 120.717 -0.754 . . . . 0.47 111.395 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 1.034 HG12 ' HG3' ' A' ' 56' ' ' GLU . 1.5 tp -71.69 -34.57 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 120.574 0.226 . . . . 1.16 110.449 177.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 66.4 mttm -86.12 -15.82 39.94 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-O 121.686 0.755 . . . . 3.8 109.173 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -72.13 -35.52 69.14 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.283 -0.871 . . . . 1.28 108.681 165.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.65 ' HB3' ' HD2' ' A' ' 60' ' ' LYS . 9.4 m-70 -86.74 -2.83 58.86 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.607 -0.724 . . . . 4.34 112.327 175.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -125.16 -67.99 0.87 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.436 0.636 . . . . 3.0 110.963 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.506 ' C ' ' H ' ' A' ' 210' ' ' SER . 19.8 m -69.17 144.79 95.61 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 114.974 -1.012 . . . . 2.01 110.324 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -67.59 34.72 0.15 Allowed 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.878 2.385 . . . . 2.59 112.919 174.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.506 ' H ' ' C ' ' A' ' 208' ' ' THR . 44.4 t -78.7 -26.37 44.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.371 0.605 . . . . 2.55 109.603 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -71.13 -7.86 49.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.574 -0.739 . . . . 6.11 110.926 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.575 ' O ' ' HD2' ' A' ' 212' ' ' ARG . 2.4 tmm_? -68.24 -19.11 64.71 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.071 -0.714 . . . . 7.55 109.071 176.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -129.54 45.88 1.11 Allowed Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.574 -0.739 . . . . 3.73 111.376 174.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -67.33 142.28 56.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.011 0.434 . . . . 6.11 110.201 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -141.22 126.71 18.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.184 -0.462 . . . . 7.27 110.865 -176.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -171.33 -69.38 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.063 -0.717 . . . . 6.82 109.063 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 59.62 -166.11 0.19 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.823 -0.626 . . . . 5.77 111.009 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 13.8 m -110.18 -27.9 8.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.812 0.339 . . . . 6.85 110.582 178.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -134.18 -177.38 4.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 9.48 110.199 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 35.3 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.62 -0.705 . . . . 8.48 109.891 177.96 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.847 ' HG2' ' HB2' ' A' ' 4' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 120.449 0.166 . . . . 4.31 111.312 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.675 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -51.29 -61.81 2.01 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 123.618 0.767 . . . . 2.25 112.202 -173.795 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.541 ' HB2' HG23 ' A' ' 87' ' ' ILE . 91.3 m-85 -61.2 -26.42 67.71 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 116.033 -0.53 . . . . 0.45 110.372 -170.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.847 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 45.8 tttt -73.05 -45.04 59.78 Favored 'General case' 0 N--CA 1.417 -2.099 0 N-CA-C 107.639 -1.245 . . . . 2.06 107.639 -177.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.49 -40.24 59.14 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.831 -0.622 . . . . 1.2 111.307 176.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.675 HD12 ' O ' ' A' ' 2' ' ' ASP . 2.3 mp -81.18 -38.89 16.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.869 0.842 . . . . 1.76 109.58 -174.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.662 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -75.36 -39.79 58.88 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.533 -1.212 . . . . 1.11 111.805 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 44.7 mt-30 -63.01 -30.03 71.29 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.609 -1.178 . . . . 2.14 109.688 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.614 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 79.6 mt-30 -79.35 -46.62 17.29 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.895 -1.048 . . . . 3.04 108.671 171.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.965 HG23 ' HZ2' ' A' ' 130' ' ' LYS . 0.3 OUTLIER -60.17 -37.19 79.42 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.946 -1.024 . . . . 1.1 112.59 -176.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.496 ' HA ' ' CB ' ' A' ' 128' ' ' SER . . . -51.72 -51.7 54.1 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-O 120.929 0.395 . . . . 1.04 111.494 178.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -80.45 -10.58 59.74 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.191 -0.459 . . . . 2.31 110.952 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.614 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 49.3 mt-10 -75.11 -50.66 15.65 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.381 0.61 . . . . 2.54 109.701 174.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.693 HG22 ' N ' ' A' ' 152' ' ' GLY . 11.2 p -71.96 -37.79 62.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 122.235 1.017 . . . . 1.21 109.925 -177.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.485 HD11 ' SD ' ' A' ' 124' ' ' MET . 0.9 OUTLIER -72.05 -20.54 61.66 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 114.591 -1.186 . . . . 1.26 109.199 173.837 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.437 ' HA2' ' NH1' ' A' ' 19' ' ' ARG . . . -66.16 -18.46 67.08 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 114.184 -1.371 . . . . 0.57 110.21 172.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.614 ' CD2' ' HA ' ' A' ' 14' ' ' VAL . 33.5 m-85 -88.93 -26.49 21.53 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.249 -0.475 . . . . 3.59 109.919 177.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.551 ' HB2' ' HZ ' ' A' ' 170' ' ' PHE . 12.1 t-20 -71.44 -20.48 62.1 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 119.884 -0.726 . . . . 2.1 109.775 173.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.437 ' NH1' ' HA2' ' A' ' 16' ' ' GLY . 20.1 mtp180 -97.89 -20.72 17.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.444 -0.798 . . . . 3.26 110.383 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -115.51 103.0 10.31 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.401 -0.818 . . . . 2.16 110.709 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.804 ' HB ' ' CH2' ' A' ' 24' ' ' TRP . 23.3 p -121.94 99.18 6.3 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.618 0.723 . . . . 2.24 109.862 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.7 m -148.27 144.62 27.75 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.497 -0.774 . . . . 2.46 111.149 -165.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.33 -45.31 3.02 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.793 -0.639 . . . . 1.45 114.12 169.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.804 ' CH2' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -82.59 -157.22 0.2 Allowed 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 113.137 0.792 . . . . 2.24 113.137 -172.386 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.987 ' HE3' ' HA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER 179.36 149.55 0.28 Allowed 'General case' 0 CA--C 1.494 -1.184 0 CA-C-N 115.161 -0.927 . . . . 3.43 110.087 -165.099 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 3.3 m -60.16 124.97 15.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 114.397 -1.274 . . . . 2.21 112.068 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.656 HG11 ' HE2' ' A' ' 48' ' ' TYR . 14.4 p -98.36 -25.46 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 114.262 -1.336 . . . . 1.83 108.22 174.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.493 ' HA ' ' HD2' ' A' ' 28' ' ' LYS . 20.8 tptt -154.68 149.39 26.52 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 119.672 -0.811 . . . . 2.87 111.262 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.574 HG22 ' HA ' ' A' ' 34' ' ' THR . 34.4 p -145.36 151.63 38.59 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.715 -0.675 . . . . 1.92 109.755 175.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.653 ' O ' ' HG2' ' A' ' 31' ' ' LYS . 42.3 m -128.59 44.97 2.86 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.851 0.357 . . . . 2.37 110.489 175.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.653 ' HG2' ' O ' ' A' ' 30' ' ' SER . 0.1 OUTLIER 62.38 19.81 11.37 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.509 1.123 . . . . 4.84 112.001 169.251 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.428 ' HA ' ' HD2' ' A' ' 32' ' ' LYS . 35.6 tptt -174.63 -20.93 0.01 OUTLIER 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.569 0.7 . . . . 2.05 109.885 175.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.786 HG21 ' HA3' ' A' ' 52' ' ' GLY . 41.8 pt -117.64 156.32 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.805 -1.089 . . . . 1.42 109.517 171.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.574 ' HA ' HG22 ' A' ' 29' ' ' THR . 88.4 m -151.54 115.33 4.91 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.648 -0.706 . . . . 1.22 110.408 -164.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.667 HG13 HG12 ' A' ' 50' ' ' VAL . 6.3 m -113.12 118.13 57.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.106 0.479 . . . . 1.52 112.009 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 2.7 p -101.15 128.48 47.22 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.552 -0.749 . . . . 1.74 110.645 177.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.579 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 42.5 t -106.71 128.4 54.17 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.161 -0.927 . . . . 1.72 111.058 -171.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 21.9 ttpp -122.14 -93.87 0.51 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.335 -0.393 . . . . 2.45 111.015 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.436 ' H ' ' HB3' ' A' ' 38' ' ' LYS . . . -165.63 137.58 4.04 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.849 0.357 . . . . 2.17 110.747 -177.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.587 ' HA ' ' HG3' ' A' ' 172' ' ' GLN . 32.2 t -88.93 -95.1 0.1 Allowed 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.443 -0.799 . . . . 2.51 110.27 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' A' ' 41' ' ' ARG . 10.6 ttm180 -86.88 13.2 9.41 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.917 -1.142 . . . . 7.41 107.917 171.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.464 ' H ' ' C ' ' A' ' 40' ' ' SER . 35.0 pttt 37.07 48.34 0.71 Allowed 'General case' 0 C--N 1.342 0.25 0 CA-C-N 113.244 -1.798 . . . . 6.84 112.694 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -158.31 -56.89 0.07 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.842 -1.072 . . . . 6.42 109.352 -175.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -134.0 74.63 1.55 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.152 -0.931 . . . . 6.31 109.114 176.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 135.53 148.46 5.63 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.751 -0.659 . . . . 1.74 112.087 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 18.0 m120 -118.66 156.75 28.71 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.957 -0.386 . . . . 2.45 109.957 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.53 ' HG ' ' HB2' ' A' ' 172' ' ' GLN . 3.2 tt -98.59 135.27 40.36 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.25 -1.019 . . . . 1.49 108.25 177.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.656 ' HE2' HG11 ' A' ' 27' ' ' VAL . 60.1 m-85 -122.58 123.61 41.59 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.925 0.393 . . . . 1.52 110.336 -173.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.573 ' HD3' ' CD2' ' A' ' 170' ' ' PHE . 0.0 OUTLIER -99.02 103.38 15.32 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.129 -0.693 . . . . 3.34 109.129 178.361 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.76 HG23 ' HB3' ' A' ' 169' ' ' MET . 0.9 OUTLIER -85.92 150.13 4.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 108.745 -0.835 . . . . 1.98 108.745 178.477 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.823 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 74.1 tt0 -158.76 108.1 1.96 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.103 0.477 . . . . 1.07 110.0 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.786 ' HA3' HG21 ' A' ' 33' ' ' ILE . . . -145.33 145.08 13.95 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.846 -0.902 . . . . 0.35 110.846 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 66.2 mt -89.07 126.41 42.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 117.623 0.711 . . . . 1.3 111.249 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.463 ' HA ' ' HD2' ' A' ' 55' ' ' PRO . 44.9 mt -106.65 110.27 63.64 Favored Pre-proline 0 N--CA 1.447 -0.607 0 CA-C-N 115.995 -0.548 . . . . 1.07 109.797 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 54' ' ' ILE . 9.8 Cg_endo -52.1 66.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.477 0.511 1 C-N-CA 125.729 4.286 . . . . 0.74 113.598 174.574 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.609 ' HG2' HG13 ' A' ' 203' ' ' ILE . 10.1 tp10 -165.02 171.57 13.78 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.17 -1.048 . . . . 1.68 108.17 174.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.473 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 83.6 p -80.5 141.32 52.53 Favored Pre-proline 0 N--CA 1.428 -1.56 0 CA-C-O 121.477 0.656 . . . . 1.58 109.849 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.714 ' HA ' HD11 ' A' ' 61' ' ' LEU . 8.7 Cg_endo -51.7 -15.22 2.69 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 124.528 3.485 . . . . 0.74 111.734 171.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.53 -44.75 41.95 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.464 -0.789 . . . . 1.31 111.037 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.565 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 2.2 tpmt? -69.53 -30.64 68.52 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.028 -1.101 . . . . 3.78 108.028 178.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 1.038 HD22 HD12 ' A' ' 203' ' ' ILE . 94.0 mt -61.88 -57.73 10.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.33 -1.305 . . . . 1.09 110.73 175.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.46 ' HB3' ' HB3' ' A' ' 125' ' ' ASN . 17.4 p -64.73 -9.75 22.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.196 0.522 . . . . 1.94 110.507 176.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -89.24 -30.91 18.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.86 -0.609 . . . . 1.32 111.957 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.703 ' HD2' ' CZ2' ' A' ' 74' ' ' TRP . 18.7 p90 -89.84 -43.4 10.65 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 120.152 -0.619 . . . . 0.79 111.828 -172.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.678 HD11 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -90.77 5.54 47.89 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 120.371 -0.532 . . . . 2.15 112.061 -173.597 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.416 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 9.7 t80 -27.72 -69.58 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 O-C-N 124.743 1.277 . . . . 2.06 113.095 -167.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.456 ' HA ' ' CZ ' ' A' ' 71' ' ' ARG . 7.3 tt0 -175.1 -40.81 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 114.13 1.159 . . . . 4.31 114.13 173.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.8 t -155.06 7.13 0.26 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.527 0.936 . . . . 1.89 113.527 -163.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -116.6 0.26 20.17 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 118.709 -1.71 . . . . 1.71 115.209 -169.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.634 ' O ' HG23 ' A' ' 73' ' ' THR . 38.2 t70 -178.15 -27.82 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.385 0.592 . . . . 2.19 110.562 -177.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.622 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -55.29 -34.97 64.59 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 115.478 -0.783 . . . . 3.95 111.302 -172.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.789 HG21 HD11 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -92.77 -7.78 10.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.744 -0.382 . . . . 1.42 111.077 -175.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.809 ' HA ' ' HB2' ' A' ' 216' ' ' HIS . 1.3 t -88.19 -27.96 21.5 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 119.914 -0.714 . . . . 1.45 109.743 -176.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.703 ' CZ2' ' HD2' ' A' ' 64' ' ' PHE . 29.4 p-90 -101.45 -8.88 21.59 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.168 -0.613 . . . . 0.78 111.282 177.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.696 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 27.6 t0 -87.36 159.3 18.78 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 114.286 1.217 . . . . 2.19 114.286 -165.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.4 ' H ' ' CG ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -98.75 -26.17 14.43 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 112.637 -2.074 . . . . 3.68 111.268 -176.306 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.2 m -105.83 -3.43 21.94 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.004 -0.739 . . . . 2.08 109.004 -173.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.789 HD11 HG21 ' A' ' 72' ' ' ILE . 72.6 mt -110.47 159.17 17.74 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.902 -1.045 . . . . 1.16 111.354 -174.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.555 ' CG ' ' HG3' ' A' ' 99' ' ' GLN . 9.8 mm-40 -138.9 -62.52 0.55 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.949 -1.023 . . . . 2.23 111.403 -176.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.529 HG21 ' HB3' ' A' ' 79' ' ' GLN . 23.6 t -140.48 124.72 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.439 -0.346 . . . . 1.44 111.047 -167.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.46 ' CD1' HD11 ' A' ' 72' ' ' ILE . 49.1 p90 -95.5 148.61 22.31 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 122.984 0.514 . . . . 5.73 110.987 175.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.73 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 18.2 m120 -156.91 108.1 2.38 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.651 -0.5 . . . . 1.86 109.651 169.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.475 ' CG ' ' HD3' ' A' ' 86' ' ' ARG . 0.7 OUTLIER -66.82 103.58 1.15 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.953 -0.758 . . . . 2.52 108.953 177.089 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.745 HG12 ' HG2' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -80.8 -82.15 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 121.167 0.508 . . . . 1.19 110.513 -173.298 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.59 ' HB3' HD11 ' A' ' 93' ' ' ILE . 9.3 t60 -126.12 104.86 8.47 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.541 -0.754 . . . . 2.59 109.273 -172.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.475 ' HD3' ' CG ' ' A' ' 83' ' ' MET . 47.5 mtm180 -92.75 115.23 27.92 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.437 -0.579 . . . . 2.83 109.437 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -80.21 -40.56 20.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.476 -0.784 . . . . 1.17 110.925 -169.725 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.456 ' CG ' ' H ' ' A' ' 89' ' ' SER . 12.4 t70 -151.63 -162.73 1.59 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.012 -0.736 . . . . 1.86 109.012 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.456 ' H ' ' CG ' ' A' ' 88' ' ' ASP . 34.1 t -76.23 -17.64 59.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 117.944 0.338 . . . . 1.94 111.368 -174.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.2 p30 -136.08 17.2 3.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.825 0.345 . . . . 1.87 110.792 -175.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.601 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -129.77 107.07 9.13 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.365 -0.976 . . . . 1.12 108.365 -178.383 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.594 ' O ' HD13 ' A' ' 114' ' ' LEU . 27.2 m-85 -125.44 170.92 10.91 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.314 0.578 . . . . 0.52 111.135 -172.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.637 ' O ' HG22 ' A' ' 84' ' ' VAL . 16.9 mt -137.36 121.56 23.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 107.409 -1.33 . . . . 1.1 107.409 170.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 14.3 t -111.92 127.84 55.97 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.244 0.545 . . . . 2.61 111.26 -176.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.73 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 26.0 t60 -81.66 83.11 7.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.753 0.787 . . . . 2.17 109.01 169.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 20.0 m -94.03 113.1 25.01 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.579 -1.191 . . . . 1.19 111.342 -177.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.424 ' CG1' ' HB ' ' A' ' 80' ' ' VAL . 43.4 mm -77.02 120.9 28.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 108.63 -0.878 . . . . 1.63 108.63 171.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.1 m -110.98 128.99 56.02 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.023 -0.99 . . . . 1.72 111.217 -171.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.555 ' HG3' ' CG ' ' A' ' 79' ' ' GLN . 22.4 mt-30 -95.71 71.02 3.03 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.985 -0.552 . . . . 2.29 110.644 177.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.449 ' O ' HG23 ' A' ' 106' ' ' ILE . 49.7 m -85.06 64.19 8.55 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.918 -0.771 . . . . 4.07 108.918 173.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.404 ' HD1' ' HB3' ' A' ' 99' ' ' GLN . 25.3 p90 -77.29 99.32 5.47 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 122.273 1.035 . . . . 6.11 113.559 -168.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.618 ' HB2' HD11 ' A' ' 106' ' ' ILE . . . -118.73 82.3 1.83 Allowed 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 106.119 -1.808 . . . . 1.98 106.119 157.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.9 t -73.56 18.65 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 114.874 -1.057 . . . . 3.6 112.762 -161.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.19 -17.7 64.3 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.085 -1.206 . . . . 2.2 110.085 173.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.1 m -151.3 -44.09 0.11 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.948 -0.626 . . . . 2.08 110.209 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.618 HD11 ' HB2' ' A' ' 102' ' ' ALA . 77.3 mt -71.64 131.59 34.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.507 -0.77 . . . . 1.53 112.013 -173.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.4 m -100.34 166.44 12.64 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 108.526 -0.916 . . . . 1.71 108.526 170.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -46.32 125.31 8.78 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.035 1.823 . . . . 1.31 110.893 173.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.589 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 29.5 ttm180 -102.65 151.99 21.71 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 120.042 -0.663 . . . . 4.06 110.141 -167.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.689 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 20.8 t0 -113.01 127.23 56.17 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.736 -0.666 . . . . 1.37 109.344 -171.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.423 ' HB2' ' O ' ' A' ' 96' ' ' THR . 3.5 m-30 -113.43 134.13 54.82 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.537 0.684 . . . . 3.01 111.305 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 1.061 HG12 ' HD2' ' A' ' 145' ' ' ARG . 35.2 mm -124.36 76.39 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 107.105 -1.443 . . . . 1.2 107.105 167.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 129' ' ' SER . 7.1 p-10 -85.88 115.75 23.7 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.116 -0.947 . . . . 1.86 109.994 -176.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 1.007 HD23 ' HE2' ' A' ' 130' ' ' LYS . 11.2 tp -80.65 111.58 17.21 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-O 121.914 0.864 . . . . 1.08 109.08 169.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 129' ' ' SER . 0.1 OUTLIER -119.09 125.31 74.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-N 113.841 -1.527 . . . . 1.08 111.544 -163.303 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.662 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 11.5 t80 -104.83 112.71 25.92 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 115.114 -0.948 . . . . 2.81 110.054 172.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.803 HG12 HG21 ' A' ' 127' ' ' ILE . 73.7 mt -94.14 99.57 9.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.639 -0.71 . . . . 1.53 109.607 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.501 ' HD2' ' CZ ' ' A' ' 120' ' ' TYR . 35.9 ttmt -118.14 141.02 48.93 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.931 -0.577 . . . . 1.81 109.872 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.491 ' O ' ' HD2' ' A' ' 119' ' ' ARG . 7.9 tmm_? -118.75 98.08 6.04 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.966 -0.753 . . . . 3.22 108.966 177.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.584 ' CB ' ' HB3' ' A' ' 123' ' ' ASN . 96.5 m-85 -64.66 114.05 4.15 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.631 -1.248 . . . . 1.28 107.631 172.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -37.21 99.07 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 O-C-N 124.572 1.17 . . . . 2.28 112.688 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 56.59 34.12 63.71 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 114.159 -1.382 . . . . 0.79 112.708 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.584 ' HB3' ' CB ' ' A' ' 120' ' ' TYR . 4.6 t-20 -127.48 -49.1 1.41 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.174 -0.513 . . . . 2.06 110.266 -177.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.554 ' HG2' ' HB ' ' A' ' 154' ' ' VAL . 3.9 ttm -163.08 133.76 4.65 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 120.323 -0.551 . . . . 1.73 112.127 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.552 ' ND2' ' HB2' ' A' ' 58' ' ' PRO . 29.1 m-80 -104.63 78.97 1.5 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.23 -1.026 . . . . 2.07 108.23 174.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.64 ' CG1' HG12 ' A' ' 154' ' ' VAL . 0.5 OUTLIER -103.91 139.77 23.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 113.387 0.884 . . . . 1.06 113.387 -169.21 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.803 HG21 HG12 ' A' ' 117' ' ' ILE . 25.7 pt -108.84 111.42 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 108.907 -0.775 . . . . 1.26 108.907 163.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.533 ' HB2' HG21 ' A' ' 10' ' ' THR . 13.4 p -97.29 109.4 22.16 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.46 0.647 . . . . 1.53 110.957 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.578 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 5.5 p -113.55 155.8 24.75 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.817 -0.628 . . . . 1.81 111.86 -168.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 1.007 ' HE2' HD23 ' A' ' 114' ' ' LEU . 14.8 mtmm -140.74 134.18 29.91 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 108.132 -1.062 . . . . 2.75 108.132 173.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 41.1 p -69.79 96.33 0.98 Allowed 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.955 -1.128 . . . . 1.94 107.955 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.424 HG12 ' HE2' ' A' ' 3' ' ' PHE . 2.3 t -107.56 124.01 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 CA-C-N 114.534 -1.212 . . . . 1.64 110.788 -163.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -98.19 48.68 1.0 Allowed 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 113.264 -1.789 . . . . 2.17 109.735 -165.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.795 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 1.5 p90 -81.68 159.14 67.21 Favored Pre-proline 0 C--N 1.313 -0.983 0 CA-C-N 113.343 -1.753 . . . . 0.67 110.549 -171.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 1.9 Cg_endo -47.84 -42.1 31.28 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.672 2.915 . . . . 1.66 115.709 -172.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.795 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 18.0 tt0 -70.27 -11.82 61.17 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 111.824 0.305 . . . . 3.5 111.824 -162.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.489 ' HB2' HG13 ' A' ' 84' ' ' VAL . 0.7 OUTLIER -157.3 99.74 1.93 Allowed Pre-proline 0 C--N 1.321 -0.654 0 C-N-CA 119.407 -0.917 . . . . 6.41 113.406 177.317 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -90.23 160.93 4.69 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.003 3.135 . . . . 2.31 111.42 171.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.534 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 87.3 Cg_endo -94.58 -161.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.91 2.407 . . . . 1.27 113.361 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.5 t -148.52 -157.47 0.82 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.585 -0.895 . . . . 1.88 108.585 -178.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.1 p -89.98 -36.72 14.8 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.617 -0.433 . . . . 2.43 111.397 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.31 -35.59 58.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.9 0.381 . . . . 2.18 110.171 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.689 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 99.2 m-85 -107.71 111.39 23.56 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 109.497 -0.557 . . . . 1.33 109.497 -178.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.589 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 1.1 tp -98.38 112.88 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 N-CA-C 108.87 -0.789 . . . . 1.4 108.87 -176.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 1.061 ' HD2' HG12 ' A' ' 112' ' ' ILE . 2.6 tpp85 -60.16 97.44 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.323 -0.992 . . . . 5.14 108.323 173.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -64.38 133.8 38.98 Favored Glycine 0 CA--C 1.503 -0.683 0 CA-C-N 115.575 -0.739 . . . . 1.05 112.288 -171.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.514 ' CD2' ' HD2' ' A' ' 176' ' ' ARG . 2.6 m-85 -83.74 79.25 9.52 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 122.308 1.052 . . . . 4.68 112.115 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.492 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 5.8 t30 -80.74 83.34 6.52 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 113.45 -1.705 . . . . 2.29 108.407 167.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.531 ' HB3' ' HD2' ' A' ' 150' ' ' PRO . 96.6 m-70 -49.63 161.3 0.52 Allowed Pre-proline 0 C--O 1.219 -0.534 0 CA-C-O 118.628 -0.701 . . . . 2.95 109.755 175.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' A' ' 149' ' ' HIS . 5.7 Cg_endo -47.5 75.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 124.276 3.318 . . . . 0.77 114.135 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 170' ' ' PHE . 25.4 p -138.61 167.61 21.57 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.057 -1.46 . . . . 1.97 107.057 175.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.693 ' N ' HG22 ' A' ' 14' ' ' VAL . . . -153.69 -138.74 2.72 Favored Glycine 0 N--CA 1.433 -1.562 0 C-N-CA 118.733 -1.699 . . . . 0.55 113.51 -167.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.451 ' HB3' ' CG1' ' A' ' 127' ' ' ILE . 63.3 t80 -163.06 93.19 0.79 Allowed 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 107.949 -1.13 . . . . 0.8 107.949 -163.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.646 HG11 ' HE1' ' A' ' 170' ' ' PHE . 7.7 m -102.81 138.29 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-O 121.88 0.848 . . . . 1.03 110.653 -176.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . 0.415 ' HB2' ' HB2' ' A' ' 125' ' ' ASN . 71.4 m -112.13 110.56 20.9 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.252 -0.885 . . . . 2.3 109.296 175.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.766 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 16.4 m -101.38 122.21 48.9 Favored Pre-proline 0 C--N 1.318 -0.766 0 C-N-CA 120.602 -0.439 . . . . 1.45 111.256 -169.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.499 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 51.4 Cg_exo -55.49 115.06 2.18 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.12 1.88 . . . . 0.72 110.689 170.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.509 ' SD ' ' HB2' ' A' ' 166' ' ' LYS . 74.6 mmm -75.08 -172.11 1.57 Allowed 'General case' 0 CA--C 1.505 -0.763 0 C-N-CA 120.765 -0.374 . . . . 1.72 110.75 -177.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -69.85 -31.64 69.6 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 108.537 -0.912 . . . . 2.63 108.537 170.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.558 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 2.6 mm-40 -98.3 27.85 4.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.928 -1.033 . . . . 2.05 108.79 175.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.571 ' OD1' ' HD3' ' A' ' 162' ' ' PRO . 5.5 p30 -36.52 -47.37 1.6 Allowed Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 116.226 1.936 . . . . 2.19 116.226 -166.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.571 ' HD3' ' OD1' ' A' ' 161' ' ' ASN . 72.8 Cg_endo -75.54 -14.57 19.96 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 CA-C-N 121.621 1.615 . . . . 0.86 113.208 -175.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -111.62 -27.31 8.61 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.001 0.429 . . . . 1.34 110.657 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.558 ' HB2' ' HB2' ' A' ' 160' ' ' GLU . 66.4 m-85 -140.65 131.77 26.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.512 -0.767 . . . . 1.46 109.546 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.666 ' HB2' ' HD3' ' A' ' 58' ' ' PRO . 17.5 t -126.99 152.92 46.57 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.843 -0.743 . . . . 2.05 111.125 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.868 ' HG3' HG13 ' A' ' 168' ' ' VAL . 1.8 tppp? -91.69 104.35 16.83 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.51 -0.768 . . . . 1.4 111.509 -176.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.617 HD12 HG12 ' A' ' 196' ' ' ILE . 0.7 OUTLIER -84.8 100.91 11.85 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.066 -0.97 . . . . 1.07 108.883 174.514 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.868 HG13 ' HG3' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -124.5 128.92 73.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.667 0.746 . . . . 1.11 110.8 178.025 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.76 ' HB3' HG23 ' A' ' 50' ' ' VAL . 25.2 ttt -132.51 162.49 31.1 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.858 -0.793 . . . . 1.79 108.858 -171.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.646 ' HE1' HG11 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -139.51 108.24 5.94 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.323 -1.362 . . . . 4.22 107.323 -173.468 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.436 HG11 ' OG1' ' A' ' 173' ' ' THR . 30.6 t -106.45 98.3 6.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 124.044 0.84 . . . . 2.01 109.878 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.587 ' HG3' ' HA ' ' A' ' 40' ' ' SER . 49.9 tt0 -100.1 11.98 38.04 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 106.909 -1.515 . . . . 2.66 106.909 173.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 1.1 m -61.09 127.29 30.79 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.207 -1.815 . . . . 2.2 110.534 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.426 ' HG2' ' HB2' ' A' ' 147' ' ' TYR . 13.0 pt-20 -97.36 -15.64 20.62 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.375 -0.972 . . . . 2.45 108.375 175.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.497 ' O ' ' HG2' ' A' ' 176' ' ' ARG . 23.8 mmt 68.11 -66.12 0.23 Allowed 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 114.543 -1.208 . . . . 4.15 110.553 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.565 ' HA ' HD11 ' A' ' 179' ' ' LEU . 0.9 OUTLIER 54.49 179.54 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.982 1.313 . . . . 6.51 111.455 -176.738 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.401 ' HA3' HG12 ' A' ' 144' ' ' ILE . . . 87.66 69.61 1.29 Allowed Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 120.522 -0.847 . . . . 2.26 112.21 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 76.5 tttt 69.5 72.62 0.25 Allowed 'General case' 0 CA--C 1.532 0.253 0 O-C-N 124.12 0.541 . . . . 6.69 111.973 170.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.677 HD12 HD12 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -156.52 150.27 24.81 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.788 -0.642 . . . . 2.21 110.72 173.33 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.479 ' O ' HD11 ' A' ' 184' ' ' ILE . 18.2 m -112.7 166.95 9.97 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.576 -0.738 . . . . 2.31 109.106 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 180' ' ' SER . 94.8 Cg_exo -45.4 -43.8 17.04 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.494 2.129 . . . . 1.86 113.064 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.401 ' O ' ' HE2' ' A' ' 186' ' ' LYS . 0.7 OUTLIER -64.17 -19.34 65.25 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.162 0.506 . . . . 2.45 111.612 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.443 ' CG1' ' H ' ' A' ' 180' ' ' SER . 31.2 mm -91.56 -44.64 14.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 122.467 1.127 . . . . 1.69 108.9 -176.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.677 HD12 HD12 ' A' ' 179' ' ' LEU . 1.2 mp -68.05 -36.87 77.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 113.073 -1.876 . . . . 1.77 111.555 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -63.94 -17.98 63.8 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.112 -0.699 . . . . 2.89 109.112 177.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.401 ' HE2' ' O ' ' A' ' 182' ' ' SER . 51.4 mtmt -93.04 -45.28 7.99 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.381 -0.827 . . . . 1.71 109.919 172.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.647 HG23 ' HA ' ' A' ' 184' ' ' ILE . 6.8 t -63.58 -30.23 71.38 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.329 0.492 . . . . 1.3 112.329 -169.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' MET . . . . . 0.704 ' O ' ' HG ' ' A' ' 192' ' ' LEU . 0.2 OUTLIER -75.13 -63.39 0.72 Allowed Pre-proline 0 C--N 1.33 -0.244 0 C-N-CA 120.956 -0.298 . . . . 1.39 110.877 179.524 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.507 ' HD3' ' CB ' ' A' ' 188' ' ' MET . 32.2 Cg_exo -59.03 -33.62 98.77 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.275 1.984 . . . . 1.15 112.367 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.701 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 9.3 t -71.21 -22.61 61.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.825 0.345 . . . . 1.95 110.407 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -91.83 -43.68 9.38 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.031 -0.532 . . . . 1.92 110.733 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.704 ' HG ' ' O ' ' A' ' 188' ' ' MET . 51.7 mt -53.11 -59.39 4.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.575 -0.739 . . . . 1.68 111.703 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.476 ' O ' ' HG ' ' A' ' 197' ' ' LEU . 1.1 m -73.91 -30.57 28.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.089 -0.96 . . . . 1.32 109.345 -171.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.701 ' HB2' ' O ' ' A' ' 190' ' ' SER . 1.0 OUTLIER -67.79 -44.15 78.06 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 114.04 -1.436 . . . . 2.6 110.315 179.128 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.585 ' O ' ' HB2' ' A' ' 198' ' ' ASN . 0.9 OUTLIER -59.91 -27.42 66.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.045 0.45 . . . . 2.73 110.728 176.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.617 HG12 HD12 ' A' ' 167' ' ' LEU . 33.7 mt -79.27 -31.03 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 120.983 0.42 . . . . 1.11 111.286 173.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 94.7 mt -75.68 -30.7 59.45 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.235 0.54 . . . . 1.57 110.026 176.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.585 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 7.6 m-20 -47.22 -47.43 24.45 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.712 -1.131 . . . . 2.18 107.967 162.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.675 ' HA ' ' CE2' ' A' ' 64' ' ' PHE . . . -77.54 -44.84 27.27 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 115.005 -0.998 . . . . 1.04 111.292 -173.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 31.5 mmtp -54.63 -41.84 70.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.527 0.679 . . . . 1.51 110.696 175.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.522 ' HA ' ' HE3' ' A' ' 204' ' ' LYS . 2.2 t70 -84.37 -47.62 10.52 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.969 -1.014 . . . . 1.94 110.094 -175.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . 0.528 ' HA2' ' HB3' ' A' ' 205' ' ' ALA . . . -63.25 -29.33 74.14 Favored Glycine 0 N--CA 1.459 0.232 0 C-N-CA 120.726 -0.749 . . . . 0.47 112.489 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 1.038 HD12 HD22 ' A' ' 61' ' ' LEU . 3.0 tp -69.79 -38.58 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-O 120.848 0.356 . . . . 1.16 110.453 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.773 ' HA ' ' HG2' ' A' ' 207' ' ' ARG . 0.0 OUTLIER -90.59 -17.16 27.41 Favored 'General case' 0 C--O 1.207 -1.169 0 N-CA-C 109.284 -0.635 . . . . 3.8 109.284 177.291 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.528 ' HB3' ' HA2' ' A' ' 202' ' ' GLY . . . -67.64 -26.51 66.26 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.171 -0.677 . . . . 1.28 109.171 168.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.561 ' CE1' ' HA ' ' A' ' 64' ' ' PHE . 4.7 m-70 -83.15 -43.06 16.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.392 -0.822 . . . . 4.34 112.976 174.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.773 ' HG2' ' HA ' ' A' ' 204' ' ' LYS . 10.6 ptt180 -88.38 -40.71 13.33 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.482 0.658 . . . . 3.0 111.093 -176.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.593 ' HB ' ' O ' ' A' ' 204' ' ' LYS . 97.4 m -101.19 156.96 34.53 Favored Pre-proline 0 C--N 1.311 -1.107 0 CA-C-N 115.099 -0.955 . . . . 2.01 109.04 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . 0.451 ' HD2' HG21 ' A' ' 208' ' ' THR . 11.7 Cg_endo -59.28 -93.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 120.981 1.121 . . . . 2.59 110.434 166.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 93.5 p 49.26 25.67 1.31 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.426 0.899 . . . . 2.55 113.426 172.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -96.5 27.66 3.72 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.668 -0.864 . . . . 6.11 108.668 175.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -64.76 -25.75 68.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.691 -1.14 . . . . 7.55 110.146 176.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -112.17 36.92 3.9 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.684 -0.689 . . . . 3.73 111.553 176.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -55.42 138.52 45.86 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.91 -0.404 . . . . 6.11 109.91 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . 0.529 ' HB3' ' O ' ' A' ' 75' ' ' ASP . 20.9 t-80 -104.49 -7.65 19.65 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.521 0.563 . . . . 7.27 112.521 -170.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . 0.809 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 27.1 t-80 -79.58 60.71 3.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.786 0.803 . . . . 6.82 109.353 176.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -160.43 53.3 0.32 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.845 -1.07 . . . . 5.77 108.499 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 11.0 m -91.08 0.76 57.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.102 -0.954 . . . . 6.85 110.491 -175.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -139.42 136.07 34.29 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.819 -0.628 . . . . 9.48 110.231 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.354 -0.831 . . . . 8.48 110.875 179.951 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 mtp . . . . . 0 N--CA 1.482 1.153 0 N-CA-C 109.416 -0.587 . . . . 4.31 109.416 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.611 ' O ' HD13 ' A' ' 6' ' ' ILE . 15.2 t70 -95.77 -55.17 3.09 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 109.313 -0.625 . . . . 2.25 109.313 177.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.508 ' O ' HD22 ' A' ' 114' ' ' LEU . 70.5 m-85 -59.55 -34.82 73.16 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.667 0.746 . . . . 0.45 109.598 -177.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.565 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 45.1 tttt -70.48 -42.47 71.37 Favored 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 114.644 -1.162 . . . . 2.06 108.085 -178.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.89 -41.9 62.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.844 -0.617 . . . . 1.2 111.616 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.664 ' O ' ' HB ' ' A' ' 10' ' ' THR . 1.3 mp -79.26 -48.15 21.57 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 N-CA-C 108.714 -0.847 . . . . 1.76 108.714 -175.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -57.54 -47.42 82.06 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.779 -1.1 . . . . 1.11 111.974 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.565 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 13.1 mt-30 -60.34 -36.22 77.48 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 113.889 -1.505 . . . . 2.14 111.631 -176.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.27 -18.16 26.13 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.396 -0.82 . . . . 3.04 109.506 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.664 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -83.18 -38.6 22.11 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.19 -0.914 . . . . 1.1 111.233 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.406 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -49.54 -59.89 3.35 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-O 121.218 0.532 . . . . 1.04 110.81 176.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -67.4 -11.54 58.0 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.284 -0.871 . . . . 2.31 111.787 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.589 ' HB3' ' HA ' ' A' ' 10' ' ' THR . 0.6 OUTLIER -87.3 -42.11 13.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 110.267 -0.272 . . . . 2.54 110.267 -179.164 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.634 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -75.48 -34.16 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 122.305 1.05 . . . . 1.21 108.539 177.617 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.516 HD12 ' SD ' ' A' ' 124' ' ' MET . 0.6 OUTLIER -68.39 -29.29 67.95 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 114.32 -1.309 . . . . 1.26 108.379 172.305 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 20' ' ' ASP . . . -64.99 -17.93 63.91 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 113.571 -1.65 . . . . 0.57 110.706 177.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.634 ' CD2' ' HA ' ' A' ' 14' ' ' VAL . 23.6 m-85 -84.6 -26.25 28.04 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 109.427 -0.583 . . . . 3.59 109.427 176.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 170' ' ' PHE . 2.6 t30 -72.09 -15.75 62.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.768 -0.651 . . . . 2.1 110.086 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -116.31 10.97 14.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.456 -0.793 . . . . 3.26 110.467 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 27.5 t70 -111.36 107.22 16.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.943 -0.571 . . . . 2.16 110.684 -176.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.556 HG22 ' CZ2' ' A' ' 24' ' ' TRP . 53.3 p -125.87 112.75 16.35 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.624 0.25 . . . . 2.24 110.642 -176.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.2 p -177.5 117.65 0.1 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.861 -0.609 . . . . 2.46 111.817 -168.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.3 33.89 82.46 Favored Glycine 0 C--O 1.23 -0.144 0 C-N-CA 121.337 -0.458 . . . . 1.45 113.404 173.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.556 ' CZ2' HG22 ' A' ' 21' ' ' THR . 0.1 OUTLIER -119.97 -168.28 1.58 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.289 -0.634 . . . . 2.24 109.289 177.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 36' ' ' SER . 8.0 mtmm -174.95 156.42 2.2 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 107.999 -1.111 . . . . 3.43 107.999 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.565 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 2.3 p -78.46 119.64 27.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-O 121.817 0.817 . . . . 2.21 109.25 175.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 35' ' ' VAL . 8.2 p -86.61 -24.76 6.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 114.845 -1.07 . . . . 1.83 109.382 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 tppt? -172.31 150.73 2.41 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.634 0.605 . . . . 2.87 112.634 -176.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.512 HG23 ' HA ' ' A' ' 34' ' ' THR . 69.3 p -134.43 148.42 50.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.553 -0.749 . . . . 1.92 109.682 173.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.508 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 50.3 m -152.78 84.1 1.23 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.557 0.577 . . . . 2.37 112.557 177.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 30' ' ' SER . 3.2 mptp? 79.66 71.31 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.942 0.497 . . . . 4.84 111.365 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.465 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 65.2 mttm 73.26 20.87 3.19 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.299 -0.864 . . . . 2.05 111.724 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.489 ' HB ' ' H ' ' A' ' 30' ' ' SER . 2.5 mt -108.44 166.78 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.942 0 CA-C-O 121.149 0.499 . . . . 1.42 110.771 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.512 ' HA ' HG23 ' A' ' 29' ' ' THR . 48.7 m -158.43 102.54 1.74 Allowed 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.589 -1.187 . . . . 1.22 109.304 176.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 27' ' ' VAL . 21.8 t -96.3 103.1 14.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.993 -0.549 . . . . 1.52 109.537 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 81.0 p -96.22 123.49 39.87 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.502 0.667 . . . . 1.74 110.911 -178.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.0 p -94.36 127.85 40.5 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.762 -1.108 . . . . 1.72 110.898 -176.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -136.51 123.38 21.33 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.624 -0.716 . . . . 2.45 110.028 175.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 46' ' ' ASN . . . -55.41 127.59 30.29 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.36 0.504 . . . . 2.17 112.36 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.538 ' OG ' ' HB2' ' A' ' 47' ' ' LEU . 20.4 m -85.95 137.59 32.62 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.323 -0.621 . . . . 2.51 109.323 176.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.573 ' NE ' ' HA ' ' A' ' 41' ' ' ARG . 4.4 mmp_? -88.55 13.07 12.87 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.786 0.327 . . . . 7.41 111.165 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.467 ' HD2' ' N ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -64.36 -22.92 67.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.215 -0.448 . . . . 6.84 110.369 175.346 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.467 ' N ' ' HD2' ' A' ' 42' ' ' LYS . 70.3 t80 174.82 -89.02 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.443 0.464 . . . . 6.42 109.898 177.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -151.86 82.88 1.28 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.846 -0.798 . . . . 6.31 108.846 176.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.77 129.15 1.87 Allowed Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 109.539 -1.424 . . . . 1.74 109.539 -177.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.533 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 15.9 m120 -82.78 136.48 34.67 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.024 0.44 . . . . 2.45 110.887 -175.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.538 ' HB2' ' OG ' ' A' ' 40' ' ' SER . 8.4 tt -87.76 140.75 29.19 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.468 -0.938 . . . . 1.49 108.468 173.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -121.52 118.49 29.43 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.658 -0.417 . . . . 1.52 110.42 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.422 ' HG3' ' CD2' ' A' ' 170' ' ' PHE . 37.1 ttt-85 -97.5 112.08 24.08 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.121 -0.696 . . . . 3.34 109.121 176.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.491 HG13 ' HB3' ' A' ' 169' ' ' MET . 0.9 OUTLIER -107.24 119.56 57.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.907 -0.588 . . . . 1.98 109.97 -172.848 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.53 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 35.9 tt0 -134.5 117.15 15.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.028 -0.533 . . . . 1.07 111.296 -166.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 32' ' ' LYS . . . -145.66 144.75 13.37 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 121.05 -0.595 . . . . 0.35 111.643 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 78.9 mt -86.09 131.5 34.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 117.249 0.525 . . . . 1.3 111.175 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.424 ' CD1' ' HB1' ' A' ' 199' ' ' ALA . 55.5 mt -110.46 108.24 58.37 Favored Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-N 115.493 -0.776 . . . . 1.07 109.034 176.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -62.37 56.12 0.13 Allowed 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 124.422 3.415 . . . . 0.74 115.393 -173.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -164.35 -162.97 0.71 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.876 -0.416 . . . . 1.68 109.876 167.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 78.2 p -77.45 138.12 63.6 Favored Pre-proline 0 N--CA 1.431 -1.424 0 CA-C-O 121.918 0.866 . . . . 1.58 112.135 -168.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.512 ' HA ' HD13 ' A' ' 61' ' ' LEU . 18.1 Cg_exo -62.44 -13.6 34.03 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.504 2.802 . . . . 0.74 109.899 172.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.46 -53.38 19.51 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.194 -1.366 . . . . 1.31 110.964 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.477 ' HG2' HD12 ' A' ' 203' ' ' ILE . 15.1 ttpt -68.62 -27.55 66.12 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.244 -1.021 . . . . 3.78 108.244 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.697 ' O ' HD11 ' A' ' 65' ' ' LEU . 28.9 mt -56.99 -60.45 3.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.159 -0.928 . . . . 1.09 110.409 170.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.8 p -62.57 -15.9 53.5 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 121.81 -0.556 . . . . 1.94 110.839 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -92.36 -26.73 17.94 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.048 0.758 . . . . 1.32 113.048 -176.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.648 ' CE2' ' HA ' ' A' ' 199' ' ' ALA . 6.5 p90 -89.2 -41.48 12.21 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.731 -0.606 . . . . 0.79 110.866 -174.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.697 HD11 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -92.93 7.92 41.94 Favored 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 120.761 -0.376 . . . . 2.15 110.02 -179.286 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -44.55 -71.53 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.214 -0.903 . . . . 2.06 112.452 -168.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -139.7 -74.42 0.36 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.204 -0.598 . . . . 4.31 112.522 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.703 ' HB ' ' CD1' ' A' ' 81' ' ' TYR . 9.0 t -156.77 30.92 0.31 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.753 0.787 . . . . 1.89 110.695 -168.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.0 -46.96 4.02 Favored Glycine 0 CA--C 1.49 -1.487 0 C-N-CA 120.01 -1.091 . . . . 1.71 112.636 -173.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.47 ' O ' HG23 ' A' ' 73' ' ' THR . 19.3 p-10 -152.6 -18.18 0.16 Allowed 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.151 -1.025 . . . . 2.19 110.795 -171.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.698 ' HA ' ' CZ2' ' A' ' 74' ' ' TRP . 2.7 ptp180 -48.89 -39.36 25.62 Favored 'General case' 0 C--O 1.218 -0.589 0 C-N-CA 122.759 0.423 . . . . 3.95 110.572 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.529 ' N ' ' HG3' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -88.58 -7.91 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 C-N-CA 120.569 -0.453 . . . . 1.42 111.242 -175.643 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 215' ' ' HIS . 0.8 OUTLIER -97.0 -32.76 11.84 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 119.791 -0.763 . . . . 1.45 111.135 -173.811 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.698 ' CZ2' ' HA ' ' A' ' 71' ' ' ARG . 7.8 p-90 -101.63 -3.49 28.23 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.55 -0.46 . . . . 0.78 111.283 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.695 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 4.8 t70 -65.06 -178.64 0.47 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.869 0.842 . . . . 2.19 112.356 -172.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.677 ' HG2' ' OD1' ' A' ' 198' ' ' ASN . 66.8 mmtt -104.56 -33.26 8.6 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.793 -1.094 . . . . 3.68 108.852 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.478 ' HA ' ' HB2' ' A' ' 99' ' ' GLN . 16.8 m -134.61 19.52 3.59 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.344 -0.844 . . . . 2.08 112.203 -170.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.479 HD11 HG23 ' A' ' 72' ' ' ILE . 27.7 mt -108.17 153.42 23.2 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.026 0.441 . . . . 1.16 110.508 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.486 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 26.1 mm-40 -134.28 -67.0 0.59 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.671 -0.695 . . . . 2.23 110.606 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 96' ' ' THR . 2.4 t -136.73 112.01 11.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.674 -0.694 . . . . 1.44 110.847 -170.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.703 ' CD1' ' HB ' ' A' ' 68' ' ' THR . 18.0 t80 -98.92 137.79 36.98 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.013 -0.736 . . . . 5.73 109.013 175.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -143.16 107.44 4.76 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.442 -0.577 . . . . 1.86 109.442 -175.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.467 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 2.8 mtm -66.77 102.25 0.92 Allowed 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.996 -0.742 . . . . 2.52 108.996 174.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.3 OUTLIER -72.9 -71.01 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.919 -0.582 . . . . 1.19 110.843 -170.075 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -133.19 118.66 18.9 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.677 -0.861 . . . . 2.59 108.677 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.467 ' HD3' ' SD ' ' A' ' 83' ' ' MET . 44.0 mtm180 -93.89 105.27 17.29 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.126 0.489 . . . . 2.83 109.965 -175.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.632 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -69.08 -44.45 81.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.355 -0.839 . . . . 1.17 110.945 -175.323 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.444 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 15.0 t70 -147.9 168.0 23.37 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.928 -1.033 . . . . 1.86 108.253 -173.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.2 m -68.05 -3.67 10.96 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.594 0.235 . . . . 1.94 111.112 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -130.77 4.52 4.56 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 110.177 -0.305 . . . . 1.87 110.177 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.632 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -133.3 108.79 8.95 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 109.114 -0.698 . . . . 1.12 109.114 -172.433 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.63 ' O ' HD12 ' A' ' 114' ' ' LEU . 17.1 m-85 -125.38 174.74 7.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.876 -0.602 . . . . 0.52 110.127 -174.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.557 HG23 ' CE1' ' A' ' 134' ' ' PHE . 39.4 mt -131.55 132.79 62.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 107.927 -1.138 . . . . 1.1 107.927 171.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.45 ' HB3' ' OH ' ' A' ' 81' ' ' TYR . 23.6 p -110.93 106.26 15.32 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.585 -0.446 . . . . 2.61 111.961 -171.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.576 ' HA ' ' O ' ' A' ' 111' ' ' PHE . 2.1 t60 -81.23 90.06 6.07 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.441 -0.948 . . . . 2.17 108.441 167.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.62 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 35.0 m -115.47 114.58 25.22 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.555 -0.748 . . . . 1.19 111.938 -171.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 38.1 mm -76.52 121.98 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 109.01 -0.737 . . . . 1.63 109.01 174.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' A' ' 109' ' ' ARG . 25.7 m -109.4 143.73 38.58 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.544 -1.207 . . . . 1.72 109.861 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.486 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 22.2 mt-30 -71.59 174.19 7.03 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.693 -0.685 . . . . 2.29 111.625 -176.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.9 t -85.74 94.21 9.05 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.42 -0.809 . . . . 4.07 109.547 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.453 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 50.1 t80 -91.63 116.3 28.76 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.473 -0.936 . . . . 6.11 108.473 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.522 ' HB3' HD13 ' A' ' 106' ' ' ILE . . . 71.44 69.79 0.17 Allowed 'General case' 0 C--N 1.32 -0.677 0 O-C-N 124.452 1.095 . . . . 1.98 108.235 -172.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.8 m -64.41 4.6 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 114.459 -1.246 . . . . 3.6 113.013 -173.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 102' ' ' ALA . . . -77.44 -45.94 10.57 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.411 -0.899 . . . . 2.2 111.948 -178.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 74.2 m -130.96 0.51 4.24 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.815 0.34 . . . . 2.08 111.329 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.522 HD13 ' HB3' ' A' ' 102' ' ' ALA . 73.6 mt -119.03 125.08 74.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.163 0.506 . . . . 1.53 111.159 -176.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.467 ' OG ' ' HD2' ' A' ' 108' ' ' PRO . 32.4 t -92.19 159.83 36.6 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.354 -0.839 . . . . 1.71 109.25 178.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.467 ' HD2' ' OG ' ' A' ' 107' ' ' SER . 97.2 Cg_exo -44.63 142.37 4.85 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.44 2.093 . . . . 1.31 111.374 171.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.693 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 29.1 ttp-105 -126.21 130.8 51.67 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.545 -0.462 . . . . 4.06 109.879 -167.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 9.1 t0 -104.73 125.07 50.45 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.736 -0.468 . . . . 1.37 109.736 -176.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.62 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 12.0 m-30 -95.97 143.65 26.96 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.244 0.545 . . . . 3.01 110.621 -172.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.629 ' CG2' ' HE1' ' A' ' 134' ' ' PHE . 26.9 mm -138.36 61.2 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 107.085 -1.45 . . . . 1.2 107.085 170.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.464 ' OD1' ' HB2' ' A' ' 148' ' ' ASN . 45.7 m-20 -96.46 125.41 40.93 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.658 -1.156 . . . . 1.86 109.766 -175.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.63 HD12 ' O ' ' A' ' 92' ' ' PHE . 7.7 tp -75.22 126.89 31.94 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.988 -0.551 . . . . 1.08 109.524 173.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -127.01 128.18 70.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.596 -0.729 . . . . 1.08 111.929 -165.475 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.521 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 7.7 t80 -113.15 114.23 26.5 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.156 -0.929 . . . . 2.81 110.324 175.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.454 HG12 HG23 ' A' ' 127' ' ' ILE . 71.9 mt -90.41 99.29 9.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.84 -0.618 . . . . 1.53 109.401 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.475 ' HB3' HG21 ' A' ' 126' ' ' ILE . 15.4 tppt? -102.4 123.06 45.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.572 -0.74 . . . . 1.81 110.948 -173.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -103.07 93.28 4.93 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.869 -0.605 . . . . 3.22 109.443 177.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -70.97 106.12 3.54 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 107.181 -1.414 . . . . 1.28 107.181 168.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -26.1 92.98 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 O-C-N 125.123 1.514 . . . . 2.28 113.631 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 53.7 43.27 68.98 Favored Glycine 0 CA--C 1.508 -0.385 0 CA-C-N 115.316 -0.856 . . . . 0.79 112.176 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.644 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 3.6 t-20 -139.02 -47.77 0.49 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.054 -0.573 . . . . 2.06 110.585 -174.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.516 ' SD ' HD12 ' A' ' 15' ' ' LEU . 2.4 mtt -161.13 121.21 2.69 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 120.953 0.406 . . . . 1.73 110.919 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -106.34 75.16 1.07 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.452 -0.944 . . . . 2.07 108.452 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.651 ' HA ' ' O ' ' A' ' 153' ' ' PHE . 0.5 OUTLIER -97.08 141.5 15.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.004 -0.998 . . . . 1.06 112.866 -172.173 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.695 ' O ' HG13 ' A' ' 127' ' ' ILE . 6.4 pt -109.45 108.97 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-O 121.756 0.789 . . . . 1.26 108.99 163.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 56.4 p -95.25 117.93 31.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.191 0.519 . . . . 1.53 110.955 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.548 ' HB2' ' SG ' ' A' ' 151' ' ' CYS . 20.1 m -114.6 151.57 33.25 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.199 0.523 . . . . 1.81 111.458 -174.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.456 ' CE ' HD23 ' A' ' 114' ' ' LEU . 10.3 mtmm -140.92 130.12 23.53 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.787 -0.82 . . . . 2.75 108.787 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.407 ' HB3' ' H ' ' A' ' 148' ' ' ASN . 21.7 p -73.76 101.46 3.71 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.832 -0.803 . . . . 1.94 108.832 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.3 m -105.72 173.55 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 120.048 -0.661 . . . . 1.64 110.173 -176.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -135.65 65.42 1.54 Allowed 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 122.069 0.938 . . . . 2.17 109.354 -174.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.629 ' HE1' ' CG2' ' A' ' 112' ' ' ILE . 1.0 OUTLIER -97.08 153.62 38.44 Favored Pre-proline 0 C--N 1.317 -0.839 0 CA-C-N 114.088 -1.414 . . . . 0.67 108.852 -175.644 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -83.39 5.42 6.41 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.082 1.855 . . . . 1.66 116.483 -166.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.581 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 11.8 tp10 -76.06 -15.95 60.02 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 119.253 0.933 . . . . 3.5 108.505 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -156.75 114.73 2.03 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 113.315 0.857 . . . . 6.41 113.315 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -95.06 139.43 0.98 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.671 2.914 . . . . 2.31 111.85 169.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -80.6 -165.4 0.34 Allowed 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.608 2.205 . . . . 1.27 112.988 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.1 m -147.62 152.37 37.78 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.94 -1.133 . . . . 1.88 107.94 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.1 t -61.45 -16.9 51.47 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.953 0.723 . . . . 2.43 112.953 -167.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -82.72 -18.52 40.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.943 0.402 . . . . 2.18 110.94 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.489 ' HB3' ' CB ' ' A' ' 110' ' ' ASP . 94.1 m-85 -130.82 109.15 10.37 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.73 -0.668 . . . . 1.33 109.804 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.693 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 2.1 tp -89.19 115.02 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 CA-C-N 115.795 -0.638 . . . . 1.4 109.659 -169.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.548 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 30.3 ttp180 -36.02 115.75 0.35 Allowed 'General case' 0 C--N 1.327 -0.403 0 O-C-N 124.618 1.198 . . . . 5.14 111.076 175.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -42.63 108.0 0.13 Allowed Glycine 0 CA--C 1.496 -1.096 0 O-C-N 124.655 1.222 . . . . 1.05 112.358 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.61 ' HB2' ' HB3' ' A' ' 174' ' ' GLU . 1.3 p90 -86.01 55.33 3.48 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.201 -0.499 . . . . 4.68 111.835 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.686 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 84.5 m-20 -98.64 65.36 1.57 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.489 -0.778 . . . . 2.29 110.702 -177.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -54.44 146.2 34.36 Favored Pre-proline 0 N--CA 1.467 0.379 0 CA-C-N 115.843 -0.617 . . . . 2.95 110.421 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -10.01 62.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.312 1 C-N-CA 126.853 5.035 . . . . 0.77 115.838 -161.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . 0.686 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 27.6 p -84.19 171.13 13.07 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.347 -1.297 . . . . 1.97 109.069 173.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' A' ' 169' ' ' MET . . . -167.8 -168.04 29.35 Favored Glycine 0 N--CA 1.433 -1.552 0 C-N-CA 119.744 -1.217 . . . . 0.55 111.854 177.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.651 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 39.9 t80 -162.66 77.01 0.46 Allowed 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 109.064 -0.717 . . . . 0.8 109.064 -165.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.551 ' CG2' HG12 ' A' ' 168' ' ' VAL . 3.9 m -89.27 121.6 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 122.034 0.921 . . . . 1.03 110.607 -175.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 32.3 m -100.43 112.74 25.13 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.037 -0.983 . . . . 2.3 108.728 175.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.404 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 7.1 m -106.8 111.43 63.83 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 116.492 -0.322 . . . . 1.45 111.406 -171.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.644 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 57.7 Cg_exo -52.16 119.34 5.62 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.421 2.081 . . . . 0.72 111.002 168.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 72.2 mtp -81.37 -169.98 2.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.976 0.417 . . . . 1.72 111.348 -176.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -67.28 -30.53 70.42 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.854 -0.795 . . . . 2.63 108.854 169.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.419 ' C ' ' HD2' ' A' ' 162' ' ' PRO . 47.1 mm-40 -104.32 28.79 6.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.607 -1.179 . . . . 2.05 109.274 175.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.572 ' OD1' ' HD3' ' A' ' 162' ' ' PRO . 4.8 p30 -34.81 -47.82 0.94 Allowed Pre-proline 0 N--CA 1.472 0.643 0 N-CA-C 116.16 1.911 . . . . 2.19 116.16 -171.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.572 ' HD3' ' OD1' ' A' ' 161' ' ' ASN . 66.3 Cg_endo -72.51 -25.09 18.27 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 CA-C-N 121.534 1.584 . . . . 0.86 112.378 -174.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -100.78 -25.55 14.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.761 -0.654 . . . . 1.34 110.919 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -142.48 119.99 11.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.986 -0.552 . . . . 1.46 110.238 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.583 ' OG ' HD11 ' A' ' 61' ' ' LEU . 13.8 p -114.47 140.83 48.4 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.169 0.509 . . . . 2.05 110.972 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.53 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 2.0 tppp? -91.51 104.04 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.892 0.853 . . . . 1.4 111.577 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.548 HD21 ' CE2' ' A' ' 153' ' ' PHE . 0.8 OUTLIER -89.49 111.61 22.55 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.87 -1.059 . . . . 1.07 109.241 177.756 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.551 HG12 ' CG2' ' A' ' 154' ' ' VAL . 0.1 OUTLIER -132.16 116.41 29.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 122.099 0.952 . . . . 1.11 111.91 175.094 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.491 ' HB3' HG13 ' A' ' 50' ' ' VAL . 19.4 ttt -112.57 158.99 19.29 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.462 -1.244 . . . . 1.79 108.817 -175.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.525 ' CD1' HG21 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -140.06 151.15 45.17 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 110.47 -0.196 . . . . 4.22 110.47 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.504 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 6.6 m -136.87 128.23 42.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 O-C-N 123.385 0.428 . . . . 2.01 110.931 173.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -108.15 49.7 0.8 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.106 -1.442 . . . . 2.66 107.106 174.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -47.68 130.65 14.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.383 -1.735 . . . . 2.2 113.541 -166.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.61 ' HB3' ' HB2' ' A' ' 147' ' ' TYR . 21.9 tt0 -88.49 -33.19 17.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.274 -0.876 . . . . 2.45 111.04 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.471 ' SD ' HG12 ' A' ' 184' ' ' ILE . 68.9 mtm 61.21 50.97 4.54 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.183 0.516 . . . . 4.15 110.567 171.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.585 ' HG3' ' HB3' ' A' ' 147' ' ' TYR . 74.2 mtp85 -58.99 -30.24 67.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.228 -0.896 . . . . 6.51 111.9 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -66.04 -20.48 68.92 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.849 -0.691 . . . . 2.26 111.99 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 51.46 82.46 0.06 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.266 0.626 . . . . 6.69 111.772 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.548 ' HB2' ' CD1' ' A' ' 184' ' ' ILE . 0.4 OUTLIER -84.52 -158.39 0.34 Allowed 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.629 -0.878 . . . . 2.21 108.629 177.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.523 ' O ' HD13 ' A' ' 184' ' ' ILE . 50.2 m -112.05 151.38 43.55 Favored Pre-proline 0 C--N 1.315 -0.897 0 N-CA-C 108.802 -0.814 . . . . 2.31 108.802 178.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.598 ' O ' ' HG2' ' A' ' 185' ' ' GLU . 62.0 Cg_exo -39.68 -56.0 1.48 Allowed 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 123.327 2.685 . . . . 1.86 113.373 -177.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 14.6 m -64.97 -11.74 42.06 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.483 0.549 . . . . 2.45 112.483 -175.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.461 ' HA ' ' CE ' ' A' ' 186' ' ' LYS . 33.0 mm -90.73 -43.89 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-O 122.528 1.156 . . . . 1.69 108.724 -177.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.64 ' HA ' ' CG2' ' A' ' 187' ' ' THR . 1.4 mp -66.69 -34.14 68.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 112.889 -1.959 . . . . 1.77 110.597 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.598 ' HG2' ' O ' ' A' ' 181' ' ' PRO . 18.1 mm-40 -62.04 -21.33 64.82 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.793 -1.094 . . . . 2.89 109.39 174.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.461 ' CE ' ' HA ' ' A' ' 183' ' ' ILE . 50.8 mtmt -92.53 -49.34 6.17 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.382 -0.826 . . . . 1.71 110.222 172.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.64 ' CG2' ' HA ' ' A' ' 184' ' ' ILE . 6.5 t -61.55 -35.08 76.74 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.328 0.492 . . . . 1.3 112.328 -168.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' MET . . . . . 0.598 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 2.1 mmt -80.35 -61.24 0.44 Allowed Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 119.921 -0.712 . . . . 1.39 111.946 -177.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.598 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 8.0 Cg_exo -73.38 -12.53 25.16 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.03 1.82 . . . . 1.15 112.545 -172.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.564 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 11.6 t -91.82 -33.48 14.94 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.784 -0.366 . . . . 1.95 110.311 176.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.2 OUTLIER -81.27 -38.4 26.92 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.44 -0.346 . . . . 1.92 110.538 -173.556 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 188' ' ' MET . 54.7 mt -67.61 -44.68 77.47 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.888 0.375 . . . . 1.68 111.277 -176.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.449 ' HB ' HD13 ' A' ' 33' ' ' ILE . 2.1 m -66.95 -31.94 55.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.54 0.686 . . . . 1.32 109.354 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.564 ' HB2' ' O ' ' A' ' 190' ' ' SER . 0.6 OUTLIER -74.34 -27.23 60.59 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.668 -1.151 . . . . 2.6 110.628 179.534 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.419 ' O ' ' HB2' ' A' ' 198' ' ' ASN . 2.6 t80 -73.66 -30.27 62.82 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.623 -0.88 . . . . 2.73 108.623 175.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.69 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 17.6 mt -77.25 -34.3 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 116.079 -0.51 . . . . 1.11 110.703 173.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 74.2 mt -67.49 -37.04 82.26 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 121.229 0.538 . . . . 1.57 109.702 174.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.677 ' OD1' ' HG2' ' A' ' 76' ' ' LYS . 22.0 m-20 -50.65 -36.26 34.66 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.718 -1.128 . . . . 2.18 109.671 167.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.648 ' HA ' ' CE2' ' A' ' 64' ' ' PHE . . . -81.04 -42.35 21.23 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 115.926 -0.579 . . . . 1.04 110.944 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.69 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 10.3 mmmm -58.81 -38.89 79.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.548 0.689 . . . . 1.51 110.164 176.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -88.75 -43.54 11.2 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.902 -1.045 . . . . 1.94 111.092 -178.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 206' ' ' HIS . . . -66.75 -31.52 78.62 Favored Glycine 0 CA--C 1.504 -0.626 0 C-N-CA 121.009 -0.615 . . . . 0.47 111.984 -176.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.618 ' CD1' HD21 ' A' ' 61' ' ' LEU . 4.7 tp -67.67 -34.47 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-O 121.274 0.559 . . . . 1.16 110.107 178.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.588 ' HA ' ' HG2' ' A' ' 207' ' ' ARG . 54.2 mttp -87.21 -30.63 20.82 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.813 -0.631 . . . . 3.8 109.555 -178.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -61.98 -31.74 72.13 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.353 -0.84 . . . . 1.28 109.231 168.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' A' ' 202' ' ' GLY . 4.1 t60 -77.94 -20.36 52.9 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.943 -1.026 . . . . 4.34 111.618 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.588 ' HG2' ' HA ' ' A' ' 204' ' ' LYS . 14.2 ptm180 -101.92 -47.28 4.63 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 119.855 -0.738 . . . . 3.0 111.724 176.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.542 HG23 ' O ' ' A' ' 204' ' ' LYS . 1.3 t -100.9 155.13 36.68 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.055 -0.72 . . . . 2.01 109.055 -176.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . 0.537 ' HD2' ' OG1' ' A' ' 208' ' ' THR . 44.4 Cg_endo -68.01 66.12 0.96 Allowed 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.691 2.261 . . . . 2.59 112.706 178.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 18.5 t -109.79 37.96 2.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.485 0.659 . . . . 2.55 110.044 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -110.17 14.14 22.93 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.105 -0.702 . . . . 6.11 109.105 172.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -61.34 -22.3 64.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.202 -0.908 . . . . 7.55 111.106 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -119.56 39.13 2.58 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 110.988 -0.845 . . . . 3.73 110.988 175.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -68.62 150.31 48.13 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.045 -0.354 . . . . 6.11 110.045 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . 0.531 ' O ' ' HA ' ' A' ' 73' ' ' THR . 40.7 p-80 -120.24 135.39 55.01 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.165 -0.68 . . . . 7.27 109.165 173.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -138.85 125.39 20.61 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 110.029 -0.36 . . . . 6.82 110.029 -173.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -130.21 66.53 1.49 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.452 0.644 . . . . 5.77 110.654 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.2 t -91.94 -24.72 19.18 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.938 -0.764 . . . . 6.85 108.938 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -142.25 98.06 3.24 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.249 -0.887 . . . . 9.48 109.515 177.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 5.2 t . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.597 -0.716 . . . . 8.48 109.646 -179.046 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 121.161 0.505 . . . . 4.31 110.062 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.568 ' O ' HD11 ' A' ' 6' ' ' ILE . 7.5 m-20 -101.26 -74.52 0.61 Allowed 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 116.133 -0.485 . . . . 2.25 110.518 -175.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.57 ' HA ' HD11 ' A' ' 6' ' ' ILE . 81.2 m-85 -60.67 -29.08 69.08 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 115.465 -0.789 . . . . 0.45 110.586 -170.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.603 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 21.0 ttmt -74.05 -37.13 64.38 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 107.952 -1.129 . . . . 2.06 107.952 -174.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.71 -37.23 78.32 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.568 -0.742 . . . . 1.2 110.556 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.612 HG21 ' HE3' ' A' ' 130' ' ' LYS . 1.7 mp -82.75 -39.35 15.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.922 0.868 . . . . 1.76 109.131 -174.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.66 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -75.89 -37.41 58.87 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.275 -1.329 . . . . 1.11 111.595 -177.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.603 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 15.2 mt-30 -65.94 -28.24 68.77 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.346 -0.843 . . . . 2.14 109.803 176.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -81.06 -34.89 32.42 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.753 -1.112 . . . . 3.04 109.555 174.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.702 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.3 OUTLIER -74.1 -36.5 64.26 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.067 -0.969 . . . . 1.1 111.486 -179.25 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.507 ' O ' ' HB3' ' A' ' 15' ' ' LEU . . . -46.14 -53.77 9.83 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-O 120.911 0.386 . . . . 1.04 110.651 172.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -78.81 -1.68 36.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.924 -0.58 . . . . 2.31 111.989 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.649 ' HB3' ' HA ' ' A' ' 10' ' ' THR . 0.8 OUTLIER -87.87 -49.45 7.09 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.767 -0.827 . . . . 2.54 108.767 175.389 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.651 HG22 ' N ' ' A' ' 152' ' ' GLY . 13.0 p -69.39 -40.7 80.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 122.237 1.017 . . . . 1.21 109.039 178.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.507 ' HB3' ' O ' ' A' ' 11' ' ' ALA . 0.9 OUTLIER -73.74 -17.92 61.05 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 114.378 -1.283 . . . . 1.26 109.186 175.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.537 ' HA2' ' NE ' ' A' ' 19' ' ' ARG . . . -58.0 -32.85 67.35 Favored Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 109.728 -1.349 . . . . 0.57 109.728 171.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.488 ' HD1' ' O ' ' A' ' 13' ' ' GLU . 9.5 m-85 -88.05 -15.71 35.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.872 -0.664 . . . . 3.59 109.894 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.48 ' HA ' ' NH1' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -89.43 -19.84 24.66 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 120.414 -0.514 . . . . 2.1 110.429 176.363 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.537 ' NE ' ' HA2' ' A' ' 16' ' ' GLY . 17.2 ptt180 -96.02 -21.58 17.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.35 -0.387 . . . . 3.26 111.574 -171.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -130.83 157.23 43.44 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 119.615 -0.834 . . . . 2.16 111.174 170.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 71.5 p -136.29 158.09 45.24 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.91 -1.041 . . . . 2.24 109.389 -173.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.0 t -170.17 -148.57 0.06 Allowed 'General case' 0 C--O 1.234 0.272 0 C-N-CA 120.083 -0.647 . . . . 2.46 111.05 -172.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.73 75.16 0.73 Allowed Glycine 0 C--N 1.331 0.29 0 CA-C-N 116.227 -0.442 . . . . 1.45 113.494 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.855 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -109.27 -153.06 0.5 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.4 -0.592 . . . . 2.24 109.4 172.203 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' A' ' 25' ' ' LYS . 8.5 ttpt -178.43 126.27 0.11 Allowed 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 108.263 -1.014 . . . . 3.43 108.263 -176.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.575 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 3.2 m -64.89 123.22 17.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 122.057 0.932 . . . . 2.21 110.667 174.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.9 p -93.74 -24.03 5.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 114.353 -1.294 . . . . 1.83 108.271 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 28' ' ' LYS . 5.4 tptm -155.44 133.85 11.73 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 119.744 -0.782 . . . . 2.87 112.146 -177.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.852 HG21 ' HA ' ' A' ' 34' ' ' THR . 45.9 p -137.07 101.5 4.57 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.274 -0.639 . . . . 1.92 109.274 169.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 13.8 m -140.92 108.69 5.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.278 -0.419 . . . . 2.37 110.961 -175.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 30' ' ' SER . 56.7 mttm 79.6 64.46 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.752 0.657 . . . . 4.84 111.627 176.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 44.3 tptt 75.33 15.65 2.8 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.101 -0.5 . . . . 2.05 112.233 168.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.908 HG21 ' HA3' ' A' ' 52' ' ' GLY . 31.7 pt -135.08 169.96 20.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.551 0.691 . . . . 1.42 112.833 -172.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.852 ' HA ' HG21 ' A' ' 29' ' ' THR . 87.7 m -152.15 106.01 3.12 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.572 -1.195 . . . . 1.22 110.696 -169.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.963 HG12 HD12 ' A' ' 192' ' ' LEU . 2.3 t -101.95 108.13 23.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.252 -0.431 . . . . 1.52 110.31 -177.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.575 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 1.6 p -102.96 127.17 50.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.506 0.669 . . . . 1.74 111.38 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.2 p -98.02 121.65 40.19 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.12 -0.945 . . . . 1.72 111.385 -174.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.855 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 5.3 ttpp -163.75 99.33 0.89 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.992 -0.549 . . . . 2.45 112.08 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 38' ' ' LYS . . . 179.31 -78.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.772 0.656 . . . . 2.17 112.772 168.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.437 ' C ' ' H ' ' A' ' 42' ' ' LYS . 19.2 t 67.03 -100.25 0.06 Allowed 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.365 -1.346 . . . . 2.51 107.365 -165.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 68.73 -40.87 0.45 Allowed 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.431 0.457 . . . . 7.41 110.938 177.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.437 ' H ' ' C ' ' A' ' 40' ' ' SER . 33.0 mmtp -56.46 -49.42 74.69 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.644 -0.707 . . . . 6.84 109.202 169.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 74.1 t80 172.17 -76.6 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 114.957 -1.02 . . . . 6.42 110.379 -175.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -138.63 83.79 1.98 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.559 0.695 . . . . 6.31 109.691 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.54 -152.98 6.37 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 110.672 -0.971 . . . . 1.74 110.672 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -160.18 141.02 12.07 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.646 0.26 . . . . 2.45 110.688 174.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.996 HD11 ' HB2' ' A' ' 172' ' ' GLN . 10.6 tt -86.25 135.55 33.51 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.379 -1.341 . . . . 1.49 107.379 170.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.442 ' HB2' HD22 ' A' ' 192' ' ' LEU . 99.6 m-85 -109.92 117.33 33.51 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.219 0.533 . . . . 1.52 110.321 -172.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.634 ' HD3' ' CZ3' ' A' ' 24' ' ' TRP . 28.3 ttt180 -93.75 107.53 19.4 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.225 -0.898 . . . . 3.34 110.279 177.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.555 HG23 HD21 ' A' ' 192' ' ' LEU . 0.0 OUTLIER -82.87 140.84 15.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.406 -0.961 . . . . 1.98 108.406 174.555 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.755 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 54.7 tt0 -151.52 108.61 3.56 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.054 0.454 . . . . 1.07 109.983 -178.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.908 ' HA3' HG21 ' A' ' 33' ' ' ILE . . . -145.46 154.9 26.23 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 111.153 -0.779 . . . . 0.35 111.153 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.0 mt -97.86 114.36 34.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 119.918 -0.713 . . . . 1.3 111.205 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.453 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 68.7 mt -92.31 111.6 51.2 Favored Pre-proline 0 N--CA 1.443 -0.821 0 N-CA-C 108.373 -0.973 . . . . 1.07 108.373 170.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 22.0 Cg_exo -66.52 54.57 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 124.266 3.311 . . . . 0.74 113.167 -177.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.657 ' HG2' HG13 ' A' ' 203' ' ' ILE . 10.8 tp10 -151.65 167.63 27.53 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 107.417 -1.327 . . . . 1.68 107.417 175.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.509 ' HB3' ' HA ' ' A' ' 162' ' ' PRO . 23.8 p -70.12 137.09 86.94 Favored Pre-proline 0 N--CA 1.431 -1.397 0 CA-C-O 121.683 0.754 . . . . 1.58 111.404 -176.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.798 ' HA ' HD13 ' A' ' 61' ' ' LEU . 6.3 Cg_endo -49.55 -18.18 2.31 Favored 'Trans proline' 0 C--O 1.23 0.116 0 C-N-CA 124.698 3.598 . . . . 0.74 111.677 170.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.85 -47.82 50.37 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.082 -0.963 . . . . 1.31 110.692 176.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.814 ' HD2' ' HB3' ' A' ' 206' ' ' HIS . 4.5 tppt? -68.02 -29.83 68.93 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.71 -0.848 . . . . 3.78 108.71 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 1.009 HD22 HD13 ' A' ' 203' ' ' ILE . 88.5 mt -60.02 -53.97 51.54 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.906 -1.043 . . . . 1.09 110.25 174.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.506 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 19.3 p -68.05 -12.61 61.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.107 0.479 . . . . 1.94 110.44 175.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.484 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 37.8 t70 -82.28 -33.06 29.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.794 -0.639 . . . . 1.32 111.409 -177.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.506 ' CE2' ' HA ' ' A' ' 61' ' ' LEU . 15.4 p90 -83.7 -47.51 11.13 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.404 -0.518 . . . . 0.79 110.976 -177.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.506 ' CD2' ' HA ' ' A' ' 62' ' ' SER . 0.7 OUTLIER -83.5 -1.79 54.46 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.4 -0.52 . . . . 2.15 111.904 -172.154 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -38.34 -47.94 1.28 Allowed 'General case' 0 C--N 1.327 -0.373 0 O-C-N 124.806 1.316 . . . . 2.06 114.448 -162.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -162.21 -84.09 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 114.261 1.208 . . . . 4.31 114.261 -175.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.746 ' HB ' ' CD1' ' A' ' 81' ' ' TYR . 10.8 t -150.86 13.57 0.71 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.406 0.521 . . . . 1.89 112.406 -166.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -111.25 -6.67 25.54 Favored Glycine 0 C--N 1.306 -1.132 0 C-N-CA 118.987 -1.578 . . . . 1.71 113.203 -165.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.734 ' O ' HG21 ' A' ' 73' ' ' THR . 12.9 t70 -162.41 -41.45 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.369 0.604 . . . . 2.19 110.136 -167.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.694 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 1.5 ptp180 -49.92 -47.42 52.3 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.904 -1.044 . . . . 3.95 111.64 -176.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.853 HG21 HD13 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -90.05 -8.04 10.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.697 -0.401 . . . . 1.42 111.054 -174.333 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.734 HG21 ' O ' ' A' ' 70' ' ' ASP . 4.8 t -83.29 -35.67 25.09 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 119.171 -1.011 . . . . 1.45 110.089 -176.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.713 ' HZ3' ' HB2' ' A' ' 198' ' ' ASN . 20.4 p-90 -103.27 -6.09 22.41 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.413 -0.515 . . . . 0.78 111.982 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.798 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 5.5 t70 -67.24 172.93 4.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.864 0.84 . . . . 2.19 112.288 -170.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.451 ' H ' ' HG3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -118.08 -11.12 10.22 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.52 -1.218 . . . . 3.68 111.61 -174.327 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.1 m -140.88 17.36 2.31 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.496 0.665 . . . . 2.08 109.899 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.853 HD13 HG21 ' A' ' 72' ' ' ILE . 21.9 mt -108.03 157.33 18.34 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.593 -0.73 . . . . 1.16 110.624 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.759 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 16.4 mm-40 -131.89 -71.1 0.56 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.577 -0.738 . . . . 2.23 111.074 -178.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.854 ' HB ' HD11 ' A' ' 97' ' ' ILE . 15.1 t -137.41 142.8 35.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.599 -0.728 . . . . 1.44 109.892 -170.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.746 ' CD1' ' HB ' ' A' ' 68' ' ' THR . 25.3 t80 -124.2 137.51 54.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.989 0.423 . . . . 5.73 110.431 176.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.879 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 5.3 m-20 -128.97 111.78 13.37 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.664 -0.865 . . . . 1.86 108.664 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.702 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 20.1 ttm -75.85 96.37 3.69 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.838 -0.801 . . . . 2.52 108.838 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.63 HG22 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -78.54 -83.31 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 116.36 -0.382 . . . . 1.19 111.741 -168.52 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.462 ' HB2' HD11 ' A' ' 93' ' ' ILE . 32.1 m170 -122.56 122.75 39.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.27 0.557 . . . . 2.59 110.25 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.744 ' HG2' ' HD2' ' A' ' 92' ' ' PHE . 81.2 mtm180 -105.68 108.79 20.49 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.225 -0.898 . . . . 2.83 109.219 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -72.68 -39.95 61.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.428 -0.806 . . . . 1.17 110.067 -173.763 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -152.08 -171.0 3.8 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.409 -0.814 . . . . 1.86 109.188 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.6 t -78.88 -5.56 53.9 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.795 0.331 . . . . 1.94 110.389 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -122.81 -4.3 8.63 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.94 -0.393 . . . . 1.87 109.94 -176.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.648 HG22 ' HD1' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -135.93 112.06 9.69 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.301 -0.629 . . . . 1.12 109.301 -169.132 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.744 ' HD2' ' HG2' ' A' ' 86' ' ' ARG . 10.8 m-85 -125.39 178.73 5.45 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.651 -0.5 . . . . 0.52 109.651 -177.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.63 ' O ' HG22 ' A' ' 84' ' ' VAL . 42.6 mt -133.0 128.94 57.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 107.094 -1.447 . . . . 1.1 107.094 168.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.5 ' SG ' ' HB2' ' A' ' 113' ' ' ASP . 6.6 p -113.18 112.32 23.58 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.122 0.487 . . . . 2.61 112.13 -170.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.879 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 4.7 t-160 -82.64 93.96 7.46 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.64 -0.874 . . . . 2.17 108.64 170.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 21.8 m -113.11 111.57 22.35 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.25 -0.432 . . . . 1.19 111.965 -172.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.854 HD11 ' HB ' ' A' ' 80' ' ' VAL . 3.4 mp -77.27 120.42 27.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 108.642 -0.874 . . . . 1.63 108.642 174.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 49.6 m -111.72 138.37 48.39 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.368 -0.833 . . . . 1.72 111.909 -170.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.759 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 42.6 mt-30 -91.31 75.59 6.06 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.089 -0.505 . . . . 2.29 109.784 174.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.8 t -90.12 102.0 14.72 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.047 -0.723 . . . . 4.07 109.047 -177.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -120.38 112.87 19.54 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.156 0.503 . . . . 6.11 111.594 -177.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.423 ' C ' ' H ' ' A' ' 104' ' ' GLY . . . -98.89 71.12 1.88 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.613 -0.721 . . . . 1.98 109.359 169.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 93.1 t 74.75 -38.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 115.655 -0.702 . . . . 3.6 111.197 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 102' ' ' ALA . . . 159.95 -7.98 0.14 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.629 -0.796 . . . . 2.2 112.7 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.476 ' HB2' HG23 ' A' ' 183' ' ' ILE . 1.2 m -68.76 -7.4 33.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.159 0.504 . . . . 2.08 111.449 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.461 HG21 ' O ' ' A' ' 107' ' ' SER . 65.7 mt -129.6 141.75 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 116.101 -0.499 . . . . 1.53 111.034 -173.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.461 ' O ' HG21 ' A' ' 106' ' ' ILE . 19.8 m -94.26 164.88 18.87 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.661 -0.699 . . . . 1.71 109.539 173.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.22 141.67 30.65 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.234 1.956 . . . . 1.31 111.458 173.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.738 HH22 HD23 ' A' ' 179' ' ' LEU . 54.6 mtt180 -116.33 173.95 6.32 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.049 0.452 . . . . 4.06 110.689 -174.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.818 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 9.8 t70 -132.72 123.07 25.56 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.56 -0.746 . . . . 1.37 109.04 -177.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.525 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 9.6 m-30 -103.63 140.42 37.59 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.146 0.498 . . . . 3.01 111.366 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.662 HG13 ' HA ' ' A' ' 137' ' ' TYR . 25.5 mm -132.38 75.14 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.124 -0.944 . . . . 1.2 108.691 173.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.884 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 17.2 m-20 -99.85 123.18 43.84 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.695 -0.684 . . . . 1.86 110.808 -173.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.607 HD13 ' O ' ' A' ' 92' ' ' PHE . 7.6 tp -76.38 123.53 26.12 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 108.71 -0.848 . . . . 1.08 108.71 167.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -127.15 124.62 64.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.562 -0.744 . . . . 1.08 112.384 -163.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.66 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 54.5 t80 -109.75 118.23 35.97 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.273 -0.876 . . . . 2.81 110.947 174.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.479 HG13 ' HB ' ' A' ' 127' ' ' ILE . 5.1 mp -97.5 120.85 47.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.787 -0.642 . . . . 1.53 109.923 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.417 ' HB3' ' CE2' ' A' ' 116' ' ' TYR . 14.0 ptpt -140.56 147.41 39.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.041 0.448 . . . . 1.81 110.714 177.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.481 ' C ' ' HD2' ' A' ' 119' ' ' ARG . 1.7 tmm_? -125.64 99.97 6.23 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 109.014 -0.735 . . . . 3.22 109.014 -176.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -63.45 116.32 5.45 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.406 -1.331 . . . . 1.28 107.406 169.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.405 ' HA ' ' NH1' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -33.09 90.13 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 O-C-N 125.12 1.513 . . . . 2.28 114.682 -175.451 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 58.05 29.32 62.22 Favored Glycine 0 C--O 1.229 -0.198 0 CA-C-N 114.716 -1.129 . . . . 0.79 112.62 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.417 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 33.7 t-20 -119.72 -49.18 2.34 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.538 -0.541 . . . . 2.06 109.538 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.433 ' HE2' ' HB2' ' A' ' 124' ' ' MET . 1.9 mtm -161.93 122.74 2.64 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.972 0.415 . . . . 1.73 111.226 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.484 HD22 ' HB3' ' A' ' 62' ' ' SER . 59.3 t30 -109.4 80.82 1.36 Allowed 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.716 -0.846 . . . . 2.07 108.716 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.711 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -100.57 139.48 21.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.232 -0.895 . . . . 1.06 112.81 -173.191 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.645 ' O ' HG13 ' A' ' 127' ' ' ILE . 1.9 pt -108.64 116.58 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 108.318 -0.993 . . . . 1.26 108.318 160.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 26.5 p -87.54 156.98 19.27 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.102 -0.703 . . . . 1.53 109.102 175.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.884 ' HB3' ' HB3' ' A' ' 113' ' ' ASP . 50.2 m -153.9 136.35 15.02 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.758 0.313 . . . . 1.81 111.576 -178.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.882 ' HE2' ' HG3' ' A' ' 150' ' ' PRO . 4.6 mtpm? -131.04 122.77 27.37 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 107.824 -1.176 . . . . 2.75 107.824 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.574 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 70.4 p -64.49 99.02 0.28 Allowed 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.098 -1.445 . . . . 1.94 107.098 174.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.419 HG13 ' HE1' ' A' ' 3' ' ' PHE . 0.4 OUTLIER -107.57 137.34 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 CA-C-N 115.265 -0.879 . . . . 1.64 108.709 -165.531 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.602 ' HA ' ' CG ' ' A' ' 137' ' ' TYR . 9.8 p-10 -92.05 69.57 5.35 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.678 -1.147 . . . . 2.17 110.543 -167.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.711 ' CZ ' ' HB3' ' A' ' 136' ' ' GLU . 1.7 p90 -105.15 173.36 3.33 Favored Pre-proline 0 CA--C 1.546 0.82 0 CA-C-N 113.927 -1.488 . . . . 0.67 108.313 -176.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.527 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 31.8 Cg_exo -28.05 -57.17 0.12 Allowed 'Trans proline' 0 CA--C 1.548 1.182 0 C-N-CA 124.875 3.716 . . . . 1.66 116.964 -177.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.711 ' HB3' ' CZ ' ' A' ' 134' ' ' PHE . 17.8 tp10 -80.77 -21.44 41.03 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.635 0.606 . . . . 3.5 112.635 -174.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.662 ' HA ' HG13 ' A' ' 112' ' ' ILE . 17.8 t80 -49.43 -43.12 69.95 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 114.403 1.26 . . . . 6.41 114.403 -177.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.451 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 32.0 Cg_exo -39.31 119.55 0.52 Allowed 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 122.386 2.057 . . . . 2.31 113.28 175.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.899 ' HB3' ' HD3' ' A' ' 145' ' ' ARG . 50.6 Cg_endo -89.14 -163.1 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.422 2.748 . . . . 1.27 113.773 -172.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.5 m -142.73 -169.32 2.97 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.79 -0.819 . . . . 1.88 108.79 -175.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.8 t -80.46 -45.31 17.78 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.18 -0.608 . . . . 2.43 110.028 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -69.58 -28.31 65.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.073 -0.512 . . . . 2.18 110.86 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.818 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 65.5 m-85 -118.87 109.12 15.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.975 -0.557 . . . . 1.33 110.542 -174.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.643 HD12 ' HG3' ' A' ' 176' ' ' ARG . 2.5 tp -98.66 111.95 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-O 121.314 0.578 . . . . 1.4 109.695 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.899 ' HD3' ' HB3' ' A' ' 139' ' ' PRO . 4.7 mpt_? -57.89 100.48 0.06 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.814 -1.085 . . . . 5.14 110.888 176.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -66.99 115.53 7.31 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 110.404 -1.079 . . . . 1.05 110.404 174.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -84.55 86.16 7.33 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.486 0.66 . . . . 4.68 110.612 -173.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.463 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 90.5 m-20 -70.42 105.62 3.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.987 -1.006 . . . . 2.29 110.411 175.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.632 ' HB3' ' HB3' ' A' ' 172' ' ' GLN . 25.3 t60 -57.82 126.59 76.93 Favored Pre-proline 0 CA--C 1.506 -0.745 0 N-CA-C 107.609 -1.256 . . . . 2.95 107.609 167.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.882 ' HG3' ' HE2' ' A' ' 130' ' ' LYS . 23.7 Cg_exo -12.13 69.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 1 C-N-CA 126.853 5.035 . . . . 0.77 115.37 -173.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 24.1 p -77.47 178.41 7.24 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.241 -1.345 . . . . 1.97 110.574 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.651 ' N ' HG22 ' A' ' 14' ' ' VAL . . . -170.56 -164.9 27.06 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 120.309 -0.948 . . . . 0.55 111.675 175.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -161.38 73.19 0.44 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.632 -0.877 . . . . 0.8 108.632 -164.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.711 HG12 ' HB ' ' A' ' 126' ' ' ILE . 8.4 m -83.24 115.26 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-O 122.113 0.959 . . . . 1.03 110.32 -175.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 64.3 m -98.27 107.58 20.08 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.417 -0.811 . . . . 2.3 109.027 177.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.714 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 10.1 m -97.63 112.64 61.92 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 116.28 -0.418 . . . . 1.45 111.023 -170.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.538 ' HB3' ' ND2' ' A' ' 161' ' ' ASN . 52.4 Cg_exo -51.76 120.48 7.13 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.376 2.05 . . . . 0.72 110.598 172.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.95 ' HA ' ' HE1' ' A' ' 158' ' ' MET . 2.7 mmt -79.87 -167.92 1.43 Allowed 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.234 0.54 . . . . 1.72 111.453 -175.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -70.97 -16.78 62.66 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.485 -0.779 . . . . 2.63 110.026 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.513 ' HB3' ' HB1' ' A' ' 163' ' ' ALA . 38.6 mt-10 -117.38 21.16 13.26 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 115.467 -0.788 . . . . 2.05 110.408 178.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.673 ' HB3' ' CD ' ' A' ' 162' ' ' PRO . 18.7 t-20 29.79 -87.06 0.0 OUTLIER Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 125.87 1.668 . . . . 2.19 115.044 175.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.673 ' CD ' ' HB3' ' A' ' 161' ' ' ASN . 85.1 Cg_endo -75.81 -12.62 19.95 Favored 'Trans proline' 0 C--N 1.368 1.557 0 CA-C-N 121.888 1.71 . . . . 0.86 112.928 -175.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.513 ' HB1' ' HB3' ' A' ' 160' ' ' GLU . . . -89.97 -36.92 14.69 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.898 -0.592 . . . . 1.34 110.563 -178.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.678 ' O ' ' HB2' ' A' ' 158' ' ' MET . 73.6 m-85 -136.97 133.14 35.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.279 -0.419 . . . . 1.46 110.424 176.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.788 ' HB2' ' HD3' ' A' ' 58' ' ' PRO . 25.3 t -125.11 144.59 50.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.342 0.592 . . . . 2.05 110.951 174.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.755 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.8 tppp? -97.37 99.81 11.25 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.993 0.901 . . . . 1.4 110.684 -178.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.8 106.97 15.91 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.323 -1.308 . . . . 1.07 109.201 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.621 HG13 HG22 ' A' ' 154' ' ' VAL . 0.1 OUTLIER -129.41 126.27 63.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.675 0.75 . . . . 1.11 111.804 176.667 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 14.6 ttt -129.74 153.08 48.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.182 -0.917 . . . . 1.79 110.021 -171.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.767 ' HB3' HD23 ' A' ' 47' ' ' LEU . 47.6 m-85 -134.24 140.52 46.51 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.684 -0.234 . . . . 4.22 111.146 -178.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.591 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 4.7 m -140.07 131.6 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 O-C-N 123.645 0.591 . . . . 2.01 111.549 171.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.996 ' HB2' HD11 ' A' ' 47' ' ' LEU . 13.3 tt0 -120.02 33.55 5.56 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 105.954 -1.869 . . . . 2.66 105.954 169.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.632 HG23 ' HE2' ' A' ' 175' ' ' MET . 35.9 m -54.94 147.27 15.77 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 112.697 -2.047 . . . . 2.2 112.733 -171.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -84.74 -40.36 17.39 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.573 -0.74 . . . . 2.45 110.663 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.632 ' HE2' HG23 ' A' ' 173' ' ' THR . 21.7 mmt 48.0 57.21 6.3 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-O 121.207 0.527 . . . . 4.15 109.771 -174.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.643 ' HG3' HD12 ' A' ' 144' ' ' ILE . 13.6 ptm180 -73.49 43.41 0.14 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.097 -0.956 . . . . 6.51 112.724 -174.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -99.98 22.36 40.58 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 111.737 -0.545 . . . . 2.26 111.737 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 65.2 tttp 65.36 70.98 0.45 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.588 0.709 . . . . 6.69 111.142 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.738 HD23 HH22 ' A' ' 109' ' ' ARG . 5.8 mp -107.08 168.91 8.88 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.976 0.893 . . . . 2.21 110.599 176.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.48 ' HB3' HG12 ' A' ' 183' ' ' ILE . 42.5 t -112.77 154.8 44.71 Favored Pre-proline 0 C--N 1.307 -1.251 0 CA-C-N 113.978 -1.465 . . . . 2.31 107.11 177.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.583 ' O ' ' HG2' ' A' ' 185' ' ' GLU . 71.0 Cg_exo -40.19 -47.72 4.07 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.546 2.164 . . . . 1.86 112.71 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 36.7 t -67.16 -14.74 63.19 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.125 -0.488 . . . . 2.45 112.198 -177.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.517 ' HB ' ' HB3' ' A' ' 179' ' ' LEU . 24.4 mm -90.24 -41.74 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.845 0 CA-C-O 122.274 1.035 . . . . 1.69 108.331 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.662 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.2 mp -62.99 -35.7 72.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 112.986 -1.915 . . . . 1.77 110.726 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.583 ' HG2' ' O ' ' A' ' 181' ' ' PRO . 18.5 mm-40 -57.19 -29.65 63.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.133 -0.94 . . . . 2.89 109.564 174.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.515 ' HE2' ' HA ' ' A' ' 183' ' ' ILE . 46.0 mtmt -93.05 -40.46 10.51 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.161 -0.927 . . . . 1.71 111.088 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.662 HG22 ' HA ' ' A' ' 184' ' ' ILE . 6.5 t -64.75 -37.67 88.39 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.236 0.458 . . . . 1.3 112.236 -171.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' MET . . . . . 0.797 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 7.7 mmt -74.88 -60.43 1.23 Allowed Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 120.747 -0.381 . . . . 1.39 111.347 -174.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.797 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 61.3 Cg_exo -54.02 -32.06 66.99 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.174 1.916 . . . . 1.15 112.579 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.739 ' O ' ' HB3' ' A' ' 194' ' ' ASN . 49.0 m -72.87 -23.71 60.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.431 -0.35 . . . . 1.95 111.031 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -92.56 -37.82 12.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.348 0.594 . . . . 1.92 111.6 -175.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.963 HD12 HG12 ' A' ' 35' ' ' VAL . 3.7 mt -67.02 -51.32 56.35 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.659 0.743 . . . . 1.68 110.79 -176.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.693 ' O ' HD21 ' A' ' 197' ' ' LEU . 1.6 m -69.6 -41.29 80.24 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.129 0 CA-C-N 115.061 -0.972 . . . . 1.32 108.756 -176.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.739 ' HB3' ' O ' ' A' ' 190' ' ' SER . 0.0 OUTLIER -57.48 -37.75 73.42 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.668 0.618 . . . . 2.6 112.668 178.706 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -64.28 -31.82 73.17 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 119.884 -0.726 . . . . 2.73 110.009 174.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.626 HG22 HG22 ' A' ' 33' ' ' ILE . 8.6 mt -78.58 -33.89 17.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 122.003 0.906 . . . . 1.11 111.205 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.693 HD21 ' O ' ' A' ' 193' ' ' VAL . 3.3 mm? -78.26 -30.6 48.69 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.014 -0.994 . . . . 1.57 110.723 -173.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.713 ' HB2' ' HZ3' ' A' ' 74' ' ' TRP . 12.1 p30 -67.39 -29.82 69.43 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.528 -1.286 . . . . 2.18 107.528 167.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.669 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -73.19 -37.25 66.55 Favored 'General case' 0 N--CA 1.435 -1.187 0 O-C-N 121.97 -0.456 . . . . 1.04 110.254 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 33.0 mmtp -61.7 -43.36 99.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.76 0.79 . . . . 1.51 109.915 174.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.557 ' O ' ' HG3' ' A' ' 204' ' ' LYS . 10.2 t70 -81.69 -40.72 22.37 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.703 -1.135 . . . . 1.94 110.841 -171.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -70.98 -33.87 65.34 Favored Glycine 0 C--O 1.226 -0.406 0 C-N-CA 121.105 -0.569 . . . . 0.47 111.729 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 1.009 HD13 HD22 ' A' ' 61' ' ' LEU . 1.6 tp -70.17 -35.76 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 110.058 -0.349 . . . . 1.16 110.058 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.616 ' O ' ' HB ' ' A' ' 208' ' ' THR . 2.2 pptp? -81.59 -23.95 36.77 Favored 'General case' 0 C--O 1.213 -0.846 0 N-CA-C 108.678 -0.86 . . . . 3.8 108.678 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.557 ' HA ' ' HB3' ' A' ' 210' ' ' SER . . . -65.46 -34.5 78.42 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 109.094 -0.706 . . . . 1.28 109.094 167.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.814 ' HB3' ' HD2' ' A' ' 60' ' ' LYS . 10.5 m170 -93.06 3.0 56.49 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.837 1.051 . . . . 4.34 113.837 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' A' ' 203' ' ' ILE . 4.2 ptp180 -130.51 -41.77 1.2 Allowed 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.358 -0.839 . . . . 3.0 111.442 172.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.616 ' HB ' ' O ' ' A' ' 204' ' ' LYS . 51.6 m -88.05 146.17 37.87 Favored Pre-proline 0 C--N 1.315 -0.928 0 CA-C-N 115.638 -0.71 . . . . 2.01 109.493 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . 0.455 ' HD2' HG22 ' A' ' 208' ' ' THR . 27.3 Cg_endo -64.21 60.96 0.24 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.82 2.347 . . . . 2.59 112.484 174.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.557 ' HB3' ' HA ' ' A' ' 205' ' ' ALA . 34.4 t -96.05 13.71 26.2 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.655 -0.702 . . . . 2.55 109.705 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.448 ' HD2' ' O ' ' A' ' 205' ' ' ALA . 0.0 OUTLIER -89.59 12.73 15.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.694 -0.684 . . . . 6.11 110.869 -178.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.405 ' HA ' ' HD3' ' A' ' 212' ' ' ARG . 6.7 tpp180 -76.33 -38.53 55.82 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.902 -0.777 . . . . 7.55 108.902 175.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -99.16 32.69 6.84 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.433 -0.803 . . . . 3.73 111.934 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -71.33 142.11 50.44 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.599 -0.889 . . . . 6.11 108.599 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -105.73 -11.99 16.07 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.026 0.75 . . . . 7.27 113.026 -173.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 83.0 t60 55.98 46.34 22.09 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.577 0.703 . . . . 6.82 110.028 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.574 ' HA ' ' OG ' ' A' ' 220' ' ' SER . 2.5 t-20 -110.01 36.42 3.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.807 -0.633 . . . . 5.77 111.062 -170.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 38.7 t -86.0 -46.16 10.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.294 0.569 . . . . 6.85 109.828 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -132.11 64.57 1.6 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.757 -0.656 . . . . 9.48 109.848 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' SER . . . . . 0.574 ' OG ' ' HA ' ' A' ' 217' ' ' ASN . 6.5 m . . . . . 0 C--O 1.245 0.861 0 CA-C-O 118.337 -0.84 . . . . 8.48 109.64 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.87 ' HB3' HG21 ' A' ' 87' ' ' ILE . 14.9 tpt . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 109.818 -0.438 . . . . 4.31 109.818 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.487 ' H ' ' HG3' ' A' ' 1' ' ' MET . 1.0 OUTLIER -50.25 -43.87 53.28 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 123.436 0.695 . . . . 2.25 112.547 -171.552 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.878 ' HA ' HD11 ' A' ' 6' ' ' ILE . 97.2 m-85 -68.53 -27.97 66.58 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.079 0.466 . . . . 0.45 109.837 -172.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.552 ' HD2' ' CG ' ' A' ' 88' ' ' ASP . 17.5 tttm -76.31 -2.45 31.66 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.551 -0.75 . . . . 2.06 109.697 177.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.591 ' O ' ' HG2' ' A' ' 9' ' ' GLN . . . -92.96 -43.44 8.93 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.398 0.618 . . . . 1.2 109.972 170.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.878 HD11 ' HA ' ' A' ' 3' ' ' PHE . 1.3 mp -81.57 -43.01 19.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 122.01 0.91 . . . . 1.76 109.398 -171.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.618 ' HB2' ' HB2' ' A' ' 116' ' ' TYR . . . -76.06 -37.31 58.42 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.105 -1.407 . . . . 1.11 111.584 -176.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.504 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 7.3 mt-30 -65.91 -29.73 70.2 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.474 -0.785 . . . . 2.14 109.992 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.597 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 79.1 mm-40 -77.69 -38.8 46.68 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.038 -0.983 . . . . 3.04 108.499 174.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.547 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.4 OUTLIER -65.57 -36.53 84.05 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.534 -1.212 . . . . 1.1 111.962 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.607 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -46.57 -59.49 2.97 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.198 0.523 . . . . 1.04 111.159 172.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -66.56 -16.65 64.32 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.49 -0.777 . . . . 2.31 112.045 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.597 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 44.2 mt-10 -73.32 -52.37 14.15 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.001 0.429 . . . . 2.54 109.888 175.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.689 HG21 ' N ' ' A' ' 152' ' ' GLY . 11.8 p -73.2 -40.17 57.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.649 0.738 . . . . 1.21 110.453 -177.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.538 HD23 ' HE3' ' A' ' 124' ' ' MET . 0.5 OUTLIER -67.2 -23.81 65.78 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-O 121.916 0.865 . . . . 1.26 108.824 173.523 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.95 -18.05 66.13 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 113.986 -1.461 . . . . 0.57 110.38 177.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.63 ' CD2' ' HA ' ' A' ' 14' ' ' VAL . 23.7 m-85 -91.14 -21.34 21.23 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.076 -0.712 . . . . 3.59 109.076 176.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.511 ' HA ' ' HZ ' ' A' ' 170' ' ' PHE . 3.5 t-20 -72.29 -14.82 61.85 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.463 0.649 . . . . 2.1 109.989 178.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.493 ' HD2' HD21 ' A' ' 15' ' ' LEU . 22.2 mtp180 -115.72 -20.38 10.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.484 -0.78 . . . . 3.26 110.835 -175.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -97.01 132.76 42.5 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.066 0.46 . . . . 2.16 111.413 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 43.1 p -134.21 119.28 18.6 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.85 -0.614 . . . . 2.24 109.637 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.457 ' HB2' ' HE3' ' A' ' 38' ' ' LYS . 0.8 OUTLIER -135.57 -143.87 0.2 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.862 -0.608 . . . . 2.46 110.343 -169.135 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.4 63.33 1.8 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.349 -0.453 . . . . 1.45 112.73 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.531 ' CH2' ' HD3' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -119.86 -175.76 3.04 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.15 -1.056 . . . . 2.24 108.15 171.393 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.445 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 8.7 mtpp -171.4 133.11 0.8 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.712 -0.848 . . . . 3.43 108.712 -176.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.765 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 1.6 p -59.96 116.73 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-O 121.714 0.769 . . . . 2.21 109.681 170.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.4 p -92.05 -23.7 5.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 114.695 -1.139 . . . . 1.83 109.081 -177.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 2.7 tppt? -153.1 139.63 18.72 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.82 -0.627 . . . . 2.87 111.488 -173.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.555 HG21 ' HA ' ' A' ' 34' ' ' THR . 31.2 p -137.92 142.93 40.58 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.002 -0.545 . . . . 1.92 110.373 175.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.722 ' HB3' HG12 ' A' ' 33' ' ' ILE . 35.4 t -89.95 -143.98 0.16 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.618 -1.253 . . . . 2.37 107.618 168.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -103.05 18.89 20.61 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.532 -0.467 . . . . 4.84 110.06 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.439 ' HD2' ' HA ' ' A' ' 32' ' ' LYS . 33.8 tptt -168.97 3.77 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.189 0.44 . . . . 2.05 112.189 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.944 HG22 ' HA3' ' A' ' 52' ' ' GLY . 42.8 pt -138.72 168.46 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.913 0.387 . . . . 1.42 111.735 -174.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.555 ' HA ' HG21 ' A' ' 29' ' ' THR . 88.0 m -146.59 119.56 8.76 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.223 -0.899 . . . . 1.22 110.64 -166.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.749 HG21 HG21 ' A' ' 50' ' ' VAL . 7.1 t -111.41 102.0 13.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.608 -0.516 . . . . 1.52 109.608 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.765 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 18.1 m -99.14 126.79 44.99 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.651 0.739 . . . . 1.74 111.338 -177.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 t -97.75 124.04 41.94 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.439 -1.255 . . . . 1.72 109.76 -177.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.457 ' HE3' ' HB2' ' A' ' 22' ' ' SER . 85.3 tttt -121.02 -100.57 0.43 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.618 -0.719 . . . . 2.45 110.151 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.811 ' HA ' ' HA ' ' A' ' 46' ' ' ASN . . . 179.68 143.85 0.16 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.756 -0.461 . . . . 2.17 109.756 -175.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.4 p -106.44 -43.66 4.71 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.376 0.608 . . . . 2.51 109.56 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 57.59 8.11 0.61 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 114.521 -1.218 . . . . 7.41 112.687 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -66.36 -24.85 66.57 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.596 -0.89 . . . . 6.84 108.596 175.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 84.0 t80 172.99 -55.2 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.021 -0.99 . . . . 6.42 109.313 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -65.42 -70.58 0.23 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.011 -0.995 . . . . 6.31 112.411 -170.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 170.92 -96.29 0.11 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.031 -1.08 . . . . 1.74 112.863 -176.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.811 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 18.4 m120 -90.88 170.18 10.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.483 0.659 . . . . 2.45 112.07 -172.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.54 HD21 ' N ' ' A' ' 48' ' ' TYR . 4.3 tt -136.75 137.19 39.62 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.444 -1.688 . . . . 1.49 106.444 175.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.565 ' HB2' HG13 ' A' ' 171' ' ' VAL . 42.2 m-85 -118.52 128.3 54.45 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 120.545 -0.462 . . . . 1.52 110.992 -172.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.531 ' HD3' ' CH2' ' A' ' 24' ' ' TRP . 15.1 ttp180 -99.29 117.24 33.3 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.913 -0.773 . . . . 3.34 108.913 173.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.749 HG21 HG21 ' A' ' 35' ' ' VAL . 7.8 p -106.7 120.49 57.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 108.403 -0.962 . . . . 1.98 108.403 175.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.625 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 35.2 tt0 -139.98 121.06 14.7 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.225 -0.898 . . . . 1.07 110.419 -167.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.944 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -148.23 162.47 28.8 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 111.016 -0.834 . . . . 0.35 111.016 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.6 mt -97.6 119.11 45.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 C-N-CA 120.197 -0.601 . . . . 1.3 111.004 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.647 HG12 ' HD3' ' A' ' 200' ' ' LYS . 72.6 mt -97.3 114.12 64.29 Favored Pre-proline 0 N--CA 1.443 -0.785 0 N-CA-C 108.884 -0.784 . . . . 1.07 108.884 172.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 23.6 Cg_exo -65.66 57.14 0.36 Allowed 'Trans proline' 0 N--CA 1.474 0.347 0 C-N-CA 124.422 3.415 . . . . 0.74 113.223 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.461 ' HG2' HG13 ' A' ' 203' ' ' ILE . 11.4 tp10 -157.42 167.88 28.94 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 108.207 -1.035 . . . . 1.68 108.207 176.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.494 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 20.0 p -69.49 141.37 90.67 Favored Pre-proline 0 N--CA 1.429 -1.511 0 CA-C-O 122.09 0.948 . . . . 1.58 111.637 -175.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.58 ' HA ' HD13 ' A' ' 61' ' ' LEU . 32.3 Cg_exo -59.68 -15.39 31.22 Favored 'Trans proline' 0 CA--C 1.518 -0.29 0 C-N-CA 124.505 3.47 . . . . 0.74 110.534 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.03 -53.33 21.03 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.195 -1.366 . . . . 1.31 111.011 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.58 ' HA ' ' HB3' ' A' ' 63' ' ' ASP . 13.6 ttpt -70.97 -23.47 62.22 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.812 -0.81 . . . . 3.78 108.812 -177.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 1.046 HD21 HD12 ' A' ' 203' ' ' ILE . 45.0 mt -60.72 -55.74 29.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.006 -0.997 . . . . 1.09 109.756 171.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.1 p -68.63 -9.24 48.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.007 0.432 . . . . 1.94 110.724 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.58 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 29.4 t70 -90.17 -28.36 18.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.021 -0.536 . . . . 1.32 111.828 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.665 ' CD2' ' HA ' ' A' ' 61' ' ' LEU . 8.8 p90 -86.32 -43.69 12.69 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 120.378 -0.529 . . . . 0.79 110.967 -174.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.7 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -89.62 7.61 35.63 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.975 -0.29 . . . . 2.15 110.973 -174.462 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -53.19 -71.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.467 -0.788 . . . . 2.06 111.875 -164.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 165.08 133.56 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 108.363 -0.977 . . . . 4.31 108.363 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.89 ' HA ' ' NH2' ' A' ' 71' ' ' ARG . 5.8 t 46.73 31.63 1.48 Allowed 'General case' 0 C--N 1.313 -1.007 0 O-C-N 124.534 1.146 . . . . 1.89 112.66 177.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.546 ' O ' ' HB3' ' A' ' 70' ' ' ASP . . . -88.69 -44.7 5.11 Favored Glycine 0 N--CA 1.427 -1.947 0 CA-C-N 115.173 -0.921 . . . . 1.71 110.859 -176.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.546 ' HB3' ' O ' ' A' ' 69' ' ' GLY . 29.4 p-10 152.35 -5.12 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 113.139 -1.53 . . . . 2.19 108.23 -166.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.89 ' NH2' ' HA ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -46.96 -27.79 1.4 Allowed 'General case' 0 C--O 1.211 -0.957 0 N-CA-C 113.536 0.939 . . . . 3.95 113.536 178.757 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.711 HD13 ' NH1' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -92.18 -14.37 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 119.124 -1.031 . . . . 1.42 111.047 178.719 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.504 ' HA ' ' ND2' ' A' ' 217' ' ' ASN . 0.7 OUTLIER -86.01 -28.05 24.42 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 120.27 -0.572 . . . . 1.45 110.239 -173.68 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.679 ' CE2' ' HA ' ' A' ' 71' ' ' ARG . 14.8 p-90 -107.22 -4.86 18.32 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.467 -0.493 . . . . 0.78 111.924 178.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.8 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 5.6 t70 -71.99 174.87 6.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.506 0.67 . . . . 2.19 111.453 -172.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.809 ' HG2' ' HB3' ' A' ' 198' ' ' ASN . 8.1 mmmt -108.91 -25.41 10.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.199 -0.909 . . . . 3.68 109.76 -177.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.6 m -127.6 11.51 6.78 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.34 -0.846 . . . . 2.08 111.266 -173.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.669 HD11 HG22 ' A' ' 72' ' ' ILE . 15.9 mt -107.36 152.23 24.44 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.142 0.496 . . . . 1.16 111.471 -178.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.528 ' HB3' HG23 ' A' ' 80' ' ' VAL . 43.2 mt-30 -118.92 -70.49 0.79 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.447 -0.797 . . . . 2.23 111.225 178.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.528 HG23 ' HB3' ' A' ' 79' ' ' GLN . 22.0 t -148.66 124.31 2.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.468 -0.787 . . . . 1.44 110.556 -166.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.909 ' HH ' ' HG3' ' A' ' 83' ' ' MET . 48.7 t80 -109.71 142.54 40.76 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.416 -0.514 . . . . 5.73 111.213 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.499 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 0.9 OUTLIER -136.74 118.71 15.3 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.928 -1.138 . . . . 1.86 107.928 -179.455 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.909 ' HG3' ' HH ' ' A' ' 81' ' ' TYR . 2.0 ttt -68.5 107.48 2.93 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.696 -0.684 . . . . 2.52 109.358 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.7 HG22 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -84.31 -71.57 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 120.22 -0.592 . . . . 1.19 111.411 -170.608 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -137.9 108.95 6.75 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.017 -0.538 . . . . 2.59 109.884 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.961 ' HG2' ' HD2' ' A' ' 92' ' ' PHE . 68.1 mtp180 -85.32 129.47 34.8 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.31 -0.626 . . . . 2.83 109.31 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.87 HG21 ' HB3' ' A' ' 1' ' ' MET . 0.7 OUTLIER -86.99 -54.52 7.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.428 -0.805 . . . . 1.17 109.969 -172.217 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.552 ' CG ' ' HD2' ' A' ' 4' ' ' LYS . 6.8 m-20 -136.15 -142.98 0.18 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.636 -1.165 . . . . 1.86 108.808 -177.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.2 t -95.02 -12.22 27.01 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.609 -0.515 . . . . 1.94 109.609 175.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -128.27 3.54 5.75 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.039 -0.528 . . . . 1.87 110.428 -171.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.553 ' HB ' ' HB ' ' A' ' 87' ' ' ILE . 0.3 OUTLIER -132.38 121.35 23.33 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.599 -0.889 . . . . 1.12 108.599 -172.201 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.961 ' HD2' ' HG2' ' A' ' 86' ' ' ARG . 14.1 m-85 -133.21 176.14 8.77 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 120.954 0.407 . . . . 0.52 110.267 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.7 ' O ' HG22 ' A' ' 84' ' ' VAL . 21.8 mt -133.09 125.93 52.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 107.354 -1.35 . . . . 1.1 107.354 168.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.584 ' HA ' ' HE1' ' A' ' 81' ' ' TYR . 94.6 m -106.58 108.41 19.9 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.101 -0.499 . . . . 2.61 112.153 -169.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.574 ' HA ' ' O ' ' A' ' 111' ' ' PHE . 8.4 t60 -84.75 103.62 14.0 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.024 -0.732 . . . . 2.17 109.024 171.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.725 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 27.9 m -127.34 119.91 27.33 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.244 -0.435 . . . . 1.19 111.84 -173.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 32.9 mm -77.67 138.94 19.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.076 -0.713 . . . . 1.63 109.076 174.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 1.3 m -113.58 152.34 30.44 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.58 -0.737 . . . . 1.72 110.244 -171.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -89.58 166.58 13.56 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.397 -0.365 . . . . 2.29 110.147 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.1 m -88.51 88.59 7.67 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.038 -0.528 . . . . 4.07 111.317 -172.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.434 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 6.6 p90 -86.67 96.09 10.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.432 0.634 . . . . 6.11 110.472 176.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 101' ' ' PHE . . . 152.41 10.01 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 113.779 -1.555 . . . . 1.98 108.833 -177.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 60.2 t 71.63 -39.25 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 115.58 -0.736 . . . . 3.6 112.121 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -165.68 -22.24 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.049 -1.072 . . . . 2.2 113.655 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.615 ' HB3' HD12 ' A' ' 183' ' ' ILE . 25.1 m -58.01 -63.0 1.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 117.207 0.503 . . . . 2.08 111.115 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.526 HD11 HG22 ' A' ' 183' ' ' ILE . 5.2 mp -83.0 105.31 12.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.361 -0.607 . . . . 1.53 109.361 175.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.543 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 17.7 m -71.1 164.83 53.47 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.695 -0.684 . . . . 1.71 111.035 -178.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' A' ' 107' ' ' SER . 2.0 Cg_endo -45.15 114.6 0.7 Allowed 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 123.38 2.72 . . . . 1.31 111.397 176.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.59 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 23.0 ttp180 -102.99 158.54 16.22 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.99 -0.55 . . . . 4.06 110.836 -168.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.918 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 8.2 t0 -113.37 122.94 48.87 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.059 -0.719 . . . . 1.37 109.059 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.725 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 6.0 m-85 -99.38 132.07 44.96 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 120.855 0.36 . . . . 3.01 110.471 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.525 HD11 ' HA ' ' A' ' 95' ' ' HIS . 30.1 mm -133.46 68.09 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.069 -1.085 . . . . 1.2 108.069 171.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.9 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 4.5 m-20 -90.76 115.86 28.17 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.718 -1.128 . . . . 1.86 109.799 -177.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.634 ' O ' ' HA ' ' A' ' 129' ' ' SER . 6.3 tp -74.6 120.85 20.71 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 108.564 -0.902 . . . . 1.08 108.564 169.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.534 HG12 ' SG ' ' A' ' 94' ' ' CYS . 0.1 OUTLIER -125.46 126.15 70.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 115.115 -0.948 . . . . 1.08 111.824 -164.319 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.618 ' HB2' ' HB2' ' A' ' 7' ' ' ALA . 50.9 t80 -110.63 120.11 41.35 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 114.456 -1.247 . . . . 2.81 110.211 174.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.679 HG12 HG21 ' A' ' 127' ' ' ILE . 74.2 mt -100.25 103.26 14.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.824 -0.625 . . . . 1.53 110.359 -177.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.923 ' HZ3' ' HH ' ' A' ' 120' ' ' TYR . 26.7 ttmt -124.73 133.84 53.04 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.114 0.483 . . . . 1.81 110.211 177.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.533 ' O ' ' HD2' ' A' ' 119' ' ' ARG . 0.4 OUTLIER -110.91 119.57 39.53 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 108.573 -0.899 . . . . 3.22 108.573 173.057 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.923 ' HH ' ' HZ3' ' A' ' 118' ' ' LYS . 99.1 m-85 -75.98 104.8 6.68 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.455 -1.683 . . . . 1.28 106.455 164.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -52.04 98.3 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 122.302 1.049 . . . . 2.28 112.598 -171.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.402 ' C ' HD21 ' A' ' 123' ' ' ASN . . . 84.89 24.41 45.36 Favored Glycine 0 CA--C 1.504 -0.595 0 CA-C-N 113.451 -1.704 . . . . 0.79 112.14 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.62 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 1.0 OUTLIER -126.02 -57.71 1.41 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.723 -0.739 . . . . 2.06 109.617 175.224 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.538 ' HE3' HD23 ' A' ' 15' ' ' LEU . 2.8 mpp? -160.48 135.27 7.62 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.894 -0.594 . . . . 1.73 110.544 -170.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.427 ' HB2' ' HB2' ' A' ' 155' ' ' CYS . 21.9 m-80 -115.02 87.18 2.6 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.312 -0.996 . . . . 2.07 108.312 176.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.588 ' HB ' HG11 ' A' ' 154' ' ' VAL . 0.4 OUTLIER -110.0 143.76 19.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 112.976 0.732 . . . . 1.06 112.976 -170.527 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.679 HG21 HG12 ' A' ' 117' ' ' ILE . 5.2 pt -110.51 113.98 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.478 -0.934 . . . . 1.26 108.478 161.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.607 ' HB3' ' HA ' ' A' ' 11' ' ' ALA . 22.6 p -94.13 124.08 37.91 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.239 -0.437 . . . . 1.53 110.693 178.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.9 ' HB3' ' HB3' ' A' ' 113' ' ' ASP . 19.8 m -125.32 141.91 51.8 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.089 0.471 . . . . 1.81 111.801 -170.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.578 ' HE3' HG22 ' A' ' 6' ' ' ILE . 5.5 mtpm? -131.32 126.11 34.48 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 107.97 -1.122 . . . . 2.75 107.97 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.6 p -64.89 97.45 0.23 Allowed 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.337 -1.357 . . . . 1.94 107.337 172.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.68 140.27 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 N-CA-C 108.766 -0.827 . . . . 1.64 108.766 -165.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -97.23 81.37 3.02 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.162 -0.927 . . . . 2.17 108.676 -172.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.471 ' HE1' ' CG2' ' A' ' 112' ' ' ILE . 0.5 OUTLIER -111.74 152.54 44.2 Favored Pre-proline 0 C--N 1.311 -1.066 0 CA-C-N 114.374 -1.285 . . . . 0.67 109.902 -173.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.75 -18.94 66.19 Favored 'Trans proline' 0 N--CA 1.48 0.701 0 C-N-CA 123.732 2.954 . . . . 1.66 116.156 -167.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.422 ' CB ' ' CE2' ' A' ' 134' ' ' PHE . 2.6 tp10 -68.86 -29.33 67.61 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 121.608 0.718 . . . . 3.5 109.771 -172.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.486 ' CD2' HD13 ' A' ' 112' ' ' ILE . 32.4 t80 -158.25 106.94 1.7 Allowed Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 114.807 -1.088 . . . . 6.41 113.828 -175.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.461 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 3.7 Cg_endo -87.44 155.0 7.88 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.172 2.581 . . . . 2.31 109.881 161.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -67.27 -165.13 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 121.982 1.788 . . . . 1.27 112.438 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 13.9 t -136.47 -159.37 0.95 Allowed 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 109.071 -0.714 . . . . 1.88 109.071 -170.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 41.9 m -82.49 -42.05 18.96 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.39 -0.524 . . . . 2.43 111.693 -176.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -95.93 -29.9 13.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.095 0.474 . . . . 2.18 110.0 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.918 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 25.5 m-85 -85.14 109.5 18.32 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.739 -0.664 . . . . 1.33 110.113 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.59 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 0.9 OUTLIER -96.95 115.37 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 108.404 -0.962 . . . . 1.4 108.404 177.517 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.687 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 20.7 ttm180 -55.38 107.9 0.37 Allowed 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.084 -0.71 . . . . 5.14 109.084 174.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -59.4 111.13 3.18 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 110.959 -0.856 . . . . 1.05 110.959 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -84.01 75.5 10.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 122.183 0.992 . . . . 4.68 111.465 -175.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.538 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 16.5 m-20 -79.12 99.52 6.99 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 113.741 -1.572 . . . . 2.29 108.565 171.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.499 ' O ' ' N ' ' A' ' 151' ' ' CYS . 77.0 m-70 -60.25 152.84 61.26 Favored Pre-proline 0 C--O 1.22 -0.463 0 N-CA-C 107.513 -1.292 . . . . 2.95 107.513 173.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.547 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 32.1 Cg_exo -24.67 70.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.181 1 C-N-CA 126.116 4.544 . . . . 0.77 115.544 -173.494 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 170' ' ' PHE . 25.8 p -97.41 -174.26 2.88 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.987 -1.006 . . . . 1.97 109.907 176.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.689 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -172.26 -161.7 23.19 Favored Glycine 0 N--CA 1.433 -1.544 0 C-N-CA 119.775 -1.202 . . . . 0.55 112.001 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.467 ' CE2' ' HG ' ' A' ' 65' ' ' LEU . 72.4 t80 -161.83 91.17 0.8 Allowed 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.53 -0.915 . . . . 0.8 108.53 -168.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.591 ' CG2' HG11 ' A' ' 168' ' ' VAL . 2.4 m -100.96 131.15 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-O 121.856 0.836 . . . . 1.03 110.83 -173.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . 0.427 ' HB2' ' HB2' ' A' ' 125' ' ' ASN . 74.9 m -110.16 109.36 19.84 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.069 -0.969 . . . . 2.3 109.62 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.452 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 19.9 m -105.73 121.22 46.65 Favored Pre-proline 0 C--N 1.318 -0.801 0 N-CA-C 112.15 0.426 . . . . 1.45 112.15 -167.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.62 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 59.8 Cg_exo -51.69 126.02 18.55 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.953 2.435 . . . . 0.72 111.875 170.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.604 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 0.2 OUTLIER -88.01 -170.67 3.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.189 0.519 . . . . 1.72 111.561 -178.445 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -77.97 -24.45 48.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.426 0.631 . . . . 2.63 109.547 168.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 37.8 mt-10 -100.65 27.29 5.97 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.052 -1.092 . . . . 2.05 108.052 172.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.716 ' HB3' ' HD3' ' A' ' 162' ' ' PRO . 0.2 OUTLIER -14.99 -71.73 0.02 OUTLIER Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 126.478 1.911 . . . . 2.19 115.074 -174.188 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.716 ' HD3' ' HB3' ' A' ' 161' ' ' ASN . 73.0 Cg_endo -73.36 -15.86 24.93 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 121.268 1.312 . . . . 0.86 113.516 -170.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -104.45 -25.58 12.75 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.161 -0.472 . . . . 1.34 110.993 -176.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.604 ' O ' ' HB2' ' A' ' 158' ' ' MET . 49.6 m-85 -141.03 122.29 14.82 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.497 -0.557 . . . . 1.46 109.497 177.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 45.5 t -114.13 145.71 41.28 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.488 -0.485 . . . . 2.05 110.578 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.625 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.8 tppp? -92.13 101.83 14.35 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 122.049 0.928 . . . . 1.4 111.142 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 0.9 OUTLIER -87.49 105.01 17.01 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.385 -1.28 . . . . 1.07 109.31 178.748 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.591 HG11 ' CG2' ' A' ' 154' ' ' VAL . 0.1 OUTLIER -128.78 117.2 43.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 122.171 0.986 . . . . 1.11 112.004 178.112 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.416 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 23.0 ttt -116.97 147.25 42.45 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.814 -1.084 . . . . 1.79 109.496 -177.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.591 ' O ' ' HB2' ' A' ' 151' ' ' CYS . 92.9 m-85 -122.34 128.02 50.51 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.076 -0.713 . . . . 4.22 109.076 177.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.581 ' HB ' HD23 ' A' ' 192' ' ' LEU . 2.5 p -111.12 117.98 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-O 121.744 0.783 . . . . 2.01 110.003 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.623 HE22 ' HH ' ' A' ' 17' ' ' TYR . 13.7 tt0 -113.7 48.67 1.04 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.268 -1.012 . . . . 2.66 108.268 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.864 ' HB ' ' SD ' ' A' ' 175' ' ' MET . 0.0 OUTLIER -72.01 136.47 46.72 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.058 -1.428 . . . . 2.2 113.247 -170.745 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -92.76 -31.82 14.91 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.927 -0.579 . . . . 2.45 111.39 174.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.884 ' HB3' HD13 ' A' ' 179' ' ' LEU . 4.3 mpp? 54.93 57.77 5.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.077 0.465 . . . . 4.15 110.231 -172.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -60.06 -9.29 3.02 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.569 -0.741 . . . . 6.51 112.187 177.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -77.83 18.34 4.99 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 121.226 -0.511 . . . . 2.26 113.308 -177.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 81.5 tttt 59.28 69.7 0.7 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.498 0.666 . . . . 6.69 111.504 175.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.884 HD13 ' HB3' ' A' ' 175' ' ' MET . 4.4 mp -99.01 174.18 6.47 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 107.907 -1.146 . . . . 2.21 107.907 174.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.563 ' HB2' HG12 ' A' ' 183' ' ' ILE . 19.5 m -112.17 156.92 41.24 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 108.882 -0.784 . . . . 2.31 108.882 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -46.26 -39.45 21.22 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 121.972 1.781 . . . . 1.86 111.589 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.6 p -75.27 -10.42 59.44 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 115.095 -0.957 . . . . 2.45 112.606 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.773 ' HA ' ' HE2' ' A' ' 186' ' ' LYS . 8.0 mm -91.78 -28.47 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 122.872 1.32 . . . . 1.69 109.398 177.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.675 ' HA ' ' CG2' ' A' ' 187' ' ' THR . 0.9 OUTLIER -86.46 -33.47 7.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 112.886 -1.961 . . . . 1.77 110.366 -169.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.462 ' OE2' ' HB3' ' A' ' 186' ' ' LYS . 0.0 OUTLIER -60.71 -25.53 66.49 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.558 -0.746 . . . . 2.89 110.612 173.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.773 ' HE2' ' HA ' ' A' ' 183' ' ' ILE . 0.0 OUTLIER -93.37 -36.53 12.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 1.71 110.477 174.774 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.675 ' CG2' ' HA ' ' A' ' 184' ' ' ILE . 5.7 t -66.47 -26.7 67.32 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 120.716 -0.394 . . . . 1.3 111.832 -171.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' MET . . . . . 0.604 ' HE1' HG21 ' A' ' 187' ' ' THR . 4.2 mmt -76.93 -60.09 0.85 Allowed Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.683 -0.407 . . . . 1.39 111.65 -177.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.504 ' O ' HG13 ' A' ' 193' ' ' VAL . 18.2 Cg_endo -60.54 -36.61 85.23 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 121.668 1.579 . . . . 1.15 111.76 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.591 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 7.8 t -70.07 -23.55 63.1 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.971 0.415 . . . . 1.95 110.763 -176.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.434 HD21 ' C ' ' A' ' 191' ' ' ASN . 0.2 OUTLIER -91.06 -45.59 8.61 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.332 -0.394 . . . . 1.92 110.494 -178.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.627 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 80.3 mt -72.14 -45.91 58.6 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.083 -0.508 . . . . 1.68 112.146 -170.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 189' ' ' PRO . 1.8 m -75.68 -33.25 25.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.736 0.779 . . . . 1.32 108.948 -173.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.591 ' HB2' ' O ' ' A' ' 190' ' ' SER . 1.1 t30 -62.94 -49.13 75.96 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.052 -1.431 . . . . 2.6 109.773 175.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.662 ' HA ' ' OD1' ' A' ' 198' ' ' ASN . 5.2 t80 -56.56 -30.49 63.19 Favored 'General case' 0 C--O 1.233 0.222 0 O-C-N 123.739 0.649 . . . . 2.73 109.999 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.612 ' O ' ' HB2' ' A' ' 199' ' ' ALA . 8.7 mt -78.7 -39.83 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-N 115.992 -0.549 . . . . 1.11 112.437 177.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.633 HD12 ' N ' ' A' ' 198' ' ' ASN . 2.8 pp -80.41 -21.72 41.96 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 119.304 -0.958 . . . . 1.57 111.076 -176.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.809 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 1.6 p-10 -74.64 -13.91 60.7 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 118.816 -1.153 . . . . 2.18 108.281 166.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' A' ' 196' ' ' ILE . . . -82.25 -27.31 32.52 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.266 -1.013 . . . . 1.04 108.266 170.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.647 ' HD3' HG12 ' A' ' 54' ' ' ILE . 26.3 mmtp -69.36 -38.85 78.29 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.543 -0.753 . . . . 1.51 109.333 173.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -86.53 -39.61 16.06 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 114.783 -1.099 . . . . 1.94 110.169 -176.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . 0.408 ' HA2' ' HB2' ' A' ' 205' ' ' ALA . . . -70.51 -29.55 69.74 Favored Glycine 0 CA--C 1.503 -0.715 0 C-N-CA 120.994 -0.622 . . . . 0.47 111.602 -178.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 1.046 HD12 HD21 ' A' ' 61' ' ' LEU . 2.8 tp -71.59 -31.47 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 109.606 -0.516 . . . . 1.16 109.606 177.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.553 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 53.3 mttp -86.5 -23.74 25.82 Favored 'General case' 0 C--O 1.204 -1.293 0 N-CA-C 108.836 -0.801 . . . . 3.8 108.836 176.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.408 ' HB2' ' HA2' ' A' ' 202' ' ' GLY . . . -66.15 -31.24 71.98 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.221 -0.659 . . . . 1.28 109.221 169.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.446 ' CE1' ' HA ' ' A' ' 64' ' ' PHE . 56.1 m80 -92.46 -6.82 49.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.6 -0.727 . . . . 4.34 112.469 176.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.404 ' HD3' ' C ' ' A' ' 207' ' ' ARG . 0.5 OUTLIER -110.46 -60.43 1.81 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.954 0.883 . . . . 3.0 109.957 176.835 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 204' ' ' LYS . 94.5 m -84.42 143.15 41.18 Favored Pre-proline 0 C--N 1.311 -1.09 0 CA-C-N 114.184 -1.371 . . . . 2.01 109.884 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -69.27 51.26 0.74 Allowed 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.673 2.249 . . . . 2.59 111.799 173.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 33.9 t -66.66 -28.78 68.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.806 -0.634 . . . . 2.55 111.142 -176.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.413 ' H ' ' HD3' ' A' ' 211' ' ' ARG . 0.0 OUTLIER -100.44 14.53 30.86 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.617 -0.433 . . . . 6.11 110.982 -179.185 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -62.36 -41.77 98.87 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.117 -0.698 . . . . 7.55 109.117 175.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -102.04 71.96 0.34 Allowed Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.902 -0.879 . . . . 3.73 110.902 172.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -87.12 121.4 29.52 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.841 0.353 . . . . 6.11 110.532 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -132.81 79.8 1.86 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.43 -0.35 . . . . 7.27 111.079 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 69.64 119.24 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.477 0.711 . . . . 6.82 112.456 175.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.504 ' ND2' ' HA ' ' A' ' 73' ' ' THR . 26.3 p-10 -100.88 27.26 6.11 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.176 -0.676 . . . . 5.77 109.176 171.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 8.9 m -60.97 -37.19 81.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.287 -0.87 . . . . 6.85 110.996 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -152.07 156.98 40.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.091 -0.504 . . . . 9.48 110.602 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 C--O 1.251 1.179 0 N-CA-C 108.754 -0.832 . . . . 8.48 108.754 170.436 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 ptt? . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 120.915 0.388 . . . . 4.31 110.467 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.536 ' O ' HD13 ' A' ' 6' ' ' ILE . 10.1 m-20 -113.85 -30.98 6.57 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 116.49 -0.323 . . . . 2.25 110.929 -176.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.483 ' CD2' HD12 ' A' ' 87' ' ' ILE . 95.4 m-85 -67.24 -32.14 72.98 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.604 0.716 . . . . 0.45 109.466 -176.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.542 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 18.1 tttt -75.48 -1.33 23.64 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 114.594 -1.185 . . . . 2.06 109.855 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -93.28 -42.47 9.31 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.951 -0.568 . . . . 1.2 110.06 171.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.637 ' O ' ' HB ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -84.2 -35.47 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-O 121.08 0.467 . . . . 1.76 110.511 -174.371 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.526 ' HB3' ' HB2' ' A' ' 116' ' ' TYR . . . -80.19 -40.7 26.69 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.096 -0.957 . . . . 1.11 111.338 -176.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.542 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 4.0 mt-30 -63.45 -32.8 74.34 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.079 -0.964 . . . . 2.14 109.658 176.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.627 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 13.2 mm100 -78.68 -42.75 27.69 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.613 -1.176 . . . . 3.04 109.1 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.637 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -60.24 -35.73 76.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.656 -0.702 . . . . 1.1 111.257 179.73 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.455 ' HA ' ' OG ' ' A' ' 128' ' ' SER . . . -48.79 -58.92 4.05 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 121.098 0.475 . . . . 1.04 110.94 171.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -71.99 -18.18 62.0 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.711 -0.677 . . . . 2.31 111.564 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.627 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 49.9 mt-10 -68.76 -56.73 7.12 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.03 -0.73 . . . . 2.54 109.03 172.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.705 HG22 ' CE2' ' A' ' 170' ' ' PHE . 11.9 p -68.97 -41.77 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.893 -0.594 . . . . 1.21 111.228 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.33 -31.55 65.81 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.543 -0.753 . . . . 1.26 109.219 174.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.62 -28.33 73.1 Favored Glycine 0 CA--C 1.503 -0.715 0 CA-C-N 114.21 -1.359 . . . . 0.57 110.324 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.491 ' HD1' ' O ' ' A' ' 13' ' ' GLU . 11.6 m-85 -93.05 -16.86 24.52 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.763 -0.718 . . . . 3.59 109.636 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.82 -6.16 40.1 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.54 0.686 . . . . 2.1 109.199 -175.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -110.16 -17.32 13.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.641 -1.163 . . . . 3.26 109.714 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -100.44 138.19 37.83 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.433 -0.803 . . . . 2.16 110.239 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 40.3 p -137.29 88.91 2.38 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.363 0.602 . . . . 2.24 111.336 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.1 p -173.78 146.25 1.24 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.173 -0.921 . . . . 2.46 111.451 -178.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.487 ' O ' ' HG3' ' A' ' 38' ' ' LYS . . . 92.81 2.27 67.11 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 121.294 -0.479 . . . . 1.45 112.807 174.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.481 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -120.04 -158.29 0.74 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.925 0.393 . . . . 2.24 110.878 -176.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.29 119.24 0.91 Allowed 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 108.811 -0.811 . . . . 3.43 108.811 -174.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.6 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 3.1 p -64.24 117.38 4.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 C-N-CA 119.37 -0.932 . . . . 2.21 109.726 175.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.4 p -94.09 -23.72 5.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 114.317 -1.311 . . . . 1.83 108.944 -176.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.516 ' C ' ' HD3' ' A' ' 28' ' ' LYS . 0.5 OUTLIER -157.57 123.71 4.79 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 120.252 -0.579 . . . . 2.87 110.199 -174.471 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -151.34 152.07 32.64 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.208 0.528 . . . . 1.92 111.485 -178.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.3 t -112.12 -147.95 0.42 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.579 -0.897 . . . . 2.37 108.579 175.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.405 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -99.32 25.87 6.53 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.444 0.64 . . . . 4.84 109.38 176.122 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.529 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 25.6 mmtm -156.73 -44.85 0.07 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 114.911 -1.04 . . . . 2.05 111.814 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.417 HG22 ' HA3' ' A' ' 52' ' ' GLY . 24.0 pt -104.87 160.42 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-O 120.766 0.317 . . . . 1.42 111.394 -175.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.58 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 2.6 m -149.72 109.9 4.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.548 -0.751 . . . . 1.22 110.487 -171.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.3 t -103.07 102.13 13.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.161 0.505 . . . . 1.52 109.943 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.6 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 2.9 p -97.48 124.66 41.78 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.5 -0.773 . . . . 1.74 111.693 -176.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.7 t -103.27 125.53 49.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.537 -1.211 . . . . 1.72 109.527 -175.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 23' ' ' GLY . 29.4 ttpt -120.55 -91.53 0.56 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.348 -0.387 . . . . 2.45 111.283 -176.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' A' ' 46' ' ' ASN . . . -176.53 137.53 0.28 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 110.272 -0.27 . . . . 2.17 110.272 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.7 p -78.39 159.49 28.3 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.88 -0.415 . . . . 2.51 109.88 176.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -58.22 -40.9 82.85 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.945 0.402 . . . . 7.41 110.639 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -76.38 -20.56 57.05 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.241 -0.436 . . . . 6.84 110.921 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 43.9 t80 74.61 13.8 3.56 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.506 -0.77 . . . . 6.42 110.46 170.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -87.96 15.32 7.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.375 0.607 . . . . 6.31 110.251 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 171.08 167.65 31.68 Favored Glycine 0 N--CA 1.425 -2.061 0 N-CA-C 109.036 -1.626 . . . . 1.74 109.036 -171.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 77.5 m-20 -98.51 143.62 28.73 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 120.948 0.404 . . . . 2.45 110.992 -177.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.712 HD23 ' CD1' ' A' ' 170' ' ' PHE . 4.9 tt -84.76 133.25 34.36 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.95 -1.13 . . . . 1.49 107.95 175.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.54 ' N ' HD21 ' A' ' 47' ' ' LEU . 97.9 m-85 -113.66 128.59 56.48 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.003 0.43 . . . . 1.52 110.092 -176.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.443 ' HD2' ' CH2' ' A' ' 24' ' ' TRP . 3.8 tmt_? -122.88 131.35 53.7 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.598 -0.728 . . . . 3.34 109.274 177.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 34' ' ' THR . 10.1 p -116.49 151.35 18.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.046 0.45 . . . . 1.98 110.543 -176.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.419 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 27.3 tt0 -148.36 108.81 4.14 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.444 -0.798 . . . . 1.07 109.408 -172.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.529 ' HA2' ' O ' ' A' ' 32' ' ' LYS . . . -140.91 138.5 8.93 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 119.978 -1.106 . . . . 0.35 112.306 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 67.6 mt -84.56 129.3 37.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.033 0.444 . . . . 1.3 110.139 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 63.8 mt -109.59 119.0 49.19 Favored Pre-proline 0 N--CA 1.442 -0.839 0 CA-C-N 115.767 -0.651 . . . . 1.07 109.612 177.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 34.0 Cg_exo -61.67 69.17 0.1 Allowed 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 124.262 3.308 . . . . 0.74 112.685 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.592 ' HG2' ' CG1' ' A' ' 203' ' ' ILE . 7.6 tp10 -163.79 176.68 9.3 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.061 -1.088 . . . . 1.68 108.061 176.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.5 ' H ' ' HG3' ' A' ' 56' ' ' GLU . 53.4 p -84.75 153.78 61.13 Favored Pre-proline 0 N--CA 1.427 -1.603 0 CA-C-O 121.332 0.587 . . . . 1.58 110.298 176.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.475 ' HA ' HD11 ' A' ' 61' ' ' LEU . 11.9 Cg_exo -68.28 -9.58 26.31 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.742 2.961 . . . . 0.74 110.26 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.53 -48.72 25.32 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.687 -1.142 . . . . 1.31 111.153 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.412 ' NZ ' ' HB2' ' A' ' 207' ' ' ARG . 0.3 OUTLIER -72.93 -26.5 61.41 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.788 -0.819 . . . . 3.78 108.788 -178.392 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.566 HD22 ' CD1' ' A' ' 203' ' ' ILE . 83.3 mt -64.13 -53.49 48.81 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 114.729 -1.123 . . . . 1.09 109.796 173.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.413 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 18.1 m -64.29 -13.45 49.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.502 -0.772 . . . . 1.94 110.442 175.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -84.95 -42.82 14.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.833 -0.621 . . . . 1.32 111.564 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.555 ' CD2' ' HA ' ' A' ' 61' ' ' LEU . 11.9 p90 -73.3 -44.38 59.19 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 120.571 -0.452 . . . . 0.79 111.2 -174.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.413 ' CD2' ' HA ' ' A' ' 62' ' ' SER . 0.7 OUTLIER -80.79 -16.79 52.87 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 120.433 -0.507 . . . . 2.15 111.965 -173.264 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.642 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 34.8 t80 -26.3 -72.28 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 O-C-N 124.6 1.188 . . . . 2.06 113.811 -153.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.642 ' HG2' ' O ' ' A' ' 66' ' ' TYR . 5.4 mm-40 175.8 115.95 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.08 0 C-N-CA 124.32 1.048 . . . . 4.31 108.229 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.732 ' HB ' ' CD1' ' A' ' 81' ' ' TYR . 13.3 t 39.83 31.46 0.08 Allowed 'General case' 0 C--N 1.319 -0.753 0 O-C-N 124.348 1.03 . . . . 1.89 112.584 -177.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.3 -38.79 8.79 Favored Glycine 0 N--CA 1.436 -1.357 0 CA-C-N 115.5 -0.773 . . . . 1.71 113.001 -168.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.649 ' O ' HG23 ' A' ' 73' ' ' THR . 23.3 t70 169.59 -22.04 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.338 -0.986 . . . . 2.19 108.338 -163.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.766 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 3.9 ptp180 -43.8 -48.07 8.14 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 114.772 -1.103 . . . . 3.95 111.165 -178.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.544 ' N ' ' HG3' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -79.32 -16.08 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 C-N-CA 120.695 -0.402 . . . . 1.42 111.613 -172.325 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.649 HG23 ' O ' ' A' ' 70' ' ' ASP . 1.3 t -82.41 -35.86 27.25 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 119.8 -0.76 . . . . 1.45 109.995 -174.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.549 ' CZ2' ' HA ' ' A' ' 71' ' ' ARG . 16.8 p-90 -100.96 -3.7 29.01 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.343 -0.543 . . . . 0.78 111.387 -177.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.766 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 3.0 t70 -75.27 177.31 6.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.717 -0.674 . . . . 2.19 112.269 -170.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.579 ' HG3' ' OD1' ' A' ' 198' ' ' ASN . 0.0 OUTLIER -133.94 -12.43 2.56 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.539 -0.755 . . . . 3.68 111.4 179.246 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.4 m -111.33 -1.73 15.91 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.306 -0.998 . . . . 2.08 108.306 178.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 68.3 mt -110.79 176.81 4.88 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.566 -1.197 . . . . 1.16 110.037 -178.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -149.02 -67.95 0.22 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.495 -0.775 . . . . 2.23 110.002 -176.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.467 ' HB ' HD12 ' A' ' 97' ' ' ILE . 26.0 t -143.89 135.87 22.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.643 -0.708 . . . . 1.44 109.808 -173.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.732 ' CD1' ' HB ' ' A' ' 68' ' ' THR . 11.4 t80 -112.24 139.29 47.91 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.801 -0.444 . . . . 5.73 109.801 176.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.537 ' O ' ' HB3' ' A' ' 95' ' ' HIS . 17.1 m120 -137.71 114.76 10.8 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.902 -0.777 . . . . 1.86 108.902 175.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 48.6 tpp -75.53 113.02 12.47 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.736 -0.838 . . . . 2.52 108.736 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -85.88 -69.74 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.154 0.502 . . . . 1.19 110.201 -170.142 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -132.91 124.75 28.43 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.718 -0.673 . . . . 2.59 109.7 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.9 mtt180 -101.87 129.06 48.02 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.86 -0.793 . . . . 2.83 108.86 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -91.51 -39.08 11.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.468 0.651 . . . . 1.17 109.418 -176.336 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -150.7 -169.4 3.38 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.98 -1.009 . . . . 1.86 108.764 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.1 m -80.15 -4.41 52.86 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.858 0.361 . . . . 1.94 110.742 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -135.69 13.3 3.43 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 109.884 -0.414 . . . . 1.87 109.884 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.508 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -139.01 111.09 7.32 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 109.009 -0.737 . . . . 1.12 109.009 -176.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.574 ' O ' HD13 ' A' ' 114' ' ' LEU . 41.5 m-85 -128.76 178.96 5.98 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.845 -0.616 . . . . 0.52 110.274 -173.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.541 ' O ' HG23 ' A' ' 84' ' ' VAL . 39.1 mt -132.81 124.68 51.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 108.258 -1.016 . . . . 1.1 108.258 169.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.724 ' SG ' HG12 ' A' ' 115' ' ' VAL . 75.2 m -92.82 107.67 19.4 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.1 -0.5 . . . . 2.61 112.196 -171.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.537 ' HB3' ' O ' ' A' ' 82' ' ' ASN . 5.3 t60 -87.11 81.85 7.89 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.027 -1.101 . . . . 2.17 108.027 164.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.431 ' OG1' ' HB3' ' A' ' 94' ' ' CYS . 90.5 m -108.3 113.0 25.75 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.72 -1.127 . . . . 1.19 111.761 -170.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.467 HD12 ' HB ' ' A' ' 80' ' ' VAL . 3.2 mp -77.58 121.57 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 108.227 -1.027 . . . . 1.63 108.227 173.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.596 ' HB ' ' O ' ' A' ' 109' ' ' ARG . 71.8 m -111.27 149.37 31.14 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.94 -1.027 . . . . 1.72 110.771 -171.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -116.55 57.46 0.77 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.046 0.45 . . . . 2.29 110.559 -176.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.9 p -80.98 56.38 2.75 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.562 0.696 . . . . 4.07 110.287 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.496 ' CZ ' ' HA2' ' A' ' 104' ' ' GLY . 22.8 t80 -83.34 97.27 8.83 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.274 -0.876 . . . . 6.11 110.452 -173.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.564 ' O ' HG11 ' A' ' 103' ' ' VAL . . . -88.72 77.99 7.77 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.908 -0.587 . . . . 1.98 110.363 175.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.564 HG11 ' O ' ' A' ' 102' ' ' ALA . 0.3 OUTLIER 72.52 -15.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.468 1.107 . . . . 3.6 112.713 170.569 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.496 ' HA2' ' CZ ' ' A' ' 101' ' ' PHE . . . 139.56 -15.31 3.16 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.189 -1.005 . . . . 2.2 112.602 177.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.2 m -73.05 -13.41 61.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.284 0.564 . . . . 2.08 110.475 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 44.0 mt -124.46 118.88 54.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.52 -0.764 . . . . 1.53 109.95 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.8 m -77.17 155.1 82.41 Favored Pre-proline 0 C--N 1.319 -0.753 0 N-CA-C 109.366 -0.605 . . . . 1.71 109.366 174.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -44.71 122.92 4.4 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.681 2.254 . . . . 1.31 111.031 173.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.608 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 33.3 ttp180 -118.67 137.44 53.3 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.712 -0.395 . . . . 4.06 110.097 -167.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.585 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 22.0 t70 -107.47 147.52 30.36 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 120.754 0.311 . . . . 1.37 110.635 -171.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -118.81 155.64 30.82 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.366 0.603 . . . . 3.01 111.589 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.582 ' HA ' ' O ' ' A' ' 94' ' ' CYS . 35.5 mm -135.78 76.83 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 107.59 -1.263 . . . . 1.2 107.59 170.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 2.1 m-20 -98.91 120.61 39.63 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.579 -0.737 . . . . 1.86 110.577 -176.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.574 HD13 ' O ' ' A' ' 92' ' ' PHE . 9.4 tp -75.62 122.04 23.35 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 121.701 0.762 . . . . 1.08 109.361 172.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.724 HG12 ' SG ' ' A' ' 94' ' ' CYS . 0.1 OUTLIER -123.58 125.7 71.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-N 114.591 -1.186 . . . . 1.08 112.374 -165.123 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.526 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 91.0 t80 -112.87 123.92 51.42 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.332 -0.849 . . . . 2.81 110.637 172.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.503 HG13 HG21 ' A' ' 127' ' ' ILE . 4.5 mp -92.07 110.74 23.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.366 -0.834 . . . . 1.53 109.783 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.417 ' HB3' HG22 ' A' ' 126' ' ' ILE . 24.8 ttmm -113.41 142.82 45.44 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.032 -0.531 . . . . 1.81 110.596 -176.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -129.01 89.8 2.93 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 116.003 -0.544 . . . . 3.22 110.563 -174.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.433 ' HB3' ' HB2' ' A' ' 123' ' ' ASN . 36.9 m-85 -72.29 108.75 5.59 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 107.829 -1.174 . . . . 1.28 107.829 167.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -39.81 100.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 O-C-N 124.665 1.228 . . . . 2.28 112.813 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.41 ' C ' ' HG2' ' A' ' 157' ' ' PRO . . . 67.12 26.87 73.34 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 114.039 -1.437 . . . . 0.79 113.113 176.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.493 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 10.4 m120 -127.38 -46.13 1.49 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.688 -0.256 . . . . 2.06 110.64 176.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.537 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 5.8 mtm -162.19 131.17 4.3 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 120.516 -0.474 . . . . 1.73 111.96 -176.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -112.42 86.02 2.27 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.612 -1.255 . . . . 2.07 107.612 167.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.481 ' CG1' HG11 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -97.78 135.74 31.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.136 -0.938 . . . . 1.06 112.244 -172.576 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.665 ' O ' HG13 ' A' ' 127' ' ' ILE . 13.9 pt -101.05 108.89 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 108.576 -0.898 . . . . 1.26 108.576 164.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 1.7 m -75.86 161.05 29.31 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.624 -0.88 . . . . 1.53 108.624 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.542 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 11.3 p -157.33 121.11 4.18 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.334 0.588 . . . . 1.81 111.618 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.8 ttmt -127.94 110.71 12.81 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.436 -1.32 . . . . 2.75 107.436 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.402 ' OG ' ' HA ' ' A' ' 147' ' ' TYR . 22.9 t -58.71 98.84 0.04 OUTLIER 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 107.629 -1.248 . . . . 1.94 107.629 -178.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.427 HG11 ' HB3' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -107.59 133.84 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.107 0 CA-C-N 114.833 -1.076 . . . . 1.64 108.727 -165.321 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -94.09 71.15 3.94 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.898 -1.047 . . . . 2.17 109.076 -169.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.475 ' O ' ' HB3' ' A' ' 137' ' ' TYR . 1.8 p90 -99.26 175.06 2.62 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 114.4 -1.273 . . . . 0.67 109.488 -172.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -41.98 -50.4 5.2 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.739 2.959 . . . . 1.66 116.479 -174.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -88.12 -5.13 58.62 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.604 0.716 . . . . 3.5 111.604 -170.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.475 ' HB3' ' O ' ' A' ' 134' ' ' PHE . 22.8 t80 -56.72 -48.94 96.37 Favored Pre-proline 0 C--N 1.315 -0.927 0 N-CA-C 114.914 1.45 . . . . 6.41 114.914 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 137' ' ' TYR . 66.6 Cg_exo -32.29 110.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 123.821 3.014 . . . . 2.31 114.467 -174.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.618 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 82.3 Cg_endo -83.84 -160.72 0.12 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.687 2.925 . . . . 1.27 114.036 -175.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.9 p -136.64 -164.35 1.56 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.279 -0.873 . . . . 1.88 108.943 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.6 p -89.77 -29.83 18.42 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.126 -0.63 . . . . 2.43 110.972 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -83.45 -33.32 25.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 2.18 110.732 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -107.67 109.41 21.01 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 109.425 -0.583 . . . . 1.33 109.425 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.608 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 2.4 tp -100.63 106.66 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 C-N-CA 120.123 -0.631 . . . . 1.4 109.646 -176.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.618 ' NH2' ' HA ' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -59.43 99.98 0.07 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.109 -0.95 . . . . 5.14 110.715 178.825 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -65.82 122.24 21.54 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.597 -0.729 . . . . 1.05 111.297 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.493 ' HB3' ' HB2' ' A' ' 174' ' ' GLU . 3.5 t80 -85.05 78.55 9.87 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.623 0.725 . . . . 4.68 110.372 -177.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.669 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 89.0 m-20 -72.55 106.11 4.48 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.736 -1.12 . . . . 2.29 110.325 175.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.407 ' O ' ' N ' ' A' ' 151' ' ' CYS . 83.0 m-70 -75.91 144.77 76.65 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 109.545 -0.539 . . . . 2.95 109.545 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -13.49 61.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.181 1 C-N-CA 127.599 5.533 . . . . 0.77 116.374 -166.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . 0.669 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 19.7 p -89.99 -175.08 4.47 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.451 -0.795 . . . . 1.97 110.329 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.671 ' N ' HG21 ' A' ' 14' ' ' VAL . . . 178.99 -161.81 28.33 Favored Glycine 0 N--CA 1.435 -1.371 0 C-N-CA 120.456 -0.878 . . . . 0.55 111.479 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.438 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 32.5 t80 -161.38 91.42 0.85 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.075 -1.083 . . . . 0.8 108.075 -165.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.562 ' CG2' HG11 ' A' ' 168' ' ' VAL . 2.7 m -98.41 132.62 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-O 122.106 0.955 . . . . 1.03 111.123 -174.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 124' ' ' MET . 16.5 t -109.55 119.28 38.93 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.228 -0.897 . . . . 2.3 109.186 176.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.524 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 6.2 m -116.44 122.41 31.98 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.614 -0.266 . . . . 1.45 111.162 -171.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.493 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 46.0 Cg_exo -53.65 126.64 22.48 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.973 1.782 . . . . 0.72 110.655 169.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.619 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 70.8 mmm -85.24 -166.61 1.55 Allowed 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.119 0.485 . . . . 1.72 111.139 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -74.57 -35.51 63.03 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 121.562 0.696 . . . . 2.63 109.225 175.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -102.6 29.49 5.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.874 -1.057 . . . . 2.05 108.876 173.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.451 ' HB3' ' N ' ' A' ' 158' ' ' MET . 2.7 p-10 -28.5 -55.83 0.25 Allowed Pre-proline 0 N--CA 1.475 0.812 0 N-CA-C 116.407 2.002 . . . . 2.19 116.407 -171.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.408 ' HD3' ' CG ' ' A' ' 161' ' ' ASN . 55.3 Cg_endo -68.83 -13.59 37.19 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 121.738 1.656 . . . . 0.86 112.722 -173.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -109.92 -32.69 6.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.984 -0.553 . . . . 1.34 110.765 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.619 ' O ' ' HB2' ' A' ' 158' ' ' MET . 88.3 m-85 -138.76 126.91 22.66 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.417 -0.586 . . . . 1.46 109.417 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 73.6 m -125.65 154.22 42.67 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.181 0.515 . . . . 2.05 111.853 -176.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.524 ' HB3' ' HB2' ' A' ' 156' ' ' SER . 2.0 tppp? -96.77 105.25 17.34 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.887 0.851 . . . . 1.4 112.081 -174.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.438 HD13 ' CZ ' ' A' ' 153' ' ' PHE . 0.6 OUTLIER -92.82 108.82 20.29 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.579 -1.191 . . . . 1.07 109.242 175.572 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.562 HG11 ' CG2' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -129.92 134.2 63.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.448 0.642 . . . . 1.11 111.504 177.206 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.564 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 17.7 ttt -143.49 151.3 40.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.518 -0.765 . . . . 1.79 109.321 -174.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.712 ' CD1' HD23 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -136.03 151.96 50.4 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.366 -0.605 . . . . 4.22 109.366 170.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.532 ' N ' ' HD1' ' A' ' 170' ' ' PHE . 3.9 p -134.85 132.83 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 115.746 -0.661 . . . . 2.01 110.078 176.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.515 ' OE1' HD13 ' A' ' 47' ' ' LEU . 24.9 tt0 -121.09 65.73 0.86 Allowed 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 107.135 -1.432 . . . . 2.66 107.135 177.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.509 HG23 ' OD1' ' A' ' 148' ' ' ASN . 1.4 m -68.94 149.47 48.82 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 113.54 -1.664 . . . . 2.2 110.465 -175.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.493 ' HB2' ' HB3' ' A' ' 147' ' ' TYR . 4.0 tp10 -81.91 -15.09 55.07 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.187 -0.46 . . . . 2.45 109.872 177.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.415 ' H ' HG21 ' A' ' 173' ' ' THR . 35.9 mtt 68.67 32.6 4.14 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.274 -0.876 . . . . 4.15 110.201 175.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.422 ' HB3' HD11 ' A' ' 144' ' ' ILE . 31.2 mmm180 -66.02 159.85 25.0 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.704 -0.68 . . . . 6.51 110.016 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 109.99 -171.51 14.98 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.951 -0.642 . . . . 2.26 111.565 -175.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -102.75 69.49 1.07 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.995 0.426 . . . . 6.69 110.154 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.514 HD11 ' N ' ' A' ' 179' ' ' LEU . 1.7 mp -119.44 161.8 19.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.469 0.652 . . . . 2.21 109.537 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 17.0 m -113.83 157.94 40.44 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-N 114.925 -1.034 . . . . 2.31 108.953 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -42.6 -46.36 8.13 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.813 2.342 . . . . 1.86 113.176 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.553 ' O ' ' HE2' ' A' ' 186' ' ' LYS . 9.3 m -69.22 -15.37 63.36 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.163 -0.472 . . . . 2.45 111.877 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 12.0 mm -90.29 -29.39 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 CA-C-O 122.551 1.167 . . . . 1.69 108.997 -175.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.651 ' HA ' ' CG2' ' A' ' 187' ' ' THR . 0.9 OUTLIER -83.39 -37.12 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 113.113 -1.858 . . . . 1.77 110.516 -172.103 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.482 ' O ' ' HG2' ' A' ' 189' ' ' PRO . 9.2 pt-20 -64.41 -16.72 62.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.489 -0.778 . . . . 2.89 109.343 174.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.553 ' HE2' ' O ' ' A' ' 182' ' ' SER . 52.1 mtmt -92.05 -43.7 9.26 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.775 -0.648 . . . . 1.71 110.376 170.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.651 ' CG2' ' HA ' ' A' ' 184' ' ' ILE . 13.5 t -64.83 -40.33 95.01 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.841 0.682 . . . . 1.3 112.841 -169.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' MET . . . . . 0.532 ' CE ' HG22 ' A' ' 187' ' ' THR . 0.1 OUTLIER -78.04 -61.2 0.61 Allowed Pre-proline 0 N--CA 1.467 0.424 0 CA-C-N 118.407 0.549 . . . . 1.39 111.951 -178.456 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.578 ' O ' HG13 ' A' ' 193' ' ' VAL . 51.6 Cg_exo -56.26 -38.74 94.54 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.04 1.827 . . . . 1.15 112.258 -176.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.401 ' O ' HG21 ' A' ' 193' ' ' VAL . 23.2 t -72.21 -37.31 69.26 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.414 -0.587 . . . . 1.95 109.414 -177.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.429 ' HA ' ' HB2' ' A' ' 194' ' ' ASN . 2.6 t-20 -67.4 -31.93 72.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.019 -0.537 . . . . 1.92 110.408 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.499 ' HB3' ' CG1' ' A' ' 50' ' ' VAL . 40.5 mt -69.34 -46.22 67.59 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 120.738 0.304 . . . . 1.68 111.007 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 189' ' ' PRO . 0.9 OUTLIER -65.06 -34.25 69.28 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 N-CA-C 108.716 -0.846 . . . . 1.32 108.716 176.543 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.429 ' HB2' ' HA ' ' A' ' 191' ' ' ASN . 35.0 m-20 -63.64 -45.32 90.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.179 -1.373 . . . . 2.6 111.483 178.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.416 ' HA ' ' ND2' ' A' ' 198' ' ' ASN . 6.3 m-85 -59.15 -31.38 68.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.967 0.413 . . . . 2.73 110.417 175.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.433 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 34.3 mt -81.75 -27.17 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-N 116.157 -0.474 . . . . 1.11 111.319 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.43 ' HA ' HD23 ' A' ' 197' ' ' LEU . 62.4 mt -74.57 -40.16 61.81 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-O 121.108 0.48 . . . . 1.57 109.811 175.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.579 ' OD1' ' HG3' ' A' ' 76' ' ' LYS . 76.5 m-20 -50.07 -37.86 35.6 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.706 -1.134 . . . . 2.18 108.53 166.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.629 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -78.17 -43.94 27.25 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 116.081 -0.509 . . . . 1.04 110.905 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.556 ' O ' ' HG3' ' A' ' 204' ' ' LYS . 35.6 mmtm -55.96 -44.5 78.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.256 0.551 . . . . 1.51 110.565 174.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -87.58 -38.41 15.99 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.495 -0.775 . . . . 1.94 110.856 -173.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -68.39 -29.42 73.08 Favored Glycine 0 C--O 1.228 -0.243 0 C-N-CA 121.102 -0.57 . . . . 0.47 111.999 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.629 ' HB ' ' O ' ' A' ' 199' ' ' ALA . 2.8 tp -70.55 -31.68 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-O 120.92 0.391 . . . . 1.16 109.949 177.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.556 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 89.3 mttt -84.33 -32.84 24.06 Favored 'General case' 0 C--O 1.21 -1.006 0 N-CA-C 108.514 -0.921 . . . . 3.8 108.514 176.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.526 ' HA ' ' CB ' ' A' ' 211' ' ' ARG . . . -58.41 -32.22 68.43 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.923 -0.581 . . . . 1.28 109.525 170.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -94.62 5.15 52.7 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.615 -0.72 . . . . 4.34 111.728 174.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.454 ' HB3' ' HA ' ' A' ' 204' ' ' LYS . 73.7 ttt180 -113.29 -61.17 1.78 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.899 0.38 . . . . 3.0 111.763 174.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 28.8 p -79.15 138.11 56.51 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.444 0.64 . . . . 2.01 111.86 -170.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -56.26 -22.82 42.57 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 124.009 3.139 . . . . 2.59 112.847 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 35.4 t -68.86 -55.91 9.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.848 -0.614 . . . . 2.55 111.338 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.526 ' CB ' ' HA ' ' A' ' 205' ' ' ALA . 10.6 mpt_? -87.03 -20.82 26.64 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.126 0.417 . . . . 6.11 112.126 -173.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -74.82 -15.57 60.73 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.21 -0.596 . . . . 7.55 109.934 176.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -115.99 28.44 7.66 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.794 -0.922 . . . . 3.73 110.794 174.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -77.06 111.78 13.0 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.871 -0.418 . . . . 6.11 109.871 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -99.02 132.89 44.0 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.496 -0.32 . . . . 7.27 110.507 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 58.87 69.79 0.7 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.384 -0.825 . . . . 6.82 110.362 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.475 ' ND2' ' HA ' ' A' ' 74' ' ' TRP . 52.4 t30 -81.5 102.6 10.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.993 -0.549 . . . . 5.77 110.274 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 24.8 m -67.4 -50.26 60.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.787 -0.642 . . . . 6.85 110.817 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -170.02 128.99 0.91 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.022 -0.362 . . . . 9.48 110.022 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' SER . . . . . 0.429 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 46.7 t . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.536 -0.745 . . . . 8.48 109.864 176.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 1.01 ' HG3' ' HB3' ' A' ' 4' ' ' LYS . 24.9 tpp . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 109.051 -0.722 . . . . 4.31 109.051 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.492 ' O ' HD12 ' A' ' 6' ' ' ILE . 9.0 m-20 64.08 -98.84 0.07 Allowed 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 114.606 -1.179 . . . . 2.25 112.006 168.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.596 ' HB2' HG21 ' A' ' 87' ' ' ILE . 76.0 m-85 -61.99 -26.54 68.28 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 121.236 0.541 . . . . 0.45 110.098 -172.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 1.01 ' HB3' ' HG3' ' A' ' 1' ' ' MET . 39.4 tttt -80.93 -36.44 31.01 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 107.453 -1.314 . . . . 2.06 107.453 -176.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.18 -43.57 82.78 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.897 -0.592 . . . . 1.2 111.32 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.492 HD12 ' O ' ' A' ' 2' ' ' ASP . 0.9 OUTLIER -82.75 -32.88 10.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 122.169 0.985 . . . . 1.76 109.191 -172.648 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.645 ' HB2' ' HB2' ' A' ' 116' ' ' TYR . . . -81.21 -37.79 28.06 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.176 -1.375 . . . . 1.11 111.718 -177.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.862 HE21 ' HH ' ' A' ' 116' ' ' TYR . 19.5 mt-30 -61.77 -30.13 70.59 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.421 -0.809 . . . . 2.14 109.704 175.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.639 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 76.3 mt-30 -78.32 -39.67 38.99 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.482 -1.236 . . . . 3.04 109.365 173.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.656 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.4 OUTLIER -72.94 -33.47 65.94 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.424 -0.807 . . . . 1.1 112.198 -175.185 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -48.05 -57.92 5.15 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.986 0.422 . . . . 1.04 111.698 174.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.669 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 4.2 pt20 -76.57 1.33 17.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.259 -0.428 . . . . 2.31 111.605 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.639 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 10.6 mm-40 -82.8 -48.83 10.36 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.01 -0.737 . . . . 2.54 109.01 169.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.95 HG23 ' HD1' ' A' ' 170' ' ' PHE . 7.4 p -72.0 -34.06 49.45 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-O 121.47 0.653 . . . . 1.21 109.818 175.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.669 ' HB3' ' HA ' ' A' ' 12' ' ' GLN . 0.8 OUTLIER -68.15 -26.18 65.64 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 122.361 1.077 . . . . 1.26 108.325 172.609 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 20' ' ' ASP . . . -68.75 -20.05 73.84 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 113.797 -1.547 . . . . 0.57 109.627 177.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.633 ' HD2' ' HA ' ' A' ' 14' ' ' VAL . 32.1 m-85 -91.08 -22.27 20.81 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 114.315 -0.943 . . . . 3.59 109.376 176.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 15' ' ' LEU . 5.6 t-20 -60.06 -28.7 68.0 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.356 -0.838 . . . . 2.1 109.615 175.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.534 ' HD2' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -115.22 10.89 16.11 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.58 -0.448 . . . . 3.26 111.397 175.189 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.573 ' CB ' ' HA ' ' A' ' 17' ' ' TYR . 50.7 t0 -89.6 69.93 7.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.499 0.666 . . . . 2.16 109.69 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.561 HG23 ' CH2' ' A' ' 24' ' ' TRP . 34.5 p -104.96 105.86 16.09 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.674 -0.694 . . . . 2.24 110.812 -176.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.5 p -169.87 -88.18 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.558 -0.746 . . . . 2.46 111.454 -173.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.48 ' O ' ' HG3' ' A' ' 38' ' ' LYS . . . -84.76 52.18 4.66 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 116.086 -0.507 . . . . 1.45 113.418 -173.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.867 ' HZ3' ' HD3' ' A' ' 49' ' ' ARG . 0.2 OUTLIER -119.61 -160.05 0.8 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.572 -0.529 . . . . 2.24 109.572 176.21 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.1 ttpp -176.09 110.65 0.1 Allowed 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 108.634 -0.876 . . . . 3.43 108.634 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.704 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 0.9 OUTLIER -61.14 118.27 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 CA-C-O 121.818 0.818 . . . . 2.21 110.303 175.084 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.635 HG21 ' HH ' ' A' ' 48' ' ' TYR . 3.2 m -98.49 -25.16 4.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 114.317 -1.31 . . . . 1.83 110.011 -178.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.425 ' HB3' ' CG2' ' A' ' 35' ' ' VAL . 0.9 OUTLIER -154.67 135.39 13.58 Favored 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 119.472 -0.891 . . . . 2.87 110.09 -178.007 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.504 HG22 ' HA ' ' A' ' 34' ' ' THR . 73.2 p -138.98 153.26 48.15 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.282 0.563 . . . . 1.92 110.748 177.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.651 ' HB3' HG12 ' A' ' 33' ' ' ILE . 14.9 t -113.86 -164.4 0.93 Allowed 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.456 -1.313 . . . . 2.37 107.456 173.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -93.8 19.31 8.99 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.999 0.428 . . . . 4.84 109.912 -176.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.831 ' HA ' ' HE2' ' A' ' 32' ' ' LYS . 3.6 mmpt? -155.02 -17.98 0.11 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.119 -0.946 . . . . 2.05 111.573 175.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.802 HG22 ' HA3' ' A' ' 52' ' ' GLY . 35.8 pt -131.35 170.82 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.902 0.382 . . . . 1.42 111.907 -172.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.504 ' HA ' HG22 ' A' ' 29' ' ' THR . 23.1 m -160.81 123.12 3.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.325 -0.852 . . . . 1.22 110.423 -167.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.608 HG13 HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -112.48 113.85 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.18 0.514 . . . . 1.52 110.692 172.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.704 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.8 OUTLIER -102.6 125.61 49.39 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.627 -0.715 . . . . 1.74 109.871 176.619 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 78.1 p -93.16 125.04 37.55 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 108.65 -0.87 . . . . 1.72 108.65 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.653 ' HA ' ' HA ' ' A' ' 24' ' ' TRP . 57.8 tttm -122.28 22.16 10.18 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.751 -0.659 . . . . 2.45 110.963 -168.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.625 ' HA ' ' HA ' ' A' ' 46' ' ' ASN . . . 60.55 122.41 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 114.857 -1.065 . . . . 2.17 113.219 175.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.446 ' H ' ' HA ' ' A' ' 46' ' ' ASN . 40.0 m -91.76 83.86 5.34 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.041 -0.726 . . . . 2.51 109.041 174.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.406 ' HD2' ' H ' ' A' ' 41' ' ' ARG . 2.1 mpt_? -69.9 -3.73 17.27 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.922 -0.581 . . . . 7.41 109.55 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -54.73 -27.25 39.43 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.974 -1.012 . . . . 6.84 110.603 172.541 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.575 ' HD2' ' CD2' ' A' ' 44' ' ' HIS . 17.5 t80 177.31 -79.0 0.0 OUTLIER 'General case' 0 C--N 1.344 0.368 0 N-CA-C 111.97 0.359 . . . . 6.42 111.97 176.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.575 ' CD2' ' HD2' ' A' ' 43' ' ' PHE . 6.5 p80 -139.5 79.77 1.74 Allowed 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 119.861 -0.736 . . . . 6.31 112.858 -170.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.643 ' HA3' ' HE2' ' A' ' 175' ' ' MET . . . 162.87 -157.33 29.34 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 119.073 -1.537 . . . . 1.74 112.547 168.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.625 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -120.17 136.71 54.53 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 120.972 0.415 . . . . 2.45 109.998 179.229 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.816 HD13 ' HE2' ' A' ' 170' ' ' PHE . 6.1 tt -78.04 147.85 34.59 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.76 -1.2 . . . . 1.49 107.76 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.815 ' HB3' HD13 ' A' ' 192' ' ' LEU . 4.9 m-85 -129.81 124.61 33.75 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 119.493 -0.883 . . . . 1.52 111.288 -172.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.867 ' HD3' ' HZ3' ' A' ' 24' ' ' TRP . 54.3 ttt-85 -120.54 109.56 15.41 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.356 -0.838 . . . . 3.34 109.147 177.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.608 HG21 HG13 ' A' ' 35' ' ' VAL . 10.4 p -100.31 150.22 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 109.515 -0.55 . . . . 1.98 109.515 -177.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.755 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 41.5 tt0 -156.03 109.6 2.73 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.856 -0.611 . . . . 1.07 110.078 -172.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.802 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -140.45 159.58 26.3 Favored Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 111.427 -0.669 . . . . 0.35 111.427 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.406 HD13 ' HZ1' ' A' ' 32' ' ' LYS . 59.6 mt -99.88 124.24 53.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 C-N-CA 120.57 -0.452 . . . . 1.3 110.753 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.629 HG12 ' HD2' ' A' ' 200' ' ' LYS . 85.7 mt -101.96 121.35 51.01 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 115.656 -0.702 . . . . 1.07 109.926 175.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -64.89 61.41 0.29 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.981 3.121 . . . . 0.74 112.878 177.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.801 ' HG2' HG13 ' A' ' 203' ' ' ILE . 6.9 tp10 -155.4 173.6 16.44 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.051 -1.092 . . . . 1.68 108.051 174.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.56 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 52.3 p -83.04 146.75 52.46 Favored Pre-proline 0 N--CA 1.425 -1.72 0 CA-C-O 121.838 0.828 . . . . 1.58 109.836 175.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.432 ' HA ' HD13 ' A' ' 61' ' ' LEU . 27.6 Cg_exo -60.72 -11.05 15.92 Favored 'Trans proline' 0 C--N 1.329 -0.461 0 C-N-CA 124.16 3.24 . . . . 0.74 111.478 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.36 -52.03 31.07 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.214 -0.903 . . . . 1.31 110.811 174.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.713 ' HE3' ' HB3' ' A' ' 64' ' ' PHE . 18.4 tptt -69.12 -24.03 64.06 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.516 -0.92 . . . . 3.78 108.516 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.742 ' HA ' ' CD1' ' A' ' 64' ' ' PHE . 46.5 mt -65.95 -58.71 4.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.642 -0.708 . . . . 1.09 110.323 172.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 125' ' ' ASN . 19.8 p -62.26 -11.23 13.84 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.83 -0.543 . . . . 1.94 110.56 176.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.469 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 25.2 t70 -90.9 -44.78 9.16 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.334 0.494 . . . . 1.32 112.334 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.823 ' HD2' ' CZ2' ' A' ' 74' ' ' TRP . 10.3 p90 -71.79 -43.26 65.98 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 121.032 -0.267 . . . . 0.79 110.721 -168.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.675 HD11 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -96.86 6.64 48.28 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.444 -0.503 . . . . 2.15 111.288 -174.59 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -42.18 -73.67 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.083 0.771 . . . . 2.06 113.083 -169.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.578 HE22 HG23 ' A' ' 115' ' ' VAL . 64.0 mm-40 -152.19 -63.24 0.17 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.17 0.509 . . . . 4.31 112.27 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.921 ' HB ' ' CD2' ' A' ' 81' ' ' TYR . 9.1 t -145.08 21.43 1.58 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.995 0.902 . . . . 1.89 109.359 -174.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -88.82 -29.82 17.06 Favored Glycine 0 CA--C 1.491 -1.44 0 CA-C-N 114.84 -1.073 . . . . 1.71 113.87 -168.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.648 ' O ' HG22 ' A' ' 73' ' ' THR . 10.4 t0 -167.28 -35.71 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.365 -0.976 . . . . 2.19 108.365 -166.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.757 ' HA ' ' CZ2' ' A' ' 74' ' ' TRP . 1.0 OUTLIER -47.83 -48.24 30.92 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 114.577 -1.192 . . . . 3.95 111.582 -172.245 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.892 HG23 HD12 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -87.35 -7.02 10.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 119.743 -0.783 . . . . 1.42 111.244 -172.675 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.648 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.4 t -90.65 -30.79 16.93 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 119.76 -0.776 . . . . 1.45 110.013 -177.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.993 ' HZ3' ' HB3' ' A' ' 198' ' ' ASN . 7.1 p-90 -102.54 -7.6 21.72 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 120.509 -0.476 . . . . 0.78 111.822 178.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.849 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 4.5 t70 -76.57 168.29 20.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.549 0.69 . . . . 2.19 111.702 -170.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.663 ' HD2' ' OD1' ' A' ' 194' ' ' ASN . 0.0 OUTLIER -118.51 -16.74 9.48 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.849 -1.069 . . . . 3.68 111.286 -177.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.4 m -113.83 7.94 17.2 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.911 -0.774 . . . . 2.08 108.911 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.892 HD12 HG23 ' A' ' 72' ' ' ILE . 29.8 mt -109.89 167.31 10.26 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.059 -0.973 . . . . 1.16 111.283 -178.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.592 ' HG2' ' HG2' ' A' ' 99' ' ' GLN . 6.6 mm100 -146.58 -71.25 0.24 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.393 -0.821 . . . . 2.23 110.686 -175.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.531 HG22 ' HB3' ' A' ' 79' ' ' GLN . 18.8 t -138.55 124.57 24.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.059 -0.973 . . . . 1.44 110.112 -170.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.921 ' CD2' ' HB ' ' A' ' 68' ' ' THR . 69.6 t80 -106.68 139.32 41.31 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.491 -0.483 . . . . 5.73 110.395 174.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.563 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 17.5 m120 -130.31 104.63 7.39 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.039 -0.726 . . . . 1.86 109.039 177.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.847 ' HE2' ' HG2' ' A' ' 86' ' ' ARG . 7.1 tpt -67.77 101.43 1.06 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.148 -0.933 . . . . 2.52 109.583 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.53 HG12 ' HG2' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -81.59 -83.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 120.481 -0.487 . . . . 1.19 111.551 -171.378 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.499 ' H ' HG22 ' A' ' 84' ' ' VAL . 49.3 m170 -118.35 127.16 53.43 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.001 0.429 . . . . 2.59 109.887 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.847 ' HG2' ' HE2' ' A' ' 83' ' ' MET . 25.5 mtm180 -108.58 120.9 43.8 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.763 -0.829 . . . . 2.83 108.763 176.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.596 HG21 ' HB2' ' A' ' 3' ' ' PHE . 0.8 OUTLIER -80.94 -55.3 8.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.424 -0.807 . . . . 1.17 112.022 -163.427 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -127.66 -83.28 0.6 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.933 -0.576 . . . . 1.86 111.085 -173.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.5 t -148.17 -31.35 0.28 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.243 0.544 . . . . 1.94 110.08 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -128.11 19.61 6.45 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.4 -0.818 . . . . 1.87 109.511 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.589 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -126.18 111.69 14.91 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.083 -1.08 . . . . 1.12 108.083 -176.802 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.724 ' HB3' ' HE3' ' A' ' 83' ' ' MET . 56.1 m-85 -122.88 171.5 9.16 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.799 -0.637 . . . . 0.52 110.566 -173.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.522 ' HB ' HG22 ' A' ' 84' ' ' VAL . 23.8 mt -131.12 130.59 63.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 107.678 -1.23 . . . . 1.1 107.678 165.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.696 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 26.5 p -101.74 128.72 47.94 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.582 -0.447 . . . . 2.61 111.353 -174.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.61 ' HA ' HD13 ' A' ' 112' ' ' ILE . 2.8 t60 -104.3 86.54 2.55 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.269 -1.011 . . . . 2.17 108.269 165.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.674 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 18.5 m -110.47 117.1 32.66 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.415 -0.811 . . . . 1.19 112.2 -168.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 42.0 mm -78.55 125.76 38.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 120.169 -0.612 . . . . 1.63 109.493 173.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.7 m -107.26 146.9 30.89 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.111 -0.949 . . . . 1.72 110.705 -173.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.592 ' HG2' ' HG2' ' A' ' 79' ' ' GLN . 1.8 mm100 -82.16 177.55 8.74 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.942 -0.572 . . . . 2.29 110.685 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.404 ' H ' ' NE2' ' A' ' 99' ' ' GLN . 41.0 t -110.08 117.45 33.77 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.588 -0.733 . . . . 4.07 110.81 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.402 ' O ' HD12 ' A' ' 106' ' ' ILE . 84.5 t80 -115.76 135.8 53.67 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 106.832 -1.544 . . . . 6.11 106.832 167.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.468 ' C ' ' H ' ' A' ' 104' ' ' GLY . . . 71.16 63.85 0.16 Allowed 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.41 -0.959 . . . . 1.98 108.41 -170.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.43 32.14 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 114.778 -1.101 . . . . 3.6 110.749 -173.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 102' ' ' ALA . . . -95.86 -5.63 59.71 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.7 -0.96 . . . . 2.2 110.7 173.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.625 ' HB3' ' HA ' ' A' ' 179' ' ' LEU . 64.8 m -155.32 -38.05 0.09 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.083 -0.558 . . . . 2.08 110.42 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.522 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 94.7 mt -80.1 126.49 39.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.569 -0.742 . . . . 1.53 112.139 -170.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.9 m -100.84 169.72 7.49 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.369 -0.832 . . . . 1.71 109.434 174.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -51.69 123.8 13.07 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.204 1.936 . . . . 1.31 110.74 171.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.661 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 39.6 ttm105 -114.82 149.22 37.38 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.382 -0.527 . . . . 4.06 110.267 -168.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.644 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 36.7 t0 -109.6 117.46 34.0 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.876 -0.416 . . . . 1.37 109.876 -174.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.674 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 9.2 m-30 -98.3 112.32 24.35 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.83 0.348 . . . . 3.01 110.877 -175.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.696 ' HA ' ' O ' ' A' ' 94' ' ' CYS . 15.2 mm -115.02 79.81 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 CA-C-N 115.509 -0.769 . . . . 1.2 109.317 172.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.567 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 45.6 m-20 -110.25 127.45 54.99 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.676 -0.693 . . . . 1.86 109.896 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.601 HD13 ' O ' ' A' ' 92' ' ' PHE . 4.0 tp -76.82 125.91 30.08 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 109.211 -0.663 . . . . 1.08 109.211 173.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.578 HG23 HE22 ' A' ' 67' ' ' GLN . 0.1 OUTLIER -123.92 125.64 71.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 115.233 -0.894 . . . . 1.08 112.321 -164.903 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.862 ' HH ' HE21 ' A' ' 8' ' ' GLN . 85.1 t80 -112.23 115.13 28.3 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.352 -0.84 . . . . 2.81 110.812 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.661 HG12 HG22 ' A' ' 127' ' ' ILE . 78.1 mt -91.27 99.29 9.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.974 -0.557 . . . . 1.53 109.668 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.554 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 2.6 tppp? -97.55 130.86 44.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.293 -0.867 . . . . 1.81 109.353 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.547 ' NH1' ' HA ' ' A' ' 121' ' ' GLU . 4.3 tmt_? -111.95 91.86 3.81 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 107.847 -1.168 . . . . 3.22 107.847 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -64.68 115.24 5.05 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 107.813 -1.181 . . . . 1.28 107.813 173.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.547 ' HA ' ' NH1' ' A' ' 119' ' ' ARG . 7.4 mm-40 -27.91 90.35 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 O-C-N 125.312 1.632 . . . . 2.28 113.398 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 52.62 41.67 57.21 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 115.271 -0.877 . . . . 0.79 112.81 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.518 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 4.1 t-20 -141.04 -39.0 0.41 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.395 0.146 . . . . 2.06 111.395 -175.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.472 ' CG ' ' HB ' ' A' ' 154' ' ' VAL . 3.4 tpp -157.13 118.32 3.67 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.312 -0.555 . . . . 1.73 111.22 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.5 ' HB3' ' HB3' ' A' ' 62' ' ' SER . 4.8 m-20 -101.08 73.67 1.54 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.509 -0.923 . . . . 2.07 108.509 175.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.688 ' HB ' HG13 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -92.34 138.48 19.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.189 -0.914 . . . . 1.06 112.667 -172.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.751 ' O ' HG13 ' A' ' 127' ' ' ILE . 1.1 pt -105.59 116.32 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 108.51 -0.922 . . . . 1.26 108.51 162.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 4.1 m -81.26 163.46 22.96 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.266 -0.642 . . . . 1.53 109.266 173.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.567 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 12.7 p -156.88 131.48 8.74 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.052 0.453 . . . . 1.81 110.968 176.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.582 ' HD3' HD22 ' A' ' 114' ' ' LEU . 20.0 mtpp -131.09 120.78 23.88 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 107.754 -1.202 . . . . 2.75 107.754 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.0 p -63.48 98.31 0.16 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.47 -0.937 . . . . 1.94 108.47 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.02 138.37 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-N 114.526 -1.215 . . . . 1.64 109.678 -165.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -100.81 74.79 1.66 Allowed 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 122.42 1.105 . . . . 2.17 110.306 -170.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.673 ' O ' ' HB3' ' A' ' 137' ' ' TYR . 3.8 p90 -106.37 175.93 1.88 Allowed Pre-proline 0 CA--C 1.554 1.127 0 CA-C-N 114.124 -1.398 . . . . 0.67 109.302 -174.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.608 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 25.0 Cg_exo -27.35 -67.27 0.05 OUTLIER 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 125.13 3.887 . . . . 1.66 117.308 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.644 ' HB3' ' CZ ' ' A' ' 134' ' ' PHE . 5.8 tp10 -68.63 -26.34 65.3 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.613 0.597 . . . . 3.5 112.613 -173.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.673 ' HB3' ' O ' ' A' ' 134' ' ' PHE . 0.5 OUTLIER -39.77 -55.23 3.72 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 115.331 1.604 . . . . 6.41 115.331 -171.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.435 ' HD2' ' O ' ' A' ' 135' ' ' PRO . 44.3 Cg_exo -35.72 106.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.366 1.495 0 C-N-CA 123.432 2.755 . . . . 2.31 114.408 -171.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.523 ' HB2' ' O ' ' A' ' 143' ' ' TYR . 72.9 Cg_endo -88.01 -147.54 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.274 2.65 . . . . 1.27 113.104 -174.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.438 ' H ' ' HB2' ' A' ' 139' ' ' PRO . 15.1 m -143.26 -171.98 3.6 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.785 -0.82 . . . . 1.88 108.785 -174.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.2 m -74.98 -38.45 61.66 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.0 -0.68 . . . . 2.43 111.247 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -77.39 -56.63 4.38 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.563 -0.532 . . . . 2.18 109.563 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.553 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 87.9 m-85 -79.41 109.49 13.82 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 115.715 -0.675 . . . . 1.33 110.16 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.661 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 1.9 tp -104.42 117.89 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 CA-C-N 115.199 -0.91 . . . . 1.4 109.495 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.644 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 0.1 OUTLIER -46.64 116.35 1.29 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.237 -0.892 . . . . 5.14 110.775 175.204 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -55.22 108.22 0.94 Allowed Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 114.971 -1.013 . . . . 1.05 111.793 176.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 1.106 ' HB3' ' HB3' ' A' ' 174' ' ' GLU . 0.2 OUTLIER -83.43 79.95 9.25 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.496 0.665 . . . . 4.68 109.878 177.174 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.666 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 84.8 m-20 -103.2 102.32 12.3 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.262 -1.336 . . . . 2.29 108.427 175.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -81.2 143.09 51.88 Favored Pre-proline 0 C--N 1.32 -0.685 0 C-N-CA 120.448 -0.501 . . . . 2.95 111.001 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.656 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 8.6 Cg_exo -10.07 59.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.411 1 C-N-CA 127.18 5.253 . . . . 0.77 116.355 -163.327 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . 0.756 ' HA ' ' CE1' ' A' ' 170' ' ' PHE . 7.8 p -85.58 -179.11 6.83 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.815 -1.084 . . . . 1.97 110.513 176.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.707 ' HA3' HG13 ' A' ' 14' ' ' VAL . . . -169.63 -168.09 31.09 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.393 -0.908 . . . . 0.55 111.677 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.561 ' CE1' HD11 ' A' ' 167' ' ' LEU . 60.8 t80 -160.18 80.8 0.69 Allowed 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.915 -1.143 . . . . 0.8 107.915 -165.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.688 HG13 ' HB ' ' A' ' 126' ' ' ILE . 7.1 m -89.53 124.52 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 121.829 0.823 . . . . 1.03 110.468 -173.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 56.6 m -106.08 113.31 26.78 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.523 -0.762 . . . . 2.3 109.165 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.739 ' HB3' ' HB3' ' A' ' 166' ' ' LYS . 15.5 t -106.07 121.72 44.69 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 116.203 -0.453 . . . . 1.45 111.535 -169.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.518 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 69.0 Cg_exo -51.7 114.99 1.83 Allowed 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.726 2.284 . . . . 0.72 111.26 169.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.655 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 0.2 OUTLIER -76.32 -167.97 0.88 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.266 0.555 . . . . 1.72 112.172 -177.03 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -67.51 -38.08 83.76 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.484 -0.932 . . . . 2.63 108.484 169.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.565 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 10.8 mm-40 -97.6 29.06 3.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.099 -1.409 . . . . 2.05 108.89 175.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.403 ' CG ' ' HD3' ' A' ' 162' ' ' PRO . 1.2 p-10 -23.84 -58.05 0.13 Allowed Pre-proline 0 N--CA 1.473 0.724 0 N-CA-C 116.515 2.043 . . . . 2.19 116.515 -169.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.403 ' HD3' ' CG ' ' A' ' 161' ' ' ASN . 63.1 Cg_endo -72.7 -19.51 24.09 Favored 'Trans proline' 0 C--N 1.35 0.621 0 CA-C-N 121.448 1.553 . . . . 0.86 113.451 -175.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -105.73 -25.27 12.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.743 0.306 . . . . 1.34 111.415 -177.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.655 ' O ' ' HB2' ' A' ' 158' ' ' MET . 52.9 m-85 -141.05 131.3 24.96 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.858 -0.793 . . . . 1.46 108.858 177.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.517 ' OG ' HD11 ' A' ' 61' ' ' LEU . 3.6 p -126.99 148.75 50.09 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.046 0.451 . . . . 2.05 111.468 -177.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.755 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.8 tppp? -91.67 104.43 16.9 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.824 0.821 . . . . 1.4 111.242 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.561 HD11 ' CE1' ' A' ' 153' ' ' PHE . 0.6 OUTLIER -89.4 106.41 18.43 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.481 -1.236 . . . . 1.07 109.762 176.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.631 HG11 HG22 ' A' ' 154' ' ' VAL . 0.1 OUTLIER -131.05 129.12 63.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.644 0.735 . . . . 1.11 111.911 176.394 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.593 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 18.2 ttt -137.8 131.7 31.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.228 -0.896 . . . . 1.79 110.17 -172.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.95 ' HD1' HG23 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -111.2 145.15 39.2 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.088 -0.645 . . . . 4.22 110.002 174.202 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.65 116.5 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-O 121.415 0.626 . . . . 2.01 110.895 176.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 170' ' ' PHE . 0.0 OUTLIER -94.98 77.28 3.56 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 106.673 -1.603 . . . . 2.66 106.673 168.109 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.57 HG22 ' HE2' ' A' ' 188' ' ' MET . 0.6 OUTLIER -74.65 128.31 35.25 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.317 -0.856 . . . . 2.2 110.89 -176.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 1.106 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 38.4 tp10 -83.1 -13.74 55.07 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.261 0.553 . . . . 2.45 110.524 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.643 ' HE2' ' HA3' ' A' ' 45' ' ' GLY . 52.3 mtt 65.4 45.11 2.93 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.317 -0.856 . . . . 4.15 109.148 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.987 ' HD2' ' H ' ' A' ' 147' ' ' TYR . 0.0 OUTLIER -28.81 -54.75 0.12 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 113.462 -1.699 . . . . 6.51 114.095 179.478 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.448 ' H ' ' HG2' ' A' ' 176' ' ' ARG . . . 170.39 170.61 34.91 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.507 -0.854 . . . . 2.26 111.849 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 106' ' ' ILE . 48.8 mmtm 68.76 48.72 0.75 Allowed 'General case' 0 C--N 1.33 -0.255 0 O-C-N 124.133 0.549 . . . . 6.69 110.727 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.639 HD11 HD12 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -173.78 146.15 1.23 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.14 -0.482 . . . . 2.21 110.936 173.637 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.518 ' HB3' ' HD2' ' A' ' 181' ' ' PRO . 31.5 m -112.05 166.28 11.23 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.451 -0.795 . . . . 2.31 109.45 -176.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 180' ' ' SER . 63.1 Cg_exo -39.33 -57.57 1.0 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.354 2.703 . . . . 1.86 114.266 -175.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 186' ' ' LYS . 19.1 m -74.07 -10.4 59.59 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.868 0.366 . . . . 2.45 111.669 -176.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.546 HG23 ' HB2' ' A' ' 105' ' ' SER . 17.6 mm -86.48 -42.08 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 CA-C-O 122.356 1.074 . . . . 1.69 108.418 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.68 ' HA ' HG23 ' A' ' 187' ' ' THR . 1.0 OUTLIER -57.98 -37.7 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 CA-C-N 113.302 -1.772 . . . . 1.77 109.674 172.17 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -61.86 -22.39 65.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.633 -1.167 . . . . 2.89 110.056 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.492 ' HE3' ' HA ' ' A' ' 183' ' ' ILE . 48.1 mttt -91.51 -49.0 6.55 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.179 -0.674 . . . . 1.71 109.179 173.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.68 HG23 ' HA ' ' A' ' 184' ' ' ILE . 11.1 t -62.93 -33.54 75.56 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.378 0.881 . . . . 1.3 113.378 -165.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' MET . . . . . 0.616 ' CE ' HG22 ' A' ' 187' ' ' THR . 0.0 OUTLIER -71.72 -65.9 0.79 Allowed Pre-proline 0 N--CA 1.469 0.504 0 CA-C-N 118.888 0.767 . . . . 1.39 111.674 179.613 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.719 ' O ' HG12 ' A' ' 193' ' ' VAL . 27.5 Cg_endo -62.39 -41.79 31.52 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.486 1.457 . . . . 1.15 111.471 -176.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.707 ' O ' ' HB3' ' A' ' 194' ' ' ASN . 68.3 m -68.43 -22.82 64.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.364 -0.38 . . . . 1.95 111.377 -174.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 187' ' ' THR . 53.9 m-20 -90.21 -37.7 13.96 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.806 -0.358 . . . . 1.92 111.474 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.815 HD13 ' HB3' ' A' ' 48' ' ' TYR . 19.2 mt -60.8 -49.72 76.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.824 0.345 . . . . 1.68 111.039 176.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.719 HG12 ' O ' ' A' ' 189' ' ' PRO . 3.0 m -65.4 -31.6 54.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.63 0.729 . . . . 1.32 110.029 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.714 ' HA ' ' HG ' ' A' ' 197' ' ' LEU . 0.0 OUTLIER -73.19 -43.62 61.08 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.674 -1.148 . . . . 2.6 111.397 -177.747 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -62.36 -26.17 68.31 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.415 -0.957 . . . . 2.73 108.415 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.597 ' O ' ' HB1' ' A' ' 199' ' ' ALA . 20.7 mt -78.37 -44.58 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-N 115.177 -0.919 . . . . 1.11 113.25 175.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.795 HD12 ' N ' ' A' ' 198' ' ' ASN . 3.0 pp -74.1 -31.83 62.97 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 119.336 -0.946 . . . . 1.57 110.332 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.993 ' HB3' ' HZ3' ' A' ' 74' ' ' TRP . 9.9 m120 -61.82 -24.58 66.97 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.118 0.485 . . . . 2.18 110.017 165.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.825 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -80.77 -29.98 36.11 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 108.713 -0.847 . . . . 1.04 108.713 177.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.629 ' HD2' HG12 ' A' ' 54' ' ' ILE . 2.9 mptm? -67.02 -46.17 75.3 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.202 -0.908 . . . . 1.51 108.685 175.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.55 -24.8 25.34 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.832 -1.076 . . . . 1.94 110.797 -170.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . 0.423 ' O ' ' HB3' ' A' ' 205' ' ' ALA . . . -78.2 -28.17 56.53 Favored Glycine 0 N--CA 1.46 0.245 0 C-N-CA 120.492 -0.861 . . . . 0.47 111.477 174.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.825 ' HB ' ' O ' ' A' ' 199' ' ' ALA . 0.9 OUTLIER -76.95 -35.22 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 123.326 0.65 . . . . 1.16 110.214 173.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 40.2 mttm -78.17 -21.66 49.88 Favored 'General case' 0 C--O 1.216 -0.698 0 N-CA-C 108.91 -0.774 . . . . 3.8 108.91 175.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 202' ' ' GLY . . . -64.46 -20.05 65.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.549 -0.751 . . . . 1.28 109.1 170.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -93.34 -51.19 5.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.254 -0.885 . . . . 4.34 111.303 170.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -76.79 -41.31 45.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.416 0.627 . . . . 3.0 111.63 -170.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 32.8 m -97.27 142.95 25.31 Favored Pre-proline 0 C--N 1.313 -0.986 0 CA-C-N 115.065 -0.97 . . . . 2.01 110.231 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.3 39.39 0.47 Allowed 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.677 2.252 . . . . 2.59 113.327 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 11.7 p -90.03 -3.49 57.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.266 0.555 . . . . 2.55 110.601 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 10.6 tpp180 -68.19 -11.98 60.17 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.651 -0.704 . . . . 6.11 110.376 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 212' ' ' ARG . 49.1 mtm180 -67.89 -22.87 65.07 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.117 0.484 . . . . 7.55 110.611 177.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -100.35 63.97 0.6 Allowed Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 110.314 -1.114 . . . . 3.73 110.314 171.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -70.38 98.42 1.41 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.128 0.489 . . . . 6.11 111.252 -172.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -171.22 -55.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.341 -0.845 . . . . 7.27 108.885 174.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 71.46 -62.2 0.46 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.735 0.814 . . . . 6.82 113.155 172.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -77.46 85.0 3.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.328 0.585 . . . . 5.77 109.879 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 12.1 m -55.49 -37.7 68.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.518 -0.765 . . . . 6.85 111.12 -176.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 71.4 t60 48.55 64.85 1.52 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.601 0.715 . . . . 9.48 110.381 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 14.0 m . . . . . 0 C--N 1.316 -0.864 0 CA-C-N 115.624 -0.716 . . . . 8.48 109.617 179.419 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.401 ' HE2' ' HB2' ' A' ' 88' ' ' ASP . 18.9 ttt . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 109.293 -0.632 . . . . 4.31 109.293 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -65.06 -50.67 65.29 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 116.108 -0.497 . . . . 2.25 110.94 -169.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.528 ' O ' ' HB1' ' A' ' 7' ' ' ALA . 65.2 m-85 -59.38 -35.0 73.1 Favored 'General case' 0 CA--C 1.502 -0.882 0 O-C-N 123.945 0.778 . . . . 0.45 110.497 -169.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.777 ' O ' ' HB3' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -74.82 -41.25 60.27 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-N 115.273 -0.876 . . . . 2.06 108.736 -177.4 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.98 -45.99 78.8 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.829 -0.623 . . . . 1.2 112.31 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.641 ' O ' ' HB ' ' A' ' 10' ' ' THR . 0.2 OUTLIER -79.44 -36.37 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 N-CA-C 108.906 -0.776 . . . . 1.76 108.906 -172.453 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.578 ' HB3' ' HB2' ' A' ' 116' ' ' TYR . . . -71.79 -47.74 51.33 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.517 -1.22 . . . . 1.11 111.474 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.777 ' HB3' ' O ' ' A' ' 4' ' ' LYS . 3.7 pt20 -53.3 -34.3 56.79 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.344 -1.298 . . . . 2.14 109.847 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.63 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 48.5 mt-30 -91.02 -31.63 16.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.879 -1.055 . . . . 3.04 109.985 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.641 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -66.42 -35.0 79.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.633 -0.712 . . . . 1.1 110.746 178.271 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.553 ' HA ' ' CB ' ' A' ' 128' ' ' SER . . . -47.44 -58.51 4.1 Favored 'General case' 0 C--O 1.226 -0.154 0 N-CA-C 112.02 0.378 . . . . 1.04 112.02 175.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.405 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 20.8 pt20 -74.96 -6.72 50.81 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.493 -0.322 . . . . 2.31 111.344 -178.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.63 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 16.6 mm-40 -81.43 -48.35 12.01 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 121.163 0.506 . . . . 2.54 109.707 175.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.71 HG22 ' N ' ' A' ' 152' ' ' GLY . 10.9 p -70.74 -37.77 70.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.798 0.809 . . . . 1.21 109.735 176.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.405 ' HB3' ' HA ' ' A' ' 12' ' ' GLN . 0.8 OUTLIER -67.24 -25.62 66.18 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 122.236 1.017 . . . . 1.26 108.338 173.068 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.491 ' HA2' ' CD ' ' A' ' 19' ' ' ARG . . . -67.86 -15.01 66.34 Favored Glycine 0 CA--C 1.5 -0.869 0 CA-C-N 113.679 -1.6 . . . . 0.57 110.539 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.8 m-30 -92.42 -19.48 22.01 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.019 -0.591 . . . . 3.59 109.489 177.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -89.88 -27.55 19.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.152 -0.476 . . . . 2.1 110.531 178.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.491 ' CD ' ' HA2' ' A' ' 16' ' ' GLY . 5.7 ptm180 -90.8 -20.25 22.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.254 0.55 . . . . 3.26 110.178 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -121.44 117.33 26.62 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.927 -0.768 . . . . 2.16 108.927 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.6 p -126.47 103.76 7.78 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.388 0.614 . . . . 2.24 111.407 -174.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.0 p -170.47 155.49 5.09 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.053 -0.976 . . . . 2.46 109.993 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.37 4.1 86.34 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.85 -0.69 . . . . 1.45 113.057 174.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.462 ' HA ' ' HB3' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -120.3 -158.07 0.73 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.815 0.341 . . . . 2.24 110.933 -178.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -172.3 125.36 0.52 Allowed 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 115.883 -0.599 . . . . 3.43 109.821 -173.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.64 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 2.5 p -69.28 112.06 3.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-O 122.29 1.043 . . . . 2.21 109.836 175.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.5 p -91.01 -23.5 5.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 113.812 -1.54 . . . . 1.83 109.138 -176.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.452 ' HB2' ' HZ1' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -156.64 124.15 5.41 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 120.223 -0.591 . . . . 2.87 111.768 -173.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.518 ' HB ' ' HA ' ' A' ' 34' ' ' THR . 0.4 OUTLIER -150.51 150.99 32.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.074 0.464 . . . . 1.92 111.062 -179.597 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.7 t -120.21 -141.09 0.34 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.503 -0.771 . . . . 2.37 109.322 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -101.55 17.7 22.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.984 0.421 . . . . 4.84 110.787 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.679 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 48.3 mmtt -154.46 -29.23 0.12 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.904 -0.589 . . . . 2.05 111.671 177.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.564 ' HA ' ' O ' ' A' ' 51' ' ' GLU . 17.8 pt -116.01 163.12 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 CA-C-O 120.767 0.317 . . . . 1.42 111.493 -172.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.518 ' HA ' ' HB ' ' A' ' 29' ' ' THR . 8.8 m -156.42 114.09 3.24 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.108 -0.951 . . . . 1.22 110.515 -172.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 49' ' ' ARG . 42.5 t -105.4 110.85 32.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.518 -0.31 . . . . 1.52 110.554 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.64 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 4.1 m -109.6 123.5 49.55 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.636 0.732 . . . . 1.74 111.092 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 28.2 p -108.2 131.11 55.0 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.32 -1.309 . . . . 1.72 112.781 -171.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.462 ' HB3' ' HA ' ' A' ' 24' ' ' TRP . 44.3 pttt -138.17 134.75 34.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.128 -0.942 . . . . 2.45 110.176 171.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 46' ' ' ASN . . . -58.99 128.13 35.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.987 -0.551 . . . . 2.17 112.081 -174.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.424 ' HG ' ' HB2' ' A' ' 47' ' ' LEU . 20.4 m -84.02 155.56 22.68 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.007 -0.542 . . . . 2.51 109.877 176.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -89.64 13.31 14.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.304 -0.407 . . . . 7.41 111.483 -174.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 5.1 mtpm? -54.56 -39.74 68.05 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.363 -0.38 . . . . 6.84 110.224 175.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.498 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 83.0 t80 157.92 -73.11 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 O-C-N 124.397 1.061 . . . . 6.42 109.468 -173.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 33.8 t60 -145.25 84.43 1.7 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.374 -0.83 . . . . 6.31 109.122 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.2 148.17 12.34 Favored Glycine 0 N--CA 1.435 -1.395 0 N-CA-C 109.148 -1.581 . . . . 1.74 109.148 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 40.7 m-80 -114.31 144.31 43.45 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 117.362 0.581 . . . . 2.45 110.611 -175.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.611 HD13 ' NE2' ' A' ' 172' ' ' GLN . 4.0 tt -90.19 134.26 34.39 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.325 -0.991 . . . . 1.49 108.325 175.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.552 ' N ' HD21 ' A' ' 47' ' ' LEU . 69.1 m-85 -121.58 120.38 34.64 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.836 -0.431 . . . . 1.52 109.836 -177.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.3 OUTLIER -101.51 117.66 35.38 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.162 -0.681 . . . . 3.34 109.162 174.538 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.505 ' HB ' ' HB3' ' A' ' 192' ' ' LEU . 14.7 p -107.17 131.89 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 108.798 -0.816 . . . . 1.98 108.798 177.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 34.0 tt0 -136.06 117.92 15.18 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.644 -0.707 . . . . 1.07 110.783 -169.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.679 ' HA2' ' O ' ' A' ' 32' ' ' LYS . . . -142.24 144.38 14.07 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.872 -0.68 . . . . 0.35 111.675 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 92.4 mt -84.85 122.87 38.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 119.635 -0.826 . . . . 1.3 110.479 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.44 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 42.0 mt -105.11 110.69 64.79 Favored Pre-proline 0 N--CA 1.443 -0.816 0 N-CA-C 108.69 -0.856 . . . . 1.07 108.69 174.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 39.5 Cg_exo -63.11 54.89 0.15 Allowed 'Trans proline' 0 N--CA 1.476 0.491 0 C-N-CA 124.442 3.428 . . . . 0.74 113.915 -177.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.578 ' OE1' ' HD2' ' A' ' 207' ' ' ARG . 10.9 tp10 -151.16 168.38 24.85 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.657 -1.238 . . . . 1.68 107.657 174.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.423 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 73.3 p -69.74 144.48 93.68 Favored Pre-proline 0 N--CA 1.43 -1.433 0 CA-C-O 121.88 0.848 . . . . 1.58 111.117 -176.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.494 ' HA ' HD13 ' A' ' 61' ' ' LEU . 23.9 Cg_exo -61.31 -15.79 42.7 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.432 2.755 . . . . 0.74 110.125 175.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.4 -47.84 58.97 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.559 -1.201 . . . . 1.31 110.862 173.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.416 ' HG2' HG13 ' A' ' 203' ' ' ILE . 2.1 tpmt? -67.19 -30.08 69.93 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.049 -1.093 . . . . 3.78 108.049 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.646 HD23 ' CD1' ' A' ' 203' ' ' ILE . 55.8 mt -62.36 -54.92 33.4 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.867 -1.061 . . . . 1.09 110.205 174.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.6 p -62.96 -9.18 8.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.071 0.462 . . . . 1.94 110.717 176.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -91.35 -33.36 15.32 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.566 0.58 . . . . 1.32 112.566 174.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.685 ' CE2' ' HA ' ' A' ' 199' ' ' ALA . 2.9 p90 -78.31 -45.05 23.65 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 120.399 -0.52 . . . . 0.79 110.69 -169.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -83.51 -7.3 59.56 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 121.056 -0.258 . . . . 2.15 111.041 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -9.95 -72.69 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 O-C-N 125.571 1.794 . . . . 2.06 114.679 -159.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -158.52 -62.4 0.08 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.713 1.005 . . . . 4.31 113.713 -172.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.672 ' OG1' ' HB2' ' A' ' 81' ' ' TYR . 11.6 t -178.35 27.96 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.352 0.596 . . . . 1.89 109.543 -162.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -127.95 -16.91 2.12 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 119.249 -1.453 . . . . 1.71 113.138 -171.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.524 ' O ' HG21 ' A' ' 73' ' ' THR . 1.7 p30 -159.34 -21.6 0.07 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 111.896 0.332 . . . . 2.19 111.896 -177.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.7 ' HA ' ' NE1' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -67.47 -16.44 64.21 Favored 'General case' 0 C--O 1.217 -0.62 0 O-C-N 122.069 -0.394 . . . . 3.95 110.982 -174.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.445 HG23 HD13 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -90.48 -20.25 6.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.234 0.54 . . . . 1.42 109.937 173.521 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.524 HG21 ' O ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -82.2 -24.47 34.91 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.603 -0.726 . . . . 1.45 110.363 -170.667 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.7 ' NE1' ' HA ' ' A' ' 71' ' ' ARG . 24.9 p-90 -108.47 -4.35 17.37 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.276 -0.569 . . . . 0.78 111.205 177.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.651 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 2.9 t70 -74.92 177.68 6.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.815 0.817 . . . . 2.19 112.659 -168.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.07 -22.81 5.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.473 -1.24 . . . . 3.68 111.007 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.1 t -121.69 9.36 10.14 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.47 -0.567 . . . . 2.08 109.47 -176.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 36.4 mt -109.1 169.5 8.64 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.649 -0.705 . . . . 1.16 110.476 177.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.557 ' HG2' ' HG2' ' A' ' 99' ' ' GLN . 10.5 mm100 -147.41 -58.78 0.26 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.75 -0.659 . . . . 2.23 111.674 -173.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 96' ' ' THR . 25.6 t -138.15 117.9 15.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 1.44 111.254 -166.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.672 ' HB2' ' OG1' ' A' ' 68' ' ' THR . 45.3 p90 -89.99 151.32 21.74 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 116.194 -0.457 . . . . 5.73 110.852 174.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.422 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 4.2 m120 -158.95 108.94 1.98 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.603 -0.726 . . . . 1.86 109.52 173.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.785 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 13.5 ttm -71.1 103.99 2.9 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.604 -0.887 . . . . 2.52 108.604 177.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.665 HG22 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -84.78 -71.96 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 120.47 -0.492 . . . . 1.19 112.029 -170.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -136.37 107.61 6.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.205 -0.452 . . . . 2.59 109.833 -175.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.785 ' HD3' ' SD ' ' A' ' 83' ' ' MET . 28.3 mtm180 -93.72 112.41 24.28 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.588 -0.523 . . . . 2.83 109.588 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.623 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -75.69 -37.08 35.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.917 -0.583 . . . . 1.17 109.614 -178.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.401 ' HB2' ' HE2' ' A' ' 1' ' ' MET . 4.4 t0 -157.69 -179.32 8.05 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.236 -0.893 . . . . 1.86 108.856 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.8 m -78.28 4.41 12.89 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.638 0.256 . . . . 1.94 110.907 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -138.35 6.17 2.54 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.355 -0.609 . . . . 1.87 109.355 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.623 ' O ' HG12 ' A' ' 87' ' ' ILE . 1.1 m -141.99 109.54 5.68 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.532 -0.914 . . . . 1.12 108.532 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.539 ' O ' HD13 ' A' ' 114' ' ' LEU . 33.9 m-85 -128.95 174.98 9.03 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.475 0.655 . . . . 0.52 110.764 -173.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.665 ' O ' HG22 ' A' ' 84' ' ' VAL . 36.2 mt -133.38 123.25 46.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 106.616 -1.624 . . . . 1.1 106.616 166.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 78.6 m -110.47 124.45 51.8 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.732 -0.387 . . . . 2.61 110.665 -173.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.524 ' HA ' ' O ' ' A' ' 111' ' ' PHE . 11.5 t-160 -89.39 118.75 29.28 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 108.507 -0.923 . . . . 2.17 108.507 168.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 89.8 m -136.98 123.45 20.83 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.727 -0.67 . . . . 1.19 111.228 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 46.5 mm -78.43 132.61 32.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 O-C-N 121.501 -0.749 . . . . 1.63 109.593 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.484 ' HB ' ' HB2' ' A' ' 109' ' ' ARG . 2.3 m -110.36 146.34 35.95 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.783 -0.644 . . . . 1.72 110.745 -174.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.557 ' HG2' ' HG2' ' A' ' 79' ' ' GLN . 7.5 mm-40 -88.6 178.63 6.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.908 -0.587 . . . . 2.29 110.443 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.8 m -118.29 95.6 4.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.734 0.302 . . . . 4.07 111.077 -175.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.41 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 38.1 t80 -92.01 96.12 10.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.767 0.318 . . . . 6.11 110.594 -177.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.597 ' O ' HG22 ' A' ' 103' ' ' VAL . . . 170.84 48.28 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.036 -0.984 . . . . 1.98 109.943 176.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 102' ' ' ALA . 2.1 m 64.02 -20.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 125.187 1.395 . . . . 3.6 113.701 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 102' ' ' ALA . . . 136.48 0.91 2.88 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.146 -1.026 . . . . 2.2 113.551 176.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.7 p -65.57 -28.9 69.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.271 0.557 . . . . 2.08 111.132 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.447 ' HA ' HD12 ' A' ' 179' ' ' LEU . 65.4 mt -94.02 145.71 7.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.421 -0.809 . . . . 1.53 110.72 -175.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.3 m -84.04 153.24 63.2 Favored Pre-proline 0 N--CA 1.449 -0.496 0 CA-C-N 116.111 -0.495 . . . . 1.71 110.06 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -60.48 137.1 71.89 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.147 1.898 . . . . 1.31 110.01 174.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.484 ' HB2' ' HB ' ' A' ' 98' ' ' THR . 54.5 mtt180 -111.92 159.69 18.14 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.604 -0.839 . . . . 4.06 111.213 -172.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.681 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 12.9 t70 -107.35 143.14 36.07 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.72 -1.215 . . . . 1.37 107.72 176.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.566 ' HB3' ' HB ' ' A' ' 96' ' ' THR . 50.6 t80 -122.36 115.07 21.66 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.59 -0.522 . . . . 3.01 109.59 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.601 HG22 ' CE1' ' A' ' 134' ' ' PHE . 12.8 mm -132.7 85.85 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.016 -0.993 . . . . 1.2 108.517 175.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.545 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 1.0 OUTLIER -116.14 131.52 56.92 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.807 -0.633 . . . . 1.86 110.944 -177.453 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.595 ' O ' ' HA ' ' A' ' 129' ' ' SER . 6.6 tp -80.77 121.87 26.46 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.241 -0.89 . . . . 1.08 109.068 172.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.76 125.71 71.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-N 115.398 -0.819 . . . . 1.08 111.747 -165.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.578 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 11.6 t80 -107.5 118.73 37.49 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.059 -0.973 . . . . 2.81 110.634 177.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.402 HG13 HG23 ' A' ' 127' ' ' ILE . 4.7 mp -94.44 100.71 11.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.03 -0.532 . . . . 1.53 109.839 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -114.02 142.69 45.86 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.717 -0.475 . . . . 1.81 109.717 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.449 ' NH1' ' HA ' ' A' ' 121' ' ' GLU . 3.2 tmt_? -127.22 95.36 4.26 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 108.503 -0.925 . . . . 3.22 108.503 -177.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -64.67 118.49 8.97 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 107.901 -1.148 . . . . 1.28 107.901 174.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.449 ' HA ' ' NH1' ' A' ' 119' ' ' ARG . 8.0 mm-40 -38.24 90.47 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.923 1.389 . . . . 2.28 113.148 -175.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 62.97 36.06 92.93 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.178 -0.919 . . . . 0.79 112.419 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.522 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 2.2 t-20 -132.85 -45.41 0.87 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.526 -0.175 . . . . 2.06 110.526 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -157.81 131.03 7.62 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 120.733 0.302 . . . . 1.73 111.812 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -106.36 79.39 1.37 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.169 -1.048 . . . . 2.07 108.169 170.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.495 ' CG1' HG13 ' A' ' 154' ' ' VAL . 0.4 OUTLIER -99.82 140.9 17.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.586 -0.734 . . . . 1.06 112.801 -171.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.723 ' O ' HG13 ' A' ' 127' ' ' ILE . 4.3 pt -110.16 110.62 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-O 121.904 0.859 . . . . 1.26 108.766 162.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.553 ' CB ' ' HA ' ' A' ' 11' ' ' ALA . 53.2 p -93.92 113.5 25.52 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 121.853 -0.529 . . . . 1.53 110.208 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.595 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 7.0 m -110.91 150.58 29.01 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.411 -0.813 . . . . 1.81 111.203 -170.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.561 ' HB3' ' HZ3' ' A' ' 130' ' ' LYS . 3.5 mtpm? -136.62 117.58 14.24 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 107.606 -1.257 . . . . 2.75 107.606 175.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.408 ' HB2' ' H ' ' A' ' 148' ' ' ASN . 33.3 t -63.51 98.37 0.17 Allowed 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.075 -1.454 . . . . 1.94 107.075 175.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.436 HG12 ' HB3' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -108.16 141.58 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.035 0 CA-C-N 114.57 -1.196 . . . . 1.64 108.988 -163.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -100.47 71.02 1.51 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 122.291 1.043 . . . . 2.17 108.682 -170.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.76 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -98.2 159.52 30.5 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-N 113.668 -1.606 . . . . 0.67 110.629 -171.589 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.96 -12.96 16.02 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.941 2.427 . . . . 1.66 114.785 -171.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.76 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 5.6 tp10 -72.41 -16.93 61.84 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 109.388 -0.597 . . . . 3.5 109.388 -172.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -163.52 118.43 1.12 Allowed Pre-proline 0 N--CA 1.448 -0.558 0 N-CA-C 113.066 0.765 . . . . 6.41 113.066 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -92.73 145.63 2.55 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.306 2.671 . . . . 2.31 110.834 166.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -72.29 -155.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.538 2.159 . . . . 1.27 112.336 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.2 m -147.15 155.92 42.55 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.823 -0.806 . . . . 1.88 108.823 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.9 p -73.11 -0.25 13.55 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.197 0.443 . . . . 2.43 112.197 -173.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -105.16 -16.12 14.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.056 0.455 . . . . 2.18 110.006 175.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -132.36 108.91 9.49 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.515 -0.766 . . . . 1.33 109.904 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.511 HG12 ' HB3' ' A' ' 176' ' ' ARG . 2.7 tp -90.75 112.88 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 C-N-CA 120.366 -0.533 . . . . 1.4 110.523 -176.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.681 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 64.9 ttp85 -49.41 102.22 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.408 -0.815 . . . . 5.14 109.741 171.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -60.08 117.43 11.34 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 110.617 -0.993 . . . . 1.05 110.617 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.45 ' HB3' ' CB ' ' A' ' 174' ' ' GLU . 65.0 t80 -83.45 85.59 7.22 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.791 0.805 . . . . 4.68 111.17 -174.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.639 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 78.7 m-20 -77.83 98.81 5.7 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.426 -1.261 . . . . 2.29 109.539 171.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.434 ' O ' ' HB3' ' A' ' 172' ' ' GLN . 24.6 t-80 -71.71 129.83 87.9 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 108.062 -1.088 . . . . 2.95 108.062 176.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.493 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 46.1 Cg_exo -13.54 66.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.122 1 C-N-CA 126.973 5.115 . . . . 0.77 115.905 -163.396 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . 0.639 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 24.2 p -112.31 156.4 22.5 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.845 -1.07 . . . . 1.97 108.553 174.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.71 ' N ' HG22 ' A' ' 14' ' ' VAL . . . -145.23 -147.35 4.61 Favored Glycine 0 N--CA 1.433 -1.528 0 C-N-CA 119.256 -1.449 . . . . 0.55 113.624 -169.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.553 ' CZ ' HD23 ' A' ' 167' ' ' LEU . 55.1 t80 -162.06 92.06 0.82 Allowed 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.472 -0.936 . . . . 0.8 108.472 -164.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.555 ' CG2' HG12 ' A' ' 168' ' ' VAL . 2.4 m -102.06 132.3 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-O 121.696 0.76 . . . . 1.03 110.776 -175.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 37.0 m -112.52 107.68 16.51 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.371 -0.831 . . . . 2.3 109.272 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.452 ' O ' ' HB3' ' A' ' 166' ' ' LYS . 9.8 m -104.75 114.13 64.22 Favored Pre-proline 0 C--N 1.315 -0.916 0 C-N-CA 120.771 -0.371 . . . . 1.45 111.267 -169.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.522 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 53.1 Cg_exo -49.8 120.88 6.49 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.511 2.14 . . . . 0.72 111.397 174.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.57 ' SD ' ' HB2' ' A' ' 166' ' ' LYS . 87.3 mmm -76.17 -165.62 0.51 Allowed 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.03 0.443 . . . . 1.72 111.429 -176.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.433 ' H ' ' HB3' ' A' ' 158' ' ' MET . 13.1 mm-40 -66.09 -22.7 66.42 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.687 -0.688 . . . . 2.63 109.708 177.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -109.16 19.58 19.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.414 -0.812 . . . . 2.05 110.047 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.512 ' HB2' ' CD ' ' A' ' 162' ' ' PRO . 13.0 m120 27.2 -91.05 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.872 1.669 . . . . 2.19 115.483 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.512 ' CD ' ' HB2' ' A' ' 161' ' ' ASN . 93.2 Cg_endo -74.76 -13.41 21.99 Favored 'Trans proline' 0 C--N 1.366 1.496 0 CA-C-N 121.709 1.646 . . . . 0.86 112.866 -173.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -89.99 -34.68 15.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.042 -0.526 . . . . 1.34 110.672 -177.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.451 ' O ' ' HB2' ' A' ' 158' ' ' MET . 78.2 m-85 -139.88 132.0 28.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.393 -0.367 . . . . 1.46 110.24 176.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 34.9 t -123.59 145.01 49.23 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.595 0.712 . . . . 2.05 111.171 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.57 ' HB2' ' SD ' ' A' ' 158' ' ' MET . 15.3 tppt? -93.87 100.94 13.02 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.268 -0.878 . . . . 1.4 111.161 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.553 HD23 ' CZ ' ' A' ' 153' ' ' PHE . 0.9 OUTLIER -85.54 108.4 17.92 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.054 -0.975 . . . . 1.07 109.335 178.614 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.555 HG12 ' CG2' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -129.31 114.55 32.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-O 122.115 0.96 . . . . 1.11 111.319 177.349 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 18.7 ttt -115.63 141.51 47.97 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.539 -1.21 . . . . 1.79 110.693 -172.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.548 ' O ' ' HB2' ' A' ' 151' ' ' CYS . 73.7 m-85 -115.69 127.47 55.18 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.545 -0.752 . . . . 4.22 110.972 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.454 HG12 ' OG1' ' A' ' 173' ' ' THR . 1.0 OUTLIER -112.48 113.64 44.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.598 -0.728 . . . . 2.01 110.042 174.19 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.611 ' NE2' HD13 ' A' ' 47' ' ' LEU . 33.9 tt0 -116.18 41.3 2.64 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 106.001 -1.852 . . . . 2.66 106.001 171.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.464 HG22 ' H ' ' A' ' 175' ' ' MET . 18.9 m -69.65 149.82 47.69 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 112.53 -2.123 . . . . 2.2 110.46 -174.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.45 ' CB ' ' HB3' ' A' ' 147' ' ' TYR . 8.1 tt0 -82.58 -11.5 58.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.482 0.658 . . . . 2.45 111.435 -175.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.493 ' HG2' ' SD ' ' A' ' 188' ' ' MET . 42.4 mtm 68.69 35.2 3.16 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.897 -1.047 . . . . 4.15 110.594 170.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.511 ' HB3' HG12 ' A' ' 144' ' ' ILE . 24.8 mmm-85 -70.43 170.39 12.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.616 -0.72 . . . . 6.51 111.7 -176.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 124.28 -7.84 8.53 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.659 -0.976 . . . . 2.26 110.659 -174.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? 60.79 49.64 6.0 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.459 0.703 . . . . 6.69 110.827 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.539 ' HB2' ' CD1' ' A' ' 184' ' ' ILE . 0.3 OUTLIER -87.26 -169.88 2.81 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 121.306 0.574 . . . . 2.21 109.668 178.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.505 ' O ' HD12 ' A' ' 184' ' ' ILE . 14.7 m -112.17 154.91 44.19 Favored Pre-proline 0 C--N 1.314 -0.936 0 N-CA-C 108.393 -0.966 . . . . 2.31 108.393 176.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -42.57 -44.59 8.44 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 122.742 2.295 . . . . 1.86 113.396 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.636 ' O ' ' HE2' ' A' ' 186' ' ' LYS . 22.3 t -71.33 -12.64 61.54 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.348 -0.387 . . . . 2.45 111.969 -177.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.451 ' HB ' ' HB3' ' A' ' 179' ' ' LEU . 27.9 mm -90.93 -41.46 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-O 122.585 1.183 . . . . 1.69 108.985 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.59 ' HA ' ' CG2' ' A' ' 187' ' ' THR . 1.1 mp -64.88 -37.8 81.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 112.887 -1.96 . . . . 1.77 111.473 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -64.16 -17.92 63.95 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.314 -0.624 . . . . 2.89 109.314 175.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.636 ' HE2' ' O ' ' A' ' 182' ' ' SER . 49.5 mtmt -92.85 -43.59 8.91 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.75 -0.659 . . . . 1.71 110.299 173.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.59 ' CG2' ' HA ' ' A' ' 184' ' ' ILE . 15.1 t -61.1 -33.42 73.33 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.734 0.642 . . . . 1.3 112.734 -169.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' MET . . . . . 0.608 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 15.6 mmt -78.43 -59.39 0.71 Allowed Pre-proline 0 C--N 1.332 -0.173 0 C-N-CA 119.646 -0.821 . . . . 1.39 110.835 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.608 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 33.9 Cg_exo -62.93 -22.07 73.58 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 121.917 1.745 . . . . 1.15 112.216 -176.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.778 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 67.2 m -81.08 -22.96 38.81 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.796 -0.362 . . . . 1.95 110.489 175.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.2 OUTLIER -91.43 -37.59 13.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.814 0.34 . . . . 1.92 111.074 -176.635 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.505 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 2.2 mt -62.13 -56.92 13.98 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.558 0.694 . . . . 1.68 111.161 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 189' ' ' PRO . 1.6 m -66.93 -32.13 56.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.707 -1.133 . . . . 1.32 109.033 -175.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.778 ' HB2' ' O ' ' A' ' 190' ' ' SER . 26.4 t30 -63.1 -48.27 79.3 Favored 'General case' 0 C--O 1.208 -1.099 0 CA-C-N 113.911 -1.495 . . . . 2.6 109.727 177.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.517 ' O ' ' HB2' ' A' ' 198' ' ' ASN . 2.8 t80 -62.04 -25.33 67.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.956 0.407 . . . . 2.73 110.283 -178.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.43 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 14.6 mt -80.22 -29.57 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-O 120.993 0.425 . . . . 1.11 110.988 174.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 83.3 mt -74.93 -36.71 62.13 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.302 0.572 . . . . 1.57 109.481 174.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.517 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 4.9 m-20 -48.56 -39.17 22.69 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.756 -1.111 . . . . 2.18 108.995 163.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.685 ' HA ' ' CE2' ' A' ' 64' ' ' PHE . . . -80.5 -44.52 19.02 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 116.027 -0.533 . . . . 1.04 111.247 -176.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 28.7 mmtp -54.41 -46.23 73.1 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.734 0.778 . . . . 1.51 110.187 173.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -80.04 -45.44 18.33 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.614 -1.175 . . . . 1.94 110.416 -175.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -64.42 -31.55 81.23 Favored Glycine 0 C--O 1.228 -0.246 0 C-N-CA 121.004 -0.617 . . . . 0.47 112.555 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.67 ' HB ' ' O ' ' A' ' 199' ' ' ALA . 1.8 tp -69.89 -37.23 72.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.836 0.351 . . . . 1.16 110.202 178.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.48 ' O ' ' HB ' ' A' ' 208' ' ' THR . 94.2 mttt -85.13 -20.81 29.74 Favored 'General case' 0 C--O 1.21 -1.024 0 N-CA-C 109.071 -0.714 . . . . 3.8 109.071 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -69.06 -34.23 74.82 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.007 -0.542 . . . . 1.28 109.682 168.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.496 ' HE1' ' CD1' ' A' ' 74' ' ' TRP . 19.4 m80 -87.54 -5.84 58.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.952 -0.567 . . . . 4.34 112.348 178.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.578 ' HD2' ' OE1' ' A' ' 56' ' ' GLU . 22.6 ttt180 -114.75 -52.57 2.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 122.198 0.999 . . . . 3.0 110.638 178.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 204' ' ' LYS . 39.8 m -100.36 154.38 37.23 Favored Pre-proline 0 C--N 1.309 -1.176 0 CA-C-N 113.922 -1.49 . . . . 2.01 108.974 -177.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . 0.403 ' HD2' HG22 ' A' ' 208' ' ' THR . 38.8 Cg_endo -68.0 53.64 0.63 Allowed 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 121.96 1.774 . . . . 2.59 111.84 172.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 74.1 m -92.43 26.36 2.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.103 -0.499 . . . . 2.55 111.031 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.99 42.55 0.94 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.267 -0.642 . . . . 6.11 109.267 173.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -66.01 -50.12 65.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.624 -0.716 . . . . 7.55 109.152 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.06 51.81 3.8 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.717 -0.754 . . . . 3.73 111.245 175.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -67.0 133.29 49.64 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.133 0.492 . . . . 6.11 111.149 -175.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -109.32 63.05 0.6 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.756 -0.656 . . . . 7.27 109.519 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -78.41 122.92 26.43 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.042 -0.725 . . . . 6.82 109.042 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.64 HD22 ' HH ' ' A' ' 81' ' ' TYR . 19.8 p-10 -79.27 79.68 5.68 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.614 0.721 . . . . 5.77 111.711 -174.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 32.3 t -76.63 -32.34 57.96 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.127 -1.064 . . . . 6.85 108.127 170.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -136.81 -66.29 0.53 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.524 -1.216 . . . . 9.48 108.345 171.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 69.7 m . . . . . 0 C--O 1.251 1.141 0 CA-C-N 115.501 -0.772 . . . . 8.48 109.689 176.115 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 120.864 0.364 . . . . 4.31 110.752 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.575 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.3 t70 -114.24 -41.01 3.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.492 0.663 . . . . 2.25 109.639 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.724 ' HA ' HD12 ' A' ' 6' ' ' ILE . 98.8 m-85 -70.46 -29.87 66.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.289 -0.868 . . . . 0.45 109.367 -175.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.54 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 27.1 tttm -74.42 -3.88 33.25 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.822 -1.081 . . . . 2.06 109.766 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.95 -44.89 8.63 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.016 -0.538 . . . . 1.2 109.95 172.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.724 HD12 ' HA ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -82.98 -41.34 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-O 121.425 0.631 . . . . 1.76 110.727 -173.024 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.558 ' HB3' ' HB2' ' A' ' 116' ' ' TYR . . . -74.39 -39.59 62.59 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.988 -1.006 . . . . 1.11 111.34 -176.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 2.4 mt-30 -68.15 -27.01 66.06 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.82 -1.082 . . . . 2.14 110.232 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -81.79 -33.12 31.02 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.765 -1.107 . . . . 3.04 109.111 172.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.629 ' HA ' ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -71.49 -39.06 71.11 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.23 -0.895 . . . . 1.1 111.723 179.704 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.605 ' HA ' ' CB ' ' A' ' 128' ' ' SER . . . -48.15 -60.13 2.87 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-O 121.109 0.48 . . . . 1.04 111.87 176.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -76.55 0.11 21.22 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.174 -0.466 . . . . 2.31 111.579 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.629 ' HB3' ' HA ' ' A' ' 10' ' ' THR . 1.1 tt0 -90.73 -45.29 8.93 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.055 -0.72 . . . . 2.54 109.055 174.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.811 HG23 ' CE2' ' A' ' 170' ' ' PHE . 4.1 p -70.44 -47.39 65.97 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.041 0 N-CA-C 109.001 -0.74 . . . . 1.21 109.001 171.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.627 ' HG ' ' OD1' ' A' ' 18' ' ' ASN . 1.0 OUTLIER -61.77 -24.96 67.17 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.362 1.077 . . . . 1.26 108.338 175.038 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 20' ' ' ASP . . . -63.19 -21.22 63.79 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 113.774 -1.557 . . . . 0.57 110.406 178.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.931 ' CE1' ' HG3' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -87.25 -33.44 19.28 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.097 -0.705 . . . . 3.59 109.097 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.627 ' OD1' ' HG ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -80.38 -16.98 53.23 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.424 0.63 . . . . 2.1 110.073 -167.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.433 ' HD2' ' CD2' ' A' ' 15' ' ' LEU . 24.9 mtp180 -101.52 -20.35 15.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.142 -0.936 . . . . 3.26 110.133 175.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 16' ' ' GLY . 35.2 t70 -118.51 84.3 2.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.787 -0.642 . . . . 2.16 109.821 -178.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.9 p -108.0 127.02 53.4 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 120.916 0.389 . . . . 2.24 111.751 -172.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.4 t 173.23 162.23 0.14 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.366 -0.834 . . . . 2.46 109.522 -173.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.44 1.73 90.21 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 121.183 -0.532 . . . . 1.45 113.111 174.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -112.75 -157.39 0.62 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.837 0.351 . . . . 2.24 110.876 -177.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 tpmt? -173.24 118.1 0.3 Allowed 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 108.851 -0.796 . . . . 3.43 108.851 -172.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.657 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 2.8 m -63.19 116.87 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.989 0 CA-C-O 122.116 0.96 . . . . 2.21 110.789 176.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.426 HG11 ' HB2' ' A' ' 28' ' ' LYS . 10.9 p -98.38 -24.74 4.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 113.979 -1.464 . . . . 1.83 109.719 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.426 ' HB2' HG11 ' A' ' 27' ' ' VAL . 1.2 tmtt? -154.37 120.39 5.29 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 119.471 -0.892 . . . . 2.87 110.537 -170.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.543 ' HB ' ' HA ' ' A' ' 34' ' ' THR . 0.2 OUTLIER -149.71 135.05 18.25 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.477 0.656 . . . . 1.92 110.506 175.096 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.4 m -88.39 -68.35 0.77 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.841 -1.072 . . . . 2.37 111.299 -173.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -166.64 18.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 121.018 -0.273 . . . . 4.84 110.856 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.493 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 16.5 tttp 178.51 -28.95 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.351 0.595 . . . . 2.05 110.312 -174.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.699 HG23 ' HA3' ' A' ' 52' ' ' GLY . 30.0 pt -98.95 152.79 4.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.96 -1.018 . . . . 1.42 109.254 174.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 3.4 m -146.47 110.87 5.12 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 123.452 0.47 . . . . 1.22 111.04 -167.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.685 ' HA ' ' O ' ' A' ' 49' ' ' ARG . 13.0 t -103.45 112.73 38.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.995 -0.372 . . . . 1.52 109.995 -177.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.657 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 84.0 p -106.83 133.93 50.75 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.193 0.597 . . . . 1.74 110.685 -177.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 49.2 m -102.45 126.67 49.56 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.297 -0.41 . . . . 1.72 110.416 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -119.71 -84.3 0.66 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.856 -0.611 . . . . 2.45 110.424 -177.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 47' ' ' LEU . . . -176.04 128.01 0.22 Allowed 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.016 0.198 . . . . 2.17 110.483 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.508 ' HA ' ' HG3' ' A' ' 172' ' ' GLN . 32.1 t -89.68 -137.5 0.12 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.772 -1.196 . . . . 2.51 107.772 173.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.494 ' NE ' ' HA ' ' A' ' 41' ' ' ARG . 3.9 tpm_? -64.35 -9.13 15.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.986 0.422 . . . . 7.41 110.172 172.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.493 ' HA ' ' HD3' ' A' ' 42' ' ' LYS . 4.0 mmtp 60.7 19.26 9.31 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.486 -0.779 . . . . 6.84 112.165 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -101.18 -42.17 6.45 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.738 -0.838 . . . . 6.42 108.738 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -161.0 72.2 0.43 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.52 -1.218 . . . . 6.31 107.983 167.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 40' ' ' SER . . . 162.92 136.11 1.93 Allowed Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 120.318 -0.944 . . . . 1.74 112.934 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -104.69 152.31 22.65 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.481 -0.933 . . . . 2.45 108.481 169.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.753 HD21 ' CD1' ' A' ' 170' ' ' PHE . 4.8 tt -82.52 130.0 35.03 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.829 -0.804 . . . . 1.49 108.829 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.505 ' N ' HD22 ' A' ' 47' ' ' LEU . 38.3 m-85 -115.45 119.12 35.17 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.466 -0.568 . . . . 1.52 109.466 -178.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.931 ' HG3' ' CE1' ' A' ' 17' ' ' TYR . 3.1 tmt_? -110.47 141.84 43.04 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.928 -0.578 . . . . 3.34 109.505 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 34' ' ' THR . 8.8 p -127.99 143.59 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-O 121.243 0.544 . . . . 1.98 109.862 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.483 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 33.4 tt0 -146.28 110.81 5.14 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.442 -0.799 . . . . 1.07 109.01 -173.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.699 ' HA3' HG23 ' A' ' 33' ' ' ILE . . . -137.81 134.72 7.11 Favored Glycine 0 N--CA 1.439 -1.13 0 C-N-CA 120.361 -0.923 . . . . 0.35 111.851 -176.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 64.4 mt -83.98 118.13 30.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 C-N-CA 119.798 -0.761 . . . . 1.3 110.327 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.462 HD11 ' HB3' ' A' ' 199' ' ' ALA . 72.3 mt -95.99 113.15 61.61 Favored Pre-proline 0 N--CA 1.435 -1.209 0 CA-C-N 115.132 -0.94 . . . . 1.07 108.599 175.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 24.9 Cg_exo -65.67 45.87 0.18 Allowed 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.825 3.017 . . . . 0.74 113.582 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.522 ' HG2' HG13 ' A' ' 203' ' ' ILE . 10.5 tp10 -135.72 178.09 7.32 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.539 -1.282 . . . . 1.68 107.539 177.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.448 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 47.9 t -81.1 139.66 49.31 Favored Pre-proline 0 N--CA 1.43 -1.473 0 CA-C-O 121.739 0.781 . . . . 1.58 110.234 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.527 ' HG3' ' HB3' ' A' ' 165' ' ' SER . 23.5 Cg_exo -61.35 -9.13 12.04 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 124.11 3.207 . . . . 0.74 110.658 177.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 63' ' ' ASP . . . -67.02 -52.3 44.14 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.981 -1.009 . . . . 1.31 110.82 174.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.584 ' HE3' ' HB3' ' A' ' 64' ' ' PHE . 7.4 tptt -72.12 -23.91 61.39 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.887 -0.783 . . . . 3.78 108.887 178.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.737 HD22 HD11 ' A' ' 203' ' ' ILE . 20.4 mt -64.42 -60.35 3.27 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.863 -0.608 . . . . 1.09 109.454 174.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.455 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 34.1 t -64.73 -14.13 57.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.563 -0.744 . . . . 1.94 110.306 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.429 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 22.6 t70 -80.83 -46.42 15.36 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.844 -0.616 . . . . 1.32 111.077 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.622 ' HB2' ' HZ2' ' A' ' 74' ' ' TRP . 7.0 p90 -76.21 -45.43 33.08 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 120.9 -0.32 . . . . 0.79 111.29 -171.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.455 ' CD2' ' HA ' ' A' ' 62' ' ' SER . 0.5 OUTLIER -80.66 -5.31 56.77 Favored 'General case' 0 CA--C 1.512 -0.487 0 O-C-N 121.833 -0.542 . . . . 2.15 111.184 -171.247 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.52 ' O ' ' HG3' ' A' ' 67' ' ' GLN . 13.0 t80 -50.73 -48.61 58.91 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 123.676 0.61 . . . . 2.06 112.181 -163.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.547 ' HG2' ' HH ' ' A' ' 81' ' ' TYR . 16.3 mt-30 155.84 115.22 0.0 OUTLIER 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 124.657 1.183 . . . . 4.31 109.32 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.818 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 6.3 t 42.53 31.49 0.29 Allowed 'General case' 0 C--N 1.315 -0.906 0 O-C-N 124.559 1.162 . . . . 1.89 113.397 175.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.93 -27.19 14.44 Favored Glycine 0 CA--C 1.496 -1.154 0 C-N-CA 120.039 -1.077 . . . . 1.71 112.166 -173.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.723 ' O ' HG23 ' A' ' 73' ' ' THR . 17.4 p-10 173.87 -28.77 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.677 -1.231 . . . . 2.19 107.677 -172.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.827 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 1.6 ptp180 -43.11 -54.43 4.4 Favored 'General case' 0 C--O 1.21 -0.983 0 CA-C-N 114.636 -1.165 . . . . 3.95 110.66 177.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.87 HG22 ' HB3' ' A' ' 78' ' ' LEU . 1.8 pp -78.34 -12.27 13.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.056 0.455 . . . . 1.42 111.503 -175.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.723 HG23 ' O ' ' A' ' 70' ' ' ASP . 1.2 t -90.22 -29.78 17.98 Favored 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 120.062 -0.655 . . . . 1.45 109.859 -168.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.622 ' HZ2' ' HB2' ' A' ' 64' ' ' PHE . 7.8 p-90 -111.53 -3.99 14.95 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.16 -0.473 . . . . 0.78 111.378 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.827 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 1.8 t70 -65.9 176.88 1.47 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 122.306 1.051 . . . . 2.19 113.399 -171.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.437 ' HG3' ' OD1' ' A' ' 194' ' ' ASN . 0.0 OUTLIER -123.0 -27.5 4.21 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.819 -1.537 . . . . 3.68 110.509 -178.037 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.42 ' HA ' ' HB2' ' A' ' 99' ' ' GLN . 50.0 m -113.12 0.58 15.0 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.073 -0.714 . . . . 2.08 109.073 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.87 ' HB3' HG22 ' A' ' 72' ' ' ILE . 53.2 mt -108.73 173.68 6.21 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.048 -0.978 . . . . 1.16 110.268 177.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.656 ' HG2' ' HG2' ' A' ' 99' ' ' GLN . 12.8 mm100 -156.87 -66.2 0.1 Allowed 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.734 0.778 . . . . 2.23 109.972 -174.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.458 HG21 ' HB3' ' A' ' 79' ' ' GLN . 17.3 t -136.96 119.17 19.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 114.586 -1.188 . . . . 1.44 109.835 -169.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.818 ' HB3' ' HB ' ' A' ' 68' ' ' THR . 0.4 OUTLIER -109.22 123.48 49.31 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.495 -0.558 . . . . 5.73 109.495 175.922 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.704 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 13.5 m120 -119.95 123.68 44.11 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.324 -0.991 . . . . 1.86 108.324 -176.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.769 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 18.3 ttm -87.73 99.01 11.77 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.69 -0.856 . . . . 2.52 108.69 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -77.49 -60.74 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.981 -0.554 . . . . 1.19 111.349 -163.742 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.63 130.29 19.07 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.862 -0.792 . . . . 2.59 108.862 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.769 ' HD3' ' SD ' ' A' ' 83' ' ' MET . 14.3 mtm180 -110.4 132.95 53.73 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.38 -0.6 . . . . 2.83 109.38 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.598 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -94.5 -44.45 13.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.769 -0.65 . . . . 1.17 111.097 -168.354 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -149.99 -161.99 1.46 Allowed 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.431 -0.951 . . . . 1.86 108.431 -174.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.1 m -65.22 -33.36 75.81 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 111.932 0.345 . . . . 1.94 111.932 -172.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -137.92 33.74 2.4 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.343 0.592 . . . . 1.87 109.647 -174.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.598 ' O ' HG12 ' A' ' 87' ' ' ILE . 1.7 m -132.54 107.09 8.23 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.971 -1.122 . . . . 1.12 107.971 -178.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.591 ' O ' HD11 ' A' ' 114' ' ' LEU . 16.9 m-85 -123.37 171.58 9.32 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.947 -0.57 . . . . 0.52 110.08 -173.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.526 ' O ' HG23 ' A' ' 84' ' ' VAL . 53.3 mt -121.81 129.87 75.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 109.11 -0.7 . . . . 1.1 109.11 170.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.82 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 0.0 OUTLIER -93.25 118.02 30.76 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.734 -1.121 . . . . 2.61 111.962 -170.432 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.704 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 22.2 t-160 -107.18 90.53 3.33 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.021 -0.733 . . . . 2.17 109.021 163.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.616 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 72.2 m -109.22 120.7 43.33 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.984 -0.553 . . . . 1.19 111.457 -176.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.8 mm -83.92 130.02 36.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.367 0.603 . . . . 1.63 110.028 174.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 3.0 m -106.11 152.58 23.23 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.793 -1.094 . . . . 1.72 110.124 -174.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.656 ' HG2' ' HG2' ' A' ' 79' ' ' GLN . 4.2 mm-40 -91.95 168.24 11.55 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.25 0.547 . . . . 2.29 111.443 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.508 ' HB3' ' O ' ' A' ' 106' ' ' ILE . 14.1 m -91.54 50.36 1.71 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.281 -0.872 . . . . 4.07 111.776 -174.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.434 ' HE2' ' HB3' ' A' ' 190' ' ' SER . 69.2 t80 -74.99 102.39 4.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.544 0.687 . . . . 6.11 111.442 -174.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.559 ' O ' ' HB ' ' A' ' 103' ' ' VAL . . . -164.09 -37.94 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.625 -1.171 . . . . 1.98 110.3 175.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.559 ' HB ' ' O ' ' A' ' 102' ' ' ALA . 7.5 p 155.77 -19.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 107.43 -1.322 . . . . 3.6 107.43 -173.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.35 24.56 3.17 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 114.426 -1.261 . . . . 2.2 111.743 -175.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.7 t -101.64 -1.78 31.93 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.346 0.593 . . . . 2.08 110.175 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.641 HG12 ' HG ' ' A' ' 179' ' ' LEU . 76.5 mt -114.78 147.91 17.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.437 -0.801 . . . . 1.53 109.624 -176.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.1 m -99.19 157.79 33.42 Favored Pre-proline 0 C--N 1.32 -0.709 0 N-CA-C 109.319 -0.623 . . . . 1.71 109.319 175.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -47.97 116.54 1.99 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.814 2.342 . . . . 1.31 111.686 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.643 ' HG3' HG22 ' A' ' 144' ' ' ILE . 34.3 ttp180 -102.08 149.22 24.48 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.007 -0.738 . . . . 4.06 109.007 -173.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.4 ' OD1' ' HA ' ' A' ' 145' ' ' ARG . 2.5 p30 -114.25 147.85 38.36 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.813 -0.755 . . . . 1.37 110.135 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.616 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 15.1 m-85 -116.25 128.51 55.65 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.325 -0.852 . . . . 3.01 110.229 174.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.82 ' HA ' ' O ' ' A' ' 94' ' ' CYS . 22.6 mm -126.8 80.87 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.33 -0.85 . . . . 1.2 109.049 169.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.698 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 10.0 m-20 -113.64 129.09 56.63 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.872 -1.058 . . . . 1.86 109.215 -178.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.591 HD11 ' O ' ' A' ' 92' ' ' PHE . 3.8 tp -74.79 121.45 21.79 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.424 0.63 . . . . 1.08 109.401 176.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -115.71 123.74 71.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 114.96 -1.018 . . . . 1.08 111.497 -164.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.644 ' HE2' ' HE3' ' A' ' 118' ' ' LYS . 90.9 t80 -114.07 125.21 53.72 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.827 -1.078 . . . . 2.81 109.895 175.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 1.066 HG12 HG23 ' A' ' 127' ' ' ILE . 85.9 mt -98.79 104.33 15.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.312 0.577 . . . . 1.53 110.358 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.803 ' HZ2' ' HH ' ' A' ' 120' ' ' TYR . 5.0 tppp? -98.73 128.04 44.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.599 -0.728 . . . . 1.81 109.267 177.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.68 92.04 3.79 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.035 -0.728 . . . . 3.22 109.035 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.803 ' HH ' ' HZ2' ' A' ' 118' ' ' LYS . 59.5 m-85 -73.12 115.15 12.11 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 115.14 -0.936 . . . . 1.28 108.737 175.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -26.53 89.67 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 O-C-N 125.637 1.836 . . . . 2.28 113.252 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 53.83 42.44 69.16 Favored Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.789 -0.641 . . . . 0.79 112.672 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.49 ' C ' ' HD2' ' A' ' 157' ' ' PRO . 3.2 t-20 -135.75 -49.21 0.7 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.331 -0.434 . . . . 2.06 110.705 -176.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.575 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 5.4 mtm -161.98 120.24 2.26 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 120.726 -0.39 . . . . 1.73 111.787 -178.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -104.35 78.68 1.51 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.422 -0.955 . . . . 2.07 108.422 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.647 ' HB ' HG13 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -92.8 138.4 20.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 114.915 -1.039 . . . . 1.06 112.791 -172.594 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 1.066 HG23 HG12 ' A' ' 117' ' ' ILE . 38.0 pt -105.51 100.68 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.93 0.872 . . . . 1.26 109.34 165.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.605 ' CB ' ' HA ' ' A' ' 11' ' ' ALA . 11.8 p -85.73 110.58 19.43 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.842 -0.617 . . . . 1.53 110.707 178.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.698 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 1.9 p -106.4 135.87 47.14 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.408 -0.814 . . . . 1.81 110.691 -176.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.59 ' HE2' ' OG1' ' A' ' 10' ' ' THR . 10.6 ttmm -128.11 112.25 14.37 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.819 -1.178 . . . . 2.75 107.819 -177.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.8 p -57.88 98.39 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.914 0 CA-C-O 121.944 0.878 . . . . 1.94 109.067 -175.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.505 HG12 ' HB3' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -110.32 134.12 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.122 0 CA-C-N 114.587 -1.188 . . . . 1.64 109.034 -165.607 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -96.19 71.15 2.81 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.719 -1.128 . . . . 2.17 108.456 -172.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.646 ' CE1' HG21 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -99.5 159.54 29.78 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 114.447 -1.251 . . . . 0.67 110.471 -172.093 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.83 -27.64 75.27 Favored 'Trans proline' 0 N--CA 1.477 0.535 0 C-N-CA 123.861 3.041 . . . . 1.66 115.679 -168.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.417 ' HG2' ' CD2' ' A' ' 134' ' ' PHE . 12.1 mm-40 -71.72 -21.71 61.73 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 120.478 -0.489 . . . . 3.5 110.08 -166.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.571 ' CD2' HG13 ' A' ' 112' ' ' ILE . 57.0 t80 -134.26 108.23 11.33 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 112.916 0.71 . . . . 6.41 112.916 -177.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -97.6 119.12 0.15 Allowed 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 123.537 2.824 . . . . 2.31 110.76 162.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -63.24 -176.94 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.271 1.981 . . . . 1.27 112.24 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.0 m -146.63 -162.35 1.51 Allowed 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.598 -0.519 . . . . 1.88 109.598 -171.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.3 m -79.91 -40.69 27.67 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.297 -0.561 . . . . 2.43 111.337 -178.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -68.09 -42.63 80.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.037 0.446 . . . . 2.18 111.176 -176.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -105.19 134.79 47.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.711 -0.677 . . . . 1.33 110.172 -173.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.643 HG22 ' HG3' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -109.93 103.51 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 CA-C-N 116.034 -0.53 . . . . 1.4 109.702 -179.504 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.524 ' HE ' ' HB ' ' A' ' 112' ' ' ILE . 12.1 ttt180 -51.7 100.78 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.552 -1.204 . . . . 5.14 110.429 178.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.35 110.13 3.06 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.662 -0.699 . . . . 1.05 112.224 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.416 ' HB3' ' HB3' ' A' ' 174' ' ' GLU . 26.4 t80 -85.42 82.2 8.41 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.258 0.551 . . . . 4.68 109.649 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.524 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 47.1 m-80 -78.21 100.45 6.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.737 -0.665 . . . . 2.29 109.747 176.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -57.76 114.96 9.5 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.314 -0.625 . . . . 2.95 109.314 176.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.416 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 65.9 Cg_exo -7.0 67.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.681 1 C-N-CA 126.152 4.568 . . . . 0.77 115.187 -159.764 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . 0.717 ' HB3' ' O ' ' A' ' 170' ' ' PHE . 2.9 m -87.75 150.78 23.37 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 115.039 -0.982 . . . . 1.97 108.404 178.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.799 ' HA3' HG22 ' A' ' 14' ' ' VAL . . . -139.83 -162.86 9.28 Favored Glycine 0 CA--C 1.494 -1.265 0 C-N-CA 118.829 -1.653 . . . . 0.55 112.649 -176.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.591 ' HB3' HG12 ' A' ' 127' ' ' ILE . 0.4 OUTLIER -160.74 83.42 0.67 Allowed 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.364 -1.347 . . . . 0.8 107.364 -164.843 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.647 HG13 ' HB ' ' A' ' 126' ' ' ILE . 4.2 m -95.28 130.38 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 CA-C-O 121.933 0.873 . . . . 1.03 110.576 -175.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . 0.575 ' O ' ' HA ' ' A' ' 124' ' ' MET . 6.0 t -110.32 118.54 36.59 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.251 -0.886 . . . . 2.3 109.446 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.607 ' HB3' ' HB3' ' A' ' 166' ' ' LYS . 9.1 t -114.78 112.6 45.09 Favored Pre-proline 0 C--N 1.319 -0.749 0 C-N-CA 120.654 -0.418 . . . . 1.45 111.625 -170.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.49 ' HD2' ' C ' ' A' ' 123' ' ' ASN . 46.8 Cg_exo -55.18 118.56 5.3 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.11 1.873 . . . . 0.72 110.166 166.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.472 ' N ' ' HB3' ' A' ' 161' ' ' ASN . 72.3 mtp -79.5 -171.78 2.93 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.717 -0.393 . . . . 1.72 111.087 -175.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -67.24 -31.19 71.37 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.481 -0.933 . . . . 2.63 108.481 169.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.406 ' C ' ' HD2' ' A' ' 162' ' ' PRO . 24.2 mt-10 -102.45 27.87 6.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.362 -1.29 . . . . 2.05 109.213 176.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.501 ' OD1' ' HD3' ' A' ' 162' ' ' PRO . 7.0 p30 -38.84 -46.96 3.45 Favored Pre-proline 0 N--CA 1.473 0.694 0 N-CA-C 115.985 1.846 . . . . 2.19 115.985 -169.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.501 ' HD3' ' OD1' ' A' ' 161' ' ' ASN . 71.2 Cg_endo -72.45 -17.63 26.75 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 CA-C-N 121.336 1.513 . . . . 0.86 112.384 -174.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -109.62 -24.43 10.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.779 -0.646 . . . . 1.34 110.933 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 161' ' ' ASN . 79.1 m-85 -141.76 121.05 13.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.065 -0.516 . . . . 1.46 109.726 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.527 ' HB3' ' HG3' ' A' ' 58' ' ' PRO . 6.8 p -117.29 142.71 46.73 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.304 -0.558 . . . . 2.05 111.187 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.622 ' HG3' HG11 ' A' ' 168' ' ' VAL . 2.3 tppp? -94.31 104.41 16.4 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 122.1 0.952 . . . . 1.4 111.822 -174.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.487 HD23 ' HE1' ' A' ' 153' ' ' PHE . 0.7 OUTLIER -90.69 104.83 17.37 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.297 -1.32 . . . . 1.07 109.517 176.179 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.622 HG11 ' HG3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -127.86 126.06 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.803 0.811 . . . . 1.11 111.533 -179.642 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.611 ' HE3' ' HB3' ' A' ' 195' ' ' PHE . 12.2 ttm -141.4 148.58 39.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.248 -0.887 . . . . 1.79 109.486 -172.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.811 ' CE2' HG23 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -129.71 143.34 50.77 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.186 -0.606 . . . . 4.22 110.345 170.256 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.545 ' HB ' HD22 ' A' ' 192' ' ' LEU . 0.9 OUTLIER -119.9 118.81 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 O-C-N 124.86 1.35 . . . . 2.01 109.985 178.394 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.538 ' HB2' ' HG ' ' A' ' 47' ' ' LEU . 10.4 tt0 -121.81 48.73 1.65 Allowed 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 106.187 -1.783 . . . . 2.66 106.187 173.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.531 ' OG1' HG11 ' A' ' 171' ' ' VAL . 5.5 m -72.13 151.34 43.08 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.024 -1.898 . . . . 2.2 111.224 -174.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 18.5 tt0 -127.57 92.97 3.59 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.542 0.687 . . . . 2.45 109.821 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.445 ' SD ' ' N ' ' A' ' 175' ' ' MET . 0.0 OUTLIER -60.98 86.23 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.456 -1.247 . . . . 4.15 110.067 174.106 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.59 ' HB2' HD12 ' A' ' 144' ' ' ILE . 14.8 mmt85 -70.18 19.98 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.083 0.771 . . . . 6.51 113.083 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 175' ' ' MET . . . 165.59 -176.7 41.07 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.303 -0.951 . . . . 2.26 113.56 175.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm 76.2 -65.25 0.32 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.056 0.942 . . . . 6.69 112.923 174.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.641 ' HG ' HG12 ' A' ' 106' ' ' ILE . 4.4 mp -85.0 160.69 19.99 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.77 0.795 . . . . 2.21 110.641 -172.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.535 ' HB3' ' HD2' ' A' ' 181' ' ' PRO . 50.5 m -112.67 164.56 15.07 Favored Pre-proline 0 C--N 1.306 -1.296 0 CA-C-N 113.923 -1.489 . . . . 2.31 108.638 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.535 ' HD2' ' HB3' ' A' ' 180' ' ' SER . 74.3 Cg_exo -37.97 -52.03 1.83 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.656 2.904 . . . . 1.86 114.247 -177.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.558 ' O ' ' HE2' ' A' ' 186' ' ' LYS . 54.6 m -75.25 -10.44 59.46 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.548 0.573 . . . . 2.45 112.548 -174.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.56 ' HB ' ' HB3' ' A' ' 179' ' ' LEU . 16.2 mm -89.86 -35.37 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 CA-C-O 122.523 1.154 . . . . 1.69 108.909 -177.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.668 ' HA ' HG23 ' A' ' 187' ' ' THR . 0.9 OUTLIER -70.01 -38.15 74.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 112.768 -2.014 . . . . 1.77 110.931 -178.728 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.411 ' HG2' ' HA ' ' A' ' 182' ' ' SER . 9.3 pt-20 -65.69 -17.91 64.94 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.155 -0.683 . . . . 2.89 109.155 175.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.558 ' HE2' ' O ' ' A' ' 182' ' ' SER . 48.2 mtmt -93.01 -38.7 11.51 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.729 -0.668 . . . . 1.71 110.081 175.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.668 HG23 ' HA ' ' A' ' 184' ' ' ILE . 11.2 t -68.73 -24.61 64.49 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 112.348 0.499 . . . . 1.3 112.348 -171.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' MET . . . . . 0.528 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 0.2 OUTLIER -79.78 -63.65 0.36 Allowed Pre-proline 0 N--CA 1.467 0.402 0 CA-C-N 118.471 0.578 . . . . 1.39 111.699 179.418 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.528 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 25.4 Cg_exo -62.7 -25.53 75.07 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.296 1.997 . . . . 1.15 112.484 -176.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.742 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 68.4 m -82.95 -28.53 29.75 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.716 -0.394 . . . . 1.95 111.306 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.629 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.2 OUTLIER -90.55 -36.49 14.44 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.9 -0.32 . . . . 1.92 111.272 -173.474 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.545 HD22 ' HB ' ' A' ' 171' ' ' VAL . 48.4 mt -65.22 -47.04 78.21 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.183 0.516 . . . . 1.68 110.587 -177.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.487 ' HB ' HD12 ' A' ' 33' ' ' ILE . 2.0 m -67.9 -30.05 46.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.584 -0.735 . . . . 1.32 109.301 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.742 ' HB2' ' O ' ' A' ' 190' ' ' SER . 1.0 OUTLIER -71.6 -37.07 71.0 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.652 -1.158 . . . . 2.6 110.247 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.611 ' HB3' ' HE3' ' A' ' 169' ' ' MET . 12.2 m-85 -61.07 -34.03 74.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.027 0.441 . . . . 2.73 110.048 172.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.539 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 54.3 mt -79.63 -28.97 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 116.082 -0.508 . . . . 1.11 110.637 176.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 197' ' ' LEU . 53.2 mt -72.8 -36.47 67.56 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-N 116.317 -0.401 . . . . 1.57 110.233 176.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.58 ' ND2' ' HA ' ' A' ' 195' ' ' PHE . 67.2 m-20 -49.06 -47.61 44.78 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.303 -0.999 . . . . 2.18 108.303 164.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.845 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -67.24 -45.49 76.56 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 115.28 -0.873 . . . . 1.04 110.12 -175.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 61.2 mmtt -53.65 -48.18 69.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.403 0.621 . . . . 1.51 109.91 173.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -75.71 -39.99 56.46 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.04 -0.982 . . . . 1.94 111.305 -169.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -76.64 -28.23 59.71 Favored Glycine 0 N--CA 1.461 0.334 0 C-N-CA 120.056 -1.069 . . . . 0.47 111.739 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.845 ' HB ' ' O ' ' A' ' 199' ' ' ALA . 0.9 OUTLIER -71.51 -38.61 68.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 123.045 0.538 . . . . 1.16 110.832 172.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.523 ' O ' ' HB ' ' A' ' 208' ' ' THR . 96.4 mttt -83.76 -17.35 41.5 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.355 0.598 . . . . 3.8 109.406 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -65.36 -25.79 67.74 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.442 -0.947 . . . . 1.28 108.442 166.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.497 ' HB3' ' O ' ' A' ' 203' ' ' ILE . 83.6 t60 -80.97 -51.75 8.19 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.246 -0.888 . . . . 4.34 111.819 175.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -91.95 -33.13 14.99 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.323 0.49 . . . . 3.0 112.323 -171.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.523 ' HB ' ' O ' ' A' ' 204' ' ' LYS . 91.6 m -99.45 151.03 37.29 Favored Pre-proline 0 C--N 1.313 -0.996 0 N-CA-C 109.554 -0.535 . . . . 2.01 109.554 -176.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -65.17 44.27 0.15 Allowed 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.729 2.286 . . . . 2.59 111.969 168.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.456 ' H ' ' C ' ' A' ' 208' ' ' THR . 22.7 t -95.01 37.95 1.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.707 0.765 . . . . 2.55 109.559 -178.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 211' ' ' ARG . 17.7 mtp85 -84.0 22.54 1.15 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.229 -0.896 . . . . 6.11 110.642 -178.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -64.71 -28.07 69.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.372 -0.831 . . . . 7.55 109.988 172.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -102.38 13.37 56.95 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.766 -0.652 . . . . 3.73 111.735 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -66.63 117.22 8.5 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.847 -0.427 . . . . 6.11 109.847 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 62.79 48.7 4.01 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.483 0.489 . . . . 7.27 111.242 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . 0.416 ' HB3' ' O ' ' A' ' 73' ' ' THR . 62.7 t-80 -76.6 -46.43 26.12 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.857 -0.423 . . . . 6.82 109.857 176.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 62.66 -168.49 0.2 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.644 -0.707 . . . . 5.77 111.476 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' SER . . . . . 0.453 ' HG ' ' NE2' ' A' ' 79' ' ' GLN . 48.1 t -98.87 -50.5 4.18 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.868 -0.606 . . . . 6.85 109.514 174.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -172.67 -27.34 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.391 -0.822 . . . . 9.48 109.757 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.25 1.119 0 N-CA-C 108.921 -0.77 . . . . 8.48 108.921 176.45 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 mmt . . . . . 0 N--CA 1.479 0.998 0 CA-C-O 121.198 0.523 . . . . 4.31 110.634 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -146.49 -65.16 0.29 Allowed 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.571 -0.899 . . . . 2.25 108.571 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.52 ' HA ' HD12 ' A' ' 6' ' ' ILE . 59.1 m-85 -66.66 -31.86 72.8 Favored 'General case' 0 CA--C 1.507 -0.707 0 O-C-N 123.58 0.55 . . . . 0.45 110.284 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 27.0 tttp -75.91 -44.34 40.76 Favored 'General case' 0 N--CA 1.418 -2.065 0 N-CA-C 107.598 -1.26 . . . . 2.06 107.598 -177.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.419 ' O ' ' HG3' ' A' ' 9' ' ' GLN . . . -50.16 -51.73 41.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.422 -0.808 . . . . 1.2 112.471 -177.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.52 HD12 ' HA ' ' A' ' 3' ' ' PHE . 0.4 OUTLIER -83.49 -30.6 8.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.312 -0.555 . . . . 1.76 110.758 -172.005 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.557 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -74.04 -41.54 61.65 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.85 0.833 . . . . 1.11 110.956 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.531 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 14.7 mt-30 -62.51 -31.23 71.96 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.259 -1.337 . . . . 2.14 110.216 177.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 5' ' ' ALA . 98.9 mt-30 -82.47 -30.85 29.7 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.999 -1.0 . . . . 3.04 109.204 174.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.605 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.6 OUTLIER -72.0 -37.72 69.77 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.682 -1.145 . . . . 1.1 111.202 -179.569 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.52 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -46.51 -62.62 1.29 Allowed 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.266 0.469 . . . . 1.04 112.266 174.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -70.01 -6.24 32.05 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.308 -0.406 . . . . 2.31 111.086 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.487 ' HB3' ' HA ' ' A' ' 10' ' ' THR . 0.2 OUTLIER -87.7 -43.0 12.24 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.215 -0.448 . . . . 2.54 110.136 179.666 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.684 HG21 ' N ' ' A' ' 152' ' ' GLY . 7.2 p -79.26 -29.83 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-O 121.841 0.829 . . . . 1.21 109.404 176.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 tt -76.15 -19.71 58.23 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 108.314 -0.995 . . . . 1.26 108.314 172.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.43 -23.42 66.65 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 113.931 -1.486 . . . . 0.57 109.62 170.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.558 ' CD2' ' HA ' ' A' ' 14' ' ' VAL . 26.3 m-85 -80.87 -32.82 34.77 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 114.935 -0.633 . . . . 3.59 109.925 176.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.462 ' ND2' ' HE2' ' A' ' 124' ' ' MET . 56.4 t30 -66.22 -13.19 59.92 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.699 0.761 . . . . 2.1 110.139 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.7 mtp180 -108.16 -2.16 19.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.285 -0.87 . . . . 3.26 109.323 178.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.461 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 28.9 t70 -105.65 119.66 39.71 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.349 -1.296 . . . . 2.16 110.473 -175.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.0 p -134.62 119.13 17.98 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.962 -0.384 . . . . 2.24 109.962 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.89 -162.58 1.3 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.252 -0.431 . . . . 2.46 111.127 -166.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -75.73 61.24 2.89 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 116.11 -0.496 . . . . 1.45 112.666 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.415 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -95.64 -156.5 0.52 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.369 -0.604 . . . . 2.24 109.369 175.067 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.48 132.65 0.29 Allowed 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 108.682 -0.859 . . . . 3.43 108.682 -178.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.578 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 2.1 p -67.57 117.45 9.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-O 121.689 0.757 . . . . 2.21 109.5 177.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.0 p -89.17 -24.37 5.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 114.748 -1.114 . . . . 1.83 108.919 -176.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.2 tptt -158.0 139.23 13.43 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.754 -0.657 . . . . 2.87 111.883 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.522 HG23 HG21 ' A' ' 26' ' ' VAL . 6.4 p -144.28 152.1 40.32 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 115.829 -0.623 . . . . 1.92 111.011 175.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.465 ' HB2' HG12 ' A' ' 33' ' ' ILE . 19.4 m -120.67 25.95 9.42 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.826 -0.625 . . . . 2.37 110.868 171.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp 68.93 39.44 1.84 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.479 0.657 . . . . 4.84 110.441 174.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.6 tptm 177.0 -30.59 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.505 -1.225 . . . . 2.05 108.313 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.517 HD11 ' HB ' ' A' ' 193' ' ' VAL . 23.0 pt -119.68 151.8 22.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 114.561 -1.199 . . . . 1.42 109.483 175.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.8 m -152.15 113.62 4.32 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 123.347 0.404 . . . . 1.22 111.158 -164.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.598 ' HA ' ' O ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -103.68 110.79 31.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.356 -0.537 . . . . 1.52 111.799 171.357 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.578 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 1.5 p -99.77 117.86 35.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.413 -0.812 . . . . 1.74 110.95 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 30.2 t -107.72 131.99 53.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.768 -1.106 . . . . 1.72 111.184 -173.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.477 ' HG3' ' H ' ' A' ' 39' ' ' ALA . 27.8 pttt -129.35 -92.61 0.45 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.497 0.554 . . . . 2.45 112.497 172.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.602 ' HA ' ' HA ' ' A' ' 46' ' ' ASN . . . -148.11 137.64 22.28 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.611 0.226 . . . . 2.17 111.611 -172.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.5 m -100.47 137.64 38.61 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.014 -0.365 . . . . 2.51 110.014 176.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 41' ' ' ARG . 61.9 mtt180 -81.01 13.91 2.51 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.31 -0.405 . . . . 7.41 111.222 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.626 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 17.5 ptpt -57.14 -33.73 67.68 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.116 -0.493 . . . . 6.84 110.221 178.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.626 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 14.7 t80 153.09 -70.88 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 O-C-N 124.992 1.432 . . . . 6.42 108.6 -175.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -140.29 84.43 1.96 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.757 0.789 . . . . 6.31 110.511 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.404 ' HA3' ' HD2' ' A' ' 42' ' ' LYS . . . -171.87 179.05 43.79 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.763 -0.732 . . . . 1.74 111.766 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.602 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 18.9 p-10 -111.4 159.32 18.13 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.858 0.361 . . . . 2.45 111.555 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.559 HD23 ' N ' ' A' ' 48' ' ' TYR . 3.9 tt -120.25 143.59 48.22 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.755 -0.831 . . . . 1.49 108.755 -176.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.559 ' N ' HD23 ' A' ' 47' ' ' LEU . 46.2 m-85 -118.46 123.56 45.47 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.888 0.375 . . . . 1.52 110.884 -172.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.598 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 27.9 ttt180 -91.22 112.08 23.84 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.716 -0.846 . . . . 3.34 108.716 169.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 192' ' ' LEU . 0.2 OUTLIER -104.95 106.82 21.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.757 0.789 . . . . 1.98 109.523 -175.715 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 42.8 tt0 -128.68 146.52 50.86 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.819 -1.082 . . . . 1.07 110.763 -169.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.49 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -168.81 146.83 10.64 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 111.018 -0.833 . . . . 0.35 111.018 175.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.42 HG12 ' HE2' ' A' ' 166' ' ' LYS . 65.9 mt -92.84 116.68 34.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 117.813 0.807 . . . . 1.3 110.428 175.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.445 HG12 ' HD3' ' A' ' 200' ' ' LYS . 70.1 mt -99.29 109.56 55.06 Favored Pre-proline 0 N--CA 1.439 -0.984 0 CA-C-N 115.314 -0.857 . . . . 1.07 108.775 174.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 53' ' ' ILE . 32.1 Cg_exo -61.11 65.66 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 124.406 3.404 . . . . 0.74 112.551 178.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.635 ' HG2' ' CG1' ' A' ' 203' ' ' ILE . 9.9 tp10 -157.12 174.23 15.8 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.858 -1.065 . . . . 1.68 108.144 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.493 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 38.1 t -79.94 139.49 53.59 Favored Pre-proline 0 N--CA 1.423 -1.804 0 CA-C-O 121.506 0.67 . . . . 1.58 109.91 179.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.531 ' HB3' ' SG ' ' A' ' 155' ' ' CYS . 31.7 Cg_exo -58.05 -15.0 20.84 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 123.91 3.073 . . . . 0.74 110.694 177.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.85 -49.15 55.27 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.519 -1.219 . . . . 1.31 111.171 175.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.418 ' HG2' HD13 ' A' ' 203' ' ' ILE . 29.4 ttmt -71.79 -28.28 63.51 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.627 0.727 . . . . 3.78 109.162 -177.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.533 HD21 ' CD1' ' A' ' 203' ' ' ILE . 68.0 mt -63.87 -51.37 64.87 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.689 -1.142 . . . . 1.09 109.75 173.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.476 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 18.2 m -67.41 -10.94 56.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.751 -0.658 . . . . 1.94 110.413 175.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -88.8 -32.68 17.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.828 -0.624 . . . . 1.32 111.72 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.521 ' CD2' ' HA ' ' A' ' 61' ' ' LEU . 8.7 p90 -82.02 -44.86 16.09 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.277 -0.569 . . . . 0.79 111.186 -176.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.476 ' CD2' ' HA ' ' A' ' 62' ' ' SER . 0.8 OUTLIER -79.5 -7.66 58.6 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.372 -0.531 . . . . 2.15 111.402 -173.872 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -36.37 -57.74 0.73 Allowed 'General case' 0 N--CA 1.465 0.291 0 O-C-N 125.02 1.45 . . . . 2.06 113.399 -157.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -156.9 -81.71 0.07 Allowed 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 112.198 0.444 . . . . 4.31 112.198 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.582 ' HB ' ' CD1' ' A' ' 81' ' ' TYR . 8.9 t -149.33 31.2 0.75 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 122.168 0.985 . . . . 1.89 109.655 -165.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.0 -39.8 4.22 Favored Glycine 0 CA--C 1.489 -1.543 0 CA-C-N 115.099 -0.955 . . . . 1.71 113.173 -169.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.513 ' O ' HG21 ' A' ' 73' ' ' THR . 3.1 p30 -163.61 -22.34 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.786 -0.707 . . . . 2.19 111.034 -171.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.564 ' O ' ' HB3' ' A' ' 75' ' ' ASP . 13.1 ptm180 -50.68 -33.17 21.57 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 122.913 0.485 . . . . 3.95 110.553 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.488 HG22 ' HG3' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -99.37 -2.74 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 CA-C-N 115.779 -0.646 . . . . 1.42 111.261 -177.726 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.513 HG21 ' O ' ' A' ' 70' ' ' ASP . 1.2 t -96.42 -30.67 13.24 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 119.523 -0.871 . . . . 1.45 110.568 -178.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.528 ' CZ2' ' HA ' ' A' ' 71' ' ' ARG . 13.7 p-90 -107.74 0.59 22.42 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.969 0.414 . . . . 0.78 111.39 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.564 ' HB3' ' O ' ' A' ' 71' ' ' ARG . 1.7 p-10 -58.9 -179.74 0.07 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 114.435 1.272 . . . . 2.19 114.435 -172.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.499 ' HG3' ' OD1' ' A' ' 194' ' ' ASN . 0.0 OUTLIER -143.11 -2.58 1.0 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 113.438 -1.71 . . . . 3.68 111.108 172.853 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 m -132.48 4.97 4.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.943 0.878 . . . . 2.08 108.94 -176.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.52 ' HB2' ' CG ' ' A' ' 75' ' ' ASP . 91.5 mt -119.1 -170.99 2.02 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.579 -1.191 . . . . 1.16 110.868 -174.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 97' ' ' ILE . 8.4 mm100 -161.31 -65.39 0.06 Allowed 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.779 0.8 . . . . 2.23 109.685 -176.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.422 HG21 ' HB3' ' A' ' 79' ' ' GLN . 6.1 t -142.3 147.07 21.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.755 -1.111 . . . . 1.44 109.146 -172.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.582 ' CD1' ' HB ' ' A' ' 68' ' ' THR . 11.6 t80 -136.29 129.61 31.7 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.807 -0.442 . . . . 5.73 109.807 177.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -131.04 121.39 24.94 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.871 -0.788 . . . . 1.86 108.871 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.538 ' HE3' ' HA ' ' A' ' 83' ' ' MET . 1.3 tpt -81.19 92.96 6.38 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.371 -0.831 . . . . 2.52 108.777 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -71.93 -83.08 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.34 -0.846 . . . . 1.19 111.112 -167.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -113.32 114.54 26.81 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.319 0.581 . . . . 2.59 109.695 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.42 ' HG2' ' HD1' ' A' ' 92' ' ' PHE . 80.9 mtm180 -97.4 108.07 20.72 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.31 -0.859 . . . . 2.83 109.204 178.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.69 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -78.47 -47.15 24.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.865 -0.607 . . . . 1.17 110.845 -173.501 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -146.04 -179.87 7.01 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.607 -0.886 . . . . 1.86 108.607 -174.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.9 m -66.8 -17.01 64.66 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.155 0.428 . . . . 1.94 112.155 -174.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -139.28 27.9 2.3 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 120.098 -0.641 . . . . 1.87 110.37 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.69 ' O ' HG12 ' A' ' 87' ' ' ILE . 1.6 m -141.17 112.61 7.49 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 107.979 -1.119 . . . . 1.12 107.979 177.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.549 ' O ' HD13 ' A' ' 114' ' ' LEU . 3.6 m-85 -134.88 177.03 8.12 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.984 -0.553 . . . . 0.52 109.876 -175.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.67 ' O ' HG23 ' A' ' 84' ' ' VAL . 22.1 mt -125.8 131.03 72.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 107.336 -1.357 . . . . 1.1 107.336 169.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.718 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 14.5 p -104.68 132.59 50.75 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.831 -0.348 . . . . 2.61 111.731 -174.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.547 ' HA ' HD13 ' A' ' 112' ' ' ILE . 14.6 t60 -103.46 95.28 5.97 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.962 -0.755 . . . . 2.17 108.962 166.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.62 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 27.4 m -115.66 121.33 42.22 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.317 -0.856 . . . . 1.19 110.838 -174.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.442 ' O ' ' HB2' ' A' ' 79' ' ' GLN . 44.5 mm -77.95 114.99 19.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.08 -0.711 . . . . 1.63 109.08 175.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.0 m -93.85 136.45 34.12 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.072 -0.967 . . . . 1.72 110.532 -175.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 24.0 mt-30 -74.77 154.63 38.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.374 0.606 . . . . 2.29 111.065 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.4 p -85.49 71.29 10.79 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.089 -0.96 . . . . 4.07 111.119 -178.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -81.66 97.58 7.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.151 -0.477 . . . . 6.11 110.658 -175.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.41 ' C ' ' H ' ' A' ' 104' ' ' GLY . . . 177.68 50.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 114.762 -1.108 . . . . 1.98 109.287 175.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 90.9 t 73.05 -40.65 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 115.548 -0.751 . . . . 3.6 111.23 -177.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 102' ' ' ALA . . . 144.66 16.99 0.2 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.953 -0.641 . . . . 2.2 112.647 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.7 m -73.14 -20.45 60.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.288 0.566 . . . . 2.08 111.121 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 17.5 mt -108.62 159.57 7.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.48 -0.782 . . . . 1.53 110.405 -170.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 25.2 m -100.31 151.84 37.66 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 108.988 -0.745 . . . . 1.71 108.988 172.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -50.19 126.42 17.27 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.715 2.276 . . . . 1.31 111.401 177.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.465 ' HG2' HG22 ' A' ' 144' ' ' ILE . 19.5 mtm180 -101.82 164.53 11.68 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.502 0.668 . . . . 4.06 112.004 -169.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.735 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 10.1 t0 -107.27 113.22 26.47 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.667 -1.151 . . . . 1.37 108.968 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.62 ' HB3' ' HB ' ' A' ' 96' ' ' THR . 57.4 t80 -100.41 107.45 19.21 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.653 -0.869 . . . . 3.01 108.653 -178.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.718 ' HA ' ' O ' ' A' ' 94' ' ' CYS . 8.5 mm -122.41 82.73 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 CA-C-N 115.404 -0.816 . . . . 1.2 108.911 177.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.522 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 1.9 m-20 -116.13 130.21 56.69 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.663 -0.698 . . . . 1.86 110.276 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.664 ' O ' ' HA ' ' A' ' 129' ' ' SER . 3.8 tp -75.34 122.54 23.89 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 115.008 -0.996 . . . . 1.08 109.519 176.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -121.8 125.45 73.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-N 114.915 -1.039 . . . . 1.08 111.875 -163.685 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.557 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 70.7 t80 -110.05 125.01 52.49 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.666 -1.152 . . . . 2.81 111.075 176.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.439 HG13 HG23 ' A' ' 127' ' ' ILE . 3.7 mp -95.42 104.66 16.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.711 -0.677 . . . . 1.53 109.371 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.494 ' HD3' ' CE1' ' A' ' 120' ' ' TYR . 36.2 tttm -109.34 149.59 29.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.119 0.485 . . . . 1.81 110.502 -175.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.1 tpp85 -126.59 97.78 5.15 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 121.65 0.738 . . . . 3.22 109.572 -176.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.494 ' CE1' ' HD3' ' A' ' 118' ' ' LYS . 24.7 m-85 -77.28 107.65 9.84 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 106.727 -1.583 . . . . 1.28 106.727 167.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -39.75 95.57 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 124.736 1.273 . . . . 2.28 112.758 -175.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 64.26 36.81 93.69 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 114.514 -1.221 . . . . 0.79 112.345 178.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.48 ' C ' ' HD2' ' A' ' 157' ' ' PRO . 2.1 t-20 -138.53 -43.2 0.49 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.535 -0.332 . . . . 2.06 110.591 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.462 ' HE2' ' ND2' ' A' ' 18' ' ' ASN . 1.1 mpt? -156.76 135.44 11.61 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.39 0.614 . . . . 1.73 111.97 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -112.78 84.89 2.06 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.821 -1.177 . . . . 2.07 107.821 170.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 153' ' ' PHE . 0.6 OUTLIER -105.77 136.91 38.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.624 -0.716 . . . . 1.06 112.351 -171.184 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.69 ' O ' HG13 ' A' ' 127' ' ' ILE . 5.5 pt -111.52 103.06 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 122.279 1.038 . . . . 1.26 109.077 167.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.52 ' HB3' ' HA ' ' A' ' 11' ' ' ALA . 28.6 p -90.45 122.39 33.26 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.657 -0.702 . . . . 1.53 110.656 -178.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.664 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 5.3 m -120.31 140.08 51.8 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.575 -0.739 . . . . 1.81 111.108 -169.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.539 ' HB3' ' HZ3' ' A' ' 130' ' ' LYS . 2.9 mtpm? -128.13 121.56 29.86 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 107.918 -1.141 . . . . 2.75 107.918 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.417 ' CB ' ' HA ' ' A' ' 147' ' ' TYR . 20.8 p -63.05 98.37 0.13 Allowed 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.32 -0.993 . . . . 1.94 108.32 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -109.6 131.7 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 CA-C-N 114.516 -1.22 . . . . 1.64 109.084 -166.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.52 65.84 3.22 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.526 -1.216 . . . . 2.17 108.821 -168.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.697 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 0.3 OUTLIER -95.16 156.06 38.23 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 113.86 -1.518 . . . . 0.67 110.054 -171.48 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -69.97 -20.17 34.19 Favored 'Trans proline' 0 N--CA 1.473 0.32 0 C-N-CA 123.328 2.685 . . . . 1.66 115.337 -167.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.697 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 7.2 tp10 -72.87 -15.92 61.59 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.169 0.509 . . . . 3.5 109.824 -171.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -158.43 111.01 1.68 Allowed Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 113.314 0.857 . . . . 6.41 113.314 175.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -97.67 144.21 0.68 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 124.033 3.156 . . . . 2.31 111.894 167.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.42 ' HG3' ' HB2' ' A' ' 145' ' ' ARG . 61.5 Cg_endo -75.64 -172.21 1.25 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.53 2.154 . . . . 1.27 112.265 178.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.5 m -141.66 -167.87 2.53 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.331 -0.989 . . . . 1.88 108.331 -175.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.4 m -73.23 -37.04 66.52 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.056 -0.658 . . . . 2.43 111.191 -178.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -73.92 -60.39 2.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.176 0.512 . . . . 2.18 109.89 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.545 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 36.7 m-85 -87.19 112.56 22.1 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 115.688 -0.687 . . . . 1.33 109.98 -178.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.465 HG22 ' HG2' ' A' ' 109' ' ' ARG . 1.7 tp -100.89 119.05 48.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 115.21 -0.904 . . . . 1.4 109.262 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.735 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 28.7 ttm-85 -51.44 100.61 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 O-C-N 124.06 0.85 . . . . 5.14 109.735 173.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -58.0 106.03 0.73 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.748 -0.941 . . . . 1.05 110.748 176.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.417 ' HA ' ' CB ' ' A' ' 131' ' ' SER . 22.6 t80 -83.99 87.39 7.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.573 0.701 . . . . 4.68 111.119 -172.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.736 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 24.3 m-80 -83.31 114.47 21.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.388 -0.823 . . . . 2.29 109.807 174.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -71.33 129.49 88.9 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.254 -1.017 . . . . 2.95 108.254 175.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.605 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 15.7 Cg_exo -16.55 69.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.973 1 C-N-CA 126.505 4.804 . . . . 0.77 116.205 -166.143 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . 0.736 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 21.9 p -97.77 -173.79 2.71 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.818 -1.083 . . . . 1.97 108.879 171.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.757 ' O ' ' HG3' ' A' ' 169' ' ' MET . . . -171.66 -150.26 7.05 Favored Glycine 0 CA--C 1.493 -1.323 0 C-N-CA 119.231 -1.462 . . . . 0.55 112.262 -177.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 57.7 t80 -161.23 96.49 1.08 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.684 -0.858 . . . . 0.8 108.684 -164.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.659 ' CG2' HG12 ' A' ' 168' ' ' VAL . 1.2 m -103.96 132.06 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-O 121.972 0.892 . . . . 1.03 110.824 -176.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . 0.531 ' SG ' ' HB3' ' A' ' 58' ' ' PRO . 10.6 t -112.4 111.69 22.72 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.068 -0.969 . . . . 2.3 109.511 177.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.49 ' HB3' ' HB3' ' A' ' 166' ' ' LYS . 27.4 t -108.9 112.34 60.24 Favored Pre-proline 0 C--N 1.316 -0.872 0 C-N-CA 120.867 -0.333 . . . . 1.45 111.346 -166.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.48 ' HD2' ' C ' ' A' ' 123' ' ' ASN . 53.5 Cg_exo -49.66 124.41 12.21 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.424 2.083 . . . . 0.72 111.161 172.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.607 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 0.2 OUTLIER -79.15 -167.78 1.27 Allowed 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.066 0.46 . . . . 1.72 111.699 -175.511 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.75 -25.67 64.86 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.798 0.809 . . . . 2.63 109.236 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -103.04 24.95 10.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.8 -1.091 . . . . 2.05 109.011 178.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.507 ' HB2' ' CD ' ' A' ' 162' ' ' PRO . 15.4 m120 13.73 -82.59 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 126.402 1.881 . . . . 2.19 115.67 178.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.507 ' CD ' ' HB2' ' A' ' 161' ' ' ASN . 94.3 Cg_endo -74.2 -12.02 23.19 Favored 'Trans proline' 0 C--N 1.362 1.289 0 CA-C-N 120.932 1.369 . . . . 0.86 113.639 -172.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -102.3 -30.98 10.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.335 -0.393 . . . . 1.34 111.452 -176.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.607 ' O ' ' HB2' ' A' ' 158' ' ' MET . 42.3 m-85 -133.78 135.51 43.92 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.607 0.242 . . . . 1.46 110.789 177.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 26.7 t -128.8 146.7 50.84 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.415 0.626 . . . . 2.05 111.124 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 156' ' ' SER . 14.3 tppt? -99.66 101.81 13.11 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.181 -0.918 . . . . 1.4 111.034 -178.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -84.67 104.28 14.51 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.631 -1.168 . . . . 1.07 108.992 178.615 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.659 HG12 ' CG2' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -131.86 114.15 24.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 122.509 1.147 . . . . 1.11 111.574 177.653 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.757 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 16.8 ttt -118.8 151.09 38.69 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 114.284 -1.325 . . . . 1.79 108.284 -176.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.7 ' O ' ' HB2' ' A' ' 151' ' ' CYS . 68.8 m-85 -120.08 139.4 52.62 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 120.272 -0.571 . . . . 4.22 110.358 173.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.403 HG21 HD21 ' A' ' 192' ' ' LEU . 1.1 t -119.13 121.47 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 O-C-N 123.854 0.722 . . . . 2.01 110.402 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -123.98 43.37 3.0 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.326 -1.361 . . . . 2.66 107.326 178.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 6.8 m -69.31 137.42 52.96 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 113.379 -1.737 . . . . 2.2 111.513 -172.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -83.95 -32.53 24.99 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.326 -0.397 . . . . 2.45 111.213 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 24.6 mmt 56.08 57.42 5.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.41 0.624 . . . . 4.15 110.026 -175.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -67.19 -1.64 4.7 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.129 -0.941 . . . . 6.51 112.101 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -76.47 -160.39 10.28 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.135 -0.555 . . . . 2.26 112.132 178.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -94.14 65.61 3.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.391 0.615 . . . . 6.69 110.503 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.493 HD12 ' N ' ' A' ' 179' ' ' LEU . 2.6 mp -115.94 153.33 31.78 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.681 0.753 . . . . 2.21 109.385 175.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.444 ' OG ' ' HD2' ' A' ' 181' ' ' PRO . 15.0 t -112.19 156.96 41.19 Favored Pre-proline 0 C--N 1.304 -1.397 0 N-CA-C 105.987 -1.857 . . . . 2.31 105.987 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.558 ' O ' ' HG2' ' A' ' 185' ' ' GLU . 60.6 Cg_exo -39.1 -47.26 2.97 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 122.464 2.109 . . . . 1.86 112.958 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.489 ' O ' ' HG3' ' A' ' 186' ' ' LYS . 11.1 t -71.13 -11.99 61.25 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.506 0.558 . . . . 2.45 112.506 -177.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.431 ' CG1' ' H ' ' A' ' 180' ' ' SER . 40.2 mm -85.97 -42.42 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-O 122.858 1.313 . . . . 1.69 107.809 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.587 ' HA ' HG21 ' A' ' 187' ' ' THR . 1.4 mp -63.51 -36.23 75.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 112.034 -2.348 . . . . 1.77 109.775 175.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.558 ' HG2' ' O ' ' A' ' 181' ' ' PRO . 62.8 mm-40 -58.89 -26.26 64.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.699 -1.137 . . . . 2.89 109.993 174.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 182' ' ' SER . 43.9 mtmt -93.13 -44.37 8.4 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.644 -0.707 . . . . 1.71 110.036 177.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.587 HG21 ' HA ' ' A' ' 184' ' ' ILE . 4.7 t -69.28 -30.8 68.98 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 115.997 -0.547 . . . . 1.3 112.049 -170.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' MET . . . . . 0.518 ' O ' ' HG ' ' A' ' 192' ' ' LEU . 1.4 mmt -80.29 -65.1 0.28 Allowed Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 112.473 0.546 . . . . 1.39 112.473 -172.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.502 ' O ' HG11 ' A' ' 193' ' ' VAL . 33.6 Cg_endo -63.37 -25.72 71.13 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 121.73 1.62 . . . . 1.15 112.944 -174.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.61 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 46.2 m -83.97 -31.48 25.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.912 0.387 . . . . 1.95 111.114 -177.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -90.87 -27.73 18.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.28 -0.418 . . . . 1.92 111.623 -173.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 188' ' ' MET . 68.0 mt -75.94 -42.94 47.14 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 120.033 -0.667 . . . . 1.68 110.312 -175.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.517 ' HB ' HD11 ' A' ' 33' ' ' ILE . 2.1 m -66.36 -31.29 52.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 108.803 -0.814 . . . . 1.32 108.803 176.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.61 ' HB2' ' O ' ' A' ' 190' ' ' SER . 1.6 t-20 -73.4 -32.33 64.39 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.33 -1.305 . . . . 2.6 110.311 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.546 ' O ' ' HB2' ' A' ' 198' ' ' ASN . 33.7 t80 -65.68 -30.92 71.67 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.169 -0.678 . . . . 2.73 109.169 175.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.46 ' O ' ' HB2' ' A' ' 199' ' ' ALA . 57.0 mt -78.08 -28.82 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 115.654 -0.703 . . . . 1.11 110.554 174.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 87.8 mt -72.41 -32.74 66.61 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 121.175 0.512 . . . . 1.57 110.025 174.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.546 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 26.2 m-80 -51.19 -42.74 61.08 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.098 -1.075 . . . . 2.18 108.098 165.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.561 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -73.88 -43.28 59.0 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 116.34 -0.391 . . . . 1.04 110.68 -177.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.445 ' HD3' HG12 ' A' ' 54' ' ' ILE . 31.7 mmtp -54.37 -44.32 72.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.524 0.678 . . . . 1.51 110.663 175.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.421 ' HA ' ' HG2' ' A' ' 204' ' ' LYS . 31.4 t70 -85.74 -38.88 17.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.328 -0.851 . . . . 1.94 110.878 -174.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -68.07 -31.16 74.55 Favored Glycine 0 CA--C 1.507 -0.437 0 C-N-CA 120.397 -0.906 . . . . 0.47 111.648 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.675 ' O ' ' HG2' ' A' ' 207' ' ' ARG . 3.0 tp -71.11 -32.9 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 109.496 -0.557 . . . . 1.16 109.496 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.657 ' O ' ' HB ' ' A' ' 208' ' ' THR . 5.6 pttp -87.29 -20.64 26.53 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 109.384 -0.598 . . . . 3.8 109.384 177.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -62.19 -38.27 88.46 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.394 -0.965 . . . . 1.28 108.394 166.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -79.47 -42.43 25.31 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.508 -0.769 . . . . 4.34 112.95 178.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.675 ' HG2' ' O ' ' A' ' 203' ' ' ILE . 13.4 ptm180 -93.1 -43.88 8.66 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.524 0.602 . . . . 3.0 111.878 -174.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.657 ' HB ' ' O ' ' A' ' 204' ' ' LYS . 88.7 m -83.2 144.36 46.85 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 115.75 -0.659 . . . . 2.01 109.431 -176.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -64.62 45.65 0.14 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.241 2.627 . . . . 2.59 113.687 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.422 ' H ' ' C ' ' A' ' 208' ' ' THR . 48.9 m -81.46 -15.11 56.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.255 0.55 . . . . 2.55 109.813 174.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 211' ' ' ARG . 48.6 mtm180 -86.05 23.78 1.44 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.726 -0.67 . . . . 6.11 110.618 176.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -57.61 -33.46 68.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.646 -0.707 . . . . 7.55 110.768 176.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -130.67 50.36 0.89 Allowed Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 111.131 -0.788 . . . . 3.73 111.131 175.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -67.69 104.97 1.76 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.866 0.365 . . . . 6.11 110.502 -176.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -83.6 -25.97 30.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.131 -0.486 . . . . 7.27 110.364 -177.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 32.3 t-80 55.06 59.63 3.92 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.432 0.634 . . . . 6.82 110.131 177.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -84.05 8.73 14.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.794 -0.639 . . . . 5.77 111.065 -175.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 3.6 p -68.02 -19.27 64.9 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.017 -0.538 . . . . 6.85 111.29 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 40.6 p-80 -80.8 125.46 30.11 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.842 -0.429 . . . . 9.48 109.842 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 14.2 t . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.925 -0.559 . . . . 8.48 109.682 -177.881 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.484 1.25 0 CA-C-O 120.675 0.274 . . . . 4.31 110.46 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.518 ' O ' HD12 ' A' ' 6' ' ' ILE . 27.6 t70 -120.34 -85.18 0.66 Allowed 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 109.297 -0.631 . . . . 2.25 109.297 178.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.861 ' HA ' HD12 ' A' ' 6' ' ' ILE . 71.9 m-85 -62.81 -30.73 71.7 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.621 0.724 . . . . 0.45 109.145 174.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.759 ' HE3' ' HE1' ' A' ' 116' ' ' TYR . 66.3 tttt -70.52 -33.96 71.76 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 107.492 -1.299 . . . . 2.06 107.492 -177.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.72 -36.57 79.16 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.215 0.531 . . . . 1.2 110.542 177.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.861 HD12 ' HA ' ' A' ' 3' ' ' PHE . 2.0 mp -81.46 -41.29 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 CA-C-O 121.982 0.896 . . . . 1.76 108.722 -174.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.665 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -80.09 -33.19 39.0 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.808 -1.542 . . . . 1.11 112.147 -174.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.769 HE21 ' HH ' ' A' ' 116' ' ' TYR . 41.5 mt-30 -69.54 -23.58 63.6 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.788 0.804 . . . . 2.14 109.495 175.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.558 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 14.4 mm100 -84.43 -47.85 10.24 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.426 -1.261 . . . . 3.04 108.876 170.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.568 ' HB ' ' HA ' ' A' ' 7' ' ' ALA . 0.6 OUTLIER -55.11 -39.35 69.28 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.124 -0.943 . . . . 1.1 112.038 178.251 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.41 ' HA ' ' OG ' ' A' ' 128' ' ' SER . . . -46.54 -57.73 4.46 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.837 0.68 . . . . 1.04 112.837 174.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -80.38 -6.48 58.09 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.416 -0.356 . . . . 2.31 111.251 -177.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.558 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 9.6 mm-40 -78.58 -51.32 10.09 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.934 -0.765 . . . . 2.54 108.934 170.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.74 HG22 ' CD2' ' A' ' 170' ' ' PHE . 7.1 p -68.22 -39.61 81.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.636 -0.711 . . . . 1.21 110.455 177.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.574 HD23 ' HH ' ' A' ' 120' ' ' TYR . 0.6 OUTLIER -68.02 -19.68 64.93 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-O 122.077 0.942 . . . . 1.26 108.619 174.744 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.52 ' HA2' ' NE ' ' A' ' 19' ' ' ARG . . . -65.1 -22.7 69.12 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 113.876 -1.511 . . . . 0.57 110.088 175.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -92.1 -12.03 34.13 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 114.973 -0.613 . . . . 3.59 110.088 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -80.47 -20.44 43.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.777 0.798 . . . . 2.1 109.131 177.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.52 ' NE ' ' HA2' ' A' ' 16' ' ' GLY . 18.8 ptt180 -105.49 -5.57 20.15 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.079 -0.964 . . . . 3.26 109.325 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -86.26 114.62 23.23 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 114.731 -1.122 . . . . 2.16 110.544 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 40.8 p -134.69 101.79 5.06 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.829 -0.804 . . . . 2.24 108.829 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.446 ' HB2' ' H ' ' A' ' 23' ' ' GLY . 3.0 p -141.76 -148.87 0.25 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.404 -0.817 . . . . 2.46 111.757 -164.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.446 ' H ' ' HB2' ' A' ' 22' ' ' SER . . . -71.81 63.66 1.21 Allowed Glycine 0 CA--C 1.52 0.396 0 O-C-N 123.379 0.424 . . . . 1.45 113.289 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 1.013 ' HA ' ' HB3' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -104.96 -157.92 0.64 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.046 -0.724 . . . . 2.24 109.046 173.05 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -173.75 120.06 0.3 Allowed 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.183 -1.043 . . . . 3.43 108.183 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.875 HG22 HG21 ' A' ' 29' ' ' THR . 2.7 p -64.02 116.57 3.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 C-N-CA 119.458 -0.897 . . . . 2.21 109.531 177.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.441 HG12 ' HE2' ' A' ' 48' ' ' TYR . 11.1 p -88.86 -22.96 6.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 114.669 -1.15 . . . . 1.83 108.739 -177.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.528 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 1.9 tppp? -157.04 122.49 4.66 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 119.867 -0.733 . . . . 2.87 112.972 -175.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.875 HG21 HG22 ' A' ' 26' ' ' VAL . 37.8 p -129.35 140.31 51.42 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.215 -0.661 . . . . 1.92 109.215 167.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.6 m -124.8 -60.69 1.36 Allowed 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.41 -0.516 . . . . 2.37 112.014 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -152.07 73.22 1.04 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.3 -0.409 . . . . 4.84 110.765 -172.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.732 ' HE3' ' HB ' ' A' ' 53' ' ' ILE . 43.2 tttp 79.21 18.32 0.82 Allowed 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 122.133 0.968 . . . . 2.05 109.431 177.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.79 HG21 ' HA3' ' A' ' 52' ' ' GLY . 5.9 pt -129.63 146.16 34.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 114.198 -1.365 . . . . 1.42 109.704 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.682 ' HA ' HG22 ' A' ' 29' ' ' THR . 52.8 m -143.55 107.56 4.71 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.975 -1.011 . . . . 1.22 110.814 -166.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.405 ' O ' HG11 ' A' ' 27' ' ' VAL . 24.4 t -100.32 103.13 14.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.888 -0.596 . . . . 1.52 109.756 176.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.738 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 87.5 p -93.42 137.4 32.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.996 -0.547 . . . . 1.74 110.553 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.8 t -129.09 135.35 48.79 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.173 0.511 . . . . 1.72 111.483 -177.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 1.013 ' HB3' ' HA ' ' A' ' 24' ' ' TRP . 41.8 pttt -148.04 161.04 42.19 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.151 -0.931 . . . . 2.45 108.824 172.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.16 130.77 43.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.775 0.322 . . . . 2.17 111.41 -177.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.613 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 21.1 p -76.0 -30.05 58.4 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.249 -0.432 . . . . 2.51 110.585 -177.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 40' ' ' SER . 9.8 ptm180 56.42 8.64 0.45 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.032 1.333 . . . . 7.41 113.948 173.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -93.44 -2.75 54.19 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.234 -1.024 . . . . 6.84 108.234 168.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -175.69 171.5 2.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 113.941 -1.481 . . . . 6.42 107.405 -176.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 52.0 p-80 -79.63 72.78 6.33 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 122.0 0.905 . . . . 6.31 110.802 -177.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.47 -173.66 28.22 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 114.988 -1.006 . . . . 1.74 111.41 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -123.68 148.8 46.19 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.266 0.555 . . . . 2.45 110.855 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.687 HD11 ' HE1' ' A' ' 170' ' ' PHE . 10.1 tt -105.8 153.2 22.23 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.187 -0.915 . . . . 1.49 109.565 -177.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.441 ' HE2' HG12 ' A' ' 27' ' ' VAL . 42.7 m-85 -128.29 129.99 47.16 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.81 0.338 . . . . 1.52 111.059 -175.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.748 ' HD3' ' CZ3' ' A' ' 24' ' ' TRP . 41.0 ttt180 -106.94 119.9 40.6 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.226 -1.027 . . . . 3.34 108.226 168.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.726 HG11 ' HB3' ' A' ' 169' ' ' MET . 0.2 OUTLIER -111.13 122.37 65.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.773 -0.649 . . . . 1.98 109.564 -171.671 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 35.3 tt0 -138.87 148.27 43.46 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.084 -0.507 . . . . 1.07 110.633 -169.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.79 ' HA3' HG21 ' A' ' 33' ' ' ILE . . . -170.77 150.73 14.53 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 110.9 -0.88 . . . . 0.35 110.9 173.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.732 ' HB ' ' HE3' ' A' ' 32' ' ' LYS . 85.1 mt -92.19 112.03 25.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 117.693 0.746 . . . . 1.3 110.01 175.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.403 HG12 ' CE ' ' A' ' 200' ' ' LYS . 68.4 mt -89.71 116.4 66.25 Favored Pre-proline 0 N--CA 1.437 -1.084 0 CA-C-N 115.329 -0.851 . . . . 1.07 109.079 176.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.41 55.44 0.31 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 124.181 3.254 . . . . 0.74 112.965 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.835 ' HG2' HG13 ' A' ' 203' ' ' ILE . 7.3 tp10 -155.98 162.85 40.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.597 -1.26 . . . . 1.68 107.597 175.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.466 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 31.3 p -71.77 140.61 83.99 Favored Pre-proline 0 N--CA 1.432 -1.328 0 CA-C-O 121.65 0.738 . . . . 1.58 110.795 -176.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.711 ' HD3' ' HB2' ' A' ' 165' ' ' SER . 10.0 Cg_endo -52.46 -11.42 1.19 Allowed 'Trans proline' 0 CA--C 1.527 0.162 0 C-N-CA 124.495 3.463 . . . . 0.74 111.761 172.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.31 -46.12 61.45 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.837 -0.62 . . . . 1.31 110.713 174.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.906 ' HE2' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -65.05 -37.36 87.32 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 107.934 -1.136 . . . . 3.78 107.934 174.307 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.77 HD21 ' CD1' ' A' ' 203' ' ' ILE . 83.5 mt -60.69 -55.2 36.09 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.719 -1.128 . . . . 1.09 110.187 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.545 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 28.3 t -67.93 -13.87 62.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.063 -0.517 . . . . 1.94 110.637 176.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.906 ' HB3' ' HE2' ' A' ' 60' ' ' LYS . 21.3 t70 -81.06 -49.12 11.28 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.573 -0.451 . . . . 1.32 110.78 -178.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.631 ' CE2' ' HA ' ' A' ' 61' ' ' LEU . 17.2 p90 -70.12 -47.81 60.18 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 120.48 -0.488 . . . . 0.79 110.876 -174.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.545 ' CD2' ' HA ' ' A' ' 62' ' ' SER . 0.8 OUTLIER -76.9 -14.27 59.89 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 120.699 -0.4 . . . . 2.15 111.463 -168.539 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.475 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 30.9 t80 -22.04 -61.17 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 O-C-N 125.233 1.583 . . . . 2.06 113.932 -163.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.546 ' H ' ' NH2' ' A' ' 71' ' ' ARG . 17.3 tm0? 175.4 -51.04 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 O-C-N 123.492 0.495 . . . . 4.31 111.09 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.497 ' HB ' ' OE1' ' A' ' 67' ' ' GLN . 6.3 t -148.23 24.15 1.03 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.668 0.618 . . . . 1.89 112.668 -169.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.725 ' N ' HH12 ' A' ' 71' ' ' ARG . . . -129.26 0.91 6.08 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 117.928 -2.082 . . . . 1.71 115.96 -167.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.72 ' O ' HG22 ' A' ' 73' ' ' THR . 19.2 t70 -171.18 -41.46 0.02 OUTLIER 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 117.816 0.808 . . . . 2.19 110.467 -172.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.771 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -74.89 -20.34 59.76 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-N 115.692 -0.685 . . . . 3.95 112.038 -162.154 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.885 HG22 HD11 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -100.83 -7.98 9.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 119.102 -1.039 . . . . 1.42 109.995 177.295 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.72 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.4 t -87.05 -35.51 18.7 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 120.24 -0.584 . . . . 1.45 109.867 -174.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.607 ' HZ2' ' CD1' ' A' ' 64' ' ' PHE . 21.1 p-90 -105.64 -2.68 23.13 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 116.258 -0.428 . . . . 0.78 111.321 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.771 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 3.0 t70 -66.61 170.45 6.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.84 0.829 . . . . 2.19 112.601 -169.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.429 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -118.0 -21.54 8.26 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.374 -1.284 . . . . 3.68 111.182 -177.062 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.7 m -122.66 7.4 9.44 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.194 0.521 . . . . 2.08 109.66 -176.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.885 HD11 HG22 ' A' ' 72' ' ' ILE . 27.0 mt -108.78 179.79 4.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.77 -0.65 . . . . 1.16 111.347 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.602 ' HB3' HG22 ' A' ' 80' ' ' VAL . 15.3 mm-40 -151.91 -67.1 0.17 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.408 -0.814 . . . . 2.23 111.349 -175.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.602 HG22 ' HB3' ' A' ' 79' ' ' GLN . 21.5 t -143.09 126.05 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.831 -0.622 . . . . 1.44 110.3 -166.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -89.81 152.93 21.04 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.374 -0.375 . . . . 5.73 110.09 173.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.842 ' HB3' ' HB3' ' A' ' 95' ' ' HIS . 28.1 t-20 -148.99 99.58 2.98 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.401 -0.592 . . . . 1.86 109.401 165.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.542 ' HE1' ' HD3' ' A' ' 86' ' ' ARG . 16.9 ttp -69.9 99.1 1.35 Allowed 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.516 -0.92 . . . . 2.52 108.516 177.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.562 HG11 ' HG2' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -78.29 -95.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.718 -0.673 . . . . 1.19 111.648 -170.576 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.456 ' H ' HG23 ' A' ' 84' ' ' VAL . 23.0 t-160 -105.2 110.46 22.84 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.642 -0.503 . . . . 2.59 109.642 -178.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.542 ' HD3' ' HE1' ' A' ' 83' ' ' MET . 21.1 mtm180 -92.65 108.79 20.25 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.384 -0.599 . . . . 2.83 109.384 178.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.581 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -67.39 -40.72 85.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.092 -0.958 . . . . 1.17 109.463 -177.202 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' A' ' 90' ' ' ASP . 38.2 t70 -156.27 159.77 39.17 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.585 -1.643 . . . . 1.86 107.068 -177.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.1 m -72.13 16.87 0.11 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.906 0.384 . . . . 1.94 111.183 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.519 ' H ' ' C ' ' A' ' 88' ' ' ASP . 16.2 t70 -137.79 1.83 2.35 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.389 -0.967 . . . . 1.87 108.389 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.581 ' O ' HG12 ' A' ' 87' ' ' ILE . 1.7 m -145.29 112.09 5.91 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 109.184 -0.672 . . . . 1.12 109.184 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.549 ' O ' HD12 ' A' ' 114' ' ' LEU . 18.6 m-85 -123.61 177.73 5.54 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.199 0.523 . . . . 0.52 110.883 -172.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.561 ' HB ' HG23 ' A' ' 84' ' ' VAL . 40.9 mt -132.97 127.37 55.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 107.588 -1.264 . . . . 1.1 107.588 169.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.608 ' SG ' HG11 ' A' ' 115' ' ' VAL . 74.5 m -100.98 107.57 19.08 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.426 -0.352 . . . . 2.61 111.921 -172.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.842 ' HB3' ' HB3' ' A' ' 82' ' ' ASN . 19.5 t-160 -82.06 74.88 9.01 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.379 -0.971 . . . . 2.17 108.379 165.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 79.5 m -95.75 111.51 23.45 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.812 -1.085 . . . . 1.19 111.982 -174.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.501 HD13 ' HB ' ' A' ' 80' ' ' VAL . 3.4 mp -78.25 123.56 35.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.992 -0.744 . . . . 1.63 108.992 172.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.534 ' HB ' ' O ' ' A' ' 109' ' ' ARG . 91.1 m -110.35 146.94 34.91 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.951 -1.022 . . . . 1.72 109.778 -173.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -82.88 -179.78 7.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.477 0.656 . . . . 2.29 111.672 -173.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.697 ' HB3' ' HD3' ' A' ' 108' ' ' PRO . 2.7 p -96.68 104.17 16.14 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.191 -0.913 . . . . 4.07 110.973 -176.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.521 ' HE2' ' HB2' ' A' ' 190' ' ' SER . 26.6 t80 -108.61 127.33 53.87 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 107.508 -1.293 . . . . 6.11 107.508 174.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.711 ' HB3' HD12 ' A' ' 106' ' ' ILE . . . 73.01 65.13 0.1 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.579 -1.267 . . . . 1.98 107.579 -168.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.608 HG11 ' HB2' ' A' ' 100' ' ' SER . 23.0 m -71.61 27.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 114.269 -1.332 . . . . 3.6 112.9 -171.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 102' ' ' ALA . . . -95.58 -36.5 5.33 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.648 -0.786 . . . . 2.2 111.338 174.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.612 ' HB2' HG23 ' A' ' 183' ' ' ILE . 63.7 m -139.46 -0.51 1.77 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.969 0.414 . . . . 2.08 111.2 -178.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.711 HD12 ' HB3' ' A' ' 102' ' ' ALA . 96.9 mt -115.6 95.4 3.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.528 0.68 . . . . 1.53 111.007 -177.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.54 ' OG ' ' HD2' ' A' ' 108' ' ' PRO . 22.8 t -79.35 159.4 72.56 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 114.758 -1.11 . . . . 1.71 108.651 173.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.697 ' HD3' ' HB3' ' A' ' 100' ' ' SER . 47.6 Cg_exo -35.91 136.64 0.2 Allowed 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.363 2.709 . . . . 1.31 112.966 173.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.662 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 17.2 ttm180 -123.07 126.42 47.05 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.232 0.539 . . . . 4.06 109.779 -172.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.764 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 9.1 t0 -100.1 119.55 38.48 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.761 -0.654 . . . . 1.37 109.256 -172.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 95' ' ' HIS . 13.0 m-85 -100.1 145.77 27.57 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.153 0.502 . . . . 3.01 112.253 -173.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.956 HG13 ' HA ' ' A' ' 137' ' ' TYR . 29.4 mm -137.87 77.2 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 114.689 -1.142 . . . . 1.2 108.264 170.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.405 ' OD2' ' HB3' ' A' ' 148' ' ' ASN . 1.0 OUTLIER -104.0 124.01 48.25 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.426 -0.806 . . . . 1.86 110.514 -177.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.549 HD12 ' O ' ' A' ' 92' ' ' PHE . 12.8 tp -74.87 123.57 25.29 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.728 0.775 . . . . 1.08 109.41 169.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.608 HG11 ' SG ' ' A' ' 94' ' ' CYS . 0.1 OUTLIER -125.81 126.76 70.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 114.564 -1.198 . . . . 1.08 111.812 -168.232 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.899 ' HE2' ' HE2' ' A' ' 118' ' ' LYS . 87.9 t80 -111.17 128.57 55.95 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.396 -0.82 . . . . 2.81 110.966 175.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.805 HG13 HG22 ' A' ' 127' ' ' ILE . 1.9 mp -88.82 99.93 9.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.911 -0.774 . . . . 1.53 108.911 178.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.899 ' HE2' ' HE2' ' A' ' 116' ' ' TYR . 16.8 tppt? -97.3 123.99 41.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.773 -0.649 . . . . 1.81 110.156 -175.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.429 ' HA ' ' HD3' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -115.46 92.09 3.81 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.495 -0.775 . . . . 3.22 110.852 -178.249 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.623 ' CB ' ' HB3' ' A' ' 123' ' ' ASN . 97.7 m-85 -70.64 101.65 2.1 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 106.147 -1.798 . . . . 1.28 106.147 163.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -47.64 96.31 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.4 1.062 . . . . 2.28 112.289 -173.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 72.03 43.26 49.37 Favored Glycine 0 CA--C 1.503 -0.665 0 CA-C-N 113.796 -1.547 . . . . 0.79 111.757 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.623 ' HB3' ' CB ' ' A' ' 120' ' ' TYR . 2.4 t-20 -146.85 -49.07 0.19 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.089 -0.556 . . . . 2.06 109.978 -178.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.549 ' HB2' ' HD2' ' A' ' 120' ' ' TYR . 1.0 OUTLIER -155.86 135.18 12.29 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.071 0.462 . . . . 1.73 110.978 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.67 80.87 1.5 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.12 -1.067 . . . . 2.07 108.12 175.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.744 HG21 ' HB3' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -103.56 140.66 21.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.538 -0.755 . . . . 1.06 112.201 -172.526 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.805 HG22 HG13 ' A' ' 117' ' ' ILE . 9.0 pt -104.74 116.62 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 108.402 -0.962 . . . . 1.26 108.402 160.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 5.0 m -75.27 163.49 27.44 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.193 -0.912 . . . . 1.53 108.69 173.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 37.1 p -155.55 138.61 15.5 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.402 0.62 . . . . 1.81 110.852 178.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.567 ' HE3' ' HB3' ' A' ' 150' ' ' PRO . 11.4 ttmt -151.96 119.63 6.1 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.669 -0.696 . . . . 2.75 109.231 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.3 p -64.81 106.73 1.27 Allowed 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 108.59 -0.892 . . . . 1.94 108.59 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.5 m -104.7 151.96 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 119.546 -0.862 . . . . 1.64 109.495 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.55 ' HA ' ' CG ' ' A' ' 137' ' ' TYR . 6.5 p-10 -109.05 64.86 0.61 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 122.809 1.29 . . . . 2.17 110.533 -170.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.731 ' CZ ' ' HB3' ' A' ' 136' ' ' GLU . 2.3 p90 -100.91 176.46 1.89 Allowed Pre-proline 0 CA--C 1.555 1.149 0 CA-C-N 113.797 -1.547 . . . . 0.67 108.946 -176.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.655 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 23.7 Cg_exo -27.67 -59.61 0.1 OUTLIER 'Trans proline' 0 CA--C 1.548 1.218 1 C-N-CA 125.347 4.031 . . . . 1.66 117.504 -178.178 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.731 ' HB3' ' CZ ' ' A' ' 134' ' ' PHE . 4.6 tp10 -74.88 -24.97 58.64 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.439 0.533 . . . . 3.5 112.439 -173.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.956 ' HA ' HG13 ' A' ' 112' ' ' ILE . 21.2 t80 -50.68 -45.05 85.82 Favored Pre-proline 0 CA--C 1.553 1.067 0 N-CA-C 115.78 1.77 . . . . 6.41 115.78 -173.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.461 ' HD2' ' O ' ' A' ' 135' ' ' PRO . 36.7 Cg_exo -38.03 116.42 0.22 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 122.975 2.45 . . . . 2.31 114.185 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.662 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 9.6 Cg_endo -89.29 -165.0 0.18 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.883 3.055 . . . . 1.27 114.335 -173.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.0 m -145.03 -171.87 3.73 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.231 -0.895 . . . . 1.88 108.617 -176.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.9 t -81.37 -30.13 33.82 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.573 -0.451 . . . . 2.43 110.593 177.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 -79.65 -29.11 40.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.364 0.602 . . . . 2.18 110.124 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.755 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 34.9 m-85 -122.13 114.14 20.48 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.68 -0.691 . . . . 1.33 110.162 -176.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.662 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 1.5 tp -95.66 112.95 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 108.063 -1.088 . . . . 1.4 108.063 178.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.92 ' HD2' HG12 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -57.75 123.96 17.48 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.645 -1.161 . . . . 5.14 111.779 -174.457 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -42.27 99.52 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 113.973 -1.467 . . . . 1.05 113.176 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 1.105 ' HB2' ' HB3' ' A' ' 174' ' ' GLU . 1.7 p90 -85.5 68.45 10.44 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.304 -0.948 . . . . 4.68 110.902 178.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.405 ' HB3' ' OD2' ' A' ' 113' ' ' ASP . 55.9 t30 -103.31 110.49 22.49 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.112 -0.949 . . . . 2.29 110.361 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.585 ' HB3' ' HD2' ' A' ' 150' ' ' PRO . 28.7 m170 -61.37 164.32 9.14 Favored Pre-proline 0 C--O 1.219 -0.536 0 CA-C-O 118.225 -0.893 . . . . 2.95 108.675 171.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.585 ' HD2' ' HB3' ' A' ' 149' ' ' HIS . 7.6 Cg_endo -49.33 74.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 123.871 3.047 . . . . 0.77 113.982 -177.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . 0.718 ' HB3' ' O ' ' A' ' 170' ' ' PHE . 18.2 m -112.65 -173.68 2.3 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.355 -0.839 . . . . 1.97 108.745 177.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.662 ' O ' ' HG3' ' A' ' 169' ' ' MET . . . -174.98 -154.72 11.42 Favored Glycine 0 CA--C 1.494 -1.235 0 C-N-CA 118.65 -1.738 . . . . 0.55 112.74 -178.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.511 ' CE2' HD21 ' A' ' 167' ' ' LEU . 39.4 t80 -160.07 85.16 0.74 Allowed 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.317 -0.994 . . . . 0.8 108.317 -163.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.666 ' CG2' HG13 ' A' ' 168' ' ' VAL . 3.1 m -94.73 126.17 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 CA-C-O 121.862 0.839 . . . . 1.03 110.625 -173.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 63.9 m -106.69 106.52 17.08 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.439 -0.8 . . . . 2.3 109.171 176.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.68 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 13.2 m -101.09 120.05 56.26 Favored Pre-proline 0 C--N 1.314 -0.939 0 C-N-CA 120.796 -0.362 . . . . 1.45 111.211 -170.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.404 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 77.6 Cg_exo -51.05 119.59 5.57 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.402 2.068 . . . . 0.72 110.965 172.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.593 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 59.2 mmm -83.49 -167.89 1.89 Allowed 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.196 0.522 . . . . 1.72 111.917 -174.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -65.06 -32.84 74.75 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.983 0.897 . . . . 2.63 109.165 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -113.48 31.13 6.7 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.154 -1.385 . . . . 2.05 109.056 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' A' ' 164' ' ' TYR . 2.1 p-10 -23.37 -55.27 0.12 Allowed Pre-proline 0 N--CA 1.475 0.788 0 N-CA-C 116.505 2.039 . . . . 2.19 116.505 -172.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -67.81 -19.31 47.07 Favored 'Trans proline' 0 C--N 1.35 0.624 0 CA-C-N 121.649 1.625 . . . . 0.86 113.146 -175.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -111.89 -22.84 10.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.355 -0.384 . . . . 1.34 111.354 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.593 ' O ' ' HB2' ' A' ' 158' ' ' MET . 94.7 m-85 -138.93 129.3 25.67 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.436 -0.579 . . . . 1.46 109.436 176.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.711 ' HB2' ' HD3' ' A' ' 58' ' ' PRO . 21.9 t -127.22 148.75 50.2 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.054 -0.659 . . . . 2.05 111.598 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.68 ' HB3' ' HB2' ' A' ' 156' ' ' SER . 11.8 tppt? -91.77 100.6 13.27 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.919 0.866 . . . . 1.4 111.261 -178.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.511 HD21 ' CE2' ' A' ' 153' ' ' PHE . 1.0 OUTLIER -88.37 105.78 17.81 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.91 -1.041 . . . . 1.07 109.089 176.417 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.67 HG11 ' HG3' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -132.5 120.21 41.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 122.497 1.141 . . . . 1.11 111.927 177.772 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.726 ' HB3' HG11 ' A' ' 50' ' ' VAL . 19.0 ttt -122.69 160.92 24.85 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 113.999 -1.455 . . . . 1.79 108.165 -178.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.74 ' CD2' HG22 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -145.77 149.03 33.62 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.228 -1.027 . . . . 4.22 108.228 170.553 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.475 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 8.5 p -137.43 132.31 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 O-C-N 124.147 0.904 . . . . 2.01 111.006 -174.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.584 ' HB3' ' HB2' ' A' ' 149' ' ' HIS . 30.9 tt0 -119.93 64.83 0.82 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.587 -1.264 . . . . 2.66 107.587 175.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.487 HG22 ' HE1' ' A' ' 147' ' ' TYR . 0.2 OUTLIER -58.07 130.54 47.08 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.885 -1.507 . . . . 2.2 111.908 -173.032 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 1.105 ' HB3' ' HB2' ' A' ' 147' ' ' TYR . 12.1 tt0 -84.07 -24.18 30.51 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.583 0.706 . . . . 2.45 111.948 -176.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 52.6 mtt 63.24 44.69 5.48 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 114.711 -1.131 . . . . 4.15 111.024 168.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.556 ' CG ' ' HG2' ' A' ' 174' ' ' GLU . 17.0 mtp180 -76.41 1.17 17.14 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.594 -0.73 . . . . 6.51 111.893 -174.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -87.2 176.71 47.16 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.896 -0.882 . . . . 2.26 110.896 174.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -91.08 73.14 6.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 117.108 0.454 . . . . 6.69 111.005 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.611 ' HB2' HD13 ' A' ' 184' ' ' ILE . 1.0 OUTLIER -111.8 156.03 22.62 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.234 -1.025 . . . . 2.21 108.234 174.444 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 67.6 m -112.8 161.51 26.19 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 108.936 -0.764 . . . . 2.31 108.936 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -41.04 -46.82 5.11 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.004 2.469 . . . . 1.86 113.121 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.414 ' O ' ' HG3' ' A' ' 186' ' ' LYS . 25.1 m -62.62 -20.21 64.54 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.419 0.525 . . . . 2.45 112.419 -178.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.612 HG23 ' HB2' ' A' ' 105' ' ' SER . 20.6 mm -90.72 -39.71 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 CA-C-O 122.465 1.126 . . . . 1.69 108.942 -177.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.649 ' HA ' HG23 ' A' ' 187' ' ' THR . 1.0 OUTLIER -70.21 -37.54 71.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 112.91 -1.95 . . . . 1.77 111.489 -176.788 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -67.12 -17.1 64.72 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.149 -0.686 . . . . 2.89 109.149 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.445 ' CE ' ' HA ' ' A' ' 183' ' ' ILE . 45.8 mtmt -90.37 -49.32 6.6 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.415 -0.811 . . . . 1.71 109.211 171.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.649 HG23 ' HA ' ' A' ' 184' ' ' ILE . 11.3 t -60.04 -31.22 69.76 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.617 0.599 . . . . 1.3 112.617 -167.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' MET . . . . . 0.87 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 7.0 mmt -80.11 -61.23 0.45 Allowed Pre-proline 0 C--N 1.327 -0.399 0 C-N-CA 120.488 -0.485 . . . . 1.39 111.296 -176.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.87 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 37.8 Cg_exo -62.21 -26.14 77.4 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.132 1.888 . . . . 1.15 112.812 -178.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.541 ' O ' ' HB3' ' A' ' 194' ' ' ASN . 98.0 p -80.7 -30.42 36.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.021 0.438 . . . . 1.95 110.713 -178.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -90.46 -34.54 15.56 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.825 -0.625 . . . . 1.92 111.518 -172.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.526 HD21 HG13 ' A' ' 50' ' ' VAL . 78.2 mt -73.24 -42.03 63.02 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.57 -0.452 . . . . 1.68 111.607 -174.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.469 HG11 ' O ' ' A' ' 189' ' ' PRO . 1.5 m -70.56 -30.08 41.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.831 -0.803 . . . . 1.32 108.831 178.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.543 ' HA ' ' HB2' ' A' ' 197' ' ' LEU . 0.1 OUTLIER -73.88 -40.63 63.08 Favored 'General case' 0 C--O 1.208 -1.117 0 CA-C-N 114.138 -1.392 . . . . 2.6 111.209 178.013 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.46 ' HD1' ' HA ' ' A' ' 195' ' ' PHE . 1.7 m-30 -56.9 -33.25 66.73 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 118.576 0.626 . . . . 2.73 109.88 172.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.608 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 46.4 mt -77.41 -31.07 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-N 115.973 -0.558 . . . . 1.11 111.316 174.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.543 ' HB2' ' HA ' ' A' ' 194' ' ' ASN . 24.0 mt -70.0 -40.92 75.01 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 110.182 -0.303 . . . . 1.57 110.182 176.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.415 ' HB3' ' CZ3' ' A' ' 74' ' ' TRP . 3.8 m-20 -49.18 -45.33 43.97 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.974 -0.75 . . . . 2.18 108.974 166.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.822 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -66.76 -44.75 80.59 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.965 -0.561 . . . . 1.04 110.22 -177.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.608 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 35.3 mmtp -57.81 -45.83 85.53 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 109.446 -0.575 . . . . 1.51 109.446 172.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -67.47 -43.97 79.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.359 -0.837 . . . . 1.94 110.756 -171.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -78.45 -20.45 71.82 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.18 -1.01 . . . . 0.47 111.666 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.835 HG13 ' HG2' ' A' ' 56' ' ' GLU . 1.0 OUTLIER -78.68 -34.33 17.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 123.439 0.695 . . . . 1.16 109.885 173.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.566 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 99.2 mttt -80.16 -30.26 38.88 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 108.697 -0.853 . . . . 3.8 108.697 177.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -58.39 -22.49 54.06 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.836 -0.62 . . . . 1.28 109.57 170.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.548 ' HB3' ' O ' ' A' ' 203' ' ' ILE . 17.2 t-80 -79.03 -48.31 14.64 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.416 -0.811 . . . . 4.34 112.071 174.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -108.08 -32.89 7.35 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.127 0.788 . . . . 3.0 113.127 -168.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.457 ' C ' ' H ' ' A' ' 210' ' ' SER . 31.3 m -98.07 142.71 25.02 Favored Pre-proline 0 C--N 1.317 -0.831 0 N-CA-C 110.096 -0.335 . . . . 2.01 110.096 -176.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.9 42.23 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.624 2.216 . . . . 2.59 112.25 174.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.457 ' H ' ' C ' ' A' ' 208' ' ' THR . 21.4 t -79.24 -18.48 52.76 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.703 -0.68 . . . . 2.55 109.67 -178.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -86.98 18.06 3.77 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.251 0.548 . . . . 6.11 110.552 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -57.7 -48.69 78.85 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.254 -0.884 . . . . 7.55 108.684 169.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -81.05 67.35 3.62 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.146 -1.182 . . . . 3.73 110.146 169.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -62.58 146.28 52.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.4 0.619 . . . . 6.11 111.6 -174.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -151.37 125.6 9.34 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.171 -0.922 . . . . 7.27 109.469 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -149.17 154.89 39.82 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.492 -0.558 . . . . 6.82 109.492 177.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -96.47 83.71 3.57 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.893 0.378 . . . . 5.77 110.691 -175.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 38.0 t -66.87 -35.89 81.05 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.609 -0.885 . . . . 6.85 108.609 172.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -177.33 -23.09 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.297 -1.319 . . . . 9.48 107.668 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 C--O 1.25 1.08 0 CA-C-N 114.945 -1.025 . . . . 8.48 109.189 169.744 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.574 ' HB2' HG22 ' A' ' 87' ' ' ILE . 15.1 mmt . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 109.854 -0.425 . . . . 4.31 109.854 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.427 ' OD2' HD13 ' A' ' 6' ' ' ILE . 36.4 t70 -66.94 -40.31 87.52 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.743 0.306 . . . . 2.25 110.369 -177.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.824 ' HA ' HD12 ' A' ' 6' ' ' ILE . 94.0 m-85 -64.98 -33.8 76.91 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.076 -0.712 . . . . 0.45 109.076 -176.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.634 ' HD2' ' CB ' ' A' ' 88' ' ' ASP . 33.5 tttm -73.79 -3.58 29.42 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.021 -0.99 . . . . 2.06 110.288 177.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 9' ' ' GLN . . . -91.37 -40.98 11.15 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.559 -0.534 . . . . 1.2 109.559 172.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.824 HD12 ' HA ' ' A' ' 3' ' ' PHE . 1.1 mp -82.51 -44.01 19.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.956 0.884 . . . . 1.76 109.487 -172.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.658 ' HB2' ' HB2' ' A' ' 116' ' ' TYR . . . -70.85 -39.3 73.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.302 -1.317 . . . . 1.11 111.422 -178.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.606 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 8.1 mt-30 -66.85 -26.14 66.76 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.99 -1.004 . . . . 2.14 110.384 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 5' ' ' ALA . 98.7 mt-30 -80.52 -37.11 32.19 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.082 -0.963 . . . . 3.04 108.843 172.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.646 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.4 OUTLIER -67.87 -37.48 81.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.666 -1.152 . . . . 1.1 111.614 -178.849 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.612 ' HA ' ' OG ' ' A' ' 128' ' ' SER . . . -46.43 -58.44 3.75 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.592 0.59 . . . . 1.04 112.592 176.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.508 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 13.1 pt20 -83.14 5.39 22.8 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.056 0.455 . . . . 2.31 110.803 -177.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.531 ' HB3' ' HA ' ' A' ' 10' ' ' THR . 0.2 OUTLIER -89.49 -49.94 6.39 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.182 -1.044 . . . . 2.54 108.182 174.978 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.675 HG21 ' N ' ' A' ' 152' ' ' GLY . 13.2 p -69.93 -36.44 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 121.828 0.823 . . . . 1.21 109.555 177.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.53 ' HG ' ' OD1' ' A' ' 18' ' ' ASN . 2.1 tt -72.87 -18.72 61.4 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 114.87 -1.059 . . . . 1.26 109.229 173.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 20' ' ' ASP . . . -61.94 -23.5 63.68 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.11 -1.405 . . . . 0.57 109.856 172.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.42 ' HB3' ' CE2' ' A' ' 170' ' ' PHE . 6.8 m-85 -91.33 -28.79 17.51 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.099 -0.55 . . . . 3.59 110.775 177.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.558 ' HA ' ' HZ ' ' A' ' 170' ' ' PHE . 0.1 OUTLIER -69.59 -15.75 63.27 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.777 -0.369 . . . . 2.1 111.335 179.401 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -117.59 -5.48 11.18 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 119.921 -0.711 . . . . 3.26 111.896 179.056 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 2.6 m-20 -121.99 135.75 54.87 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 120.919 0.39 . . . . 2.16 111.205 178.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.512 HG23 ' CZ2' ' A' ' 24' ' ' TRP . 64.4 p -137.61 120.47 16.42 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.05 -0.523 . . . . 2.24 111.411 -176.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.3 t -167.34 132.09 1.95 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.152 -0.476 . . . . 2.46 110.204 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.87 -6.06 82.04 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.859 -0.686 . . . . 1.45 113.669 172.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.803 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -111.75 -170.2 1.61 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.842 0.321 . . . . 2.24 110.625 -178.231 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.439 ' HE2' ' HB3' ' A' ' 25' ' ' LYS . 7.3 mtpt -178.6 133.22 0.13 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.884 -0.784 . . . . 3.43 108.884 -169.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.771 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 1.6 p -61.58 120.03 6.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 119.819 -0.753 . . . . 2.21 109.305 171.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 p -95.18 -23.5 5.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 114.708 -1.133 . . . . 1.83 109.123 -177.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.417 ' HD2' ' HA ' ' A' ' 28' ' ' LYS . 11.0 tptm -156.53 129.92 8.12 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.885 -0.598 . . . . 2.87 111.847 -173.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.463 HG23 HG21 ' A' ' 26' ' ' VAL . 40.2 p -122.09 149.44 43.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.429 -0.805 . . . . 1.92 109.584 173.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 51.1 m -150.4 69.78 1.0 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 121.185 -0.206 . . . . 2.37 111.204 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER 74.76 71.76 0.1 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.209 -0.451 . . . . 4.84 110.829 177.241 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.539 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 89.5 mttt 80.04 4.54 1.92 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.337 -0.847 . . . . 2.05 112.842 172.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.829 HG22 ' HA3' ' A' ' 52' ' ' GLY . 7.5 pt -115.66 143.61 25.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.069 0.461 . . . . 1.42 110.151 175.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 5.0 m -136.47 104.7 5.67 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.125 -0.943 . . . . 1.22 110.433 -163.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.7 HG22 HG23 ' A' ' 50' ' ' VAL . 3.4 t -96.48 98.85 8.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.864 -0.421 . . . . 1.52 109.864 -178.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.771 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 25.9 t -91.96 121.68 33.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.725 0.774 . . . . 1.74 110.357 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.3 t -109.01 135.21 50.55 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.341 -1.299 . . . . 1.72 110.56 -175.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.803 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 31.6 ttpt -121.92 -90.66 0.57 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.482 -0.781 . . . . 2.45 110.352 178.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.83 ' HA ' ' HA ' ' A' ' 46' ' ' ASN . . . -179.49 143.34 0.19 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.419 -0.81 . . . . 2.17 109.805 -177.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.8 m -112.03 80.79 1.37 Allowed 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.604 -0.517 . . . . 2.51 109.604 175.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -76.83 -4.43 43.54 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.791 -0.64 . . . . 7.41 109.781 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -63.09 -14.58 50.09 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.615 -0.72 . . . . 6.84 109.714 172.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -146.04 -93.57 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.646 -0.707 . . . . 6.42 109.317 175.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -171.62 68.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.914 0.388 . . . . 6.31 110.172 173.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -160.5 -140.34 2.87 Favored Glycine 0 N--CA 1.434 -1.462 0 N-CA-C 110.123 -1.191 . . . . 1.74 110.123 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.83 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 82.2 m-20 -135.22 151.64 50.81 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 110.121 -0.326 . . . . 2.45 110.121 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.506 HD22 ' N ' ' A' ' 48' ' ' TYR . 2.9 tt -104.89 137.34 42.81 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.169 -1.049 . . . . 1.49 108.169 178.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.506 ' N ' HD22 ' A' ' 47' ' ' LEU . 58.2 m-85 -124.47 126.42 45.87 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.392 -0.367 . . . . 1.52 110.137 -173.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.706 ' HG3' ' CE2' ' A' ' 170' ' ' PHE . 2.5 tmm_? -113.36 120.27 40.52 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.38 -0.6 . . . . 3.34 109.38 175.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.7 HG23 HG22 ' A' ' 35' ' ' VAL . 7.6 p -101.9 138.68 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 108.769 -0.826 . . . . 1.98 108.769 177.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.606 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 51.6 tt0 -138.63 108.07 6.16 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.467 -0.788 . . . . 1.07 109.351 -169.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.829 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -138.34 142.39 13.08 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.031 -1.08 . . . . 0.35 112.195 -177.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.0 mt -86.8 124.29 40.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 C-N-CA 120.29 -0.564 . . . . 1.3 109.886 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.548 HG12 ' HD3' ' A' ' 200' ' ' LYS . 71.7 mt -105.95 113.76 63.38 Favored Pre-proline 0 C--N 1.312 -1.05 0 N-CA-C 108.834 -0.802 . . . . 1.07 108.834 175.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -62.18 67.49 0.12 Allowed 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 124.175 3.25 . . . . 0.74 112.043 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.69 ' HG2' ' CG1' ' A' ' 203' ' ' ILE . 8.0 tp10 -161.13 172.32 16.98 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.775 -1.194 . . . . 1.68 107.775 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.445 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 6.2 p -82.09 144.7 51.38 Favored Pre-proline 0 N--CA 1.427 -1.575 0 CA-C-O 121.748 0.785 . . . . 1.58 110.356 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.764 ' HG3' ' HG ' ' A' ' 165' ' ' SER . 23.8 Cg_exo -61.71 -13.25 29.11 Favored 'Trans proline' 0 C--N 1.332 -0.297 0 C-N-CA 124.108 3.206 . . . . 0.74 110.539 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.61 -51.47 34.83 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.526 -1.215 . . . . 1.31 111.028 175.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.601 ' HB3' HD11 ' A' ' 203' ' ' ILE . 26.2 ttmt -71.06 -27.9 63.98 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.885 -0.784 . . . . 3.78 108.885 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 1.071 HD21 HD12 ' A' ' 203' ' ' ILE . 42.7 mt -63.95 -53.13 55.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.697 -1.138 . . . . 1.09 109.945 174.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.549 ' HA ' ' CD1' ' A' ' 65' ' ' LEU . 34.7 t -65.91 -11.92 50.76 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.438 -0.346 . . . . 1.94 110.317 175.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.472 ' HB2' ' HA ' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -83.1 -40.25 20.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.217 -0.447 . . . . 1.32 111.497 -179.717 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.515 ' CD2' ' HA ' ' A' ' 61' ' ' LEU . 15.6 p90 -81.37 -42.79 19.96 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 120.813 -0.355 . . . . 0.79 111.166 -174.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.749 HD11 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -85.87 10.17 14.64 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.709 0.29 . . . . 2.15 110.726 -173.02 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.541 ' N ' HH12 ' A' ' 71' ' ' ARG . 1.0 OUTLIER -42.99 -71.29 0.08 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.155 -0.93 . . . . 2.06 112.683 -169.207 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.41 -57.3 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.183 1.549 . . . . 4.31 115.183 177.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.694 ' OG1' ' HB2' ' A' ' 81' ' ' TYR . 8.8 t -159.07 23.85 0.2 Allowed 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.852 -0.53 . . . . 1.89 112.298 -161.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -127.67 1.29 6.91 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 118.501 -1.809 . . . . 1.71 115.535 -166.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.617 ' O ' HG22 ' A' ' 73' ' ' THR . 24.5 t70 -173.27 -40.63 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 117.566 0.683 . . . . 2.19 110.784 -169.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.689 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -54.87 -38.52 67.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.501 -0.772 . . . . 3.95 111.362 -173.743 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.759 HG21 HD11 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -86.11 -7.46 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-O 120.969 0.414 . . . . 1.42 110.953 -176.499 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -90.34 -26.54 19.91 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 120.077 -0.649 . . . . 1.45 109.631 -175.584 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.519 ' CZ3' ' HB3' ' A' ' 198' ' ' ASN . 24.2 p-90 -111.2 -4.68 14.91 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.595 0.591 . . . . 0.78 112.595 178.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.689 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 4.2 t70 -70.6 174.33 6.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.684 0.754 . . . . 2.19 112.348 -171.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.563 ' HG2' ' OD1' ' A' ' 198' ' ' ASN . 1.3 mmtt -106.76 -29.04 9.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.857 -1.065 . . . . 3.68 109.313 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.1 m -128.28 20.63 6.26 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.671 -1.15 . . . . 2.08 111.109 -172.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.759 HD11 HG21 ' A' ' 72' ' ' ILE . 27.1 mt -110.17 155.94 21.3 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.995 0.426 . . . . 1.16 110.45 175.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.896 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 2.7 mm-40 -128.16 -61.44 1.1 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.859 -0.609 . . . . 2.23 112.269 -170.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.702 ' CG1' ' HB ' ' A' ' 97' ' ' ILE . 2.9 p -157.15 127.02 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.644 0.735 . . . . 1.44 111.9 -170.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.694 ' HB2' ' OG1' ' A' ' 68' ' ' THR . 48.6 p90 -89.67 143.96 26.38 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.454 -1.248 . . . . 5.73 110.936 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.766 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 51.1 m-80 -150.03 109.41 3.98 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.193 -0.669 . . . . 1.86 109.193 172.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.495 ' SD ' ' HB3' ' A' ' 92' ' ' PHE . 31.0 tpp -79.88 109.43 14.31 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.89 -0.782 . . . . 2.52 108.89 177.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.644 HG12 ' HG3' ' A' ' 136' ' ' GLU . 0.0 OUTLIER -85.07 -72.39 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.857 -0.61 . . . . 1.19 110.342 -168.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.491 ' HB2' HD12 ' A' ' 93' ' ' ILE . 8.0 m-70 -126.41 121.57 32.84 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.764 -0.653 . . . . 2.59 109.741 177.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 -100.47 125.51 46.79 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.136 -1.061 . . . . 2.83 108.136 175.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.724 HG23 ' HB2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -91.34 -58.27 3.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 116.22 -0.446 . . . . 1.17 111.994 -167.072 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.634 ' CB ' ' HD2' ' A' ' 4' ' ' LYS . 15.6 m-20 -144.92 35.89 1.13 Allowed 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.604 -0.438 . . . . 1.86 112.151 -165.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.9 t 73.21 -33.2 0.26 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.154 0.582 . . . . 1.94 112.42 176.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' A' ' 88' ' ' ASP . 8.5 m-20 -117.02 10.53 13.99 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 108.485 -0.932 . . . . 1.87 108.485 -177.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.601 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -138.92 116.2 11.12 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 114.962 -1.017 . . . . 1.12 108.394 -174.381 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.589 ' O ' HD12 ' A' ' 114' ' ' LEU . 46.5 m-85 -124.41 177.36 5.93 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.196 0.522 . . . . 0.52 110.745 -175.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.626 ' O ' HG21 ' A' ' 84' ' ' VAL . 43.1 mt -135.83 118.03 21.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 107.515 -1.291 . . . . 1.1 107.515 168.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 72.5 m -100.46 109.32 21.45 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.883 0.373 . . . . 2.61 111.931 -171.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.766 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 19.6 t-160 -80.04 69.96 6.53 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.56 -0.904 . . . . 2.17 108.56 170.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 96.5 m -95.92 114.72 26.47 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.511 -1.222 . . . . 1.19 111.427 -175.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.702 ' HB ' ' CG1' ' A' ' 80' ' ' VAL . 2.7 mp -85.11 127.53 39.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.614 -0.884 . . . . 1.63 108.614 172.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 109' ' ' ARG . 12.6 t -110.86 165.37 11.9 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.937 -0.574 . . . . 1.72 110.233 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.896 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 50.5 mt-30 -115.72 74.91 0.91 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.673 -0.694 . . . . 2.29 109.429 175.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.406 ' O ' ' HB ' ' A' ' 106' ' ' ILE . 17.3 m -79.04 32.64 0.21 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.452 0.644 . . . . 4.07 110.606 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.558 ' CE2' ' HA2' ' A' ' 104' ' ' GLY . 43.8 t80 -61.2 98.49 0.08 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.865 -1.061 . . . . 6.11 110.561 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.67 -71.45 0.35 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.602 -0.726 . . . . 1.98 110.809 174.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.7 t -128.48 6.15 2.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 122.16 0.981 . . . . 3.6 108.648 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.558 ' HA2' ' CE2' ' A' ' 101' ' ' PHE . . . 106.9 0.72 36.27 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 114.576 -1.193 . . . . 2.2 110.435 -169.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -32.35 65.71 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.728 0.775 . . . . 2.08 109.533 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.826 HG12 HD23 ' A' ' 179' ' ' LEU . 8.3 mt -113.9 116.99 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-N 114.193 -1.367 . . . . 1.53 110.001 -172.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.416 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 14.2 m -71.58 164.12 60.54 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 115.976 -0.556 . . . . 1.71 109.612 175.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 107' ' ' SER . 7.9 Cg_endo -51.06 113.62 1.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.072 1.848 . . . . 1.31 110.48 172.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.653 ' HG2' HG23 ' A' ' 144' ' ' ILE . 18.7 mtm180 -90.62 137.52 32.29 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 120.321 -0.552 . . . . 4.06 109.716 -173.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.832 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 9.9 t0 -94.42 126.85 39.95 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.905 -0.776 . . . . 1.37 108.905 -177.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 95' ' ' HIS . 6.9 m-85 -107.17 146.34 31.46 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.61 0.719 . . . . 3.01 111.576 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.816 HG12 ' HD2' ' A' ' 145' ' ' ARG . 25.2 mm -137.67 68.78 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 114.301 -1.318 . . . . 1.2 107.608 172.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.837 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 1.4 m-20 -90.54 115.56 27.78 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.627 -1.17 . . . . 1.86 110.088 -176.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 129' ' ' SER . 6.1 tp -74.84 119.18 18.67 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 108.745 -0.835 . . . . 1.08 108.745 169.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.2 OUTLIER -122.99 124.13 69.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-N 115.033 -0.985 . . . . 1.08 111.675 -164.24 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.658 ' HB2' ' HB2' ' A' ' 7' ' ' ALA . 79.8 t80 -107.77 119.76 40.34 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.973 -1.012 . . . . 2.81 110.769 176.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.792 HG13 HG23 ' A' ' 127' ' ' ILE . 3.9 mp -89.85 98.87 8.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.768 -0.651 . . . . 1.53 109.608 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.451 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 39.7 ttmt -106.77 141.4 38.08 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.702 -0.681 . . . . 1.81 109.508 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.447 ' C ' ' HD2' ' A' ' 119' ' ' ARG . 0.4 OUTLIER -131.75 104.19 6.77 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 109.01 -0.737 . . . . 3.22 109.01 -177.566 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.622 ' CB ' ' HB3' ' A' ' 123' ' ' ASN . 42.7 m-85 -71.43 114.67 9.75 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 106.959 -1.497 . . . . 1.28 106.959 167.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -41.61 96.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 O-C-N 124.514 1.134 . . . . 2.28 112.293 -175.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.43 ' C ' ' HG2' ' A' ' 157' ' ' PRO . . . 61.56 36.52 92.73 Favored Glycine 0 CA--C 1.508 -0.352 0 CA-C-N 114.496 -1.229 . . . . 0.79 112.276 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.622 ' HB3' ' CB ' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -133.82 -45.81 0.8 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.524 -0.338 . . . . 2.06 110.377 -178.614 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.533 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 0.3 OUTLIER -157.72 122.64 4.4 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.848 0.356 . . . . 1.73 111.393 -177.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 155' ' ' CYS . 13.4 m120 -104.26 73.83 1.15 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.756 -0.831 . . . . 2.07 108.756 174.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.654 ' HB ' HG11 ' A' ' 154' ' ' VAL . 1.2 tt -96.57 136.11 28.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 113.245 0.831 . . . . 1.06 113.245 -172.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.792 HG23 HG13 ' A' ' 117' ' ' ILE . 21.0 pt -104.87 109.82 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-O 121.98 0.895 . . . . 1.26 109.009 163.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.612 ' OG ' ' HA ' ' A' ' 11' ' ' ALA . 1.1 m -89.84 114.42 26.16 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.441 -0.799 . . . . 1.53 110.709 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.837 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 79.3 p -114.21 145.05 42.22 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.57 0.7 . . . . 1.81 111.753 -172.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.849 ' HZ2' ' HB3' ' A' ' 130' ' ' LYS . 6.3 mtpm? -133.78 123.75 25.41 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 107.677 -1.231 . . . . 2.75 107.677 174.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.468 ' HB2' ' H ' ' A' ' 148' ' ' ASN . 32.6 t -64.28 98.85 0.25 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 105.926 -1.879 . . . . 1.94 105.926 170.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.457 HG12 ' HB3' ' A' ' 134' ' ' PHE . 0.3 OUTLIER -105.41 132.62 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 CA-C-O 121.985 0.897 . . . . 1.64 109.021 -164.012 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -88.61 68.86 8.77 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 114.02 -1.445 . . . . 2.17 109.26 -166.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.692 ' HB2' ' HD2' ' A' ' 135' ' ' PRO . 0.4 OUTLIER -107.07 175.08 2.17 Favored Pre-proline 0 CA--C 1.548 0.875 0 CA-C-N 114.997 -1.001 . . . . 0.67 109.496 -172.226 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.692 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 3.0 Cg_exo -35.91 -51.28 1.06 Allowed 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 124.802 3.668 . . . . 1.66 116.632 -175.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.644 ' HG3' HG12 ' A' ' 84' ' ' VAL . 14.0 mm-40 -82.74 -21.59 34.67 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.5 0.667 . . . . 3.5 111.474 -172.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.856 ' HH ' HH22 ' A' ' 176' ' ' ARG . 60.3 t80 -56.01 -38.59 69.82 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 115.233 1.568 . . . . 6.41 115.233 -174.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 67.8 Cg_exo -41.46 114.88 0.36 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 122.055 1.837 . . . . 2.31 112.431 173.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.591 ' HG3' ' HB2' ' A' ' 145' ' ' ARG . 1.6 Cg_endo -85.23 -153.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.792 2.995 . . . . 1.27 113.982 -173.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.2 p -136.54 -158.77 0.89 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 114.923 -1.035 . . . . 1.88 108.572 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.3 p -90.28 -36.84 14.47 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.215 -0.594 . . . . 2.43 111.488 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -75.74 -48.27 22.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.356 -0.383 . . . . 2.18 111.661 -178.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.73 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 94.9 m-85 -93.75 125.07 38.16 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.028 0.442 . . . . 1.33 110.102 -177.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.653 HG23 ' HG2' ' A' ' 109' ' ' ARG . 1.1 tp -106.94 105.91 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-N 115.723 -0.671 . . . . 1.4 109.276 -177.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.832 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 0.8 OUTLIER -58.86 100.92 0.08 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.01 -0.996 . . . . 5.14 109.818 177.816 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -63.09 117.5 11.44 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.952 -0.642 . . . . 1.05 111.746 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.486 ' HB3' ' CB ' ' A' ' 174' ' ' GLU . 34.8 t80 -85.81 82.7 8.07 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.508 0.671 . . . . 4.68 110.496 -176.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.64 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 88.2 m-20 -70.93 106.1 3.52 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.284 -0.871 . . . . 2.29 109.849 173.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.489 ' O ' ' HB3' ' A' ' 172' ' ' GLN . 36.0 m-70 -68.04 131.44 92.27 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 108.347 -0.982 . . . . 2.95 108.347 174.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.8 ' HG3' ' HE2' ' A' ' 130' ' ' LYS . 83.4 Cg_exo -17.51 68.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.927 1 C-N-CA 126.722 4.948 . . . . 0.77 115.854 -169.409 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . 0.64 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 10.0 p -99.46 -174.6 2.77 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.077 -0.965 . . . . 1.97 108.866 173.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.675 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -173.67 -150.98 7.86 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 119.14 -1.505 . . . . 0.55 112.685 -177.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 23.0 t80 -162.35 93.05 0.84 Allowed 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.929 -1.137 . . . . 0.8 107.929 -164.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.654 HG11 ' HB ' ' A' ' 126' ' ' ILE . 5.9 m -101.55 134.09 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-O 121.933 0.873 . . . . 1.03 110.621 -177.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 124' ' ' MET . 8.9 t -113.28 122.63 48.01 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.036 -0.984 . . . . 2.3 109.37 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.581 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 21.3 m -117.83 114.92 37.27 Favored Pre-proline 0 C--N 1.319 -0.755 0 C-N-CA 120.636 -0.426 . . . . 1.45 112.015 -171.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.441 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 84.8 Cg_exo -49.94 121.84 8.11 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.607 2.205 . . . . 0.72 111.544 171.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.678 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 0.5 OUTLIER -79.64 -167.73 1.33 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.156 0.503 . . . . 1.72 112.268 -173.599 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -63.81 -30.78 71.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.237 -0.892 . . . . 2.63 108.631 172.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.541 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 13.5 mm-40 -103.3 26.8 7.9 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 114.536 -1.211 . . . . 2.05 109.231 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.639 ' HB3' ' HD3' ' A' ' 162' ' ' PRO . 49.7 t-20 4.74 -77.81 0.0 OUTLIER Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 126.23 1.812 . . . . 2.19 115.357 -177.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.639 ' HD3' ' HB3' ' A' ' 161' ' ' ASN . 71.6 Cg_endo -73.69 -13.29 24.59 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 121.396 1.397 . . . . 0.86 113.912 -172.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -105.79 -27.0 11.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.526 -0.306 . . . . 1.34 111.308 -176.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.678 ' O ' ' HB2' ' A' ' 158' ' ' MET . 67.8 m-85 -137.62 133.18 34.05 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.515 -0.55 . . . . 1.46 109.515 176.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.764 ' HG ' ' HG3' ' A' ' 58' ' ' PRO . 32.3 t -129.23 147.55 51.08 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.228 0.537 . . . . 2.05 110.896 177.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.606 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.6 tppp? -93.99 103.48 15.56 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 122.043 0.925 . . . . 1.4 110.993 -178.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.445 HD22 ' CZ ' ' A' ' 153' ' ' PHE . 0.6 OUTLIER -87.26 103.45 15.46 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.345 -1.298 . . . . 1.07 109.475 177.475 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.611 HG11 HG23 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -125.4 116.38 46.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.833 0.825 . . . . 1.11 111.327 178.436 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.603 ' HE1' HD22 ' A' ' 192' ' ' LEU . 48.6 ttp -121.97 145.59 47.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.355 -0.839 . . . . 1.79 109.945 -175.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.706 ' CE2' ' HG3' ' A' ' 49' ' ' ARG . 31.3 m-85 -119.3 134.9 54.97 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 109.098 -0.704 . . . . 4.22 109.098 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 2.7 p -120.8 119.13 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-O 121.55 0.691 . . . . 2.01 109.648 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.489 ' HB3' ' O ' ' A' ' 149' ' ' HIS . 9.3 tt0 -127.05 51.25 1.9 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.734 1.254 . . . . 2.66 108.133 -176.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.474 HG21 ' H ' ' A' ' 175' ' ' MET . 11.0 m -72.63 150.89 42.63 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 113.565 -1.652 . . . . 2.2 110.77 -174.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.678 ' HG2' ' HG3' ' A' ' 176' ' ' ARG . 3.3 tt0 -82.37 -19.76 38.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.229 0.538 . . . . 2.45 111.136 -177.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.474 ' H ' HG21 ' A' ' 173' ' ' THR . 58.8 mtt 68.43 34.87 3.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.114 -0.948 . . . . 4.15 111.188 169.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.856 HH22 ' HH ' ' A' ' 137' ' ' TYR . 45.2 mtm180 -78.82 13.46 1.69 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.198 0.523 . . . . 6.51 109.913 177.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 175' ' ' MET . . . -91.15 33.79 4.56 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.785 -0.643 . . . . 2.26 113.961 -171.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp 60.22 66.67 0.93 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.2 0.444 . . . . 6.69 112.2 170.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.826 HD23 HG12 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -148.77 160.21 43.41 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.457 0.646 . . . . 2.21 111.152 -177.259 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.531 ' O ' HD12 ' A' ' 184' ' ' ILE . 6.8 m -111.86 160.51 29.5 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 114.754 -1.112 . . . . 2.31 108.552 -178.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -41.83 -46.55 6.62 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.048 2.498 . . . . 1.86 114.109 -176.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 12.2 t -72.47 -17.4 61.77 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.902 0.382 . . . . 2.45 111.504 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 21.9 mm -85.25 -35.68 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 CA-C-O 122.64 1.21 . . . . 1.69 108.384 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.675 ' HA ' HG22 ' A' ' 187' ' ' THR . 0.9 OUTLIER -68.69 -32.76 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-N 112.602 -2.09 . . . . 1.77 110.187 179.563 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.51 ' O ' ' HD2' ' A' ' 189' ' ' PRO . 12.3 mm-40 -53.47 -34.39 57.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.282 -0.872 . . . . 2.89 109.206 167.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.541 ' O ' ' HB2' ' A' ' 190' ' ' SER . 43.4 mtmt -93.22 -12.35 30.43 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.823 -1.08 . . . . 1.71 111.917 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.675 HG22 ' HA ' ' A' ' 184' ' ' ILE . 6.8 t -92.98 -45.56 7.88 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 119.1 -1.04 . . . . 1.3 112.112 175.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' MET . . . . . 0.939 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 11.2 mmt -81.42 -67.47 0.22 Allowed Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 121.184 -0.947 . . . . 1.39 111.362 -173.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.939 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 29.5 Cg_exo -60.92 -31.4 91.48 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 121.975 1.783 . . . . 1.15 112.118 -176.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.541 ' HB2' ' O ' ' A' ' 186' ' ' LYS . 48.7 m -77.96 -29.53 49.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.35 -0.386 . . . . 1.95 111.717 -176.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 187' ' ' THR . 7.9 m120 -90.37 -29.82 17.81 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.881 -0.328 . . . . 1.92 111.425 -177.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.603 HD22 ' HE1' ' A' ' 169' ' ' MET . 42.1 mt -64.02 -48.06 77.8 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 120.907 -0.317 . . . . 1.68 111.265 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.781 ' HB ' HD13 ' A' ' 33' ' ' ILE . 1.1 m -67.08 -35.65 74.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.445 0.64 . . . . 1.32 109.778 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -68.15 -30.89 70.12 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.737 -1.119 . . . . 2.6 110.94 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.481 ' O ' ' HB2' ' A' ' 198' ' ' ASN . 8.0 t80 -73.88 -27.35 61.02 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.46 -0.57 . . . . 2.73 109.46 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.431 ' O ' ' HB1' ' A' ' 199' ' ' ALA . 25.6 mt -78.56 -27.78 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-O 121.353 0.597 . . . . 1.11 110.281 173.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.474 ' HA ' HD22 ' A' ' 197' ' ' LEU . 61.1 mt -71.66 -39.63 70.18 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 109.585 -0.524 . . . . 1.57 109.585 172.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.563 ' OD1' ' HG2' ' A' ' 76' ' ' LYS . 87.0 m-20 -49.63 -38.89 33.85 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.972 -1.013 . . . . 2.18 109.58 165.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.613 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -76.13 -42.88 45.52 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 116.356 -0.384 . . . . 1.04 110.744 -178.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.548 ' HD3' HG12 ' A' ' 54' ' ' ILE . 35.9 mmtm -59.12 -42.42 90.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.507 0.67 . . . . 1.51 110.904 175.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -86.66 -37.23 18.21 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.209 -0.905 . . . . 1.94 110.641 -174.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 206' ' ' HIS . . . -70.72 -29.52 69.41 Favored Glycine 0 CA--C 1.503 -0.657 0 N-CA-C 111.395 -0.682 . . . . 0.47 111.395 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 1.071 HD12 HD21 ' A' ' 61' ' ' LEU . 2.8 tp -70.74 -33.49 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 109.629 -0.508 . . . . 1.16 109.629 177.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.463 ' HA ' ' HB3' ' A' ' 207' ' ' ARG . 40.9 mttp -85.79 -25.03 26.57 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 109.302 -0.629 . . . . 3.8 109.302 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.832 ' HA ' ' HB3' ' A' ' 210' ' ' SER . . . -65.38 -32.59 74.3 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.71 -0.848 . . . . 1.28 108.71 167.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.494 ' HB2' ' O ' ' A' ' 202' ' ' GLY . 1.8 t60 -92.98 -3.15 54.97 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 114.814 -1.085 . . . . 4.34 112.086 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.463 ' HB3' ' HA ' ' A' ' 204' ' ' LYS . 0.2 OUTLIER -119.12 -48.8 2.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.872 0.844 . . . . 3.0 110.393 -178.482 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.494 HG23 ' HD2' ' A' ' 209' ' ' PRO . 1.2 m -95.88 151.7 38.53 Favored Pre-proline 0 C--N 1.31 -1.13 0 CA-C-N 114.414 -1.267 . . . . 2.01 109.608 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . 0.494 ' HD2' HG23 ' A' ' 208' ' ' THR . 38.4 Cg_exo -59.04 73.78 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.146 2.564 . . . . 2.59 113.281 176.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.832 ' HB3' ' HA ' ' A' ' 205' ' ' ALA . 18.2 t -115.31 12.32 16.37 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 122.118 0.961 . . . . 2.55 109.136 175.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.601 ' HE ' ' HA ' ' A' ' 211' ' ' ARG . 2.0 mmp_? -102.73 11.64 37.36 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.24 -0.891 . . . . 6.11 109.518 176.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -60.42 -25.56 66.04 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.326 -0.852 . . . . 7.55 110.003 176.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -135.92 99.36 0.31 Allowed Glycine 0 N--CA 1.439 -1.102 0 CA-C-N 115.371 -0.831 . . . . 3.73 111.198 174.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.502 ' CZ ' ' HB3' ' A' ' 211' ' ' ARG . 85.4 m-85 -75.68 179.21 5.53 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.13 -0.322 . . . . 6.11 110.13 177.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 6.9 t60 73.6 131.17 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 O-C-N 123.75 0.656 . . . . 7.27 110.814 175.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -67.05 93.09 0.27 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.565 0.698 . . . . 6.82 109.839 174.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -78.29 46.88 0.64 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.183 -0.917 . . . . 5.77 112.512 -172.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 46.7 t -110.18 7.71 23.42 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.362 -0.381 . . . . 6.85 110.161 177.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 81.7 t60 57.61 41.15 26.06 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.854 0.835 . . . . 9.48 110.408 -178.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 39.4 m . . . . . 0 C--O 1.246 0.873 0 CA-C-O 118.134 -0.936 . . . . 8.48 109.449 179.484 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 111.23 0.085 . . . . 4.31 111.23 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.571 ' O ' HD13 ' A' ' 6' ' ' ILE . 32.4 t70 -174.4 -77.86 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 110.128 -0.323 . . . . 2.25 110.128 -177.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.777 ' HA ' HD12 ' A' ' 6' ' ' ILE . 70.4 m-85 -61.78 -31.01 71.19 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 108.313 -0.995 . . . . 0.45 108.313 172.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.743 ' HZ1' ' HE1' ' A' ' 116' ' ' TYR . 36.7 tttp -60.34 -49.0 79.32 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 113.803 -1.544 . . . . 2.06 107.674 177.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.401 ' HB1' ' O ' ' A' ' 2' ' ' ASP . . . -50.11 -46.31 53.55 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.972 -0.558 . . . . 1.2 112.227 -178.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.777 HD12 ' HA ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -81.52 -36.81 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 CA-C-O 121.634 0.731 . . . . 1.76 110.02 -172.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.653 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -80.63 -30.57 36.69 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.588 -1.187 . . . . 1.11 111.568 -175.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.613 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 33.9 mt-30 -65.78 -32.24 73.66 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.783 -1.098 . . . . 2.14 109.087 175.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.604 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 12.5 mm100 -81.02 -45.38 16.65 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.418 -1.265 . . . . 3.04 109.059 175.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.493 ' HB ' ' HA ' ' A' ' 7' ' ' ALA . 0.6 OUTLIER -56.26 -37.4 69.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.202 -0.908 . . . . 1.1 111.192 176.78 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.573 ' HA ' ' CB ' ' A' ' 128' ' ' SER . . . -46.86 -60.84 2.16 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 120.819 0.343 . . . . 1.04 111.796 173.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -79.04 -6.62 56.83 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.323 -0.399 . . . . 2.31 111.087 -177.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.604 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 34.3 mm-40 -78.98 -47.21 16.74 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.248 0.547 . . . . 2.54 109.545 172.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.654 ' O ' ' HD2' ' A' ' 17' ' ' TYR . 9.9 p -74.63 -41.39 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.77 0.795 . . . . 1.21 109.115 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.432 HD12 ' HE1' ' A' ' 124' ' ' MET . 2.5 tt -68.72 -21.2 64.41 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-O 121.719 0.771 . . . . 1.26 109.155 174.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.37 -17.54 61.99 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 114.017 -1.447 . . . . 0.57 110.59 172.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.766 ' HH ' HG21 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -86.49 -33.47 20.33 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.541 -0.911 . . . . 3.59 108.541 177.865 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.517 ' ND2' HG23 ' A' ' 168' ' ' VAL . 2.8 t-20 -75.97 -6.47 51.1 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.648 0.737 . . . . 2.1 110.269 -176.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -120.55 11.31 11.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.476 -0.784 . . . . 3.26 110.582 176.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -139.01 111.4 7.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.154 -0.476 . . . . 2.16 109.772 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 44.4 p -129.01 109.28 11.08 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.102 0.477 . . . . 2.24 111.933 -171.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.2 p -170.47 160.31 7.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.659 -0.7 . . . . 2.46 111.119 -175.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.63 5.72 57.01 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 116.131 -0.486 . . . . 1.45 113.981 172.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.66 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -120.42 -163.8 1.04 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.922 0.361 . . . . 2.24 110.368 -177.363 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.59 135.18 0.23 Allowed 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.451 -0.795 . . . . 3.43 109.357 -178.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.651 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 2.3 m -66.97 118.7 11.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-O 121.81 0.814 . . . . 2.21 111.001 176.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.604 ' O ' ' HD2' ' A' ' 28' ' ' LYS . 11.4 p -95.87 -28.83 3.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 114.465 -1.243 . . . . 1.83 109.446 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.604 ' HD2' ' O ' ' A' ' 27' ' ' VAL . 4.1 mptp? -151.05 133.87 15.77 Favored 'General case' 0 C--O 1.216 -0.7 0 C-N-CA 120.06 -0.656 . . . . 2.87 110.829 -170.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.528 ' HB ' ' HA ' ' A' ' 34' ' ' THR . 0.0 OUTLIER -153.0 152.1 31.02 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.902 0.382 . . . . 1.92 111.3 175.074 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.424 ' HB3' HG12 ' A' ' 33' ' ' ILE . 27.0 t -117.03 27.22 9.26 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.909 -0.587 . . . . 2.37 110.591 -176.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.655 ' HZ3' ' HB2' ' A' ' 31' ' ' LYS . 3.9 ttmp? 68.48 24.35 7.12 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.814 0.816 . . . . 4.84 109.695 175.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.485 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 6.4 tptm -167.24 -40.75 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.921 -1.036 . . . . 2.05 109.209 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.533 HG21 ' HA3' ' A' ' 52' ' ' GLY . 21.1 pt -109.66 152.51 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 CA-C-N 115.242 -0.89 . . . . 1.42 108.983 170.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.528 ' HA ' ' HB ' ' A' ' 29' ' ' THR . 56.6 m -146.29 119.41 8.84 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 123.456 0.472 . . . . 1.22 110.717 -168.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.872 HG22 HG13 ' A' ' 50' ' ' VAL . 3.7 t -109.9 110.87 33.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.86 -0.609 . . . . 1.52 110.609 -175.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.657 ' OG ' ' HB3' ' A' ' 49' ' ' ARG . 97.5 p -100.65 131.49 46.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.192 -0.458 . . . . 1.74 109.934 177.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.8 p -102.76 125.0 49.33 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.892 -0.595 . . . . 1.72 110.991 -177.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.66 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 35.7 ttpt -137.74 120.13 15.89 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.6 -0.727 . . . . 2.45 109.607 177.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.516 ' HA ' ' HA ' ' A' ' 46' ' ' ASN . . . -43.11 137.24 2.57 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.523 0.514 . . . . 2.17 111.998 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.52 ' C ' ' H ' ' A' ' 42' ' ' LYS . 10.3 m -68.52 -163.42 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.605 -0.725 . . . . 2.51 111.834 -177.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 42' ' ' LYS . 25.8 ttt180 -70.38 14.54 0.12 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.25 -0.886 . . . . 7.41 110.724 173.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.52 ' H ' ' C ' ' A' ' 40' ' ' SER . 71.1 mmtt 69.68 40.48 1.36 Allowed 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.452 0.644 . . . . 6.84 110.842 176.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -134.03 -30.23 1.22 Allowed 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.379 -0.828 . . . . 6.42 109.985 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -105.27 -65.19 1.07 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.888 -0.597 . . . . 6.31 109.87 173.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.16 -93.81 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.789 -0.925 . . . . 1.74 110.789 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 48.2 m-80 -121.36 140.95 51.44 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.707 0.289 . . . . 2.45 110.369 177.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.831 HD21 ' H ' ' A' ' 48' ' ' TYR . 2.2 tt -93.27 151.67 19.66 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 106.903 -1.517 . . . . 1.49 106.903 174.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.831 ' H ' HD21 ' A' ' 47' ' ' LEU . 49.9 m-85 -135.73 137.77 42.03 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.305 -0.558 . . . . 1.52 110.87 -170.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.719 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.9 OUTLIER -114.61 131.76 56.59 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 116.014 -0.539 . . . . 3.34 110.841 177.759 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.872 HG13 HG22 ' A' ' 35' ' ' VAL . 0.8 OUTLIER -113.11 143.99 21.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.272 0.558 . . . . 1.98 110.543 168.695 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.713 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 33.1 tt0 -140.94 109.19 5.81 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.897 -1.047 . . . . 1.07 108.921 178.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.533 ' HA3' HG21 ' A' ' 33' ' ' ILE . . . -136.55 143.52 14.93 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.569 -0.824 . . . . 0.35 111.199 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 59.5 mt -88.23 112.48 23.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 C-N-CA 119.936 -0.706 . . . . 1.3 110.352 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.656 HG12 ' HB2' ' A' ' 167' ' ' LEU . 20.8 mm -85.64 114.38 56.33 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 108.373 -0.973 . . . . 1.07 108.373 174.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -66.27 57.86 0.45 Allowed 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 123.584 2.856 . . . . 0.74 112.921 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.423 ' HB3' HG12 ' A' ' 203' ' ' ILE . 12.5 tp10 -158.81 168.1 27.71 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.521 -0.918 . . . . 1.68 108.521 174.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.419 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 34.7 p -70.59 147.41 94.65 Favored Pre-proline 0 N--CA 1.432 -1.335 0 CA-C-O 121.811 0.815 . . . . 1.58 110.849 -177.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.433 ' HG3' ' OG ' ' A' ' 165' ' ' SER . 18.7 Cg_exo -63.71 -9.33 18.13 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.911 3.074 . . . . 0.74 110.585 178.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.83 -54.47 13.43 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.902 -1.045 . . . . 1.31 110.87 175.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.715 ' O ' ' HE3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -69.63 -24.17 63.6 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.443 -0.947 . . . . 3.78 108.443 178.235 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.788 HD22 HD13 ' A' ' 203' ' ' ILE . 29.6 mt -63.64 -58.46 6.85 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.508 -0.552 . . . . 1.09 109.508 173.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.7 t -64.88 -10.86 31.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.06 0.457 . . . . 1.94 110.435 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.462 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 32.1 t70 -88.06 -37.34 16.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.995 -0.548 . . . . 1.32 111.935 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.636 ' O ' ' HB3' ' A' ' 71' ' ' ARG . 10.1 p90 -85.45 -45.67 11.62 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.371 -0.531 . . . . 0.79 111.259 -174.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.768 HD11 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -84.34 7.33 19.78 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.461 -0.57 . . . . 2.15 109.461 -172.758 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -48.93 -70.06 0.1 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.341 -1.299 . . . . 2.06 111.613 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.68 ' HG3' ' SG ' ' A' ' 94' ' ' CYS . 46.3 tt0 -179.38 -43.04 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.611 0.72 . . . . 4.31 110.159 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.404 ' HB ' ' CD2' ' A' ' 81' ' ' TYR . 5.1 t -149.72 29.43 0.75 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.158 -0.928 . . . . 1.89 109.283 -174.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' A' ' 70' ' ' ASP . . . -74.42 -36.67 49.11 Favored Glycine 0 N--CA 1.434 -1.499 0 C-N-CA 120.579 -0.819 . . . . 1.71 111.652 -170.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.637 ' O ' HG22 ' A' ' 73' ' ' THR . 20.7 p-10 163.73 -21.04 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 113.894 -1.153 . . . . 2.19 108.274 -164.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.78 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 1.2 ptp180 -39.64 -53.45 2.15 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-N 114.669 -1.151 . . . . 3.95 111.142 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.606 HG23 HD11 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -82.01 -13.13 12.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.347 -0.541 . . . . 1.42 111.447 -171.298 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.637 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.3 t -84.97 -30.16 24.47 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.592 -0.843 . . . . 1.45 109.949 -175.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.448 ' HZ2' ' HB2' ' A' ' 64' ' ' PHE . 17.8 p-90 -111.86 -4.07 14.71 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.442 0.534 . . . . 0.78 112.442 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.78 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 3.6 t70 -62.42 168.14 3.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 122.26 1.028 . . . . 2.19 113.655 -168.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.519 ' HG3' ' OD1' ' A' ' 198' ' ' ASN . 13.0 mmmt -90.95 -35.78 14.5 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.482 -1.69 . . . . 3.68 109.322 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.563 ' HA ' ' HB2' ' A' ' 99' ' ' GLN . 50.8 m -137.98 26.01 2.74 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.384 -1.28 . . . . 2.08 112.019 -171.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.606 HD11 HG23 ' A' ' 72' ' ' ILE . 44.2 mt -110.34 166.22 11.15 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.509 -0.476 . . . . 1.16 110.753 175.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.484 ' HB3' HG22 ' A' ' 80' ' ' VAL . 21.0 mm-40 -144.1 -63.85 0.37 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.807 -0.633 . . . . 2.23 111.346 -175.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.484 HG22 ' HB3' ' A' ' 79' ' ' GLN . 19.8 t -140.49 117.61 8.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.883 -0.599 . . . . 1.44 111.0 -166.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.404 ' CD2' ' HB ' ' A' ' 68' ' ' THR . 14.3 p90 -90.78 152.17 20.9 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.806 -0.442 . . . . 5.73 109.806 171.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.767 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 19.9 m120 -145.85 117.19 7.94 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.336 -0.987 . . . . 1.86 108.336 168.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.443 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 6.5 ttt -79.31 89.59 4.95 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.563 -0.903 . . . . 2.52 108.563 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -69.33 -81.57 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 115.647 -0.706 . . . . 1.19 111.231 -167.128 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.42 ' HB3' HD13 ' A' ' 93' ' ' ILE . 11.2 t60 -121.06 118.2 29.18 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.381 -0.6 . . . . 2.59 109.381 -178.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.443 ' HD3' ' SD ' ' A' ' 83' ' ' MET . 1.5 mtm180 -99.5 100.71 11.78 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.981 -0.554 . . . . 2.83 109.636 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.613 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -70.84 -41.25 77.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.399 -0.819 . . . . 1.17 110.588 -173.587 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -155.44 166.71 32.71 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.73 -1.123 . . . . 1.86 108.456 -172.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.9 m -62.33 -11.69 16.81 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.211 0.448 . . . . 1.94 112.211 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -128.27 11.45 6.42 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 120.761 -0.376 . . . . 1.87 110.226 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.613 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.7 OUTLIER -135.35 110.34 8.82 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.327 -0.62 . . . . 1.12 109.327 -174.066 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.549 ' O ' HD12 ' A' ' 114' ' ' LEU . 21.3 m-85 -128.85 171.46 12.26 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.745 -0.662 . . . . 0.52 110.616 -174.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.645 ' O ' HG23 ' A' ' 84' ' ' VAL . 32.5 mt -127.2 126.65 68.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 107.542 -1.281 . . . . 1.1 107.542 168.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.68 ' SG ' ' HG3' ' A' ' 67' ' ' GLN . 42.0 t -108.84 106.0 15.8 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.75 -0.659 . . . . 2.61 111.198 -165.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.767 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 39.0 t-80 -82.45 116.38 21.88 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.64 -0.874 . . . . 2.17 108.64 170.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.716 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 62.3 m -134.61 116.03 14.52 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 112.446 0.536 . . . . 1.19 112.446 -177.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 49.5 mm -78.11 128.19 38.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.678 -0.49 . . . . 1.63 109.678 174.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.718 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 2.1 m -102.6 147.66 26.52 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.691 -0.686 . . . . 1.72 110.905 -175.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.563 ' HB2' ' HA ' ' A' ' 77' ' ' SER . 0.8 OUTLIER -80.83 168.46 18.75 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.693 -0.685 . . . . 2.29 111.232 179.9 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.604 ' HA ' ' O ' ' A' ' 106' ' ' ILE . 3.0 m -94.59 104.18 16.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.469 -0.787 . . . . 4.07 111.039 -176.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -112.97 174.34 5.95 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 109.524 -0.547 . . . . 6.11 109.524 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.557 ' O ' HG12 ' A' ' 103' ' ' VAL . . . 60.27 61.35 1.82 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.217 -0.901 . . . . 1.98 110.162 -172.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.557 HG12 ' O ' ' A' ' 102' ' ' ALA . 0.3 OUTLIER 69.96 -21.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.09 1.356 . . . . 3.6 112.813 176.396 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 102' ' ' ALA . . . 121.6 -1.08 11.22 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.307 -0.949 . . . . 2.2 111.984 -178.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.2 m -60.73 -35.38 76.21 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.869 0.842 . . . . 2.08 108.88 174.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.604 ' O ' ' HA ' ' A' ' 100' ' ' SER . 20.3 mt -92.32 73.66 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 CA-C-N 114.586 -1.188 . . . . 1.53 108.634 175.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.616 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 13.2 m -65.51 174.13 1.63 Allowed Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.087 -0.96 . . . . 1.71 110.867 -175.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.616 ' HD2' ' HB3' ' A' ' 107' ' ' SER . 81.6 Cg_exo -42.39 111.14 0.18 Allowed 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 122.761 2.308 . . . . 1.31 112.521 -175.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.718 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 33.3 ttp180 -100.26 159.86 14.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.603 -0.726 . . . . 4.06 110.408 -174.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.928 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 12.7 t70 -115.02 131.18 57.01 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.507 -0.553 . . . . 1.37 109.507 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.716 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 6.2 m-85 -108.88 127.7 54.27 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.079 0.466 . . . . 3.01 111.076 173.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.675 HD12 ' HD2' ' A' ' 95' ' ' HIS . 14.7 mm -134.35 77.42 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.955 -1.02 . . . . 1.2 108.481 169.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.681 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 0.5 OUTLIER -107.32 129.94 54.84 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.273 -0.876 . . . . 1.86 110.592 -178.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.594 ' O ' ' HA ' ' A' ' 129' ' ' SER . 7.6 tp -78.71 118.35 20.71 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-N 115.558 -0.746 . . . . 1.08 109.285 172.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.437 HG22 ' HB ' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -118.65 126.24 75.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 CA-C-N 114.931 -1.032 . . . . 1.08 111.137 -166.078 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.743 ' HE1' ' HZ1' ' A' ' 4' ' ' LYS . 57.0 t80 -108.51 113.48 26.54 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.25 -0.886 . . . . 2.81 110.39 174.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.645 HG12 HG21 ' A' ' 127' ' ' ILE . 56.4 mt -98.19 98.54 7.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.638 -0.71 . . . . 1.53 109.767 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.592 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 34.0 ttpt -117.73 134.61 54.73 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.232 0.539 . . . . 1.81 110.256 176.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.676 ' O ' ' HD2' ' A' ' 119' ' ' ARG . 1.0 OUTLIER -103.01 118.38 36.69 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.542 -0.91 . . . . 3.22 108.542 175.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.542 ' HB3' ' HB3' ' A' ' 123' ' ' ASN . 12.2 m-85 -74.4 107.91 6.85 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.2 -1.778 . . . . 1.28 106.2 164.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.4 ' HA ' HH11 ' A' ' 119' ' ' ARG . 6.5 pt-20 -37.27 98.87 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 O-C-N 124.55 1.156 . . . . 2.28 113.389 -175.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 57.53 47.09 90.78 Favored Glycine 0 CA--C 1.503 -0.662 0 CA-C-N 113.53 -1.668 . . . . 0.79 111.658 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.542 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 50.0 t30 -144.96 -53.89 0.3 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.616 -0.792 . . . . 2.06 109.886 -173.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.432 ' HE1' HD12 ' A' ' 15' ' ' LEU . 1.9 mpp? -159.04 122.41 3.76 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.562 -0.29 . . . . 1.73 110.484 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -104.92 81.52 1.75 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.441 -0.948 . . . . 2.07 108.441 177.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.606 ' CG1' HG13 ' A' ' 154' ' ' VAL . 0.4 OUTLIER -103.16 141.96 18.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.241 -0.89 . . . . 1.06 112.739 -170.789 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.645 HG21 HG12 ' A' ' 117' ' ' ILE . 2.9 pt -110.28 115.5 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 108.398 -0.964 . . . . 1.26 108.398 161.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.573 ' CB ' ' HA ' ' A' ' 11' ' ' ALA . 15.4 p -99.4 114.98 28.21 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.968 -0.56 . . . . 1.53 110.424 177.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.681 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 9.4 p -109.71 144.9 37.45 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.394 0.616 . . . . 1.81 112.046 -173.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.731 ' HB3' ' HZ1' ' A' ' 130' ' ' LYS . 4.8 mtpm? -127.9 123.8 35.85 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 107.618 -1.253 . . . . 2.75 107.618 176.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.416 ' HB3' ' N ' ' A' ' 148' ' ' ASN . 7.0 p -65.13 94.3 0.14 Allowed 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.72 -0.844 . . . . 1.94 108.72 177.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.444 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.6 OUTLIER -107.56 129.2 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 CA-C-N 115.152 -0.931 . . . . 1.64 109.26 -166.312 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -99.3 70.78 1.76 Allowed 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 114.309 -1.314 . . . . 2.17 107.916 -167.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.843 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 0.5 OUTLIER -101.89 154.87 37.05 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 113.552 -1.658 . . . . 0.67 109.829 -169.548 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.04 -1.6 11.28 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.433 2.088 . . . . 1.66 116.041 -168.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.843 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 4.7 tp10 -76.74 -13.8 60.0 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.073 -1.084 . . . . 3.5 108.073 -178.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.404 ' HB2' HG13 ' A' ' 84' ' ' VAL . 26.1 t80 -162.8 114.95 1.1 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.119 -0.946 . . . . 6.41 112.436 175.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -95.32 140.33 1.02 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.661 2.907 . . . . 2.31 111.346 168.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.472 ' HG3' ' HB2' ' A' ' 145' ' ' ARG . 37.3 Cg_endo -70.85 -164.58 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.588 2.192 . . . . 1.27 112.965 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.3 t -139.26 -173.49 3.61 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.237 -1.023 . . . . 1.88 108.237 -176.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.0 t -82.46 -41.39 19.86 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.248 -0.581 . . . . 2.43 110.265 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -57.15 -52.46 65.21 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.144 0.497 . . . . 2.18 110.309 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.928 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 61.9 m-85 -95.82 109.99 22.23 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.316 -0.856 . . . . 1.33 109.424 -175.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.997 HD12 ' HB2' ' A' ' 176' ' ' ARG . 0.7 OUTLIER -88.46 107.52 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-N 115.67 -0.696 . . . . 1.4 109.611 -176.256 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 31.5 ttp85 -56.69 105.53 0.22 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.796 -0.638 . . . . 5.14 110.129 178.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.75 118.0 12.96 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.707 -0.679 . . . . 1.05 112.006 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.843 ' HB3' ' HB3' ' A' ' 174' ' ' GLU . 17.9 t80 -85.62 70.29 10.72 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.511 0.672 . . . . 4.68 109.628 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.66 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 11.6 t30 -64.69 96.56 0.18 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.47 -0.786 . . . . 2.29 110.083 176.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.86 117.74 28.39 Favored Pre-proline 0 C--O 1.222 -0.382 0 CA-C-N 115.758 -0.655 . . . . 2.95 110.242 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -18.32 70.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.101 1 C-N-CA 126.438 4.758 . . . . 0.77 115.664 -165.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 170' ' ' PHE . 4.4 p -122.99 169.71 10.89 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.789 -1.189 . . . . 1.97 107.789 172.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.648 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -152.21 -146.15 4.29 Favored Glycine 0 N--CA 1.434 -1.49 0 C-N-CA 118.325 -1.893 . . . . 0.55 113.805 -165.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.434 ' CZ ' HD12 ' A' ' 167' ' ' LEU . 5.8 t80 -161.36 96.77 1.08 Allowed 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.995 -1.113 . . . . 0.8 107.995 -162.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.606 HG13 ' CG1' ' A' ' 126' ' ' ILE . 4.5 m -105.83 137.88 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-O 121.679 0.752 . . . . 1.03 110.746 -175.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 83.8 m -117.71 109.63 16.85 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.161 -0.927 . . . . 2.3 109.899 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.558 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 15.4 m -111.06 125.59 30.34 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 120.794 -0.362 . . . . 1.45 111.51 -168.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 156' ' ' SER . 10.7 Cg_endo -54.54 121.05 9.08 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 122.454 2.102 . . . . 0.72 111.368 174.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.611 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 61.1 mmm -80.12 -162.85 0.48 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.217 0.532 . . . . 1.72 111.79 -176.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -70.44 -35.07 73.15 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.52 -0.763 . . . . 2.63 109.408 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -103.22 30.97 4.53 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.045 -0.98 . . . . 2.05 109.143 173.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.707 ' OD1' ' HD3' ' A' ' 162' ' ' PRO . 0.3 OUTLIER -19.77 -57.16 0.06 OUTLIER Pre-proline 0 N--CA 1.479 0.989 0 N-CA-C 117.164 2.283 . . . . 2.19 117.164 -171.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.707 ' HD3' ' OD1' ' A' ' 161' ' ' ASN . 69.8 Cg_endo -72.91 -18.17 24.71 Favored 'Trans proline' 0 C--N 1.351 0.701 0 CA-C-N 121.798 1.678 . . . . 0.86 113.255 -175.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -108.07 -26.61 10.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.196 -0.456 . . . . 1.34 110.92 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.611 ' O ' ' HB2' ' A' ' 158' ' ' MET . 94.1 m-85 -138.33 128.36 25.56 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.181 -0.674 . . . . 1.46 109.181 177.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.467 ' HB3' HD13 ' A' ' 61' ' ' LEU . 26.6 t -125.93 151.59 46.76 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.38 0.61 . . . . 2.05 111.599 -177.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.745 ' HG3' HG11 ' A' ' 168' ' ' VAL . 2.0 tppp? -90.73 103.45 16.15 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 122.019 0.914 . . . . 1.4 111.472 -176.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.746 HD11 HG12 ' A' ' 196' ' ' ILE . 0.5 OUTLIER -88.06 103.61 15.88 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.406 -1.27 . . . . 1.07 109.429 176.111 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.766 HG21 ' HH ' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -127.82 132.43 68.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.087 -0.645 . . . . 1.11 111.876 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.556 ' HE2' HG21 ' A' ' 171' ' ' VAL . 20.8 ttt -144.41 137.98 27.41 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.37 -0.377 . . . . 1.79 111.819 -170.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.664 ' CE1' ' HB2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -110.84 135.17 51.8 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 109.182 -0.673 . . . . 4.22 109.182 173.439 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 1.038 ' HB ' HD22 ' A' ' 192' ' ' LEU . 1.3 t -134.43 120.82 34.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 O-C-N 123.661 0.601 . . . . 2.01 111.056 177.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.79 ' HB2' ' HG ' ' A' ' 47' ' ' LEU . 1.3 tm0? -105.04 -32.64 8.62 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.462 -1.31 . . . . 2.66 107.462 168.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.66 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 13.2 m 20.75 107.86 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 O-C-N 126.281 2.238 . . . . 2.2 113.165 176.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.843 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 15.2 tp10 -77.36 -19.78 55.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.043 -0.526 . . . . 2.45 111.769 -161.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.648 ' HE3' HD11 ' A' ' 179' ' ' LEU . 95.6 mmm 46.62 52.75 10.77 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 110.249 -0.278 . . . . 4.15 110.249 177.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.997 ' HB2' HD12 ' A' ' 144' ' ' ILE . 15.9 mmm180 -28.38 -61.99 0.11 Allowed 'General case' 0 N--CA 1.476 0.853 0 O-C-N 125.225 1.578 . . . . 6.51 114.087 -171.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -157.51 101.19 0.2 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 119.784 -1.198 . . . . 2.26 113.679 -176.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 178' ' ' LYS . 13.1 tptm -171.61 -6.72 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.856 0.36 . . . . 6.69 110.86 173.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.648 HD11 ' HE3' ' A' ' 175' ' ' MET . 0.0 OUTLIER -137.63 175.56 9.49 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.252 0.548 . . . . 2.21 109.663 -177.571 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.505 ' O ' HD11 ' A' ' 184' ' ' ILE . 16.3 m -111.34 159.25 33.65 Favored Pre-proline 0 C--N 1.313 -1.005 0 N-CA-C 108.068 -1.086 . . . . 2.31 108.068 174.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -44.88 -37.86 12.52 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 122.765 2.31 . . . . 1.86 112.577 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.505 ' O ' ' HE2' ' A' ' 186' ' ' LYS . 3.7 p -66.31 -23.79 66.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.629 -0.714 . . . . 2.45 112.273 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.564 ' HB ' ' HB3' ' A' ' 179' ' ' LEU . 11.9 mm -90.12 -38.28 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-O 122.505 1.145 . . . . 1.69 108.76 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.647 ' CD1' ' HB2' ' A' ' 179' ' ' LEU . 0.7 OUTLIER -66.13 -38.26 81.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 113.063 -1.88 . . . . 1.77 111.375 -177.234 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.15 -18.45 65.31 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.585 -0.524 . . . . 2.89 109.585 176.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.505 ' HE2' ' O ' ' A' ' 182' ' ' SER . 45.2 mtmt -91.84 -41.59 10.55 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.814 -0.63 . . . . 1.71 109.991 173.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.703 HG21 ' HE1' ' A' ' 188' ' ' MET . 14.6 t -63.04 -28.14 69.89 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.941 0.719 . . . . 1.3 112.941 -169.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' MET . . . . . 0.703 ' HE1' HG21 ' A' ' 187' ' ' THR . 2.4 mmt -76.05 -62.89 0.67 Allowed Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 120.249 -0.581 . . . . 1.39 111.503 -177.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.592 ' O ' HG13 ' A' ' 193' ' ' VAL . 28.3 Cg_endo -61.93 -32.26 84.75 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 121.812 1.674 . . . . 1.15 111.844 -177.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.638 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 24.6 m -73.88 -23.76 59.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.357 -0.383 . . . . 1.95 110.777 -177.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.2 OUTLIER -90.39 -38.03 13.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.912 -0.403 . . . . 1.92 109.912 -176.134 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 1.038 HD22 ' HB ' ' A' ' 171' ' ' VAL . 26.7 mt -59.3 -57.31 13.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.996 -0.547 . . . . 1.68 112.022 178.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 189' ' ' PRO . 1.8 m -65.44 -32.62 59.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.595 0.712 . . . . 1.32 109.379 -175.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.638 ' HB2' ' O ' ' A' ' 190' ' ' SER . 0.4 OUTLIER -65.32 -47.04 77.93 Favored 'General case' 0 C--O 1.208 -1.112 0 CA-C-N 114.217 -1.356 . . . . 2.6 109.843 176.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.86 -28.94 66.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.786 0.327 . . . . 2.73 111.026 178.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.746 HG12 HD11 ' A' ' 167' ' ' LEU . 22.1 mt -77.32 -31.61 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-O 121.414 0.626 . . . . 1.11 110.862 175.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 68.1 mt -73.56 -38.14 65.3 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 109.562 -0.532 . . . . 1.57 109.562 176.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.519 ' OD1' ' HG3' ' A' ' 76' ' ' LYS . 3.2 m-20 -53.11 -41.69 65.23 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.11 -1.07 . . . . 2.18 108.11 168.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.717 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -67.33 -49.8 62.61 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.944 -0.571 . . . . 1.04 110.129 -178.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.446 ' HD3' HD13 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -61.09 -41.16 96.15 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 114.984 -1.007 . . . . 1.51 110.843 -179.242 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -76.99 -47.18 21.45 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-N 115.259 -0.882 . . . . 1.94 110.089 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . 0.437 ' HA3' ' CZ2' ' A' ' 74' ' ' TRP . . . -69.89 -38.45 75.45 Favored Glycine 0 CA--C 1.505 -0.543 0 C-N-CA 120.811 -0.709 . . . . 0.47 112.117 -175.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.788 HD13 HD22 ' A' ' 61' ' ' LEU . 0.9 OUTLIER -58.04 -46.25 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 110.521 -0.178 . . . . 1.16 110.521 176.327 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.651 ' HA ' ' HG3' ' A' ' 207' ' ' ARG . 62.6 mttm -84.48 -23.57 29.82 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 120.382 -0.527 . . . . 3.8 109.841 -176.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.54 -35.95 77.25 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.081 -0.711 . . . . 1.28 109.081 166.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.466 ' ND1' ' HD3' ' A' ' 60' ' ' LYS . 5.4 t-80 -85.73 -31.03 22.65 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.337 0.865 . . . . 4.34 113.337 -179.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.651 ' HG3' ' HA ' ' A' ' 204' ' ' LYS . 0.2 OUTLIER -107.97 -25.26 11.26 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.593 -0.692 . . . . 3.0 112.34 -174.181 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' A' ' 204' ' ' LYS . 98.0 m -101.26 137.04 19.57 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 109.792 -0.447 . . . . 2.01 109.792 178.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 208' ' ' THR . 29.6 Cg_exo -64.15 13.09 0.09 OUTLIER 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.308 2.672 . . . . 2.59 113.921 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.446 ' H ' ' C ' ' A' ' 208' ' ' THR . 73.8 m -67.78 -12.48 60.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.88 0.371 . . . . 2.55 110.868 176.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 4.9 ppt_? -69.81 5.13 1.61 Allowed 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 116.044 -0.525 . . . . 6.11 111.416 175.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -57.73 -28.74 64.17 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.267 0.556 . . . . 7.55 109.567 171.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -101.05 82.67 0.49 Allowed Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.549 -1.02 . . . . 3.73 110.549 171.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -66.7 124.69 23.57 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.343 0.497 . . . . 6.11 112.343 -175.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -111.85 94.13 4.8 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.862 -0.792 . . . . 7.27 108.862 166.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . 0.557 ' HA ' ' O ' ' A' ' 73' ' ' THR . 0.8 OUTLIER -104.32 141.9 35.51 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.121 -0.49 . . . . 6.82 109.993 177.197 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -80.36 23.86 0.47 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.017 0.437 . . . . 5.77 111.088 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 216' ' ' HIS . 5.6 m -67.53 -31.41 71.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.76 -0.654 . . . . 6.85 109.322 174.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -117.26 125.88 51.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.494 -0.775 . . . . 9.48 109.982 177.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.424 -0.798 . . . . 8.48 108.903 179.825 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 121.095 0.474 . . . . 4.31 110.931 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.64 ' O ' HD12 ' A' ' 6' ' ' ILE . 7.0 m-20 -65.84 -35.58 81.08 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 121.183 0.516 . . . . 2.25 110.206 -177.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.529 ' CD2' HD13 ' A' ' 87' ' ' ILE . 93.5 m-85 -66.73 -32.83 74.39 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.384 -0.825 . . . . 0.45 109.326 -175.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.655 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 2.1 tppp? -69.52 -8.25 45.42 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.82 -1.082 . . . . 2.06 110.124 177.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -92.27 -41.68 10.26 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.229 0.538 . . . . 1.2 110.337 173.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.64 HD12 ' O ' ' A' ' 2' ' ' ASP . 1.8 mp -82.45 -43.07 18.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.754 0.788 . . . . 1.76 109.456 -171.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.517 ' HB3' ' HB2' ' A' ' 116' ' ' TYR . . . -72.15 -47.22 52.56 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.312 -1.313 . . . . 1.11 111.582 -178.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.655 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 6.2 mt-30 -63.19 -26.43 68.8 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.664 -1.153 . . . . 2.14 110.762 -178.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.565 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 24.9 mt-30 -84.82 -30.81 24.24 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.324 -0.853 . . . . 3.04 109.395 172.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.547 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.4 OUTLIER -74.35 -34.72 63.47 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.513 -0.767 . . . . 1.1 111.684 -177.386 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.435 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -45.87 -54.99 7.25 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 120.345 -0.542 . . . . 1.04 111.23 172.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -75.5 -6.66 51.3 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.775 -0.648 . . . . 2.31 112.042 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.565 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 32.1 mt-10 -80.59 -52.09 7.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.712 -0.477 . . . . 2.54 109.712 173.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.692 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 14.6 p -69.57 -40.94 80.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.844 0.831 . . . . 1.21 110.193 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.78 -25.45 65.61 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 121.978 0.894 . . . . 1.26 108.608 173.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.32 -17.5 66.28 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 113.79 -1.55 . . . . 0.57 110.394 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.692 ' CD2' ' HA ' ' A' ' 14' ' ' VAL . 15.1 m-85 -89.07 -24.68 22.24 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.572 -0.899 . . . . 3.59 108.572 177.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.419 ' OD1' HG21 ' A' ' 168' ' ' VAL . 47.9 t30 -73.61 -12.0 60.61 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-O 121.337 0.589 . . . . 2.1 110.018 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -111.62 -18.7 12.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.498 -0.774 . . . . 3.26 111.216 -176.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -136.09 84.13 2.06 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.326 -0.397 . . . . 2.16 111.459 -174.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -151.0 139.5 20.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 2.24 111.64 178.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.9 m -167.53 -45.26 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.017 -0.538 . . . . 2.46 110.031 -173.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -81.68 47.79 3.72 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.834 -0.621 . . . . 1.45 113.188 -176.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.537 ' O ' ' HE2' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -120.65 -147.3 0.39 Allowed 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.605 -0.517 . . . . 2.24 109.605 178.188 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.537 ' HE2' ' O ' ' A' ' 24' ' ' TRP . 0.0 OUTLIER 178.57 123.84 0.05 OUTLIER 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.954 -0.758 . . . . 3.43 108.954 -175.036 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.517 ' CG1' HG22 ' A' ' 34' ' ' THR . 3.7 m -65.13 119.81 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.818 0 CA-C-O 122.358 1.075 . . . . 2.21 111.605 176.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.57 -23.96 4.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 113.692 -1.595 . . . . 1.83 109.07 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 28' ' ' LYS . 8.3 tppt? -152.9 109.9 3.48 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 119.82 -0.752 . . . . 2.87 111.756 -176.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.602 ' HB ' ' HA ' ' A' ' 34' ' ' THR . 1.3 t -151.89 152.64 32.82 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.196 0.522 . . . . 1.92 111.484 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.7 t -113.24 -94.93 0.45 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.354 -0.839 . . . . 2.37 110.165 176.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -148.32 19.15 1.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.297 0.57 . . . . 4.84 110.737 176.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.657 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 38.5 mmtm -150.05 -33.92 0.18 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.707 -0.679 . . . . 2.05 110.138 176.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.5 HD13 ' HB ' ' A' ' 193' ' ' VAL . 16.3 pt -113.55 149.95 15.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.603 -0.726 . . . . 1.42 109.746 -177.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.602 ' HA ' ' HB ' ' A' ' 29' ' ' THR . 0.2 OUTLIER -151.17 107.67 3.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 123.12 0.262 . . . . 1.22 111.604 -166.248 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.526 ' CG2' HG11 ' A' ' 193' ' ' VAL . 21.4 t -95.57 109.63 22.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.953 0.406 . . . . 1.52 110.315 176.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 2.3 p -105.11 123.36 47.68 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.526 -0.761 . . . . 1.74 110.773 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 77.9 p -103.47 129.19 50.56 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.914 -1.039 . . . . 1.72 110.284 -174.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 24.5 ttpp -119.29 -91.16 0.56 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.996 -0.547 . . . . 2.45 111.289 -173.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 46' ' ' ASN . . . -177.1 141.54 0.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.59 -0.522 . . . . 2.17 109.59 -177.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 67.5 p -74.46 146.61 42.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.059 0.457 . . . . 2.51 110.096 175.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -62.24 -28.13 69.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.269 -0.878 . . . . 7.41 112.38 -176.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -93.18 -17.35 23.83 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 120.795 -0.362 . . . . 6.84 110.938 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 3.1 t80 85.67 31.5 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.557 0 O-C-N 124.433 1.083 . . . . 6.42 108.694 172.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 -85.77 -18.39 33.12 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.021 -0.99 . . . . 6.31 109.533 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.33 -139.4 3.63 Favored Glycine 0 N--CA 1.427 -1.934 0 N-CA-C 109.502 -1.439 . . . . 1.74 109.502 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 73.0 m-20 -121.81 147.79 45.51 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.054 0.454 . . . . 2.45 111.301 -177.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.498 HD22 ' N ' ' A' ' 48' ' ' TYR . 3.2 tt -98.48 138.68 35.35 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.865 -1.161 . . . . 1.49 107.865 174.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.498 ' N ' HD22 ' A' ' 47' ' ' LEU . 73.2 m-85 -120.03 130.69 54.83 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 110.168 -0.308 . . . . 1.52 110.168 -174.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.464 ' HD3' ' CZ3' ' A' ' 24' ' ' TRP . 37.4 ttt-85 -120.29 121.42 38.63 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.268 -0.424 . . . . 3.34 110.06 175.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 34' ' ' THR . 9.4 p -104.99 145.98 12.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 120.11 -0.636 . . . . 1.98 109.655 174.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.527 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 29.6 tt0 -144.33 113.09 6.69 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.534 -0.757 . . . . 1.07 110.155 -171.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.657 ' HA2' ' O ' ' A' ' 32' ' ' LYS . . . -143.85 143.26 12.03 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.682 -0.771 . . . . 0.35 111.934 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.8 mt -87.54 120.59 36.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 120.147 -0.621 . . . . 1.3 110.691 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.451 ' CD1' ' HB1' ' A' ' 199' ' ' ALA . 36.4 mt -102.69 120.2 53.52 Favored Pre-proline 0 N--CA 1.442 -0.865 0 CA-C-N 115.556 -0.747 . . . . 1.07 109.728 178.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -62.57 60.03 0.14 Allowed 'Trans proline' 0 N--CA 1.473 0.319 0 C-N-CA 124.299 3.333 . . . . 0.74 113.93 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.601 ' HG2' HG13 ' A' ' 203' ' ' ILE . 9.6 tp10 -150.91 175.54 11.95 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.879 -0.785 . . . . 1.68 108.879 174.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.544 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 12.8 m -80.94 143.32 53.25 Favored Pre-proline 0 N--CA 1.425 -1.702 0 CA-C-O 121.365 0.602 . . . . 1.58 109.488 172.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 57' ' ' SER . 35.5 Cg_exo -57.95 -14.32 18.09 Favored 'Trans proline' 0 C--N 1.333 -0.272 0 C-N-CA 124.092 3.195 . . . . 0.74 111.501 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.32 -50.9 42.25 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.207 -0.906 . . . . 1.31 111.31 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.476 ' O ' ' HE3' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -67.66 -27.35 66.78 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.387 -0.968 . . . . 3.78 108.387 179.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.742 ' O ' HD12 ' A' ' 65' ' ' LEU . 40.6 mt -62.9 -57.96 9.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.19 -0.914 . . . . 1.09 110.473 172.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.663 ' OG ' ' HB3' ' A' ' 125' ' ' ASN . 66.5 m -60.49 -16.1 33.54 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.92 -0.488 . . . . 1.94 110.861 176.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -90.1 -43.96 10.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.243 0.46 . . . . 1.32 112.243 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.636 ' CE2' ' HA ' ' A' ' 199' ' ' ALA . 5.0 p90 -73.4 -43.43 60.51 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.739 -0.385 . . . . 0.79 110.905 -171.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.742 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -86.57 -7.17 58.59 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 120.433 -0.507 . . . . 2.15 111.616 -173.288 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.515 ' N ' HD11 ' A' ' 65' ' ' LEU . 11.8 t80 -18.79 -70.44 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.95 1.406 . . . . 2.06 114.005 -163.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.472 ' OE1' ' HB2' ' A' ' 94' ' ' CYS . 8.5 tt0 -174.32 -32.26 0.01 OUTLIER 'General case' 0 C--N 1.342 0.268 0 N-CA-C 114.296 1.221 . . . . 4.31 114.296 176.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.7 t -161.97 7.87 0.06 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 119.223 -0.991 . . . . 1.89 113.462 -166.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -115.0 -22.78 4.83 Favored Glycine 0 C--N 1.314 -0.686 0 C-N-CA 118.917 -1.611 . . . . 1.71 113.901 -168.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.65 ' O ' HG23 ' A' ' 73' ' ' THR . 4.5 t70 -150.39 -29.5 0.21 Allowed 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.609 -0.436 . . . . 2.19 110.574 -176.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.85 ' HA ' ' CZ2' ' A' ' 74' ' ' TRP . 9.7 ptm180 -50.19 -43.68 52.6 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 123.33 0.652 . . . . 3.95 111.452 -173.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.506 ' N ' ' HG3' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -83.5 -13.54 11.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.896 -0.593 . . . . 1.42 110.318 -173.262 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.65 HG23 ' O ' ' A' ' 70' ' ' ASP . 0.8 OUTLIER -84.91 -31.44 23.67 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 116.02 -0.536 . . . . 1.45 109.927 -176.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.85 ' CZ2' ' HA ' ' A' ' 71' ' ' ARG . 7.4 p-90 -106.29 -10.34 16.43 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 120.27 -0.572 . . . . 0.78 111.872 -176.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.66 ' OD2' ' HG ' ' A' ' 78' ' ' LEU . 27.4 t0 -83.3 172.58 12.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.967 0.889 . . . . 2.19 111.427 -177.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.575 ' H ' ' CG ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -122.04 -13.98 8.08 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 113.979 -1.464 . . . . 3.68 111.297 -172.47 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 74.7 m -115.56 8.77 15.2 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.303 -0.629 . . . . 2.08 109.303 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.66 ' HG ' ' OD2' ' A' ' 75' ' ' ASP . 54.0 mt -109.65 171.05 7.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.363 -0.835 . . . . 1.16 110.681 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.559 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 6.4 mm-40 -150.62 -63.37 0.2 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.592 0.59 . . . . 2.23 112.592 -171.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.48 HG23 ' HB3' ' A' ' 79' ' ' GLN . 39.4 t -141.65 127.94 19.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.907 0.384 . . . . 1.44 111.076 -168.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -97.67 146.06 25.7 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.825 -0.625 . . . . 5.73 110.219 174.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 17.2 m120 -155.13 102.5 2.31 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.447 -0.575 . . . . 1.86 109.447 174.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.09 110.06 2.38 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.196 -0.668 . . . . 2.52 109.196 177.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -93.14 -49.09 13.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.521 -0.309 . . . . 1.19 111.55 -172.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -147.74 108.13 4.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.124 0.487 . . . . 2.59 111.144 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.411 ' HG2' ' HD2' ' A' ' 92' ' ' PHE . 20.7 mtt180 -89.66 107.04 18.86 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.564 -0.744 . . . . 2.83 109.828 176.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.626 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -75.85 -41.34 39.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.095 0.474 . . . . 1.17 110.033 -177.805 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -155.6 -168.12 2.72 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.3 -1.0 . . . . 1.86 108.3 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.6 m -80.63 -5.62 57.15 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 117.567 0.167 . . . . 1.94 111.345 -177.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -130.16 4.35 4.82 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.83 -0.433 . . . . 1.87 109.83 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.626 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.5 OUTLIER -137.87 116.33 12.01 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.609 -0.885 . . . . 1.12 108.609 -173.564 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.557 ' O ' HD12 ' A' ' 114' ' ' LEU . 11.0 m-85 -137.2 176.29 8.84 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.232 0.539 . . . . 0.52 110.57 -175.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.554 ' O ' HG23 ' A' ' 84' ' ' VAL . 21.6 mt -134.94 127.43 48.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 106.759 -1.571 . . . . 1.1 106.759 166.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.472 ' HB2' ' OE1' ' A' ' 67' ' ' GLN . 31.2 t -117.15 129.58 56.06 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.389 -0.525 . . . . 2.61 111.266 -176.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.503 ' HA ' HD12 ' A' ' 112' ' ' ILE . 24.3 t60 -87.35 85.38 7.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.268 -0.878 . . . . 2.17 109.173 173.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 60.2 m -100.42 113.37 26.07 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.644 -1.162 . . . . 1.19 112.177 -173.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.463 HD11 ' OD1' ' A' ' 110' ' ' ASP . 31.0 mm -76.52 126.21 36.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.309 -0.626 . . . . 1.63 109.309 174.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.2 m -113.35 142.74 45.5 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.328 -0.851 . . . . 1.72 111.272 -174.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.559 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 25.3 mt-30 -97.28 80.79 2.94 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.495 -0.557 . . . . 2.29 109.495 173.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.3 m -94.86 86.54 4.71 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.168 -0.469 . . . . 4.07 110.041 -177.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.4 ' HA ' ' HB ' ' A' ' 106' ' ' ILE . 42.3 p90 -123.38 117.17 24.59 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.18 0.514 . . . . 6.11 112.064 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -85.96 75.78 9.93 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.536 -0.913 . . . . 1.98 108.536 165.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 98.4 t 78.74 -36.08 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 114.924 -1.034 . . . . 3.6 111.032 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 157.05 -7.62 0.21 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.136 -1.03 . . . . 2.2 113.374 178.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.8 t -72.96 -6.63 46.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.16 0.505 . . . . 2.08 110.368 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.502 HG12 ' HG ' ' A' ' 179' ' ' LEU . 26.3 mt -122.91 136.6 59.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.872 -0.603 . . . . 1.53 110.156 -177.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.1 m -87.44 152.41 52.22 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 116.163 -0.472 . . . . 1.71 110.325 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -47.97 143.08 14.27 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.686 2.257 . . . . 1.31 111.632 173.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.568 ' HG2' HG23 ' A' ' 144' ' ' ILE . 20.2 mtm180 -123.64 174.76 7.25 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.639 -0.504 . . . . 4.06 109.639 -173.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.676 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 31.0 t70 -131.61 138.88 48.99 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.339 -0.391 . . . . 1.37 110.045 176.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -110.07 125.54 53.06 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.105 -0.498 . . . . 3.01 110.375 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.606 ' O ' ' HA ' ' A' ' 131' ' ' SER . 47.6 mm -109.39 70.54 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 108.362 -0.977 . . . . 1.2 108.362 170.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.494 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 43.7 m-20 -88.35 117.7 27.46 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.638 -0.71 . . . . 1.86 111.03 -174.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.561 ' O ' ' HA ' ' A' ' 129' ' ' SER . 9.4 tp -75.0 124.7 27.44 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.342 -0.984 . . . . 1.08 108.342 165.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -132.25 126.5 55.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 115.465 -0.789 . . . . 1.08 112.404 -163.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.517 ' HB2' ' HB3' ' A' ' 7' ' ' ALA . 58.9 t80 -110.72 116.36 31.17 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.092 -0.958 . . . . 2.81 110.425 172.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.413 HG12 ' CG2' ' A' ' 127' ' ' ILE . 86.6 mt -94.31 112.0 26.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.54 -0.755 . . . . 1.53 110.222 -177.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.429 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 17.1 ttmm -137.95 142.43 40.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.132 -0.485 . . . . 1.81 110.63 -176.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.439 ' HD2' ' C ' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -117.72 113.72 22.27 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 107.86 -1.163 . . . . 3.22 107.86 172.472 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.422 ' CB ' ' HB3' ' A' ' 123' ' ' ASN . 56.0 m-85 -67.48 117.25 9.19 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.667 -1.235 . . . . 1.28 107.667 170.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.429 ' HA ' ' NE ' ' A' ' 119' ' ' ARG . 22.1 mm-40 -35.66 94.58 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 O-C-N 124.789 1.306 . . . . 2.28 112.938 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 58.8 41.71 96.13 Favored Glycine 0 CA--C 1.505 -0.569 0 CA-C-N 114.618 -1.174 . . . . 0.79 112.406 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.422 ' HB3' ' CB ' ' A' ' 120' ' ' TYR . 3.2 t-20 -138.68 -49.93 0.54 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.446 -0.377 . . . . 2.06 110.705 -177.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.409 ' O ' ' HA ' ' A' ' 119' ' ' ARG . 2.0 tpp -159.97 118.84 2.76 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.046 0.45 . . . . 1.73 111.491 -175.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.663 ' HB3' ' OG ' ' A' ' 62' ' ' SER . 6.0 m120 -97.93 79.21 2.61 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.779 -0.823 . . . . 2.07 108.779 177.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.5 ' HB ' HG11 ' A' ' 154' ' ' VAL . 0.5 OUTLIER -105.37 141.06 21.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 113.193 0.812 . . . . 1.06 113.193 -169.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.689 ' O ' HG13 ' A' ' 127' ' ' ILE . 2.3 pt -107.9 115.05 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 107.979 -1.119 . . . . 1.26 107.979 159.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.597 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 36.5 p -82.96 154.2 24.63 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.946 -0.761 . . . . 1.53 108.946 175.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.561 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 9.0 p -154.63 131.45 10.78 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.947 0.403 . . . . 1.81 111.858 -175.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.57 ' HB3' ' HZ3' ' A' ' 130' ' ' LYS . 1.0 OUTLIER -131.32 120.97 23.9 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 107.632 -1.248 . . . . 2.75 107.632 175.312 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.606 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 52.5 m -66.17 101.04 0.66 Allowed 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.215 -1.402 . . . . 1.94 107.215 175.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.99 143.21 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.879 0 CA-C-N 114.568 -1.196 . . . . 1.64 109.193 -164.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -95.27 70.72 3.21 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 122.983 1.373 . . . . 2.17 110.176 -170.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.559 ' O ' ' HB3' ' A' ' 137' ' ' TYR . 1.7 p90 -97.75 177.22 1.7 Allowed Pre-proline 0 CA--C 1.554 1.129 0 CA-C-N 113.688 -1.596 . . . . 0.67 109.326 -174.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.401 ' HB2' ' OE2' ' A' ' 136' ' ' GLU . 59.9 Cg_exo -44.28 -47.71 10.47 Favored 'Trans proline' 0 CA--C 1.55 1.304 0 C-N-CA 123.752 2.968 . . . . 1.66 117.106 -175.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.404 ' HG2' ' CE2' ' A' ' 134' ' ' PHE . 2.0 mm-40 -88.71 -5.15 58.3 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 121.595 -0.691 . . . . 3.5 111.416 -172.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.559 ' HB3' ' O ' ' A' ' 134' ' ' PHE . 22.9 t80 -54.33 -45.63 99.21 Favored Pre-proline 0 C--N 1.314 -0.961 0 N-CA-C 115.384 1.624 . . . . 6.41 115.384 -177.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 137' ' ' TYR . 24.7 Cg_exo -32.54 111.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 123.874 3.049 . . . . 2.31 114.875 -175.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.586 ' HA ' ' CZ ' ' A' ' 145' ' ' ARG . 5.8 Cg_exo -79.8 -160.81 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.282 2.655 . . . . 1.27 114.056 -177.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 13.6 m -145.58 -160.85 1.2 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.284 -1.326 . . . . 1.88 108.502 -176.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 31.1 t -88.69 -41.91 12.3 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.534 -0.467 . . . . 2.43 111.048 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -70.9 -30.9 67.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.898 0.38 . . . . 2.18 111.147 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -120.32 115.02 22.73 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 121.234 0.54 . . . . 1.33 110.327 -176.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.568 HG23 ' HG2' ' A' ' 109' ' ' ARG . 3.4 tp -105.53 113.81 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 115.23 -0.896 . . . . 1.4 109.967 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.676 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 5.2 mpt_? -54.74 99.61 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.763 -1.108 . . . . 5.14 110.914 175.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -67.51 112.51 4.84 Favored Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 109.372 -1.491 . . . . 1.05 109.372 171.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.476 ' HB3' ' CB ' ' A' ' 174' ' ' GLU . 3.2 t80 -84.16 81.45 8.8 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.362 0.601 . . . . 4.68 110.515 -169.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.632 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 70.7 m-20 -70.66 99.26 1.64 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.999 -1.001 . . . . 2.29 110.191 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 172' ' ' GLN . 70.9 m-70 -69.99 146.33 95.01 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.198 -0.455 . . . . 2.95 109.911 176.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.544 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 75.5 Cg_exo -15.21 64.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.239 1 C-N-CA 127.414 5.409 . . . . 0.77 115.709 -164.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . 0.632 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 25.4 p -89.81 -174.84 4.43 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.682 -1.144 . . . . 1.97 110.36 178.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.601 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -177.8 -161.09 25.45 Favored Glycine 0 N--CA 1.435 -1.41 0 C-N-CA 120.385 -0.912 . . . . 0.55 111.77 177.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.593 ' CE1' ' HG ' ' A' ' 65' ' ' LEU . 48.1 t80 -161.72 88.92 0.72 Allowed 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.474 -0.936 . . . . 0.8 108.474 -167.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.516 ' CG2' HG11 ' A' ' 168' ' ' VAL . 2.6 m -98.63 132.53 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-O 121.65 0.738 . . . . 1.03 110.864 -173.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 125' ' ' ASN . 47.8 m -113.55 108.57 17.35 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.508 -0.769 . . . . 2.3 109.352 177.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.476 ' HB3' ' HB3' ' A' ' 166' ' ' LYS . 18.3 t -102.31 122.99 44.69 Favored Pre-proline 0 C--N 1.312 -1.058 0 CA-C-O 120.842 0.353 . . . . 1.45 111.657 -167.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -52.79 118.1 4.39 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.766 2.311 . . . . 0.72 111.666 170.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.492 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 78.1 mmm -82.96 -165.08 0.98 Allowed 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 120.977 0.417 . . . . 1.72 111.411 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -76.89 -24.79 52.53 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.741 0.782 . . . . 2.63 109.138 173.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.415 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 22.5 mm-40 -102.57 27.06 7.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.823 -1.08 . . . . 2.05 108.821 172.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -12.22 -71.32 0.01 OUTLIER Pre-proline 0 N--CA 1.479 0.987 0 N-CA-C 115.675 1.732 . . . . 2.19 115.675 -174.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -72.7 -16.27 26.72 Favored 'Trans proline' 0 C--N 1.351 0.665 0 CA-C-N 120.498 1.213 . . . . 0.86 113.596 -172.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -103.09 -29.27 11.45 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.899 0.38 . . . . 1.34 110.885 -177.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.492 ' O ' ' HB2' ' A' ' 158' ' ' MET . 82.2 m-85 -139.93 125.98 19.78 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.348 -0.612 . . . . 1.46 109.348 177.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.416 ' OG ' HD11 ' A' ' 61' ' ' LEU . 4.4 p -122.13 147.81 45.69 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.156 0.503 . . . . 2.05 110.978 -177.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.527 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.9 tppp? -91.94 104.61 17.01 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.757 0.789 . . . . 1.4 111.009 -176.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.413 HD21 ' CZ ' ' A' ' 153' ' ' PHE . 0.8 OUTLIER -89.52 109.86 20.76 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.916 -1.038 . . . . 1.07 109.039 -179.371 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.516 HG11 ' CG2' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -130.58 128.76 63.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 121.692 0.758 . . . . 1.11 111.783 177.114 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.485 ' HG2' ' N ' ' A' ' 170' ' ' PHE . 23.0 ttm -124.3 153.05 42.32 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.306 -0.861 . . . . 1.79 109.536 -176.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.549 ' O ' ' HB2' ' A' ' 151' ' ' CYS . 8.6 m-85 -133.5 139.8 46.87 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.568 -0.901 . . . . 4.22 108.568 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 11.1 p -138.02 116.77 14.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.618 0.723 . . . . 2.01 111.533 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.462 ' O ' ' HB2' ' A' ' 149' ' ' HIS . 28.8 tt0 -111.26 56.76 0.63 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.646 -0.872 . . . . 2.66 108.646 174.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 9.1 t -73.45 145.53 45.68 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.877 0.846 . . . . 2.2 111.269 -174.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.476 ' CB ' ' HB3' ' A' ' 147' ' ' TYR . 6.6 tp10 -84.53 -30.9 24.75 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.681 -1.145 . . . . 2.45 109.947 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 64.7 mtm 49.02 64.13 1.85 Allowed 'General case' 0 CA--C 1.518 -0.28 0 O-C-N 123.461 0.476 . . . . 4.15 110.0 -173.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -49.44 -39.98 35.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.131 -0.94 . . . . 6.51 110.849 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -83.04 80.16 1.85 Allowed Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 109.352 -1.499 . . . . 2.26 109.352 166.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -80.64 152.24 28.6 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.303 0.573 . . . . 6.69 112.05 -167.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.506 ' HB2' ' CD1' ' A' ' 184' ' ' ILE . 0.5 OUTLIER -111.58 -152.07 0.49 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.063 -0.971 . . . . 2.21 108.755 176.864 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.495 ' O ' HD13 ' A' ' 184' ' ' ILE . 43.8 t -110.61 149.82 40.84 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 108.228 -1.027 . . . . 2.31 108.228 174.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -43.88 -45.44 11.38 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.171 2.581 . . . . 1.86 113.016 -177.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 12.0 m -62.91 -18.88 63.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.494 . . . . 2.45 112.078 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.529 ' HA ' ' HE2' ' A' ' 186' ' ' LYS . 13.3 mm -91.48 -38.32 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-O 122.432 1.111 . . . . 1.69 108.991 -177.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.666 ' HA ' ' CG2' ' A' ' 187' ' ' THR . 1.2 mp -74.49 -34.72 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 CA-C-N 113.089 -1.868 . . . . 1.77 111.334 -176.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.414 ' O ' ' HG2' ' A' ' 189' ' ' PRO . 11.1 pt-20 -67.4 -17.25 64.65 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.93 -0.767 . . . . 2.89 108.93 176.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.529 ' HE2' ' HA ' ' A' ' 183' ' ' ILE . 51.6 mtmt -91.96 -42.67 9.88 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.376 -0.829 . . . . 1.71 109.953 171.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.666 ' CG2' ' HA ' ' A' ' 184' ' ' ILE . 7.4 t -70.01 -41.04 74.87 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.192 -0.603 . . . . 1.3 112.366 -170.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' MET . . . . . 0.535 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 34.9 mmm -76.38 -55.48 1.68 Allowed Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 112.441 0.534 . . . . 1.39 112.441 -174.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.535 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 23.8 Cg_exo -65.48 -19.07 60.93 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 121.945 1.763 . . . . 1.15 112.234 -175.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 51.5 m -85.87 -42.06 14.44 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.734 -0.469 . . . . 1.95 109.734 177.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -64.16 -39.13 93.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 1.92 111.136 -175.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.504 ' HB3' ' CG1' ' A' ' 50' ' ' VAL . 30.7 mt -68.05 -44.71 75.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.627 0.251 . . . . 1.68 111.179 -176.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.526 HG11 ' CG2' ' A' ' 35' ' ' VAL . 17.9 m -74.18 -24.85 19.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 120.27 -0.572 . . . . 1.32 110.56 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -68.71 -39.18 80.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.187 -0.46 . . . . 2.6 110.445 172.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.656 ' HA ' ' ND2' ' A' ' 198' ' ' ASN . 4.9 m-85 -70.8 -20.03 62.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.132 0.491 . . . . 2.73 111.014 176.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.671 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 33.5 mt -82.62 -29.55 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 C-N-CA 119.494 -0.882 . . . . 1.11 110.496 170.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 47.2 mt -69.38 -43.74 72.91 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.518 -0.31 . . . . 1.57 110.773 178.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.656 ' ND2' ' HA ' ' A' ' 195' ' ' PHE . 13.1 p30 -60.97 -22.6 64.63 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.964 -0.562 . . . . 2.18 109.886 171.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.686 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -80.79 -43.11 20.6 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 116.51 -0.314 . . . . 1.04 110.317 177.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.671 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 12.8 mmmm -57.1 -47.05 82.01 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.659 -0.867 . . . . 1.51 108.659 172.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -71.19 -45.87 62.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.266 -1.333 . . . . 1.94 111.53 -175.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -72.02 -22.76 78.69 Favored Glycine 0 N--CA 1.463 0.442 0 C-N-CA 120.517 -0.849 . . . . 0.47 112.099 -178.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.686 ' HB ' ' O ' ' A' ' 199' ' ' ALA . 1.0 OUTLIER -82.24 -36.16 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 120.966 0.412 . . . . 1.16 110.603 175.157 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.467 ' O ' ' HB ' ' A' ' 208' ' ' THR . 26.5 mtpt -73.87 -28.47 61.58 Favored 'General case' 0 C--O 1.209 -1.041 0 N-CA-C 108.636 -0.876 . . . . 3.8 108.636 176.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.568 ' O ' ' HD2' ' A' ' 211' ' ' ARG . . . -54.04 -32.91 55.92 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.505 -0.771 . . . . 1.28 109.682 169.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.533 ' HB3' ' O ' ' A' ' 203' ' ' ILE . 15.0 t-80 -71.13 -46.55 61.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 4.34 111.882 178.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.456 ' HG2' ' HA ' ' A' ' 204' ' ' LYS . 10.4 ptm85 -97.85 -31.55 12.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.503 0.668 . . . . 3.0 111.462 -170.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 204' ' ' LYS . 28.0 m -92.47 141.31 24.6 Favored Pre-proline 0 C--N 1.313 -0.996 0 CA-C-N 115.176 -0.92 . . . . 2.01 109.169 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.34 42.07 0.26 Allowed 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 123.042 2.495 . . . . 2.59 113.573 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 208' ' ' THR . 28.9 t -94.33 -22.96 18.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.125 0.488 . . . . 2.55 109.855 177.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.568 ' HD2' ' O ' ' A' ' 205' ' ' ALA . 0.0 OUTLIER -79.99 1.53 27.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.041 -0.527 . . . . 6.11 110.572 -179.741 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -71.68 -39.45 70.24 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.573 -0.529 . . . . 7.55 109.573 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -110.02 51.42 0.7 Allowed Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.265 -0.734 . . . . 3.73 111.265 175.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -68.02 156.59 37.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.905 0.383 . . . . 6.11 110.863 -177.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -127.71 144.47 51.08 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.117 -0.492 . . . . 7.27 110.605 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . 0.65 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 22.6 m170 -93.7 -173.14 3.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.621 -0.718 . . . . 6.82 111.024 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -74.41 126.94 31.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.956 -0.565 . . . . 5.77 110.879 -178.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 1.9 p -71.56 -25.39 62.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.178 -0.919 . . . . 6.85 110.856 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -91.19 -173.5 3.65 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.022 -0.536 . . . . 9.48 109.706 176.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 17.4 m . . . . . 0 C--O 1.252 1.208 0 CA-C-O 118.055 -0.974 . . . . 8.48 110.925 177.912 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.658 ' SD ' HG23 ' A' ' 87' ' ' ILE . 2.6 ttt . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 109.872 -0.418 . . . . 4.31 109.872 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.704 ' O ' HD11 ' A' ' 6' ' ' ILE . 20.1 t70 -113.64 -59.99 1.94 Allowed 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 110.058 -0.349 . . . . 2.25 110.058 -176.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.699 ' HA ' HD13 ' A' ' 6' ' ' ILE . 96.0 m-85 -67.76 -30.11 69.48 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 122.006 0.908 . . . . 0.45 108.569 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.528 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 9.2 tttm -75.68 -4.32 39.63 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.916 -1.493 . . . . 2.06 109.893 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.407 ' O ' ' HG2' ' A' ' 9' ' ' GLN . . . -92.74 -46.22 7.66 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.339 0.59 . . . . 1.2 109.686 174.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.704 HD11 ' O ' ' A' ' 2' ' ' ASP . 0.0 OUTLIER -82.34 -38.8 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-N 115.693 -0.685 . . . . 1.76 110.464 -171.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.618 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -78.04 -38.08 45.41 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.843 -1.071 . . . . 1.11 111.391 -176.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.948 HE21 ' HH ' ' A' ' 116' ' ' TYR . 21.6 mt-30 -65.68 -25.79 67.49 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.179 -0.919 . . . . 2.14 110.316 177.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.507 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 16.4 mm100 -89.71 -36.45 15.2 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.051 -0.977 . . . . 3.04 109.531 173.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.589 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -64.81 -34.47 78.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.626 -0.716 . . . . 1.1 111.259 179.031 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.528 ' HA ' ' OG ' ' A' ' 128' ' ' SER . . . -48.21 -61.07 2.17 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.703 0.763 . . . . 1.04 110.464 171.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -66.71 -17.0 64.63 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.471 -1.24 . . . . 2.31 112.025 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 35.2 mt-10 -68.73 -57.35 5.77 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 109.595 -0.521 . . . . 2.54 109.595 174.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.721 ' CG2' ' HA ' ' A' ' 151' ' ' CYS . 1.2 t -70.4 -43.38 78.26 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 CA-C-O 121.811 0.815 . . . . 1.21 110.979 -174.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.499 HD23 ' HD2' ' A' ' 19' ' ' ARG . 1.0 OUTLIER -64.48 -33.11 75.12 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.471 -1.241 . . . . 1.26 109.308 174.813 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.406 ' HA2' ' HD3' ' A' ' 19' ' ' ARG . . . -65.07 -16.41 62.03 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 114.56 -1.2 . . . . 0.57 111.281 175.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.702 ' HD2' ' HA ' ' A' ' 14' ' ' VAL . 54.8 m-85 -89.58 -25.82 21.14 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 108.234 -1.024 . . . . 3.59 108.234 174.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.438 ' OD1' ' HE3' ' A' ' 124' ' ' MET . 2.1 t-20 -68.85 -10.63 58.0 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.635 0.731 . . . . 2.1 109.093 175.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.499 ' HD2' HD23 ' A' ' 15' ' ' LEU . 11.3 mtp180 -112.19 -20.79 11.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.875 -1.057 . . . . 3.26 110.322 178.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -123.08 58.93 1.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.775 0.798 . . . . 2.16 110.702 -176.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.846 ' HB ' ' CZ2' ' A' ' 24' ' ' TRP . 0.7 OUTLIER -122.89 127.57 49.15 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.856 -0.611 . . . . 2.24 110.544 176.687 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.5 t -179.28 -33.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.508 -0.769 . . . . 2.46 110.068 -170.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.85 -17.35 76.79 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.618 -0.719 . . . . 1.45 112.916 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 1.013 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -89.81 -155.99 0.39 Allowed 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 112.563 0.579 . . . . 2.24 112.563 179.324 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.501 ' HE3' ' HA ' ' A' ' 25' ' ' LYS . 0.8 OUTLIER -171.68 134.79 0.84 Allowed 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 115.204 -0.907 . . . . 3.43 109.465 -164.671 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.679 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 5.2 m -66.0 122.05 16.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 122.062 0.934 . . . . 2.21 111.486 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.482 HG23 ' HE2' ' A' ' 48' ' ' TYR . 30.1 m -95.76 -23.19 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-N 113.906 -1.497 . . . . 1.83 108.517 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.479 ' HD2' ' HA ' ' A' ' 28' ' ' LYS . 15.1 tptm -161.98 131.25 4.47 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 120.251 -0.579 . . . . 2.87 111.185 -176.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.756 HG22 ' HA ' ' A' ' 34' ' ' THR . 77.4 p -131.81 152.18 51.16 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.224 -0.444 . . . . 1.92 109.827 172.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.516 ' HB3' HG12 ' A' ' 33' ' ' ILE . 22.9 t -111.67 -138.98 0.38 Allowed 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.268 -0.641 . . . . 2.37 109.268 177.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -103.62 18.13 22.56 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 122.451 -0.155 . . . . 4.84 110.835 -178.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.3 tptt -175.12 2.98 0.01 OUTLIER 'General case' 0 C--O 1.237 0.422 0 N-CA-C 112.098 0.407 . . . . 2.05 112.098 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.89 HG21 ' HA3' ' A' ' 52' ' ' GLY . 38.1 pt -139.3 166.34 21.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 120.783 0.325 . . . . 1.42 111.376 -175.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.756 ' HA ' HG22 ' A' ' 29' ' ' THR . 24.1 m -152.02 112.38 4.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.425 -0.807 . . . . 1.22 110.685 -165.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.891 HG21 HG12 ' A' ' 50' ' ' VAL . 2.3 t -107.16 103.89 16.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.842 0.353 . . . . 1.52 110.242 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.679 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 4.3 p -102.5 127.58 49.49 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 122.957 0.503 . . . . 1.74 110.273 179.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 6.9 t -120.53 135.71 55.0 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.402 0.62 . . . . 1.72 112.152 -172.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 1.013 ' HB3' ' HB3' ' A' ' 24' ' ' TRP . 0.2 OUTLIER -128.42 142.12 51.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.77 -1.105 . . . . 2.45 109.632 175.899 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 46' ' ' ASN . . . -56.55 126.8 28.22 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.668 0.618 . . . . 2.17 112.668 -172.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.493 ' H ' ' HA ' ' A' ' 46' ' ' ASN . 17.6 m -75.44 139.26 42.18 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.988 -0.551 . . . . 2.51 109.721 175.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -86.77 13.07 9.44 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.296 0.48 . . . . 7.41 112.296 -175.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 46.3 mttm -54.32 -37.18 64.55 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.976 -0.289 . . . . 6.84 110.469 169.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.498 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 62.5 t80 166.49 -77.46 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 O-C-N 124.204 0.94 . . . . 6.42 109.575 -175.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -139.84 87.2 2.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.859 -0.61 . . . . 6.31 109.508 178.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.34 -169.42 21.1 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 109.973 -1.251 . . . . 1.74 109.973 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.493 ' HA ' ' H ' ' A' ' 40' ' ' SER . 2.8 p-10 -154.66 131.2 10.58 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 117.685 0.743 . . . . 2.45 111.445 178.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.675 HD21 ' N ' ' A' ' 48' ' ' TYR . 5.2 tt -83.7 150.8 25.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.726 -1.125 . . . . 1.49 108.565 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.675 ' N ' HD21 ' A' ' 47' ' ' LEU . 70.9 m-85 -120.31 131.88 55.07 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.931 0.395 . . . . 1.52 110.941 -174.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.508 ' HG2' ' CE2' ' A' ' 170' ' ' PHE . 0.6 OUTLIER -112.44 115.45 28.7 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.266 -1.012 . . . . 3.34 108.266 173.22 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.891 HG12 HG21 ' A' ' 35' ' ' VAL . 2.0 m -101.49 150.35 6.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 120.407 -0.517 . . . . 1.98 110.477 173.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.631 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 45.7 tt0 -151.15 109.38 3.75 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.986 -1.006 . . . . 1.07 109.49 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.89 ' HA3' HG21 ' A' ' 33' ' ' ILE . . . -139.99 143.16 13.34 Favored Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 110.909 -0.876 . . . . 0.35 110.909 178.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.0 mt -88.62 125.3 41.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 C-N-CA 119.574 -0.85 . . . . 1.3 111.051 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.48 HG12 ' HD3' ' A' ' 200' ' ' LYS . 45.4 mt -106.04 99.1 21.13 Favored Pre-proline 0 N--CA 1.442 -0.871 0 N-CA-C 108.046 -1.094 . . . . 1.07 108.046 173.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.759 ' HA ' ' HA ' ' A' ' 164' ' ' TYR . 38.3 Cg_endo -65.14 49.89 0.2 Allowed 'Trans proline' 0 N--CA 1.479 0.67 1 C-N-CA 125.506 4.137 . . . . 0.74 115.406 -170.358 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.451 ' OE2' HG22 ' A' ' 54' ' ' ILE . 2.2 pm0 -139.34 -153.67 0.48 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.065 -0.717 . . . . 1.68 109.065 165.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.454 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 44.0 t -92.28 140.78 24.43 Favored Pre-proline 0 N--CA 1.422 -1.826 0 CA-C-O 122.006 0.908 . . . . 1.58 111.141 -174.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.889 ' HG3' ' HG ' ' A' ' 165' ' ' SER . 31.1 Cg_exo -57.36 -14.84 17.11 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 124.201 3.267 . . . . 0.74 110.306 174.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 63' ' ' ASP . . . -69.55 -47.34 63.99 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.939 -1.028 . . . . 1.31 111.134 174.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.961 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -66.54 -35.48 80.33 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.082 -1.081 . . . . 3.78 108.082 178.263 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 1.019 HD23 HD12 ' A' ' 203' ' ' ILE . 37.1 mt -60.72 -55.44 33.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.87 -1.059 . . . . 1.09 110.833 177.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.451 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 42.5 t -67.36 -10.27 49.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.68 0.276 . . . . 1.94 110.734 177.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.535 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -85.83 -45.72 11.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.475 -0.33 . . . . 1.32 111.158 -178.631 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.475 ' O ' ' HB3' ' A' ' 71' ' ' ARG . 11.3 p90 -77.78 -43.36 30.91 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.662 -0.245 . . . . 0.79 111.574 -172.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.451 ' CD2' ' HA ' ' A' ' 62' ' ' SER . 1.0 OUTLIER -75.31 -8.94 58.01 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 122.187 -0.321 . . . . 2.15 111.484 -169.406 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.516 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 26.2 t80 -26.4 -56.7 0.08 Allowed 'General case' 0 N--CA 1.462 0.151 0 O-C-N 125.431 1.707 . . . . 2.06 114.11 -163.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.516 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 8.5 tt0 166.02 -38.62 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.595 0.712 . . . . 4.31 110.861 -175.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.9 t -165.55 19.84 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.253 -0.885 . . . . 1.89 110.155 -164.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 70' ' ' ASP . . . -78.01 -34.68 37.11 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.252 -0.975 . . . . 1.71 111.702 -173.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.622 ' O ' HG23 ' A' ' 73' ' ' THR . 16.4 p-10 166.63 -17.7 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.12 -1.04 . . . . 2.19 108.549 -167.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.847 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -45.57 -38.21 6.25 Favored 'General case' 0 C--O 1.209 -1.034 0 CA-C-N 115.324 -0.853 . . . . 3.95 111.755 176.021 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.596 HG21 HD12 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -89.87 -7.47 10.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 120.383 -0.527 . . . . 1.42 111.386 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.622 HG23 ' O ' ' A' ' 70' ' ' ASP . 0.8 OUTLIER -92.41 -27.77 17.28 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 120.395 -0.522 . . . . 1.45 110.618 -173.352 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.805 ' HZ3' ' HB2' ' A' ' 198' ' ' ASN . 11.9 p-90 -112.79 -3.06 14.26 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.795 -0.362 . . . . 0.78 111.699 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.847 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 4.1 t70 -70.18 175.66 4.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 122.335 1.064 . . . . 2.19 112.231 -172.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.839 ' HD2' ' HB3' ' A' ' 198' ' ' ASN . 0.0 OUTLIER -118.37 -12.8 9.84 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.8 -1.545 . . . . 3.68 110.195 -174.166 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.52 ' HA ' ' HB2' ' A' ' 99' ' ' GLN . 0.1 OUTLIER -130.31 2.81 4.67 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.198 -0.91 . . . . 2.08 109.921 178.094 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.758 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 62.1 mt -109.15 149.82 28.78 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.057 -0.52 . . . . 1.16 110.834 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.569 ' HG2' ' HG2' ' A' ' 99' ' ' GLN . 15.0 mm100 -132.56 -59.02 0.92 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.465 -0.789 . . . . 2.23 111.288 -175.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.722 ' HB ' HD11 ' A' ' 97' ' ' ILE . 18.1 t -140.7 125.44 18.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.521 -0.763 . . . . 1.44 110.633 -165.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.444 ' CD2' HD13 ' A' ' 72' ' ' ILE . 50.4 p90 -94.88 153.53 17.66 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.601 -0.727 . . . . 5.73 110.44 174.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.478 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 1.2 m120 -152.82 109.37 3.42 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.718 -0.475 . . . . 1.86 109.718 167.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.5 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 3.3 ttt -75.03 94.87 2.93 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.266 -1.013 . . . . 2.52 108.266 178.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -74.66 -73.03 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-O 121.215 0.531 . . . . 1.19 111.258 -166.683 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -136.34 120.6 17.91 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.783 -0.644 . . . . 2.59 109.592 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.853 ' HG2' ' HD2' ' A' ' 92' ' ' PHE . 38.6 mtm180 -97.15 123.19 40.84 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.453 -0.794 . . . . 2.83 109.684 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.658 HG23 ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -82.37 -40.73 17.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.833 -0.621 . . . . 1.17 109.819 -174.123 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' A' ' 89' ' ' SER . 9.3 t70 -147.88 -161.92 1.44 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.384 -0.969 . . . . 1.86 108.384 177.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.437 ' H ' ' CG ' ' A' ' 88' ' ' ASP . 20.2 m -83.08 -7.78 59.61 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.739 0.304 . . . . 1.94 110.81 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -137.65 15.99 2.91 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.26 0.553 . . . . 1.87 110.258 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.698 HG21 ' HD2' ' A' ' 116' ' ' TYR . 0.7 OUTLIER -134.37 109.92 9.11 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 107.916 -1.142 . . . . 1.12 107.916 -179.287 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.853 ' HD2' ' HG2' ' A' ' 86' ' ' ARG . 5.1 m-85 -132.14 178.9 6.44 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.316 0.579 . . . . 0.52 110.797 -174.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.611 ' O ' HG23 ' A' ' 84' ' ' VAL . 19.3 mt -138.3 130.4 38.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 106.966 -1.494 . . . . 1.1 106.966 169.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 48.0 t -116.0 122.13 44.32 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.621 -0.432 . . . . 2.61 110.92 -172.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.535 ' HA ' HD13 ' A' ' 112' ' ' ILE . 10.5 t60 -85.95 83.98 7.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.862 0.839 . . . . 2.17 109.175 173.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.773 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 18.9 m -90.69 118.07 29.83 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.485 -1.234 . . . . 1.19 111.442 -176.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.722 HD11 ' HB ' ' A' ' 80' ' ' VAL . 3.5 mp -91.58 123.37 43.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.758 -0.831 . . . . 1.63 108.758 170.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 109' ' ' ARG . 15.2 t -110.29 171.41 7.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.061 -0.518 . . . . 1.72 110.978 -174.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.569 ' HG2' ' HG2' ' A' ' 79' ' ' GLN . 4.7 mm100 -95.59 172.57 7.98 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.107 -0.951 . . . . 2.29 111.897 -172.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.9 m -94.05 86.68 5.08 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.075 -0.966 . . . . 4.07 111.276 -175.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.469 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 9.9 p90 -98.28 118.65 35.41 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.96 -1.126 . . . . 6.11 107.96 173.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.664 ' HB1' HD11 ' A' ' 106' ' ' ILE . . . 73.02 59.51 0.11 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.962 -1.017 . . . . 1.98 108.574 -168.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 106' ' ' ILE . 7.8 p -67.09 0.27 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 114.57 -1.196 . . . . 3.6 112.52 -171.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.18 -29.17 74.43 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.605 -0.807 . . . . 2.2 111.791 177.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.922 ' HB2' HG23 ' A' ' 183' ' ' ILE . 72.5 m -142.09 9.18 1.89 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.115 0.483 . . . . 2.08 110.658 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.664 HD11 ' HB1' ' A' ' 102' ' ' ALA . 64.2 mt -130.74 108.29 15.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.2 0.524 . . . . 1.53 110.964 -176.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.478 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.3 p -100.66 176.33 1.96 Allowed Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.205 -0.907 . . . . 1.71 109.965 177.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 87.9 Cg_exo -47.55 109.9 0.26 Allowed 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 122.306 2.004 . . . . 1.31 111.135 174.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.63 ' HG3' HG21 ' A' ' 144' ' ' ILE . 18.4 ttm180 -111.06 151.69 27.77 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.168 -0.469 . . . . 4.06 111.134 -167.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.839 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 6.5 t70 -99.28 134.06 42.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.761 -0.654 . . . . 1.37 110.847 -176.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.773 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 17.8 m-85 -118.21 114.71 23.43 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.81 -0.632 . . . . 3.01 110.143 173.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.535 HD13 ' HA ' ' A' ' 95' ' ' HIS . 26.2 mm -108.95 76.24 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.722 -0.844 . . . . 1.2 108.722 170.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.754 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 1.6 m-20 -95.48 119.89 34.77 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.847 -0.615 . . . . 1.86 110.306 -178.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.653 ' O ' ' HA ' ' A' ' 129' ' ' SER . 3.9 tp -75.36 121.79 22.79 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 108.672 -0.862 . . . . 1.08 108.672 170.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -126.6 123.97 64.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-N 115.296 -0.865 . . . . 1.08 111.732 -164.14 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.948 ' HH ' HE21 ' A' ' 8' ' ' GLN . 24.1 t80 -105.95 111.91 24.75 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.786 -1.097 . . . . 2.81 110.023 175.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.921 HG12 HG21 ' A' ' 127' ' ' ILE . 73.2 mt -92.9 99.15 9.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.039 -0.528 . . . . 1.53 109.608 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.689 ' HB2' ' HE1' ' A' ' 116' ' ' TYR . 36.7 ttpt -124.35 138.17 54.4 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.989 -0.55 . . . . 1.81 110.546 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 119' ' ' ARG . 0.1 OUTLIER -116.09 111.95 21.03 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-O 122.117 0.961 . . . . 3.22 109.697 177.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.577 ' HB2' ' HB3' ' A' ' 123' ' ' ASN . 18.2 m-85 -68.05 104.0 1.65 Allowed 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 105.523 -2.028 . . . . 1.28 105.523 163.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -53.17 98.29 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 122.262 1.029 . . . . 2.28 113.023 -168.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 84.91 23.09 50.92 Favored Glycine 0 CA--C 1.504 -0.632 0 CA-C-N 113.483 -1.689 . . . . 0.79 111.785 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.577 ' HB3' ' HB2' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -127.33 -50.74 1.41 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.63 -0.785 . . . . 2.06 109.213 179.081 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.481 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 0.9 OUTLIER -161.47 143.06 11.54 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.138 -0.483 . . . . 1.73 111.282 -177.272 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -116.62 84.41 2.13 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.471 -0.937 . . . . 2.07 108.471 169.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.615 ' CG1' HG11 ' A' ' 154' ' ' VAL . 0.7 OUTLIER -102.26 135.0 41.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 112.951 0.722 . . . . 1.06 112.951 -172.141 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.921 HG21 HG12 ' A' ' 117' ' ' ILE . 31.7 pt -100.15 107.34 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.914 0.864 . . . . 1.26 109.023 164.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.528 ' OG ' ' HA ' ' A' ' 11' ' ' ALA . 1.2 m -88.38 109.38 19.95 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.453 -0.794 . . . . 1.53 110.638 -178.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.754 ' HB3' ' HB3' ' A' ' 113' ' ' ASP . 12.8 m -114.74 145.16 42.39 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.248 0.547 . . . . 1.81 111.733 -170.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.644 ' HB3' ' HZ1' ' A' ' 130' ' ' LYS . 3.2 mtpm? -137.66 121.78 17.94 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 107.387 -1.338 . . . . 2.75 107.387 174.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 78.9 p -64.04 98.4 0.21 Allowed 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.11 -1.441 . . . . 1.94 107.11 175.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.457 HG12 ' HB3' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -109.03 140.21 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.836 0 N-CA-C 108.731 -0.84 . . . . 1.64 108.731 -165.488 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -102.68 86.89 2.85 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 122.459 1.124 . . . . 2.17 109.245 -174.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.747 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 1.3 p90 -117.33 154.5 50.31 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 114.012 -1.449 . . . . 0.67 111.526 -166.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 3.2 Cg_exo -42.09 -47.0 7.01 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 124.77 3.646 . . . . 1.66 115.883 -174.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.747 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 7.3 tp10 -65.64 -25.55 67.41 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 120.731 0.301 . . . . 3.5 110.749 -163.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.542 ' HB2' HG12 ' A' ' 84' ' ' VAL . 10.1 t80 -150.26 101.77 3.15 Favored Pre-proline 0 N--CA 1.441 -0.908 0 N-CA-C 113.237 0.829 . . . . 6.41 113.237 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -88.94 134.4 2.63 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.261 2.641 . . . . 2.31 109.746 163.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.5 -171.92 0.41 Allowed 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.439 2.093 . . . . 1.27 112.424 -176.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 62.2 p -133.22 -179.7 5.66 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 109.356 -0.609 . . . . 1.88 109.356 -172.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.2 m -86.21 11.38 12.12 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.125 0.488 . . . . 2.43 110.658 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -120.14 -44.74 2.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.781 -0.645 . . . . 2.18 109.773 173.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.839 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 85.0 m-85 -94.28 109.71 21.51 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.193 -0.669 . . . . 1.33 109.193 175.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.63 HG21 ' HG3' ' A' ' 109' ' ' ARG . 1.0 OUTLIER -95.11 107.69 19.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.783 -0.644 . . . . 1.4 110.177 -175.391 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 2.7 ttp180 -56.84 99.88 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.407 -0.815 . . . . 5.14 109.803 175.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -66.23 128.87 31.25 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.097 -0.801 . . . . 1.05 111.097 179.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.65 ' HB3' ' HB3' ' A' ' 174' ' ' GLU . 65.0 t80 -84.84 86.84 7.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.524 0.678 . . . . 4.68 110.989 -175.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 53.1 t30 -82.06 116.18 21.53 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.153 -0.93 . . . . 2.29 109.361 171.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.733 ' HB3' ' HB3' ' A' ' 172' ' ' GLN . 57.6 t-80 -58.19 154.72 29.43 Favored Pre-proline 0 C--O 1.217 -0.614 0 CA-C-O 118.142 -0.932 . . . . 2.95 108.656 173.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.612 ' HD2' ' CD2' ' A' ' 149' ' ' HIS . 60.9 Cg_exo -37.74 78.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 123.916 3.077 . . . . 0.77 112.618 169.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . 0.721 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 72.7 m -135.1 149.49 50.06 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.973 -1.467 . . . . 1.97 107.904 -176.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.607 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -138.76 -147.0 5.07 Favored Glycine 0 N--CA 1.432 -1.623 0 C-N-CA 119.051 -1.547 . . . . 0.55 113.038 -170.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.655 ' HE1' HD22 ' A' ' 167' ' ' LEU . 7.5 t80 -160.74 82.72 0.66 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.915 -1.513 . . . . 0.8 106.915 -167.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.615 HG11 ' CG1' ' A' ' 126' ' ' ILE . 4.1 m -93.27 140.98 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 CA-C-O 122.044 0.926 . . . . 1.03 110.597 -172.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . 0.658 ' SG ' ' HB3' ' A' ' 58' ' ' PRO . 1.6 t -117.09 126.44 52.84 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 114.731 -1.122 . . . . 2.3 109.077 177.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.725 ' HB3' ' HB3' ' A' ' 166' ' ' LYS . 11.2 t -120.48 121.16 29.38 Favored Pre-proline 0 C--N 1.31 -1.138 0 C-N-CA 120.146 -0.622 . . . . 1.45 111.669 -172.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 67.8 Cg_exo -50.38 108.65 0.23 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.035 1.823 . . . . 0.72 110.373 166.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.718 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 54.0 mmm -72.06 -165.74 0.19 Allowed 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.67 0.747 . . . . 1.72 112.175 -174.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -67.25 -24.28 65.79 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.903 -1.044 . . . . 2.63 110.177 177.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.52 ' HB3' ' HB2' ' A' ' 163' ' ' ALA . 54.5 mm-40 -108.05 14.05 25.51 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.754 -0.657 . . . . 2.05 110.085 177.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.657 ' HB3' ' CD ' ' A' ' 162' ' ' PRO . 47.0 t-20 29.25 -89.84 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 125.684 1.594 . . . . 2.19 114.762 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.657 ' CD ' ' HB3' ' A' ' 161' ' ' ASN . 72.0 Cg_endo -74.42 -13.76 22.76 Favored 'Trans proline' 0 C--N 1.367 1.528 0 CA-C-N 121.854 1.698 . . . . 0.86 113.093 -175.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.52 ' HB2' ' HB3' ' A' ' 160' ' ' GLU . . . -91.76 -29.94 16.52 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.864 -0.607 . . . . 1.34 110.679 -177.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.759 ' HA ' ' HA ' ' A' ' 55' ' ' PRO . 85.3 m-85 -143.65 124.78 14.48 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.398 -0.593 . . . . 1.46 109.398 176.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.889 ' HG ' ' HG3' ' A' ' 58' ' ' PRO . 21.4 t -112.87 145.52 40.54 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 119.905 -0.718 . . . . 2.05 110.593 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.749 ' HG3' HG12 ' A' ' 168' ' ' VAL . 2.5 tppp? -94.01 112.59 24.44 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.519 0.676 . . . . 1.4 111.266 -176.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.655 HD22 ' HE1' ' A' ' 153' ' ' PHE . 0.6 OUTLIER -95.54 104.35 16.26 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.283 -0.871 . . . . 1.07 109.37 173.905 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.749 HG12 ' HG3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -125.4 134.54 66.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.223 0.535 . . . . 1.11 110.603 176.673 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.611 ' HB3' HG22 ' A' ' 50' ' ' VAL . 20.7 ttt -140.85 143.24 34.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.164 -0.471 . . . . 1.79 110.219 -169.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.702 ' O ' ' HB3' ' A' ' 151' ' ' CYS . 34.0 m-85 -120.42 139.13 53.28 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.057 -0.72 . . . . 4.22 109.057 177.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.494 ' HB ' HD23 ' A' ' 192' ' ' LEU . 0.9 OUTLIER -143.42 125.62 12.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 O-C-N 123.492 0.495 . . . . 2.01 111.286 178.551 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.733 ' HB3' ' HB3' ' A' ' 149' ' ' HIS . 20.3 tt0 -124.73 51.46 1.63 Allowed 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 107.158 -1.423 . . . . 2.66 107.158 171.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.516 ' HB ' ' SD ' ' A' ' 188' ' ' MET . 7.4 m -75.36 127.55 33.39 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.806 -1.543 . . . . 2.2 110.542 -175.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.65 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 28.6 tt0 -83.39 -28.06 29.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.491 -0.777 . . . . 2.45 111.554 -173.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.555 ' O ' HD12 ' A' ' 179' ' ' LEU . 23.2 mmt 48.64 53.79 11.66 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.174 0.511 . . . . 4.15 110.247 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.485 ' HD2' ' OE2' ' A' ' 174' ' ' GLU . 11.6 ptm180 -75.24 48.46 0.41 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.419 -0.809 . . . . 6.51 111.662 -176.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -127.79 48.77 0.95 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.92 -0.657 . . . . 2.26 112.662 -177.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 28.0 tptp 70.56 59.67 0.22 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.346 0.593 . . . . 6.69 111.653 174.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.598 ' HB2' HD12 ' A' ' 184' ' ' ILE . 4.6 mp -116.67 169.22 9.52 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.026 -0.731 . . . . 2.21 109.026 171.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.472 ' HB3' HG12 ' A' ' 183' ' ' ILE . 46.9 t -112.81 151.31 43.91 Favored Pre-proline 0 C--N 1.306 -1.286 0 N-CA-C 107.612 -1.255 . . . . 2.31 107.612 176.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.61 ' O ' ' HG3' ' A' ' 185' ' ' GLU . 76.6 Cg_exo -40.92 -44.92 4.98 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 122.501 2.134 . . . . 1.86 112.283 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.552 ' O ' ' HG3' ' A' ' 186' ' ' LYS . 14.3 p -63.06 -25.18 68.25 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.832 -0.622 . . . . 2.45 112.317 -178.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.922 HG23 ' HB2' ' A' ' 105' ' ' SER . 9.1 mm -83.39 -29.5 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.878 0 CA-C-O 122.802 1.287 . . . . 1.69 108.401 -176.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.682 ' HA ' HG22 ' A' ' 187' ' ' THR . 0.9 OUTLIER -79.93 -34.33 15.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 112.541 -2.118 . . . . 1.77 109.924 -175.773 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.61 ' HG3' ' O ' ' A' ' 181' ' ' PRO . 35.1 mt-10 -66.49 -18.6 65.45 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.935 -1.029 . . . . 2.89 109.584 172.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 182' ' ' SER . 53.0 mtmt -93.0 -44.61 8.33 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.413 -0.812 . . . . 1.71 110.79 174.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.682 HG22 ' HA ' ' A' ' 184' ' ' ILE . 14.3 t -66.09 -43.0 88.55 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.612 0.597 . . . . 1.3 112.612 -170.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' MET . . . . . 0.611 ' HE1' ' HA ' ' A' ' 188' ' ' MET . 29.1 mmt -73.68 -57.31 2.6 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 112.713 0.634 . . . . 1.39 112.713 -172.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.635 ' O ' HG11 ' A' ' 193' ' ' VAL . 27.3 Cg_endo -62.18 -30.48 82.01 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 121.616 1.544 . . . . 1.15 112.119 -177.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.2 t -75.99 -33.12 59.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.237 0.541 . . . . 1.95 109.824 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 187' ' ' THR . 63.9 t30 -73.0 -44.24 61.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.678 -0.692 . . . . 1.92 111.274 -174.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.573 ' HB3' HG21 ' A' ' 50' ' ' VAL . 18.5 mt -65.23 -42.62 93.24 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.754 0.311 . . . . 1.68 111.333 -175.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.635 HG11 ' O ' ' A' ' 189' ' ' PRO . 1.5 m -67.45 -31.89 54.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.908 0.861 . . . . 1.32 109.354 178.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.412 ' HB3' ' HE3' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -70.08 -34.68 73.47 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.284 -1.325 . . . . 2.6 110.997 177.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.622 ' HA ' ' ND2' ' A' ' 198' ' ' ASN . 3.3 m-85 -71.69 -24.53 61.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.24 0.543 . . . . 2.73 110.433 174.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.654 HG12 HD13 ' A' ' 167' ' ' LEU . 59.2 mt -82.08 -29.44 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-O 121.31 0.576 . . . . 1.11 110.511 172.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.477 HD22 ' HA ' ' A' ' 197' ' ' LEU . 44.6 mt -72.21 -42.6 65.57 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 116.16 -0.473 . . . . 1.57 110.736 177.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.839 ' HB3' ' HD2' ' A' ' 76' ' ' LYS . 5.9 p30 -59.55 -24.0 63.33 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 108.96 -0.755 . . . . 2.18 108.96 171.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.651 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -80.94 -44.83 17.63 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 120.415 -0.514 . . . . 1.04 110.222 176.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.48 ' HD3' HG12 ' A' ' 54' ' ' ILE . 22.5 mmtp -54.8 -42.89 72.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.02 -0.537 . . . . 1.51 110.856 175.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.533 ' O ' ' HD3' ' A' ' 204' ' ' LYS . 9.9 t70 -87.88 -46.26 9.56 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.007 -0.542 . . . . 1.94 110.327 -178.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . 0.696 ' HA2' ' HB1' ' A' ' 205' ' ' ALA . . . -61.19 -25.9 65.22 Favored Glycine 0 C--O 1.224 -0.508 0 CA-C-N 115.849 -0.614 . . . . 0.47 112.277 -178.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 1.019 HD12 HD23 ' A' ' 61' ' ' LEU . 3.0 tp -67.89 -43.07 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-O 119.27 -0.395 . . . . 1.16 111.239 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.717 ' HA ' ' HB3' ' A' ' 207' ' ' ARG . 0.0 OUTLIER -91.25 -13.54 32.56 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 118.732 0.696 . . . . 3.8 109.228 176.532 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.696 ' HB1' ' HA2' ' A' ' 202' ' ' GLY . . . -66.14 -29.73 70.09 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.532 -0.914 . . . . 1.28 108.532 164.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.583 ' HD2' ' HE2' ' A' ' 60' ' ' LYS . 6.6 t60 -100.48 -7.23 24.45 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.589 -1.187 . . . . 4.34 111.286 178.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.717 ' HB3' ' HA ' ' A' ' 204' ' ' LYS . 0.7 OUTLIER -112.95 -62.81 1.53 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.552 0.692 . . . . 3.0 110.448 -178.525 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.505 ' OG1' ' HB2' ' A' ' 204' ' ' LYS . 62.3 m -73.78 135.12 77.95 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 114.684 -1.144 . . . . 2.01 110.316 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 208' ' ' THR . 11.2 Cg_exo -71.52 43.98 0.57 Allowed 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 123.036 2.491 . . . . 2.59 112.689 178.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 31.2 t -98.79 -47.93 5.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.123 -0.489 . . . . 2.55 110.775 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.405 ' HB2' ' HA ' ' A' ' 205' ' ' ALA . 6.5 mpt_? -90.95 35.34 0.9 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.423 -0.353 . . . . 6.11 111.429 -174.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -78.66 -33.32 47.23 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.167 -0.679 . . . . 7.55 109.167 171.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.86 48.72 3.28 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.435 -1.066 . . . . 3.73 110.435 171.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -66.05 140.71 58.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.184 0.516 . . . . 6.11 111.764 -174.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -86.77 120.18 27.79 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.711 -0.848 . . . . 7.27 108.711 174.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -132.44 175.21 9.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.569 -0.287 . . . . 6.82 111.104 -172.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 68.94 178.96 0.25 Allowed 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.702 0.626 . . . . 5.77 110.951 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 13.8 m -85.27 -2.17 57.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.149 -0.478 . . . . 6.85 110.685 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -143.16 133.47 24.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.102 -0.499 . . . . 9.48 110.394 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 73.2 m . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.872 -0.585 . . . . 8.48 109.515 176.405 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.992 0.425 . . . . 4.31 110.533 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -106.6 -44.75 4.4 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 109.288 -0.634 . . . . 2.25 109.288 -175.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.666 ' HA ' HD12 ' A' ' 6' ' ' ILE . 96.6 m-85 -65.65 -37.03 85.4 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.191 -0.913 . . . . 0.45 109.186 -175.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.639 ' HG2' ' HG3' ' A' ' 8' ' ' GLN . 4.4 ttmt -81.75 2.94 27.62 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.121 -0.945 . . . . 2.06 110.476 -176.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -92.87 -49.42 6.06 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.359 0.599 . . . . 1.2 109.485 173.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.666 HD12 ' HA ' ' A' ' 3' ' ' PHE . 0.3 OUTLIER -83.8 -37.68 13.42 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.606 0 CA-C-N 115.354 -0.839 . . . . 1.76 110.181 -173.091 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.608 ' HB3' ' HB2' ' A' ' 116' ' ' TYR . . . -71.5 -44.1 65.32 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.587 0.708 . . . . 1.11 111.531 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.639 ' HG3' ' HG2' ' A' ' 4' ' ' LYS . 11.1 mt-30 -60.13 -32.83 71.38 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.917 -1.038 . . . . 2.14 110.516 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.557 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 25.6 mm-40 -85.75 -32.06 22.06 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.221 -0.899 . . . . 3.04 109.266 175.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.672 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.6 OUTLIER -62.26 -39.5 93.09 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.927 -1.033 . . . . 1.1 111.042 176.513 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.42 ' HA ' ' CB ' ' A' ' 128' ' ' SER . . . -47.43 -63.04 1.15 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 121.148 0.499 . . . . 1.04 111.529 173.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -71.57 -13.0 61.65 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.851 -0.613 . . . . 2.31 111.831 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.557 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 44.9 mm-40 -69.6 -58.12 4.34 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.764 0.792 . . . . 2.54 109.298 173.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.821 HG21 ' N ' ' A' ' 152' ' ' GLY . 5.3 p -68.01 -40.13 82.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 114.648 -1.16 . . . . 1.21 109.717 -177.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.556 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -68.14 -22.83 64.84 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 114.787 -1.097 . . . . 1.26 109.08 176.342 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.73 ' HA2' ' HD3' ' A' ' 19' ' ' ARG . . . -63.28 -25.34 68.29 Favored Glycine 0 CA--C 1.5 -0.847 0 CA-C-N 114.474 -1.239 . . . . 0.57 110.444 177.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -88.83 -12.25 42.48 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.699 -0.852 . . . . 3.59 108.699 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -83.96 -9.27 58.81 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.321 -0.854 . . . . 2.1 110.027 172.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.73 ' HD3' ' HA2' ' A' ' 16' ' ' GLY . 48.4 mtp180 -106.85 -23.89 12.23 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 116.183 -0.462 . . . . 3.26 110.884 -172.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -150.88 170.77 18.5 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.038 -0.528 . . . . 2.16 110.513 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.505 HG22 ' CZ2' ' A' ' 24' ' ' TRP . 75.1 p -133.51 134.02 42.91 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.57 -0.741 . . . . 2.24 109.792 -175.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.4 t -139.25 107.5 5.78 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.263 0.468 . . . . 2.46 112.263 -170.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.82 34.13 81.25 Favored Glycine 0 C--N 1.331 0.282 0 CA-C-N 115.528 -0.76 . . . . 1.45 114.405 168.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.906 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -121.29 -166.31 1.34 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 117.183 0.491 . . . . 2.24 110.273 175.141 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.61 140.38 0.6 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.392 -0.822 . . . . 3.43 109.225 -175.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.662 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 0.1 OUTLIER -60.33 117.08 2.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.457 -0.792 . . . . 2.21 110.378 174.01 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.9 p -92.05 -25.96 5.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 114.727 -1.124 . . . . 1.83 109.295 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.464 ' O ' HG22 ' A' ' 35' ' ' VAL . 3.0 tmmm? -161.24 146.63 14.01 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 119.264 -0.974 . . . . 2.87 112.274 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.863 HG22 ' HA ' ' A' ' 34' ' ' THR . 42.9 p -143.67 152.27 41.12 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.798 -0.637 . . . . 1.92 109.722 176.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.9 m -102.38 -90.01 0.36 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.523 -0.308 . . . . 2.37 110.631 176.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.481 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 82.0 tttt -155.28 31.65 0.38 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.122 0.487 . . . . 4.84 110.502 175.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.49 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 6.1 mmtm 178.9 -20.47 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.4 -0.818 . . . . 2.05 110.039 179.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.482 ' CD1' ' HB ' ' A' ' 193' ' ' VAL . 31.0 pt -115.45 160.85 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.353 -0.839 . . . . 1.42 110.701 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.863 ' HA ' HG22 ' A' ' 29' ' ' THR . 52.5 m -155.15 110.09 3.01 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.314 -0.857 . . . . 1.22 110.697 -163.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.733 ' HA ' ' O ' ' A' ' 49' ' ' ARG . 6.0 m -103.12 117.83 49.15 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 CA-C-O 121.023 0.44 . . . . 1.52 111.824 176.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.662 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 7.2 m -105.78 124.69 49.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.658 -0.701 . . . . 1.74 109.655 175.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.8 p -110.75 133.85 52.98 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.759 -0.655 . . . . 1.72 111.868 -172.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.906 ' HB3' ' HB3' ' A' ' 24' ' ' TRP . 23.0 pttt -139.21 157.5 45.81 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.546 -0.752 . . . . 2.45 109.26 171.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.04 127.79 33.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.759 0.314 . . . . 2.17 110.202 177.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.481 ' HG ' ' HG3' ' A' ' 172' ' ' GLN . 25.3 t -64.59 -35.8 82.17 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.71 -0.677 . . . . 2.51 112.383 -172.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 71.84 -41.51 0.51 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.928 0.891 . . . . 7.41 112.092 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -81.4 -2.25 48.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.375 0.607 . . . . 6.84 109.962 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -155.53 146.74 22.64 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 107.247 -1.39 . . . . 6.42 107.247 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -76.04 64.39 1.92 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.524 0.678 . . . . 6.31 110.392 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.28 -151.71 6.54 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 114.961 -1.018 . . . . 1.74 110.617 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.463 HD22 ' HH ' ' A' ' 48' ' ' TYR . 23.2 p-10 -131.99 147.07 52.43 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.531 0.681 . . . . 2.45 111.212 178.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.587 HD23 ' N ' ' A' ' 48' ' ' TYR . 3.5 tt -99.97 146.18 27.0 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.724 -1.125 . . . . 1.49 108.673 -176.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.62 ' HB2' HD12 ' A' ' 192' ' ' LEU . 56.9 m-85 -124.99 138.39 54.23 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 121.261 -0.176 . . . . 1.52 110.623 -177.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.733 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 4.3 ttm180 -104.65 120.0 40.29 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.093 -0.706 . . . . 3.34 109.093 167.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.658 ' HB ' ' HB3' ' A' ' 192' ' ' LEU . 9.0 p -102.93 134.73 43.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.004 -1.11 . . . . 1.98 108.004 172.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.618 ' HG3' ' HB ' ' A' ' 168' ' ' VAL . 2.7 tt0 -148.02 110.65 4.72 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.058 -0.519 . . . . 1.07 110.579 -165.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 32' ' ' LYS . . . -142.61 154.34 25.13 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 111.111 -0.796 . . . . 0.35 111.111 179.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.612 HD11 ' HZ2' ' A' ' 166' ' ' LYS . 2.7 mp -96.33 126.98 48.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 C-N-CA 119.256 -0.977 . . . . 1.3 110.393 176.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.493 ' CD1' ' HB1' ' A' ' 199' ' ' ALA . 66.2 mt -104.57 112.77 65.41 Favored Pre-proline 0 N--CA 1.44 -0.959 0 CA-C-N 114.937 -1.029 . . . . 1.07 109.33 177.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 28.8 Cg_exo -64.56 59.87 0.27 Allowed 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 124.259 3.306 . . . . 0.74 113.111 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.939 ' HG3' HG13 ' A' ' 203' ' ' ILE . 0.2 OUTLIER -134.37 -164.31 1.49 Allowed 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.041 -1.466 . . . . 1.68 107.041 174.075 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.561 ' H ' ' CD ' ' A' ' 56' ' ' GLU . 20.0 m -101.73 150.5 37.38 Favored Pre-proline 0 N--CA 1.421 -1.889 0 N-CA-C 108.816 -0.809 . . . . 1.58 108.816 169.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.55 ' HA ' HD13 ' A' ' 61' ' ' LEU . 14.9 Cg_exo -66.63 -7.72 18.92 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.605 2.87 . . . . 0.74 110.2 -178.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.68 -53.09 17.06 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.803 -1.09 . . . . 1.31 111.411 175.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.671 ' HE3' ' HB3' ' A' ' 64' ' ' PHE . 16.2 tptt -69.21 -28.29 66.24 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.254 -1.017 . . . . 3.78 108.254 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.681 ' O ' HD22 ' A' ' 65' ' ' LEU . 63.9 mt -62.45 -51.67 66.59 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.825 -1.08 . . . . 1.09 110.008 174.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.567 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 39.3 t -75.35 -4.96 42.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.735 0.302 . . . . 1.94 110.571 176.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.506 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 31.3 t70 -90.63 -43.06 10.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.313 -0.403 . . . . 1.32 110.829 178.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.794 ' O ' ' HB3' ' A' ' 71' ' ' ARG . 8.1 p90 -76.49 -44.97 33.02 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.903 -0.319 . . . . 0.79 111.146 -175.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.681 HD22 ' O ' ' A' ' 61' ' ' LEU . 1.2 pt? -77.64 6.2 7.73 Favored 'General case' 0 CA--C 1.509 -0.604 0 O-C-N 122.277 -0.264 . . . . 2.15 111.227 -164.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -46.77 -14.53 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.961 0 O-C-N 124.326 1.016 . . . . 2.06 113.074 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.627 ' HA ' ' HD2' ' A' ' 71' ' ' ARG . 0.4 OUTLIER 87.68 -38.18 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 124.73 1.212 . . . . 4.31 110.509 168.305 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.606 ' OG1' ' HB2' ' A' ' 81' ' ' TYR . 15.0 t -138.2 23.8 2.77 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.793 0.806 . . . . 1.89 110.811 -177.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -108.06 -61.29 0.55 Allowed Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 119.616 -1.278 . . . . 1.71 112.912 -177.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.679 ' O ' HG22 ' A' ' 73' ' ' THR . 18.9 t70 -134.05 -25.19 1.61 Allowed 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.881 0.848 . . . . 2.19 110.009 -169.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.794 ' HB3' ' O ' ' A' ' 64' ' ' PHE . 0.3 OUTLIER -69.0 -37.22 78.57 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 114.724 -1.125 . . . . 3.95 109.658 -163.385 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 1.101 HG22 HD13 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -76.11 -21.5 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 115.277 -0.874 . . . . 1.42 110.066 -176.223 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.679 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.2 t -81.02 -26.22 36.59 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 119.972 -0.691 . . . . 1.45 109.986 -172.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.705 ' CE2' ' HA ' ' A' ' 71' ' ' ARG . 24.8 p-90 -110.4 0.02 17.72 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.12 -0.491 . . . . 0.78 111.373 177.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.622 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 2.3 t70 -66.83 176.13 2.16 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.82 0.819 . . . . 2.19 112.527 -170.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.457 ' HD3' ' N ' ' A' ' 77' ' ' SER . 0.0 OUTLIER -129.19 -17.3 3.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.555 -1.202 . . . . 3.68 111.507 -174.636 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.457 ' N ' ' HD3' ' A' ' 76' ' ' LYS . 67.9 m -130.32 24.6 5.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.658 0.742 . . . . 2.08 109.372 178.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 1.101 HD13 HG22 ' A' ' 72' ' ' ILE . 18.9 mt -116.01 -167.21 1.23 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.301 -0.863 . . . . 1.16 112.293 177.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.462 ' HB3' HG22 ' A' ' 80' ' ' VAL . 1.9 mm100 -161.63 -74.79 0.05 Allowed 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.637 -0.71 . . . . 2.23 112.205 -167.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' A' ' 79' ' ' GLN . 23.0 t -139.4 122.09 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.917 0.389 . . . . 1.44 111.764 -167.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.606 ' HB2' ' OG1' ' A' ' 68' ' ' THR . 23.1 p90 -96.53 154.08 17.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.056 -0.52 . . . . 5.73 112.009 176.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.464 ' HB2' ' HD1' ' A' ' 95' ' ' HIS . 11.7 m-20 -162.08 111.29 1.48 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.46 -0.791 . . . . 1.86 109.541 168.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 30.9 ttm -72.26 109.87 6.3 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.15 -1.056 . . . . 2.52 108.15 174.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.511 HG23 ' HB ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -87.59 -88.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.893 0.377 . . . . 1.19 111.34 -170.73 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.536 ' HB3' HD13 ' A' ' 93' ' ' ILE . 54.3 t60 -113.34 124.81 53.33 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.174 0.511 . . . . 2.59 110.137 -177.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.0 mtt180 -104.68 133.96 48.64 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.942 -0.762 . . . . 2.83 108.942 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.519 HD12 ' CD2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -94.32 -39.38 10.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.685 0.755 . . . . 1.17 109.171 -175.789 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.423 ' HB2' ' HE2' ' A' ' 4' ' ' LYS . 4.0 t0 -150.9 -169.79 3.48 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.609 -1.178 . . . . 1.86 108.136 176.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.6 t -79.95 -3.57 48.78 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.74 0.305 . . . . 1.94 110.707 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -136.46 17.57 3.14 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.395 0.617 . . . . 1.87 109.758 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.694 HG22 ' HD2' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -138.42 108.37 6.34 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 108.662 -0.866 . . . . 1.12 108.662 179.513 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.592 ' O ' HD11 ' A' ' 114' ' ' LEU . 30.7 m-85 -126.58 177.23 6.64 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.418 0.628 . . . . 0.52 110.959 -173.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.536 HD13 ' HB3' ' A' ' 85' ' ' HIS . 28.4 mt -136.07 132.98 50.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 107.029 -1.471 . . . . 1.1 107.029 167.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.417 ' SG ' ' HB2' ' A' ' 113' ' ' ASP . 7.7 p -115.36 127.39 55.37 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.177 0.513 . . . . 2.61 111.927 -175.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.601 ' HD2' HD11 ' A' ' 112' ' ' ILE . 41.7 t-80 -89.51 91.32 8.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.721 -0.672 . . . . 2.17 109.192 169.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 86.7 m -110.34 109.17 19.49 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.399 -0.819 . . . . 1.19 111.592 -174.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.461 ' CG1' ' HB ' ' A' ' 80' ' ' VAL . 27.4 mm -77.85 120.07 27.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.699 -0.852 . . . . 1.63 108.699 171.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.4 t -110.77 153.96 24.6 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.14 0.495 . . . . 1.72 109.942 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.537 ' C ' ' H ' ' A' ' 101' ' ' PHE . 3.4 mt-30 -115.85 75.11 0.93 Allowed 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.81 -0.632 . . . . 2.29 109.385 175.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.5 m -75.18 21.62 0.12 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.356 0.598 . . . . 4.07 110.936 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.537 ' H ' ' C ' ' A' ' 99' ' ' GLN . 39.1 t80 -48.4 99.53 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.898 1.279 . . . . 6.11 111.149 176.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.554 ' HB1' HD12 ' A' ' 106' ' ' ILE . . . -66.53 -71.04 0.21 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.484 -0.78 . . . . 1.98 110.99 175.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 103' ' ' VAL . 14.4 p -145.74 16.89 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 122.466 1.127 . . . . 3.6 108.339 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.507 ' HA2' ' CE2' ' A' ' 101' ' ' PHE . . . 115.47 -5.52 21.19 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 114.653 -1.158 . . . . 2.2 111.5 -176.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.22 -18.24 53.3 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.657 0.741 . . . . 2.08 110.05 -177.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.554 HD12 ' HB1' ' A' ' 102' ' ' ALA . 26.9 mt -126.6 124.2 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 115.048 -0.978 . . . . 1.53 110.152 -172.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.433 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 13.7 m -86.05 163.46 42.95 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 109.108 -0.701 . . . . 1.71 109.108 176.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 107' ' ' SER . 9.3 Cg_endo -53.2 131.65 44.13 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.241 1.961 . . . . 1.31 111.254 174.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.634 ' HG2' HG22 ' A' ' 144' ' ' ILE . 45.9 mtt180 -106.44 157.06 17.91 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.101 -0.703 . . . . 4.06 109.101 -178.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.818 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 13.6 t0 -106.57 116.16 31.46 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.91 -0.774 . . . . 1.37 108.91 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.612 ' HE1' ' HA3' ' A' ' 146' ' ' GLY . 3.3 m-30 -99.57 128.39 45.68 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.012 0.435 . . . . 3.01 110.492 -177.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.801 HG13 ' HA ' ' A' ' 137' ' ' TYR . 27.3 mm -123.61 75.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 108.769 -0.826 . . . . 1.2 108.769 173.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.918 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 20.8 m-20 -89.83 118.03 29.11 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.163 -0.926 . . . . 1.86 109.786 -177.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.592 HD11 ' O ' ' A' ' 92' ' ' PHE . 3.8 tp -75.03 114.66 13.76 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 107.875 -1.157 . . . . 1.08 107.875 166.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -118.77 122.16 68.72 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 CA-C-N 114.474 -1.239 . . . . 1.08 111.121 -164.529 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.694 ' HD2' HG22 ' A' ' 91' ' ' THR . 29.1 t80 -106.32 111.11 23.56 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.656 -1.156 . . . . 2.81 109.252 176.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.975 HG12 HG21 ' A' ' 127' ' ' ILE . 82.5 mt -87.81 98.12 7.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.953 0.882 . . . . 1.53 109.27 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.651 ' HE2' ' HE1' ' A' ' 116' ' ' TYR . 16.2 tppt? -99.62 112.56 24.77 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.103 -1.408 . . . . 1.81 108.93 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.518 ' NH1' ' HG2' ' A' ' 121' ' ' GLU . 0.1 OUTLIER -106.13 108.86 20.58 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 122.108 0.956 . . . . 3.22 108.526 177.039 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.535 ' CB ' ' HB2' ' A' ' 123' ' ' ASN . 91.0 m-85 -76.61 108.36 9.56 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 105.933 -1.877 . . . . 1.28 105.933 167.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.518 ' HG2' ' NH1' ' A' ' 119' ' ' ARG . 44.7 mt-10 -40.21 93.35 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.879 1.362 . . . . 2.28 112.84 -174.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 71.0 35.27 64.72 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 114.634 -1.166 . . . . 0.79 112.497 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.535 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 13.3 m120 -133.32 -54.35 0.9 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.853 -0.673 . . . . 2.06 110.032 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.514 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 2.8 mpp? -160.07 121.8 3.21 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.154 -0.476 . . . . 1.73 110.655 -175.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -107.93 81.8 1.55 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.412 -0.958 . . . . 2.07 108.412 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.572 ' CG1' HG11 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -99.81 137.93 25.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.239 -0.891 . . . . 1.06 112.967 -170.709 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.975 HG21 HG12 ' A' ' 117' ' ' ILE . 41.2 pt -99.25 104.35 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 121.833 0.825 . . . . 1.26 109.281 166.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 0.7 OUTLIER -87.04 109.26 19.28 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.429 -0.805 . . . . 1.53 109.82 179.214 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.918 ' HB3' ' HB3' ' A' ' 113' ' ' ASP . 14.1 m -118.26 137.78 52.81 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.016 0.436 . . . . 1.81 112.132 -166.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.692 ' HZ3' ' HB3' ' A' ' 130' ' ' LYS . 3.4 mtpm? -132.47 124.6 28.87 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 107.732 -1.21 . . . . 2.75 107.732 178.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 15.6 p -64.37 99.82 0.32 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.924 -1.51 . . . . 1.94 106.924 173.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.43 135.69 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 CA-C-O 121.504 0.669 . . . . 1.64 109.369 -164.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -87.41 81.38 7.85 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.841 -1.072 . . . . 2.17 109.583 -171.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.74 ' CZ ' ' HB3' ' A' ' 136' ' ' GLU . 0.8 OUTLIER -121.96 176.26 2.1 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-N 115.092 -0.958 . . . . 0.67 108.469 -176.548 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.537 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 50.3 Cg_exo -24.43 -64.49 0.04 OUTLIER 'Trans proline' 0 CA--C 1.551 1.353 1 C-N-CA 125.474 4.116 . . . . 1.66 117.329 -179.386 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.74 ' HB3' ' CZ ' ' A' ' 134' ' ' PHE . 6.2 tp10 -72.8 -30.69 64.27 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.466 0.543 . . . . 3.5 112.466 -174.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.906 ' HH ' HH22 ' A' ' 176' ' ' ARG . 32.1 t80 -51.17 -41.87 77.48 Favored Pre-proline 0 CA--C 1.552 1.056 0 N-CA-C 115.651 1.722 . . . . 6.41 115.651 -170.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.457 ' HD2' ' O ' ' A' ' 135' ' ' PRO . 73.4 Cg_exo -45.86 108.43 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 122.515 2.143 . . . . 2.31 113.746 177.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.979 ' HB3' ' HD3' ' A' ' 145' ' ' ARG . 95.0 Cg_endo -99.97 -158.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.024 3.149 . . . . 1.27 114.053 -177.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.8 t -135.85 -155.09 0.61 Allowed 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.476 -1.305 . . . . 1.88 107.476 177.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.2 m -90.47 -41.19 11.57 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.405 -0.518 . . . . 2.43 111.451 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -64.45 -53.36 49.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.759 0.314 . . . . 2.18 110.538 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -95.48 108.94 21.2 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 108.923 -0.769 . . . . 1.33 108.923 175.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.634 HG22 ' HG2' ' A' ' 109' ' ' ARG . 1.2 tt -104.52 119.08 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 CA-C-N 115.056 -0.975 . . . . 1.4 110.721 -173.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.979 ' HD3' ' HB3' ' A' ' 139' ' ' PRO . 1.3 mpt_? -63.41 99.31 0.2 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.264 -1.334 . . . . 5.14 109.732 173.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.612 ' HA3' ' HE1' ' A' ' 111' ' ' PHE . . . -61.36 111.83 4.21 Favored Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 110.096 -1.202 . . . . 1.05 110.096 176.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.594 ' HB3' ' HB3' ' A' ' 174' ' ' GLU . 39.5 t80 -84.47 84.65 7.58 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.832 0.825 . . . . 4.68 110.441 -172.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.649 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 87.6 m-20 -72.82 99.57 2.68 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.485 -1.234 . . . . 2.29 109.838 174.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.507 ' HB2' ' HG2' ' A' ' 172' ' ' GLN . 51.0 m-70 -60.89 137.23 93.62 Favored Pre-proline 0 CA--C 1.51 -0.582 0 N-CA-C 107.992 -1.114 . . . . 2.95 107.992 172.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.672 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 32.3 Cg_exo -21.97 67.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.168 1 C-N-CA 126.79 4.994 . . . . 0.77 115.796 -170.176 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . 0.709 ' HB2' ' O ' ' A' ' 170' ' ' PHE . 22.3 p -96.0 -175.11 3.3 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.155 -0.93 . . . . 1.97 109.574 176.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.821 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -177.07 171.37 44.24 Favored Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 119.597 -1.287 . . . . 0.55 111.942 -177.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.607 ' HB3' ' CG1' ' A' ' 127' ' ' ILE . 2.6 t80 -140.26 84.39 1.96 Allowed 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.002 -1.481 . . . . 0.8 107.002 -159.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.572 HG11 ' CG1' ' A' ' 126' ' ' ILE . 2.9 m -93.16 143.36 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 121.988 0.899 . . . . 1.03 111.113 -170.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . 0.544 ' SG ' ' HB3' ' A' ' 58' ' ' PRO . 3.6 t -119.81 126.49 51.13 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.558 -1.201 . . . . 2.3 108.976 175.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.571 ' H ' ' HB3' ' A' ' 166' ' ' LYS . 5.5 m -119.02 112.18 36.55 Favored Pre-proline 0 C--N 1.318 -0.781 0 C-N-CA 119.234 -0.986 . . . . 1.45 111.43 -173.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 57.1 Cg_exo -51.27 105.52 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 121.77 1.647 . . . . 0.72 109.864 167.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.624 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 21.4 mtp -72.18 -171.23 0.72 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.548 0.69 . . . . 1.72 112.532 -170.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -62.59 -20.16 64.45 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.047 -0.979 . . . . 2.63 109.715 174.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 11.5 mm-40 -105.95 10.44 32.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.368 -0.833 . . . . 2.05 110.251 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.464 ' CB ' ' CD ' ' A' ' 162' ' ' PRO . 44.1 m-80 27.32 -93.48 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.928 0 N-CA-C 115.13 1.53 . . . . 2.19 115.13 -177.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.464 ' CD ' ' CB ' ' A' ' 161' ' ' ASN . 95.3 Cg_endo -76.04 -10.79 19.63 Favored 'Trans proline' 0 C--N 1.367 1.541 0 CA-C-N 121.864 1.701 . . . . 0.86 112.942 -173.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.46 ' HB2' ' HB3' ' A' ' 160' ' ' GLU . . . -89.76 -34.85 16.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.983 -0.553 . . . . 1.34 110.34 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.624 ' O ' ' HB2' ' A' ' 158' ' ' MET . 88.8 m-85 -140.35 118.94 12.3 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.375 -0.602 . . . . 1.46 109.375 178.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 69.4 m -116.93 136.86 52.62 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.311 0.576 . . . . 2.05 110.642 -178.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.685 ' HG3' HG13 ' A' ' 168' ' ' VAL . 41.1 tptt -80.34 128.53 33.66 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.645 -0.707 . . . . 1.4 111.784 -174.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.714 HD13 HG12 ' A' ' 196' ' ' ILE . 0.3 OUTLIER -112.45 100.77 9.02 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.303 -0.862 . . . . 1.07 110.575 165.885 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.685 HG13 ' HG3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -125.87 117.52 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 121.712 0.768 . . . . 1.11 110.981 175.445 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.424 ' SD ' ' O ' ' A' ' 152' ' ' GLY . 5.5 tpt -128.67 135.75 49.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.391 -0.822 . . . . 1.79 110.176 -173.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.709 ' O ' ' HB2' ' A' ' 151' ' ' CYS . 41.1 m-85 -111.29 128.07 55.83 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.685 -0.688 . . . . 4.22 109.311 -177.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.98 ' HB ' HD22 ' A' ' 192' ' ' LEU . 0.8 OUTLIER -110.41 121.04 62.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.361 0.601 . . . . 2.01 110.535 -176.016 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.507 ' HG2' ' HB2' ' A' ' 149' ' ' HIS . 49.9 tt0 -129.8 49.54 2.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 122.482 1.134 . . . . 2.66 108.417 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 22.0 m -77.31 140.24 39.97 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 113.772 -1.558 . . . . 2.2 111.448 -173.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.594 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 15.0 tt0 -84.61 -28.8 26.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.598 -0.728 . . . . 2.45 111.699 -176.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.501 ' SD ' ' HE2' ' A' ' 188' ' ' MET . 49.8 mtm 47.9 47.56 18.43 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.058 0.456 . . . . 4.15 110.959 174.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.906 HH22 ' HH ' ' A' ' 137' ' ' TYR . 38.9 mtm-85 -48.29 -51.58 25.24 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 114.68 1.363 . . . . 6.51 114.68 -166.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -162.75 83.94 0.11 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 119.253 -1.451 . . . . 2.26 113.872 -175.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 12.6 tptp -162.31 4.86 0.05 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.942 0.371 . . . . 6.69 111.038 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.771 ' HB3' ' HB ' ' A' ' 183' ' ' ILE . 1.2 mp -144.24 172.79 12.43 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.418 0.628 . . . . 2.21 110.689 -177.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.457 ' O ' HD12 ' A' ' 184' ' ' ILE . 42.7 m -113.59 162.67 21.34 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 114.663 -1.153 . . . . 2.31 108.016 171.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -44.05 -44.31 12.34 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 122.614 2.209 . . . . 1.86 113.103 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.467 ' O ' ' HE2' ' A' ' 186' ' ' LYS . 10.8 p -70.36 -14.79 62.72 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.121 -0.49 . . . . 2.45 112.142 -177.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.771 ' HB ' ' HB3' ' A' ' 179' ' ' LEU . 11.4 mm -91.36 -38.65 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 CA-C-O 122.386 1.088 . . . . 1.69 109.144 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.672 ' CD1' ' HB2' ' A' ' 179' ' ' LEU . 0.7 OUTLIER -66.68 -38.35 81.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 113.001 -1.909 . . . . 1.77 111.106 -176.881 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -62.4 -21.47 65.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.872 -0.604 . . . . 2.89 109.382 176.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.467 ' HE2' ' O ' ' A' ' 182' ' ' SER . 47.0 mtmt -92.46 -41.56 10.23 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.317 -0.856 . . . . 1.71 110.419 175.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.646 HG21 ' HA ' ' A' ' 184' ' ' ILE . 13.6 t -63.08 -35.28 79.73 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.071 0.767 . . . . 1.3 113.071 -168.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' MET . . . . . 0.773 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 30.9 mmt -77.72 -60.71 0.68 Allowed Pre-proline 0 C--N 1.33 -0.24 0 C-N-CA 120.266 -0.574 . . . . 1.39 111.52 -177.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.773 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 36.9 Cg_exo -58.17 -37.87 93.65 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.925 1.75 . . . . 1.15 112.399 -177.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 41.7 m -70.88 -32.45 69.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.789 0.328 . . . . 1.95 110.764 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -75.16 -43.02 54.74 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.911 -0.586 . . . . 1.92 110.053 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.98 HD22 ' HB ' ' A' ' 171' ' ' VAL . 95.2 mt -52.97 -55.17 25.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.453 -0.794 . . . . 1.68 112.264 176.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.673 HG12 ' O ' ' A' ' 189' ' ' PRO . 1.3 m -66.4 -31.57 54.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.668 0.747 . . . . 1.32 109.648 -177.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 190' ' ' SER . 0.6 OUTLIER -69.68 -38.06 76.88 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.49 -1.232 . . . . 2.6 111.202 179.028 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.51 ' HB3' ' HE2' ' A' ' 153' ' ' PHE . 3.1 m-30 -62.41 -32.89 73.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.021 0.439 . . . . 2.73 110.26 173.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.714 HG12 HD13 ' A' ' 167' ' ' LEU . 38.8 mt -79.44 -29.57 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-O 120.95 0.405 . . . . 1.11 111.065 177.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.481 HD22 ' HA ' ' A' ' 197' ' ' LEU . 51.9 mt -72.03 -37.52 69.71 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.037 0.446 . . . . 1.57 109.956 176.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.505 ' HB3' ' CH2' ' A' ' 74' ' ' TRP . 13.4 m120 -47.4 -50.55 22.29 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.841 -1.072 . . . . 2.18 108.676 163.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.813 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -66.29 -46.3 77.48 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 115.057 -0.974 . . . . 1.04 110.581 -174.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.704 ' O ' ' HG2' ' A' ' 204' ' ' LYS . 27.9 mmtp -53.69 -50.34 66.07 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 123.814 0.696 . . . . 1.51 109.615 174.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -76.44 -38.98 54.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.372 -0.831 . . . . 1.94 111.73 -169.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -68.78 -35.02 78.99 Favored Glycine 0 N--CA 1.463 0.447 0 C-N-CA 119.865 -1.16 . . . . 0.47 110.486 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.939 HG13 ' HG3' ' A' ' 56' ' ' GLU . 1.1 mp -65.07 -35.75 76.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 114.186 -1.007 . . . . 1.16 110.973 173.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.704 ' HG2' ' O ' ' A' ' 200' ' ' LYS . 52.7 mmtt -75.2 -39.34 60.23 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 108.81 -0.811 . . . . 3.8 108.81 177.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.621 ' HA ' ' HB3' ' A' ' 211' ' ' ARG . . . -55.82 -35.08 65.95 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.18 -0.918 . . . . 1.28 109.099 173.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.609 ' HB3' ' O ' ' A' ' 203' ' ' ILE . 73.3 t60 -61.53 -43.49 98.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.12 -0.945 . . . . 4.34 112.049 174.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.471 ' HG3' ' N ' ' A' ' 208' ' ' THR . 7.8 ptp180 -130.53 -46.47 1.07 Allowed 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.655 0.983 . . . . 3.0 113.655 -170.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.476 ' HB ' ' HB3' ' A' ' 204' ' ' LYS . 25.0 m -69.74 137.06 87.83 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-O 120.738 0.304 . . . . 2.01 110.863 -171.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 208' ' ' THR . 31.0 Cg_exo -63.65 7.07 0.21 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.465 2.777 . . . . 2.59 113.38 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.415 ' H ' ' C ' ' A' ' 208' ' ' THR . 12.8 p -67.35 -21.22 65.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.054 0.454 . . . . 2.55 110.238 175.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.621 ' HB3' ' HA ' ' A' ' 205' ' ' ALA . 3.3 ppt_? -77.18 15.47 0.72 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.232 0.539 . . . . 6.11 111.048 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -61.07 -37.55 83.07 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.293 -0.632 . . . . 7.55 109.293 170.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -102.53 45.1 1.39 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.541 -0.754 . . . . 3.73 111.361 176.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -75.19 136.57 41.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.804 0.335 . . . . 6.11 110.241 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -118.75 97.75 5.88 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.168 0.509 . . . . 7.27 111.381 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 33.0 t-80 -89.98 42.07 1.08 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.496 -0.775 . . . . 6.82 109.383 178.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -91.32 85.19 5.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.613 -0.721 . . . . 5.77 110.187 -175.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 6.0 p -87.86 -0.38 56.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.74 -0.664 . . . . 6.85 111.493 -176.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -100.52 -75.55 0.58 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.64 -0.504 . . . . 9.48 109.64 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 17.0 t . . . . . 0 C--O 1.248 1.023 0 N-CA-C 108.513 -0.921 . . . . 8.48 108.513 174.1 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 120.855 0.36 . . . . 4.31 111.02 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.759 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.2 m-20 -69.55 -35.28 75.27 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.087 -0.709 . . . . 2.25 109.087 -177.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.64 ' HA ' ' CD1' ' A' ' 6' ' ' ILE . 89.8 m-85 -67.68 -34.02 76.08 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.203 -0.908 . . . . 0.45 109.096 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.592 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 21.9 tttp -78.92 -1.16 33.92 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 114.363 -1.289 . . . . 2.06 109.751 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -92.66 -43.85 8.88 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.295 0.569 . . . . 1.2 110.209 172.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.759 HD13 ' O ' ' A' ' 2' ' ' ASP . 0.0 OUTLIER -83.0 -37.24 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-N 115.519 -0.764 . . . . 1.76 110.269 -172.614 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.472 ' HB3' ' HB2' ' A' ' 116' ' ' TYR . . . -80.69 -40.85 24.72 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.483 -1.235 . . . . 1.11 111.535 -176.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.592 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 8.2 mt-30 -65.7 -29.6 70.17 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.2 -0.909 . . . . 2.14 110.153 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.656 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 14.8 mm100 -82.74 -33.59 27.42 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.211 -0.904 . . . . 3.04 109.208 175.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.653 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -70.92 -35.16 72.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.257 -0.883 . . . . 1.1 111.423 -179.469 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.44 ' HA ' ' OG ' ' A' ' 128' ' ' SER . . . -43.87 -61.54 1.4 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.928 0.394 . . . . 1.04 112.038 172.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -74.73 -11.08 60.08 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.477 -0.329 . . . . 2.31 111.728 -177.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.656 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 53.9 mt-10 -71.55 -56.01 6.72 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.069 -0.715 . . . . 2.54 109.069 172.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.743 HG23 ' N ' ' A' ' 152' ' ' GLY . 10.6 p -68.27 -38.21 79.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 122.838 1.304 . . . . 1.21 109.721 -175.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.439 ' HB3' ' O ' ' A' ' 11' ' ' ALA . 0.5 OUTLIER -76.11 -18.88 58.97 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 113.791 -1.55 . . . . 1.26 109.248 178.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.403 ' HA2' ' HD3' ' A' ' 19' ' ' ARG . . . -61.95 -27.93 69.5 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 114.144 -1.389 . . . . 0.57 110.04 172.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.446 ' HD1' ' O ' ' A' ' 13' ' ' GLU . 24.4 m-85 -86.03 -15.91 39.86 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.16 -0.52 . . . . 3.59 110.055 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -85.99 -3.51 58.95 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 119.526 -0.87 . . . . 2.1 110.051 172.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.403 ' HD3' ' HA2' ' A' ' 16' ' ' GLY . 35.2 mtp180 -105.62 -21.51 13.18 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.113 -0.367 . . . . 3.26 111.486 -178.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -146.26 154.1 41.34 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.242 -0.435 . . . . 2.16 111.018 174.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.491 ' HB ' ' CZ2' ' A' ' 24' ' ' TRP . 70.4 p -135.52 129.91 33.79 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.722 -0.672 . . . . 2.24 111.229 -172.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.5 p -174.85 157.0 2.36 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.192 0.307 . . . . 2.46 111.76 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.69 3.64 90.56 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.903 -0.59 . . . . 1.45 113.774 170.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.491 ' CZ2' ' HB ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -120.58 -158.39 0.75 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 117.191 0.496 . . . . 2.24 111.456 -176.511 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.37 119.88 0.32 Allowed 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 108.735 -0.839 . . . . 3.43 108.735 -174.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.58 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 0.3 OUTLIER -55.16 121.71 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-O 122.06 0.933 . . . . 2.21 111.389 174.64 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.13 -25.35 3.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 113.971 -1.468 . . . . 1.83 109.99 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.424 ' HD2' ' HA ' ' A' ' 28' ' ' LYS . 9.4 tptm -142.98 121.93 12.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 119.75 -0.78 . . . . 2.87 112.503 -173.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.463 HG23 ' HA ' ' A' ' 34' ' ' THR . 41.6 p -135.59 121.75 20.22 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.367 -0.605 . . . . 1.92 109.367 172.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.2 t -85.14 -79.01 0.24 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 121.064 -0.254 . . . . 2.37 110.415 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -164.08 19.37 0.06 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.479 0.657 . . . . 4.84 109.832 176.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -173.54 3.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.662 -0.699 . . . . 2.05 110.369 -175.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.48 ' CD1' ' HB ' ' A' ' 193' ' ' VAL . 28.9 pt -140.85 167.46 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-O 120.79 0.329 . . . . 1.42 110.875 -171.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.463 ' HA ' HG23 ' A' ' 29' ' ' THR . 26.2 m -152.95 104.72 2.86 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.208 -0.451 . . . . 1.22 111.19 -171.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.597 ' CG1' HD12 ' A' ' 192' ' ' LEU . 11.4 t -101.57 121.02 51.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 1.52 110.086 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.58 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 5.6 m -113.02 128.55 56.53 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.187 -0.46 . . . . 1.74 110.223 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.0 p -97.94 130.24 44.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.667 -0.697 . . . . 1.72 110.345 -176.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -120.68 -98.46 0.45 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.671 -0.695 . . . . 2.45 111.243 -173.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.16 137.81 6.33 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.663 -0.495 . . . . 2.17 109.663 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.49 ' C ' ' H ' ' A' ' 42' ' ' LYS . 8.5 t -82.8 -155.7 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.099 0.476 . . . . 2.51 110.518 -177.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.428 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 42.7 ttt180 -74.32 11.8 0.89 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.93 -0.577 . . . . 7.41 109.978 175.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.49 ' H ' ' C ' ' A' ' 40' ' ' SER . 32.7 mmtp 60.82 39.7 16.78 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 115.654 -0.703 . . . . 6.84 110.566 -178.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -143.94 2.42 1.18 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.936 -0.575 . . . . 6.42 109.918 -176.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.474 ' NE2' ' HG3' ' A' ' 174' ' ' GLU . 19.6 m-70 -151.08 -45.07 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.043 -0.526 . . . . 6.31 111.181 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 171.89 -117.94 0.7 Allowed Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.385 -0.912 . . . . 1.74 112.74 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -128.74 155.13 45.59 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.362 0.601 . . . . 2.45 111.355 -173.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 171' ' ' VAL . 10.0 tt -93.5 152.38 19.1 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.023 -0.989 . . . . 1.49 109.56 -176.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.546 ' N ' HD23 ' A' ' 47' ' ' LEU . 71.7 m-85 -127.78 134.17 49.48 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.65 0.262 . . . . 1.52 110.745 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.539 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.8 OUTLIER -118.6 126.48 52.05 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 108.999 -0.741 . . . . 3.34 108.999 175.915 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 192' ' ' LEU . 14.8 p -114.75 150.03 16.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.725 -0.472 . . . . 1.98 109.725 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.447 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 37.9 tt0 -155.38 109.84 2.92 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.987 -0.552 . . . . 1.07 110.351 -170.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.408 ' HA3' HG21 ' A' ' 33' ' ' ILE . . . -138.83 160.43 25.7 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.615 -0.802 . . . . 0.35 111.791 178.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.402 ' O ' ' HD3' ' A' ' 55' ' ' PRO . 58.6 mt -100.89 114.92 41.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 C-N-CA 120.57 -0.452 . . . . 1.3 110.786 179.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 40.1 mt -94.42 112.83 59.15 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.666 -0.697 . . . . 1.07 109.431 175.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 53' ' ' ILE . 31.7 Cg_exo -61.34 70.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 124.566 3.511 . . . . 0.74 112.893 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.472 ' HG3' ' CG1' ' A' ' 203' ' ' ILE . 0.1 OUTLIER -155.06 -167.77 2.67 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.89 -1.05 . . . . 1.68 108.555 177.089 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.3 t -101.41 146.77 32.77 Favored Pre-proline 0 N--CA 1.421 -1.884 0 N-CA-C 108.485 -0.932 . . . . 1.58 108.485 174.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.599 ' HB3' ' SG ' ' A' ' 155' ' ' CYS . 24.6 Cg_exo -61.62 -12.7 26.0 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.486 2.791 . . . . 0.74 110.442 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.08 -44.65 53.28 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.74 -1.118 . . . . 1.31 111.325 176.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.48 ' CG ' HD12 ' A' ' 203' ' ' ILE . 6.5 tppt? -71.49 -31.94 67.68 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 108.293 -1.003 . . . . 3.78 108.293 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.572 HD21 ' CD1' ' A' ' 203' ' ' ILE . 63.6 mt -62.15 -51.91 65.96 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.388 -1.278 . . . . 1.09 110.429 175.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.8 m -64.7 -15.24 61.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.048 0.451 . . . . 1.94 110.613 173.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -84.73 -52.3 6.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.036 -0.529 . . . . 1.32 111.795 -177.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.696 ' CE2' ' HA ' ' A' ' 199' ' ' ALA . 10.2 p90 -70.03 -40.63 75.05 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.727 0.269 . . . . 0.79 111.727 -172.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.453 HD21 ' O ' ' A' ' 61' ' ' LEU . 0.6 OUTLIER -79.75 -21.35 44.58 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 120.357 -0.537 . . . . 2.15 112.054 -170.059 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.534 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 1.8 t80 -5.77 -71.77 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 O-C-N 125.214 1.571 . . . . 2.06 113.18 -156.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.534 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 4.8 tp60 175.93 -37.7 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.565 0.541 . . . . 4.31 111.815 167.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.414 ' OG1' ' HB2' ' A' ' 81' ' ' TYR . 12.7 t -146.57 12.02 1.14 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.364 0.505 . . . . 1.89 112.364 -168.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -118.99 -5.26 11.92 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 119.122 -1.513 . . . . 1.71 113.887 -171.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.647 ' O ' HG23 ' A' ' 73' ' ' THR . 0.5 OUTLIER -170.96 -31.74 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.631 0 CA-C-O 121.415 0.626 . . . . 2.19 109.844 -177.944 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.496 ' HG2' ' CD1' ' A' ' 78' ' ' LEU . 8.0 ttt180 -40.9 -50.09 3.23 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 125.461 1.504 . . . . 3.95 111.086 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.456 HG22 HD11 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -91.15 -7.52 10.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.813 -1.085 . . . . 1.42 111.241 -176.189 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER -84.79 -34.6 22.73 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 120.545 -0.462 . . . . 1.45 110.298 -173.758 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.662 ' CZ3' ' HB2' ' A' ' 198' ' ' ASN . 20.8 p-90 -91.78 -42.38 10.14 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 120.056 -0.658 . . . . 0.78 109.314 174.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.7 t70 56.83 141.96 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.203 1.927 . . . . 2.19 116.203 159.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.543 ' HD3' ' N ' ' A' ' 77' ' ' SER . 0.0 OUTLIER -139.29 -29.09 0.76 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.567 -0.742 . . . . 3.68 111.989 163.733 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.543 ' N ' ' HD3' ' A' ' 76' ' ' LYS . 63.0 m -136.51 22.18 3.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.081 0.943 . . . . 2.08 108.524 176.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.496 ' CD1' ' HG2' ' A' ' 71' ' ' ARG . 43.8 mt -110.01 -173.79 2.34 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.241 -1.345 . . . . 1.16 110.163 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.566 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 3.4 mm100 -160.36 -66.18 0.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.925 0.343 . . . . 2.23 111.925 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.48 ' HB ' ' CG1' ' A' ' 97' ' ' ILE . 40.4 t -143.71 133.53 20.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.984 0.421 . . . . 1.44 111.136 -167.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.414 ' HB2' ' OG1' ' A' ' 68' ' ' THR . 20.3 p90 -100.49 145.17 28.61 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.643 -0.708 . . . . 5.73 110.754 175.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.565 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 18.4 m120 -150.8 102.56 3.01 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.798 -0.816 . . . . 1.86 108.798 170.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.52 107.36 2.45 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.638 -0.505 . . . . 2.52 109.638 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.478 ' CG1' ' HG2' ' A' ' 136' ' ' GLU . 0.0 OUTLIER -84.36 -56.73 5.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.608 -0.723 . . . . 1.19 110.948 -170.433 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -147.51 113.05 5.65 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.001 -0.545 . . . . 2.59 110.244 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -95.91 120.78 36.79 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.562 -0.903 . . . . 2.83 108.562 176.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.603 HG12 ' O ' ' A' ' 91' ' ' THR . 1.2 mm -72.9 -53.35 18.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.976 -1.011 . . . . 1.17 110.277 -168.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.514 ' CG ' ' HZ3' ' A' ' 4' ' ' LYS . 1.3 p30 -140.23 -97.2 0.15 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.633 -0.712 . . . . 1.86 111.492 176.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.6 t -137.98 -12.44 1.46 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.846 -0.161 . . . . 1.94 111.041 -177.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -131.3 8.57 4.68 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.169 0.509 . . . . 1.87 109.713 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.603 ' O ' HG12 ' A' ' 87' ' ' ILE . 9.0 m -139.6 118.15 12.22 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 107.591 -1.263 . . . . 1.12 107.591 -172.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.595 ' O ' HD13 ' A' ' 114' ' ' LEU . 35.8 m-85 -132.92 174.99 9.75 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.243 0.544 . . . . 0.52 110.854 -171.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.523 HD13 ' CE1' ' A' ' 3' ' ' PHE . 25.5 mt -133.97 123.5 44.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 107.255 -1.387 . . . . 1.1 107.255 165.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.0 t -112.6 122.09 46.68 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.372 0.606 . . . . 2.61 111.532 -176.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.565 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 31.2 t-80 -78.84 88.74 4.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.864 0.84 . . . . 2.17 108.84 168.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 19.1 m -97.37 114.17 25.93 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.514 -1.221 . . . . 1.19 111.183 -176.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.48 ' CG1' ' HB ' ' A' ' 80' ' ' VAL . 36.8 mm -76.98 124.72 35.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.909 -0.774 . . . . 1.63 108.909 173.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.1 m -111.19 133.22 53.71 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.011 -0.995 . . . . 1.72 111.562 -170.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.566 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 30.6 mt-30 -89.36 83.91 6.43 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.687 -0.486 . . . . 2.29 109.687 172.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.47 ' O ' ' HB ' ' A' ' 106' ' ' ILE . 36.3 m -91.98 96.09 10.17 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.907 -0.405 . . . . 4.07 109.907 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -122.57 100.29 6.85 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 112.558 0.577 . . . . 6.11 112.558 -178.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.537 ' O ' HG12 ' A' ' 103' ' ' VAL . . . -92.99 76.33 4.73 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.059 -0.719 . . . . 1.98 109.059 168.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 102' ' ' ALA . 1.3 p 58.44 12.31 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.215 1.006 . . . . 3.6 112.409 178.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.43 -4.55 21.57 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.345 -0.931 . . . . 2.2 112.805 176.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.3 m -71.38 -14.04 62.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.185 0.517 . . . . 2.08 111.189 178.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 100' ' ' SER . 16.3 mt -131.41 144.21 38.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.907 -0.588 . . . . 1.53 109.879 -173.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.414 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 15.5 m -99.43 169.21 8.43 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 109.867 -0.419 . . . . 1.71 109.867 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 107' ' ' SER . 80.1 Cg_exo -46.54 128.18 12.42 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.201 1.934 . . . . 1.31 111.108 172.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.59 ' HG2' ' O ' ' A' ' 144' ' ' ILE . 33.3 ttp180 -116.81 162.43 17.72 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 120.993 0.425 . . . . 4.06 110.068 -170.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.48 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 6.4 t70 -112.14 162.14 15.77 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.285 -1.006 . . . . 1.37 108.285 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.455 ' CE2' ' HB3' ' A' ' 113' ' ' ASP . 3.0 t80 -149.7 136.15 19.15 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.059 0.457 . . . . 3.01 111.266 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.631 ' O ' ' HA ' ' A' ' 131' ' ' SER . 46.3 mm -122.75 89.86 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 N-CA-C 108.423 -0.955 . . . . 1.2 108.423 172.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.455 ' HB3' ' CE2' ' A' ' 111' ' ' PHE . 2.0 p30 -95.3 113.45 25.12 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.384 -0.825 . . . . 1.86 110.685 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.595 HD13 ' O ' ' A' ' 92' ' ' PHE . 8.4 tp -76.43 121.16 22.66 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 119.19 -1.004 . . . . 1.08 108.45 162.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -127.64 126.6 67.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-N 115.007 -0.997 . . . . 1.08 111.949 -165.872 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.93 ' HH ' ' HD3' ' A' ' 118' ' ' LYS . 10.2 t80 -109.42 113.1 25.62 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.201 -0.909 . . . . 2.81 110.42 174.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.447 HG12 HG23 ' A' ' 127' ' ' ILE . 80.4 mt -96.72 113.76 31.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.719 -0.673 . . . . 1.53 109.734 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.93 ' HD3' ' HH ' ' A' ' 116' ' ' TYR . 37.8 ttpt -137.74 141.14 40.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.004 0.43 . . . . 1.81 110.398 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.546 ' O ' ' HD3' ' A' ' 119' ' ' ARG . 0.1 OUTLIER -113.57 113.7 25.45 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 121.956 0.884 . . . . 3.22 109.012 177.31 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.536 ' CE1' ' HE3' ' A' ' 118' ' ' LYS . 3.5 m-85 -69.02 110.56 4.52 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.046 -1.465 . . . . 1.28 107.046 168.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -35.85 94.53 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 O-C-N 124.769 1.293 . . . . 2.28 113.141 -175.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 59.79 50.69 64.94 Favored Glycine 0 CA--C 1.504 -0.647 0 CA-C-N 114.63 -1.168 . . . . 0.79 111.842 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.523 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 60.8 t30 -149.36 -53.12 0.16 Allowed 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.99 -0.605 . . . . 2.06 110.061 -176.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.492 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 1.8 mpp? -158.73 119.67 3.34 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.864 0.364 . . . . 1.73 111.701 -177.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -101.71 84.5 2.57 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.209 -1.034 . . . . 2.07 108.209 176.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.512 ' HA ' ' HA ' ' A' ' 154' ' ' VAL . 0.5 OUTLIER -101.61 140.59 19.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 112.903 0.705 . . . . 1.06 112.903 -170.426 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.647 ' O ' HG13 ' A' ' 127' ' ' ILE . 8.0 pt -108.96 112.16 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 108.675 -0.861 . . . . 1.26 108.675 163.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.569 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 4.3 m -80.1 155.56 27.45 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.972 -0.751 . . . . 1.53 108.972 175.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 80.8 p -149.82 131.63 15.08 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.61 0.719 . . . . 1.81 111.821 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.8 mtpp -132.63 122.77 25.2 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.628 -1.249 . . . . 2.75 107.628 175.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.631 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 17.7 t -70.8 104.88 3.02 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 106.81 -1.552 . . . . 1.94 106.81 175.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.0 m -102.9 152.59 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 C-N-CA 119.417 -0.913 . . . . 1.64 110.01 -174.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.634 ' HA ' ' CG ' ' A' ' 137' ' ' TYR . 8.4 p-10 -108.47 55.65 0.64 Allowed 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 123.204 1.478 . . . . 2.17 109.872 -168.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 136' ' ' GLU . 0.7 OUTLIER -91.57 178.33 1.81 Allowed Pre-proline 0 CA--C 1.553 1.086 0 CA-C-N 112.719 -2.037 . . . . 0.67 109.083 -175.322 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.522 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 9.0 Cg_exo -32.19 -56.28 0.29 Allowed 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 124.654 3.57 . . . . 1.66 117.366 -176.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 134' ' ' PHE . 10.2 tp10 -74.18 -29.66 61.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.479 0.581 . . . . 3.5 112.389 -174.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.634 ' CG ' ' HA ' ' A' ' 133' ' ' ASP . 13.0 t80 -46.18 -42.24 26.76 Favored Pre-proline 0 CA--C 1.552 1.037 0 N-CA-C 116.1 1.889 . . . . 6.41 116.1 -173.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.456 ' HD2' ' O ' ' A' ' 135' ' ' PRO . 73.4 Cg_exo -42.58 107.07 0.08 OUTLIER 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.251 1.967 . . . . 2.31 113.165 176.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -96.68 -159.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.544 2.83 . . . . 1.27 113.487 -174.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.7 m -143.94 -161.8 1.34 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.419 -0.956 . . . . 1.88 108.419 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.2 m -82.86 -47.23 12.08 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.118 -0.633 . . . . 2.43 110.904 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -65.38 -23.31 66.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.311 -0.404 . . . . 2.18 111.263 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.48 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 95.0 m-85 -132.16 108.12 9.07 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.361 -0.607 . . . . 1.33 109.361 177.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.59 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -104.07 116.69 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 109.019 -0.734 . . . . 1.4 109.019 178.192 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.519 ' HD2' HG12 ' A' ' 112' ' ' ILE . 0.8 OUTLIER -59.58 98.72 0.05 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.382 -0.826 . . . . 5.14 109.686 172.377 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -59.61 114.3 6.13 Favored Glycine 0 CA--C 1.504 -0.609 0 N-CA-C 111.107 -0.797 . . . . 1.05 111.107 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -84.89 88.48 7.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.875 0.845 . . . . 4.68 111.17 -169.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 66.7 t30 -84.31 123.97 30.74 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.645 -1.161 . . . . 2.29 110.801 178.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.429 ' O ' ' N ' ' A' ' 151' ' ' CYS . 46.0 m80 -74.68 161.63 77.02 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 119.022 -0.513 . . . . 2.95 109.882 176.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 149' ' ' HIS . 5.4 Cg_endo -48.06 76.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 124.514 3.476 . . . . 0.77 114.651 -178.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . 0.692 ' SG ' ' HA ' ' A' ' 171' ' ' VAL . 14.3 p -129.53 -174.09 3.2 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.251 -1.018 . . . . 1.97 108.251 171.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.743 ' N ' HG23 ' A' ' 14' ' ' VAL . . . -167.79 -147.33 5.27 Favored Glycine 0 N--CA 1.436 -1.319 0 C-N-CA 118.542 -1.789 . . . . 0.55 113.426 -173.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.544 ' CZ ' HD11 ' A' ' 167' ' ' LEU . 39.2 t80 -160.94 94.42 1.02 Allowed 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.76 -1.2 . . . . 0.8 107.76 -162.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.655 ' CG2' HG13 ' A' ' 168' ' ' VAL . 3.4 m -105.76 148.98 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 CA-C-O 121.969 0.89 . . . . 1.03 111.307 -173.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . 0.599 ' SG ' ' HB3' ' A' ' 58' ' ' PRO . 12.1 t -117.44 137.72 52.32 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.911 -1.04 . . . . 2.3 108.597 173.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.484 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 12.6 m -129.61 116.57 18.37 Favored Pre-proline 0 C--N 1.31 -1.122 0 C-N-CA 120.394 -0.522 . . . . 1.45 111.038 -177.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 55.8 Cg_exo -49.85 122.43 9.0 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.496 2.131 . . . . 0.72 111.378 173.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.664 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 0.7 OUTLIER -80.43 -167.13 1.23 Allowed 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.055 0.455 . . . . 1.72 112.079 -175.9 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -67.8 -26.53 66.13 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.565 -0.743 . . . . 2.63 109.366 176.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.463 ' HB3' ' HB2' ' A' ' 163' ' ' ALA . 34.4 mm-40 -97.62 13.76 29.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.246 -0.888 . . . . 2.05 109.86 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.449 ' CB ' ' CD ' ' A' ' 162' ' ' PRO . 13.9 m120 25.78 -89.13 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 125.708 1.603 . . . . 2.19 115.21 -177.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' A' ' 161' ' ' ASN . 84.1 Cg_endo -74.32 -10.49 22.41 Favored 'Trans proline' 0 C--N 1.366 1.448 0 CA-C-N 121.596 1.606 . . . . 0.86 113.473 -174.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 160' ' ' GLU . . . -96.12 -34.51 11.67 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.536 -0.302 . . . . 1.34 111.573 -177.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.664 ' O ' ' HB2' ' A' ' 158' ' ' MET . 81.9 m-85 -136.64 135.34 38.2 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.981 -0.377 . . . . 1.46 109.981 178.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 57.4 m -126.09 143.77 50.99 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.35 0.595 . . . . 2.05 111.618 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 156' ' ' SER . 1.9 tppp? -91.64 107.96 19.57 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.38 -0.827 . . . . 1.4 110.751 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.544 HD11 ' CZ ' ' A' ' 153' ' ' PHE . 0.5 OUTLIER -93.08 107.67 19.41 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.209 -0.905 . . . . 1.07 109.309 175.224 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.655 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -131.77 129.4 61.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.865 0.841 . . . . 1.11 111.753 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.557 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 11.3 ttt -140.91 151.34 44.17 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.009 -0.996 . . . . 1.79 108.98 -172.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.703 ' CE2' HG21 ' A' ' 14' ' ' VAL . 1.0 OUTLIER -144.83 152.39 40.22 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.88 -0.785 . . . . 4.22 108.88 171.199 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.692 ' HA ' ' SG ' ' A' ' 151' ' ' CYS . 12.6 p -138.12 127.7 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 O-C-N 123.907 0.755 . . . . 2.01 111.728 -172.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.511 ' HB2' ' CD1' ' A' ' 47' ' ' LEU . 24.2 tt0 -116.65 48.83 1.22 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.044 0.926 . . . . 2.66 108.518 174.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 1.7 t -74.65 152.67 39.17 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.029 -0.987 . . . . 2.2 111.024 -173.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.474 ' HG3' ' NE2' ' A' ' 44' ' ' HIS . 21.7 tt0 -95.71 -30.67 13.61 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.191 -0.913 . . . . 2.45 109.838 173.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 37.7 mtp 36.93 65.07 0.52 Allowed 'General case' 0 C--O 1.233 0.222 0 O-C-N 124.247 0.967 . . . . 4.15 112.616 -177.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.471 ' HB2' HD11 ' A' ' 144' ' ' ILE . 96.3 mtt180 -54.45 175.11 0.05 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.675 -0.693 . . . . 6.51 111.427 174.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 124.5 -152.13 17.39 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.765 -0.934 . . . . 2.26 110.765 -174.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -101.21 53.96 0.84 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.461 0.648 . . . . 6.69 110.229 178.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.448 HD11 ' N ' ' A' ' 179' ' ' LEU . 3.1 mp -113.08 148.82 34.45 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.591 0.71 . . . . 2.21 109.489 175.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.479 ' H ' ' CG1' ' A' ' 183' ' ' ILE . 15.0 m -113.99 167.39 9.6 Favored Pre-proline 0 C--N 1.302 -1.469 0 CA-C-N 114.662 -1.153 . . . . 2.31 107.891 178.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -48.34 -33.49 22.59 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 121.781 1.654 . . . . 1.86 111.842 177.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.437 ' O ' ' HG3' ' A' ' 186' ' ' LYS . 14.2 p -75.92 -13.49 60.26 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.542 -0.754 . . . . 2.45 112.572 -178.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.543 ' HA ' ' HE2' ' A' ' 186' ' ' LYS . 40.5 mm -92.11 -47.22 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-O 122.508 1.147 . . . . 1.69 109.301 -178.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.591 ' HA ' ' CG2' ' A' ' 187' ' ' THR . 1.5 mp -60.62 -35.57 64.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 112.678 -2.055 . . . . 1.77 111.14 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -70.14 -17.23 63.19 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.583 -0.735 . . . . 2.89 109.158 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.543 ' HE2' ' HA ' ' A' ' 183' ' ' ILE . 43.6 mtmt -92.11 -39.73 11.44 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.533 -0.758 . . . . 1.71 109.707 172.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.591 ' CG2' ' HA ' ' A' ' 184' ' ' ILE . 6.4 t -73.68 -36.63 65.33 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 119.645 -0.822 . . . . 1.3 112.538 -170.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' MET . . . . . 0.505 ' O ' HD13 ' A' ' 192' ' ' LEU . 37.6 mmm -70.32 -56.76 6.44 Favored Pre-proline 0 C--O 1.226 -0.176 0 C-N-CA 120.272 -0.571 . . . . 1.39 112.39 -175.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 188' ' ' MET . 18.9 Cg_endo -57.73 -18.76 35.17 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 122.232 1.955 . . . . 1.15 112.392 -176.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 33.9 t -86.24 -38.48 17.54 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.13 -0.693 . . . . 1.95 109.13 174.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -68.12 -42.71 79.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.324 -0.853 . . . . 1.92 111.638 -172.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.597 HD12 ' CG1' ' A' ' 35' ' ' VAL . 1.1 mt -62.02 -48.99 77.81 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.572 0.701 . . . . 1.68 110.959 -177.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.48 ' HB ' ' CD1' ' A' ' 33' ' ' ILE . 1.3 m -67.67 -32.65 57.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.057 -0.974 . . . . 1.32 109.672 -177.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 190' ' ' SER . 8.3 m-80 -76.68 -29.11 56.19 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.529 -1.214 . . . . 2.6 110.942 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.733 ' HA ' ' OD1' ' A' ' 198' ' ' ASN . 0.5 OUTLIER -66.38 -33.0 74.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.866 0.841 . . . . 2.73 109.475 171.071 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.672 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 22.6 mt -75.54 -27.86 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-N 115.707 -0.679 . . . . 1.11 110.799 173.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 53.1 mt -71.26 -42.42 68.81 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-N 116.651 -0.25 . . . . 1.57 111.365 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.733 ' OD1' ' HA ' ' A' ' 195' ' ' PHE . 1.4 p-10 -59.6 -23.75 63.23 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.155 -1.018 . . . . 2.18 108.952 171.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.696 ' HA ' ' CE2' ' A' ' 64' ' ' PHE . . . -81.32 -46.14 15.15 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 119.975 -0.69 . . . . 1.04 111.132 176.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.672 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 13.8 mmmm -55.22 -43.59 74.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 1.51 110.251 177.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -92.1 -33.82 14.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.738 -0.664 . . . . 1.94 112.013 -174.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -66.61 -29.1 74.21 Favored Glycine 0 N--CA 1.463 0.435 0 C-N-CA 120.784 -0.722 . . . . 0.47 111.377 176.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.572 ' CD1' HD21 ' A' ' 61' ' ' LEU . 3.2 tp -71.34 -28.67 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 109.44 -0.578 . . . . 1.16 109.44 176.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 79.1 mttt -79.07 -40.8 30.31 Favored 'General case' 0 C--O 1.209 -1.074 0 N-CA-C 107.861 -1.163 . . . . 3.8 107.861 174.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -55.95 -27.74 53.82 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.415 -0.811 . . . . 1.28 109.9 172.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.637 ' CE1' ' HA ' ' A' ' 64' ' ' PHE . 12.2 m-70 -103.15 7.25 38.74 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.383 0.883 . . . . 4.34 113.383 175.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 203' ' ' ILE . 0.2 OUTLIER -128.37 -53.68 1.27 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.284 0.564 . . . . 3.0 110.808 174.713 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.475 ' N ' ' O ' ' A' ' 204' ' ' LYS . 59.9 m -80.59 130.71 63.57 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 115.353 -0.839 . . . . 2.01 110.027 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -74.16 2.75 5.8 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 122.769 2.313 . . . . 2.59 113.464 -176.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.406 ' H ' HG22 ' A' ' 208' ' ' THR . 58.0 m -86.84 38.52 0.8 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.017 0.437 . . . . 2.55 111.388 -178.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.568 ' HA ' ' CB ' ' A' ' 214' ' ' PHE . 0.0 OUTLIER -111.73 7.7 20.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.335 -0.393 . . . . 6.11 110.29 175.783 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -60.04 -34.82 73.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.329 0.585 . . . . 7.55 109.973 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -128.21 24.98 4.95 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 115.36 -0.837 . . . . 3.73 111.607 176.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.568 ' CB ' ' HA ' ' A' ' 211' ' ' ARG . 86.1 t80 -86.88 96.49 10.24 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 120.895 -0.322 . . . . 6.11 110.626 -177.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 42.57 36.17 0.77 Allowed 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.352 1.032 . . . . 7.27 112.357 173.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . 0.427 ' HA ' ' O ' ' A' ' 73' ' ' THR . 8.5 t60 -83.45 23.82 0.89 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.911 0.386 . . . . 6.82 111.612 -169.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 50.12 48.58 21.85 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.768 -0.651 . . . . 5.77 111.59 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.9 p -79.3 -14.71 58.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.073 -0.512 . . . . 6.85 111.087 -178.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 10.5 t60 73.24 -54.84 0.69 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.48 0.712 . . . . 9.48 111.611 175.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 21.8 t . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.334 -0.841 . . . . 8.48 109.734 179.867 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 tpt . . . . . 0 N--CA 1.48 1.064 0 N-CA-C 110.64 -0.133 . . . . 4.31 110.64 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.595 ' O ' HD11 ' A' ' 6' ' ' ILE . 15.3 t70 174.46 -69.8 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.758 0.789 . . . . 2.25 108.96 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.609 ' HA ' ' CD1' ' A' ' 6' ' ' ILE . 95.5 m-85 -71.82 -25.47 62.0 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.015 -0.993 . . . . 0.45 108.402 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.571 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 11.6 tptm -67.05 -9.44 39.21 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 114.716 -1.129 . . . . 2.06 109.669 175.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 2' ' ' ASP . . . -90.86 -49.98 6.14 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 115.823 -0.626 . . . . 1.2 109.658 175.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.609 ' CD1' ' HA ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -83.19 -34.54 11.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.453 0.644 . . . . 1.76 110.984 -170.834 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.555 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -79.13 -39.48 33.48 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.136 -0.938 . . . . 1.11 111.269 -176.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.571 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 5.6 mt-30 -67.6 -24.75 65.52 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.147 -1.388 . . . . 2.14 110.192 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.57 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 55.7 mt-30 -83.85 -50.56 7.97 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.099 -0.955 . . . . 3.04 108.827 170.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.553 ' HB ' ' HA ' ' A' ' 7' ' ' ALA . 0.8 OUTLIER -46.01 -44.92 15.54 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.029 0.932 . . . . 1.1 112.656 175.276 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.457 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -50.87 -55.99 14.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.063 0.459 . . . . 1.04 111.748 175.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -76.18 -5.99 49.3 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.088 -0.506 . . . . 2.31 111.586 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 39.3 mm-40 -81.13 -52.39 7.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.26 0.552 . . . . 2.54 109.553 172.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.857 HG23 ' CE2' ' A' ' 170' ' ' PHE . 6.4 p -68.37 -38.72 79.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.366 -0.834 . . . . 1.21 110.631 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.97 -22.36 65.92 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.178 -0.919 . . . . 1.26 108.805 173.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.541 ' HA2' ' NE ' ' A' ' 19' ' ' ARG . . . -64.05 -22.69 67.1 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 114.033 -1.44 . . . . 0.57 110.18 176.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.435 ' HA ' ' HB3' ' A' ' 20' ' ' ASP . 5.9 m-85 -90.34 -16.79 28.51 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.41 -0.589 . . . . 3.59 109.41 177.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.483 ' HB2' ' NH2' ' A' ' 49' ' ' ARG . 2.4 t-20 -76.51 -14.37 60.03 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.488 0.661 . . . . 2.1 109.937 176.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.541 ' NE ' ' HA2' ' A' ' 16' ' ' GLY . 10.9 ptt180 -113.49 8.95 17.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.467 -0.788 . . . . 3.26 109.668 174.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.435 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 25.5 t70 -112.83 92.82 4.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.198 -0.91 . . . . 2.16 109.502 175.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.466 HG22 ' CH2' ' A' ' 24' ' ' TRP . 24.0 p -131.36 88.82 2.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.236 0.541 . . . . 2.24 111.539 -176.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -177.45 -50.42 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.569 -0.741 . . . . 2.46 111.18 -178.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.87 -9.7 79.72 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 121.235 -0.507 . . . . 1.45 112.99 -174.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.514 ' CB ' ' HG2' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -76.93 -160.88 0.17 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.177 0.513 . . . . 2.24 111.426 177.209 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -171.7 114.62 0.36 Allowed 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 109.028 -0.731 . . . . 3.43 109.028 -175.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.558 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 1.7 m -64.82 128.02 26.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.963 0.887 . . . . 2.21 111.987 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.9 m -118.79 -24.32 3.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 113.845 -1.525 . . . . 1.83 110.46 -178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.458 ' HD2' ' HA ' ' A' ' 28' ' ' LYS . 15.5 tptp -145.96 129.55 17.0 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.037 -0.665 . . . . 2.87 111.518 -174.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.482 HG22 ' HA ' ' A' ' 34' ' ' THR . 24.1 p -146.06 152.78 39.88 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.21 -0.45 . . . . 1.92 110.527 178.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.2 t -106.6 -102.45 0.34 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.097 -0.705 . . . . 2.37 109.097 171.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -142.25 18.02 2.07 Favored 'General case' 0 N--CA 1.463 0.208 0 O-C-N 122.064 -0.398 . . . . 4.84 111.377 175.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -169.4 8.27 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.271 0.558 . . . . 2.05 110.07 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.488 HG22 ' HA3' ' A' ' 52' ' ' GLY . 12.7 pt -142.92 160.88 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 115.382 -0.827 . . . . 1.42 109.891 -176.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.482 ' HA ' HG22 ' A' ' 29' ' ' THR . 93.1 m -158.18 111.25 2.4 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 111.793 0.294 . . . . 1.22 111.793 -164.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.581 ' CG2' HG12 ' A' ' 193' ' ' VAL . 5.0 t -98.56 117.71 43.97 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 N-CA-C 109.379 -0.601 . . . . 1.52 109.379 177.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.558 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -118.81 125.25 49.14 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 116.11 -0.495 . . . . 1.74 110.218 -176.637 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 73.4 p -101.17 143.26 31.48 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.398 0.618 . . . . 1.72 112.169 -172.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.514 ' HG2' ' CB ' ' A' ' 24' ' ' TRP . 15.5 mtmt -124.95 131.35 53.44 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.996 -1.002 . . . . 2.45 108.413 172.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.86 114.3 2.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.468 0.175 . . . . 2.17 110.93 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.4 m -61.61 139.48 58.27 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.356 0.598 . . . . 2.51 110.598 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -97.43 -12.07 23.14 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.634 -0.712 . . . . 7.41 109.97 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -87.82 -8.6 55.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.709 -0.678 . . . . 6.84 109.973 -175.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -173.76 162.01 3.96 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.356 -0.979 . . . . 6.42 108.356 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -80.18 62.63 4.4 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.999 0.428 . . . . 6.31 111.365 -174.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -137.5 -166.11 10.63 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.416 -1.074 . . . . 1.74 110.416 175.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -131.22 134.95 46.95 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.564 0.697 . . . . 2.45 110.896 177.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' A' ' 37' ' ' SER . 10.0 tt -86.52 147.72 25.84 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.821 -1.082 . . . . 1.49 109.254 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.45 ' N ' HD21 ' A' ' 47' ' ' LEU . 92.9 m-85 -123.21 119.59 30.67 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.839 -0.344 . . . . 1.52 111.109 -175.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.764 ' CD ' ' HB3' ' A' ' 170' ' ' PHE . 21.8 tpt180 -110.73 117.65 34.04 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.309 -0.626 . . . . 3.34 109.309 173.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 34' ' ' THR . 12.5 p -103.94 150.61 7.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.75 0.31 . . . . 1.98 110.259 -179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.531 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 35.2 tt0 -153.41 122.06 6.35 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.785 -0.643 . . . . 1.07 110.764 -172.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.488 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -156.13 161.7 30.93 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.198 -0.761 . . . . 0.35 111.198 175.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 70.3 mt -98.11 130.39 46.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 117.345 0.572 . . . . 1.3 111.229 -178.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 61.9 mt -107.8 116.9 56.61 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.355 -0.839 . . . . 1.07 109.789 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -63.56 61.51 0.2 Allowed 'Trans proline' 0 N--CA 1.476 0.457 0 C-N-CA 124.172 3.248 . . . . 0.74 113.787 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.553 ' HG3' ' H ' ' A' ' 57' ' ' SER . 6.5 tp10 -152.29 -171.33 3.9 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.796 -0.816 . . . . 1.68 108.796 174.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.553 ' H ' ' HG3' ' A' ' 56' ' ' GLU . 73.9 p -89.76 146.42 35.41 Favored Pre-proline 0 N--CA 1.427 -1.62 0 CA-C-O 121.546 0.689 . . . . 1.58 110.517 176.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.578 ' HB3' ' SG ' ' A' ' 155' ' ' CYS . 37.2 Cg_exo -60.71 -11.19 16.45 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 124.102 3.201 . . . . 0.74 111.098 176.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.75 -51.52 10.4 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 114.752 -1.113 . . . . 1.31 110.919 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.454 ' CG ' HD12 ' A' ' 203' ' ' ILE . 3.6 tppt? -66.15 -30.3 70.75 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.283 -1.006 . . . . 3.78 108.283 -178.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.541 HD22 ' CD1' ' A' ' 203' ' ' ILE . 48.6 mt -60.67 -58.62 7.68 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.468 -1.242 . . . . 1.09 110.428 174.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.435 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 7.7 p -66.57 -6.55 15.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.866 0.365 . . . . 1.94 111.104 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -86.88 -41.38 14.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.402 -0.363 . . . . 1.32 111.896 176.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.557 ' O ' ' HB3' ' A' ' 71' ' ' ARG . 6.1 p90 -77.4 -41.28 40.59 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.47 -0.492 . . . . 0.79 110.844 -172.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.58 HD13 ' CD1' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -84.74 7.77 19.43 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 110.342 -0.244 . . . . 2.15 110.342 -171.546 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.472 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 41.1 t80 -55.99 0.6 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.878 0 O-C-N 124.216 0.948 . . . . 2.06 112.936 -173.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 15.8 mm100 82.13 -28.13 0.12 Allowed 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 124.315 1.046 . . . . 4.31 110.822 171.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.409 ' H ' ' C ' ' A' ' 66' ' ' TYR . 8.8 t -125.34 22.07 7.83 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.457 -1.312 . . . . 1.89 107.457 171.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.1 3.96 84.5 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 113.864 -1.516 . . . . 1.71 111.805 -176.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.702 ' O ' HG21 ' A' ' 73' ' ' THR . 12.0 t70 92.6 2.8 0.08 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 122.582 1.182 . . . . 2.19 108.333 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.811 ' HA ' ' CE2' ' A' ' 74' ' ' TRP . 5.6 ptm180 -54.34 -40.27 67.87 Favored 'General case' 0 C--O 1.209 -1.057 0 CA-C-N 113.535 -1.666 . . . . 3.95 110.088 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.721 ' N ' ' HG3' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -65.61 -26.02 38.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.646 -1.161 . . . . 1.42 110.792 -175.3 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.702 HG21 ' O ' ' A' ' 70' ' ' ASP . 0.9 OUTLIER -81.66 -31.25 32.39 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.491 -0.777 . . . . 1.45 109.986 -174.386 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.811 ' CE2' ' HA ' ' A' ' 71' ' ' ARG . 27.6 p-90 -111.57 0.82 16.55 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.283 -0.567 . . . . 0.78 111.396 -177.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.688 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 5.3 t70 -68.25 175.62 3.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.512 0.673 . . . . 2.19 111.723 -175.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.485 ' HG2' ' ND2' ' A' ' 198' ' ' ASN . 28.9 mmmt -95.96 -40.65 9.17 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.563 -0.744 . . . . 3.68 109.832 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.8 t -119.72 16.14 12.73 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.439 -0.8 . . . . 2.08 111.356 -171.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 56.1 mt -110.91 -179.32 3.71 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.537 -0.465 . . . . 1.16 111.924 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.569 ' HG2' ' HG2' ' A' ' 99' ' ' GLN . 12.0 mm-40 -154.94 -61.59 0.12 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.519 -0.764 . . . . 2.23 111.219 -175.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.672 ' O ' ' HA ' ' A' ' 96' ' ' THR . 30.6 t -142.46 127.74 16.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.377 -0.374 . . . . 1.44 110.648 -166.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.459 ' HB3' ' CD1' ' A' ' 72' ' ' ILE . 42.8 p90 -95.41 146.62 24.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.611 0.243 . . . . 5.73 110.639 176.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 58.4 m-80 -153.45 107.18 3.02 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.548 -0.538 . . . . 1.86 109.548 176.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.03 96.61 3.84 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.259 -0.645 . . . . 2.52 109.259 177.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -73.12 -62.78 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.352 0.596 . . . . 1.19 110.805 -169.358 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -133.97 113.96 12.73 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.275 -0.875 . . . . 2.59 108.824 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.2 mtt180 -98.28 103.74 15.71 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.971 -0.751 . . . . 2.83 108.971 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -72.23 -46.2 58.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.456 -0.793 . . . . 1.17 110.989 -171.551 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -141.92 -163.75 1.65 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.87 -0.789 . . . . 1.86 108.87 -173.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.4 m -81.18 -14.8 57.21 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.844 0.354 . . . . 1.94 110.3 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -131.82 14.81 4.83 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 110.078 -0.342 . . . . 1.87 110.078 -175.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.578 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.4 OUTLIER -134.11 110.95 9.95 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 108.682 -0.858 . . . . 1.12 108.682 -175.097 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.526 ' O ' HD13 ' A' ' 114' ' ' LEU . 21.7 m-85 -130.24 169.34 15.52 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.953 -0.567 . . . . 0.52 110.391 -173.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.593 ' O ' HG23 ' A' ' 84' ' ' VAL . 28.4 mt -135.06 123.89 41.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 107.43 -1.322 . . . . 1.1 107.43 169.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 65.2 m -110.27 125.44 53.12 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.636 -0.425 . . . . 2.61 111.315 -175.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 22.2 t60 -90.91 87.65 6.72 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 122.134 0.969 . . . . 2.17 108.702 168.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.672 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 89.6 m -102.56 130.77 49.51 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.275 -1.329 . . . . 1.19 109.926 -177.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.402 ' O ' ' HB2' ' A' ' 79' ' ' GLN . 47.1 mm -80.99 128.82 38.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 C-N-CA 119.671 -0.811 . . . . 1.63 108.891 172.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.575 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 1.5 m -102.28 143.95 31.41 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.969 -0.559 . . . . 1.72 110.255 -176.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.569 ' HG2' ' HG2' ' A' ' 79' ' ' GLN . 5.5 mm-40 -85.98 179.16 7.05 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.948 -0.569 . . . . 2.29 110.804 178.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.427 ' HB3' ' O ' ' A' ' 106' ' ' ILE . 8.3 m -107.69 75.52 1.01 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.586 -0.733 . . . . 4.07 110.823 -176.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.419 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 79.6 t80 -86.77 98.28 11.08 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.606 -0.438 . . . . 6.11 111.197 -177.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' A' ' 101' ' ' PHE . . . 165.92 59.2 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 O-C-N 124.728 1.268 . . . . 1.98 109.489 171.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 86.1 t 71.75 -40.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-N 115.591 -0.732 . . . . 3.6 111.856 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 139.09 18.71 0.5 Allowed Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.898 -0.667 . . . . 2.2 112.668 177.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 39.1 m -87.44 10.73 16.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.059 0.456 . . . . 2.08 111.127 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.427 ' O ' ' HB3' ' A' ' 100' ' ' SER . 60.4 mt -129.85 139.68 50.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.916 -0.584 . . . . 1.53 109.523 -177.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 48.4 m -84.91 152.9 59.95 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 110.083 -0.34 . . . . 1.71 110.083 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.94 130.98 36.78 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.768 2.312 . . . . 1.31 111.048 177.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.641 ' HG2' ' O ' ' A' ' 144' ' ' ILE . 12.2 ttp180 -109.73 154.92 22.23 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.285 -0.566 . . . . 4.06 111.046 -167.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.427 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 5.1 t0 -95.33 140.82 29.67 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.658 -0.867 . . . . 1.37 108.658 174.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.655 ' CE1' ' HB2' ' A' ' 113' ' ' ASP . 13.4 t80 -123.76 108.74 12.85 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.664 -0.865 . . . . 3.01 108.664 -179.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.624 HG21 ' CE1' ' A' ' 134' ' ' PHE . 12.6 mm -124.1 74.78 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 107.933 -1.136 . . . . 1.2 107.933 173.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.655 ' HB2' ' CE1' ' A' ' 111' ' ' PHE . 1.0 OUTLIER -102.48 124.18 47.58 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.587 -0.733 . . . . 1.86 110.094 -176.39 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.526 HD13 ' O ' ' A' ' 92' ' ' PHE . 10.6 tp -76.98 121.97 24.23 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 115.265 -0.88 . . . . 1.08 109.364 174.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -122.82 123.95 69.36 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 CA-C-N 114.157 -1.383 . . . . 1.08 111.503 -166.561 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.555 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 53.8 t80 -117.22 125.4 51.09 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.647 -0.706 . . . . 2.81 110.571 175.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 126' ' ' ILE . 91.8 mt -96.96 99.24 8.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.484 -0.78 . . . . 1.53 110.54 -177.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -101.86 135.1 44.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.11 -0.95 . . . . 1.81 108.867 178.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.519 ' O ' ' HD3' ' A' ' 119' ' ' ARG . 0.1 OUTLIER -124.19 110.6 14.87 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 121.903 0.859 . . . . 3.22 108.907 176.368 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.564 ' CB ' ' HB3' ' A' ' 123' ' ' ASN . 59.3 m-85 -77.88 116.83 18.68 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.064 -1.088 . . . . 1.28 108.064 171.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.427 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 1.6 mp0 -28.7 93.72 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 O-C-N 125.086 1.491 . . . . 2.28 113.321 178.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 56.29 36.86 70.69 Favored Glycine 0 CA--C 1.507 -0.451 0 CA-C-N 115.117 -0.947 . . . . 0.79 112.312 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.564 ' HB3' ' CB ' ' A' ' 120' ' ' TYR . 59.2 t30 -128.83 -53.4 1.23 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.971 -0.614 . . . . 2.06 109.694 -176.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.554 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 0.4 OUTLIER -157.14 125.36 5.57 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.112 -0.495 . . . . 1.73 110.986 -179.069 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -107.75 82.59 1.67 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.248 -1.019 . . . . 2.07 108.248 175.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.492 ' CG1' HG12 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -100.93 139.37 22.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.892 -0.595 . . . . 1.06 112.421 -171.74 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.401 ' HB ' HG12 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -107.4 119.45 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 107.358 -1.349 . . . . 1.26 107.358 159.428 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.545 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 30.3 p -82.88 167.3 18.18 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.037 -0.727 . . . . 1.53 109.037 174.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.404 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 67.7 p -158.48 120.01 3.49 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.9 0.381 . . . . 1.81 110.231 -178.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.48 ' NZ ' HD21 ' A' ' 114' ' ' LEU . 3.1 ttpm? -131.95 115.01 15.32 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 108.128 -1.064 . . . . 2.75 108.128 -176.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 96.9 p -61.78 100.14 0.14 Allowed 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 107.698 -1.223 . . . . 1.94 107.698 -177.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.44 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -107.77 138.23 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.115 0 CA-C-N 115.163 -0.926 . . . . 1.64 108.847 -165.351 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -99.76 64.32 1.26 Allowed 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 122.432 1.11 . . . . 2.17 108.64 -168.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.797 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -90.74 162.02 34.52 Favored Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 113.387 -1.733 . . . . 0.67 110.64 -171.596 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -77.86 -12.91 16.21 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 123.072 2.514 . . . . 1.66 114.762 -173.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.797 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 5.7 tp10 -72.7 -17.78 61.6 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 109.48 -0.563 . . . . 3.5 109.48 -171.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -163.13 112.01 1.03 Allowed Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 113.351 0.871 . . . . 6.41 113.351 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -83.96 126.0 3.77 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 123.077 2.518 . . . . 2.31 110.035 163.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.445 ' HG3' ' HB2' ' A' ' 145' ' ' ARG . 11.2 Cg_endo -52.54 -92.47 0.0 OUTLIER 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 123.447 2.765 . . . . 1.27 114.956 -168.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.1 t -172.53 171.52 4.57 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.621 -0.511 . . . . 1.88 109.621 -174.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.8 p -90.22 -15.41 31.46 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.228 -0.656 . . . . 2.43 109.228 171.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -98.56 -50.44 4.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.582 -0.736 . . . . 2.18 110.133 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.427 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 40.2 m-85 -83.44 130.4 35.03 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 115.847 -0.615 . . . . 1.33 109.455 176.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.641 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -100.9 113.53 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 N-CA-C 107.991 -1.114 . . . . 1.4 107.991 -179.407 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.445 ' HB2' ' HG3' ' A' ' 139' ' ' PRO . 6.4 tmm_? -57.41 97.38 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.674 -1.232 . . . . 5.14 107.674 170.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.486 ' HA3' ' NH1' ' A' ' 109' ' ' ARG . . . -66.07 129.0 31.85 Favored Glycine 0 CA--C 1.49 -1.477 0 N-CA-C 110.63 -0.988 . . . . 1.05 110.63 -176.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -82.74 107.05 15.08 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.515 1.15 . . . . 4.68 110.733 -175.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -110.36 110.97 21.96 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.05 -1.886 . . . . 2.29 108.396 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.508 ' O ' ' N ' ' A' ' 151' ' ' CYS . 29.6 m-70 -57.63 163.29 3.91 Favored Pre-proline 0 C--O 1.217 -0.628 0 CA-C-O 118.174 -0.917 . . . . 2.95 109.012 175.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.509 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 1.2 Cg_endo -44.12 77.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 123.841 3.027 . . . . 0.77 113.719 178.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . 0.565 ' HB3' ' O ' ' A' ' 170' ' ' PHE . 45.4 m -108.96 -171.81 1.92 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.999 -1.0 . . . . 1.97 109.325 177.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.618 ' O ' ' HG3' ' A' ' 169' ' ' MET . . . 174.45 -153.29 16.04 Favored Glycine 0 N--CA 1.435 -1.421 0 C-N-CA 119.028 -1.558 . . . . 0.55 112.644 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.58 ' CD1' HD13 ' A' ' 65' ' ' LEU . 3.6 t80 -156.47 97.96 1.79 Allowed 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.517 -1.29 . . . . 0.8 107.517 -163.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.616 ' CG2' HG11 ' A' ' 168' ' ' VAL . 2.6 m -105.56 146.25 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 C-N-CA 119.705 -0.798 . . . . 1.03 110.856 -174.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . 0.578 ' SG ' ' HB3' ' A' ' 58' ' ' PRO . 18.5 t -118.57 138.19 52.72 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.042 -0.981 . . . . 2.3 108.439 173.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.507 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 12.4 m -123.24 111.22 30.41 Favored Pre-proline 0 C--N 1.307 -1.263 0 C-N-CA 120.697 -0.401 . . . . 1.45 110.878 -177.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.444 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 71.4 Cg_exo -50.22 117.74 3.4 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.43 2.087 . . . . 0.72 111.045 170.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.425 ' HB3' ' H ' ' A' ' 159' ' ' GLU . 88.6 mmm -79.13 -162.72 0.42 Allowed 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.066 0.46 . . . . 1.72 111.462 -175.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.425 ' H ' ' HB3' ' A' ' 158' ' ' MET . 19.7 mm-40 -75.38 -35.97 60.99 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.615 -0.883 . . . . 2.63 108.615 172.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.405 ' C ' ' HD2' ' A' ' 162' ' ' PRO . 16.5 mt-10 -96.92 29.18 3.16 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.161 -1.381 . . . . 2.05 108.636 174.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.52 ' ND2' ' HD3' ' A' ' 162' ' ' PRO . 5.2 p-10 -34.18 -47.28 0.77 Allowed Pre-proline 0 N--CA 1.471 0.611 0 N-CA-C 116.398 1.999 . . . . 2.19 116.398 -168.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.52 ' HD3' ' ND2' ' A' ' 161' ' ' ASN . 71.3 Cg_endo -73.94 -17.85 22.09 Favored 'Trans proline' 0 C--N 1.351 0.703 0 CA-C-N 121.755 1.662 . . . . 0.86 113.047 -176.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -109.16 -25.89 10.4 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.191 -0.459 . . . . 1.34 110.832 -178.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -138.3 124.7 20.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.825 -0.625 . . . . 1.46 109.467 176.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 3.7 p -125.62 142.25 51.61 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.155 0.502 . . . . 2.05 111.154 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.531 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.9 tppp? -88.27 119.6 28.83 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.629 0.728 . . . . 1.4 111.482 -175.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.559 HD11 ' CZ ' ' A' ' 153' ' ' PHE . 0.3 OUTLIER -101.96 117.17 34.27 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.244 -0.889 . . . . 1.07 110.099 176.64 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.616 HG11 ' CG2' ' A' ' 154' ' ' VAL . 0.1 OUTLIER -140.84 126.41 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-O 121.558 0.694 . . . . 1.11 112.413 177.699 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.618 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 12.1 ttt -145.44 145.72 31.23 Favored 'General case' 0 C--O 1.22 -0.485 0 C-N-CA 123.091 0.556 . . . . 1.79 110.919 -170.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.857 ' CE2' HG23 ' A' ' 14' ' ' VAL . 12.1 p90 -136.95 162.73 32.47 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.375 0.607 . . . . 4.22 112.223 171.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.524 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 1.4 m -136.54 143.53 35.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 113.592 -1.64 . . . . 2.01 110.481 173.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.479 ' HB3' ' HB2' ' A' ' 149' ' ' HIS . 7.7 tt0 -120.29 54.95 1.02 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.889 -1.522 . . . . 2.66 106.889 172.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.1 m -64.02 144.5 57.04 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 113.791 -1.55 . . . . 2.2 110.708 -173.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.478 ' HG3' ' H ' ' A' ' 176' ' ' ARG . 10.3 pt-20 -81.89 -3.27 53.77 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.714 -0.394 . . . . 2.45 110.531 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.502 ' C ' ' HG3' ' A' ' 176' ' ' ARG . 61.1 mtt 80.87 9.77 1.05 Allowed 'General case' 0 N--CA 1.468 0.467 0 O-C-N 123.947 0.779 . . . . 4.15 109.402 176.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.502 ' HG3' ' C ' ' A' ' 175' ' ' MET . 3.3 mtt85 63.62 -87.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.358 -1.292 . . . . 6.51 111.156 177.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -97.92 2.14 59.88 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 111.408 -0.677 . . . . 2.26 111.408 177.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 4.0 tmtp? 67.88 96.85 0.06 Allowed 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.44 0.696 . . . . 6.69 110.249 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.498 HD23 ' NH1' ' A' ' 176' ' ' ARG . 0.6 OUTLIER -82.06 -150.98 0.09 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.773 -0.648 . . . . 2.21 109.438 -178.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.508 ' O ' HD12 ' A' ' 184' ' ' ILE . 43.5 m -111.24 152.19 43.65 Favored Pre-proline 0 C--N 1.318 -0.795 0 N-CA-C 108.591 -0.892 . . . . 2.31 108.591 174.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -42.82 -46.47 8.5 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.052 2.502 . . . . 1.86 113.523 -177.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.553 ' O ' ' HE2' ' A' ' 186' ' ' LYS . 22.9 t -66.51 -15.95 63.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.778 0.323 . . . . 2.45 111.594 -177.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.485 ' HA ' ' HE2' ' A' ' 186' ' ' LYS . 15.9 mm -91.27 -37.53 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-O 122.498 1.142 . . . . 1.69 108.793 -178.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.628 ' HA ' ' CG2' ' A' ' 187' ' ' THR . 1.1 mp -73.61 -33.05 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 113.103 -1.862 . . . . 1.77 111.168 -175.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 189' ' ' PRO . 10.4 pt-20 -65.57 -21.73 66.62 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.83 -0.804 . . . . 2.89 108.83 173.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.565 ' O ' ' HB2' ' A' ' 190' ' ' SER . 49.2 mtmt -92.36 -24.71 18.82 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.648 -0.705 . . . . 1.71 110.026 176.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.628 ' CG2' ' HA ' ' A' ' 184' ' ' ILE . 4.5 t -91.18 -47.98 7.2 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 119.499 -0.88 . . . . 1.3 112.772 -178.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' MET . . . . . 0.561 ' O ' ' HG ' ' A' ' 192' ' ' LEU . 0.0 OUTLIER -80.48 -71.04 0.15 Allowed Pre-proline 0 N--CA 1.471 0.593 0 CA-C-N 119.403 1.002 . . . . 1.39 112.447 -175.651 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.413 ' HG2' ' O ' ' A' ' 185' ' ' GLU . 44.7 Cg_endo -68.25 -22.93 39.53 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.307 1.338 . . . . 1.15 112.022 -171.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.565 ' HB2' ' O ' ' A' ' 186' ' ' LYS . 66.9 m -83.83 -23.99 31.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.733 -0.667 . . . . 1.95 110.707 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 187' ' ' THR . 55.0 t30 -89.85 -25.4 21.05 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.439 -0.505 . . . . 1.92 110.834 178.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 188' ' ' MET . 15.5 mt -68.84 -47.69 65.39 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.777 0.322 . . . . 1.68 111.029 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.581 HG12 ' CG2' ' A' ' 35' ' ' VAL . 3.8 m -67.89 -23.19 28.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 120.353 -0.539 . . . . 1.32 110.165 175.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -76.45 -31.06 57.6 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.831 -0.622 . . . . 2.6 110.835 176.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -67.14 -31.36 71.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.077 0.465 . . . . 2.73 109.78 171.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.551 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 63.2 mt -77.66 -30.07 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 116.121 -0.49 . . . . 1.11 110.62 174.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 57.1 mt -71.69 -38.76 70.56 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-O 121.468 0.651 . . . . 1.57 109.434 173.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.495 ' ND2' ' HA ' ' A' ' 75' ' ' ASP . 2.6 m120 -54.5 -35.26 62.94 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.393 -1.276 . . . . 2.18 109.112 167.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.659 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -75.59 -43.74 46.65 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 120.483 -0.487 . . . . 1.04 110.413 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.616 ' O ' ' HG3' ' A' ' 204' ' ' LYS . 32.0 mmtp -56.11 -44.21 78.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.135 0.493 . . . . 1.51 110.613 174.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -85.41 -41.14 15.69 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.585 -0.734 . . . . 1.94 111.419 -174.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . 0.496 ' HA3' ' CH2' ' A' ' 74' ' ' TRP . . . -68.26 -27.99 73.5 Favored Glycine 0 CA--C 1.507 -0.458 0 N-CA-C 111.502 -0.639 . . . . 0.47 111.502 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.659 ' HB ' ' O ' ' A' ' 199' ' ' ALA . 2.8 tp -71.7 -31.41 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 109.327 -0.62 . . . . 1.16 109.327 176.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.616 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 57.5 mttp -84.63 -25.07 28.8 Favored 'General case' 0 C--O 1.208 -1.093 0 N-CA-C 108.528 -0.916 . . . . 3.8 108.528 176.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.54 ' HA ' ' OG ' ' A' ' 210' ' ' SER . . . -68.23 -25.35 65.16 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.675 -0.693 . . . . 1.28 109.701 170.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 48.0 m80 -97.97 -8.91 27.06 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.578 -0.737 . . . . 4.34 112.746 174.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.466 ' HD2' ' OE1' ' A' ' 56' ' ' GLU . 26.6 ttt180 -112.92 -60.02 1.94 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.617 0.722 . . . . 3.0 110.55 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' A' ' 204' ' ' LYS . 30.6 m -71.0 142.49 87.77 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 114.771 -1.104 . . . . 2.01 109.57 176.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -70.82 49.81 0.99 Allowed 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.175 1.916 . . . . 2.59 112.352 175.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.54 ' OG ' ' HA ' ' A' ' 205' ' ' ALA . 22.7 p -80.69 -37.69 30.29 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.89 0.376 . . . . 2.55 110.206 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 211' ' ' ARG . 31.0 mtp-105 -79.69 4.42 16.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.158 0.504 . . . . 6.11 110.673 177.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -69.94 -40.54 75.42 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.952 -1.129 . . . . 7.55 107.952 165.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -87.09 -43.93 5.81 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 114.895 -1.048 . . . . 3.73 111.147 173.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -83.89 96.8 8.92 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.249 0.547 . . . . 6.11 110.089 176.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -99.36 75.9 2.01 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.039 -0.528 . . . . 7.27 110.707 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 78.1 t60 57.4 84.08 0.1 Allowed 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.441 -0.8 . . . . 6.82 109.772 -177.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -49.65 112.21 0.62 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.044 -0.98 . . . . 5.77 112.079 -174.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 16.5 m -109.75 5.02 22.39 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.698 -0.683 . . . . 6.85 109.681 176.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 61.1 m80 71.26 173.24 0.31 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.088 -0.96 . . . . 9.48 111.187 178.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 18.4 p . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.307 -0.854 . . . . 8.48 110.587 -179.483 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 120.821 0.343 . . . . 4.31 110.281 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.736 ' O ' HD11 ' A' ' 6' ' ' ILE . 15.5 m-20 -81.47 -37.34 28.12 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 108.392 -0.966 . . . . 2.25 108.392 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.797 ' HA ' HD13 ' A' ' 6' ' ' ILE . 82.7 m-85 -63.6 -35.63 81.14 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 114.676 -1.147 . . . . 0.45 109.168 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.739 ' O ' ' HB3' ' A' ' 8' ' ' GLN . 23.2 tptm -60.81 -47.97 83.92 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 115.302 -0.863 . . . . 2.06 109.074 178.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.17 -46.31 62.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.924 -0.58 . . . . 1.2 112.125 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.797 HD13 ' HA ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -80.63 -36.5 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 CA-C-O 121.674 0.75 . . . . 1.76 109.562 -172.148 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.633 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . . . -76.86 -43.24 36.92 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.239 -1.346 . . . . 1.11 111.472 -175.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.739 ' HB3' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -60.96 -33.53 73.34 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.202 -1.363 . . . . 2.14 109.086 -178.406 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.528 ' HG2' ' HG3' ' A' ' 8' ' ' GLN . 25.6 mm-40 -92.47 -32.85 14.74 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.86 -1.064 . . . . 3.04 110.674 -178.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.706 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.4 OUTLIER -75.75 -26.56 57.53 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.786 -0.365 . . . . 1.1 110.753 178.028 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -49.34 -44.39 44.54 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 120.208 -0.597 . . . . 1.04 111.811 170.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.66 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 4.0 pt20 -83.73 -1.5 54.27 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 122.075 -0.391 . . . . 2.31 110.986 176.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 29.4 mm-40 -88.45 -44.9 10.38 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.803 -0.443 . . . . 2.54 109.803 174.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.689 ' HA ' ' HE2' ' A' ' 170' ' ' PHE . 3.9 p -66.51 -39.96 85.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 122.116 0.96 . . . . 1.21 108.912 170.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.66 ' HB3' ' HA ' ' A' ' 12' ' ' GLN . 0.9 OUTLIER -66.9 -21.98 65.98 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 114.749 -1.114 . . . . 1.26 108.084 172.552 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.689 ' HA2' ' NE ' ' A' ' 19' ' ' ARG . . . -62.47 -24.44 65.86 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 113.909 -1.496 . . . . 0.57 110.268 176.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.447 ' HD1' ' O ' ' A' ' 13' ' ' GLU . 19.6 m-85 -92.55 -8.55 44.07 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.246 -0.477 . . . . 3.59 109.946 178.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.605 HD22 ' HE3' ' A' ' 124' ' ' MET . 0.3 OUTLIER -89.47 -10.97 44.36 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 119.295 -0.962 . . . . 2.1 108.608 176.999 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.689 ' NE ' ' HA2' ' A' ' 16' ' ' GLY . 19.5 ptt85 -122.64 3.25 9.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.618 -1.173 . . . . 3.26 110.561 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.636 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 23.0 t70 -90.28 112.8 24.47 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 116.223 -0.444 . . . . 2.16 110.821 -175.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.8 p -129.96 93.81 3.58 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.691 0.758 . . . . 2.24 109.334 176.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.1 t -127.26 -78.19 0.58 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.638 -1.165 . . . . 2.46 111.202 -169.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.09 60.38 0.55 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.52 -0.848 . . . . 1.45 112.374 -177.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -120.39 -163.73 1.03 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.107 0.479 . . . . 2.24 110.221 176.869 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.503 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 1.2 mtpp -176.77 135.65 0.22 Allowed 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.201 -1.037 . . . . 3.43 108.201 -172.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.607 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 3.2 m -66.55 123.88 20.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.895 0.855 . . . . 2.21 110.703 177.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.2 p -97.76 -23.25 4.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 114.199 -1.364 . . . . 1.83 108.795 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.507 ' HA ' ' HD2' ' A' ' 28' ' ' LYS . 10.0 tptm -155.47 112.93 3.32 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 119.995 -0.682 . . . . 2.87 111.824 -174.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.936 HG21 ' HA ' ' A' ' 34' ' ' THR . 75.2 p -130.97 126.93 37.32 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.54 -0.541 . . . . 1.92 109.54 172.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.3 m -85.18 -79.94 0.22 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.536 -0.302 . . . . 2.37 110.984 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.511 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 7.2 ptpp? -159.17 28.55 0.21 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.498 0.189 . . . . 4.84 110.894 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.609 ' HB2' ' HZ3' ' A' ' 32' ' ' LYS . 1.4 ttmp? 170.35 -20.7 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.979 -0.555 . . . . 2.05 110.31 -176.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.873 HG23 ' HA3' ' A' ' 52' ' ' GLY . 46.1 pt -109.26 157.3 9.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.771 -0.65 . . . . 1.42 110.486 178.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.936 ' HA ' HG21 ' A' ' 29' ' ' THR . 85.6 m -148.79 100.07 3.05 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.65 -0.705 . . . . 1.22 111.133 -164.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.93 HG12 HD12 ' A' ' 192' ' ' LEU . 2.3 t -96.06 106.98 19.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.871 0.367 . . . . 1.52 110.281 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.607 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 6.0 p -96.62 126.04 41.52 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.453 0.645 . . . . 1.74 110.735 177.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.2 t -103.29 127.75 50.53 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.782 -1.099 . . . . 1.72 109.199 -176.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.512 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 25.1 ttpp -120.13 -86.41 0.65 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.33 -0.395 . . . . 2.45 110.983 -177.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.785 ' HA ' ' HA ' ' A' ' 46' ' ' ASN . . . -176.33 149.01 0.8 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.996 -0.372 . . . . 2.17 109.996 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.945 ' HB2' ' HB2' ' A' ' 47' ' ' LEU . 39.9 t -145.4 -37.5 0.27 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.105 0.479 . . . . 2.51 110.68 178.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 66.97 8.52 6.17 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 114.79 -1.096 . . . . 7.41 111.558 -177.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.5 ' HD2' ' HB3' ' A' ' 40' ' ' SER . 0.0 OUTLIER -70.57 -14.32 62.45 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 121.158 -0.217 . . . . 6.84 111.377 -178.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -174.77 -72.49 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 120.511 -0.476 . . . . 6.42 110.605 -176.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -104.17 37.85 1.99 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.703 0.763 . . . . 6.31 110.707 -175.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.2 -51.18 3.21 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.307 -0.86 . . . . 1.74 113.918 173.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.785 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 3.6 m-20 -105.53 169.76 8.28 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.054 0.761 . . . . 2.45 113.054 -166.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.945 ' HB2' ' HB2' ' A' ' 40' ' ' SER . 9.7 tt -128.85 147.78 50.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.171 -1.377 . . . . 1.49 107.615 178.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.44 ' N ' HD21 ' A' ' 47' ' ' LEU . 94.0 m-85 -122.71 134.35 54.46 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.151 -0.62 . . . . 1.52 111.587 -170.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.486 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 2.6 tmt_? -130.67 118.56 21.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.813 -0.631 . . . . 3.34 111.044 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.891 HG12 HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -92.5 153.35 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-O 120.989 0.423 . . . . 1.98 110.642 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.479 ' CG ' ' HD2' ' A' ' 166' ' ' LYS . 16.3 tt0 -153.31 106.56 2.98 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.557 -0.905 . . . . 1.07 108.557 178.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.873 ' HA3' HG23 ' A' ' 33' ' ' ILE . . . -140.94 141.21 11.07 Favored Glycine 0 CA--C 1.498 -0.998 0 C-N-CA 120.239 -0.981 . . . . 0.35 111.542 -178.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' ' 165' ' ' SER . 61.6 mt -88.44 120.35 37.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 C-N-CA 120.206 -0.598 . . . . 1.3 110.89 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.645 HG12 ' HD3' ' A' ' 200' ' ' LYS . 63.7 mt -95.74 119.2 65.36 Favored Pre-proline 0 N--CA 1.443 -0.785 0 N-CA-C 109.096 -0.705 . . . . 1.07 109.096 173.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 28.1 Cg_exo -64.72 59.35 0.28 Allowed 'Trans proline' 0 N--CA 1.473 0.268 0 C-N-CA 124.08 3.187 . . . . 0.74 112.959 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.425 ' HG2' ' CG1' ' A' ' 203' ' ' ILE . 14.5 tp10 -156.21 175.85 13.45 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.287 -1.375 . . . . 1.68 107.287 177.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.422 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 43.3 p -88.81 141.66 30.01 Favored Pre-proline 0 N--CA 1.429 -1.522 0 CA-C-O 121.512 0.672 . . . . 1.58 110.211 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.794 ' HD3' ' HB3' ' A' ' 165' ' ' SER . 6.3 Cg_endo -49.34 -14.85 0.63 Allowed 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 124.963 3.775 . . . . 0.74 112.587 173.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.76 -47.74 29.45 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 116.11 -0.495 . . . . 1.31 111.204 176.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.624 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 1.4 tpmt? -67.64 -31.42 71.42 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.841 -1.17 . . . . 3.78 107.841 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 1.087 HD21 HD12 ' A' ' 203' ' ' ILE . 83.2 mt -63.23 -56.29 17.88 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.034 -1.439 . . . . 1.09 110.778 175.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.2 t -62.95 -12.17 23.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.67 0.271 . . . . 1.94 110.564 177.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -84.04 -41.91 16.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.369 -0.378 . . . . 1.32 112.0 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.765 ' HD2' ' CZ2' ' A' ' 74' ' ' TRP . 15.4 p90 -85.88 -42.02 14.46 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.399 0.518 . . . . 0.79 112.399 -170.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.728 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -89.95 4.49 49.89 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.06 0.391 . . . . 2.15 111.932 -170.08 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.601 ' O ' ' HG3' ' A' ' 67' ' ' GLN . 75.2 t80 -41.89 -73.1 0.05 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.973 0.731 . . . . 2.06 112.973 -166.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.601 ' HG3' ' O ' ' A' ' 66' ' ' TYR . 72.4 mt-30 -168.07 -61.57 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.7 0.762 . . . . 4.31 110.462 -178.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.846 ' HB ' ' CD2' ' A' ' 81' ' ' TYR . 10.2 t -126.23 26.19 6.5 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.111 -1.44 . . . . 1.89 107.111 178.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.686 ' O ' ' HB2' ' A' ' 70' ' ' ASP . . . -72.15 -14.12 76.48 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 113.531 -1.668 . . . . 1.71 112.735 -169.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.686 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 15.1 t70 132.91 -8.95 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 O-C-N 125.844 1.555 . . . . 2.19 107.051 -171.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.767 ' HA ' ' CE2' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -59.41 -36.24 75.48 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.525 -1.216 . . . . 3.95 111.239 -170.089 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 1.005 HG21 HD13 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -80.5 -14.14 12.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.581 -0.448 . . . . 1.42 110.973 -175.84 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.654 HG23 ' O ' ' A' ' 70' ' ' ASP . 1.1 t -88.11 -31.7 19.07 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 119.972 -0.691 . . . . 1.45 110.15 -176.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.887 ' HZ3' ' HB3' ' A' ' 198' ' ' ASN . 15.0 p-90 -100.64 -7.21 24.16 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.411 -0.516 . . . . 0.78 111.023 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.798 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 5.7 t70 -73.7 167.98 20.3 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.47 0.653 . . . . 2.19 110.267 -177.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.431 ' H ' ' HG3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -112.8 -16.17 12.8 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.923 -1.035 . . . . 3.68 111.512 -172.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.1 t -119.62 9.02 11.35 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.339 0.59 . . . . 2.08 109.456 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 1.005 HD13 HG21 ' A' ' 72' ' ' ILE . 19.9 mt -109.72 159.68 16.95 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.625 -0.716 . . . . 1.16 112.421 -175.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.573 ' HB3' HG22 ' A' ' 80' ' ' VAL . 7.7 mt-30 -131.94 -69.7 0.59 Allowed 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 114.807 -1.088 . . . . 2.23 110.432 178.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.573 HG22 ' HB3' ' A' ' 79' ' ' GLN . 21.3 t -142.84 136.32 26.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.875 -1.057 . . . . 1.44 110.254 -165.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.846 ' CD2' ' HB ' ' A' ' 68' ' ' THR . 80.6 t80 -116.91 146.56 42.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.053 0.454 . . . . 5.73 111.334 177.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.738 ' HB2' ' HD2' ' A' ' 95' ' ' HIS . 14.0 m120 -142.69 124.01 14.69 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.42 -0.809 . . . . 1.86 109.037 175.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.486 ' HG3' ' HH ' ' A' ' 81' ' ' TYR . 2.3 ttt -82.11 97.13 8.03 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.597 -0.89 . . . . 2.52 108.597 -178.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.692 HG11 ' HB2' ' A' ' 137' ' ' TYR . 0.1 OUTLIER -72.92 -80.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.914 -0.584 . . . . 1.19 111.908 -167.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.592 ' HB2' ' HG2' ' A' ' 136' ' ' GLU . 10.4 t60 -126.03 118.36 25.17 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.976 -0.75 . . . . 2.59 108.976 -177.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.429 ' HD3' ' SD ' ' A' ' 83' ' ' MET . 50.4 mtm180 -103.31 103.14 13.13 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.4 -0.593 . . . . 2.83 109.4 -175.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.608 HG23 ' HB2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -67.74 -41.32 85.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.081 -0.963 . . . . 1.17 110.402 -173.547 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -148.35 -161.38 1.33 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.878 -1.156 . . . . 1.86 107.878 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.7 m -93.4 3.87 54.9 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.07 0.462 . . . . 1.94 109.915 175.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -125.07 -3.43 7.58 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 109.07 -0.715 . . . . 1.87 109.07 -175.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.606 HG21 HD13 ' A' ' 114' ' ' LEU . 2.1 m -145.92 116.52 7.61 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 109.288 -0.634 . . . . 1.12 109.288 -171.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.575 ' HB2' HE22 ' A' ' 67' ' ' GLN . 10.8 m-85 -129.82 176.88 7.68 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.175 -0.676 . . . . 0.52 109.175 -177.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.665 HD12 ' HB2' ' A' ' 114' ' ' LEU . 1.3 mm -122.43 131.81 72.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 107.851 -1.166 . . . . 1.1 107.851 168.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.403 ' CB ' ' HE1' ' A' ' 81' ' ' TYR . 18.4 p -107.11 107.14 17.98 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.871 -0.331 . . . . 2.61 111.643 -173.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.738 ' HD2' ' HB2' ' A' ' 82' ' ' ASN . 49.4 t60 -81.72 103.57 11.5 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.385 -0.969 . . . . 2.17 108.385 167.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.819 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 33.1 m -125.4 111.18 14.83 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.891 -0.595 . . . . 1.19 111.75 -170.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' A' ' 79' ' ' GLN . 29.0 mm -77.11 136.56 24.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 120.142 -0.623 . . . . 1.63 109.739 177.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.501 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 1.8 m -112.75 147.05 37.67 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.988 -1.005 . . . . 1.72 109.942 -171.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.557 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 6.8 mt-30 -88.82 157.04 18.6 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.962 -0.563 . . . . 2.29 110.403 -178.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 10.1 m -76.87 84.64 3.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.657 -0.701 . . . . 4.07 109.959 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.405 ' HE2' ' HG1' ' A' ' 187' ' ' THR . 14.2 p90 -92.22 175.29 6.91 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 115.871 -0.604 . . . . 6.11 109.371 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 1.036 ' HB1' ' HD2' ' A' ' 186' ' ' LYS . . . 65.71 40.64 4.29 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.132 -0.94 . . . . 1.98 109.726 -173.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.503 HG11 ' O ' ' A' ' 102' ' ' ALA . 0.3 OUTLIER 69.77 -25.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.929 1.292 . . . . 3.6 112.623 177.39 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 102' ' ' ALA . . . 140.96 -0.46 1.84 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.311 -0.947 . . . . 2.2 112.404 -176.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.672 ' HB3' HD12 ' A' ' 183' ' ' ILE . 16.5 m -64.15 -25.18 67.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.717 0.77 . . . . 2.08 109.97 174.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.48 HD13 ' CB ' ' A' ' 102' ' ' ALA . 44.1 mt -112.59 111.64 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-N 115.025 -0.988 . . . . 1.53 109.722 -177.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.8 p -68.15 157.34 87.58 Favored Pre-proline 0 C--O 1.237 0.44 0 CA-C-N 115.433 -0.803 . . . . 1.71 111.934 -172.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -45.44 124.44 6.51 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 123.252 2.635 . . . . 1.31 110.793 175.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.61 ' HG3' HG23 ' A' ' 144' ' ' ILE . 2.7 ttm180 -122.25 157.19 32.2 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.623 -0.831 . . . . 4.06 110.552 -168.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.625 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 12.3 t0 -126.52 131.03 51.69 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 109.608 -0.516 . . . . 1.37 109.608 176.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.819 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 20.0 m-85 -99.96 131.91 45.64 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 120.946 0.403 . . . . 3.01 110.436 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.47 HG22 ' HE1' ' A' ' 134' ' ' PHE . 20.5 mm -129.8 74.49 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 108.152 -1.055 . . . . 1.2 108.152 168.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.64 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 41.8 m-20 -106.44 140.28 39.59 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.981 -1.009 . . . . 1.86 109.304 -178.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.665 ' HB2' HD12 ' A' ' 93' ' ' ILE . 5.3 tp -81.93 122.6 27.96 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.162 -0.681 . . . . 1.08 109.162 174.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -117.35 124.05 72.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-O 122.236 1.017 . . . . 1.08 111.981 -166.84 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.89 ' CE2' ' HB3' ' A' ' 128' ' ' SER . 0.1 OUTLIER -113.51 118.42 34.4 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.552 -1.658 . . . . 2.81 110.02 -176.092 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 126' ' ' ILE . 3.9 mp -105.31 99.38 8.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.544 -0.539 . . . . 1.53 109.544 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -107.5 144.17 34.85 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.599 -0.728 . . . . 1.81 109.718 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.447 ' NH1' ' HA ' ' A' ' 121' ' ' GLU . 3.3 tmt_? -121.09 94.1 4.23 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 108.144 -1.058 . . . . 3.22 108.144 -176.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.561 ' CB ' ' HB2' ' A' ' 123' ' ' ASN . 89.5 m-85 -63.73 115.84 5.16 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 106.806 -1.553 . . . . 1.28 106.806 172.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.447 ' HA ' ' NH1' ' A' ' 119' ' ' ARG . 21.0 mt-10 -48.22 85.26 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 O-C-N 125.031 1.457 . . . . 2.28 113.014 -171.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 77.25 29.07 57.0 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 114.91 -1.041 . . . . 0.79 112.509 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.561 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 14.4 m120 -125.5 -51.04 1.62 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.668 -0.266 . . . . 2.06 110.337 178.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.605 ' HE3' HD22 ' A' ' 18' ' ' ASN . 1.9 mpt? -157.03 131.93 8.87 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.834 0.349 . . . . 1.73 111.267 -174.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.417 ' OD1' ' HG2' ' A' ' 119' ' ' ARG . 63.9 m-20 -105.91 79.5 1.43 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.611 -1.255 . . . . 2.07 107.611 171.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.612 ' HB ' HG11 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -89.52 124.83 42.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.699 -0.682 . . . . 1.06 112.213 -173.101 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.549 HG21 HD22 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -107.02 116.89 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 107.528 -1.286 . . . . 1.26 107.528 160.214 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.89 ' HB3' ' CE2' ' A' ' 116' ' ' TYR . 37.9 t -127.88 167.22 16.9 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.425 -0.954 . . . . 1.53 108.425 174.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.64 ' HB3' ' HB3' ' A' ' 113' ' ' ASP . 73.0 m -145.16 137.84 26.15 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.637 -0.505 . . . . 1.81 109.637 -168.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.473 ' HE2' ' HG3' ' A' ' 150' ' ' PRO . 47.0 tttm -123.86 116.21 22.57 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.302 -1.37 . . . . 2.75 107.302 -171.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.654 ' HB3' ' N ' ' A' ' 148' ' ' ASN . 11.8 p -58.65 101.29 0.08 Allowed 'General case' 0 N--CA 1.432 -1.354 0 O-C-N 124.26 0.975 . . . . 1.94 109.303 -173.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.435 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.8 OUTLIER -116.3 131.99 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.139 0 CA-C-N 114.933 -1.03 . . . . 1.64 109.918 -167.392 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -98.24 78.66 2.49 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.742 -1.117 . . . . 2.17 108.209 -175.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.798 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -109.96 156.88 39.22 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 115.395 -0.82 . . . . 0.67 110.264 -171.745 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -75.93 -16.61 18.11 Favored 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.818 2.345 . . . . 1.66 115.267 -169.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.798 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 8.6 tp10 -69.15 -16.47 63.65 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.311 0.577 . . . . 3.5 110.023 -171.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.692 ' HB2' HG11 ' A' ' 84' ' ' VAL . 1.7 t80 -165.5 104.61 0.75 Allowed Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.492 -0.777 . . . . 6.41 112.074 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -88.72 145.18 5.58 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.324 2.683 . . . . 2.31 110.813 170.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -70.27 -166.74 0.21 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.419 2.079 . . . . 1.27 111.762 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.4 m -140.21 -169.75 2.82 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.987 -0.746 . . . . 1.88 108.987 -174.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.9 t -79.45 -37.78 36.17 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 119.899 -0.72 . . . . 2.43 110.249 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -83.28 -17.64 41.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.086 0.469 . . . . 2.18 110.387 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.476 ' HB3' ' CB ' ' A' ' 110' ' ' ASP . 85.9 m-85 -114.65 108.3 16.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.844 -0.616 . . . . 1.33 110.28 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.61 HG23 ' HG3' ' A' ' 109' ' ' ARG . 1.0 OUTLIER -95.39 106.76 18.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.089 -0.505 . . . . 1.4 109.927 -178.267 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.625 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 35.1 ttm180 -50.16 105.37 0.09 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.977 -0.556 . . . . 5.14 111.156 178.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.47 ' HA2' ' CZ ' ' A' ' 176' ' ' ARG . . . -64.32 112.72 5.23 Favored Glycine 0 N--CA 1.437 -1.281 0 CA-C-N 115.337 -0.847 . . . . 1.05 111.887 176.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.785 ' HB2' ' HD3' ' A' ' 176' ' ' ARG . 0.2 OUTLIER -85.58 93.05 8.71 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.058 0.456 . . . . 4.68 109.878 178.114 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.654 ' N ' ' HB3' ' A' ' 131' ' ' SER . 80.1 m-20 -88.86 81.64 6.9 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.579 -0.737 . . . . 2.29 109.741 175.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.526 ' CD2' ' HD2' ' A' ' 150' ' ' PRO . 0.1 OUTLIER -47.85 123.37 9.74 Favored Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 115.141 -0.936 . . . . 2.95 110.104 179.269 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.526 ' HD2' ' CD2' ' A' ' 149' ' ' HIS . 53.6 Cg_exo -14.31 67.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.223 1 C-N-CA 126.725 4.95 . . . . 0.77 115.712 -161.693 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . 0.706 ' HB2' ' O ' ' A' ' 170' ' ' PHE . 24.5 p -123.86 145.82 48.83 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.005 -0.998 . . . . 1.97 109.512 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.566 ' HA3' ' HG ' ' A' ' 128' ' ' SER . . . -151.26 -134.16 2.13 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 119.012 -1.566 . . . . 0.55 114.004 -175.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.599 ' CE1' HD22 ' A' ' 167' ' ' LEU . 33.0 t80 -161.59 80.71 0.58 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.644 -0.873 . . . . 0.8 108.644 -157.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.646 HG22 HG11 ' A' ' 168' ' ' VAL . 12.6 m -91.66 135.53 26.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.647 0.737 . . . . 1.03 110.561 -174.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . 0.54 ' HG ' HD13 ' A' ' 61' ' ' LEU . 15.2 t -112.19 124.21 51.94 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.271 -0.877 . . . . 2.3 109.122 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.932 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 5.2 m -115.8 110.24 44.45 Favored Pre-proline 0 C--N 1.311 -1.072 0 C-N-CA 120.133 -0.627 . . . . 1.45 111.656 -174.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.496 ' HA ' ' HG3' ' A' ' 58' ' ' PRO . 1.1 Cg_endo -49.2 116.93 2.5 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.668 2.245 . . . . 0.72 110.7 168.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.586 ' SD ' ' HB2' ' A' ' 166' ' ' LYS . 84.6 mmm -82.67 -167.23 1.54 Allowed 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.163 0.506 . . . . 1.72 111.737 -173.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -75.66 -22.35 56.82 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.703 -0.68 . . . . 2.63 109.677 172.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 43.8 mm-40 -104.42 27.56 7.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.829 -1.078 . . . . 2.05 108.805 173.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.732 ' HB3' ' HD3' ' A' ' 162' ' ' PRO . 48.1 t-20 -8.27 -73.24 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 126.547 1.939 . . . . 2.19 115.177 -176.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.732 ' HD3' ' HB3' ' A' ' 161' ' ' ASN . 73.0 Cg_endo -74.28 -13.49 23.15 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 121.312 1.342 . . . . 0.86 114.137 -171.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -108.64 -26.1 10.54 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.918 0.389 . . . . 1.34 111.081 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.57 ' HB2' ' HB2' ' A' ' 160' ' ' GLU . 89.4 m-85 -139.76 126.79 20.97 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.02 -0.537 . . . . 1.46 109.579 178.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.794 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 13.1 p -124.43 147.07 48.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.05 0.452 . . . . 2.05 111.228 -177.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.932 ' HB3' ' HB2' ' A' ' 156' ' ' SER . 1.6 tppp? -91.98 102.24 14.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.56 0.695 . . . . 1.4 111.47 -177.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.599 HD22 ' CE1' ' A' ' 153' ' ' PHE . 0.8 OUTLIER -90.61 107.29 19.08 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.288 -0.869 . . . . 1.07 109.396 175.827 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.646 HG11 HG22 ' A' ' 154' ' ' VAL . 0.1 OUTLIER -129.48 128.21 65.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.626 0.727 . . . . 1.11 111.87 178.084 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.531 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 11.7 ttt -137.97 135.92 36.47 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 115.253 -0.885 . . . . 1.79 109.897 -172.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.74 ' CD1' HD23 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -126.91 151.11 48.88 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.231 -0.588 . . . . 4.22 109.902 176.741 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.639 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 4.0 m -129.18 130.18 67.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-O 121.537 0.684 . . . . 2.01 112.017 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.598 ' HG3' ' OG ' ' A' ' 40' ' ' SER . 22.8 tt0 -119.8 37.31 4.24 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.396 -1.705 . . . . 2.66 106.396 170.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 6.7 m -52.21 131.75 32.88 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 113.27 -1.786 . . . . 2.2 111.259 -174.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.556 ' CB ' ' HB3' ' A' ' 147' ' ' TYR . 0.4 OUTLIER -81.58 -28.01 34.01 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 112.029 0.381 . . . . 2.45 112.029 -169.24 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 17.4 mmt 44.38 62.77 1.89 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.308 0.575 . . . . 4.15 111.652 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.785 ' HD3' ' HB2' ' A' ' 147' ' ' TYR . 0.0 OUTLIER -59.52 -37.13 77.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.124 -0.943 . . . . 6.51 110.276 177.495 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -62.36 154.86 40.91 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.249 -0.741 . . . . 2.26 111.249 175.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.652 ' HZ1' ' HB2' ' A' ' 178' ' ' LYS . 0.2 OUTLIER -80.24 97.09 6.8 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.112 0.482 . . . . 6.69 111.794 -173.485 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.588 ' HB2' HD12 ' A' ' 184' ' ' ILE . 4.6 mp -105.96 165.19 11.38 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.991 -1.485 . . . . 2.21 106.991 167.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.464 ' H ' ' CG1' ' A' ' 183' ' ' ILE . 44.0 m -112.46 162.35 21.95 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 108.332 -0.988 . . . . 2.31 108.332 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.406 ' O ' ' HG2' ' A' ' 185' ' ' GLU . 95.1 Cg_exo -43.3 -48.44 8.16 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.157 1.905 . . . . 1.86 111.892 178.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.1 m -67.51 -12.61 60.73 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.77 -0.65 . . . . 2.45 112.51 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.672 HD12 ' HB3' ' A' ' 105' ' ' SER . 35.3 mm -91.37 -42.91 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.955 0 CA-C-O 122.228 1.013 . . . . 1.69 108.77 -178.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.67 ' HA ' ' CG2' ' A' ' 187' ' ' THR . 1.6 mp -66.66 -31.69 54.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 113.269 -1.787 . . . . 1.77 110.437 178.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.426 ' O ' ' HD2' ' A' ' 189' ' ' PRO . 7.5 mm-40 -65.46 -28.91 69.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.102 -0.954 . . . . 2.89 108.733 175.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 1.036 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 2.7 ptpt -93.08 -26.29 17.53 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.719 -1.128 . . . . 1.71 110.852 178.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.67 ' CG2' ' HA ' ' A' ' 184' ' ' ILE . 6.2 t -78.34 -44.33 25.41 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 119.996 -0.682 . . . . 1.3 112.01 -176.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' MET . . . . . 0.942 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 2.5 mmt -80.15 -68.63 0.21 Allowed Pre-proline 0 N--CA 1.455 -0.194 0 C-N-CA 120.058 -0.657 . . . . 1.39 110.756 -173.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.942 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 36.7 Cg_exo -60.6 -15.57 37.58 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 122.66 2.24 . . . . 1.15 113.184 -171.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 33.3 t -86.07 -45.27 11.56 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.734 -0.469 . . . . 1.95 109.734 175.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.643 ' HA ' ' HB2' ' A' ' 194' ' ' ASN . 6.5 t30 -85.17 -21.6 29.13 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.598 -0.441 . . . . 1.92 112.187 -167.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.93 HD12 HG12 ' A' ' 35' ' ' VAL . 2.4 mt -60.26 -51.97 67.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.872 0.844 . . . . 1.68 109.844 173.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.537 ' HB ' ' CD1' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -72.12 -32.32 42.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 114.594 -1.184 . . . . 1.32 109.781 -178.011 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.643 ' HB2' ' HA ' ' A' ' 191' ' ' ASN . 0.9 OUTLIER -72.24 -30.54 64.98 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.646 -1.161 . . . . 2.6 111.721 -179.327 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -70.58 -29.12 65.46 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.516 -0.474 . . . . 2.73 109.918 173.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.518 HG12 HD12 ' A' ' 167' ' ' LEU . 39.1 mt -76.18 -26.54 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-O 121.315 0.579 . . . . 1.11 110.375 173.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 197' ' ' LEU . 55.3 mt -70.0 -42.74 72.63 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 116.126 -0.488 . . . . 1.57 109.947 173.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.887 ' HB3' ' HZ3' ' A' ' 74' ' ' TRP . 91.2 m-20 -50.53 -33.21 20.74 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.983 -1.008 . . . . 2.18 109.846 168.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.66 ' HA ' ' CE2' ' A' ' 64' ' ' PHE . . . -80.52 -40.51 25.91 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 116.229 -0.441 . . . . 1.04 111.099 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.645 ' HD3' HG12 ' A' ' 54' ' ' ILE . 25.7 mmtm -60.05 -42.05 93.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.559 0.695 . . . . 1.51 110.094 176.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -84.51 -43.54 14.46 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.968 -1.015 . . . . 1.94 110.689 -176.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -65.01 -30.91 79.25 Favored Glycine 0 C--O 1.228 -0.235 0 C-N-CA 120.661 -0.78 . . . . 0.47 111.833 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 1.087 HD12 HD21 ' A' ' 61' ' ' LEU . 3.3 tp -70.53 -39.03 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 123.005 -0.115 . . . . 1.16 110.771 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.527 ' O ' HG21 ' A' ' 208' ' ' THR . 41.4 pttt -83.98 -28.42 27.77 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.524 -0.547 . . . . 3.8 109.524 -178.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -63.95 -33.59 76.06 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.374 -0.83 . . . . 1.28 109.356 170.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.446 ' HE2' ' HB3' ' A' ' 70' ' ' ASP . 7.5 m-70 -93.56 -2.09 54.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.267 -0.879 . . . . 4.34 112.023 175.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.571 ' HB2' ' O ' ' A' ' 203' ' ' ILE . 2.1 tmt_? -103.05 -54.45 2.62 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.814 -0.439 . . . . 3.0 109.814 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.527 HG21 ' O ' ' A' ' 204' ' ' LYS . 7.4 t -101.4 148.79 35.68 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 108.64 -0.874 . . . . 2.01 108.64 176.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . 0.428 ' HD2' ' OG1' ' A' ' 208' ' ' THR . 45.6 Cg_endo -69.57 46.71 0.49 Allowed 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.577 2.185 . . . . 2.59 113.109 178.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 89.4 p -78.88 -17.52 55.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.355 0.598 . . . . 2.55 109.684 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.782 ' HA ' ' HB2' ' A' ' 214' ' ' PHE . 5.5 mmm180 -71.77 -14.57 62.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.433 -0.803 . . . . 6.11 111.001 175.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -63.07 -45.08 93.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.602 -0.518 . . . . 7.55 109.602 175.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -103.62 34.88 5.42 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 111.402 -0.679 . . . . 3.73 111.402 176.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.782 ' HB2' ' HA ' ' A' ' 211' ' ' ARG . 78.8 t80 -91.02 141.45 28.82 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.235 -0.283 . . . . 6.11 110.235 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -66.58 88.24 0.13 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.729 -0.471 . . . . 7.27 109.729 174.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 28.4 p-80 -88.66 106.29 18.24 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.312 0.577 . . . . 6.82 110.884 -176.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -77.77 119.6 21.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.43 -0.804 . . . . 5.77 110.592 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.0 p -86.74 -48.83 7.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.896 -0.593 . . . . 6.85 111.464 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -147.38 134.96 20.94 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.957 -0.386 . . . . 9.48 109.957 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 18.8 m . . . . . 0 C--O 1.252 1.196 0 O-C-N 123.627 0.579 . . . . 8.48 111.474 179.048 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.0 t70 . . . . . 0 CA--C 1.508 -0.635 0 N-CA-C 108.903 -0.777 . . . . 2.25 108.903 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.502 ' CD2' HD12 ' A' ' 87' ' ' ILE . 59.1 m-85 -63.86 -33.15 75.04 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.459 0.647 . . . . 0.42999999999999999 109.341 177.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.529 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 5.7 mttp -70.1 -46.63 64.45 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 115.119 -0.946 . . . . 1.51 108.498 178.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -47.49 -48.58 27.04 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 112.324 0.49 . . . . 0.54000000000000004 112.324 -176.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.572 ' O ' ' HB ' ' A' ' 10' ' ' THR . 0.2 OUTLIER -82.95 -34.06 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 121.291 0.567 . . . . 1.0700000000000001 110.041 -173.032 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.498 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -78.83 -42.76 26.81 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.058 -0.973 . . . . 0.34000000000000002 111.767 -176.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.564 ' HG2' ' CZ ' ' A' ' 116' ' ' TYR . 34.6 mt-30 -59.35 -32.95 70.58 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.729 -1.123 . . . . 1.5900000000000001 110.103 175.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.695 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 16.3 mm-40 -79.09 -41.7 28.07 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.104 -0.953 . . . . 2.4700000000000002 108.778 173.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.619 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.3 OUTLIER -63.36 -35.53 80.71 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.039 -0.982 . . . . 0.47999999999999998 111.625 -176.931 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.463 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -46.26 -63.05 1.09 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.941 0.4 . . . . 0.31 111.4 170.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.468 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 10.4 pt20 -72.69 -9.86 59.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.289 -0.414 . . . . 1.6399999999999999 112.051 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.695 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 51.0 mt-10 -77.95 -50.23 12.57 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.631 -0.507 . . . . 2.54 109.631 174.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.627 HG21 ' N ' ' A' ' 152' ' ' GLY . 5.8 p -68.65 -39.42 80.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 122.049 0.928 . . . . 0.53000000000000003 109.393 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.468 ' HB3' ' HA ' ' A' ' 12' ' ' GLN . 0.8 OUTLIER -66.9 -27.57 67.61 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 114.548 -1.206 . . . . 0.59999999999999998 108.93 173.184 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.93 -17.86 63.69 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 113.97 -1.468 . . . . 0.56999999999999995 110.662 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.504 ' CD2' ' HA ' ' A' ' 14' ' ' VAL . 17.9 m-85 -90.63 -22.65 21.11 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.089 -0.556 . . . . 3.27 109.508 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.492 ' CB ' ' HZ ' ' A' ' 170' ' ' PHE . 0.1 OUTLIER -69.67 -24.38 63.6 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 120.184 -0.607 . . . . 2.0299999999999998 109.385 176.996 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.23 9.7 27.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.324 -0.853 . . . . 2.7200000000000002 110.118 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.425 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 29.6 t70 -123.08 74.9 1.25 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.444 -0.798 . . . . 2.1600000000000001 109.108 177.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.439 HG22 ' CH2' ' A' ' 24' ' ' TRP . 53.2 p -102.83 88.84 3.29 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.453 0.644 . . . . 1.8200000000000001 111.183 -172.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.1 p -173.4 168.64 4.55 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.659 -1.155 . . . . 2.1899999999999999 110.127 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.57 9.69 62.24 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 121.171 -0.538 . . . . 1.1000000000000001 112.908 175.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.463 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -120.44 -158.95 0.77 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.88 0.371 . . . . 1.6699999999999999 111.395 -177.521 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.51 122.37 0.35 Allowed 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.155 -0.683 . . . . 2.9500000000000002 109.155 -168.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 3.1 m -65.12 124.12 19.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 122.084 0.945 . . . . 1.5600000000000001 111.252 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.3 p -102.02 -24.4 4.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 113.918 -1.492 . . . . 1.22 108.84 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.403 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 17.7 tppt? -147.81 112.73 5.44 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.903 -0.59 . . . . 2.4100000000000001 111.89 -174.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.56 HG22 ' HA ' ' A' ' 34' ' ' THR . 43.2 p -130.0 151.04 50.98 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.163 -0.472 . . . . 1.3799999999999999 110.314 173.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.3 t -118.84 -98.85 0.45 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.27 -0.423 . . . . 2.3700000000000001 110.027 174.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -144.86 17.52 1.61 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.624 0.726 . . . . 4.5499999999999998 110.035 176.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.573 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 13.1 tptm -167.92 -0.6 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.677 -0.692 . . . . 1.4199999999999999 110.738 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 51' ' ' GLU . 41.7 pt -136.44 154.02 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 120.951 0.405 . . . . 0.76000000000000001 110.802 -176.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.56 ' HA ' HG22 ' A' ' 29' ' ' THR . 54.4 m -150.2 99.59 2.82 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.675 -0.693 . . . . 0.57999999999999996 111.299 -168.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.487 HG11 ' HA ' ' A' ' 189' ' ' PRO . 9.9 t -92.48 118.77 38.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.928 -0.397 . . . . 0.85999999999999999 109.928 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.544 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -118.64 124.4 47.31 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.435 0.636 . . . . 1.1000000000000001 111.117 -176.664 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.528 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 22.4 m -95.28 122.48 38.02 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.721 -1.127 . . . . 1.27 111.037 -175.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 29.1 ttmt . . . . . 0 C--N 1.324 -0.524 0 CA-C-N 116.508 -0.315 . . . . 1.9099999999999999 111.354 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.528 ' OD1' ' HB3' ' A' ' 37' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.706 0.289 . . . . 2.0499999999999998 110.251 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.705 HD23 ' N ' ' A' ' 48' ' ' TYR . 6.4 tt -96.97 147.55 23.87 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.283 -0.636 . . . . 0.87 109.283 -177.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.705 ' N ' HD23 ' A' ' 47' ' ' LEU . 46.9 m-85 -117.88 124.36 48.1 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.643 -0.502 . . . . 0.98999999999999999 109.643 -176.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.439 ' HD3' HG23 ' A' ' 168' ' ' VAL . 1.4 tmm_? -117.88 120.69 38.65 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.343 -0.39 . . . . 2.9199999999999999 109.989 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.537 ' CG1' ' HB3' ' A' ' 192' ' ' LEU . 11.3 p -103.45 149.79 7.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 120.696 -0.402 . . . . 1.3300000000000001 110.088 177.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.552 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 34.1 tt0 -143.63 111.36 6.01 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.914 -0.584 . . . . 1.0700000000000001 110.036 -172.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.573 ' HA2' ' O ' ' A' ' 32' ' ' LYS . . . -140.73 138.86 9.23 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.323 -0.941 . . . . 0.28999999999999998 112.498 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.416 ' HB ' ' HE2' ' A' ' 32' ' ' LYS . 63.6 mt -90.23 113.93 27.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 120.168 -0.613 . . . . 0.57999999999999996 110.786 177.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.48 ' CD1' ' HB1' ' A' ' 199' ' ' ALA . 57.4 mt -95.89 116.53 66.29 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.627 -0.715 . . . . 0.34999999999999998 109.454 175.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -61.91 64.26 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 124.381 3.388 . . . . 0.62 113.065 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.566 ' HG2' ' CG1' ' A' ' 203' ' ' ILE . 12.4 tp10 -156.84 173.43 17.0 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.656 -0.868 . . . . 1.6799999999999999 108.656 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.49 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 10.2 m -81.63 142.07 49.12 Favored Pre-proline 0 N--CA 1.423 -1.796 0 N-CA-C 109.332 -0.618 . . . . 1.1799999999999999 109.332 178.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 57' ' ' SER . 31.2 Cg_exo -59.08 -12.31 15.3 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 123.723 2.949 . . . . 0.52000000000000002 111.038 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.9 -50.21 37.49 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.825 -1.079 . . . . 0.64000000000000001 111.292 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.447 ' HB3' HD11 ' A' ' 203' ' ' ILE . 17.4 ttmm -71.02 -27.59 63.79 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.089 -0.708 . . . . 3.2999999999999998 109.089 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.971 HD23 HD13 ' A' ' 203' ' ' ILE . 47.0 mt -62.3 -55.8 24.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.86 -1.063 . . . . 0.40999999999999998 109.666 173.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.534 ' HA ' ' CD1' ' A' ' 65' ' ' LEU . 13.7 p -71.84 -1.64 14.92 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.135 0.493 . . . . 1.29 110.83 176.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -88.85 -30.25 19.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.923 -0.58 . . . . 1.3200000000000001 111.141 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.7 ' CE1' ' HB3' ' A' ' 65' ' ' LEU . 6.1 p90 -90.02 -46.07 8.75 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 120.774 -0.37 . . . . 0.60999999999999999 111.06 -174.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.704 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -87.56 6.97 31.76 Favored 'General case' 0 CA--C 1.517 -0.302 0 O-C-N 121.811 -0.556 . . . . 1.5 110.535 -173.545 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -48.44 -63.43 1.08 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.8 -1.091 . . . . 1.52 112.496 -167.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.465 ' O ' ' HD2' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -154.73 -85.32 0.06 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 119.433 -0.907 . . . . 3.6000000000000001 112.942 -175.683 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.638 ' HB ' ' CD1' ' A' ' 81' ' ' TYR . 9.1 t -141.06 21.52 2.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.965 0.412 . . . . 1.48 111.583 -164.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -115.95 0.98 21.31 Favored Glycine 0 C--N 1.311 -0.833 0 C-N-CA 118.716 -1.707 . . . . 1.46 113.97 -164.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.559 ' O ' HG22 ' A' ' 73' ' ' THR . 6.6 p-10 179.17 -31.81 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.258 -0.645 . . . . 2.1899999999999999 109.258 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.626 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 18.3 ttt180 -34.57 -59.45 0.46 Allowed 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 125.649 1.58 . . . . 3.3799999999999999 111.189 176.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.703 HD13 ' H ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -88.8 -6.98 10.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.879 -1.055 . . . . 0.70999999999999996 111.223 -172.929 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.559 HG22 ' O ' ' A' ' 70' ' ' ASP . 0.7 OUTLIER -88.21 -45.13 10.34 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 120.326 -0.549 . . . . 0.96999999999999997 110.523 -171.614 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.517 ' CZ3' ' HB2' ' A' ' 198' ' ' ASN . 18.7 p-90 -102.24 1.38 35.81 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 120.54 -0.464 . . . . 0.75 110.95 -174.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.626 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 5.3 t70 -71.03 -171.07 0.51 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.878 0.846 . . . . 2.1899999999999999 111.578 -175.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.64 ' HD3' ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -126.34 -29.07 3.01 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.678 -1.146 . . . . 3.1899999999999999 109.217 -175.694 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.1 m -120.01 8.87 11.08 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.372 -0.831 . . . . 1.5800000000000001 110.142 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.567 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 39.6 mt -108.9 155.39 20.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.99 0.424 . . . . 0.70999999999999996 110.336 178.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.578 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 5.2 mm-40 -132.04 -69.37 0.6 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.54 -0.755 . . . . 1.73 111.509 -175.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.49 HG23 ' HB3' ' A' ' 79' ' ' GLN . 14.4 t -139.01 134.05 41.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.125 -0.489 . . . . 0.78000000000000003 110.377 -171.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.638 ' CD1' ' HB ' ' A' ' 68' ' ' THR . 15.9 t80 -117.53 137.05 52.82 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.827 -0.434 . . . . 5.4000000000000004 109.827 175.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.423 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 20.3 m120 -136.6 124.58 22.81 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.655 -0.869 . . . . 1.6899999999999999 108.655 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.472 ' CG ' ' HD3' ' A' ' 86' ' ' ARG . 21.4 tpp -80.21 97.2 6.83 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.163 -0.926 . . . . 2.0499999999999998 109.272 -176.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -75.65 -77.08 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.099 -0.501 . . . . 0.64000000000000001 111.817 -170.557 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -136.01 103.54 5.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.984 0.421 . . . . 1.96 110.459 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.472 ' HD3' ' CG ' ' A' ' 83' ' ' MET . 85.1 mtm180 -83.95 133.7 34.69 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.204 -0.665 . . . . 2.4399999999999999 109.204 175.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.623 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -86.57 -47.16 16.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.624 -0.716 . . . . 0.46999999999999997 109.32 -174.449 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -142.15 -152.34 0.4 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.224 -0.898 . . . . 1.8600000000000001 108.948 175.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.3 m -88.33 -7.86 56.04 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.039 0.385 . . . . 1.4399999999999999 112.039 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -134.4 14.99 3.77 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 120.365 -0.534 . . . . 1.8700000000000001 110.481 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.623 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.5 OUTLIER -136.49 103.96 5.42 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 108.09 -1.078 . . . . 0.46000000000000002 108.09 -178.68 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.605 ' O ' HD12 ' A' ' 114' ' ' LEU . 10.2 m-85 -120.65 172.59 7.75 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.008 0.432 . . . . 0.42999999999999999 110.224 -173.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.633 ' O ' HG23 ' A' ' 84' ' ' VAL . 42.4 mt -132.56 128.46 57.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 107.541 -1.281 . . . . 0.40999999999999998 107.541 168.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.592 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 26.1 p -106.6 129.91 54.45 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.407 -0.361 . . . . 2.0099999999999998 111.542 -173.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.538 ' HA ' HD13 ' A' ' 112' ' ' ILE . 4.1 t60 -94.35 90.93 6.46 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.148 -1.056 . . . . 1.23 108.148 163.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 85.3 m -108.53 109.33 20.55 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.536 -0.756 . . . . 0.5 111.787 -173.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.441 ' O ' ' HB2' ' A' ' 79' ' ' GLN . 44.7 mm -77.65 121.46 30.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.564 -0.902 . . . . 1.03 108.564 171.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.427 ' CG2' ' HB2' ' A' ' 109' ' ' ARG . 14.7 t -112.55 156.51 22.53 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.689 0.757 . . . . 1.3799999999999999 111.222 -176.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.578 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 20.9 mt-30 . . . . . 0 C--N 1.312 -1.033 0 CA-C-N 114.481 -1.236 . . . . 1.8200000000000001 108.938 176.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 62.0 mt . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 110.337 -0.245 . . . . 1.1200000000000001 110.337 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.0 m -99.06 151.38 37.36 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.66 -0.496 . . . . 1.3500000000000001 109.66 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.16 147.95 10.61 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.162 2.575 . . . . 1.0700000000000001 112.195 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.508 ' HG2' HG23 ' A' ' 144' ' ' ILE . 42.6 mtt180 -121.97 157.08 32.08 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.709 -0.796 . . . . 3.4500000000000002 111.748 -170.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.824 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 7.1 t0 -104.48 116.74 32.63 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.276 -0.875 . . . . 1.3700000000000001 109.17 174.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.525 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 13.3 m-30 -100.56 109.77 21.88 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.89 -0.506 . . . . 2.4100000000000001 110.664 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.601 HG21 ' CE1' ' A' ' 134' ' ' PHE . 24.5 mm -104.96 76.15 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 N-CA-C 109.12 -0.696 . . . . 0.42999999999999999 109.12 173.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.595 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 25.7 m-20 -99.54 124.15 44.46 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.649 -0.705 . . . . 1.8600000000000001 110.435 -178.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.605 HD12 ' O ' ' A' ' 92' ' ' PHE . 3.5 tp -75.74 127.19 32.51 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 108.378 -0.971 . . . . 0.28000000000000003 108.378 169.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -128.62 124.51 61.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-N 115.485 -0.78 . . . . 0.26000000000000001 112.133 -163.582 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.564 ' CZ ' ' HG2' ' A' ' 8' ' ' GLN . 67.5 t80 -114.36 121.13 42.67 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.923 -1.035 . . . . 2.5699999999999998 110.943 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.564 HG12 HG22 ' A' ' 127' ' ' ILE . 88.7 mt -95.72 122.31 47.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.801 -0.636 . . . . 0.89000000000000001 110.438 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.42 ' HE2' ' HE2' ' A' ' 116' ' ' TYR . 13.4 tppt? -131.41 134.57 46.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.964 -0.562 . . . . 1.2 111.255 -173.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.0 tpp180 -112.93 100.49 8.68 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.908 -0.587 . . . . 2.7999999999999998 109.616 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -75.11 107.39 7.16 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.571 -1.27 . . . . 0.82999999999999996 107.571 169.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 1.7 mp0 -26.44 97.12 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 O-C-N 125.024 1.453 . . . . 2.2799999999999998 113.535 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 56.7 31.89 61.1 Favored Glycine 0 CA--C 1.51 -0.22 0 CA-C-N 114.565 -1.198 . . . . 0.76000000000000001 113.242 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.645 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 5.8 m-20 -125.95 -49.01 1.61 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.957 -0.386 . . . . 1.6499999999999999 109.957 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.403 ' SD ' ' HB3' ' A' ' 123' ' ' ASN . 2.2 mpt? -157.56 141.3 15.79 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 110.259 -0.275 . . . . 1.1200000000000001 110.259 -178.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -120.33 85.93 2.48 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.404 -0.961 . . . . 1.6200000000000001 108.404 167.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.469 ' CG1' HG12 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -97.65 144.47 10.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.29 -1.323 . . . . 0.29999999999999999 112.282 -171.71 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.66 ' O ' HG13 ' A' ' 127' ' ' ILE . 2.1 pt -109.03 116.1 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 108.1 -1.074 . . . . 0.58999999999999997 108.1 161.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.592 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 43.3 p -83.94 159.05 21.36 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.822 -0.807 . . . . 1.1799999999999999 108.822 173.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.595 ' HB3' ' HB3' ' A' ' 113' ' ' ASP . 20.4 m -153.15 128.64 9.97 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 120.675 0.274 . . . . 1.24 111.05 -175.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -128.28 121.01 28.26 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 107.929 -1.137 . . . . 2.2599999999999998 107.929 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.457 ' HB2' ' H ' ' A' ' 148' ' ' ASN . 48.0 t -63.58 100.16 0.26 Allowed 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.318 -1.364 . . . . 1.3899999999999999 107.318 174.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -108.58 140.08 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.057 0 CA-C-N 114.348 -1.296 . . . . 1.05 108.691 -165.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -96.2 73.15 2.9 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.182 -0.917 . . . . 2.1699999999999999 109.633 -171.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.787 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -105.38 150.87 39.44 Favored Pre-proline 0 N--CA 1.437 -1.103 0 CA-C-N 114.704 -1.134 . . . . 0.53000000000000003 109.234 -174.856 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 8.2 Cg_exo -76.29 -9.77 19.04 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.736 2.291 . . . . 1.28 115.224 -169.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.787 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 7.4 tp10 -73.13 -13.25 61.14 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.906 -0.405 . . . . 3.5 109.906 -172.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.477 ' HB2' HG11 ' A' ' 84' ' ' VAL . 20.0 t80 -152.68 120.43 3.14 Favored Pre-proline 0 N--CA 1.449 -0.487 0 N-CA-C 113.419 0.896 . . . . 6.1200000000000001 113.419 174.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -99.92 134.83 0.22 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 124.046 3.164 . . . . 1.77 111.774 167.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.408 ' HG3' ' HB2' ' A' ' 145' ' ' ARG . 83.1 Cg_endo -79.23 -159.31 0.1 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.592 2.195 . . . . 1.25 112.136 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.0 p -145.48 -167.84 2.8 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.434 -0.58 . . . . 1.6000000000000001 109.434 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.1 t -88.58 -19.94 25.66 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.558 -0.457 . . . . 1.97 109.813 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -77.15 -32.26 56.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.053 -0.521 . . . . 2.1800000000000002 109.95 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.445 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 73.4 m-85 -130.58 114.97 16.12 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 115.659 -0.701 . . . . 1.23 109.461 176.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.508 HG23 ' HG2' ' A' ' 109' ' ' ARG . 2.0 tp -94.36 113.92 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 109.136 -0.69 . . . . 0.81999999999999995 109.136 -175.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.824 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 41.4 ttp180 -50.4 99.41 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.122 -0.945 . . . . 4.4199999999999999 109.672 173.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.6 122.04 26.85 Favored Glycine 0 N--CA 1.434 -1.483 0 CA-C-N 115.068 -0.969 . . . . 0.79000000000000004 111.784 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -82.16 79.42 8.66 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.876 0.846 . . . . 4.4400000000000004 110.955 177.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.457 ' H ' ' HB2' ' A' ' 131' ' ' SER . 17.4 m-20 -85.79 87.69 7.44 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.888 -1.505 . . . . 1.6200000000000001 108.435 172.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.5 ' HB2' ' HG2' ' A' ' 172' ' ' GLN . 96.4 m-70 -58.68 150.87 55.44 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-O 118.711 -0.661 . . . . 2.3199999999999998 109.367 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.619 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 50.9 Cg_exo -18.62 68.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.198 1 C-N-CA 127.055 5.17 . . . . 0.53000000000000003 116.12 -173.053 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 151' ' ' CYS . . . . . 0.568 ' HB2' ' O ' ' A' ' 170' ' ' PHE . 19.6 p -97.24 -173.81 2.77 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.618 -1.174 . . . . 1.5800000000000001 110.413 174.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.627 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -174.04 -160.65 22.69 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 120.573 -0.823 . . . . 0.42999999999999999 112.044 177.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.474 ' CZ ' HD11 ' A' ' 167' ' ' LEU . 35.4 t80 -161.57 96.08 1.03 Allowed 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.291 -1.003 . . . . 0.59999999999999998 108.291 -167.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.591 ' CG2' HG13 ' A' ' 168' ' ' VAL . 2.3 m -104.15 136.24 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 121.838 0.828 . . . . 0.31 111.188 -173.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 77.6 m -115.49 112.43 22.24 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.101 -0.954 . . . . 1.55 109.048 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.472 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 6.5 m -111.21 118.5 47.6 Favored Pre-proline 0 C--N 1.32 -0.7 0 C-N-CA 120.638 -0.425 . . . . 1.0600000000000001 111.762 -169.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.645 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 39.6 Cg_exo -49.88 119.65 5.07 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.265 1.977 . . . . 0.56000000000000005 111.136 170.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.585 ' SD ' ' HB2' ' A' ' 166' ' ' LYS . 60.4 mmm -79.68 -163.54 0.54 Allowed 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 120.916 0.389 . . . . 1.1599999999999999 111.376 -177.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -68.97 -26.33 64.98 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.476 0.655 . . . . 2.6299999999999999 109.978 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -98.88 15.51 25.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.454 -0.794 . . . . 2.0499999999999998 109.251 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.53 ' HB2' ' CD ' ' A' ' 162' ' ' PRO . 41.0 m-80 23.02 -87.81 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 126.051 1.74 . . . . 1.9299999999999999 115.484 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.53 ' CD ' ' HB2' ' A' ' 161' ' ' ASN . 73.5 Cg_endo -72.31 -16.7 27.89 Favored 'Trans proline' 0 C--N 1.364 1.374 0 CA-C-N 121.539 1.585 . . . . 0.72999999999999998 113.147 -174.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -90.93 -35.28 14.81 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.25 -0.432 . . . . 0.68000000000000005 111.181 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.571 ' O ' ' HB2' ' A' ' 158' ' ' MET . 93.8 m-85 -139.51 133.26 30.62 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.763 -0.458 . . . . 0.93000000000000005 109.763 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.417 ' HB3' HD11 ' A' ' 61' ' ' LEU . 32.4 t -125.99 148.09 49.37 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.514 0.673 . . . . 1.4099999999999999 111.092 -177.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.585 ' HB2' ' SD ' ' A' ' 158' ' ' MET . 1.8 tppp? -96.21 102.36 14.14 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.117 -0.947 . . . . 0.73999999999999999 111.235 -177.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.474 HD11 ' CZ ' ' A' ' 153' ' ' PHE . 0.5 OUTLIER -86.84 109.32 19.21 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.511 -1.222 . . . . 0.27000000000000002 109.006 177.958 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.591 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -131.32 128.74 61.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.439 0.638 . . . . 0.28000000000000003 111.804 177.422 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 23.1 ttt -129.79 145.16 51.57 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.808 -0.633 . . . . 1.24 110.692 -174.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.607 ' CD1' HG22 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -125.72 141.73 51.86 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.463 -0.79 . . . . 3.3700000000000001 109.474 -178.926 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 4.3 p -150.25 137.59 13.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 120.439 -0.504 . . . . 1.3999999999999999 110.512 173.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.531 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 19.8 pm0 -127.4 52.67 1.8 Allowed 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 122.528 1.156 . . . . 2.1699999999999999 108.358 178.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.449 HG23 ' OD1' ' A' ' 148' ' ' ASN . 1.8 m -56.14 148.16 18.71 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 113.492 -1.686 . . . . 1.6499999999999999 112.112 -174.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 . . . . . 0 CA--C 1.533 0.302 0 CA-C-N 115.571 -0.741 . . . . 2.4500000000000002 112.666 -178.245 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.439 ' HA ' ' CE ' ' A' ' 186' ' ' LYS . 27.3 mm . . . . . 0 CA--C 1.5 -0.953 0 CA-C-O 122.947 1.356 . . . . 1.1200000000000001 107.979 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.966 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.4 mp -74.05 -35.16 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.691 0 CA-C-N 112.199 -2.273 . . . . 1.1299999999999999 110.149 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -57.77 -26.42 61.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.961 -1.018 . . . . 2.8900000000000001 109.833 171.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.439 ' CE ' ' HA ' ' A' ' 183' ' ' ILE . 50.9 mtmt -92.76 -36.87 12.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.512 -0.767 . . . . 1.28 111.224 176.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.966 HG22 ' HA ' ' A' ' 184' ' ' ILE . 6.2 t -68.49 -45.71 71.63 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.259 0.466 . . . . 0.62 112.259 -172.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' MET . . . . . 0.588 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 32.3 mmt -80.05 -57.88 0.64 Allowed Pre-proline 0 N--CA 1.464 0.258 0 N-CA-C 112.712 0.634 . . . . 1.0600000000000001 112.712 -173.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.656 ' O ' HG13 ' A' ' 193' ' ' VAL . 39.5 Cg_exo -58.21 -40.23 78.05 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.642 1.561 . . . . 0.91000000000000003 112.163 -175.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 69.8 m -77.24 -24.54 51.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.24 -0.436 . . . . 1.5 111.111 -175.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ASN . . . . . 0.579 ' HB2' ' O ' ' A' ' 187' ' ' THR . 46.5 t30 -80.15 -34.9 37.29 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.66 -0.416 . . . . 1.8799999999999999 110.529 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.537 ' HB3' ' CG1' ' A' ' 50' ' ' VAL . 53.9 mt -68.91 -42.95 76.17 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 120.633 0.254 . . . . 1.0900000000000001 111.027 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.656 HG13 ' O ' ' A' ' 189' ' ' PRO . 2.4 m -62.38 -31.43 51.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 121.65 0.738 . . . . 0.68000000000000005 109.179 176.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.406 ' HA ' ' HB2' ' A' ' 197' ' ' LEU . 1.0 OUTLIER -75.26 -31.12 60.68 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.366 -1.288 . . . . 2.0699999999999998 111.076 -179.409 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -68.75 -28.13 66.53 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 121.348 0.594 . . . . 2.0 109.775 171.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.546 ' O ' ' HD3' ' A' ' 200' ' ' LYS . 28.7 mt -81.86 -26.09 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-O 121.255 0.55 . . . . 0.31 111.206 173.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.406 ' HB2' ' HA ' ' A' ' 194' ' ' ASN . 37.6 mt -72.04 -43.06 65.55 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-N 116.346 -0.388 . . . . 1.03 110.403 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.517 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 5.4 p30 -55.71 -30.68 61.54 Favored 'General case' 0 C--O 1.213 -0.856 0 N-CA-C 108.428 -0.952 . . . . 1.8999999999999999 108.428 170.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.66 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -76.19 -45.42 33.32 Favored 'General case' 0 N--CA 1.428 -1.537 0 O-C-N 121.64 -0.663 . . . . 0.28999999999999998 110.422 -178.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.546 ' HD3' ' O ' ' A' ' 196' ' ' ILE . 1.5 mptm? -56.29 -45.11 80.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.877 -0.601 . . . . 0.96999999999999997 111.263 174.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -86.52 -37.02 18.62 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.43 -0.805 . . . . 1.9399999999999999 111.421 -173.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' GLY . . . . . 0.474 ' HA3' ' CH2' ' A' ' 74' ' ' TRP . . . -68.71 -32.58 74.51 Favored Glycine 0 N--CA 1.462 0.395 0 C-N-CA 120.999 -0.619 . . . . 0.46999999999999997 111.746 177.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.971 HD13 HD23 ' A' ' 61' ' ' LEU . 2.4 tp -69.88 -34.96 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 110.068 -0.345 . . . . 0.60999999999999999 110.068 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -89.34 -20.55 23.89 Favored 'General case' 0 C--O 1.215 -0.714 0 N-CA-C 109.305 -0.628 . . . . 3.3700000000000001 109.305 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.732 0 N-CA-C 108.719 -0.845 . . . . 1.02 108.719 168.096 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 . . . . . 0 CA--C 1.508 -0.655 0 CA-C-O 121.254 0.549 . . . . 2.25 109.745 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.79 ' HA ' HD12 ' A' ' 6' ' ' ILE . 96.4 m-85 -68.64 -30.03 68.65 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.477 -0.783 . . . . 0.42999999999999999 109.056 -176.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.62 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 3.0 tppp? -70.72 -7.42 44.61 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 114.95 -1.023 . . . . 1.51 109.986 176.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.71 -42.15 10.88 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.151 0.501 . . . . 0.54000000000000004 109.804 174.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.79 HD12 ' HA ' ' A' ' 3' ' ' PHE . 1.3 mp -81.82 -43.9 19.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.98 -0.748 . . . . 1.0700000000000001 108.98 -172.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.888 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -67.68 -47.96 67.98 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.546 -1.206 . . . . 0.34000000000000002 111.653 -178.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.62 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 4.3 mt-30 -63.9 -27.02 68.86 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.27 -1.332 . . . . 1.5900000000000001 110.722 -176.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.477 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 99.6 mt-30 -82.45 -39.2 22.89 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.201 -0.909 . . . . 2.4700000000000002 109.211 171.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.931 HG21 ' HZ2' ' A' ' 130' ' ' LYS . 0.5 OUTLIER -65.44 -37.67 87.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.844 -1.071 . . . . 0.47999999999999998 112.401 -177.67 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.52 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -47.36 -53.05 14.77 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.132 0.419 . . . . 0.31 112.132 176.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.564 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 28.3 pt20 -79.87 -4.54 52.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.75 0.31 . . . . 1.6399999999999999 111.115 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 10' ' ' THR . 70.8 mm-40 -75.98 -54.38 6.96 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.206 -0.664 . . . . 2.54 109.206 172.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.621 HG21 ' N ' ' A' ' 152' ' ' GLY . 12.6 p -70.18 -36.83 69.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 114.82 -1.082 . . . . 0.53000000000000003 110.334 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.564 ' HB3' ' HA ' ' A' ' 12' ' ' GLN . 0.6 OUTLIER -69.16 -24.4 64.07 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-O 122.059 0.933 . . . . 0.59999999999999998 108.869 174.785 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.45 -17.74 68.95 Favored Glycine 0 CA--C 1.501 -0.833 0 CA-C-N 113.755 -1.566 . . . . 0.56999999999999995 109.967 177.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.576 ' HA ' ' CB ' ' A' ' 20' ' ' ASP . 30.8 m-85 -90.39 -23.85 20.95 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 114.755 -0.723 . . . . 3.27 109.381 176.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.549 ' HA ' ' HZ ' ' A' ' 170' ' ' PHE . 66.2 t30 -66.48 -19.74 65.86 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-O 121.452 0.644 . . . . 2.0299999999999998 109.541 176.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -120.2 10.58 11.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.433 -0.803 . . . . 2.7200000000000002 110.294 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.576 ' CB ' ' HA ' ' A' ' 17' ' ' TYR . 9.2 t70 -86.07 -31.58 21.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.258 -0.883 . . . . 2.1600000000000001 110.773 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.3 t -16.65 86.99 0.0 OUTLIER 'General case' 0 C--O 1.235 0.309 0 O-C-N 125.485 1.741 . . . . 1.8200000000000001 113.733 -169.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.5 t -172.64 137.48 0.8 Allowed 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.352 -1.749 . . . . 2.1899999999999999 109.068 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.37 -11.5 68.77 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.637 -0.792 . . . . 1.1000000000000001 112.19 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.833 ' HA ' ' HB3' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -104.39 -160.24 0.75 Allowed 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 120.97 0.414 . . . . 1.6699999999999999 110.775 -179.634 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.471 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 2.0 tmmm? -170.48 128.97 0.83 Allowed 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 115.442 -0.799 . . . . 2.9500000000000002 109.18 -174.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.581 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 0.1 OUTLIER -70.35 109.3 2.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-O 121.947 0.879 . . . . 1.5600000000000001 109.374 175.017 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 p -93.19 -25.07 5.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 114.172 -1.376 . . . . 1.22 109.46 -172.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.456 ' HD2' ' HA ' ' A' ' 28' ' ' LYS . 17.4 tptp -153.95 132.03 11.78 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 119.755 -0.778 . . . . 2.4100000000000001 112.015 -175.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.702 ' HB ' ' HA ' ' A' ' 34' ' ' THR . 0.0 OUTLIER -152.01 152.76 32.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.236 0.541 . . . . 1.3799999999999999 112.06 177.292 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 35.6 m -104.6 25.68 9.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.423 -0.808 . . . . 2.3700000000000001 110.499 175.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 30' ' ' SER . 28.6 mmmt 75.53 19.0 2.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.81 -0.632 . . . . 4.5499999999999998 111.911 175.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.581 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 9.3 mmtp -164.76 -30.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.795 -0.639 . . . . 1.4199999999999999 110.073 175.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.906 HG22 ' HA3' ' A' ' 52' ' ' GLY . 29.7 pt -110.87 136.9 45.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 108.629 -0.878 . . . . 0.76000000000000001 108.629 171.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.702 ' HA ' ' HB ' ' A' ' 29' ' ' THR . 0.2 OUTLIER -140.35 115.62 9.91 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.506 0.194 . . . . 0.57999999999999996 111.206 -162.439 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.687 HG22 HG23 ' A' ' 50' ' ' VAL . 6.2 t -99.67 115.04 39.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.957 0.408 . . . . 0.85999999999999999 110.563 -177.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.581 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -107.81 122.76 47.42 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.844 -0.617 . . . . 1.1000000000000001 110.226 -177.679 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.5 t -114.73 131.46 56.76 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.908 -0.587 . . . . 1.27 112.301 -172.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.833 ' HB3' ' HA ' ' A' ' 24' ' ' TRP . 56.5 pttt . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 115.516 -0.765 . . . . 1.9099999999999999 110.057 167.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.443 -0.787 0 CA-C-O 121.39 0.614 . . . . 2.0499999999999998 111.311 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.531 HD23 ' N ' ' A' ' 48' ' ' TYR . 3.1 tt -104.8 133.64 49.28 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.735 -1.209 . . . . 0.87 107.735 176.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.531 ' N ' HD23 ' A' ' 47' ' ' LEU . 22.7 m-85 -117.54 124.42 48.67 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.959 -0.386 . . . . 0.98999999999999999 109.959 -175.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.595 ' HD3' ' CH2' ' A' ' 24' ' ' TRP . 11.6 ttp180 -105.43 116.99 32.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.01 -0.541 . . . . 2.9199999999999999 109.769 175.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.687 HG23 HG22 ' A' ' 35' ' ' VAL . 8.8 p -100.69 136.33 32.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 C-N-CA 119.802 -0.759 . . . . 1.3300000000000001 109.027 174.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.877 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 27.6 tt0 -137.8 108.8 6.73 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.359 -0.837 . . . . 1.0700000000000001 109.963 -169.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.906 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -139.4 140.42 10.84 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.248 -0.977 . . . . 0.28999999999999998 111.828 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 67.7 mt -84.69 116.82 28.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 C-N-CA 120.005 -0.678 . . . . 0.57999999999999996 110.656 178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.545 HG12 ' HD3' ' A' ' 200' ' ' LYS . 63.6 mt -101.54 113.35 65.85 Favored Pre-proline 0 C--N 1.314 -0.974 0 N-CA-C 108.355 -0.98 . . . . 0.34999999999999998 108.355 173.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.533 ' HA ' ' HA ' ' A' ' 164' ' ' TYR . 28.3 Cg_exo -64.12 56.25 0.22 Allowed 'Trans proline' 0 N--CA 1.478 0.561 0 C-N-CA 124.574 3.516 . . . . 0.62 114.105 -174.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.999 ' HG3' HG12 ' A' ' 203' ' ' ILE . 63.4 mm-40 -132.34 -157.19 0.8 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.628 -0.715 . . . . 1.6799999999999999 109.581 176.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 62.7 p -101.11 145.44 30.42 Favored Pre-proline 0 N--CA 1.415 -2.19 0 CA-C-N 114.798 -1.092 . . . . 1.1799999999999999 108.286 168.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 57' ' ' SER . 39.9 Cg_exo -56.84 -11.1 6.51 Favored 'Trans proline' 0 C--N 1.324 -0.727 0 C-N-CA 123.967 3.112 . . . . 0.52000000000000002 110.989 175.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.42 -48.47 9.61 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.857 -1.065 . . . . 0.64000000000000001 111.438 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.623 ' HG2' HG13 ' A' ' 203' ' ' ILE . 3.4 tppt? -62.76 -33.62 75.54 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.52 -0.919 . . . . 3.2999999999999998 108.52 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.978 HD23 HD13 ' A' ' 203' ' ' ILE . 70.9 mt -57.19 -56.91 15.65 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.737 -1.12 . . . . 0.40999999999999998 110.864 173.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.482 ' HA ' ' CD1' ' A' ' 65' ' ' LEU . 53.0 m -65.92 -8.34 21.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.292 0.568 . . . . 1.29 110.643 177.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' A' ' 60' ' ' LYS . 25.1 t70 -88.34 -32.31 18.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.672 -0.694 . . . . 1.3200000000000001 111.83 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.615 ' CD2' ' HA ' ' A' ' 61' ' ' LEU . 16.2 p90 -79.58 -43.53 22.79 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 120.225 -0.59 . . . . 0.60999999999999999 110.019 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.653 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -91.16 3.84 53.75 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 120.548 -0.461 . . . . 1.5 111.962 -174.523 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.407 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 24.8 t80 -14.1 -70.66 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 125.378 1.674 . . . . 1.52 113.475 -169.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.456 ' NE2' HG21 ' A' ' 115' ' ' VAL . 7.0 tp-100 -176.19 -47.17 0.01 OUTLIER 'General case' 0 C--N 1.341 0.233 0 N-CA-C 113.147 0.795 . . . . 3.6000000000000001 113.147 172.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.631 ' OG1' ' HB2' ' A' ' 81' ' ' TYR . 10.6 t -160.11 23.14 0.17 Allowed 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.136 -0.626 . . . . 1.48 111.766 -167.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -126.94 -14.01 2.86 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 118.655 -1.736 . . . . 1.46 114.479 -170.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.667 ' O ' HG22 ' A' ' 73' ' ' THR . 4.8 t70 -157.17 -33.65 0.08 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.384 0.611 . . . . 2.1899999999999999 110.726 -172.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.676 ' O ' ' HB3' ' A' ' 75' ' ' ASP . 2.0 ptp180 -52.3 -39.55 60.68 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.075 -0.966 . . . . 3.3799999999999999 111.693 -173.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.81 ' H ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -87.96 -5.26 10.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.841 -0.618 . . . . 0.70999999999999996 111.442 -175.492 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.667 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.3 t -88.63 -27.43 21.32 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 119.104 -1.038 . . . . 0.96999999999999997 109.418 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.993 ' HZ3' ' HB2' ' A' ' 198' ' ' ASN . 30.7 p-90 -112.32 -0.2 15.5 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.914 -0.585 . . . . 0.75 111.888 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.691 ' CG ' ' HB2' ' A' ' 78' ' ' LEU . 0.9 OUTLIER -68.07 176.96 2.4 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 114.107 1.151 . . . . 2.1899999999999999 114.107 -167.335 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.498 ' NZ ' ' HB2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -143.45 -4.41 0.88 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 113.708 -1.587 . . . . 3.1899999999999999 111.412 170.43 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.8 m -121.35 6.82 10.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.437 0.636 . . . . 1.5800000000000001 109.75 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.691 ' HB2' ' CG ' ' A' ' 75' ' ' ASP . 98.7 mt -118.52 -158.36 0.72 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.295 -0.866 . . . . 0.70999999999999996 110.323 -175.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.443 ' HB3' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -173.57 -58.99 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.871 0.367 . . . . 1.73 111.201 -173.428 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 96' ' ' THR . 39.9 t -145.42 139.41 21.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.307 -0.406 . . . . 0.78000000000000003 110.747 -169.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.727 ' HB3' HD12 ' A' ' 72' ' ' ILE . 44.4 p90 -104.89 152.79 22.2 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.899 -0.591 . . . . 5.4000000000000004 111.537 177.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.89 ' HB3' ' HB3' ' A' ' 95' ' ' HIS . 50.7 t-20 -160.09 104.72 1.51 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.477 -0.564 . . . . 1.6899999999999999 109.477 172.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.9 ttt -74.2 92.45 2.23 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.394 -0.965 . . . . 2.0499999999999998 108.394 176.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -77.12 -63.25 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.86 -0.609 . . . . 0.64000000000000001 111.571 -169.329 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.553 ' HB3' HD12 ' A' ' 93' ' ' ILE . 54.5 t-80 -140.09 113.83 8.75 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.824 -0.436 . . . . 1.96 109.824 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.07 132.71 42.59 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.516 -0.92 . . . . 2.4399999999999999 108.516 175.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.663 HG21 ' HB2' ' A' ' 3' ' ' PHE . 0.1 OUTLIER -90.44 -48.84 14.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.148 0.499 . . . . 0.46999999999999997 111.181 -170.298 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.507 ' CG ' ' H ' ' A' ' 89' ' ' SER . 25.3 t70 -157.14 -148.37 0.21 Allowed 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.588 -0.893 . . . . 1.8600000000000001 108.588 -173.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.507 ' H ' ' CG ' ' A' ' 88' ' ' ASP . 47.6 t -59.26 -49.93 75.94 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.644 0.609 . . . . 1.4399999999999999 112.644 -170.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.721 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 17.7 m-20 -139.91 39.93 1.98 Allowed 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.837 0.827 . . . . 1.8700000000000001 108.895 -171.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.663 ' O ' HG12 ' A' ' 87' ' ' ILE . 1.7 m -135.08 113.21 11.19 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.356 -1.35 . . . . 0.46000000000000002 107.356 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.592 ' O ' HD12 ' A' ' 114' ' ' LEU . 25.8 m-85 -131.0 174.32 10.12 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.594 0.711 . . . . 0.42999999999999999 111.07 -173.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.553 HD12 ' HB3' ' A' ' 85' ' ' HIS . 29.9 mt -131.76 132.98 61.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 106.305 -1.739 . . . . 0.40999999999999998 106.305 165.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 34.2 t -122.35 135.6 54.74 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.064 -0.654 . . . . 2.0099999999999998 110.616 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.89 ' HB3' ' HB3' ' A' ' 82' ' ' ASN . 6.8 t-160 -99.66 80.7 2.39 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 124.37 1.044 . . . . 1.23 109.157 172.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.892 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 93.0 m -89.9 150.35 22.23 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 115.129 -0.941 . . . . 0.5 109.909 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.443 ' HB ' ' HB3' ' A' ' 79' ' ' GLN . 49.4 mm -101.48 131.16 49.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 108.618 -0.882 . . . . 1.03 108.618 167.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.623 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 17.2 m -110.5 126.45 54.39 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.857 -0.61 . . . . 1.3799999999999999 111.493 -171.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 . . . . . 0 C--N 1.323 -0.552 0 CA-C-O 121.247 0.546 . . . . 1.8200000000000001 110.405 177.265 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.504 ' CD1' HG22 ' A' ' 183' ' ' ILE . 3.4 mp . . . . . 0 N--CA 1.45 -0.447 0 N-CA-C 108.757 -0.831 . . . . 1.1200000000000001 108.757 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.3 m -76.96 160.03 77.27 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 109.927 -0.397 . . . . 1.3500000000000001 109.927 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.404 ' HB2' ' CD1' ' A' ' 143' ' ' TYR . 76.0 Cg_exo -49.59 145.31 17.27 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.446 2.097 . . . . 1.0700000000000001 111.249 174.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.771 ' CZ ' ' HA2' ' A' ' 146' ' ' GLY . 0.2 OUTLIER -107.44 141.44 38.84 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 119.803 -0.759 . . . . 3.4500000000000002 110.164 -170.102 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.615 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 12.0 t70 -94.69 115.16 27.2 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 107.81 -1.181 . . . . 1.3700000000000001 107.81 177.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.892 ' HB3' ' HB ' ' A' ' 96' ' ' THR . 63.9 t80 -97.87 108.92 21.74 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.789 -0.448 . . . . 2.4100000000000001 109.789 -168.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.622 ' CG2' ' HE1' ' A' ' 134' ' ' PHE . 13.5 mm -123.71 75.81 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 N-CA-C 108.811 -0.811 . . . . 0.42999999999999999 108.811 173.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.788 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 0.7 OUTLIER -109.41 124.78 51.57 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.466 -0.788 . . . . 1.8600000000000001 110.745 -177.819 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 1.007 HD23 ' HE2' ' A' ' 130' ' ' LYS . 8.9 tp -75.61 117.03 16.94 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 115.275 -0.875 . . . . 0.28000000000000003 109.275 171.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.495 HG23 ' HB ' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -118.41 123.97 72.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-N 114.484 -1.235 . . . . 0.26000000000000001 111.491 -164.402 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.888 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 35.9 t80 -109.93 121.69 45.82 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.585 -0.734 . . . . 2.5699999999999998 111.2 175.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.897 HG13 HG22 ' A' ' 127' ' ' ILE . 3.6 mp -87.39 99.42 8.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.505 -0.924 . . . . 0.89000000000000001 108.505 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.872 ' HD3' ' HE2' ' A' ' 116' ' ' TYR . 57.3 tptt -102.28 131.16 49.04 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.893 -1.049 . . . . 1.2 110.079 -174.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.433 ' HD2' ' C ' ' A' ' 119' ' ' ARG . 4.0 tpt180 -125.61 88.97 2.95 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 108.505 -0.924 . . . . 2.7999999999999998 108.505 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.651 ' CB ' ' HB3' ' A' ' 123' ' ' ASN . 53.9 m-85 -69.42 119.17 13.26 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.759 -1.11 . . . . 0.82999999999999996 108.359 172.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -33.53 95.89 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 125.024 1.453 . . . . 2.2799999999999998 112.955 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 53.95 42.05 69.45 Favored Glycine 0 CA--C 1.508 -0.38 0 CA-C-N 114.684 -1.144 . . . . 0.76000000000000001 112.041 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.651 ' HB3' ' CB ' ' A' ' 120' ' ' TYR . 3.3 t-20 -132.71 -49.76 0.9 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.922 -0.639 . . . . 1.6499999999999999 110.273 -175.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.443 ' CG ' ' HB ' ' A' ' 154' ' ' VAL . 3.9 tpp -158.37 144.31 16.99 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.637 -0.425 . . . . 1.1200000000000001 111.383 -178.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.402 ' OD1' ' HD3' ' A' ' 119' ' ' ARG . 0.7 OUTLIER -120.09 81.22 1.71 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.378 -0.971 . . . . 1.6200000000000001 108.378 172.336 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.745 HG23 ' HB3' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -109.01 146.26 14.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.212 -0.904 . . . . 0.29999999999999999 113.424 -170.541 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.897 HG22 HG13 ' A' ' 117' ' ' ILE . 4.6 pt -107.58 110.72 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.549 0.69 . . . . 0.58999999999999997 109.155 161.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.52 ' HB3' ' HA ' ' A' ' 11' ' ' ALA . 15.8 p -93.83 112.4 24.25 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.325 0.583 . . . . 1.1799999999999999 111.06 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.788 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 54.6 p -102.86 158.85 15.98 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.724 -0.671 . . . . 1.24 111.68 -171.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 1.007 ' HE2' HD23 ' A' ' 114' ' ' LEU . 4.5 mtmm -147.39 124.44 11.4 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 115.939 -0.573 . . . . 2.2599999999999998 109.457 175.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.401 ' HB3' ' H ' ' A' ' 148' ' ' ASN . 31.9 p -67.04 91.63 0.22 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.336 -0.987 . . . . 1.3899999999999999 108.336 174.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.93 133.84 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 CA-C-N 115.131 -0.94 . . . . 1.05 109.274 -163.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.447 ' HB2' HH22 ' A' ' 145' ' ' ARG . 9.2 t70 -94.51 73.4 3.77 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.479 -1.237 . . . . 2.1699999999999999 108.761 -167.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.745 ' O ' ' HB3' ' A' ' 137' ' ' TYR . 1.6 p90 -107.02 173.75 2.93 Favored Pre-proline 0 CA--C 1.554 1.101 0 CA-C-N 114.85 -1.068 . . . . 0.53000000000000003 110.709 -170.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.61 ' HB2' ' OE2' ' A' ' 136' ' ' GLU . 60.2 Cg_exo -53.13 -48.61 21.16 Favored 'Trans proline' 0 N--CA 1.486 1.079 0 C-N-CA 123.292 2.661 . . . . 1.28 116.438 -171.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.703 ' HG2' ' CE2' ' A' ' 134' ' ' PHE . 0.6 OUTLIER -79.43 -9.3 59.57 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 121.53 0.681 . . . . 3.5 111.595 -173.147 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.809 ' HE1' ' HG3' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -54.4 -38.98 71.64 Favored Pre-proline 0 CA--C 1.556 1.196 0 N-CA-C 116.888 2.181 . . . . 6.1200000000000001 116.888 -172.239 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.499 ' HD2' ' C ' ' A' ' 136' ' ' GLU . 34.2 Cg_exo -30.52 110.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 123.875 3.05 . . . . 1.77 115.901 -170.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.49 ' HG3' ' HB2' ' A' ' 145' ' ' ARG . 29.6 Cg_endo -89.88 -155.89 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 124.345 3.363 . . . . 1.25 112.308 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 38.8 m -148.47 143.92 27.05 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 108.727 -0.842 . . . . 1.6000000000000001 108.727 177.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.7 p -58.17 -17.57 19.64 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.568 1.322 . . . . 1.97 114.568 -167.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -83.11 -15.93 48.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.099 0.409 . . . . 2.1800000000000002 111.103 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.404 ' CD1' ' HB2' ' A' ' 108' ' ' PRO . 72.8 m-85 -126.11 108.75 11.64 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.255 -1.017 . . . . 1.23 108.255 175.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.684 HG23 ' HD2' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -82.91 111.73 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 C-N-CA 120.123 -0.631 . . . . 0.81999999999999995 109.395 -171.253 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.809 ' HG3' ' HE1' ' A' ' 137' ' ' TYR . 0.2 OUTLIER -41.36 113.91 0.45 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.939 0.4 . . . . 4.4199999999999999 110.632 171.003 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.771 ' HA2' ' CZ ' ' A' ' 109' ' ' ARG . . . -51.29 130.18 33.21 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.047 -0.978 . . . . 0.79000000000000004 112.478 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.909 ' HB3' ' HG3' ' A' ' 174' ' ' GLU . 0.2 OUTLIER -104.99 63.85 0.71 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.743 0.782 . . . . 4.4400000000000004 109.873 175.82 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.585 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 81.8 m-20 -86.88 108.28 18.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.156 -1.384 . . . . 1.6200000000000001 109.558 178.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -80.31 132.18 60.01 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 109.468 -0.567 . . . . 2.3199999999999998 109.468 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.524 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 51.9 Cg_exo -9.25 61.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.009 1 C-N-CA 126.828 5.019 . . . . 0.53000000000000003 115.628 -161.671 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 151' ' ' CYS . . . . . 0.715 ' HB3' ' O ' ' A' ' 170' ' ' PHE . 3.0 m -76.97 -174.75 3.24 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.931 -1.031 . . . . 1.5800000000000001 109.618 174.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.621 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -171.29 -163.94 26.14 Favored Glycine 0 N--CA 1.429 -1.784 0 C-N-CA 119.666 -1.254 . . . . 0.42999999999999999 111.828 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.476 ' HB3' ' CG1' ' A' ' 127' ' ' ILE . 52.9 t80 -161.92 79.18 0.54 Allowed 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.687 -1.227 . . . . 0.59999999999999998 107.687 -168.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.726 HG12 ' HB ' ' A' ' 126' ' ' ILE . 5.2 m -90.33 128.66 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-O 121.733 0.777 . . . . 0.31 110.422 -174.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 60.8 m -99.82 111.18 23.52 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.305 -0.998 . . . . 1.55 108.305 171.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.812 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 18.9 m -97.6 119.79 61.92 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 115.817 -0.629 . . . . 1.0600000000000001 111.378 -170.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.527 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 50.7 Cg_exo -55.28 111.87 0.88 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.454 2.103 . . . . 0.56000000000000005 111.074 170.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 74.3 mmm -74.99 -166.33 0.47 Allowed 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.373 0.606 . . . . 1.1599999999999999 111.634 -177.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.42 ' H ' ' HB3' ' A' ' 158' ' ' MET . 3.9 tp10 -70.97 -34.52 71.5 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.624 -0.88 . . . . 2.6299999999999999 108.624 174.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -102.06 30.34 4.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.371 -1.286 . . . . 2.0499999999999998 108.918 175.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.623 ' OD1' ' HD3' ' A' ' 162' ' ' PRO . 3.7 p30 -31.43 -48.86 0.42 Allowed Pre-proline 0 N--CA 1.475 0.815 0 N-CA-C 117.107 2.262 . . . . 1.9299999999999999 117.107 -168.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.623 ' HD3' ' OD1' ' A' ' 161' ' ' ASN . 71.6 Cg_endo -76.83 -9.93 18.27 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 CA-C-N 121.976 1.741 . . . . 0.72999999999999998 113.177 -175.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -116.47 -22.66 8.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.042 -0.526 . . . . 0.68000000000000005 110.801 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 55' ' ' PRO . 61.8 m-85 -136.25 121.39 19.0 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.357 -0.608 . . . . 0.93000000000000005 109.357 174.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 38.6 t -116.97 139.47 50.62 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.555 -0.458 . . . . 1.4099999999999999 110.439 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.877 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 2.3 tppp? -89.12 105.35 17.73 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.866 0.841 . . . . 0.73999999999999999 110.984 -177.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.588 HD23 HD13 ' A' ' 61' ' ' LEU . 0.9 OUTLIER -86.82 102.05 13.92 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.338 -0.846 . . . . 0.27000000000000002 108.905 178.409 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.691 HG12 ' HG3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -124.5 119.33 56.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.955 0.884 . . . . 0.28000000000000003 111.587 178.246 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 21.5 ttt -120.04 148.74 43.19 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.824 -1.08 . . . . 1.24 109.532 -175.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.715 ' O ' ' HB3' ' A' ' 151' ' ' CYS . 38.7 m-85 -127.09 135.06 50.24 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.336 -0.986 . . . . 3.3700000000000001 108.336 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.438 HG22 HG22 ' A' ' 173' ' ' THR . 7.8 p -126.69 118.58 51.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.682 0.753 . . . . 1.3999999999999999 110.965 177.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.01 63.7 0.7 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.443 -0.947 . . . . 2.1699999999999999 108.443 177.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 147' ' ' TYR . 3.8 t -98.24 154.18 17.97 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.767 -1.106 . . . . 1.6499999999999999 110.145 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.909 ' HG3' ' HB3' ' A' ' 147' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 112.45 0.537 . . . . 2.4500000000000002 112.45 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.598 ' HA ' ' HE3' ' A' ' 186' ' ' LYS . 8.2 mm . . . . . 0 CA--C 1.511 -0.555 0 CA-C-O 122.224 1.012 . . . . 1.1200000000000001 109.147 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 1.007 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.0 OUTLIER -74.96 -31.87 26.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 113.389 -1.732 . . . . 1.1299999999999999 110.741 -177.834 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.89 -19.94 58.45 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.218 -1.03 . . . . 2.8900000000000001 108.218 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.598 ' HE3' ' HA ' ' A' ' 183' ' ' ILE . 0.2 OUTLIER -91.89 -24.52 19.29 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.085 -1.416 . . . . 1.28 110.31 173.854 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 187' ' ' THR . . . . . 1.007 HG22 ' HA ' ' A' ' 184' ' ' ILE . 3.5 t -89.5 -41.14 12.21 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 119.975 -0.69 . . . . 0.62 112.763 -177.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' MET . . . . . 0.907 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 21.7 mmt -80.67 -65.64 0.26 Allowed Pre-proline 0 N--CA 1.467 0.383 0 O-C-N 121.619 -0.676 . . . . 1.0600000000000001 112.108 -174.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.907 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 17.3 Cg_exo -65.63 -20.8 59.78 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.184 1.923 . . . . 0.91000000000000003 112.162 -173.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.441 ' HB3' ' O ' ' A' ' 186' ' ' LYS . 22.6 t -84.64 -36.28 22.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.989 -0.551 . . . . 1.5 110.187 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -79.98 -37.06 35.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.249 -0.432 . . . . 1.8799999999999999 111.579 -174.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.623 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 20.3 mt -67.07 -45.8 76.24 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 121.007 -0.277 . . . . 1.0900000000000001 111.516 -175.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.838 ' HB ' HD12 ' A' ' 33' ' ' ILE . 27.9 m -71.73 -24.12 22.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.1 -0.64 . . . . 0.68000000000000005 110.406 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.425 ' HB3' ' HE3' ' A' ' 76' ' ' LYS . 4.1 m-20 -73.35 -32.83 64.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.869 -0.605 . . . . 2.0699999999999998 110.755 174.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.636 ' HA ' ' OD1' ' A' ' 198' ' ' ASN . 2.2 m-85 -65.1 -30.74 71.7 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.139 0.495 . . . . 2.0 110.319 174.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.502 HG12 HD12 ' A' ' 167' ' ' LEU . 60.4 mt -79.6 -24.58 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-O 121.365 0.603 . . . . 0.31 110.644 175.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 197' ' ' LEU . 34.2 mt -73.11 -42.82 62.51 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.274 -0.421 . . . . 1.03 110.827 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.993 ' HB2' ' HZ3' ' A' ' 74' ' ' TRP . 1.8 p-10 -67.43 -15.07 63.47 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.386 -0.926 . . . . 1.8999999999999999 109.469 171.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.691 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -80.81 -42.27 21.95 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 109.404 -0.591 . . . . 0.28999999999999998 109.404 173.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.545 ' HD3' HG12 ' A' ' 54' ' ' ILE . 28.1 mmtp -59.56 -44.69 93.2 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 121.553 0.692 . . . . 0.96999999999999997 110.013 173.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -80.48 -39.81 27.33 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.897 -1.047 . . . . 1.9399999999999999 110.984 -174.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -69.51 -31.2 70.92 Favored Glycine 0 CA--C 1.507 -0.464 0 C-N-CA 120.717 -0.754 . . . . 0.46999999999999997 111.395 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.999 HG12 ' HG3' ' A' ' 56' ' ' GLU . 1.5 tp -71.69 -34.57 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 120.574 0.226 . . . . 0.60999999999999999 110.449 177.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 66.4 mttm -86.12 -15.82 39.94 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-O 121.686 0.755 . . . . 3.3700000000000001 109.173 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.952 0 CA-C-N 115.283 -0.871 . . . . 1.02 108.681 165.658 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.626 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.7 OUTLIER . . . . . 0 CA--C 1.513 -0.459 0 N-CA-C 112.202 0.445 . . . . 2.25 112.202 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.693 ' HD2' HD22 ' A' ' 114' ' ' LEU . 91.3 m-85 -61.2 -26.42 67.71 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 116.033 -0.53 . . . . 0.42999999999999999 110.372 -170.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.541 ' HG2' ' HG3' ' A' ' 8' ' ' GLN . 45.8 tttt -73.05 -45.04 59.78 Favored 'General case' 0 N--CA 1.417 -2.099 0 N-CA-C 107.639 -1.245 . . . . 1.51 107.639 -177.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.49 -40.24 59.14 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.831 -0.622 . . . . 0.54000000000000004 111.307 176.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.626 HD12 ' O ' ' A' ' 2' ' ' ASP . 2.3 mp -81.18 -38.89 16.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.869 0.842 . . . . 1.0700000000000001 109.58 -174.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.84 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -75.36 -39.79 58.88 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.533 -1.212 . . . . 0.34000000000000002 111.805 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.541 ' HG3' ' HG2' ' A' ' 4' ' ' LYS . 14.1 mt-30 -63.01 -30.03 71.29 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.609 -1.178 . . . . 1.5900000000000001 109.688 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.622 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 79.6 mt-30 -79.35 -46.62 17.29 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.895 -1.048 . . . . 2.4700000000000002 108.671 171.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.736 HG21 ' HZ2' ' A' ' 130' ' ' LYS . 0.3 OUTLIER -60.17 -37.19 79.42 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.946 -1.024 . . . . 0.47999999999999998 112.59 -176.937 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.501 ' HA ' ' CB ' ' A' ' 128' ' ' SER . . . -51.72 -51.7 54.1 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-O 120.929 0.395 . . . . 0.31 111.494 178.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 20.8 pt20 -80.45 -10.58 59.74 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.191 -0.459 . . . . 1.6399999999999999 110.952 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.622 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 49.3 mt-10 -75.11 -50.66 15.65 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.381 0.61 . . . . 2.54 109.701 174.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.71 HG21 ' N ' ' A' ' 152' ' ' GLY . 11.2 p -71.96 -37.79 62.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 122.235 1.017 . . . . 0.53000000000000003 109.925 -177.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.477 HD12 ' SD ' ' A' ' 124' ' ' MET . 0.9 OUTLIER -72.05 -20.54 61.66 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 114.591 -1.186 . . . . 0.59999999999999998 109.199 173.837 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.455 ' HA2' ' NH1' ' A' ' 19' ' ' ARG . . . -66.16 -18.46 67.08 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 114.184 -1.371 . . . . 0.56999999999999995 110.21 172.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.618 ' CD2' ' HA ' ' A' ' 14' ' ' VAL . 33.5 m-85 -88.93 -26.49 21.53 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.249 -0.475 . . . . 3.27 109.919 177.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.568 ' HB2' ' HZ ' ' A' ' 170' ' ' PHE . 3.5 t30 -71.44 -20.48 62.1 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 119.884 -0.726 . . . . 2.0299999999999998 109.775 173.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.455 ' NH1' ' HA2' ' A' ' 16' ' ' GLY . 20.1 mtp180 -97.89 -20.72 17.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.444 -0.798 . . . . 2.7200000000000002 110.383 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -115.51 103.0 10.31 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.401 -0.818 . . . . 2.1600000000000001 110.709 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.8 ' HB ' ' CH2' ' A' ' 24' ' ' TRP . 23.3 p -121.94 99.18 6.3 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.618 0.723 . . . . 1.8200000000000001 109.862 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.7 m -148.27 144.62 27.75 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.497 -0.774 . . . . 2.1899999999999999 111.149 -165.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.33 -45.31 3.02 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.793 -0.639 . . . . 1.1000000000000001 114.12 169.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.8 ' CH2' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -82.59 -157.22 0.2 Allowed 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 113.137 0.792 . . . . 1.6699999999999999 113.137 -172.386 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.987 ' HE3' ' HA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER 179.36 149.55 0.28 Allowed 'General case' 0 CA--C 1.494 -1.184 0 CA-C-N 115.161 -0.927 . . . . 2.9500000000000002 110.087 -165.099 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 3.3 m -60.16 124.97 15.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 114.397 -1.274 . . . . 1.5600000000000001 112.068 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.664 HG11 ' HE2' ' A' ' 48' ' ' TYR . 14.4 p -98.36 -25.46 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 114.262 -1.336 . . . . 1.22 108.22 174.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.486 ' HD2' ' HA ' ' A' ' 28' ' ' LYS . 20.8 tptt -154.68 149.39 26.52 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 119.672 -0.811 . . . . 2.4100000000000001 111.262 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.592 HG22 ' HA ' ' A' ' 34' ' ' THR . 34.4 p -145.36 151.63 38.59 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.715 -0.675 . . . . 1.3799999999999999 109.755 175.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.665 ' O ' ' HG2' ' A' ' 31' ' ' LYS . 42.3 m -128.59 44.97 2.86 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.851 0.357 . . . . 2.3700000000000001 110.489 175.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.665 ' HG2' ' O ' ' A' ' 30' ' ' SER . 0.1 OUTLIER 62.38 19.81 11.37 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.509 1.123 . . . . 4.5499999999999998 112.001 169.251 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.467 ' HD2' ' HA ' ' A' ' 32' ' ' LYS . 35.6 tptt -174.63 -20.93 0.01 OUTLIER 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.569 0.7 . . . . 1.4199999999999999 109.885 175.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.829 HG22 ' HA3' ' A' ' 52' ' ' GLY . 41.8 pt -117.64 156.32 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.805 -1.089 . . . . 0.76000000000000001 109.517 171.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.592 ' HA ' HG22 ' A' ' 29' ' ' THR . 88.4 m -151.54 115.33 4.91 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.648 -0.706 . . . . 0.57999999999999996 110.408 -164.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.663 HG12 HG12 ' A' ' 50' ' ' VAL . 6.3 m -113.12 118.13 57.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.106 0.479 . . . . 0.85999999999999999 112.009 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 2.7 p -101.15 128.48 47.22 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.552 -0.749 . . . . 1.1000000000000001 110.645 177.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.594 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 42.5 t -106.71 128.4 54.17 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.161 -0.927 . . . . 1.27 111.058 -171.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.459 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 21.9 ttpp . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 116.335 -0.393 . . . . 1.9099999999999999 111.015 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.418 ' HB2' ' CE1' ' A' ' 48' ' ' TYR . 18.0 m120 . . . . . 0 C--O 1.227 -0.113 0 N-CA-C 109.957 -0.386 . . . . 2.0499999999999998 109.957 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.56 HD23 ' N ' ' A' ' 48' ' ' TYR . 3.2 tt -98.59 135.27 40.36 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.25 -1.019 . . . . 0.87 108.25 177.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.664 ' HE2' HG11 ' A' ' 27' ' ' VAL . 60.1 m-85 -122.58 123.61 41.59 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.925 0.393 . . . . 0.98999999999999999 110.336 -173.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.593 ' HD3' ' CD2' ' A' ' 170' ' ' PHE . 0.0 OUTLIER -99.02 103.38 15.32 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.129 -0.693 . . . . 2.9199999999999999 109.129 178.361 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.729 HG22 ' HB3' ' A' ' 169' ' ' MET . 0.9 OUTLIER -85.92 150.13 4.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 108.745 -0.835 . . . . 1.3300000000000001 108.745 178.477 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.856 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 74.1 tt0 -158.76 108.1 1.96 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.103 0.477 . . . . 1.0700000000000001 110.0 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.829 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -145.33 145.08 13.95 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.846 -0.902 . . . . 0.28999999999999998 110.846 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 66.2 mt -89.07 126.41 42.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 117.623 0.711 . . . . 0.57999999999999996 111.249 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 55' ' ' PRO . 44.9 mt -106.65 110.27 63.64 Favored Pre-proline 0 N--CA 1.447 -0.607 0 CA-C-N 115.995 -0.548 . . . . 0.34999999999999998 109.797 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 54' ' ' ILE . 9.8 Cg_endo -52.1 66.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.477 0.511 1 C-N-CA 125.729 4.286 . . . . 0.62 113.598 174.574 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.627 ' HG2' HG13 ' A' ' 203' ' ' ILE . 10.1 tp10 -165.02 171.57 13.78 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.17 -1.048 . . . . 1.6799999999999999 108.17 174.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.45 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 83.6 p -80.5 141.32 52.53 Favored Pre-proline 0 N--CA 1.428 -1.56 0 CA-C-O 121.477 0.656 . . . . 1.1799999999999999 109.849 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.738 ' HA ' HD12 ' A' ' 61' ' ' LEU . 8.7 Cg_endo -51.7 -15.22 2.69 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 124.528 3.485 . . . . 0.52000000000000002 111.734 171.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.53 -44.75 41.95 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.464 -0.789 . . . . 0.64000000000000001 111.037 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.617 ' HE3' ' HA ' ' A' ' 60' ' ' LYS . 2.2 tpmt? -69.53 -30.64 68.52 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.028 -1.101 . . . . 3.2999999999999998 108.028 178.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.011 HD23 HD13 ' A' ' 203' ' ' ILE . 94.0 mt -61.88 -57.73 10.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.33 -1.305 . . . . 0.40999999999999998 110.73 175.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.482 ' HB3' ' HB3' ' A' ' 125' ' ' ASN . 17.4 p -64.73 -9.75 22.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.196 0.522 . . . . 1.29 110.507 176.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -89.24 -30.91 18.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.86 -0.609 . . . . 1.3200000000000001 111.957 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.705 ' HD2' ' CZ2' ' A' ' 74' ' ' TRP . 18.7 p90 -89.84 -43.4 10.65 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 120.152 -0.619 . . . . 0.60999999999999999 111.828 -172.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.685 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -90.77 5.54 47.89 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 120.371 -0.532 . . . . 1.5 112.061 -173.597 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.418 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 9.7 t80 -27.72 -69.58 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 O-C-N 124.743 1.277 . . . . 1.52 113.095 -167.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.483 ' HA ' ' CZ ' ' A' ' 71' ' ' ARG . 7.3 tt0 -175.1 -40.81 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 114.13 1.159 . . . . 3.6000000000000001 114.13 173.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.8 t -155.06 7.13 0.26 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.527 0.936 . . . . 1.48 113.527 -163.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -116.6 0.26 20.17 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 118.709 -1.71 . . . . 1.46 115.209 -169.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.635 ' O ' HG22 ' A' ' 73' ' ' THR . 38.2 t70 -178.15 -27.82 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.385 0.592 . . . . 2.1899999999999999 110.562 -177.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.648 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -55.29 -34.97 64.59 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 115.478 -0.783 . . . . 3.3799999999999999 111.302 -172.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.803 HG22 HD13 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -92.77 -7.78 10.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.744 -0.382 . . . . 0.70999999999999996 111.077 -175.904 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.635 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.3 t -88.19 -27.96 21.5 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 119.914 -0.714 . . . . 0.96999999999999997 109.743 -176.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.705 ' CZ2' ' HD2' ' A' ' 64' ' ' PHE . 29.4 p-90 -101.45 -8.88 21.59 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.168 -0.613 . . . . 0.75 111.282 177.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.704 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 27.6 t0 -87.36 159.3 18.78 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 114.286 1.217 . . . . 2.1899999999999999 114.286 -165.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.75 -26.17 14.43 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 112.637 -2.074 . . . . 3.1899999999999999 111.268 -176.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.2 m -105.83 -3.43 21.94 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.004 -0.739 . . . . 1.5800000000000001 109.004 -173.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.803 HD13 HG22 ' A' ' 72' ' ' ILE . 72.6 mt -110.47 159.17 17.74 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.902 -1.045 . . . . 0.70999999999999996 111.354 -174.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.554 ' CG ' ' HG3' ' A' ' 99' ' ' GLN . 9.8 mm-40 -138.9 -62.52 0.55 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.949 -1.023 . . . . 1.73 111.403 -176.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.545 HG23 ' HB3' ' A' ' 79' ' ' GLN . 23.6 t -140.48 124.72 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.439 -0.346 . . . . 0.78000000000000003 111.047 -167.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -95.5 148.61 22.31 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 122.984 0.514 . . . . 5.4000000000000004 110.987 175.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.744 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 18.2 m120 -156.91 108.1 2.38 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.651 -0.5 . . . . 1.6899999999999999 109.651 169.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.471 ' CG ' ' HD3' ' A' ' 86' ' ' ARG . 0.7 OUTLIER -66.82 103.58 1.15 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.953 -0.758 . . . . 2.0499999999999998 108.953 177.089 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.714 HG12 ' HG2' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -80.8 -82.15 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 121.167 0.508 . . . . 0.64000000000000001 110.513 -173.298 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.604 ' HB3' HD12 ' A' ' 93' ' ' ILE . 9.3 t60 -126.12 104.86 8.47 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.541 -0.754 . . . . 1.96 109.273 -172.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.471 ' HD3' ' CG ' ' A' ' 83' ' ' MET . 47.5 mtm180 -92.75 115.23 27.92 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.437 -0.579 . . . . 2.4399999999999999 109.437 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.609 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -80.21 -40.56 20.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.476 -0.784 . . . . 0.46999999999999997 110.925 -169.725 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.419 ' CG ' ' H ' ' A' ' 89' ' ' SER . 12.4 t70 -151.63 -162.73 1.59 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.012 -0.736 . . . . 1.8600000000000001 109.012 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.419 ' H ' ' CG ' ' A' ' 88' ' ' ASP . 34.1 t -76.23 -17.64 59.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 117.944 0.338 . . . . 1.4399999999999999 111.368 -174.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.2 p30 -136.08 17.2 3.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.825 0.345 . . . . 1.8700000000000001 110.792 -175.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.609 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -129.77 107.07 9.13 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.365 -0.976 . . . . 0.46000000000000002 108.365 -178.383 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.605 ' O ' HD12 ' A' ' 114' ' ' LEU . 27.2 m-85 -125.44 170.92 10.91 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.314 0.578 . . . . 0.42999999999999999 111.135 -172.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.667 ' O ' HG23 ' A' ' 84' ' ' VAL . 16.9 mt -137.36 121.56 23.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 107.409 -1.33 . . . . 0.40999999999999998 107.409 170.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 14.3 t -111.92 127.84 55.97 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.244 0.545 . . . . 2.0099999999999998 111.26 -176.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.744 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 9.2 t-80 -81.66 83.11 7.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.753 0.787 . . . . 1.23 109.01 169.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 20.0 m -94.03 113.1 25.01 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.579 -1.191 . . . . 0.5 111.342 -177.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.433 ' CG1' ' HB ' ' A' ' 80' ' ' VAL . 43.4 mm -77.02 120.9 28.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 108.63 -0.878 . . . . 1.03 108.63 171.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.1 m -110.98 128.99 56.02 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.023 -0.99 . . . . 1.3799999999999999 111.217 -171.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.554 ' HG3' ' CG ' ' A' ' 79' ' ' GLN . 22.4 mt-30 . . . . . 0 C--N 1.316 -0.886 0 CA-C-N 115.985 -0.552 . . . . 1.8200000000000001 110.644 177.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.429 HG23 ' NH2' ' A' ' 109' ' ' ARG . 77.3 mt . . . . . 0 C--O 1.233 0.212 0 CA-C-O 121.065 0.46 . . . . 1.1200000000000001 112.013 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.4 m -100.34 166.44 12.64 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 108.526 -0.916 . . . . 1.3500000000000001 108.526 170.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -46.32 125.31 8.78 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.035 1.823 . . . . 1.0700000000000001 110.893 173.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.604 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 29.5 ttm180 -102.65 151.99 21.71 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 120.042 -0.663 . . . . 3.4500000000000002 110.141 -167.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.703 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 20.8 t0 -113.01 127.23 56.17 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.736 -0.666 . . . . 1.3700000000000001 109.344 -171.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.427 ' HB2' ' O ' ' A' ' 96' ' ' THR . 3.5 m-30 -113.43 134.13 54.82 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.537 0.684 . . . . 2.4100000000000001 111.305 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 1.081 HG12 ' HD2' ' A' ' 145' ' ' ARG . 35.2 mm -124.36 76.39 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 107.105 -1.443 . . . . 0.42999999999999999 107.105 167.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.541 ' O ' HG12 ' A' ' 115' ' ' VAL . 7.1 p-10 -85.88 115.75 23.7 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.116 -0.947 . . . . 1.8600000000000001 109.994 -176.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 1.078 HD23 ' HE2' ' A' ' 130' ' ' LYS . 11.2 tp -80.65 111.58 17.21 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-O 121.914 0.864 . . . . 0.28000000000000003 109.08 169.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.541 HG12 ' O ' ' A' ' 113' ' ' ASP . 0.1 OUTLIER -119.09 125.31 74.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-N 113.841 -1.527 . . . . 0.26000000000000001 111.544 -163.303 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.84 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 11.5 t80 -104.83 112.71 25.92 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 115.114 -0.948 . . . . 2.5699999999999998 110.054 172.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.825 HG12 HG22 ' A' ' 127' ' ' ILE . 73.7 mt -94.14 99.57 9.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.639 -0.71 . . . . 0.89000000000000001 109.607 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.522 ' HD2' ' CZ ' ' A' ' 120' ' ' TYR . 35.9 ttmt -118.14 141.02 48.93 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.931 -0.577 . . . . 1.2 109.872 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.481 ' HD2' ' O ' ' A' ' 119' ' ' ARG . 7.9 tmm_? -118.75 98.08 6.04 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.966 -0.753 . . . . 2.7999999999999998 108.966 177.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.59 ' CB ' ' HB3' ' A' ' 123' ' ' ASN . 96.5 m-85 -64.66 114.05 4.15 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.631 -1.248 . . . . 0.82999999999999996 107.631 172.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -37.21 99.07 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 O-C-N 124.572 1.17 . . . . 2.2799999999999998 112.688 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 56.59 34.12 63.71 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 114.159 -1.382 . . . . 0.76000000000000001 112.708 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.59 ' HB3' ' CB ' ' A' ' 120' ' ' TYR . 4.6 t-20 -127.48 -49.1 1.41 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.174 -0.513 . . . . 1.6499999999999999 110.266 -177.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.579 ' HG2' ' HB ' ' A' ' 154' ' ' VAL . 3.9 ttm -163.08 133.76 4.65 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 120.323 -0.551 . . . . 1.1200000000000001 112.127 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.482 ' HB3' ' HB3' ' A' ' 62' ' ' SER . 13.9 m120 -104.63 78.97 1.5 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.23 -1.026 . . . . 1.6200000000000001 108.23 174.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.65 ' CG1' HG12 ' A' ' 154' ' ' VAL . 0.5 OUTLIER -103.91 139.77 23.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 113.387 0.884 . . . . 0.29999999999999999 113.387 -169.21 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.825 HG22 HG12 ' A' ' 117' ' ' ILE . 25.7 pt -108.84 111.42 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 108.907 -0.775 . . . . 0.58999999999999997 108.907 163.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.52 ' OG ' ' HB3' ' A' ' 116' ' ' TYR . 13.4 p -97.29 109.4 22.16 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.46 0.647 . . . . 1.1799999999999999 110.957 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.604 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 5.5 p -113.55 155.8 24.75 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.817 -0.628 . . . . 1.24 111.86 -168.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 1.078 ' HE2' HD23 ' A' ' 114' ' ' LEU . 14.8 mtmm -140.74 134.18 29.91 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 108.132 -1.062 . . . . 2.2599999999999998 108.132 173.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.457 ' HB3' ' H ' ' A' ' 148' ' ' ASN . 41.1 p -69.79 96.33 0.98 Allowed 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.955 -1.128 . . . . 1.3899999999999999 107.955 174.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.453 HG11 ' HE2' ' A' ' 3' ' ' PHE . 2.3 t -107.56 124.01 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 CA-C-N 114.534 -1.212 . . . . 1.05 110.788 -163.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -98.19 48.68 1.0 Allowed 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 113.264 -1.789 . . . . 2.1699999999999999 109.735 -165.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.813 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 1.5 p90 -81.68 159.14 67.21 Favored Pre-proline 0 C--N 1.313 -0.983 0 CA-C-N 113.343 -1.753 . . . . 0.53000000000000003 110.549 -171.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.484 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 1.9 Cg_endo -47.84 -42.1 31.28 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.672 2.915 . . . . 1.28 115.709 -172.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.813 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 18.0 tt0 -70.27 -11.82 61.17 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 111.824 0.305 . . . . 3.5 111.824 -162.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.516 ' HB2' HG11 ' A' ' 84' ' ' VAL . 0.7 OUTLIER -157.3 99.74 1.93 Allowed Pre-proline 0 C--N 1.321 -0.654 0 C-N-CA 119.407 -0.917 . . . . 6.1200000000000001 113.406 177.317 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -90.23 160.93 4.69 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.003 3.135 . . . . 1.77 111.42 171.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.529 ' HB3' ' HB2' ' A' ' 145' ' ' ARG . 87.3 Cg_endo -94.58 -161.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.91 2.407 . . . . 1.25 113.361 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.5 t -148.52 -157.47 0.82 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.585 -0.895 . . . . 1.6000000000000001 108.585 -178.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.1 p -89.98 -36.72 14.8 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.617 -0.433 . . . . 1.97 111.397 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.31 -35.59 58.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.9 0.381 . . . . 2.1800000000000002 110.171 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.703 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 99.2 m-85 -107.71 111.39 23.56 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 109.497 -0.557 . . . . 1.23 109.497 -178.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.604 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 1.1 tp -98.38 112.88 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 N-CA-C 108.87 -0.789 . . . . 0.81999999999999995 108.87 -176.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 1.081 ' HD2' HG12 ' A' ' 112' ' ' ILE . 2.6 tpp85 -60.16 97.44 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.323 -0.992 . . . . 4.4199999999999999 108.323 173.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -64.38 133.8 38.98 Favored Glycine 0 CA--C 1.503 -0.683 0 CA-C-N 115.575 -0.739 . . . . 0.79000000000000004 112.288 -171.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.47 ' HB2' ' HG2' ' A' ' 174' ' ' GLU . 2.6 m-85 -83.74 79.25 9.52 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 122.308 1.052 . . . . 4.4400000000000004 112.115 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.482 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 5.8 t30 -80.74 83.34 6.52 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 113.45 -1.705 . . . . 1.6200000000000001 108.407 167.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.513 ' HB3' ' HD2' ' A' ' 150' ' ' PRO . 96.6 m-70 -49.63 161.3 0.52 Allowed Pre-proline 0 C--O 1.219 -0.534 0 CA-C-O 118.628 -0.701 . . . . 2.3199999999999998 109.755 175.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 149' ' ' HIS . 5.7 Cg_endo -47.5 75.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 124.276 3.318 . . . . 0.53000000000000003 114.135 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' CYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 170' ' ' PHE . 25.4 p -138.61 167.61 21.57 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.057 -1.46 . . . . 1.5800000000000001 107.057 175.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.71 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -153.69 -138.74 2.72 Favored Glycine 0 N--CA 1.433 -1.562 0 C-N-CA 118.733 -1.699 . . . . 0.42999999999999999 113.51 -167.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.464 ' HB3' ' CG1' ' A' ' 127' ' ' ILE . 63.3 t80 -163.06 93.19 0.79 Allowed 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 107.949 -1.13 . . . . 0.59999999999999998 107.949 -163.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.729 HG23 HG13 ' A' ' 168' ' ' VAL . 7.7 m -102.81 138.29 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-O 121.88 0.848 . . . . 0.31 110.653 -176.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' CYS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 125' ' ' ASN . 71.4 m -112.13 110.56 20.9 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.252 -0.885 . . . . 1.55 109.296 175.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.777 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 16.4 m -101.38 122.21 48.9 Favored Pre-proline 0 C--N 1.318 -0.766 0 C-N-CA 120.602 -0.439 . . . . 1.0600000000000001 111.256 -169.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.52 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 51.4 Cg_exo -55.49 115.06 2.18 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.12 1.88 . . . . 0.56000000000000005 110.689 170.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.524 ' SD ' ' HB2' ' A' ' 166' ' ' LYS . 74.6 mmm -75.08 -172.11 1.57 Allowed 'General case' 0 CA--C 1.505 -0.763 0 C-N-CA 120.765 -0.374 . . . . 1.1599999999999999 110.75 -177.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -69.85 -31.64 69.6 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 108.537 -0.912 . . . . 2.6299999999999999 108.537 170.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 2.6 mm-40 -98.3 27.85 4.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.928 -1.033 . . . . 2.0499999999999998 108.79 175.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.576 ' OD1' ' HD3' ' A' ' 162' ' ' PRO . 5.5 p30 -36.52 -47.37 1.6 Allowed Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 116.226 1.936 . . . . 1.9299999999999999 116.226 -166.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.576 ' HD3' ' OD1' ' A' ' 161' ' ' ASN . 72.8 Cg_endo -75.54 -14.57 19.96 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 CA-C-N 121.621 1.615 . . . . 0.72999999999999998 113.208 -175.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -111.62 -27.31 8.61 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.001 0.429 . . . . 0.68000000000000005 110.657 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.583 ' HB2' ' HB2' ' A' ' 160' ' ' GLU . 66.4 m-85 -140.65 131.77 26.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.512 -0.767 . . . . 0.93000000000000005 109.546 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.66 ' HB2' ' HD3' ' A' ' 58' ' ' PRO . 17.5 t -126.99 152.92 46.57 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.843 -0.743 . . . . 1.4099999999999999 111.125 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.856 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.8 tppp? -91.69 104.35 16.83 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.51 -0.768 . . . . 0.73999999999999999 111.509 -176.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.605 HD12 HG12 ' A' ' 196' ' ' ILE . 0.7 OUTLIER -84.8 100.91 11.85 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.066 -0.97 . . . . 0.27000000000000002 108.883 174.514 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.761 HG12 ' HG3' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -124.5 128.92 73.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.667 0.746 . . . . 0.28000000000000003 110.8 178.025 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.729 ' HB3' HG22 ' A' ' 50' ' ' VAL . 25.2 ttt -132.51 162.49 31.1 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.858 -0.793 . . . . 1.24 108.858 -171.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.655 ' HE1' HG13 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -139.51 108.24 5.94 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.323 -1.362 . . . . 3.3700000000000001 107.323 -173.468 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.447 HG13 ' OG1' ' A' ' 173' ' ' THR . 30.6 t -106.45 98.3 6.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 124.044 0.84 . . . . 1.3999999999999999 109.878 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.496 ' HB2' ' HG ' ' A' ' 47' ' ' LEU . 49.9 tt0 -100.1 11.98 38.04 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 106.909 -1.515 . . . . 2.1699999999999999 106.909 173.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 1.1 m -61.09 127.29 30.79 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.207 -1.815 . . . . 1.6499999999999999 110.534 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.47 ' HG2' ' HB2' ' A' ' 147' ' ' TYR . 13.0 pt-20 . . . . . 0 CA--C 1.514 -0.431 0 N-CA-C 108.375 -0.972 . . . . 2.4500000000000002 108.375 175.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.423 ' HA ' ' HE2' ' A' ' 186' ' ' LYS . 31.2 mm . . . . . 0 CA--C 1.515 -0.401 0 CA-C-O 122.467 1.127 . . . . 1.1200000000000001 108.9 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.992 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.2 mp -68.05 -36.87 77.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 113.073 -1.876 . . . . 1.1299999999999999 111.555 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -63.94 -17.98 63.8 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.112 -0.699 . . . . 2.8900000000000001 109.112 177.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.423 ' HE2' ' HA ' ' A' ' 183' ' ' ILE . 51.4 mtmt -93.04 -45.28 7.99 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.381 -0.827 . . . . 1.28 109.919 172.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.992 HG22 ' HA ' ' A' ' 184' ' ' ILE . 6.8 t -63.58 -30.23 71.38 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.329 0.492 . . . . 0.62 112.329 -169.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' MET . . . . . 0.712 ' O ' ' HG ' ' A' ' 192' ' ' LEU . 0.2 OUTLIER -75.13 -63.39 0.72 Allowed Pre-proline 0 C--N 1.33 -0.244 0 C-N-CA 120.956 -0.298 . . . . 1.0600000000000001 110.877 179.524 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.515 ' HD3' ' CB ' ' A' ' 188' ' ' MET . 32.2 Cg_exo -59.03 -33.62 98.77 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.275 1.984 . . . . 0.91000000000000003 112.367 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.708 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 9.3 t -71.21 -22.61 61.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.825 0.345 . . . . 1.5 110.407 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -91.83 -43.68 9.38 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.031 -0.532 . . . . 1.8799999999999999 110.733 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.712 ' HG ' ' O ' ' A' ' 188' ' ' MET . 51.7 mt -53.11 -59.39 4.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.575 -0.739 . . . . 1.0900000000000001 111.703 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.477 ' O ' ' HG ' ' A' ' 197' ' ' LEU . 1.1 m -73.91 -30.57 28.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.089 -0.96 . . . . 0.68000000000000005 109.345 -171.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.708 ' HB2' ' O ' ' A' ' 190' ' ' SER . 1.0 OUTLIER -67.79 -44.15 78.06 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 114.04 -1.436 . . . . 2.0699999999999998 110.315 179.128 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.592 ' O ' ' HB2' ' A' ' 198' ' ' ASN . 0.9 OUTLIER -59.91 -27.42 66.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.045 0.45 . . . . 2.0 110.728 176.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.702 HG21 HG21 ' A' ' 33' ' ' ILE . 33.7 mt -79.27 -31.03 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 120.983 0.42 . . . . 0.31 111.286 173.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 94.7 mt -75.68 -30.7 59.45 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.235 0.54 . . . . 1.03 110.026 176.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.592 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 7.6 m-20 -47.22 -47.43 24.45 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.712 -1.131 . . . . 1.8999999999999999 107.967 162.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.655 ' HA ' ' CE2' ' A' ' 64' ' ' PHE . . . -77.54 -44.84 27.27 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 115.005 -0.998 . . . . 0.28999999999999998 111.292 -173.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 31.5 mmtp -54.63 -41.84 70.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.527 0.679 . . . . 0.96999999999999997 110.696 175.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ASP . . . . . 0.538 ' HA ' ' HE3' ' A' ' 204' ' ' LYS . 2.2 t70 -84.37 -47.62 10.52 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.969 -1.014 . . . . 1.9399999999999999 110.094 -175.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' GLY . . . . . 0.501 ' HA2' ' HB3' ' A' ' 205' ' ' ALA . . . -63.25 -29.33 74.14 Favored Glycine 0 N--CA 1.459 0.232 0 C-N-CA 120.726 -0.749 . . . . 0.46999999999999997 112.489 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 1.011 HD13 HD23 ' A' ' 61' ' ' LEU . 3.0 tp -69.79 -38.58 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-O 120.848 0.356 . . . . 0.60999999999999999 110.453 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.538 ' HE3' ' HA ' ' A' ' 201' ' ' ASP . 0.0 OUTLIER -90.59 -17.16 27.41 Favored 'General case' 0 C--O 1.207 -1.169 0 N-CA-C 109.284 -0.635 . . . . 3.3700000000000001 109.284 177.291 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.501 ' HB3' ' HA2' ' A' ' 202' ' ' GLY . . . . . . . . 0 C--N 1.318 -0.79 0 N-CA-C 109.171 -0.677 . . . . 1.02 109.171 168.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.469 ' O ' HD12 ' A' ' 6' ' ' ILE . 15.2 t70 . . . . . 0 CA--C 1.509 -0.621 0 N-CA-C 109.313 -0.625 . . . . 2.25 109.313 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.536 ' HA ' HD12 ' A' ' 6' ' ' ILE . 70.5 m-85 -59.55 -34.82 73.16 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.667 0.746 . . . . 0.42999999999999999 109.598 -177.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.502 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 45.1 tttt -70.48 -42.47 71.37 Favored 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 114.644 -1.162 . . . . 1.51 108.085 -178.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.89 -41.9 62.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.844 -0.617 . . . . 0.54000000000000004 111.616 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.677 ' O ' ' HB ' ' A' ' 10' ' ' THR . 1.3 mp -79.26 -48.15 21.57 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 N-CA-C 108.714 -0.847 . . . . 1.0700000000000001 108.714 -175.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.968 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -57.54 -47.42 82.06 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.779 -1.1 . . . . 0.34000000000000002 111.974 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.502 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 13.1 mt-30 -60.34 -36.22 77.48 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 113.889 -1.505 . . . . 1.5900000000000001 111.631 -176.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.27 -18.16 26.13 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.396 -0.82 . . . . 2.4700000000000002 109.506 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.677 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -83.18 -38.6 22.11 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.19 -0.914 . . . . 0.47999999999999998 111.233 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.429 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -49.54 -59.89 3.35 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-O 121.218 0.532 . . . . 0.31 110.81 176.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -67.4 -11.54 58.0 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.284 -0.871 . . . . 1.6399999999999999 111.787 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.62 ' HB3' ' HA ' ' A' ' 10' ' ' THR . 0.6 OUTLIER -87.3 -42.11 13.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 110.267 -0.272 . . . . 2.54 110.267 -179.164 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.783 HG11 ' HA3' ' A' ' 152' ' ' GLY . 0.4 OUTLIER -75.48 -34.16 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 122.305 1.05 . . . . 0.53000000000000003 108.539 177.617 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.547 HD11 ' SD ' ' A' ' 124' ' ' MET . 0.6 OUTLIER -68.39 -29.29 67.95 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 114.32 -1.309 . . . . 0.59999999999999998 108.379 172.305 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 20' ' ' ASP . . . -64.99 -17.93 63.91 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 113.571 -1.65 . . . . 0.56999999999999995 110.706 177.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.636 ' CD2' ' HA ' ' A' ' 14' ' ' VAL . 23.6 m-85 -84.6 -26.25 28.04 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 109.427 -0.583 . . . . 3.27 109.427 176.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.501 ' HB2' ' CZ ' ' A' ' 170' ' ' PHE . 2.6 t30 -72.09 -15.75 62.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.768 -0.651 . . . . 2.0299999999999998 110.086 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -116.31 10.97 14.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.456 -0.793 . . . . 2.7200000000000002 110.467 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.502 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 27.5 t70 -111.36 107.22 16.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.943 -0.571 . . . . 2.1600000000000001 110.684 -176.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.514 HG22 ' CZ2' ' A' ' 24' ' ' TRP . 53.3 p -125.87 112.75 16.35 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.624 0.25 . . . . 1.8200000000000001 110.642 -176.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.2 p -177.5 117.65 0.1 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.861 -0.609 . . . . 2.1899999999999999 111.817 -168.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.3 33.89 82.46 Favored Glycine 0 C--O 1.23 -0.144 0 C-N-CA 121.337 -0.458 . . . . 1.1000000000000001 113.404 173.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.514 ' CZ2' HG22 ' A' ' 21' ' ' THR . 0.1 OUTLIER -119.97 -168.28 1.58 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.289 -0.634 . . . . 1.6699999999999999 109.289 177.928 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 36' ' ' SER . 8.0 mtmm -174.95 156.42 2.2 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 107.999 -1.111 . . . . 2.9500000000000002 107.999 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 2.3 p -78.46 119.64 27.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-O 121.817 0.817 . . . . 1.5600000000000001 109.25 175.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 35' ' ' VAL . 8.2 p -86.61 -24.76 6.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 114.845 -1.07 . . . . 1.22 109.382 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 28' ' ' LYS . 9.1 tppt? -172.31 150.73 2.41 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.634 0.605 . . . . 2.4100000000000001 112.634 -176.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.706 HG22 ' HA ' ' A' ' 34' ' ' THR . 69.3 p -134.43 148.42 50.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.553 -0.749 . . . . 1.3799999999999999 109.682 173.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.524 ' H ' ' HB ' ' A' ' 33' ' ' ILE . 50.3 m -152.78 84.1 1.23 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.557 0.577 . . . . 2.3700000000000001 112.557 177.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 30' ' ' SER . 3.2 mptp? 79.66 71.31 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.942 0.497 . . . . 4.5499999999999998 111.365 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.483 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 65.2 mttm 73.26 20.87 3.19 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.299 -0.864 . . . . 1.4199999999999999 111.724 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.527 HD12 ' HB ' ' A' ' 193' ' ' VAL . 2.5 mt -108.44 166.78 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.942 0 CA-C-O 121.149 0.499 . . . . 0.76000000000000001 110.771 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.706 ' HA ' HG22 ' A' ' 29' ' ' THR . 48.7 m -158.43 102.54 1.74 Allowed 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.589 -1.187 . . . . 0.57999999999999996 109.304 176.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.491 ' O ' HG12 ' A' ' 27' ' ' VAL . 21.8 t -96.3 103.1 14.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.993 -0.549 . . . . 0.85999999999999999 109.537 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 81.0 p -96.22 123.49 39.87 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.502 0.667 . . . . 1.1000000000000001 110.911 -178.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.0 p -94.36 127.85 40.5 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.762 -1.108 . . . . 1.27 110.898 -176.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt . . . . . 0 C--N 1.32 -0.706 0 CA-C-N 115.624 -0.716 . . . . 1.9099999999999999 110.028 175.664 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.9 m120 . . . . . 0 N--CA 1.445 -0.698 0 CA-C-O 121.024 0.44 . . . . 2.0499999999999998 110.887 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 171' ' ' VAL . 8.4 tt -87.76 140.75 29.19 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.468 -0.938 . . . . 0.87 108.468 173.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.413 ' HB2' HD11 ' A' ' 192' ' ' LEU . 68.7 m-85 -121.52 118.49 29.43 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.658 -0.417 . . . . 0.98999999999999999 110.42 -177.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 49' ' ' ARG . 37.1 ttt-85 -97.5 112.08 24.08 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.121 -0.696 . . . . 2.9199999999999999 109.121 176.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.65 HG13 ' HB3' ' A' ' 169' ' ' MET . 0.9 OUTLIER -107.24 119.56 57.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.907 -0.588 . . . . 1.3300000000000001 109.97 -172.848 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.564 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 35.9 tt0 -134.5 117.15 15.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.028 -0.533 . . . . 1.0700000000000001 111.296 -166.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 32' ' ' LYS . . . -145.66 144.75 13.37 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 121.05 -0.595 . . . . 0.28999999999999998 111.643 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 78.9 mt -86.09 131.5 34.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 117.249 0.525 . . . . 0.57999999999999996 111.175 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.447 HD13 ' HB1' ' A' ' 199' ' ' ALA . 55.5 mt -110.46 108.24 58.37 Favored Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-N 115.493 -0.776 . . . . 0.34999999999999998 109.034 176.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 164' ' ' TYR . 38.8 Cg_exo -62.37 56.12 0.13 Allowed 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 124.422 3.415 . . . . 0.62 115.393 -173.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.437 ' HB2' ' H ' ' A' ' 57' ' ' SER . 0.9 OUTLIER -164.35 -162.97 0.71 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.876 -0.416 . . . . 1.6799999999999999 109.876 167.75 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.437 ' H ' ' HB2' ' A' ' 56' ' ' GLU . 78.2 p -77.45 138.12 63.6 Favored Pre-proline 0 N--CA 1.431 -1.424 0 CA-C-O 121.918 0.866 . . . . 1.1799999999999999 112.135 -168.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.57 ' HA ' HD12 ' A' ' 61' ' ' LEU . 18.1 Cg_exo -62.44 -13.6 34.03 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.504 2.802 . . . . 0.52000000000000002 109.899 172.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.46 -53.38 19.51 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.194 -1.366 . . . . 0.64000000000000001 110.964 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.422 ' HB3' ' HE2' ' A' ' 60' ' ' LYS . 15.1 ttpt -68.62 -27.55 66.12 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.244 -1.021 . . . . 3.2999999999999998 108.244 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.983 HD23 HD13 ' A' ' 203' ' ' ILE . 28.9 mt -56.99 -60.45 3.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.159 -0.928 . . . . 0.40999999999999998 110.409 170.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.8 p -62.57 -15.9 53.5 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 121.81 -0.556 . . . . 1.29 110.839 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -92.36 -26.73 17.94 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.048 0.758 . . . . 1.3200000000000001 113.048 -176.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.64 ' CE2' ' HA ' ' A' ' 199' ' ' ALA . 6.5 p90 -89.2 -41.48 12.21 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.731 -0.606 . . . . 0.60999999999999999 110.866 -174.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.712 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -92.93 7.92 41.94 Favored 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 120.761 -0.376 . . . . 1.5 110.02 -179.286 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -44.55 -71.53 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.214 -0.903 . . . . 1.52 112.452 -168.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -139.7 -74.42 0.36 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.204 -0.598 . . . . 3.6000000000000001 112.522 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.711 ' HB ' ' CD1' ' A' ' 81' ' ' TYR . 9.0 t -156.77 30.92 0.31 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.753 0.787 . . . . 1.48 110.695 -168.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.0 -46.96 4.02 Favored Glycine 0 CA--C 1.49 -1.487 0 C-N-CA 120.01 -1.091 . . . . 1.46 112.636 -173.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.478 ' O ' HG22 ' A' ' 73' ' ' THR . 19.3 p-10 -152.6 -18.18 0.16 Allowed 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.151 -1.025 . . . . 2.1899999999999999 110.795 -171.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.708 ' HA ' ' CZ2' ' A' ' 74' ' ' TRP . 2.7 ptp180 -48.89 -39.36 25.62 Favored 'General case' 0 C--O 1.218 -0.589 0 C-N-CA 122.759 0.423 . . . . 3.3799999999999999 110.572 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.636 HD13 ' H ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -88.58 -7.91 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 C-N-CA 120.569 -0.453 . . . . 0.70999999999999996 111.242 -175.643 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 70' ' ' ASP . 0.8 OUTLIER -97.0 -32.76 11.84 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 119.791 -0.763 . . . . 0.96999999999999997 111.135 -173.811 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.708 ' CZ2' ' HA ' ' A' ' 71' ' ' ARG . 7.8 p-90 -101.63 -3.49 28.23 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.55 -0.46 . . . . 0.75 111.283 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.696 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 4.8 t70 -65.06 -178.64 0.47 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.869 0.842 . . . . 2.1899999999999999 112.356 -172.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.688 ' HG2' ' OD1' ' A' ' 198' ' ' ASN . 66.8 mmtt -104.56 -33.26 8.6 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.793 -1.094 . . . . 3.1899999999999999 108.852 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.513 ' HA ' ' HB2' ' A' ' 99' ' ' GLN . 16.8 m -134.61 19.52 3.59 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.344 -0.844 . . . . 1.5800000000000001 112.203 -170.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.583 HD13 HG22 ' A' ' 72' ' ' ILE . 27.7 mt -108.17 153.42 23.2 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.026 0.441 . . . . 0.70999999999999996 110.508 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.51 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 26.1 mm-40 -134.28 -67.0 0.59 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.671 -0.695 . . . . 1.73 110.606 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 96' ' ' THR . 2.4 t -136.73 112.01 11.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.674 -0.694 . . . . 0.78000000000000003 110.847 -170.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.711 ' CD1' ' HB ' ' A' ' 68' ' ' THR . 18.0 t80 -98.92 137.79 36.98 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.013 -0.736 . . . . 5.4000000000000004 109.013 175.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -143.16 107.44 4.76 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.442 -0.577 . . . . 1.6899999999999999 109.442 -175.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.487 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 2.8 mtm -66.77 102.25 0.92 Allowed 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.996 -0.742 . . . . 2.0499999999999998 108.996 174.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.545 HG11 ' HZ ' ' A' ' 134' ' ' PHE . 0.3 OUTLIER -72.9 -71.01 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.919 -0.582 . . . . 0.64000000000000001 110.843 -170.075 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -133.19 118.66 18.9 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.677 -0.861 . . . . 1.96 108.677 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.487 ' HD3' ' SD ' ' A' ' 83' ' ' MET . 44.0 mtm180 -93.89 105.27 17.29 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.126 0.489 . . . . 2.4399999999999999 109.965 -175.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.646 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -69.08 -44.45 81.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.355 -0.839 . . . . 0.46999999999999997 110.945 -175.323 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.456 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 15.0 t70 -147.9 168.0 23.37 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.928 -1.033 . . . . 1.8600000000000001 108.253 -173.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.2 m -68.05 -3.67 10.96 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.594 0.235 . . . . 1.4399999999999999 111.112 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -130.77 4.52 4.56 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 110.177 -0.305 . . . . 1.8700000000000001 110.177 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.646 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -133.3 108.79 8.95 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 109.114 -0.698 . . . . 0.46000000000000002 109.114 -172.433 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.65 ' O ' HD12 ' A' ' 114' ' ' LEU . 17.1 m-85 -125.38 174.74 7.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.876 -0.602 . . . . 0.42999999999999999 110.127 -174.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.545 HG21 ' CE1' ' A' ' 134' ' ' PHE . 39.4 mt -131.55 132.79 62.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 107.927 -1.138 . . . . 0.40999999999999998 107.927 171.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.468 ' HB3' ' OH ' ' A' ' 81' ' ' TYR . 23.6 p -110.93 106.26 15.32 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.585 -0.446 . . . . 2.0099999999999998 111.961 -171.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.587 ' HA ' ' O ' ' A' ' 111' ' ' PHE . 2.1 t60 -81.23 90.06 6.07 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.441 -0.948 . . . . 1.23 108.441 167.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.633 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 35.0 m -115.47 114.58 25.22 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.555 -0.748 . . . . 0.5 111.938 -171.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 38.1 mm -76.52 121.98 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 109.01 -0.737 . . . . 1.03 109.01 174.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.464 ' HB ' ' O ' ' A' ' 109' ' ' ARG . 25.7 m -109.4 143.73 38.58 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.544 -1.207 . . . . 1.3799999999999999 109.861 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.513 ' HB2' ' HA ' ' A' ' 77' ' ' SER . 22.2 mt-30 . . . . . 0 C--N 1.323 -0.578 0 CA-C-N 115.693 -0.685 . . . . 1.8200000000000001 111.625 -176.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 73.6 mt . . . . . 0 N--CA 1.451 -0.397 0 CA-C-O 121.163 0.506 . . . . 1.1200000000000001 111.159 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.475 ' OG ' ' HD2' ' A' ' 108' ' ' PRO . 32.4 t -92.19 159.83 36.6 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.354 -0.839 . . . . 1.3500000000000001 109.25 178.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.475 ' HD2' ' OG ' ' A' ' 107' ' ' SER . 97.2 Cg_exo -44.63 142.37 4.85 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.44 2.093 . . . . 1.0700000000000001 111.374 171.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.714 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 29.1 ttp-105 -126.21 130.8 51.67 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.545 -0.462 . . . . 3.4500000000000002 109.879 -167.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.554 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 9.1 t0 -104.73 125.07 50.45 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.736 -0.468 . . . . 1.3700000000000001 109.736 -176.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.633 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 12.0 m-30 -95.97 143.65 26.96 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.244 0.545 . . . . 2.4100000000000001 110.621 -172.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.642 ' CG2' ' HE1' ' A' ' 134' ' ' PHE . 26.9 mm -138.36 61.2 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 107.085 -1.45 . . . . 0.42999999999999999 107.085 170.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.494 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 45.7 m-20 -96.46 125.41 40.93 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.658 -1.156 . . . . 1.8600000000000001 109.766 -175.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.65 HD12 ' O ' ' A' ' 92' ' ' PHE . 7.7 tp -75.22 126.89 31.94 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.988 -0.551 . . . . 0.28000000000000003 109.524 173.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -127.01 128.18 70.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.596 -0.729 . . . . 0.26000000000000001 111.929 -165.475 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.968 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 7.7 t80 -113.15 114.23 26.5 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.156 -0.929 . . . . 2.5699999999999998 110.324 175.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.649 HG12 HG22 ' A' ' 127' ' ' ILE . 71.9 mt -90.41 99.29 9.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.84 -0.618 . . . . 0.89000000000000001 109.401 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.507 ' HB3' HG23 ' A' ' 126' ' ' ILE . 15.4 tppt? -102.4 123.06 45.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.572 -0.74 . . . . 1.2 110.948 -173.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -103.07 93.28 4.93 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.869 -0.605 . . . . 2.7999999999999998 109.443 177.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -70.97 106.12 3.54 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 107.181 -1.414 . . . . 0.82999999999999996 107.181 168.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -26.1 92.98 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 O-C-N 125.123 1.514 . . . . 2.2799999999999998 113.631 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 53.7 43.27 68.98 Favored Glycine 0 CA--C 1.508 -0.385 0 CA-C-N 115.316 -0.856 . . . . 0.76000000000000001 112.176 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.662 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 47.9 t30 -139.02 -47.77 0.49 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.054 -0.573 . . . . 1.6499999999999999 110.585 -174.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.547 ' SD ' HD11 ' A' ' 15' ' ' LEU . 2.4 mtt -161.13 121.21 2.69 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 120.953 0.406 . . . . 1.1200000000000001 110.919 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -106.34 75.16 1.07 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.452 -0.944 . . . . 1.6200000000000001 108.452 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.759 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.5 OUTLIER -97.08 141.5 15.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.004 -0.998 . . . . 0.29999999999999999 112.866 -172.173 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.706 ' O ' HG13 ' A' ' 127' ' ' ILE . 6.4 pt -109.45 108.97 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-O 121.756 0.789 . . . . 0.58999999999999997 108.99 163.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 56.4 p -95.25 117.93 31.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.191 0.519 . . . . 1.1799999999999999 110.955 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.565 ' HB2' ' SG ' ' A' ' 151' ' ' CYS . 20.1 m -114.6 151.57 33.25 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.199 0.523 . . . . 1.24 111.458 -174.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.559 ' HZ3' HG21 ' A' ' 10' ' ' THR . 10.3 mtmm -140.92 130.12 23.53 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.787 -0.82 . . . . 2.2599999999999998 108.787 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.445 ' HB3' ' H ' ' A' ' 148' ' ' ASN . 21.7 p -73.76 101.46 3.71 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.832 -0.803 . . . . 1.3899999999999999 108.832 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.3 m -105.72 173.55 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 120.048 -0.661 . . . . 1.05 110.173 -176.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -135.65 65.42 1.54 Allowed 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 122.069 0.938 . . . . 2.1699999999999999 109.354 -174.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.642 ' HE1' ' CG2' ' A' ' 112' ' ' ILE . 1.0 OUTLIER -97.08 153.62 38.44 Favored Pre-proline 0 C--N 1.317 -0.839 0 CA-C-N 114.088 -1.414 . . . . 0.53000000000000003 108.852 -175.644 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -83.39 5.42 6.41 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.082 1.855 . . . . 1.28 116.483 -166.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.602 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 11.8 tp10 -76.06 -15.95 60.02 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 119.253 0.933 . . . . 3.5 108.505 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -156.75 114.73 2.03 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 113.315 0.857 . . . . 6.1200000000000001 113.315 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -95.06 139.43 0.98 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.671 2.914 . . . . 1.77 111.85 169.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -80.6 -165.4 0.34 Allowed 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.608 2.205 . . . . 1.25 112.988 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.1 m -147.62 152.37 37.78 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.94 -1.133 . . . . 1.6000000000000001 107.94 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.1 t -61.45 -16.9 51.47 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.953 0.723 . . . . 1.97 112.953 -167.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -82.72 -18.52 40.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.943 0.402 . . . . 2.1800000000000002 110.94 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.508 ' HB3' ' CB ' ' A' ' 110' ' ' ASP . 94.1 m-85 -130.82 109.15 10.37 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.73 -0.668 . . . . 1.23 109.804 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.714 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 2.1 tp -89.19 115.02 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 CA-C-N 115.795 -0.638 . . . . 0.81999999999999995 109.659 -169.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.554 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 30.3 ttp180 -36.02 115.75 0.35 Allowed 'General case' 0 C--N 1.327 -0.403 0 O-C-N 124.618 1.198 . . . . 4.4199999999999999 111.076 175.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.492 ' H ' ' HA ' ' A' ' 111' ' ' PHE . . . -42.63 108.0 0.13 Allowed Glycine 0 CA--C 1.496 -1.096 0 O-C-N 124.655 1.222 . . . . 0.79000000000000004 112.358 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.661 ' HB2' ' HB3' ' A' ' 174' ' ' GLU . 1.3 p90 -86.01 55.33 3.48 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.201 -0.499 . . . . 4.4400000000000004 111.835 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.703 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 84.5 m-20 -98.64 65.36 1.57 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.489 -0.778 . . . . 1.6200000000000001 110.702 -177.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -54.44 146.2 34.36 Favored Pre-proline 0 N--CA 1.467 0.379 0 CA-C-N 115.843 -0.617 . . . . 2.3199999999999998 110.421 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -10.01 62.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.312 1 C-N-CA 126.853 5.035 . . . . 0.53000000000000003 115.838 -161.915 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 151' ' ' CYS . . . . . 0.703 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 27.6 p -84.19 171.13 13.07 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.347 -1.297 . . . . 1.5800000000000001 109.069 173.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.783 ' HA3' HG11 ' A' ' 14' ' ' VAL . . . -167.8 -168.04 29.35 Favored Glycine 0 N--CA 1.433 -1.552 0 C-N-CA 119.744 -1.217 . . . . 0.42999999999999999 111.854 177.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.651 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 39.9 t80 -162.66 77.01 0.46 Allowed 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 109.064 -0.717 . . . . 0.59999999999999998 109.064 -165.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.759 HG12 ' HB ' ' A' ' 126' ' ' ILE . 3.9 m -89.27 121.6 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 122.034 0.921 . . . . 0.31 110.607 -175.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 32.3 m -100.43 112.74 25.13 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.037 -0.983 . . . . 1.55 108.728 175.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.414 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 7.1 m -106.8 111.43 63.83 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 116.492 -0.322 . . . . 1.0600000000000001 111.406 -171.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.662 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 57.7 Cg_exo -52.16 119.34 5.62 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.421 2.081 . . . . 0.56000000000000005 111.002 168.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.4 ' N ' ' HB3' ' A' ' 161' ' ' ASN . 72.2 mtp -81.37 -169.98 2.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.976 0.417 . . . . 1.1599999999999999 111.348 -176.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -67.28 -30.53 70.42 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.854 -0.795 . . . . 2.6299999999999999 108.854 169.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.423 ' C ' ' HD2' ' A' ' 162' ' ' PRO . 47.1 mm-40 -104.32 28.79 6.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.607 -1.179 . . . . 2.0499999999999998 109.274 175.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.577 ' OD1' ' HD3' ' A' ' 162' ' ' PRO . 4.8 p30 -34.81 -47.82 0.94 Allowed Pre-proline 0 N--CA 1.472 0.643 0 N-CA-C 116.16 1.911 . . . . 1.9299999999999999 116.16 -171.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.577 ' HD3' ' OD1' ' A' ' 161' ' ' ASN . 66.3 Cg_endo -72.51 -25.09 18.27 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 CA-C-N 121.534 1.584 . . . . 0.72999999999999998 112.378 -174.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -100.78 -25.55 14.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.761 -0.654 . . . . 0.68000000000000005 110.919 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 55' ' ' PRO . 73.1 m-85 -142.48 119.99 11.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.986 -0.552 . . . . 0.93000000000000005 110.238 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.449 ' OG ' HD11 ' A' ' 61' ' ' LEU . 13.8 p -114.47 140.83 48.4 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.169 0.509 . . . . 1.4099999999999999 110.972 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.564 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 2.0 tppp? -91.51 104.04 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.892 0.853 . . . . 0.73999999999999999 111.577 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.506 HD21 ' CE2' ' A' ' 153' ' ' PHE . 0.8 OUTLIER -89.49 111.61 22.55 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.87 -1.059 . . . . 0.27000000000000002 109.241 177.756 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.65 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.1 OUTLIER -132.16 116.41 29.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 122.099 0.952 . . . . 0.28000000000000003 111.91 175.094 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.65 ' HB3' HG13 ' A' ' 50' ' ' VAL . 19.4 ttt -112.57 158.99 19.29 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.462 -1.244 . . . . 1.24 108.817 -175.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.667 ' HE1' HG13 ' A' ' 154' ' ' VAL . 0.1 OUTLIER -140.06 151.15 45.17 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 110.47 -0.196 . . . . 3.3700000000000001 110.47 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.517 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 6.6 m -136.87 128.23 42.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 O-C-N 123.385 0.428 . . . . 1.3999999999999999 110.931 173.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -108.15 49.7 0.8 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.106 -1.442 . . . . 2.1699999999999999 107.106 174.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -47.68 130.65 14.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.383 -1.735 . . . . 1.6499999999999999 113.541 -166.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.661 ' HB3' ' HB2' ' A' ' 147' ' ' TYR . 21.9 tt0 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.274 -0.876 . . . . 2.4500000000000002 111.04 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.468 ' HA ' ' CE ' ' A' ' 186' ' ' LYS . 33.0 mm . . . . . 0 CA--C 1.503 -0.864 0 CA-C-O 122.528 1.156 . . . . 1.1200000000000001 108.724 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 1.086 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.4 mp -66.69 -34.14 68.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 112.889 -1.959 . . . . 1.1299999999999999 110.597 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -62.04 -21.33 64.82 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.793 -1.094 . . . . 2.8900000000000001 109.39 174.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.468 ' CE ' ' HA ' ' A' ' 183' ' ' ILE . 50.8 mtmt -92.53 -49.34 6.17 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.382 -0.826 . . . . 1.28 110.222 172.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' THR . . . . . 1.086 HG22 ' HA ' ' A' ' 184' ' ' ILE . 6.5 t -61.55 -35.08 76.74 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.328 0.492 . . . . 0.62 112.328 -168.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' MET . . . . . 0.611 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 2.1 mmt -80.35 -61.24 0.44 Allowed Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 119.921 -0.712 . . . . 1.0600000000000001 111.946 -177.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.611 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 8.0 Cg_exo -73.38 -12.53 25.16 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.03 1.82 . . . . 0.91000000000000003 112.545 -172.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.55 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 11.6 t -91.82 -33.48 14.94 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.784 -0.366 . . . . 1.5 110.311 176.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.2 OUTLIER -81.27 -38.4 26.92 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.44 -0.346 . . . . 1.8799999999999999 110.538 -173.556 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.461 ' HB3' HG11 ' A' ' 50' ' ' VAL . 54.7 mt -67.61 -44.68 77.47 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.888 0.375 . . . . 1.0900000000000001 111.277 -176.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.527 ' HB ' HD12 ' A' ' 33' ' ' ILE . 2.1 m -66.95 -31.94 55.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.54 0.686 . . . . 0.68000000000000005 109.354 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.55 ' HB2' ' O ' ' A' ' 190' ' ' SER . 0.6 OUTLIER -74.34 -27.23 60.59 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.668 -1.151 . . . . 2.0699999999999998 110.628 179.534 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.438 ' O ' ' HB2' ' A' ' 198' ' ' ASN . 2.6 t80 -73.66 -30.27 62.82 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.623 -0.88 . . . . 2.0 108.623 175.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.694 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 17.6 mt -77.25 -34.3 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 116.079 -0.51 . . . . 0.31 110.703 173.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 74.2 mt -67.49 -37.04 82.26 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 121.229 0.538 . . . . 1.03 109.702 174.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.688 ' OD1' ' HG2' ' A' ' 76' ' ' LYS . 22.0 m-20 -50.65 -36.26 34.66 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.718 -1.128 . . . . 1.8999999999999999 109.671 167.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.64 ' HA ' ' CE2' ' A' ' 64' ' ' PHE . . . -81.04 -42.35 21.23 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 115.926 -0.579 . . . . 0.28999999999999998 110.944 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.694 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 10.3 mmmm -58.81 -38.89 79.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.548 0.689 . . . . 0.96999999999999997 110.164 176.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -88.75 -43.54 11.2 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.902 -1.045 . . . . 1.9399999999999999 111.092 -178.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -66.75 -31.52 78.62 Favored Glycine 0 CA--C 1.504 -0.626 0 C-N-CA 121.009 -0.615 . . . . 0.46999999999999997 111.984 -176.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.983 HD13 HD23 ' A' ' 61' ' ' LEU . 4.7 tp -67.67 -34.47 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-O 121.274 0.559 . . . . 0.60999999999999999 110.107 178.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -87.21 -30.63 20.82 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.813 -0.631 . . . . 3.3700000000000001 109.555 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.875 0 CA-C-N 115.353 -0.84 . . . . 1.02 109.231 168.277 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.462 ' O ' HD12 ' A' ' 6' ' ' ILE . 7.5 m-20 . . . . . 0 CA--C 1.503 -0.827 0 CA-C-O 120.744 0.307 . . . . 2.25 110.518 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.67 ' HA ' HD12 ' A' ' 6' ' ' ILE . 81.2 m-85 -60.67 -29.08 69.08 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 115.465 -0.789 . . . . 0.42999999999999999 110.586 -170.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.564 ' HG2' ' HG3' ' A' ' 8' ' ' GLN . 21.0 ttmt -74.05 -37.13 64.38 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 107.952 -1.129 . . . . 1.51 107.952 -174.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.71 -37.23 78.32 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.568 -0.742 . . . . 0.54000000000000004 110.556 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.67 HD12 ' HA ' ' A' ' 3' ' ' PHE . 1.7 mp -82.75 -39.35 15.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.922 0.868 . . . . 1.0700000000000001 109.131 -174.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -75.89 -37.41 58.87 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.275 -1.329 . . . . 0.34000000000000002 111.595 -177.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.564 ' HG3' ' HG2' ' A' ' 4' ' ' LYS . 15.2 mt-30 -65.94 -28.24 68.77 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.346 -0.843 . . . . 1.5900000000000001 109.803 176.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -81.06 -34.89 32.42 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.753 -1.112 . . . . 2.4700000000000002 109.555 174.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.724 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.3 OUTLIER -74.1 -36.5 64.26 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.067 -0.969 . . . . 0.47999999999999998 111.486 -179.25 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.513 ' O ' ' HB3' ' A' ' 15' ' ' LEU . . . -46.14 -53.77 9.83 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-O 120.911 0.386 . . . . 0.31 110.651 172.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -78.81 -1.68 36.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.924 -0.58 . . . . 1.6399999999999999 111.989 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.684 ' HB3' ' HA ' ' A' ' 10' ' ' THR . 0.8 OUTLIER -87.87 -49.45 7.09 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.767 -0.827 . . . . 2.54 108.767 175.389 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.63 HG21 ' N ' ' A' ' 152' ' ' GLY . 13.0 p -69.39 -40.7 80.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 122.237 1.017 . . . . 0.53000000000000003 109.039 178.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.552 HD23 ' HD3' ' A' ' 19' ' ' ARG . 0.9 OUTLIER -73.74 -17.92 61.05 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 114.378 -1.283 . . . . 0.59999999999999998 109.186 175.979 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.55 ' HA2' ' NE ' ' A' ' 19' ' ' ARG . . . -58.0 -32.85 67.35 Favored Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 109.728 -1.349 . . . . 0.56999999999999995 109.728 171.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.496 ' HD1' ' O ' ' A' ' 13' ' ' GLU . 9.5 m-85 -88.05 -15.71 35.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.872 -0.664 . . . . 3.27 109.894 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.485 ' HA ' ' NH1' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -89.43 -19.84 24.66 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 120.414 -0.514 . . . . 2.0299999999999998 110.429 176.363 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.552 ' HD3' HD23 ' A' ' 15' ' ' LEU . 17.2 ptt180 -96.02 -21.58 17.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.35 -0.387 . . . . 2.7200000000000002 111.574 -171.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -130.83 157.23 43.44 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 119.615 -0.834 . . . . 2.1600000000000001 111.174 170.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 71.5 p -136.29 158.09 45.24 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.91 -1.041 . . . . 1.8200000000000001 109.389 -173.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.0 t -170.17 -148.57 0.06 Allowed 'General case' 0 C--O 1.234 0.272 0 C-N-CA 120.083 -0.647 . . . . 2.1899999999999999 111.05 -172.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.73 75.16 0.73 Allowed Glycine 0 C--N 1.331 0.29 0 CA-C-N 116.227 -0.442 . . . . 1.1000000000000001 113.494 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.882 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -109.27 -153.06 0.5 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.4 -0.592 . . . . 1.6699999999999999 109.4 172.203 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.5 ttpt -178.43 126.27 0.11 Allowed 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 108.263 -1.014 . . . . 2.9500000000000002 108.263 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.603 HG11 HG23 ' A' ' 34' ' ' THR . 3.2 m -64.89 123.22 17.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 122.057 0.932 . . . . 1.5600000000000001 110.667 174.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.9 p -93.74 -24.03 5.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 114.353 -1.294 . . . . 1.22 108.271 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.4 tptm -155.44 133.85 11.73 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 119.744 -0.782 . . . . 2.4100000000000001 112.146 -177.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.862 HG22 ' HA ' ' A' ' 34' ' ' THR . 45.9 p -137.07 101.5 4.57 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.274 -0.639 . . . . 1.3799999999999999 109.274 169.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.425 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 13.8 m -140.92 108.69 5.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.278 -0.419 . . . . 2.3700000000000001 110.961 -175.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 30' ' ' SER . 56.7 mttm 79.6 64.46 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.752 0.657 . . . . 4.5499999999999998 111.627 176.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 44.3 tptt 75.33 15.65 2.8 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.101 -0.5 . . . . 1.4199999999999999 112.233 168.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.984 HG22 ' HA3' ' A' ' 52' ' ' GLY . 31.7 pt -135.08 169.96 20.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.551 0.691 . . . . 0.76000000000000001 112.833 -172.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.862 ' HA ' HG22 ' A' ' 29' ' ' THR . 87.7 m -152.15 106.01 3.12 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.572 -1.195 . . . . 0.57999999999999996 110.696 -169.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.956 HG11 HD13 ' A' ' 192' ' ' LEU . 2.3 t -101.95 108.13 23.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.252 -0.431 . . . . 0.85999999999999999 110.31 -177.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 1.6 p -102.96 127.17 50.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.506 0.669 . . . . 1.1000000000000001 111.38 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.2 p -98.02 121.65 40.19 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.12 -0.945 . . . . 1.27 111.385 -174.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.882 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 5.3 ttpp . . . . . 0 C--N 1.325 -0.468 0 CA-C-N 115.992 -0.549 . . . . 1.9099999999999999 112.08 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 CA--C 1.512 -0.519 0 CA-C-O 120.646 0.26 . . . . 2.0499999999999998 110.688 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 1.007 HD12 ' HB2' ' A' ' 172' ' ' GLN . 10.6 tt -86.25 135.55 33.51 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.379 -1.341 . . . . 0.87 107.379 170.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.454 ' HB2' HD21 ' A' ' 192' ' ' LEU . 99.6 m-85 -109.92 117.33 33.51 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.219 0.533 . . . . 0.98999999999999999 110.321 -172.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.651 ' HD3' ' CZ3' ' A' ' 24' ' ' TRP . 28.3 ttt180 -93.75 107.53 19.4 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.225 -0.898 . . . . 2.9199999999999999 110.279 177.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.598 HG13 HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -82.87 140.84 15.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.406 -0.961 . . . . 1.3300000000000001 108.406 174.555 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.785 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 54.7 tt0 -151.52 108.61 3.56 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.054 0.454 . . . . 1.0700000000000001 109.983 -178.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.984 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -145.46 154.9 26.23 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 111.153 -0.779 . . . . 0.28999999999999998 111.153 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.0 mt -97.86 114.36 34.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 119.918 -0.713 . . . . 0.57999999999999996 111.205 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.464 HD13 ' HB1' ' A' ' 199' ' ' ALA . 68.7 mt -92.31 111.6 51.2 Favored Pre-proline 0 N--CA 1.443 -0.821 0 N-CA-C 108.373 -0.973 . . . . 0.34999999999999998 108.373 170.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 22.0 Cg_exo -66.52 54.57 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 124.266 3.311 . . . . 0.62 113.167 -177.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.683 ' HG2' HG13 ' A' ' 203' ' ' ILE . 10.8 tp10 -151.65 167.63 27.53 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 107.417 -1.327 . . . . 1.6799999999999999 107.417 175.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.484 ' HB3' ' HA ' ' A' ' 162' ' ' PRO . 23.8 p -70.12 137.09 86.94 Favored Pre-proline 0 N--CA 1.431 -1.397 0 CA-C-O 121.683 0.754 . . . . 1.1799999999999999 111.404 -176.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.786 ' HD3' ' HB2' ' A' ' 165' ' ' SER . 6.3 Cg_endo -49.55 -18.18 2.31 Favored 'Trans proline' 0 C--O 1.23 0.116 0 C-N-CA 124.698 3.598 . . . . 0.52000000000000002 111.677 170.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.85 -47.82 50.37 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.082 -0.963 . . . . 0.64000000000000001 110.692 176.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.502 ' HA ' ' HB3' ' A' ' 63' ' ' ASP . 4.5 tppt? -68.02 -29.83 68.93 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.71 -0.848 . . . . 3.2999999999999998 108.71 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.957 HD23 HD13 ' A' ' 203' ' ' ILE . 88.5 mt -60.02 -53.97 51.54 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.906 -1.043 . . . . 0.40999999999999998 110.25 174.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.511 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 19.3 p -68.05 -12.61 61.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.107 0.479 . . . . 1.29 110.44 175.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.502 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 37.8 t70 -82.28 -33.06 29.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.794 -0.639 . . . . 1.3200000000000001 111.409 -177.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.54 ' CE2' ' HA ' ' A' ' 61' ' ' LEU . 15.4 p90 -83.7 -47.51 11.13 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.404 -0.518 . . . . 0.60999999999999999 110.976 -177.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.511 ' CD2' ' HA ' ' A' ' 62' ' ' SER . 0.7 OUTLIER -83.5 -1.79 54.46 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.4 -0.52 . . . . 1.5 111.904 -172.154 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -38.34 -47.94 1.28 Allowed 'General case' 0 C--N 1.327 -0.373 0 O-C-N 124.806 1.316 . . . . 1.52 114.448 -162.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -162.21 -84.09 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 114.261 1.208 . . . . 3.6000000000000001 114.261 -175.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.754 ' HB ' ' CD1' ' A' ' 81' ' ' TYR . 10.8 t -150.86 13.57 0.71 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.406 0.521 . . . . 1.48 112.406 -166.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -111.25 -6.67 25.54 Favored Glycine 0 C--N 1.306 -1.132 0 C-N-CA 118.987 -1.578 . . . . 1.46 113.203 -165.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.741 ' O ' HG22 ' A' ' 73' ' ' THR . 12.9 t70 -162.41 -41.45 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.369 0.604 . . . . 2.1899999999999999 110.136 -167.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.704 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 1.5 ptp180 -49.92 -47.42 52.3 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.904 -1.044 . . . . 3.3799999999999999 111.64 -176.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.863 HG22 HD13 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -90.05 -8.04 10.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.697 -0.401 . . . . 0.70999999999999996 111.054 -174.333 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.741 HG22 ' O ' ' A' ' 70' ' ' ASP . 4.8 t -83.29 -35.67 25.09 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 119.171 -1.011 . . . . 0.96999999999999997 110.089 -176.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.712 ' HZ3' ' HB2' ' A' ' 198' ' ' ASN . 20.4 p-90 -103.27 -6.09 22.41 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.413 -0.515 . . . . 0.75 111.982 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.814 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 5.5 t70 -67.24 172.93 4.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.864 0.84 . . . . 2.1899999999999999 112.288 -170.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.477 ' H ' ' HG3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -118.08 -11.12 10.22 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.52 -1.218 . . . . 3.1899999999999999 111.61 -174.327 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.1 m -140.88 17.36 2.31 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.496 0.665 . . . . 1.5800000000000001 109.899 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.863 HD13 HG22 ' A' ' 72' ' ' ILE . 21.9 mt -108.03 157.33 18.34 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.593 -0.73 . . . . 0.70999999999999996 110.624 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.789 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 3.5 mm100 -131.89 -71.1 0.56 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.577 -0.738 . . . . 1.73 111.074 -178.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.86 ' HB ' HD13 ' A' ' 97' ' ' ILE . 15.1 t -137.41 142.8 35.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.599 -0.728 . . . . 0.78000000000000003 109.892 -170.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.754 ' CD1' ' HB ' ' A' ' 68' ' ' THR . 25.3 t80 -124.2 137.51 54.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.989 0.423 . . . . 5.4000000000000004 110.431 176.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.892 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 5.3 m-20 -128.97 111.78 13.37 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.664 -0.865 . . . . 1.6899999999999999 108.664 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.712 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 20.1 ttm -75.85 96.37 3.69 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.838 -0.801 . . . . 2.0499999999999998 108.838 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -78.54 -83.31 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 116.36 -0.382 . . . . 0.64000000000000001 111.741 -168.52 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.497 ' HB2' HD12 ' A' ' 93' ' ' ILE . 32.1 m170 -122.56 122.75 39.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.27 0.557 . . . . 1.96 110.25 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.712 ' HD3' ' SD ' ' A' ' 83' ' ' MET . 81.2 mtm180 -105.68 108.79 20.49 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.225 -0.898 . . . . 2.4399999999999999 109.219 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.515 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -72.68 -39.95 61.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.428 -0.806 . . . . 0.46999999999999997 110.067 -173.763 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -152.08 -171.0 3.8 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.409 -0.814 . . . . 1.8600000000000001 109.188 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.6 t -78.88 -5.56 53.9 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.795 0.331 . . . . 1.4399999999999999 110.389 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -122.81 -4.3 8.63 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.94 -0.393 . . . . 1.8700000000000001 109.94 -176.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.715 HG23 ' HD1' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -135.93 112.06 9.69 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.301 -0.629 . . . . 0.46000000000000002 109.301 -169.132 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.707 ' HD2' ' HG2' ' A' ' 86' ' ' ARG . 10.8 m-85 -125.39 178.73 5.45 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.651 -0.5 . . . . 0.42999999999999999 109.651 -177.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.66 ' O ' HG23 ' A' ' 84' ' ' VAL . 42.6 mt -133.0 128.94 57.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 107.094 -1.447 . . . . 0.40999999999999998 107.094 168.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 113' ' ' ASP . 6.6 p -113.18 112.32 23.58 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.122 0.487 . . . . 2.0099999999999998 112.13 -170.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.892 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 4.7 t-160 -82.64 93.96 7.46 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.64 -0.874 . . . . 1.23 108.64 170.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.544 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 21.8 m -113.11 111.57 22.35 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.25 -0.432 . . . . 0.5 111.965 -172.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.86 HD13 ' HB ' ' A' ' 80' ' ' VAL . 3.4 mp -77.27 120.42 27.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 108.642 -0.874 . . . . 1.03 108.642 174.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 49.6 m -111.72 138.37 48.39 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.368 -0.833 . . . . 1.3799999999999999 111.909 -170.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.789 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 42.6 mt-30 . . . . . 0 C--N 1.32 -0.687 0 CA-C-N 116.089 -0.505 . . . . 1.8200000000000001 109.784 174.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.461 HG22 ' O ' ' A' ' 107' ' ' SER . 65.7 mt . . . . . 0 N--CA 1.448 -0.555 0 CA-C-O 120.937 0.398 . . . . 1.1200000000000001 111.034 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.461 ' O ' HG22 ' A' ' 106' ' ' ILE . 19.8 m -94.26 164.88 18.87 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.661 -0.699 . . . . 1.3500000000000001 109.539 173.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.22 141.67 30.65 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.234 1.956 . . . . 1.0700000000000001 111.458 173.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.652 ' HG2' HG23 ' A' ' 144' ' ' ILE . 54.6 mtt180 -116.33 173.95 6.32 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.049 0.452 . . . . 3.4500000000000002 110.689 -174.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.822 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 9.8 t70 -132.72 123.07 25.56 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.56 -0.746 . . . . 1.3700000000000001 109.04 -177.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.544 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 9.6 m-30 -103.63 140.42 37.59 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.146 0.498 . . . . 2.4100000000000001 111.366 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.678 HG13 ' HA ' ' A' ' 137' ' ' TYR . 25.5 mm -132.38 75.14 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.124 -0.944 . . . . 0.42999999999999999 108.691 173.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.902 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 17.2 m-20 -99.85 123.18 43.84 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.695 -0.684 . . . . 1.8600000000000001 110.808 -173.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.614 HD12 ' O ' ' A' ' 92' ' ' PHE . 7.6 tp -76.38 123.53 26.12 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 108.71 -0.848 . . . . 0.28000000000000003 108.71 167.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.606 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -127.15 124.62 64.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.562 -0.744 . . . . 0.26000000000000001 112.384 -163.635 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.715 ' HD1' HG23 ' A' ' 91' ' ' THR . 54.5 t80 -109.75 118.23 35.97 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.273 -0.876 . . . . 2.5699999999999998 110.947 174.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.465 HG13 ' HB ' ' A' ' 127' ' ' ILE . 5.1 mp -97.5 120.85 47.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.787 -0.642 . . . . 0.89000000000000001 109.923 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.423 ' HB3' ' CE2' ' A' ' 116' ' ' TYR . 14.0 ptpt -140.56 147.41 39.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.041 0.448 . . . . 1.2 110.714 177.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.475 ' C ' ' HD2' ' A' ' 119' ' ' ARG . 1.7 tmm_? -125.64 99.97 6.23 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 109.014 -0.735 . . . . 2.7999999999999998 109.014 -176.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -63.45 116.32 5.45 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.406 -1.331 . . . . 0.82999999999999996 107.406 169.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.415 ' HG3' ' H ' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -33.09 90.13 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 O-C-N 125.12 1.513 . . . . 2.2799999999999998 114.682 -175.451 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 58.05 29.32 62.22 Favored Glycine 0 C--O 1.229 -0.198 0 CA-C-N 114.716 -1.129 . . . . 0.76000000000000001 112.62 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.429 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 33.7 t-20 -119.72 -49.18 2.34 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.538 -0.541 . . . . 1.6499999999999999 109.538 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 1.9 mtm -161.93 122.74 2.64 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.972 0.415 . . . . 1.1200000000000001 111.226 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -109.4 80.82 1.36 Allowed 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.716 -0.846 . . . . 1.6200000000000001 108.716 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.821 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -100.57 139.48 21.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.232 -0.895 . . . . 0.29999999999999999 112.81 -173.191 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.656 ' O ' HG13 ' A' ' 127' ' ' ILE . 1.9 pt -108.64 116.58 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 108.318 -0.993 . . . . 0.58999999999999997 108.318 160.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.606 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 26.5 p -87.54 156.98 19.27 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.102 -0.703 . . . . 1.1799999999999999 109.102 175.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.902 ' HB3' ' HB3' ' A' ' 113' ' ' ASP . 50.2 m -153.9 136.35 15.02 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.758 0.313 . . . . 1.24 111.576 -178.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.892 ' HE2' ' HG3' ' A' ' 150' ' ' PRO . 4.6 mtpm? -131.04 122.77 27.37 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 107.824 -1.176 . . . . 2.2599999999999998 107.824 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.578 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 70.4 p -64.49 99.02 0.28 Allowed 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.098 -1.445 . . . . 1.3899999999999999 107.098 174.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.57 137.34 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 CA-C-N 115.265 -0.879 . . . . 1.05 108.709 -165.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.617 ' HA ' ' CG ' ' A' ' 137' ' ' TYR . 9.8 p-10 -92.05 69.57 5.35 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.678 -1.147 . . . . 2.1699999999999999 110.543 -167.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.721 ' CZ ' ' HB3' ' A' ' 136' ' ' GLU . 1.7 p90 -105.15 173.36 3.33 Favored Pre-proline 0 CA--C 1.546 0.82 0 CA-C-N 113.927 -1.488 . . . . 0.53000000000000003 108.313 -176.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.535 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 31.8 Cg_exo -28.05 -57.17 0.12 Allowed 'Trans proline' 0 CA--C 1.548 1.182 0 C-N-CA 124.875 3.716 . . . . 1.28 116.964 -177.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.721 ' HB3' ' CZ ' ' A' ' 134' ' ' PHE . 17.8 tp10 -80.77 -21.44 41.03 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.635 0.606 . . . . 3.5 112.635 -174.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.678 ' HA ' HG13 ' A' ' 112' ' ' ILE . 17.8 t80 -49.43 -43.12 69.95 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 114.403 1.26 . . . . 6.1200000000000001 114.403 -177.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.507 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 32.0 Cg_exo -39.31 119.55 0.52 Allowed 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 122.386 2.057 . . . . 1.77 113.28 175.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.887 ' HB3' ' HD3' ' A' ' 145' ' ' ARG . 50.6 Cg_endo -89.14 -163.1 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.422 2.748 . . . . 1.25 113.773 -172.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.5 m -142.73 -169.32 2.97 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.79 -0.819 . . . . 1.6000000000000001 108.79 -175.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.8 t -80.46 -45.31 17.78 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.18 -0.608 . . . . 1.97 110.028 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -69.58 -28.31 65.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.073 -0.512 . . . . 2.1800000000000002 110.86 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.822 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 65.5 m-85 -118.87 109.12 15.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.975 -0.557 . . . . 1.23 110.542 -174.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.652 HG23 ' HG2' ' A' ' 109' ' ' ARG . 2.5 tp -98.66 111.95 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-O 121.314 0.578 . . . . 0.81999999999999995 109.695 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.887 ' HD3' ' HB3' ' A' ' 139' ' ' PRO . 4.7 mpt_? -57.89 100.48 0.06 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.814 -1.085 . . . . 4.4199999999999999 110.888 176.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -66.99 115.53 7.31 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 110.404 -1.079 . . . . 0.79000000000000004 110.404 174.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.406 ' HB3' ' HB3' ' A' ' 174' ' ' GLU . 24.8 t80 -84.55 86.16 7.33 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.486 0.66 . . . . 4.4400000000000004 110.612 -173.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.472 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 90.5 m-20 -70.42 105.62 3.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.987 -1.006 . . . . 1.6200000000000001 110.411 175.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.669 ' HB3' ' HB3' ' A' ' 172' ' ' GLN . 25.3 t60 -57.82 126.59 76.93 Favored Pre-proline 0 CA--C 1.506 -0.745 0 N-CA-C 107.609 -1.256 . . . . 2.3199999999999998 107.609 167.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.892 ' HG3' ' HE2' ' A' ' 130' ' ' LYS . 23.7 Cg_exo -12.13 69.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 1 C-N-CA 126.853 5.035 . . . . 0.53000000000000003 115.37 -173.975 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 151' ' ' CYS . . . . . 0.472 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 24.1 p -77.47 178.41 7.24 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.241 -1.345 . . . . 1.5800000000000001 110.574 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.63 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -170.56 -164.9 27.06 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 120.309 -0.948 . . . . 0.42999999999999999 111.675 175.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -161.38 73.19 0.44 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.632 -0.877 . . . . 0.59999999999999998 108.632 -164.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.822 HG23 HG13 ' A' ' 168' ' ' VAL . 8.4 m -83.24 115.26 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-O 122.113 0.959 . . . . 0.31 110.32 -175.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 64.3 m -98.27 107.58 20.08 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.417 -0.811 . . . . 1.55 109.027 177.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.722 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 10.1 m -97.63 112.64 61.92 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 116.28 -0.418 . . . . 1.0600000000000001 111.023 -170.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.558 ' HB3' ' ND2' ' A' ' 161' ' ' ASN . 52.4 Cg_exo -51.76 120.48 7.13 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.376 2.05 . . . . 0.56000000000000005 110.598 172.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.687 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 2.7 mmt -79.87 -167.92 1.43 Allowed 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.234 0.54 . . . . 1.1599999999999999 111.453 -175.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -70.97 -16.78 62.66 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.485 -0.779 . . . . 2.6299999999999999 110.026 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 163' ' ' ALA . 38.6 mt-10 -117.38 21.16 13.26 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 115.467 -0.788 . . . . 2.0499999999999998 110.408 178.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.669 ' HB3' ' CD ' ' A' ' 162' ' ' PRO . 18.7 t-20 29.79 -87.06 0.0 OUTLIER Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 125.87 1.668 . . . . 1.9299999999999999 115.044 175.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.669 ' CD ' ' HB3' ' A' ' 161' ' ' ASN . 85.1 Cg_endo -75.81 -12.62 19.95 Favored 'Trans proline' 0 C--N 1.368 1.557 0 CA-C-N 121.888 1.71 . . . . 0.72999999999999998 112.928 -175.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.559 ' HB3' ' HB3' ' A' ' 160' ' ' GLU . . . -89.97 -36.92 14.69 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.898 -0.592 . . . . 0.68000000000000005 110.563 -178.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.687 ' O ' ' HB2' ' A' ' 158' ' ' MET . 73.6 m-85 -136.97 133.14 35.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.279 -0.419 . . . . 0.93000000000000005 110.424 176.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.786 ' HB2' ' HD3' ' A' ' 58' ' ' PRO . 25.3 t -125.11 144.59 50.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.342 0.592 . . . . 1.4099999999999999 110.951 174.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.785 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.8 tppp? -97.37 99.81 11.25 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.993 0.901 . . . . 0.73999999999999999 110.684 -178.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.8 106.97 15.91 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.323 -1.308 . . . . 0.27000000000000002 109.201 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.822 HG13 HG23 ' A' ' 154' ' ' VAL . 0.1 OUTLIER -129.41 126.27 63.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.675 0.75 . . . . 0.28000000000000003 111.804 176.667 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 14.6 ttt -129.74 153.08 48.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.182 -0.917 . . . . 1.24 110.021 -171.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.767 ' HB3' HD21 ' A' ' 47' ' ' LEU . 47.6 m-85 -134.24 140.52 46.51 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.684 -0.234 . . . . 3.3700000000000001 111.146 -178.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.607 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 4.7 m -140.07 131.6 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 O-C-N 123.645 0.591 . . . . 1.3999999999999999 111.549 171.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 1.007 ' HB2' HD12 ' A' ' 47' ' ' LEU . 13.3 tt0 -120.02 33.55 5.56 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 105.954 -1.869 . . . . 2.1699999999999999 105.954 169.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 35.9 m -54.94 147.27 15.77 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 112.697 -2.047 . . . . 1.6499999999999999 112.733 -171.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 2.4 tp10 . . . . . 0 N--CA 1.448 -0.536 0 CA-C-N 115.573 -0.74 . . . . 2.4500000000000002 110.663 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.558 ' HA ' ' HE2' ' A' ' 186' ' ' LYS . 24.4 mm . . . . . 0 CA--C 1.503 -0.845 0 CA-C-O 122.274 1.035 . . . . 1.1200000000000001 108.331 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 1.005 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.2 mp -62.99 -35.7 72.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 112.986 -1.915 . . . . 1.1299999999999999 110.726 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -57.19 -29.65 63.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.133 -0.94 . . . . 2.8900000000000001 109.564 174.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.558 ' HE2' ' HA ' ' A' ' 183' ' ' ILE . 46.0 mtmt -93.05 -40.46 10.51 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.161 -0.927 . . . . 1.28 111.088 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' THR . . . . . 1.005 HG22 ' HA ' ' A' ' 184' ' ' ILE . 6.5 t -64.75 -37.67 88.39 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.236 0.458 . . . . 0.62 112.236 -171.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' MET . . . . . 0.825 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 7.7 mmt -74.88 -60.43 1.23 Allowed Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 120.747 -0.381 . . . . 1.0600000000000001 111.347 -174.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.825 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 61.3 Cg_exo -54.02 -32.06 66.99 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.174 1.916 . . . . 0.91000000000000003 112.579 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.74 ' O ' ' HB3' ' A' ' 194' ' ' ASN . 49.0 m -72.87 -23.71 60.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.431 -0.35 . . . . 1.5 111.031 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -92.56 -37.82 12.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.348 0.594 . . . . 1.8799999999999999 111.6 -175.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.956 HD13 HG11 ' A' ' 35' ' ' VAL . 3.7 mt -67.02 -51.32 56.35 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.659 0.743 . . . . 1.0900000000000001 110.79 -176.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.688 ' O ' HD23 ' A' ' 197' ' ' LEU . 1.6 m -69.6 -41.29 80.24 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.129 0 CA-C-N 115.061 -0.972 . . . . 0.68000000000000005 108.756 -176.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.74 ' HB3' ' O ' ' A' ' 190' ' ' SER . 0.0 OUTLIER -57.48 -37.75 73.42 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.668 0.618 . . . . 2.0699999999999998 112.668 178.706 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -64.28 -31.82 73.17 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 119.884 -0.726 . . . . 2.0 110.009 174.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.852 HG21 HG21 ' A' ' 33' ' ' ILE . 8.6 mt -78.58 -33.89 17.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 122.003 0.906 . . . . 0.31 111.205 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.688 HD23 ' O ' ' A' ' 193' ' ' VAL . 3.3 mm? -78.26 -30.6 48.69 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.014 -0.994 . . . . 1.03 110.723 -173.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.712 ' HB2' ' HZ3' ' A' ' 74' ' ' TRP . 12.1 p30 -67.39 -29.82 69.43 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.528 -1.286 . . . . 1.8999999999999999 107.528 167.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.695 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -73.19 -37.25 66.55 Favored 'General case' 0 N--CA 1.435 -1.187 0 O-C-N 121.97 -0.456 . . . . 0.28999999999999998 110.254 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 33.0 mmtp -61.7 -43.36 99.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.76 0.79 . . . . 0.96999999999999997 109.915 174.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ASP . . . . . 0.574 ' O ' ' HG3' ' A' ' 204' ' ' LYS . 10.2 t70 -81.69 -40.72 22.37 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.703 -1.135 . . . . 1.9399999999999999 110.841 -171.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -70.98 -33.87 65.34 Favored Glycine 0 C--O 1.226 -0.406 0 C-N-CA 121.105 -0.569 . . . . 0.46999999999999997 111.729 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.957 HD13 HD23 ' A' ' 61' ' ' LEU . 1.6 tp -70.17 -35.76 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 110.058 -0.349 . . . . 0.60999999999999999 110.058 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.574 ' HG3' ' O ' ' A' ' 201' ' ' ASP . 2.2 pptp? -81.59 -23.95 36.77 Favored 'General case' 0 C--O 1.213 -0.846 0 N-CA-C 108.678 -0.86 . . . . 3.3700000000000001 108.678 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.096 0 N-CA-C 109.094 -0.706 . . . . 1.02 109.094 167.758 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.451 ' O ' ' HB3' ' A' ' 5' ' ' ALA . 1.0 OUTLIER . . . . . 0 CA--C 1.512 -0.488 0 N-CA-C 112.547 0.573 . . . . 2.25 112.547 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.889 ' HA ' HD12 ' A' ' 6' ' ' ILE . 97.2 m-85 -68.53 -27.97 66.58 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.079 0.466 . . . . 0.42999999999999999 109.837 -172.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.564 ' HD2' ' CG ' ' A' ' 88' ' ' ASP . 17.5 tttm -76.31 -2.45 31.66 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.551 -0.75 . . . . 1.51 109.697 177.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.61 ' O ' ' HG2' ' A' ' 9' ' ' GLN . . . -92.96 -43.44 8.93 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.398 0.618 . . . . 0.54000000000000004 109.972 170.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.889 HD12 ' HA ' ' A' ' 3' ' ' PHE . 1.3 mp -81.57 -43.01 19.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 122.01 0.91 . . . . 1.0700000000000001 109.398 -171.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.467 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -76.06 -37.31 58.42 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.105 -1.407 . . . . 0.34000000000000002 111.584 -176.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 7.3 mt-30 -65.91 -29.73 70.2 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.474 -0.785 . . . . 1.5900000000000001 109.992 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.61 ' HG2' ' O ' ' A' ' 5' ' ' ALA . 79.1 mm-40 -77.69 -38.8 46.68 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.038 -0.983 . . . . 2.4700000000000002 108.499 174.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.555 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.4 OUTLIER -65.57 -36.53 84.05 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.534 -1.212 . . . . 0.47999999999999998 111.962 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.625 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -46.57 -59.49 2.97 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.198 0.523 . . . . 0.31 111.159 172.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -66.56 -16.65 64.32 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.49 -0.777 . . . . 1.6399999999999999 112.045 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.608 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 44.2 mt-10 -73.32 -52.37 14.15 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.001 0.429 . . . . 2.54 109.888 175.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.687 HG21 ' N ' ' A' ' 152' ' ' GLY . 11.8 p -73.2 -40.17 57.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.649 0.738 . . . . 0.53000000000000003 110.453 -177.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.554 HD23 ' HD2' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -67.2 -23.81 65.78 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-O 121.916 0.865 . . . . 0.59999999999999998 108.824 173.523 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.95 -18.05 66.13 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 113.986 -1.461 . . . . 0.56999999999999995 110.38 177.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.633 ' CD2' ' HA ' ' A' ' 14' ' ' VAL . 23.7 m-85 -91.14 -21.34 21.23 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.076 -0.712 . . . . 3.27 109.076 176.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.512 ' HA ' ' HZ ' ' A' ' 170' ' ' PHE . 63.5 t30 -72.29 -14.82 61.85 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.463 0.649 . . . . 2.0299999999999998 109.989 178.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.554 ' HD2' HD23 ' A' ' 15' ' ' LEU . 22.2 mtp180 -115.72 -20.38 10.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.484 -0.78 . . . . 2.7200000000000002 110.835 -175.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -97.01 132.76 42.5 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.066 0.46 . . . . 2.1600000000000001 111.413 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 43.1 p -134.21 119.28 18.6 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.85 -0.614 . . . . 1.8200000000000001 109.637 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.459 ' HB2' ' HE3' ' A' ' 38' ' ' LYS . 0.8 OUTLIER -135.57 -143.87 0.2 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.862 -0.608 . . . . 2.1899999999999999 110.343 -169.135 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.4 63.33 1.8 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.349 -0.453 . . . . 1.1000000000000001 112.73 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.534 ' CH2' ' HD3' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -119.86 -175.76 3.04 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.15 -1.056 . . . . 1.6699999999999999 108.15 171.393 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.427 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 8.7 mtpp -171.4 133.11 0.8 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.712 -0.848 . . . . 2.9500000000000002 108.712 -176.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.765 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 1.6 p -59.96 116.73 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-O 121.714 0.769 . . . . 1.5600000000000001 109.681 170.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.4 p -92.05 -23.7 5.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 114.695 -1.139 . . . . 1.22 109.081 -177.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 2.7 tppt? -153.1 139.63 18.72 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.82 -0.627 . . . . 2.4100000000000001 111.488 -173.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.6 HG22 ' HA ' ' A' ' 34' ' ' THR . 31.2 p -137.92 142.93 40.58 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.002 -0.545 . . . . 1.3799999999999999 110.373 175.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.761 ' HB3' HG12 ' A' ' 33' ' ' ILE . 35.4 t -89.95 -143.98 0.16 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.618 -1.253 . . . . 2.3700000000000001 107.618 168.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -103.05 18.89 20.61 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.532 -0.467 . . . . 4.5499999999999998 110.06 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.442 ' HD2' ' HA ' ' A' ' 32' ' ' LYS . 33.8 tptt -168.97 3.77 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.189 0.44 . . . . 1.4199999999999999 112.189 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.971 HG22 ' HA3' ' A' ' 52' ' ' GLY . 42.8 pt -138.72 168.46 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.913 0.387 . . . . 0.76000000000000001 111.735 -174.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.6 ' HA ' HG22 ' A' ' 29' ' ' THR . 88.0 m -146.59 119.56 8.76 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.223 -0.899 . . . . 0.57999999999999996 110.64 -166.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.712 HG22 HG23 ' A' ' 50' ' ' VAL . 7.1 t -111.41 102.0 13.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.608 -0.516 . . . . 0.85999999999999999 109.608 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.765 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 18.1 m -99.14 126.79 44.99 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.651 0.739 . . . . 1.1000000000000001 111.338 -177.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 t -97.75 124.04 41.94 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.439 -1.255 . . . . 1.27 109.76 -177.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.459 ' HE3' ' HB2' ' A' ' 22' ' ' SER . 85.3 tttt . . . . . 0 C--N 1.317 -0.822 0 CA-C-N 115.618 -0.719 . . . . 1.9099999999999999 110.151 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.4 m120 . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 121.483 0.659 . . . . 2.0499999999999998 112.07 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.566 HD11 HE21 ' A' ' 172' ' ' GLN . 4.3 tt -136.75 137.19 39.62 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.444 -1.688 . . . . 0.87 106.444 175.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.591 ' HB2' HG12 ' A' ' 171' ' ' VAL . 42.2 m-85 -118.52 128.3 54.45 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 120.545 -0.462 . . . . 0.98999999999999999 110.992 -172.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.534 ' HD3' ' CH2' ' A' ' 24' ' ' TRP . 15.1 ttp180 -99.29 117.24 33.3 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.913 -0.773 . . . . 2.9199999999999999 108.913 173.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.712 HG23 HG22 ' A' ' 35' ' ' VAL . 7.8 p -106.7 120.49 57.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 108.403 -0.962 . . . . 1.3300000000000001 108.403 175.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.657 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 35.2 tt0 -139.98 121.06 14.7 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.225 -0.898 . . . . 1.0700000000000001 110.419 -167.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.971 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -148.23 162.47 28.8 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 111.016 -0.834 . . . . 0.28999999999999998 111.016 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.6 mt -97.6 119.11 45.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 C-N-CA 120.197 -0.601 . . . . 0.57999999999999996 111.004 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.686 HG12 ' HD3' ' A' ' 200' ' ' LYS . 72.6 mt -97.3 114.12 64.29 Favored Pre-proline 0 N--CA 1.443 -0.785 0 N-CA-C 108.884 -0.784 . . . . 0.34999999999999998 108.884 172.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 23.6 Cg_exo -65.66 57.14 0.36 Allowed 'Trans proline' 0 N--CA 1.474 0.347 0 C-N-CA 124.422 3.415 . . . . 0.62 113.223 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.494 ' HG2' HG13 ' A' ' 203' ' ' ILE . 11.4 tp10 -157.42 167.88 28.94 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 108.207 -1.035 . . . . 1.6799999999999999 108.207 176.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.507 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 20.0 p -69.49 141.37 90.67 Favored Pre-proline 0 N--CA 1.429 -1.511 0 CA-C-O 122.09 0.948 . . . . 1.1799999999999999 111.637 -175.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.581 ' HA ' HD12 ' A' ' 61' ' ' LEU . 32.3 Cg_exo -59.68 -15.39 31.22 Favored 'Trans proline' 0 CA--C 1.518 -0.29 0 C-N-CA 124.505 3.47 . . . . 0.52000000000000002 110.534 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.03 -53.33 21.03 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.195 -1.366 . . . . 0.64000000000000001 111.011 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.612 ' HA ' ' HB3' ' A' ' 63' ' ' ASP . 13.6 ttpt -70.97 -23.47 62.22 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.812 -0.81 . . . . 3.2999999999999998 108.812 -177.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.019 HD23 HD13 ' A' ' 203' ' ' ILE . 45.0 mt -60.72 -55.74 29.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.006 -0.997 . . . . 0.40999999999999998 109.756 171.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.1 p -68.63 -9.24 48.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.007 0.432 . . . . 1.29 110.724 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.612 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 29.4 t70 -90.17 -28.36 18.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.021 -0.536 . . . . 1.3200000000000001 111.828 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.673 ' CD2' ' HA ' ' A' ' 61' ' ' LEU . 8.8 p90 -86.32 -43.69 12.69 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 120.378 -0.529 . . . . 0.60999999999999999 110.967 -174.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.711 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -89.62 7.61 35.63 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.975 -0.29 . . . . 1.5 110.973 -174.462 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -53.19 -71.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.467 -0.788 . . . . 1.52 111.875 -164.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 165.08 133.56 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 108.363 -0.977 . . . . 3.6000000000000001 108.363 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.909 ' HA ' ' NH2' ' A' ' 71' ' ' ARG . 5.8 t 46.73 31.63 1.48 Allowed 'General case' 0 C--N 1.313 -1.007 0 O-C-N 124.534 1.146 . . . . 1.48 112.66 177.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.533 ' O ' ' HB3' ' A' ' 70' ' ' ASP . . . -88.69 -44.7 5.11 Favored Glycine 0 N--CA 1.427 -1.947 0 CA-C-N 115.173 -0.921 . . . . 1.46 110.859 -176.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.533 ' HB3' ' O ' ' A' ' 69' ' ' GLY . 29.4 p-10 152.35 -5.12 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 113.139 -1.53 . . . . 2.1899999999999999 108.23 -166.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.909 ' NH2' ' HA ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -46.96 -27.79 1.4 Allowed 'General case' 0 C--O 1.211 -0.957 0 N-CA-C 113.536 0.939 . . . . 3.3799999999999999 113.536 178.757 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.703 HD13 ' NH1' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -92.18 -14.37 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 119.124 -1.031 . . . . 0.70999999999999996 111.047 178.719 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.51 HG22 ' O ' ' A' ' 70' ' ' ASP . 0.7 OUTLIER -86.01 -28.05 24.42 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 120.27 -0.572 . . . . 0.96999999999999997 110.239 -173.68 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.696 ' CE2' ' HA ' ' A' ' 71' ' ' ARG . 14.8 p-90 -107.22 -4.86 18.32 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.467 -0.493 . . . . 0.75 111.924 178.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.809 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 5.6 t70 -71.99 174.87 6.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.506 0.67 . . . . 2.1899999999999999 111.453 -172.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.822 ' HG2' ' HB3' ' A' ' 198' ' ' ASN . 8.1 mmmt -108.91 -25.41 10.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.199 -0.909 . . . . 3.1899999999999999 109.76 -177.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.6 m -127.6 11.51 6.78 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.34 -0.846 . . . . 1.5800000000000001 111.266 -173.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.7 HD13 HG22 ' A' ' 72' ' ' ILE . 15.9 mt -107.36 152.23 24.44 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.142 0.496 . . . . 0.70999999999999996 111.471 -178.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.544 ' HB3' HG23 ' A' ' 80' ' ' VAL . 43.2 mt-30 -118.92 -70.49 0.79 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.447 -0.797 . . . . 1.73 111.225 178.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.544 HG23 ' HB3' ' A' ' 79' ' ' GLN . 22.0 t -148.66 124.31 2.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.468 -0.787 . . . . 0.78000000000000003 110.556 -166.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.893 ' HB3' HH21 ' A' ' 71' ' ' ARG . 48.7 t80 -109.71 142.54 40.76 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.416 -0.514 . . . . 5.4000000000000004 111.213 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -136.74 118.71 15.3 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.928 -1.138 . . . . 1.6899999999999999 107.928 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.546 ' SD ' ' HD2' ' A' ' 86' ' ' ARG . 2.0 ttt -68.5 107.48 2.93 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.696 -0.684 . . . . 2.0499999999999998 109.358 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -84.31 -71.57 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 120.22 -0.592 . . . . 0.64000000000000001 111.411 -170.608 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -137.9 108.95 6.75 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.017 -0.538 . . . . 1.96 109.884 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.953 ' HG2' ' HD2' ' A' ' 92' ' ' PHE . 68.1 mtp180 -85.32 129.47 34.8 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.31 -0.626 . . . . 2.4399999999999999 109.31 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.739 HG21 ' HB2' ' A' ' 3' ' ' PHE . 0.7 OUTLIER -86.99 -54.52 7.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.428 -0.805 . . . . 0.46999999999999997 109.969 -172.217 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.564 ' CG ' ' HD2' ' A' ' 4' ' ' LYS . 6.8 m-20 -136.15 -142.98 0.18 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.636 -1.165 . . . . 1.8600000000000001 108.808 -177.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.2 t -95.02 -12.22 27.01 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.609 -0.515 . . . . 1.4399999999999999 109.609 175.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -128.27 3.54 5.75 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.039 -0.528 . . . . 1.8700000000000001 110.428 -171.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.59 ' HB ' ' HB ' ' A' ' 87' ' ' ILE . 0.3 OUTLIER -132.38 121.35 23.33 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.599 -0.889 . . . . 0.46000000000000002 108.599 -172.201 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.953 ' HD2' ' HG2' ' A' ' 86' ' ' ARG . 14.1 m-85 -133.21 176.14 8.77 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 120.954 0.407 . . . . 0.42999999999999999 110.267 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.728 ' O ' HG23 ' A' ' 84' ' ' VAL . 21.8 mt -133.09 125.93 52.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 107.354 -1.35 . . . . 0.40999999999999998 107.354 168.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.556 ' HA ' ' HE1' ' A' ' 81' ' ' TYR . 94.6 m -106.58 108.41 19.9 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.101 -0.499 . . . . 2.0099999999999998 112.153 -169.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.577 ' HA ' ' O ' ' A' ' 111' ' ' PHE . 7.1 t-80 -84.75 103.62 14.0 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.024 -0.732 . . . . 1.23 109.024 171.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.734 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 27.9 m -127.34 119.91 27.33 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.244 -0.435 . . . . 0.5 111.84 -173.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 32.9 mm -77.67 138.94 19.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.076 -0.713 . . . . 1.03 109.076 174.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 1.3 m -113.58 152.34 30.44 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.58 -0.737 . . . . 1.3799999999999999 110.244 -171.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 . . . . . 0 C--N 1.316 -0.855 0 CA-C-N 116.397 -0.365 . . . . 1.8200000000000001 110.147 177.106 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.486 HD11 HG22 ' A' ' 183' ' ' ILE . 5.2 mp . . . . . 0 N--CA 1.45 -0.459 0 N-CA-C 109.361 -0.607 . . . . 1.1200000000000001 109.361 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.527 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 17.7 m -71.1 164.83 53.47 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.695 -0.684 . . . . 1.3500000000000001 111.035 -178.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 107' ' ' SER . 2.0 Cg_endo -45.15 114.6 0.7 Allowed 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 123.38 2.72 . . . . 1.0700000000000001 111.397 176.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.612 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 23.0 ttp180 -102.99 158.54 16.22 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.99 -0.55 . . . . 3.4500000000000002 110.836 -168.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.928 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 8.2 t0 -113.37 122.94 48.87 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.059 -0.719 . . . . 1.3700000000000001 109.059 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.734 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 6.0 m-85 -99.38 132.07 44.96 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 120.855 0.36 . . . . 2.4100000000000001 110.471 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.572 HD13 ' HA ' ' A' ' 95' ' ' HIS . 30.1 mm -133.46 68.09 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.069 -1.085 . . . . 0.42999999999999999 108.069 171.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.91 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 4.5 m-20 -90.76 115.86 28.17 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.718 -1.128 . . . . 1.8600000000000001 109.799 -177.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 129' ' ' SER . 6.3 tp -74.6 120.85 20.71 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 108.564 -0.902 . . . . 0.28000000000000003 108.564 169.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -125.46 126.15 70.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 115.115 -0.948 . . . . 0.26000000000000001 111.824 -164.319 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.588 ' CE2' ' HB2' ' A' ' 118' ' ' LYS . 50.9 t80 -110.63 120.11 41.35 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 114.456 -1.247 . . . . 2.5699999999999998 110.211 174.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.695 HG12 HG22 ' A' ' 127' ' ' ILE . 74.2 mt -100.25 103.26 14.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.824 -0.625 . . . . 0.89000000000000001 110.359 -177.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.588 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 26.7 ttmt -124.73 133.84 53.04 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.114 0.483 . . . . 1.2 110.211 177.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.528 ' HD2' ' O ' ' A' ' 119' ' ' ARG . 0.4 OUTLIER -110.91 119.57 39.53 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 108.573 -0.899 . . . . 2.7999999999999998 108.573 173.057 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.52 ' CB ' ' HB2' ' A' ' 123' ' ' ASN . 99.1 m-85 -75.98 104.8 6.68 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.455 -1.683 . . . . 0.82999999999999996 106.455 164.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -52.04 98.3 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 122.302 1.049 . . . . 2.2799999999999998 112.598 -171.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 84.89 24.41 45.36 Favored Glycine 0 CA--C 1.504 -0.595 0 CA-C-N 113.451 -1.704 . . . . 0.76000000000000001 112.14 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.632 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 3.8 m-20 -126.02 -57.71 1.41 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.723 -0.739 . . . . 1.6499999999999999 109.617 175.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.404 ' O ' ' HA ' ' A' ' 119' ' ' ARG . 2.8 mpp? -160.48 135.27 7.62 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.894 -0.594 . . . . 1.1200000000000001 110.544 -170.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.469 ' HB2' ' HB2' ' A' ' 155' ' ' CYS . 21.9 m-80 -115.02 87.18 2.6 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.312 -0.996 . . . . 1.6200000000000001 108.312 176.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.632 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.4 OUTLIER -110.0 143.76 19.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 112.976 0.732 . . . . 0.29999999999999999 112.976 -170.527 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.695 HG22 HG12 ' A' ' 117' ' ' ILE . 5.2 pt -110.51 113.98 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.478 -0.934 . . . . 0.58999999999999997 108.478 161.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.625 ' HB3' ' HA ' ' A' ' 11' ' ' ALA . 22.6 p -94.13 124.08 37.91 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.239 -0.437 . . . . 1.1799999999999999 110.693 178.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.91 ' HB3' ' HB3' ' A' ' 113' ' ' ASP . 19.8 m -125.32 141.91 51.8 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.089 0.471 . . . . 1.24 111.801 -170.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.57 ' HE3' HG22 ' A' ' 6' ' ' ILE . 5.5 mtpm? -131.32 126.11 34.48 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 107.97 -1.122 . . . . 2.2599999999999998 107.97 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.6 p -64.89 97.45 0.23 Allowed 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.337 -1.357 . . . . 1.3899999999999999 107.337 172.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.68 140.27 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 N-CA-C 108.766 -0.827 . . . . 1.05 108.766 -165.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -97.23 81.37 3.02 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.162 -0.927 . . . . 2.1699999999999999 108.676 -172.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.498 ' HE1' HG21 ' A' ' 112' ' ' ILE . 0.5 OUTLIER -111.74 152.54 44.2 Favored Pre-proline 0 C--N 1.311 -1.066 0 CA-C-N 114.374 -1.285 . . . . 0.53000000000000003 109.902 -173.864 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.75 -18.94 66.19 Favored 'Trans proline' 0 N--CA 1.48 0.701 0 C-N-CA 123.732 2.954 . . . . 1.28 116.156 -167.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.441 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 2.6 tp10 -68.86 -29.33 67.61 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 121.608 0.718 . . . . 3.5 109.771 -172.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.563 ' CD2' HD11 ' A' ' 112' ' ' ILE . 32.4 t80 -158.25 106.94 1.7 Allowed Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 114.807 -1.088 . . . . 6.1200000000000001 113.828 -175.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.455 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 3.7 Cg_endo -87.44 155.0 7.88 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.172 2.581 . . . . 1.77 109.881 161.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -67.27 -165.13 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 121.982 1.788 . . . . 1.25 112.438 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 13.9 t -136.47 -159.37 0.95 Allowed 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 109.071 -0.714 . . . . 1.6000000000000001 109.071 -170.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 41.9 m -82.49 -42.05 18.96 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.39 -0.524 . . . . 1.97 111.693 -176.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -95.93 -29.9 13.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.095 0.474 . . . . 2.1800000000000002 110.0 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.928 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 25.5 m-85 -85.14 109.5 18.32 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.739 -0.664 . . . . 1.23 110.113 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.612 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 0.9 OUTLIER -96.95 115.37 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 108.404 -0.962 . . . . 0.81999999999999995 108.404 177.517 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.672 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 20.7 ttm180 -55.38 107.9 0.37 Allowed 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.084 -0.71 . . . . 4.4199999999999999 109.084 174.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -59.4 111.13 3.18 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 110.959 -0.856 . . . . 0.79000000000000004 110.959 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -84.01 75.5 10.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 122.183 0.992 . . . . 4.4400000000000004 111.465 -175.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.559 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 16.5 m-20 -79.12 99.52 6.99 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 113.741 -1.572 . . . . 1.6200000000000001 108.565 171.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.499 ' O ' ' N ' ' A' ' 151' ' ' CYS . 77.0 m-70 -60.25 152.84 61.26 Favored Pre-proline 0 C--O 1.22 -0.463 0 N-CA-C 107.513 -1.292 . . . . 2.3199999999999998 107.513 173.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.555 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 32.1 Cg_exo -24.67 70.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.181 1 C-N-CA 126.116 4.544 . . . . 0.53000000000000003 115.544 -173.494 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 151' ' ' CYS . . . . . 0.612 ' HB2' ' O ' ' A' ' 170' ' ' PHE . 25.8 p -97.41 -174.26 2.88 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.987 -1.006 . . . . 1.5800000000000001 109.907 176.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.687 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -172.26 -161.7 23.19 Favored Glycine 0 N--CA 1.433 -1.544 0 C-N-CA 119.775 -1.202 . . . . 0.42999999999999999 112.001 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.469 ' CE2' ' HG ' ' A' ' 65' ' ' LEU . 72.4 t80 -161.83 91.17 0.8 Allowed 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.53 -0.915 . . . . 0.59999999999999998 108.53 -168.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.643 ' CG2' HG13 ' A' ' 168' ' ' VAL . 2.4 m -100.96 131.15 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-O 121.856 0.836 . . . . 0.31 110.83 -173.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' CYS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 125' ' ' ASN . 74.9 m -110.16 109.36 19.84 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.069 -0.969 . . . . 1.55 109.62 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.469 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 19.9 m -105.73 121.22 46.65 Favored Pre-proline 0 C--N 1.318 -0.801 0 N-CA-C 112.15 0.426 . . . . 1.0600000000000001 112.15 -167.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.664 ' HB3' ' ND2' ' A' ' 161' ' ' ASN . 59.8 Cg_exo -51.69 126.02 18.55 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.953 2.435 . . . . 0.56000000000000005 111.875 170.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.617 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 0.2 OUTLIER -88.01 -170.67 3.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.189 0.519 . . . . 1.1599999999999999 111.561 -178.445 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -77.97 -24.45 48.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.426 0.631 . . . . 2.6299999999999999 109.547 168.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 37.8 mt-10 -100.65 27.29 5.97 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.052 -1.092 . . . . 2.0499999999999998 108.052 172.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.745 ' HB3' ' HD3' ' A' ' 162' ' ' PRO . 51.1 t-20 -14.99 -71.73 0.02 OUTLIER Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 126.478 1.911 . . . . 1.9299999999999999 115.074 -174.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.745 ' HD3' ' HB3' ' A' ' 161' ' ' ASN . 73.0 Cg_endo -73.36 -15.86 24.93 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 121.268 1.312 . . . . 0.72999999999999998 113.516 -170.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -104.45 -25.58 12.75 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.161 -0.472 . . . . 0.68000000000000005 110.993 -176.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.617 ' O ' ' HB2' ' A' ' 158' ' ' MET . 49.6 m-85 -141.03 122.29 14.82 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.497 -0.557 . . . . 0.93000000000000005 109.497 177.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 45.5 t -114.13 145.71 41.28 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.488 -0.485 . . . . 1.4099999999999999 110.578 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.657 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.8 tppp? -92.13 101.83 14.35 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 122.049 0.928 . . . . 0.73999999999999999 111.142 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 0.9 OUTLIER -87.49 105.01 17.01 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.385 -1.28 . . . . 0.27000000000000002 109.31 178.748 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.643 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.1 OUTLIER -128.78 117.2 43.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 122.171 0.986 . . . . 0.28000000000000003 112.004 178.112 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.435 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 23.0 ttt -116.97 147.25 42.45 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.814 -1.084 . . . . 1.24 109.496 -177.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.612 ' O ' ' HB2' ' A' ' 151' ' ' CYS . 92.9 m-85 -122.34 128.02 50.51 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.076 -0.713 . . . . 3.3700000000000001 109.076 177.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.598 ' HB ' HD21 ' A' ' 192' ' ' LEU . 2.5 p -111.12 117.98 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-O 121.744 0.783 . . . . 1.3999999999999999 110.003 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.566 HE21 HD11 ' A' ' 47' ' ' LEU . 13.7 tt0 -113.7 48.67 1.04 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.268 -1.012 . . . . 2.1699999999999999 108.268 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.01 136.47 46.72 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.058 -1.428 . . . . 1.6499999999999999 113.247 -170.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 . . . . . 0 N--CA 1.451 -0.392 0 CA-C-N 115.927 -0.579 . . . . 2.4500000000000002 111.39 174.625 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.809 ' HA ' ' HE2' ' A' ' 186' ' ' LYS . 8.0 mm . . . . . 0 N--CA 1.47 0.574 0 CA-C-O 122.872 1.32 . . . . 1.1200000000000001 109.398 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.954 ' HA ' HG22 ' A' ' 187' ' ' THR . 0.9 OUTLIER -86.46 -33.47 7.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 112.886 -1.961 . . . . 1.1299999999999999 110.366 -169.886 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.47 ' OE2' ' HB3' ' A' ' 186' ' ' LYS . 0.0 OUTLIER -60.71 -25.53 66.49 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.558 -0.746 . . . . 2.8900000000000001 110.612 173.95 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.809 ' HE2' ' HA ' ' A' ' 183' ' ' ILE . 0.0 OUTLIER -93.37 -36.53 12.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 1.28 110.477 174.774 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.954 HG22 ' HA ' ' A' ' 184' ' ' ILE . 5.7 t -66.47 -26.7 67.32 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 120.716 -0.394 . . . . 0.62 111.832 -171.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' MET . . . . . 0.59 ' HE2' ' HA ' ' A' ' 188' ' ' MET . 4.2 mmt -76.93 -60.09 0.85 Allowed Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.683 -0.407 . . . . 1.0600000000000001 111.65 -177.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.492 ' O ' HG13 ' A' ' 193' ' ' VAL . 18.2 Cg_endo -60.54 -36.61 85.23 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 121.668 1.579 . . . . 0.91000000000000003 111.76 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.596 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 7.8 t -70.07 -23.55 63.1 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.971 0.415 . . . . 1.5 110.763 -176.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -91.06 -45.59 8.61 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.332 -0.394 . . . . 1.8799999999999999 110.494 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.641 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 80.3 mt -72.14 -45.91 58.6 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.083 -0.508 . . . . 1.0900000000000001 112.146 -170.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.492 HG13 ' O ' ' A' ' 189' ' ' PRO . 1.8 m -75.68 -33.25 25.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.736 0.779 . . . . 0.68000000000000005 108.948 -173.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.596 ' HB2' ' O ' ' A' ' 190' ' ' SER . 1.1 t30 -62.94 -49.13 75.96 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.052 -1.431 . . . . 2.0699999999999998 109.773 175.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.656 ' HA ' ' OD1' ' A' ' 198' ' ' ASN . 5.2 t80 -56.56 -30.49 63.19 Favored 'General case' 0 C--O 1.233 0.222 0 O-C-N 123.739 0.649 . . . . 2.0 109.999 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.75 HG21 HG21 ' A' ' 33' ' ' ILE . 8.7 mt -78.7 -39.83 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-N 115.992 -0.549 . . . . 0.31 112.437 177.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.641 ' HA ' ' HG2' ' A' ' 200' ' ' LYS . 2.8 pp -80.41 -21.72 41.96 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 119.304 -0.958 . . . . 1.03 111.076 -176.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.822 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 1.6 p-10 -74.64 -13.91 60.7 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 118.816 -1.153 . . . . 1.8999999999999999 108.281 166.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.63 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -82.25 -27.31 32.52 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.266 -1.013 . . . . 0.28999999999999998 108.266 170.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.686 ' HD3' HG12 ' A' ' 54' ' ' ILE . 26.3 mmtp -69.36 -38.85 78.29 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.543 -0.753 . . . . 0.96999999999999997 109.333 173.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -86.53 -39.61 16.06 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 114.783 -1.099 . . . . 1.9399999999999999 110.169 -176.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -70.51 -29.55 69.74 Favored Glycine 0 CA--C 1.503 -0.715 0 C-N-CA 120.994 -0.622 . . . . 0.46999999999999997 111.602 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 1.019 HD13 HD23 ' A' ' 61' ' ' LEU . 2.8 tp -71.59 -31.47 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 109.606 -0.516 . . . . 0.60999999999999999 109.606 177.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.561 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 53.3 mttp -86.5 -23.74 25.82 Favored 'General case' 0 C--O 1.204 -1.293 0 N-CA-C 108.836 -0.801 . . . . 3.3700000000000001 108.836 176.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.973 0 N-CA-C 109.221 -0.659 . . . . 1.02 109.221 169.525 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.402 ' O ' ' HB3' ' A' ' 5' ' ' ALA . 10.1 m-20 . . . . . 0 CA--C 1.512 -0.503 0 CA-C-O 120.771 0.32 . . . . 2.25 110.929 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.578 ' HD1' HD22 ' A' ' 114' ' ' LEU . 95.4 m-85 -67.24 -32.14 72.98 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.604 0.716 . . . . 0.42999999999999999 109.466 -176.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.522 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 18.1 tttt -75.48 -1.33 23.64 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 114.594 -1.185 . . . . 1.51 109.855 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 2' ' ' ASP . . . -93.28 -42.47 9.31 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.951 -0.568 . . . . 0.54000000000000004 110.06 171.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.635 ' O ' ' HB ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -84.2 -35.47 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-O 121.08 0.467 . . . . 1.0700000000000001 110.511 -174.371 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.489 ' HB2' HD21 ' A' ' 114' ' ' LEU . . . -80.19 -40.7 26.69 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.096 -0.957 . . . . 0.34000000000000002 111.338 -176.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.522 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 4.0 mt-30 -63.45 -32.8 74.34 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.079 -0.964 . . . . 1.5900000000000001 109.658 176.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.635 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 77.4 mm-40 -78.68 -42.75 27.69 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.613 -1.176 . . . . 2.4700000000000002 109.1 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.635 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -60.24 -35.73 76.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.656 -0.702 . . . . 0.47999999999999998 111.257 179.73 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.456 ' HA ' ' OG ' ' A' ' 128' ' ' SER . . . -48.79 -58.92 4.05 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 121.098 0.475 . . . . 0.31 110.94 171.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -71.99 -18.18 62.0 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.711 -0.677 . . . . 1.6399999999999999 111.564 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.635 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 49.9 mt-10 -68.76 -56.73 7.12 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.03 -0.73 . . . . 2.54 109.03 172.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.695 HG23 ' CE2' ' A' ' 170' ' ' PHE . 11.9 p -68.97 -41.77 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.893 -0.594 . . . . 0.53000000000000003 111.228 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.33 -31.55 65.81 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.543 -0.753 . . . . 0.59999999999999998 109.219 174.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.62 -28.33 73.1 Favored Glycine 0 CA--C 1.503 -0.715 0 CA-C-N 114.21 -1.359 . . . . 0.56999999999999995 110.324 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.492 ' HD1' ' O ' ' A' ' 13' ' ' GLU . 11.6 m-85 -93.05 -16.86 24.52 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.763 -0.718 . . . . 3.27 109.636 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.82 -6.16 40.1 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.54 0.686 . . . . 2.0299999999999998 109.199 -175.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -110.16 -17.32 13.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.641 -1.163 . . . . 2.7200000000000002 109.714 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -100.44 138.19 37.83 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.433 -0.803 . . . . 2.1600000000000001 110.239 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 40.3 p -137.29 88.91 2.38 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.363 0.602 . . . . 1.8200000000000001 111.336 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.1 p -173.78 146.25 1.24 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.173 -0.921 . . . . 2.1899999999999999 111.451 -178.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.495 ' O ' ' HG3' ' A' ' 38' ' ' LYS . . . 92.81 2.27 67.11 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 121.294 -0.479 . . . . 1.1000000000000001 112.807 174.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.498 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -120.04 -158.29 0.74 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.925 0.393 . . . . 1.6699999999999999 110.878 -176.075 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.29 119.24 0.91 Allowed 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 108.811 -0.811 . . . . 2.9500000000000002 108.811 -174.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.603 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 3.1 p -64.24 117.38 4.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 C-N-CA 119.37 -0.932 . . . . 1.5600000000000001 109.726 175.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.4 p -94.09 -23.72 5.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 114.317 -1.311 . . . . 1.22 108.944 -176.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.504 ' HD3' ' C ' ' A' ' 28' ' ' LYS . 0.5 OUTLIER -157.57 123.71 4.79 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 120.252 -0.579 . . . . 2.4100000000000001 110.199 -174.471 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.415 ' HB ' ' HA ' ' A' ' 34' ' ' THR . 0.9 OUTLIER -151.34 152.07 32.64 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.208 0.528 . . . . 1.3799999999999999 111.485 -178.463 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.3 t -112.12 -147.95 0.42 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.579 -0.897 . . . . 2.3700000000000001 108.579 175.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.32 25.87 6.53 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.444 0.64 . . . . 4.5499999999999998 109.38 176.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.545 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 25.6 mmtm -156.73 -44.85 0.07 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 114.911 -1.04 . . . . 1.4199999999999999 111.814 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.459 HG22 ' HA3' ' A' ' 52' ' ' GLY . 24.0 pt -104.87 160.42 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-O 120.766 0.317 . . . . 0.76000000000000001 111.394 -175.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 2.6 m -149.72 109.9 4.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.548 -0.751 . . . . 0.57999999999999996 110.487 -171.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.42 HG22 HG23 ' A' ' 50' ' ' VAL . 16.3 t -103.07 102.13 13.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.161 0.505 . . . . 0.85999999999999999 109.943 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 2.9 p -97.48 124.66 41.78 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.5 -0.773 . . . . 1.1000000000000001 111.693 -176.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.7 t -103.27 125.53 49.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.537 -1.211 . . . . 1.27 109.527 -175.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 29.4 ttpt . . . . . 0 C--N 1.317 -0.818 0 CA-C-N 116.348 -0.387 . . . . 1.9099999999999999 111.283 -176.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 . . . . . 0 N--CA 1.437 -1.101 0 CA-C-O 120.948 0.404 . . . . 2.0499999999999998 110.992 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.751 HD21 ' CD1' ' A' ' 170' ' ' PHE . 4.9 tt -84.76 133.25 34.36 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.95 -1.13 . . . . 0.87 107.95 175.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.624 ' N ' HD23 ' A' ' 47' ' ' LEU . 97.9 m-85 -113.66 128.59 56.48 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.003 0.43 . . . . 0.98999999999999999 110.092 -176.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.441 ' HD2' ' CH2' ' A' ' 24' ' ' TRP . 3.8 tmt_? -122.88 131.35 53.7 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.598 -0.728 . . . . 2.9199999999999999 109.274 177.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 34' ' ' THR . 10.1 p -116.49 151.35 18.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.046 0.45 . . . . 1.3300000000000001 110.543 -176.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.448 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 27.3 tt0 -148.36 108.81 4.14 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.444 -0.798 . . . . 1.0700000000000001 109.408 -172.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 32' ' ' LYS . . . -140.91 138.5 8.93 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 119.978 -1.106 . . . . 0.28999999999999998 112.306 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 67.6 mt -84.56 129.3 37.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.033 0.444 . . . . 0.57999999999999996 110.139 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 63.8 mt -109.59 119.0 49.19 Favored Pre-proline 0 N--CA 1.442 -0.839 0 CA-C-N 115.767 -0.651 . . . . 0.34999999999999998 109.612 177.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 34.0 Cg_exo -61.67 69.17 0.1 Allowed 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 124.262 3.308 . . . . 0.62 112.685 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.596 ' HG2' ' CG1' ' A' ' 203' ' ' ILE . 7.6 tp10 -163.79 176.68 9.3 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.061 -1.088 . . . . 1.6799999999999999 108.061 176.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.506 ' H ' ' HG3' ' A' ' 56' ' ' GLU . 53.4 p -84.75 153.78 61.13 Favored Pre-proline 0 N--CA 1.427 -1.603 0 CA-C-O 121.332 0.587 . . . . 1.1799999999999999 110.298 176.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.5 ' HA ' HD12 ' A' ' 61' ' ' LEU . 11.9 Cg_exo -68.28 -9.58 26.31 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.742 2.961 . . . . 0.52000000000000002 110.26 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.53 -48.72 25.32 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.687 -1.142 . . . . 0.64000000000000001 111.153 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -72.93 -26.5 61.41 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.788 -0.819 . . . . 3.2999999999999998 108.788 -178.392 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.031 HD23 HD13 ' A' ' 203' ' ' ILE . 83.3 mt -64.13 -53.49 48.81 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 114.729 -1.123 . . . . 0.40999999999999998 109.796 173.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.425 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 18.1 m -64.29 -13.45 49.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.502 -0.772 . . . . 1.29 110.442 175.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.427 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 24.6 t70 -84.95 -42.82 14.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.833 -0.621 . . . . 1.3200000000000001 111.564 -178.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.571 ' CD2' ' HA ' ' A' ' 61' ' ' LEU . 11.9 p90 -73.3 -44.38 59.19 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 120.571 -0.452 . . . . 0.60999999999999999 111.2 -174.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.425 ' CD2' ' HA ' ' A' ' 62' ' ' SER . 0.7 OUTLIER -80.79 -16.79 52.87 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 120.433 -0.507 . . . . 1.5 111.965 -173.264 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.631 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 34.8 t80 -26.3 -72.28 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 O-C-N 124.6 1.188 . . . . 1.52 113.811 -153.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.631 ' HG2' ' O ' ' A' ' 66' ' ' TYR . 5.4 mm-40 175.8 115.95 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.08 0 C-N-CA 124.32 1.048 . . . . 3.6000000000000001 108.229 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.727 ' HB ' ' CD1' ' A' ' 81' ' ' TYR . 13.3 t 39.83 31.46 0.08 Allowed 'General case' 0 C--N 1.319 -0.753 0 O-C-N 124.348 1.03 . . . . 1.48 112.584 -177.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.3 -38.79 8.79 Favored Glycine 0 N--CA 1.436 -1.357 0 CA-C-N 115.5 -0.773 . . . . 1.46 113.001 -168.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.655 ' O ' HG22 ' A' ' 73' ' ' THR . 23.3 t70 169.59 -22.04 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.338 -0.986 . . . . 2.1899999999999999 108.338 -163.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.775 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 3.9 ptp180 -43.8 -48.07 8.14 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 114.772 -1.103 . . . . 3.3799999999999999 111.165 -178.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.767 HD13 ' H ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -79.32 -16.08 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 C-N-CA 120.695 -0.402 . . . . 0.70999999999999996 111.613 -172.325 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.655 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.3 t -82.41 -35.86 27.25 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 119.8 -0.76 . . . . 0.96999999999999997 109.995 -174.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.559 ' CZ2' ' HA ' ' A' ' 71' ' ' ARG . 16.8 p-90 -100.96 -3.7 29.01 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.343 -0.543 . . . . 0.75 111.387 -177.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.775 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 3.0 t70 -75.27 177.31 6.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.717 -0.674 . . . . 2.1899999999999999 112.269 -170.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.608 ' HG3' ' OD1' ' A' ' 198' ' ' ASN . 0.0 OUTLIER -133.94 -12.43 2.56 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.539 -0.755 . . . . 3.1899999999999999 111.4 179.246 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.4 m -111.33 -1.73 15.91 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.306 -0.998 . . . . 1.5800000000000001 108.306 178.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.616 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 68.3 mt -110.79 176.81 4.88 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.566 -1.197 . . . . 0.70999999999999996 110.037 -178.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -149.02 -67.95 0.22 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.495 -0.775 . . . . 1.73 110.002 -176.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.503 ' HB ' HD13 ' A' ' 97' ' ' ILE . 26.0 t -143.89 135.87 22.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.643 -0.708 . . . . 0.78000000000000003 109.808 -173.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.727 ' CD1' ' HB ' ' A' ' 68' ' ' THR . 11.4 t80 -112.24 139.29 47.91 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.801 -0.444 . . . . 5.4000000000000004 109.801 176.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.551 ' O ' ' HB3' ' A' ' 95' ' ' HIS . 17.1 m120 -137.71 114.76 10.8 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.902 -0.777 . . . . 1.6899999999999999 108.902 175.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.423 ' HG2' ' NE ' ' A' ' 86' ' ' ARG . 48.6 tpp -75.53 113.02 12.47 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.736 -0.838 . . . . 2.0499999999999998 108.736 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -85.88 -69.74 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.154 0.502 . . . . 0.64000000000000001 110.201 -170.142 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.43 ' HB3' HD12 ' A' ' 93' ' ' ILE . 80.6 t60 -132.91 124.75 28.43 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.718 -0.673 . . . . 1.96 109.7 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.423 ' NE ' ' HG2' ' A' ' 83' ' ' MET . 40.9 mtt180 -101.87 129.06 48.02 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.86 -0.793 . . . . 2.4399999999999999 108.86 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.523 HG21 ' HB2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -91.51 -39.08 11.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.468 0.651 . . . . 0.46999999999999997 109.418 -176.336 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -150.7 -169.4 3.38 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.98 -1.009 . . . . 1.8600000000000001 108.764 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.1 m -80.15 -4.41 52.86 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.858 0.361 . . . . 1.4399999999999999 110.742 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -135.69 13.3 3.43 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 109.884 -0.414 . . . . 1.8700000000000001 109.884 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.511 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -139.01 111.09 7.32 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 109.009 -0.737 . . . . 0.46000000000000002 109.009 -176.781 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.602 ' O ' HD12 ' A' ' 114' ' ' LEU . 41.5 m-85 -128.76 178.96 5.98 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.845 -0.616 . . . . 0.42999999999999999 110.274 -173.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.562 ' O ' HG23 ' A' ' 84' ' ' VAL . 39.1 mt -132.81 124.68 51.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 108.258 -1.016 . . . . 0.40999999999999998 108.258 169.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.643 ' SG ' HG11 ' A' ' 115' ' ' VAL . 75.2 m -92.82 107.67 19.4 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.1 -0.5 . . . . 2.0099999999999998 112.196 -171.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.58 ' HA ' HD13 ' A' ' 112' ' ' ILE . 5.3 t60 -87.11 81.85 7.89 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.027 -1.101 . . . . 1.23 108.027 164.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.444 ' OG1' ' HB3' ' A' ' 94' ' ' CYS . 90.5 m -108.3 113.0 25.75 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.72 -1.127 . . . . 0.5 111.761 -170.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.503 HD13 ' HB ' ' A' ' 80' ' ' VAL . 3.2 mp -77.58 121.57 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 108.227 -1.027 . . . . 1.03 108.227 173.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.599 ' HB ' ' O ' ' A' ' 109' ' ' ARG . 71.8 m -111.27 149.37 31.14 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.94 -1.027 . . . . 1.3799999999999999 110.771 -171.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 C--N 1.319 -0.749 0 CA-C-O 121.046 0.45 . . . . 1.8200000000000001 110.559 -176.237 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 44.0 mt . . . . . 0 N--CA 1.447 -0.595 0 N-CA-C 109.95 -0.389 . . . . 1.1200000000000001 109.95 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.8 m -77.17 155.1 82.41 Favored Pre-proline 0 C--N 1.319 -0.753 0 N-CA-C 109.366 -0.605 . . . . 1.3500000000000001 109.366 174.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -44.71 122.92 4.4 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.681 2.254 . . . . 1.0700000000000001 111.031 173.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.625 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 33.3 ttp180 -118.67 137.44 53.3 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.712 -0.395 . . . . 3.4500000000000002 110.097 -167.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.592 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 22.0 t70 -107.47 147.52 30.36 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 120.754 0.311 . . . . 1.3700000000000001 110.635 -171.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -118.81 155.64 30.82 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.366 0.603 . . . . 2.4100000000000001 111.589 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.628 HG21 ' HE1' ' A' ' 134' ' ' PHE . 35.5 mm -135.78 76.83 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 107.59 -1.263 . . . . 0.42999999999999999 107.59 170.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.57 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 2.1 m-20 -98.91 120.61 39.63 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.579 -0.737 . . . . 1.8600000000000001 110.577 -176.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 92' ' ' PHE . 9.4 tp -75.62 122.04 23.35 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 121.701 0.762 . . . . 0.28000000000000003 109.361 172.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.643 HG11 ' SG ' ' A' ' 94' ' ' CYS . 0.1 OUTLIER -123.58 125.7 71.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-N 114.591 -1.186 . . . . 0.26000000000000001 112.374 -165.123 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.452 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 91.0 t80 -112.87 123.92 51.42 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.332 -0.849 . . . . 2.5699999999999998 110.637 172.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.556 HG13 HG22 ' A' ' 127' ' ' ILE . 4.5 mp -92.07 110.74 23.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.366 -0.834 . . . . 0.89000000000000001 109.783 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.464 ' HB3' HG23 ' A' ' 126' ' ' ILE . 24.8 ttmm -113.41 142.82 45.44 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.032 -0.531 . . . . 1.2 110.596 -176.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -129.01 89.8 2.93 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 116.003 -0.544 . . . . 2.7999999999999998 110.563 -174.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.474 ' HB3' ' HB2' ' A' ' 123' ' ' ASN . 36.9 m-85 -72.29 108.75 5.59 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 107.829 -1.174 . . . . 0.82999999999999996 107.829 167.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -39.81 100.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 O-C-N 124.665 1.228 . . . . 2.2799999999999998 112.813 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.413 ' C ' ' HG2' ' A' ' 157' ' ' PRO . . . 67.12 26.87 73.34 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 114.039 -1.437 . . . . 0.76000000000000001 113.113 176.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.514 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 93.1 m-20 -127.38 -46.13 1.49 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.688 -0.256 . . . . 1.6499999999999999 110.64 176.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.551 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 5.8 mtm -162.19 131.17 4.3 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 120.516 -0.474 . . . . 1.1200000000000001 111.96 -176.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -112.42 86.02 2.27 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.612 -1.255 . . . . 1.6200000000000001 107.612 167.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.595 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -97.78 135.74 31.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.136 -0.938 . . . . 0.29999999999999999 112.244 -172.576 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.681 ' O ' HG13 ' A' ' 127' ' ' ILE . 13.9 pt -101.05 108.89 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 108.576 -0.898 . . . . 0.58999999999999997 108.576 164.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.555 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 1.7 m -75.86 161.05 29.31 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.624 -0.88 . . . . 1.1799999999999999 108.624 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.57 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 11.3 p -157.33 121.11 4.18 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.334 0.588 . . . . 1.24 111.618 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.8 ttmt -127.94 110.71 12.81 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.436 -1.32 . . . . 2.2599999999999998 107.436 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.416 ' OG ' ' HA ' ' A' ' 147' ' ' TYR . 22.9 t -58.71 98.84 0.04 OUTLIER 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 107.629 -1.248 . . . . 1.3899999999999999 107.629 -178.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.427 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -107.59 133.84 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.107 0 CA-C-N 114.833 -1.076 . . . . 1.05 108.727 -165.321 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -94.09 71.15 3.94 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.898 -1.047 . . . . 2.1699999999999999 109.076 -169.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.628 ' HE1' HG21 ' A' ' 112' ' ' ILE . 1.8 p90 -99.26 175.06 2.62 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 114.4 -1.273 . . . . 0.53000000000000003 109.488 -172.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -41.98 -50.4 5.2 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.739 2.959 . . . . 1.28 116.479 -174.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -88.12 -5.13 58.62 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.604 0.716 . . . . 3.5 111.604 -170.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.484 ' HB3' ' O ' ' A' ' 134' ' ' PHE . 22.8 t80 -56.72 -48.94 96.37 Favored Pre-proline 0 C--N 1.315 -0.927 0 N-CA-C 114.914 1.45 . . . . 6.1200000000000001 114.914 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 137' ' ' TYR . 66.6 Cg_exo -32.29 110.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 123.821 3.014 . . . . 1.77 114.467 -174.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.598 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 82.3 Cg_endo -83.84 -160.72 0.12 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.687 2.925 . . . . 1.25 114.036 -175.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.9 p -136.64 -164.35 1.56 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.279 -0.873 . . . . 1.6000000000000001 108.943 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.6 p -89.77 -29.83 18.42 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.126 -0.63 . . . . 1.97 110.972 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -83.45 -33.32 25.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 2.1800000000000002 110.732 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -107.67 109.41 21.01 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 109.425 -0.583 . . . . 1.23 109.425 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.625 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 2.4 tp -100.63 106.66 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 C-N-CA 120.123 -0.631 . . . . 0.81999999999999995 109.646 -176.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.598 ' NH2' ' HA ' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -59.43 99.98 0.07 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.109 -0.95 . . . . 4.4199999999999999 110.715 178.825 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -65.82 122.24 21.54 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.597 -0.729 . . . . 0.79000000000000004 111.297 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.536 ' HB3' ' HB2' ' A' ' 174' ' ' GLU . 3.5 t80 -85.05 78.55 9.87 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.623 0.725 . . . . 4.4400000000000004 110.372 -177.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.685 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 89.0 m-20 -72.55 106.11 4.48 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.736 -1.12 . . . . 1.6200000000000001 110.325 175.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.407 ' O ' ' N ' ' A' ' 151' ' ' CYS . 83.0 m-70 -75.91 144.77 76.65 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 109.545 -0.539 . . . . 2.3199999999999998 109.545 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -13.49 61.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.181 1 C-N-CA 127.599 5.533 . . . . 0.53000000000000003 116.374 -166.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' CYS . . . . . 0.685 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 19.7 p -89.99 -175.08 4.47 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.451 -0.795 . . . . 1.5800000000000001 110.329 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.633 ' N ' HG21 ' A' ' 14' ' ' VAL . . . 178.99 -161.81 28.33 Favored Glycine 0 N--CA 1.435 -1.371 0 C-N-CA 120.456 -0.878 . . . . 0.42999999999999999 111.479 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.499 ' CZ ' HD11 ' A' ' 167' ' ' LEU . 32.5 t80 -161.38 91.42 0.85 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.075 -1.083 . . . . 0.59999999999999998 108.075 -165.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.595 HG12 ' HB ' ' A' ' 126' ' ' ILE . 2.7 m -98.41 132.62 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-O 122.106 0.955 . . . . 0.31 111.123 -174.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' CYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 124' ' ' MET . 16.5 t -109.55 119.28 38.93 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.228 -0.897 . . . . 1.55 109.186 176.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.544 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 6.2 m -116.44 122.41 31.98 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.614 -0.266 . . . . 1.0600000000000001 111.162 -171.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.514 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 46.0 Cg_exo -53.65 126.64 22.48 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.973 1.782 . . . . 0.56000000000000005 110.655 169.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.628 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 70.8 mmm -85.24 -166.61 1.55 Allowed 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.119 0.485 . . . . 1.1599999999999999 111.139 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -74.57 -35.51 63.03 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 121.562 0.696 . . . . 2.6299999999999999 109.225 175.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -102.6 29.49 5.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.874 -1.057 . . . . 2.0499999999999998 108.876 173.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.471 ' HA ' ' O ' ' A' ' 164' ' ' TYR . 2.7 p-10 -28.5 -55.83 0.25 Allowed Pre-proline 0 N--CA 1.475 0.812 0 N-CA-C 116.407 2.002 . . . . 1.9299999999999999 116.407 -171.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.44 ' HD3' ' CG ' ' A' ' 161' ' ' ASN . 55.3 Cg_endo -68.83 -13.59 37.19 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 121.738 1.656 . . . . 0.72999999999999998 112.722 -173.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -109.92 -32.69 6.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.984 -0.553 . . . . 0.68000000000000005 110.765 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.628 ' O ' ' HB2' ' A' ' 158' ' ' MET . 88.3 m-85 -138.76 126.91 22.66 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.417 -0.586 . . . . 0.93000000000000005 109.417 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.467 ' HB2' HD11 ' A' ' 61' ' ' LEU . 73.6 m -125.65 154.22 42.67 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.181 0.515 . . . . 1.4099999999999999 111.853 -176.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.544 ' HB3' ' HB2' ' A' ' 156' ' ' SER . 2.0 tppp? -96.77 105.25 17.34 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.887 0.851 . . . . 0.73999999999999999 112.081 -174.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.499 HD11 ' CZ ' ' A' ' 153' ' ' PHE . 0.6 OUTLIER -92.82 108.82 20.29 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.579 -1.191 . . . . 0.27000000000000002 109.242 175.572 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.592 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -129.92 134.2 63.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.448 0.642 . . . . 0.28000000000000003 111.504 177.206 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.582 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 17.7 ttt -143.49 151.3 40.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.518 -0.765 . . . . 1.24 109.321 -174.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.751 ' CD1' HD21 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -136.03 151.96 50.4 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.366 -0.605 . . . . 3.3700000000000001 109.366 170.777 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.537 ' N ' ' HD1' ' A' ' 170' ' ' PHE . 3.9 p -134.85 132.83 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 115.746 -0.661 . . . . 1.3999999999999999 110.078 176.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.666 ' NE2' HD12 ' A' ' 47' ' ' LEU . 33.1 tt0 -121.09 65.73 0.86 Allowed 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 107.135 -1.432 . . . . 2.1699999999999999 107.135 177.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.511 HG23 ' OD1' ' A' ' 148' ' ' ASN . 1.4 m -68.94 149.47 48.82 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 113.54 -1.664 . . . . 1.6499999999999999 110.465 -175.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 147' ' ' TYR . 4.0 tp10 . . . . . 0 N--CA 1.449 -0.524 0 CA-C-N 116.187 -0.46 . . . . 2.4500000000000002 109.872 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 12.0 mm . . . . . 0 CA--C 1.509 -0.629 0 CA-C-O 122.551 1.167 . . . . 1.1200000000000001 108.997 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.979 ' HA ' HG22 ' A' ' 187' ' ' THR . 0.9 OUTLIER -83.39 -37.12 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 113.113 -1.858 . . . . 1.1299999999999999 110.516 -172.103 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 189' ' ' PRO . 9.2 pt-20 -64.41 -16.72 62.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.489 -0.778 . . . . 2.8900000000000001 109.343 174.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -92.05 -43.7 9.26 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.775 -0.648 . . . . 1.28 110.376 170.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.979 HG22 ' HA ' ' A' ' 184' ' ' ILE . 13.5 t -64.83 -40.33 95.01 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.841 0.682 . . . . 0.62 112.841 -169.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' MET . . . . . 0.496 ' SD ' HG23 ' A' ' 187' ' ' THR . 0.1 OUTLIER -78.04 -61.2 0.61 Allowed Pre-proline 0 N--CA 1.467 0.424 0 CA-C-N 118.407 0.549 . . . . 1.0600000000000001 111.951 -178.456 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.606 ' O ' HG13 ' A' ' 193' ' ' VAL . 51.6 Cg_exo -56.26 -38.74 94.54 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.04 1.827 . . . . 0.91000000000000003 112.258 -176.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.41 ' O ' HG22 ' A' ' 193' ' ' VAL . 23.2 t -72.21 -37.31 69.26 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.414 -0.587 . . . . 1.5 109.414 -177.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ASN . . . . . 0.452 ' HA ' ' HB2' ' A' ' 194' ' ' ASN . 2.6 t-20 -67.4 -31.93 72.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.019 -0.537 . . . . 1.8799999999999999 110.408 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.51 ' HB3' ' CG1' ' A' ' 50' ' ' VAL . 40.5 mt -69.34 -46.22 67.59 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 120.738 0.304 . . . . 1.0900000000000001 111.007 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.606 HG13 ' O ' ' A' ' 189' ' ' PRO . 0.9 OUTLIER -65.06 -34.25 69.28 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 N-CA-C 108.716 -0.846 . . . . 0.68000000000000005 108.716 176.543 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.452 ' HB2' ' HA ' ' A' ' 191' ' ' ASN . 35.0 m-20 -63.64 -45.32 90.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.179 -1.373 . . . . 2.0699999999999998 111.483 178.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.419 ' HA ' ' ND2' ' A' ' 198' ' ' ASN . 6.3 m-85 -59.15 -31.38 68.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.967 0.413 . . . . 2.0 110.417 175.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.474 HG12 HD12 ' A' ' 167' ' ' LEU . 34.3 mt -81.75 -27.17 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-N 116.157 -0.474 . . . . 0.31 111.319 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 62.4 mt -74.57 -40.16 61.81 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-O 121.108 0.48 . . . . 1.03 109.811 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.608 ' OD1' ' HG3' ' A' ' 76' ' ' LYS . 76.5 m-20 -50.07 -37.86 35.6 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.706 -1.134 . . . . 1.8999999999999999 108.53 166.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.648 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -78.17 -43.94 27.25 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 116.081 -0.509 . . . . 0.28999999999999998 110.905 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.56 ' O ' ' HG3' ' A' ' 204' ' ' LYS . 35.6 mmtm -55.96 -44.5 78.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.256 0.551 . . . . 0.96999999999999997 110.565 174.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -87.58 -38.41 15.99 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.495 -0.775 . . . . 1.9399999999999999 110.856 -173.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' GLY . . . . . 0.431 ' HA2' ' HB3' ' A' ' 205' ' ' ALA . . . -68.39 -29.42 73.08 Favored Glycine 0 C--O 1.228 -0.243 0 C-N-CA 121.102 -0.57 . . . . 0.46999999999999997 111.999 178.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 1.031 HD13 HD23 ' A' ' 61' ' ' LEU . 2.8 tp -70.55 -31.68 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-O 120.92 0.391 . . . . 0.60999999999999999 109.949 177.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.56 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 89.3 mttt -84.33 -32.84 24.06 Favored 'General case' 0 C--O 1.21 -1.006 0 N-CA-C 108.514 -0.921 . . . . 3.3700000000000001 108.514 176.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.431 ' HB3' ' HA2' ' A' ' 202' ' ' GLY . . . . . . . . 0 C--N 1.314 -0.95 0 CA-C-N 115.923 -0.581 . . . . 1.02 109.525 170.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 . . . . . 0 CA--C 1.505 -0.78 0 N-CA-C 112.006 0.373 . . . . 2.25 112.006 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.635 ' HB3' HD11 ' A' ' 114' ' ' LEU . 76.0 m-85 -61.99 -26.54 68.28 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 121.236 0.541 . . . . 0.42999999999999999 110.098 -172.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.578 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 39.4 tttt -80.93 -36.44 31.01 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 107.453 -1.314 . . . . 1.51 107.453 -176.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.18 -43.57 82.78 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.897 -0.592 . . . . 0.54000000000000004 111.32 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 3' ' ' PHE . 0.9 OUTLIER -82.75 -32.88 10.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 122.169 0.985 . . . . 1.0700000000000001 109.191 -172.648 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.612 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -81.21 -37.79 28.06 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.176 -1.375 . . . . 0.34000000000000002 111.718 -177.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.578 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 19.5 mt-30 -61.77 -30.13 70.59 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.421 -0.809 . . . . 1.5900000000000001 109.704 175.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.654 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 76.3 mt-30 -78.32 -39.67 38.99 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.482 -1.236 . . . . 2.4700000000000002 109.365 173.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.657 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.4 OUTLIER -72.94 -33.47 65.94 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.424 -0.807 . . . . 0.47999999999999998 112.198 -175.185 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -48.05 -57.92 5.15 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.986 0.422 . . . . 0.31 111.698 174.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.718 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 21.8 pt20 -76.57 1.33 17.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.259 -0.428 . . . . 1.6399999999999999 111.605 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.654 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 10.6 mm-40 -82.8 -48.83 10.36 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.01 -0.737 . . . . 2.54 109.01 169.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.96 HG23 ' HD1' ' A' ' 170' ' ' PHE . 7.4 p -72.0 -34.06 49.45 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-O 121.47 0.653 . . . . 0.53000000000000003 109.818 175.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.718 ' HB3' ' HA ' ' A' ' 12' ' ' GLN . 0.8 OUTLIER -68.15 -26.18 65.64 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 122.361 1.077 . . . . 0.59999999999999998 108.325 172.609 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 20' ' ' ASP . . . -68.75 -20.05 73.84 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 113.797 -1.547 . . . . 0.56999999999999995 109.627 177.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.627 ' HD2' ' HA ' ' A' ' 14' ' ' VAL . 32.1 m-85 -91.08 -22.27 20.81 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 114.315 -0.943 . . . . 3.27 109.376 176.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.487 ' HB3' ' O ' ' A' ' 15' ' ' LEU . 39.7 t30 -60.06 -28.7 68.0 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.356 -0.838 . . . . 2.0299999999999998 109.615 175.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.554 ' HD2' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -115.22 10.89 16.11 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.58 -0.448 . . . . 2.7200000000000002 111.397 175.189 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.577 ' CB ' ' HA ' ' A' ' 17' ' ' TYR . 50.7 t0 -89.6 69.93 7.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.499 0.666 . . . . 2.1600000000000001 109.69 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.518 HG22 ' CH2' ' A' ' 24' ' ' TRP . 34.5 p -104.96 105.86 16.09 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.674 -0.694 . . . . 1.8200000000000001 110.812 -176.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.5 p -169.87 -88.18 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.558 -0.746 . . . . 2.1899999999999999 111.454 -173.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.496 ' O ' ' HG3' ' A' ' 38' ' ' LYS . . . -84.76 52.18 4.66 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 116.086 -0.507 . . . . 1.1000000000000001 113.418 -173.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.871 ' HZ3' ' HD3' ' A' ' 49' ' ' ARG . 0.2 OUTLIER -119.61 -160.05 0.8 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.572 -0.529 . . . . 1.6699999999999999 109.572 176.21 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.1 ttpp -176.09 110.65 0.1 Allowed 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 108.634 -0.876 . . . . 2.9500000000000002 108.634 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.737 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 0.9 OUTLIER -61.14 118.27 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 CA-C-O 121.818 0.818 . . . . 1.5600000000000001 110.303 175.084 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.2 m -98.49 -25.16 4.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 114.317 -1.31 . . . . 1.22 110.011 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.43 ' HB3' ' CG2' ' A' ' 35' ' ' VAL . 0.9 OUTLIER -154.67 135.39 13.58 Favored 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 119.472 -0.891 . . . . 2.4100000000000001 110.09 -178.007 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.502 HG22 ' HA ' ' A' ' 34' ' ' THR . 73.2 p -138.98 153.26 48.15 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.282 0.563 . . . . 1.3799999999999999 110.748 177.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.692 ' HB3' HG12 ' A' ' 33' ' ' ILE . 14.9 t -113.86 -164.4 0.93 Allowed 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.456 -1.313 . . . . 2.3700000000000001 107.456 173.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -93.8 19.31 8.99 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.999 0.428 . . . . 4.5499999999999998 109.912 -176.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.85 ' HE2' ' HA ' ' A' ' 32' ' ' LYS . 3.6 mmpt? -155.02 -17.98 0.11 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.119 -0.946 . . . . 1.4199999999999999 111.573 175.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.828 HG22 ' HA3' ' A' ' 52' ' ' GLY . 35.8 pt -131.35 170.82 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.902 0.382 . . . . 0.76000000000000001 111.907 -172.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.502 ' HA ' HG22 ' A' ' 29' ' ' THR . 23.1 m -160.81 123.12 3.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.325 -0.852 . . . . 0.57999999999999996 110.423 -167.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.578 HG13 HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -112.48 113.85 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.18 0.514 . . . . 0.85999999999999999 110.692 172.788 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.737 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.8 OUTLIER -102.6 125.61 49.39 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.627 -0.715 . . . . 1.1000000000000001 109.871 176.619 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 78.1 p -93.16 125.04 37.55 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 108.65 -0.87 . . . . 1.27 108.65 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.668 ' HA ' ' HA ' ' A' ' 24' ' ' TRP . 57.8 tttm . . . . . 0 C--N 1.305 -1.364 0 CA-C-N 115.751 -0.659 . . . . 1.9099999999999999 110.963 -168.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.445 -0.683 0 CA-C-O 120.972 0.415 . . . . 2.0499999999999998 109.998 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.856 HD11 ' HE2' ' A' ' 170' ' ' PHE . 6.1 tt -78.04 147.85 34.59 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.76 -1.2 . . . . 0.87 107.76 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.834 ' HB3' HD11 ' A' ' 192' ' ' LEU . 4.9 m-85 -129.81 124.61 33.75 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 119.493 -0.883 . . . . 0.98999999999999999 111.288 -172.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.871 ' HD3' ' HZ3' ' A' ' 24' ' ' TRP . 54.3 ttt-85 -120.54 109.56 15.41 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.356 -0.838 . . . . 2.9199999999999999 109.147 177.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.578 HG23 HG13 ' A' ' 35' ' ' VAL . 10.4 p -100.31 150.22 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 109.515 -0.55 . . . . 1.3300000000000001 109.515 -177.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.785 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 41.5 tt0 -156.03 109.6 2.73 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.856 -0.611 . . . . 1.0700000000000001 110.078 -172.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.828 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -140.45 159.58 26.3 Favored Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 111.427 -0.669 . . . . 0.28999999999999998 111.427 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 59.6 mt -99.88 124.24 53.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 C-N-CA 120.57 -0.452 . . . . 0.57999999999999996 110.753 178.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.636 HG12 ' HD2' ' A' ' 200' ' ' LYS . 85.7 mt -101.96 121.35 51.01 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 115.656 -0.702 . . . . 0.34999999999999998 109.926 175.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -64.89 61.41 0.29 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.981 3.121 . . . . 0.62 112.878 177.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.821 ' HG2' HG13 ' A' ' 203' ' ' ILE . 6.9 tp10 -155.4 173.6 16.44 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.051 -1.092 . . . . 1.6799999999999999 108.051 174.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.552 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 52.3 p -83.04 146.75 52.46 Favored Pre-proline 0 N--CA 1.425 -1.72 0 CA-C-O 121.838 0.828 . . . . 1.1799999999999999 109.836 175.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 57' ' ' SER . 27.6 Cg_exo -60.72 -11.05 15.92 Favored 'Trans proline' 0 C--N 1.329 -0.461 0 C-N-CA 124.16 3.24 . . . . 0.52000000000000002 111.478 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.36 -52.03 31.07 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.214 -0.903 . . . . 0.64000000000000001 110.811 174.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.75 ' HE3' ' HB3' ' A' ' 64' ' ' PHE . 18.4 tptt -69.12 -24.03 64.06 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.516 -0.92 . . . . 3.2999999999999998 108.516 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.746 ' HA ' ' CD1' ' A' ' 64' ' ' PHE . 46.5 mt -65.95 -58.71 4.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.642 -0.708 . . . . 0.40999999999999998 110.323 172.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.525 ' HB3' ' HB3' ' A' ' 125' ' ' ASN . 19.8 p -62.26 -11.23 13.84 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.83 -0.543 . . . . 1.29 110.56 176.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.476 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 25.2 t70 -90.9 -44.78 9.16 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.334 0.494 . . . . 1.3200000000000001 112.334 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.829 ' HD2' ' CZ2' ' A' ' 74' ' ' TRP . 10.3 p90 -71.79 -43.26 65.98 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 121.032 -0.267 . . . . 0.60999999999999999 110.721 -168.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.686 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -96.86 6.64 48.28 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.444 -0.503 . . . . 1.5 111.288 -174.59 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -42.18 -73.67 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.083 0.771 . . . . 1.52 113.083 -169.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -152.19 -63.24 0.17 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.17 0.509 . . . . 3.6000000000000001 112.27 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.93 ' HB ' ' CD2' ' A' ' 81' ' ' TYR . 9.1 t -145.08 21.43 1.58 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.995 0.902 . . . . 1.48 109.359 -174.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -88.82 -29.82 17.06 Favored Glycine 0 CA--C 1.491 -1.44 0 CA-C-N 114.84 -1.073 . . . . 1.46 113.87 -168.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.655 ' O ' HG22 ' A' ' 73' ' ' THR . 10.4 t0 -167.28 -35.71 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.365 -0.976 . . . . 2.1899999999999999 108.365 -166.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.766 ' HA ' ' CZ2' ' A' ' 74' ' ' TRP . 1.0 OUTLIER -47.83 -48.24 30.92 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 114.577 -1.192 . . . . 3.3799999999999999 111.582 -172.245 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.887 HG22 HD13 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -87.35 -7.02 10.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 119.743 -0.783 . . . . 0.70999999999999996 111.244 -172.675 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.655 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.4 t -90.65 -30.79 16.93 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 119.76 -0.776 . . . . 0.96999999999999997 110.013 -177.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 1.002 ' HZ3' ' HB3' ' A' ' 198' ' ' ASN . 7.1 p-90 -102.54 -7.6 21.72 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 120.509 -0.476 . . . . 0.75 111.822 178.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.865 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 4.5 t70 -76.57 168.29 20.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.549 0.69 . . . . 2.1899999999999999 111.702 -170.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.681 ' HD2' ' OD1' ' A' ' 194' ' ' ASN . 0.0 OUTLIER -118.51 -16.74 9.48 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.849 -1.069 . . . . 3.1899999999999999 111.286 -177.873 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.4 m -113.83 7.94 17.2 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.911 -0.774 . . . . 1.5800000000000001 108.911 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.887 HD13 HG22 ' A' ' 72' ' ' ILE . 29.8 mt -109.89 167.31 10.26 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.059 -0.973 . . . . 0.70999999999999996 111.283 -178.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.612 ' HG2' ' HG2' ' A' ' 99' ' ' GLN . 6.6 mm100 -146.58 -71.25 0.24 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.393 -0.821 . . . . 1.73 110.686 -175.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.554 HG23 ' HB3' ' A' ' 79' ' ' GLN . 18.8 t -138.55 124.57 24.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.059 -0.973 . . . . 0.78000000000000003 110.112 -170.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.93 ' CD2' ' HB ' ' A' ' 68' ' ' THR . 69.6 t80 -106.68 139.32 41.31 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.491 -0.483 . . . . 5.4000000000000004 110.395 174.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.576 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 17.5 m120 -130.31 104.63 7.39 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.039 -0.726 . . . . 1.6899999999999999 109.039 177.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.534 ' HE1' ' HG2' ' A' ' 86' ' ' ARG . 7.1 tpt -67.77 101.43 1.06 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.148 -0.933 . . . . 2.0499999999999998 109.583 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.553 HG23 ' HB ' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -81.59 -83.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 120.481 -0.487 . . . . 0.64000000000000001 111.551 -171.378 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.519 ' HB2' HD12 ' A' ' 93' ' ' ILE . 49.3 m170 -118.35 127.16 53.43 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.001 0.429 . . . . 1.96 109.887 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.534 ' HG2' ' HE1' ' A' ' 83' ' ' MET . 25.5 mtm180 -108.58 120.9 43.8 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.763 -0.829 . . . . 2.4399999999999999 108.763 176.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.603 HG12 ' O ' ' A' ' 91' ' ' THR . 0.8 OUTLIER -80.94 -55.3 8.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.424 -0.807 . . . . 0.46999999999999997 112.022 -163.427 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -127.66 -83.28 0.6 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.933 -0.576 . . . . 1.8600000000000001 111.085 -173.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.5 t -148.17 -31.35 0.28 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.243 0.544 . . . . 1.4399999999999999 110.08 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -128.11 19.61 6.45 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.4 -0.818 . . . . 1.8700000000000001 109.511 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.603 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -126.18 111.69 14.91 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.083 -1.08 . . . . 0.46000000000000002 108.083 -176.802 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.615 ' O ' HD12 ' A' ' 114' ' ' LEU . 56.1 m-85 -122.88 171.5 9.16 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.799 -0.637 . . . . 0.42999999999999999 110.566 -173.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.553 ' HB ' HG23 ' A' ' 84' ' ' VAL . 23.8 mt -131.12 130.59 63.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 107.678 -1.23 . . . . 0.40999999999999998 107.678 165.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.697 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 26.5 p -101.74 128.72 47.94 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.582 -0.447 . . . . 2.0099999999999998 111.353 -174.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.663 ' HA ' HD13 ' A' ' 112' ' ' ILE . 2.8 t60 -104.3 86.54 2.55 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.269 -1.011 . . . . 1.23 108.269 165.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.691 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 18.5 m -110.47 117.1 32.66 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.415 -0.811 . . . . 0.5 112.2 -168.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 42.0 mm -78.55 125.76 38.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 120.169 -0.612 . . . . 1.03 109.493 173.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.7 m -107.26 146.9 30.89 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.111 -0.949 . . . . 1.3799999999999999 110.705 -173.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.612 ' HG2' ' HG2' ' A' ' 79' ' ' GLN . 6.6 mm-40 . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 115.942 -0.572 . . . . 1.8200000000000001 110.685 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 94.7 mt . . . . . 0 N--CA 1.451 -0.406 0 CA-C-O 121.263 0.554 . . . . 1.1200000000000001 112.139 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.416 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 15.9 m -100.84 169.72 7.49 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.369 -0.832 . . . . 1.3500000000000001 109.434 174.047 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 107' ' ' SER . 65.5 Cg_exo -51.69 123.8 13.07 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.204 1.936 . . . . 1.0700000000000001 110.74 171.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.681 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 39.6 ttm105 -114.82 149.22 37.38 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.382 -0.527 . . . . 3.4500000000000002 110.267 -168.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.644 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 36.7 t0 -109.6 117.46 34.0 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.876 -0.416 . . . . 1.3700000000000001 109.876 -174.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.691 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 9.2 m-30 -98.3 112.32 24.35 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.83 0.348 . . . . 2.4100000000000001 110.877 -175.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.697 ' HA ' ' O ' ' A' ' 94' ' ' CYS . 15.2 mm -115.02 79.81 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 CA-C-N 115.509 -0.769 . . . . 0.42999999999999999 109.317 172.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.588 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 45.6 m-20 -110.25 127.45 54.99 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.676 -0.693 . . . . 1.8600000000000001 109.896 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.635 HD11 ' HB3' ' A' ' 3' ' ' PHE . 4.0 tp -76.82 125.91 30.08 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 109.211 -0.663 . . . . 0.28000000000000003 109.211 173.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -123.92 125.64 71.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 115.233 -0.894 . . . . 0.26000000000000001 112.321 -164.903 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.612 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 85.1 t80 -112.23 115.13 28.3 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.352 -0.84 . . . . 2.5699999999999998 110.812 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.656 HG12 HG22 ' A' ' 127' ' ' ILE . 78.1 mt -91.27 99.29 9.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.974 -0.557 . . . . 0.89000000000000001 109.668 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.558 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 2.6 tppp? -97.55 130.86 44.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.293 -0.867 . . . . 1.2 109.353 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.551 ' NH1' ' HA ' ' A' ' 121' ' ' GLU . 4.3 tmt_? -111.95 91.86 3.81 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 107.847 -1.168 . . . . 2.7999999999999998 107.847 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.412 ' CE1' ' HG2' ' A' ' 118' ' ' LYS . 60.9 m-85 -64.68 115.24 5.05 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 107.813 -1.181 . . . . 0.82999999999999996 107.813 173.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.551 ' HA ' ' NH1' ' A' ' 119' ' ' ARG . 7.4 mm-40 -27.91 90.35 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 O-C-N 125.312 1.632 . . . . 2.2799999999999998 113.398 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 52.62 41.67 57.21 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 115.271 -0.877 . . . . 0.76000000000000001 112.81 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.541 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 64.9 t30 -141.04 -39.0 0.41 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.395 0.146 . . . . 1.6499999999999999 111.395 -175.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.489 ' CG ' ' HB ' ' A' ' 154' ' ' VAL . 3.4 tpp -157.13 118.32 3.67 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.312 -0.555 . . . . 1.1200000000000001 111.22 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.525 ' HB3' ' HB3' ' A' ' 62' ' ' SER . 4.8 m-20 -101.08 73.67 1.54 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.509 -0.923 . . . . 1.6200000000000001 108.509 175.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.799 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -92.34 138.48 19.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.189 -0.914 . . . . 0.29999999999999999 112.667 -172.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.746 HG13 ' O ' ' A' ' 127' ' ' ILE . 1.1 pt -105.59 116.32 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 108.51 -0.922 . . . . 0.58999999999999997 108.51 162.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 4.1 m -81.26 163.46 22.96 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.266 -0.642 . . . . 1.1799999999999999 109.266 173.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.588 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 12.7 p -156.88 131.48 8.74 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.052 0.453 . . . . 1.24 110.968 176.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.53 ' HD3' HD23 ' A' ' 114' ' ' LEU . 20.0 mtpp -131.09 120.78 23.88 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 107.754 -1.202 . . . . 2.2599999999999998 107.754 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.427 ' HB3' ' H ' ' A' ' 148' ' ' ASN . 4.0 p -63.48 98.31 0.16 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.47 -0.937 . . . . 1.3899999999999999 108.47 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.02 138.37 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-N 114.526 -1.215 . . . . 1.05 109.678 -165.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -100.81 74.79 1.66 Allowed 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 122.42 1.105 . . . . 2.1699999999999999 110.306 -170.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.687 ' O ' ' HB3' ' A' ' 137' ' ' TYR . 3.8 p90 -106.37 175.93 1.88 Allowed Pre-proline 0 CA--C 1.554 1.127 0 CA-C-N 114.124 -1.398 . . . . 0.53000000000000003 109.302 -174.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.617 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 25.0 Cg_exo -27.35 -67.27 0.05 OUTLIER 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 125.13 3.887 . . . . 1.28 117.308 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.656 ' HB3' ' CZ ' ' A' ' 134' ' ' PHE . 5.8 tp10 -68.63 -26.34 65.3 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.613 0.597 . . . . 3.5 112.613 -173.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.687 ' HB3' ' O ' ' A' ' 134' ' ' PHE . 0.5 OUTLIER -39.77 -55.23 3.72 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 115.331 1.604 . . . . 6.1200000000000001 115.331 -171.87 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.457 ' HD2' ' O ' ' A' ' 135' ' ' PRO . 44.3 Cg_exo -35.72 106.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.366 1.495 0 C-N-CA 123.432 2.755 . . . . 1.77 114.408 -171.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.542 ' HB2' ' O ' ' A' ' 143' ' ' TYR . 72.9 Cg_endo -88.01 -147.54 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.274 2.65 . . . . 1.25 113.104 -174.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.1 m -143.26 -171.98 3.6 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.785 -0.82 . . . . 1.6000000000000001 108.785 -174.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.2 m -74.98 -38.45 61.66 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.0 -0.68 . . . . 1.97 111.247 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -77.39 -56.63 4.38 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.563 -0.532 . . . . 2.1800000000000002 109.563 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.58 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 87.9 m-85 -79.41 109.49 13.82 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 115.715 -0.675 . . . . 1.23 110.16 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.681 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 1.9 tp -104.42 117.89 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 CA-C-N 115.199 -0.91 . . . . 0.81999999999999995 109.495 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.644 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 0.1 OUTLIER -46.64 116.35 1.29 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.237 -0.892 . . . . 4.4199999999999999 110.775 175.204 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -55.22 108.22 0.94 Allowed Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 114.971 -1.013 . . . . 0.79000000000000004 111.793 176.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 1.116 ' HB3' ' HB3' ' A' ' 174' ' ' GLU . 0.2 OUTLIER -83.43 79.95 9.25 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.496 0.665 . . . . 4.4400000000000004 109.878 177.174 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.682 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 84.8 m-20 -103.2 102.32 12.3 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.262 -1.336 . . . . 1.6200000000000001 108.427 175.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -81.2 143.09 51.88 Favored Pre-proline 0 C--N 1.32 -0.685 0 C-N-CA 120.448 -0.501 . . . . 2.3199999999999998 111.001 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.657 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 8.6 Cg_exo -10.07 59.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.411 1 C-N-CA 127.18 5.253 . . . . 0.53000000000000003 116.355 -163.327 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 151' ' ' CYS . . . . . 0.759 ' HA ' ' CE1' ' A' ' 170' ' ' PHE . 7.8 p -85.58 -179.11 6.83 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.815 -1.084 . . . . 1.5800000000000001 110.513 176.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.706 ' HA3' HG11 ' A' ' 14' ' ' VAL . . . -169.63 -168.09 31.09 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.393 -0.908 . . . . 0.42999999999999999 111.677 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.562 ' CE1' HD11 ' A' ' 167' ' ' LEU . 60.8 t80 -160.18 80.8 0.69 Allowed 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.915 -1.143 . . . . 0.59999999999999998 107.915 -165.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.799 HG12 ' HB ' ' A' ' 126' ' ' ILE . 7.1 m -89.53 124.52 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 121.829 0.823 . . . . 0.31 110.468 -173.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 56.6 m -106.08 113.31 26.78 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.523 -0.762 . . . . 1.55 109.165 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.737 ' HB3' ' HB3' ' A' ' 166' ' ' LYS . 15.5 t -106.07 121.72 44.69 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 116.203 -0.453 . . . . 1.0600000000000001 111.535 -169.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.541 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 69.0 Cg_exo -51.7 114.99 1.83 Allowed 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.726 2.284 . . . . 0.56000000000000005 111.26 169.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.668 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 0.2 OUTLIER -76.32 -167.97 0.88 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.266 0.555 . . . . 1.1599999999999999 112.172 -177.03 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -67.51 -38.08 83.76 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.484 -0.932 . . . . 2.6299999999999999 108.484 169.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.592 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 10.8 mm-40 -97.6 29.06 3.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.099 -1.409 . . . . 2.0499999999999998 108.89 175.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.434 ' CG ' ' HD3' ' A' ' 162' ' ' PRO . 1.2 p-10 -23.84 -58.05 0.13 Allowed Pre-proline 0 N--CA 1.473 0.724 0 N-CA-C 116.515 2.043 . . . . 1.9299999999999999 116.515 -169.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.434 ' HD3' ' CG ' ' A' ' 161' ' ' ASN . 63.1 Cg_endo -72.7 -19.51 24.09 Favored 'Trans proline' 0 C--N 1.35 0.621 0 CA-C-N 121.448 1.553 . . . . 0.72999999999999998 113.451 -175.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -105.73 -25.27 12.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.743 0.306 . . . . 0.68000000000000005 111.415 -177.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.668 ' O ' ' HB2' ' A' ' 158' ' ' MET . 52.9 m-85 -141.05 131.3 24.96 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.858 -0.793 . . . . 0.93000000000000005 108.858 177.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.477 ' OG ' HD11 ' A' ' 61' ' ' LEU . 3.6 p -126.99 148.75 50.09 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.046 0.451 . . . . 1.4099999999999999 111.468 -177.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.785 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.8 tppp? -91.67 104.43 16.9 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.824 0.821 . . . . 0.73999999999999999 111.242 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.562 HD11 ' CE1' ' A' ' 153' ' ' PHE . 0.6 OUTLIER -89.4 106.41 18.43 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.481 -1.236 . . . . 0.27000000000000002 109.762 176.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.724 HG13 HG23 ' A' ' 154' ' ' VAL . 0.1 OUTLIER -131.05 129.12 63.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.644 0.735 . . . . 0.28000000000000003 111.911 176.394 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.606 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 18.2 ttt -137.8 131.7 31.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.228 -0.896 . . . . 1.24 110.17 -172.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.96 ' HD1' HG23 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -111.2 145.15 39.2 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.088 -0.645 . . . . 3.3700000000000001 110.002 174.202 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.65 116.5 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-O 121.415 0.626 . . . . 1.3999999999999999 110.895 176.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.528 ' HB2' ' CZ ' ' A' ' 170' ' ' PHE . 0.0 OUTLIER -94.98 77.28 3.56 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 106.673 -1.603 . . . . 2.1699999999999999 106.673 168.109 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.422 HG21 ' CE ' ' A' ' 188' ' ' MET . 0.6 OUTLIER -74.65 128.31 35.25 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.317 -0.856 . . . . 1.6499999999999999 110.89 -176.827 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 1.116 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 38.4 tp10 . . . . . 0 N--CA 1.447 -0.575 0 CA-C-O 121.261 0.553 . . . . 2.4500000000000002 110.524 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.506 ' HA ' ' HE3' ' A' ' 186' ' ' LYS . 17.6 mm . . . . . 0 CA--C 1.511 -0.53 0 CA-C-O 122.356 1.074 . . . . 1.1200000000000001 108.418 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.97 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.0 OUTLIER -57.98 -37.7 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 CA-C-N 113.302 -1.772 . . . . 1.1299999999999999 109.674 172.17 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -61.86 -22.39 65.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.633 -1.167 . . . . 2.8900000000000001 110.056 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.506 ' HE3' ' HA ' ' A' ' 183' ' ' ILE . 48.1 mttt -91.51 -49.0 6.55 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.179 -0.674 . . . . 1.28 109.179 173.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.97 HG22 ' HA ' ' A' ' 184' ' ' ILE . 11.1 t -62.93 -33.54 75.56 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.378 0.881 . . . . 0.62 113.378 -165.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' MET . . . . . 0.643 ' HE3' HG23 ' A' ' 187' ' ' THR . 0.0 OUTLIER -71.72 -65.9 0.79 Allowed Pre-proline 0 N--CA 1.469 0.504 0 CA-C-N 118.888 0.767 . . . . 1.0600000000000001 111.674 179.613 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.711 ' O ' HG13 ' A' ' 193' ' ' VAL . 27.5 Cg_endo -62.39 -41.79 31.52 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.486 1.457 . . . . 0.91000000000000003 111.471 -176.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.71 ' O ' ' HB3' ' A' ' 194' ' ' ASN . 68.3 m -68.43 -22.82 64.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.364 -0.38 . . . . 1.5 111.377 -174.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 187' ' ' THR . 53.9 m-20 -90.21 -37.7 13.96 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.806 -0.358 . . . . 1.8799999999999999 111.474 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.834 HD11 ' HB3' ' A' ' 48' ' ' TYR . 19.2 mt -60.8 -49.72 76.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.824 0.345 . . . . 1.0900000000000001 111.039 176.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.711 HG13 ' O ' ' A' ' 189' ' ' PRO . 3.0 m -65.4 -31.6 54.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.63 0.729 . . . . 0.68000000000000005 110.029 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.737 ' HA ' ' HG ' ' A' ' 197' ' ' LEU . 0.0 OUTLIER -73.19 -43.62 61.08 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.674 -1.148 . . . . 2.0699999999999998 111.397 -177.747 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -62.36 -26.17 68.31 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.415 -0.957 . . . . 2.0 108.415 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.623 HG21 HG21 ' A' ' 33' ' ' ILE . 20.7 mt -78.37 -44.58 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-N 115.177 -0.919 . . . . 0.31 113.25 175.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.792 HD12 ' N ' ' A' ' 198' ' ' ASN . 3.0 pp -74.1 -31.83 62.97 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 119.336 -0.946 . . . . 1.03 110.332 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 1.002 ' HB3' ' HZ3' ' A' ' 74' ' ' TRP . 9.9 m120 -61.82 -24.58 66.97 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.118 0.485 . . . . 1.8999999999999999 110.017 165.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.832 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -80.77 -29.98 36.11 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 108.713 -0.847 . . . . 0.28999999999999998 108.713 177.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.636 ' HD2' HG12 ' A' ' 54' ' ' ILE . 2.9 mptm? -67.02 -46.17 75.3 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.202 -0.908 . . . . 0.96999999999999997 108.685 175.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.55 -24.8 25.34 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.832 -1.076 . . . . 1.9399999999999999 110.797 -170.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 205' ' ' ALA . . . -78.2 -28.17 56.53 Favored Glycine 0 N--CA 1.46 0.245 0 C-N-CA 120.492 -0.861 . . . . 0.46999999999999997 111.477 174.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.832 ' HB ' ' O ' ' A' ' 199' ' ' ALA . 0.9 OUTLIER -76.95 -35.22 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 123.326 0.65 . . . . 0.60999999999999999 110.214 173.853 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 40.2 mttm -78.17 -21.66 49.88 Favored 'General case' 0 C--O 1.216 -0.698 0 N-CA-C 108.91 -0.774 . . . . 3.3700000000000001 108.91 175.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 202' ' ' GLY . . . . . . . . 0 C--N 1.321 -0.636 0 CA-C-N 115.549 -0.751 . . . . 1.02 109.1 170.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 . . . . . 0 CA--C 1.504 -0.807 0 CA-C-O 119.916 -0.088 . . . . 2.25 110.94 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.56 ' HB2' HG21 ' A' ' 87' ' ' ILE . 65.2 m-85 -59.38 -35.0 73.1 Favored 'General case' 0 CA--C 1.502 -0.882 0 O-C-N 123.945 0.778 . . . . 0.42999999999999999 110.497 -169.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.755 ' O ' ' HB3' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -74.82 -41.25 60.27 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-N 115.273 -0.876 . . . . 1.51 108.736 -177.4 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.413 ' HA ' ' OE1' ' A' ' 8' ' ' GLN . . . -55.98 -45.99 78.8 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.829 -0.623 . . . . 0.54000000000000004 112.31 -178.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.64 ' O ' ' HB ' ' A' ' 10' ' ' THR . 0.2 OUTLIER -79.44 -36.37 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 N-CA-C 108.906 -0.776 . . . . 1.0700000000000001 108.906 -172.453 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.794 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -71.79 -47.74 51.33 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.517 -1.22 . . . . 0.34000000000000002 111.474 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.755 ' HB3' ' O ' ' A' ' 4' ' ' LYS . 3.7 pt20 -53.3 -34.3 56.79 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.344 -1.298 . . . . 1.5900000000000001 109.847 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.645 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 48.5 mt-30 -91.02 -31.63 16.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.879 -1.055 . . . . 2.4700000000000002 109.985 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.64 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -66.42 -35.0 79.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.633 -0.712 . . . . 0.47999999999999998 110.746 178.271 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.573 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -47.44 -58.51 4.1 Favored 'General case' 0 C--O 1.226 -0.154 0 N-CA-C 112.02 0.378 . . . . 0.31 112.02 175.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.463 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 20.8 pt20 -74.96 -6.72 50.81 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.493 -0.322 . . . . 1.6399999999999999 111.344 -178.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.645 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 16.6 mm-40 -81.43 -48.35 12.01 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 121.163 0.506 . . . . 2.54 109.707 175.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.733 HG21 ' N ' ' A' ' 152' ' ' GLY . 10.9 p -70.74 -37.77 70.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.798 0.809 . . . . 0.53000000000000003 109.735 176.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.463 ' HB3' ' HA ' ' A' ' 12' ' ' GLN . 0.8 OUTLIER -67.24 -25.62 66.18 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 122.236 1.017 . . . . 0.59999999999999998 108.338 173.068 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.5 ' HA2' ' CD ' ' A' ' 19' ' ' ARG . . . -67.86 -15.01 66.34 Favored Glycine 0 CA--C 1.5 -0.869 0 CA-C-N 113.679 -1.6 . . . . 0.56999999999999995 110.539 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.8 m-30 -92.42 -19.48 22.01 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.019 -0.591 . . . . 3.27 109.489 177.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -89.88 -27.55 19.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.152 -0.476 . . . . 2.0299999999999998 110.531 178.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.5 ' CD ' ' HA2' ' A' ' 16' ' ' GLY . 5.7 ptm180 -90.8 -20.25 22.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.254 0.55 . . . . 2.7200000000000002 110.178 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -121.44 117.33 26.62 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.927 -0.768 . . . . 2.1600000000000001 108.927 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.6 p -126.47 103.76 7.78 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.388 0.614 . . . . 1.8200000000000001 111.407 -174.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.0 p -170.47 155.49 5.09 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.053 -0.976 . . . . 2.1899999999999999 109.993 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.37 4.1 86.34 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.85 -0.69 . . . . 1.1000000000000001 113.057 174.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.481 ' HA ' ' HB3' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -120.3 -158.07 0.73 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.815 0.341 . . . . 1.6699999999999999 110.933 -178.655 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -172.3 125.36 0.52 Allowed 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 115.883 -0.599 . . . . 2.9500000000000002 109.821 -173.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.685 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 2.5 p -69.28 112.06 3.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-O 122.29 1.043 . . . . 1.5600000000000001 109.836 175.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.5 p -91.01 -23.5 5.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 113.812 -1.54 . . . . 1.22 109.138 -176.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.439 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -156.64 124.15 5.41 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 120.223 -0.591 . . . . 2.4100000000000001 111.768 -173.621 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.537 ' HB ' ' HA ' ' A' ' 34' ' ' THR . 0.4 OUTLIER -150.51 150.99 32.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.074 0.464 . . . . 1.3799999999999999 111.062 -179.597 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.7 t -120.21 -141.09 0.34 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.503 -0.771 . . . . 2.3700000000000001 109.322 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -101.55 17.7 22.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.984 0.421 . . . . 4.5499999999999998 110.787 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.697 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 48.3 mmtt -154.46 -29.23 0.12 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.904 -0.589 . . . . 1.4199999999999999 111.671 177.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.556 ' HA ' ' O ' ' A' ' 51' ' ' GLU . 17.8 pt -116.01 163.12 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 CA-C-O 120.767 0.317 . . . . 0.76000000000000001 111.493 -172.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.537 ' HA ' ' HB ' ' A' ' 29' ' ' THR . 8.8 m -156.42 114.09 3.24 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.108 -0.951 . . . . 0.57999999999999996 110.515 -172.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 49' ' ' ARG . 42.5 t -105.4 110.85 32.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.518 -0.31 . . . . 0.85999999999999999 110.554 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.685 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 4.1 m -109.6 123.5 49.55 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.636 0.732 . . . . 1.1000000000000001 111.092 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 28.2 p -108.2 131.11 55.0 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.32 -1.309 . . . . 1.27 112.781 -171.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.481 ' HB3' ' HA ' ' A' ' 24' ' ' TRP . 44.3 pttt . . . . . 0 C--N 1.323 -0.564 0 CA-C-N 115.128 -0.942 . . . . 1.9099999999999999 110.176 171.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 . . . . . 0 N--CA 1.449 -0.523 0 CA-C-O 120.843 0.354 . . . . 2.0499999999999998 110.611 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.612 HD12 ' NE2' ' A' ' 172' ' ' GLN . 4.0 tt -90.19 134.26 34.39 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.325 -0.991 . . . . 0.87 108.325 175.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.61 ' N ' HD23 ' A' ' 47' ' ' LEU . 69.1 m-85 -121.58 120.38 34.64 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.836 -0.431 . . . . 0.98999999999999999 109.836 -177.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.539 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.3 OUTLIER -101.51 117.66 35.38 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.162 -0.681 . . . . 2.9199999999999999 109.162 174.538 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.596 HG22 HD12 ' A' ' 196' ' ' ILE . 14.7 p -107.17 131.89 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 108.798 -0.816 . . . . 1.3300000000000001 108.798 177.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.556 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 34.0 tt0 -136.06 117.92 15.18 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.644 -0.707 . . . . 1.0700000000000001 110.783 -169.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.697 ' HA2' ' O ' ' A' ' 32' ' ' LYS . . . -142.24 144.38 14.07 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.872 -0.68 . . . . 0.28999999999999998 111.675 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 92.4 mt -84.85 122.87 38.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 119.635 -0.826 . . . . 0.57999999999999996 110.479 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.429 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 42.0 mt -105.11 110.69 64.79 Favored Pre-proline 0 N--CA 1.443 -0.816 0 N-CA-C 108.69 -0.856 . . . . 0.34999999999999998 108.69 174.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 164' ' ' TYR . 39.5 Cg_exo -63.11 54.89 0.15 Allowed 'Trans proline' 0 N--CA 1.476 0.491 0 C-N-CA 124.442 3.428 . . . . 0.62 113.915 -177.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.47 ' HG2' HG13 ' A' ' 203' ' ' ILE . 10.9 tp10 -151.16 168.38 24.85 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.657 -1.238 . . . . 1.6799999999999999 107.657 174.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.445 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 73.3 p -69.74 144.48 93.68 Favored Pre-proline 0 N--CA 1.43 -1.433 0 CA-C-O 121.88 0.848 . . . . 1.1799999999999999 111.117 -176.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.495 ' HA ' HD12 ' A' ' 61' ' ' LEU . 23.9 Cg_exo -61.31 -15.79 42.7 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.432 2.755 . . . . 0.52000000000000002 110.125 175.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.4 -47.84 58.97 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.559 -1.201 . . . . 0.64000000000000001 110.862 173.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.438 ' HG2' HG13 ' A' ' 203' ' ' ILE . 2.1 tpmt? -67.19 -30.08 69.93 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.049 -1.093 . . . . 3.2999999999999998 108.049 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.842 HD23 HD13 ' A' ' 203' ' ' ILE . 55.8 mt -62.36 -54.92 33.4 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.867 -1.061 . . . . 0.40999999999999998 110.205 174.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.6 p -62.96 -9.18 8.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.071 0.462 . . . . 1.29 110.717 176.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -91.35 -33.36 15.32 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.566 0.58 . . . . 1.3200000000000001 112.566 174.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.666 ' CE2' ' HA ' ' A' ' 199' ' ' ALA . 2.9 p90 -78.31 -45.05 23.65 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 120.399 -0.52 . . . . 0.60999999999999999 110.69 -169.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -83.51 -7.3 59.56 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 121.056 -0.258 . . . . 1.5 111.041 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -9.95 -72.69 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 O-C-N 125.571 1.794 . . . . 1.52 114.679 -159.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -158.52 -62.4 0.08 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.713 1.005 . . . . 3.6000000000000001 113.713 -172.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.678 ' OG1' ' HB2' ' A' ' 81' ' ' TYR . 11.6 t -178.35 27.96 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.352 0.596 . . . . 1.48 109.543 -162.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -127.95 -16.91 2.12 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 119.249 -1.453 . . . . 1.46 113.138 -171.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.538 ' O ' HG22 ' A' ' 73' ' ' THR . 1.7 p30 -159.34 -21.6 0.07 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 111.896 0.332 . . . . 2.1899999999999999 111.896 -177.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.704 ' HA ' ' NE1' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -67.47 -16.44 64.21 Favored 'General case' 0 C--O 1.217 -0.62 0 O-C-N 122.069 -0.394 . . . . 3.3799999999999999 110.982 -174.913 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.665 HD13 ' H ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -90.48 -20.25 6.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.234 0.54 . . . . 0.70999999999999996 109.937 173.521 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.538 HG22 ' O ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -82.2 -24.47 34.91 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.603 -0.726 . . . . 0.96999999999999997 110.363 -170.667 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.704 ' NE1' ' HA ' ' A' ' 71' ' ' ARG . 24.9 p-90 -108.47 -4.35 17.37 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.276 -0.569 . . . . 0.75 111.205 177.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.658 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 2.9 t70 -74.92 177.68 6.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.815 0.817 . . . . 2.1899999999999999 112.659 -168.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.422 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -123.07 -22.81 5.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.473 -1.24 . . . . 3.1899999999999999 111.007 -179.217 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.1 t -121.69 9.36 10.14 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.47 -0.567 . . . . 1.5800000000000001 109.47 -176.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.607 HD13 HG22 ' A' ' 72' ' ' ILE . 36.4 mt -109.1 169.5 8.64 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.649 -0.705 . . . . 0.70999999999999996 110.476 177.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.611 ' HG2' ' HG2' ' A' ' 99' ' ' GLN . 10.5 mm100 -147.41 -58.78 0.26 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.75 -0.659 . . . . 1.73 111.674 -173.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.636 ' O ' ' HA ' ' A' ' 96' ' ' THR . 25.6 t -138.15 117.9 15.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.78000000000000003 111.254 -166.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.678 ' HB2' ' OG1' ' A' ' 68' ' ' THR . 45.3 p90 -89.99 151.32 21.74 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 116.194 -0.457 . . . . 5.4000000000000004 110.852 174.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.446 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 4.2 m120 -158.95 108.94 1.98 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.603 -0.726 . . . . 1.6899999999999999 109.52 173.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.805 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 13.5 ttm -71.1 103.99 2.9 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.604 -0.887 . . . . 2.0499999999999998 108.604 177.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -84.78 -71.96 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 120.47 -0.492 . . . . 0.64000000000000001 112.029 -170.771 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.418 ' HB3' HD12 ' A' ' 93' ' ' ILE . 21.1 t60 -136.37 107.61 6.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.205 -0.452 . . . . 1.96 109.833 -175.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.805 ' HD3' ' SD ' ' A' ' 83' ' ' MET . 28.3 mtm180 -93.72 112.41 24.28 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.588 -0.523 . . . . 2.4399999999999999 109.588 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.632 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -75.69 -37.08 35.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.917 -0.583 . . . . 0.46999999999999997 109.614 -178.913 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -157.69 -179.32 8.05 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.236 -0.893 . . . . 1.8600000000000001 108.856 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.8 m -78.28 4.41 12.89 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.638 0.256 . . . . 1.4399999999999999 110.907 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -138.35 6.17 2.54 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.355 -0.609 . . . . 1.8700000000000001 109.355 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.632 ' O ' HG12 ' A' ' 87' ' ' ILE . 1.1 m -141.99 109.54 5.68 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.532 -0.914 . . . . 0.46000000000000002 108.532 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.547 ' O ' HD12 ' A' ' 114' ' ' LEU . 33.9 m-85 -128.95 174.98 9.03 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.475 0.655 . . . . 0.42999999999999999 110.764 -173.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.718 ' O ' HG23 ' A' ' 84' ' ' VAL . 36.2 mt -133.38 123.25 46.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 106.616 -1.624 . . . . 0.40999999999999998 106.616 166.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 78.6 m -110.47 124.45 51.8 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.732 -0.387 . . . . 2.0099999999999998 110.665 -173.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.51 ' HA ' ' O ' ' A' ' 111' ' ' PHE . 11.5 t-160 -89.39 118.75 29.28 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 108.507 -0.923 . . . . 1.23 108.507 168.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.636 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 89.8 m -136.98 123.45 20.83 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.727 -0.67 . . . . 0.5 111.228 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 46.5 mm -78.43 132.61 32.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 O-C-N 121.501 -0.749 . . . . 1.03 109.593 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.5 ' HB ' ' HB2' ' A' ' 109' ' ' ARG . 2.3 m -110.36 146.34 35.95 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.783 -0.644 . . . . 1.3799999999999999 110.745 -174.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.611 ' HG2' ' HG2' ' A' ' 79' ' ' GLN . 7.5 mm-40 . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 115.908 -0.587 . . . . 1.8200000000000001 110.443 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 65.4 mt . . . . . 0 N--CA 1.448 -0.566 0 CA-C-O 120.618 0.247 . . . . 1.1200000000000001 110.72 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.3 m -84.04 153.24 63.2 Favored Pre-proline 0 N--CA 1.449 -0.496 0 CA-C-N 116.111 -0.495 . . . . 1.3500000000000001 110.06 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -60.48 137.1 71.89 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.147 1.898 . . . . 1.0700000000000001 110.01 174.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.5 ' HB2' ' HB ' ' A' ' 98' ' ' THR . 54.5 mtt180 -111.92 159.69 18.14 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.604 -0.839 . . . . 3.4500000000000002 111.213 -172.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.681 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 12.9 t70 -107.35 143.14 36.07 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.72 -1.215 . . . . 1.3700000000000001 107.72 176.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.585 ' HB3' ' HB ' ' A' ' 96' ' ' THR . 50.6 t80 -122.36 115.07 21.66 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.59 -0.522 . . . . 2.4100000000000001 109.59 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.668 HG21 ' CE1' ' A' ' 134' ' ' PHE . 12.8 mm -132.7 85.85 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.016 -0.993 . . . . 0.42999999999999999 108.517 175.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.582 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 1.0 OUTLIER -116.14 131.52 56.92 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.807 -0.633 . . . . 1.8600000000000001 110.944 -177.453 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.622 ' O ' ' HA ' ' A' ' 129' ' ' SER . 6.6 tp -80.77 121.87 26.46 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.241 -0.89 . . . . 0.28000000000000003 109.068 172.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.453 HG23 ' HB ' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -123.76 125.71 71.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-N 115.398 -0.819 . . . . 0.26000000000000001 111.747 -165.235 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.794 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 11.6 t80 -107.5 118.73 37.49 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.059 -0.973 . . . . 2.5699999999999998 110.634 177.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.547 HG13 HG22 ' A' ' 127' ' ' ILE . 4.7 mp -94.44 100.71 11.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.03 -0.532 . . . . 0.89000000000000001 109.839 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -114.02 142.69 45.86 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.717 -0.475 . . . . 1.2 109.717 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.457 ' NH1' ' HA ' ' A' ' 121' ' ' GLU . 3.2 tmt_? -127.22 95.36 4.26 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 108.503 -0.925 . . . . 2.7999999999999998 108.503 -177.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -64.67 118.49 8.97 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 107.901 -1.148 . . . . 0.82999999999999996 107.901 174.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.457 ' HA ' ' NH1' ' A' ' 119' ' ' ARG . 8.0 mm-40 -38.24 90.47 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.923 1.389 . . . . 2.2799999999999998 113.148 -175.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 62.97 36.06 92.93 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.178 -0.919 . . . . 0.76000000000000001 112.419 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.533 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 65.7 t30 -132.85 -45.41 0.87 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.526 -0.175 . . . . 1.6499999999999999 110.526 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.401 ' O ' ' HA ' ' A' ' 119' ' ' ARG . 1.6 mpt? -157.81 131.03 7.62 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 120.733 0.302 . . . . 1.1200000000000001 111.812 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -106.36 79.39 1.37 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.169 -1.048 . . . . 1.6200000000000001 108.169 170.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.507 ' CG1' HG12 ' A' ' 154' ' ' VAL . 0.4 OUTLIER -99.82 140.9 17.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.586 -0.734 . . . . 0.29999999999999999 112.801 -171.96 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.738 ' O ' HG13 ' A' ' 127' ' ' ILE . 4.3 pt -110.16 110.62 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-O 121.904 0.859 . . . . 0.58999999999999997 108.766 162.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.573 ' HB3' ' HA ' ' A' ' 11' ' ' ALA . 53.2 p -93.92 113.5 25.52 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 121.853 -0.529 . . . . 1.1799999999999999 110.208 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.622 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 7.0 m -110.91 150.58 29.01 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.411 -0.813 . . . . 1.24 111.203 -170.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.424 ' HE2' ' HG3' ' A' ' 150' ' ' PRO . 3.5 mtpm? -136.62 117.58 14.24 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 107.606 -1.257 . . . . 2.2599999999999998 107.606 175.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.504 ' HB2' ' H ' ' A' ' 148' ' ' ASN . 33.3 t -63.51 98.37 0.17 Allowed 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.075 -1.454 . . . . 1.3899999999999999 107.075 175.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.445 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -108.16 141.58 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.035 0 CA-C-N 114.57 -1.196 . . . . 1.05 108.988 -163.753 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -100.47 71.02 1.51 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 122.291 1.043 . . . . 2.1699999999999999 108.682 -170.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.775 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -98.2 159.52 30.5 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-N 113.668 -1.606 . . . . 0.53000000000000003 110.629 -171.589 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.96 -12.96 16.02 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.941 2.427 . . . . 1.28 114.785 -171.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.775 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 5.6 tp10 -72.41 -16.93 61.84 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 109.388 -0.597 . . . . 3.5 109.388 -172.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.464 ' HB2' HG11 ' A' ' 84' ' ' VAL . 15.5 t80 -163.52 118.43 1.12 Allowed Pre-proline 0 N--CA 1.448 -0.558 0 N-CA-C 113.066 0.765 . . . . 6.1200000000000001 113.066 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 95.8 Cg_endo -92.73 145.63 2.55 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.306 2.671 . . . . 1.77 110.834 166.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 138' ' ' PRO . 7.3 Cg_exo -72.29 -155.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.538 2.159 . . . . 1.25 112.336 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.2 m -147.15 155.92 42.55 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.823 -0.806 . . . . 1.6000000000000001 108.823 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.9 p -73.11 -0.25 13.55 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.197 0.443 . . . . 1.97 112.197 -173.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -105.16 -16.12 14.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.056 0.455 . . . . 2.1800000000000002 110.006 175.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.411 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 87.9 m-85 -132.36 108.91 9.49 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.515 -0.766 . . . . 1.23 109.904 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.41 HG23 ' HG2' ' A' ' 109' ' ' ARG . 2.7 tp -90.75 112.88 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 C-N-CA 120.366 -0.533 . . . . 0.81999999999999995 110.523 -176.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.681 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 64.9 ttp85 -49.41 102.22 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.408 -0.815 . . . . 4.4199999999999999 109.741 171.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -60.08 117.43 11.34 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 110.617 -0.993 . . . . 0.79000000000000004 110.617 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.465 ' HB3' ' CB ' ' A' ' 174' ' ' GLU . 65.0 t80 -83.45 85.59 7.22 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.791 0.805 . . . . 4.4400000000000004 111.17 -174.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.642 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 78.7 m-20 -77.83 98.81 5.7 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.426 -1.261 . . . . 1.6200000000000001 109.539 171.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.448 ' O ' ' HB3' ' A' ' 172' ' ' GLN . 24.6 t-80 -71.71 129.83 87.9 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 108.062 -1.088 . . . . 2.3199999999999998 108.062 176.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.52 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 46.1 Cg_exo -13.54 66.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.122 1 C-N-CA 126.973 5.115 . . . . 0.53000000000000003 115.905 -163.396 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 151' ' ' CYS . . . . . 0.642 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 24.2 p -112.31 156.4 22.5 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.845 -1.07 . . . . 1.5800000000000001 108.553 174.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.733 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -145.23 -147.35 4.61 Favored Glycine 0 N--CA 1.433 -1.528 0 C-N-CA 119.256 -1.449 . . . . 0.42999999999999999 113.624 -169.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.533 ' CZ ' HD21 ' A' ' 167' ' ' LEU . 55.1 t80 -162.06 92.06 0.82 Allowed 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.472 -0.936 . . . . 0.59999999999999998 108.472 -164.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.577 ' CG2' HG13 ' A' ' 168' ' ' VAL . 2.4 m -102.06 132.3 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-O 121.696 0.76 . . . . 0.31 110.776 -175.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 37.0 m -112.52 107.68 16.51 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.371 -0.831 . . . . 1.55 109.272 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.463 ' O ' ' HB3' ' A' ' 166' ' ' LYS . 9.8 m -104.75 114.13 64.22 Favored Pre-proline 0 C--N 1.315 -0.916 0 C-N-CA 120.771 -0.371 . . . . 1.0600000000000001 111.267 -169.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.533 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 53.1 Cg_exo -49.8 120.88 6.49 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.511 2.14 . . . . 0.56000000000000005 111.397 174.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.588 ' SD ' ' HB2' ' A' ' 166' ' ' LYS . 87.3 mmm -76.17 -165.62 0.51 Allowed 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.03 0.443 . . . . 1.1599999999999999 111.429 -176.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -66.09 -22.7 66.42 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.687 -0.688 . . . . 2.6299999999999999 109.708 177.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -109.16 19.58 19.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.414 -0.812 . . . . 2.0499999999999998 110.047 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.536 ' HB2' ' CD ' ' A' ' 162' ' ' PRO . 11.7 m-80 27.2 -91.05 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.872 1.669 . . . . 1.9299999999999999 115.483 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.536 ' CD ' ' HB2' ' A' ' 161' ' ' ASN . 93.2 Cg_endo -74.76 -13.41 21.99 Favored 'Trans proline' 0 C--N 1.366 1.496 0 CA-C-N 121.709 1.646 . . . . 0.72999999999999998 112.866 -173.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -89.99 -34.68 15.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.042 -0.526 . . . . 0.68000000000000005 110.672 -177.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.444 ' O ' ' HB2' ' A' ' 158' ' ' MET . 78.2 m-85 -139.88 132.0 28.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.393 -0.367 . . . . 0.93000000000000005 110.24 176.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 34.9 t -123.59 145.01 49.23 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.595 0.712 . . . . 1.4099999999999999 111.171 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.588 ' HB2' ' SD ' ' A' ' 158' ' ' MET . 15.3 tppt? -93.87 100.94 13.02 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.268 -0.878 . . . . 0.73999999999999999 111.161 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.533 HD21 ' CZ ' ' A' ' 153' ' ' PHE . 0.9 OUTLIER -85.54 108.4 17.92 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.054 -0.975 . . . . 0.27000000000000002 109.335 178.614 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.577 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -129.31 114.55 32.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-O 122.115 0.96 . . . . 0.28000000000000003 111.319 177.349 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 18.7 ttt -115.63 141.51 47.97 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.539 -1.21 . . . . 1.24 110.693 -172.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.548 ' O ' ' HB2' ' A' ' 151' ' ' CYS . 73.7 m-85 -115.69 127.47 55.18 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.545 -0.752 . . . . 3.3700000000000001 110.972 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.451 HG13 ' OG1' ' A' ' 173' ' ' THR . 1.0 OUTLIER -112.48 113.64 44.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.598 -0.728 . . . . 1.3999999999999999 110.042 174.19 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.612 ' NE2' HD12 ' A' ' 47' ' ' LEU . 33.9 tt0 -116.18 41.3 2.64 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 106.001 -1.852 . . . . 2.1699999999999999 106.001 171.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.451 ' OG1' HG13 ' A' ' 171' ' ' VAL . 18.9 m -69.65 149.82 47.69 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 112.53 -2.123 . . . . 1.6499999999999999 110.46 -174.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.465 ' CB ' ' HB3' ' A' ' 147' ' ' TYR . 8.1 tt0 . . . . . 0 C--N 1.325 -0.475 0 CA-C-O 121.482 0.658 . . . . 2.4500000000000002 111.435 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.448 ' HA ' ' CE ' ' A' ' 186' ' ' LYS . 27.9 mm . . . . . 0 CA--C 1.506 -0.715 0 CA-C-O 122.585 1.183 . . . . 1.1200000000000001 108.985 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.94 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.1 mp -64.88 -37.8 81.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 112.887 -1.96 . . . . 1.1299999999999999 111.473 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -64.16 -17.92 63.95 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.314 -0.624 . . . . 2.8900000000000001 109.314 175.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.448 ' CE ' ' HA ' ' A' ' 183' ' ' ILE . 49.5 mtmt -92.85 -43.59 8.91 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.75 -0.659 . . . . 1.28 110.299 173.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.94 HG22 ' HA ' ' A' ' 184' ' ' ILE . 15.1 t -61.1 -33.42 73.33 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.734 0.642 . . . . 0.62 112.734 -169.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' MET . . . . . 0.631 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 15.6 mmt -78.43 -59.39 0.71 Allowed Pre-proline 0 C--N 1.332 -0.173 0 C-N-CA 119.646 -0.821 . . . . 1.0600000000000001 110.835 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.631 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 33.9 Cg_exo -62.93 -22.07 73.58 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 121.917 1.745 . . . . 0.91000000000000003 112.216 -176.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.783 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 67.2 m -81.08 -22.96 38.81 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.796 -0.362 . . . . 1.5 110.489 175.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.2 OUTLIER -91.43 -37.59 13.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.814 0.34 . . . . 1.8799999999999999 111.074 -176.635 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.534 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 2.2 mt -62.13 -56.92 13.98 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.558 0.694 . . . . 1.0900000000000001 111.161 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 189' ' ' PRO . 1.6 m -66.93 -32.13 56.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.707 -1.133 . . . . 0.68000000000000005 109.033 -175.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.783 ' HB2' ' O ' ' A' ' 190' ' ' SER . 26.4 t30 -63.1 -48.27 79.3 Favored 'General case' 0 C--O 1.208 -1.099 0 CA-C-N 113.911 -1.495 . . . . 2.0699999999999998 109.727 177.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.53 ' O ' ' HB2' ' A' ' 198' ' ' ASN . 2.8 t80 -62.04 -25.33 67.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.956 0.407 . . . . 2.0 110.283 -178.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.596 HD12 HG22 ' A' ' 50' ' ' VAL . 14.6 mt -80.22 -29.57 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-O 120.993 0.425 . . . . 0.31 110.988 174.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 83.3 mt -74.93 -36.71 62.13 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.302 0.572 . . . . 1.03 109.481 174.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.53 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 4.9 m-20 -48.56 -39.17 22.69 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.756 -1.111 . . . . 1.8999999999999999 108.995 163.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.703 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -80.5 -44.52 19.02 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 116.027 -0.533 . . . . 0.28999999999999998 111.247 -176.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 28.7 mmtp -54.41 -46.23 73.1 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.734 0.778 . . . . 0.96999999999999997 110.187 173.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -80.04 -45.44 18.33 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.614 -1.175 . . . . 1.9399999999999999 110.416 -175.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -64.42 -31.55 81.23 Favored Glycine 0 C--O 1.228 -0.246 0 C-N-CA 121.004 -0.617 . . . . 0.46999999999999997 112.555 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.842 HD13 HD23 ' A' ' 61' ' ' LEU . 1.8 tp -69.89 -37.23 72.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.836 0.351 . . . . 0.60999999999999999 110.202 178.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -85.13 -20.81 29.74 Favored 'General case' 0 C--O 1.21 -1.024 0 N-CA-C 109.071 -0.714 . . . . 3.3700000000000001 109.071 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.974 0 CA-C-N 116.007 -0.542 . . . . 1.02 109.682 168.166 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.51 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.3 t70 . . . . . 0 CA--C 1.516 -0.357 0 CA-C-O 121.492 0.663 . . . . 2.25 109.639 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.817 ' HA ' HD11 ' A' ' 6' ' ' ILE . 98.8 m-85 -70.46 -29.87 66.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.289 -0.868 . . . . 0.42999999999999999 109.367 -175.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.524 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 27.1 tttm -74.42 -3.88 33.25 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.822 -1.081 . . . . 1.51 109.766 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 2' ' ' ASP . . . -91.95 -44.89 8.63 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.016 -0.538 . . . . 0.54000000000000004 109.95 172.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.817 HD11 ' HA ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -82.98 -41.34 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-O 121.425 0.631 . . . . 1.0700000000000001 110.727 -173.024 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.626 ' HB2' HD21 ' A' ' 114' ' ' LEU . . . -74.39 -39.59 62.59 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.988 -1.006 . . . . 0.34000000000000002 111.34 -176.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.524 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 2.4 mt-30 -68.15 -27.01 66.06 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.82 -1.082 . . . . 1.5900000000000001 110.232 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -81.79 -33.12 31.02 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.765 -1.107 . . . . 2.4700000000000002 109.111 172.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.65 ' HA ' ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -71.49 -39.06 71.11 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.23 -0.895 . . . . 0.47999999999999998 111.723 179.704 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.621 ' HA ' ' CB ' ' A' ' 128' ' ' SER . . . -48.15 -60.13 2.87 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-O 121.109 0.48 . . . . 0.31 111.87 176.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.419 ' H ' ' HG2' ' A' ' 12' ' ' GLN . 20.3 pt20 -76.55 0.11 21.22 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.174 -0.466 . . . . 1.6399999999999999 111.579 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.65 ' HB3' ' HA ' ' A' ' 10' ' ' THR . 1.1 tt0 -90.73 -45.29 8.93 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.055 -0.72 . . . . 2.54 109.055 174.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.823 HG23 ' CE2' ' A' ' 170' ' ' PHE . 4.1 p -70.44 -47.39 65.97 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.041 0 N-CA-C 109.001 -0.74 . . . . 0.53000000000000003 109.001 171.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.627 ' HG ' ' OD1' ' A' ' 18' ' ' ASN . 1.0 OUTLIER -61.77 -24.96 67.17 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.362 1.077 . . . . 0.59999999999999998 108.338 175.038 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 20' ' ' ASP . . . -63.19 -21.22 63.79 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 113.774 -1.557 . . . . 0.56999999999999995 110.406 178.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.926 ' CE1' ' HG3' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -87.25 -33.44 19.28 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.097 -0.705 . . . . 3.27 109.097 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.627 ' OD1' ' HG ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -80.38 -16.98 53.23 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.424 0.63 . . . . 2.0299999999999998 110.073 -167.884 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.458 ' HD2' HD23 ' A' ' 15' ' ' LEU . 24.9 mtp180 -101.52 -20.35 15.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.142 -0.936 . . . . 2.7200000000000002 110.133 175.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 16' ' ' GLY . 35.2 t70 -118.51 84.3 2.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.787 -0.642 . . . . 2.1600000000000001 109.821 -178.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.9 p -108.0 127.02 53.4 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 120.916 0.389 . . . . 1.8200000000000001 111.751 -172.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.4 t 173.23 162.23 0.14 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.366 -0.834 . . . . 2.1899999999999999 109.522 -173.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.44 1.73 90.21 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 121.183 -0.532 . . . . 1.1000000000000001 113.111 174.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -112.75 -157.39 0.62 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.837 0.351 . . . . 1.6699999999999999 110.876 -177.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 tpmt? -173.24 118.1 0.3 Allowed 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 108.851 -0.796 . . . . 2.9500000000000002 108.851 -172.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.662 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 2.8 m -63.19 116.87 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.989 0 CA-C-O 122.116 0.96 . . . . 1.5600000000000001 110.789 176.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.459 HG13 ' HB2' ' A' ' 28' ' ' LYS . 10.9 p -98.38 -24.74 4.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 113.979 -1.464 . . . . 1.22 109.719 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.459 ' HB2' HG13 ' A' ' 27' ' ' VAL . 1.2 tmtt? -154.37 120.39 5.29 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 119.471 -0.892 . . . . 2.4100000000000001 110.537 -170.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.542 ' HB ' ' HA ' ' A' ' 34' ' ' THR . 0.2 OUTLIER -149.71 135.05 18.25 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.477 0.656 . . . . 1.3799999999999999 110.506 175.096 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.4 m -88.39 -68.35 0.77 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.841 -1.072 . . . . 2.3700000000000001 111.299 -173.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -166.64 18.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 121.018 -0.273 . . . . 4.5499999999999998 110.856 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.506 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 16.5 tttp 178.51 -28.95 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.351 0.595 . . . . 1.4199999999999999 110.312 -174.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.724 HG22 ' HA3' ' A' ' 52' ' ' GLY . 30.0 pt -98.95 152.79 4.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.96 -1.018 . . . . 0.76000000000000001 109.254 174.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.562 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 3.4 m -146.47 110.87 5.12 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 123.452 0.47 . . . . 0.57999999999999996 111.04 -167.37 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.684 ' HA ' ' O ' ' A' ' 49' ' ' ARG . 13.0 t -103.45 112.73 38.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.995 -0.372 . . . . 0.85999999999999999 109.995 -177.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.662 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 84.0 p -106.83 133.93 50.75 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.193 0.597 . . . . 1.1000000000000001 110.685 -177.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 49.2 m -102.45 126.67 49.56 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.297 -0.41 . . . . 1.27 110.416 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp . . . . . 0 C--N 1.319 -0.723 0 CA-C-N 115.856 -0.611 . . . . 1.9099999999999999 110.424 -177.569 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 . . . . . 0 CA--C 1.511 -0.541 0 N-CA-C 108.481 -0.933 . . . . 2.0499999999999998 108.481 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.768 HD21 ' CD1' ' A' ' 170' ' ' PHE . 4.8 tt -82.52 130.0 35.03 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.829 -0.804 . . . . 0.87 108.829 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.539 ' N ' HD23 ' A' ' 47' ' ' LEU . 38.3 m-85 -115.45 119.12 35.17 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.466 -0.568 . . . . 0.98999999999999999 109.466 -178.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.926 ' HG3' ' CE1' ' A' ' 17' ' ' TYR . 3.1 tmt_? -110.47 141.84 43.04 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.928 -0.578 . . . . 2.9199999999999999 109.505 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 34' ' ' THR . 8.8 p -127.99 143.59 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-O 121.243 0.544 . . . . 1.3300000000000001 109.862 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.504 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 33.4 tt0 -146.28 110.81 5.14 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.442 -0.799 . . . . 1.0700000000000001 109.01 -173.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.724 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -137.81 134.72 7.11 Favored Glycine 0 N--CA 1.439 -1.13 0 C-N-CA 120.361 -0.923 . . . . 0.28999999999999998 111.851 -176.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 64.4 mt -83.98 118.13 30.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 C-N-CA 119.798 -0.761 . . . . 0.57999999999999996 110.327 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.407 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 72.3 mt -95.99 113.15 61.61 Favored Pre-proline 0 N--CA 1.435 -1.209 0 CA-C-N 115.132 -0.94 . . . . 0.34999999999999998 108.599 175.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 24.9 Cg_exo -65.67 45.87 0.18 Allowed 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.825 3.017 . . . . 0.62 113.582 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.576 ' HG2' HG13 ' A' ' 203' ' ' ILE . 10.5 tp10 -135.72 178.09 7.32 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.539 -1.282 . . . . 1.6799999999999999 107.539 177.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.451 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 47.9 t -81.1 139.66 49.31 Favored Pre-proline 0 N--CA 1.43 -1.473 0 CA-C-O 121.739 0.781 . . . . 1.1799999999999999 110.234 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.542 ' HG3' ' HB3' ' A' ' 165' ' ' SER . 23.5 Cg_exo -61.35 -9.13 12.04 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 124.11 3.207 . . . . 0.52000000000000002 110.658 177.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 63' ' ' ASP . . . -67.02 -52.3 44.14 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.981 -1.009 . . . . 0.64000000000000001 110.82 174.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.62 ' HE3' ' HB3' ' A' ' 64' ' ' PHE . 7.4 tptt -72.12 -23.91 61.39 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.887 -0.783 . . . . 3.2999999999999998 108.887 178.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.714 HD23 ' CD1' ' A' ' 203' ' ' ILE . 20.4 mt -64.42 -60.35 3.27 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.863 -0.608 . . . . 0.40999999999999998 109.454 174.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.461 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 34.1 t -64.73 -14.13 57.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.563 -0.744 . . . . 1.29 110.306 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 22.6 t70 -80.83 -46.42 15.36 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.844 -0.616 . . . . 1.3200000000000001 111.077 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.625 ' HB2' ' HZ2' ' A' ' 74' ' ' TRP . 7.0 p90 -76.21 -45.43 33.08 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 120.9 -0.32 . . . . 0.60999999999999999 111.29 -171.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.461 ' CD2' ' HA ' ' A' ' 62' ' ' SER . 0.5 OUTLIER -80.66 -5.31 56.77 Favored 'General case' 0 CA--C 1.512 -0.487 0 O-C-N 121.833 -0.542 . . . . 1.5 111.184 -171.247 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.522 ' O ' ' HG3' ' A' ' 67' ' ' GLN . 13.0 t80 -50.73 -48.61 58.91 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 123.676 0.61 . . . . 1.52 112.181 -163.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.524 ' HG2' ' CZ ' ' A' ' 81' ' ' TYR . 16.3 mt-30 155.84 115.22 0.0 OUTLIER 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 124.657 1.183 . . . . 3.6000000000000001 109.32 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.788 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 6.3 t 42.53 31.49 0.29 Allowed 'General case' 0 C--N 1.315 -0.906 0 O-C-N 124.559 1.162 . . . . 1.48 113.397 175.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.93 -27.19 14.44 Favored Glycine 0 CA--C 1.496 -1.154 0 C-N-CA 120.039 -1.077 . . . . 1.46 112.166 -173.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.729 ' O ' HG22 ' A' ' 73' ' ' THR . 17.4 p-10 173.87 -28.77 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.677 -1.231 . . . . 2.1899999999999999 107.677 -172.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.83 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 1.6 ptp180 -43.11 -54.43 4.4 Favored 'General case' 0 C--O 1.21 -0.983 0 CA-C-N 114.636 -1.165 . . . . 3.3799999999999999 110.66 177.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.883 HG22 ' HB3' ' A' ' 78' ' ' LEU . 1.8 pp -78.34 -12.27 13.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.056 0.455 . . . . 0.70999999999999996 111.503 -175.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.729 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.2 t -90.22 -29.78 17.98 Favored 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 120.062 -0.655 . . . . 0.96999999999999997 109.859 -168.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.625 ' HZ2' ' HB2' ' A' ' 64' ' ' PHE . 7.8 p-90 -111.53 -3.99 14.95 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.16 -0.473 . . . . 0.75 111.378 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.83 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 1.8 t70 -65.9 176.88 1.47 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 122.306 1.051 . . . . 2.1899999999999999 113.399 -171.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.451 ' HG3' ' OD1' ' A' ' 194' ' ' ASN . 0.0 OUTLIER -123.0 -27.5 4.21 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.819 -1.537 . . . . 3.1899999999999999 110.509 -178.037 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.436 ' HA ' ' HB2' ' A' ' 99' ' ' GLN . 50.0 m -113.12 0.58 15.0 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.073 -0.714 . . . . 1.5800000000000001 109.073 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.883 ' HB3' HG22 ' A' ' 72' ' ' ILE . 53.2 mt -108.73 173.68 6.21 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.048 -0.978 . . . . 0.70999999999999996 110.268 177.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.678 ' HG2' ' HG2' ' A' ' 99' ' ' GLN . 12.8 mm100 -156.87 -66.2 0.1 Allowed 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.734 0.778 . . . . 1.73 109.972 -174.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.472 HG23 ' HB3' ' A' ' 79' ' ' GLN . 17.3 t -136.96 119.17 19.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 114.586 -1.188 . . . . 0.78000000000000003 109.835 -169.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.788 ' HB3' ' HB ' ' A' ' 68' ' ' THR . 0.4 OUTLIER -109.22 123.48 49.31 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.495 -0.558 . . . . 5.4000000000000004 109.495 175.922 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.708 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 13.5 m120 -119.95 123.68 44.11 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.324 -0.991 . . . . 1.6899999999999999 108.324 -176.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.79 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 18.3 ttm -87.73 99.01 11.77 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.69 -0.856 . . . . 2.0499999999999998 108.69 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.582 HG11 ' HZ ' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -77.49 -60.74 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.981 -0.554 . . . . 0.64000000000000001 111.349 -163.742 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.63 130.29 19.07 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.862 -0.792 . . . . 1.96 108.862 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.79 ' HD3' ' SD ' ' A' ' 83' ' ' MET . 14.3 mtm180 -110.4 132.95 53.73 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.38 -0.6 . . . . 2.4399999999999999 109.38 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.605 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -94.5 -44.45 13.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.769 -0.65 . . . . 0.46999999999999997 111.097 -168.354 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -149.99 -161.99 1.46 Allowed 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.431 -0.951 . . . . 1.8600000000000001 108.431 -174.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.1 m -65.22 -33.36 75.81 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 111.932 0.345 . . . . 1.4399999999999999 111.932 -172.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -137.92 33.74 2.4 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.343 0.592 . . . . 1.8700000000000001 109.647 -174.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.605 ' O ' HG12 ' A' ' 87' ' ' ILE . 1.7 m -132.54 107.09 8.23 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.971 -1.122 . . . . 0.46000000000000002 107.971 -178.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.599 ' O ' HD12 ' A' ' 114' ' ' LEU . 16.9 m-85 -123.37 171.58 9.32 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.947 -0.57 . . . . 0.42999999999999999 110.08 -173.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.545 ' O ' HG23 ' A' ' 84' ' ' VAL . 53.3 mt -121.81 129.87 75.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 109.11 -0.7 . . . . 0.40999999999999998 109.11 170.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.792 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 0.0 OUTLIER -93.25 118.02 30.76 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.734 -1.121 . . . . 2.0099999999999998 111.962 -170.432 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.708 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 22.2 t-160 -107.18 90.53 3.33 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.021 -0.733 . . . . 1.23 109.021 163.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.626 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 72.2 m -109.22 120.7 43.33 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.984 -0.553 . . . . 0.5 111.457 -176.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.8 mm -83.92 130.02 36.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.367 0.603 . . . . 1.03 110.028 174.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 3.0 m -106.11 152.58 23.23 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.793 -1.094 . . . . 1.3799999999999999 110.124 -174.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.678 ' HG2' ' HG2' ' A' ' 79' ' ' GLN . 4.4 mm100 . . . . . 0 C--N 1.319 -0.744 0 CA-C-O 121.25 0.547 . . . . 1.8200000000000001 111.443 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 76.5 mt . . . . . 0 N--CA 1.451 -0.402 0 N-CA-C 109.624 -0.51 . . . . 1.1200000000000001 109.624 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.1 m -99.19 157.79 33.42 Favored Pre-proline 0 C--N 1.32 -0.709 0 N-CA-C 109.319 -0.623 . . . . 1.3500000000000001 109.319 175.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -47.97 116.54 1.99 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.814 2.342 . . . . 1.0700000000000001 111.686 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.658 ' HG3' HG23 ' A' ' 144' ' ' ILE . 34.3 ttp180 -102.08 149.22 24.48 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.007 -0.738 . . . . 3.4500000000000002 109.007 -173.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.405 ' OD1' ' HA ' ' A' ' 145' ' ' ARG . 2.5 p30 -114.25 147.85 38.36 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.813 -0.755 . . . . 1.3700000000000001 110.135 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.626 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 15.1 m-85 -116.25 128.51 55.65 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.325 -0.852 . . . . 2.4100000000000001 110.229 174.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.792 ' HA ' ' O ' ' A' ' 94' ' ' CYS . 22.6 mm -126.8 80.87 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.33 -0.85 . . . . 0.42999999999999999 109.049 169.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.729 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 10.0 m-20 -113.64 129.09 56.63 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.872 -1.058 . . . . 1.8600000000000001 109.215 -178.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.626 HD21 ' HB2' ' A' ' 7' ' ' ALA . 3.8 tp -74.79 121.45 21.79 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.424 0.63 . . . . 0.28000000000000003 109.401 176.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -115.71 123.74 71.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 114.96 -1.018 . . . . 0.26000000000000001 111.497 -164.804 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.663 ' HE2' ' HE3' ' A' ' 118' ' ' LYS . 90.9 t80 -114.07 125.21 53.72 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.827 -1.078 . . . . 2.5699999999999998 109.895 175.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 1.099 HG12 HG22 ' A' ' 127' ' ' ILE . 85.9 mt -98.79 104.33 15.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.312 0.577 . . . . 0.89000000000000001 110.358 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.663 ' HE3' ' HE2' ' A' ' 116' ' ' TYR . 5.0 tppp? -98.73 128.04 44.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.599 -0.728 . . . . 1.2 109.267 177.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.68 92.04 3.79 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.035 -0.728 . . . . 2.7999999999999998 109.035 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.446 ' HB3' ' HB3' ' A' ' 123' ' ' ASN . 59.5 m-85 -73.12 115.15 12.11 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 115.14 -0.936 . . . . 0.82999999999999996 108.737 175.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -26.53 89.67 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 O-C-N 125.637 1.836 . . . . 2.2799999999999998 113.252 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 53.83 42.44 69.16 Favored Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.789 -0.641 . . . . 0.76000000000000001 112.672 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.505 ' C ' ' HD2' ' A' ' 157' ' ' PRO . 52.7 t30 -135.75 -49.21 0.7 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.331 -0.434 . . . . 1.6499999999999999 110.705 -176.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.584 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 5.4 mtm -161.98 120.24 2.26 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 120.726 -0.39 . . . . 1.1200000000000001 111.787 -178.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -104.35 78.68 1.51 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.422 -0.955 . . . . 1.6200000000000001 108.422 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.682 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -92.8 138.4 20.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 114.915 -1.039 . . . . 0.29999999999999999 112.791 -172.594 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 1.099 HG22 HG12 ' A' ' 117' ' ' ILE . 38.0 pt -105.51 100.68 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.93 0.872 . . . . 0.58999999999999997 109.34 165.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.621 ' CB ' ' HA ' ' A' ' 11' ' ' ALA . 11.8 p -85.73 110.58 19.43 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.842 -0.617 . . . . 1.1799999999999999 110.707 178.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.729 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 1.9 p -106.4 135.87 47.14 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.408 -0.814 . . . . 1.24 110.691 -176.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.608 ' HE2' ' OG1' ' A' ' 10' ' ' THR . 10.6 ttmm -128.11 112.25 14.37 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.819 -1.178 . . . . 2.2599999999999998 107.819 -177.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.8 p -57.88 98.39 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.914 0 CA-C-O 121.944 0.878 . . . . 1.3899999999999999 109.067 -175.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.55 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -110.32 134.12 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.122 0 CA-C-N 114.587 -1.188 . . . . 1.05 109.034 -165.607 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -96.19 71.15 2.81 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.719 -1.128 . . . . 2.1699999999999999 108.456 -172.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.687 ' CE1' HG21 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -99.5 159.54 29.78 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 114.447 -1.251 . . . . 0.53000000000000003 110.471 -172.093 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.83 -27.64 75.27 Favored 'Trans proline' 0 N--CA 1.477 0.535 0 C-N-CA 123.861 3.041 . . . . 1.28 115.679 -168.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.432 ' HG2' ' CD2' ' A' ' 134' ' ' PHE . 12.1 mm-40 -71.72 -21.71 61.73 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 120.478 -0.489 . . . . 3.5 110.08 -166.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.577 ' CD2' HG13 ' A' ' 112' ' ' ILE . 57.0 t80 -134.26 108.23 11.33 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 112.916 0.71 . . . . 6.1200000000000001 112.916 -177.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -97.6 119.12 0.15 Allowed 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 123.537 2.824 . . . . 1.77 110.76 162.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -63.24 -176.94 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.271 1.981 . . . . 1.25 112.24 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.0 m -146.63 -162.35 1.51 Allowed 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.598 -0.519 . . . . 1.6000000000000001 109.598 -171.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.3 m -79.91 -40.69 27.67 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.297 -0.561 . . . . 1.97 111.337 -178.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -68.09 -42.63 80.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.037 0.446 . . . . 2.1800000000000002 111.176 -176.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -105.19 134.79 47.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.711 -0.677 . . . . 1.23 110.172 -173.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.658 HG23 ' HG3' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -109.93 103.51 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 CA-C-N 116.034 -0.53 . . . . 0.81999999999999995 109.702 -179.504 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.542 ' HE ' ' HB ' ' A' ' 112' ' ' ILE . 12.1 ttt180 -51.7 100.78 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.552 -1.204 . . . . 4.4199999999999999 110.429 178.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.35 110.13 3.06 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.662 -0.699 . . . . 0.79000000000000004 112.224 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.452 ' HB3' ' HB3' ' A' ' 174' ' ' GLU . 26.4 t80 -85.42 82.2 8.41 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.258 0.551 . . . . 4.4400000000000004 109.649 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.533 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 47.1 m-80 -78.21 100.45 6.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.737 -0.665 . . . . 1.6200000000000001 109.747 176.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -57.76 114.96 9.5 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.314 -0.625 . . . . 2.3199999999999998 109.314 176.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.437 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 65.9 Cg_exo -7.0 67.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.681 1 C-N-CA 126.152 4.568 . . . . 0.53000000000000003 115.187 -159.764 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 151' ' ' CYS . . . . . 0.736 ' HB3' ' O ' ' A' ' 170' ' ' PHE . 2.9 m -87.75 150.78 23.37 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 115.039 -0.982 . . . . 1.5800000000000001 108.404 178.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.822 ' HA3' HG21 ' A' ' 14' ' ' VAL . . . -139.83 -162.86 9.28 Favored Glycine 0 CA--C 1.494 -1.265 0 C-N-CA 118.829 -1.653 . . . . 0.42999999999999999 112.649 -176.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.615 ' HB3' HG12 ' A' ' 127' ' ' ILE . 0.4 OUTLIER -160.74 83.42 0.67 Allowed 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.364 -1.347 . . . . 0.59999999999999998 107.364 -164.843 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.772 HG23 HG13 ' A' ' 168' ' ' VAL . 4.2 m -95.28 130.38 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 CA-C-O 121.933 0.873 . . . . 0.31 110.576 -175.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' CYS . . . . . 0.584 ' O ' ' HA ' ' A' ' 124' ' ' MET . 6.0 t -110.32 118.54 36.59 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.251 -0.886 . . . . 1.55 109.446 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.617 ' HB3' ' HB3' ' A' ' 166' ' ' LYS . 9.1 t -114.78 112.6 45.09 Favored Pre-proline 0 C--N 1.319 -0.749 0 C-N-CA 120.654 -0.418 . . . . 1.0600000000000001 111.625 -170.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.505 ' HD2' ' C ' ' A' ' 123' ' ' ASN . 46.8 Cg_exo -55.18 118.56 5.3 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.11 1.873 . . . . 0.56000000000000005 110.166 166.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.485 ' N ' ' HB3' ' A' ' 161' ' ' ASN . 72.3 mtp -79.5 -171.78 2.93 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.717 -0.393 . . . . 1.1599999999999999 111.087 -175.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -67.24 -31.19 71.37 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.481 -0.933 . . . . 2.6299999999999999 108.481 169.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.411 ' C ' ' HD2' ' A' ' 162' ' ' PRO . 24.2 mt-10 -102.45 27.87 6.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.362 -1.29 . . . . 2.0499999999999998 109.213 176.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.498 ' OD1' ' HD3' ' A' ' 162' ' ' PRO . 7.0 p30 -38.84 -46.96 3.45 Favored Pre-proline 0 N--CA 1.473 0.694 0 N-CA-C 115.985 1.846 . . . . 1.9299999999999999 115.985 -169.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.498 ' HD3' ' OD1' ' A' ' 161' ' ' ASN . 71.2 Cg_endo -72.45 -17.63 26.75 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 CA-C-N 121.336 1.513 . . . . 0.72999999999999998 112.384 -174.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -109.62 -24.43 10.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.779 -0.646 . . . . 0.68000000000000005 110.933 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.462 ' O ' ' HA ' ' A' ' 161' ' ' ASN . 79.1 m-85 -141.76 121.05 13.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.065 -0.516 . . . . 0.93000000000000005 109.726 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.542 ' HB3' ' HG3' ' A' ' 58' ' ' PRO . 6.8 p -117.29 142.71 46.73 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.304 -0.558 . . . . 1.4099999999999999 111.187 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.617 ' HB3' ' HB3' ' A' ' 156' ' ' SER . 2.3 tppp? -94.31 104.41 16.4 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 122.1 0.952 . . . . 0.73999999999999999 111.822 -174.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.49 HD12 HG12 ' A' ' 196' ' ' ILE . 0.7 OUTLIER -90.69 104.83 17.37 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.297 -1.32 . . . . 0.27000000000000002 109.517 176.179 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.772 HG13 HG23 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -127.86 126.06 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.803 0.811 . . . . 0.28000000000000003 111.533 -179.642 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.574 ' O ' ' HG2' ' A' ' 49' ' ' ARG . 12.2 ttm -141.4 148.58 39.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.248 -0.887 . . . . 1.24 109.486 -172.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.823 ' CE2' HG23 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -129.71 143.34 50.77 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.186 -0.606 . . . . 3.3700000000000001 110.345 170.256 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.55 ' HB ' HD21 ' A' ' 192' ' ' LEU . 0.9 OUTLIER -119.9 118.81 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 O-C-N 124.86 1.35 . . . . 1.3999999999999999 109.985 178.394 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.517 ' HB2' ' HG ' ' A' ' 47' ' ' LEU . 63.3 tt0 -121.81 48.73 1.65 Allowed 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 106.187 -1.783 . . . . 2.1699999999999999 106.187 173.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 5.5 m -72.13 151.34 43.08 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.024 -1.898 . . . . 1.6499999999999999 111.224 -174.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.452 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 18.5 tt0 . . . . . 0 N--CA 1.438 -1.061 0 CA-C-O 121.542 0.687 . . . . 2.4500000000000002 109.821 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.446 ' HA ' ' HE3' ' A' ' 186' ' ' LYS . 16.2 mm . . . . . 0 CA--C 1.507 -0.708 0 CA-C-O 122.523 1.154 . . . . 1.1200000000000001 108.909 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.931 ' HA ' HG22 ' A' ' 187' ' ' THR . 0.9 OUTLIER -70.01 -38.15 74.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 112.768 -2.014 . . . . 1.1299999999999999 110.931 -178.728 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.69 -17.91 64.94 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.155 -0.683 . . . . 2.8900000000000001 109.155 175.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.446 ' HE3' ' HA ' ' A' ' 183' ' ' ILE . 48.2 mtmt -93.01 -38.7 11.51 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.729 -0.668 . . . . 1.28 110.081 175.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.931 HG22 ' HA ' ' A' ' 184' ' ' ILE . 11.2 t -68.73 -24.61 64.49 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 112.348 0.499 . . . . 0.62 112.348 -171.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' MET . . . . . 0.558 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 0.2 OUTLIER -79.78 -63.65 0.36 Allowed Pre-proline 0 N--CA 1.467 0.402 0 CA-C-N 118.471 0.578 . . . . 1.0600000000000001 111.699 179.418 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.558 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 25.4 Cg_exo -62.7 -25.53 75.07 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.296 1.997 . . . . 0.91000000000000003 112.484 -176.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.746 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 68.4 m -82.95 -28.53 29.75 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.716 -0.394 . . . . 1.5 111.306 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ASN . . . . . 0.652 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.2 OUTLIER -90.55 -36.49 14.44 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.9 -0.32 . . . . 1.8799999999999999 111.272 -173.474 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.55 HD21 ' HB ' ' A' ' 171' ' ' VAL . 48.4 mt -65.22 -47.04 78.21 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.183 0.516 . . . . 1.0900000000000001 110.587 -177.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.477 ' HB ' HD12 ' A' ' 33' ' ' ILE . 2.0 m -67.9 -30.05 46.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.584 -0.735 . . . . 0.68000000000000005 109.301 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.746 ' HB2' ' O ' ' A' ' 190' ' ' SER . 1.0 OUTLIER -71.6 -37.07 71.0 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.652 -1.158 . . . . 2.0699999999999998 110.247 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.587 ' HA ' ' ND2' ' A' ' 198' ' ' ASN . 12.2 m-85 -61.07 -34.03 74.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.027 0.441 . . . . 2.0 110.048 172.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.545 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 54.3 mt -79.63 -28.97 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 116.082 -0.508 . . . . 0.31 110.637 176.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.445 ' HB2' ' HA ' ' A' ' 194' ' ' ASN . 53.2 mt -72.8 -36.47 67.56 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-N 116.317 -0.401 . . . . 1.03 110.233 176.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.587 ' ND2' ' HA ' ' A' ' 195' ' ' PHE . 67.2 m-20 -49.06 -47.61 44.78 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.303 -0.999 . . . . 1.8999999999999999 108.303 164.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.858 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -67.24 -45.49 76.56 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 115.28 -0.873 . . . . 0.28999999999999998 110.12 -175.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 61.2 mmtt -53.65 -48.18 69.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.403 0.621 . . . . 0.96999999999999997 109.91 173.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -75.71 -39.99 56.46 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.04 -0.982 . . . . 1.9399999999999999 111.305 -169.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -76.64 -28.23 59.71 Favored Glycine 0 N--CA 1.461 0.334 0 C-N-CA 120.056 -1.069 . . . . 0.46999999999999997 111.739 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.858 ' HB ' ' O ' ' A' ' 199' ' ' ALA . 0.9 OUTLIER -71.51 -38.61 68.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 123.045 0.538 . . . . 0.60999999999999999 110.832 172.969 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -83.76 -17.35 41.5 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.355 0.598 . . . . 3.3700000000000001 109.406 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.03 0 N-CA-C 108.442 -0.947 . . . . 1.02 108.442 166.866 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.6 t70 . . . . . 0 N--CA 1.442 -0.844 0 N-CA-C 108.571 -0.899 . . . . 2.25 108.571 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.542 ' HA ' HD11 ' A' ' 6' ' ' ILE . 59.1 m-85 -66.66 -31.86 72.8 Favored 'General case' 0 CA--C 1.507 -0.707 0 O-C-N 123.58 0.55 . . . . 0.42999999999999999 110.284 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 27.0 tttp -75.91 -44.34 40.76 Favored 'General case' 0 N--CA 1.418 -2.065 0 N-CA-C 107.598 -1.26 . . . . 1.51 107.598 -177.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.408 ' O ' ' HG3' ' A' ' 9' ' ' GLN . . . -50.16 -51.73 41.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.422 -0.808 . . . . 0.54000000000000004 112.471 -177.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.542 HD11 ' HA ' ' A' ' 3' ' ' PHE . 0.4 OUTLIER -83.49 -30.6 8.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.312 -0.555 . . . . 1.0700000000000001 110.758 -172.005 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.497 ' HA ' ' HB ' ' A' ' 10' ' ' THR . . . -74.04 -41.54 61.65 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.85 0.833 . . . . 0.34000000000000002 110.956 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.486 ' HG2' ' CZ ' ' A' ' 116' ' ' TYR . 14.7 mt-30 -62.51 -31.23 71.96 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.259 -1.337 . . . . 1.5900000000000001 110.216 177.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 5' ' ' ALA . 98.9 mt-30 -82.47 -30.85 29.7 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.999 -1.0 . . . . 2.4700000000000002 109.204 174.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.624 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.6 OUTLIER -72.0 -37.72 69.77 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.682 -1.145 . . . . 0.47999999999999998 111.202 -179.569 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.541 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -46.51 -62.62 1.29 Allowed 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.266 0.469 . . . . 0.31 112.266 174.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -70.01 -6.24 32.05 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.308 -0.406 . . . . 1.6399999999999999 111.086 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.52 ' HB3' ' HA ' ' A' ' 10' ' ' THR . 0.2 OUTLIER -87.7 -43.0 12.24 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.215 -0.448 . . . . 2.54 110.136 179.666 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.712 HG21 ' N ' ' A' ' 152' ' ' GLY . 7.2 p -79.26 -29.83 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-O 121.841 0.829 . . . . 0.53000000000000003 109.404 176.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 tt -76.15 -19.71 58.23 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 108.314 -0.995 . . . . 0.59999999999999998 108.314 172.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.43 -23.42 66.65 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 113.931 -1.486 . . . . 0.56999999999999995 109.62 170.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.558 ' CD2' ' HA ' ' A' ' 14' ' ' VAL . 26.3 m-85 -80.87 -32.82 34.77 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 114.935 -0.633 . . . . 3.27 109.925 176.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -66.22 -13.19 59.92 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.699 0.761 . . . . 2.0299999999999998 110.139 177.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.7 mtp180 -108.16 -2.16 19.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.285 -0.87 . . . . 2.7200000000000002 109.323 178.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.496 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 28.9 t70 -105.65 119.66 39.71 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.349 -1.296 . . . . 2.1600000000000001 110.473 -175.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.0 p -134.62 119.13 17.98 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.962 -0.384 . . . . 1.8200000000000001 109.962 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.89 -162.58 1.3 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.252 -0.431 . . . . 2.1899999999999999 111.127 -166.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -75.73 61.24 2.89 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 116.11 -0.496 . . . . 1.1000000000000001 112.666 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.441 ' HA ' ' HB3' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -95.64 -156.5 0.52 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.369 -0.604 . . . . 1.6699999999999999 109.369 175.067 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.48 132.65 0.29 Allowed 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 108.682 -0.859 . . . . 2.9500000000000002 108.682 -178.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.824 HG21 HG23 ' A' ' 29' ' ' THR . 2.1 p -67.57 117.45 9.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-O 121.689 0.757 . . . . 1.5600000000000001 109.5 177.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.0 p -89.17 -24.37 5.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 114.748 -1.114 . . . . 1.22 108.919 -176.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.2 tptt -158.0 139.23 13.43 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.754 -0.657 . . . . 2.4100000000000001 111.883 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.824 HG23 HG21 ' A' ' 26' ' ' VAL . 6.4 p -144.28 152.1 40.32 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 115.829 -0.623 . . . . 1.3799999999999999 111.011 175.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.478 ' HB2' HG12 ' A' ' 33' ' ' ILE . 19.4 m -120.67 25.95 9.42 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.826 -0.625 . . . . 2.3700000000000001 110.868 171.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp 68.93 39.44 1.84 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.479 0.657 . . . . 4.5499999999999998 110.441 174.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.6 tptm 177.0 -30.59 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.505 -1.225 . . . . 1.4199999999999999 108.313 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.8 HD12 ' HB ' ' A' ' 193' ' ' VAL . 23.0 pt -119.68 151.8 22.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 114.561 -1.199 . . . . 0.76000000000000001 109.483 175.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.62 ' HA ' HG22 ' A' ' 29' ' ' THR . 89.8 m -152.15 113.62 4.32 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 123.347 0.404 . . . . 0.57999999999999996 111.158 -164.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -103.68 110.79 31.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.356 -0.537 . . . . 0.85999999999999999 111.799 171.357 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 1.5 p -99.77 117.86 35.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.413 -0.812 . . . . 1.1000000000000001 110.95 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 30.2 t -107.72 131.99 53.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.768 -1.106 . . . . 1.27 111.184 -173.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.441 ' HB3' ' HA ' ' A' ' 24' ' ' TRP . 27.8 pttt . . . . . 0 C--N 1.327 -0.39 0 N-CA-C 112.497 0.554 . . . . 1.9099999999999999 112.497 172.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.666 ' N ' HD21 ' A' ' 46' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.255 0 CA-C-O 120.858 0.361 . . . . 2.0499999999999998 111.555 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.57 HD23 ' N ' ' A' ' 48' ' ' TYR . 3.9 tt -120.25 143.59 48.22 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.755 -0.831 . . . . 0.87 108.755 -176.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.57 ' N ' HD23 ' A' ' 47' ' ' LEU . 46.2 m-85 -118.46 123.56 45.47 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.888 0.375 . . . . 0.98999999999999999 110.884 -172.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 27.9 ttt180 -91.22 112.08 23.84 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.716 -0.846 . . . . 2.9199999999999999 108.716 169.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.516 HG13 ' HB3' ' A' ' 169' ' ' MET . 0.2 OUTLIER -104.95 106.82 21.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.757 0.789 . . . . 1.3300000000000001 109.523 -175.715 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 42.8 tt0 -128.68 146.52 50.86 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.819 -1.082 . . . . 1.0700000000000001 110.763 -169.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.532 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -168.81 146.83 10.64 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 111.018 -0.833 . . . . 0.28999999999999998 111.018 175.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.458 HG12 ' HE2' ' A' ' 166' ' ' LYS . 65.9 mt -92.84 116.68 34.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 117.813 0.807 . . . . 0.57999999999999996 110.428 175.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.455 HG12 ' HD3' ' A' ' 200' ' ' LYS . 70.1 mt -99.29 109.56 55.06 Favored Pre-proline 0 N--CA 1.439 -0.984 0 CA-C-N 115.314 -0.857 . . . . 0.34999999999999998 108.775 174.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 53' ' ' ILE . 32.1 Cg_exo -61.11 65.66 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 124.406 3.404 . . . . 0.62 112.551 178.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.65 ' HG2' ' CG1' ' A' ' 203' ' ' ILE . 9.9 tp10 -157.12 174.23 15.8 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.858 -1.065 . . . . 1.6799999999999999 108.144 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.476 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 38.1 t -79.94 139.49 53.59 Favored Pre-proline 0 N--CA 1.423 -1.804 0 CA-C-O 121.506 0.67 . . . . 1.1799999999999999 109.91 179.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.515 ' HB3' ' SG ' ' A' ' 155' ' ' CYS . 31.7 Cg_exo -58.05 -15.0 20.84 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 123.91 3.073 . . . . 0.52000000000000002 110.694 177.1 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.85 -49.15 55.27 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.519 -1.219 . . . . 0.64000000000000001 111.171 175.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.624 ' HB3' HD11 ' A' ' 203' ' ' ILE . 29.4 ttmt -71.79 -28.28 63.51 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.627 0.727 . . . . 3.2999999999999998 109.162 -177.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.034 HD23 HD13 ' A' ' 203' ' ' ILE . 68.0 mt -63.87 -51.37 64.87 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.689 -1.142 . . . . 0.40999999999999998 109.75 173.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.486 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 18.2 m -67.41 -10.94 56.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.751 -0.658 . . . . 1.29 110.413 175.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -88.8 -32.68 17.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.828 -0.624 . . . . 1.3200000000000001 111.72 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.536 ' CD2' ' HA ' ' A' ' 61' ' ' LEU . 8.7 p90 -82.02 -44.86 16.09 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.277 -0.569 . . . . 0.60999999999999999 111.186 -176.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.486 ' CD2' ' HA ' ' A' ' 62' ' ' SER . 0.8 OUTLIER -79.5 -7.66 58.6 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.372 -0.531 . . . . 1.5 111.402 -173.872 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -36.37 -57.74 0.73 Allowed 'General case' 0 N--CA 1.465 0.291 0 O-C-N 125.02 1.45 . . . . 1.52 113.399 -157.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.409 ' O ' ' HD3' ' A' ' 71' ' ' ARG . 76.9 mt-30 -156.9 -81.71 0.07 Allowed 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 112.198 0.444 . . . . 3.6000000000000001 112.198 -177.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.596 ' HB ' ' CD1' ' A' ' 81' ' ' TYR . 8.9 t -149.33 31.2 0.75 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 122.168 0.985 . . . . 1.48 109.655 -165.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.0 -39.8 4.22 Favored Glycine 0 CA--C 1.489 -1.543 0 CA-C-N 115.099 -0.955 . . . . 1.46 113.173 -169.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.51 ' O ' HG22 ' A' ' 73' ' ' THR . 3.1 p30 -163.61 -22.34 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.786 -0.707 . . . . 2.1899999999999999 111.034 -171.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.634 ' HG3' HG23 ' A' ' 72' ' ' ILE . 13.1 ptm180 -50.68 -33.17 21.57 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 122.913 0.485 . . . . 3.3799999999999999 110.553 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.634 HG23 ' HG3' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -99.37 -2.74 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 CA-C-N 115.779 -0.646 . . . . 0.70999999999999996 111.261 -177.726 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.51 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.2 t -96.42 -30.67 13.24 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 119.523 -0.871 . . . . 0.96999999999999997 110.568 -178.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.537 ' CZ2' ' HA ' ' A' ' 71' ' ' ARG . 13.7 p-90 -107.74 0.59 22.42 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.969 0.414 . . . . 0.75 111.39 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.582 ' HB3' ' O ' ' A' ' 71' ' ' ARG . 1.7 p-10 -58.9 -179.74 0.07 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 114.435 1.272 . . . . 2.1899999999999999 114.435 -172.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.511 ' HG3' ' OD1' ' A' ' 194' ' ' ASN . 0.0 OUTLIER -143.11 -2.58 1.0 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 113.438 -1.71 . . . . 3.1899999999999999 111.108 172.853 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 m -132.48 4.97 4.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.943 0.878 . . . . 1.5800000000000001 108.94 -176.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.527 ' HB2' ' CG ' ' A' ' 75' ' ' ASP . 91.5 mt -119.1 -170.99 2.02 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.579 -1.191 . . . . 0.70999999999999996 110.868 -174.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.47 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 8.4 mm100 -161.31 -65.39 0.06 Allowed 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.779 0.8 . . . . 1.73 109.685 -176.252 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.462 HG23 ' HB3' ' A' ' 79' ' ' GLN . 6.1 t -142.3 147.07 21.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.755 -1.111 . . . . 0.78000000000000003 109.146 -172.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.596 ' CD1' ' HB ' ' A' ' 68' ' ' THR . 11.6 t80 -136.29 129.61 31.7 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.807 -0.442 . . . . 5.4000000000000004 109.807 177.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -131.04 121.39 24.94 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.871 -0.788 . . . . 1.6899999999999999 108.871 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.451 ' CE ' ' HA ' ' A' ' 83' ' ' MET . 1.3 tpt -81.19 92.96 6.38 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.371 -0.831 . . . . 2.0499999999999998 108.777 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -71.93 -83.08 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.34 -0.846 . . . . 0.64000000000000001 111.112 -167.921 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -113.32 114.54 26.81 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.319 0.581 . . . . 1.96 109.695 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.42 ' HG2' ' HD1' ' A' ' 92' ' ' PHE . 80.9 mtm180 -97.4 108.07 20.72 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.31 -0.859 . . . . 2.4399999999999999 109.204 178.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.703 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -78.47 -47.15 24.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.865 -0.607 . . . . 0.46999999999999997 110.845 -173.501 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -146.04 -179.87 7.01 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.607 -0.886 . . . . 1.8600000000000001 108.607 -174.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.9 m -66.8 -17.01 64.66 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.155 0.428 . . . . 1.4399999999999999 112.155 -174.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -139.28 27.9 2.3 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 120.098 -0.641 . . . . 1.8700000000000001 110.37 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.703 ' O ' HG12 ' A' ' 87' ' ' ILE . 1.6 m -141.17 112.61 7.49 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 107.979 -1.119 . . . . 0.46000000000000002 107.979 177.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.575 ' O ' HD12 ' A' ' 114' ' ' LEU . 3.6 m-85 -134.88 177.03 8.12 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.984 -0.553 . . . . 0.42999999999999999 109.876 -175.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.711 ' O ' HG23 ' A' ' 84' ' ' VAL . 22.1 mt -125.8 131.03 72.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 107.336 -1.357 . . . . 0.40999999999999998 107.336 169.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.715 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 14.5 p -104.68 132.59 50.75 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.831 -0.348 . . . . 2.0099999999999998 111.731 -174.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.734 ' HA ' HD13 ' A' ' 112' ' ' ILE . 14.6 t60 -103.46 95.28 5.97 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.962 -0.755 . . . . 1.23 108.962 166.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.644 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 27.4 m -115.66 121.33 42.22 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.317 -0.856 . . . . 0.5 110.838 -174.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.446 ' O ' ' HB2' ' A' ' 79' ' ' GLN . 44.5 mm -77.95 114.99 19.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.08 -0.711 . . . . 1.03 109.08 175.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.409 ' HB ' ' HB2' ' A' ' 109' ' ' ARG . 3.0 m -93.85 136.45 34.12 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.072 -0.967 . . . . 1.3799999999999999 110.532 -175.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 24.0 mt-30 . . . . . 0 C--N 1.324 -0.523 0 CA-C-O 121.374 0.606 . . . . 1.8200000000000001 111.065 178.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 17.5 mt . . . . . 0 N--CA 1.451 -0.386 0 N-CA-C 110.405 -0.22 . . . . 1.1200000000000001 110.405 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 25.2 m -100.31 151.84 37.66 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 108.988 -0.745 . . . . 1.3500000000000001 108.988 172.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -50.19 126.42 17.27 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.715 2.276 . . . . 1.0700000000000001 111.401 177.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.483 ' HG2' HG23 ' A' ' 144' ' ' ILE . 19.5 mtm180 -101.82 164.53 11.68 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.502 0.668 . . . . 3.4500000000000002 112.004 -169.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.726 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 10.1 t0 -107.27 113.22 26.47 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.667 -1.151 . . . . 1.3700000000000001 108.968 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.644 ' HB3' ' HB ' ' A' ' 96' ' ' THR . 57.4 t80 -100.41 107.45 19.21 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.653 -0.869 . . . . 2.4100000000000001 108.653 -178.341 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.734 HD13 ' HA ' ' A' ' 95' ' ' HIS . 8.5 mm -122.41 82.73 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 CA-C-N 115.404 -0.816 . . . . 0.42999999999999999 108.911 177.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 1.9 m-20 -116.13 130.21 56.69 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.663 -0.698 . . . . 1.8600000000000001 110.276 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.695 ' O ' ' HA ' ' A' ' 129' ' ' SER . 3.8 tp -75.34 122.54 23.89 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 115.008 -0.996 . . . . 0.28000000000000003 109.519 176.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -121.8 125.45 73.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-N 114.915 -1.039 . . . . 0.26000000000000001 111.875 -163.685 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.648 ' HD1' ' HG1' ' A' ' 91' ' ' THR . 70.7 t80 -110.05 125.01 52.49 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.666 -1.152 . . . . 2.5699999999999998 111.075 176.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.632 HG13 HG22 ' A' ' 127' ' ' ILE . 3.7 mp -95.42 104.66 16.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.711 -0.677 . . . . 0.89000000000000001 109.371 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.505 ' HD3' ' CE1' ' A' ' 120' ' ' TYR . 36.2 tttm -109.34 149.59 29.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.119 0.485 . . . . 1.2 110.502 -175.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.1 tpp85 -126.59 97.78 5.15 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 121.65 0.738 . . . . 2.7999999999999998 109.572 -176.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.505 ' CE1' ' HD3' ' A' ' 118' ' ' LYS . 24.7 m-85 -77.28 107.65 9.84 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 106.727 -1.583 . . . . 0.82999999999999996 106.727 167.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -39.75 95.57 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 124.736 1.273 . . . . 2.2799999999999998 112.758 -175.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 64.26 36.81 93.69 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 114.514 -1.221 . . . . 0.76000000000000001 112.345 178.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.493 ' C ' ' HD2' ' A' ' 157' ' ' PRO . 65.9 t30 -138.53 -43.2 0.49 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.535 -0.332 . . . . 1.6499999999999999 110.591 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -156.76 135.44 11.61 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.39 0.614 . . . . 1.1200000000000001 111.97 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -112.78 84.89 2.06 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.821 -1.177 . . . . 1.6200000000000001 107.821 170.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 153' ' ' PHE . 0.6 OUTLIER -105.77 136.91 38.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.624 -0.716 . . . . 0.29999999999999999 112.351 -171.184 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.704 ' O ' HG13 ' A' ' 127' ' ' ILE . 5.5 pt -111.52 103.06 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 122.279 1.038 . . . . 0.58999999999999997 109.077 167.186 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.541 ' HB3' ' HA ' ' A' ' 11' ' ' ALA . 28.6 p -90.45 122.39 33.26 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.657 -0.702 . . . . 1.1799999999999999 110.656 -178.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.695 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 5.3 m -120.31 140.08 51.8 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.575 -0.739 . . . . 1.24 111.108 -169.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.487 ' HE3' ' HB ' ' A' ' 6' ' ' ILE . 2.9 mtpm? -128.13 121.56 29.86 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 107.918 -1.141 . . . . 2.2599999999999998 107.918 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.438 ' HB3' ' H ' ' A' ' 148' ' ' ASN . 20.8 p -63.05 98.37 0.13 Allowed 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.32 -0.993 . . . . 1.3899999999999999 108.32 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -109.6 131.7 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 CA-C-N 114.516 -1.22 . . . . 1.05 109.084 -166.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.52 65.84 3.22 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.526 -1.216 . . . . 2.1699999999999999 108.821 -168.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.719 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 0.3 OUTLIER -95.16 156.06 38.23 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 113.86 -1.518 . . . . 0.53000000000000003 110.054 -171.48 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -69.97 -20.17 34.19 Favored 'Trans proline' 0 N--CA 1.473 0.32 0 C-N-CA 123.328 2.685 . . . . 1.28 115.337 -167.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.719 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 7.2 tp10 -72.87 -15.92 61.59 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.169 0.509 . . . . 3.5 109.824 -171.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -158.43 111.01 1.68 Allowed Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 113.314 0.857 . . . . 6.1200000000000001 113.314 175.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -97.67 144.21 0.68 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 124.033 3.156 . . . . 1.77 111.894 167.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.424 ' HG3' ' HB2' ' A' ' 145' ' ' ARG . 61.5 Cg_endo -75.64 -172.21 1.25 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.53 2.154 . . . . 1.25 112.265 178.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.5 m -141.66 -167.87 2.53 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.331 -0.989 . . . . 1.6000000000000001 108.331 -175.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.4 m -73.23 -37.04 66.52 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.056 -0.658 . . . . 1.97 111.191 -178.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -73.92 -60.39 2.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.176 0.512 . . . . 2.1800000000000002 109.89 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.602 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 36.7 m-85 -87.19 112.56 22.1 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 115.688 -0.687 . . . . 1.23 109.98 -178.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.483 HG23 ' HG2' ' A' ' 109' ' ' ARG . 1.7 tp -100.89 119.05 48.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 115.21 -0.904 . . . . 0.81999999999999995 109.262 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.726 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 28.7 ttm-85 -51.44 100.61 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 O-C-N 124.06 0.85 . . . . 4.4199999999999999 109.735 173.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -58.0 106.03 0.73 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.748 -0.941 . . . . 0.79000000000000004 110.748 176.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.433 ' HA ' ' CB ' ' A' ' 131' ' ' SER . 22.6 t80 -83.99 87.39 7.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.573 0.701 . . . . 4.4400000000000004 111.119 -172.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.753 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 24.3 m-80 -83.31 114.47 21.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.388 -0.823 . . . . 1.6200000000000001 109.807 174.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -71.33 129.49 88.9 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.254 -1.017 . . . . 2.3199999999999998 108.254 175.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.624 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 15.7 Cg_exo -16.55 69.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.973 1 C-N-CA 126.505 4.804 . . . . 0.53000000000000003 116.205 -166.143 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 151' ' ' CYS . . . . . 0.753 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 21.9 p -97.77 -173.79 2.71 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.818 -1.083 . . . . 1.5800000000000001 108.879 171.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.772 ' O ' ' HG3' ' A' ' 169' ' ' MET . . . -171.66 -150.26 7.05 Favored Glycine 0 CA--C 1.493 -1.323 0 C-N-CA 119.231 -1.462 . . . . 0.42999999999999999 112.262 -177.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.515 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 57.7 t80 -161.23 96.49 1.08 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.684 -0.858 . . . . 0.59999999999999998 108.684 -164.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.659 ' CG2' HG13 ' A' ' 168' ' ' VAL . 1.2 m -103.96 132.06 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-O 121.972 0.892 . . . . 0.31 110.824 -176.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' CYS . . . . . 0.515 ' SG ' ' HB3' ' A' ' 58' ' ' PRO . 10.6 t -112.4 111.69 22.72 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.068 -0.969 . . . . 1.55 109.511 177.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.492 ' HB3' ' HB3' ' A' ' 166' ' ' LYS . 27.4 t -108.9 112.34 60.24 Favored Pre-proline 0 C--N 1.316 -0.872 0 C-N-CA 120.867 -0.333 . . . . 1.0600000000000001 111.346 -166.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.493 ' HD2' ' C ' ' A' ' 123' ' ' ASN . 53.5 Cg_exo -49.66 124.41 12.21 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.424 2.083 . . . . 0.56000000000000005 111.161 172.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.62 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 0.2 OUTLIER -79.15 -167.78 1.27 Allowed 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.066 0.46 . . . . 1.1599999999999999 111.699 -175.511 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.75 -25.67 64.86 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.798 0.809 . . . . 2.6299999999999999 109.236 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -103.04 24.95 10.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.8 -1.091 . . . . 2.0499999999999998 109.011 178.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.538 ' HB2' ' HD3' ' A' ' 162' ' ' PRO . 21.4 m-80 13.73 -82.59 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 126.402 1.881 . . . . 1.9299999999999999 115.67 178.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.538 ' HD3' ' HB2' ' A' ' 161' ' ' ASN . 94.3 Cg_endo -74.2 -12.02 23.19 Favored 'Trans proline' 0 C--N 1.362 1.289 0 CA-C-N 120.932 1.369 . . . . 0.72999999999999998 113.639 -172.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -102.3 -30.98 10.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.335 -0.393 . . . . 0.68000000000000005 111.452 -176.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.62 ' O ' ' HB2' ' A' ' 158' ' ' MET . 42.3 m-85 -133.78 135.51 43.92 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.607 0.242 . . . . 0.93000000000000005 110.789 177.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 26.7 t -128.8 146.7 50.84 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.415 0.626 . . . . 1.4099999999999999 111.124 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.532 ' HG3' HG12 ' A' ' 168' ' ' VAL . 14.3 tppt? -99.66 101.81 13.11 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.181 -0.918 . . . . 0.73999999999999999 111.034 -178.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -84.67 104.28 14.51 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.631 -1.168 . . . . 0.27000000000000002 108.992 178.615 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.659 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -131.86 114.15 24.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 122.509 1.147 . . . . 0.28000000000000003 111.574 177.653 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.772 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 16.8 ttt -118.8 151.09 38.69 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 114.284 -1.325 . . . . 1.24 108.284 -176.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.704 ' O ' ' HB2' ' A' ' 151' ' ' CYS . 68.8 m-85 -120.08 139.4 52.62 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 120.272 -0.571 . . . . 3.3700000000000001 110.358 173.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.416 HG21 HD21 ' A' ' 192' ' ' LEU . 1.1 t -119.13 121.47 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 O-C-N 123.854 0.722 . . . . 1.3999999999999999 110.402 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -123.98 43.37 3.0 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.326 -1.361 . . . . 2.1699999999999999 107.326 178.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 6.8 m -69.31 137.42 52.96 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 113.379 -1.737 . . . . 1.6499999999999999 111.513 -172.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.408 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 9.1 tp10 . . . . . 0 N--CA 1.451 -0.409 0 CA-C-N 116.326 -0.397 . . . . 2.4500000000000002 111.213 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.413 ' HA ' ' CE ' ' A' ' 186' ' ' LYS . 40.2 mm . . . . . 0 CA--C 1.502 -0.882 0 CA-C-O 122.858 1.313 . . . . 1.1200000000000001 107.809 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.992 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.4 mp -63.51 -36.23 75.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 112.034 -2.348 . . . . 1.1299999999999999 109.775 175.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -58.89 -26.26 64.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.699 -1.137 . . . . 2.8900000000000001 109.993 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.413 ' CE ' ' HA ' ' A' ' 183' ' ' ILE . 43.9 mtmt -93.13 -44.37 8.4 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.644 -0.707 . . . . 1.28 110.036 177.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.992 HG22 ' HA ' ' A' ' 184' ' ' ILE . 4.7 t -69.28 -30.8 68.98 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 115.997 -0.547 . . . . 0.62 112.049 -170.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' MET . . . . . 0.531 ' O ' ' HG ' ' A' ' 192' ' ' LEU . 1.4 mmt -80.29 -65.1 0.28 Allowed Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 112.473 0.546 . . . . 1.0600000000000001 112.473 -172.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 33.6 Cg_endo -63.37 -25.72 71.13 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 121.73 1.62 . . . . 0.91000000000000003 112.944 -174.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.616 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 46.2 m -83.97 -31.48 25.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.912 0.387 . . . . 1.5 111.114 -177.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -90.87 -27.73 18.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.28 -0.418 . . . . 1.8799999999999999 111.623 -173.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 188' ' ' MET . 68.0 mt -75.94 -42.94 47.14 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 120.033 -0.667 . . . . 1.0900000000000001 110.312 -175.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.8 ' HB ' HD12 ' A' ' 33' ' ' ILE . 2.1 m -66.36 -31.29 52.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 108.803 -0.814 . . . . 0.68000000000000005 108.803 176.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.616 ' HB2' ' O ' ' A' ' 190' ' ' SER . 1.6 t-20 -73.4 -32.33 64.39 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.33 -1.305 . . . . 2.0699999999999998 110.311 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.56 ' O ' ' HB2' ' A' ' 198' ' ' ASN . 33.7 t80 -65.68 -30.92 71.67 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.169 -0.678 . . . . 2.0 109.169 175.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.452 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 57.0 mt -78.08 -28.82 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 115.654 -0.703 . . . . 0.31 110.554 174.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 87.8 mt -72.41 -32.74 66.61 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 121.175 0.512 . . . . 1.03 110.025 174.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.56 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 26.2 m-80 -51.19 -42.74 61.08 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.098 -1.075 . . . . 1.8999999999999999 108.098 165.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.604 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -73.88 -43.28 59.0 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 116.34 -0.391 . . . . 0.28999999999999998 110.68 -177.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.455 ' HD3' HG12 ' A' ' 54' ' ' ILE . 31.7 mmtp -54.37 -44.32 72.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.524 0.678 . . . . 0.96999999999999997 110.663 175.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' ASP . . . . . 0.446 ' HA ' ' HG2' ' A' ' 204' ' ' LYS . 31.4 t70 -85.74 -38.88 17.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.328 -0.851 . . . . 1.9399999999999999 110.878 -174.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -68.07 -31.16 74.55 Favored Glycine 0 CA--C 1.507 -0.437 0 C-N-CA 120.397 -0.906 . . . . 0.46999999999999997 111.648 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 1.034 HD13 HD23 ' A' ' 61' ' ' LEU . 3.0 tp -71.11 -32.9 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 109.496 -0.557 . . . . 0.60999999999999999 109.496 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.446 ' HG2' ' HA ' ' A' ' 201' ' ' ASP . 5.6 pttp -87.29 -20.64 26.53 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 109.384 -0.598 . . . . 3.3700000000000001 109.384 177.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.975 0 N-CA-C 108.394 -0.965 . . . . 1.02 108.394 166.162 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.6 t70 . . . . . 0 CA--C 1.512 -0.486 0 N-CA-C 109.297 -0.631 . . . . 2.25 109.297 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.893 ' HA ' HD12 ' A' ' 6' ' ' ILE . 71.9 m-85 -62.81 -30.73 71.7 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.621 0.724 . . . . 0.42999999999999999 109.145 174.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.769 ' HE3' ' HE1' ' A' ' 116' ' ' TYR . 66.3 tttt -70.52 -33.96 71.76 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 107.492 -1.299 . . . . 1.51 107.492 -177.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.72 -36.57 79.16 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.215 0.531 . . . . 0.54000000000000004 110.542 177.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.893 HD12 ' HA ' ' A' ' 3' ' ' PHE . 2.0 mp -81.46 -41.29 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 CA-C-O 121.982 0.896 . . . . 1.0700000000000001 108.722 -174.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.672 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -80.09 -33.19 39.0 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.808 -1.542 . . . . 0.34000000000000002 112.147 -174.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.61 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 13.9 mt-30 -69.54 -23.58 63.6 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.788 0.804 . . . . 1.5900000000000001 109.495 175.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.572 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 14.4 mm100 -84.43 -47.85 10.24 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.426 -1.261 . . . . 2.4700000000000002 108.876 170.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.642 ' HB ' ' HA ' ' A' ' 7' ' ' ALA . 0.6 OUTLIER -55.11 -39.35 69.28 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.124 -0.943 . . . . 0.47999999999999998 112.038 178.251 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -46.54 -57.73 4.46 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.837 0.68 . . . . 0.31 112.837 174.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.431 ' H ' ' HG2' ' A' ' 12' ' ' GLN . 16.2 pt20 -80.38 -6.48 58.09 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.416 -0.356 . . . . 1.6399999999999999 111.251 -177.125 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 9.6 mm-40 -78.58 -51.32 10.09 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.934 -0.765 . . . . 2.54 108.934 170.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.75 HG23 ' CD2' ' A' ' 170' ' ' PHE . 7.1 p -68.22 -39.61 81.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.636 -0.711 . . . . 0.53000000000000003 110.455 177.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.522 HD12 HG11 ' A' ' 154' ' ' VAL . 0.6 OUTLIER -68.02 -19.68 64.93 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-O 122.077 0.942 . . . . 0.59999999999999998 108.619 174.744 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.534 ' HA2' ' NE ' ' A' ' 19' ' ' ARG . . . -65.1 -22.7 69.12 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 113.876 -1.511 . . . . 0.56999999999999995 110.088 175.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.438 ' HA ' ' HB3' ' A' ' 20' ' ' ASP . 13.8 m-85 -92.1 -12.03 34.13 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 114.973 -0.613 . . . . 3.27 110.088 178.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -80.47 -20.44 43.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.777 0.798 . . . . 2.0299999999999998 109.131 177.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.534 ' NE ' ' HA2' ' A' ' 16' ' ' GLY . 18.8 ptt180 -105.49 -5.57 20.15 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.079 -0.964 . . . . 2.7200000000000002 109.325 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.438 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 12.8 t70 -86.26 114.62 23.23 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 114.731 -1.122 . . . . 2.1600000000000001 110.544 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 40.8 p -134.69 101.79 5.06 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.829 -0.804 . . . . 1.8200000000000001 108.829 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.0 p -141.76 -148.87 0.25 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.404 -0.817 . . . . 2.1899999999999999 111.757 -164.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.81 63.66 1.21 Allowed Glycine 0 CA--C 1.52 0.396 0 O-C-N 123.379 0.424 . . . . 1.1000000000000001 113.289 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 1.026 ' HA ' ' HB3' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -104.96 -157.92 0.64 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.046 -0.724 . . . . 1.6699999999999999 109.046 173.05 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.426 ' HE3' ' HA ' ' A' ' 25' ' ' LYS . 1.7 tpmt? -173.75 120.06 0.3 Allowed 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.183 -1.043 . . . . 2.9500000000000002 108.183 -177.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.922 HG21 HG23 ' A' ' 29' ' ' THR . 2.7 p -64.02 116.57 3.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 C-N-CA 119.458 -0.897 . . . . 1.5600000000000001 109.531 177.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.452 HG11 ' HE2' ' A' ' 48' ' ' TYR . 11.1 p -88.86 -22.96 6.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 114.669 -1.15 . . . . 1.22 108.739 -177.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.493 ' HD3' ' HA ' ' A' ' 28' ' ' LYS . 1.9 tppp? -157.04 122.49 4.66 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 119.867 -0.733 . . . . 2.4100000000000001 112.972 -175.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.922 HG23 HG21 ' A' ' 26' ' ' VAL . 37.8 p -129.35 140.31 51.42 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.215 -0.661 . . . . 1.3799999999999999 109.215 167.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.6 m -124.8 -60.69 1.36 Allowed 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.41 -0.516 . . . . 2.3700000000000001 112.014 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -152.07 73.22 1.04 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.3 -0.409 . . . . 4.5499999999999998 110.765 -172.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.754 ' HE3' ' HB ' ' A' ' 53' ' ' ILE . 43.2 tttp 79.21 18.32 0.82 Allowed 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 122.133 0.968 . . . . 1.4199999999999999 109.431 177.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.813 HG22 ' HA3' ' A' ' 52' ' ' GLY . 5.9 pt -129.63 146.16 34.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 114.198 -1.365 . . . . 0.76000000000000001 109.704 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.724 ' HA ' HG22 ' A' ' 29' ' ' THR . 52.8 m -143.55 107.56 4.71 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.975 -1.011 . . . . 0.57999999999999996 110.814 -166.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 27' ' ' VAL . 24.4 t -100.32 103.13 14.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.888 -0.596 . . . . 0.85999999999999999 109.756 176.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.772 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 87.5 p -93.42 137.4 32.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.996 -0.547 . . . . 1.1000000000000001 110.553 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.8 t -129.09 135.35 48.79 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.173 0.511 . . . . 1.27 111.483 -177.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 1.026 ' HB3' ' HA ' ' A' ' 24' ' ' TRP . 41.8 pttt . . . . . 0 C--N 1.32 -0.677 0 CA-C-N 115.151 -0.931 . . . . 1.9099999999999999 108.824 172.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.628 HD21 ' N ' ' A' ' 46' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.445 0 CA-C-O 121.266 0.555 . . . . 2.0499999999999998 110.855 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.705 HD11 ' HE1' ' A' ' 170' ' ' PHE . 10.1 tt -105.8 153.2 22.23 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.187 -0.915 . . . . 0.87 109.565 -177.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.452 ' HE2' HG11 ' A' ' 27' ' ' VAL . 42.7 m-85 -128.29 129.99 47.16 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.81 0.338 . . . . 0.98999999999999999 111.059 -175.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.764 ' HD3' ' CZ3' ' A' ' 24' ' ' TRP . 41.0 ttt180 -106.94 119.9 40.6 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.226 -1.027 . . . . 2.9199999999999999 108.226 168.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.72 HG13 ' HB3' ' A' ' 169' ' ' MET . 0.2 OUTLIER -111.13 122.37 65.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.773 -0.649 . . . . 1.3300000000000001 109.564 -171.671 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 35.3 tt0 -138.87 148.27 43.46 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.084 -0.507 . . . . 1.0700000000000001 110.633 -169.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.813 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -170.77 150.73 14.53 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 110.9 -0.88 . . . . 0.28999999999999998 110.9 173.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.754 ' HB ' ' HE3' ' A' ' 32' ' ' LYS . 85.1 mt -92.19 112.03 25.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 117.693 0.746 . . . . 0.57999999999999996 110.01 175.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.419 HG12 ' CE ' ' A' ' 200' ' ' LYS . 68.4 mt -89.71 116.4 66.25 Favored Pre-proline 0 N--CA 1.437 -1.084 0 CA-C-N 115.329 -0.851 . . . . 0.34999999999999998 109.079 176.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.41 55.44 0.31 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 124.181 3.254 . . . . 0.62 112.965 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.865 ' HG2' HG13 ' A' ' 203' ' ' ILE . 7.3 tp10 -155.98 162.85 40.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.597 -1.26 . . . . 1.6799999999999999 107.597 175.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.481 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 31.3 p -71.77 140.61 83.99 Favored Pre-proline 0 N--CA 1.432 -1.328 0 CA-C-O 121.65 0.738 . . . . 1.1799999999999999 110.795 -176.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.709 ' HD3' ' HB2' ' A' ' 165' ' ' SER . 10.0 Cg_endo -52.46 -11.42 1.19 Allowed 'Trans proline' 0 CA--C 1.527 0.162 0 C-N-CA 124.495 3.463 . . . . 0.52000000000000002 111.761 172.013 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.31 -46.12 61.45 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.837 -0.62 . . . . 0.64000000000000001 110.713 174.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.903 ' HE2' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -65.05 -37.36 87.32 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 107.934 -1.136 . . . . 3.2999999999999998 107.934 174.307 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.727 HD23 ' CD1' ' A' ' 203' ' ' ILE . 83.5 mt -60.69 -55.2 36.09 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.719 -1.128 . . . . 0.40999999999999998 110.187 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.554 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 28.3 t -67.93 -13.87 62.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.063 -0.517 . . . . 1.29 110.637 176.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.903 ' HB3' ' HE2' ' A' ' 60' ' ' LYS . 21.3 t70 -81.06 -49.12 11.28 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.573 -0.451 . . . . 1.3200000000000001 110.78 -178.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.655 ' CE2' ' HA ' ' A' ' 61' ' ' LEU . 17.2 p90 -70.12 -47.81 60.18 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 120.48 -0.488 . . . . 0.60999999999999999 110.876 -174.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.554 ' CD2' ' HA ' ' A' ' 62' ' ' SER . 0.8 OUTLIER -76.9 -14.27 59.89 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 120.699 -0.4 . . . . 1.5 111.463 -168.539 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.475 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 30.9 t80 -22.04 -61.17 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 O-C-N 125.233 1.583 . . . . 1.52 113.932 -163.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.599 ' H ' ' NH2' ' A' ' 71' ' ' ARG . 17.3 tm0? 175.4 -51.04 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 O-C-N 123.492 0.495 . . . . 3.6000000000000001 111.09 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.488 ' HB ' ' OE1' ' A' ' 67' ' ' GLN . 6.3 t -148.23 24.15 1.03 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.668 0.618 . . . . 1.48 112.668 -169.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.709 ' N ' HH12 ' A' ' 71' ' ' ARG . . . -129.26 0.91 6.08 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 117.928 -2.082 . . . . 1.46 115.96 -167.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.72 ' O ' HG22 ' A' ' 73' ' ' THR . 19.2 t70 -171.18 -41.46 0.02 OUTLIER 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 117.816 0.808 . . . . 2.1899999999999999 110.467 -172.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.772 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -74.89 -20.34 59.76 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-N 115.692 -0.685 . . . . 3.3799999999999999 112.038 -162.154 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.932 HG22 HD13 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -100.83 -7.98 9.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 119.102 -1.039 . . . . 0.70999999999999996 109.995 177.295 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.72 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.4 t -87.05 -35.51 18.7 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 120.24 -0.584 . . . . 0.96999999999999997 109.867 -174.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.604 ' HZ2' ' CD1' ' A' ' 64' ' ' PHE . 21.1 p-90 -105.64 -2.68 23.13 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 116.258 -0.428 . . . . 0.75 111.321 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.772 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 3.0 t70 -66.61 170.45 6.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.84 0.829 . . . . 2.1899999999999999 112.601 -169.077 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.503 ' HG2' ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -118.0 -21.54 8.26 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.374 -1.284 . . . . 3.1899999999999999 111.182 -177.062 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.7 m -122.66 7.4 9.44 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.194 0.521 . . . . 1.5800000000000001 109.66 -176.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.932 HD13 HG22 ' A' ' 72' ' ' ILE . 27.0 mt -108.78 179.79 4.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.77 -0.65 . . . . 0.70999999999999996 111.347 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.623 ' HB3' HG23 ' A' ' 80' ' ' VAL . 15.3 mm-40 -151.91 -67.1 0.17 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.408 -0.814 . . . . 1.73 111.349 -175.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.623 HG23 ' HB3' ' A' ' 79' ' ' GLN . 21.5 t -143.09 126.05 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.831 -0.622 . . . . 0.78000000000000003 110.3 -166.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -89.81 152.93 21.04 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.374 -0.375 . . . . 5.4000000000000004 110.09 173.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.813 ' HB3' ' HB3' ' A' ' 95' ' ' HIS . 28.1 t-20 -148.99 99.58 2.98 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.401 -0.592 . . . . 1.6899999999999999 109.401 165.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 16.9 ttp -69.9 99.1 1.35 Allowed 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.516 -0.92 . . . . 2.0499999999999998 108.516 177.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.658 HG23 ' HB ' ' A' ' 93' ' ' ILE . 0.2 OUTLIER -78.29 -95.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.718 -0.673 . . . . 0.64000000000000001 111.648 -170.576 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.487 ' H ' HG23 ' A' ' 84' ' ' VAL . 23.0 t-160 -105.2 110.46 22.84 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.642 -0.503 . . . . 1.96 109.642 -178.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -92.65 108.79 20.25 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.384 -0.599 . . . . 2.4399999999999999 109.384 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.592 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -67.39 -40.72 85.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.092 -0.958 . . . . 0.46999999999999997 109.463 -177.202 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.486 ' C ' ' H ' ' A' ' 90' ' ' ASP . 38.2 t70 -156.27 159.77 39.17 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.585 -1.643 . . . . 1.8600000000000001 107.068 -177.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.1 m -72.13 16.87 0.11 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.906 0.384 . . . . 1.4399999999999999 111.183 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.486 ' H ' ' C ' ' A' ' 88' ' ' ASP . 16.2 t70 -137.79 1.83 2.35 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.389 -0.967 . . . . 1.8700000000000001 108.389 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.592 ' O ' HG12 ' A' ' 87' ' ' ILE . 1.7 m -145.29 112.09 5.91 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 109.184 -0.672 . . . . 0.46000000000000002 109.184 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.557 ' O ' HD12 ' A' ' 114' ' ' LEU . 18.6 m-85 -123.61 177.73 5.54 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.199 0.523 . . . . 0.42999999999999999 110.883 -172.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.658 ' HB ' HG23 ' A' ' 84' ' ' VAL . 40.9 mt -132.97 127.37 55.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 107.588 -1.264 . . . . 0.40999999999999998 107.588 169.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.577 ' SG ' HG11 ' A' ' 115' ' ' VAL . 74.5 m -100.98 107.57 19.08 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.426 -0.352 . . . . 2.0099999999999998 111.921 -172.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.813 ' HB3' ' HB3' ' A' ' 82' ' ' ASN . 19.5 t-160 -82.06 74.88 9.01 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.379 -0.971 . . . . 1.23 108.379 165.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.413 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 79.5 m -95.75 111.51 23.45 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.812 -1.085 . . . . 0.5 111.982 -174.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.49 HD13 ' HB ' ' A' ' 80' ' ' VAL . 3.4 mp -78.25 123.56 35.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.992 -0.744 . . . . 1.03 108.992 172.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' A' ' 109' ' ' ARG . 91.1 m -110.35 146.94 34.91 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.951 -1.022 . . . . 1.3799999999999999 109.778 -173.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 121.477 0.656 . . . . 1.8200000000000001 111.672 -173.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.647 HG23 ' NH2' ' A' ' 109' ' ' ARG . 96.9 mt . . . . . 0 N--CA 1.449 -0.501 0 CA-C-O 121.528 0.68 . . . . 1.1200000000000001 111.007 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.54 ' OG ' ' HD2' ' A' ' 108' ' ' PRO . 22.8 t -79.35 159.4 72.56 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 114.758 -1.11 . . . . 1.3500000000000001 108.651 173.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.54 ' HD2' ' OG ' ' A' ' 107' ' ' SER . 47.6 Cg_exo -35.91 136.64 0.2 Allowed 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.363 2.709 . . . . 1.0700000000000001 112.966 173.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.683 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 17.2 ttm180 -123.07 126.42 47.05 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.232 0.539 . . . . 3.4500000000000002 109.779 -172.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.784 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 9.1 t0 -100.1 119.55 38.48 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.761 -0.654 . . . . 1.3700000000000001 109.256 -172.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 95' ' ' HIS . 13.0 m-85 -100.1 145.77 27.57 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.153 0.502 . . . . 2.4100000000000001 112.253 -173.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.961 HG12 ' HD2' ' A' ' 145' ' ' ARG . 29.4 mm -137.87 77.2 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 114.689 -1.142 . . . . 0.42999999999999999 108.264 170.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.41 ' OD2' ' HB3' ' A' ' 148' ' ' ASN . 1.0 OUTLIER -104.0 124.01 48.25 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.426 -0.806 . . . . 1.8600000000000001 110.514 -177.943 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.557 HD12 ' O ' ' A' ' 92' ' ' PHE . 12.8 tp -74.87 123.57 25.29 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.728 0.775 . . . . 0.28000000000000003 109.41 169.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.577 HG11 ' SG ' ' A' ' 94' ' ' CYS . 0.1 OUTLIER -125.81 126.76 70.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 114.564 -1.198 . . . . 0.26000000000000001 111.812 -168.232 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.885 ' HE2' ' HE2' ' A' ' 118' ' ' LYS . 87.9 t80 -111.17 128.57 55.95 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.396 -0.82 . . . . 2.5699999999999998 110.966 175.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.811 HG13 HG22 ' A' ' 127' ' ' ILE . 1.9 mp -88.82 99.93 9.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.911 -0.774 . . . . 0.89000000000000001 108.911 178.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.885 ' HE2' ' HE2' ' A' ' 116' ' ' TYR . 16.8 tppt? -97.3 123.99 41.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.773 -0.649 . . . . 1.2 110.156 -175.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -115.46 92.09 3.81 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.495 -0.775 . . . . 2.7999999999999998 110.852 -178.249 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.656 ' HB3' ' HB3' ' A' ' 123' ' ' ASN . 97.7 m-85 -70.64 101.65 2.1 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 106.147 -1.798 . . . . 0.82999999999999996 106.147 163.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -47.64 96.31 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.4 1.062 . . . . 2.2799999999999998 112.289 -173.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 72.03 43.26 49.37 Favored Glycine 0 CA--C 1.503 -0.665 0 CA-C-N 113.796 -1.547 . . . . 0.76000000000000001 111.757 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.656 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 65.8 t30 -146.85 -49.07 0.19 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.089 -0.556 . . . . 1.6499999999999999 109.978 -178.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.568 ' HB2' ' HD2' ' A' ' 120' ' ' TYR . 1.0 OUTLIER -155.86 135.18 12.29 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.071 0.462 . . . . 1.1200000000000001 110.978 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.67 80.87 1.5 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.12 -1.067 . . . . 1.6200000000000001 108.12 175.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.744 HG23 ' HB3' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -103.56 140.66 21.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.538 -0.755 . . . . 0.29999999999999999 112.201 -172.526 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.811 HG22 HG13 ' A' ' 117' ' ' ILE . 9.0 pt -104.74 116.62 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 108.402 -0.962 . . . . 0.58999999999999997 108.402 160.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 5.0 m -75.27 163.49 27.44 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.193 -0.912 . . . . 1.1799999999999999 108.69 173.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 37.1 p -155.55 138.61 15.5 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.402 0.62 . . . . 1.24 110.852 178.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.587 ' HE3' ' HB3' ' A' ' 150' ' ' PRO . 11.4 ttmt -151.96 119.63 6.1 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.669 -0.696 . . . . 2.2599999999999998 109.231 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.3 p -64.81 106.73 1.27 Allowed 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 108.59 -0.892 . . . . 1.3899999999999999 108.59 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.5 m -104.7 151.96 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 119.546 -0.862 . . . . 1.05 109.495 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.561 ' HA ' ' CG ' ' A' ' 137' ' ' TYR . 6.5 p-10 -109.05 64.86 0.61 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 122.809 1.29 . . . . 2.1699999999999999 110.533 -170.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.748 ' CZ ' ' HB3' ' A' ' 136' ' ' GLU . 2.3 p90 -100.91 176.46 1.89 Allowed Pre-proline 0 CA--C 1.555 1.149 0 CA-C-N 113.797 -1.547 . . . . 0.53000000000000003 108.946 -176.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.657 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 23.7 Cg_exo -27.67 -59.61 0.1 OUTLIER 'Trans proline' 0 CA--C 1.548 1.218 1 C-N-CA 125.347 4.031 . . . . 1.28 117.504 -178.178 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.748 ' HB3' ' CZ ' ' A' ' 134' ' ' PHE . 4.6 tp10 -74.88 -24.97 58.64 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.439 0.533 . . . . 3.5 112.439 -173.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.955 ' HA ' HG13 ' A' ' 112' ' ' ILE . 21.2 t80 -50.68 -45.05 85.82 Favored Pre-proline 0 CA--C 1.553 1.067 0 N-CA-C 115.78 1.77 . . . . 6.1200000000000001 115.78 -173.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.475 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 36.7 Cg_exo -38.03 116.42 0.22 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 122.975 2.45 . . . . 1.77 114.185 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.665 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 9.6 Cg_endo -89.29 -165.0 0.18 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.883 3.055 . . . . 1.25 114.335 -173.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.0 m -145.03 -171.87 3.73 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.231 -0.895 . . . . 1.6000000000000001 108.617 -176.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.9 t -81.37 -30.13 33.82 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.573 -0.451 . . . . 1.97 110.593 177.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 -79.65 -29.11 40.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.364 0.602 . . . . 2.1800000000000002 110.124 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.784 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 34.9 m-85 -122.13 114.14 20.48 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.68 -0.691 . . . . 1.23 110.162 -176.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.683 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 1.5 tp -95.66 112.95 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 108.063 -1.088 . . . . 0.81999999999999995 108.063 178.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.961 ' HD2' HG12 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -57.75 123.96 17.48 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.645 -1.161 . . . . 4.4199999999999999 111.779 -174.457 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -42.27 99.52 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 113.973 -1.467 . . . . 0.79000000000000004 113.176 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 1.097 ' HB2' ' HB3' ' A' ' 174' ' ' GLU . 1.7 p90 -85.5 68.45 10.44 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.304 -0.948 . . . . 4.4400000000000004 110.902 178.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.41 ' HB3' ' OD2' ' A' ' 113' ' ' ASP . 55.9 t30 -103.31 110.49 22.49 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.112 -0.949 . . . . 1.6200000000000001 110.361 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.603 ' HB2' ' HB3' ' A' ' 172' ' ' GLN . 28.7 m170 -61.37 164.32 9.14 Favored Pre-proline 0 C--O 1.219 -0.536 0 CA-C-O 118.225 -0.893 . . . . 2.3199999999999998 108.675 171.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.587 ' HB3' ' HE3' ' A' ' 130' ' ' LYS . 7.6 Cg_endo -49.33 74.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 123.871 3.047 . . . . 0.53000000000000003 113.982 -177.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' CYS . . . . . 0.731 ' HB3' ' O ' ' A' ' 170' ' ' PHE . 18.2 m -112.65 -173.68 2.3 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.355 -0.839 . . . . 1.5800000000000001 108.745 177.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.675 ' O ' ' HG3' ' A' ' 169' ' ' MET . . . -174.98 -154.72 11.42 Favored Glycine 0 CA--C 1.494 -1.235 0 C-N-CA 118.65 -1.738 . . . . 0.42999999999999999 112.74 -178.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.453 ' CE2' HD21 ' A' ' 167' ' ' LEU . 39.4 t80 -160.07 85.16 0.74 Allowed 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.317 -0.994 . . . . 0.59999999999999998 108.317 -163.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.698 ' CG2' HG13 ' A' ' 168' ' ' VAL . 3.1 m -94.73 126.17 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 CA-C-O 121.862 0.839 . . . . 0.31 110.625 -173.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 63.9 m -106.69 106.52 17.08 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.439 -0.8 . . . . 1.55 109.171 176.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.69 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 13.2 m -101.09 120.05 56.26 Favored Pre-proline 0 C--N 1.314 -0.939 0 C-N-CA 120.796 -0.362 . . . . 1.0600000000000001 111.211 -170.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.418 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 77.6 Cg_exo -51.05 119.59 5.57 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.402 2.068 . . . . 0.56000000000000005 110.965 172.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.597 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 59.2 mmm -83.49 -167.89 1.89 Allowed 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.196 0.522 . . . . 1.1599999999999999 111.917 -174.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -65.06 -32.84 74.75 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.983 0.897 . . . . 2.6299999999999999 109.165 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -113.48 31.13 6.7 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.154 -1.385 . . . . 2.0499999999999998 109.056 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 164' ' ' TYR . 2.1 p-10 -23.37 -55.27 0.12 Allowed Pre-proline 0 N--CA 1.475 0.788 0 N-CA-C 116.505 2.039 . . . . 1.9299999999999999 116.505 -172.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.405 ' HD3' ' CG ' ' A' ' 161' ' ' ASN . 48.7 Cg_endo -67.81 -19.31 47.07 Favored 'Trans proline' 0 C--N 1.35 0.624 0 CA-C-N 121.649 1.625 . . . . 0.72999999999999998 113.146 -175.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -111.89 -22.84 10.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.355 -0.384 . . . . 0.68000000000000005 111.354 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.597 ' O ' ' HB2' ' A' ' 158' ' ' MET . 94.7 m-85 -138.93 129.3 25.67 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.436 -0.579 . . . . 0.93000000000000005 109.436 176.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.709 ' HB2' ' HD3' ' A' ' 58' ' ' PRO . 21.9 t -127.22 148.75 50.2 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.054 -0.659 . . . . 1.4099999999999999 111.598 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.69 ' HB3' ' HB2' ' A' ' 156' ' ' SER . 11.8 tppt? -91.77 100.6 13.27 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.919 0.866 . . . . 0.73999999999999999 111.261 -178.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 1.0 OUTLIER -88.37 105.78 17.81 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.91 -1.041 . . . . 0.27000000000000002 109.089 176.417 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.698 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.1 OUTLIER -132.5 120.21 41.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 122.497 1.141 . . . . 0.28000000000000003 111.927 177.772 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.72 ' HB3' HG13 ' A' ' 50' ' ' VAL . 19.0 ttt -122.69 160.92 24.85 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 113.999 -1.455 . . . . 1.24 108.165 -178.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.75 ' CD2' HG23 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -145.77 149.03 33.62 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.228 -1.027 . . . . 3.3700000000000001 108.228 170.553 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.477 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 8.5 p -137.43 132.31 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 O-C-N 124.147 0.904 . . . . 1.3999999999999999 111.006 -174.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.603 ' HB3' ' HB2' ' A' ' 149' ' ' HIS . 19.0 tt0 -119.93 64.83 0.82 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.587 -1.264 . . . . 2.1699999999999999 107.587 175.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.476 HG22 ' HE1' ' A' ' 147' ' ' TYR . 0.2 OUTLIER -58.07 130.54 47.08 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.885 -1.507 . . . . 1.6499999999999999 111.908 -173.032 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 1.097 ' HB3' ' HB2' ' A' ' 147' ' ' TYR . 12.1 tt0 . . . . . 0 N--CA 1.455 -0.197 0 CA-C-O 121.583 0.706 . . . . 2.4500000000000002 111.948 -176.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.492 ' HA ' ' HE2' ' A' ' 186' ' ' LYS . 20.6 mm . . . . . 0 CA--C 1.506 -0.714 0 CA-C-O 122.465 1.126 . . . . 1.1200000000000001 108.942 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 1.005 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.0 OUTLIER -70.21 -37.54 71.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 112.91 -1.95 . . . . 1.1299999999999999 111.489 -176.788 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -67.12 -17.1 64.72 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.149 -0.686 . . . . 2.8900000000000001 109.149 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.492 ' HE2' ' HA ' ' A' ' 183' ' ' ILE . 45.8 mtmt -90.37 -49.32 6.6 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.415 -0.811 . . . . 1.28 109.211 171.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' THR . . . . . 1.005 HG22 ' HA ' ' A' ' 184' ' ' ILE . 11.3 t -60.04 -31.22 69.76 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.617 0.599 . . . . 0.62 112.617 -167.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' MET . . . . . 0.872 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 7.0 mmt -80.11 -61.23 0.45 Allowed Pre-proline 0 C--N 1.327 -0.399 0 C-N-CA 120.488 -0.485 . . . . 1.0600000000000001 111.296 -176.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.872 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 37.8 Cg_exo -62.21 -26.14 77.4 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.132 1.888 . . . . 0.91000000000000003 112.812 -178.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.544 ' O ' ' HB3' ' A' ' 194' ' ' ASN . 98.0 p -80.7 -30.42 36.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.021 0.438 . . . . 1.5 110.713 -178.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -90.46 -34.54 15.56 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.825 -0.625 . . . . 1.8799999999999999 111.518 -172.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.536 HD22 HG11 ' A' ' 50' ' ' VAL . 78.2 mt -73.24 -42.03 63.02 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.57 -0.452 . . . . 1.0900000000000001 111.607 -174.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 189' ' ' PRO . 1.5 m -70.56 -30.08 41.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.831 -0.803 . . . . 0.68000000000000005 108.831 178.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.569 ' HA ' ' HB2' ' A' ' 197' ' ' LEU . 0.1 OUTLIER -73.88 -40.63 63.08 Favored 'General case' 0 C--O 1.208 -1.117 0 CA-C-N 114.138 -1.392 . . . . 2.0699999999999998 111.209 178.013 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.479 ' HD1' ' HA ' ' A' ' 195' ' ' PHE . 1.7 m-30 -56.9 -33.25 66.73 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 118.576 0.626 . . . . 2.0 109.88 172.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.614 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 46.4 mt -77.41 -31.07 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-N 115.973 -0.558 . . . . 0.31 111.316 174.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.569 ' HB2' ' HA ' ' A' ' 194' ' ' ASN . 24.0 mt -70.0 -40.92 75.01 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 110.182 -0.303 . . . . 1.03 110.182 176.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.413 ' HB3' ' CH2' ' A' ' 74' ' ' TRP . 3.8 m-20 -49.18 -45.33 43.97 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.974 -0.75 . . . . 1.8999999999999999 108.974 166.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.83 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -66.76 -44.75 80.59 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.965 -0.561 . . . . 0.28999999999999998 110.22 -177.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.614 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 35.3 mmtp -57.81 -45.83 85.53 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 109.446 -0.575 . . . . 0.96999999999999997 109.446 172.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -67.47 -43.97 79.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.359 -0.837 . . . . 1.9399999999999999 110.756 -171.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -78.45 -20.45 71.82 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.18 -1.01 . . . . 0.46999999999999997 111.666 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.865 HG13 ' HG2' ' A' ' 56' ' ' GLU . 1.0 OUTLIER -78.68 -34.33 17.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 123.439 0.695 . . . . 0.60999999999999999 109.885 173.812 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.558 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 99.2 mttt -80.16 -30.26 38.88 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 108.697 -0.853 . . . . 3.3700000000000001 108.697 177.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.757 0 CA-C-N 115.836 -0.62 . . . . 1.02 109.57 170.725 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.445 ' OD2' HD11 ' A' ' 6' ' ' ILE . 36.4 t70 . . . . . 0 CA--C 1.512 -0.503 0 CA-C-O 120.743 0.306 . . . . 2.25 110.369 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.853 ' HA ' HD12 ' A' ' 6' ' ' ILE . 94.0 m-85 -64.98 -33.8 76.91 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.076 -0.712 . . . . 0.42999999999999999 109.076 -176.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.646 ' HD2' ' CB ' ' A' ' 88' ' ' ASP . 33.5 tttm -73.79 -3.58 29.42 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.021 -0.99 . . . . 1.51 110.288 177.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.463 ' O ' ' HG3' ' A' ' 9' ' ' GLN . . . -91.37 -40.98 11.15 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.559 -0.534 . . . . 0.54000000000000004 109.559 172.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.853 HD12 ' HA ' ' A' ' 3' ' ' PHE . 1.1 mp -82.51 -44.01 19.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.956 0.884 . . . . 1.0700000000000001 109.487 -172.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.534 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -70.85 -39.3 73.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.302 -1.317 . . . . 0.34000000000000002 111.422 -178.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.574 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 8.1 mt-30 -66.85 -26.14 66.76 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.99 -1.004 . . . . 1.5900000000000001 110.384 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 5' ' ' ALA . 98.7 mt-30 -80.52 -37.11 32.19 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.082 -0.963 . . . . 2.4700000000000002 108.843 172.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.654 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.4 OUTLIER -67.87 -37.48 81.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.666 -1.152 . . . . 0.47999999999999998 111.614 -178.849 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.597 ' HA ' ' OG ' ' A' ' 128' ' ' SER . . . -46.43 -58.44 3.75 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.592 0.59 . . . . 0.31 112.592 176.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.525 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 13.1 pt20 -83.14 5.39 22.8 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.056 0.455 . . . . 1.6399999999999999 110.803 -177.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.564 ' HB3' ' HA ' ' A' ' 10' ' ' THR . 0.2 OUTLIER -89.49 -49.94 6.39 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.182 -1.044 . . . . 2.54 108.182 174.978 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.668 HG21 ' N ' ' A' ' 152' ' ' GLY . 13.2 p -69.93 -36.44 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 121.828 0.823 . . . . 0.53000000000000003 109.555 177.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.538 ' HG ' ' OD1' ' A' ' 18' ' ' ASN . 2.1 tt -72.87 -18.72 61.4 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 114.87 -1.059 . . . . 0.59999999999999998 109.229 173.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 20' ' ' ASP . . . -61.94 -23.5 63.68 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.11 -1.405 . . . . 0.56999999999999995 109.856 172.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.446 ' HB3' ' CE2' ' A' ' 170' ' ' PHE . 6.8 m-85 -91.33 -28.79 17.51 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.099 -0.55 . . . . 3.27 110.775 177.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.538 ' OD1' ' HG ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -69.59 -15.75 63.27 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.777 -0.369 . . . . 2.0299999999999998 111.335 179.401 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -117.59 -5.48 11.18 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 119.921 -0.711 . . . . 2.7200000000000002 111.896 179.056 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 2.6 m-20 -121.99 135.75 54.87 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 120.919 0.39 . . . . 2.1600000000000001 111.205 178.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.474 HG22 ' CZ2' ' A' ' 24' ' ' TRP . 64.4 p -137.61 120.47 16.42 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.05 -0.523 . . . . 1.8200000000000001 111.411 -176.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.3 t -167.34 132.09 1.95 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.152 -0.476 . . . . 2.1899999999999999 110.204 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.87 -6.06 82.04 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.859 -0.686 . . . . 1.1000000000000001 113.669 172.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.808 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -111.75 -170.2 1.61 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.842 0.321 . . . . 1.6699999999999999 110.625 -178.231 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.443 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 7.3 mtpt -178.6 133.22 0.13 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.884 -0.784 . . . . 2.9500000000000002 108.884 -169.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.797 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 1.6 p -61.58 120.03 6.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 119.819 -0.753 . . . . 1.5600000000000001 109.305 171.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 p -95.18 -23.5 5.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 114.708 -1.133 . . . . 1.22 109.123 -177.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.422 ' HD2' ' HA ' ' A' ' 28' ' ' LYS . 11.0 tptm -156.53 129.92 8.12 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.885 -0.598 . . . . 2.4100000000000001 111.847 -173.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.472 HG23 HG21 ' A' ' 26' ' ' VAL . 40.2 p -122.09 149.44 43.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.429 -0.805 . . . . 1.3799999999999999 109.584 173.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 51.1 m -150.4 69.78 1.0 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 121.185 -0.206 . . . . 2.3700000000000001 111.204 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER 74.76 71.76 0.1 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.209 -0.451 . . . . 4.5499999999999998 110.829 177.241 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.553 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 89.5 mttt 80.04 4.54 1.92 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.337 -0.847 . . . . 1.4199999999999999 112.842 172.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.849 HG22 ' HA3' ' A' ' 52' ' ' GLY . 7.5 pt -115.66 143.61 25.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.069 0.461 . . . . 0.76000000000000001 110.151 175.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 5.0 m -136.47 104.7 5.67 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.125 -0.943 . . . . 0.57999999999999996 110.433 -163.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.682 HG22 HG23 ' A' ' 50' ' ' VAL . 3.4 t -96.48 98.85 8.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.864 -0.421 . . . . 0.85999999999999999 109.864 -178.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.797 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 25.9 t -91.96 121.68 33.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.725 0.774 . . . . 1.1000000000000001 110.357 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.3 t -109.01 135.21 50.55 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.341 -1.299 . . . . 1.27 110.56 -175.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.808 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 31.6 ttpt . . . . . 0 C--N 1.319 -0.759 0 CA-C-N 115.482 -0.781 . . . . 1.9099999999999999 110.352 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 110.121 -0.326 . . . . 2.0499999999999998 110.121 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.557 HD23 ' N ' ' A' ' 48' ' ' TYR . 2.9 tt -104.89 137.34 42.81 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.169 -1.049 . . . . 0.87 108.169 178.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.557 ' N ' HD23 ' A' ' 47' ' ' LEU . 58.2 m-85 -124.47 126.42 45.87 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.392 -0.367 . . . . 0.98999999999999999 110.137 -173.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.712 ' HG3' ' CE2' ' A' ' 170' ' ' PHE . 2.5 tmm_? -113.36 120.27 40.52 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.38 -0.6 . . . . 2.9199999999999999 109.38 175.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.682 HG23 HG22 ' A' ' 35' ' ' VAL . 7.6 p -101.9 138.68 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 108.769 -0.826 . . . . 1.3300000000000001 108.769 177.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.636 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 51.6 tt0 -138.63 108.07 6.16 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.467 -0.788 . . . . 1.0700000000000001 109.351 -169.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.849 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -138.34 142.39 13.08 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.031 -1.08 . . . . 0.28999999999999998 112.195 -177.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.0 mt -86.8 124.29 40.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 C-N-CA 120.29 -0.564 . . . . 0.57999999999999996 109.886 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.539 HG12 ' HD3' ' A' ' 200' ' ' LYS . 71.7 mt -105.95 113.76 63.38 Favored Pre-proline 0 C--N 1.312 -1.05 0 N-CA-C 108.834 -0.802 . . . . 0.34999999999999998 108.834 175.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -62.18 67.49 0.12 Allowed 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 124.175 3.25 . . . . 0.62 112.043 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.698 ' HG2' ' CG1' ' A' ' 203' ' ' ILE . 8.0 tp10 -161.13 172.32 16.98 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.775 -1.194 . . . . 1.6799999999999999 107.775 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.465 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 6.2 p -82.09 144.7 51.38 Favored Pre-proline 0 N--CA 1.427 -1.575 0 CA-C-O 121.748 0.785 . . . . 1.1799999999999999 110.356 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.497 ' HB3' ' SG ' ' A' ' 155' ' ' CYS . 23.8 Cg_exo -61.71 -13.25 29.11 Favored 'Trans proline' 0 C--N 1.332 -0.297 0 C-N-CA 124.108 3.206 . . . . 0.52000000000000002 110.539 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.61 -51.47 34.83 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.526 -1.215 . . . . 0.64000000000000001 111.028 175.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.52 ' HE3' ' HB2' ' A' ' 60' ' ' LYS . 26.2 ttmt -71.06 -27.9 63.98 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.885 -0.784 . . . . 3.2999999999999998 108.885 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.054 HD23 HD13 ' A' ' 203' ' ' ILE . 42.7 mt -63.95 -53.13 55.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.697 -1.138 . . . . 0.40999999999999998 109.945 174.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.552 ' HA ' ' CD1' ' A' ' 65' ' ' LEU . 34.7 t -65.91 -11.92 50.76 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.438 -0.346 . . . . 1.29 110.317 175.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.5 ' HB2' ' HA ' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -83.1 -40.25 20.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.217 -0.447 . . . . 1.3200000000000001 111.497 -179.717 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.525 ' CD2' ' HA ' ' A' ' 61' ' ' LEU . 15.6 p90 -81.37 -42.79 19.96 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 120.813 -0.355 . . . . 0.60999999999999999 111.166 -174.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.769 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -85.87 10.17 14.64 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.709 0.29 . . . . 1.5 110.726 -173.02 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.558 ' N ' HH12 ' A' ' 71' ' ' ARG . 1.0 OUTLIER -42.99 -71.29 0.08 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.155 -0.93 . . . . 1.52 112.683 -169.207 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.41 -57.3 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.183 1.549 . . . . 3.6000000000000001 115.183 177.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.694 ' OG1' ' HB2' ' A' ' 81' ' ' TYR . 8.8 t -159.07 23.85 0.2 Allowed 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.852 -0.53 . . . . 1.48 112.298 -161.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.418 ' H ' ' CZ ' ' A' ' 71' ' ' ARG . . . -127.67 1.29 6.91 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 118.501 -1.809 . . . . 1.46 115.535 -166.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.619 ' O ' HG22 ' A' ' 73' ' ' THR . 24.5 t70 -173.27 -40.63 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 117.566 0.683 . . . . 2.1899999999999999 110.784 -169.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.695 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -54.87 -38.52 67.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.501 -0.772 . . . . 3.3799999999999999 111.362 -173.743 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.795 HG22 HD13 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -86.11 -7.46 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-O 120.969 0.414 . . . . 0.70999999999999996 110.953 -176.499 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -90.34 -26.54 19.91 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 120.077 -0.649 . . . . 0.96999999999999997 109.631 -175.584 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.506 ' CE2' ' HA ' ' A' ' 71' ' ' ARG . 24.2 p-90 -111.2 -4.68 14.91 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.595 0.591 . . . . 0.75 112.595 178.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.695 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 4.2 t70 -70.6 174.33 6.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.684 0.754 . . . . 2.1899999999999999 112.348 -171.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.585 ' HG2' ' OD1' ' A' ' 198' ' ' ASN . 1.3 mmtt -106.76 -29.04 9.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.857 -1.065 . . . . 3.1899999999999999 109.313 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.1 m -128.28 20.63 6.26 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.671 -1.15 . . . . 1.5800000000000001 111.109 -172.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.795 HD13 HG22 ' A' ' 72' ' ' ILE . 27.1 mt -110.17 155.94 21.3 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.995 0.426 . . . . 0.70999999999999996 110.45 175.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.912 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 3.3 mm100 -128.16 -61.44 1.1 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.859 -0.609 . . . . 1.73 112.269 -170.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.71 ' CG1' ' HB ' ' A' ' 97' ' ' ILE . 2.9 p -157.15 127.02 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.644 0.735 . . . . 0.78000000000000003 111.9 -170.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.694 ' HB2' ' OG1' ' A' ' 68' ' ' THR . 48.6 p90 -89.67 143.96 26.38 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.454 -1.248 . . . . 5.4000000000000004 110.936 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.783 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 51.1 m-80 -150.03 109.41 3.98 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.193 -0.669 . . . . 1.6899999999999999 109.193 172.003 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.504 ' SD ' ' HB3' ' A' ' 92' ' ' PHE . 31.0 tpp -79.88 109.43 14.31 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.89 -0.782 . . . . 2.0499999999999998 108.89 177.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -85.07 -72.39 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.857 -0.61 . . . . 0.64000000000000001 110.342 -168.813 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.522 ' HB2' HD12 ' A' ' 93' ' ' ILE . 8.0 m-70 -126.41 121.57 32.84 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.764 -0.653 . . . . 1.96 109.741 177.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 -100.47 125.51 46.79 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.136 -1.061 . . . . 2.4399999999999999 108.136 175.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.733 HG21 ' HB2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -91.34 -58.27 3.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 116.22 -0.446 . . . . 0.46999999999999997 111.994 -167.072 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.646 ' CB ' ' HD2' ' A' ' 4' ' ' LYS . 15.6 m-20 -144.92 35.89 1.13 Allowed 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.604 -0.438 . . . . 1.8600000000000001 112.151 -165.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.9 t 73.21 -33.2 0.26 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.154 0.582 . . . . 1.4399999999999999 112.42 176.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -117.02 10.53 13.99 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 108.485 -0.932 . . . . 1.8700000000000001 108.485 -177.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.613 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -138.92 116.2 11.12 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 114.962 -1.017 . . . . 0.46000000000000002 108.394 -174.381 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.597 ' O ' HD12 ' A' ' 114' ' ' LEU . 46.5 m-85 -124.41 177.36 5.93 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.196 0.522 . . . . 0.42999999999999999 110.745 -175.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.646 ' O ' HG23 ' A' ' 84' ' ' VAL . 43.1 mt -135.83 118.03 21.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 107.515 -1.291 . . . . 0.40999999999999998 107.515 168.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 72.5 m -100.46 109.32 21.45 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.883 0.373 . . . . 2.0099999999999998 111.931 -171.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.783 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 19.6 t-160 -80.04 69.96 6.53 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.56 -0.904 . . . . 1.23 108.56 170.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.406 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 96.5 m -95.92 114.72 26.47 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.511 -1.222 . . . . 0.5 111.427 -175.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.71 ' HB ' ' CG1' ' A' ' 80' ' ' VAL . 2.7 mp -85.11 127.53 39.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.614 -0.884 . . . . 1.03 108.614 172.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 109' ' ' ARG . 12.6 t -110.86 165.37 11.9 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.937 -0.574 . . . . 1.3799999999999999 110.233 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.912 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 50.5 mt-30 . . . . . 0 C--N 1.312 -1.041 0 CA-C-N 115.673 -0.694 . . . . 1.8200000000000001 109.429 175.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.3 mt . . . . . 0 N--CA 1.441 -0.912 0 N-CA-C 110.001 -0.37 . . . . 1.1200000000000001 110.001 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.403 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 14.2 m -71.58 164.12 60.54 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 115.976 -0.556 . . . . 1.3500000000000001 109.612 175.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 107' ' ' SER . 7.9 Cg_endo -51.06 113.62 1.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.072 1.848 . . . . 1.0700000000000001 110.48 172.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.661 ' HG2' HG23 ' A' ' 144' ' ' ILE . 18.7 mtm180 -90.62 137.52 32.29 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 120.321 -0.552 . . . . 3.4500000000000002 109.716 -173.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.839 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 9.9 t0 -94.42 126.85 39.95 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.905 -0.776 . . . . 1.3700000000000001 108.905 -177.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 95' ' ' HIS . 6.9 m-85 -107.17 146.34 31.46 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.61 0.719 . . . . 2.4100000000000001 111.576 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.833 HG12 ' HD2' ' A' ' 145' ' ' ARG . 25.2 mm -137.67 68.78 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 114.301 -1.318 . . . . 0.42999999999999999 107.608 172.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.853 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 1.4 m-20 -90.54 115.56 27.78 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.627 -1.17 . . . . 1.8600000000000001 110.088 -176.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.627 ' O ' ' HA ' ' A' ' 129' ' ' SER . 6.1 tp -74.84 119.18 18.67 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 108.745 -0.835 . . . . 0.28000000000000003 108.745 169.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.2 OUTLIER -122.99 124.13 69.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-N 115.033 -0.985 . . . . 0.26000000000000001 111.675 -164.24 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.534 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 79.8 t80 -107.77 119.76 40.34 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.973 -1.012 . . . . 2.5699999999999998 110.769 176.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.813 HG13 HG22 ' A' ' 127' ' ' ILE . 3.9 mp -89.85 98.87 8.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.768 -0.651 . . . . 0.89000000000000001 109.608 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.451 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 39.7 ttmt -106.77 141.4 38.08 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.702 -0.681 . . . . 1.2 109.508 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 124' ' ' MET . 0.4 OUTLIER -131.75 104.19 6.77 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 109.01 -0.737 . . . . 2.7999999999999998 109.01 -177.566 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.632 ' CB ' ' HB3' ' A' ' 123' ' ' ASN . 42.7 m-85 -71.43 114.67 9.75 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 106.959 -1.497 . . . . 0.82999999999999996 106.959 167.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -41.61 96.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 O-C-N 124.514 1.134 . . . . 2.2799999999999998 112.293 -175.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.432 ' C ' ' HG2' ' A' ' 157' ' ' PRO . . . 61.56 36.52 92.73 Favored Glycine 0 CA--C 1.508 -0.352 0 CA-C-N 114.496 -1.229 . . . . 0.76000000000000001 112.276 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.632 ' HB3' ' CB ' ' A' ' 120' ' ' TYR . 33.9 t-20 -133.82 -45.81 0.8 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.524 -0.338 . . . . 1.6499999999999999 110.377 -178.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.532 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 0.3 OUTLIER -157.72 122.64 4.4 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.848 0.356 . . . . 1.1200000000000001 111.393 -177.889 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 155' ' ' CYS . 13.4 m120 -104.26 73.83 1.15 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.756 -0.831 . . . . 1.6200000000000001 108.756 174.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.678 ' HB ' HG12 ' A' ' 154' ' ' VAL . 1.2 tt -96.57 136.11 28.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 113.245 0.831 . . . . 0.29999999999999999 113.245 -172.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.813 HG22 HG13 ' A' ' 117' ' ' ILE . 21.0 pt -104.87 109.82 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-O 121.98 0.895 . . . . 0.58999999999999997 109.009 163.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.597 ' OG ' ' HA ' ' A' ' 11' ' ' ALA . 1.1 m -89.84 114.42 26.16 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.441 -0.799 . . . . 1.1799999999999999 110.709 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.853 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 79.3 p -114.21 145.05 42.22 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.57 0.7 . . . . 1.24 111.753 -172.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.811 ' HE2' ' HG3' ' A' ' 150' ' ' PRO . 6.3 mtpm? -133.78 123.75 25.41 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 107.677 -1.231 . . . . 2.2599999999999998 107.677 174.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.525 ' HB2' ' H ' ' A' ' 148' ' ' ASN . 32.6 t -64.28 98.85 0.25 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 105.926 -1.879 . . . . 1.3899999999999999 105.926 170.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.472 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.3 OUTLIER -105.41 132.62 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 CA-C-O 121.985 0.897 . . . . 1.05 109.021 -164.012 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.405 ' HA ' ' CD1' ' A' ' 137' ' ' TYR . 5.4 t70 -88.61 68.86 8.77 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 114.02 -1.445 . . . . 2.1699999999999999 109.26 -166.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.695 ' HB2' ' HD2' ' A' ' 135' ' ' PRO . 0.4 OUTLIER -107.07 175.08 2.17 Favored Pre-proline 0 CA--C 1.548 0.875 0 CA-C-N 114.997 -1.001 . . . . 0.53000000000000003 109.496 -172.226 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.695 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 3.0 Cg_exo -35.91 -51.28 1.06 Allowed 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 124.802 3.668 . . . . 1.28 116.632 -175.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.613 ' HG3' HG12 ' A' ' 84' ' ' VAL . 14.0 mm-40 -82.74 -21.59 34.67 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.5 0.667 . . . . 3.5 111.474 -172.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.78 ' HD2' ' HB ' ' A' ' 112' ' ' ILE . 60.3 t80 -56.01 -38.59 69.82 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 115.233 1.568 . . . . 6.1200000000000001 115.233 -174.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.528 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 67.8 Cg_exo -41.46 114.88 0.36 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 122.055 1.837 . . . . 1.77 112.431 173.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.618 ' HG3' ' HB2' ' A' ' 145' ' ' ARG . 1.6 Cg_endo -85.23 -153.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.792 2.995 . . . . 1.25 113.982 -173.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.2 p -136.54 -158.77 0.89 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 114.923 -1.035 . . . . 1.6000000000000001 108.572 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.3 p -90.28 -36.84 14.47 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.215 -0.594 . . . . 1.97 111.488 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -75.74 -48.27 22.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.356 -0.383 . . . . 2.1800000000000002 111.661 -178.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.756 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 94.9 m-85 -93.75 125.07 38.16 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.028 0.442 . . . . 1.23 110.102 -177.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.661 HG23 ' HG2' ' A' ' 109' ' ' ARG . 1.1 tp -106.94 105.91 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-N 115.723 -0.671 . . . . 0.81999999999999995 109.276 -177.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.839 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 0.8 OUTLIER -58.86 100.92 0.08 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.01 -0.996 . . . . 4.4199999999999999 109.818 177.816 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -63.09 117.5 11.44 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.952 -0.642 . . . . 0.79000000000000004 111.746 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.498 ' HB3' ' CB ' ' A' ' 174' ' ' GLU . 34.8 t80 -85.81 82.7 8.07 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.508 0.671 . . . . 4.4400000000000004 110.496 -176.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.648 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 88.2 m-20 -70.93 106.1 3.52 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.284 -0.871 . . . . 1.6200000000000001 109.849 173.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.502 ' O ' ' HB3' ' A' ' 172' ' ' GLN . 36.0 m-70 -68.04 131.44 92.27 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 108.347 -0.982 . . . . 2.3199999999999998 108.347 174.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.811 ' HG3' ' HE2' ' A' ' 130' ' ' LYS . 83.4 Cg_exo -17.51 68.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.927 1 C-N-CA 126.722 4.948 . . . . 0.53000000000000003 115.854 -169.409 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 151' ' ' CYS . . . . . 0.648 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 10.0 p -99.46 -174.6 2.77 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.077 -0.965 . . . . 1.5800000000000001 108.866 173.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.668 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -173.67 -150.98 7.86 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 119.14 -1.505 . . . . 0.42999999999999999 112.685 -177.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 23.0 t80 -162.35 93.05 0.84 Allowed 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.929 -1.137 . . . . 0.59999999999999998 107.929 -164.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.734 HG23 HG13 ' A' ' 168' ' ' VAL . 5.9 m -101.55 134.09 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-O 121.933 0.873 . . . . 0.31 110.621 -177.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' CYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 124' ' ' MET . 8.9 t -113.28 122.63 48.01 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.036 -0.984 . . . . 1.55 109.37 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.59 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 21.3 m -117.83 114.92 37.27 Favored Pre-proline 0 C--N 1.319 -0.755 0 C-N-CA 120.636 -0.426 . . . . 1.0600000000000001 112.015 -171.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.459 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 84.8 Cg_exo -49.94 121.84 8.11 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.607 2.205 . . . . 0.56000000000000005 111.544 171.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.69 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 0.5 OUTLIER -79.64 -167.73 1.33 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.156 0.503 . . . . 1.1599999999999999 112.268 -173.599 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.413 ' H ' ' HG2' ' A' ' 159' ' ' GLU . 5.2 mm-40 -63.81 -30.78 71.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.237 -0.892 . . . . 2.6299999999999999 108.631 172.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 13.5 mm-40 -103.3 26.8 7.9 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 114.536 -1.211 . . . . 2.0499999999999998 109.231 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.668 ' HB3' ' HD3' ' A' ' 162' ' ' PRO . 49.7 t-20 4.74 -77.81 0.0 OUTLIER Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 126.23 1.812 . . . . 1.9299999999999999 115.357 -177.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.668 ' HD3' ' HB3' ' A' ' 161' ' ' ASN . 71.6 Cg_endo -73.69 -13.29 24.59 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 121.396 1.397 . . . . 0.72999999999999998 113.912 -172.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -105.79 -27.0 11.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.526 -0.306 . . . . 0.68000000000000005 111.308 -176.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.69 ' O ' ' HB2' ' A' ' 158' ' ' MET . 67.8 m-85 -137.62 133.18 34.05 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.515 -0.55 . . . . 0.93000000000000005 109.515 176.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.438 ' HB3' HD11 ' A' ' 61' ' ' LEU . 32.3 t -129.23 147.55 51.08 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.228 0.537 . . . . 1.4099999999999999 110.896 177.185 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.636 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.6 tppp? -93.99 103.48 15.56 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 122.043 0.925 . . . . 0.73999999999999999 110.993 -178.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.42 HD11 ' CZ ' ' A' ' 153' ' ' PHE . 0.6 OUTLIER -87.26 103.45 15.46 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.345 -1.298 . . . . 0.27000000000000002 109.475 177.475 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.734 HG13 HG23 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -125.4 116.38 46.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.833 0.825 . . . . 0.28000000000000003 111.327 178.436 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 48.6 ttp -121.97 145.59 47.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.355 -0.839 . . . . 1.24 109.945 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.712 ' CE2' ' HG3' ' A' ' 49' ' ' ARG . 31.3 m-85 -119.3 134.9 54.97 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 109.098 -0.704 . . . . 3.3700000000000001 109.098 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.415 ' HB ' HD21 ' A' ' 192' ' ' LEU . 2.7 p -120.8 119.13 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-O 121.55 0.691 . . . . 1.3999999999999999 109.648 178.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.502 ' HB3' ' O ' ' A' ' 149' ' ' HIS . 9.3 tt0 -127.05 51.25 1.9 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.734 1.254 . . . . 2.1699999999999999 108.133 -176.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 11.0 m -72.63 150.89 42.63 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 113.565 -1.652 . . . . 1.6499999999999999 110.77 -174.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.498 ' CB ' ' HB3' ' A' ' 147' ' ' TYR . 3.3 tt0 . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 121.229 0.538 . . . . 2.4500000000000002 111.136 -177.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.406 ' HA ' ' HE3' ' A' ' 186' ' ' LYS . 21.9 mm . . . . . 0 CA--C 1.506 -0.738 0 CA-C-O 122.64 1.21 . . . . 1.1200000000000001 108.384 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 1.032 ' HA ' HG22 ' A' ' 187' ' ' THR . 0.9 OUTLIER -68.69 -32.76 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-N 112.602 -2.09 . . . . 1.1299999999999999 110.187 179.563 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.501 ' O ' ' HD2' ' A' ' 189' ' ' PRO . 12.3 mm-40 -53.47 -34.39 57.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.282 -0.872 . . . . 2.8900000000000001 109.206 167.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 190' ' ' SER . 43.4 mtmt -93.22 -12.35 30.43 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.823 -1.08 . . . . 1.28 111.917 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' THR . . . . . 1.032 HG22 ' HA ' ' A' ' 184' ' ' ILE . 6.8 t -92.98 -45.56 7.88 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 119.1 -1.04 . . . . 0.62 112.112 175.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' MET . . . . . 0.933 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 11.2 mmt -81.42 -67.47 0.22 Allowed Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 121.184 -0.947 . . . . 1.0600000000000001 111.362 -173.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.933 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 29.5 Cg_exo -60.92 -31.4 91.48 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 121.975 1.783 . . . . 0.91000000000000003 112.118 -176.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.543 ' HB2' ' O ' ' A' ' 186' ' ' LYS . 48.7 m -77.96 -29.53 49.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.35 -0.386 . . . . 1.5 111.717 -176.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 187' ' ' THR . 85.8 m-20 -90.37 -29.82 17.81 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.881 -0.328 . . . . 1.8799999999999999 111.425 -177.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' A' ' 188' ' ' MET . 42.1 mt -64.02 -48.06 77.8 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 120.907 -0.317 . . . . 1.0900000000000001 111.265 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.812 ' HB ' HD12 ' A' ' 33' ' ' ILE . 1.1 m -67.08 -35.65 74.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.445 0.64 . . . . 0.68000000000000005 109.778 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -68.15 -30.89 70.12 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.737 -1.119 . . . . 2.0699999999999998 110.94 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.495 ' O ' ' HB2' ' A' ' 198' ' ' ASN . 8.0 t80 -73.88 -27.35 61.02 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.46 -0.57 . . . . 2.0 109.46 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.456 HG21 ' CG2' ' A' ' 33' ' ' ILE . 25.6 mt -78.56 -27.78 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-O 121.353 0.597 . . . . 0.31 110.281 173.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 197' ' ' LEU . 61.1 mt -71.66 -39.63 70.18 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 109.585 -0.524 . . . . 1.03 109.585 172.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.585 ' OD1' ' HG2' ' A' ' 76' ' ' LYS . 87.0 m-20 -49.63 -38.89 33.85 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.972 -1.013 . . . . 1.8999999999999999 109.58 165.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.635 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -76.13 -42.88 45.52 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 116.356 -0.384 . . . . 0.28999999999999998 110.744 -178.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.539 ' HD3' HG12 ' A' ' 54' ' ' ILE . 35.9 mmtm -59.12 -42.42 90.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.507 0.67 . . . . 0.96999999999999997 110.904 175.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -86.66 -37.23 18.21 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.209 -0.905 . . . . 1.9399999999999999 110.641 -174.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -70.72 -29.52 69.41 Favored Glycine 0 CA--C 1.503 -0.657 0 N-CA-C 111.395 -0.682 . . . . 0.46999999999999997 111.395 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 1.054 HD13 HD23 ' A' ' 61' ' ' LEU . 2.8 tp -70.74 -33.49 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 109.629 -0.508 . . . . 0.60999999999999999 109.629 177.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 40.9 mttp -85.79 -25.03 26.57 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 109.302 -0.629 . . . . 3.3700000000000001 109.302 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.906 0 N-CA-C 108.71 -0.848 . . . . 1.02 108.71 167.061 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.518 ' O ' HD13 ' A' ' 6' ' ' ILE . 32.4 t70 . . . . . 0 CA--C 1.521 -0.163 0 N-CA-C 110.128 -0.323 . . . . 2.25 110.128 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.918 ' HA ' HD11 ' A' ' 6' ' ' ILE . 70.4 m-85 -61.78 -31.01 71.19 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 108.313 -0.995 . . . . 0.42999999999999999 108.313 172.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.556 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 36.7 tttp -60.34 -49.0 79.32 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 113.803 -1.544 . . . . 1.51 107.674 177.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -50.11 -46.31 53.55 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.972 -0.558 . . . . 0.54000000000000004 112.227 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.918 HD11 ' HA ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -81.52 -36.81 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 CA-C-O 121.634 0.731 . . . . 1.0700000000000001 110.02 -172.897 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.674 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -80.63 -30.57 36.69 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.588 -1.187 . . . . 0.34000000000000002 111.568 -175.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.556 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 9.6 mt-30 -65.78 -32.24 73.66 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.783 -1.098 . . . . 1.5900000000000001 109.087 175.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.616 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 12.5 mm100 -81.02 -45.38 16.65 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.418 -1.265 . . . . 2.4700000000000002 109.059 175.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.553 ' HB ' ' HA ' ' A' ' 7' ' ' ALA . 0.6 OUTLIER -56.26 -37.4 69.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.202 -0.908 . . . . 0.47999999999999998 111.192 176.78 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.578 ' HA ' ' CB ' ' A' ' 128' ' ' SER . . . -46.86 -60.84 2.16 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 120.819 0.343 . . . . 0.31 111.796 173.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -79.04 -6.62 56.83 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.323 -0.399 . . . . 1.6399999999999999 111.087 -177.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.616 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 34.3 mm-40 -78.98 -47.21 16.74 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.248 0.547 . . . . 2.54 109.545 172.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.681 HG21 ' N ' ' A' ' 152' ' ' GLY . 9.9 p -74.63 -41.39 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.77 0.795 . . . . 0.53000000000000003 109.115 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 tt -68.72 -21.2 64.41 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-O 121.719 0.771 . . . . 0.59999999999999998 109.155 174.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.37 -17.54 61.99 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 114.017 -1.447 . . . . 0.56999999999999995 110.59 172.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.656 ' HD2' ' O ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -86.49 -33.47 20.33 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.541 -0.911 . . . . 3.27 108.541 177.865 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -75.97 -6.47 51.1 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.648 0.737 . . . . 2.0299999999999998 110.269 -176.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -120.55 11.31 11.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.476 -0.784 . . . . 2.7200000000000002 110.582 176.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -139.01 111.4 7.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.154 -0.476 . . . . 2.1600000000000001 109.772 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 44.4 p -129.01 109.28 11.08 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.102 0.477 . . . . 1.8200000000000001 111.933 -171.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.2 p -170.47 160.31 7.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.659 -0.7 . . . . 2.1899999999999999 111.119 -175.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.63 5.72 57.01 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 116.131 -0.486 . . . . 1.1000000000000001 113.981 172.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.671 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -120.42 -163.8 1.04 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.922 0.361 . . . . 1.6699999999999999 110.368 -177.363 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.59 135.18 0.23 Allowed 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.451 -0.795 . . . . 2.9500000000000002 109.357 -178.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.678 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 2.3 m -66.97 118.7 11.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-O 121.81 0.814 . . . . 1.5600000000000001 111.001 176.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.621 ' O ' ' HD2' ' A' ' 28' ' ' LYS . 11.4 p -95.87 -28.83 3.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 114.465 -1.243 . . . . 1.22 109.446 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.621 ' HD2' ' O ' ' A' ' 27' ' ' VAL . 4.1 mptp? -151.05 133.87 15.77 Favored 'General case' 0 C--O 1.216 -0.7 0 C-N-CA 120.06 -0.656 . . . . 2.4100000000000001 110.829 -170.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.535 ' HB ' ' HA ' ' A' ' 34' ' ' THR . 0.0 OUTLIER -153.0 152.1 31.02 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.902 0.382 . . . . 1.3799999999999999 111.3 175.074 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.453 ' HB3' HG12 ' A' ' 33' ' ' ILE . 27.0 t -117.03 27.22 9.26 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.909 -0.587 . . . . 2.3700000000000001 110.591 -176.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? 68.48 24.35 7.12 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.814 0.816 . . . . 4.5499999999999998 109.695 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.499 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 6.4 tptm -167.24 -40.75 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.921 -1.036 . . . . 1.4199999999999999 109.209 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.565 HG22 ' HA3' ' A' ' 52' ' ' GLY . 21.1 pt -109.66 152.51 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 CA-C-N 115.242 -0.89 . . . . 0.76000000000000001 108.983 170.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.535 ' HA ' ' HB ' ' A' ' 29' ' ' THR . 56.6 m -146.29 119.41 8.84 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 123.456 0.472 . . . . 0.57999999999999996 110.717 -168.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.868 HG22 HG12 ' A' ' 50' ' ' VAL . 3.7 t -109.9 110.87 33.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.86 -0.609 . . . . 0.85999999999999999 110.609 -175.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.678 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 97.5 p -100.65 131.49 46.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.192 -0.458 . . . . 1.1000000000000001 109.934 177.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.8 p -102.76 125.0 49.33 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.892 -0.595 . . . . 1.27 110.991 -177.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.671 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 35.7 ttpt . . . . . 0 C--N 1.318 -0.783 0 CA-C-N 115.6 -0.727 . . . . 1.9099999999999999 109.607 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 . . . . . 0 N--CA 1.451 -0.396 0 CA-C-O 120.707 0.289 . . . . 2.0499999999999998 110.369 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.777 ' HG ' ' HB2' ' A' ' 172' ' ' GLN . 2.2 tt -93.27 151.67 19.66 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 106.903 -1.517 . . . . 0.87 106.903 174.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.77 ' H ' HD23 ' A' ' 47' ' ' LEU . 49.9 m-85 -135.73 137.77 42.03 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.305 -0.558 . . . . 0.98999999999999999 110.87 -170.11 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.718 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.9 OUTLIER -114.61 131.76 56.59 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 116.014 -0.539 . . . . 2.9199999999999999 110.841 177.759 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.868 HG12 HG22 ' A' ' 35' ' ' VAL . 0.8 OUTLIER -113.11 143.99 21.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.272 0.558 . . . . 1.3300000000000001 110.543 168.695 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.729 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 33.1 tt0 -140.94 109.19 5.81 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.897 -1.047 . . . . 1.0700000000000001 108.921 178.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.565 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -136.55 143.52 14.93 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.569 -0.824 . . . . 0.28999999999999998 111.199 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 59.5 mt -88.23 112.48 23.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 C-N-CA 119.936 -0.706 . . . . 0.57999999999999996 110.352 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.698 HG12 ' HB2' ' A' ' 167' ' ' LEU . 20.8 mm -85.64 114.38 56.33 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 108.373 -0.973 . . . . 0.34999999999999998 108.373 174.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -66.27 57.86 0.45 Allowed 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 123.584 2.856 . . . . 0.62 112.921 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.445 ' HB3' HG12 ' A' ' 203' ' ' ILE . 12.5 tp10 -158.81 168.1 27.71 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.521 -0.918 . . . . 1.6799999999999999 108.521 174.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.439 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 34.7 p -70.59 147.41 94.65 Favored Pre-proline 0 N--CA 1.432 -1.335 0 CA-C-O 121.811 0.815 . . . . 1.1799999999999999 110.849 -177.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.471 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 18.7 Cg_exo -63.71 -9.33 18.13 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.911 3.074 . . . . 0.52000000000000002 110.585 178.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.83 -54.47 13.43 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.902 -1.045 . . . . 0.64000000000000001 110.87 175.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.714 ' HE3' ' O ' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -69.63 -24.17 63.6 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.443 -0.947 . . . . 3.2999999999999998 108.443 178.235 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.777 ' O ' HD12 ' A' ' 65' ' ' LEU . 29.6 mt -63.64 -58.46 6.85 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.508 -0.552 . . . . 0.40999999999999998 109.508 173.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.7 t -64.88 -10.86 31.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.06 0.457 . . . . 1.29 110.435 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.482 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 32.1 t70 -88.06 -37.34 16.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.995 -0.548 . . . . 1.3200000000000001 111.935 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.645 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 10.1 p90 -85.45 -45.67 11.62 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.371 -0.531 . . . . 0.60999999999999999 111.259 -174.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.777 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -84.34 7.33 19.78 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.461 -0.57 . . . . 1.5 109.461 -172.758 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -48.93 -70.06 0.1 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.341 -1.299 . . . . 1.52 111.613 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.701 ' HG3' ' SG ' ' A' ' 94' ' ' CYS . 7.5 tt0 -179.38 -43.04 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.611 0.72 . . . . 3.6000000000000001 110.159 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.1 t -149.72 29.43 0.75 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.158 -0.928 . . . . 1.48 109.283 -174.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 70' ' ' ASP . . . -74.42 -36.67 49.11 Favored Glycine 0 N--CA 1.434 -1.499 0 C-N-CA 120.579 -0.819 . . . . 1.46 111.652 -170.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.645 ' OD1' ' HA ' ' A' ' 64' ' ' PHE . 20.7 p-10 163.73 -21.04 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 113.894 -1.153 . . . . 2.1899999999999999 108.274 -164.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.778 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 1.2 ptp180 -39.64 -53.45 2.15 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-N 114.669 -1.151 . . . . 3.3799999999999999 111.142 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.674 HG22 HD13 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -82.01 -13.13 12.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.347 -0.541 . . . . 0.70999999999999996 111.447 -171.298 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.645 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.3 t -84.97 -30.16 24.47 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.592 -0.843 . . . . 0.96999999999999997 109.949 -175.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.456 ' CZ2' ' HA3' ' A' ' 202' ' ' GLY . 17.8 p-90 -111.86 -4.07 14.71 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.442 0.534 . . . . 0.75 112.442 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.778 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 3.6 t70 -62.42 168.14 3.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 122.26 1.028 . . . . 2.1899999999999999 113.655 -168.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.538 ' HG3' ' OD1' ' A' ' 198' ' ' ASN . 13.0 mmmt -90.95 -35.78 14.5 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.482 -1.69 . . . . 3.1899999999999999 109.322 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.584 ' HA ' ' HB2' ' A' ' 99' ' ' GLN . 50.8 m -137.98 26.01 2.74 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.384 -1.28 . . . . 1.5800000000000001 112.019 -171.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.674 HD13 HG22 ' A' ' 72' ' ' ILE . 44.2 mt -110.34 166.22 11.15 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.509 -0.476 . . . . 0.70999999999999996 110.753 175.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.514 ' HB3' HG23 ' A' ' 80' ' ' VAL . 21.0 mm-40 -144.1 -63.85 0.37 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.807 -0.633 . . . . 1.73 111.346 -175.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.514 HG23 ' HB3' ' A' ' 79' ' ' GLN . 19.8 t -140.49 117.61 8.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.883 -0.599 . . . . 0.78000000000000003 111.0 -166.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -90.78 152.17 20.9 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.806 -0.442 . . . . 5.4000000000000004 109.806 171.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.774 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 19.9 m120 -145.85 117.19 7.94 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.336 -0.987 . . . . 1.6899999999999999 108.336 168.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.447 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 6.5 ttt -79.31 89.59 4.95 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.563 -0.903 . . . . 2.0499999999999998 108.563 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -69.33 -81.57 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 115.647 -0.706 . . . . 0.64000000000000001 111.231 -167.128 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.448 ' HB3' HD12 ' A' ' 93' ' ' ILE . 11.2 t60 -121.06 118.2 29.18 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.381 -0.6 . . . . 1.96 109.381 -178.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.447 ' HD3' ' SD ' ' A' ' 83' ' ' MET . 1.5 mtm180 -99.5 100.71 11.78 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.981 -0.554 . . . . 2.4399999999999999 109.636 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.623 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -70.84 -41.25 77.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.399 -0.819 . . . . 0.46999999999999997 110.588 -173.587 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -155.44 166.71 32.71 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.73 -1.123 . . . . 1.8600000000000001 108.456 -172.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.9 m -62.33 -11.69 16.81 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.211 0.448 . . . . 1.4399999999999999 112.211 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -128.27 11.45 6.42 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 120.761 -0.376 . . . . 1.8700000000000001 110.226 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.623 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.7 OUTLIER -135.35 110.34 8.82 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.327 -0.62 . . . . 0.46000000000000002 109.327 -174.066 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.564 ' O ' HD12 ' A' ' 114' ' ' LEU . 21.3 m-85 -128.85 171.46 12.26 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.745 -0.662 . . . . 0.42999999999999999 110.616 -174.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.669 ' O ' HG23 ' A' ' 84' ' ' VAL . 32.5 mt -127.2 126.65 68.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 107.542 -1.281 . . . . 0.40999999999999998 107.542 168.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.701 ' SG ' ' HG3' ' A' ' 67' ' ' GLN . 42.0 t -108.84 106.0 15.8 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.75 -0.659 . . . . 2.0099999999999998 111.198 -165.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.774 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 39.0 t-80 -82.45 116.38 21.88 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.64 -0.874 . . . . 1.23 108.64 170.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.749 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 62.3 m -134.61 116.03 14.52 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 112.446 0.536 . . . . 0.5 112.446 -177.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 49.5 mm -78.11 128.19 38.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.678 -0.49 . . . . 1.03 109.678 174.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.727 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 2.1 m -102.6 147.66 26.52 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.691 -0.686 . . . . 1.3799999999999999 110.905 -175.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.584 ' HB2' ' HA ' ' A' ' 77' ' ' SER . 3.2 mm-40 . . . . . 0 C--N 1.32 -0.694 0 CA-C-N 115.693 -0.685 . . . . 1.8200000000000001 111.232 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.3 mt . . . . . 0 N--CA 1.442 -0.852 0 N-CA-C 108.634 -0.876 . . . . 1.1200000000000001 108.634 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.653 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 13.2 m -65.51 174.13 1.63 Allowed Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.087 -0.96 . . . . 1.3500000000000001 110.867 -175.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.653 ' HD2' ' HB3' ' A' ' 107' ' ' SER . 81.6 Cg_exo -42.39 111.14 0.18 Allowed 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 122.761 2.308 . . . . 1.0700000000000001 112.521 -175.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.727 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 33.3 ttp180 -100.26 159.86 14.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.603 -0.726 . . . . 3.4500000000000002 110.408 -174.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.962 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 12.7 t70 -115.02 131.18 57.01 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.507 -0.553 . . . . 1.3700000000000001 109.507 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.749 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 6.2 m-85 -108.88 127.7 54.27 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.079 0.466 . . . . 2.4100000000000001 111.076 173.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.645 ' CG2' ' HE1' ' A' ' 134' ' ' PHE . 14.7 mm -134.35 77.42 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.955 -1.02 . . . . 0.42999999999999999 108.481 169.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.701 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 0.5 OUTLIER -107.32 129.94 54.84 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.273 -0.876 . . . . 1.8600000000000001 110.592 -178.933 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.617 ' O ' ' HA ' ' A' ' 129' ' ' SER . 7.6 tp -78.71 118.35 20.71 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-N 115.558 -0.746 . . . . 0.28000000000000003 109.285 172.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.483 HG23 ' HB ' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -118.65 126.24 75.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 CA-C-N 114.931 -1.032 . . . . 0.26000000000000001 111.137 -166.078 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.674 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 57.0 t80 -108.51 113.48 26.54 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.25 -0.886 . . . . 2.5699999999999998 110.39 174.274 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.67 HG12 HG22 ' A' ' 127' ' ' ILE . 56.4 mt -98.19 98.54 7.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.638 -0.71 . . . . 0.89000000000000001 109.767 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.609 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 34.0 ttpt -117.73 134.61 54.73 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.232 0.539 . . . . 1.2 110.256 176.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.672 ' HD2' ' O ' ' A' ' 119' ' ' ARG . 1.0 OUTLIER -103.01 118.38 36.69 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.542 -0.91 . . . . 2.7999999999999998 108.542 175.907 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.567 ' HB3' ' HB3' ' A' ' 123' ' ' ASN . 12.2 m-85 -74.4 107.91 6.85 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.2 -1.778 . . . . 0.82999999999999996 106.2 164.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.411 ' HA ' HH11 ' A' ' 119' ' ' ARG . 6.5 pt-20 -37.27 98.87 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 O-C-N 124.55 1.156 . . . . 2.2799999999999998 113.389 -175.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 57.53 47.09 90.78 Favored Glycine 0 CA--C 1.503 -0.662 0 CA-C-N 113.53 -1.668 . . . . 0.76000000000000001 111.658 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.567 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 2.1 t-20 -144.96 -53.89 0.3 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.616 -0.792 . . . . 1.6499999999999999 109.886 -173.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.42 ' HG3' ' OG ' ' A' ' 156' ' ' SER . 1.9 mpp? -159.04 122.41 3.76 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.562 -0.29 . . . . 1.1200000000000001 110.484 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -104.92 81.52 1.75 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.441 -0.948 . . . . 1.6200000000000001 108.441 177.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.636 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.4 OUTLIER -103.16 141.96 18.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.241 -0.89 . . . . 0.29999999999999999 112.739 -170.789 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.67 HG22 HG12 ' A' ' 117' ' ' ILE . 2.9 pt -110.28 115.5 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 108.398 -0.964 . . . . 0.58999999999999997 108.398 161.175 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.578 ' CB ' ' HA ' ' A' ' 11' ' ' ALA . 15.4 p -99.4 114.98 28.21 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.968 -0.56 . . . . 1.1799999999999999 110.424 177.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.701 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 9.4 p -109.71 144.9 37.45 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.394 0.616 . . . . 1.24 112.046 -173.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.413 ' HE3' ' HB ' ' A' ' 6' ' ' ILE . 4.8 mtpm? -127.9 123.8 35.85 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 107.618 -1.253 . . . . 2.2599999999999998 107.618 176.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.429 ' HB3' ' N ' ' A' ' 148' ' ' ASN . 7.0 p -65.13 94.3 0.14 Allowed 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.72 -0.844 . . . . 1.3899999999999999 108.72 177.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.432 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.6 OUTLIER -107.56 129.2 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 CA-C-N 115.152 -0.931 . . . . 1.05 109.26 -166.312 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -99.3 70.78 1.76 Allowed 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 114.309 -1.314 . . . . 2.1699999999999999 107.916 -167.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.858 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 0.5 OUTLIER -101.89 154.87 37.05 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 113.552 -1.658 . . . . 0.53000000000000003 109.829 -169.548 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.04 -1.6 11.28 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.433 2.088 . . . . 1.28 116.041 -168.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.858 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 4.7 tp10 -76.74 -13.8 60.0 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.073 -1.084 . . . . 3.5 108.073 -178.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.429 ' HB2' HG11 ' A' ' 84' ' ' VAL . 26.1 t80 -162.8 114.95 1.1 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.119 -0.946 . . . . 6.1200000000000001 112.436 175.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 137' ' ' TYR . 19.7 Cg_endo -95.32 140.33 1.02 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.661 2.907 . . . . 1.77 111.346 168.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.472 ' HG3' ' HB2' ' A' ' 145' ' ' ARG . 37.3 Cg_endo -70.85 -164.58 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.588 2.192 . . . . 1.25 112.965 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.3 t -139.26 -173.49 3.61 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.237 -1.023 . . . . 1.6000000000000001 108.237 -176.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.0 t -82.46 -41.39 19.86 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.248 -0.581 . . . . 1.97 110.265 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -57.15 -52.46 65.21 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.144 0.497 . . . . 2.1800000000000002 110.309 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.962 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 61.9 m-85 -95.82 109.99 22.23 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.316 -0.856 . . . . 1.23 109.424 -175.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.616 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -88.46 107.52 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-N 115.67 -0.696 . . . . 0.81999999999999995 109.611 -176.256 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.553 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 31.5 ttp85 -56.69 105.53 0.22 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.796 -0.638 . . . . 4.4199999999999999 110.129 178.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.75 118.0 12.96 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.707 -0.679 . . . . 0.79000000000000004 112.006 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.88 ' HB3' ' HB3' ' A' ' 174' ' ' GLU . 17.9 t80 -85.62 70.29 10.72 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.511 0.672 . . . . 4.4400000000000004 109.628 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.651 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 11.6 t30 -64.69 96.56 0.18 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.47 -0.786 . . . . 1.6200000000000001 110.083 176.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.86 117.74 28.39 Favored Pre-proline 0 C--O 1.222 -0.382 0 CA-C-N 115.758 -0.655 . . . . 2.3199999999999998 110.242 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -18.32 70.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.101 1 C-N-CA 126.438 4.758 . . . . 0.53000000000000003 115.664 -165.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' CYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 170' ' ' PHE . 4.4 p -122.99 169.71 10.89 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.789 -1.189 . . . . 1.5800000000000001 107.789 172.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.681 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -152.21 -146.15 4.29 Favored Glycine 0 N--CA 1.434 -1.49 0 C-N-CA 118.325 -1.893 . . . . 0.42999999999999999 113.805 -165.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.428 ' CZ ' HD11 ' A' ' 167' ' ' LEU . 5.8 t80 -161.36 96.77 1.08 Allowed 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.995 -1.113 . . . . 0.59999999999999998 107.995 -162.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.693 HG23 HG13 ' A' ' 168' ' ' VAL . 4.5 m -105.83 137.88 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-O 121.679 0.752 . . . . 0.31 110.746 -175.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 83.8 m -117.71 109.63 16.85 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.161 -0.927 . . . . 1.55 109.899 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.567 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 15.4 m -111.06 125.59 30.34 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 120.794 -0.362 . . . . 1.0600000000000001 111.51 -168.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 156' ' ' SER . 10.7 Cg_endo -54.54 121.05 9.08 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 122.454 2.102 . . . . 0.56000000000000005 111.368 174.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.617 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 61.1 mmm -80.12 -162.85 0.48 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.217 0.532 . . . . 1.1599999999999999 111.79 -176.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -70.44 -35.07 73.15 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.52 -0.763 . . . . 2.6299999999999999 109.408 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -103.22 30.97 4.53 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.045 -0.98 . . . . 2.0499999999999998 109.143 173.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.745 ' OD1' ' HD3' ' A' ' 162' ' ' PRO . 0.3 OUTLIER -19.77 -57.16 0.06 OUTLIER Pre-proline 0 N--CA 1.479 0.989 0 N-CA-C 117.164 2.283 . . . . 1.9299999999999999 117.164 -171.983 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.745 ' HD3' ' OD1' ' A' ' 161' ' ' ASN . 69.8 Cg_endo -72.91 -18.17 24.71 Favored 'Trans proline' 0 C--N 1.351 0.701 0 CA-C-N 121.798 1.678 . . . . 0.72999999999999998 113.255 -175.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -108.07 -26.61 10.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.196 -0.456 . . . . 0.68000000000000005 110.92 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.617 ' O ' ' HB2' ' A' ' 158' ' ' MET . 94.1 m-85 -138.33 128.36 25.56 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.181 -0.674 . . . . 0.93000000000000005 109.181 177.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.472 ' HB3' HD11 ' A' ' 61' ' ' LEU . 26.6 t -125.93 151.59 46.76 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.38 0.61 . . . . 1.4099999999999999 111.599 -177.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.729 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 2.0 tppp? -90.73 103.45 16.15 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 122.019 0.914 . . . . 0.73999999999999999 111.472 -176.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.727 HD12 HG12 ' A' ' 196' ' ' ILE . 0.5 OUTLIER -88.06 103.61 15.88 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.406 -1.27 . . . . 0.27000000000000002 109.429 176.111 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.693 HG13 HG23 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -127.82 132.43 68.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.087 -0.645 . . . . 0.28000000000000003 111.876 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.514 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 20.8 ttt -144.41 137.98 27.41 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.37 -0.377 . . . . 1.24 111.819 -170.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.674 ' CE1' ' HB2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -110.84 135.17 51.8 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 109.182 -0.673 . . . . 3.3700000000000001 109.182 173.439 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 1.029 ' HB ' HD21 ' A' ' 192' ' ' LEU . 1.3 t -134.43 120.82 34.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 O-C-N 123.661 0.601 . . . . 1.3999999999999999 111.056 177.043 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.777 ' HB2' ' HG ' ' A' ' 47' ' ' LEU . 1.3 tm0? -105.04 -32.64 8.62 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.462 -1.31 . . . . 2.1699999999999999 107.462 168.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.651 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 13.2 m 20.75 107.86 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 O-C-N 126.281 2.238 . . . . 1.6499999999999999 113.165 176.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.88 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 15.2 tp10 . . . . . 0 C--N 1.32 -0.681 0 CA-C-N 116.043 -0.526 . . . . 2.4500000000000002 111.769 -161.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.501 ' HA ' ' CE ' ' A' ' 186' ' ' LYS . 11.9 mm . . . . . 0 CA--C 1.511 -0.529 0 CA-C-O 122.505 1.145 . . . . 1.1200000000000001 108.76 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.931 ' HA ' HG22 ' A' ' 187' ' ' THR . 0.7 OUTLIER -66.13 -38.26 81.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 113.063 -1.88 . . . . 1.1299999999999999 111.375 -177.234 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.15 -18.45 65.31 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.585 -0.524 . . . . 2.8900000000000001 109.585 176.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.501 ' CE ' ' HA ' ' A' ' 183' ' ' ILE . 45.2 mtmt -91.84 -41.59 10.55 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.814 -0.63 . . . . 1.28 109.991 173.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.931 HG22 ' HA ' ' A' ' 184' ' ' ILE . 14.6 t -63.04 -28.14 69.89 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.941 0.719 . . . . 0.62 112.941 -169.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' MET . . . . . 0.606 ' HE2' ' HA ' ' A' ' 188' ' ' MET . 2.4 mmt -76.05 -62.89 0.67 Allowed Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 120.249 -0.581 . . . . 1.0600000000000001 111.503 -177.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.576 ' O ' HG13 ' A' ' 193' ' ' VAL . 28.3 Cg_endo -61.93 -32.26 84.75 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 121.812 1.674 . . . . 0.91000000000000003 111.844 -177.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.639 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 24.6 m -73.88 -23.76 59.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.357 -0.383 . . . . 1.5 110.777 -177.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.2 OUTLIER -90.39 -38.03 13.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.912 -0.403 . . . . 1.8799999999999999 109.912 -176.134 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 1.029 HD21 ' HB ' ' A' ' 171' ' ' VAL . 26.7 mt -59.3 -57.31 13.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.996 -0.547 . . . . 1.0900000000000001 112.022 178.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 189' ' ' PRO . 1.8 m -65.44 -32.62 59.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.595 0.712 . . . . 0.68000000000000005 109.379 -175.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.639 ' HB2' ' O ' ' A' ' 190' ' ' SER . 0.4 OUTLIER -65.32 -47.04 77.93 Favored 'General case' 0 C--O 1.208 -1.112 0 CA-C-N 114.217 -1.356 . . . . 2.0699999999999998 109.843 176.873 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.86 -28.94 66.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.786 0.327 . . . . 2.0 111.026 178.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.727 HG12 HD12 ' A' ' 167' ' ' LEU . 22.1 mt -77.32 -31.61 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-O 121.414 0.626 . . . . 0.31 110.862 175.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 68.1 mt -73.56 -38.14 65.3 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 109.562 -0.532 . . . . 1.03 109.562 176.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.538 ' OD1' ' HG3' ' A' ' 76' ' ' LYS . 3.2 m-20 -53.11 -41.69 65.23 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.11 -1.07 . . . . 1.8999999999999999 108.11 168.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.738 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -67.33 -49.8 62.61 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.944 -0.571 . . . . 0.28999999999999998 110.129 -178.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.54 ' HD3' HD13 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -61.09 -41.16 96.15 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 114.984 -1.007 . . . . 0.96999999999999997 110.843 -179.242 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -76.99 -47.18 21.45 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-N 115.259 -0.882 . . . . 1.9399999999999999 110.089 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' GLY . . . . . 0.456 ' HA3' ' CZ2' ' A' ' 74' ' ' TRP . . . -69.89 -38.45 75.45 Favored Glycine 0 CA--C 1.505 -0.543 0 C-N-CA 120.811 -0.709 . . . . 0.46999999999999997 112.117 -175.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.738 ' HB ' ' O ' ' A' ' 199' ' ' ALA . 0.9 OUTLIER -58.04 -46.25 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 110.521 -0.178 . . . . 0.60999999999999999 110.521 176.327 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -84.48 -23.57 29.82 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 120.382 -0.527 . . . . 3.3700000000000001 109.841 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.88 0 N-CA-C 109.081 -0.711 . . . . 1.02 109.081 166.827 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.506 ' O ' HD12 ' A' ' 6' ' ' ILE . 7.0 m-20 . . . . . 0 CA--C 1.507 -0.684 0 CA-C-O 121.183 0.516 . . . . 2.25 110.206 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.627 ' HD1' HD22 ' A' ' 114' ' ' LEU . 93.5 m-85 -66.73 -32.83 74.39 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.384 -0.825 . . . . 0.42999999999999999 109.326 -175.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.636 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 2.1 tppp? -69.52 -8.25 45.42 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.82 -1.082 . . . . 1.51 110.124 177.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -92.27 -41.68 10.26 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.229 0.538 . . . . 0.54000000000000004 110.337 173.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.556 HD12 ' HA ' ' A' ' 3' ' ' PHE . 1.8 mp -82.45 -43.07 18.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.754 0.788 . . . . 1.0700000000000001 109.456 -171.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -72.15 -47.22 52.56 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.312 -1.313 . . . . 0.34000000000000002 111.582 -178.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.636 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 17.2 mt-30 -63.19 -26.43 68.8 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.664 -1.153 . . . . 1.5900000000000001 110.762 -178.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.581 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 96.2 mt-30 -84.82 -30.81 24.24 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.324 -0.853 . . . . 2.4700000000000002 109.395 172.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.552 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.4 OUTLIER -74.35 -34.72 63.47 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.513 -0.767 . . . . 0.47999999999999998 111.684 -177.386 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.467 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -45.87 -54.99 7.25 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 120.345 -0.542 . . . . 0.31 111.23 172.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -75.5 -6.66 51.3 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.775 -0.648 . . . . 1.6399999999999999 112.042 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.581 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 32.1 mt-10 -80.59 -52.09 7.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.712 -0.477 . . . . 2.54 109.712 173.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.699 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 14.6 p -69.57 -40.94 80.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.844 0.831 . . . . 0.53000000000000003 110.193 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.44 HD13 ' CE1' ' A' ' 120' ' ' TYR . 0.4 OUTLIER -67.78 -25.45 65.61 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 121.978 0.894 . . . . 0.59999999999999998 108.608 173.707 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.32 -17.5 66.28 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 113.79 -1.55 . . . . 0.56999999999999995 110.394 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.699 ' CD2' ' HA ' ' A' ' 14' ' ' VAL . 15.1 m-85 -89.07 -24.68 22.24 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.572 -0.899 . . . . 3.27 108.572 177.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -73.61 -12.0 60.61 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-O 121.337 0.589 . . . . 2.0299999999999998 110.018 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -111.62 -18.7 12.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.498 -0.774 . . . . 2.7200000000000002 111.216 -176.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -136.09 84.13 2.06 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.326 -0.397 . . . . 2.1600000000000001 111.459 -174.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -151.0 139.5 20.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 1.8200000000000001 111.64 178.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.9 m -167.53 -45.26 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.017 -0.538 . . . . 2.1899999999999999 110.031 -173.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -81.68 47.79 3.72 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.834 -0.621 . . . . 1.1000000000000001 113.188 -176.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.548 ' O ' ' HE2' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -120.65 -147.3 0.39 Allowed 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.605 -0.517 . . . . 1.6699999999999999 109.605 178.188 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.548 ' HE2' ' O ' ' A' ' 24' ' ' TRP . 0.0 OUTLIER 178.57 123.84 0.05 OUTLIER 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.954 -0.758 . . . . 2.9500000000000002 108.954 -175.036 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.578 ' CG1' HG22 ' A' ' 34' ' ' THR . 3.7 m -65.13 119.81 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.818 0 CA-C-O 122.358 1.075 . . . . 1.5600000000000001 111.605 176.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.455 HG13 ' HB3' ' A' ' 189' ' ' PRO . 7.7 p -99.57 -23.96 4.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 113.692 -1.595 . . . . 1.22 109.07 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 189' ' ' PRO . 8.3 tppt? -152.9 109.9 3.48 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 119.82 -0.752 . . . . 2.4100000000000001 111.756 -176.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.618 ' HB ' ' HA ' ' A' ' 34' ' ' THR . 1.3 t -151.89 152.64 32.82 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.196 0.522 . . . . 1.3799999999999999 111.484 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.7 t -113.24 -94.93 0.45 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.354 -0.839 . . . . 2.3700000000000001 110.165 176.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -148.32 19.15 1.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.297 0.57 . . . . 4.5499999999999998 110.737 176.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.673 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 38.5 mmtm -150.05 -33.92 0.18 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.707 -0.679 . . . . 1.4199999999999999 110.138 176.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.642 HD12 ' HB ' ' A' ' 193' ' ' VAL . 16.3 pt -113.55 149.95 15.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.603 -0.726 . . . . 0.76000000000000001 109.746 -177.181 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.618 ' HA ' ' HB ' ' A' ' 29' ' ' THR . 0.2 OUTLIER -151.17 107.67 3.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 123.12 0.262 . . . . 0.57999999999999996 111.604 -166.248 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.538 ' CG2' HG13 ' A' ' 193' ' ' VAL . 21.4 t -95.57 109.63 22.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.953 0.406 . . . . 0.85999999999999999 110.315 176.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 2.3 p -105.11 123.36 47.68 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.526 -0.761 . . . . 1.1000000000000001 110.773 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 77.9 p -103.47 129.19 50.56 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.914 -1.039 . . . . 1.27 110.284 -174.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.451 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 24.5 ttpp . . . . . 0 C--N 1.317 -0.829 0 CA-C-N 115.996 -0.547 . . . . 1.9099999999999999 111.289 -173.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 . . . . . 0 N--CA 1.442 -0.864 0 CA-C-O 121.054 0.454 . . . . 2.0499999999999998 111.301 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.54 HD23 ' N ' ' A' ' 48' ' ' TYR . 3.2 tt -98.48 138.68 35.35 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.865 -1.161 . . . . 0.87 107.865 174.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.54 ' N ' HD23 ' A' ' 47' ' ' LEU . 73.2 m-85 -120.03 130.69 54.83 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 110.168 -0.308 . . . . 0.98999999999999999 110.168 -174.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.484 ' HD3' ' CZ3' ' A' ' 24' ' ' TRP . 37.4 ttt-85 -120.29 121.42 38.63 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.268 -0.424 . . . . 2.9199999999999999 110.06 175.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.515 ' CG1' ' HB3' ' A' ' 192' ' ' LEU . 9.4 p -104.99 145.98 12.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 120.11 -0.636 . . . . 1.3300000000000001 109.655 174.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.555 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 29.6 tt0 -144.33 113.09 6.69 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.534 -0.757 . . . . 1.0700000000000001 110.155 -171.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.673 ' HA2' ' O ' ' A' ' 32' ' ' LYS . . . -143.85 143.26 12.03 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.682 -0.771 . . . . 0.28999999999999998 111.934 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.8 mt -87.54 120.59 36.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 120.147 -0.621 . . . . 0.57999999999999996 110.691 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 36.4 mt -102.69 120.2 53.52 Favored Pre-proline 0 N--CA 1.442 -0.865 0 CA-C-N 115.556 -0.747 . . . . 0.34999999999999998 109.728 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -62.57 60.03 0.14 Allowed 'Trans proline' 0 N--CA 1.473 0.319 0 C-N-CA 124.299 3.333 . . . . 0.62 113.93 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.643 ' HG2' HG13 ' A' ' 203' ' ' ILE . 9.6 tp10 -150.91 175.54 11.95 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.879 -0.785 . . . . 1.6799999999999999 108.879 174.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.529 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 12.8 m -80.94 143.32 53.25 Favored Pre-proline 0 N--CA 1.425 -1.702 0 CA-C-O 121.365 0.602 . . . . 1.1799999999999999 109.488 172.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 57' ' ' SER . 35.5 Cg_exo -57.95 -14.32 18.09 Favored 'Trans proline' 0 C--N 1.333 -0.272 0 C-N-CA 124.092 3.195 . . . . 0.52000000000000002 111.501 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.32 -50.9 42.25 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.207 -0.906 . . . . 0.64000000000000001 111.31 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.47 ' O ' ' HE3' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -67.66 -27.35 66.78 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.387 -0.968 . . . . 3.2999999999999998 108.387 179.774 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.752 ' O ' HD12 ' A' ' 65' ' ' LEU . 40.6 mt -62.9 -57.96 9.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.19 -0.914 . . . . 0.40999999999999998 110.473 172.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.665 ' OG ' ' HB3' ' A' ' 125' ' ' ASN . 66.5 m -60.49 -16.1 33.54 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.92 -0.488 . . . . 1.29 110.861 176.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -90.1 -43.96 10.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.243 0.46 . . . . 1.3200000000000001 112.243 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.645 ' CE2' ' HA ' ' A' ' 199' ' ' ALA . 5.0 p90 -73.4 -43.43 60.51 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.739 -0.385 . . . . 0.60999999999999999 110.905 -171.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.752 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -86.57 -7.17 58.59 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 120.433 -0.507 . . . . 1.5 111.616 -173.288 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.525 ' N ' HD13 ' A' ' 65' ' ' LEU . 11.8 t80 -18.79 -70.44 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.95 1.406 . . . . 1.52 114.005 -163.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.486 ' OE1' ' HB2' ' A' ' 94' ' ' CYS . 8.5 tt0 -174.32 -32.26 0.01 OUTLIER 'General case' 0 C--N 1.342 0.268 0 N-CA-C 114.296 1.221 . . . . 3.6000000000000001 114.296 176.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.7 t -161.97 7.87 0.06 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 119.223 -0.991 . . . . 1.48 113.462 -166.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -115.0 -22.78 4.83 Favored Glycine 0 C--N 1.314 -0.686 0 C-N-CA 118.917 -1.611 . . . . 1.46 113.901 -168.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.655 ' O ' HG22 ' A' ' 73' ' ' THR . 4.5 t70 -150.39 -29.5 0.21 Allowed 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.609 -0.436 . . . . 2.1899999999999999 110.574 -176.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.856 ' HA ' ' CZ2' ' A' ' 74' ' ' TRP . 9.7 ptm180 -50.19 -43.68 52.6 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 123.33 0.652 . . . . 3.3799999999999999 111.452 -173.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.748 HD13 ' H ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -83.5 -13.54 11.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.896 -0.593 . . . . 0.70999999999999996 110.318 -173.262 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.655 HG22 ' O ' ' A' ' 70' ' ' ASP . 0.8 OUTLIER -84.91 -31.44 23.67 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 116.02 -0.536 . . . . 0.96999999999999997 109.927 -176.958 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.856 ' CZ2' ' HA ' ' A' ' 71' ' ' ARG . 7.4 p-90 -106.29 -10.34 16.43 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 120.27 -0.572 . . . . 0.75 111.872 -176.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.674 ' OD2' ' HG ' ' A' ' 78' ' ' LEU . 27.4 t0 -83.3 172.58 12.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.967 0.889 . . . . 2.1899999999999999 111.427 -177.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.53 ' H ' ' CG ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -122.04 -13.98 8.08 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 113.979 -1.464 . . . . 3.1899999999999999 111.297 -172.47 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 74.7 m -115.56 8.77 15.2 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.303 -0.629 . . . . 1.5800000000000001 109.303 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.674 ' HG ' ' OD2' ' A' ' 75' ' ' ASP . 54.0 mt -109.65 171.05 7.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.363 -0.835 . . . . 0.70999999999999996 110.681 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.602 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 6.4 mm-40 -150.62 -63.37 0.2 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.592 0.59 . . . . 1.73 112.592 -171.152 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.507 HG23 ' HB3' ' A' ' 79' ' ' GLN . 39.4 t -141.65 127.94 19.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.907 0.384 . . . . 0.78000000000000003 111.076 -168.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.585 ' HB3' HD12 ' A' ' 72' ' ' ILE . 41.1 p90 -97.67 146.06 25.7 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.825 -0.625 . . . . 5.4000000000000004 110.219 174.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.503 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 17.2 m120 -155.13 102.5 2.31 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.447 -0.575 . . . . 1.6899999999999999 109.447 174.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.09 110.06 2.38 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.196 -0.668 . . . . 2.0499999999999998 109.196 177.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -93.14 -49.09 13.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.521 -0.309 . . . . 0.64000000000000001 111.55 -172.875 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.442 ' HB3' HD12 ' A' ' 93' ' ' ILE . 17.6 t-80 -147.74 108.13 4.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.124 0.487 . . . . 1.96 111.144 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.443 ' HG2' ' HD2' ' A' ' 92' ' ' PHE . 20.7 mtt180 -89.66 107.04 18.86 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.564 -0.744 . . . . 2.4399999999999999 109.828 176.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.64 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -75.85 -41.34 39.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.095 0.474 . . . . 0.46999999999999997 110.033 -177.805 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -155.6 -168.12 2.72 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.3 -1.0 . . . . 1.8600000000000001 108.3 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.6 m -80.63 -5.62 57.15 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 117.567 0.167 . . . . 1.4399999999999999 111.345 -177.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -130.16 4.35 4.82 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.83 -0.433 . . . . 1.8700000000000001 109.83 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.64 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.5 OUTLIER -137.87 116.33 12.01 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.609 -0.885 . . . . 0.46000000000000002 108.609 -173.564 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.576 ' O ' HD12 ' A' ' 114' ' ' LEU . 11.0 m-85 -137.2 176.29 8.84 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.232 0.539 . . . . 0.42999999999999999 110.57 -175.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.571 ' O ' HG23 ' A' ' 84' ' ' VAL . 21.6 mt -134.94 127.43 48.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 106.759 -1.571 . . . . 0.40999999999999998 106.759 166.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.486 ' HB2' ' OE1' ' A' ' 67' ' ' GLN . 31.2 t -117.15 129.58 56.06 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.389 -0.525 . . . . 2.0099999999999998 111.266 -176.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.556 ' HA ' HD13 ' A' ' 112' ' ' ILE . 24.3 t60 -87.35 85.38 7.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.268 -0.878 . . . . 1.23 109.173 173.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 60.2 m -100.42 113.37 26.07 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.644 -1.162 . . . . 0.5 112.177 -173.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.469 HD13 ' OD1' ' A' ' 110' ' ' ASP . 31.0 mm -76.52 126.21 36.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.309 -0.626 . . . . 1.03 109.309 174.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.2 m -113.35 142.74 45.5 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.328 -0.851 . . . . 1.3799999999999999 111.272 -174.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.602 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 25.3 mt-30 . . . . . 0 C--N 1.318 -0.796 0 N-CA-C 109.495 -0.557 . . . . 1.8200000000000001 109.495 173.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.448 HD11 HG22 ' A' ' 183' ' ' ILE . 26.3 mt . . . . . 0 N--CA 1.45 -0.461 0 N-CA-C 110.156 -0.313 . . . . 1.1200000000000001 110.156 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.1 m -87.44 152.41 52.22 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 116.163 -0.472 . . . . 1.3500000000000001 110.325 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -47.97 143.08 14.27 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.686 2.257 . . . . 1.0700000000000001 111.632 173.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.568 ' HG2' HG23 ' A' ' 144' ' ' ILE . 20.2 mtm180 -123.64 174.76 7.25 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.639 -0.504 . . . . 3.4500000000000002 109.639 -173.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.685 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 31.0 t70 -131.61 138.88 48.99 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.339 -0.391 . . . . 1.3700000000000001 110.045 176.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -110.07 125.54 53.06 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.105 -0.498 . . . . 2.4100000000000001 110.375 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.612 ' CG2' ' HE1' ' A' ' 134' ' ' PHE . 47.6 mm -109.39 70.54 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 108.362 -0.977 . . . . 0.42999999999999999 108.362 170.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 43.7 m-20 -88.35 117.7 27.46 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.638 -0.71 . . . . 1.8600000000000001 111.03 -174.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.627 HD22 ' HD1' ' A' ' 3' ' ' PHE . 9.4 tp -75.0 124.7 27.44 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.342 -0.984 . . . . 0.28000000000000003 108.342 165.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.615 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -132.25 126.5 55.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 115.465 -0.789 . . . . 0.26000000000000001 112.404 -163.811 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.532 ' HD1' ' HG1' ' A' ' 91' ' ' THR . 58.9 t80 -110.72 116.36 31.17 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.092 -0.958 . . . . 2.5699999999999998 110.425 172.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.453 HG12 HG22 ' A' ' 127' ' ' ILE . 86.6 mt -94.31 112.0 26.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.54 -0.755 . . . . 0.89000000000000001 110.222 -177.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.439 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 17.1 ttmm -137.95 142.43 40.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.132 -0.485 . . . . 1.2 110.63 -176.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.447 ' NE ' ' HA ' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -117.72 113.72 22.27 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 107.86 -1.163 . . . . 2.7999999999999998 107.86 172.472 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.44 ' CE1' HD13 ' A' ' 15' ' ' LEU . 56.0 m-85 -67.48 117.25 9.19 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.667 -1.235 . . . . 0.82999999999999996 107.667 170.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.447 ' HA ' ' NE ' ' A' ' 119' ' ' ARG . 22.1 mm-40 -35.66 94.58 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 O-C-N 124.789 1.306 . . . . 2.2799999999999998 112.938 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 58.8 41.71 96.13 Favored Glycine 0 CA--C 1.505 -0.569 0 CA-C-N 114.618 -1.174 . . . . 0.76000000000000001 112.406 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.431 ' HB3' ' CB ' ' A' ' 120' ' ' TYR . 66.4 t30 -138.68 -49.93 0.54 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.446 -0.377 . . . . 1.6499999999999999 110.705 -177.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.421 ' O ' ' HA ' ' A' ' 119' ' ' ARG . 2.0 tpp -159.97 118.84 2.76 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.046 0.45 . . . . 1.1200000000000001 111.491 -175.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.665 ' HB3' ' OG ' ' A' ' 62' ' ' SER . 6.0 m120 -97.93 79.21 2.61 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.779 -0.823 . . . . 1.6200000000000001 108.779 177.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.556 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.5 OUTLIER -105.37 141.06 21.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 113.193 0.812 . . . . 0.29999999999999999 113.193 -169.707 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.704 ' O ' HG13 ' A' ' 127' ' ' ILE . 2.3 pt -107.9 115.05 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 107.979 -1.119 . . . . 0.58999999999999997 107.979 159.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.615 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 36.5 p -82.96 154.2 24.63 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.946 -0.761 . . . . 1.1799999999999999 108.946 175.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.587 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 9.0 p -154.63 131.45 10.78 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.947 0.403 . . . . 1.24 111.858 -175.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -131.32 120.97 23.9 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 107.632 -1.248 . . . . 2.2599999999999998 107.632 175.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.611 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 52.5 m -66.17 101.04 0.66 Allowed 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.215 -1.402 . . . . 1.3899999999999999 107.215 175.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.99 143.21 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.879 0 CA-C-N 114.568 -1.196 . . . . 1.05 109.193 -164.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -95.27 70.72 3.21 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 122.983 1.373 . . . . 2.1699999999999999 110.176 -170.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.612 ' HE1' ' CG2' ' A' ' 112' ' ' ILE . 1.7 p90 -97.75 177.22 1.7 Allowed Pre-proline 0 CA--C 1.554 1.129 0 CA-C-N 113.688 -1.596 . . . . 0.53000000000000003 109.326 -174.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.421 ' HB2' ' OE2' ' A' ' 136' ' ' GLU . 59.9 Cg_exo -44.28 -47.71 10.47 Favored 'Trans proline' 0 CA--C 1.55 1.304 0 C-N-CA 123.752 2.968 . . . . 1.28 117.106 -175.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.421 ' OE2' ' HB2' ' A' ' 135' ' ' PRO . 2.0 mm-40 -88.71 -5.15 58.3 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 121.595 -0.691 . . . . 3.5 111.416 -172.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.575 ' HB3' ' O ' ' A' ' 134' ' ' PHE . 22.9 t80 -54.33 -45.63 99.21 Favored Pre-proline 0 C--N 1.314 -0.961 0 N-CA-C 115.384 1.624 . . . . 6.1200000000000001 115.384 -177.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 24.7 Cg_exo -32.54 111.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 123.874 3.049 . . . . 1.77 114.875 -175.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.544 ' HA ' ' CZ ' ' A' ' 145' ' ' ARG . 5.8 Cg_exo -79.8 -160.81 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.282 2.655 . . . . 1.25 114.056 -177.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 13.6 m -145.58 -160.85 1.2 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.284 -1.326 . . . . 1.6000000000000001 108.502 -176.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 31.1 t -88.69 -41.91 12.3 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.534 -0.467 . . . . 1.97 111.048 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -70.9 -30.9 67.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.898 0.38 . . . . 2.1800000000000002 111.147 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -120.32 115.02 22.73 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 121.234 0.54 . . . . 1.23 110.327 -176.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.568 HG23 ' HG2' ' A' ' 109' ' ' ARG . 3.4 tp -105.53 113.81 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 115.23 -0.896 . . . . 0.81999999999999995 109.967 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.685 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 5.2 mpt_? -54.74 99.61 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.763 -1.108 . . . . 4.4199999999999999 110.914 175.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -67.51 112.51 4.84 Favored Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 109.372 -1.491 . . . . 0.79000000000000004 109.372 171.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.5 ' HB3' ' CB ' ' A' ' 174' ' ' GLU . 3.2 t80 -84.16 81.45 8.8 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.362 0.601 . . . . 4.4400000000000004 110.515 -169.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.652 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 70.7 m-20 -70.66 99.26 1.64 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.999 -1.001 . . . . 1.6200000000000001 110.191 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.458 ' HB2' ' O ' ' A' ' 172' ' ' GLN . 70.9 m-70 -69.99 146.33 95.01 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.198 -0.455 . . . . 2.3199999999999998 109.911 176.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.545 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 75.5 Cg_exo -15.21 64.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.239 1 C-N-CA 127.414 5.409 . . . . 0.53000000000000003 115.709 -164.959 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 151' ' ' CYS . . . . . 0.652 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 25.4 p -89.81 -174.84 4.43 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.682 -1.144 . . . . 1.5800000000000001 110.36 178.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.575 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -177.8 -161.09 25.45 Favored Glycine 0 N--CA 1.435 -1.41 0 C-N-CA 120.385 -0.912 . . . . 0.42999999999999999 111.77 177.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.596 ' CE1' ' HG ' ' A' ' 65' ' ' LEU . 48.1 t80 -161.72 88.92 0.72 Allowed 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.474 -0.936 . . . . 0.59999999999999998 108.474 -167.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.583 HG23 HG13 ' A' ' 168' ' ' VAL . 2.6 m -98.63 132.53 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-O 121.65 0.738 . . . . 0.31 110.864 -173.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' CYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 125' ' ' ASN . 47.8 m -113.55 108.57 17.35 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.508 -0.769 . . . . 1.55 109.352 177.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.487 ' HB3' ' HB3' ' A' ' 166' ' ' LYS . 18.3 t -102.31 122.99 44.69 Favored Pre-proline 0 C--N 1.312 -1.058 0 CA-C-O 120.842 0.353 . . . . 1.0600000000000001 111.657 -167.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.405 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 77.9 Cg_exo -52.79 118.1 4.39 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.766 2.311 . . . . 0.56000000000000005 111.666 170.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.493 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 78.1 mmm -82.96 -165.08 0.98 Allowed 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 120.977 0.417 . . . . 1.1599999999999999 111.411 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.417 ' H ' ' HB3' ' A' ' 158' ' ' MET . 9.1 mm-40 -76.89 -24.79 52.53 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.741 0.782 . . . . 2.6299999999999999 109.138 173.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 22.5 mm-40 -102.57 27.06 7.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.823 -1.08 . . . . 2.0499999999999998 108.821 172.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.424 ' HB3' ' HD3' ' A' ' 162' ' ' PRO . 15.9 t30 -12.22 -71.32 0.01 OUTLIER Pre-proline 0 N--CA 1.479 0.987 0 N-CA-C 115.675 1.732 . . . . 1.9299999999999999 115.675 -174.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' A' ' 161' ' ' ASN . 70.6 Cg_endo -72.7 -16.27 26.72 Favored 'Trans proline' 0 C--N 1.351 0.665 0 CA-C-N 120.498 1.213 . . . . 0.72999999999999998 113.596 -172.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -103.09 -29.27 11.45 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.899 0.38 . . . . 0.68000000000000005 110.885 -177.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.493 ' O ' ' HB2' ' A' ' 158' ' ' MET . 82.2 m-85 -139.93 125.98 19.78 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.348 -0.612 . . . . 0.93000000000000005 109.348 177.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.409 ' OG ' HD11 ' A' ' 61' ' ' LEU . 4.4 p -122.13 147.81 45.69 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.156 0.503 . . . . 1.4099999999999999 110.978 -177.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.555 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.9 tppp? -91.94 104.61 17.01 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.757 0.789 . . . . 0.73999999999999999 111.009 -176.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.52 109.86 20.76 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.916 -1.038 . . . . 0.27000000000000002 109.039 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.583 HG13 HG23 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -130.58 128.76 63.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 121.692 0.758 . . . . 0.28000000000000003 111.783 177.114 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.488 ' HG2' ' N ' ' A' ' 170' ' ' PHE . 23.0 ttm -124.3 153.05 42.32 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.306 -0.861 . . . . 1.24 109.536 -176.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.568 ' O ' ' HB2' ' A' ' 151' ' ' CYS . 8.6 m-85 -133.5 139.8 46.87 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.568 -0.901 . . . . 3.3700000000000001 108.568 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 11.1 p -138.02 116.77 14.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.618 0.723 . . . . 1.3999999999999999 111.533 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 149' ' ' HIS . 28.8 tt0 -111.26 56.76 0.63 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.646 -0.872 . . . . 2.1699999999999999 108.646 174.11 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 9.1 t -73.45 145.53 45.68 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.877 0.846 . . . . 1.6499999999999999 111.269 -174.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.5 ' CB ' ' HB3' ' A' ' 147' ' ' TYR . 6.6 tp10 . . . . . 0 N--CA 1.445 -0.676 0 CA-C-N 114.681 -1.145 . . . . 2.4500000000000002 109.947 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.566 ' HA ' ' HE2' ' A' ' 186' ' ' LYS . 13.3 mm . . . . . 0 CA--C 1.507 -0.679 0 CA-C-O 122.432 1.111 . . . . 1.1200000000000001 108.991 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 1.025 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.2 mp -74.49 -34.72 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 CA-C-N 113.089 -1.868 . . . . 1.1299999999999999 111.334 -176.12 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 189' ' ' PRO . 11.1 pt-20 -67.4 -17.25 64.65 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.93 -0.767 . . . . 2.8900000000000001 108.93 176.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.566 ' HE2' ' HA ' ' A' ' 183' ' ' ILE . 51.6 mtmt -91.96 -42.67 9.88 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.376 -0.829 . . . . 1.28 109.953 171.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' THR . . . . . 1.025 HG22 ' HA ' ' A' ' 184' ' ' ILE . 7.4 t -70.01 -41.04 74.87 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.192 -0.603 . . . . 0.62 112.366 -170.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' MET . . . . . 0.55 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 34.9 mmm -76.38 -55.48 1.68 Allowed Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 112.441 0.534 . . . . 1.0600000000000001 112.441 -174.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.55 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 23.8 Cg_exo -65.48 -19.07 60.93 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 121.945 1.763 . . . . 0.91000000000000003 112.234 -175.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 51.5 m -85.87 -42.06 14.44 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.734 -0.469 . . . . 1.5 109.734 177.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -64.16 -39.13 93.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 1.8799999999999999 111.136 -175.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.527 HD12 HG13 ' A' ' 35' ' ' VAL . 30.7 mt -68.05 -44.71 75.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.627 0.251 . . . . 1.0900000000000001 111.179 -176.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.642 ' HB ' HD12 ' A' ' 33' ' ' ILE . 17.9 m -74.18 -24.85 19.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 120.27 -0.572 . . . . 0.68000000000000005 110.56 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -68.71 -39.18 80.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.187 -0.46 . . . . 2.0699999999999998 110.445 172.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.667 ' HA ' ' ND2' ' A' ' 198' ' ' ASN . 4.9 m-85 -70.8 -20.03 62.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.132 0.491 . . . . 2.0 111.014 176.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.674 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 33.5 mt -82.62 -29.55 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 C-N-CA 119.494 -0.882 . . . . 0.31 110.496 170.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 47.2 mt -69.38 -43.74 72.91 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.518 -0.31 . . . . 1.03 110.773 178.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.667 ' ND2' ' HA ' ' A' ' 195' ' ' PHE . 13.1 p30 -60.97 -22.6 64.63 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.964 -0.562 . . . . 1.8999999999999999 109.886 171.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.708 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -80.79 -43.11 20.6 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 116.51 -0.314 . . . . 0.28999999999999998 110.317 177.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.674 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 12.8 mmmm -57.1 -47.05 82.01 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.659 -0.867 . . . . 0.96999999999999997 108.659 172.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -71.19 -45.87 62.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.266 -1.333 . . . . 1.9399999999999999 111.53 -175.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -72.02 -22.76 78.69 Favored Glycine 0 N--CA 1.463 0.442 0 C-N-CA 120.517 -0.849 . . . . 0.46999999999999997 112.099 -178.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.708 ' HB ' ' O ' ' A' ' 199' ' ' ALA . 1.0 OUTLIER -82.24 -36.16 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 120.966 0.412 . . . . 0.60999999999999999 110.603 175.157 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 26.5 mtpt -73.87 -28.47 61.58 Favored 'General case' 0 C--O 1.209 -1.041 0 N-CA-C 108.636 -0.876 . . . . 3.3700000000000001 108.636 176.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.983 0 CA-C-N 115.505 -0.771 . . . . 1.02 109.682 169.118 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.637 ' O ' HD13 ' A' ' 6' ' ' ILE . 20.1 t70 . . . . . 0 CA--C 1.513 -0.445 0 N-CA-C 110.058 -0.349 . . . . 2.25 110.058 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.842 ' HA ' HD11 ' A' ' 6' ' ' ILE . 96.0 m-85 -67.76 -30.11 69.48 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 122.006 0.908 . . . . 0.42999999999999999 108.569 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 9.2 tttm -75.68 -4.32 39.63 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.916 -1.493 . . . . 1.51 109.893 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.425 ' O ' ' HG2' ' A' ' 9' ' ' GLN . . . -92.74 -46.22 7.66 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.339 0.59 . . . . 0.54000000000000004 109.686 174.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.842 HD11 ' HA ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -82.34 -38.8 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-N 115.693 -0.685 . . . . 1.0700000000000001 110.464 -171.915 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.562 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -78.04 -38.08 45.41 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.843 -1.071 . . . . 0.34000000000000002 111.391 -176.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.501 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 7.1 mt-30 -65.68 -25.79 67.49 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.179 -0.919 . . . . 1.5900000000000001 110.316 177.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.52 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 86.8 mm-40 -89.71 -36.45 15.2 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.051 -0.977 . . . . 2.4700000000000002 109.531 173.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.593 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -64.81 -34.47 78.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.626 -0.716 . . . . 0.47999999999999998 111.259 179.031 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.529 ' HA ' ' OG ' ' A' ' 128' ' ' SER . . . -48.21 -61.07 2.17 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.703 0.763 . . . . 0.31 110.464 171.139 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -66.71 -17.0 64.63 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.471 -1.24 . . . . 1.6399999999999999 112.025 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 35.2 mt-10 -68.73 -57.35 5.77 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 109.595 -0.521 . . . . 2.54 109.595 174.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.713 ' CG2' ' HA ' ' A' ' 151' ' ' CYS . 1.2 t -70.4 -43.38 78.26 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 CA-C-O 121.811 0.815 . . . . 0.53000000000000003 110.979 -174.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.559 HD23 ' HD2' ' A' ' 19' ' ' ARG . 1.0 OUTLIER -64.48 -33.11 75.12 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.471 -1.241 . . . . 0.59999999999999998 109.308 174.813 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.427 ' HA2' ' HD3' ' A' ' 19' ' ' ARG . . . -65.07 -16.41 62.03 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 114.56 -1.2 . . . . 0.56999999999999995 111.281 175.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.709 ' HD2' ' HA ' ' A' ' 14' ' ' VAL . 54.8 m-85 -89.58 -25.82 21.14 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 108.234 -1.024 . . . . 3.27 108.234 174.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.409 ' HA ' ' HZ ' ' A' ' 170' ' ' PHE . 65.6 t30 -68.85 -10.63 58.0 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.635 0.731 . . . . 2.0299999999999998 109.093 175.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.559 ' HD2' HD23 ' A' ' 15' ' ' LEU . 11.3 mtp180 -112.19 -20.79 11.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.875 -1.057 . . . . 2.7200000000000002 110.322 178.056 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -123.08 58.93 1.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.775 0.798 . . . . 2.1600000000000001 110.702 -176.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.856 ' HB ' ' CZ2' ' A' ' 24' ' ' TRP . 0.7 OUTLIER -122.89 127.57 49.15 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.856 -0.611 . . . . 1.8200000000000001 110.544 176.687 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.5 t -179.28 -33.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.508 -0.769 . . . . 2.1899999999999999 110.068 -170.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.85 -17.35 76.79 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.618 -0.719 . . . . 1.1000000000000001 112.916 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 1.012 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -89.81 -155.99 0.39 Allowed 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 112.563 0.579 . . . . 1.6699999999999999 112.563 179.324 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.521 ' HE3' ' HA ' ' A' ' 25' ' ' LYS . 0.8 OUTLIER -171.68 134.79 0.84 Allowed 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 115.204 -0.907 . . . . 2.9500000000000002 109.465 -164.671 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.689 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 5.2 m -66.0 122.05 16.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 122.062 0.934 . . . . 1.5600000000000001 111.486 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.514 HG21 ' HE2' ' A' ' 48' ' ' TYR . 30.1 m -95.76 -23.19 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-N 113.906 -1.497 . . . . 1.22 108.517 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.521 ' HD2' ' HA ' ' A' ' 28' ' ' LYS . 15.1 tptm -161.98 131.25 4.47 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 120.251 -0.579 . . . . 2.4100000000000001 111.185 -176.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.76 HG22 ' HA ' ' A' ' 34' ' ' THR . 77.4 p -131.81 152.18 51.16 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.224 -0.444 . . . . 1.3799999999999999 109.827 172.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.551 ' HB3' HG12 ' A' ' 33' ' ' ILE . 22.9 t -111.67 -138.98 0.38 Allowed 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.268 -0.641 . . . . 2.3700000000000001 109.268 177.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -103.62 18.13 22.56 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 122.451 -0.155 . . . . 4.5499999999999998 110.835 -178.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.3 tptt -175.12 2.98 0.01 OUTLIER 'General case' 0 C--O 1.237 0.422 0 N-CA-C 112.098 0.407 . . . . 1.4199999999999999 112.098 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.924 HG22 ' HA3' ' A' ' 52' ' ' GLY . 38.1 pt -139.3 166.34 21.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 120.783 0.325 . . . . 0.76000000000000001 111.376 -175.096 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.76 ' HA ' HG22 ' A' ' 29' ' ' THR . 24.1 m -152.02 112.38 4.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.425 -0.807 . . . . 0.57999999999999996 110.685 -165.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.884 HG22 HG12 ' A' ' 50' ' ' VAL . 2.3 t -107.16 103.89 16.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.842 0.353 . . . . 0.85999999999999999 110.242 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.689 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 4.3 p -102.5 127.58 49.49 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 122.957 0.503 . . . . 1.1000000000000001 110.273 179.09 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 6.9 t -120.53 135.71 55.0 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.402 0.62 . . . . 1.27 112.152 -172.161 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 1.012 ' HB3' ' HB3' ' A' ' 24' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 114.77 -1.105 . . . . 1.9099999999999999 109.632 175.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 121.413 0.625 . . . . 2.0499999999999998 111.445 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.681 HD23 ' N ' ' A' ' 48' ' ' TYR . 5.2 tt -83.7 150.8 25.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.726 -1.125 . . . . 0.87 108.565 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.681 ' N ' HD23 ' A' ' 47' ' ' LEU . 70.9 m-85 -120.31 131.88 55.07 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.931 0.395 . . . . 0.98999999999999999 110.941 -174.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.507 ' HG2' ' CE2' ' A' ' 170' ' ' PHE . 0.6 OUTLIER -112.44 115.45 28.7 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.266 -1.012 . . . . 2.9199999999999999 108.266 173.22 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.884 HG12 HG22 ' A' ' 35' ' ' VAL . 2.0 m -101.49 150.35 6.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 120.407 -0.517 . . . . 1.3300000000000001 110.477 173.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.652 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 45.7 tt0 -151.15 109.38 3.75 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.986 -1.006 . . . . 1.0700000000000001 109.49 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.924 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -139.99 143.16 13.34 Favored Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 110.909 -0.876 . . . . 0.28999999999999998 110.909 178.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.0 mt -88.62 125.3 41.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 C-N-CA 119.574 -0.85 . . . . 0.57999999999999996 111.051 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.47 HG12 ' HD3' ' A' ' 200' ' ' LYS . 45.4 mt -106.04 99.1 21.13 Favored Pre-proline 0 N--CA 1.442 -0.871 0 N-CA-C 108.046 -1.094 . . . . 0.34999999999999998 108.046 173.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.814 ' HA ' ' HA ' ' A' ' 164' ' ' TYR . 38.3 Cg_endo -65.14 49.89 0.2 Allowed 'Trans proline' 0 N--CA 1.479 0.67 1 C-N-CA 125.506 4.137 . . . . 0.62 115.406 -170.358 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.496 ' HB2' ' H ' ' A' ' 57' ' ' SER . 2.2 pm0 -139.34 -153.67 0.48 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.065 -0.717 . . . . 1.6799999999999999 109.065 165.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.496 ' H ' ' HB2' ' A' ' 56' ' ' GLU . 44.0 t -92.28 140.78 24.43 Favored Pre-proline 0 N--CA 1.422 -1.826 0 CA-C-O 122.006 0.908 . . . . 1.1799999999999999 111.141 -174.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.639 ' HB3' ' SG ' ' A' ' 155' ' ' CYS . 31.1 Cg_exo -57.36 -14.84 17.11 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 124.201 3.267 . . . . 0.52000000000000002 110.306 174.278 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.54 ' O ' ' HB2' ' A' ' 63' ' ' ASP . . . -69.55 -47.34 63.99 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.939 -1.028 . . . . 0.64000000000000001 111.134 174.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 1.001 ' HE3' ' HA ' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -66.54 -35.48 80.33 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.082 -1.081 . . . . 3.2999999999999998 108.082 178.263 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.971 HD23 HD13 ' A' ' 203' ' ' ILE . 37.1 mt -60.72 -55.44 33.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.87 -1.059 . . . . 0.40999999999999998 110.833 177.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.456 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 42.5 t -67.36 -10.27 49.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.68 0.276 . . . . 1.29 110.734 177.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.54 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -85.83 -45.72 11.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.475 -0.33 . . . . 1.3200000000000001 111.158 -178.631 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.479 ' CE2' ' HA ' ' A' ' 61' ' ' LEU . 11.3 p90 -77.78 -43.36 30.91 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.662 -0.245 . . . . 0.60999999999999999 111.574 -172.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.456 ' CD2' ' HA ' ' A' ' 62' ' ' SER . 1.0 OUTLIER -75.31 -8.94 58.01 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 122.187 -0.321 . . . . 1.5 111.484 -169.406 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.525 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 26.2 t80 -26.4 -56.7 0.08 Allowed 'General case' 0 N--CA 1.462 0.151 0 O-C-N 125.431 1.707 . . . . 1.52 114.11 -163.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.525 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 8.5 tt0 166.02 -38.62 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.595 0.712 . . . . 3.6000000000000001 110.861 -175.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.9 t -165.55 19.84 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.253 -0.885 . . . . 1.48 110.155 -164.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 70' ' ' ASP . . . -78.01 -34.68 37.11 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.252 -0.975 . . . . 1.46 111.702 -173.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.624 ' O ' HG22 ' A' ' 73' ' ' THR . 16.4 p-10 166.63 -17.7 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.12 -1.04 . . . . 2.1899999999999999 108.549 -167.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.858 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -45.57 -38.21 6.25 Favored 'General case' 0 C--O 1.209 -1.034 0 CA-C-N 115.324 -0.853 . . . . 3.3799999999999999 111.755 176.021 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.655 ' H ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -89.87 -7.47 10.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 120.383 -0.527 . . . . 0.70999999999999996 111.386 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.624 HG22 ' O ' ' A' ' 70' ' ' ASP . 0.8 OUTLIER -92.41 -27.77 17.28 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 120.395 -0.522 . . . . 0.96999999999999997 110.618 -173.352 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.808 ' HZ3' ' HB2' ' A' ' 198' ' ' ASN . 11.9 p-90 -112.79 -3.06 14.26 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.795 -0.362 . . . . 0.75 111.699 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.858 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 4.1 t70 -70.18 175.66 4.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 122.335 1.064 . . . . 2.1899999999999999 112.231 -172.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.863 ' HD2' ' HB3' ' A' ' 198' ' ' ASN . 0.0 OUTLIER -118.37 -12.8 9.84 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.8 -1.545 . . . . 3.1899999999999999 110.195 -174.166 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.555 ' HA ' ' HB2' ' A' ' 99' ' ' GLN . 0.1 OUTLIER -130.31 2.81 4.67 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.198 -0.91 . . . . 1.5800000000000001 109.921 178.094 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.774 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 62.1 mt -109.15 149.82 28.78 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.057 -0.52 . . . . 0.70999999999999996 110.834 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.593 ' HG2' ' HG2' ' A' ' 99' ' ' GLN . 15.0 mm100 -132.56 -59.02 0.92 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.465 -0.789 . . . . 1.73 111.288 -175.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.732 ' HB ' HD13 ' A' ' 97' ' ' ILE . 18.1 t -140.7 125.44 18.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.521 -0.763 . . . . 0.78000000000000003 110.633 -165.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -94.88 153.53 17.66 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.601 -0.727 . . . . 5.4000000000000004 110.44 174.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.501 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 1.2 m120 -152.82 109.37 3.42 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.718 -0.475 . . . . 1.6899999999999999 109.718 167.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.513 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 3.3 ttt -75.03 94.87 2.93 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.266 -1.013 . . . . 2.0499999999999998 108.266 178.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -74.66 -73.03 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-O 121.215 0.531 . . . . 0.64000000000000001 111.258 -166.683 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -136.34 120.6 17.91 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.783 -0.644 . . . . 1.96 109.592 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.837 ' HG2' ' HD2' ' A' ' 92' ' ' PHE . 38.6 mtm180 -97.15 123.19 40.84 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.453 -0.794 . . . . 2.4399999999999999 109.684 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.651 HG21 ' HB2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -82.37 -40.73 17.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.833 -0.621 . . . . 0.46999999999999997 109.819 -174.123 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -147.88 -161.92 1.44 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.384 -0.969 . . . . 1.8600000000000001 108.384 177.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.2 m -83.08 -7.78 59.61 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.739 0.304 . . . . 1.4399999999999999 110.81 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -137.65 15.99 2.91 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.26 0.553 . . . . 1.8700000000000001 110.258 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.716 HG23 ' HD2' ' A' ' 116' ' ' TYR . 0.7 OUTLIER -134.37 109.92 9.11 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 107.916 -1.142 . . . . 0.46000000000000002 107.916 -179.287 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.837 ' HD2' ' HG2' ' A' ' 86' ' ' ARG . 5.1 m-85 -132.14 178.9 6.44 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.316 0.579 . . . . 0.42999999999999999 110.797 -174.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.637 ' O ' HG23 ' A' ' 84' ' ' VAL . 19.3 mt -138.3 130.4 38.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 106.966 -1.494 . . . . 0.40999999999999998 106.966 169.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 48.0 t -116.0 122.13 44.32 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.621 -0.432 . . . . 2.0099999999999998 110.92 -172.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.572 ' HA ' HD13 ' A' ' 112' ' ' ILE . 10.5 t60 -85.95 83.98 7.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.862 0.839 . . . . 1.23 109.175 173.094 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.796 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 18.9 m -90.69 118.07 29.83 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.485 -1.234 . . . . 0.5 111.442 -176.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.732 HD13 ' HB ' ' A' ' 80' ' ' VAL . 3.5 mp -91.58 123.37 43.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.758 -0.831 . . . . 1.03 108.758 170.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 109' ' ' ARG . 15.2 t -110.29 171.41 7.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.061 -0.518 . . . . 1.3799999999999999 110.978 -174.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.593 ' HG2' ' HG2' ' A' ' 79' ' ' GLN . 4.7 mm100 . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 115.107 -0.951 . . . . 1.8200000000000001 111.897 -172.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 64.2 mt . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 121.2 0.524 . . . . 1.1200000000000001 110.964 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.508 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.3 p -100.66 176.33 1.96 Allowed Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.205 -0.907 . . . . 1.3500000000000001 109.965 177.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.508 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 87.9 Cg_exo -47.55 109.9 0.26 Allowed 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 122.306 2.004 . . . . 1.0700000000000001 111.135 174.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.617 ' HG3' HG23 ' A' ' 144' ' ' ILE . 18.4 ttm180 -111.06 151.69 27.77 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.168 -0.469 . . . . 3.4500000000000002 111.134 -167.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.867 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 6.5 t70 -99.28 134.06 42.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.761 -0.654 . . . . 1.3700000000000001 110.847 -176.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.796 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 17.8 m-85 -118.21 114.71 23.43 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.81 -0.632 . . . . 2.4100000000000001 110.143 173.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.572 HD13 ' HA ' ' A' ' 95' ' ' HIS . 26.2 mm -108.95 76.24 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.722 -0.844 . . . . 0.42999999999999999 108.722 170.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.764 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 1.6 m-20 -95.48 119.89 34.77 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.847 -0.615 . . . . 1.8600000000000001 110.306 -178.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.678 ' O ' ' HA ' ' A' ' 129' ' ' SER . 3.9 tp -75.36 121.79 22.79 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 108.672 -0.862 . . . . 0.28000000000000003 108.672 170.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -126.6 123.97 64.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-N 115.296 -0.865 . . . . 0.26000000000000001 111.732 -164.14 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.716 ' HD2' HG23 ' A' ' 91' ' ' THR . 24.1 t80 -105.95 111.91 24.75 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.786 -1.097 . . . . 2.5699999999999998 110.023 175.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.929 HG12 HG22 ' A' ' 127' ' ' ILE . 73.2 mt -92.9 99.15 9.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.039 -0.528 . . . . 0.89000000000000001 109.608 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.694 ' HB2' ' CE1' ' A' ' 116' ' ' TYR . 36.7 ttpt -124.35 138.17 54.4 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.989 -0.55 . . . . 1.2 110.546 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.479 ' O ' ' HD3' ' A' ' 119' ' ' ARG . 0.1 OUTLIER -116.09 111.95 21.03 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-O 122.117 0.961 . . . . 2.7999999999999998 109.697 177.952 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.61 ' HB2' ' HB3' ' A' ' 123' ' ' ASN . 18.2 m-85 -68.05 104.0 1.65 Allowed 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 105.523 -2.028 . . . . 0.82999999999999996 105.523 163.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.46 ' H ' ' HG2' ' A' ' 121' ' ' GLU . 4.1 pt-20 -53.17 98.29 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 122.262 1.029 . . . . 2.2799999999999998 113.023 -168.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 84.91 23.09 50.92 Favored Glycine 0 CA--C 1.504 -0.632 0 CA-C-N 113.483 -1.689 . . . . 0.76000000000000001 111.785 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.61 ' HB3' ' HB2' ' A' ' 120' ' ' TYR . 14.2 t-20 -127.33 -50.74 1.41 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.63 -0.785 . . . . 1.6499999999999999 109.213 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.469 ' O ' ' HA ' ' A' ' 119' ' ' ARG . 0.9 OUTLIER -161.47 143.06 11.54 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.138 -0.483 . . . . 1.1200000000000001 111.282 -177.272 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -116.62 84.41 2.13 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.471 -0.937 . . . . 1.6200000000000001 108.471 169.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.624 ' CG1' HG12 ' A' ' 154' ' ' VAL . 0.7 OUTLIER -102.26 135.0 41.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 112.951 0.722 . . . . 0.29999999999999999 112.951 -172.141 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.929 HG22 HG12 ' A' ' 117' ' ' ILE . 31.7 pt -100.15 107.34 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.914 0.864 . . . . 0.58999999999999997 109.023 164.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.553 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 1.2 m -88.38 109.38 19.95 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.453 -0.794 . . . . 1.1799999999999999 110.638 -178.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.764 ' HB3' ' HB3' ' A' ' 113' ' ' ASP . 12.8 m -114.74 145.16 42.39 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.248 0.547 . . . . 1.24 111.733 -170.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.616 ' HE2' ' HG3' ' A' ' 150' ' ' PRO . 3.2 mtpm? -137.66 121.78 17.94 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 107.387 -1.338 . . . . 2.2599999999999998 107.387 174.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 78.9 p -64.04 98.4 0.21 Allowed 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.11 -1.441 . . . . 1.3899999999999999 107.11 175.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.485 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -109.03 140.21 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.836 0 N-CA-C 108.731 -0.84 . . . . 1.05 108.731 -165.488 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -102.68 86.89 2.85 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 122.459 1.124 . . . . 2.1699999999999999 109.245 -174.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.763 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 1.3 p90 -117.33 154.5 50.31 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 114.012 -1.449 . . . . 0.53000000000000003 111.526 -166.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 3.2 Cg_exo -42.09 -47.0 7.01 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 124.77 3.646 . . . . 1.28 115.883 -174.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.763 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 7.3 tp10 -65.64 -25.55 67.41 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 120.731 0.301 . . . . 3.5 110.749 -163.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.577 ' HB2' HG11 ' A' ' 84' ' ' VAL . 10.1 t80 -150.26 101.77 3.15 Favored Pre-proline 0 N--CA 1.441 -0.908 0 N-CA-C 113.237 0.829 . . . . 6.1200000000000001 113.237 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -88.94 134.4 2.63 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.261 2.641 . . . . 1.77 109.746 163.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.5 -171.92 0.41 Allowed 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.439 2.093 . . . . 1.25 112.424 -176.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 62.2 p -133.22 -179.7 5.66 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 109.356 -0.609 . . . . 1.6000000000000001 109.356 -172.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.2 m -86.21 11.38 12.12 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.125 0.488 . . . . 1.97 110.658 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -120.14 -44.74 2.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.781 -0.645 . . . . 2.1800000000000002 109.773 173.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.867 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 85.0 m-85 -94.28 109.71 21.51 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.193 -0.669 . . . . 1.23 109.193 175.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.617 HG23 ' HG3' ' A' ' 109' ' ' ARG . 1.0 OUTLIER -95.11 107.69 19.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.783 -0.644 . . . . 0.81999999999999995 110.177 -175.391 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 2.7 ttp180 -56.84 99.88 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.407 -0.815 . . . . 4.4199999999999999 109.803 175.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -66.23 128.87 31.25 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.097 -0.801 . . . . 0.79000000000000004 111.097 179.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.672 ' HB3' ' HB3' ' A' ' 174' ' ' GLU . 65.0 t80 -84.84 86.84 7.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.524 0.678 . . . . 4.4400000000000004 110.989 -175.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 53.1 t30 -82.06 116.18 21.53 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.153 -0.93 . . . . 1.6200000000000001 109.361 171.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.757 ' HB3' ' HB3' ' A' ' 172' ' ' GLN . 76.3 t60 -58.19 154.72 29.43 Favored Pre-proline 0 C--O 1.217 -0.614 0 CA-C-O 118.142 -0.932 . . . . 2.3199999999999998 108.656 173.011 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.616 ' HG3' ' HE2' ' A' ' 130' ' ' LYS . 60.9 Cg_exo -37.74 78.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 123.916 3.077 . . . . 0.53000000000000003 112.618 169.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' CYS . . . . . 0.716 ' HB3' ' O ' ' A' ' 170' ' ' PHE . 72.7 m -135.1 149.49 50.06 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.973 -1.467 . . . . 1.5800000000000001 107.904 -176.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.596 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -138.76 -147.0 5.07 Favored Glycine 0 N--CA 1.432 -1.623 0 C-N-CA 119.051 -1.547 . . . . 0.42999999999999999 113.038 -170.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.663 ' HE1' HD21 ' A' ' 167' ' ' LEU . 7.5 t80 -160.74 82.72 0.66 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.915 -1.513 . . . . 0.59999999999999998 106.915 -167.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.693 HG23 HG13 ' A' ' 168' ' ' VAL . 4.1 m -93.27 140.98 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 CA-C-O 122.044 0.926 . . . . 0.31 110.597 -172.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' CYS . . . . . 0.639 ' SG ' ' HB3' ' A' ' 58' ' ' PRO . 1.6 t -117.09 126.44 52.84 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 114.731 -1.122 . . . . 1.55 109.077 177.05 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.723 ' HB3' ' HB3' ' A' ' 166' ' ' LYS . 11.2 t -120.48 121.16 29.38 Favored Pre-proline 0 C--N 1.31 -1.138 0 C-N-CA 120.146 -0.622 . . . . 1.0600000000000001 111.669 -172.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 67.8 Cg_exo -50.38 108.65 0.23 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.035 1.823 . . . . 0.56000000000000005 110.373 166.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.723 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 54.0 mmm -72.06 -165.74 0.19 Allowed 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.67 0.747 . . . . 1.1599999999999999 112.175 -174.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.434 ' H ' ' HB3' ' A' ' 158' ' ' MET . 27.1 mt-10 -67.25 -24.28 65.79 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.903 -1.044 . . . . 2.6299999999999999 110.177 177.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 163' ' ' ALA . 54.5 mm-40 -108.05 14.05 25.51 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.754 -0.657 . . . . 2.0499999999999998 110.085 177.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.652 ' HB3' ' CD ' ' A' ' 162' ' ' PRO . 47.0 t-20 29.25 -89.84 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 125.684 1.594 . . . . 1.9299999999999999 114.762 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.652 ' CD ' ' HB3' ' A' ' 161' ' ' ASN . 72.0 Cg_endo -74.42 -13.76 22.76 Favored 'Trans proline' 0 C--N 1.367 1.528 0 CA-C-N 121.854 1.698 . . . . 0.72999999999999998 113.093 -175.344 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.551 ' HB3' ' HB3' ' A' ' 160' ' ' GLU . . . -91.76 -29.94 16.52 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.864 -0.607 . . . . 0.68000000000000005 110.679 -177.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.814 ' HA ' ' HA ' ' A' ' 55' ' ' PRO . 85.3 m-85 -143.65 124.78 14.48 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.398 -0.593 . . . . 0.93000000000000005 109.398 176.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.438 ' OG ' HD12 ' A' ' 61' ' ' LEU . 21.4 t -112.87 145.52 40.54 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 119.905 -0.718 . . . . 1.4099999999999999 110.593 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.723 ' HB3' ' HB3' ' A' ' 156' ' ' SER . 2.5 tppp? -94.01 112.59 24.44 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.519 0.676 . . . . 0.73999999999999999 111.266 -176.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.663 HD21 ' HE1' ' A' ' 153' ' ' PHE . 0.6 OUTLIER -95.54 104.35 16.26 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.283 -0.871 . . . . 0.27000000000000002 109.37 173.905 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.721 HG12 ' HG3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -125.4 134.54 66.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.223 0.535 . . . . 0.28000000000000003 110.603 176.673 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.643 ' HB3' HG23 ' A' ' 50' ' ' VAL . 20.7 ttt -140.85 143.24 34.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.164 -0.471 . . . . 1.24 110.219 -169.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.716 ' O ' ' HB3' ' A' ' 151' ' ' CYS . 34.0 m-85 -120.42 139.13 53.28 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.057 -0.72 . . . . 3.3700000000000001 109.057 177.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.488 ' HB ' HD21 ' A' ' 192' ' ' LEU . 0.9 OUTLIER -143.42 125.62 12.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 O-C-N 123.492 0.495 . . . . 1.3999999999999999 111.286 178.551 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.757 ' HB3' ' HB3' ' A' ' 149' ' ' HIS . 20.3 tt0 -124.73 51.46 1.63 Allowed 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 107.158 -1.423 . . . . 2.1699999999999999 107.158 171.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 7.4 m -75.36 127.55 33.39 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.806 -1.543 . . . . 1.6499999999999999 110.542 -175.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.672 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 28.6 tt0 . . . . . 0 C--N 1.323 -0.566 0 CA-C-N 115.491 -0.777 . . . . 2.4500000000000002 111.554 -173.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.503 ' HA ' ' CE ' ' A' ' 186' ' ' LYS . 9.1 mm . . . . . 0 CA--C 1.502 -0.878 0 CA-C-O 122.802 1.287 . . . . 1.1200000000000001 108.401 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 1.024 ' HA ' HG22 ' A' ' 187' ' ' THR . 0.9 OUTLIER -79.93 -34.33 15.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 112.541 -2.118 . . . . 1.1299999999999999 109.924 -175.773 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -66.49 -18.6 65.45 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.935 -1.029 . . . . 2.8900000000000001 109.584 172.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.503 ' CE ' ' HA ' ' A' ' 183' ' ' ILE . 53.0 mtmt -93.0 -44.61 8.33 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.413 -0.812 . . . . 1.28 110.79 174.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' THR . . . . . 1.024 HG22 ' HA ' ' A' ' 184' ' ' ILE . 14.3 t -66.09 -43.0 88.55 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.612 0.597 . . . . 0.62 112.612 -170.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' MET . . . . . 0.526 ' SD ' ' HB ' ' A' ' 173' ' ' THR . 29.1 mmt -73.68 -57.31 2.6 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 112.713 0.634 . . . . 1.0600000000000001 112.713 -172.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.617 ' O ' HG13 ' A' ' 193' ' ' VAL . 27.3 Cg_endo -62.18 -30.48 82.01 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 121.616 1.544 . . . . 0.91000000000000003 112.119 -177.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.2 t -75.99 -33.12 59.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.237 0.541 . . . . 1.5 109.824 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 187' ' ' THR . 63.9 t30 -73.0 -44.24 61.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.678 -0.692 . . . . 1.8799999999999999 111.274 -174.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.494 ' HB3' HG21 ' A' ' 50' ' ' VAL . 18.5 mt -65.23 -42.62 93.24 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.754 0.311 . . . . 1.0900000000000001 111.333 -175.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.617 HG13 ' O ' ' A' ' 189' ' ' PRO . 1.5 m -67.45 -31.89 54.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.908 0.861 . . . . 0.68000000000000005 109.354 178.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.433 ' HB3' ' HE3' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -70.08 -34.68 73.47 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.284 -1.325 . . . . 2.0699999999999998 110.997 177.998 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.634 ' HA ' ' ND2' ' A' ' 198' ' ' ASN . 3.3 m-85 -71.69 -24.53 61.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.24 0.543 . . . . 2.0 110.433 174.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.646 HG12 HD12 ' A' ' 167' ' ' LEU . 59.2 mt -82.08 -29.44 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-O 121.31 0.576 . . . . 0.31 110.511 172.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 44.6 mt -72.21 -42.6 65.57 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 116.16 -0.473 . . . . 1.03 110.736 177.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.863 ' HB3' ' HD2' ' A' ' 76' ' ' LYS . 5.9 p30 -59.55 -24.0 63.33 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 108.96 -0.755 . . . . 1.8999999999999999 108.96 171.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.678 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -80.94 -44.83 17.63 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 120.415 -0.514 . . . . 0.28999999999999998 110.222 176.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.47 ' HD3' HG12 ' A' ' 54' ' ' ILE . 22.5 mmtp -54.8 -42.89 72.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.02 -0.537 . . . . 0.96999999999999997 110.856 175.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' ASP . . . . . 0.542 ' O ' ' HD3' ' A' ' 204' ' ' LYS . 9.9 t70 -87.88 -46.26 9.56 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.007 -0.542 . . . . 1.9399999999999999 110.327 -178.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' GLY . . . . . 0.682 ' HA2' ' HB3' ' A' ' 205' ' ' ALA . . . -61.19 -25.9 65.22 Favored Glycine 0 C--O 1.224 -0.508 0 CA-C-N 115.849 -0.614 . . . . 0.46999999999999997 112.277 -178.007 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.971 HD13 HD23 ' A' ' 61' ' ' LEU . 3.0 tp -67.89 -43.07 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-O 119.27 -0.395 . . . . 0.60999999999999999 111.239 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.542 ' HD3' ' O ' ' A' ' 201' ' ' ASP . 0.0 OUTLIER -91.25 -13.54 32.56 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 118.732 0.696 . . . . 3.3700000000000001 109.228 176.532 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.682 ' HB3' ' HA2' ' A' ' 202' ' ' GLY . . . . . . . . 0 C--N 1.314 -0.95 0 N-CA-C 108.532 -0.914 . . . . 1.02 108.532 164.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.1 t70 . . . . . 0 CA--C 1.504 -0.826 0 N-CA-C 109.288 -0.634 . . . . 2.25 109.288 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.605 ' HA ' ' CD1' ' A' ' 6' ' ' ILE . 96.6 m-85 -65.65 -37.03 85.4 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.191 -0.913 . . . . 0.42999999999999999 109.186 -175.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.668 ' HG2' ' HG3' ' A' ' 8' ' ' GLN . 4.4 ttmt -81.75 2.94 27.62 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.121 -0.945 . . . . 1.51 110.476 -176.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -92.87 -49.42 6.06 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.359 0.599 . . . . 0.54000000000000004 109.485 173.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.605 ' CD1' ' HA ' ' A' ' 3' ' ' PHE . 0.3 OUTLIER -83.8 -37.68 13.42 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.606 0 CA-C-N 115.354 -0.839 . . . . 1.0700000000000001 110.181 -173.091 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.628 ' HA ' ' HB ' ' A' ' 10' ' ' THR . . . -71.5 -44.1 65.32 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.587 0.708 . . . . 0.34000000000000002 111.531 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.668 ' HG3' ' HG2' ' A' ' 4' ' ' LYS . 11.7 mt-30 -60.13 -32.83 71.38 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.917 -1.038 . . . . 1.5900000000000001 110.516 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.567 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 25.6 mm-40 -85.75 -32.06 22.06 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.221 -0.899 . . . . 2.4700000000000002 109.266 175.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.681 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.6 OUTLIER -62.26 -39.5 93.09 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.927 -1.033 . . . . 0.47999999999999998 111.042 176.513 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.418 ' HA ' ' CB ' ' A' ' 128' ' ' SER . . . -47.43 -63.04 1.15 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 121.148 0.499 . . . . 0.31 111.529 173.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -71.57 -13.0 61.65 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.851 -0.613 . . . . 1.6399999999999999 111.831 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 44.9 mm-40 -69.6 -58.12 4.34 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.764 0.792 . . . . 2.54 109.298 173.094 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.811 HG21 ' N ' ' A' ' 152' ' ' GLY . 5.3 p -68.01 -40.13 82.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 114.648 -1.16 . . . . 0.53000000000000003 109.717 -177.236 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.551 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -68.14 -22.83 64.84 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 114.787 -1.097 . . . . 0.59999999999999998 109.08 176.342 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.744 ' HA2' ' HD3' ' A' ' 19' ' ' ARG . . . -63.28 -25.34 68.29 Favored Glycine 0 CA--C 1.5 -0.847 0 CA-C-N 114.474 -1.239 . . . . 0.56999999999999995 110.444 177.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -88.83 -12.25 42.48 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.699 -0.852 . . . . 3.27 108.699 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -83.96 -9.27 58.81 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.321 -0.854 . . . . 2.0299999999999998 110.027 172.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.744 ' HD3' ' HA2' ' A' ' 16' ' ' GLY . 48.4 mtp180 -106.85 -23.89 12.23 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 116.183 -0.462 . . . . 2.7200000000000002 110.884 -172.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -150.88 170.77 18.5 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.038 -0.528 . . . . 2.1600000000000001 110.513 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.465 HG22 ' CZ2' ' A' ' 24' ' ' TRP . 75.1 p -133.51 134.02 42.91 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.57 -0.741 . . . . 1.8200000000000001 109.792 -175.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.4 t -139.25 107.5 5.78 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.263 0.468 . . . . 2.1899999999999999 112.263 -170.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.82 34.13 81.25 Favored Glycine 0 C--N 1.331 0.282 0 CA-C-N 115.528 -0.76 . . . . 1.1000000000000001 114.405 168.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.92 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -121.29 -166.31 1.34 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 117.183 0.491 . . . . 1.6699999999999999 110.273 175.141 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.61 140.38 0.6 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.392 -0.822 . . . . 2.9500000000000002 109.225 -175.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.691 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 0.1 OUTLIER -60.33 117.08 2.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.457 -0.792 . . . . 1.5600000000000001 110.378 174.01 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.9 p -92.05 -25.96 5.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 114.727 -1.124 . . . . 1.22 109.295 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.46 ' O ' HG22 ' A' ' 35' ' ' VAL . 3.0 tmmm? -161.24 146.63 14.01 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 119.264 -0.974 . . . . 2.4100000000000001 112.274 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.871 HG22 ' HA ' ' A' ' 34' ' ' THR . 42.9 p -143.67 152.27 41.12 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.798 -0.637 . . . . 1.3799999999999999 109.722 176.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.9 m -102.38 -90.01 0.36 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.523 -0.308 . . . . 2.3700000000000001 110.631 176.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.474 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 82.0 tttt -155.28 31.65 0.38 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.122 0.487 . . . . 4.5499999999999998 110.502 175.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.516 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 6.1 mmtm 178.9 -20.47 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.4 -0.818 . . . . 1.4199999999999999 110.039 179.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.477 HG22 ' HA3' ' A' ' 52' ' ' GLY . 31.0 pt -115.45 160.85 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.353 -0.839 . . . . 0.76000000000000001 110.701 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.871 ' HA ' HG22 ' A' ' 29' ' ' THR . 52.5 m -155.15 110.09 3.01 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.314 -0.857 . . . . 0.57999999999999996 110.697 -163.271 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.712 ' HA ' ' O ' ' A' ' 49' ' ' ARG . 6.0 m -103.12 117.83 49.15 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 CA-C-O 121.023 0.44 . . . . 0.85999999999999999 111.824 176.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.691 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 7.2 m -105.78 124.69 49.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.658 -0.701 . . . . 1.1000000000000001 109.655 175.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.8 p -110.75 133.85 52.98 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.759 -0.655 . . . . 1.27 111.868 -172.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.92 ' HB3' ' HB3' ' A' ' 24' ' ' TRP . 23.0 pttt . . . . . 0 C--N 1.32 -0.696 0 CA-C-N 115.546 -0.752 . . . . 1.9099999999999999 109.26 171.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.571 HD21 ' N ' ' A' ' 46' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.422 0 CA-C-O 121.531 0.681 . . . . 2.0499999999999998 111.212 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.614 HD23 ' N ' ' A' ' 48' ' ' TYR . 3.5 tt -99.97 146.18 27.0 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.724 -1.125 . . . . 0.87 108.673 -176.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.645 ' HB2' HD11 ' A' ' 192' ' ' LEU . 56.9 m-85 -124.99 138.39 54.23 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 121.261 -0.176 . . . . 0.98999999999999999 110.623 -177.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.712 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 4.3 ttm180 -104.65 120.0 40.29 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.093 -0.706 . . . . 2.9199999999999999 109.093 167.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.664 ' HB ' ' HB3' ' A' ' 192' ' ' LEU . 9.0 p -102.93 134.73 43.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.004 -1.11 . . . . 1.3300000000000001 108.004 172.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.654 ' HG3' ' HB ' ' A' ' 168' ' ' VAL . 2.7 tt0 -148.02 110.65 4.72 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.058 -0.519 . . . . 1.0700000000000001 110.579 -165.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 32' ' ' LYS . . . -142.61 154.34 25.13 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 111.111 -0.796 . . . . 0.28999999999999998 111.111 179.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.612 HG12 ' SD ' ' A' ' 158' ' ' MET . 2.7 mp -96.33 126.98 48.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 C-N-CA 119.256 -0.977 . . . . 0.57999999999999996 110.393 176.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.424 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 66.2 mt -104.57 112.77 65.41 Favored Pre-proline 0 N--CA 1.44 -0.959 0 CA-C-N 114.937 -1.029 . . . . 0.34999999999999998 109.33 177.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 28.8 Cg_exo -64.56 59.87 0.27 Allowed 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 124.259 3.306 . . . . 0.62 113.111 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.965 ' HG3' HG13 ' A' ' 203' ' ' ILE . 0.2 OUTLIER -134.37 -164.31 1.49 Allowed 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.041 -1.466 . . . . 1.6799999999999999 107.041 174.075 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.56 ' H ' ' CD ' ' A' ' 56' ' ' GLU . 20.0 m -101.73 150.5 37.38 Favored Pre-proline 0 N--CA 1.421 -1.889 0 N-CA-C 108.816 -0.809 . . . . 1.1799999999999999 108.816 169.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.528 ' HB3' ' SG ' ' A' ' 155' ' ' CYS . 14.9 Cg_exo -66.63 -7.72 18.92 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.605 2.87 . . . . 0.52000000000000002 110.2 -178.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.68 -53.09 17.06 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.803 -1.09 . . . . 0.64000000000000001 111.411 175.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.713 ' HE3' ' HB3' ' A' ' 64' ' ' PHE . 16.2 tptt -69.21 -28.29 66.24 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.254 -1.017 . . . . 3.2999999999999998 108.254 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.666 HD23 HD11 ' A' ' 203' ' ' ILE . 63.9 mt -62.45 -51.67 66.59 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.825 -1.08 . . . . 0.40999999999999998 110.008 174.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.571 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 39.3 t -75.35 -4.96 42.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.735 0.302 . . . . 1.29 110.571 176.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.5 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 31.3 t70 -90.63 -43.06 10.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.313 -0.403 . . . . 1.3200000000000001 110.829 178.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.795 ' O ' ' HB3' ' A' ' 71' ' ' ARG . 8.1 p90 -76.49 -44.97 33.02 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.903 -0.319 . . . . 0.60999999999999999 111.146 -175.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.665 HD22 ' O ' ' A' ' 61' ' ' LEU . 1.2 pt? -77.64 6.2 7.73 Favored 'General case' 0 CA--C 1.509 -0.604 0 O-C-N 122.277 -0.264 . . . . 1.5 111.227 -164.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -46.77 -14.53 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.961 0 O-C-N 124.326 1.016 . . . . 1.52 113.074 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.626 ' HA ' ' HD2' ' A' ' 71' ' ' ARG . 8.8 mt-30 87.68 -38.18 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 124.73 1.212 . . . . 3.6000000000000001 110.509 168.305 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.61 ' OG1' ' HB2' ' A' ' 81' ' ' TYR . 15.0 t -138.2 23.8 2.77 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.793 0.806 . . . . 1.48 110.811 -177.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -108.06 -61.29 0.55 Allowed Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 119.616 -1.278 . . . . 1.46 112.912 -177.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.689 ' O ' HG22 ' A' ' 73' ' ' THR . 18.9 t70 -134.05 -25.19 1.61 Allowed 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.881 0.848 . . . . 2.1899999999999999 110.009 -169.095 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.795 ' HB3' ' O ' ' A' ' 64' ' ' PHE . 0.3 OUTLIER -69.0 -37.22 78.57 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 114.724 -1.125 . . . . 3.3799999999999999 109.658 -163.385 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.101 HG22 HD13 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -76.11 -21.5 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 115.277 -0.874 . . . . 0.70999999999999996 110.066 -176.223 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.689 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.2 t -81.02 -26.22 36.59 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 119.972 -0.691 . . . . 0.96999999999999997 109.986 -172.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.712 ' CE2' ' HA ' ' A' ' 71' ' ' ARG . 24.8 p-90 -110.4 0.02 17.72 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.12 -0.491 . . . . 0.75 111.373 177.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.617 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 2.3 t70 -66.83 176.13 2.16 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.82 0.819 . . . . 2.1899999999999999 112.527 -170.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.46 ' HD3' ' N ' ' A' ' 77' ' ' SER . 0.0 OUTLIER -129.19 -17.3 3.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.555 -1.202 . . . . 3.1899999999999999 111.507 -174.636 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.46 ' N ' ' HD3' ' A' ' 76' ' ' LYS . 67.9 m -130.32 24.6 5.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.658 0.742 . . . . 1.5800000000000001 109.372 178.25 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.101 HD13 HG22 ' A' ' 72' ' ' ILE . 18.9 mt -116.01 -167.21 1.23 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.301 -0.863 . . . . 0.70999999999999996 112.293 177.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.471 ' HB3' HG23 ' A' ' 80' ' ' VAL . 1.9 mm100 -161.63 -74.79 0.05 Allowed 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.637 -0.71 . . . . 1.73 112.205 -167.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.471 HG23 ' HB3' ' A' ' 79' ' ' GLN . 23.0 t -139.4 122.09 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.917 0.389 . . . . 0.78000000000000003 111.764 -167.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.641 ' HB3' HD12 ' A' ' 72' ' ' ILE . 23.1 p90 -96.53 154.08 17.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.056 -0.52 . . . . 5.4000000000000004 112.009 176.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -162.08 111.29 1.48 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.46 -0.791 . . . . 1.6899999999999999 109.541 168.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 30.9 ttm -72.26 109.87 6.3 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.15 -1.056 . . . . 2.0499999999999998 108.15 174.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.525 HG23 ' HB ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -87.59 -88.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.893 0.377 . . . . 0.64000000000000001 111.34 -170.73 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.546 ' HB3' HD12 ' A' ' 93' ' ' ILE . 54.3 t60 -113.34 124.81 53.33 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.174 0.511 . . . . 1.96 110.137 -177.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.0 mtt180 -104.68 133.96 48.64 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.942 -0.762 . . . . 2.4399999999999999 108.942 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.52 HD12 ' CD2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -94.32 -39.38 10.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.685 0.755 . . . . 0.46999999999999997 109.171 -175.789 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.439 ' HB2' ' HE2' ' A' ' 4' ' ' LYS . 4.0 t0 -150.9 -169.79 3.48 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.609 -1.178 . . . . 1.8600000000000001 108.136 176.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.6 t -79.95 -3.57 48.78 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.74 0.305 . . . . 1.4399999999999999 110.707 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -136.46 17.57 3.14 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.395 0.617 . . . . 1.8700000000000001 109.758 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.722 HG23 ' HD2' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -138.42 108.37 6.34 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 108.662 -0.866 . . . . 0.46000000000000002 108.662 179.513 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.598 ' O ' HD12 ' A' ' 114' ' ' LEU . 30.7 m-85 -126.58 177.23 6.64 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.418 0.628 . . . . 0.42999999999999999 110.959 -173.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.546 HD12 ' HB3' ' A' ' 85' ' ' HIS . 28.4 mt -136.07 132.98 50.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 107.029 -1.471 . . . . 0.40999999999999998 107.029 167.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.425 ' SG ' ' HB2' ' A' ' 113' ' ' ASP . 7.7 p -115.36 127.39 55.37 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.177 0.513 . . . . 2.0099999999999998 111.927 -175.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.597 ' HD2' HD11 ' A' ' 112' ' ' ILE . 41.7 t-80 -89.51 91.32 8.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.721 -0.672 . . . . 1.23 109.192 169.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 86.7 m -110.34 109.17 19.49 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.399 -0.819 . . . . 0.5 111.592 -174.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.471 ' CG1' ' HB ' ' A' ' 80' ' ' VAL . 27.4 mm -77.85 120.07 27.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.699 -0.852 . . . . 1.03 108.699 171.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.4 t -110.77 153.96 24.6 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.14 0.495 . . . . 1.3799999999999999 109.942 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 . . . . . 0 C--N 1.308 -1.234 0 CA-C-N 115.81 -0.632 . . . . 1.8200000000000001 109.385 175.755 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.9 mt . . . . . 0 N--CA 1.445 -0.717 0 N-CA-C 110.152 -0.314 . . . . 1.1200000000000001 110.152 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.418 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 13.7 m -86.05 163.46 42.95 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 109.108 -0.701 . . . . 1.3500000000000001 109.108 176.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 107' ' ' SER . 9.3 Cg_endo -53.2 131.65 44.13 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.241 1.961 . . . . 1.0700000000000001 111.254 174.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.627 ' HG2' HG23 ' A' ' 144' ' ' ILE . 45.9 mtt180 -106.44 157.06 17.91 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.101 -0.703 . . . . 3.4500000000000002 109.101 -178.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.827 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 13.6 t0 -106.57 116.16 31.46 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.91 -0.774 . . . . 1.3700000000000001 108.91 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.621 ' HE1' ' HA3' ' A' ' 146' ' ' GLY . 3.3 m-30 -99.57 128.39 45.68 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.012 0.435 . . . . 2.4100000000000001 110.492 -177.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.787 HG13 ' HA ' ' A' ' 137' ' ' TYR . 27.3 mm -123.61 75.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 108.769 -0.826 . . . . 0.42999999999999999 108.769 173.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.918 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 20.8 m-20 -89.83 118.03 29.11 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.163 -0.926 . . . . 1.8600000000000001 109.786 -177.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.598 HD12 ' O ' ' A' ' 92' ' ' PHE . 3.8 tp -75.03 114.66 13.76 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 107.875 -1.157 . . . . 0.28000000000000003 107.875 166.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -118.77 122.16 68.72 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 CA-C-N 114.474 -1.239 . . . . 0.26000000000000001 111.121 -164.529 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.722 ' HD2' HG23 ' A' ' 91' ' ' THR . 29.1 t80 -106.32 111.11 23.56 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.656 -1.156 . . . . 2.5699999999999998 109.252 176.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.991 HG12 HG22 ' A' ' 127' ' ' ILE . 82.5 mt -87.81 98.12 7.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.953 0.882 . . . . 0.89000000000000001 109.27 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.634 ' HE2' ' HE1' ' A' ' 116' ' ' TYR . 16.2 tppt? -99.62 112.56 24.77 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.103 -1.408 . . . . 1.2 108.93 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.528 ' NH1' ' HG2' ' A' ' 121' ' ' GLU . 0.1 OUTLIER -106.13 108.86 20.58 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 122.108 0.956 . . . . 2.7999999999999998 108.526 177.039 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.556 ' CB ' ' HB2' ' A' ' 123' ' ' ASN . 91.0 m-85 -76.61 108.36 9.56 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 105.933 -1.877 . . . . 0.82999999999999996 105.933 167.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.528 ' HG2' ' NH1' ' A' ' 119' ' ' ARG . 44.7 mt-10 -40.21 93.35 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.879 1.362 . . . . 2.2799999999999998 112.84 -174.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 71.0 35.27 64.72 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 114.634 -1.166 . . . . 0.76000000000000001 112.497 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.556 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 13.3 m120 -133.32 -54.35 0.9 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.853 -0.673 . . . . 1.6499999999999999 110.032 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.496 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 2.8 mpp? -160.07 121.8 3.21 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.154 -0.476 . . . . 1.1200000000000001 110.655 -175.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -107.93 81.8 1.55 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.412 -0.958 . . . . 1.6200000000000001 108.412 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.58 ' CG1' HG12 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -99.81 137.93 25.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.239 -0.891 . . . . 0.29999999999999999 112.967 -170.709 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.991 HG22 HG12 ' A' ' 117' ' ' ILE . 41.2 pt -99.25 104.35 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 121.833 0.825 . . . . 0.58999999999999997 109.281 166.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 0.7 OUTLIER -87.04 109.26 19.28 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.429 -0.805 . . . . 1.1799999999999999 109.82 179.214 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.918 ' HB3' ' HB3' ' A' ' 113' ' ' ASP . 14.1 m -118.26 137.78 52.81 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.016 0.436 . . . . 1.24 112.132 -166.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.494 ' HE3' ' HB ' ' A' ' 6' ' ' ILE . 3.4 mtpm? -132.47 124.6 28.87 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 107.732 -1.21 . . . . 2.2599999999999998 107.732 178.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 15.6 p -64.37 99.82 0.32 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.924 -1.51 . . . . 1.3899999999999999 106.924 173.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.43 135.69 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 CA-C-O 121.504 0.669 . . . . 1.05 109.369 -164.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -87.41 81.38 7.85 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.841 -1.072 . . . . 2.1699999999999999 109.583 -171.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.754 ' CZ ' ' HB3' ' A' ' 136' ' ' GLU . 0.8 OUTLIER -121.96 176.26 2.1 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-N 115.092 -0.958 . . . . 0.53000000000000003 108.469 -176.548 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.536 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 50.3 Cg_exo -24.43 -64.49 0.04 OUTLIER 'Trans proline' 0 CA--C 1.551 1.353 1 C-N-CA 125.474 4.116 . . . . 1.28 117.329 -179.386 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.754 ' HB3' ' CZ ' ' A' ' 134' ' ' PHE . 6.2 tp10 -72.8 -30.69 64.27 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.466 0.543 . . . . 3.5 112.466 -174.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.787 ' HA ' HG13 ' A' ' 112' ' ' ILE . 32.1 t80 -51.17 -41.87 77.48 Favored Pre-proline 0 CA--C 1.552 1.056 0 N-CA-C 115.651 1.722 . . . . 6.1200000000000001 115.651 -170.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.465 ' HD2' ' O ' ' A' ' 135' ' ' PRO . 73.4 Cg_exo -45.86 108.43 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 122.515 2.143 . . . . 1.77 113.746 177.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 1.001 ' HB3' ' HD3' ' A' ' 145' ' ' ARG . 95.0 Cg_endo -99.97 -158.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.024 3.149 . . . . 1.25 114.053 -177.264 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.8 t -135.85 -155.09 0.61 Allowed 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.476 -1.305 . . . . 1.6000000000000001 107.476 177.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.2 m -90.47 -41.19 11.57 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.405 -0.518 . . . . 1.97 111.451 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -64.45 -53.36 49.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.759 0.314 . . . . 2.1800000000000002 110.538 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -95.48 108.94 21.2 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 108.923 -0.769 . . . . 1.23 108.923 175.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.627 HG23 ' HG2' ' A' ' 109' ' ' ARG . 1.2 tt -104.52 119.08 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 CA-C-N 115.056 -0.975 . . . . 0.81999999999999995 110.721 -173.016 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 1.001 ' HD3' ' HB3' ' A' ' 139' ' ' PRO . 1.3 mpt_? -63.41 99.31 0.2 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.264 -1.334 . . . . 4.4199999999999999 109.732 173.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.621 ' HA3' ' HE1' ' A' ' 111' ' ' PHE . . . -61.36 111.83 4.21 Favored Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 110.096 -1.202 . . . . 0.79000000000000004 110.096 176.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.628 ' HB3' ' HB3' ' A' ' 174' ' ' GLU . 39.5 t80 -84.47 84.65 7.58 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.832 0.825 . . . . 4.4400000000000004 110.441 -172.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.656 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 87.6 m-20 -72.82 99.57 2.68 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.485 -1.234 . . . . 1.6200000000000001 109.838 174.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.508 ' HB2' ' HG2' ' A' ' 172' ' ' GLN . 51.0 m-70 -60.89 137.23 93.62 Favored Pre-proline 0 CA--C 1.51 -0.582 0 N-CA-C 107.992 -1.114 . . . . 2.3199999999999998 107.992 172.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.681 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 32.3 Cg_exo -21.97 67.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.168 1 C-N-CA 126.79 4.994 . . . . 0.53000000000000003 115.796 -170.176 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 151' ' ' CYS . . . . . 0.723 ' HB2' ' O ' ' A' ' 170' ' ' PHE . 22.3 p -96.0 -175.11 3.3 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.155 -0.93 . . . . 1.5800000000000001 109.574 176.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.811 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -177.07 171.37 44.24 Favored Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 119.597 -1.287 . . . . 0.42999999999999999 111.942 -177.048 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.618 ' HB3' ' CG1' ' A' ' 127' ' ' ILE . 2.6 t80 -140.26 84.39 1.96 Allowed 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.002 -1.481 . . . . 0.59999999999999998 107.002 -159.136 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.636 ' CG2' HG13 ' A' ' 168' ' ' VAL . 2.9 m -93.16 143.36 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 121.988 0.899 . . . . 0.31 111.113 -170.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' CYS . . . . . 0.528 ' SG ' ' HB3' ' A' ' 58' ' ' PRO . 3.6 t -119.81 126.49 51.13 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.558 -1.201 . . . . 1.55 108.976 175.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.662 ' H ' ' HB3' ' A' ' 166' ' ' LYS . 5.5 m -119.02 112.18 36.55 Favored Pre-proline 0 C--N 1.318 -0.781 0 C-N-CA 119.234 -0.986 . . . . 1.0600000000000001 111.43 -173.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 57.1 Cg_exo -51.27 105.52 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 121.77 1.647 . . . . 0.56000000000000005 109.864 167.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.631 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 21.4 mtp -72.18 -171.23 0.72 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.548 0.69 . . . . 1.1599999999999999 112.532 -170.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -62.59 -20.16 64.45 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.047 -0.979 . . . . 2.6299999999999999 109.715 174.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.483 ' HB3' ' HB3' ' A' ' 163' ' ' ALA . 11.5 mm-40 -105.95 10.44 32.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.368 -0.833 . . . . 2.0499999999999998 110.251 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.464 ' CB ' ' CD ' ' A' ' 162' ' ' PRO . 44.1 m-80 27.32 -93.48 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.928 0 N-CA-C 115.13 1.53 . . . . 1.9299999999999999 115.13 -177.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.464 ' CD ' ' CB ' ' A' ' 161' ' ' ASN . 95.3 Cg_endo -76.04 -10.79 19.63 Favored 'Trans proline' 0 C--N 1.367 1.541 0 CA-C-N 121.864 1.701 . . . . 0.72999999999999998 112.942 -173.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' A' ' 160' ' ' GLU . . . -89.76 -34.85 16.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.983 -0.553 . . . . 0.68000000000000005 110.34 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.631 ' O ' ' HB2' ' A' ' 158' ' ' MET . 88.8 m-85 -140.35 118.94 12.3 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.375 -0.602 . . . . 0.93000000000000005 109.375 178.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.403 ' HB3' HD12 ' A' ' 61' ' ' LEU . 69.4 m -116.93 136.86 52.62 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.311 0.576 . . . . 1.4099999999999999 110.642 -178.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.736 ' HG3' HG12 ' A' ' 168' ' ' VAL . 41.1 tptt -80.34 128.53 33.66 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.645 -0.707 . . . . 0.73999999999999999 111.784 -174.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.702 HD12 HG12 ' A' ' 196' ' ' ILE . 0.3 OUTLIER -112.45 100.77 9.02 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.303 -0.862 . . . . 0.27000000000000002 110.575 165.885 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.736 HG12 ' HG3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -125.87 117.52 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 121.712 0.768 . . . . 0.28000000000000003 110.981 175.445 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.424 ' SD ' ' O ' ' A' ' 152' ' ' GLY . 5.5 tpt -128.67 135.75 49.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.391 -0.822 . . . . 1.24 110.176 -173.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.723 ' O ' ' HB2' ' A' ' 151' ' ' CYS . 41.1 m-85 -111.29 128.07 55.83 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.685 -0.688 . . . . 3.3700000000000001 109.311 -177.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 1.019 ' HB ' HD21 ' A' ' 192' ' ' LEU . 0.8 OUTLIER -110.41 121.04 62.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.361 0.601 . . . . 1.3999999999999999 110.535 -176.016 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.508 ' HG2' ' HB2' ' A' ' 149' ' ' HIS . 49.9 tt0 -129.8 49.54 2.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 122.482 1.134 . . . . 2.1699999999999999 108.417 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 22.0 m -77.31 140.24 39.97 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 113.772 -1.558 . . . . 1.6499999999999999 111.448 -173.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 15.0 tt0 . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 115.598 -0.728 . . . . 2.4500000000000002 111.699 -176.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 11.4 mm . . . . . 0 CA--C 1.509 -0.632 0 CA-C-O 122.386 1.088 . . . . 1.1200000000000001 109.144 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.935 ' HA ' HG22 ' A' ' 187' ' ' THR . 0.7 OUTLIER -66.68 -38.35 81.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 113.001 -1.909 . . . . 1.1299999999999999 111.106 -176.881 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -62.4 -21.47 65.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.872 -0.604 . . . . 2.8900000000000001 109.382 176.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -92.46 -41.56 10.23 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.317 -0.856 . . . . 1.28 110.419 175.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.935 HG22 ' HA ' ' A' ' 184' ' ' ILE . 13.6 t -63.08 -35.28 79.73 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.071 0.767 . . . . 0.62 113.071 -168.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' MET . . . . . 0.785 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 30.9 mmt -77.72 -60.71 0.68 Allowed Pre-proline 0 C--N 1.33 -0.24 0 C-N-CA 120.266 -0.574 . . . . 1.0600000000000001 111.52 -177.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.785 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 36.9 Cg_exo -58.17 -37.87 93.65 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.925 1.75 . . . . 0.91000000000000003 112.399 -177.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 41.7 m -70.88 -32.45 69.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.789 0.328 . . . . 1.5 110.764 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -75.16 -43.02 54.74 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.911 -0.586 . . . . 1.8799999999999999 110.053 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 1.019 HD21 ' HB ' ' A' ' 171' ' ' VAL . 95.2 mt -52.97 -55.17 25.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.453 -0.794 . . . . 1.0900000000000001 112.264 176.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 189' ' ' PRO . 1.3 m -66.4 -31.57 54.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.668 0.747 . . . . 0.68000000000000005 109.648 -177.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 190' ' ' SER . 0.6 OUTLIER -69.68 -38.06 76.88 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.49 -1.232 . . . . 2.0699999999999998 111.202 179.028 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.532 ' HB3' ' HE2' ' A' ' 153' ' ' PHE . 3.1 m-30 -62.41 -32.89 73.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.021 0.439 . . . . 2.0 110.26 173.041 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.702 HG12 HD12 ' A' ' 167' ' ' LEU . 38.8 mt -79.44 -29.57 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-O 120.95 0.405 . . . . 0.31 111.065 177.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 51.9 mt -72.03 -37.52 69.71 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.037 0.446 . . . . 1.03 109.956 176.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.513 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 13.4 m120 -47.4 -50.55 22.29 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.841 -1.072 . . . . 1.8999999999999999 108.676 163.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.813 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -66.29 -46.3 77.48 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 115.057 -0.974 . . . . 0.28999999999999998 110.581 -174.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.702 ' O ' ' HG2' ' A' ' 204' ' ' LYS . 27.9 mmtp -53.69 -50.34 66.07 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 123.814 0.696 . . . . 0.96999999999999997 109.615 174.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -76.44 -38.98 54.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.372 -0.831 . . . . 1.9399999999999999 111.73 -169.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -68.78 -35.02 78.99 Favored Glycine 0 N--CA 1.463 0.447 0 C-N-CA 119.865 -1.16 . . . . 0.46999999999999997 110.486 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.965 HG13 ' HG3' ' A' ' 56' ' ' GLU . 1.1 mp -65.07 -35.75 76.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 114.186 -1.007 . . . . 0.60999999999999999 110.973 173.237 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.702 ' HG2' ' O ' ' A' ' 200' ' ' LYS . 52.7 mmtt -75.2 -39.34 60.23 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 108.81 -0.811 . . . . 3.3700000000000001 108.81 177.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.933 0 CA-C-N 115.18 -0.918 . . . . 1.02 109.099 173.16 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.657 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.2 m-20 . . . . . 0 CA--C 1.507 -0.69 0 N-CA-C 109.087 -0.709 . . . . 2.25 109.087 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.842 ' HA ' HD11 ' A' ' 6' ' ' ILE . 89.8 m-85 -67.68 -34.02 76.08 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.203 -0.908 . . . . 0.42999999999999999 109.096 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.572 ' HG2' ' OE1' ' A' ' 8' ' ' GLN . 21.9 tttp -78.92 -1.16 33.92 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 114.363 -1.289 . . . . 1.51 109.751 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -92.66 -43.85 8.88 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.295 0.569 . . . . 0.54000000000000004 110.209 172.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.842 HD11 ' HA ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -83.0 -37.24 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-N 115.519 -0.764 . . . . 1.0700000000000001 110.269 -172.614 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.417 ' HB2' HD21 ' A' ' 114' ' ' LEU . . . -80.69 -40.85 24.72 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.483 -1.235 . . . . 0.34000000000000002 111.535 -176.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.572 ' OE1' ' HG2' ' A' ' 4' ' ' LYS . 8.2 mt-30 -65.7 -29.6 70.17 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.2 -0.909 . . . . 1.5900000000000001 110.153 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.659 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 14.8 mm100 -82.74 -33.59 27.42 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.211 -0.904 . . . . 2.4700000000000002 109.208 175.016 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.658 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -70.92 -35.16 72.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.257 -0.883 . . . . 0.47999999999999998 111.423 -179.469 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 15' ' ' LEU . . . -43.87 -61.54 1.4 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.928 0.394 . . . . 0.31 112.038 172.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -74.73 -11.08 60.08 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.477 -0.329 . . . . 1.6399999999999999 111.728 -177.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.659 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 53.9 mt-10 -71.55 -56.01 6.72 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.069 -0.715 . . . . 2.54 109.069 172.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.752 HG21 ' N ' ' A' ' 152' ' ' GLY . 10.6 p -68.27 -38.21 79.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 122.838 1.304 . . . . 0.53000000000000003 109.721 -175.189 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.443 ' HB3' ' O ' ' A' ' 11' ' ' ALA . 0.5 OUTLIER -76.11 -18.88 58.97 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 113.791 -1.55 . . . . 0.59999999999999998 109.248 178.945 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.412 ' HA2' ' HD3' ' A' ' 19' ' ' ARG . . . -61.95 -27.93 69.5 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 114.144 -1.389 . . . . 0.56999999999999995 110.04 172.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.45 ' HD1' ' O ' ' A' ' 13' ' ' GLU . 24.4 m-85 -86.03 -15.91 39.86 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.16 -0.52 . . . . 3.27 110.055 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.412 ' OD1' HG11 ' A' ' 168' ' ' VAL . 42.7 t30 -85.99 -3.51 58.95 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 119.526 -0.87 . . . . 2.0299999999999998 110.051 172.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.412 ' HD3' ' HA2' ' A' ' 16' ' ' GLY . 35.2 mtp180 -105.62 -21.51 13.18 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.113 -0.367 . . . . 2.7200000000000002 111.486 -178.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -146.26 154.1 41.34 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.242 -0.435 . . . . 2.1600000000000001 111.018 174.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.488 ' HB ' ' CZ2' ' A' ' 24' ' ' TRP . 70.4 p -135.52 129.91 33.79 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.722 -0.672 . . . . 1.8200000000000001 111.229 -172.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.5 p -174.85 157.0 2.36 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.192 0.307 . . . . 2.1899999999999999 111.76 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.69 3.64 90.56 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.903 -0.59 . . . . 1.1000000000000001 113.774 170.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.488 ' CZ2' ' HB ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -120.58 -158.39 0.75 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 117.191 0.496 . . . . 1.6699999999999999 111.456 -176.511 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.37 119.88 0.32 Allowed 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 108.735 -0.839 . . . . 2.9500000000000002 108.735 -174.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.604 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 0.3 OUTLIER -55.16 121.71 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-O 122.06 0.933 . . . . 1.5600000000000001 111.389 174.64 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.13 -25.35 3.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 113.971 -1.468 . . . . 1.22 109.99 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 28' ' ' LYS . 9.4 tptm -142.98 121.93 12.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 119.75 -0.78 . . . . 2.4100000000000001 112.503 -173.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.535 HG22 ' HA ' ' A' ' 34' ' ' THR . 41.6 p -135.59 121.75 20.22 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.367 -0.605 . . . . 1.3799999999999999 109.367 172.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.2 t -85.14 -79.01 0.24 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 121.064 -0.254 . . . . 2.3700000000000001 110.415 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -164.08 19.37 0.06 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.479 0.657 . . . . 4.5499999999999998 109.832 176.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -173.54 3.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.662 -0.699 . . . . 1.4199999999999999 110.369 -175.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.476 ' CD1' ' HB ' ' A' ' 193' ' ' VAL . 28.9 pt -140.85 167.46 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-O 120.79 0.329 . . . . 0.76000000000000001 110.875 -171.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.535 ' HA ' HG22 ' A' ' 29' ' ' THR . 26.2 m -152.95 104.72 2.86 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.208 -0.451 . . . . 0.57999999999999996 111.19 -171.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.627 HG11 HD13 ' A' ' 192' ' ' LEU . 11.4 t -101.57 121.02 51.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.85999999999999999 110.086 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.604 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 5.6 m -113.02 128.55 56.53 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.187 -0.46 . . . . 1.1000000000000001 110.223 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.0 p -97.94 130.24 44.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.667 -0.697 . . . . 1.27 110.345 -176.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.407 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 57.9 tttm . . . . . 0 C--N 1.316 -0.87 0 CA-C-N 115.671 -0.695 . . . . 1.9099999999999999 111.243 -173.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.615 ' N ' HD21 ' A' ' 46' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.579 0 CA-C-O 121.362 0.601 . . . . 2.0499999999999998 111.355 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.656 HD12 ' HB2' ' A' ' 172' ' ' GLN . 10.0 tt -93.5 152.38 19.1 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.023 -0.989 . . . . 0.87 109.56 -176.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.551 ' N ' HD23 ' A' ' 47' ' ' LEU . 71.7 m-85 -127.78 134.17 49.48 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.65 0.262 . . . . 0.98999999999999999 110.745 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.532 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.8 OUTLIER -118.6 126.48 52.05 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 108.999 -0.741 . . . . 2.9199999999999999 108.999 175.915 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.589 HG23 HG22 ' A' ' 35' ' ' VAL . 14.8 p -114.75 150.03 16.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.725 -0.472 . . . . 1.3300000000000001 109.725 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.469 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 37.9 tt0 -155.38 109.84 2.92 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.987 -0.552 . . . . 1.0700000000000001 110.351 -170.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.474 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -138.83 160.43 25.7 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.615 -0.802 . . . . 0.28999999999999998 111.791 178.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.6 mt -100.89 114.92 41.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 C-N-CA 120.57 -0.452 . . . . 0.57999999999999996 110.786 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 40.1 mt -94.42 112.83 59.15 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.666 -0.697 . . . . 0.34999999999999998 109.431 175.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.34 70.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 124.566 3.511 . . . . 0.62 112.893 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.488 ' HG3' ' CG1' ' A' ' 203' ' ' ILE . 0.1 OUTLIER -155.06 -167.77 2.67 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.89 -1.05 . . . . 1.6799999999999999 108.555 177.089 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.3 t -101.41 146.77 32.77 Favored Pre-proline 0 N--CA 1.421 -1.884 0 N-CA-C 108.485 -0.932 . . . . 1.1799999999999999 108.485 174.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.577 ' HB3' ' SG ' ' A' ' 155' ' ' CYS . 24.6 Cg_exo -61.62 -12.7 26.0 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.486 2.791 . . . . 0.52000000000000002 110.442 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.08 -44.65 53.28 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.74 -1.118 . . . . 0.64000000000000001 111.325 176.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.512 ' HB3' HD11 ' A' ' 203' ' ' ILE . 6.5 tppt? -71.49 -31.94 67.68 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 108.293 -1.003 . . . . 3.2999999999999998 108.293 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.974 HD23 HD13 ' A' ' 203' ' ' ILE . 63.6 mt -62.15 -51.91 65.96 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.388 -1.278 . . . . 0.40999999999999998 110.429 175.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.8 m -64.7 -15.24 61.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.048 0.451 . . . . 1.29 110.613 173.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -84.73 -52.3 6.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.036 -0.529 . . . . 1.3200000000000001 111.795 -177.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.701 ' CE2' ' HA ' ' A' ' 199' ' ' ALA . 10.2 p90 -70.03 -40.63 75.05 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.727 0.269 . . . . 0.60999999999999999 111.727 -172.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.454 HD22 ' O ' ' A' ' 61' ' ' LEU . 0.6 OUTLIER -79.75 -21.35 44.58 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 120.357 -0.537 . . . . 1.5 112.054 -170.059 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.535 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 1.8 t80 -5.77 -71.77 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 O-C-N 125.214 1.571 . . . . 1.52 113.18 -156.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.535 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 4.8 tp60 175.93 -37.7 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.565 0.541 . . . . 3.6000000000000001 111.815 167.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.416 ' OG1' ' HB2' ' A' ' 81' ' ' TYR . 12.7 t -146.57 12.02 1.14 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.364 0.505 . . . . 1.48 112.364 -168.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -118.99 -5.26 11.92 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 119.122 -1.513 . . . . 1.46 113.887 -171.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.662 ' O ' HG22 ' A' ' 73' ' ' THR . 0.5 OUTLIER -170.96 -31.74 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.631 0 CA-C-O 121.415 0.626 . . . . 2.1899999999999999 109.844 -177.944 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.503 ' HG2' HD11 ' A' ' 78' ' ' LEU . 8.0 ttt180 -40.9 -50.09 3.23 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 125.461 1.504 . . . . 3.3799999999999999 111.086 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.791 HD13 ' H ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -91.15 -7.52 10.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.813 -1.085 . . . . 0.70999999999999996 111.241 -176.189 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.662 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER -84.79 -34.6 22.73 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 120.545 -0.462 . . . . 0.96999999999999997 110.298 -173.758 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.684 ' CZ3' ' HB2' ' A' ' 198' ' ' ASN . 20.8 p-90 -91.78 -42.38 10.14 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 120.056 -0.658 . . . . 0.75 109.314 174.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.7 t70 56.83 141.96 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.203 1.927 . . . . 2.1899999999999999 116.203 159.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.543 ' CG ' ' HB3' ' A' ' 198' ' ' ASN . 0.0 OUTLIER -139.29 -29.09 0.76 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.567 -0.742 . . . . 3.1899999999999999 111.989 163.733 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.539 ' N ' ' HD3' ' A' ' 76' ' ' LYS . 63.0 m -136.51 22.18 3.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.081 0.943 . . . . 1.5800000000000001 108.524 176.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.593 HD13 HG22 ' A' ' 72' ' ' ILE . 43.8 mt -110.01 -173.79 2.34 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.241 -1.345 . . . . 0.70999999999999996 110.163 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.61 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 14.6 mm-40 -160.36 -66.18 0.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.925 0.343 . . . . 1.73 111.925 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.498 HG23 ' HB3' ' A' ' 79' ' ' GLN . 40.4 t -143.71 133.53 20.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.984 0.421 . . . . 0.78000000000000003 111.136 -167.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.446 ' HB3' HD12 ' A' ' 72' ' ' ILE . 20.3 p90 -100.49 145.17 28.61 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.643 -0.708 . . . . 5.4000000000000004 110.754 175.081 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.589 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 18.4 m120 -150.8 102.56 3.01 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.798 -0.816 . . . . 1.6899999999999999 108.798 170.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.52 107.36 2.45 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.638 -0.505 . . . . 2.0499999999999998 109.638 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.477 ' CG1' ' HG2' ' A' ' 136' ' ' GLU . 0.0 OUTLIER -84.36 -56.73 5.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.608 -0.723 . . . . 0.64000000000000001 110.948 -170.433 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -147.51 113.05 5.65 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.001 -0.545 . . . . 1.96 110.244 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -95.91 120.78 36.79 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.562 -0.903 . . . . 2.4399999999999999 108.562 176.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.617 HG12 ' O ' ' A' ' 91' ' ' THR . 1.2 mm -72.9 -53.35 18.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.976 -1.011 . . . . 0.46999999999999997 110.277 -168.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -140.23 -97.2 0.15 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.633 -0.712 . . . . 1.8600000000000001 111.492 176.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.6 t -137.98 -12.44 1.46 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.846 -0.161 . . . . 1.4399999999999999 111.041 -177.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -131.3 8.57 4.68 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.169 0.509 . . . . 1.8700000000000001 109.713 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.617 ' O ' HG12 ' A' ' 87' ' ' ILE . 9.0 m -139.6 118.15 12.22 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 107.591 -1.263 . . . . 0.46000000000000002 107.591 -172.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.619 ' O ' HD12 ' A' ' 114' ' ' LEU . 35.8 m-85 -132.92 174.99 9.75 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.243 0.544 . . . . 0.42999999999999999 110.854 -171.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.524 HD11 ' CE1' ' A' ' 3' ' ' PHE . 25.5 mt -133.97 123.5 44.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 107.255 -1.387 . . . . 0.40999999999999998 107.255 165.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.0 t -112.6 122.09 46.68 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.372 0.606 . . . . 2.0099999999999998 111.532 -176.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.589 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 31.2 t-80 -78.84 88.74 4.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.864 0.84 . . . . 1.23 108.84 168.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 19.1 m -97.37 114.17 25.93 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.514 -1.221 . . . . 0.5 111.183 -176.156 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.493 ' CG1' ' HB ' ' A' ' 80' ' ' VAL . 36.8 mm -76.98 124.72 35.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.909 -0.774 . . . . 1.03 108.909 173.167 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.1 m -111.19 133.22 53.71 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.011 -0.995 . . . . 1.3799999999999999 111.562 -170.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.61 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 30.6 mt-30 . . . . . 0 C--N 1.317 -0.823 0 N-CA-C 109.687 -0.486 . . . . 1.8200000000000001 109.687 172.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 16.3 mt . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 109.879 -0.415 . . . . 1.1200000000000001 109.879 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.437 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 15.5 m -99.43 169.21 8.43 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 109.867 -0.419 . . . . 1.3500000000000001 109.867 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 107' ' ' SER . 80.1 Cg_exo -46.54 128.18 12.42 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.201 1.934 . . . . 1.0700000000000001 111.108 172.13 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.636 ' HG3' HG23 ' A' ' 144' ' ' ILE . 33.3 ttp180 -116.81 162.43 17.72 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 120.993 0.425 . . . . 3.4500000000000002 110.068 -170.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.503 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 6.4 t70 -112.14 162.14 15.77 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.285 -1.006 . . . . 1.3700000000000001 108.285 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.457 ' CZ ' ' HB3' ' A' ' 113' ' ' ASP . 3.0 t80 -149.7 136.15 19.15 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.059 0.457 . . . . 2.4100000000000001 111.266 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.651 HG21 ' CE1' ' A' ' 134' ' ' PHE . 46.3 mm -122.75 89.86 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 N-CA-C 108.423 -0.955 . . . . 0.42999999999999999 108.423 172.403 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.457 ' HB3' ' CZ ' ' A' ' 111' ' ' PHE . 2.0 p30 -95.3 113.45 25.12 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.384 -0.825 . . . . 1.8600000000000001 110.685 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.619 HD12 ' O ' ' A' ' 92' ' ' PHE . 8.4 tp -76.43 121.16 22.66 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 119.19 -1.004 . . . . 0.28000000000000003 108.45 162.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -127.64 126.6 67.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-N 115.007 -0.997 . . . . 0.26000000000000001 111.949 -165.872 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.428 ' CD2' ' HA ' ' A' ' 8' ' ' GLN . 10.2 t80 -109.42 113.1 25.62 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.201 -0.909 . . . . 2.5699999999999998 110.42 174.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.592 HG12 HG22 ' A' ' 127' ' ' ILE . 80.4 mt -96.72 113.76 31.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.719 -0.673 . . . . 0.89000000000000001 109.734 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.552 ' HE3' ' CE1' ' A' ' 120' ' ' TYR . 37.8 ttpt -137.74 141.14 40.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.004 0.43 . . . . 1.2 110.398 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.548 ' HD3' ' O ' ' A' ' 119' ' ' ARG . 0.1 OUTLIER -113.57 113.7 25.45 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 121.956 0.884 . . . . 2.7999999999999998 109.012 177.31 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.552 ' CE1' ' HE3' ' A' ' 118' ' ' LYS . 3.5 m-85 -69.02 110.56 4.52 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.046 -1.465 . . . . 0.82999999999999996 107.046 168.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -35.85 94.53 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 O-C-N 124.769 1.293 . . . . 2.2799999999999998 113.141 -175.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 59.79 50.69 64.94 Favored Glycine 0 CA--C 1.504 -0.647 0 CA-C-N 114.63 -1.168 . . . . 0.76000000000000001 111.842 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.532 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 60.8 t30 -149.36 -53.12 0.16 Allowed 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.99 -0.605 . . . . 1.6499999999999999 110.061 -176.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 1.8 mpp? -158.73 119.67 3.34 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.864 0.364 . . . . 1.1200000000000001 111.701 -177.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -101.71 84.5 2.57 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.209 -1.034 . . . . 1.6200000000000001 108.209 176.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.536 ' CG1' HG12 ' A' ' 154' ' ' VAL . 0.5 OUTLIER -101.61 140.59 19.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 112.903 0.705 . . . . 0.29999999999999999 112.903 -170.426 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.658 ' O ' HG13 ' A' ' 127' ' ' ILE . 8.0 pt -108.96 112.16 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 108.675 -0.861 . . . . 0.58999999999999997 108.675 163.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.576 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 4.3 m -80.1 155.56 27.45 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.972 -0.751 . . . . 1.1799999999999999 108.972 175.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 80.8 p -149.82 131.63 15.08 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.61 0.719 . . . . 1.24 111.821 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.8 mtpp -132.63 122.77 25.2 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.628 -1.249 . . . . 2.2599999999999998 107.628 175.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.639 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 17.7 t -70.8 104.88 3.02 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 106.81 -1.552 . . . . 1.3899999999999999 106.81 175.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.0 m -102.9 152.59 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 C-N-CA 119.417 -0.913 . . . . 1.05 110.01 -174.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.662 ' HA ' ' CG ' ' A' ' 137' ' ' TYR . 8.4 p-10 -108.47 55.65 0.64 Allowed 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 123.204 1.478 . . . . 2.1699999999999999 109.872 -168.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.651 ' CE1' HG21 ' A' ' 112' ' ' ILE . 0.7 OUTLIER -91.57 178.33 1.81 Allowed Pre-proline 0 CA--C 1.553 1.086 0 CA-C-N 112.719 -2.037 . . . . 0.53000000000000003 109.083 -175.322 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.548 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 9.0 Cg_exo -32.19 -56.28 0.29 Allowed 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 124.654 3.57 . . . . 1.28 117.366 -176.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.608 ' HB3' ' CZ ' ' A' ' 134' ' ' PHE . 10.2 tp10 -74.18 -29.66 61.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.479 0.581 . . . . 3.5 112.389 -174.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.662 ' CG ' ' HA ' ' A' ' 133' ' ' ASP . 13.0 t80 -46.18 -42.24 26.76 Favored Pre-proline 0 CA--C 1.552 1.037 0 N-CA-C 116.1 1.889 . . . . 6.1200000000000001 116.1 -173.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.467 ' HD2' ' O ' ' A' ' 135' ' ' PRO . 73.4 Cg_exo -42.58 107.07 0.08 OUTLIER 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.251 1.967 . . . . 1.77 113.165 176.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -96.68 -159.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.544 2.83 . . . . 1.25 113.487 -174.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.7 m -143.94 -161.8 1.34 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.419 -0.956 . . . . 1.6000000000000001 108.419 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.2 m -82.86 -47.23 12.08 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.118 -0.633 . . . . 1.97 110.904 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -65.38 -23.31 66.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.311 -0.404 . . . . 2.1800000000000002 111.263 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.503 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 95.0 m-85 -132.16 108.12 9.07 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.361 -0.607 . . . . 1.23 109.361 177.172 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.636 HG23 ' HG3' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -104.07 116.69 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 109.019 -0.734 . . . . 0.81999999999999995 109.019 178.192 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.531 ' HD2' HG12 ' A' ' 112' ' ' ILE . 0.8 OUTLIER -59.58 98.72 0.05 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.382 -0.826 . . . . 4.4199999999999999 109.686 172.377 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -59.61 114.3 6.13 Favored Glycine 0 CA--C 1.504 -0.609 0 N-CA-C 111.107 -0.797 . . . . 0.79000000000000004 111.107 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -84.89 88.48 7.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.875 0.845 . . . . 4.4400000000000004 111.17 -169.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.549 ' H ' ' HB2' ' A' ' 131' ' ' SER . 66.7 t30 -84.31 123.97 30.74 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.645 -1.161 . . . . 1.6200000000000001 110.801 178.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.429 ' O ' ' N ' ' A' ' 151' ' ' CYS . 46.0 m80 -74.68 161.63 77.02 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 119.022 -0.513 . . . . 2.3199999999999998 109.882 176.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 149' ' ' HIS . 5.4 Cg_endo -48.06 76.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 124.514 3.476 . . . . 0.53000000000000003 114.651 -178.069 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' CYS . . . . . 0.707 ' SG ' ' HA ' ' A' ' 171' ' ' VAL . 14.3 p -129.53 -174.09 3.2 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.251 -1.018 . . . . 1.5800000000000001 108.251 171.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.752 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -167.79 -147.33 5.27 Favored Glycine 0 N--CA 1.436 -1.319 0 C-N-CA 118.542 -1.789 . . . . 0.42999999999999999 113.426 -173.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.579 ' CZ ' HD11 ' A' ' 167' ' ' LEU . 39.2 t80 -160.94 94.42 1.02 Allowed 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.76 -1.2 . . . . 0.59999999999999998 107.76 -162.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.686 ' CG2' HG13 ' A' ' 168' ' ' VAL . 3.4 m -105.76 148.98 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 CA-C-O 121.969 0.89 . . . . 0.31 111.307 -173.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' CYS . . . . . 0.577 ' SG ' ' HB3' ' A' ' 58' ' ' PRO . 12.1 t -117.44 137.72 52.32 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.911 -1.04 . . . . 1.55 108.597 173.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.495 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 12.6 m -129.61 116.57 18.37 Favored Pre-proline 0 C--N 1.31 -1.122 0 C-N-CA 120.394 -0.522 . . . . 1.0600000000000001 111.038 -177.154 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.532 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 55.8 Cg_exo -49.85 122.43 9.0 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.496 2.131 . . . . 0.56000000000000005 111.378 173.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.673 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 0.7 OUTLIER -80.43 -167.13 1.23 Allowed 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.055 0.455 . . . . 1.1599999999999999 112.079 -175.9 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -67.8 -26.53 66.13 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.565 -0.743 . . . . 2.6299999999999999 109.366 176.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 163' ' ' ALA . 34.4 mm-40 -97.62 13.76 29.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.246 -0.888 . . . . 2.0499999999999998 109.86 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.449 ' CB ' ' CD ' ' A' ' 162' ' ' PRO . 21.9 m-80 25.78 -89.13 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 125.708 1.603 . . . . 1.9299999999999999 115.21 -177.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' A' ' 161' ' ' ASN . 84.1 Cg_endo -74.32 -10.49 22.41 Favored 'Trans proline' 0 C--N 1.366 1.448 0 CA-C-N 121.596 1.606 . . . . 0.72999999999999998 113.473 -174.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 160' ' ' GLU . . . -96.12 -34.51 11.67 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.536 -0.302 . . . . 0.68000000000000005 111.573 -177.227 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.673 ' O ' ' HB2' ' A' ' 158' ' ' MET . 81.9 m-85 -136.64 135.34 38.2 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.981 -0.377 . . . . 0.93000000000000005 109.981 178.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.401 ' HB2' HD11 ' A' ' 61' ' ' LEU . 57.4 m -126.09 143.77 50.99 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.35 0.595 . . . . 1.4099999999999999 111.618 -177.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 156' ' ' SER . 1.9 tppp? -91.64 107.96 19.57 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.38 -0.827 . . . . 0.73999999999999999 110.751 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.579 HD11 ' CZ ' ' A' ' 153' ' ' PHE . 0.5 OUTLIER -93.08 107.67 19.41 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.209 -0.905 . . . . 0.27000000000000002 109.309 175.224 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.686 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -131.77 129.4 61.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.865 0.841 . . . . 0.28000000000000003 111.753 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.569 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 11.3 ttt -140.91 151.34 44.17 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.009 -0.996 . . . . 1.24 108.98 -172.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.718 ' CE2' HG23 ' A' ' 14' ' ' VAL . 1.0 OUTLIER -144.83 152.39 40.22 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.88 -0.785 . . . . 3.3700000000000001 108.88 171.199 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.707 ' HA ' ' SG ' ' A' ' 151' ' ' CYS . 12.6 p -138.12 127.7 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 O-C-N 123.907 0.755 . . . . 1.3999999999999999 111.728 -172.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.656 ' HB2' HD12 ' A' ' 47' ' ' LEU . 24.2 tt0 -116.65 48.83 1.22 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.044 0.926 . . . . 2.1699999999999999 108.518 174.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 1.7 t -74.65 152.67 39.17 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.029 -0.987 . . . . 1.6499999999999999 111.024 -173.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 . . . . . 0 N--CA 1.441 -0.898 0 CA-C-N 115.191 -0.913 . . . . 2.4500000000000002 109.838 173.774 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.58 ' HA ' ' HE2' ' A' ' 186' ' ' LYS . 40.5 mm . . . . . 0 CA--C 1.51 -0.591 0 CA-C-O 122.508 1.147 . . . . 1.1200000000000001 109.301 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.99 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.5 mp -60.62 -35.57 64.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 112.678 -2.055 . . . . 1.1299999999999999 111.14 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -70.14 -17.23 63.19 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.583 -0.735 . . . . 2.8900000000000001 109.158 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.58 ' HE2' ' HA ' ' A' ' 183' ' ' ILE . 43.6 mtmt -92.11 -39.73 11.44 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.533 -0.758 . . . . 1.28 109.707 172.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.99 HG22 ' HA ' ' A' ' 184' ' ' ILE . 6.4 t -73.68 -36.63 65.33 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 119.645 -0.822 . . . . 0.62 112.538 -170.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' MET . . . . . 0.579 ' O ' HD12 ' A' ' 192' ' ' LEU . 37.6 mmm -70.32 -56.76 6.44 Favored Pre-proline 0 C--O 1.226 -0.176 0 C-N-CA 120.272 -0.571 . . . . 1.0600000000000001 112.39 -175.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 188' ' ' MET . 18.9 Cg_endo -57.73 -18.76 35.17 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 122.232 1.955 . . . . 0.91000000000000003 112.392 -176.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.404 ' O ' HG22 ' A' ' 193' ' ' VAL . 33.9 t -86.24 -38.48 17.54 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.13 -0.693 . . . . 1.5 109.13 174.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -68.12 -42.71 79.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.324 -0.853 . . . . 1.8799999999999999 111.638 -172.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.627 HD13 HG11 ' A' ' 35' ' ' VAL . 1.1 mt -62.02 -48.99 77.81 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.572 0.701 . . . . 1.0900000000000001 110.959 -177.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.478 ' O ' ' HG ' ' A' ' 197' ' ' LEU . 1.3 m -67.67 -32.65 57.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.057 -0.974 . . . . 0.68000000000000005 109.672 -177.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -76.68 -29.11 56.19 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.529 -1.214 . . . . 2.0699999999999998 110.942 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.729 ' HA ' ' OD1' ' A' ' 198' ' ' ASN . 0.5 OUTLIER -66.38 -33.0 74.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.866 0.841 . . . . 2.0 109.475 171.071 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.676 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 22.6 mt -75.54 -27.86 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-N 115.707 -0.679 . . . . 0.31 110.799 173.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 53.1 mt -71.26 -42.42 68.81 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-N 116.651 -0.25 . . . . 1.03 111.365 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.729 ' OD1' ' HA ' ' A' ' 195' ' ' PHE . 1.4 p-10 -59.6 -23.75 63.23 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.155 -1.018 . . . . 1.8999999999999999 108.952 171.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.701 ' HA ' ' CE2' ' A' ' 64' ' ' PHE . . . -81.32 -46.14 15.15 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 119.975 -0.69 . . . . 0.28999999999999998 111.132 176.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.676 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 13.8 mmmm -55.22 -43.59 74.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.96999999999999997 110.251 177.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -92.1 -33.82 14.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.738 -0.664 . . . . 1.9399999999999999 112.013 -174.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -66.61 -29.1 74.21 Favored Glycine 0 N--CA 1.463 0.435 0 C-N-CA 120.784 -0.722 . . . . 0.46999999999999997 111.377 176.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.974 HD13 HD23 ' A' ' 61' ' ' LEU . 3.2 tp -71.34 -28.67 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 109.44 -0.578 . . . . 0.60999999999999999 109.44 176.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.612 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 79.1 mttt -79.07 -40.8 30.31 Favored 'General case' 0 C--O 1.209 -1.074 0 N-CA-C 107.861 -1.163 . . . . 3.3700000000000001 107.861 174.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.042 0 CA-C-N 115.415 -0.811 . . . . 1.02 109.9 172.417 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 5' ' ' ALA . 15.3 t70 . . . . . 0 CA--C 1.51 -0.577 0 CA-C-O 121.758 0.789 . . . . 2.25 108.96 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.652 ' HA ' HD11 ' A' ' 6' ' ' ILE . 95.5 m-85 -71.82 -25.47 62.0 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.015 -0.993 . . . . 0.42999999999999999 108.402 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.544 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 11.6 tptm -67.05 -9.44 39.21 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 114.716 -1.129 . . . . 1.51 109.669 175.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 2' ' ' ASP . . . -90.86 -49.98 6.14 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 115.823 -0.626 . . . . 0.54000000000000004 109.658 175.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.652 HD11 ' HA ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -83.19 -34.54 11.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.453 0.644 . . . . 1.0700000000000001 110.984 -170.834 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.698 ' HB2' HD21 ' A' ' 114' ' ' LEU . . . -79.13 -39.48 33.48 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.136 -0.938 . . . . 0.34000000000000002 111.269 -176.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.544 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 5.6 mt-30 -67.6 -24.75 65.52 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.147 -1.388 . . . . 1.5900000000000001 110.192 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.58 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 55.7 mt-30 -83.85 -50.56 7.97 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.099 -0.955 . . . . 2.4700000000000002 108.827 170.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.62 ' HB ' ' HA ' ' A' ' 7' ' ' ALA . 0.8 OUTLIER -46.01 -44.92 15.54 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.029 0.932 . . . . 0.47999999999999998 112.656 175.276 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.481 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -50.87 -55.99 14.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.063 0.459 . . . . 0.31 111.748 175.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -76.18 -5.99 49.3 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.088 -0.506 . . . . 1.6399999999999999 111.586 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 39.3 mm-40 -81.13 -52.39 7.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.26 0.552 . . . . 2.54 109.553 172.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.877 HG23 ' CE2' ' A' ' 170' ' ' PHE . 6.4 p -68.37 -38.72 79.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.366 -0.834 . . . . 0.53000000000000003 110.631 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.97 -22.36 65.92 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.178 -0.919 . . . . 0.59999999999999998 108.805 173.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.554 ' HA2' ' NE ' ' A' ' 19' ' ' ARG . . . -64.05 -22.69 67.1 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 114.033 -1.44 . . . . 0.56999999999999995 110.18 176.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.468 ' HA ' ' HB3' ' A' ' 20' ' ' ASP . 5.9 m-85 -90.34 -16.79 28.51 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.41 -0.589 . . . . 3.27 109.41 177.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.477 ' HB2' ' NH2' ' A' ' 49' ' ' ARG . 2.4 t-20 -76.51 -14.37 60.03 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.488 0.661 . . . . 2.0299999999999998 109.937 176.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.554 ' NE ' ' HA2' ' A' ' 16' ' ' GLY . 10.9 ptt180 -113.49 8.95 17.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.467 -0.788 . . . . 2.7200000000000002 109.668 174.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.468 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 25.5 t70 -112.83 92.82 4.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.198 -0.91 . . . . 2.1600000000000001 109.502 175.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.478 HG22 ' CH2' ' A' ' 24' ' ' TRP . 24.0 p -131.36 88.82 2.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.236 0.541 . . . . 1.8200000000000001 111.539 -176.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -177.45 -50.42 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.569 -0.741 . . . . 2.1899999999999999 111.18 -178.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.87 -9.7 79.72 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 121.235 -0.507 . . . . 1.1000000000000001 112.99 -174.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.529 ' CB ' ' HG2' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -76.93 -160.88 0.17 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.177 0.513 . . . . 1.6699999999999999 111.426 177.209 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -171.7 114.62 0.36 Allowed 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 109.028 -0.731 . . . . 2.9500000000000002 109.028 -175.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.588 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 1.7 m -64.82 128.02 26.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.963 0.887 . . . . 1.5600000000000001 111.987 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.9 m -118.79 -24.32 3.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 113.845 -1.525 . . . . 1.22 110.46 -178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.459 ' HA ' ' HD2' ' A' ' 28' ' ' LYS . 15.5 tptp -145.96 129.55 17.0 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.037 -0.665 . . . . 2.4100000000000001 111.518 -174.2 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.691 HG22 ' HA ' ' A' ' 34' ' ' THR . 24.1 p -146.06 152.78 39.88 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.21 -0.45 . . . . 1.3799999999999999 110.527 178.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.2 t -106.6 -102.45 0.34 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.097 -0.705 . . . . 2.3700000000000001 109.097 171.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -142.25 18.02 2.07 Favored 'General case' 0 N--CA 1.463 0.208 0 O-C-N 122.064 -0.398 . . . . 4.5499999999999998 111.377 175.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -169.4 8.27 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.271 0.558 . . . . 1.4199999999999999 110.07 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.655 HG22 ' HA3' ' A' ' 52' ' ' GLY . 12.7 pt -142.92 160.88 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 115.382 -0.827 . . . . 0.76000000000000001 109.891 -176.304 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.691 ' HA ' HG22 ' A' ' 29' ' ' THR . 93.1 m -158.18 111.25 2.4 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 111.793 0.294 . . . . 0.57999999999999996 111.793 -164.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.588 ' CG2' HG13 ' A' ' 193' ' ' VAL . 5.0 t -98.56 117.71 43.97 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 N-CA-C 109.379 -0.601 . . . . 0.85999999999999999 109.379 177.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -118.81 125.25 49.14 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 116.11 -0.495 . . . . 1.1000000000000001 110.218 -176.637 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 73.4 p -101.17 143.26 31.48 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.398 0.618 . . . . 1.27 112.169 -172.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.529 ' HG2' ' CB ' ' A' ' 24' ' ' TRP . 15.5 mtmt . . . . . 0 C--N 1.317 -0.825 0 CA-C-N 114.996 -1.002 . . . . 1.9099999999999999 108.413 172.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.587 ' N ' HD21 ' A' ' 46' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.401 0 CA-C-O 121.564 0.697 . . . . 2.0499999999999998 110.896 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.565 ' O ' ' HA ' ' A' ' 37' ' ' SER . 10.0 tt -86.52 147.72 25.84 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.821 -1.082 . . . . 0.87 109.254 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.455 ' N ' HD23 ' A' ' 47' ' ' LEU . 92.9 m-85 -123.21 119.59 30.67 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.839 -0.344 . . . . 0.98999999999999999 111.109 -175.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.783 ' CD ' ' HB3' ' A' ' 170' ' ' PHE . 21.8 tpt180 -110.73 117.65 34.04 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.309 -0.626 . . . . 2.9199999999999999 109.309 173.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 35' ' ' VAL . 12.5 p -103.94 150.61 7.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.75 0.31 . . . . 1.3300000000000001 110.259 -179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.561 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 35.2 tt0 -153.41 122.06 6.35 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.785 -0.643 . . . . 1.0700000000000001 110.764 -172.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.655 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -156.13 161.7 30.93 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.198 -0.761 . . . . 0.28999999999999998 111.198 175.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 70.3 mt -98.11 130.39 46.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 117.345 0.572 . . . . 0.57999999999999996 111.229 -178.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 61.9 mt -107.8 116.9 56.61 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.355 -0.839 . . . . 0.34999999999999998 109.789 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -63.56 61.51 0.2 Allowed 'Trans proline' 0 N--CA 1.476 0.457 0 C-N-CA 124.172 3.248 . . . . 0.62 113.787 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.573 ' HG3' ' H ' ' A' ' 57' ' ' SER . 6.5 tp10 -152.29 -171.33 3.9 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.796 -0.816 . . . . 1.6799999999999999 108.796 174.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.573 ' H ' ' HG3' ' A' ' 56' ' ' GLU . 73.9 p -89.76 146.42 35.41 Favored Pre-proline 0 N--CA 1.427 -1.62 0 CA-C-O 121.546 0.689 . . . . 1.1799999999999999 110.517 176.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.558 ' HB3' ' SG ' ' A' ' 155' ' ' CYS . 37.2 Cg_exo -60.71 -11.19 16.45 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 124.102 3.201 . . . . 0.52000000000000002 111.098 176.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.75 -51.52 10.4 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 114.752 -1.113 . . . . 0.64000000000000001 110.919 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.531 ' HB3' HD11 ' A' ' 203' ' ' ILE . 3.6 tppt? -66.15 -30.3 70.75 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.283 -1.006 . . . . 3.2999999999999998 108.283 -178.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.034 HD23 HD13 ' A' ' 203' ' ' ILE . 48.6 mt -60.67 -58.62 7.68 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.468 -1.242 . . . . 0.40999999999999998 110.428 174.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.437 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 7.7 p -66.57 -6.55 15.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.866 0.365 . . . . 1.29 111.104 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -86.88 -41.38 14.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.402 -0.363 . . . . 1.3200000000000001 111.896 176.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.576 ' O ' ' HB3' ' A' ' 71' ' ' ARG . 6.1 p90 -77.4 -41.28 40.59 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.47 -0.492 . . . . 0.60999999999999999 110.844 -172.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.542 HD13 ' CD1' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -84.74 7.77 19.43 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 110.342 -0.244 . . . . 1.5 110.342 -171.546 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.467 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 41.1 t80 -55.99 0.6 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.878 0 O-C-N 124.216 0.948 . . . . 1.52 112.936 -173.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 15.8 mm100 82.13 -28.13 0.12 Allowed 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 124.315 1.046 . . . . 3.6000000000000001 110.822 171.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.8 t -125.34 22.07 7.83 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.457 -1.312 . . . . 1.48 107.457 171.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.1 3.96 84.5 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 113.864 -1.516 . . . . 1.46 111.805 -176.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.708 ' O ' HG22 ' A' ' 73' ' ' THR . 12.0 t70 92.6 2.8 0.08 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 122.582 1.182 . . . . 2.1899999999999999 108.333 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.829 ' HA ' ' CE2' ' A' ' 74' ' ' TRP . 5.6 ptm180 -54.34 -40.27 67.87 Favored 'General case' 0 C--O 1.209 -1.057 0 CA-C-N 113.535 -1.666 . . . . 3.3799999999999999 110.088 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.796 HD13 ' H ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -65.61 -26.02 38.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.646 -1.161 . . . . 0.70999999999999996 110.792 -175.3 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.708 HG22 ' O ' ' A' ' 70' ' ' ASP . 0.9 OUTLIER -81.66 -31.25 32.39 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.491 -0.777 . . . . 0.96999999999999997 109.986 -174.386 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.829 ' CE2' ' HA ' ' A' ' 71' ' ' ARG . 27.6 p-90 -111.57 0.82 16.55 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.283 -0.567 . . . . 0.75 111.396 -177.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.699 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 5.3 t70 -68.25 175.62 3.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.512 0.673 . . . . 2.1899999999999999 111.723 -175.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.492 ' HG2' ' OD1' ' A' ' 198' ' ' ASN . 28.9 mmmt -95.96 -40.65 9.17 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.563 -0.744 . . . . 3.1899999999999999 109.832 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.8 t -119.72 16.14 12.73 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.439 -0.8 . . . . 1.5800000000000001 111.356 -171.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.638 HD13 HG22 ' A' ' 72' ' ' ILE . 56.1 mt -110.91 -179.32 3.71 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.537 -0.465 . . . . 0.70999999999999996 111.924 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.603 ' HG2' ' HG2' ' A' ' 99' ' ' GLN . 12.0 mm-40 -154.94 -61.59 0.12 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.519 -0.764 . . . . 1.73 111.219 -175.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 96' ' ' THR . 30.6 t -142.46 127.74 16.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.377 -0.374 . . . . 0.78000000000000003 110.648 -166.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.746 ' HB3' HD12 ' A' ' 72' ' ' ILE . 42.8 p90 -95.41 146.62 24.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.611 0.243 . . . . 5.4000000000000004 110.639 176.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.509 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 58.4 m-80 -153.45 107.18 3.02 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.548 -0.538 . . . . 1.6899999999999999 109.548 176.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.03 96.61 3.84 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.259 -0.645 . . . . 2.0499999999999998 109.259 177.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -73.12 -62.78 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.352 0.596 . . . . 0.64000000000000001 110.805 -169.358 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.445 ' HB3' HD12 ' A' ' 93' ' ' ILE . 15.5 t60 -133.97 113.96 12.73 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.275 -0.875 . . . . 1.96 108.824 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.2 mtt180 -98.28 103.74 15.71 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.971 -0.751 . . . . 2.4399999999999999 108.971 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.591 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -72.23 -46.2 58.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.456 -0.793 . . . . 0.46999999999999997 110.989 -171.551 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -141.92 -163.75 1.65 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.87 -0.789 . . . . 1.8600000000000001 108.87 -173.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.4 m -81.18 -14.8 57.21 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.844 0.354 . . . . 1.4399999999999999 110.3 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -131.82 14.81 4.83 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 110.078 -0.342 . . . . 1.8700000000000001 110.078 -175.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.591 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.4 OUTLIER -134.11 110.95 9.95 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 108.682 -0.858 . . . . 0.46000000000000002 108.682 -175.097 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.534 ' O ' HD12 ' A' ' 114' ' ' LEU . 21.7 m-85 -130.24 169.34 15.52 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.953 -0.567 . . . . 0.42999999999999999 110.391 -173.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.65 ' O ' HG23 ' A' ' 84' ' ' VAL . 28.4 mt -135.06 123.89 41.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 107.43 -1.322 . . . . 0.40999999999999998 107.43 169.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 65.2 m -110.27 125.44 53.12 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.636 -0.425 . . . . 2.0099999999999998 111.315 -175.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.631 ' HA ' HD13 ' A' ' 112' ' ' ILE . 22.2 t60 -90.91 87.65 6.72 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 122.134 0.969 . . . . 1.23 108.702 168.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 89.6 m -102.56 130.77 49.51 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.275 -1.329 . . . . 0.5 109.926 -177.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.406 ' O ' ' HB2' ' A' ' 79' ' ' GLN . 47.1 mm -80.99 128.82 38.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 C-N-CA 119.671 -0.811 . . . . 1.03 108.891 172.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.601 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 1.5 m -102.28 143.95 31.41 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.969 -0.559 . . . . 1.3799999999999999 110.255 -176.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.603 ' HG2' ' HG2' ' A' ' 79' ' ' GLN . 5.6 mm100 . . . . . 0 C--N 1.323 -0.58 0 CA-C-N 115.948 -0.569 . . . . 1.8200000000000001 110.804 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 60.4 mt . . . . . 0 N--CA 1.45 -0.447 0 N-CA-C 109.523 -0.547 . . . . 1.1200000000000001 109.523 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 48.4 m -84.91 152.9 59.95 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 110.083 -0.34 . . . . 1.3500000000000001 110.083 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.94 130.98 36.78 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.768 2.312 . . . . 1.0700000000000001 111.048 177.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 144' ' ' ILE . 12.2 ttp180 -109.73 154.92 22.23 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.285 -0.566 . . . . 3.4500000000000002 111.046 -167.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.46 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 5.1 t0 -95.33 140.82 29.67 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.658 -0.867 . . . . 1.3700000000000001 108.658 174.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.661 ' CE1' ' HB2' ' A' ' 113' ' ' ASP . 13.4 t80 -123.76 108.74 12.85 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.664 -0.865 . . . . 2.4100000000000001 108.664 -179.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.699 HG21 ' CE1' ' A' ' 134' ' ' PHE . 12.6 mm -124.1 74.78 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 107.933 -1.136 . . . . 0.42999999999999999 107.933 173.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.661 ' HB2' ' CE1' ' A' ' 111' ' ' PHE . 1.0 OUTLIER -102.48 124.18 47.58 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.587 -0.733 . . . . 1.8600000000000001 110.094 -176.39 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.698 HD21 ' HB2' ' A' ' 7' ' ' ALA . 10.6 tp -76.98 121.97 24.23 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 115.265 -0.88 . . . . 0.28000000000000003 109.364 174.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -122.82 123.95 69.36 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 CA-C-N 114.157 -1.383 . . . . 0.26000000000000001 111.503 -166.561 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.555 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 53.8 t80 -117.22 125.4 51.09 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.647 -0.706 . . . . 2.5699999999999998 110.571 175.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' A' ' 126' ' ' ILE . 91.8 mt -96.96 99.24 8.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.484 -0.78 . . . . 0.89000000000000001 110.54 -177.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -101.86 135.1 44.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.11 -0.95 . . . . 1.2 108.867 178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.521 ' HD3' ' O ' ' A' ' 119' ' ' ARG . 0.1 OUTLIER -124.19 110.6 14.87 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 121.903 0.859 . . . . 2.7999999999999998 108.907 176.368 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.571 ' CB ' ' HB3' ' A' ' 123' ' ' ASN . 59.3 m-85 -77.88 116.83 18.68 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.064 -1.088 . . . . 0.82999999999999996 108.064 171.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.52 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 1.6 mp0 -28.7 93.72 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 O-C-N 125.086 1.491 . . . . 2.2799999999999998 113.321 178.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 56.29 36.86 70.69 Favored Glycine 0 CA--C 1.507 -0.451 0 CA-C-N 115.117 -0.947 . . . . 0.76000000000000001 112.312 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.571 ' HB3' ' CB ' ' A' ' 120' ' ' TYR . 59.2 t30 -128.83 -53.4 1.23 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.971 -0.614 . . . . 1.6499999999999999 109.694 -176.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.54 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 0.4 OUTLIER -157.14 125.36 5.57 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.112 -0.495 . . . . 1.1200000000000001 110.986 -179.069 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -107.75 82.59 1.67 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.248 -1.019 . . . . 1.6200000000000001 108.248 175.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.499 ' CG1' HG12 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -100.93 139.37 22.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.892 -0.595 . . . . 0.29999999999999999 112.421 -171.74 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -107.4 119.45 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 107.358 -1.349 . . . . 0.58999999999999997 107.358 159.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 30.3 p -82.88 167.3 18.18 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.037 -0.727 . . . . 1.1799999999999999 109.037 174.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.425 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 67.7 p -158.48 120.01 3.49 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.9 0.381 . . . . 1.24 110.231 -178.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.617 ' CE ' HD23 ' A' ' 114' ' ' LEU . 3.1 ttpm? -131.95 115.01 15.32 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 108.128 -1.064 . . . . 2.2599999999999998 108.128 -176.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.403 ' CB ' ' H ' ' A' ' 148' ' ' ASN . 96.9 p -61.78 100.14 0.14 Allowed 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 107.698 -1.223 . . . . 1.3899999999999999 107.698 -177.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.464 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -107.77 138.23 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.115 0 CA-C-N 115.163 -0.926 . . . . 1.05 108.847 -165.351 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -99.76 64.32 1.26 Allowed 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 122.432 1.11 . . . . 2.1699999999999999 108.64 -168.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.813 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -90.74 162.02 34.52 Favored Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 113.387 -1.733 . . . . 0.53000000000000003 110.64 -171.596 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -77.86 -12.91 16.21 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 123.072 2.514 . . . . 1.28 114.762 -173.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.813 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 5.7 tp10 -72.7 -17.78 61.6 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 109.48 -0.563 . . . . 3.5 109.48 -171.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.47 ' HB2' HG11 ' A' ' 84' ' ' VAL . 18.8 t80 -163.13 112.01 1.03 Allowed Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 113.351 0.871 . . . . 6.1200000000000001 113.351 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -83.96 126.0 3.77 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 123.077 2.518 . . . . 1.77 110.035 163.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.462 ' HG3' ' HB2' ' A' ' 145' ' ' ARG . 11.2 Cg_endo -52.54 -92.47 0.0 OUTLIER 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 123.447 2.765 . . . . 1.25 114.956 -168.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.1 t -172.53 171.52 4.57 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.621 -0.511 . . . . 1.6000000000000001 109.621 -174.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.8 p -90.22 -15.41 31.46 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.228 -0.656 . . . . 1.97 109.228 171.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -98.56 -50.44 4.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.582 -0.736 . . . . 2.1800000000000002 110.133 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.46 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 40.2 m-85 -83.44 130.4 35.03 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 115.847 -0.615 . . . . 1.23 109.455 176.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.664 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -100.9 113.53 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 N-CA-C 107.991 -1.114 . . . . 0.81999999999999995 107.991 -179.407 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.462 ' HB2' ' HG3' ' A' ' 139' ' ' PRO . 6.4 tmm_? -57.41 97.38 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.674 -1.232 . . . . 4.4199999999999999 107.674 170.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.493 ' HA3' ' HD2' ' A' ' 109' ' ' ARG . . . -66.07 129.0 31.85 Favored Glycine 0 CA--C 1.49 -1.477 0 N-CA-C 110.63 -0.988 . . . . 0.79000000000000004 110.63 -176.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.463 ' H ' ' HG2' ' A' ' 174' ' ' GLU . 41.4 t80 -82.74 107.05 15.08 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.515 1.15 . . . . 4.4400000000000004 110.733 -175.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.403 ' H ' ' CB ' ' A' ' 131' ' ' SER . 55.2 t30 -110.36 110.97 21.96 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.05 -1.886 . . . . 1.6200000000000001 108.396 178.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.508 ' O ' ' N ' ' A' ' 151' ' ' CYS . 38.3 m80 -57.63 163.29 3.91 Favored Pre-proline 0 C--O 1.217 -0.628 0 CA-C-O 118.174 -0.917 . . . . 2.3199999999999998 109.012 175.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.517 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 1.2 Cg_endo -44.12 77.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 123.841 3.027 . . . . 0.53000000000000003 113.719 178.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' CYS . . . . . 0.58 ' HB3' ' O ' ' A' ' 170' ' ' PHE . 45.4 m -108.96 -171.81 1.92 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.999 -1.0 . . . . 1.5800000000000001 109.325 177.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.632 ' O ' ' HG3' ' A' ' 169' ' ' MET . . . 174.45 -153.29 16.04 Favored Glycine 0 N--CA 1.435 -1.421 0 C-N-CA 119.028 -1.558 . . . . 0.42999999999999999 112.644 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.601 ' CZ ' HD11 ' A' ' 167' ' ' LEU . 3.6 t80 -156.47 97.96 1.79 Allowed 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.517 -1.29 . . . . 0.59999999999999998 107.517 -163.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.63 ' CG2' HG13 ' A' ' 168' ' ' VAL . 2.6 m -105.56 146.25 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 C-N-CA 119.705 -0.798 . . . . 0.31 110.856 -174.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' CYS . . . . . 0.57 ' SG ' HD12 ' A' ' 61' ' ' LEU . 18.5 t -118.57 138.19 52.72 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.042 -0.981 . . . . 1.55 108.439 173.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.52 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 12.4 m -123.24 111.22 30.41 Favored Pre-proline 0 C--N 1.307 -1.263 0 C-N-CA 120.697 -0.401 . . . . 1.0600000000000001 110.878 -177.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.454 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 71.4 Cg_exo -50.22 117.74 3.4 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.43 2.087 . . . . 0.56000000000000005 111.045 170.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.425 ' O ' ' HB3' ' A' ' 161' ' ' ASN . 88.6 mmm -79.13 -162.72 0.42 Allowed 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.066 0.46 . . . . 1.1599999999999999 111.462 -175.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -75.38 -35.97 60.99 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.615 -0.883 . . . . 2.6299999999999999 108.615 172.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.411 ' C ' ' HD2' ' A' ' 162' ' ' PRO . 16.5 mt-10 -96.92 29.18 3.16 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.161 -1.381 . . . . 2.0499999999999998 108.636 174.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.479 ' CG ' ' HD3' ' A' ' 162' ' ' PRO . 3.4 p30 -34.18 -47.28 0.77 Allowed Pre-proline 0 N--CA 1.471 0.611 0 N-CA-C 116.398 1.999 . . . . 1.9299999999999999 116.398 -168.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.479 ' HD3' ' CG ' ' A' ' 161' ' ' ASN . 71.3 Cg_endo -73.94 -17.85 22.09 Favored 'Trans proline' 0 C--N 1.351 0.703 0 CA-C-N 121.755 1.662 . . . . 0.72999999999999998 113.047 -176.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -109.16 -25.89 10.4 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.191 -0.459 . . . . 0.68000000000000005 110.832 -178.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 161' ' ' ASN . 79.6 m-85 -138.3 124.7 20.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.825 -0.625 . . . . 0.93000000000000005 109.467 176.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 3.7 p -125.62 142.25 51.61 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.155 0.502 . . . . 1.4099999999999999 111.154 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.561 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.9 tppp? -88.27 119.6 28.83 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.629 0.728 . . . . 0.73999999999999999 111.482 -175.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.601 HD11 ' CZ ' ' A' ' 153' ' ' PHE . 0.3 OUTLIER -101.96 117.17 34.27 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.244 -0.889 . . . . 0.27000000000000002 110.099 176.64 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.63 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.1 OUTLIER -140.84 126.41 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-O 121.558 0.694 . . . . 0.28000000000000003 112.413 177.699 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.632 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 12.1 ttt -145.44 145.72 31.23 Favored 'General case' 0 C--O 1.22 -0.485 0 C-N-CA 123.091 0.556 . . . . 1.24 110.919 -170.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.877 ' CE2' HG23 ' A' ' 14' ' ' VAL . 12.1 p90 -136.95 162.73 32.47 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.375 0.607 . . . . 3.3700000000000001 112.223 171.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.536 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 1.4 m -136.54 143.53 35.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 113.592 -1.64 . . . . 1.3999999999999999 110.481 173.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.499 ' HB3' ' HB2' ' A' ' 149' ' ' HIS . 41.1 tt0 -120.29 54.95 1.02 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.889 -1.522 . . . . 2.1699999999999999 106.889 172.148 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.1 m -64.02 144.5 57.04 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 113.791 -1.55 . . . . 1.6499999999999999 110.708 -173.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.463 ' HG2' ' H ' ' A' ' 147' ' ' TYR . 10.3 pt-20 . . . . . 0 C--O 1.233 0.217 0 C-N-CA 120.714 -0.394 . . . . 2.4500000000000002 110.531 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.527 ' HA ' ' HE2' ' A' ' 186' ' ' LYS . 15.9 mm . . . . . 0 CA--C 1.508 -0.668 0 CA-C-O 122.498 1.142 . . . . 1.1200000000000001 108.793 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 1.024 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.1 mp -73.61 -33.05 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 113.103 -1.862 . . . . 1.1299999999999999 111.168 -175.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 189' ' ' PRO . 10.4 pt-20 -65.57 -21.73 66.62 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.83 -0.804 . . . . 2.8900000000000001 108.83 173.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.574 ' O ' ' HB2' ' A' ' 190' ' ' SER . 49.2 mtmt -92.36 -24.71 18.82 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.648 -0.705 . . . . 1.28 110.026 176.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' THR . . . . . 1.024 HG22 ' HA ' ' A' ' 184' ' ' ILE . 4.5 t -91.18 -47.98 7.2 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 119.499 -0.88 . . . . 0.62 112.772 -178.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' MET . . . . . 0.572 ' O ' ' HG ' ' A' ' 192' ' ' LEU . 0.0 OUTLIER -80.48 -71.04 0.15 Allowed Pre-proline 0 N--CA 1.471 0.593 0 CA-C-N 119.403 1.002 . . . . 1.0600000000000001 112.447 -175.651 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.428 ' HG2' ' O ' ' A' ' 185' ' ' GLU . 44.7 Cg_endo -68.25 -22.93 39.53 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.307 1.338 . . . . 0.91000000000000003 112.022 -171.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.574 ' HB2' ' O ' ' A' ' 186' ' ' LYS . 66.9 m -83.83 -23.99 31.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.733 -0.667 . . . . 1.5 110.707 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 187' ' ' THR . 55.0 t30 -89.85 -25.4 21.05 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.439 -0.505 . . . . 1.8799999999999999 110.834 178.23 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 188' ' ' MET . 15.5 mt -68.84 -47.69 65.39 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.777 0.322 . . . . 1.0900000000000001 111.029 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.588 HG13 ' CG2' ' A' ' 35' ' ' VAL . 3.8 m -67.89 -23.19 28.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 120.353 -0.539 . . . . 0.68000000000000005 110.165 175.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -76.45 -31.06 57.6 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.831 -0.622 . . . . 2.0699999999999998 110.835 176.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -67.14 -31.36 71.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.077 0.465 . . . . 2.0 109.78 171.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.555 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 63.2 mt -77.66 -30.07 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 116.121 -0.49 . . . . 0.31 110.62 174.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 57.1 mt -71.69 -38.76 70.56 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-O 121.468 0.651 . . . . 1.03 109.434 173.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.513 ' ND2' ' HA ' ' A' ' 75' ' ' ASP . 2.6 m120 -54.5 -35.26 62.94 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.393 -1.276 . . . . 1.8999999999999999 109.112 167.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.681 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -75.59 -43.74 46.65 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 120.483 -0.487 . . . . 0.28999999999999998 110.413 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.617 ' O ' ' HG3' ' A' ' 204' ' ' LYS . 32.0 mmtp -56.11 -44.21 78.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.135 0.493 . . . . 0.96999999999999997 110.613 174.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -85.41 -41.14 15.69 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.585 -0.734 . . . . 1.9399999999999999 111.419 -174.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' GLY . . . . . 0.523 ' HA3' ' CH2' ' A' ' 74' ' ' TRP . . . -68.26 -27.99 73.5 Favored Glycine 0 CA--C 1.507 -0.458 0 N-CA-C 111.502 -0.639 . . . . 0.46999999999999997 111.502 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 1.034 HD13 HD23 ' A' ' 61' ' ' LEU . 2.8 tp -71.7 -31.41 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 109.327 -0.62 . . . . 0.60999999999999999 109.327 176.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.617 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 57.5 mttp -84.63 -25.07 28.8 Favored 'General case' 0 C--O 1.208 -1.093 0 N-CA-C 108.528 -0.916 . . . . 3.3700000000000001 108.528 176.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.443 ' HB3' ' HA2' ' A' ' 202' ' ' GLY . . . . . . . . 0 C--N 1.312 -1.046 0 CA-C-N 115.675 -0.693 . . . . 1.02 109.701 170.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.653 ' O ' HD13 ' A' ' 6' ' ' ILE . 15.5 m-20 . . . . . 0 CA--C 1.5 -0.972 0 N-CA-C 108.392 -0.966 . . . . 2.25 108.392 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.952 ' HA ' HD11 ' A' ' 6' ' ' ILE . 82.7 m-85 -63.6 -35.63 81.14 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 114.676 -1.147 . . . . 0.42999999999999999 109.168 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.705 ' O ' ' HB3' ' A' ' 8' ' ' GLN . 23.2 tptm -60.81 -47.97 83.92 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 115.302 -0.863 . . . . 1.51 109.074 178.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.17 -46.31 62.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.924 -0.58 . . . . 0.54000000000000004 112.125 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.952 HD11 ' HA ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -80.63 -36.5 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 CA-C-O 121.674 0.75 . . . . 1.0700000000000001 109.562 -172.148 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.6 ' HB1' ' HB3' ' A' ' 116' ' ' TYR . . . -76.86 -43.24 36.92 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.239 -1.346 . . . . 0.34000000000000002 111.472 -175.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.705 ' HB3' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -60.96 -33.53 73.34 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.202 -1.363 . . . . 1.5900000000000001 109.086 -178.406 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.545 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 15.2 mm100 -92.47 -32.85 14.74 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.86 -1.064 . . . . 2.4700000000000002 110.674 -178.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.722 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.4 OUTLIER -75.75 -26.56 57.53 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.786 -0.365 . . . . 0.47999999999999998 110.753 178.028 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -49.34 -44.39 44.54 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 120.208 -0.597 . . . . 0.31 111.811 170.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.691 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 27.9 pt20 -83.73 -1.5 54.27 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 122.075 -0.391 . . . . 1.6399999999999999 110.986 176.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 29.4 mm-40 -88.45 -44.9 10.38 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.803 -0.443 . . . . 2.54 109.803 174.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.712 ' HA ' ' HE2' ' A' ' 170' ' ' PHE . 3.9 p -66.51 -39.96 85.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 122.116 0.96 . . . . 0.53000000000000003 108.912 170.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.691 ' HB3' ' HA ' ' A' ' 12' ' ' GLN . 0.9 OUTLIER -66.9 -21.98 65.98 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 114.749 -1.114 . . . . 0.59999999999999998 108.084 172.552 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.691 ' HA2' ' NE ' ' A' ' 19' ' ' ARG . . . -62.47 -24.44 65.86 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 113.909 -1.496 . . . . 0.56999999999999995 110.268 176.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.452 ' HD1' ' O ' ' A' ' 13' ' ' GLU . 19.6 m-85 -92.55 -8.55 44.07 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.246 -0.477 . . . . 3.27 109.946 178.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.47 -10.97 44.36 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 119.295 -0.962 . . . . 2.0299999999999998 108.608 176.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.691 ' NE ' ' HA2' ' A' ' 16' ' ' GLY . 19.5 ptt85 -122.64 3.25 9.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.618 -1.173 . . . . 2.7200000000000002 110.561 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.649 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 23.0 t70 -90.28 112.8 24.47 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 116.223 -0.444 . . . . 2.1600000000000001 110.821 -175.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.8 p -129.96 93.81 3.58 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.691 0.758 . . . . 1.8200000000000001 109.334 176.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.1 t -127.26 -78.19 0.58 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.638 -1.165 . . . . 2.1899999999999999 111.202 -169.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.09 60.38 0.55 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.52 -0.848 . . . . 1.1000000000000001 112.374 -177.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.513 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -120.39 -163.73 1.03 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.107 0.479 . . . . 1.6699999999999999 110.221 176.869 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 1.2 mtpp -176.77 135.65 0.22 Allowed 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.201 -1.037 . . . . 2.9500000000000002 108.201 -172.169 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 3.2 m -66.55 123.88 20.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.895 0.855 . . . . 1.5600000000000001 110.703 177.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.2 p -97.76 -23.25 4.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 114.199 -1.364 . . . . 1.22 108.795 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.502 ' HD2' ' HA ' ' A' ' 28' ' ' LYS . 10.0 tptm -155.47 112.93 3.32 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 119.995 -0.682 . . . . 2.4100000000000001 111.824 -174.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.932 HG22 ' HA ' ' A' ' 34' ' ' THR . 75.2 p -130.97 126.93 37.32 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.54 -0.541 . . . . 1.3799999999999999 109.54 172.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.3 m -85.18 -79.94 0.22 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.536 -0.302 . . . . 2.3700000000000001 110.984 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 7.2 ptpp? -159.17 28.55 0.21 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.498 0.189 . . . . 4.5499999999999998 110.894 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.537 ' HB2' ' NZ ' ' A' ' 32' ' ' LYS . 1.4 ttmp? 170.35 -20.7 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.979 -0.555 . . . . 1.4199999999999999 110.31 -176.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.899 HG22 ' HA3' ' A' ' 52' ' ' GLY . 46.1 pt -109.26 157.3 9.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.771 -0.65 . . . . 0.76000000000000001 110.486 178.179 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.932 ' HA ' HG22 ' A' ' 29' ' ' THR . 85.6 m -148.79 100.07 3.05 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.65 -0.705 . . . . 0.57999999999999996 111.133 -164.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.925 HG11 HD13 ' A' ' 192' ' ' LEU . 2.3 t -96.06 106.98 19.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.871 0.367 . . . . 0.85999999999999999 110.281 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 6.0 p -96.62 126.04 41.52 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.453 0.645 . . . . 1.1000000000000001 110.735 177.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.2 t -103.29 127.75 50.53 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.782 -1.099 . . . . 1.27 109.199 -176.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.513 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 25.1 ttpp . . . . . 0 C--N 1.319 -0.744 0 CA-C-N 116.33 -0.395 . . . . 1.9099999999999999 110.983 -177.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 N--CA 1.449 -0.509 0 N-CA-C 113.054 0.761 . . . . 2.0499999999999998 113.054 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.751 HD21 ' CD1' ' A' ' 170' ' ' PHE . 9.7 tt -128.85 147.78 50.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.171 -1.377 . . . . 0.87 107.615 178.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.444 ' N ' HD23 ' A' ' 47' ' ' LEU . 94.0 m-85 -122.71 134.35 54.46 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.151 -0.62 . . . . 0.98999999999999999 111.587 -170.274 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 2.6 tmt_? -130.67 118.56 21.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.813 -0.631 . . . . 2.9199999999999999 111.044 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.915 HG13 HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -92.5 153.35 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-O 120.989 0.423 . . . . 1.3300000000000001 110.642 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.488 ' CG ' ' HD2' ' A' ' 166' ' ' LYS . 16.3 tt0 -153.31 106.56 2.98 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.557 -0.905 . . . . 1.0700000000000001 108.557 178.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.899 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -140.94 141.21 11.07 Favored Glycine 0 CA--C 1.498 -0.998 0 C-N-CA 120.239 -0.981 . . . . 0.28999999999999998 111.542 -178.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 165' ' ' SER . 61.6 mt -88.44 120.35 37.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 C-N-CA 120.206 -0.598 . . . . 0.57999999999999996 110.89 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.663 HG12 ' HD3' ' A' ' 200' ' ' LYS . 63.7 mt -95.74 119.2 65.36 Favored Pre-proline 0 N--CA 1.443 -0.785 0 N-CA-C 109.096 -0.705 . . . . 0.34999999999999998 109.096 173.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 163' ' ' ALA . 28.1 Cg_exo -64.72 59.35 0.28 Allowed 'Trans proline' 0 N--CA 1.473 0.268 0 C-N-CA 124.08 3.187 . . . . 0.62 112.959 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.443 ' HG2' HG13 ' A' ' 203' ' ' ILE . 14.5 tp10 -156.21 175.85 13.45 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.287 -1.375 . . . . 1.6799999999999999 107.287 177.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.491 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 43.3 p -88.81 141.66 30.01 Favored Pre-proline 0 N--CA 1.429 -1.522 0 CA-C-O 121.512 0.672 . . . . 1.1799999999999999 110.211 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.832 ' HD3' ' HB3' ' A' ' 165' ' ' SER . 6.3 Cg_endo -49.34 -14.85 0.63 Allowed 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 124.963 3.775 . . . . 0.52000000000000002 112.587 173.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.76 -47.74 29.45 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 116.11 -0.495 . . . . 0.64000000000000001 111.204 176.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.668 ' HE3' ' HA ' ' A' ' 60' ' ' LYS . 1.4 tpmt? -67.64 -31.42 71.42 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.841 -1.17 . . . . 3.2999999999999998 107.841 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.009 HD23 HD13 ' A' ' 203' ' ' ILE . 83.2 mt -63.23 -56.29 17.88 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.034 -1.439 . . . . 0.40999999999999998 110.778 175.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.2 t -62.95 -12.17 23.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.67 0.271 . . . . 1.29 110.564 177.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -84.04 -41.91 16.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.369 -0.378 . . . . 1.3200000000000001 112.0 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.771 ' HD2' ' CZ2' ' A' ' 74' ' ' TRP . 15.4 p90 -85.88 -42.02 14.46 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.399 0.518 . . . . 0.60999999999999999 112.399 -170.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.741 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -89.95 4.49 49.89 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.06 0.391 . . . . 1.5 111.932 -170.08 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.617 ' O ' ' HG3' ' A' ' 67' ' ' GLN . 75.2 t80 -41.89 -73.1 0.05 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.973 0.731 . . . . 1.52 112.973 -166.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.617 ' HG3' ' O ' ' A' ' 66' ' ' TYR . 15.8 mt-30 -168.07 -61.57 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.7 0.762 . . . . 3.6000000000000001 110.462 -178.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.855 ' HB ' ' CD2' ' A' ' 81' ' ' TYR . 10.2 t -126.23 26.19 6.5 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.111 -1.44 . . . . 1.48 107.111 178.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.699 ' O ' ' HB2' ' A' ' 70' ' ' ASP . . . -72.15 -14.12 76.48 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 113.531 -1.668 . . . . 1.46 112.735 -169.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.699 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 15.1 t70 132.91 -8.95 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 O-C-N 125.844 1.555 . . . . 2.1899999999999999 107.051 -171.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.779 ' HA ' ' CE2' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -59.41 -36.24 75.48 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.525 -1.216 . . . . 3.3799999999999999 111.239 -170.089 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.073 HG22 HD13 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -80.5 -14.14 12.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.581 -0.448 . . . . 0.70999999999999996 110.973 -175.84 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.663 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.1 t -88.11 -31.7 19.07 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 119.972 -0.691 . . . . 0.96999999999999997 110.15 -176.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.858 ' HZ3' ' HB3' ' A' ' 198' ' ' ASN . 15.0 p-90 -100.64 -7.21 24.16 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.411 -0.516 . . . . 0.75 111.023 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.811 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 5.7 t70 -73.7 167.98 20.3 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.47 0.653 . . . . 2.1899999999999999 110.267 -177.073 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.8 -16.17 12.8 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.923 -1.035 . . . . 3.1899999999999999 111.512 -172.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.1 t -119.62 9.02 11.35 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.339 0.59 . . . . 1.5800000000000001 109.456 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.073 HD13 HG22 ' A' ' 72' ' ' ILE . 19.9 mt -109.72 159.68 16.95 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.625 -0.716 . . . . 0.70999999999999996 112.421 -175.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.626 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 7.7 mt-30 -131.94 -69.7 0.59 Allowed 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 114.807 -1.088 . . . . 1.73 110.432 178.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.558 HG23 ' HB3' ' A' ' 79' ' ' GLN . 21.3 t -142.84 136.32 26.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.875 -1.057 . . . . 0.78000000000000003 110.254 -165.102 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.855 ' CD2' ' HB ' ' A' ' 68' ' ' THR . 80.6 t80 -116.91 146.56 42.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.053 0.454 . . . . 5.4000000000000004 111.334 177.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.44 ' HB2' ' ND1' ' A' ' 95' ' ' HIS . 14.0 m120 -142.69 124.01 14.69 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.42 -0.809 . . . . 1.6899999999999999 109.037 175.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.453 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 2.3 ttt -82.11 97.13 8.03 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.597 -0.89 . . . . 2.0499999999999998 108.597 -178.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.703 HG11 ' HB2' ' A' ' 137' ' ' TYR . 0.1 OUTLIER -72.92 -80.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.914 -0.584 . . . . 0.64000000000000001 111.908 -167.954 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.592 ' HB2' ' HG2' ' A' ' 136' ' ' GLU . 10.4 t60 -126.03 118.36 25.17 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.976 -0.75 . . . . 1.96 108.976 -177.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.453 ' HD3' ' SD ' ' A' ' 83' ' ' MET . 50.4 mtm180 -103.31 103.14 13.13 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.4 -0.593 . . . . 2.4399999999999999 109.4 -175.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.606 HG21 ' HB2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -67.74 -41.32 85.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.081 -0.963 . . . . 0.46999999999999997 110.402 -173.547 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -148.35 -161.38 1.33 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.878 -1.156 . . . . 1.8600000000000001 107.878 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.7 m -93.4 3.87 54.9 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.07 0.462 . . . . 1.4399999999999999 109.915 175.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -125.07 -3.43 7.58 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 109.07 -0.715 . . . . 1.8700000000000001 109.07 -175.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.564 HG22 HD11 ' A' ' 114' ' ' LEU . 2.1 m -145.92 116.52 7.61 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 109.288 -0.634 . . . . 0.46000000000000002 109.288 -171.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.572 ' O ' HD12 ' A' ' 114' ' ' LEU . 10.8 m-85 -129.82 176.88 7.68 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.175 -0.676 . . . . 0.42999999999999999 109.175 -177.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.635 HD13 ' HB2' ' A' ' 114' ' ' LEU . 1.3 mm -122.43 131.81 72.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 107.851 -1.166 . . . . 0.40999999999999998 107.851 168.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 18.4 p -107.11 107.14 17.98 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.871 -0.331 . . . . 2.0099999999999998 111.643 -173.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.514 ' HA ' HD13 ' A' ' 112' ' ' ILE . 15.3 t-80 -81.72 103.57 11.5 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.385 -0.969 . . . . 1.23 108.385 167.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.838 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 33.1 m -125.4 111.18 14.83 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.891 -0.595 . . . . 0.5 111.75 -170.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' A' ' 79' ' ' GLN . 29.0 mm -77.11 136.56 24.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 120.142 -0.623 . . . . 1.03 109.739 177.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 1.8 m -112.75 147.05 37.67 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.988 -1.005 . . . . 1.3799999999999999 109.942 -171.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.626 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 16.6 mt-30 . . . . . 0 C--N 1.317 -0.83 0 CA-C-N 115.962 -0.563 . . . . 1.8200000000000001 110.403 -178.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.412 HD11 ' HB ' ' A' ' 187' ' ' THR . 44.1 mt . . . . . 0 N--CA 1.445 -0.705 0 N-CA-C 109.722 -0.473 . . . . 1.1200000000000001 109.722 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.8 p -68.15 157.34 87.58 Favored Pre-proline 0 C--O 1.237 0.44 0 CA-C-N 115.433 -0.803 . . . . 1.3500000000000001 111.934 -172.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -45.44 124.44 6.51 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 123.252 2.635 . . . . 1.0700000000000001 110.793 175.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.607 ' HG3' HG23 ' A' ' 144' ' ' ILE . 2.7 ttm180 -122.25 157.19 32.2 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.623 -0.831 . . . . 3.4500000000000002 110.552 -168.001 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.629 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 12.3 t0 -126.52 131.03 51.69 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 109.608 -0.516 . . . . 1.3700000000000001 109.608 176.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.838 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 20.0 m-85 -99.96 131.91 45.64 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 120.946 0.403 . . . . 2.4100000000000001 110.436 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.514 HD13 ' HA ' ' A' ' 95' ' ' HIS . 20.5 mm -129.8 74.49 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 108.152 -1.055 . . . . 0.42999999999999999 108.152 168.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.673 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 41.8 m-20 -106.44 140.28 39.59 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.981 -1.009 . . . . 1.8600000000000001 109.304 -178.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.635 ' HB2' HD13 ' A' ' 93' ' ' ILE . 5.3 tp -81.93 122.6 27.96 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.162 -0.681 . . . . 0.28000000000000003 109.162 174.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -117.35 124.05 72.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-O 122.236 1.017 . . . . 0.26000000000000001 111.981 -166.84 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.885 ' CE2' ' HB3' ' A' ' 128' ' ' SER . 0.1 OUTLIER -113.51 118.42 34.4 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.552 -1.658 . . . . 2.5699999999999998 110.02 -176.092 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 126' ' ' ILE . 3.9 mp -105.31 99.38 8.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.544 -0.539 . . . . 0.89000000000000001 109.544 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -107.5 144.17 34.85 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.599 -0.728 . . . . 1.2 109.718 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.442 ' NH1' ' HA ' ' A' ' 121' ' ' GLU . 3.3 tmt_? -121.09 94.1 4.23 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 108.144 -1.058 . . . . 2.7999999999999998 108.144 -176.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.569 ' CB ' ' HB2' ' A' ' 123' ' ' ASN . 89.5 m-85 -63.73 115.84 5.16 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 106.806 -1.553 . . . . 0.82999999999999996 106.806 172.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.442 ' HA ' ' NH1' ' A' ' 119' ' ' ARG . 21.0 mt-10 -48.22 85.26 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 O-C-N 125.031 1.457 . . . . 2.2799999999999998 113.014 -171.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 77.25 29.07 57.0 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 114.91 -1.041 . . . . 0.76000000000000001 112.509 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.569 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 14.4 m120 -125.5 -51.04 1.62 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.668 -0.266 . . . . 1.6499999999999999 110.337 178.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.405 ' HA ' ' HD2' ' A' ' 157' ' ' PRO . 1.9 mpt? -157.03 131.93 8.87 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.834 0.349 . . . . 1.1200000000000001 111.267 -174.049 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.438 ' OD1' ' HG2' ' A' ' 119' ' ' ARG . 63.9 m-20 -105.91 79.5 1.43 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.611 -1.255 . . . . 1.6200000000000001 107.611 171.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.604 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -89.52 124.83 42.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.699 -0.682 . . . . 0.29999999999999999 112.213 -173.101 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.468 ' CG2' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -107.02 116.89 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 107.528 -1.286 . . . . 0.58999999999999997 107.528 160.214 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.885 ' HB3' ' CE2' ' A' ' 116' ' ' TYR . 37.9 t -127.88 167.22 16.9 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.425 -0.954 . . . . 1.1799999999999999 108.425 174.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.673 ' HB3' ' HB3' ' A' ' 113' ' ' ASP . 73.0 m -145.16 137.84 26.15 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.637 -0.505 . . . . 1.24 109.637 -168.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.471 ' HE2' ' HG3' ' A' ' 150' ' ' PRO . 47.0 tttm -123.86 116.21 22.57 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.302 -1.37 . . . . 2.2599999999999998 107.302 -171.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.672 ' HB3' ' N ' ' A' ' 148' ' ' ASN . 11.8 p -58.65 101.29 0.08 Allowed 'General case' 0 N--CA 1.432 -1.354 0 O-C-N 124.26 0.975 . . . . 1.3899999999999999 109.303 -173.178 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.435 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.8 OUTLIER -116.3 131.99 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.139 0 CA-C-N 114.933 -1.03 . . . . 1.05 109.918 -167.392 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -98.24 78.66 2.49 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.742 -1.117 . . . . 2.1699999999999999 108.209 -175.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.814 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -109.96 156.88 39.22 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 115.395 -0.82 . . . . 0.53000000000000003 110.264 -171.745 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -75.93 -16.61 18.11 Favored 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.818 2.345 . . . . 1.28 115.267 -169.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.814 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 8.6 tp10 -69.15 -16.47 63.65 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.311 0.577 . . . . 3.5 110.023 -171.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.703 ' HB2' HG11 ' A' ' 84' ' ' VAL . 1.7 t80 -165.5 104.61 0.75 Allowed Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.492 -0.777 . . . . 6.1200000000000001 112.074 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -88.72 145.18 5.58 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.324 2.683 . . . . 1.77 110.813 170.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -70.27 -166.74 0.21 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.419 2.079 . . . . 1.25 111.762 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.4 m -140.21 -169.75 2.82 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.987 -0.746 . . . . 1.6000000000000001 108.987 -174.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.9 t -79.45 -37.78 36.17 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 119.899 -0.72 . . . . 1.97 110.249 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -83.28 -17.64 41.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.086 0.469 . . . . 2.1800000000000002 110.387 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.485 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 85.9 m-85 -114.65 108.3 16.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.844 -0.616 . . . . 1.23 110.28 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.607 HG23 ' HG3' ' A' ' 109' ' ' ARG . 1.0 OUTLIER -95.39 106.76 18.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.089 -0.505 . . . . 0.81999999999999995 109.927 -178.267 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.629 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 35.1 ttm180 -50.16 105.37 0.09 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.977 -0.556 . . . . 4.4199999999999999 111.156 178.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -64.32 112.72 5.23 Favored Glycine 0 N--CA 1.437 -1.281 0 CA-C-N 115.337 -0.847 . . . . 0.79000000000000004 111.887 176.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.574 ' HB3' ' CB ' ' A' ' 174' ' ' GLU . 0.2 OUTLIER -85.58 93.05 8.71 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.058 0.456 . . . . 4.4400000000000004 109.878 178.114 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.672 ' N ' ' HB3' ' A' ' 131' ' ' SER . 80.1 m-20 -88.86 81.64 6.9 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.579 -0.737 . . . . 1.6200000000000001 109.741 175.084 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.527 ' CD2' ' HD2' ' A' ' 150' ' ' PRO . 0.1 OUTLIER -47.85 123.37 9.74 Favored Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 115.141 -0.936 . . . . 2.3199999999999998 110.104 179.269 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.527 ' HD2' ' CD2' ' A' ' 149' ' ' HIS . 53.6 Cg_exo -14.31 67.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.223 1 C-N-CA 126.725 4.95 . . . . 0.53000000000000003 115.712 -161.693 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 151' ' ' CYS . . . . . 0.718 ' HB2' ' O ' ' A' ' 170' ' ' PHE . 24.5 p -123.86 145.82 48.83 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.005 -0.998 . . . . 1.5800000000000001 109.512 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 128' ' ' SER . . . -151.26 -134.16 2.13 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 119.012 -1.566 . . . . 0.42999999999999999 114.004 -175.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.532 ' CE1' HD21 ' A' ' 167' ' ' LEU . 33.0 t80 -161.59 80.71 0.58 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.644 -0.873 . . . . 0.59999999999999998 108.644 -157.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.767 HG23 HG13 ' A' ' 168' ' ' VAL . 12.6 m -91.66 135.53 26.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.647 0.737 . . . . 0.31 110.561 -174.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 58' ' ' PRO . 15.2 t -112.19 124.21 51.94 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.271 -0.877 . . . . 1.55 109.122 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.937 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 5.2 m -115.8 110.24 44.45 Favored Pre-proline 0 C--N 1.311 -1.072 0 C-N-CA 120.133 -0.627 . . . . 1.0600000000000001 111.656 -174.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.483 ' HD2' ' HA ' ' A' ' 156' ' ' SER . 1.1 Cg_endo -49.2 116.93 2.5 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.668 2.245 . . . . 0.56000000000000005 110.7 168.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.597 ' SD ' ' HB2' ' A' ' 166' ' ' LYS . 84.6 mmm -82.67 -167.23 1.54 Allowed 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.163 0.506 . . . . 1.1599999999999999 111.737 -173.219 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -75.66 -22.35 56.82 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.703 -0.68 . . . . 2.6299999999999999 109.677 172.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.6 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 43.8 mm-40 -104.42 27.56 7.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.829 -1.078 . . . . 2.0499999999999998 108.805 173.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.755 ' HB3' ' HD3' ' A' ' 162' ' ' PRO . 48.1 t-20 -8.27 -73.24 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 126.547 1.939 . . . . 1.9299999999999999 115.177 -176.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.755 ' HD3' ' HB3' ' A' ' 161' ' ' ASN . 73.0 Cg_endo -74.28 -13.49 23.15 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 121.312 1.342 . . . . 0.72999999999999998 114.137 -171.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 55' ' ' PRO . . . -108.64 -26.1 10.54 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.918 0.389 . . . . 0.68000000000000005 111.081 -176.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.6 ' HB2' ' HB2' ' A' ' 160' ' ' GLU . 89.4 m-85 -139.76 126.79 20.97 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.02 -0.537 . . . . 0.93000000000000005 109.579 178.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.832 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 13.1 p -124.43 147.07 48.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.05 0.452 . . . . 1.4099999999999999 111.228 -177.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.937 ' HB3' ' HB2' ' A' ' 156' ' ' SER . 1.6 tppp? -91.98 102.24 14.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.56 0.695 . . . . 0.73999999999999999 111.47 -177.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.532 HD21 ' CE1' ' A' ' 153' ' ' PHE . 0.8 OUTLIER -90.61 107.29 19.08 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.288 -0.869 . . . . 0.27000000000000002 109.396 175.827 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.767 HG13 HG23 ' A' ' 154' ' ' VAL . 0.1 OUTLIER -129.48 128.21 65.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.626 0.727 . . . . 0.28000000000000003 111.87 178.084 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.541 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 11.7 ttt -137.97 135.92 36.47 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 115.253 -0.885 . . . . 1.24 109.897 -172.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.751 ' CD1' HD21 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -126.91 151.11 48.88 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.231 -0.588 . . . . 3.3700000000000001 109.902 176.741 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.638 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 4.0 m -129.18 130.18 67.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-O 121.537 0.684 . . . . 1.3999999999999999 112.017 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -119.8 37.31 4.24 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.396 -1.705 . . . . 2.1699999999999999 106.396 170.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 6.7 m -52.21 131.75 32.88 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 113.27 -1.786 . . . . 1.6499999999999999 111.259 -174.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.574 ' CB ' ' HB3' ' A' ' 147' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--N 1.333 -0.117 0 N-CA-C 112.029 0.381 . . . . 2.4500000000000002 112.029 -169.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.643 ' HA ' ' HE3' ' A' ' 186' ' ' LYS . 35.3 mm . . . . . 0 CA--C 1.5 -0.955 0 CA-C-O 122.228 1.013 . . . . 1.1200000000000001 108.77 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 1.03 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.6 mp -66.66 -31.69 54.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 113.269 -1.787 . . . . 1.1299999999999999 110.437 178.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.423 ' O ' ' HD2' ' A' ' 189' ' ' PRO . 7.5 mm-40 -65.46 -28.91 69.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.102 -0.954 . . . . 2.8900000000000001 108.733 175.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.643 ' HE3' ' HA ' ' A' ' 183' ' ' ILE . 2.7 ptpt -93.08 -26.29 17.53 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.719 -1.128 . . . . 1.28 110.852 178.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' THR . . . . . 1.03 HG22 ' HA ' ' A' ' 184' ' ' ILE . 6.2 t -78.34 -44.33 25.41 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 119.996 -0.682 . . . . 0.62 112.01 -176.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' MET . . . . . 0.948 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 2.5 mmt -80.15 -68.63 0.21 Allowed Pre-proline 0 N--CA 1.455 -0.194 0 C-N-CA 120.058 -0.657 . . . . 1.0600000000000001 110.756 -173.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.948 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 36.7 Cg_exo -60.6 -15.57 37.58 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 122.66 2.24 . . . . 0.91000000000000003 113.184 -171.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 33.3 t -86.07 -45.27 11.56 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.734 -0.469 . . . . 1.5 109.734 175.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' ASN . . . . . 0.684 ' HA ' ' HB2' ' A' ' 194' ' ' ASN . 6.5 t30 -85.17 -21.6 29.13 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.598 -0.441 . . . . 1.8799999999999999 112.187 -167.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.925 HD13 HG11 ' A' ' 35' ' ' VAL . 2.4 mt -60.26 -51.97 67.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.872 0.844 . . . . 1.0900000000000001 109.844 173.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.543 ' HB ' ' CD1' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -72.12 -32.32 42.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 114.594 -1.184 . . . . 0.68000000000000005 109.781 -178.011 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.684 ' HB2' ' HA ' ' A' ' 191' ' ' ASN . 0.9 OUTLIER -72.24 -30.54 64.98 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.646 -1.161 . . . . 2.0699999999999998 111.721 -179.327 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -70.58 -29.12 65.46 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.516 -0.474 . . . . 2.0 109.918 173.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.527 HG21 HG21 ' A' ' 33' ' ' ILE . 39.1 mt -76.18 -26.54 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-O 121.315 0.579 . . . . 0.31 110.375 173.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 194' ' ' ASN . 55.3 mt -70.0 -42.74 72.63 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 116.126 -0.488 . . . . 1.03 109.947 173.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.858 ' HB3' ' HZ3' ' A' ' 74' ' ' TRP . 91.2 m-20 -50.53 -33.21 20.74 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.983 -1.008 . . . . 1.8999999999999999 109.846 168.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.658 ' HA ' ' CE2' ' A' ' 64' ' ' PHE . . . -80.52 -40.51 25.91 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 116.229 -0.441 . . . . 0.28999999999999998 111.099 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.663 ' HD3' HG12 ' A' ' 54' ' ' ILE . 25.7 mmtm -60.05 -42.05 93.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.559 0.695 . . . . 0.96999999999999997 110.094 176.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -84.51 -43.54 14.46 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.968 -1.015 . . . . 1.9399999999999999 110.689 -176.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -65.01 -30.91 79.25 Favored Glycine 0 C--O 1.228 -0.235 0 C-N-CA 120.661 -0.78 . . . . 0.46999999999999997 111.833 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 1.009 HD13 HD23 ' A' ' 61' ' ' LEU . 3.3 tp -70.53 -39.03 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 123.005 -0.115 . . . . 0.60999999999999999 110.771 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 41.4 pttt -83.98 -28.42 27.77 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.524 -0.547 . . . . 3.3700000000000001 109.524 -178.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.774 0 CA-C-N 115.374 -0.83 . . . . 1.02 109.356 170.26 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.5 mtm . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 120.754 0.312 . . . . 3.8599999999999999 110.684 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -153.8 -64.31 0.14 Allowed 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.903 -0.777 . . . . 2.25 108.903 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.502 ' CD2' HD12 ' A' ' 87' ' ' ILE . 59.1 m-85 -63.86 -33.15 75.04 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.459 0.647 . . . . 0.42999999999999999 109.341 177.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.529 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 5.7 mttp -70.1 -46.63 64.45 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 115.119 -0.946 . . . . 1.51 108.498 178.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -47.49 -48.58 27.04 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 112.324 0.49 . . . . 0.54000000000000004 112.324 -176.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.572 ' O ' ' HB ' ' A' ' 10' ' ' THR . 0.2 OUTLIER -82.95 -34.06 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 121.291 0.567 . . . . 1.0700000000000001 110.041 -173.032 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.498 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -78.83 -42.76 26.81 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.058 -0.973 . . . . 0.34000000000000002 111.767 -176.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.564 ' HG2' ' CZ ' ' A' ' 116' ' ' TYR . 34.6 mt-30 -59.35 -32.95 70.58 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.729 -1.123 . . . . 1.5900000000000001 110.103 175.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.695 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 16.3 mm-40 -79.09 -41.7 28.07 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.104 -0.953 . . . . 2.4700000000000002 108.778 173.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.619 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.3 OUTLIER -63.36 -35.53 80.71 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.039 -0.982 . . . . 0.47999999999999998 111.625 -176.931 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.463 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -46.26 -63.05 1.09 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.941 0.4 . . . . 0.31 111.4 170.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.468 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 10.4 pt20 -72.69 -9.86 59.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.289 -0.414 . . . . 1.6399999999999999 112.051 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.695 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 51.0 mt-10 -77.95 -50.23 12.57 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.631 -0.507 . . . . 2.54 109.631 174.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.627 HG21 ' N ' ' A' ' 152' ' ' GLY . 5.8 p -68.65 -39.42 80.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 122.049 0.928 . . . . 0.53000000000000003 109.393 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.468 ' HB3' ' HA ' ' A' ' 12' ' ' GLN . 0.8 OUTLIER -66.9 -27.57 67.61 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 114.548 -1.206 . . . . 0.59999999999999998 108.93 173.184 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.93 -17.86 63.69 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 113.97 -1.468 . . . . 0.56999999999999995 110.662 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.504 ' CD2' ' HA ' ' A' ' 14' ' ' VAL . 17.9 m-85 -90.63 -22.65 21.11 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.089 -0.556 . . . . 3.27 109.508 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.492 ' CB ' ' HZ ' ' A' ' 170' ' ' PHE . 0.1 OUTLIER -69.67 -24.38 63.6 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 120.184 -0.607 . . . . 2.0299999999999998 109.385 176.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.23 9.7 27.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.324 -0.853 . . . . 2.7200000000000002 110.118 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.425 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 29.6 t70 -123.08 74.9 1.25 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.444 -0.798 . . . . 2.1600000000000001 109.108 177.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.439 HG22 ' CH2' ' A' ' 24' ' ' TRP . 53.2 p -102.83 88.84 3.29 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.453 0.644 . . . . 1.8200000000000001 111.183 -172.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.1 p -173.4 168.64 4.55 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.659 -1.155 . . . . 2.1899999999999999 110.127 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.57 9.69 62.24 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 121.171 -0.538 . . . . 1.1000000000000001 112.908 175.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.463 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -120.44 -158.95 0.77 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.88 0.371 . . . . 1.6699999999999999 111.395 -177.521 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.51 122.37 0.35 Allowed 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.155 -0.683 . . . . 2.9500000000000002 109.155 -168.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 3.1 m -65.12 124.12 19.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 122.084 0.945 . . . . 1.5600000000000001 111.252 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.3 p -102.02 -24.4 4.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 113.918 -1.492 . . . . 1.22 108.84 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.403 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 17.7 tppt? -147.81 112.73 5.44 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.903 -0.59 . . . . 2.4100000000000001 111.89 -174.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.56 HG22 ' HA ' ' A' ' 34' ' ' THR . 43.2 p -130.0 151.04 50.98 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.163 -0.472 . . . . 1.3799999999999999 110.314 173.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.3 t -118.84 -98.85 0.45 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.27 -0.423 . . . . 2.3700000000000001 110.027 174.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -144.86 17.52 1.61 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.624 0.726 . . . . 4.5499999999999998 110.035 176.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.573 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 13.1 tptm -167.92 -0.6 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.677 -0.692 . . . . 1.4199999999999999 110.738 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 51' ' ' GLU . 41.7 pt -136.44 154.02 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 120.951 0.405 . . . . 0.76000000000000001 110.802 -176.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.56 ' HA ' HG22 ' A' ' 29' ' ' THR . 54.4 m -150.2 99.59 2.82 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.675 -0.693 . . . . 0.57999999999999996 111.299 -168.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.487 HG11 ' HA ' ' A' ' 189' ' ' PRO . 9.9 t -92.48 118.77 38.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.928 -0.397 . . . . 0.85999999999999999 109.928 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.544 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -118.64 124.4 47.31 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.435 0.636 . . . . 1.1000000000000001 111.117 -176.664 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.528 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 22.4 m -95.28 122.48 38.02 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.721 -1.127 . . . . 1.27 111.037 -175.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 29.1 ttmt -119.21 -90.85 0.57 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.508 -0.315 . . . . 1.9099999999999999 111.354 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.451 ' H ' ' HB3' ' A' ' 38' ' ' LYS . . . -159.84 130.72 5.79 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.246 -0.279 . . . . 1.6799999999999999 110.246 -174.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.435 ' CB ' ' HB2' ' A' ' 172' ' ' GLN . 4.2 p -77.71 -40.61 40.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.577 -0.283 . . . . 2.0899999999999999 110.947 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 67.25 -40.44 0.39 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.822 0.849 . . . . 6.6100000000000003 112.679 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.401 ' HD2' ' N ' ' A' ' 42' ' ' LYS . 0.3 OUTLIER -91.94 18.92 7.18 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.749 -0.463 . . . . 6.46 109.749 174.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -167.27 149.45 5.98 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.418 -1.327 . . . . 5.6500000000000004 107.418 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -79.77 59.34 3.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.098 0.475 . . . . 5.5599999999999996 110.638 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.83 -129.61 1.91 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.968 -0.634 . . . . 1.5600000000000001 112.482 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.528 ' OD1' ' HB3' ' A' ' 37' ' ' SER . 0.1 OUTLIER -151.51 152.48 33.03 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.706 0.289 . . . . 2.0499999999999998 110.251 177.725 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.705 HD23 ' N ' ' A' ' 48' ' ' TYR . 6.4 tt -96.97 147.55 23.87 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.283 -0.636 . . . . 0.87 109.283 -177.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.705 ' N ' HD23 ' A' ' 47' ' ' LEU . 46.9 m-85 -117.88 124.36 48.1 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.643 -0.502 . . . . 0.98999999999999999 109.643 -176.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.439 ' HD3' HG23 ' A' ' 168' ' ' VAL . 1.4 tmm_? -117.88 120.69 38.65 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.343 -0.39 . . . . 2.9199999999999999 109.989 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.537 ' CG1' ' HB3' ' A' ' 192' ' ' LEU . 11.3 p -103.45 149.79 7.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 120.696 -0.402 . . . . 1.3300000000000001 110.088 177.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.552 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 34.1 tt0 -143.63 111.36 6.01 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.914 -0.584 . . . . 1.0700000000000001 110.036 -172.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.573 ' HA2' ' O ' ' A' ' 32' ' ' LYS . . . -140.73 138.86 9.23 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.323 -0.941 . . . . 0.28999999999999998 112.498 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.416 ' HB ' ' HE2' ' A' ' 32' ' ' LYS . 63.6 mt -90.23 113.93 27.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 120.168 -0.613 . . . . 0.57999999999999996 110.786 177.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.48 ' CD1' ' HB1' ' A' ' 199' ' ' ALA . 57.4 mt -95.89 116.53 66.29 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.627 -0.715 . . . . 0.34999999999999998 109.454 175.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -61.91 64.26 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 124.381 3.388 . . . . 0.62 113.065 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.566 ' HG2' ' CG1' ' A' ' 203' ' ' ILE . 12.4 tp10 -156.84 173.43 17.0 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.656 -0.868 . . . . 1.6799999999999999 108.656 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.49 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 10.2 m -81.63 142.07 49.12 Favored Pre-proline 0 N--CA 1.423 -1.796 0 N-CA-C 109.332 -0.618 . . . . 1.1799999999999999 109.332 178.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 57' ' ' SER . 31.2 Cg_exo -59.08 -12.31 15.3 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 123.723 2.949 . . . . 0.52000000000000002 111.038 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.9 -50.21 37.49 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.825 -1.079 . . . . 0.64000000000000001 111.292 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.447 ' HB3' HD11 ' A' ' 203' ' ' ILE . 17.4 ttmm -71.02 -27.59 63.79 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.089 -0.708 . . . . 3.2999999999999998 109.089 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.971 HD23 HD13 ' A' ' 203' ' ' ILE . 47.0 mt -62.3 -55.8 24.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.86 -1.063 . . . . 0.40999999999999998 109.666 173.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.534 ' HA ' ' CD1' ' A' ' 65' ' ' LEU . 13.7 p -71.84 -1.64 14.92 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.135 0.493 . . . . 1.29 110.83 176.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -88.85 -30.25 19.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.923 -0.58 . . . . 1.3200000000000001 111.141 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.7 ' CE1' ' HB3' ' A' ' 65' ' ' LEU . 6.1 p90 -90.02 -46.07 8.75 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 120.774 -0.37 . . . . 0.60999999999999999 111.06 -174.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.704 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -87.56 6.97 31.76 Favored 'General case' 0 CA--C 1.517 -0.302 0 O-C-N 121.811 -0.556 . . . . 1.5 110.535 -173.545 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -48.44 -63.43 1.08 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.8 -1.091 . . . . 1.52 112.496 -167.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.465 ' O ' ' HD2' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -154.73 -85.32 0.06 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 119.433 -0.907 . . . . 3.6000000000000001 112.942 -175.683 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.638 ' HB ' ' CD1' ' A' ' 81' ' ' TYR . 9.1 t -141.06 21.52 2.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.965 0.412 . . . . 1.48 111.583 -164.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -115.95 0.98 21.31 Favored Glycine 0 C--N 1.311 -0.833 0 C-N-CA 118.716 -1.707 . . . . 1.46 113.97 -164.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.559 ' O ' HG22 ' A' ' 73' ' ' THR . 6.6 p-10 179.17 -31.81 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.258 -0.645 . . . . 2.1899999999999999 109.258 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.626 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 18.3 ttt180 -34.57 -59.45 0.46 Allowed 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 125.649 1.58 . . . . 3.3799999999999999 111.189 176.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.703 HD13 ' H ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -88.8 -6.98 10.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.879 -1.055 . . . . 0.70999999999999996 111.223 -172.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.559 HG22 ' O ' ' A' ' 70' ' ' ASP . 0.7 OUTLIER -88.21 -45.13 10.34 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 120.326 -0.549 . . . . 0.96999999999999997 110.523 -171.614 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.517 ' CZ3' ' HB2' ' A' ' 198' ' ' ASN . 18.7 p-90 -102.24 1.38 35.81 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 120.54 -0.464 . . . . 0.75 110.95 -174.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.626 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 5.3 t70 -71.03 -171.07 0.51 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.878 0.846 . . . . 2.1899999999999999 111.578 -175.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.64 ' HD3' ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -126.34 -29.07 3.01 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.678 -1.146 . . . . 3.1899999999999999 109.217 -175.694 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.1 m -120.01 8.87 11.08 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.372 -0.831 . . . . 1.5800000000000001 110.142 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.567 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 39.6 mt -108.9 155.39 20.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.99 0.424 . . . . 0.70999999999999996 110.336 178.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.578 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 5.2 mm-40 -132.04 -69.37 0.6 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.54 -0.755 . . . . 1.73 111.509 -175.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.49 HG23 ' HB3' ' A' ' 79' ' ' GLN . 14.4 t -139.01 134.05 41.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.125 -0.489 . . . . 0.78000000000000003 110.377 -171.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.638 ' CD1' ' HB ' ' A' ' 68' ' ' THR . 15.9 t80 -117.53 137.05 52.82 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.827 -0.434 . . . . 5.4000000000000004 109.827 175.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.423 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 20.3 m120 -136.6 124.58 22.81 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.655 -0.869 . . . . 1.6899999999999999 108.655 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.472 ' CG ' ' HD3' ' A' ' 86' ' ' ARG . 21.4 tpp -80.21 97.2 6.83 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.163 -0.926 . . . . 2.0499999999999998 109.272 -176.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -75.65 -77.08 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.099 -0.501 . . . . 0.64000000000000001 111.817 -170.557 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -136.01 103.54 5.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.984 0.421 . . . . 1.96 110.459 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.472 ' HD3' ' CG ' ' A' ' 83' ' ' MET . 85.1 mtm180 -83.95 133.7 34.69 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.204 -0.665 . . . . 2.4399999999999999 109.204 175.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.623 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -86.57 -47.16 16.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.624 -0.716 . . . . 0.46999999999999997 109.32 -174.449 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -142.15 -152.34 0.4 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.224 -0.898 . . . . 1.8600000000000001 108.948 175.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.3 m -88.33 -7.86 56.04 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.039 0.385 . . . . 1.4399999999999999 112.039 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -134.4 14.99 3.77 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 120.365 -0.534 . . . . 1.8700000000000001 110.481 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.623 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.5 OUTLIER -136.49 103.96 5.42 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 108.09 -1.078 . . . . 0.46000000000000002 108.09 -178.68 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.605 ' O ' HD12 ' A' ' 114' ' ' LEU . 10.2 m-85 -120.65 172.59 7.75 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.008 0.432 . . . . 0.42999999999999999 110.224 -173.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.633 ' O ' HG23 ' A' ' 84' ' ' VAL . 42.4 mt -132.56 128.46 57.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 107.541 -1.281 . . . . 0.40999999999999998 107.541 168.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.592 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 26.1 p -106.6 129.91 54.45 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.407 -0.361 . . . . 2.0099999999999998 111.542 -173.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.538 ' HA ' HD13 ' A' ' 112' ' ' ILE . 4.1 t60 -94.35 90.93 6.46 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.148 -1.056 . . . . 1.23 108.148 163.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 85.3 m -108.53 109.33 20.55 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.536 -0.756 . . . . 0.5 111.787 -173.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.441 ' O ' ' HB2' ' A' ' 79' ' ' GLN . 44.7 mm -77.65 121.46 30.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.564 -0.902 . . . . 1.03 108.564 171.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.427 ' CG2' ' HB2' ' A' ' 109' ' ' ARG . 14.7 t -112.55 156.51 22.53 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.689 0.757 . . . . 1.3799999999999999 111.222 -176.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.578 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 20.9 mt-30 -107.48 37.7 2.34 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.481 -1.236 . . . . 1.8200000000000001 108.938 176.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 66.7 m -79.76 65.18 4.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.909 -0.587 . . . . 3.9100000000000001 110.045 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.493 ' HA ' ' HB ' ' A' ' 106' ' ' ILE . 46.2 p90 -117.82 128.21 54.63 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 115.552 -0.749 . . . . 5.1600000000000001 110.263 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.678 ' H ' HD12 ' A' ' 106' ' ' ILE . . . -77.22 64.72 2.68 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.942 -1.026 . . . . 1.98 110.959 177.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 97.7 t 74.25 -42.09 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.077 -0.965 . . . . 3.1699999999999999 112.939 172.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -167.4 -23.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 119.032 -1.556 . . . . 1.96 114.783 -176.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.0 m -83.55 2.82 35.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 117.874 0.837 . . . . 1.8799999999999999 111.239 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.678 HD12 ' H ' ' A' ' 102' ' ' ALA . 62.0 mt -136.9 140.63 42.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.943 -0.571 . . . . 1.1200000000000001 110.337 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.0 m -99.06 151.38 37.36 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.66 -0.496 . . . . 1.3500000000000001 109.66 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.16 147.95 10.61 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.162 2.575 . . . . 1.0700000000000001 112.195 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.508 ' HG2' HG23 ' A' ' 144' ' ' ILE . 42.6 mtt180 -121.97 157.08 32.08 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.709 -0.796 . . . . 3.4500000000000002 111.748 -170.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.824 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 7.1 t0 -104.48 116.74 32.63 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.276 -0.875 . . . . 1.3700000000000001 109.17 174.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.525 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 13.3 m-30 -100.56 109.77 21.88 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.89 -0.506 . . . . 2.4100000000000001 110.664 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.601 HG21 ' CE1' ' A' ' 134' ' ' PHE . 24.5 mm -104.96 76.15 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 N-CA-C 109.12 -0.696 . . . . 0.42999999999999999 109.12 173.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.595 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 25.7 m-20 -99.54 124.15 44.46 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.649 -0.705 . . . . 1.8600000000000001 110.435 -178.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.605 HD12 ' O ' ' A' ' 92' ' ' PHE . 3.5 tp -75.74 127.19 32.51 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 108.378 -0.971 . . . . 0.28000000000000003 108.378 169.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -128.62 124.51 61.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-N 115.485 -0.78 . . . . 0.26000000000000001 112.133 -163.582 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.564 ' CZ ' ' HG2' ' A' ' 8' ' ' GLN . 67.5 t80 -114.36 121.13 42.67 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.923 -1.035 . . . . 2.5699999999999998 110.943 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.564 HG12 HG22 ' A' ' 127' ' ' ILE . 88.7 mt -95.72 122.31 47.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.801 -0.636 . . . . 0.89000000000000001 110.438 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.42 ' HE2' ' HE2' ' A' ' 116' ' ' TYR . 13.4 tppt? -131.41 134.57 46.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.964 -0.562 . . . . 1.2 111.255 -173.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.0 tpp180 -112.93 100.49 8.68 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.908 -0.587 . . . . 2.7999999999999998 109.616 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -75.11 107.39 7.16 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.571 -1.27 . . . . 0.82999999999999996 107.571 169.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 1.7 mp0 -26.44 97.12 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 O-C-N 125.024 1.453 . . . . 2.2799999999999998 113.535 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 56.7 31.89 61.1 Favored Glycine 0 CA--C 1.51 -0.22 0 CA-C-N 114.565 -1.198 . . . . 0.76000000000000001 113.242 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.645 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 5.8 m-20 -125.95 -49.01 1.61 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.957 -0.386 . . . . 1.6499999999999999 109.957 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.403 ' SD ' ' HB3' ' A' ' 123' ' ' ASN . 2.2 mpt? -157.56 141.3 15.79 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 110.259 -0.275 . . . . 1.1200000000000001 110.259 -178.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -120.33 85.93 2.48 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.404 -0.961 . . . . 1.6200000000000001 108.404 167.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.469 ' CG1' HG12 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -97.65 144.47 10.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.29 -1.323 . . . . 0.29999999999999999 112.282 -171.71 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.66 ' O ' HG13 ' A' ' 127' ' ' ILE . 2.1 pt -109.03 116.1 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 108.1 -1.074 . . . . 0.58999999999999997 108.1 161.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.592 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 43.3 p -83.94 159.05 21.36 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.822 -0.807 . . . . 1.1799999999999999 108.822 173.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.595 ' HB3' ' HB3' ' A' ' 113' ' ' ASP . 20.4 m -153.15 128.64 9.97 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 120.675 0.274 . . . . 1.24 111.05 -175.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -128.28 121.01 28.26 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 107.929 -1.137 . . . . 2.2599999999999998 107.929 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.457 ' HB2' ' H ' ' A' ' 148' ' ' ASN . 48.0 t -63.58 100.16 0.26 Allowed 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.318 -1.364 . . . . 1.3899999999999999 107.318 174.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -108.58 140.08 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.057 0 CA-C-N 114.348 -1.296 . . . . 1.05 108.691 -165.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -96.2 73.15 2.9 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.182 -0.917 . . . . 2.1699999999999999 109.633 -171.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.787 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -105.38 150.87 39.44 Favored Pre-proline 0 N--CA 1.437 -1.103 0 CA-C-N 114.704 -1.134 . . . . 0.53000000000000003 109.234 -174.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 8.2 Cg_exo -76.29 -9.77 19.04 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.736 2.291 . . . . 1.28 115.224 -169.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.787 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 7.4 tp10 -73.13 -13.25 61.14 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.906 -0.405 . . . . 3.5 109.906 -172.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.477 ' HB2' HG11 ' A' ' 84' ' ' VAL . 20.0 t80 -152.68 120.43 3.14 Favored Pre-proline 0 N--CA 1.449 -0.487 0 N-CA-C 113.419 0.896 . . . . 6.1200000000000001 113.419 174.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -99.92 134.83 0.22 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 124.046 3.164 . . . . 1.77 111.774 167.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.408 ' HG3' ' HB2' ' A' ' 145' ' ' ARG . 83.1 Cg_endo -79.23 -159.31 0.1 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.592 2.195 . . . . 1.25 112.136 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.0 p -145.48 -167.84 2.8 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.434 -0.58 . . . . 1.6000000000000001 109.434 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.1 t -88.58 -19.94 25.66 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.558 -0.457 . . . . 1.97 109.813 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -77.15 -32.26 56.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.053 -0.521 . . . . 2.1800000000000002 109.95 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.445 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 73.4 m-85 -130.58 114.97 16.12 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 115.659 -0.701 . . . . 1.23 109.461 176.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.508 HG23 ' HG2' ' A' ' 109' ' ' ARG . 2.0 tp -94.36 113.92 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 109.136 -0.69 . . . . 0.81999999999999995 109.136 -175.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.824 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 41.4 ttp180 -50.4 99.41 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.122 -0.945 . . . . 4.4199999999999999 109.672 173.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.6 122.04 26.85 Favored Glycine 0 N--CA 1.434 -1.483 0 CA-C-N 115.068 -0.969 . . . . 0.79000000000000004 111.784 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.619 ' H ' ' NH1' ' A' ' 176' ' ' ARG . 2.8 m-85 -82.16 79.42 8.66 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.876 0.846 . . . . 4.4400000000000004 110.955 177.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.457 ' H ' ' HB2' ' A' ' 131' ' ' SER . 17.4 m-20 -85.79 87.69 7.44 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.888 -1.505 . . . . 1.6200000000000001 108.435 172.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.5 ' HB2' ' HG2' ' A' ' 172' ' ' GLN . 96.4 m-70 -58.68 150.87 55.44 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-O 118.711 -0.661 . . . . 2.3199999999999998 109.367 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.619 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 50.9 Cg_exo -18.62 68.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.198 1 C-N-CA 127.055 5.17 . . . . 0.53000000000000003 116.12 -173.053 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' CYS . . . . . 0.568 ' HB2' ' O ' ' A' ' 170' ' ' PHE . 19.6 p -97.24 -173.81 2.77 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.618 -1.174 . . . . 1.5800000000000001 110.413 174.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.627 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -174.04 -160.65 22.69 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 120.573 -0.823 . . . . 0.42999999999999999 112.044 177.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.474 ' CZ ' HD11 ' A' ' 167' ' ' LEU . 35.4 t80 -161.57 96.08 1.03 Allowed 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.291 -1.003 . . . . 0.59999999999999998 108.291 -167.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.591 ' CG2' HG13 ' A' ' 168' ' ' VAL . 2.3 m -104.15 136.24 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 121.838 0.828 . . . . 0.31 111.188 -173.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 77.6 m -115.49 112.43 22.24 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.101 -0.954 . . . . 1.55 109.048 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.472 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 6.5 m -111.21 118.5 47.6 Favored Pre-proline 0 C--N 1.32 -0.7 0 C-N-CA 120.638 -0.425 . . . . 1.0600000000000001 111.762 -169.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.645 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 39.6 Cg_exo -49.88 119.65 5.07 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.265 1.977 . . . . 0.56000000000000005 111.136 170.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.585 ' SD ' ' HB2' ' A' ' 166' ' ' LYS . 60.4 mmm -79.68 -163.54 0.54 Allowed 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 120.916 0.389 . . . . 1.1599999999999999 111.376 -177.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -68.97 -26.33 64.98 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.476 0.655 . . . . 2.6299999999999999 109.978 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -98.88 15.51 25.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.454 -0.794 . . . . 2.0499999999999998 109.251 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.53 ' HB2' ' CD ' ' A' ' 162' ' ' PRO . 41.0 m-80 23.02 -87.81 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 126.051 1.74 . . . . 1.9299999999999999 115.484 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.53 ' CD ' ' HB2' ' A' ' 161' ' ' ASN . 73.5 Cg_endo -72.31 -16.7 27.89 Favored 'Trans proline' 0 C--N 1.364 1.374 0 CA-C-N 121.539 1.585 . . . . 0.72999999999999998 113.147 -174.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -90.93 -35.28 14.81 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.25 -0.432 . . . . 0.68000000000000005 111.181 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.571 ' O ' ' HB2' ' A' ' 158' ' ' MET . 93.8 m-85 -139.51 133.26 30.62 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.763 -0.458 . . . . 0.93000000000000005 109.763 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.417 ' HB3' HD11 ' A' ' 61' ' ' LEU . 32.4 t -125.99 148.09 49.37 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.514 0.673 . . . . 1.4099999999999999 111.092 -177.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.585 ' HB2' ' SD ' ' A' ' 158' ' ' MET . 1.8 tppp? -96.21 102.36 14.14 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.117 -0.947 . . . . 0.73999999999999999 111.235 -177.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.474 HD11 ' CZ ' ' A' ' 153' ' ' PHE . 0.5 OUTLIER -86.84 109.32 19.21 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.511 -1.222 . . . . 0.27000000000000002 109.006 177.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.591 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -131.32 128.74 61.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.439 0.638 . . . . 0.28000000000000003 111.804 177.422 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 23.1 ttt -129.79 145.16 51.57 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.808 -0.633 . . . . 1.24 110.692 -174.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.607 ' CD1' HG22 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -125.72 141.73 51.86 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.463 -0.79 . . . . 3.3700000000000001 109.474 -178.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 4.3 p -150.25 137.59 13.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 120.439 -0.504 . . . . 1.3999999999999999 110.512 173.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.531 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 19.8 pm0 -127.4 52.67 1.8 Allowed 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 122.528 1.156 . . . . 2.1699999999999999 108.358 178.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.578 ' HB ' ' SD ' ' A' ' 175' ' ' MET . 1.8 m -56.14 148.16 18.71 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 113.492 -1.686 . . . . 1.6499999999999999 112.112 -174.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.496 ' OE1' ' HB3' ' A' ' 176' ' ' ARG . 38.3 tt0 -83.24 -26.9 30.31 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.571 -0.741 . . . . 2.4500000000000002 112.666 -178.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.578 ' SD ' ' HB ' ' A' ' 173' ' ' THR . 3.8 mpp? 44.45 56.07 5.27 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.167 0.508 . . . . 3.7400000000000002 110.918 -173.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.619 ' NH1' ' H ' ' A' ' 147' ' ' TYR . 0.0 OUTLIER -71.8 -1.58 14.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.424 -0.807 . . . . 5.7800000000000002 112.225 -175.413 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -81.97 -163.18 31.65 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.612 -0.804 . . . . 2.2599999999999998 111.996 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -94.82 78.95 3.67 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.042 0.449 . . . . 6.2300000000000004 110.296 -177.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.63 ' HB2' HD11 ' A' ' 184' ' ' ILE . 2.2 mp -121.02 162.55 19.76 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 109.237 -0.653 . . . . 1.6399999999999999 109.237 175.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.51 ' O ' HD12 ' A' ' 184' ' ' ILE . 14.9 m -114.09 161.03 30.16 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 108.393 -0.966 . . . . 2.04 108.393 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.433 ' O ' ' HG2' ' A' ' 185' ' ' GLU . 75.1 Cg_exo -41.02 -50.1 4.29 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 122.751 2.3 . . . . 1.74 113.114 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.496 ' O ' ' HG3' ' A' ' 186' ' ' LYS . 12.6 m -70.18 -15.01 62.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.344 0.498 . . . . 2.1400000000000001 112.344 -176.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.464 ' CG1' ' H ' ' A' ' 180' ' ' SER . 27.3 mm -84.59 -37.3 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-O 122.947 1.356 . . . . 1.1200000000000001 107.979 -176.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.966 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.4 mp -74.05 -35.16 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.691 0 CA-C-N 112.199 -2.273 . . . . 1.1299999999999999 110.149 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 181' ' ' PRO . 36.3 mm-40 -57.77 -26.42 61.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.961 -1.018 . . . . 2.8900000000000001 109.833 171.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 182' ' ' SER . 50.9 mtmt -92.76 -36.87 12.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.512 -0.767 . . . . 1.28 111.224 176.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.966 HG22 ' HA ' ' A' ' 184' ' ' ILE . 6.2 t -68.49 -45.71 71.63 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.259 0.466 . . . . 0.62 112.259 -172.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' MET . . . . . 0.588 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 32.3 mmt -80.05 -57.88 0.64 Allowed Pre-proline 0 N--CA 1.464 0.258 0 N-CA-C 112.712 0.634 . . . . 1.0600000000000001 112.712 -173.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.656 ' O ' HG13 ' A' ' 193' ' ' VAL . 39.5 Cg_exo -58.21 -40.23 78.05 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.642 1.561 . . . . 0.91000000000000003 112.163 -175.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 69.8 m -77.24 -24.54 51.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.24 -0.436 . . . . 1.5 111.111 -175.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ASN . . . . . 0.579 ' HB2' ' O ' ' A' ' 187' ' ' THR . 46.5 t30 -80.15 -34.9 37.29 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.66 -0.416 . . . . 1.8799999999999999 110.529 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.537 ' HB3' ' CG1' ' A' ' 50' ' ' VAL . 53.9 mt -68.91 -42.95 76.17 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 120.633 0.254 . . . . 1.0900000000000001 111.027 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.656 HG13 ' O ' ' A' ' 189' ' ' PRO . 2.4 m -62.38 -31.43 51.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 121.65 0.738 . . . . 0.68000000000000005 109.179 176.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.406 ' HA ' ' HB2' ' A' ' 197' ' ' LEU . 1.0 OUTLIER -75.26 -31.12 60.68 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.366 -1.288 . . . . 2.0699999999999998 111.076 -179.409 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -68.75 -28.13 66.53 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 121.348 0.594 . . . . 2.0 109.775 171.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.546 ' O ' ' HD3' ' A' ' 200' ' ' LYS . 28.7 mt -81.86 -26.09 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-O 121.255 0.55 . . . . 0.31 111.206 173.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.406 ' HB2' ' HA ' ' A' ' 194' ' ' ASN . 37.6 mt -72.04 -43.06 65.55 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-N 116.346 -0.388 . . . . 1.03 110.403 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.517 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 5.4 p30 -55.71 -30.68 61.54 Favored 'General case' 0 C--O 1.213 -0.856 0 N-CA-C 108.428 -0.952 . . . . 1.8999999999999999 108.428 170.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.66 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -76.19 -45.42 33.32 Favored 'General case' 0 N--CA 1.428 -1.537 0 O-C-N 121.64 -0.663 . . . . 0.28999999999999998 110.422 -178.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.546 ' HD3' ' O ' ' A' ' 196' ' ' ILE . 1.5 mptm? -56.29 -45.11 80.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.877 -0.601 . . . . 0.96999999999999997 111.263 174.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -86.52 -37.02 18.62 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.43 -0.805 . . . . 1.9399999999999999 111.421 -173.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' GLY . . . . . 0.474 ' HA3' ' CH2' ' A' ' 74' ' ' TRP . . . -68.71 -32.58 74.51 Favored Glycine 0 N--CA 1.462 0.395 0 C-N-CA 120.999 -0.619 . . . . 0.46999999999999997 111.746 177.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.971 HD13 HD23 ' A' ' 61' ' ' LEU . 2.4 tp -69.88 -34.96 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 110.068 -0.345 . . . . 0.60999999999999999 110.068 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.478 ' O ' ' HB ' ' A' ' 208' ' ' THR . 65.3 mttm -89.34 -20.55 23.89 Favored 'General case' 0 C--O 1.215 -0.714 0 N-CA-C 109.305 -0.628 . . . . 3.3700000000000001 109.305 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -63.92 -37.15 86.34 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.719 -0.845 . . . . 1.02 108.719 168.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.48 ' HE1' ' OD2' ' A' ' 70' ' ' ASP . 35.6 m80 -76.34 -41.38 48.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.249 -0.887 . . . . 3.6299999999999999 111.831 174.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 203' ' ' ILE . 0.5 OUTLIER -87.14 -57.24 3.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.577 0.703 . . . . 2.5899999999999999 110.977 -170.604 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 204' ' ' LYS . 97.3 m -81.23 146.17 57.66 Favored Pre-proline 0 C--N 1.315 -0.934 0 CA-C-N 114.874 -1.057 . . . . 1.8400000000000001 110.2 -178.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -65.44 60.4 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.559 2.173 . . . . 2.3500000000000001 111.914 171.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.7 t -107.09 22.8 15.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.755 0.788 . . . . 2.3100000000000001 109.182 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 -90.08 2.5 55.17 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.385 -0.825 . . . . 5.4500000000000002 109.749 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -68.78 -23.14 64.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.27 -0.877 . . . . 6.8600000000000003 109.987 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -100.41 62.99 0.62 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.34 -1.104 . . . . 3.3700000000000001 110.34 169.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -69.24 99.75 1.21 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.03 0.443 . . . . 5.21 110.868 -174.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -93.03 111.38 22.99 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.944 -0.571 . . . . 6.46 110.093 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 67.0 147.98 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 O-C-N 123.837 0.71 . . . . 6.0899999999999999 111.21 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -72.52 112.69 8.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.283 0.563 . . . . 5.1200000000000001 110.385 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 11.8 m -53.96 -46.14 71.52 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 114.74 -1.118 . . . . 6.7599999999999998 112.461 -173.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -112.39 21.64 15.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.746 0.307 . . . . 8.8200000000000003 110.231 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 18.7 m . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.104 -0.95 . . . . 8.4800000000000004 110.755 -179.123 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.578 ' HG3' HG22 ' A' ' 87' ' ' ILE . 1.1 mpt? . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 120.862 0.363 . . . . 3.8599999999999999 110.866 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -81.7 -26.06 34.95 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 121.254 0.549 . . . . 2.25 109.745 -176.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.79 ' HA ' HD12 ' A' ' 6' ' ' ILE . 96.4 m-85 -68.64 -30.03 68.65 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.477 -0.783 . . . . 0.42999999999999999 109.056 -176.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.62 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 3.0 tppp? -70.72 -7.42 44.61 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 114.95 -1.023 . . . . 1.51 109.986 176.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.71 -42.15 10.88 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.151 0.501 . . . . 0.54000000000000004 109.804 174.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.79 HD12 ' HA ' ' A' ' 3' ' ' PHE . 1.3 mp -81.82 -43.9 19.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.98 -0.748 . . . . 1.0700000000000001 108.98 -172.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.888 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -67.68 -47.96 67.98 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.546 -1.206 . . . . 0.34000000000000002 111.653 -178.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.62 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 4.3 mt-30 -63.9 -27.02 68.86 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.27 -1.332 . . . . 1.5900000000000001 110.722 -176.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.477 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 99.6 mt-30 -82.45 -39.2 22.89 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.201 -0.909 . . . . 2.4700000000000002 109.211 171.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.931 HG21 ' HZ2' ' A' ' 130' ' ' LYS . 0.5 OUTLIER -65.44 -37.67 87.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.844 -1.071 . . . . 0.47999999999999998 112.401 -177.67 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.52 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -47.36 -53.05 14.77 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.132 0.419 . . . . 0.31 112.132 176.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.564 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 28.3 pt20 -79.87 -4.54 52.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.75 0.31 . . . . 1.6399999999999999 111.115 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 10' ' ' THR . 70.8 mm-40 -75.98 -54.38 6.96 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.206 -0.664 . . . . 2.54 109.206 172.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.621 HG21 ' N ' ' A' ' 152' ' ' GLY . 12.6 p -70.18 -36.83 69.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 114.82 -1.082 . . . . 0.53000000000000003 110.334 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.564 ' HB3' ' HA ' ' A' ' 12' ' ' GLN . 0.6 OUTLIER -69.16 -24.4 64.07 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-O 122.059 0.933 . . . . 0.59999999999999998 108.869 174.785 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.45 -17.74 68.95 Favored Glycine 0 CA--C 1.501 -0.833 0 CA-C-N 113.755 -1.566 . . . . 0.56999999999999995 109.967 177.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.576 ' HA ' ' CB ' ' A' ' 20' ' ' ASP . 30.8 m-85 -90.39 -23.85 20.95 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 114.755 -0.723 . . . . 3.27 109.381 176.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.549 ' HA ' ' HZ ' ' A' ' 170' ' ' PHE . 66.2 t30 -66.48 -19.74 65.86 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-O 121.452 0.644 . . . . 2.0299999999999998 109.541 176.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -120.2 10.58 11.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.433 -0.803 . . . . 2.7200000000000002 110.294 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.576 ' CB ' ' HA ' ' A' ' 17' ' ' TYR . 9.2 t70 -86.07 -31.58 21.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.258 -0.883 . . . . 2.1600000000000001 110.773 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.3 t -16.65 86.99 0.0 OUTLIER 'General case' 0 C--O 1.235 0.309 0 O-C-N 125.485 1.741 . . . . 1.8200000000000001 113.733 -169.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.5 t -172.64 137.48 0.8 Allowed 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.352 -1.749 . . . . 2.1899999999999999 109.068 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.37 -11.5 68.77 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.637 -0.792 . . . . 1.1000000000000001 112.19 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.833 ' HA ' ' HB3' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -104.39 -160.24 0.75 Allowed 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 120.97 0.414 . . . . 1.6699999999999999 110.775 -179.634 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.471 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 2.0 tmmm? -170.48 128.97 0.83 Allowed 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 115.442 -0.799 . . . . 2.9500000000000002 109.18 -174.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.581 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 0.1 OUTLIER -70.35 109.3 2.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-O 121.947 0.879 . . . . 1.5600000000000001 109.374 175.017 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 p -93.19 -25.07 5.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 114.172 -1.376 . . . . 1.22 109.46 -172.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.456 ' HD2' ' HA ' ' A' ' 28' ' ' LYS . 17.4 tptp -153.95 132.03 11.78 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 119.755 -0.778 . . . . 2.4100000000000001 112.015 -175.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.702 ' HB ' ' HA ' ' A' ' 34' ' ' THR . 0.0 OUTLIER -152.01 152.76 32.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.236 0.541 . . . . 1.3799999999999999 112.06 177.292 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 35.6 m -104.6 25.68 9.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.423 -0.808 . . . . 2.3700000000000001 110.499 175.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 30' ' ' SER . 28.6 mmmt 75.53 19.0 2.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.81 -0.632 . . . . 4.5499999999999998 111.911 175.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.581 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 9.3 mmtp -164.76 -30.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.795 -0.639 . . . . 1.4199999999999999 110.073 175.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.906 HG22 ' HA3' ' A' ' 52' ' ' GLY . 29.7 pt -110.87 136.9 45.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 108.629 -0.878 . . . . 0.76000000000000001 108.629 171.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.702 ' HA ' ' HB ' ' A' ' 29' ' ' THR . 0.2 OUTLIER -140.35 115.62 9.91 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.506 0.194 . . . . 0.57999999999999996 111.206 -162.439 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.687 HG22 HG23 ' A' ' 50' ' ' VAL . 6.2 t -99.67 115.04 39.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.957 0.408 . . . . 0.85999999999999999 110.563 -177.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.581 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -107.81 122.76 47.42 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.844 -0.617 . . . . 1.1000000000000001 110.226 -177.679 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.5 t -114.73 131.46 56.76 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.908 -0.587 . . . . 1.27 112.301 -172.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.833 ' HB3' ' HA ' ' A' ' 24' ' ' TRP . 56.5 pttt -153.13 148.49 27.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.516 -0.765 . . . . 1.9099999999999999 110.057 167.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.691 ' HA ' ' HA ' ' A' ' 46' ' ' ASN . . . -53.01 126.62 21.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.216 -0.447 . . . . 1.6799999999999999 110.24 175.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.513 ' OG ' ' HB2' ' A' ' 47' ' ' LEU . 4.7 m -66.04 -22.4 66.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.618 -0.719 . . . . 2.0899999999999999 111.771 -173.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 40' ' ' SER . 17.3 mmm180 76.08 -10.1 1.34 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 124.032 0.833 . . . . 6.6100000000000003 112.412 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.39 -10.83 60.29 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.62 -0.511 . . . . 6.46 109.62 174.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.658 ' HD1' ' H ' ' A' ' 44' ' ' HIS . 0.5 OUTLIER 172.73 -169.95 0.03 OUTLIER 'General case' 0 C--O 1.236 0.378 0 N-CA-C 106.191 -1.781 . . . . 5.6500000000000004 106.191 177.718 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.658 ' H ' ' HD1' ' A' ' 43' ' ' PHE . 19.9 t-80 -83.72 83.59 7.86 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.827 -0.749 . . . . 5.5599999999999996 109.686 175.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.61 139.44 5.93 Favored Glycine 0 N--CA 1.432 -1.59 0 N-CA-C 108.61 -1.796 . . . . 1.5600000000000001 108.61 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.691 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 4.5 m-20 -92.47 146.81 23.39 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.39 0.614 . . . . 2.0499999999999998 111.311 -174.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.531 HD23 ' N ' ' A' ' 48' ' ' TYR . 3.1 tt -104.8 133.64 49.28 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.735 -1.209 . . . . 0.87 107.735 176.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.531 ' N ' HD23 ' A' ' 47' ' ' LEU . 22.7 m-85 -117.54 124.42 48.67 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.959 -0.386 . . . . 0.98999999999999999 109.959 -175.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.595 ' HD3' ' CH2' ' A' ' 24' ' ' TRP . 11.6 ttp180 -105.43 116.99 32.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.01 -0.541 . . . . 2.9199999999999999 109.769 175.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.687 HG23 HG22 ' A' ' 35' ' ' VAL . 8.8 p -100.69 136.33 32.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 C-N-CA 119.802 -0.759 . . . . 1.3300000000000001 109.027 174.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.877 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 27.6 tt0 -137.8 108.8 6.73 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.359 -0.837 . . . . 1.0700000000000001 109.963 -169.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.906 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -139.4 140.42 10.84 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.248 -0.977 . . . . 0.28999999999999998 111.828 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 67.7 mt -84.69 116.82 28.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 C-N-CA 120.005 -0.678 . . . . 0.57999999999999996 110.656 178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.545 HG12 ' HD3' ' A' ' 200' ' ' LYS . 63.6 mt -101.54 113.35 65.85 Favored Pre-proline 0 C--N 1.314 -0.974 0 N-CA-C 108.355 -0.98 . . . . 0.34999999999999998 108.355 173.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.533 ' HA ' ' HA ' ' A' ' 164' ' ' TYR . 28.3 Cg_exo -64.12 56.25 0.22 Allowed 'Trans proline' 0 N--CA 1.478 0.561 0 C-N-CA 124.574 3.516 . . . . 0.62 114.105 -174.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.999 ' HG3' HG12 ' A' ' 203' ' ' ILE . 63.4 mm-40 -132.34 -157.19 0.8 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.628 -0.715 . . . . 1.6799999999999999 109.581 176.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 62.7 p -101.11 145.44 30.42 Favored Pre-proline 0 N--CA 1.415 -2.19 0 CA-C-N 114.798 -1.092 . . . . 1.1799999999999999 108.286 168.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 57' ' ' SER . 39.9 Cg_exo -56.84 -11.1 6.51 Favored 'Trans proline' 0 C--N 1.324 -0.727 0 C-N-CA 123.967 3.112 . . . . 0.52000000000000002 110.989 175.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.42 -48.47 9.61 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.857 -1.065 . . . . 0.64000000000000001 111.438 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.685 ' HD2' ' HB3' ' A' ' 206' ' ' HIS . 3.4 tppt? -62.76 -33.62 75.54 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.52 -0.919 . . . . 3.2999999999999998 108.52 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.978 HD23 HD13 ' A' ' 203' ' ' ILE . 70.9 mt -57.19 -56.91 15.65 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.737 -1.12 . . . . 0.40999999999999998 110.864 173.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.482 ' HA ' ' CD1' ' A' ' 65' ' ' LEU . 53.0 m -65.92 -8.34 21.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.292 0.568 . . . . 1.29 110.643 177.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' A' ' 60' ' ' LYS . 25.1 t70 -88.34 -32.31 18.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.672 -0.694 . . . . 1.3200000000000001 111.83 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.615 ' CD2' ' HA ' ' A' ' 61' ' ' LEU . 16.2 p90 -79.58 -43.53 22.79 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 120.225 -0.59 . . . . 0.60999999999999999 110.019 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.653 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -91.16 3.84 53.75 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 120.548 -0.461 . . . . 1.5 111.962 -174.523 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.407 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 24.8 t80 -14.1 -70.66 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 125.378 1.674 . . . . 1.52 113.475 -169.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.456 ' NE2' HG21 ' A' ' 115' ' ' VAL . 7.0 tp-100 -176.19 -47.17 0.01 OUTLIER 'General case' 0 C--N 1.341 0.233 0 N-CA-C 113.147 0.795 . . . . 3.6000000000000001 113.147 172.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.631 ' OG1' ' HB2' ' A' ' 81' ' ' TYR . 10.6 t -160.11 23.14 0.17 Allowed 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.136 -0.626 . . . . 1.48 111.766 -167.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -126.94 -14.01 2.86 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 118.655 -1.736 . . . . 1.46 114.479 -170.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.667 ' O ' HG22 ' A' ' 73' ' ' THR . 4.8 t70 -157.17 -33.65 0.08 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.384 0.611 . . . . 2.1899999999999999 110.726 -172.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.676 ' O ' ' HB3' ' A' ' 75' ' ' ASP . 2.0 ptp180 -52.3 -39.55 60.68 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.075 -0.966 . . . . 3.3799999999999999 111.693 -173.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.81 ' H ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -87.96 -5.26 10.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.841 -0.618 . . . . 0.70999999999999996 111.442 -175.492 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.667 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.3 t -88.63 -27.43 21.32 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 119.104 -1.038 . . . . 0.96999999999999997 109.418 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.993 ' HZ3' ' HB2' ' A' ' 198' ' ' ASN . 30.7 p-90 -112.32 -0.2 15.5 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.914 -0.585 . . . . 0.75 111.888 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.691 ' CG ' ' HB2' ' A' ' 78' ' ' LEU . 0.9 OUTLIER -68.07 176.96 2.4 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 114.107 1.151 . . . . 2.1899999999999999 114.107 -167.335 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.498 ' NZ ' ' HB2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -143.45 -4.41 0.88 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 113.708 -1.587 . . . . 3.1899999999999999 111.412 170.43 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.8 m -121.35 6.82 10.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.437 0.636 . . . . 1.5800000000000001 109.75 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.691 ' HB2' ' CG ' ' A' ' 75' ' ' ASP . 98.7 mt -118.52 -158.36 0.72 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.295 -0.866 . . . . 0.70999999999999996 110.323 -175.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.443 ' HB3' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -173.57 -58.99 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.871 0.367 . . . . 1.73 111.201 -173.428 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 96' ' ' THR . 39.9 t -145.42 139.41 21.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.307 -0.406 . . . . 0.78000000000000003 110.747 -169.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.727 ' HB3' HD12 ' A' ' 72' ' ' ILE . 44.4 p90 -104.89 152.79 22.2 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.899 -0.591 . . . . 5.4000000000000004 111.537 177.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.89 ' HB3' ' HB3' ' A' ' 95' ' ' HIS . 50.7 t-20 -160.09 104.72 1.51 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.477 -0.564 . . . . 1.6899999999999999 109.477 172.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.9 ttt -74.2 92.45 2.23 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.394 -0.965 . . . . 2.0499999999999998 108.394 176.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -77.12 -63.25 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.86 -0.609 . . . . 0.64000000000000001 111.571 -169.329 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.553 ' HB3' HD12 ' A' ' 93' ' ' ILE . 54.5 t-80 -140.09 113.83 8.75 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.824 -0.436 . . . . 1.96 109.824 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.07 132.71 42.59 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.516 -0.92 . . . . 2.4399999999999999 108.516 175.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.663 HG21 ' HB2' ' A' ' 3' ' ' PHE . 0.1 OUTLIER -90.44 -48.84 14.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.148 0.499 . . . . 0.46999999999999997 111.181 -170.298 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.507 ' CG ' ' H ' ' A' ' 89' ' ' SER . 25.3 t70 -157.14 -148.37 0.21 Allowed 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.588 -0.893 . . . . 1.8600000000000001 108.588 -173.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.507 ' H ' ' CG ' ' A' ' 88' ' ' ASP . 47.6 t -59.26 -49.93 75.94 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.644 0.609 . . . . 1.4399999999999999 112.644 -170.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.721 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 17.7 m-20 -139.91 39.93 1.98 Allowed 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.837 0.827 . . . . 1.8700000000000001 108.895 -171.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.663 ' O ' HG12 ' A' ' 87' ' ' ILE . 1.7 m -135.08 113.21 11.19 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.356 -1.35 . . . . 0.46000000000000002 107.356 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.592 ' O ' HD12 ' A' ' 114' ' ' LEU . 25.8 m-85 -131.0 174.32 10.12 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.594 0.711 . . . . 0.42999999999999999 111.07 -173.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.553 HD12 ' HB3' ' A' ' 85' ' ' HIS . 29.9 mt -131.76 132.98 61.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 106.305 -1.739 . . . . 0.40999999999999998 106.305 165.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 34.2 t -122.35 135.6 54.74 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.064 -0.654 . . . . 2.0099999999999998 110.616 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.89 ' HB3' ' HB3' ' A' ' 82' ' ' ASN . 6.8 t-160 -99.66 80.7 2.39 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 124.37 1.044 . . . . 1.23 109.157 172.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.892 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 93.0 m -89.9 150.35 22.23 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 115.129 -0.941 . . . . 0.5 109.909 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.443 ' HB ' ' HB3' ' A' ' 79' ' ' GLN . 49.4 mm -101.48 131.16 49.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 108.618 -0.882 . . . . 1.03 108.618 167.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.623 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 17.2 m -110.5 126.45 54.39 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.857 -0.61 . . . . 1.3799999999999999 111.493 -171.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -91.96 43.04 1.12 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.247 0.546 . . . . 1.8200000000000001 110.405 177.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.3 t -92.79 70.98 4.81 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.372 0.606 . . . . 3.9100000000000001 109.703 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -112.24 114.41 27.18 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.412 -0.813 . . . . 5.1600000000000001 110.731 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.595 ' HB1' ' HD2' ' A' ' 186' ' ' LYS . . . -70.52 71.64 0.48 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.897 -1.047 . . . . 1.98 110.099 173.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 92.6 t 77.53 -40.68 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 114.811 -1.086 . . . . 3.1699999999999999 110.937 176.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 166.5 -16.11 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.833 -0.699 . . . . 1.96 112.473 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.8 m -65.63 -48.8 70.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.1 0.476 . . . . 1.8799999999999999 109.82 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.751 HG21 HH11 ' A' ' 176' ' ' ARG . 3.4 mp -86.56 121.85 38.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 108.757 -0.831 . . . . 1.1200000000000001 108.757 170.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.3 m -76.96 160.03 77.27 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 109.927 -0.397 . . . . 1.3500000000000001 109.927 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.404 ' HB2' ' CD1' ' A' ' 143' ' ' TYR . 76.0 Cg_exo -49.59 145.31 17.27 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.446 2.097 . . . . 1.0700000000000001 111.249 174.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.771 ' CZ ' ' HA2' ' A' ' 146' ' ' GLY . 0.2 OUTLIER -107.44 141.44 38.84 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 119.803 -0.759 . . . . 3.4500000000000002 110.164 -170.102 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.615 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 12.0 t70 -94.69 115.16 27.2 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 107.81 -1.181 . . . . 1.3700000000000001 107.81 177.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.892 ' HB3' ' HB ' ' A' ' 96' ' ' THR . 63.9 t80 -97.87 108.92 21.74 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.789 -0.448 . . . . 2.4100000000000001 109.789 -168.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.622 ' CG2' ' HE1' ' A' ' 134' ' ' PHE . 13.5 mm -123.71 75.81 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 N-CA-C 108.811 -0.811 . . . . 0.42999999999999999 108.811 173.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.788 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 0.7 OUTLIER -109.41 124.78 51.57 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.466 -0.788 . . . . 1.8600000000000001 110.745 -177.819 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 1.007 HD23 ' HE2' ' A' ' 130' ' ' LYS . 8.9 tp -75.61 117.03 16.94 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 115.275 -0.875 . . . . 0.28000000000000003 109.275 171.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.495 HG23 ' HB ' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -118.41 123.97 72.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-N 114.484 -1.235 . . . . 0.26000000000000001 111.491 -164.402 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.888 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 35.9 t80 -109.93 121.69 45.82 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.585 -0.734 . . . . 2.5699999999999998 111.2 175.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.897 HG13 HG22 ' A' ' 127' ' ' ILE . 3.6 mp -87.39 99.42 8.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.505 -0.924 . . . . 0.89000000000000001 108.505 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.872 ' HD3' ' HE2' ' A' ' 116' ' ' TYR . 57.3 tptt -102.28 131.16 49.04 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.893 -1.049 . . . . 1.2 110.079 -174.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.433 ' HD2' ' C ' ' A' ' 119' ' ' ARG . 4.0 tpt180 -125.61 88.97 2.95 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 108.505 -0.924 . . . . 2.7999999999999998 108.505 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.651 ' CB ' ' HB3' ' A' ' 123' ' ' ASN . 53.9 m-85 -69.42 119.17 13.26 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.759 -1.11 . . . . 0.82999999999999996 108.359 172.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -33.53 95.89 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 125.024 1.453 . . . . 2.2799999999999998 112.955 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 53.95 42.05 69.45 Favored Glycine 0 CA--C 1.508 -0.38 0 CA-C-N 114.684 -1.144 . . . . 0.76000000000000001 112.041 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.651 ' HB3' ' CB ' ' A' ' 120' ' ' TYR . 3.3 t-20 -132.71 -49.76 0.9 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.922 -0.639 . . . . 1.6499999999999999 110.273 -175.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.443 ' CG ' ' HB ' ' A' ' 154' ' ' VAL . 3.9 tpp -158.37 144.31 16.99 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.637 -0.425 . . . . 1.1200000000000001 111.383 -178.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.402 ' OD1' ' HD3' ' A' ' 119' ' ' ARG . 0.7 OUTLIER -120.09 81.22 1.71 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.378 -0.971 . . . . 1.6200000000000001 108.378 172.336 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.745 HG23 ' HB3' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -109.01 146.26 14.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.212 -0.904 . . . . 0.29999999999999999 113.424 -170.541 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.897 HG22 HG13 ' A' ' 117' ' ' ILE . 4.6 pt -107.58 110.72 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.549 0.69 . . . . 0.58999999999999997 109.155 161.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.52 ' HB3' ' HA ' ' A' ' 11' ' ' ALA . 15.8 p -93.83 112.4 24.25 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.325 0.583 . . . . 1.1799999999999999 111.06 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.788 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 54.6 p -102.86 158.85 15.98 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.724 -0.671 . . . . 1.24 111.68 -171.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 1.007 ' HE2' HD23 ' A' ' 114' ' ' LEU . 4.5 mtmm -147.39 124.44 11.4 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 115.939 -0.573 . . . . 2.2599999999999998 109.457 175.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.401 ' HB3' ' H ' ' A' ' 148' ' ' ASN . 31.9 p -67.04 91.63 0.22 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.336 -0.987 . . . . 1.3899999999999999 108.336 174.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.93 133.84 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 CA-C-N 115.131 -0.94 . . . . 1.05 109.274 -163.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.447 ' HB2' HH22 ' A' ' 145' ' ' ARG . 9.2 t70 -94.51 73.4 3.77 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.479 -1.237 . . . . 2.1699999999999999 108.761 -167.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.745 ' O ' ' HB3' ' A' ' 137' ' ' TYR . 1.6 p90 -107.02 173.75 2.93 Favored Pre-proline 0 CA--C 1.554 1.101 0 CA-C-N 114.85 -1.068 . . . . 0.53000000000000003 110.709 -170.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.61 ' HB2' ' OE2' ' A' ' 136' ' ' GLU . 60.2 Cg_exo -53.13 -48.61 21.16 Favored 'Trans proline' 0 N--CA 1.486 1.079 0 C-N-CA 123.292 2.661 . . . . 1.28 116.438 -171.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.703 ' HG2' ' CE2' ' A' ' 134' ' ' PHE . 0.6 OUTLIER -79.43 -9.3 59.57 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 121.53 0.681 . . . . 3.5 111.595 -173.147 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.809 ' HE1' ' HG3' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -54.4 -38.98 71.64 Favored Pre-proline 0 CA--C 1.556 1.196 0 N-CA-C 116.888 2.181 . . . . 6.1200000000000001 116.888 -172.239 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.499 ' HD2' ' C ' ' A' ' 136' ' ' GLU . 34.2 Cg_exo -30.52 110.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 123.875 3.05 . . . . 1.77 115.901 -170.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.49 ' HG3' ' HB2' ' A' ' 145' ' ' ARG . 29.6 Cg_endo -89.88 -155.89 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 124.345 3.363 . . . . 1.25 112.308 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 38.8 m -148.47 143.92 27.05 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 108.727 -0.842 . . . . 1.6000000000000001 108.727 177.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.7 p -58.17 -17.57 19.64 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.568 1.322 . . . . 1.97 114.568 -167.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -83.11 -15.93 48.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.099 0.409 . . . . 2.1800000000000002 111.103 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.404 ' CD1' ' HB2' ' A' ' 108' ' ' PRO . 72.8 m-85 -126.11 108.75 11.64 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.255 -1.017 . . . . 1.23 108.255 175.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.684 HG23 ' HD2' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -82.91 111.73 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 C-N-CA 120.123 -0.631 . . . . 0.81999999999999995 109.395 -171.253 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.809 ' HG3' ' HE1' ' A' ' 137' ' ' TYR . 0.2 OUTLIER -41.36 113.91 0.45 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.939 0.4 . . . . 4.4199999999999999 110.632 171.003 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.771 ' HA2' ' CZ ' ' A' ' 109' ' ' ARG . . . -51.29 130.18 33.21 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.047 -0.978 . . . . 0.79000000000000004 112.478 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.909 ' HB3' ' HG3' ' A' ' 174' ' ' GLU . 0.2 OUTLIER -104.99 63.85 0.71 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.743 0.782 . . . . 4.4400000000000004 109.873 175.82 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.585 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 81.8 m-20 -86.88 108.28 18.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.156 -1.384 . . . . 1.6200000000000001 109.558 178.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -80.31 132.18 60.01 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 109.468 -0.567 . . . . 2.3199999999999998 109.468 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.524 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 51.9 Cg_exo -9.25 61.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.009 1 C-N-CA 126.828 5.019 . . . . 0.53000000000000003 115.628 -161.671 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 151' ' ' CYS . . . . . 0.715 ' HB3' ' O ' ' A' ' 170' ' ' PHE . 3.0 m -76.97 -174.75 3.24 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.931 -1.031 . . . . 1.5800000000000001 109.618 174.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.621 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -171.29 -163.94 26.14 Favored Glycine 0 N--CA 1.429 -1.784 0 C-N-CA 119.666 -1.254 . . . . 0.42999999999999999 111.828 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.476 ' HB3' ' CG1' ' A' ' 127' ' ' ILE . 52.9 t80 -161.92 79.18 0.54 Allowed 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.687 -1.227 . . . . 0.59999999999999998 107.687 -168.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.726 HG12 ' HB ' ' A' ' 126' ' ' ILE . 5.2 m -90.33 128.66 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-O 121.733 0.777 . . . . 0.31 110.422 -174.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 60.8 m -99.82 111.18 23.52 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.305 -0.998 . . . . 1.55 108.305 171.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.812 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 18.9 m -97.6 119.79 61.92 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 115.817 -0.629 . . . . 1.0600000000000001 111.378 -170.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.527 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 50.7 Cg_exo -55.28 111.87 0.88 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.454 2.103 . . . . 0.56000000000000005 111.074 170.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 74.3 mmm -74.99 -166.33 0.47 Allowed 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.373 0.606 . . . . 1.1599999999999999 111.634 -177.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.42 ' H ' ' HB3' ' A' ' 158' ' ' MET . 3.9 tp10 -70.97 -34.52 71.5 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.624 -0.88 . . . . 2.6299999999999999 108.624 174.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -102.06 30.34 4.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.371 -1.286 . . . . 2.0499999999999998 108.918 175.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.623 ' OD1' ' HD3' ' A' ' 162' ' ' PRO . 3.7 p30 -31.43 -48.86 0.42 Allowed Pre-proline 0 N--CA 1.475 0.815 0 N-CA-C 117.107 2.262 . . . . 1.9299999999999999 117.107 -168.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.623 ' HD3' ' OD1' ' A' ' 161' ' ' ASN . 71.6 Cg_endo -76.83 -9.93 18.27 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 CA-C-N 121.976 1.741 . . . . 0.72999999999999998 113.177 -175.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -116.47 -22.66 8.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.042 -0.526 . . . . 0.68000000000000005 110.801 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 55' ' ' PRO . 61.8 m-85 -136.25 121.39 19.0 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.357 -0.608 . . . . 0.93000000000000005 109.357 174.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 38.6 t -116.97 139.47 50.62 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.555 -0.458 . . . . 1.4099999999999999 110.439 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.877 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 2.3 tppp? -89.12 105.35 17.73 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.866 0.841 . . . . 0.73999999999999999 110.984 -177.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.588 HD23 HD13 ' A' ' 61' ' ' LEU . 0.9 OUTLIER -86.82 102.05 13.92 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.338 -0.846 . . . . 0.27000000000000002 108.905 178.409 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.691 HG12 ' HG3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -124.5 119.33 56.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.955 0.884 . . . . 0.28000000000000003 111.587 178.246 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 21.5 ttt -120.04 148.74 43.19 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.824 -1.08 . . . . 1.24 109.532 -175.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.715 ' O ' ' HB3' ' A' ' 151' ' ' CYS . 38.7 m-85 -127.09 135.06 50.24 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.336 -0.986 . . . . 3.3700000000000001 108.336 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.438 HG22 HG22 ' A' ' 173' ' ' THR . 7.8 p -126.69 118.58 51.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.682 0.753 . . . . 1.3999999999999999 110.965 177.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.01 63.7 0.7 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.443 -0.947 . . . . 2.1699999999999999 108.443 177.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 147' ' ' TYR . 3.8 t -98.24 154.18 17.97 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.767 -1.106 . . . . 1.6499999999999999 110.145 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.909 ' HG3' ' HB3' ' A' ' 147' ' ' TYR . 0.0 OUTLIER -80.3 14.89 1.76 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.45 0.537 . . . . 2.4500000000000002 112.45 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.612 ' HB2' ' O ' ' A' ' 174' ' ' GLU . 26.3 mmt 81.53 19.81 0.38 Allowed 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.598 0.713 . . . . 3.7400000000000002 110.153 169.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.751 HH11 HG21 ' A' ' 106' ' ' ILE . 0.0 OUTLIER 39.39 74.4 0.09 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 113.77 -1.559 . . . . 5.7800000000000002 113.257 172.352 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 108.82 -15.88 33.92 Favored Glycine 0 C--N 1.311 -0.809 0 CA-C-N 115.262 -0.881 . . . . 2.2599999999999998 112.873 177.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 61.5 tttp 66.96 85.4 0.14 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.382 0.611 . . . . 6.2300000000000004 110.416 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.61 ' H ' HD22 ' A' ' 179' ' ' LEU . 0.1 OUTLIER -88.81 -151.91 0.22 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.812 -0.631 . . . . 1.6399999999999999 110.839 -176.097 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.432 ' OG ' ' HD2' ' A' ' 181' ' ' PRO . 26.6 t -111.28 152.79 44.07 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.017 -1.105 . . . . 2.04 108.017 174.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.432 ' HD2' ' OG ' ' A' ' 180' ' ' SER . 44.7 Cg_exo -36.25 -50.5 1.21 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.599 2.866 . . . . 1.74 114.205 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.1 m -65.12 -16.87 63.96 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.466 0.543 . . . . 2.1400000000000001 112.466 -176.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.598 ' HA ' ' HE3' ' A' ' 186' ' ' LYS . 8.2 mm -92.01 -35.33 6.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 122.224 1.012 . . . . 1.1200000000000001 109.147 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 1.007 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.0 OUTLIER -74.96 -31.87 26.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 113.389 -1.732 . . . . 1.1299999999999999 110.741 -177.834 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.89 -19.94 58.45 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.218 -1.03 . . . . 2.8900000000000001 108.218 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.598 ' HE3' ' HA ' ' A' ' 183' ' ' ILE . 0.2 OUTLIER -91.89 -24.52 19.29 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.085 -1.416 . . . . 1.28 110.31 173.854 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 187' ' ' THR . . . . . 1.007 HG22 ' HA ' ' A' ' 184' ' ' ILE . 3.5 t -89.5 -41.14 12.21 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 119.975 -0.69 . . . . 0.62 112.763 -177.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' MET . . . . . 0.907 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 21.7 mmt -80.67 -65.64 0.26 Allowed Pre-proline 0 N--CA 1.467 0.383 0 O-C-N 121.619 -0.676 . . . . 1.0600000000000001 112.108 -174.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.907 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 17.3 Cg_exo -65.63 -20.8 59.78 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.184 1.923 . . . . 0.91000000000000003 112.162 -173.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.441 ' HB3' ' O ' ' A' ' 186' ' ' LYS . 22.6 t -84.64 -36.28 22.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.989 -0.551 . . . . 1.5 110.187 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -79.98 -37.06 35.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.249 -0.432 . . . . 1.8799999999999999 111.579 -174.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.623 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 20.3 mt -67.07 -45.8 76.24 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 121.007 -0.277 . . . . 1.0900000000000001 111.516 -175.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.838 ' HB ' HD12 ' A' ' 33' ' ' ILE . 27.9 m -71.73 -24.12 22.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.1 -0.64 . . . . 0.68000000000000005 110.406 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.425 ' HB3' ' HE3' ' A' ' 76' ' ' LYS . 4.1 m-20 -73.35 -32.83 64.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.869 -0.605 . . . . 2.0699999999999998 110.755 174.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.636 ' HA ' ' OD1' ' A' ' 198' ' ' ASN . 2.2 m-85 -65.1 -30.74 71.7 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.139 0.495 . . . . 2.0 110.319 174.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.502 HG12 HD12 ' A' ' 167' ' ' LEU . 60.4 mt -79.6 -24.58 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-O 121.365 0.603 . . . . 0.31 110.644 175.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 197' ' ' LEU . 34.2 mt -73.11 -42.82 62.51 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.274 -0.421 . . . . 1.03 110.827 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.993 ' HB2' ' HZ3' ' A' ' 74' ' ' TRP . 1.8 p-10 -67.43 -15.07 63.47 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.386 -0.926 . . . . 1.8999999999999999 109.469 171.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.691 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -80.81 -42.27 21.95 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 109.404 -0.591 . . . . 0.28999999999999998 109.404 173.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.545 ' HD3' HG12 ' A' ' 54' ' ' ILE . 28.1 mmtp -59.56 -44.69 93.2 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 121.553 0.692 . . . . 0.96999999999999997 110.013 173.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -80.48 -39.81 27.33 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.897 -1.047 . . . . 1.9399999999999999 110.984 -174.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -69.51 -31.2 70.92 Favored Glycine 0 CA--C 1.507 -0.464 0 C-N-CA 120.717 -0.754 . . . . 0.46999999999999997 111.395 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.999 HG12 ' HG3' ' A' ' 56' ' ' GLU . 1.5 tp -71.69 -34.57 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 120.574 0.226 . . . . 0.60999999999999999 110.449 177.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 66.4 mttm -86.12 -15.82 39.94 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-O 121.686 0.755 . . . . 3.3700000000000001 109.173 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -72.13 -35.52 69.14 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.283 -0.871 . . . . 1.02 108.681 165.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.685 ' HB3' ' HD2' ' A' ' 60' ' ' LYS . 9.4 m-70 -86.74 -2.83 58.86 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.607 -0.724 . . . . 3.6299999999999999 112.327 175.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.407 ' HB3' ' HA ' ' A' ' 204' ' ' LYS . 75.9 ttt180 -125.16 -67.99 0.87 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.436 0.636 . . . . 2.5899999999999999 110.963 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.475 ' C ' ' H ' ' A' ' 210' ' ' SER . 19.8 m -69.17 144.79 95.61 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 114.974 -1.012 . . . . 1.8400000000000001 110.324 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 208' ' ' THR . 22.6 Cg_exo -67.59 34.72 0.15 Allowed 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.878 2.385 . . . . 2.3500000000000001 112.919 174.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.475 ' H ' ' C ' ' A' ' 208' ' ' THR . 44.4 t -78.7 -26.37 44.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.371 0.605 . . . . 2.3100000000000001 109.603 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 211' ' ' ARG . 26.2 ttt180 -71.13 -7.86 49.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.574 -0.739 . . . . 5.4500000000000002 110.926 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.58 ' O ' ' HD2' ' A' ' 212' ' ' ARG . 2.4 tmm_? -68.24 -19.11 64.71 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.071 -0.714 . . . . 6.8600000000000003 109.071 176.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -129.54 45.88 1.11 Allowed Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.574 -0.739 . . . . 3.3700000000000001 111.376 174.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -67.33 142.28 56.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.011 0.434 . . . . 5.21 110.201 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -141.22 126.71 18.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.184 -0.462 . . . . 6.46 110.865 -176.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -171.33 -69.38 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.063 -0.717 . . . . 6.0899999999999999 109.063 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 59.62 -166.11 0.19 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.823 -0.626 . . . . 5.1200000000000001 111.009 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 13.8 m -110.18 -27.9 8.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.812 0.339 . . . . 6.7599999999999998 110.582 178.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -134.18 -177.38 4.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 8.8200000000000003 110.199 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 35.3 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.62 -0.705 . . . . 8.4800000000000004 109.891 177.96 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.861 ' HG2' ' HB2' ' A' ' 4' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 120.449 0.166 . . . . 3.8599999999999999 111.312 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.626 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -51.29 -61.81 2.01 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 123.618 0.767 . . . . 2.25 112.202 -173.795 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.693 ' HD2' HD22 ' A' ' 114' ' ' LEU . 91.3 m-85 -61.2 -26.42 67.71 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 116.033 -0.53 . . . . 0.42999999999999999 110.372 -170.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.861 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 45.8 tttt -73.05 -45.04 59.78 Favored 'General case' 0 N--CA 1.417 -2.099 0 N-CA-C 107.639 -1.245 . . . . 1.51 107.639 -177.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.49 -40.24 59.14 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.831 -0.622 . . . . 0.54000000000000004 111.307 176.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.626 HD12 ' O ' ' A' ' 2' ' ' ASP . 2.3 mp -81.18 -38.89 16.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.869 0.842 . . . . 1.0700000000000001 109.58 -174.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.84 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -75.36 -39.79 58.88 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.533 -1.212 . . . . 0.34000000000000002 111.805 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.541 ' HG3' ' HG2' ' A' ' 4' ' ' LYS . 14.1 mt-30 -63.01 -30.03 71.29 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.609 -1.178 . . . . 1.5900000000000001 109.688 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.622 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 79.6 mt-30 -79.35 -46.62 17.29 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.895 -1.048 . . . . 2.4700000000000002 108.671 171.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.736 HG21 ' HZ2' ' A' ' 130' ' ' LYS . 0.3 OUTLIER -60.17 -37.19 79.42 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.946 -1.024 . . . . 0.47999999999999998 112.59 -176.937 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.501 ' HA ' ' CB ' ' A' ' 128' ' ' SER . . . -51.72 -51.7 54.1 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-O 120.929 0.395 . . . . 0.31 111.494 178.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 20.8 pt20 -80.45 -10.58 59.74 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.191 -0.459 . . . . 1.6399999999999999 110.952 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.622 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 49.3 mt-10 -75.11 -50.66 15.65 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.381 0.61 . . . . 2.54 109.701 174.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.71 HG21 ' N ' ' A' ' 152' ' ' GLY . 11.2 p -71.96 -37.79 62.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 122.235 1.017 . . . . 0.53000000000000003 109.925 -177.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.477 HD12 ' SD ' ' A' ' 124' ' ' MET . 0.9 OUTLIER -72.05 -20.54 61.66 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 114.591 -1.186 . . . . 0.59999999999999998 109.199 173.837 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.455 ' HA2' ' NH1' ' A' ' 19' ' ' ARG . . . -66.16 -18.46 67.08 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 114.184 -1.371 . . . . 0.56999999999999995 110.21 172.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.618 ' CD2' ' HA ' ' A' ' 14' ' ' VAL . 33.5 m-85 -88.93 -26.49 21.53 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.249 -0.475 . . . . 3.27 109.919 177.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.568 ' HB2' ' HZ ' ' A' ' 170' ' ' PHE . 3.5 t30 -71.44 -20.48 62.1 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 119.884 -0.726 . . . . 2.0299999999999998 109.775 173.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.455 ' NH1' ' HA2' ' A' ' 16' ' ' GLY . 20.1 mtp180 -97.89 -20.72 17.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.444 -0.798 . . . . 2.7200000000000002 110.383 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -115.51 103.0 10.31 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.401 -0.818 . . . . 2.1600000000000001 110.709 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.8 ' HB ' ' CH2' ' A' ' 24' ' ' TRP . 23.3 p -121.94 99.18 6.3 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.618 0.723 . . . . 1.8200000000000001 109.862 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.7 m -148.27 144.62 27.75 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.497 -0.774 . . . . 2.1899999999999999 111.149 -165.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.33 -45.31 3.02 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.793 -0.639 . . . . 1.1000000000000001 114.12 169.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.8 ' CH2' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -82.59 -157.22 0.2 Allowed 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 113.137 0.792 . . . . 1.6699999999999999 113.137 -172.386 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.987 ' HE3' ' HA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER 179.36 149.55 0.28 Allowed 'General case' 0 CA--C 1.494 -1.184 0 CA-C-N 115.161 -0.927 . . . . 2.9500000000000002 110.087 -165.099 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 3.3 m -60.16 124.97 15.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 114.397 -1.274 . . . . 1.5600000000000001 112.068 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.664 HG11 ' HE2' ' A' ' 48' ' ' TYR . 14.4 p -98.36 -25.46 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 114.262 -1.336 . . . . 1.22 108.22 174.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.486 ' HD2' ' HA ' ' A' ' 28' ' ' LYS . 20.8 tptt -154.68 149.39 26.52 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 119.672 -0.811 . . . . 2.4100000000000001 111.262 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.592 HG22 ' HA ' ' A' ' 34' ' ' THR . 34.4 p -145.36 151.63 38.59 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.715 -0.675 . . . . 1.3799999999999999 109.755 175.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.665 ' O ' ' HG2' ' A' ' 31' ' ' LYS . 42.3 m -128.59 44.97 2.86 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.851 0.357 . . . . 2.3700000000000001 110.489 175.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.665 ' HG2' ' O ' ' A' ' 30' ' ' SER . 0.1 OUTLIER 62.38 19.81 11.37 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.509 1.123 . . . . 4.5499999999999998 112.001 169.251 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.467 ' HD2' ' HA ' ' A' ' 32' ' ' LYS . 35.6 tptt -174.63 -20.93 0.01 OUTLIER 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.569 0.7 . . . . 1.4199999999999999 109.885 175.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.829 HG22 ' HA3' ' A' ' 52' ' ' GLY . 41.8 pt -117.64 156.32 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.805 -1.089 . . . . 0.76000000000000001 109.517 171.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.592 ' HA ' HG22 ' A' ' 29' ' ' THR . 88.4 m -151.54 115.33 4.91 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.648 -0.706 . . . . 0.57999999999999996 110.408 -164.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.663 HG12 HG12 ' A' ' 50' ' ' VAL . 6.3 m -113.12 118.13 57.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.106 0.479 . . . . 0.85999999999999999 112.009 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 2.7 p -101.15 128.48 47.22 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.552 -0.749 . . . . 1.1000000000000001 110.645 177.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.594 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 42.5 t -106.71 128.4 54.17 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.161 -0.927 . . . . 1.27 111.058 -171.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.459 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 21.9 ttpp -122.14 -93.87 0.51 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.335 -0.393 . . . . 1.9099999999999999 111.015 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.431 ' H ' ' HB3' ' A' ' 38' ' ' LYS . . . -165.63 137.58 4.04 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.849 0.357 . . . . 1.6799999999999999 110.747 -177.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.614 ' HA ' ' HG3' ' A' ' 172' ' ' GLN . 32.2 t -88.93 -95.1 0.1 Allowed 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.443 -0.799 . . . . 2.0899999999999999 110.27 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.443 HH11 ' HD3' ' A' ' 41' ' ' ARG . 10.6 ttm180 -86.88 13.2 9.41 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.917 -1.142 . . . . 6.6100000000000003 107.917 171.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.43 ' H ' ' C ' ' A' ' 40' ' ' SER . 35.0 pttt 37.07 48.34 0.71 Allowed 'General case' 0 C--N 1.342 0.25 0 CA-C-N 113.244 -1.798 . . . . 6.46 112.694 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -158.31 -56.89 0.07 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.842 -1.072 . . . . 5.6500000000000004 109.352 -175.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -134.0 74.63 1.55 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.152 -0.931 . . . . 5.5599999999999996 109.114 176.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 135.53 148.46 5.63 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.751 -0.659 . . . . 1.5600000000000001 112.087 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 18.0 m120 -118.66 156.75 28.71 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.957 -0.386 . . . . 2.0499999999999998 109.957 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.56 HD23 ' N ' ' A' ' 48' ' ' TYR . 3.2 tt -98.59 135.27 40.36 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.25 -1.019 . . . . 0.87 108.25 177.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.664 ' HE2' HG11 ' A' ' 27' ' ' VAL . 60.1 m-85 -122.58 123.61 41.59 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.925 0.393 . . . . 0.98999999999999999 110.336 -173.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.593 ' HD3' ' CD2' ' A' ' 170' ' ' PHE . 0.0 OUTLIER -99.02 103.38 15.32 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.129 -0.693 . . . . 2.9199999999999999 109.129 178.361 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.729 HG22 ' HB3' ' A' ' 169' ' ' MET . 0.9 OUTLIER -85.92 150.13 4.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 108.745 -0.835 . . . . 1.3300000000000001 108.745 178.477 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.856 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 74.1 tt0 -158.76 108.1 1.96 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.103 0.477 . . . . 1.0700000000000001 110.0 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.829 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -145.33 145.08 13.95 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.846 -0.902 . . . . 0.28999999999999998 110.846 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 66.2 mt -89.07 126.41 42.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 117.623 0.711 . . . . 0.57999999999999996 111.249 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 55' ' ' PRO . 44.9 mt -106.65 110.27 63.64 Favored Pre-proline 0 N--CA 1.447 -0.607 0 CA-C-N 115.995 -0.548 . . . . 0.34999999999999998 109.797 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 54' ' ' ILE . 9.8 Cg_endo -52.1 66.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.477 0.511 1 C-N-CA 125.729 4.286 . . . . 0.62 113.598 174.574 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.627 ' HG2' HG13 ' A' ' 203' ' ' ILE . 10.1 tp10 -165.02 171.57 13.78 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.17 -1.048 . . . . 1.6799999999999999 108.17 174.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.45 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 83.6 p -80.5 141.32 52.53 Favored Pre-proline 0 N--CA 1.428 -1.56 0 CA-C-O 121.477 0.656 . . . . 1.1799999999999999 109.849 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.738 ' HA ' HD12 ' A' ' 61' ' ' LEU . 8.7 Cg_endo -51.7 -15.22 2.69 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 124.528 3.485 . . . . 0.52000000000000002 111.734 171.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.53 -44.75 41.95 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.464 -0.789 . . . . 0.64000000000000001 111.037 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.617 ' HE3' ' HA ' ' A' ' 60' ' ' LYS . 2.2 tpmt? -69.53 -30.64 68.52 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.028 -1.101 . . . . 3.2999999999999998 108.028 178.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.011 HD23 HD13 ' A' ' 203' ' ' ILE . 94.0 mt -61.88 -57.73 10.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.33 -1.305 . . . . 0.40999999999999998 110.73 175.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.482 ' HB3' ' HB3' ' A' ' 125' ' ' ASN . 17.4 p -64.73 -9.75 22.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.196 0.522 . . . . 1.29 110.507 176.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -89.24 -30.91 18.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.86 -0.609 . . . . 1.3200000000000001 111.957 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.705 ' HD2' ' CZ2' ' A' ' 74' ' ' TRP . 18.7 p90 -89.84 -43.4 10.65 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 120.152 -0.619 . . . . 0.60999999999999999 111.828 -172.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.685 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -90.77 5.54 47.89 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 120.371 -0.532 . . . . 1.5 112.061 -173.597 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.418 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 9.7 t80 -27.72 -69.58 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 O-C-N 124.743 1.277 . . . . 1.52 113.095 -167.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.483 ' HA ' ' CZ ' ' A' ' 71' ' ' ARG . 7.3 tt0 -175.1 -40.81 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 114.13 1.159 . . . . 3.6000000000000001 114.13 173.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.8 t -155.06 7.13 0.26 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.527 0.936 . . . . 1.48 113.527 -163.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -116.6 0.26 20.17 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 118.709 -1.71 . . . . 1.46 115.209 -169.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.635 ' O ' HG22 ' A' ' 73' ' ' THR . 38.2 t70 -178.15 -27.82 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.385 0.592 . . . . 2.1899999999999999 110.562 -177.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.648 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -55.29 -34.97 64.59 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 115.478 -0.783 . . . . 3.3799999999999999 111.302 -172.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.803 HG22 HD13 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -92.77 -7.78 10.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.744 -0.382 . . . . 0.70999999999999996 111.077 -175.904 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.795 ' HA ' ' HB2' ' A' ' 216' ' ' HIS . 1.3 t -88.19 -27.96 21.5 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 119.914 -0.714 . . . . 0.96999999999999997 109.743 -176.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.705 ' CZ2' ' HD2' ' A' ' 64' ' ' PHE . 29.4 p-90 -101.45 -8.88 21.59 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.168 -0.613 . . . . 0.75 111.282 177.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.704 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 27.6 t0 -87.36 159.3 18.78 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 114.286 1.217 . . . . 2.1899999999999999 114.286 -165.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.75 -26.17 14.43 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 112.637 -2.074 . . . . 3.1899999999999999 111.268 -176.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.2 m -105.83 -3.43 21.94 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.004 -0.739 . . . . 1.5800000000000001 109.004 -173.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.803 HD13 HG22 ' A' ' 72' ' ' ILE . 72.6 mt -110.47 159.17 17.74 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.902 -1.045 . . . . 0.70999999999999996 111.354 -174.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.554 ' CG ' ' HG3' ' A' ' 99' ' ' GLN . 9.8 mm-40 -138.9 -62.52 0.55 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.949 -1.023 . . . . 1.73 111.403 -176.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.545 HG23 ' HB3' ' A' ' 79' ' ' GLN . 23.6 t -140.48 124.72 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.439 -0.346 . . . . 0.78000000000000003 111.047 -167.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -95.5 148.61 22.31 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 122.984 0.514 . . . . 5.4000000000000004 110.987 175.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.744 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 18.2 m120 -156.91 108.1 2.38 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.651 -0.5 . . . . 1.6899999999999999 109.651 169.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.471 ' CG ' ' HD3' ' A' ' 86' ' ' ARG . 0.7 OUTLIER -66.82 103.58 1.15 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.953 -0.758 . . . . 2.0499999999999998 108.953 177.089 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.714 HG12 ' HG2' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -80.8 -82.15 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 121.167 0.508 . . . . 0.64000000000000001 110.513 -173.298 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.604 ' HB3' HD12 ' A' ' 93' ' ' ILE . 9.3 t60 -126.12 104.86 8.47 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.541 -0.754 . . . . 1.96 109.273 -172.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.471 ' HD3' ' CG ' ' A' ' 83' ' ' MET . 47.5 mtm180 -92.75 115.23 27.92 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.437 -0.579 . . . . 2.4399999999999999 109.437 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.609 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -80.21 -40.56 20.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.476 -0.784 . . . . 0.46999999999999997 110.925 -169.725 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.419 ' CG ' ' H ' ' A' ' 89' ' ' SER . 12.4 t70 -151.63 -162.73 1.59 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.012 -0.736 . . . . 1.8600000000000001 109.012 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.419 ' H ' ' CG ' ' A' ' 88' ' ' ASP . 34.1 t -76.23 -17.64 59.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 117.944 0.338 . . . . 1.4399999999999999 111.368 -174.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.2 p30 -136.08 17.2 3.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.825 0.345 . . . . 1.8700000000000001 110.792 -175.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.609 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -129.77 107.07 9.13 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.365 -0.976 . . . . 0.46000000000000002 108.365 -178.383 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.605 ' O ' HD12 ' A' ' 114' ' ' LEU . 27.2 m-85 -125.44 170.92 10.91 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.314 0.578 . . . . 0.42999999999999999 111.135 -172.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.667 ' O ' HG23 ' A' ' 84' ' ' VAL . 16.9 mt -137.36 121.56 23.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 107.409 -1.33 . . . . 0.40999999999999998 107.409 170.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 14.3 t -111.92 127.84 55.97 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.244 0.545 . . . . 2.0099999999999998 111.26 -176.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.744 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 9.2 t-80 -81.66 83.11 7.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.753 0.787 . . . . 1.23 109.01 169.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 20.0 m -94.03 113.1 25.01 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.579 -1.191 . . . . 0.5 111.342 -177.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.433 ' CG1' ' HB ' ' A' ' 80' ' ' VAL . 43.4 mm -77.02 120.9 28.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 108.63 -0.878 . . . . 1.03 108.63 171.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.1 m -110.98 128.99 56.02 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.023 -0.99 . . . . 1.3799999999999999 111.217 -171.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.554 ' HG3' ' CG ' ' A' ' 79' ' ' GLN . 22.4 mt-30 -95.71 71.02 3.03 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.985 -0.552 . . . . 1.8200000000000001 110.644 177.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.44 ' O ' HG21 ' A' ' 106' ' ' ILE . 49.7 m -85.06 64.19 8.55 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.918 -0.771 . . . . 3.9100000000000001 108.918 173.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.407 ' HD1' ' HB3' ' A' ' 99' ' ' GLN . 25.3 p90 -77.29 99.32 5.47 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 122.273 1.035 . . . . 5.1600000000000001 113.559 -168.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.944 ' HB3' HD12 ' A' ' 106' ' ' ILE . . . -118.73 82.3 1.83 Allowed 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 106.119 -1.808 . . . . 1.98 106.119 157.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.9 t -73.56 18.65 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 114.874 -1.057 . . . . 3.1699999999999999 112.762 -161.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.19 -17.7 64.3 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.085 -1.206 . . . . 1.96 110.085 173.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.1 m -151.3 -44.09 0.11 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.948 -0.626 . . . . 1.8799999999999999 110.209 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.944 HD12 ' HB3' ' A' ' 102' ' ' ALA . 77.3 mt -71.64 131.59 34.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.507 -0.77 . . . . 1.1200000000000001 112.013 -173.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.4 m -100.34 166.44 12.64 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 108.526 -0.916 . . . . 1.3500000000000001 108.526 170.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -46.32 125.31 8.78 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.035 1.823 . . . . 1.0700000000000001 110.893 173.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.604 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 29.5 ttm180 -102.65 151.99 21.71 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 120.042 -0.663 . . . . 3.4500000000000002 110.141 -167.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.703 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 20.8 t0 -113.01 127.23 56.17 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.736 -0.666 . . . . 1.3700000000000001 109.344 -171.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.427 ' HB2' ' O ' ' A' ' 96' ' ' THR . 3.5 m-30 -113.43 134.13 54.82 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.537 0.684 . . . . 2.4100000000000001 111.305 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 1.081 HG12 ' HD2' ' A' ' 145' ' ' ARG . 35.2 mm -124.36 76.39 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 107.105 -1.443 . . . . 0.42999999999999999 107.105 167.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.541 ' O ' HG12 ' A' ' 115' ' ' VAL . 7.1 p-10 -85.88 115.75 23.7 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.116 -0.947 . . . . 1.8600000000000001 109.994 -176.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 1.078 HD23 ' HE2' ' A' ' 130' ' ' LYS . 11.2 tp -80.65 111.58 17.21 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-O 121.914 0.864 . . . . 0.28000000000000003 109.08 169.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.541 HG12 ' O ' ' A' ' 113' ' ' ASP . 0.1 OUTLIER -119.09 125.31 74.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-N 113.841 -1.527 . . . . 0.26000000000000001 111.544 -163.303 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.84 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 11.5 t80 -104.83 112.71 25.92 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 115.114 -0.948 . . . . 2.5699999999999998 110.054 172.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.825 HG12 HG22 ' A' ' 127' ' ' ILE . 73.7 mt -94.14 99.57 9.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.639 -0.71 . . . . 0.89000000000000001 109.607 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.522 ' HD2' ' CZ ' ' A' ' 120' ' ' TYR . 35.9 ttmt -118.14 141.02 48.93 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.931 -0.577 . . . . 1.2 109.872 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.481 ' HD2' ' O ' ' A' ' 119' ' ' ARG . 7.9 tmm_? -118.75 98.08 6.04 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.966 -0.753 . . . . 2.7999999999999998 108.966 177.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.59 ' CB ' ' HB3' ' A' ' 123' ' ' ASN . 96.5 m-85 -64.66 114.05 4.15 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.631 -1.248 . . . . 0.82999999999999996 107.631 172.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -37.21 99.07 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 O-C-N 124.572 1.17 . . . . 2.2799999999999998 112.688 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 56.59 34.12 63.71 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 114.159 -1.382 . . . . 0.76000000000000001 112.708 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.59 ' HB3' ' CB ' ' A' ' 120' ' ' TYR . 4.6 t-20 -127.48 -49.1 1.41 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.174 -0.513 . . . . 1.6499999999999999 110.266 -177.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.579 ' HG2' ' HB ' ' A' ' 154' ' ' VAL . 3.9 ttm -163.08 133.76 4.65 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 120.323 -0.551 . . . . 1.1200000000000001 112.127 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.482 ' HB3' ' HB3' ' A' ' 62' ' ' SER . 13.9 m120 -104.63 78.97 1.5 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.23 -1.026 . . . . 1.6200000000000001 108.23 174.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.65 ' CG1' HG12 ' A' ' 154' ' ' VAL . 0.5 OUTLIER -103.91 139.77 23.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 113.387 0.884 . . . . 0.29999999999999999 113.387 -169.21 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.825 HG22 HG12 ' A' ' 117' ' ' ILE . 25.7 pt -108.84 111.42 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 108.907 -0.775 . . . . 0.58999999999999997 108.907 163.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.52 ' OG ' ' HB3' ' A' ' 116' ' ' TYR . 13.4 p -97.29 109.4 22.16 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.46 0.647 . . . . 1.1799999999999999 110.957 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.604 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 5.5 p -113.55 155.8 24.75 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.817 -0.628 . . . . 1.24 111.86 -168.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 1.078 ' HE2' HD23 ' A' ' 114' ' ' LEU . 14.8 mtmm -140.74 134.18 29.91 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 108.132 -1.062 . . . . 2.2599999999999998 108.132 173.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.457 ' HB3' ' H ' ' A' ' 148' ' ' ASN . 41.1 p -69.79 96.33 0.98 Allowed 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.955 -1.128 . . . . 1.3899999999999999 107.955 174.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.453 HG11 ' HE2' ' A' ' 3' ' ' PHE . 2.3 t -107.56 124.01 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 CA-C-N 114.534 -1.212 . . . . 1.05 110.788 -163.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -98.19 48.68 1.0 Allowed 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 113.264 -1.789 . . . . 2.1699999999999999 109.735 -165.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.813 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 1.5 p90 -81.68 159.14 67.21 Favored Pre-proline 0 C--N 1.313 -0.983 0 CA-C-N 113.343 -1.753 . . . . 0.53000000000000003 110.549 -171.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.484 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 1.9 Cg_endo -47.84 -42.1 31.28 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.672 2.915 . . . . 1.28 115.709 -172.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.813 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 18.0 tt0 -70.27 -11.82 61.17 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 111.824 0.305 . . . . 3.5 111.824 -162.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.516 ' HB2' HG11 ' A' ' 84' ' ' VAL . 0.7 OUTLIER -157.3 99.74 1.93 Allowed Pre-proline 0 C--N 1.321 -0.654 0 C-N-CA 119.407 -0.917 . . . . 6.1200000000000001 113.406 177.317 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -90.23 160.93 4.69 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.003 3.135 . . . . 1.77 111.42 171.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.529 ' HB3' ' HB2' ' A' ' 145' ' ' ARG . 87.3 Cg_endo -94.58 -161.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.91 2.407 . . . . 1.25 113.361 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.5 t -148.52 -157.47 0.82 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.585 -0.895 . . . . 1.6000000000000001 108.585 -178.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.1 p -89.98 -36.72 14.8 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.617 -0.433 . . . . 1.97 111.397 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.31 -35.59 58.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.9 0.381 . . . . 2.1800000000000002 110.171 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.703 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 99.2 m-85 -107.71 111.39 23.56 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 109.497 -0.557 . . . . 1.23 109.497 -178.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.604 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 1.1 tp -98.38 112.88 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 N-CA-C 108.87 -0.789 . . . . 0.81999999999999995 108.87 -176.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 1.081 ' HD2' HG12 ' A' ' 112' ' ' ILE . 2.6 tpp85 -60.16 97.44 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.323 -0.992 . . . . 4.4199999999999999 108.323 173.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 175' ' ' MET . . . -64.38 133.8 38.98 Favored Glycine 0 CA--C 1.503 -0.683 0 CA-C-N 115.575 -0.739 . . . . 0.79000000000000004 112.288 -171.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.538 ' CD2' ' HD2' ' A' ' 176' ' ' ARG . 2.6 m-85 -83.74 79.25 9.52 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 122.308 1.052 . . . . 4.4400000000000004 112.115 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.482 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 5.8 t30 -80.74 83.34 6.52 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 113.45 -1.705 . . . . 1.6200000000000001 108.407 167.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.513 ' HB3' ' HD2' ' A' ' 150' ' ' PRO . 96.6 m-70 -49.63 161.3 0.52 Allowed Pre-proline 0 C--O 1.219 -0.534 0 CA-C-O 118.628 -0.701 . . . . 2.3199999999999998 109.755 175.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 149' ' ' HIS . 5.7 Cg_endo -47.5 75.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 124.276 3.318 . . . . 0.53000000000000003 114.135 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' CYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 170' ' ' PHE . 25.4 p -138.61 167.61 21.57 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.057 -1.46 . . . . 1.5800000000000001 107.057 175.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.71 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -153.69 -138.74 2.72 Favored Glycine 0 N--CA 1.433 -1.562 0 C-N-CA 118.733 -1.699 . . . . 0.42999999999999999 113.51 -167.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.464 ' HB3' ' CG1' ' A' ' 127' ' ' ILE . 63.3 t80 -163.06 93.19 0.79 Allowed 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 107.949 -1.13 . . . . 0.59999999999999998 107.949 -163.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.729 HG23 HG13 ' A' ' 168' ' ' VAL . 7.7 m -102.81 138.29 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-O 121.88 0.848 . . . . 0.31 110.653 -176.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' CYS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 125' ' ' ASN . 71.4 m -112.13 110.56 20.9 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.252 -0.885 . . . . 1.55 109.296 175.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.777 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 16.4 m -101.38 122.21 48.9 Favored Pre-proline 0 C--N 1.318 -0.766 0 C-N-CA 120.602 -0.439 . . . . 1.0600000000000001 111.256 -169.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.52 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 51.4 Cg_exo -55.49 115.06 2.18 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.12 1.88 . . . . 0.56000000000000005 110.689 170.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.524 ' SD ' ' HB2' ' A' ' 166' ' ' LYS . 74.6 mmm -75.08 -172.11 1.57 Allowed 'General case' 0 CA--C 1.505 -0.763 0 C-N-CA 120.765 -0.374 . . . . 1.1599999999999999 110.75 -177.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -69.85 -31.64 69.6 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 108.537 -0.912 . . . . 2.6299999999999999 108.537 170.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 2.6 mm-40 -98.3 27.85 4.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.928 -1.033 . . . . 2.0499999999999998 108.79 175.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.576 ' OD1' ' HD3' ' A' ' 162' ' ' PRO . 5.5 p30 -36.52 -47.37 1.6 Allowed Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 116.226 1.936 . . . . 1.9299999999999999 116.226 -166.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.576 ' HD3' ' OD1' ' A' ' 161' ' ' ASN . 72.8 Cg_endo -75.54 -14.57 19.96 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 CA-C-N 121.621 1.615 . . . . 0.72999999999999998 113.208 -175.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -111.62 -27.31 8.61 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.001 0.429 . . . . 0.68000000000000005 110.657 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.583 ' HB2' ' HB2' ' A' ' 160' ' ' GLU . 66.4 m-85 -140.65 131.77 26.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.512 -0.767 . . . . 0.93000000000000005 109.546 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.66 ' HB2' ' HD3' ' A' ' 58' ' ' PRO . 17.5 t -126.99 152.92 46.57 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.843 -0.743 . . . . 1.4099999999999999 111.125 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.856 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.8 tppp? -91.69 104.35 16.83 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.51 -0.768 . . . . 0.73999999999999999 111.509 -176.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.605 HD12 HG12 ' A' ' 196' ' ' ILE . 0.7 OUTLIER -84.8 100.91 11.85 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.066 -0.97 . . . . 0.27000000000000002 108.883 174.514 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.761 HG12 ' HG3' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -124.5 128.92 73.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.667 0.746 . . . . 0.28000000000000003 110.8 178.025 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.729 ' HB3' HG22 ' A' ' 50' ' ' VAL . 25.2 ttt -132.51 162.49 31.1 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.858 -0.793 . . . . 1.24 108.858 -171.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.655 ' HE1' HG13 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -139.51 108.24 5.94 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.323 -1.362 . . . . 3.3700000000000001 107.323 -173.468 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.447 HG13 ' OG1' ' A' ' 173' ' ' THR . 30.6 t -106.45 98.3 6.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 124.044 0.84 . . . . 1.3999999999999999 109.878 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.614 ' HG3' ' HA ' ' A' ' 40' ' ' SER . 49.9 tt0 -100.1 11.98 38.04 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 106.909 -1.515 . . . . 2.1699999999999999 106.909 173.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 1.1 m -61.09 127.29 30.79 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.207 -1.815 . . . . 1.6499999999999999 110.534 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.47 ' HG2' ' HB2' ' A' ' 147' ' ' TYR . 13.0 pt-20 -97.36 -15.64 20.62 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.375 -0.972 . . . . 2.4500000000000002 108.375 175.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.511 ' O ' ' HG2' ' A' ' 176' ' ' ARG . 23.8 mmt 68.11 -66.12 0.23 Allowed 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 114.543 -1.208 . . . . 3.7400000000000002 110.553 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.585 ' HA ' HD11 ' A' ' 179' ' ' LEU . 0.9 OUTLIER 54.49 179.54 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.982 1.313 . . . . 5.7800000000000002 111.455 -176.738 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.414 ' HA3' HG12 ' A' ' 144' ' ' ILE . . . 87.66 69.61 1.29 Allowed Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 120.522 -0.847 . . . . 2.2599999999999998 112.21 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 76.5 tttt 69.5 72.62 0.25 Allowed 'General case' 0 CA--C 1.532 0.253 0 O-C-N 124.12 0.541 . . . . 6.2300000000000004 111.973 170.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.748 HD13 HD11 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -156.52 150.27 24.81 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.788 -0.642 . . . . 1.6399999999999999 110.72 173.33 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.499 ' H ' ' CG1' ' A' ' 183' ' ' ILE . 18.2 m -112.7 166.95 9.97 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.576 -0.738 . . . . 2.04 109.106 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 180' ' ' SER . 94.8 Cg_exo -45.4 -43.8 17.04 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.494 2.129 . . . . 1.74 113.064 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.405 ' O ' ' HE2' ' A' ' 186' ' ' LYS . 0.7 OUTLIER -64.17 -19.34 65.25 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.162 0.506 . . . . 2.1400000000000001 111.612 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.499 ' CG1' ' H ' ' A' ' 180' ' ' SER . 31.2 mm -91.56 -44.64 14.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 122.467 1.127 . . . . 1.1200000000000001 108.9 -176.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.992 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.2 mp -68.05 -36.87 77.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 113.073 -1.876 . . . . 1.1299999999999999 111.555 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -63.94 -17.98 63.8 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.112 -0.699 . . . . 2.8900000000000001 109.112 177.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.423 ' HE2' ' HA ' ' A' ' 183' ' ' ILE . 51.4 mtmt -93.04 -45.28 7.99 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.381 -0.827 . . . . 1.28 109.919 172.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.992 HG22 ' HA ' ' A' ' 184' ' ' ILE . 6.8 t -63.58 -30.23 71.38 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.329 0.492 . . . . 0.62 112.329 -169.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' MET . . . . . 0.712 ' O ' ' HG ' ' A' ' 192' ' ' LEU . 0.2 OUTLIER -75.13 -63.39 0.72 Allowed Pre-proline 0 C--N 1.33 -0.244 0 C-N-CA 120.956 -0.298 . . . . 1.0600000000000001 110.877 179.524 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.515 ' HD3' ' CB ' ' A' ' 188' ' ' MET . 32.2 Cg_exo -59.03 -33.62 98.77 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.275 1.984 . . . . 0.91000000000000003 112.367 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.708 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 9.3 t -71.21 -22.61 61.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.825 0.345 . . . . 1.5 110.407 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -91.83 -43.68 9.38 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.031 -0.532 . . . . 1.8799999999999999 110.733 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.712 ' HG ' ' O ' ' A' ' 188' ' ' MET . 51.7 mt -53.11 -59.39 4.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.575 -0.739 . . . . 1.0900000000000001 111.703 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.477 ' O ' ' HG ' ' A' ' 197' ' ' LEU . 1.1 m -73.91 -30.57 28.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.089 -0.96 . . . . 0.68000000000000005 109.345 -171.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.708 ' HB2' ' O ' ' A' ' 190' ' ' SER . 1.0 OUTLIER -67.79 -44.15 78.06 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 114.04 -1.436 . . . . 2.0699999999999998 110.315 179.128 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.592 ' O ' ' HB2' ' A' ' 198' ' ' ASN . 0.9 OUTLIER -59.91 -27.42 66.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.045 0.45 . . . . 2.0 110.728 176.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.702 HG21 HG21 ' A' ' 33' ' ' ILE . 33.7 mt -79.27 -31.03 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 120.983 0.42 . . . . 0.31 111.286 173.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 94.7 mt -75.68 -30.7 59.45 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.235 0.54 . . . . 1.03 110.026 176.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.592 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 7.6 m-20 -47.22 -47.43 24.45 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.712 -1.131 . . . . 1.8999999999999999 107.967 162.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.655 ' HA ' ' CE2' ' A' ' 64' ' ' PHE . . . -77.54 -44.84 27.27 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 115.005 -0.998 . . . . 0.28999999999999998 111.292 -173.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 31.5 mmtp -54.63 -41.84 70.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.527 0.679 . . . . 0.96999999999999997 110.696 175.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.538 ' HA ' ' HE3' ' A' ' 204' ' ' LYS . 2.2 t70 -84.37 -47.62 10.52 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.969 -1.014 . . . . 1.9399999999999999 110.094 -175.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' GLY . . . . . 0.501 ' HA2' ' HB3' ' A' ' 205' ' ' ALA . . . -63.25 -29.33 74.14 Favored Glycine 0 N--CA 1.459 0.232 0 C-N-CA 120.726 -0.749 . . . . 0.46999999999999997 112.489 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 1.011 HD13 HD23 ' A' ' 61' ' ' LEU . 3.0 tp -69.79 -38.58 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-O 120.848 0.356 . . . . 0.60999999999999999 110.453 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.787 ' HA ' ' HG2' ' A' ' 207' ' ' ARG . 0.0 OUTLIER -90.59 -17.16 27.41 Favored 'General case' 0 C--O 1.207 -1.169 0 N-CA-C 109.284 -0.635 . . . . 3.3700000000000001 109.284 177.291 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.501 ' HB3' ' HA2' ' A' ' 202' ' ' GLY . . . -67.64 -26.51 66.26 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.171 -0.677 . . . . 1.02 109.171 168.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.571 ' CE1' ' HA ' ' A' ' 64' ' ' PHE . 4.7 m-70 -83.15 -43.06 16.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.392 -0.822 . . . . 3.6299999999999999 112.976 174.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.787 ' HG2' ' HA ' ' A' ' 204' ' ' LYS . 10.6 ptt180 -88.38 -40.71 13.33 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.482 0.658 . . . . 2.5899999999999999 111.093 -176.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.608 ' HB ' ' O ' ' A' ' 204' ' ' LYS . 97.4 m -101.19 156.96 34.53 Favored Pre-proline 0 C--N 1.311 -1.107 0 CA-C-N 115.099 -0.955 . . . . 1.8400000000000001 109.04 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.449 ' HD2' HG23 ' A' ' 208' ' ' THR . 11.7 Cg_endo -59.28 -93.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 120.981 1.121 . . . . 2.3500000000000001 110.434 166.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 93.5 p 49.26 25.67 1.31 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.426 0.899 . . . . 2.3100000000000001 113.426 172.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -96.5 27.66 3.72 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.668 -0.864 . . . . 5.4500000000000002 108.668 175.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -64.76 -25.75 68.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.691 -1.14 . . . . 6.8600000000000003 110.146 176.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -112.17 36.92 3.9 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.684 -0.689 . . . . 3.3700000000000001 111.553 176.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -55.42 138.52 45.86 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.91 -0.404 . . . . 5.21 109.91 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' HIS . . . . . 0.53 ' HB3' ' O ' ' A' ' 75' ' ' ASP . 20.9 t-80 -104.49 -7.65 19.65 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.521 0.563 . . . . 6.46 112.521 -170.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' HIS . . . . . 0.795 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 27.1 t-80 -79.58 60.71 3.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.786 0.803 . . . . 6.0899999999999999 109.353 176.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -160.43 53.3 0.32 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.845 -1.07 . . . . 5.1200000000000001 108.499 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 11.0 m -91.08 0.76 57.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.102 -0.954 . . . . 6.7599999999999998 110.491 -175.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -139.42 136.07 34.29 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.819 -0.628 . . . . 8.8200000000000003 110.231 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.354 -0.831 . . . . 8.4800000000000004 110.875 179.951 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 mtp . . . . . 0 N--CA 1.482 1.153 0 N-CA-C 109.416 -0.587 . . . . 3.8599999999999999 109.416 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.469 ' O ' HD12 ' A' ' 6' ' ' ILE . 15.2 t70 -95.77 -55.17 3.09 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 109.313 -0.625 . . . . 2.25 109.313 177.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.536 ' HA ' HD12 ' A' ' 6' ' ' ILE . 70.5 m-85 -59.55 -34.82 73.16 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.667 0.746 . . . . 0.42999999999999999 109.598 -177.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.502 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 45.1 tttt -70.48 -42.47 71.37 Favored 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 114.644 -1.162 . . . . 1.51 108.085 -178.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.89 -41.9 62.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.844 -0.617 . . . . 0.54000000000000004 111.616 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.677 ' O ' ' HB ' ' A' ' 10' ' ' THR . 1.3 mp -79.26 -48.15 21.57 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 N-CA-C 108.714 -0.847 . . . . 1.0700000000000001 108.714 -175.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.968 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -57.54 -47.42 82.06 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.779 -1.1 . . . . 0.34000000000000002 111.974 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.502 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 13.1 mt-30 -60.34 -36.22 77.48 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 113.889 -1.505 . . . . 1.5900000000000001 111.631 -176.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.27 -18.16 26.13 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.396 -0.82 . . . . 2.4700000000000002 109.506 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.677 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -83.18 -38.6 22.11 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.19 -0.914 . . . . 0.47999999999999998 111.233 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.429 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -49.54 -59.89 3.35 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-O 121.218 0.532 . . . . 0.31 110.81 176.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -67.4 -11.54 58.0 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.284 -0.871 . . . . 1.6399999999999999 111.787 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.62 ' HB3' ' HA ' ' A' ' 10' ' ' THR . 0.6 OUTLIER -87.3 -42.11 13.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 110.267 -0.272 . . . . 2.54 110.267 -179.164 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.783 HG11 ' HA3' ' A' ' 152' ' ' GLY . 0.4 OUTLIER -75.48 -34.16 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 122.305 1.05 . . . . 0.53000000000000003 108.539 177.617 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.547 HD11 ' SD ' ' A' ' 124' ' ' MET . 0.6 OUTLIER -68.39 -29.29 67.95 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 114.32 -1.309 . . . . 0.59999999999999998 108.379 172.305 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 20' ' ' ASP . . . -64.99 -17.93 63.91 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 113.571 -1.65 . . . . 0.56999999999999995 110.706 177.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.636 ' CD2' ' HA ' ' A' ' 14' ' ' VAL . 23.6 m-85 -84.6 -26.25 28.04 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 109.427 -0.583 . . . . 3.27 109.427 176.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.501 ' HB2' ' CZ ' ' A' ' 170' ' ' PHE . 2.6 t30 -72.09 -15.75 62.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.768 -0.651 . . . . 2.0299999999999998 110.086 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -116.31 10.97 14.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.456 -0.793 . . . . 2.7200000000000002 110.467 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.502 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 27.5 t70 -111.36 107.22 16.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.943 -0.571 . . . . 2.1600000000000001 110.684 -176.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.514 HG22 ' CZ2' ' A' ' 24' ' ' TRP . 53.3 p -125.87 112.75 16.35 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.624 0.25 . . . . 1.8200000000000001 110.642 -176.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.2 p -177.5 117.65 0.1 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.861 -0.609 . . . . 2.1899999999999999 111.817 -168.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.3 33.89 82.46 Favored Glycine 0 C--O 1.23 -0.144 0 C-N-CA 121.337 -0.458 . . . . 1.1000000000000001 113.404 173.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.514 ' CZ2' HG22 ' A' ' 21' ' ' THR . 0.1 OUTLIER -119.97 -168.28 1.58 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.289 -0.634 . . . . 1.6699999999999999 109.289 177.928 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 36' ' ' SER . 8.0 mtmm -174.95 156.42 2.2 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 107.999 -1.111 . . . . 2.9500000000000002 107.999 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 2.3 p -78.46 119.64 27.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-O 121.817 0.817 . . . . 1.5600000000000001 109.25 175.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 35' ' ' VAL . 8.2 p -86.61 -24.76 6.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 114.845 -1.07 . . . . 1.22 109.382 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 28' ' ' LYS . 9.1 tppt? -172.31 150.73 2.41 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.634 0.605 . . . . 2.4100000000000001 112.634 -176.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.706 HG22 ' HA ' ' A' ' 34' ' ' THR . 69.3 p -134.43 148.42 50.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.553 -0.749 . . . . 1.3799999999999999 109.682 173.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.524 ' H ' ' HB ' ' A' ' 33' ' ' ILE . 50.3 m -152.78 84.1 1.23 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.557 0.577 . . . . 2.3700000000000001 112.557 177.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 30' ' ' SER . 3.2 mptp? 79.66 71.31 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.942 0.497 . . . . 4.5499999999999998 111.365 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.483 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 65.2 mttm 73.26 20.87 3.19 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.299 -0.864 . . . . 1.4199999999999999 111.724 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.527 HD12 ' HB ' ' A' ' 193' ' ' VAL . 2.5 mt -108.44 166.78 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.942 0 CA-C-O 121.149 0.499 . . . . 0.76000000000000001 110.771 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.706 ' HA ' HG22 ' A' ' 29' ' ' THR . 48.7 m -158.43 102.54 1.74 Allowed 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.589 -1.187 . . . . 0.57999999999999996 109.304 176.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.491 ' O ' HG12 ' A' ' 27' ' ' VAL . 21.8 t -96.3 103.1 14.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.993 -0.549 . . . . 0.85999999999999999 109.537 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 81.0 p -96.22 123.49 39.87 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.502 0.667 . . . . 1.1000000000000001 110.911 -178.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.0 p -94.36 127.85 40.5 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.762 -1.108 . . . . 1.27 110.898 -176.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -136.51 123.38 21.33 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.624 -0.716 . . . . 1.9099999999999999 110.028 175.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 46' ' ' ASN . . . -55.41 127.59 30.29 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.36 0.504 . . . . 1.6799999999999999 112.36 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.55 ' OG ' ' HB2' ' A' ' 47' ' ' LEU . 20.4 m -85.95 137.59 32.62 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.323 -0.621 . . . . 2.0899999999999999 109.323 176.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.582 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 4.4 mmp_? -88.55 13.07 12.87 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.786 0.327 . . . . 6.6100000000000003 111.165 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.48 ' HD2' ' N ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -64.36 -22.92 67.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.215 -0.448 . . . . 6.46 110.369 175.346 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.48 ' N ' ' HD2' ' A' ' 42' ' ' LYS . 70.3 t80 174.82 -89.02 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.443 0.464 . . . . 5.6500000000000004 109.898 177.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -151.86 82.88 1.28 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.846 -0.798 . . . . 5.5599999999999996 108.846 176.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.77 129.15 1.87 Allowed Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 109.539 -1.424 . . . . 1.5600000000000001 109.539 -177.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.581 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 15.9 m120 -82.78 136.48 34.67 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.024 0.44 . . . . 2.0499999999999998 110.887 -175.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.55 ' HB2' ' OG ' ' A' ' 40' ' ' SER . 8.4 tt -87.76 140.75 29.19 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.468 -0.938 . . . . 0.87 108.468 173.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.413 ' HB2' HD11 ' A' ' 192' ' ' LEU . 68.7 m-85 -121.52 118.49 29.43 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.658 -0.417 . . . . 0.98999999999999999 110.42 -177.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 49' ' ' ARG . 37.1 ttt-85 -97.5 112.08 24.08 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.121 -0.696 . . . . 2.9199999999999999 109.121 176.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.65 HG13 ' HB3' ' A' ' 169' ' ' MET . 0.9 OUTLIER -107.24 119.56 57.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.907 -0.588 . . . . 1.3300000000000001 109.97 -172.848 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.564 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 35.9 tt0 -134.5 117.15 15.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.028 -0.533 . . . . 1.0700000000000001 111.296 -166.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 32' ' ' LYS . . . -145.66 144.75 13.37 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 121.05 -0.595 . . . . 0.28999999999999998 111.643 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 78.9 mt -86.09 131.5 34.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 117.249 0.525 . . . . 0.57999999999999996 111.175 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.447 HD13 ' HB1' ' A' ' 199' ' ' ALA . 55.5 mt -110.46 108.24 58.37 Favored Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-N 115.493 -0.776 . . . . 0.34999999999999998 109.034 176.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 164' ' ' TYR . 38.8 Cg_exo -62.37 56.12 0.13 Allowed 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 124.422 3.415 . . . . 0.62 115.393 -173.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.437 ' HB2' ' H ' ' A' ' 57' ' ' SER . 0.9 OUTLIER -164.35 -162.97 0.71 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.876 -0.416 . . . . 1.6799999999999999 109.876 167.75 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.437 ' H ' ' HB2' ' A' ' 56' ' ' GLU . 78.2 p -77.45 138.12 63.6 Favored Pre-proline 0 N--CA 1.431 -1.424 0 CA-C-O 121.918 0.866 . . . . 1.1799999999999999 112.135 -168.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.57 ' HA ' HD12 ' A' ' 61' ' ' LEU . 18.1 Cg_exo -62.44 -13.6 34.03 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.504 2.802 . . . . 0.52000000000000002 109.899 172.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.46 -53.38 19.51 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.194 -1.366 . . . . 0.64000000000000001 110.964 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.422 ' HB3' ' HE2' ' A' ' 60' ' ' LYS . 15.1 ttpt -68.62 -27.55 66.12 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.244 -1.021 . . . . 3.2999999999999998 108.244 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.983 HD23 HD13 ' A' ' 203' ' ' ILE . 28.9 mt -56.99 -60.45 3.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.159 -0.928 . . . . 0.40999999999999998 110.409 170.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.8 p -62.57 -15.9 53.5 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 121.81 -0.556 . . . . 1.29 110.839 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -92.36 -26.73 17.94 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.048 0.758 . . . . 1.3200000000000001 113.048 -176.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.64 ' CE2' ' HA ' ' A' ' 199' ' ' ALA . 6.5 p90 -89.2 -41.48 12.21 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.731 -0.606 . . . . 0.60999999999999999 110.866 -174.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.712 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -92.93 7.92 41.94 Favored 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 120.761 -0.376 . . . . 1.5 110.02 -179.286 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -44.55 -71.53 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.214 -0.903 . . . . 1.52 112.452 -168.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -139.7 -74.42 0.36 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.204 -0.598 . . . . 3.6000000000000001 112.522 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.711 ' HB ' ' CD1' ' A' ' 81' ' ' TYR . 9.0 t -156.77 30.92 0.31 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.753 0.787 . . . . 1.48 110.695 -168.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.0 -46.96 4.02 Favored Glycine 0 CA--C 1.49 -1.487 0 C-N-CA 120.01 -1.091 . . . . 1.46 112.636 -173.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.478 ' O ' HG22 ' A' ' 73' ' ' THR . 19.3 p-10 -152.6 -18.18 0.16 Allowed 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.151 -1.025 . . . . 2.1899999999999999 110.795 -171.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.708 ' HA ' ' CZ2' ' A' ' 74' ' ' TRP . 2.7 ptp180 -48.89 -39.36 25.62 Favored 'General case' 0 C--O 1.218 -0.589 0 C-N-CA 122.759 0.423 . . . . 3.3799999999999999 110.572 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.636 HD13 ' H ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -88.58 -7.91 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 C-N-CA 120.569 -0.453 . . . . 0.70999999999999996 111.242 -175.643 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 215' ' ' HIS . 0.8 OUTLIER -97.0 -32.76 11.84 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 119.791 -0.763 . . . . 0.96999999999999997 111.135 -173.811 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.708 ' CZ2' ' HA ' ' A' ' 71' ' ' ARG . 7.8 p-90 -101.63 -3.49 28.23 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.55 -0.46 . . . . 0.75 111.283 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.696 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 4.8 t70 -65.06 -178.64 0.47 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.869 0.842 . . . . 2.1899999999999999 112.356 -172.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.688 ' HG2' ' OD1' ' A' ' 198' ' ' ASN . 66.8 mmtt -104.56 -33.26 8.6 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.793 -1.094 . . . . 3.1899999999999999 108.852 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.513 ' HA ' ' HB2' ' A' ' 99' ' ' GLN . 16.8 m -134.61 19.52 3.59 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.344 -0.844 . . . . 1.5800000000000001 112.203 -170.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.583 HD13 HG22 ' A' ' 72' ' ' ILE . 27.7 mt -108.17 153.42 23.2 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.026 0.441 . . . . 0.70999999999999996 110.508 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.51 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 26.1 mm-40 -134.28 -67.0 0.59 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.671 -0.695 . . . . 1.73 110.606 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 96' ' ' THR . 2.4 t -136.73 112.01 11.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.674 -0.694 . . . . 0.78000000000000003 110.847 -170.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.711 ' CD1' ' HB ' ' A' ' 68' ' ' THR . 18.0 t80 -98.92 137.79 36.98 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.013 -0.736 . . . . 5.4000000000000004 109.013 175.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -143.16 107.44 4.76 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.442 -0.577 . . . . 1.6899999999999999 109.442 -175.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.487 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 2.8 mtm -66.77 102.25 0.92 Allowed 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.996 -0.742 . . . . 2.0499999999999998 108.996 174.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.545 HG11 ' HZ ' ' A' ' 134' ' ' PHE . 0.3 OUTLIER -72.9 -71.01 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.919 -0.582 . . . . 0.64000000000000001 110.843 -170.075 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -133.19 118.66 18.9 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.677 -0.861 . . . . 1.96 108.677 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.487 ' HD3' ' SD ' ' A' ' 83' ' ' MET . 44.0 mtm180 -93.89 105.27 17.29 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.126 0.489 . . . . 2.4399999999999999 109.965 -175.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.646 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -69.08 -44.45 81.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.355 -0.839 . . . . 0.46999999999999997 110.945 -175.323 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.456 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 15.0 t70 -147.9 168.0 23.37 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.928 -1.033 . . . . 1.8600000000000001 108.253 -173.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.2 m -68.05 -3.67 10.96 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.594 0.235 . . . . 1.4399999999999999 111.112 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -130.77 4.52 4.56 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 110.177 -0.305 . . . . 1.8700000000000001 110.177 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.646 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -133.3 108.79 8.95 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 109.114 -0.698 . . . . 0.46000000000000002 109.114 -172.433 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.65 ' O ' HD12 ' A' ' 114' ' ' LEU . 17.1 m-85 -125.38 174.74 7.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.876 -0.602 . . . . 0.42999999999999999 110.127 -174.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.545 HG21 ' CE1' ' A' ' 134' ' ' PHE . 39.4 mt -131.55 132.79 62.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 107.927 -1.138 . . . . 0.40999999999999998 107.927 171.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.468 ' HB3' ' OH ' ' A' ' 81' ' ' TYR . 23.6 p -110.93 106.26 15.32 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.585 -0.446 . . . . 2.0099999999999998 111.961 -171.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.587 ' HA ' ' O ' ' A' ' 111' ' ' PHE . 2.1 t60 -81.23 90.06 6.07 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.441 -0.948 . . . . 1.23 108.441 167.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.633 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 35.0 m -115.47 114.58 25.22 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.555 -0.748 . . . . 0.5 111.938 -171.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 38.1 mm -76.52 121.98 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 109.01 -0.737 . . . . 1.03 109.01 174.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.464 ' HB ' ' O ' ' A' ' 109' ' ' ARG . 25.7 m -109.4 143.73 38.58 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.544 -1.207 . . . . 1.3799999999999999 109.861 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.513 ' HB2' ' HA ' ' A' ' 77' ' ' SER . 22.2 mt-30 -71.59 174.19 7.03 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.693 -0.685 . . . . 1.8200000000000001 111.625 -176.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.9 t -85.74 94.21 9.05 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.42 -0.809 . . . . 3.9100000000000001 109.547 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -91.63 116.3 28.76 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.473 -0.936 . . . . 5.1600000000000001 108.473 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.785 ' HB3' HD12 ' A' ' 106' ' ' ILE . . . 71.44 69.79 0.17 Allowed 'General case' 0 C--N 1.32 -0.677 0 O-C-N 124.452 1.095 . . . . 1.98 108.235 -172.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.8 m -64.41 4.6 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 114.459 -1.246 . . . . 3.1699999999999999 113.013 -173.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -77.44 -45.94 10.57 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.411 -0.899 . . . . 1.96 111.948 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.453 ' HB2' HG21 ' A' ' 183' ' ' ILE . 74.2 m -130.96 0.51 4.24 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.815 0.34 . . . . 1.8799999999999999 111.329 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.785 HD12 ' HB3' ' A' ' 102' ' ' ALA . 73.6 mt -119.03 125.08 74.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.163 0.506 . . . . 1.1200000000000001 111.159 -176.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.475 ' OG ' ' HD2' ' A' ' 108' ' ' PRO . 32.4 t -92.19 159.83 36.6 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.354 -0.839 . . . . 1.3500000000000001 109.25 178.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.475 ' HD2' ' OG ' ' A' ' 107' ' ' SER . 97.2 Cg_exo -44.63 142.37 4.85 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.44 2.093 . . . . 1.0700000000000001 111.374 171.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.714 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 29.1 ttp-105 -126.21 130.8 51.67 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.545 -0.462 . . . . 3.4500000000000002 109.879 -167.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.554 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 9.1 t0 -104.73 125.07 50.45 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.736 -0.468 . . . . 1.3700000000000001 109.736 -176.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.633 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 12.0 m-30 -95.97 143.65 26.96 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.244 0.545 . . . . 2.4100000000000001 110.621 -172.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.642 ' CG2' ' HE1' ' A' ' 134' ' ' PHE . 26.9 mm -138.36 61.2 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 107.085 -1.45 . . . . 0.42999999999999999 107.085 170.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.494 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 45.7 m-20 -96.46 125.41 40.93 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.658 -1.156 . . . . 1.8600000000000001 109.766 -175.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.65 HD12 ' O ' ' A' ' 92' ' ' PHE . 7.7 tp -75.22 126.89 31.94 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.988 -0.551 . . . . 0.28000000000000003 109.524 173.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -127.01 128.18 70.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.596 -0.729 . . . . 0.26000000000000001 111.929 -165.475 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.968 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 7.7 t80 -113.15 114.23 26.5 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.156 -0.929 . . . . 2.5699999999999998 110.324 175.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.649 HG12 HG22 ' A' ' 127' ' ' ILE . 71.9 mt -90.41 99.29 9.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.84 -0.618 . . . . 0.89000000000000001 109.401 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.507 ' HB3' HG23 ' A' ' 126' ' ' ILE . 15.4 tppt? -102.4 123.06 45.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.572 -0.74 . . . . 1.2 110.948 -173.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -103.07 93.28 4.93 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.869 -0.605 . . . . 2.7999999999999998 109.443 177.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -70.97 106.12 3.54 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 107.181 -1.414 . . . . 0.82999999999999996 107.181 168.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -26.1 92.98 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 O-C-N 125.123 1.514 . . . . 2.2799999999999998 113.631 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 53.7 43.27 68.98 Favored Glycine 0 CA--C 1.508 -0.385 0 CA-C-N 115.316 -0.856 . . . . 0.76000000000000001 112.176 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.662 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 47.9 t30 -139.02 -47.77 0.49 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.054 -0.573 . . . . 1.6499999999999999 110.585 -174.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.547 ' SD ' HD11 ' A' ' 15' ' ' LEU . 2.4 mtt -161.13 121.21 2.69 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 120.953 0.406 . . . . 1.1200000000000001 110.919 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -106.34 75.16 1.07 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.452 -0.944 . . . . 1.6200000000000001 108.452 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.759 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.5 OUTLIER -97.08 141.5 15.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.004 -0.998 . . . . 0.29999999999999999 112.866 -172.173 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.706 ' O ' HG13 ' A' ' 127' ' ' ILE . 6.4 pt -109.45 108.97 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-O 121.756 0.789 . . . . 0.58999999999999997 108.99 163.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 56.4 p -95.25 117.93 31.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.191 0.519 . . . . 1.1799999999999999 110.955 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.565 ' HB2' ' SG ' ' A' ' 151' ' ' CYS . 20.1 m -114.6 151.57 33.25 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.199 0.523 . . . . 1.24 111.458 -174.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.559 ' HZ3' HG21 ' A' ' 10' ' ' THR . 10.3 mtmm -140.92 130.12 23.53 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.787 -0.82 . . . . 2.2599999999999998 108.787 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.445 ' HB3' ' H ' ' A' ' 148' ' ' ASN . 21.7 p -73.76 101.46 3.71 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.832 -0.803 . . . . 1.3899999999999999 108.832 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.3 m -105.72 173.55 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 120.048 -0.661 . . . . 1.05 110.173 -176.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -135.65 65.42 1.54 Allowed 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 122.069 0.938 . . . . 2.1699999999999999 109.354 -174.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.642 ' HE1' ' CG2' ' A' ' 112' ' ' ILE . 1.0 OUTLIER -97.08 153.62 38.44 Favored Pre-proline 0 C--N 1.317 -0.839 0 CA-C-N 114.088 -1.414 . . . . 0.53000000000000003 108.852 -175.644 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -83.39 5.42 6.41 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.082 1.855 . . . . 1.28 116.483 -166.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.602 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 11.8 tp10 -76.06 -15.95 60.02 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 119.253 0.933 . . . . 3.5 108.505 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -156.75 114.73 2.03 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 113.315 0.857 . . . . 6.1200000000000001 113.315 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -95.06 139.43 0.98 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.671 2.914 . . . . 1.77 111.85 169.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -80.6 -165.4 0.34 Allowed 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.608 2.205 . . . . 1.25 112.988 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.1 m -147.62 152.37 37.78 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.94 -1.133 . . . . 1.6000000000000001 107.94 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.1 t -61.45 -16.9 51.47 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.953 0.723 . . . . 1.97 112.953 -167.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -82.72 -18.52 40.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.943 0.402 . . . . 2.1800000000000002 110.94 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.508 ' HB3' ' CB ' ' A' ' 110' ' ' ASP . 94.1 m-85 -130.82 109.15 10.37 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.73 -0.668 . . . . 1.23 109.804 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.714 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 2.1 tp -89.19 115.02 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 CA-C-N 115.795 -0.638 . . . . 0.81999999999999995 109.659 -169.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.554 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 30.3 ttp180 -36.02 115.75 0.35 Allowed 'General case' 0 C--N 1.327 -0.403 0 O-C-N 124.618 1.198 . . . . 4.4199999999999999 111.076 175.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.492 ' H ' ' HA ' ' A' ' 111' ' ' PHE . . . -42.63 108.0 0.13 Allowed Glycine 0 CA--C 1.496 -1.096 0 O-C-N 124.655 1.222 . . . . 0.79000000000000004 112.358 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.661 ' HB2' ' HB3' ' A' ' 174' ' ' GLU . 1.3 p90 -86.01 55.33 3.48 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.201 -0.499 . . . . 4.4400000000000004 111.835 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.703 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 84.5 m-20 -98.64 65.36 1.57 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.489 -0.778 . . . . 1.6200000000000001 110.702 -177.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -54.44 146.2 34.36 Favored Pre-proline 0 N--CA 1.467 0.379 0 CA-C-N 115.843 -0.617 . . . . 2.3199999999999998 110.421 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -10.01 62.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.312 1 C-N-CA 126.853 5.035 . . . . 0.53000000000000003 115.838 -161.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' CYS . . . . . 0.703 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 27.6 p -84.19 171.13 13.07 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.347 -1.297 . . . . 1.5800000000000001 109.069 173.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.783 ' HA3' HG11 ' A' ' 14' ' ' VAL . . . -167.8 -168.04 29.35 Favored Glycine 0 N--CA 1.433 -1.552 0 C-N-CA 119.744 -1.217 . . . . 0.42999999999999999 111.854 177.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.651 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 39.9 t80 -162.66 77.01 0.46 Allowed 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 109.064 -0.717 . . . . 0.59999999999999998 109.064 -165.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.759 HG12 ' HB ' ' A' ' 126' ' ' ILE . 3.9 m -89.27 121.6 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 122.034 0.921 . . . . 0.31 110.607 -175.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 32.3 m -100.43 112.74 25.13 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.037 -0.983 . . . . 1.55 108.728 175.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.414 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 7.1 m -106.8 111.43 63.83 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 116.492 -0.322 . . . . 1.0600000000000001 111.406 -171.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.662 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 57.7 Cg_exo -52.16 119.34 5.62 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.421 2.081 . . . . 0.56000000000000005 111.002 168.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.4 ' N ' ' HB3' ' A' ' 161' ' ' ASN . 72.2 mtp -81.37 -169.98 2.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.976 0.417 . . . . 1.1599999999999999 111.348 -176.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -67.28 -30.53 70.42 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.854 -0.795 . . . . 2.6299999999999999 108.854 169.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.423 ' C ' ' HD2' ' A' ' 162' ' ' PRO . 47.1 mm-40 -104.32 28.79 6.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.607 -1.179 . . . . 2.0499999999999998 109.274 175.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.577 ' OD1' ' HD3' ' A' ' 162' ' ' PRO . 4.8 p30 -34.81 -47.82 0.94 Allowed Pre-proline 0 N--CA 1.472 0.643 0 N-CA-C 116.16 1.911 . . . . 1.9299999999999999 116.16 -171.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.577 ' HD3' ' OD1' ' A' ' 161' ' ' ASN . 66.3 Cg_endo -72.51 -25.09 18.27 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 CA-C-N 121.534 1.584 . . . . 0.72999999999999998 112.378 -174.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -100.78 -25.55 14.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.761 -0.654 . . . . 0.68000000000000005 110.919 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 55' ' ' PRO . 73.1 m-85 -142.48 119.99 11.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.986 -0.552 . . . . 0.93000000000000005 110.238 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.449 ' OG ' HD11 ' A' ' 61' ' ' LEU . 13.8 p -114.47 140.83 48.4 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.169 0.509 . . . . 1.4099999999999999 110.972 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.564 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 2.0 tppp? -91.51 104.04 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.892 0.853 . . . . 0.73999999999999999 111.577 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.506 HD21 ' CE2' ' A' ' 153' ' ' PHE . 0.8 OUTLIER -89.49 111.61 22.55 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.87 -1.059 . . . . 0.27000000000000002 109.241 177.756 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.65 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.1 OUTLIER -132.16 116.41 29.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 122.099 0.952 . . . . 0.28000000000000003 111.91 175.094 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.65 ' HB3' HG13 ' A' ' 50' ' ' VAL . 19.4 ttt -112.57 158.99 19.29 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.462 -1.244 . . . . 1.24 108.817 -175.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.667 ' HE1' HG13 ' A' ' 154' ' ' VAL . 0.1 OUTLIER -140.06 151.15 45.17 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 110.47 -0.196 . . . . 3.3700000000000001 110.47 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.517 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 6.6 m -136.87 128.23 42.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 O-C-N 123.385 0.428 . . . . 1.3999999999999999 110.931 173.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -108.15 49.7 0.8 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.106 -1.442 . . . . 2.1699999999999999 107.106 174.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -47.68 130.65 14.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.383 -1.735 . . . . 1.6499999999999999 113.541 -166.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.661 ' HB3' ' HB2' ' A' ' 147' ' ' TYR . 21.9 tt0 -88.49 -33.19 17.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.274 -0.876 . . . . 2.4500000000000002 111.04 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.484 ' SD ' HG12 ' A' ' 184' ' ' ILE . 68.9 mtm 61.21 50.97 4.54 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.183 0.516 . . . . 3.7400000000000002 110.567 171.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.601 ' HG3' ' HB3' ' A' ' 147' ' ' TYR . 74.2 mtp85 -58.99 -30.24 67.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.228 -0.896 . . . . 5.7800000000000002 111.9 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -66.04 -20.48 68.92 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.849 -0.691 . . . . 2.2599999999999998 111.99 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 51.46 82.46 0.06 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.266 0.626 . . . . 6.2300000000000004 111.772 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.641 HD22 ' H ' ' A' ' 179' ' ' LEU . 0.4 OUTLIER -84.52 -158.39 0.34 Allowed 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.629 -0.878 . . . . 1.6399999999999999 108.629 177.75 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.541 ' O ' HD12 ' A' ' 184' ' ' ILE . 50.2 m -112.05 151.38 43.55 Favored Pre-proline 0 C--N 1.315 -0.897 0 N-CA-C 108.802 -0.814 . . . . 2.04 108.802 178.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.615 ' O ' ' HG2' ' A' ' 185' ' ' GLU . 62.0 Cg_exo -39.68 -56.0 1.48 Allowed 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 123.327 2.685 . . . . 1.74 113.373 -177.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 14.6 m -64.97 -11.74 42.06 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.483 0.549 . . . . 2.1400000000000001 112.483 -175.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.468 ' HA ' ' CE ' ' A' ' 186' ' ' LYS . 33.0 mm -90.73 -43.89 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-O 122.528 1.156 . . . . 1.1200000000000001 108.724 -177.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 1.086 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.4 mp -66.69 -34.14 68.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 112.889 -1.959 . . . . 1.1299999999999999 110.597 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.615 ' HG2' ' O ' ' A' ' 181' ' ' PRO . 18.1 mm-40 -62.04 -21.33 64.82 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.793 -1.094 . . . . 2.8900000000000001 109.39 174.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.468 ' CE ' ' HA ' ' A' ' 183' ' ' ILE . 50.8 mtmt -92.53 -49.34 6.17 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.382 -0.826 . . . . 1.28 110.222 172.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' THR . . . . . 1.086 HG22 ' HA ' ' A' ' 184' ' ' ILE . 6.5 t -61.55 -35.08 76.74 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.328 0.492 . . . . 0.62 112.328 -168.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' MET . . . . . 0.611 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 2.1 mmt -80.35 -61.24 0.44 Allowed Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 119.921 -0.712 . . . . 1.0600000000000001 111.946 -177.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.611 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 8.0 Cg_exo -73.38 -12.53 25.16 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.03 1.82 . . . . 0.91000000000000003 112.545 -172.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.55 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 11.6 t -91.82 -33.48 14.94 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.784 -0.366 . . . . 1.5 110.311 176.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.2 OUTLIER -81.27 -38.4 26.92 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.44 -0.346 . . . . 1.8799999999999999 110.538 -173.556 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.461 ' HB3' HG11 ' A' ' 50' ' ' VAL . 54.7 mt -67.61 -44.68 77.47 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.888 0.375 . . . . 1.0900000000000001 111.277 -176.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.527 ' HB ' HD12 ' A' ' 33' ' ' ILE . 2.1 m -66.95 -31.94 55.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.54 0.686 . . . . 0.68000000000000005 109.354 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.55 ' HB2' ' O ' ' A' ' 190' ' ' SER . 0.6 OUTLIER -74.34 -27.23 60.59 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.668 -1.151 . . . . 2.0699999999999998 110.628 179.534 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.438 ' O ' ' HB2' ' A' ' 198' ' ' ASN . 2.6 t80 -73.66 -30.27 62.82 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.623 -0.88 . . . . 2.0 108.623 175.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.694 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 17.6 mt -77.25 -34.3 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 116.079 -0.51 . . . . 0.31 110.703 173.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 74.2 mt -67.49 -37.04 82.26 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 121.229 0.538 . . . . 1.03 109.702 174.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.688 ' OD1' ' HG2' ' A' ' 76' ' ' LYS . 22.0 m-20 -50.65 -36.26 34.66 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.718 -1.128 . . . . 1.8999999999999999 109.671 167.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.64 ' HA ' ' CE2' ' A' ' 64' ' ' PHE . . . -81.04 -42.35 21.23 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 115.926 -0.579 . . . . 0.28999999999999998 110.944 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.694 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 10.3 mmmm -58.81 -38.89 79.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.548 0.689 . . . . 0.96999999999999997 110.164 176.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -88.75 -43.54 11.2 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.902 -1.045 . . . . 1.9399999999999999 111.092 -178.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 206' ' ' HIS . . . -66.75 -31.52 78.62 Favored Glycine 0 CA--C 1.504 -0.626 0 C-N-CA 121.009 -0.615 . . . . 0.46999999999999997 111.984 -176.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.983 HD13 HD23 ' A' ' 61' ' ' LEU . 4.7 tp -67.67 -34.47 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-O 121.274 0.559 . . . . 0.60999999999999999 110.107 178.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.617 ' HA ' ' HG2' ' A' ' 207' ' ' ARG . 54.2 mttp -87.21 -30.63 20.82 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.813 -0.631 . . . . 3.3700000000000001 109.555 -178.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.412 ' HA ' ' HB3' ' A' ' 210' ' ' SER . . . -61.98 -31.74 72.13 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.353 -0.84 . . . . 1.02 109.231 168.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.474 ' HB2' ' O ' ' A' ' 202' ' ' GLY . 4.1 t60 -77.94 -20.36 52.9 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.943 -1.026 . . . . 3.6299999999999999 111.618 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.617 ' HG2' ' HA ' ' A' ' 204' ' ' LYS . 14.2 ptm180 -101.92 -47.28 4.63 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 119.855 -0.738 . . . . 2.5899999999999999 111.724 176.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.551 HG22 ' O ' ' A' ' 204' ' ' LYS . 1.3 t -100.9 155.13 36.68 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.055 -0.72 . . . . 1.8400000000000001 109.055 -176.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.545 ' HD2' ' OG1' ' A' ' 208' ' ' THR . 44.4 Cg_endo -68.01 66.12 0.96 Allowed 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.691 2.261 . . . . 2.3500000000000001 112.706 178.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.412 ' HB3' ' HA ' ' A' ' 205' ' ' ALA . 18.5 t -109.79 37.96 2.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.485 0.659 . . . . 2.3100000000000001 110.044 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -110.17 14.14 22.93 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.105 -0.702 . . . . 5.4500000000000002 109.105 172.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -61.34 -22.3 64.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.202 -0.908 . . . . 6.8600000000000003 111.106 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -119.56 39.13 2.58 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 110.988 -0.845 . . . . 3.3700000000000001 110.988 175.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -68.62 150.31 48.13 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.045 -0.354 . . . . 5.21 110.045 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' HIS . . . . . 0.548 ' O ' ' HA ' ' A' ' 73' ' ' THR . 40.7 p-80 -120.24 135.39 55.01 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.165 -0.68 . . . . 6.46 109.165 173.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -138.85 125.39 20.61 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 110.029 -0.36 . . . . 6.0899999999999999 110.029 -173.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -130.21 66.53 1.49 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.452 0.644 . . . . 5.1200000000000001 110.654 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.2 t -91.94 -24.72 19.18 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.938 -0.764 . . . . 6.7599999999999998 108.938 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -142.25 98.06 3.24 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.249 -0.887 . . . . 8.8200000000000003 109.515 177.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 5.2 t . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.597 -0.716 . . . . 8.4800000000000004 109.646 -179.046 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 121.161 0.505 . . . . 3.8599999999999999 110.062 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.462 ' O ' HD12 ' A' ' 6' ' ' ILE . 7.5 m-20 -101.26 -74.52 0.61 Allowed 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 116.133 -0.485 . . . . 2.25 110.518 -175.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.67 ' HA ' HD12 ' A' ' 6' ' ' ILE . 81.2 m-85 -60.67 -29.08 69.08 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 115.465 -0.789 . . . . 0.42999999999999999 110.586 -170.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.564 ' HG2' ' HG3' ' A' ' 8' ' ' GLN . 21.0 ttmt -74.05 -37.13 64.38 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 107.952 -1.129 . . . . 1.51 107.952 -174.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.71 -37.23 78.32 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.568 -0.742 . . . . 0.54000000000000004 110.556 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.67 HD12 ' HA ' ' A' ' 3' ' ' PHE . 1.7 mp -82.75 -39.35 15.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.922 0.868 . . . . 1.0700000000000001 109.131 -174.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -75.89 -37.41 58.87 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.275 -1.329 . . . . 0.34000000000000002 111.595 -177.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.564 ' HG3' ' HG2' ' A' ' 4' ' ' LYS . 15.2 mt-30 -65.94 -28.24 68.77 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.346 -0.843 . . . . 1.5900000000000001 109.803 176.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -81.06 -34.89 32.42 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.753 -1.112 . . . . 2.4700000000000002 109.555 174.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.724 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.3 OUTLIER -74.1 -36.5 64.26 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.067 -0.969 . . . . 0.47999999999999998 111.486 -179.25 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.513 ' O ' ' HB3' ' A' ' 15' ' ' LEU . . . -46.14 -53.77 9.83 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-O 120.911 0.386 . . . . 0.31 110.651 172.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -78.81 -1.68 36.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.924 -0.58 . . . . 1.6399999999999999 111.989 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.684 ' HB3' ' HA ' ' A' ' 10' ' ' THR . 0.8 OUTLIER -87.87 -49.45 7.09 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.767 -0.827 . . . . 2.54 108.767 175.389 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.63 HG21 ' N ' ' A' ' 152' ' ' GLY . 13.0 p -69.39 -40.7 80.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 122.237 1.017 . . . . 0.53000000000000003 109.039 178.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.552 HD23 ' HD3' ' A' ' 19' ' ' ARG . 0.9 OUTLIER -73.74 -17.92 61.05 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 114.378 -1.283 . . . . 0.59999999999999998 109.186 175.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.55 ' HA2' ' NE ' ' A' ' 19' ' ' ARG . . . -58.0 -32.85 67.35 Favored Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 109.728 -1.349 . . . . 0.56999999999999995 109.728 171.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.496 ' HD1' ' O ' ' A' ' 13' ' ' GLU . 9.5 m-85 -88.05 -15.71 35.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.872 -0.664 . . . . 3.27 109.894 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.485 ' HA ' ' NH1' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -89.43 -19.84 24.66 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 120.414 -0.514 . . . . 2.0299999999999998 110.429 176.363 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.552 ' HD3' HD23 ' A' ' 15' ' ' LEU . 17.2 ptt180 -96.02 -21.58 17.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.35 -0.387 . . . . 2.7200000000000002 111.574 -171.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -130.83 157.23 43.44 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 119.615 -0.834 . . . . 2.1600000000000001 111.174 170.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 71.5 p -136.29 158.09 45.24 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.91 -1.041 . . . . 1.8200000000000001 109.389 -173.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.0 t -170.17 -148.57 0.06 Allowed 'General case' 0 C--O 1.234 0.272 0 C-N-CA 120.083 -0.647 . . . . 2.1899999999999999 111.05 -172.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.73 75.16 0.73 Allowed Glycine 0 C--N 1.331 0.29 0 CA-C-N 116.227 -0.442 . . . . 1.1000000000000001 113.494 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.882 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -109.27 -153.06 0.5 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.4 -0.592 . . . . 1.6699999999999999 109.4 172.203 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.5 ttpt -178.43 126.27 0.11 Allowed 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 108.263 -1.014 . . . . 2.9500000000000002 108.263 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.603 HG11 HG23 ' A' ' 34' ' ' THR . 3.2 m -64.89 123.22 17.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 122.057 0.932 . . . . 1.5600000000000001 110.667 174.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.9 p -93.74 -24.03 5.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 114.353 -1.294 . . . . 1.22 108.271 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.4 tptm -155.44 133.85 11.73 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 119.744 -0.782 . . . . 2.4100000000000001 112.146 -177.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.862 HG22 ' HA ' ' A' ' 34' ' ' THR . 45.9 p -137.07 101.5 4.57 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.274 -0.639 . . . . 1.3799999999999999 109.274 169.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.425 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 13.8 m -140.92 108.69 5.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.278 -0.419 . . . . 2.3700000000000001 110.961 -175.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 30' ' ' SER . 56.7 mttm 79.6 64.46 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.752 0.657 . . . . 4.5499999999999998 111.627 176.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 44.3 tptt 75.33 15.65 2.8 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.101 -0.5 . . . . 1.4199999999999999 112.233 168.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.984 HG22 ' HA3' ' A' ' 52' ' ' GLY . 31.7 pt -135.08 169.96 20.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.551 0.691 . . . . 0.76000000000000001 112.833 -172.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.862 ' HA ' HG22 ' A' ' 29' ' ' THR . 87.7 m -152.15 106.01 3.12 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.572 -1.195 . . . . 0.57999999999999996 110.696 -169.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.956 HG11 HD13 ' A' ' 192' ' ' LEU . 2.3 t -101.95 108.13 23.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.252 -0.431 . . . . 0.85999999999999999 110.31 -177.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 1.6 p -102.96 127.17 50.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.506 0.669 . . . . 1.1000000000000001 111.38 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.2 p -98.02 121.65 40.19 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.12 -0.945 . . . . 1.27 111.385 -174.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.882 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 5.3 ttpp -163.75 99.33 0.89 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.992 -0.549 . . . . 1.9099999999999999 112.08 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.497 ' HB3' ' H ' ' A' ' 47' ' ' LEU . . . 179.31 -78.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.772 0.656 . . . . 1.6799999999999999 112.772 168.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.412 ' C ' ' H ' ' A' ' 42' ' ' LYS . 19.2 t 67.03 -100.25 0.06 Allowed 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.365 -1.346 . . . . 2.0899999999999999 107.365 -165.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 68.73 -40.87 0.45 Allowed 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.431 0.457 . . . . 6.6100000000000003 110.938 177.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 33.0 mmtp -56.46 -49.42 74.69 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.644 -0.707 . . . . 6.46 109.202 169.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.436 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 74.1 t80 172.17 -76.6 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 114.957 -1.02 . . . . 5.6500000000000004 110.379 -175.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -138.63 83.79 1.98 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.559 0.695 . . . . 5.5599999999999996 109.691 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.54 -152.98 6.37 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 110.672 -0.971 . . . . 1.5600000000000001 110.672 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -160.18 141.02 12.07 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.646 0.26 . . . . 2.0499999999999998 110.688 174.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 1.007 HD12 ' HB2' ' A' ' 172' ' ' GLN . 10.6 tt -86.25 135.55 33.51 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.379 -1.341 . . . . 0.87 107.379 170.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.454 ' HB2' HD21 ' A' ' 192' ' ' LEU . 99.6 m-85 -109.92 117.33 33.51 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.219 0.533 . . . . 0.98999999999999999 110.321 -172.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.651 ' HD3' ' CZ3' ' A' ' 24' ' ' TRP . 28.3 ttt180 -93.75 107.53 19.4 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.225 -0.898 . . . . 2.9199999999999999 110.279 177.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.598 HG13 HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -82.87 140.84 15.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.406 -0.961 . . . . 1.3300000000000001 108.406 174.555 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.785 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 54.7 tt0 -151.52 108.61 3.56 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.054 0.454 . . . . 1.0700000000000001 109.983 -178.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.984 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -145.46 154.9 26.23 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 111.153 -0.779 . . . . 0.28999999999999998 111.153 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.0 mt -97.86 114.36 34.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 119.918 -0.713 . . . . 0.57999999999999996 111.205 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.464 HD13 ' HB1' ' A' ' 199' ' ' ALA . 68.7 mt -92.31 111.6 51.2 Favored Pre-proline 0 N--CA 1.443 -0.821 0 N-CA-C 108.373 -0.973 . . . . 0.34999999999999998 108.373 170.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 22.0 Cg_exo -66.52 54.57 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 124.266 3.311 . . . . 0.62 113.167 -177.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.683 ' HG2' HG13 ' A' ' 203' ' ' ILE . 10.8 tp10 -151.65 167.63 27.53 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 107.417 -1.327 . . . . 1.6799999999999999 107.417 175.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.484 ' HB3' ' HA ' ' A' ' 162' ' ' PRO . 23.8 p -70.12 137.09 86.94 Favored Pre-proline 0 N--CA 1.431 -1.397 0 CA-C-O 121.683 0.754 . . . . 1.1799999999999999 111.404 -176.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.786 ' HD3' ' HB2' ' A' ' 165' ' ' SER . 6.3 Cg_endo -49.55 -18.18 2.31 Favored 'Trans proline' 0 C--O 1.23 0.116 0 C-N-CA 124.698 3.598 . . . . 0.52000000000000002 111.677 170.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.85 -47.82 50.37 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.082 -0.963 . . . . 0.64000000000000001 110.692 176.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.847 ' HD2' ' HB3' ' A' ' 206' ' ' HIS . 4.5 tppt? -68.02 -29.83 68.93 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.71 -0.848 . . . . 3.2999999999999998 108.71 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.957 HD23 HD13 ' A' ' 203' ' ' ILE . 88.5 mt -60.02 -53.97 51.54 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.906 -1.043 . . . . 0.40999999999999998 110.25 174.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.511 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 19.3 p -68.05 -12.61 61.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.107 0.479 . . . . 1.29 110.44 175.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.502 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 37.8 t70 -82.28 -33.06 29.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.794 -0.639 . . . . 1.3200000000000001 111.409 -177.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.54 ' CE2' ' HA ' ' A' ' 61' ' ' LEU . 15.4 p90 -83.7 -47.51 11.13 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.404 -0.518 . . . . 0.60999999999999999 110.976 -177.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.511 ' CD2' ' HA ' ' A' ' 62' ' ' SER . 0.7 OUTLIER -83.5 -1.79 54.46 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.4 -0.52 . . . . 1.5 111.904 -172.154 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -38.34 -47.94 1.28 Allowed 'General case' 0 C--N 1.327 -0.373 0 O-C-N 124.806 1.316 . . . . 1.52 114.448 -162.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -162.21 -84.09 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 114.261 1.208 . . . . 3.6000000000000001 114.261 -175.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.754 ' HB ' ' CD1' ' A' ' 81' ' ' TYR . 10.8 t -150.86 13.57 0.71 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.406 0.521 . . . . 1.48 112.406 -166.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -111.25 -6.67 25.54 Favored Glycine 0 C--N 1.306 -1.132 0 C-N-CA 118.987 -1.578 . . . . 1.46 113.203 -165.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.741 ' O ' HG22 ' A' ' 73' ' ' THR . 12.9 t70 -162.41 -41.45 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.369 0.604 . . . . 2.1899999999999999 110.136 -167.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.704 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 1.5 ptp180 -49.92 -47.42 52.3 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.904 -1.044 . . . . 3.3799999999999999 111.64 -176.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.863 HG22 HD13 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -90.05 -8.04 10.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.697 -0.401 . . . . 0.70999999999999996 111.054 -174.333 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.741 HG22 ' O ' ' A' ' 70' ' ' ASP . 4.8 t -83.29 -35.67 25.09 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 119.171 -1.011 . . . . 0.96999999999999997 110.089 -176.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.712 ' HZ3' ' HB2' ' A' ' 198' ' ' ASN . 20.4 p-90 -103.27 -6.09 22.41 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.413 -0.515 . . . . 0.75 111.982 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.814 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 5.5 t70 -67.24 172.93 4.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.864 0.84 . . . . 2.1899999999999999 112.288 -170.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.477 ' H ' ' HG3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -118.08 -11.12 10.22 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.52 -1.218 . . . . 3.1899999999999999 111.61 -174.327 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.1 m -140.88 17.36 2.31 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.496 0.665 . . . . 1.5800000000000001 109.899 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.863 HD13 HG22 ' A' ' 72' ' ' ILE . 21.9 mt -108.03 157.33 18.34 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.593 -0.73 . . . . 0.70999999999999996 110.624 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.789 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 3.5 mm100 -131.89 -71.1 0.56 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.577 -0.738 . . . . 1.73 111.074 -178.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.86 ' HB ' HD13 ' A' ' 97' ' ' ILE . 15.1 t -137.41 142.8 35.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.599 -0.728 . . . . 0.78000000000000003 109.892 -170.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.754 ' CD1' ' HB ' ' A' ' 68' ' ' THR . 25.3 t80 -124.2 137.51 54.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.989 0.423 . . . . 5.4000000000000004 110.431 176.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.892 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 5.3 m-20 -128.97 111.78 13.37 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.664 -0.865 . . . . 1.6899999999999999 108.664 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.712 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 20.1 ttm -75.85 96.37 3.69 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.838 -0.801 . . . . 2.0499999999999998 108.838 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -78.54 -83.31 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 116.36 -0.382 . . . . 0.64000000000000001 111.741 -168.52 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.497 ' HB2' HD12 ' A' ' 93' ' ' ILE . 32.1 m170 -122.56 122.75 39.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.27 0.557 . . . . 1.96 110.25 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.712 ' HD3' ' SD ' ' A' ' 83' ' ' MET . 81.2 mtm180 -105.68 108.79 20.49 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.225 -0.898 . . . . 2.4399999999999999 109.219 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.515 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -72.68 -39.95 61.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.428 -0.806 . . . . 0.46999999999999997 110.067 -173.763 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -152.08 -171.0 3.8 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.409 -0.814 . . . . 1.8600000000000001 109.188 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.6 t -78.88 -5.56 53.9 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.795 0.331 . . . . 1.4399999999999999 110.389 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -122.81 -4.3 8.63 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.94 -0.393 . . . . 1.8700000000000001 109.94 -176.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.715 HG23 ' HD1' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -135.93 112.06 9.69 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.301 -0.629 . . . . 0.46000000000000002 109.301 -169.132 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.707 ' HD2' ' HG2' ' A' ' 86' ' ' ARG . 10.8 m-85 -125.39 178.73 5.45 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.651 -0.5 . . . . 0.42999999999999999 109.651 -177.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.66 ' O ' HG23 ' A' ' 84' ' ' VAL . 42.6 mt -133.0 128.94 57.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 107.094 -1.447 . . . . 0.40999999999999998 107.094 168.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 113' ' ' ASP . 6.6 p -113.18 112.32 23.58 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.122 0.487 . . . . 2.0099999999999998 112.13 -170.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.892 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 4.7 t-160 -82.64 93.96 7.46 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.64 -0.874 . . . . 1.23 108.64 170.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.544 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 21.8 m -113.11 111.57 22.35 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.25 -0.432 . . . . 0.5 111.965 -172.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.86 HD13 ' HB ' ' A' ' 80' ' ' VAL . 3.4 mp -77.27 120.42 27.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 108.642 -0.874 . . . . 1.03 108.642 174.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 49.6 m -111.72 138.37 48.39 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.368 -0.833 . . . . 1.3799999999999999 111.909 -170.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.789 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 42.6 mt-30 -91.31 75.59 6.06 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.089 -0.505 . . . . 1.8200000000000001 109.784 174.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.8 t -90.12 102.0 14.72 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.047 -0.723 . . . . 3.9100000000000001 109.047 -177.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -120.38 112.87 19.54 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.156 0.503 . . . . 5.1600000000000001 111.594 -177.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.416 ' HB1' ' HB2' ' A' ' 186' ' ' LYS . . . -98.89 71.12 1.88 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.613 -0.721 . . . . 1.98 109.359 169.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 102' ' ' ALA . 93.1 t 74.75 -38.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 115.655 -0.702 . . . . 3.1699999999999999 111.197 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.95 -7.98 0.14 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.629 -0.796 . . . . 1.96 112.7 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.463 ' HB2' HG23 ' A' ' 183' ' ' ILE . 1.2 m -68.76 -7.4 33.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.159 0.504 . . . . 1.8799999999999999 111.449 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.461 HG22 ' O ' ' A' ' 107' ' ' SER . 65.7 mt -129.6 141.75 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 116.101 -0.499 . . . . 1.1200000000000001 111.034 -173.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.461 ' O ' HG22 ' A' ' 106' ' ' ILE . 19.8 m -94.26 164.88 18.87 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.661 -0.699 . . . . 1.3500000000000001 109.539 173.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.22 141.67 30.65 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.234 1.956 . . . . 1.0700000000000001 111.458 173.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.752 HH22 HD21 ' A' ' 179' ' ' LEU . 54.6 mtt180 -116.33 173.95 6.32 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.049 0.452 . . . . 3.4500000000000002 110.689 -174.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.822 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 9.8 t70 -132.72 123.07 25.56 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.56 -0.746 . . . . 1.3700000000000001 109.04 -177.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.544 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 9.6 m-30 -103.63 140.42 37.59 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.146 0.498 . . . . 2.4100000000000001 111.366 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.678 HG13 ' HA ' ' A' ' 137' ' ' TYR . 25.5 mm -132.38 75.14 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.124 -0.944 . . . . 0.42999999999999999 108.691 173.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.902 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 17.2 m-20 -99.85 123.18 43.84 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.695 -0.684 . . . . 1.8600000000000001 110.808 -173.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.614 HD12 ' O ' ' A' ' 92' ' ' PHE . 7.6 tp -76.38 123.53 26.12 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 108.71 -0.848 . . . . 0.28000000000000003 108.71 167.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.606 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -127.15 124.62 64.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.562 -0.744 . . . . 0.26000000000000001 112.384 -163.635 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.715 ' HD1' HG23 ' A' ' 91' ' ' THR . 54.5 t80 -109.75 118.23 35.97 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.273 -0.876 . . . . 2.5699999999999998 110.947 174.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.465 HG13 ' HB ' ' A' ' 127' ' ' ILE . 5.1 mp -97.5 120.85 47.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.787 -0.642 . . . . 0.89000000000000001 109.923 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.423 ' HB3' ' CE2' ' A' ' 116' ' ' TYR . 14.0 ptpt -140.56 147.41 39.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.041 0.448 . . . . 1.2 110.714 177.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.475 ' HD2' ' C ' ' A' ' 119' ' ' ARG . 1.7 tmm_? -125.64 99.97 6.23 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 109.014 -0.735 . . . . 2.7999999999999998 109.014 -176.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -63.45 116.32 5.45 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.406 -1.331 . . . . 0.82999999999999996 107.406 169.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.415 ' HG3' ' H ' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -33.09 90.13 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 O-C-N 125.12 1.513 . . . . 2.2799999999999998 114.682 -175.451 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 58.05 29.32 62.22 Favored Glycine 0 C--O 1.229 -0.198 0 CA-C-N 114.716 -1.129 . . . . 0.76000000000000001 112.62 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.429 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 33.7 t-20 -119.72 -49.18 2.34 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.538 -0.541 . . . . 1.6499999999999999 109.538 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 1.9 mtm -161.93 122.74 2.64 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.972 0.415 . . . . 1.1200000000000001 111.226 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -109.4 80.82 1.36 Allowed 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.716 -0.846 . . . . 1.6200000000000001 108.716 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.821 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -100.57 139.48 21.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.232 -0.895 . . . . 0.29999999999999999 112.81 -173.191 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.656 HG13 ' O ' ' A' ' 127' ' ' ILE . 1.9 pt -108.64 116.58 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 108.318 -0.993 . . . . 0.58999999999999997 108.318 160.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.606 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 26.5 p -87.54 156.98 19.27 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.102 -0.703 . . . . 1.1799999999999999 109.102 175.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.902 ' HB3' ' HB3' ' A' ' 113' ' ' ASP . 50.2 m -153.9 136.35 15.02 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.758 0.313 . . . . 1.24 111.576 -178.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.892 ' HE2' ' HG3' ' A' ' 150' ' ' PRO . 4.6 mtpm? -131.04 122.77 27.37 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 107.824 -1.176 . . . . 2.2599999999999998 107.824 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.578 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 70.4 p -64.49 99.02 0.28 Allowed 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.098 -1.445 . . . . 1.3899999999999999 107.098 174.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.57 137.34 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 CA-C-N 115.265 -0.879 . . . . 1.05 108.709 -165.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.617 ' HA ' ' CG ' ' A' ' 137' ' ' TYR . 9.8 p-10 -92.05 69.57 5.35 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.678 -1.147 . . . . 2.1699999999999999 110.543 -167.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.721 ' CZ ' ' HB3' ' A' ' 136' ' ' GLU . 1.7 p90 -105.15 173.36 3.33 Favored Pre-proline 0 CA--C 1.546 0.82 0 CA-C-N 113.927 -1.488 . . . . 0.53000000000000003 108.313 -176.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.535 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 31.8 Cg_exo -28.05 -57.17 0.12 Allowed 'Trans proline' 0 CA--C 1.548 1.182 0 C-N-CA 124.875 3.716 . . . . 1.28 116.964 -177.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.721 ' HB3' ' CZ ' ' A' ' 134' ' ' PHE . 17.8 tp10 -80.77 -21.44 41.03 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.635 0.606 . . . . 3.5 112.635 -174.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.678 ' HA ' HG13 ' A' ' 112' ' ' ILE . 17.8 t80 -49.43 -43.12 69.95 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 114.403 1.26 . . . . 6.1200000000000001 114.403 -177.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.507 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 32.0 Cg_exo -39.31 119.55 0.52 Allowed 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 122.386 2.057 . . . . 1.77 113.28 175.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.887 ' HB3' ' HD3' ' A' ' 145' ' ' ARG . 50.6 Cg_endo -89.14 -163.1 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.422 2.748 . . . . 1.25 113.773 -172.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.5 m -142.73 -169.32 2.97 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.79 -0.819 . . . . 1.6000000000000001 108.79 -175.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.8 t -80.46 -45.31 17.78 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.18 -0.608 . . . . 1.97 110.028 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -69.58 -28.31 65.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.073 -0.512 . . . . 2.1800000000000002 110.86 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.822 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 65.5 m-85 -118.87 109.12 15.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.975 -0.557 . . . . 1.23 110.542 -174.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.659 HD11 ' HG3' ' A' ' 176' ' ' ARG . 2.5 tp -98.66 111.95 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-O 121.314 0.578 . . . . 0.81999999999999995 109.695 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.887 ' HD3' ' HB3' ' A' ' 139' ' ' PRO . 4.7 mpt_? -57.89 100.48 0.06 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.814 -1.085 . . . . 4.4199999999999999 110.888 176.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -66.99 115.53 7.31 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 110.404 -1.079 . . . . 0.79000000000000004 110.404 174.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.406 ' HB3' ' HB3' ' A' ' 174' ' ' GLU . 24.8 t80 -84.55 86.16 7.33 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.486 0.66 . . . . 4.4400000000000004 110.612 -173.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.472 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 90.5 m-20 -70.42 105.62 3.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.987 -1.006 . . . . 1.6200000000000001 110.411 175.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.669 ' HB3' ' HB3' ' A' ' 172' ' ' GLN . 25.3 t60 -57.82 126.59 76.93 Favored Pre-proline 0 CA--C 1.506 -0.745 0 N-CA-C 107.609 -1.256 . . . . 2.3199999999999998 107.609 167.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.892 ' HG3' ' HE2' ' A' ' 130' ' ' LYS . 23.7 Cg_exo -12.13 69.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 1 C-N-CA 126.853 5.035 . . . . 0.53000000000000003 115.37 -173.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 151' ' ' CYS . . . . . 0.472 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 24.1 p -77.47 178.41 7.24 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.241 -1.345 . . . . 1.5800000000000001 110.574 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.63 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -170.56 -164.9 27.06 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 120.309 -0.948 . . . . 0.42999999999999999 111.675 175.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -161.38 73.19 0.44 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.632 -0.877 . . . . 0.59999999999999998 108.632 -164.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.822 HG23 HG13 ' A' ' 168' ' ' VAL . 8.4 m -83.24 115.26 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-O 122.113 0.959 . . . . 0.31 110.32 -175.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 64.3 m -98.27 107.58 20.08 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.417 -0.811 . . . . 1.55 109.027 177.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.722 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 10.1 m -97.63 112.64 61.92 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 116.28 -0.418 . . . . 1.0600000000000001 111.023 -170.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.558 ' HB3' ' ND2' ' A' ' 161' ' ' ASN . 52.4 Cg_exo -51.76 120.48 7.13 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.376 2.05 . . . . 0.56000000000000005 110.598 172.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.687 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 2.7 mmt -79.87 -167.92 1.43 Allowed 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.234 0.54 . . . . 1.1599999999999999 111.453 -175.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -70.97 -16.78 62.66 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.485 -0.779 . . . . 2.6299999999999999 110.026 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 163' ' ' ALA . 38.6 mt-10 -117.38 21.16 13.26 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 115.467 -0.788 . . . . 2.0499999999999998 110.408 178.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.669 ' HB3' ' CD ' ' A' ' 162' ' ' PRO . 18.7 t-20 29.79 -87.06 0.0 OUTLIER Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 125.87 1.668 . . . . 1.9299999999999999 115.044 175.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.669 ' CD ' ' HB3' ' A' ' 161' ' ' ASN . 85.1 Cg_endo -75.81 -12.62 19.95 Favored 'Trans proline' 0 C--N 1.368 1.557 0 CA-C-N 121.888 1.71 . . . . 0.72999999999999998 112.928 -175.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.559 ' HB3' ' HB3' ' A' ' 160' ' ' GLU . . . -89.97 -36.92 14.69 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.898 -0.592 . . . . 0.68000000000000005 110.563 -178.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.687 ' O ' ' HB2' ' A' ' 158' ' ' MET . 73.6 m-85 -136.97 133.14 35.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.279 -0.419 . . . . 0.93000000000000005 110.424 176.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.786 ' HB2' ' HD3' ' A' ' 58' ' ' PRO . 25.3 t -125.11 144.59 50.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.342 0.592 . . . . 1.4099999999999999 110.951 174.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.785 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.8 tppp? -97.37 99.81 11.25 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.993 0.901 . . . . 0.73999999999999999 110.684 -178.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.8 106.97 15.91 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.323 -1.308 . . . . 0.27000000000000002 109.201 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.822 HG13 HG23 ' A' ' 154' ' ' VAL . 0.1 OUTLIER -129.41 126.27 63.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.675 0.75 . . . . 0.28000000000000003 111.804 176.667 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 14.6 ttt -129.74 153.08 48.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.182 -0.917 . . . . 1.24 110.021 -171.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.767 ' HB3' HD21 ' A' ' 47' ' ' LEU . 47.6 m-85 -134.24 140.52 46.51 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.684 -0.234 . . . . 3.3700000000000001 111.146 -178.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.607 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 4.7 m -140.07 131.6 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 O-C-N 123.645 0.591 . . . . 1.3999999999999999 111.549 171.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 1.007 ' HB2' HD12 ' A' ' 47' ' ' LEU . 13.3 tt0 -120.02 33.55 5.56 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 105.954 -1.869 . . . . 2.1699999999999999 105.954 169.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 35.9 m -54.94 147.27 15.77 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 112.697 -2.047 . . . . 1.6499999999999999 112.733 -171.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 2.4 tp10 -84.74 -40.36 17.39 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.573 -0.74 . . . . 2.4500000000000002 110.663 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 21.7 mmt 48.0 57.21 6.3 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-O 121.207 0.527 . . . . 3.7400000000000002 109.771 -174.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.659 ' HG3' HD11 ' A' ' 144' ' ' ILE . 13.6 ptm180 -73.49 43.41 0.14 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.097 -0.956 . . . . 5.7800000000000002 112.724 -174.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -99.98 22.36 40.58 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 111.737 -0.545 . . . . 2.2599999999999998 111.737 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 65.2 tttp 65.36 70.98 0.45 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.588 0.709 . . . . 6.2300000000000004 111.142 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.752 HD21 HH22 ' A' ' 109' ' ' ARG . 5.8 mp -107.08 168.91 8.88 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.976 0.893 . . . . 1.6399999999999999 110.599 176.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.498 ' HB3' HG12 ' A' ' 183' ' ' ILE . 42.5 t -112.77 154.8 44.71 Favored Pre-proline 0 C--N 1.307 -1.251 0 CA-C-N 113.978 -1.465 . . . . 2.04 107.11 177.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.603 ' O ' ' HG2' ' A' ' 185' ' ' GLU . 71.0 Cg_exo -40.19 -47.72 4.07 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.546 2.164 . . . . 1.74 112.71 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 36.7 t -67.16 -14.74 63.19 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.125 -0.488 . . . . 2.1400000000000001 112.198 -177.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.558 ' HA ' ' HE2' ' A' ' 186' ' ' LYS . 24.4 mm -90.24 -41.74 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.845 0 CA-C-O 122.274 1.035 . . . . 1.1200000000000001 108.331 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 1.005 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.2 mp -62.99 -35.7 72.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 112.986 -1.915 . . . . 1.1299999999999999 110.726 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.603 ' HG2' ' O ' ' A' ' 181' ' ' PRO . 18.5 mm-40 -57.19 -29.65 63.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.133 -0.94 . . . . 2.8900000000000001 109.564 174.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.558 ' HE2' ' HA ' ' A' ' 183' ' ' ILE . 46.0 mtmt -93.05 -40.46 10.51 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.161 -0.927 . . . . 1.28 111.088 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' THR . . . . . 1.005 HG22 ' HA ' ' A' ' 184' ' ' ILE . 6.5 t -64.75 -37.67 88.39 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.236 0.458 . . . . 0.62 112.236 -171.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' MET . . . . . 0.825 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 7.7 mmt -74.88 -60.43 1.23 Allowed Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 120.747 -0.381 . . . . 1.0600000000000001 111.347 -174.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.825 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 61.3 Cg_exo -54.02 -32.06 66.99 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.174 1.916 . . . . 0.91000000000000003 112.579 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.74 ' O ' ' HB3' ' A' ' 194' ' ' ASN . 49.0 m -72.87 -23.71 60.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.431 -0.35 . . . . 1.5 111.031 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -92.56 -37.82 12.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.348 0.594 . . . . 1.8799999999999999 111.6 -175.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.956 HD13 HG11 ' A' ' 35' ' ' VAL . 3.7 mt -67.02 -51.32 56.35 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.659 0.743 . . . . 1.0900000000000001 110.79 -176.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.688 ' O ' HD23 ' A' ' 197' ' ' LEU . 1.6 m -69.6 -41.29 80.24 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.129 0 CA-C-N 115.061 -0.972 . . . . 0.68000000000000005 108.756 -176.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.74 ' HB3' ' O ' ' A' ' 190' ' ' SER . 0.0 OUTLIER -57.48 -37.75 73.42 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.668 0.618 . . . . 2.0699999999999998 112.668 178.706 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -64.28 -31.82 73.17 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 119.884 -0.726 . . . . 2.0 110.009 174.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.852 HG21 HG21 ' A' ' 33' ' ' ILE . 8.6 mt -78.58 -33.89 17.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 122.003 0.906 . . . . 0.31 111.205 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.688 HD23 ' O ' ' A' ' 193' ' ' VAL . 3.3 mm? -78.26 -30.6 48.69 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.014 -0.994 . . . . 1.03 110.723 -173.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.712 ' HB2' ' HZ3' ' A' ' 74' ' ' TRP . 12.1 p30 -67.39 -29.82 69.43 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.528 -1.286 . . . . 1.8999999999999999 107.528 167.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.695 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -73.19 -37.25 66.55 Favored 'General case' 0 N--CA 1.435 -1.187 0 O-C-N 121.97 -0.456 . . . . 0.28999999999999998 110.254 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 33.0 mmtp -61.7 -43.36 99.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.76 0.79 . . . . 0.96999999999999997 109.915 174.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.574 ' O ' ' HG3' ' A' ' 204' ' ' LYS . 10.2 t70 -81.69 -40.72 22.37 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.703 -1.135 . . . . 1.9399999999999999 110.841 -171.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -70.98 -33.87 65.34 Favored Glycine 0 C--O 1.226 -0.406 0 C-N-CA 121.105 -0.569 . . . . 0.46999999999999997 111.729 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.957 HD13 HD23 ' A' ' 61' ' ' LEU . 1.6 tp -70.17 -35.76 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 110.058 -0.349 . . . . 0.60999999999999999 110.058 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.621 ' O ' ' HB ' ' A' ' 208' ' ' THR . 2.2 pptp? -81.59 -23.95 36.77 Favored 'General case' 0 C--O 1.213 -0.846 0 N-CA-C 108.678 -0.86 . . . . 3.3700000000000001 108.678 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.579 ' HA ' ' HB3' ' A' ' 210' ' ' SER . . . -65.46 -34.5 78.42 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 109.094 -0.706 . . . . 1.02 109.094 167.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.847 ' HB3' ' HD2' ' A' ' 60' ' ' LYS . 10.5 m170 -93.06 3.0 56.49 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.837 1.051 . . . . 3.6299999999999999 113.837 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' A' ' 203' ' ' ILE . 4.2 ptp180 -130.51 -41.77 1.2 Allowed 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.358 -0.839 . . . . 2.5899999999999999 111.442 172.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.621 ' HB ' ' O ' ' A' ' 204' ' ' LYS . 51.6 m -88.05 146.17 37.87 Favored Pre-proline 0 C--N 1.315 -0.928 0 CA-C-N 115.638 -0.71 . . . . 1.8400000000000001 109.493 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.46 ' HD2' HG23 ' A' ' 208' ' ' THR . 27.3 Cg_endo -64.21 60.96 0.24 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.82 2.347 . . . . 2.3500000000000001 112.484 174.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.579 ' HB3' ' HA ' ' A' ' 205' ' ' ALA . 34.4 t -96.05 13.71 26.2 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.655 -0.702 . . . . 2.3100000000000001 109.705 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.47 ' HD2' ' O ' ' A' ' 205' ' ' ALA . 0.0 OUTLIER -89.59 12.73 15.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.694 -0.684 . . . . 5.4500000000000002 110.869 -178.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.411 ' HD3' ' HA ' ' A' ' 212' ' ' ARG . 6.7 tpp180 -76.33 -38.53 55.82 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.902 -0.777 . . . . 6.8600000000000003 108.902 175.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -99.16 32.69 6.84 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.433 -0.803 . . . . 3.3700000000000001 111.934 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -71.33 142.11 50.44 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.599 -0.889 . . . . 5.21 108.599 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -105.73 -11.99 16.07 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.026 0.75 . . . . 6.46 113.026 -173.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 83.0 t60 55.98 46.34 22.09 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.577 0.703 . . . . 6.0899999999999999 110.028 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.586 ' HA ' ' OG ' ' A' ' 220' ' ' SER . 2.5 t-20 -110.01 36.42 3.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.807 -0.633 . . . . 5.1200000000000001 111.062 -170.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 38.7 t -86.0 -46.16 10.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.294 0.569 . . . . 6.7599999999999998 109.828 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -132.11 64.57 1.6 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.757 -0.656 . . . . 8.8200000000000003 109.848 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' SER . . . . . 0.586 ' OG ' ' HA ' ' A' ' 217' ' ' ASN . 6.5 m . . . . . 0 C--O 1.245 0.861 0 CA-C-O 118.337 -0.84 . . . . 8.4800000000000004 109.64 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.888 ' HB3' HG22 ' A' ' 87' ' ' ILE . 14.9 tpt . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 109.818 -0.438 . . . . 3.8599999999999999 109.818 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.457 ' H ' ' HG3' ' A' ' 1' ' ' MET . 1.0 OUTLIER -50.25 -43.87 53.28 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 123.436 0.695 . . . . 2.25 112.547 -171.552 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.889 ' HA ' HD12 ' A' ' 6' ' ' ILE . 97.2 m-85 -68.53 -27.97 66.58 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.079 0.466 . . . . 0.42999999999999999 109.837 -172.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.564 ' HD2' ' CG ' ' A' ' 88' ' ' ASP . 17.5 tttm -76.31 -2.45 31.66 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.551 -0.75 . . . . 1.51 109.697 177.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.61 ' O ' ' HG2' ' A' ' 9' ' ' GLN . . . -92.96 -43.44 8.93 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.398 0.618 . . . . 0.54000000000000004 109.972 170.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.889 HD12 ' HA ' ' A' ' 3' ' ' PHE . 1.3 mp -81.57 -43.01 19.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 122.01 0.91 . . . . 1.0700000000000001 109.398 -171.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.467 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -76.06 -37.31 58.42 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.105 -1.407 . . . . 0.34000000000000002 111.584 -176.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 7.3 mt-30 -65.91 -29.73 70.2 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.474 -0.785 . . . . 1.5900000000000001 109.992 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.61 ' HG2' ' O ' ' A' ' 5' ' ' ALA . 79.1 mm-40 -77.69 -38.8 46.68 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.038 -0.983 . . . . 2.4700000000000002 108.499 174.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.555 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.4 OUTLIER -65.57 -36.53 84.05 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.534 -1.212 . . . . 0.47999999999999998 111.962 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.625 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -46.57 -59.49 2.97 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.198 0.523 . . . . 0.31 111.159 172.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -66.56 -16.65 64.32 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.49 -0.777 . . . . 1.6399999999999999 112.045 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.608 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 44.2 mt-10 -73.32 -52.37 14.15 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.001 0.429 . . . . 2.54 109.888 175.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.687 HG21 ' N ' ' A' ' 152' ' ' GLY . 11.8 p -73.2 -40.17 57.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.649 0.738 . . . . 0.53000000000000003 110.453 -177.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.554 HD23 ' HD2' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -67.2 -23.81 65.78 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-O 121.916 0.865 . . . . 0.59999999999999998 108.824 173.523 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.95 -18.05 66.13 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 113.986 -1.461 . . . . 0.56999999999999995 110.38 177.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.633 ' CD2' ' HA ' ' A' ' 14' ' ' VAL . 23.7 m-85 -91.14 -21.34 21.23 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.076 -0.712 . . . . 3.27 109.076 176.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.512 ' HA ' ' HZ ' ' A' ' 170' ' ' PHE . 63.5 t30 -72.29 -14.82 61.85 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.463 0.649 . . . . 2.0299999999999998 109.989 178.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.554 ' HD2' HD23 ' A' ' 15' ' ' LEU . 22.2 mtp180 -115.72 -20.38 10.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.484 -0.78 . . . . 2.7200000000000002 110.835 -175.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -97.01 132.76 42.5 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.066 0.46 . . . . 2.1600000000000001 111.413 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 43.1 p -134.21 119.28 18.6 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.85 -0.614 . . . . 1.8200000000000001 109.637 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.459 ' HB2' ' HE3' ' A' ' 38' ' ' LYS . 0.8 OUTLIER -135.57 -143.87 0.2 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.862 -0.608 . . . . 2.1899999999999999 110.343 -169.135 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.4 63.33 1.8 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.349 -0.453 . . . . 1.1000000000000001 112.73 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.534 ' CH2' ' HD3' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -119.86 -175.76 3.04 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.15 -1.056 . . . . 1.6699999999999999 108.15 171.393 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.427 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 8.7 mtpp -171.4 133.11 0.8 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.712 -0.848 . . . . 2.9500000000000002 108.712 -176.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.765 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 1.6 p -59.96 116.73 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-O 121.714 0.769 . . . . 1.5600000000000001 109.681 170.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.4 p -92.05 -23.7 5.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 114.695 -1.139 . . . . 1.22 109.081 -177.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 2.7 tppt? -153.1 139.63 18.72 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.82 -0.627 . . . . 2.4100000000000001 111.488 -173.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.6 HG22 ' HA ' ' A' ' 34' ' ' THR . 31.2 p -137.92 142.93 40.58 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.002 -0.545 . . . . 1.3799999999999999 110.373 175.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.761 ' HB3' HG12 ' A' ' 33' ' ' ILE . 35.4 t -89.95 -143.98 0.16 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.618 -1.253 . . . . 2.3700000000000001 107.618 168.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -103.05 18.89 20.61 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.532 -0.467 . . . . 4.5499999999999998 110.06 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.442 ' HD2' ' HA ' ' A' ' 32' ' ' LYS . 33.8 tptt -168.97 3.77 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.189 0.44 . . . . 1.4199999999999999 112.189 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.971 HG22 ' HA3' ' A' ' 52' ' ' GLY . 42.8 pt -138.72 168.46 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.913 0.387 . . . . 0.76000000000000001 111.735 -174.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.6 ' HA ' HG22 ' A' ' 29' ' ' THR . 88.0 m -146.59 119.56 8.76 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.223 -0.899 . . . . 0.57999999999999996 110.64 -166.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.712 HG22 HG23 ' A' ' 50' ' ' VAL . 7.1 t -111.41 102.0 13.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.608 -0.516 . . . . 0.85999999999999999 109.608 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.765 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 18.1 m -99.14 126.79 44.99 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.651 0.739 . . . . 1.1000000000000001 111.338 -177.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 t -97.75 124.04 41.94 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.439 -1.255 . . . . 1.27 109.76 -177.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.459 ' HE3' ' HB2' ' A' ' 22' ' ' SER . 85.3 tttt -121.02 -100.57 0.43 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.618 -0.719 . . . . 1.9099999999999999 110.151 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.832 ' HA ' ' HA ' ' A' ' 46' ' ' ASN . . . 179.68 143.85 0.16 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.756 -0.461 . . . . 1.6799999999999999 109.756 -175.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.4 p -106.44 -43.66 4.71 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.376 0.608 . . . . 2.0899999999999999 109.56 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 57.59 8.11 0.61 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 114.521 -1.218 . . . . 6.6100000000000003 112.687 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -66.36 -24.85 66.57 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.596 -0.89 . . . . 6.46 108.596 175.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 84.0 t80 172.99 -55.2 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.021 -0.99 . . . . 5.6500000000000004 109.313 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -65.42 -70.58 0.23 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.011 -0.995 . . . . 5.5599999999999996 112.411 -170.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 170.92 -96.29 0.11 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.031 -1.08 . . . . 1.5600000000000001 112.863 -176.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.832 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 18.4 m120 -90.88 170.18 10.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.483 0.659 . . . . 2.0499999999999998 112.07 -172.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.566 HD11 HE21 ' A' ' 172' ' ' GLN . 4.3 tt -136.75 137.19 39.62 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.444 -1.688 . . . . 0.87 106.444 175.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.591 ' HB2' HG12 ' A' ' 171' ' ' VAL . 42.2 m-85 -118.52 128.3 54.45 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 120.545 -0.462 . . . . 0.98999999999999999 110.992 -172.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.534 ' HD3' ' CH2' ' A' ' 24' ' ' TRP . 15.1 ttp180 -99.29 117.24 33.3 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.913 -0.773 . . . . 2.9199999999999999 108.913 173.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.712 HG23 HG22 ' A' ' 35' ' ' VAL . 7.8 p -106.7 120.49 57.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 108.403 -0.962 . . . . 1.3300000000000001 108.403 175.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.657 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 35.2 tt0 -139.98 121.06 14.7 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.225 -0.898 . . . . 1.0700000000000001 110.419 -167.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.971 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -148.23 162.47 28.8 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 111.016 -0.834 . . . . 0.28999999999999998 111.016 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.6 mt -97.6 119.11 45.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 C-N-CA 120.197 -0.601 . . . . 0.57999999999999996 111.004 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.686 HG12 ' HD3' ' A' ' 200' ' ' LYS . 72.6 mt -97.3 114.12 64.29 Favored Pre-proline 0 N--CA 1.443 -0.785 0 N-CA-C 108.884 -0.784 . . . . 0.34999999999999998 108.884 172.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 23.6 Cg_exo -65.66 57.14 0.36 Allowed 'Trans proline' 0 N--CA 1.474 0.347 0 C-N-CA 124.422 3.415 . . . . 0.62 113.223 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.494 ' HG2' HG13 ' A' ' 203' ' ' ILE . 11.4 tp10 -157.42 167.88 28.94 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 108.207 -1.035 . . . . 1.6799999999999999 108.207 176.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.507 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 20.0 p -69.49 141.37 90.67 Favored Pre-proline 0 N--CA 1.429 -1.511 0 CA-C-O 122.09 0.948 . . . . 1.1799999999999999 111.637 -175.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.581 ' HA ' HD12 ' A' ' 61' ' ' LEU . 32.3 Cg_exo -59.68 -15.39 31.22 Favored 'Trans proline' 0 CA--C 1.518 -0.29 0 C-N-CA 124.505 3.47 . . . . 0.52000000000000002 110.534 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.03 -53.33 21.03 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.195 -1.366 . . . . 0.64000000000000001 111.011 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.612 ' HA ' ' HB3' ' A' ' 63' ' ' ASP . 13.6 ttpt -70.97 -23.47 62.22 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.812 -0.81 . . . . 3.2999999999999998 108.812 -177.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.019 HD23 HD13 ' A' ' 203' ' ' ILE . 45.0 mt -60.72 -55.74 29.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.006 -0.997 . . . . 0.40999999999999998 109.756 171.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.1 p -68.63 -9.24 48.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.007 0.432 . . . . 1.29 110.724 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.612 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 29.4 t70 -90.17 -28.36 18.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.021 -0.536 . . . . 1.3200000000000001 111.828 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.673 ' CD2' ' HA ' ' A' ' 61' ' ' LEU . 8.8 p90 -86.32 -43.69 12.69 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 120.378 -0.529 . . . . 0.60999999999999999 110.967 -174.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.711 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -89.62 7.61 35.63 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.975 -0.29 . . . . 1.5 110.973 -174.462 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -53.19 -71.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.467 -0.788 . . . . 1.52 111.875 -164.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 165.08 133.56 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 108.363 -0.977 . . . . 3.6000000000000001 108.363 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.909 ' HA ' ' NH2' ' A' ' 71' ' ' ARG . 5.8 t 46.73 31.63 1.48 Allowed 'General case' 0 C--N 1.313 -1.007 0 O-C-N 124.534 1.146 . . . . 1.48 112.66 177.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.533 ' O ' ' HB3' ' A' ' 70' ' ' ASP . . . -88.69 -44.7 5.11 Favored Glycine 0 N--CA 1.427 -1.947 0 CA-C-N 115.173 -0.921 . . . . 1.46 110.859 -176.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.533 ' HB3' ' O ' ' A' ' 69' ' ' GLY . 29.4 p-10 152.35 -5.12 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 113.139 -1.53 . . . . 2.1899999999999999 108.23 -166.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.909 ' NH2' ' HA ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -46.96 -27.79 1.4 Allowed 'General case' 0 C--O 1.211 -0.957 0 N-CA-C 113.536 0.939 . . . . 3.3799999999999999 113.536 178.757 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.703 HD13 ' NH1' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -92.18 -14.37 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 119.124 -1.031 . . . . 0.70999999999999996 111.047 178.719 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.515 ' HA ' ' ND2' ' A' ' 217' ' ' ASN . 0.7 OUTLIER -86.01 -28.05 24.42 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 120.27 -0.572 . . . . 0.96999999999999997 110.239 -173.68 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.696 ' CE2' ' HA ' ' A' ' 71' ' ' ARG . 14.8 p-90 -107.22 -4.86 18.32 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.467 -0.493 . . . . 0.75 111.924 178.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.809 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 5.6 t70 -71.99 174.87 6.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.506 0.67 . . . . 2.1899999999999999 111.453 -172.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.822 ' HG2' ' HB3' ' A' ' 198' ' ' ASN . 8.1 mmmt -108.91 -25.41 10.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.199 -0.909 . . . . 3.1899999999999999 109.76 -177.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.6 m -127.6 11.51 6.78 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.34 -0.846 . . . . 1.5800000000000001 111.266 -173.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.7 HD13 HG22 ' A' ' 72' ' ' ILE . 15.9 mt -107.36 152.23 24.44 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.142 0.496 . . . . 0.70999999999999996 111.471 -178.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.544 ' HB3' HG23 ' A' ' 80' ' ' VAL . 43.2 mt-30 -118.92 -70.49 0.79 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.447 -0.797 . . . . 1.73 111.225 178.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.544 HG23 ' HB3' ' A' ' 79' ' ' GLN . 22.0 t -148.66 124.31 2.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.468 -0.787 . . . . 0.78000000000000003 110.556 -166.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.893 ' HB3' HH21 ' A' ' 71' ' ' ARG . 48.7 t80 -109.71 142.54 40.76 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.416 -0.514 . . . . 5.4000000000000004 111.213 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -136.74 118.71 15.3 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.928 -1.138 . . . . 1.6899999999999999 107.928 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.546 ' SD ' ' HD2' ' A' ' 86' ' ' ARG . 2.0 ttt -68.5 107.48 2.93 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.696 -0.684 . . . . 2.0499999999999998 109.358 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -84.31 -71.57 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 120.22 -0.592 . . . . 0.64000000000000001 111.411 -170.608 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -137.9 108.95 6.75 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.017 -0.538 . . . . 1.96 109.884 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.953 ' HG2' ' HD2' ' A' ' 92' ' ' PHE . 68.1 mtp180 -85.32 129.47 34.8 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.31 -0.626 . . . . 2.4399999999999999 109.31 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.888 HG22 ' HB3' ' A' ' 1' ' ' MET . 0.7 OUTLIER -86.99 -54.52 7.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.428 -0.805 . . . . 0.46999999999999997 109.969 -172.217 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.564 ' CG ' ' HD2' ' A' ' 4' ' ' LYS . 6.8 m-20 -136.15 -142.98 0.18 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.636 -1.165 . . . . 1.8600000000000001 108.808 -177.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.2 t -95.02 -12.22 27.01 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.609 -0.515 . . . . 1.4399999999999999 109.609 175.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -128.27 3.54 5.75 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.039 -0.528 . . . . 1.8700000000000001 110.428 -171.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.59 ' HB ' ' HB ' ' A' ' 87' ' ' ILE . 0.3 OUTLIER -132.38 121.35 23.33 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.599 -0.889 . . . . 0.46000000000000002 108.599 -172.201 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.953 ' HD2' ' HG2' ' A' ' 86' ' ' ARG . 14.1 m-85 -133.21 176.14 8.77 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 120.954 0.407 . . . . 0.42999999999999999 110.267 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.728 ' O ' HG23 ' A' ' 84' ' ' VAL . 21.8 mt -133.09 125.93 52.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 107.354 -1.35 . . . . 0.40999999999999998 107.354 168.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.556 ' HA ' ' HE1' ' A' ' 81' ' ' TYR . 94.6 m -106.58 108.41 19.9 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.101 -0.499 . . . . 2.0099999999999998 112.153 -169.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.577 ' HA ' ' O ' ' A' ' 111' ' ' PHE . 7.1 t-80 -84.75 103.62 14.0 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.024 -0.732 . . . . 1.23 109.024 171.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.734 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 27.9 m -127.34 119.91 27.33 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.244 -0.435 . . . . 0.5 111.84 -173.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 32.9 mm -77.67 138.94 19.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.076 -0.713 . . . . 1.03 109.076 174.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 1.3 m -113.58 152.34 30.44 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.58 -0.737 . . . . 1.3799999999999999 110.244 -171.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -89.58 166.58 13.56 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.397 -0.365 . . . . 1.8200000000000001 110.147 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.1 m -88.51 88.59 7.67 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.038 -0.528 . . . . 3.9100000000000001 111.317 -172.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.435 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 6.6 p90 -86.67 96.09 10.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.432 0.634 . . . . 5.1600000000000001 110.472 176.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.443 ' HB3' ' H ' ' A' ' 106' ' ' ILE . . . 152.41 10.01 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 113.779 -1.555 . . . . 1.98 108.833 -177.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.413 ' H ' ' H ' ' A' ' 102' ' ' ALA . 60.2 t 71.63 -39.25 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 115.58 -0.736 . . . . 3.1699999999999999 112.121 -177.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -165.68 -22.24 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.049 -1.072 . . . . 1.96 113.655 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.604 ' HB3' HD12 ' A' ' 183' ' ' ILE . 25.1 m -58.01 -63.0 1.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 117.207 0.503 . . . . 1.8799999999999999 111.115 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.486 HD11 HG22 ' A' ' 183' ' ' ILE . 5.2 mp -83.0 105.31 12.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.361 -0.607 . . . . 1.1200000000000001 109.361 175.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.527 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 17.7 m -71.1 164.83 53.47 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.695 -0.684 . . . . 1.3500000000000001 111.035 -178.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 107' ' ' SER . 2.0 Cg_endo -45.15 114.6 0.7 Allowed 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 123.38 2.72 . . . . 1.0700000000000001 111.397 176.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.612 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 23.0 ttp180 -102.99 158.54 16.22 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.99 -0.55 . . . . 3.4500000000000002 110.836 -168.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.928 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 8.2 t0 -113.37 122.94 48.87 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.059 -0.719 . . . . 1.3700000000000001 109.059 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.734 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 6.0 m-85 -99.38 132.07 44.96 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 120.855 0.36 . . . . 2.4100000000000001 110.471 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.572 HD13 ' HA ' ' A' ' 95' ' ' HIS . 30.1 mm -133.46 68.09 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.069 -1.085 . . . . 0.42999999999999999 108.069 171.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.91 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 4.5 m-20 -90.76 115.86 28.17 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.718 -1.128 . . . . 1.8600000000000001 109.799 -177.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 129' ' ' SER . 6.3 tp -74.6 120.85 20.71 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 108.564 -0.902 . . . . 0.28000000000000003 108.564 169.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -125.46 126.15 70.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 115.115 -0.948 . . . . 0.26000000000000001 111.824 -164.319 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.588 ' CE2' ' HB2' ' A' ' 118' ' ' LYS . 50.9 t80 -110.63 120.11 41.35 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 114.456 -1.247 . . . . 2.5699999999999998 110.211 174.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.695 HG12 HG22 ' A' ' 127' ' ' ILE . 74.2 mt -100.25 103.26 14.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.824 -0.625 . . . . 0.89000000000000001 110.359 -177.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.588 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 26.7 ttmt -124.73 133.84 53.04 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.114 0.483 . . . . 1.2 110.211 177.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.528 ' HD2' ' O ' ' A' ' 119' ' ' ARG . 0.4 OUTLIER -110.91 119.57 39.53 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 108.573 -0.899 . . . . 2.7999999999999998 108.573 173.057 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.52 ' CB ' ' HB2' ' A' ' 123' ' ' ASN . 99.1 m-85 -75.98 104.8 6.68 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.455 -1.683 . . . . 0.82999999999999996 106.455 164.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -52.04 98.3 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 122.302 1.049 . . . . 2.2799999999999998 112.598 -171.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 84.89 24.41 45.36 Favored Glycine 0 CA--C 1.504 -0.595 0 CA-C-N 113.451 -1.704 . . . . 0.76000000000000001 112.14 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.632 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 3.8 m-20 -126.02 -57.71 1.41 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.723 -0.739 . . . . 1.6499999999999999 109.617 175.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.404 ' O ' ' HA ' ' A' ' 119' ' ' ARG . 2.8 mpp? -160.48 135.27 7.62 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.894 -0.594 . . . . 1.1200000000000001 110.544 -170.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.469 ' HB2' ' HB2' ' A' ' 155' ' ' CYS . 21.9 m-80 -115.02 87.18 2.6 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.312 -0.996 . . . . 1.6200000000000001 108.312 176.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.632 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.4 OUTLIER -110.0 143.76 19.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 112.976 0.732 . . . . 0.29999999999999999 112.976 -170.527 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.695 HG22 HG12 ' A' ' 117' ' ' ILE . 5.2 pt -110.51 113.98 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.478 -0.934 . . . . 0.58999999999999997 108.478 161.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.625 ' HB3' ' HA ' ' A' ' 11' ' ' ALA . 22.6 p -94.13 124.08 37.91 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.239 -0.437 . . . . 1.1799999999999999 110.693 178.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.91 ' HB3' ' HB3' ' A' ' 113' ' ' ASP . 19.8 m -125.32 141.91 51.8 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.089 0.471 . . . . 1.24 111.801 -170.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.57 ' HE3' HG22 ' A' ' 6' ' ' ILE . 5.5 mtpm? -131.32 126.11 34.48 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 107.97 -1.122 . . . . 2.2599999999999998 107.97 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.6 p -64.89 97.45 0.23 Allowed 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.337 -1.357 . . . . 1.3899999999999999 107.337 172.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.68 140.27 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 N-CA-C 108.766 -0.827 . . . . 1.05 108.766 -165.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -97.23 81.37 3.02 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.162 -0.927 . . . . 2.1699999999999999 108.676 -172.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.498 ' HE1' HG21 ' A' ' 112' ' ' ILE . 0.5 OUTLIER -111.74 152.54 44.2 Favored Pre-proline 0 C--N 1.311 -1.066 0 CA-C-N 114.374 -1.285 . . . . 0.53000000000000003 109.902 -173.864 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.75 -18.94 66.19 Favored 'Trans proline' 0 N--CA 1.48 0.701 0 C-N-CA 123.732 2.954 . . . . 1.28 116.156 -167.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.441 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 2.6 tp10 -68.86 -29.33 67.61 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 121.608 0.718 . . . . 3.5 109.771 -172.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.563 ' CD2' HD11 ' A' ' 112' ' ' ILE . 32.4 t80 -158.25 106.94 1.7 Allowed Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 114.807 -1.088 . . . . 6.1200000000000001 113.828 -175.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.455 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 3.7 Cg_endo -87.44 155.0 7.88 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.172 2.581 . . . . 1.77 109.881 161.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -67.27 -165.13 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 121.982 1.788 . . . . 1.25 112.438 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 13.9 t -136.47 -159.37 0.95 Allowed 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 109.071 -0.714 . . . . 1.6000000000000001 109.071 -170.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 41.9 m -82.49 -42.05 18.96 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.39 -0.524 . . . . 1.97 111.693 -176.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -95.93 -29.9 13.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.095 0.474 . . . . 2.1800000000000002 110.0 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.928 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 25.5 m-85 -85.14 109.5 18.32 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.739 -0.664 . . . . 1.23 110.113 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.612 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 0.9 OUTLIER -96.95 115.37 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 108.404 -0.962 . . . . 0.81999999999999995 108.404 177.517 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.672 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 20.7 ttm180 -55.38 107.9 0.37 Allowed 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.084 -0.71 . . . . 4.4199999999999999 109.084 174.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -59.4 111.13 3.18 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 110.959 -0.856 . . . . 0.79000000000000004 110.959 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -84.01 75.5 10.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 122.183 0.992 . . . . 4.4400000000000004 111.465 -175.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.559 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 16.5 m-20 -79.12 99.52 6.99 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 113.741 -1.572 . . . . 1.6200000000000001 108.565 171.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.499 ' O ' ' N ' ' A' ' 151' ' ' CYS . 77.0 m-70 -60.25 152.84 61.26 Favored Pre-proline 0 C--O 1.22 -0.463 0 N-CA-C 107.513 -1.292 . . . . 2.3199999999999998 107.513 173.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.555 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 32.1 Cg_exo -24.67 70.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.181 1 C-N-CA 126.116 4.544 . . . . 0.53000000000000003 115.544 -173.494 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 151' ' ' CYS . . . . . 0.612 ' HB2' ' O ' ' A' ' 170' ' ' PHE . 25.8 p -97.41 -174.26 2.88 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.987 -1.006 . . . . 1.5800000000000001 109.907 176.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.687 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -172.26 -161.7 23.19 Favored Glycine 0 N--CA 1.433 -1.544 0 C-N-CA 119.775 -1.202 . . . . 0.42999999999999999 112.001 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.469 ' CE2' ' HG ' ' A' ' 65' ' ' LEU . 72.4 t80 -161.83 91.17 0.8 Allowed 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.53 -0.915 . . . . 0.59999999999999998 108.53 -168.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.643 ' CG2' HG13 ' A' ' 168' ' ' VAL . 2.4 m -100.96 131.15 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-O 121.856 0.836 . . . . 0.31 110.83 -173.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' CYS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 125' ' ' ASN . 74.9 m -110.16 109.36 19.84 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.069 -0.969 . . . . 1.55 109.62 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.469 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 19.9 m -105.73 121.22 46.65 Favored Pre-proline 0 C--N 1.318 -0.801 0 N-CA-C 112.15 0.426 . . . . 1.0600000000000001 112.15 -167.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.664 ' HB3' ' ND2' ' A' ' 161' ' ' ASN . 59.8 Cg_exo -51.69 126.02 18.55 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.953 2.435 . . . . 0.56000000000000005 111.875 170.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.617 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 0.2 OUTLIER -88.01 -170.67 3.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.189 0.519 . . . . 1.1599999999999999 111.561 -178.445 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -77.97 -24.45 48.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.426 0.631 . . . . 2.6299999999999999 109.547 168.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 37.8 mt-10 -100.65 27.29 5.97 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.052 -1.092 . . . . 2.0499999999999998 108.052 172.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.745 ' HB3' ' HD3' ' A' ' 162' ' ' PRO . 51.1 t-20 -14.99 -71.73 0.02 OUTLIER Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 126.478 1.911 . . . . 1.9299999999999999 115.074 -174.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.745 ' HD3' ' HB3' ' A' ' 161' ' ' ASN . 73.0 Cg_endo -73.36 -15.86 24.93 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 121.268 1.312 . . . . 0.72999999999999998 113.516 -170.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -104.45 -25.58 12.75 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.161 -0.472 . . . . 0.68000000000000005 110.993 -176.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.617 ' O ' ' HB2' ' A' ' 158' ' ' MET . 49.6 m-85 -141.03 122.29 14.82 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.497 -0.557 . . . . 0.93000000000000005 109.497 177.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 45.5 t -114.13 145.71 41.28 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.488 -0.485 . . . . 1.4099999999999999 110.578 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.657 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.8 tppp? -92.13 101.83 14.35 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 122.049 0.928 . . . . 0.73999999999999999 111.142 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 0.9 OUTLIER -87.49 105.01 17.01 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.385 -1.28 . . . . 0.27000000000000002 109.31 178.748 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.643 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.1 OUTLIER -128.78 117.2 43.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 122.171 0.986 . . . . 0.28000000000000003 112.004 178.112 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.435 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 23.0 ttt -116.97 147.25 42.45 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.814 -1.084 . . . . 1.24 109.496 -177.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.612 ' O ' ' HB2' ' A' ' 151' ' ' CYS . 92.9 m-85 -122.34 128.02 50.51 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.076 -0.713 . . . . 3.3700000000000001 109.076 177.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.598 ' HB ' HD21 ' A' ' 192' ' ' LEU . 2.5 p -111.12 117.98 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-O 121.744 0.783 . . . . 1.3999999999999999 110.003 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.566 HE21 HD11 ' A' ' 47' ' ' LEU . 13.7 tt0 -113.7 48.67 1.04 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.268 -1.012 . . . . 2.1699999999999999 108.268 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.877 ' HB ' ' SD ' ' A' ' 175' ' ' MET . 0.0 OUTLIER -72.01 136.47 46.72 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.058 -1.428 . . . . 1.6499999999999999 113.247 -170.745 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -92.76 -31.82 14.91 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.927 -0.579 . . . . 2.4500000000000002 111.39 174.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.889 ' HB3' HD13 ' A' ' 179' ' ' LEU . 4.3 mpp? 54.93 57.77 5.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.077 0.465 . . . . 3.7400000000000002 110.231 -172.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.405 ' HB2' HD11 ' A' ' 144' ' ' ILE . 16.5 mmt180 -60.06 -9.29 3.02 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.569 -0.741 . . . . 5.7800000000000002 112.187 177.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -77.83 18.34 4.99 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 121.226 -0.511 . . . . 2.2599999999999998 113.308 -177.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 81.5 tttt 59.28 69.7 0.7 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.498 0.666 . . . . 6.2300000000000004 111.504 175.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.889 HD13 ' HB3' ' A' ' 175' ' ' MET . 4.4 mp -99.01 174.18 6.47 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 107.907 -1.146 . . . . 1.6399999999999999 107.907 174.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.611 ' H ' HG13 ' A' ' 183' ' ' ILE . 19.5 m -112.17 156.92 41.24 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 108.882 -0.784 . . . . 2.04 108.882 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -46.26 -39.45 21.22 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 121.972 1.781 . . . . 1.74 111.589 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.6 p -75.27 -10.42 59.44 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 115.095 -0.957 . . . . 2.1400000000000001 112.606 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.809 ' HA ' ' HE2' ' A' ' 186' ' ' LYS . 8.0 mm -91.78 -28.47 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 122.872 1.32 . . . . 1.1200000000000001 109.398 177.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.954 ' HA ' HG22 ' A' ' 187' ' ' THR . 0.9 OUTLIER -86.46 -33.47 7.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 112.886 -1.961 . . . . 1.1299999999999999 110.366 -169.886 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.47 ' OE2' ' HB3' ' A' ' 186' ' ' LYS . 0.0 OUTLIER -60.71 -25.53 66.49 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.558 -0.746 . . . . 2.8900000000000001 110.612 173.95 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.809 ' HE2' ' HA ' ' A' ' 183' ' ' ILE . 0.0 OUTLIER -93.37 -36.53 12.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 1.28 110.477 174.774 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.954 HG22 ' HA ' ' A' ' 184' ' ' ILE . 5.7 t -66.47 -26.7 67.32 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 120.716 -0.394 . . . . 0.62 111.832 -171.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' MET . . . . . 0.59 ' HE2' ' HA ' ' A' ' 188' ' ' MET . 4.2 mmt -76.93 -60.09 0.85 Allowed Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.683 -0.407 . . . . 1.0600000000000001 111.65 -177.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.492 ' O ' HG13 ' A' ' 193' ' ' VAL . 18.2 Cg_endo -60.54 -36.61 85.23 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 121.668 1.579 . . . . 0.91000000000000003 111.76 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.596 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 7.8 t -70.07 -23.55 63.1 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.971 0.415 . . . . 1.5 110.763 -176.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -91.06 -45.59 8.61 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.332 -0.394 . . . . 1.8799999999999999 110.494 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.641 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 80.3 mt -72.14 -45.91 58.6 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.083 -0.508 . . . . 1.0900000000000001 112.146 -170.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.492 HG13 ' O ' ' A' ' 189' ' ' PRO . 1.8 m -75.68 -33.25 25.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.736 0.779 . . . . 0.68000000000000005 108.948 -173.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.596 ' HB2' ' O ' ' A' ' 190' ' ' SER . 1.1 t30 -62.94 -49.13 75.96 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.052 -1.431 . . . . 2.0699999999999998 109.773 175.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.656 ' HA ' ' OD1' ' A' ' 198' ' ' ASN . 5.2 t80 -56.56 -30.49 63.19 Favored 'General case' 0 C--O 1.233 0.222 0 O-C-N 123.739 0.649 . . . . 2.0 109.999 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.75 HG21 HG21 ' A' ' 33' ' ' ILE . 8.7 mt -78.7 -39.83 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-N 115.992 -0.549 . . . . 0.31 112.437 177.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.641 ' HA ' ' HG2' ' A' ' 200' ' ' LYS . 2.8 pp -80.41 -21.72 41.96 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 119.304 -0.958 . . . . 1.03 111.076 -176.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.822 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 1.6 p-10 -74.64 -13.91 60.7 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 118.816 -1.153 . . . . 1.8999999999999999 108.281 166.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.63 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -82.25 -27.31 32.52 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.266 -1.013 . . . . 0.28999999999999998 108.266 170.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.686 ' HD3' HG12 ' A' ' 54' ' ' ILE . 26.3 mmtp -69.36 -38.85 78.29 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.543 -0.753 . . . . 0.96999999999999997 109.333 173.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -86.53 -39.61 16.06 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 114.783 -1.099 . . . . 1.9399999999999999 110.169 -176.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -70.51 -29.55 69.74 Favored Glycine 0 CA--C 1.503 -0.715 0 C-N-CA 120.994 -0.622 . . . . 0.46999999999999997 111.602 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 1.019 HD13 HD23 ' A' ' 61' ' ' LEU . 2.8 tp -71.59 -31.47 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 109.606 -0.516 . . . . 0.60999999999999999 109.606 177.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.561 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 53.3 mttp -86.5 -23.74 25.82 Favored 'General case' 0 C--O 1.204 -1.293 0 N-CA-C 108.836 -0.801 . . . . 3.3700000000000001 108.836 176.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -66.15 -31.24 71.98 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.221 -0.659 . . . . 1.02 109.221 169.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.464 ' CE1' ' HA ' ' A' ' 64' ' ' PHE . 56.1 m80 -92.46 -6.82 49.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.6 -0.727 . . . . 3.6299999999999999 112.469 176.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 207' ' ' ARG . 0.5 OUTLIER -110.46 -60.43 1.81 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.954 0.883 . . . . 2.5899999999999999 109.957 176.835 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.434 ' HA ' ' HD3' ' A' ' 209' ' ' PRO . 94.5 m -84.42 143.15 41.18 Favored Pre-proline 0 C--N 1.311 -1.09 0 CA-C-N 114.184 -1.371 . . . . 1.8400000000000001 109.884 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 208' ' ' THR . 17.7 Cg_exo -69.27 51.26 0.74 Allowed 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.673 2.249 . . . . 2.3500000000000001 111.799 173.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 33.9 t -66.66 -28.78 68.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.806 -0.634 . . . . 2.3100000000000001 111.142 -176.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.501 ' H ' ' HD3' ' A' ' 211' ' ' ARG . 0.0 OUTLIER -100.44 14.53 30.86 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.617 -0.433 . . . . 5.4500000000000002 110.982 -179.185 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -62.36 -41.77 98.87 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.117 -0.698 . . . . 6.8600000000000003 109.117 175.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -102.04 71.96 0.34 Allowed Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.902 -0.879 . . . . 3.3700000000000001 110.902 172.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -87.12 121.4 29.52 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.841 0.353 . . . . 5.21 110.532 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -132.81 79.8 1.86 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.43 -0.35 . . . . 6.46 111.079 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 69.64 119.24 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.477 0.711 . . . . 6.0899999999999999 112.456 175.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.515 ' ND2' ' HA ' ' A' ' 73' ' ' THR . 26.3 p-10 -100.88 27.26 6.11 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.176 -0.676 . . . . 5.1200000000000001 109.176 171.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 8.9 m -60.97 -37.19 81.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.287 -0.87 . . . . 6.7599999999999998 110.996 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -152.07 156.98 40.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.091 -0.504 . . . . 8.8200000000000003 110.602 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 C--O 1.251 1.179 0 N-CA-C 108.754 -0.832 . . . . 8.4800000000000004 108.754 170.436 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 ptt? . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 120.915 0.388 . . . . 3.8599999999999999 110.467 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.402 ' O ' ' HB3' ' A' ' 5' ' ' ALA . 10.1 m-20 -113.85 -30.98 6.57 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 116.49 -0.323 . . . . 2.25 110.929 -176.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.578 ' HD1' HD22 ' A' ' 114' ' ' LEU . 95.4 m-85 -67.24 -32.14 72.98 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.604 0.716 . . . . 0.42999999999999999 109.466 -176.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.522 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 18.1 tttt -75.48 -1.33 23.64 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 114.594 -1.185 . . . . 1.51 109.855 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 2' ' ' ASP . . . -93.28 -42.47 9.31 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.951 -0.568 . . . . 0.54000000000000004 110.06 171.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.635 ' O ' ' HB ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -84.2 -35.47 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-O 121.08 0.467 . . . . 1.0700000000000001 110.511 -174.371 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.489 ' HB2' HD21 ' A' ' 114' ' ' LEU . . . -80.19 -40.7 26.69 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.096 -0.957 . . . . 0.34000000000000002 111.338 -176.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.522 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 4.0 mt-30 -63.45 -32.8 74.34 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.079 -0.964 . . . . 1.5900000000000001 109.658 176.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.635 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 77.4 mm-40 -78.68 -42.75 27.69 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.613 -1.176 . . . . 2.4700000000000002 109.1 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.635 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -60.24 -35.73 76.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.656 -0.702 . . . . 0.47999999999999998 111.257 179.73 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.456 ' HA ' ' OG ' ' A' ' 128' ' ' SER . . . -48.79 -58.92 4.05 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 121.098 0.475 . . . . 0.31 110.94 171.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -71.99 -18.18 62.0 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.711 -0.677 . . . . 1.6399999999999999 111.564 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.635 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 49.9 mt-10 -68.76 -56.73 7.12 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.03 -0.73 . . . . 2.54 109.03 172.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.695 HG23 ' CE2' ' A' ' 170' ' ' PHE . 11.9 p -68.97 -41.77 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.893 -0.594 . . . . 0.53000000000000003 111.228 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.33 -31.55 65.81 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.543 -0.753 . . . . 0.59999999999999998 109.219 174.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.62 -28.33 73.1 Favored Glycine 0 CA--C 1.503 -0.715 0 CA-C-N 114.21 -1.359 . . . . 0.56999999999999995 110.324 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.492 ' HD1' ' O ' ' A' ' 13' ' ' GLU . 11.6 m-85 -93.05 -16.86 24.52 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.763 -0.718 . . . . 3.27 109.636 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.82 -6.16 40.1 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.54 0.686 . . . . 2.0299999999999998 109.199 -175.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -110.16 -17.32 13.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.641 -1.163 . . . . 2.7200000000000002 109.714 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -100.44 138.19 37.83 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.433 -0.803 . . . . 2.1600000000000001 110.239 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 40.3 p -137.29 88.91 2.38 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.363 0.602 . . . . 1.8200000000000001 111.336 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.1 p -173.78 146.25 1.24 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.173 -0.921 . . . . 2.1899999999999999 111.451 -178.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.495 ' O ' ' HG3' ' A' ' 38' ' ' LYS . . . 92.81 2.27 67.11 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 121.294 -0.479 . . . . 1.1000000000000001 112.807 174.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.498 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -120.04 -158.29 0.74 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.925 0.393 . . . . 1.6699999999999999 110.878 -176.075 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.29 119.24 0.91 Allowed 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 108.811 -0.811 . . . . 2.9500000000000002 108.811 -174.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.603 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 3.1 p -64.24 117.38 4.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 C-N-CA 119.37 -0.932 . . . . 1.5600000000000001 109.726 175.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.4 p -94.09 -23.72 5.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 114.317 -1.311 . . . . 1.22 108.944 -176.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.504 ' HD3' ' C ' ' A' ' 28' ' ' LYS . 0.5 OUTLIER -157.57 123.71 4.79 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 120.252 -0.579 . . . . 2.4100000000000001 110.199 -174.471 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.415 ' HB ' ' HA ' ' A' ' 34' ' ' THR . 0.9 OUTLIER -151.34 152.07 32.64 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.208 0.528 . . . . 1.3799999999999999 111.485 -178.463 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.3 t -112.12 -147.95 0.42 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.579 -0.897 . . . . 2.3700000000000001 108.579 175.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.32 25.87 6.53 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.444 0.64 . . . . 4.5499999999999998 109.38 176.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.545 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 25.6 mmtm -156.73 -44.85 0.07 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 114.911 -1.04 . . . . 1.4199999999999999 111.814 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.459 HG22 ' HA3' ' A' ' 52' ' ' GLY . 24.0 pt -104.87 160.42 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-O 120.766 0.317 . . . . 0.76000000000000001 111.394 -175.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 2.6 m -149.72 109.9 4.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.548 -0.751 . . . . 0.57999999999999996 110.487 -171.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.42 HG22 HG23 ' A' ' 50' ' ' VAL . 16.3 t -103.07 102.13 13.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.161 0.505 . . . . 0.85999999999999999 109.943 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 2.9 p -97.48 124.66 41.78 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.5 -0.773 . . . . 1.1000000000000001 111.693 -176.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.7 t -103.27 125.53 49.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.537 -1.211 . . . . 1.27 109.527 -175.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 29.4 ttpt -120.55 -91.53 0.56 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.348 -0.387 . . . . 1.9099999999999999 111.283 -176.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 46' ' ' ASN . . . -176.53 137.53 0.28 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 110.272 -0.27 . . . . 1.6799999999999999 110.272 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.7 p -78.39 159.49 28.3 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.88 -0.415 . . . . 2.0899999999999999 109.88 176.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -58.22 -40.9 82.85 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.945 0.402 . . . . 6.6100000000000003 110.639 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -76.38 -20.56 57.05 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.241 -0.436 . . . . 6.46 110.921 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 43.9 t80 74.61 13.8 3.56 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.506 -0.77 . . . . 5.6500000000000004 110.46 170.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -87.96 15.32 7.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.375 0.607 . . . . 5.5599999999999996 110.251 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 171.08 167.65 31.68 Favored Glycine 0 N--CA 1.425 -2.061 0 N-CA-C 109.036 -1.626 . . . . 1.5600000000000001 109.036 -171.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 77.5 m-20 -98.51 143.62 28.73 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 120.948 0.404 . . . . 2.0499999999999998 110.992 -177.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.751 HD21 ' CD1' ' A' ' 170' ' ' PHE . 4.9 tt -84.76 133.25 34.36 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.95 -1.13 . . . . 0.87 107.95 175.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.624 ' N ' HD23 ' A' ' 47' ' ' LEU . 97.9 m-85 -113.66 128.59 56.48 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.003 0.43 . . . . 0.98999999999999999 110.092 -176.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.441 ' HD2' ' CH2' ' A' ' 24' ' ' TRP . 3.8 tmt_? -122.88 131.35 53.7 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.598 -0.728 . . . . 2.9199999999999999 109.274 177.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 34' ' ' THR . 10.1 p -116.49 151.35 18.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.046 0.45 . . . . 1.3300000000000001 110.543 -176.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.448 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 27.3 tt0 -148.36 108.81 4.14 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.444 -0.798 . . . . 1.0700000000000001 109.408 -172.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 32' ' ' LYS . . . -140.91 138.5 8.93 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 119.978 -1.106 . . . . 0.28999999999999998 112.306 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 67.6 mt -84.56 129.3 37.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.033 0.444 . . . . 0.57999999999999996 110.139 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 63.8 mt -109.59 119.0 49.19 Favored Pre-proline 0 N--CA 1.442 -0.839 0 CA-C-N 115.767 -0.651 . . . . 0.34999999999999998 109.612 177.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 34.0 Cg_exo -61.67 69.17 0.1 Allowed 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 124.262 3.308 . . . . 0.62 112.685 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.596 ' HG2' ' CG1' ' A' ' 203' ' ' ILE . 7.6 tp10 -163.79 176.68 9.3 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.061 -1.088 . . . . 1.6799999999999999 108.061 176.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.506 ' H ' ' HG3' ' A' ' 56' ' ' GLU . 53.4 p -84.75 153.78 61.13 Favored Pre-proline 0 N--CA 1.427 -1.603 0 CA-C-O 121.332 0.587 . . . . 1.1799999999999999 110.298 176.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.5 ' HA ' HD12 ' A' ' 61' ' ' LEU . 11.9 Cg_exo -68.28 -9.58 26.31 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.742 2.961 . . . . 0.52000000000000002 110.26 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.53 -48.72 25.32 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.687 -1.142 . . . . 0.64000000000000001 111.153 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -72.93 -26.5 61.41 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.788 -0.819 . . . . 3.2999999999999998 108.788 -178.392 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.031 HD23 HD13 ' A' ' 203' ' ' ILE . 83.3 mt -64.13 -53.49 48.81 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 114.729 -1.123 . . . . 0.40999999999999998 109.796 173.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.425 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 18.1 m -64.29 -13.45 49.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.502 -0.772 . . . . 1.29 110.442 175.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.427 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 24.6 t70 -84.95 -42.82 14.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.833 -0.621 . . . . 1.3200000000000001 111.564 -178.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.571 ' CD2' ' HA ' ' A' ' 61' ' ' LEU . 11.9 p90 -73.3 -44.38 59.19 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 120.571 -0.452 . . . . 0.60999999999999999 111.2 -174.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.425 ' CD2' ' HA ' ' A' ' 62' ' ' SER . 0.7 OUTLIER -80.79 -16.79 52.87 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 120.433 -0.507 . . . . 1.5 111.965 -173.264 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.631 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 34.8 t80 -26.3 -72.28 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 O-C-N 124.6 1.188 . . . . 1.52 113.811 -153.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.631 ' HG2' ' O ' ' A' ' 66' ' ' TYR . 5.4 mm-40 175.8 115.95 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.08 0 C-N-CA 124.32 1.048 . . . . 3.6000000000000001 108.229 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.727 ' HB ' ' CD1' ' A' ' 81' ' ' TYR . 13.3 t 39.83 31.46 0.08 Allowed 'General case' 0 C--N 1.319 -0.753 0 O-C-N 124.348 1.03 . . . . 1.48 112.584 -177.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.3 -38.79 8.79 Favored Glycine 0 N--CA 1.436 -1.357 0 CA-C-N 115.5 -0.773 . . . . 1.46 113.001 -168.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.655 ' O ' HG22 ' A' ' 73' ' ' THR . 23.3 t70 169.59 -22.04 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.338 -0.986 . . . . 2.1899999999999999 108.338 -163.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.775 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 3.9 ptp180 -43.8 -48.07 8.14 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 114.772 -1.103 . . . . 3.3799999999999999 111.165 -178.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.767 HD13 ' H ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -79.32 -16.08 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 C-N-CA 120.695 -0.402 . . . . 0.70999999999999996 111.613 -172.325 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.655 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.3 t -82.41 -35.86 27.25 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 119.8 -0.76 . . . . 0.96999999999999997 109.995 -174.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.559 ' CZ2' ' HA ' ' A' ' 71' ' ' ARG . 16.8 p-90 -100.96 -3.7 29.01 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.343 -0.543 . . . . 0.75 111.387 -177.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.775 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 3.0 t70 -75.27 177.31 6.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.717 -0.674 . . . . 2.1899999999999999 112.269 -170.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.608 ' HG3' ' OD1' ' A' ' 198' ' ' ASN . 0.0 OUTLIER -133.94 -12.43 2.56 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.539 -0.755 . . . . 3.1899999999999999 111.4 179.246 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.4 m -111.33 -1.73 15.91 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.306 -0.998 . . . . 1.5800000000000001 108.306 178.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.616 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 68.3 mt -110.79 176.81 4.88 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.566 -1.197 . . . . 0.70999999999999996 110.037 -178.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -149.02 -67.95 0.22 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.495 -0.775 . . . . 1.73 110.002 -176.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.503 ' HB ' HD13 ' A' ' 97' ' ' ILE . 26.0 t -143.89 135.87 22.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.643 -0.708 . . . . 0.78000000000000003 109.808 -173.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.727 ' CD1' ' HB ' ' A' ' 68' ' ' THR . 11.4 t80 -112.24 139.29 47.91 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.801 -0.444 . . . . 5.4000000000000004 109.801 176.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.551 ' O ' ' HB3' ' A' ' 95' ' ' HIS . 17.1 m120 -137.71 114.76 10.8 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.902 -0.777 . . . . 1.6899999999999999 108.902 175.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.423 ' HG2' ' NE ' ' A' ' 86' ' ' ARG . 48.6 tpp -75.53 113.02 12.47 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.736 -0.838 . . . . 2.0499999999999998 108.736 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -85.88 -69.74 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.154 0.502 . . . . 0.64000000000000001 110.201 -170.142 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.43 ' HB3' HD12 ' A' ' 93' ' ' ILE . 80.6 t60 -132.91 124.75 28.43 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.718 -0.673 . . . . 1.96 109.7 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.423 ' NE ' ' HG2' ' A' ' 83' ' ' MET . 40.9 mtt180 -101.87 129.06 48.02 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.86 -0.793 . . . . 2.4399999999999999 108.86 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.523 HG21 ' HB2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -91.51 -39.08 11.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.468 0.651 . . . . 0.46999999999999997 109.418 -176.336 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -150.7 -169.4 3.38 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.98 -1.009 . . . . 1.8600000000000001 108.764 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.1 m -80.15 -4.41 52.86 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.858 0.361 . . . . 1.4399999999999999 110.742 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -135.69 13.3 3.43 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 109.884 -0.414 . . . . 1.8700000000000001 109.884 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.511 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -139.01 111.09 7.32 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 109.009 -0.737 . . . . 0.46000000000000002 109.009 -176.781 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.602 ' O ' HD12 ' A' ' 114' ' ' LEU . 41.5 m-85 -128.76 178.96 5.98 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.845 -0.616 . . . . 0.42999999999999999 110.274 -173.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.562 ' O ' HG23 ' A' ' 84' ' ' VAL . 39.1 mt -132.81 124.68 51.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 108.258 -1.016 . . . . 0.40999999999999998 108.258 169.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.643 ' SG ' HG11 ' A' ' 115' ' ' VAL . 75.2 m -92.82 107.67 19.4 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.1 -0.5 . . . . 2.0099999999999998 112.196 -171.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.58 ' HA ' HD13 ' A' ' 112' ' ' ILE . 5.3 t60 -87.11 81.85 7.89 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.027 -1.101 . . . . 1.23 108.027 164.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.444 ' OG1' ' HB3' ' A' ' 94' ' ' CYS . 90.5 m -108.3 113.0 25.75 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.72 -1.127 . . . . 0.5 111.761 -170.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.503 HD13 ' HB ' ' A' ' 80' ' ' VAL . 3.2 mp -77.58 121.57 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 108.227 -1.027 . . . . 1.03 108.227 173.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.599 ' HB ' ' O ' ' A' ' 109' ' ' ARG . 71.8 m -111.27 149.37 31.14 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.94 -1.027 . . . . 1.3799999999999999 110.771 -171.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -116.55 57.46 0.77 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.046 0.45 . . . . 1.8200000000000001 110.559 -176.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.9 p -80.98 56.38 2.75 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.562 0.696 . . . . 3.9100000000000001 110.287 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.508 ' CZ ' ' HA2' ' A' ' 104' ' ' GLY . 22.8 t80 -83.34 97.27 8.83 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.274 -0.876 . . . . 5.1600000000000001 110.452 -173.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.576 ' O ' HG12 ' A' ' 103' ' ' VAL . . . -88.72 77.99 7.77 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.908 -0.587 . . . . 1.98 110.363 175.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 102' ' ' ALA . 0.3 OUTLIER 72.52 -15.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.468 1.107 . . . . 3.1699999999999999 112.713 170.569 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.508 ' HA2' ' CZ ' ' A' ' 101' ' ' PHE . . . 139.56 -15.31 3.16 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.189 -1.005 . . . . 1.96 112.602 177.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.2 m -73.05 -13.41 61.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.284 0.564 . . . . 1.8799999999999999 110.475 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 44.0 mt -124.46 118.88 54.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.52 -0.764 . . . . 1.1200000000000001 109.95 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.8 m -77.17 155.1 82.41 Favored Pre-proline 0 C--N 1.319 -0.753 0 N-CA-C 109.366 -0.605 . . . . 1.3500000000000001 109.366 174.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -44.71 122.92 4.4 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.681 2.254 . . . . 1.0700000000000001 111.031 173.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.625 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 33.3 ttp180 -118.67 137.44 53.3 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.712 -0.395 . . . . 3.4500000000000002 110.097 -167.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.592 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 22.0 t70 -107.47 147.52 30.36 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 120.754 0.311 . . . . 1.3700000000000001 110.635 -171.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -118.81 155.64 30.82 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.366 0.603 . . . . 2.4100000000000001 111.589 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.628 HG21 ' HE1' ' A' ' 134' ' ' PHE . 35.5 mm -135.78 76.83 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 107.59 -1.263 . . . . 0.42999999999999999 107.59 170.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.57 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 2.1 m-20 -98.91 120.61 39.63 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.579 -0.737 . . . . 1.8600000000000001 110.577 -176.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 92' ' ' PHE . 9.4 tp -75.62 122.04 23.35 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 121.701 0.762 . . . . 0.28000000000000003 109.361 172.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.643 HG11 ' SG ' ' A' ' 94' ' ' CYS . 0.1 OUTLIER -123.58 125.7 71.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-N 114.591 -1.186 . . . . 0.26000000000000001 112.374 -165.123 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.452 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 91.0 t80 -112.87 123.92 51.42 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.332 -0.849 . . . . 2.5699999999999998 110.637 172.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.556 HG13 HG22 ' A' ' 127' ' ' ILE . 4.5 mp -92.07 110.74 23.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.366 -0.834 . . . . 0.89000000000000001 109.783 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.464 ' HB3' HG23 ' A' ' 126' ' ' ILE . 24.8 ttmm -113.41 142.82 45.44 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.032 -0.531 . . . . 1.2 110.596 -176.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -129.01 89.8 2.93 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 116.003 -0.544 . . . . 2.7999999999999998 110.563 -174.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.474 ' HB3' ' HB2' ' A' ' 123' ' ' ASN . 36.9 m-85 -72.29 108.75 5.59 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 107.829 -1.174 . . . . 0.82999999999999996 107.829 167.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -39.81 100.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 O-C-N 124.665 1.228 . . . . 2.2799999999999998 112.813 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.413 ' C ' ' HG2' ' A' ' 157' ' ' PRO . . . 67.12 26.87 73.34 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 114.039 -1.437 . . . . 0.76000000000000001 113.113 176.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.514 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 93.1 m-20 -127.38 -46.13 1.49 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.688 -0.256 . . . . 1.6499999999999999 110.64 176.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.551 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 5.8 mtm -162.19 131.17 4.3 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 120.516 -0.474 . . . . 1.1200000000000001 111.96 -176.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -112.42 86.02 2.27 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.612 -1.255 . . . . 1.6200000000000001 107.612 167.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.595 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -97.78 135.74 31.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.136 -0.938 . . . . 0.29999999999999999 112.244 -172.576 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.681 ' O ' HG13 ' A' ' 127' ' ' ILE . 13.9 pt -101.05 108.89 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 108.576 -0.898 . . . . 0.58999999999999997 108.576 164.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.555 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 1.7 m -75.86 161.05 29.31 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.624 -0.88 . . . . 1.1799999999999999 108.624 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.57 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 11.3 p -157.33 121.11 4.18 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.334 0.588 . . . . 1.24 111.618 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.8 ttmt -127.94 110.71 12.81 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.436 -1.32 . . . . 2.2599999999999998 107.436 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.416 ' OG ' ' HA ' ' A' ' 147' ' ' TYR . 22.9 t -58.71 98.84 0.04 OUTLIER 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 107.629 -1.248 . . . . 1.3899999999999999 107.629 -178.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.427 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -107.59 133.84 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.107 0 CA-C-N 114.833 -1.076 . . . . 1.05 108.727 -165.321 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -94.09 71.15 3.94 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.898 -1.047 . . . . 2.1699999999999999 109.076 -169.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.628 ' HE1' HG21 ' A' ' 112' ' ' ILE . 1.8 p90 -99.26 175.06 2.62 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 114.4 -1.273 . . . . 0.53000000000000003 109.488 -172.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -41.98 -50.4 5.2 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.739 2.959 . . . . 1.28 116.479 -174.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -88.12 -5.13 58.62 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.604 0.716 . . . . 3.5 111.604 -170.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.484 ' HB3' ' O ' ' A' ' 134' ' ' PHE . 22.8 t80 -56.72 -48.94 96.37 Favored Pre-proline 0 C--N 1.315 -0.927 0 N-CA-C 114.914 1.45 . . . . 6.1200000000000001 114.914 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 137' ' ' TYR . 66.6 Cg_exo -32.29 110.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 123.821 3.014 . . . . 1.77 114.467 -174.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.598 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 82.3 Cg_endo -83.84 -160.72 0.12 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.687 2.925 . . . . 1.25 114.036 -175.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.9 p -136.64 -164.35 1.56 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.279 -0.873 . . . . 1.6000000000000001 108.943 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.6 p -89.77 -29.83 18.42 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.126 -0.63 . . . . 1.97 110.972 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -83.45 -33.32 25.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 2.1800000000000002 110.732 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -107.67 109.41 21.01 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 109.425 -0.583 . . . . 1.23 109.425 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.625 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 2.4 tp -100.63 106.66 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 C-N-CA 120.123 -0.631 . . . . 0.81999999999999995 109.646 -176.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.598 ' NH2' ' HA ' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -59.43 99.98 0.07 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.109 -0.95 . . . . 4.4199999999999999 110.715 178.825 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -65.82 122.24 21.54 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.597 -0.729 . . . . 0.79000000000000004 111.297 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.536 ' HB3' ' HB2' ' A' ' 174' ' ' GLU . 3.5 t80 -85.05 78.55 9.87 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.623 0.725 . . . . 4.4400000000000004 110.372 -177.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.685 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 89.0 m-20 -72.55 106.11 4.48 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.736 -1.12 . . . . 1.6200000000000001 110.325 175.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.445 ' CB ' HE21 ' A' ' 172' ' ' GLN . 83.0 m-70 -75.91 144.77 76.65 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 109.545 -0.539 . . . . 2.3199999999999998 109.545 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -13.49 61.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.181 1 C-N-CA 127.599 5.533 . . . . 0.53000000000000003 116.374 -166.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' CYS . . . . . 0.685 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 19.7 p -89.99 -175.08 4.47 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.451 -0.795 . . . . 1.5800000000000001 110.329 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.633 ' N ' HG21 ' A' ' 14' ' ' VAL . . . 178.99 -161.81 28.33 Favored Glycine 0 N--CA 1.435 -1.371 0 C-N-CA 120.456 -0.878 . . . . 0.42999999999999999 111.479 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.499 ' CZ ' HD11 ' A' ' 167' ' ' LEU . 32.5 t80 -161.38 91.42 0.85 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.075 -1.083 . . . . 0.59999999999999998 108.075 -165.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.595 HG12 ' HB ' ' A' ' 126' ' ' ILE . 2.7 m -98.41 132.62 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-O 122.106 0.955 . . . . 0.31 111.123 -174.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' CYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 124' ' ' MET . 16.5 t -109.55 119.28 38.93 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.228 -0.897 . . . . 1.55 109.186 176.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.544 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 6.2 m -116.44 122.41 31.98 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.614 -0.266 . . . . 1.0600000000000001 111.162 -171.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.514 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 46.0 Cg_exo -53.65 126.64 22.48 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.973 1.782 . . . . 0.56000000000000005 110.655 169.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.628 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 70.8 mmm -85.24 -166.61 1.55 Allowed 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.119 0.485 . . . . 1.1599999999999999 111.139 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -74.57 -35.51 63.03 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 121.562 0.696 . . . . 2.6299999999999999 109.225 175.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -102.6 29.49 5.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.874 -1.057 . . . . 2.0499999999999998 108.876 173.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.471 ' HA ' ' O ' ' A' ' 164' ' ' TYR . 2.7 p-10 -28.5 -55.83 0.25 Allowed Pre-proline 0 N--CA 1.475 0.812 0 N-CA-C 116.407 2.002 . . . . 1.9299999999999999 116.407 -171.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.44 ' HD3' ' CG ' ' A' ' 161' ' ' ASN . 55.3 Cg_endo -68.83 -13.59 37.19 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 121.738 1.656 . . . . 0.72999999999999998 112.722 -173.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -109.92 -32.69 6.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.984 -0.553 . . . . 0.68000000000000005 110.765 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.628 ' O ' ' HB2' ' A' ' 158' ' ' MET . 88.3 m-85 -138.76 126.91 22.66 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.417 -0.586 . . . . 0.93000000000000005 109.417 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.467 ' HB2' HD11 ' A' ' 61' ' ' LEU . 73.6 m -125.65 154.22 42.67 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.181 0.515 . . . . 1.4099999999999999 111.853 -176.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.544 ' HB3' ' HB2' ' A' ' 156' ' ' SER . 2.0 tppp? -96.77 105.25 17.34 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.887 0.851 . . . . 0.73999999999999999 112.081 -174.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.499 HD11 ' CZ ' ' A' ' 153' ' ' PHE . 0.6 OUTLIER -92.82 108.82 20.29 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.579 -1.191 . . . . 0.27000000000000002 109.242 175.572 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.592 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -129.92 134.2 63.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.448 0.642 . . . . 0.28000000000000003 111.504 177.206 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.582 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 17.7 ttt -143.49 151.3 40.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.518 -0.765 . . . . 1.24 109.321 -174.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.751 ' CD1' HD21 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -136.03 151.96 50.4 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.366 -0.605 . . . . 3.3700000000000001 109.366 170.777 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.537 ' N ' ' HD1' ' A' ' 170' ' ' PHE . 3.9 p -134.85 132.83 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 115.746 -0.661 . . . . 1.3999999999999999 110.078 176.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.51 ' OE1' HD12 ' A' ' 47' ' ' LEU . 24.9 tt0 -121.09 65.73 0.86 Allowed 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 107.135 -1.432 . . . . 2.1699999999999999 107.135 177.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.511 HG23 ' OD1' ' A' ' 148' ' ' ASN . 1.4 m -68.94 149.47 48.82 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 113.54 -1.664 . . . . 1.6499999999999999 110.465 -175.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 147' ' ' TYR . 4.0 tp10 -81.91 -15.09 55.07 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.187 -0.46 . . . . 2.4500000000000002 109.872 177.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.476 ' H ' HG22 ' A' ' 173' ' ' THR . 35.9 mtt 68.67 32.6 4.14 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.274 -0.876 . . . . 3.7400000000000002 110.201 175.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.498 ' HB3' HD11 ' A' ' 144' ' ' ILE . 31.2 mmm180 -66.02 159.85 25.0 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.704 -0.68 . . . . 5.7800000000000002 110.016 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 109.99 -171.51 14.98 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.951 -0.642 . . . . 2.2599999999999998 111.565 -175.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -102.75 69.49 1.07 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.995 0.426 . . . . 6.2300000000000004 110.154 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.65 ' HB2' HD11 ' A' ' 184' ' ' ILE . 1.7 mp -119.44 161.8 19.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.469 0.652 . . . . 1.6399999999999999 109.537 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.505 ' O ' HD12 ' A' ' 184' ' ' ILE . 17.0 m -113.83 157.94 40.44 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-N 114.925 -1.034 . . . . 2.04 108.953 -177.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -42.6 -46.36 8.13 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.813 2.342 . . . . 1.74 113.176 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.562 ' O ' ' HE2' ' A' ' 186' ' ' LYS . 9.3 m -69.22 -15.37 63.36 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.163 -0.472 . . . . 2.1400000000000001 111.877 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.467 HG13 ' H ' ' A' ' 180' ' ' SER . 12.0 mm -90.29 -29.39 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 CA-C-O 122.551 1.167 . . . . 1.1200000000000001 108.997 -175.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.979 ' HA ' HG22 ' A' ' 187' ' ' THR . 0.9 OUTLIER -83.39 -37.12 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 113.113 -1.858 . . . . 1.1299999999999999 110.516 -172.103 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 189' ' ' PRO . 9.2 pt-20 -64.41 -16.72 62.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.489 -0.778 . . . . 2.8900000000000001 109.343 174.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.562 ' HE2' ' O ' ' A' ' 182' ' ' SER . 52.1 mtmt -92.05 -43.7 9.26 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.775 -0.648 . . . . 1.28 110.376 170.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.979 HG22 ' HA ' ' A' ' 184' ' ' ILE . 13.5 t -64.83 -40.33 95.01 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.841 0.682 . . . . 0.62 112.841 -169.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' MET . . . . . 0.496 ' SD ' HG23 ' A' ' 187' ' ' THR . 0.1 OUTLIER -78.04 -61.2 0.61 Allowed Pre-proline 0 N--CA 1.467 0.424 0 CA-C-N 118.407 0.549 . . . . 1.0600000000000001 111.951 -178.456 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.606 ' O ' HG13 ' A' ' 193' ' ' VAL . 51.6 Cg_exo -56.26 -38.74 94.54 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.04 1.827 . . . . 0.91000000000000003 112.258 -176.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.41 ' O ' HG22 ' A' ' 193' ' ' VAL . 23.2 t -72.21 -37.31 69.26 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.414 -0.587 . . . . 1.5 109.414 -177.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ASN . . . . . 0.452 ' HA ' ' HB2' ' A' ' 194' ' ' ASN . 2.6 t-20 -67.4 -31.93 72.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.019 -0.537 . . . . 1.8799999999999999 110.408 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.51 ' HB3' ' CG1' ' A' ' 50' ' ' VAL . 40.5 mt -69.34 -46.22 67.59 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 120.738 0.304 . . . . 1.0900000000000001 111.007 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.606 HG13 ' O ' ' A' ' 189' ' ' PRO . 0.9 OUTLIER -65.06 -34.25 69.28 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 N-CA-C 108.716 -0.846 . . . . 0.68000000000000005 108.716 176.543 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.452 ' HB2' ' HA ' ' A' ' 191' ' ' ASN . 35.0 m-20 -63.64 -45.32 90.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.179 -1.373 . . . . 2.0699999999999998 111.483 178.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.419 ' HA ' ' ND2' ' A' ' 198' ' ' ASN . 6.3 m-85 -59.15 -31.38 68.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.967 0.413 . . . . 2.0 110.417 175.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.474 HG12 HD12 ' A' ' 167' ' ' LEU . 34.3 mt -81.75 -27.17 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-N 116.157 -0.474 . . . . 0.31 111.319 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 62.4 mt -74.57 -40.16 61.81 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-O 121.108 0.48 . . . . 1.03 109.811 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.608 ' OD1' ' HG3' ' A' ' 76' ' ' LYS . 76.5 m-20 -50.07 -37.86 35.6 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.706 -1.134 . . . . 1.8999999999999999 108.53 166.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.648 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -78.17 -43.94 27.25 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 116.081 -0.509 . . . . 0.28999999999999998 110.905 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.56 ' O ' ' HG3' ' A' ' 204' ' ' LYS . 35.6 mmtm -55.96 -44.5 78.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.256 0.551 . . . . 0.96999999999999997 110.565 174.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -87.58 -38.41 15.99 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.495 -0.775 . . . . 1.9399999999999999 110.856 -173.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' GLY . . . . . 0.431 ' HA2' ' HB3' ' A' ' 205' ' ' ALA . . . -68.39 -29.42 73.08 Favored Glycine 0 C--O 1.228 -0.243 0 C-N-CA 121.102 -0.57 . . . . 0.46999999999999997 111.999 178.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 1.031 HD13 HD23 ' A' ' 61' ' ' LEU . 2.8 tp -70.55 -31.68 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-O 120.92 0.391 . . . . 0.60999999999999999 109.949 177.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.56 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 89.3 mttt -84.33 -32.84 24.06 Favored 'General case' 0 C--O 1.21 -1.006 0 N-CA-C 108.514 -0.921 . . . . 3.3700000000000001 108.514 176.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.542 ' HA ' ' CB ' ' A' ' 211' ' ' ARG . . . -58.41 -32.22 68.43 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.923 -0.581 . . . . 1.02 109.525 170.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -94.62 5.15 52.7 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.615 -0.72 . . . . 3.6299999999999999 111.728 174.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.48 ' HB3' ' HA ' ' A' ' 204' ' ' LYS . 73.7 ttt180 -113.29 -61.17 1.78 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.899 0.38 . . . . 2.5899999999999999 111.763 174.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 28.8 p -79.15 138.11 56.51 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.444 0.64 . . . . 1.8400000000000001 111.86 -170.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.48 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 13.4 Cg_endo -56.26 -22.82 42.57 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 124.009 3.139 . . . . 2.3500000000000001 112.847 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 35.4 t -68.86 -55.91 9.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.848 -0.614 . . . . 2.3100000000000001 111.338 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.542 ' CB ' ' HA ' ' A' ' 205' ' ' ALA . 10.6 mpt_? -87.03 -20.82 26.64 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.126 0.417 . . . . 5.4500000000000002 112.126 -173.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.48 ' HG2' ' HA ' ' A' ' 209' ' ' PRO . 13.2 ptm180 -74.82 -15.57 60.73 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.21 -0.596 . . . . 6.8600000000000003 109.934 176.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -115.99 28.44 7.66 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.794 -0.922 . . . . 3.3700000000000001 110.794 174.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -77.06 111.78 13.0 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.871 -0.418 . . . . 5.21 109.871 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -99.02 132.89 44.0 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.496 -0.32 . . . . 6.46 110.507 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 58.87 69.79 0.7 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.384 -0.825 . . . . 6.0899999999999999 110.362 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.487 ' ND2' ' HA ' ' A' ' 74' ' ' TRP . 52.4 t30 -81.5 102.6 10.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.993 -0.549 . . . . 5.1200000000000001 110.274 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 24.8 m -67.4 -50.26 60.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.787 -0.642 . . . . 6.7599999999999998 110.817 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -170.02 128.99 0.91 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.022 -0.362 . . . . 8.8200000000000003 110.022 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' SER . . . . . 0.446 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 46.7 t . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.536 -0.745 . . . . 8.4800000000000004 109.864 176.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 1.044 ' HG3' ' HB3' ' A' ' 4' ' ' LYS . 24.9 tpp . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 109.051 -0.722 . . . . 3.8599999999999999 109.051 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 64.08 -98.84 0.07 Allowed 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 114.606 -1.179 . . . . 2.25 112.006 168.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.635 ' HB3' HD11 ' A' ' 114' ' ' LEU . 76.0 m-85 -61.99 -26.54 68.28 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 121.236 0.541 . . . . 0.42999999999999999 110.098 -172.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 1.044 ' HB3' ' HG3' ' A' ' 1' ' ' MET . 39.4 tttt -80.93 -36.44 31.01 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 107.453 -1.314 . . . . 1.51 107.453 -176.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.18 -43.57 82.78 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.897 -0.592 . . . . 0.54000000000000004 111.32 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 3' ' ' PHE . 0.9 OUTLIER -82.75 -32.88 10.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 122.169 0.985 . . . . 1.0700000000000001 109.191 -172.648 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.612 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -81.21 -37.79 28.06 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.176 -1.375 . . . . 0.34000000000000002 111.718 -177.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.578 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 19.5 mt-30 -61.77 -30.13 70.59 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.421 -0.809 . . . . 1.5900000000000001 109.704 175.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.654 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 76.3 mt-30 -78.32 -39.67 38.99 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.482 -1.236 . . . . 2.4700000000000002 109.365 173.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.657 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.4 OUTLIER -72.94 -33.47 65.94 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.424 -0.807 . . . . 0.47999999999999998 112.198 -175.185 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -48.05 -57.92 5.15 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.986 0.422 . . . . 0.31 111.698 174.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.718 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 21.8 pt20 -76.57 1.33 17.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.259 -0.428 . . . . 1.6399999999999999 111.605 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.654 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 10.6 mm-40 -82.8 -48.83 10.36 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.01 -0.737 . . . . 2.54 109.01 169.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.96 HG23 ' HD1' ' A' ' 170' ' ' PHE . 7.4 p -72.0 -34.06 49.45 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-O 121.47 0.653 . . . . 0.53000000000000003 109.818 175.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.718 ' HB3' ' HA ' ' A' ' 12' ' ' GLN . 0.8 OUTLIER -68.15 -26.18 65.64 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 122.361 1.077 . . . . 0.59999999999999998 108.325 172.609 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 20' ' ' ASP . . . -68.75 -20.05 73.84 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 113.797 -1.547 . . . . 0.56999999999999995 109.627 177.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.627 ' HD2' ' HA ' ' A' ' 14' ' ' VAL . 32.1 m-85 -91.08 -22.27 20.81 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 114.315 -0.943 . . . . 3.27 109.376 176.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.487 ' HB3' ' O ' ' A' ' 15' ' ' LEU . 39.7 t30 -60.06 -28.7 68.0 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.356 -0.838 . . . . 2.0299999999999998 109.615 175.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.554 ' HD2' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -115.22 10.89 16.11 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.58 -0.448 . . . . 2.7200000000000002 111.397 175.189 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.577 ' CB ' ' HA ' ' A' ' 17' ' ' TYR . 50.7 t0 -89.6 69.93 7.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.499 0.666 . . . . 2.1600000000000001 109.69 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.518 HG22 ' CH2' ' A' ' 24' ' ' TRP . 34.5 p -104.96 105.86 16.09 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.674 -0.694 . . . . 1.8200000000000001 110.812 -176.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.5 p -169.87 -88.18 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.558 -0.746 . . . . 2.1899999999999999 111.454 -173.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.496 ' O ' ' HG3' ' A' ' 38' ' ' LYS . . . -84.76 52.18 4.66 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 116.086 -0.507 . . . . 1.1000000000000001 113.418 -173.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.871 ' HZ3' ' HD3' ' A' ' 49' ' ' ARG . 0.2 OUTLIER -119.61 -160.05 0.8 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.572 -0.529 . . . . 1.6699999999999999 109.572 176.21 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.1 ttpp -176.09 110.65 0.1 Allowed 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 108.634 -0.876 . . . . 2.9500000000000002 108.634 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.737 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 0.9 OUTLIER -61.14 118.27 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 CA-C-O 121.818 0.818 . . . . 1.5600000000000001 110.303 175.084 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.2 m -98.49 -25.16 4.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 114.317 -1.31 . . . . 1.22 110.011 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.43 ' HB3' ' CG2' ' A' ' 35' ' ' VAL . 0.9 OUTLIER -154.67 135.39 13.58 Favored 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 119.472 -0.891 . . . . 2.4100000000000001 110.09 -178.007 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.502 HG22 ' HA ' ' A' ' 34' ' ' THR . 73.2 p -138.98 153.26 48.15 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.282 0.563 . . . . 1.3799999999999999 110.748 177.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.692 ' HB3' HG12 ' A' ' 33' ' ' ILE . 14.9 t -113.86 -164.4 0.93 Allowed 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.456 -1.313 . . . . 2.3700000000000001 107.456 173.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -93.8 19.31 8.99 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.999 0.428 . . . . 4.5499999999999998 109.912 -176.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.85 ' HE2' ' HA ' ' A' ' 32' ' ' LYS . 3.6 mmpt? -155.02 -17.98 0.11 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.119 -0.946 . . . . 1.4199999999999999 111.573 175.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.828 HG22 ' HA3' ' A' ' 52' ' ' GLY . 35.8 pt -131.35 170.82 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.902 0.382 . . . . 0.76000000000000001 111.907 -172.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.502 ' HA ' HG22 ' A' ' 29' ' ' THR . 23.1 m -160.81 123.12 3.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.325 -0.852 . . . . 0.57999999999999996 110.423 -167.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.578 HG13 HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -112.48 113.85 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.18 0.514 . . . . 0.85999999999999999 110.692 172.788 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.737 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.8 OUTLIER -102.6 125.61 49.39 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.627 -0.715 . . . . 1.1000000000000001 109.871 176.619 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 78.1 p -93.16 125.04 37.55 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 108.65 -0.87 . . . . 1.27 108.65 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.668 ' HA ' ' HA ' ' A' ' 24' ' ' TRP . 57.8 tttm -122.28 22.16 10.18 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.751 -0.659 . . . . 1.9099999999999999 110.963 -168.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.676 ' HA ' ' HA ' ' A' ' 46' ' ' ASN . . . 60.55 122.41 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 114.857 -1.065 . . . . 1.6799999999999999 113.219 175.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.426 ' H ' ' HA ' ' A' ' 46' ' ' ASN . 40.0 m -91.76 83.86 5.34 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.041 -0.726 . . . . 2.0899999999999999 109.041 174.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.48 ' H ' ' HD2' ' A' ' 41' ' ' ARG . 2.1 mpt_? -69.9 -3.73 17.27 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.922 -0.581 . . . . 6.6100000000000003 109.55 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -54.73 -27.25 39.43 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.974 -1.012 . . . . 6.46 110.603 172.541 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.476 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 17.5 t80 177.31 -79.0 0.0 OUTLIER 'General case' 0 C--N 1.344 0.368 0 N-CA-C 111.97 0.359 . . . . 5.6500000000000004 111.97 176.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.406 ' O ' ' CG ' ' A' ' 44' ' ' HIS . 32.4 p-80 -139.5 79.77 1.74 Allowed 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 119.861 -0.736 . . . . 5.5599999999999996 112.858 -170.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 162.87 -157.33 29.34 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 119.073 -1.537 . . . . 1.5600000000000001 112.547 168.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.676 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -120.17 136.71 54.53 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 120.972 0.415 . . . . 2.0499999999999998 109.998 179.229 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.856 HD11 ' HE2' ' A' ' 170' ' ' PHE . 6.1 tt -78.04 147.85 34.59 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.76 -1.2 . . . . 0.87 107.76 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.834 ' HB3' HD11 ' A' ' 192' ' ' LEU . 4.9 m-85 -129.81 124.61 33.75 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 119.493 -0.883 . . . . 0.98999999999999999 111.288 -172.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.871 ' HD3' ' HZ3' ' A' ' 24' ' ' TRP . 54.3 ttt-85 -120.54 109.56 15.41 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.356 -0.838 . . . . 2.9199999999999999 109.147 177.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.578 HG23 HG13 ' A' ' 35' ' ' VAL . 10.4 p -100.31 150.22 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 109.515 -0.55 . . . . 1.3300000000000001 109.515 -177.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.785 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 41.5 tt0 -156.03 109.6 2.73 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.856 -0.611 . . . . 1.0700000000000001 110.078 -172.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.828 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -140.45 159.58 26.3 Favored Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 111.427 -0.669 . . . . 0.28999999999999998 111.427 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 59.6 mt -99.88 124.24 53.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 C-N-CA 120.57 -0.452 . . . . 0.57999999999999996 110.753 178.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.636 HG12 ' HD2' ' A' ' 200' ' ' LYS . 85.7 mt -101.96 121.35 51.01 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 115.656 -0.702 . . . . 0.34999999999999998 109.926 175.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -64.89 61.41 0.29 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.981 3.121 . . . . 0.62 112.878 177.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.821 ' HG2' HG13 ' A' ' 203' ' ' ILE . 6.9 tp10 -155.4 173.6 16.44 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.051 -1.092 . . . . 1.6799999999999999 108.051 174.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.552 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 52.3 p -83.04 146.75 52.46 Favored Pre-proline 0 N--CA 1.425 -1.72 0 CA-C-O 121.838 0.828 . . . . 1.1799999999999999 109.836 175.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 57' ' ' SER . 27.6 Cg_exo -60.72 -11.05 15.92 Favored 'Trans proline' 0 C--N 1.329 -0.461 0 C-N-CA 124.16 3.24 . . . . 0.52000000000000002 111.478 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.36 -52.03 31.07 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.214 -0.903 . . . . 0.64000000000000001 110.811 174.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.75 ' HE3' ' HB3' ' A' ' 64' ' ' PHE . 18.4 tptt -69.12 -24.03 64.06 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.516 -0.92 . . . . 3.2999999999999998 108.516 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.746 ' HA ' ' CD1' ' A' ' 64' ' ' PHE . 46.5 mt -65.95 -58.71 4.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.642 -0.708 . . . . 0.40999999999999998 110.323 172.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.525 ' HB3' ' HB3' ' A' ' 125' ' ' ASN . 19.8 p -62.26 -11.23 13.84 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.83 -0.543 . . . . 1.29 110.56 176.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.476 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 25.2 t70 -90.9 -44.78 9.16 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.334 0.494 . . . . 1.3200000000000001 112.334 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.829 ' HD2' ' CZ2' ' A' ' 74' ' ' TRP . 10.3 p90 -71.79 -43.26 65.98 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 121.032 -0.267 . . . . 0.60999999999999999 110.721 -168.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.686 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -96.86 6.64 48.28 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.444 -0.503 . . . . 1.5 111.288 -174.59 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -42.18 -73.67 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.083 0.771 . . . . 1.52 113.083 -169.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -152.19 -63.24 0.17 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.17 0.509 . . . . 3.6000000000000001 112.27 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.93 ' HB ' ' CD2' ' A' ' 81' ' ' TYR . 9.1 t -145.08 21.43 1.58 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.995 0.902 . . . . 1.48 109.359 -174.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -88.82 -29.82 17.06 Favored Glycine 0 CA--C 1.491 -1.44 0 CA-C-N 114.84 -1.073 . . . . 1.46 113.87 -168.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.655 ' O ' HG22 ' A' ' 73' ' ' THR . 10.4 t0 -167.28 -35.71 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.365 -0.976 . . . . 2.1899999999999999 108.365 -166.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.766 ' HA ' ' CZ2' ' A' ' 74' ' ' TRP . 1.0 OUTLIER -47.83 -48.24 30.92 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 114.577 -1.192 . . . . 3.3799999999999999 111.582 -172.245 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.887 HG22 HD13 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -87.35 -7.02 10.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 119.743 -0.783 . . . . 0.70999999999999996 111.244 -172.675 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.655 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.4 t -90.65 -30.79 16.93 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 119.76 -0.776 . . . . 0.96999999999999997 110.013 -177.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 1.002 ' HZ3' ' HB3' ' A' ' 198' ' ' ASN . 7.1 p-90 -102.54 -7.6 21.72 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 120.509 -0.476 . . . . 0.75 111.822 178.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.865 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 4.5 t70 -76.57 168.29 20.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.549 0.69 . . . . 2.1899999999999999 111.702 -170.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.681 ' HD2' ' OD1' ' A' ' 194' ' ' ASN . 0.0 OUTLIER -118.51 -16.74 9.48 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.849 -1.069 . . . . 3.1899999999999999 111.286 -177.873 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.4 m -113.83 7.94 17.2 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.911 -0.774 . . . . 1.5800000000000001 108.911 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.887 HD13 HG22 ' A' ' 72' ' ' ILE . 29.8 mt -109.89 167.31 10.26 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.059 -0.973 . . . . 0.70999999999999996 111.283 -178.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.612 ' HG2' ' HG2' ' A' ' 99' ' ' GLN . 6.6 mm100 -146.58 -71.25 0.24 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.393 -0.821 . . . . 1.73 110.686 -175.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.554 HG23 ' HB3' ' A' ' 79' ' ' GLN . 18.8 t -138.55 124.57 24.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.059 -0.973 . . . . 0.78000000000000003 110.112 -170.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.93 ' CD2' ' HB ' ' A' ' 68' ' ' THR . 69.6 t80 -106.68 139.32 41.31 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.491 -0.483 . . . . 5.4000000000000004 110.395 174.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.576 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 17.5 m120 -130.31 104.63 7.39 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.039 -0.726 . . . . 1.6899999999999999 109.039 177.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.534 ' HE1' ' HG2' ' A' ' 86' ' ' ARG . 7.1 tpt -67.77 101.43 1.06 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.148 -0.933 . . . . 2.0499999999999998 109.583 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.553 HG23 ' HB ' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -81.59 -83.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 120.481 -0.487 . . . . 0.64000000000000001 111.551 -171.378 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.519 ' HB2' HD12 ' A' ' 93' ' ' ILE . 49.3 m170 -118.35 127.16 53.43 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.001 0.429 . . . . 1.96 109.887 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.534 ' HG2' ' HE1' ' A' ' 83' ' ' MET . 25.5 mtm180 -108.58 120.9 43.8 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.763 -0.829 . . . . 2.4399999999999999 108.763 176.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.603 HG12 ' O ' ' A' ' 91' ' ' THR . 0.8 OUTLIER -80.94 -55.3 8.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.424 -0.807 . . . . 0.46999999999999997 112.022 -163.427 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -127.66 -83.28 0.6 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.933 -0.576 . . . . 1.8600000000000001 111.085 -173.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.5 t -148.17 -31.35 0.28 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.243 0.544 . . . . 1.4399999999999999 110.08 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -128.11 19.61 6.45 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.4 -0.818 . . . . 1.8700000000000001 109.511 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.603 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -126.18 111.69 14.91 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.083 -1.08 . . . . 0.46000000000000002 108.083 -176.802 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.615 ' O ' HD12 ' A' ' 114' ' ' LEU . 56.1 m-85 -122.88 171.5 9.16 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.799 -0.637 . . . . 0.42999999999999999 110.566 -173.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.553 ' HB ' HG23 ' A' ' 84' ' ' VAL . 23.8 mt -131.12 130.59 63.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 107.678 -1.23 . . . . 0.40999999999999998 107.678 165.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.697 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 26.5 p -101.74 128.72 47.94 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.582 -0.447 . . . . 2.0099999999999998 111.353 -174.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.663 ' HA ' HD13 ' A' ' 112' ' ' ILE . 2.8 t60 -104.3 86.54 2.55 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.269 -1.011 . . . . 1.23 108.269 165.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.691 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 18.5 m -110.47 117.1 32.66 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.415 -0.811 . . . . 0.5 112.2 -168.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 42.0 mm -78.55 125.76 38.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 120.169 -0.612 . . . . 1.03 109.493 173.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.7 m -107.26 146.9 30.89 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.111 -0.949 . . . . 1.3799999999999999 110.705 -173.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.612 ' HG2' ' HG2' ' A' ' 79' ' ' GLN . 6.6 mm-40 -82.16 177.55 8.74 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.942 -0.572 . . . . 1.8200000000000001 110.685 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 41.0 t -110.08 117.45 33.77 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.588 -0.733 . . . . 3.9100000000000001 110.81 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.423 ' O ' HD12 ' A' ' 106' ' ' ILE . 84.5 t80 -115.76 135.8 53.67 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 106.832 -1.544 . . . . 5.1600000000000001 106.832 167.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.455 ' HB3' HD12 ' A' ' 106' ' ' ILE . . . 71.16 63.85 0.16 Allowed 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.41 -0.959 . . . . 1.98 108.41 -170.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.43 32.14 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 114.778 -1.101 . . . . 3.1699999999999999 110.749 -173.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 102' ' ' ALA . . . -95.86 -5.63 59.71 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.7 -0.96 . . . . 1.96 110.7 173.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.635 ' HB3' ' HA ' ' A' ' 179' ' ' LEU . 64.8 m -155.32 -38.05 0.09 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.083 -0.558 . . . . 1.8799999999999999 110.42 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 94.7 mt -80.1 126.49 39.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.569 -0.742 . . . . 1.1200000000000001 112.139 -170.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.416 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 15.9 m -100.84 169.72 7.49 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.369 -0.832 . . . . 1.3500000000000001 109.434 174.047 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 107' ' ' SER . 65.5 Cg_exo -51.69 123.8 13.07 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.204 1.936 . . . . 1.0700000000000001 110.74 171.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.681 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 39.6 ttm105 -114.82 149.22 37.38 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.382 -0.527 . . . . 3.4500000000000002 110.267 -168.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.644 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 36.7 t0 -109.6 117.46 34.0 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.876 -0.416 . . . . 1.3700000000000001 109.876 -174.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.691 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 9.2 m-30 -98.3 112.32 24.35 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.83 0.348 . . . . 2.4100000000000001 110.877 -175.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.697 ' HA ' ' O ' ' A' ' 94' ' ' CYS . 15.2 mm -115.02 79.81 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 CA-C-N 115.509 -0.769 . . . . 0.42999999999999999 109.317 172.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.588 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 45.6 m-20 -110.25 127.45 54.99 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.676 -0.693 . . . . 1.8600000000000001 109.896 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.635 HD11 ' HB3' ' A' ' 3' ' ' PHE . 4.0 tp -76.82 125.91 30.08 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 109.211 -0.663 . . . . 0.28000000000000003 109.211 173.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -123.92 125.64 71.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 115.233 -0.894 . . . . 0.26000000000000001 112.321 -164.903 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.612 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 85.1 t80 -112.23 115.13 28.3 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.352 -0.84 . . . . 2.5699999999999998 110.812 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.656 HG12 HG22 ' A' ' 127' ' ' ILE . 78.1 mt -91.27 99.29 9.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.974 -0.557 . . . . 0.89000000000000001 109.668 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.558 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 2.6 tppp? -97.55 130.86 44.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.293 -0.867 . . . . 1.2 109.353 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.551 ' NH1' ' HA ' ' A' ' 121' ' ' GLU . 4.3 tmt_? -111.95 91.86 3.81 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 107.847 -1.168 . . . . 2.7999999999999998 107.847 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.412 ' CE1' ' HG2' ' A' ' 118' ' ' LYS . 60.9 m-85 -64.68 115.24 5.05 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 107.813 -1.181 . . . . 0.82999999999999996 107.813 173.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.551 ' HA ' ' NH1' ' A' ' 119' ' ' ARG . 7.4 mm-40 -27.91 90.35 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 O-C-N 125.312 1.632 . . . . 2.2799999999999998 113.398 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 52.62 41.67 57.21 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 115.271 -0.877 . . . . 0.76000000000000001 112.81 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.541 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 64.9 t30 -141.04 -39.0 0.41 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.395 0.146 . . . . 1.6499999999999999 111.395 -175.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.489 ' CG ' ' HB ' ' A' ' 154' ' ' VAL . 3.4 tpp -157.13 118.32 3.67 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.312 -0.555 . . . . 1.1200000000000001 111.22 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.525 ' HB3' ' HB3' ' A' ' 62' ' ' SER . 4.8 m-20 -101.08 73.67 1.54 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.509 -0.923 . . . . 1.6200000000000001 108.509 175.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.799 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -92.34 138.48 19.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.189 -0.914 . . . . 0.29999999999999999 112.667 -172.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.746 HG13 ' O ' ' A' ' 127' ' ' ILE . 1.1 pt -105.59 116.32 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 108.51 -0.922 . . . . 0.58999999999999997 108.51 162.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 4.1 m -81.26 163.46 22.96 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.266 -0.642 . . . . 1.1799999999999999 109.266 173.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.588 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 12.7 p -156.88 131.48 8.74 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.052 0.453 . . . . 1.24 110.968 176.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.53 ' HD3' HD23 ' A' ' 114' ' ' LEU . 20.0 mtpp -131.09 120.78 23.88 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 107.754 -1.202 . . . . 2.2599999999999998 107.754 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.427 ' HB3' ' H ' ' A' ' 148' ' ' ASN . 4.0 p -63.48 98.31 0.16 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.47 -0.937 . . . . 1.3899999999999999 108.47 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.02 138.37 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-N 114.526 -1.215 . . . . 1.05 109.678 -165.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -100.81 74.79 1.66 Allowed 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 122.42 1.105 . . . . 2.1699999999999999 110.306 -170.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.687 ' O ' ' HB3' ' A' ' 137' ' ' TYR . 3.8 p90 -106.37 175.93 1.88 Allowed Pre-proline 0 CA--C 1.554 1.127 0 CA-C-N 114.124 -1.398 . . . . 0.53000000000000003 109.302 -174.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.617 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 25.0 Cg_exo -27.35 -67.27 0.05 OUTLIER 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 125.13 3.887 . . . . 1.28 117.308 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.656 ' HB3' ' CZ ' ' A' ' 134' ' ' PHE . 5.8 tp10 -68.63 -26.34 65.3 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.613 0.597 . . . . 3.5 112.613 -173.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.687 ' HB3' ' O ' ' A' ' 134' ' ' PHE . 0.5 OUTLIER -39.77 -55.23 3.72 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 115.331 1.604 . . . . 6.1200000000000001 115.331 -171.87 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.457 ' HD2' ' O ' ' A' ' 135' ' ' PRO . 44.3 Cg_exo -35.72 106.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.366 1.495 0 C-N-CA 123.432 2.755 . . . . 1.77 114.408 -171.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.542 ' HB2' ' O ' ' A' ' 143' ' ' TYR . 72.9 Cg_endo -88.01 -147.54 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.274 2.65 . . . . 1.25 113.104 -174.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.1 m -143.26 -171.98 3.6 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.785 -0.82 . . . . 1.6000000000000001 108.785 -174.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.2 m -74.98 -38.45 61.66 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.0 -0.68 . . . . 1.97 111.247 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -77.39 -56.63 4.38 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.563 -0.532 . . . . 2.1800000000000002 109.563 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.58 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 87.9 m-85 -79.41 109.49 13.82 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 115.715 -0.675 . . . . 1.23 110.16 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.681 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 1.9 tp -104.42 117.89 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 CA-C-N 115.199 -0.91 . . . . 0.81999999999999995 109.495 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.644 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 0.1 OUTLIER -46.64 116.35 1.29 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.237 -0.892 . . . . 4.4199999999999999 110.775 175.204 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -55.22 108.22 0.94 Allowed Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 114.971 -1.013 . . . . 0.79000000000000004 111.793 176.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 1.116 ' HB3' ' HB3' ' A' ' 174' ' ' GLU . 0.2 OUTLIER -83.43 79.95 9.25 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.496 0.665 . . . . 4.4400000000000004 109.878 177.174 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.682 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 84.8 m-20 -103.2 102.32 12.3 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.262 -1.336 . . . . 1.6200000000000001 108.427 175.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -81.2 143.09 51.88 Favored Pre-proline 0 C--N 1.32 -0.685 0 C-N-CA 120.448 -0.501 . . . . 2.3199999999999998 111.001 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.657 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 8.6 Cg_exo -10.07 59.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.411 1 C-N-CA 127.18 5.253 . . . . 0.53000000000000003 116.355 -163.327 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 151' ' ' CYS . . . . . 0.759 ' HA ' ' CE1' ' A' ' 170' ' ' PHE . 7.8 p -85.58 -179.11 6.83 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.815 -1.084 . . . . 1.5800000000000001 110.513 176.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.706 ' HA3' HG11 ' A' ' 14' ' ' VAL . . . -169.63 -168.09 31.09 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.393 -0.908 . . . . 0.42999999999999999 111.677 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.562 ' CE1' HD11 ' A' ' 167' ' ' LEU . 60.8 t80 -160.18 80.8 0.69 Allowed 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.915 -1.143 . . . . 0.59999999999999998 107.915 -165.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.799 HG12 ' HB ' ' A' ' 126' ' ' ILE . 7.1 m -89.53 124.52 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 121.829 0.823 . . . . 0.31 110.468 -173.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 56.6 m -106.08 113.31 26.78 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.523 -0.762 . . . . 1.55 109.165 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.737 ' HB3' ' HB3' ' A' ' 166' ' ' LYS . 15.5 t -106.07 121.72 44.69 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 116.203 -0.453 . . . . 1.0600000000000001 111.535 -169.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.541 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 69.0 Cg_exo -51.7 114.99 1.83 Allowed 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.726 2.284 . . . . 0.56000000000000005 111.26 169.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.668 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 0.2 OUTLIER -76.32 -167.97 0.88 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.266 0.555 . . . . 1.1599999999999999 112.172 -177.03 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -67.51 -38.08 83.76 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.484 -0.932 . . . . 2.6299999999999999 108.484 169.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.592 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 10.8 mm-40 -97.6 29.06 3.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.099 -1.409 . . . . 2.0499999999999998 108.89 175.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.434 ' CG ' ' HD3' ' A' ' 162' ' ' PRO . 1.2 p-10 -23.84 -58.05 0.13 Allowed Pre-proline 0 N--CA 1.473 0.724 0 N-CA-C 116.515 2.043 . . . . 1.9299999999999999 116.515 -169.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.434 ' HD3' ' CG ' ' A' ' 161' ' ' ASN . 63.1 Cg_endo -72.7 -19.51 24.09 Favored 'Trans proline' 0 C--N 1.35 0.621 0 CA-C-N 121.448 1.553 . . . . 0.72999999999999998 113.451 -175.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -105.73 -25.27 12.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.743 0.306 . . . . 0.68000000000000005 111.415 -177.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.668 ' O ' ' HB2' ' A' ' 158' ' ' MET . 52.9 m-85 -141.05 131.3 24.96 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.858 -0.793 . . . . 0.93000000000000005 108.858 177.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.477 ' OG ' HD11 ' A' ' 61' ' ' LEU . 3.6 p -126.99 148.75 50.09 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.046 0.451 . . . . 1.4099999999999999 111.468 -177.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.785 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.8 tppp? -91.67 104.43 16.9 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.824 0.821 . . . . 0.73999999999999999 111.242 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.562 HD11 ' CE1' ' A' ' 153' ' ' PHE . 0.6 OUTLIER -89.4 106.41 18.43 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.481 -1.236 . . . . 0.27000000000000002 109.762 176.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.724 HG13 HG23 ' A' ' 154' ' ' VAL . 0.1 OUTLIER -131.05 129.12 63.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.644 0.735 . . . . 0.28000000000000003 111.911 176.394 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.606 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 18.2 ttt -137.8 131.7 31.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.228 -0.896 . . . . 1.24 110.17 -172.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.96 ' HD1' HG23 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -111.2 145.15 39.2 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.088 -0.645 . . . . 3.3700000000000001 110.002 174.202 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.65 116.5 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-O 121.415 0.626 . . . . 1.3999999999999999 110.895 176.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.528 ' HB2' ' CZ ' ' A' ' 170' ' ' PHE . 0.0 OUTLIER -94.98 77.28 3.56 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 106.673 -1.603 . . . . 2.1699999999999999 106.673 168.109 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.422 HG21 ' CE ' ' A' ' 188' ' ' MET . 0.6 OUTLIER -74.65 128.31 35.25 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.317 -0.856 . . . . 1.6499999999999999 110.89 -176.827 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 1.116 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 38.4 tp10 -83.1 -13.74 55.07 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.261 0.553 . . . . 2.4500000000000002 110.524 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 52.3 mtt 65.4 45.11 2.93 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.317 -0.856 . . . . 3.7400000000000002 109.148 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.069 ' HD2' ' H ' ' A' ' 147' ' ' TYR . 0.0 OUTLIER -28.81 -54.75 0.12 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 113.462 -1.699 . . . . 5.7800000000000002 114.095 179.478 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.446 ' H ' ' HG2' ' A' ' 176' ' ' ARG . . . 170.39 170.61 34.91 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.507 -0.854 . . . . 2.2599999999999998 111.849 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 106' ' ' ILE . 48.8 mmtm 68.76 48.72 0.75 Allowed 'General case' 0 C--N 1.33 -0.255 0 O-C-N 124.133 0.549 . . . . 6.2300000000000004 110.727 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.711 HD13 HD11 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -173.78 146.15 1.23 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.14 -0.482 . . . . 1.6399999999999999 110.936 173.637 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.54 ' HB3' ' HD2' ' A' ' 181' ' ' PRO . 31.5 m -112.05 166.28 11.23 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.451 -0.795 . . . . 2.04 109.45 -176.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' A' ' 180' ' ' SER . 63.1 Cg_exo -39.33 -57.57 1.0 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.354 2.703 . . . . 1.74 114.266 -175.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.492 ' O ' ' HG3' ' A' ' 186' ' ' LYS . 19.1 m -74.07 -10.4 59.59 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.868 0.366 . . . . 2.1400000000000001 111.669 -176.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.569 HG21 ' HB2' ' A' ' 105' ' ' SER . 17.6 mm -86.48 -42.08 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 CA-C-O 122.356 1.074 . . . . 1.1200000000000001 108.418 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.97 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.0 OUTLIER -57.98 -37.7 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 CA-C-N 113.302 -1.772 . . . . 1.1299999999999999 109.674 172.17 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -61.86 -22.39 65.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.633 -1.167 . . . . 2.8900000000000001 110.056 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.506 ' HE3' ' HA ' ' A' ' 183' ' ' ILE . 48.1 mttt -91.51 -49.0 6.55 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.179 -0.674 . . . . 1.28 109.179 173.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.97 HG22 ' HA ' ' A' ' 184' ' ' ILE . 11.1 t -62.93 -33.54 75.56 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.378 0.881 . . . . 0.62 113.378 -165.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' MET . . . . . 0.643 ' HE3' HG23 ' A' ' 187' ' ' THR . 0.0 OUTLIER -71.72 -65.9 0.79 Allowed Pre-proline 0 N--CA 1.469 0.504 0 CA-C-N 118.888 0.767 . . . . 1.0600000000000001 111.674 179.613 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.711 ' O ' HG13 ' A' ' 193' ' ' VAL . 27.5 Cg_endo -62.39 -41.79 31.52 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.486 1.457 . . . . 0.91000000000000003 111.471 -176.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.71 ' O ' ' HB3' ' A' ' 194' ' ' ASN . 68.3 m -68.43 -22.82 64.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.364 -0.38 . . . . 1.5 111.377 -174.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 187' ' ' THR . 53.9 m-20 -90.21 -37.7 13.96 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.806 -0.358 . . . . 1.8799999999999999 111.474 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.834 HD11 ' HB3' ' A' ' 48' ' ' TYR . 19.2 mt -60.8 -49.72 76.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.824 0.345 . . . . 1.0900000000000001 111.039 176.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.711 HG13 ' O ' ' A' ' 189' ' ' PRO . 3.0 m -65.4 -31.6 54.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.63 0.729 . . . . 0.68000000000000005 110.029 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.737 ' HA ' ' HG ' ' A' ' 197' ' ' LEU . 0.0 OUTLIER -73.19 -43.62 61.08 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.674 -1.148 . . . . 2.0699999999999998 111.397 -177.747 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -62.36 -26.17 68.31 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.415 -0.957 . . . . 2.0 108.415 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.623 HG21 HG21 ' A' ' 33' ' ' ILE . 20.7 mt -78.37 -44.58 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-N 115.177 -0.919 . . . . 0.31 113.25 175.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.792 HD12 ' N ' ' A' ' 198' ' ' ASN . 3.0 pp -74.1 -31.83 62.97 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 119.336 -0.946 . . . . 1.03 110.332 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 1.002 ' HB3' ' HZ3' ' A' ' 74' ' ' TRP . 9.9 m120 -61.82 -24.58 66.97 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.118 0.485 . . . . 1.8999999999999999 110.017 165.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.832 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -80.77 -29.98 36.11 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 108.713 -0.847 . . . . 0.28999999999999998 108.713 177.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.636 ' HD2' HG12 ' A' ' 54' ' ' ILE . 2.9 mptm? -67.02 -46.17 75.3 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.202 -0.908 . . . . 0.96999999999999997 108.685 175.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.55 -24.8 25.34 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.832 -1.076 . . . . 1.9399999999999999 110.797 -170.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 205' ' ' ALA . . . -78.2 -28.17 56.53 Favored Glycine 0 N--CA 1.46 0.245 0 C-N-CA 120.492 -0.861 . . . . 0.46999999999999997 111.477 174.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.832 ' HB ' ' O ' ' A' ' 199' ' ' ALA . 0.9 OUTLIER -76.95 -35.22 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 123.326 0.65 . . . . 0.60999999999999999 110.214 173.853 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 40.2 mttm -78.17 -21.66 49.88 Favored 'General case' 0 C--O 1.216 -0.698 0 N-CA-C 108.91 -0.774 . . . . 3.3700000000000001 108.91 175.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 202' ' ' GLY . . . -64.46 -20.05 65.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.549 -0.751 . . . . 1.02 109.1 170.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -93.34 -51.19 5.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.254 -0.885 . . . . 3.6299999999999999 111.303 170.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -76.79 -41.31 45.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.416 0.627 . . . . 2.5899999999999999 111.63 -170.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 32.8 m -97.27 142.95 25.31 Favored Pre-proline 0 C--N 1.313 -0.986 0 CA-C-N 115.065 -0.97 . . . . 1.8400000000000001 110.231 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.3 39.39 0.47 Allowed 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.677 2.252 . . . . 2.3500000000000001 113.327 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 11.7 p -90.03 -3.49 57.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.266 0.555 . . . . 2.3100000000000001 110.601 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 10.6 tpp180 -68.19 -11.98 60.17 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.651 -0.704 . . . . 5.4500000000000002 110.376 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 212' ' ' ARG . 49.1 mtm180 -67.89 -22.87 65.07 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.117 0.484 . . . . 6.8600000000000003 110.611 177.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -100.35 63.97 0.6 Allowed Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 110.314 -1.114 . . . . 3.3700000000000001 110.314 171.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -70.38 98.42 1.41 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.128 0.489 . . . . 5.21 111.252 -172.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -171.22 -55.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.341 -0.845 . . . . 6.46 108.885 174.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 71.46 -62.2 0.46 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.735 0.814 . . . . 6.0899999999999999 113.155 172.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -77.46 85.0 3.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.328 0.585 . . . . 5.1200000000000001 109.879 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 12.1 m -55.49 -37.7 68.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.518 -0.765 . . . . 6.7599999999999998 111.12 -176.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 71.4 t60 48.55 64.85 1.52 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.601 0.715 . . . . 8.8200000000000003 110.381 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 14.0 m . . . . . 0 C--N 1.316 -0.864 0 CA-C-N 115.624 -0.716 . . . . 8.4800000000000004 109.617 179.419 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.9 ttt . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 109.293 -0.632 . . . . 3.8599999999999999 109.293 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -65.06 -50.67 65.29 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 116.108 -0.497 . . . . 2.25 110.94 -169.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.56 ' HB2' HG21 ' A' ' 87' ' ' ILE . 65.2 m-85 -59.38 -35.0 73.1 Favored 'General case' 0 CA--C 1.502 -0.882 0 O-C-N 123.945 0.778 . . . . 0.42999999999999999 110.497 -169.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.755 ' O ' ' HB3' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -74.82 -41.25 60.27 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-N 115.273 -0.876 . . . . 1.51 108.736 -177.4 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.413 ' HA ' ' OE1' ' A' ' 8' ' ' GLN . . . -55.98 -45.99 78.8 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.829 -0.623 . . . . 0.54000000000000004 112.31 -178.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.64 ' O ' ' HB ' ' A' ' 10' ' ' THR . 0.2 OUTLIER -79.44 -36.37 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 N-CA-C 108.906 -0.776 . . . . 1.0700000000000001 108.906 -172.453 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.794 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -71.79 -47.74 51.33 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.517 -1.22 . . . . 0.34000000000000002 111.474 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.755 ' HB3' ' O ' ' A' ' 4' ' ' LYS . 3.7 pt20 -53.3 -34.3 56.79 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.344 -1.298 . . . . 1.5900000000000001 109.847 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.645 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 48.5 mt-30 -91.02 -31.63 16.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.879 -1.055 . . . . 2.4700000000000002 109.985 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.64 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -66.42 -35.0 79.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.633 -0.712 . . . . 0.47999999999999998 110.746 178.271 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.573 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -47.44 -58.51 4.1 Favored 'General case' 0 C--O 1.226 -0.154 0 N-CA-C 112.02 0.378 . . . . 0.31 112.02 175.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.463 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 20.8 pt20 -74.96 -6.72 50.81 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.493 -0.322 . . . . 1.6399999999999999 111.344 -178.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.645 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 16.6 mm-40 -81.43 -48.35 12.01 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 121.163 0.506 . . . . 2.54 109.707 175.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.733 HG21 ' N ' ' A' ' 152' ' ' GLY . 10.9 p -70.74 -37.77 70.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.798 0.809 . . . . 0.53000000000000003 109.735 176.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.463 ' HB3' ' HA ' ' A' ' 12' ' ' GLN . 0.8 OUTLIER -67.24 -25.62 66.18 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 122.236 1.017 . . . . 0.59999999999999998 108.338 173.068 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.5 ' HA2' ' CD ' ' A' ' 19' ' ' ARG . . . -67.86 -15.01 66.34 Favored Glycine 0 CA--C 1.5 -0.869 0 CA-C-N 113.679 -1.6 . . . . 0.56999999999999995 110.539 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.8 m-30 -92.42 -19.48 22.01 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.019 -0.591 . . . . 3.27 109.489 177.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -89.88 -27.55 19.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.152 -0.476 . . . . 2.0299999999999998 110.531 178.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.5 ' CD ' ' HA2' ' A' ' 16' ' ' GLY . 5.7 ptm180 -90.8 -20.25 22.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.254 0.55 . . . . 2.7200000000000002 110.178 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -121.44 117.33 26.62 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.927 -0.768 . . . . 2.1600000000000001 108.927 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.6 p -126.47 103.76 7.78 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.388 0.614 . . . . 1.8200000000000001 111.407 -174.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.0 p -170.47 155.49 5.09 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.053 -0.976 . . . . 2.1899999999999999 109.993 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.37 4.1 86.34 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.85 -0.69 . . . . 1.1000000000000001 113.057 174.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.481 ' HA ' ' HB3' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -120.3 -158.07 0.73 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.815 0.341 . . . . 1.6699999999999999 110.933 -178.655 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -172.3 125.36 0.52 Allowed 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 115.883 -0.599 . . . . 2.9500000000000002 109.821 -173.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.685 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 2.5 p -69.28 112.06 3.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-O 122.29 1.043 . . . . 1.5600000000000001 109.836 175.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.5 p -91.01 -23.5 5.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 113.812 -1.54 . . . . 1.22 109.138 -176.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.439 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -156.64 124.15 5.41 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 120.223 -0.591 . . . . 2.4100000000000001 111.768 -173.621 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.537 ' HB ' ' HA ' ' A' ' 34' ' ' THR . 0.4 OUTLIER -150.51 150.99 32.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.074 0.464 . . . . 1.3799999999999999 111.062 -179.597 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.7 t -120.21 -141.09 0.34 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.503 -0.771 . . . . 2.3700000000000001 109.322 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -101.55 17.7 22.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.984 0.421 . . . . 4.5499999999999998 110.787 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.697 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 48.3 mmtt -154.46 -29.23 0.12 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.904 -0.589 . . . . 1.4199999999999999 111.671 177.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.556 ' HA ' ' O ' ' A' ' 51' ' ' GLU . 17.8 pt -116.01 163.12 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 CA-C-O 120.767 0.317 . . . . 0.76000000000000001 111.493 -172.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.537 ' HA ' ' HB ' ' A' ' 29' ' ' THR . 8.8 m -156.42 114.09 3.24 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.108 -0.951 . . . . 0.57999999999999996 110.515 -172.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 49' ' ' ARG . 42.5 t -105.4 110.85 32.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.518 -0.31 . . . . 0.85999999999999999 110.554 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.685 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 4.1 m -109.6 123.5 49.55 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.636 0.732 . . . . 1.1000000000000001 111.092 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 28.2 p -108.2 131.11 55.0 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.32 -1.309 . . . . 1.27 112.781 -171.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.481 ' HB3' ' HA ' ' A' ' 24' ' ' TRP . 44.3 pttt -138.17 134.75 34.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.128 -0.942 . . . . 1.9099999999999999 110.176 171.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 46' ' ' ASN . . . -58.99 128.13 35.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.987 -0.551 . . . . 1.6799999999999999 112.081 -174.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.4 m -84.02 155.56 22.68 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.007 -0.542 . . . . 2.0899999999999999 109.877 176.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -89.64 13.31 14.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.304 -0.407 . . . . 6.6100000000000003 111.483 -174.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 5.1 mtpm? -54.56 -39.74 68.05 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.363 -0.38 . . . . 6.46 110.224 175.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.519 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 83.0 t80 157.92 -73.11 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 O-C-N 124.397 1.061 . . . . 5.6500000000000004 109.468 -173.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 33.8 t60 -145.25 84.43 1.7 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.374 -0.83 . . . . 5.5599999999999996 109.122 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.2 148.17 12.34 Favored Glycine 0 N--CA 1.435 -1.395 0 N-CA-C 109.148 -1.581 . . . . 1.5600000000000001 109.148 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 40.7 m-80 -114.31 144.31 43.45 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 117.362 0.581 . . . . 2.0499999999999998 110.611 -175.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.612 HD12 ' NE2' ' A' ' 172' ' ' GLN . 4.0 tt -90.19 134.26 34.39 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.325 -0.991 . . . . 0.87 108.325 175.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.61 ' N ' HD23 ' A' ' 47' ' ' LEU . 69.1 m-85 -121.58 120.38 34.64 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.836 -0.431 . . . . 0.98999999999999999 109.836 -177.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.539 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.3 OUTLIER -101.51 117.66 35.38 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.162 -0.681 . . . . 2.9199999999999999 109.162 174.538 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.596 HG22 HD12 ' A' ' 196' ' ' ILE . 14.7 p -107.17 131.89 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 108.798 -0.816 . . . . 1.3300000000000001 108.798 177.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.556 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 34.0 tt0 -136.06 117.92 15.18 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.644 -0.707 . . . . 1.0700000000000001 110.783 -169.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.697 ' HA2' ' O ' ' A' ' 32' ' ' LYS . . . -142.24 144.38 14.07 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.872 -0.68 . . . . 0.28999999999999998 111.675 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 92.4 mt -84.85 122.87 38.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 119.635 -0.826 . . . . 0.57999999999999996 110.479 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.429 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 42.0 mt -105.11 110.69 64.79 Favored Pre-proline 0 N--CA 1.443 -0.816 0 N-CA-C 108.69 -0.856 . . . . 0.34999999999999998 108.69 174.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 164' ' ' TYR . 39.5 Cg_exo -63.11 54.89 0.15 Allowed 'Trans proline' 0 N--CA 1.476 0.491 0 C-N-CA 124.442 3.428 . . . . 0.62 113.915 -177.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.591 ' OE1' ' HD2' ' A' ' 207' ' ' ARG . 10.9 tp10 -151.16 168.38 24.85 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.657 -1.238 . . . . 1.6799999999999999 107.657 174.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.445 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 73.3 p -69.74 144.48 93.68 Favored Pre-proline 0 N--CA 1.43 -1.433 0 CA-C-O 121.88 0.848 . . . . 1.1799999999999999 111.117 -176.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.495 ' HA ' HD12 ' A' ' 61' ' ' LEU . 23.9 Cg_exo -61.31 -15.79 42.7 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.432 2.755 . . . . 0.52000000000000002 110.125 175.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.4 -47.84 58.97 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.559 -1.201 . . . . 0.64000000000000001 110.862 173.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.438 ' HG2' HG13 ' A' ' 203' ' ' ILE . 2.1 tpmt? -67.19 -30.08 69.93 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.049 -1.093 . . . . 3.2999999999999998 108.049 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.842 HD23 HD13 ' A' ' 203' ' ' ILE . 55.8 mt -62.36 -54.92 33.4 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.867 -1.061 . . . . 0.40999999999999998 110.205 174.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.6 p -62.96 -9.18 8.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.071 0.462 . . . . 1.29 110.717 176.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -91.35 -33.36 15.32 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.566 0.58 . . . . 1.3200000000000001 112.566 174.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.666 ' CE2' ' HA ' ' A' ' 199' ' ' ALA . 2.9 p90 -78.31 -45.05 23.65 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 120.399 -0.52 . . . . 0.60999999999999999 110.69 -169.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -83.51 -7.3 59.56 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 121.056 -0.258 . . . . 1.5 111.041 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -9.95 -72.69 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 O-C-N 125.571 1.794 . . . . 1.52 114.679 -159.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -158.52 -62.4 0.08 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.713 1.005 . . . . 3.6000000000000001 113.713 -172.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.678 ' OG1' ' HB2' ' A' ' 81' ' ' TYR . 11.6 t -178.35 27.96 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.352 0.596 . . . . 1.48 109.543 -162.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -127.95 -16.91 2.12 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 119.249 -1.453 . . . . 1.46 113.138 -171.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.538 ' O ' HG22 ' A' ' 73' ' ' THR . 1.7 p30 -159.34 -21.6 0.07 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 111.896 0.332 . . . . 2.1899999999999999 111.896 -177.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.704 ' HA ' ' NE1' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -67.47 -16.44 64.21 Favored 'General case' 0 C--O 1.217 -0.62 0 O-C-N 122.069 -0.394 . . . . 3.3799999999999999 110.982 -174.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.665 HD13 ' H ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -90.48 -20.25 6.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.234 0.54 . . . . 0.70999999999999996 109.937 173.521 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.538 HG22 ' O ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -82.2 -24.47 34.91 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.603 -0.726 . . . . 0.96999999999999997 110.363 -170.667 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.704 ' NE1' ' HA ' ' A' ' 71' ' ' ARG . 24.9 p-90 -108.47 -4.35 17.37 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.276 -0.569 . . . . 0.75 111.205 177.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.658 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 2.9 t70 -74.92 177.68 6.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.815 0.817 . . . . 2.1899999999999999 112.659 -168.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.422 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -123.07 -22.81 5.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.473 -1.24 . . . . 3.1899999999999999 111.007 -179.217 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.1 t -121.69 9.36 10.14 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.47 -0.567 . . . . 1.5800000000000001 109.47 -176.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.607 HD13 HG22 ' A' ' 72' ' ' ILE . 36.4 mt -109.1 169.5 8.64 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.649 -0.705 . . . . 0.70999999999999996 110.476 177.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.611 ' HG2' ' HG2' ' A' ' 99' ' ' GLN . 10.5 mm100 -147.41 -58.78 0.26 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.75 -0.659 . . . . 1.73 111.674 -173.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.636 ' O ' ' HA ' ' A' ' 96' ' ' THR . 25.6 t -138.15 117.9 15.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.78000000000000003 111.254 -166.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.678 ' HB2' ' OG1' ' A' ' 68' ' ' THR . 45.3 p90 -89.99 151.32 21.74 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 116.194 -0.457 . . . . 5.4000000000000004 110.852 174.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.446 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 4.2 m120 -158.95 108.94 1.98 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.603 -0.726 . . . . 1.6899999999999999 109.52 173.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.805 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 13.5 ttm -71.1 103.99 2.9 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.604 -0.887 . . . . 2.0499999999999998 108.604 177.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -84.78 -71.96 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 120.47 -0.492 . . . . 0.64000000000000001 112.029 -170.771 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.418 ' HB3' HD12 ' A' ' 93' ' ' ILE . 21.1 t60 -136.37 107.61 6.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.205 -0.452 . . . . 1.96 109.833 -175.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.805 ' HD3' ' SD ' ' A' ' 83' ' ' MET . 28.3 mtm180 -93.72 112.41 24.28 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.588 -0.523 . . . . 2.4399999999999999 109.588 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.632 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -75.69 -37.08 35.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.917 -0.583 . . . . 0.46999999999999997 109.614 -178.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -157.69 -179.32 8.05 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.236 -0.893 . . . . 1.8600000000000001 108.856 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.8 m -78.28 4.41 12.89 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.638 0.256 . . . . 1.4399999999999999 110.907 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -138.35 6.17 2.54 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.355 -0.609 . . . . 1.8700000000000001 109.355 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.632 ' O ' HG12 ' A' ' 87' ' ' ILE . 1.1 m -141.99 109.54 5.68 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.532 -0.914 . . . . 0.46000000000000002 108.532 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.547 ' O ' HD12 ' A' ' 114' ' ' LEU . 33.9 m-85 -128.95 174.98 9.03 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.475 0.655 . . . . 0.42999999999999999 110.764 -173.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.718 ' O ' HG23 ' A' ' 84' ' ' VAL . 36.2 mt -133.38 123.25 46.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 106.616 -1.624 . . . . 0.40999999999999998 106.616 166.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 78.6 m -110.47 124.45 51.8 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.732 -0.387 . . . . 2.0099999999999998 110.665 -173.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.51 ' HA ' ' O ' ' A' ' 111' ' ' PHE . 11.5 t-160 -89.39 118.75 29.28 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 108.507 -0.923 . . . . 1.23 108.507 168.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.636 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 89.8 m -136.98 123.45 20.83 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.727 -0.67 . . . . 0.5 111.228 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 46.5 mm -78.43 132.61 32.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 O-C-N 121.501 -0.749 . . . . 1.03 109.593 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.5 ' HB ' ' HB2' ' A' ' 109' ' ' ARG . 2.3 m -110.36 146.34 35.95 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.783 -0.644 . . . . 1.3799999999999999 110.745 -174.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.611 ' HG2' ' HG2' ' A' ' 79' ' ' GLN . 7.5 mm-40 -88.6 178.63 6.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.908 -0.587 . . . . 1.8200000000000001 110.443 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.8 m -118.29 95.6 4.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.734 0.302 . . . . 3.9100000000000001 111.077 -175.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -92.01 96.12 10.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.767 0.318 . . . . 5.1600000000000001 110.594 -177.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.602 ' O ' HG22 ' A' ' 103' ' ' VAL . . . 170.84 48.28 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.036 -0.984 . . . . 1.98 109.943 176.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 102' ' ' ALA . 2.1 m 64.02 -20.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 125.187 1.395 . . . . 3.1699999999999999 113.701 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.48 0.91 2.88 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.146 -1.026 . . . . 1.96 113.551 176.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.7 p -65.57 -28.9 69.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.271 0.557 . . . . 1.8799999999999999 111.132 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.553 ' HA ' HD11 ' A' ' 179' ' ' LEU . 65.4 mt -94.02 145.71 7.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.421 -0.809 . . . . 1.1200000000000001 110.72 -175.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.3 m -84.04 153.24 63.2 Favored Pre-proline 0 N--CA 1.449 -0.496 0 CA-C-N 116.111 -0.495 . . . . 1.3500000000000001 110.06 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -60.48 137.1 71.89 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.147 1.898 . . . . 1.0700000000000001 110.01 174.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.5 ' HB2' ' HB ' ' A' ' 98' ' ' THR . 54.5 mtt180 -111.92 159.69 18.14 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.604 -0.839 . . . . 3.4500000000000002 111.213 -172.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.681 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 12.9 t70 -107.35 143.14 36.07 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.72 -1.215 . . . . 1.3700000000000001 107.72 176.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.585 ' HB3' ' HB ' ' A' ' 96' ' ' THR . 50.6 t80 -122.36 115.07 21.66 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.59 -0.522 . . . . 2.4100000000000001 109.59 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.668 HG21 ' CE1' ' A' ' 134' ' ' PHE . 12.8 mm -132.7 85.85 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.016 -0.993 . . . . 0.42999999999999999 108.517 175.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.582 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 1.0 OUTLIER -116.14 131.52 56.92 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.807 -0.633 . . . . 1.8600000000000001 110.944 -177.453 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.622 ' O ' ' HA ' ' A' ' 129' ' ' SER . 6.6 tp -80.77 121.87 26.46 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.241 -0.89 . . . . 0.28000000000000003 109.068 172.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.453 HG23 ' HB ' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -123.76 125.71 71.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-N 115.398 -0.819 . . . . 0.26000000000000001 111.747 -165.235 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.794 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 11.6 t80 -107.5 118.73 37.49 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.059 -0.973 . . . . 2.5699999999999998 110.634 177.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.547 HG13 HG22 ' A' ' 127' ' ' ILE . 4.7 mp -94.44 100.71 11.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.03 -0.532 . . . . 0.89000000000000001 109.839 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -114.02 142.69 45.86 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.717 -0.475 . . . . 1.2 109.717 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.457 ' NH1' ' HA ' ' A' ' 121' ' ' GLU . 3.2 tmt_? -127.22 95.36 4.26 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 108.503 -0.925 . . . . 2.7999999999999998 108.503 -177.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -64.67 118.49 8.97 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 107.901 -1.148 . . . . 0.82999999999999996 107.901 174.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.457 ' HA ' ' NH1' ' A' ' 119' ' ' ARG . 8.0 mm-40 -38.24 90.47 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.923 1.389 . . . . 2.2799999999999998 113.148 -175.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 62.97 36.06 92.93 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.178 -0.919 . . . . 0.76000000000000001 112.419 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.533 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 65.7 t30 -132.85 -45.41 0.87 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.526 -0.175 . . . . 1.6499999999999999 110.526 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.401 ' O ' ' HA ' ' A' ' 119' ' ' ARG . 1.6 mpt? -157.81 131.03 7.62 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 120.733 0.302 . . . . 1.1200000000000001 111.812 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -106.36 79.39 1.37 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.169 -1.048 . . . . 1.6200000000000001 108.169 170.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.507 ' CG1' HG12 ' A' ' 154' ' ' VAL . 0.4 OUTLIER -99.82 140.9 17.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.586 -0.734 . . . . 0.29999999999999999 112.801 -171.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.738 ' O ' HG13 ' A' ' 127' ' ' ILE . 4.3 pt -110.16 110.62 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-O 121.904 0.859 . . . . 0.58999999999999997 108.766 162.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.573 ' HB3' ' HA ' ' A' ' 11' ' ' ALA . 53.2 p -93.92 113.5 25.52 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 121.853 -0.529 . . . . 1.1799999999999999 110.208 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.622 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 7.0 m -110.91 150.58 29.01 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.411 -0.813 . . . . 1.24 111.203 -170.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.424 ' HE2' ' HG3' ' A' ' 150' ' ' PRO . 3.5 mtpm? -136.62 117.58 14.24 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 107.606 -1.257 . . . . 2.2599999999999998 107.606 175.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.504 ' HB2' ' H ' ' A' ' 148' ' ' ASN . 33.3 t -63.51 98.37 0.17 Allowed 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.075 -1.454 . . . . 1.3899999999999999 107.075 175.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.445 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -108.16 141.58 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.035 0 CA-C-N 114.57 -1.196 . . . . 1.05 108.988 -163.753 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -100.47 71.02 1.51 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 122.291 1.043 . . . . 2.1699999999999999 108.682 -170.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.775 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -98.2 159.52 30.5 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-N 113.668 -1.606 . . . . 0.53000000000000003 110.629 -171.589 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.96 -12.96 16.02 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.941 2.427 . . . . 1.28 114.785 -171.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.775 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 5.6 tp10 -72.41 -16.93 61.84 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 109.388 -0.597 . . . . 3.5 109.388 -172.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.464 ' HB2' HG11 ' A' ' 84' ' ' VAL . 15.5 t80 -163.52 118.43 1.12 Allowed Pre-proline 0 N--CA 1.448 -0.558 0 N-CA-C 113.066 0.765 . . . . 6.1200000000000001 113.066 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 95.8 Cg_endo -92.73 145.63 2.55 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.306 2.671 . . . . 1.77 110.834 166.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 138' ' ' PRO . 7.3 Cg_exo -72.29 -155.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.538 2.159 . . . . 1.25 112.336 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.2 m -147.15 155.92 42.55 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.823 -0.806 . . . . 1.6000000000000001 108.823 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.9 p -73.11 -0.25 13.55 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.197 0.443 . . . . 1.97 112.197 -173.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -105.16 -16.12 14.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.056 0.455 . . . . 2.1800000000000002 110.006 175.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.411 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 87.9 m-85 -132.36 108.91 9.49 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.515 -0.766 . . . . 1.23 109.904 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.549 HG12 ' HB3' ' A' ' 176' ' ' ARG . 2.7 tp -90.75 112.88 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 C-N-CA 120.366 -0.533 . . . . 0.81999999999999995 110.523 -176.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.681 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 64.9 ttp85 -49.41 102.22 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.408 -0.815 . . . . 4.4199999999999999 109.741 171.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -60.08 117.43 11.34 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 110.617 -0.993 . . . . 0.79000000000000004 110.617 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.465 ' HB3' ' CB ' ' A' ' 174' ' ' GLU . 65.0 t80 -83.45 85.59 7.22 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.791 0.805 . . . . 4.4400000000000004 111.17 -174.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.642 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 78.7 m-20 -77.83 98.81 5.7 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.426 -1.261 . . . . 1.6200000000000001 109.539 171.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.448 ' O ' ' HB3' ' A' ' 172' ' ' GLN . 24.6 t-80 -71.71 129.83 87.9 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 108.062 -1.088 . . . . 2.3199999999999998 108.062 176.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.52 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 46.1 Cg_exo -13.54 66.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.122 1 C-N-CA 126.973 5.115 . . . . 0.53000000000000003 115.905 -163.396 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 151' ' ' CYS . . . . . 0.642 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 24.2 p -112.31 156.4 22.5 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.845 -1.07 . . . . 1.5800000000000001 108.553 174.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.733 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -145.23 -147.35 4.61 Favored Glycine 0 N--CA 1.433 -1.528 0 C-N-CA 119.256 -1.449 . . . . 0.42999999999999999 113.624 -169.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.533 ' CZ ' HD21 ' A' ' 167' ' ' LEU . 55.1 t80 -162.06 92.06 0.82 Allowed 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.472 -0.936 . . . . 0.59999999999999998 108.472 -164.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.577 ' CG2' HG13 ' A' ' 168' ' ' VAL . 2.4 m -102.06 132.3 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-O 121.696 0.76 . . . . 0.31 110.776 -175.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 37.0 m -112.52 107.68 16.51 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.371 -0.831 . . . . 1.55 109.272 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.463 ' O ' ' HB3' ' A' ' 166' ' ' LYS . 9.8 m -104.75 114.13 64.22 Favored Pre-proline 0 C--N 1.315 -0.916 0 C-N-CA 120.771 -0.371 . . . . 1.0600000000000001 111.267 -169.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.533 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 53.1 Cg_exo -49.8 120.88 6.49 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.511 2.14 . . . . 0.56000000000000005 111.397 174.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.588 ' SD ' ' HB2' ' A' ' 166' ' ' LYS . 87.3 mmm -76.17 -165.62 0.51 Allowed 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.03 0.443 . . . . 1.1599999999999999 111.429 -176.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -66.09 -22.7 66.42 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.687 -0.688 . . . . 2.6299999999999999 109.708 177.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -109.16 19.58 19.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.414 -0.812 . . . . 2.0499999999999998 110.047 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.536 ' HB2' ' CD ' ' A' ' 162' ' ' PRO . 11.7 m-80 27.2 -91.05 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.872 1.669 . . . . 1.9299999999999999 115.483 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.536 ' CD ' ' HB2' ' A' ' 161' ' ' ASN . 93.2 Cg_endo -74.76 -13.41 21.99 Favored 'Trans proline' 0 C--N 1.366 1.496 0 CA-C-N 121.709 1.646 . . . . 0.72999999999999998 112.866 -173.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -89.99 -34.68 15.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.042 -0.526 . . . . 0.68000000000000005 110.672 -177.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.444 ' O ' ' HB2' ' A' ' 158' ' ' MET . 78.2 m-85 -139.88 132.0 28.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.393 -0.367 . . . . 0.93000000000000005 110.24 176.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 34.9 t -123.59 145.01 49.23 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.595 0.712 . . . . 1.4099999999999999 111.171 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.588 ' HB2' ' SD ' ' A' ' 158' ' ' MET . 15.3 tppt? -93.87 100.94 13.02 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.268 -0.878 . . . . 0.73999999999999999 111.161 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.533 HD21 ' CZ ' ' A' ' 153' ' ' PHE . 0.9 OUTLIER -85.54 108.4 17.92 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.054 -0.975 . . . . 0.27000000000000002 109.335 178.614 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.577 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -129.31 114.55 32.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-O 122.115 0.96 . . . . 0.28000000000000003 111.319 177.349 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 18.7 ttt -115.63 141.51 47.97 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.539 -1.21 . . . . 1.24 110.693 -172.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.548 ' O ' ' HB2' ' A' ' 151' ' ' CYS . 73.7 m-85 -115.69 127.47 55.18 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.545 -0.752 . . . . 3.3700000000000001 110.972 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.451 HG13 ' OG1' ' A' ' 173' ' ' THR . 1.0 OUTLIER -112.48 113.64 44.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.598 -0.728 . . . . 1.3999999999999999 110.042 174.19 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.612 ' NE2' HD12 ' A' ' 47' ' ' LEU . 33.9 tt0 -116.18 41.3 2.64 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 106.001 -1.852 . . . . 2.1699999999999999 106.001 171.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.552 HG22 ' H ' ' A' ' 175' ' ' MET . 18.9 m -69.65 149.82 47.69 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 112.53 -2.123 . . . . 1.6499999999999999 110.46 -174.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.465 ' CB ' ' HB3' ' A' ' 147' ' ' TYR . 8.1 tt0 -82.58 -11.5 58.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.482 0.658 . . . . 2.4500000000000002 111.435 -175.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.552 ' H ' HG22 ' A' ' 173' ' ' THR . 42.4 mtm 68.69 35.2 3.16 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.897 -1.047 . . . . 3.7400000000000002 110.594 170.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.549 ' HB3' HG12 ' A' ' 144' ' ' ILE . 24.8 mmm-85 -70.43 170.39 12.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.616 -0.72 . . . . 5.7800000000000002 111.7 -176.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 124.28 -7.84 8.53 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.659 -0.976 . . . . 2.2599999999999998 110.659 -174.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? 60.79 49.64 6.0 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.459 0.703 . . . . 6.2300000000000004 110.827 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.553 HD11 ' HA ' ' A' ' 106' ' ' ILE . 0.3 OUTLIER -87.26 -169.88 2.81 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 121.306 0.574 . . . . 1.6399999999999999 109.668 178.823 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.499 ' O ' HD12 ' A' ' 184' ' ' ILE . 14.7 m -112.17 154.91 44.19 Favored Pre-proline 0 C--N 1.314 -0.936 0 N-CA-C 108.393 -0.966 . . . . 2.04 108.393 176.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -42.57 -44.59 8.44 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 122.742 2.295 . . . . 1.74 113.396 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.65 ' O ' ' HE2' ' A' ' 186' ' ' LYS . 22.3 t -71.33 -12.64 61.54 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.348 -0.387 . . . . 2.1400000000000001 111.969 -177.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.476 ' HB ' ' HB3' ' A' ' 179' ' ' LEU . 27.9 mm -90.93 -41.46 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-O 122.585 1.183 . . . . 1.1200000000000001 108.985 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.94 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.1 mp -64.88 -37.8 81.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 112.887 -1.96 . . . . 1.1299999999999999 111.473 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -64.16 -17.92 63.95 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.314 -0.624 . . . . 2.8900000000000001 109.314 175.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.65 ' HE2' ' O ' ' A' ' 182' ' ' SER . 49.5 mtmt -92.85 -43.59 8.91 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.75 -0.659 . . . . 1.28 110.299 173.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.94 HG22 ' HA ' ' A' ' 184' ' ' ILE . 15.1 t -61.1 -33.42 73.33 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.734 0.642 . . . . 0.62 112.734 -169.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' MET . . . . . 0.631 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 15.6 mmt -78.43 -59.39 0.71 Allowed Pre-proline 0 C--N 1.332 -0.173 0 C-N-CA 119.646 -0.821 . . . . 1.0600000000000001 110.835 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.631 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 33.9 Cg_exo -62.93 -22.07 73.58 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 121.917 1.745 . . . . 0.91000000000000003 112.216 -176.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.783 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 67.2 m -81.08 -22.96 38.81 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.796 -0.362 . . . . 1.5 110.489 175.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.2 OUTLIER -91.43 -37.59 13.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.814 0.34 . . . . 1.8799999999999999 111.074 -176.635 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.534 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 2.2 mt -62.13 -56.92 13.98 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.558 0.694 . . . . 1.0900000000000001 111.161 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 189' ' ' PRO . 1.6 m -66.93 -32.13 56.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.707 -1.133 . . . . 0.68000000000000005 109.033 -175.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.783 ' HB2' ' O ' ' A' ' 190' ' ' SER . 26.4 t30 -63.1 -48.27 79.3 Favored 'General case' 0 C--O 1.208 -1.099 0 CA-C-N 113.911 -1.495 . . . . 2.0699999999999998 109.727 177.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.53 ' O ' ' HB2' ' A' ' 198' ' ' ASN . 2.8 t80 -62.04 -25.33 67.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.956 0.407 . . . . 2.0 110.283 -178.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.596 HD12 HG22 ' A' ' 50' ' ' VAL . 14.6 mt -80.22 -29.57 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-O 120.993 0.425 . . . . 0.31 110.988 174.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 83.3 mt -74.93 -36.71 62.13 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.302 0.572 . . . . 1.03 109.481 174.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.53 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 4.9 m-20 -48.56 -39.17 22.69 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.756 -1.111 . . . . 1.8999999999999999 108.995 163.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.703 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -80.5 -44.52 19.02 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 116.027 -0.533 . . . . 0.28999999999999998 111.247 -176.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 28.7 mmtp -54.41 -46.23 73.1 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.734 0.778 . . . . 0.96999999999999997 110.187 173.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -80.04 -45.44 18.33 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.614 -1.175 . . . . 1.9399999999999999 110.416 -175.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -64.42 -31.55 81.23 Favored Glycine 0 C--O 1.228 -0.246 0 C-N-CA 121.004 -0.617 . . . . 0.46999999999999997 112.555 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.842 HD13 HD23 ' A' ' 61' ' ' LEU . 1.8 tp -69.89 -37.23 72.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.836 0.351 . . . . 0.60999999999999999 110.202 178.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.49 ' O ' ' HB ' ' A' ' 208' ' ' THR . 94.2 mttt -85.13 -20.81 29.74 Favored 'General case' 0 C--O 1.21 -1.024 0 N-CA-C 109.071 -0.714 . . . . 3.3700000000000001 109.071 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -69.06 -34.23 74.82 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.007 -0.542 . . . . 1.02 109.682 168.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.497 ' HE1' ' CD1' ' A' ' 74' ' ' TRP . 19.4 m80 -87.54 -5.84 58.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.952 -0.567 . . . . 3.6299999999999999 112.348 178.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.591 ' HD2' ' OE1' ' A' ' 56' ' ' GLU . 22.6 ttt180 -114.75 -52.57 2.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 122.198 0.999 . . . . 2.5899999999999999 110.638 178.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.546 HG23 ' HD2' ' A' ' 209' ' ' PRO . 39.8 m -100.36 154.38 37.23 Favored Pre-proline 0 C--N 1.309 -1.176 0 CA-C-N 113.922 -1.49 . . . . 1.8400000000000001 108.974 -177.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.546 ' HD2' HG23 ' A' ' 208' ' ' THR . 38.8 Cg_endo -68.0 53.64 0.63 Allowed 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 121.96 1.774 . . . . 2.3500000000000001 111.84 172.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 74.1 m -92.43 26.36 2.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.103 -0.499 . . . . 2.3100000000000001 111.031 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.99 42.55 0.94 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.267 -0.642 . . . . 5.4500000000000002 109.267 173.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -66.01 -50.12 65.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.624 -0.716 . . . . 6.8600000000000003 109.152 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.06 51.81 3.8 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.717 -0.754 . . . . 3.3700000000000001 111.245 175.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -67.0 133.29 49.64 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.133 0.492 . . . . 5.21 111.149 -175.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -109.32 63.05 0.6 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.756 -0.656 . . . . 6.46 109.519 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -78.41 122.92 26.43 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.042 -0.725 . . . . 6.0899999999999999 109.042 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -79.27 79.68 5.68 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.614 0.721 . . . . 5.1200000000000001 111.711 -174.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 32.3 t -76.63 -32.34 57.96 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.127 -1.064 . . . . 6.7599999999999998 108.127 170.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -136.81 -66.29 0.53 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.524 -1.216 . . . . 8.8200000000000003 108.345 171.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 69.7 m . . . . . 0 C--O 1.251 1.141 0 CA-C-N 115.501 -0.772 . . . . 8.4800000000000004 109.689 176.115 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 120.864 0.364 . . . . 3.8599999999999999 110.752 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.51 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.3 t70 -114.24 -41.01 3.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.492 0.663 . . . . 2.25 109.639 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.817 ' HA ' HD11 ' A' ' 6' ' ' ILE . 98.8 m-85 -70.46 -29.87 66.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.289 -0.868 . . . . 0.42999999999999999 109.367 -175.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.524 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 27.1 tttm -74.42 -3.88 33.25 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.822 -1.081 . . . . 1.51 109.766 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 2' ' ' ASP . . . -91.95 -44.89 8.63 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.016 -0.538 . . . . 0.54000000000000004 109.95 172.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.817 HD11 ' HA ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -82.98 -41.34 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-O 121.425 0.631 . . . . 1.0700000000000001 110.727 -173.024 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.626 ' HB2' HD21 ' A' ' 114' ' ' LEU . . . -74.39 -39.59 62.59 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.988 -1.006 . . . . 0.34000000000000002 111.34 -176.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.524 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 2.4 mt-30 -68.15 -27.01 66.06 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.82 -1.082 . . . . 1.5900000000000001 110.232 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -81.79 -33.12 31.02 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.765 -1.107 . . . . 2.4700000000000002 109.111 172.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.65 ' HA ' ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -71.49 -39.06 71.11 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.23 -0.895 . . . . 0.47999999999999998 111.723 179.704 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.621 ' HA ' ' CB ' ' A' ' 128' ' ' SER . . . -48.15 -60.13 2.87 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-O 121.109 0.48 . . . . 0.31 111.87 176.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.419 ' H ' ' HG2' ' A' ' 12' ' ' GLN . 20.3 pt20 -76.55 0.11 21.22 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.174 -0.466 . . . . 1.6399999999999999 111.579 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.65 ' HB3' ' HA ' ' A' ' 10' ' ' THR . 1.1 tt0 -90.73 -45.29 8.93 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.055 -0.72 . . . . 2.54 109.055 174.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.823 HG23 ' CE2' ' A' ' 170' ' ' PHE . 4.1 p -70.44 -47.39 65.97 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.041 0 N-CA-C 109.001 -0.74 . . . . 0.53000000000000003 109.001 171.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.627 ' HG ' ' OD1' ' A' ' 18' ' ' ASN . 1.0 OUTLIER -61.77 -24.96 67.17 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.362 1.077 . . . . 0.59999999999999998 108.338 175.038 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 20' ' ' ASP . . . -63.19 -21.22 63.79 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 113.774 -1.557 . . . . 0.56999999999999995 110.406 178.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.926 ' CE1' ' HG3' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -87.25 -33.44 19.28 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.097 -0.705 . . . . 3.27 109.097 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.627 ' OD1' ' HG ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -80.38 -16.98 53.23 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.424 0.63 . . . . 2.0299999999999998 110.073 -167.884 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.458 ' HD2' HD23 ' A' ' 15' ' ' LEU . 24.9 mtp180 -101.52 -20.35 15.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.142 -0.936 . . . . 2.7200000000000002 110.133 175.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 16' ' ' GLY . 35.2 t70 -118.51 84.3 2.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.787 -0.642 . . . . 2.1600000000000001 109.821 -178.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.9 p -108.0 127.02 53.4 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 120.916 0.389 . . . . 1.8200000000000001 111.751 -172.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.4 t 173.23 162.23 0.14 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.366 -0.834 . . . . 2.1899999999999999 109.522 -173.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.44 1.73 90.21 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 121.183 -0.532 . . . . 1.1000000000000001 113.111 174.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -112.75 -157.39 0.62 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.837 0.351 . . . . 1.6699999999999999 110.876 -177.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 tpmt? -173.24 118.1 0.3 Allowed 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 108.851 -0.796 . . . . 2.9500000000000002 108.851 -172.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.662 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 2.8 m -63.19 116.87 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.989 0 CA-C-O 122.116 0.96 . . . . 1.5600000000000001 110.789 176.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.459 HG13 ' HB2' ' A' ' 28' ' ' LYS . 10.9 p -98.38 -24.74 4.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 113.979 -1.464 . . . . 1.22 109.719 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.459 ' HB2' HG13 ' A' ' 27' ' ' VAL . 1.2 tmtt? -154.37 120.39 5.29 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 119.471 -0.892 . . . . 2.4100000000000001 110.537 -170.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.542 ' HB ' ' HA ' ' A' ' 34' ' ' THR . 0.2 OUTLIER -149.71 135.05 18.25 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.477 0.656 . . . . 1.3799999999999999 110.506 175.096 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.4 m -88.39 -68.35 0.77 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.841 -1.072 . . . . 2.3700000000000001 111.299 -173.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -166.64 18.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 121.018 -0.273 . . . . 4.5499999999999998 110.856 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.506 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 16.5 tttp 178.51 -28.95 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.351 0.595 . . . . 1.4199999999999999 110.312 -174.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.724 HG22 ' HA3' ' A' ' 52' ' ' GLY . 30.0 pt -98.95 152.79 4.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.96 -1.018 . . . . 0.76000000000000001 109.254 174.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.562 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 3.4 m -146.47 110.87 5.12 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 123.452 0.47 . . . . 0.57999999999999996 111.04 -167.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.684 ' HA ' ' O ' ' A' ' 49' ' ' ARG . 13.0 t -103.45 112.73 38.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.995 -0.372 . . . . 0.85999999999999999 109.995 -177.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.662 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 84.0 p -106.83 133.93 50.75 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.193 0.597 . . . . 1.1000000000000001 110.685 -177.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 49.2 m -102.45 126.67 49.56 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.297 -0.41 . . . . 1.27 110.416 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -119.71 -84.3 0.66 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.856 -0.611 . . . . 1.9099999999999999 110.424 -177.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 47' ' ' LEU . . . -176.04 128.01 0.22 Allowed 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.016 0.198 . . . . 1.6799999999999999 110.483 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.55 ' HA ' ' HG3' ' A' ' 172' ' ' GLN . 32.1 t -89.68 -137.5 0.12 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.772 -1.196 . . . . 2.0899999999999999 107.772 173.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.516 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 3.9 tpm_? -64.35 -9.13 15.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.986 0.422 . . . . 6.6100000000000003 110.172 172.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.497 ' HD3' ' HA ' ' A' ' 42' ' ' LYS . 4.0 mmtp 60.7 19.26 9.31 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.486 -0.779 . . . . 6.46 112.165 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -101.18 -42.17 6.45 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.738 -0.838 . . . . 5.6500000000000004 108.738 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -161.0 72.2 0.43 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.52 -1.218 . . . . 5.5599999999999996 107.983 167.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 40' ' ' SER . . . 162.92 136.11 1.93 Allowed Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 120.318 -0.944 . . . . 1.5600000000000001 112.934 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -104.69 152.31 22.65 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.481 -0.933 . . . . 2.0499999999999998 108.481 169.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.768 HD21 ' CD1' ' A' ' 170' ' ' PHE . 4.8 tt -82.52 130.0 35.03 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.829 -0.804 . . . . 0.87 108.829 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.539 ' N ' HD23 ' A' ' 47' ' ' LEU . 38.3 m-85 -115.45 119.12 35.17 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.466 -0.568 . . . . 0.98999999999999999 109.466 -178.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.926 ' HG3' ' CE1' ' A' ' 17' ' ' TYR . 3.1 tmt_? -110.47 141.84 43.04 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.928 -0.578 . . . . 2.9199999999999999 109.505 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 34' ' ' THR . 8.8 p -127.99 143.59 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-O 121.243 0.544 . . . . 1.3300000000000001 109.862 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.504 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 33.4 tt0 -146.28 110.81 5.14 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.442 -0.799 . . . . 1.0700000000000001 109.01 -173.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.724 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -137.81 134.72 7.11 Favored Glycine 0 N--CA 1.439 -1.13 0 C-N-CA 120.361 -0.923 . . . . 0.28999999999999998 111.851 -176.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 64.4 mt -83.98 118.13 30.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 C-N-CA 119.798 -0.761 . . . . 0.57999999999999996 110.327 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.407 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 72.3 mt -95.99 113.15 61.61 Favored Pre-proline 0 N--CA 1.435 -1.209 0 CA-C-N 115.132 -0.94 . . . . 0.34999999999999998 108.599 175.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 24.9 Cg_exo -65.67 45.87 0.18 Allowed 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.825 3.017 . . . . 0.62 113.582 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.576 ' HG2' HG13 ' A' ' 203' ' ' ILE . 10.5 tp10 -135.72 178.09 7.32 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.539 -1.282 . . . . 1.6799999999999999 107.539 177.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.451 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 47.9 t -81.1 139.66 49.31 Favored Pre-proline 0 N--CA 1.43 -1.473 0 CA-C-O 121.739 0.781 . . . . 1.1799999999999999 110.234 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.542 ' HG3' ' HB3' ' A' ' 165' ' ' SER . 23.5 Cg_exo -61.35 -9.13 12.04 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 124.11 3.207 . . . . 0.52000000000000002 110.658 177.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 63' ' ' ASP . . . -67.02 -52.3 44.14 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.981 -1.009 . . . . 0.64000000000000001 110.82 174.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.62 ' HE3' ' HB3' ' A' ' 64' ' ' PHE . 7.4 tptt -72.12 -23.91 61.39 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.887 -0.783 . . . . 3.2999999999999998 108.887 178.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.714 HD23 ' CD1' ' A' ' 203' ' ' ILE . 20.4 mt -64.42 -60.35 3.27 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.863 -0.608 . . . . 0.40999999999999998 109.454 174.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.461 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 34.1 t -64.73 -14.13 57.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.563 -0.744 . . . . 1.29 110.306 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 22.6 t70 -80.83 -46.42 15.36 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.844 -0.616 . . . . 1.3200000000000001 111.077 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.625 ' HB2' ' HZ2' ' A' ' 74' ' ' TRP . 7.0 p90 -76.21 -45.43 33.08 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 120.9 -0.32 . . . . 0.60999999999999999 111.29 -171.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.461 ' CD2' ' HA ' ' A' ' 62' ' ' SER . 0.5 OUTLIER -80.66 -5.31 56.77 Favored 'General case' 0 CA--C 1.512 -0.487 0 O-C-N 121.833 -0.542 . . . . 1.5 111.184 -171.247 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.522 ' O ' ' HG3' ' A' ' 67' ' ' GLN . 13.0 t80 -50.73 -48.61 58.91 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 123.676 0.61 . . . . 1.52 112.181 -163.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.524 ' HG2' ' CZ ' ' A' ' 81' ' ' TYR . 16.3 mt-30 155.84 115.22 0.0 OUTLIER 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 124.657 1.183 . . . . 3.6000000000000001 109.32 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.788 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 6.3 t 42.53 31.49 0.29 Allowed 'General case' 0 C--N 1.315 -0.906 0 O-C-N 124.559 1.162 . . . . 1.48 113.397 175.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.93 -27.19 14.44 Favored Glycine 0 CA--C 1.496 -1.154 0 C-N-CA 120.039 -1.077 . . . . 1.46 112.166 -173.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.729 ' O ' HG22 ' A' ' 73' ' ' THR . 17.4 p-10 173.87 -28.77 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.677 -1.231 . . . . 2.1899999999999999 107.677 -172.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.83 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 1.6 ptp180 -43.11 -54.43 4.4 Favored 'General case' 0 C--O 1.21 -0.983 0 CA-C-N 114.636 -1.165 . . . . 3.3799999999999999 110.66 177.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.883 HG22 ' HB3' ' A' ' 78' ' ' LEU . 1.8 pp -78.34 -12.27 13.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.056 0.455 . . . . 0.70999999999999996 111.503 -175.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.729 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.2 t -90.22 -29.78 17.98 Favored 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 120.062 -0.655 . . . . 0.96999999999999997 109.859 -168.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.625 ' HZ2' ' HB2' ' A' ' 64' ' ' PHE . 7.8 p-90 -111.53 -3.99 14.95 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.16 -0.473 . . . . 0.75 111.378 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.83 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 1.8 t70 -65.9 176.88 1.47 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 122.306 1.051 . . . . 2.1899999999999999 113.399 -171.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.451 ' HG3' ' OD1' ' A' ' 194' ' ' ASN . 0.0 OUTLIER -123.0 -27.5 4.21 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.819 -1.537 . . . . 3.1899999999999999 110.509 -178.037 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.436 ' HA ' ' HB2' ' A' ' 99' ' ' GLN . 50.0 m -113.12 0.58 15.0 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.073 -0.714 . . . . 1.5800000000000001 109.073 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.883 ' HB3' HG22 ' A' ' 72' ' ' ILE . 53.2 mt -108.73 173.68 6.21 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.048 -0.978 . . . . 0.70999999999999996 110.268 177.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.678 ' HG2' ' HG2' ' A' ' 99' ' ' GLN . 12.8 mm100 -156.87 -66.2 0.1 Allowed 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.734 0.778 . . . . 1.73 109.972 -174.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.472 HG23 ' HB3' ' A' ' 79' ' ' GLN . 17.3 t -136.96 119.17 19.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 114.586 -1.188 . . . . 0.78000000000000003 109.835 -169.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.788 ' HB3' ' HB ' ' A' ' 68' ' ' THR . 0.4 OUTLIER -109.22 123.48 49.31 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.495 -0.558 . . . . 5.4000000000000004 109.495 175.922 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.708 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 13.5 m120 -119.95 123.68 44.11 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.324 -0.991 . . . . 1.6899999999999999 108.324 -176.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.79 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 18.3 ttm -87.73 99.01 11.77 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.69 -0.856 . . . . 2.0499999999999998 108.69 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.582 HG11 ' HZ ' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -77.49 -60.74 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.981 -0.554 . . . . 0.64000000000000001 111.349 -163.742 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.63 130.29 19.07 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.862 -0.792 . . . . 1.96 108.862 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.79 ' HD3' ' SD ' ' A' ' 83' ' ' MET . 14.3 mtm180 -110.4 132.95 53.73 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.38 -0.6 . . . . 2.4399999999999999 109.38 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.605 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -94.5 -44.45 13.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.769 -0.65 . . . . 0.46999999999999997 111.097 -168.354 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -149.99 -161.99 1.46 Allowed 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.431 -0.951 . . . . 1.8600000000000001 108.431 -174.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.1 m -65.22 -33.36 75.81 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 111.932 0.345 . . . . 1.4399999999999999 111.932 -172.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -137.92 33.74 2.4 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.343 0.592 . . . . 1.8700000000000001 109.647 -174.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.605 ' O ' HG12 ' A' ' 87' ' ' ILE . 1.7 m -132.54 107.09 8.23 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.971 -1.122 . . . . 0.46000000000000002 107.971 -178.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.599 ' O ' HD12 ' A' ' 114' ' ' LEU . 16.9 m-85 -123.37 171.58 9.32 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.947 -0.57 . . . . 0.42999999999999999 110.08 -173.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.545 ' O ' HG23 ' A' ' 84' ' ' VAL . 53.3 mt -121.81 129.87 75.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 109.11 -0.7 . . . . 0.40999999999999998 109.11 170.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.792 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 0.0 OUTLIER -93.25 118.02 30.76 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.734 -1.121 . . . . 2.0099999999999998 111.962 -170.432 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.708 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 22.2 t-160 -107.18 90.53 3.33 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.021 -0.733 . . . . 1.23 109.021 163.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.626 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 72.2 m -109.22 120.7 43.33 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.984 -0.553 . . . . 0.5 111.457 -176.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.8 mm -83.92 130.02 36.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.367 0.603 . . . . 1.03 110.028 174.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 3.0 m -106.11 152.58 23.23 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.793 -1.094 . . . . 1.3799999999999999 110.124 -174.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.678 ' HG2' ' HG2' ' A' ' 79' ' ' GLN . 4.4 mm100 -91.95 168.24 11.55 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.25 0.547 . . . . 1.8200000000000001 111.443 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.506 ' HB3' ' O ' ' A' ' 106' ' ' ILE . 14.1 m -91.54 50.36 1.71 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.281 -0.872 . . . . 3.9100000000000001 111.776 -174.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.446 ' HE2' ' HB3' ' A' ' 190' ' ' SER . 69.2 t80 -74.99 102.39 4.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.544 0.687 . . . . 5.1600000000000001 111.442 -174.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.569 ' O ' ' HB ' ' A' ' 103' ' ' VAL . . . -164.09 -37.94 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.625 -1.171 . . . . 1.98 110.3 175.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.569 ' HB ' ' O ' ' A' ' 102' ' ' ALA . 7.5 p 155.77 -19.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 107.43 -1.322 . . . . 3.1699999999999999 107.43 -173.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.35 24.56 3.17 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 114.426 -1.261 . . . . 1.96 111.743 -175.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.7 t -101.64 -1.78 31.93 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.346 0.593 . . . . 1.8799999999999999 110.175 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.635 HG12 ' HG ' ' A' ' 179' ' ' LEU . 76.5 mt -114.78 147.91 17.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.437 -0.801 . . . . 1.1200000000000001 109.624 -176.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.1 m -99.19 157.79 33.42 Favored Pre-proline 0 C--N 1.32 -0.709 0 N-CA-C 109.319 -0.623 . . . . 1.3500000000000001 109.319 175.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -47.97 116.54 1.99 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.814 2.342 . . . . 1.0700000000000001 111.686 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.658 ' HG3' HG23 ' A' ' 144' ' ' ILE . 34.3 ttp180 -102.08 149.22 24.48 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.007 -0.738 . . . . 3.4500000000000002 109.007 -173.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.405 ' OD1' ' HA ' ' A' ' 145' ' ' ARG . 2.5 p30 -114.25 147.85 38.36 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.813 -0.755 . . . . 1.3700000000000001 110.135 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.626 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 15.1 m-85 -116.25 128.51 55.65 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.325 -0.852 . . . . 2.4100000000000001 110.229 174.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.792 ' HA ' ' O ' ' A' ' 94' ' ' CYS . 22.6 mm -126.8 80.87 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.33 -0.85 . . . . 0.42999999999999999 109.049 169.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.729 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 10.0 m-20 -113.64 129.09 56.63 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.872 -1.058 . . . . 1.8600000000000001 109.215 -178.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.626 HD21 ' HB2' ' A' ' 7' ' ' ALA . 3.8 tp -74.79 121.45 21.79 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.424 0.63 . . . . 0.28000000000000003 109.401 176.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -115.71 123.74 71.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 114.96 -1.018 . . . . 0.26000000000000001 111.497 -164.804 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.663 ' HE2' ' HE3' ' A' ' 118' ' ' LYS . 90.9 t80 -114.07 125.21 53.72 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.827 -1.078 . . . . 2.5699999999999998 109.895 175.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 1.099 HG12 HG22 ' A' ' 127' ' ' ILE . 85.9 mt -98.79 104.33 15.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.312 0.577 . . . . 0.89000000000000001 110.358 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.663 ' HE3' ' HE2' ' A' ' 116' ' ' TYR . 5.0 tppp? -98.73 128.04 44.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.599 -0.728 . . . . 1.2 109.267 177.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.68 92.04 3.79 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.035 -0.728 . . . . 2.7999999999999998 109.035 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.446 ' HB3' ' HB3' ' A' ' 123' ' ' ASN . 59.5 m-85 -73.12 115.15 12.11 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 115.14 -0.936 . . . . 0.82999999999999996 108.737 175.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -26.53 89.67 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 O-C-N 125.637 1.836 . . . . 2.2799999999999998 113.252 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 53.83 42.44 69.16 Favored Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.789 -0.641 . . . . 0.76000000000000001 112.672 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.505 ' C ' ' HD2' ' A' ' 157' ' ' PRO . 52.7 t30 -135.75 -49.21 0.7 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.331 -0.434 . . . . 1.6499999999999999 110.705 -176.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.584 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 5.4 mtm -161.98 120.24 2.26 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 120.726 -0.39 . . . . 1.1200000000000001 111.787 -178.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -104.35 78.68 1.51 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.422 -0.955 . . . . 1.6200000000000001 108.422 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.682 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -92.8 138.4 20.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 114.915 -1.039 . . . . 0.29999999999999999 112.791 -172.594 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 1.099 HG22 HG12 ' A' ' 117' ' ' ILE . 38.0 pt -105.51 100.68 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.93 0.872 . . . . 0.58999999999999997 109.34 165.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.621 ' CB ' ' HA ' ' A' ' 11' ' ' ALA . 11.8 p -85.73 110.58 19.43 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.842 -0.617 . . . . 1.1799999999999999 110.707 178.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.729 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 1.9 p -106.4 135.87 47.14 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.408 -0.814 . . . . 1.24 110.691 -176.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.608 ' HE2' ' OG1' ' A' ' 10' ' ' THR . 10.6 ttmm -128.11 112.25 14.37 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.819 -1.178 . . . . 2.2599999999999998 107.819 -177.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.8 p -57.88 98.39 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.914 0 CA-C-O 121.944 0.878 . . . . 1.3899999999999999 109.067 -175.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.55 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -110.32 134.12 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.122 0 CA-C-N 114.587 -1.188 . . . . 1.05 109.034 -165.607 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -96.19 71.15 2.81 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.719 -1.128 . . . . 2.1699999999999999 108.456 -172.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.687 ' CE1' HG21 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -99.5 159.54 29.78 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 114.447 -1.251 . . . . 0.53000000000000003 110.471 -172.093 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.83 -27.64 75.27 Favored 'Trans proline' 0 N--CA 1.477 0.535 0 C-N-CA 123.861 3.041 . . . . 1.28 115.679 -168.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.432 ' HG2' ' CD2' ' A' ' 134' ' ' PHE . 12.1 mm-40 -71.72 -21.71 61.73 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 120.478 -0.489 . . . . 3.5 110.08 -166.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.577 ' CD2' HG13 ' A' ' 112' ' ' ILE . 57.0 t80 -134.26 108.23 11.33 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 112.916 0.71 . . . . 6.1200000000000001 112.916 -177.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -97.6 119.12 0.15 Allowed 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 123.537 2.824 . . . . 1.77 110.76 162.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -63.24 -176.94 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.271 1.981 . . . . 1.25 112.24 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.0 m -146.63 -162.35 1.51 Allowed 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.598 -0.519 . . . . 1.6000000000000001 109.598 -171.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.3 m -79.91 -40.69 27.67 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.297 -0.561 . . . . 1.97 111.337 -178.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -68.09 -42.63 80.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.037 0.446 . . . . 2.1800000000000002 111.176 -176.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -105.19 134.79 47.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.711 -0.677 . . . . 1.23 110.172 -173.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.658 HG23 ' HG3' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -109.93 103.51 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 CA-C-N 116.034 -0.53 . . . . 0.81999999999999995 109.702 -179.504 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.542 ' HE ' ' HB ' ' A' ' 112' ' ' ILE . 12.1 ttt180 -51.7 100.78 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.552 -1.204 . . . . 4.4199999999999999 110.429 178.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.35 110.13 3.06 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.662 -0.699 . . . . 0.79000000000000004 112.224 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.452 ' HB3' ' HB3' ' A' ' 174' ' ' GLU . 26.4 t80 -85.42 82.2 8.41 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.258 0.551 . . . . 4.4400000000000004 109.649 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.533 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 47.1 m-80 -78.21 100.45 6.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.737 -0.665 . . . . 1.6200000000000001 109.747 176.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -57.76 114.96 9.5 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.314 -0.625 . . . . 2.3199999999999998 109.314 176.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.437 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 65.9 Cg_exo -7.0 67.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.681 1 C-N-CA 126.152 4.568 . . . . 0.53000000000000003 115.187 -159.764 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 151' ' ' CYS . . . . . 0.736 ' HB3' ' O ' ' A' ' 170' ' ' PHE . 2.9 m -87.75 150.78 23.37 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 115.039 -0.982 . . . . 1.5800000000000001 108.404 178.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.822 ' HA3' HG21 ' A' ' 14' ' ' VAL . . . -139.83 -162.86 9.28 Favored Glycine 0 CA--C 1.494 -1.265 0 C-N-CA 118.829 -1.653 . . . . 0.42999999999999999 112.649 -176.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.615 ' HB3' HG12 ' A' ' 127' ' ' ILE . 0.4 OUTLIER -160.74 83.42 0.67 Allowed 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.364 -1.347 . . . . 0.59999999999999998 107.364 -164.843 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.772 HG23 HG13 ' A' ' 168' ' ' VAL . 4.2 m -95.28 130.38 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 CA-C-O 121.933 0.873 . . . . 0.31 110.576 -175.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' CYS . . . . . 0.584 ' O ' ' HA ' ' A' ' 124' ' ' MET . 6.0 t -110.32 118.54 36.59 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.251 -0.886 . . . . 1.55 109.446 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.617 ' HB3' ' HB3' ' A' ' 166' ' ' LYS . 9.1 t -114.78 112.6 45.09 Favored Pre-proline 0 C--N 1.319 -0.749 0 C-N-CA 120.654 -0.418 . . . . 1.0600000000000001 111.625 -170.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.505 ' HD2' ' C ' ' A' ' 123' ' ' ASN . 46.8 Cg_exo -55.18 118.56 5.3 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.11 1.873 . . . . 0.56000000000000005 110.166 166.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.485 ' N ' ' HB3' ' A' ' 161' ' ' ASN . 72.3 mtp -79.5 -171.78 2.93 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.717 -0.393 . . . . 1.1599999999999999 111.087 -175.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -67.24 -31.19 71.37 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.481 -0.933 . . . . 2.6299999999999999 108.481 169.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.411 ' C ' ' HD2' ' A' ' 162' ' ' PRO . 24.2 mt-10 -102.45 27.87 6.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.362 -1.29 . . . . 2.0499999999999998 109.213 176.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.498 ' OD1' ' HD3' ' A' ' 162' ' ' PRO . 7.0 p30 -38.84 -46.96 3.45 Favored Pre-proline 0 N--CA 1.473 0.694 0 N-CA-C 115.985 1.846 . . . . 1.9299999999999999 115.985 -169.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.498 ' HD3' ' OD1' ' A' ' 161' ' ' ASN . 71.2 Cg_endo -72.45 -17.63 26.75 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 CA-C-N 121.336 1.513 . . . . 0.72999999999999998 112.384 -174.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -109.62 -24.43 10.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.779 -0.646 . . . . 0.68000000000000005 110.933 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.462 ' O ' ' HA ' ' A' ' 161' ' ' ASN . 79.1 m-85 -141.76 121.05 13.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.065 -0.516 . . . . 0.93000000000000005 109.726 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.542 ' HB3' ' HG3' ' A' ' 58' ' ' PRO . 6.8 p -117.29 142.71 46.73 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.304 -0.558 . . . . 1.4099999999999999 111.187 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.617 ' HB3' ' HB3' ' A' ' 156' ' ' SER . 2.3 tppp? -94.31 104.41 16.4 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 122.1 0.952 . . . . 0.73999999999999999 111.822 -174.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.49 HD12 HG12 ' A' ' 196' ' ' ILE . 0.7 OUTLIER -90.69 104.83 17.37 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.297 -1.32 . . . . 0.27000000000000002 109.517 176.179 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.772 HG13 HG23 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -127.86 126.06 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.803 0.811 . . . . 0.28000000000000003 111.533 -179.642 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.574 ' O ' ' HG2' ' A' ' 49' ' ' ARG . 12.2 ttm -141.4 148.58 39.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.248 -0.887 . . . . 1.24 109.486 -172.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.823 ' CE2' HG23 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -129.71 143.34 50.77 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.186 -0.606 . . . . 3.3700000000000001 110.345 170.256 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.55 ' HB ' HD21 ' A' ' 192' ' ' LEU . 0.9 OUTLIER -119.9 118.81 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 O-C-N 124.86 1.35 . . . . 1.3999999999999999 109.985 178.394 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.55 ' HG3' ' HA ' ' A' ' 40' ' ' SER . 10.4 tt0 -121.81 48.73 1.65 Allowed 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 106.187 -1.783 . . . . 2.1699999999999999 106.187 173.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 5.5 m -72.13 151.34 43.08 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.024 -1.898 . . . . 1.6499999999999999 111.224 -174.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.452 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 18.5 tt0 -127.57 92.97 3.59 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.542 0.687 . . . . 2.4500000000000002 109.821 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.98 86.23 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.456 -1.247 . . . . 3.7400000000000002 110.067 174.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.599 ' HB2' HD11 ' A' ' 144' ' ' ILE . 14.8 mmt85 -70.18 19.98 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.083 0.771 . . . . 5.7800000000000002 113.083 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 165.59 -176.7 41.07 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.303 -0.951 . . . . 2.2599999999999998 113.56 175.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm 76.2 -65.25 0.32 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.056 0.942 . . . . 6.2300000000000004 112.923 174.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.635 ' HG ' HG12 ' A' ' 106' ' ' ILE . 4.4 mp -85.0 160.69 19.99 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.77 0.795 . . . . 1.6399999999999999 110.641 -172.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.546 ' HB3' ' HD2' ' A' ' 181' ' ' PRO . 50.5 m -112.67 164.56 15.07 Favored Pre-proline 0 C--N 1.306 -1.296 0 CA-C-N 113.923 -1.489 . . . . 2.04 108.638 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 180' ' ' SER . 74.3 Cg_exo -37.97 -52.03 1.83 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.656 2.904 . . . . 1.74 114.247 -177.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.572 ' O ' ' HE2' ' A' ' 186' ' ' LYS . 54.6 m -75.25 -10.44 59.46 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.548 0.573 . . . . 2.1400000000000001 112.548 -174.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.566 ' HB ' ' HB3' ' A' ' 179' ' ' LEU . 16.2 mm -89.86 -35.37 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 CA-C-O 122.523 1.154 . . . . 1.1200000000000001 108.909 -177.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.931 ' HA ' HG22 ' A' ' 187' ' ' THR . 0.9 OUTLIER -70.01 -38.15 74.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 112.768 -2.014 . . . . 1.1299999999999999 110.931 -178.728 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.438 ' HG2' ' HA ' ' A' ' 182' ' ' SER . 9.3 pt-20 -65.69 -17.91 64.94 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.155 -0.683 . . . . 2.8900000000000001 109.155 175.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.572 ' HE2' ' O ' ' A' ' 182' ' ' SER . 48.2 mtmt -93.01 -38.7 11.51 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.729 -0.668 . . . . 1.28 110.081 175.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.931 HG22 ' HA ' ' A' ' 184' ' ' ILE . 11.2 t -68.73 -24.61 64.49 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 112.348 0.499 . . . . 0.62 112.348 -171.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' MET . . . . . 0.558 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 0.2 OUTLIER -79.78 -63.65 0.36 Allowed Pre-proline 0 N--CA 1.467 0.402 0 CA-C-N 118.471 0.578 . . . . 1.0600000000000001 111.699 179.418 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.558 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 25.4 Cg_exo -62.7 -25.53 75.07 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.296 1.997 . . . . 0.91000000000000003 112.484 -176.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.746 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 68.4 m -82.95 -28.53 29.75 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.716 -0.394 . . . . 1.5 111.306 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ASN . . . . . 0.652 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.2 OUTLIER -90.55 -36.49 14.44 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.9 -0.32 . . . . 1.8799999999999999 111.272 -173.474 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.55 HD21 ' HB ' ' A' ' 171' ' ' VAL . 48.4 mt -65.22 -47.04 78.21 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.183 0.516 . . . . 1.0900000000000001 110.587 -177.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.477 ' HB ' HD12 ' A' ' 33' ' ' ILE . 2.0 m -67.9 -30.05 46.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.584 -0.735 . . . . 0.68000000000000005 109.301 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.746 ' HB2' ' O ' ' A' ' 190' ' ' SER . 1.0 OUTLIER -71.6 -37.07 71.0 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.652 -1.158 . . . . 2.0699999999999998 110.247 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.587 ' HA ' ' ND2' ' A' ' 198' ' ' ASN . 12.2 m-85 -61.07 -34.03 74.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.027 0.441 . . . . 2.0 110.048 172.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.545 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 54.3 mt -79.63 -28.97 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 116.082 -0.508 . . . . 0.31 110.637 176.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.445 ' HB2' ' HA ' ' A' ' 194' ' ' ASN . 53.2 mt -72.8 -36.47 67.56 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-N 116.317 -0.401 . . . . 1.03 110.233 176.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.587 ' ND2' ' HA ' ' A' ' 195' ' ' PHE . 67.2 m-20 -49.06 -47.61 44.78 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.303 -0.999 . . . . 1.8999999999999999 108.303 164.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.858 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -67.24 -45.49 76.56 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 115.28 -0.873 . . . . 0.28999999999999998 110.12 -175.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 61.2 mmtt -53.65 -48.18 69.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.403 0.621 . . . . 0.96999999999999997 109.91 173.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -75.71 -39.99 56.46 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.04 -0.982 . . . . 1.9399999999999999 111.305 -169.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -76.64 -28.23 59.71 Favored Glycine 0 N--CA 1.461 0.334 0 C-N-CA 120.056 -1.069 . . . . 0.46999999999999997 111.739 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.858 ' HB ' ' O ' ' A' ' 199' ' ' ALA . 0.9 OUTLIER -71.51 -38.61 68.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 123.045 0.538 . . . . 0.60999999999999999 110.832 172.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.53 ' O ' ' HB ' ' A' ' 208' ' ' THR . 96.4 mttt -83.76 -17.35 41.5 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.355 0.598 . . . . 3.3700000000000001 109.406 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -65.36 -25.79 67.74 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.442 -0.947 . . . . 1.02 108.442 166.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.512 ' HB3' ' O ' ' A' ' 203' ' ' ILE . 83.6 t60 -80.97 -51.75 8.19 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.246 -0.888 . . . . 3.6299999999999999 111.819 175.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -91.95 -33.13 14.99 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.323 0.49 . . . . 2.5899999999999999 112.323 -171.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.53 ' HB ' ' O ' ' A' ' 204' ' ' LYS . 91.6 m -99.45 151.03 37.29 Favored Pre-proline 0 C--N 1.313 -0.996 0 N-CA-C 109.554 -0.535 . . . . 1.8400000000000001 109.554 -176.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -65.17 44.27 0.15 Allowed 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.729 2.286 . . . . 2.3500000000000001 111.969 168.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.419 ' H ' ' C ' ' A' ' 208' ' ' THR . 22.7 t -95.01 37.95 1.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.707 0.765 . . . . 2.3100000000000001 109.559 -178.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 211' ' ' ARG . 17.7 mtp85 -84.0 22.54 1.15 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.229 -0.896 . . . . 5.4500000000000002 110.642 -178.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -64.71 -28.07 69.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.372 -0.831 . . . . 6.8600000000000003 109.988 172.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -102.38 13.37 56.95 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.766 -0.652 . . . . 3.3700000000000001 111.735 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -66.63 117.22 8.5 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.847 -0.427 . . . . 5.21 109.847 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 62.79 48.7 4.01 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.483 0.489 . . . . 6.46 111.242 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' HIS . . . . . 0.432 ' HB3' ' O ' ' A' ' 73' ' ' THR . 62.7 t-80 -76.6 -46.43 26.12 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.857 -0.423 . . . . 6.0899999999999999 109.857 176.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 62.66 -168.49 0.2 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.644 -0.707 . . . . 5.1200000000000001 111.476 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' A' ' 79' ' ' GLN . 48.1 t -98.87 -50.5 4.18 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.868 -0.606 . . . . 6.7599999999999998 109.514 174.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -172.67 -27.34 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.391 -0.822 . . . . 8.8200000000000003 109.757 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.25 1.119 0 N-CA-C 108.921 -0.77 . . . . 8.4800000000000004 108.921 176.45 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 mmt . . . . . 0 N--CA 1.479 0.998 0 CA-C-O 121.198 0.523 . . . . 3.8599999999999999 110.634 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -146.49 -65.16 0.29 Allowed 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.571 -0.899 . . . . 2.25 108.571 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.542 ' HA ' HD11 ' A' ' 6' ' ' ILE . 59.1 m-85 -66.66 -31.86 72.8 Favored 'General case' 0 CA--C 1.507 -0.707 0 O-C-N 123.58 0.55 . . . . 0.42999999999999999 110.284 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 27.0 tttp -75.91 -44.34 40.76 Favored 'General case' 0 N--CA 1.418 -2.065 0 N-CA-C 107.598 -1.26 . . . . 1.51 107.598 -177.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.408 ' O ' ' HG3' ' A' ' 9' ' ' GLN . . . -50.16 -51.73 41.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.422 -0.808 . . . . 0.54000000000000004 112.471 -177.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.542 HD11 ' HA ' ' A' ' 3' ' ' PHE . 0.4 OUTLIER -83.49 -30.6 8.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.312 -0.555 . . . . 1.0700000000000001 110.758 -172.005 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.497 ' HA ' ' HB ' ' A' ' 10' ' ' THR . . . -74.04 -41.54 61.65 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.85 0.833 . . . . 0.34000000000000002 110.956 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.486 ' HG2' ' CZ ' ' A' ' 116' ' ' TYR . 14.7 mt-30 -62.51 -31.23 71.96 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.259 -1.337 . . . . 1.5900000000000001 110.216 177.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 5' ' ' ALA . 98.9 mt-30 -82.47 -30.85 29.7 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.999 -1.0 . . . . 2.4700000000000002 109.204 174.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.624 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.6 OUTLIER -72.0 -37.72 69.77 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.682 -1.145 . . . . 0.47999999999999998 111.202 -179.569 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.541 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -46.51 -62.62 1.29 Allowed 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.266 0.469 . . . . 0.31 112.266 174.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -70.01 -6.24 32.05 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.308 -0.406 . . . . 1.6399999999999999 111.086 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.52 ' HB3' ' HA ' ' A' ' 10' ' ' THR . 0.2 OUTLIER -87.7 -43.0 12.24 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.215 -0.448 . . . . 2.54 110.136 179.666 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.712 HG21 ' N ' ' A' ' 152' ' ' GLY . 7.2 p -79.26 -29.83 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-O 121.841 0.829 . . . . 0.53000000000000003 109.404 176.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 tt -76.15 -19.71 58.23 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 108.314 -0.995 . . . . 0.59999999999999998 108.314 172.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.43 -23.42 66.65 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 113.931 -1.486 . . . . 0.56999999999999995 109.62 170.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.558 ' CD2' ' HA ' ' A' ' 14' ' ' VAL . 26.3 m-85 -80.87 -32.82 34.77 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 114.935 -0.633 . . . . 3.27 109.925 176.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -66.22 -13.19 59.92 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.699 0.761 . . . . 2.0299999999999998 110.139 177.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.7 mtp180 -108.16 -2.16 19.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.285 -0.87 . . . . 2.7200000000000002 109.323 178.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.496 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 28.9 t70 -105.65 119.66 39.71 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.349 -1.296 . . . . 2.1600000000000001 110.473 -175.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.0 p -134.62 119.13 17.98 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.962 -0.384 . . . . 1.8200000000000001 109.962 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.89 -162.58 1.3 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.252 -0.431 . . . . 2.1899999999999999 111.127 -166.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -75.73 61.24 2.89 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 116.11 -0.496 . . . . 1.1000000000000001 112.666 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.441 ' HA ' ' HB3' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -95.64 -156.5 0.52 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.369 -0.604 . . . . 1.6699999999999999 109.369 175.067 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.48 132.65 0.29 Allowed 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 108.682 -0.859 . . . . 2.9500000000000002 108.682 -178.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.824 HG21 HG23 ' A' ' 29' ' ' THR . 2.1 p -67.57 117.45 9.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-O 121.689 0.757 . . . . 1.5600000000000001 109.5 177.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.0 p -89.17 -24.37 5.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 114.748 -1.114 . . . . 1.22 108.919 -176.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.2 tptt -158.0 139.23 13.43 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.754 -0.657 . . . . 2.4100000000000001 111.883 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.824 HG23 HG21 ' A' ' 26' ' ' VAL . 6.4 p -144.28 152.1 40.32 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 115.829 -0.623 . . . . 1.3799999999999999 111.011 175.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.478 ' HB2' HG12 ' A' ' 33' ' ' ILE . 19.4 m -120.67 25.95 9.42 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.826 -0.625 . . . . 2.3700000000000001 110.868 171.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp 68.93 39.44 1.84 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.479 0.657 . . . . 4.5499999999999998 110.441 174.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.6 tptm 177.0 -30.59 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.505 -1.225 . . . . 1.4199999999999999 108.313 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.8 HD12 ' HB ' ' A' ' 193' ' ' VAL . 23.0 pt -119.68 151.8 22.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 114.561 -1.199 . . . . 0.76000000000000001 109.483 175.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.62 ' HA ' HG22 ' A' ' 29' ' ' THR . 89.8 m -152.15 113.62 4.32 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 123.347 0.404 . . . . 0.57999999999999996 111.158 -164.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -103.68 110.79 31.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.356 -0.537 . . . . 0.85999999999999999 111.799 171.357 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 1.5 p -99.77 117.86 35.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.413 -0.812 . . . . 1.1000000000000001 110.95 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 30.2 t -107.72 131.99 53.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.768 -1.106 . . . . 1.27 111.184 -173.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.453 ' HG3' ' H ' ' A' ' 39' ' ' ALA . 27.8 pttt -129.35 -92.61 0.45 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.497 0.554 . . . . 1.9099999999999999 112.497 172.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.657 ' HA ' ' HA ' ' A' ' 46' ' ' ASN . . . -148.11 137.64 22.28 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.611 0.226 . . . . 1.6799999999999999 111.611 -172.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.5 m -100.47 137.64 38.61 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.014 -0.365 . . . . 2.0899999999999999 110.014 176.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 41' ' ' ARG . 61.9 mtt180 -81.01 13.91 2.51 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.31 -0.405 . . . . 6.6100000000000003 111.222 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.644 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 17.5 ptpt -57.14 -33.73 67.68 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.116 -0.493 . . . . 6.46 110.221 178.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.644 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 14.7 t80 153.09 -70.88 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 O-C-N 124.992 1.432 . . . . 5.6500000000000004 108.6 -175.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -140.29 84.43 1.96 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.757 0.789 . . . . 5.5599999999999996 110.511 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.411 ' HA3' ' HD2' ' A' ' 42' ' ' LYS . . . -171.87 179.05 43.79 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.763 -0.732 . . . . 1.5600000000000001 111.766 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.657 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 18.9 p-10 -111.4 159.32 18.13 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.858 0.361 . . . . 2.0499999999999998 111.555 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.57 HD23 ' N ' ' A' ' 48' ' ' TYR . 3.9 tt -120.25 143.59 48.22 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.755 -0.831 . . . . 0.87 108.755 -176.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.57 ' N ' HD23 ' A' ' 47' ' ' LEU . 46.2 m-85 -118.46 123.56 45.47 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.888 0.375 . . . . 0.98999999999999999 110.884 -172.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 27.9 ttt180 -91.22 112.08 23.84 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.716 -0.846 . . . . 2.9199999999999999 108.716 169.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.516 HG13 ' HB3' ' A' ' 169' ' ' MET . 0.2 OUTLIER -104.95 106.82 21.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.757 0.789 . . . . 1.3300000000000001 109.523 -175.715 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 42.8 tt0 -128.68 146.52 50.86 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.819 -1.082 . . . . 1.0700000000000001 110.763 -169.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.532 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -168.81 146.83 10.64 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 111.018 -0.833 . . . . 0.28999999999999998 111.018 175.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.458 HG12 ' HE2' ' A' ' 166' ' ' LYS . 65.9 mt -92.84 116.68 34.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 117.813 0.807 . . . . 0.57999999999999996 110.428 175.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.455 HG12 ' HD3' ' A' ' 200' ' ' LYS . 70.1 mt -99.29 109.56 55.06 Favored Pre-proline 0 N--CA 1.439 -0.984 0 CA-C-N 115.314 -0.857 . . . . 0.34999999999999998 108.775 174.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 53' ' ' ILE . 32.1 Cg_exo -61.11 65.66 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 124.406 3.404 . . . . 0.62 112.551 178.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.65 ' HG2' ' CG1' ' A' ' 203' ' ' ILE . 9.9 tp10 -157.12 174.23 15.8 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.858 -1.065 . . . . 1.6799999999999999 108.144 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.476 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 38.1 t -79.94 139.49 53.59 Favored Pre-proline 0 N--CA 1.423 -1.804 0 CA-C-O 121.506 0.67 . . . . 1.1799999999999999 109.91 179.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.515 ' HB3' ' SG ' ' A' ' 155' ' ' CYS . 31.7 Cg_exo -58.05 -15.0 20.84 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 123.91 3.073 . . . . 0.52000000000000002 110.694 177.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.85 -49.15 55.27 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.519 -1.219 . . . . 0.64000000000000001 111.171 175.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.624 ' HB3' HD11 ' A' ' 203' ' ' ILE . 29.4 ttmt -71.79 -28.28 63.51 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.627 0.727 . . . . 3.2999999999999998 109.162 -177.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.034 HD23 HD13 ' A' ' 203' ' ' ILE . 68.0 mt -63.87 -51.37 64.87 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.689 -1.142 . . . . 0.40999999999999998 109.75 173.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.486 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 18.2 m -67.41 -10.94 56.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.751 -0.658 . . . . 1.29 110.413 175.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -88.8 -32.68 17.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.828 -0.624 . . . . 1.3200000000000001 111.72 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.536 ' CD2' ' HA ' ' A' ' 61' ' ' LEU . 8.7 p90 -82.02 -44.86 16.09 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.277 -0.569 . . . . 0.60999999999999999 111.186 -176.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.486 ' CD2' ' HA ' ' A' ' 62' ' ' SER . 0.8 OUTLIER -79.5 -7.66 58.6 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.372 -0.531 . . . . 1.5 111.402 -173.872 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -36.37 -57.74 0.73 Allowed 'General case' 0 N--CA 1.465 0.291 0 O-C-N 125.02 1.45 . . . . 1.52 113.399 -157.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.409 ' O ' ' HD3' ' A' ' 71' ' ' ARG . 76.9 mt-30 -156.9 -81.71 0.07 Allowed 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 112.198 0.444 . . . . 3.6000000000000001 112.198 -177.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.596 ' HB ' ' CD1' ' A' ' 81' ' ' TYR . 8.9 t -149.33 31.2 0.75 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 122.168 0.985 . . . . 1.48 109.655 -165.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.0 -39.8 4.22 Favored Glycine 0 CA--C 1.489 -1.543 0 CA-C-N 115.099 -0.955 . . . . 1.46 113.173 -169.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.51 ' O ' HG22 ' A' ' 73' ' ' THR . 3.1 p30 -163.61 -22.34 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.786 -0.707 . . . . 2.1899999999999999 111.034 -171.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.634 ' HG3' HG23 ' A' ' 72' ' ' ILE . 13.1 ptm180 -50.68 -33.17 21.57 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 122.913 0.485 . . . . 3.3799999999999999 110.553 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.634 HG23 ' HG3' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -99.37 -2.74 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 CA-C-N 115.779 -0.646 . . . . 0.70999999999999996 111.261 -177.726 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.51 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.2 t -96.42 -30.67 13.24 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 119.523 -0.871 . . . . 0.96999999999999997 110.568 -178.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.537 ' CZ2' ' HA ' ' A' ' 71' ' ' ARG . 13.7 p-90 -107.74 0.59 22.42 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.969 0.414 . . . . 0.75 111.39 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.582 ' HB3' ' O ' ' A' ' 71' ' ' ARG . 1.7 p-10 -58.9 -179.74 0.07 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 114.435 1.272 . . . . 2.1899999999999999 114.435 -172.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.511 ' HG3' ' OD1' ' A' ' 194' ' ' ASN . 0.0 OUTLIER -143.11 -2.58 1.0 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 113.438 -1.71 . . . . 3.1899999999999999 111.108 172.853 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 m -132.48 4.97 4.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.943 0.878 . . . . 1.5800000000000001 108.94 -176.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.527 ' HB2' ' CG ' ' A' ' 75' ' ' ASP . 91.5 mt -119.1 -170.99 2.02 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.579 -1.191 . . . . 0.70999999999999996 110.868 -174.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.47 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 8.4 mm100 -161.31 -65.39 0.06 Allowed 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.779 0.8 . . . . 1.73 109.685 -176.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.462 HG23 ' HB3' ' A' ' 79' ' ' GLN . 6.1 t -142.3 147.07 21.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.755 -1.111 . . . . 0.78000000000000003 109.146 -172.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.596 ' CD1' ' HB ' ' A' ' 68' ' ' THR . 11.6 t80 -136.29 129.61 31.7 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.807 -0.442 . . . . 5.4000000000000004 109.807 177.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -131.04 121.39 24.94 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.871 -0.788 . . . . 1.6899999999999999 108.871 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.451 ' CE ' ' HA ' ' A' ' 83' ' ' MET . 1.3 tpt -81.19 92.96 6.38 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.371 -0.831 . . . . 2.0499999999999998 108.777 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -71.93 -83.08 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.34 -0.846 . . . . 0.64000000000000001 111.112 -167.921 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -113.32 114.54 26.81 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.319 0.581 . . . . 1.96 109.695 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.42 ' HG2' ' HD1' ' A' ' 92' ' ' PHE . 80.9 mtm180 -97.4 108.07 20.72 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.31 -0.859 . . . . 2.4399999999999999 109.204 178.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.703 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -78.47 -47.15 24.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.865 -0.607 . . . . 0.46999999999999997 110.845 -173.501 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -146.04 -179.87 7.01 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.607 -0.886 . . . . 1.8600000000000001 108.607 -174.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.9 m -66.8 -17.01 64.66 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.155 0.428 . . . . 1.4399999999999999 112.155 -174.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -139.28 27.9 2.3 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 120.098 -0.641 . . . . 1.8700000000000001 110.37 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.703 ' O ' HG12 ' A' ' 87' ' ' ILE . 1.6 m -141.17 112.61 7.49 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 107.979 -1.119 . . . . 0.46000000000000002 107.979 177.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.575 ' O ' HD12 ' A' ' 114' ' ' LEU . 3.6 m-85 -134.88 177.03 8.12 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.984 -0.553 . . . . 0.42999999999999999 109.876 -175.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.711 ' O ' HG23 ' A' ' 84' ' ' VAL . 22.1 mt -125.8 131.03 72.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 107.336 -1.357 . . . . 0.40999999999999998 107.336 169.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.715 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 14.5 p -104.68 132.59 50.75 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.831 -0.348 . . . . 2.0099999999999998 111.731 -174.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.734 ' HA ' HD13 ' A' ' 112' ' ' ILE . 14.6 t60 -103.46 95.28 5.97 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.962 -0.755 . . . . 1.23 108.962 166.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.644 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 27.4 m -115.66 121.33 42.22 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.317 -0.856 . . . . 0.5 110.838 -174.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.446 ' O ' ' HB2' ' A' ' 79' ' ' GLN . 44.5 mm -77.95 114.99 19.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.08 -0.711 . . . . 1.03 109.08 175.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.409 ' HB ' ' HB2' ' A' ' 109' ' ' ARG . 3.0 m -93.85 136.45 34.12 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.072 -0.967 . . . . 1.3799999999999999 110.532 -175.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 24.0 mt-30 -74.77 154.63 38.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.374 0.606 . . . . 1.8200000000000001 111.065 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.4 p -85.49 71.29 10.79 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.089 -0.96 . . . . 3.9100000000000001 111.119 -178.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -81.66 97.58 7.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.151 -0.477 . . . . 5.1600000000000001 110.658 -175.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 177.68 50.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 114.762 -1.108 . . . . 1.98 109.287 175.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 90.9 t 73.05 -40.65 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 115.548 -0.751 . . . . 3.1699999999999999 111.23 -177.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 144.66 16.99 0.2 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.953 -0.641 . . . . 1.96 112.647 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.7 m -73.14 -20.45 60.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.288 0.566 . . . . 1.8799999999999999 111.121 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 17.5 mt -108.62 159.57 7.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.48 -0.782 . . . . 1.1200000000000001 110.405 -170.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 25.2 m -100.31 151.84 37.66 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 108.988 -0.745 . . . . 1.3500000000000001 108.988 172.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -50.19 126.42 17.27 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.715 2.276 . . . . 1.0700000000000001 111.401 177.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.483 ' HG2' HG23 ' A' ' 144' ' ' ILE . 19.5 mtm180 -101.82 164.53 11.68 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.502 0.668 . . . . 3.4500000000000002 112.004 -169.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.726 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 10.1 t0 -107.27 113.22 26.47 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.667 -1.151 . . . . 1.3700000000000001 108.968 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.644 ' HB3' ' HB ' ' A' ' 96' ' ' THR . 57.4 t80 -100.41 107.45 19.21 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.653 -0.869 . . . . 2.4100000000000001 108.653 -178.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.734 HD13 ' HA ' ' A' ' 95' ' ' HIS . 8.5 mm -122.41 82.73 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 CA-C-N 115.404 -0.816 . . . . 0.42999999999999999 108.911 177.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 1.9 m-20 -116.13 130.21 56.69 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.663 -0.698 . . . . 1.8600000000000001 110.276 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.695 ' O ' ' HA ' ' A' ' 129' ' ' SER . 3.8 tp -75.34 122.54 23.89 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 115.008 -0.996 . . . . 0.28000000000000003 109.519 176.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -121.8 125.45 73.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-N 114.915 -1.039 . . . . 0.26000000000000001 111.875 -163.685 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.648 ' HD1' ' HG1' ' A' ' 91' ' ' THR . 70.7 t80 -110.05 125.01 52.49 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.666 -1.152 . . . . 2.5699999999999998 111.075 176.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.632 HG13 HG22 ' A' ' 127' ' ' ILE . 3.7 mp -95.42 104.66 16.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.711 -0.677 . . . . 0.89000000000000001 109.371 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.505 ' HD3' ' CE1' ' A' ' 120' ' ' TYR . 36.2 tttm -109.34 149.59 29.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.119 0.485 . . . . 1.2 110.502 -175.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.1 tpp85 -126.59 97.78 5.15 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 121.65 0.738 . . . . 2.7999999999999998 109.572 -176.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.505 ' CE1' ' HD3' ' A' ' 118' ' ' LYS . 24.7 m-85 -77.28 107.65 9.84 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 106.727 -1.583 . . . . 0.82999999999999996 106.727 167.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -39.75 95.57 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 124.736 1.273 . . . . 2.2799999999999998 112.758 -175.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 64.26 36.81 93.69 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 114.514 -1.221 . . . . 0.76000000000000001 112.345 178.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.493 ' C ' ' HD2' ' A' ' 157' ' ' PRO . 65.9 t30 -138.53 -43.2 0.49 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.535 -0.332 . . . . 1.6499999999999999 110.591 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -156.76 135.44 11.61 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.39 0.614 . . . . 1.1200000000000001 111.97 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -112.78 84.89 2.06 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.821 -1.177 . . . . 1.6200000000000001 107.821 170.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 153' ' ' PHE . 0.6 OUTLIER -105.77 136.91 38.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.624 -0.716 . . . . 0.29999999999999999 112.351 -171.184 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.704 ' O ' HG13 ' A' ' 127' ' ' ILE . 5.5 pt -111.52 103.06 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 122.279 1.038 . . . . 0.58999999999999997 109.077 167.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.541 ' HB3' ' HA ' ' A' ' 11' ' ' ALA . 28.6 p -90.45 122.39 33.26 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.657 -0.702 . . . . 1.1799999999999999 110.656 -178.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.695 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 5.3 m -120.31 140.08 51.8 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.575 -0.739 . . . . 1.24 111.108 -169.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.487 ' HE3' ' HB ' ' A' ' 6' ' ' ILE . 2.9 mtpm? -128.13 121.56 29.86 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 107.918 -1.141 . . . . 2.2599999999999998 107.918 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.438 ' HB3' ' H ' ' A' ' 148' ' ' ASN . 20.8 p -63.05 98.37 0.13 Allowed 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.32 -0.993 . . . . 1.3899999999999999 108.32 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -109.6 131.7 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 CA-C-N 114.516 -1.22 . . . . 1.05 109.084 -166.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.52 65.84 3.22 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.526 -1.216 . . . . 2.1699999999999999 108.821 -168.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.719 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 0.3 OUTLIER -95.16 156.06 38.23 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 113.86 -1.518 . . . . 0.53000000000000003 110.054 -171.48 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -69.97 -20.17 34.19 Favored 'Trans proline' 0 N--CA 1.473 0.32 0 C-N-CA 123.328 2.685 . . . . 1.28 115.337 -167.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.719 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 7.2 tp10 -72.87 -15.92 61.59 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.169 0.509 . . . . 3.5 109.824 -171.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -158.43 111.01 1.68 Allowed Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 113.314 0.857 . . . . 6.1200000000000001 113.314 175.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -97.67 144.21 0.68 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 124.033 3.156 . . . . 1.77 111.894 167.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.424 ' HG3' ' HB2' ' A' ' 145' ' ' ARG . 61.5 Cg_endo -75.64 -172.21 1.25 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.53 2.154 . . . . 1.25 112.265 178.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.5 m -141.66 -167.87 2.53 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.331 -0.989 . . . . 1.6000000000000001 108.331 -175.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.4 m -73.23 -37.04 66.52 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.056 -0.658 . . . . 1.97 111.191 -178.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -73.92 -60.39 2.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.176 0.512 . . . . 2.1800000000000002 109.89 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.602 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 36.7 m-85 -87.19 112.56 22.1 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 115.688 -0.687 . . . . 1.23 109.98 -178.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.483 HG23 ' HG2' ' A' ' 109' ' ' ARG . 1.7 tp -100.89 119.05 48.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 115.21 -0.904 . . . . 0.81999999999999995 109.262 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.726 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 28.7 ttm-85 -51.44 100.61 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 O-C-N 124.06 0.85 . . . . 4.4199999999999999 109.735 173.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -58.0 106.03 0.73 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.748 -0.941 . . . . 0.79000000000000004 110.748 176.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.433 ' HA ' ' CB ' ' A' ' 131' ' ' SER . 22.6 t80 -83.99 87.39 7.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.573 0.701 . . . . 4.4400000000000004 111.119 -172.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.753 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 24.3 m-80 -83.31 114.47 21.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.388 -0.823 . . . . 1.6200000000000001 109.807 174.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -71.33 129.49 88.9 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.254 -1.017 . . . . 2.3199999999999998 108.254 175.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.624 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 15.7 Cg_exo -16.55 69.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.973 1 C-N-CA 126.505 4.804 . . . . 0.53000000000000003 116.205 -166.143 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 151' ' ' CYS . . . . . 0.753 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 21.9 p -97.77 -173.79 2.71 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.818 -1.083 . . . . 1.5800000000000001 108.879 171.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.772 ' O ' ' HG3' ' A' ' 169' ' ' MET . . . -171.66 -150.26 7.05 Favored Glycine 0 CA--C 1.493 -1.323 0 C-N-CA 119.231 -1.462 . . . . 0.42999999999999999 112.262 -177.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.515 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 57.7 t80 -161.23 96.49 1.08 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.684 -0.858 . . . . 0.59999999999999998 108.684 -164.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.659 ' CG2' HG13 ' A' ' 168' ' ' VAL . 1.2 m -103.96 132.06 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-O 121.972 0.892 . . . . 0.31 110.824 -176.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' CYS . . . . . 0.515 ' SG ' ' HB3' ' A' ' 58' ' ' PRO . 10.6 t -112.4 111.69 22.72 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.068 -0.969 . . . . 1.55 109.511 177.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.492 ' HB3' ' HB3' ' A' ' 166' ' ' LYS . 27.4 t -108.9 112.34 60.24 Favored Pre-proline 0 C--N 1.316 -0.872 0 C-N-CA 120.867 -0.333 . . . . 1.0600000000000001 111.346 -166.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.493 ' HD2' ' C ' ' A' ' 123' ' ' ASN . 53.5 Cg_exo -49.66 124.41 12.21 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.424 2.083 . . . . 0.56000000000000005 111.161 172.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.62 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 0.2 OUTLIER -79.15 -167.78 1.27 Allowed 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.066 0.46 . . . . 1.1599999999999999 111.699 -175.511 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.75 -25.67 64.86 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.798 0.809 . . . . 2.6299999999999999 109.236 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -103.04 24.95 10.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.8 -1.091 . . . . 2.0499999999999998 109.011 178.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.538 ' HB2' ' HD3' ' A' ' 162' ' ' PRO . 21.4 m-80 13.73 -82.59 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 126.402 1.881 . . . . 1.9299999999999999 115.67 178.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.538 ' HD3' ' HB2' ' A' ' 161' ' ' ASN . 94.3 Cg_endo -74.2 -12.02 23.19 Favored 'Trans proline' 0 C--N 1.362 1.289 0 CA-C-N 120.932 1.369 . . . . 0.72999999999999998 113.639 -172.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -102.3 -30.98 10.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.335 -0.393 . . . . 0.68000000000000005 111.452 -176.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.62 ' O ' ' HB2' ' A' ' 158' ' ' MET . 42.3 m-85 -133.78 135.51 43.92 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.607 0.242 . . . . 0.93000000000000005 110.789 177.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 26.7 t -128.8 146.7 50.84 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.415 0.626 . . . . 1.4099999999999999 111.124 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.532 ' HG3' HG12 ' A' ' 168' ' ' VAL . 14.3 tppt? -99.66 101.81 13.11 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.181 -0.918 . . . . 0.73999999999999999 111.034 -178.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -84.67 104.28 14.51 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.631 -1.168 . . . . 0.27000000000000002 108.992 178.615 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.659 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -131.86 114.15 24.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 122.509 1.147 . . . . 0.28000000000000003 111.574 177.653 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.772 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 16.8 ttt -118.8 151.09 38.69 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 114.284 -1.325 . . . . 1.24 108.284 -176.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.704 ' O ' ' HB2' ' A' ' 151' ' ' CYS . 68.8 m-85 -120.08 139.4 52.62 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 120.272 -0.571 . . . . 3.3700000000000001 110.358 173.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.416 HG21 HD21 ' A' ' 192' ' ' LEU . 1.1 t -119.13 121.47 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 O-C-N 123.854 0.722 . . . . 1.3999999999999999 110.402 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -123.98 43.37 3.0 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.326 -1.361 . . . . 2.1699999999999999 107.326 178.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 6.8 m -69.31 137.42 52.96 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 113.379 -1.737 . . . . 1.6499999999999999 111.513 -172.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.408 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 9.1 tp10 -83.95 -32.53 24.99 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.326 -0.397 . . . . 2.4500000000000002 111.213 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 24.6 mmt 56.08 57.42 5.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.41 0.624 . . . . 3.7400000000000002 110.026 -175.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -67.19 -1.64 4.7 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.129 -0.941 . . . . 5.7800000000000002 112.101 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -76.47 -160.39 10.28 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.135 -0.555 . . . . 2.2599999999999998 112.132 178.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -94.14 65.61 3.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.391 0.615 . . . . 6.2300000000000004 110.503 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 179' ' ' LEU . 2.6 mp -115.94 153.33 31.78 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.681 0.753 . . . . 1.6399999999999999 109.385 175.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.511 ' H ' ' CG1' ' A' ' 183' ' ' ILE . 15.0 t -112.19 156.96 41.19 Favored Pre-proline 0 C--N 1.304 -1.397 0 N-CA-C 105.987 -1.857 . . . . 2.04 105.987 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.577 ' O ' ' HG2' ' A' ' 185' ' ' GLU . 60.6 Cg_exo -39.1 -47.26 2.97 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 122.464 2.109 . . . . 1.74 112.958 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.496 ' O ' ' HG3' ' A' ' 186' ' ' LYS . 11.1 t -71.13 -11.99 61.25 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.506 0.558 . . . . 2.1400000000000001 112.506 -177.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.511 ' CG1' ' H ' ' A' ' 180' ' ' SER . 40.2 mm -85.97 -42.42 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-O 122.858 1.313 . . . . 1.1200000000000001 107.809 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.992 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.4 mp -63.51 -36.23 75.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 112.034 -2.348 . . . . 1.1299999999999999 109.775 175.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.577 ' HG2' ' O ' ' A' ' 181' ' ' PRO . 62.8 mm-40 -58.89 -26.26 64.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.699 -1.137 . . . . 2.8900000000000001 109.993 174.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 182' ' ' SER . 43.9 mtmt -93.13 -44.37 8.4 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.644 -0.707 . . . . 1.28 110.036 177.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.992 HG22 ' HA ' ' A' ' 184' ' ' ILE . 4.7 t -69.28 -30.8 68.98 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 115.997 -0.547 . . . . 0.62 112.049 -170.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' MET . . . . . 0.531 ' O ' ' HG ' ' A' ' 192' ' ' LEU . 1.4 mmt -80.29 -65.1 0.28 Allowed Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 112.473 0.546 . . . . 1.0600000000000001 112.473 -172.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 33.6 Cg_endo -63.37 -25.72 71.13 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 121.73 1.62 . . . . 0.91000000000000003 112.944 -174.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.616 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 46.2 m -83.97 -31.48 25.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.912 0.387 . . . . 1.5 111.114 -177.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -90.87 -27.73 18.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.28 -0.418 . . . . 1.8799999999999999 111.623 -173.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 188' ' ' MET . 68.0 mt -75.94 -42.94 47.14 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 120.033 -0.667 . . . . 1.0900000000000001 110.312 -175.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.8 ' HB ' HD12 ' A' ' 33' ' ' ILE . 2.1 m -66.36 -31.29 52.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 108.803 -0.814 . . . . 0.68000000000000005 108.803 176.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.616 ' HB2' ' O ' ' A' ' 190' ' ' SER . 1.6 t-20 -73.4 -32.33 64.39 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.33 -1.305 . . . . 2.0699999999999998 110.311 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.56 ' O ' ' HB2' ' A' ' 198' ' ' ASN . 33.7 t80 -65.68 -30.92 71.67 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.169 -0.678 . . . . 2.0 109.169 175.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.452 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 57.0 mt -78.08 -28.82 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 115.654 -0.703 . . . . 0.31 110.554 174.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 87.8 mt -72.41 -32.74 66.61 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 121.175 0.512 . . . . 1.03 110.025 174.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.56 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 26.2 m-80 -51.19 -42.74 61.08 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.098 -1.075 . . . . 1.8999999999999999 108.098 165.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.604 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -73.88 -43.28 59.0 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 116.34 -0.391 . . . . 0.28999999999999998 110.68 -177.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.455 ' HD3' HG12 ' A' ' 54' ' ' ILE . 31.7 mmtp -54.37 -44.32 72.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.524 0.678 . . . . 0.96999999999999997 110.663 175.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.446 ' HA ' ' HG2' ' A' ' 204' ' ' LYS . 31.4 t70 -85.74 -38.88 17.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.328 -0.851 . . . . 1.9399999999999999 110.878 -174.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -68.07 -31.16 74.55 Favored Glycine 0 CA--C 1.507 -0.437 0 C-N-CA 120.397 -0.906 . . . . 0.46999999999999997 111.648 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 1.034 HD13 HD23 ' A' ' 61' ' ' LEU . 3.0 tp -71.11 -32.9 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 109.496 -0.557 . . . . 0.60999999999999999 109.496 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.657 ' O ' ' HB ' ' A' ' 208' ' ' THR . 5.6 pttp -87.29 -20.64 26.53 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 109.384 -0.598 . . . . 3.3700000000000001 109.384 177.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -62.19 -38.27 88.46 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.394 -0.965 . . . . 1.02 108.394 166.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -79.47 -42.43 25.31 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.508 -0.769 . . . . 3.6299999999999999 112.95 178.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.672 ' HG2' ' O ' ' A' ' 203' ' ' ILE . 13.4 ptm180 -93.1 -43.88 8.66 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.524 0.602 . . . . 2.5899999999999999 111.878 -174.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.657 ' HB ' ' O ' ' A' ' 204' ' ' LYS . 88.7 m -83.2 144.36 46.85 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 115.75 -0.659 . . . . 1.8400000000000001 109.431 -176.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -64.62 45.65 0.14 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.241 2.627 . . . . 2.3500000000000001 113.687 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 48.9 m -81.46 -15.11 56.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.255 0.55 . . . . 2.3100000000000001 109.813 174.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 211' ' ' ARG . 48.6 mtm180 -86.05 23.78 1.44 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.726 -0.67 . . . . 5.4500000000000002 110.618 176.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -57.61 -33.46 68.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.646 -0.707 . . . . 6.8600000000000003 110.768 176.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -130.67 50.36 0.89 Allowed Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 111.131 -0.788 . . . . 3.3700000000000001 111.131 175.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -67.69 104.97 1.76 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.866 0.365 . . . . 5.21 110.502 -176.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -83.6 -25.97 30.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.131 -0.486 . . . . 6.46 110.364 -177.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 32.3 t-80 55.06 59.63 3.92 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.432 0.634 . . . . 6.0899999999999999 110.131 177.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -84.05 8.73 14.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.794 -0.639 . . . . 5.1200000000000001 111.065 -175.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 3.6 p -68.02 -19.27 64.9 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.017 -0.538 . . . . 6.7599999999999998 111.29 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 40.6 p-80 -80.8 125.46 30.11 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.842 -0.429 . . . . 8.8200000000000003 109.842 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 14.2 t . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.925 -0.559 . . . . 8.4800000000000004 109.682 -177.881 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.484 1.25 0 CA-C-O 120.675 0.274 . . . . 3.8599999999999999 110.46 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -120.34 -85.18 0.66 Allowed 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 109.297 -0.631 . . . . 2.25 109.297 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.893 ' HA ' HD12 ' A' ' 6' ' ' ILE . 71.9 m-85 -62.81 -30.73 71.7 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.621 0.724 . . . . 0.42999999999999999 109.145 174.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.769 ' HE3' ' HE1' ' A' ' 116' ' ' TYR . 66.3 tttt -70.52 -33.96 71.76 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 107.492 -1.299 . . . . 1.51 107.492 -177.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.72 -36.57 79.16 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.215 0.531 . . . . 0.54000000000000004 110.542 177.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.893 HD12 ' HA ' ' A' ' 3' ' ' PHE . 2.0 mp -81.46 -41.29 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 CA-C-O 121.982 0.896 . . . . 1.0700000000000001 108.722 -174.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.672 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -80.09 -33.19 39.0 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.808 -1.542 . . . . 0.34000000000000002 112.147 -174.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.61 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 13.9 mt-30 -69.54 -23.58 63.6 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.788 0.804 . . . . 1.5900000000000001 109.495 175.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.572 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 14.4 mm100 -84.43 -47.85 10.24 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.426 -1.261 . . . . 2.4700000000000002 108.876 170.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.642 ' HB ' ' HA ' ' A' ' 7' ' ' ALA . 0.6 OUTLIER -55.11 -39.35 69.28 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.124 -0.943 . . . . 0.47999999999999998 112.038 178.251 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -46.54 -57.73 4.46 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.837 0.68 . . . . 0.31 112.837 174.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.431 ' H ' ' HG2' ' A' ' 12' ' ' GLN . 16.2 pt20 -80.38 -6.48 58.09 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.416 -0.356 . . . . 1.6399999999999999 111.251 -177.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 9.6 mm-40 -78.58 -51.32 10.09 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.934 -0.765 . . . . 2.54 108.934 170.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.75 HG23 ' CD2' ' A' ' 170' ' ' PHE . 7.1 p -68.22 -39.61 81.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.636 -0.711 . . . . 0.53000000000000003 110.455 177.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.522 HD12 HG11 ' A' ' 154' ' ' VAL . 0.6 OUTLIER -68.02 -19.68 64.93 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-O 122.077 0.942 . . . . 0.59999999999999998 108.619 174.744 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.534 ' HA2' ' NE ' ' A' ' 19' ' ' ARG . . . -65.1 -22.7 69.12 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 113.876 -1.511 . . . . 0.56999999999999995 110.088 175.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.438 ' HA ' ' HB3' ' A' ' 20' ' ' ASP . 13.8 m-85 -92.1 -12.03 34.13 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 114.973 -0.613 . . . . 3.27 110.088 178.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -80.47 -20.44 43.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.777 0.798 . . . . 2.0299999999999998 109.131 177.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.534 ' NE ' ' HA2' ' A' ' 16' ' ' GLY . 18.8 ptt180 -105.49 -5.57 20.15 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.079 -0.964 . . . . 2.7200000000000002 109.325 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.438 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 12.8 t70 -86.26 114.62 23.23 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 114.731 -1.122 . . . . 2.1600000000000001 110.544 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 40.8 p -134.69 101.79 5.06 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.829 -0.804 . . . . 1.8200000000000001 108.829 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.0 p -141.76 -148.87 0.25 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.404 -0.817 . . . . 2.1899999999999999 111.757 -164.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.81 63.66 1.21 Allowed Glycine 0 CA--C 1.52 0.396 0 O-C-N 123.379 0.424 . . . . 1.1000000000000001 113.289 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 1.026 ' HA ' ' HB3' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -104.96 -157.92 0.64 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.046 -0.724 . . . . 1.6699999999999999 109.046 173.05 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.426 ' HE3' ' HA ' ' A' ' 25' ' ' LYS . 1.7 tpmt? -173.75 120.06 0.3 Allowed 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.183 -1.043 . . . . 2.9500000000000002 108.183 -177.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.922 HG21 HG23 ' A' ' 29' ' ' THR . 2.7 p -64.02 116.57 3.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 C-N-CA 119.458 -0.897 . . . . 1.5600000000000001 109.531 177.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.452 HG11 ' HE2' ' A' ' 48' ' ' TYR . 11.1 p -88.86 -22.96 6.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 114.669 -1.15 . . . . 1.22 108.739 -177.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.493 ' HD3' ' HA ' ' A' ' 28' ' ' LYS . 1.9 tppp? -157.04 122.49 4.66 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 119.867 -0.733 . . . . 2.4100000000000001 112.972 -175.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.922 HG23 HG21 ' A' ' 26' ' ' VAL . 37.8 p -129.35 140.31 51.42 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.215 -0.661 . . . . 1.3799999999999999 109.215 167.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.6 m -124.8 -60.69 1.36 Allowed 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.41 -0.516 . . . . 2.3700000000000001 112.014 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -152.07 73.22 1.04 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.3 -0.409 . . . . 4.5499999999999998 110.765 -172.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.754 ' HE3' ' HB ' ' A' ' 53' ' ' ILE . 43.2 tttp 79.21 18.32 0.82 Allowed 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 122.133 0.968 . . . . 1.4199999999999999 109.431 177.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.813 HG22 ' HA3' ' A' ' 52' ' ' GLY . 5.9 pt -129.63 146.16 34.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 114.198 -1.365 . . . . 0.76000000000000001 109.704 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.724 ' HA ' HG22 ' A' ' 29' ' ' THR . 52.8 m -143.55 107.56 4.71 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.975 -1.011 . . . . 0.57999999999999996 110.814 -166.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 27' ' ' VAL . 24.4 t -100.32 103.13 14.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.888 -0.596 . . . . 0.85999999999999999 109.756 176.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.772 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 87.5 p -93.42 137.4 32.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.996 -0.547 . . . . 1.1000000000000001 110.553 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.8 t -129.09 135.35 48.79 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.173 0.511 . . . . 1.27 111.483 -177.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 1.026 ' HB3' ' HA ' ' A' ' 24' ' ' TRP . 41.8 pttt -148.04 161.04 42.19 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.151 -0.931 . . . . 1.9099999999999999 108.824 172.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.16 130.77 43.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.775 0.322 . . . . 1.6799999999999999 111.41 -177.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.626 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 21.1 p -76.0 -30.05 58.4 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.249 -0.432 . . . . 2.0899999999999999 110.585 -177.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.626 ' HG2' ' O ' ' A' ' 40' ' ' SER . 9.8 ptm180 56.42 8.64 0.45 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.032 1.333 . . . . 6.6100000000000003 113.948 173.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -93.44 -2.75 54.19 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.234 -1.024 . . . . 6.46 108.234 168.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -175.69 171.5 2.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 113.941 -1.481 . . . . 5.6500000000000004 107.405 -176.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 52.0 p-80 -79.63 72.78 6.33 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 122.0 0.905 . . . . 5.5599999999999996 110.802 -177.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.47 -173.66 28.22 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 114.988 -1.006 . . . . 1.5600000000000001 111.41 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -123.68 148.8 46.19 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.266 0.555 . . . . 2.0499999999999998 110.855 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.705 HD11 ' HE1' ' A' ' 170' ' ' PHE . 10.1 tt -105.8 153.2 22.23 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.187 -0.915 . . . . 0.87 109.565 -177.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.452 ' HE2' HG11 ' A' ' 27' ' ' VAL . 42.7 m-85 -128.29 129.99 47.16 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.81 0.338 . . . . 0.98999999999999999 111.059 -175.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.764 ' HD3' ' CZ3' ' A' ' 24' ' ' TRP . 41.0 ttt180 -106.94 119.9 40.6 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.226 -1.027 . . . . 2.9199999999999999 108.226 168.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.72 HG13 ' HB3' ' A' ' 169' ' ' MET . 0.2 OUTLIER -111.13 122.37 65.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.773 -0.649 . . . . 1.3300000000000001 109.564 -171.671 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 35.3 tt0 -138.87 148.27 43.46 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.084 -0.507 . . . . 1.0700000000000001 110.633 -169.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.813 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -170.77 150.73 14.53 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 110.9 -0.88 . . . . 0.28999999999999998 110.9 173.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.754 ' HB ' ' HE3' ' A' ' 32' ' ' LYS . 85.1 mt -92.19 112.03 25.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 117.693 0.746 . . . . 0.57999999999999996 110.01 175.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.419 HG12 ' CE ' ' A' ' 200' ' ' LYS . 68.4 mt -89.71 116.4 66.25 Favored Pre-proline 0 N--CA 1.437 -1.084 0 CA-C-N 115.329 -0.851 . . . . 0.34999999999999998 109.079 176.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.41 55.44 0.31 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 124.181 3.254 . . . . 0.62 112.965 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.865 ' HG2' HG13 ' A' ' 203' ' ' ILE . 7.3 tp10 -155.98 162.85 40.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.597 -1.26 . . . . 1.6799999999999999 107.597 175.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.481 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 31.3 p -71.77 140.61 83.99 Favored Pre-proline 0 N--CA 1.432 -1.328 0 CA-C-O 121.65 0.738 . . . . 1.1799999999999999 110.795 -176.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.709 ' HD3' ' HB2' ' A' ' 165' ' ' SER . 10.0 Cg_endo -52.46 -11.42 1.19 Allowed 'Trans proline' 0 CA--C 1.527 0.162 0 C-N-CA 124.495 3.463 . . . . 0.52000000000000002 111.761 172.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.31 -46.12 61.45 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.837 -0.62 . . . . 0.64000000000000001 110.713 174.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.903 ' HE2' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -65.05 -37.36 87.32 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 107.934 -1.136 . . . . 3.2999999999999998 107.934 174.307 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.727 HD23 ' CD1' ' A' ' 203' ' ' ILE . 83.5 mt -60.69 -55.2 36.09 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.719 -1.128 . . . . 0.40999999999999998 110.187 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.554 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 28.3 t -67.93 -13.87 62.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.063 -0.517 . . . . 1.29 110.637 176.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.903 ' HB3' ' HE2' ' A' ' 60' ' ' LYS . 21.3 t70 -81.06 -49.12 11.28 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.573 -0.451 . . . . 1.3200000000000001 110.78 -178.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.655 ' CE2' ' HA ' ' A' ' 61' ' ' LEU . 17.2 p90 -70.12 -47.81 60.18 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 120.48 -0.488 . . . . 0.60999999999999999 110.876 -174.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.554 ' CD2' ' HA ' ' A' ' 62' ' ' SER . 0.8 OUTLIER -76.9 -14.27 59.89 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 120.699 -0.4 . . . . 1.5 111.463 -168.539 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.475 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 30.9 t80 -22.04 -61.17 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 O-C-N 125.233 1.583 . . . . 1.52 113.932 -163.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.599 ' H ' ' NH2' ' A' ' 71' ' ' ARG . 17.3 tm0? 175.4 -51.04 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 O-C-N 123.492 0.495 . . . . 3.6000000000000001 111.09 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.488 ' HB ' ' OE1' ' A' ' 67' ' ' GLN . 6.3 t -148.23 24.15 1.03 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.668 0.618 . . . . 1.48 112.668 -169.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.709 ' N ' HH12 ' A' ' 71' ' ' ARG . . . -129.26 0.91 6.08 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 117.928 -2.082 . . . . 1.46 115.96 -167.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.72 ' O ' HG22 ' A' ' 73' ' ' THR . 19.2 t70 -171.18 -41.46 0.02 OUTLIER 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 117.816 0.808 . . . . 2.1899999999999999 110.467 -172.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.772 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -74.89 -20.34 59.76 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-N 115.692 -0.685 . . . . 3.3799999999999999 112.038 -162.154 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.932 HG22 HD13 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -100.83 -7.98 9.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 119.102 -1.039 . . . . 0.70999999999999996 109.995 177.295 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.72 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.4 t -87.05 -35.51 18.7 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 120.24 -0.584 . . . . 0.96999999999999997 109.867 -174.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.604 ' HZ2' ' CD1' ' A' ' 64' ' ' PHE . 21.1 p-90 -105.64 -2.68 23.13 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 116.258 -0.428 . . . . 0.75 111.321 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.772 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 3.0 t70 -66.61 170.45 6.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.84 0.829 . . . . 2.1899999999999999 112.601 -169.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.503 ' HG2' ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -118.0 -21.54 8.26 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.374 -1.284 . . . . 3.1899999999999999 111.182 -177.062 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.7 m -122.66 7.4 9.44 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.194 0.521 . . . . 1.5800000000000001 109.66 -176.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.932 HD13 HG22 ' A' ' 72' ' ' ILE . 27.0 mt -108.78 179.79 4.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.77 -0.65 . . . . 0.70999999999999996 111.347 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.623 ' HB3' HG23 ' A' ' 80' ' ' VAL . 15.3 mm-40 -151.91 -67.1 0.17 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.408 -0.814 . . . . 1.73 111.349 -175.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.623 HG23 ' HB3' ' A' ' 79' ' ' GLN . 21.5 t -143.09 126.05 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.831 -0.622 . . . . 0.78000000000000003 110.3 -166.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -89.81 152.93 21.04 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.374 -0.375 . . . . 5.4000000000000004 110.09 173.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.813 ' HB3' ' HB3' ' A' ' 95' ' ' HIS . 28.1 t-20 -148.99 99.58 2.98 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.401 -0.592 . . . . 1.6899999999999999 109.401 165.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 16.9 ttp -69.9 99.1 1.35 Allowed 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.516 -0.92 . . . . 2.0499999999999998 108.516 177.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.658 HG23 ' HB ' ' A' ' 93' ' ' ILE . 0.2 OUTLIER -78.29 -95.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.718 -0.673 . . . . 0.64000000000000001 111.648 -170.576 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.487 ' H ' HG23 ' A' ' 84' ' ' VAL . 23.0 t-160 -105.2 110.46 22.84 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.642 -0.503 . . . . 1.96 109.642 -178.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -92.65 108.79 20.25 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.384 -0.599 . . . . 2.4399999999999999 109.384 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.592 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -67.39 -40.72 85.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.092 -0.958 . . . . 0.46999999999999997 109.463 -177.202 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.486 ' C ' ' H ' ' A' ' 90' ' ' ASP . 38.2 t70 -156.27 159.77 39.17 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.585 -1.643 . . . . 1.8600000000000001 107.068 -177.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.1 m -72.13 16.87 0.11 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.906 0.384 . . . . 1.4399999999999999 111.183 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.486 ' H ' ' C ' ' A' ' 88' ' ' ASP . 16.2 t70 -137.79 1.83 2.35 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.389 -0.967 . . . . 1.8700000000000001 108.389 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.592 ' O ' HG12 ' A' ' 87' ' ' ILE . 1.7 m -145.29 112.09 5.91 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 109.184 -0.672 . . . . 0.46000000000000002 109.184 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.557 ' O ' HD12 ' A' ' 114' ' ' LEU . 18.6 m-85 -123.61 177.73 5.54 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.199 0.523 . . . . 0.42999999999999999 110.883 -172.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.658 ' HB ' HG23 ' A' ' 84' ' ' VAL . 40.9 mt -132.97 127.37 55.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 107.588 -1.264 . . . . 0.40999999999999998 107.588 169.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.577 ' SG ' HG11 ' A' ' 115' ' ' VAL . 74.5 m -100.98 107.57 19.08 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.426 -0.352 . . . . 2.0099999999999998 111.921 -172.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.813 ' HB3' ' HB3' ' A' ' 82' ' ' ASN . 19.5 t-160 -82.06 74.88 9.01 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.379 -0.971 . . . . 1.23 108.379 165.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.413 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 79.5 m -95.75 111.51 23.45 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.812 -1.085 . . . . 0.5 111.982 -174.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.49 HD13 ' HB ' ' A' ' 80' ' ' VAL . 3.4 mp -78.25 123.56 35.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.992 -0.744 . . . . 1.03 108.992 172.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' A' ' 109' ' ' ARG . 91.1 m -110.35 146.94 34.91 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.951 -1.022 . . . . 1.3799999999999999 109.778 -173.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -82.88 -179.78 7.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.477 0.656 . . . . 1.8200000000000001 111.672 -173.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.691 ' HB3' ' HD3' ' A' ' 108' ' ' PRO . 2.7 p -96.68 104.17 16.14 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.191 -0.913 . . . . 3.9100000000000001 110.973 -176.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.519 ' HE2' ' HB2' ' A' ' 190' ' ' SER . 26.6 t80 -108.61 127.33 53.87 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 107.508 -1.293 . . . . 5.1600000000000001 107.508 174.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.858 ' HB3' HD12 ' A' ' 106' ' ' ILE . . . 73.01 65.13 0.1 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.579 -1.267 . . . . 1.98 107.579 -168.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.612 HG12 ' HB2' ' A' ' 100' ' ' SER . 23.0 m -71.61 27.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 114.269 -1.332 . . . . 3.1699999999999999 112.9 -171.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 102' ' ' ALA . . . -95.58 -36.5 5.33 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.648 -0.786 . . . . 1.96 111.338 174.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.636 ' HB2' HG21 ' A' ' 183' ' ' ILE . 63.7 m -139.46 -0.51 1.77 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.969 0.414 . . . . 1.8799999999999999 111.2 -178.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.858 HD12 ' HB3' ' A' ' 102' ' ' ALA . 96.9 mt -115.6 95.4 3.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.528 0.68 . . . . 1.1200000000000001 111.007 -177.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.54 ' OG ' ' HD2' ' A' ' 108' ' ' PRO . 22.8 t -79.35 159.4 72.56 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 114.758 -1.11 . . . . 1.3500000000000001 108.651 173.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.691 ' HD3' ' HB3' ' A' ' 100' ' ' SER . 47.6 Cg_exo -35.91 136.64 0.2 Allowed 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.363 2.709 . . . . 1.0700000000000001 112.966 173.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.683 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 17.2 ttm180 -123.07 126.42 47.05 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.232 0.539 . . . . 3.4500000000000002 109.779 -172.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.784 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 9.1 t0 -100.1 119.55 38.48 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.761 -0.654 . . . . 1.3700000000000001 109.256 -172.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 95' ' ' HIS . 13.0 m-85 -100.1 145.77 27.57 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.153 0.502 . . . . 2.4100000000000001 112.253 -173.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.961 HG12 ' HD2' ' A' ' 145' ' ' ARG . 29.4 mm -137.87 77.2 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 114.689 -1.142 . . . . 0.42999999999999999 108.264 170.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.41 ' OD2' ' HB3' ' A' ' 148' ' ' ASN . 1.0 OUTLIER -104.0 124.01 48.25 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.426 -0.806 . . . . 1.8600000000000001 110.514 -177.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.557 HD12 ' O ' ' A' ' 92' ' ' PHE . 12.8 tp -74.87 123.57 25.29 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.728 0.775 . . . . 0.28000000000000003 109.41 169.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.577 HG11 ' SG ' ' A' ' 94' ' ' CYS . 0.1 OUTLIER -125.81 126.76 70.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 114.564 -1.198 . . . . 0.26000000000000001 111.812 -168.232 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.885 ' HE2' ' HE2' ' A' ' 118' ' ' LYS . 87.9 t80 -111.17 128.57 55.95 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.396 -0.82 . . . . 2.5699999999999998 110.966 175.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.811 HG13 HG22 ' A' ' 127' ' ' ILE . 1.9 mp -88.82 99.93 9.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.911 -0.774 . . . . 0.89000000000000001 108.911 178.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.885 ' HE2' ' HE2' ' A' ' 116' ' ' TYR . 16.8 tppt? -97.3 123.99 41.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.773 -0.649 . . . . 1.2 110.156 -175.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -115.46 92.09 3.81 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.495 -0.775 . . . . 2.7999999999999998 110.852 -178.249 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.656 ' HB3' ' HB3' ' A' ' 123' ' ' ASN . 97.7 m-85 -70.64 101.65 2.1 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 106.147 -1.798 . . . . 0.82999999999999996 106.147 163.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -47.64 96.31 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.4 1.062 . . . . 2.2799999999999998 112.289 -173.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 72.03 43.26 49.37 Favored Glycine 0 CA--C 1.503 -0.665 0 CA-C-N 113.796 -1.547 . . . . 0.76000000000000001 111.757 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.656 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 65.8 t30 -146.85 -49.07 0.19 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.089 -0.556 . . . . 1.6499999999999999 109.978 -178.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.568 ' HB2' ' HD2' ' A' ' 120' ' ' TYR . 1.0 OUTLIER -155.86 135.18 12.29 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.071 0.462 . . . . 1.1200000000000001 110.978 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.67 80.87 1.5 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.12 -1.067 . . . . 1.6200000000000001 108.12 175.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.744 HG23 ' HB3' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -103.56 140.66 21.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.538 -0.755 . . . . 0.29999999999999999 112.201 -172.526 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.811 HG22 HG13 ' A' ' 117' ' ' ILE . 9.0 pt -104.74 116.62 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 108.402 -0.962 . . . . 0.58999999999999997 108.402 160.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 5.0 m -75.27 163.49 27.44 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.193 -0.912 . . . . 1.1799999999999999 108.69 173.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 37.1 p -155.55 138.61 15.5 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.402 0.62 . . . . 1.24 110.852 178.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.587 ' HE3' ' HB3' ' A' ' 150' ' ' PRO . 11.4 ttmt -151.96 119.63 6.1 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.669 -0.696 . . . . 2.2599999999999998 109.231 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.3 p -64.81 106.73 1.27 Allowed 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 108.59 -0.892 . . . . 1.3899999999999999 108.59 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.5 m -104.7 151.96 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 119.546 -0.862 . . . . 1.05 109.495 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.561 ' HA ' ' CG ' ' A' ' 137' ' ' TYR . 6.5 p-10 -109.05 64.86 0.61 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 122.809 1.29 . . . . 2.1699999999999999 110.533 -170.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.748 ' CZ ' ' HB3' ' A' ' 136' ' ' GLU . 2.3 p90 -100.91 176.46 1.89 Allowed Pre-proline 0 CA--C 1.555 1.149 0 CA-C-N 113.797 -1.547 . . . . 0.53000000000000003 108.946 -176.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.657 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 23.7 Cg_exo -27.67 -59.61 0.1 OUTLIER 'Trans proline' 0 CA--C 1.548 1.218 1 C-N-CA 125.347 4.031 . . . . 1.28 117.504 -178.178 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.748 ' HB3' ' CZ ' ' A' ' 134' ' ' PHE . 4.6 tp10 -74.88 -24.97 58.64 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.439 0.533 . . . . 3.5 112.439 -173.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.955 ' HA ' HG13 ' A' ' 112' ' ' ILE . 21.2 t80 -50.68 -45.05 85.82 Favored Pre-proline 0 CA--C 1.553 1.067 0 N-CA-C 115.78 1.77 . . . . 6.1200000000000001 115.78 -173.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.475 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 36.7 Cg_exo -38.03 116.42 0.22 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 122.975 2.45 . . . . 1.77 114.185 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.665 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 9.6 Cg_endo -89.29 -165.0 0.18 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.883 3.055 . . . . 1.25 114.335 -173.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.0 m -145.03 -171.87 3.73 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.231 -0.895 . . . . 1.6000000000000001 108.617 -176.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.9 t -81.37 -30.13 33.82 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.573 -0.451 . . . . 1.97 110.593 177.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 -79.65 -29.11 40.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.364 0.602 . . . . 2.1800000000000002 110.124 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.784 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 34.9 m-85 -122.13 114.14 20.48 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.68 -0.691 . . . . 1.23 110.162 -176.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.683 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 1.5 tp -95.66 112.95 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 108.063 -1.088 . . . . 0.81999999999999995 108.063 178.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.961 ' HD2' HG12 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -57.75 123.96 17.48 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.645 -1.161 . . . . 4.4199999999999999 111.779 -174.457 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -42.27 99.52 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 113.973 -1.467 . . . . 0.79000000000000004 113.176 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 1.097 ' HB2' ' HB3' ' A' ' 174' ' ' GLU . 1.7 p90 -85.5 68.45 10.44 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.304 -0.948 . . . . 4.4400000000000004 110.902 178.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.41 ' HB3' ' OD2' ' A' ' 113' ' ' ASP . 55.9 t30 -103.31 110.49 22.49 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.112 -0.949 . . . . 1.6200000000000001 110.361 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.603 ' HB2' ' HB3' ' A' ' 172' ' ' GLN . 28.7 m170 -61.37 164.32 9.14 Favored Pre-proline 0 C--O 1.219 -0.536 0 CA-C-O 118.225 -0.893 . . . . 2.3199999999999998 108.675 171.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.587 ' HB3' ' HE3' ' A' ' 130' ' ' LYS . 7.6 Cg_endo -49.33 74.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 123.871 3.047 . . . . 0.53000000000000003 113.982 -177.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' CYS . . . . . 0.731 ' HB3' ' O ' ' A' ' 170' ' ' PHE . 18.2 m -112.65 -173.68 2.3 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.355 -0.839 . . . . 1.5800000000000001 108.745 177.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.675 ' O ' ' HG3' ' A' ' 169' ' ' MET . . . -174.98 -154.72 11.42 Favored Glycine 0 CA--C 1.494 -1.235 0 C-N-CA 118.65 -1.738 . . . . 0.42999999999999999 112.74 -178.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.453 ' CE2' HD21 ' A' ' 167' ' ' LEU . 39.4 t80 -160.07 85.16 0.74 Allowed 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.317 -0.994 . . . . 0.59999999999999998 108.317 -163.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.698 ' CG2' HG13 ' A' ' 168' ' ' VAL . 3.1 m -94.73 126.17 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 CA-C-O 121.862 0.839 . . . . 0.31 110.625 -173.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 63.9 m -106.69 106.52 17.08 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.439 -0.8 . . . . 1.55 109.171 176.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.69 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 13.2 m -101.09 120.05 56.26 Favored Pre-proline 0 C--N 1.314 -0.939 0 C-N-CA 120.796 -0.362 . . . . 1.0600000000000001 111.211 -170.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.418 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 77.6 Cg_exo -51.05 119.59 5.57 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.402 2.068 . . . . 0.56000000000000005 110.965 172.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.597 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 59.2 mmm -83.49 -167.89 1.89 Allowed 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.196 0.522 . . . . 1.1599999999999999 111.917 -174.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -65.06 -32.84 74.75 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.983 0.897 . . . . 2.6299999999999999 109.165 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -113.48 31.13 6.7 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.154 -1.385 . . . . 2.0499999999999998 109.056 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 164' ' ' TYR . 2.1 p-10 -23.37 -55.27 0.12 Allowed Pre-proline 0 N--CA 1.475 0.788 0 N-CA-C 116.505 2.039 . . . . 1.9299999999999999 116.505 -172.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.405 ' HD3' ' CG ' ' A' ' 161' ' ' ASN . 48.7 Cg_endo -67.81 -19.31 47.07 Favored 'Trans proline' 0 C--N 1.35 0.624 0 CA-C-N 121.649 1.625 . . . . 0.72999999999999998 113.146 -175.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -111.89 -22.84 10.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.355 -0.384 . . . . 0.68000000000000005 111.354 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.597 ' O ' ' HB2' ' A' ' 158' ' ' MET . 94.7 m-85 -138.93 129.3 25.67 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.436 -0.579 . . . . 0.93000000000000005 109.436 176.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.709 ' HB2' ' HD3' ' A' ' 58' ' ' PRO . 21.9 t -127.22 148.75 50.2 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.054 -0.659 . . . . 1.4099999999999999 111.598 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.69 ' HB3' ' HB2' ' A' ' 156' ' ' SER . 11.8 tppt? -91.77 100.6 13.27 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.919 0.866 . . . . 0.73999999999999999 111.261 -178.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 1.0 OUTLIER -88.37 105.78 17.81 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.91 -1.041 . . . . 0.27000000000000002 109.089 176.417 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.698 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.1 OUTLIER -132.5 120.21 41.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 122.497 1.141 . . . . 0.28000000000000003 111.927 177.772 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.72 ' HB3' HG13 ' A' ' 50' ' ' VAL . 19.0 ttt -122.69 160.92 24.85 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 113.999 -1.455 . . . . 1.24 108.165 -178.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.75 ' CD2' HG23 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -145.77 149.03 33.62 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.228 -1.027 . . . . 3.3700000000000001 108.228 170.553 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.477 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 8.5 p -137.43 132.31 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 O-C-N 124.147 0.904 . . . . 1.3999999999999999 111.006 -174.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.603 ' HB3' ' HB2' ' A' ' 149' ' ' HIS . 19.0 tt0 -119.93 64.83 0.82 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.587 -1.264 . . . . 2.1699999999999999 107.587 175.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.476 HG22 ' HE1' ' A' ' 147' ' ' TYR . 0.2 OUTLIER -58.07 130.54 47.08 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.885 -1.507 . . . . 1.6499999999999999 111.908 -173.032 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 1.097 ' HB3' ' HB2' ' A' ' 147' ' ' TYR . 12.1 tt0 -84.07 -24.18 30.51 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.583 0.706 . . . . 2.4500000000000002 111.948 -176.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 52.6 mtt 63.24 44.69 5.48 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 114.711 -1.131 . . . . 3.7400000000000002 111.024 168.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.555 ' CG ' ' HG2' ' A' ' 174' ' ' GLU . 17.0 mtp180 -76.41 1.17 17.14 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.594 -0.73 . . . . 5.7800000000000002 111.893 -174.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -87.2 176.71 47.16 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.896 -0.882 . . . . 2.2599999999999998 110.896 174.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -91.08 73.14 6.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 117.108 0.454 . . . . 6.2300000000000004 111.005 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.66 ' HB2' HD11 ' A' ' 184' ' ' ILE . 1.0 OUTLIER -111.8 156.03 22.62 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.234 -1.025 . . . . 1.6399999999999999 108.234 174.444 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 67.6 m -112.8 161.51 26.19 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 108.936 -0.764 . . . . 2.04 108.936 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -41.04 -46.82 5.11 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.004 2.469 . . . . 1.74 113.121 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' A' ' 186' ' ' LYS . 25.1 m -62.62 -20.21 64.54 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.419 0.525 . . . . 2.1400000000000001 112.419 -178.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.636 HG21 ' HB2' ' A' ' 105' ' ' SER . 20.6 mm -90.72 -39.71 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 CA-C-O 122.465 1.126 . . . . 1.1200000000000001 108.942 -177.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 1.005 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.0 OUTLIER -70.21 -37.54 71.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 112.91 -1.95 . . . . 1.1299999999999999 111.489 -176.788 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -67.12 -17.1 64.72 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.149 -0.686 . . . . 2.8900000000000001 109.149 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.492 ' HE2' ' HA ' ' A' ' 183' ' ' ILE . 45.8 mtmt -90.37 -49.32 6.6 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.415 -0.811 . . . . 1.28 109.211 171.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' THR . . . . . 1.005 HG22 ' HA ' ' A' ' 184' ' ' ILE . 11.3 t -60.04 -31.22 69.76 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.617 0.599 . . . . 0.62 112.617 -167.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' MET . . . . . 0.872 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 7.0 mmt -80.11 -61.23 0.45 Allowed Pre-proline 0 C--N 1.327 -0.399 0 C-N-CA 120.488 -0.485 . . . . 1.0600000000000001 111.296 -176.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.872 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 37.8 Cg_exo -62.21 -26.14 77.4 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.132 1.888 . . . . 0.91000000000000003 112.812 -178.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.544 ' O ' ' HB3' ' A' ' 194' ' ' ASN . 98.0 p -80.7 -30.42 36.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.021 0.438 . . . . 1.5 110.713 -178.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -90.46 -34.54 15.56 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.825 -0.625 . . . . 1.8799999999999999 111.518 -172.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.536 HD22 HG11 ' A' ' 50' ' ' VAL . 78.2 mt -73.24 -42.03 63.02 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.57 -0.452 . . . . 1.0900000000000001 111.607 -174.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 189' ' ' PRO . 1.5 m -70.56 -30.08 41.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.831 -0.803 . . . . 0.68000000000000005 108.831 178.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.569 ' HA ' ' HB2' ' A' ' 197' ' ' LEU . 0.1 OUTLIER -73.88 -40.63 63.08 Favored 'General case' 0 C--O 1.208 -1.117 0 CA-C-N 114.138 -1.392 . . . . 2.0699999999999998 111.209 178.013 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.479 ' HD1' ' HA ' ' A' ' 195' ' ' PHE . 1.7 m-30 -56.9 -33.25 66.73 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 118.576 0.626 . . . . 2.0 109.88 172.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.614 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 46.4 mt -77.41 -31.07 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-N 115.973 -0.558 . . . . 0.31 111.316 174.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.569 ' HB2' ' HA ' ' A' ' 194' ' ' ASN . 24.0 mt -70.0 -40.92 75.01 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 110.182 -0.303 . . . . 1.03 110.182 176.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.413 ' HB3' ' CH2' ' A' ' 74' ' ' TRP . 3.8 m-20 -49.18 -45.33 43.97 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.974 -0.75 . . . . 1.8999999999999999 108.974 166.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.83 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -66.76 -44.75 80.59 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.965 -0.561 . . . . 0.28999999999999998 110.22 -177.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.614 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 35.3 mmtp -57.81 -45.83 85.53 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 109.446 -0.575 . . . . 0.96999999999999997 109.446 172.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -67.47 -43.97 79.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.359 -0.837 . . . . 1.9399999999999999 110.756 -171.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -78.45 -20.45 71.82 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.18 -1.01 . . . . 0.46999999999999997 111.666 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.865 HG13 ' HG2' ' A' ' 56' ' ' GLU . 1.0 OUTLIER -78.68 -34.33 17.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 123.439 0.695 . . . . 0.60999999999999999 109.885 173.812 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.558 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 99.2 mttt -80.16 -30.26 38.88 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 108.697 -0.853 . . . . 3.3700000000000001 108.697 177.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -58.39 -22.49 54.06 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.836 -0.62 . . . . 1.02 109.57 170.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.564 ' HB3' ' O ' ' A' ' 203' ' ' ILE . 17.2 t-80 -79.03 -48.31 14.64 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.416 -0.811 . . . . 3.6299999999999999 112.071 174.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -108.08 -32.89 7.35 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.127 0.788 . . . . 2.5899999999999999 113.127 -168.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.427 ' C ' ' H ' ' A' ' 210' ' ' SER . 31.3 m -98.07 142.71 25.02 Favored Pre-proline 0 C--N 1.317 -0.831 0 N-CA-C 110.096 -0.335 . . . . 1.8400000000000001 110.096 -176.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.9 42.23 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.624 2.216 . . . . 2.3500000000000001 112.25 174.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.427 ' H ' ' C ' ' A' ' 208' ' ' THR . 21.4 t -79.24 -18.48 52.76 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.703 -0.68 . . . . 2.3100000000000001 109.67 -178.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -86.98 18.06 3.77 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.251 0.548 . . . . 5.4500000000000002 110.552 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -57.7 -48.69 78.85 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.254 -0.884 . . . . 6.8600000000000003 108.684 169.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -81.05 67.35 3.62 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.146 -1.182 . . . . 3.3700000000000001 110.146 169.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -62.58 146.28 52.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.4 0.619 . . . . 5.21 111.6 -174.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -151.37 125.6 9.34 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.171 -0.922 . . . . 6.46 109.469 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -149.17 154.89 39.82 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.492 -0.558 . . . . 6.0899999999999999 109.492 177.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -96.47 83.71 3.57 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.893 0.378 . . . . 5.1200000000000001 110.691 -175.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 38.0 t -66.87 -35.89 81.05 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.609 -0.885 . . . . 6.7599999999999998 108.609 172.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -177.33 -23.09 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.297 -1.319 . . . . 8.8200000000000003 107.668 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 C--O 1.25 1.08 0 CA-C-N 114.945 -1.025 . . . . 8.4800000000000004 109.189 169.744 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.569 ' HB2' HG22 ' A' ' 87' ' ' ILE . 15.1 mmt . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 109.854 -0.425 . . . . 3.8599999999999999 109.854 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.445 ' OD2' HD11 ' A' ' 6' ' ' ILE . 36.4 t70 -66.94 -40.31 87.52 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.743 0.306 . . . . 2.25 110.369 -177.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.853 ' HA ' HD12 ' A' ' 6' ' ' ILE . 94.0 m-85 -64.98 -33.8 76.91 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.076 -0.712 . . . . 0.42999999999999999 109.076 -176.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.646 ' HD2' ' CB ' ' A' ' 88' ' ' ASP . 33.5 tttm -73.79 -3.58 29.42 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.021 -0.99 . . . . 1.51 110.288 177.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.463 ' O ' ' HG3' ' A' ' 9' ' ' GLN . . . -91.37 -40.98 11.15 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.559 -0.534 . . . . 0.54000000000000004 109.559 172.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.853 HD12 ' HA ' ' A' ' 3' ' ' PHE . 1.1 mp -82.51 -44.01 19.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.956 0.884 . . . . 1.0700000000000001 109.487 -172.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.534 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -70.85 -39.3 73.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.302 -1.317 . . . . 0.34000000000000002 111.422 -178.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.574 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 8.1 mt-30 -66.85 -26.14 66.76 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.99 -1.004 . . . . 1.5900000000000001 110.384 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 5' ' ' ALA . 98.7 mt-30 -80.52 -37.11 32.19 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.082 -0.963 . . . . 2.4700000000000002 108.843 172.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.654 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.4 OUTLIER -67.87 -37.48 81.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.666 -1.152 . . . . 0.47999999999999998 111.614 -178.849 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.597 ' HA ' ' OG ' ' A' ' 128' ' ' SER . . . -46.43 -58.44 3.75 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.592 0.59 . . . . 0.31 112.592 176.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.525 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 13.1 pt20 -83.14 5.39 22.8 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.056 0.455 . . . . 1.6399999999999999 110.803 -177.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.564 ' HB3' ' HA ' ' A' ' 10' ' ' THR . 0.2 OUTLIER -89.49 -49.94 6.39 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.182 -1.044 . . . . 2.54 108.182 174.978 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.668 HG21 ' N ' ' A' ' 152' ' ' GLY . 13.2 p -69.93 -36.44 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 121.828 0.823 . . . . 0.53000000000000003 109.555 177.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.538 ' HG ' ' OD1' ' A' ' 18' ' ' ASN . 2.1 tt -72.87 -18.72 61.4 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 114.87 -1.059 . . . . 0.59999999999999998 109.229 173.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 20' ' ' ASP . . . -61.94 -23.5 63.68 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.11 -1.405 . . . . 0.56999999999999995 109.856 172.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.446 ' HB3' ' CE2' ' A' ' 170' ' ' PHE . 6.8 m-85 -91.33 -28.79 17.51 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.099 -0.55 . . . . 3.27 110.775 177.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.538 ' OD1' ' HG ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -69.59 -15.75 63.27 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.777 -0.369 . . . . 2.0299999999999998 111.335 179.401 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -117.59 -5.48 11.18 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 119.921 -0.711 . . . . 2.7200000000000002 111.896 179.056 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 2.6 m-20 -121.99 135.75 54.87 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 120.919 0.39 . . . . 2.1600000000000001 111.205 178.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.474 HG22 ' CZ2' ' A' ' 24' ' ' TRP . 64.4 p -137.61 120.47 16.42 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.05 -0.523 . . . . 1.8200000000000001 111.411 -176.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.3 t -167.34 132.09 1.95 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.152 -0.476 . . . . 2.1899999999999999 110.204 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.87 -6.06 82.04 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.859 -0.686 . . . . 1.1000000000000001 113.669 172.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.808 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -111.75 -170.2 1.61 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.842 0.321 . . . . 1.6699999999999999 110.625 -178.231 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.443 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 7.3 mtpt -178.6 133.22 0.13 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.884 -0.784 . . . . 2.9500000000000002 108.884 -169.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.797 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 1.6 p -61.58 120.03 6.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 119.819 -0.753 . . . . 1.5600000000000001 109.305 171.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 p -95.18 -23.5 5.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 114.708 -1.133 . . . . 1.22 109.123 -177.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.422 ' HD2' ' HA ' ' A' ' 28' ' ' LYS . 11.0 tptm -156.53 129.92 8.12 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.885 -0.598 . . . . 2.4100000000000001 111.847 -173.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.472 HG23 HG21 ' A' ' 26' ' ' VAL . 40.2 p -122.09 149.44 43.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.429 -0.805 . . . . 1.3799999999999999 109.584 173.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 51.1 m -150.4 69.78 1.0 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 121.185 -0.206 . . . . 2.3700000000000001 111.204 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER 74.76 71.76 0.1 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.209 -0.451 . . . . 4.5499999999999998 110.829 177.241 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.553 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 89.5 mttt 80.04 4.54 1.92 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.337 -0.847 . . . . 1.4199999999999999 112.842 172.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.849 HG22 ' HA3' ' A' ' 52' ' ' GLY . 7.5 pt -115.66 143.61 25.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.069 0.461 . . . . 0.76000000000000001 110.151 175.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 5.0 m -136.47 104.7 5.67 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.125 -0.943 . . . . 0.57999999999999996 110.433 -163.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.682 HG22 HG23 ' A' ' 50' ' ' VAL . 3.4 t -96.48 98.85 8.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.864 -0.421 . . . . 0.85999999999999999 109.864 -178.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.797 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 25.9 t -91.96 121.68 33.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.725 0.774 . . . . 1.1000000000000001 110.357 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.3 t -109.01 135.21 50.55 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.341 -1.299 . . . . 1.27 110.56 -175.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.808 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 31.6 ttpt -121.92 -90.66 0.57 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.482 -0.781 . . . . 1.9099999999999999 110.352 178.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.843 ' HA ' ' HA ' ' A' ' 46' ' ' ASN . . . -179.49 143.34 0.19 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.419 -0.81 . . . . 1.6799999999999999 109.805 -177.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.8 m -112.03 80.79 1.37 Allowed 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.604 -0.517 . . . . 2.0899999999999999 109.604 175.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -76.83 -4.43 43.54 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.791 -0.64 . . . . 6.6100000000000003 109.781 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -63.09 -14.58 50.09 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.615 -0.72 . . . . 6.46 109.714 172.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -146.04 -93.57 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.646 -0.707 . . . . 5.6500000000000004 109.317 175.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -171.62 68.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.914 0.388 . . . . 5.5599999999999996 110.172 173.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -160.5 -140.34 2.87 Favored Glycine 0 N--CA 1.434 -1.462 0 N-CA-C 110.123 -1.191 . . . . 1.5600000000000001 110.123 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.843 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 82.2 m-20 -135.22 151.64 50.81 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 110.121 -0.326 . . . . 2.0499999999999998 110.121 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.557 HD23 ' N ' ' A' ' 48' ' ' TYR . 2.9 tt -104.89 137.34 42.81 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.169 -1.049 . . . . 0.87 108.169 178.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.557 ' N ' HD23 ' A' ' 47' ' ' LEU . 58.2 m-85 -124.47 126.42 45.87 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.392 -0.367 . . . . 0.98999999999999999 110.137 -173.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.712 ' HG3' ' CE2' ' A' ' 170' ' ' PHE . 2.5 tmm_? -113.36 120.27 40.52 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.38 -0.6 . . . . 2.9199999999999999 109.38 175.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.682 HG23 HG22 ' A' ' 35' ' ' VAL . 7.6 p -101.9 138.68 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 108.769 -0.826 . . . . 1.3300000000000001 108.769 177.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.636 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 51.6 tt0 -138.63 108.07 6.16 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.467 -0.788 . . . . 1.0700000000000001 109.351 -169.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.849 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -138.34 142.39 13.08 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.031 -1.08 . . . . 0.28999999999999998 112.195 -177.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.0 mt -86.8 124.29 40.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 C-N-CA 120.29 -0.564 . . . . 0.57999999999999996 109.886 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.539 HG12 ' HD3' ' A' ' 200' ' ' LYS . 71.7 mt -105.95 113.76 63.38 Favored Pre-proline 0 C--N 1.312 -1.05 0 N-CA-C 108.834 -0.802 . . . . 0.34999999999999998 108.834 175.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -62.18 67.49 0.12 Allowed 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 124.175 3.25 . . . . 0.62 112.043 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.698 ' HG2' ' CG1' ' A' ' 203' ' ' ILE . 8.0 tp10 -161.13 172.32 16.98 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.775 -1.194 . . . . 1.6799999999999999 107.775 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.465 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 6.2 p -82.09 144.7 51.38 Favored Pre-proline 0 N--CA 1.427 -1.575 0 CA-C-O 121.748 0.785 . . . . 1.1799999999999999 110.356 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.497 ' HB3' ' SG ' ' A' ' 155' ' ' CYS . 23.8 Cg_exo -61.71 -13.25 29.11 Favored 'Trans proline' 0 C--N 1.332 -0.297 0 C-N-CA 124.108 3.206 . . . . 0.52000000000000002 110.539 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.61 -51.47 34.83 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.526 -1.215 . . . . 0.64000000000000001 111.028 175.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.52 ' HE3' ' HB2' ' A' ' 60' ' ' LYS . 26.2 ttmt -71.06 -27.9 63.98 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.885 -0.784 . . . . 3.2999999999999998 108.885 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.054 HD23 HD13 ' A' ' 203' ' ' ILE . 42.7 mt -63.95 -53.13 55.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.697 -1.138 . . . . 0.40999999999999998 109.945 174.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.552 ' HA ' ' CD1' ' A' ' 65' ' ' LEU . 34.7 t -65.91 -11.92 50.76 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.438 -0.346 . . . . 1.29 110.317 175.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.5 ' HB2' ' HA ' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -83.1 -40.25 20.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.217 -0.447 . . . . 1.3200000000000001 111.497 -179.717 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.525 ' CD2' ' HA ' ' A' ' 61' ' ' LEU . 15.6 p90 -81.37 -42.79 19.96 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 120.813 -0.355 . . . . 0.60999999999999999 111.166 -174.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.769 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -85.87 10.17 14.64 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.709 0.29 . . . . 1.5 110.726 -173.02 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.558 ' N ' HH12 ' A' ' 71' ' ' ARG . 1.0 OUTLIER -42.99 -71.29 0.08 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.155 -0.93 . . . . 1.52 112.683 -169.207 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.41 -57.3 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.183 1.549 . . . . 3.6000000000000001 115.183 177.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.694 ' OG1' ' HB2' ' A' ' 81' ' ' TYR . 8.8 t -159.07 23.85 0.2 Allowed 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.852 -0.53 . . . . 1.48 112.298 -161.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.418 ' H ' ' CZ ' ' A' ' 71' ' ' ARG . . . -127.67 1.29 6.91 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 118.501 -1.809 . . . . 1.46 115.535 -166.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.619 ' O ' HG22 ' A' ' 73' ' ' THR . 24.5 t70 -173.27 -40.63 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 117.566 0.683 . . . . 2.1899999999999999 110.784 -169.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.695 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -54.87 -38.52 67.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.501 -0.772 . . . . 3.3799999999999999 111.362 -173.743 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.795 HG22 HD13 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -86.11 -7.46 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-O 120.969 0.414 . . . . 0.70999999999999996 110.953 -176.499 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -90.34 -26.54 19.91 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 120.077 -0.649 . . . . 0.96999999999999997 109.631 -175.584 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.506 ' CE2' ' HA ' ' A' ' 71' ' ' ARG . 24.2 p-90 -111.2 -4.68 14.91 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.595 0.591 . . . . 0.75 112.595 178.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.695 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 4.2 t70 -70.6 174.33 6.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.684 0.754 . . . . 2.1899999999999999 112.348 -171.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.585 ' HG2' ' OD1' ' A' ' 198' ' ' ASN . 1.3 mmtt -106.76 -29.04 9.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.857 -1.065 . . . . 3.1899999999999999 109.313 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.1 m -128.28 20.63 6.26 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.671 -1.15 . . . . 1.5800000000000001 111.109 -172.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.795 HD13 HG22 ' A' ' 72' ' ' ILE . 27.1 mt -110.17 155.94 21.3 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.995 0.426 . . . . 0.70999999999999996 110.45 175.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.912 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 2.7 mm-40 -128.16 -61.44 1.1 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.859 -0.609 . . . . 1.73 112.269 -170.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.71 ' CG1' ' HB ' ' A' ' 97' ' ' ILE . 2.9 p -157.15 127.02 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.644 0.735 . . . . 0.78000000000000003 111.9 -170.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.694 ' HB2' ' OG1' ' A' ' 68' ' ' THR . 48.6 p90 -89.67 143.96 26.38 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.454 -1.248 . . . . 5.4000000000000004 110.936 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.783 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 51.1 m-80 -150.03 109.41 3.98 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.193 -0.669 . . . . 1.6899999999999999 109.193 172.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.504 ' SD ' ' HB3' ' A' ' 92' ' ' PHE . 31.0 tpp -79.88 109.43 14.31 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.89 -0.782 . . . . 2.0499999999999998 108.89 177.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -85.07 -72.39 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.857 -0.61 . . . . 0.64000000000000001 110.342 -168.813 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.522 ' HB2' HD12 ' A' ' 93' ' ' ILE . 8.0 m-70 -126.41 121.57 32.84 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.764 -0.653 . . . . 1.96 109.741 177.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 -100.47 125.51 46.79 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.136 -1.061 . . . . 2.4399999999999999 108.136 175.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.733 HG21 ' HB2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -91.34 -58.27 3.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 116.22 -0.446 . . . . 0.46999999999999997 111.994 -167.072 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.646 ' CB ' ' HD2' ' A' ' 4' ' ' LYS . 15.6 m-20 -144.92 35.89 1.13 Allowed 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.604 -0.438 . . . . 1.8600000000000001 112.151 -165.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.9 t 73.21 -33.2 0.26 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.154 0.582 . . . . 1.4399999999999999 112.42 176.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -117.02 10.53 13.99 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 108.485 -0.932 . . . . 1.8700000000000001 108.485 -177.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.613 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -138.92 116.2 11.12 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 114.962 -1.017 . . . . 0.46000000000000002 108.394 -174.381 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.597 ' O ' HD12 ' A' ' 114' ' ' LEU . 46.5 m-85 -124.41 177.36 5.93 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.196 0.522 . . . . 0.42999999999999999 110.745 -175.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.646 ' O ' HG23 ' A' ' 84' ' ' VAL . 43.1 mt -135.83 118.03 21.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 107.515 -1.291 . . . . 0.40999999999999998 107.515 168.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 72.5 m -100.46 109.32 21.45 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.883 0.373 . . . . 2.0099999999999998 111.931 -171.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.783 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 19.6 t-160 -80.04 69.96 6.53 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.56 -0.904 . . . . 1.23 108.56 170.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.406 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 96.5 m -95.92 114.72 26.47 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.511 -1.222 . . . . 0.5 111.427 -175.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.71 ' HB ' ' CG1' ' A' ' 80' ' ' VAL . 2.7 mp -85.11 127.53 39.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.614 -0.884 . . . . 1.03 108.614 172.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 109' ' ' ARG . 12.6 t -110.86 165.37 11.9 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.937 -0.574 . . . . 1.3799999999999999 110.233 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.912 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 50.5 mt-30 -115.72 74.91 0.91 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.673 -0.694 . . . . 1.8200000000000001 109.429 175.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.421 ' O ' ' HB ' ' A' ' 106' ' ' ILE . 17.3 m -79.04 32.64 0.21 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.452 0.644 . . . . 3.9100000000000001 110.606 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.571 ' CE2' ' HA2' ' A' ' 104' ' ' GLY . 43.8 t80 -61.2 98.49 0.08 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.865 -1.061 . . . . 5.1600000000000001 110.561 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.67 -71.45 0.35 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.602 -0.726 . . . . 1.98 110.809 174.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.7 t -128.48 6.15 2.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 122.16 0.981 . . . . 3.1699999999999999 108.648 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.571 ' HA2' ' CE2' ' A' ' 101' ' ' PHE . . . 106.9 0.72 36.27 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 114.576 -1.193 . . . . 1.96 110.435 -169.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -32.35 65.71 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.728 0.775 . . . . 1.8799999999999999 109.533 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.804 HG12 HD23 ' A' ' 179' ' ' LEU . 8.3 mt -113.9 116.99 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-N 114.193 -1.367 . . . . 1.1200000000000001 110.001 -172.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.403 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 14.2 m -71.58 164.12 60.54 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 115.976 -0.556 . . . . 1.3500000000000001 109.612 175.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 107' ' ' SER . 7.9 Cg_endo -51.06 113.62 1.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.072 1.848 . . . . 1.0700000000000001 110.48 172.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.661 ' HG2' HG23 ' A' ' 144' ' ' ILE . 18.7 mtm180 -90.62 137.52 32.29 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 120.321 -0.552 . . . . 3.4500000000000002 109.716 -173.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.839 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 9.9 t0 -94.42 126.85 39.95 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.905 -0.776 . . . . 1.3700000000000001 108.905 -177.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 95' ' ' HIS . 6.9 m-85 -107.17 146.34 31.46 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.61 0.719 . . . . 2.4100000000000001 111.576 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.833 HG12 ' HD2' ' A' ' 145' ' ' ARG . 25.2 mm -137.67 68.78 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 114.301 -1.318 . . . . 0.42999999999999999 107.608 172.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.853 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 1.4 m-20 -90.54 115.56 27.78 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.627 -1.17 . . . . 1.8600000000000001 110.088 -176.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.627 ' O ' ' HA ' ' A' ' 129' ' ' SER . 6.1 tp -74.84 119.18 18.67 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 108.745 -0.835 . . . . 0.28000000000000003 108.745 169.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.2 OUTLIER -122.99 124.13 69.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-N 115.033 -0.985 . . . . 0.26000000000000001 111.675 -164.24 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.534 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 79.8 t80 -107.77 119.76 40.34 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.973 -1.012 . . . . 2.5699999999999998 110.769 176.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.813 HG13 HG22 ' A' ' 127' ' ' ILE . 3.9 mp -89.85 98.87 8.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.768 -0.651 . . . . 0.89000000000000001 109.608 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.451 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 39.7 ttmt -106.77 141.4 38.08 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.702 -0.681 . . . . 1.2 109.508 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 124' ' ' MET . 0.4 OUTLIER -131.75 104.19 6.77 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 109.01 -0.737 . . . . 2.7999999999999998 109.01 -177.566 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.632 ' CB ' ' HB3' ' A' ' 123' ' ' ASN . 42.7 m-85 -71.43 114.67 9.75 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 106.959 -1.497 . . . . 0.82999999999999996 106.959 167.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -41.61 96.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 O-C-N 124.514 1.134 . . . . 2.2799999999999998 112.293 -175.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.432 ' C ' ' HG2' ' A' ' 157' ' ' PRO . . . 61.56 36.52 92.73 Favored Glycine 0 CA--C 1.508 -0.352 0 CA-C-N 114.496 -1.229 . . . . 0.76000000000000001 112.276 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.632 ' HB3' ' CB ' ' A' ' 120' ' ' TYR . 33.9 t-20 -133.82 -45.81 0.8 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.524 -0.338 . . . . 1.6499999999999999 110.377 -178.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.532 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 0.3 OUTLIER -157.72 122.64 4.4 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.848 0.356 . . . . 1.1200000000000001 111.393 -177.889 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 155' ' ' CYS . 13.4 m120 -104.26 73.83 1.15 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.756 -0.831 . . . . 1.6200000000000001 108.756 174.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.678 ' HB ' HG12 ' A' ' 154' ' ' VAL . 1.2 tt -96.57 136.11 28.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 113.245 0.831 . . . . 0.29999999999999999 113.245 -172.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.813 HG22 HG13 ' A' ' 117' ' ' ILE . 21.0 pt -104.87 109.82 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-O 121.98 0.895 . . . . 0.58999999999999997 109.009 163.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.597 ' OG ' ' HA ' ' A' ' 11' ' ' ALA . 1.1 m -89.84 114.42 26.16 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.441 -0.799 . . . . 1.1799999999999999 110.709 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.853 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 79.3 p -114.21 145.05 42.22 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.57 0.7 . . . . 1.24 111.753 -172.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.811 ' HE2' ' HG3' ' A' ' 150' ' ' PRO . 6.3 mtpm? -133.78 123.75 25.41 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 107.677 -1.231 . . . . 2.2599999999999998 107.677 174.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.525 ' HB2' ' H ' ' A' ' 148' ' ' ASN . 32.6 t -64.28 98.85 0.25 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 105.926 -1.879 . . . . 1.3899999999999999 105.926 170.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.472 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.3 OUTLIER -105.41 132.62 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 CA-C-O 121.985 0.897 . . . . 1.05 109.021 -164.012 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.405 ' HA ' ' CD1' ' A' ' 137' ' ' TYR . 5.4 t70 -88.61 68.86 8.77 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 114.02 -1.445 . . . . 2.1699999999999999 109.26 -166.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.695 ' HB2' ' HD2' ' A' ' 135' ' ' PRO . 0.4 OUTLIER -107.07 175.08 2.17 Favored Pre-proline 0 CA--C 1.548 0.875 0 CA-C-N 114.997 -1.001 . . . . 0.53000000000000003 109.496 -172.226 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.695 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 3.0 Cg_exo -35.91 -51.28 1.06 Allowed 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 124.802 3.668 . . . . 1.28 116.632 -175.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.613 ' HG3' HG12 ' A' ' 84' ' ' VAL . 14.0 mm-40 -82.74 -21.59 34.67 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.5 0.667 . . . . 3.5 111.474 -172.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.78 ' HD2' ' HB ' ' A' ' 112' ' ' ILE . 60.3 t80 -56.01 -38.59 69.82 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 115.233 1.568 . . . . 6.1200000000000001 115.233 -174.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.528 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 67.8 Cg_exo -41.46 114.88 0.36 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 122.055 1.837 . . . . 1.77 112.431 173.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.618 ' HG3' ' HB2' ' A' ' 145' ' ' ARG . 1.6 Cg_endo -85.23 -153.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.792 2.995 . . . . 1.25 113.982 -173.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.2 p -136.54 -158.77 0.89 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 114.923 -1.035 . . . . 1.6000000000000001 108.572 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.3 p -90.28 -36.84 14.47 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.215 -0.594 . . . . 1.97 111.488 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -75.74 -48.27 22.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.356 -0.383 . . . . 2.1800000000000002 111.661 -178.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.756 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 94.9 m-85 -93.75 125.07 38.16 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.028 0.442 . . . . 1.23 110.102 -177.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.661 HG23 ' HG2' ' A' ' 109' ' ' ARG . 1.1 tp -106.94 105.91 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-N 115.723 -0.671 . . . . 0.81999999999999995 109.276 -177.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.839 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 0.8 OUTLIER -58.86 100.92 0.08 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.01 -0.996 . . . . 4.4199999999999999 109.818 177.816 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -63.09 117.5 11.44 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.952 -0.642 . . . . 0.79000000000000004 111.746 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.498 ' HB3' ' CB ' ' A' ' 174' ' ' GLU . 34.8 t80 -85.81 82.7 8.07 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.508 0.671 . . . . 4.4400000000000004 110.496 -176.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.648 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 88.2 m-20 -70.93 106.1 3.52 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.284 -0.871 . . . . 1.6200000000000001 109.849 173.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.502 ' O ' ' HB3' ' A' ' 172' ' ' GLN . 36.0 m-70 -68.04 131.44 92.27 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 108.347 -0.982 . . . . 2.3199999999999998 108.347 174.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.811 ' HG3' ' HE2' ' A' ' 130' ' ' LYS . 83.4 Cg_exo -17.51 68.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.927 1 C-N-CA 126.722 4.948 . . . . 0.53000000000000003 115.854 -169.409 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 151' ' ' CYS . . . . . 0.648 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 10.0 p -99.46 -174.6 2.77 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.077 -0.965 . . . . 1.5800000000000001 108.866 173.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.668 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -173.67 -150.98 7.86 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 119.14 -1.505 . . . . 0.42999999999999999 112.685 -177.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 23.0 t80 -162.35 93.05 0.84 Allowed 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.929 -1.137 . . . . 0.59999999999999998 107.929 -164.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.734 HG23 HG13 ' A' ' 168' ' ' VAL . 5.9 m -101.55 134.09 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-O 121.933 0.873 . . . . 0.31 110.621 -177.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' CYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 124' ' ' MET . 8.9 t -113.28 122.63 48.01 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.036 -0.984 . . . . 1.55 109.37 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.59 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 21.3 m -117.83 114.92 37.27 Favored Pre-proline 0 C--N 1.319 -0.755 0 C-N-CA 120.636 -0.426 . . . . 1.0600000000000001 112.015 -171.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.459 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 84.8 Cg_exo -49.94 121.84 8.11 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.607 2.205 . . . . 0.56000000000000005 111.544 171.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.69 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 0.5 OUTLIER -79.64 -167.73 1.33 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.156 0.503 . . . . 1.1599999999999999 112.268 -173.599 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.413 ' H ' ' HG2' ' A' ' 159' ' ' GLU . 5.2 mm-40 -63.81 -30.78 71.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.237 -0.892 . . . . 2.6299999999999999 108.631 172.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 13.5 mm-40 -103.3 26.8 7.9 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 114.536 -1.211 . . . . 2.0499999999999998 109.231 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.668 ' HB3' ' HD3' ' A' ' 162' ' ' PRO . 49.7 t-20 4.74 -77.81 0.0 OUTLIER Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 126.23 1.812 . . . . 1.9299999999999999 115.357 -177.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.668 ' HD3' ' HB3' ' A' ' 161' ' ' ASN . 71.6 Cg_endo -73.69 -13.29 24.59 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 121.396 1.397 . . . . 0.72999999999999998 113.912 -172.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -105.79 -27.0 11.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.526 -0.306 . . . . 0.68000000000000005 111.308 -176.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.69 ' O ' ' HB2' ' A' ' 158' ' ' MET . 67.8 m-85 -137.62 133.18 34.05 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.515 -0.55 . . . . 0.93000000000000005 109.515 176.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.438 ' HB3' HD11 ' A' ' 61' ' ' LEU . 32.3 t -129.23 147.55 51.08 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.228 0.537 . . . . 1.4099999999999999 110.896 177.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.636 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.6 tppp? -93.99 103.48 15.56 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 122.043 0.925 . . . . 0.73999999999999999 110.993 -178.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.42 HD11 ' CZ ' ' A' ' 153' ' ' PHE . 0.6 OUTLIER -87.26 103.45 15.46 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.345 -1.298 . . . . 0.27000000000000002 109.475 177.475 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.734 HG13 HG23 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -125.4 116.38 46.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.833 0.825 . . . . 0.28000000000000003 111.327 178.436 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 48.6 ttp -121.97 145.59 47.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.355 -0.839 . . . . 1.24 109.945 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.712 ' CE2' ' HG3' ' A' ' 49' ' ' ARG . 31.3 m-85 -119.3 134.9 54.97 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 109.098 -0.704 . . . . 3.3700000000000001 109.098 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.415 ' HB ' HD21 ' A' ' 192' ' ' LEU . 2.7 p -120.8 119.13 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-O 121.55 0.691 . . . . 1.3999999999999999 109.648 178.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.502 ' HB3' ' O ' ' A' ' 149' ' ' HIS . 9.3 tt0 -127.05 51.25 1.9 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.734 1.254 . . . . 2.1699999999999999 108.133 -176.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.551 HG22 ' H ' ' A' ' 175' ' ' MET . 11.0 m -72.63 150.89 42.63 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 113.565 -1.652 . . . . 1.6499999999999999 110.77 -174.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.7 ' HG2' ' HG3' ' A' ' 176' ' ' ARG . 3.3 tt0 -82.37 -19.76 38.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.229 0.538 . . . . 2.4500000000000002 111.136 -177.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.551 ' H ' HG22 ' A' ' 173' ' ' THR . 58.8 mtt 68.43 34.87 3.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.114 -0.948 . . . . 3.7400000000000002 111.188 169.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.7 ' HG3' ' HG2' ' A' ' 174' ' ' GLU . 45.2 mtm180 -78.82 13.46 1.69 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.198 0.523 . . . . 5.7800000000000002 109.913 177.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 175' ' ' MET . . . -91.15 33.79 4.56 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.785 -0.643 . . . . 2.2599999999999998 113.961 -171.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp 60.22 66.67 0.93 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.2 0.444 . . . . 6.2300000000000004 112.2 170.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.804 HD23 HG12 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -148.77 160.21 43.41 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.457 0.646 . . . . 1.6399999999999999 111.152 -177.259 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.474 ' O ' HD12 ' A' ' 184' ' ' ILE . 6.8 m -111.86 160.51 29.5 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 114.754 -1.112 . . . . 2.04 108.552 -178.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -41.83 -46.55 6.62 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.048 2.498 . . . . 1.74 114.109 -176.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.413 ' O ' ' HE2' ' A' ' 186' ' ' LYS . 12.2 t -72.47 -17.4 61.77 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.902 0.382 . . . . 2.1400000000000001 111.504 -177.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.406 ' HA ' ' HE3' ' A' ' 186' ' ' LYS . 21.9 mm -85.25 -35.68 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 CA-C-O 122.64 1.21 . . . . 1.1200000000000001 108.384 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 1.032 ' HA ' HG22 ' A' ' 187' ' ' THR . 0.9 OUTLIER -68.69 -32.76 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-N 112.602 -2.09 . . . . 1.1299999999999999 110.187 179.563 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.501 ' O ' ' HD2' ' A' ' 189' ' ' PRO . 12.3 mm-40 -53.47 -34.39 57.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.282 -0.872 . . . . 2.8900000000000001 109.206 167.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 190' ' ' SER . 43.4 mtmt -93.22 -12.35 30.43 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.823 -1.08 . . . . 1.28 111.917 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' THR . . . . . 1.032 HG22 ' HA ' ' A' ' 184' ' ' ILE . 6.8 t -92.98 -45.56 7.88 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 119.1 -1.04 . . . . 0.62 112.112 175.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' MET . . . . . 0.933 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 11.2 mmt -81.42 -67.47 0.22 Allowed Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 121.184 -0.947 . . . . 1.0600000000000001 111.362 -173.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.933 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 29.5 Cg_exo -60.92 -31.4 91.48 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 121.975 1.783 . . . . 0.91000000000000003 112.118 -176.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.543 ' HB2' ' O ' ' A' ' 186' ' ' LYS . 48.7 m -77.96 -29.53 49.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.35 -0.386 . . . . 1.5 111.717 -176.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 187' ' ' THR . 85.8 m-20 -90.37 -29.82 17.81 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.881 -0.328 . . . . 1.8799999999999999 111.425 -177.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' A' ' 188' ' ' MET . 42.1 mt -64.02 -48.06 77.8 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 120.907 -0.317 . . . . 1.0900000000000001 111.265 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.812 ' HB ' HD12 ' A' ' 33' ' ' ILE . 1.1 m -67.08 -35.65 74.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.445 0.64 . . . . 0.68000000000000005 109.778 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -68.15 -30.89 70.12 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.737 -1.119 . . . . 2.0699999999999998 110.94 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.495 ' O ' ' HB2' ' A' ' 198' ' ' ASN . 8.0 t80 -73.88 -27.35 61.02 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.46 -0.57 . . . . 2.0 109.46 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.456 HG21 ' CG2' ' A' ' 33' ' ' ILE . 25.6 mt -78.56 -27.78 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-O 121.353 0.597 . . . . 0.31 110.281 173.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 197' ' ' LEU . 61.1 mt -71.66 -39.63 70.18 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 109.585 -0.524 . . . . 1.03 109.585 172.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.585 ' OD1' ' HG2' ' A' ' 76' ' ' LYS . 87.0 m-20 -49.63 -38.89 33.85 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.972 -1.013 . . . . 1.8999999999999999 109.58 165.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.635 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -76.13 -42.88 45.52 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 116.356 -0.384 . . . . 0.28999999999999998 110.744 -178.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.539 ' HD3' HG12 ' A' ' 54' ' ' ILE . 35.9 mmtm -59.12 -42.42 90.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.507 0.67 . . . . 0.96999999999999997 110.904 175.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -86.66 -37.23 18.21 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.209 -0.905 . . . . 1.9399999999999999 110.641 -174.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' GLY . . . . . 0.514 ' O ' ' HB2' ' A' ' 206' ' ' HIS . . . -70.72 -29.52 69.41 Favored Glycine 0 CA--C 1.503 -0.657 0 N-CA-C 111.395 -0.682 . . . . 0.46999999999999997 111.395 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 1.054 HD13 HD23 ' A' ' 61' ' ' LEU . 2.8 tp -70.74 -33.49 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 109.629 -0.508 . . . . 0.60999999999999999 109.629 177.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.47 ' HA ' ' HB3' ' A' ' 207' ' ' ARG . 40.9 mttp -85.79 -25.03 26.57 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 109.302 -0.629 . . . . 3.3700000000000001 109.302 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.865 ' HA ' ' HB3' ' A' ' 210' ' ' SER . . . -65.38 -32.59 74.3 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.71 -0.848 . . . . 1.02 108.71 167.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.514 ' HB2' ' O ' ' A' ' 202' ' ' GLY . 1.8 t60 -92.98 -3.15 54.97 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 114.814 -1.085 . . . . 3.6299999999999999 112.086 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.47 ' HB3' ' HA ' ' A' ' 204' ' ' LYS . 0.2 OUTLIER -119.12 -48.8 2.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.872 0.844 . . . . 2.5899999999999999 110.393 -178.482 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.572 HG23 ' HD2' ' A' ' 209' ' ' PRO . 1.2 m -95.88 151.7 38.53 Favored Pre-proline 0 C--N 1.31 -1.13 0 CA-C-N 114.414 -1.267 . . . . 1.8400000000000001 109.608 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.572 ' HD2' HG23 ' A' ' 208' ' ' THR . 38.4 Cg_exo -59.04 73.78 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.146 2.564 . . . . 2.3500000000000001 113.281 176.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.865 ' HB3' ' HA ' ' A' ' 205' ' ' ALA . 18.2 t -115.31 12.32 16.37 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 122.118 0.961 . . . . 2.3100000000000001 109.136 175.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.605 ' HA ' ' HE ' ' A' ' 211' ' ' ARG . 2.0 mmp_? -102.73 11.64 37.36 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.24 -0.891 . . . . 5.4500000000000002 109.518 176.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -60.42 -25.56 66.04 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.326 -0.852 . . . . 6.8600000000000003 110.003 176.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -135.92 99.36 0.31 Allowed Glycine 0 N--CA 1.439 -1.102 0 CA-C-N 115.371 -0.831 . . . . 3.3700000000000001 111.198 174.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 211' ' ' ARG . 85.4 m-85 -75.68 179.21 5.53 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.13 -0.322 . . . . 5.21 110.13 177.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 6.9 t60 73.6 131.17 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 O-C-N 123.75 0.656 . . . . 6.46 110.814 175.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -67.05 93.09 0.27 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.565 0.698 . . . . 6.0899999999999999 109.839 174.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -78.29 46.88 0.64 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.183 -0.917 . . . . 5.1200000000000001 112.512 -172.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 46.7 t -110.18 7.71 23.42 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.362 -0.381 . . . . 6.7599999999999998 110.161 177.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 81.7 t60 57.61 41.15 26.06 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.854 0.835 . . . . 8.8200000000000003 110.408 -178.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 39.4 m . . . . . 0 C--O 1.246 0.873 0 CA-C-O 118.134 -0.936 . . . . 8.4800000000000004 109.449 179.484 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.417 ' HB3' ' HB2' ' A' ' 4' ' ' LYS . 14.1 tpt . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 111.23 0.085 . . . . 3.8599999999999999 111.23 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.518 ' O ' HD13 ' A' ' 6' ' ' ILE . 32.4 t70 -174.4 -77.86 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 110.128 -0.323 . . . . 2.25 110.128 -177.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.918 ' HA ' HD11 ' A' ' 6' ' ' ILE . 70.4 m-85 -61.78 -31.01 71.19 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 108.313 -0.995 . . . . 0.42999999999999999 108.313 172.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.556 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 36.7 tttp -60.34 -49.0 79.32 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 113.803 -1.544 . . . . 1.51 107.674 177.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -50.11 -46.31 53.55 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.972 -0.558 . . . . 0.54000000000000004 112.227 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.918 HD11 ' HA ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -81.52 -36.81 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 CA-C-O 121.634 0.731 . . . . 1.0700000000000001 110.02 -172.897 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.674 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -80.63 -30.57 36.69 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.588 -1.187 . . . . 0.34000000000000002 111.568 -175.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.556 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 9.6 mt-30 -65.78 -32.24 73.66 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.783 -1.098 . . . . 1.5900000000000001 109.087 175.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.616 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 12.5 mm100 -81.02 -45.38 16.65 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.418 -1.265 . . . . 2.4700000000000002 109.059 175.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.553 ' HB ' ' HA ' ' A' ' 7' ' ' ALA . 0.6 OUTLIER -56.26 -37.4 69.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.202 -0.908 . . . . 0.47999999999999998 111.192 176.78 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.578 ' HA ' ' CB ' ' A' ' 128' ' ' SER . . . -46.86 -60.84 2.16 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 120.819 0.343 . . . . 0.31 111.796 173.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -79.04 -6.62 56.83 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.323 -0.399 . . . . 1.6399999999999999 111.087 -177.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.616 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 34.3 mm-40 -78.98 -47.21 16.74 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.248 0.547 . . . . 2.54 109.545 172.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.681 HG21 ' N ' ' A' ' 152' ' ' GLY . 9.9 p -74.63 -41.39 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.77 0.795 . . . . 0.53000000000000003 109.115 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 tt -68.72 -21.2 64.41 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-O 121.719 0.771 . . . . 0.59999999999999998 109.155 174.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.37 -17.54 61.99 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 114.017 -1.447 . . . . 0.56999999999999995 110.59 172.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.656 ' HD2' ' O ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -86.49 -33.47 20.33 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.541 -0.911 . . . . 3.27 108.541 177.865 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -75.97 -6.47 51.1 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.648 0.737 . . . . 2.0299999999999998 110.269 -176.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -120.55 11.31 11.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.476 -0.784 . . . . 2.7200000000000002 110.582 176.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -139.01 111.4 7.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.154 -0.476 . . . . 2.1600000000000001 109.772 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 44.4 p -129.01 109.28 11.08 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.102 0.477 . . . . 1.8200000000000001 111.933 -171.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.2 p -170.47 160.31 7.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.659 -0.7 . . . . 2.1899999999999999 111.119 -175.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.63 5.72 57.01 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 116.131 -0.486 . . . . 1.1000000000000001 113.981 172.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.671 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -120.42 -163.8 1.04 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.922 0.361 . . . . 1.6699999999999999 110.368 -177.363 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.59 135.18 0.23 Allowed 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.451 -0.795 . . . . 2.9500000000000002 109.357 -178.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.678 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 2.3 m -66.97 118.7 11.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-O 121.81 0.814 . . . . 1.5600000000000001 111.001 176.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.621 ' O ' ' HD2' ' A' ' 28' ' ' LYS . 11.4 p -95.87 -28.83 3.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 114.465 -1.243 . . . . 1.22 109.446 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.621 ' HD2' ' O ' ' A' ' 27' ' ' VAL . 4.1 mptp? -151.05 133.87 15.77 Favored 'General case' 0 C--O 1.216 -0.7 0 C-N-CA 120.06 -0.656 . . . . 2.4100000000000001 110.829 -170.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.535 ' HB ' ' HA ' ' A' ' 34' ' ' THR . 0.0 OUTLIER -153.0 152.1 31.02 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.902 0.382 . . . . 1.3799999999999999 111.3 175.074 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.453 ' HB3' HG12 ' A' ' 33' ' ' ILE . 27.0 t -117.03 27.22 9.26 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.909 -0.587 . . . . 2.3700000000000001 110.591 -176.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? 68.48 24.35 7.12 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.814 0.816 . . . . 4.5499999999999998 109.695 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.499 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 6.4 tptm -167.24 -40.75 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.921 -1.036 . . . . 1.4199999999999999 109.209 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.565 HG22 ' HA3' ' A' ' 52' ' ' GLY . 21.1 pt -109.66 152.51 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 CA-C-N 115.242 -0.89 . . . . 0.76000000000000001 108.983 170.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.535 ' HA ' ' HB ' ' A' ' 29' ' ' THR . 56.6 m -146.29 119.41 8.84 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 123.456 0.472 . . . . 0.57999999999999996 110.717 -168.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.868 HG22 HG12 ' A' ' 50' ' ' VAL . 3.7 t -109.9 110.87 33.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.86 -0.609 . . . . 0.85999999999999999 110.609 -175.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.678 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 97.5 p -100.65 131.49 46.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.192 -0.458 . . . . 1.1000000000000001 109.934 177.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.8 p -102.76 125.0 49.33 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.892 -0.595 . . . . 1.27 110.991 -177.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.671 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 35.7 ttpt -137.74 120.13 15.89 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.6 -0.727 . . . . 1.9099999999999999 109.607 177.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 46' ' ' ASN . . . -43.11 137.24 2.57 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.523 0.514 . . . . 1.6799999999999999 111.998 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 42' ' ' LYS . 10.3 m -68.52 -163.42 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.605 -0.725 . . . . 2.0899999999999999 111.834 -177.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.43 ' O ' ' HB2' ' A' ' 42' ' ' LYS . 25.8 ttt180 -70.38 14.54 0.12 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.25 -0.886 . . . . 6.6100000000000003 110.724 173.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.482 ' H ' ' C ' ' A' ' 40' ' ' SER . 71.1 mmtt 69.68 40.48 1.36 Allowed 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.452 0.644 . . . . 6.46 110.842 176.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -134.03 -30.23 1.22 Allowed 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.379 -0.828 . . . . 5.6500000000000004 109.985 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -105.27 -65.19 1.07 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.888 -0.597 . . . . 5.5599999999999996 109.87 173.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.16 -93.81 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.789 -0.925 . . . . 1.5600000000000001 110.789 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 48.2 m-80 -121.36 140.95 51.44 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.707 0.289 . . . . 2.0499999999999998 110.369 177.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.777 ' HG ' ' HB2' ' A' ' 172' ' ' GLN . 2.2 tt -93.27 151.67 19.66 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 106.903 -1.517 . . . . 0.87 106.903 174.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.77 ' H ' HD23 ' A' ' 47' ' ' LEU . 49.9 m-85 -135.73 137.77 42.03 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.305 -0.558 . . . . 0.98999999999999999 110.87 -170.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.718 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.9 OUTLIER -114.61 131.76 56.59 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 116.014 -0.539 . . . . 2.9199999999999999 110.841 177.759 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.868 HG12 HG22 ' A' ' 35' ' ' VAL . 0.8 OUTLIER -113.11 143.99 21.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.272 0.558 . . . . 1.3300000000000001 110.543 168.695 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.729 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 33.1 tt0 -140.94 109.19 5.81 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.897 -1.047 . . . . 1.0700000000000001 108.921 178.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.565 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -136.55 143.52 14.93 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.569 -0.824 . . . . 0.28999999999999998 111.199 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 59.5 mt -88.23 112.48 23.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 C-N-CA 119.936 -0.706 . . . . 0.57999999999999996 110.352 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.698 HG12 ' HB2' ' A' ' 167' ' ' LEU . 20.8 mm -85.64 114.38 56.33 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 108.373 -0.973 . . . . 0.34999999999999998 108.373 174.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -66.27 57.86 0.45 Allowed 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 123.584 2.856 . . . . 0.62 112.921 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.445 ' HB3' HG12 ' A' ' 203' ' ' ILE . 12.5 tp10 -158.81 168.1 27.71 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.521 -0.918 . . . . 1.6799999999999999 108.521 174.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.439 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 34.7 p -70.59 147.41 94.65 Favored Pre-proline 0 N--CA 1.432 -1.335 0 CA-C-O 121.811 0.815 . . . . 1.1799999999999999 110.849 -177.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.471 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 18.7 Cg_exo -63.71 -9.33 18.13 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.911 3.074 . . . . 0.52000000000000002 110.585 178.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.83 -54.47 13.43 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.902 -1.045 . . . . 0.64000000000000001 110.87 175.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.714 ' HE3' ' O ' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -69.63 -24.17 63.6 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.443 -0.947 . . . . 3.2999999999999998 108.443 178.235 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.777 ' O ' HD12 ' A' ' 65' ' ' LEU . 29.6 mt -63.64 -58.46 6.85 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.508 -0.552 . . . . 0.40999999999999998 109.508 173.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.7 t -64.88 -10.86 31.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.06 0.457 . . . . 1.29 110.435 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.482 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 32.1 t70 -88.06 -37.34 16.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.995 -0.548 . . . . 1.3200000000000001 111.935 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.645 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 10.1 p90 -85.45 -45.67 11.62 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.371 -0.531 . . . . 0.60999999999999999 111.259 -174.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.777 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -84.34 7.33 19.78 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.461 -0.57 . . . . 1.5 109.461 -172.758 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -48.93 -70.06 0.1 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.341 -1.299 . . . . 1.52 111.613 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.701 ' HG3' ' SG ' ' A' ' 94' ' ' CYS . 7.5 tt0 -179.38 -43.04 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.611 0.72 . . . . 3.6000000000000001 110.159 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.1 t -149.72 29.43 0.75 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.158 -0.928 . . . . 1.48 109.283 -174.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 70' ' ' ASP . . . -74.42 -36.67 49.11 Favored Glycine 0 N--CA 1.434 -1.499 0 C-N-CA 120.579 -0.819 . . . . 1.46 111.652 -170.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.645 ' OD1' ' HA ' ' A' ' 64' ' ' PHE . 20.7 p-10 163.73 -21.04 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 113.894 -1.153 . . . . 2.1899999999999999 108.274 -164.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.778 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 1.2 ptp180 -39.64 -53.45 2.15 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-N 114.669 -1.151 . . . . 3.3799999999999999 111.142 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.674 HG22 HD13 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -82.01 -13.13 12.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.347 -0.541 . . . . 0.70999999999999996 111.447 -171.298 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.645 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.3 t -84.97 -30.16 24.47 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.592 -0.843 . . . . 0.96999999999999997 109.949 -175.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.456 ' CZ2' ' HA3' ' A' ' 202' ' ' GLY . 17.8 p-90 -111.86 -4.07 14.71 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.442 0.534 . . . . 0.75 112.442 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.778 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 3.6 t70 -62.42 168.14 3.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 122.26 1.028 . . . . 2.1899999999999999 113.655 -168.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.538 ' HG3' ' OD1' ' A' ' 198' ' ' ASN . 13.0 mmmt -90.95 -35.78 14.5 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.482 -1.69 . . . . 3.1899999999999999 109.322 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.584 ' HA ' ' HB2' ' A' ' 99' ' ' GLN . 50.8 m -137.98 26.01 2.74 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.384 -1.28 . . . . 1.5800000000000001 112.019 -171.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.674 HD13 HG22 ' A' ' 72' ' ' ILE . 44.2 mt -110.34 166.22 11.15 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.509 -0.476 . . . . 0.70999999999999996 110.753 175.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.514 ' HB3' HG23 ' A' ' 80' ' ' VAL . 21.0 mm-40 -144.1 -63.85 0.37 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.807 -0.633 . . . . 1.73 111.346 -175.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.514 HG23 ' HB3' ' A' ' 79' ' ' GLN . 19.8 t -140.49 117.61 8.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.883 -0.599 . . . . 0.78000000000000003 111.0 -166.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -90.78 152.17 20.9 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.806 -0.442 . . . . 5.4000000000000004 109.806 171.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.774 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 19.9 m120 -145.85 117.19 7.94 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.336 -0.987 . . . . 1.6899999999999999 108.336 168.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.447 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 6.5 ttt -79.31 89.59 4.95 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.563 -0.903 . . . . 2.0499999999999998 108.563 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -69.33 -81.57 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 115.647 -0.706 . . . . 0.64000000000000001 111.231 -167.128 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.448 ' HB3' HD12 ' A' ' 93' ' ' ILE . 11.2 t60 -121.06 118.2 29.18 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.381 -0.6 . . . . 1.96 109.381 -178.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.447 ' HD3' ' SD ' ' A' ' 83' ' ' MET . 1.5 mtm180 -99.5 100.71 11.78 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.981 -0.554 . . . . 2.4399999999999999 109.636 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.623 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -70.84 -41.25 77.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.399 -0.819 . . . . 0.46999999999999997 110.588 -173.587 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -155.44 166.71 32.71 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.73 -1.123 . . . . 1.8600000000000001 108.456 -172.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.9 m -62.33 -11.69 16.81 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.211 0.448 . . . . 1.4399999999999999 112.211 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -128.27 11.45 6.42 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 120.761 -0.376 . . . . 1.8700000000000001 110.226 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.623 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.7 OUTLIER -135.35 110.34 8.82 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.327 -0.62 . . . . 0.46000000000000002 109.327 -174.066 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.564 ' O ' HD12 ' A' ' 114' ' ' LEU . 21.3 m-85 -128.85 171.46 12.26 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.745 -0.662 . . . . 0.42999999999999999 110.616 -174.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.669 ' O ' HG23 ' A' ' 84' ' ' VAL . 32.5 mt -127.2 126.65 68.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 107.542 -1.281 . . . . 0.40999999999999998 107.542 168.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.701 ' SG ' ' HG3' ' A' ' 67' ' ' GLN . 42.0 t -108.84 106.0 15.8 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.75 -0.659 . . . . 2.0099999999999998 111.198 -165.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.774 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 39.0 t-80 -82.45 116.38 21.88 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.64 -0.874 . . . . 1.23 108.64 170.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.749 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 62.3 m -134.61 116.03 14.52 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 112.446 0.536 . . . . 0.5 112.446 -177.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 49.5 mm -78.11 128.19 38.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.678 -0.49 . . . . 1.03 109.678 174.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.727 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 2.1 m -102.6 147.66 26.52 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.691 -0.686 . . . . 1.3799999999999999 110.905 -175.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.584 ' HB2' ' HA ' ' A' ' 77' ' ' SER . 3.2 mm-40 -80.83 168.46 18.75 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.693 -0.685 . . . . 1.8200000000000001 111.232 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.611 ' HA ' ' O ' ' A' ' 106' ' ' ILE . 3.0 m -94.59 104.18 16.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.469 -0.787 . . . . 3.9100000000000001 111.039 -176.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -112.97 174.34 5.95 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 109.524 -0.547 . . . . 5.1600000000000001 109.524 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.567 ' O ' HG12 ' A' ' 103' ' ' VAL . . . 60.27 61.35 1.82 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.217 -0.901 . . . . 1.98 110.162 -172.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 102' ' ' ALA . 0.3 OUTLIER 69.96 -21.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.09 1.356 . . . . 3.1699999999999999 112.813 176.396 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.6 -1.08 11.22 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.307 -0.949 . . . . 1.96 111.984 -178.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.2 m -60.73 -35.38 76.21 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.869 0.842 . . . . 1.8799999999999999 108.88 174.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.611 ' O ' ' HA ' ' A' ' 100' ' ' SER . 20.3 mt -92.32 73.66 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 CA-C-N 114.586 -1.188 . . . . 1.1200000000000001 108.634 175.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.653 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 13.2 m -65.51 174.13 1.63 Allowed Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.087 -0.96 . . . . 1.3500000000000001 110.867 -175.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.653 ' HD2' ' HB3' ' A' ' 107' ' ' SER . 81.6 Cg_exo -42.39 111.14 0.18 Allowed 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 122.761 2.308 . . . . 1.0700000000000001 112.521 -175.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.727 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 33.3 ttp180 -100.26 159.86 14.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.603 -0.726 . . . . 3.4500000000000002 110.408 -174.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.962 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 12.7 t70 -115.02 131.18 57.01 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.507 -0.553 . . . . 1.3700000000000001 109.507 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.749 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 6.2 m-85 -108.88 127.7 54.27 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.079 0.466 . . . . 2.4100000000000001 111.076 173.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.645 ' CG2' ' HE1' ' A' ' 134' ' ' PHE . 14.7 mm -134.35 77.42 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.955 -1.02 . . . . 0.42999999999999999 108.481 169.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.701 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 0.5 OUTLIER -107.32 129.94 54.84 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.273 -0.876 . . . . 1.8600000000000001 110.592 -178.933 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.617 ' O ' ' HA ' ' A' ' 129' ' ' SER . 7.6 tp -78.71 118.35 20.71 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-N 115.558 -0.746 . . . . 0.28000000000000003 109.285 172.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.483 HG23 ' HB ' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -118.65 126.24 75.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 CA-C-N 114.931 -1.032 . . . . 0.26000000000000001 111.137 -166.078 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.674 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 57.0 t80 -108.51 113.48 26.54 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.25 -0.886 . . . . 2.5699999999999998 110.39 174.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.67 HG12 HG22 ' A' ' 127' ' ' ILE . 56.4 mt -98.19 98.54 7.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.638 -0.71 . . . . 0.89000000000000001 109.767 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.609 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 34.0 ttpt -117.73 134.61 54.73 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.232 0.539 . . . . 1.2 110.256 176.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.672 ' HD2' ' O ' ' A' ' 119' ' ' ARG . 1.0 OUTLIER -103.01 118.38 36.69 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.542 -0.91 . . . . 2.7999999999999998 108.542 175.907 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.567 ' HB3' ' HB3' ' A' ' 123' ' ' ASN . 12.2 m-85 -74.4 107.91 6.85 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.2 -1.778 . . . . 0.82999999999999996 106.2 164.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.411 ' HA ' HH11 ' A' ' 119' ' ' ARG . 6.5 pt-20 -37.27 98.87 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 O-C-N 124.55 1.156 . . . . 2.2799999999999998 113.389 -175.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 57.53 47.09 90.78 Favored Glycine 0 CA--C 1.503 -0.662 0 CA-C-N 113.53 -1.668 . . . . 0.76000000000000001 111.658 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.567 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 2.1 t-20 -144.96 -53.89 0.3 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.616 -0.792 . . . . 1.6499999999999999 109.886 -173.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.42 ' HG3' ' OG ' ' A' ' 156' ' ' SER . 1.9 mpp? -159.04 122.41 3.76 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.562 -0.29 . . . . 1.1200000000000001 110.484 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -104.92 81.52 1.75 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.441 -0.948 . . . . 1.6200000000000001 108.441 177.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.636 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.4 OUTLIER -103.16 141.96 18.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.241 -0.89 . . . . 0.29999999999999999 112.739 -170.789 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.67 HG22 HG12 ' A' ' 117' ' ' ILE . 2.9 pt -110.28 115.5 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 108.398 -0.964 . . . . 0.58999999999999997 108.398 161.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.578 ' CB ' ' HA ' ' A' ' 11' ' ' ALA . 15.4 p -99.4 114.98 28.21 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.968 -0.56 . . . . 1.1799999999999999 110.424 177.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.701 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 9.4 p -109.71 144.9 37.45 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.394 0.616 . . . . 1.24 112.046 -173.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.413 ' HE3' ' HB ' ' A' ' 6' ' ' ILE . 4.8 mtpm? -127.9 123.8 35.85 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 107.618 -1.253 . . . . 2.2599999999999998 107.618 176.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.429 ' HB3' ' N ' ' A' ' 148' ' ' ASN . 7.0 p -65.13 94.3 0.14 Allowed 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.72 -0.844 . . . . 1.3899999999999999 108.72 177.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.432 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.6 OUTLIER -107.56 129.2 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 CA-C-N 115.152 -0.931 . . . . 1.05 109.26 -166.312 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -99.3 70.78 1.76 Allowed 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 114.309 -1.314 . . . . 2.1699999999999999 107.916 -167.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.858 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 0.5 OUTLIER -101.89 154.87 37.05 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 113.552 -1.658 . . . . 0.53000000000000003 109.829 -169.548 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.04 -1.6 11.28 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.433 2.088 . . . . 1.28 116.041 -168.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.858 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 4.7 tp10 -76.74 -13.8 60.0 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.073 -1.084 . . . . 3.5 108.073 -178.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.429 ' HB2' HG11 ' A' ' 84' ' ' VAL . 26.1 t80 -162.8 114.95 1.1 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.119 -0.946 . . . . 6.1200000000000001 112.436 175.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 137' ' ' TYR . 19.7 Cg_endo -95.32 140.33 1.02 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.661 2.907 . . . . 1.77 111.346 168.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.472 ' HG3' ' HB2' ' A' ' 145' ' ' ARG . 37.3 Cg_endo -70.85 -164.58 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.588 2.192 . . . . 1.25 112.965 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.3 t -139.26 -173.49 3.61 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.237 -1.023 . . . . 1.6000000000000001 108.237 -176.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.0 t -82.46 -41.39 19.86 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.248 -0.581 . . . . 1.97 110.265 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -57.15 -52.46 65.21 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.144 0.497 . . . . 2.1800000000000002 110.309 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.962 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 61.9 m-85 -95.82 109.99 22.23 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.316 -0.856 . . . . 1.23 109.424 -175.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.999 HD11 ' HB2' ' A' ' 176' ' ' ARG . 0.7 OUTLIER -88.46 107.52 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-N 115.67 -0.696 . . . . 0.81999999999999995 109.611 -176.256 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.553 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 31.5 ttp85 -56.69 105.53 0.22 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.796 -0.638 . . . . 4.4199999999999999 110.129 178.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.75 118.0 12.96 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.707 -0.679 . . . . 0.79000000000000004 112.006 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.88 ' HB3' ' HB3' ' A' ' 174' ' ' GLU . 17.9 t80 -85.62 70.29 10.72 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.511 0.672 . . . . 4.4400000000000004 109.628 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.651 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 11.6 t30 -64.69 96.56 0.18 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.47 -0.786 . . . . 1.6200000000000001 110.083 176.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.86 117.74 28.39 Favored Pre-proline 0 C--O 1.222 -0.382 0 CA-C-N 115.758 -0.655 . . . . 2.3199999999999998 110.242 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -18.32 70.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.101 1 C-N-CA 126.438 4.758 . . . . 0.53000000000000003 115.664 -165.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' CYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 170' ' ' PHE . 4.4 p -122.99 169.71 10.89 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.789 -1.189 . . . . 1.5800000000000001 107.789 172.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.681 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -152.21 -146.15 4.29 Favored Glycine 0 N--CA 1.434 -1.49 0 C-N-CA 118.325 -1.893 . . . . 0.42999999999999999 113.805 -165.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.428 ' CZ ' HD11 ' A' ' 167' ' ' LEU . 5.8 t80 -161.36 96.77 1.08 Allowed 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.995 -1.113 . . . . 0.59999999999999998 107.995 -162.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.693 HG23 HG13 ' A' ' 168' ' ' VAL . 4.5 m -105.83 137.88 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-O 121.679 0.752 . . . . 0.31 110.746 -175.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 83.8 m -117.71 109.63 16.85 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.161 -0.927 . . . . 1.55 109.899 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.567 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 15.4 m -111.06 125.59 30.34 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 120.794 -0.362 . . . . 1.0600000000000001 111.51 -168.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 156' ' ' SER . 10.7 Cg_endo -54.54 121.05 9.08 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 122.454 2.102 . . . . 0.56000000000000005 111.368 174.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.617 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 61.1 mmm -80.12 -162.85 0.48 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.217 0.532 . . . . 1.1599999999999999 111.79 -176.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -70.44 -35.07 73.15 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.52 -0.763 . . . . 2.6299999999999999 109.408 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -103.22 30.97 4.53 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.045 -0.98 . . . . 2.0499999999999998 109.143 173.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.745 ' OD1' ' HD3' ' A' ' 162' ' ' PRO . 0.3 OUTLIER -19.77 -57.16 0.06 OUTLIER Pre-proline 0 N--CA 1.479 0.989 0 N-CA-C 117.164 2.283 . . . . 1.9299999999999999 117.164 -171.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.745 ' HD3' ' OD1' ' A' ' 161' ' ' ASN . 69.8 Cg_endo -72.91 -18.17 24.71 Favored 'Trans proline' 0 C--N 1.351 0.701 0 CA-C-N 121.798 1.678 . . . . 0.72999999999999998 113.255 -175.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -108.07 -26.61 10.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.196 -0.456 . . . . 0.68000000000000005 110.92 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.617 ' O ' ' HB2' ' A' ' 158' ' ' MET . 94.1 m-85 -138.33 128.36 25.56 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.181 -0.674 . . . . 0.93000000000000005 109.181 177.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.472 ' HB3' HD11 ' A' ' 61' ' ' LEU . 26.6 t -125.93 151.59 46.76 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.38 0.61 . . . . 1.4099999999999999 111.599 -177.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.729 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 2.0 tppp? -90.73 103.45 16.15 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 122.019 0.914 . . . . 0.73999999999999999 111.472 -176.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.727 HD12 HG12 ' A' ' 196' ' ' ILE . 0.5 OUTLIER -88.06 103.61 15.88 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.406 -1.27 . . . . 0.27000000000000002 109.429 176.111 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.693 HG13 HG23 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -127.82 132.43 68.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.087 -0.645 . . . . 0.28000000000000003 111.876 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.514 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 20.8 ttt -144.41 137.98 27.41 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.37 -0.377 . . . . 1.24 111.819 -170.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.674 ' CE1' ' HB2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -110.84 135.17 51.8 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 109.182 -0.673 . . . . 3.3700000000000001 109.182 173.439 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 1.029 ' HB ' HD21 ' A' ' 192' ' ' LEU . 1.3 t -134.43 120.82 34.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 O-C-N 123.661 0.601 . . . . 1.3999999999999999 111.056 177.043 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.777 ' HB2' ' HG ' ' A' ' 47' ' ' LEU . 1.3 tm0? -105.04 -32.64 8.62 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.462 -1.31 . . . . 2.1699999999999999 107.462 168.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.651 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 13.2 m 20.75 107.86 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 O-C-N 126.281 2.238 . . . . 1.6499999999999999 113.165 176.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.88 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 15.2 tp10 -77.36 -19.78 55.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.043 -0.526 . . . . 2.4500000000000002 111.769 -161.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.651 ' HE2' HD11 ' A' ' 179' ' ' LEU . 95.6 mmm 46.62 52.75 10.77 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 110.249 -0.278 . . . . 3.7400000000000002 110.249 177.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.999 ' HB2' HD11 ' A' ' 144' ' ' ILE . 15.9 mmm180 -28.38 -61.99 0.11 Allowed 'General case' 0 N--CA 1.476 0.853 0 O-C-N 125.225 1.578 . . . . 5.7800000000000002 114.087 -171.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -157.51 101.19 0.2 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 119.784 -1.198 . . . . 2.2599999999999998 113.679 -176.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.446 ' HA ' ' HD2' ' A' ' 178' ' ' LYS . 13.1 tptm -171.61 -6.72 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.856 0.36 . . . . 6.2300000000000004 110.86 173.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.669 ' HB2' HD12 ' A' ' 184' ' ' ILE . 0.0 OUTLIER -137.63 175.56 9.49 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.252 0.548 . . . . 1.6399999999999999 109.663 -177.571 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.439 ' O ' HD12 ' A' ' 184' ' ' ILE . 16.3 m -111.34 159.25 33.65 Favored Pre-proline 0 C--N 1.313 -1.005 0 N-CA-C 108.068 -1.086 . . . . 2.04 108.068 174.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -44.88 -37.86 12.52 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 122.765 2.31 . . . . 1.74 112.577 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.516 ' O ' ' HE2' ' A' ' 186' ' ' LYS . 3.7 p -66.31 -23.79 66.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.629 -0.714 . . . . 2.1400000000000001 112.273 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.576 ' HB ' ' HB3' ' A' ' 179' ' ' LEU . 11.9 mm -90.12 -38.28 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-O 122.505 1.145 . . . . 1.1200000000000001 108.76 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.931 ' HA ' HG22 ' A' ' 187' ' ' THR . 0.7 OUTLIER -66.13 -38.26 81.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 113.063 -1.88 . . . . 1.1299999999999999 111.375 -177.234 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.15 -18.45 65.31 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.585 -0.524 . . . . 2.8900000000000001 109.585 176.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.516 ' HE2' ' O ' ' A' ' 182' ' ' SER . 45.2 mtmt -91.84 -41.59 10.55 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.814 -0.63 . . . . 1.28 109.991 173.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.931 HG22 ' HA ' ' A' ' 184' ' ' ILE . 14.6 t -63.04 -28.14 69.89 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.941 0.719 . . . . 0.62 112.941 -169.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' MET . . . . . 0.606 ' HE2' ' HA ' ' A' ' 188' ' ' MET . 2.4 mmt -76.05 -62.89 0.67 Allowed Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 120.249 -0.581 . . . . 1.0600000000000001 111.503 -177.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.576 ' O ' HG13 ' A' ' 193' ' ' VAL . 28.3 Cg_endo -61.93 -32.26 84.75 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 121.812 1.674 . . . . 0.91000000000000003 111.844 -177.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.639 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 24.6 m -73.88 -23.76 59.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.357 -0.383 . . . . 1.5 110.777 -177.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.2 OUTLIER -90.39 -38.03 13.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.912 -0.403 . . . . 1.8799999999999999 109.912 -176.134 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 1.029 HD21 ' HB ' ' A' ' 171' ' ' VAL . 26.7 mt -59.3 -57.31 13.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.996 -0.547 . . . . 1.0900000000000001 112.022 178.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 189' ' ' PRO . 1.8 m -65.44 -32.62 59.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.595 0.712 . . . . 0.68000000000000005 109.379 -175.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.639 ' HB2' ' O ' ' A' ' 190' ' ' SER . 0.4 OUTLIER -65.32 -47.04 77.93 Favored 'General case' 0 C--O 1.208 -1.112 0 CA-C-N 114.217 -1.356 . . . . 2.0699999999999998 109.843 176.873 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.86 -28.94 66.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.786 0.327 . . . . 2.0 111.026 178.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.727 HG12 HD12 ' A' ' 167' ' ' LEU . 22.1 mt -77.32 -31.61 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-O 121.414 0.626 . . . . 0.31 110.862 175.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 68.1 mt -73.56 -38.14 65.3 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 109.562 -0.532 . . . . 1.03 109.562 176.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.538 ' OD1' ' HG3' ' A' ' 76' ' ' LYS . 3.2 m-20 -53.11 -41.69 65.23 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.11 -1.07 . . . . 1.8999999999999999 108.11 168.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.738 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -67.33 -49.8 62.61 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.944 -0.571 . . . . 0.28999999999999998 110.129 -178.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.54 ' HD3' HD13 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -61.09 -41.16 96.15 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 114.984 -1.007 . . . . 0.96999999999999997 110.843 -179.242 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -76.99 -47.18 21.45 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-N 115.259 -0.882 . . . . 1.9399999999999999 110.089 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' GLY . . . . . 0.456 ' HA3' ' CZ2' ' A' ' 74' ' ' TRP . . . -69.89 -38.45 75.45 Favored Glycine 0 CA--C 1.505 -0.543 0 C-N-CA 120.811 -0.709 . . . . 0.46999999999999997 112.117 -175.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.738 ' HB ' ' O ' ' A' ' 199' ' ' ALA . 0.9 OUTLIER -58.04 -46.25 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 110.521 -0.178 . . . . 0.60999999999999999 110.521 176.327 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.646 ' HA ' ' HG3' ' A' ' 207' ' ' ARG . 62.6 mttm -84.48 -23.57 29.82 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 120.382 -0.527 . . . . 3.3700000000000001 109.841 -176.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.54 -35.95 77.25 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.081 -0.711 . . . . 1.02 109.081 166.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.483 ' ND1' ' HD3' ' A' ' 60' ' ' LYS . 5.4 t-80 -85.73 -31.03 22.65 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.337 0.865 . . . . 3.6299999999999999 113.337 -179.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.646 ' HG3' ' HA ' ' A' ' 204' ' ' LYS . 0.2 OUTLIER -107.97 -25.26 11.26 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.593 -0.692 . . . . 2.5899999999999999 112.34 -174.181 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.506 ' HB ' ' O ' ' A' ' 204' ' ' LYS . 98.0 m -101.26 137.04 19.57 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 109.792 -0.447 . . . . 1.8400000000000001 109.792 178.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 208' ' ' THR . 29.6 Cg_exo -64.15 13.09 0.09 OUTLIER 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.308 2.672 . . . . 2.3500000000000001 113.921 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.412 ' H ' ' C ' ' A' ' 208' ' ' THR . 73.8 m -67.78 -12.48 60.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.88 0.371 . . . . 2.3100000000000001 110.868 176.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 4.9 ppt_? -69.81 5.13 1.61 Allowed 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 116.044 -0.525 . . . . 5.4500000000000002 111.416 175.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -57.73 -28.74 64.17 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.267 0.556 . . . . 6.8600000000000003 109.567 171.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -101.05 82.67 0.49 Allowed Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.549 -1.02 . . . . 3.3700000000000001 110.549 171.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -66.7 124.69 23.57 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.343 0.497 . . . . 5.21 112.343 -175.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -111.85 94.13 4.8 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.862 -0.792 . . . . 6.46 108.862 166.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' HIS . . . . . 0.569 ' HA ' ' O ' ' A' ' 73' ' ' THR . 0.8 OUTLIER -104.32 141.9 35.51 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.121 -0.49 . . . . 6.0899999999999999 109.993 177.197 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -80.36 23.86 0.47 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.017 0.437 . . . . 5.1200000000000001 111.088 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 5.6 m -67.53 -31.41 71.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.76 -0.654 . . . . 6.7599999999999998 109.322 174.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -117.26 125.88 51.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.494 -0.775 . . . . 8.8200000000000003 109.982 177.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.424 -0.798 . . . . 8.4800000000000004 108.903 179.825 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 121.095 0.474 . . . . 3.8599999999999999 110.931 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.506 ' O ' HD12 ' A' ' 6' ' ' ILE . 7.0 m-20 -65.84 -35.58 81.08 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 121.183 0.516 . . . . 2.25 110.206 -177.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.627 ' HD1' HD22 ' A' ' 114' ' ' LEU . 93.5 m-85 -66.73 -32.83 74.39 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.384 -0.825 . . . . 0.42999999999999999 109.326 -175.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.636 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 2.1 tppp? -69.52 -8.25 45.42 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.82 -1.082 . . . . 1.51 110.124 177.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -92.27 -41.68 10.26 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.229 0.538 . . . . 0.54000000000000004 110.337 173.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.556 HD12 ' HA ' ' A' ' 3' ' ' PHE . 1.8 mp -82.45 -43.07 18.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.754 0.788 . . . . 1.0700000000000001 109.456 -171.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -72.15 -47.22 52.56 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.312 -1.313 . . . . 0.34000000000000002 111.582 -178.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.636 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 17.2 mt-30 -63.19 -26.43 68.8 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.664 -1.153 . . . . 1.5900000000000001 110.762 -178.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.581 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 96.2 mt-30 -84.82 -30.81 24.24 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.324 -0.853 . . . . 2.4700000000000002 109.395 172.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.552 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.4 OUTLIER -74.35 -34.72 63.47 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.513 -0.767 . . . . 0.47999999999999998 111.684 -177.386 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.467 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -45.87 -54.99 7.25 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 120.345 -0.542 . . . . 0.31 111.23 172.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -75.5 -6.66 51.3 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.775 -0.648 . . . . 1.6399999999999999 112.042 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.581 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 32.1 mt-10 -80.59 -52.09 7.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.712 -0.477 . . . . 2.54 109.712 173.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.699 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 14.6 p -69.57 -40.94 80.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.844 0.831 . . . . 0.53000000000000003 110.193 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.44 HD13 ' CE1' ' A' ' 120' ' ' TYR . 0.4 OUTLIER -67.78 -25.45 65.61 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 121.978 0.894 . . . . 0.59999999999999998 108.608 173.707 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.32 -17.5 66.28 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 113.79 -1.55 . . . . 0.56999999999999995 110.394 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.699 ' CD2' ' HA ' ' A' ' 14' ' ' VAL . 15.1 m-85 -89.07 -24.68 22.24 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.572 -0.899 . . . . 3.27 108.572 177.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -73.61 -12.0 60.61 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-O 121.337 0.589 . . . . 2.0299999999999998 110.018 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -111.62 -18.7 12.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.498 -0.774 . . . . 2.7200000000000002 111.216 -176.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -136.09 84.13 2.06 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.326 -0.397 . . . . 2.1600000000000001 111.459 -174.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -151.0 139.5 20.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 1.8200000000000001 111.64 178.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.9 m -167.53 -45.26 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.017 -0.538 . . . . 2.1899999999999999 110.031 -173.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -81.68 47.79 3.72 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.834 -0.621 . . . . 1.1000000000000001 113.188 -176.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.548 ' O ' ' HE2' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -120.65 -147.3 0.39 Allowed 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.605 -0.517 . . . . 1.6699999999999999 109.605 178.188 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.548 ' HE2' ' O ' ' A' ' 24' ' ' TRP . 0.0 OUTLIER 178.57 123.84 0.05 OUTLIER 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.954 -0.758 . . . . 2.9500000000000002 108.954 -175.036 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.578 ' CG1' HG22 ' A' ' 34' ' ' THR . 3.7 m -65.13 119.81 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.818 0 CA-C-O 122.358 1.075 . . . . 1.5600000000000001 111.605 176.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.455 HG13 ' HB3' ' A' ' 189' ' ' PRO . 7.7 p -99.57 -23.96 4.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 113.692 -1.595 . . . . 1.22 109.07 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 189' ' ' PRO . 8.3 tppt? -152.9 109.9 3.48 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 119.82 -0.752 . . . . 2.4100000000000001 111.756 -176.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.618 ' HB ' ' HA ' ' A' ' 34' ' ' THR . 1.3 t -151.89 152.64 32.82 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.196 0.522 . . . . 1.3799999999999999 111.484 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.7 t -113.24 -94.93 0.45 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.354 -0.839 . . . . 2.3700000000000001 110.165 176.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -148.32 19.15 1.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.297 0.57 . . . . 4.5499999999999998 110.737 176.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.673 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 38.5 mmtm -150.05 -33.92 0.18 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.707 -0.679 . . . . 1.4199999999999999 110.138 176.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.642 HD12 ' HB ' ' A' ' 193' ' ' VAL . 16.3 pt -113.55 149.95 15.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.603 -0.726 . . . . 0.76000000000000001 109.746 -177.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.618 ' HA ' ' HB ' ' A' ' 29' ' ' THR . 0.2 OUTLIER -151.17 107.67 3.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 123.12 0.262 . . . . 0.57999999999999996 111.604 -166.248 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.538 ' CG2' HG13 ' A' ' 193' ' ' VAL . 21.4 t -95.57 109.63 22.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.953 0.406 . . . . 0.85999999999999999 110.315 176.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 2.3 p -105.11 123.36 47.68 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.526 -0.761 . . . . 1.1000000000000001 110.773 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 77.9 p -103.47 129.19 50.56 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.914 -1.039 . . . . 1.27 110.284 -174.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.451 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 24.5 ttpp -119.29 -91.16 0.56 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.996 -0.547 . . . . 1.9099999999999999 111.289 -173.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 46' ' ' ASN . . . -177.1 141.54 0.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.59 -0.522 . . . . 1.6799999999999999 109.59 -177.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 67.5 p -74.46 146.61 42.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.059 0.457 . . . . 2.0899999999999999 110.096 175.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -62.24 -28.13 69.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.269 -0.878 . . . . 6.6100000000000003 112.38 -176.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -93.18 -17.35 23.83 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 120.795 -0.362 . . . . 6.46 110.938 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 3.1 t80 85.67 31.5 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.557 0 O-C-N 124.433 1.083 . . . . 5.6500000000000004 108.694 172.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 -85.77 -18.39 33.12 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.021 -0.99 . . . . 5.5599999999999996 109.533 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.33 -139.4 3.63 Favored Glycine 0 N--CA 1.427 -1.934 0 N-CA-C 109.502 -1.439 . . . . 1.5600000000000001 109.502 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 73.0 m-20 -121.81 147.79 45.51 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.054 0.454 . . . . 2.0499999999999998 111.301 -177.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.54 HD23 ' N ' ' A' ' 48' ' ' TYR . 3.2 tt -98.48 138.68 35.35 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.865 -1.161 . . . . 0.87 107.865 174.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.54 ' N ' HD23 ' A' ' 47' ' ' LEU . 73.2 m-85 -120.03 130.69 54.83 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 110.168 -0.308 . . . . 0.98999999999999999 110.168 -174.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.484 ' HD3' ' CZ3' ' A' ' 24' ' ' TRP . 37.4 ttt-85 -120.29 121.42 38.63 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.268 -0.424 . . . . 2.9199999999999999 110.06 175.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.515 ' CG1' ' HB3' ' A' ' 192' ' ' LEU . 9.4 p -104.99 145.98 12.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 120.11 -0.636 . . . . 1.3300000000000001 109.655 174.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.555 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 29.6 tt0 -144.33 113.09 6.69 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.534 -0.757 . . . . 1.0700000000000001 110.155 -171.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.673 ' HA2' ' O ' ' A' ' 32' ' ' LYS . . . -143.85 143.26 12.03 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.682 -0.771 . . . . 0.28999999999999998 111.934 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.8 mt -87.54 120.59 36.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 120.147 -0.621 . . . . 0.57999999999999996 110.691 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 36.4 mt -102.69 120.2 53.52 Favored Pre-proline 0 N--CA 1.442 -0.865 0 CA-C-N 115.556 -0.747 . . . . 0.34999999999999998 109.728 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -62.57 60.03 0.14 Allowed 'Trans proline' 0 N--CA 1.473 0.319 0 C-N-CA 124.299 3.333 . . . . 0.62 113.93 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.643 ' HG2' HG13 ' A' ' 203' ' ' ILE . 9.6 tp10 -150.91 175.54 11.95 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.879 -0.785 . . . . 1.6799999999999999 108.879 174.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.529 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 12.8 m -80.94 143.32 53.25 Favored Pre-proline 0 N--CA 1.425 -1.702 0 CA-C-O 121.365 0.602 . . . . 1.1799999999999999 109.488 172.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 57' ' ' SER . 35.5 Cg_exo -57.95 -14.32 18.09 Favored 'Trans proline' 0 C--N 1.333 -0.272 0 C-N-CA 124.092 3.195 . . . . 0.52000000000000002 111.501 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.32 -50.9 42.25 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.207 -0.906 . . . . 0.64000000000000001 111.31 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.47 ' O ' ' HE3' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -67.66 -27.35 66.78 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.387 -0.968 . . . . 3.2999999999999998 108.387 179.774 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.752 ' O ' HD12 ' A' ' 65' ' ' LEU . 40.6 mt -62.9 -57.96 9.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.19 -0.914 . . . . 0.40999999999999998 110.473 172.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.665 ' OG ' ' HB3' ' A' ' 125' ' ' ASN . 66.5 m -60.49 -16.1 33.54 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.92 -0.488 . . . . 1.29 110.861 176.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -90.1 -43.96 10.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.243 0.46 . . . . 1.3200000000000001 112.243 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.645 ' CE2' ' HA ' ' A' ' 199' ' ' ALA . 5.0 p90 -73.4 -43.43 60.51 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.739 -0.385 . . . . 0.60999999999999999 110.905 -171.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.752 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -86.57 -7.17 58.59 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 120.433 -0.507 . . . . 1.5 111.616 -173.288 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.525 ' N ' HD13 ' A' ' 65' ' ' LEU . 11.8 t80 -18.79 -70.44 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.95 1.406 . . . . 1.52 114.005 -163.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.486 ' OE1' ' HB2' ' A' ' 94' ' ' CYS . 8.5 tt0 -174.32 -32.26 0.01 OUTLIER 'General case' 0 C--N 1.342 0.268 0 N-CA-C 114.296 1.221 . . . . 3.6000000000000001 114.296 176.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.7 t -161.97 7.87 0.06 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 119.223 -0.991 . . . . 1.48 113.462 -166.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -115.0 -22.78 4.83 Favored Glycine 0 C--N 1.314 -0.686 0 C-N-CA 118.917 -1.611 . . . . 1.46 113.901 -168.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.655 ' O ' HG22 ' A' ' 73' ' ' THR . 4.5 t70 -150.39 -29.5 0.21 Allowed 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.609 -0.436 . . . . 2.1899999999999999 110.574 -176.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.856 ' HA ' ' CZ2' ' A' ' 74' ' ' TRP . 9.7 ptm180 -50.19 -43.68 52.6 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 123.33 0.652 . . . . 3.3799999999999999 111.452 -173.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.748 HD13 ' H ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -83.5 -13.54 11.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.896 -0.593 . . . . 0.70999999999999996 110.318 -173.262 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.661 ' OG1' ' HA ' ' A' ' 216' ' ' HIS . 0.8 OUTLIER -84.91 -31.44 23.67 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 116.02 -0.536 . . . . 0.96999999999999997 109.927 -176.958 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.856 ' CZ2' ' HA ' ' A' ' 71' ' ' ARG . 7.4 p-90 -106.29 -10.34 16.43 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 120.27 -0.572 . . . . 0.75 111.872 -176.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.674 ' OD2' ' HG ' ' A' ' 78' ' ' LEU . 27.4 t0 -83.3 172.58 12.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.967 0.889 . . . . 2.1899999999999999 111.427 -177.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.53 ' H ' ' CG ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -122.04 -13.98 8.08 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 113.979 -1.464 . . . . 3.1899999999999999 111.297 -172.47 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 74.7 m -115.56 8.77 15.2 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.303 -0.629 . . . . 1.5800000000000001 109.303 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.674 ' HG ' ' OD2' ' A' ' 75' ' ' ASP . 54.0 mt -109.65 171.05 7.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.363 -0.835 . . . . 0.70999999999999996 110.681 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.602 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 6.4 mm-40 -150.62 -63.37 0.2 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.592 0.59 . . . . 1.73 112.592 -171.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.507 HG23 ' HB3' ' A' ' 79' ' ' GLN . 39.4 t -141.65 127.94 19.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.907 0.384 . . . . 0.78000000000000003 111.076 -168.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.585 ' HB3' HD12 ' A' ' 72' ' ' ILE . 41.1 p90 -97.67 146.06 25.7 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.825 -0.625 . . . . 5.4000000000000004 110.219 174.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.503 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 17.2 m120 -155.13 102.5 2.31 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.447 -0.575 . . . . 1.6899999999999999 109.447 174.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.09 110.06 2.38 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.196 -0.668 . . . . 2.0499999999999998 109.196 177.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -93.14 -49.09 13.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.521 -0.309 . . . . 0.64000000000000001 111.55 -172.875 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.442 ' HB3' HD12 ' A' ' 93' ' ' ILE . 17.6 t-80 -147.74 108.13 4.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.124 0.487 . . . . 1.96 111.144 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.443 ' HG2' ' HD2' ' A' ' 92' ' ' PHE . 20.7 mtt180 -89.66 107.04 18.86 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.564 -0.744 . . . . 2.4399999999999999 109.828 176.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.64 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -75.85 -41.34 39.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.095 0.474 . . . . 0.46999999999999997 110.033 -177.805 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -155.6 -168.12 2.72 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.3 -1.0 . . . . 1.8600000000000001 108.3 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.6 m -80.63 -5.62 57.15 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 117.567 0.167 . . . . 1.4399999999999999 111.345 -177.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -130.16 4.35 4.82 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.83 -0.433 . . . . 1.8700000000000001 109.83 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.64 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.5 OUTLIER -137.87 116.33 12.01 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.609 -0.885 . . . . 0.46000000000000002 108.609 -173.564 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.576 ' O ' HD12 ' A' ' 114' ' ' LEU . 11.0 m-85 -137.2 176.29 8.84 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.232 0.539 . . . . 0.42999999999999999 110.57 -175.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.571 ' O ' HG23 ' A' ' 84' ' ' VAL . 21.6 mt -134.94 127.43 48.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 106.759 -1.571 . . . . 0.40999999999999998 106.759 166.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.486 ' HB2' ' OE1' ' A' ' 67' ' ' GLN . 31.2 t -117.15 129.58 56.06 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.389 -0.525 . . . . 2.0099999999999998 111.266 -176.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.556 ' HA ' HD13 ' A' ' 112' ' ' ILE . 24.3 t60 -87.35 85.38 7.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.268 -0.878 . . . . 1.23 109.173 173.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 60.2 m -100.42 113.37 26.07 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.644 -1.162 . . . . 0.5 112.177 -173.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.469 HD13 ' OD1' ' A' ' 110' ' ' ASP . 31.0 mm -76.52 126.21 36.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.309 -0.626 . . . . 1.03 109.309 174.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.2 m -113.35 142.74 45.5 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.328 -0.851 . . . . 1.3799999999999999 111.272 -174.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.602 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 25.3 mt-30 -97.28 80.79 2.94 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.495 -0.557 . . . . 1.8200000000000001 109.495 173.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.3 m -94.86 86.54 4.71 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.168 -0.469 . . . . 3.9100000000000001 110.041 -177.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.426 ' HA ' ' HB ' ' A' ' 106' ' ' ILE . 42.3 p90 -123.38 117.17 24.59 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.18 0.514 . . . . 5.1600000000000001 112.064 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.403 ' O ' ' HB ' ' A' ' 103' ' ' VAL . . . -85.96 75.78 9.93 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.536 -0.913 . . . . 1.98 108.536 165.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 102' ' ' ALA . 98.4 t 78.74 -36.08 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 114.924 -1.034 . . . . 3.1699999999999999 111.032 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 157.05 -7.62 0.21 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.136 -1.03 . . . . 1.96 113.374 178.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.8 t -72.96 -6.63 46.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.16 0.505 . . . . 1.8799999999999999 110.368 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.497 HG12 ' HG ' ' A' ' 179' ' ' LEU . 26.3 mt -122.91 136.6 59.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.872 -0.603 . . . . 1.1200000000000001 110.156 -177.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.1 m -87.44 152.41 52.22 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 116.163 -0.472 . . . . 1.3500000000000001 110.325 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -47.97 143.08 14.27 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.686 2.257 . . . . 1.0700000000000001 111.632 173.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.568 ' HG2' HG23 ' A' ' 144' ' ' ILE . 20.2 mtm180 -123.64 174.76 7.25 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.639 -0.504 . . . . 3.4500000000000002 109.639 -173.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.685 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 31.0 t70 -131.61 138.88 48.99 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.339 -0.391 . . . . 1.3700000000000001 110.045 176.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -110.07 125.54 53.06 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.105 -0.498 . . . . 2.4100000000000001 110.375 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.612 ' CG2' ' HE1' ' A' ' 134' ' ' PHE . 47.6 mm -109.39 70.54 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 108.362 -0.977 . . . . 0.42999999999999999 108.362 170.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 43.7 m-20 -88.35 117.7 27.46 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.638 -0.71 . . . . 1.8600000000000001 111.03 -174.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.627 HD22 ' HD1' ' A' ' 3' ' ' PHE . 9.4 tp -75.0 124.7 27.44 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.342 -0.984 . . . . 0.28000000000000003 108.342 165.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.615 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -132.25 126.5 55.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 115.465 -0.789 . . . . 0.26000000000000001 112.404 -163.811 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.532 ' HD1' ' HG1' ' A' ' 91' ' ' THR . 58.9 t80 -110.72 116.36 31.17 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.092 -0.958 . . . . 2.5699999999999998 110.425 172.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.453 HG12 HG22 ' A' ' 127' ' ' ILE . 86.6 mt -94.31 112.0 26.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.54 -0.755 . . . . 0.89000000000000001 110.222 -177.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.439 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 17.1 ttmm -137.95 142.43 40.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.132 -0.485 . . . . 1.2 110.63 -176.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.447 ' NE ' ' HA ' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -117.72 113.72 22.27 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 107.86 -1.163 . . . . 2.7999999999999998 107.86 172.472 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.44 ' CE1' HD13 ' A' ' 15' ' ' LEU . 56.0 m-85 -67.48 117.25 9.19 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.667 -1.235 . . . . 0.82999999999999996 107.667 170.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.447 ' HA ' ' NE ' ' A' ' 119' ' ' ARG . 22.1 mm-40 -35.66 94.58 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 O-C-N 124.789 1.306 . . . . 2.2799999999999998 112.938 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 58.8 41.71 96.13 Favored Glycine 0 CA--C 1.505 -0.569 0 CA-C-N 114.618 -1.174 . . . . 0.76000000000000001 112.406 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.431 ' HB3' ' CB ' ' A' ' 120' ' ' TYR . 66.4 t30 -138.68 -49.93 0.54 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.446 -0.377 . . . . 1.6499999999999999 110.705 -177.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.421 ' O ' ' HA ' ' A' ' 119' ' ' ARG . 2.0 tpp -159.97 118.84 2.76 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.046 0.45 . . . . 1.1200000000000001 111.491 -175.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.665 ' HB3' ' OG ' ' A' ' 62' ' ' SER . 6.0 m120 -97.93 79.21 2.61 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.779 -0.823 . . . . 1.6200000000000001 108.779 177.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.556 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.5 OUTLIER -105.37 141.06 21.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 113.193 0.812 . . . . 0.29999999999999999 113.193 -169.707 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.704 ' O ' HG13 ' A' ' 127' ' ' ILE . 2.3 pt -107.9 115.05 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 107.979 -1.119 . . . . 0.58999999999999997 107.979 159.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.615 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 36.5 p -82.96 154.2 24.63 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.946 -0.761 . . . . 1.1799999999999999 108.946 175.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.587 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 9.0 p -154.63 131.45 10.78 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.947 0.403 . . . . 1.24 111.858 -175.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -131.32 120.97 23.9 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 107.632 -1.248 . . . . 2.2599999999999998 107.632 175.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.611 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 52.5 m -66.17 101.04 0.66 Allowed 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.215 -1.402 . . . . 1.3899999999999999 107.215 175.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.99 143.21 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.879 0 CA-C-N 114.568 -1.196 . . . . 1.05 109.193 -164.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -95.27 70.72 3.21 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 122.983 1.373 . . . . 2.1699999999999999 110.176 -170.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.612 ' HE1' ' CG2' ' A' ' 112' ' ' ILE . 1.7 p90 -97.75 177.22 1.7 Allowed Pre-proline 0 CA--C 1.554 1.129 0 CA-C-N 113.688 -1.596 . . . . 0.53000000000000003 109.326 -174.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.421 ' HB2' ' OE2' ' A' ' 136' ' ' GLU . 59.9 Cg_exo -44.28 -47.71 10.47 Favored 'Trans proline' 0 CA--C 1.55 1.304 0 C-N-CA 123.752 2.968 . . . . 1.28 117.106 -175.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.421 ' OE2' ' HB2' ' A' ' 135' ' ' PRO . 2.0 mm-40 -88.71 -5.15 58.3 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 121.595 -0.691 . . . . 3.5 111.416 -172.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.575 ' HB3' ' O ' ' A' ' 134' ' ' PHE . 22.9 t80 -54.33 -45.63 99.21 Favored Pre-proline 0 C--N 1.314 -0.961 0 N-CA-C 115.384 1.624 . . . . 6.1200000000000001 115.384 -177.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 24.7 Cg_exo -32.54 111.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 123.874 3.049 . . . . 1.77 114.875 -175.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.544 ' HA ' ' CZ ' ' A' ' 145' ' ' ARG . 5.8 Cg_exo -79.8 -160.81 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.282 2.655 . . . . 1.25 114.056 -177.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 13.6 m -145.58 -160.85 1.2 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.284 -1.326 . . . . 1.6000000000000001 108.502 -176.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 31.1 t -88.69 -41.91 12.3 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.534 -0.467 . . . . 1.97 111.048 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -70.9 -30.9 67.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.898 0.38 . . . . 2.1800000000000002 111.147 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -120.32 115.02 22.73 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 121.234 0.54 . . . . 1.23 110.327 -176.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.568 HG23 ' HG2' ' A' ' 109' ' ' ARG . 3.4 tp -105.53 113.81 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 115.23 -0.896 . . . . 0.81999999999999995 109.967 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.685 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 5.2 mpt_? -54.74 99.61 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.763 -1.108 . . . . 4.4199999999999999 110.914 175.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -67.51 112.51 4.84 Favored Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 109.372 -1.491 . . . . 0.79000000000000004 109.372 171.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.5 ' HB3' ' CB ' ' A' ' 174' ' ' GLU . 3.2 t80 -84.16 81.45 8.8 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.362 0.601 . . . . 4.4400000000000004 110.515 -169.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.652 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 70.7 m-20 -70.66 99.26 1.64 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.999 -1.001 . . . . 1.6200000000000001 110.191 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.458 ' HB2' ' O ' ' A' ' 172' ' ' GLN . 70.9 m-70 -69.99 146.33 95.01 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.198 -0.455 . . . . 2.3199999999999998 109.911 176.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.545 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 75.5 Cg_exo -15.21 64.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.239 1 C-N-CA 127.414 5.409 . . . . 0.53000000000000003 115.709 -164.959 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 151' ' ' CYS . . . . . 0.652 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 25.4 p -89.81 -174.84 4.43 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.682 -1.144 . . . . 1.5800000000000001 110.36 178.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.575 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -177.8 -161.09 25.45 Favored Glycine 0 N--CA 1.435 -1.41 0 C-N-CA 120.385 -0.912 . . . . 0.42999999999999999 111.77 177.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.596 ' CE1' ' HG ' ' A' ' 65' ' ' LEU . 48.1 t80 -161.72 88.92 0.72 Allowed 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.474 -0.936 . . . . 0.59999999999999998 108.474 -167.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.583 HG23 HG13 ' A' ' 168' ' ' VAL . 2.6 m -98.63 132.53 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-O 121.65 0.738 . . . . 0.31 110.864 -173.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' CYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 125' ' ' ASN . 47.8 m -113.55 108.57 17.35 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.508 -0.769 . . . . 1.55 109.352 177.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.487 ' HB3' ' HB3' ' A' ' 166' ' ' LYS . 18.3 t -102.31 122.99 44.69 Favored Pre-proline 0 C--N 1.312 -1.058 0 CA-C-O 120.842 0.353 . . . . 1.0600000000000001 111.657 -167.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.405 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 77.9 Cg_exo -52.79 118.1 4.39 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.766 2.311 . . . . 0.56000000000000005 111.666 170.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.493 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 78.1 mmm -82.96 -165.08 0.98 Allowed 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 120.977 0.417 . . . . 1.1599999999999999 111.411 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.417 ' H ' ' HB3' ' A' ' 158' ' ' MET . 9.1 mm-40 -76.89 -24.79 52.53 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.741 0.782 . . . . 2.6299999999999999 109.138 173.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 22.5 mm-40 -102.57 27.06 7.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.823 -1.08 . . . . 2.0499999999999998 108.821 172.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.424 ' HB3' ' HD3' ' A' ' 162' ' ' PRO . 15.9 t30 -12.22 -71.32 0.01 OUTLIER Pre-proline 0 N--CA 1.479 0.987 0 N-CA-C 115.675 1.732 . . . . 1.9299999999999999 115.675 -174.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' A' ' 161' ' ' ASN . 70.6 Cg_endo -72.7 -16.27 26.72 Favored 'Trans proline' 0 C--N 1.351 0.665 0 CA-C-N 120.498 1.213 . . . . 0.72999999999999998 113.596 -172.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -103.09 -29.27 11.45 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.899 0.38 . . . . 0.68000000000000005 110.885 -177.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.493 ' O ' ' HB2' ' A' ' 158' ' ' MET . 82.2 m-85 -139.93 125.98 19.78 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.348 -0.612 . . . . 0.93000000000000005 109.348 177.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.409 ' OG ' HD11 ' A' ' 61' ' ' LEU . 4.4 p -122.13 147.81 45.69 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.156 0.503 . . . . 1.4099999999999999 110.978 -177.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.555 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.9 tppp? -91.94 104.61 17.01 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.757 0.789 . . . . 0.73999999999999999 111.009 -176.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.52 109.86 20.76 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.916 -1.038 . . . . 0.27000000000000002 109.039 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.583 HG13 HG23 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -130.58 128.76 63.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 121.692 0.758 . . . . 0.28000000000000003 111.783 177.114 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.488 ' HG2' ' N ' ' A' ' 170' ' ' PHE . 23.0 ttm -124.3 153.05 42.32 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.306 -0.861 . . . . 1.24 109.536 -176.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.568 ' O ' ' HB2' ' A' ' 151' ' ' CYS . 8.6 m-85 -133.5 139.8 46.87 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.568 -0.901 . . . . 3.3700000000000001 108.568 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 11.1 p -138.02 116.77 14.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.618 0.723 . . . . 1.3999999999999999 111.533 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 149' ' ' HIS . 28.8 tt0 -111.26 56.76 0.63 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.646 -0.872 . . . . 2.1699999999999999 108.646 174.11 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 9.1 t -73.45 145.53 45.68 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.877 0.846 . . . . 1.6499999999999999 111.269 -174.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.5 ' CB ' ' HB3' ' A' ' 147' ' ' TYR . 6.6 tp10 -84.53 -30.9 24.75 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.681 -1.145 . . . . 2.4500000000000002 109.947 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.474 ' HG3' HG23 ' A' ' 173' ' ' THR . 64.7 mtm 49.02 64.13 1.85 Allowed 'General case' 0 CA--C 1.518 -0.28 0 O-C-N 123.461 0.476 . . . . 3.7400000000000002 110.0 -173.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.406 ' HB2' HD11 ' A' ' 144' ' ' ILE . 24.0 mmm180 -49.44 -39.98 35.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.131 -0.94 . . . . 5.7800000000000002 110.849 176.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -83.04 80.16 1.85 Allowed Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 109.352 -1.499 . . . . 2.2599999999999998 109.352 166.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -80.64 152.24 28.6 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.303 0.573 . . . . 6.2300000000000004 112.05 -167.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.511 ' HB2' ' CD1' ' A' ' 184' ' ' ILE . 0.5 OUTLIER -111.58 -152.07 0.49 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.063 -0.971 . . . . 1.6399999999999999 108.755 176.864 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.5 ' O ' HD12 ' A' ' 184' ' ' ILE . 43.8 t -110.61 149.82 40.84 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 108.228 -1.027 . . . . 2.04 108.228 174.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -43.88 -45.44 11.38 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.171 2.581 . . . . 1.74 113.016 -177.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 12.0 m -62.91 -18.88 63.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.494 . . . . 2.1400000000000001 112.078 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.566 ' HA ' ' HE2' ' A' ' 186' ' ' LYS . 13.3 mm -91.48 -38.32 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-O 122.432 1.111 . . . . 1.1200000000000001 108.991 -177.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 1.025 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.2 mp -74.49 -34.72 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 CA-C-N 113.089 -1.868 . . . . 1.1299999999999999 111.334 -176.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 189' ' ' PRO . 11.1 pt-20 -67.4 -17.25 64.65 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.93 -0.767 . . . . 2.8900000000000001 108.93 176.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.566 ' HE2' ' HA ' ' A' ' 183' ' ' ILE . 51.6 mtmt -91.96 -42.67 9.88 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.376 -0.829 . . . . 1.28 109.953 171.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' THR . . . . . 1.025 HG22 ' HA ' ' A' ' 184' ' ' ILE . 7.4 t -70.01 -41.04 74.87 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.192 -0.603 . . . . 0.62 112.366 -170.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' MET . . . . . 0.55 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 34.9 mmm -76.38 -55.48 1.68 Allowed Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 112.441 0.534 . . . . 1.0600000000000001 112.441 -174.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.55 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 23.8 Cg_exo -65.48 -19.07 60.93 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 121.945 1.763 . . . . 0.91000000000000003 112.234 -175.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 51.5 m -85.87 -42.06 14.44 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.734 -0.469 . . . . 1.5 109.734 177.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -64.16 -39.13 93.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 1.8799999999999999 111.136 -175.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.527 HD12 HG13 ' A' ' 35' ' ' VAL . 30.7 mt -68.05 -44.71 75.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.627 0.251 . . . . 1.0900000000000001 111.179 -176.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.642 ' HB ' HD12 ' A' ' 33' ' ' ILE . 17.9 m -74.18 -24.85 19.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 120.27 -0.572 . . . . 0.68000000000000005 110.56 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -68.71 -39.18 80.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.187 -0.46 . . . . 2.0699999999999998 110.445 172.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.667 ' HA ' ' ND2' ' A' ' 198' ' ' ASN . 4.9 m-85 -70.8 -20.03 62.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.132 0.491 . . . . 2.0 111.014 176.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.674 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 33.5 mt -82.62 -29.55 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 C-N-CA 119.494 -0.882 . . . . 0.31 110.496 170.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 47.2 mt -69.38 -43.74 72.91 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.518 -0.31 . . . . 1.03 110.773 178.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.667 ' ND2' ' HA ' ' A' ' 195' ' ' PHE . 13.1 p30 -60.97 -22.6 64.63 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.964 -0.562 . . . . 1.8999999999999999 109.886 171.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.708 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -80.79 -43.11 20.6 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 116.51 -0.314 . . . . 0.28999999999999998 110.317 177.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.674 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 12.8 mmmm -57.1 -47.05 82.01 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.659 -0.867 . . . . 0.96999999999999997 108.659 172.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -71.19 -45.87 62.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.266 -1.333 . . . . 1.9399999999999999 111.53 -175.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -72.02 -22.76 78.69 Favored Glycine 0 N--CA 1.463 0.442 0 C-N-CA 120.517 -0.849 . . . . 0.46999999999999997 112.099 -178.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.708 ' HB ' ' O ' ' A' ' 199' ' ' ALA . 1.0 OUTLIER -82.24 -36.16 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 120.966 0.412 . . . . 0.60999999999999999 110.603 175.157 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.469 ' HA ' ' HG2' ' A' ' 207' ' ' ARG . 26.5 mtpt -73.87 -28.47 61.58 Favored 'General case' 0 C--O 1.209 -1.041 0 N-CA-C 108.636 -0.876 . . . . 3.3700000000000001 108.636 176.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.573 ' O ' ' HD2' ' A' ' 211' ' ' ARG . . . -54.04 -32.91 55.92 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.505 -0.771 . . . . 1.02 109.682 169.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.548 ' HB3' ' O ' ' A' ' 203' ' ' ILE . 15.0 t-80 -71.13 -46.55 61.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 3.6299999999999999 111.882 178.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.469 ' HG2' ' HA ' ' A' ' 204' ' ' LYS . 10.4 ptm85 -97.85 -31.55 12.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.503 0.668 . . . . 2.5899999999999999 111.462 -170.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.451 ' HB ' ' O ' ' A' ' 204' ' ' LYS . 28.0 m -92.47 141.31 24.6 Favored Pre-proline 0 C--N 1.313 -0.996 0 CA-C-N 115.176 -0.92 . . . . 1.8400000000000001 109.169 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.34 42.07 0.26 Allowed 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 123.042 2.495 . . . . 2.3500000000000001 113.573 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 28.9 t -94.33 -22.96 18.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.125 0.488 . . . . 2.3100000000000001 109.855 177.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.573 ' HD2' ' O ' ' A' ' 205' ' ' ALA . 0.0 OUTLIER -79.99 1.53 27.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.041 -0.527 . . . . 5.4500000000000002 110.572 -179.741 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -71.68 -39.45 70.24 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.573 -0.529 . . . . 6.8600000000000003 109.573 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -110.02 51.42 0.7 Allowed Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.265 -0.734 . . . . 3.3700000000000001 111.265 175.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -68.02 156.59 37.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.905 0.383 . . . . 5.21 110.863 -177.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -127.71 144.47 51.08 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.117 -0.492 . . . . 6.46 110.605 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' HIS . . . . . 0.661 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 22.6 m170 -93.7 -173.14 3.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.621 -0.718 . . . . 6.0899999999999999 111.024 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -74.41 126.94 31.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.956 -0.565 . . . . 5.1200000000000001 110.879 -178.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 1.9 p -71.56 -25.39 62.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.178 -0.919 . . . . 6.7599999999999998 110.856 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -91.19 -173.5 3.65 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.022 -0.536 . . . . 8.8200000000000003 109.706 176.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 17.4 m . . . . . 0 C--O 1.252 1.208 0 CA-C-O 118.055 -0.974 . . . . 8.4800000000000004 110.925 177.912 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.673 ' SD ' HG22 ' A' ' 87' ' ' ILE . 2.6 ttt . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 109.872 -0.418 . . . . 3.8599999999999999 109.872 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.637 ' O ' HD13 ' A' ' 6' ' ' ILE . 20.1 t70 -113.64 -59.99 1.94 Allowed 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 110.058 -0.349 . . . . 2.25 110.058 -176.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.842 ' HA ' HD11 ' A' ' 6' ' ' ILE . 96.0 m-85 -67.76 -30.11 69.48 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 122.006 0.908 . . . . 0.42999999999999999 108.569 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 9.2 tttm -75.68 -4.32 39.63 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.916 -1.493 . . . . 1.51 109.893 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.425 ' O ' ' HG2' ' A' ' 9' ' ' GLN . . . -92.74 -46.22 7.66 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.339 0.59 . . . . 0.54000000000000004 109.686 174.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.842 HD11 ' HA ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -82.34 -38.8 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-N 115.693 -0.685 . . . . 1.0700000000000001 110.464 -171.915 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.562 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -78.04 -38.08 45.41 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.843 -1.071 . . . . 0.34000000000000002 111.391 -176.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.501 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 7.1 mt-30 -65.68 -25.79 67.49 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.179 -0.919 . . . . 1.5900000000000001 110.316 177.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.52 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 86.8 mm-40 -89.71 -36.45 15.2 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.051 -0.977 . . . . 2.4700000000000002 109.531 173.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.593 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -64.81 -34.47 78.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.626 -0.716 . . . . 0.47999999999999998 111.259 179.031 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.529 ' HA ' ' OG ' ' A' ' 128' ' ' SER . . . -48.21 -61.07 2.17 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.703 0.763 . . . . 0.31 110.464 171.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -66.71 -17.0 64.63 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.471 -1.24 . . . . 1.6399999999999999 112.025 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 35.2 mt-10 -68.73 -57.35 5.77 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 109.595 -0.521 . . . . 2.54 109.595 174.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.713 ' CG2' ' HA ' ' A' ' 151' ' ' CYS . 1.2 t -70.4 -43.38 78.26 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 CA-C-O 121.811 0.815 . . . . 0.53000000000000003 110.979 -174.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.559 HD23 ' HD2' ' A' ' 19' ' ' ARG . 1.0 OUTLIER -64.48 -33.11 75.12 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.471 -1.241 . . . . 0.59999999999999998 109.308 174.813 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.427 ' HA2' ' HD3' ' A' ' 19' ' ' ARG . . . -65.07 -16.41 62.03 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 114.56 -1.2 . . . . 0.56999999999999995 111.281 175.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.709 ' HD2' ' HA ' ' A' ' 14' ' ' VAL . 54.8 m-85 -89.58 -25.82 21.14 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 108.234 -1.024 . . . . 3.27 108.234 174.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.409 ' HA ' ' HZ ' ' A' ' 170' ' ' PHE . 65.6 t30 -68.85 -10.63 58.0 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.635 0.731 . . . . 2.0299999999999998 109.093 175.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.559 ' HD2' HD23 ' A' ' 15' ' ' LEU . 11.3 mtp180 -112.19 -20.79 11.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.875 -1.057 . . . . 2.7200000000000002 110.322 178.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -123.08 58.93 1.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.775 0.798 . . . . 2.1600000000000001 110.702 -176.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.856 ' HB ' ' CZ2' ' A' ' 24' ' ' TRP . 0.7 OUTLIER -122.89 127.57 49.15 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.856 -0.611 . . . . 1.8200000000000001 110.544 176.687 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.5 t -179.28 -33.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.508 -0.769 . . . . 2.1899999999999999 110.068 -170.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.85 -17.35 76.79 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.618 -0.719 . . . . 1.1000000000000001 112.916 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 1.012 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -89.81 -155.99 0.39 Allowed 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 112.563 0.579 . . . . 1.6699999999999999 112.563 179.324 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.521 ' HE3' ' HA ' ' A' ' 25' ' ' LYS . 0.8 OUTLIER -171.68 134.79 0.84 Allowed 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 115.204 -0.907 . . . . 2.9500000000000002 109.465 -164.671 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.689 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 5.2 m -66.0 122.05 16.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 122.062 0.934 . . . . 1.5600000000000001 111.486 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.514 HG21 ' HE2' ' A' ' 48' ' ' TYR . 30.1 m -95.76 -23.19 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-N 113.906 -1.497 . . . . 1.22 108.517 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.521 ' HD2' ' HA ' ' A' ' 28' ' ' LYS . 15.1 tptm -161.98 131.25 4.47 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 120.251 -0.579 . . . . 2.4100000000000001 111.185 -176.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.76 HG22 ' HA ' ' A' ' 34' ' ' THR . 77.4 p -131.81 152.18 51.16 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.224 -0.444 . . . . 1.3799999999999999 109.827 172.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.551 ' HB3' HG12 ' A' ' 33' ' ' ILE . 22.9 t -111.67 -138.98 0.38 Allowed 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.268 -0.641 . . . . 2.3700000000000001 109.268 177.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -103.62 18.13 22.56 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 122.451 -0.155 . . . . 4.5499999999999998 110.835 -178.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.3 tptt -175.12 2.98 0.01 OUTLIER 'General case' 0 C--O 1.237 0.422 0 N-CA-C 112.098 0.407 . . . . 1.4199999999999999 112.098 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.924 HG22 ' HA3' ' A' ' 52' ' ' GLY . 38.1 pt -139.3 166.34 21.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 120.783 0.325 . . . . 0.76000000000000001 111.376 -175.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.76 ' HA ' HG22 ' A' ' 29' ' ' THR . 24.1 m -152.02 112.38 4.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.425 -0.807 . . . . 0.57999999999999996 110.685 -165.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.884 HG22 HG12 ' A' ' 50' ' ' VAL . 2.3 t -107.16 103.89 16.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.842 0.353 . . . . 0.85999999999999999 110.242 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.689 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 4.3 p -102.5 127.58 49.49 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 122.957 0.503 . . . . 1.1000000000000001 110.273 179.09 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 6.9 t -120.53 135.71 55.0 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.402 0.62 . . . . 1.27 112.152 -172.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 1.012 ' HB3' ' HB3' ' A' ' 24' ' ' TRP . 0.2 OUTLIER -128.42 142.12 51.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.77 -1.105 . . . . 1.9099999999999999 109.632 175.899 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 46' ' ' ASN . . . -56.55 126.8 28.22 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.668 0.618 . . . . 1.6799999999999999 112.668 -172.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.476 ' H ' ' HA ' ' A' ' 46' ' ' ASN . 17.6 m -75.44 139.26 42.18 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.988 -0.551 . . . . 2.0899999999999999 109.721 175.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -86.77 13.07 9.44 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.296 0.48 . . . . 6.6100000000000003 112.296 -175.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 46.3 mttm -54.32 -37.18 64.55 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.976 -0.289 . . . . 6.46 110.469 169.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.513 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 62.5 t80 166.49 -77.46 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 O-C-N 124.204 0.94 . . . . 5.6500000000000004 109.575 -175.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -139.84 87.2 2.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.859 -0.61 . . . . 5.5599999999999996 109.508 178.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.34 -169.42 21.1 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 109.973 -1.251 . . . . 1.5600000000000001 109.973 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 2.8 p-10 -154.66 131.2 10.58 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 117.685 0.743 . . . . 2.0499999999999998 111.445 178.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.681 HD23 ' N ' ' A' ' 48' ' ' TYR . 5.2 tt -83.7 150.8 25.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.726 -1.125 . . . . 0.87 108.565 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.681 ' N ' HD23 ' A' ' 47' ' ' LEU . 70.9 m-85 -120.31 131.88 55.07 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.931 0.395 . . . . 0.98999999999999999 110.941 -174.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.507 ' HG2' ' CE2' ' A' ' 170' ' ' PHE . 0.6 OUTLIER -112.44 115.45 28.7 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.266 -1.012 . . . . 2.9199999999999999 108.266 173.22 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.884 HG12 HG22 ' A' ' 35' ' ' VAL . 2.0 m -101.49 150.35 6.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 120.407 -0.517 . . . . 1.3300000000000001 110.477 173.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.652 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 45.7 tt0 -151.15 109.38 3.75 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.986 -1.006 . . . . 1.0700000000000001 109.49 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.924 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -139.99 143.16 13.34 Favored Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 110.909 -0.876 . . . . 0.28999999999999998 110.909 178.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.0 mt -88.62 125.3 41.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 C-N-CA 119.574 -0.85 . . . . 0.57999999999999996 111.051 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.47 HG12 ' HD3' ' A' ' 200' ' ' LYS . 45.4 mt -106.04 99.1 21.13 Favored Pre-proline 0 N--CA 1.442 -0.871 0 N-CA-C 108.046 -1.094 . . . . 0.34999999999999998 108.046 173.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.814 ' HA ' ' HA ' ' A' ' 164' ' ' TYR . 38.3 Cg_endo -65.14 49.89 0.2 Allowed 'Trans proline' 0 N--CA 1.479 0.67 1 C-N-CA 125.506 4.137 . . . . 0.62 115.406 -170.358 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.496 ' HB2' ' H ' ' A' ' 57' ' ' SER . 2.2 pm0 -139.34 -153.67 0.48 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.065 -0.717 . . . . 1.6799999999999999 109.065 165.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.496 ' H ' ' HB2' ' A' ' 56' ' ' GLU . 44.0 t -92.28 140.78 24.43 Favored Pre-proline 0 N--CA 1.422 -1.826 0 CA-C-O 122.006 0.908 . . . . 1.1799999999999999 111.141 -174.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.639 ' HB3' ' SG ' ' A' ' 155' ' ' CYS . 31.1 Cg_exo -57.36 -14.84 17.11 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 124.201 3.267 . . . . 0.52000000000000002 110.306 174.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.54 ' O ' ' HB2' ' A' ' 63' ' ' ASP . . . -69.55 -47.34 63.99 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.939 -1.028 . . . . 0.64000000000000001 111.134 174.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 1.001 ' HE3' ' HA ' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -66.54 -35.48 80.33 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.082 -1.081 . . . . 3.2999999999999998 108.082 178.263 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.971 HD23 HD13 ' A' ' 203' ' ' ILE . 37.1 mt -60.72 -55.44 33.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.87 -1.059 . . . . 0.40999999999999998 110.833 177.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.456 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 42.5 t -67.36 -10.27 49.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.68 0.276 . . . . 1.29 110.734 177.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.54 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -85.83 -45.72 11.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.475 -0.33 . . . . 1.3200000000000001 111.158 -178.631 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.479 ' CE2' ' HA ' ' A' ' 61' ' ' LEU . 11.3 p90 -77.78 -43.36 30.91 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.662 -0.245 . . . . 0.60999999999999999 111.574 -172.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.456 ' CD2' ' HA ' ' A' ' 62' ' ' SER . 1.0 OUTLIER -75.31 -8.94 58.01 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 122.187 -0.321 . . . . 1.5 111.484 -169.406 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.525 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 26.2 t80 -26.4 -56.7 0.08 Allowed 'General case' 0 N--CA 1.462 0.151 0 O-C-N 125.431 1.707 . . . . 1.52 114.11 -163.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.525 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 8.5 tt0 166.02 -38.62 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.595 0.712 . . . . 3.6000000000000001 110.861 -175.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.9 t -165.55 19.84 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.253 -0.885 . . . . 1.48 110.155 -164.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 70' ' ' ASP . . . -78.01 -34.68 37.11 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.252 -0.975 . . . . 1.46 111.702 -173.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.624 ' O ' HG22 ' A' ' 73' ' ' THR . 16.4 p-10 166.63 -17.7 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.12 -1.04 . . . . 2.1899999999999999 108.549 -167.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.858 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -45.57 -38.21 6.25 Favored 'General case' 0 C--O 1.209 -1.034 0 CA-C-N 115.324 -0.853 . . . . 3.3799999999999999 111.755 176.021 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.655 ' H ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -89.87 -7.47 10.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 120.383 -0.527 . . . . 0.70999999999999996 111.386 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.624 HG22 ' O ' ' A' ' 70' ' ' ASP . 0.8 OUTLIER -92.41 -27.77 17.28 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 120.395 -0.522 . . . . 0.96999999999999997 110.618 -173.352 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.808 ' HZ3' ' HB2' ' A' ' 198' ' ' ASN . 11.9 p-90 -112.79 -3.06 14.26 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.795 -0.362 . . . . 0.75 111.699 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.858 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 4.1 t70 -70.18 175.66 4.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 122.335 1.064 . . . . 2.1899999999999999 112.231 -172.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.863 ' HD2' ' HB3' ' A' ' 198' ' ' ASN . 0.0 OUTLIER -118.37 -12.8 9.84 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.8 -1.545 . . . . 3.1899999999999999 110.195 -174.166 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.555 ' HA ' ' HB2' ' A' ' 99' ' ' GLN . 0.1 OUTLIER -130.31 2.81 4.67 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.198 -0.91 . . . . 1.5800000000000001 109.921 178.094 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.774 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 62.1 mt -109.15 149.82 28.78 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.057 -0.52 . . . . 0.70999999999999996 110.834 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.593 ' HG2' ' HG2' ' A' ' 99' ' ' GLN . 23.0 mm-40 -132.56 -59.02 0.92 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.465 -0.789 . . . . 1.73 111.288 -175.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.732 ' HB ' HD13 ' A' ' 97' ' ' ILE . 18.1 t -140.7 125.44 18.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.521 -0.763 . . . . 0.78000000000000003 110.633 -165.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -94.88 153.53 17.66 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.601 -0.727 . . . . 5.4000000000000004 110.44 174.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.501 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 1.2 m120 -152.82 109.37 3.42 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.718 -0.475 . . . . 1.6899999999999999 109.718 167.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.513 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 3.3 ttt -75.03 94.87 2.93 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.266 -1.013 . . . . 2.0499999999999998 108.266 178.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -74.66 -73.03 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-O 121.215 0.531 . . . . 0.64000000000000001 111.258 -166.683 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -136.34 120.6 17.91 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.783 -0.644 . . . . 1.96 109.592 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.837 ' HG2' ' HD2' ' A' ' 92' ' ' PHE . 38.6 mtm180 -97.15 123.19 40.84 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.453 -0.794 . . . . 2.4399999999999999 109.684 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.673 HG22 ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -82.37 -40.73 17.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.833 -0.621 . . . . 0.46999999999999997 109.819 -174.123 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -147.88 -161.92 1.44 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.384 -0.969 . . . . 1.8600000000000001 108.384 177.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.2 m -83.08 -7.78 59.61 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.739 0.304 . . . . 1.4399999999999999 110.81 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -137.65 15.99 2.91 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.26 0.553 . . . . 1.8700000000000001 110.258 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.716 HG23 ' HD2' ' A' ' 116' ' ' TYR . 0.7 OUTLIER -134.37 109.92 9.11 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 107.916 -1.142 . . . . 0.46000000000000002 107.916 -179.287 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.837 ' HD2' ' HG2' ' A' ' 86' ' ' ARG . 5.1 m-85 -132.14 178.9 6.44 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.316 0.579 . . . . 0.42999999999999999 110.797 -174.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.637 ' O ' HG23 ' A' ' 84' ' ' VAL . 19.3 mt -138.3 130.4 38.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 106.966 -1.494 . . . . 0.40999999999999998 106.966 169.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 48.0 t -116.0 122.13 44.32 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.621 -0.432 . . . . 2.0099999999999998 110.92 -172.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.572 ' HA ' HD13 ' A' ' 112' ' ' ILE . 10.5 t60 -85.95 83.98 7.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.862 0.839 . . . . 1.23 109.175 173.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.796 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 18.9 m -90.69 118.07 29.83 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.485 -1.234 . . . . 0.5 111.442 -176.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.732 HD13 ' HB ' ' A' ' 80' ' ' VAL . 3.5 mp -91.58 123.37 43.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.758 -0.831 . . . . 1.03 108.758 170.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 109' ' ' ARG . 15.2 t -110.29 171.41 7.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.061 -0.518 . . . . 1.3799999999999999 110.978 -174.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.593 ' HG2' ' HG2' ' A' ' 79' ' ' GLN . 4.7 mm100 -95.59 172.57 7.98 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.107 -0.951 . . . . 1.8200000000000001 111.897 -172.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.9 m -94.05 86.68 5.08 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.075 -0.966 . . . . 3.9100000000000001 111.276 -175.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.406 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 9.9 p90 -98.28 118.65 35.41 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.96 -1.126 . . . . 5.1600000000000001 107.96 173.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.777 ' HB3' HD12 ' A' ' 106' ' ' ILE . . . 73.02 59.51 0.11 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.962 -1.017 . . . . 1.98 108.574 -168.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 106' ' ' ILE . 7.8 p -67.09 0.27 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 114.57 -1.196 . . . . 3.1699999999999999 112.52 -171.042 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.18 -29.17 74.43 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.605 -0.807 . . . . 1.96 111.791 177.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.948 ' HB2' HG21 ' A' ' 183' ' ' ILE . 72.5 m -142.09 9.18 1.89 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.115 0.483 . . . . 1.8799999999999999 110.658 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.777 HD12 ' HB3' ' A' ' 102' ' ' ALA . 64.2 mt -130.74 108.29 15.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.2 0.524 . . . . 1.1200000000000001 110.964 -176.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.508 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.3 p -100.66 176.33 1.96 Allowed Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.205 -0.907 . . . . 1.3500000000000001 109.965 177.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.508 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 87.9 Cg_exo -47.55 109.9 0.26 Allowed 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 122.306 2.004 . . . . 1.0700000000000001 111.135 174.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.617 ' HG3' HG23 ' A' ' 144' ' ' ILE . 18.4 ttm180 -111.06 151.69 27.77 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.168 -0.469 . . . . 3.4500000000000002 111.134 -167.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.867 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 6.5 t70 -99.28 134.06 42.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.761 -0.654 . . . . 1.3700000000000001 110.847 -176.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.796 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 17.8 m-85 -118.21 114.71 23.43 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.81 -0.632 . . . . 2.4100000000000001 110.143 173.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.572 HD13 ' HA ' ' A' ' 95' ' ' HIS . 26.2 mm -108.95 76.24 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.722 -0.844 . . . . 0.42999999999999999 108.722 170.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.764 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 1.6 m-20 -95.48 119.89 34.77 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.847 -0.615 . . . . 1.8600000000000001 110.306 -178.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.678 ' O ' ' HA ' ' A' ' 129' ' ' SER . 3.9 tp -75.36 121.79 22.79 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 108.672 -0.862 . . . . 0.28000000000000003 108.672 170.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -126.6 123.97 64.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-N 115.296 -0.865 . . . . 0.26000000000000001 111.732 -164.14 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.716 ' HD2' HG23 ' A' ' 91' ' ' THR . 24.1 t80 -105.95 111.91 24.75 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.786 -1.097 . . . . 2.5699999999999998 110.023 175.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.929 HG12 HG22 ' A' ' 127' ' ' ILE . 73.2 mt -92.9 99.15 9.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.039 -0.528 . . . . 0.89000000000000001 109.608 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.694 ' HB2' ' CE1' ' A' ' 116' ' ' TYR . 36.7 ttpt -124.35 138.17 54.4 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.989 -0.55 . . . . 1.2 110.546 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.479 ' O ' ' HD3' ' A' ' 119' ' ' ARG . 0.1 OUTLIER -116.09 111.95 21.03 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-O 122.117 0.961 . . . . 2.7999999999999998 109.697 177.952 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.61 ' HB2' ' HB3' ' A' ' 123' ' ' ASN . 18.2 m-85 -68.05 104.0 1.65 Allowed 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 105.523 -2.028 . . . . 0.82999999999999996 105.523 163.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.46 ' H ' ' HG2' ' A' ' 121' ' ' GLU . 4.1 pt-20 -53.17 98.29 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 122.262 1.029 . . . . 2.2799999999999998 113.023 -168.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 84.91 23.09 50.92 Favored Glycine 0 CA--C 1.504 -0.632 0 CA-C-N 113.483 -1.689 . . . . 0.76000000000000001 111.785 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.61 ' HB3' ' HB2' ' A' ' 120' ' ' TYR . 14.2 t-20 -127.33 -50.74 1.41 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.63 -0.785 . . . . 1.6499999999999999 109.213 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.469 ' O ' ' HA ' ' A' ' 119' ' ' ARG . 0.9 OUTLIER -161.47 143.06 11.54 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.138 -0.483 . . . . 1.1200000000000001 111.282 -177.272 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -116.62 84.41 2.13 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.471 -0.937 . . . . 1.6200000000000001 108.471 169.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.624 ' CG1' HG12 ' A' ' 154' ' ' VAL . 0.7 OUTLIER -102.26 135.0 41.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 112.951 0.722 . . . . 0.29999999999999999 112.951 -172.141 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.929 HG22 HG12 ' A' ' 117' ' ' ILE . 31.7 pt -100.15 107.34 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.914 0.864 . . . . 0.58999999999999997 109.023 164.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.553 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 1.2 m -88.38 109.38 19.95 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.453 -0.794 . . . . 1.1799999999999999 110.638 -178.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.764 ' HB3' ' HB3' ' A' ' 113' ' ' ASP . 12.8 m -114.74 145.16 42.39 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.248 0.547 . . . . 1.24 111.733 -170.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.616 ' HE2' ' HG3' ' A' ' 150' ' ' PRO . 3.2 mtpm? -137.66 121.78 17.94 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 107.387 -1.338 . . . . 2.2599999999999998 107.387 174.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 78.9 p -64.04 98.4 0.21 Allowed 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.11 -1.441 . . . . 1.3899999999999999 107.11 175.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.485 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -109.03 140.21 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.836 0 N-CA-C 108.731 -0.84 . . . . 1.05 108.731 -165.488 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -102.68 86.89 2.85 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 122.459 1.124 . . . . 2.1699999999999999 109.245 -174.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.763 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 1.3 p90 -117.33 154.5 50.31 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 114.012 -1.449 . . . . 0.53000000000000003 111.526 -166.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 3.2 Cg_exo -42.09 -47.0 7.01 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 124.77 3.646 . . . . 1.28 115.883 -174.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.763 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 7.3 tp10 -65.64 -25.55 67.41 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 120.731 0.301 . . . . 3.5 110.749 -163.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.577 ' HB2' HG11 ' A' ' 84' ' ' VAL . 10.1 t80 -150.26 101.77 3.15 Favored Pre-proline 0 N--CA 1.441 -0.908 0 N-CA-C 113.237 0.829 . . . . 6.1200000000000001 113.237 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -88.94 134.4 2.63 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.261 2.641 . . . . 1.77 109.746 163.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.5 -171.92 0.41 Allowed 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.439 2.093 . . . . 1.25 112.424 -176.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 62.2 p -133.22 -179.7 5.66 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 109.356 -0.609 . . . . 1.6000000000000001 109.356 -172.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.2 m -86.21 11.38 12.12 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.125 0.488 . . . . 1.97 110.658 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -120.14 -44.74 2.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.781 -0.645 . . . . 2.1800000000000002 109.773 173.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.867 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 85.0 m-85 -94.28 109.71 21.51 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.193 -0.669 . . . . 1.23 109.193 175.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.617 HG23 ' HG3' ' A' ' 109' ' ' ARG . 1.0 OUTLIER -95.11 107.69 19.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.783 -0.644 . . . . 0.81999999999999995 110.177 -175.391 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 2.7 ttp180 -56.84 99.88 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.407 -0.815 . . . . 4.4199999999999999 109.803 175.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -66.23 128.87 31.25 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.097 -0.801 . . . . 0.79000000000000004 111.097 179.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.672 ' HB3' ' HB3' ' A' ' 174' ' ' GLU . 65.0 t80 -84.84 86.84 7.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.524 0.678 . . . . 4.4400000000000004 110.989 -175.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 53.1 t30 -82.06 116.18 21.53 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.153 -0.93 . . . . 1.6200000000000001 109.361 171.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.757 ' HB3' ' HB3' ' A' ' 172' ' ' GLN . 76.3 t60 -58.19 154.72 29.43 Favored Pre-proline 0 C--O 1.217 -0.614 0 CA-C-O 118.142 -0.932 . . . . 2.3199999999999998 108.656 173.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.616 ' HG3' ' HE2' ' A' ' 130' ' ' LYS . 60.9 Cg_exo -37.74 78.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 123.916 3.077 . . . . 0.53000000000000003 112.618 169.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' CYS . . . . . 0.716 ' HB3' ' O ' ' A' ' 170' ' ' PHE . 72.7 m -135.1 149.49 50.06 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.973 -1.467 . . . . 1.5800000000000001 107.904 -176.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.596 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -138.76 -147.0 5.07 Favored Glycine 0 N--CA 1.432 -1.623 0 C-N-CA 119.051 -1.547 . . . . 0.42999999999999999 113.038 -170.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.663 ' HE1' HD21 ' A' ' 167' ' ' LEU . 7.5 t80 -160.74 82.72 0.66 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.915 -1.513 . . . . 0.59999999999999998 106.915 -167.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.693 HG23 HG13 ' A' ' 168' ' ' VAL . 4.1 m -93.27 140.98 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 CA-C-O 122.044 0.926 . . . . 0.31 110.597 -172.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' CYS . . . . . 0.639 ' SG ' ' HB3' ' A' ' 58' ' ' PRO . 1.6 t -117.09 126.44 52.84 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 114.731 -1.122 . . . . 1.55 109.077 177.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.723 ' HB3' ' HB3' ' A' ' 166' ' ' LYS . 11.2 t -120.48 121.16 29.38 Favored Pre-proline 0 C--N 1.31 -1.138 0 C-N-CA 120.146 -0.622 . . . . 1.0600000000000001 111.669 -172.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 67.8 Cg_exo -50.38 108.65 0.23 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.035 1.823 . . . . 0.56000000000000005 110.373 166.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.723 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 54.0 mmm -72.06 -165.74 0.19 Allowed 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.67 0.747 . . . . 1.1599999999999999 112.175 -174.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.434 ' H ' ' HB3' ' A' ' 158' ' ' MET . 27.1 mt-10 -67.25 -24.28 65.79 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.903 -1.044 . . . . 2.6299999999999999 110.177 177.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 163' ' ' ALA . 54.5 mm-40 -108.05 14.05 25.51 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.754 -0.657 . . . . 2.0499999999999998 110.085 177.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.652 ' HB3' ' CD ' ' A' ' 162' ' ' PRO . 47.0 t-20 29.25 -89.84 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 125.684 1.594 . . . . 1.9299999999999999 114.762 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.652 ' CD ' ' HB3' ' A' ' 161' ' ' ASN . 72.0 Cg_endo -74.42 -13.76 22.76 Favored 'Trans proline' 0 C--N 1.367 1.528 0 CA-C-N 121.854 1.698 . . . . 0.72999999999999998 113.093 -175.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.551 ' HB3' ' HB3' ' A' ' 160' ' ' GLU . . . -91.76 -29.94 16.52 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.864 -0.607 . . . . 0.68000000000000005 110.679 -177.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.814 ' HA ' ' HA ' ' A' ' 55' ' ' PRO . 85.3 m-85 -143.65 124.78 14.48 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.398 -0.593 . . . . 0.93000000000000005 109.398 176.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.438 ' OG ' HD12 ' A' ' 61' ' ' LEU . 21.4 t -112.87 145.52 40.54 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 119.905 -0.718 . . . . 1.4099999999999999 110.593 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.723 ' HB3' ' HB3' ' A' ' 156' ' ' SER . 2.5 tppp? -94.01 112.59 24.44 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.519 0.676 . . . . 0.73999999999999999 111.266 -176.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.663 HD21 ' HE1' ' A' ' 153' ' ' PHE . 0.6 OUTLIER -95.54 104.35 16.26 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.283 -0.871 . . . . 0.27000000000000002 109.37 173.905 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.721 HG12 ' HG3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -125.4 134.54 66.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.223 0.535 . . . . 0.28000000000000003 110.603 176.673 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.643 ' HB3' HG23 ' A' ' 50' ' ' VAL . 20.7 ttt -140.85 143.24 34.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.164 -0.471 . . . . 1.24 110.219 -169.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.716 ' O ' ' HB3' ' A' ' 151' ' ' CYS . 34.0 m-85 -120.42 139.13 53.28 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.057 -0.72 . . . . 3.3700000000000001 109.057 177.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.488 ' HB ' HD21 ' A' ' 192' ' ' LEU . 0.9 OUTLIER -143.42 125.62 12.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 O-C-N 123.492 0.495 . . . . 1.3999999999999999 111.286 178.551 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.757 ' HB3' ' HB3' ' A' ' 149' ' ' HIS . 20.3 tt0 -124.73 51.46 1.63 Allowed 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 107.158 -1.423 . . . . 2.1699999999999999 107.158 171.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 7.4 m -75.36 127.55 33.39 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.806 -1.543 . . . . 1.6499999999999999 110.542 -175.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.672 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 28.6 tt0 -83.39 -28.06 29.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.491 -0.777 . . . . 2.4500000000000002 111.554 -173.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.565 ' O ' HD13 ' A' ' 179' ' ' LEU . 23.2 mmt 48.64 53.79 11.66 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.174 0.511 . . . . 3.7400000000000002 110.247 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.484 ' HD2' ' OE2' ' A' ' 174' ' ' GLU . 11.6 ptm180 -75.24 48.46 0.41 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.419 -0.809 . . . . 5.7800000000000002 111.662 -176.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.402 ' HA3' HG12 ' A' ' 144' ' ' ILE . . . -127.79 48.77 0.95 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.92 -0.657 . . . . 2.2599999999999998 112.662 -177.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 28.0 tptp 70.56 59.67 0.22 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.346 0.593 . . . . 6.2300000000000004 111.653 174.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.61 ' HB2' HD11 ' A' ' 184' ' ' ILE . 4.6 mp -116.67 169.22 9.52 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.026 -0.731 . . . . 1.6399999999999999 109.026 171.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.494 ' HB3' HG12 ' A' ' 183' ' ' ILE . 46.9 t -112.81 151.31 43.91 Favored Pre-proline 0 C--N 1.306 -1.286 0 N-CA-C 107.612 -1.255 . . . . 2.04 107.612 176.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.621 ' O ' ' HG3' ' A' ' 185' ' ' GLU . 76.6 Cg_exo -40.92 -44.92 4.98 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 122.501 2.134 . . . . 1.74 112.283 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.548 ' O ' ' HG3' ' A' ' 186' ' ' LYS . 14.3 p -63.06 -25.18 68.25 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.832 -0.622 . . . . 2.1400000000000001 112.317 -178.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.948 HG21 ' HB2' ' A' ' 105' ' ' SER . 9.1 mm -83.39 -29.5 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.878 0 CA-C-O 122.802 1.287 . . . . 1.1200000000000001 108.401 -176.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 1.024 ' HA ' HG22 ' A' ' 187' ' ' THR . 0.9 OUTLIER -79.93 -34.33 15.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 112.541 -2.118 . . . . 1.1299999999999999 109.924 -175.773 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.621 ' HG3' ' O ' ' A' ' 181' ' ' PRO . 35.1 mt-10 -66.49 -18.6 65.45 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.935 -1.029 . . . . 2.8900000000000001 109.584 172.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' A' ' 182' ' ' SER . 53.0 mtmt -93.0 -44.61 8.33 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.413 -0.812 . . . . 1.28 110.79 174.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' THR . . . . . 1.024 HG22 ' HA ' ' A' ' 184' ' ' ILE . 14.3 t -66.09 -43.0 88.55 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.612 0.597 . . . . 0.62 112.612 -170.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' MET . . . . . 0.555 ' HE2' ' HA ' ' A' ' 188' ' ' MET . 29.1 mmt -73.68 -57.31 2.6 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 112.713 0.634 . . . . 1.0600000000000001 112.713 -172.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.617 ' O ' HG13 ' A' ' 193' ' ' VAL . 27.3 Cg_endo -62.18 -30.48 82.01 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 121.616 1.544 . . . . 0.91000000000000003 112.119 -177.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.2 t -75.99 -33.12 59.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.237 0.541 . . . . 1.5 109.824 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 187' ' ' THR . 63.9 t30 -73.0 -44.24 61.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.678 -0.692 . . . . 1.8799999999999999 111.274 -174.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.494 ' HB3' HG21 ' A' ' 50' ' ' VAL . 18.5 mt -65.23 -42.62 93.24 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.754 0.311 . . . . 1.0900000000000001 111.333 -175.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.617 HG13 ' O ' ' A' ' 189' ' ' PRO . 1.5 m -67.45 -31.89 54.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.908 0.861 . . . . 0.68000000000000005 109.354 178.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.433 ' HB3' ' HE3' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -70.08 -34.68 73.47 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.284 -1.325 . . . . 2.0699999999999998 110.997 177.998 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.634 ' HA ' ' ND2' ' A' ' 198' ' ' ASN . 3.3 m-85 -71.69 -24.53 61.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.24 0.543 . . . . 2.0 110.433 174.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.646 HG12 HD12 ' A' ' 167' ' ' LEU . 59.2 mt -82.08 -29.44 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-O 121.31 0.576 . . . . 0.31 110.511 172.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 44.6 mt -72.21 -42.6 65.57 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 116.16 -0.473 . . . . 1.03 110.736 177.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.863 ' HB3' ' HD2' ' A' ' 76' ' ' LYS . 5.9 p30 -59.55 -24.0 63.33 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 108.96 -0.755 . . . . 1.8999999999999999 108.96 171.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.678 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -80.94 -44.83 17.63 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 120.415 -0.514 . . . . 0.28999999999999998 110.222 176.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.47 ' HD3' HG12 ' A' ' 54' ' ' ILE . 22.5 mmtp -54.8 -42.89 72.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.02 -0.537 . . . . 0.96999999999999997 110.856 175.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.542 ' O ' ' HD3' ' A' ' 204' ' ' LYS . 9.9 t70 -87.88 -46.26 9.56 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.007 -0.542 . . . . 1.9399999999999999 110.327 -178.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' GLY . . . . . 0.682 ' HA2' ' HB3' ' A' ' 205' ' ' ALA . . . -61.19 -25.9 65.22 Favored Glycine 0 C--O 1.224 -0.508 0 CA-C-N 115.849 -0.614 . . . . 0.46999999999999997 112.277 -178.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.971 HD13 HD23 ' A' ' 61' ' ' LEU . 3.0 tp -67.89 -43.07 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-O 119.27 -0.395 . . . . 0.60999999999999999 111.239 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.731 ' HA ' ' HB3' ' A' ' 207' ' ' ARG . 0.0 OUTLIER -91.25 -13.54 32.56 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 118.732 0.696 . . . . 3.3700000000000001 109.228 176.532 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.682 ' HB3' ' HA2' ' A' ' 202' ' ' GLY . . . -66.14 -29.73 70.09 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.532 -0.914 . . . . 1.02 108.532 164.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.6 ' HD2' ' HE2' ' A' ' 60' ' ' LYS . 6.6 t60 -100.48 -7.23 24.45 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.589 -1.187 . . . . 3.6299999999999999 111.286 178.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.731 ' HB3' ' HA ' ' A' ' 204' ' ' LYS . 0.7 OUTLIER -112.95 -62.81 1.53 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.552 0.692 . . . . 2.5899999999999999 110.448 -178.525 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.521 ' OG1' ' HB2' ' A' ' 204' ' ' LYS . 62.3 m -73.78 135.12 77.95 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 114.684 -1.144 . . . . 1.8400000000000001 110.316 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 208' ' ' THR . 11.2 Cg_exo -71.52 43.98 0.57 Allowed 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 123.036 2.491 . . . . 2.3500000000000001 112.689 178.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 31.2 t -98.79 -47.93 5.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.123 -0.489 . . . . 2.3100000000000001 110.775 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.431 ' HB2' ' HA ' ' A' ' 205' ' ' ALA . 6.5 mpt_? -90.95 35.34 0.9 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.423 -0.353 . . . . 5.4500000000000002 111.429 -174.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -78.66 -33.32 47.23 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.167 -0.679 . . . . 6.8600000000000003 109.167 171.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.86 48.72 3.28 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.435 -1.066 . . . . 3.3700000000000001 110.435 171.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -66.05 140.71 58.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.184 0.516 . . . . 5.21 111.764 -174.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -86.77 120.18 27.79 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.711 -0.848 . . . . 6.46 108.711 174.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -132.44 175.21 9.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.569 -0.287 . . . . 6.0899999999999999 111.104 -172.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 68.94 178.96 0.25 Allowed 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.702 0.626 . . . . 5.1200000000000001 110.951 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 13.8 m -85.27 -2.17 57.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.149 -0.478 . . . . 6.7599999999999998 110.685 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -143.16 133.47 24.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.102 -0.499 . . . . 8.8200000000000003 110.394 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 73.2 m . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.872 -0.585 . . . . 8.4800000000000004 109.515 176.405 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.992 0.425 . . . . 3.8599999999999999 110.533 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -106.6 -44.75 4.4 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 109.288 -0.634 . . . . 2.25 109.288 -175.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.605 ' HA ' ' CD1' ' A' ' 6' ' ' ILE . 96.6 m-85 -65.65 -37.03 85.4 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.191 -0.913 . . . . 0.42999999999999999 109.186 -175.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.668 ' HG2' ' HG3' ' A' ' 8' ' ' GLN . 4.4 ttmt -81.75 2.94 27.62 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.121 -0.945 . . . . 1.51 110.476 -176.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -92.87 -49.42 6.06 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.359 0.599 . . . . 0.54000000000000004 109.485 173.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.605 ' CD1' ' HA ' ' A' ' 3' ' ' PHE . 0.3 OUTLIER -83.8 -37.68 13.42 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.606 0 CA-C-N 115.354 -0.839 . . . . 1.0700000000000001 110.181 -173.091 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.628 ' HA ' ' HB ' ' A' ' 10' ' ' THR . . . -71.5 -44.1 65.32 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.587 0.708 . . . . 0.34000000000000002 111.531 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.668 ' HG3' ' HG2' ' A' ' 4' ' ' LYS . 11.7 mt-30 -60.13 -32.83 71.38 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.917 -1.038 . . . . 1.5900000000000001 110.516 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.567 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 25.6 mm-40 -85.75 -32.06 22.06 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.221 -0.899 . . . . 2.4700000000000002 109.266 175.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.681 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.6 OUTLIER -62.26 -39.5 93.09 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.927 -1.033 . . . . 0.47999999999999998 111.042 176.513 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.418 ' HA ' ' CB ' ' A' ' 128' ' ' SER . . . -47.43 -63.04 1.15 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 121.148 0.499 . . . . 0.31 111.529 173.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -71.57 -13.0 61.65 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.851 -0.613 . . . . 1.6399999999999999 111.831 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 44.9 mm-40 -69.6 -58.12 4.34 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.764 0.792 . . . . 2.54 109.298 173.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.811 HG21 ' N ' ' A' ' 152' ' ' GLY . 5.3 p -68.01 -40.13 82.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 114.648 -1.16 . . . . 0.53000000000000003 109.717 -177.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.551 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -68.14 -22.83 64.84 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 114.787 -1.097 . . . . 0.59999999999999998 109.08 176.342 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.744 ' HA2' ' HD3' ' A' ' 19' ' ' ARG . . . -63.28 -25.34 68.29 Favored Glycine 0 CA--C 1.5 -0.847 0 CA-C-N 114.474 -1.239 . . . . 0.56999999999999995 110.444 177.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -88.83 -12.25 42.48 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.699 -0.852 . . . . 3.27 108.699 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -83.96 -9.27 58.81 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.321 -0.854 . . . . 2.0299999999999998 110.027 172.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.744 ' HD3' ' HA2' ' A' ' 16' ' ' GLY . 48.4 mtp180 -106.85 -23.89 12.23 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 116.183 -0.462 . . . . 2.7200000000000002 110.884 -172.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -150.88 170.77 18.5 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.038 -0.528 . . . . 2.1600000000000001 110.513 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.465 HG22 ' CZ2' ' A' ' 24' ' ' TRP . 75.1 p -133.51 134.02 42.91 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.57 -0.741 . . . . 1.8200000000000001 109.792 -175.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.4 t -139.25 107.5 5.78 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.263 0.468 . . . . 2.1899999999999999 112.263 -170.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.82 34.13 81.25 Favored Glycine 0 C--N 1.331 0.282 0 CA-C-N 115.528 -0.76 . . . . 1.1000000000000001 114.405 168.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.92 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -121.29 -166.31 1.34 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 117.183 0.491 . . . . 1.6699999999999999 110.273 175.141 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.61 140.38 0.6 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.392 -0.822 . . . . 2.9500000000000002 109.225 -175.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.691 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 0.1 OUTLIER -60.33 117.08 2.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.457 -0.792 . . . . 1.5600000000000001 110.378 174.01 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.9 p -92.05 -25.96 5.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 114.727 -1.124 . . . . 1.22 109.295 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.46 ' O ' HG22 ' A' ' 35' ' ' VAL . 3.0 tmmm? -161.24 146.63 14.01 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 119.264 -0.974 . . . . 2.4100000000000001 112.274 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.871 HG22 ' HA ' ' A' ' 34' ' ' THR . 42.9 p -143.67 152.27 41.12 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.798 -0.637 . . . . 1.3799999999999999 109.722 176.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.9 m -102.38 -90.01 0.36 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.523 -0.308 . . . . 2.3700000000000001 110.631 176.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.474 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 82.0 tttt -155.28 31.65 0.38 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.122 0.487 . . . . 4.5499999999999998 110.502 175.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.516 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 6.1 mmtm 178.9 -20.47 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.4 -0.818 . . . . 1.4199999999999999 110.039 179.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.477 HG22 ' HA3' ' A' ' 52' ' ' GLY . 31.0 pt -115.45 160.85 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.353 -0.839 . . . . 0.76000000000000001 110.701 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.871 ' HA ' HG22 ' A' ' 29' ' ' THR . 52.5 m -155.15 110.09 3.01 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.314 -0.857 . . . . 0.57999999999999996 110.697 -163.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.712 ' HA ' ' O ' ' A' ' 49' ' ' ARG . 6.0 m -103.12 117.83 49.15 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 CA-C-O 121.023 0.44 . . . . 0.85999999999999999 111.824 176.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.691 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 7.2 m -105.78 124.69 49.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.658 -0.701 . . . . 1.1000000000000001 109.655 175.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.8 p -110.75 133.85 52.98 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.759 -0.655 . . . . 1.27 111.868 -172.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.92 ' HB3' ' HB3' ' A' ' 24' ' ' TRP . 23.0 pttt -139.21 157.5 45.81 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.546 -0.752 . . . . 1.9099999999999999 109.26 171.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.04 127.79 33.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.759 0.314 . . . . 1.6799999999999999 110.202 177.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.445 ' H ' ' HA ' ' A' ' 46' ' ' ASN . 25.3 t -64.59 -35.8 82.17 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.71 -0.677 . . . . 2.0899999999999999 112.383 -172.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 71.84 -41.51 0.51 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.928 0.891 . . . . 6.6100000000000003 112.092 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -81.4 -2.25 48.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.375 0.607 . . . . 6.46 109.962 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -155.53 146.74 22.64 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 107.247 -1.39 . . . . 5.6500000000000004 107.247 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -76.04 64.39 1.92 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.524 0.678 . . . . 5.5599999999999996 110.392 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.28 -151.71 6.54 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 114.961 -1.018 . . . . 1.5600000000000001 110.617 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.445 ' HA ' ' H ' ' A' ' 40' ' ' SER . 23.2 p-10 -131.99 147.07 52.43 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.531 0.681 . . . . 2.0499999999999998 111.212 178.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.614 HD23 ' N ' ' A' ' 48' ' ' TYR . 3.5 tt -99.97 146.18 27.0 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.724 -1.125 . . . . 0.87 108.673 -176.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.645 ' HB2' HD11 ' A' ' 192' ' ' LEU . 56.9 m-85 -124.99 138.39 54.23 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 121.261 -0.176 . . . . 0.98999999999999999 110.623 -177.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.712 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 4.3 ttm180 -104.65 120.0 40.29 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.093 -0.706 . . . . 2.9199999999999999 109.093 167.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.664 ' HB ' ' HB3' ' A' ' 192' ' ' LEU . 9.0 p -102.93 134.73 43.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.004 -1.11 . . . . 1.3300000000000001 108.004 172.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.654 ' HG3' ' HB ' ' A' ' 168' ' ' VAL . 2.7 tt0 -148.02 110.65 4.72 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.058 -0.519 . . . . 1.0700000000000001 110.579 -165.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 32' ' ' LYS . . . -142.61 154.34 25.13 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 111.111 -0.796 . . . . 0.28999999999999998 111.111 179.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.612 HG12 ' SD ' ' A' ' 158' ' ' MET . 2.7 mp -96.33 126.98 48.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 C-N-CA 119.256 -0.977 . . . . 0.57999999999999996 110.393 176.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.424 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 66.2 mt -104.57 112.77 65.41 Favored Pre-proline 0 N--CA 1.44 -0.959 0 CA-C-N 114.937 -1.029 . . . . 0.34999999999999998 109.33 177.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 28.8 Cg_exo -64.56 59.87 0.27 Allowed 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 124.259 3.306 . . . . 0.62 113.111 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.965 ' HG3' HG13 ' A' ' 203' ' ' ILE . 0.2 OUTLIER -134.37 -164.31 1.49 Allowed 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.041 -1.466 . . . . 1.6799999999999999 107.041 174.075 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.56 ' H ' ' CD ' ' A' ' 56' ' ' GLU . 20.0 m -101.73 150.5 37.38 Favored Pre-proline 0 N--CA 1.421 -1.889 0 N-CA-C 108.816 -0.809 . . . . 1.1799999999999999 108.816 169.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.528 ' HB3' ' SG ' ' A' ' 155' ' ' CYS . 14.9 Cg_exo -66.63 -7.72 18.92 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.605 2.87 . . . . 0.52000000000000002 110.2 -178.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.68 -53.09 17.06 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.803 -1.09 . . . . 0.64000000000000001 111.411 175.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.713 ' HE3' ' HB3' ' A' ' 64' ' ' PHE . 16.2 tptt -69.21 -28.29 66.24 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.254 -1.017 . . . . 3.2999999999999998 108.254 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.666 HD23 HD11 ' A' ' 203' ' ' ILE . 63.9 mt -62.45 -51.67 66.59 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.825 -1.08 . . . . 0.40999999999999998 110.008 174.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.571 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 39.3 t -75.35 -4.96 42.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.735 0.302 . . . . 1.29 110.571 176.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.5 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 31.3 t70 -90.63 -43.06 10.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.313 -0.403 . . . . 1.3200000000000001 110.829 178.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.795 ' O ' ' HB3' ' A' ' 71' ' ' ARG . 8.1 p90 -76.49 -44.97 33.02 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.903 -0.319 . . . . 0.60999999999999999 111.146 -175.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.665 HD22 ' O ' ' A' ' 61' ' ' LEU . 1.2 pt? -77.64 6.2 7.73 Favored 'General case' 0 CA--C 1.509 -0.604 0 O-C-N 122.277 -0.264 . . . . 1.5 111.227 -164.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -46.77 -14.53 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.961 0 O-C-N 124.326 1.016 . . . . 1.52 113.074 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.626 ' HA ' ' HD2' ' A' ' 71' ' ' ARG . 8.8 mt-30 87.68 -38.18 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 124.73 1.212 . . . . 3.6000000000000001 110.509 168.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.61 ' OG1' ' HB2' ' A' ' 81' ' ' TYR . 15.0 t -138.2 23.8 2.77 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.793 0.806 . . . . 1.48 110.811 -177.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -108.06 -61.29 0.55 Allowed Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 119.616 -1.278 . . . . 1.46 112.912 -177.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.689 ' O ' HG22 ' A' ' 73' ' ' THR . 18.9 t70 -134.05 -25.19 1.61 Allowed 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.881 0.848 . . . . 2.1899999999999999 110.009 -169.095 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.795 ' HB3' ' O ' ' A' ' 64' ' ' PHE . 0.3 OUTLIER -69.0 -37.22 78.57 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 114.724 -1.125 . . . . 3.3799999999999999 109.658 -163.385 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.101 HG22 HD13 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -76.11 -21.5 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 115.277 -0.874 . . . . 0.70999999999999996 110.066 -176.223 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.689 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.2 t -81.02 -26.22 36.59 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 119.972 -0.691 . . . . 0.96999999999999997 109.986 -172.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.712 ' CE2' ' HA ' ' A' ' 71' ' ' ARG . 24.8 p-90 -110.4 0.02 17.72 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.12 -0.491 . . . . 0.75 111.373 177.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.617 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 2.3 t70 -66.83 176.13 2.16 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.82 0.819 . . . . 2.1899999999999999 112.527 -170.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.46 ' HD3' ' N ' ' A' ' 77' ' ' SER . 0.0 OUTLIER -129.19 -17.3 3.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.555 -1.202 . . . . 3.1899999999999999 111.507 -174.636 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.46 ' N ' ' HD3' ' A' ' 76' ' ' LYS . 67.9 m -130.32 24.6 5.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.658 0.742 . . . . 1.5800000000000001 109.372 178.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.101 HD13 HG22 ' A' ' 72' ' ' ILE . 18.9 mt -116.01 -167.21 1.23 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.301 -0.863 . . . . 0.70999999999999996 112.293 177.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.471 ' HB3' HG23 ' A' ' 80' ' ' VAL . 1.9 mm100 -161.63 -74.79 0.05 Allowed 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.637 -0.71 . . . . 1.73 112.205 -167.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.471 HG23 ' HB3' ' A' ' 79' ' ' GLN . 23.0 t -139.4 122.09 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.917 0.389 . . . . 0.78000000000000003 111.764 -167.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.641 ' HB3' HD12 ' A' ' 72' ' ' ILE . 23.1 p90 -96.53 154.08 17.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.056 -0.52 . . . . 5.4000000000000004 112.009 176.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -162.08 111.29 1.48 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.46 -0.791 . . . . 1.6899999999999999 109.541 168.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 30.9 ttm -72.26 109.87 6.3 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.15 -1.056 . . . . 2.0499999999999998 108.15 174.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.525 HG23 ' HB ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -87.59 -88.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.893 0.377 . . . . 0.64000000000000001 111.34 -170.73 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.546 ' HB3' HD12 ' A' ' 93' ' ' ILE . 54.3 t60 -113.34 124.81 53.33 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.174 0.511 . . . . 1.96 110.137 -177.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.0 mtt180 -104.68 133.96 48.64 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.942 -0.762 . . . . 2.4399999999999999 108.942 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.52 HD12 ' CD2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -94.32 -39.38 10.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.685 0.755 . . . . 0.46999999999999997 109.171 -175.789 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.439 ' HB2' ' HE2' ' A' ' 4' ' ' LYS . 4.0 t0 -150.9 -169.79 3.48 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.609 -1.178 . . . . 1.8600000000000001 108.136 176.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.6 t -79.95 -3.57 48.78 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.74 0.305 . . . . 1.4399999999999999 110.707 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -136.46 17.57 3.14 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.395 0.617 . . . . 1.8700000000000001 109.758 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.722 HG23 ' HD2' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -138.42 108.37 6.34 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 108.662 -0.866 . . . . 0.46000000000000002 108.662 179.513 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.598 ' O ' HD12 ' A' ' 114' ' ' LEU . 30.7 m-85 -126.58 177.23 6.64 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.418 0.628 . . . . 0.42999999999999999 110.959 -173.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.546 HD12 ' HB3' ' A' ' 85' ' ' HIS . 28.4 mt -136.07 132.98 50.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 107.029 -1.471 . . . . 0.40999999999999998 107.029 167.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.425 ' SG ' ' HB2' ' A' ' 113' ' ' ASP . 7.7 p -115.36 127.39 55.37 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.177 0.513 . . . . 2.0099999999999998 111.927 -175.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.597 ' HD2' HD11 ' A' ' 112' ' ' ILE . 41.7 t-80 -89.51 91.32 8.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.721 -0.672 . . . . 1.23 109.192 169.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 86.7 m -110.34 109.17 19.49 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.399 -0.819 . . . . 0.5 111.592 -174.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.471 ' CG1' ' HB ' ' A' ' 80' ' ' VAL . 27.4 mm -77.85 120.07 27.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.699 -0.852 . . . . 1.03 108.699 171.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.4 t -110.77 153.96 24.6 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.14 0.495 . . . . 1.3799999999999999 109.942 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.488 ' C ' ' H ' ' A' ' 101' ' ' PHE . 6.5 mt-30 -115.85 75.11 0.93 Allowed 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.81 -0.632 . . . . 1.8200000000000001 109.385 175.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.5 m -75.18 21.62 0.12 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.356 0.598 . . . . 3.9100000000000001 110.936 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.513 ' CE2' ' HA2' ' A' ' 104' ' ' GLY . 39.1 t80 -48.4 99.53 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.898 1.279 . . . . 5.1600000000000001 111.149 176.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.527 ' HB2' HD12 ' A' ' 106' ' ' ILE . . . -66.53 -71.04 0.21 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.484 -0.78 . . . . 1.98 110.99 175.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.432 ' O ' HG22 ' A' ' 103' ' ' VAL . 14.4 p -145.74 16.89 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 122.466 1.127 . . . . 3.1699999999999999 108.339 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.513 ' HA2' ' CE2' ' A' ' 101' ' ' PHE . . . 115.47 -5.52 21.19 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 114.653 -1.158 . . . . 1.96 111.5 -176.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.22 -18.24 53.3 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.657 0.741 . . . . 1.8799999999999999 110.05 -177.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.527 HD12 ' HB2' ' A' ' 102' ' ' ALA . 26.9 mt -126.6 124.2 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 115.048 -0.978 . . . . 1.1200000000000001 110.152 -172.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.418 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 13.7 m -86.05 163.46 42.95 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 109.108 -0.701 . . . . 1.3500000000000001 109.108 176.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 107' ' ' SER . 9.3 Cg_endo -53.2 131.65 44.13 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.241 1.961 . . . . 1.0700000000000001 111.254 174.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.627 ' HG2' HG23 ' A' ' 144' ' ' ILE . 45.9 mtt180 -106.44 157.06 17.91 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.101 -0.703 . . . . 3.4500000000000002 109.101 -178.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.827 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 13.6 t0 -106.57 116.16 31.46 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.91 -0.774 . . . . 1.3700000000000001 108.91 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.621 ' HE1' ' HA3' ' A' ' 146' ' ' GLY . 3.3 m-30 -99.57 128.39 45.68 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.012 0.435 . . . . 2.4100000000000001 110.492 -177.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.787 HG13 ' HA ' ' A' ' 137' ' ' TYR . 27.3 mm -123.61 75.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 108.769 -0.826 . . . . 0.42999999999999999 108.769 173.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.918 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 20.8 m-20 -89.83 118.03 29.11 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.163 -0.926 . . . . 1.8600000000000001 109.786 -177.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.598 HD12 ' O ' ' A' ' 92' ' ' PHE . 3.8 tp -75.03 114.66 13.76 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 107.875 -1.157 . . . . 0.28000000000000003 107.875 166.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -118.77 122.16 68.72 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 CA-C-N 114.474 -1.239 . . . . 0.26000000000000001 111.121 -164.529 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.722 ' HD2' HG23 ' A' ' 91' ' ' THR . 29.1 t80 -106.32 111.11 23.56 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.656 -1.156 . . . . 2.5699999999999998 109.252 176.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.991 HG12 HG22 ' A' ' 127' ' ' ILE . 82.5 mt -87.81 98.12 7.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.953 0.882 . . . . 0.89000000000000001 109.27 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.634 ' HE2' ' HE1' ' A' ' 116' ' ' TYR . 16.2 tppt? -99.62 112.56 24.77 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.103 -1.408 . . . . 1.2 108.93 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.528 ' NH1' ' HG2' ' A' ' 121' ' ' GLU . 0.1 OUTLIER -106.13 108.86 20.58 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 122.108 0.956 . . . . 2.7999999999999998 108.526 177.039 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.556 ' CB ' ' HB2' ' A' ' 123' ' ' ASN . 91.0 m-85 -76.61 108.36 9.56 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 105.933 -1.877 . . . . 0.82999999999999996 105.933 167.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.528 ' HG2' ' NH1' ' A' ' 119' ' ' ARG . 44.7 mt-10 -40.21 93.35 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.879 1.362 . . . . 2.2799999999999998 112.84 -174.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 71.0 35.27 64.72 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 114.634 -1.166 . . . . 0.76000000000000001 112.497 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.556 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 13.3 m120 -133.32 -54.35 0.9 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.853 -0.673 . . . . 1.6499999999999999 110.032 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.496 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 2.8 mpp? -160.07 121.8 3.21 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.154 -0.476 . . . . 1.1200000000000001 110.655 -175.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -107.93 81.8 1.55 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.412 -0.958 . . . . 1.6200000000000001 108.412 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.58 ' CG1' HG12 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -99.81 137.93 25.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.239 -0.891 . . . . 0.29999999999999999 112.967 -170.709 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.991 HG22 HG12 ' A' ' 117' ' ' ILE . 41.2 pt -99.25 104.35 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 121.833 0.825 . . . . 0.58999999999999997 109.281 166.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 0.7 OUTLIER -87.04 109.26 19.28 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.429 -0.805 . . . . 1.1799999999999999 109.82 179.214 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.918 ' HB3' ' HB3' ' A' ' 113' ' ' ASP . 14.1 m -118.26 137.78 52.81 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.016 0.436 . . . . 1.24 112.132 -166.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.494 ' HE3' ' HB ' ' A' ' 6' ' ' ILE . 3.4 mtpm? -132.47 124.6 28.87 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 107.732 -1.21 . . . . 2.2599999999999998 107.732 178.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 15.6 p -64.37 99.82 0.32 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.924 -1.51 . . . . 1.3899999999999999 106.924 173.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.43 135.69 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 CA-C-O 121.504 0.669 . . . . 1.05 109.369 -164.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -87.41 81.38 7.85 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.841 -1.072 . . . . 2.1699999999999999 109.583 -171.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.754 ' CZ ' ' HB3' ' A' ' 136' ' ' GLU . 0.8 OUTLIER -121.96 176.26 2.1 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-N 115.092 -0.958 . . . . 0.53000000000000003 108.469 -176.548 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.536 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 50.3 Cg_exo -24.43 -64.49 0.04 OUTLIER 'Trans proline' 0 CA--C 1.551 1.353 1 C-N-CA 125.474 4.116 . . . . 1.28 117.329 -179.386 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.754 ' HB3' ' CZ ' ' A' ' 134' ' ' PHE . 6.2 tp10 -72.8 -30.69 64.27 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.466 0.543 . . . . 3.5 112.466 -174.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.787 ' HA ' HG13 ' A' ' 112' ' ' ILE . 32.1 t80 -51.17 -41.87 77.48 Favored Pre-proline 0 CA--C 1.552 1.056 0 N-CA-C 115.651 1.722 . . . . 6.1200000000000001 115.651 -170.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.465 ' HD2' ' O ' ' A' ' 135' ' ' PRO . 73.4 Cg_exo -45.86 108.43 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 122.515 2.143 . . . . 1.77 113.746 177.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 1.001 ' HB3' ' HD3' ' A' ' 145' ' ' ARG . 95.0 Cg_endo -99.97 -158.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.024 3.149 . . . . 1.25 114.053 -177.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.8 t -135.85 -155.09 0.61 Allowed 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.476 -1.305 . . . . 1.6000000000000001 107.476 177.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.2 m -90.47 -41.19 11.57 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.405 -0.518 . . . . 1.97 111.451 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -64.45 -53.36 49.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.759 0.314 . . . . 2.1800000000000002 110.538 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -95.48 108.94 21.2 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 108.923 -0.769 . . . . 1.23 108.923 175.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.627 HG23 ' HG2' ' A' ' 109' ' ' ARG . 1.2 tt -104.52 119.08 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 CA-C-N 115.056 -0.975 . . . . 0.81999999999999995 110.721 -173.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 1.001 ' HD3' ' HB3' ' A' ' 139' ' ' PRO . 1.3 mpt_? -63.41 99.31 0.2 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.264 -1.334 . . . . 4.4199999999999999 109.732 173.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.621 ' HA3' ' HE1' ' A' ' 111' ' ' PHE . . . -61.36 111.83 4.21 Favored Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 110.096 -1.202 . . . . 0.79000000000000004 110.096 176.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.628 ' HB3' ' HB3' ' A' ' 174' ' ' GLU . 39.5 t80 -84.47 84.65 7.58 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.832 0.825 . . . . 4.4400000000000004 110.441 -172.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.656 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 87.6 m-20 -72.82 99.57 2.68 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.485 -1.234 . . . . 1.6200000000000001 109.838 174.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.508 ' HB2' ' HG2' ' A' ' 172' ' ' GLN . 51.0 m-70 -60.89 137.23 93.62 Favored Pre-proline 0 CA--C 1.51 -0.582 0 N-CA-C 107.992 -1.114 . . . . 2.3199999999999998 107.992 172.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.681 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 32.3 Cg_exo -21.97 67.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.168 1 C-N-CA 126.79 4.994 . . . . 0.53000000000000003 115.796 -170.176 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 151' ' ' CYS . . . . . 0.723 ' HB2' ' O ' ' A' ' 170' ' ' PHE . 22.3 p -96.0 -175.11 3.3 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.155 -0.93 . . . . 1.5800000000000001 109.574 176.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.811 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -177.07 171.37 44.24 Favored Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 119.597 -1.287 . . . . 0.42999999999999999 111.942 -177.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.618 ' HB3' ' CG1' ' A' ' 127' ' ' ILE . 2.6 t80 -140.26 84.39 1.96 Allowed 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.002 -1.481 . . . . 0.59999999999999998 107.002 -159.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.636 ' CG2' HG13 ' A' ' 168' ' ' VAL . 2.9 m -93.16 143.36 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 121.988 0.899 . . . . 0.31 111.113 -170.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' CYS . . . . . 0.528 ' SG ' ' HB3' ' A' ' 58' ' ' PRO . 3.6 t -119.81 126.49 51.13 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.558 -1.201 . . . . 1.55 108.976 175.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.662 ' H ' ' HB3' ' A' ' 166' ' ' LYS . 5.5 m -119.02 112.18 36.55 Favored Pre-proline 0 C--N 1.318 -0.781 0 C-N-CA 119.234 -0.986 . . . . 1.0600000000000001 111.43 -173.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 57.1 Cg_exo -51.27 105.52 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 121.77 1.647 . . . . 0.56000000000000005 109.864 167.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.631 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 21.4 mtp -72.18 -171.23 0.72 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.548 0.69 . . . . 1.1599999999999999 112.532 -170.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -62.59 -20.16 64.45 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.047 -0.979 . . . . 2.6299999999999999 109.715 174.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.483 ' HB3' ' HB3' ' A' ' 163' ' ' ALA . 11.5 mm-40 -105.95 10.44 32.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.368 -0.833 . . . . 2.0499999999999998 110.251 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.464 ' CB ' ' CD ' ' A' ' 162' ' ' PRO . 44.1 m-80 27.32 -93.48 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.928 0 N-CA-C 115.13 1.53 . . . . 1.9299999999999999 115.13 -177.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.464 ' CD ' ' CB ' ' A' ' 161' ' ' ASN . 95.3 Cg_endo -76.04 -10.79 19.63 Favored 'Trans proline' 0 C--N 1.367 1.541 0 CA-C-N 121.864 1.701 . . . . 0.72999999999999998 112.942 -173.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' A' ' 160' ' ' GLU . . . -89.76 -34.85 16.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.983 -0.553 . . . . 0.68000000000000005 110.34 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.631 ' O ' ' HB2' ' A' ' 158' ' ' MET . 88.8 m-85 -140.35 118.94 12.3 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.375 -0.602 . . . . 0.93000000000000005 109.375 178.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.403 ' HB3' HD12 ' A' ' 61' ' ' LEU . 69.4 m -116.93 136.86 52.62 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.311 0.576 . . . . 1.4099999999999999 110.642 -178.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.736 ' HG3' HG12 ' A' ' 168' ' ' VAL . 41.1 tptt -80.34 128.53 33.66 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.645 -0.707 . . . . 0.73999999999999999 111.784 -174.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.702 HD12 HG12 ' A' ' 196' ' ' ILE . 0.3 OUTLIER -112.45 100.77 9.02 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.303 -0.862 . . . . 0.27000000000000002 110.575 165.885 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.736 HG12 ' HG3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -125.87 117.52 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 121.712 0.768 . . . . 0.28000000000000003 110.981 175.445 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.424 ' SD ' ' O ' ' A' ' 152' ' ' GLY . 5.5 tpt -128.67 135.75 49.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.391 -0.822 . . . . 1.24 110.176 -173.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.723 ' O ' ' HB2' ' A' ' 151' ' ' CYS . 41.1 m-85 -111.29 128.07 55.83 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.685 -0.688 . . . . 3.3700000000000001 109.311 -177.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 1.019 ' HB ' HD21 ' A' ' 192' ' ' LEU . 0.8 OUTLIER -110.41 121.04 62.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.361 0.601 . . . . 1.3999999999999999 110.535 -176.016 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.508 ' HG2' ' HB2' ' A' ' 149' ' ' HIS . 49.9 tt0 -129.8 49.54 2.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 122.482 1.134 . . . . 2.1699999999999999 108.417 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 22.0 m -77.31 140.24 39.97 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 113.772 -1.558 . . . . 1.6499999999999999 111.448 -173.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 15.0 tt0 -84.61 -28.8 26.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.598 -0.728 . . . . 2.4500000000000002 111.699 -176.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 49.8 mtm 47.9 47.56 18.43 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.058 0.456 . . . . 3.7400000000000002 110.959 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.465 ' CG ' ' HG2' ' A' ' 174' ' ' GLU . 38.9 mtm-85 -48.29 -51.58 25.24 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 114.68 1.363 . . . . 5.7800000000000002 114.68 -166.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -162.75 83.94 0.11 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 119.253 -1.451 . . . . 2.2599999999999998 113.872 -175.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 12.6 tptp -162.31 4.86 0.05 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.942 0.371 . . . . 6.2300000000000004 111.038 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.785 ' HB3' ' HB ' ' A' ' 183' ' ' ILE . 1.2 mp -144.24 172.79 12.43 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.418 0.628 . . . . 1.6399999999999999 110.689 -177.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.471 ' O ' HD12 ' A' ' 184' ' ' ILE . 42.7 m -113.59 162.67 21.34 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 114.663 -1.153 . . . . 2.04 108.016 171.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -44.05 -44.31 12.34 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 122.614 2.209 . . . . 1.74 113.103 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.484 ' O ' ' HE2' ' A' ' 186' ' ' LYS . 10.8 p -70.36 -14.79 62.72 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.121 -0.49 . . . . 2.1400000000000001 112.142 -177.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.785 ' HB ' ' HB3' ' A' ' 179' ' ' LEU . 11.4 mm -91.36 -38.65 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 CA-C-O 122.386 1.088 . . . . 1.1200000000000001 109.144 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.935 ' HA ' HG22 ' A' ' 187' ' ' THR . 0.7 OUTLIER -66.68 -38.35 81.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 113.001 -1.909 . . . . 1.1299999999999999 111.106 -176.881 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -62.4 -21.47 65.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.872 -0.604 . . . . 2.8900000000000001 109.382 176.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.484 ' HE2' ' O ' ' A' ' 182' ' ' SER . 47.0 mtmt -92.46 -41.56 10.23 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.317 -0.856 . . . . 1.28 110.419 175.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.935 HG22 ' HA ' ' A' ' 184' ' ' ILE . 13.6 t -63.08 -35.28 79.73 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.071 0.767 . . . . 0.62 113.071 -168.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' MET . . . . . 0.785 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 30.9 mmt -77.72 -60.71 0.68 Allowed Pre-proline 0 C--N 1.33 -0.24 0 C-N-CA 120.266 -0.574 . . . . 1.0600000000000001 111.52 -177.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.785 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 36.9 Cg_exo -58.17 -37.87 93.65 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.925 1.75 . . . . 0.91000000000000003 112.399 -177.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 41.7 m -70.88 -32.45 69.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.789 0.328 . . . . 1.5 110.764 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -75.16 -43.02 54.74 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.911 -0.586 . . . . 1.8799999999999999 110.053 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 1.019 HD21 ' HB ' ' A' ' 171' ' ' VAL . 95.2 mt -52.97 -55.17 25.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.453 -0.794 . . . . 1.0900000000000001 112.264 176.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 189' ' ' PRO . 1.3 m -66.4 -31.57 54.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.668 0.747 . . . . 0.68000000000000005 109.648 -177.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 190' ' ' SER . 0.6 OUTLIER -69.68 -38.06 76.88 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.49 -1.232 . . . . 2.0699999999999998 111.202 179.028 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.532 ' HB3' ' HE2' ' A' ' 153' ' ' PHE . 3.1 m-30 -62.41 -32.89 73.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.021 0.439 . . . . 2.0 110.26 173.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.702 HG12 HD12 ' A' ' 167' ' ' LEU . 38.8 mt -79.44 -29.57 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-O 120.95 0.405 . . . . 0.31 111.065 177.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 51.9 mt -72.03 -37.52 69.71 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.037 0.446 . . . . 1.03 109.956 176.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.513 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 13.4 m120 -47.4 -50.55 22.29 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.841 -1.072 . . . . 1.8999999999999999 108.676 163.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.813 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -66.29 -46.3 77.48 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 115.057 -0.974 . . . . 0.28999999999999998 110.581 -174.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.702 ' O ' ' HG2' ' A' ' 204' ' ' LYS . 27.9 mmtp -53.69 -50.34 66.07 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 123.814 0.696 . . . . 0.96999999999999997 109.615 174.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -76.44 -38.98 54.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.372 -0.831 . . . . 1.9399999999999999 111.73 -169.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -68.78 -35.02 78.99 Favored Glycine 0 N--CA 1.463 0.447 0 C-N-CA 119.865 -1.16 . . . . 0.46999999999999997 110.486 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.965 HG13 ' HG3' ' A' ' 56' ' ' GLU . 1.1 mp -65.07 -35.75 76.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 114.186 -1.007 . . . . 0.60999999999999999 110.973 173.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.702 ' HG2' ' O ' ' A' ' 200' ' ' LYS . 52.7 mmtt -75.2 -39.34 60.23 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 108.81 -0.811 . . . . 3.3700000000000001 108.81 177.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.644 ' HA ' ' HB3' ' A' ' 211' ' ' ARG . . . -55.82 -35.08 65.95 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.18 -0.918 . . . . 1.02 109.099 173.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.619 ' HB3' ' O ' ' A' ' 203' ' ' ILE . 73.3 t60 -61.53 -43.49 98.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.12 -0.945 . . . . 3.6299999999999999 112.049 174.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.47 ' HG3' ' N ' ' A' ' 208' ' ' THR . 7.8 ptp180 -130.53 -46.47 1.07 Allowed 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.655 0.983 . . . . 2.5899999999999999 113.655 -170.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.484 ' OG1' ' HD2' ' A' ' 204' ' ' LYS . 25.0 m -69.74 137.06 87.83 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-O 120.738 0.304 . . . . 1.8400000000000001 110.863 -171.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 208' ' ' THR . 31.0 Cg_exo -63.65 7.07 0.21 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.465 2.777 . . . . 2.3500000000000001 113.38 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 12.8 p -67.35 -21.22 65.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.054 0.454 . . . . 2.3100000000000001 110.238 175.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.644 ' HB3' ' HA ' ' A' ' 205' ' ' ALA . 3.3 ppt_? -77.18 15.47 0.72 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.232 0.539 . . . . 5.4500000000000002 111.048 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -61.07 -37.55 83.07 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.293 -0.632 . . . . 6.8600000000000003 109.293 170.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -102.53 45.1 1.39 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.541 -0.754 . . . . 3.3700000000000001 111.361 176.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -75.19 136.57 41.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.804 0.335 . . . . 5.21 110.241 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -118.75 97.75 5.88 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.168 0.509 . . . . 6.46 111.381 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 33.0 t-80 -89.98 42.07 1.08 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.496 -0.775 . . . . 6.0899999999999999 109.383 178.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -91.32 85.19 5.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.613 -0.721 . . . . 5.1200000000000001 110.187 -175.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 6.0 p -87.86 -0.38 56.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.74 -0.664 . . . . 6.7599999999999998 111.493 -176.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -100.52 -75.55 0.58 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.64 -0.504 . . . . 8.8200000000000003 109.64 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 17.0 t . . . . . 0 C--O 1.248 1.023 0 N-CA-C 108.513 -0.921 . . . . 8.4800000000000004 108.513 174.1 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 120.855 0.36 . . . . 3.8599999999999999 111.02 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.657 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.2 m-20 -69.55 -35.28 75.27 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.087 -0.709 . . . . 2.25 109.087 -177.015 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.842 ' HA ' HD11 ' A' ' 6' ' ' ILE . 89.8 m-85 -67.68 -34.02 76.08 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.203 -0.908 . . . . 0.42999999999999999 109.096 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.572 ' HG2' ' OE1' ' A' ' 8' ' ' GLN . 21.9 tttp -78.92 -1.16 33.92 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 114.363 -1.289 . . . . 1.51 109.751 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -92.66 -43.85 8.88 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.295 0.569 . . . . 0.54000000000000004 110.209 172.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.842 HD11 ' HA ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -83.0 -37.24 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-N 115.519 -0.764 . . . . 1.0700000000000001 110.269 -172.614 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.417 ' HB2' HD21 ' A' ' 114' ' ' LEU . . . -80.69 -40.85 24.72 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.483 -1.235 . . . . 0.34000000000000002 111.535 -176.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.572 ' OE1' ' HG2' ' A' ' 4' ' ' LYS . 8.2 mt-30 -65.7 -29.6 70.17 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.2 -0.909 . . . . 1.5900000000000001 110.153 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.659 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 14.8 mm100 -82.74 -33.59 27.42 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.211 -0.904 . . . . 2.4700000000000002 109.208 175.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.658 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -70.92 -35.16 72.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.257 -0.883 . . . . 0.47999999999999998 111.423 -179.469 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 15' ' ' LEU . . . -43.87 -61.54 1.4 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.928 0.394 . . . . 0.31 112.038 172.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -74.73 -11.08 60.08 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.477 -0.329 . . . . 1.6399999999999999 111.728 -177.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.659 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 53.9 mt-10 -71.55 -56.01 6.72 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.069 -0.715 . . . . 2.54 109.069 172.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.752 HG21 ' N ' ' A' ' 152' ' ' GLY . 10.6 p -68.27 -38.21 79.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 122.838 1.304 . . . . 0.53000000000000003 109.721 -175.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.443 ' HB3' ' O ' ' A' ' 11' ' ' ALA . 0.5 OUTLIER -76.11 -18.88 58.97 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 113.791 -1.55 . . . . 0.59999999999999998 109.248 178.945 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.412 ' HA2' ' HD3' ' A' ' 19' ' ' ARG . . . -61.95 -27.93 69.5 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 114.144 -1.389 . . . . 0.56999999999999995 110.04 172.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.45 ' HD1' ' O ' ' A' ' 13' ' ' GLU . 24.4 m-85 -86.03 -15.91 39.86 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.16 -0.52 . . . . 3.27 110.055 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.412 ' OD1' HG11 ' A' ' 168' ' ' VAL . 42.7 t30 -85.99 -3.51 58.95 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 119.526 -0.87 . . . . 2.0299999999999998 110.051 172.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.412 ' HD3' ' HA2' ' A' ' 16' ' ' GLY . 35.2 mtp180 -105.62 -21.51 13.18 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.113 -0.367 . . . . 2.7200000000000002 111.486 -178.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -146.26 154.1 41.34 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.242 -0.435 . . . . 2.1600000000000001 111.018 174.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.488 ' HB ' ' CZ2' ' A' ' 24' ' ' TRP . 70.4 p -135.52 129.91 33.79 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.722 -0.672 . . . . 1.8200000000000001 111.229 -172.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.5 p -174.85 157.0 2.36 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.192 0.307 . . . . 2.1899999999999999 111.76 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.69 3.64 90.56 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.903 -0.59 . . . . 1.1000000000000001 113.774 170.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.488 ' CZ2' ' HB ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -120.58 -158.39 0.75 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 117.191 0.496 . . . . 1.6699999999999999 111.456 -176.511 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.37 119.88 0.32 Allowed 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 108.735 -0.839 . . . . 2.9500000000000002 108.735 -174.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.604 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 0.3 OUTLIER -55.16 121.71 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-O 122.06 0.933 . . . . 1.5600000000000001 111.389 174.64 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.13 -25.35 3.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 113.971 -1.468 . . . . 1.22 109.99 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 28' ' ' LYS . 9.4 tptm -142.98 121.93 12.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 119.75 -0.78 . . . . 2.4100000000000001 112.503 -173.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.535 HG22 ' HA ' ' A' ' 34' ' ' THR . 41.6 p -135.59 121.75 20.22 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.367 -0.605 . . . . 1.3799999999999999 109.367 172.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.2 t -85.14 -79.01 0.24 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 121.064 -0.254 . . . . 2.3700000000000001 110.415 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -164.08 19.37 0.06 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.479 0.657 . . . . 4.5499999999999998 109.832 176.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -173.54 3.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.662 -0.699 . . . . 1.4199999999999999 110.369 -175.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.476 ' CD1' ' HB ' ' A' ' 193' ' ' VAL . 28.9 pt -140.85 167.46 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-O 120.79 0.329 . . . . 0.76000000000000001 110.875 -171.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.535 ' HA ' HG22 ' A' ' 29' ' ' THR . 26.2 m -152.95 104.72 2.86 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.208 -0.451 . . . . 0.57999999999999996 111.19 -171.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.627 HG11 HD13 ' A' ' 192' ' ' LEU . 11.4 t -101.57 121.02 51.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.85999999999999999 110.086 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.604 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 5.6 m -113.02 128.55 56.53 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.187 -0.46 . . . . 1.1000000000000001 110.223 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.0 p -97.94 130.24 44.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.667 -0.697 . . . . 1.27 110.345 -176.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.407 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 57.9 tttm -120.68 -98.46 0.45 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.671 -0.695 . . . . 1.9099999999999999 111.243 -173.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.16 137.81 6.33 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.663 -0.495 . . . . 1.6799999999999999 109.663 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.45 ' C ' ' H ' ' A' ' 42' ' ' LYS . 8.5 t -82.8 -155.7 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.099 0.476 . . . . 2.0899999999999999 110.518 -177.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 42.7 ttt180 -74.32 11.8 0.89 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.93 -0.577 . . . . 6.6100000000000003 109.978 175.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.45 ' H ' ' C ' ' A' ' 40' ' ' SER . 32.7 mmtp 60.82 39.7 16.78 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 115.654 -0.703 . . . . 6.46 110.566 -178.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -143.94 2.42 1.18 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.936 -0.575 . . . . 5.6500000000000004 109.918 -176.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.48 ' NE2' ' HG3' ' A' ' 174' ' ' GLU . 19.6 m-70 -151.08 -45.07 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.043 -0.526 . . . . 5.5599999999999996 111.181 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 171.89 -117.94 0.7 Allowed Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.385 -0.912 . . . . 1.5600000000000001 112.74 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -128.74 155.13 45.59 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.362 0.601 . . . . 2.0499999999999998 111.355 -173.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.656 HD12 ' HB2' ' A' ' 172' ' ' GLN . 10.0 tt -93.5 152.38 19.1 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.023 -0.989 . . . . 0.87 109.56 -176.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.551 ' N ' HD23 ' A' ' 47' ' ' LEU . 71.7 m-85 -127.78 134.17 49.48 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.65 0.262 . . . . 0.98999999999999999 110.745 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.532 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.8 OUTLIER -118.6 126.48 52.05 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 108.999 -0.741 . . . . 2.9199999999999999 108.999 175.915 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.589 HG23 HG22 ' A' ' 35' ' ' VAL . 14.8 p -114.75 150.03 16.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.725 -0.472 . . . . 1.3300000000000001 109.725 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.469 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 37.9 tt0 -155.38 109.84 2.92 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.987 -0.552 . . . . 1.0700000000000001 110.351 -170.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.474 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -138.83 160.43 25.7 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.615 -0.802 . . . . 0.28999999999999998 111.791 178.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.6 mt -100.89 114.92 41.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 C-N-CA 120.57 -0.452 . . . . 0.57999999999999996 110.786 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 40.1 mt -94.42 112.83 59.15 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.666 -0.697 . . . . 0.34999999999999998 109.431 175.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.34 70.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 124.566 3.511 . . . . 0.62 112.893 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.488 ' HG3' ' CG1' ' A' ' 203' ' ' ILE . 0.1 OUTLIER -155.06 -167.77 2.67 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.89 -1.05 . . . . 1.6799999999999999 108.555 177.089 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.3 t -101.41 146.77 32.77 Favored Pre-proline 0 N--CA 1.421 -1.884 0 N-CA-C 108.485 -0.932 . . . . 1.1799999999999999 108.485 174.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.577 ' HB3' ' SG ' ' A' ' 155' ' ' CYS . 24.6 Cg_exo -61.62 -12.7 26.0 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.486 2.791 . . . . 0.52000000000000002 110.442 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.08 -44.65 53.28 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.74 -1.118 . . . . 0.64000000000000001 111.325 176.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.512 ' HB3' HD11 ' A' ' 203' ' ' ILE . 6.5 tppt? -71.49 -31.94 67.68 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 108.293 -1.003 . . . . 3.2999999999999998 108.293 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.974 HD23 HD13 ' A' ' 203' ' ' ILE . 63.6 mt -62.15 -51.91 65.96 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.388 -1.278 . . . . 0.40999999999999998 110.429 175.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.8 m -64.7 -15.24 61.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.048 0.451 . . . . 1.29 110.613 173.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -84.73 -52.3 6.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.036 -0.529 . . . . 1.3200000000000001 111.795 -177.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.701 ' CE2' ' HA ' ' A' ' 199' ' ' ALA . 10.2 p90 -70.03 -40.63 75.05 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.727 0.269 . . . . 0.60999999999999999 111.727 -172.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.454 HD22 ' O ' ' A' ' 61' ' ' LEU . 0.6 OUTLIER -79.75 -21.35 44.58 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 120.357 -0.537 . . . . 1.5 112.054 -170.059 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.535 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 1.8 t80 -5.77 -71.77 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 O-C-N 125.214 1.571 . . . . 1.52 113.18 -156.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.535 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 4.8 tp60 175.93 -37.7 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.565 0.541 . . . . 3.6000000000000001 111.815 167.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.416 ' OG1' ' HB2' ' A' ' 81' ' ' TYR . 12.7 t -146.57 12.02 1.14 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.364 0.505 . . . . 1.48 112.364 -168.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -118.99 -5.26 11.92 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 119.122 -1.513 . . . . 1.46 113.887 -171.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.662 ' O ' HG22 ' A' ' 73' ' ' THR . 0.5 OUTLIER -170.96 -31.74 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.631 0 CA-C-O 121.415 0.626 . . . . 2.1899999999999999 109.844 -177.944 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.503 ' HG2' HD11 ' A' ' 78' ' ' LEU . 8.0 ttt180 -40.9 -50.09 3.23 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 125.461 1.504 . . . . 3.3799999999999999 111.086 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.791 ' H ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -91.15 -7.52 10.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.813 -1.085 . . . . 0.70999999999999996 111.241 -176.189 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.662 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER -84.79 -34.6 22.73 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 120.545 -0.462 . . . . 0.96999999999999997 110.298 -173.758 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.684 ' CZ3' ' HB2' ' A' ' 198' ' ' ASN . 20.8 p-90 -91.78 -42.38 10.14 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 120.056 -0.658 . . . . 0.75 109.314 174.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.7 t70 56.83 141.96 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.203 1.927 . . . . 2.1899999999999999 116.203 159.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.543 ' CG ' ' HB3' ' A' ' 198' ' ' ASN . 0.0 OUTLIER -139.29 -29.09 0.76 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.567 -0.742 . . . . 3.1899999999999999 111.989 163.733 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.539 ' N ' ' HD3' ' A' ' 76' ' ' LYS . 63.0 m -136.51 22.18 3.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.081 0.943 . . . . 1.5800000000000001 108.524 176.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.593 HD13 HG22 ' A' ' 72' ' ' ILE . 43.8 mt -110.01 -173.79 2.34 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.241 -1.345 . . . . 0.70999999999999996 110.163 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.61 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 14.6 mm-40 -160.36 -66.18 0.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.925 0.343 . . . . 1.73 111.925 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.498 HG23 ' HB3' ' A' ' 79' ' ' GLN . 40.4 t -143.71 133.53 20.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.984 0.421 . . . . 0.78000000000000003 111.136 -167.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.446 ' HB3' HD12 ' A' ' 72' ' ' ILE . 20.3 p90 -100.49 145.17 28.61 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.643 -0.708 . . . . 5.4000000000000004 110.754 175.081 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.589 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 18.4 m120 -150.8 102.56 3.01 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.798 -0.816 . . . . 1.6899999999999999 108.798 170.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.52 107.36 2.45 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.638 -0.505 . . . . 2.0499999999999998 109.638 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.477 ' CG1' ' HG2' ' A' ' 136' ' ' GLU . 0.0 OUTLIER -84.36 -56.73 5.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.608 -0.723 . . . . 0.64000000000000001 110.948 -170.433 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -147.51 113.05 5.65 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.001 -0.545 . . . . 1.96 110.244 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -95.91 120.78 36.79 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.562 -0.903 . . . . 2.4399999999999999 108.562 176.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.617 HG12 ' O ' ' A' ' 91' ' ' THR . 1.2 mm -72.9 -53.35 18.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.976 -1.011 . . . . 0.46999999999999997 110.277 -168.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -140.23 -97.2 0.15 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.633 -0.712 . . . . 1.8600000000000001 111.492 176.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.6 t -137.98 -12.44 1.46 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.846 -0.161 . . . . 1.4399999999999999 111.041 -177.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -131.3 8.57 4.68 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.169 0.509 . . . . 1.8700000000000001 109.713 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.617 ' O ' HG12 ' A' ' 87' ' ' ILE . 9.0 m -139.6 118.15 12.22 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 107.591 -1.263 . . . . 0.46000000000000002 107.591 -172.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.619 ' O ' HD12 ' A' ' 114' ' ' LEU . 35.8 m-85 -132.92 174.99 9.75 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.243 0.544 . . . . 0.42999999999999999 110.854 -171.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.524 HD11 ' CE1' ' A' ' 3' ' ' PHE . 25.5 mt -133.97 123.5 44.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 107.255 -1.387 . . . . 0.40999999999999998 107.255 165.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.0 t -112.6 122.09 46.68 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.372 0.606 . . . . 2.0099999999999998 111.532 -176.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.589 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 31.2 t-80 -78.84 88.74 4.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.864 0.84 . . . . 1.23 108.84 168.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 19.1 m -97.37 114.17 25.93 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.514 -1.221 . . . . 0.5 111.183 -176.156 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.493 ' CG1' ' HB ' ' A' ' 80' ' ' VAL . 36.8 mm -76.98 124.72 35.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.909 -0.774 . . . . 1.03 108.909 173.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.1 m -111.19 133.22 53.71 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.011 -0.995 . . . . 1.3799999999999999 111.562 -170.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.61 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 30.6 mt-30 -89.36 83.91 6.43 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.687 -0.486 . . . . 1.8200000000000001 109.687 172.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.475 ' O ' ' HB ' ' A' ' 106' ' ' ILE . 36.3 m -91.98 96.09 10.17 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.907 -0.405 . . . . 3.9100000000000001 109.907 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -122.57 100.29 6.85 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 112.558 0.577 . . . . 5.1600000000000001 112.558 -178.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.543 ' O ' HG12 ' A' ' 103' ' ' VAL . . . -92.99 76.33 4.73 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.059 -0.719 . . . . 1.98 109.059 168.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 102' ' ' ALA . 1.3 p 58.44 12.31 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.215 1.006 . . . . 3.1699999999999999 112.409 178.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.43 -4.55 21.57 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.345 -0.931 . . . . 1.96 112.805 176.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.452 ' HB3' HD12 ' A' ' 183' ' ' ILE . 20.3 m -71.38 -14.04 62.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.185 0.517 . . . . 1.8799999999999999 111.189 178.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.475 ' HB ' ' O ' ' A' ' 100' ' ' SER . 16.3 mt -131.41 144.21 38.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.907 -0.588 . . . . 1.1200000000000001 109.879 -173.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.437 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 15.5 m -99.43 169.21 8.43 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 109.867 -0.419 . . . . 1.3500000000000001 109.867 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 107' ' ' SER . 80.1 Cg_exo -46.54 128.18 12.42 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.201 1.934 . . . . 1.0700000000000001 111.108 172.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.636 ' HG3' HG23 ' A' ' 144' ' ' ILE . 33.3 ttp180 -116.81 162.43 17.72 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 120.993 0.425 . . . . 3.4500000000000002 110.068 -170.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.503 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 6.4 t70 -112.14 162.14 15.77 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.285 -1.006 . . . . 1.3700000000000001 108.285 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.457 ' CZ ' ' HB3' ' A' ' 113' ' ' ASP . 3.0 t80 -149.7 136.15 19.15 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.059 0.457 . . . . 2.4100000000000001 111.266 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.651 HG21 ' CE1' ' A' ' 134' ' ' PHE . 46.3 mm -122.75 89.86 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 N-CA-C 108.423 -0.955 . . . . 0.42999999999999999 108.423 172.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.457 ' HB3' ' CZ ' ' A' ' 111' ' ' PHE . 2.0 p30 -95.3 113.45 25.12 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.384 -0.825 . . . . 1.8600000000000001 110.685 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.619 HD12 ' O ' ' A' ' 92' ' ' PHE . 8.4 tp -76.43 121.16 22.66 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 119.19 -1.004 . . . . 0.28000000000000003 108.45 162.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -127.64 126.6 67.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-N 115.007 -0.997 . . . . 0.26000000000000001 111.949 -165.872 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.428 ' CD2' ' HA ' ' A' ' 8' ' ' GLN . 10.2 t80 -109.42 113.1 25.62 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.201 -0.909 . . . . 2.5699999999999998 110.42 174.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.592 HG12 HG22 ' A' ' 127' ' ' ILE . 80.4 mt -96.72 113.76 31.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.719 -0.673 . . . . 0.89000000000000001 109.734 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.552 ' HE3' ' CE1' ' A' ' 120' ' ' TYR . 37.8 ttpt -137.74 141.14 40.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.004 0.43 . . . . 1.2 110.398 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.548 ' O ' ' HD3' ' A' ' 119' ' ' ARG . 0.1 OUTLIER -113.57 113.7 25.45 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 121.956 0.884 . . . . 2.7999999999999998 109.012 177.31 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.552 ' CE1' ' HE3' ' A' ' 118' ' ' LYS . 3.5 m-85 -69.02 110.56 4.52 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.046 -1.465 . . . . 0.82999999999999996 107.046 168.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -35.85 94.53 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 O-C-N 124.769 1.293 . . . . 2.2799999999999998 113.141 -175.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 59.79 50.69 64.94 Favored Glycine 0 CA--C 1.504 -0.647 0 CA-C-N 114.63 -1.168 . . . . 0.76000000000000001 111.842 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.532 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 60.8 t30 -149.36 -53.12 0.16 Allowed 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.99 -0.605 . . . . 1.6499999999999999 110.061 -176.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 1.8 mpp? -158.73 119.67 3.34 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.864 0.364 . . . . 1.1200000000000001 111.701 -177.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -101.71 84.5 2.57 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.209 -1.034 . . . . 1.6200000000000001 108.209 176.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.536 ' CG1' HG12 ' A' ' 154' ' ' VAL . 0.5 OUTLIER -101.61 140.59 19.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 112.903 0.705 . . . . 0.29999999999999999 112.903 -170.426 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.658 HG13 ' O ' ' A' ' 127' ' ' ILE . 8.0 pt -108.96 112.16 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 108.675 -0.861 . . . . 0.58999999999999997 108.675 163.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.576 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 4.3 m -80.1 155.56 27.45 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.972 -0.751 . . . . 1.1799999999999999 108.972 175.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 80.8 p -149.82 131.63 15.08 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.61 0.719 . . . . 1.24 111.821 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.8 mtpp -132.63 122.77 25.2 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.628 -1.249 . . . . 2.2599999999999998 107.628 175.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.639 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 17.7 t -70.8 104.88 3.02 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 106.81 -1.552 . . . . 1.3899999999999999 106.81 175.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.0 m -102.9 152.59 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 C-N-CA 119.417 -0.913 . . . . 1.05 110.01 -174.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.662 ' HA ' ' CG ' ' A' ' 137' ' ' TYR . 8.4 p-10 -108.47 55.65 0.64 Allowed 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 123.204 1.478 . . . . 2.1699999999999999 109.872 -168.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.651 ' CE1' HG21 ' A' ' 112' ' ' ILE . 0.7 OUTLIER -91.57 178.33 1.81 Allowed Pre-proline 0 CA--C 1.553 1.086 0 CA-C-N 112.719 -2.037 . . . . 0.53000000000000003 109.083 -175.322 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.548 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 9.0 Cg_exo -32.19 -56.28 0.29 Allowed 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 124.654 3.57 . . . . 1.28 117.366 -176.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.608 ' HB3' ' CZ ' ' A' ' 134' ' ' PHE . 10.2 tp10 -74.18 -29.66 61.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.479 0.581 . . . . 3.5 112.389 -174.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.662 ' CG ' ' HA ' ' A' ' 133' ' ' ASP . 13.0 t80 -46.18 -42.24 26.76 Favored Pre-proline 0 CA--C 1.552 1.037 0 N-CA-C 116.1 1.889 . . . . 6.1200000000000001 116.1 -173.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.467 ' HD2' ' O ' ' A' ' 135' ' ' PRO . 73.4 Cg_exo -42.58 107.07 0.08 OUTLIER 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.251 1.967 . . . . 1.77 113.165 176.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -96.68 -159.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.544 2.83 . . . . 1.25 113.487 -174.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.7 m -143.94 -161.8 1.34 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.419 -0.956 . . . . 1.6000000000000001 108.419 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.2 m -82.86 -47.23 12.08 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.118 -0.633 . . . . 1.97 110.904 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -65.38 -23.31 66.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.311 -0.404 . . . . 2.1800000000000002 111.263 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.503 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 95.0 m-85 -132.16 108.12 9.07 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.361 -0.607 . . . . 1.23 109.361 177.172 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.68 HD11 ' HB2' ' A' ' 176' ' ' ARG . 0.2 OUTLIER -104.07 116.69 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 109.019 -0.734 . . . . 0.81999999999999995 109.019 178.192 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.531 ' HD2' HG12 ' A' ' 112' ' ' ILE . 0.8 OUTLIER -59.58 98.72 0.05 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.382 -0.826 . . . . 4.4199999999999999 109.686 172.377 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -59.61 114.3 6.13 Favored Glycine 0 CA--C 1.504 -0.609 0 N-CA-C 111.107 -0.797 . . . . 0.79000000000000004 111.107 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -84.89 88.48 7.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.875 0.845 . . . . 4.4400000000000004 111.17 -169.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.549 ' H ' ' HB2' ' A' ' 131' ' ' SER . 66.7 t30 -84.31 123.97 30.74 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.645 -1.161 . . . . 1.6200000000000001 110.801 178.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.429 ' O ' ' N ' ' A' ' 151' ' ' CYS . 46.0 m80 -74.68 161.63 77.02 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 119.022 -0.513 . . . . 2.3199999999999998 109.882 176.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 149' ' ' HIS . 5.4 Cg_endo -48.06 76.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 124.514 3.476 . . . . 0.53000000000000003 114.651 -178.069 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' CYS . . . . . 0.707 ' SG ' ' HA ' ' A' ' 171' ' ' VAL . 14.3 p -129.53 -174.09 3.2 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.251 -1.018 . . . . 1.5800000000000001 108.251 171.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.752 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -167.79 -147.33 5.27 Favored Glycine 0 N--CA 1.436 -1.319 0 C-N-CA 118.542 -1.789 . . . . 0.42999999999999999 113.426 -173.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.579 ' CZ ' HD11 ' A' ' 167' ' ' LEU . 39.2 t80 -160.94 94.42 1.02 Allowed 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.76 -1.2 . . . . 0.59999999999999998 107.76 -162.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.686 ' CG2' HG13 ' A' ' 168' ' ' VAL . 3.4 m -105.76 148.98 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 CA-C-O 121.969 0.89 . . . . 0.31 111.307 -173.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' CYS . . . . . 0.577 ' SG ' ' HB3' ' A' ' 58' ' ' PRO . 12.1 t -117.44 137.72 52.32 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.911 -1.04 . . . . 1.55 108.597 173.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.495 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 12.6 m -129.61 116.57 18.37 Favored Pre-proline 0 C--N 1.31 -1.122 0 C-N-CA 120.394 -0.522 . . . . 1.0600000000000001 111.038 -177.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.532 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 55.8 Cg_exo -49.85 122.43 9.0 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.496 2.131 . . . . 0.56000000000000005 111.378 173.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.673 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 0.7 OUTLIER -80.43 -167.13 1.23 Allowed 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.055 0.455 . . . . 1.1599999999999999 112.079 -175.9 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -67.8 -26.53 66.13 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.565 -0.743 . . . . 2.6299999999999999 109.366 176.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 163' ' ' ALA . 34.4 mm-40 -97.62 13.76 29.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.246 -0.888 . . . . 2.0499999999999998 109.86 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.449 ' CB ' ' CD ' ' A' ' 162' ' ' PRO . 21.9 m-80 25.78 -89.13 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 125.708 1.603 . . . . 1.9299999999999999 115.21 -177.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' A' ' 161' ' ' ASN . 84.1 Cg_endo -74.32 -10.49 22.41 Favored 'Trans proline' 0 C--N 1.366 1.448 0 CA-C-N 121.596 1.606 . . . . 0.72999999999999998 113.473 -174.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 160' ' ' GLU . . . -96.12 -34.51 11.67 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.536 -0.302 . . . . 0.68000000000000005 111.573 -177.227 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.673 ' O ' ' HB2' ' A' ' 158' ' ' MET . 81.9 m-85 -136.64 135.34 38.2 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.981 -0.377 . . . . 0.93000000000000005 109.981 178.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.401 ' HB2' HD11 ' A' ' 61' ' ' LEU . 57.4 m -126.09 143.77 50.99 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.35 0.595 . . . . 1.4099999999999999 111.618 -177.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 156' ' ' SER . 1.9 tppp? -91.64 107.96 19.57 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.38 -0.827 . . . . 0.73999999999999999 110.751 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.579 HD11 ' CZ ' ' A' ' 153' ' ' PHE . 0.5 OUTLIER -93.08 107.67 19.41 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.209 -0.905 . . . . 0.27000000000000002 109.309 175.224 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.686 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -131.77 129.4 61.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.865 0.841 . . . . 0.28000000000000003 111.753 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.569 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 11.3 ttt -140.91 151.34 44.17 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.009 -0.996 . . . . 1.24 108.98 -172.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.718 ' CE2' HG23 ' A' ' 14' ' ' VAL . 1.0 OUTLIER -144.83 152.39 40.22 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.88 -0.785 . . . . 3.3700000000000001 108.88 171.199 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.707 ' HA ' ' SG ' ' A' ' 151' ' ' CYS . 12.6 p -138.12 127.7 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 O-C-N 123.907 0.755 . . . . 1.3999999999999999 111.728 -172.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.656 ' HB2' HD12 ' A' ' 47' ' ' LEU . 24.2 tt0 -116.65 48.83 1.22 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.044 0.926 . . . . 2.1699999999999999 108.518 174.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 1.7 t -74.65 152.67 39.17 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.029 -0.987 . . . . 1.6499999999999999 111.024 -173.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.48 ' HG3' ' NE2' ' A' ' 44' ' ' HIS . 21.7 tt0 -95.71 -30.67 13.61 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.191 -0.913 . . . . 2.4500000000000002 109.838 173.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 37.7 mtp 36.93 65.07 0.52 Allowed 'General case' 0 C--O 1.233 0.222 0 O-C-N 124.247 0.967 . . . . 3.7400000000000002 112.616 -177.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.68 ' HB2' HD11 ' A' ' 144' ' ' ILE . 96.3 mtt180 -54.45 175.11 0.05 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.675 -0.693 . . . . 5.7800000000000002 111.427 174.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 124.5 -152.13 17.39 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.765 -0.934 . . . . 2.2599999999999998 110.765 -174.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -101.21 53.96 0.84 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.461 0.648 . . . . 6.2300000000000004 110.229 178.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 179' ' ' LEU . 3.1 mp -113.08 148.82 34.45 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.591 0.71 . . . . 1.6399999999999999 109.489 175.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.543 ' H ' ' CG1' ' A' ' 183' ' ' ILE . 15.0 m -113.99 167.39 9.6 Favored Pre-proline 0 C--N 1.302 -1.469 0 CA-C-N 114.662 -1.153 . . . . 2.04 107.891 178.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -48.34 -33.49 22.59 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 121.781 1.654 . . . . 1.74 111.842 177.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.442 ' O ' ' HG3' ' A' ' 186' ' ' LYS . 14.2 p -75.92 -13.49 60.26 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.542 -0.754 . . . . 2.1400000000000001 112.572 -178.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.58 ' HA ' ' HE2' ' A' ' 186' ' ' LYS . 40.5 mm -92.11 -47.22 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-O 122.508 1.147 . . . . 1.1200000000000001 109.301 -178.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.99 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.5 mp -60.62 -35.57 64.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 112.678 -2.055 . . . . 1.1299999999999999 111.14 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -70.14 -17.23 63.19 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.583 -0.735 . . . . 2.8900000000000001 109.158 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.58 ' HE2' ' HA ' ' A' ' 183' ' ' ILE . 43.6 mtmt -92.11 -39.73 11.44 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.533 -0.758 . . . . 1.28 109.707 172.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.99 HG22 ' HA ' ' A' ' 184' ' ' ILE . 6.4 t -73.68 -36.63 65.33 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 119.645 -0.822 . . . . 0.62 112.538 -170.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' MET . . . . . 0.579 ' O ' HD12 ' A' ' 192' ' ' LEU . 37.6 mmm -70.32 -56.76 6.44 Favored Pre-proline 0 C--O 1.226 -0.176 0 C-N-CA 120.272 -0.571 . . . . 1.0600000000000001 112.39 -175.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 188' ' ' MET . 18.9 Cg_endo -57.73 -18.76 35.17 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 122.232 1.955 . . . . 0.91000000000000003 112.392 -176.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.404 ' O ' HG22 ' A' ' 193' ' ' VAL . 33.9 t -86.24 -38.48 17.54 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.13 -0.693 . . . . 1.5 109.13 174.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -68.12 -42.71 79.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.324 -0.853 . . . . 1.8799999999999999 111.638 -172.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.627 HD13 HG11 ' A' ' 35' ' ' VAL . 1.1 mt -62.02 -48.99 77.81 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.572 0.701 . . . . 1.0900000000000001 110.959 -177.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.478 ' O ' ' HG ' ' A' ' 197' ' ' LEU . 1.3 m -67.67 -32.65 57.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.057 -0.974 . . . . 0.68000000000000005 109.672 -177.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -76.68 -29.11 56.19 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.529 -1.214 . . . . 2.0699999999999998 110.942 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.729 ' HA ' ' OD1' ' A' ' 198' ' ' ASN . 0.5 OUTLIER -66.38 -33.0 74.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.866 0.841 . . . . 2.0 109.475 171.071 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.676 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 22.6 mt -75.54 -27.86 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-N 115.707 -0.679 . . . . 0.31 110.799 173.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 53.1 mt -71.26 -42.42 68.81 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-N 116.651 -0.25 . . . . 1.03 111.365 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.729 ' OD1' ' HA ' ' A' ' 195' ' ' PHE . 1.4 p-10 -59.6 -23.75 63.23 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.155 -1.018 . . . . 1.8999999999999999 108.952 171.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.701 ' HA ' ' CE2' ' A' ' 64' ' ' PHE . . . -81.32 -46.14 15.15 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 119.975 -0.69 . . . . 0.28999999999999998 111.132 176.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.676 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 13.8 mmmm -55.22 -43.59 74.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.96999999999999997 110.251 177.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -92.1 -33.82 14.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.738 -0.664 . . . . 1.9399999999999999 112.013 -174.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -66.61 -29.1 74.21 Favored Glycine 0 N--CA 1.463 0.435 0 C-N-CA 120.784 -0.722 . . . . 0.46999999999999997 111.377 176.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.974 HD13 HD23 ' A' ' 61' ' ' LEU . 3.2 tp -71.34 -28.67 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 109.44 -0.578 . . . . 0.60999999999999999 109.44 176.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.612 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 79.1 mttt -79.07 -40.8 30.31 Favored 'General case' 0 C--O 1.209 -1.074 0 N-CA-C 107.861 -1.163 . . . . 3.3700000000000001 107.861 174.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.415 ' HA ' ' HB3' ' A' ' 211' ' ' ARG . . . -55.95 -27.74 53.82 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.415 -0.811 . . . . 1.02 109.9 172.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.649 ' CE1' ' HA ' ' A' ' 64' ' ' PHE . 12.2 m-70 -103.15 7.25 38.74 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.383 0.883 . . . . 3.6299999999999999 113.383 175.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.504 ' HB3' ' O ' ' A' ' 203' ' ' ILE . 0.2 OUTLIER -128.37 -53.68 1.27 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.284 0.564 . . . . 2.5899999999999999 110.808 174.713 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.475 ' N ' ' O ' ' A' ' 204' ' ' LYS . 59.9 m -80.59 130.71 63.57 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 115.353 -0.839 . . . . 1.8400000000000001 110.027 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -74.16 2.75 5.8 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 122.769 2.313 . . . . 2.3500000000000001 113.464 -176.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.466 ' H ' HG22 ' A' ' 208' ' ' THR . 58.0 m -86.84 38.52 0.8 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.017 0.437 . . . . 2.3100000000000001 111.388 -178.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.599 ' H ' ' HD3' ' A' ' 211' ' ' ARG . 0.0 OUTLIER -111.73 7.7 20.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.335 -0.393 . . . . 5.4500000000000002 110.29 175.783 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -60.04 -34.82 73.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.329 0.585 . . . . 6.8600000000000003 109.973 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -128.21 24.98 4.95 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 115.36 -0.837 . . . . 3.3700000000000001 111.607 176.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.573 ' CB ' ' HA ' ' A' ' 211' ' ' ARG . 86.1 t80 -86.88 96.49 10.24 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 120.895 -0.322 . . . . 5.21 110.626 -177.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 42.57 36.17 0.77 Allowed 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.352 1.032 . . . . 6.46 112.357 173.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' HIS . . . . . 0.449 ' HA ' ' O ' ' A' ' 73' ' ' THR . 8.5 t60 -83.45 23.82 0.89 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.911 0.386 . . . . 6.0899999999999999 111.612 -169.081 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 50.12 48.58 21.85 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.768 -0.651 . . . . 5.1200000000000001 111.59 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.9 p -79.3 -14.71 58.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.073 -0.512 . . . . 6.7599999999999998 111.087 -178.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 10.5 t60 73.24 -54.84 0.69 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.48 0.712 . . . . 8.8200000000000003 111.611 175.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 21.8 t . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.334 -0.841 . . . . 8.4800000000000004 109.734 179.867 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 tpt . . . . . 0 N--CA 1.48 1.064 0 N-CA-C 110.64 -0.133 . . . . 3.8599999999999999 110.64 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 5' ' ' ALA . 15.3 t70 174.46 -69.8 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.758 0.789 . . . . 2.25 108.96 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.652 ' HA ' HD11 ' A' ' 6' ' ' ILE . 95.5 m-85 -71.82 -25.47 62.0 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.015 -0.993 . . . . 0.42999999999999999 108.402 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.544 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 11.6 tptm -67.05 -9.44 39.21 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 114.716 -1.129 . . . . 1.51 109.669 175.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 2' ' ' ASP . . . -90.86 -49.98 6.14 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 115.823 -0.626 . . . . 0.54000000000000004 109.658 175.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.652 HD11 ' HA ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -83.19 -34.54 11.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.453 0.644 . . . . 1.0700000000000001 110.984 -170.834 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.698 ' HB2' HD21 ' A' ' 114' ' ' LEU . . . -79.13 -39.48 33.48 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.136 -0.938 . . . . 0.34000000000000002 111.269 -176.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.544 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 5.6 mt-30 -67.6 -24.75 65.52 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.147 -1.388 . . . . 1.5900000000000001 110.192 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.58 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 55.7 mt-30 -83.85 -50.56 7.97 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.099 -0.955 . . . . 2.4700000000000002 108.827 170.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.62 ' HB ' ' HA ' ' A' ' 7' ' ' ALA . 0.8 OUTLIER -46.01 -44.92 15.54 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.029 0.932 . . . . 0.47999999999999998 112.656 175.276 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.481 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -50.87 -55.99 14.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.063 0.459 . . . . 0.31 111.748 175.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -76.18 -5.99 49.3 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.088 -0.506 . . . . 1.6399999999999999 111.586 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 39.3 mm-40 -81.13 -52.39 7.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.26 0.552 . . . . 2.54 109.553 172.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.877 HG23 ' CE2' ' A' ' 170' ' ' PHE . 6.4 p -68.37 -38.72 79.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.366 -0.834 . . . . 0.53000000000000003 110.631 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.97 -22.36 65.92 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.178 -0.919 . . . . 0.59999999999999998 108.805 173.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.554 ' HA2' ' NE ' ' A' ' 19' ' ' ARG . . . -64.05 -22.69 67.1 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 114.033 -1.44 . . . . 0.56999999999999995 110.18 176.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.468 ' HA ' ' HB3' ' A' ' 20' ' ' ASP . 5.9 m-85 -90.34 -16.79 28.51 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.41 -0.589 . . . . 3.27 109.41 177.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.477 ' HB2' ' NH2' ' A' ' 49' ' ' ARG . 2.4 t-20 -76.51 -14.37 60.03 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.488 0.661 . . . . 2.0299999999999998 109.937 176.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.554 ' NE ' ' HA2' ' A' ' 16' ' ' GLY . 10.9 ptt180 -113.49 8.95 17.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.467 -0.788 . . . . 2.7200000000000002 109.668 174.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.468 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 25.5 t70 -112.83 92.82 4.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.198 -0.91 . . . . 2.1600000000000001 109.502 175.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.478 HG22 ' CH2' ' A' ' 24' ' ' TRP . 24.0 p -131.36 88.82 2.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.236 0.541 . . . . 1.8200000000000001 111.539 -176.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -177.45 -50.42 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.569 -0.741 . . . . 2.1899999999999999 111.18 -178.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.87 -9.7 79.72 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 121.235 -0.507 . . . . 1.1000000000000001 112.99 -174.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.529 ' CB ' ' HG2' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -76.93 -160.88 0.17 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.177 0.513 . . . . 1.6699999999999999 111.426 177.209 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -171.7 114.62 0.36 Allowed 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 109.028 -0.731 . . . . 2.9500000000000002 109.028 -175.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.588 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 1.7 m -64.82 128.02 26.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.963 0.887 . . . . 1.5600000000000001 111.987 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.9 m -118.79 -24.32 3.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 113.845 -1.525 . . . . 1.22 110.46 -178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.459 ' HD2' ' HA ' ' A' ' 28' ' ' LYS . 15.5 tptp -145.96 129.55 17.0 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.037 -0.665 . . . . 2.4100000000000001 111.518 -174.2 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.691 HG22 ' HA ' ' A' ' 34' ' ' THR . 24.1 p -146.06 152.78 39.88 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.21 -0.45 . . . . 1.3799999999999999 110.527 178.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.2 t -106.6 -102.45 0.34 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.097 -0.705 . . . . 2.3700000000000001 109.097 171.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -142.25 18.02 2.07 Favored 'General case' 0 N--CA 1.463 0.208 0 O-C-N 122.064 -0.398 . . . . 4.5499999999999998 111.377 175.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -169.4 8.27 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.271 0.558 . . . . 1.4199999999999999 110.07 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.655 HG22 ' HA3' ' A' ' 52' ' ' GLY . 12.7 pt -142.92 160.88 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 115.382 -0.827 . . . . 0.76000000000000001 109.891 -176.304 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.691 ' HA ' HG22 ' A' ' 29' ' ' THR . 93.1 m -158.18 111.25 2.4 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 111.793 0.294 . . . . 0.57999999999999996 111.793 -164.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.588 ' CG2' HG13 ' A' ' 193' ' ' VAL . 5.0 t -98.56 117.71 43.97 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 N-CA-C 109.379 -0.601 . . . . 0.85999999999999999 109.379 177.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -118.81 125.25 49.14 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 116.11 -0.495 . . . . 1.1000000000000001 110.218 -176.637 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 73.4 p -101.17 143.26 31.48 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.398 0.618 . . . . 1.27 112.169 -172.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.529 ' HG2' ' CB ' ' A' ' 24' ' ' TRP . 15.5 mtmt -124.95 131.35 53.44 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.996 -1.002 . . . . 1.9099999999999999 108.413 172.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.86 114.3 2.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.468 0.175 . . . . 1.6799999999999999 110.93 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.4 m -61.61 139.48 58.27 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.356 0.598 . . . . 2.0899999999999999 110.598 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -97.43 -12.07 23.14 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.634 -0.712 . . . . 6.6100000000000003 109.97 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -87.82 -8.6 55.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.709 -0.678 . . . . 6.46 109.973 -175.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -173.76 162.01 3.96 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.356 -0.979 . . . . 5.6500000000000004 108.356 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -80.18 62.63 4.4 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.999 0.428 . . . . 5.5599999999999996 111.365 -174.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -137.5 -166.11 10.63 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.416 -1.074 . . . . 1.5600000000000001 110.416 175.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -131.22 134.95 46.95 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.564 0.697 . . . . 2.0499999999999998 110.896 177.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.565 ' O ' ' HA ' ' A' ' 37' ' ' SER . 10.0 tt -86.52 147.72 25.84 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.821 -1.082 . . . . 0.87 109.254 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.455 ' N ' HD23 ' A' ' 47' ' ' LEU . 92.9 m-85 -123.21 119.59 30.67 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.839 -0.344 . . . . 0.98999999999999999 111.109 -175.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.783 ' CD ' ' HB3' ' A' ' 170' ' ' PHE . 21.8 tpt180 -110.73 117.65 34.04 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.309 -0.626 . . . . 2.9199999999999999 109.309 173.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 35' ' ' VAL . 12.5 p -103.94 150.61 7.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.75 0.31 . . . . 1.3300000000000001 110.259 -179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.561 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 35.2 tt0 -153.41 122.06 6.35 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.785 -0.643 . . . . 1.0700000000000001 110.764 -172.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.655 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -156.13 161.7 30.93 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.198 -0.761 . . . . 0.28999999999999998 111.198 175.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 70.3 mt -98.11 130.39 46.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 117.345 0.572 . . . . 0.57999999999999996 111.229 -178.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 61.9 mt -107.8 116.9 56.61 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.355 -0.839 . . . . 0.34999999999999998 109.789 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -63.56 61.51 0.2 Allowed 'Trans proline' 0 N--CA 1.476 0.457 0 C-N-CA 124.172 3.248 . . . . 0.62 113.787 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.573 ' HG3' ' H ' ' A' ' 57' ' ' SER . 6.5 tp10 -152.29 -171.33 3.9 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.796 -0.816 . . . . 1.6799999999999999 108.796 174.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.573 ' H ' ' HG3' ' A' ' 56' ' ' GLU . 73.9 p -89.76 146.42 35.41 Favored Pre-proline 0 N--CA 1.427 -1.62 0 CA-C-O 121.546 0.689 . . . . 1.1799999999999999 110.517 176.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.558 ' HB3' ' SG ' ' A' ' 155' ' ' CYS . 37.2 Cg_exo -60.71 -11.19 16.45 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 124.102 3.201 . . . . 0.52000000000000002 111.098 176.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.75 -51.52 10.4 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 114.752 -1.113 . . . . 0.64000000000000001 110.919 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.531 ' HB3' HD11 ' A' ' 203' ' ' ILE . 3.6 tppt? -66.15 -30.3 70.75 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.283 -1.006 . . . . 3.2999999999999998 108.283 -178.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.034 HD23 HD13 ' A' ' 203' ' ' ILE . 48.6 mt -60.67 -58.62 7.68 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.468 -1.242 . . . . 0.40999999999999998 110.428 174.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.437 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 7.7 p -66.57 -6.55 15.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.866 0.365 . . . . 1.29 111.104 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -86.88 -41.38 14.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.402 -0.363 . . . . 1.3200000000000001 111.896 176.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.576 ' O ' ' HB3' ' A' ' 71' ' ' ARG . 6.1 p90 -77.4 -41.28 40.59 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.47 -0.492 . . . . 0.60999999999999999 110.844 -172.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.542 HD13 ' CD1' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -84.74 7.77 19.43 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 110.342 -0.244 . . . . 1.5 110.342 -171.546 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.467 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 41.1 t80 -55.99 0.6 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.878 0 O-C-N 124.216 0.948 . . . . 1.52 112.936 -173.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 15.8 mm100 82.13 -28.13 0.12 Allowed 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 124.315 1.046 . . . . 3.6000000000000001 110.822 171.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.8 t -125.34 22.07 7.83 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.457 -1.312 . . . . 1.48 107.457 171.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.1 3.96 84.5 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 113.864 -1.516 . . . . 1.46 111.805 -176.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.708 ' O ' HG22 ' A' ' 73' ' ' THR . 12.0 t70 92.6 2.8 0.08 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 122.582 1.182 . . . . 2.1899999999999999 108.333 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.829 ' HA ' ' CE2' ' A' ' 74' ' ' TRP . 5.6 ptm180 -54.34 -40.27 67.87 Favored 'General case' 0 C--O 1.209 -1.057 0 CA-C-N 113.535 -1.666 . . . . 3.3799999999999999 110.088 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.796 ' H ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -65.61 -26.02 38.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.646 -1.161 . . . . 0.70999999999999996 110.792 -175.3 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.708 HG22 ' O ' ' A' ' 70' ' ' ASP . 0.9 OUTLIER -81.66 -31.25 32.39 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.491 -0.777 . . . . 0.96999999999999997 109.986 -174.386 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.829 ' CE2' ' HA ' ' A' ' 71' ' ' ARG . 27.6 p-90 -111.57 0.82 16.55 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.283 -0.567 . . . . 0.75 111.396 -177.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.699 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 5.3 t70 -68.25 175.62 3.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.512 0.673 . . . . 2.1899999999999999 111.723 -175.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.492 ' HG2' ' OD1' ' A' ' 198' ' ' ASN . 28.9 mmmt -95.96 -40.65 9.17 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.563 -0.744 . . . . 3.1899999999999999 109.832 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.8 t -119.72 16.14 12.73 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.439 -0.8 . . . . 1.5800000000000001 111.356 -171.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.638 HD13 HG22 ' A' ' 72' ' ' ILE . 56.1 mt -110.91 -179.32 3.71 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.537 -0.465 . . . . 0.70999999999999996 111.924 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.603 ' HG2' ' HG2' ' A' ' 99' ' ' GLN . 12.0 mm-40 -154.94 -61.59 0.12 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.519 -0.764 . . . . 1.73 111.219 -175.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 96' ' ' THR . 30.6 t -142.46 127.74 16.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.377 -0.374 . . . . 0.78000000000000003 110.648 -166.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.746 ' HB3' HD12 ' A' ' 72' ' ' ILE . 42.8 p90 -95.41 146.62 24.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.611 0.243 . . . . 5.4000000000000004 110.639 176.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.509 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 58.4 m-80 -153.45 107.18 3.02 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.548 -0.538 . . . . 1.6899999999999999 109.548 176.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.03 96.61 3.84 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.259 -0.645 . . . . 2.0499999999999998 109.259 177.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -73.12 -62.78 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.352 0.596 . . . . 0.64000000000000001 110.805 -169.358 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.445 ' HB3' HD12 ' A' ' 93' ' ' ILE . 15.5 t60 -133.97 113.96 12.73 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.275 -0.875 . . . . 1.96 108.824 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.2 mtt180 -98.28 103.74 15.71 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.971 -0.751 . . . . 2.4399999999999999 108.971 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.591 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -72.23 -46.2 58.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.456 -0.793 . . . . 0.46999999999999997 110.989 -171.551 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -141.92 -163.75 1.65 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.87 -0.789 . . . . 1.8600000000000001 108.87 -173.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.4 m -81.18 -14.8 57.21 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.844 0.354 . . . . 1.4399999999999999 110.3 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -131.82 14.81 4.83 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 110.078 -0.342 . . . . 1.8700000000000001 110.078 -175.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.591 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.4 OUTLIER -134.11 110.95 9.95 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 108.682 -0.858 . . . . 0.46000000000000002 108.682 -175.097 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.534 ' O ' HD12 ' A' ' 114' ' ' LEU . 21.7 m-85 -130.24 169.34 15.52 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.953 -0.567 . . . . 0.42999999999999999 110.391 -173.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.65 ' O ' HG23 ' A' ' 84' ' ' VAL . 28.4 mt -135.06 123.89 41.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 107.43 -1.322 . . . . 0.40999999999999998 107.43 169.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 65.2 m -110.27 125.44 53.12 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.636 -0.425 . . . . 2.0099999999999998 111.315 -175.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.631 ' HA ' HD13 ' A' ' 112' ' ' ILE . 22.2 t60 -90.91 87.65 6.72 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 122.134 0.969 . . . . 1.23 108.702 168.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 89.6 m -102.56 130.77 49.51 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.275 -1.329 . . . . 0.5 109.926 -177.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.406 ' O ' ' HB2' ' A' ' 79' ' ' GLN . 47.1 mm -80.99 128.82 38.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 C-N-CA 119.671 -0.811 . . . . 1.03 108.891 172.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.601 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 1.5 m -102.28 143.95 31.41 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.969 -0.559 . . . . 1.3799999999999999 110.255 -176.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.603 ' HG2' ' HG2' ' A' ' 79' ' ' GLN . 5.6 mm100 -85.98 179.16 7.05 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.948 -0.569 . . . . 1.8200000000000001 110.804 178.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' A' ' 106' ' ' ILE . 8.3 m -107.69 75.52 1.01 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.586 -0.733 . . . . 3.9100000000000001 110.823 -176.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.423 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 79.6 t80 -86.77 98.28 11.08 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.606 -0.438 . . . . 5.1600000000000001 111.197 -177.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 101' ' ' PHE . . . 165.92 59.2 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 O-C-N 124.728 1.268 . . . . 1.98 109.489 171.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 86.1 t 71.75 -40.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-N 115.591 -0.732 . . . . 3.1699999999999999 111.856 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 139.09 18.71 0.5 Allowed Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.898 -0.667 . . . . 1.96 112.668 177.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 39.1 m -87.44 10.73 16.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.059 0.456 . . . . 1.8799999999999999 111.127 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 100' ' ' SER . 60.4 mt -129.85 139.68 50.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.916 -0.584 . . . . 1.1200000000000001 109.523 -177.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 48.4 m -84.91 152.9 59.95 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 110.083 -0.34 . . . . 1.3500000000000001 110.083 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.94 130.98 36.78 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.768 2.312 . . . . 1.0700000000000001 111.048 177.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 144' ' ' ILE . 12.2 ttp180 -109.73 154.92 22.23 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.285 -0.566 . . . . 3.4500000000000002 111.046 -167.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.46 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 5.1 t0 -95.33 140.82 29.67 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.658 -0.867 . . . . 1.3700000000000001 108.658 174.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.661 ' CE1' ' HB2' ' A' ' 113' ' ' ASP . 13.4 t80 -123.76 108.74 12.85 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.664 -0.865 . . . . 2.4100000000000001 108.664 -179.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.699 HG21 ' CE1' ' A' ' 134' ' ' PHE . 12.6 mm -124.1 74.78 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 107.933 -1.136 . . . . 0.42999999999999999 107.933 173.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.661 ' HB2' ' CE1' ' A' ' 111' ' ' PHE . 1.0 OUTLIER -102.48 124.18 47.58 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.587 -0.733 . . . . 1.8600000000000001 110.094 -176.39 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.698 HD21 ' HB2' ' A' ' 7' ' ' ALA . 10.6 tp -76.98 121.97 24.23 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 115.265 -0.88 . . . . 0.28000000000000003 109.364 174.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -122.82 123.95 69.36 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 CA-C-N 114.157 -1.383 . . . . 0.26000000000000001 111.503 -166.561 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.555 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 53.8 t80 -117.22 125.4 51.09 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.647 -0.706 . . . . 2.5699999999999998 110.571 175.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' A' ' 126' ' ' ILE . 91.8 mt -96.96 99.24 8.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.484 -0.78 . . . . 0.89000000000000001 110.54 -177.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -101.86 135.1 44.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.11 -0.95 . . . . 1.2 108.867 178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.521 ' O ' ' HD3' ' A' ' 119' ' ' ARG . 0.1 OUTLIER -124.19 110.6 14.87 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 121.903 0.859 . . . . 2.7999999999999998 108.907 176.368 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.571 ' CB ' ' HB3' ' A' ' 123' ' ' ASN . 59.3 m-85 -77.88 116.83 18.68 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.064 -1.088 . . . . 0.82999999999999996 108.064 171.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.52 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 1.6 mp0 -28.7 93.72 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 O-C-N 125.086 1.491 . . . . 2.2799999999999998 113.321 178.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 56.29 36.86 70.69 Favored Glycine 0 CA--C 1.507 -0.451 0 CA-C-N 115.117 -0.947 . . . . 0.76000000000000001 112.312 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.571 ' HB3' ' CB ' ' A' ' 120' ' ' TYR . 59.2 t30 -128.83 -53.4 1.23 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.971 -0.614 . . . . 1.6499999999999999 109.694 -176.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.54 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 0.4 OUTLIER -157.14 125.36 5.57 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.112 -0.495 . . . . 1.1200000000000001 110.986 -179.069 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -107.75 82.59 1.67 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.248 -1.019 . . . . 1.6200000000000001 108.248 175.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.499 ' CG1' HG12 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -100.93 139.37 22.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.892 -0.595 . . . . 0.29999999999999999 112.421 -171.74 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -107.4 119.45 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 107.358 -1.349 . . . . 0.58999999999999997 107.358 159.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 30.3 p -82.88 167.3 18.18 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.037 -0.727 . . . . 1.1799999999999999 109.037 174.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.425 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 67.7 p -158.48 120.01 3.49 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.9 0.381 . . . . 1.24 110.231 -178.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.617 ' CE ' HD23 ' A' ' 114' ' ' LEU . 3.1 ttpm? -131.95 115.01 15.32 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 108.128 -1.064 . . . . 2.2599999999999998 108.128 -176.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.403 ' CB ' ' H ' ' A' ' 148' ' ' ASN . 96.9 p -61.78 100.14 0.14 Allowed 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 107.698 -1.223 . . . . 1.3899999999999999 107.698 -177.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.464 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -107.77 138.23 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.115 0 CA-C-N 115.163 -0.926 . . . . 1.05 108.847 -165.351 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -99.76 64.32 1.26 Allowed 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 122.432 1.11 . . . . 2.1699999999999999 108.64 -168.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.813 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -90.74 162.02 34.52 Favored Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 113.387 -1.733 . . . . 0.53000000000000003 110.64 -171.596 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -77.86 -12.91 16.21 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 123.072 2.514 . . . . 1.28 114.762 -173.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.813 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 5.7 tp10 -72.7 -17.78 61.6 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 109.48 -0.563 . . . . 3.5 109.48 -171.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.47 ' HB2' HG11 ' A' ' 84' ' ' VAL . 18.8 t80 -163.13 112.01 1.03 Allowed Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 113.351 0.871 . . . . 6.1200000000000001 113.351 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -83.96 126.0 3.77 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 123.077 2.518 . . . . 1.77 110.035 163.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.462 ' HG3' ' HB2' ' A' ' 145' ' ' ARG . 11.2 Cg_endo -52.54 -92.47 0.0 OUTLIER 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 123.447 2.765 . . . . 1.25 114.956 -168.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.1 t -172.53 171.52 4.57 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.621 -0.511 . . . . 1.6000000000000001 109.621 -174.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.8 p -90.22 -15.41 31.46 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.228 -0.656 . . . . 1.97 109.228 171.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -98.56 -50.44 4.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.582 -0.736 . . . . 2.1800000000000002 110.133 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.46 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 40.2 m-85 -83.44 130.4 35.03 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 115.847 -0.615 . . . . 1.23 109.455 176.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.664 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -100.9 113.53 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 N-CA-C 107.991 -1.114 . . . . 0.81999999999999995 107.991 -179.407 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.462 ' HB2' ' HG3' ' A' ' 139' ' ' PRO . 6.4 tmm_? -57.41 97.38 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.674 -1.232 . . . . 4.4199999999999999 107.674 170.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.493 ' HA3' ' HD2' ' A' ' 109' ' ' ARG . . . -66.07 129.0 31.85 Favored Glycine 0 CA--C 1.49 -1.477 0 N-CA-C 110.63 -0.988 . . . . 0.79000000000000004 110.63 -176.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.463 ' H ' ' HG2' ' A' ' 174' ' ' GLU . 41.4 t80 -82.74 107.05 15.08 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.515 1.15 . . . . 4.4400000000000004 110.733 -175.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.403 ' H ' ' CB ' ' A' ' 131' ' ' SER . 55.2 t30 -110.36 110.97 21.96 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.05 -1.886 . . . . 1.6200000000000001 108.396 178.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.508 ' O ' ' N ' ' A' ' 151' ' ' CYS . 38.3 m80 -57.63 163.29 3.91 Favored Pre-proline 0 C--O 1.217 -0.628 0 CA-C-O 118.174 -0.917 . . . . 2.3199999999999998 109.012 175.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.517 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 1.2 Cg_endo -44.12 77.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 123.841 3.027 . . . . 0.53000000000000003 113.719 178.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' CYS . . . . . 0.58 ' HB3' ' O ' ' A' ' 170' ' ' PHE . 45.4 m -108.96 -171.81 1.92 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.999 -1.0 . . . . 1.5800000000000001 109.325 177.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.632 ' O ' ' HG3' ' A' ' 169' ' ' MET . . . 174.45 -153.29 16.04 Favored Glycine 0 N--CA 1.435 -1.421 0 C-N-CA 119.028 -1.558 . . . . 0.42999999999999999 112.644 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.601 ' CZ ' HD11 ' A' ' 167' ' ' LEU . 3.6 t80 -156.47 97.96 1.79 Allowed 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.517 -1.29 . . . . 0.59999999999999998 107.517 -163.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.63 ' CG2' HG13 ' A' ' 168' ' ' VAL . 2.6 m -105.56 146.25 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 C-N-CA 119.705 -0.798 . . . . 0.31 110.856 -174.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' CYS . . . . . 0.57 ' SG ' HD12 ' A' ' 61' ' ' LEU . 18.5 t -118.57 138.19 52.72 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.042 -0.981 . . . . 1.55 108.439 173.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.52 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 12.4 m -123.24 111.22 30.41 Favored Pre-proline 0 C--N 1.307 -1.263 0 C-N-CA 120.697 -0.401 . . . . 1.0600000000000001 110.878 -177.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.454 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 71.4 Cg_exo -50.22 117.74 3.4 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.43 2.087 . . . . 0.56000000000000005 111.045 170.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.425 ' O ' ' HB3' ' A' ' 161' ' ' ASN . 88.6 mmm -79.13 -162.72 0.42 Allowed 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.066 0.46 . . . . 1.1599999999999999 111.462 -175.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -75.38 -35.97 60.99 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.615 -0.883 . . . . 2.6299999999999999 108.615 172.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.411 ' C ' ' HD2' ' A' ' 162' ' ' PRO . 16.5 mt-10 -96.92 29.18 3.16 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.161 -1.381 . . . . 2.0499999999999998 108.636 174.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.479 ' CG ' ' HD3' ' A' ' 162' ' ' PRO . 3.4 p30 -34.18 -47.28 0.77 Allowed Pre-proline 0 N--CA 1.471 0.611 0 N-CA-C 116.398 1.999 . . . . 1.9299999999999999 116.398 -168.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.479 ' HD3' ' CG ' ' A' ' 161' ' ' ASN . 71.3 Cg_endo -73.94 -17.85 22.09 Favored 'Trans proline' 0 C--N 1.351 0.703 0 CA-C-N 121.755 1.662 . . . . 0.72999999999999998 113.047 -176.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -109.16 -25.89 10.4 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.191 -0.459 . . . . 0.68000000000000005 110.832 -178.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 161' ' ' ASN . 79.6 m-85 -138.3 124.7 20.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.825 -0.625 . . . . 0.93000000000000005 109.467 176.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 3.7 p -125.62 142.25 51.61 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.155 0.502 . . . . 1.4099999999999999 111.154 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.561 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.9 tppp? -88.27 119.6 28.83 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.629 0.728 . . . . 0.73999999999999999 111.482 -175.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.601 HD11 ' CZ ' ' A' ' 153' ' ' PHE . 0.3 OUTLIER -101.96 117.17 34.27 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.244 -0.889 . . . . 0.27000000000000002 110.099 176.64 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.63 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.1 OUTLIER -140.84 126.41 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-O 121.558 0.694 . . . . 0.28000000000000003 112.413 177.699 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.632 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 12.1 ttt -145.44 145.72 31.23 Favored 'General case' 0 C--O 1.22 -0.485 0 C-N-CA 123.091 0.556 . . . . 1.24 110.919 -170.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.877 ' CE2' HG23 ' A' ' 14' ' ' VAL . 12.1 p90 -136.95 162.73 32.47 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.375 0.607 . . . . 3.3700000000000001 112.223 171.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.536 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 1.4 m -136.54 143.53 35.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 113.592 -1.64 . . . . 1.3999999999999999 110.481 173.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.499 ' HB3' ' HB2' ' A' ' 149' ' ' HIS . 7.7 tt0 -120.29 54.95 1.02 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.889 -1.522 . . . . 2.1699999999999999 106.889 172.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.1 m -64.02 144.5 57.04 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 113.791 -1.55 . . . . 1.6499999999999999 110.708 -173.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.537 ' HG3' ' H ' ' A' ' 176' ' ' ARG . 10.3 pt-20 -81.89 -3.27 53.77 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.714 -0.394 . . . . 2.4500000000000002 110.531 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.498 ' C ' ' HG3' ' A' ' 176' ' ' ARG . 61.1 mtt 80.87 9.77 1.05 Allowed 'General case' 0 N--CA 1.468 0.467 0 O-C-N 123.947 0.779 . . . . 3.7400000000000002 109.402 176.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.537 ' H ' ' HG3' ' A' ' 174' ' ' GLU . 3.3 mtt85 63.62 -87.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.358 -1.292 . . . . 5.7800000000000002 111.156 177.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.435 ' H ' ' HB2' ' A' ' 176' ' ' ARG . . . -97.92 2.14 59.88 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 111.408 -0.677 . . . . 2.2599999999999998 111.408 177.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 4.0 tmtp? 67.88 96.85 0.06 Allowed 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.44 0.696 . . . . 6.2300000000000004 110.249 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.583 ' H ' HD22 ' A' ' 179' ' ' LEU . 0.6 OUTLIER -82.06 -150.98 0.09 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.773 -0.648 . . . . 1.6399999999999999 109.438 -178.934 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.481 ' O ' HD12 ' A' ' 184' ' ' ILE . 43.5 m -111.24 152.19 43.65 Favored Pre-proline 0 C--N 1.318 -0.795 0 N-CA-C 108.591 -0.892 . . . . 2.04 108.591 174.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -42.82 -46.47 8.5 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.052 2.502 . . . . 1.74 113.523 -177.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.55 ' O ' ' HE2' ' A' ' 186' ' ' LYS . 22.9 t -66.51 -15.95 63.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.778 0.323 . . . . 2.1400000000000001 111.594 -177.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.527 ' HA ' ' HE2' ' A' ' 186' ' ' LYS . 15.9 mm -91.27 -37.53 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-O 122.498 1.142 . . . . 1.1200000000000001 108.793 -178.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 1.024 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.1 mp -73.61 -33.05 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 113.103 -1.862 . . . . 1.1299999999999999 111.168 -175.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 189' ' ' PRO . 10.4 pt-20 -65.57 -21.73 66.62 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.83 -0.804 . . . . 2.8900000000000001 108.83 173.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.574 ' O ' ' HB2' ' A' ' 190' ' ' SER . 49.2 mtmt -92.36 -24.71 18.82 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.648 -0.705 . . . . 1.28 110.026 176.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' THR . . . . . 1.024 HG22 ' HA ' ' A' ' 184' ' ' ILE . 4.5 t -91.18 -47.98 7.2 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 119.499 -0.88 . . . . 0.62 112.772 -178.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' MET . . . . . 0.572 ' O ' ' HG ' ' A' ' 192' ' ' LEU . 0.0 OUTLIER -80.48 -71.04 0.15 Allowed Pre-proline 0 N--CA 1.471 0.593 0 CA-C-N 119.403 1.002 . . . . 1.0600000000000001 112.447 -175.651 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.428 ' HG2' ' O ' ' A' ' 185' ' ' GLU . 44.7 Cg_endo -68.25 -22.93 39.53 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.307 1.338 . . . . 0.91000000000000003 112.022 -171.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.574 ' HB2' ' O ' ' A' ' 186' ' ' LYS . 66.9 m -83.83 -23.99 31.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.733 -0.667 . . . . 1.5 110.707 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 187' ' ' THR . 55.0 t30 -89.85 -25.4 21.05 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.439 -0.505 . . . . 1.8799999999999999 110.834 178.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 188' ' ' MET . 15.5 mt -68.84 -47.69 65.39 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.777 0.322 . . . . 1.0900000000000001 111.029 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.588 HG13 ' CG2' ' A' ' 35' ' ' VAL . 3.8 m -67.89 -23.19 28.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 120.353 -0.539 . . . . 0.68000000000000005 110.165 175.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -76.45 -31.06 57.6 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.831 -0.622 . . . . 2.0699999999999998 110.835 176.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -67.14 -31.36 71.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.077 0.465 . . . . 2.0 109.78 171.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.555 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 63.2 mt -77.66 -30.07 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 116.121 -0.49 . . . . 0.31 110.62 174.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 57.1 mt -71.69 -38.76 70.56 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-O 121.468 0.651 . . . . 1.03 109.434 173.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.513 ' ND2' ' HA ' ' A' ' 75' ' ' ASP . 2.6 m120 -54.5 -35.26 62.94 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.393 -1.276 . . . . 1.8999999999999999 109.112 167.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.681 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -75.59 -43.74 46.65 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 120.483 -0.487 . . . . 0.28999999999999998 110.413 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.617 ' O ' ' HG3' ' A' ' 204' ' ' LYS . 32.0 mmtp -56.11 -44.21 78.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.135 0.493 . . . . 0.96999999999999997 110.613 174.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -85.41 -41.14 15.69 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.585 -0.734 . . . . 1.9399999999999999 111.419 -174.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' GLY . . . . . 0.523 ' HA3' ' CH2' ' A' ' 74' ' ' TRP . . . -68.26 -27.99 73.5 Favored Glycine 0 CA--C 1.507 -0.458 0 N-CA-C 111.502 -0.639 . . . . 0.46999999999999997 111.502 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 1.034 HD13 HD23 ' A' ' 61' ' ' LEU . 2.8 tp -71.7 -31.41 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 109.327 -0.62 . . . . 0.60999999999999999 109.327 176.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.617 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 57.5 mttp -84.63 -25.07 28.8 Favored 'General case' 0 C--O 1.208 -1.093 0 N-CA-C 108.528 -0.916 . . . . 3.3700000000000001 108.528 176.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.547 ' HA ' ' OG ' ' A' ' 210' ' ' SER . . . -68.23 -25.35 65.16 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.675 -0.693 . . . . 1.02 109.701 170.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 48.0 m80 -97.97 -8.91 27.06 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.578 -0.737 . . . . 3.6299999999999999 112.746 174.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.475 ' HD2' ' OE1' ' A' ' 56' ' ' GLU . 26.6 ttt180 -112.92 -60.02 1.94 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.617 0.722 . . . . 2.5899999999999999 110.55 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.485 ' HB ' ' O ' ' A' ' 204' ' ' LYS . 30.6 m -71.0 142.49 87.77 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 114.771 -1.104 . . . . 1.8400000000000001 109.57 176.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -70.82 49.81 0.99 Allowed 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.175 1.916 . . . . 2.3500000000000001 112.352 175.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.547 ' OG ' ' HA ' ' A' ' 205' ' ' ALA . 22.7 p -80.69 -37.69 30.29 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.89 0.376 . . . . 2.3100000000000001 110.206 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 211' ' ' ARG . 31.0 mtp-105 -79.69 4.42 16.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.158 0.504 . . . . 5.4500000000000002 110.673 177.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -69.94 -40.54 75.42 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.952 -1.129 . . . . 6.8600000000000003 107.952 165.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -87.09 -43.93 5.81 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 114.895 -1.048 . . . . 3.3700000000000001 111.147 173.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -83.89 96.8 8.92 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.249 0.547 . . . . 5.21 110.089 176.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -99.36 75.9 2.01 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.039 -0.528 . . . . 6.46 110.707 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 78.1 t60 57.4 84.08 0.1 Allowed 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.441 -0.8 . . . . 6.0899999999999999 109.772 -177.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -49.65 112.21 0.62 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.044 -0.98 . . . . 5.1200000000000001 112.079 -174.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 16.5 m -109.75 5.02 22.39 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.698 -0.683 . . . . 6.7599999999999998 109.681 176.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 61.1 m80 71.26 173.24 0.31 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.088 -0.96 . . . . 8.8200000000000003 111.187 178.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 18.4 p . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.307 -0.854 . . . . 8.4800000000000004 110.587 -179.483 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 120.821 0.343 . . . . 3.8599999999999999 110.281 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.653 ' O ' HD13 ' A' ' 6' ' ' ILE . 15.5 m-20 -81.47 -37.34 28.12 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 108.392 -0.966 . . . . 2.25 108.392 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.952 ' HA ' HD11 ' A' ' 6' ' ' ILE . 82.7 m-85 -63.6 -35.63 81.14 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 114.676 -1.147 . . . . 0.42999999999999999 109.168 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.705 ' O ' ' HB3' ' A' ' 8' ' ' GLN . 23.2 tptm -60.81 -47.97 83.92 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 115.302 -0.863 . . . . 1.51 109.074 178.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.17 -46.31 62.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.924 -0.58 . . . . 0.54000000000000004 112.125 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.952 HD11 ' HA ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -80.63 -36.5 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 CA-C-O 121.674 0.75 . . . . 1.0700000000000001 109.562 -172.148 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.6 ' HB1' ' HB3' ' A' ' 116' ' ' TYR . . . -76.86 -43.24 36.92 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.239 -1.346 . . . . 0.34000000000000002 111.472 -175.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.705 ' HB3' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -60.96 -33.53 73.34 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.202 -1.363 . . . . 1.5900000000000001 109.086 -178.406 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.545 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 15.2 mm100 -92.47 -32.85 14.74 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.86 -1.064 . . . . 2.4700000000000002 110.674 -178.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.722 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.4 OUTLIER -75.75 -26.56 57.53 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.786 -0.365 . . . . 0.47999999999999998 110.753 178.028 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -49.34 -44.39 44.54 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 120.208 -0.597 . . . . 0.31 111.811 170.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.691 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 27.9 pt20 -83.73 -1.5 54.27 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 122.075 -0.391 . . . . 1.6399999999999999 110.986 176.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 29.4 mm-40 -88.45 -44.9 10.38 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.803 -0.443 . . . . 2.54 109.803 174.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.712 ' HA ' ' HE2' ' A' ' 170' ' ' PHE . 3.9 p -66.51 -39.96 85.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 122.116 0.96 . . . . 0.53000000000000003 108.912 170.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.691 ' HB3' ' HA ' ' A' ' 12' ' ' GLN . 0.9 OUTLIER -66.9 -21.98 65.98 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 114.749 -1.114 . . . . 0.59999999999999998 108.084 172.552 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.691 ' HA2' ' NE ' ' A' ' 19' ' ' ARG . . . -62.47 -24.44 65.86 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 113.909 -1.496 . . . . 0.56999999999999995 110.268 176.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.452 ' HD1' ' O ' ' A' ' 13' ' ' GLU . 19.6 m-85 -92.55 -8.55 44.07 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.246 -0.477 . . . . 3.27 109.946 178.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.47 -10.97 44.36 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 119.295 -0.962 . . . . 2.0299999999999998 108.608 176.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.691 ' NE ' ' HA2' ' A' ' 16' ' ' GLY . 19.5 ptt85 -122.64 3.25 9.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.618 -1.173 . . . . 2.7200000000000002 110.561 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.649 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 23.0 t70 -90.28 112.8 24.47 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 116.223 -0.444 . . . . 2.1600000000000001 110.821 -175.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.8 p -129.96 93.81 3.58 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.691 0.758 . . . . 1.8200000000000001 109.334 176.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.1 t -127.26 -78.19 0.58 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.638 -1.165 . . . . 2.1899999999999999 111.202 -169.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.09 60.38 0.55 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.52 -0.848 . . . . 1.1000000000000001 112.374 -177.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.513 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -120.39 -163.73 1.03 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.107 0.479 . . . . 1.6699999999999999 110.221 176.869 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 1.2 mtpp -176.77 135.65 0.22 Allowed 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.201 -1.037 . . . . 2.9500000000000002 108.201 -172.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 3.2 m -66.55 123.88 20.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.895 0.855 . . . . 1.5600000000000001 110.703 177.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.2 p -97.76 -23.25 4.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 114.199 -1.364 . . . . 1.22 108.795 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.502 ' HD2' ' HA ' ' A' ' 28' ' ' LYS . 10.0 tptm -155.47 112.93 3.32 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 119.995 -0.682 . . . . 2.4100000000000001 111.824 -174.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.932 HG22 ' HA ' ' A' ' 34' ' ' THR . 75.2 p -130.97 126.93 37.32 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.54 -0.541 . . . . 1.3799999999999999 109.54 172.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.3 m -85.18 -79.94 0.22 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.536 -0.302 . . . . 2.3700000000000001 110.984 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 7.2 ptpp? -159.17 28.55 0.21 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.498 0.189 . . . . 4.5499999999999998 110.894 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.537 ' HB2' ' NZ ' ' A' ' 32' ' ' LYS . 1.4 ttmp? 170.35 -20.7 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.979 -0.555 . . . . 1.4199999999999999 110.31 -176.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.899 HG22 ' HA3' ' A' ' 52' ' ' GLY . 46.1 pt -109.26 157.3 9.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.771 -0.65 . . . . 0.76000000000000001 110.486 178.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.932 ' HA ' HG22 ' A' ' 29' ' ' THR . 85.6 m -148.79 100.07 3.05 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.65 -0.705 . . . . 0.57999999999999996 111.133 -164.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.925 HG11 HD13 ' A' ' 192' ' ' LEU . 2.3 t -96.06 106.98 19.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.871 0.367 . . . . 0.85999999999999999 110.281 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 6.0 p -96.62 126.04 41.52 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.453 0.645 . . . . 1.1000000000000001 110.735 177.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.2 t -103.29 127.75 50.53 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.782 -1.099 . . . . 1.27 109.199 -176.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.513 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 25.1 ttpp -120.13 -86.41 0.65 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.33 -0.395 . . . . 1.9099999999999999 110.983 -177.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.8 ' HA ' ' HA ' ' A' ' 46' ' ' ASN . . . -176.33 149.01 0.8 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.996 -0.372 . . . . 1.6799999999999999 109.996 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.966 ' HB2' ' HB2' ' A' ' 47' ' ' LEU . 39.9 t -145.4 -37.5 0.27 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.105 0.479 . . . . 2.0899999999999999 110.68 178.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 66.97 8.52 6.17 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 114.79 -1.096 . . . . 6.6100000000000003 111.558 -177.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.495 ' HD2' ' HB3' ' A' ' 40' ' ' SER . 0.0 OUTLIER -70.57 -14.32 62.45 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 121.158 -0.217 . . . . 6.46 111.377 -178.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -174.77 -72.49 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 120.511 -0.476 . . . . 5.6500000000000004 110.605 -176.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -104.17 37.85 1.99 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.703 0.763 . . . . 5.5599999999999996 110.707 -175.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.2 -51.18 3.21 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.307 -0.86 . . . . 1.5600000000000001 113.918 173.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.8 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 3.6 m-20 -105.53 169.76 8.28 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.054 0.761 . . . . 2.0499999999999998 113.054 -166.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.966 ' HB2' ' HB2' ' A' ' 40' ' ' SER . 9.7 tt -128.85 147.78 50.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.171 -1.377 . . . . 0.87 107.615 178.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.444 ' N ' HD23 ' A' ' 47' ' ' LEU . 94.0 m-85 -122.71 134.35 54.46 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.151 -0.62 . . . . 0.98999999999999999 111.587 -170.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 2.6 tmt_? -130.67 118.56 21.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.813 -0.631 . . . . 2.9199999999999999 111.044 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.915 HG13 HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -92.5 153.35 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-O 120.989 0.423 . . . . 1.3300000000000001 110.642 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.488 ' CG ' ' HD2' ' A' ' 166' ' ' LYS . 16.3 tt0 -153.31 106.56 2.98 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.557 -0.905 . . . . 1.0700000000000001 108.557 178.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.899 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -140.94 141.21 11.07 Favored Glycine 0 CA--C 1.498 -0.998 0 C-N-CA 120.239 -0.981 . . . . 0.28999999999999998 111.542 -178.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 165' ' ' SER . 61.6 mt -88.44 120.35 37.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 C-N-CA 120.206 -0.598 . . . . 0.57999999999999996 110.89 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.663 HG12 ' HD3' ' A' ' 200' ' ' LYS . 63.7 mt -95.74 119.2 65.36 Favored Pre-proline 0 N--CA 1.443 -0.785 0 N-CA-C 109.096 -0.705 . . . . 0.34999999999999998 109.096 173.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 163' ' ' ALA . 28.1 Cg_exo -64.72 59.35 0.28 Allowed 'Trans proline' 0 N--CA 1.473 0.268 0 C-N-CA 124.08 3.187 . . . . 0.62 112.959 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.443 ' HG2' HG13 ' A' ' 203' ' ' ILE . 14.5 tp10 -156.21 175.85 13.45 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.287 -1.375 . . . . 1.6799999999999999 107.287 177.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.491 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 43.3 p -88.81 141.66 30.01 Favored Pre-proline 0 N--CA 1.429 -1.522 0 CA-C-O 121.512 0.672 . . . . 1.1799999999999999 110.211 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.832 ' HD3' ' HB3' ' A' ' 165' ' ' SER . 6.3 Cg_endo -49.34 -14.85 0.63 Allowed 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 124.963 3.775 . . . . 0.52000000000000002 112.587 173.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.76 -47.74 29.45 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 116.11 -0.495 . . . . 0.64000000000000001 111.204 176.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.668 ' HE3' ' HA ' ' A' ' 60' ' ' LYS . 1.4 tpmt? -67.64 -31.42 71.42 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.841 -1.17 . . . . 3.2999999999999998 107.841 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.009 HD23 HD13 ' A' ' 203' ' ' ILE . 83.2 mt -63.23 -56.29 17.88 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.034 -1.439 . . . . 0.40999999999999998 110.778 175.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.2 t -62.95 -12.17 23.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.67 0.271 . . . . 1.29 110.564 177.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -84.04 -41.91 16.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.369 -0.378 . . . . 1.3200000000000001 112.0 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.771 ' HD2' ' CZ2' ' A' ' 74' ' ' TRP . 15.4 p90 -85.88 -42.02 14.46 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.399 0.518 . . . . 0.60999999999999999 112.399 -170.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.741 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -89.95 4.49 49.89 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.06 0.391 . . . . 1.5 111.932 -170.08 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.617 ' O ' ' HG3' ' A' ' 67' ' ' GLN . 75.2 t80 -41.89 -73.1 0.05 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.973 0.731 . . . . 1.52 112.973 -166.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.617 ' HG3' ' O ' ' A' ' 66' ' ' TYR . 15.8 mt-30 -168.07 -61.57 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.7 0.762 . . . . 3.6000000000000001 110.462 -178.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.855 ' HB ' ' CD2' ' A' ' 81' ' ' TYR . 10.2 t -126.23 26.19 6.5 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.111 -1.44 . . . . 1.48 107.111 178.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.699 ' O ' ' HB2' ' A' ' 70' ' ' ASP . . . -72.15 -14.12 76.48 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 113.531 -1.668 . . . . 1.46 112.735 -169.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.699 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 15.1 t70 132.91 -8.95 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 O-C-N 125.844 1.555 . . . . 2.1899999999999999 107.051 -171.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.779 ' HA ' ' CE2' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -59.41 -36.24 75.48 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.525 -1.216 . . . . 3.3799999999999999 111.239 -170.089 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.073 HG22 HD13 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -80.5 -14.14 12.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.581 -0.448 . . . . 0.70999999999999996 110.973 -175.84 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.663 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.1 t -88.11 -31.7 19.07 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 119.972 -0.691 . . . . 0.96999999999999997 110.15 -176.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.858 ' HZ3' ' HB3' ' A' ' 198' ' ' ASN . 15.0 p-90 -100.64 -7.21 24.16 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.411 -0.516 . . . . 0.75 111.023 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.811 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 5.7 t70 -73.7 167.98 20.3 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.47 0.653 . . . . 2.1899999999999999 110.267 -177.073 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.8 -16.17 12.8 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.923 -1.035 . . . . 3.1899999999999999 111.512 -172.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.1 t -119.62 9.02 11.35 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.339 0.59 . . . . 1.5800000000000001 109.456 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.073 HD13 HG22 ' A' ' 72' ' ' ILE . 19.9 mt -109.72 159.68 16.95 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.625 -0.716 . . . . 0.70999999999999996 112.421 -175.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.626 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 7.7 mt-30 -131.94 -69.7 0.59 Allowed 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 114.807 -1.088 . . . . 1.73 110.432 178.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.558 HG23 ' HB3' ' A' ' 79' ' ' GLN . 21.3 t -142.84 136.32 26.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.875 -1.057 . . . . 0.78000000000000003 110.254 -165.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.855 ' CD2' ' HB ' ' A' ' 68' ' ' THR . 80.6 t80 -116.91 146.56 42.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.053 0.454 . . . . 5.4000000000000004 111.334 177.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.44 ' HB2' ' ND1' ' A' ' 95' ' ' HIS . 14.0 m120 -142.69 124.01 14.69 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.42 -0.809 . . . . 1.6899999999999999 109.037 175.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.453 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 2.3 ttt -82.11 97.13 8.03 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.597 -0.89 . . . . 2.0499999999999998 108.597 -178.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.703 HG11 ' HB2' ' A' ' 137' ' ' TYR . 0.1 OUTLIER -72.92 -80.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.914 -0.584 . . . . 0.64000000000000001 111.908 -167.954 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.592 ' HB2' ' HG2' ' A' ' 136' ' ' GLU . 10.4 t60 -126.03 118.36 25.17 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.976 -0.75 . . . . 1.96 108.976 -177.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.453 ' HD3' ' SD ' ' A' ' 83' ' ' MET . 50.4 mtm180 -103.31 103.14 13.13 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.4 -0.593 . . . . 2.4399999999999999 109.4 -175.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.606 HG21 ' HB2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -67.74 -41.32 85.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.081 -0.963 . . . . 0.46999999999999997 110.402 -173.547 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -148.35 -161.38 1.33 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.878 -1.156 . . . . 1.8600000000000001 107.878 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.7 m -93.4 3.87 54.9 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.07 0.462 . . . . 1.4399999999999999 109.915 175.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -125.07 -3.43 7.58 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 109.07 -0.715 . . . . 1.8700000000000001 109.07 -175.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.564 HG22 HD11 ' A' ' 114' ' ' LEU . 2.1 m -145.92 116.52 7.61 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 109.288 -0.634 . . . . 0.46000000000000002 109.288 -171.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.572 ' O ' HD12 ' A' ' 114' ' ' LEU . 10.8 m-85 -129.82 176.88 7.68 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.175 -0.676 . . . . 0.42999999999999999 109.175 -177.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.635 HD13 ' HB2' ' A' ' 114' ' ' LEU . 1.3 mm -122.43 131.81 72.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 107.851 -1.166 . . . . 0.40999999999999998 107.851 168.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 18.4 p -107.11 107.14 17.98 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.871 -0.331 . . . . 2.0099999999999998 111.643 -173.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.514 ' HA ' HD13 ' A' ' 112' ' ' ILE . 15.3 t-80 -81.72 103.57 11.5 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.385 -0.969 . . . . 1.23 108.385 167.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.838 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 33.1 m -125.4 111.18 14.83 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.891 -0.595 . . . . 0.5 111.75 -170.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' A' ' 79' ' ' GLN . 29.0 mm -77.11 136.56 24.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 120.142 -0.623 . . . . 1.03 109.739 177.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 1.8 m -112.75 147.05 37.67 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.988 -1.005 . . . . 1.3799999999999999 109.942 -171.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.626 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 16.6 mt-30 -88.82 157.04 18.6 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.962 -0.563 . . . . 1.8200000000000001 110.403 -178.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 10.1 m -76.87 84.64 3.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.657 -0.701 . . . . 3.9100000000000001 109.959 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -92.22 175.29 6.91 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 115.871 -0.604 . . . . 5.1600000000000001 109.371 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 1.114 ' HB1' ' HD2' ' A' ' 186' ' ' LYS . . . 65.71 40.64 4.29 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.132 -0.94 . . . . 1.98 109.726 -173.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 102' ' ' ALA . 0.3 OUTLIER 69.77 -25.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.929 1.292 . . . . 3.1699999999999999 112.623 177.39 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 140.96 -0.46 1.84 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.311 -0.947 . . . . 1.96 112.404 -176.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.718 ' HB3' HD12 ' A' ' 183' ' ' ILE . 16.5 m -64.15 -25.18 67.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.717 0.77 . . . . 1.8799999999999999 109.97 174.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.538 HD12 ' CB ' ' A' ' 102' ' ' ALA . 44.1 mt -112.59 111.64 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-N 115.025 -0.988 . . . . 1.1200000000000001 109.722 -177.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.8 p -68.15 157.34 87.58 Favored Pre-proline 0 C--O 1.237 0.44 0 CA-C-N 115.433 -0.803 . . . . 1.3500000000000001 111.934 -172.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -45.44 124.44 6.51 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 123.252 2.635 . . . . 1.0700000000000001 110.793 175.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.607 ' HG3' HG23 ' A' ' 144' ' ' ILE . 2.7 ttm180 -122.25 157.19 32.2 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.623 -0.831 . . . . 3.4500000000000002 110.552 -168.001 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.629 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 12.3 t0 -126.52 131.03 51.69 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 109.608 -0.516 . . . . 1.3700000000000001 109.608 176.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.838 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 20.0 m-85 -99.96 131.91 45.64 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 120.946 0.403 . . . . 2.4100000000000001 110.436 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.514 HD13 ' HA ' ' A' ' 95' ' ' HIS . 20.5 mm -129.8 74.49 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 108.152 -1.055 . . . . 0.42999999999999999 108.152 168.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.673 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 41.8 m-20 -106.44 140.28 39.59 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.981 -1.009 . . . . 1.8600000000000001 109.304 -178.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.635 ' HB2' HD13 ' A' ' 93' ' ' ILE . 5.3 tp -81.93 122.6 27.96 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.162 -0.681 . . . . 0.28000000000000003 109.162 174.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -117.35 124.05 72.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-O 122.236 1.017 . . . . 0.26000000000000001 111.981 -166.84 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.885 ' CE2' ' HB3' ' A' ' 128' ' ' SER . 0.1 OUTLIER -113.51 118.42 34.4 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.552 -1.658 . . . . 2.5699999999999998 110.02 -176.092 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 126' ' ' ILE . 3.9 mp -105.31 99.38 8.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.544 -0.539 . . . . 0.89000000000000001 109.544 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -107.5 144.17 34.85 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.599 -0.728 . . . . 1.2 109.718 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.442 ' NH1' ' HA ' ' A' ' 121' ' ' GLU . 3.3 tmt_? -121.09 94.1 4.23 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 108.144 -1.058 . . . . 2.7999999999999998 108.144 -176.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.569 ' CB ' ' HB2' ' A' ' 123' ' ' ASN . 89.5 m-85 -63.73 115.84 5.16 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 106.806 -1.553 . . . . 0.82999999999999996 106.806 172.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.442 ' HA ' ' NH1' ' A' ' 119' ' ' ARG . 21.0 mt-10 -48.22 85.26 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 O-C-N 125.031 1.457 . . . . 2.2799999999999998 113.014 -171.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 77.25 29.07 57.0 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 114.91 -1.041 . . . . 0.76000000000000001 112.509 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.569 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 14.4 m120 -125.5 -51.04 1.62 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.668 -0.266 . . . . 1.6499999999999999 110.337 178.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.405 ' HA ' ' HD2' ' A' ' 157' ' ' PRO . 1.9 mpt? -157.03 131.93 8.87 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.834 0.349 . . . . 1.1200000000000001 111.267 -174.049 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.438 ' OD1' ' HG2' ' A' ' 119' ' ' ARG . 63.9 m-20 -105.91 79.5 1.43 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.611 -1.255 . . . . 1.6200000000000001 107.611 171.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.604 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -89.52 124.83 42.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.699 -0.682 . . . . 0.29999999999999999 112.213 -173.101 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.468 ' CG2' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -107.02 116.89 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 107.528 -1.286 . . . . 0.58999999999999997 107.528 160.214 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.885 ' HB3' ' CE2' ' A' ' 116' ' ' TYR . 37.9 t -127.88 167.22 16.9 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.425 -0.954 . . . . 1.1799999999999999 108.425 174.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.673 ' HB3' ' HB3' ' A' ' 113' ' ' ASP . 73.0 m -145.16 137.84 26.15 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.637 -0.505 . . . . 1.24 109.637 -168.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.471 ' HE2' ' HG3' ' A' ' 150' ' ' PRO . 47.0 tttm -123.86 116.21 22.57 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.302 -1.37 . . . . 2.2599999999999998 107.302 -171.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.672 ' HB3' ' N ' ' A' ' 148' ' ' ASN . 11.8 p -58.65 101.29 0.08 Allowed 'General case' 0 N--CA 1.432 -1.354 0 O-C-N 124.26 0.975 . . . . 1.3899999999999999 109.303 -173.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.435 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.8 OUTLIER -116.3 131.99 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.139 0 CA-C-N 114.933 -1.03 . . . . 1.05 109.918 -167.392 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -98.24 78.66 2.49 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.742 -1.117 . . . . 2.1699999999999999 108.209 -175.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.814 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -109.96 156.88 39.22 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 115.395 -0.82 . . . . 0.53000000000000003 110.264 -171.745 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -75.93 -16.61 18.11 Favored 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.818 2.345 . . . . 1.28 115.267 -169.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.814 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 8.6 tp10 -69.15 -16.47 63.65 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.311 0.577 . . . . 3.5 110.023 -171.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.703 ' HB2' HG11 ' A' ' 84' ' ' VAL . 1.7 t80 -165.5 104.61 0.75 Allowed Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.492 -0.777 . . . . 6.1200000000000001 112.074 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -88.72 145.18 5.58 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.324 2.683 . . . . 1.77 110.813 170.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -70.27 -166.74 0.21 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.419 2.079 . . . . 1.25 111.762 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.4 m -140.21 -169.75 2.82 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.987 -0.746 . . . . 1.6000000000000001 108.987 -174.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.9 t -79.45 -37.78 36.17 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 119.899 -0.72 . . . . 1.97 110.249 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -83.28 -17.64 41.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.086 0.469 . . . . 2.1800000000000002 110.387 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.485 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 85.9 m-85 -114.65 108.3 16.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.844 -0.616 . . . . 1.23 110.28 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.607 HG23 ' HG3' ' A' ' 109' ' ' ARG . 1.0 OUTLIER -95.39 106.76 18.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.089 -0.505 . . . . 0.81999999999999995 109.927 -178.267 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.629 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 35.1 ttm180 -50.16 105.37 0.09 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.977 -0.556 . . . . 4.4199999999999999 111.156 178.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.47 ' HA2' ' CZ ' ' A' ' 176' ' ' ARG . . . -64.32 112.72 5.23 Favored Glycine 0 N--CA 1.437 -1.281 0 CA-C-N 115.337 -0.847 . . . . 0.79000000000000004 111.887 176.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.783 ' HB2' ' HD3' ' A' ' 176' ' ' ARG . 0.2 OUTLIER -85.58 93.05 8.71 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.058 0.456 . . . . 4.4400000000000004 109.878 178.114 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.672 ' N ' ' HB3' ' A' ' 131' ' ' SER . 80.1 m-20 -88.86 81.64 6.9 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.579 -0.737 . . . . 1.6200000000000001 109.741 175.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.527 ' CD2' ' HD2' ' A' ' 150' ' ' PRO . 0.1 OUTLIER -47.85 123.37 9.74 Favored Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 115.141 -0.936 . . . . 2.3199999999999998 110.104 179.269 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.527 ' HD2' ' CD2' ' A' ' 149' ' ' HIS . 53.6 Cg_exo -14.31 67.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.223 1 C-N-CA 126.725 4.95 . . . . 0.53000000000000003 115.712 -161.693 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 151' ' ' CYS . . . . . 0.718 ' HB2' ' O ' ' A' ' 170' ' ' PHE . 24.5 p -123.86 145.82 48.83 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.005 -0.998 . . . . 1.5800000000000001 109.512 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 128' ' ' SER . . . -151.26 -134.16 2.13 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 119.012 -1.566 . . . . 0.42999999999999999 114.004 -175.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.532 ' CE1' HD21 ' A' ' 167' ' ' LEU . 33.0 t80 -161.59 80.71 0.58 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.644 -0.873 . . . . 0.59999999999999998 108.644 -157.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.767 HG23 HG13 ' A' ' 168' ' ' VAL . 12.6 m -91.66 135.53 26.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.647 0.737 . . . . 0.31 110.561 -174.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 58' ' ' PRO . 15.2 t -112.19 124.21 51.94 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.271 -0.877 . . . . 1.55 109.122 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.937 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 5.2 m -115.8 110.24 44.45 Favored Pre-proline 0 C--N 1.311 -1.072 0 C-N-CA 120.133 -0.627 . . . . 1.0600000000000001 111.656 -174.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.483 ' HD2' ' HA ' ' A' ' 156' ' ' SER . 1.1 Cg_endo -49.2 116.93 2.5 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.668 2.245 . . . . 0.56000000000000005 110.7 168.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.597 ' SD ' ' HB2' ' A' ' 166' ' ' LYS . 84.6 mmm -82.67 -167.23 1.54 Allowed 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.163 0.506 . . . . 1.1599999999999999 111.737 -173.219 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -75.66 -22.35 56.82 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.703 -0.68 . . . . 2.6299999999999999 109.677 172.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.6 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 43.8 mm-40 -104.42 27.56 7.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.829 -1.078 . . . . 2.0499999999999998 108.805 173.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.755 ' HB3' ' HD3' ' A' ' 162' ' ' PRO . 48.1 t-20 -8.27 -73.24 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 126.547 1.939 . . . . 1.9299999999999999 115.177 -176.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.755 ' HD3' ' HB3' ' A' ' 161' ' ' ASN . 73.0 Cg_endo -74.28 -13.49 23.15 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 121.312 1.342 . . . . 0.72999999999999998 114.137 -171.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 55' ' ' PRO . . . -108.64 -26.1 10.54 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.918 0.389 . . . . 0.68000000000000005 111.081 -176.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.6 ' HB2' ' HB2' ' A' ' 160' ' ' GLU . 89.4 m-85 -139.76 126.79 20.97 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.02 -0.537 . . . . 0.93000000000000005 109.579 178.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.832 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 13.1 p -124.43 147.07 48.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.05 0.452 . . . . 1.4099999999999999 111.228 -177.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.937 ' HB3' ' HB2' ' A' ' 156' ' ' SER . 1.6 tppp? -91.98 102.24 14.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.56 0.695 . . . . 0.73999999999999999 111.47 -177.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.532 HD21 ' CE1' ' A' ' 153' ' ' PHE . 0.8 OUTLIER -90.61 107.29 19.08 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.288 -0.869 . . . . 0.27000000000000002 109.396 175.827 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.767 HG13 HG23 ' A' ' 154' ' ' VAL . 0.1 OUTLIER -129.48 128.21 65.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.626 0.727 . . . . 0.28000000000000003 111.87 178.084 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.541 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 11.7 ttt -137.97 135.92 36.47 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 115.253 -0.885 . . . . 1.24 109.897 -172.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.751 ' CD1' HD21 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -126.91 151.11 48.88 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.231 -0.588 . . . . 3.3700000000000001 109.902 176.741 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.638 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 4.0 m -129.18 130.18 67.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-O 121.537 0.684 . . . . 1.3999999999999999 112.017 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.602 ' HG3' ' OG ' ' A' ' 40' ' ' SER . 22.8 tt0 -119.8 37.31 4.24 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.396 -1.705 . . . . 2.1699999999999999 106.396 170.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 6.7 m -52.21 131.75 32.88 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 113.27 -1.786 . . . . 1.6499999999999999 111.259 -174.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.574 ' CB ' ' HB3' ' A' ' 147' ' ' TYR . 0.4 OUTLIER -81.58 -28.01 34.01 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 112.029 0.381 . . . . 2.4500000000000002 112.029 -169.24 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.41 ' H ' HH21 ' A' ' 176' ' ' ARG . 17.4 mmt 44.38 62.77 1.89 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.308 0.575 . . . . 3.7400000000000002 111.652 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.783 ' HD3' ' HB2' ' A' ' 147' ' ' TYR . 0.0 OUTLIER -59.52 -37.13 77.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.124 -0.943 . . . . 5.7800000000000002 110.276 177.495 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -62.36 154.86 40.91 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.249 -0.741 . . . . 2.2599999999999998 111.249 175.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.24 97.09 6.8 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.112 0.482 . . . . 6.2300000000000004 111.794 -173.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.603 ' HB2' HD11 ' A' ' 184' ' ' ILE . 4.6 mp -105.96 165.19 11.38 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.991 -1.485 . . . . 1.6399999999999999 106.991 167.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.54 ' H ' ' CG1' ' A' ' 183' ' ' ILE . 44.0 m -112.46 162.35 21.95 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 108.332 -0.988 . . . . 2.04 108.332 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.428 ' O ' ' HG2' ' A' ' 185' ' ' GLU . 95.1 Cg_exo -43.3 -48.44 8.16 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.157 1.905 . . . . 1.74 111.892 178.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.1 m -67.51 -12.61 60.73 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.77 -0.65 . . . . 2.1400000000000001 112.51 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.718 HD12 ' HB3' ' A' ' 105' ' ' SER . 35.3 mm -91.37 -42.91 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.955 0 CA-C-O 122.228 1.013 . . . . 1.1200000000000001 108.77 -178.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 1.03 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.6 mp -66.66 -31.69 54.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 113.269 -1.787 . . . . 1.1299999999999999 110.437 178.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 181' ' ' PRO . 7.5 mm-40 -65.46 -28.91 69.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.102 -0.954 . . . . 2.8900000000000001 108.733 175.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 1.114 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 2.7 ptpt -93.08 -26.29 17.53 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.719 -1.128 . . . . 1.28 110.852 178.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' THR . . . . . 1.03 HG22 ' HA ' ' A' ' 184' ' ' ILE . 6.2 t -78.34 -44.33 25.41 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 119.996 -0.682 . . . . 0.62 112.01 -176.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' MET . . . . . 0.948 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 2.5 mmt -80.15 -68.63 0.21 Allowed Pre-proline 0 N--CA 1.455 -0.194 0 C-N-CA 120.058 -0.657 . . . . 1.0600000000000001 110.756 -173.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.948 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 36.7 Cg_exo -60.6 -15.57 37.58 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 122.66 2.24 . . . . 0.91000000000000003 113.184 -171.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 33.3 t -86.07 -45.27 11.56 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.734 -0.469 . . . . 1.5 109.734 175.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' ASN . . . . . 0.684 ' HA ' ' HB2' ' A' ' 194' ' ' ASN . 6.5 t30 -85.17 -21.6 29.13 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.598 -0.441 . . . . 1.8799999999999999 112.187 -167.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.925 HD13 HG11 ' A' ' 35' ' ' VAL . 2.4 mt -60.26 -51.97 67.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.872 0.844 . . . . 1.0900000000000001 109.844 173.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.543 ' HB ' ' CD1' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -72.12 -32.32 42.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 114.594 -1.184 . . . . 0.68000000000000005 109.781 -178.011 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.684 ' HB2' ' HA ' ' A' ' 191' ' ' ASN . 0.9 OUTLIER -72.24 -30.54 64.98 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.646 -1.161 . . . . 2.0699999999999998 111.721 -179.327 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -70.58 -29.12 65.46 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.516 -0.474 . . . . 2.0 109.918 173.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.527 HG21 HG21 ' A' ' 33' ' ' ILE . 39.1 mt -76.18 -26.54 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-O 121.315 0.579 . . . . 0.31 110.375 173.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 194' ' ' ASN . 55.3 mt -70.0 -42.74 72.63 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 116.126 -0.488 . . . . 1.03 109.947 173.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.858 ' HB3' ' HZ3' ' A' ' 74' ' ' TRP . 91.2 m-20 -50.53 -33.21 20.74 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.983 -1.008 . . . . 1.8999999999999999 109.846 168.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.658 ' HA ' ' CE2' ' A' ' 64' ' ' PHE . . . -80.52 -40.51 25.91 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 116.229 -0.441 . . . . 0.28999999999999998 111.099 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.663 ' HD3' HG12 ' A' ' 54' ' ' ILE . 25.7 mmtm -60.05 -42.05 93.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.559 0.695 . . . . 0.96999999999999997 110.094 176.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -84.51 -43.54 14.46 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.968 -1.015 . . . . 1.9399999999999999 110.689 -176.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -65.01 -30.91 79.25 Favored Glycine 0 C--O 1.228 -0.235 0 C-N-CA 120.661 -0.78 . . . . 0.46999999999999997 111.833 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 1.009 HD13 HD23 ' A' ' 61' ' ' LEU . 3.3 tp -70.53 -39.03 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 123.005 -0.115 . . . . 0.60999999999999999 110.771 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.539 ' O ' HG22 ' A' ' 208' ' ' THR . 41.4 pttt -83.98 -28.42 27.77 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.524 -0.547 . . . . 3.3700000000000001 109.524 -178.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -63.95 -33.59 76.06 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.374 -0.83 . . . . 1.02 109.356 170.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -93.56 -2.09 54.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.267 -0.879 . . . . 3.6299999999999999 112.023 175.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.589 ' HB2' ' O ' ' A' ' 203' ' ' ILE . 2.1 tmt_? -103.05 -54.45 2.62 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.814 -0.439 . . . . 2.5899999999999999 109.814 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.539 HG22 ' O ' ' A' ' 204' ' ' LYS . 7.4 t -101.4 148.79 35.68 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 108.64 -0.874 . . . . 1.8400000000000001 108.64 176.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.432 ' HD2' ' OG1' ' A' ' 208' ' ' THR . 45.6 Cg_endo -69.57 46.71 0.49 Allowed 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.577 2.185 . . . . 2.3500000000000001 113.109 178.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 89.4 p -78.88 -17.52 55.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.355 0.598 . . . . 2.3100000000000001 109.684 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.81 ' HA ' ' HB2' ' A' ' 214' ' ' PHE . 5.5 mmm180 -71.77 -14.57 62.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.433 -0.803 . . . . 5.4500000000000002 111.001 175.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -63.07 -45.08 93.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.602 -0.518 . . . . 6.8600000000000003 109.602 175.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -103.62 34.88 5.42 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 111.402 -0.679 . . . . 3.3700000000000001 111.402 176.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.81 ' HB2' ' HA ' ' A' ' 211' ' ' ARG . 78.8 t80 -91.02 141.45 28.82 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.235 -0.283 . . . . 5.21 110.235 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -66.58 88.24 0.13 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.729 -0.471 . . . . 6.46 109.729 174.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 28.4 p-80 -88.66 106.29 18.24 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.312 0.577 . . . . 6.0899999999999999 110.884 -176.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -77.77 119.6 21.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.43 -0.804 . . . . 5.1200000000000001 110.592 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.0 p -86.74 -48.83 7.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.896 -0.593 . . . . 6.7599999999999998 111.464 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -147.38 134.96 20.94 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.957 -0.386 . . . . 8.8200000000000003 109.957 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 18.8 m . . . . . 0 C--O 1.252 1.196 0 O-C-N 123.627 0.579 . . . . 8.4800000000000004 111.474 179.048 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.0 t70 . . . . . 0 CA--C 1.508 -0.635 0 N-CA-C 108.903 -0.777 . . . . 2.25 108.903 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.502 ' CD2' HD12 ' A' ' 87' ' ' ILE . 59.1 m-85 -63.86 -33.15 75.04 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.459 0.647 . . . . 0.42999999999999999 109.341 177.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.529 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 5.7 mttp -70.1 -46.63 64.45 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 115.119 -0.946 . . . . 1.51 108.498 178.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -47.49 -48.58 27.04 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 112.324 0.49 . . . . 0.54000000000000004 112.324 -176.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.572 ' O ' ' HB ' ' A' ' 10' ' ' THR . 0.2 OUTLIER -82.95 -34.06 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 121.291 0.567 . . . . 1.0700000000000001 110.041 -173.032 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.498 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -78.83 -42.76 26.81 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.058 -0.973 . . . . 0.34000000000000002 111.767 -176.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.564 ' HG2' ' CZ ' ' A' ' 116' ' ' TYR . 34.6 mt-30 -59.35 -32.95 70.58 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.729 -1.123 . . . . 1.5900000000000001 110.103 175.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.695 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 16.3 mm-40 -79.09 -41.7 28.07 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.104 -0.953 . . . . 2.4700000000000002 108.778 173.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.619 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.3 OUTLIER -63.36 -35.53 80.71 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.039 -0.982 . . . . 0.47999999999999998 111.625 -176.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.463 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -46.26 -63.05 1.09 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.941 0.4 . . . . 0.31 111.4 170.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.468 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 10.4 pt20 -72.69 -9.86 59.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.289 -0.414 . . . . 1.6399999999999999 112.051 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.695 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 51.0 mt-10 -77.95 -50.23 12.57 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.631 -0.507 . . . . 2.54 109.631 174.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.627 HG21 ' N ' ' A' ' 152' ' ' GLY . 5.8 p -68.65 -39.42 80.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 122.049 0.928 . . . . 0.53000000000000003 109.393 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.468 ' HB3' ' HA ' ' A' ' 12' ' ' GLN . 0.8 OUTLIER -66.9 -27.57 67.61 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 114.548 -1.206 . . . . 0.59999999999999998 108.93 173.184 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.93 -17.86 63.69 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 113.97 -1.468 . . . . 0.56999999999999995 110.662 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.504 ' CD2' ' HA ' ' A' ' 14' ' ' VAL . 17.9 m-85 -90.63 -22.65 21.11 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.089 -0.556 . . . . 3.27 109.508 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.492 ' CB ' ' HZ ' ' A' ' 170' ' ' PHE . 0.1 OUTLIER -69.67 -24.38 63.6 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 120.184 -0.607 . . . . 2.0299999999999998 109.385 176.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.23 9.7 27.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.324 -0.853 . . . . 2.7200000000000002 110.118 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.425 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 29.6 t70 -123.08 74.9 1.25 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.444 -0.798 . . . . 2.1600000000000001 109.108 177.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.439 HG22 ' CH2' ' A' ' 24' ' ' TRP . 53.2 p -102.83 88.84 3.29 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.453 0.644 . . . . 1.8200000000000001 111.183 -172.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.1 p -173.4 168.64 4.55 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.659 -1.155 . . . . 2.1899999999999999 110.127 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.57 9.69 62.24 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 121.171 -0.538 . . . . 1.1000000000000001 112.908 175.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.463 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -120.44 -158.95 0.77 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.88 0.371 . . . . 1.6699999999999999 111.395 -177.521 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.51 122.37 0.35 Allowed 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.155 -0.683 . . . . 2.9500000000000002 109.155 -168.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 3.1 m -65.12 124.12 19.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 122.084 0.945 . . . . 1.5600000000000001 111.252 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.3 p -102.02 -24.4 4.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 113.918 -1.492 . . . . 1.22 108.84 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.403 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 17.7 tppt? -147.81 112.73 5.44 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.903 -0.59 . . . . 2.4100000000000001 111.89 -174.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.56 HG22 ' HA ' ' A' ' 34' ' ' THR . 43.2 p -130.0 151.04 50.98 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.163 -0.472 . . . . 1.3799999999999999 110.314 173.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.3 t -118.84 -98.85 0.45 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.27 -0.423 . . . . 2.3700000000000001 110.027 174.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -144.86 17.52 1.61 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.624 0.726 . . . . 4.5499999999999998 110.035 176.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.573 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 13.1 tptm -167.92 -0.6 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.677 -0.692 . . . . 1.4199999999999999 110.738 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 51' ' ' GLU . 41.7 pt -136.44 154.02 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 120.951 0.405 . . . . 0.76000000000000001 110.802 -176.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.56 ' HA ' HG22 ' A' ' 29' ' ' THR . 54.4 m -150.2 99.59 2.82 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.675 -0.693 . . . . 0.57999999999999996 111.299 -168.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.487 HG11 ' HA ' ' A' ' 189' ' ' PRO . 9.9 t -92.48 118.77 38.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.928 -0.397 . . . . 0.85999999999999999 109.928 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.544 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -118.64 124.4 47.31 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.435 0.636 . . . . 1.1000000000000001 111.117 -176.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.528 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 22.4 m -95.28 122.48 38.02 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.721 -1.127 . . . . 1.27 111.037 -175.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 29.1 ttmt . . . . . 0 C--N 1.324 -0.524 0 CA-C-N 116.508 -0.315 . . . . 1.9099999999999999 111.354 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.528 ' OD1' ' HB3' ' A' ' 37' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.706 0.289 . . . . 2.0499999999999998 110.251 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.705 HD23 ' N ' ' A' ' 48' ' ' TYR . 6.4 tt -96.97 147.55 23.87 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.283 -0.636 . . . . 0.87 109.283 -177.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.705 ' N ' HD23 ' A' ' 47' ' ' LEU . 46.9 m-85 -117.88 124.36 48.1 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.643 -0.502 . . . . 0.98999999999999999 109.643 -176.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.439 ' HD3' HG23 ' A' ' 168' ' ' VAL . 1.4 tmm_? -117.88 120.69 38.65 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.343 -0.39 . . . . 2.9199999999999999 109.989 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.537 ' CG1' ' HB3' ' A' ' 192' ' ' LEU . 11.3 p -103.45 149.79 7.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 120.696 -0.402 . . . . 1.3300000000000001 110.088 177.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.552 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 34.1 tt0 -143.63 111.36 6.01 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.914 -0.584 . . . . 1.0700000000000001 110.036 -172.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.573 ' HA2' ' O ' ' A' ' 32' ' ' LYS . . . -140.73 138.86 9.23 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.323 -0.941 . . . . 0.28999999999999998 112.498 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.416 ' HB ' ' HE2' ' A' ' 32' ' ' LYS . 63.6 mt -90.23 113.93 27.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 120.168 -0.613 . . . . 0.57999999999999996 110.786 177.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.48 ' CD1' ' HB1' ' A' ' 199' ' ' ALA . 57.4 mt -95.89 116.53 66.29 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.627 -0.715 . . . . 0.34999999999999998 109.454 175.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -61.91 64.26 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 124.381 3.388 . . . . 0.62 113.065 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.566 ' HG2' ' CG1' ' A' ' 203' ' ' ILE . 12.4 tp10 -156.84 173.43 17.0 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.656 -0.868 . . . . 1.6799999999999999 108.656 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.49 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 10.2 m -81.63 142.07 49.12 Favored Pre-proline 0 N--CA 1.423 -1.796 0 N-CA-C 109.332 -0.618 . . . . 1.1799999999999999 109.332 178.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 57' ' ' SER . 31.2 Cg_exo -59.08 -12.31 15.3 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 123.723 2.949 . . . . 0.52000000000000002 111.038 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.9 -50.21 37.49 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.825 -1.079 . . . . 0.64000000000000001 111.292 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.447 ' HB3' HD11 ' A' ' 203' ' ' ILE . 17.4 ttmm -71.02 -27.59 63.79 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.089 -0.708 . . . . 3.2999999999999998 109.089 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.971 HD23 HD13 ' A' ' 203' ' ' ILE . 47.0 mt -62.3 -55.8 24.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.86 -1.063 . . . . 0.40999999999999998 109.666 173.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.534 ' HA ' ' CD1' ' A' ' 65' ' ' LEU . 13.7 p -71.84 -1.64 14.92 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.135 0.493 . . . . 1.29 110.83 176.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -88.85 -30.25 19.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.923 -0.58 . . . . 1.3200000000000001 111.141 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.7 ' CE1' ' HB3' ' A' ' 65' ' ' LEU . 6.1 p90 -90.02 -46.07 8.75 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 120.774 -0.37 . . . . 0.60999999999999999 111.06 -174.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.704 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -87.56 6.97 31.76 Favored 'General case' 0 CA--C 1.517 -0.302 0 O-C-N 121.811 -0.556 . . . . 1.5 110.535 -173.545 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -48.44 -63.43 1.08 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.8 -1.091 . . . . 1.52 112.496 -167.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.465 ' O ' ' HD2' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -154.73 -85.32 0.06 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 119.433 -0.907 . . . . 3.6000000000000001 112.942 -175.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.638 ' HB ' ' CD1' ' A' ' 81' ' ' TYR . 9.1 t -141.06 21.52 2.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.965 0.412 . . . . 1.48 111.583 -164.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -115.95 0.98 21.31 Favored Glycine 0 C--N 1.311 -0.833 0 C-N-CA 118.716 -1.707 . . . . 1.46 113.97 -164.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.559 ' O ' HG22 ' A' ' 73' ' ' THR . 6.6 p-10 179.17 -31.81 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.258 -0.645 . . . . 2.1899999999999999 109.258 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.626 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 18.3 ttt180 -34.57 -59.45 0.46 Allowed 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 125.649 1.58 . . . . 3.3799999999999999 111.189 176.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.703 HD13 ' H ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -88.8 -6.98 10.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.879 -1.055 . . . . 0.70999999999999996 111.223 -172.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.559 HG22 ' O ' ' A' ' 70' ' ' ASP . 0.7 OUTLIER -88.21 -45.13 10.34 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 120.326 -0.549 . . . . 0.96999999999999997 110.523 -171.614 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.517 ' CZ3' ' HB2' ' A' ' 198' ' ' ASN . 18.7 p-90 -102.24 1.38 35.81 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 120.54 -0.464 . . . . 0.75 110.95 -174.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.626 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 5.3 t70 -71.03 -171.07 0.51 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.878 0.846 . . . . 2.1899999999999999 111.578 -175.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.64 ' HD3' ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -126.34 -29.07 3.01 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.678 -1.146 . . . . 3.1899999999999999 109.217 -175.694 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.1 m -120.01 8.87 11.08 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.372 -0.831 . . . . 1.5800000000000001 110.142 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.567 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 39.6 mt -108.9 155.39 20.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.99 0.424 . . . . 0.70999999999999996 110.336 178.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.578 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 5.2 mm-40 -132.04 -69.37 0.6 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.54 -0.755 . . . . 1.73 111.509 -175.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.49 HG23 ' HB3' ' A' ' 79' ' ' GLN . 14.4 t -139.01 134.05 41.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.125 -0.489 . . . . 0.78000000000000003 110.377 -171.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.638 ' CD1' ' HB ' ' A' ' 68' ' ' THR . 15.9 t80 -117.53 137.05 52.82 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.827 -0.434 . . . . 5.4000000000000004 109.827 175.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.423 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 20.3 m120 -136.6 124.58 22.81 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.655 -0.869 . . . . 1.6899999999999999 108.655 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.472 ' CG ' ' HD3' ' A' ' 86' ' ' ARG . 21.4 tpp -80.21 97.2 6.83 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.163 -0.926 . . . . 2.0499999999999998 109.272 -176.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -75.65 -77.08 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.099 -0.501 . . . . 0.64000000000000001 111.817 -170.557 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -136.01 103.54 5.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.984 0.421 . . . . 1.96 110.459 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.472 ' HD3' ' CG ' ' A' ' 83' ' ' MET . 85.1 mtm180 -83.95 133.7 34.69 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.204 -0.665 . . . . 2.4399999999999999 109.204 175.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.623 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -86.57 -47.16 16.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.624 -0.716 . . . . 0.46999999999999997 109.32 -174.449 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -142.15 -152.34 0.4 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.224 -0.898 . . . . 1.8600000000000001 108.948 175.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.3 m -88.33 -7.86 56.04 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.039 0.385 . . . . 1.4399999999999999 112.039 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -134.4 14.99 3.77 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 120.365 -0.534 . . . . 1.8700000000000001 110.481 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.623 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.5 OUTLIER -136.49 103.96 5.42 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 108.09 -1.078 . . . . 0.46000000000000002 108.09 -178.68 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.605 ' O ' HD12 ' A' ' 114' ' ' LEU . 10.2 m-85 -120.65 172.59 7.75 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.008 0.432 . . . . 0.42999999999999999 110.224 -173.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.633 ' O ' HG23 ' A' ' 84' ' ' VAL . 42.4 mt -132.56 128.46 57.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 107.541 -1.281 . . . . 0.40999999999999998 107.541 168.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.592 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 26.1 p -106.6 129.91 54.45 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.407 -0.361 . . . . 2.0099999999999998 111.542 -173.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.538 ' HA ' HD13 ' A' ' 112' ' ' ILE . 4.1 t60 -94.35 90.93 6.46 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.148 -1.056 . . . . 1.23 108.148 163.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 85.3 m -108.53 109.33 20.55 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.536 -0.756 . . . . 0.5 111.787 -173.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.441 ' O ' ' HB2' ' A' ' 79' ' ' GLN . 44.7 mm -77.65 121.46 30.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.564 -0.902 . . . . 1.03 108.564 171.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.427 ' CG2' ' HB2' ' A' ' 109' ' ' ARG . 14.7 t -112.55 156.51 22.53 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.689 0.757 . . . . 1.3799999999999999 111.222 -176.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.578 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 20.9 mt-30 . . . . . 0 C--N 1.312 -1.033 0 CA-C-N 114.481 -1.236 . . . . 1.8200000000000001 108.938 176.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 62.0 mt . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 110.337 -0.245 . . . . 1.1200000000000001 110.337 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.0 m -99.06 151.38 37.36 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.66 -0.496 . . . . 1.3500000000000001 109.66 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.16 147.95 10.61 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.162 2.575 . . . . 1.0700000000000001 112.195 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.508 ' HG2' HG23 ' A' ' 144' ' ' ILE . 42.6 mtt180 -121.97 157.08 32.08 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.709 -0.796 . . . . 3.4500000000000002 111.748 -170.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.824 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 7.1 t0 -104.48 116.74 32.63 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.276 -0.875 . . . . 1.3700000000000001 109.17 174.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.525 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 13.3 m-30 -100.56 109.77 21.88 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.89 -0.506 . . . . 2.4100000000000001 110.664 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.601 HG21 ' CE1' ' A' ' 134' ' ' PHE . 24.5 mm -104.96 76.15 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 N-CA-C 109.12 -0.696 . . . . 0.42999999999999999 109.12 173.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.595 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 25.7 m-20 -99.54 124.15 44.46 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.649 -0.705 . . . . 1.8600000000000001 110.435 -178.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.605 HD12 ' O ' ' A' ' 92' ' ' PHE . 3.5 tp -75.74 127.19 32.51 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 108.378 -0.971 . . . . 0.28000000000000003 108.378 169.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -128.62 124.51 61.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-N 115.485 -0.78 . . . . 0.26000000000000001 112.133 -163.582 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.564 ' CZ ' ' HG2' ' A' ' 8' ' ' GLN . 67.5 t80 -114.36 121.13 42.67 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.923 -1.035 . . . . 2.5699999999999998 110.943 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.564 HG12 HG22 ' A' ' 127' ' ' ILE . 88.7 mt -95.72 122.31 47.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.801 -0.636 . . . . 0.89000000000000001 110.438 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.42 ' HE2' ' HE2' ' A' ' 116' ' ' TYR . 13.4 tppt? -131.41 134.57 46.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.964 -0.562 . . . . 1.2 111.255 -173.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.0 tpp180 -112.93 100.49 8.68 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.908 -0.587 . . . . 2.7999999999999998 109.616 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -75.11 107.39 7.16 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.571 -1.27 . . . . 0.82999999999999996 107.571 169.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 1.7 mp0 -26.44 97.12 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 O-C-N 125.024 1.453 . . . . 2.2799999999999998 113.535 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.418 ' C ' HD22 ' A' ' 123' ' ' ASN . . . 56.7 31.89 61.1 Favored Glycine 0 CA--C 1.51 -0.22 0 CA-C-N 114.565 -1.198 . . . . 0.76000000000000001 113.242 177.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.645 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 0.8 OUTLIER -125.95 -49.01 1.61 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.957 -0.386 . . . . 1.6499999999999999 109.957 179.372 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.403 ' SD ' ' HB3' ' A' ' 123' ' ' ASN . 2.2 mpt? -157.56 141.3 15.79 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 110.259 -0.275 . . . . 1.1200000000000001 110.259 -178.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -120.33 85.93 2.48 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.404 -0.961 . . . . 1.6200000000000001 108.404 167.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.469 ' CG1' HG12 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -97.65 144.47 10.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.29 -1.323 . . . . 0.29999999999999999 112.282 -171.71 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.66 ' O ' HG13 ' A' ' 127' ' ' ILE . 2.1 pt -109.03 116.1 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 108.1 -1.074 . . . . 0.58999999999999997 108.1 161.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.592 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 43.3 p -83.94 159.05 21.36 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.822 -0.807 . . . . 1.1799999999999999 108.822 173.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.595 ' HB3' ' HB3' ' A' ' 113' ' ' ASP . 20.4 m -153.15 128.64 9.97 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 120.675 0.274 . . . . 1.24 111.05 -175.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -128.28 121.01 28.26 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 107.929 -1.137 . . . . 2.2599999999999998 107.929 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.457 ' HB2' ' H ' ' A' ' 148' ' ' ASN . 48.0 t -63.58 100.16 0.26 Allowed 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.318 -1.364 . . . . 1.3899999999999999 107.318 174.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -108.58 140.08 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.057 0 CA-C-N 114.348 -1.296 . . . . 1.05 108.691 -165.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -96.2 73.15 2.9 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.182 -0.917 . . . . 2.1699999999999999 109.633 -171.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.787 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -105.38 150.87 39.44 Favored Pre-proline 0 N--CA 1.437 -1.103 0 CA-C-N 114.704 -1.134 . . . . 0.53000000000000003 109.234 -174.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 8.2 Cg_exo -76.29 -9.77 19.04 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.736 2.291 . . . . 1.28 115.224 -169.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.787 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 7.4 tp10 -73.13 -13.25 61.14 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.906 -0.405 . . . . 3.5 109.906 -172.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.477 ' HB2' HG11 ' A' ' 84' ' ' VAL . 20.0 t80 -152.68 120.43 3.14 Favored Pre-proline 0 N--CA 1.449 -0.487 0 N-CA-C 113.419 0.896 . . . . 6.1200000000000001 113.419 174.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -99.92 134.83 0.22 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 124.046 3.164 . . . . 1.77 111.774 167.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.408 ' HG3' ' HB2' ' A' ' 145' ' ' ARG . 83.1 Cg_endo -79.23 -159.31 0.1 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.592 2.195 . . . . 1.25 112.136 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.0 p -145.48 -167.84 2.8 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.434 -0.58 . . . . 1.6000000000000001 109.434 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.1 t -88.58 -19.94 25.66 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.558 -0.457 . . . . 1.97 109.813 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -77.15 -32.26 56.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.053 -0.521 . . . . 2.1800000000000002 109.95 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.445 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 73.4 m-85 -130.58 114.97 16.12 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 115.659 -0.701 . . . . 1.23 109.461 176.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.508 HG23 ' HG2' ' A' ' 109' ' ' ARG . 2.0 tp -94.36 113.92 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 109.136 -0.69 . . . . 0.81999999999999995 109.136 -175.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.824 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 41.4 ttp180 -50.4 99.41 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.122 -0.945 . . . . 4.4199999999999999 109.672 173.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.6 122.04 26.85 Favored Glycine 0 N--CA 1.434 -1.483 0 CA-C-N 115.068 -0.969 . . . . 0.79000000000000004 111.784 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -82.16 79.42 8.66 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.876 0.846 . . . . 4.4400000000000004 110.955 177.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.457 ' H ' ' HB2' ' A' ' 131' ' ' SER . 17.4 m-20 -85.79 87.69 7.44 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.888 -1.505 . . . . 1.6200000000000001 108.435 172.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.5 ' HB2' ' HG2' ' A' ' 172' ' ' GLN . 96.4 m-70 -58.68 150.87 55.44 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-O 118.711 -0.661 . . . . 2.3199999999999998 109.367 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.619 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 50.9 Cg_exo -18.62 68.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.198 1 C-N-CA 127.055 5.17 . . . . 0.53000000000000003 116.12 -173.053 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . 0.568 ' HB2' ' O ' ' A' ' 170' ' ' PHE . 19.6 p -97.24 -173.81 2.77 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.618 -1.174 . . . . 1.5800000000000001 110.413 174.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.627 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -174.04 -160.65 22.69 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 120.573 -0.823 . . . . 0.42999999999999999 112.044 177.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.474 ' CZ ' HD11 ' A' ' 167' ' ' LEU . 35.4 t80 -161.57 96.08 1.03 Allowed 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.291 -1.003 . . . . 0.59999999999999998 108.291 -167.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.591 ' CG2' HG13 ' A' ' 168' ' ' VAL . 2.3 m -104.15 136.24 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 121.838 0.828 . . . . 0.31 111.188 -173.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 77.6 m -115.49 112.43 22.24 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.101 -0.954 . . . . 1.55 109.048 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.472 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 6.5 m -111.21 118.5 47.6 Favored Pre-proline 0 C--N 1.32 -0.7 0 C-N-CA 120.638 -0.425 . . . . 1.0600000000000001 111.762 -169.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.645 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 39.6 Cg_exo -49.88 119.65 5.07 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.265 1.977 . . . . 0.56000000000000005 111.136 170.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.585 ' SD ' ' HB2' ' A' ' 166' ' ' LYS . 60.4 mmm -79.68 -163.54 0.54 Allowed 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 120.916 0.389 . . . . 1.1599999999999999 111.376 -177.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -68.97 -26.33 64.98 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.476 0.655 . . . . 2.6299999999999999 109.978 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -98.88 15.51 25.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.454 -0.794 . . . . 2.0499999999999998 109.251 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.53 ' HB2' ' CD ' ' A' ' 162' ' ' PRO . 41.0 m-80 23.02 -87.81 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 126.051 1.74 . . . . 1.9299999999999999 115.484 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.53 ' CD ' ' HB2' ' A' ' 161' ' ' ASN . 73.5 Cg_endo -72.31 -16.7 27.89 Favored 'Trans proline' 0 C--N 1.364 1.374 0 CA-C-N 121.539 1.585 . . . . 0.72999999999999998 113.147 -174.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -90.93 -35.28 14.81 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.25 -0.432 . . . . 0.68000000000000005 111.181 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.571 ' O ' ' HB2' ' A' ' 158' ' ' MET . 93.8 m-85 -139.51 133.26 30.62 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.763 -0.458 . . . . 0.93000000000000005 109.763 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.417 ' HB3' HD11 ' A' ' 61' ' ' LEU . 32.4 t -125.99 148.09 49.37 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.514 0.673 . . . . 1.4099999999999999 111.092 -177.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.585 ' HB2' ' SD ' ' A' ' 158' ' ' MET . 1.8 tppp? -96.21 102.36 14.14 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.117 -0.947 . . . . 0.73999999999999999 111.235 -177.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.474 HD11 ' CZ ' ' A' ' 153' ' ' PHE . 0.5 OUTLIER -86.84 109.32 19.21 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.511 -1.222 . . . . 0.27000000000000002 109.006 177.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.591 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -131.32 128.74 61.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.439 0.638 . . . . 0.28000000000000003 111.804 177.422 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 23.1 ttt -129.79 145.16 51.57 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.808 -0.633 . . . . 1.24 110.692 -174.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.607 ' CD1' HG22 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -125.72 141.73 51.86 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.463 -0.79 . . . . 3.3700000000000001 109.474 -178.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 4.3 p -150.25 137.59 13.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 120.439 -0.504 . . . . 1.3999999999999999 110.512 173.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.639 HE21 ' N ' ' A' ' 172' ' ' GLN . 0.0 OUTLIER -127.4 52.67 1.8 Allowed 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 122.528 1.156 . . . . 2.1699999999999999 108.358 178.214 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.449 HG23 ' OD1' ' A' ' 148' ' ' ASN . 1.8 m -56.14 148.16 18.71 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 113.492 -1.686 . . . . 1.6499999999999999 112.112 -174.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 . . . . . 0 CA--C 1.533 0.302 0 CA-C-N 115.571 -0.741 . . . . 2.4500000000000002 112.666 -178.245 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.439 ' HA ' ' CE ' ' A' ' 186' ' ' LYS . 27.3 mm . . . . . 0 CA--C 1.5 -0.953 0 CA-C-O 122.947 1.356 . . . . 1.1200000000000001 107.979 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.966 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.4 mp -74.05 -35.16 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.691 0 CA-C-N 112.199 -2.273 . . . . 1.1299999999999999 110.149 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -57.77 -26.42 61.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.961 -1.018 . . . . 2.8900000000000001 109.833 171.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.439 ' CE ' ' HA ' ' A' ' 183' ' ' ILE . 50.9 mtmt -92.76 -36.87 12.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.512 -0.767 . . . . 1.28 111.224 176.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.966 HG22 ' HA ' ' A' ' 184' ' ' ILE . 6.2 t -68.49 -45.71 71.63 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.259 0.466 . . . . 0.62 112.259 -172.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . 0.588 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 32.3 mmt -80.05 -57.88 0.64 Allowed Pre-proline 0 N--CA 1.464 0.258 0 N-CA-C 112.712 0.634 . . . . 1.0600000000000001 112.712 -173.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.656 ' O ' HG13 ' A' ' 193' ' ' VAL . 39.5 Cg_exo -58.21 -40.23 78.05 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.642 1.561 . . . . 0.91000000000000003 112.163 -175.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 69.8 m -77.24 -24.54 51.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.24 -0.436 . . . . 1.5 111.111 -175.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.579 ' HB2' ' O ' ' A' ' 187' ' ' THR . 46.5 t30 -80.15 -34.9 37.29 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.66 -0.416 . . . . 1.8799999999999999 110.529 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.537 ' HB3' ' CG1' ' A' ' 50' ' ' VAL . 53.9 mt -68.91 -42.95 76.17 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 120.633 0.254 . . . . 1.0900000000000001 111.027 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.656 HG13 ' O ' ' A' ' 189' ' ' PRO . 2.4 m -62.38 -31.43 51.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 121.65 0.738 . . . . 0.68000000000000005 109.179 176.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.406 ' HA ' ' HB2' ' A' ' 197' ' ' LEU . 1.0 OUTLIER -75.26 -31.12 60.68 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.366 -1.288 . . . . 2.0699999999999998 111.076 -179.409 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -68.75 -28.13 66.53 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 121.348 0.594 . . . . 2.0 109.775 171.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.546 ' O ' ' HD3' ' A' ' 200' ' ' LYS . 28.7 mt -81.86 -26.09 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-O 121.255 0.55 . . . . 0.31 111.206 173.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.406 ' HB2' ' HA ' ' A' ' 194' ' ' ASN . 37.6 mt -72.04 -43.06 65.55 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-N 116.346 -0.388 . . . . 1.03 110.403 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.517 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 5.4 p30 -55.71 -30.68 61.54 Favored 'General case' 0 C--O 1.213 -0.856 0 N-CA-C 108.428 -0.952 . . . . 1.8999999999999999 108.428 170.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.66 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -76.19 -45.42 33.32 Favored 'General case' 0 N--CA 1.428 -1.537 0 O-C-N 121.64 -0.663 . . . . 0.28999999999999998 110.422 -178.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.546 ' HD3' ' O ' ' A' ' 196' ' ' ILE . 1.5 mptm? -56.29 -45.11 80.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.877 -0.601 . . . . 0.96999999999999997 111.263 174.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -86.52 -37.02 18.62 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.43 -0.805 . . . . 1.9399999999999999 111.421 -173.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . 0.474 ' HA3' ' CH2' ' A' ' 74' ' ' TRP . . . -68.71 -32.58 74.51 Favored Glycine 0 N--CA 1.462 0.395 0 C-N-CA 120.999 -0.619 . . . . 0.46999999999999997 111.746 177.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.971 HD13 HD23 ' A' ' 61' ' ' LEU . 2.4 tp -69.88 -34.96 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 110.068 -0.345 . . . . 0.60999999999999999 110.068 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -89.34 -20.55 23.89 Favored 'General case' 0 C--O 1.215 -0.714 0 N-CA-C 109.305 -0.628 . . . . 3.3700000000000001 109.305 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.732 0 N-CA-C 108.719 -0.845 . . . . 1.02 108.719 168.096 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 . . . . . 0 CA--C 1.508 -0.655 0 CA-C-O 121.254 0.549 . . . . 2.25 109.745 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.79 ' HA ' HD12 ' A' ' 6' ' ' ILE . 96.4 m-85 -68.64 -30.03 68.65 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.477 -0.783 . . . . 0.42999999999999999 109.056 -176.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.62 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 3.0 tppp? -70.72 -7.42 44.61 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 114.95 -1.023 . . . . 1.51 109.986 176.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.71 -42.15 10.88 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.151 0.501 . . . . 0.54000000000000004 109.804 174.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.79 HD12 ' HA ' ' A' ' 3' ' ' PHE . 1.3 mp -81.82 -43.9 19.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.98 -0.748 . . . . 1.0700000000000001 108.98 -172.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.888 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -67.68 -47.96 67.98 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.546 -1.206 . . . . 0.34000000000000002 111.653 -178.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.62 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 4.3 mt-30 -63.9 -27.02 68.86 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.27 -1.332 . . . . 1.5900000000000001 110.722 -176.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.477 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 27.7 mt-30 -82.45 -39.2 22.89 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.201 -0.909 . . . . 2.4700000000000002 109.211 171.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.931 HG21 ' HZ2' ' A' ' 130' ' ' LYS . 0.5 OUTLIER -65.44 -37.67 87.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.844 -1.071 . . . . 0.47999999999999998 112.401 -177.67 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.52 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -47.36 -53.05 14.77 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.132 0.419 . . . . 0.31 112.132 176.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.564 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 28.3 pt20 -79.87 -4.54 52.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.75 0.31 . . . . 1.6399999999999999 111.115 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 10' ' ' THR . 70.8 mm-40 -75.98 -54.38 6.96 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.206 -0.664 . . . . 2.54 109.206 172.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.621 HG21 ' N ' ' A' ' 152' ' ' GLY . 12.6 p -70.18 -36.83 69.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 114.82 -1.082 . . . . 0.53000000000000003 110.334 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.564 ' HB3' ' HA ' ' A' ' 12' ' ' GLN . 0.6 OUTLIER -69.16 -24.4 64.07 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-O 122.059 0.933 . . . . 0.59999999999999998 108.869 174.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.45 -17.74 68.95 Favored Glycine 0 CA--C 1.501 -0.833 0 CA-C-N 113.755 -1.566 . . . . 0.56999999999999995 109.967 177.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.576 ' HA ' ' CB ' ' A' ' 20' ' ' ASP . 30.8 m-85 -90.39 -23.85 20.95 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 114.755 -0.723 . . . . 3.27 109.381 176.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.549 ' HA ' ' HZ ' ' A' ' 170' ' ' PHE . 66.2 t30 -66.48 -19.74 65.86 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-O 121.452 0.644 . . . . 2.0299999999999998 109.541 176.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -120.2 10.58 11.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.433 -0.803 . . . . 2.7200000000000002 110.294 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.576 ' CB ' ' HA ' ' A' ' 17' ' ' TYR . 9.2 t70 -86.07 -31.58 21.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.258 -0.883 . . . . 2.1600000000000001 110.773 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.3 t -16.65 86.99 0.0 OUTLIER 'General case' 0 C--O 1.235 0.309 0 O-C-N 125.485 1.741 . . . . 1.8200000000000001 113.733 -169.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.5 t -172.64 137.48 0.8 Allowed 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.352 -1.749 . . . . 2.1899999999999999 109.068 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.37 -11.5 68.77 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.637 -0.792 . . . . 1.1000000000000001 112.19 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.833 ' HA ' ' HB3' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -104.39 -160.24 0.75 Allowed 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 120.97 0.414 . . . . 1.6699999999999999 110.775 -179.634 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.471 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 2.0 tmmm? -170.48 128.97 0.83 Allowed 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 115.442 -0.799 . . . . 2.9500000000000002 109.18 -174.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.581 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 0.1 OUTLIER -70.35 109.3 2.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-O 121.947 0.879 . . . . 1.5600000000000001 109.374 175.017 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 p -93.19 -25.07 5.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 114.172 -1.376 . . . . 1.22 109.46 -172.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.456 ' HD2' ' HA ' ' A' ' 28' ' ' LYS . 17.4 tptp -153.95 132.03 11.78 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 119.755 -0.778 . . . . 2.4100000000000001 112.015 -175.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.702 ' HB ' ' HA ' ' A' ' 34' ' ' THR . 0.0 OUTLIER -152.01 152.76 32.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.236 0.541 . . . . 1.3799999999999999 112.06 177.292 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 35.6 m -104.6 25.68 9.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.423 -0.808 . . . . 2.3700000000000001 110.499 175.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 30' ' ' SER . 28.6 mmmt 75.53 19.0 2.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.81 -0.632 . . . . 4.5499999999999998 111.911 175.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.581 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 9.3 mmtp -164.76 -30.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.795 -0.639 . . . . 1.4199999999999999 110.073 175.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.906 HG22 ' HA3' ' A' ' 52' ' ' GLY . 29.7 pt -110.87 136.9 45.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 108.629 -0.878 . . . . 0.76000000000000001 108.629 171.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.702 ' HA ' ' HB ' ' A' ' 29' ' ' THR . 0.2 OUTLIER -140.35 115.62 9.91 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.506 0.194 . . . . 0.57999999999999996 111.206 -162.439 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.687 HG22 HG23 ' A' ' 50' ' ' VAL . 6.2 t -99.67 115.04 39.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.957 0.408 . . . . 0.85999999999999999 110.563 -177.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.581 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -107.81 122.76 47.42 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.844 -0.617 . . . . 1.1000000000000001 110.226 -177.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.5 t -114.73 131.46 56.76 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.908 -0.587 . . . . 1.27 112.301 -172.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.833 ' HB3' ' HA ' ' A' ' 24' ' ' TRP . 56.5 pttt . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 115.516 -0.765 . . . . 1.9099999999999999 110.057 167.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.443 -0.787 0 CA-C-O 121.39 0.614 . . . . 2.0499999999999998 111.311 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.531 HD23 ' N ' ' A' ' 48' ' ' TYR . 3.1 tt -104.8 133.64 49.28 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.735 -1.209 . . . . 0.87 107.735 176.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.531 ' N ' HD23 ' A' ' 47' ' ' LEU . 22.7 m-85 -117.54 124.42 48.67 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.959 -0.386 . . . . 0.98999999999999999 109.959 -175.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.595 ' HD3' ' CH2' ' A' ' 24' ' ' TRP . 11.6 ttp180 -105.43 116.99 32.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.01 -0.541 . . . . 2.9199999999999999 109.769 175.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.687 HG23 HG22 ' A' ' 35' ' ' VAL . 8.8 p -100.69 136.33 32.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 C-N-CA 119.802 -0.759 . . . . 1.3300000000000001 109.027 174.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.877 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 27.6 tt0 -137.8 108.8 6.73 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.359 -0.837 . . . . 1.0700000000000001 109.963 -169.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.906 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -139.4 140.42 10.84 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.248 -0.977 . . . . 0.28999999999999998 111.828 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 67.7 mt -84.69 116.82 28.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 C-N-CA 120.005 -0.678 . . . . 0.57999999999999996 110.656 178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.545 HG12 ' HD3' ' A' ' 200' ' ' LYS . 63.6 mt -101.54 113.35 65.85 Favored Pre-proline 0 C--N 1.314 -0.974 0 N-CA-C 108.355 -0.98 . . . . 0.34999999999999998 108.355 173.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.533 ' HA ' ' HA ' ' A' ' 164' ' ' TYR . 28.3 Cg_exo -64.12 56.25 0.22 Allowed 'Trans proline' 0 N--CA 1.478 0.561 0 C-N-CA 124.574 3.516 . . . . 0.62 114.105 -174.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.999 ' HG3' HG12 ' A' ' 203' ' ' ILE . 63.4 mm-40 -132.34 -157.19 0.8 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.628 -0.715 . . . . 1.6799999999999999 109.581 176.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 62.7 p -101.11 145.44 30.42 Favored Pre-proline 0 N--CA 1.415 -2.19 0 CA-C-N 114.798 -1.092 . . . . 1.1799999999999999 108.286 168.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 57' ' ' SER . 39.9 Cg_exo -56.84 -11.1 6.51 Favored 'Trans proline' 0 C--N 1.324 -0.727 0 C-N-CA 123.967 3.112 . . . . 0.52000000000000002 110.989 175.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.42 -48.47 9.61 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.857 -1.065 . . . . 0.64000000000000001 111.438 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.623 ' HG2' HG13 ' A' ' 203' ' ' ILE . 3.4 tppt? -62.76 -33.62 75.54 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.52 -0.919 . . . . 3.2999999999999998 108.52 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.978 HD23 HD13 ' A' ' 203' ' ' ILE . 70.9 mt -57.19 -56.91 15.65 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.737 -1.12 . . . . 0.40999999999999998 110.864 173.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.482 ' HA ' ' CD1' ' A' ' 65' ' ' LEU . 53.0 m -65.92 -8.34 21.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.292 0.568 . . . . 1.29 110.643 177.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' A' ' 60' ' ' LYS . 25.1 t70 -88.34 -32.31 18.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.672 -0.694 . . . . 1.3200000000000001 111.83 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.615 ' CD2' ' HA ' ' A' ' 61' ' ' LEU . 16.2 p90 -79.58 -43.53 22.79 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 120.225 -0.59 . . . . 0.60999999999999999 110.019 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.653 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -91.16 3.84 53.75 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 120.548 -0.461 . . . . 1.5 111.962 -174.523 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.407 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 24.8 t80 -14.1 -70.66 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 125.378 1.674 . . . . 1.52 113.475 -169.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.456 ' NE2' HG21 ' A' ' 115' ' ' VAL . 7.0 tp-100 -176.19 -47.17 0.01 OUTLIER 'General case' 0 C--N 1.341 0.233 0 N-CA-C 113.147 0.795 . . . . 3.6000000000000001 113.147 172.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.631 ' OG1' ' HB2' ' A' ' 81' ' ' TYR . 10.6 t -160.11 23.14 0.17 Allowed 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.136 -0.626 . . . . 1.48 111.766 -167.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -126.94 -14.01 2.86 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 118.655 -1.736 . . . . 1.46 114.479 -170.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.667 ' O ' HG22 ' A' ' 73' ' ' THR . 4.8 t70 -157.17 -33.65 0.08 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.384 0.611 . . . . 2.1899999999999999 110.726 -172.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.676 ' O ' ' HB3' ' A' ' 75' ' ' ASP . 2.0 ptp180 -52.3 -39.55 60.68 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.075 -0.966 . . . . 3.3799999999999999 111.693 -173.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.81 ' H ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -87.96 -5.26 10.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.841 -0.618 . . . . 0.70999999999999996 111.442 -175.492 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.667 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.3 t -88.63 -27.43 21.32 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 119.104 -1.038 . . . . 0.96999999999999997 109.418 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.993 ' HZ3' ' HB2' ' A' ' 198' ' ' ASN . 30.7 p-90 -112.32 -0.2 15.5 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.914 -0.585 . . . . 0.75 111.888 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.691 ' CG ' ' HB2' ' A' ' 78' ' ' LEU . 0.9 OUTLIER -68.07 176.96 2.4 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 114.107 1.151 . . . . 2.1899999999999999 114.107 -167.335 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.498 ' NZ ' ' HB2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -143.45 -4.41 0.88 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 113.708 -1.587 . . . . 3.1899999999999999 111.412 170.43 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.8 m -121.35 6.82 10.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.437 0.636 . . . . 1.5800000000000001 109.75 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.691 ' HB2' ' CG ' ' A' ' 75' ' ' ASP . 98.7 mt -118.52 -158.36 0.72 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.295 -0.866 . . . . 0.70999999999999996 110.323 -175.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.443 ' HB3' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -173.57 -58.99 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.871 0.367 . . . . 1.73 111.201 -173.428 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 96' ' ' THR . 39.9 t -145.42 139.41 21.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.307 -0.406 . . . . 0.78000000000000003 110.747 -169.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.727 ' HB3' HD12 ' A' ' 72' ' ' ILE . 44.4 p90 -104.89 152.79 22.2 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.899 -0.591 . . . . 5.4000000000000004 111.537 177.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.89 ' HB3' ' HB3' ' A' ' 95' ' ' HIS . 50.7 t-20 -160.09 104.72 1.51 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.477 -0.564 . . . . 1.6899999999999999 109.477 172.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.9 ttt -74.2 92.45 2.23 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.394 -0.965 . . . . 2.0499999999999998 108.394 176.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -77.12 -63.25 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.86 -0.609 . . . . 0.64000000000000001 111.571 -169.329 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.553 ' HB3' HD12 ' A' ' 93' ' ' ILE . 9.5 t60 -140.09 113.83 8.75 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.824 -0.436 . . . . 1.96 109.824 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.07 132.71 42.59 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.516 -0.92 . . . . 2.4399999999999999 108.516 175.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.663 HG21 ' HB2' ' A' ' 3' ' ' PHE . 0.1 OUTLIER -90.44 -48.84 14.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.148 0.499 . . . . 0.46999999999999997 111.181 -170.298 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.507 ' CG ' ' H ' ' A' ' 89' ' ' SER . 25.3 t70 -157.14 -148.37 0.21 Allowed 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.588 -0.893 . . . . 1.8600000000000001 108.588 -173.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.507 ' H ' ' CG ' ' A' ' 88' ' ' ASP . 47.6 t -59.26 -49.93 75.94 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.644 0.609 . . . . 1.4399999999999999 112.644 -170.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.721 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 17.7 m-20 -139.91 39.93 1.98 Allowed 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.837 0.827 . . . . 1.8700000000000001 108.895 -171.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.663 ' O ' HG12 ' A' ' 87' ' ' ILE . 1.7 m -135.08 113.21 11.19 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.356 -1.35 . . . . 0.46000000000000002 107.356 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.592 ' O ' HD12 ' A' ' 114' ' ' LEU . 25.8 m-85 -131.0 174.32 10.12 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.594 0.711 . . . . 0.42999999999999999 111.07 -173.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.553 HD12 ' HB3' ' A' ' 85' ' ' HIS . 29.9 mt -131.76 132.98 61.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 106.305 -1.739 . . . . 0.40999999999999998 106.305 165.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 34.2 t -122.35 135.6 54.74 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.064 -0.654 . . . . 2.0099999999999998 110.616 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.89 ' HB3' ' HB3' ' A' ' 82' ' ' ASN . 6.8 t-160 -99.66 80.7 2.39 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 124.37 1.044 . . . . 1.23 109.157 172.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.892 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 93.0 m -89.9 150.35 22.23 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 115.129 -0.941 . . . . 0.5 109.909 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.443 ' HB ' ' HB3' ' A' ' 79' ' ' GLN . 49.4 mm -101.48 131.16 49.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 108.618 -0.882 . . . . 1.03 108.618 167.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.623 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 17.2 m -110.5 126.45 54.39 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.857 -0.61 . . . . 1.3799999999999999 111.493 -171.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 . . . . . 0 C--N 1.323 -0.552 0 CA-C-O 121.247 0.546 . . . . 1.8200000000000001 110.405 177.265 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.504 ' CD1' HG22 ' A' ' 183' ' ' ILE . 3.4 mp . . . . . 0 N--CA 1.45 -0.447 0 N-CA-C 108.757 -0.831 . . . . 1.1200000000000001 108.757 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.3 m -76.96 160.03 77.27 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 109.927 -0.397 . . . . 1.3500000000000001 109.927 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.404 ' HB2' ' CD1' ' A' ' 143' ' ' TYR . 76.0 Cg_exo -49.59 145.31 17.27 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.446 2.097 . . . . 1.0700000000000001 111.249 174.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.771 ' CZ ' ' HA2' ' A' ' 146' ' ' GLY . 0.2 OUTLIER -107.44 141.44 38.84 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 119.803 -0.759 . . . . 3.4500000000000002 110.164 -170.102 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.615 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 12.0 t70 -94.69 115.16 27.2 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 107.81 -1.181 . . . . 1.3700000000000001 107.81 177.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.892 ' HB3' ' HB ' ' A' ' 96' ' ' THR . 63.9 t80 -97.87 108.92 21.74 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.789 -0.448 . . . . 2.4100000000000001 109.789 -168.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.622 ' CG2' ' HE1' ' A' ' 134' ' ' PHE . 13.5 mm -123.71 75.81 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 N-CA-C 108.811 -0.811 . . . . 0.42999999999999999 108.811 173.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.788 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 0.7 OUTLIER -109.41 124.78 51.57 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.466 -0.788 . . . . 1.8600000000000001 110.745 -177.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 1.007 HD23 ' HE2' ' A' ' 130' ' ' LYS . 8.9 tp -75.61 117.03 16.94 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 115.275 -0.875 . . . . 0.28000000000000003 109.275 171.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.495 HG23 ' HB ' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -118.41 123.97 72.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-N 114.484 -1.235 . . . . 0.26000000000000001 111.491 -164.402 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.888 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 35.9 t80 -109.93 121.69 45.82 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.585 -0.734 . . . . 2.5699999999999998 111.2 175.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.897 HG13 HG22 ' A' ' 127' ' ' ILE . 3.6 mp -87.39 99.42 8.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.505 -0.924 . . . . 0.89000000000000001 108.505 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.872 ' HD3' ' HE2' ' A' ' 116' ' ' TYR . 57.3 tptt -102.28 131.16 49.04 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.893 -1.049 . . . . 1.2 110.079 -174.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.433 ' HD2' ' C ' ' A' ' 119' ' ' ARG . 4.0 tpt180 -125.61 88.97 2.95 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 108.505 -0.924 . . . . 2.7999999999999998 108.505 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.651 ' CB ' ' HB3' ' A' ' 123' ' ' ASN . 53.9 m-85 -69.42 119.17 13.26 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.759 -1.11 . . . . 0.82999999999999996 108.359 172.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -33.53 95.89 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 125.024 1.453 . . . . 2.2799999999999998 112.955 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 53.95 42.05 69.45 Favored Glycine 0 CA--C 1.508 -0.38 0 CA-C-N 114.684 -1.144 . . . . 0.76000000000000001 112.041 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.651 ' HB3' ' CB ' ' A' ' 120' ' ' TYR . 3.3 t-20 -132.71 -49.76 0.9 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.922 -0.639 . . . . 1.6499999999999999 110.273 -175.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.443 ' CG ' ' HB ' ' A' ' 154' ' ' VAL . 3.9 tpp -158.37 144.31 16.99 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.637 -0.425 . . . . 1.1200000000000001 111.383 -178.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.402 ' OD1' ' HD3' ' A' ' 119' ' ' ARG . 0.7 OUTLIER -120.09 81.22 1.71 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.378 -0.971 . . . . 1.6200000000000001 108.378 172.336 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.745 HG23 ' HB3' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -109.01 146.26 14.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.212 -0.904 . . . . 0.29999999999999999 113.424 -170.541 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.897 HG22 HG13 ' A' ' 117' ' ' ILE . 4.6 pt -107.58 110.72 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.549 0.69 . . . . 0.58999999999999997 109.155 161.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.52 ' HB3' ' HA ' ' A' ' 11' ' ' ALA . 15.8 p -93.83 112.4 24.25 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.325 0.583 . . . . 1.1799999999999999 111.06 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.788 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 54.6 p -102.86 158.85 15.98 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.724 -0.671 . . . . 1.24 111.68 -171.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 1.007 ' HE2' HD23 ' A' ' 114' ' ' LEU . 4.5 mtmm -147.39 124.44 11.4 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 115.939 -0.573 . . . . 2.2599999999999998 109.457 175.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.401 ' HB3' ' H ' ' A' ' 148' ' ' ASN . 31.9 p -67.04 91.63 0.22 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.336 -0.987 . . . . 1.3899999999999999 108.336 174.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.93 133.84 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 CA-C-N 115.131 -0.94 . . . . 1.05 109.274 -163.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.447 ' HB2' HH22 ' A' ' 145' ' ' ARG . 9.2 t70 -94.51 73.4 3.77 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.479 -1.237 . . . . 2.1699999999999999 108.761 -167.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.745 ' O ' ' HB3' ' A' ' 137' ' ' TYR . 1.6 p90 -107.02 173.75 2.93 Favored Pre-proline 0 CA--C 1.554 1.101 0 CA-C-N 114.85 -1.068 . . . . 0.53000000000000003 110.709 -170.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.61 ' HB2' ' OE2' ' A' ' 136' ' ' GLU . 60.2 Cg_exo -53.13 -48.61 21.16 Favored 'Trans proline' 0 N--CA 1.486 1.079 0 C-N-CA 123.292 2.661 . . . . 1.28 116.438 -171.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.703 ' HG2' ' CE2' ' A' ' 134' ' ' PHE . 0.6 OUTLIER -79.43 -9.3 59.57 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 121.53 0.681 . . . . 3.5 111.595 -173.147 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.809 ' HE1' ' HG3' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -54.4 -38.98 71.64 Favored Pre-proline 0 CA--C 1.556 1.196 0 N-CA-C 116.888 2.181 . . . . 6.1200000000000001 116.888 -172.239 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.499 ' HD2' ' C ' ' A' ' 136' ' ' GLU . 34.2 Cg_exo -30.52 110.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 123.875 3.05 . . . . 1.77 115.901 -170.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.49 ' HG3' ' HB2' ' A' ' 145' ' ' ARG . 29.6 Cg_endo -89.88 -155.89 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 124.345 3.363 . . . . 1.25 112.308 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 38.8 m -148.47 143.92 27.05 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 108.727 -0.842 . . . . 1.6000000000000001 108.727 177.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.7 p -58.17 -17.57 19.64 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.568 1.322 . . . . 1.97 114.568 -167.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.416 HD22 ' HA ' ' A' ' 142' ' ' ASN . 8.1 m120 -83.11 -15.93 48.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.099 0.409 . . . . 2.1800000000000002 111.103 177.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.404 ' CD1' ' HB2' ' A' ' 108' ' ' PRO . 72.8 m-85 -126.11 108.75 11.64 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.255 -1.017 . . . . 1.23 108.255 175.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.684 HG23 ' HD2' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -82.91 111.73 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 C-N-CA 120.123 -0.631 . . . . 0.81999999999999995 109.395 -171.253 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.809 ' HG3' ' HE1' ' A' ' 137' ' ' TYR . 0.2 OUTLIER -41.36 113.91 0.45 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.939 0.4 . . . . 4.4199999999999999 110.632 171.003 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.771 ' HA2' ' CZ ' ' A' ' 109' ' ' ARG . . . -51.29 130.18 33.21 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.047 -0.978 . . . . 0.79000000000000004 112.478 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.909 ' HB3' ' HG3' ' A' ' 174' ' ' GLU . 0.2 OUTLIER -104.99 63.85 0.71 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.743 0.782 . . . . 4.4400000000000004 109.873 175.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.585 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 81.8 m-20 -86.88 108.28 18.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.156 -1.384 . . . . 1.6200000000000001 109.558 178.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -80.31 132.18 60.01 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 109.468 -0.567 . . . . 2.3199999999999998 109.468 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.524 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 51.9 Cg_exo -9.25 61.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.009 1 C-N-CA 126.828 5.019 . . . . 0.53000000000000003 115.628 -161.671 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . 0.715 ' HB3' ' O ' ' A' ' 170' ' ' PHE . 3.0 m -76.97 -174.75 3.24 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.931 -1.031 . . . . 1.5800000000000001 109.618 174.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.621 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -171.29 -163.94 26.14 Favored Glycine 0 N--CA 1.429 -1.784 0 C-N-CA 119.666 -1.254 . . . . 0.42999999999999999 111.828 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.476 ' HB3' ' CG1' ' A' ' 127' ' ' ILE . 52.9 t80 -161.92 79.18 0.54 Allowed 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.687 -1.227 . . . . 0.59999999999999998 107.687 -168.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.726 HG12 ' HB ' ' A' ' 126' ' ' ILE . 5.2 m -90.33 128.66 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-O 121.733 0.777 . . . . 0.31 110.422 -174.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 60.8 m -99.82 111.18 23.52 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.305 -0.998 . . . . 1.55 108.305 171.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.812 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 18.9 m -97.6 119.79 61.92 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 115.817 -0.629 . . . . 1.0600000000000001 111.378 -170.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.527 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 50.7 Cg_exo -55.28 111.87 0.88 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.454 2.103 . . . . 0.56000000000000005 111.074 170.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 74.3 mmm -74.99 -166.33 0.47 Allowed 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.373 0.606 . . . . 1.1599999999999999 111.634 -177.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.42 ' H ' ' HB3' ' A' ' 158' ' ' MET . 3.9 tp10 -70.97 -34.52 71.5 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.624 -0.88 . . . . 2.6299999999999999 108.624 174.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -102.06 30.34 4.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.371 -1.286 . . . . 2.0499999999999998 108.918 175.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.623 ' OD1' ' HD3' ' A' ' 162' ' ' PRO . 3.7 p30 -31.43 -48.86 0.42 Allowed Pre-proline 0 N--CA 1.475 0.815 0 N-CA-C 117.107 2.262 . . . . 1.9299999999999999 117.107 -168.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.623 ' HD3' ' OD1' ' A' ' 161' ' ' ASN . 71.6 Cg_endo -76.83 -9.93 18.27 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 CA-C-N 121.976 1.741 . . . . 0.72999999999999998 113.177 -175.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -116.47 -22.66 8.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.042 -0.526 . . . . 0.68000000000000005 110.801 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 55' ' ' PRO . 61.8 m-85 -136.25 121.39 19.0 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.357 -0.608 . . . . 0.93000000000000005 109.357 174.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 38.6 t -116.97 139.47 50.62 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.555 -0.458 . . . . 1.4099999999999999 110.439 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.877 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 2.3 tppp? -89.12 105.35 17.73 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.866 0.841 . . . . 0.73999999999999999 110.984 -177.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.588 HD23 HD13 ' A' ' 61' ' ' LEU . 0.9 OUTLIER -86.82 102.05 13.92 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.338 -0.846 . . . . 0.27000000000000002 108.905 178.409 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.691 HG12 ' HG3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -124.5 119.33 56.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.955 0.884 . . . . 0.28000000000000003 111.587 178.246 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 21.5 ttt -120.04 148.74 43.19 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.824 -1.08 . . . . 1.24 109.532 -175.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.715 ' O ' ' HB3' ' A' ' 151' ' ' CYS . 38.7 m-85 -127.09 135.06 50.24 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.336 -0.986 . . . . 3.3700000000000001 108.336 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.438 HG22 HG22 ' A' ' 173' ' ' THR . 7.8 p -126.69 118.58 51.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.682 0.753 . . . . 1.3999999999999999 110.965 177.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.01 63.7 0.7 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.443 -0.947 . . . . 2.1699999999999999 108.443 177.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 147' ' ' TYR . 3.8 t -98.24 154.18 17.97 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.767 -1.106 . . . . 1.6499999999999999 110.145 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.909 ' HG3' ' HB3' ' A' ' 147' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 112.45 0.537 . . . . 2.4500000000000002 112.45 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.598 ' HA ' ' HE3' ' A' ' 186' ' ' LYS . 8.2 mm . . . . . 0 CA--C 1.511 -0.555 0 CA-C-O 122.224 1.012 . . . . 1.1200000000000001 109.147 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 1.007 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.0 OUTLIER -74.96 -31.87 26.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 113.389 -1.732 . . . . 1.1299999999999999 110.741 -177.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.89 -19.94 58.45 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.218 -1.03 . . . . 2.8900000000000001 108.218 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.598 ' HE3' ' HA ' ' A' ' 183' ' ' ILE . 0.2 OUTLIER -91.89 -24.52 19.29 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.085 -1.416 . . . . 1.28 110.31 173.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 1.007 HG22 ' HA ' ' A' ' 184' ' ' ILE . 3.5 t -89.5 -41.14 12.21 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 119.975 -0.69 . . . . 0.62 112.763 -177.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . 0.907 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 21.7 mmt -80.67 -65.64 0.26 Allowed Pre-proline 0 N--CA 1.467 0.383 0 O-C-N 121.619 -0.676 . . . . 1.0600000000000001 112.108 -174.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.907 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 17.3 Cg_exo -65.63 -20.8 59.78 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.184 1.923 . . . . 0.91000000000000003 112.162 -173.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.441 ' HB3' ' O ' ' A' ' 186' ' ' LYS . 22.6 t -84.64 -36.28 22.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.989 -0.551 . . . . 1.5 110.187 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -79.98 -37.06 35.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.249 -0.432 . . . . 1.8799999999999999 111.579 -174.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.623 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 20.3 mt -67.07 -45.8 76.24 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 121.007 -0.277 . . . . 1.0900000000000001 111.516 -175.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.838 ' HB ' HD12 ' A' ' 33' ' ' ILE . 27.9 m -71.73 -24.12 22.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.1 -0.64 . . . . 0.68000000000000005 110.406 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.425 ' HB3' ' HE3' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -73.35 -32.83 64.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.869 -0.605 . . . . 2.0699999999999998 110.755 174.058 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.636 ' HA ' ' OD1' ' A' ' 198' ' ' ASN . 2.2 m-85 -65.1 -30.74 71.7 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.139 0.495 . . . . 2.0 110.319 174.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.502 HG12 HD12 ' A' ' 167' ' ' LEU . 60.4 mt -79.6 -24.58 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-O 121.365 0.603 . . . . 0.31 110.644 175.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 197' ' ' LEU . 34.2 mt -73.11 -42.82 62.51 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.274 -0.421 . . . . 1.03 110.827 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.993 ' HB2' ' HZ3' ' A' ' 74' ' ' TRP . 1.8 p-10 -67.43 -15.07 63.47 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.386 -0.926 . . . . 1.8999999999999999 109.469 171.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.691 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -80.81 -42.27 21.95 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 109.404 -0.591 . . . . 0.28999999999999998 109.404 173.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.545 ' HD3' HG12 ' A' ' 54' ' ' ILE . 28.1 mmtp -59.56 -44.69 93.2 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 121.553 0.692 . . . . 0.96999999999999997 110.013 173.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -80.48 -39.81 27.33 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.897 -1.047 . . . . 1.9399999999999999 110.984 -174.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -69.51 -31.2 70.92 Favored Glycine 0 CA--C 1.507 -0.464 0 C-N-CA 120.717 -0.754 . . . . 0.46999999999999997 111.395 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.999 HG12 ' HG3' ' A' ' 56' ' ' GLU . 1.5 tp -71.69 -34.57 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 120.574 0.226 . . . . 0.60999999999999999 110.449 177.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 66.4 mttm -86.12 -15.82 39.94 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-O 121.686 0.755 . . . . 3.3700000000000001 109.173 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.952 0 CA-C-N 115.283 -0.871 . . . . 1.02 108.681 165.658 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.626 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.7 OUTLIER . . . . . 0 CA--C 1.513 -0.459 0 N-CA-C 112.202 0.445 . . . . 2.25 112.202 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.693 ' HD2' HD22 ' A' ' 114' ' ' LEU . 91.3 m-85 -61.2 -26.42 67.71 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 116.033 -0.53 . . . . 0.42999999999999999 110.372 -170.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.541 ' HG2' ' HG3' ' A' ' 8' ' ' GLN . 45.8 tttt -73.05 -45.04 59.78 Favored 'General case' 0 N--CA 1.417 -2.099 0 N-CA-C 107.639 -1.245 . . . . 1.51 107.639 -177.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.49 -40.24 59.14 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.831 -0.622 . . . . 0.54000000000000004 111.307 176.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.626 HD12 ' O ' ' A' ' 2' ' ' ASP . 2.3 mp -81.18 -38.89 16.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.869 0.842 . . . . 1.0700000000000001 109.58 -174.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.84 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -75.36 -39.79 58.88 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.533 -1.212 . . . . 0.34000000000000002 111.805 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.541 ' HG3' ' HG2' ' A' ' 4' ' ' LYS . 44.7 mt-30 -63.01 -30.03 71.29 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.609 -1.178 . . . . 1.5900000000000001 109.688 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.622 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 79.6 mt-30 -79.35 -46.62 17.29 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.895 -1.048 . . . . 2.4700000000000002 108.671 171.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.736 HG21 ' HZ2' ' A' ' 130' ' ' LYS . 0.3 OUTLIER -60.17 -37.19 79.42 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.946 -1.024 . . . . 0.47999999999999998 112.59 -176.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.501 ' HA ' ' CB ' ' A' ' 128' ' ' SER . . . -51.72 -51.7 54.1 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-O 120.929 0.395 . . . . 0.31 111.494 178.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 20.8 pt20 -80.45 -10.58 59.74 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.191 -0.459 . . . . 1.6399999999999999 110.952 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.622 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 49.3 mt-10 -75.11 -50.66 15.65 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.381 0.61 . . . . 2.54 109.701 174.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.71 HG21 ' N ' ' A' ' 152' ' ' GLY . 11.2 p -71.96 -37.79 62.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 122.235 1.017 . . . . 0.53000000000000003 109.925 -177.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.477 HD12 ' SD ' ' A' ' 124' ' ' MET . 0.9 OUTLIER -72.05 -20.54 61.66 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 114.591 -1.186 . . . . 0.59999999999999998 109.199 173.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.455 ' HA2' ' NH1' ' A' ' 19' ' ' ARG . . . -66.16 -18.46 67.08 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 114.184 -1.371 . . . . 0.56999999999999995 110.21 172.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.618 ' CD2' ' HA ' ' A' ' 14' ' ' VAL . 33.5 m-85 -88.93 -26.49 21.53 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.249 -0.475 . . . . 3.27 109.919 177.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.568 ' HB2' ' HZ ' ' A' ' 170' ' ' PHE . 12.1 t-20 -71.44 -20.48 62.1 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 119.884 -0.726 . . . . 2.0299999999999998 109.775 173.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.455 ' NH1' ' HA2' ' A' ' 16' ' ' GLY . 20.1 mtp180 -97.89 -20.72 17.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.444 -0.798 . . . . 2.7200000000000002 110.383 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -115.51 103.0 10.31 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.401 -0.818 . . . . 2.1600000000000001 110.709 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.8 ' HB ' ' CH2' ' A' ' 24' ' ' TRP . 23.3 p -121.94 99.18 6.3 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.618 0.723 . . . . 1.8200000000000001 109.862 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.7 m -148.27 144.62 27.75 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.497 -0.774 . . . . 2.1899999999999999 111.149 -165.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.33 -45.31 3.02 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.793 -0.639 . . . . 1.1000000000000001 114.12 169.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.8 ' CH2' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -82.59 -157.22 0.2 Allowed 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 113.137 0.792 . . . . 1.6699999999999999 113.137 -172.386 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.987 ' HE3' ' HA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER 179.36 149.55 0.28 Allowed 'General case' 0 CA--C 1.494 -1.184 0 CA-C-N 115.161 -0.927 . . . . 2.9500000000000002 110.087 -165.099 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 3.3 m -60.16 124.97 15.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 114.397 -1.274 . . . . 1.5600000000000001 112.068 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.664 HG11 ' HE2' ' A' ' 48' ' ' TYR . 14.4 p -98.36 -25.46 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 114.262 -1.336 . . . . 1.22 108.22 174.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.486 ' HD2' ' HA ' ' A' ' 28' ' ' LYS . 20.8 tptt -154.68 149.39 26.52 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 119.672 -0.811 . . . . 2.4100000000000001 111.262 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.592 HG22 ' HA ' ' A' ' 34' ' ' THR . 34.4 p -145.36 151.63 38.59 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.715 -0.675 . . . . 1.3799999999999999 109.755 175.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.665 ' O ' ' HG2' ' A' ' 31' ' ' LYS . 42.3 m -128.59 44.97 2.86 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.851 0.357 . . . . 2.3700000000000001 110.489 175.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.665 ' HG2' ' O ' ' A' ' 30' ' ' SER . 0.1 OUTLIER 62.38 19.81 11.37 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.509 1.123 . . . . 4.5499999999999998 112.001 169.251 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.467 ' HD2' ' HA ' ' A' ' 32' ' ' LYS . 35.6 tptt -174.63 -20.93 0.01 OUTLIER 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.569 0.7 . . . . 1.4199999999999999 109.885 175.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.829 HG22 ' HA3' ' A' ' 52' ' ' GLY . 41.8 pt -117.64 156.32 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.805 -1.089 . . . . 0.76000000000000001 109.517 171.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.592 ' HA ' HG22 ' A' ' 29' ' ' THR . 88.4 m -151.54 115.33 4.91 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.648 -0.706 . . . . 0.57999999999999996 110.408 -164.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.663 HG12 HG12 ' A' ' 50' ' ' VAL . 6.3 m -113.12 118.13 57.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.106 0.479 . . . . 0.85999999999999999 112.009 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 2.7 p -101.15 128.48 47.22 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.552 -0.749 . . . . 1.1000000000000001 110.645 177.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.594 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 42.5 t -106.71 128.4 54.17 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.161 -0.927 . . . . 1.27 111.058 -171.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.459 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 21.9 ttpp . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 116.335 -0.393 . . . . 1.9099999999999999 111.015 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.418 ' HB2' ' CE1' ' A' ' 48' ' ' TYR . 18.0 m120 . . . . . 0 C--O 1.227 -0.113 0 N-CA-C 109.957 -0.386 . . . . 2.0499999999999998 109.957 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.56 HD23 ' N ' ' A' ' 48' ' ' TYR . 3.2 tt -98.59 135.27 40.36 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.25 -1.019 . . . . 0.87 108.25 177.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.664 ' HE2' HG11 ' A' ' 27' ' ' VAL . 60.1 m-85 -122.58 123.61 41.59 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.925 0.393 . . . . 0.98999999999999999 110.336 -173.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.593 ' HD3' ' CD2' ' A' ' 170' ' ' PHE . 0.0 OUTLIER -99.02 103.38 15.32 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.129 -0.693 . . . . 2.9199999999999999 109.129 178.361 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.729 HG22 ' HB3' ' A' ' 169' ' ' MET . 0.9 OUTLIER -85.92 150.13 4.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 108.745 -0.835 . . . . 1.3300000000000001 108.745 178.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.856 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 74.1 tt0 -158.76 108.1 1.96 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.103 0.477 . . . . 1.0700000000000001 110.0 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.829 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -145.33 145.08 13.95 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.846 -0.902 . . . . 0.28999999999999998 110.846 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 66.2 mt -89.07 126.41 42.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 117.623 0.711 . . . . 0.57999999999999996 111.249 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 55' ' ' PRO . 44.9 mt -106.65 110.27 63.64 Favored Pre-proline 0 N--CA 1.447 -0.607 0 CA-C-N 115.995 -0.548 . . . . 0.34999999999999998 109.797 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 54' ' ' ILE . 9.8 Cg_endo -52.1 66.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.477 0.511 1 C-N-CA 125.729 4.286 . . . . 0.62 113.598 174.574 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.627 ' HG2' HG13 ' A' ' 203' ' ' ILE . 10.1 tp10 -165.02 171.57 13.78 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.17 -1.048 . . . . 1.6799999999999999 108.17 174.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.45 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 83.6 p -80.5 141.32 52.53 Favored Pre-proline 0 N--CA 1.428 -1.56 0 CA-C-O 121.477 0.656 . . . . 1.1799999999999999 109.849 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.738 ' HA ' HD12 ' A' ' 61' ' ' LEU . 8.7 Cg_endo -51.7 -15.22 2.69 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 124.528 3.485 . . . . 0.52000000000000002 111.734 171.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.53 -44.75 41.95 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.464 -0.789 . . . . 0.64000000000000001 111.037 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.617 ' HE3' ' HA ' ' A' ' 60' ' ' LYS . 2.2 tpmt? -69.53 -30.64 68.52 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.028 -1.101 . . . . 3.2999999999999998 108.028 178.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.011 HD23 HD13 ' A' ' 203' ' ' ILE . 94.0 mt -61.88 -57.73 10.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.33 -1.305 . . . . 0.40999999999999998 110.73 175.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.482 ' HB3' ' HB3' ' A' ' 125' ' ' ASN . 17.4 p -64.73 -9.75 22.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.196 0.522 . . . . 1.29 110.507 176.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -89.24 -30.91 18.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.86 -0.609 . . . . 1.3200000000000001 111.957 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.705 ' HD2' ' CZ2' ' A' ' 74' ' ' TRP . 18.7 p90 -89.84 -43.4 10.65 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 120.152 -0.619 . . . . 0.60999999999999999 111.828 -172.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.685 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -90.77 5.54 47.89 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 120.371 -0.532 . . . . 1.5 112.061 -173.597 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.418 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 9.7 t80 -27.72 -69.58 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 O-C-N 124.743 1.277 . . . . 1.52 113.095 -167.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.483 ' HA ' ' CZ ' ' A' ' 71' ' ' ARG . 7.3 tt0 -175.1 -40.81 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 114.13 1.159 . . . . 3.6000000000000001 114.13 173.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.8 t -155.06 7.13 0.26 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.527 0.936 . . . . 1.48 113.527 -163.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -116.6 0.26 20.17 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 118.709 -1.71 . . . . 1.46 115.209 -169.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.635 ' O ' HG22 ' A' ' 73' ' ' THR . 38.2 t70 -178.15 -27.82 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.385 0.592 . . . . 2.1899999999999999 110.562 -177.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.648 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -55.29 -34.97 64.59 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 115.478 -0.783 . . . . 3.3799999999999999 111.302 -172.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.803 HG22 HD13 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -92.77 -7.78 10.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.744 -0.382 . . . . 0.70999999999999996 111.077 -175.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.635 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.3 t -88.19 -27.96 21.5 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 119.914 -0.714 . . . . 0.96999999999999997 109.743 -176.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.705 ' CZ2' ' HD2' ' A' ' 64' ' ' PHE . 29.4 p-90 -101.45 -8.88 21.59 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.168 -0.613 . . . . 0.75 111.282 177.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.704 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 27.6 t0 -87.36 159.3 18.78 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 114.286 1.217 . . . . 2.1899999999999999 114.286 -165.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.75 -26.17 14.43 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 112.637 -2.074 . . . . 3.1899999999999999 111.268 -176.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.2 m -105.83 -3.43 21.94 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.004 -0.739 . . . . 1.5800000000000001 109.004 -173.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.803 HD13 HG22 ' A' ' 72' ' ' ILE . 72.6 mt -110.47 159.17 17.74 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.902 -1.045 . . . . 0.70999999999999996 111.354 -174.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.554 ' CG ' ' HG3' ' A' ' 99' ' ' GLN . 9.8 mm-40 -138.9 -62.52 0.55 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.949 -1.023 . . . . 1.73 111.403 -176.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.545 HG23 ' HB3' ' A' ' 79' ' ' GLN . 23.6 t -140.48 124.72 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.439 -0.346 . . . . 0.78000000000000003 111.047 -167.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -95.5 148.61 22.31 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 122.984 0.514 . . . . 5.4000000000000004 110.987 175.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.744 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 18.2 m120 -156.91 108.1 2.38 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.651 -0.5 . . . . 1.6899999999999999 109.651 169.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.471 ' CG ' ' HD3' ' A' ' 86' ' ' ARG . 0.7 OUTLIER -66.82 103.58 1.15 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.953 -0.758 . . . . 2.0499999999999998 108.953 177.089 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.714 HG12 ' HG2' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -80.8 -82.15 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 121.167 0.508 . . . . 0.64000000000000001 110.513 -173.298 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.604 ' HB3' HD12 ' A' ' 93' ' ' ILE . 9.3 t60 -126.12 104.86 8.47 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.541 -0.754 . . . . 1.96 109.273 -172.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.471 ' HD3' ' CG ' ' A' ' 83' ' ' MET . 47.5 mtm180 -92.75 115.23 27.92 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.437 -0.579 . . . . 2.4399999999999999 109.437 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.609 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -80.21 -40.56 20.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.476 -0.784 . . . . 0.46999999999999997 110.925 -169.725 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.419 ' CG ' ' H ' ' A' ' 89' ' ' SER . 12.4 t70 -151.63 -162.73 1.59 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.012 -0.736 . . . . 1.8600000000000001 109.012 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.419 ' H ' ' CG ' ' A' ' 88' ' ' ASP . 34.1 t -76.23 -17.64 59.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 117.944 0.338 . . . . 1.4399999999999999 111.368 -174.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.2 p30 -136.08 17.2 3.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.825 0.345 . . . . 1.8700000000000001 110.792 -175.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.609 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -129.77 107.07 9.13 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.365 -0.976 . . . . 0.46000000000000002 108.365 -178.383 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.605 ' O ' HD12 ' A' ' 114' ' ' LEU . 27.2 m-85 -125.44 170.92 10.91 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.314 0.578 . . . . 0.42999999999999999 111.135 -172.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.667 ' O ' HG23 ' A' ' 84' ' ' VAL . 16.9 mt -137.36 121.56 23.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 107.409 -1.33 . . . . 0.40999999999999998 107.409 170.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 14.3 t -111.92 127.84 55.97 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.244 0.545 . . . . 2.0099999999999998 111.26 -176.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.744 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 26.0 t60 -81.66 83.11 7.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.753 0.787 . . . . 1.23 109.01 169.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 20.0 m -94.03 113.1 25.01 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.579 -1.191 . . . . 0.5 111.342 -177.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.433 ' CG1' ' HB ' ' A' ' 80' ' ' VAL . 43.4 mm -77.02 120.9 28.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 108.63 -0.878 . . . . 1.03 108.63 171.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.1 m -110.98 128.99 56.02 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.023 -0.99 . . . . 1.3799999999999999 111.217 -171.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.554 ' HG3' ' CG ' ' A' ' 79' ' ' GLN . 22.4 mt-30 . . . . . 0 C--N 1.316 -0.886 0 CA-C-N 115.985 -0.552 . . . . 1.8200000000000001 110.644 177.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.429 HG23 ' NH2' ' A' ' 109' ' ' ARG . 77.3 mt . . . . . 0 C--O 1.233 0.212 0 CA-C-O 121.065 0.46 . . . . 1.1200000000000001 112.013 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.4 m -100.34 166.44 12.64 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 108.526 -0.916 . . . . 1.3500000000000001 108.526 170.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -46.32 125.31 8.78 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.035 1.823 . . . . 1.0700000000000001 110.893 173.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.604 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 29.5 ttm180 -102.65 151.99 21.71 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 120.042 -0.663 . . . . 3.4500000000000002 110.141 -167.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.703 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 20.8 t0 -113.01 127.23 56.17 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.736 -0.666 . . . . 1.3700000000000001 109.344 -171.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.427 ' HB2' ' O ' ' A' ' 96' ' ' THR . 3.5 m-30 -113.43 134.13 54.82 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.537 0.684 . . . . 2.4100000000000001 111.305 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 1.081 HG12 ' HD2' ' A' ' 145' ' ' ARG . 35.2 mm -124.36 76.39 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 107.105 -1.443 . . . . 0.42999999999999999 107.105 167.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.541 ' O ' HG12 ' A' ' 115' ' ' VAL . 7.1 p-10 -85.88 115.75 23.7 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.116 -0.947 . . . . 1.8600000000000001 109.994 -176.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 1.078 HD23 ' HE2' ' A' ' 130' ' ' LYS . 11.2 tp -80.65 111.58 17.21 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-O 121.914 0.864 . . . . 0.28000000000000003 109.08 169.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.541 HG12 ' O ' ' A' ' 113' ' ' ASP . 0.1 OUTLIER -119.09 125.31 74.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-N 113.841 -1.527 . . . . 0.26000000000000001 111.544 -163.303 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.84 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 11.5 t80 -104.83 112.71 25.92 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 115.114 -0.948 . . . . 2.5699999999999998 110.054 172.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.825 HG12 HG22 ' A' ' 127' ' ' ILE . 73.7 mt -94.14 99.57 9.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.639 -0.71 . . . . 0.89000000000000001 109.607 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.522 ' HD2' ' CZ ' ' A' ' 120' ' ' TYR . 35.9 ttmt -118.14 141.02 48.93 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.931 -0.577 . . . . 1.2 109.872 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.481 ' HD2' ' O ' ' A' ' 119' ' ' ARG . 7.9 tmm_? -118.75 98.08 6.04 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.966 -0.753 . . . . 2.7999999999999998 108.966 177.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.59 ' CB ' ' HB3' ' A' ' 123' ' ' ASN . 96.5 m-85 -64.66 114.05 4.15 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.631 -1.248 . . . . 0.82999999999999996 107.631 172.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -37.21 99.07 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 O-C-N 124.572 1.17 . . . . 2.2799999999999998 112.688 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 56.59 34.12 63.71 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 114.159 -1.382 . . . . 0.76000000000000001 112.708 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.59 ' HB3' ' CB ' ' A' ' 120' ' ' TYR . 4.6 t-20 -127.48 -49.1 1.41 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.174 -0.513 . . . . 1.6499999999999999 110.266 -177.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.579 ' HG2' ' HB ' ' A' ' 154' ' ' VAL . 3.9 ttm -163.08 133.76 4.65 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 120.323 -0.551 . . . . 1.1200000000000001 112.127 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.568 ' ND2' ' HB2' ' A' ' 58' ' ' PRO . 29.1 m-80 -104.63 78.97 1.5 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.23 -1.026 . . . . 1.6200000000000001 108.23 174.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.65 ' CG1' HG12 ' A' ' 154' ' ' VAL . 0.5 OUTLIER -103.91 139.77 23.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 113.387 0.884 . . . . 0.29999999999999999 113.387 -169.21 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.825 HG22 HG12 ' A' ' 117' ' ' ILE . 25.7 pt -108.84 111.42 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 108.907 -0.775 . . . . 0.58999999999999997 108.907 163.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.52 ' OG ' ' HB3' ' A' ' 116' ' ' TYR . 13.4 p -97.29 109.4 22.16 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.46 0.647 . . . . 1.1799999999999999 110.957 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.604 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 5.5 p -113.55 155.8 24.75 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.817 -0.628 . . . . 1.24 111.86 -168.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 1.078 ' HE2' HD23 ' A' ' 114' ' ' LEU . 14.8 mtmm -140.74 134.18 29.91 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 108.132 -1.062 . . . . 2.2599999999999998 108.132 173.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.457 ' HB3' ' H ' ' A' ' 148' ' ' ASN . 41.1 p -69.79 96.33 0.98 Allowed 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.955 -1.128 . . . . 1.3899999999999999 107.955 174.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.453 HG11 ' HE2' ' A' ' 3' ' ' PHE . 2.3 t -107.56 124.01 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 CA-C-N 114.534 -1.212 . . . . 1.05 110.788 -163.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -98.19 48.68 1.0 Allowed 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 113.264 -1.789 . . . . 2.1699999999999999 109.735 -165.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.813 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 1.5 p90 -81.68 159.14 67.21 Favored Pre-proline 0 C--N 1.313 -0.983 0 CA-C-N 113.343 -1.753 . . . . 0.53000000000000003 110.549 -171.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.484 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 1.9 Cg_endo -47.84 -42.1 31.28 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.672 2.915 . . . . 1.28 115.709 -172.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.813 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 18.0 tt0 -70.27 -11.82 61.17 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 111.824 0.305 . . . . 3.5 111.824 -162.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.516 ' HB2' HG11 ' A' ' 84' ' ' VAL . 0.7 OUTLIER -157.3 99.74 1.93 Allowed Pre-proline 0 C--N 1.321 -0.654 0 C-N-CA 119.407 -0.917 . . . . 6.1200000000000001 113.406 177.317 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -90.23 160.93 4.69 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.003 3.135 . . . . 1.77 111.42 171.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.529 ' HB3' ' HB2' ' A' ' 145' ' ' ARG . 87.3 Cg_endo -94.58 -161.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.91 2.407 . . . . 1.25 113.361 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.5 t -148.52 -157.47 0.82 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.585 -0.895 . . . . 1.6000000000000001 108.585 -178.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.1 p -89.98 -36.72 14.8 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.617 -0.433 . . . . 1.97 111.397 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.31 -35.59 58.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.9 0.381 . . . . 2.1800000000000002 110.171 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.703 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 99.2 m-85 -107.71 111.39 23.56 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 109.497 -0.557 . . . . 1.23 109.497 -178.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.604 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 1.1 tp -98.38 112.88 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 N-CA-C 108.87 -0.789 . . . . 0.81999999999999995 108.87 -176.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 1.081 ' HD2' HG12 ' A' ' 112' ' ' ILE . 2.6 tpp85 -60.16 97.44 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.323 -0.992 . . . . 4.4199999999999999 108.323 173.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -64.38 133.8 38.98 Favored Glycine 0 CA--C 1.503 -0.683 0 CA-C-N 115.575 -0.739 . . . . 0.79000000000000004 112.288 -171.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.47 ' HB2' ' HG2' ' A' ' 174' ' ' GLU . 2.6 m-85 -83.74 79.25 9.52 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 122.308 1.052 . . . . 4.4400000000000004 112.115 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.482 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 5.8 t30 -80.74 83.34 6.52 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 113.45 -1.705 . . . . 1.6200000000000001 108.407 167.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.513 ' HB3' ' HD2' ' A' ' 150' ' ' PRO . 96.6 m-70 -49.63 161.3 0.52 Allowed Pre-proline 0 C--O 1.219 -0.534 0 CA-C-O 118.628 -0.701 . . . . 2.3199999999999998 109.755 175.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 149' ' ' HIS . 5.7 Cg_endo -47.5 75.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 124.276 3.318 . . . . 0.53000000000000003 114.135 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 170' ' ' PHE . 25.4 p -138.61 167.61 21.57 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.057 -1.46 . . . . 1.5800000000000001 107.057 175.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.71 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -153.69 -138.74 2.72 Favored Glycine 0 N--CA 1.433 -1.562 0 C-N-CA 118.733 -1.699 . . . . 0.42999999999999999 113.51 -167.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.464 ' HB3' ' CG1' ' A' ' 127' ' ' ILE . 63.3 t80 -163.06 93.19 0.79 Allowed 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 107.949 -1.13 . . . . 0.59999999999999998 107.949 -163.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.729 HG23 HG13 ' A' ' 168' ' ' VAL . 7.7 m -102.81 138.29 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-O 121.88 0.848 . . . . 0.31 110.653 -176.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 125' ' ' ASN . 71.4 m -112.13 110.56 20.9 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.252 -0.885 . . . . 1.55 109.296 175.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.777 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 16.4 m -101.38 122.21 48.9 Favored Pre-proline 0 C--N 1.318 -0.766 0 C-N-CA 120.602 -0.439 . . . . 1.0600000000000001 111.256 -169.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.52 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 51.4 Cg_exo -55.49 115.06 2.18 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.12 1.88 . . . . 0.56000000000000005 110.689 170.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.524 ' SD ' ' HB2' ' A' ' 166' ' ' LYS . 74.6 mmm -75.08 -172.11 1.57 Allowed 'General case' 0 CA--C 1.505 -0.763 0 C-N-CA 120.765 -0.374 . . . . 1.1599999999999999 110.75 -177.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -69.85 -31.64 69.6 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 108.537 -0.912 . . . . 2.6299999999999999 108.537 170.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 2.6 mm-40 -98.3 27.85 4.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.928 -1.033 . . . . 2.0499999999999998 108.79 175.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.576 ' OD1' ' HD3' ' A' ' 162' ' ' PRO . 5.5 p30 -36.52 -47.37 1.6 Allowed Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 116.226 1.936 . . . . 1.9299999999999999 116.226 -166.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.576 ' HD3' ' OD1' ' A' ' 161' ' ' ASN . 72.8 Cg_endo -75.54 -14.57 19.96 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 CA-C-N 121.621 1.615 . . . . 0.72999999999999998 113.208 -175.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -111.62 -27.31 8.61 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.001 0.429 . . . . 0.68000000000000005 110.657 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.583 ' HB2' ' HB2' ' A' ' 160' ' ' GLU . 66.4 m-85 -140.65 131.77 26.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.512 -0.767 . . . . 0.93000000000000005 109.546 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.66 ' HB2' ' HD3' ' A' ' 58' ' ' PRO . 17.5 t -126.99 152.92 46.57 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.843 -0.743 . . . . 1.4099999999999999 111.125 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.856 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.8 tppp? -91.69 104.35 16.83 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.51 -0.768 . . . . 0.73999999999999999 111.509 -176.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.605 HD12 HG12 ' A' ' 196' ' ' ILE . 0.7 OUTLIER -84.8 100.91 11.85 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.066 -0.97 . . . . 0.27000000000000002 108.883 174.514 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.761 HG12 ' HG3' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -124.5 128.92 73.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.667 0.746 . . . . 0.28000000000000003 110.8 178.025 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.729 ' HB3' HG22 ' A' ' 50' ' ' VAL . 25.2 ttt -132.51 162.49 31.1 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.858 -0.793 . . . . 1.24 108.858 -171.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.655 ' HE1' HG13 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -139.51 108.24 5.94 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.323 -1.362 . . . . 3.3700000000000001 107.323 -173.468 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.447 HG13 ' OG1' ' A' ' 173' ' ' THR . 30.6 t -106.45 98.3 6.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 124.044 0.84 . . . . 1.3999999999999999 109.878 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.496 ' HB2' ' HG ' ' A' ' 47' ' ' LEU . 49.9 tt0 -100.1 11.98 38.04 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 106.909 -1.515 . . . . 2.1699999999999999 106.909 173.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 1.1 m -61.09 127.29 30.79 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.207 -1.815 . . . . 1.6499999999999999 110.534 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.47 ' HG2' ' HB2' ' A' ' 147' ' ' TYR . 13.0 pt-20 . . . . . 0 CA--C 1.514 -0.431 0 N-CA-C 108.375 -0.972 . . . . 2.4500000000000002 108.375 175.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.423 ' HA ' ' HE2' ' A' ' 186' ' ' LYS . 31.2 mm . . . . . 0 CA--C 1.515 -0.401 0 CA-C-O 122.467 1.127 . . . . 1.1200000000000001 108.9 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.992 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.2 mp -68.05 -36.87 77.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 113.073 -1.876 . . . . 1.1299999999999999 111.555 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -63.94 -17.98 63.8 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.112 -0.699 . . . . 2.8900000000000001 109.112 177.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.423 ' HE2' ' HA ' ' A' ' 183' ' ' ILE . 51.4 mtmt -93.04 -45.28 7.99 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.381 -0.827 . . . . 1.28 109.919 172.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.992 HG22 ' HA ' ' A' ' 184' ' ' ILE . 6.8 t -63.58 -30.23 71.38 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.329 0.492 . . . . 0.62 112.329 -169.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . 0.712 ' O ' ' HG ' ' A' ' 192' ' ' LEU . 0.2 OUTLIER -75.13 -63.39 0.72 Allowed Pre-proline 0 C--N 1.33 -0.244 0 C-N-CA 120.956 -0.298 . . . . 1.0600000000000001 110.877 179.524 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.515 ' HD3' ' CB ' ' A' ' 188' ' ' MET . 32.2 Cg_exo -59.03 -33.62 98.77 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.275 1.984 . . . . 0.91000000000000003 112.367 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.708 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 9.3 t -71.21 -22.61 61.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.825 0.345 . . . . 1.5 110.407 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -91.83 -43.68 9.38 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.031 -0.532 . . . . 1.8799999999999999 110.733 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.712 ' HG ' ' O ' ' A' ' 188' ' ' MET . 51.7 mt -53.11 -59.39 4.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.575 -0.739 . . . . 1.0900000000000001 111.703 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.477 ' O ' ' HG ' ' A' ' 197' ' ' LEU . 1.1 m -73.91 -30.57 28.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.089 -0.96 . . . . 0.68000000000000005 109.345 -171.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.708 ' HB2' ' O ' ' A' ' 190' ' ' SER . 1.0 OUTLIER -67.79 -44.15 78.06 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 114.04 -1.436 . . . . 2.0699999999999998 110.315 179.128 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.592 ' O ' ' HB2' ' A' ' 198' ' ' ASN . 0.9 OUTLIER -59.91 -27.42 66.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.045 0.45 . . . . 2.0 110.728 176.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.702 HG21 HG21 ' A' ' 33' ' ' ILE . 33.7 mt -79.27 -31.03 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 120.983 0.42 . . . . 0.31 111.286 173.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 94.7 mt -75.68 -30.7 59.45 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.235 0.54 . . . . 1.03 110.026 176.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.592 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 7.6 m-20 -47.22 -47.43 24.45 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.712 -1.131 . . . . 1.8999999999999999 107.967 162.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.655 ' HA ' ' CE2' ' A' ' 64' ' ' PHE . . . -77.54 -44.84 27.27 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 115.005 -0.998 . . . . 0.28999999999999998 111.292 -173.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 31.5 mmtp -54.63 -41.84 70.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.527 0.679 . . . . 0.96999999999999997 110.696 175.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . 0.538 ' HA ' ' HE3' ' A' ' 204' ' ' LYS . 2.2 t70 -84.37 -47.62 10.52 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.969 -1.014 . . . . 1.9399999999999999 110.094 -175.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . 0.501 ' HA2' ' HB3' ' A' ' 205' ' ' ALA . . . -63.25 -29.33 74.14 Favored Glycine 0 N--CA 1.459 0.232 0 C-N-CA 120.726 -0.749 . . . . 0.46999999999999997 112.489 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 1.011 HD13 HD23 ' A' ' 61' ' ' LEU . 3.0 tp -69.79 -38.58 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-O 120.848 0.356 . . . . 0.60999999999999999 110.453 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.538 ' HE3' ' HA ' ' A' ' 201' ' ' ASP . 0.0 OUTLIER -90.59 -17.16 27.41 Favored 'General case' 0 C--O 1.207 -1.169 0 N-CA-C 109.284 -0.635 . . . . 3.3700000000000001 109.284 177.291 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.501 ' HB3' ' HA2' ' A' ' 202' ' ' GLY . . . . . . . . 0 C--N 1.318 -0.79 0 N-CA-C 109.171 -0.677 . . . . 1.02 109.171 168.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.469 ' O ' HD12 ' A' ' 6' ' ' ILE . 15.2 t70 . . . . . 0 CA--C 1.509 -0.621 0 N-CA-C 109.313 -0.625 . . . . 2.25 109.313 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.536 ' HA ' HD12 ' A' ' 6' ' ' ILE . 70.5 m-85 -59.55 -34.82 73.16 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.667 0.746 . . . . 0.42999999999999999 109.598 -177.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.502 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 45.1 tttt -70.48 -42.47 71.37 Favored 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 114.644 -1.162 . . . . 1.51 108.085 -178.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.89 -41.9 62.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.844 -0.617 . . . . 0.54000000000000004 111.616 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.677 ' O ' ' HB ' ' A' ' 10' ' ' THR . 1.3 mp -79.26 -48.15 21.57 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 N-CA-C 108.714 -0.847 . . . . 1.0700000000000001 108.714 -175.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.968 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -57.54 -47.42 82.06 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.779 -1.1 . . . . 0.34000000000000002 111.974 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.502 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 13.1 mt-30 -60.34 -36.22 77.48 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 113.889 -1.505 . . . . 1.5900000000000001 111.631 -176.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.27 -18.16 26.13 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.396 -0.82 . . . . 2.4700000000000002 109.506 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.677 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -83.18 -38.6 22.11 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.19 -0.914 . . . . 0.47999999999999998 111.233 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.429 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -49.54 -59.89 3.35 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-O 121.218 0.532 . . . . 0.31 110.81 176.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -67.4 -11.54 58.0 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.284 -0.871 . . . . 1.6399999999999999 111.787 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.62 ' HB3' ' HA ' ' A' ' 10' ' ' THR . 0.6 OUTLIER -87.3 -42.11 13.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 110.267 -0.272 . . . . 2.54 110.267 -179.164 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.783 HG11 ' HA3' ' A' ' 152' ' ' GLY . 0.4 OUTLIER -75.48 -34.16 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 122.305 1.05 . . . . 0.53000000000000003 108.539 177.617 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.547 HD11 ' SD ' ' A' ' 124' ' ' MET . 0.6 OUTLIER -68.39 -29.29 67.95 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 114.32 -1.309 . . . . 0.59999999999999998 108.379 172.305 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 20' ' ' ASP . . . -64.99 -17.93 63.91 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 113.571 -1.65 . . . . 0.56999999999999995 110.706 177.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.636 ' CD2' ' HA ' ' A' ' 14' ' ' VAL . 23.6 m-85 -84.6 -26.25 28.04 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 109.427 -0.583 . . . . 3.27 109.427 176.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.501 ' HB2' ' CZ ' ' A' ' 170' ' ' PHE . 2.6 t30 -72.09 -15.75 62.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.768 -0.651 . . . . 2.0299999999999998 110.086 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -116.31 10.97 14.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.456 -0.793 . . . . 2.7200000000000002 110.467 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.502 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 27.5 t70 -111.36 107.22 16.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.943 -0.571 . . . . 2.1600000000000001 110.684 -176.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.514 HG22 ' CZ2' ' A' ' 24' ' ' TRP . 53.3 p -125.87 112.75 16.35 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.624 0.25 . . . . 1.8200000000000001 110.642 -176.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.2 p -177.5 117.65 0.1 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.861 -0.609 . . . . 2.1899999999999999 111.817 -168.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.3 33.89 82.46 Favored Glycine 0 C--O 1.23 -0.144 0 C-N-CA 121.337 -0.458 . . . . 1.1000000000000001 113.404 173.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.514 ' CZ2' HG22 ' A' ' 21' ' ' THR . 0.1 OUTLIER -119.97 -168.28 1.58 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.289 -0.634 . . . . 1.6699999999999999 109.289 177.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 36' ' ' SER . 8.0 mtmm -174.95 156.42 2.2 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 107.999 -1.111 . . . . 2.9500000000000002 107.999 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 2.3 p -78.46 119.64 27.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-O 121.817 0.817 . . . . 1.5600000000000001 109.25 175.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 35' ' ' VAL . 8.2 p -86.61 -24.76 6.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 114.845 -1.07 . . . . 1.22 109.382 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 28' ' ' LYS . 9.1 tppt? -172.31 150.73 2.41 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.634 0.605 . . . . 2.4100000000000001 112.634 -176.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.706 HG22 ' HA ' ' A' ' 34' ' ' THR . 69.3 p -134.43 148.42 50.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.553 -0.749 . . . . 1.3799999999999999 109.682 173.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.524 ' H ' ' HB ' ' A' ' 33' ' ' ILE . 50.3 m -152.78 84.1 1.23 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.557 0.577 . . . . 2.3700000000000001 112.557 177.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 30' ' ' SER . 3.2 mptp? 79.66 71.31 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.942 0.497 . . . . 4.5499999999999998 111.365 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.483 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 65.2 mttm 73.26 20.87 3.19 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.299 -0.864 . . . . 1.4199999999999999 111.724 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.527 HD12 ' HB ' ' A' ' 193' ' ' VAL . 2.5 mt -108.44 166.78 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.942 0 CA-C-O 121.149 0.499 . . . . 0.76000000000000001 110.771 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.706 ' HA ' HG22 ' A' ' 29' ' ' THR . 48.7 m -158.43 102.54 1.74 Allowed 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.589 -1.187 . . . . 0.57999999999999996 109.304 176.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.491 ' O ' HG12 ' A' ' 27' ' ' VAL . 21.8 t -96.3 103.1 14.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.993 -0.549 . . . . 0.85999999999999999 109.537 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 81.0 p -96.22 123.49 39.87 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.502 0.667 . . . . 1.1000000000000001 110.911 -178.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.0 p -94.36 127.85 40.5 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.762 -1.108 . . . . 1.27 110.898 -176.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt . . . . . 0 C--N 1.32 -0.706 0 CA-C-N 115.624 -0.716 . . . . 1.9099999999999999 110.028 175.664 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.9 m120 . . . . . 0 N--CA 1.445 -0.698 0 CA-C-O 121.024 0.44 . . . . 2.0499999999999998 110.887 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 171' ' ' VAL . 8.4 tt -87.76 140.75 29.19 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.468 -0.938 . . . . 0.87 108.468 173.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.413 ' HB2' HD11 ' A' ' 192' ' ' LEU . 68.7 m-85 -121.52 118.49 29.43 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.658 -0.417 . . . . 0.98999999999999999 110.42 -177.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 49' ' ' ARG . 37.1 ttt-85 -97.5 112.08 24.08 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.121 -0.696 . . . . 2.9199999999999999 109.121 176.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.65 HG13 ' HB3' ' A' ' 169' ' ' MET . 0.9 OUTLIER -107.24 119.56 57.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.907 -0.588 . . . . 1.3300000000000001 109.97 -172.848 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.564 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 35.9 tt0 -134.5 117.15 15.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.028 -0.533 . . . . 1.0700000000000001 111.296 -166.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 32' ' ' LYS . . . -145.66 144.75 13.37 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 121.05 -0.595 . . . . 0.28999999999999998 111.643 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 78.9 mt -86.09 131.5 34.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 117.249 0.525 . . . . 0.57999999999999996 111.175 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.447 HD13 ' HB1' ' A' ' 199' ' ' ALA . 55.5 mt -110.46 108.24 58.37 Favored Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-N 115.493 -0.776 . . . . 0.34999999999999998 109.034 176.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 164' ' ' TYR . 38.8 Cg_exo -62.37 56.12 0.13 Allowed 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 124.422 3.415 . . . . 0.62 115.393 -173.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.437 ' HB2' ' H ' ' A' ' 57' ' ' SER . 0.9 OUTLIER -164.35 -162.97 0.71 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.876 -0.416 . . . . 1.6799999999999999 109.876 167.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.437 ' H ' ' HB2' ' A' ' 56' ' ' GLU . 78.2 p -77.45 138.12 63.6 Favored Pre-proline 0 N--CA 1.431 -1.424 0 CA-C-O 121.918 0.866 . . . . 1.1799999999999999 112.135 -168.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.57 ' HA ' HD12 ' A' ' 61' ' ' LEU . 18.1 Cg_exo -62.44 -13.6 34.03 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.504 2.802 . . . . 0.52000000000000002 109.899 172.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.46 -53.38 19.51 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.194 -1.366 . . . . 0.64000000000000001 110.964 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.422 ' HB3' ' HE2' ' A' ' 60' ' ' LYS . 15.1 ttpt -68.62 -27.55 66.12 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.244 -1.021 . . . . 3.2999999999999998 108.244 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.983 HD23 HD13 ' A' ' 203' ' ' ILE . 28.9 mt -56.99 -60.45 3.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.159 -0.928 . . . . 0.40999999999999998 110.409 170.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.8 p -62.57 -15.9 53.5 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 121.81 -0.556 . . . . 1.29 110.839 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -92.36 -26.73 17.94 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.048 0.758 . . . . 1.3200000000000001 113.048 -176.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.64 ' CE2' ' HA ' ' A' ' 199' ' ' ALA . 6.5 p90 -89.2 -41.48 12.21 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.731 -0.606 . . . . 0.60999999999999999 110.866 -174.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.712 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -92.93 7.92 41.94 Favored 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 120.761 -0.376 . . . . 1.5 110.02 -179.286 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -44.55 -71.53 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.214 -0.903 . . . . 1.52 112.452 -168.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -139.7 -74.42 0.36 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.204 -0.598 . . . . 3.6000000000000001 112.522 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.711 ' HB ' ' CD1' ' A' ' 81' ' ' TYR . 9.0 t -156.77 30.92 0.31 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.753 0.787 . . . . 1.48 110.695 -168.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.0 -46.96 4.02 Favored Glycine 0 CA--C 1.49 -1.487 0 C-N-CA 120.01 -1.091 . . . . 1.46 112.636 -173.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.478 ' O ' HG22 ' A' ' 73' ' ' THR . 19.3 p-10 -152.6 -18.18 0.16 Allowed 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.151 -1.025 . . . . 2.1899999999999999 110.795 -171.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.708 ' HA ' ' CZ2' ' A' ' 74' ' ' TRP . 2.7 ptp180 -48.89 -39.36 25.62 Favored 'General case' 0 C--O 1.218 -0.589 0 C-N-CA 122.759 0.423 . . . . 3.3799999999999999 110.572 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.636 HD13 ' H ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -88.58 -7.91 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 C-N-CA 120.569 -0.453 . . . . 0.70999999999999996 111.242 -175.643 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 70' ' ' ASP . 0.8 OUTLIER -97.0 -32.76 11.84 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 119.791 -0.763 . . . . 0.96999999999999997 111.135 -173.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.708 ' CZ2' ' HA ' ' A' ' 71' ' ' ARG . 7.8 p-90 -101.63 -3.49 28.23 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.55 -0.46 . . . . 0.75 111.283 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.696 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 4.8 t70 -65.06 -178.64 0.47 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.869 0.842 . . . . 2.1899999999999999 112.356 -172.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.688 ' HG2' ' OD1' ' A' ' 198' ' ' ASN . 66.8 mmtt -104.56 -33.26 8.6 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.793 -1.094 . . . . 3.1899999999999999 108.852 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.513 ' HA ' ' HB2' ' A' ' 99' ' ' GLN . 16.8 m -134.61 19.52 3.59 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.344 -0.844 . . . . 1.5800000000000001 112.203 -170.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.583 HD13 HG22 ' A' ' 72' ' ' ILE . 27.7 mt -108.17 153.42 23.2 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.026 0.441 . . . . 0.70999999999999996 110.508 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.51 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 26.1 mm-40 -134.28 -67.0 0.59 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.671 -0.695 . . . . 1.73 110.606 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 96' ' ' THR . 2.4 t -136.73 112.01 11.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.674 -0.694 . . . . 0.78000000000000003 110.847 -170.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.711 ' CD1' ' HB ' ' A' ' 68' ' ' THR . 18.0 t80 -98.92 137.79 36.98 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.013 -0.736 . . . . 5.4000000000000004 109.013 175.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -143.16 107.44 4.76 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.442 -0.577 . . . . 1.6899999999999999 109.442 -175.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.487 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 2.8 mtm -66.77 102.25 0.92 Allowed 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.996 -0.742 . . . . 2.0499999999999998 108.996 174.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.545 HG11 ' HZ ' ' A' ' 134' ' ' PHE . 0.3 OUTLIER -72.9 -71.01 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.919 -0.582 . . . . 0.64000000000000001 110.843 -170.075 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -133.19 118.66 18.9 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.677 -0.861 . . . . 1.96 108.677 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.487 ' HD3' ' SD ' ' A' ' 83' ' ' MET . 44.0 mtm180 -93.89 105.27 17.29 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.126 0.489 . . . . 2.4399999999999999 109.965 -175.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.646 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -69.08 -44.45 81.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.355 -0.839 . . . . 0.46999999999999997 110.945 -175.323 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.456 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 15.0 t70 -147.9 168.0 23.37 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.928 -1.033 . . . . 1.8600000000000001 108.253 -173.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.2 m -68.05 -3.67 10.96 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.594 0.235 . . . . 1.4399999999999999 111.112 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -130.77 4.52 4.56 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 110.177 -0.305 . . . . 1.8700000000000001 110.177 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.646 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -133.3 108.79 8.95 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 109.114 -0.698 . . . . 0.46000000000000002 109.114 -172.433 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.65 ' O ' HD12 ' A' ' 114' ' ' LEU . 17.1 m-85 -125.38 174.74 7.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.876 -0.602 . . . . 0.42999999999999999 110.127 -174.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.545 HG21 ' CE1' ' A' ' 134' ' ' PHE . 39.4 mt -131.55 132.79 62.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 107.927 -1.138 . . . . 0.40999999999999998 107.927 171.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.468 ' HB3' ' OH ' ' A' ' 81' ' ' TYR . 23.6 p -110.93 106.26 15.32 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.585 -0.446 . . . . 2.0099999999999998 111.961 -171.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.587 ' HA ' ' O ' ' A' ' 111' ' ' PHE . 2.1 t60 -81.23 90.06 6.07 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.441 -0.948 . . . . 1.23 108.441 167.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.633 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 35.0 m -115.47 114.58 25.22 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.555 -0.748 . . . . 0.5 111.938 -171.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 38.1 mm -76.52 121.98 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 109.01 -0.737 . . . . 1.03 109.01 174.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.464 ' HB ' ' O ' ' A' ' 109' ' ' ARG . 25.7 m -109.4 143.73 38.58 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.544 -1.207 . . . . 1.3799999999999999 109.861 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.513 ' HB2' ' HA ' ' A' ' 77' ' ' SER . 22.2 mt-30 . . . . . 0 C--N 1.323 -0.578 0 CA-C-N 115.693 -0.685 . . . . 1.8200000000000001 111.625 -176.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 73.6 mt . . . . . 0 N--CA 1.451 -0.397 0 CA-C-O 121.163 0.506 . . . . 1.1200000000000001 111.159 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.475 ' OG ' ' HD2' ' A' ' 108' ' ' PRO . 32.4 t -92.19 159.83 36.6 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.354 -0.839 . . . . 1.3500000000000001 109.25 178.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.475 ' HD2' ' OG ' ' A' ' 107' ' ' SER . 97.2 Cg_exo -44.63 142.37 4.85 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.44 2.093 . . . . 1.0700000000000001 111.374 171.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.714 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 29.1 ttp-105 -126.21 130.8 51.67 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.545 -0.462 . . . . 3.4500000000000002 109.879 -167.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.554 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 9.1 t0 -104.73 125.07 50.45 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.736 -0.468 . . . . 1.3700000000000001 109.736 -176.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.633 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 12.0 m-30 -95.97 143.65 26.96 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.244 0.545 . . . . 2.4100000000000001 110.621 -172.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.642 ' CG2' ' HE1' ' A' ' 134' ' ' PHE . 26.9 mm -138.36 61.2 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 107.085 -1.45 . . . . 0.42999999999999999 107.085 170.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.494 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 45.7 m-20 -96.46 125.41 40.93 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.658 -1.156 . . . . 1.8600000000000001 109.766 -175.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.65 HD12 ' O ' ' A' ' 92' ' ' PHE . 7.7 tp -75.22 126.89 31.94 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.988 -0.551 . . . . 0.28000000000000003 109.524 173.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -127.01 128.18 70.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.596 -0.729 . . . . 0.26000000000000001 111.929 -165.475 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.968 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 7.7 t80 -113.15 114.23 26.5 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.156 -0.929 . . . . 2.5699999999999998 110.324 175.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.649 HG12 HG22 ' A' ' 127' ' ' ILE . 71.9 mt -90.41 99.29 9.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.84 -0.618 . . . . 0.89000000000000001 109.401 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.507 ' HB3' HG23 ' A' ' 126' ' ' ILE . 15.4 tppt? -102.4 123.06 45.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.572 -0.74 . . . . 1.2 110.948 -173.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -103.07 93.28 4.93 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.869 -0.605 . . . . 2.7999999999999998 109.443 177.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -70.97 106.12 3.54 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 107.181 -1.414 . . . . 0.82999999999999996 107.181 168.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -26.1 92.98 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 O-C-N 125.123 1.514 . . . . 2.2799999999999998 113.631 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 53.7 43.27 68.98 Favored Glycine 0 CA--C 1.508 -0.385 0 CA-C-N 115.316 -0.856 . . . . 0.76000000000000001 112.176 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.662 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 3.6 t-20 -139.02 -47.77 0.49 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.054 -0.573 . . . . 1.6499999999999999 110.585 -174.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.547 ' SD ' HD11 ' A' ' 15' ' ' LEU . 2.4 mtt -161.13 121.21 2.69 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 120.953 0.406 . . . . 1.1200000000000001 110.919 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -106.34 75.16 1.07 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.452 -0.944 . . . . 1.6200000000000001 108.452 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.759 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.5 OUTLIER -97.08 141.5 15.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.004 -0.998 . . . . 0.29999999999999999 112.866 -172.173 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.706 ' O ' HG13 ' A' ' 127' ' ' ILE . 6.4 pt -109.45 108.97 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-O 121.756 0.789 . . . . 0.58999999999999997 108.99 163.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 56.4 p -95.25 117.93 31.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.191 0.519 . . . . 1.1799999999999999 110.955 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.565 ' HB2' ' SG ' ' A' ' 151' ' ' CYS . 20.1 m -114.6 151.57 33.25 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.199 0.523 . . . . 1.24 111.458 -174.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.559 ' HZ3' HG21 ' A' ' 10' ' ' THR . 10.3 mtmm -140.92 130.12 23.53 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.787 -0.82 . . . . 2.2599999999999998 108.787 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.445 ' HB3' ' H ' ' A' ' 148' ' ' ASN . 21.7 p -73.76 101.46 3.71 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.832 -0.803 . . . . 1.3899999999999999 108.832 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.3 m -105.72 173.55 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 120.048 -0.661 . . . . 1.05 110.173 -176.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -135.65 65.42 1.54 Allowed 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 122.069 0.938 . . . . 2.1699999999999999 109.354 -174.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.642 ' HE1' ' CG2' ' A' ' 112' ' ' ILE . 1.0 OUTLIER -97.08 153.62 38.44 Favored Pre-proline 0 C--N 1.317 -0.839 0 CA-C-N 114.088 -1.414 . . . . 0.53000000000000003 108.852 -175.644 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -83.39 5.42 6.41 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.082 1.855 . . . . 1.28 116.483 -166.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.602 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 11.8 tp10 -76.06 -15.95 60.02 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 119.253 0.933 . . . . 3.5 108.505 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -156.75 114.73 2.03 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 113.315 0.857 . . . . 6.1200000000000001 113.315 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -95.06 139.43 0.98 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.671 2.914 . . . . 1.77 111.85 169.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -80.6 -165.4 0.34 Allowed 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.608 2.205 . . . . 1.25 112.988 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.1 m -147.62 152.37 37.78 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.94 -1.133 . . . . 1.6000000000000001 107.94 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.1 t -61.45 -16.9 51.47 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.953 0.723 . . . . 1.97 112.953 -167.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -82.72 -18.52 40.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.943 0.402 . . . . 2.1800000000000002 110.94 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.508 ' HB3' ' CB ' ' A' ' 110' ' ' ASP . 94.1 m-85 -130.82 109.15 10.37 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.73 -0.668 . . . . 1.23 109.804 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.714 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 2.1 tp -89.19 115.02 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 CA-C-N 115.795 -0.638 . . . . 0.81999999999999995 109.659 -169.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.554 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 30.3 ttp180 -36.02 115.75 0.35 Allowed 'General case' 0 C--N 1.327 -0.403 0 O-C-N 124.618 1.198 . . . . 4.4199999999999999 111.076 175.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.492 ' H ' ' HA ' ' A' ' 111' ' ' PHE . . . -42.63 108.0 0.13 Allowed Glycine 0 CA--C 1.496 -1.096 0 O-C-N 124.655 1.222 . . . . 0.79000000000000004 112.358 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.661 ' HB2' ' HB3' ' A' ' 174' ' ' GLU . 1.3 p90 -86.01 55.33 3.48 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.201 -0.499 . . . . 4.4400000000000004 111.835 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.703 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 84.5 m-20 -98.64 65.36 1.57 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.489 -0.778 . . . . 1.6200000000000001 110.702 -177.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -54.44 146.2 34.36 Favored Pre-proline 0 N--CA 1.467 0.379 0 CA-C-N 115.843 -0.617 . . . . 2.3199999999999998 110.421 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -10.01 62.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.312 1 C-N-CA 126.853 5.035 . . . . 0.53000000000000003 115.838 -161.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . 0.703 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 27.6 p -84.19 171.13 13.07 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.347 -1.297 . . . . 1.5800000000000001 109.069 173.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.783 ' HA3' HG11 ' A' ' 14' ' ' VAL . . . -167.8 -168.04 29.35 Favored Glycine 0 N--CA 1.433 -1.552 0 C-N-CA 119.744 -1.217 . . . . 0.42999999999999999 111.854 177.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.651 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 39.9 t80 -162.66 77.01 0.46 Allowed 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 109.064 -0.717 . . . . 0.59999999999999998 109.064 -165.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.759 HG12 ' HB ' ' A' ' 126' ' ' ILE . 3.9 m -89.27 121.6 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 122.034 0.921 . . . . 0.31 110.607 -175.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 32.3 m -100.43 112.74 25.13 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.037 -0.983 . . . . 1.55 108.728 175.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.414 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 7.1 m -106.8 111.43 63.83 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 116.492 -0.322 . . . . 1.0600000000000001 111.406 -171.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.662 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 57.7 Cg_exo -52.16 119.34 5.62 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.421 2.081 . . . . 0.56000000000000005 111.002 168.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.4 ' N ' ' HB3' ' A' ' 161' ' ' ASN . 72.2 mtp -81.37 -169.98 2.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.976 0.417 . . . . 1.1599999999999999 111.348 -176.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -67.28 -30.53 70.42 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.854 -0.795 . . . . 2.6299999999999999 108.854 169.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.423 ' C ' ' HD2' ' A' ' 162' ' ' PRO . 47.1 mm-40 -104.32 28.79 6.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.607 -1.179 . . . . 2.0499999999999998 109.274 175.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.577 ' OD1' ' HD3' ' A' ' 162' ' ' PRO . 4.8 p30 -34.81 -47.82 0.94 Allowed Pre-proline 0 N--CA 1.472 0.643 0 N-CA-C 116.16 1.911 . . . . 1.9299999999999999 116.16 -171.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.577 ' HD3' ' OD1' ' A' ' 161' ' ' ASN . 66.3 Cg_endo -72.51 -25.09 18.27 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 CA-C-N 121.534 1.584 . . . . 0.72999999999999998 112.378 -174.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -100.78 -25.55 14.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.761 -0.654 . . . . 0.68000000000000005 110.919 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 55' ' ' PRO . 73.1 m-85 -142.48 119.99 11.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.986 -0.552 . . . . 0.93000000000000005 110.238 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.449 ' OG ' HD11 ' A' ' 61' ' ' LEU . 13.8 p -114.47 140.83 48.4 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.169 0.509 . . . . 1.4099999999999999 110.972 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.564 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 2.0 tppp? -91.51 104.04 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.892 0.853 . . . . 0.73999999999999999 111.577 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.506 HD21 ' CE2' ' A' ' 153' ' ' PHE . 0.8 OUTLIER -89.49 111.61 22.55 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.87 -1.059 . . . . 0.27000000000000002 109.241 177.756 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.65 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.1 OUTLIER -132.16 116.41 29.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 122.099 0.952 . . . . 0.28000000000000003 111.91 175.094 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.65 ' HB3' HG13 ' A' ' 50' ' ' VAL . 19.4 ttt -112.57 158.99 19.29 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.462 -1.244 . . . . 1.24 108.817 -175.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.667 ' HE1' HG13 ' A' ' 154' ' ' VAL . 0.1 OUTLIER -140.06 151.15 45.17 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 110.47 -0.196 . . . . 3.3700000000000001 110.47 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.517 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 6.6 m -136.87 128.23 42.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 O-C-N 123.385 0.428 . . . . 1.3999999999999999 110.931 173.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -108.15 49.7 0.8 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.106 -1.442 . . . . 2.1699999999999999 107.106 174.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -47.68 130.65 14.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.383 -1.735 . . . . 1.6499999999999999 113.541 -166.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.661 ' HB3' ' HB2' ' A' ' 147' ' ' TYR . 21.9 tt0 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.274 -0.876 . . . . 2.4500000000000002 111.04 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.468 ' HA ' ' CE ' ' A' ' 186' ' ' LYS . 33.0 mm . . . . . 0 CA--C 1.503 -0.864 0 CA-C-O 122.528 1.156 . . . . 1.1200000000000001 108.724 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 1.086 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.4 mp -66.69 -34.14 68.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 112.889 -1.959 . . . . 1.1299999999999999 110.597 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -62.04 -21.33 64.82 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.793 -1.094 . . . . 2.8900000000000001 109.39 174.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.468 ' CE ' ' HA ' ' A' ' 183' ' ' ILE . 50.8 mtmt -92.53 -49.34 6.17 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.382 -0.826 . . . . 1.28 110.222 172.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 1.086 HG22 ' HA ' ' A' ' 184' ' ' ILE . 6.5 t -61.55 -35.08 76.74 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.328 0.492 . . . . 0.62 112.328 -168.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . 0.611 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 2.1 mmt -80.35 -61.24 0.44 Allowed Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 119.921 -0.712 . . . . 1.0600000000000001 111.946 -177.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.611 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 8.0 Cg_exo -73.38 -12.53 25.16 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.03 1.82 . . . . 0.91000000000000003 112.545 -172.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.55 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 11.6 t -91.82 -33.48 14.94 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.784 -0.366 . . . . 1.5 110.311 176.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.2 OUTLIER -81.27 -38.4 26.92 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.44 -0.346 . . . . 1.8799999999999999 110.538 -173.556 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.461 ' HB3' HG11 ' A' ' 50' ' ' VAL . 54.7 mt -67.61 -44.68 77.47 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.888 0.375 . . . . 1.0900000000000001 111.277 -176.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.527 ' HB ' HD12 ' A' ' 33' ' ' ILE . 2.1 m -66.95 -31.94 55.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.54 0.686 . . . . 0.68000000000000005 109.354 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.55 ' HB2' ' O ' ' A' ' 190' ' ' SER . 0.6 OUTLIER -74.34 -27.23 60.59 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.668 -1.151 . . . . 2.0699999999999998 110.628 179.534 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.438 ' O ' ' HB2' ' A' ' 198' ' ' ASN . 2.6 t80 -73.66 -30.27 62.82 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.623 -0.88 . . . . 2.0 108.623 175.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.694 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 17.6 mt -77.25 -34.3 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 116.079 -0.51 . . . . 0.31 110.703 173.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 74.2 mt -67.49 -37.04 82.26 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 121.229 0.538 . . . . 1.03 109.702 174.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.688 ' OD1' ' HG2' ' A' ' 76' ' ' LYS . 22.0 m-20 -50.65 -36.26 34.66 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.718 -1.128 . . . . 1.8999999999999999 109.671 167.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.64 ' HA ' ' CE2' ' A' ' 64' ' ' PHE . . . -81.04 -42.35 21.23 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 115.926 -0.579 . . . . 0.28999999999999998 110.944 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.694 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 10.3 mmmm -58.81 -38.89 79.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.548 0.689 . . . . 0.96999999999999997 110.164 176.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -88.75 -43.54 11.2 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.902 -1.045 . . . . 1.9399999999999999 111.092 -178.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -66.75 -31.52 78.62 Favored Glycine 0 CA--C 1.504 -0.626 0 C-N-CA 121.009 -0.615 . . . . 0.46999999999999997 111.984 -176.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.983 HD13 HD23 ' A' ' 61' ' ' LEU . 4.7 tp -67.67 -34.47 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-O 121.274 0.559 . . . . 0.60999999999999999 110.107 178.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -87.21 -30.63 20.82 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.813 -0.631 . . . . 3.3700000000000001 109.555 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.875 0 CA-C-N 115.353 -0.84 . . . . 1.02 109.231 168.277 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.462 ' O ' HD12 ' A' ' 6' ' ' ILE . 7.5 m-20 . . . . . 0 CA--C 1.503 -0.827 0 CA-C-O 120.744 0.307 . . . . 2.25 110.518 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.67 ' HA ' HD12 ' A' ' 6' ' ' ILE . 81.2 m-85 -60.67 -29.08 69.08 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 115.465 -0.789 . . . . 0.42999999999999999 110.586 -170.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.564 ' HG2' ' HG3' ' A' ' 8' ' ' GLN . 21.0 ttmt -74.05 -37.13 64.38 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 107.952 -1.129 . . . . 1.51 107.952 -174.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.71 -37.23 78.32 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.568 -0.742 . . . . 0.54000000000000004 110.556 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.67 HD12 ' HA ' ' A' ' 3' ' ' PHE . 1.7 mp -82.75 -39.35 15.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.922 0.868 . . . . 1.0700000000000001 109.131 -174.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -75.89 -37.41 58.87 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.275 -1.329 . . . . 0.34000000000000002 111.595 -177.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.564 ' HG3' ' HG2' ' A' ' 4' ' ' LYS . 15.2 mt-30 -65.94 -28.24 68.77 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.346 -0.843 . . . . 1.5900000000000001 109.803 176.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -81.06 -34.89 32.42 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.753 -1.112 . . . . 2.4700000000000002 109.555 174.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.724 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.3 OUTLIER -74.1 -36.5 64.26 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.067 -0.969 . . . . 0.47999999999999998 111.486 -179.25 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.513 ' O ' ' HB3' ' A' ' 15' ' ' LEU . . . -46.14 -53.77 9.83 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-O 120.911 0.386 . . . . 0.31 110.651 172.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -78.81 -1.68 36.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.924 -0.58 . . . . 1.6399999999999999 111.989 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.684 ' HB3' ' HA ' ' A' ' 10' ' ' THR . 0.8 OUTLIER -87.87 -49.45 7.09 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.767 -0.827 . . . . 2.54 108.767 175.389 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.63 HG21 ' N ' ' A' ' 152' ' ' GLY . 13.0 p -69.39 -40.7 80.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 122.237 1.017 . . . . 0.53000000000000003 109.039 178.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.552 HD23 ' HD3' ' A' ' 19' ' ' ARG . 0.9 OUTLIER -73.74 -17.92 61.05 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 114.378 -1.283 . . . . 0.59999999999999998 109.186 175.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.55 ' HA2' ' NE ' ' A' ' 19' ' ' ARG . . . -58.0 -32.85 67.35 Favored Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 109.728 -1.349 . . . . 0.56999999999999995 109.728 171.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.496 ' HD1' ' O ' ' A' ' 13' ' ' GLU . 9.5 m-85 -88.05 -15.71 35.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.872 -0.664 . . . . 3.27 109.894 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.485 ' HA ' ' NH1' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -89.43 -19.84 24.66 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 120.414 -0.514 . . . . 2.0299999999999998 110.429 176.363 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.552 ' HD3' HD23 ' A' ' 15' ' ' LEU . 17.2 ptt180 -96.02 -21.58 17.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.35 -0.387 . . . . 2.7200000000000002 111.574 -171.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -130.83 157.23 43.44 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 119.615 -0.834 . . . . 2.1600000000000001 111.174 170.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 71.5 p -136.29 158.09 45.24 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.91 -1.041 . . . . 1.8200000000000001 109.389 -173.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.0 t -170.17 -148.57 0.06 Allowed 'General case' 0 C--O 1.234 0.272 0 C-N-CA 120.083 -0.647 . . . . 2.1899999999999999 111.05 -172.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.73 75.16 0.73 Allowed Glycine 0 C--N 1.331 0.29 0 CA-C-N 116.227 -0.442 . . . . 1.1000000000000001 113.494 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.882 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -109.27 -153.06 0.5 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.4 -0.592 . . . . 1.6699999999999999 109.4 172.203 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.5 ttpt -178.43 126.27 0.11 Allowed 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 108.263 -1.014 . . . . 2.9500000000000002 108.263 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.603 HG11 HG23 ' A' ' 34' ' ' THR . 3.2 m -64.89 123.22 17.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 122.057 0.932 . . . . 1.5600000000000001 110.667 174.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.9 p -93.74 -24.03 5.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 114.353 -1.294 . . . . 1.22 108.271 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.4 tptm -155.44 133.85 11.73 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 119.744 -0.782 . . . . 2.4100000000000001 112.146 -177.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.862 HG22 ' HA ' ' A' ' 34' ' ' THR . 45.9 p -137.07 101.5 4.57 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.274 -0.639 . . . . 1.3799999999999999 109.274 169.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.425 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 13.8 m -140.92 108.69 5.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.278 -0.419 . . . . 2.3700000000000001 110.961 -175.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 30' ' ' SER . 56.7 mttm 79.6 64.46 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.752 0.657 . . . . 4.5499999999999998 111.627 176.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 44.3 tptt 75.33 15.65 2.8 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.101 -0.5 . . . . 1.4199999999999999 112.233 168.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.984 HG22 ' HA3' ' A' ' 52' ' ' GLY . 31.7 pt -135.08 169.96 20.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.551 0.691 . . . . 0.76000000000000001 112.833 -172.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.862 ' HA ' HG22 ' A' ' 29' ' ' THR . 87.7 m -152.15 106.01 3.12 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.572 -1.195 . . . . 0.57999999999999996 110.696 -169.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.956 HG11 HD13 ' A' ' 192' ' ' LEU . 2.3 t -101.95 108.13 23.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.252 -0.431 . . . . 0.85999999999999999 110.31 -177.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 1.6 p -102.96 127.17 50.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.506 0.669 . . . . 1.1000000000000001 111.38 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.2 p -98.02 121.65 40.19 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.12 -0.945 . . . . 1.27 111.385 -174.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.882 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 5.3 ttpp . . . . . 0 C--N 1.325 -0.468 0 CA-C-N 115.992 -0.549 . . . . 1.9099999999999999 112.08 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 CA--C 1.512 -0.519 0 CA-C-O 120.646 0.26 . . . . 2.0499999999999998 110.688 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 1.007 HD12 ' HB2' ' A' ' 172' ' ' GLN . 10.6 tt -86.25 135.55 33.51 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.379 -1.341 . . . . 0.87 107.379 170.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.454 ' HB2' HD21 ' A' ' 192' ' ' LEU . 99.6 m-85 -109.92 117.33 33.51 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.219 0.533 . . . . 0.98999999999999999 110.321 -172.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.651 ' HD3' ' CZ3' ' A' ' 24' ' ' TRP . 28.3 ttt180 -93.75 107.53 19.4 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.225 -0.898 . . . . 2.9199999999999999 110.279 177.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.598 HG13 HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -82.87 140.84 15.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.406 -0.961 . . . . 1.3300000000000001 108.406 174.555 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.785 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 54.7 tt0 -151.52 108.61 3.56 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.054 0.454 . . . . 1.0700000000000001 109.983 -178.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.984 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -145.46 154.9 26.23 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 111.153 -0.779 . . . . 0.28999999999999998 111.153 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.0 mt -97.86 114.36 34.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 119.918 -0.713 . . . . 0.57999999999999996 111.205 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.464 HD13 ' HB1' ' A' ' 199' ' ' ALA . 68.7 mt -92.31 111.6 51.2 Favored Pre-proline 0 N--CA 1.443 -0.821 0 N-CA-C 108.373 -0.973 . . . . 0.34999999999999998 108.373 170.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 22.0 Cg_exo -66.52 54.57 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 124.266 3.311 . . . . 0.62 113.167 -177.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.683 ' HG2' HG13 ' A' ' 203' ' ' ILE . 10.8 tp10 -151.65 167.63 27.53 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 107.417 -1.327 . . . . 1.6799999999999999 107.417 175.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.484 ' HB3' ' HA ' ' A' ' 162' ' ' PRO . 23.8 p -70.12 137.09 86.94 Favored Pre-proline 0 N--CA 1.431 -1.397 0 CA-C-O 121.683 0.754 . . . . 1.1799999999999999 111.404 -176.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.786 ' HD3' ' HB2' ' A' ' 165' ' ' SER . 6.3 Cg_endo -49.55 -18.18 2.31 Favored 'Trans proline' 0 C--O 1.23 0.116 0 C-N-CA 124.698 3.598 . . . . 0.52000000000000002 111.677 170.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.85 -47.82 50.37 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.082 -0.963 . . . . 0.64000000000000001 110.692 176.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.502 ' HA ' ' HB3' ' A' ' 63' ' ' ASP . 4.5 tppt? -68.02 -29.83 68.93 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.71 -0.848 . . . . 3.2999999999999998 108.71 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.957 HD23 HD13 ' A' ' 203' ' ' ILE . 88.5 mt -60.02 -53.97 51.54 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.906 -1.043 . . . . 0.40999999999999998 110.25 174.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.514 ' CB ' HD21 ' A' ' 125' ' ' ASN . 19.3 p -68.05 -12.61 61.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.107 0.479 . . . . 1.29 110.44 175.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.502 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 37.8 t70 -82.28 -33.06 29.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.794 -0.639 . . . . 1.3200000000000001 111.409 -177.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.54 ' CE2' ' HA ' ' A' ' 61' ' ' LEU . 15.4 p90 -83.7 -47.51 11.13 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.404 -0.518 . . . . 0.60999999999999999 110.976 -177.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.511 ' CD2' ' HA ' ' A' ' 62' ' ' SER . 0.7 OUTLIER -83.5 -1.79 54.46 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.4 -0.52 . . . . 1.5 111.904 -172.154 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -38.34 -47.94 1.28 Allowed 'General case' 0 C--N 1.327 -0.373 0 O-C-N 124.806 1.316 . . . . 1.52 114.448 -162.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -162.21 -84.09 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 114.261 1.208 . . . . 3.6000000000000001 114.261 -175.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.754 ' HB ' ' CD1' ' A' ' 81' ' ' TYR . 10.8 t -150.86 13.57 0.71 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.406 0.521 . . . . 1.48 112.406 -166.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -111.25 -6.67 25.54 Favored Glycine 0 C--N 1.306 -1.132 0 C-N-CA 118.987 -1.578 . . . . 1.46 113.203 -165.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.741 ' O ' HG22 ' A' ' 73' ' ' THR . 12.9 t70 -162.41 -41.45 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.369 0.604 . . . . 2.1899999999999999 110.136 -167.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.704 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 1.5 ptp180 -49.92 -47.42 52.3 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.904 -1.044 . . . . 3.3799999999999999 111.64 -176.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.863 HG22 HD13 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -90.05 -8.04 10.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.697 -0.401 . . . . 0.70999999999999996 111.054 -174.333 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.741 HG22 ' O ' ' A' ' 70' ' ' ASP . 4.8 t -83.29 -35.67 25.09 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 119.171 -1.011 . . . . 0.96999999999999997 110.089 -176.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.712 ' HZ3' ' HB2' ' A' ' 198' ' ' ASN . 20.4 p-90 -103.27 -6.09 22.41 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.413 -0.515 . . . . 0.75 111.982 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.814 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 5.5 t70 -67.24 172.93 4.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.864 0.84 . . . . 2.1899999999999999 112.288 -170.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.477 ' H ' ' HG3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -118.08 -11.12 10.22 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.52 -1.218 . . . . 3.1899999999999999 111.61 -174.327 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.1 m -140.88 17.36 2.31 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.496 0.665 . . . . 1.5800000000000001 109.899 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.863 HD13 HG22 ' A' ' 72' ' ' ILE . 21.9 mt -108.03 157.33 18.34 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.593 -0.73 . . . . 0.70999999999999996 110.624 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.789 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 16.4 mm-40 -131.89 -71.1 0.56 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.577 -0.738 . . . . 1.73 111.074 -178.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.86 ' HB ' HD13 ' A' ' 97' ' ' ILE . 15.1 t -137.41 142.8 35.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.599 -0.728 . . . . 0.78000000000000003 109.892 -170.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.754 ' CD1' ' HB ' ' A' ' 68' ' ' THR . 25.3 t80 -124.2 137.51 54.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.989 0.423 . . . . 5.4000000000000004 110.431 176.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.892 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 5.3 m-20 -128.97 111.78 13.37 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.664 -0.865 . . . . 1.6899999999999999 108.664 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.712 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 20.1 ttm -75.85 96.37 3.69 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.838 -0.801 . . . . 2.0499999999999998 108.838 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -78.54 -83.31 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 116.36 -0.382 . . . . 0.64000000000000001 111.741 -168.52 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.497 ' HB2' HD12 ' A' ' 93' ' ' ILE . 32.1 m170 -122.56 122.75 39.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.27 0.557 . . . . 1.96 110.25 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.712 ' HD3' ' SD ' ' A' ' 83' ' ' MET . 81.2 mtm180 -105.68 108.79 20.49 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.225 -0.898 . . . . 2.4399999999999999 109.219 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.515 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -72.68 -39.95 61.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.428 -0.806 . . . . 0.46999999999999997 110.067 -173.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -152.08 -171.0 3.8 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.409 -0.814 . . . . 1.8600000000000001 109.188 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.6 t -78.88 -5.56 53.9 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.795 0.331 . . . . 1.4399999999999999 110.389 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -122.81 -4.3 8.63 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.94 -0.393 . . . . 1.8700000000000001 109.94 -176.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.715 HG23 ' HD1' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -135.93 112.06 9.69 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.301 -0.629 . . . . 0.46000000000000002 109.301 -169.132 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.707 ' HD2' ' HG2' ' A' ' 86' ' ' ARG . 10.8 m-85 -125.39 178.73 5.45 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.651 -0.5 . . . . 0.42999999999999999 109.651 -177.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.66 ' O ' HG23 ' A' ' 84' ' ' VAL . 42.6 mt -133.0 128.94 57.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 107.094 -1.447 . . . . 0.40999999999999998 107.094 168.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 113' ' ' ASP . 6.6 p -113.18 112.32 23.58 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.122 0.487 . . . . 2.0099999999999998 112.13 -170.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.892 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 4.7 t-160 -82.64 93.96 7.46 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.64 -0.874 . . . . 1.23 108.64 170.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.544 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 21.8 m -113.11 111.57 22.35 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.25 -0.432 . . . . 0.5 111.965 -172.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.86 HD13 ' HB ' ' A' ' 80' ' ' VAL . 3.4 mp -77.27 120.42 27.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 108.642 -0.874 . . . . 1.03 108.642 174.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 49.6 m -111.72 138.37 48.39 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.368 -0.833 . . . . 1.3799999999999999 111.909 -170.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.789 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 42.6 mt-30 . . . . . 0 C--N 1.32 -0.687 0 CA-C-N 116.089 -0.505 . . . . 1.8200000000000001 109.784 174.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.461 HG22 ' O ' ' A' ' 107' ' ' SER . 65.7 mt . . . . . 0 N--CA 1.448 -0.555 0 CA-C-O 120.937 0.398 . . . . 1.1200000000000001 111.034 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.461 ' O ' HG22 ' A' ' 106' ' ' ILE . 19.8 m -94.26 164.88 18.87 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.661 -0.699 . . . . 1.3500000000000001 109.539 173.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.22 141.67 30.65 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.234 1.956 . . . . 1.0700000000000001 111.458 173.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.652 ' HG2' HG23 ' A' ' 144' ' ' ILE . 54.6 mtt180 -116.33 173.95 6.32 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.049 0.452 . . . . 3.4500000000000002 110.689 -174.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.822 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 9.8 t70 -132.72 123.07 25.56 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.56 -0.746 . . . . 1.3700000000000001 109.04 -177.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.544 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 9.6 m-30 -103.63 140.42 37.59 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.146 0.498 . . . . 2.4100000000000001 111.366 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.678 HG13 ' HA ' ' A' ' 137' ' ' TYR . 25.5 mm -132.38 75.14 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.124 -0.944 . . . . 0.42999999999999999 108.691 173.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.902 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 17.2 m-20 -99.85 123.18 43.84 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.695 -0.684 . . . . 1.8600000000000001 110.808 -173.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.614 HD12 ' O ' ' A' ' 92' ' ' PHE . 7.6 tp -76.38 123.53 26.12 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 108.71 -0.848 . . . . 0.28000000000000003 108.71 167.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.606 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -127.15 124.62 64.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.562 -0.744 . . . . 0.26000000000000001 112.384 -163.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.715 ' HD1' HG23 ' A' ' 91' ' ' THR . 54.5 t80 -109.75 118.23 35.97 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.273 -0.876 . . . . 2.5699999999999998 110.947 174.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.465 HG13 ' HB ' ' A' ' 127' ' ' ILE . 5.1 mp -97.5 120.85 47.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.787 -0.642 . . . . 0.89000000000000001 109.923 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.423 ' HB3' ' CE2' ' A' ' 116' ' ' TYR . 14.0 ptpt -140.56 147.41 39.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.041 0.448 . . . . 1.2 110.714 177.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.475 ' C ' ' HD2' ' A' ' 119' ' ' ARG . 1.7 tmm_? -125.64 99.97 6.23 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 109.014 -0.735 . . . . 2.7999999999999998 109.014 -176.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -63.45 116.32 5.45 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.406 -1.331 . . . . 0.82999999999999996 107.406 169.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.415 ' HG3' ' H ' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -33.09 90.13 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 O-C-N 125.12 1.513 . . . . 2.2799999999999998 114.682 -175.451 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 58.05 29.32 62.22 Favored Glycine 0 C--O 1.229 -0.198 0 CA-C-N 114.716 -1.129 . . . . 0.76000000000000001 112.62 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.429 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 33.7 t-20 -119.72 -49.18 2.34 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.538 -0.541 . . . . 1.6499999999999999 109.538 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 1.9 mtm -161.93 122.74 2.64 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.972 0.415 . . . . 1.1200000000000001 111.226 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.514 HD21 ' CB ' ' A' ' 62' ' ' SER . 59.3 t30 -109.4 80.82 1.36 Allowed 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.716 -0.846 . . . . 1.6200000000000001 108.716 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.821 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -100.57 139.48 21.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.232 -0.895 . . . . 0.29999999999999999 112.81 -173.191 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.656 ' O ' HG13 ' A' ' 127' ' ' ILE . 1.9 pt -108.64 116.58 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 108.318 -0.993 . . . . 0.58999999999999997 108.318 160.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.606 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 26.5 p -87.54 156.98 19.27 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.102 -0.703 . . . . 1.1799999999999999 109.102 175.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.902 ' HB3' ' HB3' ' A' ' 113' ' ' ASP . 50.2 m -153.9 136.35 15.02 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.758 0.313 . . . . 1.24 111.576 -178.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.892 ' HE2' ' HG3' ' A' ' 150' ' ' PRO . 4.6 mtpm? -131.04 122.77 27.37 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 107.824 -1.176 . . . . 2.2599999999999998 107.824 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.578 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 70.4 p -64.49 99.02 0.28 Allowed 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.098 -1.445 . . . . 1.3899999999999999 107.098 174.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.57 137.34 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 CA-C-N 115.265 -0.879 . . . . 1.05 108.709 -165.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.617 ' HA ' ' CG ' ' A' ' 137' ' ' TYR . 9.8 p-10 -92.05 69.57 5.35 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.678 -1.147 . . . . 2.1699999999999999 110.543 -167.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.721 ' CZ ' ' HB3' ' A' ' 136' ' ' GLU . 1.7 p90 -105.15 173.36 3.33 Favored Pre-proline 0 CA--C 1.546 0.82 0 CA-C-N 113.927 -1.488 . . . . 0.53000000000000003 108.313 -176.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.535 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 31.8 Cg_exo -28.05 -57.17 0.12 Allowed 'Trans proline' 0 CA--C 1.548 1.182 0 C-N-CA 124.875 3.716 . . . . 1.28 116.964 -177.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.721 ' HB3' ' CZ ' ' A' ' 134' ' ' PHE . 17.8 tp10 -80.77 -21.44 41.03 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.635 0.606 . . . . 3.5 112.635 -174.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.678 ' HA ' HG13 ' A' ' 112' ' ' ILE . 17.8 t80 -49.43 -43.12 69.95 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 114.403 1.26 . . . . 6.1200000000000001 114.403 -177.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.507 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 32.0 Cg_exo -39.31 119.55 0.52 Allowed 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 122.386 2.057 . . . . 1.77 113.28 175.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.887 ' HB3' ' HD3' ' A' ' 145' ' ' ARG . 50.6 Cg_endo -89.14 -163.1 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.422 2.748 . . . . 1.25 113.773 -172.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.5 m -142.73 -169.32 2.97 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.79 -0.819 . . . . 1.6000000000000001 108.79 -175.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.8 t -80.46 -45.31 17.78 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.18 -0.608 . . . . 1.97 110.028 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -69.58 -28.31 65.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.073 -0.512 . . . . 2.1800000000000002 110.86 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.822 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 65.5 m-85 -118.87 109.12 15.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.975 -0.557 . . . . 1.23 110.542 -174.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.652 HG23 ' HG2' ' A' ' 109' ' ' ARG . 2.5 tp -98.66 111.95 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-O 121.314 0.578 . . . . 0.81999999999999995 109.695 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.887 ' HD3' ' HB3' ' A' ' 139' ' ' PRO . 4.7 mpt_? -57.89 100.48 0.06 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.814 -1.085 . . . . 4.4199999999999999 110.888 176.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -66.99 115.53 7.31 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 110.404 -1.079 . . . . 0.79000000000000004 110.404 174.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.406 ' HB3' ' HB3' ' A' ' 174' ' ' GLU . 24.8 t80 -84.55 86.16 7.33 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.486 0.66 . . . . 4.4400000000000004 110.612 -173.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.472 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 90.5 m-20 -70.42 105.62 3.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.987 -1.006 . . . . 1.6200000000000001 110.411 175.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.669 ' HB3' ' HB3' ' A' ' 172' ' ' GLN . 25.3 t60 -57.82 126.59 76.93 Favored Pre-proline 0 CA--C 1.506 -0.745 0 N-CA-C 107.609 -1.256 . . . . 2.3199999999999998 107.609 167.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.892 ' HG3' ' HE2' ' A' ' 130' ' ' LYS . 23.7 Cg_exo -12.13 69.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 1 C-N-CA 126.853 5.035 . . . . 0.53000000000000003 115.37 -173.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . 0.472 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 24.1 p -77.47 178.41 7.24 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.241 -1.345 . . . . 1.5800000000000001 110.574 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.63 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -170.56 -164.9 27.06 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 120.309 -0.948 . . . . 0.42999999999999999 111.675 175.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -161.38 73.19 0.44 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.632 -0.877 . . . . 0.59999999999999998 108.632 -164.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.822 HG23 HG13 ' A' ' 168' ' ' VAL . 8.4 m -83.24 115.26 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-O 122.113 0.959 . . . . 0.31 110.32 -175.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 64.3 m -98.27 107.58 20.08 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.417 -0.811 . . . . 1.55 109.027 177.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.722 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 10.1 m -97.63 112.64 61.92 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 116.28 -0.418 . . . . 1.0600000000000001 111.023 -170.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.558 ' HB3' ' ND2' ' A' ' 161' ' ' ASN . 52.4 Cg_exo -51.76 120.48 7.13 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.376 2.05 . . . . 0.56000000000000005 110.598 172.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.687 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 2.7 mmt -79.87 -167.92 1.43 Allowed 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.234 0.54 . . . . 1.1599999999999999 111.453 -175.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -70.97 -16.78 62.66 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.485 -0.779 . . . . 2.6299999999999999 110.026 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 163' ' ' ALA . 38.6 mt-10 -117.38 21.16 13.26 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 115.467 -0.788 . . . . 2.0499999999999998 110.408 178.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.669 ' HB3' ' CD ' ' A' ' 162' ' ' PRO . 18.7 t-20 29.79 -87.06 0.0 OUTLIER Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 125.87 1.668 . . . . 1.9299999999999999 115.044 175.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.669 ' CD ' ' HB3' ' A' ' 161' ' ' ASN . 85.1 Cg_endo -75.81 -12.62 19.95 Favored 'Trans proline' 0 C--N 1.368 1.557 0 CA-C-N 121.888 1.71 . . . . 0.72999999999999998 112.928 -175.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.559 ' HB3' ' HB3' ' A' ' 160' ' ' GLU . . . -89.97 -36.92 14.69 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.898 -0.592 . . . . 0.68000000000000005 110.563 -178.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.687 ' O ' ' HB2' ' A' ' 158' ' ' MET . 73.6 m-85 -136.97 133.14 35.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.279 -0.419 . . . . 0.93000000000000005 110.424 176.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.786 ' HB2' ' HD3' ' A' ' 58' ' ' PRO . 25.3 t -125.11 144.59 50.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.342 0.592 . . . . 1.4099999999999999 110.951 174.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.785 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.8 tppp? -97.37 99.81 11.25 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.993 0.901 . . . . 0.73999999999999999 110.684 -178.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.8 106.97 15.91 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.323 -1.308 . . . . 0.27000000000000002 109.201 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.822 HG13 HG23 ' A' ' 154' ' ' VAL . 0.1 OUTLIER -129.41 126.27 63.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.675 0.75 . . . . 0.28000000000000003 111.804 176.667 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 14.6 ttt -129.74 153.08 48.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.182 -0.917 . . . . 1.24 110.021 -171.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.767 ' HB3' HD21 ' A' ' 47' ' ' LEU . 47.6 m-85 -134.24 140.52 46.51 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.684 -0.234 . . . . 3.3700000000000001 111.146 -178.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.607 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 4.7 m -140.07 131.6 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 O-C-N 123.645 0.591 . . . . 1.3999999999999999 111.549 171.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 1.007 ' HB2' HD12 ' A' ' 47' ' ' LEU . 13.3 tt0 -120.02 33.55 5.56 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 105.954 -1.869 . . . . 2.1699999999999999 105.954 169.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 35.9 m -54.94 147.27 15.77 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 112.697 -2.047 . . . . 1.6499999999999999 112.733 -171.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 2.4 tp10 . . . . . 0 N--CA 1.448 -0.536 0 CA-C-N 115.573 -0.74 . . . . 2.4500000000000002 110.663 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.558 ' HA ' ' HE2' ' A' ' 186' ' ' LYS . 24.4 mm . . . . . 0 CA--C 1.503 -0.845 0 CA-C-O 122.274 1.035 . . . . 1.1200000000000001 108.331 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 1.005 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.2 mp -62.99 -35.7 72.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 112.986 -1.915 . . . . 1.1299999999999999 110.726 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -57.19 -29.65 63.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.133 -0.94 . . . . 2.8900000000000001 109.564 174.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.558 ' HE2' ' HA ' ' A' ' 183' ' ' ILE . 46.0 mtmt -93.05 -40.46 10.51 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.161 -0.927 . . . . 1.28 111.088 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 1.005 HG22 ' HA ' ' A' ' 184' ' ' ILE . 6.5 t -64.75 -37.67 88.39 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.236 0.458 . . . . 0.62 112.236 -171.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . 0.825 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 7.7 mmt -74.88 -60.43 1.23 Allowed Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 120.747 -0.381 . . . . 1.0600000000000001 111.347 -174.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.825 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 61.3 Cg_exo -54.02 -32.06 66.99 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.174 1.916 . . . . 0.91000000000000003 112.579 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.74 ' O ' ' HB3' ' A' ' 194' ' ' ASN . 49.0 m -72.87 -23.71 60.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.431 -0.35 . . . . 1.5 111.031 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -92.56 -37.82 12.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.348 0.594 . . . . 1.8799999999999999 111.6 -175.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.956 HD13 HG11 ' A' ' 35' ' ' VAL . 3.7 mt -67.02 -51.32 56.35 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.659 0.743 . . . . 1.0900000000000001 110.79 -176.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.688 ' O ' HD23 ' A' ' 197' ' ' LEU . 1.6 m -69.6 -41.29 80.24 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.129 0 CA-C-N 115.061 -0.972 . . . . 0.68000000000000005 108.756 -176.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.74 ' HB3' ' O ' ' A' ' 190' ' ' SER . 0.0 OUTLIER -57.48 -37.75 73.42 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.668 0.618 . . . . 2.0699999999999998 112.668 178.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -64.28 -31.82 73.17 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 119.884 -0.726 . . . . 2.0 110.009 174.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.852 HG21 HG21 ' A' ' 33' ' ' ILE . 8.6 mt -78.58 -33.89 17.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 122.003 0.906 . . . . 0.31 111.205 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.688 HD23 ' O ' ' A' ' 193' ' ' VAL . 3.3 mm? -78.26 -30.6 48.69 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.014 -0.994 . . . . 1.03 110.723 -173.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.712 ' HB2' ' HZ3' ' A' ' 74' ' ' TRP . 12.1 p30 -67.39 -29.82 69.43 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.528 -1.286 . . . . 1.8999999999999999 107.528 167.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.695 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -73.19 -37.25 66.55 Favored 'General case' 0 N--CA 1.435 -1.187 0 O-C-N 121.97 -0.456 . . . . 0.28999999999999998 110.254 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 33.0 mmtp -61.7 -43.36 99.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.76 0.79 . . . . 0.96999999999999997 109.915 174.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . 0.574 ' O ' ' HG3' ' A' ' 204' ' ' LYS . 10.2 t70 -81.69 -40.72 22.37 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.703 -1.135 . . . . 1.9399999999999999 110.841 -171.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -70.98 -33.87 65.34 Favored Glycine 0 C--O 1.226 -0.406 0 C-N-CA 121.105 -0.569 . . . . 0.46999999999999997 111.729 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.957 HD13 HD23 ' A' ' 61' ' ' LEU . 1.6 tp -70.17 -35.76 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 110.058 -0.349 . . . . 0.60999999999999999 110.058 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.574 ' HG3' ' O ' ' A' ' 201' ' ' ASP . 2.2 pptp? -81.59 -23.95 36.77 Favored 'General case' 0 C--O 1.213 -0.846 0 N-CA-C 108.678 -0.86 . . . . 3.3700000000000001 108.678 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.096 0 N-CA-C 109.094 -0.706 . . . . 1.02 109.094 167.758 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.451 ' O ' ' HB3' ' A' ' 5' ' ' ALA . 1.0 OUTLIER . . . . . 0 CA--C 1.512 -0.488 0 N-CA-C 112.547 0.573 . . . . 2.25 112.547 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.889 ' HA ' HD12 ' A' ' 6' ' ' ILE . 97.2 m-85 -68.53 -27.97 66.58 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.079 0.466 . . . . 0.42999999999999999 109.837 -172.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.564 ' HD2' ' CG ' ' A' ' 88' ' ' ASP . 17.5 tttm -76.31 -2.45 31.66 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.551 -0.75 . . . . 1.51 109.697 177.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.61 ' O ' ' HG2' ' A' ' 9' ' ' GLN . . . -92.96 -43.44 8.93 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.398 0.618 . . . . 0.54000000000000004 109.972 170.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.889 HD12 ' HA ' ' A' ' 3' ' ' PHE . 1.3 mp -81.57 -43.01 19.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 122.01 0.91 . . . . 1.0700000000000001 109.398 -171.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.467 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -76.06 -37.31 58.42 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.105 -1.407 . . . . 0.34000000000000002 111.584 -176.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 7.3 mt-30 -65.91 -29.73 70.2 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.474 -0.785 . . . . 1.5900000000000001 109.992 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.61 ' HG2' ' O ' ' A' ' 5' ' ' ALA . 79.1 mm-40 -77.69 -38.8 46.68 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.038 -0.983 . . . . 2.4700000000000002 108.499 174.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.555 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.4 OUTLIER -65.57 -36.53 84.05 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.534 -1.212 . . . . 0.47999999999999998 111.962 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.625 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -46.57 -59.49 2.97 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.198 0.523 . . . . 0.31 111.159 172.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -66.56 -16.65 64.32 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.49 -0.777 . . . . 1.6399999999999999 112.045 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.608 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 44.2 mt-10 -73.32 -52.37 14.15 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.001 0.429 . . . . 2.54 109.888 175.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.687 HG21 ' N ' ' A' ' 152' ' ' GLY . 11.8 p -73.2 -40.17 57.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.649 0.738 . . . . 0.53000000000000003 110.453 -177.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.554 HD23 ' HD2' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -67.2 -23.81 65.78 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-O 121.916 0.865 . . . . 0.59999999999999998 108.824 173.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.95 -18.05 66.13 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 113.986 -1.461 . . . . 0.56999999999999995 110.38 177.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.633 ' CD2' ' HA ' ' A' ' 14' ' ' VAL . 23.7 m-85 -91.14 -21.34 21.23 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.076 -0.712 . . . . 3.27 109.076 176.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.512 ' HA ' ' HZ ' ' A' ' 170' ' ' PHE . 3.5 t-20 -72.29 -14.82 61.85 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.463 0.649 . . . . 2.0299999999999998 109.989 178.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.554 ' HD2' HD23 ' A' ' 15' ' ' LEU . 22.2 mtp180 -115.72 -20.38 10.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.484 -0.78 . . . . 2.7200000000000002 110.835 -175.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -97.01 132.76 42.5 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.066 0.46 . . . . 2.1600000000000001 111.413 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 43.1 p -134.21 119.28 18.6 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.85 -0.614 . . . . 1.8200000000000001 109.637 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.459 ' HB2' ' HE3' ' A' ' 38' ' ' LYS . 0.8 OUTLIER -135.57 -143.87 0.2 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.862 -0.608 . . . . 2.1899999999999999 110.343 -169.135 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.4 63.33 1.8 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.349 -0.453 . . . . 1.1000000000000001 112.73 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.534 ' CH2' ' HD3' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -119.86 -175.76 3.04 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.15 -1.056 . . . . 1.6699999999999999 108.15 171.393 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.427 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 8.7 mtpp -171.4 133.11 0.8 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.712 -0.848 . . . . 2.9500000000000002 108.712 -176.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.765 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 1.6 p -59.96 116.73 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-O 121.714 0.769 . . . . 1.5600000000000001 109.681 170.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.4 p -92.05 -23.7 5.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 114.695 -1.139 . . . . 1.22 109.081 -177.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 2.7 tppt? -153.1 139.63 18.72 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.82 -0.627 . . . . 2.4100000000000001 111.488 -173.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.6 HG22 ' HA ' ' A' ' 34' ' ' THR . 31.2 p -137.92 142.93 40.58 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.002 -0.545 . . . . 1.3799999999999999 110.373 175.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.761 ' HB3' HG12 ' A' ' 33' ' ' ILE . 35.4 t -89.95 -143.98 0.16 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.618 -1.253 . . . . 2.3700000000000001 107.618 168.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -103.05 18.89 20.61 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.532 -0.467 . . . . 4.5499999999999998 110.06 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.442 ' HD2' ' HA ' ' A' ' 32' ' ' LYS . 33.8 tptt -168.97 3.77 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.189 0.44 . . . . 1.4199999999999999 112.189 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.971 HG22 ' HA3' ' A' ' 52' ' ' GLY . 42.8 pt -138.72 168.46 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.913 0.387 . . . . 0.76000000000000001 111.735 -174.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.6 ' HA ' HG22 ' A' ' 29' ' ' THR . 88.0 m -146.59 119.56 8.76 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.223 -0.899 . . . . 0.57999999999999996 110.64 -166.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.712 HG22 HG23 ' A' ' 50' ' ' VAL . 7.1 t -111.41 102.0 13.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.608 -0.516 . . . . 0.85999999999999999 109.608 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.765 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 18.1 m -99.14 126.79 44.99 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.651 0.739 . . . . 1.1000000000000001 111.338 -177.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 t -97.75 124.04 41.94 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.439 -1.255 . . . . 1.27 109.76 -177.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.459 ' HE3' ' HB2' ' A' ' 22' ' ' SER . 85.3 tttt . . . . . 0 C--N 1.317 -0.822 0 CA-C-N 115.618 -0.719 . . . . 1.9099999999999999 110.151 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.4 m120 . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 121.483 0.659 . . . . 2.0499999999999998 112.07 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.566 HD11 HE21 ' A' ' 172' ' ' GLN . 4.3 tt -136.75 137.19 39.62 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.444 -1.688 . . . . 0.87 106.444 175.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.591 ' HB2' HG12 ' A' ' 171' ' ' VAL . 42.2 m-85 -118.52 128.3 54.45 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 120.545 -0.462 . . . . 0.98999999999999999 110.992 -172.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.534 ' HD3' ' CH2' ' A' ' 24' ' ' TRP . 15.1 ttp180 -99.29 117.24 33.3 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.913 -0.773 . . . . 2.9199999999999999 108.913 173.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.712 HG23 HG22 ' A' ' 35' ' ' VAL . 7.8 p -106.7 120.49 57.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 108.403 -0.962 . . . . 1.3300000000000001 108.403 175.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.657 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 35.2 tt0 -139.98 121.06 14.7 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.225 -0.898 . . . . 1.0700000000000001 110.419 -167.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.971 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -148.23 162.47 28.8 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 111.016 -0.834 . . . . 0.28999999999999998 111.016 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.6 mt -97.6 119.11 45.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 C-N-CA 120.197 -0.601 . . . . 0.57999999999999996 111.004 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.686 HG12 ' HD3' ' A' ' 200' ' ' LYS . 72.6 mt -97.3 114.12 64.29 Favored Pre-proline 0 N--CA 1.443 -0.785 0 N-CA-C 108.884 -0.784 . . . . 0.34999999999999998 108.884 172.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 23.6 Cg_exo -65.66 57.14 0.36 Allowed 'Trans proline' 0 N--CA 1.474 0.347 0 C-N-CA 124.422 3.415 . . . . 0.62 113.223 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.494 ' HG2' HG13 ' A' ' 203' ' ' ILE . 11.4 tp10 -157.42 167.88 28.94 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 108.207 -1.035 . . . . 1.6799999999999999 108.207 176.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.507 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 20.0 p -69.49 141.37 90.67 Favored Pre-proline 0 N--CA 1.429 -1.511 0 CA-C-O 122.09 0.948 . . . . 1.1799999999999999 111.637 -175.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.581 ' HA ' HD12 ' A' ' 61' ' ' LEU . 32.3 Cg_exo -59.68 -15.39 31.22 Favored 'Trans proline' 0 CA--C 1.518 -0.29 0 C-N-CA 124.505 3.47 . . . . 0.52000000000000002 110.534 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.03 -53.33 21.03 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.195 -1.366 . . . . 0.64000000000000001 111.011 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.612 ' HA ' ' HB3' ' A' ' 63' ' ' ASP . 13.6 ttpt -70.97 -23.47 62.22 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.812 -0.81 . . . . 3.2999999999999998 108.812 -177.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.019 HD23 HD13 ' A' ' 203' ' ' ILE . 45.0 mt -60.72 -55.74 29.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.006 -0.997 . . . . 0.40999999999999998 109.756 171.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.1 p -68.63 -9.24 48.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.007 0.432 . . . . 1.29 110.724 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.612 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 29.4 t70 -90.17 -28.36 18.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.021 -0.536 . . . . 1.3200000000000001 111.828 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.673 ' CD2' ' HA ' ' A' ' 61' ' ' LEU . 8.8 p90 -86.32 -43.69 12.69 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 120.378 -0.529 . . . . 0.60999999999999999 110.967 -174.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.711 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -89.62 7.61 35.63 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.975 -0.29 . . . . 1.5 110.973 -174.462 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -53.19 -71.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.467 -0.788 . . . . 1.52 111.875 -164.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 165.08 133.56 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 108.363 -0.977 . . . . 3.6000000000000001 108.363 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.909 ' HA ' ' NH2' ' A' ' 71' ' ' ARG . 5.8 t 46.73 31.63 1.48 Allowed 'General case' 0 C--N 1.313 -1.007 0 O-C-N 124.534 1.146 . . . . 1.48 112.66 177.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.533 ' O ' ' HB3' ' A' ' 70' ' ' ASP . . . -88.69 -44.7 5.11 Favored Glycine 0 N--CA 1.427 -1.947 0 CA-C-N 115.173 -0.921 . . . . 1.46 110.859 -176.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.533 ' HB3' ' O ' ' A' ' 69' ' ' GLY . 29.4 p-10 152.35 -5.12 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 113.139 -1.53 . . . . 2.1899999999999999 108.23 -166.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.909 ' NH2' ' HA ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -46.96 -27.79 1.4 Allowed 'General case' 0 C--O 1.211 -0.957 0 N-CA-C 113.536 0.939 . . . . 3.3799999999999999 113.536 178.757 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.703 HD13 ' NH1' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -92.18 -14.37 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 119.124 -1.031 . . . . 0.70999999999999996 111.047 178.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.51 HG22 ' O ' ' A' ' 70' ' ' ASP . 0.7 OUTLIER -86.01 -28.05 24.42 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 120.27 -0.572 . . . . 0.96999999999999997 110.239 -173.68 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.696 ' CE2' ' HA ' ' A' ' 71' ' ' ARG . 14.8 p-90 -107.22 -4.86 18.32 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.467 -0.493 . . . . 0.75 111.924 178.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.809 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 5.6 t70 -71.99 174.87 6.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.506 0.67 . . . . 2.1899999999999999 111.453 -172.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.822 ' HG2' ' HB3' ' A' ' 198' ' ' ASN . 8.1 mmmt -108.91 -25.41 10.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.199 -0.909 . . . . 3.1899999999999999 109.76 -177.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.6 m -127.6 11.51 6.78 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.34 -0.846 . . . . 1.5800000000000001 111.266 -173.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.7 HD13 HG22 ' A' ' 72' ' ' ILE . 15.9 mt -107.36 152.23 24.44 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.142 0.496 . . . . 0.70999999999999996 111.471 -178.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.544 ' HB3' HG23 ' A' ' 80' ' ' VAL . 43.2 mt-30 -118.92 -70.49 0.79 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.447 -0.797 . . . . 1.73 111.225 178.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.544 HG23 ' HB3' ' A' ' 79' ' ' GLN . 22.0 t -148.66 124.31 2.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.468 -0.787 . . . . 0.78000000000000003 110.556 -166.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.893 ' HB3' HH21 ' A' ' 71' ' ' ARG . 48.7 t80 -109.71 142.54 40.76 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.416 -0.514 . . . . 5.4000000000000004 111.213 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.512 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 0.9 OUTLIER -136.74 118.71 15.3 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.928 -1.138 . . . . 1.6899999999999999 107.928 -179.455 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.546 ' SD ' ' HD2' ' A' ' 86' ' ' ARG . 2.0 ttt -68.5 107.48 2.93 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.696 -0.684 . . . . 2.0499999999999998 109.358 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -84.31 -71.57 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 120.22 -0.592 . . . . 0.64000000000000001 111.411 -170.608 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -137.9 108.95 6.75 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.017 -0.538 . . . . 1.96 109.884 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.953 ' HG2' ' HD2' ' A' ' 92' ' ' PHE . 68.1 mtp180 -85.32 129.47 34.8 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.31 -0.626 . . . . 2.4399999999999999 109.31 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.739 HG21 ' HB2' ' A' ' 3' ' ' PHE . 0.7 OUTLIER -86.99 -54.52 7.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.428 -0.805 . . . . 0.46999999999999997 109.969 -172.217 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.564 ' CG ' ' HD2' ' A' ' 4' ' ' LYS . 6.8 m-20 -136.15 -142.98 0.18 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.636 -1.165 . . . . 1.8600000000000001 108.808 -177.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.2 t -95.02 -12.22 27.01 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.609 -0.515 . . . . 1.4399999999999999 109.609 175.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -128.27 3.54 5.75 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.039 -0.528 . . . . 1.8700000000000001 110.428 -171.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.59 ' HB ' ' HB ' ' A' ' 87' ' ' ILE . 0.3 OUTLIER -132.38 121.35 23.33 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.599 -0.889 . . . . 0.46000000000000002 108.599 -172.201 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.953 ' HD2' ' HG2' ' A' ' 86' ' ' ARG . 14.1 m-85 -133.21 176.14 8.77 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 120.954 0.407 . . . . 0.42999999999999999 110.267 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.728 ' O ' HG23 ' A' ' 84' ' ' VAL . 21.8 mt -133.09 125.93 52.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 107.354 -1.35 . . . . 0.40999999999999998 107.354 168.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.556 ' HA ' ' HE1' ' A' ' 81' ' ' TYR . 94.6 m -106.58 108.41 19.9 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.101 -0.499 . . . . 2.0099999999999998 112.153 -169.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.577 ' HA ' ' O ' ' A' ' 111' ' ' PHE . 8.4 t60 -84.75 103.62 14.0 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.024 -0.732 . . . . 1.23 109.024 171.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.734 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 27.9 m -127.34 119.91 27.33 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.244 -0.435 . . . . 0.5 111.84 -173.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 32.9 mm -77.67 138.94 19.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.076 -0.713 . . . . 1.03 109.076 174.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 1.3 m -113.58 152.34 30.44 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.58 -0.737 . . . . 1.3799999999999999 110.244 -171.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 . . . . . 0 C--N 1.316 -0.855 0 CA-C-N 116.397 -0.365 . . . . 1.8200000000000001 110.147 177.106 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.486 HD11 HG22 ' A' ' 183' ' ' ILE . 5.2 mp . . . . . 0 N--CA 1.45 -0.459 0 N-CA-C 109.361 -0.607 . . . . 1.1200000000000001 109.361 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.527 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 17.7 m -71.1 164.83 53.47 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.695 -0.684 . . . . 1.3500000000000001 111.035 -178.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 107' ' ' SER . 2.0 Cg_endo -45.15 114.6 0.7 Allowed 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 123.38 2.72 . . . . 1.0700000000000001 111.397 176.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.612 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 23.0 ttp180 -102.99 158.54 16.22 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.99 -0.55 . . . . 3.4500000000000002 110.836 -168.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.928 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 8.2 t0 -113.37 122.94 48.87 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.059 -0.719 . . . . 1.3700000000000001 109.059 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.734 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 6.0 m-85 -99.38 132.07 44.96 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 120.855 0.36 . . . . 2.4100000000000001 110.471 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.572 HD13 ' HA ' ' A' ' 95' ' ' HIS . 30.1 mm -133.46 68.09 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.069 -1.085 . . . . 0.42999999999999999 108.069 171.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.91 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 4.5 m-20 -90.76 115.86 28.17 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.718 -1.128 . . . . 1.8600000000000001 109.799 -177.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 129' ' ' SER . 6.3 tp -74.6 120.85 20.71 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 108.564 -0.902 . . . . 0.28000000000000003 108.564 169.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -125.46 126.15 70.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 115.115 -0.948 . . . . 0.26000000000000001 111.824 -164.319 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.588 ' CE2' ' HB2' ' A' ' 118' ' ' LYS . 50.9 t80 -110.63 120.11 41.35 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 114.456 -1.247 . . . . 2.5699999999999998 110.211 174.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.695 HG12 HG22 ' A' ' 127' ' ' ILE . 74.2 mt -100.25 103.26 14.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.824 -0.625 . . . . 0.89000000000000001 110.359 -177.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.588 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 26.7 ttmt -124.73 133.84 53.04 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.114 0.483 . . . . 1.2 110.211 177.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.528 ' HD2' ' O ' ' A' ' 119' ' ' ARG . 0.4 OUTLIER -110.91 119.57 39.53 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 108.573 -0.899 . . . . 2.7999999999999998 108.573 173.057 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.52 ' CB ' ' HB2' ' A' ' 123' ' ' ASN . 99.1 m-85 -75.98 104.8 6.68 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.455 -1.683 . . . . 0.82999999999999996 106.455 164.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -52.04 98.3 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 122.302 1.049 . . . . 2.2799999999999998 112.598 -171.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.434 ' C ' HD22 ' A' ' 123' ' ' ASN . . . 84.89 24.41 45.36 Favored Glycine 0 CA--C 1.504 -0.595 0 CA-C-N 113.451 -1.704 . . . . 0.76000000000000001 112.14 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.632 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 1.0 OUTLIER -126.02 -57.71 1.41 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.723 -0.739 . . . . 1.6499999999999999 109.617 175.224 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.404 ' O ' ' HA ' ' A' ' 119' ' ' ARG . 2.8 mpp? -160.48 135.27 7.62 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.894 -0.594 . . . . 1.1200000000000001 110.544 -170.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.469 ' HB2' ' HB2' ' A' ' 155' ' ' CYS . 21.9 m-80 -115.02 87.18 2.6 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.312 -0.996 . . . . 1.6200000000000001 108.312 176.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.632 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.4 OUTLIER -110.0 143.76 19.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 112.976 0.732 . . . . 0.29999999999999999 112.976 -170.527 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.695 HG22 HG12 ' A' ' 117' ' ' ILE . 5.2 pt -110.51 113.98 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.478 -0.934 . . . . 0.58999999999999997 108.478 161.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.625 ' HB3' ' HA ' ' A' ' 11' ' ' ALA . 22.6 p -94.13 124.08 37.91 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.239 -0.437 . . . . 1.1799999999999999 110.693 178.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.91 ' HB3' ' HB3' ' A' ' 113' ' ' ASP . 19.8 m -125.32 141.91 51.8 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.089 0.471 . . . . 1.24 111.801 -170.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.57 ' HE3' HG22 ' A' ' 6' ' ' ILE . 5.5 mtpm? -131.32 126.11 34.48 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 107.97 -1.122 . . . . 2.2599999999999998 107.97 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.6 p -64.89 97.45 0.23 Allowed 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.337 -1.357 . . . . 1.3899999999999999 107.337 172.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.68 140.27 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 N-CA-C 108.766 -0.827 . . . . 1.05 108.766 -165.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -97.23 81.37 3.02 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.162 -0.927 . . . . 2.1699999999999999 108.676 -172.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.498 ' HE1' HG21 ' A' ' 112' ' ' ILE . 0.5 OUTLIER -111.74 152.54 44.2 Favored Pre-proline 0 C--N 1.311 -1.066 0 CA-C-N 114.374 -1.285 . . . . 0.53000000000000003 109.902 -173.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.75 -18.94 66.19 Favored 'Trans proline' 0 N--CA 1.48 0.701 0 C-N-CA 123.732 2.954 . . . . 1.28 116.156 -167.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.441 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 2.6 tp10 -68.86 -29.33 67.61 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 121.608 0.718 . . . . 3.5 109.771 -172.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.563 ' CD2' HD11 ' A' ' 112' ' ' ILE . 32.4 t80 -158.25 106.94 1.7 Allowed Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 114.807 -1.088 . . . . 6.1200000000000001 113.828 -175.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.455 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 3.7 Cg_endo -87.44 155.0 7.88 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.172 2.581 . . . . 1.77 109.881 161.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -67.27 -165.13 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 121.982 1.788 . . . . 1.25 112.438 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 13.9 t -136.47 -159.37 0.95 Allowed 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 109.071 -0.714 . . . . 1.6000000000000001 109.071 -170.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 41.9 m -82.49 -42.05 18.96 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.39 -0.524 . . . . 1.97 111.693 -176.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -95.93 -29.9 13.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.095 0.474 . . . . 2.1800000000000002 110.0 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.928 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 25.5 m-85 -85.14 109.5 18.32 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.739 -0.664 . . . . 1.23 110.113 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.612 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 0.9 OUTLIER -96.95 115.37 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 108.404 -0.962 . . . . 0.81999999999999995 108.404 177.517 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.672 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 20.7 ttm180 -55.38 107.9 0.37 Allowed 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.084 -0.71 . . . . 4.4199999999999999 109.084 174.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -59.4 111.13 3.18 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 110.959 -0.856 . . . . 0.79000000000000004 110.959 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -84.01 75.5 10.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 122.183 0.992 . . . . 4.4400000000000004 111.465 -175.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.559 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 16.5 m-20 -79.12 99.52 6.99 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 113.741 -1.572 . . . . 1.6200000000000001 108.565 171.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.499 ' O ' ' N ' ' A' ' 151' ' ' CYS . 77.0 m-70 -60.25 152.84 61.26 Favored Pre-proline 0 C--O 1.22 -0.463 0 N-CA-C 107.513 -1.292 . . . . 2.3199999999999998 107.513 173.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.555 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 32.1 Cg_exo -24.67 70.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.181 1 C-N-CA 126.116 4.544 . . . . 0.53000000000000003 115.544 -173.494 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . 0.612 ' HB2' ' O ' ' A' ' 170' ' ' PHE . 25.8 p -97.41 -174.26 2.88 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.987 -1.006 . . . . 1.5800000000000001 109.907 176.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.687 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -172.26 -161.7 23.19 Favored Glycine 0 N--CA 1.433 -1.544 0 C-N-CA 119.775 -1.202 . . . . 0.42999999999999999 112.001 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.469 ' CE2' ' HG ' ' A' ' 65' ' ' LEU . 72.4 t80 -161.83 91.17 0.8 Allowed 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.53 -0.915 . . . . 0.59999999999999998 108.53 -168.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.643 ' CG2' HG13 ' A' ' 168' ' ' VAL . 2.4 m -100.96 131.15 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-O 121.856 0.836 . . . . 0.31 110.83 -173.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 125' ' ' ASN . 74.9 m -110.16 109.36 19.84 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.069 -0.969 . . . . 1.55 109.62 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.469 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 19.9 m -105.73 121.22 46.65 Favored Pre-proline 0 C--N 1.318 -0.801 0 N-CA-C 112.15 0.426 . . . . 1.0600000000000001 112.15 -167.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.632 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 59.8 Cg_exo -51.69 126.02 18.55 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.953 2.435 . . . . 0.56000000000000005 111.875 170.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.617 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 0.2 OUTLIER -88.01 -170.67 3.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.189 0.519 . . . . 1.1599999999999999 111.561 -178.445 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -77.97 -24.45 48.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.426 0.631 . . . . 2.6299999999999999 109.547 168.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 37.8 mt-10 -100.65 27.29 5.97 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.052 -1.092 . . . . 2.0499999999999998 108.052 172.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.745 ' HB3' ' HD3' ' A' ' 162' ' ' PRO . 0.2 OUTLIER -14.99 -71.73 0.02 OUTLIER Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 126.478 1.911 . . . . 1.9299999999999999 115.074 -174.188 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.745 ' HD3' ' HB3' ' A' ' 161' ' ' ASN . 73.0 Cg_endo -73.36 -15.86 24.93 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 121.268 1.312 . . . . 0.72999999999999998 113.516 -170.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -104.45 -25.58 12.75 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.161 -0.472 . . . . 0.68000000000000005 110.993 -176.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.617 ' O ' ' HB2' ' A' ' 158' ' ' MET . 49.6 m-85 -141.03 122.29 14.82 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.497 -0.557 . . . . 0.93000000000000005 109.497 177.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 45.5 t -114.13 145.71 41.28 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.488 -0.485 . . . . 1.4099999999999999 110.578 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.657 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.8 tppp? -92.13 101.83 14.35 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 122.049 0.928 . . . . 0.73999999999999999 111.142 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 0.9 OUTLIER -87.49 105.01 17.01 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.385 -1.28 . . . . 0.27000000000000002 109.31 178.748 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.643 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.1 OUTLIER -128.78 117.2 43.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 122.171 0.986 . . . . 0.28000000000000003 112.004 178.112 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.435 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 23.0 ttt -116.97 147.25 42.45 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.814 -1.084 . . . . 1.24 109.496 -177.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.612 ' O ' ' HB2' ' A' ' 151' ' ' CYS . 92.9 m-85 -122.34 128.02 50.51 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.076 -0.713 . . . . 3.3700000000000001 109.076 177.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.598 ' HB ' HD21 ' A' ' 192' ' ' LEU . 2.5 p -111.12 117.98 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-O 121.744 0.783 . . . . 1.3999999999999999 110.003 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.566 HE21 HD11 ' A' ' 47' ' ' LEU . 13.7 tt0 -113.7 48.67 1.04 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.268 -1.012 . . . . 2.1699999999999999 108.268 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.01 136.47 46.72 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.058 -1.428 . . . . 1.6499999999999999 113.247 -170.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 . . . . . 0 N--CA 1.451 -0.392 0 CA-C-N 115.927 -0.579 . . . . 2.4500000000000002 111.39 174.625 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.809 ' HA ' ' HE2' ' A' ' 186' ' ' LYS . 8.0 mm . . . . . 0 N--CA 1.47 0.574 0 CA-C-O 122.872 1.32 . . . . 1.1200000000000001 109.398 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.954 ' HA ' HG22 ' A' ' 187' ' ' THR . 0.9 OUTLIER -86.46 -33.47 7.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 112.886 -1.961 . . . . 1.1299999999999999 110.366 -169.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.47 ' OE2' ' HB3' ' A' ' 186' ' ' LYS . 0.0 OUTLIER -60.71 -25.53 66.49 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.558 -0.746 . . . . 2.8900000000000001 110.612 173.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.809 ' HE2' ' HA ' ' A' ' 183' ' ' ILE . 0.0 OUTLIER -93.37 -36.53 12.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 1.28 110.477 174.774 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.954 HG22 ' HA ' ' A' ' 184' ' ' ILE . 5.7 t -66.47 -26.7 67.32 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 120.716 -0.394 . . . . 0.62 111.832 -171.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . 0.59 ' HE2' ' HA ' ' A' ' 188' ' ' MET . 4.2 mmt -76.93 -60.09 0.85 Allowed Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.683 -0.407 . . . . 1.0600000000000001 111.65 -177.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.492 ' O ' HG13 ' A' ' 193' ' ' VAL . 18.2 Cg_endo -60.54 -36.61 85.23 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 121.668 1.579 . . . . 0.91000000000000003 111.76 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.596 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 7.8 t -70.07 -23.55 63.1 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.971 0.415 . . . . 1.5 110.763 -176.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.436 HD22 ' C ' ' A' ' 191' ' ' ASN . 0.2 OUTLIER -91.06 -45.59 8.61 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.332 -0.394 . . . . 1.8799999999999999 110.494 -178.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.641 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 80.3 mt -72.14 -45.91 58.6 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.083 -0.508 . . . . 1.0900000000000001 112.146 -170.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.492 HG13 ' O ' ' A' ' 189' ' ' PRO . 1.8 m -75.68 -33.25 25.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.736 0.779 . . . . 0.68000000000000005 108.948 -173.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.596 ' HB2' ' O ' ' A' ' 190' ' ' SER . 1.1 t30 -62.94 -49.13 75.96 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.052 -1.431 . . . . 2.0699999999999998 109.773 175.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.656 ' HA ' ' OD1' ' A' ' 198' ' ' ASN . 5.2 t80 -56.56 -30.49 63.19 Favored 'General case' 0 C--O 1.233 0.222 0 O-C-N 123.739 0.649 . . . . 2.0 109.999 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.75 HG21 HG21 ' A' ' 33' ' ' ILE . 8.7 mt -78.7 -39.83 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-N 115.992 -0.549 . . . . 0.31 112.437 177.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.641 ' HA ' ' HG2' ' A' ' 200' ' ' LYS . 2.8 pp -80.41 -21.72 41.96 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 119.304 -0.958 . . . . 1.03 111.076 -176.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.822 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 1.6 p-10 -74.64 -13.91 60.7 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 118.816 -1.153 . . . . 1.8999999999999999 108.281 166.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.63 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -82.25 -27.31 32.52 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.266 -1.013 . . . . 0.28999999999999998 108.266 170.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.686 ' HD3' HG12 ' A' ' 54' ' ' ILE . 26.3 mmtp -69.36 -38.85 78.29 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.543 -0.753 . . . . 0.96999999999999997 109.333 173.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -86.53 -39.61 16.06 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 114.783 -1.099 . . . . 1.9399999999999999 110.169 -176.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -70.51 -29.55 69.74 Favored Glycine 0 CA--C 1.503 -0.715 0 C-N-CA 120.994 -0.622 . . . . 0.46999999999999997 111.602 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 1.019 HD13 HD23 ' A' ' 61' ' ' LEU . 2.8 tp -71.59 -31.47 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 109.606 -0.516 . . . . 0.60999999999999999 109.606 177.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.561 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 53.3 mttp -86.5 -23.74 25.82 Favored 'General case' 0 C--O 1.204 -1.293 0 N-CA-C 108.836 -0.801 . . . . 3.3700000000000001 108.836 176.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.973 0 N-CA-C 109.221 -0.659 . . . . 1.02 109.221 169.525 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.402 ' O ' ' HB3' ' A' ' 5' ' ' ALA . 10.1 m-20 . . . . . 0 CA--C 1.512 -0.503 0 CA-C-O 120.771 0.32 . . . . 2.25 110.929 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.578 ' HD1' HD22 ' A' ' 114' ' ' LEU . 95.4 m-85 -67.24 -32.14 72.98 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.604 0.716 . . . . 0.42999999999999999 109.466 -176.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.522 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 18.1 tttt -75.48 -1.33 23.64 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 114.594 -1.185 . . . . 1.51 109.855 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 2' ' ' ASP . . . -93.28 -42.47 9.31 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.951 -0.568 . . . . 0.54000000000000004 110.06 171.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.635 ' O ' ' HB ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -84.2 -35.47 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-O 121.08 0.467 . . . . 1.0700000000000001 110.511 -174.371 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.489 ' HB2' HD21 ' A' ' 114' ' ' LEU . . . -80.19 -40.7 26.69 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.096 -0.957 . . . . 0.34000000000000002 111.338 -176.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.522 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 4.0 mt-30 -63.45 -32.8 74.34 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.079 -0.964 . . . . 1.5900000000000001 109.658 176.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.635 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 13.2 mm100 -78.68 -42.75 27.69 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.613 -1.176 . . . . 2.4700000000000002 109.1 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.635 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -60.24 -35.73 76.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.656 -0.702 . . . . 0.47999999999999998 111.257 179.73 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.456 ' HA ' ' OG ' ' A' ' 128' ' ' SER . . . -48.79 -58.92 4.05 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 121.098 0.475 . . . . 0.31 110.94 171.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -71.99 -18.18 62.0 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.711 -0.677 . . . . 1.6399999999999999 111.564 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.635 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 49.9 mt-10 -68.76 -56.73 7.12 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.03 -0.73 . . . . 2.54 109.03 172.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.695 HG23 ' CE2' ' A' ' 170' ' ' PHE . 11.9 p -68.97 -41.77 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.893 -0.594 . . . . 0.53000000000000003 111.228 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.33 -31.55 65.81 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.543 -0.753 . . . . 0.59999999999999998 109.219 174.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.62 -28.33 73.1 Favored Glycine 0 CA--C 1.503 -0.715 0 CA-C-N 114.21 -1.359 . . . . 0.56999999999999995 110.324 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.492 ' HD1' ' O ' ' A' ' 13' ' ' GLU . 11.6 m-85 -93.05 -16.86 24.52 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.763 -0.718 . . . . 3.27 109.636 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.82 -6.16 40.1 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.54 0.686 . . . . 2.0299999999999998 109.199 -175.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -110.16 -17.32 13.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.641 -1.163 . . . . 2.7200000000000002 109.714 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -100.44 138.19 37.83 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.433 -0.803 . . . . 2.1600000000000001 110.239 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 40.3 p -137.29 88.91 2.38 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.363 0.602 . . . . 1.8200000000000001 111.336 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.1 p -173.78 146.25 1.24 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.173 -0.921 . . . . 2.1899999999999999 111.451 -178.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.495 ' O ' ' HG3' ' A' ' 38' ' ' LYS . . . 92.81 2.27 67.11 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 121.294 -0.479 . . . . 1.1000000000000001 112.807 174.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.498 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -120.04 -158.29 0.74 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.925 0.393 . . . . 1.6699999999999999 110.878 -176.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.29 119.24 0.91 Allowed 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 108.811 -0.811 . . . . 2.9500000000000002 108.811 -174.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.603 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 3.1 p -64.24 117.38 4.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 C-N-CA 119.37 -0.932 . . . . 1.5600000000000001 109.726 175.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.4 p -94.09 -23.72 5.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 114.317 -1.311 . . . . 1.22 108.944 -176.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.504 ' HD3' ' C ' ' A' ' 28' ' ' LYS . 0.5 OUTLIER -157.57 123.71 4.79 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 120.252 -0.579 . . . . 2.4100000000000001 110.199 -174.471 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.415 ' HB ' ' HA ' ' A' ' 34' ' ' THR . 0.9 OUTLIER -151.34 152.07 32.64 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.208 0.528 . . . . 1.3799999999999999 111.485 -178.463 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.3 t -112.12 -147.95 0.42 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.579 -0.897 . . . . 2.3700000000000001 108.579 175.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.32 25.87 6.53 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.444 0.64 . . . . 4.5499999999999998 109.38 176.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.545 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 25.6 mmtm -156.73 -44.85 0.07 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 114.911 -1.04 . . . . 1.4199999999999999 111.814 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.459 HG22 ' HA3' ' A' ' 52' ' ' GLY . 24.0 pt -104.87 160.42 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-O 120.766 0.317 . . . . 0.76000000000000001 111.394 -175.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 2.6 m -149.72 109.9 4.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.548 -0.751 . . . . 0.57999999999999996 110.487 -171.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.42 HG22 HG23 ' A' ' 50' ' ' VAL . 16.3 t -103.07 102.13 13.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.161 0.505 . . . . 0.85999999999999999 109.943 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 2.9 p -97.48 124.66 41.78 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.5 -0.773 . . . . 1.1000000000000001 111.693 -176.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.7 t -103.27 125.53 49.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.537 -1.211 . . . . 1.27 109.527 -175.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 29.4 ttpt . . . . . 0 C--N 1.317 -0.818 0 CA-C-N 116.348 -0.387 . . . . 1.9099999999999999 111.283 -176.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 . . . . . 0 N--CA 1.437 -1.101 0 CA-C-O 120.948 0.404 . . . . 2.0499999999999998 110.992 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.751 HD21 ' CD1' ' A' ' 170' ' ' PHE . 4.9 tt -84.76 133.25 34.36 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.95 -1.13 . . . . 0.87 107.95 175.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.624 ' N ' HD23 ' A' ' 47' ' ' LEU . 97.9 m-85 -113.66 128.59 56.48 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.003 0.43 . . . . 0.98999999999999999 110.092 -176.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.441 ' HD2' ' CH2' ' A' ' 24' ' ' TRP . 3.8 tmt_? -122.88 131.35 53.7 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.598 -0.728 . . . . 2.9199999999999999 109.274 177.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 34' ' ' THR . 10.1 p -116.49 151.35 18.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.046 0.45 . . . . 1.3300000000000001 110.543 -176.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.448 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 27.3 tt0 -148.36 108.81 4.14 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.444 -0.798 . . . . 1.0700000000000001 109.408 -172.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 32' ' ' LYS . . . -140.91 138.5 8.93 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 119.978 -1.106 . . . . 0.28999999999999998 112.306 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 67.6 mt -84.56 129.3 37.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.033 0.444 . . . . 0.57999999999999996 110.139 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 63.8 mt -109.59 119.0 49.19 Favored Pre-proline 0 N--CA 1.442 -0.839 0 CA-C-N 115.767 -0.651 . . . . 0.34999999999999998 109.612 177.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 34.0 Cg_exo -61.67 69.17 0.1 Allowed 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 124.262 3.308 . . . . 0.62 112.685 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.596 ' HG2' ' CG1' ' A' ' 203' ' ' ILE . 7.6 tp10 -163.79 176.68 9.3 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.061 -1.088 . . . . 1.6799999999999999 108.061 176.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.506 ' H ' ' HG3' ' A' ' 56' ' ' GLU . 53.4 p -84.75 153.78 61.13 Favored Pre-proline 0 N--CA 1.427 -1.603 0 CA-C-O 121.332 0.587 . . . . 1.1799999999999999 110.298 176.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.5 ' HA ' HD12 ' A' ' 61' ' ' LEU . 11.9 Cg_exo -68.28 -9.58 26.31 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.742 2.961 . . . . 0.52000000000000002 110.26 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.53 -48.72 25.32 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.687 -1.142 . . . . 0.64000000000000001 111.153 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -72.93 -26.5 61.41 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.788 -0.819 . . . . 3.2999999999999998 108.788 -178.392 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.031 HD23 HD13 ' A' ' 203' ' ' ILE . 83.3 mt -64.13 -53.49 48.81 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 114.729 -1.123 . . . . 0.40999999999999998 109.796 173.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.425 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 18.1 m -64.29 -13.45 49.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.502 -0.772 . . . . 1.29 110.442 175.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.427 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 24.6 t70 -84.95 -42.82 14.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.833 -0.621 . . . . 1.3200000000000001 111.564 -178.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.571 ' CD2' ' HA ' ' A' ' 61' ' ' LEU . 11.9 p90 -73.3 -44.38 59.19 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 120.571 -0.452 . . . . 0.60999999999999999 111.2 -174.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.425 ' CD2' ' HA ' ' A' ' 62' ' ' SER . 0.7 OUTLIER -80.79 -16.79 52.87 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 120.433 -0.507 . . . . 1.5 111.965 -173.264 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.631 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 34.8 t80 -26.3 -72.28 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 O-C-N 124.6 1.188 . . . . 1.52 113.811 -153.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.631 ' HG2' ' O ' ' A' ' 66' ' ' TYR . 5.4 mm-40 175.8 115.95 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.08 0 C-N-CA 124.32 1.048 . . . . 3.6000000000000001 108.229 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.727 ' HB ' ' CD1' ' A' ' 81' ' ' TYR . 13.3 t 39.83 31.46 0.08 Allowed 'General case' 0 C--N 1.319 -0.753 0 O-C-N 124.348 1.03 . . . . 1.48 112.584 -177.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.3 -38.79 8.79 Favored Glycine 0 N--CA 1.436 -1.357 0 CA-C-N 115.5 -0.773 . . . . 1.46 113.001 -168.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.655 ' O ' HG22 ' A' ' 73' ' ' THR . 23.3 t70 169.59 -22.04 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.338 -0.986 . . . . 2.1899999999999999 108.338 -163.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.775 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 3.9 ptp180 -43.8 -48.07 8.14 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 114.772 -1.103 . . . . 3.3799999999999999 111.165 -178.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.767 HD13 ' H ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -79.32 -16.08 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 C-N-CA 120.695 -0.402 . . . . 0.70999999999999996 111.613 -172.325 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.655 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.3 t -82.41 -35.86 27.25 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 119.8 -0.76 . . . . 0.96999999999999997 109.995 -174.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.559 ' CZ2' ' HA ' ' A' ' 71' ' ' ARG . 16.8 p-90 -100.96 -3.7 29.01 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.343 -0.543 . . . . 0.75 111.387 -177.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.775 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 3.0 t70 -75.27 177.31 6.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.717 -0.674 . . . . 2.1899999999999999 112.269 -170.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.608 ' HG3' ' OD1' ' A' ' 198' ' ' ASN . 0.0 OUTLIER -133.94 -12.43 2.56 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.539 -0.755 . . . . 3.1899999999999999 111.4 179.246 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.4 m -111.33 -1.73 15.91 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.306 -0.998 . . . . 1.5800000000000001 108.306 178.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.616 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 68.3 mt -110.79 176.81 4.88 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.566 -1.197 . . . . 0.70999999999999996 110.037 -178.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -149.02 -67.95 0.22 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.495 -0.775 . . . . 1.73 110.002 -176.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.503 ' HB ' HD13 ' A' ' 97' ' ' ILE . 26.0 t -143.89 135.87 22.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.643 -0.708 . . . . 0.78000000000000003 109.808 -173.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.727 ' CD1' ' HB ' ' A' ' 68' ' ' THR . 11.4 t80 -112.24 139.29 47.91 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.801 -0.444 . . . . 5.4000000000000004 109.801 176.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.551 ' O ' ' HB3' ' A' ' 95' ' ' HIS . 17.1 m120 -137.71 114.76 10.8 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.902 -0.777 . . . . 1.6899999999999999 108.902 175.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.423 ' HG2' ' NE ' ' A' ' 86' ' ' ARG . 48.6 tpp -75.53 113.02 12.47 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.736 -0.838 . . . . 2.0499999999999998 108.736 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -85.88 -69.74 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.154 0.502 . . . . 0.64000000000000001 110.201 -170.142 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.43 ' HB3' HD12 ' A' ' 93' ' ' ILE . 80.6 t60 -132.91 124.75 28.43 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.718 -0.673 . . . . 1.96 109.7 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.423 ' NE ' ' HG2' ' A' ' 83' ' ' MET . 40.9 mtt180 -101.87 129.06 48.02 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.86 -0.793 . . . . 2.4399999999999999 108.86 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.523 HG21 ' HB2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -91.51 -39.08 11.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.468 0.651 . . . . 0.46999999999999997 109.418 -176.336 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -150.7 -169.4 3.38 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.98 -1.009 . . . . 1.8600000000000001 108.764 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.1 m -80.15 -4.41 52.86 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.858 0.361 . . . . 1.4399999999999999 110.742 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -135.69 13.3 3.43 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 109.884 -0.414 . . . . 1.8700000000000001 109.884 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.511 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -139.01 111.09 7.32 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 109.009 -0.737 . . . . 0.46000000000000002 109.009 -176.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.602 ' O ' HD12 ' A' ' 114' ' ' LEU . 41.5 m-85 -128.76 178.96 5.98 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.845 -0.616 . . . . 0.42999999999999999 110.274 -173.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.562 ' O ' HG23 ' A' ' 84' ' ' VAL . 39.1 mt -132.81 124.68 51.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 108.258 -1.016 . . . . 0.40999999999999998 108.258 169.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.643 ' SG ' HG11 ' A' ' 115' ' ' VAL . 75.2 m -92.82 107.67 19.4 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.1 -0.5 . . . . 2.0099999999999998 112.196 -171.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.58 ' HA ' HD13 ' A' ' 112' ' ' ILE . 5.3 t60 -87.11 81.85 7.89 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.027 -1.101 . . . . 1.23 108.027 164.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.444 ' OG1' ' HB3' ' A' ' 94' ' ' CYS . 90.5 m -108.3 113.0 25.75 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.72 -1.127 . . . . 0.5 111.761 -170.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.503 HD13 ' HB ' ' A' ' 80' ' ' VAL . 3.2 mp -77.58 121.57 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 108.227 -1.027 . . . . 1.03 108.227 173.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.599 ' HB ' ' O ' ' A' ' 109' ' ' ARG . 71.8 m -111.27 149.37 31.14 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.94 -1.027 . . . . 1.3799999999999999 110.771 -171.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 C--N 1.319 -0.749 0 CA-C-O 121.046 0.45 . . . . 1.8200000000000001 110.559 -176.237 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 44.0 mt . . . . . 0 N--CA 1.447 -0.595 0 N-CA-C 109.95 -0.389 . . . . 1.1200000000000001 109.95 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.8 m -77.17 155.1 82.41 Favored Pre-proline 0 C--N 1.319 -0.753 0 N-CA-C 109.366 -0.605 . . . . 1.3500000000000001 109.366 174.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -44.71 122.92 4.4 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.681 2.254 . . . . 1.0700000000000001 111.031 173.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.625 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 33.3 ttp180 -118.67 137.44 53.3 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.712 -0.395 . . . . 3.4500000000000002 110.097 -167.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.592 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 22.0 t70 -107.47 147.52 30.36 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 120.754 0.311 . . . . 1.3700000000000001 110.635 -171.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -118.81 155.64 30.82 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.366 0.603 . . . . 2.4100000000000001 111.589 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.628 HG21 ' HE1' ' A' ' 134' ' ' PHE . 35.5 mm -135.78 76.83 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 107.59 -1.263 . . . . 0.42999999999999999 107.59 170.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.57 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 2.1 m-20 -98.91 120.61 39.63 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.579 -0.737 . . . . 1.8600000000000001 110.577 -176.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 92' ' ' PHE . 9.4 tp -75.62 122.04 23.35 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 121.701 0.762 . . . . 0.28000000000000003 109.361 172.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.643 HG11 ' SG ' ' A' ' 94' ' ' CYS . 0.1 OUTLIER -123.58 125.7 71.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-N 114.591 -1.186 . . . . 0.26000000000000001 112.374 -165.123 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.452 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 91.0 t80 -112.87 123.92 51.42 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.332 -0.849 . . . . 2.5699999999999998 110.637 172.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.556 HG13 HG22 ' A' ' 127' ' ' ILE . 4.5 mp -92.07 110.74 23.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.366 -0.834 . . . . 0.89000000000000001 109.783 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.464 ' HB3' HG23 ' A' ' 126' ' ' ILE . 24.8 ttmm -113.41 142.82 45.44 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.032 -0.531 . . . . 1.2 110.596 -176.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -129.01 89.8 2.93 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 116.003 -0.544 . . . . 2.7999999999999998 110.563 -174.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.474 ' HB3' ' HB2' ' A' ' 123' ' ' ASN . 36.9 m-85 -72.29 108.75 5.59 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 107.829 -1.174 . . . . 0.82999999999999996 107.829 167.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -39.81 100.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 O-C-N 124.665 1.228 . . . . 2.2799999999999998 112.813 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.413 ' C ' ' HG2' ' A' ' 157' ' ' PRO . . . 67.12 26.87 73.34 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 114.039 -1.437 . . . . 0.76000000000000001 113.113 176.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.514 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 10.4 m120 -127.38 -46.13 1.49 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.688 -0.256 . . . . 1.6499999999999999 110.64 176.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.551 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 5.8 mtm -162.19 131.17 4.3 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 120.516 -0.474 . . . . 1.1200000000000001 111.96 -176.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -112.42 86.02 2.27 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.612 -1.255 . . . . 1.6200000000000001 107.612 167.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.595 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -97.78 135.74 31.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.136 -0.938 . . . . 0.29999999999999999 112.244 -172.576 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.681 ' O ' HG13 ' A' ' 127' ' ' ILE . 13.9 pt -101.05 108.89 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 108.576 -0.898 . . . . 0.58999999999999997 108.576 164.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.555 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 1.7 m -75.86 161.05 29.31 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.624 -0.88 . . . . 1.1799999999999999 108.624 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.57 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 11.3 p -157.33 121.11 4.18 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.334 0.588 . . . . 1.24 111.618 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.8 ttmt -127.94 110.71 12.81 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.436 -1.32 . . . . 2.2599999999999998 107.436 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.416 ' OG ' ' HA ' ' A' ' 147' ' ' TYR . 22.9 t -58.71 98.84 0.04 OUTLIER 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 107.629 -1.248 . . . . 1.3899999999999999 107.629 -178.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.427 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -107.59 133.84 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.107 0 CA-C-N 114.833 -1.076 . . . . 1.05 108.727 -165.321 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -94.09 71.15 3.94 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.898 -1.047 . . . . 2.1699999999999999 109.076 -169.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.628 ' HE1' HG21 ' A' ' 112' ' ' ILE . 1.8 p90 -99.26 175.06 2.62 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 114.4 -1.273 . . . . 0.53000000000000003 109.488 -172.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -41.98 -50.4 5.2 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.739 2.959 . . . . 1.28 116.479 -174.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -88.12 -5.13 58.62 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.604 0.716 . . . . 3.5 111.604 -170.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.484 ' HB3' ' O ' ' A' ' 134' ' ' PHE . 22.8 t80 -56.72 -48.94 96.37 Favored Pre-proline 0 C--N 1.315 -0.927 0 N-CA-C 114.914 1.45 . . . . 6.1200000000000001 114.914 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 137' ' ' TYR . 66.6 Cg_exo -32.29 110.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 123.821 3.014 . . . . 1.77 114.467 -174.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.598 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 82.3 Cg_endo -83.84 -160.72 0.12 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.687 2.925 . . . . 1.25 114.036 -175.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.9 p -136.64 -164.35 1.56 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.279 -0.873 . . . . 1.6000000000000001 108.943 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.6 p -89.77 -29.83 18.42 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.126 -0.63 . . . . 1.97 110.972 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -83.45 -33.32 25.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 2.1800000000000002 110.732 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -107.67 109.41 21.01 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 109.425 -0.583 . . . . 1.23 109.425 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.625 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 2.4 tp -100.63 106.66 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 C-N-CA 120.123 -0.631 . . . . 0.81999999999999995 109.646 -176.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.598 ' NH2' ' HA ' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -59.43 99.98 0.07 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.109 -0.95 . . . . 4.4199999999999999 110.715 178.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -65.82 122.24 21.54 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.597 -0.729 . . . . 0.79000000000000004 111.297 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.536 ' HB3' ' HB2' ' A' ' 174' ' ' GLU . 3.5 t80 -85.05 78.55 9.87 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.623 0.725 . . . . 4.4400000000000004 110.372 -177.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.685 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 89.0 m-20 -72.55 106.11 4.48 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.736 -1.12 . . . . 1.6200000000000001 110.325 175.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.445 ' CB ' HE21 ' A' ' 172' ' ' GLN . 83.0 m-70 -75.91 144.77 76.65 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 109.545 -0.539 . . . . 2.3199999999999998 109.545 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -13.49 61.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.181 1 C-N-CA 127.599 5.533 . . . . 0.53000000000000003 116.374 -166.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . 0.685 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 19.7 p -89.99 -175.08 4.47 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.451 -0.795 . . . . 1.5800000000000001 110.329 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.633 ' N ' HG21 ' A' ' 14' ' ' VAL . . . 178.99 -161.81 28.33 Favored Glycine 0 N--CA 1.435 -1.371 0 C-N-CA 120.456 -0.878 . . . . 0.42999999999999999 111.479 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.499 ' CZ ' HD11 ' A' ' 167' ' ' LEU . 32.5 t80 -161.38 91.42 0.85 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.075 -1.083 . . . . 0.59999999999999998 108.075 -165.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.595 HG12 ' HB ' ' A' ' 126' ' ' ILE . 2.7 m -98.41 132.62 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-O 122.106 0.955 . . . . 0.31 111.123 -174.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 124' ' ' MET . 16.5 t -109.55 119.28 38.93 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.228 -0.897 . . . . 1.55 109.186 176.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.544 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 6.2 m -116.44 122.41 31.98 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.614 -0.266 . . . . 1.0600000000000001 111.162 -171.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.514 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 46.0 Cg_exo -53.65 126.64 22.48 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.973 1.782 . . . . 0.56000000000000005 110.655 169.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.628 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 70.8 mmm -85.24 -166.61 1.55 Allowed 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.119 0.485 . . . . 1.1599999999999999 111.139 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -74.57 -35.51 63.03 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 121.562 0.696 . . . . 2.6299999999999999 109.225 175.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -102.6 29.49 5.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.874 -1.057 . . . . 2.0499999999999998 108.876 173.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.471 ' HA ' ' O ' ' A' ' 164' ' ' TYR . 2.7 p-10 -28.5 -55.83 0.25 Allowed Pre-proline 0 N--CA 1.475 0.812 0 N-CA-C 116.407 2.002 . . . . 1.9299999999999999 116.407 -171.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.44 ' HD3' ' CG ' ' A' ' 161' ' ' ASN . 55.3 Cg_endo -68.83 -13.59 37.19 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 121.738 1.656 . . . . 0.72999999999999998 112.722 -173.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -109.92 -32.69 6.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.984 -0.553 . . . . 0.68000000000000005 110.765 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.628 ' O ' ' HB2' ' A' ' 158' ' ' MET . 88.3 m-85 -138.76 126.91 22.66 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.417 -0.586 . . . . 0.93000000000000005 109.417 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.467 ' HB2' HD11 ' A' ' 61' ' ' LEU . 73.6 m -125.65 154.22 42.67 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.181 0.515 . . . . 1.4099999999999999 111.853 -176.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.544 ' HB3' ' HB2' ' A' ' 156' ' ' SER . 2.0 tppp? -96.77 105.25 17.34 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.887 0.851 . . . . 0.73999999999999999 112.081 -174.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.499 HD11 ' CZ ' ' A' ' 153' ' ' PHE . 0.6 OUTLIER -92.82 108.82 20.29 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.579 -1.191 . . . . 0.27000000000000002 109.242 175.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.592 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -129.92 134.2 63.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.448 0.642 . . . . 0.28000000000000003 111.504 177.206 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.582 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 17.7 ttt -143.49 151.3 40.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.518 -0.765 . . . . 1.24 109.321 -174.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.751 ' CD1' HD21 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -136.03 151.96 50.4 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.366 -0.605 . . . . 3.3700000000000001 109.366 170.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.537 ' N ' ' HD1' ' A' ' 170' ' ' PHE . 3.9 p -134.85 132.83 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 115.746 -0.661 . . . . 1.3999999999999999 110.078 176.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.51 ' OE1' HD12 ' A' ' 47' ' ' LEU . 24.9 tt0 -121.09 65.73 0.86 Allowed 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 107.135 -1.432 . . . . 2.1699999999999999 107.135 177.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.511 HG23 ' OD1' ' A' ' 148' ' ' ASN . 1.4 m -68.94 149.47 48.82 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 113.54 -1.664 . . . . 1.6499999999999999 110.465 -175.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 147' ' ' TYR . 4.0 tp10 . . . . . 0 N--CA 1.449 -0.524 0 CA-C-N 116.187 -0.46 . . . . 2.4500000000000002 109.872 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 12.0 mm . . . . . 0 CA--C 1.509 -0.629 0 CA-C-O 122.551 1.167 . . . . 1.1200000000000001 108.997 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.979 ' HA ' HG22 ' A' ' 187' ' ' THR . 0.9 OUTLIER -83.39 -37.12 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 113.113 -1.858 . . . . 1.1299999999999999 110.516 -172.103 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 189' ' ' PRO . 9.2 pt-20 -64.41 -16.72 62.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.489 -0.778 . . . . 2.8900000000000001 109.343 174.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -92.05 -43.7 9.26 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.775 -0.648 . . . . 1.28 110.376 170.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.979 HG22 ' HA ' ' A' ' 184' ' ' ILE . 13.5 t -64.83 -40.33 95.01 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.841 0.682 . . . . 0.62 112.841 -169.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . 0.496 ' SD ' HG23 ' A' ' 187' ' ' THR . 0.1 OUTLIER -78.04 -61.2 0.61 Allowed Pre-proline 0 N--CA 1.467 0.424 0 CA-C-N 118.407 0.549 . . . . 1.0600000000000001 111.951 -178.456 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.606 ' O ' HG13 ' A' ' 193' ' ' VAL . 51.6 Cg_exo -56.26 -38.74 94.54 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.04 1.827 . . . . 0.91000000000000003 112.258 -176.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.41 ' O ' HG22 ' A' ' 193' ' ' VAL . 23.2 t -72.21 -37.31 69.26 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.414 -0.587 . . . . 1.5 109.414 -177.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.452 ' HA ' ' HB2' ' A' ' 194' ' ' ASN . 2.6 t-20 -67.4 -31.93 72.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.019 -0.537 . . . . 1.8799999999999999 110.408 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.51 ' HB3' ' CG1' ' A' ' 50' ' ' VAL . 40.5 mt -69.34 -46.22 67.59 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 120.738 0.304 . . . . 1.0900000000000001 111.007 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.606 HG13 ' O ' ' A' ' 189' ' ' PRO . 0.9 OUTLIER -65.06 -34.25 69.28 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 N-CA-C 108.716 -0.846 . . . . 0.68000000000000005 108.716 176.543 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.452 ' HB2' ' HA ' ' A' ' 191' ' ' ASN . 35.0 m-20 -63.64 -45.32 90.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.179 -1.373 . . . . 2.0699999999999998 111.483 178.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.419 ' HA ' ' ND2' ' A' ' 198' ' ' ASN . 6.3 m-85 -59.15 -31.38 68.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.967 0.413 . . . . 2.0 110.417 175.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.474 HG12 HD12 ' A' ' 167' ' ' LEU . 34.3 mt -81.75 -27.17 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-N 116.157 -0.474 . . . . 0.31 111.319 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 62.4 mt -74.57 -40.16 61.81 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-O 121.108 0.48 . . . . 1.03 109.811 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.608 ' OD1' ' HG3' ' A' ' 76' ' ' LYS . 76.5 m-20 -50.07 -37.86 35.6 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.706 -1.134 . . . . 1.8999999999999999 108.53 166.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.648 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -78.17 -43.94 27.25 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 116.081 -0.509 . . . . 0.28999999999999998 110.905 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.56 ' O ' ' HG3' ' A' ' 204' ' ' LYS . 35.6 mmtm -55.96 -44.5 78.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.256 0.551 . . . . 0.96999999999999997 110.565 174.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -87.58 -38.41 15.99 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.495 -0.775 . . . . 1.9399999999999999 110.856 -173.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . 0.431 ' HA2' ' HB3' ' A' ' 205' ' ' ALA . . . -68.39 -29.42 73.08 Favored Glycine 0 C--O 1.228 -0.243 0 C-N-CA 121.102 -0.57 . . . . 0.46999999999999997 111.999 178.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 1.031 HD13 HD23 ' A' ' 61' ' ' LEU . 2.8 tp -70.55 -31.68 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-O 120.92 0.391 . . . . 0.60999999999999999 109.949 177.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.56 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 89.3 mttt -84.33 -32.84 24.06 Favored 'General case' 0 C--O 1.21 -1.006 0 N-CA-C 108.514 -0.921 . . . . 3.3700000000000001 108.514 176.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.431 ' HB3' ' HA2' ' A' ' 202' ' ' GLY . . . . . . . . 0 C--N 1.314 -0.95 0 CA-C-N 115.923 -0.581 . . . . 1.02 109.525 170.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 . . . . . 0 CA--C 1.505 -0.78 0 N-CA-C 112.006 0.373 . . . . 2.25 112.006 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.635 ' HB3' HD11 ' A' ' 114' ' ' LEU . 76.0 m-85 -61.99 -26.54 68.28 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 121.236 0.541 . . . . 0.42999999999999999 110.098 -172.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.578 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 39.4 tttt -80.93 -36.44 31.01 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 107.453 -1.314 . . . . 1.51 107.453 -176.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.18 -43.57 82.78 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.897 -0.592 . . . . 0.54000000000000004 111.32 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 3' ' ' PHE . 0.9 OUTLIER -82.75 -32.88 10.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 122.169 0.985 . . . . 1.0700000000000001 109.191 -172.648 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.612 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -81.21 -37.79 28.06 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.176 -1.375 . . . . 0.34000000000000002 111.718 -177.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.578 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 19.5 mt-30 -61.77 -30.13 70.59 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.421 -0.809 . . . . 1.5900000000000001 109.704 175.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.654 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 76.3 mt-30 -78.32 -39.67 38.99 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.482 -1.236 . . . . 2.4700000000000002 109.365 173.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.657 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.4 OUTLIER -72.94 -33.47 65.94 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.424 -0.807 . . . . 0.47999999999999998 112.198 -175.185 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -48.05 -57.92 5.15 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.986 0.422 . . . . 0.31 111.698 174.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.718 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 4.2 pt20 -76.57 1.33 17.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.259 -0.428 . . . . 1.6399999999999999 111.605 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.654 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 10.6 mm-40 -82.8 -48.83 10.36 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.01 -0.737 . . . . 2.54 109.01 169.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.96 HG23 ' HD1' ' A' ' 170' ' ' PHE . 7.4 p -72.0 -34.06 49.45 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-O 121.47 0.653 . . . . 0.53000000000000003 109.818 175.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.718 ' HB3' ' HA ' ' A' ' 12' ' ' GLN . 0.8 OUTLIER -68.15 -26.18 65.64 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 122.361 1.077 . . . . 0.59999999999999998 108.325 172.609 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 20' ' ' ASP . . . -68.75 -20.05 73.84 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 113.797 -1.547 . . . . 0.56999999999999995 109.627 177.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.627 ' HD2' ' HA ' ' A' ' 14' ' ' VAL . 32.1 m-85 -91.08 -22.27 20.81 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 114.315 -0.943 . . . . 3.27 109.376 176.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.487 ' HB3' ' O ' ' A' ' 15' ' ' LEU . 5.6 t-20 -60.06 -28.7 68.0 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.356 -0.838 . . . . 2.0299999999999998 109.615 175.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.554 ' HD2' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -115.22 10.89 16.11 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.58 -0.448 . . . . 2.7200000000000002 111.397 175.189 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.577 ' CB ' ' HA ' ' A' ' 17' ' ' TYR . 50.7 t0 -89.6 69.93 7.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.499 0.666 . . . . 2.1600000000000001 109.69 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.518 HG22 ' CH2' ' A' ' 24' ' ' TRP . 34.5 p -104.96 105.86 16.09 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.674 -0.694 . . . . 1.8200000000000001 110.812 -176.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.5 p -169.87 -88.18 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.558 -0.746 . . . . 2.1899999999999999 111.454 -173.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.496 ' O ' ' HG3' ' A' ' 38' ' ' LYS . . . -84.76 52.18 4.66 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 116.086 -0.507 . . . . 1.1000000000000001 113.418 -173.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.871 ' HZ3' ' HD3' ' A' ' 49' ' ' ARG . 0.2 OUTLIER -119.61 -160.05 0.8 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.572 -0.529 . . . . 1.6699999999999999 109.572 176.21 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.1 ttpp -176.09 110.65 0.1 Allowed 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 108.634 -0.876 . . . . 2.9500000000000002 108.634 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.737 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 0.9 OUTLIER -61.14 118.27 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 CA-C-O 121.818 0.818 . . . . 1.5600000000000001 110.303 175.084 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.2 m -98.49 -25.16 4.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 114.317 -1.31 . . . . 1.22 110.011 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.43 ' HB3' ' CG2' ' A' ' 35' ' ' VAL . 0.9 OUTLIER -154.67 135.39 13.58 Favored 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 119.472 -0.891 . . . . 2.4100000000000001 110.09 -178.007 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.502 HG22 ' HA ' ' A' ' 34' ' ' THR . 73.2 p -138.98 153.26 48.15 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.282 0.563 . . . . 1.3799999999999999 110.748 177.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.692 ' HB3' HG12 ' A' ' 33' ' ' ILE . 14.9 t -113.86 -164.4 0.93 Allowed 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.456 -1.313 . . . . 2.3700000000000001 107.456 173.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -93.8 19.31 8.99 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.999 0.428 . . . . 4.5499999999999998 109.912 -176.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.85 ' HE2' ' HA ' ' A' ' 32' ' ' LYS . 3.6 mmpt? -155.02 -17.98 0.11 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.119 -0.946 . . . . 1.4199999999999999 111.573 175.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.828 HG22 ' HA3' ' A' ' 52' ' ' GLY . 35.8 pt -131.35 170.82 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.902 0.382 . . . . 0.76000000000000001 111.907 -172.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.502 ' HA ' HG22 ' A' ' 29' ' ' THR . 23.1 m -160.81 123.12 3.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.325 -0.852 . . . . 0.57999999999999996 110.423 -167.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.578 HG13 HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -112.48 113.85 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.18 0.514 . . . . 0.85999999999999999 110.692 172.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.737 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.8 OUTLIER -102.6 125.61 49.39 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.627 -0.715 . . . . 1.1000000000000001 109.871 176.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 78.1 p -93.16 125.04 37.55 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 108.65 -0.87 . . . . 1.27 108.65 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.668 ' HA ' ' HA ' ' A' ' 24' ' ' TRP . 57.8 tttm . . . . . 0 C--N 1.305 -1.364 0 CA-C-N 115.751 -0.659 . . . . 1.9099999999999999 110.963 -168.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.445 -0.683 0 CA-C-O 120.972 0.415 . . . . 2.0499999999999998 109.998 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.856 HD11 ' HE2' ' A' ' 170' ' ' PHE . 6.1 tt -78.04 147.85 34.59 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.76 -1.2 . . . . 0.87 107.76 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.834 ' HB3' HD11 ' A' ' 192' ' ' LEU . 4.9 m-85 -129.81 124.61 33.75 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 119.493 -0.883 . . . . 0.98999999999999999 111.288 -172.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.871 ' HD3' ' HZ3' ' A' ' 24' ' ' TRP . 54.3 ttt-85 -120.54 109.56 15.41 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.356 -0.838 . . . . 2.9199999999999999 109.147 177.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.578 HG23 HG13 ' A' ' 35' ' ' VAL . 10.4 p -100.31 150.22 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 109.515 -0.55 . . . . 1.3300000000000001 109.515 -177.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.785 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 41.5 tt0 -156.03 109.6 2.73 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.856 -0.611 . . . . 1.0700000000000001 110.078 -172.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.828 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -140.45 159.58 26.3 Favored Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 111.427 -0.669 . . . . 0.28999999999999998 111.427 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 59.6 mt -99.88 124.24 53.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 C-N-CA 120.57 -0.452 . . . . 0.57999999999999996 110.753 178.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.636 HG12 ' HD2' ' A' ' 200' ' ' LYS . 85.7 mt -101.96 121.35 51.01 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 115.656 -0.702 . . . . 0.34999999999999998 109.926 175.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -64.89 61.41 0.29 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.981 3.121 . . . . 0.62 112.878 177.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.821 ' HG2' HG13 ' A' ' 203' ' ' ILE . 6.9 tp10 -155.4 173.6 16.44 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.051 -1.092 . . . . 1.6799999999999999 108.051 174.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.552 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 52.3 p -83.04 146.75 52.46 Favored Pre-proline 0 N--CA 1.425 -1.72 0 CA-C-O 121.838 0.828 . . . . 1.1799999999999999 109.836 175.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 57' ' ' SER . 27.6 Cg_exo -60.72 -11.05 15.92 Favored 'Trans proline' 0 C--N 1.329 -0.461 0 C-N-CA 124.16 3.24 . . . . 0.52000000000000002 111.478 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.36 -52.03 31.07 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.214 -0.903 . . . . 0.64000000000000001 110.811 174.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.75 ' HE3' ' HB3' ' A' ' 64' ' ' PHE . 18.4 tptt -69.12 -24.03 64.06 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.516 -0.92 . . . . 3.2999999999999998 108.516 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.746 ' HA ' ' CD1' ' A' ' 64' ' ' PHE . 46.5 mt -65.95 -58.71 4.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.642 -0.708 . . . . 0.40999999999999998 110.323 172.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.525 ' HB3' ' HB3' ' A' ' 125' ' ' ASN . 19.8 p -62.26 -11.23 13.84 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.83 -0.543 . . . . 1.29 110.56 176.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.476 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 25.2 t70 -90.9 -44.78 9.16 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.334 0.494 . . . . 1.3200000000000001 112.334 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.829 ' HD2' ' CZ2' ' A' ' 74' ' ' TRP . 10.3 p90 -71.79 -43.26 65.98 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 121.032 -0.267 . . . . 0.60999999999999999 110.721 -168.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.686 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -96.86 6.64 48.28 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.444 -0.503 . . . . 1.5 111.288 -174.59 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -42.18 -73.67 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.083 0.771 . . . . 1.52 113.083 -169.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.641 HE22 HG21 ' A' ' 115' ' ' VAL . 64.0 mm-40 -152.19 -63.24 0.17 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.17 0.509 . . . . 3.6000000000000001 112.27 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.93 ' HB ' ' CD2' ' A' ' 81' ' ' TYR . 9.1 t -145.08 21.43 1.58 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.995 0.902 . . . . 1.48 109.359 -174.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -88.82 -29.82 17.06 Favored Glycine 0 CA--C 1.491 -1.44 0 CA-C-N 114.84 -1.073 . . . . 1.46 113.87 -168.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.655 ' O ' HG22 ' A' ' 73' ' ' THR . 10.4 t0 -167.28 -35.71 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.365 -0.976 . . . . 2.1899999999999999 108.365 -166.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.766 ' HA ' ' CZ2' ' A' ' 74' ' ' TRP . 1.0 OUTLIER -47.83 -48.24 30.92 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 114.577 -1.192 . . . . 3.3799999999999999 111.582 -172.245 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.887 HG22 HD13 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -87.35 -7.02 10.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 119.743 -0.783 . . . . 0.70999999999999996 111.244 -172.675 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.655 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.4 t -90.65 -30.79 16.93 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 119.76 -0.776 . . . . 0.96999999999999997 110.013 -177.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 1.002 ' HZ3' ' HB3' ' A' ' 198' ' ' ASN . 7.1 p-90 -102.54 -7.6 21.72 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 120.509 -0.476 . . . . 0.75 111.822 178.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.865 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 4.5 t70 -76.57 168.29 20.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.549 0.69 . . . . 2.1899999999999999 111.702 -170.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.681 ' HD2' ' OD1' ' A' ' 194' ' ' ASN . 0.0 OUTLIER -118.51 -16.74 9.48 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.849 -1.069 . . . . 3.1899999999999999 111.286 -177.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.4 m -113.83 7.94 17.2 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.911 -0.774 . . . . 1.5800000000000001 108.911 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.887 HD13 HG22 ' A' ' 72' ' ' ILE . 29.8 mt -109.89 167.31 10.26 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.059 -0.973 . . . . 0.70999999999999996 111.283 -178.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.612 ' HG2' ' HG2' ' A' ' 99' ' ' GLN . 6.6 mm100 -146.58 -71.25 0.24 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.393 -0.821 . . . . 1.73 110.686 -175.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.554 HG23 ' HB3' ' A' ' 79' ' ' GLN . 18.8 t -138.55 124.57 24.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.059 -0.973 . . . . 0.78000000000000003 110.112 -170.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.93 ' CD2' ' HB ' ' A' ' 68' ' ' THR . 69.6 t80 -106.68 139.32 41.31 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.491 -0.483 . . . . 5.4000000000000004 110.395 174.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.576 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 17.5 m120 -130.31 104.63 7.39 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.039 -0.726 . . . . 1.6899999999999999 109.039 177.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.534 ' HE1' ' HG2' ' A' ' 86' ' ' ARG . 7.1 tpt -67.77 101.43 1.06 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.148 -0.933 . . . . 2.0499999999999998 109.583 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.553 HG23 ' HB ' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -81.59 -83.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 120.481 -0.487 . . . . 0.64000000000000001 111.551 -171.378 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.519 ' HB2' HD12 ' A' ' 93' ' ' ILE . 49.3 m170 -118.35 127.16 53.43 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.001 0.429 . . . . 1.96 109.887 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.534 ' HG2' ' HE1' ' A' ' 83' ' ' MET . 25.5 mtm180 -108.58 120.9 43.8 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.763 -0.829 . . . . 2.4399999999999999 108.763 176.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.603 HG12 ' O ' ' A' ' 91' ' ' THR . 0.8 OUTLIER -80.94 -55.3 8.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.424 -0.807 . . . . 0.46999999999999997 112.022 -163.427 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -127.66 -83.28 0.6 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.933 -0.576 . . . . 1.8600000000000001 111.085 -173.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.5 t -148.17 -31.35 0.28 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.243 0.544 . . . . 1.4399999999999999 110.08 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -128.11 19.61 6.45 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.4 -0.818 . . . . 1.8700000000000001 109.511 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.603 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -126.18 111.69 14.91 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.083 -1.08 . . . . 0.46000000000000002 108.083 -176.802 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.615 ' O ' HD12 ' A' ' 114' ' ' LEU . 56.1 m-85 -122.88 171.5 9.16 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.799 -0.637 . . . . 0.42999999999999999 110.566 -173.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.553 ' HB ' HG23 ' A' ' 84' ' ' VAL . 23.8 mt -131.12 130.59 63.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 107.678 -1.23 . . . . 0.40999999999999998 107.678 165.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.697 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 26.5 p -101.74 128.72 47.94 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.582 -0.447 . . . . 2.0099999999999998 111.353 -174.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.663 ' HA ' HD13 ' A' ' 112' ' ' ILE . 2.8 t60 -104.3 86.54 2.55 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.269 -1.011 . . . . 1.23 108.269 165.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.691 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 18.5 m -110.47 117.1 32.66 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.415 -0.811 . . . . 0.5 112.2 -168.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 42.0 mm -78.55 125.76 38.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 120.169 -0.612 . . . . 1.03 109.493 173.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.7 m -107.26 146.9 30.89 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.111 -0.949 . . . . 1.3799999999999999 110.705 -173.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.612 ' HG2' ' HG2' ' A' ' 79' ' ' GLN . 1.8 mm100 . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 115.942 -0.572 . . . . 1.8200000000000001 110.685 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 94.7 mt . . . . . 0 N--CA 1.451 -0.406 0 CA-C-O 121.263 0.554 . . . . 1.1200000000000001 112.139 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.416 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 15.9 m -100.84 169.72 7.49 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.369 -0.832 . . . . 1.3500000000000001 109.434 174.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 107' ' ' SER . 65.5 Cg_exo -51.69 123.8 13.07 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.204 1.936 . . . . 1.0700000000000001 110.74 171.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.681 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 39.6 ttm105 -114.82 149.22 37.38 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.382 -0.527 . . . . 3.4500000000000002 110.267 -168.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.644 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 36.7 t0 -109.6 117.46 34.0 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.876 -0.416 . . . . 1.3700000000000001 109.876 -174.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.691 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 9.2 m-30 -98.3 112.32 24.35 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.83 0.348 . . . . 2.4100000000000001 110.877 -175.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.697 ' HA ' ' O ' ' A' ' 94' ' ' CYS . 15.2 mm -115.02 79.81 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 CA-C-N 115.509 -0.769 . . . . 0.42999999999999999 109.317 172.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.588 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 45.6 m-20 -110.25 127.45 54.99 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.676 -0.693 . . . . 1.8600000000000001 109.896 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.635 HD11 ' HB3' ' A' ' 3' ' ' PHE . 4.0 tp -76.82 125.91 30.08 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 109.211 -0.663 . . . . 0.28000000000000003 109.211 173.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.641 HG21 HE22 ' A' ' 67' ' ' GLN . 0.1 OUTLIER -123.92 125.64 71.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 115.233 -0.894 . . . . 0.26000000000000001 112.321 -164.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.612 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 85.1 t80 -112.23 115.13 28.3 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.352 -0.84 . . . . 2.5699999999999998 110.812 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.656 HG12 HG22 ' A' ' 127' ' ' ILE . 78.1 mt -91.27 99.29 9.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.974 -0.557 . . . . 0.89000000000000001 109.668 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.558 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 2.6 tppp? -97.55 130.86 44.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.293 -0.867 . . . . 1.2 109.353 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.551 ' NH1' ' HA ' ' A' ' 121' ' ' GLU . 4.3 tmt_? -111.95 91.86 3.81 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 107.847 -1.168 . . . . 2.7999999999999998 107.847 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.412 ' CE1' ' HG2' ' A' ' 118' ' ' LYS . 60.9 m-85 -64.68 115.24 5.05 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 107.813 -1.181 . . . . 0.82999999999999996 107.813 173.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.551 ' HA ' ' NH1' ' A' ' 119' ' ' ARG . 7.4 mm-40 -27.91 90.35 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 O-C-N 125.312 1.632 . . . . 2.2799999999999998 113.398 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 52.62 41.67 57.21 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 115.271 -0.877 . . . . 0.76000000000000001 112.81 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.541 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 4.1 t-20 -141.04 -39.0 0.41 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.395 0.146 . . . . 1.6499999999999999 111.395 -175.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.489 ' CG ' ' HB ' ' A' ' 154' ' ' VAL . 3.4 tpp -157.13 118.32 3.67 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.312 -0.555 . . . . 1.1200000000000001 111.22 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.525 ' HB3' ' HB3' ' A' ' 62' ' ' SER . 4.8 m-20 -101.08 73.67 1.54 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.509 -0.923 . . . . 1.6200000000000001 108.509 175.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.799 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -92.34 138.48 19.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.189 -0.914 . . . . 0.29999999999999999 112.667 -172.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.746 HG13 ' O ' ' A' ' 127' ' ' ILE . 1.1 pt -105.59 116.32 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 108.51 -0.922 . . . . 0.58999999999999997 108.51 162.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 4.1 m -81.26 163.46 22.96 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.266 -0.642 . . . . 1.1799999999999999 109.266 173.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.588 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 12.7 p -156.88 131.48 8.74 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.052 0.453 . . . . 1.24 110.968 176.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.53 ' HD3' HD23 ' A' ' 114' ' ' LEU . 20.0 mtpp -131.09 120.78 23.88 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 107.754 -1.202 . . . . 2.2599999999999998 107.754 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.427 ' HB3' ' H ' ' A' ' 148' ' ' ASN . 4.0 p -63.48 98.31 0.16 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.47 -0.937 . . . . 1.3899999999999999 108.47 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.02 138.37 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-N 114.526 -1.215 . . . . 1.05 109.678 -165.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -100.81 74.79 1.66 Allowed 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 122.42 1.105 . . . . 2.1699999999999999 110.306 -170.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.687 ' O ' ' HB3' ' A' ' 137' ' ' TYR . 3.8 p90 -106.37 175.93 1.88 Allowed Pre-proline 0 CA--C 1.554 1.127 0 CA-C-N 114.124 -1.398 . . . . 0.53000000000000003 109.302 -174.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.617 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 25.0 Cg_exo -27.35 -67.27 0.05 OUTLIER 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 125.13 3.887 . . . . 1.28 117.308 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.656 ' HB3' ' CZ ' ' A' ' 134' ' ' PHE . 5.8 tp10 -68.63 -26.34 65.3 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.613 0.597 . . . . 3.5 112.613 -173.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.687 ' HB3' ' O ' ' A' ' 134' ' ' PHE . 0.5 OUTLIER -39.77 -55.23 3.72 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 115.331 1.604 . . . . 6.1200000000000001 115.331 -171.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.457 ' HD2' ' O ' ' A' ' 135' ' ' PRO . 44.3 Cg_exo -35.72 106.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.366 1.495 0 C-N-CA 123.432 2.755 . . . . 1.77 114.408 -171.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.542 ' HB2' ' O ' ' A' ' 143' ' ' TYR . 72.9 Cg_endo -88.01 -147.54 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.274 2.65 . . . . 1.25 113.104 -174.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.1 m -143.26 -171.98 3.6 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.785 -0.82 . . . . 1.6000000000000001 108.785 -174.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.2 m -74.98 -38.45 61.66 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.0 -0.68 . . . . 1.97 111.247 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -77.39 -56.63 4.38 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.563 -0.532 . . . . 2.1800000000000002 109.563 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.58 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 87.9 m-85 -79.41 109.49 13.82 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 115.715 -0.675 . . . . 1.23 110.16 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.681 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 1.9 tp -104.42 117.89 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 CA-C-N 115.199 -0.91 . . . . 0.81999999999999995 109.495 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.644 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 0.1 OUTLIER -46.64 116.35 1.29 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.237 -0.892 . . . . 4.4199999999999999 110.775 175.204 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -55.22 108.22 0.94 Allowed Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 114.971 -1.013 . . . . 0.79000000000000004 111.793 176.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 1.116 ' HB3' ' HB3' ' A' ' 174' ' ' GLU . 0.2 OUTLIER -83.43 79.95 9.25 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.496 0.665 . . . . 4.4400000000000004 109.878 177.174 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.682 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 84.8 m-20 -103.2 102.32 12.3 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.262 -1.336 . . . . 1.6200000000000001 108.427 175.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -81.2 143.09 51.88 Favored Pre-proline 0 C--N 1.32 -0.685 0 C-N-CA 120.448 -0.501 . . . . 2.3199999999999998 111.001 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.657 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 8.6 Cg_exo -10.07 59.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.411 1 C-N-CA 127.18 5.253 . . . . 0.53000000000000003 116.355 -163.327 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . 0.759 ' HA ' ' CE1' ' A' ' 170' ' ' PHE . 7.8 p -85.58 -179.11 6.83 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.815 -1.084 . . . . 1.5800000000000001 110.513 176.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.706 ' HA3' HG11 ' A' ' 14' ' ' VAL . . . -169.63 -168.09 31.09 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.393 -0.908 . . . . 0.42999999999999999 111.677 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.562 ' CE1' HD11 ' A' ' 167' ' ' LEU . 60.8 t80 -160.18 80.8 0.69 Allowed 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.915 -1.143 . . . . 0.59999999999999998 107.915 -165.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.799 HG12 ' HB ' ' A' ' 126' ' ' ILE . 7.1 m -89.53 124.52 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 121.829 0.823 . . . . 0.31 110.468 -173.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 56.6 m -106.08 113.31 26.78 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.523 -0.762 . . . . 1.55 109.165 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.737 ' HB3' ' HB3' ' A' ' 166' ' ' LYS . 15.5 t -106.07 121.72 44.69 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 116.203 -0.453 . . . . 1.0600000000000001 111.535 -169.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.541 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 69.0 Cg_exo -51.7 114.99 1.83 Allowed 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.726 2.284 . . . . 0.56000000000000005 111.26 169.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.668 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 0.2 OUTLIER -76.32 -167.97 0.88 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.266 0.555 . . . . 1.1599999999999999 112.172 -177.03 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -67.51 -38.08 83.76 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.484 -0.932 . . . . 2.6299999999999999 108.484 169.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.592 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 10.8 mm-40 -97.6 29.06 3.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.099 -1.409 . . . . 2.0499999999999998 108.89 175.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.434 ' CG ' ' HD3' ' A' ' 162' ' ' PRO . 1.2 p-10 -23.84 -58.05 0.13 Allowed Pre-proline 0 N--CA 1.473 0.724 0 N-CA-C 116.515 2.043 . . . . 1.9299999999999999 116.515 -169.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.434 ' HD3' ' CG ' ' A' ' 161' ' ' ASN . 63.1 Cg_endo -72.7 -19.51 24.09 Favored 'Trans proline' 0 C--N 1.35 0.621 0 CA-C-N 121.448 1.553 . . . . 0.72999999999999998 113.451 -175.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -105.73 -25.27 12.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.743 0.306 . . . . 0.68000000000000005 111.415 -177.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.668 ' O ' ' HB2' ' A' ' 158' ' ' MET . 52.9 m-85 -141.05 131.3 24.96 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.858 -0.793 . . . . 0.93000000000000005 108.858 177.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.477 ' OG ' HD11 ' A' ' 61' ' ' LEU . 3.6 p -126.99 148.75 50.09 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.046 0.451 . . . . 1.4099999999999999 111.468 -177.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.785 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.8 tppp? -91.67 104.43 16.9 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.824 0.821 . . . . 0.73999999999999999 111.242 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.562 HD11 ' CE1' ' A' ' 153' ' ' PHE . 0.6 OUTLIER -89.4 106.41 18.43 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.481 -1.236 . . . . 0.27000000000000002 109.762 176.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.724 HG13 HG23 ' A' ' 154' ' ' VAL . 0.1 OUTLIER -131.05 129.12 63.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.644 0.735 . . . . 0.28000000000000003 111.911 176.394 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.606 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 18.2 ttt -137.8 131.7 31.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.228 -0.896 . . . . 1.24 110.17 -172.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.96 ' HD1' HG23 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -111.2 145.15 39.2 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.088 -0.645 . . . . 3.3700000000000001 110.002 174.202 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.65 116.5 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-O 121.415 0.626 . . . . 1.3999999999999999 110.895 176.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.528 ' HB2' ' CZ ' ' A' ' 170' ' ' PHE . 0.0 OUTLIER -94.98 77.28 3.56 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 106.673 -1.603 . . . . 2.1699999999999999 106.673 168.109 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.422 HG21 ' CE ' ' A' ' 188' ' ' MET . 0.6 OUTLIER -74.65 128.31 35.25 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.317 -0.856 . . . . 1.6499999999999999 110.89 -176.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 1.116 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 38.4 tp10 . . . . . 0 N--CA 1.447 -0.575 0 CA-C-O 121.261 0.553 . . . . 2.4500000000000002 110.524 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.506 ' HA ' ' HE3' ' A' ' 186' ' ' LYS . 17.6 mm . . . . . 0 CA--C 1.511 -0.53 0 CA-C-O 122.356 1.074 . . . . 1.1200000000000001 108.418 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.97 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.0 OUTLIER -57.98 -37.7 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 CA-C-N 113.302 -1.772 . . . . 1.1299999999999999 109.674 172.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -61.86 -22.39 65.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.633 -1.167 . . . . 2.8900000000000001 110.056 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.506 ' HE3' ' HA ' ' A' ' 183' ' ' ILE . 48.1 mttt -91.51 -49.0 6.55 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.179 -0.674 . . . . 1.28 109.179 173.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.97 HG22 ' HA ' ' A' ' 184' ' ' ILE . 11.1 t -62.93 -33.54 75.56 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.378 0.881 . . . . 0.62 113.378 -165.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . 0.643 ' HE3' HG23 ' A' ' 187' ' ' THR . 0.0 OUTLIER -71.72 -65.9 0.79 Allowed Pre-proline 0 N--CA 1.469 0.504 0 CA-C-N 118.888 0.767 . . . . 1.0600000000000001 111.674 179.613 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.711 ' O ' HG13 ' A' ' 193' ' ' VAL . 27.5 Cg_endo -62.39 -41.79 31.52 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.486 1.457 . . . . 0.91000000000000003 111.471 -176.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.71 ' O ' ' HB3' ' A' ' 194' ' ' ASN . 68.3 m -68.43 -22.82 64.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.364 -0.38 . . . . 1.5 111.377 -174.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 187' ' ' THR . 53.9 m-20 -90.21 -37.7 13.96 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.806 -0.358 . . . . 1.8799999999999999 111.474 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.834 HD11 ' HB3' ' A' ' 48' ' ' TYR . 19.2 mt -60.8 -49.72 76.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.824 0.345 . . . . 1.0900000000000001 111.039 176.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.711 HG13 ' O ' ' A' ' 189' ' ' PRO . 3.0 m -65.4 -31.6 54.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.63 0.729 . . . . 0.68000000000000005 110.029 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.737 ' HA ' ' HG ' ' A' ' 197' ' ' LEU . 0.0 OUTLIER -73.19 -43.62 61.08 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.674 -1.148 . . . . 2.0699999999999998 111.397 -177.747 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -62.36 -26.17 68.31 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.415 -0.957 . . . . 2.0 108.415 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.623 HG21 HG21 ' A' ' 33' ' ' ILE . 20.7 mt -78.37 -44.58 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-N 115.177 -0.919 . . . . 0.31 113.25 175.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.792 HD12 ' N ' ' A' ' 198' ' ' ASN . 3.0 pp -74.1 -31.83 62.97 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 119.336 -0.946 . . . . 1.03 110.332 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 1.002 ' HB3' ' HZ3' ' A' ' 74' ' ' TRP . 9.9 m120 -61.82 -24.58 66.97 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.118 0.485 . . . . 1.8999999999999999 110.017 165.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.832 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -80.77 -29.98 36.11 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 108.713 -0.847 . . . . 0.28999999999999998 108.713 177.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.636 ' HD2' HG12 ' A' ' 54' ' ' ILE . 2.9 mptm? -67.02 -46.17 75.3 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.202 -0.908 . . . . 0.96999999999999997 108.685 175.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.55 -24.8 25.34 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.832 -1.076 . . . . 1.9399999999999999 110.797 -170.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 205' ' ' ALA . . . -78.2 -28.17 56.53 Favored Glycine 0 N--CA 1.46 0.245 0 C-N-CA 120.492 -0.861 . . . . 0.46999999999999997 111.477 174.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.832 ' HB ' ' O ' ' A' ' 199' ' ' ALA . 0.9 OUTLIER -76.95 -35.22 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 123.326 0.65 . . . . 0.60999999999999999 110.214 173.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 40.2 mttm -78.17 -21.66 49.88 Favored 'General case' 0 C--O 1.216 -0.698 0 N-CA-C 108.91 -0.774 . . . . 3.3700000000000001 108.91 175.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 202' ' ' GLY . . . . . . . . 0 C--N 1.321 -0.636 0 CA-C-N 115.549 -0.751 . . . . 1.02 109.1 170.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 . . . . . 0 CA--C 1.504 -0.807 0 CA-C-O 119.916 -0.088 . . . . 2.25 110.94 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.56 ' HB2' HG21 ' A' ' 87' ' ' ILE . 65.2 m-85 -59.38 -35.0 73.1 Favored 'General case' 0 CA--C 1.502 -0.882 0 O-C-N 123.945 0.778 . . . . 0.42999999999999999 110.497 -169.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.755 ' O ' ' HB3' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -74.82 -41.25 60.27 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-N 115.273 -0.876 . . . . 1.51 108.736 -177.4 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.413 ' HA ' ' OE1' ' A' ' 8' ' ' GLN . . . -55.98 -45.99 78.8 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.829 -0.623 . . . . 0.54000000000000004 112.31 -178.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.64 ' O ' ' HB ' ' A' ' 10' ' ' THR . 0.2 OUTLIER -79.44 -36.37 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 N-CA-C 108.906 -0.776 . . . . 1.0700000000000001 108.906 -172.453 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.794 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -71.79 -47.74 51.33 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.517 -1.22 . . . . 0.34000000000000002 111.474 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.755 ' HB3' ' O ' ' A' ' 4' ' ' LYS . 3.7 pt20 -53.3 -34.3 56.79 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.344 -1.298 . . . . 1.5900000000000001 109.847 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.645 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 48.5 mt-30 -91.02 -31.63 16.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.879 -1.055 . . . . 2.4700000000000002 109.985 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.64 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -66.42 -35.0 79.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.633 -0.712 . . . . 0.47999999999999998 110.746 178.271 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.573 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -47.44 -58.51 4.1 Favored 'General case' 0 C--O 1.226 -0.154 0 N-CA-C 112.02 0.378 . . . . 0.31 112.02 175.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.463 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 20.8 pt20 -74.96 -6.72 50.81 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.493 -0.322 . . . . 1.6399999999999999 111.344 -178.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.645 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 16.6 mm-40 -81.43 -48.35 12.01 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 121.163 0.506 . . . . 2.54 109.707 175.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.733 HG21 ' N ' ' A' ' 152' ' ' GLY . 10.9 p -70.74 -37.77 70.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.798 0.809 . . . . 0.53000000000000003 109.735 176.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.463 ' HB3' ' HA ' ' A' ' 12' ' ' GLN . 0.8 OUTLIER -67.24 -25.62 66.18 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 122.236 1.017 . . . . 0.59999999999999998 108.338 173.068 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.5 ' HA2' ' CD ' ' A' ' 19' ' ' ARG . . . -67.86 -15.01 66.34 Favored Glycine 0 CA--C 1.5 -0.869 0 CA-C-N 113.679 -1.6 . . . . 0.56999999999999995 110.539 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.8 m-30 -92.42 -19.48 22.01 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.019 -0.591 . . . . 3.27 109.489 177.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -89.88 -27.55 19.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.152 -0.476 . . . . 2.0299999999999998 110.531 178.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.5 ' CD ' ' HA2' ' A' ' 16' ' ' GLY . 5.7 ptm180 -90.8 -20.25 22.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.254 0.55 . . . . 2.7200000000000002 110.178 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -121.44 117.33 26.62 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.927 -0.768 . . . . 2.1600000000000001 108.927 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.6 p -126.47 103.76 7.78 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.388 0.614 . . . . 1.8200000000000001 111.407 -174.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.0 p -170.47 155.49 5.09 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.053 -0.976 . . . . 2.1899999999999999 109.993 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.37 4.1 86.34 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.85 -0.69 . . . . 1.1000000000000001 113.057 174.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.481 ' HA ' ' HB3' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -120.3 -158.07 0.73 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.815 0.341 . . . . 1.6699999999999999 110.933 -178.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -172.3 125.36 0.52 Allowed 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 115.883 -0.599 . . . . 2.9500000000000002 109.821 -173.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.685 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 2.5 p -69.28 112.06 3.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-O 122.29 1.043 . . . . 1.5600000000000001 109.836 175.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.5 p -91.01 -23.5 5.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 113.812 -1.54 . . . . 1.22 109.138 -176.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.439 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -156.64 124.15 5.41 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 120.223 -0.591 . . . . 2.4100000000000001 111.768 -173.621 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.537 ' HB ' ' HA ' ' A' ' 34' ' ' THR . 0.4 OUTLIER -150.51 150.99 32.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.074 0.464 . . . . 1.3799999999999999 111.062 -179.597 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.7 t -120.21 -141.09 0.34 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.503 -0.771 . . . . 2.3700000000000001 109.322 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -101.55 17.7 22.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.984 0.421 . . . . 4.5499999999999998 110.787 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.697 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 48.3 mmtt -154.46 -29.23 0.12 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.904 -0.589 . . . . 1.4199999999999999 111.671 177.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.556 ' HA ' ' O ' ' A' ' 51' ' ' GLU . 17.8 pt -116.01 163.12 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 CA-C-O 120.767 0.317 . . . . 0.76000000000000001 111.493 -172.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.537 ' HA ' ' HB ' ' A' ' 29' ' ' THR . 8.8 m -156.42 114.09 3.24 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.108 -0.951 . . . . 0.57999999999999996 110.515 -172.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 49' ' ' ARG . 42.5 t -105.4 110.85 32.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.518 -0.31 . . . . 0.85999999999999999 110.554 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.685 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 4.1 m -109.6 123.5 49.55 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.636 0.732 . . . . 1.1000000000000001 111.092 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 28.2 p -108.2 131.11 55.0 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.32 -1.309 . . . . 1.27 112.781 -171.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.481 ' HB3' ' HA ' ' A' ' 24' ' ' TRP . 44.3 pttt . . . . . 0 C--N 1.323 -0.564 0 CA-C-N 115.128 -0.942 . . . . 1.9099999999999999 110.176 171.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 . . . . . 0 N--CA 1.449 -0.523 0 CA-C-O 120.843 0.354 . . . . 2.0499999999999998 110.611 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.612 HD12 ' NE2' ' A' ' 172' ' ' GLN . 4.0 tt -90.19 134.26 34.39 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.325 -0.991 . . . . 0.87 108.325 175.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.61 ' N ' HD23 ' A' ' 47' ' ' LEU . 69.1 m-85 -121.58 120.38 34.64 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.836 -0.431 . . . . 0.98999999999999999 109.836 -177.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.539 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.3 OUTLIER -101.51 117.66 35.38 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.162 -0.681 . . . . 2.9199999999999999 109.162 174.538 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.596 HG22 HD12 ' A' ' 196' ' ' ILE . 14.7 p -107.17 131.89 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 108.798 -0.816 . . . . 1.3300000000000001 108.798 177.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.556 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 34.0 tt0 -136.06 117.92 15.18 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.644 -0.707 . . . . 1.0700000000000001 110.783 -169.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.697 ' HA2' ' O ' ' A' ' 32' ' ' LYS . . . -142.24 144.38 14.07 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.872 -0.68 . . . . 0.28999999999999998 111.675 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 92.4 mt -84.85 122.87 38.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 119.635 -0.826 . . . . 0.57999999999999996 110.479 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.429 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 42.0 mt -105.11 110.69 64.79 Favored Pre-proline 0 N--CA 1.443 -0.816 0 N-CA-C 108.69 -0.856 . . . . 0.34999999999999998 108.69 174.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 164' ' ' TYR . 39.5 Cg_exo -63.11 54.89 0.15 Allowed 'Trans proline' 0 N--CA 1.476 0.491 0 C-N-CA 124.442 3.428 . . . . 0.62 113.915 -177.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.47 ' HG2' HG13 ' A' ' 203' ' ' ILE . 10.9 tp10 -151.16 168.38 24.85 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.657 -1.238 . . . . 1.6799999999999999 107.657 174.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.445 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 73.3 p -69.74 144.48 93.68 Favored Pre-proline 0 N--CA 1.43 -1.433 0 CA-C-O 121.88 0.848 . . . . 1.1799999999999999 111.117 -176.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.495 ' HA ' HD12 ' A' ' 61' ' ' LEU . 23.9 Cg_exo -61.31 -15.79 42.7 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.432 2.755 . . . . 0.52000000000000002 110.125 175.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.4 -47.84 58.97 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.559 -1.201 . . . . 0.64000000000000001 110.862 173.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.438 ' HG2' HG13 ' A' ' 203' ' ' ILE . 2.1 tpmt? -67.19 -30.08 69.93 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.049 -1.093 . . . . 3.2999999999999998 108.049 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.842 HD23 HD13 ' A' ' 203' ' ' ILE . 55.8 mt -62.36 -54.92 33.4 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.867 -1.061 . . . . 0.40999999999999998 110.205 174.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.6 p -62.96 -9.18 8.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.071 0.462 . . . . 1.29 110.717 176.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -91.35 -33.36 15.32 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.566 0.58 . . . . 1.3200000000000001 112.566 174.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.666 ' CE2' ' HA ' ' A' ' 199' ' ' ALA . 2.9 p90 -78.31 -45.05 23.65 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 120.399 -0.52 . . . . 0.60999999999999999 110.69 -169.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -83.51 -7.3 59.56 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 121.056 -0.258 . . . . 1.5 111.041 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -9.95 -72.69 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 O-C-N 125.571 1.794 . . . . 1.52 114.679 -159.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -158.52 -62.4 0.08 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.713 1.005 . . . . 3.6000000000000001 113.713 -172.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.678 ' OG1' ' HB2' ' A' ' 81' ' ' TYR . 11.6 t -178.35 27.96 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.352 0.596 . . . . 1.48 109.543 -162.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -127.95 -16.91 2.12 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 119.249 -1.453 . . . . 1.46 113.138 -171.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.538 ' O ' HG22 ' A' ' 73' ' ' THR . 1.7 p30 -159.34 -21.6 0.07 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 111.896 0.332 . . . . 2.1899999999999999 111.896 -177.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.704 ' HA ' ' NE1' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -67.47 -16.44 64.21 Favored 'General case' 0 C--O 1.217 -0.62 0 O-C-N 122.069 -0.394 . . . . 3.3799999999999999 110.982 -174.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.665 HD13 ' H ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -90.48 -20.25 6.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.234 0.54 . . . . 0.70999999999999996 109.937 173.521 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.538 HG22 ' O ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -82.2 -24.47 34.91 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.603 -0.726 . . . . 0.96999999999999997 110.363 -170.667 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.704 ' NE1' ' HA ' ' A' ' 71' ' ' ARG . 24.9 p-90 -108.47 -4.35 17.37 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.276 -0.569 . . . . 0.75 111.205 177.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.658 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 2.9 t70 -74.92 177.68 6.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.815 0.817 . . . . 2.1899999999999999 112.659 -168.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.422 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -123.07 -22.81 5.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.473 -1.24 . . . . 3.1899999999999999 111.007 -179.217 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.1 t -121.69 9.36 10.14 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.47 -0.567 . . . . 1.5800000000000001 109.47 -176.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.607 HD13 HG22 ' A' ' 72' ' ' ILE . 36.4 mt -109.1 169.5 8.64 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.649 -0.705 . . . . 0.70999999999999996 110.476 177.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.611 ' HG2' ' HG2' ' A' ' 99' ' ' GLN . 10.5 mm100 -147.41 -58.78 0.26 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.75 -0.659 . . . . 1.73 111.674 -173.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.636 ' O ' ' HA ' ' A' ' 96' ' ' THR . 25.6 t -138.15 117.9 15.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.78000000000000003 111.254 -166.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.678 ' HB2' ' OG1' ' A' ' 68' ' ' THR . 45.3 p90 -89.99 151.32 21.74 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 116.194 -0.457 . . . . 5.4000000000000004 110.852 174.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.446 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 4.2 m120 -158.95 108.94 1.98 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.603 -0.726 . . . . 1.6899999999999999 109.52 173.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.805 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 13.5 ttm -71.1 103.99 2.9 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.604 -0.887 . . . . 2.0499999999999998 108.604 177.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -84.78 -71.96 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 120.47 -0.492 . . . . 0.64000000000000001 112.029 -170.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.418 ' HB3' HD12 ' A' ' 93' ' ' ILE . 21.1 t60 -136.37 107.61 6.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.205 -0.452 . . . . 1.96 109.833 -175.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.805 ' HD3' ' SD ' ' A' ' 83' ' ' MET . 28.3 mtm180 -93.72 112.41 24.28 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.588 -0.523 . . . . 2.4399999999999999 109.588 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.632 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -75.69 -37.08 35.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.917 -0.583 . . . . 0.46999999999999997 109.614 -178.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -157.69 -179.32 8.05 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.236 -0.893 . . . . 1.8600000000000001 108.856 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.8 m -78.28 4.41 12.89 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.638 0.256 . . . . 1.4399999999999999 110.907 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -138.35 6.17 2.54 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.355 -0.609 . . . . 1.8700000000000001 109.355 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.632 ' O ' HG12 ' A' ' 87' ' ' ILE . 1.1 m -141.99 109.54 5.68 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.532 -0.914 . . . . 0.46000000000000002 108.532 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.547 ' O ' HD12 ' A' ' 114' ' ' LEU . 33.9 m-85 -128.95 174.98 9.03 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.475 0.655 . . . . 0.42999999999999999 110.764 -173.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.718 ' O ' HG23 ' A' ' 84' ' ' VAL . 36.2 mt -133.38 123.25 46.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 106.616 -1.624 . . . . 0.40999999999999998 106.616 166.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 78.6 m -110.47 124.45 51.8 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.732 -0.387 . . . . 2.0099999999999998 110.665 -173.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.51 ' HA ' ' O ' ' A' ' 111' ' ' PHE . 11.5 t-160 -89.39 118.75 29.28 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 108.507 -0.923 . . . . 1.23 108.507 168.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.636 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 89.8 m -136.98 123.45 20.83 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.727 -0.67 . . . . 0.5 111.228 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 46.5 mm -78.43 132.61 32.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 O-C-N 121.501 -0.749 . . . . 1.03 109.593 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.5 ' HB ' ' HB2' ' A' ' 109' ' ' ARG . 2.3 m -110.36 146.34 35.95 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.783 -0.644 . . . . 1.3799999999999999 110.745 -174.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.611 ' HG2' ' HG2' ' A' ' 79' ' ' GLN . 7.5 mm-40 . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 115.908 -0.587 . . . . 1.8200000000000001 110.443 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 65.4 mt . . . . . 0 N--CA 1.448 -0.566 0 CA-C-O 120.618 0.247 . . . . 1.1200000000000001 110.72 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.3 m -84.04 153.24 63.2 Favored Pre-proline 0 N--CA 1.449 -0.496 0 CA-C-N 116.111 -0.495 . . . . 1.3500000000000001 110.06 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -60.48 137.1 71.89 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.147 1.898 . . . . 1.0700000000000001 110.01 174.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.5 ' HB2' ' HB ' ' A' ' 98' ' ' THR . 54.5 mtt180 -111.92 159.69 18.14 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.604 -0.839 . . . . 3.4500000000000002 111.213 -172.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.681 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 12.9 t70 -107.35 143.14 36.07 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.72 -1.215 . . . . 1.3700000000000001 107.72 176.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.585 ' HB3' ' HB ' ' A' ' 96' ' ' THR . 50.6 t80 -122.36 115.07 21.66 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.59 -0.522 . . . . 2.4100000000000001 109.59 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.668 HG21 ' CE1' ' A' ' 134' ' ' PHE . 12.8 mm -132.7 85.85 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.016 -0.993 . . . . 0.42999999999999999 108.517 175.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.582 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 1.0 OUTLIER -116.14 131.52 56.92 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.807 -0.633 . . . . 1.8600000000000001 110.944 -177.453 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.622 ' O ' ' HA ' ' A' ' 129' ' ' SER . 6.6 tp -80.77 121.87 26.46 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.241 -0.89 . . . . 0.28000000000000003 109.068 172.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.453 HG23 ' HB ' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -123.76 125.71 71.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-N 115.398 -0.819 . . . . 0.26000000000000001 111.747 -165.235 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.794 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 11.6 t80 -107.5 118.73 37.49 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.059 -0.973 . . . . 2.5699999999999998 110.634 177.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.547 HG13 HG22 ' A' ' 127' ' ' ILE . 4.7 mp -94.44 100.71 11.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.03 -0.532 . . . . 0.89000000000000001 109.839 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -114.02 142.69 45.86 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.717 -0.475 . . . . 1.2 109.717 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.457 ' NH1' ' HA ' ' A' ' 121' ' ' GLU . 3.2 tmt_? -127.22 95.36 4.26 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 108.503 -0.925 . . . . 2.7999999999999998 108.503 -177.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -64.67 118.49 8.97 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 107.901 -1.148 . . . . 0.82999999999999996 107.901 174.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.457 ' HA ' ' NH1' ' A' ' 119' ' ' ARG . 8.0 mm-40 -38.24 90.47 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.923 1.389 . . . . 2.2799999999999998 113.148 -175.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 62.97 36.06 92.93 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.178 -0.919 . . . . 0.76000000000000001 112.419 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.533 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 2.2 t-20 -132.85 -45.41 0.87 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.526 -0.175 . . . . 1.6499999999999999 110.526 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.401 ' O ' ' HA ' ' A' ' 119' ' ' ARG . 1.6 mpt? -157.81 131.03 7.62 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 120.733 0.302 . . . . 1.1200000000000001 111.812 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -106.36 79.39 1.37 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.169 -1.048 . . . . 1.6200000000000001 108.169 170.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.507 ' CG1' HG12 ' A' ' 154' ' ' VAL . 0.4 OUTLIER -99.82 140.9 17.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.586 -0.734 . . . . 0.29999999999999999 112.801 -171.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.738 ' O ' HG13 ' A' ' 127' ' ' ILE . 4.3 pt -110.16 110.62 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-O 121.904 0.859 . . . . 0.58999999999999997 108.766 162.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.573 ' HB3' ' HA ' ' A' ' 11' ' ' ALA . 53.2 p -93.92 113.5 25.52 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 121.853 -0.529 . . . . 1.1799999999999999 110.208 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.622 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 7.0 m -110.91 150.58 29.01 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.411 -0.813 . . . . 1.24 111.203 -170.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.424 ' HE2' ' HG3' ' A' ' 150' ' ' PRO . 3.5 mtpm? -136.62 117.58 14.24 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 107.606 -1.257 . . . . 2.2599999999999998 107.606 175.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.504 ' HB2' ' H ' ' A' ' 148' ' ' ASN . 33.3 t -63.51 98.37 0.17 Allowed 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.075 -1.454 . . . . 1.3899999999999999 107.075 175.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.445 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -108.16 141.58 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.035 0 CA-C-N 114.57 -1.196 . . . . 1.05 108.988 -163.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -100.47 71.02 1.51 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 122.291 1.043 . . . . 2.1699999999999999 108.682 -170.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.775 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -98.2 159.52 30.5 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-N 113.668 -1.606 . . . . 0.53000000000000003 110.629 -171.589 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.96 -12.96 16.02 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.941 2.427 . . . . 1.28 114.785 -171.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.775 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 5.6 tp10 -72.41 -16.93 61.84 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 109.388 -0.597 . . . . 3.5 109.388 -172.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.464 ' HB2' HG11 ' A' ' 84' ' ' VAL . 15.5 t80 -163.52 118.43 1.12 Allowed Pre-proline 0 N--CA 1.448 -0.558 0 N-CA-C 113.066 0.765 . . . . 6.1200000000000001 113.066 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 95.8 Cg_endo -92.73 145.63 2.55 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.306 2.671 . . . . 1.77 110.834 166.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 138' ' ' PRO . 7.3 Cg_exo -72.29 -155.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.538 2.159 . . . . 1.25 112.336 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.2 m -147.15 155.92 42.55 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.823 -0.806 . . . . 1.6000000000000001 108.823 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.9 p -73.11 -0.25 13.55 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.197 0.443 . . . . 1.97 112.197 -173.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -105.16 -16.12 14.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.056 0.455 . . . . 2.1800000000000002 110.006 175.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.411 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 87.9 m-85 -132.36 108.91 9.49 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.515 -0.766 . . . . 1.23 109.904 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.41 HG23 ' HG2' ' A' ' 109' ' ' ARG . 2.7 tp -90.75 112.88 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 C-N-CA 120.366 -0.533 . . . . 0.81999999999999995 110.523 -176.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.681 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 64.9 ttp85 -49.41 102.22 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.408 -0.815 . . . . 4.4199999999999999 109.741 171.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -60.08 117.43 11.34 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 110.617 -0.993 . . . . 0.79000000000000004 110.617 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.465 ' HB3' ' CB ' ' A' ' 174' ' ' GLU . 65.0 t80 -83.45 85.59 7.22 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.791 0.805 . . . . 4.4400000000000004 111.17 -174.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.642 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 78.7 m-20 -77.83 98.81 5.7 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.426 -1.261 . . . . 1.6200000000000001 109.539 171.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.448 ' O ' ' HB3' ' A' ' 172' ' ' GLN . 24.6 t-80 -71.71 129.83 87.9 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 108.062 -1.088 . . . . 2.3199999999999998 108.062 176.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.52 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 46.1 Cg_exo -13.54 66.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.122 1 C-N-CA 126.973 5.115 . . . . 0.53000000000000003 115.905 -163.396 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . 0.642 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 24.2 p -112.31 156.4 22.5 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.845 -1.07 . . . . 1.5800000000000001 108.553 174.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.733 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -145.23 -147.35 4.61 Favored Glycine 0 N--CA 1.433 -1.528 0 C-N-CA 119.256 -1.449 . . . . 0.42999999999999999 113.624 -169.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.533 ' CZ ' HD21 ' A' ' 167' ' ' LEU . 55.1 t80 -162.06 92.06 0.82 Allowed 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.472 -0.936 . . . . 0.59999999999999998 108.472 -164.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.577 ' CG2' HG13 ' A' ' 168' ' ' VAL . 2.4 m -102.06 132.3 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-O 121.696 0.76 . . . . 0.31 110.776 -175.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 37.0 m -112.52 107.68 16.51 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.371 -0.831 . . . . 1.55 109.272 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.463 ' O ' ' HB3' ' A' ' 166' ' ' LYS . 9.8 m -104.75 114.13 64.22 Favored Pre-proline 0 C--N 1.315 -0.916 0 C-N-CA 120.771 -0.371 . . . . 1.0600000000000001 111.267 -169.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.533 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 53.1 Cg_exo -49.8 120.88 6.49 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.511 2.14 . . . . 0.56000000000000005 111.397 174.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.588 ' SD ' ' HB2' ' A' ' 166' ' ' LYS . 87.3 mmm -76.17 -165.62 0.51 Allowed 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.03 0.443 . . . . 1.1599999999999999 111.429 -176.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -66.09 -22.7 66.42 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.687 -0.688 . . . . 2.6299999999999999 109.708 177.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -109.16 19.58 19.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.414 -0.812 . . . . 2.0499999999999998 110.047 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.536 ' HB2' ' CD ' ' A' ' 162' ' ' PRO . 13.0 m120 27.2 -91.05 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.872 1.669 . . . . 1.9299999999999999 115.483 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.536 ' CD ' ' HB2' ' A' ' 161' ' ' ASN . 93.2 Cg_endo -74.76 -13.41 21.99 Favored 'Trans proline' 0 C--N 1.366 1.496 0 CA-C-N 121.709 1.646 . . . . 0.72999999999999998 112.866 -173.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -89.99 -34.68 15.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.042 -0.526 . . . . 0.68000000000000005 110.672 -177.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.444 ' O ' ' HB2' ' A' ' 158' ' ' MET . 78.2 m-85 -139.88 132.0 28.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.393 -0.367 . . . . 0.93000000000000005 110.24 176.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 34.9 t -123.59 145.01 49.23 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.595 0.712 . . . . 1.4099999999999999 111.171 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.588 ' HB2' ' SD ' ' A' ' 158' ' ' MET . 15.3 tppt? -93.87 100.94 13.02 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.268 -0.878 . . . . 0.73999999999999999 111.161 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.533 HD21 ' CZ ' ' A' ' 153' ' ' PHE . 0.9 OUTLIER -85.54 108.4 17.92 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.054 -0.975 . . . . 0.27000000000000002 109.335 178.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.577 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -129.31 114.55 32.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-O 122.115 0.96 . . . . 0.28000000000000003 111.319 177.349 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 18.7 ttt -115.63 141.51 47.97 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.539 -1.21 . . . . 1.24 110.693 -172.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.548 ' O ' ' HB2' ' A' ' 151' ' ' CYS . 73.7 m-85 -115.69 127.47 55.18 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.545 -0.752 . . . . 3.3700000000000001 110.972 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.451 HG13 ' OG1' ' A' ' 173' ' ' THR . 1.0 OUTLIER -112.48 113.64 44.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.598 -0.728 . . . . 1.3999999999999999 110.042 174.19 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.612 ' NE2' HD12 ' A' ' 47' ' ' LEU . 33.9 tt0 -116.18 41.3 2.64 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 106.001 -1.852 . . . . 2.1699999999999999 106.001 171.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.451 ' OG1' HG13 ' A' ' 171' ' ' VAL . 18.9 m -69.65 149.82 47.69 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 112.53 -2.123 . . . . 1.6499999999999999 110.46 -174.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.465 ' CB ' ' HB3' ' A' ' 147' ' ' TYR . 8.1 tt0 . . . . . 0 C--N 1.325 -0.475 0 CA-C-O 121.482 0.658 . . . . 2.4500000000000002 111.435 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.448 ' HA ' ' CE ' ' A' ' 186' ' ' LYS . 27.9 mm . . . . . 0 CA--C 1.506 -0.715 0 CA-C-O 122.585 1.183 . . . . 1.1200000000000001 108.985 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.94 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.1 mp -64.88 -37.8 81.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 112.887 -1.96 . . . . 1.1299999999999999 111.473 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -64.16 -17.92 63.95 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.314 -0.624 . . . . 2.8900000000000001 109.314 175.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.448 ' CE ' ' HA ' ' A' ' 183' ' ' ILE . 49.5 mtmt -92.85 -43.59 8.91 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.75 -0.659 . . . . 1.28 110.299 173.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.94 HG22 ' HA ' ' A' ' 184' ' ' ILE . 15.1 t -61.1 -33.42 73.33 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.734 0.642 . . . . 0.62 112.734 -169.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . 0.631 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 15.6 mmt -78.43 -59.39 0.71 Allowed Pre-proline 0 C--N 1.332 -0.173 0 C-N-CA 119.646 -0.821 . . . . 1.0600000000000001 110.835 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.631 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 33.9 Cg_exo -62.93 -22.07 73.58 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 121.917 1.745 . . . . 0.91000000000000003 112.216 -176.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.783 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 67.2 m -81.08 -22.96 38.81 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.796 -0.362 . . . . 1.5 110.489 175.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.2 OUTLIER -91.43 -37.59 13.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.814 0.34 . . . . 1.8799999999999999 111.074 -176.635 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.534 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 2.2 mt -62.13 -56.92 13.98 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.558 0.694 . . . . 1.0900000000000001 111.161 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 189' ' ' PRO . 1.6 m -66.93 -32.13 56.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.707 -1.133 . . . . 0.68000000000000005 109.033 -175.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.783 ' HB2' ' O ' ' A' ' 190' ' ' SER . 26.4 t30 -63.1 -48.27 79.3 Favored 'General case' 0 C--O 1.208 -1.099 0 CA-C-N 113.911 -1.495 . . . . 2.0699999999999998 109.727 177.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.53 ' O ' ' HB2' ' A' ' 198' ' ' ASN . 2.8 t80 -62.04 -25.33 67.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.956 0.407 . . . . 2.0 110.283 -178.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.596 HD12 HG22 ' A' ' 50' ' ' VAL . 14.6 mt -80.22 -29.57 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-O 120.993 0.425 . . . . 0.31 110.988 174.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 83.3 mt -74.93 -36.71 62.13 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.302 0.572 . . . . 1.03 109.481 174.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.53 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 4.9 m-20 -48.56 -39.17 22.69 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.756 -1.111 . . . . 1.8999999999999999 108.995 163.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.703 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -80.5 -44.52 19.02 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 116.027 -0.533 . . . . 0.28999999999999998 111.247 -176.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 28.7 mmtp -54.41 -46.23 73.1 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.734 0.778 . . . . 0.96999999999999997 110.187 173.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -80.04 -45.44 18.33 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.614 -1.175 . . . . 1.9399999999999999 110.416 -175.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -64.42 -31.55 81.23 Favored Glycine 0 C--O 1.228 -0.246 0 C-N-CA 121.004 -0.617 . . . . 0.46999999999999997 112.555 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.842 HD13 HD23 ' A' ' 61' ' ' LEU . 1.8 tp -69.89 -37.23 72.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.836 0.351 . . . . 0.60999999999999999 110.202 178.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -85.13 -20.81 29.74 Favored 'General case' 0 C--O 1.21 -1.024 0 N-CA-C 109.071 -0.714 . . . . 3.3700000000000001 109.071 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.974 0 CA-C-N 116.007 -0.542 . . . . 1.02 109.682 168.166 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.51 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.3 t70 . . . . . 0 CA--C 1.516 -0.357 0 CA-C-O 121.492 0.663 . . . . 2.25 109.639 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.817 ' HA ' HD11 ' A' ' 6' ' ' ILE . 98.8 m-85 -70.46 -29.87 66.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.289 -0.868 . . . . 0.42999999999999999 109.367 -175.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.524 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 27.1 tttm -74.42 -3.88 33.25 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.822 -1.081 . . . . 1.51 109.766 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 2' ' ' ASP . . . -91.95 -44.89 8.63 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.016 -0.538 . . . . 0.54000000000000004 109.95 172.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.817 HD11 ' HA ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -82.98 -41.34 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-O 121.425 0.631 . . . . 1.0700000000000001 110.727 -173.024 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.626 ' HB2' HD21 ' A' ' 114' ' ' LEU . . . -74.39 -39.59 62.59 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.988 -1.006 . . . . 0.34000000000000002 111.34 -176.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.524 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 2.4 mt-30 -68.15 -27.01 66.06 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.82 -1.082 . . . . 1.5900000000000001 110.232 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -81.79 -33.12 31.02 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.765 -1.107 . . . . 2.4700000000000002 109.111 172.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.65 ' HA ' ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -71.49 -39.06 71.11 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.23 -0.895 . . . . 0.47999999999999998 111.723 179.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.621 ' HA ' ' CB ' ' A' ' 128' ' ' SER . . . -48.15 -60.13 2.87 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-O 121.109 0.48 . . . . 0.31 111.87 176.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.419 ' H ' ' HG2' ' A' ' 12' ' ' GLN . 20.3 pt20 -76.55 0.11 21.22 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.174 -0.466 . . . . 1.6399999999999999 111.579 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.65 ' HB3' ' HA ' ' A' ' 10' ' ' THR . 1.1 tt0 -90.73 -45.29 8.93 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.055 -0.72 . . . . 2.54 109.055 174.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.823 HG23 ' CE2' ' A' ' 170' ' ' PHE . 4.1 p -70.44 -47.39 65.97 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.041 0 N-CA-C 109.001 -0.74 . . . . 0.53000000000000003 109.001 171.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.627 ' HG ' ' OD1' ' A' ' 18' ' ' ASN . 1.0 OUTLIER -61.77 -24.96 67.17 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.362 1.077 . . . . 0.59999999999999998 108.338 175.038 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 20' ' ' ASP . . . -63.19 -21.22 63.79 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 113.774 -1.557 . . . . 0.56999999999999995 110.406 178.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.926 ' CE1' ' HG3' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -87.25 -33.44 19.28 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.097 -0.705 . . . . 3.27 109.097 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.627 ' OD1' ' HG ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -80.38 -16.98 53.23 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.424 0.63 . . . . 2.0299999999999998 110.073 -167.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.458 ' HD2' HD23 ' A' ' 15' ' ' LEU . 24.9 mtp180 -101.52 -20.35 15.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.142 -0.936 . . . . 2.7200000000000002 110.133 175.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 16' ' ' GLY . 35.2 t70 -118.51 84.3 2.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.787 -0.642 . . . . 2.1600000000000001 109.821 -178.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.9 p -108.0 127.02 53.4 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 120.916 0.389 . . . . 1.8200000000000001 111.751 -172.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.4 t 173.23 162.23 0.14 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.366 -0.834 . . . . 2.1899999999999999 109.522 -173.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.44 1.73 90.21 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 121.183 -0.532 . . . . 1.1000000000000001 113.111 174.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -112.75 -157.39 0.62 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.837 0.351 . . . . 1.6699999999999999 110.876 -177.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 tpmt? -173.24 118.1 0.3 Allowed 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 108.851 -0.796 . . . . 2.9500000000000002 108.851 -172.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.662 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 2.8 m -63.19 116.87 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.989 0 CA-C-O 122.116 0.96 . . . . 1.5600000000000001 110.789 176.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.459 HG13 ' HB2' ' A' ' 28' ' ' LYS . 10.9 p -98.38 -24.74 4.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 113.979 -1.464 . . . . 1.22 109.719 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.459 ' HB2' HG13 ' A' ' 27' ' ' VAL . 1.2 tmtt? -154.37 120.39 5.29 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 119.471 -0.892 . . . . 2.4100000000000001 110.537 -170.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.542 ' HB ' ' HA ' ' A' ' 34' ' ' THR . 0.2 OUTLIER -149.71 135.05 18.25 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.477 0.656 . . . . 1.3799999999999999 110.506 175.096 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.4 m -88.39 -68.35 0.77 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.841 -1.072 . . . . 2.3700000000000001 111.299 -173.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -166.64 18.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 121.018 -0.273 . . . . 4.5499999999999998 110.856 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.506 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 16.5 tttp 178.51 -28.95 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.351 0.595 . . . . 1.4199999999999999 110.312 -174.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.724 HG22 ' HA3' ' A' ' 52' ' ' GLY . 30.0 pt -98.95 152.79 4.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.96 -1.018 . . . . 0.76000000000000001 109.254 174.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.562 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 3.4 m -146.47 110.87 5.12 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 123.452 0.47 . . . . 0.57999999999999996 111.04 -167.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.684 ' HA ' ' O ' ' A' ' 49' ' ' ARG . 13.0 t -103.45 112.73 38.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.995 -0.372 . . . . 0.85999999999999999 109.995 -177.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.662 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 84.0 p -106.83 133.93 50.75 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.193 0.597 . . . . 1.1000000000000001 110.685 -177.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 49.2 m -102.45 126.67 49.56 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.297 -0.41 . . . . 1.27 110.416 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp . . . . . 0 C--N 1.319 -0.723 0 CA-C-N 115.856 -0.611 . . . . 1.9099999999999999 110.424 -177.569 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 . . . . . 0 CA--C 1.511 -0.541 0 N-CA-C 108.481 -0.933 . . . . 2.0499999999999998 108.481 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.768 HD21 ' CD1' ' A' ' 170' ' ' PHE . 4.8 tt -82.52 130.0 35.03 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.829 -0.804 . . . . 0.87 108.829 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.539 ' N ' HD23 ' A' ' 47' ' ' LEU . 38.3 m-85 -115.45 119.12 35.17 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.466 -0.568 . . . . 0.98999999999999999 109.466 -178.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.926 ' HG3' ' CE1' ' A' ' 17' ' ' TYR . 3.1 tmt_? -110.47 141.84 43.04 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.928 -0.578 . . . . 2.9199999999999999 109.505 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 34' ' ' THR . 8.8 p -127.99 143.59 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-O 121.243 0.544 . . . . 1.3300000000000001 109.862 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.504 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 33.4 tt0 -146.28 110.81 5.14 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.442 -0.799 . . . . 1.0700000000000001 109.01 -173.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.724 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -137.81 134.72 7.11 Favored Glycine 0 N--CA 1.439 -1.13 0 C-N-CA 120.361 -0.923 . . . . 0.28999999999999998 111.851 -176.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 64.4 mt -83.98 118.13 30.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 C-N-CA 119.798 -0.761 . . . . 0.57999999999999996 110.327 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.407 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 72.3 mt -95.99 113.15 61.61 Favored Pre-proline 0 N--CA 1.435 -1.209 0 CA-C-N 115.132 -0.94 . . . . 0.34999999999999998 108.599 175.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 24.9 Cg_exo -65.67 45.87 0.18 Allowed 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.825 3.017 . . . . 0.62 113.582 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.576 ' HG2' HG13 ' A' ' 203' ' ' ILE . 10.5 tp10 -135.72 178.09 7.32 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.539 -1.282 . . . . 1.6799999999999999 107.539 177.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.451 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 47.9 t -81.1 139.66 49.31 Favored Pre-proline 0 N--CA 1.43 -1.473 0 CA-C-O 121.739 0.781 . . . . 1.1799999999999999 110.234 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.542 ' HG3' ' HB3' ' A' ' 165' ' ' SER . 23.5 Cg_exo -61.35 -9.13 12.04 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 124.11 3.207 . . . . 0.52000000000000002 110.658 177.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 63' ' ' ASP . . . -67.02 -52.3 44.14 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.981 -1.009 . . . . 0.64000000000000001 110.82 174.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.62 ' HE3' ' HB3' ' A' ' 64' ' ' PHE . 7.4 tptt -72.12 -23.91 61.39 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.887 -0.783 . . . . 3.2999999999999998 108.887 178.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.714 HD23 ' CD1' ' A' ' 203' ' ' ILE . 20.4 mt -64.42 -60.35 3.27 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.863 -0.608 . . . . 0.40999999999999998 109.454 174.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.461 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 34.1 t -64.73 -14.13 57.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.563 -0.744 . . . . 1.29 110.306 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 22.6 t70 -80.83 -46.42 15.36 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.844 -0.616 . . . . 1.3200000000000001 111.077 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.625 ' HB2' ' HZ2' ' A' ' 74' ' ' TRP . 7.0 p90 -76.21 -45.43 33.08 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 120.9 -0.32 . . . . 0.60999999999999999 111.29 -171.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.461 ' CD2' ' HA ' ' A' ' 62' ' ' SER . 0.5 OUTLIER -80.66 -5.31 56.77 Favored 'General case' 0 CA--C 1.512 -0.487 0 O-C-N 121.833 -0.542 . . . . 1.5 111.184 -171.247 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.522 ' O ' ' HG3' ' A' ' 67' ' ' GLN . 13.0 t80 -50.73 -48.61 58.91 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 123.676 0.61 . . . . 1.52 112.181 -163.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.524 ' HG2' ' CZ ' ' A' ' 81' ' ' TYR . 16.3 mt-30 155.84 115.22 0.0 OUTLIER 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 124.657 1.183 . . . . 3.6000000000000001 109.32 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.788 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 6.3 t 42.53 31.49 0.29 Allowed 'General case' 0 C--N 1.315 -0.906 0 O-C-N 124.559 1.162 . . . . 1.48 113.397 175.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.93 -27.19 14.44 Favored Glycine 0 CA--C 1.496 -1.154 0 C-N-CA 120.039 -1.077 . . . . 1.46 112.166 -173.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.729 ' O ' HG22 ' A' ' 73' ' ' THR . 17.4 p-10 173.87 -28.77 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.677 -1.231 . . . . 2.1899999999999999 107.677 -172.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.83 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 1.6 ptp180 -43.11 -54.43 4.4 Favored 'General case' 0 C--O 1.21 -0.983 0 CA-C-N 114.636 -1.165 . . . . 3.3799999999999999 110.66 177.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.883 HG22 ' HB3' ' A' ' 78' ' ' LEU . 1.8 pp -78.34 -12.27 13.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.056 0.455 . . . . 0.70999999999999996 111.503 -175.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.729 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.2 t -90.22 -29.78 17.98 Favored 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 120.062 -0.655 . . . . 0.96999999999999997 109.859 -168.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.625 ' HZ2' ' HB2' ' A' ' 64' ' ' PHE . 7.8 p-90 -111.53 -3.99 14.95 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.16 -0.473 . . . . 0.75 111.378 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.83 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 1.8 t70 -65.9 176.88 1.47 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 122.306 1.051 . . . . 2.1899999999999999 113.399 -171.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.451 ' HG3' ' OD1' ' A' ' 194' ' ' ASN . 0.0 OUTLIER -123.0 -27.5 4.21 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.819 -1.537 . . . . 3.1899999999999999 110.509 -178.037 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.436 ' HA ' ' HB2' ' A' ' 99' ' ' GLN . 50.0 m -113.12 0.58 15.0 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.073 -0.714 . . . . 1.5800000000000001 109.073 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.883 ' HB3' HG22 ' A' ' 72' ' ' ILE . 53.2 mt -108.73 173.68 6.21 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.048 -0.978 . . . . 0.70999999999999996 110.268 177.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.678 ' HG2' ' HG2' ' A' ' 99' ' ' GLN . 12.8 mm100 -156.87 -66.2 0.1 Allowed 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.734 0.778 . . . . 1.73 109.972 -174.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.472 HG23 ' HB3' ' A' ' 79' ' ' GLN . 17.3 t -136.96 119.17 19.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 114.586 -1.188 . . . . 0.78000000000000003 109.835 -169.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.788 ' HB3' ' HB ' ' A' ' 68' ' ' THR . 0.4 OUTLIER -109.22 123.48 49.31 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.495 -0.558 . . . . 5.4000000000000004 109.495 175.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.708 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 13.5 m120 -119.95 123.68 44.11 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.324 -0.991 . . . . 1.6899999999999999 108.324 -176.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.79 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 18.3 ttm -87.73 99.01 11.77 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.69 -0.856 . . . . 2.0499999999999998 108.69 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.582 HG11 ' HZ ' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -77.49 -60.74 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.981 -0.554 . . . . 0.64000000000000001 111.349 -163.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.63 130.29 19.07 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.862 -0.792 . . . . 1.96 108.862 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.79 ' HD3' ' SD ' ' A' ' 83' ' ' MET . 14.3 mtm180 -110.4 132.95 53.73 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.38 -0.6 . . . . 2.4399999999999999 109.38 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.605 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -94.5 -44.45 13.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.769 -0.65 . . . . 0.46999999999999997 111.097 -168.354 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -149.99 -161.99 1.46 Allowed 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.431 -0.951 . . . . 1.8600000000000001 108.431 -174.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.1 m -65.22 -33.36 75.81 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 111.932 0.345 . . . . 1.4399999999999999 111.932 -172.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -137.92 33.74 2.4 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.343 0.592 . . . . 1.8700000000000001 109.647 -174.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.605 ' O ' HG12 ' A' ' 87' ' ' ILE . 1.7 m -132.54 107.09 8.23 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.971 -1.122 . . . . 0.46000000000000002 107.971 -178.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.599 ' O ' HD12 ' A' ' 114' ' ' LEU . 16.9 m-85 -123.37 171.58 9.32 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.947 -0.57 . . . . 0.42999999999999999 110.08 -173.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.545 ' O ' HG23 ' A' ' 84' ' ' VAL . 53.3 mt -121.81 129.87 75.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 109.11 -0.7 . . . . 0.40999999999999998 109.11 170.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.792 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 0.0 OUTLIER -93.25 118.02 30.76 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.734 -1.121 . . . . 2.0099999999999998 111.962 -170.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.708 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 22.2 t-160 -107.18 90.53 3.33 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.021 -0.733 . . . . 1.23 109.021 163.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.626 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 72.2 m -109.22 120.7 43.33 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.984 -0.553 . . . . 0.5 111.457 -176.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.8 mm -83.92 130.02 36.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.367 0.603 . . . . 1.03 110.028 174.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 3.0 m -106.11 152.58 23.23 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.793 -1.094 . . . . 1.3799999999999999 110.124 -174.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.678 ' HG2' ' HG2' ' A' ' 79' ' ' GLN . 4.2 mm-40 . . . . . 0 C--N 1.319 -0.744 0 CA-C-O 121.25 0.547 . . . . 1.8200000000000001 111.443 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 76.5 mt . . . . . 0 N--CA 1.451 -0.402 0 N-CA-C 109.624 -0.51 . . . . 1.1200000000000001 109.624 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.1 m -99.19 157.79 33.42 Favored Pre-proline 0 C--N 1.32 -0.709 0 N-CA-C 109.319 -0.623 . . . . 1.3500000000000001 109.319 175.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -47.97 116.54 1.99 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.814 2.342 . . . . 1.0700000000000001 111.686 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.658 ' HG3' HG23 ' A' ' 144' ' ' ILE . 34.3 ttp180 -102.08 149.22 24.48 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.007 -0.738 . . . . 3.4500000000000002 109.007 -173.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.405 ' OD1' ' HA ' ' A' ' 145' ' ' ARG . 2.5 p30 -114.25 147.85 38.36 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.813 -0.755 . . . . 1.3700000000000001 110.135 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.626 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 15.1 m-85 -116.25 128.51 55.65 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.325 -0.852 . . . . 2.4100000000000001 110.229 174.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.792 ' HA ' ' O ' ' A' ' 94' ' ' CYS . 22.6 mm -126.8 80.87 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.33 -0.85 . . . . 0.42999999999999999 109.049 169.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.729 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 10.0 m-20 -113.64 129.09 56.63 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.872 -1.058 . . . . 1.8600000000000001 109.215 -178.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.626 HD21 ' HB2' ' A' ' 7' ' ' ALA . 3.8 tp -74.79 121.45 21.79 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.424 0.63 . . . . 0.28000000000000003 109.401 176.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -115.71 123.74 71.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 114.96 -1.018 . . . . 0.26000000000000001 111.497 -164.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.663 ' HE2' ' HE3' ' A' ' 118' ' ' LYS . 90.9 t80 -114.07 125.21 53.72 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.827 -1.078 . . . . 2.5699999999999998 109.895 175.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 1.099 HG12 HG22 ' A' ' 127' ' ' ILE . 85.9 mt -98.79 104.33 15.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.312 0.577 . . . . 0.89000000000000001 110.358 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.663 ' HE3' ' HE2' ' A' ' 116' ' ' TYR . 5.0 tppp? -98.73 128.04 44.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.599 -0.728 . . . . 1.2 109.267 177.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.68 92.04 3.79 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.035 -0.728 . . . . 2.7999999999999998 109.035 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.446 ' HB3' ' HB3' ' A' ' 123' ' ' ASN . 59.5 m-85 -73.12 115.15 12.11 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 115.14 -0.936 . . . . 0.82999999999999996 108.737 175.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -26.53 89.67 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 O-C-N 125.637 1.836 . . . . 2.2799999999999998 113.252 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 53.83 42.44 69.16 Favored Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.789 -0.641 . . . . 0.76000000000000001 112.672 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.505 ' C ' ' HD2' ' A' ' 157' ' ' PRO . 3.2 t-20 -135.75 -49.21 0.7 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.331 -0.434 . . . . 1.6499999999999999 110.705 -176.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.584 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 5.4 mtm -161.98 120.24 2.26 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 120.726 -0.39 . . . . 1.1200000000000001 111.787 -178.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -104.35 78.68 1.51 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.422 -0.955 . . . . 1.6200000000000001 108.422 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.682 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -92.8 138.4 20.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 114.915 -1.039 . . . . 0.29999999999999999 112.791 -172.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 1.099 HG22 HG12 ' A' ' 117' ' ' ILE . 38.0 pt -105.51 100.68 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.93 0.872 . . . . 0.58999999999999997 109.34 165.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.621 ' CB ' ' HA ' ' A' ' 11' ' ' ALA . 11.8 p -85.73 110.58 19.43 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.842 -0.617 . . . . 1.1799999999999999 110.707 178.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.729 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 1.9 p -106.4 135.87 47.14 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.408 -0.814 . . . . 1.24 110.691 -176.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.608 ' HE2' ' OG1' ' A' ' 10' ' ' THR . 10.6 ttmm -128.11 112.25 14.37 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.819 -1.178 . . . . 2.2599999999999998 107.819 -177.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.8 p -57.88 98.39 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.914 0 CA-C-O 121.944 0.878 . . . . 1.3899999999999999 109.067 -175.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.55 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -110.32 134.12 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.122 0 CA-C-N 114.587 -1.188 . . . . 1.05 109.034 -165.607 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -96.19 71.15 2.81 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.719 -1.128 . . . . 2.1699999999999999 108.456 -172.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.687 ' CE1' HG21 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -99.5 159.54 29.78 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 114.447 -1.251 . . . . 0.53000000000000003 110.471 -172.093 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.83 -27.64 75.27 Favored 'Trans proline' 0 N--CA 1.477 0.535 0 C-N-CA 123.861 3.041 . . . . 1.28 115.679 -168.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.432 ' HG2' ' CD2' ' A' ' 134' ' ' PHE . 12.1 mm-40 -71.72 -21.71 61.73 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 120.478 -0.489 . . . . 3.5 110.08 -166.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.577 ' CD2' HG13 ' A' ' 112' ' ' ILE . 57.0 t80 -134.26 108.23 11.33 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 112.916 0.71 . . . . 6.1200000000000001 112.916 -177.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -97.6 119.12 0.15 Allowed 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 123.537 2.824 . . . . 1.77 110.76 162.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -63.24 -176.94 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.271 1.981 . . . . 1.25 112.24 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.0 m -146.63 -162.35 1.51 Allowed 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.598 -0.519 . . . . 1.6000000000000001 109.598 -171.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.3 m -79.91 -40.69 27.67 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.297 -0.561 . . . . 1.97 111.337 -178.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -68.09 -42.63 80.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.037 0.446 . . . . 2.1800000000000002 111.176 -176.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -105.19 134.79 47.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.711 -0.677 . . . . 1.23 110.172 -173.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.658 HG23 ' HG3' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -109.93 103.51 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 CA-C-N 116.034 -0.53 . . . . 0.81999999999999995 109.702 -179.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.542 ' HE ' ' HB ' ' A' ' 112' ' ' ILE . 12.1 ttt180 -51.7 100.78 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.552 -1.204 . . . . 4.4199999999999999 110.429 178.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.35 110.13 3.06 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.662 -0.699 . . . . 0.79000000000000004 112.224 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.452 ' HB3' ' HB3' ' A' ' 174' ' ' GLU . 26.4 t80 -85.42 82.2 8.41 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.258 0.551 . . . . 4.4400000000000004 109.649 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.533 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 47.1 m-80 -78.21 100.45 6.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.737 -0.665 . . . . 1.6200000000000001 109.747 176.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -57.76 114.96 9.5 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.314 -0.625 . . . . 2.3199999999999998 109.314 176.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.437 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 65.9 Cg_exo -7.0 67.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.681 1 C-N-CA 126.152 4.568 . . . . 0.53000000000000003 115.187 -159.764 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . 0.736 ' HB3' ' O ' ' A' ' 170' ' ' PHE . 2.9 m -87.75 150.78 23.37 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 115.039 -0.982 . . . . 1.5800000000000001 108.404 178.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.822 ' HA3' HG21 ' A' ' 14' ' ' VAL . . . -139.83 -162.86 9.28 Favored Glycine 0 CA--C 1.494 -1.265 0 C-N-CA 118.829 -1.653 . . . . 0.42999999999999999 112.649 -176.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.615 ' HB3' HG12 ' A' ' 127' ' ' ILE . 0.4 OUTLIER -160.74 83.42 0.67 Allowed 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.364 -1.347 . . . . 0.59999999999999998 107.364 -164.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.772 HG23 HG13 ' A' ' 168' ' ' VAL . 4.2 m -95.28 130.38 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 CA-C-O 121.933 0.873 . . . . 0.31 110.576 -175.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . 0.584 ' O ' ' HA ' ' A' ' 124' ' ' MET . 6.0 t -110.32 118.54 36.59 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.251 -0.886 . . . . 1.55 109.446 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.617 ' HB3' ' HB3' ' A' ' 166' ' ' LYS . 9.1 t -114.78 112.6 45.09 Favored Pre-proline 0 C--N 1.319 -0.749 0 C-N-CA 120.654 -0.418 . . . . 1.0600000000000001 111.625 -170.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.505 ' HD2' ' C ' ' A' ' 123' ' ' ASN . 46.8 Cg_exo -55.18 118.56 5.3 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.11 1.873 . . . . 0.56000000000000005 110.166 166.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.485 ' N ' ' HB3' ' A' ' 161' ' ' ASN . 72.3 mtp -79.5 -171.78 2.93 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.717 -0.393 . . . . 1.1599999999999999 111.087 -175.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -67.24 -31.19 71.37 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.481 -0.933 . . . . 2.6299999999999999 108.481 169.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.411 ' C ' ' HD2' ' A' ' 162' ' ' PRO . 24.2 mt-10 -102.45 27.87 6.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.362 -1.29 . . . . 2.0499999999999998 109.213 176.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.498 ' OD1' ' HD3' ' A' ' 162' ' ' PRO . 7.0 p30 -38.84 -46.96 3.45 Favored Pre-proline 0 N--CA 1.473 0.694 0 N-CA-C 115.985 1.846 . . . . 1.9299999999999999 115.985 -169.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.498 ' HD3' ' OD1' ' A' ' 161' ' ' ASN . 71.2 Cg_endo -72.45 -17.63 26.75 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 CA-C-N 121.336 1.513 . . . . 0.72999999999999998 112.384 -174.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -109.62 -24.43 10.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.779 -0.646 . . . . 0.68000000000000005 110.933 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.462 ' O ' ' HA ' ' A' ' 161' ' ' ASN . 79.1 m-85 -141.76 121.05 13.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.065 -0.516 . . . . 0.93000000000000005 109.726 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.542 ' HB3' ' HG3' ' A' ' 58' ' ' PRO . 6.8 p -117.29 142.71 46.73 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.304 -0.558 . . . . 1.4099999999999999 111.187 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.617 ' HB3' ' HB3' ' A' ' 156' ' ' SER . 2.3 tppp? -94.31 104.41 16.4 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 122.1 0.952 . . . . 0.73999999999999999 111.822 -174.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.49 HD12 HG12 ' A' ' 196' ' ' ILE . 0.7 OUTLIER -90.69 104.83 17.37 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.297 -1.32 . . . . 0.27000000000000002 109.517 176.179 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.772 HG13 HG23 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -127.86 126.06 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.803 0.811 . . . . 0.28000000000000003 111.533 -179.642 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.574 ' O ' ' HG2' ' A' ' 49' ' ' ARG . 12.2 ttm -141.4 148.58 39.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.248 -0.887 . . . . 1.24 109.486 -172.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.823 ' CE2' HG23 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -129.71 143.34 50.77 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.186 -0.606 . . . . 3.3700000000000001 110.345 170.256 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.55 ' HB ' HD21 ' A' ' 192' ' ' LEU . 0.9 OUTLIER -119.9 118.81 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 O-C-N 124.86 1.35 . . . . 1.3999999999999999 109.985 178.394 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.517 ' HB2' ' HG ' ' A' ' 47' ' ' LEU . 10.4 tt0 -121.81 48.73 1.65 Allowed 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 106.187 -1.783 . . . . 2.1699999999999999 106.187 173.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 5.5 m -72.13 151.34 43.08 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.024 -1.898 . . . . 1.6499999999999999 111.224 -174.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.452 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 18.5 tt0 . . . . . 0 N--CA 1.438 -1.061 0 CA-C-O 121.542 0.687 . . . . 2.4500000000000002 109.821 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.446 ' HA ' ' HE3' ' A' ' 186' ' ' LYS . 16.2 mm . . . . . 0 CA--C 1.507 -0.708 0 CA-C-O 122.523 1.154 . . . . 1.1200000000000001 108.909 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.931 ' HA ' HG22 ' A' ' 187' ' ' THR . 0.9 OUTLIER -70.01 -38.15 74.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 112.768 -2.014 . . . . 1.1299999999999999 110.931 -178.728 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.69 -17.91 64.94 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.155 -0.683 . . . . 2.8900000000000001 109.155 175.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.446 ' HE3' ' HA ' ' A' ' 183' ' ' ILE . 48.2 mtmt -93.01 -38.7 11.51 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.729 -0.668 . . . . 1.28 110.081 175.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.931 HG22 ' HA ' ' A' ' 184' ' ' ILE . 11.2 t -68.73 -24.61 64.49 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 112.348 0.499 . . . . 0.62 112.348 -171.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . 0.558 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 0.2 OUTLIER -79.78 -63.65 0.36 Allowed Pre-proline 0 N--CA 1.467 0.402 0 CA-C-N 118.471 0.578 . . . . 1.0600000000000001 111.699 179.418 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.558 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 25.4 Cg_exo -62.7 -25.53 75.07 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.296 1.997 . . . . 0.91000000000000003 112.484 -176.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.746 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 68.4 m -82.95 -28.53 29.75 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.716 -0.394 . . . . 1.5 111.306 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.652 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.2 OUTLIER -90.55 -36.49 14.44 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.9 -0.32 . . . . 1.8799999999999999 111.272 -173.474 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.55 HD21 ' HB ' ' A' ' 171' ' ' VAL . 48.4 mt -65.22 -47.04 78.21 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.183 0.516 . . . . 1.0900000000000001 110.587 -177.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.477 ' HB ' HD12 ' A' ' 33' ' ' ILE . 2.0 m -67.9 -30.05 46.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.584 -0.735 . . . . 0.68000000000000005 109.301 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.746 ' HB2' ' O ' ' A' ' 190' ' ' SER . 1.0 OUTLIER -71.6 -37.07 71.0 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.652 -1.158 . . . . 2.0699999999999998 110.247 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.587 ' HA ' ' ND2' ' A' ' 198' ' ' ASN . 12.2 m-85 -61.07 -34.03 74.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.027 0.441 . . . . 2.0 110.048 172.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.545 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 54.3 mt -79.63 -28.97 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 116.082 -0.508 . . . . 0.31 110.637 176.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.445 ' HB2' ' HA ' ' A' ' 194' ' ' ASN . 53.2 mt -72.8 -36.47 67.56 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-N 116.317 -0.401 . . . . 1.03 110.233 176.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.587 ' ND2' ' HA ' ' A' ' 195' ' ' PHE . 67.2 m-20 -49.06 -47.61 44.78 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.303 -0.999 . . . . 1.8999999999999999 108.303 164.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.858 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -67.24 -45.49 76.56 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 115.28 -0.873 . . . . 0.28999999999999998 110.12 -175.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 61.2 mmtt -53.65 -48.18 69.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.403 0.621 . . . . 0.96999999999999997 109.91 173.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -75.71 -39.99 56.46 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.04 -0.982 . . . . 1.9399999999999999 111.305 -169.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -76.64 -28.23 59.71 Favored Glycine 0 N--CA 1.461 0.334 0 C-N-CA 120.056 -1.069 . . . . 0.46999999999999997 111.739 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.858 ' HB ' ' O ' ' A' ' 199' ' ' ALA . 0.9 OUTLIER -71.51 -38.61 68.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 123.045 0.538 . . . . 0.60999999999999999 110.832 172.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -83.76 -17.35 41.5 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.355 0.598 . . . . 3.3700000000000001 109.406 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.03 0 N-CA-C 108.442 -0.947 . . . . 1.02 108.442 166.866 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.6 t70 . . . . . 0 N--CA 1.442 -0.844 0 N-CA-C 108.571 -0.899 . . . . 2.25 108.571 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.542 ' HA ' HD11 ' A' ' 6' ' ' ILE . 59.1 m-85 -66.66 -31.86 72.8 Favored 'General case' 0 CA--C 1.507 -0.707 0 O-C-N 123.58 0.55 . . . . 0.42999999999999999 110.284 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 27.0 tttp -75.91 -44.34 40.76 Favored 'General case' 0 N--CA 1.418 -2.065 0 N-CA-C 107.598 -1.26 . . . . 1.51 107.598 -177.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.408 ' O ' ' HG3' ' A' ' 9' ' ' GLN . . . -50.16 -51.73 41.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.422 -0.808 . . . . 0.54000000000000004 112.471 -177.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.542 HD11 ' HA ' ' A' ' 3' ' ' PHE . 0.4 OUTLIER -83.49 -30.6 8.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.312 -0.555 . . . . 1.0700000000000001 110.758 -172.005 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.497 ' HA ' ' HB ' ' A' ' 10' ' ' THR . . . -74.04 -41.54 61.65 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.85 0.833 . . . . 0.34000000000000002 110.956 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.486 ' HG2' ' CZ ' ' A' ' 116' ' ' TYR . 14.7 mt-30 -62.51 -31.23 71.96 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.259 -1.337 . . . . 1.5900000000000001 110.216 177.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 5' ' ' ALA . 98.9 mt-30 -82.47 -30.85 29.7 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.999 -1.0 . . . . 2.4700000000000002 109.204 174.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.624 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.6 OUTLIER -72.0 -37.72 69.77 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.682 -1.145 . . . . 0.47999999999999998 111.202 -179.569 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.541 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -46.51 -62.62 1.29 Allowed 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.266 0.469 . . . . 0.31 112.266 174.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -70.01 -6.24 32.05 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.308 -0.406 . . . . 1.6399999999999999 111.086 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.52 ' HB3' ' HA ' ' A' ' 10' ' ' THR . 0.2 OUTLIER -87.7 -43.0 12.24 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.215 -0.448 . . . . 2.54 110.136 179.666 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.712 HG21 ' N ' ' A' ' 152' ' ' GLY . 7.2 p -79.26 -29.83 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-O 121.841 0.829 . . . . 0.53000000000000003 109.404 176.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 tt -76.15 -19.71 58.23 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 108.314 -0.995 . . . . 0.59999999999999998 108.314 172.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.43 -23.42 66.65 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 113.931 -1.486 . . . . 0.56999999999999995 109.62 170.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.558 ' CD2' ' HA ' ' A' ' 14' ' ' VAL . 26.3 m-85 -80.87 -32.82 34.77 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 114.935 -0.633 . . . . 3.27 109.925 176.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -66.22 -13.19 59.92 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.699 0.761 . . . . 2.0299999999999998 110.139 177.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.7 mtp180 -108.16 -2.16 19.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.285 -0.87 . . . . 2.7200000000000002 109.323 178.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.496 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 28.9 t70 -105.65 119.66 39.71 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.349 -1.296 . . . . 2.1600000000000001 110.473 -175.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.0 p -134.62 119.13 17.98 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.962 -0.384 . . . . 1.8200000000000001 109.962 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.89 -162.58 1.3 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.252 -0.431 . . . . 2.1899999999999999 111.127 -166.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -75.73 61.24 2.89 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 116.11 -0.496 . . . . 1.1000000000000001 112.666 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.441 ' HA ' ' HB3' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -95.64 -156.5 0.52 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.369 -0.604 . . . . 1.6699999999999999 109.369 175.067 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.48 132.65 0.29 Allowed 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 108.682 -0.859 . . . . 2.9500000000000002 108.682 -178.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.824 HG21 HG23 ' A' ' 29' ' ' THR . 2.1 p -67.57 117.45 9.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-O 121.689 0.757 . . . . 1.5600000000000001 109.5 177.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.0 p -89.17 -24.37 5.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 114.748 -1.114 . . . . 1.22 108.919 -176.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.2 tptt -158.0 139.23 13.43 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.754 -0.657 . . . . 2.4100000000000001 111.883 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.824 HG23 HG21 ' A' ' 26' ' ' VAL . 6.4 p -144.28 152.1 40.32 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 115.829 -0.623 . . . . 1.3799999999999999 111.011 175.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.478 ' HB2' HG12 ' A' ' 33' ' ' ILE . 19.4 m -120.67 25.95 9.42 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.826 -0.625 . . . . 2.3700000000000001 110.868 171.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp 68.93 39.44 1.84 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.479 0.657 . . . . 4.5499999999999998 110.441 174.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.6 tptm 177.0 -30.59 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.505 -1.225 . . . . 1.4199999999999999 108.313 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.8 HD12 ' HB ' ' A' ' 193' ' ' VAL . 23.0 pt -119.68 151.8 22.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 114.561 -1.199 . . . . 0.76000000000000001 109.483 175.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.62 ' HA ' HG22 ' A' ' 29' ' ' THR . 89.8 m -152.15 113.62 4.32 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 123.347 0.404 . . . . 0.57999999999999996 111.158 -164.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -103.68 110.79 31.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.356 -0.537 . . . . 0.85999999999999999 111.799 171.357 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 1.5 p -99.77 117.86 35.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.413 -0.812 . . . . 1.1000000000000001 110.95 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 30.2 t -107.72 131.99 53.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.768 -1.106 . . . . 1.27 111.184 -173.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.441 ' HB3' ' HA ' ' A' ' 24' ' ' TRP . 27.8 pttt . . . . . 0 C--N 1.327 -0.39 0 N-CA-C 112.497 0.554 . . . . 1.9099999999999999 112.497 172.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 . . . . . 0 N--CA 1.454 -0.255 0 CA-C-O 120.858 0.361 . . . . 2.0499999999999998 111.555 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.57 HD23 ' N ' ' A' ' 48' ' ' TYR . 3.9 tt -120.25 143.59 48.22 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.755 -0.831 . . . . 0.87 108.755 -176.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.57 ' N ' HD23 ' A' ' 47' ' ' LEU . 46.2 m-85 -118.46 123.56 45.47 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.888 0.375 . . . . 0.98999999999999999 110.884 -172.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 27.9 ttt180 -91.22 112.08 23.84 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.716 -0.846 . . . . 2.9199999999999999 108.716 169.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.516 HG13 ' HB3' ' A' ' 169' ' ' MET . 0.2 OUTLIER -104.95 106.82 21.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.757 0.789 . . . . 1.3300000000000001 109.523 -175.715 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 42.8 tt0 -128.68 146.52 50.86 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.819 -1.082 . . . . 1.0700000000000001 110.763 -169.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.532 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -168.81 146.83 10.64 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 111.018 -0.833 . . . . 0.28999999999999998 111.018 175.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.458 HG12 ' HE2' ' A' ' 166' ' ' LYS . 65.9 mt -92.84 116.68 34.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 117.813 0.807 . . . . 0.57999999999999996 110.428 175.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.455 HG12 ' HD3' ' A' ' 200' ' ' LYS . 70.1 mt -99.29 109.56 55.06 Favored Pre-proline 0 N--CA 1.439 -0.984 0 CA-C-N 115.314 -0.857 . . . . 0.34999999999999998 108.775 174.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 53' ' ' ILE . 32.1 Cg_exo -61.11 65.66 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 124.406 3.404 . . . . 0.62 112.551 178.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.65 ' HG2' ' CG1' ' A' ' 203' ' ' ILE . 9.9 tp10 -157.12 174.23 15.8 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.858 -1.065 . . . . 1.6799999999999999 108.144 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.476 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 38.1 t -79.94 139.49 53.59 Favored Pre-proline 0 N--CA 1.423 -1.804 0 CA-C-O 121.506 0.67 . . . . 1.1799999999999999 109.91 179.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.515 ' HB3' ' SG ' ' A' ' 155' ' ' CYS . 31.7 Cg_exo -58.05 -15.0 20.84 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 123.91 3.073 . . . . 0.52000000000000002 110.694 177.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.85 -49.15 55.27 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.519 -1.219 . . . . 0.64000000000000001 111.171 175.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.624 ' HB3' HD11 ' A' ' 203' ' ' ILE . 29.4 ttmt -71.79 -28.28 63.51 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.627 0.727 . . . . 3.2999999999999998 109.162 -177.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.034 HD23 HD13 ' A' ' 203' ' ' ILE . 68.0 mt -63.87 -51.37 64.87 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.689 -1.142 . . . . 0.40999999999999998 109.75 173.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.486 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 18.2 m -67.41 -10.94 56.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.751 -0.658 . . . . 1.29 110.413 175.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -88.8 -32.68 17.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.828 -0.624 . . . . 1.3200000000000001 111.72 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.536 ' CD2' ' HA ' ' A' ' 61' ' ' LEU . 8.7 p90 -82.02 -44.86 16.09 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.277 -0.569 . . . . 0.60999999999999999 111.186 -176.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.486 ' CD2' ' HA ' ' A' ' 62' ' ' SER . 0.8 OUTLIER -79.5 -7.66 58.6 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.372 -0.531 . . . . 1.5 111.402 -173.872 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -36.37 -57.74 0.73 Allowed 'General case' 0 N--CA 1.465 0.291 0 O-C-N 125.02 1.45 . . . . 1.52 113.399 -157.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.409 ' O ' ' HD3' ' A' ' 71' ' ' ARG . 76.9 mt-30 -156.9 -81.71 0.07 Allowed 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 112.198 0.444 . . . . 3.6000000000000001 112.198 -177.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.596 ' HB ' ' CD1' ' A' ' 81' ' ' TYR . 8.9 t -149.33 31.2 0.75 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 122.168 0.985 . . . . 1.48 109.655 -165.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.0 -39.8 4.22 Favored Glycine 0 CA--C 1.489 -1.543 0 CA-C-N 115.099 -0.955 . . . . 1.46 113.173 -169.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.51 ' O ' HG22 ' A' ' 73' ' ' THR . 3.1 p30 -163.61 -22.34 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.786 -0.707 . . . . 2.1899999999999999 111.034 -171.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.634 ' HG3' HG23 ' A' ' 72' ' ' ILE . 13.1 ptm180 -50.68 -33.17 21.57 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 122.913 0.485 . . . . 3.3799999999999999 110.553 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.634 HG23 ' HG3' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -99.37 -2.74 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 CA-C-N 115.779 -0.646 . . . . 0.70999999999999996 111.261 -177.726 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.51 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.2 t -96.42 -30.67 13.24 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 119.523 -0.871 . . . . 0.96999999999999997 110.568 -178.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.537 ' CZ2' ' HA ' ' A' ' 71' ' ' ARG . 13.7 p-90 -107.74 0.59 22.42 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.969 0.414 . . . . 0.75 111.39 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.582 ' HB3' ' O ' ' A' ' 71' ' ' ARG . 1.7 p-10 -58.9 -179.74 0.07 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 114.435 1.272 . . . . 2.1899999999999999 114.435 -172.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.511 ' HG3' ' OD1' ' A' ' 194' ' ' ASN . 0.0 OUTLIER -143.11 -2.58 1.0 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 113.438 -1.71 . . . . 3.1899999999999999 111.108 172.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 m -132.48 4.97 4.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.943 0.878 . . . . 1.5800000000000001 108.94 -176.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.527 ' HB2' ' CG ' ' A' ' 75' ' ' ASP . 91.5 mt -119.1 -170.99 2.02 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.579 -1.191 . . . . 0.70999999999999996 110.868 -174.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.47 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 8.4 mm100 -161.31 -65.39 0.06 Allowed 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.779 0.8 . . . . 1.73 109.685 -176.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.462 HG23 ' HB3' ' A' ' 79' ' ' GLN . 6.1 t -142.3 147.07 21.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.755 -1.111 . . . . 0.78000000000000003 109.146 -172.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.596 ' CD1' ' HB ' ' A' ' 68' ' ' THR . 11.6 t80 -136.29 129.61 31.7 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.807 -0.442 . . . . 5.4000000000000004 109.807 177.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -131.04 121.39 24.94 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.871 -0.788 . . . . 1.6899999999999999 108.871 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.451 ' CE ' ' HA ' ' A' ' 83' ' ' MET . 1.3 tpt -81.19 92.96 6.38 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.371 -0.831 . . . . 2.0499999999999998 108.777 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -71.93 -83.08 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.34 -0.846 . . . . 0.64000000000000001 111.112 -167.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -113.32 114.54 26.81 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.319 0.581 . . . . 1.96 109.695 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.42 ' HG2' ' HD1' ' A' ' 92' ' ' PHE . 80.9 mtm180 -97.4 108.07 20.72 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.31 -0.859 . . . . 2.4399999999999999 109.204 178.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.703 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -78.47 -47.15 24.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.865 -0.607 . . . . 0.46999999999999997 110.845 -173.501 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -146.04 -179.87 7.01 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.607 -0.886 . . . . 1.8600000000000001 108.607 -174.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.9 m -66.8 -17.01 64.66 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.155 0.428 . . . . 1.4399999999999999 112.155 -174.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -139.28 27.9 2.3 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 120.098 -0.641 . . . . 1.8700000000000001 110.37 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.703 ' O ' HG12 ' A' ' 87' ' ' ILE . 1.6 m -141.17 112.61 7.49 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 107.979 -1.119 . . . . 0.46000000000000002 107.979 177.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.575 ' O ' HD12 ' A' ' 114' ' ' LEU . 3.6 m-85 -134.88 177.03 8.12 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.984 -0.553 . . . . 0.42999999999999999 109.876 -175.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.711 ' O ' HG23 ' A' ' 84' ' ' VAL . 22.1 mt -125.8 131.03 72.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 107.336 -1.357 . . . . 0.40999999999999998 107.336 169.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.715 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 14.5 p -104.68 132.59 50.75 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.831 -0.348 . . . . 2.0099999999999998 111.731 -174.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.734 ' HA ' HD13 ' A' ' 112' ' ' ILE . 14.6 t60 -103.46 95.28 5.97 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.962 -0.755 . . . . 1.23 108.962 166.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.644 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 27.4 m -115.66 121.33 42.22 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.317 -0.856 . . . . 0.5 110.838 -174.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.446 ' O ' ' HB2' ' A' ' 79' ' ' GLN . 44.5 mm -77.95 114.99 19.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.08 -0.711 . . . . 1.03 109.08 175.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.409 ' HB ' ' HB2' ' A' ' 109' ' ' ARG . 3.0 m -93.85 136.45 34.12 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.072 -0.967 . . . . 1.3799999999999999 110.532 -175.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 24.0 mt-30 . . . . . 0 C--N 1.324 -0.523 0 CA-C-O 121.374 0.606 . . . . 1.8200000000000001 111.065 178.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 17.5 mt . . . . . 0 N--CA 1.451 -0.386 0 N-CA-C 110.405 -0.22 . . . . 1.1200000000000001 110.405 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 25.2 m -100.31 151.84 37.66 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 108.988 -0.745 . . . . 1.3500000000000001 108.988 172.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -50.19 126.42 17.27 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.715 2.276 . . . . 1.0700000000000001 111.401 177.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.483 ' HG2' HG23 ' A' ' 144' ' ' ILE . 19.5 mtm180 -101.82 164.53 11.68 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.502 0.668 . . . . 3.4500000000000002 112.004 -169.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.726 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 10.1 t0 -107.27 113.22 26.47 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.667 -1.151 . . . . 1.3700000000000001 108.968 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.644 ' HB3' ' HB ' ' A' ' 96' ' ' THR . 57.4 t80 -100.41 107.45 19.21 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.653 -0.869 . . . . 2.4100000000000001 108.653 -178.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.734 HD13 ' HA ' ' A' ' 95' ' ' HIS . 8.5 mm -122.41 82.73 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 CA-C-N 115.404 -0.816 . . . . 0.42999999999999999 108.911 177.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 1.9 m-20 -116.13 130.21 56.69 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.663 -0.698 . . . . 1.8600000000000001 110.276 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.695 ' O ' ' HA ' ' A' ' 129' ' ' SER . 3.8 tp -75.34 122.54 23.89 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 115.008 -0.996 . . . . 0.28000000000000003 109.519 176.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -121.8 125.45 73.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-N 114.915 -1.039 . . . . 0.26000000000000001 111.875 -163.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.648 ' HD1' ' HG1' ' A' ' 91' ' ' THR . 70.7 t80 -110.05 125.01 52.49 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.666 -1.152 . . . . 2.5699999999999998 111.075 176.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.632 HG13 HG22 ' A' ' 127' ' ' ILE . 3.7 mp -95.42 104.66 16.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.711 -0.677 . . . . 0.89000000000000001 109.371 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.505 ' HD3' ' CE1' ' A' ' 120' ' ' TYR . 36.2 tttm -109.34 149.59 29.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.119 0.485 . . . . 1.2 110.502 -175.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.1 tpp85 -126.59 97.78 5.15 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 121.65 0.738 . . . . 2.7999999999999998 109.572 -176.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.505 ' CE1' ' HD3' ' A' ' 118' ' ' LYS . 24.7 m-85 -77.28 107.65 9.84 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 106.727 -1.583 . . . . 0.82999999999999996 106.727 167.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -39.75 95.57 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 124.736 1.273 . . . . 2.2799999999999998 112.758 -175.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 64.26 36.81 93.69 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 114.514 -1.221 . . . . 0.76000000000000001 112.345 178.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.493 ' C ' ' HD2' ' A' ' 157' ' ' PRO . 2.1 t-20 -138.53 -43.2 0.49 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.535 -0.332 . . . . 1.6499999999999999 110.591 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -156.76 135.44 11.61 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.39 0.614 . . . . 1.1200000000000001 111.97 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -112.78 84.89 2.06 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.821 -1.177 . . . . 1.6200000000000001 107.821 170.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 153' ' ' PHE . 0.6 OUTLIER -105.77 136.91 38.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.624 -0.716 . . . . 0.29999999999999999 112.351 -171.184 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.704 ' O ' HG13 ' A' ' 127' ' ' ILE . 5.5 pt -111.52 103.06 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 122.279 1.038 . . . . 0.58999999999999997 109.077 167.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.541 ' HB3' ' HA ' ' A' ' 11' ' ' ALA . 28.6 p -90.45 122.39 33.26 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.657 -0.702 . . . . 1.1799999999999999 110.656 -178.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.695 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 5.3 m -120.31 140.08 51.8 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.575 -0.739 . . . . 1.24 111.108 -169.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.487 ' HE3' ' HB ' ' A' ' 6' ' ' ILE . 2.9 mtpm? -128.13 121.56 29.86 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 107.918 -1.141 . . . . 2.2599999999999998 107.918 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.438 ' HB3' ' H ' ' A' ' 148' ' ' ASN . 20.8 p -63.05 98.37 0.13 Allowed 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.32 -0.993 . . . . 1.3899999999999999 108.32 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -109.6 131.7 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 CA-C-N 114.516 -1.22 . . . . 1.05 109.084 -166.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.52 65.84 3.22 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.526 -1.216 . . . . 2.1699999999999999 108.821 -168.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.719 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 0.3 OUTLIER -95.16 156.06 38.23 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 113.86 -1.518 . . . . 0.53000000000000003 110.054 -171.48 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -69.97 -20.17 34.19 Favored 'Trans proline' 0 N--CA 1.473 0.32 0 C-N-CA 123.328 2.685 . . . . 1.28 115.337 -167.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.719 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 7.2 tp10 -72.87 -15.92 61.59 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.169 0.509 . . . . 3.5 109.824 -171.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -158.43 111.01 1.68 Allowed Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 113.314 0.857 . . . . 6.1200000000000001 113.314 175.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -97.67 144.21 0.68 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 124.033 3.156 . . . . 1.77 111.894 167.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.424 ' HG3' ' HB2' ' A' ' 145' ' ' ARG . 61.5 Cg_endo -75.64 -172.21 1.25 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.53 2.154 . . . . 1.25 112.265 178.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.5 m -141.66 -167.87 2.53 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.331 -0.989 . . . . 1.6000000000000001 108.331 -175.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.4 m -73.23 -37.04 66.52 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.056 -0.658 . . . . 1.97 111.191 -178.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -73.92 -60.39 2.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.176 0.512 . . . . 2.1800000000000002 109.89 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.602 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 36.7 m-85 -87.19 112.56 22.1 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 115.688 -0.687 . . . . 1.23 109.98 -178.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.483 HG23 ' HG2' ' A' ' 109' ' ' ARG . 1.7 tp -100.89 119.05 48.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 115.21 -0.904 . . . . 0.81999999999999995 109.262 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.726 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 28.7 ttm-85 -51.44 100.61 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 O-C-N 124.06 0.85 . . . . 4.4199999999999999 109.735 173.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -58.0 106.03 0.73 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.748 -0.941 . . . . 0.79000000000000004 110.748 176.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.433 ' HA ' ' CB ' ' A' ' 131' ' ' SER . 22.6 t80 -83.99 87.39 7.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.573 0.701 . . . . 4.4400000000000004 111.119 -172.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.753 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 24.3 m-80 -83.31 114.47 21.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.388 -0.823 . . . . 1.6200000000000001 109.807 174.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -71.33 129.49 88.9 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.254 -1.017 . . . . 2.3199999999999998 108.254 175.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.624 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 15.7 Cg_exo -16.55 69.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.973 1 C-N-CA 126.505 4.804 . . . . 0.53000000000000003 116.205 -166.143 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . 0.753 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 21.9 p -97.77 -173.79 2.71 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.818 -1.083 . . . . 1.5800000000000001 108.879 171.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.772 ' O ' ' HG3' ' A' ' 169' ' ' MET . . . -171.66 -150.26 7.05 Favored Glycine 0 CA--C 1.493 -1.323 0 C-N-CA 119.231 -1.462 . . . . 0.42999999999999999 112.262 -177.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.515 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 57.7 t80 -161.23 96.49 1.08 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.684 -0.858 . . . . 0.59999999999999998 108.684 -164.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.659 ' CG2' HG13 ' A' ' 168' ' ' VAL . 1.2 m -103.96 132.06 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-O 121.972 0.892 . . . . 0.31 110.824 -176.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . 0.515 ' SG ' ' HB3' ' A' ' 58' ' ' PRO . 10.6 t -112.4 111.69 22.72 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.068 -0.969 . . . . 1.55 109.511 177.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.492 ' HB3' ' HB3' ' A' ' 166' ' ' LYS . 27.4 t -108.9 112.34 60.24 Favored Pre-proline 0 C--N 1.316 -0.872 0 C-N-CA 120.867 -0.333 . . . . 1.0600000000000001 111.346 -166.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.493 ' HD2' ' C ' ' A' ' 123' ' ' ASN . 53.5 Cg_exo -49.66 124.41 12.21 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.424 2.083 . . . . 0.56000000000000005 111.161 172.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.62 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 0.2 OUTLIER -79.15 -167.78 1.27 Allowed 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.066 0.46 . . . . 1.1599999999999999 111.699 -175.511 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.75 -25.67 64.86 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.798 0.809 . . . . 2.6299999999999999 109.236 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -103.04 24.95 10.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.8 -1.091 . . . . 2.0499999999999998 109.011 178.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.538 ' HB2' ' HD3' ' A' ' 162' ' ' PRO . 15.4 m120 13.73 -82.59 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 126.402 1.881 . . . . 1.9299999999999999 115.67 178.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.538 ' HD3' ' HB2' ' A' ' 161' ' ' ASN . 94.3 Cg_endo -74.2 -12.02 23.19 Favored 'Trans proline' 0 C--N 1.362 1.289 0 CA-C-N 120.932 1.369 . . . . 0.72999999999999998 113.639 -172.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -102.3 -30.98 10.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.335 -0.393 . . . . 0.68000000000000005 111.452 -176.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.62 ' O ' ' HB2' ' A' ' 158' ' ' MET . 42.3 m-85 -133.78 135.51 43.92 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.607 0.242 . . . . 0.93000000000000005 110.789 177.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 26.7 t -128.8 146.7 50.84 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.415 0.626 . . . . 1.4099999999999999 111.124 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.532 ' HG3' HG12 ' A' ' 168' ' ' VAL . 14.3 tppt? -99.66 101.81 13.11 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.181 -0.918 . . . . 0.73999999999999999 111.034 -178.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -84.67 104.28 14.51 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.631 -1.168 . . . . 0.27000000000000002 108.992 178.615 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.659 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -131.86 114.15 24.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 122.509 1.147 . . . . 0.28000000000000003 111.574 177.653 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.772 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 16.8 ttt -118.8 151.09 38.69 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 114.284 -1.325 . . . . 1.24 108.284 -176.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.704 ' O ' ' HB2' ' A' ' 151' ' ' CYS . 68.8 m-85 -120.08 139.4 52.62 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 120.272 -0.571 . . . . 3.3700000000000001 110.358 173.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.416 HG21 HD21 ' A' ' 192' ' ' LEU . 1.1 t -119.13 121.47 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 O-C-N 123.854 0.722 . . . . 1.3999999999999999 110.402 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -123.98 43.37 3.0 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.326 -1.361 . . . . 2.1699999999999999 107.326 178.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 6.8 m -69.31 137.42 52.96 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 113.379 -1.737 . . . . 1.6499999999999999 111.513 -172.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.408 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 9.1 tp10 . . . . . 0 N--CA 1.451 -0.409 0 CA-C-N 116.326 -0.397 . . . . 2.4500000000000002 111.213 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.413 ' HA ' ' CE ' ' A' ' 186' ' ' LYS . 40.2 mm . . . . . 0 CA--C 1.502 -0.882 0 CA-C-O 122.858 1.313 . . . . 1.1200000000000001 107.809 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.992 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.4 mp -63.51 -36.23 75.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 112.034 -2.348 . . . . 1.1299999999999999 109.775 175.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -58.89 -26.26 64.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.699 -1.137 . . . . 2.8900000000000001 109.993 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.413 ' CE ' ' HA ' ' A' ' 183' ' ' ILE . 43.9 mtmt -93.13 -44.37 8.4 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.644 -0.707 . . . . 1.28 110.036 177.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.992 HG22 ' HA ' ' A' ' 184' ' ' ILE . 4.7 t -69.28 -30.8 68.98 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 115.997 -0.547 . . . . 0.62 112.049 -170.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . 0.531 ' O ' ' HG ' ' A' ' 192' ' ' LEU . 1.4 mmt -80.29 -65.1 0.28 Allowed Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 112.473 0.546 . . . . 1.0600000000000001 112.473 -172.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 33.6 Cg_endo -63.37 -25.72 71.13 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 121.73 1.62 . . . . 0.91000000000000003 112.944 -174.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.616 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 46.2 m -83.97 -31.48 25.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.912 0.387 . . . . 1.5 111.114 -177.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -90.87 -27.73 18.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.28 -0.418 . . . . 1.8799999999999999 111.623 -173.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 188' ' ' MET . 68.0 mt -75.94 -42.94 47.14 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 120.033 -0.667 . . . . 1.0900000000000001 110.312 -175.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.8 ' HB ' HD12 ' A' ' 33' ' ' ILE . 2.1 m -66.36 -31.29 52.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 108.803 -0.814 . . . . 0.68000000000000005 108.803 176.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.616 ' HB2' ' O ' ' A' ' 190' ' ' SER . 1.6 t-20 -73.4 -32.33 64.39 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.33 -1.305 . . . . 2.0699999999999998 110.311 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.56 ' O ' ' HB2' ' A' ' 198' ' ' ASN . 33.7 t80 -65.68 -30.92 71.67 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.169 -0.678 . . . . 2.0 109.169 175.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.452 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 57.0 mt -78.08 -28.82 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 115.654 -0.703 . . . . 0.31 110.554 174.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 87.8 mt -72.41 -32.74 66.61 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 121.175 0.512 . . . . 1.03 110.025 174.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.56 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 26.2 m-80 -51.19 -42.74 61.08 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.098 -1.075 . . . . 1.8999999999999999 108.098 165.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.604 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -73.88 -43.28 59.0 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 116.34 -0.391 . . . . 0.28999999999999998 110.68 -177.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.455 ' HD3' HG12 ' A' ' 54' ' ' ILE . 31.7 mmtp -54.37 -44.32 72.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.524 0.678 . . . . 0.96999999999999997 110.663 175.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . 0.446 ' HA ' ' HG2' ' A' ' 204' ' ' LYS . 31.4 t70 -85.74 -38.88 17.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.328 -0.851 . . . . 1.9399999999999999 110.878 -174.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -68.07 -31.16 74.55 Favored Glycine 0 CA--C 1.507 -0.437 0 C-N-CA 120.397 -0.906 . . . . 0.46999999999999997 111.648 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 1.034 HD13 HD23 ' A' ' 61' ' ' LEU . 3.0 tp -71.11 -32.9 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 109.496 -0.557 . . . . 0.60999999999999999 109.496 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.446 ' HG2' ' HA ' ' A' ' 201' ' ' ASP . 5.6 pttp -87.29 -20.64 26.53 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 109.384 -0.598 . . . . 3.3700000000000001 109.384 177.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.975 0 N-CA-C 108.394 -0.965 . . . . 1.02 108.394 166.162 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.6 t70 . . . . . 0 CA--C 1.512 -0.486 0 N-CA-C 109.297 -0.631 . . . . 2.25 109.297 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.893 ' HA ' HD12 ' A' ' 6' ' ' ILE . 71.9 m-85 -62.81 -30.73 71.7 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.621 0.724 . . . . 0.42999999999999999 109.145 174.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.769 ' HE3' ' HE1' ' A' ' 116' ' ' TYR . 66.3 tttt -70.52 -33.96 71.76 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 107.492 -1.299 . . . . 1.51 107.492 -177.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.72 -36.57 79.16 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.215 0.531 . . . . 0.54000000000000004 110.542 177.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.893 HD12 ' HA ' ' A' ' 3' ' ' PHE . 2.0 mp -81.46 -41.29 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 CA-C-O 121.982 0.896 . . . . 1.0700000000000001 108.722 -174.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.672 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -80.09 -33.19 39.0 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.808 -1.542 . . . . 0.34000000000000002 112.147 -174.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.61 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 41.5 mt-30 -69.54 -23.58 63.6 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.788 0.804 . . . . 1.5900000000000001 109.495 175.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.572 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 14.4 mm100 -84.43 -47.85 10.24 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.426 -1.261 . . . . 2.4700000000000002 108.876 170.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.642 ' HB ' ' HA ' ' A' ' 7' ' ' ALA . 0.6 OUTLIER -55.11 -39.35 69.28 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.124 -0.943 . . . . 0.47999999999999998 112.038 178.251 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -46.54 -57.73 4.46 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.837 0.68 . . . . 0.31 112.837 174.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.431 ' H ' ' HG2' ' A' ' 12' ' ' GLN . 16.2 pt20 -80.38 -6.48 58.09 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.416 -0.356 . . . . 1.6399999999999999 111.251 -177.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 9.6 mm-40 -78.58 -51.32 10.09 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.934 -0.765 . . . . 2.54 108.934 170.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.75 HG23 ' CD2' ' A' ' 170' ' ' PHE . 7.1 p -68.22 -39.61 81.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.636 -0.711 . . . . 0.53000000000000003 110.455 177.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.522 HD12 HG11 ' A' ' 154' ' ' VAL . 0.6 OUTLIER -68.02 -19.68 64.93 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-O 122.077 0.942 . . . . 0.59999999999999998 108.619 174.744 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.534 ' HA2' ' NE ' ' A' ' 19' ' ' ARG . . . -65.1 -22.7 69.12 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 113.876 -1.511 . . . . 0.56999999999999995 110.088 175.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.438 ' HA ' ' HB3' ' A' ' 20' ' ' ASP . 13.8 m-85 -92.1 -12.03 34.13 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 114.973 -0.613 . . . . 3.27 110.088 178.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -80.47 -20.44 43.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.777 0.798 . . . . 2.0299999999999998 109.131 177.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.534 ' NE ' ' HA2' ' A' ' 16' ' ' GLY . 18.8 ptt180 -105.49 -5.57 20.15 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.079 -0.964 . . . . 2.7200000000000002 109.325 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.438 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 12.8 t70 -86.26 114.62 23.23 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 114.731 -1.122 . . . . 2.1600000000000001 110.544 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 40.8 p -134.69 101.79 5.06 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.829 -0.804 . . . . 1.8200000000000001 108.829 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.0 p -141.76 -148.87 0.25 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.404 -0.817 . . . . 2.1899999999999999 111.757 -164.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.81 63.66 1.21 Allowed Glycine 0 CA--C 1.52 0.396 0 O-C-N 123.379 0.424 . . . . 1.1000000000000001 113.289 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 1.026 ' HA ' ' HB3' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -104.96 -157.92 0.64 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.046 -0.724 . . . . 1.6699999999999999 109.046 173.05 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.426 ' HE3' ' HA ' ' A' ' 25' ' ' LYS . 1.7 tpmt? -173.75 120.06 0.3 Allowed 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.183 -1.043 . . . . 2.9500000000000002 108.183 -177.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.922 HG21 HG23 ' A' ' 29' ' ' THR . 2.7 p -64.02 116.57 3.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 C-N-CA 119.458 -0.897 . . . . 1.5600000000000001 109.531 177.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.452 HG11 ' HE2' ' A' ' 48' ' ' TYR . 11.1 p -88.86 -22.96 6.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 114.669 -1.15 . . . . 1.22 108.739 -177.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.493 ' HD3' ' HA ' ' A' ' 28' ' ' LYS . 1.9 tppp? -157.04 122.49 4.66 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 119.867 -0.733 . . . . 2.4100000000000001 112.972 -175.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.922 HG23 HG21 ' A' ' 26' ' ' VAL . 37.8 p -129.35 140.31 51.42 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.215 -0.661 . . . . 1.3799999999999999 109.215 167.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.6 m -124.8 -60.69 1.36 Allowed 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.41 -0.516 . . . . 2.3700000000000001 112.014 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -152.07 73.22 1.04 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.3 -0.409 . . . . 4.5499999999999998 110.765 -172.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.754 ' HE3' ' HB ' ' A' ' 53' ' ' ILE . 43.2 tttp 79.21 18.32 0.82 Allowed 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 122.133 0.968 . . . . 1.4199999999999999 109.431 177.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.813 HG22 ' HA3' ' A' ' 52' ' ' GLY . 5.9 pt -129.63 146.16 34.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 114.198 -1.365 . . . . 0.76000000000000001 109.704 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.724 ' HA ' HG22 ' A' ' 29' ' ' THR . 52.8 m -143.55 107.56 4.71 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.975 -1.011 . . . . 0.57999999999999996 110.814 -166.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 27' ' ' VAL . 24.4 t -100.32 103.13 14.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.888 -0.596 . . . . 0.85999999999999999 109.756 176.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.772 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 87.5 p -93.42 137.4 32.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.996 -0.547 . . . . 1.1000000000000001 110.553 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.8 t -129.09 135.35 48.79 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.173 0.511 . . . . 1.27 111.483 -177.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 1.026 ' HB3' ' HA ' ' A' ' 24' ' ' TRP . 41.8 pttt . . . . . 0 C--N 1.32 -0.677 0 CA-C-N 115.151 -0.931 . . . . 1.9099999999999999 108.824 172.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 . . . . . 0 N--CA 1.45 -0.445 0 CA-C-O 121.266 0.555 . . . . 2.0499999999999998 110.855 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.705 HD11 ' HE1' ' A' ' 170' ' ' PHE . 10.1 tt -105.8 153.2 22.23 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.187 -0.915 . . . . 0.87 109.565 -177.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.452 ' HE2' HG11 ' A' ' 27' ' ' VAL . 42.7 m-85 -128.29 129.99 47.16 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.81 0.338 . . . . 0.98999999999999999 111.059 -175.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.764 ' HD3' ' CZ3' ' A' ' 24' ' ' TRP . 41.0 ttt180 -106.94 119.9 40.6 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.226 -1.027 . . . . 2.9199999999999999 108.226 168.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.72 HG13 ' HB3' ' A' ' 169' ' ' MET . 0.2 OUTLIER -111.13 122.37 65.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.773 -0.649 . . . . 1.3300000000000001 109.564 -171.671 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 35.3 tt0 -138.87 148.27 43.46 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.084 -0.507 . . . . 1.0700000000000001 110.633 -169.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.813 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -170.77 150.73 14.53 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 110.9 -0.88 . . . . 0.28999999999999998 110.9 173.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.754 ' HB ' ' HE3' ' A' ' 32' ' ' LYS . 85.1 mt -92.19 112.03 25.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 117.693 0.746 . . . . 0.57999999999999996 110.01 175.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.419 HG12 ' CE ' ' A' ' 200' ' ' LYS . 68.4 mt -89.71 116.4 66.25 Favored Pre-proline 0 N--CA 1.437 -1.084 0 CA-C-N 115.329 -0.851 . . . . 0.34999999999999998 109.079 176.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.41 55.44 0.31 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 124.181 3.254 . . . . 0.62 112.965 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.865 ' HG2' HG13 ' A' ' 203' ' ' ILE . 7.3 tp10 -155.98 162.85 40.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.597 -1.26 . . . . 1.6799999999999999 107.597 175.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.481 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 31.3 p -71.77 140.61 83.99 Favored Pre-proline 0 N--CA 1.432 -1.328 0 CA-C-O 121.65 0.738 . . . . 1.1799999999999999 110.795 -176.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.709 ' HD3' ' HB2' ' A' ' 165' ' ' SER . 10.0 Cg_endo -52.46 -11.42 1.19 Allowed 'Trans proline' 0 CA--C 1.527 0.162 0 C-N-CA 124.495 3.463 . . . . 0.52000000000000002 111.761 172.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.31 -46.12 61.45 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.837 -0.62 . . . . 0.64000000000000001 110.713 174.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.903 ' HE2' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -65.05 -37.36 87.32 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 107.934 -1.136 . . . . 3.2999999999999998 107.934 174.307 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.727 HD23 ' CD1' ' A' ' 203' ' ' ILE . 83.5 mt -60.69 -55.2 36.09 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.719 -1.128 . . . . 0.40999999999999998 110.187 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.554 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 28.3 t -67.93 -13.87 62.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.063 -0.517 . . . . 1.29 110.637 176.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.903 ' HB3' ' HE2' ' A' ' 60' ' ' LYS . 21.3 t70 -81.06 -49.12 11.28 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.573 -0.451 . . . . 1.3200000000000001 110.78 -178.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.655 ' CE2' ' HA ' ' A' ' 61' ' ' LEU . 17.2 p90 -70.12 -47.81 60.18 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 120.48 -0.488 . . . . 0.60999999999999999 110.876 -174.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.554 ' CD2' ' HA ' ' A' ' 62' ' ' SER . 0.8 OUTLIER -76.9 -14.27 59.89 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 120.699 -0.4 . . . . 1.5 111.463 -168.539 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.475 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 30.9 t80 -22.04 -61.17 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 O-C-N 125.233 1.583 . . . . 1.52 113.932 -163.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.599 ' H ' ' NH2' ' A' ' 71' ' ' ARG . 17.3 tm0? 175.4 -51.04 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 O-C-N 123.492 0.495 . . . . 3.6000000000000001 111.09 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.488 ' HB ' ' OE1' ' A' ' 67' ' ' GLN . 6.3 t -148.23 24.15 1.03 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.668 0.618 . . . . 1.48 112.668 -169.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.709 ' N ' HH12 ' A' ' 71' ' ' ARG . . . -129.26 0.91 6.08 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 117.928 -2.082 . . . . 1.46 115.96 -167.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.72 ' O ' HG22 ' A' ' 73' ' ' THR . 19.2 t70 -171.18 -41.46 0.02 OUTLIER 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 117.816 0.808 . . . . 2.1899999999999999 110.467 -172.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.772 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -74.89 -20.34 59.76 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-N 115.692 -0.685 . . . . 3.3799999999999999 112.038 -162.154 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.932 HG22 HD13 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -100.83 -7.98 9.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 119.102 -1.039 . . . . 0.70999999999999996 109.995 177.295 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.72 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.4 t -87.05 -35.51 18.7 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 120.24 -0.584 . . . . 0.96999999999999997 109.867 -174.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.604 ' HZ2' ' CD1' ' A' ' 64' ' ' PHE . 21.1 p-90 -105.64 -2.68 23.13 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 116.258 -0.428 . . . . 0.75 111.321 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.772 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 3.0 t70 -66.61 170.45 6.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.84 0.829 . . . . 2.1899999999999999 112.601 -169.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.503 ' HG2' ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -118.0 -21.54 8.26 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.374 -1.284 . . . . 3.1899999999999999 111.182 -177.062 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.7 m -122.66 7.4 9.44 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.194 0.521 . . . . 1.5800000000000001 109.66 -176.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.932 HD13 HG22 ' A' ' 72' ' ' ILE . 27.0 mt -108.78 179.79 4.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.77 -0.65 . . . . 0.70999999999999996 111.347 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.623 ' HB3' HG23 ' A' ' 80' ' ' VAL . 15.3 mm-40 -151.91 -67.1 0.17 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.408 -0.814 . . . . 1.73 111.349 -175.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.623 HG23 ' HB3' ' A' ' 79' ' ' GLN . 21.5 t -143.09 126.05 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.831 -0.622 . . . . 0.78000000000000003 110.3 -166.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -89.81 152.93 21.04 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.374 -0.375 . . . . 5.4000000000000004 110.09 173.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.813 ' HB3' ' HB3' ' A' ' 95' ' ' HIS . 28.1 t-20 -148.99 99.58 2.98 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.401 -0.592 . . . . 1.6899999999999999 109.401 165.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 16.9 ttp -69.9 99.1 1.35 Allowed 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.516 -0.92 . . . . 2.0499999999999998 108.516 177.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.658 HG23 ' HB ' ' A' ' 93' ' ' ILE . 0.2 OUTLIER -78.29 -95.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.718 -0.673 . . . . 0.64000000000000001 111.648 -170.576 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.487 ' H ' HG23 ' A' ' 84' ' ' VAL . 23.0 t-160 -105.2 110.46 22.84 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.642 -0.503 . . . . 1.96 109.642 -178.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -92.65 108.79 20.25 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.384 -0.599 . . . . 2.4399999999999999 109.384 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.592 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -67.39 -40.72 85.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.092 -0.958 . . . . 0.46999999999999997 109.463 -177.202 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.486 ' C ' ' H ' ' A' ' 90' ' ' ASP . 38.2 t70 -156.27 159.77 39.17 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.585 -1.643 . . . . 1.8600000000000001 107.068 -177.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.1 m -72.13 16.87 0.11 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.906 0.384 . . . . 1.4399999999999999 111.183 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.486 ' H ' ' C ' ' A' ' 88' ' ' ASP . 16.2 t70 -137.79 1.83 2.35 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.389 -0.967 . . . . 1.8700000000000001 108.389 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.592 ' O ' HG12 ' A' ' 87' ' ' ILE . 1.7 m -145.29 112.09 5.91 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 109.184 -0.672 . . . . 0.46000000000000002 109.184 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.557 ' O ' HD12 ' A' ' 114' ' ' LEU . 18.6 m-85 -123.61 177.73 5.54 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.199 0.523 . . . . 0.42999999999999999 110.883 -172.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.658 ' HB ' HG23 ' A' ' 84' ' ' VAL . 40.9 mt -132.97 127.37 55.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 107.588 -1.264 . . . . 0.40999999999999998 107.588 169.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.577 ' SG ' HG11 ' A' ' 115' ' ' VAL . 74.5 m -100.98 107.57 19.08 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.426 -0.352 . . . . 2.0099999999999998 111.921 -172.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.813 ' HB3' ' HB3' ' A' ' 82' ' ' ASN . 19.5 t-160 -82.06 74.88 9.01 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.379 -0.971 . . . . 1.23 108.379 165.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.413 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 79.5 m -95.75 111.51 23.45 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.812 -1.085 . . . . 0.5 111.982 -174.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.49 HD13 ' HB ' ' A' ' 80' ' ' VAL . 3.4 mp -78.25 123.56 35.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.992 -0.744 . . . . 1.03 108.992 172.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' A' ' 109' ' ' ARG . 91.1 m -110.35 146.94 34.91 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.951 -1.022 . . . . 1.3799999999999999 109.778 -173.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 121.477 0.656 . . . . 1.8200000000000001 111.672 -173.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.647 HG23 ' NH2' ' A' ' 109' ' ' ARG . 96.9 mt . . . . . 0 N--CA 1.449 -0.501 0 CA-C-O 121.528 0.68 . . . . 1.1200000000000001 111.007 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.54 ' OG ' ' HD2' ' A' ' 108' ' ' PRO . 22.8 t -79.35 159.4 72.56 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 114.758 -1.11 . . . . 1.3500000000000001 108.651 173.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.54 ' HD2' ' OG ' ' A' ' 107' ' ' SER . 47.6 Cg_exo -35.91 136.64 0.2 Allowed 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.363 2.709 . . . . 1.0700000000000001 112.966 173.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.683 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 17.2 ttm180 -123.07 126.42 47.05 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.232 0.539 . . . . 3.4500000000000002 109.779 -172.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.784 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 9.1 t0 -100.1 119.55 38.48 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.761 -0.654 . . . . 1.3700000000000001 109.256 -172.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 95' ' ' HIS . 13.0 m-85 -100.1 145.77 27.57 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.153 0.502 . . . . 2.4100000000000001 112.253 -173.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.961 HG12 ' HD2' ' A' ' 145' ' ' ARG . 29.4 mm -137.87 77.2 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 114.689 -1.142 . . . . 0.42999999999999999 108.264 170.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.41 ' OD2' ' HB3' ' A' ' 148' ' ' ASN . 1.0 OUTLIER -104.0 124.01 48.25 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.426 -0.806 . . . . 1.8600000000000001 110.514 -177.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.557 HD12 ' O ' ' A' ' 92' ' ' PHE . 12.8 tp -74.87 123.57 25.29 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.728 0.775 . . . . 0.28000000000000003 109.41 169.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.577 HG11 ' SG ' ' A' ' 94' ' ' CYS . 0.1 OUTLIER -125.81 126.76 70.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 114.564 -1.198 . . . . 0.26000000000000001 111.812 -168.232 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.885 ' HE2' ' HE2' ' A' ' 118' ' ' LYS . 87.9 t80 -111.17 128.57 55.95 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.396 -0.82 . . . . 2.5699999999999998 110.966 175.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.811 HG13 HG22 ' A' ' 127' ' ' ILE . 1.9 mp -88.82 99.93 9.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.911 -0.774 . . . . 0.89000000000000001 108.911 178.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.885 ' HE2' ' HE2' ' A' ' 116' ' ' TYR . 16.8 tppt? -97.3 123.99 41.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.773 -0.649 . . . . 1.2 110.156 -175.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -115.46 92.09 3.81 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.495 -0.775 . . . . 2.7999999999999998 110.852 -178.249 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.656 ' HB3' ' HB3' ' A' ' 123' ' ' ASN . 97.7 m-85 -70.64 101.65 2.1 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 106.147 -1.798 . . . . 0.82999999999999996 106.147 163.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -47.64 96.31 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.4 1.062 . . . . 2.2799999999999998 112.289 -173.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 72.03 43.26 49.37 Favored Glycine 0 CA--C 1.503 -0.665 0 CA-C-N 113.796 -1.547 . . . . 0.76000000000000001 111.757 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.656 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 2.4 t-20 -146.85 -49.07 0.19 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.089 -0.556 . . . . 1.6499999999999999 109.978 -178.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.568 ' HB2' ' HD2' ' A' ' 120' ' ' TYR . 1.0 OUTLIER -155.86 135.18 12.29 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.071 0.462 . . . . 1.1200000000000001 110.978 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.67 80.87 1.5 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.12 -1.067 . . . . 1.6200000000000001 108.12 175.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.744 HG23 ' HB3' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -103.56 140.66 21.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.538 -0.755 . . . . 0.29999999999999999 112.201 -172.526 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.811 HG22 HG13 ' A' ' 117' ' ' ILE . 9.0 pt -104.74 116.62 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 108.402 -0.962 . . . . 0.58999999999999997 108.402 160.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 5.0 m -75.27 163.49 27.44 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.193 -0.912 . . . . 1.1799999999999999 108.69 173.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 37.1 p -155.55 138.61 15.5 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.402 0.62 . . . . 1.24 110.852 178.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.587 ' HE3' ' HB3' ' A' ' 150' ' ' PRO . 11.4 ttmt -151.96 119.63 6.1 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.669 -0.696 . . . . 2.2599999999999998 109.231 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.3 p -64.81 106.73 1.27 Allowed 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 108.59 -0.892 . . . . 1.3899999999999999 108.59 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.5 m -104.7 151.96 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 119.546 -0.862 . . . . 1.05 109.495 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.561 ' HA ' ' CG ' ' A' ' 137' ' ' TYR . 6.5 p-10 -109.05 64.86 0.61 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 122.809 1.29 . . . . 2.1699999999999999 110.533 -170.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.748 ' CZ ' ' HB3' ' A' ' 136' ' ' GLU . 2.3 p90 -100.91 176.46 1.89 Allowed Pre-proline 0 CA--C 1.555 1.149 0 CA-C-N 113.797 -1.547 . . . . 0.53000000000000003 108.946 -176.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.657 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 23.7 Cg_exo -27.67 -59.61 0.1 OUTLIER 'Trans proline' 0 CA--C 1.548 1.218 1 C-N-CA 125.347 4.031 . . . . 1.28 117.504 -178.178 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.748 ' HB3' ' CZ ' ' A' ' 134' ' ' PHE . 4.6 tp10 -74.88 -24.97 58.64 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.439 0.533 . . . . 3.5 112.439 -173.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.955 ' HA ' HG13 ' A' ' 112' ' ' ILE . 21.2 t80 -50.68 -45.05 85.82 Favored Pre-proline 0 CA--C 1.553 1.067 0 N-CA-C 115.78 1.77 . . . . 6.1200000000000001 115.78 -173.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.475 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 36.7 Cg_exo -38.03 116.42 0.22 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 122.975 2.45 . . . . 1.77 114.185 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.665 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 9.6 Cg_endo -89.29 -165.0 0.18 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.883 3.055 . . . . 1.25 114.335 -173.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.0 m -145.03 -171.87 3.73 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.231 -0.895 . . . . 1.6000000000000001 108.617 -176.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.9 t -81.37 -30.13 33.82 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.573 -0.451 . . . . 1.97 110.593 177.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 -79.65 -29.11 40.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.364 0.602 . . . . 2.1800000000000002 110.124 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.784 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 34.9 m-85 -122.13 114.14 20.48 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.68 -0.691 . . . . 1.23 110.162 -176.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.683 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 1.5 tp -95.66 112.95 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 108.063 -1.088 . . . . 0.81999999999999995 108.063 178.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.961 ' HD2' HG12 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -57.75 123.96 17.48 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.645 -1.161 . . . . 4.4199999999999999 111.779 -174.457 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -42.27 99.52 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 113.973 -1.467 . . . . 0.79000000000000004 113.176 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 1.097 ' HB2' ' HB3' ' A' ' 174' ' ' GLU . 1.7 p90 -85.5 68.45 10.44 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.304 -0.948 . . . . 4.4400000000000004 110.902 178.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.41 ' HB3' ' OD2' ' A' ' 113' ' ' ASP . 55.9 t30 -103.31 110.49 22.49 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.112 -0.949 . . . . 1.6200000000000001 110.361 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.603 ' HB2' ' HB3' ' A' ' 172' ' ' GLN . 28.7 m170 -61.37 164.32 9.14 Favored Pre-proline 0 C--O 1.219 -0.536 0 CA-C-O 118.225 -0.893 . . . . 2.3199999999999998 108.675 171.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.587 ' HB3' ' HE3' ' A' ' 130' ' ' LYS . 7.6 Cg_endo -49.33 74.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 123.871 3.047 . . . . 0.53000000000000003 113.982 -177.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . 0.731 ' HB3' ' O ' ' A' ' 170' ' ' PHE . 18.2 m -112.65 -173.68 2.3 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.355 -0.839 . . . . 1.5800000000000001 108.745 177.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.675 ' O ' ' HG3' ' A' ' 169' ' ' MET . . . -174.98 -154.72 11.42 Favored Glycine 0 CA--C 1.494 -1.235 0 C-N-CA 118.65 -1.738 . . . . 0.42999999999999999 112.74 -178.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.453 ' CE2' HD21 ' A' ' 167' ' ' LEU . 39.4 t80 -160.07 85.16 0.74 Allowed 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.317 -0.994 . . . . 0.59999999999999998 108.317 -163.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.698 ' CG2' HG13 ' A' ' 168' ' ' VAL . 3.1 m -94.73 126.17 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 CA-C-O 121.862 0.839 . . . . 0.31 110.625 -173.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 63.9 m -106.69 106.52 17.08 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.439 -0.8 . . . . 1.55 109.171 176.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.69 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 13.2 m -101.09 120.05 56.26 Favored Pre-proline 0 C--N 1.314 -0.939 0 C-N-CA 120.796 -0.362 . . . . 1.0600000000000001 111.211 -170.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.418 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 77.6 Cg_exo -51.05 119.59 5.57 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.402 2.068 . . . . 0.56000000000000005 110.965 172.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.597 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 59.2 mmm -83.49 -167.89 1.89 Allowed 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.196 0.522 . . . . 1.1599999999999999 111.917 -174.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -65.06 -32.84 74.75 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.983 0.897 . . . . 2.6299999999999999 109.165 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -113.48 31.13 6.7 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.154 -1.385 . . . . 2.0499999999999998 109.056 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 164' ' ' TYR . 2.1 p-10 -23.37 -55.27 0.12 Allowed Pre-proline 0 N--CA 1.475 0.788 0 N-CA-C 116.505 2.039 . . . . 1.9299999999999999 116.505 -172.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.405 ' HD3' ' CG ' ' A' ' 161' ' ' ASN . 48.7 Cg_endo -67.81 -19.31 47.07 Favored 'Trans proline' 0 C--N 1.35 0.624 0 CA-C-N 121.649 1.625 . . . . 0.72999999999999998 113.146 -175.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -111.89 -22.84 10.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.355 -0.384 . . . . 0.68000000000000005 111.354 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.597 ' O ' ' HB2' ' A' ' 158' ' ' MET . 94.7 m-85 -138.93 129.3 25.67 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.436 -0.579 . . . . 0.93000000000000005 109.436 176.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.709 ' HB2' ' HD3' ' A' ' 58' ' ' PRO . 21.9 t -127.22 148.75 50.2 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.054 -0.659 . . . . 1.4099999999999999 111.598 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.69 ' HB3' ' HB2' ' A' ' 156' ' ' SER . 11.8 tppt? -91.77 100.6 13.27 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.919 0.866 . . . . 0.73999999999999999 111.261 -178.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 1.0 OUTLIER -88.37 105.78 17.81 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.91 -1.041 . . . . 0.27000000000000002 109.089 176.417 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.698 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.1 OUTLIER -132.5 120.21 41.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 122.497 1.141 . . . . 0.28000000000000003 111.927 177.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.72 ' HB3' HG13 ' A' ' 50' ' ' VAL . 19.0 ttt -122.69 160.92 24.85 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 113.999 -1.455 . . . . 1.24 108.165 -178.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.75 ' CD2' HG23 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -145.77 149.03 33.62 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.228 -1.027 . . . . 3.3700000000000001 108.228 170.553 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.477 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 8.5 p -137.43 132.31 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 O-C-N 124.147 0.904 . . . . 1.3999999999999999 111.006 -174.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.603 ' HB3' ' HB2' ' A' ' 149' ' ' HIS . 30.9 tt0 -119.93 64.83 0.82 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.587 -1.264 . . . . 2.1699999999999999 107.587 175.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.476 HG22 ' HE1' ' A' ' 147' ' ' TYR . 0.2 OUTLIER -58.07 130.54 47.08 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.885 -1.507 . . . . 1.6499999999999999 111.908 -173.032 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 1.097 ' HB3' ' HB2' ' A' ' 147' ' ' TYR . 12.1 tt0 . . . . . 0 N--CA 1.455 -0.197 0 CA-C-O 121.583 0.706 . . . . 2.4500000000000002 111.948 -176.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.492 ' HA ' ' HE2' ' A' ' 186' ' ' LYS . 20.6 mm . . . . . 0 CA--C 1.506 -0.714 0 CA-C-O 122.465 1.126 . . . . 1.1200000000000001 108.942 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 1.005 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.0 OUTLIER -70.21 -37.54 71.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 112.91 -1.95 . . . . 1.1299999999999999 111.489 -176.788 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -67.12 -17.1 64.72 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.149 -0.686 . . . . 2.8900000000000001 109.149 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.492 ' HE2' ' HA ' ' A' ' 183' ' ' ILE . 45.8 mtmt -90.37 -49.32 6.6 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.415 -0.811 . . . . 1.28 109.211 171.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 1.005 HG22 ' HA ' ' A' ' 184' ' ' ILE . 11.3 t -60.04 -31.22 69.76 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.617 0.599 . . . . 0.62 112.617 -167.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . 0.872 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 7.0 mmt -80.11 -61.23 0.45 Allowed Pre-proline 0 C--N 1.327 -0.399 0 C-N-CA 120.488 -0.485 . . . . 1.0600000000000001 111.296 -176.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.872 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 37.8 Cg_exo -62.21 -26.14 77.4 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.132 1.888 . . . . 0.91000000000000003 112.812 -178.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.544 ' O ' ' HB3' ' A' ' 194' ' ' ASN . 98.0 p -80.7 -30.42 36.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.021 0.438 . . . . 1.5 110.713 -178.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -90.46 -34.54 15.56 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.825 -0.625 . . . . 1.8799999999999999 111.518 -172.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.536 HD22 HG11 ' A' ' 50' ' ' VAL . 78.2 mt -73.24 -42.03 63.02 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.57 -0.452 . . . . 1.0900000000000001 111.607 -174.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 189' ' ' PRO . 1.5 m -70.56 -30.08 41.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.831 -0.803 . . . . 0.68000000000000005 108.831 178.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.569 ' HA ' ' HB2' ' A' ' 197' ' ' LEU . 0.1 OUTLIER -73.88 -40.63 63.08 Favored 'General case' 0 C--O 1.208 -1.117 0 CA-C-N 114.138 -1.392 . . . . 2.0699999999999998 111.209 178.013 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.479 ' HD1' ' HA ' ' A' ' 195' ' ' PHE . 1.7 m-30 -56.9 -33.25 66.73 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 118.576 0.626 . . . . 2.0 109.88 172.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.614 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 46.4 mt -77.41 -31.07 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-N 115.973 -0.558 . . . . 0.31 111.316 174.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.569 ' HB2' ' HA ' ' A' ' 194' ' ' ASN . 24.0 mt -70.0 -40.92 75.01 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 110.182 -0.303 . . . . 1.03 110.182 176.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.413 ' HB3' ' CH2' ' A' ' 74' ' ' TRP . 3.8 m-20 -49.18 -45.33 43.97 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.974 -0.75 . . . . 1.8999999999999999 108.974 166.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.83 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -66.76 -44.75 80.59 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.965 -0.561 . . . . 0.28999999999999998 110.22 -177.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.614 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 35.3 mmtp -57.81 -45.83 85.53 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 109.446 -0.575 . . . . 0.96999999999999997 109.446 172.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -67.47 -43.97 79.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.359 -0.837 . . . . 1.9399999999999999 110.756 -171.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -78.45 -20.45 71.82 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.18 -1.01 . . . . 0.46999999999999997 111.666 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.865 HG13 ' HG2' ' A' ' 56' ' ' GLU . 1.0 OUTLIER -78.68 -34.33 17.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 123.439 0.695 . . . . 0.60999999999999999 109.885 173.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.558 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 99.2 mttt -80.16 -30.26 38.88 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 108.697 -0.853 . . . . 3.3700000000000001 108.697 177.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.757 0 CA-C-N 115.836 -0.62 . . . . 1.02 109.57 170.725 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.445 ' OD2' HD11 ' A' ' 6' ' ' ILE . 36.4 t70 . . . . . 0 CA--C 1.512 -0.503 0 CA-C-O 120.743 0.306 . . . . 2.25 110.369 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.853 ' HA ' HD12 ' A' ' 6' ' ' ILE . 94.0 m-85 -64.98 -33.8 76.91 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.076 -0.712 . . . . 0.42999999999999999 109.076 -176.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.646 ' HD2' ' CB ' ' A' ' 88' ' ' ASP . 33.5 tttm -73.79 -3.58 29.42 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.021 -0.99 . . . . 1.51 110.288 177.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.463 ' O ' ' HG3' ' A' ' 9' ' ' GLN . . . -91.37 -40.98 11.15 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.559 -0.534 . . . . 0.54000000000000004 109.559 172.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.853 HD12 ' HA ' ' A' ' 3' ' ' PHE . 1.1 mp -82.51 -44.01 19.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.956 0.884 . . . . 1.0700000000000001 109.487 -172.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.534 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -70.85 -39.3 73.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.302 -1.317 . . . . 0.34000000000000002 111.422 -178.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.574 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 8.1 mt-30 -66.85 -26.14 66.76 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.99 -1.004 . . . . 1.5900000000000001 110.384 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 5' ' ' ALA . 98.7 mt-30 -80.52 -37.11 32.19 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.082 -0.963 . . . . 2.4700000000000002 108.843 172.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.654 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.4 OUTLIER -67.87 -37.48 81.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.666 -1.152 . . . . 0.47999999999999998 111.614 -178.849 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.597 ' HA ' ' OG ' ' A' ' 128' ' ' SER . . . -46.43 -58.44 3.75 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.592 0.59 . . . . 0.31 112.592 176.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.525 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 13.1 pt20 -83.14 5.39 22.8 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.056 0.455 . . . . 1.6399999999999999 110.803 -177.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.564 ' HB3' ' HA ' ' A' ' 10' ' ' THR . 0.2 OUTLIER -89.49 -49.94 6.39 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.182 -1.044 . . . . 2.54 108.182 174.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.668 HG21 ' N ' ' A' ' 152' ' ' GLY . 13.2 p -69.93 -36.44 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 121.828 0.823 . . . . 0.53000000000000003 109.555 177.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.538 ' HG ' ' OD1' ' A' ' 18' ' ' ASN . 2.1 tt -72.87 -18.72 61.4 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 114.87 -1.059 . . . . 0.59999999999999998 109.229 173.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 20' ' ' ASP . . . -61.94 -23.5 63.68 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.11 -1.405 . . . . 0.56999999999999995 109.856 172.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.446 ' HB3' ' CE2' ' A' ' 170' ' ' PHE . 6.8 m-85 -91.33 -28.79 17.51 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.099 -0.55 . . . . 3.27 110.775 177.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.538 ' OD1' ' HG ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -69.59 -15.75 63.27 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.777 -0.369 . . . . 2.0299999999999998 111.335 179.401 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -117.59 -5.48 11.18 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 119.921 -0.711 . . . . 2.7200000000000002 111.896 179.056 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 2.6 m-20 -121.99 135.75 54.87 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 120.919 0.39 . . . . 2.1600000000000001 111.205 178.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.474 HG22 ' CZ2' ' A' ' 24' ' ' TRP . 64.4 p -137.61 120.47 16.42 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.05 -0.523 . . . . 1.8200000000000001 111.411 -176.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.3 t -167.34 132.09 1.95 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.152 -0.476 . . . . 2.1899999999999999 110.204 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.87 -6.06 82.04 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.859 -0.686 . . . . 1.1000000000000001 113.669 172.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.808 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -111.75 -170.2 1.61 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.842 0.321 . . . . 1.6699999999999999 110.625 -178.231 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.443 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 7.3 mtpt -178.6 133.22 0.13 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.884 -0.784 . . . . 2.9500000000000002 108.884 -169.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.797 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 1.6 p -61.58 120.03 6.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 119.819 -0.753 . . . . 1.5600000000000001 109.305 171.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 p -95.18 -23.5 5.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 114.708 -1.133 . . . . 1.22 109.123 -177.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.422 ' HD2' ' HA ' ' A' ' 28' ' ' LYS . 11.0 tptm -156.53 129.92 8.12 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.885 -0.598 . . . . 2.4100000000000001 111.847 -173.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.472 HG23 HG21 ' A' ' 26' ' ' VAL . 40.2 p -122.09 149.44 43.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.429 -0.805 . . . . 1.3799999999999999 109.584 173.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 51.1 m -150.4 69.78 1.0 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 121.185 -0.206 . . . . 2.3700000000000001 111.204 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER 74.76 71.76 0.1 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.209 -0.451 . . . . 4.5499999999999998 110.829 177.241 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.553 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 89.5 mttt 80.04 4.54 1.92 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.337 -0.847 . . . . 1.4199999999999999 112.842 172.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.849 HG22 ' HA3' ' A' ' 52' ' ' GLY . 7.5 pt -115.66 143.61 25.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.069 0.461 . . . . 0.76000000000000001 110.151 175.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 5.0 m -136.47 104.7 5.67 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.125 -0.943 . . . . 0.57999999999999996 110.433 -163.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.682 HG22 HG23 ' A' ' 50' ' ' VAL . 3.4 t -96.48 98.85 8.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.864 -0.421 . . . . 0.85999999999999999 109.864 -178.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.797 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 25.9 t -91.96 121.68 33.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.725 0.774 . . . . 1.1000000000000001 110.357 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.3 t -109.01 135.21 50.55 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.341 -1.299 . . . . 1.27 110.56 -175.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.808 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 31.6 ttpt . . . . . 0 C--N 1.319 -0.759 0 CA-C-N 115.482 -0.781 . . . . 1.9099999999999999 110.352 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 110.121 -0.326 . . . . 2.0499999999999998 110.121 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.557 HD23 ' N ' ' A' ' 48' ' ' TYR . 2.9 tt -104.89 137.34 42.81 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.169 -1.049 . . . . 0.87 108.169 178.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.557 ' N ' HD23 ' A' ' 47' ' ' LEU . 58.2 m-85 -124.47 126.42 45.87 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.392 -0.367 . . . . 0.98999999999999999 110.137 -173.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.712 ' HG3' ' CE2' ' A' ' 170' ' ' PHE . 2.5 tmm_? -113.36 120.27 40.52 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.38 -0.6 . . . . 2.9199999999999999 109.38 175.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.682 HG23 HG22 ' A' ' 35' ' ' VAL . 7.6 p -101.9 138.68 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 108.769 -0.826 . . . . 1.3300000000000001 108.769 177.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.636 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 51.6 tt0 -138.63 108.07 6.16 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.467 -0.788 . . . . 1.0700000000000001 109.351 -169.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.849 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -138.34 142.39 13.08 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.031 -1.08 . . . . 0.28999999999999998 112.195 -177.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.0 mt -86.8 124.29 40.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 C-N-CA 120.29 -0.564 . . . . 0.57999999999999996 109.886 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.539 HG12 ' HD3' ' A' ' 200' ' ' LYS . 71.7 mt -105.95 113.76 63.38 Favored Pre-proline 0 C--N 1.312 -1.05 0 N-CA-C 108.834 -0.802 . . . . 0.34999999999999998 108.834 175.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -62.18 67.49 0.12 Allowed 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 124.175 3.25 . . . . 0.62 112.043 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.698 ' HG2' ' CG1' ' A' ' 203' ' ' ILE . 8.0 tp10 -161.13 172.32 16.98 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.775 -1.194 . . . . 1.6799999999999999 107.775 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.465 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 6.2 p -82.09 144.7 51.38 Favored Pre-proline 0 N--CA 1.427 -1.575 0 CA-C-O 121.748 0.785 . . . . 1.1799999999999999 110.356 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.497 ' HB3' ' SG ' ' A' ' 155' ' ' CYS . 23.8 Cg_exo -61.71 -13.25 29.11 Favored 'Trans proline' 0 C--N 1.332 -0.297 0 C-N-CA 124.108 3.206 . . . . 0.52000000000000002 110.539 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.61 -51.47 34.83 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.526 -1.215 . . . . 0.64000000000000001 111.028 175.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.52 ' HE3' ' HB2' ' A' ' 60' ' ' LYS . 26.2 ttmt -71.06 -27.9 63.98 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.885 -0.784 . . . . 3.2999999999999998 108.885 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.054 HD23 HD13 ' A' ' 203' ' ' ILE . 42.7 mt -63.95 -53.13 55.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.697 -1.138 . . . . 0.40999999999999998 109.945 174.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.552 ' HA ' ' CD1' ' A' ' 65' ' ' LEU . 34.7 t -65.91 -11.92 50.76 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.438 -0.346 . . . . 1.29 110.317 175.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.5 ' HB2' ' HA ' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -83.1 -40.25 20.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.217 -0.447 . . . . 1.3200000000000001 111.497 -179.717 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.525 ' CD2' ' HA ' ' A' ' 61' ' ' LEU . 15.6 p90 -81.37 -42.79 19.96 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 120.813 -0.355 . . . . 0.60999999999999999 111.166 -174.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.769 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -85.87 10.17 14.64 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.709 0.29 . . . . 1.5 110.726 -173.02 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.558 ' N ' HH12 ' A' ' 71' ' ' ARG . 1.0 OUTLIER -42.99 -71.29 0.08 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.155 -0.93 . . . . 1.52 112.683 -169.207 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.41 -57.3 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.183 1.549 . . . . 3.6000000000000001 115.183 177.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.694 ' OG1' ' HB2' ' A' ' 81' ' ' TYR . 8.8 t -159.07 23.85 0.2 Allowed 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.852 -0.53 . . . . 1.48 112.298 -161.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.418 ' H ' ' CZ ' ' A' ' 71' ' ' ARG . . . -127.67 1.29 6.91 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 118.501 -1.809 . . . . 1.46 115.535 -166.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.619 ' O ' HG22 ' A' ' 73' ' ' THR . 24.5 t70 -173.27 -40.63 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 117.566 0.683 . . . . 2.1899999999999999 110.784 -169.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.695 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -54.87 -38.52 67.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.501 -0.772 . . . . 3.3799999999999999 111.362 -173.743 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.795 HG22 HD13 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -86.11 -7.46 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-O 120.969 0.414 . . . . 0.70999999999999996 110.953 -176.499 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -90.34 -26.54 19.91 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 120.077 -0.649 . . . . 0.96999999999999997 109.631 -175.584 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.506 ' CE2' ' HA ' ' A' ' 71' ' ' ARG . 24.2 p-90 -111.2 -4.68 14.91 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.595 0.591 . . . . 0.75 112.595 178.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.695 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 4.2 t70 -70.6 174.33 6.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.684 0.754 . . . . 2.1899999999999999 112.348 -171.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.585 ' HG2' ' OD1' ' A' ' 198' ' ' ASN . 1.3 mmtt -106.76 -29.04 9.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.857 -1.065 . . . . 3.1899999999999999 109.313 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.1 m -128.28 20.63 6.26 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.671 -1.15 . . . . 1.5800000000000001 111.109 -172.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.795 HD13 HG22 ' A' ' 72' ' ' ILE . 27.1 mt -110.17 155.94 21.3 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.995 0.426 . . . . 0.70999999999999996 110.45 175.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.912 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 2.7 mm-40 -128.16 -61.44 1.1 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.859 -0.609 . . . . 1.73 112.269 -170.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.71 ' CG1' ' HB ' ' A' ' 97' ' ' ILE . 2.9 p -157.15 127.02 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.644 0.735 . . . . 0.78000000000000003 111.9 -170.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.694 ' HB2' ' OG1' ' A' ' 68' ' ' THR . 48.6 p90 -89.67 143.96 26.38 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.454 -1.248 . . . . 5.4000000000000004 110.936 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.783 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 51.1 m-80 -150.03 109.41 3.98 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.193 -0.669 . . . . 1.6899999999999999 109.193 172.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.504 ' SD ' ' HB3' ' A' ' 92' ' ' PHE . 31.0 tpp -79.88 109.43 14.31 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.89 -0.782 . . . . 2.0499999999999998 108.89 177.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -85.07 -72.39 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.857 -0.61 . . . . 0.64000000000000001 110.342 -168.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.522 ' HB2' HD12 ' A' ' 93' ' ' ILE . 8.0 m-70 -126.41 121.57 32.84 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.764 -0.653 . . . . 1.96 109.741 177.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 -100.47 125.51 46.79 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.136 -1.061 . . . . 2.4399999999999999 108.136 175.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.733 HG21 ' HB2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -91.34 -58.27 3.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 116.22 -0.446 . . . . 0.46999999999999997 111.994 -167.072 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.646 ' CB ' ' HD2' ' A' ' 4' ' ' LYS . 15.6 m-20 -144.92 35.89 1.13 Allowed 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.604 -0.438 . . . . 1.8600000000000001 112.151 -165.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.9 t 73.21 -33.2 0.26 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.154 0.582 . . . . 1.4399999999999999 112.42 176.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -117.02 10.53 13.99 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 108.485 -0.932 . . . . 1.8700000000000001 108.485 -177.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.613 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -138.92 116.2 11.12 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 114.962 -1.017 . . . . 0.46000000000000002 108.394 -174.381 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.597 ' O ' HD12 ' A' ' 114' ' ' LEU . 46.5 m-85 -124.41 177.36 5.93 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.196 0.522 . . . . 0.42999999999999999 110.745 -175.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.646 ' O ' HG23 ' A' ' 84' ' ' VAL . 43.1 mt -135.83 118.03 21.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 107.515 -1.291 . . . . 0.40999999999999998 107.515 168.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 72.5 m -100.46 109.32 21.45 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.883 0.373 . . . . 2.0099999999999998 111.931 -171.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.783 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 19.6 t-160 -80.04 69.96 6.53 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.56 -0.904 . . . . 1.23 108.56 170.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.406 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 96.5 m -95.92 114.72 26.47 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.511 -1.222 . . . . 0.5 111.427 -175.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.71 ' HB ' ' CG1' ' A' ' 80' ' ' VAL . 2.7 mp -85.11 127.53 39.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.614 -0.884 . . . . 1.03 108.614 172.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 109' ' ' ARG . 12.6 t -110.86 165.37 11.9 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.937 -0.574 . . . . 1.3799999999999999 110.233 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.912 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 50.5 mt-30 . . . . . 0 C--N 1.312 -1.041 0 CA-C-N 115.673 -0.694 . . . . 1.8200000000000001 109.429 175.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.3 mt . . . . . 0 N--CA 1.441 -0.912 0 N-CA-C 110.001 -0.37 . . . . 1.1200000000000001 110.001 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.403 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 14.2 m -71.58 164.12 60.54 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 115.976 -0.556 . . . . 1.3500000000000001 109.612 175.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 107' ' ' SER . 7.9 Cg_endo -51.06 113.62 1.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.072 1.848 . . . . 1.0700000000000001 110.48 172.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.661 ' HG2' HG23 ' A' ' 144' ' ' ILE . 18.7 mtm180 -90.62 137.52 32.29 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 120.321 -0.552 . . . . 3.4500000000000002 109.716 -173.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.839 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 9.9 t0 -94.42 126.85 39.95 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.905 -0.776 . . . . 1.3700000000000001 108.905 -177.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 95' ' ' HIS . 6.9 m-85 -107.17 146.34 31.46 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.61 0.719 . . . . 2.4100000000000001 111.576 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.833 HG12 ' HD2' ' A' ' 145' ' ' ARG . 25.2 mm -137.67 68.78 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 114.301 -1.318 . . . . 0.42999999999999999 107.608 172.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.853 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 1.4 m-20 -90.54 115.56 27.78 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.627 -1.17 . . . . 1.8600000000000001 110.088 -176.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.627 ' O ' ' HA ' ' A' ' 129' ' ' SER . 6.1 tp -74.84 119.18 18.67 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 108.745 -0.835 . . . . 0.28000000000000003 108.745 169.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.2 OUTLIER -122.99 124.13 69.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-N 115.033 -0.985 . . . . 0.26000000000000001 111.675 -164.24 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.534 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 79.8 t80 -107.77 119.76 40.34 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.973 -1.012 . . . . 2.5699999999999998 110.769 176.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.813 HG13 HG22 ' A' ' 127' ' ' ILE . 3.9 mp -89.85 98.87 8.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.768 -0.651 . . . . 0.89000000000000001 109.608 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.451 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 39.7 ttmt -106.77 141.4 38.08 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.702 -0.681 . . . . 1.2 109.508 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 124' ' ' MET . 0.4 OUTLIER -131.75 104.19 6.77 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 109.01 -0.737 . . . . 2.7999999999999998 109.01 -177.566 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.632 ' CB ' ' HB3' ' A' ' 123' ' ' ASN . 42.7 m-85 -71.43 114.67 9.75 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 106.959 -1.497 . . . . 0.82999999999999996 106.959 167.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -41.61 96.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 O-C-N 124.514 1.134 . . . . 2.2799999999999998 112.293 -175.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.432 ' C ' ' HG2' ' A' ' 157' ' ' PRO . . . 61.56 36.52 92.73 Favored Glycine 0 CA--C 1.508 -0.352 0 CA-C-N 114.496 -1.229 . . . . 0.76000000000000001 112.276 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.632 ' HB3' ' CB ' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -133.82 -45.81 0.8 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.524 -0.338 . . . . 1.6499999999999999 110.377 -178.614 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.532 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 0.3 OUTLIER -157.72 122.64 4.4 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.848 0.356 . . . . 1.1200000000000001 111.393 -177.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 155' ' ' CYS . 13.4 m120 -104.26 73.83 1.15 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.756 -0.831 . . . . 1.6200000000000001 108.756 174.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.678 ' HB ' HG12 ' A' ' 154' ' ' VAL . 1.2 tt -96.57 136.11 28.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 113.245 0.831 . . . . 0.29999999999999999 113.245 -172.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.813 HG22 HG13 ' A' ' 117' ' ' ILE . 21.0 pt -104.87 109.82 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-O 121.98 0.895 . . . . 0.58999999999999997 109.009 163.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.597 ' OG ' ' HA ' ' A' ' 11' ' ' ALA . 1.1 m -89.84 114.42 26.16 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.441 -0.799 . . . . 1.1799999999999999 110.709 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.853 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 79.3 p -114.21 145.05 42.22 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.57 0.7 . . . . 1.24 111.753 -172.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.811 ' HE2' ' HG3' ' A' ' 150' ' ' PRO . 6.3 mtpm? -133.78 123.75 25.41 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 107.677 -1.231 . . . . 2.2599999999999998 107.677 174.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.525 ' HB2' ' H ' ' A' ' 148' ' ' ASN . 32.6 t -64.28 98.85 0.25 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 105.926 -1.879 . . . . 1.3899999999999999 105.926 170.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.472 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.3 OUTLIER -105.41 132.62 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 CA-C-O 121.985 0.897 . . . . 1.05 109.021 -164.012 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.405 ' HA ' ' CD1' ' A' ' 137' ' ' TYR . 5.4 t70 -88.61 68.86 8.77 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 114.02 -1.445 . . . . 2.1699999999999999 109.26 -166.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.695 ' HB2' ' HD2' ' A' ' 135' ' ' PRO . 0.4 OUTLIER -107.07 175.08 2.17 Favored Pre-proline 0 CA--C 1.548 0.875 0 CA-C-N 114.997 -1.001 . . . . 0.53000000000000003 109.496 -172.226 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.695 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 3.0 Cg_exo -35.91 -51.28 1.06 Allowed 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 124.802 3.668 . . . . 1.28 116.632 -175.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.613 ' HG3' HG12 ' A' ' 84' ' ' VAL . 14.0 mm-40 -82.74 -21.59 34.67 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.5 0.667 . . . . 3.5 111.474 -172.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.78 ' HD2' ' HB ' ' A' ' 112' ' ' ILE . 60.3 t80 -56.01 -38.59 69.82 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 115.233 1.568 . . . . 6.1200000000000001 115.233 -174.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.528 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 67.8 Cg_exo -41.46 114.88 0.36 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 122.055 1.837 . . . . 1.77 112.431 173.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.618 ' HG3' ' HB2' ' A' ' 145' ' ' ARG . 1.6 Cg_endo -85.23 -153.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.792 2.995 . . . . 1.25 113.982 -173.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.2 p -136.54 -158.77 0.89 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 114.923 -1.035 . . . . 1.6000000000000001 108.572 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.3 p -90.28 -36.84 14.47 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.215 -0.594 . . . . 1.97 111.488 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -75.74 -48.27 22.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.356 -0.383 . . . . 2.1800000000000002 111.661 -178.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.756 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 94.9 m-85 -93.75 125.07 38.16 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.028 0.442 . . . . 1.23 110.102 -177.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.661 HG23 ' HG2' ' A' ' 109' ' ' ARG . 1.1 tp -106.94 105.91 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-N 115.723 -0.671 . . . . 0.81999999999999995 109.276 -177.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.839 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 0.8 OUTLIER -58.86 100.92 0.08 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.01 -0.996 . . . . 4.4199999999999999 109.818 177.816 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -63.09 117.5 11.44 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.952 -0.642 . . . . 0.79000000000000004 111.746 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.498 ' HB3' ' CB ' ' A' ' 174' ' ' GLU . 34.8 t80 -85.81 82.7 8.07 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.508 0.671 . . . . 4.4400000000000004 110.496 -176.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.648 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 88.2 m-20 -70.93 106.1 3.52 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.284 -0.871 . . . . 1.6200000000000001 109.849 173.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.502 ' O ' ' HB3' ' A' ' 172' ' ' GLN . 36.0 m-70 -68.04 131.44 92.27 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 108.347 -0.982 . . . . 2.3199999999999998 108.347 174.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.811 ' HG3' ' HE2' ' A' ' 130' ' ' LYS . 83.4 Cg_exo -17.51 68.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.927 1 C-N-CA 126.722 4.948 . . . . 0.53000000000000003 115.854 -169.409 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . 0.648 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 10.0 p -99.46 -174.6 2.77 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.077 -0.965 . . . . 1.5800000000000001 108.866 173.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.668 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -173.67 -150.98 7.86 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 119.14 -1.505 . . . . 0.42999999999999999 112.685 -177.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 23.0 t80 -162.35 93.05 0.84 Allowed 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.929 -1.137 . . . . 0.59999999999999998 107.929 -164.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.734 HG23 HG13 ' A' ' 168' ' ' VAL . 5.9 m -101.55 134.09 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-O 121.933 0.873 . . . . 0.31 110.621 -177.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 124' ' ' MET . 8.9 t -113.28 122.63 48.01 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.036 -0.984 . . . . 1.55 109.37 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.59 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 21.3 m -117.83 114.92 37.27 Favored Pre-proline 0 C--N 1.319 -0.755 0 C-N-CA 120.636 -0.426 . . . . 1.0600000000000001 112.015 -171.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.459 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 84.8 Cg_exo -49.94 121.84 8.11 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.607 2.205 . . . . 0.56000000000000005 111.544 171.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.69 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 0.5 OUTLIER -79.64 -167.73 1.33 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.156 0.503 . . . . 1.1599999999999999 112.268 -173.599 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.413 ' H ' ' HG2' ' A' ' 159' ' ' GLU . 5.2 mm-40 -63.81 -30.78 71.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.237 -0.892 . . . . 2.6299999999999999 108.631 172.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 13.5 mm-40 -103.3 26.8 7.9 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 114.536 -1.211 . . . . 2.0499999999999998 109.231 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.668 ' HB3' ' HD3' ' A' ' 162' ' ' PRO . 49.7 t-20 4.74 -77.81 0.0 OUTLIER Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 126.23 1.812 . . . . 1.9299999999999999 115.357 -177.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.668 ' HD3' ' HB3' ' A' ' 161' ' ' ASN . 71.6 Cg_endo -73.69 -13.29 24.59 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 121.396 1.397 . . . . 0.72999999999999998 113.912 -172.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -105.79 -27.0 11.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.526 -0.306 . . . . 0.68000000000000005 111.308 -176.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.69 ' O ' ' HB2' ' A' ' 158' ' ' MET . 67.8 m-85 -137.62 133.18 34.05 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.515 -0.55 . . . . 0.93000000000000005 109.515 176.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.438 ' HB3' HD11 ' A' ' 61' ' ' LEU . 32.3 t -129.23 147.55 51.08 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.228 0.537 . . . . 1.4099999999999999 110.896 177.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.636 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.6 tppp? -93.99 103.48 15.56 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 122.043 0.925 . . . . 0.73999999999999999 110.993 -178.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.42 HD11 ' CZ ' ' A' ' 153' ' ' PHE . 0.6 OUTLIER -87.26 103.45 15.46 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.345 -1.298 . . . . 0.27000000000000002 109.475 177.475 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.734 HG13 HG23 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -125.4 116.38 46.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.833 0.825 . . . . 0.28000000000000003 111.327 178.436 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 48.6 ttp -121.97 145.59 47.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.355 -0.839 . . . . 1.24 109.945 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.712 ' CE2' ' HG3' ' A' ' 49' ' ' ARG . 31.3 m-85 -119.3 134.9 54.97 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 109.098 -0.704 . . . . 3.3700000000000001 109.098 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.415 ' HB ' HD21 ' A' ' 192' ' ' LEU . 2.7 p -120.8 119.13 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-O 121.55 0.691 . . . . 1.3999999999999999 109.648 178.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.502 ' HB3' ' O ' ' A' ' 149' ' ' HIS . 9.3 tt0 -127.05 51.25 1.9 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.734 1.254 . . . . 2.1699999999999999 108.133 -176.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 11.0 m -72.63 150.89 42.63 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 113.565 -1.652 . . . . 1.6499999999999999 110.77 -174.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.498 ' CB ' ' HB3' ' A' ' 147' ' ' TYR . 3.3 tt0 . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 121.229 0.538 . . . . 2.4500000000000002 111.136 -177.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.406 ' HA ' ' HE3' ' A' ' 186' ' ' LYS . 21.9 mm . . . . . 0 CA--C 1.506 -0.738 0 CA-C-O 122.64 1.21 . . . . 1.1200000000000001 108.384 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 1.032 ' HA ' HG22 ' A' ' 187' ' ' THR . 0.9 OUTLIER -68.69 -32.76 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-N 112.602 -2.09 . . . . 1.1299999999999999 110.187 179.563 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.501 ' O ' ' HD2' ' A' ' 189' ' ' PRO . 12.3 mm-40 -53.47 -34.39 57.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.282 -0.872 . . . . 2.8900000000000001 109.206 167.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 190' ' ' SER . 43.4 mtmt -93.22 -12.35 30.43 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.823 -1.08 . . . . 1.28 111.917 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 1.032 HG22 ' HA ' ' A' ' 184' ' ' ILE . 6.8 t -92.98 -45.56 7.88 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 119.1 -1.04 . . . . 0.62 112.112 175.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . 0.933 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 11.2 mmt -81.42 -67.47 0.22 Allowed Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 121.184 -0.947 . . . . 1.0600000000000001 111.362 -173.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.933 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 29.5 Cg_exo -60.92 -31.4 91.48 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 121.975 1.783 . . . . 0.91000000000000003 112.118 -176.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.543 ' HB2' ' O ' ' A' ' 186' ' ' LYS . 48.7 m -77.96 -29.53 49.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.35 -0.386 . . . . 1.5 111.717 -176.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 187' ' ' THR . 7.9 m120 -90.37 -29.82 17.81 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.881 -0.328 . . . . 1.8799999999999999 111.425 -177.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' A' ' 188' ' ' MET . 42.1 mt -64.02 -48.06 77.8 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 120.907 -0.317 . . . . 1.0900000000000001 111.265 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.812 ' HB ' HD12 ' A' ' 33' ' ' ILE . 1.1 m -67.08 -35.65 74.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.445 0.64 . . . . 0.68000000000000005 109.778 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -68.15 -30.89 70.12 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.737 -1.119 . . . . 2.0699999999999998 110.94 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.495 ' O ' ' HB2' ' A' ' 198' ' ' ASN . 8.0 t80 -73.88 -27.35 61.02 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.46 -0.57 . . . . 2.0 109.46 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.456 HG21 ' CG2' ' A' ' 33' ' ' ILE . 25.6 mt -78.56 -27.78 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-O 121.353 0.597 . . . . 0.31 110.281 173.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 197' ' ' LEU . 61.1 mt -71.66 -39.63 70.18 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 109.585 -0.524 . . . . 1.03 109.585 172.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.585 ' OD1' ' HG2' ' A' ' 76' ' ' LYS . 87.0 m-20 -49.63 -38.89 33.85 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.972 -1.013 . . . . 1.8999999999999999 109.58 165.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.635 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -76.13 -42.88 45.52 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 116.356 -0.384 . . . . 0.28999999999999998 110.744 -178.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.539 ' HD3' HG12 ' A' ' 54' ' ' ILE . 35.9 mmtm -59.12 -42.42 90.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.507 0.67 . . . . 0.96999999999999997 110.904 175.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -86.66 -37.23 18.21 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.209 -0.905 . . . . 1.9399999999999999 110.641 -174.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -70.72 -29.52 69.41 Favored Glycine 0 CA--C 1.503 -0.657 0 N-CA-C 111.395 -0.682 . . . . 0.46999999999999997 111.395 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 1.054 HD13 HD23 ' A' ' 61' ' ' LEU . 2.8 tp -70.74 -33.49 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 109.629 -0.508 . . . . 0.60999999999999999 109.629 177.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 40.9 mttp -85.79 -25.03 26.57 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 109.302 -0.629 . . . . 3.3700000000000001 109.302 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.906 0 N-CA-C 108.71 -0.848 . . . . 1.02 108.71 167.061 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.518 ' O ' HD13 ' A' ' 6' ' ' ILE . 32.4 t70 . . . . . 0 CA--C 1.521 -0.163 0 N-CA-C 110.128 -0.323 . . . . 2.25 110.128 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.918 ' HA ' HD11 ' A' ' 6' ' ' ILE . 70.4 m-85 -61.78 -31.01 71.19 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 108.313 -0.995 . . . . 0.42999999999999999 108.313 172.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.556 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 36.7 tttp -60.34 -49.0 79.32 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 113.803 -1.544 . . . . 1.51 107.674 177.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -50.11 -46.31 53.55 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.972 -0.558 . . . . 0.54000000000000004 112.227 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.918 HD11 ' HA ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -81.52 -36.81 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 CA-C-O 121.634 0.731 . . . . 1.0700000000000001 110.02 -172.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.674 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -80.63 -30.57 36.69 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.588 -1.187 . . . . 0.34000000000000002 111.568 -175.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.556 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 33.9 mt-30 -65.78 -32.24 73.66 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.783 -1.098 . . . . 1.5900000000000001 109.087 175.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.616 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 12.5 mm100 -81.02 -45.38 16.65 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.418 -1.265 . . . . 2.4700000000000002 109.059 175.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.553 ' HB ' ' HA ' ' A' ' 7' ' ' ALA . 0.6 OUTLIER -56.26 -37.4 69.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.202 -0.908 . . . . 0.47999999999999998 111.192 176.78 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.578 ' HA ' ' CB ' ' A' ' 128' ' ' SER . . . -46.86 -60.84 2.16 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 120.819 0.343 . . . . 0.31 111.796 173.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -79.04 -6.62 56.83 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.323 -0.399 . . . . 1.6399999999999999 111.087 -177.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.616 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 34.3 mm-40 -78.98 -47.21 16.74 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.248 0.547 . . . . 2.54 109.545 172.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.681 HG21 ' N ' ' A' ' 152' ' ' GLY . 9.9 p -74.63 -41.39 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.77 0.795 . . . . 0.53000000000000003 109.115 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 tt -68.72 -21.2 64.41 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-O 121.719 0.771 . . . . 0.59999999999999998 109.155 174.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.37 -17.54 61.99 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 114.017 -1.447 . . . . 0.56999999999999995 110.59 172.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.656 ' HD2' ' O ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -86.49 -33.47 20.33 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.541 -0.911 . . . . 3.27 108.541 177.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.525 ' ND2' HG21 ' A' ' 168' ' ' VAL . 2.8 t-20 -75.97 -6.47 51.1 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.648 0.737 . . . . 2.0299999999999998 110.269 -176.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -120.55 11.31 11.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.476 -0.784 . . . . 2.7200000000000002 110.582 176.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -139.01 111.4 7.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.154 -0.476 . . . . 2.1600000000000001 109.772 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 44.4 p -129.01 109.28 11.08 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.102 0.477 . . . . 1.8200000000000001 111.933 -171.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.2 p -170.47 160.31 7.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.659 -0.7 . . . . 2.1899999999999999 111.119 -175.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.63 5.72 57.01 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 116.131 -0.486 . . . . 1.1000000000000001 113.981 172.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.671 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -120.42 -163.8 1.04 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.922 0.361 . . . . 1.6699999999999999 110.368 -177.363 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.59 135.18 0.23 Allowed 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.451 -0.795 . . . . 2.9500000000000002 109.357 -178.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.678 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 2.3 m -66.97 118.7 11.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-O 121.81 0.814 . . . . 1.5600000000000001 111.001 176.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.621 ' O ' ' HD2' ' A' ' 28' ' ' LYS . 11.4 p -95.87 -28.83 3.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 114.465 -1.243 . . . . 1.22 109.446 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.621 ' HD2' ' O ' ' A' ' 27' ' ' VAL . 4.1 mptp? -151.05 133.87 15.77 Favored 'General case' 0 C--O 1.216 -0.7 0 C-N-CA 120.06 -0.656 . . . . 2.4100000000000001 110.829 -170.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.535 ' HB ' ' HA ' ' A' ' 34' ' ' THR . 0.0 OUTLIER -153.0 152.1 31.02 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.902 0.382 . . . . 1.3799999999999999 111.3 175.074 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.453 ' HB3' HG12 ' A' ' 33' ' ' ILE . 27.0 t -117.03 27.22 9.26 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.909 -0.587 . . . . 2.3700000000000001 110.591 -176.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? 68.48 24.35 7.12 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.814 0.816 . . . . 4.5499999999999998 109.695 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.499 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 6.4 tptm -167.24 -40.75 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.921 -1.036 . . . . 1.4199999999999999 109.209 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.565 HG22 ' HA3' ' A' ' 52' ' ' GLY . 21.1 pt -109.66 152.51 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 CA-C-N 115.242 -0.89 . . . . 0.76000000000000001 108.983 170.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.535 ' HA ' ' HB ' ' A' ' 29' ' ' THR . 56.6 m -146.29 119.41 8.84 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 123.456 0.472 . . . . 0.57999999999999996 110.717 -168.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.868 HG22 HG12 ' A' ' 50' ' ' VAL . 3.7 t -109.9 110.87 33.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.86 -0.609 . . . . 0.85999999999999999 110.609 -175.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.678 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 97.5 p -100.65 131.49 46.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.192 -0.458 . . . . 1.1000000000000001 109.934 177.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.8 p -102.76 125.0 49.33 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.892 -0.595 . . . . 1.27 110.991 -177.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.671 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 35.7 ttpt . . . . . 0 C--N 1.318 -0.783 0 CA-C-N 115.6 -0.727 . . . . 1.9099999999999999 109.607 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 . . . . . 0 N--CA 1.451 -0.396 0 CA-C-O 120.707 0.289 . . . . 2.0499999999999998 110.369 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.777 ' HG ' ' HB2' ' A' ' 172' ' ' GLN . 2.2 tt -93.27 151.67 19.66 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 106.903 -1.517 . . . . 0.87 106.903 174.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.77 ' H ' HD23 ' A' ' 47' ' ' LEU . 49.9 m-85 -135.73 137.77 42.03 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.305 -0.558 . . . . 0.98999999999999999 110.87 -170.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.718 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.9 OUTLIER -114.61 131.76 56.59 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 116.014 -0.539 . . . . 2.9199999999999999 110.841 177.759 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.868 HG12 HG22 ' A' ' 35' ' ' VAL . 0.8 OUTLIER -113.11 143.99 21.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.272 0.558 . . . . 1.3300000000000001 110.543 168.695 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.729 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 33.1 tt0 -140.94 109.19 5.81 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.897 -1.047 . . . . 1.0700000000000001 108.921 178.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.565 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -136.55 143.52 14.93 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.569 -0.824 . . . . 0.28999999999999998 111.199 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 59.5 mt -88.23 112.48 23.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 C-N-CA 119.936 -0.706 . . . . 0.57999999999999996 110.352 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.698 HG12 ' HB2' ' A' ' 167' ' ' LEU . 20.8 mm -85.64 114.38 56.33 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 108.373 -0.973 . . . . 0.34999999999999998 108.373 174.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -66.27 57.86 0.45 Allowed 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 123.584 2.856 . . . . 0.62 112.921 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.445 ' HB3' HG12 ' A' ' 203' ' ' ILE . 12.5 tp10 -158.81 168.1 27.71 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.521 -0.918 . . . . 1.6799999999999999 108.521 174.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.439 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 34.7 p -70.59 147.41 94.65 Favored Pre-proline 0 N--CA 1.432 -1.335 0 CA-C-O 121.811 0.815 . . . . 1.1799999999999999 110.849 -177.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.471 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 18.7 Cg_exo -63.71 -9.33 18.13 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.911 3.074 . . . . 0.52000000000000002 110.585 178.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.83 -54.47 13.43 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.902 -1.045 . . . . 0.64000000000000001 110.87 175.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.714 ' HE3' ' O ' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -69.63 -24.17 63.6 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.443 -0.947 . . . . 3.2999999999999998 108.443 178.235 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.777 ' O ' HD12 ' A' ' 65' ' ' LEU . 29.6 mt -63.64 -58.46 6.85 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.508 -0.552 . . . . 0.40999999999999998 109.508 173.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.7 t -64.88 -10.86 31.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.06 0.457 . . . . 1.29 110.435 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.482 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 32.1 t70 -88.06 -37.34 16.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.995 -0.548 . . . . 1.3200000000000001 111.935 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.645 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 10.1 p90 -85.45 -45.67 11.62 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.371 -0.531 . . . . 0.60999999999999999 111.259 -174.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.777 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -84.34 7.33 19.78 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.461 -0.57 . . . . 1.5 109.461 -172.758 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -48.93 -70.06 0.1 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.341 -1.299 . . . . 1.52 111.613 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.701 ' HG3' ' SG ' ' A' ' 94' ' ' CYS . 46.3 tt0 -179.38 -43.04 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.611 0.72 . . . . 3.6000000000000001 110.159 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.1 t -149.72 29.43 0.75 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.158 -0.928 . . . . 1.48 109.283 -174.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 70' ' ' ASP . . . -74.42 -36.67 49.11 Favored Glycine 0 N--CA 1.434 -1.499 0 C-N-CA 120.579 -0.819 . . . . 1.46 111.652 -170.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.645 ' OD1' ' HA ' ' A' ' 64' ' ' PHE . 20.7 p-10 163.73 -21.04 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 113.894 -1.153 . . . . 2.1899999999999999 108.274 -164.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.778 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 1.2 ptp180 -39.64 -53.45 2.15 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-N 114.669 -1.151 . . . . 3.3799999999999999 111.142 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.674 HG22 HD13 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -82.01 -13.13 12.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.347 -0.541 . . . . 0.70999999999999996 111.447 -171.298 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.645 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.3 t -84.97 -30.16 24.47 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.592 -0.843 . . . . 0.96999999999999997 109.949 -175.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.456 ' CZ2' ' HA3' ' A' ' 202' ' ' GLY . 17.8 p-90 -111.86 -4.07 14.71 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.442 0.534 . . . . 0.75 112.442 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.778 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 3.6 t70 -62.42 168.14 3.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 122.26 1.028 . . . . 2.1899999999999999 113.655 -168.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.538 ' HG3' ' OD1' ' A' ' 198' ' ' ASN . 13.0 mmmt -90.95 -35.78 14.5 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.482 -1.69 . . . . 3.1899999999999999 109.322 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.584 ' HA ' ' HB2' ' A' ' 99' ' ' GLN . 50.8 m -137.98 26.01 2.74 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.384 -1.28 . . . . 1.5800000000000001 112.019 -171.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.674 HD13 HG22 ' A' ' 72' ' ' ILE . 44.2 mt -110.34 166.22 11.15 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.509 -0.476 . . . . 0.70999999999999996 110.753 175.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.514 ' HB3' HG23 ' A' ' 80' ' ' VAL . 21.0 mm-40 -144.1 -63.85 0.37 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.807 -0.633 . . . . 1.73 111.346 -175.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.514 HG23 ' HB3' ' A' ' 79' ' ' GLN . 19.8 t -140.49 117.61 8.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.883 -0.599 . . . . 0.78000000000000003 111.0 -166.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -90.78 152.17 20.9 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.806 -0.442 . . . . 5.4000000000000004 109.806 171.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.774 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 19.9 m120 -145.85 117.19 7.94 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.336 -0.987 . . . . 1.6899999999999999 108.336 168.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.447 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 6.5 ttt -79.31 89.59 4.95 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.563 -0.903 . . . . 2.0499999999999998 108.563 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -69.33 -81.57 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 115.647 -0.706 . . . . 0.64000000000000001 111.231 -167.128 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.448 ' HB3' HD12 ' A' ' 93' ' ' ILE . 11.2 t60 -121.06 118.2 29.18 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.381 -0.6 . . . . 1.96 109.381 -178.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.447 ' HD3' ' SD ' ' A' ' 83' ' ' MET . 1.5 mtm180 -99.5 100.71 11.78 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.981 -0.554 . . . . 2.4399999999999999 109.636 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.623 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -70.84 -41.25 77.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.399 -0.819 . . . . 0.46999999999999997 110.588 -173.587 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -155.44 166.71 32.71 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.73 -1.123 . . . . 1.8600000000000001 108.456 -172.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.9 m -62.33 -11.69 16.81 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.211 0.448 . . . . 1.4399999999999999 112.211 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -128.27 11.45 6.42 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 120.761 -0.376 . . . . 1.8700000000000001 110.226 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.623 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.7 OUTLIER -135.35 110.34 8.82 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.327 -0.62 . . . . 0.46000000000000002 109.327 -174.066 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.564 ' O ' HD12 ' A' ' 114' ' ' LEU . 21.3 m-85 -128.85 171.46 12.26 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.745 -0.662 . . . . 0.42999999999999999 110.616 -174.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.669 ' O ' HG23 ' A' ' 84' ' ' VAL . 32.5 mt -127.2 126.65 68.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 107.542 -1.281 . . . . 0.40999999999999998 107.542 168.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.701 ' SG ' ' HG3' ' A' ' 67' ' ' GLN . 42.0 t -108.84 106.0 15.8 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.75 -0.659 . . . . 2.0099999999999998 111.198 -165.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.774 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 39.0 t-80 -82.45 116.38 21.88 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.64 -0.874 . . . . 1.23 108.64 170.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.749 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 62.3 m -134.61 116.03 14.52 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 112.446 0.536 . . . . 0.5 112.446 -177.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 49.5 mm -78.11 128.19 38.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.678 -0.49 . . . . 1.03 109.678 174.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.727 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 2.1 m -102.6 147.66 26.52 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.691 -0.686 . . . . 1.3799999999999999 110.905 -175.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.584 ' HB2' ' HA ' ' A' ' 77' ' ' SER . 0.8 OUTLIER . . . . . 0 C--N 1.32 -0.694 0 CA-C-N 115.693 -0.685 . . . . 1.8200000000000001 111.232 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.3 mt . . . . . 0 N--CA 1.442 -0.852 0 N-CA-C 108.634 -0.876 . . . . 1.1200000000000001 108.634 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.653 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 13.2 m -65.51 174.13 1.63 Allowed Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.087 -0.96 . . . . 1.3500000000000001 110.867 -175.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.653 ' HD2' ' HB3' ' A' ' 107' ' ' SER . 81.6 Cg_exo -42.39 111.14 0.18 Allowed 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 122.761 2.308 . . . . 1.0700000000000001 112.521 -175.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.727 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 33.3 ttp180 -100.26 159.86 14.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.603 -0.726 . . . . 3.4500000000000002 110.408 -174.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.962 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 12.7 t70 -115.02 131.18 57.01 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.507 -0.553 . . . . 1.3700000000000001 109.507 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.749 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 6.2 m-85 -108.88 127.7 54.27 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.079 0.466 . . . . 2.4100000000000001 111.076 173.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.645 ' CG2' ' HE1' ' A' ' 134' ' ' PHE . 14.7 mm -134.35 77.42 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.955 -1.02 . . . . 0.42999999999999999 108.481 169.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.701 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 0.5 OUTLIER -107.32 129.94 54.84 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.273 -0.876 . . . . 1.8600000000000001 110.592 -178.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.617 ' O ' ' HA ' ' A' ' 129' ' ' SER . 7.6 tp -78.71 118.35 20.71 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-N 115.558 -0.746 . . . . 0.28000000000000003 109.285 172.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.483 HG23 ' HB ' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -118.65 126.24 75.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 CA-C-N 114.931 -1.032 . . . . 0.26000000000000001 111.137 -166.078 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.674 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 57.0 t80 -108.51 113.48 26.54 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.25 -0.886 . . . . 2.5699999999999998 110.39 174.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.67 HG12 HG22 ' A' ' 127' ' ' ILE . 56.4 mt -98.19 98.54 7.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.638 -0.71 . . . . 0.89000000000000001 109.767 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.609 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 34.0 ttpt -117.73 134.61 54.73 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.232 0.539 . . . . 1.2 110.256 176.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.672 ' HD2' ' O ' ' A' ' 119' ' ' ARG . 1.0 OUTLIER -103.01 118.38 36.69 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.542 -0.91 . . . . 2.7999999999999998 108.542 175.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.567 ' HB3' ' HB3' ' A' ' 123' ' ' ASN . 12.2 m-85 -74.4 107.91 6.85 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.2 -1.778 . . . . 0.82999999999999996 106.2 164.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.411 ' HA ' HH11 ' A' ' 119' ' ' ARG . 6.5 pt-20 -37.27 98.87 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 O-C-N 124.55 1.156 . . . . 2.2799999999999998 113.389 -175.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 57.53 47.09 90.78 Favored Glycine 0 CA--C 1.503 -0.662 0 CA-C-N 113.53 -1.668 . . . . 0.76000000000000001 111.658 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.567 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 50.0 t30 -144.96 -53.89 0.3 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.616 -0.792 . . . . 1.6499999999999999 109.886 -173.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.42 ' HG3' ' OG ' ' A' ' 156' ' ' SER . 1.9 mpp? -159.04 122.41 3.76 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.562 -0.29 . . . . 1.1200000000000001 110.484 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -104.92 81.52 1.75 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.441 -0.948 . . . . 1.6200000000000001 108.441 177.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.636 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.4 OUTLIER -103.16 141.96 18.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.241 -0.89 . . . . 0.29999999999999999 112.739 -170.789 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.67 HG22 HG12 ' A' ' 117' ' ' ILE . 2.9 pt -110.28 115.5 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 108.398 -0.964 . . . . 0.58999999999999997 108.398 161.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.578 ' CB ' ' HA ' ' A' ' 11' ' ' ALA . 15.4 p -99.4 114.98 28.21 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.968 -0.56 . . . . 1.1799999999999999 110.424 177.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.701 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 9.4 p -109.71 144.9 37.45 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.394 0.616 . . . . 1.24 112.046 -173.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.413 ' HE3' ' HB ' ' A' ' 6' ' ' ILE . 4.8 mtpm? -127.9 123.8 35.85 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 107.618 -1.253 . . . . 2.2599999999999998 107.618 176.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.429 ' HB3' ' N ' ' A' ' 148' ' ' ASN . 7.0 p -65.13 94.3 0.14 Allowed 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.72 -0.844 . . . . 1.3899999999999999 108.72 177.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.432 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.6 OUTLIER -107.56 129.2 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 CA-C-N 115.152 -0.931 . . . . 1.05 109.26 -166.312 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -99.3 70.78 1.76 Allowed 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 114.309 -1.314 . . . . 2.1699999999999999 107.916 -167.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.858 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 0.5 OUTLIER -101.89 154.87 37.05 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 113.552 -1.658 . . . . 0.53000000000000003 109.829 -169.548 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.04 -1.6 11.28 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.433 2.088 . . . . 1.28 116.041 -168.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.858 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 4.7 tp10 -76.74 -13.8 60.0 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.073 -1.084 . . . . 3.5 108.073 -178.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.429 ' HB2' HG11 ' A' ' 84' ' ' VAL . 26.1 t80 -162.8 114.95 1.1 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.119 -0.946 . . . . 6.1200000000000001 112.436 175.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 137' ' ' TYR . 19.7 Cg_endo -95.32 140.33 1.02 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.661 2.907 . . . . 1.77 111.346 168.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.472 ' HG3' ' HB2' ' A' ' 145' ' ' ARG . 37.3 Cg_endo -70.85 -164.58 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.588 2.192 . . . . 1.25 112.965 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.3 t -139.26 -173.49 3.61 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.237 -1.023 . . . . 1.6000000000000001 108.237 -176.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.0 t -82.46 -41.39 19.86 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.248 -0.581 . . . . 1.97 110.265 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -57.15 -52.46 65.21 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.144 0.497 . . . . 2.1800000000000002 110.309 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.962 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 61.9 m-85 -95.82 109.99 22.23 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.316 -0.856 . . . . 1.23 109.424 -175.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.616 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -88.46 107.52 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-N 115.67 -0.696 . . . . 0.81999999999999995 109.611 -176.256 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.553 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 31.5 ttp85 -56.69 105.53 0.22 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.796 -0.638 . . . . 4.4199999999999999 110.129 178.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.75 118.0 12.96 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.707 -0.679 . . . . 0.79000000000000004 112.006 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.88 ' HB3' ' HB3' ' A' ' 174' ' ' GLU . 17.9 t80 -85.62 70.29 10.72 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.511 0.672 . . . . 4.4400000000000004 109.628 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.651 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 11.6 t30 -64.69 96.56 0.18 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.47 -0.786 . . . . 1.6200000000000001 110.083 176.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.86 117.74 28.39 Favored Pre-proline 0 C--O 1.222 -0.382 0 CA-C-N 115.758 -0.655 . . . . 2.3199999999999998 110.242 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -18.32 70.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.101 1 C-N-CA 126.438 4.758 . . . . 0.53000000000000003 115.664 -165.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 170' ' ' PHE . 4.4 p -122.99 169.71 10.89 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.789 -1.189 . . . . 1.5800000000000001 107.789 172.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.681 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -152.21 -146.15 4.29 Favored Glycine 0 N--CA 1.434 -1.49 0 C-N-CA 118.325 -1.893 . . . . 0.42999999999999999 113.805 -165.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.428 ' CZ ' HD11 ' A' ' 167' ' ' LEU . 5.8 t80 -161.36 96.77 1.08 Allowed 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.995 -1.113 . . . . 0.59999999999999998 107.995 -162.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.693 HG23 HG13 ' A' ' 168' ' ' VAL . 4.5 m -105.83 137.88 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-O 121.679 0.752 . . . . 0.31 110.746 -175.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 83.8 m -117.71 109.63 16.85 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.161 -0.927 . . . . 1.55 109.899 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.567 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 15.4 m -111.06 125.59 30.34 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 120.794 -0.362 . . . . 1.0600000000000001 111.51 -168.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 156' ' ' SER . 10.7 Cg_endo -54.54 121.05 9.08 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 122.454 2.102 . . . . 0.56000000000000005 111.368 174.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.617 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 61.1 mmm -80.12 -162.85 0.48 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.217 0.532 . . . . 1.1599999999999999 111.79 -176.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -70.44 -35.07 73.15 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.52 -0.763 . . . . 2.6299999999999999 109.408 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -103.22 30.97 4.53 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.045 -0.98 . . . . 2.0499999999999998 109.143 173.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.745 ' OD1' ' HD3' ' A' ' 162' ' ' PRO . 0.3 OUTLIER -19.77 -57.16 0.06 OUTLIER Pre-proline 0 N--CA 1.479 0.989 0 N-CA-C 117.164 2.283 . . . . 1.9299999999999999 117.164 -171.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.745 ' HD3' ' OD1' ' A' ' 161' ' ' ASN . 69.8 Cg_endo -72.91 -18.17 24.71 Favored 'Trans proline' 0 C--N 1.351 0.701 0 CA-C-N 121.798 1.678 . . . . 0.72999999999999998 113.255 -175.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -108.07 -26.61 10.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.196 -0.456 . . . . 0.68000000000000005 110.92 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.617 ' O ' ' HB2' ' A' ' 158' ' ' MET . 94.1 m-85 -138.33 128.36 25.56 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.181 -0.674 . . . . 0.93000000000000005 109.181 177.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.472 ' HB3' HD11 ' A' ' 61' ' ' LEU . 26.6 t -125.93 151.59 46.76 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.38 0.61 . . . . 1.4099999999999999 111.599 -177.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.729 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 2.0 tppp? -90.73 103.45 16.15 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 122.019 0.914 . . . . 0.73999999999999999 111.472 -176.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.727 HD12 HG12 ' A' ' 196' ' ' ILE . 0.5 OUTLIER -88.06 103.61 15.88 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.406 -1.27 . . . . 0.27000000000000002 109.429 176.111 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.693 HG13 HG23 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -127.82 132.43 68.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.087 -0.645 . . . . 0.28000000000000003 111.876 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.514 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 20.8 ttt -144.41 137.98 27.41 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.37 -0.377 . . . . 1.24 111.819 -170.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.674 ' CE1' ' HB2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -110.84 135.17 51.8 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 109.182 -0.673 . . . . 3.3700000000000001 109.182 173.439 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 1.029 ' HB ' HD21 ' A' ' 192' ' ' LEU . 1.3 t -134.43 120.82 34.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 O-C-N 123.661 0.601 . . . . 1.3999999999999999 111.056 177.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.777 ' HB2' ' HG ' ' A' ' 47' ' ' LEU . 1.3 tm0? -105.04 -32.64 8.62 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.462 -1.31 . . . . 2.1699999999999999 107.462 168.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.651 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 13.2 m 20.75 107.86 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 O-C-N 126.281 2.238 . . . . 1.6499999999999999 113.165 176.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.88 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 15.2 tp10 . . . . . 0 C--N 1.32 -0.681 0 CA-C-N 116.043 -0.526 . . . . 2.4500000000000002 111.769 -161.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.501 ' HA ' ' CE ' ' A' ' 186' ' ' LYS . 11.9 mm . . . . . 0 CA--C 1.511 -0.529 0 CA-C-O 122.505 1.145 . . . . 1.1200000000000001 108.76 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.931 ' HA ' HG22 ' A' ' 187' ' ' THR . 0.7 OUTLIER -66.13 -38.26 81.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 113.063 -1.88 . . . . 1.1299999999999999 111.375 -177.234 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.15 -18.45 65.31 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.585 -0.524 . . . . 2.8900000000000001 109.585 176.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.501 ' CE ' ' HA ' ' A' ' 183' ' ' ILE . 45.2 mtmt -91.84 -41.59 10.55 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.814 -0.63 . . . . 1.28 109.991 173.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.931 HG22 ' HA ' ' A' ' 184' ' ' ILE . 14.6 t -63.04 -28.14 69.89 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.941 0.719 . . . . 0.62 112.941 -169.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . 0.606 ' HE2' ' HA ' ' A' ' 188' ' ' MET . 2.4 mmt -76.05 -62.89 0.67 Allowed Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 120.249 -0.581 . . . . 1.0600000000000001 111.503 -177.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.576 ' O ' HG13 ' A' ' 193' ' ' VAL . 28.3 Cg_endo -61.93 -32.26 84.75 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 121.812 1.674 . . . . 0.91000000000000003 111.844 -177.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.639 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 24.6 m -73.88 -23.76 59.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.357 -0.383 . . . . 1.5 110.777 -177.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.2 OUTLIER -90.39 -38.03 13.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.912 -0.403 . . . . 1.8799999999999999 109.912 -176.134 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 1.029 HD21 ' HB ' ' A' ' 171' ' ' VAL . 26.7 mt -59.3 -57.31 13.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.996 -0.547 . . . . 1.0900000000000001 112.022 178.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 189' ' ' PRO . 1.8 m -65.44 -32.62 59.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.595 0.712 . . . . 0.68000000000000005 109.379 -175.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.639 ' HB2' ' O ' ' A' ' 190' ' ' SER . 0.4 OUTLIER -65.32 -47.04 77.93 Favored 'General case' 0 C--O 1.208 -1.112 0 CA-C-N 114.217 -1.356 . . . . 2.0699999999999998 109.843 176.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.86 -28.94 66.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.786 0.327 . . . . 2.0 111.026 178.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.727 HG12 HD12 ' A' ' 167' ' ' LEU . 22.1 mt -77.32 -31.61 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-O 121.414 0.626 . . . . 0.31 110.862 175.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 68.1 mt -73.56 -38.14 65.3 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 109.562 -0.532 . . . . 1.03 109.562 176.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.538 ' OD1' ' HG3' ' A' ' 76' ' ' LYS . 3.2 m-20 -53.11 -41.69 65.23 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.11 -1.07 . . . . 1.8999999999999999 108.11 168.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.738 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -67.33 -49.8 62.61 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.944 -0.571 . . . . 0.28999999999999998 110.129 -178.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.54 ' HD3' HD13 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -61.09 -41.16 96.15 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 114.984 -1.007 . . . . 0.96999999999999997 110.843 -179.242 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -76.99 -47.18 21.45 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-N 115.259 -0.882 . . . . 1.9399999999999999 110.089 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . 0.456 ' HA3' ' CZ2' ' A' ' 74' ' ' TRP . . . -69.89 -38.45 75.45 Favored Glycine 0 CA--C 1.505 -0.543 0 C-N-CA 120.811 -0.709 . . . . 0.46999999999999997 112.117 -175.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.738 ' HB ' ' O ' ' A' ' 199' ' ' ALA . 0.9 OUTLIER -58.04 -46.25 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 110.521 -0.178 . . . . 0.60999999999999999 110.521 176.327 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -84.48 -23.57 29.82 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 120.382 -0.527 . . . . 3.3700000000000001 109.841 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.88 0 N-CA-C 109.081 -0.711 . . . . 1.02 109.081 166.827 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.506 ' O ' HD12 ' A' ' 6' ' ' ILE . 7.0 m-20 . . . . . 0 CA--C 1.507 -0.684 0 CA-C-O 121.183 0.516 . . . . 2.25 110.206 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.627 ' HD1' HD22 ' A' ' 114' ' ' LEU . 93.5 m-85 -66.73 -32.83 74.39 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.384 -0.825 . . . . 0.42999999999999999 109.326 -175.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.636 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 2.1 tppp? -69.52 -8.25 45.42 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.82 -1.082 . . . . 1.51 110.124 177.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -92.27 -41.68 10.26 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.229 0.538 . . . . 0.54000000000000004 110.337 173.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.556 HD12 ' HA ' ' A' ' 3' ' ' PHE . 1.8 mp -82.45 -43.07 18.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.754 0.788 . . . . 1.0700000000000001 109.456 -171.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -72.15 -47.22 52.56 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.312 -1.313 . . . . 0.34000000000000002 111.582 -178.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.636 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 6.2 mt-30 -63.19 -26.43 68.8 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.664 -1.153 . . . . 1.5900000000000001 110.762 -178.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.581 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 24.9 mt-30 -84.82 -30.81 24.24 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.324 -0.853 . . . . 2.4700000000000002 109.395 172.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.552 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.4 OUTLIER -74.35 -34.72 63.47 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.513 -0.767 . . . . 0.47999999999999998 111.684 -177.386 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.467 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -45.87 -54.99 7.25 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 120.345 -0.542 . . . . 0.31 111.23 172.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -75.5 -6.66 51.3 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.775 -0.648 . . . . 1.6399999999999999 112.042 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.581 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 32.1 mt-10 -80.59 -52.09 7.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.712 -0.477 . . . . 2.54 109.712 173.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.699 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 14.6 p -69.57 -40.94 80.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.844 0.831 . . . . 0.53000000000000003 110.193 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.44 HD13 ' CE1' ' A' ' 120' ' ' TYR . 0.4 OUTLIER -67.78 -25.45 65.61 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 121.978 0.894 . . . . 0.59999999999999998 108.608 173.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.32 -17.5 66.28 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 113.79 -1.55 . . . . 0.56999999999999995 110.394 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.699 ' CD2' ' HA ' ' A' ' 14' ' ' VAL . 15.1 m-85 -89.07 -24.68 22.24 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.572 -0.899 . . . . 3.27 108.572 177.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -73.61 -12.0 60.61 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-O 121.337 0.589 . . . . 2.0299999999999998 110.018 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -111.62 -18.7 12.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.498 -0.774 . . . . 2.7200000000000002 111.216 -176.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -136.09 84.13 2.06 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.326 -0.397 . . . . 2.1600000000000001 111.459 -174.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -151.0 139.5 20.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 1.8200000000000001 111.64 178.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.9 m -167.53 -45.26 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.017 -0.538 . . . . 2.1899999999999999 110.031 -173.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -81.68 47.79 3.72 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.834 -0.621 . . . . 1.1000000000000001 113.188 -176.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.548 ' O ' ' HE2' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -120.65 -147.3 0.39 Allowed 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.605 -0.517 . . . . 1.6699999999999999 109.605 178.188 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.548 ' HE2' ' O ' ' A' ' 24' ' ' TRP . 0.0 OUTLIER 178.57 123.84 0.05 OUTLIER 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.954 -0.758 . . . . 2.9500000000000002 108.954 -175.036 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.578 ' CG1' HG22 ' A' ' 34' ' ' THR . 3.7 m -65.13 119.81 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.818 0 CA-C-O 122.358 1.075 . . . . 1.5600000000000001 111.605 176.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.455 HG13 ' HB3' ' A' ' 189' ' ' PRO . 7.7 p -99.57 -23.96 4.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 113.692 -1.595 . . . . 1.22 109.07 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 189' ' ' PRO . 8.3 tppt? -152.9 109.9 3.48 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 119.82 -0.752 . . . . 2.4100000000000001 111.756 -176.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.618 ' HB ' ' HA ' ' A' ' 34' ' ' THR . 1.3 t -151.89 152.64 32.82 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.196 0.522 . . . . 1.3799999999999999 111.484 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.7 t -113.24 -94.93 0.45 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.354 -0.839 . . . . 2.3700000000000001 110.165 176.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -148.32 19.15 1.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.297 0.57 . . . . 4.5499999999999998 110.737 176.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.673 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 38.5 mmtm -150.05 -33.92 0.18 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.707 -0.679 . . . . 1.4199999999999999 110.138 176.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.642 HD12 ' HB ' ' A' ' 193' ' ' VAL . 16.3 pt -113.55 149.95 15.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.603 -0.726 . . . . 0.76000000000000001 109.746 -177.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.618 ' HA ' ' HB ' ' A' ' 29' ' ' THR . 0.2 OUTLIER -151.17 107.67 3.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 123.12 0.262 . . . . 0.57999999999999996 111.604 -166.248 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.538 ' CG2' HG13 ' A' ' 193' ' ' VAL . 21.4 t -95.57 109.63 22.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.953 0.406 . . . . 0.85999999999999999 110.315 176.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 2.3 p -105.11 123.36 47.68 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.526 -0.761 . . . . 1.1000000000000001 110.773 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 77.9 p -103.47 129.19 50.56 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.914 -1.039 . . . . 1.27 110.284 -174.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.451 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 24.5 ttpp . . . . . 0 C--N 1.317 -0.829 0 CA-C-N 115.996 -0.547 . . . . 1.9099999999999999 111.289 -173.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 . . . . . 0 N--CA 1.442 -0.864 0 CA-C-O 121.054 0.454 . . . . 2.0499999999999998 111.301 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.54 HD23 ' N ' ' A' ' 48' ' ' TYR . 3.2 tt -98.48 138.68 35.35 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.865 -1.161 . . . . 0.87 107.865 174.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.54 ' N ' HD23 ' A' ' 47' ' ' LEU . 73.2 m-85 -120.03 130.69 54.83 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 110.168 -0.308 . . . . 0.98999999999999999 110.168 -174.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.484 ' HD3' ' CZ3' ' A' ' 24' ' ' TRP . 37.4 ttt-85 -120.29 121.42 38.63 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.268 -0.424 . . . . 2.9199999999999999 110.06 175.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.515 ' CG1' ' HB3' ' A' ' 192' ' ' LEU . 9.4 p -104.99 145.98 12.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 120.11 -0.636 . . . . 1.3300000000000001 109.655 174.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.555 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 29.6 tt0 -144.33 113.09 6.69 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.534 -0.757 . . . . 1.0700000000000001 110.155 -171.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.673 ' HA2' ' O ' ' A' ' 32' ' ' LYS . . . -143.85 143.26 12.03 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.682 -0.771 . . . . 0.28999999999999998 111.934 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.8 mt -87.54 120.59 36.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 120.147 -0.621 . . . . 0.57999999999999996 110.691 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 36.4 mt -102.69 120.2 53.52 Favored Pre-proline 0 N--CA 1.442 -0.865 0 CA-C-N 115.556 -0.747 . . . . 0.34999999999999998 109.728 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -62.57 60.03 0.14 Allowed 'Trans proline' 0 N--CA 1.473 0.319 0 C-N-CA 124.299 3.333 . . . . 0.62 113.93 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.643 ' HG2' HG13 ' A' ' 203' ' ' ILE . 9.6 tp10 -150.91 175.54 11.95 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.879 -0.785 . . . . 1.6799999999999999 108.879 174.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.529 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 12.8 m -80.94 143.32 53.25 Favored Pre-proline 0 N--CA 1.425 -1.702 0 CA-C-O 121.365 0.602 . . . . 1.1799999999999999 109.488 172.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 57' ' ' SER . 35.5 Cg_exo -57.95 -14.32 18.09 Favored 'Trans proline' 0 C--N 1.333 -0.272 0 C-N-CA 124.092 3.195 . . . . 0.52000000000000002 111.501 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.32 -50.9 42.25 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.207 -0.906 . . . . 0.64000000000000001 111.31 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.47 ' O ' ' HE3' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -67.66 -27.35 66.78 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.387 -0.968 . . . . 3.2999999999999998 108.387 179.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.752 ' O ' HD12 ' A' ' 65' ' ' LEU . 40.6 mt -62.9 -57.96 9.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.19 -0.914 . . . . 0.40999999999999998 110.473 172.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.665 ' OG ' ' HB3' ' A' ' 125' ' ' ASN . 66.5 m -60.49 -16.1 33.54 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.92 -0.488 . . . . 1.29 110.861 176.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -90.1 -43.96 10.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.243 0.46 . . . . 1.3200000000000001 112.243 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.645 ' CE2' ' HA ' ' A' ' 199' ' ' ALA . 5.0 p90 -73.4 -43.43 60.51 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.739 -0.385 . . . . 0.60999999999999999 110.905 -171.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.752 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -86.57 -7.17 58.59 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 120.433 -0.507 . . . . 1.5 111.616 -173.288 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.525 ' N ' HD13 ' A' ' 65' ' ' LEU . 11.8 t80 -18.79 -70.44 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.95 1.406 . . . . 1.52 114.005 -163.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.486 ' OE1' ' HB2' ' A' ' 94' ' ' CYS . 8.5 tt0 -174.32 -32.26 0.01 OUTLIER 'General case' 0 C--N 1.342 0.268 0 N-CA-C 114.296 1.221 . . . . 3.6000000000000001 114.296 176.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.7 t -161.97 7.87 0.06 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 119.223 -0.991 . . . . 1.48 113.462 -166.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -115.0 -22.78 4.83 Favored Glycine 0 C--N 1.314 -0.686 0 C-N-CA 118.917 -1.611 . . . . 1.46 113.901 -168.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.655 ' O ' HG22 ' A' ' 73' ' ' THR . 4.5 t70 -150.39 -29.5 0.21 Allowed 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.609 -0.436 . . . . 2.1899999999999999 110.574 -176.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.856 ' HA ' ' CZ2' ' A' ' 74' ' ' TRP . 9.7 ptm180 -50.19 -43.68 52.6 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 123.33 0.652 . . . . 3.3799999999999999 111.452 -173.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.748 HD13 ' H ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -83.5 -13.54 11.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.896 -0.593 . . . . 0.70999999999999996 110.318 -173.262 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.655 HG22 ' O ' ' A' ' 70' ' ' ASP . 0.8 OUTLIER -84.91 -31.44 23.67 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 116.02 -0.536 . . . . 0.96999999999999997 109.927 -176.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.856 ' CZ2' ' HA ' ' A' ' 71' ' ' ARG . 7.4 p-90 -106.29 -10.34 16.43 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 120.27 -0.572 . . . . 0.75 111.872 -176.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.674 ' OD2' ' HG ' ' A' ' 78' ' ' LEU . 27.4 t0 -83.3 172.58 12.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.967 0.889 . . . . 2.1899999999999999 111.427 -177.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.53 ' H ' ' CG ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -122.04 -13.98 8.08 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 113.979 -1.464 . . . . 3.1899999999999999 111.297 -172.47 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 74.7 m -115.56 8.77 15.2 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.303 -0.629 . . . . 1.5800000000000001 109.303 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.674 ' HG ' ' OD2' ' A' ' 75' ' ' ASP . 54.0 mt -109.65 171.05 7.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.363 -0.835 . . . . 0.70999999999999996 110.681 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.602 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 6.4 mm-40 -150.62 -63.37 0.2 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.592 0.59 . . . . 1.73 112.592 -171.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.507 HG23 ' HB3' ' A' ' 79' ' ' GLN . 39.4 t -141.65 127.94 19.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.907 0.384 . . . . 0.78000000000000003 111.076 -168.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.585 ' HB3' HD12 ' A' ' 72' ' ' ILE . 41.1 p90 -97.67 146.06 25.7 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.825 -0.625 . . . . 5.4000000000000004 110.219 174.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.503 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 17.2 m120 -155.13 102.5 2.31 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.447 -0.575 . . . . 1.6899999999999999 109.447 174.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.09 110.06 2.38 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.196 -0.668 . . . . 2.0499999999999998 109.196 177.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -93.14 -49.09 13.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.521 -0.309 . . . . 0.64000000000000001 111.55 -172.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.442 ' HB3' HD12 ' A' ' 93' ' ' ILE . 17.6 t-80 -147.74 108.13 4.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.124 0.487 . . . . 1.96 111.144 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.443 ' HG2' ' HD2' ' A' ' 92' ' ' PHE . 20.7 mtt180 -89.66 107.04 18.86 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.564 -0.744 . . . . 2.4399999999999999 109.828 176.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.64 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -75.85 -41.34 39.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.095 0.474 . . . . 0.46999999999999997 110.033 -177.805 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -155.6 -168.12 2.72 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.3 -1.0 . . . . 1.8600000000000001 108.3 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.6 m -80.63 -5.62 57.15 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 117.567 0.167 . . . . 1.4399999999999999 111.345 -177.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -130.16 4.35 4.82 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.83 -0.433 . . . . 1.8700000000000001 109.83 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.64 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.5 OUTLIER -137.87 116.33 12.01 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.609 -0.885 . . . . 0.46000000000000002 108.609 -173.564 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.576 ' O ' HD12 ' A' ' 114' ' ' LEU . 11.0 m-85 -137.2 176.29 8.84 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.232 0.539 . . . . 0.42999999999999999 110.57 -175.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.571 ' O ' HG23 ' A' ' 84' ' ' VAL . 21.6 mt -134.94 127.43 48.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 106.759 -1.571 . . . . 0.40999999999999998 106.759 166.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.486 ' HB2' ' OE1' ' A' ' 67' ' ' GLN . 31.2 t -117.15 129.58 56.06 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.389 -0.525 . . . . 2.0099999999999998 111.266 -176.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.556 ' HA ' HD13 ' A' ' 112' ' ' ILE . 24.3 t60 -87.35 85.38 7.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.268 -0.878 . . . . 1.23 109.173 173.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 60.2 m -100.42 113.37 26.07 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.644 -1.162 . . . . 0.5 112.177 -173.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.469 HD13 ' OD1' ' A' ' 110' ' ' ASP . 31.0 mm -76.52 126.21 36.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.309 -0.626 . . . . 1.03 109.309 174.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.2 m -113.35 142.74 45.5 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.328 -0.851 . . . . 1.3799999999999999 111.272 -174.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.602 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 25.3 mt-30 . . . . . 0 C--N 1.318 -0.796 0 N-CA-C 109.495 -0.557 . . . . 1.8200000000000001 109.495 173.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.448 HD11 HG22 ' A' ' 183' ' ' ILE . 26.3 mt . . . . . 0 N--CA 1.45 -0.461 0 N-CA-C 110.156 -0.313 . . . . 1.1200000000000001 110.156 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.1 m -87.44 152.41 52.22 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 116.163 -0.472 . . . . 1.3500000000000001 110.325 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -47.97 143.08 14.27 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.686 2.257 . . . . 1.0700000000000001 111.632 173.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.568 ' HG2' HG23 ' A' ' 144' ' ' ILE . 20.2 mtm180 -123.64 174.76 7.25 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.639 -0.504 . . . . 3.4500000000000002 109.639 -173.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.685 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 31.0 t70 -131.61 138.88 48.99 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.339 -0.391 . . . . 1.3700000000000001 110.045 176.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -110.07 125.54 53.06 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.105 -0.498 . . . . 2.4100000000000001 110.375 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.612 ' CG2' ' HE1' ' A' ' 134' ' ' PHE . 47.6 mm -109.39 70.54 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 108.362 -0.977 . . . . 0.42999999999999999 108.362 170.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 43.7 m-20 -88.35 117.7 27.46 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.638 -0.71 . . . . 1.8600000000000001 111.03 -174.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.627 HD22 ' HD1' ' A' ' 3' ' ' PHE . 9.4 tp -75.0 124.7 27.44 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.342 -0.984 . . . . 0.28000000000000003 108.342 165.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.615 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -132.25 126.5 55.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 115.465 -0.789 . . . . 0.26000000000000001 112.404 -163.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.532 ' HD1' ' HG1' ' A' ' 91' ' ' THR . 58.9 t80 -110.72 116.36 31.17 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.092 -0.958 . . . . 2.5699999999999998 110.425 172.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.453 HG12 HG22 ' A' ' 127' ' ' ILE . 86.6 mt -94.31 112.0 26.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.54 -0.755 . . . . 0.89000000000000001 110.222 -177.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.439 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 17.1 ttmm -137.95 142.43 40.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.132 -0.485 . . . . 1.2 110.63 -176.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.447 ' NE ' ' HA ' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -117.72 113.72 22.27 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 107.86 -1.163 . . . . 2.7999999999999998 107.86 172.472 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.44 ' CE1' HD13 ' A' ' 15' ' ' LEU . 56.0 m-85 -67.48 117.25 9.19 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.667 -1.235 . . . . 0.82999999999999996 107.667 170.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.447 ' HA ' ' NE ' ' A' ' 119' ' ' ARG . 22.1 mm-40 -35.66 94.58 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 O-C-N 124.789 1.306 . . . . 2.2799999999999998 112.938 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 58.8 41.71 96.13 Favored Glycine 0 CA--C 1.505 -0.569 0 CA-C-N 114.618 -1.174 . . . . 0.76000000000000001 112.406 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.431 ' HB3' ' CB ' ' A' ' 120' ' ' TYR . 3.2 t-20 -138.68 -49.93 0.54 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.446 -0.377 . . . . 1.6499999999999999 110.705 -177.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.421 ' O ' ' HA ' ' A' ' 119' ' ' ARG . 2.0 tpp -159.97 118.84 2.76 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.046 0.45 . . . . 1.1200000000000001 111.491 -175.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.665 ' HB3' ' OG ' ' A' ' 62' ' ' SER . 6.0 m120 -97.93 79.21 2.61 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.779 -0.823 . . . . 1.6200000000000001 108.779 177.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.556 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.5 OUTLIER -105.37 141.06 21.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 113.193 0.812 . . . . 0.29999999999999999 113.193 -169.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.704 ' O ' HG13 ' A' ' 127' ' ' ILE . 2.3 pt -107.9 115.05 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 107.979 -1.119 . . . . 0.58999999999999997 107.979 159.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.615 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 36.5 p -82.96 154.2 24.63 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.946 -0.761 . . . . 1.1799999999999999 108.946 175.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.587 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 9.0 p -154.63 131.45 10.78 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.947 0.403 . . . . 1.24 111.858 -175.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -131.32 120.97 23.9 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 107.632 -1.248 . . . . 2.2599999999999998 107.632 175.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.611 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 52.5 m -66.17 101.04 0.66 Allowed 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.215 -1.402 . . . . 1.3899999999999999 107.215 175.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.99 143.21 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.879 0 CA-C-N 114.568 -1.196 . . . . 1.05 109.193 -164.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -95.27 70.72 3.21 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 122.983 1.373 . . . . 2.1699999999999999 110.176 -170.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.612 ' HE1' ' CG2' ' A' ' 112' ' ' ILE . 1.7 p90 -97.75 177.22 1.7 Allowed Pre-proline 0 CA--C 1.554 1.129 0 CA-C-N 113.688 -1.596 . . . . 0.53000000000000003 109.326 -174.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.421 ' HB2' ' OE2' ' A' ' 136' ' ' GLU . 59.9 Cg_exo -44.28 -47.71 10.47 Favored 'Trans proline' 0 CA--C 1.55 1.304 0 C-N-CA 123.752 2.968 . . . . 1.28 117.106 -175.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.421 ' OE2' ' HB2' ' A' ' 135' ' ' PRO . 2.0 mm-40 -88.71 -5.15 58.3 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 121.595 -0.691 . . . . 3.5 111.416 -172.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.575 ' HB3' ' O ' ' A' ' 134' ' ' PHE . 22.9 t80 -54.33 -45.63 99.21 Favored Pre-proline 0 C--N 1.314 -0.961 0 N-CA-C 115.384 1.624 . . . . 6.1200000000000001 115.384 -177.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 24.7 Cg_exo -32.54 111.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 123.874 3.049 . . . . 1.77 114.875 -175.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.544 ' HA ' ' CZ ' ' A' ' 145' ' ' ARG . 5.8 Cg_exo -79.8 -160.81 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.282 2.655 . . . . 1.25 114.056 -177.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 13.6 m -145.58 -160.85 1.2 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.284 -1.326 . . . . 1.6000000000000001 108.502 -176.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 31.1 t -88.69 -41.91 12.3 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.534 -0.467 . . . . 1.97 111.048 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -70.9 -30.9 67.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.898 0.38 . . . . 2.1800000000000002 111.147 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -120.32 115.02 22.73 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 121.234 0.54 . . . . 1.23 110.327 -176.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.568 HG23 ' HG2' ' A' ' 109' ' ' ARG . 3.4 tp -105.53 113.81 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 115.23 -0.896 . . . . 0.81999999999999995 109.967 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.685 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 5.2 mpt_? -54.74 99.61 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.763 -1.108 . . . . 4.4199999999999999 110.914 175.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -67.51 112.51 4.84 Favored Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 109.372 -1.491 . . . . 0.79000000000000004 109.372 171.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.5 ' HB3' ' CB ' ' A' ' 174' ' ' GLU . 3.2 t80 -84.16 81.45 8.8 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.362 0.601 . . . . 4.4400000000000004 110.515 -169.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.652 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 70.7 m-20 -70.66 99.26 1.64 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.999 -1.001 . . . . 1.6200000000000001 110.191 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.458 ' HB2' ' O ' ' A' ' 172' ' ' GLN . 70.9 m-70 -69.99 146.33 95.01 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.198 -0.455 . . . . 2.3199999999999998 109.911 176.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.545 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 75.5 Cg_exo -15.21 64.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.239 1 C-N-CA 127.414 5.409 . . . . 0.53000000000000003 115.709 -164.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . 0.652 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 25.4 p -89.81 -174.84 4.43 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.682 -1.144 . . . . 1.5800000000000001 110.36 178.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.575 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -177.8 -161.09 25.45 Favored Glycine 0 N--CA 1.435 -1.41 0 C-N-CA 120.385 -0.912 . . . . 0.42999999999999999 111.77 177.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.596 ' CE1' ' HG ' ' A' ' 65' ' ' LEU . 48.1 t80 -161.72 88.92 0.72 Allowed 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.474 -0.936 . . . . 0.59999999999999998 108.474 -167.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.583 HG23 HG13 ' A' ' 168' ' ' VAL . 2.6 m -98.63 132.53 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-O 121.65 0.738 . . . . 0.31 110.864 -173.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 125' ' ' ASN . 47.8 m -113.55 108.57 17.35 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.508 -0.769 . . . . 1.55 109.352 177.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.487 ' HB3' ' HB3' ' A' ' 166' ' ' LYS . 18.3 t -102.31 122.99 44.69 Favored Pre-proline 0 C--N 1.312 -1.058 0 CA-C-O 120.842 0.353 . . . . 1.0600000000000001 111.657 -167.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.405 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 77.9 Cg_exo -52.79 118.1 4.39 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.766 2.311 . . . . 0.56000000000000005 111.666 170.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.493 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 78.1 mmm -82.96 -165.08 0.98 Allowed 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 120.977 0.417 . . . . 1.1599999999999999 111.411 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.417 ' H ' ' HB3' ' A' ' 158' ' ' MET . 9.1 mm-40 -76.89 -24.79 52.53 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.741 0.782 . . . . 2.6299999999999999 109.138 173.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 22.5 mm-40 -102.57 27.06 7.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.823 -1.08 . . . . 2.0499999999999998 108.821 172.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.424 ' HB3' ' HD3' ' A' ' 162' ' ' PRO . 15.9 t30 -12.22 -71.32 0.01 OUTLIER Pre-proline 0 N--CA 1.479 0.987 0 N-CA-C 115.675 1.732 . . . . 1.9299999999999999 115.675 -174.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' A' ' 161' ' ' ASN . 70.6 Cg_endo -72.7 -16.27 26.72 Favored 'Trans proline' 0 C--N 1.351 0.665 0 CA-C-N 120.498 1.213 . . . . 0.72999999999999998 113.596 -172.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -103.09 -29.27 11.45 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.899 0.38 . . . . 0.68000000000000005 110.885 -177.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.493 ' O ' ' HB2' ' A' ' 158' ' ' MET . 82.2 m-85 -139.93 125.98 19.78 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.348 -0.612 . . . . 0.93000000000000005 109.348 177.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.409 ' OG ' HD11 ' A' ' 61' ' ' LEU . 4.4 p -122.13 147.81 45.69 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.156 0.503 . . . . 1.4099999999999999 110.978 -177.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.555 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.9 tppp? -91.94 104.61 17.01 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.757 0.789 . . . . 0.73999999999999999 111.009 -176.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.52 109.86 20.76 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.916 -1.038 . . . . 0.27000000000000002 109.039 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.583 HG13 HG23 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -130.58 128.76 63.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 121.692 0.758 . . . . 0.28000000000000003 111.783 177.114 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.488 ' HG2' ' N ' ' A' ' 170' ' ' PHE . 23.0 ttm -124.3 153.05 42.32 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.306 -0.861 . . . . 1.24 109.536 -176.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.568 ' O ' ' HB2' ' A' ' 151' ' ' CYS . 8.6 m-85 -133.5 139.8 46.87 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.568 -0.901 . . . . 3.3700000000000001 108.568 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 11.1 p -138.02 116.77 14.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.618 0.723 . . . . 1.3999999999999999 111.533 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 149' ' ' HIS . 28.8 tt0 -111.26 56.76 0.63 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.646 -0.872 . . . . 2.1699999999999999 108.646 174.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 9.1 t -73.45 145.53 45.68 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.877 0.846 . . . . 1.6499999999999999 111.269 -174.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.5 ' CB ' ' HB3' ' A' ' 147' ' ' TYR . 6.6 tp10 . . . . . 0 N--CA 1.445 -0.676 0 CA-C-N 114.681 -1.145 . . . . 2.4500000000000002 109.947 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.566 ' HA ' ' HE2' ' A' ' 186' ' ' LYS . 13.3 mm . . . . . 0 CA--C 1.507 -0.679 0 CA-C-O 122.432 1.111 . . . . 1.1200000000000001 108.991 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 1.025 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.2 mp -74.49 -34.72 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 CA-C-N 113.089 -1.868 . . . . 1.1299999999999999 111.334 -176.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 189' ' ' PRO . 11.1 pt-20 -67.4 -17.25 64.65 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.93 -0.767 . . . . 2.8900000000000001 108.93 176.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.566 ' HE2' ' HA ' ' A' ' 183' ' ' ILE . 51.6 mtmt -91.96 -42.67 9.88 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.376 -0.829 . . . . 1.28 109.953 171.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 1.025 HG22 ' HA ' ' A' ' 184' ' ' ILE . 7.4 t -70.01 -41.04 74.87 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.192 -0.603 . . . . 0.62 112.366 -170.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . 0.55 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 34.9 mmm -76.38 -55.48 1.68 Allowed Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 112.441 0.534 . . . . 1.0600000000000001 112.441 -174.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.55 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 23.8 Cg_exo -65.48 -19.07 60.93 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 121.945 1.763 . . . . 0.91000000000000003 112.234 -175.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 51.5 m -85.87 -42.06 14.44 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.734 -0.469 . . . . 1.5 109.734 177.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -64.16 -39.13 93.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 1.8799999999999999 111.136 -175.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.527 HD12 HG13 ' A' ' 35' ' ' VAL . 30.7 mt -68.05 -44.71 75.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.627 0.251 . . . . 1.0900000000000001 111.179 -176.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.642 ' HB ' HD12 ' A' ' 33' ' ' ILE . 17.9 m -74.18 -24.85 19.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 120.27 -0.572 . . . . 0.68000000000000005 110.56 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.419 HD22 ' HA ' ' A' ' 194' ' ' ASN . 7.7 m120 -68.71 -39.18 80.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.187 -0.46 . . . . 2.0699999999999998 110.445 172.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.667 ' HA ' ' ND2' ' A' ' 198' ' ' ASN . 4.9 m-85 -70.8 -20.03 62.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.132 0.491 . . . . 2.0 111.014 176.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.674 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 33.5 mt -82.62 -29.55 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 C-N-CA 119.494 -0.882 . . . . 0.31 110.496 170.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 47.2 mt -69.38 -43.74 72.91 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.518 -0.31 . . . . 1.03 110.773 178.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.667 ' ND2' ' HA ' ' A' ' 195' ' ' PHE . 13.1 p30 -60.97 -22.6 64.63 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.964 -0.562 . . . . 1.8999999999999999 109.886 171.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.708 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -80.79 -43.11 20.6 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 116.51 -0.314 . . . . 0.28999999999999998 110.317 177.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.674 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 12.8 mmmm -57.1 -47.05 82.01 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.659 -0.867 . . . . 0.96999999999999997 108.659 172.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -71.19 -45.87 62.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.266 -1.333 . . . . 1.9399999999999999 111.53 -175.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -72.02 -22.76 78.69 Favored Glycine 0 N--CA 1.463 0.442 0 C-N-CA 120.517 -0.849 . . . . 0.46999999999999997 112.099 -178.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.708 ' HB ' ' O ' ' A' ' 199' ' ' ALA . 1.0 OUTLIER -82.24 -36.16 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 120.966 0.412 . . . . 0.60999999999999999 110.603 175.157 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 26.5 mtpt -73.87 -28.47 61.58 Favored 'General case' 0 C--O 1.209 -1.041 0 N-CA-C 108.636 -0.876 . . . . 3.3700000000000001 108.636 176.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.983 0 CA-C-N 115.505 -0.771 . . . . 1.02 109.682 169.118 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.637 ' O ' HD13 ' A' ' 6' ' ' ILE . 20.1 t70 . . . . . 0 CA--C 1.513 -0.445 0 N-CA-C 110.058 -0.349 . . . . 2.25 110.058 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.842 ' HA ' HD11 ' A' ' 6' ' ' ILE . 96.0 m-85 -67.76 -30.11 69.48 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 122.006 0.908 . . . . 0.42999999999999999 108.569 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 9.2 tttm -75.68 -4.32 39.63 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.916 -1.493 . . . . 1.51 109.893 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.425 ' O ' ' HG2' ' A' ' 9' ' ' GLN . . . -92.74 -46.22 7.66 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.339 0.59 . . . . 0.54000000000000004 109.686 174.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.842 HD11 ' HA ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -82.34 -38.8 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-N 115.693 -0.685 . . . . 1.0700000000000001 110.464 -171.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.562 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -78.04 -38.08 45.41 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.843 -1.071 . . . . 0.34000000000000002 111.391 -176.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.501 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 21.6 mt-30 -65.68 -25.79 67.49 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.179 -0.919 . . . . 1.5900000000000001 110.316 177.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.52 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 16.4 mm100 -89.71 -36.45 15.2 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.051 -0.977 . . . . 2.4700000000000002 109.531 173.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.593 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -64.81 -34.47 78.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.626 -0.716 . . . . 0.47999999999999998 111.259 179.031 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.529 ' HA ' ' OG ' ' A' ' 128' ' ' SER . . . -48.21 -61.07 2.17 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.703 0.763 . . . . 0.31 110.464 171.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -66.71 -17.0 64.63 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.471 -1.24 . . . . 1.6399999999999999 112.025 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 35.2 mt-10 -68.73 -57.35 5.77 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 109.595 -0.521 . . . . 2.54 109.595 174.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.713 ' CG2' ' HA ' ' A' ' 151' ' ' CYS . 1.2 t -70.4 -43.38 78.26 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 CA-C-O 121.811 0.815 . . . . 0.53000000000000003 110.979 -174.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.559 HD23 ' HD2' ' A' ' 19' ' ' ARG . 1.0 OUTLIER -64.48 -33.11 75.12 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.471 -1.241 . . . . 0.59999999999999998 109.308 174.813 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.427 ' HA2' ' HD3' ' A' ' 19' ' ' ARG . . . -65.07 -16.41 62.03 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 114.56 -1.2 . . . . 0.56999999999999995 111.281 175.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.709 ' HD2' ' HA ' ' A' ' 14' ' ' VAL . 54.8 m-85 -89.58 -25.82 21.14 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 108.234 -1.024 . . . . 3.27 108.234 174.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.41 HD22 ' HA ' ' A' ' 18' ' ' ASN . 2.1 t-20 -68.85 -10.63 58.0 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.635 0.731 . . . . 2.0299999999999998 109.093 175.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.559 ' HD2' HD23 ' A' ' 15' ' ' LEU . 11.3 mtp180 -112.19 -20.79 11.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.875 -1.057 . . . . 2.7200000000000002 110.322 178.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -123.08 58.93 1.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.775 0.798 . . . . 2.1600000000000001 110.702 -176.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.856 ' HB ' ' CZ2' ' A' ' 24' ' ' TRP . 0.7 OUTLIER -122.89 127.57 49.15 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.856 -0.611 . . . . 1.8200000000000001 110.544 176.687 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.5 t -179.28 -33.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.508 -0.769 . . . . 2.1899999999999999 110.068 -170.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.85 -17.35 76.79 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.618 -0.719 . . . . 1.1000000000000001 112.916 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 1.012 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -89.81 -155.99 0.39 Allowed 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 112.563 0.579 . . . . 1.6699999999999999 112.563 179.324 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.521 ' HE3' ' HA ' ' A' ' 25' ' ' LYS . 0.8 OUTLIER -171.68 134.79 0.84 Allowed 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 115.204 -0.907 . . . . 2.9500000000000002 109.465 -164.671 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.689 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 5.2 m -66.0 122.05 16.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 122.062 0.934 . . . . 1.5600000000000001 111.486 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.514 HG21 ' HE2' ' A' ' 48' ' ' TYR . 30.1 m -95.76 -23.19 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-N 113.906 -1.497 . . . . 1.22 108.517 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.521 ' HD2' ' HA ' ' A' ' 28' ' ' LYS . 15.1 tptm -161.98 131.25 4.47 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 120.251 -0.579 . . . . 2.4100000000000001 111.185 -176.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.76 HG22 ' HA ' ' A' ' 34' ' ' THR . 77.4 p -131.81 152.18 51.16 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.224 -0.444 . . . . 1.3799999999999999 109.827 172.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.551 ' HB3' HG12 ' A' ' 33' ' ' ILE . 22.9 t -111.67 -138.98 0.38 Allowed 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.268 -0.641 . . . . 2.3700000000000001 109.268 177.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -103.62 18.13 22.56 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 122.451 -0.155 . . . . 4.5499999999999998 110.835 -178.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.3 tptt -175.12 2.98 0.01 OUTLIER 'General case' 0 C--O 1.237 0.422 0 N-CA-C 112.098 0.407 . . . . 1.4199999999999999 112.098 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.924 HG22 ' HA3' ' A' ' 52' ' ' GLY . 38.1 pt -139.3 166.34 21.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 120.783 0.325 . . . . 0.76000000000000001 111.376 -175.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.76 ' HA ' HG22 ' A' ' 29' ' ' THR . 24.1 m -152.02 112.38 4.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.425 -0.807 . . . . 0.57999999999999996 110.685 -165.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.884 HG22 HG12 ' A' ' 50' ' ' VAL . 2.3 t -107.16 103.89 16.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.842 0.353 . . . . 0.85999999999999999 110.242 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.689 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 4.3 p -102.5 127.58 49.49 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 122.957 0.503 . . . . 1.1000000000000001 110.273 179.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 6.9 t -120.53 135.71 55.0 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.402 0.62 . . . . 1.27 112.152 -172.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 1.012 ' HB3' ' HB3' ' A' ' 24' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 114.77 -1.105 . . . . 1.9099999999999999 109.632 175.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 121.413 0.625 . . . . 2.0499999999999998 111.445 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.681 HD23 ' N ' ' A' ' 48' ' ' TYR . 5.2 tt -83.7 150.8 25.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.726 -1.125 . . . . 0.87 108.565 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.681 ' N ' HD23 ' A' ' 47' ' ' LEU . 70.9 m-85 -120.31 131.88 55.07 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.931 0.395 . . . . 0.98999999999999999 110.941 -174.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.507 ' HG2' ' CE2' ' A' ' 170' ' ' PHE . 0.6 OUTLIER -112.44 115.45 28.7 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.266 -1.012 . . . . 2.9199999999999999 108.266 173.22 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.884 HG12 HG22 ' A' ' 35' ' ' VAL . 2.0 m -101.49 150.35 6.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 120.407 -0.517 . . . . 1.3300000000000001 110.477 173.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.652 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 45.7 tt0 -151.15 109.38 3.75 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.986 -1.006 . . . . 1.0700000000000001 109.49 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.924 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -139.99 143.16 13.34 Favored Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 110.909 -0.876 . . . . 0.28999999999999998 110.909 178.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.0 mt -88.62 125.3 41.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 C-N-CA 119.574 -0.85 . . . . 0.57999999999999996 111.051 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.47 HG12 ' HD3' ' A' ' 200' ' ' LYS . 45.4 mt -106.04 99.1 21.13 Favored Pre-proline 0 N--CA 1.442 -0.871 0 N-CA-C 108.046 -1.094 . . . . 0.34999999999999998 108.046 173.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.814 ' HA ' ' HA ' ' A' ' 164' ' ' TYR . 38.3 Cg_endo -65.14 49.89 0.2 Allowed 'Trans proline' 0 N--CA 1.479 0.67 1 C-N-CA 125.506 4.137 . . . . 0.62 115.406 -170.358 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.496 ' HB2' ' H ' ' A' ' 57' ' ' SER . 2.2 pm0 -139.34 -153.67 0.48 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.065 -0.717 . . . . 1.6799999999999999 109.065 165.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.496 ' H ' ' HB2' ' A' ' 56' ' ' GLU . 44.0 t -92.28 140.78 24.43 Favored Pre-proline 0 N--CA 1.422 -1.826 0 CA-C-O 122.006 0.908 . . . . 1.1799999999999999 111.141 -174.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.639 ' HB3' ' SG ' ' A' ' 155' ' ' CYS . 31.1 Cg_exo -57.36 -14.84 17.11 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 124.201 3.267 . . . . 0.52000000000000002 110.306 174.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.54 ' O ' ' HB2' ' A' ' 63' ' ' ASP . . . -69.55 -47.34 63.99 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.939 -1.028 . . . . 0.64000000000000001 111.134 174.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 1.001 ' HE3' ' HA ' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -66.54 -35.48 80.33 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.082 -1.081 . . . . 3.2999999999999998 108.082 178.263 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.971 HD23 HD13 ' A' ' 203' ' ' ILE . 37.1 mt -60.72 -55.44 33.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.87 -1.059 . . . . 0.40999999999999998 110.833 177.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.456 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 42.5 t -67.36 -10.27 49.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.68 0.276 . . . . 1.29 110.734 177.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.54 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -85.83 -45.72 11.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.475 -0.33 . . . . 1.3200000000000001 111.158 -178.631 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.479 ' CE2' ' HA ' ' A' ' 61' ' ' LEU . 11.3 p90 -77.78 -43.36 30.91 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.662 -0.245 . . . . 0.60999999999999999 111.574 -172.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.456 ' CD2' ' HA ' ' A' ' 62' ' ' SER . 1.0 OUTLIER -75.31 -8.94 58.01 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 122.187 -0.321 . . . . 1.5 111.484 -169.406 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.525 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 26.2 t80 -26.4 -56.7 0.08 Allowed 'General case' 0 N--CA 1.462 0.151 0 O-C-N 125.431 1.707 . . . . 1.52 114.11 -163.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.525 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 8.5 tt0 166.02 -38.62 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.595 0.712 . . . . 3.6000000000000001 110.861 -175.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.9 t -165.55 19.84 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.253 -0.885 . . . . 1.48 110.155 -164.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 70' ' ' ASP . . . -78.01 -34.68 37.11 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.252 -0.975 . . . . 1.46 111.702 -173.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.624 ' O ' HG22 ' A' ' 73' ' ' THR . 16.4 p-10 166.63 -17.7 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.12 -1.04 . . . . 2.1899999999999999 108.549 -167.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.858 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -45.57 -38.21 6.25 Favored 'General case' 0 C--O 1.209 -1.034 0 CA-C-N 115.324 -0.853 . . . . 3.3799999999999999 111.755 176.021 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.655 ' H ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -89.87 -7.47 10.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 120.383 -0.527 . . . . 0.70999999999999996 111.386 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.624 HG22 ' O ' ' A' ' 70' ' ' ASP . 0.8 OUTLIER -92.41 -27.77 17.28 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 120.395 -0.522 . . . . 0.96999999999999997 110.618 -173.352 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.808 ' HZ3' ' HB2' ' A' ' 198' ' ' ASN . 11.9 p-90 -112.79 -3.06 14.26 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.795 -0.362 . . . . 0.75 111.699 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.858 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 4.1 t70 -70.18 175.66 4.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 122.335 1.064 . . . . 2.1899999999999999 112.231 -172.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.863 ' HD2' ' HB3' ' A' ' 198' ' ' ASN . 0.0 OUTLIER -118.37 -12.8 9.84 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.8 -1.545 . . . . 3.1899999999999999 110.195 -174.166 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.555 ' HA ' ' HB2' ' A' ' 99' ' ' GLN . 0.1 OUTLIER -130.31 2.81 4.67 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.198 -0.91 . . . . 1.5800000000000001 109.921 178.094 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.774 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 62.1 mt -109.15 149.82 28.78 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.057 -0.52 . . . . 0.70999999999999996 110.834 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.593 ' HG2' ' HG2' ' A' ' 99' ' ' GLN . 15.0 mm100 -132.56 -59.02 0.92 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.465 -0.789 . . . . 1.73 111.288 -175.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.732 ' HB ' HD13 ' A' ' 97' ' ' ILE . 18.1 t -140.7 125.44 18.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.521 -0.763 . . . . 0.78000000000000003 110.633 -165.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -94.88 153.53 17.66 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.601 -0.727 . . . . 5.4000000000000004 110.44 174.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.501 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 1.2 m120 -152.82 109.37 3.42 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.718 -0.475 . . . . 1.6899999999999999 109.718 167.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.513 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 3.3 ttt -75.03 94.87 2.93 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.266 -1.013 . . . . 2.0499999999999998 108.266 178.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -74.66 -73.03 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-O 121.215 0.531 . . . . 0.64000000000000001 111.258 -166.683 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -136.34 120.6 17.91 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.783 -0.644 . . . . 1.96 109.592 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.837 ' HG2' ' HD2' ' A' ' 92' ' ' PHE . 38.6 mtm180 -97.15 123.19 40.84 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.453 -0.794 . . . . 2.4399999999999999 109.684 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.651 HG21 ' HB2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -82.37 -40.73 17.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.833 -0.621 . . . . 0.46999999999999997 109.819 -174.123 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -147.88 -161.92 1.44 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.384 -0.969 . . . . 1.8600000000000001 108.384 177.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.2 m -83.08 -7.78 59.61 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.739 0.304 . . . . 1.4399999999999999 110.81 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -137.65 15.99 2.91 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.26 0.553 . . . . 1.8700000000000001 110.258 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.716 HG23 ' HD2' ' A' ' 116' ' ' TYR . 0.7 OUTLIER -134.37 109.92 9.11 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 107.916 -1.142 . . . . 0.46000000000000002 107.916 -179.287 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.837 ' HD2' ' HG2' ' A' ' 86' ' ' ARG . 5.1 m-85 -132.14 178.9 6.44 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.316 0.579 . . . . 0.42999999999999999 110.797 -174.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.637 ' O ' HG23 ' A' ' 84' ' ' VAL . 19.3 mt -138.3 130.4 38.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 106.966 -1.494 . . . . 0.40999999999999998 106.966 169.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 48.0 t -116.0 122.13 44.32 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.621 -0.432 . . . . 2.0099999999999998 110.92 -172.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.572 ' HA ' HD13 ' A' ' 112' ' ' ILE . 10.5 t60 -85.95 83.98 7.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.862 0.839 . . . . 1.23 109.175 173.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.796 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 18.9 m -90.69 118.07 29.83 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.485 -1.234 . . . . 0.5 111.442 -176.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.732 HD13 ' HB ' ' A' ' 80' ' ' VAL . 3.5 mp -91.58 123.37 43.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.758 -0.831 . . . . 1.03 108.758 170.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 109' ' ' ARG . 15.2 t -110.29 171.41 7.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.061 -0.518 . . . . 1.3799999999999999 110.978 -174.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.593 ' HG2' ' HG2' ' A' ' 79' ' ' GLN . 4.7 mm100 . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 115.107 -0.951 . . . . 1.8200000000000001 111.897 -172.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 64.2 mt . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 121.2 0.524 . . . . 1.1200000000000001 110.964 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.508 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.3 p -100.66 176.33 1.96 Allowed Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.205 -0.907 . . . . 1.3500000000000001 109.965 177.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.508 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 87.9 Cg_exo -47.55 109.9 0.26 Allowed 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 122.306 2.004 . . . . 1.0700000000000001 111.135 174.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.617 ' HG3' HG23 ' A' ' 144' ' ' ILE . 18.4 ttm180 -111.06 151.69 27.77 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.168 -0.469 . . . . 3.4500000000000002 111.134 -167.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.867 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 6.5 t70 -99.28 134.06 42.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.761 -0.654 . . . . 1.3700000000000001 110.847 -176.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.796 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 17.8 m-85 -118.21 114.71 23.43 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.81 -0.632 . . . . 2.4100000000000001 110.143 173.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.572 HD13 ' HA ' ' A' ' 95' ' ' HIS . 26.2 mm -108.95 76.24 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.722 -0.844 . . . . 0.42999999999999999 108.722 170.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.764 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 1.6 m-20 -95.48 119.89 34.77 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.847 -0.615 . . . . 1.8600000000000001 110.306 -178.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.678 ' O ' ' HA ' ' A' ' 129' ' ' SER . 3.9 tp -75.36 121.79 22.79 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 108.672 -0.862 . . . . 0.28000000000000003 108.672 170.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -126.6 123.97 64.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-N 115.296 -0.865 . . . . 0.26000000000000001 111.732 -164.14 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.716 ' HD2' HG23 ' A' ' 91' ' ' THR . 24.1 t80 -105.95 111.91 24.75 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.786 -1.097 . . . . 2.5699999999999998 110.023 175.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.929 HG12 HG22 ' A' ' 127' ' ' ILE . 73.2 mt -92.9 99.15 9.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.039 -0.528 . . . . 0.89000000000000001 109.608 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.694 ' HB2' ' CE1' ' A' ' 116' ' ' TYR . 36.7 ttpt -124.35 138.17 54.4 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.989 -0.55 . . . . 1.2 110.546 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.479 ' O ' ' HD3' ' A' ' 119' ' ' ARG . 0.1 OUTLIER -116.09 111.95 21.03 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-O 122.117 0.961 . . . . 2.7999999999999998 109.697 177.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.61 ' HB2' ' HB3' ' A' ' 123' ' ' ASN . 18.2 m-85 -68.05 104.0 1.65 Allowed 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 105.523 -2.028 . . . . 0.82999999999999996 105.523 163.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.46 ' H ' ' HG2' ' A' ' 121' ' ' GLU . 4.1 pt-20 -53.17 98.29 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 122.262 1.029 . . . . 2.2799999999999998 113.023 -168.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 84.91 23.09 50.92 Favored Glycine 0 CA--C 1.504 -0.632 0 CA-C-N 113.483 -1.689 . . . . 0.76000000000000001 111.785 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.61 ' HB3' ' HB2' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -127.33 -50.74 1.41 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.63 -0.785 . . . . 1.6499999999999999 109.213 179.081 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.469 ' O ' ' HA ' ' A' ' 119' ' ' ARG . 0.9 OUTLIER -161.47 143.06 11.54 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.138 -0.483 . . . . 1.1200000000000001 111.282 -177.272 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -116.62 84.41 2.13 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.471 -0.937 . . . . 1.6200000000000001 108.471 169.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.624 ' CG1' HG12 ' A' ' 154' ' ' VAL . 0.7 OUTLIER -102.26 135.0 41.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 112.951 0.722 . . . . 0.29999999999999999 112.951 -172.141 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.929 HG22 HG12 ' A' ' 117' ' ' ILE . 31.7 pt -100.15 107.34 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.914 0.864 . . . . 0.58999999999999997 109.023 164.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.553 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 1.2 m -88.38 109.38 19.95 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.453 -0.794 . . . . 1.1799999999999999 110.638 -178.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.764 ' HB3' ' HB3' ' A' ' 113' ' ' ASP . 12.8 m -114.74 145.16 42.39 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.248 0.547 . . . . 1.24 111.733 -170.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.616 ' HE2' ' HG3' ' A' ' 150' ' ' PRO . 3.2 mtpm? -137.66 121.78 17.94 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 107.387 -1.338 . . . . 2.2599999999999998 107.387 174.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 78.9 p -64.04 98.4 0.21 Allowed 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.11 -1.441 . . . . 1.3899999999999999 107.11 175.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.485 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -109.03 140.21 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.836 0 N-CA-C 108.731 -0.84 . . . . 1.05 108.731 -165.488 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -102.68 86.89 2.85 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 122.459 1.124 . . . . 2.1699999999999999 109.245 -174.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.763 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 1.3 p90 -117.33 154.5 50.31 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 114.012 -1.449 . . . . 0.53000000000000003 111.526 -166.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 3.2 Cg_exo -42.09 -47.0 7.01 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 124.77 3.646 . . . . 1.28 115.883 -174.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.763 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 7.3 tp10 -65.64 -25.55 67.41 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 120.731 0.301 . . . . 3.5 110.749 -163.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.577 ' HB2' HG11 ' A' ' 84' ' ' VAL . 10.1 t80 -150.26 101.77 3.15 Favored Pre-proline 0 N--CA 1.441 -0.908 0 N-CA-C 113.237 0.829 . . . . 6.1200000000000001 113.237 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -88.94 134.4 2.63 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.261 2.641 . . . . 1.77 109.746 163.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.5 -171.92 0.41 Allowed 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.439 2.093 . . . . 1.25 112.424 -176.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 62.2 p -133.22 -179.7 5.66 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 109.356 -0.609 . . . . 1.6000000000000001 109.356 -172.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.2 m -86.21 11.38 12.12 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.125 0.488 . . . . 1.97 110.658 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -120.14 -44.74 2.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.781 -0.645 . . . . 2.1800000000000002 109.773 173.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.867 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 85.0 m-85 -94.28 109.71 21.51 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.193 -0.669 . . . . 1.23 109.193 175.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.617 HG23 ' HG3' ' A' ' 109' ' ' ARG . 1.0 OUTLIER -95.11 107.69 19.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.783 -0.644 . . . . 0.81999999999999995 110.177 -175.391 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 2.7 ttp180 -56.84 99.88 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.407 -0.815 . . . . 4.4199999999999999 109.803 175.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -66.23 128.87 31.25 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.097 -0.801 . . . . 0.79000000000000004 111.097 179.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.672 ' HB3' ' HB3' ' A' ' 174' ' ' GLU . 65.0 t80 -84.84 86.84 7.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.524 0.678 . . . . 4.4400000000000004 110.989 -175.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 53.1 t30 -82.06 116.18 21.53 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.153 -0.93 . . . . 1.6200000000000001 109.361 171.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.757 ' HB3' ' HB3' ' A' ' 172' ' ' GLN . 57.6 t-80 -58.19 154.72 29.43 Favored Pre-proline 0 C--O 1.217 -0.614 0 CA-C-O 118.142 -0.932 . . . . 2.3199999999999998 108.656 173.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.616 ' HG3' ' HE2' ' A' ' 130' ' ' LYS . 60.9 Cg_exo -37.74 78.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 123.916 3.077 . . . . 0.53000000000000003 112.618 169.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . 0.716 ' HB3' ' O ' ' A' ' 170' ' ' PHE . 72.7 m -135.1 149.49 50.06 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.973 -1.467 . . . . 1.5800000000000001 107.904 -176.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.596 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -138.76 -147.0 5.07 Favored Glycine 0 N--CA 1.432 -1.623 0 C-N-CA 119.051 -1.547 . . . . 0.42999999999999999 113.038 -170.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.663 ' HE1' HD21 ' A' ' 167' ' ' LEU . 7.5 t80 -160.74 82.72 0.66 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.915 -1.513 . . . . 0.59999999999999998 106.915 -167.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.693 HG23 HG13 ' A' ' 168' ' ' VAL . 4.1 m -93.27 140.98 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 CA-C-O 122.044 0.926 . . . . 0.31 110.597 -172.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . 0.639 ' SG ' ' HB3' ' A' ' 58' ' ' PRO . 1.6 t -117.09 126.44 52.84 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 114.731 -1.122 . . . . 1.55 109.077 177.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.723 ' HB3' ' HB3' ' A' ' 166' ' ' LYS . 11.2 t -120.48 121.16 29.38 Favored Pre-proline 0 C--N 1.31 -1.138 0 C-N-CA 120.146 -0.622 . . . . 1.0600000000000001 111.669 -172.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 67.8 Cg_exo -50.38 108.65 0.23 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.035 1.823 . . . . 0.56000000000000005 110.373 166.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.723 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 54.0 mmm -72.06 -165.74 0.19 Allowed 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.67 0.747 . . . . 1.1599999999999999 112.175 -174.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.434 ' H ' ' HB3' ' A' ' 158' ' ' MET . 27.1 mt-10 -67.25 -24.28 65.79 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.903 -1.044 . . . . 2.6299999999999999 110.177 177.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 163' ' ' ALA . 54.5 mm-40 -108.05 14.05 25.51 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.754 -0.657 . . . . 2.0499999999999998 110.085 177.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.652 ' HB3' ' CD ' ' A' ' 162' ' ' PRO . 47.0 t-20 29.25 -89.84 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 125.684 1.594 . . . . 1.9299999999999999 114.762 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.652 ' CD ' ' HB3' ' A' ' 161' ' ' ASN . 72.0 Cg_endo -74.42 -13.76 22.76 Favored 'Trans proline' 0 C--N 1.367 1.528 0 CA-C-N 121.854 1.698 . . . . 0.72999999999999998 113.093 -175.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.551 ' HB3' ' HB3' ' A' ' 160' ' ' GLU . . . -91.76 -29.94 16.52 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.864 -0.607 . . . . 0.68000000000000005 110.679 -177.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.814 ' HA ' ' HA ' ' A' ' 55' ' ' PRO . 85.3 m-85 -143.65 124.78 14.48 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.398 -0.593 . . . . 0.93000000000000005 109.398 176.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.438 ' OG ' HD12 ' A' ' 61' ' ' LEU . 21.4 t -112.87 145.52 40.54 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 119.905 -0.718 . . . . 1.4099999999999999 110.593 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.723 ' HB3' ' HB3' ' A' ' 156' ' ' SER . 2.5 tppp? -94.01 112.59 24.44 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.519 0.676 . . . . 0.73999999999999999 111.266 -176.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.663 HD21 ' HE1' ' A' ' 153' ' ' PHE . 0.6 OUTLIER -95.54 104.35 16.26 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.283 -0.871 . . . . 0.27000000000000002 109.37 173.905 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.721 HG12 ' HG3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -125.4 134.54 66.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.223 0.535 . . . . 0.28000000000000003 110.603 176.673 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.643 ' HB3' HG23 ' A' ' 50' ' ' VAL . 20.7 ttt -140.85 143.24 34.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.164 -0.471 . . . . 1.24 110.219 -169.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.716 ' O ' ' HB3' ' A' ' 151' ' ' CYS . 34.0 m-85 -120.42 139.13 53.28 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.057 -0.72 . . . . 3.3700000000000001 109.057 177.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.488 ' HB ' HD21 ' A' ' 192' ' ' LEU . 0.9 OUTLIER -143.42 125.62 12.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 O-C-N 123.492 0.495 . . . . 1.3999999999999999 111.286 178.551 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.757 ' HB3' ' HB3' ' A' ' 149' ' ' HIS . 20.3 tt0 -124.73 51.46 1.63 Allowed 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 107.158 -1.423 . . . . 2.1699999999999999 107.158 171.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 7.4 m -75.36 127.55 33.39 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.806 -1.543 . . . . 1.6499999999999999 110.542 -175.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.672 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 28.6 tt0 . . . . . 0 C--N 1.323 -0.566 0 CA-C-N 115.491 -0.777 . . . . 2.4500000000000002 111.554 -173.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.503 ' HA ' ' CE ' ' A' ' 186' ' ' LYS . 9.1 mm . . . . . 0 CA--C 1.502 -0.878 0 CA-C-O 122.802 1.287 . . . . 1.1200000000000001 108.401 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 1.024 ' HA ' HG22 ' A' ' 187' ' ' THR . 0.9 OUTLIER -79.93 -34.33 15.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 112.541 -2.118 . . . . 1.1299999999999999 109.924 -175.773 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -66.49 -18.6 65.45 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.935 -1.029 . . . . 2.8900000000000001 109.584 172.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.503 ' CE ' ' HA ' ' A' ' 183' ' ' ILE . 53.0 mtmt -93.0 -44.61 8.33 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.413 -0.812 . . . . 1.28 110.79 174.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 1.024 HG22 ' HA ' ' A' ' 184' ' ' ILE . 14.3 t -66.09 -43.0 88.55 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.612 0.597 . . . . 0.62 112.612 -170.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . 0.526 ' SD ' ' HB ' ' A' ' 173' ' ' THR . 29.1 mmt -73.68 -57.31 2.6 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 112.713 0.634 . . . . 1.0600000000000001 112.713 -172.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.617 ' O ' HG13 ' A' ' 193' ' ' VAL . 27.3 Cg_endo -62.18 -30.48 82.01 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 121.616 1.544 . . . . 0.91000000000000003 112.119 -177.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.2 t -75.99 -33.12 59.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.237 0.541 . . . . 1.5 109.824 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 187' ' ' THR . 63.9 t30 -73.0 -44.24 61.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.678 -0.692 . . . . 1.8799999999999999 111.274 -174.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.494 ' HB3' HG21 ' A' ' 50' ' ' VAL . 18.5 mt -65.23 -42.62 93.24 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.754 0.311 . . . . 1.0900000000000001 111.333 -175.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.617 HG13 ' O ' ' A' ' 189' ' ' PRO . 1.5 m -67.45 -31.89 54.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.908 0.861 . . . . 0.68000000000000005 109.354 178.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.433 ' HB3' ' HE3' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -70.08 -34.68 73.47 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.284 -1.325 . . . . 2.0699999999999998 110.997 177.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.634 ' HA ' ' ND2' ' A' ' 198' ' ' ASN . 3.3 m-85 -71.69 -24.53 61.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.24 0.543 . . . . 2.0 110.433 174.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.646 HG12 HD12 ' A' ' 167' ' ' LEU . 59.2 mt -82.08 -29.44 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-O 121.31 0.576 . . . . 0.31 110.511 172.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 44.6 mt -72.21 -42.6 65.57 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 116.16 -0.473 . . . . 1.03 110.736 177.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.863 ' HB3' ' HD2' ' A' ' 76' ' ' LYS . 5.9 p30 -59.55 -24.0 63.33 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 108.96 -0.755 . . . . 1.8999999999999999 108.96 171.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.678 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -80.94 -44.83 17.63 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 120.415 -0.514 . . . . 0.28999999999999998 110.222 176.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.47 ' HD3' HG12 ' A' ' 54' ' ' ILE . 22.5 mmtp -54.8 -42.89 72.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.02 -0.537 . . . . 0.96999999999999997 110.856 175.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . 0.542 ' O ' ' HD3' ' A' ' 204' ' ' LYS . 9.9 t70 -87.88 -46.26 9.56 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.007 -0.542 . . . . 1.9399999999999999 110.327 -178.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . 0.682 ' HA2' ' HB3' ' A' ' 205' ' ' ALA . . . -61.19 -25.9 65.22 Favored Glycine 0 C--O 1.224 -0.508 0 CA-C-N 115.849 -0.614 . . . . 0.46999999999999997 112.277 -178.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.971 HD13 HD23 ' A' ' 61' ' ' LEU . 3.0 tp -67.89 -43.07 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-O 119.27 -0.395 . . . . 0.60999999999999999 111.239 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.542 ' HD3' ' O ' ' A' ' 201' ' ' ASP . 0.0 OUTLIER -91.25 -13.54 32.56 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 118.732 0.696 . . . . 3.3700000000000001 109.228 176.532 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.682 ' HB3' ' HA2' ' A' ' 202' ' ' GLY . . . . . . . . 0 C--N 1.314 -0.95 0 N-CA-C 108.532 -0.914 . . . . 1.02 108.532 164.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.1 t70 . . . . . 0 CA--C 1.504 -0.826 0 N-CA-C 109.288 -0.634 . . . . 2.25 109.288 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.605 ' HA ' ' CD1' ' A' ' 6' ' ' ILE . 96.6 m-85 -65.65 -37.03 85.4 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.191 -0.913 . . . . 0.42999999999999999 109.186 -175.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.668 ' HG2' ' HG3' ' A' ' 8' ' ' GLN . 4.4 ttmt -81.75 2.94 27.62 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.121 -0.945 . . . . 1.51 110.476 -176.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -92.87 -49.42 6.06 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.359 0.599 . . . . 0.54000000000000004 109.485 173.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.605 ' CD1' ' HA ' ' A' ' 3' ' ' PHE . 0.3 OUTLIER -83.8 -37.68 13.42 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.606 0 CA-C-N 115.354 -0.839 . . . . 1.0700000000000001 110.181 -173.091 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.628 ' HA ' ' HB ' ' A' ' 10' ' ' THR . . . -71.5 -44.1 65.32 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.587 0.708 . . . . 0.34000000000000002 111.531 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.668 ' HG3' ' HG2' ' A' ' 4' ' ' LYS . 11.1 mt-30 -60.13 -32.83 71.38 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.917 -1.038 . . . . 1.5900000000000001 110.516 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.567 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 25.6 mm-40 -85.75 -32.06 22.06 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.221 -0.899 . . . . 2.4700000000000002 109.266 175.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.681 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.6 OUTLIER -62.26 -39.5 93.09 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.927 -1.033 . . . . 0.47999999999999998 111.042 176.513 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.418 ' HA ' ' CB ' ' A' ' 128' ' ' SER . . . -47.43 -63.04 1.15 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 121.148 0.499 . . . . 0.31 111.529 173.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -71.57 -13.0 61.65 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.851 -0.613 . . . . 1.6399999999999999 111.831 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 44.9 mm-40 -69.6 -58.12 4.34 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.764 0.792 . . . . 2.54 109.298 173.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.811 HG21 ' N ' ' A' ' 152' ' ' GLY . 5.3 p -68.01 -40.13 82.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 114.648 -1.16 . . . . 0.53000000000000003 109.717 -177.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.551 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -68.14 -22.83 64.84 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 114.787 -1.097 . . . . 0.59999999999999998 109.08 176.342 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.744 ' HA2' ' HD3' ' A' ' 19' ' ' ARG . . . -63.28 -25.34 68.29 Favored Glycine 0 CA--C 1.5 -0.847 0 CA-C-N 114.474 -1.239 . . . . 0.56999999999999995 110.444 177.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -88.83 -12.25 42.48 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.699 -0.852 . . . . 3.27 108.699 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -83.96 -9.27 58.81 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.321 -0.854 . . . . 2.0299999999999998 110.027 172.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.744 ' HD3' ' HA2' ' A' ' 16' ' ' GLY . 48.4 mtp180 -106.85 -23.89 12.23 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 116.183 -0.462 . . . . 2.7200000000000002 110.884 -172.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -150.88 170.77 18.5 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.038 -0.528 . . . . 2.1600000000000001 110.513 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.465 HG22 ' CZ2' ' A' ' 24' ' ' TRP . 75.1 p -133.51 134.02 42.91 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.57 -0.741 . . . . 1.8200000000000001 109.792 -175.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.4 t -139.25 107.5 5.78 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.263 0.468 . . . . 2.1899999999999999 112.263 -170.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.82 34.13 81.25 Favored Glycine 0 C--N 1.331 0.282 0 CA-C-N 115.528 -0.76 . . . . 1.1000000000000001 114.405 168.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.92 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -121.29 -166.31 1.34 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 117.183 0.491 . . . . 1.6699999999999999 110.273 175.141 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.61 140.38 0.6 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.392 -0.822 . . . . 2.9500000000000002 109.225 -175.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.691 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 0.1 OUTLIER -60.33 117.08 2.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.457 -0.792 . . . . 1.5600000000000001 110.378 174.01 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.9 p -92.05 -25.96 5.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 114.727 -1.124 . . . . 1.22 109.295 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.46 ' O ' HG22 ' A' ' 35' ' ' VAL . 3.0 tmmm? -161.24 146.63 14.01 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 119.264 -0.974 . . . . 2.4100000000000001 112.274 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.871 HG22 ' HA ' ' A' ' 34' ' ' THR . 42.9 p -143.67 152.27 41.12 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.798 -0.637 . . . . 1.3799999999999999 109.722 176.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.9 m -102.38 -90.01 0.36 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.523 -0.308 . . . . 2.3700000000000001 110.631 176.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.474 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 82.0 tttt -155.28 31.65 0.38 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.122 0.487 . . . . 4.5499999999999998 110.502 175.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.516 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 6.1 mmtm 178.9 -20.47 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.4 -0.818 . . . . 1.4199999999999999 110.039 179.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.477 HG22 ' HA3' ' A' ' 52' ' ' GLY . 31.0 pt -115.45 160.85 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.353 -0.839 . . . . 0.76000000000000001 110.701 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.871 ' HA ' HG22 ' A' ' 29' ' ' THR . 52.5 m -155.15 110.09 3.01 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.314 -0.857 . . . . 0.57999999999999996 110.697 -163.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.712 ' HA ' ' O ' ' A' ' 49' ' ' ARG . 6.0 m -103.12 117.83 49.15 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 CA-C-O 121.023 0.44 . . . . 0.85999999999999999 111.824 176.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.691 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 7.2 m -105.78 124.69 49.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.658 -0.701 . . . . 1.1000000000000001 109.655 175.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.8 p -110.75 133.85 52.98 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.759 -0.655 . . . . 1.27 111.868 -172.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.92 ' HB3' ' HB3' ' A' ' 24' ' ' TRP . 23.0 pttt . . . . . 0 C--N 1.32 -0.696 0 CA-C-N 115.546 -0.752 . . . . 1.9099999999999999 109.26 171.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 . . . . . 0 N--CA 1.451 -0.422 0 CA-C-O 121.531 0.681 . . . . 2.0499999999999998 111.212 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.614 HD23 ' N ' ' A' ' 48' ' ' TYR . 3.5 tt -99.97 146.18 27.0 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.724 -1.125 . . . . 0.87 108.673 -176.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.645 ' HB2' HD11 ' A' ' 192' ' ' LEU . 56.9 m-85 -124.99 138.39 54.23 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 121.261 -0.176 . . . . 0.98999999999999999 110.623 -177.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.712 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 4.3 ttm180 -104.65 120.0 40.29 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.093 -0.706 . . . . 2.9199999999999999 109.093 167.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.664 ' HB ' ' HB3' ' A' ' 192' ' ' LEU . 9.0 p -102.93 134.73 43.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.004 -1.11 . . . . 1.3300000000000001 108.004 172.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.654 ' HG3' ' HB ' ' A' ' 168' ' ' VAL . 2.7 tt0 -148.02 110.65 4.72 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.058 -0.519 . . . . 1.0700000000000001 110.579 -165.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 32' ' ' LYS . . . -142.61 154.34 25.13 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 111.111 -0.796 . . . . 0.28999999999999998 111.111 179.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.612 HG12 ' SD ' ' A' ' 158' ' ' MET . 2.7 mp -96.33 126.98 48.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 C-N-CA 119.256 -0.977 . . . . 0.57999999999999996 110.393 176.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.424 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 66.2 mt -104.57 112.77 65.41 Favored Pre-proline 0 N--CA 1.44 -0.959 0 CA-C-N 114.937 -1.029 . . . . 0.34999999999999998 109.33 177.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 28.8 Cg_exo -64.56 59.87 0.27 Allowed 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 124.259 3.306 . . . . 0.62 113.111 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.965 ' HG3' HG13 ' A' ' 203' ' ' ILE . 0.2 OUTLIER -134.37 -164.31 1.49 Allowed 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.041 -1.466 . . . . 1.6799999999999999 107.041 174.075 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.56 ' H ' ' CD ' ' A' ' 56' ' ' GLU . 20.0 m -101.73 150.5 37.38 Favored Pre-proline 0 N--CA 1.421 -1.889 0 N-CA-C 108.816 -0.809 . . . . 1.1799999999999999 108.816 169.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.528 ' HB3' ' SG ' ' A' ' 155' ' ' CYS . 14.9 Cg_exo -66.63 -7.72 18.92 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.605 2.87 . . . . 0.52000000000000002 110.2 -178.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.68 -53.09 17.06 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.803 -1.09 . . . . 0.64000000000000001 111.411 175.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.713 ' HE3' ' HB3' ' A' ' 64' ' ' PHE . 16.2 tptt -69.21 -28.29 66.24 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.254 -1.017 . . . . 3.2999999999999998 108.254 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.666 HD23 HD11 ' A' ' 203' ' ' ILE . 63.9 mt -62.45 -51.67 66.59 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.825 -1.08 . . . . 0.40999999999999998 110.008 174.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.571 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 39.3 t -75.35 -4.96 42.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.735 0.302 . . . . 1.29 110.571 176.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.5 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 31.3 t70 -90.63 -43.06 10.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.313 -0.403 . . . . 1.3200000000000001 110.829 178.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.795 ' O ' ' HB3' ' A' ' 71' ' ' ARG . 8.1 p90 -76.49 -44.97 33.02 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.903 -0.319 . . . . 0.60999999999999999 111.146 -175.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.665 HD22 ' O ' ' A' ' 61' ' ' LEU . 1.2 pt? -77.64 6.2 7.73 Favored 'General case' 0 CA--C 1.509 -0.604 0 O-C-N 122.277 -0.264 . . . . 1.5 111.227 -164.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -46.77 -14.53 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.961 0 O-C-N 124.326 1.016 . . . . 1.52 113.074 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.626 ' HA ' ' HD2' ' A' ' 71' ' ' ARG . 0.4 OUTLIER 87.68 -38.18 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 124.73 1.212 . . . . 3.6000000000000001 110.509 168.305 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.61 ' OG1' ' HB2' ' A' ' 81' ' ' TYR . 15.0 t -138.2 23.8 2.77 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.793 0.806 . . . . 1.48 110.811 -177.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -108.06 -61.29 0.55 Allowed Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 119.616 -1.278 . . . . 1.46 112.912 -177.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.689 ' O ' HG22 ' A' ' 73' ' ' THR . 18.9 t70 -134.05 -25.19 1.61 Allowed 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.881 0.848 . . . . 2.1899999999999999 110.009 -169.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.795 ' HB3' ' O ' ' A' ' 64' ' ' PHE . 0.3 OUTLIER -69.0 -37.22 78.57 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 114.724 -1.125 . . . . 3.3799999999999999 109.658 -163.385 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.101 HG22 HD13 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -76.11 -21.5 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 115.277 -0.874 . . . . 0.70999999999999996 110.066 -176.223 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.689 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.2 t -81.02 -26.22 36.59 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 119.972 -0.691 . . . . 0.96999999999999997 109.986 -172.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.712 ' CE2' ' HA ' ' A' ' 71' ' ' ARG . 24.8 p-90 -110.4 0.02 17.72 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.12 -0.491 . . . . 0.75 111.373 177.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.617 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 2.3 t70 -66.83 176.13 2.16 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.82 0.819 . . . . 2.1899999999999999 112.527 -170.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.46 ' HD3' ' N ' ' A' ' 77' ' ' SER . 0.0 OUTLIER -129.19 -17.3 3.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.555 -1.202 . . . . 3.1899999999999999 111.507 -174.636 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.46 ' N ' ' HD3' ' A' ' 76' ' ' LYS . 67.9 m -130.32 24.6 5.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.658 0.742 . . . . 1.5800000000000001 109.372 178.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.101 HD13 HG22 ' A' ' 72' ' ' ILE . 18.9 mt -116.01 -167.21 1.23 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.301 -0.863 . . . . 0.70999999999999996 112.293 177.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.471 ' HB3' HG23 ' A' ' 80' ' ' VAL . 1.9 mm100 -161.63 -74.79 0.05 Allowed 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.637 -0.71 . . . . 1.73 112.205 -167.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.471 HG23 ' HB3' ' A' ' 79' ' ' GLN . 23.0 t -139.4 122.09 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.917 0.389 . . . . 0.78000000000000003 111.764 -167.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.641 ' HB3' HD12 ' A' ' 72' ' ' ILE . 23.1 p90 -96.53 154.08 17.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.056 -0.52 . . . . 5.4000000000000004 112.009 176.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -162.08 111.29 1.48 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.46 -0.791 . . . . 1.6899999999999999 109.541 168.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 30.9 ttm -72.26 109.87 6.3 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.15 -1.056 . . . . 2.0499999999999998 108.15 174.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.525 HG23 ' HB ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -87.59 -88.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.893 0.377 . . . . 0.64000000000000001 111.34 -170.73 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.546 ' HB3' HD12 ' A' ' 93' ' ' ILE . 54.3 t60 -113.34 124.81 53.33 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.174 0.511 . . . . 1.96 110.137 -177.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.0 mtt180 -104.68 133.96 48.64 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.942 -0.762 . . . . 2.4399999999999999 108.942 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.52 HD12 ' CD2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -94.32 -39.38 10.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.685 0.755 . . . . 0.46999999999999997 109.171 -175.789 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.439 ' HB2' ' HE2' ' A' ' 4' ' ' LYS . 4.0 t0 -150.9 -169.79 3.48 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.609 -1.178 . . . . 1.8600000000000001 108.136 176.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.6 t -79.95 -3.57 48.78 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.74 0.305 . . . . 1.4399999999999999 110.707 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -136.46 17.57 3.14 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.395 0.617 . . . . 1.8700000000000001 109.758 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.722 HG23 ' HD2' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -138.42 108.37 6.34 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 108.662 -0.866 . . . . 0.46000000000000002 108.662 179.513 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.598 ' O ' HD12 ' A' ' 114' ' ' LEU . 30.7 m-85 -126.58 177.23 6.64 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.418 0.628 . . . . 0.42999999999999999 110.959 -173.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.546 HD12 ' HB3' ' A' ' 85' ' ' HIS . 28.4 mt -136.07 132.98 50.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 107.029 -1.471 . . . . 0.40999999999999998 107.029 167.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.425 ' SG ' ' HB2' ' A' ' 113' ' ' ASP . 7.7 p -115.36 127.39 55.37 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.177 0.513 . . . . 2.0099999999999998 111.927 -175.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.597 ' HD2' HD11 ' A' ' 112' ' ' ILE . 41.7 t-80 -89.51 91.32 8.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.721 -0.672 . . . . 1.23 109.192 169.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 86.7 m -110.34 109.17 19.49 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.399 -0.819 . . . . 0.5 111.592 -174.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.471 ' CG1' ' HB ' ' A' ' 80' ' ' VAL . 27.4 mm -77.85 120.07 27.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.699 -0.852 . . . . 1.03 108.699 171.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.4 t -110.77 153.96 24.6 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.14 0.495 . . . . 1.3799999999999999 109.942 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 . . . . . 0 C--N 1.308 -1.234 0 CA-C-N 115.81 -0.632 . . . . 1.8200000000000001 109.385 175.755 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.9 mt . . . . . 0 N--CA 1.445 -0.717 0 N-CA-C 110.152 -0.314 . . . . 1.1200000000000001 110.152 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.418 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 13.7 m -86.05 163.46 42.95 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 109.108 -0.701 . . . . 1.3500000000000001 109.108 176.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 107' ' ' SER . 9.3 Cg_endo -53.2 131.65 44.13 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.241 1.961 . . . . 1.0700000000000001 111.254 174.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.627 ' HG2' HG23 ' A' ' 144' ' ' ILE . 45.9 mtt180 -106.44 157.06 17.91 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.101 -0.703 . . . . 3.4500000000000002 109.101 -178.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.827 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 13.6 t0 -106.57 116.16 31.46 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.91 -0.774 . . . . 1.3700000000000001 108.91 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.621 ' HE1' ' HA3' ' A' ' 146' ' ' GLY . 3.3 m-30 -99.57 128.39 45.68 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.012 0.435 . . . . 2.4100000000000001 110.492 -177.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.787 HG13 ' HA ' ' A' ' 137' ' ' TYR . 27.3 mm -123.61 75.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 108.769 -0.826 . . . . 0.42999999999999999 108.769 173.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.918 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 20.8 m-20 -89.83 118.03 29.11 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.163 -0.926 . . . . 1.8600000000000001 109.786 -177.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.598 HD12 ' O ' ' A' ' 92' ' ' PHE . 3.8 tp -75.03 114.66 13.76 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 107.875 -1.157 . . . . 0.28000000000000003 107.875 166.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -118.77 122.16 68.72 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 CA-C-N 114.474 -1.239 . . . . 0.26000000000000001 111.121 -164.529 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.722 ' HD2' HG23 ' A' ' 91' ' ' THR . 29.1 t80 -106.32 111.11 23.56 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.656 -1.156 . . . . 2.5699999999999998 109.252 176.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.991 HG12 HG22 ' A' ' 127' ' ' ILE . 82.5 mt -87.81 98.12 7.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.953 0.882 . . . . 0.89000000000000001 109.27 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.634 ' HE2' ' HE1' ' A' ' 116' ' ' TYR . 16.2 tppt? -99.62 112.56 24.77 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.103 -1.408 . . . . 1.2 108.93 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.528 ' NH1' ' HG2' ' A' ' 121' ' ' GLU . 0.1 OUTLIER -106.13 108.86 20.58 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 122.108 0.956 . . . . 2.7999999999999998 108.526 177.039 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.556 ' CB ' ' HB2' ' A' ' 123' ' ' ASN . 91.0 m-85 -76.61 108.36 9.56 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 105.933 -1.877 . . . . 0.82999999999999996 105.933 167.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.528 ' HG2' ' NH1' ' A' ' 119' ' ' ARG . 44.7 mt-10 -40.21 93.35 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.879 1.362 . . . . 2.2799999999999998 112.84 -174.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 71.0 35.27 64.72 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 114.634 -1.166 . . . . 0.76000000000000001 112.497 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.556 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 13.3 m120 -133.32 -54.35 0.9 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.853 -0.673 . . . . 1.6499999999999999 110.032 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.496 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 2.8 mpp? -160.07 121.8 3.21 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.154 -0.476 . . . . 1.1200000000000001 110.655 -175.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -107.93 81.8 1.55 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.412 -0.958 . . . . 1.6200000000000001 108.412 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.58 ' CG1' HG12 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -99.81 137.93 25.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.239 -0.891 . . . . 0.29999999999999999 112.967 -170.709 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.991 HG22 HG12 ' A' ' 117' ' ' ILE . 41.2 pt -99.25 104.35 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 121.833 0.825 . . . . 0.58999999999999997 109.281 166.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 0.7 OUTLIER -87.04 109.26 19.28 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.429 -0.805 . . . . 1.1799999999999999 109.82 179.214 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.918 ' HB3' ' HB3' ' A' ' 113' ' ' ASP . 14.1 m -118.26 137.78 52.81 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.016 0.436 . . . . 1.24 112.132 -166.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.494 ' HE3' ' HB ' ' A' ' 6' ' ' ILE . 3.4 mtpm? -132.47 124.6 28.87 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 107.732 -1.21 . . . . 2.2599999999999998 107.732 178.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 15.6 p -64.37 99.82 0.32 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.924 -1.51 . . . . 1.3899999999999999 106.924 173.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.43 135.69 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 CA-C-O 121.504 0.669 . . . . 1.05 109.369 -164.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -87.41 81.38 7.85 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.841 -1.072 . . . . 2.1699999999999999 109.583 -171.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.754 ' CZ ' ' HB3' ' A' ' 136' ' ' GLU . 0.8 OUTLIER -121.96 176.26 2.1 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-N 115.092 -0.958 . . . . 0.53000000000000003 108.469 -176.548 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.536 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 50.3 Cg_exo -24.43 -64.49 0.04 OUTLIER 'Trans proline' 0 CA--C 1.551 1.353 1 C-N-CA 125.474 4.116 . . . . 1.28 117.329 -179.386 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.754 ' HB3' ' CZ ' ' A' ' 134' ' ' PHE . 6.2 tp10 -72.8 -30.69 64.27 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.466 0.543 . . . . 3.5 112.466 -174.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.787 ' HA ' HG13 ' A' ' 112' ' ' ILE . 32.1 t80 -51.17 -41.87 77.48 Favored Pre-proline 0 CA--C 1.552 1.056 0 N-CA-C 115.651 1.722 . . . . 6.1200000000000001 115.651 -170.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.465 ' HD2' ' O ' ' A' ' 135' ' ' PRO . 73.4 Cg_exo -45.86 108.43 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 122.515 2.143 . . . . 1.77 113.746 177.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 1.001 ' HB3' ' HD3' ' A' ' 145' ' ' ARG . 95.0 Cg_endo -99.97 -158.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.024 3.149 . . . . 1.25 114.053 -177.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.8 t -135.85 -155.09 0.61 Allowed 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.476 -1.305 . . . . 1.6000000000000001 107.476 177.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.2 m -90.47 -41.19 11.57 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.405 -0.518 . . . . 1.97 111.451 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -64.45 -53.36 49.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.759 0.314 . . . . 2.1800000000000002 110.538 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -95.48 108.94 21.2 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 108.923 -0.769 . . . . 1.23 108.923 175.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.627 HG23 ' HG2' ' A' ' 109' ' ' ARG . 1.2 tt -104.52 119.08 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 CA-C-N 115.056 -0.975 . . . . 0.81999999999999995 110.721 -173.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 1.001 ' HD3' ' HB3' ' A' ' 139' ' ' PRO . 1.3 mpt_? -63.41 99.31 0.2 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.264 -1.334 . . . . 4.4199999999999999 109.732 173.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.621 ' HA3' ' HE1' ' A' ' 111' ' ' PHE . . . -61.36 111.83 4.21 Favored Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 110.096 -1.202 . . . . 0.79000000000000004 110.096 176.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.628 ' HB3' ' HB3' ' A' ' 174' ' ' GLU . 39.5 t80 -84.47 84.65 7.58 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.832 0.825 . . . . 4.4400000000000004 110.441 -172.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.656 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 87.6 m-20 -72.82 99.57 2.68 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.485 -1.234 . . . . 1.6200000000000001 109.838 174.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.508 ' HB2' ' HG2' ' A' ' 172' ' ' GLN . 51.0 m-70 -60.89 137.23 93.62 Favored Pre-proline 0 CA--C 1.51 -0.582 0 N-CA-C 107.992 -1.114 . . . . 2.3199999999999998 107.992 172.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.681 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 32.3 Cg_exo -21.97 67.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.168 1 C-N-CA 126.79 4.994 . . . . 0.53000000000000003 115.796 -170.176 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . 0.723 ' HB2' ' O ' ' A' ' 170' ' ' PHE . 22.3 p -96.0 -175.11 3.3 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.155 -0.93 . . . . 1.5800000000000001 109.574 176.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.811 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -177.07 171.37 44.24 Favored Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 119.597 -1.287 . . . . 0.42999999999999999 111.942 -177.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.618 ' HB3' ' CG1' ' A' ' 127' ' ' ILE . 2.6 t80 -140.26 84.39 1.96 Allowed 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.002 -1.481 . . . . 0.59999999999999998 107.002 -159.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.636 ' CG2' HG13 ' A' ' 168' ' ' VAL . 2.9 m -93.16 143.36 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 121.988 0.899 . . . . 0.31 111.113 -170.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . 0.528 ' SG ' ' HB3' ' A' ' 58' ' ' PRO . 3.6 t -119.81 126.49 51.13 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.558 -1.201 . . . . 1.55 108.976 175.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.662 ' H ' ' HB3' ' A' ' 166' ' ' LYS . 5.5 m -119.02 112.18 36.55 Favored Pre-proline 0 C--N 1.318 -0.781 0 C-N-CA 119.234 -0.986 . . . . 1.0600000000000001 111.43 -173.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 57.1 Cg_exo -51.27 105.52 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 121.77 1.647 . . . . 0.56000000000000005 109.864 167.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.631 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 21.4 mtp -72.18 -171.23 0.72 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.548 0.69 . . . . 1.1599999999999999 112.532 -170.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -62.59 -20.16 64.45 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.047 -0.979 . . . . 2.6299999999999999 109.715 174.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.483 ' HB3' ' HB3' ' A' ' 163' ' ' ALA . 11.5 mm-40 -105.95 10.44 32.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.368 -0.833 . . . . 2.0499999999999998 110.251 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.464 ' CB ' ' CD ' ' A' ' 162' ' ' PRO . 44.1 m-80 27.32 -93.48 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.928 0 N-CA-C 115.13 1.53 . . . . 1.9299999999999999 115.13 -177.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.464 ' CD ' ' CB ' ' A' ' 161' ' ' ASN . 95.3 Cg_endo -76.04 -10.79 19.63 Favored 'Trans proline' 0 C--N 1.367 1.541 0 CA-C-N 121.864 1.701 . . . . 0.72999999999999998 112.942 -173.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' A' ' 160' ' ' GLU . . . -89.76 -34.85 16.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.983 -0.553 . . . . 0.68000000000000005 110.34 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.631 ' O ' ' HB2' ' A' ' 158' ' ' MET . 88.8 m-85 -140.35 118.94 12.3 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.375 -0.602 . . . . 0.93000000000000005 109.375 178.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.403 ' HB3' HD12 ' A' ' 61' ' ' LEU . 69.4 m -116.93 136.86 52.62 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.311 0.576 . . . . 1.4099999999999999 110.642 -178.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.736 ' HG3' HG12 ' A' ' 168' ' ' VAL . 41.1 tptt -80.34 128.53 33.66 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.645 -0.707 . . . . 0.73999999999999999 111.784 -174.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.702 HD12 HG12 ' A' ' 196' ' ' ILE . 0.3 OUTLIER -112.45 100.77 9.02 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.303 -0.862 . . . . 0.27000000000000002 110.575 165.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.736 HG12 ' HG3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -125.87 117.52 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 121.712 0.768 . . . . 0.28000000000000003 110.981 175.445 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.424 ' SD ' ' O ' ' A' ' 152' ' ' GLY . 5.5 tpt -128.67 135.75 49.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.391 -0.822 . . . . 1.24 110.176 -173.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.723 ' O ' ' HB2' ' A' ' 151' ' ' CYS . 41.1 m-85 -111.29 128.07 55.83 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.685 -0.688 . . . . 3.3700000000000001 109.311 -177.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 1.019 ' HB ' HD21 ' A' ' 192' ' ' LEU . 0.8 OUTLIER -110.41 121.04 62.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.361 0.601 . . . . 1.3999999999999999 110.535 -176.016 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.508 ' HG2' ' HB2' ' A' ' 149' ' ' HIS . 49.9 tt0 -129.8 49.54 2.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 122.482 1.134 . . . . 2.1699999999999999 108.417 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 22.0 m -77.31 140.24 39.97 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 113.772 -1.558 . . . . 1.6499999999999999 111.448 -173.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 15.0 tt0 . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 115.598 -0.728 . . . . 2.4500000000000002 111.699 -176.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 11.4 mm . . . . . 0 CA--C 1.509 -0.632 0 CA-C-O 122.386 1.088 . . . . 1.1200000000000001 109.144 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.935 ' HA ' HG22 ' A' ' 187' ' ' THR . 0.7 OUTLIER -66.68 -38.35 81.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 113.001 -1.909 . . . . 1.1299999999999999 111.106 -176.881 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -62.4 -21.47 65.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.872 -0.604 . . . . 2.8900000000000001 109.382 176.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -92.46 -41.56 10.23 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.317 -0.856 . . . . 1.28 110.419 175.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.935 HG22 ' HA ' ' A' ' 184' ' ' ILE . 13.6 t -63.08 -35.28 79.73 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.071 0.767 . . . . 0.62 113.071 -168.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . 0.785 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 30.9 mmt -77.72 -60.71 0.68 Allowed Pre-proline 0 C--N 1.33 -0.24 0 C-N-CA 120.266 -0.574 . . . . 1.0600000000000001 111.52 -177.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.785 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 36.9 Cg_exo -58.17 -37.87 93.65 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.925 1.75 . . . . 0.91000000000000003 112.399 -177.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 41.7 m -70.88 -32.45 69.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.789 0.328 . . . . 1.5 110.764 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -75.16 -43.02 54.74 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.911 -0.586 . . . . 1.8799999999999999 110.053 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 1.019 HD21 ' HB ' ' A' ' 171' ' ' VAL . 95.2 mt -52.97 -55.17 25.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.453 -0.794 . . . . 1.0900000000000001 112.264 176.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 189' ' ' PRO . 1.3 m -66.4 -31.57 54.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.668 0.747 . . . . 0.68000000000000005 109.648 -177.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 190' ' ' SER . 0.6 OUTLIER -69.68 -38.06 76.88 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.49 -1.232 . . . . 2.0699999999999998 111.202 179.028 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.532 ' HB3' ' HE2' ' A' ' 153' ' ' PHE . 3.1 m-30 -62.41 -32.89 73.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.021 0.439 . . . . 2.0 110.26 173.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.702 HG12 HD12 ' A' ' 167' ' ' LEU . 38.8 mt -79.44 -29.57 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-O 120.95 0.405 . . . . 0.31 111.065 177.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 51.9 mt -72.03 -37.52 69.71 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.037 0.446 . . . . 1.03 109.956 176.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.513 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 13.4 m120 -47.4 -50.55 22.29 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.841 -1.072 . . . . 1.8999999999999999 108.676 163.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.813 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -66.29 -46.3 77.48 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 115.057 -0.974 . . . . 0.28999999999999998 110.581 -174.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.702 ' O ' ' HG2' ' A' ' 204' ' ' LYS . 27.9 mmtp -53.69 -50.34 66.07 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 123.814 0.696 . . . . 0.96999999999999997 109.615 174.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -76.44 -38.98 54.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.372 -0.831 . . . . 1.9399999999999999 111.73 -169.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -68.78 -35.02 78.99 Favored Glycine 0 N--CA 1.463 0.447 0 C-N-CA 119.865 -1.16 . . . . 0.46999999999999997 110.486 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.965 HG13 ' HG3' ' A' ' 56' ' ' GLU . 1.1 mp -65.07 -35.75 76.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 114.186 -1.007 . . . . 0.60999999999999999 110.973 173.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.702 ' HG2' ' O ' ' A' ' 200' ' ' LYS . 52.7 mmtt -75.2 -39.34 60.23 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 108.81 -0.811 . . . . 3.3700000000000001 108.81 177.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.933 0 CA-C-N 115.18 -0.918 . . . . 1.02 109.099 173.16 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.657 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.2 m-20 . . . . . 0 CA--C 1.507 -0.69 0 N-CA-C 109.087 -0.709 . . . . 2.25 109.087 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.842 ' HA ' HD11 ' A' ' 6' ' ' ILE . 89.8 m-85 -67.68 -34.02 76.08 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.203 -0.908 . . . . 0.42999999999999999 109.096 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.572 ' HG2' ' OE1' ' A' ' 8' ' ' GLN . 21.9 tttp -78.92 -1.16 33.92 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 114.363 -1.289 . . . . 1.51 109.751 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -92.66 -43.85 8.88 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.295 0.569 . . . . 0.54000000000000004 110.209 172.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.842 HD11 ' HA ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -83.0 -37.24 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-N 115.519 -0.764 . . . . 1.0700000000000001 110.269 -172.614 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.417 ' HB2' HD21 ' A' ' 114' ' ' LEU . . . -80.69 -40.85 24.72 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.483 -1.235 . . . . 0.34000000000000002 111.535 -176.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.572 ' OE1' ' HG2' ' A' ' 4' ' ' LYS . 8.2 mt-30 -65.7 -29.6 70.17 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.2 -0.909 . . . . 1.5900000000000001 110.153 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.659 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 14.8 mm100 -82.74 -33.59 27.42 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.211 -0.904 . . . . 2.4700000000000002 109.208 175.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.658 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -70.92 -35.16 72.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.257 -0.883 . . . . 0.47999999999999998 111.423 -179.469 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 15' ' ' LEU . . . -43.87 -61.54 1.4 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.928 0.394 . . . . 0.31 112.038 172.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -74.73 -11.08 60.08 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.477 -0.329 . . . . 1.6399999999999999 111.728 -177.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.659 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 53.9 mt-10 -71.55 -56.01 6.72 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.069 -0.715 . . . . 2.54 109.069 172.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.752 HG21 ' N ' ' A' ' 152' ' ' GLY . 10.6 p -68.27 -38.21 79.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 122.838 1.304 . . . . 0.53000000000000003 109.721 -175.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.443 ' HB3' ' O ' ' A' ' 11' ' ' ALA . 0.5 OUTLIER -76.11 -18.88 58.97 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 113.791 -1.55 . . . . 0.59999999999999998 109.248 178.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.412 ' HA2' ' HD3' ' A' ' 19' ' ' ARG . . . -61.95 -27.93 69.5 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 114.144 -1.389 . . . . 0.56999999999999995 110.04 172.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.45 ' HD1' ' O ' ' A' ' 13' ' ' GLU . 24.4 m-85 -86.03 -15.91 39.86 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.16 -0.52 . . . . 3.27 110.055 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.412 ' OD1' HG11 ' A' ' 168' ' ' VAL . 42.7 t30 -85.99 -3.51 58.95 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 119.526 -0.87 . . . . 2.0299999999999998 110.051 172.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.412 ' HD3' ' HA2' ' A' ' 16' ' ' GLY . 35.2 mtp180 -105.62 -21.51 13.18 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.113 -0.367 . . . . 2.7200000000000002 111.486 -178.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -146.26 154.1 41.34 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.242 -0.435 . . . . 2.1600000000000001 111.018 174.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.488 ' HB ' ' CZ2' ' A' ' 24' ' ' TRP . 70.4 p -135.52 129.91 33.79 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.722 -0.672 . . . . 1.8200000000000001 111.229 -172.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.5 p -174.85 157.0 2.36 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.192 0.307 . . . . 2.1899999999999999 111.76 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.69 3.64 90.56 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.903 -0.59 . . . . 1.1000000000000001 113.774 170.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.488 ' CZ2' ' HB ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -120.58 -158.39 0.75 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 117.191 0.496 . . . . 1.6699999999999999 111.456 -176.511 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.37 119.88 0.32 Allowed 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 108.735 -0.839 . . . . 2.9500000000000002 108.735 -174.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.604 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 0.3 OUTLIER -55.16 121.71 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-O 122.06 0.933 . . . . 1.5600000000000001 111.389 174.64 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.13 -25.35 3.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 113.971 -1.468 . . . . 1.22 109.99 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 28' ' ' LYS . 9.4 tptm -142.98 121.93 12.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 119.75 -0.78 . . . . 2.4100000000000001 112.503 -173.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.535 HG22 ' HA ' ' A' ' 34' ' ' THR . 41.6 p -135.59 121.75 20.22 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.367 -0.605 . . . . 1.3799999999999999 109.367 172.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.2 t -85.14 -79.01 0.24 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 121.064 -0.254 . . . . 2.3700000000000001 110.415 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -164.08 19.37 0.06 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.479 0.657 . . . . 4.5499999999999998 109.832 176.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -173.54 3.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.662 -0.699 . . . . 1.4199999999999999 110.369 -175.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.476 ' CD1' ' HB ' ' A' ' 193' ' ' VAL . 28.9 pt -140.85 167.46 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-O 120.79 0.329 . . . . 0.76000000000000001 110.875 -171.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.535 ' HA ' HG22 ' A' ' 29' ' ' THR . 26.2 m -152.95 104.72 2.86 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.208 -0.451 . . . . 0.57999999999999996 111.19 -171.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.627 HG11 HD13 ' A' ' 192' ' ' LEU . 11.4 t -101.57 121.02 51.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.85999999999999999 110.086 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.604 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 5.6 m -113.02 128.55 56.53 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.187 -0.46 . . . . 1.1000000000000001 110.223 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.0 p -97.94 130.24 44.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.667 -0.697 . . . . 1.27 110.345 -176.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.407 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 57.9 tttm . . . . . 0 C--N 1.316 -0.87 0 CA-C-N 115.671 -0.695 . . . . 1.9099999999999999 111.243 -173.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 . . . . . 0 N--CA 1.447 -0.579 0 CA-C-O 121.362 0.601 . . . . 2.0499999999999998 111.355 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.656 HD12 ' HB2' ' A' ' 172' ' ' GLN . 10.0 tt -93.5 152.38 19.1 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.023 -0.989 . . . . 0.87 109.56 -176.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.551 ' N ' HD23 ' A' ' 47' ' ' LEU . 71.7 m-85 -127.78 134.17 49.48 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.65 0.262 . . . . 0.98999999999999999 110.745 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.532 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.8 OUTLIER -118.6 126.48 52.05 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 108.999 -0.741 . . . . 2.9199999999999999 108.999 175.915 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.589 HG23 HG22 ' A' ' 35' ' ' VAL . 14.8 p -114.75 150.03 16.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.725 -0.472 . . . . 1.3300000000000001 109.725 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.469 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 37.9 tt0 -155.38 109.84 2.92 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.987 -0.552 . . . . 1.0700000000000001 110.351 -170.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.474 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -138.83 160.43 25.7 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.615 -0.802 . . . . 0.28999999999999998 111.791 178.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.6 mt -100.89 114.92 41.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 C-N-CA 120.57 -0.452 . . . . 0.57999999999999996 110.786 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 40.1 mt -94.42 112.83 59.15 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.666 -0.697 . . . . 0.34999999999999998 109.431 175.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.34 70.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 124.566 3.511 . . . . 0.62 112.893 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.488 ' HG3' ' CG1' ' A' ' 203' ' ' ILE . 0.1 OUTLIER -155.06 -167.77 2.67 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.89 -1.05 . . . . 1.6799999999999999 108.555 177.089 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.3 t -101.41 146.77 32.77 Favored Pre-proline 0 N--CA 1.421 -1.884 0 N-CA-C 108.485 -0.932 . . . . 1.1799999999999999 108.485 174.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.577 ' HB3' ' SG ' ' A' ' 155' ' ' CYS . 24.6 Cg_exo -61.62 -12.7 26.0 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.486 2.791 . . . . 0.52000000000000002 110.442 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.08 -44.65 53.28 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.74 -1.118 . . . . 0.64000000000000001 111.325 176.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.512 ' HB3' HD11 ' A' ' 203' ' ' ILE . 6.5 tppt? -71.49 -31.94 67.68 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 108.293 -1.003 . . . . 3.2999999999999998 108.293 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.974 HD23 HD13 ' A' ' 203' ' ' ILE . 63.6 mt -62.15 -51.91 65.96 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.388 -1.278 . . . . 0.40999999999999998 110.429 175.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.8 m -64.7 -15.24 61.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.048 0.451 . . . . 1.29 110.613 173.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -84.73 -52.3 6.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.036 -0.529 . . . . 1.3200000000000001 111.795 -177.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.701 ' CE2' ' HA ' ' A' ' 199' ' ' ALA . 10.2 p90 -70.03 -40.63 75.05 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.727 0.269 . . . . 0.60999999999999999 111.727 -172.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.454 HD22 ' O ' ' A' ' 61' ' ' LEU . 0.6 OUTLIER -79.75 -21.35 44.58 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 120.357 -0.537 . . . . 1.5 112.054 -170.059 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.535 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 1.8 t80 -5.77 -71.77 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 O-C-N 125.214 1.571 . . . . 1.52 113.18 -156.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.535 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 4.8 tp60 175.93 -37.7 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.565 0.541 . . . . 3.6000000000000001 111.815 167.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.416 ' OG1' ' HB2' ' A' ' 81' ' ' TYR . 12.7 t -146.57 12.02 1.14 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.364 0.505 . . . . 1.48 112.364 -168.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -118.99 -5.26 11.92 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 119.122 -1.513 . . . . 1.46 113.887 -171.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.662 ' O ' HG22 ' A' ' 73' ' ' THR . 0.5 OUTLIER -170.96 -31.74 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.631 0 CA-C-O 121.415 0.626 . . . . 2.1899999999999999 109.844 -177.944 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.503 ' HG2' HD11 ' A' ' 78' ' ' LEU . 8.0 ttt180 -40.9 -50.09 3.23 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 125.461 1.504 . . . . 3.3799999999999999 111.086 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.791 HD13 ' H ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -91.15 -7.52 10.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.813 -1.085 . . . . 0.70999999999999996 111.241 -176.189 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.662 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER -84.79 -34.6 22.73 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 120.545 -0.462 . . . . 0.96999999999999997 110.298 -173.758 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.684 ' CZ3' ' HB2' ' A' ' 198' ' ' ASN . 20.8 p-90 -91.78 -42.38 10.14 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 120.056 -0.658 . . . . 0.75 109.314 174.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.7 t70 56.83 141.96 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.203 1.927 . . . . 2.1899999999999999 116.203 159.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.543 ' CG ' ' HB3' ' A' ' 198' ' ' ASN . 0.0 OUTLIER -139.29 -29.09 0.76 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.567 -0.742 . . . . 3.1899999999999999 111.989 163.733 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.539 ' N ' ' HD3' ' A' ' 76' ' ' LYS . 63.0 m -136.51 22.18 3.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.081 0.943 . . . . 1.5800000000000001 108.524 176.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.593 HD13 HG22 ' A' ' 72' ' ' ILE . 43.8 mt -110.01 -173.79 2.34 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.241 -1.345 . . . . 0.70999999999999996 110.163 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.61 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 3.4 mm100 -160.36 -66.18 0.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.925 0.343 . . . . 1.73 111.925 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.498 HG23 ' HB3' ' A' ' 79' ' ' GLN . 40.4 t -143.71 133.53 20.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.984 0.421 . . . . 0.78000000000000003 111.136 -167.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.446 ' HB3' HD12 ' A' ' 72' ' ' ILE . 20.3 p90 -100.49 145.17 28.61 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.643 -0.708 . . . . 5.4000000000000004 110.754 175.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.589 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 18.4 m120 -150.8 102.56 3.01 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.798 -0.816 . . . . 1.6899999999999999 108.798 170.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.52 107.36 2.45 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.638 -0.505 . . . . 2.0499999999999998 109.638 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.477 ' CG1' ' HG2' ' A' ' 136' ' ' GLU . 0.0 OUTLIER -84.36 -56.73 5.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.608 -0.723 . . . . 0.64000000000000001 110.948 -170.433 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -147.51 113.05 5.65 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.001 -0.545 . . . . 1.96 110.244 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -95.91 120.78 36.79 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.562 -0.903 . . . . 2.4399999999999999 108.562 176.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.617 HG12 ' O ' ' A' ' 91' ' ' THR . 1.2 mm -72.9 -53.35 18.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.976 -1.011 . . . . 0.46999999999999997 110.277 -168.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -140.23 -97.2 0.15 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.633 -0.712 . . . . 1.8600000000000001 111.492 176.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.6 t -137.98 -12.44 1.46 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.846 -0.161 . . . . 1.4399999999999999 111.041 -177.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -131.3 8.57 4.68 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.169 0.509 . . . . 1.8700000000000001 109.713 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.617 ' O ' HG12 ' A' ' 87' ' ' ILE . 9.0 m -139.6 118.15 12.22 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 107.591 -1.263 . . . . 0.46000000000000002 107.591 -172.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.619 ' O ' HD12 ' A' ' 114' ' ' LEU . 35.8 m-85 -132.92 174.99 9.75 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.243 0.544 . . . . 0.42999999999999999 110.854 -171.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.524 HD11 ' CE1' ' A' ' 3' ' ' PHE . 25.5 mt -133.97 123.5 44.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 107.255 -1.387 . . . . 0.40999999999999998 107.255 165.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.0 t -112.6 122.09 46.68 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.372 0.606 . . . . 2.0099999999999998 111.532 -176.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.589 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 31.2 t-80 -78.84 88.74 4.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.864 0.84 . . . . 1.23 108.84 168.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 19.1 m -97.37 114.17 25.93 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.514 -1.221 . . . . 0.5 111.183 -176.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.493 ' CG1' ' HB ' ' A' ' 80' ' ' VAL . 36.8 mm -76.98 124.72 35.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.909 -0.774 . . . . 1.03 108.909 173.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.1 m -111.19 133.22 53.71 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.011 -0.995 . . . . 1.3799999999999999 111.562 -170.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.61 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 30.6 mt-30 . . . . . 0 C--N 1.317 -0.823 0 N-CA-C 109.687 -0.486 . . . . 1.8200000000000001 109.687 172.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 16.3 mt . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 109.879 -0.415 . . . . 1.1200000000000001 109.879 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.437 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 15.5 m -99.43 169.21 8.43 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 109.867 -0.419 . . . . 1.3500000000000001 109.867 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 107' ' ' SER . 80.1 Cg_exo -46.54 128.18 12.42 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.201 1.934 . . . . 1.0700000000000001 111.108 172.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.636 ' HG3' HG23 ' A' ' 144' ' ' ILE . 33.3 ttp180 -116.81 162.43 17.72 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 120.993 0.425 . . . . 3.4500000000000002 110.068 -170.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.503 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 6.4 t70 -112.14 162.14 15.77 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.285 -1.006 . . . . 1.3700000000000001 108.285 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.457 ' CZ ' ' HB3' ' A' ' 113' ' ' ASP . 3.0 t80 -149.7 136.15 19.15 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.059 0.457 . . . . 2.4100000000000001 111.266 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.651 HG21 ' CE1' ' A' ' 134' ' ' PHE . 46.3 mm -122.75 89.86 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 N-CA-C 108.423 -0.955 . . . . 0.42999999999999999 108.423 172.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.457 ' HB3' ' CZ ' ' A' ' 111' ' ' PHE . 2.0 p30 -95.3 113.45 25.12 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.384 -0.825 . . . . 1.8600000000000001 110.685 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.619 HD12 ' O ' ' A' ' 92' ' ' PHE . 8.4 tp -76.43 121.16 22.66 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 119.19 -1.004 . . . . 0.28000000000000003 108.45 162.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -127.64 126.6 67.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-N 115.007 -0.997 . . . . 0.26000000000000001 111.949 -165.872 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.428 ' CD2' ' HA ' ' A' ' 8' ' ' GLN . 10.2 t80 -109.42 113.1 25.62 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.201 -0.909 . . . . 2.5699999999999998 110.42 174.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.592 HG12 HG22 ' A' ' 127' ' ' ILE . 80.4 mt -96.72 113.76 31.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.719 -0.673 . . . . 0.89000000000000001 109.734 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.552 ' HE3' ' CE1' ' A' ' 120' ' ' TYR . 37.8 ttpt -137.74 141.14 40.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.004 0.43 . . . . 1.2 110.398 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.548 ' HD3' ' O ' ' A' ' 119' ' ' ARG . 0.1 OUTLIER -113.57 113.7 25.45 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 121.956 0.884 . . . . 2.7999999999999998 109.012 177.31 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.552 ' CE1' ' HE3' ' A' ' 118' ' ' LYS . 3.5 m-85 -69.02 110.56 4.52 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.046 -1.465 . . . . 0.82999999999999996 107.046 168.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -35.85 94.53 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 O-C-N 124.769 1.293 . . . . 2.2799999999999998 113.141 -175.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 59.79 50.69 64.94 Favored Glycine 0 CA--C 1.504 -0.647 0 CA-C-N 114.63 -1.168 . . . . 0.76000000000000001 111.842 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.532 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 60.8 t30 -149.36 -53.12 0.16 Allowed 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.99 -0.605 . . . . 1.6499999999999999 110.061 -176.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 1.8 mpp? -158.73 119.67 3.34 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.864 0.364 . . . . 1.1200000000000001 111.701 -177.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -101.71 84.5 2.57 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.209 -1.034 . . . . 1.6200000000000001 108.209 176.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.536 ' CG1' HG12 ' A' ' 154' ' ' VAL . 0.5 OUTLIER -101.61 140.59 19.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 112.903 0.705 . . . . 0.29999999999999999 112.903 -170.426 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.658 ' O ' HG13 ' A' ' 127' ' ' ILE . 8.0 pt -108.96 112.16 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 108.675 -0.861 . . . . 0.58999999999999997 108.675 163.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.576 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 4.3 m -80.1 155.56 27.45 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.972 -0.751 . . . . 1.1799999999999999 108.972 175.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 80.8 p -149.82 131.63 15.08 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.61 0.719 . . . . 1.24 111.821 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.8 mtpp -132.63 122.77 25.2 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.628 -1.249 . . . . 2.2599999999999998 107.628 175.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.639 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 17.7 t -70.8 104.88 3.02 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 106.81 -1.552 . . . . 1.3899999999999999 106.81 175.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.0 m -102.9 152.59 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 C-N-CA 119.417 -0.913 . . . . 1.05 110.01 -174.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.662 ' HA ' ' CG ' ' A' ' 137' ' ' TYR . 8.4 p-10 -108.47 55.65 0.64 Allowed 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 123.204 1.478 . . . . 2.1699999999999999 109.872 -168.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.651 ' CE1' HG21 ' A' ' 112' ' ' ILE . 0.7 OUTLIER -91.57 178.33 1.81 Allowed Pre-proline 0 CA--C 1.553 1.086 0 CA-C-N 112.719 -2.037 . . . . 0.53000000000000003 109.083 -175.322 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.548 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 9.0 Cg_exo -32.19 -56.28 0.29 Allowed 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 124.654 3.57 . . . . 1.28 117.366 -176.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.608 ' HB3' ' CZ ' ' A' ' 134' ' ' PHE . 10.2 tp10 -74.18 -29.66 61.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.479 0.581 . . . . 3.5 112.389 -174.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.662 ' CG ' ' HA ' ' A' ' 133' ' ' ASP . 13.0 t80 -46.18 -42.24 26.76 Favored Pre-proline 0 CA--C 1.552 1.037 0 N-CA-C 116.1 1.889 . . . . 6.1200000000000001 116.1 -173.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.467 ' HD2' ' O ' ' A' ' 135' ' ' PRO . 73.4 Cg_exo -42.58 107.07 0.08 OUTLIER 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.251 1.967 . . . . 1.77 113.165 176.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -96.68 -159.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.544 2.83 . . . . 1.25 113.487 -174.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.7 m -143.94 -161.8 1.34 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.419 -0.956 . . . . 1.6000000000000001 108.419 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.2 m -82.86 -47.23 12.08 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.118 -0.633 . . . . 1.97 110.904 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -65.38 -23.31 66.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.311 -0.404 . . . . 2.1800000000000002 111.263 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.503 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 95.0 m-85 -132.16 108.12 9.07 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.361 -0.607 . . . . 1.23 109.361 177.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.636 HG23 ' HG3' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -104.07 116.69 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 109.019 -0.734 . . . . 0.81999999999999995 109.019 178.192 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.531 ' HD2' HG12 ' A' ' 112' ' ' ILE . 0.8 OUTLIER -59.58 98.72 0.05 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.382 -0.826 . . . . 4.4199999999999999 109.686 172.377 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -59.61 114.3 6.13 Favored Glycine 0 CA--C 1.504 -0.609 0 N-CA-C 111.107 -0.797 . . . . 0.79000000000000004 111.107 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -84.89 88.48 7.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.875 0.845 . . . . 4.4400000000000004 111.17 -169.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.549 ' H ' ' HB2' ' A' ' 131' ' ' SER . 66.7 t30 -84.31 123.97 30.74 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.645 -1.161 . . . . 1.6200000000000001 110.801 178.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.429 ' O ' ' N ' ' A' ' 151' ' ' CYS . 46.0 m80 -74.68 161.63 77.02 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 119.022 -0.513 . . . . 2.3199999999999998 109.882 176.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 149' ' ' HIS . 5.4 Cg_endo -48.06 76.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 124.514 3.476 . . . . 0.53000000000000003 114.651 -178.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . 0.707 ' SG ' ' HA ' ' A' ' 171' ' ' VAL . 14.3 p -129.53 -174.09 3.2 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.251 -1.018 . . . . 1.5800000000000001 108.251 171.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.752 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -167.79 -147.33 5.27 Favored Glycine 0 N--CA 1.436 -1.319 0 C-N-CA 118.542 -1.789 . . . . 0.42999999999999999 113.426 -173.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.579 ' CZ ' HD11 ' A' ' 167' ' ' LEU . 39.2 t80 -160.94 94.42 1.02 Allowed 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.76 -1.2 . . . . 0.59999999999999998 107.76 -162.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.686 ' CG2' HG13 ' A' ' 168' ' ' VAL . 3.4 m -105.76 148.98 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 CA-C-O 121.969 0.89 . . . . 0.31 111.307 -173.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . 0.577 ' SG ' ' HB3' ' A' ' 58' ' ' PRO . 12.1 t -117.44 137.72 52.32 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.911 -1.04 . . . . 1.55 108.597 173.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.495 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 12.6 m -129.61 116.57 18.37 Favored Pre-proline 0 C--N 1.31 -1.122 0 C-N-CA 120.394 -0.522 . . . . 1.0600000000000001 111.038 -177.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.532 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 55.8 Cg_exo -49.85 122.43 9.0 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.496 2.131 . . . . 0.56000000000000005 111.378 173.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.673 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 0.7 OUTLIER -80.43 -167.13 1.23 Allowed 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.055 0.455 . . . . 1.1599999999999999 112.079 -175.9 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -67.8 -26.53 66.13 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.565 -0.743 . . . . 2.6299999999999999 109.366 176.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 163' ' ' ALA . 34.4 mm-40 -97.62 13.76 29.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.246 -0.888 . . . . 2.0499999999999998 109.86 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.449 ' CB ' ' CD ' ' A' ' 162' ' ' PRO . 13.9 m120 25.78 -89.13 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 125.708 1.603 . . . . 1.9299999999999999 115.21 -177.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' A' ' 161' ' ' ASN . 84.1 Cg_endo -74.32 -10.49 22.41 Favored 'Trans proline' 0 C--N 1.366 1.448 0 CA-C-N 121.596 1.606 . . . . 0.72999999999999998 113.473 -174.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 160' ' ' GLU . . . -96.12 -34.51 11.67 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.536 -0.302 . . . . 0.68000000000000005 111.573 -177.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.673 ' O ' ' HB2' ' A' ' 158' ' ' MET . 81.9 m-85 -136.64 135.34 38.2 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.981 -0.377 . . . . 0.93000000000000005 109.981 178.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.401 ' HB2' HD11 ' A' ' 61' ' ' LEU . 57.4 m -126.09 143.77 50.99 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.35 0.595 . . . . 1.4099999999999999 111.618 -177.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 156' ' ' SER . 1.9 tppp? -91.64 107.96 19.57 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.38 -0.827 . . . . 0.73999999999999999 110.751 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.579 HD11 ' CZ ' ' A' ' 153' ' ' PHE . 0.5 OUTLIER -93.08 107.67 19.41 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.209 -0.905 . . . . 0.27000000000000002 109.309 175.224 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.686 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -131.77 129.4 61.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.865 0.841 . . . . 0.28000000000000003 111.753 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.569 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 11.3 ttt -140.91 151.34 44.17 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.009 -0.996 . . . . 1.24 108.98 -172.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.718 ' CE2' HG23 ' A' ' 14' ' ' VAL . 1.0 OUTLIER -144.83 152.39 40.22 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.88 -0.785 . . . . 3.3700000000000001 108.88 171.199 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.707 ' HA ' ' SG ' ' A' ' 151' ' ' CYS . 12.6 p -138.12 127.7 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 O-C-N 123.907 0.755 . . . . 1.3999999999999999 111.728 -172.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.656 ' HB2' HD12 ' A' ' 47' ' ' LEU . 24.2 tt0 -116.65 48.83 1.22 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.044 0.926 . . . . 2.1699999999999999 108.518 174.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 1.7 t -74.65 152.67 39.17 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.029 -0.987 . . . . 1.6499999999999999 111.024 -173.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 . . . . . 0 N--CA 1.441 -0.898 0 CA-C-N 115.191 -0.913 . . . . 2.4500000000000002 109.838 173.774 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.58 ' HA ' ' HE2' ' A' ' 186' ' ' LYS . 40.5 mm . . . . . 0 CA--C 1.51 -0.591 0 CA-C-O 122.508 1.147 . . . . 1.1200000000000001 109.301 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.99 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.5 mp -60.62 -35.57 64.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 112.678 -2.055 . . . . 1.1299999999999999 111.14 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -70.14 -17.23 63.19 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.583 -0.735 . . . . 2.8900000000000001 109.158 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.58 ' HE2' ' HA ' ' A' ' 183' ' ' ILE . 43.6 mtmt -92.11 -39.73 11.44 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.533 -0.758 . . . . 1.28 109.707 172.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.99 HG22 ' HA ' ' A' ' 184' ' ' ILE . 6.4 t -73.68 -36.63 65.33 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 119.645 -0.822 . . . . 0.62 112.538 -170.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . 0.579 ' O ' HD12 ' A' ' 192' ' ' LEU . 37.6 mmm -70.32 -56.76 6.44 Favored Pre-proline 0 C--O 1.226 -0.176 0 C-N-CA 120.272 -0.571 . . . . 1.0600000000000001 112.39 -175.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 188' ' ' MET . 18.9 Cg_endo -57.73 -18.76 35.17 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 122.232 1.955 . . . . 0.91000000000000003 112.392 -176.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.404 ' O ' HG22 ' A' ' 193' ' ' VAL . 33.9 t -86.24 -38.48 17.54 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.13 -0.693 . . . . 1.5 109.13 174.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -68.12 -42.71 79.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.324 -0.853 . . . . 1.8799999999999999 111.638 -172.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.627 HD13 HG11 ' A' ' 35' ' ' VAL . 1.1 mt -62.02 -48.99 77.81 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.572 0.701 . . . . 1.0900000000000001 110.959 -177.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.478 ' O ' ' HG ' ' A' ' 197' ' ' LEU . 1.3 m -67.67 -32.65 57.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.057 -0.974 . . . . 0.68000000000000005 109.672 -177.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -76.68 -29.11 56.19 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.529 -1.214 . . . . 2.0699999999999998 110.942 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.729 ' HA ' ' OD1' ' A' ' 198' ' ' ASN . 0.5 OUTLIER -66.38 -33.0 74.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.866 0.841 . . . . 2.0 109.475 171.071 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.676 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 22.6 mt -75.54 -27.86 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-N 115.707 -0.679 . . . . 0.31 110.799 173.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 53.1 mt -71.26 -42.42 68.81 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-N 116.651 -0.25 . . . . 1.03 111.365 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.729 ' OD1' ' HA ' ' A' ' 195' ' ' PHE . 1.4 p-10 -59.6 -23.75 63.23 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.155 -1.018 . . . . 1.8999999999999999 108.952 171.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.701 ' HA ' ' CE2' ' A' ' 64' ' ' PHE . . . -81.32 -46.14 15.15 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 119.975 -0.69 . . . . 0.28999999999999998 111.132 176.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.676 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 13.8 mmmm -55.22 -43.59 74.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.96999999999999997 110.251 177.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -92.1 -33.82 14.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.738 -0.664 . . . . 1.9399999999999999 112.013 -174.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -66.61 -29.1 74.21 Favored Glycine 0 N--CA 1.463 0.435 0 C-N-CA 120.784 -0.722 . . . . 0.46999999999999997 111.377 176.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.974 HD13 HD23 ' A' ' 61' ' ' LEU . 3.2 tp -71.34 -28.67 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 109.44 -0.578 . . . . 0.60999999999999999 109.44 176.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.612 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 79.1 mttt -79.07 -40.8 30.31 Favored 'General case' 0 C--O 1.209 -1.074 0 N-CA-C 107.861 -1.163 . . . . 3.3700000000000001 107.861 174.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.042 0 CA-C-N 115.415 -0.811 . . . . 1.02 109.9 172.417 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 5' ' ' ALA . 15.3 t70 . . . . . 0 CA--C 1.51 -0.577 0 CA-C-O 121.758 0.789 . . . . 2.25 108.96 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.652 ' HA ' HD11 ' A' ' 6' ' ' ILE . 95.5 m-85 -71.82 -25.47 62.0 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.015 -0.993 . . . . 0.42999999999999999 108.402 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.544 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 11.6 tptm -67.05 -9.44 39.21 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 114.716 -1.129 . . . . 1.51 109.669 175.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 2' ' ' ASP . . . -90.86 -49.98 6.14 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 115.823 -0.626 . . . . 0.54000000000000004 109.658 175.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.652 HD11 ' HA ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -83.19 -34.54 11.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.453 0.644 . . . . 1.0700000000000001 110.984 -170.834 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.698 ' HB2' HD21 ' A' ' 114' ' ' LEU . . . -79.13 -39.48 33.48 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.136 -0.938 . . . . 0.34000000000000002 111.269 -176.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.544 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 5.6 mt-30 -67.6 -24.75 65.52 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.147 -1.388 . . . . 1.5900000000000001 110.192 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.58 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 55.7 mt-30 -83.85 -50.56 7.97 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.099 -0.955 . . . . 2.4700000000000002 108.827 170.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.62 ' HB ' ' HA ' ' A' ' 7' ' ' ALA . 0.8 OUTLIER -46.01 -44.92 15.54 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.029 0.932 . . . . 0.47999999999999998 112.656 175.276 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.481 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -50.87 -55.99 14.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.063 0.459 . . . . 0.31 111.748 175.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -76.18 -5.99 49.3 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.088 -0.506 . . . . 1.6399999999999999 111.586 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 39.3 mm-40 -81.13 -52.39 7.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.26 0.552 . . . . 2.54 109.553 172.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.877 HG23 ' CE2' ' A' ' 170' ' ' PHE . 6.4 p -68.37 -38.72 79.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.366 -0.834 . . . . 0.53000000000000003 110.631 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.97 -22.36 65.92 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.178 -0.919 . . . . 0.59999999999999998 108.805 173.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.554 ' HA2' ' NE ' ' A' ' 19' ' ' ARG . . . -64.05 -22.69 67.1 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 114.033 -1.44 . . . . 0.56999999999999995 110.18 176.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.468 ' HA ' ' HB3' ' A' ' 20' ' ' ASP . 5.9 m-85 -90.34 -16.79 28.51 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.41 -0.589 . . . . 3.27 109.41 177.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.477 ' HB2' ' NH2' ' A' ' 49' ' ' ARG . 2.4 t-20 -76.51 -14.37 60.03 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.488 0.661 . . . . 2.0299999999999998 109.937 176.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.554 ' NE ' ' HA2' ' A' ' 16' ' ' GLY . 10.9 ptt180 -113.49 8.95 17.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.467 -0.788 . . . . 2.7200000000000002 109.668 174.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.468 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 25.5 t70 -112.83 92.82 4.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.198 -0.91 . . . . 2.1600000000000001 109.502 175.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.478 HG22 ' CH2' ' A' ' 24' ' ' TRP . 24.0 p -131.36 88.82 2.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.236 0.541 . . . . 1.8200000000000001 111.539 -176.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -177.45 -50.42 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.569 -0.741 . . . . 2.1899999999999999 111.18 -178.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.87 -9.7 79.72 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 121.235 -0.507 . . . . 1.1000000000000001 112.99 -174.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.529 ' CB ' ' HG2' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -76.93 -160.88 0.17 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.177 0.513 . . . . 1.6699999999999999 111.426 177.209 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -171.7 114.62 0.36 Allowed 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 109.028 -0.731 . . . . 2.9500000000000002 109.028 -175.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.588 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 1.7 m -64.82 128.02 26.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.963 0.887 . . . . 1.5600000000000001 111.987 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.9 m -118.79 -24.32 3.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 113.845 -1.525 . . . . 1.22 110.46 -178.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.459 ' HA ' ' HD2' ' A' ' 28' ' ' LYS . 15.5 tptp -145.96 129.55 17.0 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.037 -0.665 . . . . 2.4100000000000001 111.518 -174.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.691 HG22 ' HA ' ' A' ' 34' ' ' THR . 24.1 p -146.06 152.78 39.88 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.21 -0.45 . . . . 1.3799999999999999 110.527 178.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.2 t -106.6 -102.45 0.34 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.097 -0.705 . . . . 2.3700000000000001 109.097 171.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -142.25 18.02 2.07 Favored 'General case' 0 N--CA 1.463 0.208 0 O-C-N 122.064 -0.398 . . . . 4.5499999999999998 111.377 175.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -169.4 8.27 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.271 0.558 . . . . 1.4199999999999999 110.07 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.655 HG22 ' HA3' ' A' ' 52' ' ' GLY . 12.7 pt -142.92 160.88 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 115.382 -0.827 . . . . 0.76000000000000001 109.891 -176.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.691 ' HA ' HG22 ' A' ' 29' ' ' THR . 93.1 m -158.18 111.25 2.4 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 111.793 0.294 . . . . 0.57999999999999996 111.793 -164.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.588 ' CG2' HG13 ' A' ' 193' ' ' VAL . 5.0 t -98.56 117.71 43.97 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 N-CA-C 109.379 -0.601 . . . . 0.85999999999999999 109.379 177.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -118.81 125.25 49.14 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 116.11 -0.495 . . . . 1.1000000000000001 110.218 -176.637 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 73.4 p -101.17 143.26 31.48 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.398 0.618 . . . . 1.27 112.169 -172.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.529 ' HG2' ' CB ' ' A' ' 24' ' ' TRP . 15.5 mtmt . . . . . 0 C--N 1.317 -0.825 0 CA-C-N 114.996 -1.002 . . . . 1.9099999999999999 108.413 172.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 . . . . . 0 N--CA 1.451 -0.401 0 CA-C-O 121.564 0.697 . . . . 2.0499999999999998 110.896 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.565 ' O ' ' HA ' ' A' ' 37' ' ' SER . 10.0 tt -86.52 147.72 25.84 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.821 -1.082 . . . . 0.87 109.254 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.455 ' N ' HD23 ' A' ' 47' ' ' LEU . 92.9 m-85 -123.21 119.59 30.67 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.839 -0.344 . . . . 0.98999999999999999 111.109 -175.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.783 ' CD ' ' HB3' ' A' ' 170' ' ' PHE . 21.8 tpt180 -110.73 117.65 34.04 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.309 -0.626 . . . . 2.9199999999999999 109.309 173.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 35' ' ' VAL . 12.5 p -103.94 150.61 7.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.75 0.31 . . . . 1.3300000000000001 110.259 -179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.561 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 35.2 tt0 -153.41 122.06 6.35 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.785 -0.643 . . . . 1.0700000000000001 110.764 -172.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.655 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -156.13 161.7 30.93 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.198 -0.761 . . . . 0.28999999999999998 111.198 175.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 70.3 mt -98.11 130.39 46.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 117.345 0.572 . . . . 0.57999999999999996 111.229 -178.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 61.9 mt -107.8 116.9 56.61 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.355 -0.839 . . . . 0.34999999999999998 109.789 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -63.56 61.51 0.2 Allowed 'Trans proline' 0 N--CA 1.476 0.457 0 C-N-CA 124.172 3.248 . . . . 0.62 113.787 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.573 ' HG3' ' H ' ' A' ' 57' ' ' SER . 6.5 tp10 -152.29 -171.33 3.9 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.796 -0.816 . . . . 1.6799999999999999 108.796 174.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.573 ' H ' ' HG3' ' A' ' 56' ' ' GLU . 73.9 p -89.76 146.42 35.41 Favored Pre-proline 0 N--CA 1.427 -1.62 0 CA-C-O 121.546 0.689 . . . . 1.1799999999999999 110.517 176.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.558 ' HB3' ' SG ' ' A' ' 155' ' ' CYS . 37.2 Cg_exo -60.71 -11.19 16.45 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 124.102 3.201 . . . . 0.52000000000000002 111.098 176.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.75 -51.52 10.4 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 114.752 -1.113 . . . . 0.64000000000000001 110.919 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.531 ' HB3' HD11 ' A' ' 203' ' ' ILE . 3.6 tppt? -66.15 -30.3 70.75 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.283 -1.006 . . . . 3.2999999999999998 108.283 -178.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.034 HD23 HD13 ' A' ' 203' ' ' ILE . 48.6 mt -60.67 -58.62 7.68 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.468 -1.242 . . . . 0.40999999999999998 110.428 174.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.437 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 7.7 p -66.57 -6.55 15.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.866 0.365 . . . . 1.29 111.104 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -86.88 -41.38 14.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.402 -0.363 . . . . 1.3200000000000001 111.896 176.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.576 ' O ' ' HB3' ' A' ' 71' ' ' ARG . 6.1 p90 -77.4 -41.28 40.59 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.47 -0.492 . . . . 0.60999999999999999 110.844 -172.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.542 HD13 ' CD1' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -84.74 7.77 19.43 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 110.342 -0.244 . . . . 1.5 110.342 -171.546 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.467 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 41.1 t80 -55.99 0.6 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.878 0 O-C-N 124.216 0.948 . . . . 1.52 112.936 -173.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 15.8 mm100 82.13 -28.13 0.12 Allowed 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 124.315 1.046 . . . . 3.6000000000000001 110.822 171.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.8 t -125.34 22.07 7.83 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.457 -1.312 . . . . 1.48 107.457 171.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.1 3.96 84.5 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 113.864 -1.516 . . . . 1.46 111.805 -176.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.708 ' O ' HG22 ' A' ' 73' ' ' THR . 12.0 t70 92.6 2.8 0.08 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 122.582 1.182 . . . . 2.1899999999999999 108.333 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.829 ' HA ' ' CE2' ' A' ' 74' ' ' TRP . 5.6 ptm180 -54.34 -40.27 67.87 Favored 'General case' 0 C--O 1.209 -1.057 0 CA-C-N 113.535 -1.666 . . . . 3.3799999999999999 110.088 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.796 HD13 ' H ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -65.61 -26.02 38.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.646 -1.161 . . . . 0.70999999999999996 110.792 -175.3 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.708 HG22 ' O ' ' A' ' 70' ' ' ASP . 0.9 OUTLIER -81.66 -31.25 32.39 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.491 -0.777 . . . . 0.96999999999999997 109.986 -174.386 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.829 ' CE2' ' HA ' ' A' ' 71' ' ' ARG . 27.6 p-90 -111.57 0.82 16.55 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.283 -0.567 . . . . 0.75 111.396 -177.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.699 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 5.3 t70 -68.25 175.62 3.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.512 0.673 . . . . 2.1899999999999999 111.723 -175.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.492 ' HG2' ' OD1' ' A' ' 198' ' ' ASN . 28.9 mmmt -95.96 -40.65 9.17 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.563 -0.744 . . . . 3.1899999999999999 109.832 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.8 t -119.72 16.14 12.73 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.439 -0.8 . . . . 1.5800000000000001 111.356 -171.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.638 HD13 HG22 ' A' ' 72' ' ' ILE . 56.1 mt -110.91 -179.32 3.71 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.537 -0.465 . . . . 0.70999999999999996 111.924 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.603 ' HG2' ' HG2' ' A' ' 99' ' ' GLN . 12.0 mm-40 -154.94 -61.59 0.12 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.519 -0.764 . . . . 1.73 111.219 -175.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 96' ' ' THR . 30.6 t -142.46 127.74 16.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.377 -0.374 . . . . 0.78000000000000003 110.648 -166.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.746 ' HB3' HD12 ' A' ' 72' ' ' ILE . 42.8 p90 -95.41 146.62 24.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.611 0.243 . . . . 5.4000000000000004 110.639 176.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.509 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 58.4 m-80 -153.45 107.18 3.02 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.548 -0.538 . . . . 1.6899999999999999 109.548 176.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.03 96.61 3.84 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.259 -0.645 . . . . 2.0499999999999998 109.259 177.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -73.12 -62.78 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.352 0.596 . . . . 0.64000000000000001 110.805 -169.358 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.445 ' HB3' HD12 ' A' ' 93' ' ' ILE . 15.5 t60 -133.97 113.96 12.73 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.275 -0.875 . . . . 1.96 108.824 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.2 mtt180 -98.28 103.74 15.71 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.971 -0.751 . . . . 2.4399999999999999 108.971 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.591 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -72.23 -46.2 58.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.456 -0.793 . . . . 0.46999999999999997 110.989 -171.551 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -141.92 -163.75 1.65 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.87 -0.789 . . . . 1.8600000000000001 108.87 -173.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.4 m -81.18 -14.8 57.21 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.844 0.354 . . . . 1.4399999999999999 110.3 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -131.82 14.81 4.83 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 110.078 -0.342 . . . . 1.8700000000000001 110.078 -175.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.591 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.4 OUTLIER -134.11 110.95 9.95 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 108.682 -0.858 . . . . 0.46000000000000002 108.682 -175.097 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.534 ' O ' HD12 ' A' ' 114' ' ' LEU . 21.7 m-85 -130.24 169.34 15.52 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.953 -0.567 . . . . 0.42999999999999999 110.391 -173.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.65 ' O ' HG23 ' A' ' 84' ' ' VAL . 28.4 mt -135.06 123.89 41.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 107.43 -1.322 . . . . 0.40999999999999998 107.43 169.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 65.2 m -110.27 125.44 53.12 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.636 -0.425 . . . . 2.0099999999999998 111.315 -175.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.631 ' HA ' HD13 ' A' ' 112' ' ' ILE . 22.2 t60 -90.91 87.65 6.72 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 122.134 0.969 . . . . 1.23 108.702 168.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 89.6 m -102.56 130.77 49.51 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.275 -1.329 . . . . 0.5 109.926 -177.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.406 ' O ' ' HB2' ' A' ' 79' ' ' GLN . 47.1 mm -80.99 128.82 38.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 C-N-CA 119.671 -0.811 . . . . 1.03 108.891 172.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.601 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 1.5 m -102.28 143.95 31.41 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.969 -0.559 . . . . 1.3799999999999999 110.255 -176.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.603 ' HG2' ' HG2' ' A' ' 79' ' ' GLN . 5.5 mm-40 . . . . . 0 C--N 1.323 -0.58 0 CA-C-N 115.948 -0.569 . . . . 1.8200000000000001 110.804 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 60.4 mt . . . . . 0 N--CA 1.45 -0.447 0 N-CA-C 109.523 -0.547 . . . . 1.1200000000000001 109.523 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 48.4 m -84.91 152.9 59.95 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 110.083 -0.34 . . . . 1.3500000000000001 110.083 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.94 130.98 36.78 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.768 2.312 . . . . 1.0700000000000001 111.048 177.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 144' ' ' ILE . 12.2 ttp180 -109.73 154.92 22.23 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.285 -0.566 . . . . 3.4500000000000002 111.046 -167.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.46 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 5.1 t0 -95.33 140.82 29.67 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.658 -0.867 . . . . 1.3700000000000001 108.658 174.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.661 ' CE1' ' HB2' ' A' ' 113' ' ' ASP . 13.4 t80 -123.76 108.74 12.85 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.664 -0.865 . . . . 2.4100000000000001 108.664 -179.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.699 HG21 ' CE1' ' A' ' 134' ' ' PHE . 12.6 mm -124.1 74.78 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 107.933 -1.136 . . . . 0.42999999999999999 107.933 173.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.661 ' HB2' ' CE1' ' A' ' 111' ' ' PHE . 1.0 OUTLIER -102.48 124.18 47.58 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.587 -0.733 . . . . 1.8600000000000001 110.094 -176.39 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.698 HD21 ' HB2' ' A' ' 7' ' ' ALA . 10.6 tp -76.98 121.97 24.23 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 115.265 -0.88 . . . . 0.28000000000000003 109.364 174.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -122.82 123.95 69.36 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 CA-C-N 114.157 -1.383 . . . . 0.26000000000000001 111.503 -166.561 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.555 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 53.8 t80 -117.22 125.4 51.09 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.647 -0.706 . . . . 2.5699999999999998 110.571 175.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' A' ' 126' ' ' ILE . 91.8 mt -96.96 99.24 8.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.484 -0.78 . . . . 0.89000000000000001 110.54 -177.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -101.86 135.1 44.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.11 -0.95 . . . . 1.2 108.867 178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.521 ' HD3' ' O ' ' A' ' 119' ' ' ARG . 0.1 OUTLIER -124.19 110.6 14.87 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 121.903 0.859 . . . . 2.7999999999999998 108.907 176.368 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.571 ' CB ' ' HB3' ' A' ' 123' ' ' ASN . 59.3 m-85 -77.88 116.83 18.68 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.064 -1.088 . . . . 0.82999999999999996 108.064 171.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.52 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 1.6 mp0 -28.7 93.72 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 O-C-N 125.086 1.491 . . . . 2.2799999999999998 113.321 178.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 56.29 36.86 70.69 Favored Glycine 0 CA--C 1.507 -0.451 0 CA-C-N 115.117 -0.947 . . . . 0.76000000000000001 112.312 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.571 ' HB3' ' CB ' ' A' ' 120' ' ' TYR . 59.2 t30 -128.83 -53.4 1.23 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.971 -0.614 . . . . 1.6499999999999999 109.694 -176.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.54 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 0.4 OUTLIER -157.14 125.36 5.57 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.112 -0.495 . . . . 1.1200000000000001 110.986 -179.069 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -107.75 82.59 1.67 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.248 -1.019 . . . . 1.6200000000000001 108.248 175.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.499 ' CG1' HG12 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -100.93 139.37 22.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.892 -0.595 . . . . 0.29999999999999999 112.421 -171.74 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -107.4 119.45 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 107.358 -1.349 . . . . 0.58999999999999997 107.358 159.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 30.3 p -82.88 167.3 18.18 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.037 -0.727 . . . . 1.1799999999999999 109.037 174.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.425 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 67.7 p -158.48 120.01 3.49 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.9 0.381 . . . . 1.24 110.231 -178.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.617 ' CE ' HD23 ' A' ' 114' ' ' LEU . 3.1 ttpm? -131.95 115.01 15.32 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 108.128 -1.064 . . . . 2.2599999999999998 108.128 -176.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.403 ' CB ' ' H ' ' A' ' 148' ' ' ASN . 96.9 p -61.78 100.14 0.14 Allowed 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 107.698 -1.223 . . . . 1.3899999999999999 107.698 -177.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.464 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -107.77 138.23 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.115 0 CA-C-N 115.163 -0.926 . . . . 1.05 108.847 -165.351 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -99.76 64.32 1.26 Allowed 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 122.432 1.11 . . . . 2.1699999999999999 108.64 -168.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.813 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -90.74 162.02 34.52 Favored Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 113.387 -1.733 . . . . 0.53000000000000003 110.64 -171.596 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -77.86 -12.91 16.21 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 123.072 2.514 . . . . 1.28 114.762 -173.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.813 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 5.7 tp10 -72.7 -17.78 61.6 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 109.48 -0.563 . . . . 3.5 109.48 -171.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.47 ' HB2' HG11 ' A' ' 84' ' ' VAL . 18.8 t80 -163.13 112.01 1.03 Allowed Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 113.351 0.871 . . . . 6.1200000000000001 113.351 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -83.96 126.0 3.77 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 123.077 2.518 . . . . 1.77 110.035 163.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.462 ' HG3' ' HB2' ' A' ' 145' ' ' ARG . 11.2 Cg_endo -52.54 -92.47 0.0 OUTLIER 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 123.447 2.765 . . . . 1.25 114.956 -168.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.1 t -172.53 171.52 4.57 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.621 -0.511 . . . . 1.6000000000000001 109.621 -174.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.8 p -90.22 -15.41 31.46 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.228 -0.656 . . . . 1.97 109.228 171.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -98.56 -50.44 4.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.582 -0.736 . . . . 2.1800000000000002 110.133 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.46 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 40.2 m-85 -83.44 130.4 35.03 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 115.847 -0.615 . . . . 1.23 109.455 176.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.664 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -100.9 113.53 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 N-CA-C 107.991 -1.114 . . . . 0.81999999999999995 107.991 -179.407 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.462 ' HB2' ' HG3' ' A' ' 139' ' ' PRO . 6.4 tmm_? -57.41 97.38 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.674 -1.232 . . . . 4.4199999999999999 107.674 170.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.493 ' HA3' ' HD2' ' A' ' 109' ' ' ARG . . . -66.07 129.0 31.85 Favored Glycine 0 CA--C 1.49 -1.477 0 N-CA-C 110.63 -0.988 . . . . 0.79000000000000004 110.63 -176.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.463 ' H ' ' HG2' ' A' ' 174' ' ' GLU . 41.4 t80 -82.74 107.05 15.08 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.515 1.15 . . . . 4.4400000000000004 110.733 -175.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.403 ' H ' ' CB ' ' A' ' 131' ' ' SER . 55.2 t30 -110.36 110.97 21.96 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.05 -1.886 . . . . 1.6200000000000001 108.396 178.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.508 ' O ' ' N ' ' A' ' 151' ' ' CYS . 29.6 m-70 -57.63 163.29 3.91 Favored Pre-proline 0 C--O 1.217 -0.628 0 CA-C-O 118.174 -0.917 . . . . 2.3199999999999998 109.012 175.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.517 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 1.2 Cg_endo -44.12 77.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 123.841 3.027 . . . . 0.53000000000000003 113.719 178.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . 0.58 ' HB3' ' O ' ' A' ' 170' ' ' PHE . 45.4 m -108.96 -171.81 1.92 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.999 -1.0 . . . . 1.5800000000000001 109.325 177.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.632 ' O ' ' HG3' ' A' ' 169' ' ' MET . . . 174.45 -153.29 16.04 Favored Glycine 0 N--CA 1.435 -1.421 0 C-N-CA 119.028 -1.558 . . . . 0.42999999999999999 112.644 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.601 ' CZ ' HD11 ' A' ' 167' ' ' LEU . 3.6 t80 -156.47 97.96 1.79 Allowed 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.517 -1.29 . . . . 0.59999999999999998 107.517 -163.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.63 ' CG2' HG13 ' A' ' 168' ' ' VAL . 2.6 m -105.56 146.25 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 C-N-CA 119.705 -0.798 . . . . 0.31 110.856 -174.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . 0.57 ' SG ' HD12 ' A' ' 61' ' ' LEU . 18.5 t -118.57 138.19 52.72 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.042 -0.981 . . . . 1.55 108.439 173.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.52 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 12.4 m -123.24 111.22 30.41 Favored Pre-proline 0 C--N 1.307 -1.263 0 C-N-CA 120.697 -0.401 . . . . 1.0600000000000001 110.878 -177.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.454 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 71.4 Cg_exo -50.22 117.74 3.4 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.43 2.087 . . . . 0.56000000000000005 111.045 170.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.425 ' O ' ' HB3' ' A' ' 161' ' ' ASN . 88.6 mmm -79.13 -162.72 0.42 Allowed 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.066 0.46 . . . . 1.1599999999999999 111.462 -175.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -75.38 -35.97 60.99 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.615 -0.883 . . . . 2.6299999999999999 108.615 172.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.411 ' C ' ' HD2' ' A' ' 162' ' ' PRO . 16.5 mt-10 -96.92 29.18 3.16 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.161 -1.381 . . . . 2.0499999999999998 108.636 174.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.516 ' ND2' ' HD3' ' A' ' 162' ' ' PRO . 5.2 p-10 -34.18 -47.28 0.77 Allowed Pre-proline 0 N--CA 1.471 0.611 0 N-CA-C 116.398 1.999 . . . . 1.9299999999999999 116.398 -168.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.516 ' HD3' ' ND2' ' A' ' 161' ' ' ASN . 71.3 Cg_endo -73.94 -17.85 22.09 Favored 'Trans proline' 0 C--N 1.351 0.703 0 CA-C-N 121.755 1.662 . . . . 0.72999999999999998 113.047 -176.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -109.16 -25.89 10.4 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.191 -0.459 . . . . 0.68000000000000005 110.832 -178.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 161' ' ' ASN . 79.6 m-85 -138.3 124.7 20.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.825 -0.625 . . . . 0.93000000000000005 109.467 176.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 3.7 p -125.62 142.25 51.61 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.155 0.502 . . . . 1.4099999999999999 111.154 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.561 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.9 tppp? -88.27 119.6 28.83 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.629 0.728 . . . . 0.73999999999999999 111.482 -175.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.601 HD11 ' CZ ' ' A' ' 153' ' ' PHE . 0.3 OUTLIER -101.96 117.17 34.27 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.244 -0.889 . . . . 0.27000000000000002 110.099 176.64 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.63 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.1 OUTLIER -140.84 126.41 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-O 121.558 0.694 . . . . 0.28000000000000003 112.413 177.699 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.632 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 12.1 ttt -145.44 145.72 31.23 Favored 'General case' 0 C--O 1.22 -0.485 0 C-N-CA 123.091 0.556 . . . . 1.24 110.919 -170.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.877 ' CE2' HG23 ' A' ' 14' ' ' VAL . 12.1 p90 -136.95 162.73 32.47 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.375 0.607 . . . . 3.3700000000000001 112.223 171.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.536 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 1.4 m -136.54 143.53 35.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 113.592 -1.64 . . . . 1.3999999999999999 110.481 173.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.499 ' HB3' ' HB2' ' A' ' 149' ' ' HIS . 7.7 tt0 -120.29 54.95 1.02 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.889 -1.522 . . . . 2.1699999999999999 106.889 172.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.1 m -64.02 144.5 57.04 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 113.791 -1.55 . . . . 1.6499999999999999 110.708 -173.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.463 ' HG2' ' H ' ' A' ' 147' ' ' TYR . 10.3 pt-20 . . . . . 0 C--O 1.233 0.217 0 C-N-CA 120.714 -0.394 . . . . 2.4500000000000002 110.531 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.527 ' HA ' ' HE2' ' A' ' 186' ' ' LYS . 15.9 mm . . . . . 0 CA--C 1.508 -0.668 0 CA-C-O 122.498 1.142 . . . . 1.1200000000000001 108.793 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 1.024 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.1 mp -73.61 -33.05 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 113.103 -1.862 . . . . 1.1299999999999999 111.168 -175.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 189' ' ' PRO . 10.4 pt-20 -65.57 -21.73 66.62 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.83 -0.804 . . . . 2.8900000000000001 108.83 173.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.574 ' O ' ' HB2' ' A' ' 190' ' ' SER . 49.2 mtmt -92.36 -24.71 18.82 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.648 -0.705 . . . . 1.28 110.026 176.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 1.024 HG22 ' HA ' ' A' ' 184' ' ' ILE . 4.5 t -91.18 -47.98 7.2 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 119.499 -0.88 . . . . 0.62 112.772 -178.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . 0.572 ' O ' ' HG ' ' A' ' 192' ' ' LEU . 0.0 OUTLIER -80.48 -71.04 0.15 Allowed Pre-proline 0 N--CA 1.471 0.593 0 CA-C-N 119.403 1.002 . . . . 1.0600000000000001 112.447 -175.651 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.428 ' HG2' ' O ' ' A' ' 185' ' ' GLU . 44.7 Cg_endo -68.25 -22.93 39.53 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.307 1.338 . . . . 0.91000000000000003 112.022 -171.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.574 ' HB2' ' O ' ' A' ' 186' ' ' LYS . 66.9 m -83.83 -23.99 31.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.733 -0.667 . . . . 1.5 110.707 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 187' ' ' THR . 55.0 t30 -89.85 -25.4 21.05 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.439 -0.505 . . . . 1.8799999999999999 110.834 178.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 188' ' ' MET . 15.5 mt -68.84 -47.69 65.39 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.777 0.322 . . . . 1.0900000000000001 111.029 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.588 HG13 ' CG2' ' A' ' 35' ' ' VAL . 3.8 m -67.89 -23.19 28.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 120.353 -0.539 . . . . 0.68000000000000005 110.165 175.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -76.45 -31.06 57.6 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.831 -0.622 . . . . 2.0699999999999998 110.835 176.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -67.14 -31.36 71.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.077 0.465 . . . . 2.0 109.78 171.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.555 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 63.2 mt -77.66 -30.07 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 116.121 -0.49 . . . . 0.31 110.62 174.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 57.1 mt -71.69 -38.76 70.56 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-O 121.468 0.651 . . . . 1.03 109.434 173.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.513 ' ND2' ' HA ' ' A' ' 75' ' ' ASP . 2.6 m120 -54.5 -35.26 62.94 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.393 -1.276 . . . . 1.8999999999999999 109.112 167.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.681 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -75.59 -43.74 46.65 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 120.483 -0.487 . . . . 0.28999999999999998 110.413 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.617 ' O ' ' HG3' ' A' ' 204' ' ' LYS . 32.0 mmtp -56.11 -44.21 78.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.135 0.493 . . . . 0.96999999999999997 110.613 174.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -85.41 -41.14 15.69 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.585 -0.734 . . . . 1.9399999999999999 111.419 -174.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . 0.523 ' HA3' ' CH2' ' A' ' 74' ' ' TRP . . . -68.26 -27.99 73.5 Favored Glycine 0 CA--C 1.507 -0.458 0 N-CA-C 111.502 -0.639 . . . . 0.46999999999999997 111.502 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 1.034 HD13 HD23 ' A' ' 61' ' ' LEU . 2.8 tp -71.7 -31.41 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 109.327 -0.62 . . . . 0.60999999999999999 109.327 176.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.617 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 57.5 mttp -84.63 -25.07 28.8 Favored 'General case' 0 C--O 1.208 -1.093 0 N-CA-C 108.528 -0.916 . . . . 3.3700000000000001 108.528 176.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.443 ' HB3' ' HA2' ' A' ' 202' ' ' GLY . . . . . . . . 0 C--N 1.312 -1.046 0 CA-C-N 115.675 -0.693 . . . . 1.02 109.701 170.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.653 ' O ' HD13 ' A' ' 6' ' ' ILE . 15.5 m-20 . . . . . 0 CA--C 1.5 -0.972 0 N-CA-C 108.392 -0.966 . . . . 2.25 108.392 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.952 ' HA ' HD11 ' A' ' 6' ' ' ILE . 82.7 m-85 -63.6 -35.63 81.14 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 114.676 -1.147 . . . . 0.42999999999999999 109.168 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.705 ' O ' ' HB3' ' A' ' 8' ' ' GLN . 23.2 tptm -60.81 -47.97 83.92 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 115.302 -0.863 . . . . 1.51 109.074 178.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.17 -46.31 62.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.924 -0.58 . . . . 0.54000000000000004 112.125 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.952 HD11 ' HA ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -80.63 -36.5 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 CA-C-O 121.674 0.75 . . . . 1.0700000000000001 109.562 -172.148 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.6 ' HB1' ' HB3' ' A' ' 116' ' ' TYR . . . -76.86 -43.24 36.92 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.239 -1.346 . . . . 0.34000000000000002 111.472 -175.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.705 ' HB3' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -60.96 -33.53 73.34 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.202 -1.363 . . . . 1.5900000000000001 109.086 -178.406 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.545 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 25.6 mm-40 -92.47 -32.85 14.74 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.86 -1.064 . . . . 2.4700000000000002 110.674 -178.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.722 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.4 OUTLIER -75.75 -26.56 57.53 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.786 -0.365 . . . . 0.47999999999999998 110.753 178.028 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -49.34 -44.39 44.54 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 120.208 -0.597 . . . . 0.31 111.811 170.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.691 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 4.0 pt20 -83.73 -1.5 54.27 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 122.075 -0.391 . . . . 1.6399999999999999 110.986 176.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 29.4 mm-40 -88.45 -44.9 10.38 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.803 -0.443 . . . . 2.54 109.803 174.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.712 ' HA ' ' HE2' ' A' ' 170' ' ' PHE . 3.9 p -66.51 -39.96 85.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 122.116 0.96 . . . . 0.53000000000000003 108.912 170.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.691 ' HB3' ' HA ' ' A' ' 12' ' ' GLN . 0.9 OUTLIER -66.9 -21.98 65.98 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 114.749 -1.114 . . . . 0.59999999999999998 108.084 172.552 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.691 ' HA2' ' NE ' ' A' ' 19' ' ' ARG . . . -62.47 -24.44 65.86 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 113.909 -1.496 . . . . 0.56999999999999995 110.268 176.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.452 ' HD1' ' O ' ' A' ' 13' ' ' GLU . 19.6 m-85 -92.55 -8.55 44.07 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.246 -0.477 . . . . 3.27 109.946 178.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.47 -10.97 44.36 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 119.295 -0.962 . . . . 2.0299999999999998 108.608 176.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.691 ' NE ' ' HA2' ' A' ' 16' ' ' GLY . 19.5 ptt85 -122.64 3.25 9.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.618 -1.173 . . . . 2.7200000000000002 110.561 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.649 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 23.0 t70 -90.28 112.8 24.47 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 116.223 -0.444 . . . . 2.1600000000000001 110.821 -175.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.8 p -129.96 93.81 3.58 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.691 0.758 . . . . 1.8200000000000001 109.334 176.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.1 t -127.26 -78.19 0.58 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.638 -1.165 . . . . 2.1899999999999999 111.202 -169.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.09 60.38 0.55 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.52 -0.848 . . . . 1.1000000000000001 112.374 -177.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.513 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -120.39 -163.73 1.03 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.107 0.479 . . . . 1.6699999999999999 110.221 176.869 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 1.2 mtpp -176.77 135.65 0.22 Allowed 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.201 -1.037 . . . . 2.9500000000000002 108.201 -172.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 3.2 m -66.55 123.88 20.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.895 0.855 . . . . 1.5600000000000001 110.703 177.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.2 p -97.76 -23.25 4.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 114.199 -1.364 . . . . 1.22 108.795 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.502 ' HD2' ' HA ' ' A' ' 28' ' ' LYS . 10.0 tptm -155.47 112.93 3.32 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 119.995 -0.682 . . . . 2.4100000000000001 111.824 -174.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.932 HG22 ' HA ' ' A' ' 34' ' ' THR . 75.2 p -130.97 126.93 37.32 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.54 -0.541 . . . . 1.3799999999999999 109.54 172.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.3 m -85.18 -79.94 0.22 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.536 -0.302 . . . . 2.3700000000000001 110.984 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 7.2 ptpp? -159.17 28.55 0.21 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.498 0.189 . . . . 4.5499999999999998 110.894 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.537 ' HB2' ' NZ ' ' A' ' 32' ' ' LYS . 1.4 ttmp? 170.35 -20.7 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.979 -0.555 . . . . 1.4199999999999999 110.31 -176.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.899 HG22 ' HA3' ' A' ' 52' ' ' GLY . 46.1 pt -109.26 157.3 9.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.771 -0.65 . . . . 0.76000000000000001 110.486 178.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.932 ' HA ' HG22 ' A' ' 29' ' ' THR . 85.6 m -148.79 100.07 3.05 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.65 -0.705 . . . . 0.57999999999999996 111.133 -164.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.925 HG11 HD13 ' A' ' 192' ' ' LEU . 2.3 t -96.06 106.98 19.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.871 0.367 . . . . 0.85999999999999999 110.281 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 6.0 p -96.62 126.04 41.52 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.453 0.645 . . . . 1.1000000000000001 110.735 177.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.2 t -103.29 127.75 50.53 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.782 -1.099 . . . . 1.27 109.199 -176.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.513 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 25.1 ttpp . . . . . 0 C--N 1.319 -0.744 0 CA-C-N 116.33 -0.395 . . . . 1.9099999999999999 110.983 -177.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 N--CA 1.449 -0.509 0 N-CA-C 113.054 0.761 . . . . 2.0499999999999998 113.054 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.751 HD21 ' CD1' ' A' ' 170' ' ' PHE . 9.7 tt -128.85 147.78 50.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.171 -1.377 . . . . 0.87 107.615 178.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.444 ' N ' HD23 ' A' ' 47' ' ' LEU . 94.0 m-85 -122.71 134.35 54.46 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.151 -0.62 . . . . 0.98999999999999999 111.587 -170.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 2.6 tmt_? -130.67 118.56 21.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.813 -0.631 . . . . 2.9199999999999999 111.044 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.915 HG13 HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -92.5 153.35 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-O 120.989 0.423 . . . . 1.3300000000000001 110.642 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.488 ' CG ' ' HD2' ' A' ' 166' ' ' LYS . 16.3 tt0 -153.31 106.56 2.98 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.557 -0.905 . . . . 1.0700000000000001 108.557 178.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.899 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -140.94 141.21 11.07 Favored Glycine 0 CA--C 1.498 -0.998 0 C-N-CA 120.239 -0.981 . . . . 0.28999999999999998 111.542 -178.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 165' ' ' SER . 61.6 mt -88.44 120.35 37.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 C-N-CA 120.206 -0.598 . . . . 0.57999999999999996 110.89 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.663 HG12 ' HD3' ' A' ' 200' ' ' LYS . 63.7 mt -95.74 119.2 65.36 Favored Pre-proline 0 N--CA 1.443 -0.785 0 N-CA-C 109.096 -0.705 . . . . 0.34999999999999998 109.096 173.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 163' ' ' ALA . 28.1 Cg_exo -64.72 59.35 0.28 Allowed 'Trans proline' 0 N--CA 1.473 0.268 0 C-N-CA 124.08 3.187 . . . . 0.62 112.959 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.443 ' HG2' HG13 ' A' ' 203' ' ' ILE . 14.5 tp10 -156.21 175.85 13.45 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.287 -1.375 . . . . 1.6799999999999999 107.287 177.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.491 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 43.3 p -88.81 141.66 30.01 Favored Pre-proline 0 N--CA 1.429 -1.522 0 CA-C-O 121.512 0.672 . . . . 1.1799999999999999 110.211 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.832 ' HD3' ' HB3' ' A' ' 165' ' ' SER . 6.3 Cg_endo -49.34 -14.85 0.63 Allowed 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 124.963 3.775 . . . . 0.52000000000000002 112.587 173.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.76 -47.74 29.45 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 116.11 -0.495 . . . . 0.64000000000000001 111.204 176.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.668 ' HE3' ' HA ' ' A' ' 60' ' ' LYS . 1.4 tpmt? -67.64 -31.42 71.42 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.841 -1.17 . . . . 3.2999999999999998 107.841 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.009 HD23 HD13 ' A' ' 203' ' ' ILE . 83.2 mt -63.23 -56.29 17.88 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.034 -1.439 . . . . 0.40999999999999998 110.778 175.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.2 t -62.95 -12.17 23.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.67 0.271 . . . . 1.29 110.564 177.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -84.04 -41.91 16.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.369 -0.378 . . . . 1.3200000000000001 112.0 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.771 ' HD2' ' CZ2' ' A' ' 74' ' ' TRP . 15.4 p90 -85.88 -42.02 14.46 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.399 0.518 . . . . 0.60999999999999999 112.399 -170.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.741 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -89.95 4.49 49.89 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.06 0.391 . . . . 1.5 111.932 -170.08 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.617 ' O ' ' HG3' ' A' ' 67' ' ' GLN . 75.2 t80 -41.89 -73.1 0.05 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.973 0.731 . . . . 1.52 112.973 -166.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.631 HE22 ' HB2' ' A' ' 92' ' ' PHE . 72.4 mt-30 -168.07 -61.57 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.7 0.762 . . . . 3.6000000000000001 110.462 -178.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.855 ' HB ' ' CD2' ' A' ' 81' ' ' TYR . 10.2 t -126.23 26.19 6.5 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.111 -1.44 . . . . 1.48 107.111 178.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.699 ' O ' ' HB2' ' A' ' 70' ' ' ASP . . . -72.15 -14.12 76.48 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 113.531 -1.668 . . . . 1.46 112.735 -169.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.699 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 15.1 t70 132.91 -8.95 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 O-C-N 125.844 1.555 . . . . 2.1899999999999999 107.051 -171.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.779 ' HA ' ' CE2' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -59.41 -36.24 75.48 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.525 -1.216 . . . . 3.3799999999999999 111.239 -170.089 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.073 HG22 HD13 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -80.5 -14.14 12.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.581 -0.448 . . . . 0.70999999999999996 110.973 -175.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.663 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.1 t -88.11 -31.7 19.07 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 119.972 -0.691 . . . . 0.96999999999999997 110.15 -176.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.858 ' HZ3' ' HB3' ' A' ' 198' ' ' ASN . 15.0 p-90 -100.64 -7.21 24.16 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.411 -0.516 . . . . 0.75 111.023 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.811 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 5.7 t70 -73.7 167.98 20.3 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.47 0.653 . . . . 2.1899999999999999 110.267 -177.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.8 -16.17 12.8 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.923 -1.035 . . . . 3.1899999999999999 111.512 -172.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.1 t -119.62 9.02 11.35 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.339 0.59 . . . . 1.5800000000000001 109.456 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.073 HD13 HG22 ' A' ' 72' ' ' ILE . 19.9 mt -109.72 159.68 16.95 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.625 -0.716 . . . . 0.70999999999999996 112.421 -175.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.626 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 7.7 mt-30 -131.94 -69.7 0.59 Allowed 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 114.807 -1.088 . . . . 1.73 110.432 178.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.558 HG23 ' HB3' ' A' ' 79' ' ' GLN . 21.3 t -142.84 136.32 26.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.875 -1.057 . . . . 0.78000000000000003 110.254 -165.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.855 ' CD2' ' HB ' ' A' ' 68' ' ' THR . 80.6 t80 -116.91 146.56 42.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.053 0.454 . . . . 5.4000000000000004 111.334 177.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.73 ' HB2' ' HD2' ' A' ' 95' ' ' HIS . 14.0 m120 -142.69 124.01 14.69 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.42 -0.809 . . . . 1.6899999999999999 109.037 175.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.453 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 2.3 ttt -82.11 97.13 8.03 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.597 -0.89 . . . . 2.0499999999999998 108.597 -178.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.703 HG11 ' HB2' ' A' ' 137' ' ' TYR . 0.1 OUTLIER -72.92 -80.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.914 -0.584 . . . . 0.64000000000000001 111.908 -167.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.592 ' HB2' ' HG2' ' A' ' 136' ' ' GLU . 10.4 t60 -126.03 118.36 25.17 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.976 -0.75 . . . . 1.96 108.976 -177.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.453 ' HD3' ' SD ' ' A' ' 83' ' ' MET . 50.4 mtm180 -103.31 103.14 13.13 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.4 -0.593 . . . . 2.4399999999999999 109.4 -175.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.606 HG21 ' HB2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -67.74 -41.32 85.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.081 -0.963 . . . . 0.46999999999999997 110.402 -173.547 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -148.35 -161.38 1.33 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.878 -1.156 . . . . 1.8600000000000001 107.878 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.7 m -93.4 3.87 54.9 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.07 0.462 . . . . 1.4399999999999999 109.915 175.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -125.07 -3.43 7.58 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 109.07 -0.715 . . . . 1.8700000000000001 109.07 -175.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.564 HG22 HD11 ' A' ' 114' ' ' LEU . 2.1 m -145.92 116.52 7.61 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 109.288 -0.634 . . . . 0.46000000000000002 109.288 -171.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.631 ' HB2' HE22 ' A' ' 67' ' ' GLN . 10.8 m-85 -129.82 176.88 7.68 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.175 -0.676 . . . . 0.42999999999999999 109.175 -177.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.635 HD13 ' HB2' ' A' ' 114' ' ' LEU . 1.3 mm -122.43 131.81 72.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 107.851 -1.166 . . . . 0.40999999999999998 107.851 168.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 18.4 p -107.11 107.14 17.98 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.871 -0.331 . . . . 2.0099999999999998 111.643 -173.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.73 ' HD2' ' HB2' ' A' ' 82' ' ' ASN . 49.4 t60 -81.72 103.57 11.5 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.385 -0.969 . . . . 1.23 108.385 167.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.838 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 33.1 m -125.4 111.18 14.83 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.891 -0.595 . . . . 0.5 111.75 -170.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' A' ' 79' ' ' GLN . 29.0 mm -77.11 136.56 24.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 120.142 -0.623 . . . . 1.03 109.739 177.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 1.8 m -112.75 147.05 37.67 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.988 -1.005 . . . . 1.3799999999999999 109.942 -171.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.626 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 6.8 mt-30 . . . . . 0 C--N 1.317 -0.83 0 CA-C-N 115.962 -0.563 . . . . 1.8200000000000001 110.403 -178.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.412 HD11 ' HB ' ' A' ' 187' ' ' THR . 44.1 mt . . . . . 0 N--CA 1.445 -0.705 0 N-CA-C 109.722 -0.473 . . . . 1.1200000000000001 109.722 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.8 p -68.15 157.34 87.58 Favored Pre-proline 0 C--O 1.237 0.44 0 CA-C-N 115.433 -0.803 . . . . 1.3500000000000001 111.934 -172.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -45.44 124.44 6.51 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 123.252 2.635 . . . . 1.0700000000000001 110.793 175.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.607 ' HG3' HG23 ' A' ' 144' ' ' ILE . 2.7 ttm180 -122.25 157.19 32.2 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.623 -0.831 . . . . 3.4500000000000002 110.552 -168.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.629 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 12.3 t0 -126.52 131.03 51.69 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 109.608 -0.516 . . . . 1.3700000000000001 109.608 176.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.838 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 20.0 m-85 -99.96 131.91 45.64 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 120.946 0.403 . . . . 2.4100000000000001 110.436 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.514 HD13 ' HA ' ' A' ' 95' ' ' HIS . 20.5 mm -129.8 74.49 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 108.152 -1.055 . . . . 0.42999999999999999 108.152 168.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.673 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 41.8 m-20 -106.44 140.28 39.59 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.981 -1.009 . . . . 1.8600000000000001 109.304 -178.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.635 ' HB2' HD13 ' A' ' 93' ' ' ILE . 5.3 tp -81.93 122.6 27.96 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.162 -0.681 . . . . 0.28000000000000003 109.162 174.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -117.35 124.05 72.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-O 122.236 1.017 . . . . 0.26000000000000001 111.981 -166.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.885 ' CE2' ' HB3' ' A' ' 128' ' ' SER . 0.1 OUTLIER -113.51 118.42 34.4 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.552 -1.658 . . . . 2.5699999999999998 110.02 -176.092 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 126' ' ' ILE . 3.9 mp -105.31 99.38 8.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.544 -0.539 . . . . 0.89000000000000001 109.544 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -107.5 144.17 34.85 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.599 -0.728 . . . . 1.2 109.718 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.442 ' NH1' ' HA ' ' A' ' 121' ' ' GLU . 3.3 tmt_? -121.09 94.1 4.23 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 108.144 -1.058 . . . . 2.7999999999999998 108.144 -176.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.569 ' CB ' ' HB2' ' A' ' 123' ' ' ASN . 89.5 m-85 -63.73 115.84 5.16 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 106.806 -1.553 . . . . 0.82999999999999996 106.806 172.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.442 ' HA ' ' NH1' ' A' ' 119' ' ' ARG . 21.0 mt-10 -48.22 85.26 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 O-C-N 125.031 1.457 . . . . 2.2799999999999998 113.014 -171.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 77.25 29.07 57.0 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 114.91 -1.041 . . . . 0.76000000000000001 112.509 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.569 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 14.4 m120 -125.5 -51.04 1.62 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.668 -0.266 . . . . 1.6499999999999999 110.337 178.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.405 ' HA ' ' HD2' ' A' ' 157' ' ' PRO . 1.9 mpt? -157.03 131.93 8.87 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.834 0.349 . . . . 1.1200000000000001 111.267 -174.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.438 ' OD1' ' HG2' ' A' ' 119' ' ' ARG . 63.9 m-20 -105.91 79.5 1.43 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.611 -1.255 . . . . 1.6200000000000001 107.611 171.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.604 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -89.52 124.83 42.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.699 -0.682 . . . . 0.29999999999999999 112.213 -173.101 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.468 ' CG2' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -107.02 116.89 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 107.528 -1.286 . . . . 0.58999999999999997 107.528 160.214 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.885 ' HB3' ' CE2' ' A' ' 116' ' ' TYR . 37.9 t -127.88 167.22 16.9 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.425 -0.954 . . . . 1.1799999999999999 108.425 174.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.673 ' HB3' ' HB3' ' A' ' 113' ' ' ASP . 73.0 m -145.16 137.84 26.15 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.637 -0.505 . . . . 1.24 109.637 -168.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.471 ' HE2' ' HG3' ' A' ' 150' ' ' PRO . 47.0 tttm -123.86 116.21 22.57 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.302 -1.37 . . . . 2.2599999999999998 107.302 -171.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.672 ' HB3' ' N ' ' A' ' 148' ' ' ASN . 11.8 p -58.65 101.29 0.08 Allowed 'General case' 0 N--CA 1.432 -1.354 0 O-C-N 124.26 0.975 . . . . 1.3899999999999999 109.303 -173.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.435 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.8 OUTLIER -116.3 131.99 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.139 0 CA-C-N 114.933 -1.03 . . . . 1.05 109.918 -167.392 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -98.24 78.66 2.49 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.742 -1.117 . . . . 2.1699999999999999 108.209 -175.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.814 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -109.96 156.88 39.22 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 115.395 -0.82 . . . . 0.53000000000000003 110.264 -171.745 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -75.93 -16.61 18.11 Favored 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.818 2.345 . . . . 1.28 115.267 -169.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.814 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 8.6 tp10 -69.15 -16.47 63.65 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.311 0.577 . . . . 3.5 110.023 -171.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.703 ' HB2' HG11 ' A' ' 84' ' ' VAL . 1.7 t80 -165.5 104.61 0.75 Allowed Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.492 -0.777 . . . . 6.1200000000000001 112.074 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -88.72 145.18 5.58 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.324 2.683 . . . . 1.77 110.813 170.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -70.27 -166.74 0.21 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.419 2.079 . . . . 1.25 111.762 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.4 m -140.21 -169.75 2.82 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.987 -0.746 . . . . 1.6000000000000001 108.987 -174.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.9 t -79.45 -37.78 36.17 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 119.899 -0.72 . . . . 1.97 110.249 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -83.28 -17.64 41.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.086 0.469 . . . . 2.1800000000000002 110.387 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.485 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 85.9 m-85 -114.65 108.3 16.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.844 -0.616 . . . . 1.23 110.28 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.607 HG23 ' HG3' ' A' ' 109' ' ' ARG . 1.0 OUTLIER -95.39 106.76 18.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.089 -0.505 . . . . 0.81999999999999995 109.927 -178.267 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.629 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 35.1 ttm180 -50.16 105.37 0.09 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.977 -0.556 . . . . 4.4199999999999999 111.156 178.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -64.32 112.72 5.23 Favored Glycine 0 N--CA 1.437 -1.281 0 CA-C-N 115.337 -0.847 . . . . 0.79000000000000004 111.887 176.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.574 ' HB3' ' CB ' ' A' ' 174' ' ' GLU . 0.2 OUTLIER -85.58 93.05 8.71 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.058 0.456 . . . . 4.4400000000000004 109.878 178.114 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.672 ' N ' ' HB3' ' A' ' 131' ' ' SER . 80.1 m-20 -88.86 81.64 6.9 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.579 -0.737 . . . . 1.6200000000000001 109.741 175.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.527 ' CD2' ' HD2' ' A' ' 150' ' ' PRO . 0.1 OUTLIER -47.85 123.37 9.74 Favored Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 115.141 -0.936 . . . . 2.3199999999999998 110.104 179.269 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.527 ' HD2' ' CD2' ' A' ' 149' ' ' HIS . 53.6 Cg_exo -14.31 67.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.223 1 C-N-CA 126.725 4.95 . . . . 0.53000000000000003 115.712 -161.693 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . 0.718 ' HB2' ' O ' ' A' ' 170' ' ' PHE . 24.5 p -123.86 145.82 48.83 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.005 -0.998 . . . . 1.5800000000000001 109.512 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 128' ' ' SER . . . -151.26 -134.16 2.13 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 119.012 -1.566 . . . . 0.42999999999999999 114.004 -175.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.532 ' CE1' HD21 ' A' ' 167' ' ' LEU . 33.0 t80 -161.59 80.71 0.58 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.644 -0.873 . . . . 0.59999999999999998 108.644 -157.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.767 HG23 HG13 ' A' ' 168' ' ' VAL . 12.6 m -91.66 135.53 26.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.647 0.737 . . . . 0.31 110.561 -174.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 58' ' ' PRO . 15.2 t -112.19 124.21 51.94 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.271 -0.877 . . . . 1.55 109.122 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.937 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 5.2 m -115.8 110.24 44.45 Favored Pre-proline 0 C--N 1.311 -1.072 0 C-N-CA 120.133 -0.627 . . . . 1.0600000000000001 111.656 -174.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.483 ' HD2' ' HA ' ' A' ' 156' ' ' SER . 1.1 Cg_endo -49.2 116.93 2.5 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.668 2.245 . . . . 0.56000000000000005 110.7 168.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.597 ' SD ' ' HB2' ' A' ' 166' ' ' LYS . 84.6 mmm -82.67 -167.23 1.54 Allowed 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.163 0.506 . . . . 1.1599999999999999 111.737 -173.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -75.66 -22.35 56.82 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.703 -0.68 . . . . 2.6299999999999999 109.677 172.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.6 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 43.8 mm-40 -104.42 27.56 7.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.829 -1.078 . . . . 2.0499999999999998 108.805 173.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.755 ' HB3' ' HD3' ' A' ' 162' ' ' PRO . 48.1 t-20 -8.27 -73.24 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 126.547 1.939 . . . . 1.9299999999999999 115.177 -176.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.755 ' HD3' ' HB3' ' A' ' 161' ' ' ASN . 73.0 Cg_endo -74.28 -13.49 23.15 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 121.312 1.342 . . . . 0.72999999999999998 114.137 -171.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 55' ' ' PRO . . . -108.64 -26.1 10.54 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.918 0.389 . . . . 0.68000000000000005 111.081 -176.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.6 ' HB2' ' HB2' ' A' ' 160' ' ' GLU . 89.4 m-85 -139.76 126.79 20.97 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.02 -0.537 . . . . 0.93000000000000005 109.579 178.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.832 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 13.1 p -124.43 147.07 48.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.05 0.452 . . . . 1.4099999999999999 111.228 -177.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.937 ' HB3' ' HB2' ' A' ' 156' ' ' SER . 1.6 tppp? -91.98 102.24 14.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.56 0.695 . . . . 0.73999999999999999 111.47 -177.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.532 HD21 ' CE1' ' A' ' 153' ' ' PHE . 0.8 OUTLIER -90.61 107.29 19.08 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.288 -0.869 . . . . 0.27000000000000002 109.396 175.827 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.767 HG13 HG23 ' A' ' 154' ' ' VAL . 0.1 OUTLIER -129.48 128.21 65.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.626 0.727 . . . . 0.28000000000000003 111.87 178.084 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.541 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 11.7 ttt -137.97 135.92 36.47 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 115.253 -0.885 . . . . 1.24 109.897 -172.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.751 ' CD1' HD21 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -126.91 151.11 48.88 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.231 -0.588 . . . . 3.3700000000000001 109.902 176.741 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.638 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 4.0 m -129.18 130.18 67.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-O 121.537 0.684 . . . . 1.3999999999999999 112.017 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -119.8 37.31 4.24 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.396 -1.705 . . . . 2.1699999999999999 106.396 170.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 6.7 m -52.21 131.75 32.88 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 113.27 -1.786 . . . . 1.6499999999999999 111.259 -174.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.574 ' CB ' ' HB3' ' A' ' 147' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--N 1.333 -0.117 0 N-CA-C 112.029 0.381 . . . . 2.4500000000000002 112.029 -169.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.643 ' HA ' ' HE3' ' A' ' 186' ' ' LYS . 35.3 mm . . . . . 0 CA--C 1.5 -0.955 0 CA-C-O 122.228 1.013 . . . . 1.1200000000000001 108.77 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 1.03 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.6 mp -66.66 -31.69 54.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 113.269 -1.787 . . . . 1.1299999999999999 110.437 178.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.423 ' O ' ' HD2' ' A' ' 189' ' ' PRO . 7.5 mm-40 -65.46 -28.91 69.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.102 -0.954 . . . . 2.8900000000000001 108.733 175.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.643 ' HE3' ' HA ' ' A' ' 183' ' ' ILE . 2.7 ptpt -93.08 -26.29 17.53 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.719 -1.128 . . . . 1.28 110.852 178.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 1.03 HG22 ' HA ' ' A' ' 184' ' ' ILE . 6.2 t -78.34 -44.33 25.41 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 119.996 -0.682 . . . . 0.62 112.01 -176.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' MET . . . . . 0.948 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 2.5 mmt -80.15 -68.63 0.21 Allowed Pre-proline 0 N--CA 1.455 -0.194 0 C-N-CA 120.058 -0.657 . . . . 1.0600000000000001 110.756 -173.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.948 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 36.7 Cg_exo -60.6 -15.57 37.58 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 122.66 2.24 . . . . 0.91000000000000003 113.184 -171.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 33.3 t -86.07 -45.27 11.56 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.734 -0.469 . . . . 1.5 109.734 175.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.684 ' HA ' ' HB2' ' A' ' 194' ' ' ASN . 6.5 t30 -85.17 -21.6 29.13 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.598 -0.441 . . . . 1.8799999999999999 112.187 -167.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.925 HD13 HG11 ' A' ' 35' ' ' VAL . 2.4 mt -60.26 -51.97 67.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.872 0.844 . . . . 1.0900000000000001 109.844 173.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.543 ' HB ' ' CD1' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -72.12 -32.32 42.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 114.594 -1.184 . . . . 0.68000000000000005 109.781 -178.011 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.684 ' HB2' ' HA ' ' A' ' 191' ' ' ASN . 0.9 OUTLIER -72.24 -30.54 64.98 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.646 -1.161 . . . . 2.0699999999999998 111.721 -179.327 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -70.58 -29.12 65.46 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.516 -0.474 . . . . 2.0 109.918 173.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.527 HG21 HG21 ' A' ' 33' ' ' ILE . 39.1 mt -76.18 -26.54 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-O 121.315 0.579 . . . . 0.31 110.375 173.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 194' ' ' ASN . 55.3 mt -70.0 -42.74 72.63 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 116.126 -0.488 . . . . 1.03 109.947 173.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.858 ' HB3' ' HZ3' ' A' ' 74' ' ' TRP . 91.2 m-20 -50.53 -33.21 20.74 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.983 -1.008 . . . . 1.8999999999999999 109.846 168.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.658 ' HA ' ' CE2' ' A' ' 64' ' ' PHE . . . -80.52 -40.51 25.91 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 116.229 -0.441 . . . . 0.28999999999999998 111.099 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.663 ' HD3' HG12 ' A' ' 54' ' ' ILE . 25.7 mmtm -60.05 -42.05 93.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.559 0.695 . . . . 0.96999999999999997 110.094 176.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -84.51 -43.54 14.46 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.968 -1.015 . . . . 1.9399999999999999 110.689 -176.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -65.01 -30.91 79.25 Favored Glycine 0 C--O 1.228 -0.235 0 C-N-CA 120.661 -0.78 . . . . 0.46999999999999997 111.833 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 1.009 HD13 HD23 ' A' ' 61' ' ' LEU . 3.3 tp -70.53 -39.03 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 123.005 -0.115 . . . . 0.60999999999999999 110.771 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 41.4 pttt -83.98 -28.42 27.77 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.524 -0.547 . . . . 3.3700000000000001 109.524 -178.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.774 0 CA-C-N 115.374 -0.83 . . . . 1.02 109.356 170.26 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.5 mtm . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 120.754 0.312 . . . . 3.8599999999999999 110.684 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -153.8 -64.31 0.14 Allowed 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.903 -0.777 . . . . 2.25 108.903 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.502 ' CD2' HD12 ' A' ' 87' ' ' ILE . 59.1 m-85 -63.86 -33.15 75.04 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.459 0.647 . . . . 0.42999999999999999 109.341 177.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.529 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 5.7 mttp -70.1 -46.63 64.45 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 115.119 -0.946 . . . . 1.51 108.498 178.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -47.49 -48.58 27.04 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 112.324 0.49 . . . . 0.54000000000000004 112.324 -176.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.572 ' O ' ' HB ' ' A' ' 10' ' ' THR . 0.2 OUTLIER -82.95 -34.06 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 121.291 0.567 . . . . 1.0700000000000001 110.041 -173.032 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.498 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -78.83 -42.76 26.81 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.058 -0.973 . . . . 0.34000000000000002 111.767 -176.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.564 ' HG2' ' CZ ' ' A' ' 116' ' ' TYR . 34.6 mt-30 -59.35 -32.95 70.58 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.729 -1.123 . . . . 1.5900000000000001 110.103 175.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.695 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 16.3 mm-40 -79.09 -41.7 28.07 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.104 -0.953 . . . . 2.4700000000000002 108.778 173.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.619 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.3 OUTLIER -63.36 -35.53 80.71 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.039 -0.982 . . . . 0.47999999999999998 111.625 -176.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.463 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -46.26 -63.05 1.09 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.941 0.4 . . . . 0.31 111.4 170.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.468 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 10.4 pt20 -72.69 -9.86 59.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.289 -0.414 . . . . 1.6399999999999999 112.051 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.695 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 51.0 mt-10 -77.95 -50.23 12.57 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.631 -0.507 . . . . 2.54 109.631 174.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.627 HG21 ' N ' ' A' ' 152' ' ' GLY . 5.8 p -68.65 -39.42 80.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 122.049 0.928 . . . . 0.53000000000000003 109.393 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.468 ' HB3' ' HA ' ' A' ' 12' ' ' GLN . 0.8 OUTLIER -66.9 -27.57 67.61 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 114.548 -1.206 . . . . 0.59999999999999998 108.93 173.184 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.93 -17.86 63.69 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 113.97 -1.468 . . . . 0.56999999999999995 110.662 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.504 ' CD2' ' HA ' ' A' ' 14' ' ' VAL . 17.9 m-85 -90.63 -22.65 21.11 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.089 -0.556 . . . . 3.27 109.508 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.492 ' CB ' ' HZ ' ' A' ' 170' ' ' PHE . 0.1 OUTLIER -69.67 -24.38 63.6 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 120.184 -0.607 . . . . 2.0299999999999998 109.385 176.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.23 9.7 27.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.324 -0.853 . . . . 2.7200000000000002 110.118 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.425 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 29.6 t70 -123.08 74.9 1.25 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.444 -0.798 . . . . 2.1600000000000001 109.108 177.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.439 HG22 ' CH2' ' A' ' 24' ' ' TRP . 53.2 p -102.83 88.84 3.29 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.453 0.644 . . . . 1.8200000000000001 111.183 -172.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.1 p -173.4 168.64 4.55 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.659 -1.155 . . . . 2.1899999999999999 110.127 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.57 9.69 62.24 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 121.171 -0.538 . . . . 1.1000000000000001 112.908 175.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.463 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -120.44 -158.95 0.77 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.88 0.371 . . . . 1.6699999999999999 111.395 -177.521 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.51 122.37 0.35 Allowed 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.155 -0.683 . . . . 2.9500000000000002 109.155 -168.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 3.1 m -65.12 124.12 19.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 122.084 0.945 . . . . 1.5600000000000001 111.252 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.3 p -102.02 -24.4 4.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 113.918 -1.492 . . . . 1.22 108.84 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.403 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 17.7 tppt? -147.81 112.73 5.44 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.903 -0.59 . . . . 2.4100000000000001 111.89 -174.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.56 HG22 ' HA ' ' A' ' 34' ' ' THR . 43.2 p -130.0 151.04 50.98 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.163 -0.472 . . . . 1.3799999999999999 110.314 173.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.3 t -118.84 -98.85 0.45 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.27 -0.423 . . . . 2.3700000000000001 110.027 174.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -144.86 17.52 1.61 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.624 0.726 . . . . 4.5499999999999998 110.035 176.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.573 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 13.1 tptm -167.92 -0.6 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.677 -0.692 . . . . 1.4199999999999999 110.738 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 51' ' ' GLU . 41.7 pt -136.44 154.02 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 120.951 0.405 . . . . 0.76000000000000001 110.802 -176.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.56 ' HA ' HG22 ' A' ' 29' ' ' THR . 54.4 m -150.2 99.59 2.82 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.675 -0.693 . . . . 0.57999999999999996 111.299 -168.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.487 HG11 ' HA ' ' A' ' 189' ' ' PRO . 9.9 t -92.48 118.77 38.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.928 -0.397 . . . . 0.85999999999999999 109.928 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.544 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -118.64 124.4 47.31 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.435 0.636 . . . . 1.1000000000000001 111.117 -176.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.528 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 22.4 m -95.28 122.48 38.02 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.721 -1.127 . . . . 1.27 111.037 -175.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 29.1 ttmt -119.21 -90.85 0.57 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.508 -0.315 . . . . 1.9099999999999999 111.354 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.451 ' H ' ' HB3' ' A' ' 38' ' ' LYS . . . -159.84 130.72 5.79 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.246 -0.279 . . . . 1.6799999999999999 110.246 -174.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.435 ' CB ' ' HB2' ' A' ' 172' ' ' GLN . 4.2 p -77.71 -40.61 40.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.577 -0.283 . . . . 2.0899999999999999 110.947 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 67.25 -40.44 0.39 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.822 0.849 . . . . 6.6100000000000003 112.679 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.401 ' HD2' ' N ' ' A' ' 42' ' ' LYS . 0.3 OUTLIER -91.94 18.92 7.18 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.749 -0.463 . . . . 6.46 109.749 174.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -167.27 149.45 5.98 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.418 -1.327 . . . . 5.6500000000000004 107.418 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -79.77 59.34 3.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.098 0.475 . . . . 5.5599999999999996 110.638 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.83 -129.61 1.91 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.968 -0.634 . . . . 1.5600000000000001 112.482 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.528 ' OD1' ' HB3' ' A' ' 37' ' ' SER . 0.1 OUTLIER -151.51 152.48 33.03 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.706 0.289 . . . . 2.0499999999999998 110.251 177.725 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.705 HD23 ' N ' ' A' ' 48' ' ' TYR . 6.4 tt -96.97 147.55 23.87 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.283 -0.636 . . . . 0.87 109.283 -177.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.705 ' N ' HD23 ' A' ' 47' ' ' LEU . 46.9 m-85 -117.88 124.36 48.1 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.643 -0.502 . . . . 0.98999999999999999 109.643 -176.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.439 ' HD3' HG23 ' A' ' 168' ' ' VAL . 1.4 tmm_? -117.88 120.69 38.65 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.343 -0.39 . . . . 2.9199999999999999 109.989 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.537 ' CG1' ' HB3' ' A' ' 192' ' ' LEU . 11.3 p -103.45 149.79 7.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 120.696 -0.402 . . . . 1.3300000000000001 110.088 177.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.552 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 34.1 tt0 -143.63 111.36 6.01 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.914 -0.584 . . . . 1.0700000000000001 110.036 -172.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.573 ' HA2' ' O ' ' A' ' 32' ' ' LYS . . . -140.73 138.86 9.23 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.323 -0.941 . . . . 0.28999999999999998 112.498 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.416 ' HB ' ' HE2' ' A' ' 32' ' ' LYS . 63.6 mt -90.23 113.93 27.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 120.168 -0.613 . . . . 0.57999999999999996 110.786 177.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.48 ' CD1' ' HB1' ' A' ' 199' ' ' ALA . 57.4 mt -95.89 116.53 66.29 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.627 -0.715 . . . . 0.34999999999999998 109.454 175.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -61.91 64.26 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 124.381 3.388 . . . . 0.62 113.065 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.566 ' HG2' ' CG1' ' A' ' 203' ' ' ILE . 12.4 tp10 -156.84 173.43 17.0 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.656 -0.868 . . . . 1.6799999999999999 108.656 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.49 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 10.2 m -81.63 142.07 49.12 Favored Pre-proline 0 N--CA 1.423 -1.796 0 N-CA-C 109.332 -0.618 . . . . 1.1799999999999999 109.332 178.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 57' ' ' SER . 31.2 Cg_exo -59.08 -12.31 15.3 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 123.723 2.949 . . . . 0.52000000000000002 111.038 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.9 -50.21 37.49 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.825 -1.079 . . . . 0.64000000000000001 111.292 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.447 ' HB3' HD11 ' A' ' 203' ' ' ILE . 17.4 ttmm -71.02 -27.59 63.79 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.089 -0.708 . . . . 3.2999999999999998 109.089 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.971 HD23 HD13 ' A' ' 203' ' ' ILE . 47.0 mt -62.3 -55.8 24.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.86 -1.063 . . . . 0.40999999999999998 109.666 173.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.534 ' HA ' ' CD1' ' A' ' 65' ' ' LEU . 13.7 p -71.84 -1.64 14.92 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.135 0.493 . . . . 1.29 110.83 176.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -88.85 -30.25 19.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.923 -0.58 . . . . 1.3200000000000001 111.141 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.7 ' CE1' ' HB3' ' A' ' 65' ' ' LEU . 6.1 p90 -90.02 -46.07 8.75 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 120.774 -0.37 . . . . 0.60999999999999999 111.06 -174.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.704 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -87.56 6.97 31.76 Favored 'General case' 0 CA--C 1.517 -0.302 0 O-C-N 121.811 -0.556 . . . . 1.5 110.535 -173.545 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -48.44 -63.43 1.08 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.8 -1.091 . . . . 1.52 112.496 -167.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.465 ' O ' ' HD2' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -154.73 -85.32 0.06 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 119.433 -0.907 . . . . 3.6000000000000001 112.942 -175.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.638 ' HB ' ' CD1' ' A' ' 81' ' ' TYR . 9.1 t -141.06 21.52 2.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.965 0.412 . . . . 1.48 111.583 -164.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -115.95 0.98 21.31 Favored Glycine 0 C--N 1.311 -0.833 0 C-N-CA 118.716 -1.707 . . . . 1.46 113.97 -164.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.559 ' O ' HG22 ' A' ' 73' ' ' THR . 6.6 p-10 179.17 -31.81 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.258 -0.645 . . . . 2.1899999999999999 109.258 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.626 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 18.3 ttt180 -34.57 -59.45 0.46 Allowed 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 125.649 1.58 . . . . 3.3799999999999999 111.189 176.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.703 HD13 ' H ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -88.8 -6.98 10.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.879 -1.055 . . . . 0.70999999999999996 111.223 -172.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.559 HG22 ' O ' ' A' ' 70' ' ' ASP . 0.7 OUTLIER -88.21 -45.13 10.34 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 120.326 -0.549 . . . . 0.96999999999999997 110.523 -171.614 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.517 ' CZ3' ' HB2' ' A' ' 198' ' ' ASN . 18.7 p-90 -102.24 1.38 35.81 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 120.54 -0.464 . . . . 0.75 110.95 -174.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.626 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 5.3 t70 -71.03 -171.07 0.51 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.878 0.846 . . . . 2.1899999999999999 111.578 -175.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.64 ' HD3' ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -126.34 -29.07 3.01 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.678 -1.146 . . . . 3.1899999999999999 109.217 -175.694 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.1 m -120.01 8.87 11.08 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.372 -0.831 . . . . 1.5800000000000001 110.142 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.567 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 39.6 mt -108.9 155.39 20.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.99 0.424 . . . . 0.70999999999999996 110.336 178.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.578 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 5.2 mm-40 -132.04 -69.37 0.6 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.54 -0.755 . . . . 1.73 111.509 -175.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.49 HG23 ' HB3' ' A' ' 79' ' ' GLN . 14.4 t -139.01 134.05 41.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.125 -0.489 . . . . 0.78000000000000003 110.377 -171.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.638 ' CD1' ' HB ' ' A' ' 68' ' ' THR . 15.9 t80 -117.53 137.05 52.82 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.827 -0.434 . . . . 5.4000000000000004 109.827 175.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.423 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 20.3 m120 -136.6 124.58 22.81 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.655 -0.869 . . . . 1.6899999999999999 108.655 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.472 ' CG ' ' HD3' ' A' ' 86' ' ' ARG . 21.4 tpp -80.21 97.2 6.83 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.163 -0.926 . . . . 2.0499999999999998 109.272 -176.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -75.65 -77.08 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.099 -0.501 . . . . 0.64000000000000001 111.817 -170.557 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -136.01 103.54 5.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.984 0.421 . . . . 1.96 110.459 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.472 ' HD3' ' CG ' ' A' ' 83' ' ' MET . 85.1 mtm180 -83.95 133.7 34.69 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.204 -0.665 . . . . 2.4399999999999999 109.204 175.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.623 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -86.57 -47.16 16.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.624 -0.716 . . . . 0.46999999999999997 109.32 -174.449 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -142.15 -152.34 0.4 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.224 -0.898 . . . . 1.8600000000000001 108.948 175.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.3 m -88.33 -7.86 56.04 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.039 0.385 . . . . 1.4399999999999999 112.039 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -134.4 14.99 3.77 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 120.365 -0.534 . . . . 1.8700000000000001 110.481 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.623 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.5 OUTLIER -136.49 103.96 5.42 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 108.09 -1.078 . . . . 0.46000000000000002 108.09 -178.68 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.605 ' O ' HD12 ' A' ' 114' ' ' LEU . 10.2 m-85 -120.65 172.59 7.75 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.008 0.432 . . . . 0.42999999999999999 110.224 -173.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.633 ' O ' HG23 ' A' ' 84' ' ' VAL . 42.4 mt -132.56 128.46 57.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 107.541 -1.281 . . . . 0.40999999999999998 107.541 168.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.592 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 26.1 p -106.6 129.91 54.45 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.407 -0.361 . . . . 2.0099999999999998 111.542 -173.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.538 ' HA ' HD13 ' A' ' 112' ' ' ILE . 4.1 t60 -94.35 90.93 6.46 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.148 -1.056 . . . . 1.23 108.148 163.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 85.3 m -108.53 109.33 20.55 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.536 -0.756 . . . . 0.5 111.787 -173.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.441 ' O ' ' HB2' ' A' ' 79' ' ' GLN . 44.7 mm -77.65 121.46 30.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.564 -0.902 . . . . 1.03 108.564 171.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.427 ' CG2' ' HB2' ' A' ' 109' ' ' ARG . 14.7 t -112.55 156.51 22.53 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.689 0.757 . . . . 1.3799999999999999 111.222 -176.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.578 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 20.9 mt-30 -107.48 37.7 2.34 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.481 -1.236 . . . . 1.8200000000000001 108.938 176.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 66.7 m -79.76 65.18 4.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.909 -0.587 . . . . 3.9100000000000001 110.045 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.493 ' HA ' ' HB ' ' A' ' 106' ' ' ILE . 46.2 p90 -117.82 128.21 54.63 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 115.552 -0.749 . . . . 5.1600000000000001 110.263 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.678 ' H ' HD12 ' A' ' 106' ' ' ILE . . . -77.22 64.72 2.68 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.942 -1.026 . . . . 1.98 110.959 177.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 97.7 t 74.25 -42.09 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.077 -0.965 . . . . 3.1699999999999999 112.939 172.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -167.4 -23.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 119.032 -1.556 . . . . 1.96 114.783 -176.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.0 m -83.55 2.82 35.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 117.874 0.837 . . . . 1.8799999999999999 111.239 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.678 HD12 ' H ' ' A' ' 102' ' ' ALA . 62.0 mt -136.9 140.63 42.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.943 -0.571 . . . . 1.1200000000000001 110.337 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.0 m -99.06 151.38 37.36 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.66 -0.496 . . . . 1.3500000000000001 109.66 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.16 147.95 10.61 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.162 2.575 . . . . 1.0700000000000001 112.195 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.508 ' HG2' HG23 ' A' ' 144' ' ' ILE . 42.6 mtt180 -121.97 157.08 32.08 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.709 -0.796 . . . . 3.4500000000000002 111.748 -170.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.824 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 7.1 t0 -104.48 116.74 32.63 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.276 -0.875 . . . . 1.3700000000000001 109.17 174.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.525 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 13.3 m-30 -100.56 109.77 21.88 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.89 -0.506 . . . . 2.4100000000000001 110.664 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.601 HG21 ' CE1' ' A' ' 134' ' ' PHE . 24.5 mm -104.96 76.15 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 N-CA-C 109.12 -0.696 . . . . 0.42999999999999999 109.12 173.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.595 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 25.7 m-20 -99.54 124.15 44.46 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.649 -0.705 . . . . 1.8600000000000001 110.435 -178.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.605 HD12 ' O ' ' A' ' 92' ' ' PHE . 3.5 tp -75.74 127.19 32.51 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 108.378 -0.971 . . . . 0.28000000000000003 108.378 169.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -128.62 124.51 61.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-N 115.485 -0.78 . . . . 0.26000000000000001 112.133 -163.582 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.564 ' CZ ' ' HG2' ' A' ' 8' ' ' GLN . 67.5 t80 -114.36 121.13 42.67 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.923 -1.035 . . . . 2.5699999999999998 110.943 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.564 HG12 HG22 ' A' ' 127' ' ' ILE . 88.7 mt -95.72 122.31 47.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.801 -0.636 . . . . 0.89000000000000001 110.438 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.42 ' HE2' ' HE2' ' A' ' 116' ' ' TYR . 13.4 tppt? -131.41 134.57 46.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.964 -0.562 . . . . 1.2 111.255 -173.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.0 tpp180 -112.93 100.49 8.68 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.908 -0.587 . . . . 2.7999999999999998 109.616 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -75.11 107.39 7.16 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.571 -1.27 . . . . 0.82999999999999996 107.571 169.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 1.7 mp0 -26.44 97.12 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 O-C-N 125.024 1.453 . . . . 2.2799999999999998 113.535 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.418 ' C ' HD22 ' A' ' 123' ' ' ASN . . . 56.7 31.89 61.1 Favored Glycine 0 CA--C 1.51 -0.22 0 CA-C-N 114.565 -1.198 . . . . 0.76000000000000001 113.242 177.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.645 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 0.8 OUTLIER -125.95 -49.01 1.61 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.957 -0.386 . . . . 1.6499999999999999 109.957 179.372 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.403 ' SD ' ' HB3' ' A' ' 123' ' ' ASN . 2.2 mpt? -157.56 141.3 15.79 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 110.259 -0.275 . . . . 1.1200000000000001 110.259 -178.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -120.33 85.93 2.48 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.404 -0.961 . . . . 1.6200000000000001 108.404 167.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.469 ' CG1' HG12 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -97.65 144.47 10.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.29 -1.323 . . . . 0.29999999999999999 112.282 -171.71 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.66 ' O ' HG13 ' A' ' 127' ' ' ILE . 2.1 pt -109.03 116.1 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 108.1 -1.074 . . . . 0.58999999999999997 108.1 161.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.592 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 43.3 p -83.94 159.05 21.36 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.822 -0.807 . . . . 1.1799999999999999 108.822 173.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.595 ' HB3' ' HB3' ' A' ' 113' ' ' ASP . 20.4 m -153.15 128.64 9.97 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 120.675 0.274 . . . . 1.24 111.05 -175.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -128.28 121.01 28.26 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 107.929 -1.137 . . . . 2.2599999999999998 107.929 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.457 ' HB2' ' H ' ' A' ' 148' ' ' ASN . 48.0 t -63.58 100.16 0.26 Allowed 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.318 -1.364 . . . . 1.3899999999999999 107.318 174.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -108.58 140.08 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.057 0 CA-C-N 114.348 -1.296 . . . . 1.05 108.691 -165.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -96.2 73.15 2.9 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.182 -0.917 . . . . 2.1699999999999999 109.633 -171.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.787 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -105.38 150.87 39.44 Favored Pre-proline 0 N--CA 1.437 -1.103 0 CA-C-N 114.704 -1.134 . . . . 0.53000000000000003 109.234 -174.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 8.2 Cg_exo -76.29 -9.77 19.04 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.736 2.291 . . . . 1.28 115.224 -169.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.787 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 7.4 tp10 -73.13 -13.25 61.14 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.906 -0.405 . . . . 3.5 109.906 -172.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.477 ' HB2' HG11 ' A' ' 84' ' ' VAL . 20.0 t80 -152.68 120.43 3.14 Favored Pre-proline 0 N--CA 1.449 -0.487 0 N-CA-C 113.419 0.896 . . . . 6.1200000000000001 113.419 174.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -99.92 134.83 0.22 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 124.046 3.164 . . . . 1.77 111.774 167.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.408 ' HG3' ' HB2' ' A' ' 145' ' ' ARG . 83.1 Cg_endo -79.23 -159.31 0.1 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.592 2.195 . . . . 1.25 112.136 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.0 p -145.48 -167.84 2.8 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.434 -0.58 . . . . 1.6000000000000001 109.434 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.1 t -88.58 -19.94 25.66 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.558 -0.457 . . . . 1.97 109.813 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -77.15 -32.26 56.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.053 -0.521 . . . . 2.1800000000000002 109.95 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.445 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 73.4 m-85 -130.58 114.97 16.12 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 115.659 -0.701 . . . . 1.23 109.461 176.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.508 HG23 ' HG2' ' A' ' 109' ' ' ARG . 2.0 tp -94.36 113.92 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 109.136 -0.69 . . . . 0.81999999999999995 109.136 -175.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.824 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 41.4 ttp180 -50.4 99.41 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.122 -0.945 . . . . 4.4199999999999999 109.672 173.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.6 122.04 26.85 Favored Glycine 0 N--CA 1.434 -1.483 0 CA-C-N 115.068 -0.969 . . . . 0.79000000000000004 111.784 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.619 ' H ' ' NH1' ' A' ' 176' ' ' ARG . 2.8 m-85 -82.16 79.42 8.66 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.876 0.846 . . . . 4.4400000000000004 110.955 177.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.457 ' H ' ' HB2' ' A' ' 131' ' ' SER . 17.4 m-20 -85.79 87.69 7.44 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.888 -1.505 . . . . 1.6200000000000001 108.435 172.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.5 ' HB2' ' HG2' ' A' ' 172' ' ' GLN . 96.4 m-70 -58.68 150.87 55.44 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-O 118.711 -0.661 . . . . 2.3199999999999998 109.367 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.619 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 50.9 Cg_exo -18.62 68.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.198 1 C-N-CA 127.055 5.17 . . . . 0.53000000000000003 116.12 -173.053 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . 0.568 ' HB2' ' O ' ' A' ' 170' ' ' PHE . 19.6 p -97.24 -173.81 2.77 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.618 -1.174 . . . . 1.5800000000000001 110.413 174.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.627 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -174.04 -160.65 22.69 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 120.573 -0.823 . . . . 0.42999999999999999 112.044 177.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.474 ' CZ ' HD11 ' A' ' 167' ' ' LEU . 35.4 t80 -161.57 96.08 1.03 Allowed 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.291 -1.003 . . . . 0.59999999999999998 108.291 -167.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.591 ' CG2' HG13 ' A' ' 168' ' ' VAL . 2.3 m -104.15 136.24 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 121.838 0.828 . . . . 0.31 111.188 -173.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 77.6 m -115.49 112.43 22.24 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.101 -0.954 . . . . 1.55 109.048 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.472 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 6.5 m -111.21 118.5 47.6 Favored Pre-proline 0 C--N 1.32 -0.7 0 C-N-CA 120.638 -0.425 . . . . 1.0600000000000001 111.762 -169.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.645 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 39.6 Cg_exo -49.88 119.65 5.07 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.265 1.977 . . . . 0.56000000000000005 111.136 170.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.585 ' SD ' ' HB2' ' A' ' 166' ' ' LYS . 60.4 mmm -79.68 -163.54 0.54 Allowed 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 120.916 0.389 . . . . 1.1599999999999999 111.376 -177.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -68.97 -26.33 64.98 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.476 0.655 . . . . 2.6299999999999999 109.978 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -98.88 15.51 25.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.454 -0.794 . . . . 2.0499999999999998 109.251 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.53 ' HB2' ' CD ' ' A' ' 162' ' ' PRO . 41.0 m-80 23.02 -87.81 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 126.051 1.74 . . . . 1.9299999999999999 115.484 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.53 ' CD ' ' HB2' ' A' ' 161' ' ' ASN . 73.5 Cg_endo -72.31 -16.7 27.89 Favored 'Trans proline' 0 C--N 1.364 1.374 0 CA-C-N 121.539 1.585 . . . . 0.72999999999999998 113.147 -174.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -90.93 -35.28 14.81 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.25 -0.432 . . . . 0.68000000000000005 111.181 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.571 ' O ' ' HB2' ' A' ' 158' ' ' MET . 93.8 m-85 -139.51 133.26 30.62 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.763 -0.458 . . . . 0.93000000000000005 109.763 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.417 ' HB3' HD11 ' A' ' 61' ' ' LEU . 32.4 t -125.99 148.09 49.37 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.514 0.673 . . . . 1.4099999999999999 111.092 -177.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.585 ' HB2' ' SD ' ' A' ' 158' ' ' MET . 1.8 tppp? -96.21 102.36 14.14 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.117 -0.947 . . . . 0.73999999999999999 111.235 -177.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.474 HD11 ' CZ ' ' A' ' 153' ' ' PHE . 0.5 OUTLIER -86.84 109.32 19.21 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.511 -1.222 . . . . 0.27000000000000002 109.006 177.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.591 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -131.32 128.74 61.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.439 0.638 . . . . 0.28000000000000003 111.804 177.422 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 23.1 ttt -129.79 145.16 51.57 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.808 -0.633 . . . . 1.24 110.692 -174.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.607 ' CD1' HG22 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -125.72 141.73 51.86 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.463 -0.79 . . . . 3.3700000000000001 109.474 -178.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 4.3 p -150.25 137.59 13.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 120.439 -0.504 . . . . 1.3999999999999999 110.512 173.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.639 HE21 ' N ' ' A' ' 172' ' ' GLN . 0.0 OUTLIER -127.4 52.67 1.8 Allowed 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 122.528 1.156 . . . . 2.1699999999999999 108.358 178.214 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.578 ' HB ' ' SD ' ' A' ' 175' ' ' MET . 1.8 m -56.14 148.16 18.71 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 113.492 -1.686 . . . . 1.6499999999999999 112.112 -174.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.496 ' OE1' ' HB3' ' A' ' 176' ' ' ARG . 38.3 tt0 -83.24 -26.9 30.31 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.571 -0.741 . . . . 2.4500000000000002 112.666 -178.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.578 ' SD ' ' HB ' ' A' ' 173' ' ' THR . 3.8 mpp? 44.45 56.07 5.27 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.167 0.508 . . . . 3.7400000000000002 110.918 -173.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.619 ' NH1' ' H ' ' A' ' 147' ' ' TYR . 0.0 OUTLIER -71.8 -1.58 14.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.424 -0.807 . . . . 5.7800000000000002 112.225 -175.413 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -81.97 -163.18 31.65 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.612 -0.804 . . . . 2.2599999999999998 111.996 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -94.82 78.95 3.67 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.042 0.449 . . . . 6.2300000000000004 110.296 -177.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.63 ' HB2' HD11 ' A' ' 184' ' ' ILE . 2.2 mp -121.02 162.55 19.76 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 109.237 -0.653 . . . . 1.6399999999999999 109.237 175.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.51 ' O ' HD12 ' A' ' 184' ' ' ILE . 14.9 m -114.09 161.03 30.16 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 108.393 -0.966 . . . . 2.04 108.393 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.433 ' O ' ' HG2' ' A' ' 185' ' ' GLU . 75.1 Cg_exo -41.02 -50.1 4.29 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 122.751 2.3 . . . . 1.74 113.114 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.496 ' O ' ' HG3' ' A' ' 186' ' ' LYS . 12.6 m -70.18 -15.01 62.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.344 0.498 . . . . 2.1400000000000001 112.344 -176.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.464 ' CG1' ' H ' ' A' ' 180' ' ' SER . 27.3 mm -84.59 -37.3 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-O 122.947 1.356 . . . . 1.1200000000000001 107.979 -176.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.966 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.4 mp -74.05 -35.16 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.691 0 CA-C-N 112.199 -2.273 . . . . 1.1299999999999999 110.149 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 181' ' ' PRO . 36.3 mm-40 -57.77 -26.42 61.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.961 -1.018 . . . . 2.8900000000000001 109.833 171.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 182' ' ' SER . 50.9 mtmt -92.76 -36.87 12.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.512 -0.767 . . . . 1.28 111.224 176.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.966 HG22 ' HA ' ' A' ' 184' ' ' ILE . 6.2 t -68.49 -45.71 71.63 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.259 0.466 . . . . 0.62 112.259 -172.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . 0.588 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 32.3 mmt -80.05 -57.88 0.64 Allowed Pre-proline 0 N--CA 1.464 0.258 0 N-CA-C 112.712 0.634 . . . . 1.0600000000000001 112.712 -173.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.656 ' O ' HG13 ' A' ' 193' ' ' VAL . 39.5 Cg_exo -58.21 -40.23 78.05 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.642 1.561 . . . . 0.91000000000000003 112.163 -175.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 69.8 m -77.24 -24.54 51.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.24 -0.436 . . . . 1.5 111.111 -175.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.579 ' HB2' ' O ' ' A' ' 187' ' ' THR . 46.5 t30 -80.15 -34.9 37.29 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.66 -0.416 . . . . 1.8799999999999999 110.529 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.537 ' HB3' ' CG1' ' A' ' 50' ' ' VAL . 53.9 mt -68.91 -42.95 76.17 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 120.633 0.254 . . . . 1.0900000000000001 111.027 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.656 HG13 ' O ' ' A' ' 189' ' ' PRO . 2.4 m -62.38 -31.43 51.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 121.65 0.738 . . . . 0.68000000000000005 109.179 176.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.406 ' HA ' ' HB2' ' A' ' 197' ' ' LEU . 1.0 OUTLIER -75.26 -31.12 60.68 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.366 -1.288 . . . . 2.0699999999999998 111.076 -179.409 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -68.75 -28.13 66.53 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 121.348 0.594 . . . . 2.0 109.775 171.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.546 ' O ' ' HD3' ' A' ' 200' ' ' LYS . 28.7 mt -81.86 -26.09 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-O 121.255 0.55 . . . . 0.31 111.206 173.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.406 ' HB2' ' HA ' ' A' ' 194' ' ' ASN . 37.6 mt -72.04 -43.06 65.55 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-N 116.346 -0.388 . . . . 1.03 110.403 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.517 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 5.4 p30 -55.71 -30.68 61.54 Favored 'General case' 0 C--O 1.213 -0.856 0 N-CA-C 108.428 -0.952 . . . . 1.8999999999999999 108.428 170.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.66 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -76.19 -45.42 33.32 Favored 'General case' 0 N--CA 1.428 -1.537 0 O-C-N 121.64 -0.663 . . . . 0.28999999999999998 110.422 -178.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.546 ' HD3' ' O ' ' A' ' 196' ' ' ILE . 1.5 mptm? -56.29 -45.11 80.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.877 -0.601 . . . . 0.96999999999999997 111.263 174.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -86.52 -37.02 18.62 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.43 -0.805 . . . . 1.9399999999999999 111.421 -173.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . 0.474 ' HA3' ' CH2' ' A' ' 74' ' ' TRP . . . -68.71 -32.58 74.51 Favored Glycine 0 N--CA 1.462 0.395 0 C-N-CA 120.999 -0.619 . . . . 0.46999999999999997 111.746 177.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.971 HD13 HD23 ' A' ' 61' ' ' LEU . 2.4 tp -69.88 -34.96 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 110.068 -0.345 . . . . 0.60999999999999999 110.068 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.478 ' O ' ' HB ' ' A' ' 208' ' ' THR . 65.3 mttm -89.34 -20.55 23.89 Favored 'General case' 0 C--O 1.215 -0.714 0 N-CA-C 109.305 -0.628 . . . . 3.3700000000000001 109.305 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -63.92 -37.15 86.34 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.719 -0.845 . . . . 1.02 108.719 168.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.48 ' HE1' ' OD2' ' A' ' 70' ' ' ASP . 35.6 m80 -76.34 -41.38 48.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.249 -0.887 . . . . 3.6299999999999999 111.831 174.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 203' ' ' ILE . 0.5 OUTLIER -87.14 -57.24 3.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.577 0.703 . . . . 2.5899999999999999 110.977 -170.604 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 204' ' ' LYS . 97.3 m -81.23 146.17 57.66 Favored Pre-proline 0 C--N 1.315 -0.934 0 CA-C-N 114.874 -1.057 . . . . 1.8400000000000001 110.2 -178.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -65.44 60.4 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.559 2.173 . . . . 2.3500000000000001 111.914 171.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.7 t -107.09 22.8 15.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.755 0.788 . . . . 2.3100000000000001 109.182 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 -90.08 2.5 55.17 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.385 -0.825 . . . . 5.4500000000000002 109.749 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -68.78 -23.14 64.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.27 -0.877 . . . . 6.8600000000000003 109.987 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -100.41 62.99 0.62 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.34 -1.104 . . . . 3.3700000000000001 110.34 169.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -69.24 99.75 1.21 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.03 0.443 . . . . 5.21 110.868 -174.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . 0.409 ' HD2' ' O ' ' A' ' 73' ' ' THR . 37.0 t60 -93.03 111.38 22.99 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.944 -0.571 . . . . 6.46 110.093 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 47.6 t60 67.0 147.98 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 O-C-N 123.837 0.71 . . . . 6.0899999999999999 111.21 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -72.52 112.69 8.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.283 0.563 . . . . 5.1200000000000001 110.385 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 11.8 m -53.96 -46.14 71.52 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 114.74 -1.118 . . . . 6.7599999999999998 112.461 -173.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -112.39 21.64 15.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.746 0.307 . . . . 8.8200000000000003 110.231 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 18.7 m . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.104 -0.95 . . . . 8.4800000000000004 110.755 -179.123 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.578 ' HG3' HG22 ' A' ' 87' ' ' ILE . 1.1 mpt? . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 120.862 0.363 . . . . 3.8599999999999999 110.866 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -81.7 -26.06 34.95 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 121.254 0.549 . . . . 2.25 109.745 -176.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.79 ' HA ' HD12 ' A' ' 6' ' ' ILE . 96.4 m-85 -68.64 -30.03 68.65 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.477 -0.783 . . . . 0.42999999999999999 109.056 -176.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.62 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 3.0 tppp? -70.72 -7.42 44.61 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 114.95 -1.023 . . . . 1.51 109.986 176.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.71 -42.15 10.88 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.151 0.501 . . . . 0.54000000000000004 109.804 174.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.79 HD12 ' HA ' ' A' ' 3' ' ' PHE . 1.3 mp -81.82 -43.9 19.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.98 -0.748 . . . . 1.0700000000000001 108.98 -172.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.888 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -67.68 -47.96 67.98 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.546 -1.206 . . . . 0.34000000000000002 111.653 -178.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.62 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 4.3 mt-30 -63.9 -27.02 68.86 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.27 -1.332 . . . . 1.5900000000000001 110.722 -176.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.477 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 27.7 mt-30 -82.45 -39.2 22.89 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.201 -0.909 . . . . 2.4700000000000002 109.211 171.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.931 HG21 ' HZ2' ' A' ' 130' ' ' LYS . 0.5 OUTLIER -65.44 -37.67 87.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.844 -1.071 . . . . 0.47999999999999998 112.401 -177.67 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.52 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -47.36 -53.05 14.77 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.132 0.419 . . . . 0.31 112.132 176.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.564 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 28.3 pt20 -79.87 -4.54 52.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.75 0.31 . . . . 1.6399999999999999 111.115 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 10' ' ' THR . 70.8 mm-40 -75.98 -54.38 6.96 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.206 -0.664 . . . . 2.54 109.206 172.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.621 HG21 ' N ' ' A' ' 152' ' ' GLY . 12.6 p -70.18 -36.83 69.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 114.82 -1.082 . . . . 0.53000000000000003 110.334 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.564 ' HB3' ' HA ' ' A' ' 12' ' ' GLN . 0.6 OUTLIER -69.16 -24.4 64.07 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-O 122.059 0.933 . . . . 0.59999999999999998 108.869 174.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.45 -17.74 68.95 Favored Glycine 0 CA--C 1.501 -0.833 0 CA-C-N 113.755 -1.566 . . . . 0.56999999999999995 109.967 177.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.576 ' HA ' ' CB ' ' A' ' 20' ' ' ASP . 30.8 m-85 -90.39 -23.85 20.95 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 114.755 -0.723 . . . . 3.27 109.381 176.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.549 ' HA ' ' HZ ' ' A' ' 170' ' ' PHE . 66.2 t30 -66.48 -19.74 65.86 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-O 121.452 0.644 . . . . 2.0299999999999998 109.541 176.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -120.2 10.58 11.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.433 -0.803 . . . . 2.7200000000000002 110.294 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.576 ' CB ' ' HA ' ' A' ' 17' ' ' TYR . 9.2 t70 -86.07 -31.58 21.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.258 -0.883 . . . . 2.1600000000000001 110.773 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.3 t -16.65 86.99 0.0 OUTLIER 'General case' 0 C--O 1.235 0.309 0 O-C-N 125.485 1.741 . . . . 1.8200000000000001 113.733 -169.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.5 t -172.64 137.48 0.8 Allowed 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.352 -1.749 . . . . 2.1899999999999999 109.068 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.37 -11.5 68.77 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.637 -0.792 . . . . 1.1000000000000001 112.19 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.833 ' HA ' ' HB3' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -104.39 -160.24 0.75 Allowed 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 120.97 0.414 . . . . 1.6699999999999999 110.775 -179.634 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.471 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 2.0 tmmm? -170.48 128.97 0.83 Allowed 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 115.442 -0.799 . . . . 2.9500000000000002 109.18 -174.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.581 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 0.1 OUTLIER -70.35 109.3 2.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-O 121.947 0.879 . . . . 1.5600000000000001 109.374 175.017 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 p -93.19 -25.07 5.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 114.172 -1.376 . . . . 1.22 109.46 -172.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.456 ' HD2' ' HA ' ' A' ' 28' ' ' LYS . 17.4 tptp -153.95 132.03 11.78 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 119.755 -0.778 . . . . 2.4100000000000001 112.015 -175.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.702 ' HB ' ' HA ' ' A' ' 34' ' ' THR . 0.0 OUTLIER -152.01 152.76 32.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.236 0.541 . . . . 1.3799999999999999 112.06 177.292 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 35.6 m -104.6 25.68 9.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.423 -0.808 . . . . 2.3700000000000001 110.499 175.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 30' ' ' SER . 28.6 mmmt 75.53 19.0 2.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.81 -0.632 . . . . 4.5499999999999998 111.911 175.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.581 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 9.3 mmtp -164.76 -30.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.795 -0.639 . . . . 1.4199999999999999 110.073 175.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.906 HG22 ' HA3' ' A' ' 52' ' ' GLY . 29.7 pt -110.87 136.9 45.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 108.629 -0.878 . . . . 0.76000000000000001 108.629 171.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.702 ' HA ' ' HB ' ' A' ' 29' ' ' THR . 0.2 OUTLIER -140.35 115.62 9.91 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.506 0.194 . . . . 0.57999999999999996 111.206 -162.439 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.687 HG22 HG23 ' A' ' 50' ' ' VAL . 6.2 t -99.67 115.04 39.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.957 0.408 . . . . 0.85999999999999999 110.563 -177.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.581 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -107.81 122.76 47.42 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.844 -0.617 . . . . 1.1000000000000001 110.226 -177.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.5 t -114.73 131.46 56.76 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.908 -0.587 . . . . 1.27 112.301 -172.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.833 ' HB3' ' HA ' ' A' ' 24' ' ' TRP . 56.5 pttt -153.13 148.49 27.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.516 -0.765 . . . . 1.9099999999999999 110.057 167.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.691 ' HA ' ' HA ' ' A' ' 46' ' ' ASN . . . -53.01 126.62 21.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.216 -0.447 . . . . 1.6799999999999999 110.24 175.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.513 ' OG ' ' HB2' ' A' ' 47' ' ' LEU . 4.7 m -66.04 -22.4 66.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.618 -0.719 . . . . 2.0899999999999999 111.771 -173.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 40' ' ' SER . 17.3 mmm180 76.08 -10.1 1.34 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 124.032 0.833 . . . . 6.6100000000000003 112.412 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.39 -10.83 60.29 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.62 -0.511 . . . . 6.46 109.62 174.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.658 ' HD1' ' H ' ' A' ' 44' ' ' HIS . 0.5 OUTLIER 172.73 -169.95 0.03 OUTLIER 'General case' 0 C--O 1.236 0.378 0 N-CA-C 106.191 -1.781 . . . . 5.6500000000000004 106.191 177.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.658 ' H ' ' HD1' ' A' ' 43' ' ' PHE . 19.9 t-80 -83.72 83.59 7.86 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.827 -0.749 . . . . 5.5599999999999996 109.686 175.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.61 139.44 5.93 Favored Glycine 0 N--CA 1.432 -1.59 0 N-CA-C 108.61 -1.796 . . . . 1.5600000000000001 108.61 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.691 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 4.5 m-20 -92.47 146.81 23.39 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.39 0.614 . . . . 2.0499999999999998 111.311 -174.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.531 HD23 ' N ' ' A' ' 48' ' ' TYR . 3.1 tt -104.8 133.64 49.28 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.735 -1.209 . . . . 0.87 107.735 176.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.531 ' N ' HD23 ' A' ' 47' ' ' LEU . 22.7 m-85 -117.54 124.42 48.67 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.959 -0.386 . . . . 0.98999999999999999 109.959 -175.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.595 ' HD3' ' CH2' ' A' ' 24' ' ' TRP . 11.6 ttp180 -105.43 116.99 32.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.01 -0.541 . . . . 2.9199999999999999 109.769 175.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.687 HG23 HG22 ' A' ' 35' ' ' VAL . 8.8 p -100.69 136.33 32.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 C-N-CA 119.802 -0.759 . . . . 1.3300000000000001 109.027 174.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.877 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 27.6 tt0 -137.8 108.8 6.73 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.359 -0.837 . . . . 1.0700000000000001 109.963 -169.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.906 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -139.4 140.42 10.84 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.248 -0.977 . . . . 0.28999999999999998 111.828 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 67.7 mt -84.69 116.82 28.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 C-N-CA 120.005 -0.678 . . . . 0.57999999999999996 110.656 178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.545 HG12 ' HD3' ' A' ' 200' ' ' LYS . 63.6 mt -101.54 113.35 65.85 Favored Pre-proline 0 C--N 1.314 -0.974 0 N-CA-C 108.355 -0.98 . . . . 0.34999999999999998 108.355 173.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.533 ' HA ' ' HA ' ' A' ' 164' ' ' TYR . 28.3 Cg_exo -64.12 56.25 0.22 Allowed 'Trans proline' 0 N--CA 1.478 0.561 0 C-N-CA 124.574 3.516 . . . . 0.62 114.105 -174.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.999 ' HG3' HG12 ' A' ' 203' ' ' ILE . 63.4 mm-40 -132.34 -157.19 0.8 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.628 -0.715 . . . . 1.6799999999999999 109.581 176.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 62.7 p -101.11 145.44 30.42 Favored Pre-proline 0 N--CA 1.415 -2.19 0 CA-C-N 114.798 -1.092 . . . . 1.1799999999999999 108.286 168.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 57' ' ' SER . 39.9 Cg_exo -56.84 -11.1 6.51 Favored 'Trans proline' 0 C--N 1.324 -0.727 0 C-N-CA 123.967 3.112 . . . . 0.52000000000000002 110.989 175.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.42 -48.47 9.61 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.857 -1.065 . . . . 0.64000000000000001 111.438 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.685 ' HD2' ' HB3' ' A' ' 206' ' ' HIS . 3.4 tppt? -62.76 -33.62 75.54 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.52 -0.919 . . . . 3.2999999999999998 108.52 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.978 HD23 HD13 ' A' ' 203' ' ' ILE . 70.9 mt -57.19 -56.91 15.65 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.737 -1.12 . . . . 0.40999999999999998 110.864 173.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.482 ' HA ' ' CD1' ' A' ' 65' ' ' LEU . 53.0 m -65.92 -8.34 21.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.292 0.568 . . . . 1.29 110.643 177.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' A' ' 60' ' ' LYS . 25.1 t70 -88.34 -32.31 18.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.672 -0.694 . . . . 1.3200000000000001 111.83 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.615 ' CD2' ' HA ' ' A' ' 61' ' ' LEU . 16.2 p90 -79.58 -43.53 22.79 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 120.225 -0.59 . . . . 0.60999999999999999 110.019 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.653 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -91.16 3.84 53.75 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 120.548 -0.461 . . . . 1.5 111.962 -174.523 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.407 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 24.8 t80 -14.1 -70.66 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 125.378 1.674 . . . . 1.52 113.475 -169.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.456 ' NE2' HG21 ' A' ' 115' ' ' VAL . 7.0 tp-100 -176.19 -47.17 0.01 OUTLIER 'General case' 0 C--N 1.341 0.233 0 N-CA-C 113.147 0.795 . . . . 3.6000000000000001 113.147 172.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.631 ' OG1' ' HB2' ' A' ' 81' ' ' TYR . 10.6 t -160.11 23.14 0.17 Allowed 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.136 -0.626 . . . . 1.48 111.766 -167.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -126.94 -14.01 2.86 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 118.655 -1.736 . . . . 1.46 114.479 -170.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.667 ' O ' HG22 ' A' ' 73' ' ' THR . 4.8 t70 -157.17 -33.65 0.08 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.384 0.611 . . . . 2.1899999999999999 110.726 -172.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.676 ' O ' ' HB3' ' A' ' 75' ' ' ASP . 2.0 ptp180 -52.3 -39.55 60.68 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.075 -0.966 . . . . 3.3799999999999999 111.693 -173.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.81 ' H ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -87.96 -5.26 10.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.841 -0.618 . . . . 0.70999999999999996 111.442 -175.492 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.667 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.3 t -88.63 -27.43 21.32 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 119.104 -1.038 . . . . 0.96999999999999997 109.418 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.993 ' HZ3' ' HB2' ' A' ' 198' ' ' ASN . 30.7 p-90 -112.32 -0.2 15.5 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.914 -0.585 . . . . 0.75 111.888 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.691 ' CG ' ' HB2' ' A' ' 78' ' ' LEU . 0.9 OUTLIER -68.07 176.96 2.4 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 114.107 1.151 . . . . 2.1899999999999999 114.107 -167.335 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.498 ' NZ ' ' HB2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -143.45 -4.41 0.88 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 113.708 -1.587 . . . . 3.1899999999999999 111.412 170.43 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.8 m -121.35 6.82 10.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.437 0.636 . . . . 1.5800000000000001 109.75 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.691 ' HB2' ' CG ' ' A' ' 75' ' ' ASP . 98.7 mt -118.52 -158.36 0.72 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.295 -0.866 . . . . 0.70999999999999996 110.323 -175.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.443 ' HB3' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -173.57 -58.99 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.871 0.367 . . . . 1.73 111.201 -173.428 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 96' ' ' THR . 39.9 t -145.42 139.41 21.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.307 -0.406 . . . . 0.78000000000000003 110.747 -169.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.727 ' HB3' HD12 ' A' ' 72' ' ' ILE . 44.4 p90 -104.89 152.79 22.2 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.899 -0.591 . . . . 5.4000000000000004 111.537 177.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.89 ' HB3' ' HB3' ' A' ' 95' ' ' HIS . 50.7 t-20 -160.09 104.72 1.51 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.477 -0.564 . . . . 1.6899999999999999 109.477 172.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.9 ttt -74.2 92.45 2.23 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.394 -0.965 . . . . 2.0499999999999998 108.394 176.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -77.12 -63.25 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.86 -0.609 . . . . 0.64000000000000001 111.571 -169.329 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.553 ' HB3' HD12 ' A' ' 93' ' ' ILE . 9.5 t60 -140.09 113.83 8.75 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.824 -0.436 . . . . 1.96 109.824 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.07 132.71 42.59 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.516 -0.92 . . . . 2.4399999999999999 108.516 175.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.663 HG21 ' HB2' ' A' ' 3' ' ' PHE . 0.1 OUTLIER -90.44 -48.84 14.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.148 0.499 . . . . 0.46999999999999997 111.181 -170.298 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.507 ' CG ' ' H ' ' A' ' 89' ' ' SER . 25.3 t70 -157.14 -148.37 0.21 Allowed 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.588 -0.893 . . . . 1.8600000000000001 108.588 -173.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.507 ' H ' ' CG ' ' A' ' 88' ' ' ASP . 47.6 t -59.26 -49.93 75.94 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.644 0.609 . . . . 1.4399999999999999 112.644 -170.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.721 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 17.7 m-20 -139.91 39.93 1.98 Allowed 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.837 0.827 . . . . 1.8700000000000001 108.895 -171.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.663 ' O ' HG12 ' A' ' 87' ' ' ILE . 1.7 m -135.08 113.21 11.19 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.356 -1.35 . . . . 0.46000000000000002 107.356 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.592 ' O ' HD12 ' A' ' 114' ' ' LEU . 25.8 m-85 -131.0 174.32 10.12 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.594 0.711 . . . . 0.42999999999999999 111.07 -173.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.553 HD12 ' HB3' ' A' ' 85' ' ' HIS . 29.9 mt -131.76 132.98 61.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 106.305 -1.739 . . . . 0.40999999999999998 106.305 165.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 34.2 t -122.35 135.6 54.74 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.064 -0.654 . . . . 2.0099999999999998 110.616 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.89 ' HB3' ' HB3' ' A' ' 82' ' ' ASN . 6.8 t-160 -99.66 80.7 2.39 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 124.37 1.044 . . . . 1.23 109.157 172.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.892 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 93.0 m -89.9 150.35 22.23 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 115.129 -0.941 . . . . 0.5 109.909 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.443 ' HB ' ' HB3' ' A' ' 79' ' ' GLN . 49.4 mm -101.48 131.16 49.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 108.618 -0.882 . . . . 1.03 108.618 167.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.623 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 17.2 m -110.5 126.45 54.39 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.857 -0.61 . . . . 1.3799999999999999 111.493 -171.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -91.96 43.04 1.12 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.247 0.546 . . . . 1.8200000000000001 110.405 177.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.3 t -92.79 70.98 4.81 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.372 0.606 . . . . 3.9100000000000001 109.703 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -112.24 114.41 27.18 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.412 -0.813 . . . . 5.1600000000000001 110.731 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.595 ' HB1' ' HD2' ' A' ' 186' ' ' LYS . . . -70.52 71.64 0.48 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.897 -1.047 . . . . 1.98 110.099 173.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 92.6 t 77.53 -40.68 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 114.811 -1.086 . . . . 3.1699999999999999 110.937 176.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 166.5 -16.11 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.833 -0.699 . . . . 1.96 112.473 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.8 m -65.63 -48.8 70.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.1 0.476 . . . . 1.8799999999999999 109.82 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.751 HG21 HH11 ' A' ' 176' ' ' ARG . 3.4 mp -86.56 121.85 38.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 108.757 -0.831 . . . . 1.1200000000000001 108.757 170.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.3 m -76.96 160.03 77.27 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 109.927 -0.397 . . . . 1.3500000000000001 109.927 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.404 ' HB2' ' CD1' ' A' ' 143' ' ' TYR . 76.0 Cg_exo -49.59 145.31 17.27 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.446 2.097 . . . . 1.0700000000000001 111.249 174.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.771 ' CZ ' ' HA2' ' A' ' 146' ' ' GLY . 0.2 OUTLIER -107.44 141.44 38.84 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 119.803 -0.759 . . . . 3.4500000000000002 110.164 -170.102 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.615 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 12.0 t70 -94.69 115.16 27.2 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 107.81 -1.181 . . . . 1.3700000000000001 107.81 177.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.892 ' HB3' ' HB ' ' A' ' 96' ' ' THR . 63.9 t80 -97.87 108.92 21.74 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.789 -0.448 . . . . 2.4100000000000001 109.789 -168.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.622 ' CG2' ' HE1' ' A' ' 134' ' ' PHE . 13.5 mm -123.71 75.81 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 N-CA-C 108.811 -0.811 . . . . 0.42999999999999999 108.811 173.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.788 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 0.7 OUTLIER -109.41 124.78 51.57 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.466 -0.788 . . . . 1.8600000000000001 110.745 -177.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 1.007 HD23 ' HE2' ' A' ' 130' ' ' LYS . 8.9 tp -75.61 117.03 16.94 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 115.275 -0.875 . . . . 0.28000000000000003 109.275 171.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.495 HG23 ' HB ' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -118.41 123.97 72.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-N 114.484 -1.235 . . . . 0.26000000000000001 111.491 -164.402 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.888 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 35.9 t80 -109.93 121.69 45.82 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.585 -0.734 . . . . 2.5699999999999998 111.2 175.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.897 HG13 HG22 ' A' ' 127' ' ' ILE . 3.6 mp -87.39 99.42 8.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.505 -0.924 . . . . 0.89000000000000001 108.505 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.872 ' HD3' ' HE2' ' A' ' 116' ' ' TYR . 57.3 tptt -102.28 131.16 49.04 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.893 -1.049 . . . . 1.2 110.079 -174.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.433 ' HD2' ' C ' ' A' ' 119' ' ' ARG . 4.0 tpt180 -125.61 88.97 2.95 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 108.505 -0.924 . . . . 2.7999999999999998 108.505 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.651 ' CB ' ' HB3' ' A' ' 123' ' ' ASN . 53.9 m-85 -69.42 119.17 13.26 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.759 -1.11 . . . . 0.82999999999999996 108.359 172.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -33.53 95.89 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 125.024 1.453 . . . . 2.2799999999999998 112.955 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 53.95 42.05 69.45 Favored Glycine 0 CA--C 1.508 -0.38 0 CA-C-N 114.684 -1.144 . . . . 0.76000000000000001 112.041 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.651 ' HB3' ' CB ' ' A' ' 120' ' ' TYR . 3.3 t-20 -132.71 -49.76 0.9 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.922 -0.639 . . . . 1.6499999999999999 110.273 -175.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.443 ' CG ' ' HB ' ' A' ' 154' ' ' VAL . 3.9 tpp -158.37 144.31 16.99 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.637 -0.425 . . . . 1.1200000000000001 111.383 -178.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.402 ' OD1' ' HD3' ' A' ' 119' ' ' ARG . 0.7 OUTLIER -120.09 81.22 1.71 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.378 -0.971 . . . . 1.6200000000000001 108.378 172.336 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.745 HG23 ' HB3' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -109.01 146.26 14.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.212 -0.904 . . . . 0.29999999999999999 113.424 -170.541 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.897 HG22 HG13 ' A' ' 117' ' ' ILE . 4.6 pt -107.58 110.72 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.549 0.69 . . . . 0.58999999999999997 109.155 161.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.52 ' HB3' ' HA ' ' A' ' 11' ' ' ALA . 15.8 p -93.83 112.4 24.25 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.325 0.583 . . . . 1.1799999999999999 111.06 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.788 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 54.6 p -102.86 158.85 15.98 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.724 -0.671 . . . . 1.24 111.68 -171.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 1.007 ' HE2' HD23 ' A' ' 114' ' ' LEU . 4.5 mtmm -147.39 124.44 11.4 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 115.939 -0.573 . . . . 2.2599999999999998 109.457 175.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.401 ' HB3' ' H ' ' A' ' 148' ' ' ASN . 31.9 p -67.04 91.63 0.22 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.336 -0.987 . . . . 1.3899999999999999 108.336 174.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.93 133.84 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 CA-C-N 115.131 -0.94 . . . . 1.05 109.274 -163.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.447 ' HB2' HH22 ' A' ' 145' ' ' ARG . 9.2 t70 -94.51 73.4 3.77 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.479 -1.237 . . . . 2.1699999999999999 108.761 -167.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.745 ' O ' ' HB3' ' A' ' 137' ' ' TYR . 1.6 p90 -107.02 173.75 2.93 Favored Pre-proline 0 CA--C 1.554 1.101 0 CA-C-N 114.85 -1.068 . . . . 0.53000000000000003 110.709 -170.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.61 ' HB2' ' OE2' ' A' ' 136' ' ' GLU . 60.2 Cg_exo -53.13 -48.61 21.16 Favored 'Trans proline' 0 N--CA 1.486 1.079 0 C-N-CA 123.292 2.661 . . . . 1.28 116.438 -171.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.703 ' HG2' ' CE2' ' A' ' 134' ' ' PHE . 0.6 OUTLIER -79.43 -9.3 59.57 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 121.53 0.681 . . . . 3.5 111.595 -173.147 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.809 ' HE1' ' HG3' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -54.4 -38.98 71.64 Favored Pre-proline 0 CA--C 1.556 1.196 0 N-CA-C 116.888 2.181 . . . . 6.1200000000000001 116.888 -172.239 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.499 ' HD2' ' C ' ' A' ' 136' ' ' GLU . 34.2 Cg_exo -30.52 110.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 123.875 3.05 . . . . 1.77 115.901 -170.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.49 ' HG3' ' HB2' ' A' ' 145' ' ' ARG . 29.6 Cg_endo -89.88 -155.89 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 124.345 3.363 . . . . 1.25 112.308 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 38.8 m -148.47 143.92 27.05 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 108.727 -0.842 . . . . 1.6000000000000001 108.727 177.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.7 p -58.17 -17.57 19.64 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.568 1.322 . . . . 1.97 114.568 -167.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.416 HD22 ' HA ' ' A' ' 142' ' ' ASN . 8.1 m120 -83.11 -15.93 48.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.099 0.409 . . . . 2.1800000000000002 111.103 177.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.404 ' CD1' ' HB2' ' A' ' 108' ' ' PRO . 72.8 m-85 -126.11 108.75 11.64 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.255 -1.017 . . . . 1.23 108.255 175.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.684 HG23 ' HD2' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -82.91 111.73 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 C-N-CA 120.123 -0.631 . . . . 0.81999999999999995 109.395 -171.253 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.809 ' HG3' ' HE1' ' A' ' 137' ' ' TYR . 0.2 OUTLIER -41.36 113.91 0.45 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.939 0.4 . . . . 4.4199999999999999 110.632 171.003 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.771 ' HA2' ' CZ ' ' A' ' 109' ' ' ARG . . . -51.29 130.18 33.21 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.047 -0.978 . . . . 0.79000000000000004 112.478 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.909 ' HB3' ' HG3' ' A' ' 174' ' ' GLU . 0.2 OUTLIER -104.99 63.85 0.71 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.743 0.782 . . . . 4.4400000000000004 109.873 175.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.585 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 81.8 m-20 -86.88 108.28 18.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.156 -1.384 . . . . 1.6200000000000001 109.558 178.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -80.31 132.18 60.01 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 109.468 -0.567 . . . . 2.3199999999999998 109.468 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.524 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 51.9 Cg_exo -9.25 61.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.009 1 C-N-CA 126.828 5.019 . . . . 0.53000000000000003 115.628 -161.671 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . 0.715 ' HB3' ' O ' ' A' ' 170' ' ' PHE . 3.0 m -76.97 -174.75 3.24 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.931 -1.031 . . . . 1.5800000000000001 109.618 174.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.621 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -171.29 -163.94 26.14 Favored Glycine 0 N--CA 1.429 -1.784 0 C-N-CA 119.666 -1.254 . . . . 0.42999999999999999 111.828 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.476 ' HB3' ' CG1' ' A' ' 127' ' ' ILE . 52.9 t80 -161.92 79.18 0.54 Allowed 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.687 -1.227 . . . . 0.59999999999999998 107.687 -168.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.726 HG12 ' HB ' ' A' ' 126' ' ' ILE . 5.2 m -90.33 128.66 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-O 121.733 0.777 . . . . 0.31 110.422 -174.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 60.8 m -99.82 111.18 23.52 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.305 -0.998 . . . . 1.55 108.305 171.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.812 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 18.9 m -97.6 119.79 61.92 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 115.817 -0.629 . . . . 1.0600000000000001 111.378 -170.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.527 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 50.7 Cg_exo -55.28 111.87 0.88 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.454 2.103 . . . . 0.56000000000000005 111.074 170.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 74.3 mmm -74.99 -166.33 0.47 Allowed 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.373 0.606 . . . . 1.1599999999999999 111.634 -177.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.42 ' H ' ' HB3' ' A' ' 158' ' ' MET . 3.9 tp10 -70.97 -34.52 71.5 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.624 -0.88 . . . . 2.6299999999999999 108.624 174.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -102.06 30.34 4.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.371 -1.286 . . . . 2.0499999999999998 108.918 175.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.623 ' OD1' ' HD3' ' A' ' 162' ' ' PRO . 3.7 p30 -31.43 -48.86 0.42 Allowed Pre-proline 0 N--CA 1.475 0.815 0 N-CA-C 117.107 2.262 . . . . 1.9299999999999999 117.107 -168.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.623 ' HD3' ' OD1' ' A' ' 161' ' ' ASN . 71.6 Cg_endo -76.83 -9.93 18.27 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 CA-C-N 121.976 1.741 . . . . 0.72999999999999998 113.177 -175.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -116.47 -22.66 8.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.042 -0.526 . . . . 0.68000000000000005 110.801 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 55' ' ' PRO . 61.8 m-85 -136.25 121.39 19.0 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.357 -0.608 . . . . 0.93000000000000005 109.357 174.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 38.6 t -116.97 139.47 50.62 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.555 -0.458 . . . . 1.4099999999999999 110.439 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.877 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 2.3 tppp? -89.12 105.35 17.73 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.866 0.841 . . . . 0.73999999999999999 110.984 -177.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.588 HD23 HD13 ' A' ' 61' ' ' LEU . 0.9 OUTLIER -86.82 102.05 13.92 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.338 -0.846 . . . . 0.27000000000000002 108.905 178.409 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.691 HG12 ' HG3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -124.5 119.33 56.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.955 0.884 . . . . 0.28000000000000003 111.587 178.246 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 21.5 ttt -120.04 148.74 43.19 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.824 -1.08 . . . . 1.24 109.532 -175.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.715 ' O ' ' HB3' ' A' ' 151' ' ' CYS . 38.7 m-85 -127.09 135.06 50.24 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.336 -0.986 . . . . 3.3700000000000001 108.336 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.438 HG22 HG22 ' A' ' 173' ' ' THR . 7.8 p -126.69 118.58 51.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.682 0.753 . . . . 1.3999999999999999 110.965 177.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.01 63.7 0.7 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.443 -0.947 . . . . 2.1699999999999999 108.443 177.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 147' ' ' TYR . 3.8 t -98.24 154.18 17.97 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.767 -1.106 . . . . 1.6499999999999999 110.145 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.909 ' HG3' ' HB3' ' A' ' 147' ' ' TYR . 0.0 OUTLIER -80.3 14.89 1.76 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.45 0.537 . . . . 2.4500000000000002 112.45 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.612 ' HB2' ' O ' ' A' ' 174' ' ' GLU . 26.3 mmt 81.53 19.81 0.38 Allowed 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.598 0.713 . . . . 3.7400000000000002 110.153 169.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.751 HH11 HG21 ' A' ' 106' ' ' ILE . 0.0 OUTLIER 39.39 74.4 0.09 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 113.77 -1.559 . . . . 5.7800000000000002 113.257 172.352 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 108.82 -15.88 33.92 Favored Glycine 0 C--N 1.311 -0.809 0 CA-C-N 115.262 -0.881 . . . . 2.2599999999999998 112.873 177.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 61.5 tttp 66.96 85.4 0.14 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.382 0.611 . . . . 6.2300000000000004 110.416 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.61 ' H ' HD22 ' A' ' 179' ' ' LEU . 0.1 OUTLIER -88.81 -151.91 0.22 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.812 -0.631 . . . . 1.6399999999999999 110.839 -176.097 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.432 ' OG ' ' HD2' ' A' ' 181' ' ' PRO . 26.6 t -111.28 152.79 44.07 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.017 -1.105 . . . . 2.04 108.017 174.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.432 ' HD2' ' OG ' ' A' ' 180' ' ' SER . 44.7 Cg_exo -36.25 -50.5 1.21 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.599 2.866 . . . . 1.74 114.205 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.1 m -65.12 -16.87 63.96 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.466 0.543 . . . . 2.1400000000000001 112.466 -176.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.598 ' HA ' ' HE3' ' A' ' 186' ' ' LYS . 8.2 mm -92.01 -35.33 6.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 122.224 1.012 . . . . 1.1200000000000001 109.147 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 1.007 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.0 OUTLIER -74.96 -31.87 26.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 113.389 -1.732 . . . . 1.1299999999999999 110.741 -177.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.89 -19.94 58.45 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.218 -1.03 . . . . 2.8900000000000001 108.218 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.598 ' HE3' ' HA ' ' A' ' 183' ' ' ILE . 0.2 OUTLIER -91.89 -24.52 19.29 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.085 -1.416 . . . . 1.28 110.31 173.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 1.007 HG22 ' HA ' ' A' ' 184' ' ' ILE . 3.5 t -89.5 -41.14 12.21 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 119.975 -0.69 . . . . 0.62 112.763 -177.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . 0.907 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 21.7 mmt -80.67 -65.64 0.26 Allowed Pre-proline 0 N--CA 1.467 0.383 0 O-C-N 121.619 -0.676 . . . . 1.0600000000000001 112.108 -174.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.907 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 17.3 Cg_exo -65.63 -20.8 59.78 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.184 1.923 . . . . 0.91000000000000003 112.162 -173.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.441 ' HB3' ' O ' ' A' ' 186' ' ' LYS . 22.6 t -84.64 -36.28 22.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.989 -0.551 . . . . 1.5 110.187 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -79.98 -37.06 35.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.249 -0.432 . . . . 1.8799999999999999 111.579 -174.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.623 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 20.3 mt -67.07 -45.8 76.24 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 121.007 -0.277 . . . . 1.0900000000000001 111.516 -175.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.838 ' HB ' HD12 ' A' ' 33' ' ' ILE . 27.9 m -71.73 -24.12 22.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.1 -0.64 . . . . 0.68000000000000005 110.406 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.425 ' HB3' ' HE3' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -73.35 -32.83 64.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.869 -0.605 . . . . 2.0699999999999998 110.755 174.058 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.636 ' HA ' ' OD1' ' A' ' 198' ' ' ASN . 2.2 m-85 -65.1 -30.74 71.7 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.139 0.495 . . . . 2.0 110.319 174.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.502 HG12 HD12 ' A' ' 167' ' ' LEU . 60.4 mt -79.6 -24.58 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-O 121.365 0.603 . . . . 0.31 110.644 175.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 197' ' ' LEU . 34.2 mt -73.11 -42.82 62.51 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.274 -0.421 . . . . 1.03 110.827 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.993 ' HB2' ' HZ3' ' A' ' 74' ' ' TRP . 1.8 p-10 -67.43 -15.07 63.47 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.386 -0.926 . . . . 1.8999999999999999 109.469 171.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.691 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -80.81 -42.27 21.95 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 109.404 -0.591 . . . . 0.28999999999999998 109.404 173.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.545 ' HD3' HG12 ' A' ' 54' ' ' ILE . 28.1 mmtp -59.56 -44.69 93.2 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 121.553 0.692 . . . . 0.96999999999999997 110.013 173.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -80.48 -39.81 27.33 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.897 -1.047 . . . . 1.9399999999999999 110.984 -174.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -69.51 -31.2 70.92 Favored Glycine 0 CA--C 1.507 -0.464 0 C-N-CA 120.717 -0.754 . . . . 0.46999999999999997 111.395 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.999 HG12 ' HG3' ' A' ' 56' ' ' GLU . 1.5 tp -71.69 -34.57 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 120.574 0.226 . . . . 0.60999999999999999 110.449 177.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 66.4 mttm -86.12 -15.82 39.94 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-O 121.686 0.755 . . . . 3.3700000000000001 109.173 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -72.13 -35.52 69.14 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.283 -0.871 . . . . 1.02 108.681 165.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.685 ' HB3' ' HD2' ' A' ' 60' ' ' LYS . 9.4 m-70 -86.74 -2.83 58.86 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.607 -0.724 . . . . 3.6299999999999999 112.327 175.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.407 ' HB3' ' HA ' ' A' ' 204' ' ' LYS . 75.9 ttt180 -125.16 -67.99 0.87 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.436 0.636 . . . . 2.5899999999999999 110.963 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.475 ' C ' ' H ' ' A' ' 210' ' ' SER . 19.8 m -69.17 144.79 95.61 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 114.974 -1.012 . . . . 1.8400000000000001 110.324 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 208' ' ' THR . 22.6 Cg_exo -67.59 34.72 0.15 Allowed 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.878 2.385 . . . . 2.3500000000000001 112.919 174.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.475 ' H ' ' C ' ' A' ' 208' ' ' THR . 44.4 t -78.7 -26.37 44.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.371 0.605 . . . . 2.3100000000000001 109.603 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 211' ' ' ARG . 26.2 ttt180 -71.13 -7.86 49.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.574 -0.739 . . . . 5.4500000000000002 110.926 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.58 ' O ' ' HD2' ' A' ' 212' ' ' ARG . 2.4 tmm_? -68.24 -19.11 64.71 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.071 -0.714 . . . . 6.8600000000000003 109.071 176.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -129.54 45.88 1.11 Allowed Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.574 -0.739 . . . . 3.3700000000000001 111.376 174.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -67.33 142.28 56.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.011 0.434 . . . . 5.21 110.201 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -141.22 126.71 18.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.184 -0.462 . . . . 6.46 110.865 -176.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -171.33 -69.38 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.063 -0.717 . . . . 6.0899999999999999 109.063 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 59.62 -166.11 0.19 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.823 -0.626 . . . . 5.1200000000000001 111.009 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 13.8 m -110.18 -27.9 8.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.812 0.339 . . . . 6.7599999999999998 110.582 178.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -134.18 -177.38 4.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 8.8200000000000003 110.199 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 35.3 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.62 -0.705 . . . . 8.4800000000000004 109.891 177.96 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.861 ' HG2' ' HB2' ' A' ' 4' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 120.449 0.166 . . . . 3.8599999999999999 111.312 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.626 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -51.29 -61.81 2.01 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 123.618 0.767 . . . . 2.25 112.202 -173.795 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.693 ' HD2' HD22 ' A' ' 114' ' ' LEU . 91.3 m-85 -61.2 -26.42 67.71 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 116.033 -0.53 . . . . 0.42999999999999999 110.372 -170.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.861 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 45.8 tttt -73.05 -45.04 59.78 Favored 'General case' 0 N--CA 1.417 -2.099 0 N-CA-C 107.639 -1.245 . . . . 1.51 107.639 -177.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.49 -40.24 59.14 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.831 -0.622 . . . . 0.54000000000000004 111.307 176.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.626 HD12 ' O ' ' A' ' 2' ' ' ASP . 2.3 mp -81.18 -38.89 16.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.869 0.842 . . . . 1.0700000000000001 109.58 -174.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.84 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -75.36 -39.79 58.88 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.533 -1.212 . . . . 0.34000000000000002 111.805 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.541 ' HG3' ' HG2' ' A' ' 4' ' ' LYS . 44.7 mt-30 -63.01 -30.03 71.29 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.609 -1.178 . . . . 1.5900000000000001 109.688 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.622 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 79.6 mt-30 -79.35 -46.62 17.29 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.895 -1.048 . . . . 2.4700000000000002 108.671 171.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.736 HG21 ' HZ2' ' A' ' 130' ' ' LYS . 0.3 OUTLIER -60.17 -37.19 79.42 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.946 -1.024 . . . . 0.47999999999999998 112.59 -176.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.501 ' HA ' ' CB ' ' A' ' 128' ' ' SER . . . -51.72 -51.7 54.1 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-O 120.929 0.395 . . . . 0.31 111.494 178.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 20.8 pt20 -80.45 -10.58 59.74 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.191 -0.459 . . . . 1.6399999999999999 110.952 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.622 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 49.3 mt-10 -75.11 -50.66 15.65 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.381 0.61 . . . . 2.54 109.701 174.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.71 HG21 ' N ' ' A' ' 152' ' ' GLY . 11.2 p -71.96 -37.79 62.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 122.235 1.017 . . . . 0.53000000000000003 109.925 -177.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.477 HD12 ' SD ' ' A' ' 124' ' ' MET . 0.9 OUTLIER -72.05 -20.54 61.66 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 114.591 -1.186 . . . . 0.59999999999999998 109.199 173.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.455 ' HA2' ' NH1' ' A' ' 19' ' ' ARG . . . -66.16 -18.46 67.08 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 114.184 -1.371 . . . . 0.56999999999999995 110.21 172.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.618 ' CD2' ' HA ' ' A' ' 14' ' ' VAL . 33.5 m-85 -88.93 -26.49 21.53 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.249 -0.475 . . . . 3.27 109.919 177.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.568 ' HB2' ' HZ ' ' A' ' 170' ' ' PHE . 12.1 t-20 -71.44 -20.48 62.1 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 119.884 -0.726 . . . . 2.0299999999999998 109.775 173.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.455 ' NH1' ' HA2' ' A' ' 16' ' ' GLY . 20.1 mtp180 -97.89 -20.72 17.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.444 -0.798 . . . . 2.7200000000000002 110.383 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -115.51 103.0 10.31 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.401 -0.818 . . . . 2.1600000000000001 110.709 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.8 ' HB ' ' CH2' ' A' ' 24' ' ' TRP . 23.3 p -121.94 99.18 6.3 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.618 0.723 . . . . 1.8200000000000001 109.862 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.7 m -148.27 144.62 27.75 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.497 -0.774 . . . . 2.1899999999999999 111.149 -165.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.33 -45.31 3.02 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.793 -0.639 . . . . 1.1000000000000001 114.12 169.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.8 ' CH2' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -82.59 -157.22 0.2 Allowed 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 113.137 0.792 . . . . 1.6699999999999999 113.137 -172.386 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.987 ' HE3' ' HA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER 179.36 149.55 0.28 Allowed 'General case' 0 CA--C 1.494 -1.184 0 CA-C-N 115.161 -0.927 . . . . 2.9500000000000002 110.087 -165.099 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 3.3 m -60.16 124.97 15.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 114.397 -1.274 . . . . 1.5600000000000001 112.068 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.664 HG11 ' HE2' ' A' ' 48' ' ' TYR . 14.4 p -98.36 -25.46 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 114.262 -1.336 . . . . 1.22 108.22 174.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.486 ' HD2' ' HA ' ' A' ' 28' ' ' LYS . 20.8 tptt -154.68 149.39 26.52 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 119.672 -0.811 . . . . 2.4100000000000001 111.262 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.592 HG22 ' HA ' ' A' ' 34' ' ' THR . 34.4 p -145.36 151.63 38.59 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.715 -0.675 . . . . 1.3799999999999999 109.755 175.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.665 ' O ' ' HG2' ' A' ' 31' ' ' LYS . 42.3 m -128.59 44.97 2.86 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.851 0.357 . . . . 2.3700000000000001 110.489 175.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.665 ' HG2' ' O ' ' A' ' 30' ' ' SER . 0.1 OUTLIER 62.38 19.81 11.37 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.509 1.123 . . . . 4.5499999999999998 112.001 169.251 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.467 ' HD2' ' HA ' ' A' ' 32' ' ' LYS . 35.6 tptt -174.63 -20.93 0.01 OUTLIER 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.569 0.7 . . . . 1.4199999999999999 109.885 175.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.829 HG22 ' HA3' ' A' ' 52' ' ' GLY . 41.8 pt -117.64 156.32 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.805 -1.089 . . . . 0.76000000000000001 109.517 171.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.592 ' HA ' HG22 ' A' ' 29' ' ' THR . 88.4 m -151.54 115.33 4.91 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.648 -0.706 . . . . 0.57999999999999996 110.408 -164.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.663 HG12 HG12 ' A' ' 50' ' ' VAL . 6.3 m -113.12 118.13 57.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.106 0.479 . . . . 0.85999999999999999 112.009 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 2.7 p -101.15 128.48 47.22 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.552 -0.749 . . . . 1.1000000000000001 110.645 177.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.594 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 42.5 t -106.71 128.4 54.17 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.161 -0.927 . . . . 1.27 111.058 -171.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.459 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 21.9 ttpp -122.14 -93.87 0.51 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.335 -0.393 . . . . 1.9099999999999999 111.015 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.431 ' H ' ' HB3' ' A' ' 38' ' ' LYS . . . -165.63 137.58 4.04 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.849 0.357 . . . . 1.6799999999999999 110.747 -177.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.614 ' HA ' ' HG3' ' A' ' 172' ' ' GLN . 32.2 t -88.93 -95.1 0.1 Allowed 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.443 -0.799 . . . . 2.0899999999999999 110.27 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.443 HH11 ' HD3' ' A' ' 41' ' ' ARG . 10.6 ttm180 -86.88 13.2 9.41 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.917 -1.142 . . . . 6.6100000000000003 107.917 171.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.43 ' H ' ' C ' ' A' ' 40' ' ' SER . 35.0 pttt 37.07 48.34 0.71 Allowed 'General case' 0 C--N 1.342 0.25 0 CA-C-N 113.244 -1.798 . . . . 6.46 112.694 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -158.31 -56.89 0.07 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.842 -1.072 . . . . 5.6500000000000004 109.352 -175.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -134.0 74.63 1.55 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.152 -0.931 . . . . 5.5599999999999996 109.114 176.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 135.53 148.46 5.63 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.751 -0.659 . . . . 1.5600000000000001 112.087 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 18.0 m120 -118.66 156.75 28.71 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.957 -0.386 . . . . 2.0499999999999998 109.957 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.56 HD23 ' N ' ' A' ' 48' ' ' TYR . 3.2 tt -98.59 135.27 40.36 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.25 -1.019 . . . . 0.87 108.25 177.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.664 ' HE2' HG11 ' A' ' 27' ' ' VAL . 60.1 m-85 -122.58 123.61 41.59 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.925 0.393 . . . . 0.98999999999999999 110.336 -173.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.593 ' HD3' ' CD2' ' A' ' 170' ' ' PHE . 0.0 OUTLIER -99.02 103.38 15.32 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.129 -0.693 . . . . 2.9199999999999999 109.129 178.361 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.729 HG22 ' HB3' ' A' ' 169' ' ' MET . 0.9 OUTLIER -85.92 150.13 4.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 108.745 -0.835 . . . . 1.3300000000000001 108.745 178.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.856 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 74.1 tt0 -158.76 108.1 1.96 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.103 0.477 . . . . 1.0700000000000001 110.0 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.829 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -145.33 145.08 13.95 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.846 -0.902 . . . . 0.28999999999999998 110.846 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 66.2 mt -89.07 126.41 42.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 117.623 0.711 . . . . 0.57999999999999996 111.249 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 55' ' ' PRO . 44.9 mt -106.65 110.27 63.64 Favored Pre-proline 0 N--CA 1.447 -0.607 0 CA-C-N 115.995 -0.548 . . . . 0.34999999999999998 109.797 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 54' ' ' ILE . 9.8 Cg_endo -52.1 66.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.477 0.511 1 C-N-CA 125.729 4.286 . . . . 0.62 113.598 174.574 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.627 ' HG2' HG13 ' A' ' 203' ' ' ILE . 10.1 tp10 -165.02 171.57 13.78 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.17 -1.048 . . . . 1.6799999999999999 108.17 174.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.45 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 83.6 p -80.5 141.32 52.53 Favored Pre-proline 0 N--CA 1.428 -1.56 0 CA-C-O 121.477 0.656 . . . . 1.1799999999999999 109.849 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.738 ' HA ' HD12 ' A' ' 61' ' ' LEU . 8.7 Cg_endo -51.7 -15.22 2.69 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 124.528 3.485 . . . . 0.52000000000000002 111.734 171.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.53 -44.75 41.95 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.464 -0.789 . . . . 0.64000000000000001 111.037 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.617 ' HE3' ' HA ' ' A' ' 60' ' ' LYS . 2.2 tpmt? -69.53 -30.64 68.52 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.028 -1.101 . . . . 3.2999999999999998 108.028 178.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.011 HD23 HD13 ' A' ' 203' ' ' ILE . 94.0 mt -61.88 -57.73 10.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.33 -1.305 . . . . 0.40999999999999998 110.73 175.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.482 ' HB3' ' HB3' ' A' ' 125' ' ' ASN . 17.4 p -64.73 -9.75 22.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.196 0.522 . . . . 1.29 110.507 176.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -89.24 -30.91 18.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.86 -0.609 . . . . 1.3200000000000001 111.957 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.705 ' HD2' ' CZ2' ' A' ' 74' ' ' TRP . 18.7 p90 -89.84 -43.4 10.65 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 120.152 -0.619 . . . . 0.60999999999999999 111.828 -172.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.685 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -90.77 5.54 47.89 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 120.371 -0.532 . . . . 1.5 112.061 -173.597 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.418 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 9.7 t80 -27.72 -69.58 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 O-C-N 124.743 1.277 . . . . 1.52 113.095 -167.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.483 ' HA ' ' CZ ' ' A' ' 71' ' ' ARG . 7.3 tt0 -175.1 -40.81 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 114.13 1.159 . . . . 3.6000000000000001 114.13 173.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.8 t -155.06 7.13 0.26 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.527 0.936 . . . . 1.48 113.527 -163.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -116.6 0.26 20.17 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 118.709 -1.71 . . . . 1.46 115.209 -169.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.635 ' O ' HG22 ' A' ' 73' ' ' THR . 38.2 t70 -178.15 -27.82 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.385 0.592 . . . . 2.1899999999999999 110.562 -177.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.648 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -55.29 -34.97 64.59 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 115.478 -0.783 . . . . 3.3799999999999999 111.302 -172.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.803 HG22 HD13 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -92.77 -7.78 10.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.744 -0.382 . . . . 0.70999999999999996 111.077 -175.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.795 ' HA ' ' HB2' ' A' ' 216' ' ' HIS . 1.3 t -88.19 -27.96 21.5 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 119.914 -0.714 . . . . 0.96999999999999997 109.743 -176.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.705 ' CZ2' ' HD2' ' A' ' 64' ' ' PHE . 29.4 p-90 -101.45 -8.88 21.59 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.168 -0.613 . . . . 0.75 111.282 177.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.704 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 27.6 t0 -87.36 159.3 18.78 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 114.286 1.217 . . . . 2.1899999999999999 114.286 -165.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.75 -26.17 14.43 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 112.637 -2.074 . . . . 3.1899999999999999 111.268 -176.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.2 m -105.83 -3.43 21.94 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.004 -0.739 . . . . 1.5800000000000001 109.004 -173.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.803 HD13 HG22 ' A' ' 72' ' ' ILE . 72.6 mt -110.47 159.17 17.74 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.902 -1.045 . . . . 0.70999999999999996 111.354 -174.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.554 ' CG ' ' HG3' ' A' ' 99' ' ' GLN . 9.8 mm-40 -138.9 -62.52 0.55 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.949 -1.023 . . . . 1.73 111.403 -176.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.545 HG23 ' HB3' ' A' ' 79' ' ' GLN . 23.6 t -140.48 124.72 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.439 -0.346 . . . . 0.78000000000000003 111.047 -167.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -95.5 148.61 22.31 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 122.984 0.514 . . . . 5.4000000000000004 110.987 175.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.744 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 18.2 m120 -156.91 108.1 2.38 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.651 -0.5 . . . . 1.6899999999999999 109.651 169.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.471 ' CG ' ' HD3' ' A' ' 86' ' ' ARG . 0.7 OUTLIER -66.82 103.58 1.15 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.953 -0.758 . . . . 2.0499999999999998 108.953 177.089 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.714 HG12 ' HG2' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -80.8 -82.15 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 121.167 0.508 . . . . 0.64000000000000001 110.513 -173.298 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.604 ' HB3' HD12 ' A' ' 93' ' ' ILE . 9.3 t60 -126.12 104.86 8.47 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.541 -0.754 . . . . 1.96 109.273 -172.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.471 ' HD3' ' CG ' ' A' ' 83' ' ' MET . 47.5 mtm180 -92.75 115.23 27.92 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.437 -0.579 . . . . 2.4399999999999999 109.437 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.609 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -80.21 -40.56 20.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.476 -0.784 . . . . 0.46999999999999997 110.925 -169.725 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.419 ' CG ' ' H ' ' A' ' 89' ' ' SER . 12.4 t70 -151.63 -162.73 1.59 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.012 -0.736 . . . . 1.8600000000000001 109.012 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.419 ' H ' ' CG ' ' A' ' 88' ' ' ASP . 34.1 t -76.23 -17.64 59.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 117.944 0.338 . . . . 1.4399999999999999 111.368 -174.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.2 p30 -136.08 17.2 3.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.825 0.345 . . . . 1.8700000000000001 110.792 -175.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.609 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -129.77 107.07 9.13 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.365 -0.976 . . . . 0.46000000000000002 108.365 -178.383 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.605 ' O ' HD12 ' A' ' 114' ' ' LEU . 27.2 m-85 -125.44 170.92 10.91 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.314 0.578 . . . . 0.42999999999999999 111.135 -172.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.667 ' O ' HG23 ' A' ' 84' ' ' VAL . 16.9 mt -137.36 121.56 23.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 107.409 -1.33 . . . . 0.40999999999999998 107.409 170.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 14.3 t -111.92 127.84 55.97 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.244 0.545 . . . . 2.0099999999999998 111.26 -176.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.744 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 26.0 t60 -81.66 83.11 7.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.753 0.787 . . . . 1.23 109.01 169.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 20.0 m -94.03 113.1 25.01 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.579 -1.191 . . . . 0.5 111.342 -177.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.433 ' CG1' ' HB ' ' A' ' 80' ' ' VAL . 43.4 mm -77.02 120.9 28.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 108.63 -0.878 . . . . 1.03 108.63 171.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.1 m -110.98 128.99 56.02 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.023 -0.99 . . . . 1.3799999999999999 111.217 -171.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.554 ' HG3' ' CG ' ' A' ' 79' ' ' GLN . 22.4 mt-30 -95.71 71.02 3.03 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.985 -0.552 . . . . 1.8200000000000001 110.644 177.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.44 ' O ' HG21 ' A' ' 106' ' ' ILE . 49.7 m -85.06 64.19 8.55 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.918 -0.771 . . . . 3.9100000000000001 108.918 173.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.407 ' HD1' ' HB3' ' A' ' 99' ' ' GLN . 25.3 p90 -77.29 99.32 5.47 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 122.273 1.035 . . . . 5.1600000000000001 113.559 -168.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.944 ' HB3' HD12 ' A' ' 106' ' ' ILE . . . -118.73 82.3 1.83 Allowed 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 106.119 -1.808 . . . . 1.98 106.119 157.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.9 t -73.56 18.65 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 114.874 -1.057 . . . . 3.1699999999999999 112.762 -161.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.19 -17.7 64.3 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.085 -1.206 . . . . 1.96 110.085 173.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.1 m -151.3 -44.09 0.11 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.948 -0.626 . . . . 1.8799999999999999 110.209 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.944 HD12 ' HB3' ' A' ' 102' ' ' ALA . 77.3 mt -71.64 131.59 34.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.507 -0.77 . . . . 1.1200000000000001 112.013 -173.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.4 m -100.34 166.44 12.64 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 108.526 -0.916 . . . . 1.3500000000000001 108.526 170.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -46.32 125.31 8.78 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.035 1.823 . . . . 1.0700000000000001 110.893 173.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.604 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 29.5 ttm180 -102.65 151.99 21.71 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 120.042 -0.663 . . . . 3.4500000000000002 110.141 -167.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.703 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 20.8 t0 -113.01 127.23 56.17 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.736 -0.666 . . . . 1.3700000000000001 109.344 -171.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.427 ' HB2' ' O ' ' A' ' 96' ' ' THR . 3.5 m-30 -113.43 134.13 54.82 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.537 0.684 . . . . 2.4100000000000001 111.305 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 1.081 HG12 ' HD2' ' A' ' 145' ' ' ARG . 35.2 mm -124.36 76.39 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 107.105 -1.443 . . . . 0.42999999999999999 107.105 167.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.541 ' O ' HG12 ' A' ' 115' ' ' VAL . 7.1 p-10 -85.88 115.75 23.7 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.116 -0.947 . . . . 1.8600000000000001 109.994 -176.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 1.078 HD23 ' HE2' ' A' ' 130' ' ' LYS . 11.2 tp -80.65 111.58 17.21 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-O 121.914 0.864 . . . . 0.28000000000000003 109.08 169.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.541 HG12 ' O ' ' A' ' 113' ' ' ASP . 0.1 OUTLIER -119.09 125.31 74.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-N 113.841 -1.527 . . . . 0.26000000000000001 111.544 -163.303 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.84 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 11.5 t80 -104.83 112.71 25.92 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 115.114 -0.948 . . . . 2.5699999999999998 110.054 172.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.825 HG12 HG22 ' A' ' 127' ' ' ILE . 73.7 mt -94.14 99.57 9.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.639 -0.71 . . . . 0.89000000000000001 109.607 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.522 ' HD2' ' CZ ' ' A' ' 120' ' ' TYR . 35.9 ttmt -118.14 141.02 48.93 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.931 -0.577 . . . . 1.2 109.872 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.481 ' HD2' ' O ' ' A' ' 119' ' ' ARG . 7.9 tmm_? -118.75 98.08 6.04 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.966 -0.753 . . . . 2.7999999999999998 108.966 177.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.59 ' CB ' ' HB3' ' A' ' 123' ' ' ASN . 96.5 m-85 -64.66 114.05 4.15 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.631 -1.248 . . . . 0.82999999999999996 107.631 172.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -37.21 99.07 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 O-C-N 124.572 1.17 . . . . 2.2799999999999998 112.688 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 56.59 34.12 63.71 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 114.159 -1.382 . . . . 0.76000000000000001 112.708 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.59 ' HB3' ' CB ' ' A' ' 120' ' ' TYR . 4.6 t-20 -127.48 -49.1 1.41 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.174 -0.513 . . . . 1.6499999999999999 110.266 -177.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.579 ' HG2' ' HB ' ' A' ' 154' ' ' VAL . 3.9 ttm -163.08 133.76 4.65 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 120.323 -0.551 . . . . 1.1200000000000001 112.127 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.568 ' ND2' ' HB2' ' A' ' 58' ' ' PRO . 29.1 m-80 -104.63 78.97 1.5 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.23 -1.026 . . . . 1.6200000000000001 108.23 174.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.65 ' CG1' HG12 ' A' ' 154' ' ' VAL . 0.5 OUTLIER -103.91 139.77 23.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 113.387 0.884 . . . . 0.29999999999999999 113.387 -169.21 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.825 HG22 HG12 ' A' ' 117' ' ' ILE . 25.7 pt -108.84 111.42 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 108.907 -0.775 . . . . 0.58999999999999997 108.907 163.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.52 ' OG ' ' HB3' ' A' ' 116' ' ' TYR . 13.4 p -97.29 109.4 22.16 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.46 0.647 . . . . 1.1799999999999999 110.957 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.604 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 5.5 p -113.55 155.8 24.75 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.817 -0.628 . . . . 1.24 111.86 -168.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 1.078 ' HE2' HD23 ' A' ' 114' ' ' LEU . 14.8 mtmm -140.74 134.18 29.91 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 108.132 -1.062 . . . . 2.2599999999999998 108.132 173.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.457 ' HB3' ' H ' ' A' ' 148' ' ' ASN . 41.1 p -69.79 96.33 0.98 Allowed 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.955 -1.128 . . . . 1.3899999999999999 107.955 174.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.453 HG11 ' HE2' ' A' ' 3' ' ' PHE . 2.3 t -107.56 124.01 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 CA-C-N 114.534 -1.212 . . . . 1.05 110.788 -163.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -98.19 48.68 1.0 Allowed 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 113.264 -1.789 . . . . 2.1699999999999999 109.735 -165.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.813 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 1.5 p90 -81.68 159.14 67.21 Favored Pre-proline 0 C--N 1.313 -0.983 0 CA-C-N 113.343 -1.753 . . . . 0.53000000000000003 110.549 -171.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.484 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 1.9 Cg_endo -47.84 -42.1 31.28 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.672 2.915 . . . . 1.28 115.709 -172.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.813 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 18.0 tt0 -70.27 -11.82 61.17 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 111.824 0.305 . . . . 3.5 111.824 -162.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.516 ' HB2' HG11 ' A' ' 84' ' ' VAL . 0.7 OUTLIER -157.3 99.74 1.93 Allowed Pre-proline 0 C--N 1.321 -0.654 0 C-N-CA 119.407 -0.917 . . . . 6.1200000000000001 113.406 177.317 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -90.23 160.93 4.69 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.003 3.135 . . . . 1.77 111.42 171.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.529 ' HB3' ' HB2' ' A' ' 145' ' ' ARG . 87.3 Cg_endo -94.58 -161.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.91 2.407 . . . . 1.25 113.361 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.5 t -148.52 -157.47 0.82 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.585 -0.895 . . . . 1.6000000000000001 108.585 -178.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.1 p -89.98 -36.72 14.8 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.617 -0.433 . . . . 1.97 111.397 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.31 -35.59 58.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.9 0.381 . . . . 2.1800000000000002 110.171 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.703 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 99.2 m-85 -107.71 111.39 23.56 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 109.497 -0.557 . . . . 1.23 109.497 -178.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.604 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 1.1 tp -98.38 112.88 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 N-CA-C 108.87 -0.789 . . . . 0.81999999999999995 108.87 -176.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 1.081 ' HD2' HG12 ' A' ' 112' ' ' ILE . 2.6 tpp85 -60.16 97.44 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.323 -0.992 . . . . 4.4199999999999999 108.323 173.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 175' ' ' MET . . . -64.38 133.8 38.98 Favored Glycine 0 CA--C 1.503 -0.683 0 CA-C-N 115.575 -0.739 . . . . 0.79000000000000004 112.288 -171.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.538 ' CD2' ' HD2' ' A' ' 176' ' ' ARG . 2.6 m-85 -83.74 79.25 9.52 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 122.308 1.052 . . . . 4.4400000000000004 112.115 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.482 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 5.8 t30 -80.74 83.34 6.52 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 113.45 -1.705 . . . . 1.6200000000000001 108.407 167.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.513 ' HB3' ' HD2' ' A' ' 150' ' ' PRO . 96.6 m-70 -49.63 161.3 0.52 Allowed Pre-proline 0 C--O 1.219 -0.534 0 CA-C-O 118.628 -0.701 . . . . 2.3199999999999998 109.755 175.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 149' ' ' HIS . 5.7 Cg_endo -47.5 75.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 124.276 3.318 . . . . 0.53000000000000003 114.135 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 170' ' ' PHE . 25.4 p -138.61 167.61 21.57 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.057 -1.46 . . . . 1.5800000000000001 107.057 175.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.71 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -153.69 -138.74 2.72 Favored Glycine 0 N--CA 1.433 -1.562 0 C-N-CA 118.733 -1.699 . . . . 0.42999999999999999 113.51 -167.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.464 ' HB3' ' CG1' ' A' ' 127' ' ' ILE . 63.3 t80 -163.06 93.19 0.79 Allowed 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 107.949 -1.13 . . . . 0.59999999999999998 107.949 -163.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.729 HG23 HG13 ' A' ' 168' ' ' VAL . 7.7 m -102.81 138.29 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-O 121.88 0.848 . . . . 0.31 110.653 -176.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 125' ' ' ASN . 71.4 m -112.13 110.56 20.9 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.252 -0.885 . . . . 1.55 109.296 175.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.777 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 16.4 m -101.38 122.21 48.9 Favored Pre-proline 0 C--N 1.318 -0.766 0 C-N-CA 120.602 -0.439 . . . . 1.0600000000000001 111.256 -169.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.52 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 51.4 Cg_exo -55.49 115.06 2.18 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.12 1.88 . . . . 0.56000000000000005 110.689 170.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.524 ' SD ' ' HB2' ' A' ' 166' ' ' LYS . 74.6 mmm -75.08 -172.11 1.57 Allowed 'General case' 0 CA--C 1.505 -0.763 0 C-N-CA 120.765 -0.374 . . . . 1.1599999999999999 110.75 -177.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -69.85 -31.64 69.6 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 108.537 -0.912 . . . . 2.6299999999999999 108.537 170.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 2.6 mm-40 -98.3 27.85 4.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.928 -1.033 . . . . 2.0499999999999998 108.79 175.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.576 ' OD1' ' HD3' ' A' ' 162' ' ' PRO . 5.5 p30 -36.52 -47.37 1.6 Allowed Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 116.226 1.936 . . . . 1.9299999999999999 116.226 -166.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.576 ' HD3' ' OD1' ' A' ' 161' ' ' ASN . 72.8 Cg_endo -75.54 -14.57 19.96 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 CA-C-N 121.621 1.615 . . . . 0.72999999999999998 113.208 -175.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -111.62 -27.31 8.61 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.001 0.429 . . . . 0.68000000000000005 110.657 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.583 ' HB2' ' HB2' ' A' ' 160' ' ' GLU . 66.4 m-85 -140.65 131.77 26.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.512 -0.767 . . . . 0.93000000000000005 109.546 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.66 ' HB2' ' HD3' ' A' ' 58' ' ' PRO . 17.5 t -126.99 152.92 46.57 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.843 -0.743 . . . . 1.4099999999999999 111.125 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.856 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.8 tppp? -91.69 104.35 16.83 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.51 -0.768 . . . . 0.73999999999999999 111.509 -176.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.605 HD12 HG12 ' A' ' 196' ' ' ILE . 0.7 OUTLIER -84.8 100.91 11.85 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.066 -0.97 . . . . 0.27000000000000002 108.883 174.514 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.761 HG12 ' HG3' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -124.5 128.92 73.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.667 0.746 . . . . 0.28000000000000003 110.8 178.025 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.729 ' HB3' HG22 ' A' ' 50' ' ' VAL . 25.2 ttt -132.51 162.49 31.1 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.858 -0.793 . . . . 1.24 108.858 -171.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.655 ' HE1' HG13 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -139.51 108.24 5.94 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.323 -1.362 . . . . 3.3700000000000001 107.323 -173.468 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.447 HG13 ' OG1' ' A' ' 173' ' ' THR . 30.6 t -106.45 98.3 6.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 124.044 0.84 . . . . 1.3999999999999999 109.878 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.614 ' HG3' ' HA ' ' A' ' 40' ' ' SER . 49.9 tt0 -100.1 11.98 38.04 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 106.909 -1.515 . . . . 2.1699999999999999 106.909 173.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 1.1 m -61.09 127.29 30.79 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.207 -1.815 . . . . 1.6499999999999999 110.534 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.47 ' HG2' ' HB2' ' A' ' 147' ' ' TYR . 13.0 pt-20 -97.36 -15.64 20.62 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.375 -0.972 . . . . 2.4500000000000002 108.375 175.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.511 ' O ' ' HG2' ' A' ' 176' ' ' ARG . 23.8 mmt 68.11 -66.12 0.23 Allowed 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 114.543 -1.208 . . . . 3.7400000000000002 110.553 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.585 ' HA ' HD11 ' A' ' 179' ' ' LEU . 0.9 OUTLIER 54.49 179.54 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.982 1.313 . . . . 5.7800000000000002 111.455 -176.738 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.414 ' HA3' HG12 ' A' ' 144' ' ' ILE . . . 87.66 69.61 1.29 Allowed Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 120.522 -0.847 . . . . 2.2599999999999998 112.21 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 76.5 tttt 69.5 72.62 0.25 Allowed 'General case' 0 CA--C 1.532 0.253 0 O-C-N 124.12 0.541 . . . . 6.2300000000000004 111.973 170.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.748 HD13 HD11 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -156.52 150.27 24.81 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.788 -0.642 . . . . 1.6399999999999999 110.72 173.33 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.499 ' H ' ' CG1' ' A' ' 183' ' ' ILE . 18.2 m -112.7 166.95 9.97 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.576 -0.738 . . . . 2.04 109.106 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 180' ' ' SER . 94.8 Cg_exo -45.4 -43.8 17.04 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.494 2.129 . . . . 1.74 113.064 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.405 ' O ' ' HE2' ' A' ' 186' ' ' LYS . 0.7 OUTLIER -64.17 -19.34 65.25 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.162 0.506 . . . . 2.1400000000000001 111.612 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.499 ' CG1' ' H ' ' A' ' 180' ' ' SER . 31.2 mm -91.56 -44.64 14.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 122.467 1.127 . . . . 1.1200000000000001 108.9 -176.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.992 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.2 mp -68.05 -36.87 77.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 113.073 -1.876 . . . . 1.1299999999999999 111.555 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -63.94 -17.98 63.8 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.112 -0.699 . . . . 2.8900000000000001 109.112 177.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.423 ' HE2' ' HA ' ' A' ' 183' ' ' ILE . 51.4 mtmt -93.04 -45.28 7.99 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.381 -0.827 . . . . 1.28 109.919 172.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.992 HG22 ' HA ' ' A' ' 184' ' ' ILE . 6.8 t -63.58 -30.23 71.38 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.329 0.492 . . . . 0.62 112.329 -169.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . 0.712 ' O ' ' HG ' ' A' ' 192' ' ' LEU . 0.2 OUTLIER -75.13 -63.39 0.72 Allowed Pre-proline 0 C--N 1.33 -0.244 0 C-N-CA 120.956 -0.298 . . . . 1.0600000000000001 110.877 179.524 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.515 ' HD3' ' CB ' ' A' ' 188' ' ' MET . 32.2 Cg_exo -59.03 -33.62 98.77 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.275 1.984 . . . . 0.91000000000000003 112.367 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.708 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 9.3 t -71.21 -22.61 61.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.825 0.345 . . . . 1.5 110.407 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -91.83 -43.68 9.38 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.031 -0.532 . . . . 1.8799999999999999 110.733 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.712 ' HG ' ' O ' ' A' ' 188' ' ' MET . 51.7 mt -53.11 -59.39 4.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.575 -0.739 . . . . 1.0900000000000001 111.703 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.477 ' O ' ' HG ' ' A' ' 197' ' ' LEU . 1.1 m -73.91 -30.57 28.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.089 -0.96 . . . . 0.68000000000000005 109.345 -171.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.708 ' HB2' ' O ' ' A' ' 190' ' ' SER . 1.0 OUTLIER -67.79 -44.15 78.06 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 114.04 -1.436 . . . . 2.0699999999999998 110.315 179.128 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.592 ' O ' ' HB2' ' A' ' 198' ' ' ASN . 0.9 OUTLIER -59.91 -27.42 66.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.045 0.45 . . . . 2.0 110.728 176.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.702 HG21 HG21 ' A' ' 33' ' ' ILE . 33.7 mt -79.27 -31.03 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 120.983 0.42 . . . . 0.31 111.286 173.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 94.7 mt -75.68 -30.7 59.45 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.235 0.54 . . . . 1.03 110.026 176.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.592 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 7.6 m-20 -47.22 -47.43 24.45 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.712 -1.131 . . . . 1.8999999999999999 107.967 162.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.655 ' HA ' ' CE2' ' A' ' 64' ' ' PHE . . . -77.54 -44.84 27.27 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 115.005 -0.998 . . . . 0.28999999999999998 111.292 -173.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 31.5 mmtp -54.63 -41.84 70.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.527 0.679 . . . . 0.96999999999999997 110.696 175.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.538 ' HA ' ' HE3' ' A' ' 204' ' ' LYS . 2.2 t70 -84.37 -47.62 10.52 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.969 -1.014 . . . . 1.9399999999999999 110.094 -175.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . 0.501 ' HA2' ' HB3' ' A' ' 205' ' ' ALA . . . -63.25 -29.33 74.14 Favored Glycine 0 N--CA 1.459 0.232 0 C-N-CA 120.726 -0.749 . . . . 0.46999999999999997 112.489 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 1.011 HD13 HD23 ' A' ' 61' ' ' LEU . 3.0 tp -69.79 -38.58 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-O 120.848 0.356 . . . . 0.60999999999999999 110.453 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.787 ' HA ' ' HG2' ' A' ' 207' ' ' ARG . 0.0 OUTLIER -90.59 -17.16 27.41 Favored 'General case' 0 C--O 1.207 -1.169 0 N-CA-C 109.284 -0.635 . . . . 3.3700000000000001 109.284 177.291 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.501 ' HB3' ' HA2' ' A' ' 202' ' ' GLY . . . -67.64 -26.51 66.26 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.171 -0.677 . . . . 1.02 109.171 168.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.571 ' CE1' ' HA ' ' A' ' 64' ' ' PHE . 4.7 m-70 -83.15 -43.06 16.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.392 -0.822 . . . . 3.6299999999999999 112.976 174.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.787 ' HG2' ' HA ' ' A' ' 204' ' ' LYS . 10.6 ptt180 -88.38 -40.71 13.33 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.482 0.658 . . . . 2.5899999999999999 111.093 -176.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.608 ' HB ' ' O ' ' A' ' 204' ' ' LYS . 97.4 m -101.19 156.96 34.53 Favored Pre-proline 0 C--N 1.311 -1.107 0 CA-C-N 115.099 -0.955 . . . . 1.8400000000000001 109.04 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.449 ' HD2' HG23 ' A' ' 208' ' ' THR . 11.7 Cg_endo -59.28 -93.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 120.981 1.121 . . . . 2.3500000000000001 110.434 166.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 93.5 p 49.26 25.67 1.31 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.426 0.899 . . . . 2.3100000000000001 113.426 172.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -96.5 27.66 3.72 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.668 -0.864 . . . . 5.4500000000000002 108.668 175.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -64.76 -25.75 68.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.691 -1.14 . . . . 6.8600000000000003 110.146 176.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -112.17 36.92 3.9 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.684 -0.689 . . . . 3.3700000000000001 111.553 176.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -55.42 138.52 45.86 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.91 -0.404 . . . . 5.21 109.91 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . 0.53 ' HB3' ' O ' ' A' ' 75' ' ' ASP . 20.9 t-80 -104.49 -7.65 19.65 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.521 0.563 . . . . 6.46 112.521 -170.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . 0.795 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 27.1 t-80 -79.58 60.71 3.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.786 0.803 . . . . 6.0899999999999999 109.353 176.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -160.43 53.3 0.32 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.845 -1.07 . . . . 5.1200000000000001 108.499 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 11.0 m -91.08 0.76 57.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.102 -0.954 . . . . 6.7599999999999998 110.491 -175.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -139.42 136.07 34.29 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.819 -0.628 . . . . 8.8200000000000003 110.231 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.354 -0.831 . . . . 8.4800000000000004 110.875 179.951 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 mtp . . . . . 0 N--CA 1.482 1.153 0 N-CA-C 109.416 -0.587 . . . . 3.8599999999999999 109.416 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.469 ' O ' HD12 ' A' ' 6' ' ' ILE . 15.2 t70 -95.77 -55.17 3.09 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 109.313 -0.625 . . . . 2.25 109.313 177.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.536 ' HA ' HD12 ' A' ' 6' ' ' ILE . 70.5 m-85 -59.55 -34.82 73.16 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.667 0.746 . . . . 0.42999999999999999 109.598 -177.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.502 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 45.1 tttt -70.48 -42.47 71.37 Favored 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 114.644 -1.162 . . . . 1.51 108.085 -178.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.89 -41.9 62.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.844 -0.617 . . . . 0.54000000000000004 111.616 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.677 ' O ' ' HB ' ' A' ' 10' ' ' THR . 1.3 mp -79.26 -48.15 21.57 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 N-CA-C 108.714 -0.847 . . . . 1.0700000000000001 108.714 -175.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.968 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -57.54 -47.42 82.06 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.779 -1.1 . . . . 0.34000000000000002 111.974 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.502 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 13.1 mt-30 -60.34 -36.22 77.48 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 113.889 -1.505 . . . . 1.5900000000000001 111.631 -176.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.27 -18.16 26.13 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.396 -0.82 . . . . 2.4700000000000002 109.506 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.677 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -83.18 -38.6 22.11 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.19 -0.914 . . . . 0.47999999999999998 111.233 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.429 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -49.54 -59.89 3.35 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-O 121.218 0.532 . . . . 0.31 110.81 176.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -67.4 -11.54 58.0 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.284 -0.871 . . . . 1.6399999999999999 111.787 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.62 ' HB3' ' HA ' ' A' ' 10' ' ' THR . 0.6 OUTLIER -87.3 -42.11 13.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 110.267 -0.272 . . . . 2.54 110.267 -179.164 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.783 HG11 ' HA3' ' A' ' 152' ' ' GLY . 0.4 OUTLIER -75.48 -34.16 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 122.305 1.05 . . . . 0.53000000000000003 108.539 177.617 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.547 HD11 ' SD ' ' A' ' 124' ' ' MET . 0.6 OUTLIER -68.39 -29.29 67.95 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 114.32 -1.309 . . . . 0.59999999999999998 108.379 172.305 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 20' ' ' ASP . . . -64.99 -17.93 63.91 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 113.571 -1.65 . . . . 0.56999999999999995 110.706 177.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.636 ' CD2' ' HA ' ' A' ' 14' ' ' VAL . 23.6 m-85 -84.6 -26.25 28.04 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 109.427 -0.583 . . . . 3.27 109.427 176.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.501 ' HB2' ' CZ ' ' A' ' 170' ' ' PHE . 2.6 t30 -72.09 -15.75 62.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.768 -0.651 . . . . 2.0299999999999998 110.086 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -116.31 10.97 14.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.456 -0.793 . . . . 2.7200000000000002 110.467 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.502 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 27.5 t70 -111.36 107.22 16.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.943 -0.571 . . . . 2.1600000000000001 110.684 -176.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.514 HG22 ' CZ2' ' A' ' 24' ' ' TRP . 53.3 p -125.87 112.75 16.35 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.624 0.25 . . . . 1.8200000000000001 110.642 -176.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.2 p -177.5 117.65 0.1 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.861 -0.609 . . . . 2.1899999999999999 111.817 -168.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.3 33.89 82.46 Favored Glycine 0 C--O 1.23 -0.144 0 C-N-CA 121.337 -0.458 . . . . 1.1000000000000001 113.404 173.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.514 ' CZ2' HG22 ' A' ' 21' ' ' THR . 0.1 OUTLIER -119.97 -168.28 1.58 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.289 -0.634 . . . . 1.6699999999999999 109.289 177.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 36' ' ' SER . 8.0 mtmm -174.95 156.42 2.2 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 107.999 -1.111 . . . . 2.9500000000000002 107.999 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 2.3 p -78.46 119.64 27.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-O 121.817 0.817 . . . . 1.5600000000000001 109.25 175.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 35' ' ' VAL . 8.2 p -86.61 -24.76 6.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 114.845 -1.07 . . . . 1.22 109.382 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 28' ' ' LYS . 9.1 tppt? -172.31 150.73 2.41 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.634 0.605 . . . . 2.4100000000000001 112.634 -176.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.706 HG22 ' HA ' ' A' ' 34' ' ' THR . 69.3 p -134.43 148.42 50.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.553 -0.749 . . . . 1.3799999999999999 109.682 173.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.524 ' H ' ' HB ' ' A' ' 33' ' ' ILE . 50.3 m -152.78 84.1 1.23 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.557 0.577 . . . . 2.3700000000000001 112.557 177.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 30' ' ' SER . 3.2 mptp? 79.66 71.31 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.942 0.497 . . . . 4.5499999999999998 111.365 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.483 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 65.2 mttm 73.26 20.87 3.19 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.299 -0.864 . . . . 1.4199999999999999 111.724 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.527 HD12 ' HB ' ' A' ' 193' ' ' VAL . 2.5 mt -108.44 166.78 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.942 0 CA-C-O 121.149 0.499 . . . . 0.76000000000000001 110.771 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.706 ' HA ' HG22 ' A' ' 29' ' ' THR . 48.7 m -158.43 102.54 1.74 Allowed 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.589 -1.187 . . . . 0.57999999999999996 109.304 176.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.491 ' O ' HG12 ' A' ' 27' ' ' VAL . 21.8 t -96.3 103.1 14.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.993 -0.549 . . . . 0.85999999999999999 109.537 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 81.0 p -96.22 123.49 39.87 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.502 0.667 . . . . 1.1000000000000001 110.911 -178.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.0 p -94.36 127.85 40.5 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.762 -1.108 . . . . 1.27 110.898 -176.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -136.51 123.38 21.33 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.624 -0.716 . . . . 1.9099999999999999 110.028 175.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 46' ' ' ASN . . . -55.41 127.59 30.29 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.36 0.504 . . . . 1.6799999999999999 112.36 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.55 ' OG ' ' HB2' ' A' ' 47' ' ' LEU . 20.4 m -85.95 137.59 32.62 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.323 -0.621 . . . . 2.0899999999999999 109.323 176.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.582 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 4.4 mmp_? -88.55 13.07 12.87 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.786 0.327 . . . . 6.6100000000000003 111.165 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.48 ' HD2' ' N ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -64.36 -22.92 67.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.215 -0.448 . . . . 6.46 110.369 175.346 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.48 ' N ' ' HD2' ' A' ' 42' ' ' LYS . 70.3 t80 174.82 -89.02 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.443 0.464 . . . . 5.6500000000000004 109.898 177.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -151.86 82.88 1.28 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.846 -0.798 . . . . 5.5599999999999996 108.846 176.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.77 129.15 1.87 Allowed Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 109.539 -1.424 . . . . 1.5600000000000001 109.539 -177.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.581 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 15.9 m120 -82.78 136.48 34.67 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.024 0.44 . . . . 2.0499999999999998 110.887 -175.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.55 ' HB2' ' OG ' ' A' ' 40' ' ' SER . 8.4 tt -87.76 140.75 29.19 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.468 -0.938 . . . . 0.87 108.468 173.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.413 ' HB2' HD11 ' A' ' 192' ' ' LEU . 68.7 m-85 -121.52 118.49 29.43 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.658 -0.417 . . . . 0.98999999999999999 110.42 -177.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 49' ' ' ARG . 37.1 ttt-85 -97.5 112.08 24.08 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.121 -0.696 . . . . 2.9199999999999999 109.121 176.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.65 HG13 ' HB3' ' A' ' 169' ' ' MET . 0.9 OUTLIER -107.24 119.56 57.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.907 -0.588 . . . . 1.3300000000000001 109.97 -172.848 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.564 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 35.9 tt0 -134.5 117.15 15.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.028 -0.533 . . . . 1.0700000000000001 111.296 -166.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 32' ' ' LYS . . . -145.66 144.75 13.37 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 121.05 -0.595 . . . . 0.28999999999999998 111.643 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 78.9 mt -86.09 131.5 34.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 117.249 0.525 . . . . 0.57999999999999996 111.175 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.447 HD13 ' HB1' ' A' ' 199' ' ' ALA . 55.5 mt -110.46 108.24 58.37 Favored Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-N 115.493 -0.776 . . . . 0.34999999999999998 109.034 176.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 164' ' ' TYR . 38.8 Cg_exo -62.37 56.12 0.13 Allowed 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 124.422 3.415 . . . . 0.62 115.393 -173.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.437 ' HB2' ' H ' ' A' ' 57' ' ' SER . 0.9 OUTLIER -164.35 -162.97 0.71 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.876 -0.416 . . . . 1.6799999999999999 109.876 167.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.437 ' H ' ' HB2' ' A' ' 56' ' ' GLU . 78.2 p -77.45 138.12 63.6 Favored Pre-proline 0 N--CA 1.431 -1.424 0 CA-C-O 121.918 0.866 . . . . 1.1799999999999999 112.135 -168.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.57 ' HA ' HD12 ' A' ' 61' ' ' LEU . 18.1 Cg_exo -62.44 -13.6 34.03 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.504 2.802 . . . . 0.52000000000000002 109.899 172.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.46 -53.38 19.51 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.194 -1.366 . . . . 0.64000000000000001 110.964 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.422 ' HB3' ' HE2' ' A' ' 60' ' ' LYS . 15.1 ttpt -68.62 -27.55 66.12 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.244 -1.021 . . . . 3.2999999999999998 108.244 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.983 HD23 HD13 ' A' ' 203' ' ' ILE . 28.9 mt -56.99 -60.45 3.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.159 -0.928 . . . . 0.40999999999999998 110.409 170.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.8 p -62.57 -15.9 53.5 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 121.81 -0.556 . . . . 1.29 110.839 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -92.36 -26.73 17.94 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.048 0.758 . . . . 1.3200000000000001 113.048 -176.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.64 ' CE2' ' HA ' ' A' ' 199' ' ' ALA . 6.5 p90 -89.2 -41.48 12.21 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.731 -0.606 . . . . 0.60999999999999999 110.866 -174.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.712 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -92.93 7.92 41.94 Favored 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 120.761 -0.376 . . . . 1.5 110.02 -179.286 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -44.55 -71.53 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.214 -0.903 . . . . 1.52 112.452 -168.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -139.7 -74.42 0.36 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.204 -0.598 . . . . 3.6000000000000001 112.522 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.711 ' HB ' ' CD1' ' A' ' 81' ' ' TYR . 9.0 t -156.77 30.92 0.31 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.753 0.787 . . . . 1.48 110.695 -168.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.0 -46.96 4.02 Favored Glycine 0 CA--C 1.49 -1.487 0 C-N-CA 120.01 -1.091 . . . . 1.46 112.636 -173.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.478 ' O ' HG22 ' A' ' 73' ' ' THR . 19.3 p-10 -152.6 -18.18 0.16 Allowed 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.151 -1.025 . . . . 2.1899999999999999 110.795 -171.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.708 ' HA ' ' CZ2' ' A' ' 74' ' ' TRP . 2.7 ptp180 -48.89 -39.36 25.62 Favored 'General case' 0 C--O 1.218 -0.589 0 C-N-CA 122.759 0.423 . . . . 3.3799999999999999 110.572 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.636 HD13 ' H ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -88.58 -7.91 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 C-N-CA 120.569 -0.453 . . . . 0.70999999999999996 111.242 -175.643 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 215' ' ' HIS . 0.8 OUTLIER -97.0 -32.76 11.84 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 119.791 -0.763 . . . . 0.96999999999999997 111.135 -173.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.708 ' CZ2' ' HA ' ' A' ' 71' ' ' ARG . 7.8 p-90 -101.63 -3.49 28.23 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.55 -0.46 . . . . 0.75 111.283 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.696 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 4.8 t70 -65.06 -178.64 0.47 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.869 0.842 . . . . 2.1899999999999999 112.356 -172.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.688 ' HG2' ' OD1' ' A' ' 198' ' ' ASN . 66.8 mmtt -104.56 -33.26 8.6 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.793 -1.094 . . . . 3.1899999999999999 108.852 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.513 ' HA ' ' HB2' ' A' ' 99' ' ' GLN . 16.8 m -134.61 19.52 3.59 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.344 -0.844 . . . . 1.5800000000000001 112.203 -170.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.583 HD13 HG22 ' A' ' 72' ' ' ILE . 27.7 mt -108.17 153.42 23.2 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.026 0.441 . . . . 0.70999999999999996 110.508 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.51 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 26.1 mm-40 -134.28 -67.0 0.59 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.671 -0.695 . . . . 1.73 110.606 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 96' ' ' THR . 2.4 t -136.73 112.01 11.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.674 -0.694 . . . . 0.78000000000000003 110.847 -170.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.711 ' CD1' ' HB ' ' A' ' 68' ' ' THR . 18.0 t80 -98.92 137.79 36.98 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.013 -0.736 . . . . 5.4000000000000004 109.013 175.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -143.16 107.44 4.76 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.442 -0.577 . . . . 1.6899999999999999 109.442 -175.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.487 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 2.8 mtm -66.77 102.25 0.92 Allowed 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.996 -0.742 . . . . 2.0499999999999998 108.996 174.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.545 HG11 ' HZ ' ' A' ' 134' ' ' PHE . 0.3 OUTLIER -72.9 -71.01 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.919 -0.582 . . . . 0.64000000000000001 110.843 -170.075 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -133.19 118.66 18.9 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.677 -0.861 . . . . 1.96 108.677 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.487 ' HD3' ' SD ' ' A' ' 83' ' ' MET . 44.0 mtm180 -93.89 105.27 17.29 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.126 0.489 . . . . 2.4399999999999999 109.965 -175.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.646 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -69.08 -44.45 81.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.355 -0.839 . . . . 0.46999999999999997 110.945 -175.323 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.456 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 15.0 t70 -147.9 168.0 23.37 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.928 -1.033 . . . . 1.8600000000000001 108.253 -173.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.2 m -68.05 -3.67 10.96 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.594 0.235 . . . . 1.4399999999999999 111.112 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -130.77 4.52 4.56 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 110.177 -0.305 . . . . 1.8700000000000001 110.177 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.646 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -133.3 108.79 8.95 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 109.114 -0.698 . . . . 0.46000000000000002 109.114 -172.433 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.65 ' O ' HD12 ' A' ' 114' ' ' LEU . 17.1 m-85 -125.38 174.74 7.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.876 -0.602 . . . . 0.42999999999999999 110.127 -174.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.545 HG21 ' CE1' ' A' ' 134' ' ' PHE . 39.4 mt -131.55 132.79 62.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 107.927 -1.138 . . . . 0.40999999999999998 107.927 171.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.468 ' HB3' ' OH ' ' A' ' 81' ' ' TYR . 23.6 p -110.93 106.26 15.32 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.585 -0.446 . . . . 2.0099999999999998 111.961 -171.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.587 ' HA ' ' O ' ' A' ' 111' ' ' PHE . 2.1 t60 -81.23 90.06 6.07 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.441 -0.948 . . . . 1.23 108.441 167.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.633 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 35.0 m -115.47 114.58 25.22 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.555 -0.748 . . . . 0.5 111.938 -171.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 38.1 mm -76.52 121.98 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 109.01 -0.737 . . . . 1.03 109.01 174.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.464 ' HB ' ' O ' ' A' ' 109' ' ' ARG . 25.7 m -109.4 143.73 38.58 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.544 -1.207 . . . . 1.3799999999999999 109.861 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.513 ' HB2' ' HA ' ' A' ' 77' ' ' SER . 22.2 mt-30 -71.59 174.19 7.03 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.693 -0.685 . . . . 1.8200000000000001 111.625 -176.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.9 t -85.74 94.21 9.05 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.42 -0.809 . . . . 3.9100000000000001 109.547 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -91.63 116.3 28.76 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.473 -0.936 . . . . 5.1600000000000001 108.473 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.785 ' HB3' HD12 ' A' ' 106' ' ' ILE . . . 71.44 69.79 0.17 Allowed 'General case' 0 C--N 1.32 -0.677 0 O-C-N 124.452 1.095 . . . . 1.98 108.235 -172.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.8 m -64.41 4.6 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 114.459 -1.246 . . . . 3.1699999999999999 113.013 -173.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -77.44 -45.94 10.57 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.411 -0.899 . . . . 1.96 111.948 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.453 ' HB2' HG21 ' A' ' 183' ' ' ILE . 74.2 m -130.96 0.51 4.24 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.815 0.34 . . . . 1.8799999999999999 111.329 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.785 HD12 ' HB3' ' A' ' 102' ' ' ALA . 73.6 mt -119.03 125.08 74.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.163 0.506 . . . . 1.1200000000000001 111.159 -176.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.475 ' OG ' ' HD2' ' A' ' 108' ' ' PRO . 32.4 t -92.19 159.83 36.6 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.354 -0.839 . . . . 1.3500000000000001 109.25 178.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.475 ' HD2' ' OG ' ' A' ' 107' ' ' SER . 97.2 Cg_exo -44.63 142.37 4.85 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.44 2.093 . . . . 1.0700000000000001 111.374 171.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.714 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 29.1 ttp-105 -126.21 130.8 51.67 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.545 -0.462 . . . . 3.4500000000000002 109.879 -167.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.554 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 9.1 t0 -104.73 125.07 50.45 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.736 -0.468 . . . . 1.3700000000000001 109.736 -176.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.633 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 12.0 m-30 -95.97 143.65 26.96 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.244 0.545 . . . . 2.4100000000000001 110.621 -172.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.642 ' CG2' ' HE1' ' A' ' 134' ' ' PHE . 26.9 mm -138.36 61.2 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 107.085 -1.45 . . . . 0.42999999999999999 107.085 170.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.494 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 45.7 m-20 -96.46 125.41 40.93 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.658 -1.156 . . . . 1.8600000000000001 109.766 -175.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.65 HD12 ' O ' ' A' ' 92' ' ' PHE . 7.7 tp -75.22 126.89 31.94 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.988 -0.551 . . . . 0.28000000000000003 109.524 173.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -127.01 128.18 70.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.596 -0.729 . . . . 0.26000000000000001 111.929 -165.475 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.968 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 7.7 t80 -113.15 114.23 26.5 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.156 -0.929 . . . . 2.5699999999999998 110.324 175.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.649 HG12 HG22 ' A' ' 127' ' ' ILE . 71.9 mt -90.41 99.29 9.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.84 -0.618 . . . . 0.89000000000000001 109.401 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.507 ' HB3' HG23 ' A' ' 126' ' ' ILE . 15.4 tppt? -102.4 123.06 45.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.572 -0.74 . . . . 1.2 110.948 -173.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -103.07 93.28 4.93 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.869 -0.605 . . . . 2.7999999999999998 109.443 177.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -70.97 106.12 3.54 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 107.181 -1.414 . . . . 0.82999999999999996 107.181 168.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -26.1 92.98 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 O-C-N 125.123 1.514 . . . . 2.2799999999999998 113.631 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 53.7 43.27 68.98 Favored Glycine 0 CA--C 1.508 -0.385 0 CA-C-N 115.316 -0.856 . . . . 0.76000000000000001 112.176 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.662 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 3.6 t-20 -139.02 -47.77 0.49 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.054 -0.573 . . . . 1.6499999999999999 110.585 -174.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.547 ' SD ' HD11 ' A' ' 15' ' ' LEU . 2.4 mtt -161.13 121.21 2.69 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 120.953 0.406 . . . . 1.1200000000000001 110.919 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -106.34 75.16 1.07 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.452 -0.944 . . . . 1.6200000000000001 108.452 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.759 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.5 OUTLIER -97.08 141.5 15.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.004 -0.998 . . . . 0.29999999999999999 112.866 -172.173 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.706 ' O ' HG13 ' A' ' 127' ' ' ILE . 6.4 pt -109.45 108.97 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-O 121.756 0.789 . . . . 0.58999999999999997 108.99 163.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 56.4 p -95.25 117.93 31.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.191 0.519 . . . . 1.1799999999999999 110.955 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.565 ' HB2' ' SG ' ' A' ' 151' ' ' CYS . 20.1 m -114.6 151.57 33.25 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.199 0.523 . . . . 1.24 111.458 -174.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.559 ' HZ3' HG21 ' A' ' 10' ' ' THR . 10.3 mtmm -140.92 130.12 23.53 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.787 -0.82 . . . . 2.2599999999999998 108.787 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.445 ' HB3' ' H ' ' A' ' 148' ' ' ASN . 21.7 p -73.76 101.46 3.71 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.832 -0.803 . . . . 1.3899999999999999 108.832 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.3 m -105.72 173.55 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 120.048 -0.661 . . . . 1.05 110.173 -176.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -135.65 65.42 1.54 Allowed 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 122.069 0.938 . . . . 2.1699999999999999 109.354 -174.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.642 ' HE1' ' CG2' ' A' ' 112' ' ' ILE . 1.0 OUTLIER -97.08 153.62 38.44 Favored Pre-proline 0 C--N 1.317 -0.839 0 CA-C-N 114.088 -1.414 . . . . 0.53000000000000003 108.852 -175.644 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -83.39 5.42 6.41 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.082 1.855 . . . . 1.28 116.483 -166.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.602 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 11.8 tp10 -76.06 -15.95 60.02 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 119.253 0.933 . . . . 3.5 108.505 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -156.75 114.73 2.03 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 113.315 0.857 . . . . 6.1200000000000001 113.315 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -95.06 139.43 0.98 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.671 2.914 . . . . 1.77 111.85 169.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -80.6 -165.4 0.34 Allowed 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.608 2.205 . . . . 1.25 112.988 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.1 m -147.62 152.37 37.78 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.94 -1.133 . . . . 1.6000000000000001 107.94 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.1 t -61.45 -16.9 51.47 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.953 0.723 . . . . 1.97 112.953 -167.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -82.72 -18.52 40.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.943 0.402 . . . . 2.1800000000000002 110.94 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.508 ' HB3' ' CB ' ' A' ' 110' ' ' ASP . 94.1 m-85 -130.82 109.15 10.37 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.73 -0.668 . . . . 1.23 109.804 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.714 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 2.1 tp -89.19 115.02 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 CA-C-N 115.795 -0.638 . . . . 0.81999999999999995 109.659 -169.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.554 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 30.3 ttp180 -36.02 115.75 0.35 Allowed 'General case' 0 C--N 1.327 -0.403 0 O-C-N 124.618 1.198 . . . . 4.4199999999999999 111.076 175.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.492 ' H ' ' HA ' ' A' ' 111' ' ' PHE . . . -42.63 108.0 0.13 Allowed Glycine 0 CA--C 1.496 -1.096 0 O-C-N 124.655 1.222 . . . . 0.79000000000000004 112.358 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.661 ' HB2' ' HB3' ' A' ' 174' ' ' GLU . 1.3 p90 -86.01 55.33 3.48 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.201 -0.499 . . . . 4.4400000000000004 111.835 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.703 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 84.5 m-20 -98.64 65.36 1.57 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.489 -0.778 . . . . 1.6200000000000001 110.702 -177.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -54.44 146.2 34.36 Favored Pre-proline 0 N--CA 1.467 0.379 0 CA-C-N 115.843 -0.617 . . . . 2.3199999999999998 110.421 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -10.01 62.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.312 1 C-N-CA 126.853 5.035 . . . . 0.53000000000000003 115.838 -161.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . 0.703 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 27.6 p -84.19 171.13 13.07 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.347 -1.297 . . . . 1.5800000000000001 109.069 173.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.783 ' HA3' HG11 ' A' ' 14' ' ' VAL . . . -167.8 -168.04 29.35 Favored Glycine 0 N--CA 1.433 -1.552 0 C-N-CA 119.744 -1.217 . . . . 0.42999999999999999 111.854 177.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.651 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 39.9 t80 -162.66 77.01 0.46 Allowed 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 109.064 -0.717 . . . . 0.59999999999999998 109.064 -165.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.759 HG12 ' HB ' ' A' ' 126' ' ' ILE . 3.9 m -89.27 121.6 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 122.034 0.921 . . . . 0.31 110.607 -175.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 32.3 m -100.43 112.74 25.13 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.037 -0.983 . . . . 1.55 108.728 175.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.414 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 7.1 m -106.8 111.43 63.83 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 116.492 -0.322 . . . . 1.0600000000000001 111.406 -171.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.662 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 57.7 Cg_exo -52.16 119.34 5.62 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.421 2.081 . . . . 0.56000000000000005 111.002 168.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.4 ' N ' ' HB3' ' A' ' 161' ' ' ASN . 72.2 mtp -81.37 -169.98 2.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.976 0.417 . . . . 1.1599999999999999 111.348 -176.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -67.28 -30.53 70.42 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.854 -0.795 . . . . 2.6299999999999999 108.854 169.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.423 ' C ' ' HD2' ' A' ' 162' ' ' PRO . 47.1 mm-40 -104.32 28.79 6.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.607 -1.179 . . . . 2.0499999999999998 109.274 175.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.577 ' OD1' ' HD3' ' A' ' 162' ' ' PRO . 4.8 p30 -34.81 -47.82 0.94 Allowed Pre-proline 0 N--CA 1.472 0.643 0 N-CA-C 116.16 1.911 . . . . 1.9299999999999999 116.16 -171.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.577 ' HD3' ' OD1' ' A' ' 161' ' ' ASN . 66.3 Cg_endo -72.51 -25.09 18.27 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 CA-C-N 121.534 1.584 . . . . 0.72999999999999998 112.378 -174.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -100.78 -25.55 14.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.761 -0.654 . . . . 0.68000000000000005 110.919 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 55' ' ' PRO . 73.1 m-85 -142.48 119.99 11.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.986 -0.552 . . . . 0.93000000000000005 110.238 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.449 ' OG ' HD11 ' A' ' 61' ' ' LEU . 13.8 p -114.47 140.83 48.4 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.169 0.509 . . . . 1.4099999999999999 110.972 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.564 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 2.0 tppp? -91.51 104.04 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.892 0.853 . . . . 0.73999999999999999 111.577 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.506 HD21 ' CE2' ' A' ' 153' ' ' PHE . 0.8 OUTLIER -89.49 111.61 22.55 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.87 -1.059 . . . . 0.27000000000000002 109.241 177.756 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.65 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.1 OUTLIER -132.16 116.41 29.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 122.099 0.952 . . . . 0.28000000000000003 111.91 175.094 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.65 ' HB3' HG13 ' A' ' 50' ' ' VAL . 19.4 ttt -112.57 158.99 19.29 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.462 -1.244 . . . . 1.24 108.817 -175.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.667 ' HE1' HG13 ' A' ' 154' ' ' VAL . 0.1 OUTLIER -140.06 151.15 45.17 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 110.47 -0.196 . . . . 3.3700000000000001 110.47 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.517 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 6.6 m -136.87 128.23 42.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 O-C-N 123.385 0.428 . . . . 1.3999999999999999 110.931 173.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -108.15 49.7 0.8 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.106 -1.442 . . . . 2.1699999999999999 107.106 174.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -47.68 130.65 14.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.383 -1.735 . . . . 1.6499999999999999 113.541 -166.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.661 ' HB3' ' HB2' ' A' ' 147' ' ' TYR . 21.9 tt0 -88.49 -33.19 17.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.274 -0.876 . . . . 2.4500000000000002 111.04 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.484 ' SD ' HG12 ' A' ' 184' ' ' ILE . 68.9 mtm 61.21 50.97 4.54 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.183 0.516 . . . . 3.7400000000000002 110.567 171.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.601 ' HG3' ' HB3' ' A' ' 147' ' ' TYR . 74.2 mtp85 -58.99 -30.24 67.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.228 -0.896 . . . . 5.7800000000000002 111.9 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -66.04 -20.48 68.92 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.849 -0.691 . . . . 2.2599999999999998 111.99 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 51.46 82.46 0.06 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.266 0.626 . . . . 6.2300000000000004 111.772 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.641 HD22 ' H ' ' A' ' 179' ' ' LEU . 0.4 OUTLIER -84.52 -158.39 0.34 Allowed 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.629 -0.878 . . . . 1.6399999999999999 108.629 177.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.541 ' O ' HD12 ' A' ' 184' ' ' ILE . 50.2 m -112.05 151.38 43.55 Favored Pre-proline 0 C--N 1.315 -0.897 0 N-CA-C 108.802 -0.814 . . . . 2.04 108.802 178.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.615 ' O ' ' HG2' ' A' ' 185' ' ' GLU . 62.0 Cg_exo -39.68 -56.0 1.48 Allowed 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 123.327 2.685 . . . . 1.74 113.373 -177.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 14.6 m -64.97 -11.74 42.06 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.483 0.549 . . . . 2.1400000000000001 112.483 -175.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.468 ' HA ' ' CE ' ' A' ' 186' ' ' LYS . 33.0 mm -90.73 -43.89 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-O 122.528 1.156 . . . . 1.1200000000000001 108.724 -177.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 1.086 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.4 mp -66.69 -34.14 68.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 112.889 -1.959 . . . . 1.1299999999999999 110.597 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.615 ' HG2' ' O ' ' A' ' 181' ' ' PRO . 18.1 mm-40 -62.04 -21.33 64.82 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.793 -1.094 . . . . 2.8900000000000001 109.39 174.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.468 ' CE ' ' HA ' ' A' ' 183' ' ' ILE . 50.8 mtmt -92.53 -49.34 6.17 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.382 -0.826 . . . . 1.28 110.222 172.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 1.086 HG22 ' HA ' ' A' ' 184' ' ' ILE . 6.5 t -61.55 -35.08 76.74 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.328 0.492 . . . . 0.62 112.328 -168.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . 0.611 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 2.1 mmt -80.35 -61.24 0.44 Allowed Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 119.921 -0.712 . . . . 1.0600000000000001 111.946 -177.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.611 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 8.0 Cg_exo -73.38 -12.53 25.16 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.03 1.82 . . . . 0.91000000000000003 112.545 -172.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.55 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 11.6 t -91.82 -33.48 14.94 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.784 -0.366 . . . . 1.5 110.311 176.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.2 OUTLIER -81.27 -38.4 26.92 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.44 -0.346 . . . . 1.8799999999999999 110.538 -173.556 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.461 ' HB3' HG11 ' A' ' 50' ' ' VAL . 54.7 mt -67.61 -44.68 77.47 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.888 0.375 . . . . 1.0900000000000001 111.277 -176.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.527 ' HB ' HD12 ' A' ' 33' ' ' ILE . 2.1 m -66.95 -31.94 55.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.54 0.686 . . . . 0.68000000000000005 109.354 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.55 ' HB2' ' O ' ' A' ' 190' ' ' SER . 0.6 OUTLIER -74.34 -27.23 60.59 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.668 -1.151 . . . . 2.0699999999999998 110.628 179.534 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.438 ' O ' ' HB2' ' A' ' 198' ' ' ASN . 2.6 t80 -73.66 -30.27 62.82 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.623 -0.88 . . . . 2.0 108.623 175.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.694 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 17.6 mt -77.25 -34.3 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 116.079 -0.51 . . . . 0.31 110.703 173.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 74.2 mt -67.49 -37.04 82.26 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 121.229 0.538 . . . . 1.03 109.702 174.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.688 ' OD1' ' HG2' ' A' ' 76' ' ' LYS . 22.0 m-20 -50.65 -36.26 34.66 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.718 -1.128 . . . . 1.8999999999999999 109.671 167.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.64 ' HA ' ' CE2' ' A' ' 64' ' ' PHE . . . -81.04 -42.35 21.23 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 115.926 -0.579 . . . . 0.28999999999999998 110.944 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.694 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 10.3 mmmm -58.81 -38.89 79.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.548 0.689 . . . . 0.96999999999999997 110.164 176.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -88.75 -43.54 11.2 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.902 -1.045 . . . . 1.9399999999999999 111.092 -178.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 206' ' ' HIS . . . -66.75 -31.52 78.62 Favored Glycine 0 CA--C 1.504 -0.626 0 C-N-CA 121.009 -0.615 . . . . 0.46999999999999997 111.984 -176.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.983 HD13 HD23 ' A' ' 61' ' ' LEU . 4.7 tp -67.67 -34.47 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-O 121.274 0.559 . . . . 0.60999999999999999 110.107 178.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.617 ' HA ' ' HG2' ' A' ' 207' ' ' ARG . 54.2 mttp -87.21 -30.63 20.82 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.813 -0.631 . . . . 3.3700000000000001 109.555 -178.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.412 ' HA ' ' HB3' ' A' ' 210' ' ' SER . . . -61.98 -31.74 72.13 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.353 -0.84 . . . . 1.02 109.231 168.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.474 ' HB2' ' O ' ' A' ' 202' ' ' GLY . 4.1 t60 -77.94 -20.36 52.9 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.943 -1.026 . . . . 3.6299999999999999 111.618 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.617 ' HG2' ' HA ' ' A' ' 204' ' ' LYS . 14.2 ptm180 -101.92 -47.28 4.63 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 119.855 -0.738 . . . . 2.5899999999999999 111.724 176.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.551 HG22 ' O ' ' A' ' 204' ' ' LYS . 1.3 t -100.9 155.13 36.68 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.055 -0.72 . . . . 1.8400000000000001 109.055 -176.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.545 ' HD2' ' OG1' ' A' ' 208' ' ' THR . 44.4 Cg_endo -68.01 66.12 0.96 Allowed 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.691 2.261 . . . . 2.3500000000000001 112.706 178.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.412 ' HB3' ' HA ' ' A' ' 205' ' ' ALA . 18.5 t -109.79 37.96 2.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.485 0.659 . . . . 2.3100000000000001 110.044 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -110.17 14.14 22.93 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.105 -0.702 . . . . 5.4500000000000002 109.105 172.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -61.34 -22.3 64.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.202 -0.908 . . . . 6.8600000000000003 111.106 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -119.56 39.13 2.58 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 110.988 -0.845 . . . . 3.3700000000000001 110.988 175.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -68.62 150.31 48.13 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.045 -0.354 . . . . 5.21 110.045 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . 0.548 ' O ' ' HA ' ' A' ' 73' ' ' THR . 40.7 p-80 -120.24 135.39 55.01 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.165 -0.68 . . . . 6.46 109.165 173.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -138.85 125.39 20.61 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 110.029 -0.36 . . . . 6.0899999999999999 110.029 -173.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -130.21 66.53 1.49 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.452 0.644 . . . . 5.1200000000000001 110.654 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.2 t -91.94 -24.72 19.18 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.938 -0.764 . . . . 6.7599999999999998 108.938 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -142.25 98.06 3.24 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.249 -0.887 . . . . 8.8200000000000003 109.515 177.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 5.2 t . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.597 -0.716 . . . . 8.4800000000000004 109.646 -179.046 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 121.161 0.505 . . . . 3.8599999999999999 110.062 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.462 ' O ' HD12 ' A' ' 6' ' ' ILE . 7.5 m-20 -101.26 -74.52 0.61 Allowed 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 116.133 -0.485 . . . . 2.25 110.518 -175.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.67 ' HA ' HD12 ' A' ' 6' ' ' ILE . 81.2 m-85 -60.67 -29.08 69.08 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 115.465 -0.789 . . . . 0.42999999999999999 110.586 -170.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.564 ' HG2' ' HG3' ' A' ' 8' ' ' GLN . 21.0 ttmt -74.05 -37.13 64.38 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 107.952 -1.129 . . . . 1.51 107.952 -174.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.71 -37.23 78.32 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.568 -0.742 . . . . 0.54000000000000004 110.556 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.67 HD12 ' HA ' ' A' ' 3' ' ' PHE . 1.7 mp -82.75 -39.35 15.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.922 0.868 . . . . 1.0700000000000001 109.131 -174.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -75.89 -37.41 58.87 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.275 -1.329 . . . . 0.34000000000000002 111.595 -177.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.564 ' HG3' ' HG2' ' A' ' 4' ' ' LYS . 15.2 mt-30 -65.94 -28.24 68.77 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.346 -0.843 . . . . 1.5900000000000001 109.803 176.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -81.06 -34.89 32.42 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.753 -1.112 . . . . 2.4700000000000002 109.555 174.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.724 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.3 OUTLIER -74.1 -36.5 64.26 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.067 -0.969 . . . . 0.47999999999999998 111.486 -179.25 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.513 ' O ' ' HB3' ' A' ' 15' ' ' LEU . . . -46.14 -53.77 9.83 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-O 120.911 0.386 . . . . 0.31 110.651 172.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -78.81 -1.68 36.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.924 -0.58 . . . . 1.6399999999999999 111.989 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.684 ' HB3' ' HA ' ' A' ' 10' ' ' THR . 0.8 OUTLIER -87.87 -49.45 7.09 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.767 -0.827 . . . . 2.54 108.767 175.389 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.63 HG21 ' N ' ' A' ' 152' ' ' GLY . 13.0 p -69.39 -40.7 80.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 122.237 1.017 . . . . 0.53000000000000003 109.039 178.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.552 HD23 ' HD3' ' A' ' 19' ' ' ARG . 0.9 OUTLIER -73.74 -17.92 61.05 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 114.378 -1.283 . . . . 0.59999999999999998 109.186 175.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.55 ' HA2' ' NE ' ' A' ' 19' ' ' ARG . . . -58.0 -32.85 67.35 Favored Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 109.728 -1.349 . . . . 0.56999999999999995 109.728 171.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.496 ' HD1' ' O ' ' A' ' 13' ' ' GLU . 9.5 m-85 -88.05 -15.71 35.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.872 -0.664 . . . . 3.27 109.894 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.485 ' HA ' ' NH1' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -89.43 -19.84 24.66 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 120.414 -0.514 . . . . 2.0299999999999998 110.429 176.363 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.552 ' HD3' HD23 ' A' ' 15' ' ' LEU . 17.2 ptt180 -96.02 -21.58 17.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.35 -0.387 . . . . 2.7200000000000002 111.574 -171.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -130.83 157.23 43.44 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 119.615 -0.834 . . . . 2.1600000000000001 111.174 170.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 71.5 p -136.29 158.09 45.24 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.91 -1.041 . . . . 1.8200000000000001 109.389 -173.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.0 t -170.17 -148.57 0.06 Allowed 'General case' 0 C--O 1.234 0.272 0 C-N-CA 120.083 -0.647 . . . . 2.1899999999999999 111.05 -172.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.73 75.16 0.73 Allowed Glycine 0 C--N 1.331 0.29 0 CA-C-N 116.227 -0.442 . . . . 1.1000000000000001 113.494 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.882 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -109.27 -153.06 0.5 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.4 -0.592 . . . . 1.6699999999999999 109.4 172.203 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.5 ttpt -178.43 126.27 0.11 Allowed 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 108.263 -1.014 . . . . 2.9500000000000002 108.263 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.603 HG11 HG23 ' A' ' 34' ' ' THR . 3.2 m -64.89 123.22 17.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 122.057 0.932 . . . . 1.5600000000000001 110.667 174.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.9 p -93.74 -24.03 5.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 114.353 -1.294 . . . . 1.22 108.271 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.4 tptm -155.44 133.85 11.73 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 119.744 -0.782 . . . . 2.4100000000000001 112.146 -177.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.862 HG22 ' HA ' ' A' ' 34' ' ' THR . 45.9 p -137.07 101.5 4.57 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.274 -0.639 . . . . 1.3799999999999999 109.274 169.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.425 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 13.8 m -140.92 108.69 5.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.278 -0.419 . . . . 2.3700000000000001 110.961 -175.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 30' ' ' SER . 56.7 mttm 79.6 64.46 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.752 0.657 . . . . 4.5499999999999998 111.627 176.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 44.3 tptt 75.33 15.65 2.8 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.101 -0.5 . . . . 1.4199999999999999 112.233 168.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.984 HG22 ' HA3' ' A' ' 52' ' ' GLY . 31.7 pt -135.08 169.96 20.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.551 0.691 . . . . 0.76000000000000001 112.833 -172.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.862 ' HA ' HG22 ' A' ' 29' ' ' THR . 87.7 m -152.15 106.01 3.12 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.572 -1.195 . . . . 0.57999999999999996 110.696 -169.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.956 HG11 HD13 ' A' ' 192' ' ' LEU . 2.3 t -101.95 108.13 23.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.252 -0.431 . . . . 0.85999999999999999 110.31 -177.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 1.6 p -102.96 127.17 50.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.506 0.669 . . . . 1.1000000000000001 111.38 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.2 p -98.02 121.65 40.19 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.12 -0.945 . . . . 1.27 111.385 -174.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.882 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 5.3 ttpp -163.75 99.33 0.89 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.992 -0.549 . . . . 1.9099999999999999 112.08 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.497 ' HB3' ' H ' ' A' ' 47' ' ' LEU . . . 179.31 -78.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.772 0.656 . . . . 1.6799999999999999 112.772 168.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.412 ' C ' ' H ' ' A' ' 42' ' ' LYS . 19.2 t 67.03 -100.25 0.06 Allowed 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.365 -1.346 . . . . 2.0899999999999999 107.365 -165.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 68.73 -40.87 0.45 Allowed 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.431 0.457 . . . . 6.6100000000000003 110.938 177.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 33.0 mmtp -56.46 -49.42 74.69 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.644 -0.707 . . . . 6.46 109.202 169.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.436 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 74.1 t80 172.17 -76.6 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 114.957 -1.02 . . . . 5.6500000000000004 110.379 -175.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -138.63 83.79 1.98 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.559 0.695 . . . . 5.5599999999999996 109.691 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.54 -152.98 6.37 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 110.672 -0.971 . . . . 1.5600000000000001 110.672 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -160.18 141.02 12.07 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.646 0.26 . . . . 2.0499999999999998 110.688 174.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 1.007 HD12 ' HB2' ' A' ' 172' ' ' GLN . 10.6 tt -86.25 135.55 33.51 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.379 -1.341 . . . . 0.87 107.379 170.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.454 ' HB2' HD21 ' A' ' 192' ' ' LEU . 99.6 m-85 -109.92 117.33 33.51 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.219 0.533 . . . . 0.98999999999999999 110.321 -172.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.651 ' HD3' ' CZ3' ' A' ' 24' ' ' TRP . 28.3 ttt180 -93.75 107.53 19.4 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.225 -0.898 . . . . 2.9199999999999999 110.279 177.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.598 HG13 HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -82.87 140.84 15.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.406 -0.961 . . . . 1.3300000000000001 108.406 174.555 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.785 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 54.7 tt0 -151.52 108.61 3.56 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.054 0.454 . . . . 1.0700000000000001 109.983 -178.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.984 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -145.46 154.9 26.23 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 111.153 -0.779 . . . . 0.28999999999999998 111.153 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.0 mt -97.86 114.36 34.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 119.918 -0.713 . . . . 0.57999999999999996 111.205 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.464 HD13 ' HB1' ' A' ' 199' ' ' ALA . 68.7 mt -92.31 111.6 51.2 Favored Pre-proline 0 N--CA 1.443 -0.821 0 N-CA-C 108.373 -0.973 . . . . 0.34999999999999998 108.373 170.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 22.0 Cg_exo -66.52 54.57 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 124.266 3.311 . . . . 0.62 113.167 -177.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.683 ' HG2' HG13 ' A' ' 203' ' ' ILE . 10.8 tp10 -151.65 167.63 27.53 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 107.417 -1.327 . . . . 1.6799999999999999 107.417 175.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.484 ' HB3' ' HA ' ' A' ' 162' ' ' PRO . 23.8 p -70.12 137.09 86.94 Favored Pre-proline 0 N--CA 1.431 -1.397 0 CA-C-O 121.683 0.754 . . . . 1.1799999999999999 111.404 -176.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.786 ' HD3' ' HB2' ' A' ' 165' ' ' SER . 6.3 Cg_endo -49.55 -18.18 2.31 Favored 'Trans proline' 0 C--O 1.23 0.116 0 C-N-CA 124.698 3.598 . . . . 0.52000000000000002 111.677 170.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.85 -47.82 50.37 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.082 -0.963 . . . . 0.64000000000000001 110.692 176.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.847 ' HD2' ' HB3' ' A' ' 206' ' ' HIS . 4.5 tppt? -68.02 -29.83 68.93 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.71 -0.848 . . . . 3.2999999999999998 108.71 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.957 HD23 HD13 ' A' ' 203' ' ' ILE . 88.5 mt -60.02 -53.97 51.54 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.906 -1.043 . . . . 0.40999999999999998 110.25 174.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.514 ' CB ' HD21 ' A' ' 125' ' ' ASN . 19.3 p -68.05 -12.61 61.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.107 0.479 . . . . 1.29 110.44 175.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.502 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 37.8 t70 -82.28 -33.06 29.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.794 -0.639 . . . . 1.3200000000000001 111.409 -177.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.54 ' CE2' ' HA ' ' A' ' 61' ' ' LEU . 15.4 p90 -83.7 -47.51 11.13 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.404 -0.518 . . . . 0.60999999999999999 110.976 -177.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.511 ' CD2' ' HA ' ' A' ' 62' ' ' SER . 0.7 OUTLIER -83.5 -1.79 54.46 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.4 -0.52 . . . . 1.5 111.904 -172.154 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -38.34 -47.94 1.28 Allowed 'General case' 0 C--N 1.327 -0.373 0 O-C-N 124.806 1.316 . . . . 1.52 114.448 -162.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -162.21 -84.09 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 114.261 1.208 . . . . 3.6000000000000001 114.261 -175.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.754 ' HB ' ' CD1' ' A' ' 81' ' ' TYR . 10.8 t -150.86 13.57 0.71 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.406 0.521 . . . . 1.48 112.406 -166.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -111.25 -6.67 25.54 Favored Glycine 0 C--N 1.306 -1.132 0 C-N-CA 118.987 -1.578 . . . . 1.46 113.203 -165.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.741 ' O ' HG22 ' A' ' 73' ' ' THR . 12.9 t70 -162.41 -41.45 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.369 0.604 . . . . 2.1899999999999999 110.136 -167.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.704 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 1.5 ptp180 -49.92 -47.42 52.3 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.904 -1.044 . . . . 3.3799999999999999 111.64 -176.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.863 HG22 HD13 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -90.05 -8.04 10.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.697 -0.401 . . . . 0.70999999999999996 111.054 -174.333 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.741 HG22 ' O ' ' A' ' 70' ' ' ASP . 4.8 t -83.29 -35.67 25.09 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 119.171 -1.011 . . . . 0.96999999999999997 110.089 -176.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.712 ' HZ3' ' HB2' ' A' ' 198' ' ' ASN . 20.4 p-90 -103.27 -6.09 22.41 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.413 -0.515 . . . . 0.75 111.982 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.814 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 5.5 t70 -67.24 172.93 4.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.864 0.84 . . . . 2.1899999999999999 112.288 -170.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.477 ' H ' ' HG3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -118.08 -11.12 10.22 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.52 -1.218 . . . . 3.1899999999999999 111.61 -174.327 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.1 m -140.88 17.36 2.31 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.496 0.665 . . . . 1.5800000000000001 109.899 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.863 HD13 HG22 ' A' ' 72' ' ' ILE . 21.9 mt -108.03 157.33 18.34 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.593 -0.73 . . . . 0.70999999999999996 110.624 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.789 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 16.4 mm-40 -131.89 -71.1 0.56 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.577 -0.738 . . . . 1.73 111.074 -178.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.86 ' HB ' HD13 ' A' ' 97' ' ' ILE . 15.1 t -137.41 142.8 35.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.599 -0.728 . . . . 0.78000000000000003 109.892 -170.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.754 ' CD1' ' HB ' ' A' ' 68' ' ' THR . 25.3 t80 -124.2 137.51 54.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.989 0.423 . . . . 5.4000000000000004 110.431 176.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.892 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 5.3 m-20 -128.97 111.78 13.37 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.664 -0.865 . . . . 1.6899999999999999 108.664 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.712 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 20.1 ttm -75.85 96.37 3.69 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.838 -0.801 . . . . 2.0499999999999998 108.838 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -78.54 -83.31 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 116.36 -0.382 . . . . 0.64000000000000001 111.741 -168.52 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.497 ' HB2' HD12 ' A' ' 93' ' ' ILE . 32.1 m170 -122.56 122.75 39.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.27 0.557 . . . . 1.96 110.25 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.712 ' HD3' ' SD ' ' A' ' 83' ' ' MET . 81.2 mtm180 -105.68 108.79 20.49 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.225 -0.898 . . . . 2.4399999999999999 109.219 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.515 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -72.68 -39.95 61.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.428 -0.806 . . . . 0.46999999999999997 110.067 -173.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -152.08 -171.0 3.8 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.409 -0.814 . . . . 1.8600000000000001 109.188 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.6 t -78.88 -5.56 53.9 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.795 0.331 . . . . 1.4399999999999999 110.389 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -122.81 -4.3 8.63 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.94 -0.393 . . . . 1.8700000000000001 109.94 -176.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.715 HG23 ' HD1' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -135.93 112.06 9.69 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.301 -0.629 . . . . 0.46000000000000002 109.301 -169.132 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.707 ' HD2' ' HG2' ' A' ' 86' ' ' ARG . 10.8 m-85 -125.39 178.73 5.45 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.651 -0.5 . . . . 0.42999999999999999 109.651 -177.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.66 ' O ' HG23 ' A' ' 84' ' ' VAL . 42.6 mt -133.0 128.94 57.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 107.094 -1.447 . . . . 0.40999999999999998 107.094 168.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 113' ' ' ASP . 6.6 p -113.18 112.32 23.58 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.122 0.487 . . . . 2.0099999999999998 112.13 -170.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.892 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 4.7 t-160 -82.64 93.96 7.46 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.64 -0.874 . . . . 1.23 108.64 170.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.544 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 21.8 m -113.11 111.57 22.35 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.25 -0.432 . . . . 0.5 111.965 -172.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.86 HD13 ' HB ' ' A' ' 80' ' ' VAL . 3.4 mp -77.27 120.42 27.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 108.642 -0.874 . . . . 1.03 108.642 174.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 49.6 m -111.72 138.37 48.39 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.368 -0.833 . . . . 1.3799999999999999 111.909 -170.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.789 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 42.6 mt-30 -91.31 75.59 6.06 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.089 -0.505 . . . . 1.8200000000000001 109.784 174.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.8 t -90.12 102.0 14.72 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.047 -0.723 . . . . 3.9100000000000001 109.047 -177.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -120.38 112.87 19.54 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.156 0.503 . . . . 5.1600000000000001 111.594 -177.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.416 ' HB1' ' HB2' ' A' ' 186' ' ' LYS . . . -98.89 71.12 1.88 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.613 -0.721 . . . . 1.98 109.359 169.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 102' ' ' ALA . 93.1 t 74.75 -38.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 115.655 -0.702 . . . . 3.1699999999999999 111.197 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.95 -7.98 0.14 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.629 -0.796 . . . . 1.96 112.7 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.463 ' HB2' HG23 ' A' ' 183' ' ' ILE . 1.2 m -68.76 -7.4 33.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.159 0.504 . . . . 1.8799999999999999 111.449 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.461 HG22 ' O ' ' A' ' 107' ' ' SER . 65.7 mt -129.6 141.75 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 116.101 -0.499 . . . . 1.1200000000000001 111.034 -173.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.461 ' O ' HG22 ' A' ' 106' ' ' ILE . 19.8 m -94.26 164.88 18.87 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.661 -0.699 . . . . 1.3500000000000001 109.539 173.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.22 141.67 30.65 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.234 1.956 . . . . 1.0700000000000001 111.458 173.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.752 HH22 HD21 ' A' ' 179' ' ' LEU . 54.6 mtt180 -116.33 173.95 6.32 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.049 0.452 . . . . 3.4500000000000002 110.689 -174.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.822 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 9.8 t70 -132.72 123.07 25.56 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.56 -0.746 . . . . 1.3700000000000001 109.04 -177.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.544 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 9.6 m-30 -103.63 140.42 37.59 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.146 0.498 . . . . 2.4100000000000001 111.366 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.678 HG13 ' HA ' ' A' ' 137' ' ' TYR . 25.5 mm -132.38 75.14 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.124 -0.944 . . . . 0.42999999999999999 108.691 173.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.902 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 17.2 m-20 -99.85 123.18 43.84 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.695 -0.684 . . . . 1.8600000000000001 110.808 -173.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.614 HD12 ' O ' ' A' ' 92' ' ' PHE . 7.6 tp -76.38 123.53 26.12 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 108.71 -0.848 . . . . 0.28000000000000003 108.71 167.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.606 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -127.15 124.62 64.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.562 -0.744 . . . . 0.26000000000000001 112.384 -163.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.715 ' HD1' HG23 ' A' ' 91' ' ' THR . 54.5 t80 -109.75 118.23 35.97 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.273 -0.876 . . . . 2.5699999999999998 110.947 174.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.465 HG13 ' HB ' ' A' ' 127' ' ' ILE . 5.1 mp -97.5 120.85 47.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.787 -0.642 . . . . 0.89000000000000001 109.923 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.423 ' HB3' ' CE2' ' A' ' 116' ' ' TYR . 14.0 ptpt -140.56 147.41 39.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.041 0.448 . . . . 1.2 110.714 177.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.475 ' HD2' ' C ' ' A' ' 119' ' ' ARG . 1.7 tmm_? -125.64 99.97 6.23 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 109.014 -0.735 . . . . 2.7999999999999998 109.014 -176.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -63.45 116.32 5.45 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.406 -1.331 . . . . 0.82999999999999996 107.406 169.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.415 ' HG3' ' H ' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -33.09 90.13 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 O-C-N 125.12 1.513 . . . . 2.2799999999999998 114.682 -175.451 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 58.05 29.32 62.22 Favored Glycine 0 C--O 1.229 -0.198 0 CA-C-N 114.716 -1.129 . . . . 0.76000000000000001 112.62 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.429 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 33.7 t-20 -119.72 -49.18 2.34 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.538 -0.541 . . . . 1.6499999999999999 109.538 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 1.9 mtm -161.93 122.74 2.64 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.972 0.415 . . . . 1.1200000000000001 111.226 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.514 HD21 ' CB ' ' A' ' 62' ' ' SER . 59.3 t30 -109.4 80.82 1.36 Allowed 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.716 -0.846 . . . . 1.6200000000000001 108.716 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.821 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -100.57 139.48 21.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.232 -0.895 . . . . 0.29999999999999999 112.81 -173.191 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.656 HG13 ' O ' ' A' ' 127' ' ' ILE . 1.9 pt -108.64 116.58 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 108.318 -0.993 . . . . 0.58999999999999997 108.318 160.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.606 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 26.5 p -87.54 156.98 19.27 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.102 -0.703 . . . . 1.1799999999999999 109.102 175.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.902 ' HB3' ' HB3' ' A' ' 113' ' ' ASP . 50.2 m -153.9 136.35 15.02 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.758 0.313 . . . . 1.24 111.576 -178.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.892 ' HE2' ' HG3' ' A' ' 150' ' ' PRO . 4.6 mtpm? -131.04 122.77 27.37 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 107.824 -1.176 . . . . 2.2599999999999998 107.824 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.578 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 70.4 p -64.49 99.02 0.28 Allowed 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.098 -1.445 . . . . 1.3899999999999999 107.098 174.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.57 137.34 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 CA-C-N 115.265 -0.879 . . . . 1.05 108.709 -165.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.617 ' HA ' ' CG ' ' A' ' 137' ' ' TYR . 9.8 p-10 -92.05 69.57 5.35 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.678 -1.147 . . . . 2.1699999999999999 110.543 -167.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.721 ' CZ ' ' HB3' ' A' ' 136' ' ' GLU . 1.7 p90 -105.15 173.36 3.33 Favored Pre-proline 0 CA--C 1.546 0.82 0 CA-C-N 113.927 -1.488 . . . . 0.53000000000000003 108.313 -176.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.535 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 31.8 Cg_exo -28.05 -57.17 0.12 Allowed 'Trans proline' 0 CA--C 1.548 1.182 0 C-N-CA 124.875 3.716 . . . . 1.28 116.964 -177.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.721 ' HB3' ' CZ ' ' A' ' 134' ' ' PHE . 17.8 tp10 -80.77 -21.44 41.03 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.635 0.606 . . . . 3.5 112.635 -174.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.678 ' HA ' HG13 ' A' ' 112' ' ' ILE . 17.8 t80 -49.43 -43.12 69.95 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 114.403 1.26 . . . . 6.1200000000000001 114.403 -177.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.507 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 32.0 Cg_exo -39.31 119.55 0.52 Allowed 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 122.386 2.057 . . . . 1.77 113.28 175.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.887 ' HB3' ' HD3' ' A' ' 145' ' ' ARG . 50.6 Cg_endo -89.14 -163.1 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.422 2.748 . . . . 1.25 113.773 -172.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.5 m -142.73 -169.32 2.97 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.79 -0.819 . . . . 1.6000000000000001 108.79 -175.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.8 t -80.46 -45.31 17.78 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.18 -0.608 . . . . 1.97 110.028 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -69.58 -28.31 65.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.073 -0.512 . . . . 2.1800000000000002 110.86 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.822 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 65.5 m-85 -118.87 109.12 15.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.975 -0.557 . . . . 1.23 110.542 -174.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.659 HD11 ' HG3' ' A' ' 176' ' ' ARG . 2.5 tp -98.66 111.95 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-O 121.314 0.578 . . . . 0.81999999999999995 109.695 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.887 ' HD3' ' HB3' ' A' ' 139' ' ' PRO . 4.7 mpt_? -57.89 100.48 0.06 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.814 -1.085 . . . . 4.4199999999999999 110.888 176.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -66.99 115.53 7.31 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 110.404 -1.079 . . . . 0.79000000000000004 110.404 174.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.406 ' HB3' ' HB3' ' A' ' 174' ' ' GLU . 24.8 t80 -84.55 86.16 7.33 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.486 0.66 . . . . 4.4400000000000004 110.612 -173.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.472 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 90.5 m-20 -70.42 105.62 3.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.987 -1.006 . . . . 1.6200000000000001 110.411 175.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.669 ' HB3' ' HB3' ' A' ' 172' ' ' GLN . 25.3 t60 -57.82 126.59 76.93 Favored Pre-proline 0 CA--C 1.506 -0.745 0 N-CA-C 107.609 -1.256 . . . . 2.3199999999999998 107.609 167.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.892 ' HG3' ' HE2' ' A' ' 130' ' ' LYS . 23.7 Cg_exo -12.13 69.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 1 C-N-CA 126.853 5.035 . . . . 0.53000000000000003 115.37 -173.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . 0.472 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 24.1 p -77.47 178.41 7.24 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.241 -1.345 . . . . 1.5800000000000001 110.574 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.63 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -170.56 -164.9 27.06 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 120.309 -0.948 . . . . 0.42999999999999999 111.675 175.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -161.38 73.19 0.44 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.632 -0.877 . . . . 0.59999999999999998 108.632 -164.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.822 HG23 HG13 ' A' ' 168' ' ' VAL . 8.4 m -83.24 115.26 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-O 122.113 0.959 . . . . 0.31 110.32 -175.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 64.3 m -98.27 107.58 20.08 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.417 -0.811 . . . . 1.55 109.027 177.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.722 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 10.1 m -97.63 112.64 61.92 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 116.28 -0.418 . . . . 1.0600000000000001 111.023 -170.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.558 ' HB3' ' ND2' ' A' ' 161' ' ' ASN . 52.4 Cg_exo -51.76 120.48 7.13 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.376 2.05 . . . . 0.56000000000000005 110.598 172.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.687 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 2.7 mmt -79.87 -167.92 1.43 Allowed 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.234 0.54 . . . . 1.1599999999999999 111.453 -175.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -70.97 -16.78 62.66 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.485 -0.779 . . . . 2.6299999999999999 110.026 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 163' ' ' ALA . 38.6 mt-10 -117.38 21.16 13.26 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 115.467 -0.788 . . . . 2.0499999999999998 110.408 178.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.669 ' HB3' ' CD ' ' A' ' 162' ' ' PRO . 18.7 t-20 29.79 -87.06 0.0 OUTLIER Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 125.87 1.668 . . . . 1.9299999999999999 115.044 175.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.669 ' CD ' ' HB3' ' A' ' 161' ' ' ASN . 85.1 Cg_endo -75.81 -12.62 19.95 Favored 'Trans proline' 0 C--N 1.368 1.557 0 CA-C-N 121.888 1.71 . . . . 0.72999999999999998 112.928 -175.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.559 ' HB3' ' HB3' ' A' ' 160' ' ' GLU . . . -89.97 -36.92 14.69 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.898 -0.592 . . . . 0.68000000000000005 110.563 -178.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.687 ' O ' ' HB2' ' A' ' 158' ' ' MET . 73.6 m-85 -136.97 133.14 35.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.279 -0.419 . . . . 0.93000000000000005 110.424 176.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.786 ' HB2' ' HD3' ' A' ' 58' ' ' PRO . 25.3 t -125.11 144.59 50.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.342 0.592 . . . . 1.4099999999999999 110.951 174.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.785 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.8 tppp? -97.37 99.81 11.25 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.993 0.901 . . . . 0.73999999999999999 110.684 -178.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.8 106.97 15.91 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.323 -1.308 . . . . 0.27000000000000002 109.201 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.822 HG13 HG23 ' A' ' 154' ' ' VAL . 0.1 OUTLIER -129.41 126.27 63.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.675 0.75 . . . . 0.28000000000000003 111.804 176.667 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 14.6 ttt -129.74 153.08 48.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.182 -0.917 . . . . 1.24 110.021 -171.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.767 ' HB3' HD21 ' A' ' 47' ' ' LEU . 47.6 m-85 -134.24 140.52 46.51 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.684 -0.234 . . . . 3.3700000000000001 111.146 -178.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.607 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 4.7 m -140.07 131.6 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 O-C-N 123.645 0.591 . . . . 1.3999999999999999 111.549 171.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 1.007 ' HB2' HD12 ' A' ' 47' ' ' LEU . 13.3 tt0 -120.02 33.55 5.56 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 105.954 -1.869 . . . . 2.1699999999999999 105.954 169.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 35.9 m -54.94 147.27 15.77 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 112.697 -2.047 . . . . 1.6499999999999999 112.733 -171.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 2.4 tp10 -84.74 -40.36 17.39 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.573 -0.74 . . . . 2.4500000000000002 110.663 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 21.7 mmt 48.0 57.21 6.3 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-O 121.207 0.527 . . . . 3.7400000000000002 109.771 -174.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.659 ' HG3' HD11 ' A' ' 144' ' ' ILE . 13.6 ptm180 -73.49 43.41 0.14 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.097 -0.956 . . . . 5.7800000000000002 112.724 -174.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -99.98 22.36 40.58 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 111.737 -0.545 . . . . 2.2599999999999998 111.737 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 65.2 tttp 65.36 70.98 0.45 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.588 0.709 . . . . 6.2300000000000004 111.142 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.752 HD21 HH22 ' A' ' 109' ' ' ARG . 5.8 mp -107.08 168.91 8.88 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.976 0.893 . . . . 1.6399999999999999 110.599 176.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.498 ' HB3' HG12 ' A' ' 183' ' ' ILE . 42.5 t -112.77 154.8 44.71 Favored Pre-proline 0 C--N 1.307 -1.251 0 CA-C-N 113.978 -1.465 . . . . 2.04 107.11 177.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.603 ' O ' ' HG2' ' A' ' 185' ' ' GLU . 71.0 Cg_exo -40.19 -47.72 4.07 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.546 2.164 . . . . 1.74 112.71 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 36.7 t -67.16 -14.74 63.19 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.125 -0.488 . . . . 2.1400000000000001 112.198 -177.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.558 ' HA ' ' HE2' ' A' ' 186' ' ' LYS . 24.4 mm -90.24 -41.74 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.845 0 CA-C-O 122.274 1.035 . . . . 1.1200000000000001 108.331 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 1.005 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.2 mp -62.99 -35.7 72.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 112.986 -1.915 . . . . 1.1299999999999999 110.726 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.603 ' HG2' ' O ' ' A' ' 181' ' ' PRO . 18.5 mm-40 -57.19 -29.65 63.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.133 -0.94 . . . . 2.8900000000000001 109.564 174.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.558 ' HE2' ' HA ' ' A' ' 183' ' ' ILE . 46.0 mtmt -93.05 -40.46 10.51 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.161 -0.927 . . . . 1.28 111.088 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 1.005 HG22 ' HA ' ' A' ' 184' ' ' ILE . 6.5 t -64.75 -37.67 88.39 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.236 0.458 . . . . 0.62 112.236 -171.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . 0.825 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 7.7 mmt -74.88 -60.43 1.23 Allowed Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 120.747 -0.381 . . . . 1.0600000000000001 111.347 -174.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.825 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 61.3 Cg_exo -54.02 -32.06 66.99 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.174 1.916 . . . . 0.91000000000000003 112.579 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.74 ' O ' ' HB3' ' A' ' 194' ' ' ASN . 49.0 m -72.87 -23.71 60.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.431 -0.35 . . . . 1.5 111.031 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -92.56 -37.82 12.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.348 0.594 . . . . 1.8799999999999999 111.6 -175.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.956 HD13 HG11 ' A' ' 35' ' ' VAL . 3.7 mt -67.02 -51.32 56.35 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.659 0.743 . . . . 1.0900000000000001 110.79 -176.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.688 ' O ' HD23 ' A' ' 197' ' ' LEU . 1.6 m -69.6 -41.29 80.24 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.129 0 CA-C-N 115.061 -0.972 . . . . 0.68000000000000005 108.756 -176.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.74 ' HB3' ' O ' ' A' ' 190' ' ' SER . 0.0 OUTLIER -57.48 -37.75 73.42 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.668 0.618 . . . . 2.0699999999999998 112.668 178.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -64.28 -31.82 73.17 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 119.884 -0.726 . . . . 2.0 110.009 174.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.852 HG21 HG21 ' A' ' 33' ' ' ILE . 8.6 mt -78.58 -33.89 17.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 122.003 0.906 . . . . 0.31 111.205 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.688 HD23 ' O ' ' A' ' 193' ' ' VAL . 3.3 mm? -78.26 -30.6 48.69 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.014 -0.994 . . . . 1.03 110.723 -173.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.712 ' HB2' ' HZ3' ' A' ' 74' ' ' TRP . 12.1 p30 -67.39 -29.82 69.43 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.528 -1.286 . . . . 1.8999999999999999 107.528 167.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.695 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -73.19 -37.25 66.55 Favored 'General case' 0 N--CA 1.435 -1.187 0 O-C-N 121.97 -0.456 . . . . 0.28999999999999998 110.254 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 33.0 mmtp -61.7 -43.36 99.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.76 0.79 . . . . 0.96999999999999997 109.915 174.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.574 ' O ' ' HG3' ' A' ' 204' ' ' LYS . 10.2 t70 -81.69 -40.72 22.37 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.703 -1.135 . . . . 1.9399999999999999 110.841 -171.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -70.98 -33.87 65.34 Favored Glycine 0 C--O 1.226 -0.406 0 C-N-CA 121.105 -0.569 . . . . 0.46999999999999997 111.729 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.957 HD13 HD23 ' A' ' 61' ' ' LEU . 1.6 tp -70.17 -35.76 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 110.058 -0.349 . . . . 0.60999999999999999 110.058 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.621 ' O ' ' HB ' ' A' ' 208' ' ' THR . 2.2 pptp? -81.59 -23.95 36.77 Favored 'General case' 0 C--O 1.213 -0.846 0 N-CA-C 108.678 -0.86 . . . . 3.3700000000000001 108.678 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.579 ' HA ' ' HB3' ' A' ' 210' ' ' SER . . . -65.46 -34.5 78.42 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 109.094 -0.706 . . . . 1.02 109.094 167.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.847 ' HB3' ' HD2' ' A' ' 60' ' ' LYS . 10.5 m170 -93.06 3.0 56.49 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.837 1.051 . . . . 3.6299999999999999 113.837 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' A' ' 203' ' ' ILE . 4.2 ptp180 -130.51 -41.77 1.2 Allowed 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.358 -0.839 . . . . 2.5899999999999999 111.442 172.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.621 ' HB ' ' O ' ' A' ' 204' ' ' LYS . 51.6 m -88.05 146.17 37.87 Favored Pre-proline 0 C--N 1.315 -0.928 0 CA-C-N 115.638 -0.71 . . . . 1.8400000000000001 109.493 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.46 ' HD2' HG23 ' A' ' 208' ' ' THR . 27.3 Cg_endo -64.21 60.96 0.24 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.82 2.347 . . . . 2.3500000000000001 112.484 174.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.579 ' HB3' ' HA ' ' A' ' 205' ' ' ALA . 34.4 t -96.05 13.71 26.2 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.655 -0.702 . . . . 2.3100000000000001 109.705 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.47 ' HD2' ' O ' ' A' ' 205' ' ' ALA . 0.0 OUTLIER -89.59 12.73 15.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.694 -0.684 . . . . 5.4500000000000002 110.869 -178.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.411 ' HD3' ' HA ' ' A' ' 212' ' ' ARG . 6.7 tpp180 -76.33 -38.53 55.82 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.902 -0.777 . . . . 6.8600000000000003 108.902 175.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -99.16 32.69 6.84 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.433 -0.803 . . . . 3.3700000000000001 111.934 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -71.33 142.11 50.44 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.599 -0.889 . . . . 5.21 108.599 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -105.73 -11.99 16.07 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.026 0.75 . . . . 6.46 113.026 -173.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 83.0 t60 55.98 46.34 22.09 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.577 0.703 . . . . 6.0899999999999999 110.028 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.586 ' HA ' ' OG ' ' A' ' 220' ' ' SER . 2.5 t-20 -110.01 36.42 3.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.807 -0.633 . . . . 5.1200000000000001 111.062 -170.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 38.7 t -86.0 -46.16 10.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.294 0.569 . . . . 6.7599999999999998 109.828 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -132.11 64.57 1.6 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.757 -0.656 . . . . 8.8200000000000003 109.848 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . 0.586 ' OG ' ' HA ' ' A' ' 217' ' ' ASN . 6.5 m . . . . . 0 C--O 1.245 0.861 0 CA-C-O 118.337 -0.84 . . . . 8.4800000000000004 109.64 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.888 ' HB3' HG22 ' A' ' 87' ' ' ILE . 14.9 tpt . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 109.818 -0.438 . . . . 3.8599999999999999 109.818 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.457 ' H ' ' HG3' ' A' ' 1' ' ' MET . 1.0 OUTLIER -50.25 -43.87 53.28 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 123.436 0.695 . . . . 2.25 112.547 -171.552 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.889 ' HA ' HD12 ' A' ' 6' ' ' ILE . 97.2 m-85 -68.53 -27.97 66.58 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.079 0.466 . . . . 0.42999999999999999 109.837 -172.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.564 ' HD2' ' CG ' ' A' ' 88' ' ' ASP . 17.5 tttm -76.31 -2.45 31.66 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.551 -0.75 . . . . 1.51 109.697 177.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.61 ' O ' ' HG2' ' A' ' 9' ' ' GLN . . . -92.96 -43.44 8.93 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.398 0.618 . . . . 0.54000000000000004 109.972 170.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.889 HD12 ' HA ' ' A' ' 3' ' ' PHE . 1.3 mp -81.57 -43.01 19.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 122.01 0.91 . . . . 1.0700000000000001 109.398 -171.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.467 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -76.06 -37.31 58.42 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.105 -1.407 . . . . 0.34000000000000002 111.584 -176.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 7.3 mt-30 -65.91 -29.73 70.2 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.474 -0.785 . . . . 1.5900000000000001 109.992 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.61 ' HG2' ' O ' ' A' ' 5' ' ' ALA . 79.1 mm-40 -77.69 -38.8 46.68 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.038 -0.983 . . . . 2.4700000000000002 108.499 174.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.555 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.4 OUTLIER -65.57 -36.53 84.05 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.534 -1.212 . . . . 0.47999999999999998 111.962 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.625 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -46.57 -59.49 2.97 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.198 0.523 . . . . 0.31 111.159 172.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -66.56 -16.65 64.32 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.49 -0.777 . . . . 1.6399999999999999 112.045 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.608 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 44.2 mt-10 -73.32 -52.37 14.15 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.001 0.429 . . . . 2.54 109.888 175.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.687 HG21 ' N ' ' A' ' 152' ' ' GLY . 11.8 p -73.2 -40.17 57.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.649 0.738 . . . . 0.53000000000000003 110.453 -177.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.554 HD23 ' HD2' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -67.2 -23.81 65.78 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-O 121.916 0.865 . . . . 0.59999999999999998 108.824 173.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.95 -18.05 66.13 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 113.986 -1.461 . . . . 0.56999999999999995 110.38 177.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.633 ' CD2' ' HA ' ' A' ' 14' ' ' VAL . 23.7 m-85 -91.14 -21.34 21.23 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.076 -0.712 . . . . 3.27 109.076 176.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.512 ' HA ' ' HZ ' ' A' ' 170' ' ' PHE . 3.5 t-20 -72.29 -14.82 61.85 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.463 0.649 . . . . 2.0299999999999998 109.989 178.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.554 ' HD2' HD23 ' A' ' 15' ' ' LEU . 22.2 mtp180 -115.72 -20.38 10.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.484 -0.78 . . . . 2.7200000000000002 110.835 -175.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -97.01 132.76 42.5 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.066 0.46 . . . . 2.1600000000000001 111.413 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 43.1 p -134.21 119.28 18.6 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.85 -0.614 . . . . 1.8200000000000001 109.637 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.459 ' HB2' ' HE3' ' A' ' 38' ' ' LYS . 0.8 OUTLIER -135.57 -143.87 0.2 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.862 -0.608 . . . . 2.1899999999999999 110.343 -169.135 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.4 63.33 1.8 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.349 -0.453 . . . . 1.1000000000000001 112.73 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.534 ' CH2' ' HD3' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -119.86 -175.76 3.04 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.15 -1.056 . . . . 1.6699999999999999 108.15 171.393 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.427 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 8.7 mtpp -171.4 133.11 0.8 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.712 -0.848 . . . . 2.9500000000000002 108.712 -176.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.765 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 1.6 p -59.96 116.73 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-O 121.714 0.769 . . . . 1.5600000000000001 109.681 170.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.4 p -92.05 -23.7 5.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 114.695 -1.139 . . . . 1.22 109.081 -177.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 2.7 tppt? -153.1 139.63 18.72 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.82 -0.627 . . . . 2.4100000000000001 111.488 -173.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.6 HG22 ' HA ' ' A' ' 34' ' ' THR . 31.2 p -137.92 142.93 40.58 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.002 -0.545 . . . . 1.3799999999999999 110.373 175.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.761 ' HB3' HG12 ' A' ' 33' ' ' ILE . 35.4 t -89.95 -143.98 0.16 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.618 -1.253 . . . . 2.3700000000000001 107.618 168.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -103.05 18.89 20.61 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.532 -0.467 . . . . 4.5499999999999998 110.06 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.442 ' HD2' ' HA ' ' A' ' 32' ' ' LYS . 33.8 tptt -168.97 3.77 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.189 0.44 . . . . 1.4199999999999999 112.189 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.971 HG22 ' HA3' ' A' ' 52' ' ' GLY . 42.8 pt -138.72 168.46 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.913 0.387 . . . . 0.76000000000000001 111.735 -174.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.6 ' HA ' HG22 ' A' ' 29' ' ' THR . 88.0 m -146.59 119.56 8.76 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.223 -0.899 . . . . 0.57999999999999996 110.64 -166.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.712 HG22 HG23 ' A' ' 50' ' ' VAL . 7.1 t -111.41 102.0 13.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.608 -0.516 . . . . 0.85999999999999999 109.608 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.765 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 18.1 m -99.14 126.79 44.99 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.651 0.739 . . . . 1.1000000000000001 111.338 -177.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 t -97.75 124.04 41.94 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.439 -1.255 . . . . 1.27 109.76 -177.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.459 ' HE3' ' HB2' ' A' ' 22' ' ' SER . 85.3 tttt -121.02 -100.57 0.43 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.618 -0.719 . . . . 1.9099999999999999 110.151 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.832 ' HA ' ' HA ' ' A' ' 46' ' ' ASN . . . 179.68 143.85 0.16 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.756 -0.461 . . . . 1.6799999999999999 109.756 -175.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.4 p -106.44 -43.66 4.71 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.376 0.608 . . . . 2.0899999999999999 109.56 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 57.59 8.11 0.61 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 114.521 -1.218 . . . . 6.6100000000000003 112.687 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -66.36 -24.85 66.57 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.596 -0.89 . . . . 6.46 108.596 175.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 84.0 t80 172.99 -55.2 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.021 -0.99 . . . . 5.6500000000000004 109.313 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -65.42 -70.58 0.23 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.011 -0.995 . . . . 5.5599999999999996 112.411 -170.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 170.92 -96.29 0.11 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.031 -1.08 . . . . 1.5600000000000001 112.863 -176.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.832 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 18.4 m120 -90.88 170.18 10.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.483 0.659 . . . . 2.0499999999999998 112.07 -172.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.566 HD11 HE21 ' A' ' 172' ' ' GLN . 4.3 tt -136.75 137.19 39.62 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.444 -1.688 . . . . 0.87 106.444 175.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.591 ' HB2' HG12 ' A' ' 171' ' ' VAL . 42.2 m-85 -118.52 128.3 54.45 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 120.545 -0.462 . . . . 0.98999999999999999 110.992 -172.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.534 ' HD3' ' CH2' ' A' ' 24' ' ' TRP . 15.1 ttp180 -99.29 117.24 33.3 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.913 -0.773 . . . . 2.9199999999999999 108.913 173.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.712 HG23 HG22 ' A' ' 35' ' ' VAL . 7.8 p -106.7 120.49 57.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 108.403 -0.962 . . . . 1.3300000000000001 108.403 175.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.657 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 35.2 tt0 -139.98 121.06 14.7 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.225 -0.898 . . . . 1.0700000000000001 110.419 -167.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.971 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -148.23 162.47 28.8 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 111.016 -0.834 . . . . 0.28999999999999998 111.016 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.6 mt -97.6 119.11 45.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 C-N-CA 120.197 -0.601 . . . . 0.57999999999999996 111.004 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.686 HG12 ' HD3' ' A' ' 200' ' ' LYS . 72.6 mt -97.3 114.12 64.29 Favored Pre-proline 0 N--CA 1.443 -0.785 0 N-CA-C 108.884 -0.784 . . . . 0.34999999999999998 108.884 172.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 23.6 Cg_exo -65.66 57.14 0.36 Allowed 'Trans proline' 0 N--CA 1.474 0.347 0 C-N-CA 124.422 3.415 . . . . 0.62 113.223 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.494 ' HG2' HG13 ' A' ' 203' ' ' ILE . 11.4 tp10 -157.42 167.88 28.94 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 108.207 -1.035 . . . . 1.6799999999999999 108.207 176.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.507 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 20.0 p -69.49 141.37 90.67 Favored Pre-proline 0 N--CA 1.429 -1.511 0 CA-C-O 122.09 0.948 . . . . 1.1799999999999999 111.637 -175.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.581 ' HA ' HD12 ' A' ' 61' ' ' LEU . 32.3 Cg_exo -59.68 -15.39 31.22 Favored 'Trans proline' 0 CA--C 1.518 -0.29 0 C-N-CA 124.505 3.47 . . . . 0.52000000000000002 110.534 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.03 -53.33 21.03 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.195 -1.366 . . . . 0.64000000000000001 111.011 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.612 ' HA ' ' HB3' ' A' ' 63' ' ' ASP . 13.6 ttpt -70.97 -23.47 62.22 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.812 -0.81 . . . . 3.2999999999999998 108.812 -177.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.019 HD23 HD13 ' A' ' 203' ' ' ILE . 45.0 mt -60.72 -55.74 29.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.006 -0.997 . . . . 0.40999999999999998 109.756 171.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.1 p -68.63 -9.24 48.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.007 0.432 . . . . 1.29 110.724 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.612 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 29.4 t70 -90.17 -28.36 18.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.021 -0.536 . . . . 1.3200000000000001 111.828 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.673 ' CD2' ' HA ' ' A' ' 61' ' ' LEU . 8.8 p90 -86.32 -43.69 12.69 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 120.378 -0.529 . . . . 0.60999999999999999 110.967 -174.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.711 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -89.62 7.61 35.63 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.975 -0.29 . . . . 1.5 110.973 -174.462 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -53.19 -71.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.467 -0.788 . . . . 1.52 111.875 -164.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 165.08 133.56 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 108.363 -0.977 . . . . 3.6000000000000001 108.363 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.909 ' HA ' ' NH2' ' A' ' 71' ' ' ARG . 5.8 t 46.73 31.63 1.48 Allowed 'General case' 0 C--N 1.313 -1.007 0 O-C-N 124.534 1.146 . . . . 1.48 112.66 177.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.533 ' O ' ' HB3' ' A' ' 70' ' ' ASP . . . -88.69 -44.7 5.11 Favored Glycine 0 N--CA 1.427 -1.947 0 CA-C-N 115.173 -0.921 . . . . 1.46 110.859 -176.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.533 ' HB3' ' O ' ' A' ' 69' ' ' GLY . 29.4 p-10 152.35 -5.12 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 113.139 -1.53 . . . . 2.1899999999999999 108.23 -166.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.909 ' NH2' ' HA ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -46.96 -27.79 1.4 Allowed 'General case' 0 C--O 1.211 -0.957 0 N-CA-C 113.536 0.939 . . . . 3.3799999999999999 113.536 178.757 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.703 HD13 ' NH1' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -92.18 -14.37 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 119.124 -1.031 . . . . 0.70999999999999996 111.047 178.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.515 ' HA ' ' ND2' ' A' ' 217' ' ' ASN . 0.7 OUTLIER -86.01 -28.05 24.42 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 120.27 -0.572 . . . . 0.96999999999999997 110.239 -173.68 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.696 ' CE2' ' HA ' ' A' ' 71' ' ' ARG . 14.8 p-90 -107.22 -4.86 18.32 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.467 -0.493 . . . . 0.75 111.924 178.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.809 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 5.6 t70 -71.99 174.87 6.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.506 0.67 . . . . 2.1899999999999999 111.453 -172.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.822 ' HG2' ' HB3' ' A' ' 198' ' ' ASN . 8.1 mmmt -108.91 -25.41 10.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.199 -0.909 . . . . 3.1899999999999999 109.76 -177.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.6 m -127.6 11.51 6.78 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.34 -0.846 . . . . 1.5800000000000001 111.266 -173.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.7 HD13 HG22 ' A' ' 72' ' ' ILE . 15.9 mt -107.36 152.23 24.44 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.142 0.496 . . . . 0.70999999999999996 111.471 -178.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.544 ' HB3' HG23 ' A' ' 80' ' ' VAL . 43.2 mt-30 -118.92 -70.49 0.79 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.447 -0.797 . . . . 1.73 111.225 178.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.544 HG23 ' HB3' ' A' ' 79' ' ' GLN . 22.0 t -148.66 124.31 2.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.468 -0.787 . . . . 0.78000000000000003 110.556 -166.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.893 ' HB3' HH21 ' A' ' 71' ' ' ARG . 48.7 t80 -109.71 142.54 40.76 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.416 -0.514 . . . . 5.4000000000000004 111.213 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.512 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 0.9 OUTLIER -136.74 118.71 15.3 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.928 -1.138 . . . . 1.6899999999999999 107.928 -179.455 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.546 ' SD ' ' HD2' ' A' ' 86' ' ' ARG . 2.0 ttt -68.5 107.48 2.93 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.696 -0.684 . . . . 2.0499999999999998 109.358 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -84.31 -71.57 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 120.22 -0.592 . . . . 0.64000000000000001 111.411 -170.608 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -137.9 108.95 6.75 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.017 -0.538 . . . . 1.96 109.884 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.953 ' HG2' ' HD2' ' A' ' 92' ' ' PHE . 68.1 mtp180 -85.32 129.47 34.8 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.31 -0.626 . . . . 2.4399999999999999 109.31 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.888 HG22 ' HB3' ' A' ' 1' ' ' MET . 0.7 OUTLIER -86.99 -54.52 7.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.428 -0.805 . . . . 0.46999999999999997 109.969 -172.217 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.564 ' CG ' ' HD2' ' A' ' 4' ' ' LYS . 6.8 m-20 -136.15 -142.98 0.18 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.636 -1.165 . . . . 1.8600000000000001 108.808 -177.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.2 t -95.02 -12.22 27.01 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.609 -0.515 . . . . 1.4399999999999999 109.609 175.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -128.27 3.54 5.75 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.039 -0.528 . . . . 1.8700000000000001 110.428 -171.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.59 ' HB ' ' HB ' ' A' ' 87' ' ' ILE . 0.3 OUTLIER -132.38 121.35 23.33 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.599 -0.889 . . . . 0.46000000000000002 108.599 -172.201 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.953 ' HD2' ' HG2' ' A' ' 86' ' ' ARG . 14.1 m-85 -133.21 176.14 8.77 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 120.954 0.407 . . . . 0.42999999999999999 110.267 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.728 ' O ' HG23 ' A' ' 84' ' ' VAL . 21.8 mt -133.09 125.93 52.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 107.354 -1.35 . . . . 0.40999999999999998 107.354 168.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.556 ' HA ' ' HE1' ' A' ' 81' ' ' TYR . 94.6 m -106.58 108.41 19.9 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.101 -0.499 . . . . 2.0099999999999998 112.153 -169.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.577 ' HA ' ' O ' ' A' ' 111' ' ' PHE . 8.4 t60 -84.75 103.62 14.0 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.024 -0.732 . . . . 1.23 109.024 171.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.734 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 27.9 m -127.34 119.91 27.33 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.244 -0.435 . . . . 0.5 111.84 -173.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 32.9 mm -77.67 138.94 19.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.076 -0.713 . . . . 1.03 109.076 174.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 1.3 m -113.58 152.34 30.44 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.58 -0.737 . . . . 1.3799999999999999 110.244 -171.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -89.58 166.58 13.56 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.397 -0.365 . . . . 1.8200000000000001 110.147 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.1 m -88.51 88.59 7.67 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.038 -0.528 . . . . 3.9100000000000001 111.317 -172.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.435 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 6.6 p90 -86.67 96.09 10.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.432 0.634 . . . . 5.1600000000000001 110.472 176.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.443 ' HB3' ' H ' ' A' ' 106' ' ' ILE . . . 152.41 10.01 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 113.779 -1.555 . . . . 1.98 108.833 -177.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.413 ' H ' ' H ' ' A' ' 102' ' ' ALA . 60.2 t 71.63 -39.25 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 115.58 -0.736 . . . . 3.1699999999999999 112.121 -177.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -165.68 -22.24 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.049 -1.072 . . . . 1.96 113.655 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.604 ' HB3' HD12 ' A' ' 183' ' ' ILE . 25.1 m -58.01 -63.0 1.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 117.207 0.503 . . . . 1.8799999999999999 111.115 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.486 HD11 HG22 ' A' ' 183' ' ' ILE . 5.2 mp -83.0 105.31 12.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.361 -0.607 . . . . 1.1200000000000001 109.361 175.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.527 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 17.7 m -71.1 164.83 53.47 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.695 -0.684 . . . . 1.3500000000000001 111.035 -178.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 107' ' ' SER . 2.0 Cg_endo -45.15 114.6 0.7 Allowed 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 123.38 2.72 . . . . 1.0700000000000001 111.397 176.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.612 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 23.0 ttp180 -102.99 158.54 16.22 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.99 -0.55 . . . . 3.4500000000000002 110.836 -168.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.928 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 8.2 t0 -113.37 122.94 48.87 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.059 -0.719 . . . . 1.3700000000000001 109.059 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.734 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 6.0 m-85 -99.38 132.07 44.96 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 120.855 0.36 . . . . 2.4100000000000001 110.471 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.572 HD13 ' HA ' ' A' ' 95' ' ' HIS . 30.1 mm -133.46 68.09 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.069 -1.085 . . . . 0.42999999999999999 108.069 171.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.91 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 4.5 m-20 -90.76 115.86 28.17 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.718 -1.128 . . . . 1.8600000000000001 109.799 -177.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 129' ' ' SER . 6.3 tp -74.6 120.85 20.71 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 108.564 -0.902 . . . . 0.28000000000000003 108.564 169.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -125.46 126.15 70.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 115.115 -0.948 . . . . 0.26000000000000001 111.824 -164.319 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.588 ' CE2' ' HB2' ' A' ' 118' ' ' LYS . 50.9 t80 -110.63 120.11 41.35 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 114.456 -1.247 . . . . 2.5699999999999998 110.211 174.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.695 HG12 HG22 ' A' ' 127' ' ' ILE . 74.2 mt -100.25 103.26 14.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.824 -0.625 . . . . 0.89000000000000001 110.359 -177.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.588 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 26.7 ttmt -124.73 133.84 53.04 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.114 0.483 . . . . 1.2 110.211 177.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.528 ' HD2' ' O ' ' A' ' 119' ' ' ARG . 0.4 OUTLIER -110.91 119.57 39.53 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 108.573 -0.899 . . . . 2.7999999999999998 108.573 173.057 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.52 ' CB ' ' HB2' ' A' ' 123' ' ' ASN . 99.1 m-85 -75.98 104.8 6.68 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.455 -1.683 . . . . 0.82999999999999996 106.455 164.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -52.04 98.3 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 122.302 1.049 . . . . 2.2799999999999998 112.598 -171.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.434 ' C ' HD22 ' A' ' 123' ' ' ASN . . . 84.89 24.41 45.36 Favored Glycine 0 CA--C 1.504 -0.595 0 CA-C-N 113.451 -1.704 . . . . 0.76000000000000001 112.14 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.632 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 1.0 OUTLIER -126.02 -57.71 1.41 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.723 -0.739 . . . . 1.6499999999999999 109.617 175.224 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.404 ' O ' ' HA ' ' A' ' 119' ' ' ARG . 2.8 mpp? -160.48 135.27 7.62 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.894 -0.594 . . . . 1.1200000000000001 110.544 -170.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.469 ' HB2' ' HB2' ' A' ' 155' ' ' CYS . 21.9 m-80 -115.02 87.18 2.6 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.312 -0.996 . . . . 1.6200000000000001 108.312 176.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.632 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.4 OUTLIER -110.0 143.76 19.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 112.976 0.732 . . . . 0.29999999999999999 112.976 -170.527 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.695 HG22 HG12 ' A' ' 117' ' ' ILE . 5.2 pt -110.51 113.98 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.478 -0.934 . . . . 0.58999999999999997 108.478 161.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.625 ' HB3' ' HA ' ' A' ' 11' ' ' ALA . 22.6 p -94.13 124.08 37.91 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.239 -0.437 . . . . 1.1799999999999999 110.693 178.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.91 ' HB3' ' HB3' ' A' ' 113' ' ' ASP . 19.8 m -125.32 141.91 51.8 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.089 0.471 . . . . 1.24 111.801 -170.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.57 ' HE3' HG22 ' A' ' 6' ' ' ILE . 5.5 mtpm? -131.32 126.11 34.48 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 107.97 -1.122 . . . . 2.2599999999999998 107.97 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.6 p -64.89 97.45 0.23 Allowed 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.337 -1.357 . . . . 1.3899999999999999 107.337 172.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.68 140.27 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 N-CA-C 108.766 -0.827 . . . . 1.05 108.766 -165.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -97.23 81.37 3.02 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.162 -0.927 . . . . 2.1699999999999999 108.676 -172.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.498 ' HE1' HG21 ' A' ' 112' ' ' ILE . 0.5 OUTLIER -111.74 152.54 44.2 Favored Pre-proline 0 C--N 1.311 -1.066 0 CA-C-N 114.374 -1.285 . . . . 0.53000000000000003 109.902 -173.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.75 -18.94 66.19 Favored 'Trans proline' 0 N--CA 1.48 0.701 0 C-N-CA 123.732 2.954 . . . . 1.28 116.156 -167.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.441 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 2.6 tp10 -68.86 -29.33 67.61 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 121.608 0.718 . . . . 3.5 109.771 -172.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.563 ' CD2' HD11 ' A' ' 112' ' ' ILE . 32.4 t80 -158.25 106.94 1.7 Allowed Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 114.807 -1.088 . . . . 6.1200000000000001 113.828 -175.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.455 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 3.7 Cg_endo -87.44 155.0 7.88 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.172 2.581 . . . . 1.77 109.881 161.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -67.27 -165.13 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 121.982 1.788 . . . . 1.25 112.438 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 13.9 t -136.47 -159.37 0.95 Allowed 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 109.071 -0.714 . . . . 1.6000000000000001 109.071 -170.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 41.9 m -82.49 -42.05 18.96 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.39 -0.524 . . . . 1.97 111.693 -176.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -95.93 -29.9 13.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.095 0.474 . . . . 2.1800000000000002 110.0 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.928 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 25.5 m-85 -85.14 109.5 18.32 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.739 -0.664 . . . . 1.23 110.113 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.612 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 0.9 OUTLIER -96.95 115.37 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 108.404 -0.962 . . . . 0.81999999999999995 108.404 177.517 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.672 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 20.7 ttm180 -55.38 107.9 0.37 Allowed 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.084 -0.71 . . . . 4.4199999999999999 109.084 174.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -59.4 111.13 3.18 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 110.959 -0.856 . . . . 0.79000000000000004 110.959 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -84.01 75.5 10.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 122.183 0.992 . . . . 4.4400000000000004 111.465 -175.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.559 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 16.5 m-20 -79.12 99.52 6.99 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 113.741 -1.572 . . . . 1.6200000000000001 108.565 171.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.499 ' O ' ' N ' ' A' ' 151' ' ' CYS . 77.0 m-70 -60.25 152.84 61.26 Favored Pre-proline 0 C--O 1.22 -0.463 0 N-CA-C 107.513 -1.292 . . . . 2.3199999999999998 107.513 173.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.555 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 32.1 Cg_exo -24.67 70.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.181 1 C-N-CA 126.116 4.544 . . . . 0.53000000000000003 115.544 -173.494 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . 0.612 ' HB2' ' O ' ' A' ' 170' ' ' PHE . 25.8 p -97.41 -174.26 2.88 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.987 -1.006 . . . . 1.5800000000000001 109.907 176.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.687 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -172.26 -161.7 23.19 Favored Glycine 0 N--CA 1.433 -1.544 0 C-N-CA 119.775 -1.202 . . . . 0.42999999999999999 112.001 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.469 ' CE2' ' HG ' ' A' ' 65' ' ' LEU . 72.4 t80 -161.83 91.17 0.8 Allowed 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.53 -0.915 . . . . 0.59999999999999998 108.53 -168.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.643 ' CG2' HG13 ' A' ' 168' ' ' VAL . 2.4 m -100.96 131.15 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-O 121.856 0.836 . . . . 0.31 110.83 -173.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 125' ' ' ASN . 74.9 m -110.16 109.36 19.84 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.069 -0.969 . . . . 1.55 109.62 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.469 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 19.9 m -105.73 121.22 46.65 Favored Pre-proline 0 C--N 1.318 -0.801 0 N-CA-C 112.15 0.426 . . . . 1.0600000000000001 112.15 -167.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.632 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 59.8 Cg_exo -51.69 126.02 18.55 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.953 2.435 . . . . 0.56000000000000005 111.875 170.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.617 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 0.2 OUTLIER -88.01 -170.67 3.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.189 0.519 . . . . 1.1599999999999999 111.561 -178.445 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -77.97 -24.45 48.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.426 0.631 . . . . 2.6299999999999999 109.547 168.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 37.8 mt-10 -100.65 27.29 5.97 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.052 -1.092 . . . . 2.0499999999999998 108.052 172.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.745 ' HB3' ' HD3' ' A' ' 162' ' ' PRO . 0.2 OUTLIER -14.99 -71.73 0.02 OUTLIER Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 126.478 1.911 . . . . 1.9299999999999999 115.074 -174.188 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.745 ' HD3' ' HB3' ' A' ' 161' ' ' ASN . 73.0 Cg_endo -73.36 -15.86 24.93 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 121.268 1.312 . . . . 0.72999999999999998 113.516 -170.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -104.45 -25.58 12.75 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.161 -0.472 . . . . 0.68000000000000005 110.993 -176.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.617 ' O ' ' HB2' ' A' ' 158' ' ' MET . 49.6 m-85 -141.03 122.29 14.82 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.497 -0.557 . . . . 0.93000000000000005 109.497 177.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 45.5 t -114.13 145.71 41.28 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.488 -0.485 . . . . 1.4099999999999999 110.578 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.657 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.8 tppp? -92.13 101.83 14.35 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 122.049 0.928 . . . . 0.73999999999999999 111.142 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 0.9 OUTLIER -87.49 105.01 17.01 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.385 -1.28 . . . . 0.27000000000000002 109.31 178.748 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.643 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.1 OUTLIER -128.78 117.2 43.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 122.171 0.986 . . . . 0.28000000000000003 112.004 178.112 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.435 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 23.0 ttt -116.97 147.25 42.45 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.814 -1.084 . . . . 1.24 109.496 -177.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.612 ' O ' ' HB2' ' A' ' 151' ' ' CYS . 92.9 m-85 -122.34 128.02 50.51 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.076 -0.713 . . . . 3.3700000000000001 109.076 177.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.598 ' HB ' HD21 ' A' ' 192' ' ' LEU . 2.5 p -111.12 117.98 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-O 121.744 0.783 . . . . 1.3999999999999999 110.003 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.566 HE21 HD11 ' A' ' 47' ' ' LEU . 13.7 tt0 -113.7 48.67 1.04 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.268 -1.012 . . . . 2.1699999999999999 108.268 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.877 ' HB ' ' SD ' ' A' ' 175' ' ' MET . 0.0 OUTLIER -72.01 136.47 46.72 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.058 -1.428 . . . . 1.6499999999999999 113.247 -170.745 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -92.76 -31.82 14.91 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.927 -0.579 . . . . 2.4500000000000002 111.39 174.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.889 ' HB3' HD13 ' A' ' 179' ' ' LEU . 4.3 mpp? 54.93 57.77 5.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.077 0.465 . . . . 3.7400000000000002 110.231 -172.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.405 ' HB2' HD11 ' A' ' 144' ' ' ILE . 16.5 mmt180 -60.06 -9.29 3.02 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.569 -0.741 . . . . 5.7800000000000002 112.187 177.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -77.83 18.34 4.99 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 121.226 -0.511 . . . . 2.2599999999999998 113.308 -177.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 81.5 tttt 59.28 69.7 0.7 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.498 0.666 . . . . 6.2300000000000004 111.504 175.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.889 HD13 ' HB3' ' A' ' 175' ' ' MET . 4.4 mp -99.01 174.18 6.47 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 107.907 -1.146 . . . . 1.6399999999999999 107.907 174.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.611 ' H ' HG13 ' A' ' 183' ' ' ILE . 19.5 m -112.17 156.92 41.24 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 108.882 -0.784 . . . . 2.04 108.882 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -46.26 -39.45 21.22 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 121.972 1.781 . . . . 1.74 111.589 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.6 p -75.27 -10.42 59.44 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 115.095 -0.957 . . . . 2.1400000000000001 112.606 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.809 ' HA ' ' HE2' ' A' ' 186' ' ' LYS . 8.0 mm -91.78 -28.47 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 122.872 1.32 . . . . 1.1200000000000001 109.398 177.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.954 ' HA ' HG22 ' A' ' 187' ' ' THR . 0.9 OUTLIER -86.46 -33.47 7.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 112.886 -1.961 . . . . 1.1299999999999999 110.366 -169.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.47 ' OE2' ' HB3' ' A' ' 186' ' ' LYS . 0.0 OUTLIER -60.71 -25.53 66.49 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.558 -0.746 . . . . 2.8900000000000001 110.612 173.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.809 ' HE2' ' HA ' ' A' ' 183' ' ' ILE . 0.0 OUTLIER -93.37 -36.53 12.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 1.28 110.477 174.774 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.954 HG22 ' HA ' ' A' ' 184' ' ' ILE . 5.7 t -66.47 -26.7 67.32 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 120.716 -0.394 . . . . 0.62 111.832 -171.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . 0.59 ' HE2' ' HA ' ' A' ' 188' ' ' MET . 4.2 mmt -76.93 -60.09 0.85 Allowed Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.683 -0.407 . . . . 1.0600000000000001 111.65 -177.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.492 ' O ' HG13 ' A' ' 193' ' ' VAL . 18.2 Cg_endo -60.54 -36.61 85.23 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 121.668 1.579 . . . . 0.91000000000000003 111.76 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.596 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 7.8 t -70.07 -23.55 63.1 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.971 0.415 . . . . 1.5 110.763 -176.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.436 HD22 ' C ' ' A' ' 191' ' ' ASN . 0.2 OUTLIER -91.06 -45.59 8.61 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.332 -0.394 . . . . 1.8799999999999999 110.494 -178.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.641 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 80.3 mt -72.14 -45.91 58.6 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.083 -0.508 . . . . 1.0900000000000001 112.146 -170.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.492 HG13 ' O ' ' A' ' 189' ' ' PRO . 1.8 m -75.68 -33.25 25.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.736 0.779 . . . . 0.68000000000000005 108.948 -173.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.596 ' HB2' ' O ' ' A' ' 190' ' ' SER . 1.1 t30 -62.94 -49.13 75.96 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.052 -1.431 . . . . 2.0699999999999998 109.773 175.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.656 ' HA ' ' OD1' ' A' ' 198' ' ' ASN . 5.2 t80 -56.56 -30.49 63.19 Favored 'General case' 0 C--O 1.233 0.222 0 O-C-N 123.739 0.649 . . . . 2.0 109.999 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.75 HG21 HG21 ' A' ' 33' ' ' ILE . 8.7 mt -78.7 -39.83 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-N 115.992 -0.549 . . . . 0.31 112.437 177.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.641 ' HA ' ' HG2' ' A' ' 200' ' ' LYS . 2.8 pp -80.41 -21.72 41.96 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 119.304 -0.958 . . . . 1.03 111.076 -176.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.822 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 1.6 p-10 -74.64 -13.91 60.7 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 118.816 -1.153 . . . . 1.8999999999999999 108.281 166.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.63 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -82.25 -27.31 32.52 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.266 -1.013 . . . . 0.28999999999999998 108.266 170.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.686 ' HD3' HG12 ' A' ' 54' ' ' ILE . 26.3 mmtp -69.36 -38.85 78.29 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.543 -0.753 . . . . 0.96999999999999997 109.333 173.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -86.53 -39.61 16.06 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 114.783 -1.099 . . . . 1.9399999999999999 110.169 -176.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -70.51 -29.55 69.74 Favored Glycine 0 CA--C 1.503 -0.715 0 C-N-CA 120.994 -0.622 . . . . 0.46999999999999997 111.602 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 1.019 HD13 HD23 ' A' ' 61' ' ' LEU . 2.8 tp -71.59 -31.47 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 109.606 -0.516 . . . . 0.60999999999999999 109.606 177.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.561 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 53.3 mttp -86.5 -23.74 25.82 Favored 'General case' 0 C--O 1.204 -1.293 0 N-CA-C 108.836 -0.801 . . . . 3.3700000000000001 108.836 176.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -66.15 -31.24 71.98 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.221 -0.659 . . . . 1.02 109.221 169.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.464 ' CE1' ' HA ' ' A' ' 64' ' ' PHE . 56.1 m80 -92.46 -6.82 49.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.6 -0.727 . . . . 3.6299999999999999 112.469 176.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 207' ' ' ARG . 0.5 OUTLIER -110.46 -60.43 1.81 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.954 0.883 . . . . 2.5899999999999999 109.957 176.835 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.434 ' HA ' ' HD3' ' A' ' 209' ' ' PRO . 94.5 m -84.42 143.15 41.18 Favored Pre-proline 0 C--N 1.311 -1.09 0 CA-C-N 114.184 -1.371 . . . . 1.8400000000000001 109.884 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 208' ' ' THR . 17.7 Cg_exo -69.27 51.26 0.74 Allowed 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.673 2.249 . . . . 2.3500000000000001 111.799 173.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 33.9 t -66.66 -28.78 68.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.806 -0.634 . . . . 2.3100000000000001 111.142 -176.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.501 ' H ' ' HD3' ' A' ' 211' ' ' ARG . 0.0 OUTLIER -100.44 14.53 30.86 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.617 -0.433 . . . . 5.4500000000000002 110.982 -179.185 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -62.36 -41.77 98.87 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.117 -0.698 . . . . 6.8600000000000003 109.117 175.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -102.04 71.96 0.34 Allowed Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.902 -0.879 . . . . 3.3700000000000001 110.902 172.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -87.12 121.4 29.52 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.841 0.353 . . . . 5.21 110.532 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -132.81 79.8 1.86 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.43 -0.35 . . . . 6.46 111.079 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 69.64 119.24 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.477 0.711 . . . . 6.0899999999999999 112.456 175.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.515 ' ND2' ' HA ' ' A' ' 73' ' ' THR . 26.3 p-10 -100.88 27.26 6.11 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.176 -0.676 . . . . 5.1200000000000001 109.176 171.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 8.9 m -60.97 -37.19 81.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.287 -0.87 . . . . 6.7599999999999998 110.996 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -152.07 156.98 40.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.091 -0.504 . . . . 8.8200000000000003 110.602 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 C--O 1.251 1.179 0 N-CA-C 108.754 -0.832 . . . . 8.4800000000000004 108.754 170.436 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 ptt? . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 120.915 0.388 . . . . 3.8599999999999999 110.467 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.402 ' O ' ' HB3' ' A' ' 5' ' ' ALA . 10.1 m-20 -113.85 -30.98 6.57 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 116.49 -0.323 . . . . 2.25 110.929 -176.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.578 ' HD1' HD22 ' A' ' 114' ' ' LEU . 95.4 m-85 -67.24 -32.14 72.98 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.604 0.716 . . . . 0.42999999999999999 109.466 -176.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.522 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 18.1 tttt -75.48 -1.33 23.64 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 114.594 -1.185 . . . . 1.51 109.855 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 2' ' ' ASP . . . -93.28 -42.47 9.31 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.951 -0.568 . . . . 0.54000000000000004 110.06 171.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.635 ' O ' ' HB ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -84.2 -35.47 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-O 121.08 0.467 . . . . 1.0700000000000001 110.511 -174.371 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.489 ' HB2' HD21 ' A' ' 114' ' ' LEU . . . -80.19 -40.7 26.69 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.096 -0.957 . . . . 0.34000000000000002 111.338 -176.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.522 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 4.0 mt-30 -63.45 -32.8 74.34 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.079 -0.964 . . . . 1.5900000000000001 109.658 176.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.635 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 13.2 mm100 -78.68 -42.75 27.69 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.613 -1.176 . . . . 2.4700000000000002 109.1 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.635 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -60.24 -35.73 76.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.656 -0.702 . . . . 0.47999999999999998 111.257 179.73 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.456 ' HA ' ' OG ' ' A' ' 128' ' ' SER . . . -48.79 -58.92 4.05 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 121.098 0.475 . . . . 0.31 110.94 171.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -71.99 -18.18 62.0 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.711 -0.677 . . . . 1.6399999999999999 111.564 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.635 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 49.9 mt-10 -68.76 -56.73 7.12 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.03 -0.73 . . . . 2.54 109.03 172.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.695 HG23 ' CE2' ' A' ' 170' ' ' PHE . 11.9 p -68.97 -41.77 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.893 -0.594 . . . . 0.53000000000000003 111.228 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.33 -31.55 65.81 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.543 -0.753 . . . . 0.59999999999999998 109.219 174.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.62 -28.33 73.1 Favored Glycine 0 CA--C 1.503 -0.715 0 CA-C-N 114.21 -1.359 . . . . 0.56999999999999995 110.324 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.492 ' HD1' ' O ' ' A' ' 13' ' ' GLU . 11.6 m-85 -93.05 -16.86 24.52 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.763 -0.718 . . . . 3.27 109.636 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.82 -6.16 40.1 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.54 0.686 . . . . 2.0299999999999998 109.199 -175.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -110.16 -17.32 13.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.641 -1.163 . . . . 2.7200000000000002 109.714 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -100.44 138.19 37.83 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.433 -0.803 . . . . 2.1600000000000001 110.239 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 40.3 p -137.29 88.91 2.38 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.363 0.602 . . . . 1.8200000000000001 111.336 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.1 p -173.78 146.25 1.24 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.173 -0.921 . . . . 2.1899999999999999 111.451 -178.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.495 ' O ' ' HG3' ' A' ' 38' ' ' LYS . . . 92.81 2.27 67.11 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 121.294 -0.479 . . . . 1.1000000000000001 112.807 174.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.498 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -120.04 -158.29 0.74 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.925 0.393 . . . . 1.6699999999999999 110.878 -176.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.29 119.24 0.91 Allowed 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 108.811 -0.811 . . . . 2.9500000000000002 108.811 -174.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.603 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 3.1 p -64.24 117.38 4.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 C-N-CA 119.37 -0.932 . . . . 1.5600000000000001 109.726 175.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.4 p -94.09 -23.72 5.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 114.317 -1.311 . . . . 1.22 108.944 -176.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.504 ' HD3' ' C ' ' A' ' 28' ' ' LYS . 0.5 OUTLIER -157.57 123.71 4.79 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 120.252 -0.579 . . . . 2.4100000000000001 110.199 -174.471 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.415 ' HB ' ' HA ' ' A' ' 34' ' ' THR . 0.9 OUTLIER -151.34 152.07 32.64 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.208 0.528 . . . . 1.3799999999999999 111.485 -178.463 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.3 t -112.12 -147.95 0.42 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.579 -0.897 . . . . 2.3700000000000001 108.579 175.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.32 25.87 6.53 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.444 0.64 . . . . 4.5499999999999998 109.38 176.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.545 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 25.6 mmtm -156.73 -44.85 0.07 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 114.911 -1.04 . . . . 1.4199999999999999 111.814 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.459 HG22 ' HA3' ' A' ' 52' ' ' GLY . 24.0 pt -104.87 160.42 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-O 120.766 0.317 . . . . 0.76000000000000001 111.394 -175.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 2.6 m -149.72 109.9 4.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.548 -0.751 . . . . 0.57999999999999996 110.487 -171.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.42 HG22 HG23 ' A' ' 50' ' ' VAL . 16.3 t -103.07 102.13 13.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.161 0.505 . . . . 0.85999999999999999 109.943 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 2.9 p -97.48 124.66 41.78 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.5 -0.773 . . . . 1.1000000000000001 111.693 -176.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.7 t -103.27 125.53 49.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.537 -1.211 . . . . 1.27 109.527 -175.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 29.4 ttpt -120.55 -91.53 0.56 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.348 -0.387 . . . . 1.9099999999999999 111.283 -176.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 46' ' ' ASN . . . -176.53 137.53 0.28 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 110.272 -0.27 . . . . 1.6799999999999999 110.272 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.7 p -78.39 159.49 28.3 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.88 -0.415 . . . . 2.0899999999999999 109.88 176.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -58.22 -40.9 82.85 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.945 0.402 . . . . 6.6100000000000003 110.639 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -76.38 -20.56 57.05 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.241 -0.436 . . . . 6.46 110.921 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 43.9 t80 74.61 13.8 3.56 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.506 -0.77 . . . . 5.6500000000000004 110.46 170.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -87.96 15.32 7.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.375 0.607 . . . . 5.5599999999999996 110.251 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 171.08 167.65 31.68 Favored Glycine 0 N--CA 1.425 -2.061 0 N-CA-C 109.036 -1.626 . . . . 1.5600000000000001 109.036 -171.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 77.5 m-20 -98.51 143.62 28.73 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 120.948 0.404 . . . . 2.0499999999999998 110.992 -177.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.751 HD21 ' CD1' ' A' ' 170' ' ' PHE . 4.9 tt -84.76 133.25 34.36 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.95 -1.13 . . . . 0.87 107.95 175.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.624 ' N ' HD23 ' A' ' 47' ' ' LEU . 97.9 m-85 -113.66 128.59 56.48 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.003 0.43 . . . . 0.98999999999999999 110.092 -176.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.441 ' HD2' ' CH2' ' A' ' 24' ' ' TRP . 3.8 tmt_? -122.88 131.35 53.7 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.598 -0.728 . . . . 2.9199999999999999 109.274 177.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 34' ' ' THR . 10.1 p -116.49 151.35 18.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.046 0.45 . . . . 1.3300000000000001 110.543 -176.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.448 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 27.3 tt0 -148.36 108.81 4.14 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.444 -0.798 . . . . 1.0700000000000001 109.408 -172.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 32' ' ' LYS . . . -140.91 138.5 8.93 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 119.978 -1.106 . . . . 0.28999999999999998 112.306 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 67.6 mt -84.56 129.3 37.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.033 0.444 . . . . 0.57999999999999996 110.139 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 63.8 mt -109.59 119.0 49.19 Favored Pre-proline 0 N--CA 1.442 -0.839 0 CA-C-N 115.767 -0.651 . . . . 0.34999999999999998 109.612 177.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 34.0 Cg_exo -61.67 69.17 0.1 Allowed 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 124.262 3.308 . . . . 0.62 112.685 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.596 ' HG2' ' CG1' ' A' ' 203' ' ' ILE . 7.6 tp10 -163.79 176.68 9.3 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.061 -1.088 . . . . 1.6799999999999999 108.061 176.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.506 ' H ' ' HG3' ' A' ' 56' ' ' GLU . 53.4 p -84.75 153.78 61.13 Favored Pre-proline 0 N--CA 1.427 -1.603 0 CA-C-O 121.332 0.587 . . . . 1.1799999999999999 110.298 176.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.5 ' HA ' HD12 ' A' ' 61' ' ' LEU . 11.9 Cg_exo -68.28 -9.58 26.31 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.742 2.961 . . . . 0.52000000000000002 110.26 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.53 -48.72 25.32 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.687 -1.142 . . . . 0.64000000000000001 111.153 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -72.93 -26.5 61.41 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.788 -0.819 . . . . 3.2999999999999998 108.788 -178.392 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.031 HD23 HD13 ' A' ' 203' ' ' ILE . 83.3 mt -64.13 -53.49 48.81 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 114.729 -1.123 . . . . 0.40999999999999998 109.796 173.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.425 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 18.1 m -64.29 -13.45 49.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.502 -0.772 . . . . 1.29 110.442 175.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.427 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 24.6 t70 -84.95 -42.82 14.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.833 -0.621 . . . . 1.3200000000000001 111.564 -178.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.571 ' CD2' ' HA ' ' A' ' 61' ' ' LEU . 11.9 p90 -73.3 -44.38 59.19 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 120.571 -0.452 . . . . 0.60999999999999999 111.2 -174.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.425 ' CD2' ' HA ' ' A' ' 62' ' ' SER . 0.7 OUTLIER -80.79 -16.79 52.87 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 120.433 -0.507 . . . . 1.5 111.965 -173.264 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.631 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 34.8 t80 -26.3 -72.28 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 O-C-N 124.6 1.188 . . . . 1.52 113.811 -153.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.631 ' HG2' ' O ' ' A' ' 66' ' ' TYR . 5.4 mm-40 175.8 115.95 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.08 0 C-N-CA 124.32 1.048 . . . . 3.6000000000000001 108.229 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.727 ' HB ' ' CD1' ' A' ' 81' ' ' TYR . 13.3 t 39.83 31.46 0.08 Allowed 'General case' 0 C--N 1.319 -0.753 0 O-C-N 124.348 1.03 . . . . 1.48 112.584 -177.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.3 -38.79 8.79 Favored Glycine 0 N--CA 1.436 -1.357 0 CA-C-N 115.5 -0.773 . . . . 1.46 113.001 -168.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.655 ' O ' HG22 ' A' ' 73' ' ' THR . 23.3 t70 169.59 -22.04 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.338 -0.986 . . . . 2.1899999999999999 108.338 -163.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.775 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 3.9 ptp180 -43.8 -48.07 8.14 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 114.772 -1.103 . . . . 3.3799999999999999 111.165 -178.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.767 HD13 ' H ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -79.32 -16.08 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 C-N-CA 120.695 -0.402 . . . . 0.70999999999999996 111.613 -172.325 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.655 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.3 t -82.41 -35.86 27.25 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 119.8 -0.76 . . . . 0.96999999999999997 109.995 -174.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.559 ' CZ2' ' HA ' ' A' ' 71' ' ' ARG . 16.8 p-90 -100.96 -3.7 29.01 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.343 -0.543 . . . . 0.75 111.387 -177.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.775 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 3.0 t70 -75.27 177.31 6.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.717 -0.674 . . . . 2.1899999999999999 112.269 -170.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.608 ' HG3' ' OD1' ' A' ' 198' ' ' ASN . 0.0 OUTLIER -133.94 -12.43 2.56 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.539 -0.755 . . . . 3.1899999999999999 111.4 179.246 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.4 m -111.33 -1.73 15.91 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.306 -0.998 . . . . 1.5800000000000001 108.306 178.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.616 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 68.3 mt -110.79 176.81 4.88 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.566 -1.197 . . . . 0.70999999999999996 110.037 -178.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -149.02 -67.95 0.22 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.495 -0.775 . . . . 1.73 110.002 -176.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.503 ' HB ' HD13 ' A' ' 97' ' ' ILE . 26.0 t -143.89 135.87 22.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.643 -0.708 . . . . 0.78000000000000003 109.808 -173.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.727 ' CD1' ' HB ' ' A' ' 68' ' ' THR . 11.4 t80 -112.24 139.29 47.91 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.801 -0.444 . . . . 5.4000000000000004 109.801 176.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.551 ' O ' ' HB3' ' A' ' 95' ' ' HIS . 17.1 m120 -137.71 114.76 10.8 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.902 -0.777 . . . . 1.6899999999999999 108.902 175.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.423 ' HG2' ' NE ' ' A' ' 86' ' ' ARG . 48.6 tpp -75.53 113.02 12.47 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.736 -0.838 . . . . 2.0499999999999998 108.736 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -85.88 -69.74 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.154 0.502 . . . . 0.64000000000000001 110.201 -170.142 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.43 ' HB3' HD12 ' A' ' 93' ' ' ILE . 80.6 t60 -132.91 124.75 28.43 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.718 -0.673 . . . . 1.96 109.7 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.423 ' NE ' ' HG2' ' A' ' 83' ' ' MET . 40.9 mtt180 -101.87 129.06 48.02 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.86 -0.793 . . . . 2.4399999999999999 108.86 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.523 HG21 ' HB2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -91.51 -39.08 11.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.468 0.651 . . . . 0.46999999999999997 109.418 -176.336 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -150.7 -169.4 3.38 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.98 -1.009 . . . . 1.8600000000000001 108.764 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.1 m -80.15 -4.41 52.86 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.858 0.361 . . . . 1.4399999999999999 110.742 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -135.69 13.3 3.43 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 109.884 -0.414 . . . . 1.8700000000000001 109.884 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.511 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -139.01 111.09 7.32 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 109.009 -0.737 . . . . 0.46000000000000002 109.009 -176.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.602 ' O ' HD12 ' A' ' 114' ' ' LEU . 41.5 m-85 -128.76 178.96 5.98 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.845 -0.616 . . . . 0.42999999999999999 110.274 -173.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.562 ' O ' HG23 ' A' ' 84' ' ' VAL . 39.1 mt -132.81 124.68 51.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 108.258 -1.016 . . . . 0.40999999999999998 108.258 169.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.643 ' SG ' HG11 ' A' ' 115' ' ' VAL . 75.2 m -92.82 107.67 19.4 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.1 -0.5 . . . . 2.0099999999999998 112.196 -171.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.58 ' HA ' HD13 ' A' ' 112' ' ' ILE . 5.3 t60 -87.11 81.85 7.89 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.027 -1.101 . . . . 1.23 108.027 164.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.444 ' OG1' ' HB3' ' A' ' 94' ' ' CYS . 90.5 m -108.3 113.0 25.75 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.72 -1.127 . . . . 0.5 111.761 -170.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.503 HD13 ' HB ' ' A' ' 80' ' ' VAL . 3.2 mp -77.58 121.57 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 108.227 -1.027 . . . . 1.03 108.227 173.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.599 ' HB ' ' O ' ' A' ' 109' ' ' ARG . 71.8 m -111.27 149.37 31.14 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.94 -1.027 . . . . 1.3799999999999999 110.771 -171.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -116.55 57.46 0.77 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.046 0.45 . . . . 1.8200000000000001 110.559 -176.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.9 p -80.98 56.38 2.75 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.562 0.696 . . . . 3.9100000000000001 110.287 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.508 ' CZ ' ' HA2' ' A' ' 104' ' ' GLY . 22.8 t80 -83.34 97.27 8.83 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.274 -0.876 . . . . 5.1600000000000001 110.452 -173.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.576 ' O ' HG12 ' A' ' 103' ' ' VAL . . . -88.72 77.99 7.77 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.908 -0.587 . . . . 1.98 110.363 175.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 102' ' ' ALA . 0.3 OUTLIER 72.52 -15.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.468 1.107 . . . . 3.1699999999999999 112.713 170.569 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.508 ' HA2' ' CZ ' ' A' ' 101' ' ' PHE . . . 139.56 -15.31 3.16 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.189 -1.005 . . . . 1.96 112.602 177.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.2 m -73.05 -13.41 61.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.284 0.564 . . . . 1.8799999999999999 110.475 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 44.0 mt -124.46 118.88 54.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.52 -0.764 . . . . 1.1200000000000001 109.95 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.8 m -77.17 155.1 82.41 Favored Pre-proline 0 C--N 1.319 -0.753 0 N-CA-C 109.366 -0.605 . . . . 1.3500000000000001 109.366 174.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -44.71 122.92 4.4 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.681 2.254 . . . . 1.0700000000000001 111.031 173.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.625 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 33.3 ttp180 -118.67 137.44 53.3 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.712 -0.395 . . . . 3.4500000000000002 110.097 -167.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.592 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 22.0 t70 -107.47 147.52 30.36 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 120.754 0.311 . . . . 1.3700000000000001 110.635 -171.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -118.81 155.64 30.82 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.366 0.603 . . . . 2.4100000000000001 111.589 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.628 HG21 ' HE1' ' A' ' 134' ' ' PHE . 35.5 mm -135.78 76.83 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 107.59 -1.263 . . . . 0.42999999999999999 107.59 170.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.57 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 2.1 m-20 -98.91 120.61 39.63 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.579 -0.737 . . . . 1.8600000000000001 110.577 -176.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 92' ' ' PHE . 9.4 tp -75.62 122.04 23.35 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 121.701 0.762 . . . . 0.28000000000000003 109.361 172.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.643 HG11 ' SG ' ' A' ' 94' ' ' CYS . 0.1 OUTLIER -123.58 125.7 71.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-N 114.591 -1.186 . . . . 0.26000000000000001 112.374 -165.123 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.452 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 91.0 t80 -112.87 123.92 51.42 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.332 -0.849 . . . . 2.5699999999999998 110.637 172.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.556 HG13 HG22 ' A' ' 127' ' ' ILE . 4.5 mp -92.07 110.74 23.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.366 -0.834 . . . . 0.89000000000000001 109.783 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.464 ' HB3' HG23 ' A' ' 126' ' ' ILE . 24.8 ttmm -113.41 142.82 45.44 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.032 -0.531 . . . . 1.2 110.596 -176.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -129.01 89.8 2.93 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 116.003 -0.544 . . . . 2.7999999999999998 110.563 -174.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.474 ' HB3' ' HB2' ' A' ' 123' ' ' ASN . 36.9 m-85 -72.29 108.75 5.59 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 107.829 -1.174 . . . . 0.82999999999999996 107.829 167.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -39.81 100.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 O-C-N 124.665 1.228 . . . . 2.2799999999999998 112.813 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.413 ' C ' ' HG2' ' A' ' 157' ' ' PRO . . . 67.12 26.87 73.34 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 114.039 -1.437 . . . . 0.76000000000000001 113.113 176.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.514 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 10.4 m120 -127.38 -46.13 1.49 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.688 -0.256 . . . . 1.6499999999999999 110.64 176.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.551 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 5.8 mtm -162.19 131.17 4.3 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 120.516 -0.474 . . . . 1.1200000000000001 111.96 -176.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -112.42 86.02 2.27 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.612 -1.255 . . . . 1.6200000000000001 107.612 167.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.595 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -97.78 135.74 31.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.136 -0.938 . . . . 0.29999999999999999 112.244 -172.576 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.681 ' O ' HG13 ' A' ' 127' ' ' ILE . 13.9 pt -101.05 108.89 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 108.576 -0.898 . . . . 0.58999999999999997 108.576 164.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.555 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 1.7 m -75.86 161.05 29.31 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.624 -0.88 . . . . 1.1799999999999999 108.624 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.57 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 11.3 p -157.33 121.11 4.18 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.334 0.588 . . . . 1.24 111.618 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.8 ttmt -127.94 110.71 12.81 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.436 -1.32 . . . . 2.2599999999999998 107.436 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.416 ' OG ' ' HA ' ' A' ' 147' ' ' TYR . 22.9 t -58.71 98.84 0.04 OUTLIER 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 107.629 -1.248 . . . . 1.3899999999999999 107.629 -178.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.427 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -107.59 133.84 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.107 0 CA-C-N 114.833 -1.076 . . . . 1.05 108.727 -165.321 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -94.09 71.15 3.94 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.898 -1.047 . . . . 2.1699999999999999 109.076 -169.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.628 ' HE1' HG21 ' A' ' 112' ' ' ILE . 1.8 p90 -99.26 175.06 2.62 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 114.4 -1.273 . . . . 0.53000000000000003 109.488 -172.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -41.98 -50.4 5.2 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.739 2.959 . . . . 1.28 116.479 -174.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -88.12 -5.13 58.62 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.604 0.716 . . . . 3.5 111.604 -170.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.484 ' HB3' ' O ' ' A' ' 134' ' ' PHE . 22.8 t80 -56.72 -48.94 96.37 Favored Pre-proline 0 C--N 1.315 -0.927 0 N-CA-C 114.914 1.45 . . . . 6.1200000000000001 114.914 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 137' ' ' TYR . 66.6 Cg_exo -32.29 110.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 123.821 3.014 . . . . 1.77 114.467 -174.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.598 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 82.3 Cg_endo -83.84 -160.72 0.12 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.687 2.925 . . . . 1.25 114.036 -175.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.9 p -136.64 -164.35 1.56 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.279 -0.873 . . . . 1.6000000000000001 108.943 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.6 p -89.77 -29.83 18.42 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.126 -0.63 . . . . 1.97 110.972 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -83.45 -33.32 25.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 2.1800000000000002 110.732 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -107.67 109.41 21.01 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 109.425 -0.583 . . . . 1.23 109.425 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.625 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 2.4 tp -100.63 106.66 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 C-N-CA 120.123 -0.631 . . . . 0.81999999999999995 109.646 -176.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.598 ' NH2' ' HA ' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -59.43 99.98 0.07 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.109 -0.95 . . . . 4.4199999999999999 110.715 178.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -65.82 122.24 21.54 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.597 -0.729 . . . . 0.79000000000000004 111.297 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.536 ' HB3' ' HB2' ' A' ' 174' ' ' GLU . 3.5 t80 -85.05 78.55 9.87 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.623 0.725 . . . . 4.4400000000000004 110.372 -177.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.685 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 89.0 m-20 -72.55 106.11 4.48 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.736 -1.12 . . . . 1.6200000000000001 110.325 175.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.445 ' CB ' HE21 ' A' ' 172' ' ' GLN . 83.0 m-70 -75.91 144.77 76.65 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 109.545 -0.539 . . . . 2.3199999999999998 109.545 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -13.49 61.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.181 1 C-N-CA 127.599 5.533 . . . . 0.53000000000000003 116.374 -166.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . 0.685 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 19.7 p -89.99 -175.08 4.47 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.451 -0.795 . . . . 1.5800000000000001 110.329 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.633 ' N ' HG21 ' A' ' 14' ' ' VAL . . . 178.99 -161.81 28.33 Favored Glycine 0 N--CA 1.435 -1.371 0 C-N-CA 120.456 -0.878 . . . . 0.42999999999999999 111.479 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.499 ' CZ ' HD11 ' A' ' 167' ' ' LEU . 32.5 t80 -161.38 91.42 0.85 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.075 -1.083 . . . . 0.59999999999999998 108.075 -165.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.595 HG12 ' HB ' ' A' ' 126' ' ' ILE . 2.7 m -98.41 132.62 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-O 122.106 0.955 . . . . 0.31 111.123 -174.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 124' ' ' MET . 16.5 t -109.55 119.28 38.93 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.228 -0.897 . . . . 1.55 109.186 176.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.544 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 6.2 m -116.44 122.41 31.98 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.614 -0.266 . . . . 1.0600000000000001 111.162 -171.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.514 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 46.0 Cg_exo -53.65 126.64 22.48 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.973 1.782 . . . . 0.56000000000000005 110.655 169.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.628 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 70.8 mmm -85.24 -166.61 1.55 Allowed 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.119 0.485 . . . . 1.1599999999999999 111.139 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -74.57 -35.51 63.03 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 121.562 0.696 . . . . 2.6299999999999999 109.225 175.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -102.6 29.49 5.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.874 -1.057 . . . . 2.0499999999999998 108.876 173.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.471 ' HA ' ' O ' ' A' ' 164' ' ' TYR . 2.7 p-10 -28.5 -55.83 0.25 Allowed Pre-proline 0 N--CA 1.475 0.812 0 N-CA-C 116.407 2.002 . . . . 1.9299999999999999 116.407 -171.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.44 ' HD3' ' CG ' ' A' ' 161' ' ' ASN . 55.3 Cg_endo -68.83 -13.59 37.19 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 121.738 1.656 . . . . 0.72999999999999998 112.722 -173.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -109.92 -32.69 6.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.984 -0.553 . . . . 0.68000000000000005 110.765 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.628 ' O ' ' HB2' ' A' ' 158' ' ' MET . 88.3 m-85 -138.76 126.91 22.66 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.417 -0.586 . . . . 0.93000000000000005 109.417 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.467 ' HB2' HD11 ' A' ' 61' ' ' LEU . 73.6 m -125.65 154.22 42.67 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.181 0.515 . . . . 1.4099999999999999 111.853 -176.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.544 ' HB3' ' HB2' ' A' ' 156' ' ' SER . 2.0 tppp? -96.77 105.25 17.34 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.887 0.851 . . . . 0.73999999999999999 112.081 -174.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.499 HD11 ' CZ ' ' A' ' 153' ' ' PHE . 0.6 OUTLIER -92.82 108.82 20.29 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.579 -1.191 . . . . 0.27000000000000002 109.242 175.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.592 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -129.92 134.2 63.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.448 0.642 . . . . 0.28000000000000003 111.504 177.206 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.582 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 17.7 ttt -143.49 151.3 40.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.518 -0.765 . . . . 1.24 109.321 -174.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.751 ' CD1' HD21 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -136.03 151.96 50.4 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.366 -0.605 . . . . 3.3700000000000001 109.366 170.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.537 ' N ' ' HD1' ' A' ' 170' ' ' PHE . 3.9 p -134.85 132.83 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 115.746 -0.661 . . . . 1.3999999999999999 110.078 176.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.51 ' OE1' HD12 ' A' ' 47' ' ' LEU . 24.9 tt0 -121.09 65.73 0.86 Allowed 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 107.135 -1.432 . . . . 2.1699999999999999 107.135 177.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.511 HG23 ' OD1' ' A' ' 148' ' ' ASN . 1.4 m -68.94 149.47 48.82 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 113.54 -1.664 . . . . 1.6499999999999999 110.465 -175.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 147' ' ' TYR . 4.0 tp10 -81.91 -15.09 55.07 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.187 -0.46 . . . . 2.4500000000000002 109.872 177.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.476 ' H ' HG22 ' A' ' 173' ' ' THR . 35.9 mtt 68.67 32.6 4.14 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.274 -0.876 . . . . 3.7400000000000002 110.201 175.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.498 ' HB3' HD11 ' A' ' 144' ' ' ILE . 31.2 mmm180 -66.02 159.85 25.0 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.704 -0.68 . . . . 5.7800000000000002 110.016 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 109.99 -171.51 14.98 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.951 -0.642 . . . . 2.2599999999999998 111.565 -175.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -102.75 69.49 1.07 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.995 0.426 . . . . 6.2300000000000004 110.154 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.65 ' HB2' HD11 ' A' ' 184' ' ' ILE . 1.7 mp -119.44 161.8 19.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.469 0.652 . . . . 1.6399999999999999 109.537 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.505 ' O ' HD12 ' A' ' 184' ' ' ILE . 17.0 m -113.83 157.94 40.44 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-N 114.925 -1.034 . . . . 2.04 108.953 -177.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -42.6 -46.36 8.13 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.813 2.342 . . . . 1.74 113.176 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.562 ' O ' ' HE2' ' A' ' 186' ' ' LYS . 9.3 m -69.22 -15.37 63.36 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.163 -0.472 . . . . 2.1400000000000001 111.877 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.467 HG13 ' H ' ' A' ' 180' ' ' SER . 12.0 mm -90.29 -29.39 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 CA-C-O 122.551 1.167 . . . . 1.1200000000000001 108.997 -175.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.979 ' HA ' HG22 ' A' ' 187' ' ' THR . 0.9 OUTLIER -83.39 -37.12 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 113.113 -1.858 . . . . 1.1299999999999999 110.516 -172.103 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 189' ' ' PRO . 9.2 pt-20 -64.41 -16.72 62.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.489 -0.778 . . . . 2.8900000000000001 109.343 174.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.562 ' HE2' ' O ' ' A' ' 182' ' ' SER . 52.1 mtmt -92.05 -43.7 9.26 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.775 -0.648 . . . . 1.28 110.376 170.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.979 HG22 ' HA ' ' A' ' 184' ' ' ILE . 13.5 t -64.83 -40.33 95.01 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.841 0.682 . . . . 0.62 112.841 -169.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . 0.496 ' SD ' HG23 ' A' ' 187' ' ' THR . 0.1 OUTLIER -78.04 -61.2 0.61 Allowed Pre-proline 0 N--CA 1.467 0.424 0 CA-C-N 118.407 0.549 . . . . 1.0600000000000001 111.951 -178.456 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.606 ' O ' HG13 ' A' ' 193' ' ' VAL . 51.6 Cg_exo -56.26 -38.74 94.54 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.04 1.827 . . . . 0.91000000000000003 112.258 -176.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.41 ' O ' HG22 ' A' ' 193' ' ' VAL . 23.2 t -72.21 -37.31 69.26 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.414 -0.587 . . . . 1.5 109.414 -177.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.452 ' HA ' ' HB2' ' A' ' 194' ' ' ASN . 2.6 t-20 -67.4 -31.93 72.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.019 -0.537 . . . . 1.8799999999999999 110.408 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.51 ' HB3' ' CG1' ' A' ' 50' ' ' VAL . 40.5 mt -69.34 -46.22 67.59 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 120.738 0.304 . . . . 1.0900000000000001 111.007 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.606 HG13 ' O ' ' A' ' 189' ' ' PRO . 0.9 OUTLIER -65.06 -34.25 69.28 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 N-CA-C 108.716 -0.846 . . . . 0.68000000000000005 108.716 176.543 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.452 ' HB2' ' HA ' ' A' ' 191' ' ' ASN . 35.0 m-20 -63.64 -45.32 90.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.179 -1.373 . . . . 2.0699999999999998 111.483 178.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.419 ' HA ' ' ND2' ' A' ' 198' ' ' ASN . 6.3 m-85 -59.15 -31.38 68.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.967 0.413 . . . . 2.0 110.417 175.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.474 HG12 HD12 ' A' ' 167' ' ' LEU . 34.3 mt -81.75 -27.17 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-N 116.157 -0.474 . . . . 0.31 111.319 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 62.4 mt -74.57 -40.16 61.81 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-O 121.108 0.48 . . . . 1.03 109.811 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.608 ' OD1' ' HG3' ' A' ' 76' ' ' LYS . 76.5 m-20 -50.07 -37.86 35.6 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.706 -1.134 . . . . 1.8999999999999999 108.53 166.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.648 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -78.17 -43.94 27.25 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 116.081 -0.509 . . . . 0.28999999999999998 110.905 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.56 ' O ' ' HG3' ' A' ' 204' ' ' LYS . 35.6 mmtm -55.96 -44.5 78.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.256 0.551 . . . . 0.96999999999999997 110.565 174.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -87.58 -38.41 15.99 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.495 -0.775 . . . . 1.9399999999999999 110.856 -173.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . 0.431 ' HA2' ' HB3' ' A' ' 205' ' ' ALA . . . -68.39 -29.42 73.08 Favored Glycine 0 C--O 1.228 -0.243 0 C-N-CA 121.102 -0.57 . . . . 0.46999999999999997 111.999 178.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 1.031 HD13 HD23 ' A' ' 61' ' ' LEU . 2.8 tp -70.55 -31.68 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-O 120.92 0.391 . . . . 0.60999999999999999 109.949 177.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.56 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 89.3 mttt -84.33 -32.84 24.06 Favored 'General case' 0 C--O 1.21 -1.006 0 N-CA-C 108.514 -0.921 . . . . 3.3700000000000001 108.514 176.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.542 ' HA ' ' CB ' ' A' ' 211' ' ' ARG . . . -58.41 -32.22 68.43 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.923 -0.581 . . . . 1.02 109.525 170.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -94.62 5.15 52.7 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.615 -0.72 . . . . 3.6299999999999999 111.728 174.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.48 ' HB3' ' HA ' ' A' ' 204' ' ' LYS . 73.7 ttt180 -113.29 -61.17 1.78 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.899 0.38 . . . . 2.5899999999999999 111.763 174.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 28.8 p -79.15 138.11 56.51 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.444 0.64 . . . . 1.8400000000000001 111.86 -170.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.48 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 13.4 Cg_endo -56.26 -22.82 42.57 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 124.009 3.139 . . . . 2.3500000000000001 112.847 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 35.4 t -68.86 -55.91 9.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.848 -0.614 . . . . 2.3100000000000001 111.338 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.542 ' CB ' ' HA ' ' A' ' 205' ' ' ALA . 10.6 mpt_? -87.03 -20.82 26.64 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.126 0.417 . . . . 5.4500000000000002 112.126 -173.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.48 ' HG2' ' HA ' ' A' ' 209' ' ' PRO . 13.2 ptm180 -74.82 -15.57 60.73 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.21 -0.596 . . . . 6.8600000000000003 109.934 176.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -115.99 28.44 7.66 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.794 -0.922 . . . . 3.3700000000000001 110.794 174.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -77.06 111.78 13.0 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.871 -0.418 . . . . 5.21 109.871 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -99.02 132.89 44.0 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.496 -0.32 . . . . 6.46 110.507 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 58.87 69.79 0.7 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.384 -0.825 . . . . 6.0899999999999999 110.362 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.487 ' ND2' ' HA ' ' A' ' 74' ' ' TRP . 52.4 t30 -81.5 102.6 10.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.993 -0.549 . . . . 5.1200000000000001 110.274 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 24.8 m -67.4 -50.26 60.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.787 -0.642 . . . . 6.7599999999999998 110.817 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -170.02 128.99 0.91 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.022 -0.362 . . . . 8.8200000000000003 110.022 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . 0.446 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 46.7 t . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.536 -0.745 . . . . 8.4800000000000004 109.864 176.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 1.044 ' HG3' ' HB3' ' A' ' 4' ' ' LYS . 24.9 tpp . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 109.051 -0.722 . . . . 3.8599999999999999 109.051 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 64.08 -98.84 0.07 Allowed 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 114.606 -1.179 . . . . 2.25 112.006 168.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.635 ' HB3' HD11 ' A' ' 114' ' ' LEU . 76.0 m-85 -61.99 -26.54 68.28 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 121.236 0.541 . . . . 0.42999999999999999 110.098 -172.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 1.044 ' HB3' ' HG3' ' A' ' 1' ' ' MET . 39.4 tttt -80.93 -36.44 31.01 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 107.453 -1.314 . . . . 1.51 107.453 -176.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.18 -43.57 82.78 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.897 -0.592 . . . . 0.54000000000000004 111.32 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 3' ' ' PHE . 0.9 OUTLIER -82.75 -32.88 10.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 122.169 0.985 . . . . 1.0700000000000001 109.191 -172.648 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.612 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -81.21 -37.79 28.06 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.176 -1.375 . . . . 0.34000000000000002 111.718 -177.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.578 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 19.5 mt-30 -61.77 -30.13 70.59 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.421 -0.809 . . . . 1.5900000000000001 109.704 175.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.654 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 76.3 mt-30 -78.32 -39.67 38.99 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.482 -1.236 . . . . 2.4700000000000002 109.365 173.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.657 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.4 OUTLIER -72.94 -33.47 65.94 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.424 -0.807 . . . . 0.47999999999999998 112.198 -175.185 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -48.05 -57.92 5.15 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.986 0.422 . . . . 0.31 111.698 174.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.718 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 4.2 pt20 -76.57 1.33 17.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.259 -0.428 . . . . 1.6399999999999999 111.605 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.654 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 10.6 mm-40 -82.8 -48.83 10.36 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.01 -0.737 . . . . 2.54 109.01 169.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.96 HG23 ' HD1' ' A' ' 170' ' ' PHE . 7.4 p -72.0 -34.06 49.45 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-O 121.47 0.653 . . . . 0.53000000000000003 109.818 175.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.718 ' HB3' ' HA ' ' A' ' 12' ' ' GLN . 0.8 OUTLIER -68.15 -26.18 65.64 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 122.361 1.077 . . . . 0.59999999999999998 108.325 172.609 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 20' ' ' ASP . . . -68.75 -20.05 73.84 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 113.797 -1.547 . . . . 0.56999999999999995 109.627 177.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.627 ' HD2' ' HA ' ' A' ' 14' ' ' VAL . 32.1 m-85 -91.08 -22.27 20.81 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 114.315 -0.943 . . . . 3.27 109.376 176.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.487 ' HB3' ' O ' ' A' ' 15' ' ' LEU . 5.6 t-20 -60.06 -28.7 68.0 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.356 -0.838 . . . . 2.0299999999999998 109.615 175.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.554 ' HD2' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -115.22 10.89 16.11 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.58 -0.448 . . . . 2.7200000000000002 111.397 175.189 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.577 ' CB ' ' HA ' ' A' ' 17' ' ' TYR . 50.7 t0 -89.6 69.93 7.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.499 0.666 . . . . 2.1600000000000001 109.69 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.518 HG22 ' CH2' ' A' ' 24' ' ' TRP . 34.5 p -104.96 105.86 16.09 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.674 -0.694 . . . . 1.8200000000000001 110.812 -176.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.5 p -169.87 -88.18 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.558 -0.746 . . . . 2.1899999999999999 111.454 -173.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.496 ' O ' ' HG3' ' A' ' 38' ' ' LYS . . . -84.76 52.18 4.66 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 116.086 -0.507 . . . . 1.1000000000000001 113.418 -173.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.871 ' HZ3' ' HD3' ' A' ' 49' ' ' ARG . 0.2 OUTLIER -119.61 -160.05 0.8 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.572 -0.529 . . . . 1.6699999999999999 109.572 176.21 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.1 ttpp -176.09 110.65 0.1 Allowed 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 108.634 -0.876 . . . . 2.9500000000000002 108.634 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.737 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 0.9 OUTLIER -61.14 118.27 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 CA-C-O 121.818 0.818 . . . . 1.5600000000000001 110.303 175.084 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.2 m -98.49 -25.16 4.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 114.317 -1.31 . . . . 1.22 110.011 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.43 ' HB3' ' CG2' ' A' ' 35' ' ' VAL . 0.9 OUTLIER -154.67 135.39 13.58 Favored 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 119.472 -0.891 . . . . 2.4100000000000001 110.09 -178.007 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.502 HG22 ' HA ' ' A' ' 34' ' ' THR . 73.2 p -138.98 153.26 48.15 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.282 0.563 . . . . 1.3799999999999999 110.748 177.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.692 ' HB3' HG12 ' A' ' 33' ' ' ILE . 14.9 t -113.86 -164.4 0.93 Allowed 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.456 -1.313 . . . . 2.3700000000000001 107.456 173.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -93.8 19.31 8.99 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.999 0.428 . . . . 4.5499999999999998 109.912 -176.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.85 ' HE2' ' HA ' ' A' ' 32' ' ' LYS . 3.6 mmpt? -155.02 -17.98 0.11 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.119 -0.946 . . . . 1.4199999999999999 111.573 175.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.828 HG22 ' HA3' ' A' ' 52' ' ' GLY . 35.8 pt -131.35 170.82 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.902 0.382 . . . . 0.76000000000000001 111.907 -172.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.502 ' HA ' HG22 ' A' ' 29' ' ' THR . 23.1 m -160.81 123.12 3.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.325 -0.852 . . . . 0.57999999999999996 110.423 -167.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.578 HG13 HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -112.48 113.85 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.18 0.514 . . . . 0.85999999999999999 110.692 172.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.737 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.8 OUTLIER -102.6 125.61 49.39 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.627 -0.715 . . . . 1.1000000000000001 109.871 176.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 78.1 p -93.16 125.04 37.55 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 108.65 -0.87 . . . . 1.27 108.65 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.668 ' HA ' ' HA ' ' A' ' 24' ' ' TRP . 57.8 tttm -122.28 22.16 10.18 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.751 -0.659 . . . . 1.9099999999999999 110.963 -168.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.676 ' HA ' ' HA ' ' A' ' 46' ' ' ASN . . . 60.55 122.41 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 114.857 -1.065 . . . . 1.6799999999999999 113.219 175.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.426 ' H ' ' HA ' ' A' ' 46' ' ' ASN . 40.0 m -91.76 83.86 5.34 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.041 -0.726 . . . . 2.0899999999999999 109.041 174.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.48 ' H ' ' HD2' ' A' ' 41' ' ' ARG . 2.1 mpt_? -69.9 -3.73 17.27 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.922 -0.581 . . . . 6.6100000000000003 109.55 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -54.73 -27.25 39.43 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.974 -1.012 . . . . 6.46 110.603 172.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.574 ' HD2' ' CD2' ' A' ' 44' ' ' HIS . 17.5 t80 177.31 -79.0 0.0 OUTLIER 'General case' 0 C--N 1.344 0.368 0 N-CA-C 111.97 0.359 . . . . 5.6500000000000004 111.97 176.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.574 ' CD2' ' HD2' ' A' ' 43' ' ' PHE . 6.5 p80 -139.5 79.77 1.74 Allowed 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 119.861 -0.736 . . . . 5.5599999999999996 112.858 -170.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 162.87 -157.33 29.34 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 119.073 -1.537 . . . . 1.5600000000000001 112.547 168.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.676 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -120.17 136.71 54.53 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 120.972 0.415 . . . . 2.0499999999999998 109.998 179.229 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.856 HD11 ' HE2' ' A' ' 170' ' ' PHE . 6.1 tt -78.04 147.85 34.59 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.76 -1.2 . . . . 0.87 107.76 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.834 ' HB3' HD11 ' A' ' 192' ' ' LEU . 4.9 m-85 -129.81 124.61 33.75 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 119.493 -0.883 . . . . 0.98999999999999999 111.288 -172.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.871 ' HD3' ' HZ3' ' A' ' 24' ' ' TRP . 54.3 ttt-85 -120.54 109.56 15.41 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.356 -0.838 . . . . 2.9199999999999999 109.147 177.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.578 HG23 HG13 ' A' ' 35' ' ' VAL . 10.4 p -100.31 150.22 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 109.515 -0.55 . . . . 1.3300000000000001 109.515 -177.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.785 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 41.5 tt0 -156.03 109.6 2.73 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.856 -0.611 . . . . 1.0700000000000001 110.078 -172.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.828 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -140.45 159.58 26.3 Favored Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 111.427 -0.669 . . . . 0.28999999999999998 111.427 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 59.6 mt -99.88 124.24 53.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 C-N-CA 120.57 -0.452 . . . . 0.57999999999999996 110.753 178.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.636 HG12 ' HD2' ' A' ' 200' ' ' LYS . 85.7 mt -101.96 121.35 51.01 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 115.656 -0.702 . . . . 0.34999999999999998 109.926 175.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -64.89 61.41 0.29 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.981 3.121 . . . . 0.62 112.878 177.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.821 ' HG2' HG13 ' A' ' 203' ' ' ILE . 6.9 tp10 -155.4 173.6 16.44 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.051 -1.092 . . . . 1.6799999999999999 108.051 174.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.552 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 52.3 p -83.04 146.75 52.46 Favored Pre-proline 0 N--CA 1.425 -1.72 0 CA-C-O 121.838 0.828 . . . . 1.1799999999999999 109.836 175.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 57' ' ' SER . 27.6 Cg_exo -60.72 -11.05 15.92 Favored 'Trans proline' 0 C--N 1.329 -0.461 0 C-N-CA 124.16 3.24 . . . . 0.52000000000000002 111.478 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.36 -52.03 31.07 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.214 -0.903 . . . . 0.64000000000000001 110.811 174.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.75 ' HE3' ' HB3' ' A' ' 64' ' ' PHE . 18.4 tptt -69.12 -24.03 64.06 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.516 -0.92 . . . . 3.2999999999999998 108.516 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.746 ' HA ' ' CD1' ' A' ' 64' ' ' PHE . 46.5 mt -65.95 -58.71 4.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.642 -0.708 . . . . 0.40999999999999998 110.323 172.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.525 ' HB3' ' HB3' ' A' ' 125' ' ' ASN . 19.8 p -62.26 -11.23 13.84 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.83 -0.543 . . . . 1.29 110.56 176.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.476 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 25.2 t70 -90.9 -44.78 9.16 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.334 0.494 . . . . 1.3200000000000001 112.334 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.829 ' HD2' ' CZ2' ' A' ' 74' ' ' TRP . 10.3 p90 -71.79 -43.26 65.98 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 121.032 -0.267 . . . . 0.60999999999999999 110.721 -168.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.686 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -96.86 6.64 48.28 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.444 -0.503 . . . . 1.5 111.288 -174.59 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -42.18 -73.67 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.083 0.771 . . . . 1.52 113.083 -169.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.641 HE22 HG21 ' A' ' 115' ' ' VAL . 64.0 mm-40 -152.19 -63.24 0.17 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.17 0.509 . . . . 3.6000000000000001 112.27 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.93 ' HB ' ' CD2' ' A' ' 81' ' ' TYR . 9.1 t -145.08 21.43 1.58 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.995 0.902 . . . . 1.48 109.359 -174.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -88.82 -29.82 17.06 Favored Glycine 0 CA--C 1.491 -1.44 0 CA-C-N 114.84 -1.073 . . . . 1.46 113.87 -168.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.655 ' O ' HG22 ' A' ' 73' ' ' THR . 10.4 t0 -167.28 -35.71 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.365 -0.976 . . . . 2.1899999999999999 108.365 -166.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.766 ' HA ' ' CZ2' ' A' ' 74' ' ' TRP . 1.0 OUTLIER -47.83 -48.24 30.92 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 114.577 -1.192 . . . . 3.3799999999999999 111.582 -172.245 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.887 HG22 HD13 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -87.35 -7.02 10.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 119.743 -0.783 . . . . 0.70999999999999996 111.244 -172.675 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.655 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.4 t -90.65 -30.79 16.93 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 119.76 -0.776 . . . . 0.96999999999999997 110.013 -177.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 1.002 ' HZ3' ' HB3' ' A' ' 198' ' ' ASN . 7.1 p-90 -102.54 -7.6 21.72 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 120.509 -0.476 . . . . 0.75 111.822 178.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.865 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 4.5 t70 -76.57 168.29 20.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.549 0.69 . . . . 2.1899999999999999 111.702 -170.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.681 ' HD2' ' OD1' ' A' ' 194' ' ' ASN . 0.0 OUTLIER -118.51 -16.74 9.48 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.849 -1.069 . . . . 3.1899999999999999 111.286 -177.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.4 m -113.83 7.94 17.2 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.911 -0.774 . . . . 1.5800000000000001 108.911 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.887 HD13 HG22 ' A' ' 72' ' ' ILE . 29.8 mt -109.89 167.31 10.26 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.059 -0.973 . . . . 0.70999999999999996 111.283 -178.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.612 ' HG2' ' HG2' ' A' ' 99' ' ' GLN . 6.6 mm100 -146.58 -71.25 0.24 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.393 -0.821 . . . . 1.73 110.686 -175.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.554 HG23 ' HB3' ' A' ' 79' ' ' GLN . 18.8 t -138.55 124.57 24.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.059 -0.973 . . . . 0.78000000000000003 110.112 -170.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.93 ' CD2' ' HB ' ' A' ' 68' ' ' THR . 69.6 t80 -106.68 139.32 41.31 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.491 -0.483 . . . . 5.4000000000000004 110.395 174.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.576 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 17.5 m120 -130.31 104.63 7.39 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.039 -0.726 . . . . 1.6899999999999999 109.039 177.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.534 ' HE1' ' HG2' ' A' ' 86' ' ' ARG . 7.1 tpt -67.77 101.43 1.06 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.148 -0.933 . . . . 2.0499999999999998 109.583 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.553 HG23 ' HB ' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -81.59 -83.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 120.481 -0.487 . . . . 0.64000000000000001 111.551 -171.378 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.519 ' HB2' HD12 ' A' ' 93' ' ' ILE . 49.3 m170 -118.35 127.16 53.43 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.001 0.429 . . . . 1.96 109.887 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.534 ' HG2' ' HE1' ' A' ' 83' ' ' MET . 25.5 mtm180 -108.58 120.9 43.8 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.763 -0.829 . . . . 2.4399999999999999 108.763 176.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.603 HG12 ' O ' ' A' ' 91' ' ' THR . 0.8 OUTLIER -80.94 -55.3 8.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.424 -0.807 . . . . 0.46999999999999997 112.022 -163.427 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -127.66 -83.28 0.6 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.933 -0.576 . . . . 1.8600000000000001 111.085 -173.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.5 t -148.17 -31.35 0.28 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.243 0.544 . . . . 1.4399999999999999 110.08 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -128.11 19.61 6.45 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.4 -0.818 . . . . 1.8700000000000001 109.511 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.603 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -126.18 111.69 14.91 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.083 -1.08 . . . . 0.46000000000000002 108.083 -176.802 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.615 ' O ' HD12 ' A' ' 114' ' ' LEU . 56.1 m-85 -122.88 171.5 9.16 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.799 -0.637 . . . . 0.42999999999999999 110.566 -173.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.553 ' HB ' HG23 ' A' ' 84' ' ' VAL . 23.8 mt -131.12 130.59 63.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 107.678 -1.23 . . . . 0.40999999999999998 107.678 165.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.697 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 26.5 p -101.74 128.72 47.94 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.582 -0.447 . . . . 2.0099999999999998 111.353 -174.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.663 ' HA ' HD13 ' A' ' 112' ' ' ILE . 2.8 t60 -104.3 86.54 2.55 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.269 -1.011 . . . . 1.23 108.269 165.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.691 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 18.5 m -110.47 117.1 32.66 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.415 -0.811 . . . . 0.5 112.2 -168.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 42.0 mm -78.55 125.76 38.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 120.169 -0.612 . . . . 1.03 109.493 173.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.7 m -107.26 146.9 30.89 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.111 -0.949 . . . . 1.3799999999999999 110.705 -173.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.612 ' HG2' ' HG2' ' A' ' 79' ' ' GLN . 1.8 mm100 -82.16 177.55 8.74 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.942 -0.572 . . . . 1.8200000000000001 110.685 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.419 ' H ' ' NE2' ' A' ' 99' ' ' GLN . 41.0 t -110.08 117.45 33.77 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.588 -0.733 . . . . 3.9100000000000001 110.81 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.423 ' O ' HD12 ' A' ' 106' ' ' ILE . 84.5 t80 -115.76 135.8 53.67 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 106.832 -1.544 . . . . 5.1600000000000001 106.832 167.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.455 ' HB3' HD12 ' A' ' 106' ' ' ILE . . . 71.16 63.85 0.16 Allowed 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.41 -0.959 . . . . 1.98 108.41 -170.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.43 32.14 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 114.778 -1.101 . . . . 3.1699999999999999 110.749 -173.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 102' ' ' ALA . . . -95.86 -5.63 59.71 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.7 -0.96 . . . . 1.96 110.7 173.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.635 ' HB3' ' HA ' ' A' ' 179' ' ' LEU . 64.8 m -155.32 -38.05 0.09 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.083 -0.558 . . . . 1.8799999999999999 110.42 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 178' ' ' LYS . 94.7 mt -80.1 126.49 39.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.569 -0.742 . . . . 1.1200000000000001 112.139 -170.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.416 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 15.9 m -100.84 169.72 7.49 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.369 -0.832 . . . . 1.3500000000000001 109.434 174.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 107' ' ' SER . 65.5 Cg_exo -51.69 123.8 13.07 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.204 1.936 . . . . 1.0700000000000001 110.74 171.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.681 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 39.6 ttm105 -114.82 149.22 37.38 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.382 -0.527 . . . . 3.4500000000000002 110.267 -168.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.644 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 36.7 t0 -109.6 117.46 34.0 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.876 -0.416 . . . . 1.3700000000000001 109.876 -174.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.691 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 9.2 m-30 -98.3 112.32 24.35 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.83 0.348 . . . . 2.4100000000000001 110.877 -175.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.697 ' HA ' ' O ' ' A' ' 94' ' ' CYS . 15.2 mm -115.02 79.81 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 CA-C-N 115.509 -0.769 . . . . 0.42999999999999999 109.317 172.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.588 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 45.6 m-20 -110.25 127.45 54.99 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.676 -0.693 . . . . 1.8600000000000001 109.896 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.635 HD11 ' HB3' ' A' ' 3' ' ' PHE . 4.0 tp -76.82 125.91 30.08 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 109.211 -0.663 . . . . 0.28000000000000003 109.211 173.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.641 HG21 HE22 ' A' ' 67' ' ' GLN . 0.1 OUTLIER -123.92 125.64 71.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 115.233 -0.894 . . . . 0.26000000000000001 112.321 -164.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.612 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 85.1 t80 -112.23 115.13 28.3 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.352 -0.84 . . . . 2.5699999999999998 110.812 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.656 HG12 HG22 ' A' ' 127' ' ' ILE . 78.1 mt -91.27 99.29 9.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.974 -0.557 . . . . 0.89000000000000001 109.668 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.558 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 2.6 tppp? -97.55 130.86 44.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.293 -0.867 . . . . 1.2 109.353 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.551 ' NH1' ' HA ' ' A' ' 121' ' ' GLU . 4.3 tmt_? -111.95 91.86 3.81 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 107.847 -1.168 . . . . 2.7999999999999998 107.847 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.412 ' CE1' ' HG2' ' A' ' 118' ' ' LYS . 60.9 m-85 -64.68 115.24 5.05 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 107.813 -1.181 . . . . 0.82999999999999996 107.813 173.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.551 ' HA ' ' NH1' ' A' ' 119' ' ' ARG . 7.4 mm-40 -27.91 90.35 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 O-C-N 125.312 1.632 . . . . 2.2799999999999998 113.398 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 52.62 41.67 57.21 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 115.271 -0.877 . . . . 0.76000000000000001 112.81 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.541 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 4.1 t-20 -141.04 -39.0 0.41 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.395 0.146 . . . . 1.6499999999999999 111.395 -175.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.489 ' CG ' ' HB ' ' A' ' 154' ' ' VAL . 3.4 tpp -157.13 118.32 3.67 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.312 -0.555 . . . . 1.1200000000000001 111.22 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.525 ' HB3' ' HB3' ' A' ' 62' ' ' SER . 4.8 m-20 -101.08 73.67 1.54 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.509 -0.923 . . . . 1.6200000000000001 108.509 175.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.799 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -92.34 138.48 19.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.189 -0.914 . . . . 0.29999999999999999 112.667 -172.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.746 HG13 ' O ' ' A' ' 127' ' ' ILE . 1.1 pt -105.59 116.32 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 108.51 -0.922 . . . . 0.58999999999999997 108.51 162.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 4.1 m -81.26 163.46 22.96 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.266 -0.642 . . . . 1.1799999999999999 109.266 173.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.588 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 12.7 p -156.88 131.48 8.74 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.052 0.453 . . . . 1.24 110.968 176.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.53 ' HD3' HD23 ' A' ' 114' ' ' LEU . 20.0 mtpp -131.09 120.78 23.88 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 107.754 -1.202 . . . . 2.2599999999999998 107.754 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.427 ' HB3' ' H ' ' A' ' 148' ' ' ASN . 4.0 p -63.48 98.31 0.16 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.47 -0.937 . . . . 1.3899999999999999 108.47 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.02 138.37 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-N 114.526 -1.215 . . . . 1.05 109.678 -165.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -100.81 74.79 1.66 Allowed 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 122.42 1.105 . . . . 2.1699999999999999 110.306 -170.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.687 ' O ' ' HB3' ' A' ' 137' ' ' TYR . 3.8 p90 -106.37 175.93 1.88 Allowed Pre-proline 0 CA--C 1.554 1.127 0 CA-C-N 114.124 -1.398 . . . . 0.53000000000000003 109.302 -174.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.617 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 25.0 Cg_exo -27.35 -67.27 0.05 OUTLIER 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 125.13 3.887 . . . . 1.28 117.308 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.656 ' HB3' ' CZ ' ' A' ' 134' ' ' PHE . 5.8 tp10 -68.63 -26.34 65.3 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.613 0.597 . . . . 3.5 112.613 -173.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.687 ' HB3' ' O ' ' A' ' 134' ' ' PHE . 0.5 OUTLIER -39.77 -55.23 3.72 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 115.331 1.604 . . . . 6.1200000000000001 115.331 -171.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.457 ' HD2' ' O ' ' A' ' 135' ' ' PRO . 44.3 Cg_exo -35.72 106.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.366 1.495 0 C-N-CA 123.432 2.755 . . . . 1.77 114.408 -171.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.542 ' HB2' ' O ' ' A' ' 143' ' ' TYR . 72.9 Cg_endo -88.01 -147.54 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.274 2.65 . . . . 1.25 113.104 -174.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.1 m -143.26 -171.98 3.6 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.785 -0.82 . . . . 1.6000000000000001 108.785 -174.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.2 m -74.98 -38.45 61.66 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.0 -0.68 . . . . 1.97 111.247 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -77.39 -56.63 4.38 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.563 -0.532 . . . . 2.1800000000000002 109.563 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.58 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 87.9 m-85 -79.41 109.49 13.82 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 115.715 -0.675 . . . . 1.23 110.16 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.681 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 1.9 tp -104.42 117.89 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 CA-C-N 115.199 -0.91 . . . . 0.81999999999999995 109.495 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.644 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 0.1 OUTLIER -46.64 116.35 1.29 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.237 -0.892 . . . . 4.4199999999999999 110.775 175.204 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -55.22 108.22 0.94 Allowed Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 114.971 -1.013 . . . . 0.79000000000000004 111.793 176.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 1.116 ' HB3' ' HB3' ' A' ' 174' ' ' GLU . 0.2 OUTLIER -83.43 79.95 9.25 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.496 0.665 . . . . 4.4400000000000004 109.878 177.174 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.682 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 84.8 m-20 -103.2 102.32 12.3 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.262 -1.336 . . . . 1.6200000000000001 108.427 175.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -81.2 143.09 51.88 Favored Pre-proline 0 C--N 1.32 -0.685 0 C-N-CA 120.448 -0.501 . . . . 2.3199999999999998 111.001 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.657 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 8.6 Cg_exo -10.07 59.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.411 1 C-N-CA 127.18 5.253 . . . . 0.53000000000000003 116.355 -163.327 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . 0.759 ' HA ' ' CE1' ' A' ' 170' ' ' PHE . 7.8 p -85.58 -179.11 6.83 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.815 -1.084 . . . . 1.5800000000000001 110.513 176.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.706 ' HA3' HG11 ' A' ' 14' ' ' VAL . . . -169.63 -168.09 31.09 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.393 -0.908 . . . . 0.42999999999999999 111.677 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.562 ' CE1' HD11 ' A' ' 167' ' ' LEU . 60.8 t80 -160.18 80.8 0.69 Allowed 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.915 -1.143 . . . . 0.59999999999999998 107.915 -165.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.799 HG12 ' HB ' ' A' ' 126' ' ' ILE . 7.1 m -89.53 124.52 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 121.829 0.823 . . . . 0.31 110.468 -173.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 56.6 m -106.08 113.31 26.78 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.523 -0.762 . . . . 1.55 109.165 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.737 ' HB3' ' HB3' ' A' ' 166' ' ' LYS . 15.5 t -106.07 121.72 44.69 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 116.203 -0.453 . . . . 1.0600000000000001 111.535 -169.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.541 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 69.0 Cg_exo -51.7 114.99 1.83 Allowed 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.726 2.284 . . . . 0.56000000000000005 111.26 169.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.668 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 0.2 OUTLIER -76.32 -167.97 0.88 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.266 0.555 . . . . 1.1599999999999999 112.172 -177.03 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -67.51 -38.08 83.76 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.484 -0.932 . . . . 2.6299999999999999 108.484 169.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.592 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 10.8 mm-40 -97.6 29.06 3.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.099 -1.409 . . . . 2.0499999999999998 108.89 175.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.434 ' CG ' ' HD3' ' A' ' 162' ' ' PRO . 1.2 p-10 -23.84 -58.05 0.13 Allowed Pre-proline 0 N--CA 1.473 0.724 0 N-CA-C 116.515 2.043 . . . . 1.9299999999999999 116.515 -169.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.434 ' HD3' ' CG ' ' A' ' 161' ' ' ASN . 63.1 Cg_endo -72.7 -19.51 24.09 Favored 'Trans proline' 0 C--N 1.35 0.621 0 CA-C-N 121.448 1.553 . . . . 0.72999999999999998 113.451 -175.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -105.73 -25.27 12.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.743 0.306 . . . . 0.68000000000000005 111.415 -177.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.668 ' O ' ' HB2' ' A' ' 158' ' ' MET . 52.9 m-85 -141.05 131.3 24.96 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.858 -0.793 . . . . 0.93000000000000005 108.858 177.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.477 ' OG ' HD11 ' A' ' 61' ' ' LEU . 3.6 p -126.99 148.75 50.09 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.046 0.451 . . . . 1.4099999999999999 111.468 -177.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.785 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.8 tppp? -91.67 104.43 16.9 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.824 0.821 . . . . 0.73999999999999999 111.242 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.562 HD11 ' CE1' ' A' ' 153' ' ' PHE . 0.6 OUTLIER -89.4 106.41 18.43 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.481 -1.236 . . . . 0.27000000000000002 109.762 176.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.724 HG13 HG23 ' A' ' 154' ' ' VAL . 0.1 OUTLIER -131.05 129.12 63.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.644 0.735 . . . . 0.28000000000000003 111.911 176.394 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.606 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 18.2 ttt -137.8 131.7 31.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.228 -0.896 . . . . 1.24 110.17 -172.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.96 ' HD1' HG23 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -111.2 145.15 39.2 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.088 -0.645 . . . . 3.3700000000000001 110.002 174.202 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.65 116.5 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-O 121.415 0.626 . . . . 1.3999999999999999 110.895 176.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.528 ' HB2' ' CZ ' ' A' ' 170' ' ' PHE . 0.0 OUTLIER -94.98 77.28 3.56 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 106.673 -1.603 . . . . 2.1699999999999999 106.673 168.109 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.422 HG21 ' CE ' ' A' ' 188' ' ' MET . 0.6 OUTLIER -74.65 128.31 35.25 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.317 -0.856 . . . . 1.6499999999999999 110.89 -176.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 1.116 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 38.4 tp10 -83.1 -13.74 55.07 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.261 0.553 . . . . 2.4500000000000002 110.524 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 52.3 mtt 65.4 45.11 2.93 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.317 -0.856 . . . . 3.7400000000000002 109.148 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.069 ' HD2' ' H ' ' A' ' 147' ' ' TYR . 0.0 OUTLIER -28.81 -54.75 0.12 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 113.462 -1.699 . . . . 5.7800000000000002 114.095 179.478 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.446 ' H ' ' HG2' ' A' ' 176' ' ' ARG . . . 170.39 170.61 34.91 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.507 -0.854 . . . . 2.2599999999999998 111.849 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 106' ' ' ILE . 48.8 mmtm 68.76 48.72 0.75 Allowed 'General case' 0 C--N 1.33 -0.255 0 O-C-N 124.133 0.549 . . . . 6.2300000000000004 110.727 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.711 HD13 HD11 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -173.78 146.15 1.23 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.14 -0.482 . . . . 1.6399999999999999 110.936 173.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.54 ' HB3' ' HD2' ' A' ' 181' ' ' PRO . 31.5 m -112.05 166.28 11.23 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.451 -0.795 . . . . 2.04 109.45 -176.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' A' ' 180' ' ' SER . 63.1 Cg_exo -39.33 -57.57 1.0 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.354 2.703 . . . . 1.74 114.266 -175.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.492 ' O ' ' HG3' ' A' ' 186' ' ' LYS . 19.1 m -74.07 -10.4 59.59 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.868 0.366 . . . . 2.1400000000000001 111.669 -176.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.569 HG21 ' HB2' ' A' ' 105' ' ' SER . 17.6 mm -86.48 -42.08 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 CA-C-O 122.356 1.074 . . . . 1.1200000000000001 108.418 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.97 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.0 OUTLIER -57.98 -37.7 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 CA-C-N 113.302 -1.772 . . . . 1.1299999999999999 109.674 172.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -61.86 -22.39 65.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.633 -1.167 . . . . 2.8900000000000001 110.056 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.506 ' HE3' ' HA ' ' A' ' 183' ' ' ILE . 48.1 mttt -91.51 -49.0 6.55 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.179 -0.674 . . . . 1.28 109.179 173.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.97 HG22 ' HA ' ' A' ' 184' ' ' ILE . 11.1 t -62.93 -33.54 75.56 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.378 0.881 . . . . 0.62 113.378 -165.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . 0.643 ' HE3' HG23 ' A' ' 187' ' ' THR . 0.0 OUTLIER -71.72 -65.9 0.79 Allowed Pre-proline 0 N--CA 1.469 0.504 0 CA-C-N 118.888 0.767 . . . . 1.0600000000000001 111.674 179.613 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.711 ' O ' HG13 ' A' ' 193' ' ' VAL . 27.5 Cg_endo -62.39 -41.79 31.52 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.486 1.457 . . . . 0.91000000000000003 111.471 -176.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.71 ' O ' ' HB3' ' A' ' 194' ' ' ASN . 68.3 m -68.43 -22.82 64.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.364 -0.38 . . . . 1.5 111.377 -174.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 187' ' ' THR . 53.9 m-20 -90.21 -37.7 13.96 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.806 -0.358 . . . . 1.8799999999999999 111.474 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.834 HD11 ' HB3' ' A' ' 48' ' ' TYR . 19.2 mt -60.8 -49.72 76.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.824 0.345 . . . . 1.0900000000000001 111.039 176.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.711 HG13 ' O ' ' A' ' 189' ' ' PRO . 3.0 m -65.4 -31.6 54.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.63 0.729 . . . . 0.68000000000000005 110.029 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.737 ' HA ' ' HG ' ' A' ' 197' ' ' LEU . 0.0 OUTLIER -73.19 -43.62 61.08 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.674 -1.148 . . . . 2.0699999999999998 111.397 -177.747 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -62.36 -26.17 68.31 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.415 -0.957 . . . . 2.0 108.415 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.623 HG21 HG21 ' A' ' 33' ' ' ILE . 20.7 mt -78.37 -44.58 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-N 115.177 -0.919 . . . . 0.31 113.25 175.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.792 HD12 ' N ' ' A' ' 198' ' ' ASN . 3.0 pp -74.1 -31.83 62.97 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 119.336 -0.946 . . . . 1.03 110.332 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 1.002 ' HB3' ' HZ3' ' A' ' 74' ' ' TRP . 9.9 m120 -61.82 -24.58 66.97 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.118 0.485 . . . . 1.8999999999999999 110.017 165.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.832 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -80.77 -29.98 36.11 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 108.713 -0.847 . . . . 0.28999999999999998 108.713 177.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.636 ' HD2' HG12 ' A' ' 54' ' ' ILE . 2.9 mptm? -67.02 -46.17 75.3 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.202 -0.908 . . . . 0.96999999999999997 108.685 175.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.55 -24.8 25.34 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.832 -1.076 . . . . 1.9399999999999999 110.797 -170.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 205' ' ' ALA . . . -78.2 -28.17 56.53 Favored Glycine 0 N--CA 1.46 0.245 0 C-N-CA 120.492 -0.861 . . . . 0.46999999999999997 111.477 174.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.832 ' HB ' ' O ' ' A' ' 199' ' ' ALA . 0.9 OUTLIER -76.95 -35.22 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 123.326 0.65 . . . . 0.60999999999999999 110.214 173.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 40.2 mttm -78.17 -21.66 49.88 Favored 'General case' 0 C--O 1.216 -0.698 0 N-CA-C 108.91 -0.774 . . . . 3.3700000000000001 108.91 175.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 202' ' ' GLY . . . -64.46 -20.05 65.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.549 -0.751 . . . . 1.02 109.1 170.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -93.34 -51.19 5.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.254 -0.885 . . . . 3.6299999999999999 111.303 170.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -76.79 -41.31 45.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.416 0.627 . . . . 2.5899999999999999 111.63 -170.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 32.8 m -97.27 142.95 25.31 Favored Pre-proline 0 C--N 1.313 -0.986 0 CA-C-N 115.065 -0.97 . . . . 1.8400000000000001 110.231 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.3 39.39 0.47 Allowed 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.677 2.252 . . . . 2.3500000000000001 113.327 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 11.7 p -90.03 -3.49 57.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.266 0.555 . . . . 2.3100000000000001 110.601 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 10.6 tpp180 -68.19 -11.98 60.17 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.651 -0.704 . . . . 5.4500000000000002 110.376 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 212' ' ' ARG . 49.1 mtm180 -67.89 -22.87 65.07 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.117 0.484 . . . . 6.8600000000000003 110.611 177.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -100.35 63.97 0.6 Allowed Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 110.314 -1.114 . . . . 3.3700000000000001 110.314 171.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -70.38 98.42 1.41 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.128 0.489 . . . . 5.21 111.252 -172.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -171.22 -55.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.341 -0.845 . . . . 6.46 108.885 174.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 71.46 -62.2 0.46 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.735 0.814 . . . . 6.0899999999999999 113.155 172.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -77.46 85.0 3.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.328 0.585 . . . . 5.1200000000000001 109.879 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 12.1 m -55.49 -37.7 68.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.518 -0.765 . . . . 6.7599999999999998 111.12 -176.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 71.4 t60 48.55 64.85 1.52 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.601 0.715 . . . . 8.8200000000000003 110.381 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 14.0 m . . . . . 0 C--N 1.316 -0.864 0 CA-C-N 115.624 -0.716 . . . . 8.4800000000000004 109.617 179.419 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.9 ttt . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 109.293 -0.632 . . . . 3.8599999999999999 109.293 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -65.06 -50.67 65.29 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 116.108 -0.497 . . . . 2.25 110.94 -169.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.56 ' HB2' HG21 ' A' ' 87' ' ' ILE . 65.2 m-85 -59.38 -35.0 73.1 Favored 'General case' 0 CA--C 1.502 -0.882 0 O-C-N 123.945 0.778 . . . . 0.42999999999999999 110.497 -169.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.755 ' O ' ' HB3' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -74.82 -41.25 60.27 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-N 115.273 -0.876 . . . . 1.51 108.736 -177.4 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.413 ' HA ' ' OE1' ' A' ' 8' ' ' GLN . . . -55.98 -45.99 78.8 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.829 -0.623 . . . . 0.54000000000000004 112.31 -178.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.64 ' O ' ' HB ' ' A' ' 10' ' ' THR . 0.2 OUTLIER -79.44 -36.37 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 N-CA-C 108.906 -0.776 . . . . 1.0700000000000001 108.906 -172.453 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.794 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -71.79 -47.74 51.33 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.517 -1.22 . . . . 0.34000000000000002 111.474 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.755 ' HB3' ' O ' ' A' ' 4' ' ' LYS . 3.7 pt20 -53.3 -34.3 56.79 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.344 -1.298 . . . . 1.5900000000000001 109.847 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.645 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 48.5 mt-30 -91.02 -31.63 16.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.879 -1.055 . . . . 2.4700000000000002 109.985 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.64 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -66.42 -35.0 79.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.633 -0.712 . . . . 0.47999999999999998 110.746 178.271 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.573 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -47.44 -58.51 4.1 Favored 'General case' 0 C--O 1.226 -0.154 0 N-CA-C 112.02 0.378 . . . . 0.31 112.02 175.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.463 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 20.8 pt20 -74.96 -6.72 50.81 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.493 -0.322 . . . . 1.6399999999999999 111.344 -178.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.645 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 16.6 mm-40 -81.43 -48.35 12.01 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 121.163 0.506 . . . . 2.54 109.707 175.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.733 HG21 ' N ' ' A' ' 152' ' ' GLY . 10.9 p -70.74 -37.77 70.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.798 0.809 . . . . 0.53000000000000003 109.735 176.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.463 ' HB3' ' HA ' ' A' ' 12' ' ' GLN . 0.8 OUTLIER -67.24 -25.62 66.18 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 122.236 1.017 . . . . 0.59999999999999998 108.338 173.068 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.5 ' HA2' ' CD ' ' A' ' 19' ' ' ARG . . . -67.86 -15.01 66.34 Favored Glycine 0 CA--C 1.5 -0.869 0 CA-C-N 113.679 -1.6 . . . . 0.56999999999999995 110.539 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.8 m-30 -92.42 -19.48 22.01 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.019 -0.591 . . . . 3.27 109.489 177.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -89.88 -27.55 19.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.152 -0.476 . . . . 2.0299999999999998 110.531 178.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.5 ' CD ' ' HA2' ' A' ' 16' ' ' GLY . 5.7 ptm180 -90.8 -20.25 22.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.254 0.55 . . . . 2.7200000000000002 110.178 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -121.44 117.33 26.62 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.927 -0.768 . . . . 2.1600000000000001 108.927 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.6 p -126.47 103.76 7.78 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.388 0.614 . . . . 1.8200000000000001 111.407 -174.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.0 p -170.47 155.49 5.09 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.053 -0.976 . . . . 2.1899999999999999 109.993 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.37 4.1 86.34 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.85 -0.69 . . . . 1.1000000000000001 113.057 174.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.481 ' HA ' ' HB3' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -120.3 -158.07 0.73 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.815 0.341 . . . . 1.6699999999999999 110.933 -178.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -172.3 125.36 0.52 Allowed 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 115.883 -0.599 . . . . 2.9500000000000002 109.821 -173.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.685 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 2.5 p -69.28 112.06 3.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-O 122.29 1.043 . . . . 1.5600000000000001 109.836 175.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.5 p -91.01 -23.5 5.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 113.812 -1.54 . . . . 1.22 109.138 -176.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.439 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -156.64 124.15 5.41 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 120.223 -0.591 . . . . 2.4100000000000001 111.768 -173.621 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.537 ' HB ' ' HA ' ' A' ' 34' ' ' THR . 0.4 OUTLIER -150.51 150.99 32.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.074 0.464 . . . . 1.3799999999999999 111.062 -179.597 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.7 t -120.21 -141.09 0.34 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.503 -0.771 . . . . 2.3700000000000001 109.322 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -101.55 17.7 22.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.984 0.421 . . . . 4.5499999999999998 110.787 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.697 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 48.3 mmtt -154.46 -29.23 0.12 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.904 -0.589 . . . . 1.4199999999999999 111.671 177.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.556 ' HA ' ' O ' ' A' ' 51' ' ' GLU . 17.8 pt -116.01 163.12 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 CA-C-O 120.767 0.317 . . . . 0.76000000000000001 111.493 -172.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.537 ' HA ' ' HB ' ' A' ' 29' ' ' THR . 8.8 m -156.42 114.09 3.24 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.108 -0.951 . . . . 0.57999999999999996 110.515 -172.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 49' ' ' ARG . 42.5 t -105.4 110.85 32.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.518 -0.31 . . . . 0.85999999999999999 110.554 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.685 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 4.1 m -109.6 123.5 49.55 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.636 0.732 . . . . 1.1000000000000001 111.092 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 28.2 p -108.2 131.11 55.0 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.32 -1.309 . . . . 1.27 112.781 -171.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.481 ' HB3' ' HA ' ' A' ' 24' ' ' TRP . 44.3 pttt -138.17 134.75 34.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.128 -0.942 . . . . 1.9099999999999999 110.176 171.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 46' ' ' ASN . . . -58.99 128.13 35.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.987 -0.551 . . . . 1.6799999999999999 112.081 -174.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.4 m -84.02 155.56 22.68 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.007 -0.542 . . . . 2.0899999999999999 109.877 176.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -89.64 13.31 14.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.304 -0.407 . . . . 6.6100000000000003 111.483 -174.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 5.1 mtpm? -54.56 -39.74 68.05 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.363 -0.38 . . . . 6.46 110.224 175.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.519 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 83.0 t80 157.92 -73.11 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 O-C-N 124.397 1.061 . . . . 5.6500000000000004 109.468 -173.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 33.8 t60 -145.25 84.43 1.7 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.374 -0.83 . . . . 5.5599999999999996 109.122 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.2 148.17 12.34 Favored Glycine 0 N--CA 1.435 -1.395 0 N-CA-C 109.148 -1.581 . . . . 1.5600000000000001 109.148 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 40.7 m-80 -114.31 144.31 43.45 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 117.362 0.581 . . . . 2.0499999999999998 110.611 -175.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.612 HD12 ' NE2' ' A' ' 172' ' ' GLN . 4.0 tt -90.19 134.26 34.39 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.325 -0.991 . . . . 0.87 108.325 175.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.61 ' N ' HD23 ' A' ' 47' ' ' LEU . 69.1 m-85 -121.58 120.38 34.64 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.836 -0.431 . . . . 0.98999999999999999 109.836 -177.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.539 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.3 OUTLIER -101.51 117.66 35.38 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.162 -0.681 . . . . 2.9199999999999999 109.162 174.538 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.596 HG22 HD12 ' A' ' 196' ' ' ILE . 14.7 p -107.17 131.89 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 108.798 -0.816 . . . . 1.3300000000000001 108.798 177.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.556 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 34.0 tt0 -136.06 117.92 15.18 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.644 -0.707 . . . . 1.0700000000000001 110.783 -169.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.697 ' HA2' ' O ' ' A' ' 32' ' ' LYS . . . -142.24 144.38 14.07 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.872 -0.68 . . . . 0.28999999999999998 111.675 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 92.4 mt -84.85 122.87 38.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 119.635 -0.826 . . . . 0.57999999999999996 110.479 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.429 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 42.0 mt -105.11 110.69 64.79 Favored Pre-proline 0 N--CA 1.443 -0.816 0 N-CA-C 108.69 -0.856 . . . . 0.34999999999999998 108.69 174.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 164' ' ' TYR . 39.5 Cg_exo -63.11 54.89 0.15 Allowed 'Trans proline' 0 N--CA 1.476 0.491 0 C-N-CA 124.442 3.428 . . . . 0.62 113.915 -177.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.591 ' OE1' ' HD2' ' A' ' 207' ' ' ARG . 10.9 tp10 -151.16 168.38 24.85 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.657 -1.238 . . . . 1.6799999999999999 107.657 174.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.445 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 73.3 p -69.74 144.48 93.68 Favored Pre-proline 0 N--CA 1.43 -1.433 0 CA-C-O 121.88 0.848 . . . . 1.1799999999999999 111.117 -176.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.495 ' HA ' HD12 ' A' ' 61' ' ' LEU . 23.9 Cg_exo -61.31 -15.79 42.7 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.432 2.755 . . . . 0.52000000000000002 110.125 175.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.4 -47.84 58.97 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.559 -1.201 . . . . 0.64000000000000001 110.862 173.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.438 ' HG2' HG13 ' A' ' 203' ' ' ILE . 2.1 tpmt? -67.19 -30.08 69.93 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.049 -1.093 . . . . 3.2999999999999998 108.049 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.842 HD23 HD13 ' A' ' 203' ' ' ILE . 55.8 mt -62.36 -54.92 33.4 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.867 -1.061 . . . . 0.40999999999999998 110.205 174.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.6 p -62.96 -9.18 8.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.071 0.462 . . . . 1.29 110.717 176.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -91.35 -33.36 15.32 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.566 0.58 . . . . 1.3200000000000001 112.566 174.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.666 ' CE2' ' HA ' ' A' ' 199' ' ' ALA . 2.9 p90 -78.31 -45.05 23.65 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 120.399 -0.52 . . . . 0.60999999999999999 110.69 -169.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -83.51 -7.3 59.56 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 121.056 -0.258 . . . . 1.5 111.041 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -9.95 -72.69 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 O-C-N 125.571 1.794 . . . . 1.52 114.679 -159.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -158.52 -62.4 0.08 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.713 1.005 . . . . 3.6000000000000001 113.713 -172.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.678 ' OG1' ' HB2' ' A' ' 81' ' ' TYR . 11.6 t -178.35 27.96 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.352 0.596 . . . . 1.48 109.543 -162.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -127.95 -16.91 2.12 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 119.249 -1.453 . . . . 1.46 113.138 -171.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.538 ' O ' HG22 ' A' ' 73' ' ' THR . 1.7 p30 -159.34 -21.6 0.07 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 111.896 0.332 . . . . 2.1899999999999999 111.896 -177.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.704 ' HA ' ' NE1' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -67.47 -16.44 64.21 Favored 'General case' 0 C--O 1.217 -0.62 0 O-C-N 122.069 -0.394 . . . . 3.3799999999999999 110.982 -174.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.665 HD13 ' H ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -90.48 -20.25 6.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.234 0.54 . . . . 0.70999999999999996 109.937 173.521 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.538 HG22 ' O ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -82.2 -24.47 34.91 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.603 -0.726 . . . . 0.96999999999999997 110.363 -170.667 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.704 ' NE1' ' HA ' ' A' ' 71' ' ' ARG . 24.9 p-90 -108.47 -4.35 17.37 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.276 -0.569 . . . . 0.75 111.205 177.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.658 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 2.9 t70 -74.92 177.68 6.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.815 0.817 . . . . 2.1899999999999999 112.659 -168.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.422 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -123.07 -22.81 5.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.473 -1.24 . . . . 3.1899999999999999 111.007 -179.217 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.1 t -121.69 9.36 10.14 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.47 -0.567 . . . . 1.5800000000000001 109.47 -176.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.607 HD13 HG22 ' A' ' 72' ' ' ILE . 36.4 mt -109.1 169.5 8.64 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.649 -0.705 . . . . 0.70999999999999996 110.476 177.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.611 ' HG2' ' HG2' ' A' ' 99' ' ' GLN . 10.5 mm100 -147.41 -58.78 0.26 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.75 -0.659 . . . . 1.73 111.674 -173.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.636 ' O ' ' HA ' ' A' ' 96' ' ' THR . 25.6 t -138.15 117.9 15.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.78000000000000003 111.254 -166.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.678 ' HB2' ' OG1' ' A' ' 68' ' ' THR . 45.3 p90 -89.99 151.32 21.74 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 116.194 -0.457 . . . . 5.4000000000000004 110.852 174.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.446 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 4.2 m120 -158.95 108.94 1.98 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.603 -0.726 . . . . 1.6899999999999999 109.52 173.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.805 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 13.5 ttm -71.1 103.99 2.9 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.604 -0.887 . . . . 2.0499999999999998 108.604 177.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -84.78 -71.96 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 120.47 -0.492 . . . . 0.64000000000000001 112.029 -170.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.418 ' HB3' HD12 ' A' ' 93' ' ' ILE . 21.1 t60 -136.37 107.61 6.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.205 -0.452 . . . . 1.96 109.833 -175.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.805 ' HD3' ' SD ' ' A' ' 83' ' ' MET . 28.3 mtm180 -93.72 112.41 24.28 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.588 -0.523 . . . . 2.4399999999999999 109.588 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.632 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -75.69 -37.08 35.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.917 -0.583 . . . . 0.46999999999999997 109.614 -178.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -157.69 -179.32 8.05 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.236 -0.893 . . . . 1.8600000000000001 108.856 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.8 m -78.28 4.41 12.89 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.638 0.256 . . . . 1.4399999999999999 110.907 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -138.35 6.17 2.54 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.355 -0.609 . . . . 1.8700000000000001 109.355 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.632 ' O ' HG12 ' A' ' 87' ' ' ILE . 1.1 m -141.99 109.54 5.68 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.532 -0.914 . . . . 0.46000000000000002 108.532 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.547 ' O ' HD12 ' A' ' 114' ' ' LEU . 33.9 m-85 -128.95 174.98 9.03 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.475 0.655 . . . . 0.42999999999999999 110.764 -173.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.718 ' O ' HG23 ' A' ' 84' ' ' VAL . 36.2 mt -133.38 123.25 46.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 106.616 -1.624 . . . . 0.40999999999999998 106.616 166.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 78.6 m -110.47 124.45 51.8 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.732 -0.387 . . . . 2.0099999999999998 110.665 -173.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.51 ' HA ' ' O ' ' A' ' 111' ' ' PHE . 11.5 t-160 -89.39 118.75 29.28 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 108.507 -0.923 . . . . 1.23 108.507 168.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.636 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 89.8 m -136.98 123.45 20.83 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.727 -0.67 . . . . 0.5 111.228 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 46.5 mm -78.43 132.61 32.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 O-C-N 121.501 -0.749 . . . . 1.03 109.593 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.5 ' HB ' ' HB2' ' A' ' 109' ' ' ARG . 2.3 m -110.36 146.34 35.95 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.783 -0.644 . . . . 1.3799999999999999 110.745 -174.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.611 ' HG2' ' HG2' ' A' ' 79' ' ' GLN . 7.5 mm-40 -88.6 178.63 6.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.908 -0.587 . . . . 1.8200000000000001 110.443 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.8 m -118.29 95.6 4.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.734 0.302 . . . . 3.9100000000000001 111.077 -175.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -92.01 96.12 10.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.767 0.318 . . . . 5.1600000000000001 110.594 -177.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.602 ' O ' HG22 ' A' ' 103' ' ' VAL . . . 170.84 48.28 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.036 -0.984 . . . . 1.98 109.943 176.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 102' ' ' ALA . 2.1 m 64.02 -20.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 125.187 1.395 . . . . 3.1699999999999999 113.701 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.48 0.91 2.88 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.146 -1.026 . . . . 1.96 113.551 176.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.7 p -65.57 -28.9 69.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.271 0.557 . . . . 1.8799999999999999 111.132 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.553 ' HA ' HD11 ' A' ' 179' ' ' LEU . 65.4 mt -94.02 145.71 7.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.421 -0.809 . . . . 1.1200000000000001 110.72 -175.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.3 m -84.04 153.24 63.2 Favored Pre-proline 0 N--CA 1.449 -0.496 0 CA-C-N 116.111 -0.495 . . . . 1.3500000000000001 110.06 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -60.48 137.1 71.89 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.147 1.898 . . . . 1.0700000000000001 110.01 174.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.5 ' HB2' ' HB ' ' A' ' 98' ' ' THR . 54.5 mtt180 -111.92 159.69 18.14 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.604 -0.839 . . . . 3.4500000000000002 111.213 -172.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.681 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 12.9 t70 -107.35 143.14 36.07 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.72 -1.215 . . . . 1.3700000000000001 107.72 176.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.585 ' HB3' ' HB ' ' A' ' 96' ' ' THR . 50.6 t80 -122.36 115.07 21.66 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.59 -0.522 . . . . 2.4100000000000001 109.59 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.668 HG21 ' CE1' ' A' ' 134' ' ' PHE . 12.8 mm -132.7 85.85 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.016 -0.993 . . . . 0.42999999999999999 108.517 175.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.582 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 1.0 OUTLIER -116.14 131.52 56.92 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.807 -0.633 . . . . 1.8600000000000001 110.944 -177.453 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.622 ' O ' ' HA ' ' A' ' 129' ' ' SER . 6.6 tp -80.77 121.87 26.46 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.241 -0.89 . . . . 0.28000000000000003 109.068 172.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.453 HG23 ' HB ' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -123.76 125.71 71.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-N 115.398 -0.819 . . . . 0.26000000000000001 111.747 -165.235 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.794 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 11.6 t80 -107.5 118.73 37.49 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.059 -0.973 . . . . 2.5699999999999998 110.634 177.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.547 HG13 HG22 ' A' ' 127' ' ' ILE . 4.7 mp -94.44 100.71 11.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.03 -0.532 . . . . 0.89000000000000001 109.839 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -114.02 142.69 45.86 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.717 -0.475 . . . . 1.2 109.717 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.457 ' NH1' ' HA ' ' A' ' 121' ' ' GLU . 3.2 tmt_? -127.22 95.36 4.26 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 108.503 -0.925 . . . . 2.7999999999999998 108.503 -177.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -64.67 118.49 8.97 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 107.901 -1.148 . . . . 0.82999999999999996 107.901 174.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.457 ' HA ' ' NH1' ' A' ' 119' ' ' ARG . 8.0 mm-40 -38.24 90.47 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.923 1.389 . . . . 2.2799999999999998 113.148 -175.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 62.97 36.06 92.93 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.178 -0.919 . . . . 0.76000000000000001 112.419 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.533 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 2.2 t-20 -132.85 -45.41 0.87 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.526 -0.175 . . . . 1.6499999999999999 110.526 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.401 ' O ' ' HA ' ' A' ' 119' ' ' ARG . 1.6 mpt? -157.81 131.03 7.62 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 120.733 0.302 . . . . 1.1200000000000001 111.812 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -106.36 79.39 1.37 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.169 -1.048 . . . . 1.6200000000000001 108.169 170.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.507 ' CG1' HG12 ' A' ' 154' ' ' VAL . 0.4 OUTLIER -99.82 140.9 17.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.586 -0.734 . . . . 0.29999999999999999 112.801 -171.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.738 ' O ' HG13 ' A' ' 127' ' ' ILE . 4.3 pt -110.16 110.62 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-O 121.904 0.859 . . . . 0.58999999999999997 108.766 162.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.573 ' HB3' ' HA ' ' A' ' 11' ' ' ALA . 53.2 p -93.92 113.5 25.52 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 121.853 -0.529 . . . . 1.1799999999999999 110.208 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.622 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 7.0 m -110.91 150.58 29.01 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.411 -0.813 . . . . 1.24 111.203 -170.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.424 ' HE2' ' HG3' ' A' ' 150' ' ' PRO . 3.5 mtpm? -136.62 117.58 14.24 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 107.606 -1.257 . . . . 2.2599999999999998 107.606 175.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.504 ' HB2' ' H ' ' A' ' 148' ' ' ASN . 33.3 t -63.51 98.37 0.17 Allowed 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.075 -1.454 . . . . 1.3899999999999999 107.075 175.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.445 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -108.16 141.58 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.035 0 CA-C-N 114.57 -1.196 . . . . 1.05 108.988 -163.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -100.47 71.02 1.51 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 122.291 1.043 . . . . 2.1699999999999999 108.682 -170.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.775 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -98.2 159.52 30.5 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-N 113.668 -1.606 . . . . 0.53000000000000003 110.629 -171.589 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.96 -12.96 16.02 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.941 2.427 . . . . 1.28 114.785 -171.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.775 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 5.6 tp10 -72.41 -16.93 61.84 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 109.388 -0.597 . . . . 3.5 109.388 -172.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.464 ' HB2' HG11 ' A' ' 84' ' ' VAL . 15.5 t80 -163.52 118.43 1.12 Allowed Pre-proline 0 N--CA 1.448 -0.558 0 N-CA-C 113.066 0.765 . . . . 6.1200000000000001 113.066 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 95.8 Cg_endo -92.73 145.63 2.55 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.306 2.671 . . . . 1.77 110.834 166.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 138' ' ' PRO . 7.3 Cg_exo -72.29 -155.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.538 2.159 . . . . 1.25 112.336 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.2 m -147.15 155.92 42.55 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.823 -0.806 . . . . 1.6000000000000001 108.823 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.9 p -73.11 -0.25 13.55 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.197 0.443 . . . . 1.97 112.197 -173.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -105.16 -16.12 14.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.056 0.455 . . . . 2.1800000000000002 110.006 175.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.411 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 87.9 m-85 -132.36 108.91 9.49 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.515 -0.766 . . . . 1.23 109.904 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.549 HG12 ' HB3' ' A' ' 176' ' ' ARG . 2.7 tp -90.75 112.88 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 C-N-CA 120.366 -0.533 . . . . 0.81999999999999995 110.523 -176.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.681 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 64.9 ttp85 -49.41 102.22 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.408 -0.815 . . . . 4.4199999999999999 109.741 171.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -60.08 117.43 11.34 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 110.617 -0.993 . . . . 0.79000000000000004 110.617 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.465 ' HB3' ' CB ' ' A' ' 174' ' ' GLU . 65.0 t80 -83.45 85.59 7.22 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.791 0.805 . . . . 4.4400000000000004 111.17 -174.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.642 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 78.7 m-20 -77.83 98.81 5.7 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.426 -1.261 . . . . 1.6200000000000001 109.539 171.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.448 ' O ' ' HB3' ' A' ' 172' ' ' GLN . 24.6 t-80 -71.71 129.83 87.9 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 108.062 -1.088 . . . . 2.3199999999999998 108.062 176.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.52 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 46.1 Cg_exo -13.54 66.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.122 1 C-N-CA 126.973 5.115 . . . . 0.53000000000000003 115.905 -163.396 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . 0.642 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 24.2 p -112.31 156.4 22.5 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.845 -1.07 . . . . 1.5800000000000001 108.553 174.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.733 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -145.23 -147.35 4.61 Favored Glycine 0 N--CA 1.433 -1.528 0 C-N-CA 119.256 -1.449 . . . . 0.42999999999999999 113.624 -169.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.533 ' CZ ' HD21 ' A' ' 167' ' ' LEU . 55.1 t80 -162.06 92.06 0.82 Allowed 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.472 -0.936 . . . . 0.59999999999999998 108.472 -164.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.577 ' CG2' HG13 ' A' ' 168' ' ' VAL . 2.4 m -102.06 132.3 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-O 121.696 0.76 . . . . 0.31 110.776 -175.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 37.0 m -112.52 107.68 16.51 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.371 -0.831 . . . . 1.55 109.272 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.463 ' O ' ' HB3' ' A' ' 166' ' ' LYS . 9.8 m -104.75 114.13 64.22 Favored Pre-proline 0 C--N 1.315 -0.916 0 C-N-CA 120.771 -0.371 . . . . 1.0600000000000001 111.267 -169.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.533 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 53.1 Cg_exo -49.8 120.88 6.49 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.511 2.14 . . . . 0.56000000000000005 111.397 174.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.588 ' SD ' ' HB2' ' A' ' 166' ' ' LYS . 87.3 mmm -76.17 -165.62 0.51 Allowed 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.03 0.443 . . . . 1.1599999999999999 111.429 -176.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -66.09 -22.7 66.42 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.687 -0.688 . . . . 2.6299999999999999 109.708 177.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -109.16 19.58 19.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.414 -0.812 . . . . 2.0499999999999998 110.047 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.536 ' HB2' ' CD ' ' A' ' 162' ' ' PRO . 13.0 m120 27.2 -91.05 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.872 1.669 . . . . 1.9299999999999999 115.483 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.536 ' CD ' ' HB2' ' A' ' 161' ' ' ASN . 93.2 Cg_endo -74.76 -13.41 21.99 Favored 'Trans proline' 0 C--N 1.366 1.496 0 CA-C-N 121.709 1.646 . . . . 0.72999999999999998 112.866 -173.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -89.99 -34.68 15.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.042 -0.526 . . . . 0.68000000000000005 110.672 -177.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.444 ' O ' ' HB2' ' A' ' 158' ' ' MET . 78.2 m-85 -139.88 132.0 28.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.393 -0.367 . . . . 0.93000000000000005 110.24 176.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 34.9 t -123.59 145.01 49.23 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.595 0.712 . . . . 1.4099999999999999 111.171 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.588 ' HB2' ' SD ' ' A' ' 158' ' ' MET . 15.3 tppt? -93.87 100.94 13.02 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.268 -0.878 . . . . 0.73999999999999999 111.161 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.533 HD21 ' CZ ' ' A' ' 153' ' ' PHE . 0.9 OUTLIER -85.54 108.4 17.92 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.054 -0.975 . . . . 0.27000000000000002 109.335 178.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.577 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -129.31 114.55 32.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-O 122.115 0.96 . . . . 0.28000000000000003 111.319 177.349 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 18.7 ttt -115.63 141.51 47.97 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.539 -1.21 . . . . 1.24 110.693 -172.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.548 ' O ' ' HB2' ' A' ' 151' ' ' CYS . 73.7 m-85 -115.69 127.47 55.18 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.545 -0.752 . . . . 3.3700000000000001 110.972 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.451 HG13 ' OG1' ' A' ' 173' ' ' THR . 1.0 OUTLIER -112.48 113.64 44.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.598 -0.728 . . . . 1.3999999999999999 110.042 174.19 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.612 ' NE2' HD12 ' A' ' 47' ' ' LEU . 33.9 tt0 -116.18 41.3 2.64 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 106.001 -1.852 . . . . 2.1699999999999999 106.001 171.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.552 HG22 ' H ' ' A' ' 175' ' ' MET . 18.9 m -69.65 149.82 47.69 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 112.53 -2.123 . . . . 1.6499999999999999 110.46 -174.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.465 ' CB ' ' HB3' ' A' ' 147' ' ' TYR . 8.1 tt0 -82.58 -11.5 58.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.482 0.658 . . . . 2.4500000000000002 111.435 -175.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.552 ' H ' HG22 ' A' ' 173' ' ' THR . 42.4 mtm 68.69 35.2 3.16 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.897 -1.047 . . . . 3.7400000000000002 110.594 170.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.549 ' HB3' HG12 ' A' ' 144' ' ' ILE . 24.8 mmm-85 -70.43 170.39 12.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.616 -0.72 . . . . 5.7800000000000002 111.7 -176.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 124.28 -7.84 8.53 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.659 -0.976 . . . . 2.2599999999999998 110.659 -174.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? 60.79 49.64 6.0 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.459 0.703 . . . . 6.2300000000000004 110.827 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.553 HD11 ' HA ' ' A' ' 106' ' ' ILE . 0.3 OUTLIER -87.26 -169.88 2.81 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 121.306 0.574 . . . . 1.6399999999999999 109.668 178.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.499 ' O ' HD12 ' A' ' 184' ' ' ILE . 14.7 m -112.17 154.91 44.19 Favored Pre-proline 0 C--N 1.314 -0.936 0 N-CA-C 108.393 -0.966 . . . . 2.04 108.393 176.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -42.57 -44.59 8.44 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 122.742 2.295 . . . . 1.74 113.396 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.65 ' O ' ' HE2' ' A' ' 186' ' ' LYS . 22.3 t -71.33 -12.64 61.54 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.348 -0.387 . . . . 2.1400000000000001 111.969 -177.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.476 ' HB ' ' HB3' ' A' ' 179' ' ' LEU . 27.9 mm -90.93 -41.46 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-O 122.585 1.183 . . . . 1.1200000000000001 108.985 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.94 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.1 mp -64.88 -37.8 81.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 112.887 -1.96 . . . . 1.1299999999999999 111.473 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -64.16 -17.92 63.95 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.314 -0.624 . . . . 2.8900000000000001 109.314 175.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.65 ' HE2' ' O ' ' A' ' 182' ' ' SER . 49.5 mtmt -92.85 -43.59 8.91 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.75 -0.659 . . . . 1.28 110.299 173.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.94 HG22 ' HA ' ' A' ' 184' ' ' ILE . 15.1 t -61.1 -33.42 73.33 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.734 0.642 . . . . 0.62 112.734 -169.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . 0.631 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 15.6 mmt -78.43 -59.39 0.71 Allowed Pre-proline 0 C--N 1.332 -0.173 0 C-N-CA 119.646 -0.821 . . . . 1.0600000000000001 110.835 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.631 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 33.9 Cg_exo -62.93 -22.07 73.58 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 121.917 1.745 . . . . 0.91000000000000003 112.216 -176.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.783 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 67.2 m -81.08 -22.96 38.81 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.796 -0.362 . . . . 1.5 110.489 175.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.2 OUTLIER -91.43 -37.59 13.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.814 0.34 . . . . 1.8799999999999999 111.074 -176.635 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.534 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 2.2 mt -62.13 -56.92 13.98 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.558 0.694 . . . . 1.0900000000000001 111.161 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 189' ' ' PRO . 1.6 m -66.93 -32.13 56.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.707 -1.133 . . . . 0.68000000000000005 109.033 -175.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.783 ' HB2' ' O ' ' A' ' 190' ' ' SER . 26.4 t30 -63.1 -48.27 79.3 Favored 'General case' 0 C--O 1.208 -1.099 0 CA-C-N 113.911 -1.495 . . . . 2.0699999999999998 109.727 177.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.53 ' O ' ' HB2' ' A' ' 198' ' ' ASN . 2.8 t80 -62.04 -25.33 67.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.956 0.407 . . . . 2.0 110.283 -178.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.596 HD12 HG22 ' A' ' 50' ' ' VAL . 14.6 mt -80.22 -29.57 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-O 120.993 0.425 . . . . 0.31 110.988 174.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 83.3 mt -74.93 -36.71 62.13 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.302 0.572 . . . . 1.03 109.481 174.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.53 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 4.9 m-20 -48.56 -39.17 22.69 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.756 -1.111 . . . . 1.8999999999999999 108.995 163.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.703 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -80.5 -44.52 19.02 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 116.027 -0.533 . . . . 0.28999999999999998 111.247 -176.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 28.7 mmtp -54.41 -46.23 73.1 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.734 0.778 . . . . 0.96999999999999997 110.187 173.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -80.04 -45.44 18.33 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.614 -1.175 . . . . 1.9399999999999999 110.416 -175.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -64.42 -31.55 81.23 Favored Glycine 0 C--O 1.228 -0.246 0 C-N-CA 121.004 -0.617 . . . . 0.46999999999999997 112.555 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.842 HD13 HD23 ' A' ' 61' ' ' LEU . 1.8 tp -69.89 -37.23 72.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.836 0.351 . . . . 0.60999999999999999 110.202 178.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.49 ' O ' ' HB ' ' A' ' 208' ' ' THR . 94.2 mttt -85.13 -20.81 29.74 Favored 'General case' 0 C--O 1.21 -1.024 0 N-CA-C 109.071 -0.714 . . . . 3.3700000000000001 109.071 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -69.06 -34.23 74.82 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.007 -0.542 . . . . 1.02 109.682 168.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.497 ' HE1' ' CD1' ' A' ' 74' ' ' TRP . 19.4 m80 -87.54 -5.84 58.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.952 -0.567 . . . . 3.6299999999999999 112.348 178.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.591 ' HD2' ' OE1' ' A' ' 56' ' ' GLU . 22.6 ttt180 -114.75 -52.57 2.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 122.198 0.999 . . . . 2.5899999999999999 110.638 178.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.546 HG23 ' HD2' ' A' ' 209' ' ' PRO . 39.8 m -100.36 154.38 37.23 Favored Pre-proline 0 C--N 1.309 -1.176 0 CA-C-N 113.922 -1.49 . . . . 1.8400000000000001 108.974 -177.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.546 ' HD2' HG23 ' A' ' 208' ' ' THR . 38.8 Cg_endo -68.0 53.64 0.63 Allowed 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 121.96 1.774 . . . . 2.3500000000000001 111.84 172.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 74.1 m -92.43 26.36 2.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.103 -0.499 . . . . 2.3100000000000001 111.031 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.99 42.55 0.94 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.267 -0.642 . . . . 5.4500000000000002 109.267 173.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -66.01 -50.12 65.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.624 -0.716 . . . . 6.8600000000000003 109.152 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.06 51.81 3.8 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.717 -0.754 . . . . 3.3700000000000001 111.245 175.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -67.0 133.29 49.64 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.133 0.492 . . . . 5.21 111.149 -175.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -109.32 63.05 0.6 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.756 -0.656 . . . . 6.46 109.519 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -78.41 122.92 26.43 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.042 -0.725 . . . . 6.0899999999999999 109.042 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -79.27 79.68 5.68 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.614 0.721 . . . . 5.1200000000000001 111.711 -174.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 32.3 t -76.63 -32.34 57.96 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.127 -1.064 . . . . 6.7599999999999998 108.127 170.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -136.81 -66.29 0.53 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.524 -1.216 . . . . 8.8200000000000003 108.345 171.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 69.7 m . . . . . 0 C--O 1.251 1.141 0 CA-C-N 115.501 -0.772 . . . . 8.4800000000000004 109.689 176.115 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 120.864 0.364 . . . . 3.8599999999999999 110.752 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.51 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.3 t70 -114.24 -41.01 3.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.492 0.663 . . . . 2.25 109.639 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.817 ' HA ' HD11 ' A' ' 6' ' ' ILE . 98.8 m-85 -70.46 -29.87 66.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.289 -0.868 . . . . 0.42999999999999999 109.367 -175.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.524 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 27.1 tttm -74.42 -3.88 33.25 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.822 -1.081 . . . . 1.51 109.766 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 2' ' ' ASP . . . -91.95 -44.89 8.63 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.016 -0.538 . . . . 0.54000000000000004 109.95 172.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.817 HD11 ' HA ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -82.98 -41.34 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-O 121.425 0.631 . . . . 1.0700000000000001 110.727 -173.024 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.626 ' HB2' HD21 ' A' ' 114' ' ' LEU . . . -74.39 -39.59 62.59 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.988 -1.006 . . . . 0.34000000000000002 111.34 -176.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.524 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 2.4 mt-30 -68.15 -27.01 66.06 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.82 -1.082 . . . . 1.5900000000000001 110.232 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -81.79 -33.12 31.02 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.765 -1.107 . . . . 2.4700000000000002 109.111 172.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.65 ' HA ' ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -71.49 -39.06 71.11 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.23 -0.895 . . . . 0.47999999999999998 111.723 179.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.621 ' HA ' ' CB ' ' A' ' 128' ' ' SER . . . -48.15 -60.13 2.87 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-O 121.109 0.48 . . . . 0.31 111.87 176.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.419 ' H ' ' HG2' ' A' ' 12' ' ' GLN . 20.3 pt20 -76.55 0.11 21.22 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.174 -0.466 . . . . 1.6399999999999999 111.579 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.65 ' HB3' ' HA ' ' A' ' 10' ' ' THR . 1.1 tt0 -90.73 -45.29 8.93 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.055 -0.72 . . . . 2.54 109.055 174.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.823 HG23 ' CE2' ' A' ' 170' ' ' PHE . 4.1 p -70.44 -47.39 65.97 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.041 0 N-CA-C 109.001 -0.74 . . . . 0.53000000000000003 109.001 171.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.627 ' HG ' ' OD1' ' A' ' 18' ' ' ASN . 1.0 OUTLIER -61.77 -24.96 67.17 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.362 1.077 . . . . 0.59999999999999998 108.338 175.038 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 20' ' ' ASP . . . -63.19 -21.22 63.79 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 113.774 -1.557 . . . . 0.56999999999999995 110.406 178.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.926 ' CE1' ' HG3' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -87.25 -33.44 19.28 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.097 -0.705 . . . . 3.27 109.097 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.627 ' OD1' ' HG ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -80.38 -16.98 53.23 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.424 0.63 . . . . 2.0299999999999998 110.073 -167.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.458 ' HD2' HD23 ' A' ' 15' ' ' LEU . 24.9 mtp180 -101.52 -20.35 15.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.142 -0.936 . . . . 2.7200000000000002 110.133 175.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 16' ' ' GLY . 35.2 t70 -118.51 84.3 2.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.787 -0.642 . . . . 2.1600000000000001 109.821 -178.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.9 p -108.0 127.02 53.4 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 120.916 0.389 . . . . 1.8200000000000001 111.751 -172.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.4 t 173.23 162.23 0.14 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.366 -0.834 . . . . 2.1899999999999999 109.522 -173.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.44 1.73 90.21 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 121.183 -0.532 . . . . 1.1000000000000001 113.111 174.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -112.75 -157.39 0.62 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.837 0.351 . . . . 1.6699999999999999 110.876 -177.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 tpmt? -173.24 118.1 0.3 Allowed 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 108.851 -0.796 . . . . 2.9500000000000002 108.851 -172.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.662 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 2.8 m -63.19 116.87 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.989 0 CA-C-O 122.116 0.96 . . . . 1.5600000000000001 110.789 176.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.459 HG13 ' HB2' ' A' ' 28' ' ' LYS . 10.9 p -98.38 -24.74 4.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 113.979 -1.464 . . . . 1.22 109.719 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.459 ' HB2' HG13 ' A' ' 27' ' ' VAL . 1.2 tmtt? -154.37 120.39 5.29 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 119.471 -0.892 . . . . 2.4100000000000001 110.537 -170.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.542 ' HB ' ' HA ' ' A' ' 34' ' ' THR . 0.2 OUTLIER -149.71 135.05 18.25 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.477 0.656 . . . . 1.3799999999999999 110.506 175.096 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.4 m -88.39 -68.35 0.77 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.841 -1.072 . . . . 2.3700000000000001 111.299 -173.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -166.64 18.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 121.018 -0.273 . . . . 4.5499999999999998 110.856 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.506 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 16.5 tttp 178.51 -28.95 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.351 0.595 . . . . 1.4199999999999999 110.312 -174.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.724 HG22 ' HA3' ' A' ' 52' ' ' GLY . 30.0 pt -98.95 152.79 4.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.96 -1.018 . . . . 0.76000000000000001 109.254 174.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.562 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 3.4 m -146.47 110.87 5.12 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 123.452 0.47 . . . . 0.57999999999999996 111.04 -167.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.684 ' HA ' ' O ' ' A' ' 49' ' ' ARG . 13.0 t -103.45 112.73 38.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.995 -0.372 . . . . 0.85999999999999999 109.995 -177.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.662 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 84.0 p -106.83 133.93 50.75 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.193 0.597 . . . . 1.1000000000000001 110.685 -177.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 49.2 m -102.45 126.67 49.56 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.297 -0.41 . . . . 1.27 110.416 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -119.71 -84.3 0.66 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.856 -0.611 . . . . 1.9099999999999999 110.424 -177.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 47' ' ' LEU . . . -176.04 128.01 0.22 Allowed 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.016 0.198 . . . . 1.6799999999999999 110.483 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.55 ' HA ' ' HG3' ' A' ' 172' ' ' GLN . 32.1 t -89.68 -137.5 0.12 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.772 -1.196 . . . . 2.0899999999999999 107.772 173.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.516 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 3.9 tpm_? -64.35 -9.13 15.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.986 0.422 . . . . 6.6100000000000003 110.172 172.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.497 ' HD3' ' HA ' ' A' ' 42' ' ' LYS . 4.0 mmtp 60.7 19.26 9.31 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.486 -0.779 . . . . 6.46 112.165 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -101.18 -42.17 6.45 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.738 -0.838 . . . . 5.6500000000000004 108.738 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -161.0 72.2 0.43 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.52 -1.218 . . . . 5.5599999999999996 107.983 167.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 40' ' ' SER . . . 162.92 136.11 1.93 Allowed Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 120.318 -0.944 . . . . 1.5600000000000001 112.934 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -104.69 152.31 22.65 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.481 -0.933 . . . . 2.0499999999999998 108.481 169.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.768 HD21 ' CD1' ' A' ' 170' ' ' PHE . 4.8 tt -82.52 130.0 35.03 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.829 -0.804 . . . . 0.87 108.829 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.539 ' N ' HD23 ' A' ' 47' ' ' LEU . 38.3 m-85 -115.45 119.12 35.17 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.466 -0.568 . . . . 0.98999999999999999 109.466 -178.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.926 ' HG3' ' CE1' ' A' ' 17' ' ' TYR . 3.1 tmt_? -110.47 141.84 43.04 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.928 -0.578 . . . . 2.9199999999999999 109.505 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 34' ' ' THR . 8.8 p -127.99 143.59 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-O 121.243 0.544 . . . . 1.3300000000000001 109.862 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.504 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 33.4 tt0 -146.28 110.81 5.14 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.442 -0.799 . . . . 1.0700000000000001 109.01 -173.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.724 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -137.81 134.72 7.11 Favored Glycine 0 N--CA 1.439 -1.13 0 C-N-CA 120.361 -0.923 . . . . 0.28999999999999998 111.851 -176.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 64.4 mt -83.98 118.13 30.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 C-N-CA 119.798 -0.761 . . . . 0.57999999999999996 110.327 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.407 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 72.3 mt -95.99 113.15 61.61 Favored Pre-proline 0 N--CA 1.435 -1.209 0 CA-C-N 115.132 -0.94 . . . . 0.34999999999999998 108.599 175.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 24.9 Cg_exo -65.67 45.87 0.18 Allowed 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.825 3.017 . . . . 0.62 113.582 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.576 ' HG2' HG13 ' A' ' 203' ' ' ILE . 10.5 tp10 -135.72 178.09 7.32 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.539 -1.282 . . . . 1.6799999999999999 107.539 177.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.451 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 47.9 t -81.1 139.66 49.31 Favored Pre-proline 0 N--CA 1.43 -1.473 0 CA-C-O 121.739 0.781 . . . . 1.1799999999999999 110.234 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.542 ' HG3' ' HB3' ' A' ' 165' ' ' SER . 23.5 Cg_exo -61.35 -9.13 12.04 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 124.11 3.207 . . . . 0.52000000000000002 110.658 177.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 63' ' ' ASP . . . -67.02 -52.3 44.14 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.981 -1.009 . . . . 0.64000000000000001 110.82 174.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.62 ' HE3' ' HB3' ' A' ' 64' ' ' PHE . 7.4 tptt -72.12 -23.91 61.39 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.887 -0.783 . . . . 3.2999999999999998 108.887 178.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.714 HD23 ' CD1' ' A' ' 203' ' ' ILE . 20.4 mt -64.42 -60.35 3.27 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.863 -0.608 . . . . 0.40999999999999998 109.454 174.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.461 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 34.1 t -64.73 -14.13 57.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.563 -0.744 . . . . 1.29 110.306 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 22.6 t70 -80.83 -46.42 15.36 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.844 -0.616 . . . . 1.3200000000000001 111.077 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.625 ' HB2' ' HZ2' ' A' ' 74' ' ' TRP . 7.0 p90 -76.21 -45.43 33.08 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 120.9 -0.32 . . . . 0.60999999999999999 111.29 -171.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.461 ' CD2' ' HA ' ' A' ' 62' ' ' SER . 0.5 OUTLIER -80.66 -5.31 56.77 Favored 'General case' 0 CA--C 1.512 -0.487 0 O-C-N 121.833 -0.542 . . . . 1.5 111.184 -171.247 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.522 ' O ' ' HG3' ' A' ' 67' ' ' GLN . 13.0 t80 -50.73 -48.61 58.91 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 123.676 0.61 . . . . 1.52 112.181 -163.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.524 ' HG2' ' CZ ' ' A' ' 81' ' ' TYR . 16.3 mt-30 155.84 115.22 0.0 OUTLIER 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 124.657 1.183 . . . . 3.6000000000000001 109.32 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.788 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 6.3 t 42.53 31.49 0.29 Allowed 'General case' 0 C--N 1.315 -0.906 0 O-C-N 124.559 1.162 . . . . 1.48 113.397 175.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.93 -27.19 14.44 Favored Glycine 0 CA--C 1.496 -1.154 0 C-N-CA 120.039 -1.077 . . . . 1.46 112.166 -173.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.729 ' O ' HG22 ' A' ' 73' ' ' THR . 17.4 p-10 173.87 -28.77 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.677 -1.231 . . . . 2.1899999999999999 107.677 -172.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.83 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 1.6 ptp180 -43.11 -54.43 4.4 Favored 'General case' 0 C--O 1.21 -0.983 0 CA-C-N 114.636 -1.165 . . . . 3.3799999999999999 110.66 177.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.883 HG22 ' HB3' ' A' ' 78' ' ' LEU . 1.8 pp -78.34 -12.27 13.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.056 0.455 . . . . 0.70999999999999996 111.503 -175.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.729 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.2 t -90.22 -29.78 17.98 Favored 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 120.062 -0.655 . . . . 0.96999999999999997 109.859 -168.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.625 ' HZ2' ' HB2' ' A' ' 64' ' ' PHE . 7.8 p-90 -111.53 -3.99 14.95 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.16 -0.473 . . . . 0.75 111.378 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.83 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 1.8 t70 -65.9 176.88 1.47 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 122.306 1.051 . . . . 2.1899999999999999 113.399 -171.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.451 ' HG3' ' OD1' ' A' ' 194' ' ' ASN . 0.0 OUTLIER -123.0 -27.5 4.21 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.819 -1.537 . . . . 3.1899999999999999 110.509 -178.037 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.436 ' HA ' ' HB2' ' A' ' 99' ' ' GLN . 50.0 m -113.12 0.58 15.0 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.073 -0.714 . . . . 1.5800000000000001 109.073 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.883 ' HB3' HG22 ' A' ' 72' ' ' ILE . 53.2 mt -108.73 173.68 6.21 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.048 -0.978 . . . . 0.70999999999999996 110.268 177.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.678 ' HG2' ' HG2' ' A' ' 99' ' ' GLN . 12.8 mm100 -156.87 -66.2 0.1 Allowed 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.734 0.778 . . . . 1.73 109.972 -174.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.472 HG23 ' HB3' ' A' ' 79' ' ' GLN . 17.3 t -136.96 119.17 19.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 114.586 -1.188 . . . . 0.78000000000000003 109.835 -169.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.788 ' HB3' ' HB ' ' A' ' 68' ' ' THR . 0.4 OUTLIER -109.22 123.48 49.31 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.495 -0.558 . . . . 5.4000000000000004 109.495 175.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.708 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 13.5 m120 -119.95 123.68 44.11 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.324 -0.991 . . . . 1.6899999999999999 108.324 -176.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.79 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 18.3 ttm -87.73 99.01 11.77 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.69 -0.856 . . . . 2.0499999999999998 108.69 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.582 HG11 ' HZ ' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -77.49 -60.74 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.981 -0.554 . . . . 0.64000000000000001 111.349 -163.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.63 130.29 19.07 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.862 -0.792 . . . . 1.96 108.862 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.79 ' HD3' ' SD ' ' A' ' 83' ' ' MET . 14.3 mtm180 -110.4 132.95 53.73 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.38 -0.6 . . . . 2.4399999999999999 109.38 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.605 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -94.5 -44.45 13.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.769 -0.65 . . . . 0.46999999999999997 111.097 -168.354 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -149.99 -161.99 1.46 Allowed 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.431 -0.951 . . . . 1.8600000000000001 108.431 -174.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.1 m -65.22 -33.36 75.81 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 111.932 0.345 . . . . 1.4399999999999999 111.932 -172.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -137.92 33.74 2.4 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.343 0.592 . . . . 1.8700000000000001 109.647 -174.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.605 ' O ' HG12 ' A' ' 87' ' ' ILE . 1.7 m -132.54 107.09 8.23 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.971 -1.122 . . . . 0.46000000000000002 107.971 -178.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.599 ' O ' HD12 ' A' ' 114' ' ' LEU . 16.9 m-85 -123.37 171.58 9.32 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.947 -0.57 . . . . 0.42999999999999999 110.08 -173.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.545 ' O ' HG23 ' A' ' 84' ' ' VAL . 53.3 mt -121.81 129.87 75.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 109.11 -0.7 . . . . 0.40999999999999998 109.11 170.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.792 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 0.0 OUTLIER -93.25 118.02 30.76 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.734 -1.121 . . . . 2.0099999999999998 111.962 -170.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.708 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 22.2 t-160 -107.18 90.53 3.33 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.021 -0.733 . . . . 1.23 109.021 163.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.626 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 72.2 m -109.22 120.7 43.33 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.984 -0.553 . . . . 0.5 111.457 -176.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.8 mm -83.92 130.02 36.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.367 0.603 . . . . 1.03 110.028 174.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 3.0 m -106.11 152.58 23.23 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.793 -1.094 . . . . 1.3799999999999999 110.124 -174.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.678 ' HG2' ' HG2' ' A' ' 79' ' ' GLN . 4.2 mm-40 -91.95 168.24 11.55 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.25 0.547 . . . . 1.8200000000000001 111.443 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.506 ' HB3' ' O ' ' A' ' 106' ' ' ILE . 14.1 m -91.54 50.36 1.71 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.281 -0.872 . . . . 3.9100000000000001 111.776 -174.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.446 ' HE2' ' HB3' ' A' ' 190' ' ' SER . 69.2 t80 -74.99 102.39 4.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.544 0.687 . . . . 5.1600000000000001 111.442 -174.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.569 ' O ' ' HB ' ' A' ' 103' ' ' VAL . . . -164.09 -37.94 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.625 -1.171 . . . . 1.98 110.3 175.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.569 ' HB ' ' O ' ' A' ' 102' ' ' ALA . 7.5 p 155.77 -19.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 107.43 -1.322 . . . . 3.1699999999999999 107.43 -173.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.35 24.56 3.17 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 114.426 -1.261 . . . . 1.96 111.743 -175.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.7 t -101.64 -1.78 31.93 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.346 0.593 . . . . 1.8799999999999999 110.175 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.635 HG12 ' HG ' ' A' ' 179' ' ' LEU . 76.5 mt -114.78 147.91 17.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.437 -0.801 . . . . 1.1200000000000001 109.624 -176.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.1 m -99.19 157.79 33.42 Favored Pre-proline 0 C--N 1.32 -0.709 0 N-CA-C 109.319 -0.623 . . . . 1.3500000000000001 109.319 175.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -47.97 116.54 1.99 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.814 2.342 . . . . 1.0700000000000001 111.686 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.658 ' HG3' HG23 ' A' ' 144' ' ' ILE . 34.3 ttp180 -102.08 149.22 24.48 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.007 -0.738 . . . . 3.4500000000000002 109.007 -173.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.405 ' OD1' ' HA ' ' A' ' 145' ' ' ARG . 2.5 p30 -114.25 147.85 38.36 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.813 -0.755 . . . . 1.3700000000000001 110.135 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.626 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 15.1 m-85 -116.25 128.51 55.65 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.325 -0.852 . . . . 2.4100000000000001 110.229 174.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.792 ' HA ' ' O ' ' A' ' 94' ' ' CYS . 22.6 mm -126.8 80.87 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.33 -0.85 . . . . 0.42999999999999999 109.049 169.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.729 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 10.0 m-20 -113.64 129.09 56.63 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.872 -1.058 . . . . 1.8600000000000001 109.215 -178.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.626 HD21 ' HB2' ' A' ' 7' ' ' ALA . 3.8 tp -74.79 121.45 21.79 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.424 0.63 . . . . 0.28000000000000003 109.401 176.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -115.71 123.74 71.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 114.96 -1.018 . . . . 0.26000000000000001 111.497 -164.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.663 ' HE2' ' HE3' ' A' ' 118' ' ' LYS . 90.9 t80 -114.07 125.21 53.72 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.827 -1.078 . . . . 2.5699999999999998 109.895 175.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 1.099 HG12 HG22 ' A' ' 127' ' ' ILE . 85.9 mt -98.79 104.33 15.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.312 0.577 . . . . 0.89000000000000001 110.358 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.663 ' HE3' ' HE2' ' A' ' 116' ' ' TYR . 5.0 tppp? -98.73 128.04 44.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.599 -0.728 . . . . 1.2 109.267 177.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.68 92.04 3.79 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.035 -0.728 . . . . 2.7999999999999998 109.035 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.446 ' HB3' ' HB3' ' A' ' 123' ' ' ASN . 59.5 m-85 -73.12 115.15 12.11 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 115.14 -0.936 . . . . 0.82999999999999996 108.737 175.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -26.53 89.67 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 O-C-N 125.637 1.836 . . . . 2.2799999999999998 113.252 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 53.83 42.44 69.16 Favored Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.789 -0.641 . . . . 0.76000000000000001 112.672 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.505 ' C ' ' HD2' ' A' ' 157' ' ' PRO . 3.2 t-20 -135.75 -49.21 0.7 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.331 -0.434 . . . . 1.6499999999999999 110.705 -176.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.584 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 5.4 mtm -161.98 120.24 2.26 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 120.726 -0.39 . . . . 1.1200000000000001 111.787 -178.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -104.35 78.68 1.51 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.422 -0.955 . . . . 1.6200000000000001 108.422 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.682 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -92.8 138.4 20.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 114.915 -1.039 . . . . 0.29999999999999999 112.791 -172.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 1.099 HG22 HG12 ' A' ' 117' ' ' ILE . 38.0 pt -105.51 100.68 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.93 0.872 . . . . 0.58999999999999997 109.34 165.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.621 ' CB ' ' HA ' ' A' ' 11' ' ' ALA . 11.8 p -85.73 110.58 19.43 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.842 -0.617 . . . . 1.1799999999999999 110.707 178.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.729 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 1.9 p -106.4 135.87 47.14 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.408 -0.814 . . . . 1.24 110.691 -176.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.608 ' HE2' ' OG1' ' A' ' 10' ' ' THR . 10.6 ttmm -128.11 112.25 14.37 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.819 -1.178 . . . . 2.2599999999999998 107.819 -177.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.8 p -57.88 98.39 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.914 0 CA-C-O 121.944 0.878 . . . . 1.3899999999999999 109.067 -175.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.55 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -110.32 134.12 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.122 0 CA-C-N 114.587 -1.188 . . . . 1.05 109.034 -165.607 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -96.19 71.15 2.81 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.719 -1.128 . . . . 2.1699999999999999 108.456 -172.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.687 ' CE1' HG21 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -99.5 159.54 29.78 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 114.447 -1.251 . . . . 0.53000000000000003 110.471 -172.093 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.83 -27.64 75.27 Favored 'Trans proline' 0 N--CA 1.477 0.535 0 C-N-CA 123.861 3.041 . . . . 1.28 115.679 -168.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.432 ' HG2' ' CD2' ' A' ' 134' ' ' PHE . 12.1 mm-40 -71.72 -21.71 61.73 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 120.478 -0.489 . . . . 3.5 110.08 -166.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.577 ' CD2' HG13 ' A' ' 112' ' ' ILE . 57.0 t80 -134.26 108.23 11.33 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 112.916 0.71 . . . . 6.1200000000000001 112.916 -177.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -97.6 119.12 0.15 Allowed 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 123.537 2.824 . . . . 1.77 110.76 162.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -63.24 -176.94 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.271 1.981 . . . . 1.25 112.24 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.0 m -146.63 -162.35 1.51 Allowed 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.598 -0.519 . . . . 1.6000000000000001 109.598 -171.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.3 m -79.91 -40.69 27.67 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.297 -0.561 . . . . 1.97 111.337 -178.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -68.09 -42.63 80.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.037 0.446 . . . . 2.1800000000000002 111.176 -176.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -105.19 134.79 47.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.711 -0.677 . . . . 1.23 110.172 -173.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.658 HG23 ' HG3' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -109.93 103.51 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 CA-C-N 116.034 -0.53 . . . . 0.81999999999999995 109.702 -179.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.542 ' HE ' ' HB ' ' A' ' 112' ' ' ILE . 12.1 ttt180 -51.7 100.78 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.552 -1.204 . . . . 4.4199999999999999 110.429 178.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.35 110.13 3.06 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.662 -0.699 . . . . 0.79000000000000004 112.224 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.452 ' HB3' ' HB3' ' A' ' 174' ' ' GLU . 26.4 t80 -85.42 82.2 8.41 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.258 0.551 . . . . 4.4400000000000004 109.649 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.533 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 47.1 m-80 -78.21 100.45 6.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.737 -0.665 . . . . 1.6200000000000001 109.747 176.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -57.76 114.96 9.5 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.314 -0.625 . . . . 2.3199999999999998 109.314 176.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.437 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 65.9 Cg_exo -7.0 67.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.681 1 C-N-CA 126.152 4.568 . . . . 0.53000000000000003 115.187 -159.764 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . 0.736 ' HB3' ' O ' ' A' ' 170' ' ' PHE . 2.9 m -87.75 150.78 23.37 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 115.039 -0.982 . . . . 1.5800000000000001 108.404 178.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.822 ' HA3' HG21 ' A' ' 14' ' ' VAL . . . -139.83 -162.86 9.28 Favored Glycine 0 CA--C 1.494 -1.265 0 C-N-CA 118.829 -1.653 . . . . 0.42999999999999999 112.649 -176.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.615 ' HB3' HG12 ' A' ' 127' ' ' ILE . 0.4 OUTLIER -160.74 83.42 0.67 Allowed 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.364 -1.347 . . . . 0.59999999999999998 107.364 -164.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.772 HG23 HG13 ' A' ' 168' ' ' VAL . 4.2 m -95.28 130.38 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 CA-C-O 121.933 0.873 . . . . 0.31 110.576 -175.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . 0.584 ' O ' ' HA ' ' A' ' 124' ' ' MET . 6.0 t -110.32 118.54 36.59 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.251 -0.886 . . . . 1.55 109.446 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.617 ' HB3' ' HB3' ' A' ' 166' ' ' LYS . 9.1 t -114.78 112.6 45.09 Favored Pre-proline 0 C--N 1.319 -0.749 0 C-N-CA 120.654 -0.418 . . . . 1.0600000000000001 111.625 -170.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.505 ' HD2' ' C ' ' A' ' 123' ' ' ASN . 46.8 Cg_exo -55.18 118.56 5.3 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.11 1.873 . . . . 0.56000000000000005 110.166 166.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.485 ' N ' ' HB3' ' A' ' 161' ' ' ASN . 72.3 mtp -79.5 -171.78 2.93 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.717 -0.393 . . . . 1.1599999999999999 111.087 -175.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -67.24 -31.19 71.37 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.481 -0.933 . . . . 2.6299999999999999 108.481 169.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.411 ' C ' ' HD2' ' A' ' 162' ' ' PRO . 24.2 mt-10 -102.45 27.87 6.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.362 -1.29 . . . . 2.0499999999999998 109.213 176.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.498 ' OD1' ' HD3' ' A' ' 162' ' ' PRO . 7.0 p30 -38.84 -46.96 3.45 Favored Pre-proline 0 N--CA 1.473 0.694 0 N-CA-C 115.985 1.846 . . . . 1.9299999999999999 115.985 -169.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.498 ' HD3' ' OD1' ' A' ' 161' ' ' ASN . 71.2 Cg_endo -72.45 -17.63 26.75 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 CA-C-N 121.336 1.513 . . . . 0.72999999999999998 112.384 -174.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -109.62 -24.43 10.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.779 -0.646 . . . . 0.68000000000000005 110.933 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.462 ' O ' ' HA ' ' A' ' 161' ' ' ASN . 79.1 m-85 -141.76 121.05 13.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.065 -0.516 . . . . 0.93000000000000005 109.726 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.542 ' HB3' ' HG3' ' A' ' 58' ' ' PRO . 6.8 p -117.29 142.71 46.73 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.304 -0.558 . . . . 1.4099999999999999 111.187 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.617 ' HB3' ' HB3' ' A' ' 156' ' ' SER . 2.3 tppp? -94.31 104.41 16.4 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 122.1 0.952 . . . . 0.73999999999999999 111.822 -174.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.49 HD12 HG12 ' A' ' 196' ' ' ILE . 0.7 OUTLIER -90.69 104.83 17.37 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.297 -1.32 . . . . 0.27000000000000002 109.517 176.179 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.772 HG13 HG23 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -127.86 126.06 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.803 0.811 . . . . 0.28000000000000003 111.533 -179.642 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.574 ' O ' ' HG2' ' A' ' 49' ' ' ARG . 12.2 ttm -141.4 148.58 39.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.248 -0.887 . . . . 1.24 109.486 -172.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.823 ' CE2' HG23 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -129.71 143.34 50.77 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.186 -0.606 . . . . 3.3700000000000001 110.345 170.256 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.55 ' HB ' HD21 ' A' ' 192' ' ' LEU . 0.9 OUTLIER -119.9 118.81 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 O-C-N 124.86 1.35 . . . . 1.3999999999999999 109.985 178.394 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.55 ' HG3' ' HA ' ' A' ' 40' ' ' SER . 10.4 tt0 -121.81 48.73 1.65 Allowed 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 106.187 -1.783 . . . . 2.1699999999999999 106.187 173.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 5.5 m -72.13 151.34 43.08 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.024 -1.898 . . . . 1.6499999999999999 111.224 -174.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.452 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 18.5 tt0 -127.57 92.97 3.59 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.542 0.687 . . . . 2.4500000000000002 109.821 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.98 86.23 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.456 -1.247 . . . . 3.7400000000000002 110.067 174.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.599 ' HB2' HD11 ' A' ' 144' ' ' ILE . 14.8 mmt85 -70.18 19.98 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.083 0.771 . . . . 5.7800000000000002 113.083 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 165.59 -176.7 41.07 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.303 -0.951 . . . . 2.2599999999999998 113.56 175.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm 76.2 -65.25 0.32 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.056 0.942 . . . . 6.2300000000000004 112.923 174.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.635 ' HG ' HG12 ' A' ' 106' ' ' ILE . 4.4 mp -85.0 160.69 19.99 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.77 0.795 . . . . 1.6399999999999999 110.641 -172.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.546 ' HB3' ' HD2' ' A' ' 181' ' ' PRO . 50.5 m -112.67 164.56 15.07 Favored Pre-proline 0 C--N 1.306 -1.296 0 CA-C-N 113.923 -1.489 . . . . 2.04 108.638 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 180' ' ' SER . 74.3 Cg_exo -37.97 -52.03 1.83 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.656 2.904 . . . . 1.74 114.247 -177.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.572 ' O ' ' HE2' ' A' ' 186' ' ' LYS . 54.6 m -75.25 -10.44 59.46 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.548 0.573 . . . . 2.1400000000000001 112.548 -174.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.566 ' HB ' ' HB3' ' A' ' 179' ' ' LEU . 16.2 mm -89.86 -35.37 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 CA-C-O 122.523 1.154 . . . . 1.1200000000000001 108.909 -177.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.931 ' HA ' HG22 ' A' ' 187' ' ' THR . 0.9 OUTLIER -70.01 -38.15 74.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 112.768 -2.014 . . . . 1.1299999999999999 110.931 -178.728 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.438 ' HG2' ' HA ' ' A' ' 182' ' ' SER . 9.3 pt-20 -65.69 -17.91 64.94 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.155 -0.683 . . . . 2.8900000000000001 109.155 175.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.572 ' HE2' ' O ' ' A' ' 182' ' ' SER . 48.2 mtmt -93.01 -38.7 11.51 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.729 -0.668 . . . . 1.28 110.081 175.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.931 HG22 ' HA ' ' A' ' 184' ' ' ILE . 11.2 t -68.73 -24.61 64.49 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 112.348 0.499 . . . . 0.62 112.348 -171.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . 0.558 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 0.2 OUTLIER -79.78 -63.65 0.36 Allowed Pre-proline 0 N--CA 1.467 0.402 0 CA-C-N 118.471 0.578 . . . . 1.0600000000000001 111.699 179.418 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.558 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 25.4 Cg_exo -62.7 -25.53 75.07 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.296 1.997 . . . . 0.91000000000000003 112.484 -176.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.746 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 68.4 m -82.95 -28.53 29.75 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.716 -0.394 . . . . 1.5 111.306 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.652 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.2 OUTLIER -90.55 -36.49 14.44 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.9 -0.32 . . . . 1.8799999999999999 111.272 -173.474 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.55 HD21 ' HB ' ' A' ' 171' ' ' VAL . 48.4 mt -65.22 -47.04 78.21 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.183 0.516 . . . . 1.0900000000000001 110.587 -177.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.477 ' HB ' HD12 ' A' ' 33' ' ' ILE . 2.0 m -67.9 -30.05 46.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.584 -0.735 . . . . 0.68000000000000005 109.301 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.746 ' HB2' ' O ' ' A' ' 190' ' ' SER . 1.0 OUTLIER -71.6 -37.07 71.0 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.652 -1.158 . . . . 2.0699999999999998 110.247 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.587 ' HA ' ' ND2' ' A' ' 198' ' ' ASN . 12.2 m-85 -61.07 -34.03 74.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.027 0.441 . . . . 2.0 110.048 172.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.545 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 54.3 mt -79.63 -28.97 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 116.082 -0.508 . . . . 0.31 110.637 176.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.445 ' HB2' ' HA ' ' A' ' 194' ' ' ASN . 53.2 mt -72.8 -36.47 67.56 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-N 116.317 -0.401 . . . . 1.03 110.233 176.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.587 ' ND2' ' HA ' ' A' ' 195' ' ' PHE . 67.2 m-20 -49.06 -47.61 44.78 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.303 -0.999 . . . . 1.8999999999999999 108.303 164.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.858 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -67.24 -45.49 76.56 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 115.28 -0.873 . . . . 0.28999999999999998 110.12 -175.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 61.2 mmtt -53.65 -48.18 69.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.403 0.621 . . . . 0.96999999999999997 109.91 173.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -75.71 -39.99 56.46 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.04 -0.982 . . . . 1.9399999999999999 111.305 -169.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -76.64 -28.23 59.71 Favored Glycine 0 N--CA 1.461 0.334 0 C-N-CA 120.056 -1.069 . . . . 0.46999999999999997 111.739 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.858 ' HB ' ' O ' ' A' ' 199' ' ' ALA . 0.9 OUTLIER -71.51 -38.61 68.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 123.045 0.538 . . . . 0.60999999999999999 110.832 172.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.53 ' O ' ' HB ' ' A' ' 208' ' ' THR . 96.4 mttt -83.76 -17.35 41.5 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.355 0.598 . . . . 3.3700000000000001 109.406 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -65.36 -25.79 67.74 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.442 -0.947 . . . . 1.02 108.442 166.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.512 ' HB3' ' O ' ' A' ' 203' ' ' ILE . 83.6 t60 -80.97 -51.75 8.19 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.246 -0.888 . . . . 3.6299999999999999 111.819 175.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -91.95 -33.13 14.99 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.323 0.49 . . . . 2.5899999999999999 112.323 -171.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.53 ' HB ' ' O ' ' A' ' 204' ' ' LYS . 91.6 m -99.45 151.03 37.29 Favored Pre-proline 0 C--N 1.313 -0.996 0 N-CA-C 109.554 -0.535 . . . . 1.8400000000000001 109.554 -176.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -65.17 44.27 0.15 Allowed 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.729 2.286 . . . . 2.3500000000000001 111.969 168.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.419 ' H ' ' C ' ' A' ' 208' ' ' THR . 22.7 t -95.01 37.95 1.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.707 0.765 . . . . 2.3100000000000001 109.559 -178.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 211' ' ' ARG . 17.7 mtp85 -84.0 22.54 1.15 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.229 -0.896 . . . . 5.4500000000000002 110.642 -178.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -64.71 -28.07 69.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.372 -0.831 . . . . 6.8600000000000003 109.988 172.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -102.38 13.37 56.95 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.766 -0.652 . . . . 3.3700000000000001 111.735 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -66.63 117.22 8.5 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.847 -0.427 . . . . 5.21 109.847 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 62.79 48.7 4.01 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.483 0.489 . . . . 6.46 111.242 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . 0.432 ' HB3' ' O ' ' A' ' 73' ' ' THR . 62.7 t-80 -76.6 -46.43 26.12 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.857 -0.423 . . . . 6.0899999999999999 109.857 176.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 62.66 -168.49 0.2 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.644 -0.707 . . . . 5.1200000000000001 111.476 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' A' ' 79' ' ' GLN . 48.1 t -98.87 -50.5 4.18 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.868 -0.606 . . . . 6.7599999999999998 109.514 174.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -172.67 -27.34 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.391 -0.822 . . . . 8.8200000000000003 109.757 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.25 1.119 0 N-CA-C 108.921 -0.77 . . . . 8.4800000000000004 108.921 176.45 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 mmt . . . . . 0 N--CA 1.479 0.998 0 CA-C-O 121.198 0.523 . . . . 3.8599999999999999 110.634 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -146.49 -65.16 0.29 Allowed 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.571 -0.899 . . . . 2.25 108.571 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.542 ' HA ' HD11 ' A' ' 6' ' ' ILE . 59.1 m-85 -66.66 -31.86 72.8 Favored 'General case' 0 CA--C 1.507 -0.707 0 O-C-N 123.58 0.55 . . . . 0.42999999999999999 110.284 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 27.0 tttp -75.91 -44.34 40.76 Favored 'General case' 0 N--CA 1.418 -2.065 0 N-CA-C 107.598 -1.26 . . . . 1.51 107.598 -177.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.408 ' O ' ' HG3' ' A' ' 9' ' ' GLN . . . -50.16 -51.73 41.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.422 -0.808 . . . . 0.54000000000000004 112.471 -177.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.542 HD11 ' HA ' ' A' ' 3' ' ' PHE . 0.4 OUTLIER -83.49 -30.6 8.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.312 -0.555 . . . . 1.0700000000000001 110.758 -172.005 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.497 ' HA ' ' HB ' ' A' ' 10' ' ' THR . . . -74.04 -41.54 61.65 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.85 0.833 . . . . 0.34000000000000002 110.956 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.486 ' HG2' ' CZ ' ' A' ' 116' ' ' TYR . 14.7 mt-30 -62.51 -31.23 71.96 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.259 -1.337 . . . . 1.5900000000000001 110.216 177.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 5' ' ' ALA . 98.9 mt-30 -82.47 -30.85 29.7 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.999 -1.0 . . . . 2.4700000000000002 109.204 174.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.624 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.6 OUTLIER -72.0 -37.72 69.77 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.682 -1.145 . . . . 0.47999999999999998 111.202 -179.569 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.541 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -46.51 -62.62 1.29 Allowed 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.266 0.469 . . . . 0.31 112.266 174.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -70.01 -6.24 32.05 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.308 -0.406 . . . . 1.6399999999999999 111.086 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.52 ' HB3' ' HA ' ' A' ' 10' ' ' THR . 0.2 OUTLIER -87.7 -43.0 12.24 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.215 -0.448 . . . . 2.54 110.136 179.666 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.712 HG21 ' N ' ' A' ' 152' ' ' GLY . 7.2 p -79.26 -29.83 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-O 121.841 0.829 . . . . 0.53000000000000003 109.404 176.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 tt -76.15 -19.71 58.23 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 108.314 -0.995 . . . . 0.59999999999999998 108.314 172.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.43 -23.42 66.65 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 113.931 -1.486 . . . . 0.56999999999999995 109.62 170.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.558 ' CD2' ' HA ' ' A' ' 14' ' ' VAL . 26.3 m-85 -80.87 -32.82 34.77 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 114.935 -0.633 . . . . 3.27 109.925 176.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -66.22 -13.19 59.92 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.699 0.761 . . . . 2.0299999999999998 110.139 177.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.7 mtp180 -108.16 -2.16 19.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.285 -0.87 . . . . 2.7200000000000002 109.323 178.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.496 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 28.9 t70 -105.65 119.66 39.71 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.349 -1.296 . . . . 2.1600000000000001 110.473 -175.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.0 p -134.62 119.13 17.98 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.962 -0.384 . . . . 1.8200000000000001 109.962 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.89 -162.58 1.3 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.252 -0.431 . . . . 2.1899999999999999 111.127 -166.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -75.73 61.24 2.89 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 116.11 -0.496 . . . . 1.1000000000000001 112.666 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.441 ' HA ' ' HB3' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -95.64 -156.5 0.52 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.369 -0.604 . . . . 1.6699999999999999 109.369 175.067 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.48 132.65 0.29 Allowed 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 108.682 -0.859 . . . . 2.9500000000000002 108.682 -178.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.824 HG21 HG23 ' A' ' 29' ' ' THR . 2.1 p -67.57 117.45 9.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-O 121.689 0.757 . . . . 1.5600000000000001 109.5 177.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.0 p -89.17 -24.37 5.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 114.748 -1.114 . . . . 1.22 108.919 -176.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.2 tptt -158.0 139.23 13.43 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.754 -0.657 . . . . 2.4100000000000001 111.883 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.824 HG23 HG21 ' A' ' 26' ' ' VAL . 6.4 p -144.28 152.1 40.32 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 115.829 -0.623 . . . . 1.3799999999999999 111.011 175.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.478 ' HB2' HG12 ' A' ' 33' ' ' ILE . 19.4 m -120.67 25.95 9.42 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.826 -0.625 . . . . 2.3700000000000001 110.868 171.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp 68.93 39.44 1.84 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.479 0.657 . . . . 4.5499999999999998 110.441 174.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.6 tptm 177.0 -30.59 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.505 -1.225 . . . . 1.4199999999999999 108.313 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.8 HD12 ' HB ' ' A' ' 193' ' ' VAL . 23.0 pt -119.68 151.8 22.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 114.561 -1.199 . . . . 0.76000000000000001 109.483 175.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.62 ' HA ' HG22 ' A' ' 29' ' ' THR . 89.8 m -152.15 113.62 4.32 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 123.347 0.404 . . . . 0.57999999999999996 111.158 -164.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -103.68 110.79 31.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.356 -0.537 . . . . 0.85999999999999999 111.799 171.357 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 1.5 p -99.77 117.86 35.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.413 -0.812 . . . . 1.1000000000000001 110.95 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 30.2 t -107.72 131.99 53.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.768 -1.106 . . . . 1.27 111.184 -173.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.453 ' HG3' ' H ' ' A' ' 39' ' ' ALA . 27.8 pttt -129.35 -92.61 0.45 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.497 0.554 . . . . 1.9099999999999999 112.497 172.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.657 ' HA ' ' HA ' ' A' ' 46' ' ' ASN . . . -148.11 137.64 22.28 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.611 0.226 . . . . 1.6799999999999999 111.611 -172.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.5 m -100.47 137.64 38.61 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.014 -0.365 . . . . 2.0899999999999999 110.014 176.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 41' ' ' ARG . 61.9 mtt180 -81.01 13.91 2.51 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.31 -0.405 . . . . 6.6100000000000003 111.222 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.644 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 17.5 ptpt -57.14 -33.73 67.68 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.116 -0.493 . . . . 6.46 110.221 178.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.644 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 14.7 t80 153.09 -70.88 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 O-C-N 124.992 1.432 . . . . 5.6500000000000004 108.6 -175.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -140.29 84.43 1.96 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.757 0.789 . . . . 5.5599999999999996 110.511 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.411 ' HA3' ' HD2' ' A' ' 42' ' ' LYS . . . -171.87 179.05 43.79 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.763 -0.732 . . . . 1.5600000000000001 111.766 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.657 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 18.9 p-10 -111.4 159.32 18.13 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.858 0.361 . . . . 2.0499999999999998 111.555 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.57 HD23 ' N ' ' A' ' 48' ' ' TYR . 3.9 tt -120.25 143.59 48.22 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.755 -0.831 . . . . 0.87 108.755 -176.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.57 ' N ' HD23 ' A' ' 47' ' ' LEU . 46.2 m-85 -118.46 123.56 45.47 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.888 0.375 . . . . 0.98999999999999999 110.884 -172.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 27.9 ttt180 -91.22 112.08 23.84 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.716 -0.846 . . . . 2.9199999999999999 108.716 169.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.516 HG13 ' HB3' ' A' ' 169' ' ' MET . 0.2 OUTLIER -104.95 106.82 21.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.757 0.789 . . . . 1.3300000000000001 109.523 -175.715 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 42.8 tt0 -128.68 146.52 50.86 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.819 -1.082 . . . . 1.0700000000000001 110.763 -169.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.532 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -168.81 146.83 10.64 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 111.018 -0.833 . . . . 0.28999999999999998 111.018 175.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.458 HG12 ' HE2' ' A' ' 166' ' ' LYS . 65.9 mt -92.84 116.68 34.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 117.813 0.807 . . . . 0.57999999999999996 110.428 175.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.455 HG12 ' HD3' ' A' ' 200' ' ' LYS . 70.1 mt -99.29 109.56 55.06 Favored Pre-proline 0 N--CA 1.439 -0.984 0 CA-C-N 115.314 -0.857 . . . . 0.34999999999999998 108.775 174.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 53' ' ' ILE . 32.1 Cg_exo -61.11 65.66 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 124.406 3.404 . . . . 0.62 112.551 178.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.65 ' HG2' ' CG1' ' A' ' 203' ' ' ILE . 9.9 tp10 -157.12 174.23 15.8 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.858 -1.065 . . . . 1.6799999999999999 108.144 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.476 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 38.1 t -79.94 139.49 53.59 Favored Pre-proline 0 N--CA 1.423 -1.804 0 CA-C-O 121.506 0.67 . . . . 1.1799999999999999 109.91 179.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.515 ' HB3' ' SG ' ' A' ' 155' ' ' CYS . 31.7 Cg_exo -58.05 -15.0 20.84 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 123.91 3.073 . . . . 0.52000000000000002 110.694 177.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.85 -49.15 55.27 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.519 -1.219 . . . . 0.64000000000000001 111.171 175.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.624 ' HB3' HD11 ' A' ' 203' ' ' ILE . 29.4 ttmt -71.79 -28.28 63.51 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.627 0.727 . . . . 3.2999999999999998 109.162 -177.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.034 HD23 HD13 ' A' ' 203' ' ' ILE . 68.0 mt -63.87 -51.37 64.87 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.689 -1.142 . . . . 0.40999999999999998 109.75 173.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.486 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 18.2 m -67.41 -10.94 56.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.751 -0.658 . . . . 1.29 110.413 175.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -88.8 -32.68 17.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.828 -0.624 . . . . 1.3200000000000001 111.72 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.536 ' CD2' ' HA ' ' A' ' 61' ' ' LEU . 8.7 p90 -82.02 -44.86 16.09 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.277 -0.569 . . . . 0.60999999999999999 111.186 -176.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.486 ' CD2' ' HA ' ' A' ' 62' ' ' SER . 0.8 OUTLIER -79.5 -7.66 58.6 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.372 -0.531 . . . . 1.5 111.402 -173.872 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -36.37 -57.74 0.73 Allowed 'General case' 0 N--CA 1.465 0.291 0 O-C-N 125.02 1.45 . . . . 1.52 113.399 -157.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.409 ' O ' ' HD3' ' A' ' 71' ' ' ARG . 76.9 mt-30 -156.9 -81.71 0.07 Allowed 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 112.198 0.444 . . . . 3.6000000000000001 112.198 -177.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.596 ' HB ' ' CD1' ' A' ' 81' ' ' TYR . 8.9 t -149.33 31.2 0.75 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 122.168 0.985 . . . . 1.48 109.655 -165.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.0 -39.8 4.22 Favored Glycine 0 CA--C 1.489 -1.543 0 CA-C-N 115.099 -0.955 . . . . 1.46 113.173 -169.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.51 ' O ' HG22 ' A' ' 73' ' ' THR . 3.1 p30 -163.61 -22.34 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.786 -0.707 . . . . 2.1899999999999999 111.034 -171.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.634 ' HG3' HG23 ' A' ' 72' ' ' ILE . 13.1 ptm180 -50.68 -33.17 21.57 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 122.913 0.485 . . . . 3.3799999999999999 110.553 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.634 HG23 ' HG3' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -99.37 -2.74 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 CA-C-N 115.779 -0.646 . . . . 0.70999999999999996 111.261 -177.726 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.51 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.2 t -96.42 -30.67 13.24 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 119.523 -0.871 . . . . 0.96999999999999997 110.568 -178.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.537 ' CZ2' ' HA ' ' A' ' 71' ' ' ARG . 13.7 p-90 -107.74 0.59 22.42 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.969 0.414 . . . . 0.75 111.39 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.582 ' HB3' ' O ' ' A' ' 71' ' ' ARG . 1.7 p-10 -58.9 -179.74 0.07 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 114.435 1.272 . . . . 2.1899999999999999 114.435 -172.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.511 ' HG3' ' OD1' ' A' ' 194' ' ' ASN . 0.0 OUTLIER -143.11 -2.58 1.0 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 113.438 -1.71 . . . . 3.1899999999999999 111.108 172.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 m -132.48 4.97 4.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.943 0.878 . . . . 1.5800000000000001 108.94 -176.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.527 ' HB2' ' CG ' ' A' ' 75' ' ' ASP . 91.5 mt -119.1 -170.99 2.02 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.579 -1.191 . . . . 0.70999999999999996 110.868 -174.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.47 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 8.4 mm100 -161.31 -65.39 0.06 Allowed 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.779 0.8 . . . . 1.73 109.685 -176.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.462 HG23 ' HB3' ' A' ' 79' ' ' GLN . 6.1 t -142.3 147.07 21.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.755 -1.111 . . . . 0.78000000000000003 109.146 -172.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.596 ' CD1' ' HB ' ' A' ' 68' ' ' THR . 11.6 t80 -136.29 129.61 31.7 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.807 -0.442 . . . . 5.4000000000000004 109.807 177.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -131.04 121.39 24.94 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.871 -0.788 . . . . 1.6899999999999999 108.871 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.451 ' CE ' ' HA ' ' A' ' 83' ' ' MET . 1.3 tpt -81.19 92.96 6.38 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.371 -0.831 . . . . 2.0499999999999998 108.777 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -71.93 -83.08 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.34 -0.846 . . . . 0.64000000000000001 111.112 -167.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -113.32 114.54 26.81 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.319 0.581 . . . . 1.96 109.695 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.42 ' HG2' ' HD1' ' A' ' 92' ' ' PHE . 80.9 mtm180 -97.4 108.07 20.72 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.31 -0.859 . . . . 2.4399999999999999 109.204 178.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.703 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -78.47 -47.15 24.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.865 -0.607 . . . . 0.46999999999999997 110.845 -173.501 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -146.04 -179.87 7.01 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.607 -0.886 . . . . 1.8600000000000001 108.607 -174.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.9 m -66.8 -17.01 64.66 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.155 0.428 . . . . 1.4399999999999999 112.155 -174.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -139.28 27.9 2.3 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 120.098 -0.641 . . . . 1.8700000000000001 110.37 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.703 ' O ' HG12 ' A' ' 87' ' ' ILE . 1.6 m -141.17 112.61 7.49 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 107.979 -1.119 . . . . 0.46000000000000002 107.979 177.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.575 ' O ' HD12 ' A' ' 114' ' ' LEU . 3.6 m-85 -134.88 177.03 8.12 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.984 -0.553 . . . . 0.42999999999999999 109.876 -175.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.711 ' O ' HG23 ' A' ' 84' ' ' VAL . 22.1 mt -125.8 131.03 72.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 107.336 -1.357 . . . . 0.40999999999999998 107.336 169.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.715 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 14.5 p -104.68 132.59 50.75 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.831 -0.348 . . . . 2.0099999999999998 111.731 -174.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.734 ' HA ' HD13 ' A' ' 112' ' ' ILE . 14.6 t60 -103.46 95.28 5.97 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.962 -0.755 . . . . 1.23 108.962 166.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.644 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 27.4 m -115.66 121.33 42.22 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.317 -0.856 . . . . 0.5 110.838 -174.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.446 ' O ' ' HB2' ' A' ' 79' ' ' GLN . 44.5 mm -77.95 114.99 19.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.08 -0.711 . . . . 1.03 109.08 175.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.409 ' HB ' ' HB2' ' A' ' 109' ' ' ARG . 3.0 m -93.85 136.45 34.12 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.072 -0.967 . . . . 1.3799999999999999 110.532 -175.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 24.0 mt-30 -74.77 154.63 38.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.374 0.606 . . . . 1.8200000000000001 111.065 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.4 p -85.49 71.29 10.79 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.089 -0.96 . . . . 3.9100000000000001 111.119 -178.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -81.66 97.58 7.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.151 -0.477 . . . . 5.1600000000000001 110.658 -175.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 177.68 50.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 114.762 -1.108 . . . . 1.98 109.287 175.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 90.9 t 73.05 -40.65 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 115.548 -0.751 . . . . 3.1699999999999999 111.23 -177.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 144.66 16.99 0.2 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.953 -0.641 . . . . 1.96 112.647 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.7 m -73.14 -20.45 60.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.288 0.566 . . . . 1.8799999999999999 111.121 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 17.5 mt -108.62 159.57 7.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.48 -0.782 . . . . 1.1200000000000001 110.405 -170.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 25.2 m -100.31 151.84 37.66 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 108.988 -0.745 . . . . 1.3500000000000001 108.988 172.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -50.19 126.42 17.27 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.715 2.276 . . . . 1.0700000000000001 111.401 177.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.483 ' HG2' HG23 ' A' ' 144' ' ' ILE . 19.5 mtm180 -101.82 164.53 11.68 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.502 0.668 . . . . 3.4500000000000002 112.004 -169.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.726 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 10.1 t0 -107.27 113.22 26.47 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.667 -1.151 . . . . 1.3700000000000001 108.968 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.644 ' HB3' ' HB ' ' A' ' 96' ' ' THR . 57.4 t80 -100.41 107.45 19.21 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.653 -0.869 . . . . 2.4100000000000001 108.653 -178.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.734 HD13 ' HA ' ' A' ' 95' ' ' HIS . 8.5 mm -122.41 82.73 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 CA-C-N 115.404 -0.816 . . . . 0.42999999999999999 108.911 177.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 1.9 m-20 -116.13 130.21 56.69 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.663 -0.698 . . . . 1.8600000000000001 110.276 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.695 ' O ' ' HA ' ' A' ' 129' ' ' SER . 3.8 tp -75.34 122.54 23.89 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 115.008 -0.996 . . . . 0.28000000000000003 109.519 176.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -121.8 125.45 73.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-N 114.915 -1.039 . . . . 0.26000000000000001 111.875 -163.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.648 ' HD1' ' HG1' ' A' ' 91' ' ' THR . 70.7 t80 -110.05 125.01 52.49 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.666 -1.152 . . . . 2.5699999999999998 111.075 176.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.632 HG13 HG22 ' A' ' 127' ' ' ILE . 3.7 mp -95.42 104.66 16.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.711 -0.677 . . . . 0.89000000000000001 109.371 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.505 ' HD3' ' CE1' ' A' ' 120' ' ' TYR . 36.2 tttm -109.34 149.59 29.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.119 0.485 . . . . 1.2 110.502 -175.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.1 tpp85 -126.59 97.78 5.15 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 121.65 0.738 . . . . 2.7999999999999998 109.572 -176.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.505 ' CE1' ' HD3' ' A' ' 118' ' ' LYS . 24.7 m-85 -77.28 107.65 9.84 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 106.727 -1.583 . . . . 0.82999999999999996 106.727 167.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -39.75 95.57 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 124.736 1.273 . . . . 2.2799999999999998 112.758 -175.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 64.26 36.81 93.69 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 114.514 -1.221 . . . . 0.76000000000000001 112.345 178.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.493 ' C ' ' HD2' ' A' ' 157' ' ' PRO . 2.1 t-20 -138.53 -43.2 0.49 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.535 -0.332 . . . . 1.6499999999999999 110.591 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -156.76 135.44 11.61 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.39 0.614 . . . . 1.1200000000000001 111.97 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -112.78 84.89 2.06 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.821 -1.177 . . . . 1.6200000000000001 107.821 170.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 153' ' ' PHE . 0.6 OUTLIER -105.77 136.91 38.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.624 -0.716 . . . . 0.29999999999999999 112.351 -171.184 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.704 ' O ' HG13 ' A' ' 127' ' ' ILE . 5.5 pt -111.52 103.06 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 122.279 1.038 . . . . 0.58999999999999997 109.077 167.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.541 ' HB3' ' HA ' ' A' ' 11' ' ' ALA . 28.6 p -90.45 122.39 33.26 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.657 -0.702 . . . . 1.1799999999999999 110.656 -178.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.695 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 5.3 m -120.31 140.08 51.8 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.575 -0.739 . . . . 1.24 111.108 -169.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.487 ' HE3' ' HB ' ' A' ' 6' ' ' ILE . 2.9 mtpm? -128.13 121.56 29.86 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 107.918 -1.141 . . . . 2.2599999999999998 107.918 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.438 ' HB3' ' H ' ' A' ' 148' ' ' ASN . 20.8 p -63.05 98.37 0.13 Allowed 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.32 -0.993 . . . . 1.3899999999999999 108.32 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -109.6 131.7 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 CA-C-N 114.516 -1.22 . . . . 1.05 109.084 -166.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.52 65.84 3.22 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.526 -1.216 . . . . 2.1699999999999999 108.821 -168.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.719 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 0.3 OUTLIER -95.16 156.06 38.23 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 113.86 -1.518 . . . . 0.53000000000000003 110.054 -171.48 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -69.97 -20.17 34.19 Favored 'Trans proline' 0 N--CA 1.473 0.32 0 C-N-CA 123.328 2.685 . . . . 1.28 115.337 -167.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.719 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 7.2 tp10 -72.87 -15.92 61.59 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.169 0.509 . . . . 3.5 109.824 -171.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -158.43 111.01 1.68 Allowed Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 113.314 0.857 . . . . 6.1200000000000001 113.314 175.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -97.67 144.21 0.68 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 124.033 3.156 . . . . 1.77 111.894 167.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.424 ' HG3' ' HB2' ' A' ' 145' ' ' ARG . 61.5 Cg_endo -75.64 -172.21 1.25 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.53 2.154 . . . . 1.25 112.265 178.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.5 m -141.66 -167.87 2.53 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.331 -0.989 . . . . 1.6000000000000001 108.331 -175.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.4 m -73.23 -37.04 66.52 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.056 -0.658 . . . . 1.97 111.191 -178.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -73.92 -60.39 2.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.176 0.512 . . . . 2.1800000000000002 109.89 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.602 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 36.7 m-85 -87.19 112.56 22.1 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 115.688 -0.687 . . . . 1.23 109.98 -178.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.483 HG23 ' HG2' ' A' ' 109' ' ' ARG . 1.7 tp -100.89 119.05 48.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 115.21 -0.904 . . . . 0.81999999999999995 109.262 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.726 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 28.7 ttm-85 -51.44 100.61 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 O-C-N 124.06 0.85 . . . . 4.4199999999999999 109.735 173.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -58.0 106.03 0.73 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.748 -0.941 . . . . 0.79000000000000004 110.748 176.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.433 ' HA ' ' CB ' ' A' ' 131' ' ' SER . 22.6 t80 -83.99 87.39 7.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.573 0.701 . . . . 4.4400000000000004 111.119 -172.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.753 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 24.3 m-80 -83.31 114.47 21.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.388 -0.823 . . . . 1.6200000000000001 109.807 174.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -71.33 129.49 88.9 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.254 -1.017 . . . . 2.3199999999999998 108.254 175.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.624 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 15.7 Cg_exo -16.55 69.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.973 1 C-N-CA 126.505 4.804 . . . . 0.53000000000000003 116.205 -166.143 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . 0.753 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 21.9 p -97.77 -173.79 2.71 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.818 -1.083 . . . . 1.5800000000000001 108.879 171.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.772 ' O ' ' HG3' ' A' ' 169' ' ' MET . . . -171.66 -150.26 7.05 Favored Glycine 0 CA--C 1.493 -1.323 0 C-N-CA 119.231 -1.462 . . . . 0.42999999999999999 112.262 -177.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.515 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 57.7 t80 -161.23 96.49 1.08 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.684 -0.858 . . . . 0.59999999999999998 108.684 -164.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.659 ' CG2' HG13 ' A' ' 168' ' ' VAL . 1.2 m -103.96 132.06 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-O 121.972 0.892 . . . . 0.31 110.824 -176.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . 0.515 ' SG ' ' HB3' ' A' ' 58' ' ' PRO . 10.6 t -112.4 111.69 22.72 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.068 -0.969 . . . . 1.55 109.511 177.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.492 ' HB3' ' HB3' ' A' ' 166' ' ' LYS . 27.4 t -108.9 112.34 60.24 Favored Pre-proline 0 C--N 1.316 -0.872 0 C-N-CA 120.867 -0.333 . . . . 1.0600000000000001 111.346 -166.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.493 ' HD2' ' C ' ' A' ' 123' ' ' ASN . 53.5 Cg_exo -49.66 124.41 12.21 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.424 2.083 . . . . 0.56000000000000005 111.161 172.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.62 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 0.2 OUTLIER -79.15 -167.78 1.27 Allowed 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.066 0.46 . . . . 1.1599999999999999 111.699 -175.511 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.75 -25.67 64.86 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.798 0.809 . . . . 2.6299999999999999 109.236 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -103.04 24.95 10.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.8 -1.091 . . . . 2.0499999999999998 109.011 178.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.538 ' HB2' ' HD3' ' A' ' 162' ' ' PRO . 15.4 m120 13.73 -82.59 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 126.402 1.881 . . . . 1.9299999999999999 115.67 178.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.538 ' HD3' ' HB2' ' A' ' 161' ' ' ASN . 94.3 Cg_endo -74.2 -12.02 23.19 Favored 'Trans proline' 0 C--N 1.362 1.289 0 CA-C-N 120.932 1.369 . . . . 0.72999999999999998 113.639 -172.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -102.3 -30.98 10.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.335 -0.393 . . . . 0.68000000000000005 111.452 -176.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.62 ' O ' ' HB2' ' A' ' 158' ' ' MET . 42.3 m-85 -133.78 135.51 43.92 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.607 0.242 . . . . 0.93000000000000005 110.789 177.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 26.7 t -128.8 146.7 50.84 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.415 0.626 . . . . 1.4099999999999999 111.124 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.532 ' HG3' HG12 ' A' ' 168' ' ' VAL . 14.3 tppt? -99.66 101.81 13.11 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.181 -0.918 . . . . 0.73999999999999999 111.034 -178.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -84.67 104.28 14.51 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.631 -1.168 . . . . 0.27000000000000002 108.992 178.615 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.659 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -131.86 114.15 24.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 122.509 1.147 . . . . 0.28000000000000003 111.574 177.653 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.772 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 16.8 ttt -118.8 151.09 38.69 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 114.284 -1.325 . . . . 1.24 108.284 -176.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.704 ' O ' ' HB2' ' A' ' 151' ' ' CYS . 68.8 m-85 -120.08 139.4 52.62 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 120.272 -0.571 . . . . 3.3700000000000001 110.358 173.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.416 HG21 HD21 ' A' ' 192' ' ' LEU . 1.1 t -119.13 121.47 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 O-C-N 123.854 0.722 . . . . 1.3999999999999999 110.402 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -123.98 43.37 3.0 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.326 -1.361 . . . . 2.1699999999999999 107.326 178.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 6.8 m -69.31 137.42 52.96 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 113.379 -1.737 . . . . 1.6499999999999999 111.513 -172.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.408 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 9.1 tp10 -83.95 -32.53 24.99 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.326 -0.397 . . . . 2.4500000000000002 111.213 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 24.6 mmt 56.08 57.42 5.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.41 0.624 . . . . 3.7400000000000002 110.026 -175.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -67.19 -1.64 4.7 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.129 -0.941 . . . . 5.7800000000000002 112.101 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -76.47 -160.39 10.28 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.135 -0.555 . . . . 2.2599999999999998 112.132 178.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -94.14 65.61 3.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.391 0.615 . . . . 6.2300000000000004 110.503 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 179' ' ' LEU . 2.6 mp -115.94 153.33 31.78 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.681 0.753 . . . . 1.6399999999999999 109.385 175.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.511 ' H ' ' CG1' ' A' ' 183' ' ' ILE . 15.0 t -112.19 156.96 41.19 Favored Pre-proline 0 C--N 1.304 -1.397 0 N-CA-C 105.987 -1.857 . . . . 2.04 105.987 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.577 ' O ' ' HG2' ' A' ' 185' ' ' GLU . 60.6 Cg_exo -39.1 -47.26 2.97 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 122.464 2.109 . . . . 1.74 112.958 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.496 ' O ' ' HG3' ' A' ' 186' ' ' LYS . 11.1 t -71.13 -11.99 61.25 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.506 0.558 . . . . 2.1400000000000001 112.506 -177.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.511 ' CG1' ' H ' ' A' ' 180' ' ' SER . 40.2 mm -85.97 -42.42 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-O 122.858 1.313 . . . . 1.1200000000000001 107.809 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.992 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.4 mp -63.51 -36.23 75.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 112.034 -2.348 . . . . 1.1299999999999999 109.775 175.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.577 ' HG2' ' O ' ' A' ' 181' ' ' PRO . 62.8 mm-40 -58.89 -26.26 64.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.699 -1.137 . . . . 2.8900000000000001 109.993 174.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 182' ' ' SER . 43.9 mtmt -93.13 -44.37 8.4 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.644 -0.707 . . . . 1.28 110.036 177.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.992 HG22 ' HA ' ' A' ' 184' ' ' ILE . 4.7 t -69.28 -30.8 68.98 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 115.997 -0.547 . . . . 0.62 112.049 -170.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . 0.531 ' O ' ' HG ' ' A' ' 192' ' ' LEU . 1.4 mmt -80.29 -65.1 0.28 Allowed Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 112.473 0.546 . . . . 1.0600000000000001 112.473 -172.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 33.6 Cg_endo -63.37 -25.72 71.13 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 121.73 1.62 . . . . 0.91000000000000003 112.944 -174.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.616 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 46.2 m -83.97 -31.48 25.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.912 0.387 . . . . 1.5 111.114 -177.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -90.87 -27.73 18.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.28 -0.418 . . . . 1.8799999999999999 111.623 -173.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 188' ' ' MET . 68.0 mt -75.94 -42.94 47.14 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 120.033 -0.667 . . . . 1.0900000000000001 110.312 -175.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.8 ' HB ' HD12 ' A' ' 33' ' ' ILE . 2.1 m -66.36 -31.29 52.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 108.803 -0.814 . . . . 0.68000000000000005 108.803 176.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.616 ' HB2' ' O ' ' A' ' 190' ' ' SER . 1.6 t-20 -73.4 -32.33 64.39 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.33 -1.305 . . . . 2.0699999999999998 110.311 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.56 ' O ' ' HB2' ' A' ' 198' ' ' ASN . 33.7 t80 -65.68 -30.92 71.67 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.169 -0.678 . . . . 2.0 109.169 175.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.452 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 57.0 mt -78.08 -28.82 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 115.654 -0.703 . . . . 0.31 110.554 174.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 87.8 mt -72.41 -32.74 66.61 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 121.175 0.512 . . . . 1.03 110.025 174.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.56 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 26.2 m-80 -51.19 -42.74 61.08 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.098 -1.075 . . . . 1.8999999999999999 108.098 165.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.604 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -73.88 -43.28 59.0 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 116.34 -0.391 . . . . 0.28999999999999998 110.68 -177.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.455 ' HD3' HG12 ' A' ' 54' ' ' ILE . 31.7 mmtp -54.37 -44.32 72.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.524 0.678 . . . . 0.96999999999999997 110.663 175.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.446 ' HA ' ' HG2' ' A' ' 204' ' ' LYS . 31.4 t70 -85.74 -38.88 17.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.328 -0.851 . . . . 1.9399999999999999 110.878 -174.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -68.07 -31.16 74.55 Favored Glycine 0 CA--C 1.507 -0.437 0 C-N-CA 120.397 -0.906 . . . . 0.46999999999999997 111.648 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 1.034 HD13 HD23 ' A' ' 61' ' ' LEU . 3.0 tp -71.11 -32.9 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 109.496 -0.557 . . . . 0.60999999999999999 109.496 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.657 ' O ' ' HB ' ' A' ' 208' ' ' THR . 5.6 pttp -87.29 -20.64 26.53 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 109.384 -0.598 . . . . 3.3700000000000001 109.384 177.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -62.19 -38.27 88.46 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.394 -0.965 . . . . 1.02 108.394 166.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -79.47 -42.43 25.31 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.508 -0.769 . . . . 3.6299999999999999 112.95 178.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.672 ' HG2' ' O ' ' A' ' 203' ' ' ILE . 13.4 ptm180 -93.1 -43.88 8.66 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.524 0.602 . . . . 2.5899999999999999 111.878 -174.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.657 ' HB ' ' O ' ' A' ' 204' ' ' LYS . 88.7 m -83.2 144.36 46.85 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 115.75 -0.659 . . . . 1.8400000000000001 109.431 -176.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -64.62 45.65 0.14 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.241 2.627 . . . . 2.3500000000000001 113.687 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 48.9 m -81.46 -15.11 56.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.255 0.55 . . . . 2.3100000000000001 109.813 174.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 211' ' ' ARG . 48.6 mtm180 -86.05 23.78 1.44 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.726 -0.67 . . . . 5.4500000000000002 110.618 176.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -57.61 -33.46 68.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.646 -0.707 . . . . 6.8600000000000003 110.768 176.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -130.67 50.36 0.89 Allowed Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 111.131 -0.788 . . . . 3.3700000000000001 111.131 175.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -67.69 104.97 1.76 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.866 0.365 . . . . 5.21 110.502 -176.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -83.6 -25.97 30.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.131 -0.486 . . . . 6.46 110.364 -177.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 32.3 t-80 55.06 59.63 3.92 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.432 0.634 . . . . 6.0899999999999999 110.131 177.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -84.05 8.73 14.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.794 -0.639 . . . . 5.1200000000000001 111.065 -175.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 3.6 p -68.02 -19.27 64.9 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.017 -0.538 . . . . 6.7599999999999998 111.29 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 40.6 p-80 -80.8 125.46 30.11 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.842 -0.429 . . . . 8.8200000000000003 109.842 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 14.2 t . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.925 -0.559 . . . . 8.4800000000000004 109.682 -177.881 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.484 1.25 0 CA-C-O 120.675 0.274 . . . . 3.8599999999999999 110.46 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -120.34 -85.18 0.66 Allowed 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 109.297 -0.631 . . . . 2.25 109.297 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.893 ' HA ' HD12 ' A' ' 6' ' ' ILE . 71.9 m-85 -62.81 -30.73 71.7 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.621 0.724 . . . . 0.42999999999999999 109.145 174.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.769 ' HE3' ' HE1' ' A' ' 116' ' ' TYR . 66.3 tttt -70.52 -33.96 71.76 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 107.492 -1.299 . . . . 1.51 107.492 -177.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.72 -36.57 79.16 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.215 0.531 . . . . 0.54000000000000004 110.542 177.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.893 HD12 ' HA ' ' A' ' 3' ' ' PHE . 2.0 mp -81.46 -41.29 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 CA-C-O 121.982 0.896 . . . . 1.0700000000000001 108.722 -174.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.672 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -80.09 -33.19 39.0 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.808 -1.542 . . . . 0.34000000000000002 112.147 -174.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.61 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 41.5 mt-30 -69.54 -23.58 63.6 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.788 0.804 . . . . 1.5900000000000001 109.495 175.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.572 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 14.4 mm100 -84.43 -47.85 10.24 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.426 -1.261 . . . . 2.4700000000000002 108.876 170.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.642 ' HB ' ' HA ' ' A' ' 7' ' ' ALA . 0.6 OUTLIER -55.11 -39.35 69.28 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.124 -0.943 . . . . 0.47999999999999998 112.038 178.251 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -46.54 -57.73 4.46 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.837 0.68 . . . . 0.31 112.837 174.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.431 ' H ' ' HG2' ' A' ' 12' ' ' GLN . 16.2 pt20 -80.38 -6.48 58.09 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.416 -0.356 . . . . 1.6399999999999999 111.251 -177.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 9.6 mm-40 -78.58 -51.32 10.09 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.934 -0.765 . . . . 2.54 108.934 170.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.75 HG23 ' CD2' ' A' ' 170' ' ' PHE . 7.1 p -68.22 -39.61 81.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.636 -0.711 . . . . 0.53000000000000003 110.455 177.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.522 HD12 HG11 ' A' ' 154' ' ' VAL . 0.6 OUTLIER -68.02 -19.68 64.93 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-O 122.077 0.942 . . . . 0.59999999999999998 108.619 174.744 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.534 ' HA2' ' NE ' ' A' ' 19' ' ' ARG . . . -65.1 -22.7 69.12 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 113.876 -1.511 . . . . 0.56999999999999995 110.088 175.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.438 ' HA ' ' HB3' ' A' ' 20' ' ' ASP . 13.8 m-85 -92.1 -12.03 34.13 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 114.973 -0.613 . . . . 3.27 110.088 178.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -80.47 -20.44 43.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.777 0.798 . . . . 2.0299999999999998 109.131 177.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.534 ' NE ' ' HA2' ' A' ' 16' ' ' GLY . 18.8 ptt180 -105.49 -5.57 20.15 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.079 -0.964 . . . . 2.7200000000000002 109.325 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.438 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 12.8 t70 -86.26 114.62 23.23 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 114.731 -1.122 . . . . 2.1600000000000001 110.544 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 40.8 p -134.69 101.79 5.06 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.829 -0.804 . . . . 1.8200000000000001 108.829 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.0 p -141.76 -148.87 0.25 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.404 -0.817 . . . . 2.1899999999999999 111.757 -164.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.81 63.66 1.21 Allowed Glycine 0 CA--C 1.52 0.396 0 O-C-N 123.379 0.424 . . . . 1.1000000000000001 113.289 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 1.026 ' HA ' ' HB3' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -104.96 -157.92 0.64 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.046 -0.724 . . . . 1.6699999999999999 109.046 173.05 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.426 ' HE3' ' HA ' ' A' ' 25' ' ' LYS . 1.7 tpmt? -173.75 120.06 0.3 Allowed 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.183 -1.043 . . . . 2.9500000000000002 108.183 -177.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.922 HG21 HG23 ' A' ' 29' ' ' THR . 2.7 p -64.02 116.57 3.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 C-N-CA 119.458 -0.897 . . . . 1.5600000000000001 109.531 177.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.452 HG11 ' HE2' ' A' ' 48' ' ' TYR . 11.1 p -88.86 -22.96 6.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 114.669 -1.15 . . . . 1.22 108.739 -177.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.493 ' HD3' ' HA ' ' A' ' 28' ' ' LYS . 1.9 tppp? -157.04 122.49 4.66 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 119.867 -0.733 . . . . 2.4100000000000001 112.972 -175.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.922 HG23 HG21 ' A' ' 26' ' ' VAL . 37.8 p -129.35 140.31 51.42 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.215 -0.661 . . . . 1.3799999999999999 109.215 167.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.6 m -124.8 -60.69 1.36 Allowed 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.41 -0.516 . . . . 2.3700000000000001 112.014 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -152.07 73.22 1.04 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.3 -0.409 . . . . 4.5499999999999998 110.765 -172.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.754 ' HE3' ' HB ' ' A' ' 53' ' ' ILE . 43.2 tttp 79.21 18.32 0.82 Allowed 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 122.133 0.968 . . . . 1.4199999999999999 109.431 177.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.813 HG22 ' HA3' ' A' ' 52' ' ' GLY . 5.9 pt -129.63 146.16 34.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 114.198 -1.365 . . . . 0.76000000000000001 109.704 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.724 ' HA ' HG22 ' A' ' 29' ' ' THR . 52.8 m -143.55 107.56 4.71 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.975 -1.011 . . . . 0.57999999999999996 110.814 -166.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 27' ' ' VAL . 24.4 t -100.32 103.13 14.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.888 -0.596 . . . . 0.85999999999999999 109.756 176.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.772 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 87.5 p -93.42 137.4 32.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.996 -0.547 . . . . 1.1000000000000001 110.553 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.8 t -129.09 135.35 48.79 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.173 0.511 . . . . 1.27 111.483 -177.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 1.026 ' HB3' ' HA ' ' A' ' 24' ' ' TRP . 41.8 pttt -148.04 161.04 42.19 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.151 -0.931 . . . . 1.9099999999999999 108.824 172.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.16 130.77 43.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.775 0.322 . . . . 1.6799999999999999 111.41 -177.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.626 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 21.1 p -76.0 -30.05 58.4 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.249 -0.432 . . . . 2.0899999999999999 110.585 -177.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.626 ' HG2' ' O ' ' A' ' 40' ' ' SER . 9.8 ptm180 56.42 8.64 0.45 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.032 1.333 . . . . 6.6100000000000003 113.948 173.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -93.44 -2.75 54.19 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.234 -1.024 . . . . 6.46 108.234 168.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -175.69 171.5 2.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 113.941 -1.481 . . . . 5.6500000000000004 107.405 -176.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 52.0 p-80 -79.63 72.78 6.33 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 122.0 0.905 . . . . 5.5599999999999996 110.802 -177.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.47 -173.66 28.22 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 114.988 -1.006 . . . . 1.5600000000000001 111.41 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -123.68 148.8 46.19 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.266 0.555 . . . . 2.0499999999999998 110.855 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.705 HD11 ' HE1' ' A' ' 170' ' ' PHE . 10.1 tt -105.8 153.2 22.23 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.187 -0.915 . . . . 0.87 109.565 -177.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.452 ' HE2' HG11 ' A' ' 27' ' ' VAL . 42.7 m-85 -128.29 129.99 47.16 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.81 0.338 . . . . 0.98999999999999999 111.059 -175.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.764 ' HD3' ' CZ3' ' A' ' 24' ' ' TRP . 41.0 ttt180 -106.94 119.9 40.6 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.226 -1.027 . . . . 2.9199999999999999 108.226 168.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.72 HG13 ' HB3' ' A' ' 169' ' ' MET . 0.2 OUTLIER -111.13 122.37 65.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.773 -0.649 . . . . 1.3300000000000001 109.564 -171.671 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 167' ' ' LEU . 35.3 tt0 -138.87 148.27 43.46 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.084 -0.507 . . . . 1.0700000000000001 110.633 -169.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.813 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -170.77 150.73 14.53 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 110.9 -0.88 . . . . 0.28999999999999998 110.9 173.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.754 ' HB ' ' HE3' ' A' ' 32' ' ' LYS . 85.1 mt -92.19 112.03 25.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 117.693 0.746 . . . . 0.57999999999999996 110.01 175.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.419 HG12 ' CE ' ' A' ' 200' ' ' LYS . 68.4 mt -89.71 116.4 66.25 Favored Pre-proline 0 N--CA 1.437 -1.084 0 CA-C-N 115.329 -0.851 . . . . 0.34999999999999998 109.079 176.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.41 55.44 0.31 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 124.181 3.254 . . . . 0.62 112.965 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.865 ' HG2' HG13 ' A' ' 203' ' ' ILE . 7.3 tp10 -155.98 162.85 40.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.597 -1.26 . . . . 1.6799999999999999 107.597 175.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.481 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 31.3 p -71.77 140.61 83.99 Favored Pre-proline 0 N--CA 1.432 -1.328 0 CA-C-O 121.65 0.738 . . . . 1.1799999999999999 110.795 -176.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.709 ' HD3' ' HB2' ' A' ' 165' ' ' SER . 10.0 Cg_endo -52.46 -11.42 1.19 Allowed 'Trans proline' 0 CA--C 1.527 0.162 0 C-N-CA 124.495 3.463 . . . . 0.52000000000000002 111.761 172.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.31 -46.12 61.45 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.837 -0.62 . . . . 0.64000000000000001 110.713 174.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.903 ' HE2' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -65.05 -37.36 87.32 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 107.934 -1.136 . . . . 3.2999999999999998 107.934 174.307 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.727 HD23 ' CD1' ' A' ' 203' ' ' ILE . 83.5 mt -60.69 -55.2 36.09 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.719 -1.128 . . . . 0.40999999999999998 110.187 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.554 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 28.3 t -67.93 -13.87 62.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.063 -0.517 . . . . 1.29 110.637 176.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.903 ' HB3' ' HE2' ' A' ' 60' ' ' LYS . 21.3 t70 -81.06 -49.12 11.28 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.573 -0.451 . . . . 1.3200000000000001 110.78 -178.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.655 ' CE2' ' HA ' ' A' ' 61' ' ' LEU . 17.2 p90 -70.12 -47.81 60.18 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 120.48 -0.488 . . . . 0.60999999999999999 110.876 -174.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.554 ' CD2' ' HA ' ' A' ' 62' ' ' SER . 0.8 OUTLIER -76.9 -14.27 59.89 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 120.699 -0.4 . . . . 1.5 111.463 -168.539 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.475 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 30.9 t80 -22.04 -61.17 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 O-C-N 125.233 1.583 . . . . 1.52 113.932 -163.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.599 ' H ' ' NH2' ' A' ' 71' ' ' ARG . 17.3 tm0? 175.4 -51.04 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 O-C-N 123.492 0.495 . . . . 3.6000000000000001 111.09 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.488 ' HB ' ' OE1' ' A' ' 67' ' ' GLN . 6.3 t -148.23 24.15 1.03 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.668 0.618 . . . . 1.48 112.668 -169.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.709 ' N ' HH12 ' A' ' 71' ' ' ARG . . . -129.26 0.91 6.08 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 117.928 -2.082 . . . . 1.46 115.96 -167.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.72 ' O ' HG22 ' A' ' 73' ' ' THR . 19.2 t70 -171.18 -41.46 0.02 OUTLIER 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 117.816 0.808 . . . . 2.1899999999999999 110.467 -172.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.772 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -74.89 -20.34 59.76 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-N 115.692 -0.685 . . . . 3.3799999999999999 112.038 -162.154 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.932 HG22 HD13 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -100.83 -7.98 9.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 119.102 -1.039 . . . . 0.70999999999999996 109.995 177.295 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.72 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.4 t -87.05 -35.51 18.7 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 120.24 -0.584 . . . . 0.96999999999999997 109.867 -174.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.604 ' HZ2' ' CD1' ' A' ' 64' ' ' PHE . 21.1 p-90 -105.64 -2.68 23.13 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 116.258 -0.428 . . . . 0.75 111.321 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.772 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 3.0 t70 -66.61 170.45 6.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.84 0.829 . . . . 2.1899999999999999 112.601 -169.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.503 ' HG2' ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -118.0 -21.54 8.26 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.374 -1.284 . . . . 3.1899999999999999 111.182 -177.062 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.7 m -122.66 7.4 9.44 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.194 0.521 . . . . 1.5800000000000001 109.66 -176.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.932 HD13 HG22 ' A' ' 72' ' ' ILE . 27.0 mt -108.78 179.79 4.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.77 -0.65 . . . . 0.70999999999999996 111.347 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.623 ' HB3' HG23 ' A' ' 80' ' ' VAL . 15.3 mm-40 -151.91 -67.1 0.17 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.408 -0.814 . . . . 1.73 111.349 -175.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.623 HG23 ' HB3' ' A' ' 79' ' ' GLN . 21.5 t -143.09 126.05 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.831 -0.622 . . . . 0.78000000000000003 110.3 -166.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -89.81 152.93 21.04 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.374 -0.375 . . . . 5.4000000000000004 110.09 173.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.813 ' HB3' ' HB3' ' A' ' 95' ' ' HIS . 28.1 t-20 -148.99 99.58 2.98 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.401 -0.592 . . . . 1.6899999999999999 109.401 165.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 16.9 ttp -69.9 99.1 1.35 Allowed 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.516 -0.92 . . . . 2.0499999999999998 108.516 177.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.658 HG23 ' HB ' ' A' ' 93' ' ' ILE . 0.2 OUTLIER -78.29 -95.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.718 -0.673 . . . . 0.64000000000000001 111.648 -170.576 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.487 ' H ' HG23 ' A' ' 84' ' ' VAL . 23.0 t-160 -105.2 110.46 22.84 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.642 -0.503 . . . . 1.96 109.642 -178.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -92.65 108.79 20.25 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.384 -0.599 . . . . 2.4399999999999999 109.384 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.592 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -67.39 -40.72 85.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.092 -0.958 . . . . 0.46999999999999997 109.463 -177.202 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.486 ' C ' ' H ' ' A' ' 90' ' ' ASP . 38.2 t70 -156.27 159.77 39.17 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.585 -1.643 . . . . 1.8600000000000001 107.068 -177.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.1 m -72.13 16.87 0.11 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.906 0.384 . . . . 1.4399999999999999 111.183 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.486 ' H ' ' C ' ' A' ' 88' ' ' ASP . 16.2 t70 -137.79 1.83 2.35 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.389 -0.967 . . . . 1.8700000000000001 108.389 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.592 ' O ' HG12 ' A' ' 87' ' ' ILE . 1.7 m -145.29 112.09 5.91 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 109.184 -0.672 . . . . 0.46000000000000002 109.184 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.557 ' O ' HD12 ' A' ' 114' ' ' LEU . 18.6 m-85 -123.61 177.73 5.54 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.199 0.523 . . . . 0.42999999999999999 110.883 -172.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.658 ' HB ' HG23 ' A' ' 84' ' ' VAL . 40.9 mt -132.97 127.37 55.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 107.588 -1.264 . . . . 0.40999999999999998 107.588 169.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.577 ' SG ' HG11 ' A' ' 115' ' ' VAL . 74.5 m -100.98 107.57 19.08 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.426 -0.352 . . . . 2.0099999999999998 111.921 -172.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.813 ' HB3' ' HB3' ' A' ' 82' ' ' ASN . 19.5 t-160 -82.06 74.88 9.01 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.379 -0.971 . . . . 1.23 108.379 165.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.413 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 79.5 m -95.75 111.51 23.45 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.812 -1.085 . . . . 0.5 111.982 -174.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.49 HD13 ' HB ' ' A' ' 80' ' ' VAL . 3.4 mp -78.25 123.56 35.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.992 -0.744 . . . . 1.03 108.992 172.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' A' ' 109' ' ' ARG . 91.1 m -110.35 146.94 34.91 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.951 -1.022 . . . . 1.3799999999999999 109.778 -173.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -82.88 -179.78 7.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.477 0.656 . . . . 1.8200000000000001 111.672 -173.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.691 ' HB3' ' HD3' ' A' ' 108' ' ' PRO . 2.7 p -96.68 104.17 16.14 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.191 -0.913 . . . . 3.9100000000000001 110.973 -176.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.519 ' HE2' ' HB2' ' A' ' 190' ' ' SER . 26.6 t80 -108.61 127.33 53.87 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 107.508 -1.293 . . . . 5.1600000000000001 107.508 174.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.858 ' HB3' HD12 ' A' ' 106' ' ' ILE . . . 73.01 65.13 0.1 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.579 -1.267 . . . . 1.98 107.579 -168.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.612 HG12 ' HB2' ' A' ' 100' ' ' SER . 23.0 m -71.61 27.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 114.269 -1.332 . . . . 3.1699999999999999 112.9 -171.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 102' ' ' ALA . . . -95.58 -36.5 5.33 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.648 -0.786 . . . . 1.96 111.338 174.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.636 ' HB2' HG21 ' A' ' 183' ' ' ILE . 63.7 m -139.46 -0.51 1.77 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.969 0.414 . . . . 1.8799999999999999 111.2 -178.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.858 HD12 ' HB3' ' A' ' 102' ' ' ALA . 96.9 mt -115.6 95.4 3.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.528 0.68 . . . . 1.1200000000000001 111.007 -177.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.54 ' OG ' ' HD2' ' A' ' 108' ' ' PRO . 22.8 t -79.35 159.4 72.56 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 114.758 -1.11 . . . . 1.3500000000000001 108.651 173.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.691 ' HD3' ' HB3' ' A' ' 100' ' ' SER . 47.6 Cg_exo -35.91 136.64 0.2 Allowed 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.363 2.709 . . . . 1.0700000000000001 112.966 173.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.683 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 17.2 ttm180 -123.07 126.42 47.05 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.232 0.539 . . . . 3.4500000000000002 109.779 -172.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.784 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 9.1 t0 -100.1 119.55 38.48 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.761 -0.654 . . . . 1.3700000000000001 109.256 -172.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 95' ' ' HIS . 13.0 m-85 -100.1 145.77 27.57 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.153 0.502 . . . . 2.4100000000000001 112.253 -173.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.961 HG12 ' HD2' ' A' ' 145' ' ' ARG . 29.4 mm -137.87 77.2 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 114.689 -1.142 . . . . 0.42999999999999999 108.264 170.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.41 ' OD2' ' HB3' ' A' ' 148' ' ' ASN . 1.0 OUTLIER -104.0 124.01 48.25 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.426 -0.806 . . . . 1.8600000000000001 110.514 -177.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.557 HD12 ' O ' ' A' ' 92' ' ' PHE . 12.8 tp -74.87 123.57 25.29 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.728 0.775 . . . . 0.28000000000000003 109.41 169.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.577 HG11 ' SG ' ' A' ' 94' ' ' CYS . 0.1 OUTLIER -125.81 126.76 70.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 114.564 -1.198 . . . . 0.26000000000000001 111.812 -168.232 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.885 ' HE2' ' HE2' ' A' ' 118' ' ' LYS . 87.9 t80 -111.17 128.57 55.95 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.396 -0.82 . . . . 2.5699999999999998 110.966 175.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.811 HG13 HG22 ' A' ' 127' ' ' ILE . 1.9 mp -88.82 99.93 9.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.911 -0.774 . . . . 0.89000000000000001 108.911 178.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.885 ' HE2' ' HE2' ' A' ' 116' ' ' TYR . 16.8 tppt? -97.3 123.99 41.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.773 -0.649 . . . . 1.2 110.156 -175.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -115.46 92.09 3.81 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.495 -0.775 . . . . 2.7999999999999998 110.852 -178.249 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.656 ' HB3' ' HB3' ' A' ' 123' ' ' ASN . 97.7 m-85 -70.64 101.65 2.1 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 106.147 -1.798 . . . . 0.82999999999999996 106.147 163.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -47.64 96.31 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.4 1.062 . . . . 2.2799999999999998 112.289 -173.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 72.03 43.26 49.37 Favored Glycine 0 CA--C 1.503 -0.665 0 CA-C-N 113.796 -1.547 . . . . 0.76000000000000001 111.757 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.656 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 2.4 t-20 -146.85 -49.07 0.19 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.089 -0.556 . . . . 1.6499999999999999 109.978 -178.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.568 ' HB2' ' HD2' ' A' ' 120' ' ' TYR . 1.0 OUTLIER -155.86 135.18 12.29 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.071 0.462 . . . . 1.1200000000000001 110.978 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.67 80.87 1.5 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.12 -1.067 . . . . 1.6200000000000001 108.12 175.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.744 HG23 ' HB3' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -103.56 140.66 21.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.538 -0.755 . . . . 0.29999999999999999 112.201 -172.526 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.811 HG22 HG13 ' A' ' 117' ' ' ILE . 9.0 pt -104.74 116.62 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 108.402 -0.962 . . . . 0.58999999999999997 108.402 160.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 5.0 m -75.27 163.49 27.44 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.193 -0.912 . . . . 1.1799999999999999 108.69 173.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 37.1 p -155.55 138.61 15.5 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.402 0.62 . . . . 1.24 110.852 178.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.587 ' HE3' ' HB3' ' A' ' 150' ' ' PRO . 11.4 ttmt -151.96 119.63 6.1 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.669 -0.696 . . . . 2.2599999999999998 109.231 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.3 p -64.81 106.73 1.27 Allowed 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 108.59 -0.892 . . . . 1.3899999999999999 108.59 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.5 m -104.7 151.96 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 119.546 -0.862 . . . . 1.05 109.495 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.561 ' HA ' ' CG ' ' A' ' 137' ' ' TYR . 6.5 p-10 -109.05 64.86 0.61 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 122.809 1.29 . . . . 2.1699999999999999 110.533 -170.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.748 ' CZ ' ' HB3' ' A' ' 136' ' ' GLU . 2.3 p90 -100.91 176.46 1.89 Allowed Pre-proline 0 CA--C 1.555 1.149 0 CA-C-N 113.797 -1.547 . . . . 0.53000000000000003 108.946 -176.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.657 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 23.7 Cg_exo -27.67 -59.61 0.1 OUTLIER 'Trans proline' 0 CA--C 1.548 1.218 1 C-N-CA 125.347 4.031 . . . . 1.28 117.504 -178.178 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.748 ' HB3' ' CZ ' ' A' ' 134' ' ' PHE . 4.6 tp10 -74.88 -24.97 58.64 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.439 0.533 . . . . 3.5 112.439 -173.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.955 ' HA ' HG13 ' A' ' 112' ' ' ILE . 21.2 t80 -50.68 -45.05 85.82 Favored Pre-proline 0 CA--C 1.553 1.067 0 N-CA-C 115.78 1.77 . . . . 6.1200000000000001 115.78 -173.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.475 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 36.7 Cg_exo -38.03 116.42 0.22 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 122.975 2.45 . . . . 1.77 114.185 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.665 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 9.6 Cg_endo -89.29 -165.0 0.18 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.883 3.055 . . . . 1.25 114.335 -173.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.0 m -145.03 -171.87 3.73 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.231 -0.895 . . . . 1.6000000000000001 108.617 -176.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.9 t -81.37 -30.13 33.82 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.573 -0.451 . . . . 1.97 110.593 177.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 -79.65 -29.11 40.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.364 0.602 . . . . 2.1800000000000002 110.124 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.784 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 34.9 m-85 -122.13 114.14 20.48 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.68 -0.691 . . . . 1.23 110.162 -176.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.683 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 1.5 tp -95.66 112.95 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 108.063 -1.088 . . . . 0.81999999999999995 108.063 178.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.961 ' HD2' HG12 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -57.75 123.96 17.48 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.645 -1.161 . . . . 4.4199999999999999 111.779 -174.457 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -42.27 99.52 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 113.973 -1.467 . . . . 0.79000000000000004 113.176 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 1.097 ' HB2' ' HB3' ' A' ' 174' ' ' GLU . 1.7 p90 -85.5 68.45 10.44 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.304 -0.948 . . . . 4.4400000000000004 110.902 178.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.41 ' HB3' ' OD2' ' A' ' 113' ' ' ASP . 55.9 t30 -103.31 110.49 22.49 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.112 -0.949 . . . . 1.6200000000000001 110.361 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.603 ' HB2' ' HB3' ' A' ' 172' ' ' GLN . 28.7 m170 -61.37 164.32 9.14 Favored Pre-proline 0 C--O 1.219 -0.536 0 CA-C-O 118.225 -0.893 . . . . 2.3199999999999998 108.675 171.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.587 ' HB3' ' HE3' ' A' ' 130' ' ' LYS . 7.6 Cg_endo -49.33 74.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 123.871 3.047 . . . . 0.53000000000000003 113.982 -177.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . 0.731 ' HB3' ' O ' ' A' ' 170' ' ' PHE . 18.2 m -112.65 -173.68 2.3 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.355 -0.839 . . . . 1.5800000000000001 108.745 177.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.675 ' O ' ' HG3' ' A' ' 169' ' ' MET . . . -174.98 -154.72 11.42 Favored Glycine 0 CA--C 1.494 -1.235 0 C-N-CA 118.65 -1.738 . . . . 0.42999999999999999 112.74 -178.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.453 ' CE2' HD21 ' A' ' 167' ' ' LEU . 39.4 t80 -160.07 85.16 0.74 Allowed 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.317 -0.994 . . . . 0.59999999999999998 108.317 -163.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.698 ' CG2' HG13 ' A' ' 168' ' ' VAL . 3.1 m -94.73 126.17 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 CA-C-O 121.862 0.839 . . . . 0.31 110.625 -173.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 63.9 m -106.69 106.52 17.08 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.439 -0.8 . . . . 1.55 109.171 176.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.69 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 13.2 m -101.09 120.05 56.26 Favored Pre-proline 0 C--N 1.314 -0.939 0 C-N-CA 120.796 -0.362 . . . . 1.0600000000000001 111.211 -170.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.418 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 77.6 Cg_exo -51.05 119.59 5.57 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.402 2.068 . . . . 0.56000000000000005 110.965 172.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.597 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 59.2 mmm -83.49 -167.89 1.89 Allowed 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.196 0.522 . . . . 1.1599999999999999 111.917 -174.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -65.06 -32.84 74.75 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.983 0.897 . . . . 2.6299999999999999 109.165 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -113.48 31.13 6.7 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.154 -1.385 . . . . 2.0499999999999998 109.056 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 164' ' ' TYR . 2.1 p-10 -23.37 -55.27 0.12 Allowed Pre-proline 0 N--CA 1.475 0.788 0 N-CA-C 116.505 2.039 . . . . 1.9299999999999999 116.505 -172.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.405 ' HD3' ' CG ' ' A' ' 161' ' ' ASN . 48.7 Cg_endo -67.81 -19.31 47.07 Favored 'Trans proline' 0 C--N 1.35 0.624 0 CA-C-N 121.649 1.625 . . . . 0.72999999999999998 113.146 -175.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -111.89 -22.84 10.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.355 -0.384 . . . . 0.68000000000000005 111.354 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.597 ' O ' ' HB2' ' A' ' 158' ' ' MET . 94.7 m-85 -138.93 129.3 25.67 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.436 -0.579 . . . . 0.93000000000000005 109.436 176.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.709 ' HB2' ' HD3' ' A' ' 58' ' ' PRO . 21.9 t -127.22 148.75 50.2 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.054 -0.659 . . . . 1.4099999999999999 111.598 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.69 ' HB3' ' HB2' ' A' ' 156' ' ' SER . 11.8 tppt? -91.77 100.6 13.27 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.919 0.866 . . . . 0.73999999999999999 111.261 -178.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 1.0 OUTLIER -88.37 105.78 17.81 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.91 -1.041 . . . . 0.27000000000000002 109.089 176.417 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.698 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.1 OUTLIER -132.5 120.21 41.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 122.497 1.141 . . . . 0.28000000000000003 111.927 177.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.72 ' HB3' HG13 ' A' ' 50' ' ' VAL . 19.0 ttt -122.69 160.92 24.85 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 113.999 -1.455 . . . . 1.24 108.165 -178.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.75 ' CD2' HG23 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -145.77 149.03 33.62 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.228 -1.027 . . . . 3.3700000000000001 108.228 170.553 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.477 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 8.5 p -137.43 132.31 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 O-C-N 124.147 0.904 . . . . 1.3999999999999999 111.006 -174.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.603 ' HB3' ' HB2' ' A' ' 149' ' ' HIS . 30.9 tt0 -119.93 64.83 0.82 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.587 -1.264 . . . . 2.1699999999999999 107.587 175.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.476 HG22 ' HE1' ' A' ' 147' ' ' TYR . 0.2 OUTLIER -58.07 130.54 47.08 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.885 -1.507 . . . . 1.6499999999999999 111.908 -173.032 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 1.097 ' HB3' ' HB2' ' A' ' 147' ' ' TYR . 12.1 tt0 -84.07 -24.18 30.51 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.583 0.706 . . . . 2.4500000000000002 111.948 -176.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 52.6 mtt 63.24 44.69 5.48 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 114.711 -1.131 . . . . 3.7400000000000002 111.024 168.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.555 ' CG ' ' HG2' ' A' ' 174' ' ' GLU . 17.0 mtp180 -76.41 1.17 17.14 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.594 -0.73 . . . . 5.7800000000000002 111.893 -174.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -87.2 176.71 47.16 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.896 -0.882 . . . . 2.2599999999999998 110.896 174.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -91.08 73.14 6.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 117.108 0.454 . . . . 6.2300000000000004 111.005 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.66 ' HB2' HD11 ' A' ' 184' ' ' ILE . 1.0 OUTLIER -111.8 156.03 22.62 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.234 -1.025 . . . . 1.6399999999999999 108.234 174.444 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 67.6 m -112.8 161.51 26.19 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 108.936 -0.764 . . . . 2.04 108.936 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -41.04 -46.82 5.11 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.004 2.469 . . . . 1.74 113.121 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' A' ' 186' ' ' LYS . 25.1 m -62.62 -20.21 64.54 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.419 0.525 . . . . 2.1400000000000001 112.419 -178.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.636 HG21 ' HB2' ' A' ' 105' ' ' SER . 20.6 mm -90.72 -39.71 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 CA-C-O 122.465 1.126 . . . . 1.1200000000000001 108.942 -177.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 1.005 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.0 OUTLIER -70.21 -37.54 71.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 112.91 -1.95 . . . . 1.1299999999999999 111.489 -176.788 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -67.12 -17.1 64.72 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.149 -0.686 . . . . 2.8900000000000001 109.149 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.492 ' HE2' ' HA ' ' A' ' 183' ' ' ILE . 45.8 mtmt -90.37 -49.32 6.6 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.415 -0.811 . . . . 1.28 109.211 171.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 1.005 HG22 ' HA ' ' A' ' 184' ' ' ILE . 11.3 t -60.04 -31.22 69.76 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.617 0.599 . . . . 0.62 112.617 -167.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . 0.872 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 7.0 mmt -80.11 -61.23 0.45 Allowed Pre-proline 0 C--N 1.327 -0.399 0 C-N-CA 120.488 -0.485 . . . . 1.0600000000000001 111.296 -176.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.872 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 37.8 Cg_exo -62.21 -26.14 77.4 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.132 1.888 . . . . 0.91000000000000003 112.812 -178.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.544 ' O ' ' HB3' ' A' ' 194' ' ' ASN . 98.0 p -80.7 -30.42 36.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.021 0.438 . . . . 1.5 110.713 -178.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -90.46 -34.54 15.56 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.825 -0.625 . . . . 1.8799999999999999 111.518 -172.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.536 HD22 HG11 ' A' ' 50' ' ' VAL . 78.2 mt -73.24 -42.03 63.02 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.57 -0.452 . . . . 1.0900000000000001 111.607 -174.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 189' ' ' PRO . 1.5 m -70.56 -30.08 41.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.831 -0.803 . . . . 0.68000000000000005 108.831 178.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.569 ' HA ' ' HB2' ' A' ' 197' ' ' LEU . 0.1 OUTLIER -73.88 -40.63 63.08 Favored 'General case' 0 C--O 1.208 -1.117 0 CA-C-N 114.138 -1.392 . . . . 2.0699999999999998 111.209 178.013 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.479 ' HD1' ' HA ' ' A' ' 195' ' ' PHE . 1.7 m-30 -56.9 -33.25 66.73 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 118.576 0.626 . . . . 2.0 109.88 172.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.614 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 46.4 mt -77.41 -31.07 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-N 115.973 -0.558 . . . . 0.31 111.316 174.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.569 ' HB2' ' HA ' ' A' ' 194' ' ' ASN . 24.0 mt -70.0 -40.92 75.01 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 110.182 -0.303 . . . . 1.03 110.182 176.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.413 ' HB3' ' CH2' ' A' ' 74' ' ' TRP . 3.8 m-20 -49.18 -45.33 43.97 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.974 -0.75 . . . . 1.8999999999999999 108.974 166.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.83 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -66.76 -44.75 80.59 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.965 -0.561 . . . . 0.28999999999999998 110.22 -177.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.614 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 35.3 mmtp -57.81 -45.83 85.53 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 109.446 -0.575 . . . . 0.96999999999999997 109.446 172.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -67.47 -43.97 79.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.359 -0.837 . . . . 1.9399999999999999 110.756 -171.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -78.45 -20.45 71.82 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.18 -1.01 . . . . 0.46999999999999997 111.666 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.865 HG13 ' HG2' ' A' ' 56' ' ' GLU . 1.0 OUTLIER -78.68 -34.33 17.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 123.439 0.695 . . . . 0.60999999999999999 109.885 173.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.558 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 99.2 mttt -80.16 -30.26 38.88 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 108.697 -0.853 . . . . 3.3700000000000001 108.697 177.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -58.39 -22.49 54.06 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.836 -0.62 . . . . 1.02 109.57 170.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.564 ' HB3' ' O ' ' A' ' 203' ' ' ILE . 17.2 t-80 -79.03 -48.31 14.64 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.416 -0.811 . . . . 3.6299999999999999 112.071 174.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -108.08 -32.89 7.35 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.127 0.788 . . . . 2.5899999999999999 113.127 -168.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.427 ' C ' ' H ' ' A' ' 210' ' ' SER . 31.3 m -98.07 142.71 25.02 Favored Pre-proline 0 C--N 1.317 -0.831 0 N-CA-C 110.096 -0.335 . . . . 1.8400000000000001 110.096 -176.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.9 42.23 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.624 2.216 . . . . 2.3500000000000001 112.25 174.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.427 ' H ' ' C ' ' A' ' 208' ' ' THR . 21.4 t -79.24 -18.48 52.76 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.703 -0.68 . . . . 2.3100000000000001 109.67 -178.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -86.98 18.06 3.77 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.251 0.548 . . . . 5.4500000000000002 110.552 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -57.7 -48.69 78.85 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.254 -0.884 . . . . 6.8600000000000003 108.684 169.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -81.05 67.35 3.62 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.146 -1.182 . . . . 3.3700000000000001 110.146 169.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -62.58 146.28 52.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.4 0.619 . . . . 5.21 111.6 -174.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -151.37 125.6 9.34 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.171 -0.922 . . . . 6.46 109.469 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -149.17 154.89 39.82 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.492 -0.558 . . . . 6.0899999999999999 109.492 177.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -96.47 83.71 3.57 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.893 0.378 . . . . 5.1200000000000001 110.691 -175.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 38.0 t -66.87 -35.89 81.05 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.609 -0.885 . . . . 6.7599999999999998 108.609 172.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -177.33 -23.09 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.297 -1.319 . . . . 8.8200000000000003 107.668 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 C--O 1.25 1.08 0 CA-C-N 114.945 -1.025 . . . . 8.4800000000000004 109.189 169.744 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.569 ' HB2' HG22 ' A' ' 87' ' ' ILE . 15.1 mmt . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 109.854 -0.425 . . . . 3.8599999999999999 109.854 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.445 ' OD2' HD11 ' A' ' 6' ' ' ILE . 36.4 t70 -66.94 -40.31 87.52 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.743 0.306 . . . . 2.25 110.369 -177.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.853 ' HA ' HD12 ' A' ' 6' ' ' ILE . 94.0 m-85 -64.98 -33.8 76.91 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.076 -0.712 . . . . 0.42999999999999999 109.076 -176.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.646 ' HD2' ' CB ' ' A' ' 88' ' ' ASP . 33.5 tttm -73.79 -3.58 29.42 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.021 -0.99 . . . . 1.51 110.288 177.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.463 ' O ' ' HG3' ' A' ' 9' ' ' GLN . . . -91.37 -40.98 11.15 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.559 -0.534 . . . . 0.54000000000000004 109.559 172.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.853 HD12 ' HA ' ' A' ' 3' ' ' PHE . 1.1 mp -82.51 -44.01 19.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.956 0.884 . . . . 1.0700000000000001 109.487 -172.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.534 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -70.85 -39.3 73.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.302 -1.317 . . . . 0.34000000000000002 111.422 -178.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.574 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 8.1 mt-30 -66.85 -26.14 66.76 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.99 -1.004 . . . . 1.5900000000000001 110.384 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 5' ' ' ALA . 98.7 mt-30 -80.52 -37.11 32.19 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.082 -0.963 . . . . 2.4700000000000002 108.843 172.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.654 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.4 OUTLIER -67.87 -37.48 81.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.666 -1.152 . . . . 0.47999999999999998 111.614 -178.849 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.597 ' HA ' ' OG ' ' A' ' 128' ' ' SER . . . -46.43 -58.44 3.75 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.592 0.59 . . . . 0.31 112.592 176.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.525 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 13.1 pt20 -83.14 5.39 22.8 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.056 0.455 . . . . 1.6399999999999999 110.803 -177.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.564 ' HB3' ' HA ' ' A' ' 10' ' ' THR . 0.2 OUTLIER -89.49 -49.94 6.39 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.182 -1.044 . . . . 2.54 108.182 174.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.668 HG21 ' N ' ' A' ' 152' ' ' GLY . 13.2 p -69.93 -36.44 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 121.828 0.823 . . . . 0.53000000000000003 109.555 177.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.538 ' HG ' ' OD1' ' A' ' 18' ' ' ASN . 2.1 tt -72.87 -18.72 61.4 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 114.87 -1.059 . . . . 0.59999999999999998 109.229 173.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 20' ' ' ASP . . . -61.94 -23.5 63.68 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.11 -1.405 . . . . 0.56999999999999995 109.856 172.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.446 ' HB3' ' CE2' ' A' ' 170' ' ' PHE . 6.8 m-85 -91.33 -28.79 17.51 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.099 -0.55 . . . . 3.27 110.775 177.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.538 ' OD1' ' HG ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -69.59 -15.75 63.27 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.777 -0.369 . . . . 2.0299999999999998 111.335 179.401 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -117.59 -5.48 11.18 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 119.921 -0.711 . . . . 2.7200000000000002 111.896 179.056 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 2.6 m-20 -121.99 135.75 54.87 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 120.919 0.39 . . . . 2.1600000000000001 111.205 178.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.474 HG22 ' CZ2' ' A' ' 24' ' ' TRP . 64.4 p -137.61 120.47 16.42 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.05 -0.523 . . . . 1.8200000000000001 111.411 -176.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.3 t -167.34 132.09 1.95 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.152 -0.476 . . . . 2.1899999999999999 110.204 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.87 -6.06 82.04 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.859 -0.686 . . . . 1.1000000000000001 113.669 172.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.808 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -111.75 -170.2 1.61 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.842 0.321 . . . . 1.6699999999999999 110.625 -178.231 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.443 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 7.3 mtpt -178.6 133.22 0.13 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.884 -0.784 . . . . 2.9500000000000002 108.884 -169.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.797 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 1.6 p -61.58 120.03 6.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 119.819 -0.753 . . . . 1.5600000000000001 109.305 171.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 p -95.18 -23.5 5.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 114.708 -1.133 . . . . 1.22 109.123 -177.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.422 ' HD2' ' HA ' ' A' ' 28' ' ' LYS . 11.0 tptm -156.53 129.92 8.12 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.885 -0.598 . . . . 2.4100000000000001 111.847 -173.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.472 HG23 HG21 ' A' ' 26' ' ' VAL . 40.2 p -122.09 149.44 43.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.429 -0.805 . . . . 1.3799999999999999 109.584 173.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 51.1 m -150.4 69.78 1.0 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 121.185 -0.206 . . . . 2.3700000000000001 111.204 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER 74.76 71.76 0.1 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.209 -0.451 . . . . 4.5499999999999998 110.829 177.241 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.553 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 89.5 mttt 80.04 4.54 1.92 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.337 -0.847 . . . . 1.4199999999999999 112.842 172.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.849 HG22 ' HA3' ' A' ' 52' ' ' GLY . 7.5 pt -115.66 143.61 25.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.069 0.461 . . . . 0.76000000000000001 110.151 175.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 5.0 m -136.47 104.7 5.67 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.125 -0.943 . . . . 0.57999999999999996 110.433 -163.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.682 HG22 HG23 ' A' ' 50' ' ' VAL . 3.4 t -96.48 98.85 8.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.864 -0.421 . . . . 0.85999999999999999 109.864 -178.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.797 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 25.9 t -91.96 121.68 33.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.725 0.774 . . . . 1.1000000000000001 110.357 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.3 t -109.01 135.21 50.55 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.341 -1.299 . . . . 1.27 110.56 -175.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.808 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 31.6 ttpt -121.92 -90.66 0.57 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.482 -0.781 . . . . 1.9099999999999999 110.352 178.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.843 ' HA ' ' HA ' ' A' ' 46' ' ' ASN . . . -179.49 143.34 0.19 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.419 -0.81 . . . . 1.6799999999999999 109.805 -177.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.8 m -112.03 80.79 1.37 Allowed 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.604 -0.517 . . . . 2.0899999999999999 109.604 175.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -76.83 -4.43 43.54 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.791 -0.64 . . . . 6.6100000000000003 109.781 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -63.09 -14.58 50.09 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.615 -0.72 . . . . 6.46 109.714 172.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -146.04 -93.57 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.646 -0.707 . . . . 5.6500000000000004 109.317 175.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -171.62 68.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.914 0.388 . . . . 5.5599999999999996 110.172 173.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -160.5 -140.34 2.87 Favored Glycine 0 N--CA 1.434 -1.462 0 N-CA-C 110.123 -1.191 . . . . 1.5600000000000001 110.123 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.843 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 82.2 m-20 -135.22 151.64 50.81 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 110.121 -0.326 . . . . 2.0499999999999998 110.121 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.557 HD23 ' N ' ' A' ' 48' ' ' TYR . 2.9 tt -104.89 137.34 42.81 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.169 -1.049 . . . . 0.87 108.169 178.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.557 ' N ' HD23 ' A' ' 47' ' ' LEU . 58.2 m-85 -124.47 126.42 45.87 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.392 -0.367 . . . . 0.98999999999999999 110.137 -173.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.712 ' HG3' ' CE2' ' A' ' 170' ' ' PHE . 2.5 tmm_? -113.36 120.27 40.52 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.38 -0.6 . . . . 2.9199999999999999 109.38 175.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.682 HG23 HG22 ' A' ' 35' ' ' VAL . 7.6 p -101.9 138.68 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 108.769 -0.826 . . . . 1.3300000000000001 108.769 177.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.636 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 51.6 tt0 -138.63 108.07 6.16 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.467 -0.788 . . . . 1.0700000000000001 109.351 -169.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.849 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -138.34 142.39 13.08 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.031 -1.08 . . . . 0.28999999999999998 112.195 -177.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.0 mt -86.8 124.29 40.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 C-N-CA 120.29 -0.564 . . . . 0.57999999999999996 109.886 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.539 HG12 ' HD3' ' A' ' 200' ' ' LYS . 71.7 mt -105.95 113.76 63.38 Favored Pre-proline 0 C--N 1.312 -1.05 0 N-CA-C 108.834 -0.802 . . . . 0.34999999999999998 108.834 175.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -62.18 67.49 0.12 Allowed 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 124.175 3.25 . . . . 0.62 112.043 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.698 ' HG2' ' CG1' ' A' ' 203' ' ' ILE . 8.0 tp10 -161.13 172.32 16.98 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.775 -1.194 . . . . 1.6799999999999999 107.775 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.465 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 6.2 p -82.09 144.7 51.38 Favored Pre-proline 0 N--CA 1.427 -1.575 0 CA-C-O 121.748 0.785 . . . . 1.1799999999999999 110.356 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.497 ' HB3' ' SG ' ' A' ' 155' ' ' CYS . 23.8 Cg_exo -61.71 -13.25 29.11 Favored 'Trans proline' 0 C--N 1.332 -0.297 0 C-N-CA 124.108 3.206 . . . . 0.52000000000000002 110.539 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.61 -51.47 34.83 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.526 -1.215 . . . . 0.64000000000000001 111.028 175.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.52 ' HE3' ' HB2' ' A' ' 60' ' ' LYS . 26.2 ttmt -71.06 -27.9 63.98 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.885 -0.784 . . . . 3.2999999999999998 108.885 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.054 HD23 HD13 ' A' ' 203' ' ' ILE . 42.7 mt -63.95 -53.13 55.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.697 -1.138 . . . . 0.40999999999999998 109.945 174.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.552 ' HA ' ' CD1' ' A' ' 65' ' ' LEU . 34.7 t -65.91 -11.92 50.76 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.438 -0.346 . . . . 1.29 110.317 175.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.5 ' HB2' ' HA ' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -83.1 -40.25 20.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.217 -0.447 . . . . 1.3200000000000001 111.497 -179.717 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.525 ' CD2' ' HA ' ' A' ' 61' ' ' LEU . 15.6 p90 -81.37 -42.79 19.96 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 120.813 -0.355 . . . . 0.60999999999999999 111.166 -174.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.769 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -85.87 10.17 14.64 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.709 0.29 . . . . 1.5 110.726 -173.02 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.558 ' N ' HH12 ' A' ' 71' ' ' ARG . 1.0 OUTLIER -42.99 -71.29 0.08 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.155 -0.93 . . . . 1.52 112.683 -169.207 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.41 -57.3 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.183 1.549 . . . . 3.6000000000000001 115.183 177.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.694 ' OG1' ' HB2' ' A' ' 81' ' ' TYR . 8.8 t -159.07 23.85 0.2 Allowed 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.852 -0.53 . . . . 1.48 112.298 -161.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.418 ' H ' ' CZ ' ' A' ' 71' ' ' ARG . . . -127.67 1.29 6.91 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 118.501 -1.809 . . . . 1.46 115.535 -166.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.619 ' O ' HG22 ' A' ' 73' ' ' THR . 24.5 t70 -173.27 -40.63 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 117.566 0.683 . . . . 2.1899999999999999 110.784 -169.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.695 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -54.87 -38.52 67.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.501 -0.772 . . . . 3.3799999999999999 111.362 -173.743 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.795 HG22 HD13 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -86.11 -7.46 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-O 120.969 0.414 . . . . 0.70999999999999996 110.953 -176.499 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -90.34 -26.54 19.91 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 120.077 -0.649 . . . . 0.96999999999999997 109.631 -175.584 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.506 ' CE2' ' HA ' ' A' ' 71' ' ' ARG . 24.2 p-90 -111.2 -4.68 14.91 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.595 0.591 . . . . 0.75 112.595 178.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.695 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 4.2 t70 -70.6 174.33 6.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.684 0.754 . . . . 2.1899999999999999 112.348 -171.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.585 ' HG2' ' OD1' ' A' ' 198' ' ' ASN . 1.3 mmtt -106.76 -29.04 9.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.857 -1.065 . . . . 3.1899999999999999 109.313 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.1 m -128.28 20.63 6.26 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.671 -1.15 . . . . 1.5800000000000001 111.109 -172.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.795 HD13 HG22 ' A' ' 72' ' ' ILE . 27.1 mt -110.17 155.94 21.3 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.995 0.426 . . . . 0.70999999999999996 110.45 175.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.912 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 2.7 mm-40 -128.16 -61.44 1.1 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.859 -0.609 . . . . 1.73 112.269 -170.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.71 ' CG1' ' HB ' ' A' ' 97' ' ' ILE . 2.9 p -157.15 127.02 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.644 0.735 . . . . 0.78000000000000003 111.9 -170.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.694 ' HB2' ' OG1' ' A' ' 68' ' ' THR . 48.6 p90 -89.67 143.96 26.38 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.454 -1.248 . . . . 5.4000000000000004 110.936 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.783 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 51.1 m-80 -150.03 109.41 3.98 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.193 -0.669 . . . . 1.6899999999999999 109.193 172.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.504 ' SD ' ' HB3' ' A' ' 92' ' ' PHE . 31.0 tpp -79.88 109.43 14.31 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.89 -0.782 . . . . 2.0499999999999998 108.89 177.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -85.07 -72.39 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.857 -0.61 . . . . 0.64000000000000001 110.342 -168.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.522 ' HB2' HD12 ' A' ' 93' ' ' ILE . 8.0 m-70 -126.41 121.57 32.84 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.764 -0.653 . . . . 1.96 109.741 177.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 -100.47 125.51 46.79 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.136 -1.061 . . . . 2.4399999999999999 108.136 175.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.733 HG21 ' HB2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -91.34 -58.27 3.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 116.22 -0.446 . . . . 0.46999999999999997 111.994 -167.072 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.646 ' CB ' ' HD2' ' A' ' 4' ' ' LYS . 15.6 m-20 -144.92 35.89 1.13 Allowed 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.604 -0.438 . . . . 1.8600000000000001 112.151 -165.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.9 t 73.21 -33.2 0.26 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.154 0.582 . . . . 1.4399999999999999 112.42 176.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -117.02 10.53 13.99 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 108.485 -0.932 . . . . 1.8700000000000001 108.485 -177.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.613 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -138.92 116.2 11.12 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 114.962 -1.017 . . . . 0.46000000000000002 108.394 -174.381 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.597 ' O ' HD12 ' A' ' 114' ' ' LEU . 46.5 m-85 -124.41 177.36 5.93 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.196 0.522 . . . . 0.42999999999999999 110.745 -175.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.646 ' O ' HG23 ' A' ' 84' ' ' VAL . 43.1 mt -135.83 118.03 21.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 107.515 -1.291 . . . . 0.40999999999999998 107.515 168.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 72.5 m -100.46 109.32 21.45 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.883 0.373 . . . . 2.0099999999999998 111.931 -171.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.783 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 19.6 t-160 -80.04 69.96 6.53 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.56 -0.904 . . . . 1.23 108.56 170.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.406 ' O ' ' HB2' ' A' ' 111' ' ' PHE . 96.5 m -95.92 114.72 26.47 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.511 -1.222 . . . . 0.5 111.427 -175.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.71 ' HB ' ' CG1' ' A' ' 80' ' ' VAL . 2.7 mp -85.11 127.53 39.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.614 -0.884 . . . . 1.03 108.614 172.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 109' ' ' ARG . 12.6 t -110.86 165.37 11.9 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.937 -0.574 . . . . 1.3799999999999999 110.233 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.912 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 50.5 mt-30 -115.72 74.91 0.91 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.673 -0.694 . . . . 1.8200000000000001 109.429 175.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.421 ' O ' ' HB ' ' A' ' 106' ' ' ILE . 17.3 m -79.04 32.64 0.21 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.452 0.644 . . . . 3.9100000000000001 110.606 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.571 ' CE2' ' HA2' ' A' ' 104' ' ' GLY . 43.8 t80 -61.2 98.49 0.08 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.865 -1.061 . . . . 5.1600000000000001 110.561 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.67 -71.45 0.35 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.602 -0.726 . . . . 1.98 110.809 174.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.7 t -128.48 6.15 2.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 122.16 0.981 . . . . 3.1699999999999999 108.648 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.571 ' HA2' ' CE2' ' A' ' 101' ' ' PHE . . . 106.9 0.72 36.27 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 114.576 -1.193 . . . . 1.96 110.435 -169.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -32.35 65.71 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.728 0.775 . . . . 1.8799999999999999 109.533 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.804 HG12 HD23 ' A' ' 179' ' ' LEU . 8.3 mt -113.9 116.99 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-N 114.193 -1.367 . . . . 1.1200000000000001 110.001 -172.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.403 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 14.2 m -71.58 164.12 60.54 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 115.976 -0.556 . . . . 1.3500000000000001 109.612 175.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 107' ' ' SER . 7.9 Cg_endo -51.06 113.62 1.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.072 1.848 . . . . 1.0700000000000001 110.48 172.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.661 ' HG2' HG23 ' A' ' 144' ' ' ILE . 18.7 mtm180 -90.62 137.52 32.29 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 120.321 -0.552 . . . . 3.4500000000000002 109.716 -173.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.839 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 9.9 t0 -94.42 126.85 39.95 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.905 -0.776 . . . . 1.3700000000000001 108.905 -177.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 95' ' ' HIS . 6.9 m-85 -107.17 146.34 31.46 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.61 0.719 . . . . 2.4100000000000001 111.576 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.833 HG12 ' HD2' ' A' ' 145' ' ' ARG . 25.2 mm -137.67 68.78 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 114.301 -1.318 . . . . 0.42999999999999999 107.608 172.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.853 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 1.4 m-20 -90.54 115.56 27.78 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.627 -1.17 . . . . 1.8600000000000001 110.088 -176.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.627 ' O ' ' HA ' ' A' ' 129' ' ' SER . 6.1 tp -74.84 119.18 18.67 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 108.745 -0.835 . . . . 0.28000000000000003 108.745 169.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.2 OUTLIER -122.99 124.13 69.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-N 115.033 -0.985 . . . . 0.26000000000000001 111.675 -164.24 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.534 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 79.8 t80 -107.77 119.76 40.34 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.973 -1.012 . . . . 2.5699999999999998 110.769 176.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.813 HG13 HG22 ' A' ' 127' ' ' ILE . 3.9 mp -89.85 98.87 8.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.768 -0.651 . . . . 0.89000000000000001 109.608 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.451 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 39.7 ttmt -106.77 141.4 38.08 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.702 -0.681 . . . . 1.2 109.508 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 124' ' ' MET . 0.4 OUTLIER -131.75 104.19 6.77 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 109.01 -0.737 . . . . 2.7999999999999998 109.01 -177.566 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.632 ' CB ' ' HB3' ' A' ' 123' ' ' ASN . 42.7 m-85 -71.43 114.67 9.75 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 106.959 -1.497 . . . . 0.82999999999999996 106.959 167.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -41.61 96.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 O-C-N 124.514 1.134 . . . . 2.2799999999999998 112.293 -175.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.432 ' C ' ' HG2' ' A' ' 157' ' ' PRO . . . 61.56 36.52 92.73 Favored Glycine 0 CA--C 1.508 -0.352 0 CA-C-N 114.496 -1.229 . . . . 0.76000000000000001 112.276 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.632 ' HB3' ' CB ' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -133.82 -45.81 0.8 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.524 -0.338 . . . . 1.6499999999999999 110.377 -178.614 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.532 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 0.3 OUTLIER -157.72 122.64 4.4 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.848 0.356 . . . . 1.1200000000000001 111.393 -177.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 155' ' ' CYS . 13.4 m120 -104.26 73.83 1.15 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.756 -0.831 . . . . 1.6200000000000001 108.756 174.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.678 ' HB ' HG12 ' A' ' 154' ' ' VAL . 1.2 tt -96.57 136.11 28.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 113.245 0.831 . . . . 0.29999999999999999 113.245 -172.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.813 HG22 HG13 ' A' ' 117' ' ' ILE . 21.0 pt -104.87 109.82 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-O 121.98 0.895 . . . . 0.58999999999999997 109.009 163.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.597 ' OG ' ' HA ' ' A' ' 11' ' ' ALA . 1.1 m -89.84 114.42 26.16 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.441 -0.799 . . . . 1.1799999999999999 110.709 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.853 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 79.3 p -114.21 145.05 42.22 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.57 0.7 . . . . 1.24 111.753 -172.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.811 ' HE2' ' HG3' ' A' ' 150' ' ' PRO . 6.3 mtpm? -133.78 123.75 25.41 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 107.677 -1.231 . . . . 2.2599999999999998 107.677 174.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.525 ' HB2' ' H ' ' A' ' 148' ' ' ASN . 32.6 t -64.28 98.85 0.25 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 105.926 -1.879 . . . . 1.3899999999999999 105.926 170.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.472 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.3 OUTLIER -105.41 132.62 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 CA-C-O 121.985 0.897 . . . . 1.05 109.021 -164.012 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.405 ' HA ' ' CD1' ' A' ' 137' ' ' TYR . 5.4 t70 -88.61 68.86 8.77 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 114.02 -1.445 . . . . 2.1699999999999999 109.26 -166.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.695 ' HB2' ' HD2' ' A' ' 135' ' ' PRO . 0.4 OUTLIER -107.07 175.08 2.17 Favored Pre-proline 0 CA--C 1.548 0.875 0 CA-C-N 114.997 -1.001 . . . . 0.53000000000000003 109.496 -172.226 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.695 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 3.0 Cg_exo -35.91 -51.28 1.06 Allowed 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 124.802 3.668 . . . . 1.28 116.632 -175.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.613 ' HG3' HG12 ' A' ' 84' ' ' VAL . 14.0 mm-40 -82.74 -21.59 34.67 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.5 0.667 . . . . 3.5 111.474 -172.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.78 ' HD2' ' HB ' ' A' ' 112' ' ' ILE . 60.3 t80 -56.01 -38.59 69.82 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 115.233 1.568 . . . . 6.1200000000000001 115.233 -174.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.528 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 67.8 Cg_exo -41.46 114.88 0.36 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 122.055 1.837 . . . . 1.77 112.431 173.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.618 ' HG3' ' HB2' ' A' ' 145' ' ' ARG . 1.6 Cg_endo -85.23 -153.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.792 2.995 . . . . 1.25 113.982 -173.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.2 p -136.54 -158.77 0.89 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 114.923 -1.035 . . . . 1.6000000000000001 108.572 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.3 p -90.28 -36.84 14.47 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.215 -0.594 . . . . 1.97 111.488 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -75.74 -48.27 22.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.356 -0.383 . . . . 2.1800000000000002 111.661 -178.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.756 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 94.9 m-85 -93.75 125.07 38.16 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.028 0.442 . . . . 1.23 110.102 -177.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.661 HG23 ' HG2' ' A' ' 109' ' ' ARG . 1.1 tp -106.94 105.91 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-N 115.723 -0.671 . . . . 0.81999999999999995 109.276 -177.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.839 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 0.8 OUTLIER -58.86 100.92 0.08 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.01 -0.996 . . . . 4.4199999999999999 109.818 177.816 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -63.09 117.5 11.44 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.952 -0.642 . . . . 0.79000000000000004 111.746 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.498 ' HB3' ' CB ' ' A' ' 174' ' ' GLU . 34.8 t80 -85.81 82.7 8.07 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.508 0.671 . . . . 4.4400000000000004 110.496 -176.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.648 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 88.2 m-20 -70.93 106.1 3.52 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.284 -0.871 . . . . 1.6200000000000001 109.849 173.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.502 ' O ' ' HB3' ' A' ' 172' ' ' GLN . 36.0 m-70 -68.04 131.44 92.27 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 108.347 -0.982 . . . . 2.3199999999999998 108.347 174.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.811 ' HG3' ' HE2' ' A' ' 130' ' ' LYS . 83.4 Cg_exo -17.51 68.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.927 1 C-N-CA 126.722 4.948 . . . . 0.53000000000000003 115.854 -169.409 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . 0.648 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 10.0 p -99.46 -174.6 2.77 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.077 -0.965 . . . . 1.5800000000000001 108.866 173.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.668 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -173.67 -150.98 7.86 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 119.14 -1.505 . . . . 0.42999999999999999 112.685 -177.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' A' ' 126' ' ' ILE . 23.0 t80 -162.35 93.05 0.84 Allowed 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.929 -1.137 . . . . 0.59999999999999998 107.929 -164.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.734 HG23 HG13 ' A' ' 168' ' ' VAL . 5.9 m -101.55 134.09 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-O 121.933 0.873 . . . . 0.31 110.621 -177.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 124' ' ' MET . 8.9 t -113.28 122.63 48.01 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.036 -0.984 . . . . 1.55 109.37 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.59 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 21.3 m -117.83 114.92 37.27 Favored Pre-proline 0 C--N 1.319 -0.755 0 C-N-CA 120.636 -0.426 . . . . 1.0600000000000001 112.015 -171.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.459 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 84.8 Cg_exo -49.94 121.84 8.11 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.607 2.205 . . . . 0.56000000000000005 111.544 171.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.69 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 0.5 OUTLIER -79.64 -167.73 1.33 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.156 0.503 . . . . 1.1599999999999999 112.268 -173.599 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.413 ' H ' ' HG2' ' A' ' 159' ' ' GLU . 5.2 mm-40 -63.81 -30.78 71.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.237 -0.892 . . . . 2.6299999999999999 108.631 172.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 13.5 mm-40 -103.3 26.8 7.9 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 114.536 -1.211 . . . . 2.0499999999999998 109.231 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.668 ' HB3' ' HD3' ' A' ' 162' ' ' PRO . 49.7 t-20 4.74 -77.81 0.0 OUTLIER Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 126.23 1.812 . . . . 1.9299999999999999 115.357 -177.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.668 ' HD3' ' HB3' ' A' ' 161' ' ' ASN . 71.6 Cg_endo -73.69 -13.29 24.59 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 121.396 1.397 . . . . 0.72999999999999998 113.912 -172.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -105.79 -27.0 11.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.526 -0.306 . . . . 0.68000000000000005 111.308 -176.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.69 ' O ' ' HB2' ' A' ' 158' ' ' MET . 67.8 m-85 -137.62 133.18 34.05 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.515 -0.55 . . . . 0.93000000000000005 109.515 176.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.438 ' HB3' HD11 ' A' ' 61' ' ' LEU . 32.3 t -129.23 147.55 51.08 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.228 0.537 . . . . 1.4099999999999999 110.896 177.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.636 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.6 tppp? -93.99 103.48 15.56 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 122.043 0.925 . . . . 0.73999999999999999 110.993 -178.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.42 HD11 ' CZ ' ' A' ' 153' ' ' PHE . 0.6 OUTLIER -87.26 103.45 15.46 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.345 -1.298 . . . . 0.27000000000000002 109.475 177.475 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.734 HG13 HG23 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -125.4 116.38 46.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.833 0.825 . . . . 0.28000000000000003 111.327 178.436 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 48.6 ttp -121.97 145.59 47.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.355 -0.839 . . . . 1.24 109.945 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.712 ' CE2' ' HG3' ' A' ' 49' ' ' ARG . 31.3 m-85 -119.3 134.9 54.97 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 109.098 -0.704 . . . . 3.3700000000000001 109.098 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.415 ' HB ' HD21 ' A' ' 192' ' ' LEU . 2.7 p -120.8 119.13 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-O 121.55 0.691 . . . . 1.3999999999999999 109.648 178.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.502 ' HB3' ' O ' ' A' ' 149' ' ' HIS . 9.3 tt0 -127.05 51.25 1.9 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.734 1.254 . . . . 2.1699999999999999 108.133 -176.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.551 HG22 ' H ' ' A' ' 175' ' ' MET . 11.0 m -72.63 150.89 42.63 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 113.565 -1.652 . . . . 1.6499999999999999 110.77 -174.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.7 ' HG2' ' HG3' ' A' ' 176' ' ' ARG . 3.3 tt0 -82.37 -19.76 38.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.229 0.538 . . . . 2.4500000000000002 111.136 -177.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.551 ' H ' HG22 ' A' ' 173' ' ' THR . 58.8 mtt 68.43 34.87 3.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.114 -0.948 . . . . 3.7400000000000002 111.188 169.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.7 ' HG3' ' HG2' ' A' ' 174' ' ' GLU . 45.2 mtm180 -78.82 13.46 1.69 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.198 0.523 . . . . 5.7800000000000002 109.913 177.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 175' ' ' MET . . . -91.15 33.79 4.56 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.785 -0.643 . . . . 2.2599999999999998 113.961 -171.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp 60.22 66.67 0.93 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.2 0.444 . . . . 6.2300000000000004 112.2 170.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.804 HD23 HG12 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -148.77 160.21 43.41 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.457 0.646 . . . . 1.6399999999999999 111.152 -177.259 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.474 ' O ' HD12 ' A' ' 184' ' ' ILE . 6.8 m -111.86 160.51 29.5 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 114.754 -1.112 . . . . 2.04 108.552 -178.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -41.83 -46.55 6.62 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.048 2.498 . . . . 1.74 114.109 -176.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.413 ' O ' ' HE2' ' A' ' 186' ' ' LYS . 12.2 t -72.47 -17.4 61.77 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.902 0.382 . . . . 2.1400000000000001 111.504 -177.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.406 ' HA ' ' HE3' ' A' ' 186' ' ' LYS . 21.9 mm -85.25 -35.68 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 CA-C-O 122.64 1.21 . . . . 1.1200000000000001 108.384 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 1.032 ' HA ' HG22 ' A' ' 187' ' ' THR . 0.9 OUTLIER -68.69 -32.76 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-N 112.602 -2.09 . . . . 1.1299999999999999 110.187 179.563 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.501 ' O ' ' HD2' ' A' ' 189' ' ' PRO . 12.3 mm-40 -53.47 -34.39 57.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.282 -0.872 . . . . 2.8900000000000001 109.206 167.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 190' ' ' SER . 43.4 mtmt -93.22 -12.35 30.43 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.823 -1.08 . . . . 1.28 111.917 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 1.032 HG22 ' HA ' ' A' ' 184' ' ' ILE . 6.8 t -92.98 -45.56 7.88 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 119.1 -1.04 . . . . 0.62 112.112 175.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . 0.933 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 11.2 mmt -81.42 -67.47 0.22 Allowed Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 121.184 -0.947 . . . . 1.0600000000000001 111.362 -173.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.933 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 29.5 Cg_exo -60.92 -31.4 91.48 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 121.975 1.783 . . . . 0.91000000000000003 112.118 -176.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.543 ' HB2' ' O ' ' A' ' 186' ' ' LYS . 48.7 m -77.96 -29.53 49.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.35 -0.386 . . . . 1.5 111.717 -176.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 187' ' ' THR . 7.9 m120 -90.37 -29.82 17.81 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.881 -0.328 . . . . 1.8799999999999999 111.425 -177.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' A' ' 188' ' ' MET . 42.1 mt -64.02 -48.06 77.8 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 120.907 -0.317 . . . . 1.0900000000000001 111.265 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.812 ' HB ' HD12 ' A' ' 33' ' ' ILE . 1.1 m -67.08 -35.65 74.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.445 0.64 . . . . 0.68000000000000005 109.778 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -68.15 -30.89 70.12 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.737 -1.119 . . . . 2.0699999999999998 110.94 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.495 ' O ' ' HB2' ' A' ' 198' ' ' ASN . 8.0 t80 -73.88 -27.35 61.02 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.46 -0.57 . . . . 2.0 109.46 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.456 HG21 ' CG2' ' A' ' 33' ' ' ILE . 25.6 mt -78.56 -27.78 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-O 121.353 0.597 . . . . 0.31 110.281 173.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 197' ' ' LEU . 61.1 mt -71.66 -39.63 70.18 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 109.585 -0.524 . . . . 1.03 109.585 172.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.585 ' OD1' ' HG2' ' A' ' 76' ' ' LYS . 87.0 m-20 -49.63 -38.89 33.85 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.972 -1.013 . . . . 1.8999999999999999 109.58 165.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.635 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -76.13 -42.88 45.52 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 116.356 -0.384 . . . . 0.28999999999999998 110.744 -178.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.539 ' HD3' HG12 ' A' ' 54' ' ' ILE . 35.9 mmtm -59.12 -42.42 90.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.507 0.67 . . . . 0.96999999999999997 110.904 175.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -86.66 -37.23 18.21 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.209 -0.905 . . . . 1.9399999999999999 110.641 -174.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . 0.514 ' O ' ' HB2' ' A' ' 206' ' ' HIS . . . -70.72 -29.52 69.41 Favored Glycine 0 CA--C 1.503 -0.657 0 N-CA-C 111.395 -0.682 . . . . 0.46999999999999997 111.395 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 1.054 HD13 HD23 ' A' ' 61' ' ' LEU . 2.8 tp -70.74 -33.49 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 109.629 -0.508 . . . . 0.60999999999999999 109.629 177.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.47 ' HA ' ' HB3' ' A' ' 207' ' ' ARG . 40.9 mttp -85.79 -25.03 26.57 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 109.302 -0.629 . . . . 3.3700000000000001 109.302 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.865 ' HA ' ' HB3' ' A' ' 210' ' ' SER . . . -65.38 -32.59 74.3 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.71 -0.848 . . . . 1.02 108.71 167.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.514 ' HB2' ' O ' ' A' ' 202' ' ' GLY . 1.8 t60 -92.98 -3.15 54.97 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 114.814 -1.085 . . . . 3.6299999999999999 112.086 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.47 ' HB3' ' HA ' ' A' ' 204' ' ' LYS . 0.2 OUTLIER -119.12 -48.8 2.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.872 0.844 . . . . 2.5899999999999999 110.393 -178.482 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.572 HG23 ' HD2' ' A' ' 209' ' ' PRO . 1.2 m -95.88 151.7 38.53 Favored Pre-proline 0 C--N 1.31 -1.13 0 CA-C-N 114.414 -1.267 . . . . 1.8400000000000001 109.608 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.572 ' HD2' HG23 ' A' ' 208' ' ' THR . 38.4 Cg_exo -59.04 73.78 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.146 2.564 . . . . 2.3500000000000001 113.281 176.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.865 ' HB3' ' HA ' ' A' ' 205' ' ' ALA . 18.2 t -115.31 12.32 16.37 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 122.118 0.961 . . . . 2.3100000000000001 109.136 175.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.605 ' HA ' ' HE ' ' A' ' 211' ' ' ARG . 2.0 mmp_? -102.73 11.64 37.36 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.24 -0.891 . . . . 5.4500000000000002 109.518 176.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -60.42 -25.56 66.04 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.326 -0.852 . . . . 6.8600000000000003 110.003 176.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -135.92 99.36 0.31 Allowed Glycine 0 N--CA 1.439 -1.102 0 CA-C-N 115.371 -0.831 . . . . 3.3700000000000001 111.198 174.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 211' ' ' ARG . 85.4 m-85 -75.68 179.21 5.53 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.13 -0.322 . . . . 5.21 110.13 177.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 6.9 t60 73.6 131.17 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 O-C-N 123.75 0.656 . . . . 6.46 110.814 175.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -67.05 93.09 0.27 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.565 0.698 . . . . 6.0899999999999999 109.839 174.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -78.29 46.88 0.64 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.183 -0.917 . . . . 5.1200000000000001 112.512 -172.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 46.7 t -110.18 7.71 23.42 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.362 -0.381 . . . . 6.7599999999999998 110.161 177.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 81.7 t60 57.61 41.15 26.06 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.854 0.835 . . . . 8.8200000000000003 110.408 -178.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 39.4 m . . . . . 0 C--O 1.246 0.873 0 CA-C-O 118.134 -0.936 . . . . 8.4800000000000004 109.449 179.484 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.417 ' HB3' ' HB2' ' A' ' 4' ' ' LYS . 14.1 tpt . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 111.23 0.085 . . . . 3.8599999999999999 111.23 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.518 ' O ' HD13 ' A' ' 6' ' ' ILE . 32.4 t70 -174.4 -77.86 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 110.128 -0.323 . . . . 2.25 110.128 -177.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.918 ' HA ' HD11 ' A' ' 6' ' ' ILE . 70.4 m-85 -61.78 -31.01 71.19 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 108.313 -0.995 . . . . 0.42999999999999999 108.313 172.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.556 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 36.7 tttp -60.34 -49.0 79.32 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 113.803 -1.544 . . . . 1.51 107.674 177.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -50.11 -46.31 53.55 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.972 -0.558 . . . . 0.54000000000000004 112.227 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.918 HD11 ' HA ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -81.52 -36.81 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 CA-C-O 121.634 0.731 . . . . 1.0700000000000001 110.02 -172.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.674 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -80.63 -30.57 36.69 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.588 -1.187 . . . . 0.34000000000000002 111.568 -175.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.556 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 33.9 mt-30 -65.78 -32.24 73.66 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.783 -1.098 . . . . 1.5900000000000001 109.087 175.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.616 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 12.5 mm100 -81.02 -45.38 16.65 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.418 -1.265 . . . . 2.4700000000000002 109.059 175.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.553 ' HB ' ' HA ' ' A' ' 7' ' ' ALA . 0.6 OUTLIER -56.26 -37.4 69.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.202 -0.908 . . . . 0.47999999999999998 111.192 176.78 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.578 ' HA ' ' CB ' ' A' ' 128' ' ' SER . . . -46.86 -60.84 2.16 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 120.819 0.343 . . . . 0.31 111.796 173.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -79.04 -6.62 56.83 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.323 -0.399 . . . . 1.6399999999999999 111.087 -177.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.616 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 34.3 mm-40 -78.98 -47.21 16.74 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.248 0.547 . . . . 2.54 109.545 172.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.681 HG21 ' N ' ' A' ' 152' ' ' GLY . 9.9 p -74.63 -41.39 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.77 0.795 . . . . 0.53000000000000003 109.115 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 tt -68.72 -21.2 64.41 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-O 121.719 0.771 . . . . 0.59999999999999998 109.155 174.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.37 -17.54 61.99 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 114.017 -1.447 . . . . 0.56999999999999995 110.59 172.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.656 ' HD2' ' O ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -86.49 -33.47 20.33 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.541 -0.911 . . . . 3.27 108.541 177.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.525 ' ND2' HG21 ' A' ' 168' ' ' VAL . 2.8 t-20 -75.97 -6.47 51.1 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.648 0.737 . . . . 2.0299999999999998 110.269 -176.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -120.55 11.31 11.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.476 -0.784 . . . . 2.7200000000000002 110.582 176.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -139.01 111.4 7.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.154 -0.476 . . . . 2.1600000000000001 109.772 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 44.4 p -129.01 109.28 11.08 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.102 0.477 . . . . 1.8200000000000001 111.933 -171.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.2 p -170.47 160.31 7.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.659 -0.7 . . . . 2.1899999999999999 111.119 -175.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.63 5.72 57.01 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 116.131 -0.486 . . . . 1.1000000000000001 113.981 172.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.671 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -120.42 -163.8 1.04 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.922 0.361 . . . . 1.6699999999999999 110.368 -177.363 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.59 135.18 0.23 Allowed 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.451 -0.795 . . . . 2.9500000000000002 109.357 -178.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.678 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 2.3 m -66.97 118.7 11.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-O 121.81 0.814 . . . . 1.5600000000000001 111.001 176.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.621 ' O ' ' HD2' ' A' ' 28' ' ' LYS . 11.4 p -95.87 -28.83 3.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 114.465 -1.243 . . . . 1.22 109.446 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.621 ' HD2' ' O ' ' A' ' 27' ' ' VAL . 4.1 mptp? -151.05 133.87 15.77 Favored 'General case' 0 C--O 1.216 -0.7 0 C-N-CA 120.06 -0.656 . . . . 2.4100000000000001 110.829 -170.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.535 ' HB ' ' HA ' ' A' ' 34' ' ' THR . 0.0 OUTLIER -153.0 152.1 31.02 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.902 0.382 . . . . 1.3799999999999999 111.3 175.074 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.453 ' HB3' HG12 ' A' ' 33' ' ' ILE . 27.0 t -117.03 27.22 9.26 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.909 -0.587 . . . . 2.3700000000000001 110.591 -176.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? 68.48 24.35 7.12 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.814 0.816 . . . . 4.5499999999999998 109.695 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.499 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 6.4 tptm -167.24 -40.75 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.921 -1.036 . . . . 1.4199999999999999 109.209 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.565 HG22 ' HA3' ' A' ' 52' ' ' GLY . 21.1 pt -109.66 152.51 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 CA-C-N 115.242 -0.89 . . . . 0.76000000000000001 108.983 170.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.535 ' HA ' ' HB ' ' A' ' 29' ' ' THR . 56.6 m -146.29 119.41 8.84 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 123.456 0.472 . . . . 0.57999999999999996 110.717 -168.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.868 HG22 HG12 ' A' ' 50' ' ' VAL . 3.7 t -109.9 110.87 33.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.86 -0.609 . . . . 0.85999999999999999 110.609 -175.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.678 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 97.5 p -100.65 131.49 46.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.192 -0.458 . . . . 1.1000000000000001 109.934 177.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.8 p -102.76 125.0 49.33 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.892 -0.595 . . . . 1.27 110.991 -177.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.671 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 35.7 ttpt -137.74 120.13 15.89 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.6 -0.727 . . . . 1.9099999999999999 109.607 177.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 46' ' ' ASN . . . -43.11 137.24 2.57 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.523 0.514 . . . . 1.6799999999999999 111.998 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 42' ' ' LYS . 10.3 m -68.52 -163.42 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.605 -0.725 . . . . 2.0899999999999999 111.834 -177.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.43 ' O ' ' HB2' ' A' ' 42' ' ' LYS . 25.8 ttt180 -70.38 14.54 0.12 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.25 -0.886 . . . . 6.6100000000000003 110.724 173.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.482 ' H ' ' C ' ' A' ' 40' ' ' SER . 71.1 mmtt 69.68 40.48 1.36 Allowed 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.452 0.644 . . . . 6.46 110.842 176.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -134.03 -30.23 1.22 Allowed 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.379 -0.828 . . . . 5.6500000000000004 109.985 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -105.27 -65.19 1.07 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.888 -0.597 . . . . 5.5599999999999996 109.87 173.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.16 -93.81 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.789 -0.925 . . . . 1.5600000000000001 110.789 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 48.2 m-80 -121.36 140.95 51.44 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.707 0.289 . . . . 2.0499999999999998 110.369 177.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.777 ' HG ' ' HB2' ' A' ' 172' ' ' GLN . 2.2 tt -93.27 151.67 19.66 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 106.903 -1.517 . . . . 0.87 106.903 174.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.77 ' H ' HD23 ' A' ' 47' ' ' LEU . 49.9 m-85 -135.73 137.77 42.03 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.305 -0.558 . . . . 0.98999999999999999 110.87 -170.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.718 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.9 OUTLIER -114.61 131.76 56.59 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 116.014 -0.539 . . . . 2.9199999999999999 110.841 177.759 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.868 HG12 HG22 ' A' ' 35' ' ' VAL . 0.8 OUTLIER -113.11 143.99 21.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.272 0.558 . . . . 1.3300000000000001 110.543 168.695 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.729 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 33.1 tt0 -140.94 109.19 5.81 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.897 -1.047 . . . . 1.0700000000000001 108.921 178.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.565 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -136.55 143.52 14.93 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.569 -0.824 . . . . 0.28999999999999998 111.199 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 59.5 mt -88.23 112.48 23.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 C-N-CA 119.936 -0.706 . . . . 0.57999999999999996 110.352 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.698 HG12 ' HB2' ' A' ' 167' ' ' LEU . 20.8 mm -85.64 114.38 56.33 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 108.373 -0.973 . . . . 0.34999999999999998 108.373 174.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -66.27 57.86 0.45 Allowed 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 123.584 2.856 . . . . 0.62 112.921 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.445 ' HB3' HG12 ' A' ' 203' ' ' ILE . 12.5 tp10 -158.81 168.1 27.71 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.521 -0.918 . . . . 1.6799999999999999 108.521 174.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.439 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 34.7 p -70.59 147.41 94.65 Favored Pre-proline 0 N--CA 1.432 -1.335 0 CA-C-O 121.811 0.815 . . . . 1.1799999999999999 110.849 -177.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.471 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 18.7 Cg_exo -63.71 -9.33 18.13 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.911 3.074 . . . . 0.52000000000000002 110.585 178.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.83 -54.47 13.43 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.902 -1.045 . . . . 0.64000000000000001 110.87 175.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.714 ' HE3' ' O ' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -69.63 -24.17 63.6 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.443 -0.947 . . . . 3.2999999999999998 108.443 178.235 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.777 ' O ' HD12 ' A' ' 65' ' ' LEU . 29.6 mt -63.64 -58.46 6.85 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.508 -0.552 . . . . 0.40999999999999998 109.508 173.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.7 t -64.88 -10.86 31.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.06 0.457 . . . . 1.29 110.435 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.482 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 32.1 t70 -88.06 -37.34 16.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.995 -0.548 . . . . 1.3200000000000001 111.935 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.645 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 10.1 p90 -85.45 -45.67 11.62 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.371 -0.531 . . . . 0.60999999999999999 111.259 -174.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.777 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -84.34 7.33 19.78 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.461 -0.57 . . . . 1.5 109.461 -172.758 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -48.93 -70.06 0.1 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.341 -1.299 . . . . 1.52 111.613 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.701 ' HG3' ' SG ' ' A' ' 94' ' ' CYS . 46.3 tt0 -179.38 -43.04 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.611 0.72 . . . . 3.6000000000000001 110.159 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.1 t -149.72 29.43 0.75 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.158 -0.928 . . . . 1.48 109.283 -174.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 70' ' ' ASP . . . -74.42 -36.67 49.11 Favored Glycine 0 N--CA 1.434 -1.499 0 C-N-CA 120.579 -0.819 . . . . 1.46 111.652 -170.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.645 ' OD1' ' HA ' ' A' ' 64' ' ' PHE . 20.7 p-10 163.73 -21.04 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 113.894 -1.153 . . . . 2.1899999999999999 108.274 -164.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.778 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 1.2 ptp180 -39.64 -53.45 2.15 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-N 114.669 -1.151 . . . . 3.3799999999999999 111.142 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.674 HG22 HD13 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -82.01 -13.13 12.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.347 -0.541 . . . . 0.70999999999999996 111.447 -171.298 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.645 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.3 t -84.97 -30.16 24.47 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.592 -0.843 . . . . 0.96999999999999997 109.949 -175.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.456 ' CZ2' ' HA3' ' A' ' 202' ' ' GLY . 17.8 p-90 -111.86 -4.07 14.71 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.442 0.534 . . . . 0.75 112.442 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.778 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 3.6 t70 -62.42 168.14 3.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 122.26 1.028 . . . . 2.1899999999999999 113.655 -168.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.538 ' HG3' ' OD1' ' A' ' 198' ' ' ASN . 13.0 mmmt -90.95 -35.78 14.5 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.482 -1.69 . . . . 3.1899999999999999 109.322 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.584 ' HA ' ' HB2' ' A' ' 99' ' ' GLN . 50.8 m -137.98 26.01 2.74 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.384 -1.28 . . . . 1.5800000000000001 112.019 -171.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.674 HD13 HG22 ' A' ' 72' ' ' ILE . 44.2 mt -110.34 166.22 11.15 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.509 -0.476 . . . . 0.70999999999999996 110.753 175.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.514 ' HB3' HG23 ' A' ' 80' ' ' VAL . 21.0 mm-40 -144.1 -63.85 0.37 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.807 -0.633 . . . . 1.73 111.346 -175.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.514 HG23 ' HB3' ' A' ' 79' ' ' GLN . 19.8 t -140.49 117.61 8.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.883 -0.599 . . . . 0.78000000000000003 111.0 -166.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -90.78 152.17 20.9 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.806 -0.442 . . . . 5.4000000000000004 109.806 171.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.774 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 19.9 m120 -145.85 117.19 7.94 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.336 -0.987 . . . . 1.6899999999999999 108.336 168.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.447 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 6.5 ttt -79.31 89.59 4.95 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.563 -0.903 . . . . 2.0499999999999998 108.563 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -69.33 -81.57 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 115.647 -0.706 . . . . 0.64000000000000001 111.231 -167.128 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.448 ' HB3' HD12 ' A' ' 93' ' ' ILE . 11.2 t60 -121.06 118.2 29.18 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.381 -0.6 . . . . 1.96 109.381 -178.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.447 ' HD3' ' SD ' ' A' ' 83' ' ' MET . 1.5 mtm180 -99.5 100.71 11.78 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.981 -0.554 . . . . 2.4399999999999999 109.636 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.623 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -70.84 -41.25 77.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.399 -0.819 . . . . 0.46999999999999997 110.588 -173.587 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -155.44 166.71 32.71 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.73 -1.123 . . . . 1.8600000000000001 108.456 -172.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.9 m -62.33 -11.69 16.81 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.211 0.448 . . . . 1.4399999999999999 112.211 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -128.27 11.45 6.42 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 120.761 -0.376 . . . . 1.8700000000000001 110.226 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.623 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.7 OUTLIER -135.35 110.34 8.82 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.327 -0.62 . . . . 0.46000000000000002 109.327 -174.066 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.564 ' O ' HD12 ' A' ' 114' ' ' LEU . 21.3 m-85 -128.85 171.46 12.26 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.745 -0.662 . . . . 0.42999999999999999 110.616 -174.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.669 ' O ' HG23 ' A' ' 84' ' ' VAL . 32.5 mt -127.2 126.65 68.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 107.542 -1.281 . . . . 0.40999999999999998 107.542 168.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.701 ' SG ' ' HG3' ' A' ' 67' ' ' GLN . 42.0 t -108.84 106.0 15.8 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.75 -0.659 . . . . 2.0099999999999998 111.198 -165.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.774 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 39.0 t-80 -82.45 116.38 21.88 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.64 -0.874 . . . . 1.23 108.64 170.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.749 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 62.3 m -134.61 116.03 14.52 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 112.446 0.536 . . . . 0.5 112.446 -177.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 49.5 mm -78.11 128.19 38.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.678 -0.49 . . . . 1.03 109.678 174.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.727 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 2.1 m -102.6 147.66 26.52 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.691 -0.686 . . . . 1.3799999999999999 110.905 -175.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.584 ' HB2' ' HA ' ' A' ' 77' ' ' SER . 0.8 OUTLIER -80.83 168.46 18.75 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.693 -0.685 . . . . 1.8200000000000001 111.232 179.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.611 ' HA ' ' O ' ' A' ' 106' ' ' ILE . 3.0 m -94.59 104.18 16.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.469 -0.787 . . . . 3.9100000000000001 111.039 -176.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -112.97 174.34 5.95 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 109.524 -0.547 . . . . 5.1600000000000001 109.524 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.567 ' O ' HG12 ' A' ' 103' ' ' VAL . . . 60.27 61.35 1.82 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.217 -0.901 . . . . 1.98 110.162 -172.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 102' ' ' ALA . 0.3 OUTLIER 69.96 -21.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.09 1.356 . . . . 3.1699999999999999 112.813 176.396 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.6 -1.08 11.22 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.307 -0.949 . . . . 1.96 111.984 -178.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.2 m -60.73 -35.38 76.21 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.869 0.842 . . . . 1.8799999999999999 108.88 174.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.611 ' O ' ' HA ' ' A' ' 100' ' ' SER . 20.3 mt -92.32 73.66 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 CA-C-N 114.586 -1.188 . . . . 1.1200000000000001 108.634 175.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.653 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 13.2 m -65.51 174.13 1.63 Allowed Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.087 -0.96 . . . . 1.3500000000000001 110.867 -175.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.653 ' HD2' ' HB3' ' A' ' 107' ' ' SER . 81.6 Cg_exo -42.39 111.14 0.18 Allowed 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 122.761 2.308 . . . . 1.0700000000000001 112.521 -175.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.727 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 33.3 ttp180 -100.26 159.86 14.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.603 -0.726 . . . . 3.4500000000000002 110.408 -174.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.962 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 12.7 t70 -115.02 131.18 57.01 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.507 -0.553 . . . . 1.3700000000000001 109.507 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.749 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 6.2 m-85 -108.88 127.7 54.27 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.079 0.466 . . . . 2.4100000000000001 111.076 173.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.645 ' CG2' ' HE1' ' A' ' 134' ' ' PHE . 14.7 mm -134.35 77.42 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.955 -1.02 . . . . 0.42999999999999999 108.481 169.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.701 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 0.5 OUTLIER -107.32 129.94 54.84 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.273 -0.876 . . . . 1.8600000000000001 110.592 -178.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.617 ' O ' ' HA ' ' A' ' 129' ' ' SER . 7.6 tp -78.71 118.35 20.71 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-N 115.558 -0.746 . . . . 0.28000000000000003 109.285 172.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.483 HG23 ' HB ' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -118.65 126.24 75.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 CA-C-N 114.931 -1.032 . . . . 0.26000000000000001 111.137 -166.078 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.674 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 57.0 t80 -108.51 113.48 26.54 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.25 -0.886 . . . . 2.5699999999999998 110.39 174.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.67 HG12 HG22 ' A' ' 127' ' ' ILE . 56.4 mt -98.19 98.54 7.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.638 -0.71 . . . . 0.89000000000000001 109.767 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.609 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 34.0 ttpt -117.73 134.61 54.73 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.232 0.539 . . . . 1.2 110.256 176.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.672 ' HD2' ' O ' ' A' ' 119' ' ' ARG . 1.0 OUTLIER -103.01 118.38 36.69 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.542 -0.91 . . . . 2.7999999999999998 108.542 175.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.567 ' HB3' ' HB3' ' A' ' 123' ' ' ASN . 12.2 m-85 -74.4 107.91 6.85 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.2 -1.778 . . . . 0.82999999999999996 106.2 164.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.411 ' HA ' HH11 ' A' ' 119' ' ' ARG . 6.5 pt-20 -37.27 98.87 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 O-C-N 124.55 1.156 . . . . 2.2799999999999998 113.389 -175.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 57.53 47.09 90.78 Favored Glycine 0 CA--C 1.503 -0.662 0 CA-C-N 113.53 -1.668 . . . . 0.76000000000000001 111.658 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.567 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . 50.0 t30 -144.96 -53.89 0.3 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.616 -0.792 . . . . 1.6499999999999999 109.886 -173.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.42 ' HG3' ' OG ' ' A' ' 156' ' ' SER . 1.9 mpp? -159.04 122.41 3.76 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.562 -0.29 . . . . 1.1200000000000001 110.484 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -104.92 81.52 1.75 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.441 -0.948 . . . . 1.6200000000000001 108.441 177.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.636 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.4 OUTLIER -103.16 141.96 18.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.241 -0.89 . . . . 0.29999999999999999 112.739 -170.789 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.67 HG22 HG12 ' A' ' 117' ' ' ILE . 2.9 pt -110.28 115.5 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 108.398 -0.964 . . . . 0.58999999999999997 108.398 161.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.578 ' CB ' ' HA ' ' A' ' 11' ' ' ALA . 15.4 p -99.4 114.98 28.21 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.968 -0.56 . . . . 1.1799999999999999 110.424 177.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.701 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 9.4 p -109.71 144.9 37.45 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.394 0.616 . . . . 1.24 112.046 -173.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.413 ' HE3' ' HB ' ' A' ' 6' ' ' ILE . 4.8 mtpm? -127.9 123.8 35.85 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 107.618 -1.253 . . . . 2.2599999999999998 107.618 176.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.429 ' HB3' ' N ' ' A' ' 148' ' ' ASN . 7.0 p -65.13 94.3 0.14 Allowed 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.72 -0.844 . . . . 1.3899999999999999 108.72 177.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.432 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.6 OUTLIER -107.56 129.2 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 CA-C-N 115.152 -0.931 . . . . 1.05 109.26 -166.312 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -99.3 70.78 1.76 Allowed 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 114.309 -1.314 . . . . 2.1699999999999999 107.916 -167.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.858 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 0.5 OUTLIER -101.89 154.87 37.05 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 113.552 -1.658 . . . . 0.53000000000000003 109.829 -169.548 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.04 -1.6 11.28 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.433 2.088 . . . . 1.28 116.041 -168.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.858 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 4.7 tp10 -76.74 -13.8 60.0 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.073 -1.084 . . . . 3.5 108.073 -178.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.429 ' HB2' HG11 ' A' ' 84' ' ' VAL . 26.1 t80 -162.8 114.95 1.1 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.119 -0.946 . . . . 6.1200000000000001 112.436 175.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 137' ' ' TYR . 19.7 Cg_endo -95.32 140.33 1.02 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.661 2.907 . . . . 1.77 111.346 168.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.472 ' HG3' ' HB2' ' A' ' 145' ' ' ARG . 37.3 Cg_endo -70.85 -164.58 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.588 2.192 . . . . 1.25 112.965 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.3 t -139.26 -173.49 3.61 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.237 -1.023 . . . . 1.6000000000000001 108.237 -176.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.0 t -82.46 -41.39 19.86 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.248 -0.581 . . . . 1.97 110.265 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -57.15 -52.46 65.21 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.144 0.497 . . . . 2.1800000000000002 110.309 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.962 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 61.9 m-85 -95.82 109.99 22.23 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.316 -0.856 . . . . 1.23 109.424 -175.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.999 HD11 ' HB2' ' A' ' 176' ' ' ARG . 0.7 OUTLIER -88.46 107.52 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-N 115.67 -0.696 . . . . 0.81999999999999995 109.611 -176.256 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.553 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 31.5 ttp85 -56.69 105.53 0.22 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.796 -0.638 . . . . 4.4199999999999999 110.129 178.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.75 118.0 12.96 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.707 -0.679 . . . . 0.79000000000000004 112.006 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.88 ' HB3' ' HB3' ' A' ' 174' ' ' GLU . 17.9 t80 -85.62 70.29 10.72 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.511 0.672 . . . . 4.4400000000000004 109.628 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.651 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 11.6 t30 -64.69 96.56 0.18 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.47 -0.786 . . . . 1.6200000000000001 110.083 176.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.86 117.74 28.39 Favored Pre-proline 0 C--O 1.222 -0.382 0 CA-C-N 115.758 -0.655 . . . . 2.3199999999999998 110.242 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -18.32 70.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.101 1 C-N-CA 126.438 4.758 . . . . 0.53000000000000003 115.664 -165.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 170' ' ' PHE . 4.4 p -122.99 169.71 10.89 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.789 -1.189 . . . . 1.5800000000000001 107.789 172.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.681 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -152.21 -146.15 4.29 Favored Glycine 0 N--CA 1.434 -1.49 0 C-N-CA 118.325 -1.893 . . . . 0.42999999999999999 113.805 -165.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.428 ' CZ ' HD11 ' A' ' 167' ' ' LEU . 5.8 t80 -161.36 96.77 1.08 Allowed 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.995 -1.113 . . . . 0.59999999999999998 107.995 -162.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.693 HG23 HG13 ' A' ' 168' ' ' VAL . 4.5 m -105.83 137.88 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-O 121.679 0.752 . . . . 0.31 110.746 -175.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 83.8 m -117.71 109.63 16.85 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.161 -0.927 . . . . 1.55 109.899 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.567 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 15.4 m -111.06 125.59 30.34 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 120.794 -0.362 . . . . 1.0600000000000001 111.51 -168.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 156' ' ' SER . 10.7 Cg_endo -54.54 121.05 9.08 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 122.454 2.102 . . . . 0.56000000000000005 111.368 174.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.617 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 61.1 mmm -80.12 -162.85 0.48 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.217 0.532 . . . . 1.1599999999999999 111.79 -176.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -70.44 -35.07 73.15 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.52 -0.763 . . . . 2.6299999999999999 109.408 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -103.22 30.97 4.53 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.045 -0.98 . . . . 2.0499999999999998 109.143 173.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.745 ' OD1' ' HD3' ' A' ' 162' ' ' PRO . 0.3 OUTLIER -19.77 -57.16 0.06 OUTLIER Pre-proline 0 N--CA 1.479 0.989 0 N-CA-C 117.164 2.283 . . . . 1.9299999999999999 117.164 -171.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.745 ' HD3' ' OD1' ' A' ' 161' ' ' ASN . 69.8 Cg_endo -72.91 -18.17 24.71 Favored 'Trans proline' 0 C--N 1.351 0.701 0 CA-C-N 121.798 1.678 . . . . 0.72999999999999998 113.255 -175.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -108.07 -26.61 10.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.196 -0.456 . . . . 0.68000000000000005 110.92 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.617 ' O ' ' HB2' ' A' ' 158' ' ' MET . 94.1 m-85 -138.33 128.36 25.56 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.181 -0.674 . . . . 0.93000000000000005 109.181 177.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.472 ' HB3' HD11 ' A' ' 61' ' ' LEU . 26.6 t -125.93 151.59 46.76 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.38 0.61 . . . . 1.4099999999999999 111.599 -177.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.729 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 2.0 tppp? -90.73 103.45 16.15 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 122.019 0.914 . . . . 0.73999999999999999 111.472 -176.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.727 HD12 HG12 ' A' ' 196' ' ' ILE . 0.5 OUTLIER -88.06 103.61 15.88 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.406 -1.27 . . . . 0.27000000000000002 109.429 176.111 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.693 HG13 HG23 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -127.82 132.43 68.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.087 -0.645 . . . . 0.28000000000000003 111.876 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.514 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 20.8 ttt -144.41 137.98 27.41 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.37 -0.377 . . . . 1.24 111.819 -170.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.674 ' CE1' ' HB2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -110.84 135.17 51.8 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 109.182 -0.673 . . . . 3.3700000000000001 109.182 173.439 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 1.029 ' HB ' HD21 ' A' ' 192' ' ' LEU . 1.3 t -134.43 120.82 34.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 O-C-N 123.661 0.601 . . . . 1.3999999999999999 111.056 177.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.777 ' HB2' ' HG ' ' A' ' 47' ' ' LEU . 1.3 tm0? -105.04 -32.64 8.62 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.462 -1.31 . . . . 2.1699999999999999 107.462 168.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.651 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 13.2 m 20.75 107.86 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 O-C-N 126.281 2.238 . . . . 1.6499999999999999 113.165 176.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.88 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 15.2 tp10 -77.36 -19.78 55.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.043 -0.526 . . . . 2.4500000000000002 111.769 -161.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.651 ' HE2' HD11 ' A' ' 179' ' ' LEU . 95.6 mmm 46.62 52.75 10.77 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 110.249 -0.278 . . . . 3.7400000000000002 110.249 177.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.999 ' HB2' HD11 ' A' ' 144' ' ' ILE . 15.9 mmm180 -28.38 -61.99 0.11 Allowed 'General case' 0 N--CA 1.476 0.853 0 O-C-N 125.225 1.578 . . . . 5.7800000000000002 114.087 -171.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -157.51 101.19 0.2 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 119.784 -1.198 . . . . 2.2599999999999998 113.679 -176.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.446 ' HA ' ' HD2' ' A' ' 178' ' ' LYS . 13.1 tptm -171.61 -6.72 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.856 0.36 . . . . 6.2300000000000004 110.86 173.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.669 ' HB2' HD12 ' A' ' 184' ' ' ILE . 0.0 OUTLIER -137.63 175.56 9.49 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.252 0.548 . . . . 1.6399999999999999 109.663 -177.571 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.439 ' O ' HD12 ' A' ' 184' ' ' ILE . 16.3 m -111.34 159.25 33.65 Favored Pre-proline 0 C--N 1.313 -1.005 0 N-CA-C 108.068 -1.086 . . . . 2.04 108.068 174.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -44.88 -37.86 12.52 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 122.765 2.31 . . . . 1.74 112.577 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.516 ' O ' ' HE2' ' A' ' 186' ' ' LYS . 3.7 p -66.31 -23.79 66.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.629 -0.714 . . . . 2.1400000000000001 112.273 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.576 ' HB ' ' HB3' ' A' ' 179' ' ' LEU . 11.9 mm -90.12 -38.28 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-O 122.505 1.145 . . . . 1.1200000000000001 108.76 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.931 ' HA ' HG22 ' A' ' 187' ' ' THR . 0.7 OUTLIER -66.13 -38.26 81.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 113.063 -1.88 . . . . 1.1299999999999999 111.375 -177.234 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.15 -18.45 65.31 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.585 -0.524 . . . . 2.8900000000000001 109.585 176.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.516 ' HE2' ' O ' ' A' ' 182' ' ' SER . 45.2 mtmt -91.84 -41.59 10.55 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.814 -0.63 . . . . 1.28 109.991 173.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.931 HG22 ' HA ' ' A' ' 184' ' ' ILE . 14.6 t -63.04 -28.14 69.89 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.941 0.719 . . . . 0.62 112.941 -169.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . 0.606 ' HE2' ' HA ' ' A' ' 188' ' ' MET . 2.4 mmt -76.05 -62.89 0.67 Allowed Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 120.249 -0.581 . . . . 1.0600000000000001 111.503 -177.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.576 ' O ' HG13 ' A' ' 193' ' ' VAL . 28.3 Cg_endo -61.93 -32.26 84.75 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 121.812 1.674 . . . . 0.91000000000000003 111.844 -177.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.639 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 24.6 m -73.88 -23.76 59.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.357 -0.383 . . . . 1.5 110.777 -177.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.2 OUTLIER -90.39 -38.03 13.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.912 -0.403 . . . . 1.8799999999999999 109.912 -176.134 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 1.029 HD21 ' HB ' ' A' ' 171' ' ' VAL . 26.7 mt -59.3 -57.31 13.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.996 -0.547 . . . . 1.0900000000000001 112.022 178.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 189' ' ' PRO . 1.8 m -65.44 -32.62 59.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.595 0.712 . . . . 0.68000000000000005 109.379 -175.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.639 ' HB2' ' O ' ' A' ' 190' ' ' SER . 0.4 OUTLIER -65.32 -47.04 77.93 Favored 'General case' 0 C--O 1.208 -1.112 0 CA-C-N 114.217 -1.356 . . . . 2.0699999999999998 109.843 176.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.86 -28.94 66.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.786 0.327 . . . . 2.0 111.026 178.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.727 HG12 HD12 ' A' ' 167' ' ' LEU . 22.1 mt -77.32 -31.61 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-O 121.414 0.626 . . . . 0.31 110.862 175.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 68.1 mt -73.56 -38.14 65.3 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 109.562 -0.532 . . . . 1.03 109.562 176.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.538 ' OD1' ' HG3' ' A' ' 76' ' ' LYS . 3.2 m-20 -53.11 -41.69 65.23 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.11 -1.07 . . . . 1.8999999999999999 108.11 168.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.738 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -67.33 -49.8 62.61 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.944 -0.571 . . . . 0.28999999999999998 110.129 -178.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.54 ' HD3' HD13 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -61.09 -41.16 96.15 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 114.984 -1.007 . . . . 0.96999999999999997 110.843 -179.242 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -76.99 -47.18 21.45 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-N 115.259 -0.882 . . . . 1.9399999999999999 110.089 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . 0.456 ' HA3' ' CZ2' ' A' ' 74' ' ' TRP . . . -69.89 -38.45 75.45 Favored Glycine 0 CA--C 1.505 -0.543 0 C-N-CA 120.811 -0.709 . . . . 0.46999999999999997 112.117 -175.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.738 ' HB ' ' O ' ' A' ' 199' ' ' ALA . 0.9 OUTLIER -58.04 -46.25 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 110.521 -0.178 . . . . 0.60999999999999999 110.521 176.327 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.646 ' HA ' ' HG3' ' A' ' 207' ' ' ARG . 62.6 mttm -84.48 -23.57 29.82 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 120.382 -0.527 . . . . 3.3700000000000001 109.841 -176.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.54 -35.95 77.25 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.081 -0.711 . . . . 1.02 109.081 166.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.483 ' ND1' ' HD3' ' A' ' 60' ' ' LYS . 5.4 t-80 -85.73 -31.03 22.65 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.337 0.865 . . . . 3.6299999999999999 113.337 -179.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.646 ' HG3' ' HA ' ' A' ' 204' ' ' LYS . 0.2 OUTLIER -107.97 -25.26 11.26 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.593 -0.692 . . . . 2.5899999999999999 112.34 -174.181 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.506 ' HB ' ' O ' ' A' ' 204' ' ' LYS . 98.0 m -101.26 137.04 19.57 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 109.792 -0.447 . . . . 1.8400000000000001 109.792 178.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 208' ' ' THR . 29.6 Cg_exo -64.15 13.09 0.09 OUTLIER 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.308 2.672 . . . . 2.3500000000000001 113.921 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.412 ' H ' ' C ' ' A' ' 208' ' ' THR . 73.8 m -67.78 -12.48 60.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.88 0.371 . . . . 2.3100000000000001 110.868 176.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 4.9 ppt_? -69.81 5.13 1.61 Allowed 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 116.044 -0.525 . . . . 5.4500000000000002 111.416 175.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -57.73 -28.74 64.17 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.267 0.556 . . . . 6.8600000000000003 109.567 171.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -101.05 82.67 0.49 Allowed Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.549 -1.02 . . . . 3.3700000000000001 110.549 171.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -66.7 124.69 23.57 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.343 0.497 . . . . 5.21 112.343 -175.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -111.85 94.13 4.8 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.862 -0.792 . . . . 6.46 108.862 166.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . 0.569 ' HA ' ' O ' ' A' ' 73' ' ' THR . 0.8 OUTLIER -104.32 141.9 35.51 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.121 -0.49 . . . . 6.0899999999999999 109.993 177.197 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -80.36 23.86 0.47 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.017 0.437 . . . . 5.1200000000000001 111.088 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 5.6 m -67.53 -31.41 71.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.76 -0.654 . . . . 6.7599999999999998 109.322 174.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -117.26 125.88 51.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.494 -0.775 . . . . 8.8200000000000003 109.982 177.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.424 -0.798 . . . . 8.4800000000000004 108.903 179.825 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 121.095 0.474 . . . . 3.8599999999999999 110.931 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.506 ' O ' HD12 ' A' ' 6' ' ' ILE . 7.0 m-20 -65.84 -35.58 81.08 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 121.183 0.516 . . . . 2.25 110.206 -177.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.627 ' HD1' HD22 ' A' ' 114' ' ' LEU . 93.5 m-85 -66.73 -32.83 74.39 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.384 -0.825 . . . . 0.42999999999999999 109.326 -175.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.636 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 2.1 tppp? -69.52 -8.25 45.42 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.82 -1.082 . . . . 1.51 110.124 177.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -92.27 -41.68 10.26 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.229 0.538 . . . . 0.54000000000000004 110.337 173.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.556 HD12 ' HA ' ' A' ' 3' ' ' PHE . 1.8 mp -82.45 -43.07 18.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.754 0.788 . . . . 1.0700000000000001 109.456 -171.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -72.15 -47.22 52.56 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.312 -1.313 . . . . 0.34000000000000002 111.582 -178.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.636 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 6.2 mt-30 -63.19 -26.43 68.8 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.664 -1.153 . . . . 1.5900000000000001 110.762 -178.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.581 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 24.9 mt-30 -84.82 -30.81 24.24 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.324 -0.853 . . . . 2.4700000000000002 109.395 172.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.552 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.4 OUTLIER -74.35 -34.72 63.47 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.513 -0.767 . . . . 0.47999999999999998 111.684 -177.386 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.467 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -45.87 -54.99 7.25 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 120.345 -0.542 . . . . 0.31 111.23 172.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -75.5 -6.66 51.3 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.775 -0.648 . . . . 1.6399999999999999 112.042 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.581 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 32.1 mt-10 -80.59 -52.09 7.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.712 -0.477 . . . . 2.54 109.712 173.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.699 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 14.6 p -69.57 -40.94 80.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.844 0.831 . . . . 0.53000000000000003 110.193 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.44 HD13 ' CE1' ' A' ' 120' ' ' TYR . 0.4 OUTLIER -67.78 -25.45 65.61 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 121.978 0.894 . . . . 0.59999999999999998 108.608 173.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.32 -17.5 66.28 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 113.79 -1.55 . . . . 0.56999999999999995 110.394 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.699 ' CD2' ' HA ' ' A' ' 14' ' ' VAL . 15.1 m-85 -89.07 -24.68 22.24 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.572 -0.899 . . . . 3.27 108.572 177.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -73.61 -12.0 60.61 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-O 121.337 0.589 . . . . 2.0299999999999998 110.018 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -111.62 -18.7 12.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.498 -0.774 . . . . 2.7200000000000002 111.216 -176.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -136.09 84.13 2.06 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.326 -0.397 . . . . 2.1600000000000001 111.459 -174.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -151.0 139.5 20.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 1.8200000000000001 111.64 178.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.9 m -167.53 -45.26 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.017 -0.538 . . . . 2.1899999999999999 110.031 -173.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -81.68 47.79 3.72 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.834 -0.621 . . . . 1.1000000000000001 113.188 -176.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.548 ' O ' ' HE2' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -120.65 -147.3 0.39 Allowed 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.605 -0.517 . . . . 1.6699999999999999 109.605 178.188 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.548 ' HE2' ' O ' ' A' ' 24' ' ' TRP . 0.0 OUTLIER 178.57 123.84 0.05 OUTLIER 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.954 -0.758 . . . . 2.9500000000000002 108.954 -175.036 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.578 ' CG1' HG22 ' A' ' 34' ' ' THR . 3.7 m -65.13 119.81 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.818 0 CA-C-O 122.358 1.075 . . . . 1.5600000000000001 111.605 176.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.455 HG13 ' HB3' ' A' ' 189' ' ' PRO . 7.7 p -99.57 -23.96 4.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 113.692 -1.595 . . . . 1.22 109.07 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 189' ' ' PRO . 8.3 tppt? -152.9 109.9 3.48 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 119.82 -0.752 . . . . 2.4100000000000001 111.756 -176.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.618 ' HB ' ' HA ' ' A' ' 34' ' ' THR . 1.3 t -151.89 152.64 32.82 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.196 0.522 . . . . 1.3799999999999999 111.484 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.7 t -113.24 -94.93 0.45 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.354 -0.839 . . . . 2.3700000000000001 110.165 176.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -148.32 19.15 1.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.297 0.57 . . . . 4.5499999999999998 110.737 176.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.673 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 38.5 mmtm -150.05 -33.92 0.18 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.707 -0.679 . . . . 1.4199999999999999 110.138 176.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.642 HD12 ' HB ' ' A' ' 193' ' ' VAL . 16.3 pt -113.55 149.95 15.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.603 -0.726 . . . . 0.76000000000000001 109.746 -177.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.618 ' HA ' ' HB ' ' A' ' 29' ' ' THR . 0.2 OUTLIER -151.17 107.67 3.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 123.12 0.262 . . . . 0.57999999999999996 111.604 -166.248 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.538 ' CG2' HG13 ' A' ' 193' ' ' VAL . 21.4 t -95.57 109.63 22.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.953 0.406 . . . . 0.85999999999999999 110.315 176.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 2.3 p -105.11 123.36 47.68 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.526 -0.761 . . . . 1.1000000000000001 110.773 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 77.9 p -103.47 129.19 50.56 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.914 -1.039 . . . . 1.27 110.284 -174.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.451 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 24.5 ttpp -119.29 -91.16 0.56 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.996 -0.547 . . . . 1.9099999999999999 111.289 -173.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 46' ' ' ASN . . . -177.1 141.54 0.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.59 -0.522 . . . . 1.6799999999999999 109.59 -177.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 67.5 p -74.46 146.61 42.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.059 0.457 . . . . 2.0899999999999999 110.096 175.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -62.24 -28.13 69.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.269 -0.878 . . . . 6.6100000000000003 112.38 -176.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -93.18 -17.35 23.83 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 120.795 -0.362 . . . . 6.46 110.938 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 3.1 t80 85.67 31.5 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.557 0 O-C-N 124.433 1.083 . . . . 5.6500000000000004 108.694 172.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 -85.77 -18.39 33.12 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.021 -0.99 . . . . 5.5599999999999996 109.533 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.33 -139.4 3.63 Favored Glycine 0 N--CA 1.427 -1.934 0 N-CA-C 109.502 -1.439 . . . . 1.5600000000000001 109.502 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 73.0 m-20 -121.81 147.79 45.51 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.054 0.454 . . . . 2.0499999999999998 111.301 -177.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.54 HD23 ' N ' ' A' ' 48' ' ' TYR . 3.2 tt -98.48 138.68 35.35 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.865 -1.161 . . . . 0.87 107.865 174.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.54 ' N ' HD23 ' A' ' 47' ' ' LEU . 73.2 m-85 -120.03 130.69 54.83 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 110.168 -0.308 . . . . 0.98999999999999999 110.168 -174.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.484 ' HD3' ' CZ3' ' A' ' 24' ' ' TRP . 37.4 ttt-85 -120.29 121.42 38.63 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.268 -0.424 . . . . 2.9199999999999999 110.06 175.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.515 ' CG1' ' HB3' ' A' ' 192' ' ' LEU . 9.4 p -104.99 145.98 12.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 120.11 -0.636 . . . . 1.3300000000000001 109.655 174.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.555 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 29.6 tt0 -144.33 113.09 6.69 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.534 -0.757 . . . . 1.0700000000000001 110.155 -171.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.673 ' HA2' ' O ' ' A' ' 32' ' ' LYS . . . -143.85 143.26 12.03 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.682 -0.771 . . . . 0.28999999999999998 111.934 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.8 mt -87.54 120.59 36.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 120.147 -0.621 . . . . 0.57999999999999996 110.691 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 36.4 mt -102.69 120.2 53.52 Favored Pre-proline 0 N--CA 1.442 -0.865 0 CA-C-N 115.556 -0.747 . . . . 0.34999999999999998 109.728 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -62.57 60.03 0.14 Allowed 'Trans proline' 0 N--CA 1.473 0.319 0 C-N-CA 124.299 3.333 . . . . 0.62 113.93 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.643 ' HG2' HG13 ' A' ' 203' ' ' ILE . 9.6 tp10 -150.91 175.54 11.95 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.879 -0.785 . . . . 1.6799999999999999 108.879 174.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.529 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 12.8 m -80.94 143.32 53.25 Favored Pre-proline 0 N--CA 1.425 -1.702 0 CA-C-O 121.365 0.602 . . . . 1.1799999999999999 109.488 172.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 57' ' ' SER . 35.5 Cg_exo -57.95 -14.32 18.09 Favored 'Trans proline' 0 C--N 1.333 -0.272 0 C-N-CA 124.092 3.195 . . . . 0.52000000000000002 111.501 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.32 -50.9 42.25 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.207 -0.906 . . . . 0.64000000000000001 111.31 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.47 ' O ' ' HE3' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -67.66 -27.35 66.78 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.387 -0.968 . . . . 3.2999999999999998 108.387 179.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.752 ' O ' HD12 ' A' ' 65' ' ' LEU . 40.6 mt -62.9 -57.96 9.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.19 -0.914 . . . . 0.40999999999999998 110.473 172.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.665 ' OG ' ' HB3' ' A' ' 125' ' ' ASN . 66.5 m -60.49 -16.1 33.54 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.92 -0.488 . . . . 1.29 110.861 176.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -90.1 -43.96 10.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.243 0.46 . . . . 1.3200000000000001 112.243 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.645 ' CE2' ' HA ' ' A' ' 199' ' ' ALA . 5.0 p90 -73.4 -43.43 60.51 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.739 -0.385 . . . . 0.60999999999999999 110.905 -171.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.752 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -86.57 -7.17 58.59 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 120.433 -0.507 . . . . 1.5 111.616 -173.288 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.525 ' N ' HD13 ' A' ' 65' ' ' LEU . 11.8 t80 -18.79 -70.44 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.95 1.406 . . . . 1.52 114.005 -163.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.486 ' OE1' ' HB2' ' A' ' 94' ' ' CYS . 8.5 tt0 -174.32 -32.26 0.01 OUTLIER 'General case' 0 C--N 1.342 0.268 0 N-CA-C 114.296 1.221 . . . . 3.6000000000000001 114.296 176.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.7 t -161.97 7.87 0.06 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 119.223 -0.991 . . . . 1.48 113.462 -166.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -115.0 -22.78 4.83 Favored Glycine 0 C--N 1.314 -0.686 0 C-N-CA 118.917 -1.611 . . . . 1.46 113.901 -168.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.655 ' O ' HG22 ' A' ' 73' ' ' THR . 4.5 t70 -150.39 -29.5 0.21 Allowed 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.609 -0.436 . . . . 2.1899999999999999 110.574 -176.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.856 ' HA ' ' CZ2' ' A' ' 74' ' ' TRP . 9.7 ptm180 -50.19 -43.68 52.6 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 123.33 0.652 . . . . 3.3799999999999999 111.452 -173.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.748 HD13 ' H ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -83.5 -13.54 11.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.896 -0.593 . . . . 0.70999999999999996 110.318 -173.262 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.661 ' OG1' ' HA ' ' A' ' 216' ' ' HIS . 0.8 OUTLIER -84.91 -31.44 23.67 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 116.02 -0.536 . . . . 0.96999999999999997 109.927 -176.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.856 ' CZ2' ' HA ' ' A' ' 71' ' ' ARG . 7.4 p-90 -106.29 -10.34 16.43 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 120.27 -0.572 . . . . 0.75 111.872 -176.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.674 ' OD2' ' HG ' ' A' ' 78' ' ' LEU . 27.4 t0 -83.3 172.58 12.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.967 0.889 . . . . 2.1899999999999999 111.427 -177.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.53 ' H ' ' CG ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -122.04 -13.98 8.08 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 113.979 -1.464 . . . . 3.1899999999999999 111.297 -172.47 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 74.7 m -115.56 8.77 15.2 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.303 -0.629 . . . . 1.5800000000000001 109.303 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.674 ' HG ' ' OD2' ' A' ' 75' ' ' ASP . 54.0 mt -109.65 171.05 7.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.363 -0.835 . . . . 0.70999999999999996 110.681 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.602 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 6.4 mm-40 -150.62 -63.37 0.2 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.592 0.59 . . . . 1.73 112.592 -171.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.507 HG23 ' HB3' ' A' ' 79' ' ' GLN . 39.4 t -141.65 127.94 19.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.907 0.384 . . . . 0.78000000000000003 111.076 -168.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.585 ' HB3' HD12 ' A' ' 72' ' ' ILE . 41.1 p90 -97.67 146.06 25.7 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.825 -0.625 . . . . 5.4000000000000004 110.219 174.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.503 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 17.2 m120 -155.13 102.5 2.31 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.447 -0.575 . . . . 1.6899999999999999 109.447 174.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.09 110.06 2.38 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.196 -0.668 . . . . 2.0499999999999998 109.196 177.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -93.14 -49.09 13.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.521 -0.309 . . . . 0.64000000000000001 111.55 -172.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.442 ' HB3' HD12 ' A' ' 93' ' ' ILE . 17.6 t-80 -147.74 108.13 4.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.124 0.487 . . . . 1.96 111.144 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.443 ' HG2' ' HD2' ' A' ' 92' ' ' PHE . 20.7 mtt180 -89.66 107.04 18.86 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.564 -0.744 . . . . 2.4399999999999999 109.828 176.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.64 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -75.85 -41.34 39.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.095 0.474 . . . . 0.46999999999999997 110.033 -177.805 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -155.6 -168.12 2.72 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.3 -1.0 . . . . 1.8600000000000001 108.3 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.6 m -80.63 -5.62 57.15 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 117.567 0.167 . . . . 1.4399999999999999 111.345 -177.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -130.16 4.35 4.82 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.83 -0.433 . . . . 1.8700000000000001 109.83 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.64 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.5 OUTLIER -137.87 116.33 12.01 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.609 -0.885 . . . . 0.46000000000000002 108.609 -173.564 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.576 ' O ' HD12 ' A' ' 114' ' ' LEU . 11.0 m-85 -137.2 176.29 8.84 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.232 0.539 . . . . 0.42999999999999999 110.57 -175.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.571 ' O ' HG23 ' A' ' 84' ' ' VAL . 21.6 mt -134.94 127.43 48.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 106.759 -1.571 . . . . 0.40999999999999998 106.759 166.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.486 ' HB2' ' OE1' ' A' ' 67' ' ' GLN . 31.2 t -117.15 129.58 56.06 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.389 -0.525 . . . . 2.0099999999999998 111.266 -176.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.556 ' HA ' HD13 ' A' ' 112' ' ' ILE . 24.3 t60 -87.35 85.38 7.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.268 -0.878 . . . . 1.23 109.173 173.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 60.2 m -100.42 113.37 26.07 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.644 -1.162 . . . . 0.5 112.177 -173.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.469 HD13 ' OD1' ' A' ' 110' ' ' ASP . 31.0 mm -76.52 126.21 36.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.309 -0.626 . . . . 1.03 109.309 174.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.2 m -113.35 142.74 45.5 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.328 -0.851 . . . . 1.3799999999999999 111.272 -174.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.602 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 25.3 mt-30 -97.28 80.79 2.94 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.495 -0.557 . . . . 1.8200000000000001 109.495 173.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.3 m -94.86 86.54 4.71 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.168 -0.469 . . . . 3.9100000000000001 110.041 -177.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.426 ' HA ' ' HB ' ' A' ' 106' ' ' ILE . 42.3 p90 -123.38 117.17 24.59 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.18 0.514 . . . . 5.1600000000000001 112.064 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.403 ' O ' ' HB ' ' A' ' 103' ' ' VAL . . . -85.96 75.78 9.93 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.536 -0.913 . . . . 1.98 108.536 165.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 102' ' ' ALA . 98.4 t 78.74 -36.08 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 114.924 -1.034 . . . . 3.1699999999999999 111.032 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 157.05 -7.62 0.21 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.136 -1.03 . . . . 1.96 113.374 178.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.8 t -72.96 -6.63 46.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.16 0.505 . . . . 1.8799999999999999 110.368 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.497 HG12 ' HG ' ' A' ' 179' ' ' LEU . 26.3 mt -122.91 136.6 59.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.872 -0.603 . . . . 1.1200000000000001 110.156 -177.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.1 m -87.44 152.41 52.22 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 116.163 -0.472 . . . . 1.3500000000000001 110.325 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -47.97 143.08 14.27 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.686 2.257 . . . . 1.0700000000000001 111.632 173.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.568 ' HG2' HG23 ' A' ' 144' ' ' ILE . 20.2 mtm180 -123.64 174.76 7.25 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.639 -0.504 . . . . 3.4500000000000002 109.639 -173.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.685 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 31.0 t70 -131.61 138.88 48.99 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.339 -0.391 . . . . 1.3700000000000001 110.045 176.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -110.07 125.54 53.06 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.105 -0.498 . . . . 2.4100000000000001 110.375 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.612 ' CG2' ' HE1' ' A' ' 134' ' ' PHE . 47.6 mm -109.39 70.54 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 108.362 -0.977 . . . . 0.42999999999999999 108.362 170.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' A' ' 129' ' ' SER . 43.7 m-20 -88.35 117.7 27.46 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.638 -0.71 . . . . 1.8600000000000001 111.03 -174.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.627 HD22 ' HD1' ' A' ' 3' ' ' PHE . 9.4 tp -75.0 124.7 27.44 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.342 -0.984 . . . . 0.28000000000000003 108.342 165.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.615 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -132.25 126.5 55.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 115.465 -0.789 . . . . 0.26000000000000001 112.404 -163.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.532 ' HD1' ' HG1' ' A' ' 91' ' ' THR . 58.9 t80 -110.72 116.36 31.17 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.092 -0.958 . . . . 2.5699999999999998 110.425 172.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.453 HG12 HG22 ' A' ' 127' ' ' ILE . 86.6 mt -94.31 112.0 26.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.54 -0.755 . . . . 0.89000000000000001 110.222 -177.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.439 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 17.1 ttmm -137.95 142.43 40.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.132 -0.485 . . . . 1.2 110.63 -176.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.447 ' NE ' ' HA ' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -117.72 113.72 22.27 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 107.86 -1.163 . . . . 2.7999999999999998 107.86 172.472 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.44 ' CE1' HD13 ' A' ' 15' ' ' LEU . 56.0 m-85 -67.48 117.25 9.19 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.667 -1.235 . . . . 0.82999999999999996 107.667 170.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.447 ' HA ' ' NE ' ' A' ' 119' ' ' ARG . 22.1 mm-40 -35.66 94.58 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 O-C-N 124.789 1.306 . . . . 2.2799999999999998 112.938 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 58.8 41.71 96.13 Favored Glycine 0 CA--C 1.505 -0.569 0 CA-C-N 114.618 -1.174 . . . . 0.76000000000000001 112.406 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.431 ' HB3' ' CB ' ' A' ' 120' ' ' TYR . 3.2 t-20 -138.68 -49.93 0.54 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.446 -0.377 . . . . 1.6499999999999999 110.705 -177.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.421 ' O ' ' HA ' ' A' ' 119' ' ' ARG . 2.0 tpp -159.97 118.84 2.76 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.046 0.45 . . . . 1.1200000000000001 111.491 -175.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.665 ' HB3' ' OG ' ' A' ' 62' ' ' SER . 6.0 m120 -97.93 79.21 2.61 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.779 -0.823 . . . . 1.6200000000000001 108.779 177.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.556 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.5 OUTLIER -105.37 141.06 21.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 113.193 0.812 . . . . 0.29999999999999999 113.193 -169.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.704 ' O ' HG13 ' A' ' 127' ' ' ILE . 2.3 pt -107.9 115.05 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 107.979 -1.119 . . . . 0.58999999999999997 107.979 159.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.615 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 36.5 p -82.96 154.2 24.63 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.946 -0.761 . . . . 1.1799999999999999 108.946 175.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.587 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 9.0 p -154.63 131.45 10.78 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.947 0.403 . . . . 1.24 111.858 -175.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -131.32 120.97 23.9 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 107.632 -1.248 . . . . 2.2599999999999998 107.632 175.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.611 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 52.5 m -66.17 101.04 0.66 Allowed 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.215 -1.402 . . . . 1.3899999999999999 107.215 175.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.99 143.21 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.879 0 CA-C-N 114.568 -1.196 . . . . 1.05 109.193 -164.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -95.27 70.72 3.21 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 122.983 1.373 . . . . 2.1699999999999999 110.176 -170.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.612 ' HE1' ' CG2' ' A' ' 112' ' ' ILE . 1.7 p90 -97.75 177.22 1.7 Allowed Pre-proline 0 CA--C 1.554 1.129 0 CA-C-N 113.688 -1.596 . . . . 0.53000000000000003 109.326 -174.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.421 ' HB2' ' OE2' ' A' ' 136' ' ' GLU . 59.9 Cg_exo -44.28 -47.71 10.47 Favored 'Trans proline' 0 CA--C 1.55 1.304 0 C-N-CA 123.752 2.968 . . . . 1.28 117.106 -175.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.421 ' OE2' ' HB2' ' A' ' 135' ' ' PRO . 2.0 mm-40 -88.71 -5.15 58.3 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 121.595 -0.691 . . . . 3.5 111.416 -172.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.575 ' HB3' ' O ' ' A' ' 134' ' ' PHE . 22.9 t80 -54.33 -45.63 99.21 Favored Pre-proline 0 C--N 1.314 -0.961 0 N-CA-C 115.384 1.624 . . . . 6.1200000000000001 115.384 -177.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 24.7 Cg_exo -32.54 111.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 123.874 3.049 . . . . 1.77 114.875 -175.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.544 ' HA ' ' CZ ' ' A' ' 145' ' ' ARG . 5.8 Cg_exo -79.8 -160.81 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.282 2.655 . . . . 1.25 114.056 -177.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 13.6 m -145.58 -160.85 1.2 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.284 -1.326 . . . . 1.6000000000000001 108.502 -176.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 31.1 t -88.69 -41.91 12.3 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.534 -0.467 . . . . 1.97 111.048 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -70.9 -30.9 67.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.898 0.38 . . . . 2.1800000000000002 111.147 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -120.32 115.02 22.73 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 121.234 0.54 . . . . 1.23 110.327 -176.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.568 HG23 ' HG2' ' A' ' 109' ' ' ARG . 3.4 tp -105.53 113.81 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 115.23 -0.896 . . . . 0.81999999999999995 109.967 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.685 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 5.2 mpt_? -54.74 99.61 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.763 -1.108 . . . . 4.4199999999999999 110.914 175.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -67.51 112.51 4.84 Favored Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 109.372 -1.491 . . . . 0.79000000000000004 109.372 171.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.5 ' HB3' ' CB ' ' A' ' 174' ' ' GLU . 3.2 t80 -84.16 81.45 8.8 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.362 0.601 . . . . 4.4400000000000004 110.515 -169.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.652 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 70.7 m-20 -70.66 99.26 1.64 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.999 -1.001 . . . . 1.6200000000000001 110.191 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.458 ' HB2' ' O ' ' A' ' 172' ' ' GLN . 70.9 m-70 -69.99 146.33 95.01 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.198 -0.455 . . . . 2.3199999999999998 109.911 176.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.545 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 75.5 Cg_exo -15.21 64.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.239 1 C-N-CA 127.414 5.409 . . . . 0.53000000000000003 115.709 -164.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . 0.652 ' SG ' ' HB3' ' A' ' 148' ' ' ASN . 25.4 p -89.81 -174.84 4.43 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.682 -1.144 . . . . 1.5800000000000001 110.36 178.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.575 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -177.8 -161.09 25.45 Favored Glycine 0 N--CA 1.435 -1.41 0 C-N-CA 120.385 -0.912 . . . . 0.42999999999999999 111.77 177.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.596 ' CE1' ' HG ' ' A' ' 65' ' ' LEU . 48.1 t80 -161.72 88.92 0.72 Allowed 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.474 -0.936 . . . . 0.59999999999999998 108.474 -167.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.583 HG23 HG13 ' A' ' 168' ' ' VAL . 2.6 m -98.63 132.53 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-O 121.65 0.738 . . . . 0.31 110.864 -173.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 125' ' ' ASN . 47.8 m -113.55 108.57 17.35 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.508 -0.769 . . . . 1.55 109.352 177.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.487 ' HB3' ' HB3' ' A' ' 166' ' ' LYS . 18.3 t -102.31 122.99 44.69 Favored Pre-proline 0 C--N 1.312 -1.058 0 CA-C-O 120.842 0.353 . . . . 1.0600000000000001 111.657 -167.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.405 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 77.9 Cg_exo -52.79 118.1 4.39 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.766 2.311 . . . . 0.56000000000000005 111.666 170.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.493 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 78.1 mmm -82.96 -165.08 0.98 Allowed 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 120.977 0.417 . . . . 1.1599999999999999 111.411 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.417 ' H ' ' HB3' ' A' ' 158' ' ' MET . 9.1 mm-40 -76.89 -24.79 52.53 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.741 0.782 . . . . 2.6299999999999999 109.138 173.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 22.5 mm-40 -102.57 27.06 7.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.823 -1.08 . . . . 2.0499999999999998 108.821 172.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.424 ' HB3' ' HD3' ' A' ' 162' ' ' PRO . 15.9 t30 -12.22 -71.32 0.01 OUTLIER Pre-proline 0 N--CA 1.479 0.987 0 N-CA-C 115.675 1.732 . . . . 1.9299999999999999 115.675 -174.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' A' ' 161' ' ' ASN . 70.6 Cg_endo -72.7 -16.27 26.72 Favored 'Trans proline' 0 C--N 1.351 0.665 0 CA-C-N 120.498 1.213 . . . . 0.72999999999999998 113.596 -172.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -103.09 -29.27 11.45 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.899 0.38 . . . . 0.68000000000000005 110.885 -177.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.493 ' O ' ' HB2' ' A' ' 158' ' ' MET . 82.2 m-85 -139.93 125.98 19.78 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.348 -0.612 . . . . 0.93000000000000005 109.348 177.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.409 ' OG ' HD11 ' A' ' 61' ' ' LEU . 4.4 p -122.13 147.81 45.69 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.156 0.503 . . . . 1.4099999999999999 110.978 -177.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.555 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.9 tppp? -91.94 104.61 17.01 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.757 0.789 . . . . 0.73999999999999999 111.009 -176.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.52 109.86 20.76 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.916 -1.038 . . . . 0.27000000000000002 109.039 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.583 HG13 HG23 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -130.58 128.76 63.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 121.692 0.758 . . . . 0.28000000000000003 111.783 177.114 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.488 ' HG2' ' N ' ' A' ' 170' ' ' PHE . 23.0 ttm -124.3 153.05 42.32 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.306 -0.861 . . . . 1.24 109.536 -176.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.568 ' O ' ' HB2' ' A' ' 151' ' ' CYS . 8.6 m-85 -133.5 139.8 46.87 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.568 -0.901 . . . . 3.3700000000000001 108.568 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 11.1 p -138.02 116.77 14.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.618 0.723 . . . . 1.3999999999999999 111.533 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 149' ' ' HIS . 28.8 tt0 -111.26 56.76 0.63 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.646 -0.872 . . . . 2.1699999999999999 108.646 174.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 9.1 t -73.45 145.53 45.68 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.877 0.846 . . . . 1.6499999999999999 111.269 -174.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.5 ' CB ' ' HB3' ' A' ' 147' ' ' TYR . 6.6 tp10 -84.53 -30.9 24.75 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.681 -1.145 . . . . 2.4500000000000002 109.947 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.474 ' HG3' HG23 ' A' ' 173' ' ' THR . 64.7 mtm 49.02 64.13 1.85 Allowed 'General case' 0 CA--C 1.518 -0.28 0 O-C-N 123.461 0.476 . . . . 3.7400000000000002 110.0 -173.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.406 ' HB2' HD11 ' A' ' 144' ' ' ILE . 24.0 mmm180 -49.44 -39.98 35.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.131 -0.94 . . . . 5.7800000000000002 110.849 176.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -83.04 80.16 1.85 Allowed Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 109.352 -1.499 . . . . 2.2599999999999998 109.352 166.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -80.64 152.24 28.6 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.303 0.573 . . . . 6.2300000000000004 112.05 -167.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.511 ' HB2' ' CD1' ' A' ' 184' ' ' ILE . 0.5 OUTLIER -111.58 -152.07 0.49 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.063 -0.971 . . . . 1.6399999999999999 108.755 176.864 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.5 ' O ' HD12 ' A' ' 184' ' ' ILE . 43.8 t -110.61 149.82 40.84 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 108.228 -1.027 . . . . 2.04 108.228 174.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -43.88 -45.44 11.38 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.171 2.581 . . . . 1.74 113.016 -177.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 12.0 m -62.91 -18.88 63.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.494 . . . . 2.1400000000000001 112.078 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.566 ' HA ' ' HE2' ' A' ' 186' ' ' LYS . 13.3 mm -91.48 -38.32 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-O 122.432 1.111 . . . . 1.1200000000000001 108.991 -177.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 1.025 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.2 mp -74.49 -34.72 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 CA-C-N 113.089 -1.868 . . . . 1.1299999999999999 111.334 -176.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 189' ' ' PRO . 11.1 pt-20 -67.4 -17.25 64.65 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.93 -0.767 . . . . 2.8900000000000001 108.93 176.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.566 ' HE2' ' HA ' ' A' ' 183' ' ' ILE . 51.6 mtmt -91.96 -42.67 9.88 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.376 -0.829 . . . . 1.28 109.953 171.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 1.025 HG22 ' HA ' ' A' ' 184' ' ' ILE . 7.4 t -70.01 -41.04 74.87 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.192 -0.603 . . . . 0.62 112.366 -170.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . 0.55 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 34.9 mmm -76.38 -55.48 1.68 Allowed Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 112.441 0.534 . . . . 1.0600000000000001 112.441 -174.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.55 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 23.8 Cg_exo -65.48 -19.07 60.93 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 121.945 1.763 . . . . 0.91000000000000003 112.234 -175.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 51.5 m -85.87 -42.06 14.44 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.734 -0.469 . . . . 1.5 109.734 177.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -64.16 -39.13 93.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 1.8799999999999999 111.136 -175.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.527 HD12 HG13 ' A' ' 35' ' ' VAL . 30.7 mt -68.05 -44.71 75.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.627 0.251 . . . . 1.0900000000000001 111.179 -176.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.642 ' HB ' HD12 ' A' ' 33' ' ' ILE . 17.9 m -74.18 -24.85 19.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 120.27 -0.572 . . . . 0.68000000000000005 110.56 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.419 HD22 ' HA ' ' A' ' 194' ' ' ASN . 7.7 m120 -68.71 -39.18 80.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.187 -0.46 . . . . 2.0699999999999998 110.445 172.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.667 ' HA ' ' ND2' ' A' ' 198' ' ' ASN . 4.9 m-85 -70.8 -20.03 62.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.132 0.491 . . . . 2.0 111.014 176.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.674 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 33.5 mt -82.62 -29.55 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 C-N-CA 119.494 -0.882 . . . . 0.31 110.496 170.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 47.2 mt -69.38 -43.74 72.91 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.518 -0.31 . . . . 1.03 110.773 178.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.667 ' ND2' ' HA ' ' A' ' 195' ' ' PHE . 13.1 p30 -60.97 -22.6 64.63 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.964 -0.562 . . . . 1.8999999999999999 109.886 171.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.708 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -80.79 -43.11 20.6 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 116.51 -0.314 . . . . 0.28999999999999998 110.317 177.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.674 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 12.8 mmmm -57.1 -47.05 82.01 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.659 -0.867 . . . . 0.96999999999999997 108.659 172.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -71.19 -45.87 62.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.266 -1.333 . . . . 1.9399999999999999 111.53 -175.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -72.02 -22.76 78.69 Favored Glycine 0 N--CA 1.463 0.442 0 C-N-CA 120.517 -0.849 . . . . 0.46999999999999997 112.099 -178.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.708 ' HB ' ' O ' ' A' ' 199' ' ' ALA . 1.0 OUTLIER -82.24 -36.16 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 120.966 0.412 . . . . 0.60999999999999999 110.603 175.157 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.469 ' HA ' ' HG2' ' A' ' 207' ' ' ARG . 26.5 mtpt -73.87 -28.47 61.58 Favored 'General case' 0 C--O 1.209 -1.041 0 N-CA-C 108.636 -0.876 . . . . 3.3700000000000001 108.636 176.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.573 ' O ' ' HD2' ' A' ' 211' ' ' ARG . . . -54.04 -32.91 55.92 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.505 -0.771 . . . . 1.02 109.682 169.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.548 ' HB3' ' O ' ' A' ' 203' ' ' ILE . 15.0 t-80 -71.13 -46.55 61.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 3.6299999999999999 111.882 178.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.469 ' HG2' ' HA ' ' A' ' 204' ' ' LYS . 10.4 ptm85 -97.85 -31.55 12.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.503 0.668 . . . . 2.5899999999999999 111.462 -170.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.451 ' HB ' ' O ' ' A' ' 204' ' ' LYS . 28.0 m -92.47 141.31 24.6 Favored Pre-proline 0 C--N 1.313 -0.996 0 CA-C-N 115.176 -0.92 . . . . 1.8400000000000001 109.169 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.34 42.07 0.26 Allowed 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 123.042 2.495 . . . . 2.3500000000000001 113.573 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 28.9 t -94.33 -22.96 18.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.125 0.488 . . . . 2.3100000000000001 109.855 177.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.573 ' HD2' ' O ' ' A' ' 205' ' ' ALA . 0.0 OUTLIER -79.99 1.53 27.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.041 -0.527 . . . . 5.4500000000000002 110.572 -179.741 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -71.68 -39.45 70.24 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.573 -0.529 . . . . 6.8600000000000003 109.573 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -110.02 51.42 0.7 Allowed Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.265 -0.734 . . . . 3.3700000000000001 111.265 175.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -68.02 156.59 37.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.905 0.383 . . . . 5.21 110.863 -177.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -127.71 144.47 51.08 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.117 -0.492 . . . . 6.46 110.605 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . 0.661 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 22.6 m170 -93.7 -173.14 3.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.621 -0.718 . . . . 6.0899999999999999 111.024 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -74.41 126.94 31.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.956 -0.565 . . . . 5.1200000000000001 110.879 -178.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 1.9 p -71.56 -25.39 62.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.178 -0.919 . . . . 6.7599999999999998 110.856 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -91.19 -173.5 3.65 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.022 -0.536 . . . . 8.8200000000000003 109.706 176.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 17.4 m . . . . . 0 C--O 1.252 1.208 0 CA-C-O 118.055 -0.974 . . . . 8.4800000000000004 110.925 177.912 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.673 ' SD ' HG22 ' A' ' 87' ' ' ILE . 2.6 ttt . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 109.872 -0.418 . . . . 3.8599999999999999 109.872 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.637 ' O ' HD13 ' A' ' 6' ' ' ILE . 20.1 t70 -113.64 -59.99 1.94 Allowed 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 110.058 -0.349 . . . . 2.25 110.058 -176.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.842 ' HA ' HD11 ' A' ' 6' ' ' ILE . 96.0 m-85 -67.76 -30.11 69.48 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 122.006 0.908 . . . . 0.42999999999999999 108.569 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 9.2 tttm -75.68 -4.32 39.63 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.916 -1.493 . . . . 1.51 109.893 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.425 ' O ' ' HG2' ' A' ' 9' ' ' GLN . . . -92.74 -46.22 7.66 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.339 0.59 . . . . 0.54000000000000004 109.686 174.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.842 HD11 ' HA ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -82.34 -38.8 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-N 115.693 -0.685 . . . . 1.0700000000000001 110.464 -171.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.562 ' HB1' ' HB2' ' A' ' 116' ' ' TYR . . . -78.04 -38.08 45.41 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.843 -1.071 . . . . 0.34000000000000002 111.391 -176.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.501 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 21.6 mt-30 -65.68 -25.79 67.49 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.179 -0.919 . . . . 1.5900000000000001 110.316 177.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.52 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 16.4 mm100 -89.71 -36.45 15.2 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.051 -0.977 . . . . 2.4700000000000002 109.531 173.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.593 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -64.81 -34.47 78.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.626 -0.716 . . . . 0.47999999999999998 111.259 179.031 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.529 ' HA ' ' OG ' ' A' ' 128' ' ' SER . . . -48.21 -61.07 2.17 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.703 0.763 . . . . 0.31 110.464 171.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -66.71 -17.0 64.63 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.471 -1.24 . . . . 1.6399999999999999 112.025 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 35.2 mt-10 -68.73 -57.35 5.77 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 109.595 -0.521 . . . . 2.54 109.595 174.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.713 ' CG2' ' HA ' ' A' ' 151' ' ' CYS . 1.2 t -70.4 -43.38 78.26 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 CA-C-O 121.811 0.815 . . . . 0.53000000000000003 110.979 -174.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.559 HD23 ' HD2' ' A' ' 19' ' ' ARG . 1.0 OUTLIER -64.48 -33.11 75.12 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.471 -1.241 . . . . 0.59999999999999998 109.308 174.813 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.427 ' HA2' ' HD3' ' A' ' 19' ' ' ARG . . . -65.07 -16.41 62.03 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 114.56 -1.2 . . . . 0.56999999999999995 111.281 175.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.709 ' HD2' ' HA ' ' A' ' 14' ' ' VAL . 54.8 m-85 -89.58 -25.82 21.14 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 108.234 -1.024 . . . . 3.27 108.234 174.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.41 HD22 ' HA ' ' A' ' 18' ' ' ASN . 2.1 t-20 -68.85 -10.63 58.0 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.635 0.731 . . . . 2.0299999999999998 109.093 175.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.559 ' HD2' HD23 ' A' ' 15' ' ' LEU . 11.3 mtp180 -112.19 -20.79 11.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.875 -1.057 . . . . 2.7200000000000002 110.322 178.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -123.08 58.93 1.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.775 0.798 . . . . 2.1600000000000001 110.702 -176.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.856 ' HB ' ' CZ2' ' A' ' 24' ' ' TRP . 0.7 OUTLIER -122.89 127.57 49.15 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.856 -0.611 . . . . 1.8200000000000001 110.544 176.687 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.5 t -179.28 -33.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.508 -0.769 . . . . 2.1899999999999999 110.068 -170.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.85 -17.35 76.79 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.618 -0.719 . . . . 1.1000000000000001 112.916 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 1.012 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -89.81 -155.99 0.39 Allowed 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 112.563 0.579 . . . . 1.6699999999999999 112.563 179.324 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.521 ' HE3' ' HA ' ' A' ' 25' ' ' LYS . 0.8 OUTLIER -171.68 134.79 0.84 Allowed 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 115.204 -0.907 . . . . 2.9500000000000002 109.465 -164.671 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.689 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 5.2 m -66.0 122.05 16.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 122.062 0.934 . . . . 1.5600000000000001 111.486 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.514 HG21 ' HE2' ' A' ' 48' ' ' TYR . 30.1 m -95.76 -23.19 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-N 113.906 -1.497 . . . . 1.22 108.517 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.521 ' HD2' ' HA ' ' A' ' 28' ' ' LYS . 15.1 tptm -161.98 131.25 4.47 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 120.251 -0.579 . . . . 2.4100000000000001 111.185 -176.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.76 HG22 ' HA ' ' A' ' 34' ' ' THR . 77.4 p -131.81 152.18 51.16 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.224 -0.444 . . . . 1.3799999999999999 109.827 172.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.551 ' HB3' HG12 ' A' ' 33' ' ' ILE . 22.9 t -111.67 -138.98 0.38 Allowed 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.268 -0.641 . . . . 2.3700000000000001 109.268 177.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -103.62 18.13 22.56 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 122.451 -0.155 . . . . 4.5499999999999998 110.835 -178.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.3 tptt -175.12 2.98 0.01 OUTLIER 'General case' 0 C--O 1.237 0.422 0 N-CA-C 112.098 0.407 . . . . 1.4199999999999999 112.098 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.924 HG22 ' HA3' ' A' ' 52' ' ' GLY . 38.1 pt -139.3 166.34 21.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 120.783 0.325 . . . . 0.76000000000000001 111.376 -175.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.76 ' HA ' HG22 ' A' ' 29' ' ' THR . 24.1 m -152.02 112.38 4.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.425 -0.807 . . . . 0.57999999999999996 110.685 -165.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.884 HG22 HG12 ' A' ' 50' ' ' VAL . 2.3 t -107.16 103.89 16.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.842 0.353 . . . . 0.85999999999999999 110.242 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.689 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 4.3 p -102.5 127.58 49.49 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 122.957 0.503 . . . . 1.1000000000000001 110.273 179.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 6.9 t -120.53 135.71 55.0 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.402 0.62 . . . . 1.27 112.152 -172.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 1.012 ' HB3' ' HB3' ' A' ' 24' ' ' TRP . 0.2 OUTLIER -128.42 142.12 51.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.77 -1.105 . . . . 1.9099999999999999 109.632 175.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 46' ' ' ASN . . . -56.55 126.8 28.22 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.668 0.618 . . . . 1.6799999999999999 112.668 -172.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.476 ' H ' ' HA ' ' A' ' 46' ' ' ASN . 17.6 m -75.44 139.26 42.18 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.988 -0.551 . . . . 2.0899999999999999 109.721 175.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -86.77 13.07 9.44 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.296 0.48 . . . . 6.6100000000000003 112.296 -175.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 46.3 mttm -54.32 -37.18 64.55 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.976 -0.289 . . . . 6.46 110.469 169.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.513 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 62.5 t80 166.49 -77.46 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 O-C-N 124.204 0.94 . . . . 5.6500000000000004 109.575 -175.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -139.84 87.2 2.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.859 -0.61 . . . . 5.5599999999999996 109.508 178.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.34 -169.42 21.1 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 109.973 -1.251 . . . . 1.5600000000000001 109.973 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 2.8 p-10 -154.66 131.2 10.58 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 117.685 0.743 . . . . 2.0499999999999998 111.445 178.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.681 HD23 ' N ' ' A' ' 48' ' ' TYR . 5.2 tt -83.7 150.8 25.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.726 -1.125 . . . . 0.87 108.565 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.681 ' N ' HD23 ' A' ' 47' ' ' LEU . 70.9 m-85 -120.31 131.88 55.07 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.931 0.395 . . . . 0.98999999999999999 110.941 -174.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.507 ' HG2' ' CE2' ' A' ' 170' ' ' PHE . 0.6 OUTLIER -112.44 115.45 28.7 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.266 -1.012 . . . . 2.9199999999999999 108.266 173.22 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.884 HG12 HG22 ' A' ' 35' ' ' VAL . 2.0 m -101.49 150.35 6.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 120.407 -0.517 . . . . 1.3300000000000001 110.477 173.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.652 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 45.7 tt0 -151.15 109.38 3.75 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.986 -1.006 . . . . 1.0700000000000001 109.49 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.924 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -139.99 143.16 13.34 Favored Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 110.909 -0.876 . . . . 0.28999999999999998 110.909 178.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.0 mt -88.62 125.3 41.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 C-N-CA 119.574 -0.85 . . . . 0.57999999999999996 111.051 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.47 HG12 ' HD3' ' A' ' 200' ' ' LYS . 45.4 mt -106.04 99.1 21.13 Favored Pre-proline 0 N--CA 1.442 -0.871 0 N-CA-C 108.046 -1.094 . . . . 0.34999999999999998 108.046 173.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.814 ' HA ' ' HA ' ' A' ' 164' ' ' TYR . 38.3 Cg_endo -65.14 49.89 0.2 Allowed 'Trans proline' 0 N--CA 1.479 0.67 1 C-N-CA 125.506 4.137 . . . . 0.62 115.406 -170.358 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.496 ' HB2' ' H ' ' A' ' 57' ' ' SER . 2.2 pm0 -139.34 -153.67 0.48 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.065 -0.717 . . . . 1.6799999999999999 109.065 165.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.496 ' H ' ' HB2' ' A' ' 56' ' ' GLU . 44.0 t -92.28 140.78 24.43 Favored Pre-proline 0 N--CA 1.422 -1.826 0 CA-C-O 122.006 0.908 . . . . 1.1799999999999999 111.141 -174.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.639 ' HB3' ' SG ' ' A' ' 155' ' ' CYS . 31.1 Cg_exo -57.36 -14.84 17.11 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 124.201 3.267 . . . . 0.52000000000000002 110.306 174.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.54 ' O ' ' HB2' ' A' ' 63' ' ' ASP . . . -69.55 -47.34 63.99 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.939 -1.028 . . . . 0.64000000000000001 111.134 174.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 1.001 ' HE3' ' HA ' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -66.54 -35.48 80.33 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.082 -1.081 . . . . 3.2999999999999998 108.082 178.263 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.971 HD23 HD13 ' A' ' 203' ' ' ILE . 37.1 mt -60.72 -55.44 33.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.87 -1.059 . . . . 0.40999999999999998 110.833 177.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.456 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 42.5 t -67.36 -10.27 49.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.68 0.276 . . . . 1.29 110.734 177.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.54 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -85.83 -45.72 11.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.475 -0.33 . . . . 1.3200000000000001 111.158 -178.631 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.479 ' CE2' ' HA ' ' A' ' 61' ' ' LEU . 11.3 p90 -77.78 -43.36 30.91 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.662 -0.245 . . . . 0.60999999999999999 111.574 -172.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.456 ' CD2' ' HA ' ' A' ' 62' ' ' SER . 1.0 OUTLIER -75.31 -8.94 58.01 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 122.187 -0.321 . . . . 1.5 111.484 -169.406 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.525 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 26.2 t80 -26.4 -56.7 0.08 Allowed 'General case' 0 N--CA 1.462 0.151 0 O-C-N 125.431 1.707 . . . . 1.52 114.11 -163.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.525 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 8.5 tt0 166.02 -38.62 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.595 0.712 . . . . 3.6000000000000001 110.861 -175.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.9 t -165.55 19.84 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.253 -0.885 . . . . 1.48 110.155 -164.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 70' ' ' ASP . . . -78.01 -34.68 37.11 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.252 -0.975 . . . . 1.46 111.702 -173.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.624 ' O ' HG22 ' A' ' 73' ' ' THR . 16.4 p-10 166.63 -17.7 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.12 -1.04 . . . . 2.1899999999999999 108.549 -167.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.858 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -45.57 -38.21 6.25 Favored 'General case' 0 C--O 1.209 -1.034 0 CA-C-N 115.324 -0.853 . . . . 3.3799999999999999 111.755 176.021 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.655 ' H ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -89.87 -7.47 10.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 120.383 -0.527 . . . . 0.70999999999999996 111.386 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.624 HG22 ' O ' ' A' ' 70' ' ' ASP . 0.8 OUTLIER -92.41 -27.77 17.28 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 120.395 -0.522 . . . . 0.96999999999999997 110.618 -173.352 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.808 ' HZ3' ' HB2' ' A' ' 198' ' ' ASN . 11.9 p-90 -112.79 -3.06 14.26 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.795 -0.362 . . . . 0.75 111.699 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.858 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 4.1 t70 -70.18 175.66 4.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 122.335 1.064 . . . . 2.1899999999999999 112.231 -172.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.863 ' HD2' ' HB3' ' A' ' 198' ' ' ASN . 0.0 OUTLIER -118.37 -12.8 9.84 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.8 -1.545 . . . . 3.1899999999999999 110.195 -174.166 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.555 ' HA ' ' HB2' ' A' ' 99' ' ' GLN . 0.1 OUTLIER -130.31 2.81 4.67 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.198 -0.91 . . . . 1.5800000000000001 109.921 178.094 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.774 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 62.1 mt -109.15 149.82 28.78 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.057 -0.52 . . . . 0.70999999999999996 110.834 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.593 ' HG2' ' HG2' ' A' ' 99' ' ' GLN . 15.0 mm100 -132.56 -59.02 0.92 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.465 -0.789 . . . . 1.73 111.288 -175.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.732 ' HB ' HD13 ' A' ' 97' ' ' ILE . 18.1 t -140.7 125.44 18.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.521 -0.763 . . . . 0.78000000000000003 110.633 -165.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -94.88 153.53 17.66 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.601 -0.727 . . . . 5.4000000000000004 110.44 174.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.501 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 1.2 m120 -152.82 109.37 3.42 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.718 -0.475 . . . . 1.6899999999999999 109.718 167.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.513 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 3.3 ttt -75.03 94.87 2.93 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.266 -1.013 . . . . 2.0499999999999998 108.266 178.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -74.66 -73.03 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-O 121.215 0.531 . . . . 0.64000000000000001 111.258 -166.683 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -136.34 120.6 17.91 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.783 -0.644 . . . . 1.96 109.592 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.837 ' HG2' ' HD2' ' A' ' 92' ' ' PHE . 38.6 mtm180 -97.15 123.19 40.84 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.453 -0.794 . . . . 2.4399999999999999 109.684 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.673 HG22 ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -82.37 -40.73 17.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.833 -0.621 . . . . 0.46999999999999997 109.819 -174.123 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -147.88 -161.92 1.44 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.384 -0.969 . . . . 1.8600000000000001 108.384 177.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.2 m -83.08 -7.78 59.61 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.739 0.304 . . . . 1.4399999999999999 110.81 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -137.65 15.99 2.91 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.26 0.553 . . . . 1.8700000000000001 110.258 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.716 HG23 ' HD2' ' A' ' 116' ' ' TYR . 0.7 OUTLIER -134.37 109.92 9.11 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 107.916 -1.142 . . . . 0.46000000000000002 107.916 -179.287 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.837 ' HD2' ' HG2' ' A' ' 86' ' ' ARG . 5.1 m-85 -132.14 178.9 6.44 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.316 0.579 . . . . 0.42999999999999999 110.797 -174.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.637 ' O ' HG23 ' A' ' 84' ' ' VAL . 19.3 mt -138.3 130.4 38.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 106.966 -1.494 . . . . 0.40999999999999998 106.966 169.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 48.0 t -116.0 122.13 44.32 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.621 -0.432 . . . . 2.0099999999999998 110.92 -172.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.572 ' HA ' HD13 ' A' ' 112' ' ' ILE . 10.5 t60 -85.95 83.98 7.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.862 0.839 . . . . 1.23 109.175 173.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.796 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 18.9 m -90.69 118.07 29.83 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.485 -1.234 . . . . 0.5 111.442 -176.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.732 HD13 ' HB ' ' A' ' 80' ' ' VAL . 3.5 mp -91.58 123.37 43.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.758 -0.831 . . . . 1.03 108.758 170.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 109' ' ' ARG . 15.2 t -110.29 171.41 7.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.061 -0.518 . . . . 1.3799999999999999 110.978 -174.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.593 ' HG2' ' HG2' ' A' ' 79' ' ' GLN . 4.7 mm100 -95.59 172.57 7.98 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.107 -0.951 . . . . 1.8200000000000001 111.897 -172.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.9 m -94.05 86.68 5.08 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.075 -0.966 . . . . 3.9100000000000001 111.276 -175.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.406 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 9.9 p90 -98.28 118.65 35.41 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.96 -1.126 . . . . 5.1600000000000001 107.96 173.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.777 ' HB3' HD12 ' A' ' 106' ' ' ILE . . . 73.02 59.51 0.11 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.962 -1.017 . . . . 1.98 108.574 -168.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 106' ' ' ILE . 7.8 p -67.09 0.27 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 114.57 -1.196 . . . . 3.1699999999999999 112.52 -171.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.18 -29.17 74.43 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.605 -0.807 . . . . 1.96 111.791 177.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.948 ' HB2' HG21 ' A' ' 183' ' ' ILE . 72.5 m -142.09 9.18 1.89 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.115 0.483 . . . . 1.8799999999999999 110.658 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.777 HD12 ' HB3' ' A' ' 102' ' ' ALA . 64.2 mt -130.74 108.29 15.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.2 0.524 . . . . 1.1200000000000001 110.964 -176.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.508 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.3 p -100.66 176.33 1.96 Allowed Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.205 -0.907 . . . . 1.3500000000000001 109.965 177.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.508 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 87.9 Cg_exo -47.55 109.9 0.26 Allowed 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 122.306 2.004 . . . . 1.0700000000000001 111.135 174.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.617 ' HG3' HG23 ' A' ' 144' ' ' ILE . 18.4 ttm180 -111.06 151.69 27.77 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.168 -0.469 . . . . 3.4500000000000002 111.134 -167.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.867 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 6.5 t70 -99.28 134.06 42.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.761 -0.654 . . . . 1.3700000000000001 110.847 -176.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.796 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 17.8 m-85 -118.21 114.71 23.43 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.81 -0.632 . . . . 2.4100000000000001 110.143 173.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.572 HD13 ' HA ' ' A' ' 95' ' ' HIS . 26.2 mm -108.95 76.24 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.722 -0.844 . . . . 0.42999999999999999 108.722 170.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.764 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 1.6 m-20 -95.48 119.89 34.77 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.847 -0.615 . . . . 1.8600000000000001 110.306 -178.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.678 ' O ' ' HA ' ' A' ' 129' ' ' SER . 3.9 tp -75.36 121.79 22.79 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 108.672 -0.862 . . . . 0.28000000000000003 108.672 170.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -126.6 123.97 64.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-N 115.296 -0.865 . . . . 0.26000000000000001 111.732 -164.14 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.716 ' HD2' HG23 ' A' ' 91' ' ' THR . 24.1 t80 -105.95 111.91 24.75 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.786 -1.097 . . . . 2.5699999999999998 110.023 175.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.929 HG12 HG22 ' A' ' 127' ' ' ILE . 73.2 mt -92.9 99.15 9.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.039 -0.528 . . . . 0.89000000000000001 109.608 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.694 ' HB2' ' CE1' ' A' ' 116' ' ' TYR . 36.7 ttpt -124.35 138.17 54.4 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.989 -0.55 . . . . 1.2 110.546 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.479 ' O ' ' HD3' ' A' ' 119' ' ' ARG . 0.1 OUTLIER -116.09 111.95 21.03 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-O 122.117 0.961 . . . . 2.7999999999999998 109.697 177.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.61 ' HB2' ' HB3' ' A' ' 123' ' ' ASN . 18.2 m-85 -68.05 104.0 1.65 Allowed 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 105.523 -2.028 . . . . 0.82999999999999996 105.523 163.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.46 ' H ' ' HG2' ' A' ' 121' ' ' GLU . 4.1 pt-20 -53.17 98.29 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 122.262 1.029 . . . . 2.2799999999999998 113.023 -168.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 84.91 23.09 50.92 Favored Glycine 0 CA--C 1.504 -0.632 0 CA-C-N 113.483 -1.689 . . . . 0.76000000000000001 111.785 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.61 ' HB3' ' HB2' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -127.33 -50.74 1.41 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.63 -0.785 . . . . 1.6499999999999999 109.213 179.081 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.469 ' O ' ' HA ' ' A' ' 119' ' ' ARG . 0.9 OUTLIER -161.47 143.06 11.54 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.138 -0.483 . . . . 1.1200000000000001 111.282 -177.272 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -116.62 84.41 2.13 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.471 -0.937 . . . . 1.6200000000000001 108.471 169.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.624 ' CG1' HG12 ' A' ' 154' ' ' VAL . 0.7 OUTLIER -102.26 135.0 41.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 112.951 0.722 . . . . 0.29999999999999999 112.951 -172.141 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.929 HG22 HG12 ' A' ' 117' ' ' ILE . 31.7 pt -100.15 107.34 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.914 0.864 . . . . 0.58999999999999997 109.023 164.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.553 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 1.2 m -88.38 109.38 19.95 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.453 -0.794 . . . . 1.1799999999999999 110.638 -178.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.764 ' HB3' ' HB3' ' A' ' 113' ' ' ASP . 12.8 m -114.74 145.16 42.39 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.248 0.547 . . . . 1.24 111.733 -170.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.616 ' HE2' ' HG3' ' A' ' 150' ' ' PRO . 3.2 mtpm? -137.66 121.78 17.94 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 107.387 -1.338 . . . . 2.2599999999999998 107.387 174.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 78.9 p -64.04 98.4 0.21 Allowed 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.11 -1.441 . . . . 1.3899999999999999 107.11 175.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.485 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -109.03 140.21 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.836 0 N-CA-C 108.731 -0.84 . . . . 1.05 108.731 -165.488 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -102.68 86.89 2.85 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 122.459 1.124 . . . . 2.1699999999999999 109.245 -174.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.763 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 1.3 p90 -117.33 154.5 50.31 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 114.012 -1.449 . . . . 0.53000000000000003 111.526 -166.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 3.2 Cg_exo -42.09 -47.0 7.01 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 124.77 3.646 . . . . 1.28 115.883 -174.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.763 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 7.3 tp10 -65.64 -25.55 67.41 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 120.731 0.301 . . . . 3.5 110.749 -163.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.577 ' HB2' HG11 ' A' ' 84' ' ' VAL . 10.1 t80 -150.26 101.77 3.15 Favored Pre-proline 0 N--CA 1.441 -0.908 0 N-CA-C 113.237 0.829 . . . . 6.1200000000000001 113.237 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -88.94 134.4 2.63 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.261 2.641 . . . . 1.77 109.746 163.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.5 -171.92 0.41 Allowed 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.439 2.093 . . . . 1.25 112.424 -176.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 62.2 p -133.22 -179.7 5.66 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 109.356 -0.609 . . . . 1.6000000000000001 109.356 -172.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.2 m -86.21 11.38 12.12 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.125 0.488 . . . . 1.97 110.658 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -120.14 -44.74 2.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.781 -0.645 . . . . 2.1800000000000002 109.773 173.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.867 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 85.0 m-85 -94.28 109.71 21.51 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.193 -0.669 . . . . 1.23 109.193 175.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.617 HG23 ' HG3' ' A' ' 109' ' ' ARG . 1.0 OUTLIER -95.11 107.69 19.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.783 -0.644 . . . . 0.81999999999999995 110.177 -175.391 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 2.7 ttp180 -56.84 99.88 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.407 -0.815 . . . . 4.4199999999999999 109.803 175.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -66.23 128.87 31.25 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.097 -0.801 . . . . 0.79000000000000004 111.097 179.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.672 ' HB3' ' HB3' ' A' ' 174' ' ' GLU . 65.0 t80 -84.84 86.84 7.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.524 0.678 . . . . 4.4400000000000004 110.989 -175.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 53.1 t30 -82.06 116.18 21.53 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.153 -0.93 . . . . 1.6200000000000001 109.361 171.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.757 ' HB3' ' HB3' ' A' ' 172' ' ' GLN . 57.6 t-80 -58.19 154.72 29.43 Favored Pre-proline 0 C--O 1.217 -0.614 0 CA-C-O 118.142 -0.932 . . . . 2.3199999999999998 108.656 173.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.616 ' HG3' ' HE2' ' A' ' 130' ' ' LYS . 60.9 Cg_exo -37.74 78.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 123.916 3.077 . . . . 0.53000000000000003 112.618 169.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . 0.716 ' HB3' ' O ' ' A' ' 170' ' ' PHE . 72.7 m -135.1 149.49 50.06 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.973 -1.467 . . . . 1.5800000000000001 107.904 -176.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.596 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -138.76 -147.0 5.07 Favored Glycine 0 N--CA 1.432 -1.623 0 C-N-CA 119.051 -1.547 . . . . 0.42999999999999999 113.038 -170.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.663 ' HE1' HD21 ' A' ' 167' ' ' LEU . 7.5 t80 -160.74 82.72 0.66 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.915 -1.513 . . . . 0.59999999999999998 106.915 -167.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.693 HG23 HG13 ' A' ' 168' ' ' VAL . 4.1 m -93.27 140.98 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 CA-C-O 122.044 0.926 . . . . 0.31 110.597 -172.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . 0.639 ' SG ' ' HB3' ' A' ' 58' ' ' PRO . 1.6 t -117.09 126.44 52.84 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 114.731 -1.122 . . . . 1.55 109.077 177.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.723 ' HB3' ' HB3' ' A' ' 166' ' ' LYS . 11.2 t -120.48 121.16 29.38 Favored Pre-proline 0 C--N 1.31 -1.138 0 C-N-CA 120.146 -0.622 . . . . 1.0600000000000001 111.669 -172.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 67.8 Cg_exo -50.38 108.65 0.23 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.035 1.823 . . . . 0.56000000000000005 110.373 166.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.723 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 54.0 mmm -72.06 -165.74 0.19 Allowed 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.67 0.747 . . . . 1.1599999999999999 112.175 -174.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.434 ' H ' ' HB3' ' A' ' 158' ' ' MET . 27.1 mt-10 -67.25 -24.28 65.79 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.903 -1.044 . . . . 2.6299999999999999 110.177 177.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 163' ' ' ALA . 54.5 mm-40 -108.05 14.05 25.51 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.754 -0.657 . . . . 2.0499999999999998 110.085 177.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.652 ' HB3' ' CD ' ' A' ' 162' ' ' PRO . 47.0 t-20 29.25 -89.84 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 125.684 1.594 . . . . 1.9299999999999999 114.762 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.652 ' CD ' ' HB3' ' A' ' 161' ' ' ASN . 72.0 Cg_endo -74.42 -13.76 22.76 Favored 'Trans proline' 0 C--N 1.367 1.528 0 CA-C-N 121.854 1.698 . . . . 0.72999999999999998 113.093 -175.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.551 ' HB3' ' HB3' ' A' ' 160' ' ' GLU . . . -91.76 -29.94 16.52 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.864 -0.607 . . . . 0.68000000000000005 110.679 -177.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.814 ' HA ' ' HA ' ' A' ' 55' ' ' PRO . 85.3 m-85 -143.65 124.78 14.48 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.398 -0.593 . . . . 0.93000000000000005 109.398 176.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.438 ' OG ' HD12 ' A' ' 61' ' ' LEU . 21.4 t -112.87 145.52 40.54 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 119.905 -0.718 . . . . 1.4099999999999999 110.593 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.723 ' HB3' ' HB3' ' A' ' 156' ' ' SER . 2.5 tppp? -94.01 112.59 24.44 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.519 0.676 . . . . 0.73999999999999999 111.266 -176.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.663 HD21 ' HE1' ' A' ' 153' ' ' PHE . 0.6 OUTLIER -95.54 104.35 16.26 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.283 -0.871 . . . . 0.27000000000000002 109.37 173.905 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.721 HG12 ' HG3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -125.4 134.54 66.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.223 0.535 . . . . 0.28000000000000003 110.603 176.673 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.643 ' HB3' HG23 ' A' ' 50' ' ' VAL . 20.7 ttt -140.85 143.24 34.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.164 -0.471 . . . . 1.24 110.219 -169.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.716 ' O ' ' HB3' ' A' ' 151' ' ' CYS . 34.0 m-85 -120.42 139.13 53.28 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.057 -0.72 . . . . 3.3700000000000001 109.057 177.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.488 ' HB ' HD21 ' A' ' 192' ' ' LEU . 0.9 OUTLIER -143.42 125.62 12.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 O-C-N 123.492 0.495 . . . . 1.3999999999999999 111.286 178.551 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.757 ' HB3' ' HB3' ' A' ' 149' ' ' HIS . 20.3 tt0 -124.73 51.46 1.63 Allowed 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 107.158 -1.423 . . . . 2.1699999999999999 107.158 171.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 7.4 m -75.36 127.55 33.39 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.806 -1.543 . . . . 1.6499999999999999 110.542 -175.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.672 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 28.6 tt0 -83.39 -28.06 29.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.491 -0.777 . . . . 2.4500000000000002 111.554 -173.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.565 ' O ' HD13 ' A' ' 179' ' ' LEU . 23.2 mmt 48.64 53.79 11.66 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.174 0.511 . . . . 3.7400000000000002 110.247 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.484 ' HD2' ' OE2' ' A' ' 174' ' ' GLU . 11.6 ptm180 -75.24 48.46 0.41 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.419 -0.809 . . . . 5.7800000000000002 111.662 -176.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.402 ' HA3' HG12 ' A' ' 144' ' ' ILE . . . -127.79 48.77 0.95 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.92 -0.657 . . . . 2.2599999999999998 112.662 -177.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 28.0 tptp 70.56 59.67 0.22 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.346 0.593 . . . . 6.2300000000000004 111.653 174.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.61 ' HB2' HD11 ' A' ' 184' ' ' ILE . 4.6 mp -116.67 169.22 9.52 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.026 -0.731 . . . . 1.6399999999999999 109.026 171.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.494 ' HB3' HG12 ' A' ' 183' ' ' ILE . 46.9 t -112.81 151.31 43.91 Favored Pre-proline 0 C--N 1.306 -1.286 0 N-CA-C 107.612 -1.255 . . . . 2.04 107.612 176.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.621 ' O ' ' HG3' ' A' ' 185' ' ' GLU . 76.6 Cg_exo -40.92 -44.92 4.98 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 122.501 2.134 . . . . 1.74 112.283 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.548 ' O ' ' HG3' ' A' ' 186' ' ' LYS . 14.3 p -63.06 -25.18 68.25 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.832 -0.622 . . . . 2.1400000000000001 112.317 -178.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.948 HG21 ' HB2' ' A' ' 105' ' ' SER . 9.1 mm -83.39 -29.5 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.878 0 CA-C-O 122.802 1.287 . . . . 1.1200000000000001 108.401 -176.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 1.024 ' HA ' HG22 ' A' ' 187' ' ' THR . 0.9 OUTLIER -79.93 -34.33 15.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 112.541 -2.118 . . . . 1.1299999999999999 109.924 -175.773 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.621 ' HG3' ' O ' ' A' ' 181' ' ' PRO . 35.1 mt-10 -66.49 -18.6 65.45 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.935 -1.029 . . . . 2.8900000000000001 109.584 172.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' A' ' 182' ' ' SER . 53.0 mtmt -93.0 -44.61 8.33 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.413 -0.812 . . . . 1.28 110.79 174.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 1.024 HG22 ' HA ' ' A' ' 184' ' ' ILE . 14.3 t -66.09 -43.0 88.55 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.612 0.597 . . . . 0.62 112.612 -170.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . 0.555 ' HE2' ' HA ' ' A' ' 188' ' ' MET . 29.1 mmt -73.68 -57.31 2.6 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 112.713 0.634 . . . . 1.0600000000000001 112.713 -172.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.617 ' O ' HG13 ' A' ' 193' ' ' VAL . 27.3 Cg_endo -62.18 -30.48 82.01 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 121.616 1.544 . . . . 0.91000000000000003 112.119 -177.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.2 t -75.99 -33.12 59.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.237 0.541 . . . . 1.5 109.824 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 187' ' ' THR . 63.9 t30 -73.0 -44.24 61.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.678 -0.692 . . . . 1.8799999999999999 111.274 -174.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.494 ' HB3' HG21 ' A' ' 50' ' ' VAL . 18.5 mt -65.23 -42.62 93.24 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.754 0.311 . . . . 1.0900000000000001 111.333 -175.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.617 HG13 ' O ' ' A' ' 189' ' ' PRO . 1.5 m -67.45 -31.89 54.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.908 0.861 . . . . 0.68000000000000005 109.354 178.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.433 ' HB3' ' HE3' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -70.08 -34.68 73.47 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.284 -1.325 . . . . 2.0699999999999998 110.997 177.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.634 ' HA ' ' ND2' ' A' ' 198' ' ' ASN . 3.3 m-85 -71.69 -24.53 61.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.24 0.543 . . . . 2.0 110.433 174.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.646 HG12 HD12 ' A' ' 167' ' ' LEU . 59.2 mt -82.08 -29.44 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-O 121.31 0.576 . . . . 0.31 110.511 172.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 44.6 mt -72.21 -42.6 65.57 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 116.16 -0.473 . . . . 1.03 110.736 177.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.863 ' HB3' ' HD2' ' A' ' 76' ' ' LYS . 5.9 p30 -59.55 -24.0 63.33 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 108.96 -0.755 . . . . 1.8999999999999999 108.96 171.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.678 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -80.94 -44.83 17.63 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 120.415 -0.514 . . . . 0.28999999999999998 110.222 176.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.47 ' HD3' HG12 ' A' ' 54' ' ' ILE . 22.5 mmtp -54.8 -42.89 72.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.02 -0.537 . . . . 0.96999999999999997 110.856 175.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.542 ' O ' ' HD3' ' A' ' 204' ' ' LYS . 9.9 t70 -87.88 -46.26 9.56 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.007 -0.542 . . . . 1.9399999999999999 110.327 -178.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . 0.682 ' HA2' ' HB3' ' A' ' 205' ' ' ALA . . . -61.19 -25.9 65.22 Favored Glycine 0 C--O 1.224 -0.508 0 CA-C-N 115.849 -0.614 . . . . 0.46999999999999997 112.277 -178.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.971 HD13 HD23 ' A' ' 61' ' ' LEU . 3.0 tp -67.89 -43.07 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-O 119.27 -0.395 . . . . 0.60999999999999999 111.239 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.731 ' HA ' ' HB3' ' A' ' 207' ' ' ARG . 0.0 OUTLIER -91.25 -13.54 32.56 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 118.732 0.696 . . . . 3.3700000000000001 109.228 176.532 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.682 ' HB3' ' HA2' ' A' ' 202' ' ' GLY . . . -66.14 -29.73 70.09 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.532 -0.914 . . . . 1.02 108.532 164.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.6 ' HD2' ' HE2' ' A' ' 60' ' ' LYS . 6.6 t60 -100.48 -7.23 24.45 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.589 -1.187 . . . . 3.6299999999999999 111.286 178.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.731 ' HB3' ' HA ' ' A' ' 204' ' ' LYS . 0.7 OUTLIER -112.95 -62.81 1.53 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.552 0.692 . . . . 2.5899999999999999 110.448 -178.525 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.521 ' OG1' ' HB2' ' A' ' 204' ' ' LYS . 62.3 m -73.78 135.12 77.95 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 114.684 -1.144 . . . . 1.8400000000000001 110.316 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 208' ' ' THR . 11.2 Cg_exo -71.52 43.98 0.57 Allowed 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 123.036 2.491 . . . . 2.3500000000000001 112.689 178.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 31.2 t -98.79 -47.93 5.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.123 -0.489 . . . . 2.3100000000000001 110.775 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.431 ' HB2' ' HA ' ' A' ' 205' ' ' ALA . 6.5 mpt_? -90.95 35.34 0.9 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.423 -0.353 . . . . 5.4500000000000002 111.429 -174.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -78.66 -33.32 47.23 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.167 -0.679 . . . . 6.8600000000000003 109.167 171.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.86 48.72 3.28 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.435 -1.066 . . . . 3.3700000000000001 110.435 171.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -66.05 140.71 58.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.184 0.516 . . . . 5.21 111.764 -174.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -86.77 120.18 27.79 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.711 -0.848 . . . . 6.46 108.711 174.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -132.44 175.21 9.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.569 -0.287 . . . . 6.0899999999999999 111.104 -172.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 68.94 178.96 0.25 Allowed 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.702 0.626 . . . . 5.1200000000000001 110.951 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 13.8 m -85.27 -2.17 57.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.149 -0.478 . . . . 6.7599999999999998 110.685 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -143.16 133.47 24.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.102 -0.499 . . . . 8.8200000000000003 110.394 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 73.2 m . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.872 -0.585 . . . . 8.4800000000000004 109.515 176.405 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.992 0.425 . . . . 3.8599999999999999 110.533 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -106.6 -44.75 4.4 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 109.288 -0.634 . . . . 2.25 109.288 -175.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.605 ' HA ' ' CD1' ' A' ' 6' ' ' ILE . 96.6 m-85 -65.65 -37.03 85.4 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.191 -0.913 . . . . 0.42999999999999999 109.186 -175.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.668 ' HG2' ' HG3' ' A' ' 8' ' ' GLN . 4.4 ttmt -81.75 2.94 27.62 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.121 -0.945 . . . . 1.51 110.476 -176.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -92.87 -49.42 6.06 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.359 0.599 . . . . 0.54000000000000004 109.485 173.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.605 ' CD1' ' HA ' ' A' ' 3' ' ' PHE . 0.3 OUTLIER -83.8 -37.68 13.42 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.606 0 CA-C-N 115.354 -0.839 . . . . 1.0700000000000001 110.181 -173.091 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.628 ' HA ' ' HB ' ' A' ' 10' ' ' THR . . . -71.5 -44.1 65.32 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.587 0.708 . . . . 0.34000000000000002 111.531 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.668 ' HG3' ' HG2' ' A' ' 4' ' ' LYS . 11.1 mt-30 -60.13 -32.83 71.38 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.917 -1.038 . . . . 1.5900000000000001 110.516 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.567 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 25.6 mm-40 -85.75 -32.06 22.06 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.221 -0.899 . . . . 2.4700000000000002 109.266 175.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.681 ' OG1' ' HB3' ' A' ' 150' ' ' PRO . 0.6 OUTLIER -62.26 -39.5 93.09 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.927 -1.033 . . . . 0.47999999999999998 111.042 176.513 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.418 ' HA ' ' CB ' ' A' ' 128' ' ' SER . . . -47.43 -63.04 1.15 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 121.148 0.499 . . . . 0.31 111.529 173.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -71.57 -13.0 61.65 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.851 -0.613 . . . . 1.6399999999999999 111.831 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 44.9 mm-40 -69.6 -58.12 4.34 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.764 0.792 . . . . 2.54 109.298 173.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.811 HG21 ' N ' ' A' ' 152' ' ' GLY . 5.3 p -68.01 -40.13 82.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 114.648 -1.16 . . . . 0.53000000000000003 109.717 -177.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.551 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -68.14 -22.83 64.84 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 114.787 -1.097 . . . . 0.59999999999999998 109.08 176.342 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.744 ' HA2' ' HD3' ' A' ' 19' ' ' ARG . . . -63.28 -25.34 68.29 Favored Glycine 0 CA--C 1.5 -0.847 0 CA-C-N 114.474 -1.239 . . . . 0.56999999999999995 110.444 177.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -88.83 -12.25 42.48 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.699 -0.852 . . . . 3.27 108.699 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -83.96 -9.27 58.81 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.321 -0.854 . . . . 2.0299999999999998 110.027 172.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.744 ' HD3' ' HA2' ' A' ' 16' ' ' GLY . 48.4 mtp180 -106.85 -23.89 12.23 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 116.183 -0.462 . . . . 2.7200000000000002 110.884 -172.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -150.88 170.77 18.5 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.038 -0.528 . . . . 2.1600000000000001 110.513 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.465 HG22 ' CZ2' ' A' ' 24' ' ' TRP . 75.1 p -133.51 134.02 42.91 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.57 -0.741 . . . . 1.8200000000000001 109.792 -175.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.4 t -139.25 107.5 5.78 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.263 0.468 . . . . 2.1899999999999999 112.263 -170.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.82 34.13 81.25 Favored Glycine 0 C--N 1.331 0.282 0 CA-C-N 115.528 -0.76 . . . . 1.1000000000000001 114.405 168.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.92 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -121.29 -166.31 1.34 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 117.183 0.491 . . . . 1.6699999999999999 110.273 175.141 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.61 140.38 0.6 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.392 -0.822 . . . . 2.9500000000000002 109.225 -175.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.691 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 0.1 OUTLIER -60.33 117.08 2.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.457 -0.792 . . . . 1.5600000000000001 110.378 174.01 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.9 p -92.05 -25.96 5.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 114.727 -1.124 . . . . 1.22 109.295 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.46 ' O ' HG22 ' A' ' 35' ' ' VAL . 3.0 tmmm? -161.24 146.63 14.01 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 119.264 -0.974 . . . . 2.4100000000000001 112.274 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.871 HG22 ' HA ' ' A' ' 34' ' ' THR . 42.9 p -143.67 152.27 41.12 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.798 -0.637 . . . . 1.3799999999999999 109.722 176.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.9 m -102.38 -90.01 0.36 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.523 -0.308 . . . . 2.3700000000000001 110.631 176.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.474 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 82.0 tttt -155.28 31.65 0.38 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.122 0.487 . . . . 4.5499999999999998 110.502 175.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.516 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 6.1 mmtm 178.9 -20.47 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.4 -0.818 . . . . 1.4199999999999999 110.039 179.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.477 HG22 ' HA3' ' A' ' 52' ' ' GLY . 31.0 pt -115.45 160.85 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.353 -0.839 . . . . 0.76000000000000001 110.701 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.871 ' HA ' HG22 ' A' ' 29' ' ' THR . 52.5 m -155.15 110.09 3.01 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.314 -0.857 . . . . 0.57999999999999996 110.697 -163.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.712 ' HA ' ' O ' ' A' ' 49' ' ' ARG . 6.0 m -103.12 117.83 49.15 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 CA-C-O 121.023 0.44 . . . . 0.85999999999999999 111.824 176.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.691 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 7.2 m -105.78 124.69 49.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.658 -0.701 . . . . 1.1000000000000001 109.655 175.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.8 p -110.75 133.85 52.98 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.759 -0.655 . . . . 1.27 111.868 -172.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.92 ' HB3' ' HB3' ' A' ' 24' ' ' TRP . 23.0 pttt -139.21 157.5 45.81 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.546 -0.752 . . . . 1.9099999999999999 109.26 171.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.04 127.79 33.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.759 0.314 . . . . 1.6799999999999999 110.202 177.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.445 ' H ' ' HA ' ' A' ' 46' ' ' ASN . 25.3 t -64.59 -35.8 82.17 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.71 -0.677 . . . . 2.0899999999999999 112.383 -172.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 71.84 -41.51 0.51 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.928 0.891 . . . . 6.6100000000000003 112.092 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -81.4 -2.25 48.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.375 0.607 . . . . 6.46 109.962 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -155.53 146.74 22.64 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 107.247 -1.39 . . . . 5.6500000000000004 107.247 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -76.04 64.39 1.92 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.524 0.678 . . . . 5.5599999999999996 110.392 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.28 -151.71 6.54 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 114.961 -1.018 . . . . 1.5600000000000001 110.617 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.445 ' HA ' ' H ' ' A' ' 40' ' ' SER . 23.2 p-10 -131.99 147.07 52.43 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.531 0.681 . . . . 2.0499999999999998 111.212 178.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.614 HD23 ' N ' ' A' ' 48' ' ' TYR . 3.5 tt -99.97 146.18 27.0 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.724 -1.125 . . . . 0.87 108.673 -176.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.645 ' HB2' HD11 ' A' ' 192' ' ' LEU . 56.9 m-85 -124.99 138.39 54.23 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 121.261 -0.176 . . . . 0.98999999999999999 110.623 -177.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.712 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 4.3 ttm180 -104.65 120.0 40.29 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.093 -0.706 . . . . 2.9199999999999999 109.093 167.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.664 ' HB ' ' HB3' ' A' ' 192' ' ' LEU . 9.0 p -102.93 134.73 43.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.004 -1.11 . . . . 1.3300000000000001 108.004 172.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.654 ' HG3' ' HB ' ' A' ' 168' ' ' VAL . 2.7 tt0 -148.02 110.65 4.72 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.058 -0.519 . . . . 1.0700000000000001 110.579 -165.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 32' ' ' LYS . . . -142.61 154.34 25.13 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 111.111 -0.796 . . . . 0.28999999999999998 111.111 179.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.612 HG12 ' SD ' ' A' ' 158' ' ' MET . 2.7 mp -96.33 126.98 48.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 C-N-CA 119.256 -0.977 . . . . 0.57999999999999996 110.393 176.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.424 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 66.2 mt -104.57 112.77 65.41 Favored Pre-proline 0 N--CA 1.44 -0.959 0 CA-C-N 114.937 -1.029 . . . . 0.34999999999999998 109.33 177.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 54' ' ' ILE . 28.8 Cg_exo -64.56 59.87 0.27 Allowed 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 124.259 3.306 . . . . 0.62 113.111 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.965 ' HG3' HG13 ' A' ' 203' ' ' ILE . 0.2 OUTLIER -134.37 -164.31 1.49 Allowed 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.041 -1.466 . . . . 1.6799999999999999 107.041 174.075 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.56 ' H ' ' CD ' ' A' ' 56' ' ' GLU . 20.0 m -101.73 150.5 37.38 Favored Pre-proline 0 N--CA 1.421 -1.889 0 N-CA-C 108.816 -0.809 . . . . 1.1799999999999999 108.816 169.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.528 ' HB3' ' SG ' ' A' ' 155' ' ' CYS . 14.9 Cg_exo -66.63 -7.72 18.92 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.605 2.87 . . . . 0.52000000000000002 110.2 -178.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.68 -53.09 17.06 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.803 -1.09 . . . . 0.64000000000000001 111.411 175.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.713 ' HE3' ' HB3' ' A' ' 64' ' ' PHE . 16.2 tptt -69.21 -28.29 66.24 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.254 -1.017 . . . . 3.2999999999999998 108.254 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.666 HD23 HD11 ' A' ' 203' ' ' ILE . 63.9 mt -62.45 -51.67 66.59 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.825 -1.08 . . . . 0.40999999999999998 110.008 174.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.571 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 39.3 t -75.35 -4.96 42.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.735 0.302 . . . . 1.29 110.571 176.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.5 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 31.3 t70 -90.63 -43.06 10.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.313 -0.403 . . . . 1.3200000000000001 110.829 178.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.795 ' O ' ' HB3' ' A' ' 71' ' ' ARG . 8.1 p90 -76.49 -44.97 33.02 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.903 -0.319 . . . . 0.60999999999999999 111.146 -175.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.665 HD22 ' O ' ' A' ' 61' ' ' LEU . 1.2 pt? -77.64 6.2 7.73 Favored 'General case' 0 CA--C 1.509 -0.604 0 O-C-N 122.277 -0.264 . . . . 1.5 111.227 -164.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -46.77 -14.53 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.961 0 O-C-N 124.326 1.016 . . . . 1.52 113.074 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.626 ' HA ' ' HD2' ' A' ' 71' ' ' ARG . 0.4 OUTLIER 87.68 -38.18 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 124.73 1.212 . . . . 3.6000000000000001 110.509 168.305 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.61 ' OG1' ' HB2' ' A' ' 81' ' ' TYR . 15.0 t -138.2 23.8 2.77 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.793 0.806 . . . . 1.48 110.811 -177.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -108.06 -61.29 0.55 Allowed Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 119.616 -1.278 . . . . 1.46 112.912 -177.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.689 ' O ' HG22 ' A' ' 73' ' ' THR . 18.9 t70 -134.05 -25.19 1.61 Allowed 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.881 0.848 . . . . 2.1899999999999999 110.009 -169.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.795 ' HB3' ' O ' ' A' ' 64' ' ' PHE . 0.3 OUTLIER -69.0 -37.22 78.57 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 114.724 -1.125 . . . . 3.3799999999999999 109.658 -163.385 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.101 HG22 HD13 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -76.11 -21.5 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 115.277 -0.874 . . . . 0.70999999999999996 110.066 -176.223 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.689 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.2 t -81.02 -26.22 36.59 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 119.972 -0.691 . . . . 0.96999999999999997 109.986 -172.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.712 ' CE2' ' HA ' ' A' ' 71' ' ' ARG . 24.8 p-90 -110.4 0.02 17.72 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.12 -0.491 . . . . 0.75 111.373 177.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.617 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 2.3 t70 -66.83 176.13 2.16 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.82 0.819 . . . . 2.1899999999999999 112.527 -170.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.46 ' HD3' ' N ' ' A' ' 77' ' ' SER . 0.0 OUTLIER -129.19 -17.3 3.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.555 -1.202 . . . . 3.1899999999999999 111.507 -174.636 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.46 ' N ' ' HD3' ' A' ' 76' ' ' LYS . 67.9 m -130.32 24.6 5.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.658 0.742 . . . . 1.5800000000000001 109.372 178.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.101 HD13 HG22 ' A' ' 72' ' ' ILE . 18.9 mt -116.01 -167.21 1.23 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.301 -0.863 . . . . 0.70999999999999996 112.293 177.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.471 ' HB3' HG23 ' A' ' 80' ' ' VAL . 1.9 mm100 -161.63 -74.79 0.05 Allowed 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.637 -0.71 . . . . 1.73 112.205 -167.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.471 HG23 ' HB3' ' A' ' 79' ' ' GLN . 23.0 t -139.4 122.09 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.917 0.389 . . . . 0.78000000000000003 111.764 -167.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.641 ' HB3' HD12 ' A' ' 72' ' ' ILE . 23.1 p90 -96.53 154.08 17.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.056 -0.52 . . . . 5.4000000000000004 112.009 176.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -162.08 111.29 1.48 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.46 -0.791 . . . . 1.6899999999999999 109.541 168.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 30.9 ttm -72.26 109.87 6.3 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.15 -1.056 . . . . 2.0499999999999998 108.15 174.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.525 HG23 ' HB ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -87.59 -88.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.893 0.377 . . . . 0.64000000000000001 111.34 -170.73 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.546 ' HB3' HD12 ' A' ' 93' ' ' ILE . 54.3 t60 -113.34 124.81 53.33 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.174 0.511 . . . . 1.96 110.137 -177.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.0 mtt180 -104.68 133.96 48.64 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.942 -0.762 . . . . 2.4399999999999999 108.942 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.52 HD12 ' CD2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -94.32 -39.38 10.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.685 0.755 . . . . 0.46999999999999997 109.171 -175.789 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.439 ' HB2' ' HE2' ' A' ' 4' ' ' LYS . 4.0 t0 -150.9 -169.79 3.48 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.609 -1.178 . . . . 1.8600000000000001 108.136 176.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.6 t -79.95 -3.57 48.78 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.74 0.305 . . . . 1.4399999999999999 110.707 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -136.46 17.57 3.14 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.395 0.617 . . . . 1.8700000000000001 109.758 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.722 HG23 ' HD2' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -138.42 108.37 6.34 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 108.662 -0.866 . . . . 0.46000000000000002 108.662 179.513 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.598 ' O ' HD12 ' A' ' 114' ' ' LEU . 30.7 m-85 -126.58 177.23 6.64 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.418 0.628 . . . . 0.42999999999999999 110.959 -173.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.546 HD12 ' HB3' ' A' ' 85' ' ' HIS . 28.4 mt -136.07 132.98 50.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 107.029 -1.471 . . . . 0.40999999999999998 107.029 167.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.425 ' SG ' ' HB2' ' A' ' 113' ' ' ASP . 7.7 p -115.36 127.39 55.37 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.177 0.513 . . . . 2.0099999999999998 111.927 -175.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.597 ' HD2' HD11 ' A' ' 112' ' ' ILE . 41.7 t-80 -89.51 91.32 8.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.721 -0.672 . . . . 1.23 109.192 169.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 86.7 m -110.34 109.17 19.49 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.399 -0.819 . . . . 0.5 111.592 -174.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.471 ' CG1' ' HB ' ' A' ' 80' ' ' VAL . 27.4 mm -77.85 120.07 27.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.699 -0.852 . . . . 1.03 108.699 171.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.4 t -110.77 153.96 24.6 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.14 0.495 . . . . 1.3799999999999999 109.942 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.488 ' C ' ' H ' ' A' ' 101' ' ' PHE . 3.4 mt-30 -115.85 75.11 0.93 Allowed 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.81 -0.632 . . . . 1.8200000000000001 109.385 175.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.5 m -75.18 21.62 0.12 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.356 0.598 . . . . 3.9100000000000001 110.936 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.513 ' CE2' ' HA2' ' A' ' 104' ' ' GLY . 39.1 t80 -48.4 99.53 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.898 1.279 . . . . 5.1600000000000001 111.149 176.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.527 ' HB2' HD12 ' A' ' 106' ' ' ILE . . . -66.53 -71.04 0.21 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.484 -0.78 . . . . 1.98 110.99 175.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.432 ' O ' HG22 ' A' ' 103' ' ' VAL . 14.4 p -145.74 16.89 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 122.466 1.127 . . . . 3.1699999999999999 108.339 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.513 ' HA2' ' CE2' ' A' ' 101' ' ' PHE . . . 115.47 -5.52 21.19 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 114.653 -1.158 . . . . 1.96 111.5 -176.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.22 -18.24 53.3 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.657 0.741 . . . . 1.8799999999999999 110.05 -177.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.527 HD12 ' HB2' ' A' ' 102' ' ' ALA . 26.9 mt -126.6 124.2 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 115.048 -0.978 . . . . 1.1200000000000001 110.152 -172.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.418 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 13.7 m -86.05 163.46 42.95 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 109.108 -0.701 . . . . 1.3500000000000001 109.108 176.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 107' ' ' SER . 9.3 Cg_endo -53.2 131.65 44.13 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.241 1.961 . . . . 1.0700000000000001 111.254 174.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.627 ' HG2' HG23 ' A' ' 144' ' ' ILE . 45.9 mtt180 -106.44 157.06 17.91 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.101 -0.703 . . . . 3.4500000000000002 109.101 -178.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.827 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 13.6 t0 -106.57 116.16 31.46 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.91 -0.774 . . . . 1.3700000000000001 108.91 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.621 ' HE1' ' HA3' ' A' ' 146' ' ' GLY . 3.3 m-30 -99.57 128.39 45.68 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.012 0.435 . . . . 2.4100000000000001 110.492 -177.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.787 HG13 ' HA ' ' A' ' 137' ' ' TYR . 27.3 mm -123.61 75.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 108.769 -0.826 . . . . 0.42999999999999999 108.769 173.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.918 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 20.8 m-20 -89.83 118.03 29.11 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.163 -0.926 . . . . 1.8600000000000001 109.786 -177.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.598 HD12 ' O ' ' A' ' 92' ' ' PHE . 3.8 tp -75.03 114.66 13.76 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 107.875 -1.157 . . . . 0.28000000000000003 107.875 166.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -118.77 122.16 68.72 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 CA-C-N 114.474 -1.239 . . . . 0.26000000000000001 111.121 -164.529 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.722 ' HD2' HG23 ' A' ' 91' ' ' THR . 29.1 t80 -106.32 111.11 23.56 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.656 -1.156 . . . . 2.5699999999999998 109.252 176.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.991 HG12 HG22 ' A' ' 127' ' ' ILE . 82.5 mt -87.81 98.12 7.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.953 0.882 . . . . 0.89000000000000001 109.27 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.634 ' HE2' ' HE1' ' A' ' 116' ' ' TYR . 16.2 tppt? -99.62 112.56 24.77 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.103 -1.408 . . . . 1.2 108.93 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.528 ' NH1' ' HG2' ' A' ' 121' ' ' GLU . 0.1 OUTLIER -106.13 108.86 20.58 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 122.108 0.956 . . . . 2.7999999999999998 108.526 177.039 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.556 ' CB ' ' HB2' ' A' ' 123' ' ' ASN . 91.0 m-85 -76.61 108.36 9.56 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 105.933 -1.877 . . . . 0.82999999999999996 105.933 167.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.528 ' HG2' ' NH1' ' A' ' 119' ' ' ARG . 44.7 mt-10 -40.21 93.35 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.879 1.362 . . . . 2.2799999999999998 112.84 -174.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 71.0 35.27 64.72 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 114.634 -1.166 . . . . 0.76000000000000001 112.497 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.556 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 13.3 m120 -133.32 -54.35 0.9 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.853 -0.673 . . . . 1.6499999999999999 110.032 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.496 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 2.8 mpp? -160.07 121.8 3.21 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.154 -0.476 . . . . 1.1200000000000001 110.655 -175.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -107.93 81.8 1.55 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.412 -0.958 . . . . 1.6200000000000001 108.412 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.58 ' CG1' HG12 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -99.81 137.93 25.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.239 -0.891 . . . . 0.29999999999999999 112.967 -170.709 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.991 HG22 HG12 ' A' ' 117' ' ' ILE . 41.2 pt -99.25 104.35 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 121.833 0.825 . . . . 0.58999999999999997 109.281 166.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 0.7 OUTLIER -87.04 109.26 19.28 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.429 -0.805 . . . . 1.1799999999999999 109.82 179.214 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.918 ' HB3' ' HB3' ' A' ' 113' ' ' ASP . 14.1 m -118.26 137.78 52.81 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.016 0.436 . . . . 1.24 112.132 -166.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.494 ' HE3' ' HB ' ' A' ' 6' ' ' ILE . 3.4 mtpm? -132.47 124.6 28.87 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 107.732 -1.21 . . . . 2.2599999999999998 107.732 178.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 15.6 p -64.37 99.82 0.32 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.924 -1.51 . . . . 1.3899999999999999 106.924 173.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.43 135.69 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 CA-C-O 121.504 0.669 . . . . 1.05 109.369 -164.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -87.41 81.38 7.85 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.841 -1.072 . . . . 2.1699999999999999 109.583 -171.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.754 ' CZ ' ' HB3' ' A' ' 136' ' ' GLU . 0.8 OUTLIER -121.96 176.26 2.1 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-N 115.092 -0.958 . . . . 0.53000000000000003 108.469 -176.548 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.536 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 50.3 Cg_exo -24.43 -64.49 0.04 OUTLIER 'Trans proline' 0 CA--C 1.551 1.353 1 C-N-CA 125.474 4.116 . . . . 1.28 117.329 -179.386 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.754 ' HB3' ' CZ ' ' A' ' 134' ' ' PHE . 6.2 tp10 -72.8 -30.69 64.27 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.466 0.543 . . . . 3.5 112.466 -174.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.787 ' HA ' HG13 ' A' ' 112' ' ' ILE . 32.1 t80 -51.17 -41.87 77.48 Favored Pre-proline 0 CA--C 1.552 1.056 0 N-CA-C 115.651 1.722 . . . . 6.1200000000000001 115.651 -170.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.465 ' HD2' ' O ' ' A' ' 135' ' ' PRO . 73.4 Cg_exo -45.86 108.43 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 122.515 2.143 . . . . 1.77 113.746 177.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 1.001 ' HB3' ' HD3' ' A' ' 145' ' ' ARG . 95.0 Cg_endo -99.97 -158.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.024 3.149 . . . . 1.25 114.053 -177.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.8 t -135.85 -155.09 0.61 Allowed 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.476 -1.305 . . . . 1.6000000000000001 107.476 177.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.2 m -90.47 -41.19 11.57 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.405 -0.518 . . . . 1.97 111.451 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -64.45 -53.36 49.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.759 0.314 . . . . 2.1800000000000002 110.538 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -95.48 108.94 21.2 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 108.923 -0.769 . . . . 1.23 108.923 175.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.627 HG23 ' HG2' ' A' ' 109' ' ' ARG . 1.2 tt -104.52 119.08 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 CA-C-N 115.056 -0.975 . . . . 0.81999999999999995 110.721 -173.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 1.001 ' HD3' ' HB3' ' A' ' 139' ' ' PRO . 1.3 mpt_? -63.41 99.31 0.2 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.264 -1.334 . . . . 4.4199999999999999 109.732 173.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.621 ' HA3' ' HE1' ' A' ' 111' ' ' PHE . . . -61.36 111.83 4.21 Favored Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 110.096 -1.202 . . . . 0.79000000000000004 110.096 176.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.628 ' HB3' ' HB3' ' A' ' 174' ' ' GLU . 39.5 t80 -84.47 84.65 7.58 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.832 0.825 . . . . 4.4400000000000004 110.441 -172.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.656 ' HB3' ' SG ' ' A' ' 151' ' ' CYS . 87.6 m-20 -72.82 99.57 2.68 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.485 -1.234 . . . . 1.6200000000000001 109.838 174.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.508 ' HB2' ' HG2' ' A' ' 172' ' ' GLN . 51.0 m-70 -60.89 137.23 93.62 Favored Pre-proline 0 CA--C 1.51 -0.582 0 N-CA-C 107.992 -1.114 . . . . 2.3199999999999998 107.992 172.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.681 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 32.3 Cg_exo -21.97 67.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.168 1 C-N-CA 126.79 4.994 . . . . 0.53000000000000003 115.796 -170.176 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . 0.723 ' HB2' ' O ' ' A' ' 170' ' ' PHE . 22.3 p -96.0 -175.11 3.3 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.155 -0.93 . . . . 1.5800000000000001 109.574 176.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.811 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -177.07 171.37 44.24 Favored Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 119.597 -1.287 . . . . 0.42999999999999999 111.942 -177.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.618 ' HB3' ' CG1' ' A' ' 127' ' ' ILE . 2.6 t80 -140.26 84.39 1.96 Allowed 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.002 -1.481 . . . . 0.59999999999999998 107.002 -159.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.636 ' CG2' HG13 ' A' ' 168' ' ' VAL . 2.9 m -93.16 143.36 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 121.988 0.899 . . . . 0.31 111.113 -170.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . 0.528 ' SG ' ' HB3' ' A' ' 58' ' ' PRO . 3.6 t -119.81 126.49 51.13 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.558 -1.201 . . . . 1.55 108.976 175.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.662 ' H ' ' HB3' ' A' ' 166' ' ' LYS . 5.5 m -119.02 112.18 36.55 Favored Pre-proline 0 C--N 1.318 -0.781 0 C-N-CA 119.234 -0.986 . . . . 1.0600000000000001 111.43 -173.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 57.1 Cg_exo -51.27 105.52 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 121.77 1.647 . . . . 0.56000000000000005 109.864 167.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.631 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 21.4 mtp -72.18 -171.23 0.72 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.548 0.69 . . . . 1.1599999999999999 112.532 -170.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -62.59 -20.16 64.45 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.047 -0.979 . . . . 2.6299999999999999 109.715 174.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.483 ' HB3' ' HB3' ' A' ' 163' ' ' ALA . 11.5 mm-40 -105.95 10.44 32.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.368 -0.833 . . . . 2.0499999999999998 110.251 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.464 ' CB ' ' CD ' ' A' ' 162' ' ' PRO . 44.1 m-80 27.32 -93.48 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.928 0 N-CA-C 115.13 1.53 . . . . 1.9299999999999999 115.13 -177.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.464 ' CD ' ' CB ' ' A' ' 161' ' ' ASN . 95.3 Cg_endo -76.04 -10.79 19.63 Favored 'Trans proline' 0 C--N 1.367 1.541 0 CA-C-N 121.864 1.701 . . . . 0.72999999999999998 112.942 -173.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' A' ' 160' ' ' GLU . . . -89.76 -34.85 16.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.983 -0.553 . . . . 0.68000000000000005 110.34 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.631 ' O ' ' HB2' ' A' ' 158' ' ' MET . 88.8 m-85 -140.35 118.94 12.3 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.375 -0.602 . . . . 0.93000000000000005 109.375 178.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.403 ' HB3' HD12 ' A' ' 61' ' ' LEU . 69.4 m -116.93 136.86 52.62 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.311 0.576 . . . . 1.4099999999999999 110.642 -178.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.736 ' HG3' HG12 ' A' ' 168' ' ' VAL . 41.1 tptt -80.34 128.53 33.66 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.645 -0.707 . . . . 0.73999999999999999 111.784 -174.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.702 HD12 HG12 ' A' ' 196' ' ' ILE . 0.3 OUTLIER -112.45 100.77 9.02 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.303 -0.862 . . . . 0.27000000000000002 110.575 165.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.736 HG12 ' HG3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER -125.87 117.52 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 121.712 0.768 . . . . 0.28000000000000003 110.981 175.445 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.424 ' SD ' ' O ' ' A' ' 152' ' ' GLY . 5.5 tpt -128.67 135.75 49.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.391 -0.822 . . . . 1.24 110.176 -173.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.723 ' O ' ' HB2' ' A' ' 151' ' ' CYS . 41.1 m-85 -111.29 128.07 55.83 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.685 -0.688 . . . . 3.3700000000000001 109.311 -177.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 1.019 ' HB ' HD21 ' A' ' 192' ' ' LEU . 0.8 OUTLIER -110.41 121.04 62.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.361 0.601 . . . . 1.3999999999999999 110.535 -176.016 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.508 ' HG2' ' HB2' ' A' ' 149' ' ' HIS . 49.9 tt0 -129.8 49.54 2.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 122.482 1.134 . . . . 2.1699999999999999 108.417 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 22.0 m -77.31 140.24 39.97 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 113.772 -1.558 . . . . 1.6499999999999999 111.448 -173.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 15.0 tt0 -84.61 -28.8 26.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.598 -0.728 . . . . 2.4500000000000002 111.699 -176.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 49.8 mtm 47.9 47.56 18.43 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.058 0.456 . . . . 3.7400000000000002 110.959 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.465 ' CG ' ' HG2' ' A' ' 174' ' ' GLU . 38.9 mtm-85 -48.29 -51.58 25.24 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 114.68 1.363 . . . . 5.7800000000000002 114.68 -166.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -162.75 83.94 0.11 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 119.253 -1.451 . . . . 2.2599999999999998 113.872 -175.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 12.6 tptp -162.31 4.86 0.05 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.942 0.371 . . . . 6.2300000000000004 111.038 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.785 ' HB3' ' HB ' ' A' ' 183' ' ' ILE . 1.2 mp -144.24 172.79 12.43 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.418 0.628 . . . . 1.6399999999999999 110.689 -177.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.471 ' O ' HD12 ' A' ' 184' ' ' ILE . 42.7 m -113.59 162.67 21.34 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 114.663 -1.153 . . . . 2.04 108.016 171.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -44.05 -44.31 12.34 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 122.614 2.209 . . . . 1.74 113.103 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.484 ' O ' ' HE2' ' A' ' 186' ' ' LYS . 10.8 p -70.36 -14.79 62.72 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.121 -0.49 . . . . 2.1400000000000001 112.142 -177.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.785 ' HB ' ' HB3' ' A' ' 179' ' ' LEU . 11.4 mm -91.36 -38.65 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 CA-C-O 122.386 1.088 . . . . 1.1200000000000001 109.144 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.935 ' HA ' HG22 ' A' ' 187' ' ' THR . 0.7 OUTLIER -66.68 -38.35 81.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 113.001 -1.909 . . . . 1.1299999999999999 111.106 -176.881 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -62.4 -21.47 65.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.872 -0.604 . . . . 2.8900000000000001 109.382 176.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.484 ' HE2' ' O ' ' A' ' 182' ' ' SER . 47.0 mtmt -92.46 -41.56 10.23 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.317 -0.856 . . . . 1.28 110.419 175.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.935 HG22 ' HA ' ' A' ' 184' ' ' ILE . 13.6 t -63.08 -35.28 79.73 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.071 0.767 . . . . 0.62 113.071 -168.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . 0.785 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 30.9 mmt -77.72 -60.71 0.68 Allowed Pre-proline 0 C--N 1.33 -0.24 0 C-N-CA 120.266 -0.574 . . . . 1.0600000000000001 111.52 -177.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.785 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 36.9 Cg_exo -58.17 -37.87 93.65 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.925 1.75 . . . . 0.91000000000000003 112.399 -177.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' ' 194' ' ' ASN . 41.7 m -70.88 -32.45 69.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.789 0.328 . . . . 1.5 110.764 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -75.16 -43.02 54.74 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.911 -0.586 . . . . 1.8799999999999999 110.053 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 1.019 HD21 ' HB ' ' A' ' 171' ' ' VAL . 95.2 mt -52.97 -55.17 25.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.453 -0.794 . . . . 1.0900000000000001 112.264 176.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 189' ' ' PRO . 1.3 m -66.4 -31.57 54.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.668 0.747 . . . . 0.68000000000000005 109.648 -177.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 190' ' ' SER . 0.6 OUTLIER -69.68 -38.06 76.88 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.49 -1.232 . . . . 2.0699999999999998 111.202 179.028 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.532 ' HB3' ' HE2' ' A' ' 153' ' ' PHE . 3.1 m-30 -62.41 -32.89 73.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.021 0.439 . . . . 2.0 110.26 173.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.702 HG12 HD12 ' A' ' 167' ' ' LEU . 38.8 mt -79.44 -29.57 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-O 120.95 0.405 . . . . 0.31 111.065 177.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 51.9 mt -72.03 -37.52 69.71 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.037 0.446 . . . . 1.03 109.956 176.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.513 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 13.4 m120 -47.4 -50.55 22.29 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.841 -1.072 . . . . 1.8999999999999999 108.676 163.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.813 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -66.29 -46.3 77.48 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 115.057 -0.974 . . . . 0.28999999999999998 110.581 -174.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.702 ' O ' ' HG2' ' A' ' 204' ' ' LYS . 27.9 mmtp -53.69 -50.34 66.07 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 123.814 0.696 . . . . 0.96999999999999997 109.615 174.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -76.44 -38.98 54.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.372 -0.831 . . . . 1.9399999999999999 111.73 -169.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -68.78 -35.02 78.99 Favored Glycine 0 N--CA 1.463 0.447 0 C-N-CA 119.865 -1.16 . . . . 0.46999999999999997 110.486 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.965 HG13 ' HG3' ' A' ' 56' ' ' GLU . 1.1 mp -65.07 -35.75 76.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 114.186 -1.007 . . . . 0.60999999999999999 110.973 173.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.702 ' HG2' ' O ' ' A' ' 200' ' ' LYS . 52.7 mmtt -75.2 -39.34 60.23 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 108.81 -0.811 . . . . 3.3700000000000001 108.81 177.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.644 ' HA ' ' HB3' ' A' ' 211' ' ' ARG . . . -55.82 -35.08 65.95 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.18 -0.918 . . . . 1.02 109.099 173.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.619 ' HB3' ' O ' ' A' ' 203' ' ' ILE . 73.3 t60 -61.53 -43.49 98.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.12 -0.945 . . . . 3.6299999999999999 112.049 174.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.47 ' HG3' ' N ' ' A' ' 208' ' ' THR . 7.8 ptp180 -130.53 -46.47 1.07 Allowed 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.655 0.983 . . . . 2.5899999999999999 113.655 -170.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.484 ' OG1' ' HD2' ' A' ' 204' ' ' LYS . 25.0 m -69.74 137.06 87.83 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-O 120.738 0.304 . . . . 1.8400000000000001 110.863 -171.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 208' ' ' THR . 31.0 Cg_exo -63.65 7.07 0.21 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.465 2.777 . . . . 2.3500000000000001 113.38 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 12.8 p -67.35 -21.22 65.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.054 0.454 . . . . 2.3100000000000001 110.238 175.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.644 ' HB3' ' HA ' ' A' ' 205' ' ' ALA . 3.3 ppt_? -77.18 15.47 0.72 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.232 0.539 . . . . 5.4500000000000002 111.048 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -61.07 -37.55 83.07 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.293 -0.632 . . . . 6.8600000000000003 109.293 170.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -102.53 45.1 1.39 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.541 -0.754 . . . . 3.3700000000000001 111.361 176.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -75.19 136.57 41.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.804 0.335 . . . . 5.21 110.241 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -118.75 97.75 5.88 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.168 0.509 . . . . 6.46 111.381 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 33.0 t-80 -89.98 42.07 1.08 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.496 -0.775 . . . . 6.0899999999999999 109.383 178.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -91.32 85.19 5.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.613 -0.721 . . . . 5.1200000000000001 110.187 -175.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 6.0 p -87.86 -0.38 56.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.74 -0.664 . . . . 6.7599999999999998 111.493 -176.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -100.52 -75.55 0.58 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.64 -0.504 . . . . 8.8200000000000003 109.64 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 17.0 t . . . . . 0 C--O 1.248 1.023 0 N-CA-C 108.513 -0.921 . . . . 8.4800000000000004 108.513 174.1 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 120.855 0.36 . . . . 3.8599999999999999 111.02 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.657 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.2 m-20 -69.55 -35.28 75.27 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.087 -0.709 . . . . 2.25 109.087 -177.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.842 ' HA ' HD11 ' A' ' 6' ' ' ILE . 89.8 m-85 -67.68 -34.02 76.08 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.203 -0.908 . . . . 0.42999999999999999 109.096 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.572 ' HG2' ' OE1' ' A' ' 8' ' ' GLN . 21.9 tttp -78.92 -1.16 33.92 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 114.363 -1.289 . . . . 1.51 109.751 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -92.66 -43.85 8.88 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.295 0.569 . . . . 0.54000000000000004 110.209 172.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.842 HD11 ' HA ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -83.0 -37.24 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-N 115.519 -0.764 . . . . 1.0700000000000001 110.269 -172.614 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.417 ' HB2' HD21 ' A' ' 114' ' ' LEU . . . -80.69 -40.85 24.72 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.483 -1.235 . . . . 0.34000000000000002 111.535 -176.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.572 ' OE1' ' HG2' ' A' ' 4' ' ' LYS . 8.2 mt-30 -65.7 -29.6 70.17 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.2 -0.909 . . . . 1.5900000000000001 110.153 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.659 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 14.8 mm100 -82.74 -33.59 27.42 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.211 -0.904 . . . . 2.4700000000000002 109.208 175.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.658 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -70.92 -35.16 72.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.257 -0.883 . . . . 0.47999999999999998 111.423 -179.469 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 15' ' ' LEU . . . -43.87 -61.54 1.4 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.928 0.394 . . . . 0.31 112.038 172.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -74.73 -11.08 60.08 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.477 -0.329 . . . . 1.6399999999999999 111.728 -177.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.659 ' HG3' ' O ' ' A' ' 9' ' ' GLN . 53.9 mt-10 -71.55 -56.01 6.72 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.069 -0.715 . . . . 2.54 109.069 172.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.752 HG21 ' N ' ' A' ' 152' ' ' GLY . 10.6 p -68.27 -38.21 79.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 122.838 1.304 . . . . 0.53000000000000003 109.721 -175.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.443 ' HB3' ' O ' ' A' ' 11' ' ' ALA . 0.5 OUTLIER -76.11 -18.88 58.97 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 113.791 -1.55 . . . . 0.59999999999999998 109.248 178.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.412 ' HA2' ' HD3' ' A' ' 19' ' ' ARG . . . -61.95 -27.93 69.5 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 114.144 -1.389 . . . . 0.56999999999999995 110.04 172.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.45 ' HD1' ' O ' ' A' ' 13' ' ' GLU . 24.4 m-85 -86.03 -15.91 39.86 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.16 -0.52 . . . . 3.27 110.055 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.412 ' OD1' HG11 ' A' ' 168' ' ' VAL . 42.7 t30 -85.99 -3.51 58.95 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 119.526 -0.87 . . . . 2.0299999999999998 110.051 172.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.412 ' HD3' ' HA2' ' A' ' 16' ' ' GLY . 35.2 mtp180 -105.62 -21.51 13.18 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.113 -0.367 . . . . 2.7200000000000002 111.486 -178.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -146.26 154.1 41.34 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.242 -0.435 . . . . 2.1600000000000001 111.018 174.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.488 ' HB ' ' CZ2' ' A' ' 24' ' ' TRP . 70.4 p -135.52 129.91 33.79 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.722 -0.672 . . . . 1.8200000000000001 111.229 -172.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.5 p -174.85 157.0 2.36 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.192 0.307 . . . . 2.1899999999999999 111.76 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.69 3.64 90.56 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.903 -0.59 . . . . 1.1000000000000001 113.774 170.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.488 ' CZ2' ' HB ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -120.58 -158.39 0.75 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 117.191 0.496 . . . . 1.6699999999999999 111.456 -176.511 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.37 119.88 0.32 Allowed 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 108.735 -0.839 . . . . 2.9500000000000002 108.735 -174.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.604 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 0.3 OUTLIER -55.16 121.71 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-O 122.06 0.933 . . . . 1.5600000000000001 111.389 174.64 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.13 -25.35 3.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 113.971 -1.468 . . . . 1.22 109.99 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 28' ' ' LYS . 9.4 tptm -142.98 121.93 12.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 119.75 -0.78 . . . . 2.4100000000000001 112.503 -173.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.535 HG22 ' HA ' ' A' ' 34' ' ' THR . 41.6 p -135.59 121.75 20.22 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.367 -0.605 . . . . 1.3799999999999999 109.367 172.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.2 t -85.14 -79.01 0.24 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 121.064 -0.254 . . . . 2.3700000000000001 110.415 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -164.08 19.37 0.06 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.479 0.657 . . . . 4.5499999999999998 109.832 176.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -173.54 3.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.662 -0.699 . . . . 1.4199999999999999 110.369 -175.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.476 ' CD1' ' HB ' ' A' ' 193' ' ' VAL . 28.9 pt -140.85 167.46 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-O 120.79 0.329 . . . . 0.76000000000000001 110.875 -171.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.535 ' HA ' HG22 ' A' ' 29' ' ' THR . 26.2 m -152.95 104.72 2.86 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.208 -0.451 . . . . 0.57999999999999996 111.19 -171.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.627 HG11 HD13 ' A' ' 192' ' ' LEU . 11.4 t -101.57 121.02 51.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.85999999999999999 110.086 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.604 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 5.6 m -113.02 128.55 56.53 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.187 -0.46 . . . . 1.1000000000000001 110.223 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.0 p -97.94 130.24 44.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.667 -0.697 . . . . 1.27 110.345 -176.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.407 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 57.9 tttm -120.68 -98.46 0.45 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.671 -0.695 . . . . 1.9099999999999999 111.243 -173.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.16 137.81 6.33 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.663 -0.495 . . . . 1.6799999999999999 109.663 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.45 ' C ' ' H ' ' A' ' 42' ' ' LYS . 8.5 t -82.8 -155.7 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.099 0.476 . . . . 2.0899999999999999 110.518 -177.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 42.7 ttt180 -74.32 11.8 0.89 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.93 -0.577 . . . . 6.6100000000000003 109.978 175.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.45 ' H ' ' C ' ' A' ' 40' ' ' SER . 32.7 mmtp 60.82 39.7 16.78 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 115.654 -0.703 . . . . 6.46 110.566 -178.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -143.94 2.42 1.18 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.936 -0.575 . . . . 5.6500000000000004 109.918 -176.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.48 ' NE2' ' HG3' ' A' ' 174' ' ' GLU . 19.6 m-70 -151.08 -45.07 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.043 -0.526 . . . . 5.5599999999999996 111.181 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 171.89 -117.94 0.7 Allowed Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.385 -0.912 . . . . 1.5600000000000001 112.74 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -128.74 155.13 45.59 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.362 0.601 . . . . 2.0499999999999998 111.355 -173.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.656 HD12 ' HB2' ' A' ' 172' ' ' GLN . 10.0 tt -93.5 152.38 19.1 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.023 -0.989 . . . . 0.87 109.56 -176.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.551 ' N ' HD23 ' A' ' 47' ' ' LEU . 71.7 m-85 -127.78 134.17 49.48 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.65 0.262 . . . . 0.98999999999999999 110.745 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.532 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 0.8 OUTLIER -118.6 126.48 52.05 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 108.999 -0.741 . . . . 2.9199999999999999 108.999 175.915 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.589 HG23 HG22 ' A' ' 35' ' ' VAL . 14.8 p -114.75 150.03 16.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.725 -0.472 . . . . 1.3300000000000001 109.725 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.469 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 37.9 tt0 -155.38 109.84 2.92 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.987 -0.552 . . . . 1.0700000000000001 110.351 -170.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.474 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -138.83 160.43 25.7 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.615 -0.802 . . . . 0.28999999999999998 111.791 178.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.6 mt -100.89 114.92 41.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 C-N-CA 120.57 -0.452 . . . . 0.57999999999999996 110.786 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 40.1 mt -94.42 112.83 59.15 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.666 -0.697 . . . . 0.34999999999999998 109.431 175.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.34 70.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 124.566 3.511 . . . . 0.62 112.893 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.488 ' HG3' ' CG1' ' A' ' 203' ' ' ILE . 0.1 OUTLIER -155.06 -167.77 2.67 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.89 -1.05 . . . . 1.6799999999999999 108.555 177.089 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.3 t -101.41 146.77 32.77 Favored Pre-proline 0 N--CA 1.421 -1.884 0 N-CA-C 108.485 -0.932 . . . . 1.1799999999999999 108.485 174.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.577 ' HB3' ' SG ' ' A' ' 155' ' ' CYS . 24.6 Cg_exo -61.62 -12.7 26.0 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.486 2.791 . . . . 0.52000000000000002 110.442 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.08 -44.65 53.28 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.74 -1.118 . . . . 0.64000000000000001 111.325 176.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.512 ' HB3' HD11 ' A' ' 203' ' ' ILE . 6.5 tppt? -71.49 -31.94 67.68 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 108.293 -1.003 . . . . 3.2999999999999998 108.293 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.974 HD23 HD13 ' A' ' 203' ' ' ILE . 63.6 mt -62.15 -51.91 65.96 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.388 -1.278 . . . . 0.40999999999999998 110.429 175.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.8 m -64.7 -15.24 61.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.048 0.451 . . . . 1.29 110.613 173.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -84.73 -52.3 6.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.036 -0.529 . . . . 1.3200000000000001 111.795 -177.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.701 ' CE2' ' HA ' ' A' ' 199' ' ' ALA . 10.2 p90 -70.03 -40.63 75.05 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.727 0.269 . . . . 0.60999999999999999 111.727 -172.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.454 HD22 ' O ' ' A' ' 61' ' ' LEU . 0.6 OUTLIER -79.75 -21.35 44.58 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 120.357 -0.537 . . . . 1.5 112.054 -170.059 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.535 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 1.8 t80 -5.77 -71.77 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 O-C-N 125.214 1.571 . . . . 1.52 113.18 -156.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.535 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 4.8 tp60 175.93 -37.7 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.565 0.541 . . . . 3.6000000000000001 111.815 167.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.416 ' OG1' ' HB2' ' A' ' 81' ' ' TYR . 12.7 t -146.57 12.02 1.14 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.364 0.505 . . . . 1.48 112.364 -168.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -118.99 -5.26 11.92 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 119.122 -1.513 . . . . 1.46 113.887 -171.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.662 ' O ' HG22 ' A' ' 73' ' ' THR . 0.5 OUTLIER -170.96 -31.74 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.631 0 CA-C-O 121.415 0.626 . . . . 2.1899999999999999 109.844 -177.944 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.503 ' HG2' HD11 ' A' ' 78' ' ' LEU . 8.0 ttt180 -40.9 -50.09 3.23 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 125.461 1.504 . . . . 3.3799999999999999 111.086 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.791 ' H ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -91.15 -7.52 10.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.813 -1.085 . . . . 0.70999999999999996 111.241 -176.189 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.662 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER -84.79 -34.6 22.73 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 120.545 -0.462 . . . . 0.96999999999999997 110.298 -173.758 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.684 ' CZ3' ' HB2' ' A' ' 198' ' ' ASN . 20.8 p-90 -91.78 -42.38 10.14 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 120.056 -0.658 . . . . 0.75 109.314 174.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.7 t70 56.83 141.96 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.203 1.927 . . . . 2.1899999999999999 116.203 159.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.543 ' CG ' ' HB3' ' A' ' 198' ' ' ASN . 0.0 OUTLIER -139.29 -29.09 0.76 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.567 -0.742 . . . . 3.1899999999999999 111.989 163.733 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.539 ' N ' ' HD3' ' A' ' 76' ' ' LYS . 63.0 m -136.51 22.18 3.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.081 0.943 . . . . 1.5800000000000001 108.524 176.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.593 HD13 HG22 ' A' ' 72' ' ' ILE . 43.8 mt -110.01 -173.79 2.34 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.241 -1.345 . . . . 0.70999999999999996 110.163 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.61 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 3.4 mm100 -160.36 -66.18 0.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.925 0.343 . . . . 1.73 111.925 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.498 HG23 ' HB3' ' A' ' 79' ' ' GLN . 40.4 t -143.71 133.53 20.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.984 0.421 . . . . 0.78000000000000003 111.136 -167.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.446 ' HB3' HD12 ' A' ' 72' ' ' ILE . 20.3 p90 -100.49 145.17 28.61 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.643 -0.708 . . . . 5.4000000000000004 110.754 175.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.589 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 18.4 m120 -150.8 102.56 3.01 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.798 -0.816 . . . . 1.6899999999999999 108.798 170.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.52 107.36 2.45 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.638 -0.505 . . . . 2.0499999999999998 109.638 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.477 ' CG1' ' HG2' ' A' ' 136' ' ' GLU . 0.0 OUTLIER -84.36 -56.73 5.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.608 -0.723 . . . . 0.64000000000000001 110.948 -170.433 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -147.51 113.05 5.65 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.001 -0.545 . . . . 1.96 110.244 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -95.91 120.78 36.79 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.562 -0.903 . . . . 2.4399999999999999 108.562 176.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.617 HG12 ' O ' ' A' ' 91' ' ' THR . 1.2 mm -72.9 -53.35 18.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.976 -1.011 . . . . 0.46999999999999997 110.277 -168.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -140.23 -97.2 0.15 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.633 -0.712 . . . . 1.8600000000000001 111.492 176.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.6 t -137.98 -12.44 1.46 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.846 -0.161 . . . . 1.4399999999999999 111.041 -177.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -131.3 8.57 4.68 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.169 0.509 . . . . 1.8700000000000001 109.713 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.617 ' O ' HG12 ' A' ' 87' ' ' ILE . 9.0 m -139.6 118.15 12.22 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 107.591 -1.263 . . . . 0.46000000000000002 107.591 -172.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.619 ' O ' HD12 ' A' ' 114' ' ' LEU . 35.8 m-85 -132.92 174.99 9.75 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.243 0.544 . . . . 0.42999999999999999 110.854 -171.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.524 HD11 ' CE1' ' A' ' 3' ' ' PHE . 25.5 mt -133.97 123.5 44.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 107.255 -1.387 . . . . 0.40999999999999998 107.255 165.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.0 t -112.6 122.09 46.68 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.372 0.606 . . . . 2.0099999999999998 111.532 -176.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.589 ' HB3' ' HB2' ' A' ' 82' ' ' ASN . 31.2 t-80 -78.84 88.74 4.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.864 0.84 . . . . 1.23 108.84 168.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 111' ' ' PHE . 19.1 m -97.37 114.17 25.93 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.514 -1.221 . . . . 0.5 111.183 -176.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.493 ' CG1' ' HB ' ' A' ' 80' ' ' VAL . 36.8 mm -76.98 124.72 35.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.909 -0.774 . . . . 1.03 108.909 173.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.1 m -111.19 133.22 53.71 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.011 -0.995 . . . . 1.3799999999999999 111.562 -170.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.61 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 30.6 mt-30 -89.36 83.91 6.43 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.687 -0.486 . . . . 1.8200000000000001 109.687 172.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.475 ' O ' ' HB ' ' A' ' 106' ' ' ILE . 36.3 m -91.98 96.09 10.17 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.907 -0.405 . . . . 3.9100000000000001 109.907 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -122.57 100.29 6.85 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 112.558 0.577 . . . . 5.1600000000000001 112.558 -178.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.543 ' O ' HG12 ' A' ' 103' ' ' VAL . . . -92.99 76.33 4.73 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.059 -0.719 . . . . 1.98 109.059 168.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 102' ' ' ALA . 1.3 p 58.44 12.31 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.215 1.006 . . . . 3.1699999999999999 112.409 178.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.43 -4.55 21.57 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.345 -0.931 . . . . 1.96 112.805 176.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.452 ' HB3' HD12 ' A' ' 183' ' ' ILE . 20.3 m -71.38 -14.04 62.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.185 0.517 . . . . 1.8799999999999999 111.189 178.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.475 ' HB ' ' O ' ' A' ' 100' ' ' SER . 16.3 mt -131.41 144.21 38.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.907 -0.588 . . . . 1.1200000000000001 109.879 -173.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.437 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 15.5 m -99.43 169.21 8.43 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 109.867 -0.419 . . . . 1.3500000000000001 109.867 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 107' ' ' SER . 80.1 Cg_exo -46.54 128.18 12.42 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.201 1.934 . . . . 1.0700000000000001 111.108 172.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.636 ' HG3' HG23 ' A' ' 144' ' ' ILE . 33.3 ttp180 -116.81 162.43 17.72 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 120.993 0.425 . . . . 3.4500000000000002 110.068 -170.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.503 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 6.4 t70 -112.14 162.14 15.77 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.285 -1.006 . . . . 1.3700000000000001 108.285 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.457 ' CZ ' ' HB3' ' A' ' 113' ' ' ASP . 3.0 t80 -149.7 136.15 19.15 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.059 0.457 . . . . 2.4100000000000001 111.266 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.651 HG21 ' CE1' ' A' ' 134' ' ' PHE . 46.3 mm -122.75 89.86 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 N-CA-C 108.423 -0.955 . . . . 0.42999999999999999 108.423 172.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.457 ' HB3' ' CZ ' ' A' ' 111' ' ' PHE . 2.0 p30 -95.3 113.45 25.12 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.384 -0.825 . . . . 1.8600000000000001 110.685 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.619 HD12 ' O ' ' A' ' 92' ' ' PHE . 8.4 tp -76.43 121.16 22.66 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 119.19 -1.004 . . . . 0.28000000000000003 108.45 162.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -127.64 126.6 67.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-N 115.007 -0.997 . . . . 0.26000000000000001 111.949 -165.872 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.428 ' CD2' ' HA ' ' A' ' 8' ' ' GLN . 10.2 t80 -109.42 113.1 25.62 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.201 -0.909 . . . . 2.5699999999999998 110.42 174.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.592 HG12 HG22 ' A' ' 127' ' ' ILE . 80.4 mt -96.72 113.76 31.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.719 -0.673 . . . . 0.89000000000000001 109.734 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.552 ' HE3' ' CE1' ' A' ' 120' ' ' TYR . 37.8 ttpt -137.74 141.14 40.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.004 0.43 . . . . 1.2 110.398 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.548 ' O ' ' HD3' ' A' ' 119' ' ' ARG . 0.1 OUTLIER -113.57 113.7 25.45 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 121.956 0.884 . . . . 2.7999999999999998 109.012 177.31 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.552 ' CE1' ' HE3' ' A' ' 118' ' ' LYS . 3.5 m-85 -69.02 110.56 4.52 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.046 -1.465 . . . . 0.82999999999999996 107.046 168.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -35.85 94.53 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 O-C-N 124.769 1.293 . . . . 2.2799999999999998 113.141 -175.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 59.79 50.69 64.94 Favored Glycine 0 CA--C 1.504 -0.647 0 CA-C-N 114.63 -1.168 . . . . 0.76000000000000001 111.842 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.532 ' O ' ' HD2' ' A' ' 157' ' ' PRO . 60.8 t30 -149.36 -53.12 0.16 Allowed 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.99 -0.605 . . . . 1.6499999999999999 110.061 -176.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 1.8 mpp? -158.73 119.67 3.34 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.864 0.364 . . . . 1.1200000000000001 111.701 -177.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -101.71 84.5 2.57 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.209 -1.034 . . . . 1.6200000000000001 108.209 176.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.536 ' CG1' HG12 ' A' ' 154' ' ' VAL . 0.5 OUTLIER -101.61 140.59 19.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 112.903 0.705 . . . . 0.29999999999999999 112.903 -170.426 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.658 HG13 ' O ' ' A' ' 127' ' ' ILE . 8.0 pt -108.96 112.16 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 108.675 -0.861 . . . . 0.58999999999999997 108.675 163.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.576 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 4.3 m -80.1 155.56 27.45 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.972 -0.751 . . . . 1.1799999999999999 108.972 175.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 80.8 p -149.82 131.63 15.08 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.61 0.719 . . . . 1.24 111.821 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.8 mtpp -132.63 122.77 25.2 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.628 -1.249 . . . . 2.2599999999999998 107.628 175.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.639 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 17.7 t -70.8 104.88 3.02 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 106.81 -1.552 . . . . 1.3899999999999999 106.81 175.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.0 m -102.9 152.59 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 C-N-CA 119.417 -0.913 . . . . 1.05 110.01 -174.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.662 ' HA ' ' CG ' ' A' ' 137' ' ' TYR . 8.4 p-10 -108.47 55.65 0.64 Allowed 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 123.204 1.478 . . . . 2.1699999999999999 109.872 -168.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.651 ' CE1' HG21 ' A' ' 112' ' ' ILE . 0.7 OUTLIER -91.57 178.33 1.81 Allowed Pre-proline 0 CA--C 1.553 1.086 0 CA-C-N 112.719 -2.037 . . . . 0.53000000000000003 109.083 -175.322 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.548 ' HD2' ' HB2' ' A' ' 134' ' ' PHE . 9.0 Cg_exo -32.19 -56.28 0.29 Allowed 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 124.654 3.57 . . . . 1.28 117.366 -176.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.608 ' HB3' ' CZ ' ' A' ' 134' ' ' PHE . 10.2 tp10 -74.18 -29.66 61.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.479 0.581 . . . . 3.5 112.389 -174.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.662 ' CG ' ' HA ' ' A' ' 133' ' ' ASP . 13.0 t80 -46.18 -42.24 26.76 Favored Pre-proline 0 CA--C 1.552 1.037 0 N-CA-C 116.1 1.889 . . . . 6.1200000000000001 116.1 -173.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.467 ' HD2' ' O ' ' A' ' 135' ' ' PRO . 73.4 Cg_exo -42.58 107.07 0.08 OUTLIER 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.251 1.967 . . . . 1.77 113.165 176.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -96.68 -159.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.544 2.83 . . . . 1.25 113.487 -174.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.7 m -143.94 -161.8 1.34 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.419 -0.956 . . . . 1.6000000000000001 108.419 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.2 m -82.86 -47.23 12.08 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.118 -0.633 . . . . 1.97 110.904 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -65.38 -23.31 66.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.311 -0.404 . . . . 2.1800000000000002 111.263 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.503 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 95.0 m-85 -132.16 108.12 9.07 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.361 -0.607 . . . . 1.23 109.361 177.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.68 HD11 ' HB2' ' A' ' 176' ' ' ARG . 0.2 OUTLIER -104.07 116.69 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 109.019 -0.734 . . . . 0.81999999999999995 109.019 178.192 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.531 ' HD2' HG12 ' A' ' 112' ' ' ILE . 0.8 OUTLIER -59.58 98.72 0.05 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.382 -0.826 . . . . 4.4199999999999999 109.686 172.377 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -59.61 114.3 6.13 Favored Glycine 0 CA--C 1.504 -0.609 0 N-CA-C 111.107 -0.797 . . . . 0.79000000000000004 111.107 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -84.89 88.48 7.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.875 0.845 . . . . 4.4400000000000004 111.17 -169.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.549 ' H ' ' HB2' ' A' ' 131' ' ' SER . 66.7 t30 -84.31 123.97 30.74 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.645 -1.161 . . . . 1.6200000000000001 110.801 178.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.429 ' O ' ' N ' ' A' ' 151' ' ' CYS . 46.0 m80 -74.68 161.63 77.02 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 119.022 -0.513 . . . . 2.3199999999999998 109.882 176.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 149' ' ' HIS . 5.4 Cg_endo -48.06 76.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 124.514 3.476 . . . . 0.53000000000000003 114.651 -178.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . 0.707 ' SG ' ' HA ' ' A' ' 171' ' ' VAL . 14.3 p -129.53 -174.09 3.2 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.251 -1.018 . . . . 1.5800000000000001 108.251 171.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.752 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -167.79 -147.33 5.27 Favored Glycine 0 N--CA 1.436 -1.319 0 C-N-CA 118.542 -1.789 . . . . 0.42999999999999999 113.426 -173.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.579 ' CZ ' HD11 ' A' ' 167' ' ' LEU . 39.2 t80 -160.94 94.42 1.02 Allowed 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.76 -1.2 . . . . 0.59999999999999998 107.76 -162.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.686 ' CG2' HG13 ' A' ' 168' ' ' VAL . 3.4 m -105.76 148.98 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 CA-C-O 121.969 0.89 . . . . 0.31 111.307 -173.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . 0.577 ' SG ' ' HB3' ' A' ' 58' ' ' PRO . 12.1 t -117.44 137.72 52.32 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.911 -1.04 . . . . 1.55 108.597 173.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.495 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 12.6 m -129.61 116.57 18.37 Favored Pre-proline 0 C--N 1.31 -1.122 0 C-N-CA 120.394 -0.522 . . . . 1.0600000000000001 111.038 -177.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.532 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 55.8 Cg_exo -49.85 122.43 9.0 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.496 2.131 . . . . 0.56000000000000005 111.378 173.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.673 ' HB2' ' O ' ' A' ' 164' ' ' TYR . 0.7 OUTLIER -80.43 -167.13 1.23 Allowed 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.055 0.455 . . . . 1.1599999999999999 112.079 -175.9 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -67.8 -26.53 66.13 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.565 -0.743 . . . . 2.6299999999999999 109.366 176.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 163' ' ' ALA . 34.4 mm-40 -97.62 13.76 29.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.246 -0.888 . . . . 2.0499999999999998 109.86 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.449 ' CB ' ' CD ' ' A' ' 162' ' ' PRO . 13.9 m120 25.78 -89.13 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 125.708 1.603 . . . . 1.9299999999999999 115.21 -177.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' A' ' 161' ' ' ASN . 84.1 Cg_endo -74.32 -10.49 22.41 Favored 'Trans proline' 0 C--N 1.366 1.448 0 CA-C-N 121.596 1.606 . . . . 0.72999999999999998 113.473 -174.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 160' ' ' GLU . . . -96.12 -34.51 11.67 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.536 -0.302 . . . . 0.68000000000000005 111.573 -177.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.673 ' O ' ' HB2' ' A' ' 158' ' ' MET . 81.9 m-85 -136.64 135.34 38.2 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.981 -0.377 . . . . 0.93000000000000005 109.981 178.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.401 ' HB2' HD11 ' A' ' 61' ' ' LEU . 57.4 m -126.09 143.77 50.99 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.35 0.595 . . . . 1.4099999999999999 111.618 -177.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 156' ' ' SER . 1.9 tppp? -91.64 107.96 19.57 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.38 -0.827 . . . . 0.73999999999999999 110.751 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.579 HD11 ' CZ ' ' A' ' 153' ' ' PHE . 0.5 OUTLIER -93.08 107.67 19.41 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.209 -0.905 . . . . 0.27000000000000002 109.309 175.224 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.686 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -131.77 129.4 61.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.865 0.841 . . . . 0.28000000000000003 111.753 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.569 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 11.3 ttt -140.91 151.34 44.17 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.009 -0.996 . . . . 1.24 108.98 -172.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.718 ' CE2' HG23 ' A' ' 14' ' ' VAL . 1.0 OUTLIER -144.83 152.39 40.22 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.88 -0.785 . . . . 3.3700000000000001 108.88 171.199 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.707 ' HA ' ' SG ' ' A' ' 151' ' ' CYS . 12.6 p -138.12 127.7 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 O-C-N 123.907 0.755 . . . . 1.3999999999999999 111.728 -172.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.656 ' HB2' HD12 ' A' ' 47' ' ' LEU . 24.2 tt0 -116.65 48.83 1.22 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.044 0.926 . . . . 2.1699999999999999 108.518 174.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 148' ' ' ASN . 1.7 t -74.65 152.67 39.17 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.029 -0.987 . . . . 1.6499999999999999 111.024 -173.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.48 ' HG3' ' NE2' ' A' ' 44' ' ' HIS . 21.7 tt0 -95.71 -30.67 13.61 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.191 -0.913 . . . . 2.4500000000000002 109.838 173.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 37.7 mtp 36.93 65.07 0.52 Allowed 'General case' 0 C--O 1.233 0.222 0 O-C-N 124.247 0.967 . . . . 3.7400000000000002 112.616 -177.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.68 ' HB2' HD11 ' A' ' 144' ' ' ILE . 96.3 mtt180 -54.45 175.11 0.05 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.675 -0.693 . . . . 5.7800000000000002 111.427 174.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 124.5 -152.13 17.39 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.765 -0.934 . . . . 2.2599999999999998 110.765 -174.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -101.21 53.96 0.84 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.461 0.648 . . . . 6.2300000000000004 110.229 178.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 179' ' ' LEU . 3.1 mp -113.08 148.82 34.45 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.591 0.71 . . . . 1.6399999999999999 109.489 175.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.543 ' H ' ' CG1' ' A' ' 183' ' ' ILE . 15.0 m -113.99 167.39 9.6 Favored Pre-proline 0 C--N 1.302 -1.469 0 CA-C-N 114.662 -1.153 . . . . 2.04 107.891 178.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -48.34 -33.49 22.59 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 121.781 1.654 . . . . 1.74 111.842 177.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.442 ' O ' ' HG3' ' A' ' 186' ' ' LYS . 14.2 p -75.92 -13.49 60.26 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.542 -0.754 . . . . 2.1400000000000001 112.572 -178.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.58 ' HA ' ' HE2' ' A' ' 186' ' ' LYS . 40.5 mm -92.11 -47.22 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-O 122.508 1.147 . . . . 1.1200000000000001 109.301 -178.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.99 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.5 mp -60.62 -35.57 64.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 112.678 -2.055 . . . . 1.1299999999999999 111.14 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -70.14 -17.23 63.19 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.583 -0.735 . . . . 2.8900000000000001 109.158 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.58 ' HE2' ' HA ' ' A' ' 183' ' ' ILE . 43.6 mtmt -92.11 -39.73 11.44 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.533 -0.758 . . . . 1.28 109.707 172.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.99 HG22 ' HA ' ' A' ' 184' ' ' ILE . 6.4 t -73.68 -36.63 65.33 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 119.645 -0.822 . . . . 0.62 112.538 -170.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . 0.579 ' O ' HD12 ' A' ' 192' ' ' LEU . 37.6 mmm -70.32 -56.76 6.44 Favored Pre-proline 0 C--O 1.226 -0.176 0 C-N-CA 120.272 -0.571 . . . . 1.0600000000000001 112.39 -175.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 188' ' ' MET . 18.9 Cg_endo -57.73 -18.76 35.17 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 122.232 1.955 . . . . 0.91000000000000003 112.392 -176.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.404 ' O ' HG22 ' A' ' 193' ' ' VAL . 33.9 t -86.24 -38.48 17.54 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.13 -0.693 . . . . 1.5 109.13 174.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -68.12 -42.71 79.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.324 -0.853 . . . . 1.8799999999999999 111.638 -172.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.627 HD13 HG11 ' A' ' 35' ' ' VAL . 1.1 mt -62.02 -48.99 77.81 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.572 0.701 . . . . 1.0900000000000001 110.959 -177.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.478 ' O ' ' HG ' ' A' ' 197' ' ' LEU . 1.3 m -67.67 -32.65 57.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.057 -0.974 . . . . 0.68000000000000005 109.672 -177.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -76.68 -29.11 56.19 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.529 -1.214 . . . . 2.0699999999999998 110.942 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.729 ' HA ' ' OD1' ' A' ' 198' ' ' ASN . 0.5 OUTLIER -66.38 -33.0 74.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.866 0.841 . . . . 2.0 109.475 171.071 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.676 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 22.6 mt -75.54 -27.86 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-N 115.707 -0.679 . . . . 0.31 110.799 173.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 53.1 mt -71.26 -42.42 68.81 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-N 116.651 -0.25 . . . . 1.03 111.365 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.729 ' OD1' ' HA ' ' A' ' 195' ' ' PHE . 1.4 p-10 -59.6 -23.75 63.23 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.155 -1.018 . . . . 1.8999999999999999 108.952 171.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.701 ' HA ' ' CE2' ' A' ' 64' ' ' PHE . . . -81.32 -46.14 15.15 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 119.975 -0.69 . . . . 0.28999999999999998 111.132 176.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.676 ' HG2' ' O ' ' A' ' 196' ' ' ILE . 13.8 mmmm -55.22 -43.59 74.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.96999999999999997 110.251 177.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -92.1 -33.82 14.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.738 -0.664 . . . . 1.9399999999999999 112.013 -174.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -66.61 -29.1 74.21 Favored Glycine 0 N--CA 1.463 0.435 0 C-N-CA 120.784 -0.722 . . . . 0.46999999999999997 111.377 176.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.974 HD13 HD23 ' A' ' 61' ' ' LEU . 3.2 tp -71.34 -28.67 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 109.44 -0.578 . . . . 0.60999999999999999 109.44 176.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.612 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 79.1 mttt -79.07 -40.8 30.31 Favored 'General case' 0 C--O 1.209 -1.074 0 N-CA-C 107.861 -1.163 . . . . 3.3700000000000001 107.861 174.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.415 ' HA ' ' HB3' ' A' ' 211' ' ' ARG . . . -55.95 -27.74 53.82 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.415 -0.811 . . . . 1.02 109.9 172.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.649 ' CE1' ' HA ' ' A' ' 64' ' ' PHE . 12.2 m-70 -103.15 7.25 38.74 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.383 0.883 . . . . 3.6299999999999999 113.383 175.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.504 ' HB3' ' O ' ' A' ' 203' ' ' ILE . 0.2 OUTLIER -128.37 -53.68 1.27 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.284 0.564 . . . . 2.5899999999999999 110.808 174.713 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.475 ' N ' ' O ' ' A' ' 204' ' ' LYS . 59.9 m -80.59 130.71 63.57 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 115.353 -0.839 . . . . 1.8400000000000001 110.027 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -74.16 2.75 5.8 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 122.769 2.313 . . . . 2.3500000000000001 113.464 -176.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.466 ' H ' HG22 ' A' ' 208' ' ' THR . 58.0 m -86.84 38.52 0.8 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.017 0.437 . . . . 2.3100000000000001 111.388 -178.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.599 ' H ' ' HD3' ' A' ' 211' ' ' ARG . 0.0 OUTLIER -111.73 7.7 20.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.335 -0.393 . . . . 5.4500000000000002 110.29 175.783 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -60.04 -34.82 73.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.329 0.585 . . . . 6.8600000000000003 109.973 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -128.21 24.98 4.95 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 115.36 -0.837 . . . . 3.3700000000000001 111.607 176.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.573 ' CB ' ' HA ' ' A' ' 211' ' ' ARG . 86.1 t80 -86.88 96.49 10.24 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 120.895 -0.322 . . . . 5.21 110.626 -177.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 42.57 36.17 0.77 Allowed 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.352 1.032 . . . . 6.46 112.357 173.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . 0.449 ' HA ' ' O ' ' A' ' 73' ' ' THR . 8.5 t60 -83.45 23.82 0.89 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.911 0.386 . . . . 6.0899999999999999 111.612 -169.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 50.12 48.58 21.85 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.768 -0.651 . . . . 5.1200000000000001 111.59 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.9 p -79.3 -14.71 58.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.073 -0.512 . . . . 6.7599999999999998 111.087 -178.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 10.5 t60 73.24 -54.84 0.69 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.48 0.712 . . . . 8.8200000000000003 111.611 175.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 21.8 t . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.334 -0.841 . . . . 8.4800000000000004 109.734 179.867 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 tpt . . . . . 0 N--CA 1.48 1.064 0 N-CA-C 110.64 -0.133 . . . . 3.8599999999999999 110.64 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 5' ' ' ALA . 15.3 t70 174.46 -69.8 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.758 0.789 . . . . 2.25 108.96 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.652 ' HA ' HD11 ' A' ' 6' ' ' ILE . 95.5 m-85 -71.82 -25.47 62.0 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.015 -0.993 . . . . 0.42999999999999999 108.402 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.544 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 11.6 tptm -67.05 -9.44 39.21 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 114.716 -1.129 . . . . 1.51 109.669 175.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 2' ' ' ASP . . . -90.86 -49.98 6.14 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 115.823 -0.626 . . . . 0.54000000000000004 109.658 175.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.652 HD11 ' HA ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -83.19 -34.54 11.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.453 0.644 . . . . 1.0700000000000001 110.984 -170.834 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.698 ' HB2' HD21 ' A' ' 114' ' ' LEU . . . -79.13 -39.48 33.48 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.136 -0.938 . . . . 0.34000000000000002 111.269 -176.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.544 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 5.6 mt-30 -67.6 -24.75 65.52 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.147 -1.388 . . . . 1.5900000000000001 110.192 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.58 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 55.7 mt-30 -83.85 -50.56 7.97 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.099 -0.955 . . . . 2.4700000000000002 108.827 170.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.62 ' HB ' ' HA ' ' A' ' 7' ' ' ALA . 0.8 OUTLIER -46.01 -44.92 15.54 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.029 0.932 . . . . 0.47999999999999998 112.656 175.276 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.481 ' HA ' ' HB3' ' A' ' 128' ' ' SER . . . -50.87 -55.99 14.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.063 0.459 . . . . 0.31 111.748 175.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -76.18 -5.99 49.3 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.088 -0.506 . . . . 1.6399999999999999 111.586 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 39.3 mm-40 -81.13 -52.39 7.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.26 0.552 . . . . 2.54 109.553 172.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.877 HG23 ' CE2' ' A' ' 170' ' ' PHE . 6.4 p -68.37 -38.72 79.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.366 -0.834 . . . . 0.53000000000000003 110.631 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.97 -22.36 65.92 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.178 -0.919 . . . . 0.59999999999999998 108.805 173.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.554 ' HA2' ' NE ' ' A' ' 19' ' ' ARG . . . -64.05 -22.69 67.1 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 114.033 -1.44 . . . . 0.56999999999999995 110.18 176.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.468 ' HA ' ' HB3' ' A' ' 20' ' ' ASP . 5.9 m-85 -90.34 -16.79 28.51 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.41 -0.589 . . . . 3.27 109.41 177.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.477 ' HB2' ' NH2' ' A' ' 49' ' ' ARG . 2.4 t-20 -76.51 -14.37 60.03 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.488 0.661 . . . . 2.0299999999999998 109.937 176.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.554 ' NE ' ' HA2' ' A' ' 16' ' ' GLY . 10.9 ptt180 -113.49 8.95 17.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.467 -0.788 . . . . 2.7200000000000002 109.668 174.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.468 ' HB3' ' HA ' ' A' ' 17' ' ' TYR . 25.5 t70 -112.83 92.82 4.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.198 -0.91 . . . . 2.1600000000000001 109.502 175.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.478 HG22 ' CH2' ' A' ' 24' ' ' TRP . 24.0 p -131.36 88.82 2.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.236 0.541 . . . . 1.8200000000000001 111.539 -176.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -177.45 -50.42 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.569 -0.741 . . . . 2.1899999999999999 111.18 -178.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.87 -9.7 79.72 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 121.235 -0.507 . . . . 1.1000000000000001 112.99 -174.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.529 ' CB ' ' HG2' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -76.93 -160.88 0.17 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.177 0.513 . . . . 1.6699999999999999 111.426 177.209 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -171.7 114.62 0.36 Allowed 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 109.028 -0.731 . . . . 2.9500000000000002 109.028 -175.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.588 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 1.7 m -64.82 128.02 26.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.963 0.887 . . . . 1.5600000000000001 111.987 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.9 m -118.79 -24.32 3.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 113.845 -1.525 . . . . 1.22 110.46 -178.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.459 ' HD2' ' HA ' ' A' ' 28' ' ' LYS . 15.5 tptp -145.96 129.55 17.0 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.037 -0.665 . . . . 2.4100000000000001 111.518 -174.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.691 HG22 ' HA ' ' A' ' 34' ' ' THR . 24.1 p -146.06 152.78 39.88 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.21 -0.45 . . . . 1.3799999999999999 110.527 178.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.2 t -106.6 -102.45 0.34 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.097 -0.705 . . . . 2.3700000000000001 109.097 171.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -142.25 18.02 2.07 Favored 'General case' 0 N--CA 1.463 0.208 0 O-C-N 122.064 -0.398 . . . . 4.5499999999999998 111.377 175.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -169.4 8.27 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.271 0.558 . . . . 1.4199999999999999 110.07 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.655 HG22 ' HA3' ' A' ' 52' ' ' GLY . 12.7 pt -142.92 160.88 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 115.382 -0.827 . . . . 0.76000000000000001 109.891 -176.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.691 ' HA ' HG22 ' A' ' 29' ' ' THR . 93.1 m -158.18 111.25 2.4 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 111.793 0.294 . . . . 0.57999999999999996 111.793 -164.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.588 ' CG2' HG13 ' A' ' 193' ' ' VAL . 5.0 t -98.56 117.71 43.97 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 N-CA-C 109.379 -0.601 . . . . 0.85999999999999999 109.379 177.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -118.81 125.25 49.14 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 116.11 -0.495 . . . . 1.1000000000000001 110.218 -176.637 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 73.4 p -101.17 143.26 31.48 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.398 0.618 . . . . 1.27 112.169 -172.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.529 ' HG2' ' CB ' ' A' ' 24' ' ' TRP . 15.5 mtmt -124.95 131.35 53.44 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.996 -1.002 . . . . 1.9099999999999999 108.413 172.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.86 114.3 2.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.468 0.175 . . . . 1.6799999999999999 110.93 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.4 m -61.61 139.48 58.27 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.356 0.598 . . . . 2.0899999999999999 110.598 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -97.43 -12.07 23.14 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.634 -0.712 . . . . 6.6100000000000003 109.97 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -87.82 -8.6 55.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.709 -0.678 . . . . 6.46 109.973 -175.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -173.76 162.01 3.96 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.356 -0.979 . . . . 5.6500000000000004 108.356 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -80.18 62.63 4.4 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.999 0.428 . . . . 5.5599999999999996 111.365 -174.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -137.5 -166.11 10.63 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.416 -1.074 . . . . 1.5600000000000001 110.416 175.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -131.22 134.95 46.95 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.564 0.697 . . . . 2.0499999999999998 110.896 177.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.565 ' O ' ' HA ' ' A' ' 37' ' ' SER . 10.0 tt -86.52 147.72 25.84 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.821 -1.082 . . . . 0.87 109.254 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.455 ' N ' HD23 ' A' ' 47' ' ' LEU . 92.9 m-85 -123.21 119.59 30.67 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.839 -0.344 . . . . 0.98999999999999999 111.109 -175.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.783 ' CD ' ' HB3' ' A' ' 170' ' ' PHE . 21.8 tpt180 -110.73 117.65 34.04 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.309 -0.626 . . . . 2.9199999999999999 109.309 173.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 35' ' ' VAL . 12.5 p -103.94 150.61 7.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.75 0.31 . . . . 1.3300000000000001 110.259 -179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.561 ' HG3' ' HD2' ' A' ' 166' ' ' LYS . 35.2 tt0 -153.41 122.06 6.35 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.785 -0.643 . . . . 1.0700000000000001 110.764 -172.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.655 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -156.13 161.7 30.93 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.198 -0.761 . . . . 0.28999999999999998 111.198 175.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 70.3 mt -98.11 130.39 46.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 117.345 0.572 . . . . 0.57999999999999996 111.229 -178.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 61.9 mt -107.8 116.9 56.61 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.355 -0.839 . . . . 0.34999999999999998 109.789 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -63.56 61.51 0.2 Allowed 'Trans proline' 0 N--CA 1.476 0.457 0 C-N-CA 124.172 3.248 . . . . 0.62 113.787 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.573 ' HG3' ' H ' ' A' ' 57' ' ' SER . 6.5 tp10 -152.29 -171.33 3.9 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.796 -0.816 . . . . 1.6799999999999999 108.796 174.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.573 ' H ' ' HG3' ' A' ' 56' ' ' GLU . 73.9 p -89.76 146.42 35.41 Favored Pre-proline 0 N--CA 1.427 -1.62 0 CA-C-O 121.546 0.689 . . . . 1.1799999999999999 110.517 176.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.558 ' HB3' ' SG ' ' A' ' 155' ' ' CYS . 37.2 Cg_exo -60.71 -11.19 16.45 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 124.102 3.201 . . . . 0.52000000000000002 111.098 176.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.75 -51.52 10.4 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 114.752 -1.113 . . . . 0.64000000000000001 110.919 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.531 ' HB3' HD11 ' A' ' 203' ' ' ILE . 3.6 tppt? -66.15 -30.3 70.75 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.283 -1.006 . . . . 3.2999999999999998 108.283 -178.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.034 HD23 HD13 ' A' ' 203' ' ' ILE . 48.6 mt -60.67 -58.62 7.68 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.468 -1.242 . . . . 0.40999999999999998 110.428 174.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.437 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 7.7 p -66.57 -6.55 15.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.866 0.365 . . . . 1.29 111.104 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -86.88 -41.38 14.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.402 -0.363 . . . . 1.3200000000000001 111.896 176.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.576 ' O ' ' HB3' ' A' ' 71' ' ' ARG . 6.1 p90 -77.4 -41.28 40.59 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.47 -0.492 . . . . 0.60999999999999999 110.844 -172.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.542 HD13 ' CD1' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -84.74 7.77 19.43 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 110.342 -0.244 . . . . 1.5 110.342 -171.546 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.467 ' O ' ' HB2' ' A' ' 67' ' ' GLN . 41.1 t80 -55.99 0.6 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.878 0 O-C-N 124.216 0.948 . . . . 1.52 112.936 -173.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 15.8 mm100 82.13 -28.13 0.12 Allowed 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 124.315 1.046 . . . . 3.6000000000000001 110.822 171.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.8 t -125.34 22.07 7.83 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.457 -1.312 . . . . 1.48 107.457 171.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.1 3.96 84.5 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 113.864 -1.516 . . . . 1.46 111.805 -176.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.708 ' O ' HG22 ' A' ' 73' ' ' THR . 12.0 t70 92.6 2.8 0.08 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 122.582 1.182 . . . . 2.1899999999999999 108.333 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.829 ' HA ' ' CE2' ' A' ' 74' ' ' TRP . 5.6 ptm180 -54.34 -40.27 67.87 Favored 'General case' 0 C--O 1.209 -1.057 0 CA-C-N 113.535 -1.666 . . . . 3.3799999999999999 110.088 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.796 ' H ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -65.61 -26.02 38.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.646 -1.161 . . . . 0.70999999999999996 110.792 -175.3 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.708 HG22 ' O ' ' A' ' 70' ' ' ASP . 0.9 OUTLIER -81.66 -31.25 32.39 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.491 -0.777 . . . . 0.96999999999999997 109.986 -174.386 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.829 ' CE2' ' HA ' ' A' ' 71' ' ' ARG . 27.6 p-90 -111.57 0.82 16.55 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.283 -0.567 . . . . 0.75 111.396 -177.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.699 ' HB2' ' O ' ' A' ' 71' ' ' ARG . 5.3 t70 -68.25 175.62 3.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.512 0.673 . . . . 2.1899999999999999 111.723 -175.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.492 ' HG2' ' OD1' ' A' ' 198' ' ' ASN . 28.9 mmmt -95.96 -40.65 9.17 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.563 -0.744 . . . . 3.1899999999999999 109.832 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.8 t -119.72 16.14 12.73 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.439 -0.8 . . . . 1.5800000000000001 111.356 -171.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.638 HD13 HG22 ' A' ' 72' ' ' ILE . 56.1 mt -110.91 -179.32 3.71 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.537 -0.465 . . . . 0.70999999999999996 111.924 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.603 ' HG2' ' HG2' ' A' ' 99' ' ' GLN . 12.0 mm-40 -154.94 -61.59 0.12 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.519 -0.764 . . . . 1.73 111.219 -175.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 96' ' ' THR . 30.6 t -142.46 127.74 16.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.377 -0.374 . . . . 0.78000000000000003 110.648 -166.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.746 ' HB3' HD12 ' A' ' 72' ' ' ILE . 42.8 p90 -95.41 146.62 24.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.611 0.243 . . . . 5.4000000000000004 110.639 176.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.509 ' HB2' ' HB3' ' A' ' 95' ' ' HIS . 58.4 m-80 -153.45 107.18 3.02 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.548 -0.538 . . . . 1.6899999999999999 109.548 176.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.03 96.61 3.84 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.259 -0.645 . . . . 2.0499999999999998 109.259 177.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -73.12 -62.78 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.352 0.596 . . . . 0.64000000000000001 110.805 -169.358 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.445 ' HB3' HD12 ' A' ' 93' ' ' ILE . 15.5 t60 -133.97 113.96 12.73 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.275 -0.875 . . . . 1.96 108.824 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.2 mtt180 -98.28 103.74 15.71 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.971 -0.751 . . . . 2.4399999999999999 108.971 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.591 HG12 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -72.23 -46.2 58.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.456 -0.793 . . . . 0.46999999999999997 110.989 -171.551 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -141.92 -163.75 1.65 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.87 -0.789 . . . . 1.8600000000000001 108.87 -173.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.4 m -81.18 -14.8 57.21 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.844 0.354 . . . . 1.4399999999999999 110.3 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -131.82 14.81 4.83 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 110.078 -0.342 . . . . 1.8700000000000001 110.078 -175.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.591 ' O ' HG12 ' A' ' 87' ' ' ILE . 0.4 OUTLIER -134.11 110.95 9.95 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 108.682 -0.858 . . . . 0.46000000000000002 108.682 -175.097 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.534 ' O ' HD12 ' A' ' 114' ' ' LEU . 21.7 m-85 -130.24 169.34 15.52 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.953 -0.567 . . . . 0.42999999999999999 110.391 -173.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.65 ' O ' HG23 ' A' ' 84' ' ' VAL . 28.4 mt -135.06 123.89 41.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 107.43 -1.322 . . . . 0.40999999999999998 107.43 169.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 65.2 m -110.27 125.44 53.12 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.636 -0.425 . . . . 2.0099999999999998 111.315 -175.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.631 ' HA ' HD13 ' A' ' 112' ' ' ILE . 22.2 t60 -90.91 87.65 6.72 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 122.134 0.969 . . . . 1.23 108.702 168.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 89.6 m -102.56 130.77 49.51 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.275 -1.329 . . . . 0.5 109.926 -177.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.406 ' O ' ' HB2' ' A' ' 79' ' ' GLN . 47.1 mm -80.99 128.82 38.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 C-N-CA 119.671 -0.811 . . . . 1.03 108.891 172.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.601 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 1.5 m -102.28 143.95 31.41 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.969 -0.559 . . . . 1.3799999999999999 110.255 -176.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.603 ' HG2' ' HG2' ' A' ' 79' ' ' GLN . 5.5 mm-40 -85.98 179.16 7.05 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.948 -0.569 . . . . 1.8200000000000001 110.804 178.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' A' ' 106' ' ' ILE . 8.3 m -107.69 75.52 1.01 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.586 -0.733 . . . . 3.9100000000000001 110.823 -176.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.423 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 79.6 t80 -86.77 98.28 11.08 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.606 -0.438 . . . . 5.1600000000000001 111.197 -177.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 101' ' ' PHE . . . 165.92 59.2 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 O-C-N 124.728 1.268 . . . . 1.98 109.489 171.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 86.1 t 71.75 -40.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-N 115.591 -0.732 . . . . 3.1699999999999999 111.856 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 139.09 18.71 0.5 Allowed Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.898 -0.667 . . . . 1.96 112.668 177.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 39.1 m -87.44 10.73 16.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.059 0.456 . . . . 1.8799999999999999 111.127 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 100' ' ' SER . 60.4 mt -129.85 139.68 50.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.916 -0.584 . . . . 1.1200000000000001 109.523 -177.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 48.4 m -84.91 152.9 59.95 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 110.083 -0.34 . . . . 1.3500000000000001 110.083 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.94 130.98 36.78 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.768 2.312 . . . . 1.0700000000000001 111.048 177.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 144' ' ' ILE . 12.2 ttp180 -109.73 154.92 22.23 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.285 -0.566 . . . . 3.4500000000000002 111.046 -167.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.46 ' HB2' ' HB3' ' A' ' 143' ' ' TYR . 5.1 t0 -95.33 140.82 29.67 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.658 -0.867 . . . . 1.3700000000000001 108.658 174.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.661 ' CE1' ' HB2' ' A' ' 113' ' ' ASP . 13.4 t80 -123.76 108.74 12.85 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.664 -0.865 . . . . 2.4100000000000001 108.664 -179.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.699 HG21 ' CE1' ' A' ' 134' ' ' PHE . 12.6 mm -124.1 74.78 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 107.933 -1.136 . . . . 0.42999999999999999 107.933 173.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.661 ' HB2' ' CE1' ' A' ' 111' ' ' PHE . 1.0 OUTLIER -102.48 124.18 47.58 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.587 -0.733 . . . . 1.8600000000000001 110.094 -176.39 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.698 HD21 ' HB2' ' A' ' 7' ' ' ALA . 10.6 tp -76.98 121.97 24.23 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 115.265 -0.88 . . . . 0.28000000000000003 109.364 174.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -122.82 123.95 69.36 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 CA-C-N 114.157 -1.383 . . . . 0.26000000000000001 111.503 -166.561 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.555 ' HB2' ' HB1' ' A' ' 7' ' ' ALA . 53.8 t80 -117.22 125.4 51.09 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.647 -0.706 . . . . 2.5699999999999998 110.571 175.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' A' ' 126' ' ' ILE . 91.8 mt -96.96 99.24 8.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.484 -0.78 . . . . 0.89000000000000001 110.54 -177.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -101.86 135.1 44.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.11 -0.95 . . . . 1.2 108.867 178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.521 ' O ' ' HD3' ' A' ' 119' ' ' ARG . 0.1 OUTLIER -124.19 110.6 14.87 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 121.903 0.859 . . . . 2.7999999999999998 108.907 176.368 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.571 ' CB ' ' HB3' ' A' ' 123' ' ' ASN . 59.3 m-85 -77.88 116.83 18.68 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.064 -1.088 . . . . 0.82999999999999996 108.064 171.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.52 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 1.6 mp0 -28.7 93.72 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 O-C-N 125.086 1.491 . . . . 2.2799999999999998 113.321 178.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 56.29 36.86 70.69 Favored Glycine 0 CA--C 1.507 -0.451 0 CA-C-N 115.117 -0.947 . . . . 0.76000000000000001 112.312 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.571 ' HB3' ' CB ' ' A' ' 120' ' ' TYR . 59.2 t30 -128.83 -53.4 1.23 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.971 -0.614 . . . . 1.6499999999999999 109.694 -176.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.54 ' HA ' ' O ' ' A' ' 155' ' ' CYS . 0.4 OUTLIER -157.14 125.36 5.57 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.112 -0.495 . . . . 1.1200000000000001 110.986 -179.069 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -107.75 82.59 1.67 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.248 -1.019 . . . . 1.6200000000000001 108.248 175.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.499 ' CG1' HG12 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -100.93 139.37 22.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.892 -0.595 . . . . 0.29999999999999999 112.421 -171.74 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -107.4 119.45 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 107.358 -1.349 . . . . 0.58999999999999997 107.358 159.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 30.3 p -82.88 167.3 18.18 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.037 -0.727 . . . . 1.1799999999999999 109.037 174.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.425 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 67.7 p -158.48 120.01 3.49 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.9 0.381 . . . . 1.24 110.231 -178.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.617 ' CE ' HD23 ' A' ' 114' ' ' LEU . 3.1 ttpm? -131.95 115.01 15.32 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 108.128 -1.064 . . . . 2.2599999999999998 108.128 -176.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.403 ' CB ' ' H ' ' A' ' 148' ' ' ASN . 96.9 p -61.78 100.14 0.14 Allowed 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 107.698 -1.223 . . . . 1.3899999999999999 107.698 -177.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.464 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -107.77 138.23 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.115 0 CA-C-N 115.163 -0.926 . . . . 1.05 108.847 -165.351 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -99.76 64.32 1.26 Allowed 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 122.432 1.11 . . . . 2.1699999999999999 108.64 -168.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.813 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -90.74 162.02 34.52 Favored Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 113.387 -1.733 . . . . 0.53000000000000003 110.64 -171.596 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -77.86 -12.91 16.21 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 123.072 2.514 . . . . 1.28 114.762 -173.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.813 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 5.7 tp10 -72.7 -17.78 61.6 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 109.48 -0.563 . . . . 3.5 109.48 -171.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.47 ' HB2' HG11 ' A' ' 84' ' ' VAL . 18.8 t80 -163.13 112.01 1.03 Allowed Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 113.351 0.871 . . . . 6.1200000000000001 113.351 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -83.96 126.0 3.77 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 123.077 2.518 . . . . 1.77 110.035 163.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.462 ' HG3' ' HB2' ' A' ' 145' ' ' ARG . 11.2 Cg_endo -52.54 -92.47 0.0 OUTLIER 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 123.447 2.765 . . . . 1.25 114.956 -168.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.1 t -172.53 171.52 4.57 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.621 -0.511 . . . . 1.6000000000000001 109.621 -174.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.8 p -90.22 -15.41 31.46 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.228 -0.656 . . . . 1.97 109.228 171.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -98.56 -50.44 4.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.582 -0.736 . . . . 2.1800000000000002 110.133 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.46 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 40.2 m-85 -83.44 130.4 35.03 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 115.847 -0.615 . . . . 1.23 109.455 176.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.664 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -100.9 113.53 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 N-CA-C 107.991 -1.114 . . . . 0.81999999999999995 107.991 -179.407 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.462 ' HB2' ' HG3' ' A' ' 139' ' ' PRO . 6.4 tmm_? -57.41 97.38 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.674 -1.232 . . . . 4.4199999999999999 107.674 170.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.493 ' HA3' ' HD2' ' A' ' 109' ' ' ARG . . . -66.07 129.0 31.85 Favored Glycine 0 CA--C 1.49 -1.477 0 N-CA-C 110.63 -0.988 . . . . 0.79000000000000004 110.63 -176.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.463 ' H ' ' HG2' ' A' ' 174' ' ' GLU . 41.4 t80 -82.74 107.05 15.08 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.515 1.15 . . . . 4.4400000000000004 110.733 -175.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.403 ' H ' ' CB ' ' A' ' 131' ' ' SER . 55.2 t30 -110.36 110.97 21.96 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.05 -1.886 . . . . 1.6200000000000001 108.396 178.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.508 ' O ' ' N ' ' A' ' 151' ' ' CYS . 29.6 m-70 -57.63 163.29 3.91 Favored Pre-proline 0 C--O 1.217 -0.628 0 CA-C-O 118.174 -0.917 . . . . 2.3199999999999998 109.012 175.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.517 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 1.2 Cg_endo -44.12 77.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 123.841 3.027 . . . . 0.53000000000000003 113.719 178.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . 0.58 ' HB3' ' O ' ' A' ' 170' ' ' PHE . 45.4 m -108.96 -171.81 1.92 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.999 -1.0 . . . . 1.5800000000000001 109.325 177.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.632 ' O ' ' HG3' ' A' ' 169' ' ' MET . . . 174.45 -153.29 16.04 Favored Glycine 0 N--CA 1.435 -1.421 0 C-N-CA 119.028 -1.558 . . . . 0.42999999999999999 112.644 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.601 ' CZ ' HD11 ' A' ' 167' ' ' LEU . 3.6 t80 -156.47 97.96 1.79 Allowed 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.517 -1.29 . . . . 0.59999999999999998 107.517 -163.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.63 ' CG2' HG13 ' A' ' 168' ' ' VAL . 2.6 m -105.56 146.25 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 C-N-CA 119.705 -0.798 . . . . 0.31 110.856 -174.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . 0.57 ' SG ' HD12 ' A' ' 61' ' ' LEU . 18.5 t -118.57 138.19 52.72 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.042 -0.981 . . . . 1.55 108.439 173.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.52 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 12.4 m -123.24 111.22 30.41 Favored Pre-proline 0 C--N 1.307 -1.263 0 C-N-CA 120.697 -0.401 . . . . 1.0600000000000001 110.878 -177.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.454 ' HD2' ' O ' ' A' ' 123' ' ' ASN . 71.4 Cg_exo -50.22 117.74 3.4 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.43 2.087 . . . . 0.56000000000000005 111.045 170.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.425 ' O ' ' HB3' ' A' ' 161' ' ' ASN . 88.6 mmm -79.13 -162.72 0.42 Allowed 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.066 0.46 . . . . 1.1599999999999999 111.462 -175.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -75.38 -35.97 60.99 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.615 -0.883 . . . . 2.6299999999999999 108.615 172.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.411 ' C ' ' HD2' ' A' ' 162' ' ' PRO . 16.5 mt-10 -96.92 29.18 3.16 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.161 -1.381 . . . . 2.0499999999999998 108.636 174.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.516 ' ND2' ' HD3' ' A' ' 162' ' ' PRO . 5.2 p-10 -34.18 -47.28 0.77 Allowed Pre-proline 0 N--CA 1.471 0.611 0 N-CA-C 116.398 1.999 . . . . 1.9299999999999999 116.398 -168.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.516 ' HD3' ' ND2' ' A' ' 161' ' ' ASN . 71.3 Cg_endo -73.94 -17.85 22.09 Favored 'Trans proline' 0 C--N 1.351 0.703 0 CA-C-N 121.755 1.662 . . . . 0.72999999999999998 113.047 -176.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -109.16 -25.89 10.4 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.191 -0.459 . . . . 0.68000000000000005 110.832 -178.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 161' ' ' ASN . 79.6 m-85 -138.3 124.7 20.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.825 -0.625 . . . . 0.93000000000000005 109.467 176.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 3.7 p -125.62 142.25 51.61 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.155 0.502 . . . . 1.4099999999999999 111.154 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.561 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 1.9 tppp? -88.27 119.6 28.83 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.629 0.728 . . . . 0.73999999999999999 111.482 -175.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.601 HD11 ' CZ ' ' A' ' 153' ' ' PHE . 0.3 OUTLIER -101.96 117.17 34.27 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.244 -0.889 . . . . 0.27000000000000002 110.099 176.64 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.63 HG13 ' CG2' ' A' ' 154' ' ' VAL . 0.1 OUTLIER -140.84 126.41 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-O 121.558 0.694 . . . . 0.28000000000000003 112.413 177.699 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.632 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 12.1 ttt -145.44 145.72 31.23 Favored 'General case' 0 C--O 1.22 -0.485 0 C-N-CA 123.091 0.556 . . . . 1.24 110.919 -170.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.877 ' CE2' HG23 ' A' ' 14' ' ' VAL . 12.1 p90 -136.95 162.73 32.47 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.375 0.607 . . . . 3.3700000000000001 112.223 171.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.536 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 1.4 m -136.54 143.53 35.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 113.592 -1.64 . . . . 1.3999999999999999 110.481 173.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.499 ' HB3' ' HB2' ' A' ' 149' ' ' HIS . 7.7 tt0 -120.29 54.95 1.02 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.889 -1.522 . . . . 2.1699999999999999 106.889 172.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.1 m -64.02 144.5 57.04 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 113.791 -1.55 . . . . 1.6499999999999999 110.708 -173.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.537 ' HG3' ' H ' ' A' ' 176' ' ' ARG . 10.3 pt-20 -81.89 -3.27 53.77 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.714 -0.394 . . . . 2.4500000000000002 110.531 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.498 ' C ' ' HG3' ' A' ' 176' ' ' ARG . 61.1 mtt 80.87 9.77 1.05 Allowed 'General case' 0 N--CA 1.468 0.467 0 O-C-N 123.947 0.779 . . . . 3.7400000000000002 109.402 176.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.537 ' H ' ' HG3' ' A' ' 174' ' ' GLU . 3.3 mtt85 63.62 -87.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.358 -1.292 . . . . 5.7800000000000002 111.156 177.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.435 ' H ' ' HB2' ' A' ' 176' ' ' ARG . . . -97.92 2.14 59.88 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 111.408 -0.677 . . . . 2.2599999999999998 111.408 177.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 4.0 tmtp? 67.88 96.85 0.06 Allowed 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.44 0.696 . . . . 6.2300000000000004 110.249 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.583 ' H ' HD22 ' A' ' 179' ' ' LEU . 0.6 OUTLIER -82.06 -150.98 0.09 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.773 -0.648 . . . . 1.6399999999999999 109.438 -178.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.481 ' O ' HD12 ' A' ' 184' ' ' ILE . 43.5 m -111.24 152.19 43.65 Favored Pre-proline 0 C--N 1.318 -0.795 0 N-CA-C 108.591 -0.892 . . . . 2.04 108.591 174.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -42.82 -46.47 8.5 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.052 2.502 . . . . 1.74 113.523 -177.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.55 ' O ' ' HE2' ' A' ' 186' ' ' LYS . 22.9 t -66.51 -15.95 63.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.778 0.323 . . . . 2.1400000000000001 111.594 -177.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.527 ' HA ' ' HE2' ' A' ' 186' ' ' LYS . 15.9 mm -91.27 -37.53 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-O 122.498 1.142 . . . . 1.1200000000000001 108.793 -178.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 1.024 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.1 mp -73.61 -33.05 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 113.103 -1.862 . . . . 1.1299999999999999 111.168 -175.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 189' ' ' PRO . 10.4 pt-20 -65.57 -21.73 66.62 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.83 -0.804 . . . . 2.8900000000000001 108.83 173.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.574 ' O ' ' HB2' ' A' ' 190' ' ' SER . 49.2 mtmt -92.36 -24.71 18.82 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.648 -0.705 . . . . 1.28 110.026 176.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 1.024 HG22 ' HA ' ' A' ' 184' ' ' ILE . 4.5 t -91.18 -47.98 7.2 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 119.499 -0.88 . . . . 0.62 112.772 -178.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . 0.572 ' O ' ' HG ' ' A' ' 192' ' ' LEU . 0.0 OUTLIER -80.48 -71.04 0.15 Allowed Pre-proline 0 N--CA 1.471 0.593 0 CA-C-N 119.403 1.002 . . . . 1.0600000000000001 112.447 -175.651 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.428 ' HG2' ' O ' ' A' ' 185' ' ' GLU . 44.7 Cg_endo -68.25 -22.93 39.53 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.307 1.338 . . . . 0.91000000000000003 112.022 -171.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.574 ' HB2' ' O ' ' A' ' 186' ' ' LYS . 66.9 m -83.83 -23.99 31.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.733 -0.667 . . . . 1.5 110.707 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 187' ' ' THR . 55.0 t30 -89.85 -25.4 21.05 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.439 -0.505 . . . . 1.8799999999999999 110.834 178.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 188' ' ' MET . 15.5 mt -68.84 -47.69 65.39 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.777 0.322 . . . . 1.0900000000000001 111.029 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.588 HG13 ' CG2' ' A' ' 35' ' ' VAL . 3.8 m -67.89 -23.19 28.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 120.353 -0.539 . . . . 0.68000000000000005 110.165 175.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -76.45 -31.06 57.6 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.831 -0.622 . . . . 2.0699999999999998 110.835 176.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -67.14 -31.36 71.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.077 0.465 . . . . 2.0 109.78 171.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.555 ' O ' ' HG2' ' A' ' 200' ' ' LYS . 63.2 mt -77.66 -30.07 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 116.121 -0.49 . . . . 0.31 110.62 174.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 193' ' ' VAL . 57.1 mt -71.69 -38.76 70.56 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-O 121.468 0.651 . . . . 1.03 109.434 173.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.513 ' ND2' ' HA ' ' A' ' 75' ' ' ASP . 2.6 m120 -54.5 -35.26 62.94 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.393 -1.276 . . . . 1.8999999999999999 109.112 167.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.681 ' O ' ' HB ' ' A' ' 203' ' ' ILE . . . -75.59 -43.74 46.65 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 120.483 -0.487 . . . . 0.28999999999999998 110.413 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.617 ' O ' ' HG3' ' A' ' 204' ' ' LYS . 32.0 mmtp -56.11 -44.21 78.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.135 0.493 . . . . 0.96999999999999997 110.613 174.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -85.41 -41.14 15.69 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.585 -0.734 . . . . 1.9399999999999999 111.419 -174.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . 0.523 ' HA3' ' CH2' ' A' ' 74' ' ' TRP . . . -68.26 -27.99 73.5 Favored Glycine 0 CA--C 1.507 -0.458 0 N-CA-C 111.502 -0.639 . . . . 0.46999999999999997 111.502 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 1.034 HD13 HD23 ' A' ' 61' ' ' LEU . 2.8 tp -71.7 -31.41 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 109.327 -0.62 . . . . 0.60999999999999999 109.327 176.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.617 ' HG3' ' O ' ' A' ' 200' ' ' LYS . 57.5 mttp -84.63 -25.07 28.8 Favored 'General case' 0 C--O 1.208 -1.093 0 N-CA-C 108.528 -0.916 . . . . 3.3700000000000001 108.528 176.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.547 ' HA ' ' OG ' ' A' ' 210' ' ' SER . . . -68.23 -25.35 65.16 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.675 -0.693 . . . . 1.02 109.701 170.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 48.0 m80 -97.97 -8.91 27.06 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.578 -0.737 . . . . 3.6299999999999999 112.746 174.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.475 ' HD2' ' OE1' ' A' ' 56' ' ' GLU . 26.6 ttt180 -112.92 -60.02 1.94 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.617 0.722 . . . . 2.5899999999999999 110.55 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.485 ' HB ' ' O ' ' A' ' 204' ' ' LYS . 30.6 m -71.0 142.49 87.77 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 114.771 -1.104 . . . . 1.8400000000000001 109.57 176.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -70.82 49.81 0.99 Allowed 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.175 1.916 . . . . 2.3500000000000001 112.352 175.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.547 ' OG ' ' HA ' ' A' ' 205' ' ' ALA . 22.7 p -80.69 -37.69 30.29 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.89 0.376 . . . . 2.3100000000000001 110.206 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 211' ' ' ARG . 31.0 mtp-105 -79.69 4.42 16.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.158 0.504 . . . . 5.4500000000000002 110.673 177.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -69.94 -40.54 75.42 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.952 -1.129 . . . . 6.8600000000000003 107.952 165.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -87.09 -43.93 5.81 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 114.895 -1.048 . . . . 3.3700000000000001 111.147 173.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -83.89 96.8 8.92 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.249 0.547 . . . . 5.21 110.089 176.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -99.36 75.9 2.01 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.039 -0.528 . . . . 6.46 110.707 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 78.1 t60 57.4 84.08 0.1 Allowed 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.441 -0.8 . . . . 6.0899999999999999 109.772 -177.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -49.65 112.21 0.62 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.044 -0.98 . . . . 5.1200000000000001 112.079 -174.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 16.5 m -109.75 5.02 22.39 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.698 -0.683 . . . . 6.7599999999999998 109.681 176.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 61.1 m80 71.26 173.24 0.31 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.088 -0.96 . . . . 8.8200000000000003 111.187 178.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 18.4 p . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.307 -0.854 . . . . 8.4800000000000004 110.587 -179.483 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 120.821 0.343 . . . . 3.8599999999999999 110.281 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.653 ' O ' HD13 ' A' ' 6' ' ' ILE . 15.5 m-20 -81.47 -37.34 28.12 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 108.392 -0.966 . . . . 2.25 108.392 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.952 ' HA ' HD11 ' A' ' 6' ' ' ILE . 82.7 m-85 -63.6 -35.63 81.14 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 114.676 -1.147 . . . . 0.42999999999999999 109.168 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.705 ' O ' ' HB3' ' A' ' 8' ' ' GLN . 23.2 tptm -60.81 -47.97 83.92 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 115.302 -0.863 . . . . 1.51 109.074 178.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.17 -46.31 62.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.924 -0.58 . . . . 0.54000000000000004 112.125 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.952 HD11 ' HA ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -80.63 -36.5 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 CA-C-O 121.674 0.75 . . . . 1.0700000000000001 109.562 -172.148 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.6 ' HB1' ' HB3' ' A' ' 116' ' ' TYR . . . -76.86 -43.24 36.92 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.239 -1.346 . . . . 0.34000000000000002 111.472 -175.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.705 ' HB3' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -60.96 -33.53 73.34 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.202 -1.363 . . . . 1.5900000000000001 109.086 -178.406 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.545 ' O ' ' HG2' ' A' ' 13' ' ' GLU . 25.6 mm-40 -92.47 -32.85 14.74 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.86 -1.064 . . . . 2.4700000000000002 110.674 -178.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.722 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 0.4 OUTLIER -75.75 -26.56 57.53 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.786 -0.365 . . . . 0.47999999999999998 110.753 178.028 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -49.34 -44.39 44.54 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 120.208 -0.597 . . . . 0.31 111.811 170.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.691 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 4.0 pt20 -83.73 -1.5 54.27 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 122.075 -0.391 . . . . 1.6399999999999999 110.986 176.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 29.4 mm-40 -88.45 -44.9 10.38 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.803 -0.443 . . . . 2.54 109.803 174.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.712 ' HA ' ' HE2' ' A' ' 170' ' ' PHE . 3.9 p -66.51 -39.96 85.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 122.116 0.96 . . . . 0.53000000000000003 108.912 170.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.691 ' HB3' ' HA ' ' A' ' 12' ' ' GLN . 0.9 OUTLIER -66.9 -21.98 65.98 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 114.749 -1.114 . . . . 0.59999999999999998 108.084 172.552 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.691 ' HA2' ' NE ' ' A' ' 19' ' ' ARG . . . -62.47 -24.44 65.86 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 113.909 -1.496 . . . . 0.56999999999999995 110.268 176.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.452 ' HD1' ' O ' ' A' ' 13' ' ' GLU . 19.6 m-85 -92.55 -8.55 44.07 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.246 -0.477 . . . . 3.27 109.946 178.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.47 -10.97 44.36 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 119.295 -0.962 . . . . 2.0299999999999998 108.608 176.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.691 ' NE ' ' HA2' ' A' ' 16' ' ' GLY . 19.5 ptt85 -122.64 3.25 9.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.618 -1.173 . . . . 2.7200000000000002 110.561 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.649 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 23.0 t70 -90.28 112.8 24.47 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 116.223 -0.444 . . . . 2.1600000000000001 110.821 -175.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.8 p -129.96 93.81 3.58 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.691 0.758 . . . . 1.8200000000000001 109.334 176.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.1 t -127.26 -78.19 0.58 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.638 -1.165 . . . . 2.1899999999999999 111.202 -169.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.09 60.38 0.55 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.52 -0.848 . . . . 1.1000000000000001 112.374 -177.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.513 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -120.39 -163.73 1.03 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.107 0.479 . . . . 1.6699999999999999 110.221 176.869 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 1.2 mtpp -176.77 135.65 0.22 Allowed 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.201 -1.037 . . . . 2.9500000000000002 108.201 -172.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 3.2 m -66.55 123.88 20.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.895 0.855 . . . . 1.5600000000000001 110.703 177.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.2 p -97.76 -23.25 4.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 114.199 -1.364 . . . . 1.22 108.795 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.502 ' HD2' ' HA ' ' A' ' 28' ' ' LYS . 10.0 tptm -155.47 112.93 3.32 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 119.995 -0.682 . . . . 2.4100000000000001 111.824 -174.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.932 HG22 ' HA ' ' A' ' 34' ' ' THR . 75.2 p -130.97 126.93 37.32 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.54 -0.541 . . . . 1.3799999999999999 109.54 172.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.3 m -85.18 -79.94 0.22 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.536 -0.302 . . . . 2.3700000000000001 110.984 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 7.2 ptpp? -159.17 28.55 0.21 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.498 0.189 . . . . 4.5499999999999998 110.894 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.537 ' HB2' ' NZ ' ' A' ' 32' ' ' LYS . 1.4 ttmp? 170.35 -20.7 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.979 -0.555 . . . . 1.4199999999999999 110.31 -176.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.899 HG22 ' HA3' ' A' ' 52' ' ' GLY . 46.1 pt -109.26 157.3 9.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.771 -0.65 . . . . 0.76000000000000001 110.486 178.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.932 ' HA ' HG22 ' A' ' 29' ' ' THR . 85.6 m -148.79 100.07 3.05 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.65 -0.705 . . . . 0.57999999999999996 111.133 -164.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.925 HG11 HD13 ' A' ' 192' ' ' LEU . 2.3 t -96.06 106.98 19.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.871 0.367 . . . . 0.85999999999999999 110.281 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 6.0 p -96.62 126.04 41.52 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.453 0.645 . . . . 1.1000000000000001 110.735 177.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.2 t -103.29 127.75 50.53 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.782 -1.099 . . . . 1.27 109.199 -176.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.513 ' HB2' ' HB3' ' A' ' 24' ' ' TRP . 25.1 ttpp -120.13 -86.41 0.65 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.33 -0.395 . . . . 1.9099999999999999 110.983 -177.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.8 ' HA ' ' HA ' ' A' ' 46' ' ' ASN . . . -176.33 149.01 0.8 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.996 -0.372 . . . . 1.6799999999999999 109.996 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.966 ' HB2' ' HB2' ' A' ' 47' ' ' LEU . 39.9 t -145.4 -37.5 0.27 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.105 0.479 . . . . 2.0899999999999999 110.68 178.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 66.97 8.52 6.17 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 114.79 -1.096 . . . . 6.6100000000000003 111.558 -177.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.495 ' HD2' ' HB3' ' A' ' 40' ' ' SER . 0.0 OUTLIER -70.57 -14.32 62.45 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 121.158 -0.217 . . . . 6.46 111.377 -178.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -174.77 -72.49 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 120.511 -0.476 . . . . 5.6500000000000004 110.605 -176.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -104.17 37.85 1.99 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.703 0.763 . . . . 5.5599999999999996 110.707 -175.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.2 -51.18 3.21 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.307 -0.86 . . . . 1.5600000000000001 113.918 173.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.8 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . 3.6 m-20 -105.53 169.76 8.28 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.054 0.761 . . . . 2.0499999999999998 113.054 -166.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.966 ' HB2' ' HB2' ' A' ' 40' ' ' SER . 9.7 tt -128.85 147.78 50.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.171 -1.377 . . . . 0.87 107.615 178.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.444 ' N ' HD23 ' A' ' 47' ' ' LEU . 94.0 m-85 -122.71 134.35 54.46 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.151 -0.62 . . . . 0.98999999999999999 111.587 -170.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 2.6 tmt_? -130.67 118.56 21.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.813 -0.631 . . . . 2.9199999999999999 111.044 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.915 HG13 HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -92.5 153.35 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-O 120.989 0.423 . . . . 1.3300000000000001 110.642 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.488 ' CG ' ' HD2' ' A' ' 166' ' ' LYS . 16.3 tt0 -153.31 106.56 2.98 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.557 -0.905 . . . . 1.0700000000000001 108.557 178.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.899 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -140.94 141.21 11.07 Favored Glycine 0 CA--C 1.498 -0.998 0 C-N-CA 120.239 -0.981 . . . . 0.28999999999999998 111.542 -178.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 165' ' ' SER . 61.6 mt -88.44 120.35 37.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 C-N-CA 120.206 -0.598 . . . . 0.57999999999999996 110.89 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.663 HG12 ' HD3' ' A' ' 200' ' ' LYS . 63.7 mt -95.74 119.2 65.36 Favored Pre-proline 0 N--CA 1.443 -0.785 0 N-CA-C 109.096 -0.705 . . . . 0.34999999999999998 109.096 173.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 163' ' ' ALA . 28.1 Cg_exo -64.72 59.35 0.28 Allowed 'Trans proline' 0 N--CA 1.473 0.268 0 C-N-CA 124.08 3.187 . . . . 0.62 112.959 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.443 ' HG2' HG13 ' A' ' 203' ' ' ILE . 14.5 tp10 -156.21 175.85 13.45 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.287 -1.375 . . . . 1.6799999999999999 107.287 177.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.491 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 43.3 p -88.81 141.66 30.01 Favored Pre-proline 0 N--CA 1.429 -1.522 0 CA-C-O 121.512 0.672 . . . . 1.1799999999999999 110.211 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.832 ' HD3' ' HB3' ' A' ' 165' ' ' SER . 6.3 Cg_endo -49.34 -14.85 0.63 Allowed 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 124.963 3.775 . . . . 0.52000000000000002 112.587 173.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.76 -47.74 29.45 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 116.11 -0.495 . . . . 0.64000000000000001 111.204 176.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.668 ' HE3' ' HA ' ' A' ' 60' ' ' LYS . 1.4 tpmt? -67.64 -31.42 71.42 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.841 -1.17 . . . . 3.2999999999999998 107.841 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.009 HD23 HD13 ' A' ' 203' ' ' ILE . 83.2 mt -63.23 -56.29 17.88 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.034 -1.439 . . . . 0.40999999999999998 110.778 175.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.2 t -62.95 -12.17 23.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.67 0.271 . . . . 1.29 110.564 177.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -84.04 -41.91 16.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.369 -0.378 . . . . 1.3200000000000001 112.0 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.771 ' HD2' ' CZ2' ' A' ' 74' ' ' TRP . 15.4 p90 -85.88 -42.02 14.46 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.399 0.518 . . . . 0.60999999999999999 112.399 -170.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.741 HD12 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -89.95 4.49 49.89 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.06 0.391 . . . . 1.5 111.932 -170.08 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.617 ' O ' ' HG3' ' A' ' 67' ' ' GLN . 75.2 t80 -41.89 -73.1 0.05 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.973 0.731 . . . . 1.52 112.973 -166.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.631 HE22 ' HB2' ' A' ' 92' ' ' PHE . 72.4 mt-30 -168.07 -61.57 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.7 0.762 . . . . 3.6000000000000001 110.462 -178.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.855 ' HB ' ' CD2' ' A' ' 81' ' ' TYR . 10.2 t -126.23 26.19 6.5 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.111 -1.44 . . . . 1.48 107.111 178.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.699 ' O ' ' HB2' ' A' ' 70' ' ' ASP . . . -72.15 -14.12 76.48 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 113.531 -1.668 . . . . 1.46 112.735 -169.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.699 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 15.1 t70 132.91 -8.95 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 O-C-N 125.844 1.555 . . . . 2.1899999999999999 107.051 -171.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.779 ' HA ' ' CE2' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -59.41 -36.24 75.48 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.525 -1.216 . . . . 3.3799999999999999 111.239 -170.089 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.073 HG22 HD13 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -80.5 -14.14 12.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.581 -0.448 . . . . 0.70999999999999996 110.973 -175.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.663 HG22 ' O ' ' A' ' 70' ' ' ASP . 1.1 t -88.11 -31.7 19.07 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 119.972 -0.691 . . . . 0.96999999999999997 110.15 -176.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.858 ' HZ3' ' HB3' ' A' ' 198' ' ' ASN . 15.0 p-90 -100.64 -7.21 24.16 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.411 -0.516 . . . . 0.75 111.023 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.811 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 5.7 t70 -73.7 167.98 20.3 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.47 0.653 . . . . 2.1899999999999999 110.267 -177.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.8 -16.17 12.8 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.923 -1.035 . . . . 3.1899999999999999 111.512 -172.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.1 t -119.62 9.02 11.35 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.339 0.59 . . . . 1.5800000000000001 109.456 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.073 HD13 HG22 ' A' ' 72' ' ' ILE . 19.9 mt -109.72 159.68 16.95 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.625 -0.716 . . . . 0.70999999999999996 112.421 -175.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.626 ' HG2' ' HG3' ' A' ' 99' ' ' GLN . 7.7 mt-30 -131.94 -69.7 0.59 Allowed 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 114.807 -1.088 . . . . 1.73 110.432 178.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.558 HG23 ' HB3' ' A' ' 79' ' ' GLN . 21.3 t -142.84 136.32 26.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.875 -1.057 . . . . 0.78000000000000003 110.254 -165.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.855 ' CD2' ' HB ' ' A' ' 68' ' ' THR . 80.6 t80 -116.91 146.56 42.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.053 0.454 . . . . 5.4000000000000004 111.334 177.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.73 ' HB2' ' HD2' ' A' ' 95' ' ' HIS . 14.0 m120 -142.69 124.01 14.69 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.42 -0.809 . . . . 1.6899999999999999 109.037 175.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.453 ' SD ' ' HD3' ' A' ' 86' ' ' ARG . 2.3 ttt -82.11 97.13 8.03 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.597 -0.89 . . . . 2.0499999999999998 108.597 -178.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.703 HG11 ' HB2' ' A' ' 137' ' ' TYR . 0.1 OUTLIER -72.92 -80.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.914 -0.584 . . . . 0.64000000000000001 111.908 -167.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.592 ' HB2' ' HG2' ' A' ' 136' ' ' GLU . 10.4 t60 -126.03 118.36 25.17 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.976 -0.75 . . . . 1.96 108.976 -177.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.453 ' HD3' ' SD ' ' A' ' 83' ' ' MET . 50.4 mtm180 -103.31 103.14 13.13 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.4 -0.593 . . . . 2.4399999999999999 109.4 -175.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.606 HG21 ' HB2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -67.74 -41.32 85.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.081 -0.963 . . . . 0.46999999999999997 110.402 -173.547 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -148.35 -161.38 1.33 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.878 -1.156 . . . . 1.8600000000000001 107.878 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.7 m -93.4 3.87 54.9 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.07 0.462 . . . . 1.4399999999999999 109.915 175.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -125.07 -3.43 7.58 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 109.07 -0.715 . . . . 1.8700000000000001 109.07 -175.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.564 HG22 HD11 ' A' ' 114' ' ' LEU . 2.1 m -145.92 116.52 7.61 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 109.288 -0.634 . . . . 0.46000000000000002 109.288 -171.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.631 ' HB2' HE22 ' A' ' 67' ' ' GLN . 10.8 m-85 -129.82 176.88 7.68 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.175 -0.676 . . . . 0.42999999999999999 109.175 -177.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.635 HD13 ' HB2' ' A' ' 114' ' ' LEU . 1.3 mm -122.43 131.81 72.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 107.851 -1.166 . . . . 0.40999999999999998 107.851 168.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 18.4 p -107.11 107.14 17.98 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.871 -0.331 . . . . 2.0099999999999998 111.643 -173.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.73 ' HD2' ' HB2' ' A' ' 82' ' ' ASN . 49.4 t60 -81.72 103.57 11.5 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.385 -0.969 . . . . 1.23 108.385 167.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.838 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 33.1 m -125.4 111.18 14.83 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.891 -0.595 . . . . 0.5 111.75 -170.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' A' ' 79' ' ' GLN . 29.0 mm -77.11 136.56 24.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 120.142 -0.623 . . . . 1.03 109.739 177.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 109' ' ' ARG . 1.8 m -112.75 147.05 37.67 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.988 -1.005 . . . . 1.3799999999999999 109.942 -171.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.626 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 6.8 mt-30 -88.82 157.04 18.6 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.962 -0.563 . . . . 1.8200000000000001 110.403 -178.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 10.1 m -76.87 84.64 3.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.657 -0.701 . . . . 3.9100000000000001 109.959 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -92.22 175.29 6.91 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 115.871 -0.604 . . . . 5.1600000000000001 109.371 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 1.114 ' HB1' ' HD2' ' A' ' 186' ' ' LYS . . . 65.71 40.64 4.29 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.132 -0.94 . . . . 1.98 109.726 -173.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 102' ' ' ALA . 0.3 OUTLIER 69.77 -25.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.929 1.292 . . . . 3.1699999999999999 112.623 177.39 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 140.96 -0.46 1.84 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.311 -0.947 . . . . 1.96 112.404 -176.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.718 ' HB3' HD12 ' A' ' 183' ' ' ILE . 16.5 m -64.15 -25.18 67.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.717 0.77 . . . . 1.8799999999999999 109.97 174.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.538 HD12 ' CB ' ' A' ' 102' ' ' ALA . 44.1 mt -112.59 111.64 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-N 115.025 -0.988 . . . . 1.1200000000000001 109.722 -177.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.8 p -68.15 157.34 87.58 Favored Pre-proline 0 C--O 1.237 0.44 0 CA-C-N 115.433 -0.803 . . . . 1.3500000000000001 111.934 -172.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -45.44 124.44 6.51 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 123.252 2.635 . . . . 1.0700000000000001 110.793 175.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.607 ' HG3' HG23 ' A' ' 144' ' ' ILE . 2.7 ttm180 -122.25 157.19 32.2 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.623 -0.831 . . . . 3.4500000000000002 110.552 -168.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.629 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 12.3 t0 -126.52 131.03 51.69 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 109.608 -0.516 . . . . 1.3700000000000001 109.608 176.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.838 ' HB2' ' HB ' ' A' ' 96' ' ' THR . 20.0 m-85 -99.96 131.91 45.64 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 120.946 0.403 . . . . 2.4100000000000001 110.436 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.514 HD13 ' HA ' ' A' ' 95' ' ' HIS . 20.5 mm -129.8 74.49 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 108.152 -1.055 . . . . 0.42999999999999999 108.152 168.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.673 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 41.8 m-20 -106.44 140.28 39.59 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.981 -1.009 . . . . 1.8600000000000001 109.304 -178.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.635 ' HB2' HD13 ' A' ' 93' ' ' ILE . 5.3 tp -81.93 122.6 27.96 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.162 -0.681 . . . . 0.28000000000000003 109.162 174.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -117.35 124.05 72.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-O 122.236 1.017 . . . . 0.26000000000000001 111.981 -166.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.885 ' CE2' ' HB3' ' A' ' 128' ' ' SER . 0.1 OUTLIER -113.51 118.42 34.4 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.552 -1.658 . . . . 2.5699999999999998 110.02 -176.092 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 126' ' ' ILE . 3.9 mp -105.31 99.38 8.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.544 -0.539 . . . . 0.89000000000000001 109.544 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -107.5 144.17 34.85 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.599 -0.728 . . . . 1.2 109.718 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.442 ' NH1' ' HA ' ' A' ' 121' ' ' GLU . 3.3 tmt_? -121.09 94.1 4.23 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 108.144 -1.058 . . . . 2.7999999999999998 108.144 -176.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.569 ' CB ' ' HB2' ' A' ' 123' ' ' ASN . 89.5 m-85 -63.73 115.84 5.16 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 106.806 -1.553 . . . . 0.82999999999999996 106.806 172.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.442 ' HA ' ' NH1' ' A' ' 119' ' ' ARG . 21.0 mt-10 -48.22 85.26 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 O-C-N 125.031 1.457 . . . . 2.2799999999999998 113.014 -171.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 77.25 29.07 57.0 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 114.91 -1.041 . . . . 0.76000000000000001 112.509 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.569 ' HB2' ' CB ' ' A' ' 120' ' ' TYR . 14.4 m120 -125.5 -51.04 1.62 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.668 -0.266 . . . . 1.6499999999999999 110.337 178.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.405 ' HA ' ' HD2' ' A' ' 157' ' ' PRO . 1.9 mpt? -157.03 131.93 8.87 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.834 0.349 . . . . 1.1200000000000001 111.267 -174.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.438 ' OD1' ' HG2' ' A' ' 119' ' ' ARG . 63.9 m-20 -105.91 79.5 1.43 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.611 -1.255 . . . . 1.6200000000000001 107.611 171.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.604 ' HB ' HG12 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -89.52 124.83 42.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.699 -0.682 . . . . 0.29999999999999999 112.213 -173.101 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.468 ' CG2' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -107.02 116.89 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 107.528 -1.286 . . . . 0.58999999999999997 107.528 160.214 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.885 ' HB3' ' CE2' ' A' ' 116' ' ' TYR . 37.9 t -127.88 167.22 16.9 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.425 -0.954 . . . . 1.1799999999999999 108.425 174.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.673 ' HB3' ' HB3' ' A' ' 113' ' ' ASP . 73.0 m -145.16 137.84 26.15 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.637 -0.505 . . . . 1.24 109.637 -168.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.471 ' HE2' ' HG3' ' A' ' 150' ' ' PRO . 47.0 tttm -123.86 116.21 22.57 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.302 -1.37 . . . . 2.2599999999999998 107.302 -171.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.672 ' HB3' ' N ' ' A' ' 148' ' ' ASN . 11.8 p -58.65 101.29 0.08 Allowed 'General case' 0 N--CA 1.432 -1.354 0 O-C-N 124.26 0.975 . . . . 1.3899999999999999 109.303 -173.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.435 HG13 ' HB3' ' A' ' 134' ' ' PHE . 0.8 OUTLIER -116.3 131.99 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.139 0 CA-C-N 114.933 -1.03 . . . . 1.05 109.918 -167.392 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -98.24 78.66 2.49 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.742 -1.117 . . . . 2.1699999999999999 108.209 -175.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.814 ' CE2' ' HB3' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -109.96 156.88 39.22 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 115.395 -0.82 . . . . 0.53000000000000003 110.264 -171.745 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -75.93 -16.61 18.11 Favored 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.818 2.345 . . . . 1.28 115.267 -169.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.814 ' HB3' ' CE2' ' A' ' 134' ' ' PHE . 8.6 tp10 -69.15 -16.47 63.65 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.311 0.577 . . . . 3.5 110.023 -171.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.703 ' HB2' HG11 ' A' ' 84' ' ' VAL . 1.7 t80 -165.5 104.61 0.75 Allowed Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.492 -0.777 . . . . 6.1200000000000001 112.074 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -88.72 145.18 5.58 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.324 2.683 . . . . 1.77 110.813 170.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -70.27 -166.74 0.21 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.419 2.079 . . . . 1.25 111.762 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.4 m -140.21 -169.75 2.82 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.987 -0.746 . . . . 1.6000000000000001 108.987 -174.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.9 t -79.45 -37.78 36.17 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 119.899 -0.72 . . . . 1.97 110.249 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -83.28 -17.64 41.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.086 0.469 . . . . 2.1800000000000002 110.387 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.485 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 85.9 m-85 -114.65 108.3 16.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.844 -0.616 . . . . 1.23 110.28 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.607 HG23 ' HG3' ' A' ' 109' ' ' ARG . 1.0 OUTLIER -95.39 106.76 18.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.089 -0.505 . . . . 0.81999999999999995 109.927 -178.267 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.629 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 35.1 ttm180 -50.16 105.37 0.09 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.977 -0.556 . . . . 4.4199999999999999 111.156 178.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.47 ' HA2' ' CZ ' ' A' ' 176' ' ' ARG . . . -64.32 112.72 5.23 Favored Glycine 0 N--CA 1.437 -1.281 0 CA-C-N 115.337 -0.847 . . . . 0.79000000000000004 111.887 176.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.783 ' HB2' ' HD3' ' A' ' 176' ' ' ARG . 0.2 OUTLIER -85.58 93.05 8.71 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.058 0.456 . . . . 4.4400000000000004 109.878 178.114 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.672 ' N ' ' HB3' ' A' ' 131' ' ' SER . 80.1 m-20 -88.86 81.64 6.9 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.579 -0.737 . . . . 1.6200000000000001 109.741 175.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.527 ' CD2' ' HD2' ' A' ' 150' ' ' PRO . 0.1 OUTLIER -47.85 123.37 9.74 Favored Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 115.141 -0.936 . . . . 2.3199999999999998 110.104 179.269 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.527 ' HD2' ' CD2' ' A' ' 149' ' ' HIS . 53.6 Cg_exo -14.31 67.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.223 1 C-N-CA 126.725 4.95 . . . . 0.53000000000000003 115.712 -161.693 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . 0.718 ' HB2' ' O ' ' A' ' 170' ' ' PHE . 24.5 p -123.86 145.82 48.83 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.005 -0.998 . . . . 1.5800000000000001 109.512 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 128' ' ' SER . . . -151.26 -134.16 2.13 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 119.012 -1.566 . . . . 0.42999999999999999 114.004 -175.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.532 ' CE1' HD21 ' A' ' 167' ' ' LEU . 33.0 t80 -161.59 80.71 0.58 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.644 -0.873 . . . . 0.59999999999999998 108.644 -157.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.767 HG23 HG13 ' A' ' 168' ' ' VAL . 12.6 m -91.66 135.53 26.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.647 0.737 . . . . 0.31 110.561 -174.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 58' ' ' PRO . 15.2 t -112.19 124.21 51.94 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.271 -0.877 . . . . 1.55 109.122 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.937 ' HB2' ' HB3' ' A' ' 166' ' ' LYS . 5.2 m -115.8 110.24 44.45 Favored Pre-proline 0 C--N 1.311 -1.072 0 C-N-CA 120.133 -0.627 . . . . 1.0600000000000001 111.656 -174.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.483 ' HD2' ' HA ' ' A' ' 156' ' ' SER . 1.1 Cg_endo -49.2 116.93 2.5 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.668 2.245 . . . . 0.56000000000000005 110.7 168.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.597 ' SD ' ' HB2' ' A' ' 166' ' ' LYS . 84.6 mmm -82.67 -167.23 1.54 Allowed 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.163 0.506 . . . . 1.1599999999999999 111.737 -173.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -75.66 -22.35 56.82 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.703 -0.68 . . . . 2.6299999999999999 109.677 172.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.6 ' HB2' ' HB2' ' A' ' 164' ' ' TYR . 43.8 mm-40 -104.42 27.56 7.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.829 -1.078 . . . . 2.0499999999999998 108.805 173.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.755 ' HB3' ' HD3' ' A' ' 162' ' ' PRO . 48.1 t-20 -8.27 -73.24 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 126.547 1.939 . . . . 1.9299999999999999 115.177 -176.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.755 ' HD3' ' HB3' ' A' ' 161' ' ' ASN . 73.0 Cg_endo -74.28 -13.49 23.15 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 121.312 1.342 . . . . 0.72999999999999998 114.137 -171.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 55' ' ' PRO . . . -108.64 -26.1 10.54 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.918 0.389 . . . . 0.68000000000000005 111.081 -176.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.6 ' HB2' ' HB2' ' A' ' 160' ' ' GLU . 89.4 m-85 -139.76 126.79 20.97 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.02 -0.537 . . . . 0.93000000000000005 109.579 178.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.832 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 13.1 p -124.43 147.07 48.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.05 0.452 . . . . 1.4099999999999999 111.228 -177.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.937 ' HB3' ' HB2' ' A' ' 156' ' ' SER . 1.6 tppp? -91.98 102.24 14.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.56 0.695 . . . . 0.73999999999999999 111.47 -177.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.532 HD21 ' CE1' ' A' ' 153' ' ' PHE . 0.8 OUTLIER -90.61 107.29 19.08 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.288 -0.869 . . . . 0.27000000000000002 109.396 175.827 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.767 HG13 HG23 ' A' ' 154' ' ' VAL . 0.1 OUTLIER -129.48 128.21 65.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.626 0.727 . . . . 0.28000000000000003 111.87 178.084 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.541 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 11.7 ttt -137.97 135.92 36.47 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 115.253 -0.885 . . . . 1.24 109.897 -172.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.751 ' CD1' HD21 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -126.91 151.11 48.88 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.231 -0.588 . . . . 3.3700000000000001 109.902 176.741 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.638 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 4.0 m -129.18 130.18 67.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-O 121.537 0.684 . . . . 1.3999999999999999 112.017 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.602 ' HG3' ' OG ' ' A' ' 40' ' ' SER . 22.8 tt0 -119.8 37.31 4.24 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.396 -1.705 . . . . 2.1699999999999999 106.396 170.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 6.7 m -52.21 131.75 32.88 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 113.27 -1.786 . . . . 1.6499999999999999 111.259 -174.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.574 ' CB ' ' HB3' ' A' ' 147' ' ' TYR . 0.4 OUTLIER -81.58 -28.01 34.01 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 112.029 0.381 . . . . 2.4500000000000002 112.029 -169.24 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.41 ' H ' HH21 ' A' ' 176' ' ' ARG . 17.4 mmt 44.38 62.77 1.89 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.308 0.575 . . . . 3.7400000000000002 111.652 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.783 ' HD3' ' HB2' ' A' ' 147' ' ' TYR . 0.0 OUTLIER -59.52 -37.13 77.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.124 -0.943 . . . . 5.7800000000000002 110.276 177.495 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -62.36 154.86 40.91 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.249 -0.741 . . . . 2.2599999999999998 111.249 175.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.24 97.09 6.8 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.112 0.482 . . . . 6.2300000000000004 111.794 -173.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.603 ' HB2' HD11 ' A' ' 184' ' ' ILE . 4.6 mp -105.96 165.19 11.38 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.991 -1.485 . . . . 1.6399999999999999 106.991 167.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.54 ' H ' ' CG1' ' A' ' 183' ' ' ILE . 44.0 m -112.46 162.35 21.95 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 108.332 -0.988 . . . . 2.04 108.332 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.428 ' O ' ' HG2' ' A' ' 185' ' ' GLU . 95.1 Cg_exo -43.3 -48.44 8.16 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.157 1.905 . . . . 1.74 111.892 178.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.1 m -67.51 -12.61 60.73 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.77 -0.65 . . . . 2.1400000000000001 112.51 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.718 HD12 ' HB3' ' A' ' 105' ' ' SER . 35.3 mm -91.37 -42.91 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.955 0 CA-C-O 122.228 1.013 . . . . 1.1200000000000001 108.77 -178.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 1.03 ' HA ' HG22 ' A' ' 187' ' ' THR . 1.6 mp -66.66 -31.69 54.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 113.269 -1.787 . . . . 1.1299999999999999 110.437 178.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 181' ' ' PRO . 7.5 mm-40 -65.46 -28.91 69.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.102 -0.954 . . . . 2.8900000000000001 108.733 175.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 1.114 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 2.7 ptpt -93.08 -26.29 17.53 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.719 -1.128 . . . . 1.28 110.852 178.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 1.03 HG22 ' HA ' ' A' ' 184' ' ' ILE . 6.2 t -78.34 -44.33 25.41 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 119.996 -0.682 . . . . 0.62 112.01 -176.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . 0.948 ' HB2' ' HD3' ' A' ' 189' ' ' PRO . 2.5 mmt -80.15 -68.63 0.21 Allowed Pre-proline 0 N--CA 1.455 -0.194 0 C-N-CA 120.058 -0.657 . . . . 1.0600000000000001 110.756 -173.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.948 ' HD3' ' HB2' ' A' ' 188' ' ' MET . 36.7 Cg_exo -60.6 -15.57 37.58 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 122.66 2.24 . . . . 0.91000000000000003 113.184 -171.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 33.3 t -86.07 -45.27 11.56 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.734 -0.469 . . . . 1.5 109.734 175.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.684 ' HA ' ' HB2' ' A' ' 194' ' ' ASN . 6.5 t30 -85.17 -21.6 29.13 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.598 -0.441 . . . . 1.8799999999999999 112.187 -167.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.925 HD13 HG11 ' A' ' 35' ' ' VAL . 2.4 mt -60.26 -51.97 67.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.872 0.844 . . . . 1.0900000000000001 109.844 173.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.543 ' HB ' ' CD1' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -72.12 -32.32 42.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 114.594 -1.184 . . . . 0.68000000000000005 109.781 -178.011 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.684 ' HB2' ' HA ' ' A' ' 191' ' ' ASN . 0.9 OUTLIER -72.24 -30.54 64.98 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.646 -1.161 . . . . 2.0699999999999998 111.721 -179.327 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -70.58 -29.12 65.46 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.516 -0.474 . . . . 2.0 109.918 173.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.527 HG21 HG21 ' A' ' 33' ' ' ILE . 39.1 mt -76.18 -26.54 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-O 121.315 0.579 . . . . 0.31 110.375 173.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 194' ' ' ASN . 55.3 mt -70.0 -42.74 72.63 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 116.126 -0.488 . . . . 1.03 109.947 173.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.858 ' HB3' ' HZ3' ' A' ' 74' ' ' TRP . 91.2 m-20 -50.53 -33.21 20.74 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.983 -1.008 . . . . 1.8999999999999999 109.846 168.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.658 ' HA ' ' CE2' ' A' ' 64' ' ' PHE . . . -80.52 -40.51 25.91 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 116.229 -0.441 . . . . 0.28999999999999998 111.099 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.663 ' HD3' HG12 ' A' ' 54' ' ' ILE . 25.7 mmtm -60.05 -42.05 93.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.559 0.695 . . . . 0.96999999999999997 110.094 176.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -84.51 -43.54 14.46 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.968 -1.015 . . . . 1.9399999999999999 110.689 -176.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -65.01 -30.91 79.25 Favored Glycine 0 C--O 1.228 -0.235 0 C-N-CA 120.661 -0.78 . . . . 0.46999999999999997 111.833 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 1.009 HD13 HD23 ' A' ' 61' ' ' LEU . 3.3 tp -70.53 -39.03 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 123.005 -0.115 . . . . 0.60999999999999999 110.771 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.539 ' O ' HG22 ' A' ' 208' ' ' THR . 41.4 pttt -83.98 -28.42 27.77 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.524 -0.547 . . . . 3.3700000000000001 109.524 -178.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -63.95 -33.59 76.06 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.374 -0.83 . . . . 1.02 109.356 170.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -93.56 -2.09 54.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.267 -0.879 . . . . 3.6299999999999999 112.023 175.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.589 ' HB2' ' O ' ' A' ' 203' ' ' ILE . 2.1 tmt_? -103.05 -54.45 2.62 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.814 -0.439 . . . . 2.5899999999999999 109.814 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.539 HG22 ' O ' ' A' ' 204' ' ' LYS . 7.4 t -101.4 148.79 35.68 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 108.64 -0.874 . . . . 1.8400000000000001 108.64 176.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.432 ' HD2' ' OG1' ' A' ' 208' ' ' THR . 45.6 Cg_endo -69.57 46.71 0.49 Allowed 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.577 2.185 . . . . 2.3500000000000001 113.109 178.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 89.4 p -78.88 -17.52 55.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.355 0.598 . . . . 2.3100000000000001 109.684 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.81 ' HA ' ' HB2' ' A' ' 214' ' ' PHE . 5.5 mmm180 -71.77 -14.57 62.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.433 -0.803 . . . . 5.4500000000000002 111.001 175.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -63.07 -45.08 93.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.602 -0.518 . . . . 6.8600000000000003 109.602 175.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -103.62 34.88 5.42 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 111.402 -0.679 . . . . 3.3700000000000001 111.402 176.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.81 ' HB2' ' HA ' ' A' ' 211' ' ' ARG . 78.8 t80 -91.02 141.45 28.82 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.235 -0.283 . . . . 5.21 110.235 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -66.58 88.24 0.13 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.729 -0.471 . . . . 6.46 109.729 174.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 28.4 p-80 -88.66 106.29 18.24 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.312 0.577 . . . . 6.0899999999999999 110.884 -176.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -77.77 119.6 21.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.43 -0.804 . . . . 5.1200000000000001 110.592 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.0 p -86.74 -48.83 7.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.896 -0.593 . . . . 6.7599999999999998 111.464 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -147.38 134.96 20.94 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.957 -0.386 . . . . 8.8200000000000003 109.957 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 18.8 m . . . . . 0 C--O 1.252 1.196 0 O-C-N 123.627 0.579 . . . . 8.4800000000000004 111.474 179.048 . . . . . . . . 0 0 . 1 stop_ save_